PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Martin, J; Sykes, S; Young, S; Kota, K; Sanka, R; Sheth, N; Orvis, J; Sodergren, E; Wang, ZY; Weinstock, GM; Mitreva, M				Martin, John; Sykes, Sean; Young, Sarah; Kota, Karthik; Sanka, Ravi; Sheth, Nihar; Orvis, Joshua; Sodergren, Erica; Wang, Zhengyuan; Weinstock, George M.; Mitreva, Makedonka			Optimizing Read Mapping to Reference Genomes to Determine Composition and Species Prevalence in Microbial Communities	PLOS ONE			English	Article							SEQUENCE; ALIGNMENT	The Human Microbiome Project (HMP) aims to characterize the microbial communities of 18 body sites from healthy individuals. To accomplish this, the HMP generated two types of shotgun data: reference shotgun sequences isolated from different anatomical sites on the human body and shotgun metagenomic sequences from the microbial communities of each site. The alignment strategy for characterizing these metagenomic communities using available reference sequence is important to the success of HMP data analysis. Six next-generation aligners were used to align a community of known composition against a database comprising reference organisms known to be present in that community. All aligners report nearly complete genome coverage (>97%) for strains with over 6X depth of coverage, however they differ in speed, memory requirement and ease of use issues such as database size limitations and supported mapping strategies. The selected aligner was tested across a range of parameters to maximize sensitivity while maintaining a low false positive rate. We found that constraining alignment length had more impact on sensitivity than does constraining similarity in all cases tested. However, when reference species were replaced with phylogenetic neighbors, similarity begins to play a larger role in detection. We also show that choosing the top hit randomly when multiple, equally strong mappings are available increases overall sensitivity at the expense of taxonomic resolution. The results of this study identified a strategy that was used to map over 3 tera-bases of microbial sequence against a database of more than 5,000 reference genomes in just over a month.	[Martin, John; Kota, Karthik; Sodergren, Erica; Wang, Zhengyuan; Weinstock, George M.; Mitreva, Makedonka] Washington Univ, Sch Med, Genome Inst, St Louis, MO 63130 USA; [Sykes, Sean; Young, Sarah] MIT & Harvard, Broad Inst, Cambridge, MA USA; [Sanka, Ravi] J Craig Venter Inst, Rockville, MD USA; [Sheth, Nihar] Virginia Commonwealth Univ, Ctr Study Biol Complex, Richmond, VA USA; [Orvis, Joshua] Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 21201 USA; [Sodergren, Erica; Weinstock, George M.; Mitreva, Makedonka] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA	Washington University (WUSTL); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; J. Craig Venter Institute; Virginia Commonwealth University; University System of Maryland; University of Maryland Baltimore; Washington University (WUSTL)	Martin, J (corresponding author), Washington Univ, Sch Med, Genome Inst, St Louis, MO 63130 USA.	mmitreva@watson.wustl.edu	Wang, Zhengyuan/GWV-6069-2022; wang, zhengyuan/HGA-0435-2022; Weinstock, George M/C-6314-2013	wang, zhengyuan/0000-0002-8447-9674; Weinstock, George M/0000-0002-2997-4592; Sykes, Sean/0000-0001-8344-5176; Mitreva, Makedonka/0000-0001-9572-3436	National Institutes of Health (NIH) [NIH-NHGRI U54HG003079, U54HG004968];  [U54HG004969];  [U54AI084844];  [NIH-NIAID UH3AI083263]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004969, U54HG004968, U54HG003079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI084844, UH3AI083263] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; ; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Research at Washington University was supported by National Institutes of Health (NIH) grants NIH-NHGRI U54HG003079 and U54HG004968, at the Broad Institute by grant U54HG004969, at the J. Craig Venter Institute U54AI084844 and research at Virginia Commonwealth University was supported by grant NIH-NIAID UH3AI083263. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajdic D, 2002, P NATL ACAD SCI USA, V99, P14434, DOI 10.1073/pnas.172501299; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; DeSantis TZ, 2006, NUCLEIC ACIDS RES, V34, pW394, DOI 10.1093/nar/gkl244; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; HANCOCK JM, 1994, COMPUT APPL BIOSCI, V10, P67; Handelsman J, 2004, MICROBIOL MOL BIOL R, V68, P669, DOI 10.1128/MMBR.68.4.669-685.2004; Kumar Y, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-240; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li H, 2010, BRIEF BIOINFORM, V11, P473, DOI 10.1093/bib/bbq015; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Makarova KS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000955; Medini D, 2005, CURR OPIN GENET DEV, V15, P589, DOI 10.1016/j.gde.2005.09.006; Peterson J, 2009, GENOME RES, V19, P2317, DOI 10.1101/gr.096651.109; Rasko DA, 2004, NUCLEIC ACIDS RES, V32, P977, DOI 10.1093/nar/gkh258; Reumers J, 2012, NAT BIOTECHNOL, V30, P61, DOI 10.1038/nbt.2053; Riesenfeld CS, 2004, ENVIRON MICROBIOL, V6, P981, DOI 10.1111/j.1462-2920.2004.00664.x; Schloss PD, 2011, APPL ENVIRON MICROB, V77, P3219, DOI 10.1128/AEM.02810-10; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; Tettelin H, 2002, P NATL ACAD SCI USA, V99, P12391, DOI 10.1073/pnas.182380799; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; White O, 1999, SCIENCE, V286, P1571, DOI 10.1126/science.286.5444.1571	24	36	36	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e36427	10.1371/journal.pone.0036427	http://dx.doi.org/10.1371/journal.pone.0036427			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22719831	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000305341900009
J	Fineberg, SK; Datta, P; Stein, CS; Davidson, BL				Fineberg, Sarah K.; Datta, Poppy; Stein, Colleen S.; Davidson, Beverly L.			MiR-34a Represses Numbl in Murine Neural Progenitor Cells and Antagonizes Neuronal Differentiation	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; TUMOR-SUPPRESSOR NETWORK; MICRORNA EXPRESSION; STEM-CELLS; MIRNA EXPRESSION; GENE-EXPRESSION; MOUSE; NOTCH; P53; APOPTOSIS	MicroRNA (miRNA) function is required for normal animal development, in particular in differentiation pathways from stem cell and precursor populations. In neurogenesis, it is becoming increasingly appreciated that miRNAs act at many stages to ensure proper progression. In this study we examined the role of miR-34a in neural progenitor cells (NPC) derived from murine embryonic cortex. We found that over-expression of miR-34a in NPC significantly reduced the neuron yield upon in vitro induction of differentiation. MiR-34a has several predicted targets in the Notch pathway, which operates to balance progenitor self-renewal and differentiation during cortical neurogenesis. We tested several Notch pathway players for regulation by miR-34a in undifferentiated NPC, and found that mRNA and protein levels of Numbl, a negative regulator of Notch signaling, as well as two downstream pro-neural genes usually blocked by Notch signaling, NeuroD1 and Mash1, were diminished, while Notch1 and Cbf1 transcripts were enhanced by miR-34a over-expression. Using a luciferase reporter assay, we verified the Numbl 3'-UTR as a direct miR-34a target. Correspondingly, knock-down of endogenous miR-34a resulted in increased Numbl, NeuroD1 and Mash1, and reduced Notch1 transcript levels. Together these results implicate Numbl as a physiologically relevant target of miR-34a in NPC, allowing for enhanced Notch signaling and inhibition of neuronal differentiation. This work extends our understanding of miR-34a-mediated control of cell differentiation from cancer to mammalian nervous system development.	[Fineberg, Sarah K.; Stein, Colleen S.; Davidson, Beverly L.] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; [Datta, Poppy; Davidson, Beverly L.] Univ Iowa, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA; [Davidson, Beverly L.] Univ Iowa, Deparment Neurol, Iowa City, IA 52242 USA; [Fineberg, Sarah K.] Univ Iowa, Med Scientist Training Program, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa	Fineberg, SK (corresponding author), Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA.	beverly-davidson@uiowa.edu	Datta, Poppy/AAE-9178-2020; Fineberg, Sarah/X-1060-2019	Fineberg, Sarah/0000-0001-6024-6721; Datta, Poppy/0000-0003-4989-0975; Davidson, Beverly/0000-0002-3715-6290	March of Dimes; Roy J. Carver Trust;  [DA025132]; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA025132] Funding Source: NIH RePORTER	March of Dimes(March of Dimes); Roy J. Carver Trust; ; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Support by the March of Dimes, the Roy J. Carver Trust (BLD) and DA025132. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alimirah F, 2007, NEOPLASIA, V9, P427, DOI 10.1593/neo.07211; Aranha MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021396; Aranha MM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-514; Ason B, 2006, P NATL ACAD SCI USA, V103, P14385, DOI 10.1073/pnas.0603529103; Bak M, 2008, RNA, V14, P432, DOI 10.1261/rna.783108; Bian S, 2011, MOL NEUROBIOL; Bolos V, 2007, ENDOCR REV, V28, P339, DOI 10.1210/er.2006-0046; Bommer GT, 2007, CURR BIOL, V17, P1298, DOI 10.1016/j.cub.2007.06.068; Cao XW, 2007, GENE DEV, V21, P531, DOI 10.1101/gad.1519207; Caviness VS, 2009, TRENDS NEUROSCI, V32, P443, DOI 10.1016/j.tins.2009.05.003; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Chapman G, 2006, J CELL BIOL, V175, P535, DOI 10.1083/jcb.200602009; Choi PS, 2008, NEURON, V57, P41, DOI 10.1016/j.neuron.2007.11.018; Colaluca IN, 2008, NATURE, V451, P76, DOI 10.1038/nature06412; Dehay C, 2007, NAT REV NEUROSCI, V8, P438, DOI 10.1038/nrn2097; Fineberg SK, 2009, NEURON, V64, P303, DOI 10.1016/j.neuron.2009.10.020; Furukawa T, 2000, NEURON, V26, P383, DOI 10.1016/S0896-6273(00)81171-X; Gaiano N, 2002, ANNU REV NEUROSCI, V25, P471, DOI 10.1146/annurev.neuro.25.030702.130823; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Guessous F, 2010, CELL CYCLE, V9, P1031, DOI 10.4161/cc.9.6.10987; Harper SQ, 2006, J VIROL, V80, P9371, DOI 10.1128/JVI.00958-06; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; He XY, 2007, CANCER RES, V67, P11099, DOI 10.1158/0008-5472.CAN-07-2672; Hebert SS, 2010, HUM MOL GENET, V19, P3959, DOI 10.1093/hmg/ddq311; Hermeking H, 2010, CELL DEATH DIFFER, V17, P193, DOI 10.1038/cdd.2009.56; Hohjoh H, 2007, GENE, V391, P39, DOI 10.1016/j.gene.2006.11.018; Kageyama R, 2005, EXP CELL RES, V306, P343, DOI 10.1016/j.yexcr.2005.03.015; Li XK, 2010, NAT REV NEUROSCI, V11, P329, DOI 10.1038/nrn2739; Li YQ, 2009, CANCER RES, V69, P7569, DOI 10.1158/0008-5472.CAN-09-0529; Liu CM, 2010, CELL STEM CELL, V6, P433, DOI 10.1016/j.stem.2010.02.017; Liu LN, 2011, BIOCHEM BIOPH RES CO, V413, P426, DOI 10.1016/j.bbrc.2011.08.108; Menon SG, 2003, CANCER RES, V63, P2109; Mineno J, 2006, NUCLEIC ACIDS RES, V34, P1765, DOI 10.1093/nar/gkl096; Olsen L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007225; Pang RTK, 2010, CARCINOGENESIS, V31, P1037, DOI 10.1093/carcin/bgq066; Petersen PH, 2006, DEV NEUROSCI-BASEL, V28, P156, DOI 10.1159/000090761; Sayed D, 2011, PHYSIOL REV, V91, P827, DOI 10.1152/physrev.00006.2010; Schaefer A, 2007, J EXP MED, V204, P1553, DOI 10.1084/jem.20070823; Shen Q, 2002, DEVELOPMENT, V129, P4843; Smirnova L, 2005, EUR J NEUROSCI, V21, P1469, DOI 10.1111/j.1460-9568.2005.03978.x; Thatcher EJ, 2007, DEV DYNAM, V236, P2172, DOI 10.1002/dvdy.21211; Thomson JM, 2004, NAT METHODS, V1, P47, DOI 10.1038/NMETH704; Tivnan A, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-33; Tonelli DD, 2008, DEVELOPMENT, V135, P3911, DOI 10.1242/dev.025080; Visvanathan J, 2007, GENE DEV, V21, P744, DOI 10.1101/gad.1519107; Welch C, 2007, ONCOGENE, V26, P5017, DOI 10.1038/sj.onc.1210293; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Xu SB, 2007, J BIOL CHEM, V282, P25053, DOI 10.1074/jbc.M700501200; Yi R, 2011, J CELL SCI, V124, P1775, DOI 10.1242/jcs.069104; Yoon K, 2005, NAT NEUROSCI, V8, P709, DOI 10.1038/nn1475; Zhong WM, 1997, DEVELOPMENT, V124, P1887	51	48	50	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2012	7	6							e38562	10.1371/journal.pone.0038562	http://dx.doi.org/10.1371/journal.pone.0038562			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TU	22701667	Green Published, gold, Green Submitted			2022-12-27	WOS:000305337600030
J	Kostering, L; McKinlay, A; Stahl, C; Kaller, CP				Koestering, Lena; McKinlay, Audrey; Stahl, Christoph; Kaller, Christoph P.			Differential Patterns of Planning Impairments in Parkinson's Disease and Sub-Clinical Signs of Dementia? A Latent-Class Model-Based Approach	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; EXECUTIVE FUNCTION DEFICITS; DOPAMINERGIC MODULATION; PREFRONTAL CORTEX; TOWER; PROGRESSION; HYPOTHESIS; IMPACT	Planning impairments mark a well-documented consequence of neurodegenerative diseases such as Parkinson's disease (PD). Recently, using the Tower of London task we demonstrated that, rather than being generally impaired, PD patients selectively fail when planning requires flexible in-breadth search strategies. For a better understanding of the interindividual patterns underlying specific planning impairments, here we performed an explorative re-analysis of the original data using a latent-class model-based approach. Data-driven classification according to subjects' performance was based on a multinomial processing tree (MPT) model accommodating the impact of increased breadth versus depth of looking ahead during planning. In order to assess interindividual variability in coping with these different task demands, an extension of MPT models was used in which sample-immanent heterogeneity is accounted for by identifying different latent classes of individuals. Two latent classes were identified that differed considerably in performance for problems placing high demands on the depth of anticipatory search processes. In addition, these impairments were independent of PD diagnosis. However, latent-class mediated search depth-related deficits in planning performance were associated with poorer outcomes in dementia screenings, albeit sub-clinical. PD patients exhibited additional deficits related to the breadth of searching ahead. Taken together, results revealed dissociable impairments in specific planning processes within a single task of visuospatial problem solving. Present analyses put forward the hypothesis that cognitive sequelae of PD and sub-clinical signs of dementia may be related to differential patterns of planning impairments.	[Koestering, Lena; Kaller, Christoph P.] Univ Freiburg, Dept Neurol, Univ Med Ctr, Freiburg, Germany; [Koestering, Lena; Kaller, Christoph P.] Univ Freiburg, Freiburg Brain Imaging Ctr, D-79106 Freiburg, Germany; [McKinlay, Audrey] Univ Canterbury, Dept Psychol, Christchurch 1, New Zealand; [McKinlay, Audrey] Monash Univ, Sch Psychol & Psychiat, Melbourne, Vic 3004, Australia; [Stahl, Christoph] Univ Cologne, Dept Psychol, D-50931 Cologne, Germany	University of Freiburg; University of Freiburg; University of Canterbury; Monash University; University of Cologne	Kostering, L (corresponding author), Univ Freiburg, Dept Neurol, Univ Med Ctr, Freiburg, Germany.	christoph.kaller@uniklinik-freiburg.de		McKinlay, Audrey/0000-0001-9846-8514; Kaller, Christoph/0000-0003-1206-889X; Stahl, Christoph/0000-0002-9033-894X; Schumacher, Lena/0000-0003-3785-9866	German Federal Ministry of Education and Research (BMBF) [01GW0710, 01GW0730]	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	Christoph Kaller and Christoph Stahl were supported by grants of the German Federal Ministry of Education and Research (BMBF, grant numbers 01GW0710, 01GW0730). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batchelder WH, 1999, PSYCHON B REV, V6, P57, DOI 10.3758/BF03210812; Beck AT, 1995, BECK DEPRESSION 2 MA; Bilder RM, 2004, NEUROPSYCHOPHARMACOL, V29, P1943, DOI 10.1038/sj.npp.1300542; Carlin D, 2000, NEUROPSYCHOLOGIA, V38, P655, DOI 10.1016/S0028-3932(99)00102-5; Caviness JN, 2007, MOVEMENT DISORD, V22, P1272, DOI 10.1002/mds.21453; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cools R, 2001, CEREB CORTEX, V11, P1136, DOI 10.1093/cercor/11.12.1136; Cools R, 2002, BRAIN, V125, P584, DOI 10.1093/brain/awf052; Cools R, 2006, NEUROSCI BIOBEHAV R, V30, P1, DOI 10.1016/j.neubiorev.2005.03.024; Cools R, 2008, NEUROSCIENTIST, V14, P381, DOI 10.1177/1073858408317009; Culbertson WC, 2004, ASSESSMENT, V11, P27, DOI 10.1177/1073191103258590; Dagher A, 2001, BRAIN, V124, P1020, DOI 10.1093/brain/124.5.1020; Duke LM, 2000, NEUROPSYCHOL REV, V10, P75, DOI 10.1023/A:1009096603879; Erdfelder E, 2009, Z PSYCHOL, V217, P108, DOI 10.1027/0044-3409.217.3.108; Fahn S., 1987, UNIFIED PARKINSONS D; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Franceschi M, 2007, DEMENT GERIATR COGN, V24, P424, DOI 10.1159/000109827; Franceschi M, 2011, BEHAV NEUROL, V24, P149, DOI [10.3233/BEN-2011-0327, 10.1155/2011/754659]; GERMAN DC, 1989, ANN NEUROL, V26, P507, DOI 10.1002/ana.410260403; GRACE AA, 1991, NEUROSCIENCE, V41, P1, DOI 10.1016/0306-4522(91)90196-U; Hodgson TL, 2002, NEUROPSYCHOLOGIA, V40, P411, DOI 10.1016/S0028-3932(01)00099-9; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Janvin CC, 2006, MOVEMENT DISORD, V21, P1343, DOI 10.1002/mds.20974; Jurica P.J., 2001, DRS 2 DEMENTIA RATIN; Kaller CP, 2011, CEREB CORTEX, V21, P307, DOI 10.1093/cercor/bhq096; Kaller CP, 2011, BEHAV BRAIN RES, V216, P1, DOI 10.1016/j.bbr.2010.07.029; Kaller CP, 2004, COGNITIVE BRAIN RES, V20, P462, DOI 10.1016/j.cogbrainres.2004.04.002; Kaller CP, 2012, HUMAN BRAIN IN PRESS; Klauer KC, 2006, PSYCHOMETRIKA, V71, P7, DOI 10.1007/s11336-004-1188-3; Marchegiani A, 2010, AGING MENT HEALTH, V14, P155, DOI 10.1080/13607860903228804; McKinlay A, 2008, NEUROPSYCHOLOGIA, V46, P384, DOI 10.1016/j.neuropsychologia.2007.08.018; McKinlay A, 2009, DEMENT GERIATR COGN, V28, P121, DOI 10.1159/000235247; MORRIS RG, 1988, J NEUROL NEUROSUR PS, V51, P757, DOI 10.1136/jnnp.51.6.757; Nelson H., 1991, NATL ADULT READING T; Owen AM, 2004, NEUROSCIENTIST, V10, P525, DOI 10.1177/1073858404266776; OWEN AM, 1992, BRAIN, V115, P1727, DOI 10.1093/brain/115.6.1727; Rainville C, 2002, ARCH CLIN NEUROPSYCH, V17, P513, DOI 10.1016/S0887-6177(01)00132-9; RINNE JO, 1989, ANN NEUROL, V26, P47, DOI 10.1002/ana.410260107; Royall DR, 1998, J NEUROL NEUROSUR PS, V64, P588, DOI 10.1136/jnnp.64.5.588; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; Stahl C, 2007, BEHAV RES METHODS, V39, P267, DOI 10.3758/BF03193157; Ward G, 2005, CURR ISS THINK REASO, P1; Weintraub D, 2011, ARCH NEUROL-CHICAGO, V68, P1562, DOI 10.1001/archneurol.2011.725; WHITEHOUSE PJ, 1993, CLIN NEUROPSYCHOLOGY, P603; Winer B. J., 1962, STAT PRINCIPLES EXPT, DOI [10.1037/11774-000, DOI 10.1037/11774-000]	45	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2012	7	6							e38855	10.1371/journal.pone.0038855	http://dx.doi.org/10.1371/journal.pone.0038855			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TQ	22715417	Green Published, gold			2022-12-27	WOS:000305336800059
J	Nozza, S; Pogliaghi, M; Chiappetta, S; Spagnuolo, V; Fontana, G; Razzari, C; Tambussi, G; Faioni, EM				Nozza, Silvia; Pogliaghi, Manuela; Chiappetta, Stefania; Spagnuolo, Vincenzo; Fontana, Gessica; Razzari, Cristina; Tambussi, Giuseppe; Faioni, Elena Maria			Levels of Soluble Endothelial Protein C Receptor Are Associated with CD4(+) Changes in Maraviroc-Treated HIV-Infected Patients	PLOS ONE			English	Article							THROMBOMODULIN; INFLAMMATION; RISK	Background: Inflammation is a key feature of HIV infection and is correlated with long-term negative cardiovascular outcomes. Therapy-induced increases in CD4(+) cell counts can control inflammation, as shown by decreases of coagulation and inflammation markers during efficacious therapy. Maraviroc, a CCR5-antagonist, has resulted in larger increases in CD4(+) counts both in naive and experienced subjects compared to traditional antiretroviral therapy. Objectives and Methods: To examine if a member of the protein C anticoagulant and anti-inflammatory pathway, and marker of coagulation and inflammation, the soluble endothelial protein C receptor, is modified by infection and therapy-related variables in patients treated with Maraviroc. Endothelial protein C receptor, together with other established markers of inflammation and coagulation (CRP, IL-6, D-dimer and soluble thrombomodulin) was studied in 43 patients on traditional antiretroviral therapy and in 45 on Maraviroc during 48 weeks of follow-up. Results: Soluble endothelial protein C receptor was the only marker that could discriminate at least partially between patients with a good response to Maraviroc and patients who did not respond with an adequate increase in CD4(+) cell counts (more than 500 cells/mu L by week 48). Conclusions: Elevated levels of soluble endothelial protein C receptor, a sensitive marker of endothelial damage, indicated a low level of inflammation and coagulation activation in Maraviroc treated patients not picked up by other widely used markers. Persistent elevated levels of this marker at 48 weeks from beginning of treatment with Maraviroc were related to a poor increase in CD4(+) cells.	[Nozza, Silvia; Pogliaghi, Manuela; Chiappetta, Stefania; Spagnuolo, Vincenzo; Tambussi, Giuseppe] Ist Sci San Raffaele, Div Immunol Transplant & Infect Dis, Dept Infect & Trop Dis, I-20132 Milan, Italy; [Fontana, Gessica; Razzari, Cristina; Faioni, Elena Maria] Univ Milano & Med, Dipartimento Med Chirurgia & Odontoiatria, Milan, Italy; Azienda Osped San Paolo Polo Univ, Milan, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Nozza, S (corresponding author), Ist Sci San Raffaele, Div Immunol Transplant & Infect Dis, Dept Infect & Trop Dis, I-20132 Milan, Italy.	silvia.nozza@hsr.it	NOZZA, SILVIA/AAC-5445-2022; Chiappetta, Stefania/E-8874-2013	Chiappetta, Stefania/0000-0002-8304-4927; Tambussi, Giuseppe/0000-0002-0604-2960; Spagnuolo, Vincenzo/0000-0002-9656-7217; Nozza, Silvia/0000-0002-2673-2731; FAIONI, ELENA MARIA/0000-0001-8731-6531	European Union; NEAT [LSHP-CT-2006-037570]; AIDS Program, Italian Ministry of Health [40H34]; ViiV Healthcare	European Union(European Commission); NEAT; AIDS Program, Italian Ministry of Health; ViiV Healthcare	The study was supported by a grant under the European Union 6th Framework Programme, contract Acronim: NEAT, Number: LSHP-CT-2006-037570 and a grant under the AIDS Program, Italian Ministry of Health: Grant Number 40H34. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: Silvia Nozza and Giuseppe Tambussi have received travel grants and consultancy fees from ViiV Healthcare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Calmy A, 2009, AIDS, V23, P929, DOI 10.1097/QAD.0b013e32832995fa; Cooper DA, 2010, J INFECT DIS, V201, P803, DOI 10.1086/650697; Esmon CT, 2006, SEMIN THROMB HEMOST, V32, P49, DOI 10.1055/s-2006-939554; Esmon CT, 1999, HAEMATOLOGICA, V84, P363; Faioni EM, 2004, CRIT CARE MED, V32, pS266, DOI 10.1097/01.CCM.0000128032.85396.83; Funderburg N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013188; Gu JM, 2000, BLOOD, V95, P1687, DOI 10.1182/blood.V95.5.1687.005k08_1687_1693; Gulick RM, 2008, NEW ENGL J MED, V359, P1429, DOI 10.1056/NEJMoa0803152; Ho JE, 2009, HEART, V95, P1193, DOI 10.1136/hrt.2008.161463; Ireland H, 2005, ATHEROSCLEROSIS, V183, P283, DOI 10.1016/j.atherosclerosis.2005.02.028; Kaplan RC, 2008, AIDS, V22, P1615, DOI 10.1097/QAD.0b013e328300581d; Kline ER, 2008, AM J PHYSIOL-HEART C, V294, pH2792, DOI 10.1152/ajpheart.91447.2007; Kuller LH, 2008, PLOS MED, V5, P1496, DOI 10.1371/journal.pmed.0050203; Kurosawa S, 1998, BLOOD, V91, P725, DOI 10.1182/blood.V91.2.725; MacInnes A, 2011, HIV CLIN TRIALS, V12, P24, DOI 10.1310/hct1201-24; Montes R, 2005, J THROMB HAEMOST, V3, P1454, DOI 10.1111/j.1538-7836.2005.01297.x; Neuhaus J, 2010, J INFECT DIS, V201, P1788, DOI 10.1086/652749; Nixon DE, 2010, CURR OPIN HIV AIDS, V5, P498, DOI 10.1097/COH.0b013e32833ed6f4; Solages A, 2006, CLIN INFECT DIS, V42, P1325, DOI 10.1086/503261; Wilkin T, 2010, 17 C RETR OPP INF SA	20	7	7	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2012	7	6							e37032	10.1371/journal.pone.0037032	http://dx.doi.org/10.1371/journal.pone.0037032			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TQ	22715361	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336800002
J	Cuevas-Ramos, D; Almeda-Valdes, P; Meza-Arana, CE; Brito-Cordova, G; Gomez-Perez, FJ; Mehta, R; Oseguera-Moguel, J; Aguilar-Salinas, CA				Cuevas-Ramos, Daniel; Almeda-Valdes, Paloma; Elena Meza-Arana, Clara; Brito-Cordova, Griselda; Gomez-Perez, Francisco J.; Mehta, Roopa; Oseguera-Moguel, Jorge; Aguilar-Salinas, Carlos A.			Exercise Increases Serum Fibroblast Growth Factor 21 (FGF21) Levels	PLOS ONE			English	Article							FATTY-ACID-METABOLISM; PPAR-ALPHA; PHYSICAL-ACTIVITY; LIPID MOBILIZATION; LIPOLYSIS; INSULIN; REGULATOR; GLUCOSE; FIBROBLAST-GROWTH-FACTOR-21; PGC-1-ALPHA	Background: Fibroblast growth factor 21 (FGF21) increases glucose uptake. It is unknown if FGF21 serum levels are affected by exercise. Methodology/Principal Findings: This was a comparative longitudinal study. Anthropometric and biochemical evaluation were carried out before and after a bout of exercise and repeated after two weeks of daily supervised exercise. The study sample was composed of 60 sedentary young healthy women. The mean age was 24 +/- 3.7 years old, and the mean BMI was 21.4 +/- 7.0 kg/m(2). The anthropometric characteristics did not change after two weeks of exercise. FGF21 levels significantly increased after two weeks of exercise (276.8 ng/l (142.8-568.6) vs. (460.8 (298.2-742.1), p<0.0001)). The delta (final-basal) log of serum FGF21, adjusted for BMI, showed a significant positive correlation with basal glucose (r = 0.23, p = 0.04), mean maximal heart rate (MHR) (r = 0.54, p<0.0001), mean METs (r = 0.40, p = 0.002), delta plasma epinephrine (r = 0.53, p<0.0001) and delta plasma FFAs (r = 0.35, p = 0.006). A stepwise linear regression model showed that glucose, MHR, METs, FFAs, and epinephrine, were factors independently associated with the increment in FGF21 after the exercise program (F = 4.32; r(2) = 0.64, p<0.0001). Conclusions: Serum FGF21 levels significantly increased after two weeks of physical activity. This increment correlated positively with clinical parameters related to the adrenergic and lipolytic response to exercise.	[Cuevas-Ramos, Daniel; Almeda-Valdes, Paloma; Brito-Cordova, Griselda; Gomez-Perez, Francisco J.; Mehta, Roopa; Aguilar-Salinas, Carlos A.] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Endocrinol & Metab, Mexico City, DF, Mexico; [Elena Meza-Arana, Clara] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Internal Med, Mexico City, DF, Mexico	Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico	Cuevas-Ramos, D (corresponding author), Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Endocrinol & Metab, Mexico City, DF, Mexico.	caguilarsalinas@yahoo.com	Almeda-Valdes, Paloma/AAJ-8023-2020; Salinas, Carlos A Aguilar/AAL-4491-2020; Mehta, Roopa/AAI-7458-2021	Almeda-Valdes, Paloma/0000-0002-9701-5879; 	Comite Nacional de Ciencia y Tecnologia (CONACYT)	Comite Nacional de Ciencia y Tecnologia (CONACYT)	This work was supported by the Comite Nacional de Ciencia y Tecnologia (CONACYT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arner P, 2008, FEBS LETT, V582, P1725, DOI 10.1016/j.febslet.2008.04.038; Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Chavez AO, 2009, DIABETES CARE, V32, P1542, DOI 10.2337/dc09-0684; Chen W, 2011, J BIOL CHEM, V286, P34559, DOI 10.1074/jbc.M111.285965; Coskun T, 2008, ENDOCRINOLOGY, V149, P6018, DOI 10.1210/en.2008-0816; Cuevas-Ramos D, 2010, EUR J ENDOCRINOL, V163, P469, DOI 10.1530/EJE-10-0454; de Glisezinski I, 2009, J PHYSIOL-LONDON, V587, P3393, DOI 10.1113/jphysiol.2009.168906; Galman C, 2008, CELL METAB, V8, P169, DOI 10.1016/j.cmet.2008.06.014; Henderson GC, 2007, J PHYSIOL-LONDON, V584, P963, DOI 10.1113/jphysiol.2007.137331; Hill J, 2002, BRIT MED J, V324, P1084, DOI 10.1136/bmj.324.7345.1084; Hojman P, 2009, DIABETES, V58, P2797, DOI 10.2337/db09-0713; Hom GJ, 2001, J PHARMACOL EXP THER, V297, P299; Horton TJ, 2009, J APPL PHYSIOL, V107, P200, DOI 10.1152/japplphysiol.90812.2008; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kliewer SA, 2010, AM J CLIN NUTR, V91, p254S, DOI 10.3945/ajcn.2009.28449B; Li L, 2011, DIABETES, V60, P157, DOI 10.2337/db10-0331; Lopez-Alvarenga JC, 2001, SALUD PUBLICA MEXICO, V43, P306; LUND S, 1995, P NATL ACAD SCI USA, V92, P5817, DOI 10.1073/pnas.92.13.5817; Lundasen T, 2007, BIOCHEM BIOPH RES CO, V360, P437, DOI 10.1016/j.bbrc.2007.06.068; Mai K, 2009, DIABETES, V58, P1532, DOI 10.2337/db08-1775; Nishimura T, 2000, BBA-GENE STRUCT EXPR, V1492, P203, DOI 10.1016/S0167-4781(00)00067-1; Potthoff MJ, 2009, P NATL ACAD SCI USA, V106, P10853, DOI 10.1073/pnas.0904187106; Schoenberg KM, 2011, ENDOCRINOLOGY, V152, P4652, DOI 10.1210/en.2011-1425; Tremblay MS, 2010, APPL PHYSIOL NUTR ME, V35, P725, DOI 10.1139/H10-079; Uebanso T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022976; WAHRENBERG H, 1991, EUR J CLIN INVEST, V21, P534, DOI 10.1111/j.1365-2362.1991.tb01406.x; Yan HM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024895; Zhang X, 2008, DIABETES, V57, P1246, DOI 10.2337/db07-1476	29	114	121	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38022	10.1371/journal.pone.0038022	http://dx.doi.org/10.1371/journal.pone.0038022			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22701542	Green Published, Green Submitted, gold			2022-12-27	WOS:000305338500073
J	Lee, JC; Gutell, RR				Lee, Jung C.; Gutell, Robin R.			A Comparison of the Crystal Structures of Eukaryotic and Bacterial SSU Ribosomal RNAs Reveals Common Structural Features in the Hypervariable Regions	PLOS ONE			English	Article							EXPANSION SEGMENTS ES3; SECONDARY STRUCTURE; EVOLUTIONARY IMPLICATIONS; NUCLEOTIDE-SEQUENCE; ANGSTROM RESOLUTION; GENE SEQUENCE; SUBUNIT; COMPLEX; SITE	While the majority of the ribosomal RNA structure is conserved in the three major domains of life - archaea, bacteria, and eukaryotes, specific regions of the rRNA structure are unique to at least one of these three primary forms of life. In particular, the comparative secondary structure for the eukaryotic SSU rRNA contains several regions that are different from the analogous regions in the bacteria. Our detailed analysis of two recently determined eukaryotic 40S ribosomal crystal structures, Tetrahymena thermophila and Saccharomyces cerevisiae, and the comparison of these results with the bacterial Thermus thermophilus 30S ribosomal crystal structure: (1) revealed that the vast majority of the comparative structure model for the eukaryotic SSU rRNA is substantiated, including the secondary structure that is similar to both bacteria and archaea as well as specific for the eukaryotes, (2) resolved the secondary structure for regions of the eukaryotic SSU rRNA that were not determined with comparative methods, (3) identified eukaryotic helices that are equivalent to the bacterial helices in several of the hypervariable regions, (4) revealed that, while the coaxially stacked compound helix in the 540 region in the central domain maintains the constant length of 10 base pairs, its two constituent helices contain 5+5 bp rather than the 6+4 bp predicted with comparative analysis of archaeal and eukaryotic SSU rRNAs.	Univ Texas Austin, Ctr Computat Biol & Bioinformat, Inst Cellular & Mol Biol, Austin, TX 78712 USA; Univ Texas Austin, Sect Integrat Biol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Lee, JC (corresponding author), Milwaukee Sch Engn, Dept Chem & Phys, Milwaukee, WI USA.	lee@msoe.edu; robin.gutell@mail.utexas.edu			National Institutes of Health [R01GM067317]; Welch Foundation [F-1427]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067317] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institutes of Health (R01GM067317) and the Welch Foundation (F-1427). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkemar G, 2004, RNA, V10, P403, DOI 10.1261/rna.5135204; Alkemar G, 2003, RNA, V9, P20, DOI 10.1261/rna.2108203; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Ben-Shem A, 2011, SCIENCE, V334, P1524, DOI 10.1126/science.1212642; Bernstein HJ, 2000, TRENDS BIOCHEM SCI, V25, P453, DOI 10.1016/S0968-0004(00)01606-6; Cannone JJ, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-2; ELLIS RE, 1986, NUCLEIC ACIDS RES, V14, P2345, DOI 10.1093/nar/14.5.2345; GONZALEZ IL, 1986, AM J HUM GENET, V38, P419; Gutell RR, 2002, CURR OPIN STRUC BIOL, V12, P301, DOI 10.1016/S0959-440X(02)00339-1; GUTELL RR, 1994, MICROBIOL REV, V58, P10, DOI 10.1128/MMBR.58.1.10-26.1994; GUTELL RR, 1985, PROG NUCLEIC ACID RE, V32, P155, DOI 10.1016/S0079-6603(08)60348-7; Hansen JL, 2002, P NATL ACAD SCI USA, V99, P11670, DOI 10.1073/pnas.172404099; HENDRIKS L, 1988, FEBS LETT, V232, P115, DOI 10.1016/0014-5793(88)80398-3; HERZOG M, 1986, P NATL ACAD SCI USA, V83, P8644, DOI 10.1073/pnas.83.22.8644; JOHANSEN T, 1988, CURR GENET, V14, P265, DOI 10.1007/BF00376747; Lecompte O, 2002, NUCLEIC ACIDS RES, V30, P5382, DOI 10.1093/nar/gkf693; NEEFS JM, 1990, NUCLEIC ACIDS RES, V18, P5695, DOI 10.1093/nar/18.19.5695; NELLES L, 1984, NUCLEIC ACIDS RES, V12, P8749, DOI 10.1093/nar/12.23.8749; NELLES L, 1984, NATURWISSENSCHAFTEN, V71, P634, DOI 10.1007/BF00377899; NICKRENT DL, 1991, NUCLEIC ACIDS RES, V19, P227, DOI 10.1093/nar/19.2.227; NOLLER HF, 1972, P NATL ACAD SCI USA, V69, P3115, DOI 10.1073/pnas.69.11.3115; Rabl J, 2011, SCIENCE, V331, P730, DOI 10.1126/science.1198308; RAIRKAR A, 1988, BIOCHEMISTRY-US, V27, P582, DOI 10.1021/bi00402a013; SAYLE RA, 1995, TRENDS BIOCHEM SCI, V20, P374, DOI 10.1016/S0968-0004(00)89080-5; Spahn CMT, 2001, CELL, V107, P373, DOI 10.1016/S0092-8674(01)00539-6; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; Wimberly BT, 1999, CELL, V97, P491, DOI 10.1016/S0092-8674(00)80759-X; WINKER S, 1991, SYST APPL MICROBIOL, V14, P305, DOI 10.1016/S0723-2020(11)80303-6; WOESE CR, 1989, P NATL ACAD SCI USA, V86, P3119, DOI 10.1073/pnas.86.9.3119; ZWIEB C, 1981, NUCLEIC ACIDS RES, V9, P3621, DOI 10.1093/nar/9.15.3621	30	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38203	10.1371/journal.pone.0038203	http://dx.doi.org/10.1371/journal.pone.0038203			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693601	Green Published, Green Submitted, gold			2022-12-27	WOS:000305338500110
J	Parsa, S; Ccanto, R; Olivera, E; Scurrah, M; Alcazar, J; Rosenheim, JA				Parsa, Soroush; Ccanto, Raul; Olivera, Edgar; Scurrah, Maria; Alcazar, Jesus; Rosenheim, Jay A.			Explaining Andean Potato Weevils in Relation to Local and Landscape Features: A Facilitated Ecoinformatics Approach	PLOS ONE			English	Article							PEST; MANAGEMENT	Background: Pest impact on an agricultural field is jointly influenced by local and landscape features. Rarely, however, are these features studied together. The present study applies a "facilitated ecoinformatics" approach to jointly screen many local and landscape features of suspected importance to Andean potato weevils (Premnotrypes spp.), the most serious pests of potatoes in the high Andes. Methodology/Principal Findings: We generated a comprehensive list of predictors of weevil damage, including both local and landscape features deemed important by farmers and researchers. To test their importance, we assembled an observational dataset measuring these features across 138 randomly-selected potato fields in Huancavelica, Peru. Data for local features were generated primarily by participating farmers who were trained to maintain records of their management operations. An information theoretic approach to modeling the data resulted in 131,071 models, the best of which explained 40.2-46.4% of the observed variance in infestations. The best model considering both local and landscape features strongly outperformed the best models considering them in isolation. Multi-model inferences confirmed many, but not all of the expected patterns, and suggested gaps in local knowledge for Andean potato weevils. The most important predictors were the field's perimeter-to-area ratio, the number of nearby potato storage units, the amount of potatoes planted in close proximity to the field, and the number of insecticide treatments made early in the season. Conclusions/Significance: Results underscored the need to refine the timing of insecticide applications and to explore adjustments in potato hilling as potential control tactics for Andean weevils. We believe our study illustrates the potential of ecoinformatics research to help streamline IPM learning in agricultural learning collaboratives.	[Parsa, Soroush] CIAT, Cali, Colombia; [Ccanto, Raul; Olivera, Edgar; Scurrah, Maria] Grp Yanapai, Lima, Peru; [Alcazar, Jesus] CIP, Lima, Peru; [Parsa, Soroush; Rosenheim, Jay A.] Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA	Alliance; International Center for Tropical Agriculture - CIAT; CGIAR; International Potato Center (CIP); University of California System; University of California Davis	Parsa, S (corresponding author), CIAT, Cali, Colombia.	s.parsa@cgiar.org		Ccanto Retamozo, Raul Carlos/0000-0003-1396-213X	UC Davis University Outreach and International Programs (UOIP); McKnight Foundation Collaborative Crop Research Program (CCRP)	UC Davis University Outreach and International Programs (UOIP); McKnight Foundation Collaborative Crop Research Program (CCRP)	This project was funded by the UC Davis University Outreach and International Programs (UOIP) and the McKnight Foundation Collaborative Crop Research Program (CCRP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There are no current external funding sources for this study.	Alcazar J., 1999, Impact on a changing world. International Potato Center Program Report 1997-1998., P141; Alcazar J, 1997, PROGRAM REPORT 1995, P169; Allen KC, 2009, CROP PROT, V28, P722, DOI 10.1016/j.cropro.2009.04.007; Anderson DR, 2000, J WILDLIFE MANAGE, V64, P912, DOI 10.2307/3803199; Bianchi FJJA, 2006, P ROY SOC B-BIOL SCI, V273, P1715, DOI 10.1098/rspb.2006.3530; BJORNSTAD O, 2004, NCF PACKAGE ANAL SPA; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Calderon R, 2004, DESARROLLO COMPONENT; Ewell PT, 1990, FARMER MANAGEMENT PO; HARRIS MK, 1980, TEX AES MISC PUBL, P23; Huntington HP, 2000, ECOL APPL, V10, P1270, DOI 10.1890/1051-0761(2000)010[1270:UTEKIS]2.0.CO;2; Jimenez D, 2009, COMPUT ELECTRON AGR, V69, P198, DOI 10.1016/j.compag.2009.08.008; Kaya H. K., 2009, FRUIT VEG CEREAL SCI, V3, P39, DOI DOI 10.1016/J.BIOCONTROL.2006.04.003; Kroschel J, 2009, CROP PROT, V28, P466, DOI 10.1016/j.cropro.2009.01.008; Kuhne M, 2007, ANDEAN POTATO WEEVIL; Lacy J, 2011, AGR SYST, V104, P562, DOI 10.1016/j.agsy.2011.04.005; Lees F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001549; LEGENDRE P, 1989, VEGETATIO, V80, P107, DOI 10.1007/BF00048036; Ortiz O., 1996, Case studies of the economic impact of CIP-related technologies., P95; Ostman O, 2001, BASIC APPL ECOL, V2, P365, DOI 10.1078/1439-1791-00072; Parsa S, 2006, BIOL CONTROL, V39, P171, DOI 10.1016/j.biocontrol.2006.04.003; Parsa Soroush, 2010, American Entomologist, V56, P242; Parsa S, 2011, ECOL APPL, V21, P539, DOI 10.1890/10-0393.1; Prasifka JR, 2004, LANDSCAPE ECOL, V19, P709, DOI 10.1007/s10980-005-0279-7; Rios A, J APPL ENTO IN PRESS; Rochester WA, 2002, COMPUT ELECTRON AGR, V35, P139, DOI 10.1016/S0168-1699(02)00015-7; Rosenheim JA, 2011, J ECON ENTOMOL, V104, P331, DOI 10.1603/EC10380; SAS Institute, 2007, JMP US GUID REL 7; SPEIGHT MR, 1983, AGR ECOSYST ENVIRON, V10, P183, DOI 10.1016/0167-8809(83)90061-0; Throop HL, 2004, ECOSYSTEMS, V7, P109, DOI 10.1007/s10021-003-0225-x; TOSI J, 1960, ZONAS VIDA NATURAL P; Zaller JG, 2008, AGR ECOSYST ENVIRON, V123, P233, DOI 10.1016/j.agee.2007.07.002; Zwald NR, 2006, J DAIRY SCI, V89, P330, DOI 10.3168/jds.S0022-0302(06)72098-7	33	10	10	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e36533	10.1371/journal.pone.0036533	http://dx.doi.org/10.1371/journal.pone.0036533			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693551	Green Published, gold			2022-12-27	WOS:000305338500012
J	Sievers, C; Willing, EM; Hoffmann, M; Dreyer, C; Ramnarine, I; Magurran, A				Sievers, Caya; Willing, Eva-Maria; Hoffmann, Margarete; Dreyer, Christine; Ramnarine, Indar; Magurran, Anne			Reasons for the Invasive Success of a Guppy (Poecilia reticulata) Population in Trinidad	PLOS ONE			English	Article							GENE FLOW; ARTIFICIAL INTRODUCTION; SOCIAL RECOGNITION; CONSEQUENCES; BEHAVIOR; HYBRIDIZATION; PREFERENCES; DIVERGENCE; TRAITS; CHOICE	The introduction of non-native species into new habitats poses a major threat to native populations. Of particular interest, though often overlooked, are introductions of populations that are not fully reproductively isolated from native individuals and can hybridize with them. To address this important topic we used different approaches in a multi-pronged study, combining the effects of mate choice, shoaling behaviour and genetics. Here we present evidence that behavioural traits such as shoaling and mate choice can promote population mixing if individuals do not distinguish between native and foreign conspecifics. We examined this in the context of two guppy (Poecilia reticulata) populations that have been subject to an introduction and subsequent population mixing event in Trinidad. The introduction of Guanapo River guppies into the Turure River more than 50 years ago led to a marked reduction of the original genotype. In our experiments, female guppies did not distinguish between shoaling partners when given the choice between native and foreign individuals. Introduced fish are therefore likely to benefit from the protection of a shoal and will improve their survival chances as a result. The additional finding that male guppies do not discriminate between females on the basis of origin will further increase the process of population mixing, especially if males encounter mixed shoals. In a mesocosm experiment, in which the native and foreign populations were allowed to mate freely, we found, as expected on the basis of these behavioural interactions, that the distribution of offspring genotypes could be predicted from the proportions of the two types of founding fish. This result suggests that stochastic and environmental processes have reinforced the biological ones to bring about the genetic dominance of the invading population in the Turure River. Re-sampling the Turure for genetic analysis using SNP markers confirmed the population mixing process and showed that it is an on-going process in this river and has led to the nearly complete disappearance of the original genotype.	[Sievers, Caya; Magurran, Anne] Univ St Andrews, Scottish Oceans Inst, St Andrews, Fife, Scotland; [Willing, Eva-Maria; Hoffmann, Margarete; Dreyer, Christine] Max Planck Inst Dev Biol, Dept Mol Biol, Tubingen, Germany; [Ramnarine, Indar] Univ W Indies, Dept Life Sci, St Augustine, Trinidad Tobago	University of St Andrews; Max Planck Society; University West Indies Mona Jamaica; University West Indies Saint Augustine	Sievers, C (corresponding author), Univ St Andrews, Scottish Oceans Inst, St Andrews, Fife, Scotland.	cs583@st-andrews.ac.uk	Magurran, Anne E/D-7463-2013	Magurran, Anne/0000-0002-0036-2795	European Research Council [BioTIME 250189]	European Research Council(European Research Council (ERC)European Commission)	AEM acknowledges financial support from the European Research Council (project BioTIME 250189). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLENDORF F W, 1988, Conservation Biology, V2, P170, DOI 10.1111/j.1523-1739.1988.tb00168.x; Becher SA, 2000, J FISH BIOL, V56, P241, DOI 10.1111/j.1095-8649.2000.tb02103.x; Berger J, 2001, NAT GENET, V29, P475, DOI 10.1038/ng773; Clavero M, 2005, TRENDS ECOL EVOL, V20, P110, DOI 10.1016/j.tree.2005.01.003; Cote J, 2010, P ROY SOC B-BIOL SCI, V277, P1571, DOI 10.1098/rspb.2009.2128; Daehler CC, 2001, BIOTIC HOMOGENIZATION, P81; diCastri F, 1989, BIOL INVASIONS GLOBA, P1; DUGATKIN LA, 1992, P ROY SOC B-BIOL SCI, V249, P179, DOI 10.1098/rspb.1992.0101; Echelle AA, 1997, CONSERV BIOL, V11, P153, DOI 10.1046/j.1523-1739.1997.95427.x; Elton C. S., 1958, ECOLOGY INVASIONS AN; ENDLER JA, 1995, EVOLUTION, V49, P456, DOI [10.2307/2410270, 10.1111/j.1558-5646.1995.tb02278.x]; Evans JP, 2003, BIOL J LINN SOC, V78, P605, DOI 10.1046/j.0024-4066.2002.00193.x; GODIN JGJ, 1995, ANIM BEHAV, V49, P1427, DOI 10.1016/0003-3472(95)90063-2; GOLDSCHMIDT T, 1993, CONSERV BIOL, V7, P686, DOI 10.1046/j.1523-1739.1993.07030686.x; Griffiths SW, 1998, ANIM BEHAV, V56, P689, DOI 10.1006/anbe.1998.0767; Hanfling B, 2005, FRESHWATER BIOL, V50, P403, DOI 10.1111/j.1365-2427.2004.01330.x; Hindar K, 2006, ICES J MAR SCI, V63, P1234, DOI 10.1016/j.icesjms.2006.04.025; HOLLDOBLER B, 1977, NATURWISSENSCHAFTEN, V64, P8, DOI 10.1007/BF00439886; Holway DA, 1999, TRENDS ECOL EVOL, V14, P328, DOI 10.1016/S0169-5347(99)01636-5; Hughes KA, 1999, ANIM BEHAV, V58, P907, DOI 10.1006/anbe.1999.1225; Kelley JL, 1999, NATURE, V401, P661, DOI 10.1038/44314; Ludlow AM, 2006, P ROY SOC B-BIOL SCI, V273, P2477, DOI 10.1098/rspb.2006.3605; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; MAGURRAN AE, 1994, J FISH BIOL, V45, P401, DOI 10.1111/j.1095-8649.1994.tb01322.x; Magurran AE, 1996, BEHAVIOUR, V133, P503, DOI 10.1163/156853996X00189; MAGURRAN AE, 1992, P ROY SOC B-BIOL SCI, V248, P117, DOI 10.1098/rspb.1992.0050; MAGURRAN AE, 2005, EVOLUTIONARY ECOLOGY; Mooney HA, 2001, P NATL ACAD SCI USA, V98, P5446, DOI 10.1073/pnas.091093398; Ojanguren AF, 2004, P ROY SOC B-BIOL SCI, V271, pS427, DOI 10.1098/rsbl.2004.0207; Olden JD, 2003, AM NAT, V162, P442, DOI 10.1086/378212; Olden JD, 2004, TRENDS ECOL EVOL, V19, P18, DOI 10.1016/j.tree.2003.09.010; Rhymer JM, 1996, ANNU REV ECOL SYST, V27, P83, DOI 10.1146/annurev.ecolsys.27.1.83; RHYMER JM, 1994, AUK, V111, P970, DOI 10.2307/4088829; Russell ST, 2006, J EVOLUTION BIOL, V19, P1294, DOI 10.1111/j.1420-9101.2005.01069.x; Russell ST, 2006, BIOL J LINN SOC, V88, P397, DOI 10.1111/j.1095-8312.2006.00628.x; Schories S, 2009, ZOOTAXA, P35, DOI 10.11646/zootaxa.2266.1.2; SHAW E, 1978, AM SCI, V66, P166; SHAW PW, 1992, P ROY SOC B-BIOL SCI, V248, P111, DOI 10.1098/rspb.1992.0049; Simberloff Daniel, 1997, P221; Storfer A, 1999, BIOL CONSERV, V87, P173, DOI 10.1016/S0006-3207(98)00066-4; Suarez Andrew V., 1999, Biological Invasions, V1, P43, DOI 10.1023/A:1010038413690; Tripathi N, 2009, P ROY SOC B-BIOL SCI, V276, P2195, DOI 10.1098/rspb.2008.1930; Valero A, 2008, BIOL LETTERS, V4, P149, DOI 10.1098/rsbl.2007.0604; Ward AJW, 2009, BEHAV ECOL, V20, P511, DOI 10.1093/beheco/arp025; Ward AJW, 2007, P ROY SOC B-BIOL SCI, V274, P1071, DOI 10.1098/rspb.2006.0231; Willing EM, 2010, MOL ECOL, V19, P968, DOI 10.1111/j.1365-294X.2010.04528.x	46	15	15	0	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38404	10.1371/journal.pone.0038404	http://dx.doi.org/10.1371/journal.pone.0038404			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693621	Green Published, Green Submitted, gold			2022-12-27	WOS:000305338500144
J	Stevens, B; Chen, CL; Farrell, I; Zhang, HB; Kaur, J; Broitman, SL; Smilansky, Z; Cooperman, BS; Goldman, YE				Stevens, Benjamin; Chen, Chunlai; Farrell, Ian; Zhang, Haibo; Kaur, Jaskiran; Broitman, Steven L.; Smilansky, Zeev; Cooperman, Barry S.; Goldman, Yale E.			FRET-Based Identification of mRNAs Undergoing Translation	PLOS ONE			English	Article							RIBOSOMAL L1 STALK; IN-VIVO; PROTEIN; DYNAMICS; LIGASE; CELLS	We present proof-of-concept in vitro results demonstrating the feasibility of using single molecule fluorescence resonance energy transfer (smFRET) measurements to distinguish, in real time, between individual ribosomes programmed with several different, short mRNAs. For these measurements we use either the FRET signal generated between two tRNAs labeled with different fluorophores bound simultaneously in adjacent sites to the ribosome (tRNA-tRNA FRET) or the FRET signal generated between a labeled tRNA bound to the ribosome and a fluorescent derivative of ribosomal protein L1 (L1-tRNA FRET). With either technique, criteria were developed to identify the mRNAs, taking into account the relative activity of the mRNAs. These criteria enabled identification of the mRNA being translated by a given ribosome to within 95% confidence intervals based on the number of identified FRET traces. To upgrade the approach for natural mRNAs or more complex mixtures, the stoichiometry of labeling should be enhanced and photobleaching reduced. The potential for porting these methods into living cells is discussed.	[Stevens, Benjamin; Chen, Chunlai; Goldman, Yale E.] Univ Penn, Sch Med, Penn Muscle Inst, Philadelphia, PA 19104 USA; [Stevens, Benjamin; Smilansky, Zeev] Anima Cell Metrol Inc, Bernardsville, NJ USA; [Farrell, Ian; Zhang, Haibo; Kaur, Jaskiran; Cooperman, Barry S.] Univ Penn, Dept Chem, Philadelphia, PA 19104 USA; [Broitman, Steven L.] W Chester Univ Penn, Dept Biol, W Chester, PA USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania State System of Higher Education (PASSHE); West Chester University of Pennsylvania	Stevens, B (corresponding author), Univ Penn, Sch Med, Penn Muscle Inst, Philadelphia, PA 19104 USA.	goldmany@mail.med.upenn.edu	Chen, Chunlai/F-8410-2012		National Institute for Standards and Technology (NIST) Advanced Technology Program [70NANB7H7011]; NIH [R01GM080376]; American Heart Association Postdoctoral Fellowship [12POST8910014]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080376] Funding Source: NIH RePORTER	National Institute for Standards and Technology (NIST) Advanced Technology Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Postdoctoral Fellowship(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The research was funded by a National Institute for Standards and Technology (NIST) Advanced Technology Program grant 70NANB7H7011 to Anima Cell Metrology, Inc., NIH grant R01GM080376 to BSC and YEG, and American Heart Association Postdoctoral Fellowship (12POST8910014 to C.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alivisatos AP, 2005, ANNU REV BIOMED ENG, V7, P55, DOI 10.1146/annurev.bioeng.7.060804.100432; Barhoom S, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr601; Betteridge T, 2007, RNA, V13, P1594, DOI 10.1261/rna.475407; Blanchard SC, 2004, NAT STRUCT MOL BIOL, V11, P1008, DOI 10.1038/nsmb831; Busch R, 2006, BBA-GEN SUBJECTS, V1760, P730, DOI 10.1016/j.bbagen.2005.12.023; Chattopadhaya S, 2009, BIOORGAN MED CHEM, V17, P981, DOI 10.1016/j.bmc.2008.01.043; Chen CL, 2011, P NATL ACAD SCI USA, V108, P16980, DOI 10.1073/pnas.1106999108; Chen CL, 2011, MOL CELL, V42, P367, DOI 10.1016/j.molcel.2011.03.024; Chiu J, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh172; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.2307/2331986; Cohen AA, 2008, SCIENCE, V322, P1511, DOI 10.1126/science.1160165; Fei J, 2008, MOL CELL, V30, P348, DOI 10.1016/j.molcel.2008.03.012; Fei JY, 2009, P NATL ACAD SCI USA, V106, P15702, DOI 10.1073/pnas.0908077106; Haller A, 2011, ACCOUNTS CHEM RES, V44, P1339, DOI 10.1021/ar200035g; Hikida Y, 2010, NAT PROTOC, V5, P1312, DOI 10.1038/nprot.2010.77; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Kapanidis AN, 2004, P NATL ACAD SCI USA, V101, P8936, DOI 10.1073/pnas.0401690101; Kaur J, 2011, RNA, V17, P1393, DOI 10.1261/rna.2670811; Korlach J, 2010, METHOD ENZYMOL, V472, P431, DOI 10.1016/S0076-6879(10)72001-2; Lin XC, 2008, SPECTROSC SPECT ANAL, V28, P2615, DOI 10.3964/j.issn.1000-0593(2008)11-2615-04; Lippincott-Schwartz J, 2003, SCIENCE, V300, P87, DOI 10.1126/science.1082520; Marks KM, 2004, CHEM BIOL, V11, P347, DOI 10.1016/j.chembiol.2004.03.004; Mascarenhas J, 2001, EMBO REP, V2, P685, DOI 10.1093/embo-reports/kve160; Motorin Y, 2011, NUCLEIC ACIDS RES, V39, P1943, DOI 10.1093/nar/gkq825; ODOM OW, 1980, BIOCHEMISTRY-US, V19, P5947, DOI 10.1021/bi00567a001; Paige JS, 2011, SCIENCE, V333, P642, DOI 10.1126/science.1207339; Pan DL, 2009, RNA, V15, P346, DOI 10.1261/rna.1257509; Qin HO, 2009, BIOCHEMISTRY-US, V48, P4699, DOI 10.1021/bi900222e; RHEINBERGER HJ, 1986, J BIOL CHEM, V261, P9133; RHEINBERGER HJ, 1986, J BIOL CHEM, V261, P9140; RODNINA MV, 1995, P NATL ACAD SCI USA, V92, P1945, DOI 10.1073/pnas.92.6.1945; Sigal A, 2006, NATURE, V444, P643, DOI 10.1038/nature05316; SUBRAMANIAN AR, 1980, EUR J BIOCHEM, V112, P425, DOI 10.1111/j.1432-1033.1980.tb07222.x; Uemura S, 2010, NATURE, V464, P1012, DOI 10.1038/nature08925; Uttamapinant C, 2010, P NATL ACAD SCI USA, V107, P10914, DOI 10.1073/pnas.0914067107; Wang Y, 2007, BIOCHEMISTRY-US, V46, P10767, DOI 10.1021/bi700657d; WINTERMEYER W, 1979, EUR J BIOCHEM, V98, P465	37	9	9	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38344	10.1371/journal.pone.0038344	http://dx.doi.org/10.1371/journal.pone.0038344			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693619	gold, Green Submitted, Green Published			2022-12-27	WOS:000305338500136
J	Weber, T; Renzland, I; Baur, M; Monks, S; Herrmann, E; Huppert, V; Nurnberg, F; Schonig, K; Bartsch, D				Weber, Tillmann; Renzland, Insa; Baur, Max; Moenks, Simon; Herrmann, Elke; Huppert, Verena; Nuernberg, Frank; Schoenig, Kai; Bartsch, Dusan			Tetracycline Inducible Gene Manipulation in Serotonergic Neurons	PLOS ONE			English	Article							CONDITIONAL MOUSE MODEL; CRE-RECOMBINASE; IN-VIVO; TRANSGENIC MICE; EXPRESSION; SYSTEM; RECEPTOR; REVERSAL; DISEASE; CELLS	The serotonergic (5-HT) neuronal system has important and diverse physiological functions throughout development and adulthood. Its dysregulation during development or later in adulthood has been implicated in many neuropsychiatric disorders. Transgenic animal models designed to study the contribution of serotonergic susceptibility genes to a pathological phenotype should ideally allow to study candidate gene overexpression or gene knockout selectively in serotonergic neurons at any desired time during life. For this purpose, conditional expression systems such as the tet-system are preferable. Here, we generated a transactivator (tTA) mouse line (TPH2-tTA) that allows temporal and spatial control of tetracycline (Ptet) controlled transgene expression as well as gene deletion in 5-HT neurons. The tTA cDNA was inserted into a 196 kb PAC containing a genomic mouse Tph2 fragment (177 kb) by homologous recombination in E. coli. For functional analysis of Ptet-controlled transgene expression, TPH2-tTA mice were crossed to a Ptet-regulated lacZ reporter line (Ptet-nLacZ). In adult double-transgenic TPH2-tTA/Ptet-nLacZ mice, TPH2-tTA founder line L62-20 showed strong serotonergic beta-galactosidase expression which could be completely suppressed with doxycycline (Dox). Furthermore, Ptet-regulated gene expression could be reversibly activated or inactivated when Dox was either withdrawn or added to the system. For functional analysis of Ptet-controlled, Cre-mediated gene deletion, TPH2-tTA mice (L62-20) were crossed to double transgenic Ptet-Cre/R26R reporter mice to generate TPH2-tTA/Ptet-Cre/R26R mice. Without Dox, 5-HT specific recombination started at E12.5. With permanent Dox administration, Ptet-controlled Cre-mediated recombination was absent. Dox withdrawal either postnatally or during adulthood induced efficient recombination in serotonergic neurons of all raphe nuclei, respectively. In the enteric nervous system, recombination could not be detected. We generated a transgenic mouse tTA line (TPH2-tTA) which allows both inducible and reversible transgene expression and inducible Cre-mediated gene deletion selectively in 5-HT neurons throughout life. This will allow precise delineation of serotonergic gene functions during development and adulthood.	[Weber, Tillmann; Renzland, Insa; Baur, Max; Moenks, Simon; Herrmann, Elke; Huppert, Verena; Schoenig, Kai; Bartsch, Dusan] Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, Dept Mol Biol, D-6800 Mannheim, Germany; [Weber, Tillmann] Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, Dept Addict Behav & Addict Med, D-6800 Mannheim, Germany; [Weber, Tillmann] Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, Dept Psychiat & Psychotherapy, D-6800 Mannheim, Germany; [Nuernberg, Frank] Mannheim Univ Appl Sci, Fac Informat, Inst Appl Math, Mannheim, Germany	Central Institute of Mental Health; Ruprecht Karls University Heidelberg; Central Institute of Mental Health; Ruprecht Karls University Heidelberg; Central Institute of Mental Health; Ruprecht Karls University Heidelberg	Weber, T (corresponding author), Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, Dept Mol Biol, D-6800 Mannheim, Germany.	dusan.bartsch@zi-mannheim.de			EU [HEALTH-F2-2007-201714DEVANX]; BMBF Bernstein Center for Computational Neuroscience Heidelberg/Mannheim [01GQ1003A]; BMBF NGFN-Plus grant [01GS0851]	EU(European Commission); BMBF Bernstein Center for Computational Neuroscience Heidelberg/Mannheim(Federal Ministry of Education & Research (BMBF)); BMBF NGFN-Plus grant(Federal Ministry of Education & Research (BMBF))	EU HEALTH-F2-2007-201714DEVANX, BMBF Bernstein Center for Computational Neuroscience Heidelberg/Mannheim 01GQ1003A, BMBF NGFN-Plus grant (01GS0851) to Dusan Bartsch. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson KB, 2010, TRANSGENIC RES, V19, P715, DOI 10.1007/s11248-009-9342-4; Ansorge MS, 2008, J NEUROSCI, V28, P199, DOI 10.1523/JNEUROSCI.3973-07.2008; BARON U, 1995, NUCLEIC ACIDS RES, V23, P3605, DOI 10.1093/nar/23.17.3605; Boyle S, 2008, DEV BIOL, V313, P234, DOI 10.1016/j.ydbio.2007.10.014; Buchanan GF, 2010, P NATL ACAD SCI USA, V107, P16354, DOI 10.1073/pnas.1004587107; Burgess K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017090; Champoux M, 2002, MOL PSYCHIATR, V7, P1058, DOI 10.1038/sj.mp.4001157; Chen JS, 1998, MOL PHARMACOL, V54, P495, DOI 10.1124/mol.54.3.495; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.2307/2331986; Corbel SY, 2002, CURR OPIN BIOTECH, V13, P448, DOI 10.1016/S0958-1669(02)00361-0; Cote F, 2007, P NATL ACAD SCI USA, V104, P329, DOI 10.1073/pnas.0606722104; Dai JX, 2008, P NATL ACAD SCI USA, V105, P11981, DOI 10.1073/pnas.0801329105; Daw ND, 2002, NEURAL NETWORKS, V15, P603, DOI 10.1016/S0893-6080(02)00052-7; DEMERS P, 1968, CAN MED ASSOC J, V99, P849; Dequen F, 2010, HUM MOL GENET, V19, P2616, DOI 10.1093/hmg/ddq149; Eckenstein FP, 2006, EXP NEUROL, V198, P338, DOI 10.1016/j.expneurol.2005.12.020; Erdmann G, 2008, ENDOCRINOLOGY, V149, P3446, DOI 10.1210/en.2007-1786; Finger EC, 2007, NEUROPSYCHOPHARMACOL, V32, P206, DOI 10.1038/sj.npp.1301182; FURTH PA, 1994, P NATL ACAD SCI USA, V91, P9302, DOI 10.1073/pnas.91.20.9302; Gogos JA, 2000, CELL, V103, P609, DOI 10.1016/S0092-8674(00)00164-1; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Gross C, 2004, NAT REV NEUROSCI, V5, P545, DOI 10.1038/nrn1429; Gutknecht L, 2009, EUR NEUROPSYCHOPHARM, V19, P266, DOI 10.1016/j.euroneuro.2008.12.005; Hale MA, 2005, DEV BIOL, V286, P225, DOI 10.1016/j.ydbio.2005.07.026; Hengstler JG, 1999, DRUG METAB REV, V31, P917, DOI 10.1081/DMR-100101946; Hensler J. G., 2006, BASIC NEUROCHEMISTRY, P227; Hirsimaki Pirkko, 2002, Breast J, V8, P92, DOI 10.1046/j.1524-4741.2002.08204.x; Huh WJ, 2012, GASTROENTEROLOGY, V142, P21, DOI 10.1053/j.gastro.2011.09.050; Indra AK, 1999, NUCLEIC ACIDS RES, V27, P4324, DOI 10.1093/nar/27.22.4324; Kiermayer C, 2007, GENESIS, V45, P11, DOI 10.1002/dvg.20244; Kistner A, 1996, P NATL ACAD SCI USA, V93, P10933, DOI 10.1073/pnas.93.20.10933; Kiyasova V, 2011, J NEUROSCI, V31, P2756, DOI 10.1523/JNEUROSCI.4080-10.2011; Krestel HE, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.7.e39; Krestel HE, 2004, J NEUROSCI, V24, P10568, DOI 10.1523/JNEUROSCI.4579-03.2004; Le LQ, 2011, CANCER RES, V71, P4686, DOI 10.1158/0008-5472.CAN-10-4577; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; Lewandoski M, 2001, NAT REV GENET, V2, P743, DOI 10.1038/35093537; Li ZS, 2011, J NEUROSCI, V31, P8998, DOI 10.1523/JNEUROSCI.6684-10.2011; Lin WS, 2004, J NEUROSCI, V24, P10074, DOI 10.1523/JNEUROSCI.2604-04.2004; Liu C, 2010, NAT NEUROSCI, V13, P1190, DOI 10.1038/nn.2623; Mayes DA, 2011, CANCER RES, V71, P4675, DOI 10.1158/0008-5472.CAN-10-4558; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; Mejia JM, 2002, BIOL PSYCHIAT, V52, P811, DOI 10.1016/S0006-3223(02)01418-X; Metzger D, 2001, METHODS, V24, P71, DOI 10.1006/meth.2001.1159; Miro-Murillo M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022589; Mitsuhashi T, 2001, P NATL ACAD SCI USA, V98, P6435, DOI 10.1073/pnas.111051398; Mocanu MM, 2008, J NEUROSCI, V28, P737, DOI 10.1523/JNEUROSCI.2824-07.2008; Nagy A, 2000, GENESIS, V26, P99, DOI 10.1002/(SICI)1526-968X(200002)26:2<99::AID-GENE1>3.0.CO;2-B; Park EJ, 2008, DEV DYNAM, V237, P447, DOI 10.1002/dvdy.21415; Perea J, 2001, HUM MOL GENET, V10, P1007, DOI 10.1093/hmg/10.10.1007; Redfern CH, 1999, NAT BIOTECHNOL, V17, P165, DOI 10.1038/6165; Robertson A, 2002, GENE, V282, P65, DOI 10.1016/S0378-1119(01)00793-4; Schmidt-Supprian M, 2007, NAT IMMUNOL, V8, P665, DOI 10.1038/ni0707-665; Schonig K, 2011, TRANSGENIC RES, V20, P709, DOI 10.1007/s11248-010-9427-0; Schonig K, 2010, METHOD ENZYMOL, V477, P429, DOI 10.1016/S0076-6879(10)77022-1; Schonig K, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf134; Schonig Kai, 2003, Methods Mol Biol, V209, P69; Scott MM, 2005, P NATL ACAD SCI USA, V102, P16472, DOI 10.1073/pnas.0504510102; Shin MK, 1999, NATURE, V402, P496, DOI 10.1038/990040; Siddiqui M A, 2002, J Pak Med Assoc, V52, P211; Song NN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015998; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Tremblay P, 1998, P NATL ACAD SCI USA, V95, P12580, DOI 10.1073/pnas.95.21.12580; Urlinger S, 2000, P NATL ACAD SCI USA, V97, P7963, DOI 10.1073/pnas.130192197; Vogt MA, 2008, EXP NEUROL, V211, P25, DOI 10.1016/j.expneurol.2007.12.012; Walther DJ, 2003, SCIENCE, V299, P76, DOI 10.1126/science.1078197; Weber T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028283; Weber T, 2011, GLIA, V59, P615, DOI 10.1002/glia.21129; Weber T, 2009, FRONT MOL NEUROSCI, V2, DOI 10.3389/neuro.02.024.2009; Yadav VK, 2011, J EXP MED, V208, P41, DOI 10.1084/jem.20101940; Yamamoto A, 2000, CELL, V101, P57, DOI 10.1016/S0092-8674(00)80623-6; Ye P, 2004, J NEUROSCI RES, V78, P472, DOI 10.1002/jnr.20288; Zhao ZQ, 2006, J NEUROSCI, V26, P12781, DOI 10.1523/JNEUROSCI.4143-06.2006; Zhao ZQ, 2007, P NATL ACAD SCI USA, V104, P14519, DOI 10.1073/pnas.0705740104; Zhu PX, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000533; Zu T, 2004, J NEUROSCI, V24, P8853, DOI 10.1523/JNEUROSCI.2978-04.2004	77	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38193	10.1371/journal.pone.0038193	http://dx.doi.org/10.1371/journal.pone.0038193			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693598	Green Published, Green Submitted, gold			2022-12-27	WOS:000305338500106
J	Royer, L; Reimann, M; Stewart, AF; Schroeder, M				Royer, Loic; Reimann, Matthias; Stewart, A. Francis; Schroeder, Michael			Network Compression as a Quality Measure for Protein Interaction Networks	PLOS ONE			English	Article							INTERACTION MAP; TRANSCRIPTION ELONGATION; SACCHAROMYCES-CEREVISIAE; INTERACTION DATABASE; GRAPH COMPRESSION; YEAST; COMPLEX; IDENTIFICATION; EXPRESSION; STRATEGY	With the advent of large-scale protein interaction studies, there is much debate about data quality. Can different noise levels in the measurements be assessed by analyzing network structure? Because proteomic regulation is inherently cooperative, modular and redundant, it is inherently compressible when represented as a network. Here we propose that network compression can be used to compare false positive and false negative noise levels in protein interaction networks. We validate this hypothesis by first confirming the detrimental effect of false positives and false negatives. Second, we show that gold standard networks are more compressible. Third, we show that compressibility correlates with co-expression, co-localization, and shared function. Fourth, we also observe correlation with better protein tagging methods, physiological expression in contrast to over-expression of tagged proteins, and smart pooling approaches for yeast two-hybrid screens. Overall, this new measure is a proxy for both sensitivity and specificity and gives complementary information to standard measures such as average degree and clustering coefficients.	[Royer, Loic; Reimann, Matthias; Stewart, A. Francis; Schroeder, Michael] Biotec TU Dresden, Dresden, Germany	Technische Universitat Dresden	Royer, L (corresponding author), HHMI, JFRC, Ashburn, VA USA.	ms@biotec.tu-dresden.de	Schroeder, Michael/A-3040-2010; Stewart, A. Francis/E-7789-2010; Royer, Loic/C-7593-2017	Royer, Loic/0000-0002-9991-9724	EU; DFG; BMWi (Ponte, Hybris, GeneCloud); BMBF NGFN Program; DiGtoP (Disease genes to pathways); BMBF Format Project CLSD; dFG project Zoomable Cell	EU(European Commission); DFG(German Research Foundation (DFG)); BMWi (Ponte, Hybris, GeneCloud); BMBF NGFN Program(Federal Ministry of Education & Research (BMBF)); DiGtoP (Disease genes to pathways); BMBF Format Project CLSD; dFG project Zoomable Cell	Work by LR, MR, MS was supported by EU, DFG, BMWi (Ponte, Hybris, GeneCloud). Work by AFS was supported by the BMBF NGFN Program, DiGtoP (Disease genes to pathways). Thanks to Christof Winter for discussions and detailed comments on the figures. Thanks to Assen Roguev for discussions.; The authors kindly acknowledge funding through the EU Project Ponte and BMBF Format Project CLSD and the dFG project Zoomable Cell. Thanks to the high-performance computing center (ZIH) of the Technical University of Dresden for access to the Deimos supercomputer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand K, 2009, ENTROPY MEASURES COM; Aranda B, 2010, NUCLEIC ACIDS RES, V38, pD525, DOI 10.1093/nar/gkp878; Arifuzzaman M, 2006, GENOME RES, V16, P686, DOI 10.1101/gr.4527806; Bader GD, 2003, NUCLEIC ACIDS RES, V31, P248, DOI 10.1093/nar/gkg056; Bader GD, 2002, NAT BIOTECHNOL, V20, P991, DOI 10.1038/nbt1002-991; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Boldi P, 2004, WEBGRAPH FRAMEWORK, P595; Braun P, 2009, NAT METHODS, V6, P91, DOI [10.1038/NMETH.1281, 10.1038/nmeth.1281]; Breitkreutz A, 2010, SCIENCE, V328, P1043, DOI 10.1126/science.1176495; Breitkreutz BJ, 2008, NUCLEIC ACIDS RES, V36, pD637, DOI 10.1093/nar/gkm1001; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; Ceol A, 2010, NUCLEIC ACIDS RES, V38, pD532, DOI 10.1093/nar/gkp983; Chaitin G, 2007, META MATH QUEST OMEG; Claussen JC, 2007, PHYSICA A, V375, P365, DOI 10.1016/j.physa.2006.08.067; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; Colizza V, 2006, P NATL ACAD SCI USA, V103, P2015, DOI 10.1073/pnas.0510525103; Collins SR, 2007, MOL CELL PROTEOMICS, V6, P439, DOI 10.1074/mcp.M600381-MCP200; Cusick ME, 2009, NAT METHODS, V6, P39, DOI [10.1038/NMETH.1284, 10.1038/nmeth.1284]; Deane CM, 2002, MOL CELL PROTEOMICS, V1, P349, DOI 10.1074/mcp.M100037-MCP200; Dehmer M, 2008, APPL ARTIF INTELL, V22, P684, DOI 10.1080/08839510802164101; Dehmer M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008057; Demetrius L, 2005, PHYSICA A, V346, P682, DOI 10.1016/j.physa.2004.07.011; Deng Minghua, 2003, Pac Symp Biocomput, P140; Deo Narsingh, 1998, MFCS WORKSH COMM, P91; Deshaies RJ, 2002, MOL CELL PROTEOMICS, V1, P3, DOI 10.1074/mcp.R100001-MCP200; Diestel R., 2015, GRAPH THEORY; Dortay H, 2006, FEBS J, V273, P4631, DOI 10.1111/j.1742-4658.2006.05467.x; Erds P, 1959, PUBL MATH-DEBRECEN, V6; Ewing RM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100134; FEDER T, 1995, J COMPUT SYST SCI, V51, P261, DOI 10.1006/jcss.1995.1065; Feldmann A, 1998, J COMB OPTIM, V1, P393, DOI 10.1023/A:1009794729459; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Formstecher E, 2005, GENOME RES, V15, P376, DOI 10.1101/gr.2659105; Fraser HB, 2004, P NATL ACAD SCI USA, V101, P9033, DOI 10.1073/pnas.0402591101; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Grigoriev A, 2003, NUCLEIC ACIDS RES, V31, P4157, DOI 10.1093/nar/gkg466; Hannah D, 2008, LECT NOTES COMPUT SC, V4956, P596; Harata M, 1999, MOL BIOL CELL, V10, P2595, DOI 10.1091/mbc.10.8.2595; Hart GT, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-11-120; HERZEL H, 1994, PHYS REV E, V50, P5061, DOI 10.1103/PhysRevE.50.5061; Heymans JJ, 2002, ECOL MODEL, V149, P5, DOI 10.1016/S0304-3800(01)00511-7; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; HOLLAND PW, 1971, COMP GROUP STUD, V2, P107, DOI 10.1177/104649647100200201; Hong EL, 2008, NUCLEIC ACIDS RES, V36, pD577, DOI 10.1093/nar/gkm909; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Ito T, 2001, Tanpakushitsu Kakusan Koso, V46, P2407; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Jansen R, 2002, GENOME RES, V12, P37, DOI 10.1101/gr.205602; Jensen LJ, 2008, SCIENCE, V322, P56, DOI 10.1126/science.1164801; Jin FL, 2006, NAT METHODS, V3, P183, DOI 10.1038/nmeth859; Jukna S, 2006, GRAPH COMPLEXITY; Kiemer L, 2007, PROTEOMICS, V7, P932, DOI 10.1002/pmic.200600448; Kim PM, 2006, SCIENCE, V314, P1938, DOI 10.1126/science.1136174; Knuth DE., 1993, STANFORD GRAPH BASE; Kocsor A, 2006, BIOINFORMATICS, V22, P407, DOI 10.1093/bioinformatics/bti806; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; LaCount DJ, 2005, NATURE, V438, P103, DOI 10.1038/nature04104; Langville AN., 2004, INTERNET MATH, V1, P335, DOI [10.1080/15427951.2004.10129091, DOI 10.1080/15427951.2004.10129091]; Lee I, 2004, SCIENCE, V306, P1555, DOI 10.1126/science.1099511; Lemmens I, 2010, J PROTEOMICS, V73, P1415, DOI 10.1016/j.jprot.2010.02.001; Leskovec J., 2005, P 11 ACM SIGKDD INT, P177, DOI 10.1145/1081870.1081893; Li J, 2008, CHINESE PHYS LETT, V25, P4177, DOI 10.1088/0256-307X/25/11/093; Li M, 2001, BIOINFORMATICS, V17, P149, DOI 10.1093/bioinformatics/17.2.149; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Lima-Mendez G, 2009, MOL BIOSYST, V5, P1482, DOI 10.1039/b908681a; Lindstrom DL, 2003, MOL CELL BIOL, V23, P1368, DOI 10.1128/MCB.23.4.1368-1378.2003; Lu HI, 2002, SIAM PROC S, P223; MacArthur BD, 2008, DISCRETE APPL MATH, V156, P3525, DOI 10.1016/j.dam.2008.04.008; Manke T, 2006, J R SOC INTERFACE, V3, P843, DOI 10.1098/rsif.2006.0140; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Mewes HW, 1999, NUCLEIC ACIDS RES, V27, P44, DOI 10.1093/nar/27.1.44; Minoli D., 1975, Atti della Accademia Nazionale dei Lincei. Rendiconti, Classe di Scienze Fisiche, Matematiche e Naturali, V59, P651; Mowshowitz, 1968, B MATH BIOPHYS, V30, P75204; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Norlen K, 2002, P INT TEL SOC 14 BIE; Parrish JR, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r130; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; Pellegrini M, 1999, P NATL ACAD SCI USA, V96, P4285, DOI 10.1073/pnas.96.8.4285; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Rain JC, 2001, NATURE, V409, P211, DOI 10.1038/35051615; Randall KH, 2002, IEEE DATA COMPR CONF, P122, DOI 10.1109/DCC.2002.999950; Rashewsky, 1955, B MATH BIOPHYS, V17; Reguly Teresa, 2006, J Biol, V5, P11, DOI 10.1186/jbiol36; Royer L, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000108; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Salwinski L, 2009, NAT METHODS, V6, P860, DOI 10.1038/nmeth1209-860; Sato S, 2007, DNA RES, V14, P207, DOI 10.1093/dnares/dsm021; Schneider DA, 2006, P NATL ACAD SCI USA, V103, P12707, DOI 10.1073/pnas.0605686103; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Shen XT, 2000, NATURE, V406, P541, DOI 10.1038/35020123; Shevchenko A, 1999, BIOCHEM SOC T, V27, P549, DOI 10.1042/bst0270549; Shevchenko A, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-11-r167; Simonis N, 2009, NAT METHODS, V6, P47, DOI 10.1038/NMETH.1279; Smialowski P, 2010, NUCLEIC ACIDS RES, V38, pD540, DOI 10.1093/nar/gkp1026; Sole RV, 2004, LECT NOTES PHYS, V650, P189; Sorribas A, 2007, BIOTECHNOL BIOENG, V97, P1259, DOI 10.1002/bit.21316; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Sun J, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/06/P06001; Tarassov K, 2008, SCIENCE, V320, P1465, DOI 10.1126/science.1153878; Titz B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002292; Torreira E, 2008, STRUCTURE, V16, P1511, DOI 10.1016/j.str.2008.08.009; Tutte WT, 1998, GRAPH THEORY I HAVE; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Venkatesan K, 2009, NAT METHODS, V6, P83, DOI 10.1038/NMETH.1280; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Weiss O, 2000, J THEOR BIOL, V206, P379, DOI 10.1006/jtbi.2000.2138; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Whitty A, 2008, NAT CHEM BIOL, V4, P435, DOI 10.1038/nchembio0808-435; Wu WH, 2009, J BIOL CHEM, V284, P6200, DOI 10.1074/jbc.M808830200; Xin XF, 2009, GENOME RES, V19, P1262, DOI 10.1101/gr.090019.108; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684; Zhong JH, 2003, GENOME RES, V13, P2691, DOI 10.1101/gr.1134603	116	11	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e35729	10.1371/journal.pone.0035729	http://dx.doi.org/10.1371/journal.pone.0035729			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22719828	Green Published, gold			2022-12-27	WOS:000305583300004
J	Singh, AK; Mukhopadhyay, C; Biswas, S; Singh, VK; Mukhopadhyay, CK				Singh, Amit Kumar; Mukhopadhyay, Chaitali; Biswas, Sudipta; Singh, Vandana Kumari; Mukhopadhyay, Chinmay K.			Intracellular Pathogen Leishmania donovani Activates Hypoxia Inducible Factor-1 by Dual Mechanism for Survival Advantage within Macrophage	PLOS ONE			English	Article							NF-KAPPA-B; PROLYL HYDROXYLATION; INNATE IMMUNITY; FACTOR HIF; HIF-1-ALPHA; METABOLISM; EXPRESSION; AMAZONENSIS; FAMILY; GROWTH	Recent evidence established a crucial role for mammalian oxygen sensing transcription factor hypoxia inducible factor-1 (HIF-1) in innate immunity against intracellular pathogens. In response to most of these pathogens host phagocytes increase transcription of HIF-1 alpha, the regulatory component of HIF-1 to express various effector molecules against invaders. Leishmania donovani (LD), a protozoan parasite and the causative agent of fatal visceral leishmaniasis resides in macrophages within mammalian host. The mechanism of HIF-1 activation or its role in determining the fate of LD in infected macrophages is still not known. To determine that J774 macrophages were infected with LD and about four-fold increase in HIF-1 activity and HIF-1 alpha expression were detected. A strong increase in HIF-1 alpha expression and nuclear localization was also detected in LD-infected J774 cells, peritoneal macrophages and spleen derived macrophages of LD-infected BALB/c mice. A two-fold increase in HIF-1 alpha mRNA was detected in LD-infected macrophages suggesting involvement of a transcriptional mechanism that was confirmed by promoter activity. We further revealed that LD also induced HIF-1 alpha expression by depleting host cellular iron pool to affect prolyl hydroxylase activity resulting in to stabilization of HIF-1 alpha. To determine the role of HIF-1 on intracellular LD, cells were transfected with HIF-1 alpha siRNA to attenuate its expression and then infected with LD. Although, initial infection rate of LD in HIF-1 alpha attenuated cells was not affected but intracellular growth of LD was significantly inhibited; while, over-expression of stabilized form of HIF-1 alpha promoted intracellular growth of LD in host macrophage. Our results strongly suggest that LD activates HIF-1 by dual mechanism for its survival advantage within macrophage.	[Singh, Amit Kumar; Mukhopadhyay, Chaitali; Biswas, Sudipta; Singh, Vandana Kumari; Mukhopadhyay, Chinmay K.] Jawaharlal Nehru Univ, Special Ctr Mol Med, New Delhi 110067, India	Jawaharlal Nehru University, New Delhi	Singh, AK (corresponding author), Jawaharlal Nehru Univ, Special Ctr Mol Med, New Delhi 110067, India.	ckm2300@mail.jnu.ac.in			Wellcome Trust, UK in terms of International Senior Research Fellowship [073617]; Department of Biotechnology, India [BT/PR14798/MED/29/226/2010]; CSIR, India	Wellcome Trust, UK in terms of International Senior Research Fellowship; Department of Biotechnology, India(Department of Biotechnology (DBT) India); CSIR, India(Council of Scientific & Industrial Research (CSIR) - India)	The work was supported by the financial assistance from The Wellcome Trust, UK in terms of International Senior Research Fellowship (Ref. 073617) and Department of Biotechnology, India (BT/PR14798/MED/29/226/2010) to CKM. AKS, SB and VKS acknowledge the support of fellowships from CSIR, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aragones J, 2009, CELL METAB, V9, P11, DOI 10.1016/j.cmet.2008.10.001; Arrais-Silva WW, 2005, EXP MOL PATHOL, V78, P49, DOI 10.1016/j.yexmp.2004.09.002; Bajou K, 2008, CANCER CELL, V14, P324, DOI 10.1016/j.ccr.2008.08.012; Bayele HK, 2007, BLOOD, V110, P3039, DOI 10.1182/blood-2006-12-063289; Benita Y, 2009, NUCLEIC ACIDS RES, V37, P4587, DOI 10.1093/nar/gkp425; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Biswas S, 2007, AM J PHYSIOL-HEART C, V292, pH758, DOI 10.1152/ajpheart.00718.2006; Blouin CC, 2004, BLOOD, V103, P1124, DOI 10.1182/blood-2003-07-2427; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Burchmore RJS, 2003, P NATL ACAD SCI USA, V100, P3901, DOI 10.1073/pnas.0630165100; CHANG KP, 1980, SCIENCE, V209, P1240, DOI 10.1126/science.7403880; Chappuis F, 2007, NAT REV MICROBIOL, V5, P873, DOI 10.1038/nrmicro1748; Chen ZB, 2009, MED ONCOL, V26, P365, DOI 10.1007/s12032-008-9130-7; Contreras I, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001148; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; Das NK, 2009, CELL MICROBIOL, V11, P83, DOI 10.1111/j.1462-5822.2008.01241.x; Degrossoli A, 2007, IMMUNOL LETT, V114, P119, DOI 10.1016/j.imlet.2007.09.009; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Forget G, 2006, INFECT IMMUN, V74, P6272, DOI 10.1128/IAI.00853-05; Frede S, 2006, BIOCHEM J, V396, P517, DOI 10.1042/BJ20051839; Ghosh S, 2002, INFECT IMMUN, V70, P6828, DOI 10.1128/IAI.70.12.6828-6838.2002; Haeberle HA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003352; Hartmann H, 2008, GASTROENTEROLOGY, V134, P756, DOI 10.1053/j.gastro.2007.12.008; Huynh C, 2006, J EXP MED, V203, P2363, DOI 10.1084/jem.20060559; Hwang IIL, 2006, J VIROL, V80, P10712, DOI 10.1128/JVI.01014-06; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kempf VAJ, 2005, CIRCULATION, V111, P1054, DOI 10.1161/01.CIR.0000155608.07691.B7; Lin MT, 2008, J BIOL CHEM, V283, P15807, DOI 10.1074/jbc.M708933200; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; McConville MJ, 2007, TRENDS PARASITOL, V23, P368, DOI 10.1016/j.pt.2007.06.009; McNeill LA, 2005, ANAL BIOCHEM, V336, P125, DOI 10.1016/j.ab.2004.09.019; Mukhopadhyay CK, 2010, METHODS IN REDOX SIGNALING, P118; Mukhopadhyay CK, 2000, J BIOL CHEM, V275, P21048, DOI 10.1074/jbc.M000636200; MUKKADA AJ, 1985, SCIENCE, V229, P1099, DOI 10.1126/science.4035350; Naderer T, 2008, CELL MICROBIOL, V10, P301, DOI 10.1111/j.1462-5822.2007.01096.x; Nasimuzzaman M, 2007, J VIROL, V81, P10249, DOI 10.1128/JVI.00763-07; Nizet V, 2009, NAT REV IMMUNOL, V9, P609, DOI 10.1038/nri2607; Pan Y, 2007, MOL CELL BIOL, V27, P912, DOI 10.1128/MCB.01223-06; Peyssonnaux C, 2005, J CLIN INVEST, V115, P1806, DOI 10.1172/JCI23865; Rius J, 2008, NATURE, V453, P807, DOI 10.1038/nature06905; Ruhland A, 2007, CELL MICROBIOL, V9, P84, DOI 10.1111/j.1462-5822.2006.00769.x; Semenza GL, 2007, DRUG DISCOV TODAY, V12, P853, DOI 10.1016/j.drudis.2007.08.006; Sen S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002229; Singh VK, 2004, BIOCHEM BIOPH RES CO, V322, P1086, DOI [10.1016/j.bbrc.2004.08.016, 10.1016/j.bbrc.2004.08.020]; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Werth N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011576; Wiley M, 2010, J BIOL CHEM, V285, P26852, DOI 10.1074/jbc.M110.147041; Zarember KA, 2005, J CLIN INVEST, V115, P1702, DOI 10.1172/JCI25740; Zinkernagel AS, 2007, J MOL MED, V85, P1339, DOI 10.1007/s00109-007-0282-2	50	51	54	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2012	7	6							e38489	10.1371/journal.pone.0038489	http://dx.doi.org/10.1371/journal.pone.0038489			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UJ	22701652	gold, Green Published, Green Submitted			2022-12-27	WOS:000305340000025
J	Rakette, S; Donat, S; Ohlsen, K; Stehle, T				Rakette, Sonja; Donat, Stefanie; Ohlsen, Knut; Stehle, Thilo			Structural Analysis of Staphylococcus aureus Serine/Threonine Kinase PknB	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; CRYSTAL-STRUCTURE; ACTIVATION MECHANISM; ANTIBIOTIC-RESISTANCE; CATALYTIC SUBUNIT; DOMAIN; PHOSPHATASES; EXPRESSION; INHIBITOR; SEQUENCE	Effective treatment of infections caused by the bacterium Staphylococcus aureus remains a worldwide challenge, in part due to the constant emergence of new strains that are resistant to antibiotics. The serine/threonine kinase PknB is of particular relevance to the life cycle of S. aureus as it is involved in the regulation of purine biosynthesis, autolysis, and other central metabolic processes of the bacterium. We have determined the crystal structure of the kinase domain of PknB in complex with a non-hydrolyzable analog of the substrate ATP at 3.0 angstrom resolution. Although the purified PknB kinase is active in solution, it crystallized in an inactive, autoinhibited state. Comparison with other bacterial kinases provides insights into the determinants of catalysis, interactions of PknB with ligands, and the pathway of activation.	[Rakette, Sonja; Stehle, Thilo] Univ Tubingen, Interfac Inst Biochem, Tubingen, Germany; [Donat, Stefanie; Ohlsen, Knut] Univ Wurzburg, Inst Mol Infect Biol, Wurzburg, Germany; [Stehle, Thilo] Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37212 USA	Eberhard Karls University of Tubingen; University of Wurzburg; Vanderbilt University	Rakette, S (corresponding author), Univ Tubingen, Interfac Inst Biochem, Tubingen, Germany.	thilo.stehle@uni-tuebingen.de			Collaborative Research Grant from Deutsche Forschungsgemeinschaft [SFB-TR34]	Collaborative Research Grant from Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Collaborative Research Grant SFB-TR34 from the Deutsche Forschungsgemeinschaft via grants to KO and TS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aguilar J, 2010, MEDICINE, V89, P117, DOI 10.1097/MD.0b013e3181d5453d; Alber T, 2009, CURR OPIN STRUC BIOL, V19, P650, DOI 10.1016/j.sbi.2009.10.017; Av-Gay Y, 1999, INFECT IMMUN, V67, P5676, DOI 10.1128/IAI.67.11.5676-5682.1999; BOHACH GA, 1990, CRIT REV MICROBIOL, V17, P251, DOI 10.3109/10408419009105728; BOSSEMEYER D, 1994, TRENDS BIOCHEM SCI, V19, P201, DOI 10.1016/0968-0004(94)90022-1; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; COX S, 1994, CURR OPIN STRUC BIOL, V4, P893, DOI 10.1016/0959-440X(94)90272-0; De Lencastre H, 1999, MICROB DRUG RESIST, V5, P163, DOI 10.1089/mdr.1999.5.163; Debarbouille M, 2009, J BACTERIOL, V191, P4070, DOI 10.1128/JB.01813-08; Deftereos Savas P, 2009, Cases J, V2, P8293, DOI 10.4076/1757-1626-2-8293; Donat S, 2009, J BACTERIOL, V191, P4056, DOI 10.1128/JB.00117-09; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gille C, 2001, BIOINFORMATICS, V17, P377, DOI 10.1093/bioinformatics/17.4.377; Gordon E, 2000, J MOL BIOL, V299, P477, DOI 10.1006/jmbi.2000.3740; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Hansra NK, 2011, DERMATOL THER, V24, P263, DOI 10.1111/j.1529-8019.2011.01402.x; Hubbard SR, 1999, NAT STRUCT BIOL, V6, P711, DOI 10.1038/11468; HUNTER T, 1995, CELL, V80, P225, DOI 10.1016/0092-8674(95)90405-0; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; JEFFREY PD, 1995, NATURE, V376, P313, DOI 10.1038/376313a0; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KARLSSON R, 1993, ACTA CRYSTALLOGR D, V49, P381, DOI 10.1107/S0907444993002306; Kennelly PJ, 2002, FEMS MICROBIOL LETT, V206, P1, DOI 10.1016/S0378-1097(01)00479-7; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Kornev AP, 2008, P NATL ACAD SCI USA, V105, P14377, DOI 10.1073/pnas.0807988105; Kornev AP, 2006, P NATL ACAD SCI USA, V103, P17783, DOI 10.1073/pnas.0607656103; Kornev AP, 2010, BBA-PROTEINS PROTEOM, V1804, P440, DOI 10.1016/j.bbapap.2009.10.017; Lomas-Lopez R, 2007, FEMS MICROBIOL LETT, V272, P35, DOI 10.1111/j.1574-6968.2007.00742.x; Lombana TN, 2010, STRUCTURE, V18, P1667, DOI 10.1016/j.str.2010.09.019; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mieczkowski C, 2008, EMBO J, V27, P3186, DOI 10.1038/emboj.2008.236; Miller M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009057; Ortiz-Lombardia M, 2003, J BIOL CHEM, V278, P13094, DOI 10.1074/jbc.M300660200; Otto M, 2010, MED RES REV, V30, P1, DOI 10.1002/med.20160; Paracuellos P, 2010, J MOL BIOL, V404, P847, DOI 10.1016/j.jmb.2010.10.012; Pereira SFF, 2011, MICROBIOL MOL BIOL R, V75, P192, DOI 10.1128/MMBR.00042-10; Ruggiero A, 2011, BIOCHEM J, V435, P33, DOI 10.1042/BJ20101643; SARASTE M, 1990, TRENDS BIOCHEM SCI, V15, P430, DOI 10.1016/0968-0004(90)90281-F; SchulzeGahmen U, 1996, J MED CHEM, V39, P4540, DOI 10.1021/jm960402a; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Tamber S, 2010, INFECT IMMUN, V78, P3637, DOI 10.1128/IAI.00296-10; Taylor SS, 2011, TRENDS BIOCHEM SCI, V36, P65, DOI 10.1016/j.tibs.2010.09.006; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Truong-Bolduc QC, 2010, J BACTERIOL, V192, P2525, DOI 10.1128/JB.00018-10; Wehenkel A, 2006, FEBS LETT, V580, P3018, DOI 10.1016/j.febslet.2006.04.046; Xu WQ, 1999, MOL CELL, V3, P629, DOI 10.1016/S1097-2765(00)80356-1; Yeats C, 2002, TRENDS BIOCHEM SCI, V27, P438, DOI 10.1016/S0968-0004(02)02164-3; Young TA, 2003, NAT STRUCT BIOL, V10, P168, DOI 10.1038/nsb897; ZHENG JH, 1993, ACTA CRYSTALLOGR D, V49, P362, DOI 10.1107/S0907444993000423	52	23	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2012	7	6							e39136	10.1371/journal.pone.0039136	http://dx.doi.org/10.1371/journal.pone.0039136			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TU	22701750	Green Submitted, Green Published, gold			2022-12-27	WOS:000305337600070
J	Wang, C; Pan, Y; Zhang, QY; Wang, FM; Kong, LD				Wang, Chuang; Pan, Ying; Zhang, Qing-Yu; Wang, Fu-Meng; Kong, Ling-Dong			Quercetin and Allopurinol Ameliorate Kidney Injury in STZ-Treated Rats with Regulation of Renal NLRP3 Inflammasome Activation and Lipid Accumulation	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; SERUM URIC-ACID; DIABETIC-NEPHROPATHY; CELL-DEATH; METABOLISM; EXPRESSION; CARNITINE; OBESITY; GLOMERULOSCLEROSIS; INTERLEUKIN-18	Hyperuricemia, hyperlipidemia and inflammation are associated with diabetic nephropathy. The NLRP3 inflammasome-mediated inflammation is recently recognized in the development of kidney injury. Urate and lipid are considered as danger signals in the NLRP3 inflammasome activation. Although dietary flavonoid quercetin and allopurinol alleviate hyperuricemia, dyslipidmia and inflammation, their nephroprotective effects are currently unknown. In this study, we used streptozotocin (STZ)-induced diabetic nephropathy model with hyperuricemia and dyslipidemia in rats, and found over-expression of renal inflammasome components NLRP3, apoptosis-associated speck-like protein and Caspase-1, resulting in elevation of IL-1 beta and IL-18, with subsequently deteriorated renal injury. These findings demonstrated the possible association between renal NLRP3 inflammasome activation and lipid accumulation to superimpose causes of nephrotoxicity in STZ-treated rats. The treatment of quercetin and allopurinol regulated renal urate transport-related proteins to reduce hyperuricemia, and lipid metabolism-related genes to alleviate kidney lipid accumulation in STZ-treated rats. Furthermore, quercetin and allopurinol were found to suppress renal NLRP3 inflammasome activation, at least partly, via their anti-hyperuricemic and anti-dyslipidemic effects, resulting in the amelioration of STZ-induced the superimposed nephrotoxicity in rats. These results may provide a basis for the prevention of diabetes-associated nephrotoxicity with urate-lowering agents such as quercetin and allopurinol.	[Wang, Chuang; Pan, Ying; Zhang, Qing-Yu; Wang, Fu-Meng; Kong, Ling-Dong] Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing, Jiangsu, Peoples R China	Nanjing University	Wang, C (corresponding author), Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing, Jiangsu, Peoples R China.	kongld@nju.edu.cn			National Natural Science Foundation of China [NSFC 81025025]; National Basic Research Program of China 973 Program [2012CB517600, 2012CB517602]; Jinagsu Natural Science Foundation [BK2010365]; Program for Changjiang Scholars and Innovative Research Team in University [IRT1020]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China 973 Program(National Basic Research Program of China); Jinagsu Natural Science Foundation; Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was supported by grants from National Natural Science Foundation of China (NSFC 81025025), National Basic Research Program of China 973 Program No. 2012CB517600 (No. 2012CB517602), Jinagsu Natural Science Foundation (BK2010365) and Program for Changjiang Scholars and Innovative Research Team in University (IRT1020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Raheem IT, 2009, BIOL PHARM BULL, V32, P61, DOI 10.1248/bpb.32.61; Anjaneyulu M, 2004, CLIN EXP PHARMACOL P, V31, P244, DOI 10.1111/j.1440-1681.2004.03982.x; Arlehamn CSL, 2010, J BIOL CHEM, V285, P10508, DOI 10.1074/jbc.M109.067298; Ayodele OE, 2004, J NATL MED ASSOC, V96, P1445; Cheng QQ, 2008, MOL PHARMACEUT, V5, P77, DOI 10.1021/mp700114j; Chuang CC, 2010, AM J CLIN NUTR, V92, P1511, DOI 10.3945/ajcn.2010.29807; Dinarello CA, 2010, CURR OPIN ENDOCRINOL, V17, P314, DOI 10.1097/MED.0b013e32833bf6dc; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Edwards RL, 2007, J NUTR, V137, P2405, DOI 10.1093/jn/137.11.2405; Ergun O, 2001, UROL RES, V29, P186, DOI 10.1007/s002400100176; Eskandari HG, 2004, DIABETES RES CLIN PR, V66, P129, DOI 10.1016/j.diabres.2004.03.005; ESTEVEZ EC, 1990, CLIN RHEUMATOL, V9, P28, DOI 10.1007/BF02030237; Farfari S, 2000, DIABETES, V49, P718, DOI 10.2337/diabetes.49.5.718; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Fink SL, 2008, P NATL ACAD SCI USA, V105, P4312, DOI 10.1073/pnas.0707370105; Frigerio F, 2010, DIABETOLOGIA, V53, P331, DOI 10.1007/s00125-009-1590-6; Gasse P, 2009, AM J RESP CRIT CARE, V179, P903, DOI 10.1164/rccm.200808-1274OC; Griffith JW, 2009, J IMMUNOL, V183, P5208, DOI 10.4049/jimmunol.0713552; Guan YF, 2001, KIDNEY INT, V60, P14, DOI 10.1046/j.1523-1755.2001.00766.x; Hediger MA, 2005, PHYSIOLOGY, V20, P125, DOI 10.1152/physiol.00039.2004; Hiukka A, 2010, NAT REV ENDOCRINOL, V6, P454, DOI 10.1038/nrendo.2010.89; Hostetler HA, 2008, J BIOL CHEM, V283, P2246, DOI 10.1074/jbc.M705138200; Hovind P, 2011, J RENAL NUTR, V21, P124, DOI 10.1053/j.jrn.2010.10.024; Hovind P, 2009, DIABETES, V58, P1668, DOI 10.2337/db09-0014; Hu QH, 2009, AM J PHYSIOL-RENAL, V297, pF1080, DOI 10.1152/ajprenal.90767.2008; Iyer SS, 2009, P NATL ACAD SCI USA, V106, P20388, DOI 10.1073/pnas.0908698106; Joosten LAB, 2010, ARTHRITIS RHEUM-US, V62, P3237, DOI 10.1002/art.27667; Keembiyehetty C, 2006, MOL ENDOCRINOL, V20, P686, DOI 10.1210/me.2005-0010; Kerner J, 2000, BBA-MOL CELL BIOL L, V1486, P1, DOI 10.1016/S1388-1981(00)00044-5; Kobori M, 2011, MOL NUTR FOOD RES, V55, P530, DOI 10.1002/mnfr.201000392; Kosugi T, 2009, AM J PHYSIOL-RENAL, V297, pF481, DOI 10.1152/ajprenal.00092.2009; Kraynak AR, 1995, TOXICOL APPL PHARM, V135, P279, DOI 10.1006/taap.1995.1234; Krzystanek M, 2010, J BIOL CHEM, V285, P10583, DOI 10.1074/jbc.M109.078006; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mahesh T, 2004, PHYTOTHER RES, V18, P123, DOI 10.1002/ptr.1374; Masters SL, 2010, NAT IMMUNOL, V11, P897, DOI 10.1038/ni.1935; Minami M, 2005, BLOOD PRESSURE, V14, P120, DOI 10.1080/08037050510008878; Momeni A, 2010, IRAN J KIDNEY DIS, V4, P128; Moriwaki Y, 2003, METABOLISM, V52, P605, DOI 10.1053/meta.2003.50096; Murea M, 2010, CLIN J AM SOC NEPHRO, V5, P2373, DOI 10.2215/CJN.08160910; Navarro-Gonzalez JF, 2008, J AM SOC NEPHROL, V19, P433, DOI 10.1681/ASN.2007091048; Navarro-Gonzalez JF, 2011, NAT REV NEPHROL, V7, P327, DOI 10.1038/nrneph.2011.51; Olusi SO, 2003, HORM RES, V60, P29, DOI 10.1159/000070824; Park CW, 2006, DIABETES, V55, P885, DOI 10.2337/diabetes.55.04.06.db05-1329; PARK J, 2008, FASEB J, V22, pLB707; Poeck H, 2010, NAT IMMUNOL, V11, P63, DOI 10.1038/ni.1824; Poulain-Godefroy O, 2008, AM J PHYSIOL-REG I, V295, pR1, DOI 10.1152/ajpregu.00926.2007; Power RA, 2007, DIABETOLOGIA, V50, P824, DOI 10.1007/s00125-007-0605-4; Rajamaki K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011765; Reungjui S, 2007, J AM SOC NEPHROL, V18, P2724, DOI 10.1681/ASN.2007040416; Rivera L, 2008, OBESITY, V16, P2081, DOI 10.1038/oby.2008.315; Shigeoka AA, 2010, J IMMUNOL, V185, P6277, DOI 10.4049/jimmunol.1002330; Stienstra R, 2011, P NATL ACAD SCI USA, V108, P15324, DOI 10.1073/pnas.1100255108; Sun LJ, 2002, J BIOL CHEM, V277, P18919, DOI 10.1074/jbc.M110650200; Tamai I, 2000, J BIOL CHEM, V275, P40064, DOI 10.1074/jbc.M005340200; Tesch GH, 2007, NEPHROLOGY, V12, P261, DOI 10.1111/j.1440-1797.2007.00796.x; Tone A, 2005, DIABETOLOGIA, V48, P2402, DOI 10.1007/s00125-005-1945-6; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Vilaysane A, 2010, J AM SOC NEPHROL, V21, P1732, DOI 10.1681/ASN.2010020143; Wakil SJ, 2009, J LIPID RES, V50, pS138, DOI 10.1194/jlr.R800079-JLR200; Wang ZW, 2005, DIABETES, V54, P2328, DOI 10.2337/diabetes.54.8.2328; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Wu CH, 2009, MOL NUTR FOOD RES, V53, P984, DOI 10.1002/mnfr.200800495; Zager RA, 2005, KIDNEY INT, V67, P111, DOI 10.1111/j.1523-1755.2005.00061.x; Zager RA, 2001, KIDNEY INT, V59, P1750, DOI 10.1046/j.1523-1755.2001.0590051750.x	66	155	172	4	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2012	7	6							e38285	10.1371/journal.pone.0038285	http://dx.doi.org/10.1371/journal.pone.0038285			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TU	22701621	Green Submitted, Green Published, gold			2022-12-27	WOS:000305337600019
J	Dickson, RJ; Gloor, GB				Dickson, Russell J.; Gloor, Gregory B.			Protein Sequence Alignment Analysis by Local Covariation: Coevolution Statistics Detect Benchmark Alignment Errors	PLOS ONE			English	Article							FUNCTIONAL DIVERGENCE; GENE; CONSERVATION; INFORMATION; DATABASE; DNA	The use of sequence alignments to understand protein families is ubiquitous in molecular biology. High quality alignments are difficult to build and protein alignment remains one of the largest open problems in computational biology. Misalignments can lead to inferential errors about protein structure, folding, function, phylogeny, and residue importance. Identifying alignment errors is difficult because alignments are built and validated on the same primary criteria: sequence conservation. Local covariation identifies systematic misalignments and is independent of conservation. We demonstrate an alignment curation tool, LoCo, that integrates local covariation scores with the Jalview alignment editor. Using LoCo, we illustrate how local covariation is capable of identifying alignment errors due to the reduction of positional independence in the region of misalignment. We highlight three alignments from the benchmark database, BAliBASE 3, that contain regions of high local covariation, and investigate the causes to illustrate these types of scenarios. Two alignments contain sequential and structural shifts that cause elevated local covariation. Realignment of these misaligned segments reduces local covariation; these alternative alignments are supported with structural evidence. We also show that local covariation identifies active site residues in a validated alignment of paralogous structures. Loco is available at https://sourceforge. net/projects/locoprotein/files/	[Dickson, Russell J.; Gloor, Gregory B.] Univ Western Ontario, Dept Biochem, London, ON, Canada	Western University (University of Western Ontario)	Dickson, RJ (corresponding author), Univ Western Ontario, Dept Biochem, London, ON, Canada.	ggloor@uwo.ca	Gloor, Greg B/D-1671-2013	Gloor, Gregory/0000-0001-5803-3380	National Sciences and Engineering Council of Canada CGS scholarship; National Sciences and Engineering Council of Canada	National Sciences and Engineering Council of Canada CGS scholarship; National Sciences and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	RJD is supported by a National Sciences and Engineering Council of Canada CGS scholarship. Work in the lab of GG is supported by a Discovery Grant from the National Sciences and Engineering Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atchley WR, 2000, MOL BIOL EVOL, V17, P164, DOI 10.1093/oxfordjournals.molbev.a026229; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dickson RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011082; Dunn SD, 2008, BIOINFORMATICS, V24, P333, DOI 10.1093/bioinformatics/btm604; Edgar RC, 2010, NUCLEIC ACIDS RES, V38, P2145, DOI 10.1093/nar/gkp1196; Fares MA, 2006, GENETICS, V173, P9, DOI 10.1534/genetics.105.053249; Felsenstein J., 2004, INFERRING PHYLOGENIE; FITCH WM, 1970, BIOCHEM GENET, V4, P579, DOI 10.1007/BF00486096; Gilbert D, 2003, SEQUENCE FILE FORMAT; Gloor GB, 2010, MOL BIOL EVOL, V27, P1181, DOI 10.1093/molbev/msq004; Gu X, 1999, MOL BIOL EVOL, V16, P1664, DOI 10.1093/oxfordjournals.molbev.a026080; Gu X, 2001, MOL BIOL EVOL, V18, P453, DOI 10.1093/oxfordjournals.molbev.a003824; Gu X, 2006, MOL BIOL EVOL, V23, P1937, DOI 10.1093/molbev/msl056; Hogue CWV, 1997, TRENDS BIOCHEM SCI, V22, P314, DOI 10.1016/S0968-0004(97)01093-1; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Kass I, 2002, PROTEINS, V48, P611, DOI 10.1002/prot.10180; Kawrykow A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031362; Kim CH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-355; Kleinstiver BP, 2010, NUCLEIC ACIDS RES, V38, P2411, DOI 10.1093/nar/gkp1223; Kuziemko A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002175; LAKE JA, 1994, P NATL ACAD SCI USA, V91, P1455, DOI 10.1073/pnas.91.4.1455; Little DY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004762; Liu ZJ, 1997, NAT STRUCT BIOL, V4, P317, DOI 10.1038/nsb0497-317; Marchler-Bauer A, 2002, NUCLEIC ACIDS RES, V30, P281, DOI 10.1093/nar/30.1.281; Ni L, 1997, J BIOL CHEM, V272, P18823, DOI 10.1074/jbc.272.30.18823; Olmea O, 1999, J MOL BIOL, V293, P1221, DOI 10.1006/jmbi.1999.3208; Perez-Miller SJ, 2003, BIOCHEMISTRY-US, V42, P7100, DOI 10.1021/bi034182w; Poon A, 2005, GENETICS, V170, P989, DOI 10.1534/genetics.104.039438; Rodionov A, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-17; Takeuchi R, 2011, P NATL ACAD SCI USA, V108, P13077, DOI 10.1073/pnas.1107719108; Thangudu RR, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-55; Thompson JD, 1999, BIOINFORMATICS, V15, P87, DOI 10.1093/bioinformatics/15.1.87; Thompson JD, 2005, PROTEINS, V61, P127, DOI 10.1002/prot.20527; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Xu YB, 2010, PROTEINS, V78, P548, DOI 10.1002/prot.22576; YANOFSKY C, 1964, SCIENCE, V146, P1593, DOI 10.1126/science.146.3651.1593	38	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2012	7	6							e37645	10.1371/journal.pone.0037645	http://dx.doi.org/10.1371/journal.pone.0037645			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TQ	22715369	gold, Green Published			2022-12-27	WOS:000305336800010
J	Sanchez-Sampedro, L; Gomez, CE; Mejias-Perez, E; Sorzano, COS; Esteban, M				Sanchez-Sampedro, Lucas; Elena Gomez, Carmen; Mejias-Perez, Ernesto; Sorzano, Carlos Oscar S.; Esteban, Mariano			High Quality Long-Term CD4(+) and CD8(+) Effector Memory Populations Stimulated by DNA-LACK/MVA-LACK Regimen in Leishmania major BALB/c Model of Infection	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; PRIME-BOOST VACCINATION; T-CELLS; IFN-GAMMA; VISCERAL LEISHMANIASIS; PROTECTIVE IMMUNITY; INDUCTION; MICE; VECTOR; IMMUNIZATION	Heterologous vaccination based on priming with a plasmid DNA vector and boosting with an attenuated vaccinia virus MVA recombinant, with both vectors expressing the Leishmania infantum LACK antigen (DNA-LACK and MVA-LACK), has shown efficacy conferring protection in murine and canine models against cutaneus and visceral leishmaniasis, but the immune parameters of protection remain ill defined. Here we performed by flow cytometry an in depth analysis of the T cell populations induced in BALB/c mice during the vaccination protocol DNA-LACK/MVA-LACK, as well as after challenge with L. major parasites. In the adaptive response, there is a polyfunctional CD4(+) and CD8(+) T cell activation against LACK antigen. At the memory phase the heterologous vaccination induces high quality LACK-specific long-term CD4(+) and CD8(+) effector memory cells. After parasite challenge, there is a moderate boosting of LACK-specific CD4(+) and CD8(+) T cells. Anti-vector responses were largely CD8(+)-mediated. The immune parameters induced against LACK and triggered by the combined vaccination DNA/MVA protocol, like polyfunctionality of CD4(+) and CD8(+) T cells with an effector phenotype, could be relevant in protection against leishmaniasis.	[Sanchez-Sampedro, Lucas; Elena Gomez, Carmen; Mejias-Perez, Ernesto; Esteban, Mariano] CSIC, Ctr Nacl Biotecnol, Dept Mol & Cellular Biol, Madrid, Spain; [Sorzano, Carlos Oscar S.] CSIC, Ctr Nacl Biotecnol, Biocomp Unit, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Sanchez-Sampedro, L (corresponding author), CSIC, Ctr Nacl Biotecnol, Dept Mol & Cellular Biol, Madrid, Spain.	mesteban@cnb.csic.es	S. Sorzano, Carlos Oscar/ABE-4884-2021; Gomez, Carmen Elena/K-1940-2014; Sorzano, Carlos Oscar S S./F-2639-2016; Esteban, Mariano/ABG-5375-2020	S. Sorzano, Carlos Oscar/0000-0002-9473-283X; Gomez, Carmen Elena/0000-0002-5414-7935; Sorzano, Carlos Oscar S S./0000-0002-9473-283X; Esteban, Mariano/0000-0003-0846-2827; Mejias Perez, Ernesto/0000-0002-5208-8177	Foundation Botin; Ministry of Science and Technology;  [SAF2008-02036]	Foundation Botin; Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); 	This investigation was supported by research grant SAF2008-02036 and Foundation Botin. LSS and EMP were supported by PhD Fellowships from the Ministry of Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed SB, 2004, VACCINE, V22, P1631, DOI 10.1016/j.vaccine.2003.10.046; Bogdan C, 1990, EUROPEAN J IMMUNOLOG, P1131; Cote-Sierra J, 2002, INFECT IMMUN, V70, P240, DOI 10.1128/IAI.70.1.240-248.2002; Croft SL, 2011, CLIN MICROBIOL INFEC, V17, P1478, DOI 10.1111/j.1469-0691.2011.03630.x; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; Darrah PA, 2010, J EXP MED, V207, P1421, DOI 10.1084/jem.20092532; Dondji B, 2005, INFECT IMMUN, V73, P5286, DOI 10.1128/IAI.73.8.5286-5289.2005; Doroud D, 2011, J CONTROL RELEASE, V153, P154, DOI 10.1016/j.jconrel.2011.04.011; Duthie MS, 2012, VACCINE, V30, P134, DOI 10.1016/j.vaccine.2011.11.005; Faria DR, 2009, PARASITE IMMUNOL, V31, P432, DOI 10.1111/j.1365-3024.2009.01125.x; Ferlin WG, 1998, EUR J IMMUNOL, V28, P525, DOI 10.1002/(SICI)1521-4141(199802)28:02&lt;525::AID-IMMU525&gt;3.0.CO;2-M; Garcia-Arriaza J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012395; Gherardi MM, 2004, J IMMUNOL, V172, P6209, DOI 10.4049/jimmunol.172.10.6209; Gonzalez-Aseguinolaza G, 1999, EUR J BIOCHEM, V259, P909, DOI 10.1046/j.1432-1327.1999.00122.x; GREEN SJ, 1990, J IMMUNOL, V145, P4290; Haque A, 2010, J IMMUNOL, V184, P2583, DOI 10.4049/jimmunol.0903080; Julia V, 1996, SCIENCE, V274, P421, DOI 10.1126/science.274.5286.421; Keesen TSL, 2011, CLIN EXP IMMUNOL, V165, P338, DOI 10.1111/j.1365-2249.2011.04430.x; Khamesipour A, 2012, MICROBES INFECT, V14, P702, DOI 10.1016/j.micinf.2012.02.006; Launois P, 1997, IMMUNITY, V6, P541, DOI 10.1016/S1074-7613(00)80342-8; Launois P, 2007, MICROBES INFECT, V9, P1260, DOI 10.1016/j.micinf.2007.05.017; LIEW FY, 1990, J IMMUNOL, V145, P4306; LIEW FY, 1991, IMMUNOLOGY, V74, P304; Najera JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011406; Macedo ABB, 2012, CLIN EXP IMMUNOL, V167, P505, DOI 10.1111/j.1365-2249.2011.04536.x; Melby PC, 2001, INFECT IMMUN, V69, P4719, DOI 10.1128/IAI.69.8.4719-4725.2001; Mooij P, 2008, J VIROL, V82, P2975, DOI 10.1128/JVI.02216-07; MOUGNEAU E, 1995, SCIENCE, V268, P563, DOI 10.1126/science.7725103; Murray HW, 2000, INFECT IMMUN, V68, P6289, DOI 10.1128/IAI.68.11.6289-6293.2000; Papadogiannakis E, 2010, VET J, V186, P262, DOI 10.1016/j.tvjl.2009.08.001; Perez-Jimenez E, 2006, MICROBES INFECT, V8, P810, DOI 10.1016/j.micinf.2005.10.004; Perfetto SP, 2004, NAT REV IMMUNOL, V4, P648, DOI 10.1038/nri1416; Pingel S, 1999, J EXP MED, V189, P1111, DOI 10.1084/jem.189.7.1111; Ramos I, 2008, VACCINE, V26, P333, DOI 10.1016/j.vaccine.2007.11.021; Ramos I, 2009, VACCINE, V27, P6695, DOI 10.1016/j.vaccine.2009.08.091; Ramsay AJ, 1997, IMMUNOL CELL BIOL, V75, P382, DOI 10.1038/icb.1997.60; Reiner SL, 1998, J IMMUNOL, V160, P884; Reyes-Sandoval A, 2011, J IMMUNOL, V187, P1347, DOI 10.4049/jimmunol.1100302; Rigato PO, 2011, INFECT IMMUN, V79, P2120, DOI 10.1128/IAI.01190-10; Rostami MN, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000845; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Tapia E, 2003, MICROBES INFECT, V5, P73, DOI 10.1016/S1286-4579(02)00077-1; Tscharke DC, 2005, J EXP MED, V201, P95, DOI 10.1084/jem.20041912; Wilhelm P, 2001, J IMMUNOL, V166, P4012, DOI 10.4049/jimmunol.166.6.4012; World Health O, 2004, SCI WORK GROUP REP L; Xin L, 2011, PARASITE IMMUNOL, V33, P170, DOI 10.1111/j.1365-3024.2010.01268.x	46	23	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2012	7	6							e38859	10.1371/journal.pone.0038859	http://dx.doi.org/10.1371/journal.pone.0038859			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TQ	22715418	gold, Green Published			2022-12-27	WOS:000305336800060
J	Schino, G; Marini, C				Schino, Gabriele; Marini, Claudia			Self-Protective Function of Post-Conflict Bystander Affiliation in Mandrills	PLOS ONE			English	Article							POSTCONFLICT 3RD-PARTY AFFILIATION; DISPLACEMENT ACTIVITIES; CHIMPANZEES; RECONCILIATION; CONSOLATION; PATTERNS; MACAQUES; PRIMATES; PROPOSAL; EMPATHY	Background: Affiliative interactions exchanged between victims of aggression and individuals not involved in the original aggression (bystanders) have been observed in various species. Three hypothetical functions have been proposed for these interactions: consolation, self-protection and substitute reconciliation, but data to test them are scanty. Methodology/Principal Findings: We conducted post-conflict and matched control observations on a captive group of mandrills (Mandrillus sphinx). We found that victims often redirected aggression to bystanders, that they received most affiliation from those bystanders that were frequently the target of redirection, and that bystander affiliation reduced the likelihood of redirection. Bystander affiliation did not reduce the victim's distress (as measured by its scratching rates) and was not received primarily from kin/friends. Finally, bystander affiliation did not reduce the likelihood of renewed aggression from the original aggressor. Conclusions/Significance: These results provide support for the self-protection hypothesis but not for the consolation and substitute reconciliation hypotheses.	[Schino, Gabriele] CNR, Ist Sci & Tecnol Cogniz, Rome, Italy; [Marini, Claudia] Univ Roma La Sapienza, Dipartimento Biol & Biotecnol Charles Darwin, Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze e Tecnologie della Cognizione (ISTC-CNR); Sapienza University Rome	Schino, G (corresponding author), CNR, Ist Sci & Tecnol Cogniz, Rome, Italy.	gabriele.schino@enea.it	Schino, Gabriele/B-7569-2015	Schino, Gabriele/0000-0002-5011-4896				Allison PD, 2009, FIXED EFFECT REGRESS; AURELI F, 1991, ETHOLOGY, V89, P89; Aureli F., 2000, NATURAL CONFLICT RES; Aureli F., EVOLUTION P IN PRESS; Call J, 2002, ANIM BEHAV, V63, P209, DOI 10.1006/anbe.2001.1908; Cheney DL, 2007, BABOON METAPHYSICS; Cleasby IR, 2011, BEHAV ECOL SOCIOBIOL, V65, P2361, DOI 10.1007/s00265-011-1254-7; Cleves M., 2008, INTRO SURVIVAL ANAL; Cools AKA, 2008, ETHOLOGY, V114, P53, DOI 10.1111/j.1439-0310.2007.01443.x; Das M., 2000, NATURAL CONFLICT RES, P263; De Marco A, 2010, ANIM BEHAV, V80, P197, DOI 10.1016/j.anbehav.2010.04.016; De Waal Frans B. M., 1996, P80; DEWAAL FBM, 1979, BEHAV ECOL SOCIOBIOL, V5, P55, DOI 10.1007/BF00302695; DEWAAL FBM, 1983, BEHAVIOUR, V85, P224, DOI 10.1163/156853983X00237; Fraser ON, 2008, P NATL ACAD SCI USA, V105, P8557, DOI 10.1073/pnas.0804141105; Fraser ON, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010605; Fraser Orlaith N, 2009, Commun Integr Biol, V2, P285; Harcourt AH., 1992, COALITIONS ALLIANCES; Judge PG, 2005, ANIM BEHAV, V69, P1345, DOI 10.1016/j.anbehav.2004.08.016; Koski SE, 2007, ANIM BEHAV, V73, P133, DOI 10.1016/j.anbehav.2006.04.009; Koski SE, 2010, EUR J DEV PSYCHOL, V7, P38, DOI 10.1080/17405620902986991; Koski SE, 2009, AM J PRIMATOL, V71, P409, DOI 10.1002/ajp.20668; MAESTRIPIERI D, 1992, ANIM BEHAV, V44, P967, DOI 10.1016/S0003-3472(05)80592-5; Palagi E, 2009, ANIM BEHAV, V78, P979, DOI 10.1016/j.anbehav.2009.07.017; Preston SD, 2002, BEHAV BRAIN SCI, V25, P1, DOI 10.1017/S0140525X02000018; Romero T, 2010, J COMP PSYCHOL, V124, P278, DOI 10.1037/a0019144; Romero T, 2010, P NATL ACAD SCI USA, V107, P12110, DOI 10.1073/pnas.1006991107; Schino G, 1996, ANXIETY, V2, P186; Schino G, 2004, J COMP PSYCHOL, V118, P340, DOI 10.1037/0735-7036.118.3.340; Schino G, 2011, ANIM BEHAV, V81, P1009, DOI 10.1016/j.anbehav.2011.02.004; Seed AM, 2007, CURR BIOL, V17, P152, DOI 10.1016/j.cub.2006.11.025; StataCorp, 2009, STAT STAT SOFTW REL; van de Pol MV, 2009, ANIM BEHAV, V77, P753, DOI 10.1016/j.anbehav.2008.11.006; VEENEMA HC, 1994, BEHAV PROCESS, V31, P29, DOI 10.1016/0376-6357(94)90035-3; Watts David P., 2000, P281; WHITE H, 1980, ECONOMETRICA, V48, P817, DOI 10.2307/1912934; Wittig RM, 2007, P R SOC B, V274, P1109, DOI 10.1098/rspb.2006.0203; Wittig RM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013995	38	21	22	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2012	7	6							e38936	10.1371/journal.pone.0038936	http://dx.doi.org/10.1371/journal.pone.0038936			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TQ	22715420	Green Submitted, Green Published, gold			2022-12-27	WOS:000305336800062
J	Du, H; Feng, BR; Yang, SS; Huang, YB; Tang, YX				Du, Hai; Feng, Bo-Run; Yang, Si-Si; Huang, Yu-Bi; Tang, Yi-Xiong			The R2R3-MYB Transcription Factor Gene Family in Maize	PLOS ONE			English	Article							DNA-BINDING DOMAIN; GAMYB-LIKE GENES; MYB GENES; GLUCOSINOLATE BIOSYNTHESIS; MOLECULAR CHARACTERIZATION; ALEURONE CELLS; ZEA-MAYS; C-MYB; ARABIDOPSIS; ENCODES	MYB proteins comprise a large family of plant transcription factors, members of which perform a variety of functions in plant biological processes. To date, no genome-wide characterization of this gene family has been conducted in maize (Zea mays). In the present study, we performed a comprehensive computational analysis, to yield a complete overview of the R2R3-MYB gene family in maize, including the phylogeny, expression patterns, and also its structural and functional characteristics. The MYB gene structure in maize and Arabidopsis were highly conserved, indicating that they were originally compact in size. Subgroup-specific conserved motifs outside the MYB domain may reflect functional conservation. The genome distribution strongly supports the hypothesis that segmental and tandem duplication contribute to the expansion of maize MYB genes. We also performed an updated and comprehensive classification of the R2R3-MYB gene families in maize and other plant species. The result revealed that the functions were conserved between maize MYB genes and their putative orthologs, demonstrating the origin and evolutionary diversification of plant MYB genes. Species-specific groups/subgroups may evolve or be lost during evolution, resulting in functional divergence. Expression profile study indicated that maize R2R3-MYB genes exhibit a variety of expression patterns, suggesting diverse functions. Furthermore, computational prediction potential targets of maize microRNAs (miRNAs) revealed that miR159, miR319, and miR160 may be implicated in regulating maize R2R3-MYB genes, suggesting roles of these miRNAs in post-transcriptional regulation and transcription networks. Our comparative analysis of R2R3-MYB genes in maize confirm and extend the sequence and functional characteristics of this gene family, and will facilitate future functional analysis of the MYB gene family in maize.	[Du, Hai; Huang, Yu-Bi] Sichuan Agr Univ, Maize Res Inst, Minist Agr, Key Lab Biol & Genet Improvement Maize SW Reg, Chengdu, Sichuan, Peoples R China; [Du, Hai; Tang, Yi-Xiong] Chinese Acad Agr Sci, Biotechnol Res Inst, Beijing 100193, Peoples R China	Ministry of Agriculture & Rural Affairs; Sichuan Agricultural University; Chinese Academy of Agricultural Sciences; Biotechnology Research Institute, CAAS	Du, H (corresponding author), Sichuan Agr Univ, Maize Res Inst, Minist Agr, Key Lab Biol & Genet Improvement Maize SW Reg, Chengdu, Sichuan, Peoples R China.	yubihuang@sohu.com; tangyx@mail.caas.net.cn	Du, Hai/AHD-1445-2022	Du, Hai/0000-0003-4274-5724	State Key Basic Research and Development Plan of China [2011Cb100100, 2011Cb100106]; National Natural Science Foundation of China	State Key Basic Research and Development Plan of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This project was supported by the State Key Basic Research and Development Plan of China (2011Cb100100 and 2011Cb100106) and the National Natural Science Foundation of China (http://www.nsfc.gov.cn/Portal0/default152.htm).	Achard P, 2004, DEVELOPMENT, V131, P3357, DOI 10.1242/dev.01206; Addo-Quaye C, 2008, CURR BIOL, V18, P758, DOI 10.1016/j.cub.2008.04.042; Akagi T, 2010, PLANTA, V232, P1045, DOI 10.1007/s00425-010-1241-7; Apweiler R, 2001, NUCLEIC ACIDS RES, V29, P37, DOI 10.1093/nar/29.1.37; Aya K, 2009, PLANT CELL, V21, P1453, DOI 10.1105/tpc.108.062935; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Bailey TL, 1998, BIOINFORMATICS, V14, P48, DOI 10.1093/bioinformatics/14.1.48; Ballester AR, 2010, PLANT PHYSIOL, V152, P71, DOI 10.1104/pp.109.147322; Baumann K, 2007, DEVELOPMENT, V134, P1691, DOI 10.1242/dev.02836; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Boddu J, 2006, PLANT MOL BIOL, V60, P185, DOI 10.1007/s11103-005-3568-1; Brett D, 2002, NAT GENET, V30, P29, DOI 10.1038/ng803; Byrne ME, 2000, NATURE, V408, P967, DOI 10.1038/35050091; Cai H, 2011, MOL BIOTECHNOL; Celenza JL, 2005, PLANT PHYSIOL, V137, P253, DOI 10.1104/pp.104.054395; Chen YH, 2006, PLANT MOL BIOL, V60, P107, DOI 10.1007/s11103-005-2910-y; Colquhoun TA, 2011, J EXP BOT, V62, P1133, DOI 10.1093/jxb/erq342; CONE KC, 1993, PLANT CELL, V5, P1795, DOI 10.1105/tpc.5.12.1795; Czemmel S, 2009, PLANT PHYSIOL, V151, P1513, DOI 10.1104/pp.109.142059; Dias AP, 2003, PLANT PHYSIOL, V131, P610, DOI 10.1104/pp.012047; Dubos C, 2008, PLANT J, V55, P940, DOI 10.1111/j.1365-313X.2008.03564.x; Dubos C, 2010, TRENDS PLANT SCI, V15, P573, DOI 10.1016/j.tplants.2010.06.005; Durbarry A, 2005, PLANT PHYSIOL, V137, P297, DOI 10.1104/pp.104.053165; Feng CP, 2004, PLANT SCI, V167, P1099, DOI 10.1016/j.plantsci.2004.06.014; Fornale S, 2006, PLANT MOL BIOL, V62, P809, DOI 10.1007/s11103-006-9058-2; Gigolashvili T, 2008, NEW PHYTOL, V177, P627, DOI 10.1111/j.1469-8137.2007.02295.x; Gigolashvili T, 2007, PLANT J, V51, P247, DOI 10.1111/j.1365-313X.2007.03133.x; Gigolashvili T, 2007, PLANT J, V50, P886, DOI 10.1111/j.1365-313X.2007.03099.x; Gocal GFW, 1999, PLANT PHYSIOL, V119, P1271, DOI 10.1104/pp.119.4.1271; Gocal GFW, 2001, PLANT PHYSIOL, V127, P1682, DOI 10.1104/pp.010442; Gong XM, 2008, PLANTA, V228, P563, DOI 10.1007/s00425-008-0759-4; Grotewold E, 2000, P NATL ACAD SCI USA, V97, P13579, DOI 10.1073/pnas.250379897; GROTEWOLD E, 1991, P NATL ACAD SCI USA, V88, P4587, DOI 10.1073/pnas.88.11.4587; GUBLER F, 1995, PLANT CELL, V7, P1879, DOI 10.1105/tpc.7.11.1879; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hegvold AB, 1996, NUCLEIC ACIDS RES, V24, P3990, DOI 10.1093/nar/24.20.3990; Heine GF, 2007, MOL BIOTECHNOL, V37, P155, DOI 10.1007/s12033-007-0061-x; Heine GF, 2004, J BIOL CHEM, V279, P37878, DOI 10.1074/jbc.M405166200; Jaffe FW, 2007, J EXP BOT, V58, P1515, DOI 10.1093/jxb/erm020; Jakoby MJ, 2008, PLANT PHYSIOL, V148, P1583, DOI 10.1104/pp.108.126979; Jiang CZ, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-7-r46; Jin HL, 2000, EMBO J, V19, P6150, DOI 10.1093/emboj/19.22.6150; Kaneko M, 2004, PLANT CELL, V16, P33, DOI 10.1105/tpc.017327; Keller T, 2006, PLANT CELL, V18, P598, DOI 10.1105/tpc.105.038588; KLEMPNAUER KH, 1982, CELL, V31, P453, DOI 10.1016/0092-8674(82)90138-6; Koltai H, 2000, PLANT J, V22, P455, DOI 10.1046/j.1365-313X.2000.00754.x; Lee MM, 1999, CELL, V99, P473, DOI 10.1016/S0092-8674(00)81536-6; Legay S, 2010, NEW PHYTOL, V188, P774, DOI 10.1111/j.1469-8137.2010.03432.x; Letunic I, 2004, NUCLEIC ACIDS RES, V32, pD142, DOI 10.1093/nar/gkh088; Li SF, 2009, PLANT CELL, V21, P72, DOI 10.1105/tpc.108.063503; Lipsick JS, 1996, ONCOGENE, V13, P223; Ma QH, 2011, BIOCHIMIE, V93, P1179, DOI 10.1016/j.biochi.2011.04.012; MAROCCO A, 1989, MOL GEN GENET, V216, P183, DOI 10.1007/BF00334354; Martienssen RA, 2004, CURR OPIN PLANT BIOL, V7, P102, DOI 10.1016/j.pbi.2004.01.010; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; Matus JT, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-83; Mehrtens F, 2005, PLANT PHYSIOL, V138, P1083, DOI 10.1104/pp.104.058032; Mellway RD, 2009, PLANT PHYSIOL, V150, P924, DOI 10.1104/pp.109.139071; Millar AA, 2005, PLANT CELL, V17, P705, DOI 10.1105/tpc.104.027920; Morimoto R, 2009, PLANT MOL BIOL, V69, P273, DOI 10.1007/s11103-008-9422-5; Muller D, 2006, PLANT CELL, V18, P586, DOI 10.1105/tpc.105.038745; Murray F, 2003, PLANT J, V33, P481, DOI 10.1046/j.1365-313X.2003.01641.x; Nesi N, 2001, PLANT CELL, V13, P2099, DOI 10.1105/tpc.13.9.2099; Nicholas K.B., 1997, EMBNEW NEWS, V4, P14; NODA K, 1994, NATURE, V369, P661, DOI 10.1038/369661a0; OGATA K, 1995, NAT STRUCT BIOL, V2, P309, DOI 10.1038/nsb0495-309; OGATA K, 1994, CELL, V79, P639, DOI 10.1016/0092-8674(94)90549-5; Palmer LE, 2003, SCIENCE, V302, P2115, DOI 10.1126/science.1091265; Payne CT, 2000, GENETICS, V156, P1349; PAZARES J, 1987, EMBO J, V6, P3553, DOI 10.1002/j.1460-2075.1987.tb02684.x; Perez-Rodriguez M, 2005, DEVELOPMENT, V132, P359, DOI 10.1242/dev.01584; Pilu R, 2003, PLANT J, V36, P510, DOI 10.1046/j.1365-313X.2003.01898.x; Preston J, 2004, PLANT J, V40, P979, DOI 10.1111/j.1365-313X.2004.02280.x; Pu L, 2008, GENETICS, V180, P811, DOI 10.1534/genetics.108.093070; Rabinowicz PD, 1999, GENETICS, V153, P427; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Saitoh K, 2004, GENETICS, V168, P997, DOI 10.1534/genetics.103.018390; Schmitz G, 2002, P NATL ACAD SCI USA, V99, P1064, DOI 10.1073/pnas.022516199; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; SHARP PA, 1981, CELL, V23, P643, DOI 10.1016/0092-8674(81)90425-6; Sonbol FM, 2009, PLANT MOL BIOL, V70, P283, DOI 10.1007/s11103-009-9473-2; Sonderby IE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001322; Stracke R, 2001, CURR OPIN PLANT BIOL, V4, P447, DOI 10.1016/S1369-5266(00)00199-0; Stracke R, 2007, PLANT J, V50, P660, DOI 10.1111/j.1365-313X.2007.03078.x; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tohge T, 2005, PLANT J, V42, P218, DOI 10.1111/j.1365-313X.2005.02371.x; Tominaga R, 2007, PLANT CELL, V19, P2264, DOI 10.1105/tpc.106.045732; Tsiantis M, 1999, SCIENCE, V284, P154, DOI 10.1126/science.284.5411.154; Tsuji H, 2006, PLANT J, V47, P427, DOI 10.1111/j.1365-313X.2006.02795.x; van Aalten DMF, 1998, METHODS, V14, P318, DOI 10.1006/meth.1998.0587; Waites R, 1998, CELL, V93, P779, DOI 10.1016/S0092-8674(00)81439-7; Walker AR, 1999, PLANT CELL, V11, P1337, DOI 10.1105/tpc.11.7.1337; Wilkins O, 2009, PLANT PHYSIOL, V149, P981, DOI 10.1104/pp.108.132795; Williams CE, 1997, J BIOL CHEM, V272, P563, DOI 10.1074/jbc.272.1.563; Woodger FJ, 2003, PLANT J, V33, P707, DOI 10.1046/j.1365-313X.2003.01663.x; Zhang F, 2005, PLANT CELL, V17, P903, DOI 10.1105/tpc.104.029660; Zhang F, 2003, DEVELOPMENT, V130, P4859, DOI 10.1242/dev.00681; Zhang LC, 2012, J EXP BOT, V63, P203, DOI 10.1093/jxb/err264; Zhang LF, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000716; Zimmermann IM, 2004, PLANT J, V40, P22, DOI 10.1111/j.1365-313X.2004.02183.x	100	170	196	19	142	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e37463	10.1371/journal.pone.0037463	http://dx.doi.org/10.1371/journal.pone.0037463			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22719841	gold, Green Published, Green Submitted			2022-12-27	WOS:000305351700006
J	Frolov, RV; Singh, S				Frolov, Roman V.; Singh, Satpal			Inhibition of Ion Channels and Heart Beat in Drosophila by Selective COX-2 Inhibitor SC-791	PLOS ONE			English	Article							SENSITIVE CALCIUM-CHANNELS; LARVAL MUSCLES; CYCLOOXYGENASE-2 INHIBITION; PHARMACOLOGICAL ANALYSIS; RYANODINE RECEPTOR; CARDIAC-PACEMAKER; POTASSIUM CURRENT; MEDIATED PATHWAY; CELECOXIB; MODULATION	Recent findings suggest that modulation of ion channels might be implicated in some of the clinical effects of coxibs, selective inhibitors of cyclooxygenase-2 (COX-2). Celecoxib and its inactive analog 2,5-dimethyl-celecoxib, but not rofecoxib, can suppress or augment ionic currents and alter functioning of neurons and myocytes. To better understand these unexpected effects, we have recently investigated the mechanism of inhibition of human K(v)2.1 channels by a highly selective COX-2 inhibitor SC-791. In this study we have further explored the SC-791 action on ion channels and heartbeat in Drosophila, which lacks cyclooxygenases and thus can serve as a convenient model to study COX-2-independent mechanisms of coxibs. Using intracellular recordings in combination with a pharmacological approach and utilizing available Drosophila mutants, we found that SC-791 inhibited voltage-activated K+ and L-type Ca2+ channels in larval body-wall muscles and reduced heart rate in a concentration-dependent manner. Unlike celecoxib and several other K+ channel blockers, SC-791 did not induce arrhythmia. Instead, application of SC-791 resulted in a dramatic slowing of contractions and, at higher concentrations, in progressively weaker contractions with gradual cessation of heartbeat. Isradipine, a selective blocker of L-type Ca2+ channels, showed a similar pattern of heart arrest, though no prolongation of contractions was observed. Ryanodine was the only channel modulating compound of those tested additionally that was capable of slowing contractions. Like SC-791, ryanodine reduced heart rate without arrhythmia. However, it could not stop heartbeat completely even at 500 mu M, the highest concentration used. The magnitude of heart rate reduction, when SC-791 and ryanodine were applied together, was smaller than expected for independent mechanisms, raising the possibility that SC-791 might be interfering with excitation-contraction coupling in Drosophila heart.	[Frolov, Roman V.; Singh, Satpal] SUNY Buffalo, Dept Pharmacol & Toxicol, Buffalo, NY 14260 USA; [Frolov, Roman V.] Univ Oulu, Dept Phys Sci, Div Biophys, Oulu, Finland	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of Oulu	Frolov, RV (corresponding author), SUNY Buffalo, Dept Pharmacol & Toxicol, Buffalo, NY 14260 USA.	rvfrolov@gmail.com	Frolov, Roman/H-8099-2012; Frolov, Roman/I-3889-2016	Frolov, Roman/0000-0002-7431-5297	National Science Foundation, USA [MCB-0094477, MCB-0322461]	National Science Foundation, USA(National Science Foundation (NSF))	This work was supported by the National Science Foundation, USA, grant numbers MCB-0094477 and MCB-0322461 (http://nsf.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias II O, 2011, CHANNELS AUSTIN, V5; BATE M, 1990, DEVELOPMENT, V110, P791; Bhattacharya A, 1999, J NEUROBIOL, V39, P491, DOI 10.1002/(SICI)1097-4695(19990615)39:4<491::AID-NEU3>3.0.CO;2-6; Bliss CI, 1939, ANN APPL BIOL, V26, P585, DOI 10.1111/j.1744-7348.1939.tb06990.x; Blomme EAG, 2003, BRIT J DERMATOL, V148, P211, DOI 10.1046/j.1365-2133.2003.05065.x; Brueggemann LI, 2009, MOL PHARMACOL, V76, P1053, DOI 10.1124/mol.109.057844; Chopra M, 2000, J NEUROGENET, V14, P107, DOI 10.3109/01677060009083478; Dogne JM, 2007, CURR TOP MED CHEM, V7, P885, DOI 10.2174/156802607780636717; Dressler V, 1999, COMPUT BIOMED RES, V32, P145, DOI 10.1006/cbmr.1999.1509; Fill M, 2002, PHYSIOL REV, V82, P893, DOI 10.1152/physrev.00013.2002; Frolov RV, 2010, BRIT J PHARMACOL, V159, P405, DOI 10.1111/j.1476-5381.2009.00539.x; Frolov R.V., 2008, NEUROSCIENCE; Frolov RV, 2008, J BIOL CHEM, V283, P1518, DOI 10.1074/jbc.M708100200; Frolov RV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026344; Frolov RV, 2010, BRAIN RES, V1359, P67, DOI 10.1016/j.brainres.2010.08.062; GIELOW ML, 1995, J NEUROSCI, V15, P6085; Grosch S, 2006, JNCI-J NATL CANCER I, V98, P736, DOI 10.1093/jnci/djj206; GU GG, 1995, J NEUROBIOL, V28, P269, DOI 10.1002/neu.480280302; Gu GG, 1997, J NEUROBIOL, V33, P265, DOI 10.1002/(SICI)1097-4695(199709)33:3<265::AID-NEU5>3.0.CO;2-#; Hardy MM, 2003, J PHARMACOL EXP THER, V304, P959, DOI 10.1124/jpet.102.044545; Hasinoff BB, 2007, CARDIOVASC TOXICOL, V7, P19, DOI 10.1007/s12012-007-0002-8; Hegde P, 1999, J BIOL CHEM, V274, P22109, DOI 10.1074/jbc.274.31.22109; Jeong HS, 2010, ONCOL REP, V24, P351, DOI 10.3892/or_00000866; Johnson E, 2002, J COMP PHYSIOL B, V172, P227, DOI 10.1007/s00360-001-0246-8; Johnson E, 1997, J COMP PHYSIOL B, V167, P89, DOI 10.1007/s003600050051; Johnson E, 1998, J NEUROGENET, V12, P1, DOI 10.3109/01677069809108552; Macias A, 2010, J MOL CELL CARDIOL, V49, P984, DOI 10.1016/j.yjmcc.2010.09.012; Ocorr K, 2007, P NATL ACAD SCI USA, V104, P3943, DOI 10.1073/pnas.0609278104; Park SY, 2007, BRAIN RES, V1148, P53, DOI 10.1016/j.brainres.2007.02.023; Peron S, 2009, COMP BIOCHEM PHYS A, V154, P173, DOI 10.1016/j.cbpa.2009.04.626; Petraitis V, 2009, ANTIMICROB AGENTS CH, V53, P2382, DOI 10.1128/AAC.00329-09; Robbins J, 1999, GENET RES, V74, P121, DOI 10.1017/S0016672399003924; Sanyal S, 2006, J COMP PHYSIOL B, V176, P253, DOI 10.1007/s00360-005-0046-7; Singh A, 1999, J NEUROSCI, V19, P6838, DOI 10.1523/JNEUROSCI.19-16-06838.1999; Singh S, 1999, INT REV NEUROBIOL, V43, P191, DOI 10.1016/S0074-7742(08)60546-2; Sullivan KMC, 2000, P NATL ACAD SCI USA, V97, P5942, DOI 10.1073/pnas.110145997; Tripp CS, 2003, J INVEST DERMATOL, V121, P853, DOI 10.1046/j.1523-1747.2003.12495.x; Yefi R, 2011, J CELL BIOCHEM, V112, P3167, DOI 10.1002/jcb.23247; Zhang Y, 2007, PHARMACOL RES, V56, P267, DOI 10.1016/j.phrs.2007.07.004	39	8	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e38759	10.1371/journal.pone.0038759	http://dx.doi.org/10.1371/journal.pone.0038759			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701705	Green Published, gold, Green Submitted			2022-12-27	WOS:000305348400094
J	Krajewski, S; Kurz, J; Geisler, T; Peter, K; Wendel, HP; Straub, A				Krajewski, Stefanie; Kurz, Julia; Geisler, Tobias; Peter, Karlheinz; Wendel, Hans Peter; Straub, Andreas			Combined Blockade of ADP Receptors and PI3-Kinase p110 beta Fully Prevents Platelet and Leukocyte Activation during Hypothermic Extracorporeal Circulation	PLOS ONE			English	Article							GLYCOPROTEIN IB; CARDIOPULMONARY BYPASS; P2 RECEPTORS; MICROPARTICLES; INHIBITION; EXPRESSION; BINDING; BLOOD; IDENTIFICATION; AGGREGATION	Extracorporeal circulation (ECC) and hypothermia are used to maintain stable circulatory parameters and improve the ischemia tolerance of patients in cardiac surgery. However, ECC and hypothermia induce activation mechanisms in platelets and leukocytes, which are mediated by the platelet agonist ADP and the phosphoinositide-3-kinase (PI3K) p110 beta. Under clinical conditions these processes are associated with life-threatening complications including thromboembolism and inflammation. This study analyzes effects of ADP receptor P2Y12 and P2Y1 blockade and PI3K p110 beta inhibition on platelets and granulocytes during hypothermic ECC. Human blood was treated with the P2Y12 antagonist 2-MeSAMP, the P2Y1 antagonist MRS2179, the PI3K p110 beta inhibitor TGX-221, combinations thereof, or PBS and propylene glycol (controls). Under static in vitro conditions a concentration-dependent effect regarding the inhibition of ADP-induced platelet activation was found using 2-MeSAMP or TGX-221. Further inhibition of ADP-mediated effects was achieved with MRS2179. Next, blood was circulated in an ex vivo ECC model at 28 degrees C for 30 minutes and various platelet and granulocyte markers were investigated using flow cytometry, ELISA and platelet count analysis. GPIIb/IIIa activation induced by hypothermic ECC was inhibited using TGX-221 alone or in combination with P2Y blockers (p<0.05), while no effect of hypothermic ECC or antiplatelet agents on GPIIb/IIIa and GPIb alpha expression and von Willebrand factor binding was observed. Sole P2Y and PI3K blockade or a combination thereof inhibited P-selectin expression on platelets and platelet-derived microparticles during hypothermic ECC (p<0.05). P2Y blockade alone or combined with TGX-221 prevented ECC-induced platelet-granulocyte aggregate formation (p<0.05). Platelet adhesion to the ECC surface, platelet loss and Mac-1 expression on granulocytes were inhibited by combined P2Y and PI3K blockade (p<0.05). Combined blockade of P2Y12, P2Y1 and PI3K p110 beta completely inhibits hypothermic ECC-induced activation processes. This novel finding warrants further studies and the development of suitable pharmacological agents to decrease ECC- and hypothermia-associated complications in clinical applications.	[Krajewski, Stefanie; Kurz, Julia; Straub, Andreas] Univ Tubingen, Dept Anesthesiol & Intens Care Med, Tubingen, Germany; [Geisler, Tobias] Univ Tubingen, Dept Cardiol, Tubingen, Germany; [Peter, Karlheinz] Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia; [Wendel, Hans Peter] Univ Tubingen, Dept Thorac Cardiac & Vasc Surg, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Baker Heart and Diabetes Institute; Eberhard Karls University of Tubingen	Krajewski, S (corresponding author), Univ Tubingen, Dept Anesthesiol & Intens Care Med, Tubingen, Germany.	krajewski@thg-lab.de	Geisler, Tobias/AAO-4472-2020; Krajewski, Stefanie/AAF-1877-2019; Peter, Karlheinz/E-8772-2010; /S-2765-2019	Peter, Karlheinz/0000-0002-8040-2258; /0000-0002-8040-2258	German Research Association (Deutsche Forschungsgemeinschaft) [STR 687/2-1]; Australian Research Council	German Research Association (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); Australian Research Council(Australian Research Council)	This study was funded by the German Research Association (Deutsche Forschungsgemeinschaft; Grant number: STR 687/2-1). K. Peter was supported by a Future Fellowship of the Australian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS CS, 1990, BLOOD, V75, P128; Andrews RK, 2004, IUBMB LIFE, V56, P13, DOI 10.1080/15216540310001649831; Andrews RK, 2003, INT J BIOCHEM CELL B, V35, P1170, DOI 10.1016/S1357-2725(02)00280-7; Baurand A, 2001, EUR J PHARMACOL, V412, P213, DOI 10.1016/S0014-2999(01)00733-6; Bergmeier W, 2004, CIRC RES, V95, P677, DOI 10.1161/01.RES.0000143899.73453.11; Bhatt DL, 2009, NEW ENGL J MED, V361, P2330, DOI 10.1056/NEJMoa0908629; Bird JE, 2011, THROMB RES, V127, P560, DOI 10.1016/j.thromres.2011.02.007; Cattaneo M, 2009, J THROMB HAEMOST, V7, P262, DOI 10.1111/j.1538-7836.2009.03382.x; Cattaneo M, 2010, INTERN EMERG MED, V5, P385, DOI 10.1007/s11739-010-0363-z; Cosemans JMEM, 2006, BLOOD, V108, P3045, DOI 10.1182/blood-2006-03-006338; de Rossi LW, 2001, ANESTH ANALG, V93, P635, DOI 10.1097/00000539-200109000-00020; Evangelista V, 1996, BLOOD, V88, P4183, DOI 10.1182/blood.V88.11.4183.bloodjournal88114183; Forlow SB, 2000, BLOOD, V95, P1317, DOI 10.1182/blood.V95.4.1317.004k30_1317_1323; Gachet C, 2008, THROMB HAEMOSTASIS, V99, P466, DOI 10.1160/TH07-11-0673; Gardiner EE, 2007, J THROMB HAEMOST, V5, P1530, DOI 10.1111/j.1538-7836.2007.02590.x; Gawaz M, 2004, CARDIOVASC RES, V61, P498, DOI 10.1016/j.cardiores.2003.11.036; Gawaz M, 1999, CIRCULATION, V99, P2; Hall MW, 2002, AM J HEMATOL, V69, P45, DOI 10.1002/ajh.10018; Hechler B, 2011, PURINERG SIGNAL, V7, P293, DOI 10.1007/s11302-011-9247-6; Hiramatsu Y, 1997, J THORAC CARDIOV SUR, V113, P182, DOI 10.1016/S0022-5223(97)70414-8; Hyde JAJ, 1998, PERFUSION-UK, V13, P389, DOI 10.1177/026765919801300603; Jackson SF, 2006, CELL MOL LIFE SCI, V63, P1085, DOI 10.1007/s00018-006-6001-2; Jackson SP, 2005, NAT MED, V11, P507, DOI 10.1038/nm1232; Jacobson KA, 2010, DRUG DISCOV TODAY, V15, P570, DOI 10.1016/j.drudis.2010.05.011; Jantzen HM, 1999, THROMB HAEMOSTASIS, V81, P111; Jy W, 1995, BLOOD CELL MOL DIS, V21, p231a; Jy WC, 1995, BLOOD CELL MOL DIS, V21, P217, DOI 10.1006/bcmd.1995.0025; Krajewski S, 2012, BRIT J ANAESTH, V108, P912, DOI 10.1093/bja/aer518; Larson MK, 2003, BLOOD, V101, P1409, DOI 10.1182/blood-2002-05-1533; Martins PAD, 2006, J LEUKOCYTE BIOL, V79, P499, DOI 10.1189/jlb.0605318; Maxwell MJ, 2006, ARTERIOSCL THROM VAS, V26, P663, DOI 10.1161/01.ATV.0000201931.16535.e1; May AE, 2008, ARTERIOSCL THROM VAS, V28, pS5, DOI 10.1161/ATVBAHA.107.158915; MCCRARY JK, 1995, ANN BIOMED ENG, V23, P787, DOI 10.1007/BF02584477; MICHELSON AD, 1991, BLOOD, V77, P770; Moal V, 2003, NEPHROL DIAL TRANSPL, V18, P1834, DOI 10.1093/ndt/gfg185; Paparella D, 2004, INTENS CARE MED, V30, P1873, DOI 10.1007/s00134-004-2388-0; Peter K, 2000, CIRCULATION, V102, P1490, DOI 10.1161/01.CIR.102.13.1490; Rahman M, 2009, ANN SURG, V250, P783, DOI 10.1097/SLA.0b013e3181bd95b7; Rajagopalan S, 2008, ANESTHESIOLOGY, V108, P71, DOI 10.1097/01.anes.0000296719.73450.52; RINDER CS, 1991, ANESTHESIOLOGY, V75, P388, DOI 10.1097/00000542-199109000-00002; RUGGERI ZM, 1983, J CLIN INVEST, V72, P1, DOI 10.1172/JCI110946; Straub A, 2008, THROMB RES, V122, P383, DOI 10.1016/j.thromres.2008.01.001; Straub A, 2008, THROMB HAEMOSTASIS, V99, P609, DOI 10.1160/TH07-07-0452; Straub A, 2007, THROMB HAEMOSTASIS, V97, P608, DOI 10.1160/TH06-10-0563; Straub A, 2011, ARTERIOSCL THROM VAS, V31, P1607, DOI 10.1161/ATVBAHA.111.226373; Straub A, 2010, THROMB HAEMOSTASIS, V103, P466, DOI 10.1160/TH09-05-0325; WACHTFOGEL YT, 1987, BLOOD, V69, P324; Weerasinghe A, 1998, ANN THORAC SURG, V66, P2145, DOI 10.1016/S0003-4975(98)00749-8; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482	49	15	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e38455	10.1371/journal.pone.0038455	http://dx.doi.org/10.1371/journal.pone.0038455			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701645	Green Published, Green Submitted, gold			2022-12-27	WOS:000305348400060
J	Pfeiffer, M; Hartbauer, M; Lang, AB; Maass, W; Roemer, H				Pfeiffer, Michael; Hartbauer, Manfred; Lang, Alexander B.; Maass, Wolfgang; Roemer, Heinrich			Probing Real Sensory Worlds of Receivers with Unsupervised Clustering	PLOS ONE			English	Article							ACOUSTIC COMMUNICATION SIGNALS; AUDITORY NEURONS; BUSH-CRICKET; SPIKE TRAINS; CORTICAL DISCRIMINATION; NEURAL INFORMATION; FEATURE-EXTRACTION; INSECT HEARING; BURSTS; PATTERNS	The task of an organism to extract information about the external environment from sensory signals is based entirely on the analysis of ongoing afferent spike activity provided by the sense organs. We investigate the processing of auditory stimuli by an acoustic interneuron of insects. In contrast to most previous work we do this by using stimuli and neurophysiological recordings directly in the nocturnal tropical rainforest, where the insect communicates. Different from typical recordings in sound proof laboratories, strong environmental noise from multiple sound sources interferes with the perception of acoustic signals in these realistic scenarios. We apply a recently developed unsupervised machine learning algorithm based on probabilistic inference to find frequently occurring firing patterns in the response of the acoustic interneuron. We can thus ask how much information the central nervous system of the receiver can extract from bursts without ever being told which type and which variants of bursts are characteristic for particular stimuli. Our results show that the reliability of burst coding in the time domain is so high that identical stimuli lead to extremely similar spike pattern responses, even for different preparations on different dates, and even if one of the preparations is recorded outdoors and the other one in the sound proof lab. Simultaneous recordings in two preparations exposed to the same acoustic environment reveal that characteristics of burst patterns are largely preserved among individuals of the same species. Our study shows that burst coding can provide a reliable mechanism for acoustic insects to classify and discriminate signals under very noisy real-world conditions. This gives new insights into the neural mechanisms potentially used by bushcrickets to discriminate conspecific songs from sounds of predators in similar carrier frequency bands.	[Pfeiffer, Michael; Maass, Wolfgang] Graz Univ Technol, Inst Theoret Comp Sci, Graz, Austria; [Pfeiffer, Michael] Univ Zurich, Inst Neuroinformat, Zurich, Switzerland; [Hartbauer, Manfred; Lang, Alexander B.; Roemer, Heinrich] Karl Franzens Univ Graz, Inst Zool, Graz, Austria	Graz University of Technology; University of Zurich; University of Graz	Pfeiffer, M (corresponding author), Graz Univ Technol, Inst Theoret Comp Sci, Graz, Austria.	pfeiffer@ini.phys.ethz.ch			Austrian Science Fund [FWF P20882-B09]; Austrian Academy for Sciences; Karl-Franzens-University of Graz; Forschungskredit grant of the University of Zurich; European Union [FP7-506778, FP7-243914, 269921]; Austrian Science Fund (FWF) [P 20882] Funding Source: researchfish	Austrian Science Fund(Austrian Science Fund (FWF)); Austrian Academy for Sciences; Karl-Franzens-University of Graz; Forschungskredit grant of the University of Zurich; European Union(European Commission); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This project was supported by the Austrian Science Fund (FWF P20882-B09) to HR, the Austrian Academy for Sciences and the Karl-Franzens-University of Graz to ABL. MP has been supported by a Forschungskredit grant of the University of Zurich. Written under partial support by the European Union project # FP7-506778 (PASCAL2), project #FP7-243914 (BRAIN-I-NETS), and project #269921 (BrainScaleS) to WM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alitto HJ, 2005, J NEUROSCI, V25, P514, DOI 10.1523/JNEUROSCI.3369-04.2005; ATTNEAVE F, 1954, PSYCHOL REV, V61, P183, DOI 10.1037/h0054663; Barlow H. B., 1961, SENS COMMUN, P217, DOI DOI 10.7551/MITPRESS/9780262518420.003.0013; Brumm H, 2005, ADV STUD BEHAV, V35, P151, DOI 10.1016/S0065-3454(05)35004-2; Capranica RR, 1983, ADV VERTEBRATE NEURO, P701, DOI DOI 10.1007/978-1-4684-4412-4_36; Chiappalone M, 2005, NEUROCOMPUTING, V65, P653, DOI 10.1016/j.neucom.2004.10.094; Chittka L, 2009, TRENDS ECOL EVOL, V24, P400, DOI 10.1016/j.tree.2009.02.010; Christen M, 2006, J NEUROSCI METH, V156, P342, DOI 10.1016/j.jneumeth.2006.02.023; COCATREZILGIEN JH, 1992, J NEUROSCI METH, V41, P19, DOI 10.1016/0165-0270(92)90120-3; Creutzig F, 2009, J NEUROSCI, V29, P2575, DOI 10.1523/JNEUROSCI.0599-08.2009; Eggermont JJ, 1998, NEUROSCI BIOBEHAV R, V22, P355, DOI 10.1016/S0149-7634(97)00021-3; Eggermont JJ, 1996, NEUROREPORT, V7, P753, DOI 10.1097/00001756-199602290-00018; Eichhorn J, 2004, ADV NEUR IN, V16, P1367; Eyherabide HG, 2009, FRONT NEUROSCI-SWITZ, V3, P8, DOI 10.3389/neuro.01.002.2009; Eyherabide HG, 2008, FRONT COMPUT NEUROSC, V2, DOI 10.3389/neuro.10.003.2008; Fellous JM, 2004, J NEUROSCI, V24, P2989, DOI 10.1523/JNEUROSCI.4649-03.2004; Frey BJ, 2007, SCIENCE, V315, P972, DOI 10.1126/science.1136800; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI 10.1007/978-0-387-21606-5; Fullard JH, 1998, SPR HDB AUD, V10, P279; Gabbiani F, 1996, NATURE, V384, P564, DOI 10.1038/384564a0; Gerhardt HC., 2002, ACOUSTIC COMMUNICATI; Gourevitch B, 2007, J NEUROSCI METH, V160, P349, DOI 10.1016/j.jneumeth.2006.09.024; Green DM, 1966, SIGNAL DETECTION THE; Hartbauer M, 2010, J EXP BIOL, V213, P3036, DOI 10.1242/jeb.042432; Haven Wiley R., 1982, P131; HOY RR, 1992, EVOLUTIONARY BIOLOGY OF HEARING, P115; Izhikevich EM, 2003, TRENDS NEUROSCI, V26, P161, DOI 10.1016/S0166-2236(03)00034-1; Kepecs A, 2003, NETWORK-COMP NEURAL, V14, P103, DOI 10.1088/0954-898X/14/1/306; Krahe R, 2004, NATURE REV NEUROSCIE, V24, P10731; Kschischang FR, 2001, IEEE T INFORM THEORY, V47, P498, DOI 10.1109/18.910572; Lang Alexander B., 2006, P152; Lestienne R, 2001, PROG NEUROBIOL, V65, P545, DOI 10.1016/S0301-0082(01)00019-3; Lisman JE, 1997, TRENDS NEUROSCI, V20, P38, DOI 10.1016/S0166-2236(96)10070-9; Machens CK, 2005, NEURON, V47, P447, DOI 10.1016/j.neuron.2005.06.015; Machens CK, 2003, NAT NEUROSCI, V6, P341, DOI 10.1038/nn1036; Machens CK, 2001, J NEUROSCI, V21, P3215, DOI 10.1523/JNEUROSCI.21-09-03215.2001; Marsat G, 2007, J COMP PHYSIOL A, V193, P625, DOI 10.1007/s00359-007-0217-y; Marsat G, 2006, J NEUROSCI, V26, P10542, DOI 10.1523/JNEUROSCI.2221-06.2006; MCGREGOR PK, 1984, BEHAV ECOL SOCIOBIOL, V16, P49, DOI 10.1007/BF00293103; Metzner W, 1998, J NEUROSCI, V18, P2283; Molina J, 2005, J EXP ZOOL PART A, V303A, P1085, DOI 10.1002/jez.a.228; MORTON ES, 1975, AM NAT, V109, P17, DOI 10.1086/282971; Narayan R, 2006, J NEUROPHYSIOL, V96, P252, DOI 10.1152/jn.01257.2005; Neuhofer D, 2008, P ROY SOC B-BIOL SCI, V275, P1965, DOI 10.1098/rspb.2008.0527; Ng AY, 2002, ADV NEUR IN, V14, P849; Oswald AMM, 2004, J NEUROSCI, V24, P4351, DOI 10.1523/JNEUROSCI.0459-04.2004; Perin R, 2011, P NATL ACAD SCI USA, V108, P5419, DOI 10.1073/pnas.1016051108; POLLACK GS, 1988, J NEUROSCI, V8, P2635; RHEINLAENDER J, 1986, J COMP PHYSIOL A, V158, P647, DOI 10.1007/BF00603821; RICHARDS DG, 1980, AM NAT, V115, P381, DOI 10.1086/283568; Rieke F, 1995, P ROY SOC B-BIOL SCI, V262, P259, DOI 10.1098/rspb.1995.0204; Rieke F., 1997, SPIKES EXPLORING NEU; Rokem A, 2006, J NEUROPHYSIOL, V95, P2541, DOI 10.1152/jn.00891.2005; ROMER H, 1988, J COMP NEUROL, V275, P201, DOI 10.1002/cne.902750204; ROMER H, 1992, BEHAV ECOL SOCIOBIOL, V29, P437, DOI 10.1007/BF00170174; Romer H, 2000, J COMP PHYSIOL A, V186, P181, DOI 10.1007/s003590050018; Romer H, 1998, SPR HDB AUD, V10, P63; Romer H, 2002, EUR J NEUROSCI, V15, P1655, DOI 10.1046/j.1460-9568.2002.02003.x; ROMER H, 1986, J COMP PHYSIOL A, V159, P627, DOI 10.1007/BF00612036; Romer H., 1985, P25; RONACHER B, 1988, J COMP PHYSIOL A, V163, P517, DOI 10.1007/BF00604905; Ronacher B, 2004, J COMP PHYSIOL A, V190, P257, DOI 10.1007/s00359-004-0494-7; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Schneidman E, 2001, ADV NEUR IN, V13, P159; Schneidman E, 2001, ANAL NEURAL CO UNPUB; Schonwiesner M, 2009, P NATL ACAD SCI USA, V106, P14611, DOI 10.1073/pnas.0907682106; Schrauwen B, 2007, NEUROCOMPUTING, V70, P1247, DOI 10.1016/j.neucom.2006.11.017; Shpigelman L, 2003, ADV NEURAL INFORM PR, V15, P141; Simoncelli EP, 2001, ANNU REV NEUROSCI, V24, P1193, DOI 10.1146/annurev.neuro.24.1.1193; Stumpner A, 2006, J COMP PHYSIOL A, V192, P1359, DOI 10.1007/s00359-006-0164-z; Takahashi N, 2010, P NATL ACAD SCI USA, V107, P10244, DOI 10.1073/pnas.0914594107; Toups JV, 2006, NEUROCOMPUTING, V69, P1362, DOI 10.1016/j.neucom.2005.12.107; Turnbull L, 2005, J NEUROSCI METH, V145, P23, DOI 10.1016/j.jneumeth.2004.11.020; van Rossum MCW, 2001, NEURAL COMPUT, V13, P751, DOI 10.1162/089976601300014321; Victor JD, 2005, CURR OPIN NEUROBIOL, V15, P585, DOI 10.1016/j.conb.2005.08.002; Victor JD, 1996, J NEUROPHYSIOL, V76, P1310, DOI 10.1152/jn.1996.76.2.1310; Victor JD, 1997, NETWORK-COMP NEURAL, V8, P127, DOI 10.1088/0954-898X/8/2/003; Wang L, 2007, J NEUROSCI, V27, P582, DOI 10.1523/JNEUROSCI.3699-06.2007; Waters DA, 1996, J EXP BIOL, V199, P857; WEHNER R, 1987, J COMP PHYSIOL A, V161, P511, DOI 10.1007/BF00603659; Wen GZ, 2008, LECT NOTES COMPUT SC, V5227, P605; WILEY RH, 1978, BEHAV ECOL SOCIOBIOL, V3, P69, DOI 10.1007/BF00300047; Wyttenbach RA, 1996, SCIENCE, V273, P1542, DOI 10.1126/science.273.5281.1542	83	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e37354	10.1371/journal.pone.0037354	http://dx.doi.org/10.1371/journal.pone.0037354			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701566	gold, Green Accepted, Green Published			2022-12-27	WOS:000305348400011
J	Valero-Cabre, A; Wattiez, N; Monfort, M; Francois, C; Rivaud-Pechoux, S; Gaymard, B; Pouget, P				Valero-Cabre, Antoni; Wattiez, Nicolas; Monfort, Morgane; Francois, Chantal; Rivaud-Pechoux, Sophie; Gaymard, Bertrand; Pouget, Pierre			Frontal Non-Invasive Neurostimulation Modulates Antisaccade Preparation in Non-Human Primates	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; POSTERIOR PARIETAL CORTEX; MEMORY-GUIDED SACCADES; EYE FIELD; ELECTRICAL-STIMULATION; VISUAL-CORTEX; CORTICOSPINAL OUTPUT; OWL MONKEYS; RAT-BRAIN; MOTOR	A combination of oculometric measurements, invasive electrophysiological recordings and microstimulation have proven instrumental to study the role of the Frontal Eye Field (FEF) in saccadic activity. We hereby gauged the ability of a non-invasive neurostimulation technology, Transcranial Magnetic Stimulation (TMS), to causally interfere with frontal activity in two macaque rhesus monkeys trained to perform a saccadic antisaccade task. We show that online single pulse TMS significantly modulated antisaccade latencies. Such effects proved dependent on TMS site (effects on FEF but not on an actively stimulated control site), TMS modality (present under active but not sham TMS on the FEF area), TMS intensity (intensities of at least 40% of the TMS machine maximal output required), TMS timing (more robust for pulses delivered at 150 ms than at 100 post target onset) and visual hemifield (relative latency decreases mainly for ipsilateral AS). Our results demonstrate the feasibility of using TMS to causally modulate antisaccade-associated computations in the non-human primate brain and support the use of this approach in monkeys to study brain function and its non-invasive neuromodulation for exploratory and therapeutic purposes.	[Valero-Cabre, Antoni; Wattiez, Nicolas; Monfort, Morgane; Francois, Chantal; Rivaud-Pechoux, Sophie; Gaymard, Bertrand; Pouget, Pierre] Univ Paris 06, CNRS, INSERM, Inst Cerveau & Moelle ICM,UMR 7225,UMRS 975, Paris, France; [Valero-Cabre, Antoni] Boston Univ, Sch Med, Lab Cerebral Dynam Plast & Rehabil, Boston, MA 02118 USA; [Valero-Cabre, Antoni] Open Univ Catalonia UOC, Cognit Neurosci & Informat Technol Res Program, Barcelona, Spain	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Boston University; UOC Universitat Oberta de Catalunya	Valero-Cabre, A (corresponding author), Univ Paris 06, CNRS, INSERM, Inst Cerveau & Moelle ICM,UMR 7225,UMRS 975, Paris, France.	antoni.valerocabre@upmc.fr; pierre.pouget@upmc.fr	Pouget, Pierre/N-8031-2019	Pouget, Pierre/0000-0002-4721-7376; Valero-Cabre, Antoni/0000-0002-5033-2279	Centre National de la Recherche Scientifique, Institut des Sciences Biologiques, Projets Exploratoires Premier Soutien; USA, National Institute of Neurological Disorders and Stroke [R21NSS062317]; european Funding Program FP6; l'Agence National pour la recherche: project eraNET-NEURON BEYONDVIS	Centre National de la Recherche Scientifique, Institut des Sciences Biologiques, Projets Exploratoires Premier Soutien; USA, National Institute of Neurological Disorders and Stroke; european Funding Program FP6; l'Agence National pour la recherche: project eraNET-NEURON BEYONDVIS	This work has been made possible thanks to funding provided by Centre National de la Recherche Scientifique, Institut des Sciences Biologiques, Projets Exploratoires Premier Soutien, 2010. The work of AV-C was also supported by USA, National Institute of Neurological Disorders and Stroke R21NSS062317 and the european Funding Program FP6 and l'Agence National pour la recherche: project eraNET-NEURON BEYONDVIS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen EA, 2007, SCIENCE, V317, P1918, DOI 10.1126/science.1146426; AMASSIAN VE, 1990, ELECTROEN CLIN NEURO, V77, P390, DOI 10.1016/0168-5597(90)90061-H; Amaya F, 2010, CLIN NEUROPHYSIOL, V121, P2143, DOI 10.1016/j.clinph.2010.03.058; Armstrong KM, 2006, NEURON, V50, P791, DOI 10.1016/j.neuron.2006.05.010; Aydin-Abidin S, 2006, J PHYSL; BAKER SN, 1995, J PHYSIOL-LONDON, V488, P795, DOI 10.1113/jphysiol.1995.sp021011; BRUCE CJ, 1985, J NEUROPHYSIOL, V54, P714, DOI 10.1152/jn.1985.54.3.714; Burman DD, 1997, J NEUROPHYSIOL, V77, P2252, DOI 10.1152/jn.1997.77.5.2252; Campana G, 2007, NEUROPSYCHOLOGIA, V45, P2340, DOI 10.1016/j.neuropsychologia.2007.02.009; Condy C, 2005, BIOL PSYCHIAT, V57, P366, DOI 10.1016/j.biopsych.2004.10.036; Corbetta M, 1998, PHILOS T ROY SOC B, V353, P1353, DOI 10.1098/rstb.1998.0289; Ekstrom LB, 2008, SCIENCE, V321, P414, DOI 10.1126/science.1153276; Gaymard B, 1999, EXP BRAIN RES, V129, P288, DOI 10.1007/s002210050899; Gerits A, 2011, EXP BRAIN RES, V212, P143, DOI 10.1007/s00221-011-2710-3; Ghaly RF, 1999, NEUROL RES, V21, P714, DOI 10.1080/01616412.1999.11741003; GOULD HJ, 1986, J COMP NEUROL, V247, P297, DOI 10.1002/cne.902470303; Grosbras MH, 2003, EUR J NEUROSCI, V18, P3121, DOI 10.1111/j.1460-9568.2003.03055.x; Grosbras MH, 2002, J COGNITIVE NEUROSCI, V14, P1109, DOI 10.1162/089892902320474553; Hayashi T, 2004, ANN NEUROL, V56, P77, DOI 10.1002/ana.20151; HUERTA MF, 1987, J COMP NEUROL, V265, P332, DOI 10.1002/cne.902650304; Izawa Y, 2004, J NEUROPHYSIOL, V92, P2248, DOI 10.1152/jn.01021.2003; Izawa Y, 2004, J NEUROPHYSIOL, V92, P2261, DOI 10.1152/jn.00085.2004; Ji RR, 1998, P NATL ACAD SCI USA, V95, P15635, DOI 10.1073/pnas.95.26.15635; Jing HK, 2000, CLIN NEUROPHYSIOL, V111, P1620, DOI 10.1016/S1388-2457(00)00357-6; Kleim JA, 2007, NAT PROTOC, V2, P1675, DOI 10.1038/nprot.2007.206; Liebetanz D, 2003, J PSYCHIATR RES, V37, P277, DOI 10.1016/S0022-3956(03)00017-7; Logothetis NK, NAT NEUROSCI, V13, P1283; Luft AR, 2001, EXP BRAIN RES, V140, P112, DOI 10.1007/s002210100805; Mantovani M, 2006, NEUROCHEM INT, V49, P347, DOI 10.1016/j.neuint.2006.02.008; MARROCCO RT, 1978, BRAIN RES, V146, P23, DOI 10.1016/0006-8993(78)90215-9; Moliadze V, 2003, J PHYSIOL-LONDON, V553, P665, DOI 10.1113/jphysiol.2003.050153; Moore T, 2001, P NATL ACAD SCI USA, V98, P1273, DOI 10.1073/pnas.021549498; Moore T, 2003, NATURE, V421, P370, DOI 10.1038/nature01341; Muri RM, 2008, PROG BRAIN RES, V171, P413, DOI 10.1016/S0079-6123(08)00660-2; MURI RM, 1991, EXP BRAIN RES, V86, P219; Nagel M, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-89; Neggers SFW, 2007, J NEUROPHYSIOL, V98, P2765, DOI 10.1152/jn.00357.2007; Nyffeler T, 2008, PROG BRAIN RES, V171, P429, DOI 10.1016/S0079-6123(08)00663-8; O'Shea J, 2004, J COGNITIVE NEUROSCI, V16, P1060, DOI 10.1162/0898929041502634; Olk B, 2006, CEREB CORTEX, V16, P76, DOI 10.1093/cercor/bhi085; Pascual- Leone A, 2001, HDB TRANSCRANIAL MAG; Post A, 1999, EUR J NEUROSCI, V11, P3247, DOI 10.1046/j.1460-9568.1999.00747.x; RIVAUD S, 1994, EXP BRAIN RES, V102, P110; Ro T, 2003, EXP BRAIN RES, V150, P290, DOI 10.1007/s00221-003-1470-0; Ro T, 2002, J CLIN EXP NEUROPSYC, V24, P930, DOI 10.1076/jcen.24.7.930.8385; Ro T, 1999, NEUROPSYCHOLOGIA, V37, P225; SHIBUTANI H, 1984, EXP BRAIN RES, V55, P1; Silvanto J, 2006, J NEUROPHYSIOL, V96, P941, DOI 10.1152/jn.00015.2006; Thickbroom GW, 1996, J NEUROL SCI, V144, P114, DOI 10.1016/S0022-510X(96)00194-3; Valero-Cabre A, 2006, EXP BRAIN RES, V172, P14, DOI 10.1007/s00221-005-0307-4; Valero-Cabre A, 2005, EXP BRAIN RES, V163, P1, DOI 10.1007/s00221-004-2140-6; Valero-Cabre A, 2008, EUR J NEUROSCI, V27, P765, DOI 10.1111/j.1460-9568.2008.06045.x; Valero-Cabre A, 2007, EXP BRAIN RES, V176, P603, DOI 10.1007/s00221-006-0639-8; Wagner T, 2007, ANNU REV BIOMED ENG, V9, P527, DOI 10.1146/annurev.bioeng.9.061206.133100; WESSEL K, 1991, EXP BRAIN RES, V86, P216	55	16	16	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e38674	10.1371/journal.pone.0038674	http://dx.doi.org/10.1371/journal.pone.0038674			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701691	gold, Green Published, Green Submitted			2022-12-27	WOS:000305348400083
J	Westesson, O; Holmes, I				Westesson, Oscar; Holmes, Ian			Developing and Applying Heterogeneous Phylogenetic Models with XRate	PLOS ONE			English	Article							EVOLUTIONARY RATES; PREDICTION; GENERATION	Modeling sequence evolution on phylogenetic trees is a useful technique in computational biology. Especially powerful are models which take account of the heterogeneous nature of sequence evolution according to the "grammar" of the encoded gene features. However, beyond a modest level of model complexity, manual coding of models becomes prohibitively labor-intensive. We demonstrate, via a set of case studies, the new built-in model-prototyping capabilities of XRate (macros and Scheme extensions). These features allow rapid implementation of phylogenetic models which would have previously been far more labor-intensive. XRate 's new capabilities for lineage-specific models, ancestral sequence reconstruction, and improved annotation output are also discussed. XRate 's flexible model-specification capabilities and computational efficiency make it well-suited to developing and prototyping phylogenetic grammar models. XRate is available as part of the DART software package: http://biowiki.org/DART.	[Westesson, Oscar; Holmes, Ian] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Westesson, O (corresponding author), Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA.	ihh@berkeley.edu		Holmes, Ian/0000-0001-7639-5369	NIH [R01]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was funded from an NIH Research Project Grant Program (R01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], WIGGLE TRACK FORMAT; Ayres D. L., 2011, SYSTEMATIC BIOL; Birney E, 1997, ISMB-97 - FIFTH INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEMS FOR MOLECULAR BIOLOGY, PROCEEDINGS, P56; Bradley RK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006478; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Garber M, 2009, BIOINFORMATICS; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Heger A, 2009, MOL BIOL EVOL, V26, P1715, DOI 10.1093/molbev/msp080; JUKES T H, 1969, P21; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Klosterman PS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-428; Knudsen B, 2003, NUCLEIC ACIDS RES, V31, P3423, DOI 10.1093/nar/gkg614; Knudsen B, 1999, BIOINFORMATICS, V15, P446, DOI 10.1093/bioinformatics/15.6.446; Lunter G, 2007, BIOINFORMATICS, V23, P2485, DOI 10.1093/bioinformatics/btm350; Meyer IM, 2004, NUCLEIC ACIDS RES, V32, P776, DOI 10.1093/nar/gkh211; Pedersen JS, 2004, NUCL ACIDS RES, V32, P4925; Penn O, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000214; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Searls D B, 1995, Proc Int Conf Intell Syst Mol Biol, V3, P341; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Skinner ME, 2009, GENOME RES, V19, P1630, DOI 10.1101/gr.094607.109; Slater GS, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-31; Stein LD, 2002, GENOME RES, V12, P1599, DOI 10.1101/gr.403602; Varadarajan A, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r147; Watts J, 2009, NATURE; Yang ZH, 2000, GENETICS, V155, P431; ZUKER M, 1989, METHOD ENZYMOL, V180, P262; GFF EXCHANGE FORMAT	32	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e36898	10.1371/journal.pone.0036898	http://dx.doi.org/10.1371/journal.pone.0036898			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22693624	Green Published, Green Submitted, gold			2022-12-27	WOS:000305343900004
J	Echauri-Espinosa, RO; Callejas-Negrete, OA; Roberson, RW; Bartnicki-Garcia, S; Mourino-Perez, RR				Echauri-Espinosa, Ramon O.; Callejas-Negrete, Olga A.; Roberson, Robert W.; Bartnicki-Garcia, Salomon; Mourino-Perez, Rosa R.			Coronin Is a Component of the Endocytic Collar of Hyphae of Neurospora crassa and Is Necessary for Normal Growth and Morphogenesis	PLOS ONE			English	Article							TIP GROWTH; ACTIN CYTOSKELETON; CIRCADIAN CLOCK; SPITZENKORPER; MICROTUBULES; ORGANIZATION; DYNAMICS; ARP2/3; MICROSCOPY; MACHINERY	Coronin plays a major role in the organization and dynamics of actin in yeast. To investigate the role of coronin in a filamentous fungus (Neurospora crassa), we examined its subcellular localization using fluorescent proteins and the phenotypic consequences of coronin gene (crn-1) deletion in hyphal morphogenesis, Spitzenkorper behavior and endocytosis. Coronin-GFP was localized in patches, forming a subapical collar near the hyphal apex; significantly, it was absent from the apex. The subapical patches of coronin colocalized with fimbrin, Arp2/3 complex, and actin, altogether comprising the endocytic collar. Deletion of crn-1 resulted in reduced hyphal growth rates, distorted hyphal morphology, uneven wall thickness, and delayed establishment of polarity during germination; it also affected growth directionality and increased branching. The Spitzenkorper of Dcrn-1 mutant was unstable; it appeared and disappeared intermittently giving rise to periods of hyphoid-like and isotropic growth respectively. Uptake of FM4-64 in Dcrn-1 mutant indicated a partial disruption in endocytosis. These observations underscore coronin as an important component of F-actin remodeling in N. crassa. Although coronin is not essential in this fungus, its deletion influenced negatively the operation of the actin cytoskeleton involved in the orderly deployment of the apical growth apparatus, thus preventing normal hyphal growth and morphogenesis.	[Echauri-Espinosa, Ramon O.; Callejas-Negrete, Olga A.; Bartnicki-Garcia, Salomon; Mourino-Perez, Rosa R.] CICESE, Dept Microbiol, Ensenada, Baja California, Mexico; [Roberson, Robert W.] Arizona State Univ, Sch Life Sci, Tempe, AZ USA	CICESE - Centro de Investigacion Cientifica y de Educacion Superior de Ensenada; Arizona State University; Arizona State University-Tempe	Echauri-Espinosa, RO (corresponding author), CICESE, Dept Microbiol, Ensenada, Baja California, Mexico.	rmourino@cicese.mx	Bartnicki-Garcia, Salomon/J-3446-2016; Mouriño-Pérez, Rosa Reyna Reyna/F-9192-2014	Mouriño-Pérez, Rosa Reyna Reyna/0000-0002-7958-2212; Callejas-Negrete, Olga Alicia/0000-0002-9285-7014	Consejo Nacional de Ciencia y Tecnologia-DFG; CONACYT-Ciencia Basica [134771]; Arizona State University [LM5100R1]	Consejo Nacional de Ciencia y Tecnologia-DFG; CONACYT-Ciencia Basica; Arizona State University	This work was supported by grants from Consejo Nacional de Ciencia y Tecnologia-DFG to R. R. M. P. and CONACYT-Ciencia Basica (134771) S. B. G. and from Arizona State University (LM5100R1) to R. W. R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Penalva MA, 2010, CURR OPIN MICROBIOL, V13, P684, DOI 10.1016/j.mib.2010.09.005; Araujo-Bazan L, 2008, MOL MICROBIOL, V67, P891, DOI 10.1111/j.1365-2958.2007.06102.x; ARPAIA G, 1995, MOL GEN GENET, V247, P157, DOI 10.1007/BF00705645; Atkinson HA, 2002, FUNGAL GENET BIOL, V37, P233, DOI 10.1016/S1087-1845(02)00535-2; Baldo ET, 2005, EXP PARASITOL, V110, P114, DOI 10.1016/j.exppara.2005.02.007; Bartnicki-Garcia S, 2002, MYCOLOGY S, V15, P29; Bartnicki-Garcia S, 1990, BIOCH CELL WALLS MEM, P43; Bartnicki-Garcia Salomon, 1996, P105; BARTNICKIGARCIA S, 1989, PROTOPLASMA, V153, P46, DOI 10.1007/BF01322464; Berepiki A, 2010, EUKARYOT CELL, V9, P547, DOI 10.1128/EC.00253-09; Bharathi V, 2004, J CELL SCI, V117, P1911, DOI 10.1242/jcs.01034; Bracker CE, 1997, P SOC PHOTO-OPT INS, V2983, P67, DOI 10.1117/12.274325; Cai L, 2005, J BIOL CHEM, V280, P31913, DOI 10.1074/jbc.M504146200; Cai L, 2008, CELL, V134, P828, DOI 10.1016/j.cell.2008.06.054; D'Agostino JL, 2005, GENETICS, V171, P35, DOI 10.1534/genetics.105.040634; Davis R.H., 2000, NEUROSPORA CONTRIBUT; de Hostos EL, 1999, TRENDS CELL BIOL, V9, P345, DOI 10.1016/S0962-8924(99)01620-7; de Hostos Eugenio L., 2008, V48, P31, DOI 10.1007/978-0-387-09595-0_4; Delgado-Alvarez DL, 2010, FUNGAL GENET BIOL, V47, P573, DOI 10.1016/j.fgb.2010.03.004; Fischer-Parton S, 2000, J MICROSC-OXFORD, V198, P246, DOI 10.1046/j.1365-2818.2000.00708.x; Freitag M, 2004, FUNGAL GENET BIOL, V41, P897, DOI 10.1016/j.fgb.2004.06.008; Fuchs U, 2006, PLANT CELL, V18, P2066, DOI 10.1105/tpc.105.039388; Galletta BJ, 2009, CURR OPIN CELL BIOL, V21, P20, DOI 10.1016/j.ceb.2009.01.006; Gandhi M, 2009, MOL CELL, V34, P364, DOI 10.1016/j.molcel.2009.02.029; GIRBARDT M, 1957, PLANTA, V50, P47, DOI 10.1007/BF01912343; Goode BL, 1999, J CELL BIOL, V144, P83, DOI 10.1083/jcb.144.1.83; Grove SN, 1981, MYCOL SOC AM NEWSLET, V32, P33; Harris SD, 2005, EUKARYOT CELL, V4, P225, DOI 10.1128/EC.4.2.225-229.2005; Heil-Chapdelaine RA, 1998, CURR BIOL, V8, P1281, DOI 10.1016/S0960-9822(07)00539-8; Hervas-Aguilar A, 2010, EUKARYOT CELL, V9, P1504, DOI 10.1128/EC.00119-10; Hickey PC, 2002, FUNGAL GENET BIOL, V37, P109, DOI 10.1016/S1087-1845(02)00035-X; Hoffmann J, 1998, FUNGAL GENET BIOL, V24, P77, DOI 10.1006/fgbi.1998.1059; Horio T, 2005, MOL BIOL CELL, V16, P918, DOI 10.1091/mbc.E04-09-0798; HOWARD RJ, 1981, J CELL SCI, V48, P89; Humphries CL, 2002, J CELL BIOL, V159, P993, DOI 10.1083/jcb.200206113; Liu SL, 2011, J BIOL CHEM, V286, P17039, DOI 10.1074/jbc.M111.219964; LOROS JJ, 1989, SCIENCE, V243, P385, DOI 10.1126/science.2563175; Margolin BS, 1997, FUNGAL GENET NEWSLET, V44, P34, DOI [10.4148/1941-4765.1281, DOI 10.1128/EC.00244-07]; McDaniel DP, 2000, FUNGAL GENET BIOL, V31, P233, DOI 10.1006/fgbi.2000.1249; Mourino-Perez RR, 2006, FUNGAL GENET BIOL, V43, P389, DOI 10.1016/j.fgb.2005.10.007; Penalva MA, 2005, FUNGAL GENET BIOL, V42, P963, DOI 10.1016/j.fgb.2005.09.004; Riquelme M, 1998, FUNGAL GENET BIOL, V24, P101, DOI 10.1006/fgbi.1998.1074; ROBERSON RW, 1992, MYCOLOGIA, V84, P41, DOI 10.2307/3760400; Rybakin V, 2005, BIOESSAYS, V27, P625, DOI 10.1002/bies.20235; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Shaw BD, 2011, FUNGAL BIOL-UK, V115, P541, DOI 10.1016/j.funbio.2011.02.010; Taheri-Talesh N, 2008, MOL BIOL CELL, V19, P1439, DOI 10.1091/mbc.E07-05-0464; Torralba S, 1998, MICROBIOL-SGM, V144, P45, DOI 10.1099/00221287-144-1-45; Uetrecht AC, 2006, TRENDS CELL BIOL, V16, P421, DOI 10.1016/j.tcb.2006.06.002; Upadhyay S, 2008, MOL MICROBIOL, V68, P690, DOI 10.1111/j.1365-2958.2008.06178.x; Verdin J, 2009, MOL MICROBIOL, V74, P1044, DOI 10.1111/j.1365-2958.2009.06917.x; Virag A, 2004, FUNGAL GENET BIOL, V41, P213, DOI 10.1016/j.fgb.2003.10.010; Young ME, 2004, J CELL BIOL, V166, P629, DOI 10.1083/jcb.200404159	53	39	40	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38237	10.1371/journal.pone.0038237	http://dx.doi.org/10.1371/journal.pone.0038237			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693603	Green Submitted, gold, Green Published			2022-12-27	WOS:000305338500114
J	Haruki, H; Gonzalez, MR; Johnsson, K				Haruki, Hirohito; Gonzalez, Monica Rengifo; Johnsson, Kai			Exploiting Ligand-Protein Conjugates to Monitor Ligand-Receptor Interactions	PLOS ONE			English	Article							THROUGHPUT SCREENING ASSAYS; DIHYDROFOLATE-REDUCTASE; FLUORESCENCE POLARIZATION; ESCHERICHIA-COLI; SMALL MOLECULES; IN-VIVO; BINDING; EXPRESSION; AFFINITY; CELLS	We introduce three assays for analyzing ligand-receptor interactions based on the specific conjugation of ligands to SNAP-tag fusion proteins. Conjugation of ligands to different SNAP-tag fusions permits the validation of suspected interactions in cell extracts and fixed cells as well as the establishment of high-throughput assays. The different assays allow the analysis of strong and weak interactions. Conversion of ligands into SNAP-tag substrates thus provides access to a powerful toolbox for the analysis of their interactions with proteins.	[Haruki, Hirohito; Gonzalez, Monica Rengifo; Johnsson, Kai] Ecole Polytech Fed Lausanne, Inst Chem Sci & Engn, Inst Bioengn, Natl Ctr Competence Res NCCR Chem Biol, CH-1015 Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Haruki, H (corresponding author), Ecole Polytech Fed Lausanne, Inst Chem Sci & Engn, Inst Bioengn, Natl Ctr Competence Res NCCR Chem Biol, CH-1015 Lausanne, Switzerland.	kai.johnsson@epfl.ch	johnsson, kai/P-4222-2014	johnsson, kai/0000-0002-8002-1981	Swiss National Science Foundation [205320_132813]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the Swiss National Science Foundation (205320_132813). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albizu L, 2010, NAT CHEM BIOL, V6, P587, DOI [10.1038/nchembio.396, 10.1038/NCHEMBIO.396]; APPLEMAN JR, 1988, J BIOL CHEM, V263, P9187; Backliwal G, 2008, BIOTECHNOL BIOENG, V101, P182, DOI 10.1002/bit.21882; Backliwal G, 2008, BIOTECHNOL BIOENG, V99, P721, DOI 10.1002/bit.21596; Brun MA, 2009, J AM CHEM SOC, V131, P5873, DOI 10.1021/ja900149e; Chidley C, 2011, NAT CHEM BIOL, V7, P375, DOI [10.1038/NCHEMBIO.557, 10.1038/nchembio.557]; de Jong LAA, 2005, J CHROMATOGR B, V829, P1, DOI 10.1016/j.jchromb.2005.10.002; Gautier A, 2008, CHEM BIOL, V15, P128, DOI 10.1016/j.chembiol.2008.01.007; Gautier A, 2009, J AM CHEM SOC, V131, P17954, DOI 10.1021/ja907818q; Gendreizig S, 2003, J AM CHEM SOC, V125, P14970, DOI 10.1021/ja037883p; Haruki H, 2006, J VIROL, V80, P794, DOI 10.1128/JVI.80.2.794-801.2006; Holdgate GA, 2010, J STRUCT BIOL, V172, P142, DOI 10.1016/j.jsb.2010.06.024; Huang XY, 2003, J BIOMOL SCREEN, V8, P34, DOI 10.1177/1087057102239666; Inglese J, 2007, NAT CHEM BIOL, V3, P466, DOI 10.1038/nchembio.2007.17; Keppler A, 2003, NAT BIOTECHNOL, V21, P86, DOI 10.1038/nbt765; Larry EM, 1988, ANAL BIOCHEM, V174, P101; Lehto M, 2004, CELL TISSUE RES, V315, P39, DOI 10.1007/s00441-003-0817-y; MAYER RJ, 1986, P NATL ACAD SCI USA, V83, P7718, DOI 10.1073/pnas.83.20.7718; MURPHY DJ, 1989, BIOCHEMISTRY-US, V28, P3025, DOI 10.1021/bi00433a043; Riddle SM, 2006, ANAL BIOCHEM, V356, P108, DOI 10.1016/j.ab.2006.05.017; Rix U, 2007, BLOOD, V110, P4055, DOI 10.1182/blood-2007-07-102061; Rix U, 2009, NAT CHEM BIOL, V5, P616, DOI 10.1038/nchembio.216; Roehrl MHA, 2004, BIOCHEMISTRY-US, V43, P16056, DOI 10.1021/bi048233g; STONE SR, 1986, BIOCHIM BIOPHYS ACTA, V869, P275, DOI 10.1016/0167-4838(86)90067-1; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; WANG ZX, 1995, FEBS LETT, V360, P111, DOI 10.1016/0014-5793(95)00062-E; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhu ZR, 2009, J BIOMOL SCREEN, V14, P1157, DOI 10.1177/1087057109350114	29	14	16	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e37598	10.1371/journal.pone.0037598	http://dx.doi.org/10.1371/journal.pone.0037598			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22701522	gold, Green Submitted, Green Published			2022-12-27	WOS:000305338500043
J	Buss, C; Entringer, S; Davis, EP; Hobel, CJ; Swanson, JM; Wadhwa, PD; Sandman, CA				Buss, Claudia; Entringer, Sonja; Davis, Elysia Poggi; Hobel, Calvin J.; Swanson, James M.; Wadhwa, Pathik D.; Sandman, Curt A.			Impaired Executive Function Mediates the Association between Maternal Pre-Pregnancy Body Mass Index and Child ADHD Symptoms	PLOS ONE			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; DEFICIT HYPERACTIVITY DISORDER; PRETERM BIRTH; BEHAVIOR CHECKLIST; GESTATIONAL-AGE; WEIGHT-GAIN; PREGNANCY; BRAIN; INFLAMMATION; OBESITY	Background: Increasing evidence suggests exposure to adverse conditions in intrauterine life may increase the risk of developing attention-deficit/hyperactivity disorder (ADHD) in childhood. High maternal pre-pregnancy body mass index (BMI) has been shown to predict child ADHD symptoms, however the neurocognitive processes underlying this relationship are not known. The aim of the present study was to test the hypothesis that this association is mediated by alterations in child executive function. Methodology/Principal Findings: A population-based cohort of 174 children (mean age = 7.3 +/- 0.9 (SD) yrs, 55% girls) was evaluated for ADHD symptoms using the Child Behavior Checklist, and for neurocognitive function using the Go/No-go task. This cohort had been followed prospectively from early gestation and birth through infancy and childhood with serial measures of maternal and child prenatal and postnatal factors. Maternal pre-pregnancy BMI was a significant predictor of child ADHD symptoms (F-(1,F-158)=4.80, p=0.03) and of child performance on the Go/No-go task (F-(1,F-157)=8.37, p=0.004) after controlling for key potential confounding variables. A test of the mediation model revealed that the association between higher maternal pre-pregnancy BMI and child ADHD symptoms was mediated by impaired executive function (inefficient/less attentive processing; Sobel Test: t=2.39 (+/- 0.002, SEM), p=0.02). Conclusions/Significance: To the best of our knowledge this is the first study to report that maternal pre-pregnancy BMI-related alterations in child neurocognitive function may mediate its effects on ADHD risk. The finding is clinically significant and may extrapolate to an approximately 2.8-fold increase in the prevalence of ADHD among children of obese compared to those of non-obese mothers. These results add further evidence to the growing awareness that neurodevelopmental disorders such as ADHD may have their foundations very early in life.	[Buss, Claudia; Entringer, Sonja; Davis, Elysia Poggi; Swanson, James M.; Wadhwa, Pathik D.] Univ Calif Irvine, Sch Med, Dept Pediat, Irvine, CA 92717 USA; [Davis, Elysia Poggi; Wadhwa, Pathik D.; Sandman, Curt A.] Univ Calif Irvine, Sch Med, Dept Psychiat & Human Behav, Irvine, CA 92717 USA; [Wadhwa, Pathik D.] Univ Calif Irvine, Sch Med, Dept Obstet & Gynecol, Irvine, CA 92717 USA; [Wadhwa, Pathik D.] Univ Calif Irvine, Sch Med, Dept Epidemiol, Irvine, CA 92717 USA; [Hobel, Calvin J.] Cedars Sinai Med Ctr, Dept Obstet & Gynecol, Los Angeles, CA 90048 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; Cedars Sinai Medical Center	Buss, C (corresponding author), Univ Calif Irvine, Sch Med, Dept Pediat, Irvine, CA 92717 USA.	cbuss@uci.edu; sentring@uci.edu	Entringer, Sonja/ABB-9405-2020; Buss, Claudia/ABC-3687-2020	Buss, Claudia/0000-0002-8738-3133; Davis, Elysia/0000-0001-6345-9271; Entringer, Sonja/0000-0002-9926-7076	US PHS National Institutes of Health (NIH) [NS-41298, HD-51852, HD-28413]; NIH [RO1 MH-091351, RO1 HD-065825, R01 HD-050662, RO1 HD-06028]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD060628, R01HD065825] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD028413, R01HD050662, R01HD051852] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH091351] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041298] Funding Source: NIH RePORTER	US PHS National Institutes of Health (NIH); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by US PHS National Institutes of Health (NIH) grants NS-41298, HD-51852 and HD-28413 to CAS. Additional effort for the preparation of this manuscript was supported by NIH grants RO1 MH-091351 to CB, RO1 HD-065825 to SE, R01 HD-050662 to EPD, and RO1 HD-06028 to PDW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach TM, 2001, J CONSULT CLIN PSYCH, V69, P699, DOI 10.1037/0022-006X.69.4.699; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Andersen SL, 2003, NEUROSCI BIOBEHAV R, V27, P3, DOI 10.1016/S0149-7634(03)00005-8; Antonow-Schlorke I, 2011, P NATL ACAD SCI USA, V108, P3011, DOI 10.1073/pnas.1009838108; Baerwald KD, 1998, J NEUROSCI RES, V52, P230, DOI 10.1002/(SICI)1097-4547(19980415)52:2<230::AID-JNR11>3.3.CO;2-P; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Basu S, 2011, OBESITY, V19, P476, DOI 10.1038/oby.2010.215; Beck A.T., 1996, PSYCHOL ASSESS, V10, DOI [10.1037/t00742-000, DOI 10.1037/T00742-000]; BIEDERMAN J, 1993, J CHILD PSYCHOL PSYC, V34, P1241, DOI 10.1111/j.1469-7610.1993.tb01785.x; Bilbo SD, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.014.2009; Bouret SG, 2010, NESTLE NUTR WORKS SE, V65, P25, DOI 10.1159/000281143; Brion MJ, 2011, PEDIATRICS, V127, pE202, DOI 10.1542/peds.2010-0651; Brown AS, 2010, AM J PSYCHIAT, V167, P261, DOI 10.1176/appi.ajp.2009.09030361; Button TMM, 2007, EARLY HUM DEV, V83, P727, DOI 10.1016/j.earlhumdev.2007.07.006; Castle Lon, 2007, J Atten Disord, V10, P335, DOI 10.1177/1087054707299597; Catalano PM, 2009, DIABETES CARE, V32, P1076, DOI 10.2337/dc08-2077; CHEN WJ, 1994, J CONSULT CLIN PSYCH, V62, P1017, DOI 10.1037/0022-006X.62.5.1017; Crampton SJ, 2011, J NEUROCHEM; Diamond A, 2011, SCIENCE, V333, P959, DOI 10.1126/science.1204529; Entringer S, 2011, DIABETES, V60, pA118; Entringer S, 2010, CURR OPIN ENDOCRINOL, V17, P507, DOI 10.1097/MED.0b013e3283405921; Epstein JN, 2003, J ABNORM CHILD PSYCH, V31, P543, DOI 10.1023/A:1025405216339; Froehlich TE, 2011, CURR PSYCHIAT REP; Glover V, 2011, J CHILD PSYCHOL PSYC, V52, P356, DOI 10.1111/j.1469-7610.2011.02371.x; Golan HM, 2005, NEUROPHARMACOLOGY, V48, P903, DOI 10.1016/j.neuropharm.2004.12.023; Graciarena M, 2010, BRAIN BEHAV IMMUN, V24, P1301, DOI 10.1016/j.bbi.2010.06.005; Grayson BE, 2010, ENDOCRINOLOGY, V151, P1622, DOI 10.1210/en.2009-1019; Huda SS, 2010, SEMIN FETAL NEONAT M, V15, P70, DOI 10.1016/j.siny.2009.09.006; Huizink AC, 2006, NEUROSCI BIOBEHAV R, V30, P24, DOI 10.1016/j.neubiorev.2005.04.005; Institute of Medicine (IOM), 2009, WEIGHT GAIN PREGN RE; Konycheva G, 2011, NUTR RES, V31, P790, DOI 10.1016/j.nutres.2011.09.015; Kraemer HC, 2003, J AM ACAD CHILD PSY, V42, P1524, DOI 10.1097/00004583-200312000-00022; Lahti J, 2006, J CHILD PSYCHOL PSYC, V47, P1167, DOI 10.1111/j.1469-7610.2006.01661.x; Lampert T L, 2004, J Atten Disord, V8, P63, DOI 10.1177/108705470400800204; Li JO, 2010, EUR CHILD ADOLES PSY, V19, P747, DOI 10.1007/s00787-010-0113-9; Lindstrom K, 2011, PEDIATRICS, V127, P858, DOI 10.1542/peds.2010-1279; Linnet KM, 2006, ARCH DIS CHILD, V91, P655, DOI 10.1136/adc.2005.088872; Linnet KM, 2003, AM J PSYCHIAT, V160, P1028, DOI 10.1176/appi.ajp.160.6.1028; Lu MC, 2004, AM J OBSTET GYNECOL, V191, P691, DOI 10.1016/j.ajog.2004.04.018; Mardones F, 2005, MATERN CHILD NUTR, V1, P77, DOI 10.1111/j.1740-8709.2005.00013.x; Mullane JC, 2009, CHILD NEUROPSYCHOL, V15, P321, DOI 10.1080/09297040802348028; Nigg JT, 2005, BIOL PSYCHIAT, V57, P1424, DOI 10.1016/j.biopsych.2004.11.011; Nomura Y, 2012, ARCH PEDIAT ADOLESC; OBRIEN GD, 1981, AM J OBSTET GYNECOL, V139, P540, DOI 10.1016/0002-9378(81)90514-7; Oken Emily, 2003, BMC Pediatr, V3, P6, DOI 10.1186/1471-2431-3-6; Pastor Patricia N, 2008, Vital Health Stat 10, P1; Poelmans G, 2011, AM J PSYCHIAT, V168, P365, DOI 10.1176/appi.ajp.2010.10070948; Raudenbush SW, 2002, HIERARCHICAL LINEAR; Raznahan A, 2011, J NEUROSCI, V31, P7174, DOI 10.1523/JNEUROSCI.0054-11.2011; Rodriguez A, 2008, INT J OBESITY, V32, P550, DOI 10.1038/sj.ijo.0803741; Rodriguez A, 2010, J CHILD PSYCHOL PSYC, V51, P134, DOI 10.1111/j.1469-7610.2009.02133.x; Sandman Curt A, 2011, Int J Pept, V2011, P837596, DOI 10.1155/2011/837596; Short SJ, 2010, BIOL PSYCHIAT, V67, P965, DOI 10.1016/j.biopsych.2009.11.026; Sobel M.E., 1982, SOCIOL METHODOL, V13, P290, DOI [10.2307/270723, DOI 10.2307/270723]; Sommer KS, 2000, ADOLESCENCE, V35, P87; Swanson JD, 2008, J CHILD PSYCHOL PSYC, V49, P1009, DOI 10.1111/j.1469-7610.2008.02014.x; Swanson JM, 2007, NEUROPSYCHOL REV, V17, P39, DOI 10.1007/s11065-007-9019-9; THOENEN H, 1995, SCIENCE, V270, P593, DOI 10.1126/science.270.5236.593; Townsend JT, 1983, STOCHASTIC MODELLING; van der Toorn SLM, 2010, EUR CHILD ADOLES PSY, V19, P379, DOI 10.1007/s00787-009-0062-3; Van Lieshout RJ, 2011, OBES REV, V12, pe548, DOI 10.1111/j.1467-789X.2010.00850.x; Vuillermot S, 2010, J NEUROSCI, V30, P1270, DOI 10.1523/JNEUROSCI.5408-09.2010; Wadhwa PD, 2011, CLIN PERINATOL, V38, P351, DOI 10.1016/j.clp.2011.06.007; Wadhwa PD, 2004, AM J OBSTET GYNECOL, V191, P1063, DOI 10.1016/j.ajog.2004.06.070; Wechsler D., 2012, WAIS 4 KASIKIRJA; Willcutt EG, 2005, BIOL PSYCHIAT, V57, P1336, DOI 10.1016/j.biopsych.2005.02.006; Willette AA, 2011, BEHAV BRAIN RES, V219, P108, DOI 10.1016/j.bbr.2010.12.023; World Health Organization, 2009, GLOB DAT BAS BOD MAS; Yan X, 2011, INFLAMM BOWEL DIS, V17, P1513, DOI 10.1002/ibd.21539; Zeisel SH, 2011, SEMIN CELL DEV BIOL, V22, P624, DOI 10.1016/j.semcdb.2011.06.002	71	93	95	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2012	7	6							e37758	10.1371/journal.pone.0037758	http://dx.doi.org/10.1371/journal.pone.0037758			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WX	22719848	Green Published, gold			2022-12-27	WOS:000305350000008
J	Goll, J; Thiagarajan, M; Abubucker, S; Huttenhower, C; Yooseph, S; Methe, BA				Goll, Johannes; Thiagarajan, Mathangi; Abubucker, Sahar; Huttenhower, Curtis; Yooseph, Shibu; Methe, Barbara A.			A Case Study for Large-Scale Human Microbiome Analysis Using JCVI's Metagenomics Reports (METAREP)	PLOS ONE			English	Article							OCEAN SAMPLING EXPEDITION; PROTEIN GLYCOSYLATION; GENE; PYRUVATE; CATALOG; GENOMES; TOOL	As metagenomic studies continue to increase in their number, sequence volume and complexity, the scalability of biological analysis frameworks has become a rate-limiting factor to meaningful data interpretation. To address this issue, we have developed JCVI Metagenomics Reports (METAREP) as an open source tool to query, browse, and compare extremely large volumes of metagenomic annotations. Here we present improvements to this software including the implementation of a dynamic weighting of taxonomic and functional annotation, support for distributed searches, advanced clustering routines, and integration of additional annotation input formats. The utility of these improvements to data interpretation are demonstrated through the application of multiple comparative analysis strategies to shotgun metagenomic data produced by the National Institutes of Health Roadmap for Biomedical Research Human Microbiome Project (HMP) (http://nihroadmap.nih.gov). Specifically, the scalability of the dynamic weighting feature is evaluated and established by its application to the analysis of over 400 million weighted gene annotations derived from 14 billion short reads as predicted by the HMP Unified Metabolic Analysis Network (HUMAnN) pipeline. Further, the capacity of METAREP to facilitate the identification and simultaneous comparison of taxonomic and functional annotations including biological pathway and individual enzyme abundances from hundreds of community samples is demonstrated by providing scenarios that describe how these data can be mined to answer biological questions related to the human microbiome. These strategies provide users with a reference of how to conduct similar large-scale metagenomic analyses using METAREP with their own sequence data, while in this study they reveal insights into the nature and extent of variation in taxonomic and functional profiles across body habitats and individuals. Over one thousand HMP WGS datasets and the latest open source code are available at http://www.jcvi.org/hmp-metarep.	[Goll, Johannes; Thiagarajan, Mathangi; Methe, Barbara A.] J Craig Venter Inst, Rockville, MD USA; [Yooseph, Shibu] J Craig Venter Inst, San Diego, CA USA; [Abubucker, Sahar] Washington Univ, Sch Med, Genome Inst, St Louis, MO USA; [Huttenhower, Curtis] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	J. Craig Venter Institute; J. Craig Venter Institute; Washington University (WUSTL); Harvard University; Harvard T.H. Chan School of Public Health	Goll, J (corresponding author), J Craig Venter Inst, Rockville, MD USA.	bmethe@jcvi.org		Huttenhower, Curtis/0000-0002-1110-0096; Yooseph, Shibu/0000-0001-5581-5002	National Institutes of Health [N01 AI 30071, U54-AI084844]; Genome Institute at the Washington University School of Medicine [U54HG004968]; Harvard School of Public Health [1R01HG005969]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004968, R01HG005969] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI084844] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Genome Institute at the Washington University School of Medicine; Harvard School of Public Health; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by National Institutes of Health (http://www.nih.gov/) contracts and grants: J. Craig Venter Institute (contract # N01 AI 30071 and award # U54-AI084844); Genome Institute at the Washington University School of Medicine (award # U54HG004968); Harvard School of Public Health (award # 1R01HG005969). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; Abubucker S, METABOLIC R IN PRESS; [Anonymous], HIGH THROUG IN PRESS; Arnau J, 1997, J BACTERIOL, V179, P5884, DOI 10.1128/jb.179.18.5884-5891.1997; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bertin PN, 2011, ISME J; Buckel W, 2006, ANNU REV MICROBIOL, V60, P27, DOI 10.1146/annurev.micro.60.080805.142216; Caporaso JG, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r50; Cardenas E, 2010, APPL ENVIRON MICROB, V76, P6778, DOI 10.1128/AEM.01097-10; Caspi R, 2011, NUCL ACIDS RES; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; DATTA A, 1991, BIOCHEM BIOPH RES CO, V176, P517, DOI 10.1016/0006-291X(91)90955-7; Dewhirst FE, 2010, J BACTERIOL, V192, P5002, DOI 10.1128/JB.00542-10; Eddy Sean R, 2009, Genome Inform, V23, P205; Fell DA, 2000, NAT BIOTECHNOL, V18, P1121, DOI 10.1038/81025; Feng XY, 2010, J BIOL CHEM, V285, P39544, DOI 10.1074/jbc.M110.162958; Gilbert JA, 2010, STAND GENOMIC SCI, V3, P249, DOI [10.4056/aigs.1443528, 10.4056/sigs.1433550]; Glass EM, 2010, COLD SPRING HARB PRO, V2010; Goll J, 2010, BIOINFORMATICS, V26, P2631, DOI 10.1093/bioinformatics/btq455; Hassan BH, 2011, J BIOL CHEM, V286, P8263, DOI 10.1074/jbc.M110.194191; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Hess M, 2011, SCIENCE, V331, P463, DOI 10.1126/science.1200387; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Keitel J, COMPREHENSI IN PRESS; Leibig M, 2011, J BACTERIOL, V193, P952, DOI 10.1128/JB.01161-10; Mager DL, 2003, J CLIN PERIODONTOL, V30, P644, DOI 10.1034/j.1600-051X.2003.00376.x; Martinez JL, 2011, FEMS MICROBIOL REV, V35, P768, DOI 10.1111/j.1574-6976.2011.00282.x; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; Nelson KE, 2010, SCIENCE, V328, P994, DOI 10.1126/science.1183605; Orvis J, 2010, BIOINFORMATICS, V26, P1488, DOI 10.1093/bioinformatics/btq167; Pepke S, 2009, NAT METHODS, V6, pS22, DOI [10.1038/NMETH.1371, 10.1038/nmeth.1371]; Peterson J, 2009, GENOME RES, V19, P2317, DOI 10.1101/gr.096651.109; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Suzek BE, 2007, BIOINFORMATICS, V23, P1282, DOI 10.1093/bioinformatics/btm098; Szymanski CM, 2005, NAT REV MICROBIOL, V3, P225, DOI 10.1038/nrmicro1100; Szymanski CM, 2002, INFECT IMMUN, V70, P2242, DOI 10.1128/IAI.70.4.2242-2244.2002; Tanenbaum DM, 2010, STAND GENOMIC SCI, V2, P229, DOI 10.4056/sigs.651139; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352; Yooseph S, 2007, PLOS BIOL, V5, pe16, DOI DOI 10.1371/journal.pbio.0050016	43	9	10	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e29044	10.1371/journal.pone.0029044	http://dx.doi.org/10.1371/journal.pone.0029044			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22719821	Green Submitted, Green Published, gold			2022-12-27	WOS:000305341900004
J	Kozlov, IA; Thomsen, ER; Munchel, SE; Villegas, P; Capek, P; Gower, AJ; Pond, SJK; Chudin, E; Chee, MS				Kozlov, Igor A.; Thomsen, Elliot R.; Munchel, Sarah E.; Villegas, Patricia; Capek, Petr; Gower, Austin J.; Pond, Stephanie J. K.; Chudin, Eugene; Chee, Mark S.			A Highly Scalable Peptide-Based Assay System for Proteomics	PLOS ONE			English	Article							IN-VITRO SELECTION; HEPATITIS-C VIRUS; MESSENGER-RNA DISPLAY; PHAGE DISPLAY; TYROSINE PHOSPHORYLATION; PROTEIN-PHOSPHORYLATION; MASS-SPECTROMETRY; COMBINATORIAL SYNTHESIS; CLINICAL-APPLICATIONS; FUNCTIONAL PROTEINS	We report a scalable and cost-effective technology for generating and screening high-complexity customizable peptide sets. The peptides are made as peptide-cDNA fusions by in vitro transcription/translation from pools of DNA templates generated by microarray-based synthesis. This approach enables large custom sets of peptides to be designed in silico, manufactured cost-effectively in parallel, and assayed efficiently in a multiplexed fashion. The utility of our peptide-cDNA fusion pools was demonstrated in two activity-based assays designed to discover protease and kinase substrates. In the protease assay, cleaved peptide substrates were separated from uncleaved and identified by digital sequencing of their cognate cDNAs. We screened the 3,011 amino acid HCV proteome for susceptibility to cleavage by the HCV NS3/4A protease and identified all 3 known trans cleavage sites with high specificity. In the kinase assay, peptide substrates phosphorylated by tyrosine kinases were captured and identified by sequencing of their cDNAs. We screened a pool of 3,243 peptides against Abl kinase and showed that phosphorylation events detected were specific and consistent with the known substrate preferences of Abl kinase. Our approach is scalable and adaptable to other protein-based assays.	[Kozlov, Igor A.; Thomsen, Elliot R.; Munchel, Sarah E.; Villegas, Patricia; Capek, Petr; Gower, Austin J.; Pond, Stephanie J. K.; Chudin, Eugene; Chee, Mark S.] Prognosys Biosci Inc, La Jolla, CA USA		Kozlov, IA (corresponding author), Prognosys Biosci Inc, La Jolla, CA USA.	ikozlov@prognosysbio.com	Capek, Petr/G-1303-2012		National Institute of General Medical Sciences [R43GM085884, R43GM090392]; National Human Genome Research Institute [HG004284]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R43HG004284, R44HG004284] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R44GM085884, R43GM085884, R44GM090392, R43GM090392] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by awards R43GM085884 and R43GM090392 from the National Institute of General Medical Sciences to I. A. K. and HG004284 from the National Human Genome Research Institute to M. S. C. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amanchy R, 2008, J PROTEOME RES, V7, P3900, DOI 10.1021/pr800198w; BARTENSCHLAGER R, 1995, J VIROL, V69, P198, DOI 10.1128/JVI.69.1.198-205.1995; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Bertschinger J, 2007, PROTEIN ENG DES SEL, V20, P57, DOI 10.1093/protein/gzl055; Beyer M, 2007, SCIENCE, V318, P1888, DOI 10.1126/science.1149751; Blanco-Canosa JB, 2008, ANGEW CHEM INT EDIT, V47, P6851, DOI 10.1002/anie.200705471; Blight KJ, 1998, ANTIVIR THER, V3, P71; Bohmer FD, 2009, BRIT J HAEMATOL, V144, P127, DOI 10.1111/j.1365-2141.2008.07408.x; Bonetta L, 2005, NAT METHODS, V2, P225, DOI 10.1038/nmeth0305-225; Boschetti E, 2009, PROTEOMICS, V9, P1492, DOI 10.1002/pmic.200800389; Breitling F, 2009, MOL BIOSYST, V5, P224, DOI 10.1039/b819850k; Brown KC, 2010, CURR PHARM DESIGN, V16, P1040, DOI 10.2174/138161210790963788; Chen SH, 2005, CURR MED CHEM, V12, P2317, DOI 10.2174/0929867054864769; Chong PK, 2008, PROTEOMICS, V8, P4370, DOI 10.1002/pmic.200800051; Choudhary C, 2010, NAT REV MOL CELL BIO, V11, P427, DOI 10.1038/nrm2900; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Collins MO, 2007, PROTEOMICS, V7, P2751, DOI 10.1002/pmic.200700145; de Figueiredo P, 2004, PROTEOMICS, V4, P3128, DOI 10.1002/pmic.200300842; Dente L, 1997, J MOL BIOL, V269, P694, DOI 10.1006/jmbi.1997.1073; Diks SH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000777; Dinkel H, 2011, NUCLEIC ACIDS RES, V39, pD261, DOI 10.1093/nar/gkq1104; Estephan E, 2009, BIOTECHNOL BIOENG, V104, P1121, DOI 10.1002/bit.22478; Finlay WJJ, 2011, METHODS MOL BIOL, V681, P87, DOI 10.1007/978-1-60761-913-0_6; Frankel A, 2003, CHEM BIOL, V10, P1043, DOI 10.1016/j.chembiol.2003.11.004; George J, 2003, J BIOMOL SCREEN, V8, P72, DOI 10.1177/1087057102239778; Goto Y, 2011, NAT PROTOC, V6, P779, DOI 10.1038/nprot.2011.331; HAHM B, 1995, J VIROL, V69, P2534, DOI 10.1128/JVI.69.4.2534-2539.1995; Hanes J, 1997, P NATL ACAD SCI USA, V94, P4937, DOI 10.1073/pnas.94.10.4937; Hattori S, 2008, EXPERT REV PROTEOMIC, V5, P497, DOI 10.1586/14789450.5.3.497; He M, 2008, NAT METHODS, V5, P175, DOI [10.1038/nmeth.1178, 10.1038/NMETH.1178]; He MY, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.15.e73; Heibeck TH, 2009, J PROTEOME RES, V8, P3852, DOI 10.1021/pr900044c; Hilpert K, 2007, NAT PROTOC, V2, P1333, DOI 10.1038/nprot.2007.160; Hornbeck PV, 2004, PROTEOMICS, V4, P1551, DOI 10.1002/pmic.200300772; Jalal S, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.254pl1; Johnson SA, 2005, NAT METHODS, V2, P17, DOI 10.1038/NMETH731; Jorgensen C, 2009, SCIENCE, V326, P1502, DOI 10.1126/science.1176615; Jung JP, 2010, BIOPOLYMERS, V94, P49, DOI 10.1002/bip.21326; Keefe AD, 2001, NATURE, V410, P715, DOI 10.1038/35070613; Kong Y, 2009, J THEOR BIOL, V259, P641, DOI 10.1016/j.jtbi.2009.04.008; Kozlov IA, 2006, COMB CHEM HIGH T SCR, V9, P481, DOI 10.2174/138620706777698535; Kurz M, 2001, CHEMBIOCHEM, V2, P666, DOI 10.1002/1439-7633(20010903)2:9<666::AID-CBIC666>3.0.CO;2-#; Kwong AD, 1999, ANTIVIR RES, V41, P65; Kwong AD, 2011, NAT BIOTECHNOL, V29, P993, DOI 10.1038/nbt.2020; Lahm A, 2002, CURR DRUG TARGETS, V3, P281, DOI 10.2174/1389450023347650; Larman HB, 2011, NAT BIOTECHNOL, V29, P535, DOI 10.1038/nbt.1856; Lee S, 2010, BIOCHEMISTRY-US, V49, P1364, DOI 10.1021/bi901135x; LeProust EM, 2010, NUCLEIC ACIDS RES, V38, P2522, DOI 10.1093/nar/gkq163; Lopez-Otin C, 2002, NAT REV MOL CELL BIO, V3, P509, DOI 10.1038/nrm858; Mahler M, 2010, ANN NY ACAD SCI, V1183, P267, DOI 10.1111/j.1749-6632.2009.05127.x; Manning Brendan D, 2002, Sci STKE, V2002, ppe49, DOI 10.1126/stke.2002.162.pe49; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Manning G, 2002, TRENDS BIOCHEM SCI, V27, P514, DOI 10.1016/S0968-0004(02)02179-5; MATTHEWS DJ, 1993, SCIENCE, V260, P1113, DOI 10.1126/science.8493554; Miyamoto-Sato E, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng078; Odegrip R, 2004, P NATL ACAD SCI USA, V101, P2806, DOI 10.1073/pnas.0400219101; Ohta A, 2008, CURR OPIN CHEM BIOL, V12, P159, DOI 10.1016/j.cbpa.2007.12.009; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Overall CM, 2007, NAT REV MOL CELL BIO, V8, P245, DOI 10.1038/nrm2120; Paradela A, 2008, J PROTEOME RES, V7, P1809, DOI 10.1021/pr7006544; Parikh K, 2010, CANCER RES, V70, P2575, DOI 10.1158/0008-5472.CAN-09-3989; Peck SC, 2006, PLANT J, V45, P512, DOI 10.1111/j.1365-313X.2005.02613.x; PIELES U, 1989, NUCLEIC ACIDS RES, V17, P285, DOI 10.1093/nar/17.1.285; Piersma SR, 2010, ANAL BIOANAL CHEM, V397, P3163, DOI 10.1007/s00216-010-3784-7; Pogson M, 2009, CURR OPIN BIOTECH, V20, P390, DOI 10.1016/j.copbio.2009.07.003; Ramachandran N, 2004, SCIENCE, V305, P86, DOI 10.1126/science.1097639; Rawlings ND, 2006, NUCLEIC ACIDS RES, V34, pD270, DOI 10.1093/nar/gkj089; Roberts RW, 1997, P NATL ACAD SCI USA, V94, P12297, DOI 10.1073/pnas.94.23.12297; Rothman DM, 2005, TRENDS CELL BIOL, V15, P502, DOI 10.1016/j.tcb.2005.07.003; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; Ryan KJ., 2004, SHERRIS MED MICROBIO; Rychlewski L, 2004, J MOL BIOL, V336, P307, DOI 10.1016/j.jmb.2003.12.052; Salomon AR, 2003, P NATL ACAD SCI USA, V100, P443, DOI 10.1073/pnas.2436191100; Scholle MD, 2006, CHEMBIOCHEM, V7, P834, DOI 10.1002/cbic.200500427; Schutkowski M, 2005, CHEMBIOCHEM, V6, P513, DOI 10.1002/cbic.200400314; Sergeeva A, 2006, ADV DRUG DELIVER REV, V58, P1622, DOI 10.1016/j.addr.2006.09.018; Shiryaev SA, 2007, BIOCHEM J, V401, P743, DOI 10.1042/BJ20061136; Shiryaev SA, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0040029, 10.1371/journal.pone.0035759]; Shivange AV, 2009, CURR OPIN CHEM BIOL, V13, P19, DOI 10.1016/j.cbpa.2009.01.019; Shults MD, 2007, CHEMBIOCHEM, V8, P933, DOI 10.1002/cbic.200600522; SONGYANG Z, 1995, NATURE, V373, P536, DOI 10.1038/373536a0; Stadler V, 2008, ANGEW CHEM INT EDIT, V47, P7132, DOI 10.1002/anie.200801616; Steinkuhler C, 1996, J VIROL, V70, P6694; Steuber H, 2010, CURR TOP MED CHEM, V10, P323, DOI 10.2174/156802610790725470; Stuible M, 2008, J BIOL CHEM, V283, P15740, DOI 10.1074/jbc.M710534200; Szardenings M, 2003, J RECEPT SIG TRANSD, V23, P307, DOI 10.1081/RRS-120026973; Takahashi Terry T., 2009, V535, P293, DOI 10.1007/978-1-59745-557-2_17; Tao SC, 2006, NAT BIOTECHNOL, V24, P1253, DOI 10.1038/nbt1249; Tolbert TJ, 2002, ANGEW CHEM INT EDIT, V41, P2171, DOI 10.1002/1521-3773(20020617)41:12<2171::AID-ANIE2171>3.0.CO;2-Q; Ueda T, 2010, METHODS MOL BIOL, V607, P219, DOI 10.1007/978-1-60327-331-2_18; Ullman CG, 2011, BRIEF FUNCT GENOMICS, V10, P125, DOI 10.1093/bfgp/elr010; UY R, 1977, SCIENCE, V198, P890, DOI 10.1126/science.337487; Vasiljeva O, 2007, CURR PHARM DESIGN, V13, P387, DOI 10.2174/138161207780162962; Villen J, 2007, P NATL ACAD SCI USA, V104, P1488, DOI 10.1073/pnas.0609836104; Wetterstrand KA, 2011, DNA SEQUENCING COSTS; Whaley SR, 2000, NATURE, V405, P665, DOI 10.1038/35015043; Whitney M, 2010, J BIOL CHEM, V285, P22532, DOI 10.1074/jbc.M110.138297; Winssinger N, 2004, CHEM BIOL, V11, P1351, DOI 10.1016/j.chembiol.2004.07.015; Xu LH, 2002, CHEM BIOL, V9, P933, DOI 10.1016/S1074-5521(02)00187-4; Yamagishi Y, 2011, CHEM BIOL, V18, P1562, DOI 10.1016/j.chembiol.2011.09.013; Yang CY, 2008, BIOINFORMATICS, V24, pI14, DOI 10.1093/bioinformatics/btn297; Yen M, 2007, BIOTECHNIQUES, V43, P31, DOI 10.2144/000112502; Yonezawa M, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng119	103	13	38	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2012	7	6							e37441	10.1371/journal.pone.0037441	http://dx.doi.org/10.1371/journal.pone.0037441			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UJ	22701568	Green Published, gold, Green Submitted			2022-12-27	WOS:000305340000003
J	Brault, S; Bideau, B; Kulpa, R; Craig, CM				Brault, Sebastien; Bideau, Benoit; Kulpa, Richard; Craig, Cathy M.			Detecting Deception in Movement: The Case of the Side-Step in Rugby	PLOS ONE			English	Article							HUMAN JOINT MOTION; BIOLOGICAL MOTION; ISB RECOMMENDATION; COORDINATE SYSTEMS; VISUAL-PERCEPTION; GAIT PERCEPTION; ANTICIPATION; RECOGNITION; FRAMEWORK; GENDER	Although coordinated patterns of body movement can be used to communicate action intention, they can also be used to deceive. Often known as deceptive movements, these unpredictable patterns of body movement can give a competitive advantage to an attacker when trying to outwit a defender. In this particular study, we immersed novice and expert rugby players in an interactive virtual rugby environment to understand how the dynamics of deceptive body movement influence a defending player's decisions about how and when to act. When asked to judge final running direction, expert players who were found to tune into prospective tau-based information specified in the dynamics of 'honest' movement signals (Centre of Mass), performed significantly better than novices who tuned into the dynamics of 'deceptive' movement signals (upper trunk yaw and out-foot placement) (p<.001). These findings were further corroborated in a second experiment where players were able to move as if to intercept or 'tackle' the virtual attacker. An analysis of action responses showed that experts waited significantly longer before initiating movement (p<.001). By waiting longer and picking up more information that would inform about future running direction these experts made significantly fewer errors (p<.05). In this paper we not only present a mathematical model that describes how deception in body-based movement is detected, but we also show how perceptual expertise is manifested in action expertise. We conclude that being able to tune into the 'honest' information specifying true running action intention gives a strong competitive advantage.	[Brault, Sebastien; Bideau, Benoit; Kulpa, Richard] Univ Rennes 2, Ecole Normale Super Cachan, M2S Mouvement Sport Sante Lab, F-35043 Rennes, France; [Craig, Cathy M.] Queens Univ Belfast, Sch Psychol, Belfast BT7 1NN, Antrim, North Ireland	UDICE-French Research Universities; Universite Paris Saclay; Universite Rennes 2; Queens University Belfast	Brault, S (corresponding author), Univ Rennes 2, Ecole Normale Super Cachan, M2S Mouvement Sport Sante Lab, F-35043 Rennes, France.	sb.brault@gmail.com; cathy.craig@qub.ac.uk	Craig, Cathy/D-9833-2014; Bideau, Benoit/AAD-2052-2020	Craig, Cathy/0000-0001-5509-1120; 	International Doctoral College; European University of Brittany; British Council Alliance Travel fund; European Research Council [210007-TEMPUS_G]	International Doctoral College; European University of Brittany; British Council Alliance Travel fund; European Research Council(European Research Council (ERC)European Commission)	This study was partially supported by the International Doctoral College, European University of Brittany and the British Council Alliance Travel fund and by a Starting Independent Researcher's Grant (210007-TEMPUS_G) awarded by the European Research Council to the last author. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Abernethy B, 2007, J MOTOR BEHAV, V39, P353, DOI 10.3200/JMBR.39.5.353-368; Aglioti SM, 2008, NAT NEUROSCI, V11, P1109, DOI 10.1038/nn.2182; Baker R, 2003, J BIOMECH, V36, P300, DOI 10.1016/S0021-9290(02)00336-6; BARCLAY CD, 1978, PERCEPT PSYCHOPHYS, V23, P145, DOI 10.3758/BF03208295; Bideau B, 2004, NEUROSCI LETT, V372, P119, DOI 10.1016/j.neulet.2004.09.023; Bideau B, 2010, IEEE COMPUT GRAPH, V30, P14, DOI 10.1109/MCG.2009.134; Brault S, 2010, HUM MOVEMENT SCI, V29, P412, DOI 10.1016/j.humov.2009.12.004; Calvo-Merino B, 2005, CEREB CORTEX, V15, P1243, DOI 10.1093/cercor/bhi007; Canal-Bruland R, 2010, HUM MOVEMENT SCI, V29, P94, DOI 10.1016/j.humov.2009.10.001; Craig CM, 2000, NATURE, V405, P295, DOI 10.1038/35012690; CUTTING JE, 1977, B PSYCHONOMIC SOC, V9, P353, DOI 10.3758/BF03337021; Dessing JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013161; Dittrich WH, 1996, PERCEPTION, V25, P727, DOI 10.1068/p250727; Gibson E. J., 1991, ODYSSEY LEARNING PER; Hill H, 2000, PSYCHOL SCI, V11, P223, DOI 10.1111/1467-9280.00245; Hill H, 2001, CURR BIOL, V11, P880, DOI 10.1016/S0960-9822(01)00243-3; Hommel B, 2001, BEHAV BRAIN SCI, V24, P849, DOI 10.1017/S0140525X01000103; Jackson RC, 2006, ACTA PSYCHOL, V123, P355, DOI 10.1016/j.actpsy.2006.02.002; JOHANSSON G, 1973, PERCEPT PSYCHOPHYS, V14, P201, DOI 10.3758/BF03212378; Jokisch D, 2006, PERCEPTION, V35, P911, DOI 10.1068/p5540; KOZLOWSKI LT, 1977, PERCEPT PSYCHOPHYS, V21, P575, DOI 10.3758/BF03198740; Lange J, 2006, J VISION, V6, P836, DOI 10.1167/6.8.6; Lee DN, 1998, ECOL PSYCHOL, V10, P221, DOI 10.1207/s15326969eco103&4_4; LEE DN, 1981, NATURE, V293, P293, DOI 10.1038/293293a0; Lee DN, 2001, EXP BRAIN RES, V139, P151, DOI 10.1007/s002210100725; McIntyre J, 2001, NAT NEUROSCI, V4, P693, DOI 10.1038/89477; McLeod P, 1996, J EXP PSYCHOL HUMAN, V22, P531; Morris PH, 2010, J NONVERBAL BEHAV, V34, P1, DOI 10.1007/s10919-009-0075-0; Multon F, 2008, PRESENCE-VIRTUAL AUG, V17, P17, DOI 10.1162/pres.17.1.17; Palleroni A, 2005, NATURE, V434, P973, DOI 10.1038/434973b; Pollick FE, 2002, VISION RES, V42, P2345, DOI 10.1016/S0042-6989(02)00196-7; Pollick FE, 2001, COGNITION, V82, pB51, DOI 10.1016/S0010-0277(01)00147-0; Rizzolatti G, 2001, NAT REV NEUROSCI, V2, P661, DOI 10.1038/35090060; RUNESON S, 1983, J EXP PSYCHOL GEN, V112, P585, DOI 10.1037/0096-3445.112.4.585; Schutz-Bosbach S, 2007, TRENDS COGN SCI, V11, P349, DOI 10.1016/j.tics.2007.06.005; Sebanz N, 2009, PSYCHON B REV, V16, P170, DOI 10.3758/PBR.16.1.170; Stevenage SV, 1999, APPL COGNITIVE PSYCH, V13, P513, DOI 10.1002/(SICI)1099-0720(199912)13:6<513::AID-ACP616>3.0.CO;2-8; Stuart-Fox D, 2005, TRENDS ECOL EVOL, V20, P521, DOI 10.1016/j.tree.2005.08.004; Szamado S, 2000, ANIM BEHAV, V59, P221, DOI 10.1006/anbe.1999.1293; Troje NF, 2002, J VISION, V2, P371, DOI 10.1167/2.5.2; Van der Kamp J, 2008, INT J SPORT PSYCHOL, V39, P100; Wu G, 2005, J BIOMECH, V38, P981, DOI 10.1016/j.jbiomech.2004.05.042; Wu G, 2002, J BIOMECH, V35, P543, DOI 10.1016/S0021-9290(01)00222-6; Zatsiorsky VM, 1990, CONT PROBLEMS BIOMEC, P272	44	80	80	4	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2012	7	6							e37494	10.1371/journal.pone.0037494	http://dx.doi.org/10.1371/journal.pone.0037494			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TU	22701569	gold, Green Submitted, Green Published			2022-12-27	WOS:000305337600009
J	Omosun, YO; Blackstock, AJ; Gatei, W; Hightower, A; van Eijk, AM; Ayisi, J; Otieno, J; Lal, RB; Steketee, R; Nahlen, B; ter Kuile, FO; Slutsker, L; Shi, YP				Omosun, Yusuf O.; Blackstock, Anna J.; Gatei, Wangeci; Hightower, Allen; van Eijk, Anne Maria; Ayisi, John; Otieno, Juliana; Lal, Renu B.; Steketee, Richard; Nahlen, Bernard; ter Kuile, Feiko O.; Slutsker, Laurence; Shi, Ya Ping			Differential Association of Gene Content Polymorphisms of Killer Cell Immunoglobulin-Like Receptors with Placental Malaria in HIV- and HIV plus Mothers	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; FALCIPARUM-INFECTED ERYTHROCYTES; TO-CHILD TRANSMISSION; SUB-SAHARAN AFRICA; PLASMODIUM-FALCIPARUM; NK CELLS; GESTATIONAL-AGE; PREGNANT-WOMEN; WESTERN KENYA; CUTTING EDGE	Pregnant women have abundant natural killer (NK) cells in their placenta, and NK cell function is regulated by polymorphisms of killer cell immunoglobulin-like receptors (KIRs). Previous studies report different roles of NK cells in the immune responses to placental malaria (PM) and human immunodeficiency virus (HIV-1) infections. Given these references, the aim of this study was to determine the association between KIR gene content polymorphism and PM infection in pregnant women of known HIV-1 status. Sixteen genes in the KIR family were analyzed in 688 pregnant Kenyan women. Gene content polymorphisms were assessed in relation to PM in HIV-1 negative and HIV-1 positive women, respectively. Results showed that in HIV-1 negative women, the presence of the individual genes KIR2DL1 and KIR2DL3 increased the odds of having PM, and the KIR2DL2/KIR2DL2 homozygotes were associated with protection from PM. However, the reverse relationship was observed in HIV-1 positive women, where the presence of individual KIR2DL3 was associated with protection from PM, and KIR2DL2/KIR2DL2 homozygotes increased the odds for susceptibility to PM. Further analysis of the HIV-1 positive women stratified by CD4 counts showed that this reverse association between KIR genes and PM remained only in the individuals with high CD4 cell counts but not in those with low CD4 cell counts. Collectively, these results suggest that inhibitory KIR2DL2 and KIR2DL3, which are alleles of the same locus, play a role in the inverse effects on PM and PM/HIV co-infection and the effect of KIR genes on PM in HIV positive women is dependent on high CD4 cell counts. In addition, analysis of linkage disequilibrium (LD) of the PM relevant KIR genes showed strong LD in women without PM regardless of their HIV status while LD was broken in those with PM, indicating possible selection pressure by malaria infection on the KIR genes.	[Omosun, Yusuf O.; Blackstock, Anna J.; Gatei, Wangeci; Hightower, Allen; Steketee, Richard; Nahlen, Bernard; Slutsker, Laurence; Shi, Ya Ping] Ctr Dis Control & Prevent, Div Parasit Dis & Malaria, Ctr Global Hlth, Atlanta, GA 30333 USA; [Lal, Renu B.] Ctr Dis Control & Prevent, Div Global HIV AIDS, Ctr Global Hlth, Atlanta, GA USA; [Omosun, Yusuf O.; Blackstock, Anna J.] Atlanta Res & Educ Fdn, Atlanta, GA USA; [van Eijk, Anne Maria; Ayisi, John] Kenya Govt Med Res Ctr, Ctr Vector Biol & Control Res, Kisumu, Kenya; [Otieno, Juliana] Nyanza Prov Gen Hosp, Minist Hlth, Kisumu, Kenya; [van Eijk, Anne Maria; ter Kuile, Feiko O.] Univ Liverpool, Liverpool Sch Trop Med, Child & Reprod Hlth Grp, Liverpool L3 5QA, Merseyside, England	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Kenya Medical Research Institute; Liverpool School of Tropical Medicine; University of Liverpool	Omosun, YO (corresponding author), Ctr Dis Control & Prevent, Div Parasit Dis & Malaria, Ctr Global Hlth, Atlanta, GA 30333 USA.	yps0@cdc.gov	Nahlen, Bernard/AAH-2051-2021; van Eijk, Anna Maria/AAQ-9894-2021; Omosun, Yusuf/P-9944-2019; Kuile, Feiko ter/ABD-6681-2020	Omosun, Yusuf/0000-0003-4759-6254; Kuile, Feiko ter/0000-0003-3663-5617; gatei, wangeci/0000-0002-3644-5445; van Eijk, Anna Maria/0000-0003-1635-1289	National Office of Public Health Genomics, Centers for Disease Control and Prevention [92129RQ]; American Society for Microbiology (ASM); Coordinating Center for Infectious Diseases (CCID); Atlanta Research and Education Foundation, Atlanta Veterans Affairs Medical Center	National Office of Public Health Genomics, Centers for Disease Control and Prevention; American Society for Microbiology (ASM); Coordinating Center for Infectious Diseases (CCID); Atlanta Research and Education Foundation, Atlanta Veterans Affairs Medical Center	This study was supported by intramural funding from The National Office of Public Health Genomics, Centers for Disease Control and Prevention (Project ID# 92129RQ). Yusuf Omosun was sponsored by American Society for Microbiology (ASM) and Coordinating Center for Infectious Diseases (CCID) fellowship and The Atlanta Research and Education Foundation, Atlanta Veterans Affairs Medical Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Raddad LJ, 2006, SCIENCE, V314, P1603, DOI 10.1126/science.1132338; Artavanis-Tsakonas K, 2003, J IMMUNOL, V171, P5396, DOI 10.4049/jimmunol.171.10.5396; Ayisi JG, 2004, EMERG INFECT DIS, V10, P643, DOI 10.3201/eid1004.030303; Baratin M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000228; Benjamini Y, 1995, J ROY STAT SOC, V57, P289; Brahmbhatt H, 2003, AIDS, V17, P2539, DOI 10.1097/00002030-200311210-00020; Brahmbhatt H, 2008, JAIDS-J ACQ IMM DEF, V47, P472, DOI 10.1097/QAI.0b013e318162afe0; Brentlinger PE, 2006, LANCET INFECT DIS, V6, P100, DOI 10.1016/S1473-3099(06)70383-8; Cohen GB, 1999, IMMUNITY, V10, P661, DOI 10.1016/S1074-7613(00)80065-5; Dellicour S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000221; EVERETT ET, 1990, HUM IMMUNOL, V29, P14, DOI 10.1016/0198-8859(90)90065-W; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Faridi RM, 2009, HUM REPROD, V24, P1758, DOI 10.1093/humrep/dep047; FAUCI AS, 1988, SCIENCE, V239, P617, DOI 10.1126/science.3277274; Fried M, 1996, SCIENCE, V272, P1502, DOI 10.1126/science.272.5267.1502; Gallagher M, 2005, AIDS, V19, P1849, DOI 10.1097/01.aids.0000189846.90946.5d; Gao XJ, 2005, NAT MED, V11, P1290, DOI 10.1038/nm1333; Hiby SE, 2008, HUM REPROD, V23, P972, DOI 10.1093/humrep/den011; Hiby SE, 2004, J EXP MED, V200, P957, DOI 10.1084/jem.20041214; Hsu KC, 2002, J IMMUNOL, V169, P5118, DOI 10.4049/jimmunol.169.9.5118; Hsu KC, 2002, IMMUNOL REV, V190, P40, DOI 10.1034/j.1600-065X.2002.19004.x; Inion I, 2003, J INFECT DIS, V188, P1675, DOI 10.1086/379737; Jennes W, 2006, J IMMUNOL, V177, P6588, DOI 10.4049/jimmunol.177.10.6588; Khakoo SI, 2006, IMMUNOL REV, V214, P186, DOI 10.1111/j.1600-065X.2006.00459.x; Khakoo SI, 2004, SCIENCE, V305, P872, DOI 10.1126/science.1097670; Korbel DS, 2009, J IMMUNOL, V182, P6426, DOI 10.4049/jimmunol.0804224; Kottilil S, 2003, J INFECT DIS, V187, P1038, DOI 10.1086/368222; Kulkarni S, 2008, SEMIN IMMUNOL, V20, P343, DOI 10.1016/j.smim.2008.06.003; Kwiatkowski DP, 2005, AM J HUM GENET, V77, P171, DOI 10.1086/432519; LEWONTIN RC, 1964, GENETICS, V49, P49; Lu ZM, 2008, CELL MOL IMMUNOL, V5, P457, DOI 10.1038/cmi.2008.57; Marsh SGE, 2003, TISSUE ANTIGENS, V62, P79, DOI 10.1034/j.1399-0039.2003.00072.x; Martin MP, 2008, IMMUNOGENETICS, V60, P767, DOI 10.1007/s00251-008-0334-y; Martin Maureen P., 2008, V415, P49, DOI 10.1007/978-1-59745-570-1_3; Martin MP, 2002, NAT GENET, V31, P429, DOI 10.1038/ng934; Mavilio D, 2003, P NATL ACAD SCI USA, V100, P15011, DOI 10.1073/pnas.2336091100; Menendez C, 2000, J INFECT DIS, V181, P1740, DOI 10.1086/315449; Moffett-King A, 2002, NAT REV IMMUNOL, V2, P656, DOI 10.1038/nri886; Momot T, 2004, ARTHRITIS RHEUM-US, V50, P1561, DOI 10.1002/art.20216; Moore JM, 2000, J INFECT DIS, V182, P960, DOI 10.1086/315755; MUKADI Y, 1993, LANCET, V342, P143, DOI 10.1016/0140-6736(93)91346-N; Mwapasa V, 2004, AIDS, V18, P1051, DOI 10.1097/00002030-200404300-00014; Naniche D, 2008, HIV MED, V9, P757, DOI 10.1111/j.1468-1293.2008.00626.x; Newman KC, 2006, PLOS PATHOG, V2, P1120, DOI 10.1371/journal.ppat.0020118; Norman PJ, 2002, GENES IMMUN, V3, P86, DOI 10.1038/sj.gene.6363836; Norman PJ, 2001, IMMUNOGENETICS, V52, P195; Othoro C, 2008, INFECT IMMUN, V76, P1678, DOI 10.1128/IAI.01420-07; Parham P, 2005, NAT REV IMMUNOL, V5, P201, DOI 10.1038/nri1570; Parham P, 2005, MOL IMMUNOL, V42, P459, DOI 10.1016/j.molimm.2004.07.027; Parise ME, 1998, AM J TROP MED HYG, V59, P813, DOI 10.4269/ajtmh.1998.59.813; Paximadis M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016541; Rogerson SJ, 2003, AM J TROP MED HYG, V68, P115, DOI 10.4269/ajtmh.2003.68.1.0680115; Sander AF, 2011, J INFECT DIS, V203, P1679, DOI 10.1093/infdis/jir168; Sartelet H, 2005, PLACENTA, V26, P505, DOI 10.1016/j.placenta.2004.08.006; Scott-Algara D, 2003, J IMMUNOL, V171, P5663, DOI 10.4049/jimmunol.171.11.5663; Sharkey AM, 2008, J IMMUNOL, V181, P39, DOI 10.4049/jimmunol.181.1.39; SLATKIN M, 1994, GENETICS, V137, P331; Steketee RW, 1996, AM J TROP MED HYG, V55, P42, DOI 10.4269/ajtmh.1996.55.42; Tabiasco J, 2006, PLACENTA, V27, pS34, DOI 10.1016/j.placenta.2006.01.009; Talundzic E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031565; Taniguchi M, 2009, IMMUNOGENETICS; Ter Kuile FO, 2004, AM J TROP MED HYG, V71, P41, DOI 10.4269/ajtmh.2004.71.41; Tournoy J, 2006, LANCET, V368, P90, DOI 10.1016/S0140-6736(06)68973-3; Uhrberg M, 1997, IMMUNITY, V7, P753, DOI 10.1016/S1074-7613(00)80394-5; Van Eijk AM, 2001, AM J TROP MED HYG, V65, P623, DOI 10.4269/ajtmh.2001.65.623; Van Geertruyden JP, 2004, AM J TROP MED HYG, V71, P35, DOI 10.4269/ajtmh.2004.71.35; Varla-Leftherioti M, 2005, CHEM IMMUNOL ALLERGY, V89, P84, DOI 10.1159/000087915; Velickovic M, 2006, IMMUNOGENETICS, V58, P523, DOI 10.1007/s00251-006-0124-3; Verheyden S, 2004, LEUKEMIA, V18, P2002, DOI 10.1038/sj.leu.2403525; Yawata M, 2006, J EXP MED, V203, P633, DOI 10.1084/jem.20051884; Yoo YJ, 2007, BIOINFORMATICS, V23, P2399, DOI 10.1093/bioinformatics/btm371	71	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2012	7	6							e38617	10.1371/journal.pone.0038617	http://dx.doi.org/10.1371/journal.pone.0038617			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TQ	22715396	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000305336800038
J	Zhong, YM; Li, JM; Wang, JJ; Chen, C; Tran, JTA; Saadi, A; Yu, Q; Le, YZ; Mandal, MNA; Anderson, RE; Zhang, SX				Zhong, Yimin; Li, Jingming; Wang, Joshua J.; Chen, Chen; Tran, Julie-Thu A.; Saadi, Anisse; Yu, Qiang; Le, Yun-zheng; Mandal, Md Nawajes A.; Anderson, Robert E.; Zhang, Sarah X.			X-Box Binding Protein 1 Is Essential for the Anti-Oxidant Defense and Cell Survival in the Retinal Pigment Epithelium	PLOS ONE			English	Article							TRANSCRIPTION FACTOR XBP-1; ENDOPLASMIC-RETICULUM STRESS; MACULAR DEGENERATION; LIGHT DAMAGE; SOD1-DEFICIENT MICE; MOUSE MODEL; ER STRESS; EXPRESSION; DYSFUNCTION; ACTIVATION	Damage to the retinal pigment epithelium (RPE) is an early event in the pathogenesis of age-related macular degeneration (AMD). X-box binding protein 1 (XBP1) is a key transcription factor that regulates endoplasmic reticulum (ER) homeostasis and cell survival. This study aimed to delineate the role of endogenous XBP1 in the RPE. Our results show that in a rat model of light-induced retinal degeneration, XBP1 activation was suppressed in the RPE/choroid complex, accompanied by decreased anti-oxidant genes and increased oxidative stress. Knockdown of XBP1 by siRNA resulted in reduced expression of SOD1, SOD2, catalase, and glutathione synthase and sensitized RPE cells to oxidative damage. Using Cre/LoxP system, we generated a mouse line that lacks XBP1 only in RPE cells. Compared to wildtype littermates, RPE-XBP1 KO mice expressed less SOD1, SOD2, and catalase in the RPE, and had increased oxidative stress. At age 3 months and older, these mice exhibited apoptosis of RPE cells, decreased number of cone photoreceptors, shortened photoreceptor outer segment, reduced ONL thickness, and deficit in retinal function. Electron microscopy showed abnormal ultrastructure, Bruch's membrane thickening, and disrupted basal membrane infolding in XBP1-deficient RPE. These results indicate that XBP1 is an important gene involved in regulation of the anti-oxidant defense in the RPE, and that impaired activation of XBP1 may contribute to RPE dysfunction and cell death during retinal degeneration and AMD.	[Zhong, Yimin; Li, Jingming; Wang, Joshua J.; Chen, Chen; Le, Yun-zheng; Zhang, Sarah X.] Univ Oklahoma, Hlth Sci Ctr, Dept Med, Sect Endocrinol & Diabet, Oklahoma City, OK 73190 USA; [Zhong, Yimin; Li, Jingming; Wang, Joshua J.; Chen, Chen; Le, Yun-zheng; Zhang, Sarah X.] Univ Oklahoma, Harold Hamm Diabet Ctr, Oklahoma City, OK USA; [Tran, Julie-Thu A.; Saadi, Anisse; Mandal, Md Nawajes A.; Anderson, Robert E.] Univ Oklahoma, Hlth Sci Ctr, Dept Ophthalmol, Oklahoma City, OK USA; [Tran, Julie-Thu A.; Saadi, Anisse; Mandal, Md Nawajes A.; Anderson, Robert E.] Dean A McGee Eye Inst, Oklahoma City, OK USA; [Le, Yun-zheng; Anderson, Robert E.] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK USA; [Zhang, Sarah X.] Oklahoma Ctr Neurosci, Oklahoma City, OK USA; [Zhong, Yimin] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; Sun Yat Sen University	Zhong, YM (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Med, Sect Endocrinol & Diabet, Oklahoma City, OK 73190 USA.	xin-zhang@ouhsc.edu	li, jingming/J-5760-2012	li, jingming/0000-0003-2300-8614; Chen, Chen/0000-0001-6741-7036	National Institutes of Health [EY019949, RR17703, RR024215]; American Diabetes Association [7-11-BS-182]; Oklahoma Center for the Advancement of Science and Technology [HR10-060]; American Health Assistance Foundation [M2010088]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017703, P20RR024215] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY019949] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Oklahoma Center for the Advancement of Science and Technology; American Health Assistance Foundation(BrightFocus Foundation); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health grants EY019949, RR17703, and RR024215; Research Award 7-11-BS-182 from American Diabetes Association; Research Grant HR10-060 from Oklahoma Center for the Advancement of Science and Technology; and Research Grant M2010088 from American Health Assistance Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bazan NG, 2006, ADV EXP MED BIOL, V572, P531; Chou CC, 2008, NANO LETT, V8, P437, DOI 10.1021/nl0723634; CLAUSS IM, 1993, DEV DYNAM, V197, P146, DOI 10.1002/aja.1001970207; Dong CJ, 2002, VISION RES, V42, P1081, DOI 10.1016/S0042-6989(02)00032-9; Dunaief JL, 2002, ARCH OPHTHALMOL-CHIC, V120, P1435, DOI 10.1001/archopht.120.11.1435; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P532; Glimcher LH, 2010, ANN RHEUM DIS, V69, P67, DOI 10.1136/ard.2009.119388; Gurzov EN, 2009, CELL DEATH DIFFER, V16, P1539, DOI 10.1038/cdd.2009.99; Hao WS, 2002, NAT GENET, V32, P254, DOI 10.1038/ng984; Hashizume K, 2008, AM J PATHOL, V172, P1325, DOI 10.2353/ajpath.2008.070730; Imamura Y, 2006, P NATL ACAD SCI USA, V103, P11282, DOI 10.1073/pnas.0602131103; Iwakoshi NN, 2003, NAT IMMUNOL, V4, P321, DOI 10.1038/ni907; Jablonski MM, 2001, GLIA, V35, P14, DOI 10.1002/glia.1066; Justilien V, 2007, INVEST OPHTH VIS SCI, V48, P4407, DOI 10.1167/iovs.07-0432; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; Kassoff A, 2001, ARCH OPHTHALMOL-CHIC, V119, P1417, DOI 10.1001/archopht.119.10.1417; KLEIN R, 1993, AM J EPIDEMIOL, V137, P190, DOI 10.1093/oxfordjournals.aje.a116659; Le YZ, 2008, INVEST OPHTH VIS SCI, V49, P1248, DOI 10.1167/iovs.07-1105; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lee AH, 2008, SCIENCE, V320, P1492, DOI 10.1126/science.1158042; Li JM, 2011, J BIOL CHEM, V286, P4912, DOI 10.1074/jbc.M110.199729; Li JM, 2010, DIABETES, V59, P1528, DOI 10.2337/db09-1057; LI LX, 1993, CURR EYE RES, V12, P841, DOI 10.3109/02713689309020389; LILES MR, 1991, ARCH OPHTHALMOL-CHIC, V109, P1285, DOI 10.1001/archopht.1991.01080090111033; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Lisbona F, 2009, MOL CELL, V33, P679, DOI 10.1016/j.molcel.2009.02.017; Liu Y, 2009, CELL DEATH DIFFER, V16, P847, DOI 10.1038/cdd.2009.14; Mandal MNA, 2009, FREE RADICAL BIO MED, V46, P672, DOI 10.1016/j.freeradbiomed.2008.12.006; Marc RE, 2008, MOL VIS, V14, P782; Naidoo N, 2008, J NEUROSCI, V28, P6539, DOI 10.1523/JNEUROSCI.5685-07.2008; Organisciak DT, 2010, PROG RETIN EYE RES, V29, P113, DOI 10.1016/j.preteyeres.2009.11.004; Gavilan MP, 2009, AGING CELL, V8, P654, DOI 10.1111/j.1474-9726.2009.00519.x; Rattner A, 2008, J NEUROSCI, V28, P9880, DOI 10.1523/JNEUROSCI.2401-08.2008; Reimold AM, 1996, J EXP MED, V183, P393, DOI 10.1084/jem.183.2.393; Reimold AM, 2000, GENE DEV, V14, P152; Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509; Ryoo HD, 2007, EMBO J, V26, P242, DOI 10.1038/sj.emboj.7601477; Sandbach JM, 2001, INVEST OPHTH VIS SCI, V42, P2173; TATE DJ, 1993, INVEST OPHTH VIS SCI, V34, P2348; Tirosh B, 2006, J BIOL CHEM, V281, P5852, DOI 10.1074/jbc.M509061200; Ueki Y, 2008, J NEUROCHEM, V105, P784, DOI 10.1111/j.1471-4159.2007.05180.x; Wang W, 2011, OPHTHALMOL EYE DIS, V3, DOI 10.4137/OED.S7797; Yang LP, 2008, J NEUROSCI RES, V86, P910, DOI 10.1002/jnr.21535; Yang LP, 2007, INVEST OPHTH VIS SCI, V48, P5191, DOI 10.1167/iovs.07-0512; Yoshida H, 2007, FEBS J, P274; Zeng LF, 2009, P NATL ACAD SCI USA, V106, P8326, DOI 10.1073/pnas.0903197106	46	45	45	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2012	7	6							e38616	10.1371/journal.pone.0038616	http://dx.doi.org/10.1371/journal.pone.0038616			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TQ	22715395	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336800037
J	Moon, DC; Choi, CH; Lee, SM; Lee, JH; Kim, SI; Kim, DS; Lee, JC				Moon, Dong Chan; Choi, Chul Hee; Lee, Su Man; Lee, Jung Hwa; Kim, Seung Il; Kim, Dong Sun; Lee, Je Chul			Nuclear Translocation of Acinetobacter baumannii Transposase Induces DNA Methylation of CpG Regions in the Promoters of E-cadherin Gene	PLOS ONE			English	Article							NONNEOPLASTIC GASTRIC-MUCOSA; OUTER-MEMBRANE VESICLES; NF-KAPPA-B; HELICOBACTER-PYLORI; IMMUNE-RESPONSES; EPITHELIAL-CELLS; PROTEIN; CANCER; LOCALIZATION; PROGRESSION	Nuclear targeting of bacterial proteins has emerged as a pathogenic mechanism whereby bacterial proteins induce host cell pathology. In this study, we examined nuclear targeting of Acinetobacter baumannii transposase (Tnp) and subsequent epigenetic changes in host cells. Tnp of A. baumannii ATCC 17978 possesses nuclear localization signals (NLSs), 225RKRKRK230. Transient expression of A. baumannii Tnp fused with green fluorescent protein (GFP) resulted in the nuclear localization of these proteins in COS-7 cells, whereas the truncated Tnp without NLSs fused with GFP were exclusively localized in the cytoplasm. A. baumannii Tnp was found in outer membrane vesicles, which delivered this protein to the nucleus of host cells. Nuclear expression of A. baumannii Tnp fused with GFP in A549 cells induced DNA methylation of CpG regions in the promoters of E-cadherin (CDH1) gene, whereas the cytoplasmic localization of the truncated Tnp without NLSs fused with GFP did not induce DNA methylation. DNA methylation in the promoters of E-cadherin gene induced by nuclear targeting of A. baumannii Tnp resulted in down-regulation of gene expression. In conclusion, our data show that nuclear traffic of A. baumannii Tnp induces DNA methylation of CpG regions in the promoters of E-cadherin gene, which subsequently down-regulates gene expression. This study provides a new insight into the epigenetic control of host genes by bacterial proteins.	[Moon, Dong Chan; Lee, Jung Hwa; Lee, Je Chul] Kyungpook Natl Univ, Sch Med, Dept Microbiol, Taegu, South Korea; [Choi, Chul Hee] Univ Florida, Dept Periodontol, Gainesville, FL USA; [Lee, Su Man; Kim, Dong Sun] Kyungpook Natl Univ, Sch Med, Dept Anat, Taegu, South Korea; [Kim, Seung Il] Korea Basic Sci Inst, Div Life Sci, Taejon, South Korea	Kyungpook National University; State University System of Florida; University of Florida; Kyungpook National University; Korea Basic Science Institute (KBSI)	Moon, DC (corresponding author), Kyungpook Natl Univ, Sch Med, Dept Microbiol, Taegu, South Korea.	doskim@knu.ac.kr; leejc@knu.ac.kr		Choi, Chul Hee/0000-0003-2373-048X; Kim, Dong Sun/0000-0003-4943-0901	Basic Science Research Program through the National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2010-0016456]	Basic Science Research Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2010-0016456). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antunes LCS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022674; Arbibe L, 2007, NAT IMMUNOL, V8, P47, DOI 10.1038/ni1423; Baylin SB, 2006, NAT REV CANCER, V6, P107, DOI 10.1038/nrc1799; Benabdillah R, 2004, MICROB PATHOGENESIS, V36, P247, DOI 10.1016/j.micpath.2003.12.006; BergogneBerezin E, 1996, CLIN MICROBIOL REV, V9, P148, DOI 10.1128/CMR.9.2.148; Bhavsar AP, 2007, NATURE, V449, P827, DOI 10.1038/nature06247; Bobetsis YA, 2007, J DENT RES, V86, P169, DOI 10.1177/154405910708600212; Choi CH, 2005, CELL MICROBIOL, V7, P1127, DOI 10.1111/j.1462-5822.2005.00538.x; Choi CH, 2008, CELL MICROBIOL, V10, P309, DOI 10.1111/j.1462-5822.2007.01041.x; Choi CH, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-216; Cokol M, 2000, EMBO REP, V1, P411, DOI 10.1093/embo-reports/kvd092; Dijkshoorn L, 2007, NAT REV MICROBIOL, V5, P939, DOI 10.1038/nrmicro1789; Haraga A, 2003, INFECT IMMUN, V71, P4052, DOI 10.1128/IAI.71.7.4052-4058.2003; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Iyer LM, 2009, CELL CYCLE, V8, P1698, DOI 10.4161/cc.8.11.8580; Izaurralde E, 1998, RNA, V4, P351; Jacob S, 2002, BIOCHIMIE, V84, P27, DOI 10.1016/S0300-9084(01)01362-1; Jeyapalan JC, 2008, MECH AGEING DEV, V129, P467, DOI 10.1016/j.mad.2008.04.001; Jin JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017027; Kaise M, 2008, HELICOBACTER, V13, P35, DOI 10.1111/j.1523-5378.2008.00572.x; Kerr KM, 2007, DIS MARKERS, V23, P5, DOI 10.1155/2007/985474; Kim DS, 2007, CANCER-AM CANCER SOC, V110, P2785, DOI 10.1002/cncr.23113; Kim DS, 2007, LUNG CANCER, V58, P1, DOI 10.1016/j.lungcan.2007.04.008; Kim SW, 2009, FEMS MICROBIOL LETT, V301, P224, DOI 10.1111/j.1574-6968.2009.01820.x; Kondo E, 2001, NUCLEIC ACIDS RES, V29, P1695, DOI 10.1093/nar/29.8.1695; Konturek PC, 2009, J PHYSIOL PHARMACOL, V60, P3; Kwon SO, 2009, FEMS MICROBIOL LETT, V297, P150, DOI 10.1111/j.1574-6968.2009.01669.x; Lara-Tejero M, 2000, SCIENCE, V290, P354, DOI 10.1126/science.290.5490.354; Lee EY, 2008, MASS SPECTROM REV, V27, P535, DOI 10.1002/mas.20175; Lee HW, 2008, CLIN MICROBIOL INFEC, V14, P49, DOI 10.1111/j.1469-0691.2007.01842.x; Lee JC, 2009, J MICROBIOL, V47, P641, DOI 10.1007/s12275-009-0217-4; McSweeney LA, 2004, CELL MICROBIOL, V6, P447, DOI 10.1111/j.1462-5822.2004.00373.x; Moon DC, 2012, RES MICROBIOL, V163, P279, DOI 10.1016/j.resmic.2012.02.001; Moroianu J, 1998, J CELL BIOCHEM, V70, P231; Nardone G, 2007, DIGEST DIS, V25, P225, DOI 10.1159/000103890; Nishikubo S, 2003, J BIOL CHEM, V278, P50671, DOI 10.1074/jbc.M305062200; Okuda J, 2005, BIOCHEM BIOPH RES CO, V333, P531, DOI 10.1016/j.bbrc.2005.05.145; Paschos K, 2010, TRENDS MICROBIOL, V18, P439, DOI 10.1016/j.tim.2010.07.003; Pennini ME, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000995; Perri F, 2007, AM J GASTROENTEROL, V102, P1361, DOI 10.1111/j.1572-0241.2007.01284.x; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SEIFERT H, 1995, MEDICINE, V74, P340, DOI 10.1097/00005792-199511000-00004; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Shin JH, 2009, J MICROBIOL, V47, P728, DOI 10.1007/s12275-009-0158-y; Shiozaki H, 1996, CANCER, V77, P1605, DOI 10.1002/(SICI)1097-0142(19960415)77:8+<1605::AID-CNCR4>3.3.CO;2-R; Smith MG, 2007, GENE DEV, V21, P601, DOI 10.1101/gad.1510307; St Croix B, 1998, J CELL BIOL, V142, P557, DOI 10.1083/jcb.142.2.557; Tolg C, 2011, LAB INVEST, V91, P825, DOI 10.1038/labinvest.2010.197; van Roy F, 2008, CELL MOL LIFE SCI, V65, P3756, DOI 10.1007/s00018-008-8281-1; Wai SN, 2003, CELL, V115, P25, DOI 10.1016/S0092-8674(03)00754-2	51	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e38974	10.1371/journal.pone.0038974	http://dx.doi.org/10.1371/journal.pone.0038974			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685614	Green Submitted, Green Published, gold			2022-12-27	WOS:000305351700078
J	Schmidt, PM; Sparrow, LG; Attwood, RM; Xiao, XW; Adams, TE; McKimm-Breschkin, JL				Schmidt, Peter M.; Sparrow, Lindsay G.; Attwood, Rebecca M.; Xiao, Xiaowen; Adams, Tim E.; McKimm-Breschkin, Jennifer L.			Taking down the FLAG! How Insect Cell Expression Challenges an Established Tag-System	PLOS ONE			English	Article							TYROSINE-O-SULFATE; MONOCLONAL-ANTIBODY; NEURAMINIDASE INHIBITORS; RECOMBINANT PROTEINS; MASS-SPECTROMETRY; PHAGE DISPLAY; PURIFICATION; IDENTIFICATION; SEQUENCES; PEPTIDES	In 1988 the preceding journal of Nature Biotechnology, Bio/Technology, reported a work by Hopp and co-workers about a new tag system for the identification and purification of recombinant proteins: the FLAG-tag. Beside the extensively used hexa-his tag system the FLAG-tag has gained broad popularity due to its small size, its high solubility, the presence of an internal Enterokinase cleavage site, and the commercial availability of high-affinity anti-FLAG antibodies. Surprisingly, considering the heavy use of FLAG in numerous laboratories world-wide, we identified in insect cells a post-translational modification (PTM) that abolishes the FLAG-anti-FLAG interaction rendering this tag system ineffectual for secreted proteins. The present publication shows that the tyrosine that is part of the crucial FLAG epitope DYK is highly susceptible to sulfation, a PTM catalysed by the enzyme family of Tyrosylprotein-Sulfo-transferases (TPSTs). We showed that this modification can result in less than 20% of secreted FLAG-tagged protein being accessible for purification questioning the universal applicability of this established tag system.	[Schmidt, Peter M.; Sparrow, Lindsay G.; Attwood, Rebecca M.; Xiao, Xiaowen; Adams, Tim E.; McKimm-Breschkin, Jennifer L.] CSIRO Mat Sci & Engn, Parkville, Vic, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Schmidt, PM (corresponding author), CSL Ltd, Res Dept, Parkville, Vic, Australia.	Peter.Schmidt@CSL.com.au	Adams, Timothy E/I-6231-2012; McKimm-Breschkin, Jennifer L/D-1880-2013; Schmidt, Peter/V-3882-2019	Adams, Timothy E/0000-0003-3436-0066; Schmidt, Peter/0000-0003-1340-9086; McKimm-Breschkin, Jennifer/0000-0002-2345-6786	National Institute of Allergy and Infectious Diseases (NIAID) [RO1A1062721]; Medical Research Grant from the National Health and Medical Research Council (NHMRC) [595625]; GlaxoSmithKline (GSK) U.K.; GlaxoSmithKline (GSK) Australia; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI062721] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Medical Research Grant from the National Health and Medical Research Council (NHMRC); GlaxoSmithKline (GSK) U.K.; GlaxoSmithKline (GSK) Australia; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Grant RO1A1062721 from the National Institute of Allergy and Infectious Diseases (NIAID; http://www.niaid.nih.gov/), Medical Research Grant 595625 from the National Health and Medical Research Council (NHMRC; www.nhmrc.gov.au), and grants from GlaxoSmithKline (GSK) U.K. and Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Drake SK, 2010, INT J BIOCHEM CELL B, V42, P174, DOI 10.1016/j.biocel.2009.10.018; Einhauer A, 2001, J CHROMATOGR A, V921, P25, DOI 10.1016/S0021-9673(01)00831-7; Einhauer A, 2001, J BIOCHEM BIOPH METH, V49, P455, DOI 10.1016/S0165-022X(01)00213-5; EVANS MJ, 1995, J IMMUNOL METHODS, V184, P123, DOI 10.1016/0022-1759(95)00093-P; Geoghegan KF, 1999, ANAL BIOCHEM, V267, P169, DOI 10.1006/abio.1998.2990; Hoffhines AJ, 2006, J BIOL CHEM, V281, P37877, DOI 10.1074/jbc.M609398200; HOPP TP, 1988, BIO-TECHNOL, V6, P1204, DOI 10.1038/nbt1088-1204; Hopp TP, 1996, MOL IMMUNOL, V33, P601, DOI 10.1016/0161-5890(96)00026-0; Johnson GD, 2005, ARCH BIOCHEM BIOPHYS, V444, P7, DOI 10.1016/j.abb.2005.09.011; Kehoe JW, 2006, MOL CELL PROTEOMICS, V5, P2350, DOI 10.1074/mcp.M600314-MCP200; Kehoe JW, 2000, CHEM BIOL, V7, pR57, DOI 10.1016/S1074-5521(00)00093-4; MCKIMMBRESCHKIN JL, 1990, J IMMUNOL METHODS, V135, P277, DOI 10.1016/0022-1759(90)90282-Z; McKimmBreschkin JL, 1996, ANTIMICROB AGENTS CH, V40, P40, DOI 10.1128/AAC.40.1.40; MICELI RM, 1994, J IMMUNOL METHODS, V167, P279, DOI 10.1016/0022-1759(94)90097-3; Monigatti F, 2002, BIOINFORMATICS, V18, P769, DOI 10.1093/bioinformatics/18.5.769; Monigatti F, 2006, BBA-PROTEINS PROTEOM, V1764, P1904, DOI 10.1016/j.bbapap.2006.07.002; Monto AS, 2006, ANTIMICROB AGENTS CH, V50, P2395, DOI 10.1128/AAC.01339-05; Oakley AJ, 2010, J MED CHEM, V53, P6421, DOI 10.1021/jm100621s; PETERS J, 1995, J MOL BIOL, V245, P385, DOI 10.1006/jmbi.1994.0032; POTIER M, 1979, ANAL BIOCHEM, V94, P287, DOI 10.1016/0003-2697(79)90362-2; PRICKETT KS, 1989, BIOTECHNIQUES, V7, P580; Schmidt PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016284; Seibert C, 2008, BIOPOLYMERS, V90, P459, DOI 10.1002/bip.20821; Severs JC, 1999, RAPID COMMUN MASS SP, V13, P1016, DOI 10.1002/(SICI)1097-0231(19990615)13:11<1016::AID-RCM599>3.0.CO;2-5; Slootstra JW, 1997, MOL DIVERS, V2, P156, DOI 10.1007/BF01682203; STANKIEWICZ PJ, 1988, BIOCHEMISTRY-US, V27, P206, DOI 10.1021/bi00401a031; Stetefeld J, 2000, NAT STRUCT BIOL, V7, P772, DOI 10.1038/79006; Stone MJ, 2009, NEW BIOTECHNOL, V25, P299, DOI 10.1016/j.nbt.2009.03.011; SUIKO M, 1988, BIOCHEM BIOPH RES CO, V154, P1094, DOI 10.1016/0006-291X(88)90253-7; TRACEY AS, 1986, P NATL ACAD SCI USA, V83, P609, DOI 10.1073/pnas.83.3.609; Waugh DS, 2005, TRENDS BIOTECHNOL, V23, P316, DOI 10.1016/j.tibtech.2005.03.012; YAGAMI T, 1995, RAPID COMMUN MASS SP, V9, P1335, DOI 10.1002/rcm.1290091403; Yagami T, 2000, J PEPT RES, V56, P239, DOI 10.1034/j.1399-3011.2000.00746.x; Zhang Y, 2011, HUM GENE THER	34	20	21	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e37779	10.1371/journal.pone.0037779	http://dx.doi.org/10.1371/journal.pone.0037779			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701579	gold, Green Submitted, Green Published			2022-12-27	WOS:000305348400019
J	Kim, BJ; Yi, SY; Shim, TS; Do, SY; Yu, HK; Park, YG; Kook, YH; Kim, BJ				Kim, Byoung-Jun; Yi, Su-Yeon; Shim, Tae-Sun; Do, Seung Yeon; Yu, Hee-Kyung; Park, Young-Gil; Kook, Yoon-Hoh; Kim, Bum-Joon			Discovery of a Novel hsp65 Genotype within Mycobacterium massiliense Associated with the Rough Colony Morphology	PLOS ONE			English	Article							FRAGMENT-LENGTH-POLYMORPHISM; COMPLETE GENOME SEQUENCE; NONTUBERCULOUS MYCOBACTERIA; CLINICAL-SIGNIFICANCE; SP NOV.; IDENTIFICATION; GENE; ABSCESSUS; DIFFERENTIATION; STRAINS	So far, genetic diversity among strains within Mycobacterium massiliense has rarely been studied. To investigate the genetic diversity among M. massiliense, we conducted phylogenetic analysis based on hsp65 (603-bp) and rpoB (711-bp) sequences from 65 M. massiliense Korean isolates. We found that hsp65 sequence analysis could clearly differentiate them into two distinct genotypes, Type I and Type II, which were isolated from 35 (53.8%) and 30 patients (46.2%), respectively. The rpoB sequence analysis revealed a total of four genotypes (R-I to R-IV) within M. massiliense strains, three of which (R-I, R-II and R-III) correlated with hsp65 Type I, and other (R-IV), which correlated with Type II. Interestingly, genotyping by the hsp65 method agreed well with colony morphology. Despite some exceptions, Type I and II correlated with smooth and rough colonies, respectively. Also, both types were completely different from one another in terms of MALDI-TOF mass spectrometry profiles of whole lipid. In addition, we developed PCR-restriction analysis (PRA) based on the Hinf I digestion of 644-bp hsp65 PCR amplicons, which enables the two genotypes within M. massiliense to be easily and reliably separated. In conclusion, two distinct hsp65 genotypes exist within M. massiliense strains, which differ from one another in terms of both morphology and lipid profile. Furthermore, our data indicates that Type II is a novel M. massiliense genotype being herein presented for the first time. The disparity in clinical traits between these two hsp65 genotypes needs to be exploited in the future study.	[Kim, Byoung-Jun; Yi, Su-Yeon; Do, Seung Yeon; Kook, Yoon-Hoh; Kim, Bum-Joon] Seoul Natl Univ, Coll Med, Dept Microbiol & Immunol, Canc Res Inst,Inst Endem Dis,SNUMRC, Seoul, South Korea; [Shim, Tae-Sun] Univ Ulsan, Coll Med, Asan Med Ctr, Div Pulm & Crit Care Med,Dept Internal Med, Seoul, South Korea; [Yu, Hee-Kyung; Park, Young-Gil] Korean Natl TB Assoc, Korean Inst TB, Chungcheongbuk Do, South Korea	Seoul National University (SNU); Seoul National University Hospital; University of Ulsan; Asan Medical Center	Kim, BJ (corresponding author), Seoul Natl Univ, Coll Med, Dept Microbiol & Immunol, Canc Res Inst,Inst Endem Dis,SNUMRC, Seoul, South Korea.	kbumjoon@snu.ac.kr	Kim, Bum Joon/J-2739-2012; Kim, Bum Joon/AGY-4274-2022; Kook, Yoon-Hoh/J-5378-2012	Kim, Bum Joon/0000-0003-0085-6709; 	Ministry for Health, Welfare & Family Affairs, Republic of Korea [A101205]	Ministry for Health, Welfare & Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This study was supported by grant A101205 from the Korean Healthcare Technology R&D project, Ministry for Health, Welfare & Family Affairs, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adekambi T, 2006, INT J SYST EVOL MICR, V56, P133, DOI 10.1099/ijs.0.63969-0; Adekambi T, 2004, J CLIN MICROBIOL, V42, P5493, DOI 10.1128/JCM.42.12.5493-5501.2004; Adekambi T, 2003, J CLIN MICROBIOL, V41, P5699, DOI 10.1128/JCM.41.12.5699-5708.2003; Blauwendraat C, 2012, EUR J CLIN MICROBIOL; BUTLER WR, 1992, J CLIN MICROBIOL, V30, P2698, DOI 10.1128/JCM.30.10.2698-2704.1992; Catherinot E, 2007, INFECT IMMUN, V75, P1055, DOI 10.1128/IAI.00835-06; CDC, 1999, NAT PLAN EL SYPH US, P1; Cho AY, 2010, ANN DERMATOL, V22, P114, DOI 10.5021/ad.2010.22.1.114; Choi GE, 2011, J CLIN MICROBIOL, V49, P1107, DOI 10.1128/JCM.02318-10; Devallois A, 1997, J CLIN MICROBIOL, V35, P2969, DOI 10.1128/JCM.35.11.2969-2973.1997; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; FITCH WM, 1971, SYST ZOOL, V20, P406, DOI 10.2307/2412116; FREGNAN GB, 1962, J BACTERIOL, V83, P819, DOI 10.1128/JB.83.4.819-827.1962; Go-eun Choi，, 2012, Journal of Bacteriology and Virology, V42, P17; Han XY, 2007, AM J CLIN PATHOL, V128, P612, DOI 10.1309/1KB2GKYT1BUEYLB5; Harris KA, 2012, J CLIN MICROBIOL, V50, P1758, DOI 10.1128/JCM.00155-12; Howard ST, 2006, MICROBIOL-SGM, V152, P1581, DOI 10.1099/mic.0.28625-0; Kent PT, 1985, GUIDE LEVEL 3 LAB; Kim B-J, 2012, J BACTERIOLOGY; Kim BJ, 1999, J CLIN MICROBIOL, V37, P1714, DOI 10.1128/JCM.37.6.1714-1720.1999; Kim BJ, 2011, INT J SYST EVOL MICR; Kim BJ, 2012, J BACTERIOL, V194, P2771, DOI 10.1128/JB.00365-12; Kim BJ, 2012, J BACTERIOL, V194, P2750, DOI 10.1128/JB.00295-12; Kim H, 2005, J MICROBIOL METH, V62, P199, DOI 10.1016/j.mimet.2005.02.010; Kim H, 2005, INT J SYST EVOL MICR, V55, P1649, DOI 10.1099/ijs.0.63553-0; Kim HY, 2008, J CLIN MICROBIOL, V46, P3384, DOI 10.1128/JCM.00319-08; Kim HY, 2007, J CLIN MICROBIOL, V45, P3127, DOI 10.1128/JCM.00608-07; Kim Hyejin, 2011, Journal of Bacteriology and Virology, V41, P237; Kim K, 2010, J CLIN MICROBIOL, V48, P3073, DOI 10.1128/JCM.00939-10; Koh WJ, 2006, CHEST, V129, P341, DOI 10.1378/chest.129.2.341; Koh WJ, 2011, AM J RESP CRIT CARE, V183, P405, DOI 10.1164/rccm.201003-0395OC; Koh WJ, 2009, J CLIN MICROBIOL, V47, P3362, DOI 10.1128/JCM.00592-09; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Lee H, 2000, J CLIN MICROBIOL, V38, P2966, DOI 10.1128/JCM.38.8.2966-2971.2000; Lee HK, 2010, INT J SYST EVOL MICR, V60, P439, DOI 10.1099/ijs.0.012054-0; Lee H, 2010, MICROBIOL IMMUNOL, V54, P46, DOI 10.1111/j.1348-0421.2009.00184.x; MEIER A, 1994, ANTIMICROB AGENTS CH, V38, P381, DOI 10.1128/AAC.38.2.381; Nakanaga K, 2011, J CLIN MICROBIOL, V49, P613, DOI 10.1128/JCM.00817-10; Olivier KN, 2003, AM J RESP CRIT CARE, V167, P828, DOI 10.1164/rccm.200207-678OC; Perez E, 2004, J BIOL CHEM, V279, P42574, DOI 10.1074/jbc.M406246200; Petrini B, 2006, SCAND J INFECT DIS, V38, P246, DOI 10.1080/00365540500444652; Pulcini C, 2006, J CLIN MICROBIOL, V44, P3463, DOI 10.1128/JCM.02685-05; Rhoades ER, 2009, J IMMUNOL, V183, P1997, DOI 10.4049/jimmunol.0802181; Ripoll F, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-114; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Simmon KE, 2007, J CLIN MICROBIOL, V45, P1978, DOI 10.1128/JCM.00563-07; Soini H, 1997, J CLIN MICROBIOL, V35, P769, DOI 10.1128/JCM.35.3.769-773.1997; TAKEWAKI S, 1994, INT J SYST BACTERIOL, V44, P159, DOI 10.1099/00207713-44-1-159; Tortoli E, 2008, EMERG INFECT DIS, V14, P984, DOI 10.3201/eid1406.080194; Zelazny AM, 2009, J CLIN MICROBIOL, V47, P1985, DOI 10.1128/JCM.01688-08	50	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e38420	10.1371/journal.pone.0038420	http://dx.doi.org/10.1371/journal.pone.0038420			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22693637	Green Published, gold, Green Submitted			2022-12-27	WOS:000305343900040
J	Alvar, J; Velez, ID; Bern, C; Herrero, M; Desjeux, P; Cano, J; Jannin, J; den Boer, M				Alvar, Jorge; Velez, Ivan D.; Bern, Caryn; Herrero, Merce; Desjeux, Philippe; Cano, Jorge; Jannin, Jean; den Boer, Margriet		WHO Leishmaniasis Control Team	Leishmaniasis Worldwide and Global Estimates of Its Incidence	PLOS ONE			English	Article							NEGLECTED TROPICAL DISEASES; PASSIVE CASE DETECTION; VISCERAL LEISHMANIASIS; CUTANEOUS-LEISHMANIASIS; KALA-AZAR; HEALTH; INFECTION; BURDEN; SUDAN; CONSEQUENCES	As part of a World Health Organization-led effort to update the empirical evidence base for the leishmaniases, national experts provided leishmaniasis case data for the last 5 years and information regarding treatment and control in their respective countries and a comprehensive literature review was conducted covering publications on leishmaniasis in 98 countries and three territories (see 'Leishmaniasis Country Profiles Text S1, S2, S3, S4, S5, S6, S7, S8, S9, S10, S11, S12, S13, S14, S15, S16, S17, S18, S19, S20, S21, S22, S23, S24, S25, S26, S27, S28, S29, S30, S31, S32, S33, S34, S35, S36, S37, S38, S39, S40, S41, S42, S43, S44, S45, S46, S47, S48, S49, S50, S51, S52, S53, S54, S55, S56, S57, S58, S59, S60, S61, S62, S63, S64, S65, S66, S67, S68, S69, S70, S71, S72, S73, S74, S75, S76, S77, S78, S79, S80, S81, S82, S83, S84, S85, S86, S87, S88, S89, S90, S91, S92, S93, S94, S95, S96, S97, S98, S99, S100, S101'). Additional information was collated during meetings conducted at WHO regional level between 2007 and 2011. Two questionnaires regarding epidemiology and drug access were completed by experts and national program managers. Visceral and cutaneous leishmaniasis incidence ranges were estimated by country and epidemiological region based on reported incidence, underreporting rates if available, and the judgment of national and international experts. Based on these estimates, approximately 0.2 to 0.4 cases and 0.7 to 1.2 million VL and CL cases, respectively, occur each year. More than 90% of global VL cases occur in six countries: India, Bangladesh, Sudan, South Sudan, Ethiopia and Brazil. Cutaneous leishmaniasis is more widely distributed, with about one-third of cases occurring in each of three epidemiological regions, the Americas, the Mediterranean basin, and western Asia from the Middle East to Central Asia. The ten countries with the highest estimated case counts, Afghanistan, Algeria, Colombia, Brazil, Iran, Syria, Ethiopia, North Sudan, Costa Rica and Peru, together account for 70 to 75% of global estimated CL incidence. Mortality data were extremely sparse and generally represent hospital-based deaths only. Using an overall case-fatality rate of 10%, we reach a tentative estimate of 20,000 to 40,000 leishmaniasis deaths per year. Although the information is very poor in a number of countries, this is the first in-depth exercise to better estimate the real impact of leishmaniasis. These data should help to define control strategies and reinforce leishmaniasis advocacy.	[Alvar, Jorge; Velez, Ivan D.; Jannin, Jean; den Boer, Margriet] WHO, Leishmaniasis Control Program, Dept Control Neglected Trop Dis HTM NTD IDM, CH-1211 Geneva, Switzerland; [Velez, Ivan D.] Univ Antioquia, PECET, Medellin, Colombia; [Bern, Caryn] Ctr Dis Control & Prevent, Div Parasit Dis & Malaria, Natl Ctr Global Hlth, Atlanta, GA USA; [Herrero, Merce] WHO, Dis Prevent Programme, Addis Ababa, Ethiopia; [Herrero, Merce] WHO, Dis Control Programme, Addis Ababa, Ethiopia; [Desjeux, Philippe] Inst OneWorldHlth, San Francisco, CA USA; [Cano, Jorge] Inst Salud Carlos III, Natl Ctr Trop Med & Int Hlth, Madrid, Spain	World Health Organization; Universidad de Antioquia; Centers for Disease Control & Prevention - USA; World Health Organization; World Health Organization; Instituto de Salud Carlos III	Alvar, J (corresponding author), WHO, Leishmaniasis Control Program, Dept Control Neglected Trop Dis HTM NTD IDM, CH-1211 Geneva, Switzerland.	alvarj@who.int	Cano, Jorge/E-2962-2016; Oliveira, Fabiano/B-4251-2009; Cano, Jorge/AAV-6392-2020	Cano, Jorge/0000-0001-9864-5058; Oliveira, Fabiano/0000-0002-7924-8038; Cano, Jorge/0000-0001-9864-5058				AbouZahr C, 2000, B WORLD HEALTH ORGAN, V78, P655; Ahluwalia IB, 2003, AM J TROP MED HYG, V69, P624, DOI 10.4269/ajtmh.2003.69.624; Alvar J, 2006, TRENDS PARASITOL, V22, P552, DOI 10.1016/j.pt.2006.09.004; [Anonymous], 2011, WHO STAT INF SYST; [Anonymous], GLOB BURD DIS INJ RI; [Anonymous], 1996, GLOBAL BURDEN DIS CO; Ashford R.W., 1987, BIOL LEISHMANIASES B, V1, P366; Ashford RW, 2000, INT J PARASITOL, V30, P1269, DOI 10.1016/S0020-7519(00)00136-3; ASHFORD RW, 1992, PARASITOL TODAY, V8, P104, DOI 10.1016/0169-4758(92)90249-2; Barnett PG, 2005, AM J TROP MED HYG, V73, P720, DOI 10.4269/ajtmh.2005.73.720; Bern C, 2005, EMERG INFECT DIS, V11, P655, DOI 10.3201/eid1105.040718; Bern C, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000313; Cattand P, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P451; Chicharro C, 2003, ANN TROP MED PARASIT, V97, P75, DOI 10.1179/000349803225002552; Collin S, 2004, CLIN INFECT DIS, V38, P612, DOI 10.1086/381203; Collin SM, 2006, TROP MED INT HEALTH, V11, P509, DOI 10.1111/j.1365-3156.2006.01589.x; Conteh L, 2010, LANCET, V375, P239, DOI 10.1016/S0140-6736(09)61422-7; COPELAND HW, 1990, AM J TROP MED HYG, V43, P257, DOI 10.4269/ajtmh.1990.43.257; Desjeux P, 2004, COMP IMMUNOL MICROB, V27, P305, DOI 10.1016/j.cimid.2004.03.004; Desjeux P, 1996, CLIN DERMATOL, V14, P417, DOI 10.1016/0738-081X(96)00057-0; Desjeux P, 1991, WHO LEISH, V30, P47; Hirve S, 2010, AM J TROP MED HYG, V83, P507, DOI 10.4269/ajtmh.2010.09-0685; Hotez PJ, 2006, PLOS MED, V3, P576, DOI 10.1371/journal.pmed.0030102; Hotez PJ, 2004, CLIN INFECT DIS, V38, P871, DOI 10.1086/382077; King CH, 2005, LANCET, V365, P1561, DOI 10.1016/S0140-6736(05)66457-4; King CH, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000209; Kumar R, 1999, B WORLD HEALTH ORGAN, V77, P371; le Fichoux Y, 1999, J CLIN MICROBIOL, V37, P1953, DOI 10.1128/JCM.37.6.1953-1957.1999; Mathers CD, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000114; Mosleh IM, 2008, TROP MED INT HEALTH, V13, P855, DOI 10.1111/j.1365-3156.2008.02063.x; Narain JP, 2010, B WORLD HEALTH ORGAN, V88, P206, DOI 10.2471/BLT.09.072322; NERONOV VM, 1987, FOLIA PARASIT, V34, P1; Reithinger R, 2003, EMERG INFECT DIS, V9, P727; Rey Luís C., 2005, J. Pediatr. (Rio J.), V81, P73, DOI [10.2223/JPED.1286, 10.1590/S0021-75572005000100014]; Rose K, 2004, INT J PARASITOL, V34, P655, DOI 10.1016/j.ijpara.2004.03.001; Seaman J, 1996, INT J EPIDEMIOL, V25, P862, DOI 10.1093/ije/25.4.862; Sen Gupta P. C., 1947, Indian Medical Gazette, V82, P281; Shaw J, 1987, LEISHMANIASIS BIOL M, P292; Maia-Elkhoury ANS, 2007, REV SAUDE PUBL, V41, P929; Singh SP, 2006, TROP MED INT HEALTH, V11, P899, DOI 10.1111/j.1365-3156.2006.01647.x; Singh VP, 2010, AM J TROP MED HYG, V82, P9, DOI 10.4269/ajtmh.2010.09-0235; United Nations Development Programme, 2011, HUM DEV REP; WHO, 2010, WHO TECH REP SER, V949, P1; WHO, 2022, GLOB BURD DIS 2004 U; World Bank, 1993, INV HLTH WORLD DEV R; World Health Assembly, 2007, WORLD HLTH ASS RES W; Yadon ZE, 2001, AM J TROP MED HYG, V65, P27, DOI 10.4269/ajtmh.2001.65.27; Yamey G, 2002, BRIT MED J, V325, P176, DOI 10.1136/bmj.325.7357.176; ZIJLSTRA EE, 1994, AM J TROP MED HYG, V51, P826, DOI 10.4269/ajtmh.1994.51.826	49	3285	3407	5	298	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e35671	10.1371/journal.pone.0035671	http://dx.doi.org/10.1371/journal.pone.0035671			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693548	gold, Green Published, Green Accepted			2022-12-27	WOS:000305338500009
J	Brophy, S; Rees, A; Knox, G; Baker, J; Thomas, NE				Brophy, Sinead; Rees, Anwen; Knox, Gareth; Baker, Julien; Thomas, Non E.			Child Fitness and Father's BMI Are Important Factors in Childhood Obesity: A School Based Cross-Sectional Study	PLOS ONE			English	Article							BODY-MASS INDEX; PHYSICAL-ACTIVITY; RISK-FACTORS; METABOLIC SYNDROME; WEIGHT-GAIN; INVOLVEMENT; HEALTH; ASSOCIATION; ADOLESCENTS; PREVALENCE	Background: This study examines obesity and factors associated with obesity in children aged 11-13 years in the UK. Methods: 1147 children from ten secondary schools participated in a health survey that included blood samples, fitness test and anthropometric measures. Factors associated with obesity were examined using multilevel logistic regression. Findings: Of the children examined (490 male; 657 female) a third were overweight, 1 in 6 had elevated blood pressure, more than 1 in 10 had high cholesterol, 58% consumed more fat than recommended, whilst 37% were classified as unfit. Children in deprived areas had a higher proportion of risk factors; for example, they had higher blood pressure (20% (deprived) compared to 11% (non-deprived), difference: 9.0% (95%CI: 4.7%-13.4%)). Obesity is associated with risk factors for heart disease and diabetes. Maintaining fitness is associated with a reduction in the risk factors for heart disease (high blood pressure and cholesterol) but not on risk factors for diabetes (insulin levels). In order of importance, the main risk factors for childhood obesity are being unfit, having an obese father, and being large at birth. Conclusion: The high proportion of children with risk factors suggests future interventions need to focus on community and policy change to shift the population norm rather than targeting the behaviour of high risk individuals. Interventions need to focus on mothers' lifestyle in pregnancy, fathers' health, as well as promoting fitness among children. Obesity was not associated with deprivation. Therefore, strategies should be adopted in both deprived and non deprived areas.	[Brophy, Sinead] Swansea Univ, Coll Med, Swansea, W Glam, Wales; [Rees, Anwen; Knox, Gareth] Univ Wales Inst, Sch Sport, Cardiff, S Glam, Wales; [Baker, Julien] Univ W Scotland, Paisley, Renfrew, Scotland; [Thomas, Non E.] Swansea Univ, Ctr Children & Young Peoples Hlth & Well Being, Sch Human & Hlth Sci, Swansea, W Glam, Wales	Swansea University; University of West Scotland; Swansea University	Brophy, S (corresponding author), Swansea Univ, Coll Med, Swansea, W Glam, Wales.	s.brophy@swansea.ac.uk	ibrahim, raquib/F-5078-2012	Brophy, Sinead/0000-0001-7417-2858	Welsh Assembly Government through the National Institute of Social Care and Health Research; ESRC [ES/G007543/1] Funding Source: UKRI; Economic and Social Research Council [ES/G007543/1] Funding Source: researchfish	Welsh Assembly Government through the National Institute of Social Care and Health Research; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This study was funded by the Welsh Assembly Government through the National Institute of Social Care and Health Research. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Arluk SL, 2003, MIL MED, V168, P583, DOI 10.1093/milmed/168.7.583; Berenson GS, 1998, NEW ENGL J MED, V338, P1650, DOI 10.1056/NEJM199806043382302; Boyce WT, 2006, J AM ACAD CHILD PSY, V45, P1510, DOI 10.1097/01.chi.0000237706.50884.8b; Burke V, 2001, INT J OBESITY, V25, P147, DOI 10.1038/sj.ijo.0801538; Cole TJ, 2007, BMJ-BRIT MED J, V335, P194, DOI 10.1136/bmj.39238.399444.55; Eagle TF, 2010, AM HEART J, V160, P1185, DOI 10.1016/j.ahj.2010.09.019; Figueroa-Colon R, 2000, AM J CLIN NUTR, V71, P829, DOI 10.1093/ajcn/71.3.829; Finn K, 2002, J PEDIATR-US, V140, P81, DOI 10.1067/mpd.2002.120693; Flouri E, 2004, BRIT J EDUC PSYCHOL, V74, P141, DOI 10.1348/000709904773839806; Foot Standards Agency, 2002, MCCANC WIDD COMP FOO; Freedman DS, 2005, PEDIATRICS, V115, P22, DOI 10.1542/peds.2004-0220; Freeman E, 2012, INT J OBES; Goldman R., 2005, FATHERS INVOLVEMENT; Goodman E, 2004, J PEDIATR-US, V145, P445, DOI 10.1016/j.jpeds.2004.04.059; Griffiths LJ, 2009, ARCH DIS CHILD, V94, P577, DOI 10.1136/adc.2008.137554; Hands BP, 2011, J SCI MED SPORT, V14, P397, DOI 10.1016/j.jsams.2011.03.011; Hitze B, 2009, EUR J CLIN NUTR, V63, P739, DOI 10.1038/ejcn.2008.41; Hosmer DW, 2000, APPL LOGISTIC REGRES; Howarth S, 2008, 08045 NAT ASS WAL; Johannsen DL, 2006, OBESITY, V14, P431, DOI 10.1038/oby.2006.57; Kain J, 2005, OBES RES, V13, P2178, DOI 10.1038/oby.2005.270; LAUER RM, 1988, PEDIATRICS, V82, P309; LAUER RM, 1993, PEDIATR CLIN N AM, V40, P23; Major JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015538; McCarthy HD, 2003, BRIT MED J, V326, P624, DOI 10.1136/bmj.326.7390.624; Metcalf BS, 2011, ARCH DIS CHILD, V96, P942, DOI 10.1136/adc.2009.175927; Newland LA, 2008, EARLY CHILD DEV CARE, V178, P785, DOI 10.1080/03004430802352186; Perez-Pastor EM, 2009, INT J OBESITY, V33, P727, DOI 10.1038/ijo.2009.76; Public Health England, 2021, MCCANCE WIDDOWSONS C; Rees A, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-86; RIDDOCH C, 1990, NO IRELAND HLTH FITN; Saker Meriem, 2011, Maedica (Bucur), V6, P90; Sandercock G, 2010, ARCH DIS CHILD, V95, P46, DOI 10.1136/adc.2009.162107; Sarkadi A, 2008, ACTA PAEDIATR, V97, P153, DOI 10.1111/j.1651-2227.2007.00572.x; Shaw JE, 2006, DIABETES CARE, V29, P1170, DOI 10.2337/dc06-0013; Suttleworth I, 1995, BRIT EDUC RES J, V21, P487; Thomas NE, 2006, HLTH ED J, V65, P223; Thomas NE, 2007, PEDIATR EXERC SCI, V19, P93, DOI 10.1123/pes.19.1.93; van Sluijs EMF, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-388; Wake M, 2007, PEDIATRICS, V120, pE1520, DOI 10.1542/peds.2006-3707; Wright CM, 2001, BMJ-BRIT MED J, V323, P1280, DOI 10.1136/bmj.323.7324.1280; Zimmet P, 2007, PEDIATR DIABETES, V8, P299, DOI 10.1111/j.1399-5448.2007.00271.x	42	22	22	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e36597	10.1371/journal.pone.0036597	http://dx.doi.org/10.1371/journal.pone.0036597			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693553	Green Published, gold			2022-12-27	WOS:000305338500014
J	Kozul-Horvath, CD; Zandbergen, F; Jackson, BP; Enelow, RI; Hamilton, JW				Kozul-Horvath, Courtney D.; Zandbergen, Fokko; Jackson, Brian P.; Enelow, Richard I.; Hamilton, Joshua W.			Effects of Low-Dose Drinking Water Arsenic on Mouse Fetal and Postnatal Growth and Development	PLOS ONE			English	Article							IN-UTERO; ENDOCRINE DISRUPTOR; GENE-EXPRESSION; EXPOSURE; RECEPTOR; ALTERS; PREGNANCY; LIVER; MICE; ACTIVATION	Background: Arsenic (As) exposure is a significant worldwide environmental health concern. Chronic exposure via contaminated drinking water has been associated with an increased incidence of a number of diseases, including reproductive and developmental effects. The goal of this study was to identify adverse outcomes in a mouse model of early life exposure to low-dose drinking water As (10 ppb, current U. S. EPA Maximum Contaminant Level). Methodology and Findings: C57B6/J pups were exposed to 10 ppb As, via the dam in her drinking water, either in utero and/or during the postnatal period. Birth outcomes, the growth of the F1 offspring, and health of the dams were assessed by a variety of measurements. Birth outcomes including litter weight, number of pups, and gestational length were unaffected. However, exposure during the in utero and postnatal period resulted in significant growth deficits in the offspring after birth, which was principally a result of decreased nutrients in the dam's breast milk. Cross-fostering of the pups reversed the growth deficit. Arsenic exposed dams displayed altered liver and breast milk triglyceride levels and serum profiles during pregnancy and lactation. The growth deficits in the F1 offspring resolved following separation from the dam and cessation of exposure in male mice, but did not resolve in female mice up to six weeks of age. Conclusions/Significance: Exposure to As at the current U. S. drinking water standard during critical windows of development induces a number of adverse health outcomes for both the dam and offspring. Such effects may contribute to the increased disease risks observed in human populations.	[Kozul-Horvath, Courtney D.; Enelow, Richard I.] Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Dept Microbiol & Immunol, Hanover, NH 03756 USA; [Zandbergen, Fokko; Hamilton, Joshua W.] Marine Biol Lab, Bay Paul Ctr Comparat Mol Biol & Evolut, Woods Hole, MA 02543 USA; [Jackson, Brian P.] Dartmouth Coll, Dept Earth Sci, Hanover, NH 03755 USA; [Enelow, Richard I.] Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Dept Med, Hanover, NH 03756 USA	Dartmouth College; Marine Biological Laboratory - Woods Hole; Dartmouth College; Dartmouth College	Kozul-Horvath, CD (corresponding author), Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Dept Microbiol & Immunol, Hanover, NH 03756 USA.	jhamilton@mbl.edu	Jackson, Brian/AAL-4166-2021		National Institute of Environmental Health Sciences at the National Institutes of Health [1F32 ES019070, P42 ES007373]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES007373, F32ES019070] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institute of Environmental Health Sciences at the National Institutes of Health grants 1F32 ES019070 (CDK-H) and P42 ES007373 (BPJ, JWH, RIE and CDK-H, Dartmouth Superfund Research Program Project Grant, Project 2 and Pilot Project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abernathy CO, 1999, ENVIRON HEALTH PERSP, V107, P593, DOI 10.2307/3434403; Agency for Toxic Substances and Disease Registry (ATSDR), 2016, ADD TOX PROF ARS; Ahmad SA, 2001, ENVIRON HEALTH PERSP, V109, P629, DOI 10.2307/3455038; Andrew AS, 2007, TOXICOL SCI, V100, P75, DOI 10.1093/toxsci/kfm200; Bacq Y, 2011, CLIN RES HEPATOL GAS; Barker DJP, 2007, J INTERN MED, V261, P412, DOI 10.1111/j.1365-2796.2007.01809.x; Bodwell JE, 2006, CHEM RES TOXICOL, V19, P1619, DOI 10.1021/tx060122q; Concha G, 1998, TOXICOL SCI, V44, P185, DOI 10.1006/toxs.1998.2486; Concha G, 1998, INT ARCH OCC ENV HEA, V71, P42, DOI 10.1007/s004200050248; Davey JC, 2008, ENVIRON HEALTH PERSP, V116, P165, DOI 10.1289/ehp.10131; Davey JC, 2007, TOXICOL SCI, V98, P75, DOI 10.1093/toxsci/kfm013; Fangstrom B, 2008, ENVIRON HEALTH PERSP, V116, P963, DOI 10.1289/ehp.11094; FERM VH, 1977, ENVIRON HEALTH PERSP, V19, P215, DOI 10.2307/3428478; Fry RC, 2007, PLOS GENET, V3, P2180, DOI 10.1371/journal.pgen.0030207; Gardner RM, 2011, REPROD TOXICOL, V31, P210, DOI 10.1016/j.reprotox.2010.11.002; Grefhorst A, 2002, J BIOL CHEM, V277, P34182, DOI 10.1074/jbc.M204887200; Hamadani JD, 2010, INT J EPIDEMIOL, V39, P1206, DOI 10.1093/ije/dyp369; He WJ, 2007, TOXICOL SCI, V99, P244, DOI 10.1093/toxsci/kfm162; Hill DS, 2008, BIRTH DEFECTS RES B, V83, P40, DOI 10.1002/bdrb.20142; Hopenhayn C, 2003, EPIDEMIOLOGY, V14, P593, DOI 10.1097/01.ede.0000072104.65240.69; Hopenhayn-Rich C, 2000, ENVIRON HEALTH PERSP, V108, P667, DOI 10.2307/3434889; Jin YP, 2006, ENVIRON RES, V101, P349, DOI 10.1016/j.envres.2005.11.006; Kaltreider RC, 2001, ENVIRON HEALTH PERSP, V109, P245, DOI 10.1289/ehp.01109245; Kozul CD, 2008, CHEM-BIOL INTERACT, V173, P129, DOI 10.1016/j.cbi.2008.02.008; Kozul CD, 2009, ENVIRON HEALTH PERSP, V117, P1441, DOI 10.1289/ehp.0900911; Kozul CD, 2009, ENVIRON HEALTH PERSP, V117, P1108, DOI 10.1289/ehp.0800199; Lantz RC, 2009, TOXICOL APPL PHARM, V235, P105, DOI 10.1016/j.taap.2008.11.012; Markowski VP, 2011, BASIC CLIN PHARMACOL, V108, P326, DOI 10.1111/j.1742-7843.2010.00660.x; Martinez-Finley EJ, 2009, PHARMACOL BIOCHEM BE, V94, P271, DOI 10.1016/j.pbb.2009.09.006; Moore SE, 2009, ACTA PAEDIATR, V98, P1168, DOI 10.1111/j.1651-2227.2009.01292.x; NRC, 1999, ARS DRINK WAT; Rahman A, 2011, ENVIRON HEALTH PERSP, V119, P719, DOI 10.1289/ehp.1002265; Rahman A, 2010, EPIDEMIOLOGY, V21, P797, DOI 10.1097/EDE.0b013e3181f56a0d; Raqib R, 2009, TOXICOL LETT, V185, P197, DOI 10.1016/j.toxlet.2009.01.001; SMITH AH, 1992, ENVIRON HEALTH PERSP, V97, P259, DOI 10.2307/3431362; Smith AH, 2006, ENVIRON HEALTH PERSP, V114, P1293, DOI 10.1289/ehp.8832; Srivastava S, 2007, REPROD TOXICOL, V23, P449, DOI 10.1016/j.reprotox.2007.01.005; Straub AC, 2008, J CLIN INVEST, V118, P3980, DOI 10.1172/JCI35092; Tofail F, 2009, ENVIRON HEALTH PERSP, V117, P288, DOI 10.1289/ehp.11670; Vahter Marie, 1999, Science Progress, V82, P69; Vahter M, 2009, ANNU REV NUTR, V29, P381, DOI 10.1146/annurev-nutr-080508-141102; Waalkes MP, 2003, TOXICOL APPL PHARM, V186, P7, DOI 10.1016/S0041-008X(02)00022-4; Xi SH, 2010, BIOL TRACE ELEM RES, V134, P84, DOI 10.1007/s12011-009-8455-1	43	57	57	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38249	10.1371/journal.pone.0038249	http://dx.doi.org/10.1371/journal.pone.0038249			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693606	Green Published, gold			2022-12-27	WOS:000305338500117
J	Bertolini, G; Ramat, S; Bockisch, CJ; Marti, S; Straumann, D; Palla, A				Bertolini, Giovanni; Ramat, Stefano; Bockisch, Christopher J.; Marti, Sarah; Straumann, Dominik; Palla, Antonella			Is Vestibular Self-Motion Perception Controlled by the Velocity Storage? Insights from Patients with Chronic Degeneration of the Vestibulo-Cerebellum	PLOS ONE			English	Article							SPATIAL ORIENTATION; INERTIAL REPRESENTATION; TILT SUPPRESSION; RHESUS-MONKEYS; ANGULAR MOTION; OCULAR REFLEX; EYE-MOVEMENTS; ALERT MONKEY; NODULUS; NEURONS	Background: The rotational vestibulo-ocular reflex (rVOR) generates compensatory eye movements in response to rotational head accelerations. The velocity-storage mechanism (VSM), which is controlled by the vestibulo-cerebellar nodulus and uvula, determines the rVOR time constant. In healthy subjects, it has been suggested that self-motion perception in response to earth-vertical axis rotations depends on the VSM in a similar way as reflexive eye movements. We aimed at further investigating this hypothesis and speculated that if the rVOR and rotational self-motion perception share a common VSM, alteration in the latter, such as those occurring after a loss of the regulatory control by vestibulo-cerebellar structures, would result in similar reflexive and perceptual response changes. We therefore set out to explore both responses in patients with vestibulo-cerebellar degeneration. Methodology/Principal Findings: Reflexive eye movements and perceived rotational velocity were simultaneously recorded in 14 patients with chronic vestibulo-cerebellar degeneration (28-81yrs) and 12 age-matched healthy subjects (30-72yrs) after the sudden deceleration (90 degrees/s2) from constant-velocity (90 degrees/s) rotations about the earth-vertical yaw and pitch axes. rVOR and perceived rotational velocity data were analyzed using a two-exponential model with a direct pathway, representing semicircular canal activity, and an indirect pathway, implementing the VSM. We found that VSM time constants of rVOR and perceived rotational velocity co-varied in cerebellar patients and in healthy controls (Pearson correlation coefficient for yaw 0.95; for pitch 0.93, p<0.01). When constraining model parameters to use the same VSM time constant for rVOR and perceived rotational velocity, moreover, no significant deterioration of the quality of fit was found for both populations (variance-accounted-for >0.8). Conclusions/Significance: Our results confirm that self-motion perception in response to rotational velocity-steps may be controlled by the same velocity storage network that controls reflexive eye movements and that no additional, e. g. cortical, mechanisms are required to explain perceptual dynamics.	[Bertolini, Giovanni; Bockisch, Christopher J.; Marti, Sarah; Straumann, Dominik; Palla, Antonella] Univ Zurich Hosp, Dept Neurol, CH-8091 Zurich, Switzerland; [Bertolini, Giovanni; Ramat, Stefano] Univ Pavia, Dept Comp Sci, I-27100 Pavia, Italy; [Bockisch, Christopher J.] Univ Zurich Hosp, Dept Otorhinolaryngol Head & Neck Surg, CH-8091 Zurich, Switzerland; [Bockisch, Christopher J.] Univ Zurich Hosp, Dept Ophthalmol, CH-8091 Zurich, Switzerland	University of Zurich; University Zurich Hospital; University of Pavia; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital	Bertolini, G (corresponding author), Univ Zurich Hosp, Dept Neurol, CH-8091 Zurich, Switzerland.	bertoweb@gmail.com	Bertolini, Giovanni/H-3510-2016; Ramat, Stefano/E-6495-2011; Bertolini, Giovanni/W-4117-2019	Bertolini, Giovanni/0000-0003-2428-9454; Ramat, Stefano/0000-0001-5932-186X; Bertolini, Giovanni/0000-0003-2428-9454; Bockisch, Christopher/0000-0003-1054-2578	Swiss National Science Foundation [32323B_119376]; Betty and David Koetser Foundation for Brain Research; Baasch Medicus Foundation; Zurich Center for Integrative Human Physiology	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Betty and David Koetser Foundation for Brain Research; Baasch Medicus Foundation; Zurich Center for Integrative Human Physiology	This work was supported by the Swiss National Science Foundation #32323B_119376; the Betty and David Koetser Foundation for Brain Research; the Baasch Medicus Foundation and the Zurich Center for Integrative Human Physiology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of this manuscript.	ANGELAKI DE, 1995, J NEUROPHYSIOL, V73, P1729; ANGELAKI DE, 1994, J NEUROPHYSIOL, V71, P1222, DOI 10.1152/jn.1994.71.3.1222; ANGELAKI DE, 1995, J NEUROPHYSIOL, V73, P1716, DOI 10.1152/jn.1995.73.4.1716; Bertolini G, 2011, J NEUROPHYSIOL, V105, P209, DOI 10.1152/jn.00154.2010; BLANKS RHI, 1975, J NEUROPHYSIOL, V38, P1250, DOI 10.1152/jn.1975.38.5.1250; Bremmer F, 2011, J PHYSIOL-LONDON, V589, P815, DOI 10.1113/jphysiol.2010.195537; Bronstein AM, 2008, NEUROREPORT, V19, P691, DOI 10.1097/WNR.0b013e3282fbf9f6; BUTTNER U, 1981, EXP BRAIN RES, V41, P310; BUTTNER U, 1977, EXP BRAIN RES, V30, P435; Clement G, 2008, EXP BRAIN RES, V190, P307, DOI 10.1007/s00221-008-1471-0; Cohen B, 2003, ANN NY ACAD SCI, V1004, P359, DOI 10.1196/annals.1303.034; COHEN B, 1981, ANN NY ACAD SCI, V374, P421, DOI 10.1111/j.1749-6632.1981.tb30888.x; Cohen B, 2002, ANN NY ACAD SCI, V978, P28, DOI 10.1111/j.1749-6632.2002.tb07553.x; COHEN H, 1992, EXP BRAIN RES, V90, P526; CURTHOYS IS, 1977, ACTA OTO-LARYNGOL, V83, P258, DOI 10.3109/00016487709128843; Dai MJ, 1999, J VESTIBUL RES-EQUIL, V9, P293; Dai MJ, 2003, EXP BRAIN RES, V151, P173, DOI 10.1007/s00221-003-1479-4; Dickman JD, 2004, EXP BRAIN RES, V155, P91, DOI 10.1007/s00221-003-1692-1; FERNANDEZ C, 1971, J NEUROPHYSIOL, V34, P661, DOI 10.1152/jn.1971.34.4.661; GALIANA HL, 1995, ACTA OTO-LARYNGOL, V115, P585, DOI 10.3109/00016489509139372; Gizzi MS, 2003, CURR EYE RES, V26, P281, DOI 10.1076/ceyr.26.4.281.15426; Green AM, 2004, J NEUROPHYSIOL, V92, P905, DOI 10.1152/jn.01234.2003; Green AM, 2003, J NEUROSCI, V23, P9265; Guedry F. E., 1974, VESTIBULAR SYSTEM PA, VVI, P3; HAIN TC, 1988, ACTA OTO-LARYNGOL, V105, P13, DOI 10.3109/00016488809119440; Hastie T, 2001, SPRINGER SERIES STAT, P539; HAUSTEIN W, 1989, BIOL CYBERN, V60, P411, DOI 10.1007/BF00204696; Heide W, 1988, Adv Otorhinolaryngol, V41, P44; JAGER J, 1981, ANN NY ACAD SCI, V374, P330, DOI 10.1111/j.1749-6632.1981.tb30880.x; Jeong HS, 2007, NEUROLOGY, V68, P956, DOI 10.1212/01.wnl.0000257111.24769.d2; Leigh R. J., 2006, NEUROLOGY EYE MOVEME; MAGNIN M, 1977, EXP BRAIN RES, V28, P293; Marlinski V, 2008, J NEUROPHYSIOL, V99, P2533, DOI 10.1152/jn.00761.2007; Meng H, 2007, J NEUROSCI, V27, P13590, DOI 10.1523/JNEUROSCI.3931-07.2007; Merfeld D M, 1993, J Vestib Res, V3, P123; Moon IS, 2009, STROKE, V40, P487, DOI 10.1161/STROKEAHA.108.527762; Okada T, 1999, BRAIN, V122, P1293, DOI 10.1093/brain/122.7.1293; OMAN CM, 1987, ACTA OTO-LARYNGOL, V103, P1, DOI 10.3109/00016488709134691; Ramat S, 2009, ANN NY ACAD SCI, V1164, P140, DOI 10.1111/j.1749-6632.2009.03855.x; RAPHAN T, 1979, EXP BRAIN RES, V35, P229; Raphan T, 1977, CONTROL GAZE BRAIN S, V1, P37; Robinson DA, 1977, CONTROL GAZE BRAIN S, V1, P49; Schmahmann JD, 1998, BRAIN, V121, P561, DOI 10.1093/brain/121.4.561; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Sheliga BM, 1999, ANN NY ACAD SCI, V871, P94, DOI 10.1111/j.1749-6632.1999.tb09178.x; Sinha N, 2008, PROG BRAIN RES, V171, P277, DOI 10.1016/S0079-6123(08)00639-0; SOLOMON D, 1994, EXP BRAIN RES, V102, P57; STRAUMANN D, 1995, VISION RES, V35, P3321, DOI 10.1016/0042-6989(95)00091-R; WAESPE W, 1985, SCIENCE, V228, P199, DOI 10.1126/science.3871968; Wearne S, 1996, ANN NY ACAD SCI, V781, P364, DOI 10.1111/j.1749-6632.1996.tb15713.x; Wearne S, 1998, J NEUROPHYSIOL, V79, P2690, DOI 10.1152/jn.1998.79.5.2690; Wiest G, 1999, NEUROLOGY, V52, P417, DOI 10.1212/WNL.52.2.417	52	46	47	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2012	7	6							e36763	10.1371/journal.pone.0036763	http://dx.doi.org/10.1371/journal.pone.0036763			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WX	22719833	Green Submitted, gold, Green Accepted, Green Published			2022-12-27	WOS:000305350000001
J	Jumlongras, D; Lachke, SA; O'Connell, DJ; Aboukhalil, A; Li, X; Choe, SE; Ho, JWK; Turbe-Doan, A; Robertson, EA; Olsen, BR; Bulyk, ML; Amendt, BA; Maas, RL				Jumlongras, Dolrudee; Lachke, Salil A.; O'Connell, Daniel J.; Aboukhalil, Anton; Li, Xiao; Choe, Sung E.; Ho, Joshua W. K.; Turbe-Doan, Annick; Robertson, Erin A.; Olsen, Bjorn R.; Bulyk, Martha L.; Amendt, Brad A.; Maas, Richard L.			An Evolutionarily Conserved Enhancer Regulates Bmp4 Expression in Developing Incisor and Limb Bud	PLOS ONE			English	Article							MORPHOGENETIC PROTEIN-4 GENE; APICAL ECTODERMAL RIDGE; BINDING MICROARRAY DATA; TOOTH MORPHOGENESIS; TRANSCRIPTIONAL PROPERTIES; CRANIOFACIAL DEVELOPMENT; DNA INTERACTIONS; ONLINE DATABASE; RIEGER-SYNDROME; HAIR-FOLLICLES	To elucidate the transcriptional regulation of Bmp4 expression during organogenesis, we used phylogenetic footprinting and transgenic reporter analyses to identify Bmp4 cis-regulatory modules (CRMs). These analyses identified a regulatory region located similar to 46 kb upstream of the mouse Bmp4 transcription start site that had previously been shown to direct expression in lateral plate mesoderm. We refined this regulatory region to a 396-bp minimal enhancer, and show that it recapitulates features of endogenous Bmp4 expression in developing mandibular arch ectoderm and incisor epithelium during the initiation-stage of tooth development. In addition, this enhancer directs expression in the apical ectodermal ridge (AER) of the developing limb and in anterior and posterior limb mesenchyme. Transcript profiling of E11.5 mouse incisor dental lamina, together with protein binding microarray (PBM) analyses, allowed identification of a conserved DNA binding motif in the Bmp4 enhancer for Pitx homeoproteins, which are also expressed in the developing mandibular and incisor epithelium. In vitro electrophoretic mobility shift assays (EMSA) and in vivo transgenic reporter mutational analyses revealed that this site supports Pitx binding and that the site is necessary to recapitulate aspects of endogenous Bmp4 expression in developing craniofacial and limb tissues. Finally, Pitx2 chromatin immunoprecipitation (ChIP) demonstrated direct binding of Pitx2 to this Bmp4 enhancer site in a dental epithelial cell line. These results establish a direct molecular regulatory link between Pitx family members and Bmp4 gene expression in developing incisor epithelium.	[Jumlongras, Dolrudee; O'Connell, Daniel J.; Aboukhalil, Anton; Choe, Sung E.; Ho, Joshua W. K.; Turbe-Doan, Annick; Robertson, Erin A.; Bulyk, Martha L.; Maas, Richard L.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Genet,Dept Med, Boston, MA 02115 USA; [Jumlongras, Dolrudee; Olsen, Bjorn R.] Harvard Univ, Sch Dent Med, Dept Dev Biol, Boston, MA 02115 USA; [Lachke, Salil A.] Univ Delaware, Dept Biol Sci, Ctr Bioinformat & Computat Biol, Newark, DE USA; [Aboukhalil, Anton] MIT, Dept Aeronaut & Astronaut, Cambridge, MA 02139 USA; [Li, Xiao; Amendt, Brad A.] Texas A&M Hlth Sci Ctr, Inst Biosci & Technol, Houston, TX USA; [Ho, Joshua W. K.] Harvard Univ, Sch Med, Ctr Biomed Informat, Boston, MA USA; [Bulyk, Martha L.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Bulyk, Martha L.] Harvard Univ, Sch Med, Harvard MIT Div Hlth Sci & Technol, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard School of Dental Medicine; University of Delaware; Massachusetts Institute of Technology (MIT); Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School	Jumlongras, D (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Genet,Dept Med, Boston, MA 02115 USA.	maas@genetics.med.harvard.edu	Ho, Joshua W. K./AAK-7759-2020; Li, Xiao/X-3429-2019	Ho, Joshua W. K./0000-0003-2331-7011; Li, Xiao/0000-0001-8527-4438; Amendt, Brad A./0000-0001-6524-1006; Choe, Sung/0000-0001-9140-4198; Lachke, Salil/0000-0001-8845-010X	Harvard School of Dental Medicine Dean's Scholar Award; National Institutes of Health (NIH) MERIT Award [DE011697]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR036819] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE011697] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R37DE011697] Funding Source: NIH RePORTER	Harvard School of Dental Medicine Dean's Scholar Award; National Institutes of Health (NIH) MERIT Award; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by the Harvard School of Dental Medicine Dean's Scholar Award to Dr. Jumlongras and National Institutes of Health (NIH) MERIT Award DE011697 to Dr. Maas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg T, 1997, AID AJA3 3 0 CO 2 C; Ahituv N, 2004, HUM MOL GENET, V13, pR261, DOI 10.1093/hmg/ddh229; Ahn K, 2001, DEVELOPMENT, V128, P4449; Amen M, 2007, MOL CELL BIOL, V27, P7560, DOI 10.1128/MCB.00315-07; Andl T, 2004, DEVELOPMENT, V131, P2257, DOI 10.1242/dev.01125; Bandyopadhyay A, 2006, PLOS GENET, V2, P2116, DOI 10.1371/journal.pgen.0020216; Bejerano G, 2004, BIOINFORMATICS, V20, P40, DOI 10.1093/bioinformatics/bth946; Benazet JD, 2009, SCIENCE, V323, P1050, DOI 10.1126/science.1168755; Cao HJ, 2010, DEV BIOL, V347, P289, DOI 10.1016/j.ydbio.2010.08.031; Chandler KJ, 2009, DEV BIOL, V327, P590, DOI 10.1016/j.ydbio.2008.12.033; Chen YP, 1996, DEVELOPMENT, V122, P3035; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Feng JQ, 2002, J DENT RES, V81, P6, DOI 10.1177/154405910208100103; FENG JQ, 1995, J BIOL CHEM, V270, P28364, DOI 10.1074/jbc.270.47.28364; Gage PJ, 1999, DEVELOPMENT, V126, P4643; Green PD, 2001, GENE EXPRESSION, V9, P265, DOI 10.3727/000000001783992515; Gurnett CA, 2008, AM J HUM GENET, V83, P616, DOI 10.1016/j.ajhg.2008.10.004; Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580; Hogan BLM, 1996, CURR OPIN GENET DEV, V6, P432, DOI 10.1016/S0959-437X(96)80064-5; Hunter S, 2012, NUCLEIC ACIDS RES, V40, pD306, DOI 10.1093/nar/gkr948; JONES CM, 1991, DEVELOPMENT, V111, P531; Koop BF, 1996, P NATL ACAD SCI USA, V93, P1363, DOI 10.1073/pnas.93.4.1363; KURIHARA T, 1993, BIOCHEM BIOPH RES CO, V192, P1049, DOI 10.1006/bbrc.1993.1523; Lanctot C, 1999, DEVELOPMENT, V126, P1805; Lanctot C, 1997, DEVELOPMENT, V124, P2807; Lawson KA, 1999, GENE DEV, V13, P424, DOI 10.1101/gad.13.4.424; Lenhard Boris, 2003, J Biol, V2, P13, DOI 10.1186/1475-4924-2-13; Lin CR, 1999, NATURE, V401, P279, DOI 10.1038/45803; Liu W, 2005, DEV BIOL, V283, P282, DOI 10.1016/j.ydbio.2005.04.019; Liu W, 2005, DEVELOPMENT, V132, P1453, DOI 10.1242/dev.01676; Liu W, 2003, DEVELOPMENT, V130, P6375, DOI 10.1242/dev.00849; Loots GG, 2000, SCIENCE, V288, P136, DOI 10.1126/science.288.5463.136; Lu MF, 1999, NATURE, V401, P276, DOI 10.1038/45797; Marcil A, 2003, DEVELOPMENT, V130, P45, DOI 10.1242/dev.00192; Mitsiadis TA, 2008, DEV BIOL, V313, P887, DOI 10.1016/j.ydbio.2007.10.055; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Nagy A., 2003, MANIPULATING MOUSE E; Newburger DE, 2009, NUCLEIC ACIDS RES, V37, pD77, DOI 10.1093/nar/gkn660; Nobrega MA, 2003, SCIENCE, V302, P413, DOI 10.1126/science.1088328; O'Connell DJ, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002414; Ohazama A, 2005, J DENT RES, V84, P603, DOI 10.1177/154405910508400704; Pizette S, 2001, DEVELOPMENT, V128, P4463; Plikus MV, 2005, EVOL DEV, V7, P440, DOI 10.1111/j.1525-142X.2005.05048.x; Poulin G, 2000, MOL CELL BIOL, V20, P4826, DOI 10.1128/MCB.20.13.4826-4837.2000; Robasky K, 2011, NUCLEIC ACIDS RES, V39, pD124, DOI 10.1093/nar/gkq992; Robert B, 2007, DEV GROWTH DIFFER, V49, P455, DOI 10.1111/j.1440-169x.2007.00946.x; Santagati F, 2003, GENETICS, V165, P235; Schwartz S, 2000, GENOME RES, V10, P577, DOI 10.1101/gr.10.4.577; Schwartz S, 2003, GENOME RES, V13, P103, DOI 10.1101/gr.809403; Selever J, 2004, DEV BIOL, V276, P268, DOI 10.1016/j.ydbio.2004.08.024; SEMENZA GL, 1995, BIOCHEM BIOPH RES CO, V209, P257, DOI 10.1006/bbrc.1995.1497; Semina EV, 1996, NAT GENET, V14, P392, DOI 10.1038/ng1296-392; St Amand TR, 2000, DEV BIOL, V217, P323, DOI 10.1006/dbio.1999.9547; Szeto DP, 1999, GENE DEV, V13, P484, DOI 10.1101/gad.13.4.484; THESLEFF, 2001, ADV DENT RES, V15, P14; Thomas JW, 2003, NATURE, V424, P788, DOI 10.1038/nature01858; Tremblay JJ, 2000, NEUROENDOCRINOLOGY, V71, P277, DOI 10.1159/000054547; Van den Wijngaard A, 1999, J BONE MINER RES, V14, P1432, DOI 10.1359/jbmr.1999.14.8.1432; Venugopalan SR, 2011, J BIOL CHEM, V286, P21372, DOI 10.1074/jbc.M111.252031; Wang CKL, 2004, DEV BIOL, V269, P109, DOI 10.1016/j.ydbio.2004.01.016; Wasserman WW, 2004, NAT REV GENET, V5, P276, DOI 10.1038/nrg1315; Zhang JH, 2002, BIOCHEM BIOPH RES CO, V293, P1412, DOI 10.1016/S0006-291X(02)00416-3; Zhang X, 2002, GENE DEV, V16, P2097, DOI 10.1101/gad.1007602; Zhao GQ, 2003, GENESIS, V35, P43, DOI 10.1002/gene.10167; Zhou YL, 2000, J BIOL CHEM, V275, P12273, DOI 10.1074/jbc.275.16.12273	65	16	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2012	7	6							e38568	10.1371/journal.pone.0038568	http://dx.doi.org/10.1371/journal.pone.0038568			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UJ	22701669	Green Published, gold			2022-12-27	WOS:000305340000033
J	Yue, M; Rankin, SC; Blanchet, RT; Nulton, JD; Edwards, RA; Schifferli, DM				Yue, Min; Rankin, Shelley C.; Blanchet, Ryan T.; Nulton, James D.; Edwards, Robert A.; Schifferli, Dieter M.			Diversification of the Salmonella Fimbriae: A Model of Macro- and Microevolution	PLOS ONE			English	Article							ENTERICA SEROTYPE TYPHIMURIUM; ENTEROTOXIGENIC ESCHERICHIA-COLI; INTESTINAL COLONIZATION FACTOR; LATERAL GENE-TRANSFER; FACTOR ANTIGEN-I; UNITED-STATES; SEROVAR ENTERITIDIS; COMPARATIVE GENOMICS; PROTEIN-STRUCTURE; BIOFILM FORMATION	Bacteria of the genus Salmonella comprise a large and evolutionary related population of zoonotic pathogens that can infect mammals, including humans and domestic animals, birds, reptiles and amphibians. Salmonella carries a plethora of virulence genes, including fimbrial adhesins, some of them known to participate in mammalian or avian host colonization. Each type of fimbria has its structural subunit and biogenesis genes encoded by one fimbrial gene cluster (FGC). The accumulation of new genomic information offered a timely opportunity to better evaluate the number and types of FGCs in the Salmonella pangenome, to test the use of current classifications based on phylogeny, and to infer potential correlations between FGC evolution in various Salmonella serovars and host niches. This study focused on the FGCs of the currently deciphered 90 genomes and 60 plasmids of Salmonella. The analysis highlighted a fimbriome consisting of 35 different FGCs, of which 16 were new, each strain carrying between 5 and 14 FGCs. The Salmonella fimbriome was extremely diverse with FGC representatives in 8 out of 9 previously categorized fimbrial clades and subclades. Phylogenetic analysis of Salmonella suggested macroevolutionary shifts detectable by extensive FGC deletion and acquisition. In addition, microevolutionary drifts were best depicted by the high level of allelic variation in predicted or known adhesins, such as the type 1 fimbrial adhesin FimH for which 67 different natural alleles were identified in S. enterica subsp. I. Together with strain-specific collections of FGCs, allelic variation among adhesins attested to the pathoadaptive evolution of Salmonella towards specific hosts and tissues, potentially modulating host range, strain virulence, disease progression, and transmission efficiency. Further understanding of how each Salmonella strain utilizes its panel of FGCs and specific adhesin alleles for survival and infection will support the development of new approaches for the control of Salmonellosis.	[Yue, Min; Rankin, Shelley C.; Schifferli, Dieter M.] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA; [Blanchet, Ryan T.; Nulton, James D.; Edwards, Robert A.] San Diego State Univ, Dept Comp Sci, Coll Sci, San Diego, CA 92182 USA; [Edwards, Robert A.] Argonne Natl Lab, Math & Comp Sci Div, Argonne, IL 60439 USA	University of Pennsylvania; California State University System; San Diego State University; United States Department of Energy (DOE); Argonne National Laboratory	Yue, M (corresponding author), Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA.	dmschiff@vet.upenn.edu	Yue, Min/H-2760-2019; Tsiotra, Irini/G-6086-2012; Rankin, Shelley/ABE-4366-2020; Schifferli, Dieter/H-2002-2011; Edwards, Robert/Q-1691-2019	Yue, Min/0000-0002-6787-0794; Rankin, Shelley/0000-0002-7578-540X; Edwards, Robert/0000-0001-8383-8949	University of Pennsylvania Research Foundation grant; University of Pennsylvania Veterinary Center for Infectious Disease; National Science Foundation Division of Biological Infrastructure [NSF DBI: 0850356]; Wellcome Trust; Direct For Mathematical & Physical Scien [0827278] Funding Source: National Science Foundation	University of Pennsylvania Research Foundation grant; University of Pennsylvania Veterinary Center for Infectious Disease; National Science Foundation Division of Biological Infrastructure(National Science Foundation (NSF)); Wellcome Trust(Wellcome TrustEuropean Commission); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	University of Pennsylvania Research Foundation grant and Research Initiative Funds from the University of Pennsylvania Veterinary Center for Infectious Disease (to D. M. S.), and by grant NSF DBI: 0850356 from the National Science Foundation Division of Biological Infrastructure (to R. A. E.). Funding for the DECIPHER project was provided by the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anderson LA, 2006, AVIAN DIS, V50, P142, DOI 10.1637/7397-062105R.1; Arthurson V, 2011, FEMS MICROBIOL LETT, V314, P67, DOI 10.1111/j.1574-6968.2010.02140.x; Atterbury RJ, 2007, APPL ENVIRON MICROB, V73, P4543, DOI 10.1128/AEM.00049-07; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Ballouz S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000672; Barnhart MM, 2006, ANNU REV MICROBIOL, V60, P131, DOI 10.1146/annurev.micro.60.080805.142106; Baumler AJ, 1996, P NATL ACAD SCI USA, V93, P279, DOI 10.1073/pnas.93.1.279; Baumler AJ, 1997, TRENDS MICROBIOL, V5, P318, DOI 10.1016/S0966-842X(97)01082-2; Baumler AJ, 2000, SCIENCE, V287, P50, DOI 10.1126/science.287.5450.50; Beaver John E, 2007, Immunome Res, V3, P3, DOI 10.1186/1745-7580-3-3; Benz I, 2011, INT J MED MICROBIOL, V301, P461, DOI 10.1016/j.ijmm.2011.03.003; Berger CN, 2010, ENVIRON MICROBIOL, V12, P2385, DOI 10.1111/j.1462-2920.2010.02297.x; Berger CN, 2009, ISME J, V3, P261, DOI 10.1038/ismej.2008.95; Boddicker JD, 2002, MOL MICROBIOL, V45, P1255, DOI 10.1046/j.1365-2958.2002.03121.x; Bolton AJ, 1999, J MED MICROBIOL, V48, P801, DOI 10.1099/00222615-48-9-801; Boyd EF, 1996, APPL ENVIRON MICROB, V62, P804, DOI 10.1128/AEM.62.3.804-808.1996; Brankatschk K, 2011, J BACTERIOL, V193, P2066, DOI 10.1128/JB.00123-11; Bratlie MS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-588; Chessa D, 2009, MOL MICROBIOL, V71, P864, DOI 10.1111/j.1365-2958.2008.06566.x; Chiu CH, 2005, NUCLEIC ACIDS RES, V33, P1690, DOI 10.1093/nar/gki297; Choudhury D, 1999, SCIENCE, V285, P1061, DOI 10.1126/science.285.5430.1061; Clarkson LS, 2010, EPIDEMIOL INFECT, V138, P340, DOI 10.1017/S0950268809990586; Clayton DJ, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-228; Clegg S, 2011, J BACTERIOL, V193, P2081, DOI 10.1128/JB.00071-11; Crump JA, 2010, CLIN INFECT DIS, V50, P241, DOI 10.1086/649541; Cummings KJ, 2010, VECTOR-BORNE ZOONOT, V10, P471, DOI 10.1089/vbz.2009.0068; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; Delsuc F, 2005, NAT REV GENET, V6, P361, DOI 10.1038/nrg1603; Dodson KW, 2001, CELL, V105, P733, DOI 10.1016/S0092-8674(01)00388-9; Dorsey CW, 2005, MOL MICROBIOL, V57, P196, DOI 10.1111/j.1365-2958.2005.04666.x; Dwyer BE, 2011, MICROBIOLOGY; Edwards RA, 1996, J BACTERIOL, V178, P3426, DOI 10.1128/jb.178.12.3426-3433.1996; Edwards RA, 2002, TRENDS MICROBIOL, V10, P94, DOI 10.1016/S0966-842X(01)02293-4; Forest C, 2007, INFECT IMMUN, V75, P5264, DOI 10.1128/IAI.00674-07; Francis DH, 1999, ADV EXP MED BIOL, V473, P147; Fricke WF, 2011, J BACTERIOL, V193, P3556, DOI 10.1128/JB.00297-11; Garcia-Boronat M, 2008, NUCLEIC ACIDS RES, V36, pW35, DOI 10.1093/nar/gkn211; Golberg D, 2011, INT J FOOD MICROBIOL, V145, P250, DOI 10.1016/j.ijfoodmicro.2010.12.031; Gould L. Hannah, 2011, Morbidity and Mortality Weekly Report, V60, P1197; Grimont P. A. D., 2007, ANTIGENIC FORMULAE S; Grzymajlo K, 2010, MICROBIOL-SGM, V156, P1738, DOI 10.1099/mic.0.039206-0; Guo AZ, 2007, MICROBIOL-SGM, V153, P1059, DOI 10.1099/mic.0.2006/000331-0; Guo AZ, 2009, MICROBIOL-SGM, V155, P1623, DOI 10.1099/mic.0.026286-0; HAAHTELA K, 1986, APPL ENVIRON MICROB, V52, P1074, DOI 10.1128/AEM.52.5.1074-1079.1986; Hase K, 2009, NATURE, V462, P226, DOI 10.1038/nature08529; Hirsh D. C, 2004, VET MICROBIOL, P69; Holt KE, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-36; Huang TM, 2009, LETT APPL MICROBIOL, V48, P331, DOI 10.1111/j.1472-765X.2008.02530.x; Humphries AD, 2001, FEMS MICROBIOL LETT, V201, P121, DOI 10.1016/S0378-1097(01)00250-6; Hung CS, 2002, MOL MICROBIOL, V44, P903, DOI 10.1046/j.1365-2958.2002.02915.x; Jose J, 2007, MICROBIOL MOL BIOL R, V71, P600, DOI 10.1128/MMBR.00011-07; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Khan AS, 1996, INFECT IMMUN, V64, P3688, DOI 10.1128/IAI.64.9.3688-3693.1996; Kingsley RA, 2003, INFECT IMMUN, V71, P629, DOI 10.1128/IAI.71.2.629-640.2003; Kingsley RA, 2002, MOL MICROBIOL, V43, P895, DOI 10.1046/j.1365-2958.2002.02805.x; Kingsley RA, 2000, INFECT IMMUN, V68, P2720, DOI 10.1128/IAI.68.5.2720-2727.2000; Kinoshita K, 2003, PROTEIN SCI, V12, P1589, DOI 10.1110/ps.0368703; Kisiela D, 2005, INFECT IMMUN, V73, P6187, DOI 10.1128/IAI.73.9.6187-6190.2005; Kisiela D, 2006, MICROBIOL-SGM, V152, P1337, DOI 10.1099/mic.0.28588-0; Kisiela DI, 2011, J BIOL CHEM; Korhonen T. K., 2007, SALMONELLA MOL BIOL, P53; Kugelberg E, 2010, GENETICS, V185, P65, DOI 10.1534/genetics.110.114074; La Ragione RM, 2001, INT J MED MICROBIOL, V290, P707, DOI 10.1016/S1438-4221(01)80011-4; Lan RT, 2009, INFECT GENET EVOL, V9, P996, DOI 10.1016/j.meegid.2009.04.011; LEE JH, 1995, INFECT IMMUN, V63, P4143, DOI 10.1128/IAI.63.10.4143-4149.1995; LI J, 1994, P NATL ACAD SCI USA, V91, P2552, DOI 10.1073/pnas.91.7.2552; Li YF, 2007, J BIOL CHEM, V282, P23970, DOI 10.1074/jbc.M700921200; Lienau EK, 2011, NEW ENGL J MED, V364, P981, DOI 10.1056/NEJMc1100443; Litrup E, 2010, INFECT GENET EVOL, V10, P1132, DOI 10.1016/j.meegid.2010.07.015; Liu FY, 2011, APPL ENVIRON MICROB, V77, P4520, DOI 10.1128/AEM.00468-11; Liu FY, 2011, APPL ENVIRON MICROB, V77, P1946, DOI 10.1128/AEM.02625-10; Liu WQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004510; Mateus A, 2008, PUBLIC HEALTH, V122, P1321, DOI 10.1016/j.puhe.2008.02.007; Maurelli AT, 2007, FEMS MICROBIOL LETT, V267, P1, DOI 10.1111/j.1574-6968.2006.00526.x; McDonough PL, 2009, REPORT COMMITTEE SAL; McGuffin LJ, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-345; McQuiston JR, 2008, J BACTERIOL, V190, P7060, DOI 10.1128/JB.01552-07; Muhammad M, 2010, VET MICROBIOL, V140, P131, DOI 10.1016/j.vetmic.2009.07.009; Nuccio S-P, 2010, SALMONELLA ENTERICA; Nuccio SP, 2007, MICROBIOL MOL BIOL R, V71, P551, DOI 10.1128/MMBR.00014-07; OLD DC, 1985, J MED MICROBIOL, V20, P203, DOI 10.1099/00222615-20-2-203; Pabbaraju K, 2000, J BACTERIOL, V182, P1923, DOI 10.1128/JB.182.7.1923-1929.2000; PANG T, 1995, TRENDS MICROBIOL, V3, P253, DOI 10.1016/S0966-842X(00)88937-4; Porwollik S, 2002, P NATL ACAD SCI USA, V99, P8956, DOI 10.1073/pnas.122153699; Porwollik S, 2004, J BACTERIOL, V186, P5883, DOI 10.1128/JB.186.17.5883-5898.2004; Porwollik S, 2003, MICROBES INFECT, V5, P977, DOI 10.1016/S1286-4579(03)00186-2; Rabsch W, 2002, INFECT IMMUN, V70, P2249, DOI 10.1128/IAI.70.5.2249-2255.2002; REEVES P, 1993, TRENDS GENET, V9, P17, DOI 10.1016/0168-9525(93)90067-R; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Saldana Z, 2009, ENVIRON MICROBIOL, V11, P992, DOI 10.1111/j.1462-2920.2008.01824.x; Scallan E, 2011, EMERG INFECT DIS, V17, P7, DOI 10.3201/eid1701.P11101; Schaer BLD, 2010, J VET INTERN MED, V24, P1138, DOI 10.1111/j.1939-1676.2010.0546.x; Schifferli DM, 2005, ECOSAL ESCHERICHIA C; Schlumberger MC, 2006, CURR OPIN MICROBIOL, V9, P46, DOI 10.1016/j.mib.2005.12.006; Seth-Smith HMB, 2012, J BACTERIOL, V194, P1494, DOI 10.1128/JB.06403-11; Sheth AN, 2011, CLIN INFECT DIS, V53, P356, DOI 10.1093/cid/cir407; Sivapalasingam S, 2004, EPIDEMIOL INFECT, V132, P897, DOI 10.1017/S0950268804002717; Sokurenko EV, 2008, CELL HOST MICROBE, V4, P314, DOI 10.1016/j.chom.2008.09.005; Soyer Y, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-264; Stahlhut SG, 2009, J BACTERIOL, V191, P6592, DOI 10.1128/JB.00786-09; Stevens MP, 2009, PHILOS T R SOC B, V364, P2709, DOI 10.1098/rstb.2009.0094; Tamura K, 2011, MOL BIOL EVOLUTION; Tchesnokova V, 2011, INFECT IMMUN, V79, P3895, DOI 10.1128/IAI.05169-11; Tchesnokova V, 2010, MOL MICROBIOL, V76, P489, DOI 10.1111/j.1365-2958.2010.07116.x; Thomson NR, 2008, GENOME RES, V18, P1624, DOI 10.1101/gr.077404.108; Tindall BJ, 2005, INT J SYST EVOL MICR, V55, P521, DOI 10.1099/ijs.0.63580-0; Townsend SM, 2001, INFECT IMMUN, V69, P2894, DOI 10.1128/IAI.69.5.2894-2901.2001; Tsolis RM, 1999, INFECT IMMUN, V67, P6385; van der Velden AWM, 1998, INFECT IMMUN, V66, P2803, DOI 10.1128/IAI.66.6.2803-2808.1998; Van Loy CP, 2002, INFECT IMMUN, V70, P1694, DOI 10.1128/IAI.70.4.1694-1702.2002; Van Molle I, 2007, J MOL BIOL; Vugia D., 2009, Morbidity and Mortality Weekly Report, V58, P333; Waack S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-142; Waksman G, 2009, NAT REV MICROBIOL, V7, P765, DOI 10.1038/nrmicro2220; Weening EH, 2005, INFECT IMMUN, V73, P3358, DOI 10.1128/IAI.73.6.3358-3366.2005; Welch TJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000309; Wildschutte H, 2004, P NATL ACAD SCI USA, V101, P10644, DOI 10.1073/pnas.0404028101; Wu ST, 2008, PROTEINS, V72, P547, DOI 10.1002/prot.21945; Yen MR, 2002, BBA-BIOMEMBRANES, V1562, P6, DOI 10.1016/S0005-2736(02)00359-0; You YW, 2006, APPL ENVIRON MICROB, V72, P5777, DOI 10.1128/AEM.00791-06; Zav'yalov V, 2010, FEMS MICROBIOL REV, V34, P317, DOI 10.1111/j.1574-6976.2009.00201.x	122	69	72	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2012	7	6							e38596	10.1371/journal.pone.0038596	http://dx.doi.org/10.1371/journal.pone.0038596			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UJ	22701679	Green Published, Green Submitted, gold			2022-12-27	WOS:000305340000034
J	Cerutti-Pereyra, F; Meekan, MG; Wei, NWV; O'Shea, O; Bradshaw, CJA; Austin, CM				Cerutti-Pereyra, Florencia; Meekan, Mark G.; Wei, Nu-Wei V.; O'Shea, Owen; Bradshaw, Corey J. A.; Austin, Chris M.			Identification of Rays through DNA Barcoding: An Application for Ecologists	PLOS ONE			English	Article							FRESH-WATER CRAYFISH; SPOTTED EAGLE RAY; POPULATION-STRUCTURE; EVOLUTIONARY RELATIONSHIPS; SHARKS; PHYLOGENY; TAXONOMY; UTILITY; HISTORY; DEEP	DNA barcoding potentially offers scientists who are not expert taxonomists a powerful tool to support the accuracy of field studies involving taxa that are diverse and difficult to identify. The taxonomy of rays has received reasonable attention in Australia, although the fauna in remote locations such as Ningaloo Reef, Western Australia is poorly studied and the identification of some species in the field is problematic. Here, we report an application of DNA-barcoding to the identification of 16 species (from 10 genera) of tropical rays as part of an ecological study. Analysis of the dataset combined across all samples grouped sequences into clearly defined operational taxonomic units, with two conspicuous exceptions: the Neotrygon kuhlii species complex and the Aetobatus species complex. In the field, the group that presented the most difficulties for identification was the spotted whiptail rays, referred to as the 'uarnak' complex. Two sets of problems limited the successful application of DNA barcoding: (1) the presence of cryptic species, species complexes with unresolved taxonomic status and intra-specific geographical variation, and (2) insufficient numbers of entries in online databases that have been verified taxonomically, and the presence of lodged sequences in databases with inconsistent names. Nevertheless, we demonstrate the potential of the DNA barcoding approach to confirm field identifications and to highlight species complexes where taxonomic uncertainty might confound ecological data.	[Cerutti-Pereyra, Florencia; Wei, Nu-Wei V.] Charles Darwin Univ, Res Inst Environm & Livelihood, Darwin, NT 0909, Australia; [O'Shea, Owen] Murdoch Univ, Murdoch, WA 6150, Australia; [Bradshaw, Corey J. A.] Univ Adelaide, Inst Environm, Adelaide, SA, Australia; [Bradshaw, Corey J. A.] Univ Adelaide, Sch Earth & Environm Sci, Adelaide, SA, Australia; [Austin, Chris M.] Monash Univ, Sch Sci, Petaling Jaya, Selangor, Malaysia	Charles Darwin University; Murdoch University; University of Adelaide; University of Adelaide; Monash University; Monash University Sunway	Cerutti-Pereyra, F (corresponding author), Charles Darwin Univ, Res Inst Environm & Livelihood, Darwin, NT 0909, Australia.	chris.austin@monash.edu	Austin, Christopher/L-7022-2017; Austin, Christopher M/J-4527-2012; Bradshaw, Corey J.A./A-1311-2008	Austin, Christopher/0000-0003-1848-6267; Austin, Christopher M/0000-0003-1848-6267; Bradshaw, Corey J.A./0000-0002-5328-7741; Meekan, Mark/0000-0002-3067-9427	Australian Institute of Marine Science; Charles Darwin University; CONACYT-Mexico	Australian Institute of Marine Science; Charles Darwin University; CONACYT-Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	We thank the Australian Institute of Marine Science and Charles Darwin University for financial support, and CONACYT-Mexico for an international grant to FCP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral AR, 2007, MAR FRESHWATER RES, V58, P505, DOI 10.1071/MF07050; Austin CM, 2002, INVERTEBR SYST, V16, P357, DOI 10.1071/IT01010; AVISE JC, 1992, OIKOS, V63, P62, DOI 10.2307/3545516; Bilgmann K, 2007, MAR MAMMAL SCI, V23, P218, DOI 10.1111/j.1748-7692.2006.00099.x; Bonfil R, 1997, ELASMOBRANCH BIODIVE, P15; Bortolus A, 2008, AMBIO, V37, P114, DOI 10.1579/0044-7447(2008)37[114:ECITBS]2.0.CO;2; BRANDER K, 1981, NATURE, V290, P48, DOI 10.1038/290048a0; Bruce BD, 2006, MAR BIOL, V150, P161, DOI 10.1007/s00227-006-0325-1; Dewar H, 2008, MAR BIOL, V155, P121, DOI 10.1007/s00227-008-0988-x; Domingo-Roura X, 2006, BIOL CONSERV, V128, P425, DOI 10.1016/j.biocon.2005.08.013; Douady CJ, 2003, MOL PHYLOGENET EVOL, V26, P215, DOI 10.1016/S1055-7903(02)00333-0; Dulvy NK, 2000, CONSERV BIOL, V14, P283, DOI 10.1046/j.1523-1739.2000.98540.x; Ebach MC, 2005, BIOSCIENCE, V55, P822; Field IC, 2009, ADV MAR BIOL, V56, P275, DOI 10.1016/S0065-2881(09)56004-X; Frisk MG, 2010, CRC MAR BIOL SER, P283; Graham KJ, 2001, MAR FRESHWATER RES, V52, P549, DOI 10.1071/MF99174; Gray JE, 1851, LIST SPECIMENS FIS 1; Hajibabaei M, 2007, TRENDS GENET, V23, P167, DOI 10.1016/j.tig.2007.02.001; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Holmes BH, 2009, FISH RES, V95, P280, DOI 10.1016/j.fishres.2008.09.036; KEENAN CP, 1994, AUST J MAR FRESH RES, V45, P1123, DOI 10.1071/MF9941123; Keeney DB, 2003, MAR BIOL, V143, P1039, DOI 10.1007/s00227-003-1166-9; Khuroo AA, 2007, J NAT CONSERV, V15, P256, DOI 10.1016/j.jnc.2007.07.003; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kumar S, 2000, J MOL EVOL, V51, P544, DOI 10.1007/s002390010118; Last P.R., 1994, P1; Last PR, 2011, J FISH BIOL, V79, P1193, DOI 10.1111/j.1095-8649.2011.03095.x; LAST P R, 1987, Memoirs of the Museum of Victoria, V48, P57; Last P. R., 2010, DESCRIPTIONS NEW SHA; Last P. R., 2009, SHARKS RAYS AUSTR, V2; Last Peter R., 2010, Aqua, V16, P37; Last Peter R., 2006, Zootaxa, V1239, P19; Last PR, 2008, DESCRIPTIONS NEW AUS, P275; Last PR, 2010, DESCRIPTIONS NEW SHA, P115; Last PR, 2008, DESCRIPTIONS NEW AUS, P315; Last PR, 2008, DESCRIPTIONS NEW AUS, P303; LAWSON R, 1995, J ZOOL, V237, P101, DOI 10.1111/j.1469-7998.1995.tb02749.x; Leprovost Dames and Moore, 2000, NINGALOO MARINE PARK; Lovejoy NR, 1996, ZOOL J LINN SOC-LOND, V117, P207, DOI 10.1006/zjls.1996.0038; Manjaji-Matsumoto B. M., 2008, DESCRIPTIONS NEW AUS, V22, P293; Marshall Andrea D., 2009, Zootaxa, V2301, P1; McEachran JD, 2004, CRC MAR BIOL SER, P79; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Moritz C, 2004, PLOS BIOL, V2, P1529, DOI 10.1371/journal.pbio.0020354; Moura T, 2008, MAR FRESHWATER RES, V59, P214, DOI 10.1071/MF07192; Munasinghe DHN, 2003, J CRUSTACEAN BIOL, V23, P402, DOI 10.1651/0278-0372(2003)023[0402:UOMDSF]2.0.CO;2; Ovenden JR, 2010, MAR FRESHWATER RES, V61, P253, DOI 10.1071/MF09151; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rawlings LH, 2004, AUST J ZOOL, V52, P215, DOI 10.1071/ZO03030; Richards VP, 2009, J HERED, V100, P273, DOI 10.1093/jhered/esp005; Rocco L, 2007, GENE, V389, P80, DOI 10.1016/j.gene.2006.09.024; Ronquist F, 2005, MRBAYES 3 1 MANUAL F; Rubinoff D, 2006, CONSERV BIOL, V20, P1548, DOI 10.1111/j.1523-1739.2006.00542.x; Sandoval-Castillo J, 2004, MAR BIOL, V145, P983, DOI 10.1007/s00227-004-1378-7; Sandoval-Castillo J, 2011, J HERED, V102, P269, DOI 10.1093/jhered/esr004; Schluessel V, 2010, J ZOOL, V281, P46, DOI 10.1111/j.1469-7998.2009.00680.x; Schrey AW, 2003, CAN J FISH AQUAT SCI, V60, P670, DOI 10.1139/F03-064; Sezaki K, 1999, FISHERIES SCI, V65, P563, DOI 10.2331/fishsci.65.563; Stevens JD, 2000, ICES J MAR SCI, V57, P476, DOI 10.1006/jmsc.2000.0724; Swofford D. L, 2002, PAUP PHYLOGENETIC AN; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tautz D, 2003, TRENDS ECOL EVOL, V18, P70, DOI 10.1016/S0169-5347(02)00041-1; Taylor J. G., 1999, Journal of the Royal Society of Western Australia, V82, P57; Toffoli D, 2008, GENET MOL BIOL, V31, P324, DOI 10.1590/S1415-47572008000200028; Valentini A, 2009, TRENDS ECOL EVOL, V24, P110, DOI 10.1016/j.tree.2008.09.011; Valiere N, 2003, ANIM CONSERV, V6, P83, DOI 10.1017/S1367943003003111; Vecchione M, 2000, ICES J MAR SCI, V57, P677, DOI 10.1006/jmsc.2000.0707; Voris HK, 2000, J BIOGEOGR, V27, P1153, DOI 10.1046/j.1365-2699.2000.00489.x; Ward RD, 2009, J FISH BIOL, V74, P329, DOI 10.1111/j.1095-8649.2008.02080.x; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Ward RD, 2008, MAR FRESHWATER RES, V59, P57, DOI 10.1071/MF07148; Ward Robert D., 2007, CSIRO Marine and Atmospheric Research Paper, V014, P117; White WT, 2007, J FISH BIOL, V70, P1809, DOI 10.1111/j.1095-8649.2007.01458.x; White W.T., 2006, EC IMPORTANT SHARKS; White WT, 2010, DESCRIPTIONS NEW SHA, P141; Winchell CJ, 2004, MOL PHYLOGENET EVOL, V31, P214, DOI 10.1016/j.ympev.2003.07.010; Wynen L, 2009, MAR FRESHWATER RES, V60, P554, DOI 10.1071/MF08201; Zemlak TS, 2009, MOL ECOL RESOUR, V9, P237, DOI 10.1111/j.1755-0998.2009.02649.x	80	49	49	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2012	7	6							e36479	10.1371/journal.pone.0036479	http://dx.doi.org/10.1371/journal.pone.0036479			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TU	22701556	Green Published, gold			2022-12-27	WOS:000305337600003
J	Fang, XL; Han, LR; Cao, XQ; Zhu, MX; Zhang, X; Wang, YH				Fang, Xiang-Ling; Han, Li-Rong; Cao, Xue-Qiang; Zhu, Ming-Xuan; Zhang, Xing; Wang, Yong-Hong			Statistical Optimization of Process Variables for Antibiotic Activity of Xenorhabdus bovienii	PLOS ONE			English	Article							RESPONSE-SURFACE METHODOLOGY; PHOTORHABDUS-LUMINESCENS; METABOLITES; BACTERIA; NEMATOPHILUS; NEMATODES; ENTEROBACTERIACEAE; IDENTIFICATION; DERIVATIVES; FAMILY	The production of secondary metabolites with antibiotic properties is a common characteristic to entomopathogenic bacteria Xenorhabdus spp. These metabolites not only have diverse chemical structures but also have a wide range of bioactivities of medicinal and agricultural interests. Culture variables are critical to the production of secondary metabolites of microorganisms. Manipulating culture process variables can promote secondary metabolite biosynthesis and thus facilitate the discovery of novel natural products. This work was conducted to evaluate the effects of five process variables (initial pH, medium volume, rotary speed, temperature, and inoculation volume) on the antibiotic production of Xenorhabdus bovienii YL002 using response surface methodology. A 2(5-1) factorial central composite design was chosen to determine the combined effects of the five variables, and to design a minimum number of experiments. The experimental and predicted antibiotic activity of X. bovienii YL002 was in close agreement. Statistical analysis of the results showed that initial pH, medium volume, rotary speed and temperature had a significant effect (P<0.05) on the antibiotic production of X. bovienii YL002 at their individual level; medium volume and rotary speed showed a significant effect at a combined level and was most significant at an individual level. The maximum antibiotic activity (287.5 U/mL) was achieved at the initial pH of 8.24, medium volume of 54 mL in 250 mL flask, rotary speed of 208 rpm, temperature of 32.0 degrees C and inoculation volume of 13.8%. After optimization, the antibiotic activity was improved by 23.02% as compared with that of unoptimized conditions.	[Fang, Xiang-Ling; Han, Li-Rong; Cao, Xue-Qiang; Zhu, Ming-Xuan; Zhang, Xing; Wang, Yong-Hong] NW A&F Univ, Res & Dev Ctr Biorat Pesticides, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China	Wang, YH (corresponding author), NW A&F Univ, Res & Dev Ctr Biorat Pesticides, Yangling, Shaanxi, Peoples R China.	ylagri@126.com; yhwang@nwsuaf.edu.cn	Fang, Xiangling/G-1075-2012		Natural Science Foundation of China [31171910]; National Department Public Benefit Research Foundation of China [200903052]; Northwest A F University [52211241]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Department Public Benefit Research Foundation of China; Northwest A F University	This work was supported by the Natural Science Foundation of China (no. 31171910), National Department Public Benefit Research Foundation of China (no. 200903052) and Young People Science Program of Northwest A & F University (no. 52211241). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKHURST RJ, 1982, J GEN MICROBIOL, V128, P3061; Bode HB, 2002, CHEMBIOCHEM, V3, P619, DOI 10.1002/1439-7633(20020703)3:7<619::AID-CBIC619>3.0.CO;2-9; Chaston JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027909; Chen G, 1996, NEMATOLOGICA, V42, P124, DOI 10.1163/187529296X00139; CHEN G, 1994, BIOL CONTROL, V4, P157, DOI 10.1006/bcon.1994.1025; Chen G., 1996, THESIS S FRASER U BR; Chen XC, 2009, BIORESOURCE TECHNOL, V100, P919, DOI 10.1016/j.biortech.2008.07.062; Duchaud E, 2003, NAT BIOTECHNOL, V21, P1307, DOI 10.1038/nbt886; Fang XL, 2011, J APPL MICROBIOL, V111, P145, DOI 10.1111/j.1365-2672.2011.05033.x; Fang XL, 2008, J NW A F U, V36, P200; Gualtieri M, 2009, J ANTIBIOT, V62, P295, DOI 10.1038/ja.2009.31; Herbert EE, 2007, APPL ENVIRON MICROB, V73, P7826, DOI 10.1128/AEM.01586-07; Ji D, 2004, FEMS MICROBIOL LETT, V239, P241, DOI 10.1016/j.femsle.2004.08.041; Kaushik R, 2006, J MOL CATAL B-ENZYM, V40, P121, DOI 10.1016/j.molcatb.2006.02.019; Kontnik R, 2010, ACS CHEM BIOL, V5, P659, DOI 10.1021/cb100117k; Lai LST, 2005, ENZYME MICROB TECH, V36, P737, DOI 10.1016/j.enzmictec.2004.12.021; Lang G, 2008, J NAT PROD, V71, P1074, DOI 10.1021/np800053n; Lengyel K, 2005, SYST APPL MICROBIOL, V28, P115, DOI 10.1016/j.syapm.2004.10.004; LI JX, 1995, J NAT PRODUCTS, V58, P1081, DOI 10.1021/np50121a016; Li JX, 1997, CAN J MICROBIOL, V43, P770, DOI 10.1139/m97-110; Li Y, 2007, ENZYME MICROB TECH, V40, P1381, DOI 10.1016/j.enzmictec.2006.10.015; MAXWELL PW, 1994, APPL ENVIRON MICROB, V60, P715, DOI 10.1128/AEM.60.2.715-721.1994; MCINERNEY BV, 1991, J NAT PROD, V54, P785, DOI 10.1021/np50075a006; MCINERNEY BV, 1991, J NAT PROD, V54, P774, DOI 10.1021/np50075a005; Mudgetti R.E., 1986, MANUAL IND BIOTECHNO, P66; Ng KK, 1997, CAN J PLANT PATHOL, V19, P125, DOI 10.1080/07060669709500540; PAUL VJ, 1981, J CHEM ECOL, V7, P589, DOI 10.1007/BF00987707; Scherlach K, 2009, ORG BIOMOL CHEM, V7, P1753, DOI 10.1039/b821578b; Shapiro-Ilan David I., 2009, Archives of Phytopathology and Plant Protection, V42, P715, DOI 10.1080/03235400701390539; Wang YH, 2011, J BIOMED BIOTECHNOL, V100, P919; Wang YH, 2010, BIORESOURCE TECHNOL, V101, P7529, DOI 10.1016/j.biortech.2010.04.070; [王永宏 WANG Yonghong], 2006, [西北农林科技大学学报. 自然科学版, Journal of northwest sci-tech university of agriculture and forestry], V34, P174; Wolfe AJ, 2008, J BACTERIOL, V190, P2314, DOI 10.1128/JB.01906-07; YANG XF, 2001, CHIN MICROBIOL, V28, P12; Yang XiuFen, 2006, Chinese Journal of Biological Control, V22, P58; Zhang CH, 2009, BIORESOURCE TECHNOL, V100, P4284, DOI 10.1016/j.biortech.2009.03.022	36	10	13	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e38421	10.1371/journal.pone.0038421	http://dx.doi.org/10.1371/journal.pone.0038421			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701637	Green Published, Green Submitted, gold			2022-12-27	WOS:000305348400054
J	Nordstrom, I; Eriksson, K				Nordstrom, Inger; Eriksson, Kristina			HHV-6B Induces IFN-Lambda1 Responses in Cord Plasmacytoid Dendritic Cells through TLR9	PLOS ONE			English	Article							IFN-LAMBDA-S; INTERLEUKIN (IL)-28; III IFN; EXPRESSION; RECOGNITION; ALPHA; OLIGODEOXYNUCLEOTIDES; INFECTIONS; MODULATION; ACTIVATION	Human herpesvirus type 6B (HHV-6B) is a strong inducer of IFN-alpha and has the capacity to promote Th1 responses and block Th2 responses in vitro. In this study we addressed whether inactivated HHV-6B can also induce IFN lambda responses and to what extent interferons alpha and lambda affect Th1/Th2 polarization. We show that inactivated HHV-6B induced IFN-lambda1 (IL-29) but not IFN-lambda2 (IL-28A) responses in plasmacytoid DC and that this induction was mediated through TLR9. We have previously shown that HHV-6B promotes Th1 responses and blocks Th2 responses in both humans and mice. We now show that neutralization of IFN-alpha but not IFN-lambda1 blocked the HHV-6B-induced enhancement of Th1 responses in MLR, but did not affect the HHV-6-induced dampening of Th2 responses. Similarly, blockage of TLR9 counteracted HHV-6Bs effects on the Th1/Th2 balance. In addition, IFN-alpha but not IFN-lambda1 promoted IFN-gamma production and blocked IL-5 and IL-13 production in purified CD4+ T-cells. The lack of effect of IFN-lambda1 correlated with the absence of the IFN-lambda receptor IL-28Ralfa chain on the cell surface of both resting and activated CD4+ T-cells. We conclude that inactivated HHV-6B is a strong inducer of IFN-lambda1 in plasmacytoid DC and that this induction is TLR9-dependent. However, human CD4+ T-cells do not express the IFN-lambda receptor and are refractory to IFN-lambda1 treatment. The HHV-6B-induced alterations in the Th1/Th2 balance are instead mediated mainly through TLR9 and IFN-alpha.	[Nordstrom, Inger; Eriksson, Kristina] Univ Gothenburg, Dept Rheumatol & Inflammat Res, Sahlgrenska Acad, Gothenburg, Sweden	University of Gothenburg	Nordstrom, I (corresponding author), Univ Gothenburg, Dept Rheumatol & Inflammat Res, Sahlgrenska Acad, Gothenburg, Sweden.	kristina.eriksson@microbio.gu.se			Swedish Science Council; Cancer och Allergifonden; Petrus och Augusta Hedlunds Stiftelse; IngaBritt och Arne Lundbergs Forskningsstiftelse; Vastra Gotalandsregionen through the ALF	Swedish Science Council; Cancer och Allergifonden; Petrus och Augusta Hedlunds Stiftelse; IngaBritt och Arne Lundbergs Forskningsstiftelse; Vastra Gotalandsregionen through the ALF	These studies were supported by the Swedish Science Council, Cancer och Allergifonden, Petrus och Augusta Hedlunds Stiftelse, IngaBritt och Arne Lundbergs Forskningsstiftelse, and Vastra Gotalandsregionen through the ALF agreement. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ank N, 2006, J VIROL, V80, P4501, DOI 10.1128/JVI.80.9.4501-4509.2006; Arasteh J, 2010, IMMUNOPHARM IMMUNOT, V32, P339, DOI 10.3109/08923970903317445; Dai JH, 2009, BLOOD, V113, P5829, DOI 10.1182/blood-2008-09-179507; Dumoutier L, 2004, J BIOL CHEM, V279, P32269, DOI 10.1074/jbc.M404789200; Farkas L, 2004, J ALLERGY CLIN IMMUN, V114, P436, DOI 10.1016/j.jaci.2004.04.035; Fiola S, 2010, J IMMUNOL, V185, P3620, DOI 10.4049/jimmunol.0903736; Izaguirre A, 2003, J LEUKOCYTE BIOL, V74, P1125, DOI 10.1189/jlb.0603255; Jordan WJ, 2007, GENES IMMUN, V8, P254, DOI 10.1038/sj.gene.6364382; Jordan WJ, 2007, GENES IMMUN, V8, P13, DOI 10.1038/sj.gene.6364348; Koltsida O, 2011, EMBO MOL MED, V3, P348, DOI 10.1002/emmm.201100142; Kotenko SV, 2011, CURR OPIN IMMUNOL, V23, P583, DOI 10.1016/j.coi.2011.07.007; Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875; Lin SC, 2012, EUR J CLIN INVEST, V42, P61, DOI 10.1111/j.1365-2362.2011.02557.x; Liu BS, 2011, BLOOD, V117, P2385, DOI 10.1182/blood-2010-07-298976; Lund J, 2003, J EXP MED, V198, P513, DOI 10.1084/jem.20030162; Megjugorac NJ, 2009, J LEUKOCYTE BIOL, V86, P1359, DOI 10.1189/jlb.0509347; Mordstein M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000151; Nguyen KB, 2002, SCIENCE, V297, P2063, DOI 10.1126/science.1074900; Nordstrom I, 2010, CLIN EXP ALLERGY, V40, P882, DOI 10.1111/j.1365-2222.2010.03491.x; Osterlund PI, 2007, J IMMUNOL, V179, P3434, DOI 10.4049/jimmunol.179.6.3434; Peter M, 2008, IMMUNOLOGY, V123, P118, DOI 10.1111/j.1365-2567.2007.02718.x; Pien GC, 2002, J IMMUNOL, V169, P5827, DOI 10.4049/jimmunol.169.10.5827; Sheppard P, 2003, NAT IMMUNOL, V4, P63, DOI 10.1038/ni873; Sommereyns C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000017; Srinivas S, 2008, IMMUNOLOGY, V125, P492, DOI 10.1111/j.1365-2567.2008.02862.x; Svensson A, 2011, SCAND J IMM IN PRESS; SVENSSON A, 2010, J ALLERGY THERAPY, V1, P101; Xu XA, 1996, SCIENCE, V273, P794, DOI 10.1126/science.273.5276.794; Yu HR, 2011, CELL MOL IMMUNOL, V8, P181, DOI 10.1038/cmi.2010.84	29	10	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e38683	10.1371/journal.pone.0038683	http://dx.doi.org/10.1371/journal.pone.0038683			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701693	gold, Green Published, Green Submitted			2022-12-27	WOS:000305348400085
J	Padilla-Gamino, JL; Pochon, X; Bird, C; Concepcion, GT; Gates, RD				Padilla-Gamino, Jacqueline L.; Pochon, Xavier; Bird, Christopher; Concepcion, Gregory T.; Gates, Ruth D.			From Parent to Gamete: Vertical Transmission of Symbiodinium (Dinophyceae) ITS2 Sequence Assemblages in the Reef Building Coral Montipora capitata	PLOS ONE			English	Article							ALGAL SYMBIOSIS; ACROPORA CORALS; PLANULA LARVAE; DIVERSITY; SPECIFICITY; ZOOXANTHELLAE; PATTERNS; ACQUISITION; CARBON; ASSOCIATIONS	Parental effects are ubiquitous in nature and in many organisms play a particularly critical role in the transfer of symbionts across generations; however, their influence and relative importance in the marine environment has rarely been considered. Coral reefs are biologically diverse and productive marine ecosystems, whose success is framed by symbiosis between reef-building corals and unicellular dinoflagellates in the genus Symbiodinium. Many corals produce aposymbiotic larvae that are infected by Symbiodinium from the environment (horizontal transmission), which allows for the acquisition of new endosymbionts (different from their parents) each generation. In the remaining species, Symbiodinium are transmitted directly from parent to offspring via eggs (vertical transmission), a mechanism that perpetuates the relationship between some or all of the Symbiodinium diversity found in the parent through multiple generations. Here we examine vertical transmission in the Hawaiian coral Montipora capitata by comparing the Symbiodinium ITS2 sequence assemblages in parent colonies and the eggs they produce. Parental effects on sequence assemblages in eggs are explored in the context of the coral genotype, colony morphology, and the environment of parent colonies. Our results indicate that ITS2 sequence assemblages in eggs are generally similar to their parents, and patterns in parental assemblages are different, and reflect environmental conditions, but not colony morphology or coral genotype. We conclude that eggs released by parent colonies during mass spawning events are seeded with different ITS2 sequence assemblages, which encompass phylogenetic variability that may have profound implications for the development, settlement and survival of coral offspring.	[Padilla-Gamino, Jacqueline L.; Pochon, Xavier; Bird, Christopher; Concepcion, Gregory T.; Gates, Ruth D.] Univ Hawaii, Hawaii Inst Marine Biol, Kaneohe, HI USA; [Padilla-Gamino, Jacqueline L.] Univ Hawaii Manoa, Dept Oceanog, Honolulu, HI 96822 USA; [Padilla-Gamino, Jacqueline L.] Univ Calif Santa Barbara, Santa Barbara, CA 93106 USA; [Pochon, Xavier] Cawthron Inst, Aquaculture & Biotechnol Div, Nelson, New Zealand; [Concepcion, Gregory T.] Univ Maryland, College Pk, MD 20742 USA	University of Hawaii System; University of Hawaii System; University of Hawaii Manoa; University of California System; University of California Santa Barbara; Cawthron Institute; University System of Maryland; University of Maryland College Park	Padilla-Gamino, JL (corresponding author), Univ Hawaii, Hawaii Inst Marine Biol, Kaneohe, HI USA.	jacqueline.padilla.gamino@lifesci.ucsb.edu	Pochon, Xavier/K-5844-2019	Pochon, Xavier/0000-0001-9510-0407	Mexican National Council for Science and Technology (CONACyT); World Bank Coral Reef Targeted Research Project; Center for Microbial Oceanography Research and Education (C-MORE); National Science Foundation [OCE-0752604, OIA-0554657]; Swiss National Science Foundation [PGBEA-115118]; Edwin Pauley Foundation; Directorate For Geosciences [0752604] Funding Source: National Science Foundation	Mexican National Council for Science and Technology (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); World Bank Coral Reef Targeted Research Project; Center for Microbial Oceanography Research and Education (C-MORE); National Science Foundation(National Science Foundation (NSF)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Edwin Pauley Foundation; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	LPG was supported by the Mexican National Council for Science and Technology (CONACyT), the World Bank Coral Reef Targeted Research Project (www.gefcoral.org) and the Center for Microbial Oceanography Research and Education (C-MORE). The research was funded by the National Science Foundation (OCE-0752604 to RDG and OIA-0554657 administered by the University of Hawai'i), the Swiss National Science Foundation (PGBEA-115118 to XP), and the Edwin Pauley Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrego D, 2008, P ROY SOC B-BIOL SCI, V275, P2273, DOI 10.1098/rspb.2008.0180; Abrego D, 2009, MOL ECOL, V18, P3532, DOI 10.1111/j.1365-294X.2009.04276.x; Allemand D, 2004, CR PALEVOL, V3, P453, DOI 10.1016/j.crpv.2004.07.011; Badyaev AV, 2009, PHILOS T R SOC B, V364, P1169, DOI 10.1098/rstb.2008.0302; Baird AH, 2009, ANNU REV ECOL EVOL S, V40, P551, DOI 10.1146/annurev.ecolsys.110308.120220; Baker AC, 2003, ANNU REV ECOL EVOL S, V34, P661, DOI 10.1146/annurev.ecolsys.34.011802.132417; Baker AC, 2004, NATURE, V430, P741, DOI 10.1038/430741a; Barneah O, 2004, MAR ECOL PROG SER, V275, P89, DOI 10.3354/meps275089; Berkelmans R, 2006, P ROY SOC B-BIOL SCI, V273, P2305, DOI 10.1098/rspb.2006.3567; Cantin NE, 2009, CORAL REEFS, V28, P405, DOI 10.1007/s00338-009-0478-8; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Coffroth MA, 2005, PROTIST, V156, P19, DOI 10.1016/j.protis.2005.02.004; Concepcion GT, 2006, MOL ECOL NOTES, V6, P1208, DOI 10.1111/j.1471-8286.2006.01493.x; Correa AMS, 2009, CORAL REEFS, V28, P81, DOI 10.1007/s00338-008-0456-6; Cox EF, 2007, CORAL REEFS, V26, P721, DOI 10.1007/s00338-007-0251-9; Csaszar NBM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009751; Donelson JM, 2009, BIOL LETTERS, V5, P262, DOI 10.1098/rsbl.2008.0642; Donohue K, 2009, PHILOS T R SOC B, V364, P1059, DOI 10.1098/rstb.2008.0291; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Garren M, 2006, CORAL REEFS, V25, P503, DOI 10.1007/s00338-006-0146-1; Ginzburg LR, 1998, MATERNAL EFFECTS AS ADAPTATIONS, P42; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Herre EA, 1999, TRENDS ECOL EVOL, V14, P49, DOI 10.1016/S0169-5347(98)01529-8; Heyward A.J., 1986, Hawaii Institute of Marine Biology Technical Report, P170; Hirose M, 2008, CORAL REEFS, V27, P247, DOI 10.1007/s00338-007-0330-y; Hirose M, 2001, CORAL REEFS, V20, P273; Hunter CL, 1988, P 6 INT COR REEF S, V2, P727; Iglesias-Prieto R, 2004, P ROY SOC B-BIOL SCI, V271, P1757, DOI 10.1098/rspb.2004.2757; Jokiel PL, 2004, GLOBAL CHANGE BIOL, V10, P1627, DOI 10.1111/j.1365-2486.2004.00836.x; JOKIEL PL, 1983, B MAR SCI, V33, P181; Kaniewska P, 2008, MAR BIOL, V155, P649, DOI 10.1007/s00227-008-1061-5; LaJeunesse TC, 2005, MOL BIOL EVOL, V22, P1158, DOI 10.1093/molbev/msi042; LaJeunesse TC, 2004, CORAL REEFS, V23, P596, DOI 10.1007/s00338-004-0428-4; Little AF, 2004, SCIENCE, V304, P1492, DOI 10.1126/science.1095733; Marshall DJ, 2008, OCEANOGR MAR BIOL, V46, P203, DOI 10.1201/9781420065756.ch5; Mousseau TA, 1998, TRENDS ECOL EVOL, V13, P403, DOI 10.1016/S0169-5347(98)01472-4; MUSCATINE L, 1984, PROC R SOC SER B-BIO, V222, P181, DOI 10.1098/rspb.1984.0058; MUSCATINE L, 1981, LIMNOL OCEANOGR, V26, P601, DOI 10.4319/lo.1981.26.4.0601; Oliver TA, 2009, MAR ECOL PROG SER, V378, P93, DOI 10.3354/meps07871; Padilla-Gamino JL, 2011, CORAL REEFS, V30, P371, DOI 10.1007/s00338-010-0700-8; Padilla-Gamino JL, 2012, MAR ECOL PROG SER, V449, P145, DOI 10.3354/meps09530; Pochon X, 2006, MOL PHYLOGENET EVOL, V38, P20, DOI 10.1016/j.ympev.2005.04.028; Pochon X, 2010, MOL PHYLOGENET EVOL, V56, P492, DOI 10.1016/j.ympev.2010.03.040; Pochon X, 2010, J PHYCOL, V46, P53, DOI 10.1111/j.1529-8817.2009.00797.x; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Raymond M, 1995, EVOLUTION, V49, P1280, DOI 10.1111/j.1558-5646.1995.tb04456.x; ROWAN R, 1995, P NATL ACAD SCI USA, V92, P2850, DOI 10.1073/pnas.92.7.2850; Rowan R, 2004, NATURE, V430, P742, DOI 10.1038/430742a; Russell JA, 2006, P ROY SOC B-BIOL SCI, V273, P603, DOI 10.1098/rspb.2005.3348; Santos Scott R., 2009, Galaxea - Tokyo, V11, P139; Smith DC, 1987, BIOL SYMBIOSIS; Stat M, 2008, CORAL REEFS, V27, P763, DOI 10.1007/s00338-008-0412-5; Stat M, 2008, P NATL ACAD SCI USA, V105, P9256, DOI 10.1073/pnas.0801328105; Stat Michael, 2011, Journal of Marine Biology, V2011, P1; Stat M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015854; Stat M, 2009, MAR ECOL PROG SER, V386, P83, DOI 10.3354/meps08080; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Thompson JD., 1994, COEVOLUTIONARY PROCE; Thornhill DJ, 2006, CORAL REEFS, V25, P515, DOI 10.1007/s00338-006-0157-y; Ulstrup KE, 2003, MOL ECOL, V12, P3477, DOI 10.1046/j.1365-294X.2003.01988.x; van Oppen M, 2001, CORAL REEFS, V20, P200, DOI 10.1007/s003380100167; Van Oppen MJH, 2006, MOL ECOL, V15, P3863, DOI 10.1111/j.1365-294X.2006.03026.x; van Oppen MJH, 2001, P ROY SOC B-BIOL SCI, V268, P1759, DOI 10.1098/rspb.2001.1733; Vautrin E, 2009, TRENDS MICROBIOL, V17, P95, DOI 10.1016/j.tim.2008.12.002; Wade MJ, 1998, MATERNAL EFFECTS AS ADAPTATIONS, P5; Weis VM, 2001, CORAL REEFS, V20, P301, DOI 10.1007/s003380100179; WOLDA H, 1981, OECOLOGIA, V50, P296, DOI 10.1007/BF00344966; WULFF RD, 1986, J ECOL, V74, P99, DOI 10.2307/2260351	70	54	55	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e38440	10.1371/journal.pone.0038440	http://dx.doi.org/10.1371/journal.pone.0038440			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701642	Green Published, gold, Green Submitted			2022-12-27	WOS:000305348400058
J	Sellebjerg, F; Krakauer, M; Limborg, S; Hesse, D; Lund, H; Langkilde, A; Sondergaard, HB; Sorensen, PS				Sellebjerg, Finn; Krakauer, Martin; Limborg, Signe; Hesse, Dan; Lund, Henrik; Langkilde, Annika; Sondergaard, Helle Bach; Sorensen, Per Soelberg			Endogenous and Recombinant Type I Interferons and Disease Activity in Multiple Sclerosis	PLOS ONE			English	Article							GENE-EXPRESSION ANALYSIS; T-CELL-ACTIVATION; BETA TREATMENT; PERIPHERAL-BLOOD; DOUBLE-BLIND; IFN-BETA; CORRELATE; THERAPY; MS; PROLIFERATION	Although treatment of multiple sclerosis (MS) with the type I interferon (IFN) IFN-beta lowers disease activity, the role of endogenous type I IFN in MS remains controversial. We studied CD4+ T cells and CD4+ T cell subsets, monocytes and dendritic cells by flow cytometry and analysed the relationship with endogenous type I IFN-like activity, the effect of IFN-beta therapy, and clinical and magnetic resonance imaging (MRI) disease activity in MS patients. Endogenous type I IFN activity was associated with decreased expression of the integrin subunit CD49d (VLA-4) on CD4+ CD26(high) T cells (Th1 helper cells), and this effect was associated with less MRI disease activity. IFN-beta therapy reduced CD49d expression on CD4+ CD26(high) T cells, and the percentage of CD4+ CD26(high) T cells that were CD49d(high) correlated with clinical and MRI disease activity in patients treated with IFN-beta. Treatment with IFN-beta also increased the percentage of CD4+ T cells expressing CD71 and HLA-DR (activated T cells), and this was associated with an increased risk of clinical disease activity. In contrast, induction of CD71 and HLA-DR was not observed in untreated MS patients with evidence of endogenous type IFN I activity. In conclusion, the effects of IFN-beta treatment and endogenous type I IFN activity on VLA-4 expression are similar and associated with control of disease activity. However, immune-activating effects of treatment with IFN-beta may counteract the beneficial effects of treatment and cause an insufficient response to therapy.	[Sellebjerg, Finn; Krakauer, Martin; Limborg, Signe; Hesse, Dan; Sondergaard, Helle Bach; Sorensen, Per Soelberg] Copenhagen Univ Hosp, Rigshosp, Dept Neurol, Danish Multiple Sclerosis Ctr, Copenhagen, Denmark; [Lund, Henrik] Univ Copenhagen, Hvidovre Hosp, Danish Res Ctr Magnet Resonance, DK-2650 Hvidovre, Denmark; [Langkilde, Annika] Copenhagen Univ Hosp, Rigshosp, Dept Radiol, Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; University of Copenhagen; Rigshospitalet; University of Copenhagen	Sellebjerg, F (corresponding author), Copenhagen Univ Hosp, Rigshosp, Dept Neurol, Danish Multiple Sclerosis Ctr, Copenhagen, Denmark.	sellebjerg@dadlnet.dk	Krakauer, Martin/M-4657-2019	Krakauer, Martin/0000-0002-2191-1861; Sorensen, Per Soelberg/0000-0002-2818-3780; Sellebjerg, Finn/0000-0002-1333-9623; Sondergaard, Helle Bach/0000-0001-9435-0658; Hesse, Dan/0000-0002-9670-6037	Danish Multiple Sclerosis Society; Warwara Larsen Foundation; Johnsen Foundation; Danish Council for Independent Research [271-06-0246]; Danish Council for Strategic Research [2142-08-0039]; Biogen Idec; Merck-Serono; Novartis; Sanofi-Aventis; Teva; Genmab; GSK; Bayer Schering; Baxter; BioMS; Bayer; RoFAR; Roche; Genzyme; Danish Medical Research Council; European Union Sixth Framework Programme: Life sciences, Genomics and Biotechnology for health	Danish Multiple Sclerosis Society; Warwara Larsen Foundation; Johnsen Foundation; Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); Biogen Idec(Biogen); Merck-Serono(Merck & Company); Novartis(Novartis); Sanofi-Aventis(Sanofi-Aventis); Teva(Teva Pharmaceutical Industries); Genmab(Genmab); GSK(GlaxoSmithKline); Bayer Schering(Bayer AG); Baxter; BioMS; Bayer(Bayer AG); RoFAR; Roche(Roche Holding); Genzyme(Sanofi-AventisGenzyme Corporation); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union Sixth Framework Programme: Life sciences, Genomics and Biotechnology for health	This study was supported by grants from the Danish Multiple Sclerosis Society, the Warwara Larsen Foundation, the Johnsen Foundation, the Danish Council for Independent Research [grant 271-06-0246] and the Danish Council for Strategic Research [grant 2142-08-0039]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Finn Sellebjerg has served on scientific advisory boards for and received funding for travel from Biogen Idec, Merck-Serono, Novartis, Sanofi-Aventis and Teva; served as a consultant for Biogen Idec and Novo Nordisk; received speaker honoraria from Bayer-Schering, Biogen Idec, Merck-Serono, Novartis, Sanofi-Aventis and Schering-Ploug; has received research support from Biogen Idec, Merck-Serono, Novartis and Sanofi-Aventis; and serves as section editor on Multiple Sclerosis and Related Disorders. Dan Hesse has received funding for travel from Biogen Idec, Merck-Serono, and Sanofi-Aventis; and received speaker honoraria from Sanofi-Aventis and Biogen Idec. Signe Limborg reports no disclosures. Helle Bach Sondergaard reports no disclosures. Martin Krakauer reports no disclosures. Per Soelberg Sorensen has served on scientific advisory boards Biogen Idec, Merck Serono, Novartis, Genmab, TEVA, Elan, GSK, has been on steering committees or independent data monitoring boards in clinical trials sponsored by Merck Serono, Genmab, TEVA, GSK, Bayer Schering, and has received funding of travel for these activities; has served as Editor-in-Chief of the European Journal of Neurology, and is editorial board member for Therapeutic Advances in Neurological Disorders and Multiple Sclerosis; has received speaker honoraria from Biogen Idec, Merck Serono, TEVA, Bayer Schering, Sanofi-aventis, and Novartis; and has received research support from Biogen Idec, Bayer Schering, Merck Serono, TEVA, Baxter, Sanofi-Aventis, BioMS, Novartis, Bayer, RoFAR, Roche, Genzyme, from the Danish Multiple Sclerosis Society, the Danish Medical Research Council, and the European Union Sixth Framework Programme: Life sciences, Genomics and Biotechnology for health. This does not alter our adherence to all the PLoS ONE policies on sharing data and materials.	Baecher-Allan C, 2001, J IMMUNOL, V167, P1245, DOI 10.4049/jimmunol.167.3.1245; Barrau MA, 2000, J NEUROIMMUNOL, V111, P215, DOI 10.1016/S0165-5728(00)00357-X; Buttmann M, 2007, J NEUROIMMUNOL, V190, P170, DOI 10.1016/j.jneuroim.2007.08.009; Calabresi PA, 1997, NEUROLOGY, V49, P1111, DOI 10.1212/WNL.49.4.1111; Comabella M, 2009, BRAIN, V132, P3353, DOI 10.1093/brain/awp228; Dhib-Jalbut S, 2010, NEUROLOGY, V74, pS17, DOI 10.1212/WNL.0b013e3181c97d99; DUQUETTE P, 1993, NEUROLOGY, V43, P655, DOI 10.1212/wnl.43.4.655; Ebers GC, 1998, LANCET, V352, P1498, DOI 10.1016/S0140-6736(98)03334-0; HAFLER DA, 1985, NEW ENGL J MED, V312, P1405, DOI 10.1056/NEJM198505303122201; Havenar-Daughton C, 2006, J IMMUNOL, V176, P3315, DOI 10.4049/jimmunol.176.6.3315; Hesse D, 2011, EUR J NEUROL, V18, P266, DOI 10.1111/j.1468-1331.2010.03116.x; Hesse D, 2010, NEUROLOGY, V74, P1455, DOI 10.1212/WNL.0b013e3181dc1a94; Jacobs LD, 1996, ANN NEUROL, V39, P285, DOI 10.1002/ana.410390304; Jensen J, 2006, J NEUROIMMUNOL, V179, P163, DOI 10.1016/j.jneuroim.2006.06.024; Jensen J, 2005, CYTOKINE, V29, P24, DOI 10.1016/j.cyto.2004.09.005; Jensen J, 2004, J NEUROIMMUNOL, V149, P202, DOI 10.1016/j.jneuroim.2003.12.019; Khoury SJ, 2000, ARCH NEUROL-CHICAGO, V57, P1183, DOI 10.1001/archneur.57.8.1183; Krakauer M, 2006, J NEUROIMMUNOL, V181, P157, DOI 10.1016/j.jneuroim.2006.09.006; Krakauer M, 2006, SCAND J IMMUNOL, V64, P155, DOI 10.1111/j.1365-3083.2006.01788.x; Krug A, 2003, J EXP MED, V197, P899, DOI 10.1084/jem.20021091; Lombardi G, 2000, J IMMUNOL, V165, P3782, DOI 10.4049/jimmunol.165.7.3782; Marrack P, 1999, J EXP MED, V189, P521, DOI 10.1084/jem.189.3.521; Michel L, 2008, J CLIN INVEST, V118, P3411, DOI 10.1172/JCI35365; Ossege LM, 2001, INT IMMUNOPHARMACOL, V1, P1085, DOI 10.1016/S1567-5769(01)00039-X; Ravnborg M, 2010, LANCET NEUROL, V9, P672, DOI 10.1016/S1474-4422(10)70132-0; Sellebjerg F, 2008, MULT SCLER J, V14, P615, DOI 10.1177/1352458507085976; Sellebjerg F, 2005, MULT SCLER J, V11, P641, DOI 10.1191/1352458505ms1217oa; Sellebjerg F, 2009, EUR J NEUROL, V16, P1291, DOI 10.1111/j.1468-1331.2009.02716.x; Sorensen PS, 2009, LANCET NEUROL, V8, P519, DOI 10.1016/S1474-4422(09)70085-7; Stetson DB, 2006, IMMUNITY, V25, P373, DOI 10.1016/j.immuni.2006.08.007; Tough DF, 1996, SCIENCE, V272, P1947, DOI 10.1126/science.272.5270.1947; van Baarsen LGM, 2006, GENES IMMUN, V7, P522, DOI 10.1038/sj.gene.6364324; van der Voort LF, 2010, NEUROLOGY, V75, P1228, DOI 10.1212/WNL.0b013e3181f6c556; Weinberg Andrew D., 2005, Current Drug Targets - Inflammation and Allergy, V4, P195, DOI 10.2174/1568010053586345; Weinstock-Guttman B, 2003, J IMMUNOL, V171, P2694, DOI 10.4049/jimmunol.171.5.2694; Weinstock-Guttman B, 2008, J NEUROIMMUNOL, V205, P113, DOI 10.1016/j.jneuroim.2008.09.004; Wiesemann E, 2008, MULT SCLER J, V14, P166, DOI 10.1177/1352458507081342; Yamaguchi KD, 2008, J NEUROIMMUNOL, V195, P116, DOI 10.1016/j.jneuroim.2007.12.007	38	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e35927	10.1371/journal.pone.0035927	http://dx.doi.org/10.1371/journal.pone.0035927			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701554	Green Published, gold, Green Submitted			2022-12-27	WOS:000305348400004
J	Hindell, MA; Lydersen, C; Hop, H; Kovacs, KM				Hindell, Mark A.; Lydersen, Christian; Hop, Haakon; Kovacs, Kit M.			Pre-Partum Diet of Adult Female Bearded Seals in Years of Contrasting Ice Conditions	PLOS ONE			English	Article							ERIGNATHUS-BARBATUS; STABLE-ISOTOPES; ZOOPLANKTON COMMUNITY; FORAGING STRATEGIES; MARINE MAMMALS; FEEDING-HABITS; PHOCA-HISPIDA; BERING-SEA; SVALBARD; BEHAVIOR	Changing patterns of sea-ice distribution and extent have measurable effects on polar marine systems. Beyond the obvious impacts of key-habitat loss, it is unclear how such changes will influence ice-associated marine mammals in part because of the logistical difficulties of studying foraging behaviour or other aspects of the ecology of large, mobile animals at sea during the polar winter. This study investigated the diet of pregnant bearded seals (Erignathus barbatus) during three spring breeding periods (2005, 2006 and 2007) with markedly contrasting ice conditions in Svalbard using stable isotopes (delta C-13 and delta N-15) measured in whiskers collected from their newborn pups. The delta N-15 values in the whiskers of individual seals ranged from 11.95 to 17.45 parts per thousand, spanning almost 2 full trophic levels. Some seals were clearly dietary specialists, despite the species being characterised overall as a generalist predator. This may buffer bearded seal populations from the changes in prey distributions lower in the marine food web which seems to accompany continued changes in temperature and ice cover. Comparisons with isotopic signatures of known prey, suggested that benthic gastropods and decapods were the most common prey. Bayesian isotopic mixing models indicated that diet varied considerably among years. In the year with most fast-ice (2005), the seals had the greatest proportion of pelagic fish and lowest benthic invertebrate content, and during the year with the least ice (2006), the seals ate more benthic invertebrates and less pelagic fish. This suggests that the seals fed further offshore in years with greater ice cover, but moved in to the fjords when ice-cover was minimal, giving them access to different types of prey. Long-term trends of sea ice decline, earlier ice melt, and increased water temperatures in the Arctic are likely to have ecosystem-wide effects, including impacts on the forage bases of pagophilic seals.	[Hindell, Mark A.] Univ Tasmania, Inst Marine & Antarctic Studies, Sandy Bay, Tas, Australia; [Lydersen, Christian; Hop, Haakon; Kovacs, Kit M.] Norwegian Polar Res Inst, Tromso, Norway	University of Tasmania; Norwegian Polar Institute	Hindell, MA (corresponding author), Univ Tasmania, Inst Marine & Antarctic Studies, Sandy Bay, Tas, Australia.	mark.hindell@utas.edu.au	Hindell, Mark A/C-8368-2013; Hindell, Mark A/K-1131-2013	Hindell, Mark/0000-0002-7823-7185	Norwegian Research Council; Norwegian Polar Institute; Australian Academy of Science	Norwegian Research Council(Research Council of NorwayEuropean Commission); Norwegian Polar Institute; Australian Academy of Science	Funding came from the Norwegian Research Council, the Norwegian Polar Institute and the Australian Academy of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTONELIS GA, 1994, ARCTIC, V47, P74; Bearhop S, 2004, J ANIM ECOL, V73, P1007, DOI 10.1111/j.0021-8790.2004.00861.x; Bluhm BA, 2008, ECOL APPL, V18, pS77, DOI 10.1890/06-0562.1; Bowman DMJS, 2010, J BIOGEOGR, V37, P499, DOI 10.1111/j.1365-2699.2009.02206.x; Bradshaw CJA, 2004, ANIM BEHAV, V68, P1349, DOI 10.1016/j.anbehav.2003.12.013; Casper RM, 2006, J EXP MAR BIOL ECOL, V328, P228, DOI 10.1016/j.jembe.2005.07.009; Cherel Y, 2005, ECOLOGY, V86, P2881, DOI 10.1890/05-0562; Cherel Y, 2009, BIOL LETTERS, V5, P830, DOI 10.1098/rsbl.2009.0552; Cooper MH, 2009, POLAR BIOL, V32, P1137, DOI 10.1007/s00300-009-0614-5; Cottier FR, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029948; Dehn LA, 2007, POLAR BIOL, V30, P167, DOI 10.1007/s00300-006-0171-0; Ellingsen IH, 2008, CLIMATIC CHANGE, V87, P155, DOI 10.1007/s10584-007-9369-6; Field I, 2001, ANTARCT SCI, V13, P371, DOI 10.1017/S0954102001000529; Gjertz I, 2000, POLAR BIOL, V23, P559, DOI 10.1007/s003000000121; Gjertz I, 2000, POLAR BIOL, V23, P651, DOI 10.1007/s003000000143; Gradinger RR, 2004, POLAR BIOL, V27, P595, DOI 10.1007/s00300-004-0630-4; Greaves DK, 2004, MAR MAMMAL SCI, V20, P296, DOI 10.1111/j.1748-7692.2004.tb01158.x; Grebmeier JM, 2006, PROG OCEANOGR, V71, P331, DOI 10.1016/j.pocean.2006.10.001; Grebmeier JM, 2006, SCIENCE, V311, P1461, DOI 10.1126/science.1121365; GREBMEIER JM, 2010, EOS, V91, P161, DOI DOI 10.1029/2010EO180001; Hirons AC, 2001, CAN J ZOOL, V79, P1053, DOI 10.1139/z01-055; Hjelset AM, 1999, POLAR BIOL, V21, P186, DOI 10.1007/s003000050351; Hobson KA, 2004, MAR MAMMAL SCI, V20, P621, DOI 10.1111/j.1748-7692.2004.tb01183.x; HOBSON KA, 1992, MAR ECOL PROG SER, V84, P9, DOI 10.3354/meps084009; Jackson AL, 2009, ECOL LETT, V12, pE1, DOI 10.1111/j.1461-0248.2008.01233.x; Kovacs Kit M., 2008, Science Progress, V91, P117, DOI 10.3184/003685008X324010; Kovacs KM, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P97; Kovacs KM, 1996, J MAMMAL, V77, P1085, DOI 10.2307/1382789; Krafft BA, 2000, CAN J ZOOL, V78, P1408, DOI 10.1139/cjz-78-8-1408; Laidre KL, 2008, ECOL APPL, V18, pS97, DOI 10.1890/06-0546.1; Lavigne D.M., 1988, HARPS HOODS ICE BREE; Lydersen C, 1996, J COMP PHYSIOL B, V166, P405, DOI 10.1007/BF02337884; LYDERSEN C, 1994, CAN J ZOOL, V72, P96, DOI 10.1139/z94-013; Lydersen C, 2001, J MAMMAL, V82, P225, DOI 10.1644/1545-1542(2001)082<0225:RCBEBA>2.0.CO;2; Lydersen C, 1999, MAR ECOL PROG SER, V187, P265, DOI 10.3354/meps187265; MARKUS T, 2009, J GEOPHYS RES OCEANS, V114; Marshall CD, 2006, ANAT REC PART A, V288A, P13, DOI 10.1002/ar.a.20273; Marshall CD, 2008, J EXP BIOL, V211, P699, DOI 10.1242/jeb.009852; Maslanik JA, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL032043; Moore JW, 2008, ECOL LETT, V11, P470, DOI 10.1111/j.1461-0248.2008.01163.x; Mueter FJ, 2008, ECOL APPL, V18, P309, DOI 10.1890/07-0564.1; Newland C., 2010, MARINE ECOLOGY PROGR, V424, P247; Newsome SD, 2010, MARINE MAMMAL SCI, P9999; Newsome SD, 2007, FRONT ECOL ENVIRON, V5, P429, DOI 10.1890/060150.1; Pauly D, 1998, ICES J MAR SCI, V55, P467, DOI 10.1006/jmsc.1997.0280; Phillips DL, 2005, OECOLOGIA, V144, P520, DOI [10.1007/s00442-004-1816-8, 10.1007/s000442-004-1816-8]; Robinson PW, 2007, DEEP SEA RES 2; Semmens BX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006187; Smith T., 1987, CANADIAN B FISHERIES, V216, P1; Soreide JE, 2006, MAR ECOL PROG SER, V328, P17, DOI 10.3354/meps328017; Soreide JE, 2006, PROG OCEANOGR, V71, P59, DOI 10.1016/j.pocean.2006.06.001; Stirling I, 1997, J MARINE SYST, V10, P9, DOI 10.1016/S0924-7963(96)00054-1; Tverberg V, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC005106; Walkusz W, 2009, POLAR RES, V28, P254, DOI 10.1111/j.1751-8369.2009.00107.x; Walsh JE, 2008, ECOL APPL, V18, pS3, DOI 10.1890/06-0503.1; Wang MY, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL037820; Wassmann P, 2006, PROG OCEANOGR, V71, P232, DOI 10.1016/j.pocean.2006.10.003; West JB, 2006, TRENDS ECOL EVOL, V21, P408, DOI 10.1016/j.tree.2006.04.002; Willis KJ, 2008, POLAR BIOL, V31, P475, DOI 10.1007/s00300-007-0373-0	59	24	24	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38307	10.1371/journal.pone.0038307	http://dx.doi.org/10.1371/journal.pone.0038307			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693616	gold, Green Published			2022-12-27	WOS:000305338500127
J	Turner, P; Turner, C; Jankhot, A; Helen, N; Lee, SJ; Day, NP; White, NJ; Nosten, F; Goldblatt, D				Turner, Paul; Turner, Claudia; Jankhot, Auscharee; Helen, Naw; Lee, Sue J.; Day, Nicholas P.; White, Nicholas J.; Nosten, Francois; Goldblatt, David			A Longitudinal Study of Streptococcus pneumoniae Carriage in a Cohort of Infants and Their Mothers on the Thailand-Myanmar Border	PLOS ONE			English	Article							UPPER RESPIRATORY-TRACT; PNEUMOCOCCAL CONJUGATE VACCINE; NASOPHARYNGEAL CARRIAGE; HAEMOPHILUS-INFLUENZAE; EPIDEMIOLOGIC EVIDENCE; LATEX AGGLUTINATION; ACQUIRED-IMMUNITY; INVASIVE DISEASE; CHILDREN YOUNGER; COLONIZATION	Background: Pneumococcal disease is a major cause of childhood death. Almost a third of the world's children live in Southeast Asia, but there are few data from the region on pneumococcal colonization or disease. Our aim was to document the dynamics of pneumococcal carriage in a rural SE Asian birth cohort. Methods: We studied 234 Karen mother-infant pairs in Northwestern Thailand. Infants were followed from birth and nasopharyngeal swabs were taken from mother and infant at monthly intervals until 24 months old. Results: 8,386 swabs were cultured and 4,396 pneumococci characterized. Infants became colonized early (median 45.5 days; 95% confidence interval [CI] 44.5-46.0) and by 24 months had a median of seven (range 0-15) carriage episodes. Maternal smoking and young children in the house were associated with earlier colonization (hazard ratio [HR] 1.5 (95% CI 1.1-2.1) and 1.4 (95% CI 1.0-1.9)). For the four commonest serotypes and non-typeable pneumococci, previous exposure to homologous or heterologous serotypes resulted in an extended interval to reacquisition of the same serotype. Previous colonization by serotypes 14 and 19F was also associated with reduced carriage duration if subsequently reacquired (HR [first reacquisition] 4.1 (95% CI 1.4-12.6) and 2.6 (1.5-4.7)). Mothers acquired pneumococci less frequently, and carried them for shorter periods, than infants (acquisition rate 0.5 vs. 1.1/100 person-days, p<0.001; median duration 31.0 vs. 60.5 days, p = 0.001). 55.8% of pneumococci from infants were vaccine serotypes (13-valent pneumococcal conjugate vaccine, PCV13), compared with 27.5% from mothers (p<0.001). Non-typeable pneumococcal carriage was common, being carried at least once by 55.1% of infants and 32.0% of mothers. Conclusions: Pneumococcal carriage frequency and duration are influenced by previous exposure to both homologous and heterologous serotypes. These data will inform vaccination strategies in this population.	[Turner, Paul; Turner, Claudia; Jankhot, Auscharee; Helen, Naw; Nosten, Francois] Shoklo Malaria Res Unit, Mae Sot, Thailand; [Turner, Paul; Turner, Claudia; Lee, Sue J.; Day, Nicholas P.; White, Nicholas J.; Nosten, Francois] Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand; [Turner, Paul; Turner, Claudia; Lee, Sue J.; Day, Nicholas P.; White, Nicholas J.; Nosten, Francois] Univ Oxford, Ctr Trop Med, Oxford, England; [Goldblatt, David] UCL, Inst Child Hlth, Immunobiol Unit, London, England	Mahidol University; Mahidol Oxford Tropical Medicine Research Unit (MORU); University of Oxford; University of London; University College London	Turner, P (corresponding author), Shoklo Malaria Res Unit, Mae Sot, Thailand.	pault@tropmedres.ac	White, Nick/AAC-6527-2019; Nosten, Francois/AAC-5509-2019; White, Nicholas J/I-4629-2012; Goldblatt, David/C-5972-2008	White, Nick/0000-0002-1897-1978; Nosten, Francois/0000-0002-7951-0745; Goldblatt, David/0000-0002-0769-5242; Turner, Paul/0000-0002-1013-7815	Wellcome Trust of Great Britain [083735/Z/07/Z]; National Institute for Health Research [NF-SI-0611-10066] Funding Source: researchfish	Wellcome Trust of Great Britain(Wellcome Trust); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by the Wellcome Trust of Great Britain (Grant No. 083735/Z/07/Z to PT). Shoklo Malaria Research Unit is part of the Mahidol Oxford University Research Unit supported by the Wellcome Trust of Great Britain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullahi O, 2008, PEDIATR INFECT DIS J, V27, P59, DOI 10.1097/INF.0b013e31814da70c; Adegbola RA, 2006, TROP MED INT HEALTH, V11, P1128, DOI 10.1111/j.1365-3156.2006.01652.x; ANIANSSON G, 1992, J INFECT DIS, V165, pS38, DOI 10.1093/infdis/165-Supplement_1-S38; [Anonymous], PNEUM ANT KIT INS; [Anonymous], 2011, 10 COUNTRIES INTRO A; Coles CL, 2001, PEDIATR INFECT DIS J, V20, P289, DOI 10.1097/00006454-200103000-00014; Darboe MK, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-195; Gill CJ, 2008, B WORLD HEALTH ORGAN, V86, P929, DOI 10.2471/BLT.07.049668; Granat SM, 2007, PEDIATR INFECT DIS J, V26, P319, DOI 10.1097/01.inf.0000257425.24492.11; Granat SM, 2009, J INFECT DIS, V200, P99, DOI 10.1086/599364; GRATTEN M, 1986, BIOL NEONATE, V50, P114, DOI 10.1159/000242576; GRAY BM, 1980, J INFECT DIS, V142, P923, DOI 10.1093/infdis/142.6.923; Greenwood B, 1999, PHILOS T R SOC B, V354, P777, DOI 10.1098/rstb.1999.0430; Guo Z, 2008, METHOD INFORM MED, V47, P107, DOI 10.3414/ME0478; Hanage WP, 2005, J BACTERIOL, V187, P6223, DOI 10.1128/JB.187.17.6223-6230.2005; Harrison LM, 1999, FEMS IMMUNOL MED MIC, V25, P19, DOI 10.1111/j.1574-695X.1999.tb01323.x; Hausdorff WP, 2000, CLIN INFECT DIS, V30, P100, DOI 10.1086/313608; Hill PC, 2008, CLIN INFECT DIS, V46, P807, DOI 10.1086/528688; Hill PC, 2006, CLIN INFECT DIS, V43, P673, DOI 10.1086/506941; Hussain M, 2005, EPIDEMIOL INFECT, V133, P891, DOI 10.1017/S0950268805004012; Jebaraj R, 1999, EPIDEMIOL INFECT, V123, P383, DOI 10.1017/S0950268899003131; LAFONG AC, 1988, J CLIN PATHOL, V41, P230, DOI 10.1136/jcp.41.2.230; LEACH AJ, 1994, PEDIATR INFECT DIS J, V13, P983, DOI 10.1097/00006454-199411000-00009; Lin TY, 2010, VACCINE, V28, P7589, DOI 10.1016/j.vaccine.2010.07.053; Lopez B, 1999, EUR J CLIN MICROBIOL, V18, P771, DOI 10.1007/s100960050399; Marsh R, 2010, J CLIN MICROBIOL, V48, P831, DOI 10.1128/JCM.01701-09; Mbelle N, 1999, J INFECT DIS, V180, P1171, DOI 10.1086/315009; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; O'Brien KL, 2003, PEDIATR INFECT DIS J, V22, P133, DOI [10.1097/00006454-200302000-00009, 10.1097/00006454-200302000-00010]; Park IH, 2007, INFECT IMMUN, V75, P4482, DOI 10.1128/IAI.00510-07; Salter SJ, 2012, MICROBIOLOG IN PRESS; Scott JR, 2012, J INFECT DIS, V205, P280, DOI 10.1093/infdis/jir730; Sleeman KL, 2005, PEDIATR INFECT DIS J, V24, P121, DOI 10.1097/01.inf.0000151030.10159.b1; Spellerberg B, 2007, MANUAL OF CLINICAL MICROBIOLOGY, 9TH ED, P412; Syrjanen RK, 2001, J INFECT DIS, V184, P451, DOI 10.1086/322048; Turner P, 2012, CLIN MICROB IN PRESS; Turner P, 2011, J CLIN MICROBIOL, V49, P1784, DOI 10.1128/JCM.00157-11; VENKATESWARAN PS, 1983, J INFECT DIS, V147, P1041, DOI 10.1093/infdis/147.6.1041; Vives M, 1997, PEDIATR INFECT DIS J, V16, P852, DOI 10.1097/00006454-199709000-00007; Watson K, 2006, PEDIATR INFECT DIS J, V25, P782, DOI 10.1097/01.inf.0000232705.49634.68; Weinberger DM, 2008, J INFECT DIS, V197, P1511, DOI 10.1086/587941; Weinberger DM, 2011, LANCET, V378, P1962, DOI 10.1016/S0140-6736(10)62225-8; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823	43	94	94	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38271	10.1371/journal.pone.0038271	http://dx.doi.org/10.1371/journal.pone.0038271			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693610	Green Published, gold, Green Submitted			2022-12-27	WOS:000305338500121
J	Mei, SY				Mei, Suyu			Multi-Label Multi-Kernel Transfer Learning for Human Protein Subcellular Localization	PLOS ONE			English	Article							GENE ONTOLOGY TERMS; ENSEMBLE CLASSIFIER; LOCATION PREDICTION; MPLOC; PLOC; DATABASE; ENHANCE; FUSION; GO	Recent years have witnessed much progress in computational modelling for protein subcellular localization. However, the existing sequence-based predictive models demonstrate moderate or unsatisfactory performance, and the gene ontology (GO) based models may take the risk of performance overestimation for novel proteins. Furthermore, many human proteins have multiple subcellular locations, which renders the computational modelling more complicated. Up to the present, there are far few researches specialized for predicting the subcellular localization of human proteins that may reside in multiple cellular compartments. In this paper, we propose a multi-label multi-kernel transfer learning model for human protein subcellular localization (MLMK-TLM). MLMK-TLM proposes a multi-label confusion matrix, formally formulates three multi-labelling performance measures and adapts one-against-all multi-class probabilistic outputs to multi-label learning scenario, based on which to further extends our published work GO-TLM (gene ontology based transfer learning model for protein subcellular localization) and MK-TLM (multi-kernel transfer learning based on Chou's PseAAC formulation for protein submitochondria localization) for multiplex human protein subcellular localization. With the advantages of proper homolog knowledge transfer, comprehensive survey of model performance for novel protein and multi-labelling capability, MLMK-TLM will gain more practical applicability. The experiments on human protein benchmark dataset show that MLMK-TLM significantly outperforms the baseline model and demonstrates good multi-labelling ability for novel human proteins. Some findings (predictions) are validated by the latest Swiss-Prot database. The software can be freely downloaded at http://soft.synu.edu.cn/upload/msy.rar.	Shenyang Normal Univ, Software Coll, Shenyang, Peoples R China	Shenyang Normal University	Mei, SY (corresponding author), Shenyang Normal Univ, Software Coll, Shenyang, Peoples R China.	061021053@fudan.edu.cn						Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Barrell D, 2009, NUCLEIC ACIDS RES, V37, pD396, DOI 10.1093/nar/gkn803; Blum T, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-274; Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095; Chou KC, 2004, BIOCHEM BIOPH RES CO, V320, P1236, DOI 10.1016/j.bbrc.2004.06.073; Chou KC, 2003, BIOCHEM BIOPH RES CO, V311, P743, DOI 10.1016/j.bbrc.2003.10.062; Chou KC, 2002, J BIOL CHEM, V277, P45765, DOI 10.1074/jbc.M204161200; Chou KC, 2008, NAT PROTOC, V3, P153, DOI 10.1038/nprot.2007.494; Chou KC, 2007, J PROTEOME RES, V6, P1728, DOI 10.1021/pr060635i; Chou KC, 2007, J CELL BIOCHEM, V100, P665, DOI 10.1002/jcb.21096; Chou KC, 2006, BIOCHEM BIOPH RES CO, V347, P150, DOI 10.1016/j.bbrc.2006.06.059; Chou KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018258; Chou KC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011335; Dai W., 2007, P 24 INT C MACH LEAR; Dai W, 2008, ADV NEURAL INFORM PR, V21; Garg A, 2005, J BIOL CHEM, V280, P14427, DOI 10.1074/jbc.M411789200; Hoglund A, 2006, BIOINFORMATICS, V22, P1158, DOI 10.1093/bioinformatics/btl002; Huang WL, 2009, BIOSYSTEMS, V98, P73, DOI 10.1016/j.biosystems.2009.06.007; Huang WL, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-80; Lee K, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn619; Mak MW, 2008, IEEE ACM T COMPUT BI, V5, P416, DOI 10.1109/TCBB.2007.70256; Mei SY, 2012, J THEOR BIOL, V293, P121, DOI 10.1016/j.jtbi.2011.10.015; Mei SY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-44; Mei SY, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S17; Pan SJ, 2010, IEEE T KNOWL DATA EN, V22, P1345, DOI 10.1109/TKDE.2009.191; Pierleoni A, 2006, BIOINFORMATICS, V22, pE408, DOI 10.1093/bioinformatics/btl222; Platt J., 1999, ADV LARGE MARGIN CLA; Rajendran L, 2010, NAT REV DRUG DISCOV, V9, P29, DOI 10.1038/nrd2897; Shen HB, 2007, AMINO ACIDS, V33, P57, DOI 10.1007/s00726-006-0478-8; Shen HB, 2010, J BIOMOLECULAR STRUC, V28, P0739; Shen HB, 2007, BIOCHEM BIOPH RES CO, V355, P1006, DOI 10.1016/j.bbrc.2007.02.071; Shen HB, 2010, J THEOR BIOL, V264, P326, DOI 10.1016/j.jtbi.2010.01.018; Shen HB, 2009, ANAL BIOCHEM, V394, P269, DOI 10.1016/j.ab.2009.07.046; Tu Y, 2002, P NATL ACAD SCI USA, V99, P14031, DOI 10.1073/pnas.222164199; Tung TQ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S43; van Dijk ADJ, 2008, BIOINFORMATICS, V24, P1779, DOI 10.1093/bioinformatics/btn309; Wu TF, 2004, J MACH LEARN RES, V5, P975; Xiao X, 2011, J THEOR BIOL, V284, P42, DOI 10.1016/j.jtbi.2011.06.005; Xiao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020592; Yang Q., 2009, P JOINT C 47 ANN M A, P1; Zhu L, 2009, PROTEIN J, V28, P384, DOI 10.1007/s10930-009-9205-0	41	28	28	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e37716	10.1371/journal.pone.0037716	http://dx.doi.org/10.1371/journal.pone.0037716			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22719847	Green Submitted, Green Published, gold			2022-12-27	WOS:000305341900013
J	Sampey, BP; Freemerman, AJ; Zhang, J; Kuan, PF; Galanko, JA; O'Connell, TM; Ilkayeva, OR; Muehlbauer, MJ; Stevens, RD; Newgard, CB; Brauer, HA; Troester, MA; Makowski, L				Sampey, Brante P.; Freemerman, Alex J.; Zhang, Jimmy; Kuan, Pei-Fen; Galanko, Joseph A.; O'Connell, Thomas M.; Ilkayeva, Olga R.; Muehlbauer, Michael J.; Stevens, Robert D.; Newgard, Christopher B.; Brauer, Heather A.; Troester, Melissa A.; Makowski, Liza			Metabolomic Profiling Reveals Mitochondrial-Derived Lipid Biomarkers That Drive Obesity-Associated Inflammation	PLOS ONE			English	Article							SERUM-CHOLESTEROL CONCENTRATIONS; CORONARY-ARTERY-DISEASE; SATURATED FATTY-ACIDS; ADIPOSE-TISSUE; PALMITOLEIC ACID; RAPID DIAGNOSIS; INNATE IMMUNITY; BLOOD SPOTS; PLASMA; RISK	Obesity has reached epidemic proportions worldwide. Several animal models of obesity exist, but studies are lacking that compare traditional lard-based high fat diets (HFD) to "Cafeteria diets" (CAF) consisting of nutrient poor human junk food. Our previous work demonstrated the rapid and severe obesogenic and inflammatory consequences of CAF compared to HFD including rapid weight gain, markers of Metabolic Syndrome, multi-tissue lipid accumulation, and dramatic inflammation. To identify potential mediators of CAF-induced obesity and Metabolic Syndrome, we used metabolomic analysis to profile serum, muscle, and white adipose from rats fed CAF, HFD, or standard control diets. Principle component analysis identified elevations in clusters of fatty acids and acylcarnitines. These increases in metabolites were associated with systemic mitochondrial dysfunction that paralleled weight gain, physiologic measures of Metabolic Syndrome, and tissue inflammation in CAF-fed rats. Spearman pairwise correlations between metabolites, physiologic, and histologic findings revealed strong correlations between elevated markers of inflammation in CAF-fed animals, measured as crown like structures in adipose, and specifically the pro-inflammatory saturated fatty acids and oxidation intermediates laurate and lauroyl carnitine. Treatment of bone marrow-derived macrophages with lauroyl carnitine polarized macrophages towards the M1 pro-inflammatory phenotype through downregulation of AMPK and secretion of pro-inflammatory cytokines. Results presented herein demonstrate that compared to a traditional HFD model, the CAF diet provides a robust model for diet-induced human obesity, which models Metabolic Syndrome-related mitochondrial dysfunction in serum, muscle, and adipose, along with pro-inflammatory metabolite alterations. These data also suggest that modifying the availability or metabolism of saturated fatty acids may limit the inflammation associated with obesity leading to Metabolic Syndrome.	[Sampey, Brante P.; Freemerman, Alex J.; Zhang, Jimmy; Makowski, Liza] Univ N Carolina, Sch Med, Dept Nutr, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA; [Kuan, Pei-Fen] Univ N Carolina, Dept Biostat, Sch Med, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA; [Brauer, Heather A.; Troester, Melissa A.] Univ N Carolina, Sch Med, Dept Epidemiol, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA; [Galanko, Joseph A.] Univ N Carolina, Dept Med, Chapel Hill, NC USA; [Kuan, Pei-Fen; Troester, Melissa A.; Makowski, Liza] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Ilkayeva, Olga R.; Muehlbauer, Michael J.; Stevens, Robert D.; Newgard, Christopher B.] Duke Univ, Med Ctr, Sarah W Stedman Nutr & Metab Ctr, Durham, NC USA; [Newgard, Christopher B.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC USA; [O'Connell, Thomas M.] LipoScience Inc, Raleigh, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Duke University; Duke University; LipoScience, Inc	Sampey, BP (corresponding author), Metabolon Inc, Durham, NC USA.	liza.makowski@unc.edu	Kuan, Pei Fen/GRX-4622-2022	Sampey, Brante/0000-0001-7765-0667; Makowski, Liza/0000-0002-5337-8037; Brauer, Heather Ann/0000-0003-4394-1508	Lineberger Comprehensive Cancer Center University Cancer Research Funds; National Institutes of Health (NIH) [PO1DK58398]; Freedom to Discover Award from Bristol Meyers Squibb; NIH National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [P30DK056350, P30DK034987]; Bristol Meyers Squibb;  [AA017376];  [ES019472]; NATIONAL CANCER INSTITUTE [P50CA058223] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034987, P30DK056350, P01DK058398] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES019472, P30ES010126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R00AA017376, K99AA017376] Funding Source: NIH RePORTER	Lineberger Comprehensive Cancer Center University Cancer Research Funds; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Freedom to Discover Award from Bristol Meyers Squibb; NIH National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Bristol Meyers Squibb(Bristol-Myers Squibb); ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	The project was funded by AA017376 (http://www.niaaa.nih.gov/Pages/default.aspx), ES019472 (http://www.niehs.nih.gov/), and Lineberger Comprehensive Cancer Center University Cancer Research Funds (http://unclineberger.org/ucrf) to L. M. and National Institutes of Health (NIH) grant PO1DK58398 (http://www2.niddk.nih.gov/) and a Freedom to Discover Award from Bristol Meyers Squibb (http://www.bms.com/foundation/what_we_support/Pages/ftd_grants_awards.aspx) to C.B.N. This project is supported in part by NIH National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) grants (http://www2.niddk.nih.gov/) P30DK056350 to the UNC-CH Nutrition Obesity Research Center (L. M., J.A.G.) (http://www.sph.unc.edu/cnrc/) and P30DK034987 to the Center for Gastrointestinal Biology and Disease (L. M., J.A.G.) (https://cgibd.med.unc.edu/index.php). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors declare the following interests: The project was partially funded by A Freedom to Discover Award from Bristol Meyers Squibb (http://www.bms.com/foundation/what_we_support/Pages/ftd_grants_awards.aspx) to C.B.N. B. P. S. and T.M.O. were employed at UNC while analysis of this manuscript was completed, and currently are employed by Metabolon, Inc. and Liposcience, Inc., respectively. There are no declarations relating to employment, consultancy, patents or products in development or marketed products, etc. with regard to this work. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Adams SH, 2009, J NUTR, V139, P1073, DOI 10.3945/jn.108.103754; An J, 2004, NAT MED, V10, P268, DOI 10.1038/nm995; Babio N, 2009, NUTR METAB CARDIOVAS, V19, P563, DOI 10.1016/j.numecd.2008.10.007; Bain JR, 2009, DIABETES, V58, P2429, DOI 10.2337/db09-0580; Bradbury KE, 2010, AM J CLIN NUTR, V91, P398, DOI 10.3945/ajcn.2009.28159; Calder PC, 2008, P NUTR SOC, V67, P409, DOI 10.1017/S0029665108008690; Calle EE, 2004, NAT REV CANCER, V4, P579, DOI 10.1038/nrc1408; Cao HM, 2008, CELL, V134, P933, DOI 10.1016/j.cell.2008.07.048; CHACE DH, 1995, CLIN CHEM, V41, P62; CHACE DH, 1993, CLIN CHEM, V39, P66; Cocchi M, 1993, 3D QSAR DRUG DESIGN, V1; Crowe FL, 2006, AM J CLIN NUTR, V83, P887, DOI 10.1093/ajcn/83.4.887; Dasu MR, 2008, DIABETES, V57, P3090, DOI 10.2337/db08-0564; Davis JE, 2008, OBESITY, V16, P1248, DOI 10.1038/oby.2008.210; Deshmukh-Taskar PR, 2009, PUBLIC HEALTH NUTR, V12, P2493, DOI 10.1017/S1368980009991261; Edfeldt K, 2002, CIRCULATION, V105, P1158, DOI 10.1161/circ.105.10.1158; Fernandez-Real JM, 2005, CLIN CHEM, V51, P603, DOI 10.1373/clinchem.2004.041350; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Fogli-Cawley JJ, 2007, AM J CLIN NUTR, V86, P1193, DOI 10.1093/ajcn/86.4.1193; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Hirasawa A, 2005, NAT MED, V11, P90, DOI 10.1038/nm1168; Hotamisligil GS, 2008, NAT REV IMMUNOL, V8, P923, DOI 10.1038/nri2449; Hotamisligil GS, 2003, INT J OBESITY, V27, pS53, DOI 10.1038/sj.ijo.0802502; Huffman KM, 2011, DIABETES CARE, V34, P174, DOI 10.2337/dc10-0709; Huffman KM, 2009, DIABETES CARE, V32, P1678, DOI 10.2337/dc08-2075; Itoh Y, 2003, NATURE, V422, P173, DOI 10.1038/nature01478; Jensen MD, 2007, HORM METAB RES, V39, P722, DOI 10.1055/s-2007-990274; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Koves TR, 2005, J BIOL CHEM, V280, P33588, DOI 10.1074/jbc.M507621200; Lee JY, 2004, J BIOL CHEM, V279, P16971, DOI 10.1074/jbc.M312990200; Lee JY, 2001, J BIOL CHEM, V276, P16683, DOI 10.1074/jbc.M011695200; Lee JY, 2003, J BIOL CHEM, V278, P37041, DOI 10.1074/jbc.M305213200; Lien LF, 2009, OMICS, V13, P21, DOI 10.1089/omi.2008.0035; Lum H, 2011, J GERONTOL A-BIOL, V66, P548, DOI 10.1093/gerona/glr006; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lumeng CN, 2009, NAT MED, V15, P846, DOI 10.1038/nm0809-846; Makowski L, 2004, J NUTR, V134, p2464S, DOI 10.1093/jn/134.9.2464S; Makowski L, 2009, FASEB J, V23, P586, DOI 10.1096/fj.08-119420; McGuinness OP, 2005, ANNU REV NUTR, V25, P9, DOI 10.1146/annurev.nutr.24.012003.132159; Millington DS, 2011, METHODS MOL BIOL, V708, P55, DOI 10.1007/978-1-61737-985-7_3; MILLINGTON DS, 1992, PROG CLIN BIOL RES, V375, P339; Mozaffarian D, 2010, ANN INTERN MED, V153, P790, DOI 10.7326/0003-4819-153-12-201012210-00005; Mozaffarian D, 2010, AM J CLIN NUTR, V92, P1350, DOI 10.3945/ajcn.110.003970; Newgard CB, 2012, CELL METAB IN PRESS; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Nielsen S, 2004, J CLIN INVEST, V113, P1582, DOI [10.1172/JCI200421047, 10.1172/JCI21047]; Noland RC, 2009, J BIOL CHEM, V284, P22840, DOI 10.1074/jbc.M109.032888; Odegaard JI, 2011, ANNU REV PATHOL-MECH, V6, P275, DOI 10.1146/annurev-pathol-011110-130138; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Riccardi G, 2000, BRIT J NUTR, V83, pS143; Sag D, 2008, J IMMUNOL, V181, P8633, DOI 10.4049/jimmunol.181.12.8633; Sampey BP, 2011, OBESITY SILVER SPRIN; Sampey BP, 2011, OBESITY, V19, P1109, DOI 10.1038/oby.2011.18; Saraswathi V, 2007, J NUTR, V137, P1776, DOI 10.1093/jn/137.7.1776; Schaffaler A, 2010, TRENDS IMMUNOL, V31, P228, DOI 10.1016/j.it.2010.03.001; Schwartz EA, 2010, ARTERIOSCL THROM VAS, V30, P802, DOI 10.1161/ATVBAHA.109.201681; Shah SH, 2012, DIABETOLOGIA, V55, P321, DOI 10.1007/s00125-011-2356-5; Shah SH, 2011, CELL METAB, V13, P491, DOI 10.1016/j.cmet.2011.04.003; Shah SH, 2010, AM HEART J, V160, P371, DOI 10.1016/j.ahj.2010.06.051; Shah SH, 2010, CIRC-CARDIOVASC GENE, V3, P207, DOI 10.1161/CIRCGENETICS.109.852814; Shah SH, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.11; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Suganami T, 2010, J LEUKOCYTE BIOL, V88, P33, DOI 10.1189/jlb.0210072; Tazoe H, 2008, J PHYSIOL PHARMACOL, V59, P251; Todoric J, 2006, DIABETOLOGIA, V49, P2109, DOI 10.1007/s00125-006-0300-x; Trygg J, 2007, J PROTEOME RES, V6, P469, DOI 10.1021/pr060594q; Turer AT, 2009, CIRCULATION, V119, P1736, DOI 10.1161/CIRCULATIONAHA.108.816116; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Unger RH, 2010, BBA-MOL CELL BIOL L, V1801, P209, DOI 10.1016/j.bbalip.2009.10.006; Vats D, 2006, CELL METAB, V4, P13, DOI 10.1016/j.cmet.2006.05.011; Wall R, 2010, NUTR REV, V68, P280, DOI 10.1111/j.1753-4887.2010.00287.x; Weatherill AR, 2005, J IMMUNOL, V174, P5390, DOI 10.4049/jimmunol.174.9.5390; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wu JY, 2004, J CLIN INVEST, V113, P434, DOI 10.1172/JCI200419574; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yerlikaya H, 2011, CLIN LIPIDOL, V6, P615, DOI 10.2217/CLP.11.48; Yusof HM, 2008, PROSTAG LEUKOTR ESS, V78, P219, DOI 10.1016/j.plefa.2008.02.002	77	91	93	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2012	7	6							e38812	10.1371/journal.pone.0038812	http://dx.doi.org/10.1371/journal.pone.0038812			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UJ	22701716	Green Published, Green Submitted, gold			2022-12-27	WOS:000305340000048
J	Broach, WH; Egan, N; Wing, HJ; Payne, SM; Murphy, ER				Broach, William H.; Egan, Nicholas; Wing, Helen J.; Payne, Shelley M.; Murphy, Erin R.			VirF-Independent Regulation of Shigella virB Transcription is Mediated by the Small RNA RyhB	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEASE; III SECRETION SYSTEM; INVE GENE-EXPRESSION; H-NS; ESCHERICHIA-COLI; MESSENGER-RNA; INTRACELLULAR ENVIRONMENT; IRON-METABOLISM; VIBRIO-CHOLERAE; FLEXNERI	Infection of the human host by Shigella species requires the coordinated production of specific Shigella virulence factors, a process mediated largely by the VirF/VirB regulatory cascade. VirF promotes the transcription of virB, a gene encoding the transcriptional activator of several virulence-associated genes. This study reveals that transcription of virB is also regulated by the small RNA RyhB, and importantly, that this regulation is not achieved indirectly via modulation of VirF activity. These data are the first to demonstrate that the regulation of virB transcription can be uncoupled from the master regulator VirF. It is also established that efficient RyhB-dependent regulation of transcription is facilitated by specific nucleic acid sequences within virB. This study not only reveals RyhB-dependent regulation of virB transcription as a novel point of control in the central regulatory circuit modulating Shigella virulence, but also highlights the versatility of RyhB in controlling bacterial gene expression.	[Broach, William H.] Ohio Univ, Mol & Cellular Biol Program, Dept Biol Sci, Athens, OH 45701 USA; [Egan, Nicholas; Wing, Helen J.] Univ Nevada, Sch Life Sci, Las Vegas, NV 89154 USA; [Payne, Shelley M.] Univ Texas Austin, Sect Mol Genet & Microbiol, Austin, TX 78712 USA; [Murphy, Erin R.] Ohio Univ, Heritage Coll Osteopath Med, Dept Biomed Sci, Athens, OH 45701 USA	University System of Ohio; Ohio University; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; University of Texas System; University of Texas Austin; University System of Ohio; Ohio University	Broach, WH (corresponding author), Ohio Univ, Mol & Cellular Biol Program, Dept Biol Sci, Athens, OH 45701 USA.	murphye@ohio.edu		Murphy, Erin/0000-0002-5716-4829; Wing, Helen J./0000-0003-0123-5568	Ruth L. Kirschstein National Research Service Award National Institutes of Health (NIH) [8-FGM069312A]; Ohio University Research Committee; Ohio University Heritage College of Osteopathic Medicine; NIH [AI-16935, 5P20RR016464-10]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016464] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI016935, R01AI016935] Funding Source: NIH RePORTER	Ruth L. Kirschstein National Research Service Award National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ohio University Research Committee; Ohio University Heritage College of Osteopathic Medicine; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded in part by Ruth L. Kirschstein National Research Service Award National Institutes of Health (NIH) 8-FGM069312A, a grant from the Ohio University Research Committee and by the Ohio University Heritage College of Osteopathic Medicine (to ERM), as well as by NIH grants AI-16935 (to SMP) and 5P20RR016464-10 (to HJW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER B, 1989, MOL MICROBIOL, V3, P627, DOI 10.1111/j.1365-2958.1989.tb00210.x; Afonyushkin T, 2005, NUCLEIC ACIDS RES, V33, P1678, DOI 10.1093/nar/gki313; Africa LAA, 2011, INFECT IMMUN, V79, P4543, DOI 10.1128/IAI.05340-11; Castellanos MI, 2009, J BACTERIOL, V191, P4047, DOI 10.1128/JB.00313-09; CLERC P, 1988, CURR TOP MICROBIOL, V138, P3; Desnoyers G, 2009, EMBO J, V28, P1551, DOI 10.1038/emboj.2009.116; Dorman CJ, 1998, MOL MICROBIOL, V29, P677, DOI 10.1046/j.1365-2958.1998.00902.x; Falconi M, 1998, EMBO J, V17, P7033, DOI 10.1093/emboj/17.23.7033; Falconi M, 2001, MOL MICROBIOL, V42, P439, DOI 10.1046/j.1365-2958.2001.02646.x; FORMAL SB, 1958, J BACTERIOL, V75, P604, DOI 10.1128/JB.75.5.604-610.1958; GOLDBERG MB, 1994, INFECT IMMUN, V62, P5664, DOI 10.1128/IAI.62.12.5664-5668.1994; Gore AL, 2010, INFECT IMMUN, V78, P4674, DOI 10.1128/IAI.00589-10; Jennison AV, 2004, FEMS MICROBIOL REV, V28, P43, DOI 10.1016/j.femsre.2003.07.002; Le Gall T, 2005, MICROBIOL-SGM, V151, P951, DOI 10.1099/mic.0.27639-0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LODGE J, 1992, FEMS MICROBIOL LETT, V95, P271; Lucchini S, 2005, INFECT IMMUN, V73, P88, DOI 10.1128/IAI.73.1.88-102.2005; Masse E, 2002, P NATL ACAD SCI USA, V99, P4620, DOI 10.1073/pnas.032066599; Masse E, 2003, GENE DEV, V17, P2374, DOI 10.1101/gad.1127103; MILLER VL, 1988, J BACTERIOL, V170, P2575, DOI 10.1128/JB.170.6.2575-2583.1988; Mills M, 1997, INFECT IMMUN, V65, P5358, DOI 10.1128/IAI.65.12.5358-5363.1997; Mitobe J, 2005, J BACTERIOL, V187, P107, DOI 10.1128/JB.187.1.107-113.2005; Mitobe J, 2008, J BIOL CHEM, V283, P5738, DOI 10.1074/jbc.M710108200; Mitobe J, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-110; Murphy ER, 2007, INFECT IMMUN, V75, P3470, DOI 10.1128/IAI.00112-07; NAKAYAMA S, 1995, J BACTERIOL, V177, P5062, DOI 10.1128/jb.177.17.5062-5069.1995; OAKS EV, 1985, INFECT IMMUN, V48, P124, DOI 10.1128/IAI.48.1.124-129.1985; Oglesby AG, 2005, MOL MICROBIOL, V58, P1354, DOI 10.1111/j.1365-2958.2005.04920.x; Payne SM, 2006, BIOMETALS, V19, P173, DOI 10.1007/s10534-005-4577-x; PAYNE SM, 1977, INFECT IMMUN, V18, P94, DOI 10.1128/IAI.18.1.94-98.1977; Porter ME, 1997, MOL GEN GENET, V256, P93, DOI 10.1007/s004380050550; Porter ME, 1997, J BACTERIOL, V179, P6537, DOI 10.1128/jb.179.21.6537-6550.1997; Prevost K, 2007, MOL MICROBIOL, V64, P1260, DOI 10.1111/j.1365-2958.2007.05733.x; Prosseda G, 1998, RES MICROBIOL, V149, P15, DOI 10.1016/S0923-2508(97)83619-4; Runyen-Janecky LJ, 2002, INFECT IMMUN, V70, P4379, DOI 10.1128/IAI.70.8.4379-4388.2002; SAKAI T, 1988, MOL MICROBIOL, V2, P589, DOI 10.1111/j.1365-2958.1988.tb00067.x; Sambrook J., 2001, MOL CLONING LAB MANU; TOBE T, 1991, MOL MICROBIOL, V5, P887, DOI 10.1111/j.1365-2958.1991.tb00762.x; TOBE T, 1993, J BACTERIOL, V175, P6142, DOI 10.1128/JB.175.19.6142-6149.1993; Vecerek B, 2003, MOL MICROBIOL, V50, P897, DOI 10.1046/j.1365-2958.2003.03727.x; Wing HJ, 2004, J BACTERIOL, V186, P699, DOI 10.1128/JB.186.3.699-705.2004; Wyckoff EE, 2006, J BACTERIOL, V188, P6515, DOI 10.1128/JB.00626-06	42	26	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2012	7	6							e38592	10.1371/journal.pone.0038592	http://dx.doi.org/10.1371/journal.pone.0038592			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TU	22701677	Green Submitted, Green Published, gold			2022-12-27	WOS:000305337600032
J	Edwards, LM; Tyler, DJ; Kemp, GJ; Dwyer, RM; Johnson, A; Holloway, CJ; Nevill, AM; Clarke, K				Edwards, Lindsay M.; Tyler, Damian J.; Kemp, Graham J.; Dwyer, Renee M.; Johnson, Andrew; Holloway, Cameron J.; Nevill, Alan M.; Clarke, Kieran			The Reproducibility of 31-Phosphorus MRS Measures of Muscle Energetics at 3 Tesla in Trained Men	PLOS ONE			English	Article							PHOSPHOCREATINE RECOVERY KINETICS; MAGNETIC-RESONANCE-SPECTROSCOPY; SKELETAL-MUSCLE; MITOCHONDRIAL-FUNCTION; ATP HYDROLYSIS; P-31 MRS; IN-VIVO; ASSESSING AGREEMENT; OXIDATIVE CAPACITY; EXERCISE	Objective: Magnetic resonance spectroscopy (MRS) provides an exceptional opportunity for the study of in vivo metabolism. MRS is widely used to measure phosphorus metabolites in trained muscle, although there are no published data regarding its reproducibility in this specialized cohort. Thus, the aim of this study was to assess the reproducibility of 31 P-MRS in trained skeletal muscle. Methods: We recruited fifteen trained men (VO(2)peak = 4.7 +/- 0.8 L min(-1)/58 +/- 8 mL kg(-1) min(-1)) and performed duplicate MR experiments during plantar flexion exercise, three weeks apart. Results: Measures of resting phosphorus metabolites were reproducible, with 1.7 mM the smallest detectable difference in phosphocreatine (PCr). Measures of metabolites during exercise were less reliable: exercising PCr had a coefficient of variation (CV) of 27% during exercise, compared with 8% at rest. Estimates of mitochondrial function were variable, but experimentally useful. The CV of PCr1/2t was 40%, yet much of this variance was inter-subject such that differences of <20% were detectable with n = 15, given a significance threshold of p < 0.05. Conclusions: 31-phosphorus MRS provides reproducible and experimentally useful measures of phosphorus metabolites and mitochondrial function in trained human skeletal muscle.	[Edwards, Lindsay M.; Tyler, Damian J.; Clarke, Kieran] Univ Oxford, Dept Physiol Anat & Genet, Oxford, England; [Edwards, Lindsay M.; Tyler, Damian J.; Johnson, Andrew; Holloway, Cameron J.] John Radcliffe Hosp, Oxford Ctr Clin Magnet Resonance Res, Oxford OX3 9DU, England; [Kemp, Graham J.] Univ Liverpool, Dept Musculoskeletal Biol, Fac Hlth & Life Sci, Liverpool L69 3BX, Merseyside, England; [Dwyer, Renee M.] Univ Tasmania, Sch Med, Hobart, Tas, Australia; [Nevill, Alan M.] Wolverhampton Univ, Sch Sport Performing Arts & Leisure, Wolverhampton WV1 1DJ, W Midlands, England	University of Oxford; University of Oxford; University of Liverpool; University of Tasmania; University of Wolverhampton	Edwards, LM (corresponding author), Univ Oxford, Dept Physiol Anat & Genet, Oxford, England.	ledwards@essex.ac.uk	Nevill, Alan/Q-1010-2019; Kemp, Graham J/A-7540-2008	Nevill, Alan/0000-0003-0506-3652; Kemp, Graham J/0000-0002-8324-9666; Tyler, Damian/0000-0002-0780-8905	British Heart Foundation [RG/07/004/22659]; British Heart Foundation [FS/10/002/28078, PS/02/002/14893] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); British Heart Foundation(British Heart Foundation)	This work was funded by a Programme Grant from the British Heart Foundation (www.bhf.org.uk, grant code: RG/07/004/22659). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker A, 2006, EUR J APPL PHYSIOL, V98, P556, DOI 10.1007/s00421-006-0302-x; BEAVER WL, 1986, J APPL PHYSIOL, V60, P2020, DOI 10.1152/jappl.1986.60.6.2020; Bendahan D, 2002, BRIT J SPORT MED, V36, P282, DOI 10.1136/bjsm.36.4.282; Bingisser R, 1997, MED SCI SPORT EXER, V29, P1499, DOI 10.1097/00005768-199711000-00017; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Edwards LM, 2011, AM J PHYSIOL-REG I, V301, pR320, DOI 10.1152/ajpregu.00850.2010; Edwards LM, 2011, FASEB J, V25, P1088, DOI 10.1096/fj.10-171983; Edwards LM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010681; Freyssenet D, 2007, J APPL PHYSIOL, V102, P529, DOI 10.1152/japplphysiol.01126.2005; Gerzevic M, 2011, J STRENGTH COND RES, V25, P2470, DOI 10.1519/JSC.0b013e3181fb4111; GOLDING EM, 1995, J EXP BIOL, V198, P1775; HEITKAMP HC, 1991, INT J SPORTS MED, V12, P363, DOI 10.1055/s-2007-1024695; Holloway Cameron, 2011, Front Biosci (Schol Ed), V3, P331, DOI 10.2741/s154; Jeneson JAL, 1997, MOL CELL BIOCHEM, V174, P17, DOI 10.1023/A:1006891420109; JENESON JAL, 1995, AM J PHYSIOL-CELL PH, V268, pC1474, DOI 10.1152/ajpcell.1995.268.6.C1474; Jeneson JAL, 1996, J BIOL CHEM, V271, P27995, DOI 10.1074/jbc.271.45.27995; Jubrias SA, 2001, J APPL PHYSIOL, V90, P1663, DOI 10.1152/jappl.2001.90.5.1663; Kemp GJ, 2004, MITOCHONDRION, V4, P629, DOI 10.1016/j.mito.2004.07.017; Kemp GJ, 2004, NEPHROL DIAL TRANSPL, V19, P1520, DOI 10.1093/ndt/gfh189; KEMP GJ, 1994, MAGN RESON QUART, V10, P43; Kemp GJ, 1996, HEART, V76, P35, DOI 10.1136/hrt.76.1.35; Kemp GJ, 2007, NMR BIOMED, V20, P555, DOI 10.1002/nbm.1192; Larson-Meyer DE, 2000, NMR BIOMED, V13, P14, DOI 10.1002/(SICI)1099-1492(200002)13:1<14::AID-NBM605>3.0.CO;2-0; Layec G, 2011, NMR BIOMED, V24, P425, DOI 10.1002/nbm.1607; Layec G, 2009, MAGN RESON MED, V62, P840, DOI 10.1002/mrm.22085; Layec G, 2009, EUR J APPL PHYSIOL, V106, P229, DOI 10.1007/s00421-009-1012-y; McCully Kevin K, 2009, Dyn Med, V8, P5, DOI 10.1186/1476-5918-8-5; McKeough ZJ, 2006, RESP MED, V2, P2; McPhee JS, 2009, EXP PHYSIOL, V94, P684, DOI 10.1113/expphysiol.2008.045658; MILLER RG, 1995, MUSCLE NERVE, V18, P60, DOI 10.1002/mus.880180109; MILLER RG, 1987, MUSCLE NERVE, V10, P810, DOI 10.1002/mus.880100906; Nakagawa Y, 2005, MED SCI SPORT EXER, V37, P937, DOI 10.1249/01.mss.0000166946.94871.9b; Naressi A, 2001, COMPUT BIOL MED, V31, P269, DOI 10.1016/S0010-4825(01)00006-3; Nevill AM, 1997, BRIT J SPORT MED, V31, P314, DOI 10.1136/bjsm.31.4.314; Petersen KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMoa031314; Rimbert V, 2004, FASEB J, V18, P737, DOI 10.1096/fj.03-1104fje; Rossiter HB, 2003, J APPL PHYSIOL, V95, P1105, DOI 10.1152/japplphysiol.00964.2002; Roussel M, 2000, BBA-BIOENERGETICS, V1457, P18, DOI 10.1016/S0005-2728(99)00111-5; Trenell MI, 2006, MUSCLE NERVE, V33, P524, DOI 10.1002/mus.20484; van den Broek NMA, 2007, AM J PHYSIOL-CELL PH, V293, pC228, DOI 10.1152/ajpcell.00023.2007; Vanhamme L, 1997, J MAGN RESON, V129, P35, DOI 10.1006/jmre.1997.1244; Walter G, 1997, AM J PHYSIOL-CELL PH, V272, pC525, DOI 10.1152/ajpcell.1997.272.2.C525; WESTERHOFF HV, 1995, BIOPHYS CHEM, V54, P137, DOI 10.1016/0301-4622(94)00129-8	43	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2012	7	6							e37237	10.1371/journal.pone.0037237	http://dx.doi.org/10.1371/journal.pone.0037237			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TU	22701564	Green Published, gold			2022-12-27	WOS:000305337600006
J	Janhunen, M; Kause, A; Vehvilainen, H; Jarvisalo, O				Janhunen, Matti; Kause, Antti; Vehvilainen, Harri; Jarvisalo, Otso			Genetics of Microenvironmental Sensitivity of Body Weight in Rainbow Trout (Oncorhynchus mykiss) Selected for Improved Growth	PLOS ONE			English	Article							DEVELOPMENTAL STABILITY; QUANTITATIVE GENETICS; RESIDUAL VARIANCE; PRODUCTION TRAITS; EARLY MATURITY; BIRTH-WEIGHT; BROWN TROUT; VARIABILITY; PARAMETERS; HERITABILITY	Microenvironmental sensitivity of a genotype refers to the ability to buffer against non-specific environmental factors, and it can be quantified by the amount of residual variation in a trait expressed by the genotype's offspring within a (macro) environment. Due to the high degree of polymorphism in behavioral, growth and life-history traits, both farmed and wild salmonids are highly susceptible to microenvironmental variation, yet the heritable basis of this characteristic remains unknown. We estimated the genetic (co)variance of body weight and its residual variation in 2-year-old rainbow trout (Oncorhynchus mykiss) using a multigenerational data of 45,900 individuals from the Finnish national breeding programme. We also tested whether or not microenvironmental sensitivity has been changed as a correlated genetic response when genetic improvement for growth has been practiced over five generations. The animal model analysis revealed the presence of genetic heterogeneity both in body weight and its residual variation. Heritability of residual variation was remarkably lower (0.02) than that for body weight (0.35). However, genetic coefficient of variation was notable in both body weight (14%) and its residual variation (37%), suggesting a substantial potential for selection responses in both traits. Furthermore, a significant negative genetic correlation (-0.16) was found between body weight and its residual variation, i.e., rapidly growing genotypes are also more tolerant to perturbations in microenvironment. The genetic trends showed that fish growth was successfully increased by selective breeding (an average of 6% per generation), whereas no genetic change occurred in residual variation during the same period. The results imply that genetic improvement for body weight does not cause a concomitant increase in microenvironmental sensitivity. For commercial production, however, there may be high potential to simultaneously improve weight gain and increase its uniformity if both criteria are included in a selection index.	[Janhunen, Matti; Kause, Antti; Vehvilainen, Harri] MTT Agrifood Res Finland, Biometr Genet, Jokioinen, Finland; [Jarvisalo, Otso] Finnish Game & Fisheries Res Inst, Laukaa, Finland	Natural Resources Institute Finland (Luke); Natural Resources Institute Finland (Luke)	Janhunen, M (corresponding author), MTT Agrifood Res Finland, Biometr Genet, Jokioinen, Finland.	matti.janhunen@mtt.fi			MTT Agrifood Research Finland	MTT Agrifood Research Finland	MTT Agrifood Research Finland (url:www.mtt.fi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTT JC, 1985, BEHAVIOUR, V92, P241; Akaike H., 1973, P 2 INT S INF THEOR, P267, DOI 10.1007/978-1-4612-1694-0; Bergsma R, 2008, GENETICS, V178, P1559, DOI 10.1534/genetics.107.084236; Bijma P, 2007, GENETICS, V175, P277, DOI 10.1534/genetics.106.062711; CARDIN S, 1986, CAN J GENET CYTOL, V28, P856, DOI 10.1139/g86-119; Carlson SM, 2008, EVOL APPL, V1, P222, DOI 10.1111/j.1752-4571.2008.00025.x; Clarke GM, 1998, AM NAT, V152, P762, DOI 10.1086/286207; CLAYTON G. A., 1957, JOUR GENETICS, V55, P152, DOI 10.1007/BF02981621; CRANDELL PA, 1993, AQUACULTURE, V117, P77, DOI 10.1016/0044-8486(93)90125-I; Damgaard LH, 2003, J ANIM SCI, V81, P604; DEKKERS JCM, 1995, ANIM SCI, V61, P165, DOI 10.1017/S1357729800013667; Falconer D. S., 1996, INTRO QUANTITATIVE G; FENDERSO.OC, 1968, J FISH RES BOARD CAN, V25, P1, DOI 10.1139/f68-001; Garreau H, 2008, LIVEST SCI, V119, P55, DOI 10.1016/j.livsci.2008.02.009; GAVRILETS S, 1994, EVOLUTION, V48, P1478, DOI [10.2307/2410242, 10.1111/j.1558-5646.1994.tb02190.x]; Gilmour AR, 2009, ASREML USER GUIDE RE; Gilmour KM, 2005, INTEGR COMP BIOL, V45, P263, DOI 10.1093/icb/45.2.263; Gjedrem T, 2000, AQUAC RES, V31, P25, DOI 10.1046/j.1365-2109.2000.00389.x; GROSS MR, 1985, NATURE, V313, P47, DOI 10.1038/313047a0; Gutierrez JP, 2006, GENET SEL EVOL, V38, P445, DOI 10.1051/gse:2006014; Hall MC, 2007, P NATL ACAD SCI USA, V104, P13717, DOI 10.1073/pnas.0701936104; Hansen TF, 2011, EVOL BIOL, V38, P258, DOI 10.1007/s11692-011-9127-6; HENDERSON CR, 1986, J DAIRY SCI, V69, P1394, DOI 10.3168/jds.S0022-0302(86)80546-X; Hendry A. P., 2004, EVOLUTION ILLUMINATE; Hill WG, 2004, GENET RES, V83, P121, DOI 10.1017/S0016672304006640; HILL WG, 1984, ANIM PROD, V39, P473, DOI 10.1017/S0003356100032220; Hill WG, 2010, GENET RES, V92, P381, DOI 10.1017/S0016672310000546; Houle D, 1998, GENETICA, V102-3, P241, DOI 10.1023/A:1017034925212; HOULE D, 1992, GENETICS, V130, P195; HOVENIER R, 1993, J ANIM SCI, V71, P1429, DOI 10.2527/1993.7161429x; Ibanez-Escriche N, 2008, GENET SEL EVOL, V40, P279, DOI 10.1051/gse:2008003; JOBLING M, 1985, AQUACULTURE, V44, P83, DOI 10.1016/0044-8486(85)90011-0; Johnsson JI, 1996, CAN J FISH AQUAT SCI, V53, P1546, DOI 10.1139/cjfas-53-7-1546; Kause A, 2005, AQUACULTURE, V247, P177, DOI 10.1016/j.aquaculture.2005.02.023; Kause A, 2003, AQUACULTURE, V228, P53, DOI 10.1016/S0044-8486(03)00244-8; Kause A, 2003, J FISH BIOL, V62, P610, DOI 10.1046/j.1095-8649.2003.00051.x; Kause A, 1999, J EVOLUTION BIOL, V12, P471, DOI 10.1046/j.1420-9101.1999.00045.x; Knol EF, 2003, ADVANCES IN PORK PRODUCTION, VOL 14, P59; Kruuk LEB, 2004, PHILOS T R SOC B, V359, P873, DOI 10.1098/rstb.2003.1437; Kuukka-Anttila H, 2010, HEREDITY, V104, P20, DOI 10.1038/hdy.2009.123; LEARY RF, 1983, NATURE, V301, P71, DOI 10.1038/301071a0; LEARY RF, 1985, EVOLUTION, V39, P308, DOI [10.2307/2408364, 10.1111/j.1558-5646.1985.tb05668.x]; LEARY RF, 1984, AM NAT, V124, P540, DOI 10.1086/284293; Lerner IM, 1954, GENETIC HOMEOSTASIS; LEWONTIN RC, 1957, COLD SPRING HARB SYM, V22, P395, DOI 10.1101/SQB.1957.022.01.037; MACKAY TFC, 1994, GENETICS, V136, P937; Mangel M, 2008, B MAR SCI, V83, P107; Martyniuk CJ, 2003, J FISH BIOL, V63, P746, DOI 10.1046/j.1095-8649.2003.00188.x; MATHER K, 1953, HEREDITY, V7, P297, DOI 10.1038/hdy.1953.41; MCCARTHY ID, 1992, J FISH BIOL, V41, P257, DOI 10.1111/j.1095-8649.1992.tb02655.x; Merila J, 2000, AM NAT, V155, P301, DOI 10.1086/303330; Merila J, 1999, HEREDITY, V83, P103, DOI 10.1038/sj.hdy.6885850; Milligan BN, 2002, LIVEST PROD SCI, V76, P181, DOI 10.1016/S0301-6226(02)00012-X; Moller AP, 1997, AM NAT, V149, P916, DOI 10.1086/286030; Monsen BB, 2010, P WORLD C GEN APPL L; MOUSSEAU TA, 1987, HEREDITY, V59, P181, DOI 10.1038/hdy.1987.113; Mulder HA, 2007, GENETICS, V175, P1895, DOI 10.1534/genetics.106.063743; Mulder HA, 2009, ANIMAL, V3, P1673, DOI 10.1017/S1751731109990668; Mulder HA, 2008, GENET SEL EVOL, V40, P37, DOI 10.1051/gse:2007034; Neves HHR, 2011, LIVEST SCI, V142, P164, DOI 10.1016/j.livsci.2011.07.010; Paez DJ, 2011, J EVOLUTION BIOL, V24, P245, DOI 10.1111/j.1420-9101.2010.02159.x; Poigner J., 2000, World Rabbit Science, V8, P103; Price E. O., 1968, ADAPTATION DOMESTIC, P34; PRICE T, 1991, EVOLUTION, V45, P853, DOI 10.1111/j.1558-5646.1991.tb04354.x; Rasmussen RS, 2010, AQUACULT INT, V18, P933, DOI 10.1007/s10499-009-9313-z; REEVE ECR, 1960, GENET RES, V1, P151, DOI 10.1017/S0016672300000148; RENDEL JM, 1966, AM NAT, V100, P13, DOI 10.1086/282397; Ros M, 2004, GENETICS, V168, P2089, DOI 10.1534/genetics.104.032672; ROWE DK, 1991, CAN J FISH AQUAT SCI, V48, P405, DOI 10.1139/f91-052; RUZZANTE DE, 1994, AQUACULTURE, V120, P1, DOI 10.1016/0044-8486(94)90217-8; Sae-Lim P, 2010, AQUACULTURE, V310, P66, DOI 10.1016/j.aquaculture.2010.10.020; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Shearer KD, 2000, AQUACULTURE, V190, P343, DOI 10.1016/S0044-8486(00)00406-3; Sundstrom LF, 2004, BEHAV ECOL, V15, P192, DOI 10.1093/beheco/arg089; THODAY JM, 1955, COLD SPRING HARB SYM, V20, P318, DOI 10.1101/SQB.1955.020.01.032; Vehvilainen H, 2008, GENETICS, V180, P507, DOI 10.1534/genetics.108.089896; WADDINGTON CH, 1960, GENET RES, V1, P140, DOI 10.1017/S0016672300000136; Wagner GP, 1997, EVOLUTION, V51, P329, DOI [10.2307/2411105, 10.1111/j.1558-5646.1997.tb02420.x]; Weigensberg I, 1996, EVOLUTION, V50, P2149, DOI 10.1111/j.1558-5646.1996.tb03605.x; Wolc A, 2011, BRIT POULTRY SCI, V52, P537, DOI 10.1080/00071668.2011.625493; Wolc A, 2009, POULTRY SCI, V88, P1156, DOI 10.3382/ps.2008-00547	81	44	45	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2012	7	6							e38766	10.1371/journal.pone.0038766	http://dx.doi.org/10.1371/journal.pone.0038766			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TU	22701708	Green Published, gold			2022-12-27	WOS:000305337600041
J	Zhang, YZ; Liu, Z; Medrzycki, M; Cao, KX; Fan, YH				Zhang, Yunzhe; Liu, Zheng; Medrzycki, Magdalena; Cao, Kaixiang; Fan, Yuhong			Reduction of Hox Gene Expression by Histone H1 Depletion	PLOS ONE			English	Article							CHROMATIN-STRUCTURE; NUCLEAR REORGANIZATION; CELL FATE; DEVELOPMENTAL REGULATORS; MOUSE DEVELOPMENT; GLOBAL CONTROL; POLYCOMB; STEM; MURINE; PLURIPOTENT	The evolutionarily conserved homeotic (Hox) genes are organized in clusters and expressed collinearly to specify body patterning during embryonic development. Chromatin reorganization and decompaction are intimately connected with Hox gene activation. Linker histone H1 plays a key role in facilitating folding of higher order chromatin structure. Previous studies have shown that deletion of three somatic H1 subtypes together leads to embryonic lethality and that H1c/H1d/H1e triple knockout (TKO) embryonic stem cells (ESCs) display bulk chromatin decompaction. To investigate the potential role of H1 and higher order chromatin folding in the regulation of Hox gene expression, we systematically analyzed the expression of all 39 Hox genes in triple H1 null mouse embryos and ESCs by quantitative RT-PCR. Surprisingly, we find that H1 depletion causes significant reduction in the expression of a broad range of Hox genes in embryos and ESCs. To examine if any of the three H1 subtypes (H1c, H1d and H1e) is responsible for decreased expression of Hox gene in triple-H1 null ESCs, we derived and characterized H1c(-/-), H1d(-/-), and H1e(-/-) single-H1 null ESCs. We show that deletion of individual H1 subtypes results in down-regulation of specific Hox genes in ESCs. Finally we demonstrate that, in triple-H1- and single-H1- null ESCs, the levels of H3K4 trimethylation (H3K4me3) and H3K27 trimethylation (H3K27me3) were affected at specific Hox genes with decreased expression. Our data demonstrate that marked reduction in total H1 levels causes significant reduction in both expression and the level of active histone mark H3K4me3 at many Hox genes and that individual H1 subtypes may also contribute to the regulation of specific Hox gene expression. We suggest possible mechanisms for such an unexpected role of histone H1 in Hox gene regulation.	[Zhang, Yunzhe] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; Georgia Inst Technol, Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Zhang, YZ (corresponding author), Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA.	Yuhong.fan@biology.gatech.edu	Liu, Zheng/GVU-3695-2022	Liu, Zheng/0000-0003-4158-6768; Cao, Kaixiang/0000-0001-9953-1503	Georgia Cancer Coalition Distinguished Scholar award; National Institutes of Health (United States) grant [GM085261]; Georgia Tech; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085261] Funding Source: NIH RePORTER	Georgia Cancer Coalition Distinguished Scholar award; National Institutes of Health (United States) grant; Georgia Tech; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by a Georgia Cancer Coalition Distinguished Scholar award (to YF), National Institutes of Health (United States) grant GM085261, and Georgia Tech. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akasaka T, 2001, DEVELOPMENT, V128, P1587; Alami R, 2003, P NATL ACAD SCI USA, V100, P5920, DOI 10.1073/pnas.0736105100; Alexander T, 2009, ANNU REV CELL DEV BI, V25, P431, DOI 10.1146/annurev.cellbio.042308.113423; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Bai L, 2010, TRENDS GENET, V26, P476, DOI 10.1016/j.tig.2010.08.003; Bednar J, 1998, P NATL ACAD SCI USA, V95, P14173, DOI 10.1073/pnas.95.24.14173; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Chamberlain SJ, 2008, STEM CELLS, V26, P1496, DOI 10.1634/stemcells.2008-0102; Chambeyron S, 2005, DEVELOPMENT, V132, P2215, DOI 10.1242/dev.01813; Chambeyron S, 2004, GENE DEV, V18, P1119, DOI 10.1101/gad.292104; Christensen J, 2007, CELL, V128, P1063, DOI 10.1016/j.cell.2007.02.003; Cloos PAC, 2008, GENE DEV, V22, P1115, DOI 10.1101/gad.1652908; Deschamps J, 2007, CURR OPIN GENET DEV, V17, P422, DOI 10.1016/j.gde.2007.07.008; Dobreva G, 2006, CELL, V125, P971, DOI 10.1016/j.cell.2006.05.012; Dou YL, 2006, NAT STRUCT MOL BIOL, V13, P713, DOI 10.1038/nsmb1128; Efroni S, 2008, CELL STEM CELL, V2, P437, DOI 10.1016/j.stem.2008.03.021; Endoh M, 2008, DEVELOPMENT, V135, P1513, DOI 10.1242/dev.014340; Erzurumlu RS, 2010, NAT REV NEUROSCI, V11, P252, DOI 10.1038/nrn2804; Eskeland R, 2010, MOL CELL, V38, P452, DOI 10.1016/j.molcel.2010.02.032; Fan YH, 2005, CELL, V123, P1199, DOI 10.1016/j.cell.2005.10.028; Fan YH, 2004, METHOD ENZYMOL, V377, P85; Fan YH, 2003, MOL CELL BIOL, V23, P4559, DOI 10.1128/MCB.23.13.4559-4572.2003; Fan YH, 2001, MOL CELL BIOL, V21, P7933, DOI 10.1128/MCB.21.23.7933-7943.2001; Giambra V, 2008, MOL CELL BIOL, V28, P6123, DOI 10.1128/MCB.00233-08; Goodman FR, 2002, AM J MED GENET, V112, P256, DOI 10.1002/ajmg.10776; Gouti M, 2008, STEM CELLS, V26, P1985, DOI 10.1634/stemcells.2008-0182; GRAHAM A, 1989, CELL, V57, P367, DOI 10.1016/0092-8674(89)90912-4; Gunjan A, 1999, NUCLEIC ACIDS RES, V27, P3355, DOI 10.1093/nar/27.16.3355; Happel N, 2009, GENE, V431, P1, DOI 10.1016/j.gene.2008.11.003; Herrscher RF, 1995, GENE DEV, V9, P3067, DOI 10.1101/gad.9.24.3067; Huang TH, 1996, NUCLEIC ACIDS RES, V24, P1695, DOI 10.1093/nar/24.9.1695; IZAURRALDE E, 1989, J MOL BIOL, V210, P573, DOI 10.1016/0022-2836(89)90133-2; IZPISUABELMONTE JC, 1991, EMBO J, V10, P2279, DOI 10.1002/j.1460-2075.1991.tb07764.x; Jorgensen HF, 2006, CELL CYCLE, V5, P1411, DOI 10.4161/cc.5.13.2927; Kharchenko PV, 2008, GENOME RES, V18, P1554, DOI 10.1101/gr.075952.107; Kortschak RD, 2000, TRENDS BIOCHEM SCI, V25, P294, DOI 10.1016/S0968-0004(00)01597-8; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Leucht P, 2008, DEVELOPMENT, V135, P2845, DOI 10.1242/dev.023788; MacLean JA, 2011, MOL CELL BIOL, V31, P1275, DOI 10.1128/MCB.00734-10; Mallo M, 2010, DEV BIOL, V344, P7, DOI 10.1016/j.ydbio.2010.04.024; McIntyre DC, 2007, DEVELOPMENT, V134, P2981, DOI 10.1242/dev.007567; Medrzycki M, 2012, JOVE-J VIS EXP, DOI 10.3791/3577; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Montavon T, 2011, CELL, V147, P1132, DOI 10.1016/j.cell.2011.10.023; Morey C, 2007, DEVELOPMENT, V134, P909, DOI 10.1242/dev.02779; Noordermeer D, 2011, SCIENCE, V334, P222, DOI 10.1126/science.1207194; Oury F, 2006, SCIENCE, V313, P1408, DOI 10.1126/science.1130042; PANYIM S, 1969, BIOCHEM BIOPH RES CO, V37, P1042, DOI 10.1016/0006-291X(69)90237-X; PEHRSON J, 1980, NATURE, V285, P43, DOI 10.1038/285043a0; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; RUDDLE FH, 1994, ANNU REV GENET, V28, P423, DOI 10.1146/annurev.ge.28.120194.002231; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Shah N, 2010, NAT REV CANCER, V10, P361, DOI 10.1038/nrc2826; Soshnikova N, 2009, SCIENCE, V324, P1320, DOI 10.1126/science.1171468; Spitz F, 2003, CELL, V113, P405, DOI 10.1016/S0092-8674(03)00310-6; Stock JK, 2007, NAT CELL BIOL, V9, P1428, DOI 10.1038/ncb1663; THOMA F, 1979, J CELL BIOL, V83, P403, DOI 10.1083/jcb.83.2.403; van Lohuizen M, 1998, CELL MOL LIFE SCI, V54, P71, DOI 10.1007/s000180050126; vanderLugt NMT, 1996, MECH DEVELOP, V58, P153, DOI 10.1016/S0925-4773(96)00570-9; Vinagre T, 2010, DEV CELL, V18, P655, DOI 10.1016/j.devcel.2010.02.011; Wagner GP, 2003, P NATL ACAD SCI USA, V100, P14603, DOI 10.1073/pnas.2536656100; Wellik DM, 2007, DEV DYNAM, V236, P2454, DOI 10.1002/dvdy.21286; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Zhang YZ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002691	70	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2012	7	6							e38829	10.1371/journal.pone.0038829	http://dx.doi.org/10.1371/journal.pone.0038829			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TU	22701719	gold, Green Published			2022-12-27	WOS:000305337600047
J	Komarov, I; D'Souza, RM; Tapia, JJ				Komarov, Ivan; D'Souza, Roshan M.; Tapia, Jose-Juan			Accelerating the Gillespie tau-Leaping Method Using Graphics Processing Units	PLOS ONE			English	Article							EXACT STOCHASTIC SIMULATION; SIZE SELECTION; SYSTEMS; ALGORITHM	The Gillespie tau-Leaping Method is an approximate algorithm that is faster than the exact Direct Method (DM) due to the progression of the simulation with larger time steps. However, the procedure to compute the time leap tau is quite expensive. In this paper, we explore the acceleration of the tau-Leaping Method using Graphics Processing Unit (GPUs) for ultra-large networks (>0.5e(6) reaction channels). We have developed data structures and algorithms that take advantage of the unique hardware architecture and available libraries. Our results show that we obtain a performance gain of over 60x when compared with the best conventional implementations.	[Komarov, Ivan; D'Souza, Roshan M.] Univ Wisconsin, Dept Mech Engn, Complex Syst Simulat Lab, Milwaukee, WI 53201 USA; [Tapia, Jose-Juan] Univ Pittsburgh, Dept Computat Biol, Pittsburgh, PA USA	University of Wisconsin System; University of Wisconsin Milwaukee; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Komarov, I (corresponding author), Univ Wisconsin, Dept Mech Engn, Complex Syst Simulat Lab, Milwaukee, WI 53201 USA.	dsouza@uwm.edu	Valiyaveettill, Suresh/D-4848-2009	Valiyaveettill, Suresh/0000-0001-6990-660X	National Science Foundation (NSF) [CNS 0968519, CCF 1013278]; Division Of Computer and Network Systems [0968519] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); Division Of Computer and Network Systems(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This work was funded by the grants CNS 0968519 and CCF 1013278 from the National Science Foundation (NSF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell N, 2009, STUDENTS GUIDE TO THE MA TESOL, P1; Burrage K, 2006, PARALLEL COMPUTING B, P79; Cao Y, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2159468; Cao Y, 2004, J CHEM PHYS, V121, P4059, DOI 10.1063/1.1778376; Dittamo C, 2009, 2009 INTERNATIONAL CONFERENCE ON COMPUTER MODELING AND SIMULATION, PROCEEDINGS, P156, DOI 10.1109/ICCMS.2009.42; Gibson MA, 2000, J PHYS CHEM A, V104, P1876, DOI 10.1021/jp993732q; Gillespie DT, 2001, J CHEM PHYS, V115, P1716, DOI 10.1063/1.1378322; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Gillespie DT, 2003, J CHEM PHYS, V119, P8229, DOI 10.1063/1.1613254; Hoberock Jared, 2010, THRUST PARALLEL TEMP; Howes L., 2007, GPU GEMS, P805; Kirk D, 2010, PROGRAMMING MASSIVEL; Li H, 2006, LOGARITHMIC DIRECT M, DOI 10.1.1.79.7703; Li H, 2010, INT J HIGH PERFORM C, V24, P107, DOI 10.1177/1094342009106066; Macchiarulo L, 2008, IEEE ENG MED BIO, P1343, DOI 10.1109/IEMBS.2008.4649413; MCCOLLUMA JM, 2005, J COMPUT BIOL CHEM, V30, P39; Nickolls John, 2008, ACM Queue, V6, DOI 10.1145/1365490.1365500; Owens JD, 2007, COMPUT GRAPH FORUM, V26, P80, DOI 10.1111/j.1467-8659.2007.01012.x; Rathinam M, 2003, J CHEM PHYS, V119, P12784, DOI 10.1063/1.1627296; Sanders J., 2010, CUDA EXAMPLE INTRO G; Sanft KR, 2011, BIOINFORMATICS, V27, P2457, DOI 10.1093/bioinformatics/btr401; Schulze TP, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.036704; Stone JE, 2010, COMPUT SCI ENG, V12, P66, DOI 10.1109/MCSE.2010.69; Tian TH, 2004, J CHEM PHYS, V121, P10356, DOI 10.1063/1.1810475; Tian TH, 2005, Eighth International Conference on High-Performance Computing in Asia-Pacific Region, Proceedings, P621, DOI 10.1109/HPCASIA.2005.67; Turner TE, 2004, COMPUT BIOL CHEM, V28, P165, DOI 10.1016/j.compbiolchem.2004.05.001; VanKampen NG, 2007, NORTH-HOLL PERS LIBR, P1; Vigelius M, 2011, BIOINFORMATICS, V27, P288, DOI 10.1093/bioinformatics/btq622	28	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2012	7	6							e37370	10.1371/journal.pone.0037370	http://dx.doi.org/10.1371/journal.pone.0037370			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TQ	22715366	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000305336800007
J	Lane, A; Cheng, YY; Wright, B; Hamede, R; Levan, L; Jones, M; Ujvari, B; Belov, K				Lane, Amanda; Cheng, Yuanyuan; Wright, Belinda; Hamede, Rodrigo; Levan, Laura; Jones, Menna; Ujvari, Beata; Belov, Katherine			New Insights into the Role of MHC Diversity in Devil Facial Tumour Disease	PLOS ONE			English	Article							TASMANIAN DEVIL; SARCOPHILUS-HARRISII; CLASS-I; POPULATION-STRUCTURE; GENETIC DIVERSITY; SOCIAL-BEHAVIOR; TRANSMISSION; PATTERNS; CONTACT; DECLINE	Background: Devil facial tumour disease (DFTD) is a fatal contagious cancer that has decimated Tasmanian devil populations. The tumour has spread without invoking immune responses, possibly due to low levels of Major Histocompatibility Complex (MHC) diversity in Tasmanian devils. Animals from a region in north-western Tasmania have lower infection rates than those in the east of the state. This area is a genetic transition zone between sub-populations, with individuals from north-western Tasmania displaying greater diversity than eastern devils at MHC genes, primarily through MHC class I gene copy number variation. Here we test the hypothesis that animals that remain healthy and tumour free show predictable differences at MHC loci compared to animals that develop the disease. Methodology/Principal Findings: We compared MHC class I sequences in 29 healthy and 22 diseased Tasmanian devils from West Pencil Pine, a population in north-western Tasmania exhibiting reduced disease impacts of DFTD. Amplified alleles were assigned to four loci, Saha-UA, Saha-UB, Saha-UC and Saha-UD based on recently obtained genomic sequence data. Copy number variation (caused by a deletion) at Saha-UA was confirmed using a PCR assay. No association between the frequency of this deletion and disease status was identified. All individuals had alleles at Saha-UD, disproving theories of disease susceptibility relating to copy number variation at this locus. Genetic variation between the two sub-groups (healthy and diseased) was also compared using eight MHC-linked microsatellite markers. No significant differences were identified in allele frequency, however differences were noted in the genotype frequencies of two microsatellites located near non-antigen presenting genes within the MHC. Conclusions/Significance: We did not find predictable differences in MHC class I copy number variation to account for differences in susceptibility to DFTD. Genotypic data was equivocal but indentified genomic areas for further study.	[Lane, Amanda; Cheng, Yuanyuan; Wright, Belinda; Levan, Laura; Ujvari, Beata; Belov, Katherine] Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia; [Wright, Belinda] Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia; [Hamede, Rodrigo; Jones, Menna] Univ Tasmania, Sch Zool, Hobart, Tas, Australia; [Levan, Laura] Univ Nottingham, Sch Vet Med & Sci, Nottingham NG7 2RD, England	University of Sydney; Macquarie University; University of Tasmania; University of Nottingham	Lane, A (corresponding author), Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia.	kathy.belov@sydney.edu.au	Jones, Menna E/J-7975-2012; Ujvari, Beata/K-8722-2012; Ujvari, Beata/L-7541-2019; Cheng, Yuanyuan/M-6476-2017	Ujvari, Beata/0000-0003-2391-2988; Ujvari, Beata/0000-0003-2391-2988; Cheng, Yuanyuan/0000-0002-1747-9308; Belov, Katherine/0000-0002-9762-5554; Hamede, Rodrigo/0000-0003-1526-225X; Wright, Belinda/0000-0002-3317-8185; Jones, Menna/0000-0001-7558-9022	Australian Research Council [LP0561120, LP0989613, DP110102656, FT0992212, FT100100250]; Eric Guiler Tasmanian Devil Research grant through the University of Tasmania; Eric Guiler Tasmanian Devil Research grant through the Save the Tasmanian Devil Appeal; Tasmanian Department of Primary Industries Water; Save the Tasmanian Devil Program	Australian Research Council(Australian Research Council); Eric Guiler Tasmanian Devil Research grant through the University of Tasmania; Eric Guiler Tasmanian Devil Research grant through the Save the Tasmanian Devil Appeal; Tasmanian Department of Primary Industries Water; Save the Tasmanian Devil Program	This research project was funded by two Australian Research Council Linkage grants to MJ and H. McCallum (LP0561120), that also supported RH on an Australian Postgraduate Award Industry (APAI), and to KB and MJ (LP0989613); by an ARC Discovery Grant to MJ and KB (DP110102656); and by Eric Guiler Tasmanian Devil Research grants through the University of Tasmania and the Save the Tasmanian Devil Appeal to AL and KB and to RH and MJ (three grants). The Tasmanian Department of Primary Industries & Water and the "Save the Tasmanian Devil Program" provided financial and in-kind logistic support throughout the project and was the key industry partner on both ARC Linkage grants (LP0561120, LP0989613). KB and MJ are supported by ARC Future Fellowships (KB FT0992212; MJ FT100100250). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar A, 2004, P NATL ACAD SCI USA, V101, P3490, DOI 10.1073/pnas.0306582101; Belov K, 2011, MAMM GENOME, V22, P83, DOI 10.1007/s00335-010-9294-2; Cheng Y, 2012, IMMUNOGENET IN PRESS; Cheng Y, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-87; Cheng YY, 2012, CONSERV GENET RESOUR, V4, P463, DOI 10.1007/s12686-011-9575-4; Doxiadis GGM, 2007, P NATL ACAD SCI USA, V104, P8907, DOI 10.1073/pnas.0702964104; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hamede R, 2012, CONSERV BIOL, V26, P124, DOI 10.1111/j.1523-1739.2011.01747.x; Hamede RK, 2008, AUSTRAL ECOL, V33, P614, DOI 10.1111/j.1442-9993.2007.01827.x; Hamede RK, 2009, ECOL LETT, V12, P1147, DOI 10.1111/j.1461-0248.2009.01370.x; Hawkins CE, 2006, BIOL CONSERV, V131, P307, DOI 10.1016/j.biocon.2006.04.010; HOOD GM, POPTOOLS VERSION 3 2; Huber C, 2008, J BIOL CHEM, V283, P34002, DOI 10.1074/jbc.M803957200; IUCN, IUCN RED LIST THREAT; Jones ME, 2000, J MAMMAL, V81, P434, DOI 10.1644/1545-1542(2000)081<0434:NDASAD>2.0.CO;2; Jones ME, 2004, MOL ECOL, V13, P2197, DOI 10.1111/j.1365-294X.2004.02239.x; Jones ME, 2003, MOL ECOL NOTES, V3, P277, DOI 10.1046/j.1471-8286.2003.00425.x; Jones ME, 2008, P NATL ACAD SCI USA, V105, P10023, DOI 10.1073/pnas.0711236105; Kreiss A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022402; Lachish S, 2011, HEREDITY, V106, P172, DOI 10.1038/hdy.2010.17; Lachish S, 2009, J ANIM ECOL, V78, P427, DOI 10.1111/j.1365-2656.2008.01494.x; Lachish S, 2007, J ANIM ECOL, V76, P926, DOI 10.1111/j.1365-2656.2007.01272.x; Lai CH, 2000, GENOME RES, V10, P703, DOI 10.1101/gr.10.5.703; Lamarca V, 2007, AM J PHYSIOL-CELL PH, V293, pC1347, DOI 10.1152/ajpcell.00431.2006; Loh R, 2006, VET PATHOL, V43, P890, DOI 10.1354/vp.43-6-890; Manly BFJ, 1997, RANDOMIZATION BOOTST; McCallum H, 2009, ECOLOGY, V90, P3379, DOI 10.1890/08-1763.1; Meijer D, 2009, BREAST CANCER RES TR, V113, P253, DOI 10.1007/s10549-008-9934-3; Miller W, 2011, P NATL ACAD SCI USA, V108, P12348, DOI 10.1073/pnas.1102838108; Murchison EP, 2010, SCIENCE, V327, P84, DOI 10.1126/science.1180616; Paddle R, 2012, AUST ZO MAR IN PRESS, V35; Pasteris NG, 1999, ISOLATION CHARACTERI, P57; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pearse AM, 2006, NATURE, V439, P549, DOI 10.1038/439549a; PEMBERTON D, 1993, AUST J ZOOL, V41, P507, DOI 10.1071/ZO9930507; Piertney SB, 2006, HEREDITY, V96, P7, DOI 10.1038/sj.hdy.6800724; Prasad VK, 1996, TISSUE ANTIGENS, V47, P538, DOI 10.1111/j.1399-0039.1996.tb02596.x; Pyecroft SB, 2007, ECOHEALTH, V4, P346, DOI 10.1007/s10393-007-0126-0; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; SANTAMARIA P, 1993, HUM IMMUNOL, V37, P39, DOI 10.1016/0198-8859(93)90141-M; SCHWAIGER FW, 1993, MOL ECOL, V2, P55, DOI 10.1111/j.1365-294X.1993.tb00099.x; Siddle HV, 2007, P NATL ACAD SCI USA, V104, P16221, DOI 10.1073/pnas.0704580104; Siddle HV, 2007, IMMUNOGENETICS, V59, P753, DOI 10.1007/s00251-007-0238-2; Siddle HV, 2010, P ROY SOC B-BIOL SCI, V277, P2001, DOI 10.1098/rspb.2009.2362; Siddle HV, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-310; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Truett GE, 2000, BIOTECHNIQUES, V29, P52, DOI 10.2144/00291bm09; Woods GM, 2007, ECOHEALTH, V4, P338, DOI 10.1007/s10393-007-0117-1; Xu XM, 2002, J BIOL CHEM, V277, P48913, DOI 10.1074/jbc.M209613200	52	26	26	0	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e36955	10.1371/journal.pone.0036955	http://dx.doi.org/10.1371/journal.pone.0036955			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701561	gold, Green Published			2022-12-27	WOS:000305348400008
J	Ndziessi, G; Boyer, S; Kouanfack, C; Cohen, J; Marcellin, F; Moatti, JP; Delaporte, E; Spire, B; Laurent, C; Carrieri, MP				Ndziessi, Gilbert; Boyer, Sylvie; Kouanfack, Charles; Cohen, Julien; Marcellin, Fabienne; Moatti, Jean-Paul; Delaporte, Eric; Spire, Bruno; Laurent, Christian; Carrieri, Maria Patrizia		Stratall ANRS 12110 Esther Study G	Adherence as a Predictor of Sexual Behaviors in People Living with HIV/AIDS during the First Year of Antiretroviral Therapy in Rural Cameroon: Data from Stratall ANRS 12110/ESTHER Trial	PLOS ONE			English	Article							COTE-DIVOIRE; HIV TRANSMISSION; RISK BEHAVIOR; PREVENTION; INFECTION; DISTRICT; ACCESS; HEALTH; COHORT; UGANDA	Objective: This study aims to investigate the time pattern of inconsistence condom use (ICU) during the first year of antiretroviral therapy (ART) and its relationship with treatment adherence in naive HIV-infected adult patients. ' Methods: Data collection was nested within a longitudinal trial on HIV treatment. ICU was defined as reporting to have "never", "sometimes" or "nearly always" used condoms with one's main or casual partner(s) - either HIV-negative or of unknown HIV status in the three previous months. Adherence was defined as taking 100% of their ART prescribed doses in the 4 days before the visit and "not having interrupted treatment", even once, for more than two consecutive days during the 4 previous weeks. Mixed logistic regression was used to study the relationship between adherence and ICU. Results: Among the 459 patients enrolled, 212 (46%) during 334 visits reported to have had sexual intercourse at least once with their partner(s) - either HIV-negative or of unknown HIV status-during the first 12 months of ART. The proportion of ICU was 76%, 50% and 59% at month 0 (M0), month 6 (M6) and month 12 (M12), while 60% and 66% of patients were ART-adherent at M6 and M12, respectively. After adjustment for the frequency of sexual activity, type of sexual partner(s), perceived social class and desire for a child, patients adherent to ART were less likely to report ICU when compared with baseline (AOR [95% CI]: 0.38 [0.19-0.76]; P = 0.006). Conclusions: Adherence to ART is associated with a lower risk of ICU but this result needs to be interpreted carefully. As adherence behaviors are not only determined by problems with the healthcare systems but also by social barriers encountered by patients in their daily life, counseling should not only be ART adherence-centered but also patient-centered, including sexual risk minimization and psychosocial support.	[Ndziessi, Gilbert; Boyer, Sylvie; Cohen, Julien; Marcellin, Fabienne; Moatti, Jean-Paul; Spire, Bruno; Carrieri, Maria Patrizia] INSERM, SESSTIM U912, F-13258 Marseille, France; [Ndziessi, Gilbert; Boyer, Sylvie; Cohen, Julien; Marcellin, Fabienne; Moatti, Jean-Paul; Spire, Bruno; Carrieri, Maria Patrizia] Univ Aix Marseille, IRD, UMR S912, Marseille, France; [Ndziessi, Gilbert; Boyer, Sylvie; Cohen, Julien; Marcellin, Fabienne; Moatti, Jean-Paul; Spire, Bruno; Carrieri, Maria Patrizia] ORS PACA, Observ Reg Sante Provence Alpes Cote Azur, Marseille, France; [Kouanfack, Charles] Cent Hosp, Yaounde, Cameroon; [Delaporte, Eric; Laurent, Christian] Univ Montpellier I, UMI 233, IRD, Montpellier, France; [Delaporte, Eric] Univ Hosp, Dept Infect & Trop Dis, Montpellier, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Universite de Montpellier; CHU de Montpellier	Ndziessi, G (corresponding author), INSERM, SESSTIM U912, F-13258 Marseille, France.	gilbert.ndziessi@inserm.fr	Marcellin, Fabienne/H-7911-2019; Delaporte, Eric/J-5397-2018; Spire, Bruno/F-5546-2013	Marcellin, Fabienne/0000-0001-8853-3829; Delaporte, Eric/0000-0002-1822-9853; Spire, Bruno/0000-0002-3546-8020; AGHOKENG FOBANG, Avelin/0000-0002-1414-0237; Carrieri, Patrizia/0000-0002-6794-4837; Laurent, Christian/0000-0003-2658-7113	National Agency for Research on AIDS; Ensemble pour une Solidarite Therapeutique Hospitaliere En Reseau, France	National Agency for Research on AIDS; Ensemble pour une Solidarite Therapeutique Hospitaliere En Reseau, France	Funding provided by National Agency for Research on AIDS and Ensemble pour une Solidarite Therapeutique Hospitaliere En Reseau, France. (http://www.anrs.fr/) (http://www.esther.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, PAT MON GUID HIV CAR; Bonono C.R., 2010, ACCES DECENTRALISE T, P215; Boyer S, 2011, SOC SCI MED, V72, P1383, DOI 10.1016/j.socscimed.2011.02.030; Bunnell R, 2006, AIDS, V20, P85, DOI 10.1097/01.aids.0000196566.40702.28; Carrieri P, 2001, J ACQ IMMUN DEF SYND, V28, P232, DOI 10.1097/00042560-200111010-00005; Crepaz N, 2004, JAMA-J AM MED ASSOC, V292, P224, DOI 10.1001/jama.292.2.224; Dia A, 2010, SEX TRANSM INFECT, V86, P148, DOI 10.1136/sti.2008.035147; Diabate S, 2008, AIDS, V22, P154, DOI 10.1097/QAD.0b013e3282f029e8; Dunkle KL, 2008, LANCET, V371, P2183, DOI 10.1016/S0140-6736(08)60953-8; Kalichman SC, 2010, AIDS PATIENT CARE ST, V24, P271, DOI 10.1089/apc.2009.0309; Laurent C, 2011, LANCET INFECT DIS, V11, P825, DOI 10.1016/S1473-3099(11)70168-2; Luchters S, 2008, AIDS PATIENT CARE ST, V22, P587, DOI 10.1089/apc.2007.0247; Marcellin F, 2010, AIDS CARE, V22, P441, DOI 10.1080/09540120903202913; Moatti JP, 2003, AIDS, V17, pS69, DOI 10.1097/00002030-200317003-00010; Myer L, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000229; Namukwaya Z, 2011, JAIDS-J ACQ IMM DEF, V56, P69, DOI 10.1097/QAI.0b013e3181fdb4a8; Peltzer K, 2011, ACTA PAEDIATR, V100, P1253, DOI 10.1111/j.1651-2227.2011.02253.x; Perrine R, 2011, JAIDS-J ACQ IMM DEF, V57, pS40, DOI 10.1097/QAI.0b013e318222b5c2; Protopopescu C, 2010, TROP MED INT HEALTH, V15, P706, DOI 10.1111/j.1365-3156.2010.02524.x; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Sarna A, 2010, PUBLIC HEALTH REP, V125, P305, DOI 10.1177/003335491012500221; Singh-Manoux A, 2005, PSYCHOSOM MED, V67, P855, DOI 10.1097/01.psy.0000188434.52941.a0; *UNAIDS, 2010, REP GLOB AIDS EP; Vemazza P., 2008, B MED SUISSES, V89, P5; Venkatesh KK, 2010, AIDS, V24, P2687, DOI 10.1097/QAD.0b013e32833e78d4; Wandera B, 2011, J ACQUIR IMMUNE DEFI; Wilson DP, 2008, LANCET, V372, P314, DOI 10.1016/S0140-6736(08)61115-0; World Health Organization, 2006, PROGR GLOB ACC HIV A; World Health Organization, 2006, ANT THER HIV INF AD	29	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e36118	10.1371/journal.pone.0036118	http://dx.doi.org/10.1371/journal.pone.0036118			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959WK	22701555	gold, Green Submitted, Green Published			2022-12-27	WOS:000305348400005
J	Zgaga, L; Theodoratou, E; Kyle, J; Farrington, SM; Agakov, F; Tenesa, A; Walker, M; McNeill, G; Wright, AF; Rudan, I; Dunlop, MG; Campbell, H				Zgaga, Lina; Theodoratou, Evropi; Kyle, Janet; Farrington, Susan M.; Agakov, Felix; Tenesa, Albert; Walker, Marion; McNeill, Geraldine; Wright, Alan F.; Rudan, Igor; Dunlop, Malcolm G.; Campbell, Harry			The Association of Dietary Intake of Purine-Rich Vegetables, Sugar-Sweetened Beverages and Dairy with Plasma Urate, in a Cross-Sectional Study	PLOS ONE			English	Article							FRUCTOSE-INDUCED HYPERURICAEMIA; URINARY URIC-ACID; SOFT DRINKS; GOUT; SERUM; DISEASE; PROTEIN; MEN; CONSUMPTION; RISK	Introduction: Hyperuricemia is a strong risk factor for gout. The incidence of gout and hyperuricemia has increased recently, which is thought to be, in part, due to changes in diet and lifestyle. Objective of this study was to investigate the association between plasma urate concentration and: a) food items: dairy, sugar-sweetened beverages (SSB) and purine-rich vegetables; b) related nutrients: lactose, calcium and fructose. Methods: A total of 2,076 healthy participants (44% female) from a population-based case-control study in Scotland (1999-2006) were included in this study. Dietary data was collected using a semi-quantitative food frequency questionnaire (FFQ). Nutrient intake was calculated using FFQ and composition of foods information. Urate concentration was measured in plasma. Results: Mean urate concentration was 283.8 +/- 72.1 mmol/dL (females: 260.1668.9 mmol/dL and males: 302.3 +/- 69.2 mmol/dL). Using multivariate regression analysis we found that dairy, calcium and lactose intakes were inversely associated with urate (p = 0.008, p = 0.003, p = 0.0007, respectively). Overall SSB consumption was positively associated with urate (p = 0.008), however, energy-adjusted fructose intake was not associated with urate (p = 0.66). The intake of purine-rich vegetables was not associated to plasma urate (p = 0.38). Conclusions: Our results suggest that limiting purine-rich vegetables intake for lowering plasma urate may be ineffectual, despite current recommendations. Although a positive association between plasma urate and SSB consumption was found, there was no association with fructose intake, suggesting that fructose is not the causal agent underlying the SSB-urate association. The abundant evidence supporting the inverse association between plasma urate concentration and dairy consumption should be reflected in dietary guidelines for hyperuricemic individuals and gout patients. Further research is needed to establish which nutrients and food products influence plasma urate concentration, to inform the development of evidence-based dietary guidelines.	[Zgaga, Lina; Agakov, Felix; Rudan, Igor; Campbell, Harry] Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland; [Zgaga, Lina] Univ Zagreb, Sch Med, Andrija Stampar Sch Publ Hlth, Zagreb 41001, Croatia; [Theodoratou, Evropi; Farrington, Susan M.; Tenesa, Albert; Walker, Marion; Dunlop, Malcolm G.; Campbell, Harry] Univ Edinburgh, Inst Genet & Mol Med, Colon Canc Genet Grp, Edinburgh, Midlothian, Scotland; [Theodoratou, Evropi; Farrington, Susan M.; Tenesa, Albert; Walker, Marion; Wright, Alan F.; Dunlop, Malcolm G.; Campbell, Harry] Western Gen Hosp, MRC Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Kyle, Janet; McNeill, Geraldine] Rowett Inst Nutr & Hlth, Publ Hlth Nutr Res Grp, Bucksburn, Aberdeen, Scotland; [Agakov, Felix] Pharmatics Ltd, Edinburgh, Midlothian, Scotland; [Wright, Alan F.] Western Gen Hosp, Inst Genet & Mol Med, Edinburgh EH4 2XU, Midlothian, Scotland	University of Edinburgh; University of Zagreb; University of Edinburgh; University of Edinburgh; University of Aberdeen; University of Edinburgh	Zgaga, L (corresponding author), Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland.	lina.zgaga@ed.ac.uk; harry.campbell@ed.ac.uk	Farrington, Susan M/C-7319-2013; Theodoratou, Evropi/C-3430-2014; Farrington, Susan M/Q-2710-2019; Campbell, Harry/E-2959-2010; Dunlop, Malcolm G/F-1973-2011; Zgaga, Lina/Q-9415-2018; Rudan, Igor/I-1467-2012	Theodoratou, Evropi/0000-0001-5887-9132; Farrington, Susan M/0000-0001-5955-7389; Campbell, Harry/0000-0002-6169-6262; Dunlop, Malcolm G/0000-0002-3033-5851; Zgaga, Lina/0000-0003-4089-9703; Rudan, Igor/0000-0001-6993-6884; McNeill, Geraldine/0000-0003-0373-650X; Tenesa, Albert/0000-0003-4884-4475; Agakov, Felix/0000-0003-4280-9062	Cancer Research UK [C348/A3758, C348/A8896]; Scottish Government Chief Scientist Office [K/OPR/2/2/D333, CZB/4/94]; Medical Research Council [G0000657-53203]; Centre Grant from CORE as part of the Digestive Cancer Campaign; Cancer Research UK Fellowship [C31250/A10107]; Cancer Research UK [12076] Funding Source: researchfish; Medical Research Council [MC_PC_U127527198, MC_U127561128, MC_U127527198, MC_PC_U127561128, G0800604] Funding Source: researchfish; MRC [MC_U127561128, MC_PC_U127561128, MC_PC_U127527198, MC_U127527198, G0800604] Funding Source: UKRI	Cancer Research UK(Cancer Research UK); Scottish Government Chief Scientist Office; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Centre Grant from CORE as part of the Digestive Cancer Campaign; Cancer Research UK Fellowship(Cancer Research UK); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by grants from Cancer Research UK (C348/A3758, C348/A8896); Scottish Government Chief Scientist Office (K/OPR/2/2/D333, CZB/4/94); Medical Research Council (G0000657-53203); and Centre Grant from CORE as part of the Digestive Cancer Campaign (http://www.corecharity.org.uk). ET is funded by Cancer Research UK Fellowship C31250/A10107. There are no other financial disclosures. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott RD, 1996, STROKE, V27, P813, DOI 10.1161/01.STR.27.5.813; Annanmaki T, 2007, MOVEMENT DISORD, V22, P1133, DOI 10.1002/mds.21502; [Anonymous], 2010, R LANG ENV STAT COMP; [Anonymous], 2009, MCCANCE WIDDOWSONS C; Apovian CM, 2004, JAMA-J AM MED ASSOC, V292, P978, DOI 10.1001/jama.292.8.978; Bingham S, 2007, CANCER EPIDEM BIOMAR, V16, P1651, DOI 10.1158/1055-9965.EPI-06-1050; Bomback AS, 2010, KIDNEY INT, V77, P609, DOI 10.1038/ki.2009.500; BRESLAU NA, 1988, J CLIN ENDOCR METAB, V66, P140, DOI 10.1210/jcem-66-1-140; BRULE D, 1992, J AM COLL NUTR, V11, P353; Castenmiller JJM, 1999, J NUTR, V129, P2162, DOI 10.1093/jn/129.12.2162; Centres for Disease Control and Prevention, 1996, STAT HMNCFH; Choi HK, 2004, NEW ENGL J MED, V350, P1093, DOI 10.1056/NEJMoa035700; Choi HK, 2005, CURR OPIN RHEUMATOL, V17, P341; Choi HK, 2008, BMJ-BRIT MED J, V336, P309, DOI 10.1136/bmj.39449.819271.BE; Choi Hyon K., 2010, JAMA (Journal of the American Medical Association), V304, P2270, DOI 10.1001/jama.2010.1638; Choi JWJ, 2008, ARTHRIT RHEUM-ARTHR, V59, P109, DOI 10.1002/art.23245; CLIFFORD AJ, 1976, J NUTR, V106, P435, DOI 10.1093/jn/106.3.435; CLIFFORD AJ, 1976, J NUTR, V106, P428, DOI 10.1093/jn/106.3.428; Curhan GC, 2010, KIDNEY INT, V77, P569, DOI 10.1038/ki.2009.543; Dalbeth N, 2009, RHEUMATOLOGY, V48, P195, DOI 10.1093/rheumatology/ken416; Elliott SS, 2002, AM J CLIN NUTR, V76, P911, DOI 10.1093/ajcn/76.5.911; EMMERSON BT, 1974, ANN RHEUM DIS, V33, P276, DOI 10.1136/ard.33.3.276; FOX IH, 1972, METABOLISM, V21, P713, DOI 10.1016/0026-0495(72)90120-5; GARREL DR, 1991, AM J CLIN NUTR, V53, P665; GHADIRIAN P, 1995, EUR J EPIDEMIOL, V11, P275, DOI 10.1007/BF01719431; GIBSON T, 1983, ANN RHEUM DIS, V42, P123, DOI 10.1136/ard.42.2.123; HALLFRISCH J, 1990, FASEB J, V4, P2652, DOI 10.1096/fasebj.4.9.2189777; HARRIS CM, 1995, J CLIN EPIDEMIOL, V48, P1153, DOI 10.1016/0895-4356(94)00244-K; Hata Y, 1996, AM J CLIN NUTR, V64, P767, DOI 10.1093/ajcn/64.5.767; Holland B., 1991, MCCANCE WIDDOWSONS C, V5; Indyk HE, 2004, J AOAC INT, V87, P116; Jeroncic I, 2010, CROAT MED J, V51, P40, DOI 10.3325/cmj.2010.51.40; Johnson RJ, 2010, J AM SOC NEPHROL, V21, P2036, DOI 10.1681/ASN.2010050506; Johnson RJ, 2009, ENDOCR REV, V30, P96, DOI 10.1210/er.2008-0033; Jordan KM, 2007, RHEUMATOLOGY, V46, P1372, DOI 10.1093/rheumatology/kem056a; Kerksick CM, 2006, J STRENGTH COND RES, V20, P643, DOI 10.1519/R-17695.1; Livesey G, 2009, J NUTR, V139, pS1246, DOI 10.3945/jn.108.097949; LOENEN HMJA, 1990, J CLIN EPIDEMIOL, V43, P1297, DOI 10.1016/0895-4356(90)90095-7; Masson LF, 2003, PUBLIC HEALTH NUTR, V6, P313, DOI 10.1079/PHN2002429; Pal B, 2000, CLIN RHEUMATOL, V19, P21, DOI 10.1007/s100670050005; PERHEENT.J, 1967, LANCET, V2, P528; RAIVIO KO, 1975, METABOLISM, V24, P861, DOI 10.1016/0026-0495(75)90133-X; Schlesinger N, 2005, CURR PHARM DESIGN, V11, P4133, DOI 10.2174/138161205774913273; Sigman-Grant M, 2003, AM J CLIN NUTR, V78, p815S, DOI 10.1093/ajcn/78.4.815S; So A, 2010, J CLIN INVEST, V120, P1791, DOI 10.1172/JCI42344; STIRPE F, 1970, LANCET, V2, P1310; Sui XM, 2008, METABOLISM, V57, P845, DOI 10.1016/j.metabol.2008.01.030; Theodoratou E, 2007, CANCER EPIDEM BIOMAR, V16, P684, DOI 10.1158/1055-9965.EPI-06-0785; VERDI RJ, 1987, J DAIRY SCI, V70, P230, DOI 10.3168/jds.S0022-0302(87)80002-4; Wallace KL, 2004, J RHEUMATOL, V31, P1582; Yamakita J, 1998, ADV EXP MED BIOL, V431, P839; Zhang W, 2006, ANN RHEUM DIS, V65, P1312, DOI 10.1136/ard.2006.055269	52	77	84	3	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e38123	10.1371/journal.pone.0038123	http://dx.doi.org/10.1371/journal.pone.0038123			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701608	Green Published, Green Submitted, gold			2022-12-27	WOS:000305348400037
J	Kiware, SS; Chitnis, N; Moore, SJ; Devine, GJ; Majambere, S; Merrill, S; Killeen, GF				Kiware, Samson S.; Chitnis, Nakul; Moore, Sarah J.; Devine, Gregor J.; Majambere, Silas; Merrill, Stephen; Killeen, Gerry F.			Simplified Models of Vector Control Impact upon Malaria Transmission by Zoophagic Mosquitoes	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM INFECTION; ENTOMOLOGIC INOCULATION RATES; IMPREGNATED PLASTIC STRIPS; ANOPHELES-GAMBIAE COMPLEX; INSECTICIDE-TREATED NETS; AN.-QUADRIANNULATUS; SPATIAL REPELLENCY; HOST-PREFERENCE; BLOOD MEALS; BED NETS	Background: High coverage of personal protection measures that kill mosquitoes dramatically reduce malaria transmission where vector populations depend upon human blood. However, most primary malaria vectors outside of sub-Saharan Africa can be classified as "very zoophagic," meaning they feed occasionally (<10% of blood meals) upon humans, so personal protection interventions have negligible impact upon their survival. Methods and Findings: We extended a published malaria transmission model to examine the relationship between transmission, control, and the baseline proportion of bloodmeals obtained from humans (human blood index). The lower limit of the human blood index enables derivation of simplified models for zoophagic vectors that (1) Rely on only three field-measurable parameters. (2) Predict immediate and delayed (with and without assuming reduced human infectivity, respectively) impacts of personal protection measures upon transmission. (3) Illustrate how appreciable indirect communal-level protection for non-users can be accrued through direct personal protection of users. (4) Suggest the coverage and efficacy thresholds required to attain epidemiological impact. The findings suggest that immediate, indirect, community-wide protection of users and non-users alike may linearly relate to the efficacy of a user's direct personal protection, regardless of whether that is achieved by killing or repelling mosquitoes. High protective coverage and efficacy (>= 80%) are important to achieve epidemiologically meaningful impact. Non-users are indirectly protected because the two most common species of human malaria are strict anthroponoses. Therefore, the small proportion of mosquitoes that are killed or diverted while attacking humans can represent a large proportion of those actually transmitting malaria. Conclusions: Simplified models of malaria transmission by very zoophagic vectors may be used by control practitioners to predict intervention impact interventions using three field-measurable parameters; the proportion of human exposure to mosquitoes occurring when an intervention can be practically used, its protective efficacy when used, and the proportion of people using it.	[Kiware, Samson S.; Moore, Sarah J.; Devine, Gregor J.; Majambere, Silas; Killeen, Gerry F.] Ifakara Hlth Inst, Biomed & Environm Themat Grp, Ifakara, Tanzania; [Kiware, Samson S.; Merrill, Stephen] Marquette Univ, Dept Math Stat & Comp Sci, Milwaukee, WI 53233 USA; [Chitnis, Nakul] Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, Basel, Switzerland; [Chitnis, Nakul] Univ Basel, Basel, Switzerland; [Moore, Sarah J.] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; [Devine, Gregor J.; Majambere, Silas; Killeen, Gerry F.] Univ Liverpool, Liverpool Sch Trop Med, Vector Grp, Liverpool L3 5QA, Merseyside, England	Ifakara Health Institute; Marquette University; University of Basel; Swiss Tropical & Public Health Institute; University of Basel; University of London; London School of Hygiene & Tropical Medicine; Liverpool School of Tropical Medicine; University of Liverpool	Kiware, SS (corresponding author), Ifakara Hlth Inst, Biomed & Environm Themat Grp, Ifakara, Tanzania.	skiware@ihi.or.tz	Chitnis, Nakul/B-3105-2013; Smith, Thomas/B-5569-2015; Devine, Gregor J/H-1141-2014; Moore, Sarah J/HGE-7143-2022	Smith, Thomas/0000-0002-3650-9381; Devine, Gregor J/0000-0001-6312-0390; Moore, Sarah J/0000-0002-0938-6654; Chitnis, Nakul/0000-0002-1103-9141; Kiware, Samson/0000-0001-7252-520X	Bill & Melinda Gates Foundation [45114, 51431, 52644, 39777.01]	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This work was funded in part by the Bill & Melinda Gates Foundation through award numbers 45114 (Malaria Transmission Consortium), 51431 (Replacing DDT: Rigorous Evaluation of Spatial Repellents for the Control of Vector Borne Diseases), 52644 (Control of Anophelines by the auto-dissemination of insecticides) and 39777.01 (A stochastic simulation platform for predicting the effects of different malaria intervention strategies). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	ANDERSON R M, 1991; [Anonymous], 1987, SUPPLEMENT ANOPHELIN; [Anonymous], 2007, INS TREAT MOSQ NETS; Antonio-Nkondjio C, 2006, J MED ENTOMOL, V43, P1215, DOI 10.1603/0022-2585(2006)43[1215:COTMVS]2.0.CO;2; Balkew M, 2010, RES INSECTICIDE RESI; Bayoh MN, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-62; Beier JC, 1999, AM J TROP MED HYG, V61, P109, DOI 10.4269/ajtmh.1999.61.109; Besansky NJ, 2004, TRENDS PARASITOL, V20, P249, DOI 10.1016/j.pt.2004.03.007; Bogh C, 2001, J MED ENTOMOL, V38, P822, DOI 10.1603/0022-2585-38.6.822; Bugoro H, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-133; Chitnis N, 2010, AM J TROP MED HYG, V83, P230, DOI 10.4269/ajtmh.2010.09-0179; Coetzee M, 2000, PARASITOL TODAY, V16, P74, DOI 10.1016/S0169-4758(99)01563-X; ELLIOTT R, 1968, B WORLD HEALTH ORGAN, V38, P239; Garrett-Jones C., 1964, Bulletin of the World Health Organization, V30, P241; GARRETTJONES C, 1969, B WORLD HEALTH ORGAN, V40, P531; GARRETTJONES C, 1980, B ENTOMOL RES, V70, P165, DOI 10.1017/S0007485300007422; Geissbuhler Y, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-126; Gerry K, 2011, PARASIT VECTORS, P4; Gillies M., 1960, B ENTOMOL RES, V51, P248, DOI DOI 10.1017/S0007485300057953; Gillies M, 1962, NEW SPECIES ANOPHELE, P81; GILLIES M. T., 1964, Bulletin of Entomological Research, V55, P1, DOI 10.1017/S0007485300049221; GITHEKO AK, 1994, ACTA TROP, V58, P307, DOI 10.1016/0001-706X(94)90024-8; Govella NJ, 2010, AM J TROP MED HYG, V82, P415, DOI 10.4269/ajtmh.2010.09-0579; Griffin JT, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000324; Guerra CA, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000774; Hargreaves K, 2003, MED VET ENTOMOL, V17, P417, DOI 10.1111/j.1365-2915.2003.00460.x; Hawley WA, 2003, AM J TROP MED HYG, V68, P121, DOI 10.4269/ajtmh.2003.68.121; Hay SI, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000290; Hoffmann EJ, 2002, J MED ENTOMOL, V39, P935, DOI 10.1603/0022-2585-39.6.935; Kawada H, 2008, J AM MOSQUITO CONTR, V24, P404, DOI 10.2987/5743.1; Kawada H, 2005, J VECTOR ECOL, V30, P181; Kay B, 1979, MOSQ NEWS; Kent RJ, 2007, AM J TROP MED HYG, V76, P267, DOI 10.4269/ajtmh.2007.76.267; Killeen GF, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-121; Killeen GF, 2007, PLOS MED, V4, P1246, DOI 10.1371/journal.pmed.0040229; Killeen GF, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-161; Killeen GF, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-17; Killeen GF, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-207; Killeen GF, 2001, T ROY SOC TROP MED H, V95, P469, DOI 10.1016/S0035-9203(01)90005-7; Killeen GF, 2000, AM J TROP MED HYG, V62, P535, DOI 10.4269/ajtmh.2000.62.535; Kiszewski A, 2004, AM J TROP MED HYG, V70, P486, DOI 10.4269/ajtmh.2004.70.486; Le Menach A, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-10; Lengeler C, 2003, INDOOR RESIDUAL SPRA, P17; Lwetoijera DW, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-18; Lyimo IN, 2009, TRENDS PARASITOL, V25, P189, DOI 10.1016/j.pt.2009.01.005; Macdonald G., 1957, EPIDEMIOLOGY CONTROL; Ogoma SB, 2012, PARASIT VECTORS; Okumu FO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011573; Prior A, 2002, MED VET ENTOMOL, V16, P207, DOI 10.1046/j.1365-2915.2002.00367.x; Reddy MR, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-184; Ross A, 2006, AM J TROP MED HYG, V75, P32, DOI 10.4269/ajtmh.2006.75.32; Russell T, 2010, MALARIA J, V9, P62; Russell TL, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-80; Sama W, 2004, AM J TROP MED HYG, V70, P625, DOI 10.4269/ajtmh.2004.70.625; Saul A, 1996, PARASITOL TODAY, V12, P74, DOI 10.1016/0169-4758(96)80659-4; Saul A, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-32; SHALABY AM, 1969, ANN ENTOMOL SOC AM, V62, P1270, DOI 10.1093/aesa/62.6.1270; Simpson JE, 2011, P R SOC B; Sinka ME, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-89; Smith DL, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-87; Smith DL, 2005, NATURE, V438, P492, DOI 10.1038/nature04024; Smith T, 2006, AM J TROP MED HYG, V75, P11, DOI 10.4269/ajtmh.2006.75.2_suppl.0750011; SOTA T, 1989, MED VET ENTOMOL, V3, P337, DOI 10.1111/j.1365-2915.1989.tb00240.x; Takken W, 1999, T ROY SOC TROP MED H, V93, P578, DOI 10.1016/S0035-9203(99)90054-8; TEMPELIS CH, 1975, J MED ENTOMOL, V11, P635, DOI 10.1093/jmedent/11.6.635; Torr S, 2008, MED VET ENTOMOL, V22, P93, DOI 10.1111/j.1365-2915.2008.00723.x; Trung HD, 2005, TROP MED INT HEALTH, V10, P251, DOI 10.1111/j.1365-3156.2004.01378.x; WHITE GB, 1974, T ROY SOC TROP MED H, V68, P278, DOI 10.1016/0035-9203(74)90035-2; WHITE GB, 1972, B ENTOMOL RES, V62, P295, DOI 10.1017/S0007485300047738; Yakob L, 2011, J R SOC INTERFACE, V8, P799, DOI 10.1098/rsif.2010.0537	70	39	39	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e37661	10.1371/journal.pone.0037661	http://dx.doi.org/10.1371/journal.pone.0037661			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22701527	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000305338500048
J	Shamoun-Baranes, J; Bom, R; van Loon, EE; Ens, BJ; Oosterbeek, K; Bouten, W				Shamoun-Baranes, Judy; Bom, Roeland; van Loon, E. Emiel; Ens, Bruno J.; Oosterbeek, Kees; Bouten, Willem			From Sensor Data to Animal Behaviour: An Oystercatcher Example	PLOS ONE			English	Article							HAEMATOPUS-OSTRALEGUS; ENERGY-EXPENDITURE; ACCELERATION DATA; PELAGIC SEABIRD; FLIGHT; MOVEMENTS; MIGRATION; INSIGHTS; TRACKING; BIRDS	Animal-borne sensors enable researchers to remotely track animals, their physiological state and body movements. Accelerometers, for example, have been used in several studies to measure body movement, posture, and energy expenditure, although predominantly in marine animals. In many studies, behaviour is often inferred from expert interpretation of sensor data and not validated with direct observations of the animal. The aim of this study was to derive models that could be used to classify oystercatcher (Haematopus ostralegus) behaviour based on sensor data. We measured the location, speed, and tri-axial acceleration of three oystercatchers using a flexible GPS tracking system and conducted simultaneous visual observations of the behaviour of these birds in their natural environment. We then used these data to develop three supervised classification trees of behaviour and finally applied one of the models to calculate time-activity budgets. The model based on accelerometer data developed to classify three behaviours (fly, terrestrial locomotion, and no movement) was much more accurate (cross-validation error = 0.14) than the model based on GPS-speed alone (cross-validation error = 0.35). The most parsimonious acceleration model designed to classify eight behaviours could distinguish five: fly, forage, body care, stand, and sit (cross-validation error = 0.28); other behaviours that were observed, such as aggression or handling of prey, could not be distinguished. Model limitations and potential improvements are discussed. The workflow design presented in this study can facilitate model development, be adapted to a wide range of species, and together with the appropriate measurements, can foster the study of behaviour and habitat use of free living animals throughout their annual routine.	[Shamoun-Baranes, Judy; Bom, Roeland; van Loon, E. Emiel; Bouten, Willem] Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Amsterdam, Netherlands; [Bom, Roeland] Royal Netherlands Inst Sea Res NIOZ, Dept Marine Ecol & Evolut, Ab Den Burg, Texel, Netherlands; [Ens, Bruno J.; Oosterbeek, Kees] SOVON Dutch Ctr Field Ornithol, Coastal Ecol Team, Ab Den Burg, Texel, Netherlands	University of Amsterdam; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ)	Shamoun-Baranes, J (corresponding author), Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Amsterdam, Netherlands.	shamoun@uva.nl	Bouten, Willem/G-4383-2018; Shamoun-Baranes, Judy/Q-1311-2019; Shamoun-Baranes, Judy/C-6921-2013; van Loon, Emiel/T-3858-2019	Bouten, Willem/0000-0002-5250-8872; Shamoun-Baranes, Judy/0000-0002-1652-7646; Shamoun-Baranes, Judy/0000-0002-1652-7646; van Loon, Emiel/0000-0002-8895-0427				Aviles JM, 2004, BIODIVERS CONSERV, V13, P2015, DOI 10.1023/B:BIOC.0000039999.57645.23; Bidder OR, 2012, ZOOLOGY, V115, P58, DOI 10.1016/j.zool.2011.09.003; Blair MJ, EBCC ATLAS EUROPEAN; Bograd Steven J., 2010, Endangered Species Research, V10, P1, DOI 10.3354/esr00269; Breiman L., 1984, CLASSIFICATION REGRE; Bridge ES, 2011, BIOSCIENCE, V61, P689, DOI 10.1525/bio.2011.61.9.7; Bruderer B, 2001, IBIS, V143, P178, DOI 10.1111/j.1474-919X.2001.tb04475.x; Bruderer B, 2010, IBIS, V152, P272, DOI 10.1111/j.1474-919X.2010.01014.x; Camphuysen K, 2012, BIOL CONSERV, V156, P22, DOI 10.1016/j.biocon.2011.12.024; Cooke SJ, 2004, TRENDS ECOL EVOL, V19, P334, DOI 10.1016/j.tree.2004.04.003; Cumming GS, 2008, ECOL SOC, V13; ENS BJ, 1993, ANIM BEHAV, V45, P1199, DOI 10.1006/anbe.1993.1142; ENS BJ, 1992, J ANIM ECOL, V61, P703, DOI 10.2307/5625; Fossette S, 2012, FUNCT ECOL, V26, P324, DOI 10.1111/j.1365-2435.2011.01960.x; Gaidet N, 2010, J APPL ECOL, V47, P1147, DOI 10.1111/j.1365-2664.2010.01845.x; Gleiss AC, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1350; Gleiss AC, 2011, METHODS ECOL EVOL, V2, P23, DOI 10.1111/j.2041-210X.2010.00057.x; Green JA, 2009, J EXP BIOL, V212, P471, DOI 10.1242/jeb.026377; Guilford T, 2009, P ROY SOC B-BIOL SCI, V276, P1215, DOI 10.1098/rspb.2008.1577; Guilford TC, 2008, IBIS, V150, P462, DOI 10.1111/j.1474-919X.2008.00805.x; Halsey LG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010170; Halsey LG, 2009, J FIELD ORNITHOL, V80, P171, DOI 10.1111/j.1557-9263.2009.00219.x; Hart Kristen M., 2010, Endangered Species Research, V10, P9, DOI 10.3354/esr00238; Hastie T., 2009, UNSUPERVISED LEARNIN; Heg D, 2000, BEHAVIOUR, V137, P473, DOI 10.1163/156853900502187; Holland RA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008264; Kersten M, 1996, ARDEA, V84A, P291; Kersten M, 1996, ARDEA, V84A, P57; Klaassen RHG, 2008, BEHAV ECOL SOCIOBIOL, V62, P1427, DOI 10.1007/s00265-008-0572-x; Kuhn CE, 2009, MAR ECOL PROG SER, V393, P97, DOI 10.3354/meps08229; MCLELLAN BN, 1988, J APPL ECOL, V25, P451, DOI 10.2307/2403836; Miller PJO, 2004, J EXP BIOL, V207, P1953, DOI 10.1242/jeb.00993; Millspaugh JJ, RADIO TRACKING ANIMA; Mitani Y, 2010, BIOL LETTERS, V6, P163, DOI 10.1098/rsbl.2009.0719; NORBERG RA, 1977, J ANIM ECOL, V46, P511, DOI 10.2307/3827; Okuyama Junichi, 2010, Endangered Species Research, V10, P39, DOI 10.3354/esr00215; Pichegru L, 2007, MAR ECOL PROG SER, V350, P127, DOI 10.3354/meps07128; Prasad AM, 2006, ECOSYSTEMS, V9, P181, DOI 10.1007/s10021-005-0054-1; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Robinson WD, 2010, FRONT ECOL ENVIRON, V8, P354, DOI 10.1890/080179; Ropert-Coudert Y, 2005, FRONT ECOL ENVIRON, V3, P437, DOI 10.2307/3868660; Ropert-Coudert Y, 2004, ANIM BEHAV, V67, P985, DOI 10.1016/j.anbehav.2003.09.010; Ropert-Coudert Yan, 2010, Endangered Species Research, V10, P21, DOI 10.3354/esr00188; Ropert-Coudert Y, 2009, J AVIAN BIOL, V40, P380, DOI 10.1111/j.1600-048X.2008.04592.x; Rutz C, 2009, BIOL LETTERS, V5, P289, DOI 10.1098/rsbl.2009.0089; Sakamoto KQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005379; Schwemmer P, 2011, MAR BIOL, V158, P541, DOI 10.1007/s00227-010-1579-1; Shamoun-Baranes J, 2003, J AVIAN BIOL, V34, P97, DOI 10.1034/j.1600-048X.2003.03079.x; Shamoun-Baranes J, 2006, J EXP BIOL, V209, P3489, DOI 10.1242/jeb.02385; Shamoun-Baranes J, 2012, BIOL LETTERS, V8, P6, DOI 10.1098/rsbl.2011.0764; Shamoun-Baranes J, 2011, IBIS, V153, P411, DOI 10.1111/j.1474-919X.2010.01096.x; Shepard ELC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027375; Shepard Emily L. C., 2010, Endangered Species Research, V10, P47, DOI 10.3354/esr00084; Sutherland WJ, 2006, J APPL ECOL, V43, P617, DOI 10.1111/j.1365-2664.2006.01188.x; Themeau T. M., 1997, INTRO RECURSIVE PART; Thorup K, 2006, BEHAV ECOL, V17, P497, DOI 10.1093/beheco/arj054; van de Pol M, 2010, EVOLUTION, V64, P836, DOI 10.1111/j.1558-5646.2009.00859.x; Watanabe S, 2005, APPL ANIM BEHAV SCI, V94, P117, DOI 10.1016/j.applanim.2005.01.010; Weimerskirch H, 2005, P ROY SOC B-BIOL SCI, V272, P53, DOI 10.1098/rspb.2004.2918; Weimerskirch H, 2003, J ANIM ECOL, V72, P500, DOI 10.1046/j.1365-2656.2002.00720.x; Whitney Nicholas M., 2010, Endangered Species Research, V10, P71, DOI 10.3354/esr00247; Wilson Rory P., 2008, Endangered Species Research, V4, P123, DOI 10.3354/esr00064; Wilson RP, 2006, J ANIM ECOL, V75, P1081, DOI 10.1111/j.1365-2656.2006.01127.x; Wilson RP, 2008, ENDANGER SPECIES RES, V10, P29, DOI [10.3354/esr00091, DOI 10.3354/ESR00091]; Witte TH, 2004, J BIOMECH, V37, P1891, DOI 10.1016/j.jbiomech.2004.02.031; Yoda K, 2004, P ROY SOC B-BIOL SCI, V271, pS240, DOI 10.1098/rsbl.2003.0157; Yoda K, 2001, J EXP BIOL, V204, P685; Zijlstra W, 2003, GAIT POSTURE, V18, P1, DOI 10.1016/S0966-6362(02)00190-X	68	95	100	0	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e37997	10.1371/journal.pone.0037997	http://dx.doi.org/10.1371/journal.pone.0037997			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693586	Green Published, gold, Green Submitted			2022-12-27	WOS:000305338500070
J	Simoes, RD; Howard, KE; Dean, GA				Simoes, Rita D.; Howard, Kristina E.; Dean, Gregg A.			In Vivo Assessment of Natural Killer Cell Responses during Chronic Feline Immunodeficiency Virus Infection	PLOS ONE			English	Article							LISTERIA-MONOCYTOGENES INFECTION; ACTIVE ANTIRETROVIRAL THERAPY; PATHOGEN-FREE CATS; DENDRITIC CELLS; T-LYMPHOCYTES; HIV-1 INFECTION; LYMPH-NODES; INTRACELLULAR BACTERIUM; MONOCLONAL-ANTIBODIES; CYTOKINE RESPONSE	Accumulating evidence suggests that natural killer (NK) cells may have an important role in HIV-1 disease pathogenesis; however, in vivo studies are lacking. Feline immunodeficiency virus (FIV) infection of cats provides a valuable model to study NK cell function in vivo. The immune response against Listeria monocytogenes (Lm) is well characterized, allowing its use as an innate immune probe. We have previously shown that locally delivered IL-15 can improve Lm clearance in FIV-infected animals, and this correlated with an increase in NK cell number. In the present study, chronically FIV-infected and SPF-control cats were challenged with Lm by unilateral subcutaneous injection next to the footpad and then treated with 5-bromo-2'-deoxyuridine (BrdU). The Lm draining and contralateral control lymph nodes were evaluated for NK, NKT, CD4(+) and CD8(+) T cell number, proliferation, apoptosis, and NK cell function. Listeria monocytogenes burden was also assessed in both control and Lm draining lymph nodes. NK, NKT, CD4(+) T and CD8(+) T cells in the Lm-challenged lymph node of FIV-infected cats did not increase in number. In addition, after Lm challenge, NK cells from FIV-infected cats did not increase their proliferation rate, apoptosis was elevated, and perforin expression was not upregulated when compared to SPF-control cats. The failure of the NK cell response against Lm challenge in the draining lymph node of FIV-infected cats correlates with the delayed control and clearance of this opportunistic bacterial pathogen.	[Simoes, Rita D.; Howard, Kristina E.; Dean, Gregg A.] N Carolina State Univ, Coll Vet Med, Ctr Comparat Med & Translat Res, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University	Simoes, RD (corresponding author), N Carolina State Univ, Coll Vet Med, Ctr Comparat Med & Translat Res, Raleigh, NC 27695 USA.	gregg.dean@colostate.edu	Dean, Gregg A/A-5623-2012	Dean, Gregg A/0000-0001-7025-9550	National Institutes of Health [R01-AI047707]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047707] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health [grant number R01-AI047707]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam C, 2005, BLOOD, V106, P338, DOI 10.1182/blood-2004-09-3775; Ahmad R, 2001, J MED VIROL, V65, P431, DOI 10.1002/jmv.2053.abs; Alter G, 2006, AIDS, V20, P1549, DOI 10.1097/01.aids.0000237371.31315.48; Andre P, 1999, EUR J IMMUNOL, V29, P1076, DOI 10.1002/(SICI)1521-4141(199904)29:04<1076::AID-IMMU1076>3.0.CO;2-Z; Assogba BD, 2007, J INFECT DIS, V195, P1184, DOI 10.1086/512861; BANCROFT GJ, 1987, J IMMUNOL, V139, P1104; BANCROFT GJ, 1993, CURR OPIN IMMUNOL, V5, P503, DOI 10.1016/0952-7915(93)90030-V; Becknell B, 2005, ADV IMMUNOL, V86, P209, DOI 10.1016/S0065-2776(04)86006-1; Biancotto A, 2007, BLOOD, V109, P4272, DOI 10.1182/blood-2006-11-055764; Burkhard MJ, 2003, CURR HIV RES, V1, P15, DOI 10.2174/1570162033352101; De Boer RJ, 2003, J IMMUNOL, V170, P2479, DOI 10.4049/jimmunol.170.5.2479; Dean GA, 2006, J INFECT DIS, V193, P1520, DOI 10.1086/503873; Dean GA, 1998, J VIROL, V72, P9436, DOI 10.1128/JVI.72.12.9436-9440.1998; Dean GA, 1998, VET IMMUNOL IMMUNOP, V65, P125, DOI 10.1016/S0165-2427(98)00148-2; DUNN PL, 1991, INFECT IMMUN, V59, P2892, DOI 10.1128/IAI.59.9.2892-2900.1991; Elder JH, 1998, AIDS RES HUM RETROV, V14, P797, DOI 10.1089/aid.1998.14.797; Elder JH, 2010, CURR HIV RES, V8, P73, DOI 10.2174/157016210790416389; Giorgi JV, 1999, J INFECT DIS, V179, P859, DOI 10.1086/314660; GRATZNER HG, 1982, SCIENCE, V218, P474, DOI 10.1126/science.7123245; Hazenberg MD, 2000, BLOOD, V95, P249, DOI 10.1182/blood.V95.1.249.001k40_249_255; Howard KE, 2005, J IMMUNOL METHODS, V302, P36, DOI 10.1016/j.jim.2005.04.019; Howard KE, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-2; KAGI D, 1994, EUR J IMMUNOL, V24, P3068, DOI 10.1002/eji.1830241223; Kang SJ, 2008, IMMUNITY, V29, P819, DOI 10.1016/j.immuni.2008.09.017; KAWASAKI A, 1990, INT IMMUNOL, V2, P677, DOI 10.1093/intimm/2.7.677; Kottilil S, 2003, J INFECT DIS, V187, P1038, DOI 10.1086/368222; Kottilil S, 2007, JAIDS-J ACQ IMM DEF, V46, P151, DOI 10.1097/QAI.0b013e3180dc9909; Kovacs JA, 2001, J EXP MED, V194, P1731, DOI 10.1084/jem.194.12.1731; Luteijn R, 2011, EUR J IMMUNOL, V41, P2729, DOI 10.1002/eji.201040886; Martin MP, 2007, NAT GENET, V39, P733, DOI 10.1038/ng2035; Martin MP, 2002, NAT GENET, V31, P429, DOI 10.1038/ng934; Martin-Fontecha A, 2003, J EXP MED, V198, P615, DOI 10.1084/jem.20030448; Mikkelsen SR, 2010, VIROLOGY, V403, P163, DOI 10.1016/j.virol.2010.04.016; Mocikat R, 2003, IMMUNITY, V19, P561, DOI 10.1016/S1074-7613(03)00264-4; Mohri H, 1998, SCIENCE, V279, P1223, DOI 10.1126/science.279.5354.1223; Moretta A, 2005, TRENDS IMMUNOL, V26, P668, DOI 10.1016/j.it.2005.09.008; Moretta A, 2002, NAT REV IMMUNOL, V2, P957, DOI 10.1038/nri956; Nishimura Y, 2004, J GEN VIROL, V85, P2585, DOI 10.1099/vir.0.80102-0; Pamer EG, 2004, NAT REV IMMUNOL, V4, P812, DOI 10.1038/nri1461; Pedersen NC, 2001, VET IMMUNOL IMMUNOP, V79, P53, DOI 10.1016/S0165-2427(01)00252-5; Reeves RK, 2010, J VIROL, V84, P8959, DOI 10.1128/JVI.01126-10; Sachsenberg N, 1998, J EXP MED, V187, P1295, DOI 10.1084/jem.187.8.1295; Scott-Algara D, 2003, J IMMUNOL, V171, P5663, DOI 10.4049/jimmunol.171.11.5663; Shegarfi H, 2009, SCAND J IMMUNOL, V70, P238, DOI 10.1111/j.1365-3083.2009.02292.x; Stevens R, 2004, J VIROL, V78, P8210, DOI 10.1128/JVI.78.15.8210-8218.2004; TAKADA H, 1994, IMMUNOLOGY, V82, P106; TEIXEIRA HC, 1994, J IMMUNOL, V152, P1873; TOMPKINS MB, 1990, VET IMMUNOL IMMUNOP, V26, P305, DOI 10.1016/0165-2427(90)90115-9; ULLUM H, 1995, J EXP MED, V182, P789, DOI 10.1084/jem.182.3.789; Valentin A, 2002, P NATL ACAD SCI USA, V99, P7015, DOI 10.1073/pnas.102672999; von Andrian UH, 2003, NAT REV IMMUNOL, V3, P867, DOI 10.1038/nri1222; Voskoboinik I, 2010, IMMUNOL REV, V235, P35, DOI 10.1111/j.0105-2896.2010.00896.x; Vujanovic L, 2010, BLOOD, V116, P575, DOI 10.1182/blood-2009-08-240325; Yang JS, 1996, J VIROL, V70, P3011, DOI 10.1128/JVI.70.5.3011-3017.1996	54	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e37606	10.1371/journal.pone.0037606	http://dx.doi.org/10.1371/journal.pone.0037606			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22701523	Green Published, gold, Green Submitted			2022-12-27	WOS:000305338500044
J	Zeng, XF; Wang, T; Zhu, CR; Xing, XB; Ye, YX; Lai, XQ; Song, B; Zeng, YY				Zeng, Xiangfeng; Wang, Tong; Zhu, Cairong; Xing, Xiaobo; Ye, Yanxia; Lai, Xinqiang; Song, Bing; Zeng, Yaoying			Topographical and Biological Evidence Revealed FTY720-Mediated Anergy-Polarization of Mouse Bone Marrow-Derived Dendritic Cells In Vitro	PLOS ONE			English	Article							NITRIC-OXIDE; MEMBRANE-VESICLES; CHEMOKINE RECEPTOR; FTY720; INFLAMMATION; ATHEROSCLEROSIS; MODULATION; FINGOLIMOD; EXPRESSION; CYTOKINES	Abnormal inflammations are central therapeutic targets in numerous infectious and autoimmune diseases. Dendritic cells (DCs) are involved in these inflammations, serving as both antigen presenters and proinflammatory cytokine providers. As an immuno-suppressor applied to the therapies of multiple sclerosis and allograft transplantation, fingolimod (FTY720) was shown to affect DC migration and its crosstalk with T cells. We posit FTY720 can induce an anergy-polarized phenotype switch on DCs in vitro, especially upon endotoxic activation. A lipopolysaccharide (LPS)-induced mouse bone marrow-derived dendritic cell (BMDC) activation model was employed to test FTY720-induced phenotypic changes on immature and mature DCs. Specifically, methods for morphology, nanostructure, cytokine production, phagocytosis, endocytosis and specific antigen presentation studies were used. FTY720 induced significant alterations of surface markers, as well as decline of shape indices, cell volume, surface roughness in LPS-activated mature BMDCs. These phenotypic, morphological and topographical changes were accompanied by FTY720-mediated down-regulation of proinflammatory cytokines, including IL-6, TNF-alpha, IL-12 and MCP-1. Together with suppressed nitric oxide (NO) production and CCR7 transcription in FTY720-treated BMDCs with or without LPS activation, an inhibitory mechanism of NO and cytokine reciprocal activation was suggested. This implication was supported by the impaired phagocytotic, endocytotic and specific antigen presentation abilities observed in the FTY720-treated BMDCs. In conclusion, we demonstrated FTY720 can induce anergy-polarization in both immature and LPS-activated mature BMDCs. A possible mechanism is FTY720-mediated reciprocal suppression on the intrinsic activation pathway and cytokine production with endpoint exhibitions on phagocytosis, endocytosis, antigen presentation as well as cellular morphology and topography.	[Zeng, Xiangfeng; Wang, Tong; Ye, Yanxia; Lai, Xinqiang; Song, Bing; Zeng, Yaoying] Jinan Univ, Inst Tissue Transplantat & Immunol, Guangzhou, Guangdong, Peoples R China; [Wang, Tong] Jinan Univ, Inst Life & Hlth Engn, Guangzhou, Guangdong, Peoples R China; [Xing, Xiaobo] Jinan Univ, Dept Chem, Guangzhou, Guangdong, Peoples R China; [Zhu, Cairong] Guangzhou Women & Childrens Med Ctr, Guangzhou, Guangdong, Peoples R China; [Xing, Xiaobo] S China Normal Univ, MOE, Key Lab Laser Life Sci, Guangzhou, Guangdong, Peoples R China; [Xing, Xiaobo] S China Normal Univ, Inst Laser Life Sci, Guangzhou, Guangdong, Peoples R China	Jinan University; Jinan University; Jinan University; South China Normal University; South China Normal University	Zeng, XF (corresponding author), Jinan Univ, Inst Tissue Transplantat & Immunol, Guangzhou, Guangdong, Peoples R China.	tzengyy@jnu.edu.cn	Wang, Tong/A-2750-2011	Wang, Tong/0000-0002-5980-3380	National Natural and Science Foundation of China [81000516]; University of Washington Center for AIDS Research New Investigator Award (UW Centers for AIDS Research National Institute on Aging, National Institutes of Health) [P30 AI027757]; Fundamental Research Funds for the Central Universities of China; Doctoral Fund of Ministry of Education of China [20104401120008]; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry, China; Science and Technology Planning Project of Guangdong Province, China [2011B061300065]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027757] Funding Source: NIH RePORTER	National Natural and Science Foundation of China(National Natural Science Foundation of China (NSFC)); University of Washington Center for AIDS Research New Investigator Award (UW Centers for AIDS Research National Institute on Aging, National Institutes of Health); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities); Doctoral Fund of Ministry of Education of China(Ministry of Education, China); Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry, China(Scientific Research Foundation for the Returned Overseas Chinese ScholarsMinistry of Education, China); Science and Technology Planning Project of Guangdong Province, China; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Natural and Science Foundation of China (81000516), the University of Washington Center for AIDS Research New Investigator Award (UW Centers for AIDS Research National Institute on Aging, National Institutes of Health grant P30 AI027757), the Fundamental Research Funds for the Central Universities of China, the Doctoral Fund of Ministry of Education of China (20104401120008), and the Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry, China to TW; as well as Science and Technology Planning Project of Guangdong Province, China (2011B061300065) to CZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi K, 2007, PERSPECT MED CHEM, V1, P11; Aktas O, 2010, NAT REV NEUROL, V6, P373, DOI 10.1038/nrneurol.2010.76; Alaniz RC, 2007, J IMMUNOL, V179, P7692, DOI 10.4049/jimmunol.179.11.7692; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Blanco P, 2008, CYTOKINE GROWTH F R, V19, P41, DOI 10.1016/j.cytogfr.2007.10.004; Bobryshev YV, 2005, EUR HEART J, V26, P1700, DOI 10.1093/eurheartj/ehi282; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; Brinkmann V, 2010, NAT REV DRUG DISCOV, V9, P883, DOI 10.1038/nrd3248; Cai XF, 2010, MICRON, V41, P257, DOI 10.1016/j.micron.2009.08.011; Chaudhuri A, 2008, BLOOD, V111, P2062, DOI 10.1182/blood-2007-05-091207; Chen JK, 1999, CHEM BIOL, V6, P221, DOI 10.1016/S1074-5521(99)80038-6; Chen M, 2006, SCIENCE, V311, P1160, DOI 10.1126/science.1122545; Chino T, 2009, J LEUKOCYTE BIOL, V86, P933, DOI 10.1189/jlb.0708419; Cohen JA, 2010, NEW ENGL J MED, V362, P402, DOI 10.1056/NEJMoa0907839; DEAKIN AM, 1995, CYTOKINE, V7, P408, DOI 10.1006/cyto.1995.0056; deVera ME, 1996, P NATL ACAD SCI USA, V93, P1054, DOI 10.1073/pnas.93.3.1054; Eriksson U, 2003, NAT MED, V9, P1484, DOI 10.1038/nm960; Ferlazzo G, 2001, IMMUNOL LETT, V76, P37, DOI 10.1016/S0165-2478(00)00323-0; FUJITA T, 1994, J ANTIBIOT, V47, P208, DOI 10.7164/antibiotics.47.208; Giordano D, 2006, BLOOD, V107, P1537, DOI 10.1182/blood-2005-07-2901; Glasser SW, 2008, J IMMUNOL, V181, P621, DOI 10.4049/jimmunol.181.1.621; Gorantla S, 2008, GLIA, V56, P223, DOI 10.1002/glia.20607; Green CE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006713; Greter M, 2005, NAT MED, V11, P328, DOI 10.1038/nm1197; Harizi H, 2002, J IMMUNOL, V168, P2255, DOI 10.4049/jimmunol.168.5.2255; Heijnen HFG, 1999, BLOOD, V94, P3791, DOI 10.1182/blood.V94.11.3791.423a22_3791_3799; Heng Y, 2010, TRANSPL INT, V23, P1259, DOI 10.1111/j.1432-2277.2010.01119.x; Hussain SP, 2008, CANCER RES, V68, P7130, DOI 10.1158/0008-5472.CAN-08-0410; Idzko M, 2006, J CLIN INVEST, V116, P2935, DOI 10.1172/JCI28295; Kadiu I, 2009, CELL IMMUNOL, V258, P44, DOI 10.1016/j.cellimm.2009.03.012; Karp CL, 1998, EUR J IMMUNOL, V28, P3128, DOI 10.1002/(SICI)1521-4141(199810)28:10<3128::AID-IMMU3128>3.0.CO;2-T; Kipnis J, 2008, TRENDS IMMUNOL, V29, P455, DOI 10.1016/j.it.2008.07.007; Kobayashi M, 2001, J IMMUNOL, V167, P3585, DOI 10.4049/jimmunol.167.7.3585; Koltsova EK, 2011, TRENDS IMMUNOL, V32, P540, DOI 10.1016/j.it.2011.07.001; Lan YY, 2005, AM J TRANSPLANT, V5, P2649, DOI 10.1111/j.1600-6143.2005.01085.x; Lee GYH, 2007, TRENDS BIOTECHNOL, V25, P111, DOI 10.1016/j.tibtech.2007.01.005; Lin Y, 2005, J REPROD IMMUNOL, V68, P39, DOI 10.1016/j.jri.2005.05.002; Ludewig B, 2000, P NATL ACAD SCI USA, V97, P12752, DOI 10.1073/pnas.220427097; Marsland BJ, 2005, IMMUNITY, V22, P493, DOI 10.1016/j.immuni.2005.02.010; Marsolais D, 2011, MOL PHARMACOL, V79, P61, DOI 10.1124/mol.110.066811; Mehling M, 2008, NEUROLOGY, V71, P1261, DOI 10.1212/01.wnl.0000327609.57688.ea; Mehling M, 2011, ANN NEUROL, V69, P408, DOI 10.1002/ana.22352; Muller H, 2005, EUR J IMMUNOL, V35, P533, DOI 10.1002/eji.200425556; Paolucci C, 2000, J BIOL CHEM, V275, P19638, DOI 10.1074/jbc.M000511200; Persidsky Y, 2000, J LEUKOCYTE BIOL, V68, P413; Sallusto F, 1999, EUR J IMMUNOL, V29, P1617, DOI 10.1002/(SICI)1521-4141(199905)29:05<1617::AID-IMMU1617>3.0.CO;2-3; Sanchez-Sanchez N, 2006, J IMMUNOL, V176, P5153, DOI 10.4049/jimmunol.176.9.5153; Silverman JM, 2010, J IMMUNOL, V185, P5011, DOI 10.4049/jimmunol.1000541; Soumelis V, 2002, NAT IMMUNOL, V3, P673, DOI 10.1038/ni805; Sozzani S, 1997, J IMMUNOL, V159, P1993; Sun JS, 2010, CIRCULATION, V122, P808, DOI 10.1161/CIRCULATIONAHA.109.891887; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Verhasselt V, 1997, J IMMUNOL, V158, P2919; Wang Q, 2011, SCANNING; Wang T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002507; Wang T, 2008, J NEUROIMMUNE PHARM, V3, P173, DOI 10.1007/s11481-008-9110-x; Wysocka M, 2001, J IMMUNOL, V166, P7504, DOI 10.4049/jimmunol.166.12.7504; Xing FY, 2011, NANOSCALE RES LETT, V6, DOI 10.1186/1556-276X-6-455; Yanagawa Y, 2002, BLOOD, V100, P1948, DOI 10.1182/blood-2002-01-0260; Yanagihara S, 1998, J IMMUNOL, V161, P3096; Ye YX, 2011, IMMUNOBIOLOGY, V216, P1044, DOI 10.1016/j.imbio.2011.03.001	61	34	36	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e34830	10.1371/journal.pone.0034830	http://dx.doi.org/10.1371/journal.pone.0034830			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693544	Green Submitted, Green Published, gold			2022-12-27	WOS:000305338500005
J	Chen, WH; Guo, WW; Huang, YX; Ma, ZQ				Chen, Wenhan; Guo, William W.; Huang, Yanxin; Ma, Zhiqiang			PepMapper: A Collaborative Web Tool for Mapping Epitopes from Affinity-Selected Peptides	PLOS ONE			English	Article							PHAGE-DISPLAY LIBRARIES; B-CELL EPITOPE; MIMOTOPE ANALYSIS; PREDICTION; PROTEINS; ALGORITHM; DATABASE	Epitope mapping from affinity-selected peptides has become popular in epitope prediction, and correspondingly many Web-based tools have been developed in recent years. However, the performance of these tools varies in different circumstances. To address this problem, we employed an ensemble approach to incorporate two popular Web tools, MimoPro and Pep-3D-Search, together for taking advantages offered by both methods so as to give users more options for their specific purposes of epitope-peptide mapping. The combined operation of Union finds as many associated peptides as possible from both methods, which increases sensitivity in finding potential epitopic regions on a given antigen surface. The combined operation of Intersection achieves to some extent the mutual verification by the two methods and hence increases the likelihood of locating the genuine epitopic region on a given antigen in relation to the interacting peptides. The Consistency between Intersection and Union is an indirect sufficient condition to assess the likelihood of successful peptide-epitope mapping. On average from 27 tests, the combined operations of PepMapper outperformed either MimoPro or Pep-3D-Search alone. Therefore, PepMapper is another multipurpose mapping tool for epitope prediction from affinity-selected peptides. The Web server can be freely accessed at: http://informatics.nenu.edu.cn/PepMapper/	[Chen, Wenhan; Ma, Zhiqiang] NE Normal Univ, Sch Comp Sci & Informat Technol, Changchun, Peoples R China; [Guo, William W.] Cent Queensland Univ, Sch Informat & Commun Technol, Rockhampton, Qld 4702, Australia; [Huang, Yanxin] NE Normal Univ, Natl Engn Lab Druggable Gene & Prot Screening, Changchun, Peoples R China; [Chen, Wenhan] NE Normal Univ, Jilin Univ, Key Lab Intelligent Informat Proc, Changchun, Peoples R China	Northeast Normal University - China; Central Queensland University; Northeast Normal University - China; Jilin University; Northeast Normal University - China	Chen, WH (corresponding author), NE Normal Univ, Sch Comp Sci & Informat Technol, Changchun, Peoples R China.	huangyx356@nenu.edu.cn; mazq@nenu.edu.cn			National Natural Science Foundation of China [61172183]; Natural Science Foundation of Jilin Province [20101503, 20101506]; Scientific and Technical Project of Administration of Traditional Chinese Medicine of Jilin Province [2010pt067, 2011-zd16]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jilin Province; Scientific and Technical Project of Administration of Traditional Chinese Medicine of Jilin Province	This work was supported by the National Natural Science Foundation of China (no. 61172183), the Natural Science Foundation of Jilin Province (no. 20101503 and no. 20101506), and the Scientific and Technical Project of Administration of Traditional Chinese Medicine of Jilin Province (nos. 2010pt067 and 2011-zd16). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bryson CJ, 2010, BIODRUGS, V24, P1, DOI 10.2165/11318560-000000000-00000; Bublil EM, 2007, PROTEINS, V68, P294, DOI 10.1002/prot.21387; Chen WH, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-199; Enshell-Seijffers D, 2003, J MOL BIOL, V334, P87, DOI 10.1016/j.jmb.2003.09.002; GEYSEN HM, 1986, MOL IMMUNOL, V23, P709, DOI 10.1016/0161-5890(86)90081-7; Halperin I, 2003, PROTEIN SCI, V12, P1344, DOI 10.1110/ps.0237103; Huang J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-451; Huang J, 2012, NUCLEIC ACIDS RES, V40, pD271, DOI 10.1093/nar/gkr922; Huang J, 2011, MOLECULES, V16, P694, DOI 10.3390/molecules16010694; Huang YX, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-538; Irving MB, 2001, CURR OPIN CHEM BIOL, V5, P314, DOI 10.1016/S1367-5931(00)00208-8; Mayrose I, 2007, BIOINFORMATICS, V23, P3244, DOI 10.1093/bioinformatics/btm493; Mayrose I, 2007, NUCLEIC ACIDS RES, V35, P69, DOI 10.1093/nar/gkl975; Moreau V, 2006, BIOINFORMATICS, V22, P1088, DOI 10.1093/bioinformatics/btl012; Mumey BM, 2003, J COMPUT BIOL, V10, P555, DOI 10.1089/10665270360688183; Negi SS, 2009, BIOINFORM BIOL INSIG, V3, P71; Schreiber A, 2005, J COMPUT CHEM, V26, P879, DOI 10.1002/jcc.20229; Sun PP, 2011, MOLECULES, V16, P4971, DOI 10.3390/molecules16064971; Sussman JL, 1998, ACTA CRYSTALLOGR D, V54, P1078, DOI 10.1107/S0907444998009378; Tarnovitski N, 2006, J MOL BIOL, V359, P190, DOI 10.1016/j.jmb.2006.03.008	20	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37869	10.1371/journal.pone.0037869	http://dx.doi.org/10.1371/journal.pone.0037869			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22701536	gold, Green Published, Green Submitted			2022-12-27	WOS:000305342300133
J	Zhaoping, L; Zhe, L				Zhaoping, Li; Zhe, Li			Properties of V1 Neurons Tuned to Conjunctions of Visual Features: Application of the V1 Saliency Hypothesis to Visual Search behavior	PLOS ONE			English	Article							CLASSICAL RECEPTIVE-FIELD; CONTEXTUAL INFLUENCES; AREAS V1; COLOR; MONKEY; ORIENTATION; INTEGRATION; PARALLEL; RESPONSES; SYSTEM	From a computational theory of V1, we formulate an optimization problem to investigate neural properties in the primary visual cortex (V1) from human reaction times (RTs) in visual search. The theory is the V1 saliency hypothesis that the bottom-up saliency of any visual location is represented by the highest V1 response to it relative to the background responses. The neural properties probed are those associated with the less known V1 neurons tuned simultaneously or conjunctively in two feature dimensions. The visual search is to find a target bar unique in color (C), orientation (O), motion direction (M), or redundantly in combinations of these features (e. g., CO, MO, or CM) among uniform background bars. A feature singleton target is salient because its evoked V1 response largely escapes the iso-feature suppression on responses to the background bars. The responses of the conjunctively tuned cells are manifested in the shortening of the RT for a redundant feature target (e. g., a CO target) from that predicted by a race between the RTs for the two corresponding single feature targets (e. g., C and O targets). Our investigation enables the following testable predictions. Contextual suppression on the response of a CO-tuned or MO-tuned conjunctive cell is weaker when the contextual inputs differ from the direct inputs in both feature dimensions, rather than just one. Additionally, CO-tuned cells and MO-tuned cells are often more active than the single feature tuned cells in response to the redundant feature targets, and this occurs more frequently for the MO-tuned cells such that the MO-tuned cells are no less likely than either the M-tuned or O-tuned neurons to be the most responsive neuron to dictate saliency for an MO target.	[Zhaoping, Li] UCL, Dept Comp Sci, London, England; [Zhaoping, Li; Zhe, Li] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China	University of London; University College London; Tsinghua University	Zhaoping, L (corresponding author), UCL, Dept Comp Sci, London, England.	z.li@ucl.ac.uk	zhe, li/AAI-2248-2019	Li, Zhe/0000-0003-4176-9687	Tsinghua University 985 fund; Gatsby Charitable Foundation	Tsinghua University 985 fund; Gatsby Charitable Foundation	This work is supported by the Tsinghua University 985 fund and the Gatsby Charitable Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	ALLMAN J, 1985, PERCEPTION, V14, P105, DOI 10.1068/p140105; Angelucci A, 2002, J NEUROSCI, V22, P8633; Bakin JS, 2000, J NEUROSCI, V20, P8188; BLAKEMORE C, 1969, J PHYSIOL-LONDON, V203, P237, DOI 10.1113/jphysiol.1969.sp008862; Bodelon C, 2007, J NEUROSCI, V27, P725, DOI 10.1523/JNEUROSCI.3860-06.2007; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; Cumming BG, 2000, J NEUROSCI, V20, P4758, DOI 10.1523/JNEUROSCI.20-12-04758.2000; DeAngelis GC, 1998, NATURE, V394, P677, DOI 10.1038/29299; DUNCAN J, 1989, PSYCHOL REV, V96, P433, DOI 10.1037/0033-295X.96.3.433; Friedman HS, 2003, J PHYSIOL-LONDON, V548, P593, DOI 10.1113/jphysiol.2002.033555; Gegenfurtner KR, 1996, VISUAL NEUROSCI, V13, P161, DOI 10.1017/S0952523800007203; Girard P, 2001, J NEUROPHYSIOL, V85, P1328, DOI 10.1152/jn.2001.85.3.1328; Horwitz GD, 2005, J VISION, V5, P525, DOI 10.1167/5.6.4; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; Itti L, 2001, NAT REV NEUROSCI, V2, P194, DOI 10.1038/35058500; Janssen P, 2003, NEURON, V37, P693, DOI 10.1016/S0896-6273(03)00023-0; Jingling L, 2008, PERCEPTION, V37, P197, DOI 10.1068/p5829; Jones HE, 2001, J NEUROPHYSIOL, V86, P2011, DOI 10.1152/jn.2001.86.4.2011; KAPADIA MK, 1995, NEURON, V15, P843, DOI 10.1016/0896-6273(95)90175-2; KNIERIM JJ, 1992, J NEUROPHYSIOL, V67, P961, DOI 10.1152/jn.1992.67.4.961; Koene A, 2007, J VISION, V7, DOI 10.1167/7.11.14; Krummenacher J, 2002, J EXP PSYCHOL HUMAN, V28, P1303, DOI 10.1037//0096-1523.28.6.1303; Lamme VAF, 1998, CURR OPIN NEUROBIOL, V8, P529, DOI 10.1016/S0959-4388(98)80042-1; Lennie P, 1998, PERCEPTION, V27, P889, DOI 10.1068/p270889; LI CY, 1994, VISION RES, V34, P2337, DOI 10.1016/0042-6989(94)90280-1; Li ZP, 1999, P NATL ACAD SCI USA, V96, P10530, DOI 10.1073/pnas.96.18.10530; Li ZP, 2002, TRENDS COGN SCI, V6, P9, DOI 10.1016/S1364-6613(00)01817-9; Li ZP, 2001, NEURAL COMPUT, V13, P1749, DOI 10.1162/08997660152469332; Li ZP, 1999, NETWORK-COMP NEURAL, V10, P187, DOI 10.1088/0954-898X/10/2/305; LIVINGSTONE MS, 1984, J NEUROSCI, V4, P309; MCLEOD P, 1988, NATURE, V332, P154, DOI 10.1038/332154a0; MILLER J, 1978, J EXP PSYCHOL HUMAN, V4, P411, DOI 10.1037/0096-1523.4.3.411; MILLER J, 1982, COGNITIVE PSYCHOL, V14, P247, DOI 10.1016/0010-0285(82)90010-X; MISHKIN M, 1983, TRENDS NEUROSCI, V6, P414, DOI 10.1016/0166-2236(83)90190-X; MOISEFF A, 1981, J NEUROSCI, V1, P40, DOI 10.1523/JNEUROSCI.01-01-00040.1981; NAKAYAMA K, 1989, VISION RES, V29, P1631, DOI 10.1016/0042-6989(89)90144-2; PARADISO MA, 1988, BIOL CYBERN, V58, P35, DOI 10.1007/BF00363954; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Qiu FTT, 2005, NEURON, V47, P155, DOI 10.1016/j.neuron.2005.05.028; RAAB DH, 1962, T NEW YORK ACAD SCI, V24, P574, DOI 10.1111/j.2164-0947.1962.tb01433.x; Schiller PH, 1998, COGNITIVE NEUROSCIENCE OF ATTENTION, P3; Shipp S, 2004, TRENDS COGN SCI, V8, P223, DOI 10.1016/j.tics.2004.03.004; Shipp S, 2009, CEREB CORTEX, V19, P2230, DOI 10.1093/cercor/bhn243; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; TSO DY, 1988, J NEUROSCI, V8, P1712; ULRICH R, 1986, PERCEPT PSYCHOPHYS, V39, P248, DOI 10.3758/BF03204931; Van Zoest W, 2006, SPATIAL VISION, V19, P61, DOI 10.1163/156856806775009205; van Zoest W, 2004, J EXP PSYCHOL HUMAN, V30, P746, DOI 10.1037/0096-1523.30.4.749; von der Heydt R, 2000, VISION RES, V40, P1955, DOI 10.1016/S0042-6989(00)00044-4; Wachtler T, 2003, NEURON, V37, P681, DOI 10.1016/S0896-6273(03)00035-7; WOLFE JM, 1989, J EXP PSYCHOL HUMAN, V15, P419, DOI 10.1037/0096-1523.15.3.419; WOLFE JM, 1990, J EXP PSYCHOL HUMAN, V16, P879, DOI 10.1037/0096-1523.16.4.879; Zhang XL, 2012, NEURON, V73, P183, DOI 10.1016/j.neuron.2011.10.035; Zhaoping L, 2006, VIS COGN, V14, P911, DOI 10.1080/13506280500196035; Zhaoping L, 2003, J PHYSIOL-PARIS, V97, P503, DOI 10.1016/j.jphysparis.2004.01.008; Zhaoping L, 2007, PLOS COMPUT BIOL, V3, P616, DOI 10.1371/journal.pcbi.0030062; Zhaoping L, 2006, NETWORK-COMP NEURAL, V17, P301, DOI 10.1080/09548980600931995; Zhaoping L, 2012, J VISION, V12, DOI 10.1167/12.2.17; Zhaoping L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019248; Zhaoping L, 2009, J VISION, V9, DOI 10.1167/9.11.20; Zhaoping L, 2008, J VISION, V8, DOI 10.1167/8.5.1	63	14	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2012	7	6							e36223	10.1371/journal.pone.0036223	http://dx.doi.org/10.1371/journal.pone.0036223			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UJ	22719829	Green Published, Green Submitted, gold			2022-12-27	WOS:000305340000001
J	Eda-Fujiwara, H; Imagawa, T; Matsushita, M; Matsuda, Y; Takeuchi, HA; Satoh, R; Watanabe, A; Zandbergen, MA; Manabe, K; Kawashima, T; Bolhuis, JJ				Eda-Fujiwara, Hiroko; Imagawa, Takuya; Matsushita, Masanori; Matsuda, Yasushi; Takeuchi, Hiro-Aki; Satoh, Ryohei; Watanabe, Aiko; Zandbergen, Matthijs A.; Manabe, Kazuchika; Kawashima, Takashi; Bolhuis, Johan J.			Localized Brain Activation Related to the Strength of Auditory Learning in a Parrot	PLOS ONE			English	Article							BUDGERIGARS MELOPSITTACUS-UNDULATUS; VOCAL CONTROL PATHWAYS; IMMEDIATE-EARLY GENE; ZEBRA FINCH; NEURONAL ACTIVATION; SONG RECOGNITION; BIRDSONG MEMORY; CONTACT CALLS; ARATINGA-CANICULARIS; FEMALE BUDGERIGARS	Parrots and songbirds learn their vocalizations from a conspecific tutor, much like human infants acquire spoken language. Parrots can learn human words and it has been suggested that they can use them to communicate with humans. The caudomedial pallium in the parrot brain is homologous with that of songbirds, and analogous to the human auditory association cortex, involved in speech processing. Here we investigated neuronal activation, measured as expression of the protein product of the immediate early gene ZENK, in relation to auditory learning in the budgerigar (Melopsittacus undulatus), a parrot. Budgerigar males successfully learned to discriminate two Japanese words spoken by another male conspecific. Re-exposure to the two discriminanda led to increased neuronal activation in the caudomedial pallium, but not in the hippocampus, compared to untrained birds that were exposed to the same words, or were not exposed to words. Neuronal activation in the caudomedial pallium of the experimental birds was correlated significantly and positively with the percentage of correct responses in the discrimination task. These results suggest that in a parrot, the caudomedial pallium is involved in auditory learning. Thus, in parrots, songbirds and humans, analogous brain regions may contain the neural substrate for auditory learning and memory.	[Eda-Fujiwara, Hiroko; Watanabe, Aiko] Japan Womens Univ, Dept Chem & Biol Sci, Bunkyo Ku, Tokyo 112, Japan; [Eda-Fujiwara, Hiroko] Japan Soc Promot Sci, Chiyoda Ku, Tokyo, Japan; [Imagawa, Takuya; Matsushita, Masanori; Matsuda, Yasushi; Takeuchi, Hiro-Aki] Shizuoka Univ, Fac Sci, Dept Biol, Shizuoka 4228017, Japan; [Satoh, Ryohei] Kitasato Univ, Sch Med, Dept Physiol, Kanagawa, Japan; [Zandbergen, Matthijs A.; Bolhuis, Johan J.] Univ Utrecht, Behav Biol & Helmholtz Inst, Utrecht, Netherlands; [Manabe, Kazuchika; Kawashima, Takashi] Nihon Univ, Grad Sch Social & Cultural Studies, Saitama, Japan	Japan Womens University; Japan Society for the Promotion of Science; Shizuoka University; Kitasato University; Utrecht University; Nihon University	Eda-Fujiwara, H (corresponding author), Japan Womens Univ, Dept Chem & Biol Sci, Bunkyo Ku, Tokyo 112, Japan.	hirofujiwa@fc.jwu.ac.jp; sbhtake@ipc.shizuoka.ac.jp	Matsuda, Yasushi/AAB-4258-2021		Netherlands Organization for Scientific Research (NWO); Kayamori Foundation for informational Science Advancement; Multi-Career Path Support Model for Female Researchers project of Japan's Women University; Japan Society for the Promotion of Science (JSPS) [22-40174]; NWO grants (ALW Open Competition and GW Horizon Programme)	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Kayamori Foundation for informational Science Advancement(Kayamori Foundation of Informational Science Advancement); Multi-Career Path Support Model for Female Researchers project of Japan's Women University; Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NWO grants (ALW Open Competition and GW Horizon Programme)	This work was supported by a visiting scientist grant from Netherlands Organization for Scientific Research (NWO) to HE-F and JJB, by the Kayamori Foundation for informational Science Advancement to RS, by a Multi-Career Path Support Model for Female Researchers project of Japan's Women University to HE-F, by Japan Society for the Promotion of Science (JSPS) Grant-in-Aid for JSPS Fellows (22-40174) to HE-F, and by NWO grants (ALW Open Competition and GW Horizon Programme) to JJB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akutagawa E, 2010, J COMP NEUROL, V518, P3086, DOI 10.1002/cne.22383; [Anonymous], 1956, LEARNING INSTINCT AN; Bailey DJ, 2002, J NEUROBIOL, V52, P43, DOI 10.1002/neu.10070; Balsby TJS, 2008, P ROY SOC B-BIOL SCI, V275, P2147, DOI 10.1098/rspb.2008.0517; BAPTISTA LF, 1990, ETHOLOGY, V84, P15; Bartlett P, 1999, ETHOL ECOL EVOL, V11, P139, DOI 10.1080/08927014.1999.9522832; Bauer EE, 2008, J NEUROSCI, V28, P1509, DOI 10.1523/JNEUROSCI.3838-07.2008; Beckers GJL, 2004, CURR BIOL, V14, P1592, DOI 10.1016/j.cub.2004.08.057; Berg KS, 2012, P ROY SOC B-BIOL SCI, V279, P585, DOI 10.1098/rspb.2011.0932; Berwick RC, 2011, TRENDS COGN SCI, V15, P113, DOI 10.1016/j.tics.2011.01.002; Bolhuis JJ, 2006, NAT REV NEUROSCI, V7, P347, DOI 10.1038/nrn1904; Bolhuis JJ, 2001, EUR J NEUROSCI, V13, P2165, DOI 10.1046/j.0953-816x.2001.01588.x; Bolhuis JJ, 2000, P NATL ACAD SCI USA, V97, P2282, DOI 10.1073/pnas.030539097; Bolhuis JJ, 2010, NAT REV NEUROSCI, V11, P747, DOI 10.1038/nrn2931; Bolhuis JJ, 2010, NEUROREPORT, V21, P395, DOI 10.1097/WNR.0b013e3283385949; Bolhuis JJ, 2009, NATURE, V458, P832, DOI 10.1038/458832a; Bradbury JW, 2003, ANIMAL SOCIAL COMPLEXITY, P293; Braun K, 1999, BEHAV BRAIN RES, V98, P211, DOI 10.1016/S0166-4328(98)00086-2; Brauth S, 2002, LEARN MEMORY, V9, P76, DOI 10.1101/lm.40802; Brauth SE, 2006, BEHAV BRAIN RES, V168, P331, DOI 10.1016/j.bbr.2005.10.003; Brauth SE, 2001, J COMP NEUROL, V432, P481; Brown MW, 2000, BRAIN, PERCEPTION, MEMORY, P185; Catchpole CK, 2008, BIRD SONG: BIOLOGICAL THEMES AND VARIATIONS, 2ND EDITION, P1, DOI 10.1017/CBO9780511754791; DARWIN C, 1882, DESCENT MAN SELECTIO; Dooling Robert J., 1996, P113; Doupe AJ, 1999, ANNU REV NEUROSCI, V22, P567, DOI 10.1146/annurev.neuro.22.1.567; Durand SE, 1997, J COMP NEUROL, V377, P179, DOI 10.1002/(SICI)1096-9861(19970113)377:2<179::AID-CNE3>3.0.CO;2-0; Eda-Fujiwara H, 2003, EUR J NEUROSCI, V17, P149, DOI 10.1046/j.1460-9568.2003.02414.x; Farabaugh SM, 1997, BRAIN RES, V747, P18, DOI 10.1016/S0006-8993(96)01143-2; FARABAUGH SM, 1994, J COMP PSYCHOL, V108, P81, DOI 10.1037/0735-7036.108.1.81; Feenders G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001768; Fisher SE, 2009, TRENDS GENET, V25, P166, DOI 10.1016/j.tig.2009.03.002; Gentner TQ, 2003, NATURE, V424, P669, DOI 10.1038/nature01731; Gobes SMH, 2007, CURR BIOL, V17, P789, DOI 10.1016/j.cub.2007.03.059; Gobes SMH, 2010, P ROY SOC B-BIOL SCI, V277, P3343, DOI 10.1098/rspb.2010.0870; Gobes SMH, 2009, J COMP NEUROL, V516, P312, DOI 10.1002/cne.22113; Haesler S, 2007, PLOS BIOL, V5, P2885, DOI 10.1371/journal.pbio.0050321; Hahnloser RHR, 2010, CURR OPIN NEUROBIOL, V20, P332, DOI 10.1016/j.conb.2010.02.011; Hara E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029457; Hasegawa A, 2011, SCI REP-UK, V1, DOI 10.1038/srep00120; Hauser MD, 2002, SCIENCE, V298, P1569, DOI 10.1126/science.298.5598.1569; Hernandez AM, 2008, BEHAV PROCESS, V77, P278, DOI 10.1016/j.beproc.2007.11.001; Hile AG, 2000, ETHOLOGY, V106, P1105, DOI 10.1046/j.1439-0310.2000.00637.x; Horn G, 2004, NAT REV NEUROSCI, V5, P108, DOI 10.1038/nrn1324; Immelmann K., 1969, P61; Jarvis ED, 2004, ANN NY ACAD SCI, V1016, P749, DOI 10.1196/annals.1298.038; JARVIS ED, 1995, LEARN MEMORY, V2, P62, DOI 10.1101/lm.2.2.62; Jarvis ED, 2000, NATURE, V406, P628, DOI 10.1038/35020570; Jarvis ED, 2000, J COMP NEUROL, V419, P1, DOI 10.1002/(SICI)1096-9861(20000327)419:1<1::AID-CNE1>3.0.CO;2-M; Jarvis ED, 2005, NAT REV NEUROSCI, V6, P151, DOI 10.1038/nrn1606; Lavenex PB, 2000, J COMP NEUROL, V421, P437, DOI 10.1002/(SICI)1096-9861(20000612)421:4<437::AID-CNE1>3.0.CO;2-A; London SE, 2008, NAT NEUROSCI, V11, P579, DOI 10.1038/nn.2103; Manabe K, 2008, J ACOUST SOC AM, V123, P1729, DOI 10.1121/1.2835440; Marler P, 2000, P NATL ACAD SCI USA, V97, P2965, DOI 10.1073/pnas.97.7.2965; McKenzie TLB, 2006, NEUROBIOL LEARN MEM, V86, P330, DOI 10.1016/j.nlm.2006.05.002; MELLO C, 1995, J NEUROSCI, V15, P6919; MELLO CV, 1994, J NEUROSCI, V14, P6652; MELLO CV, 1992, P NATL ACAD SCI USA, V89, P6818, DOI 10.1073/pnas.89.15.6818; Mooney R, 2009, LEARN MEMORY, V16, P655, DOI 10.1101/lm.1065209; Moorman S, 2011, BIOESSAYS, V33, P377, DOI 10.1002/bies.201000150; MULLER SC, 1985, J COMP PHYSIOL A, V156, P1, DOI 10.1007/BF00610661; NOTTEBOHM F, 1972, AM NAT, V106, P116, DOI 10.1086/282756; Okanoya K, 2004, ADV STUD BEHAV, V34, P297, DOI 10.1016/S0065-3454(04)34008-8; Patel AD, 2009, CURR BIOL, V19, P827, DOI 10.1016/j.cub.2009.03.038; PATON JA, 1981, J NEUROSCI, V1, P1279; Pepperberg IM., 1999, ALEX STUDIES COGNITI; Phan ML, 2006, P NATL ACAD SCI USA, V103, P1088, DOI 10.1073/pnas.0510136103; Plummer TK, 2002, J NEUROBIOL, V53, P413, DOI 10.1002/neu.10120; Reiner A, 2004, J COMP NEUROL, V473, P377, DOI 10.1002/cne.20118; Riebel K, 2002, P ROY SOC B-BIOL SCI, V269, P729, DOI 10.1098/rspb.2001.1930; Schachner A, 2009, CURR BIOL, V19, P831, DOI 10.1016/j.cub.2009.03.061; STRIEDTER GF, 1994, J COMP NEUROL, V343, P35, DOI 10.1002/cne.903430104; Terpstra NJ, 2006, J COMP NEUROL, V494, P784, DOI 10.1002/cne.20831; Terpstra NJ, 2005, J COMP NEUROL, V488, P342, DOI 10.1002/cne.20592; Terpstra NJ, 2004, J NEUROSCI, V24, P4971, DOI 10.1523/JNEUROSCI.0570-04.2004; Thompson JV, 2010, J NEUROPHYSIOL, V103, P1785, DOI 10.1152/jn.00885.2009; Vehrencamp SL, 2003, ETHOLOGY, V109, P37, DOI 10.1046/j.1439-0310.2003.00850.x; Wang YA, 2010, P NATL ACAD SCI USA, V107, P12676, DOI 10.1073/pnas.1006645107; Zar J.H., 2009, BIOSTATISTICAL ANAL	79	11	11	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2012	7	6							e38803	10.1371/journal.pone.0038803	http://dx.doi.org/10.1371/journal.pone.0038803			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TU	22701714	gold, Green Published, Green Submitted			2022-12-27	WOS:000305337600045
J	Shwartz, A; Cosquer, A; Jaillon, A; Piron, A; Julliard, R; Raymond, R; Simon, L; Prevot-Julliard, AC				Shwartz, Assaf; Cosquer, Alix; Jaillon, Alexandre; Piron, Armony; Julliard, Romain; Raymond, Richard; Simon, Laurent; Prevot-Julliard, Anne-Caroline			Urban Biodiversity, City-Dwellers and Conservation: How Does an Outdoor Activity Day Affect the Human-Nature Relationship?	PLOS ONE			English	Article							ENVIRONMENTAL-EDUCATION; URBANIZATION; BELIEFS; PROGRAM; SCIENCE	Urban conservation education programs aim to increase knowledge and awareness towards biodiversity and to change attitudes and behaviour towards the environment. However, to date, few urban conservation education studies have evaluated to what extent these programs have managed to achieve their goals. In this study, we experimentally explored the influence of an urban conservation activity day on individual knowledge, awareness and actions towards biodiversity, in both the short and longer term. We organised three activity days in Paris (France), during which people were invited to participate in urban conservation efforts. Both quantitative (questionnaire) and qualitative (interviews) methods were employed to investigate the influence of this short urban nature experience on the relationships that city-dwellers develop with nearby biodiversity. We found a strong positive correlation between the levels of participation and an immediate interest towards local urban biodiversity. In the longer term, however, although participants claimed to have gained more knowledge, local awareness and interest for species in their daily environment, they did not seem to extend this interest to participating in other related activities. These results highlight the complexity of validating the effectiveness of this type of education program for achieving conservation goals. Although such a short activity may only have a limited environmental impact, it nevertheless seems to increase people's knowledge, awareness, interest and concern. We therefore believe that when repeated locally, these short conservation education programs could enhance people's experience with nature in cities and achieve conservation goals more fully.	[Shwartz, Assaf; Cosquer, Alix; Raymond, Richard; Simon, Laurent] Univ Paris Ouest Nanterre La Defense, Univ Paris 08, Univ Paris 01,Univ Paris 07,UMR CNRS 7533, Lab Dynam Sociales & Recomposit Espaces LADYSS, Paris, France; [Shwartz, Assaf; Cosquer, Alix; Jaillon, Alexandre; Piron, Armony; Julliard, Romain; Prevot-Julliard, Anne-Caroline] Museum Natl Hist Nat, UMR7204, CNRS MNHN UPMC, Lab Conservat Especes Restaurat & Suivi Populat C, F-75231 Paris, France; [Piron, Armony] Univ Liege, Inst Sci Humaines & Sociales, Lab Anthropol Sociale & Culturelle, Liege, Belgium; [Prevot-Julliard, Anne-Caroline] ISCC, Paris, France	heSam Universite; Universite Pantheon-Sorbonne; UDICE-French Research Universities; Universite Paris Cite; Universite Paris Nanterre; Universite Paris-VIII; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; University of Liege	Shwartz, A (corresponding author), Univ Paris Ouest Nanterre La Defense, Univ Paris 08, Univ Paris 01,Univ Paris 07,UMR CNRS 7533, Lab Dynam Sociales & Recomposit Espaces LADYSS, Paris, France.	shwar.a@mail.huji.ac.il		Alix, Cosquer/0000-0002-5894-1466	Ile-de-France Sustainable Development Research Network Reseau Francilien de Recherche sur le Developpement Soutenable - R2DS Ile-de-France)	Ile-de-France Sustainable Development Research Network Reseau Francilien de Recherche sur le Developpement Soutenable - R2DS Ile-de-France)	This work was supported by Ile-de-France Sustainable Development Research Network Reseau Francilien de Recherche sur le Developpement Soutenable - R2DS Ile-de-France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajzen I., 1985, ACTION CONTROL, P11, DOI [10.1007/978-3-642-69746-3_2, DOI 10.1007/978-3-642-69746-3_2]; [Anonymous], 2003, PSYCHOL THEORIES ENV; [Anonymous], 2007, J ENVIRON EDUC, V38, P33, DOI DOI 10.3200/JOEE.38.3.33-42; Basile C., 2000, J ENVIRON EDUC, V32, P121, DOI [10.1080/00958960009598668, DOI 10.1080/00958960009598668]; Bogner F.X., 1998, J ENVIRON EDUC, V29, P17, DOI [10.1080/00958969809599124, DOI 10.1080/00958969809599124]; Bogner FX, 1997, J ENVIRON PSYCHOL, V17, P111, DOI 10.1006/jevp.1997.0046; Brewer C, 2006, CONSERV BIOL, V20, P689, DOI 10.1111/j.1523-1739.2006.00467.x; Burt RS, 2005, BROKERAGE CLOSURE IN; Chatzisarantis NLD, 2007, PERS SOC PSYCHOL B, V33, P663, DOI 10.1177/0146167206297401; Clayton S., 2009, CONSERVATION PSYCHOL; Corraliza JA, 2000, ENVIRON BEHAV, V32, P832, DOI 10.1177/00139160021972829; Courtenay-Hall P., 2002, ENVIRON EDUC RES, V8, P283, DOI DOI 10.1080/13504620220145438; Dearborn DC, 2010, CONSERV BIOL, V24, P432, DOI 10.1111/j.1523-1739.2009.01328.x; Evans C, 2005, CONSERV BIOL, V19, P589, DOI 10.1111/j.1523-1739.2005.00s01.x; Falk J.H., 2005, ENVIRON EDUC RES, V11, P265, DOI [DOI 10.1080/13504620500081129, 10.1080/13504620500081129]; Fallis J, 1991, J EXPT ED, V14, P27; Ferraro PJ, 2006, PLOS BIOL, V4, P482, DOI 10.1371/journal.pbio.0040105; Festinger L., 1957, THEORY COGNITIVE DIS, V2; Gass M.A., 2003, J EXPERIENTIAL ED, V26, P34, DOI [https://doi.org/10.1177/105382590302600106, DOI 10.1177/105382590302600106]; Goddard MA, 2010, TRENDS ECOL EVOL, V25, P90, DOI 10.1016/j.tree.2009.07.016; Gregory J., 2000, SCI PUBLIC COMMUNICA; Grimm NB, 2008, SCIENCE, V319, P756, DOI 10.1126/science.1150195; Hinchliffe S, 1996, GLOBAL ENVIRON CHANG, V6, P53, DOI 10.1016/0959-3780(95)00113-1; Hunter LM, 2004, SOC NATUR RESOUR, V17, P517, DOI 10.1080/08941920490452454; INSEE, 2010, PAR GAGN NOUV FAM; Jacobsen JB, 2009, ENVIRON RESOUR ECON, V43, P137, DOI 10.1007/s10640-008-9226-8; Jacobson S.K., 2006, CONSERVATION ED OUTR; Kobori H, 2009, BIOL CONSERV, V142, P1950, DOI 10.1016/j.biocon.2009.04.017; Kollmuss A., 2002, ENVIRON EDUC RES, V8, P239, DOI [10.1080/1350462022014540, DOI 10.1080/1350462022014540, 10.1080/13504620220145401, DOI 10.1080/13504620220145401]; Kruse C.K., 2004, J ENVIRON EDUC, V35, P33, DOI DOI 10.3200/JOEE.35.4.33-45; Kuhar CW, 2010, AM J PRIMATOL, V72, P407, DOI 10.1002/ajp.20726; Leeming F.C., 2010, J ENVIRON EDUC, V24, P8, DOI DOI 10.1080/00958964.1993.9943504; Lindemann-Matthies P, 2005, INT J SCI EDUC, V27, P655, DOI 10.1080/09500690500038116; McKinney ML, 2002, BIOSCIENCE, V52, P883, DOI 10.1641/0006-3568(2002)052[0883:UBAC]2.0.CO;2; Miller JR, 2006, BIOL CONSERV, V127, P356, DOI 10.1016/j.biocon.2005.07.021; Miller JR, 2002, CONSERV BIOL, V16, P330, DOI 10.1046/j.1523-1739.2002.00420.x; Norris K., 1998, J ENVIRON EDUC, V30, P38, DOI DOI 10.1080/00958969809601862; Palmberg I.E., 2000, J ENVIRON EDUC, V31, P32, DOI [DOI 10.1080/00958960009598649, 10.1080/00958960009598649]; Pinheiro J, 2001, MIXED EFFECTS MODELS; Pooley JA, 2000, ENVIRON BEHAV, V32, P711, DOI 10.1177/0013916500325007; Prevot-Julliard AC, 2011, ENV MANAGEMENT; Rickinson M., 2001, ENVIRON EDUC RES, V7, P207, DOI [DOI 10.1080/13504620120065230, 10.1080/13504620120065230]; Rutherford C, 1998, INDIVIDUAL PARTICIPA; Storksdieck M, 2005, ENVIRON EDUC RES, V11, P353, DOI DOI 10.1080/13504620500081228; Sturgis P, 2004, PUBLIC UNDERST SCI, V13, P55, DOI 10.1177/0963662504042690; Turner WR, 2004, BIOSCIENCE, V54, P585, DOI 10.1641/0006-3568(2004)054[0585:GUATSO]2.0.CO;2; UNESCO, 1978, INT C ENV ED TBIL US; Webb TL, 2006, PSYCHOL BULL, V132, P249, DOI 10.1037/0033-2909.132.2.249	48	26	28	5	103	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2012	7	6							e38642	10.1371/journal.pone.0038642	http://dx.doi.org/10.1371/journal.pone.0038642			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TQ	22715403	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336800045
J	Adhikari, RP; Karauzum, H; Sarwar, J; Abaandou, L; Mahmoudieh, M; Boroun, AR; Vu, H; Nguyen, T; Devi, VS; Shulenin, S; Warfield, KL; Aman, MJ				Adhikari, Rajan P.; Karauzum, Hatice; Sarwar, Jawad; Abaandou, Laura; Mahmoudieh, Mahta; Boroun, Atefeh R.; Hong Vu; Tam Nguyen; Devi, V. Sathya; Shulenin, Sergey; Warfield, Kelly L.; Aman, M. Javad			Novel Structurally Designed Vaccine for S. aureus alpha-Hemolysin: Protection against Bacteremia and Pneumonia	PLOS ONE			English	Article							COMMUNITY-ASSOCIATED MRSA; STAPHYLOCOCCUS-AUREUS; PASSIVE-IMMUNIZATION; VIRULENCE GENES; TOXIN; ANTIBODIES; MODEL; INFECTION	Staphylococcus aureus (S. aureus) is a human pathogen associated with skin and soft tissue infections (SSTI) and life threatening sepsis and pneumonia. Efforts to develop effective vaccines against S. aureus have been largely unsuccessful, in part due to the variety of virulence factors produced by this organism. S. aureus alpha-hemolysin (Hla) is a pore-forming toxin expressed by most S. aureus strains and reported to play a key role in the pathogenesis of SSTI and pneumonia. Here we report a novel recombinant subunit vaccine candidate for Hla, rationally designed based on the heptameric crystal structure. This vaccine candidate, denoted AT-62aa, was tested in pneumonia and bacteremia infection models using S. aureus strain Newman and the pandemic strain USA300 (LAC). Significant protection from lethal bacteremia/sepsis and pneumonia was observed upon vaccination with AT-62aa along with a Glucopyranosyl Lipid Adjuvant-Stable Emulsion (GLA-SE) that is currently in clinical trials. Passive transfer of rabbit immunoglobulin against AT-62aa (AT62-IgG) protected mice against intraperitoneal and intranasal challenge with USA300 and produced significant reduction in bacterial burden in blood, spleen, kidney, and lungs. Our Hla-based vaccine is the first to be reported to reduce bacterial dissemination and to provide protection in a sepsis model of S. aureus infection. AT62-IgG and sera from vaccinated mice effectively neutralized the toxin in vitro and AT62-IgG inhibited the formation of Hla heptamers, suggesting antibody-mediated neutralization as the primary mechanism of action. This remarkable efficacy makes this Hla-based vaccine a prime candidate for inclusion in future multivalent S. aureus vaccine. Furthermore, identification of protective epitopes within AT-62aa could lead to novel immunotherapy for S. aureus infection.	[Adhikari, Rajan P.; Karauzum, Hatice; Sarwar, Jawad; Abaandou, Laura; Mahmoudieh, Mahta; Boroun, Atefeh R.; Hong Vu; Tam Nguyen; Devi, V. Sathya; Shulenin, Sergey; Warfield, Kelly L.; Aman, M. Javad] Integrated Biotherapeut Inc, Gaithersburg, MD USA		Adhikari, RP (corresponding author), Integrated Biotherapeut Inc, Gaithersburg, MD USA.	javad@integratedbiotherapeutics.com	Venkatarmani, Sathyadevi/AAP-1068-2020; Adhikari, Rajan/J-7396-2019	Venkatarmani, Sathyadevi/0000-0003-1242-8162; 	Integrated Bio Therapeutics (IBT)	Integrated Bio Therapeutics (IBT)	The authors have the following interests to declare. All authors, except for Tam Nguyen, are employed by Integrated Bio Therapeutics (IBT), who funded this study. Tam Nguyen served as a consultant to IBT. M. Javad Aman and Kelly L. Warfield are shareholders of Integrated BioTherapeutics. There are no products in development or marketed products to declare. The authors declare a patent application related to the vaccine described in this manuscript (PCT/US2012/024031; Filed on Feb 8, 2012, Title: IMMUNOGENIC COMPOSITION COMPRISING ALPHA-HEMOLYSIN OLIGOPEPTIDES). This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Aarestrup FM, 1999, APMIS, V107, P425, DOI 10.1111/j.1699-0463.1999.tb01576.x; Bassetti M, 2009, INT J ANTIMICROB AG, V34, pS15, DOI 10.1016/S0924-8579(09)70544-8; BHAKDI S, 1984, INFECT IMMUN, V46, P318, DOI 10.1128/IAI.46.2.318-323.1984; BHAKDI S, 1989, INFECT IMMUN, V57, P3512, DOI 10.1128/IAI.57.11.3512-3519.1989; BHAKDI S, 1991, MICROBIOL REV, V55, P733, DOI 10.1128/MMBR.55.4.733-751.1991; Bradley SF, 2005, SEMIN RESP CRIT CARE, V26, P643, DOI 10.1055/s-2005-925528; BROWN DR, 1980, INFECT IMMUN, V30, P36, DOI 10.1128/IAI.30.1.36-42.1980; Caiazza NC, 2003, J BACTERIOL, V185, P3214, DOI 10.1128/JB.185.10.3214-3217.2003; Chambers HF, 2005, NEW ENGL J MED, V352, P1485, DOI 10.1056/NEJMe058023; Coffman JD, 2002, PROTEIN EXPRES PURIF, V24, P302, DOI 10.1006/prep.2001.1556; Coler RN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016333; Coler RN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013677; Diep BA, 2006, J INFECT DIS, V193, P1495, DOI 10.1086/503777; Fattom AI, 1996, INFECT IMMUN, V64, P1659, DOI 10.1128/IAI.64.5.1659-1665.1996; Foster TJ, 2004, J CLIN INVEST, V114, P1693, DOI 10.1172/JCI200423825; Husmann M, 2009, FEBS LETT, V583, P337, DOI 10.1016/j.febslet.2008.12.028; Kennedy AD, 2010, J INFECT DIS, V202, P1050, DOI 10.1086/656043; Liang XD, 2009, INFECT IMMUN, V77, P977, DOI 10.1128/IAI.00920-08; Lin G, 2007, CURR HIV RES, V5, P514, DOI 10.2174/157016207782418489; McElroy MC, 1999, INFECT IMMUN, V67, P5541, DOI 10.1128/IAI.67.10.5541-5544.1999; Menzies BE, 1996, INFECT IMMUN, V64, P1839, DOI 10.1128/IAI.64.5.1839-1841.1996; Nara PL, 1998, VACCINE, V16, P1780, DOI 10.1016/S0264-410X(98)00168-6; Nizet V, 2007, J ALLERGY CLIN IMMUN, V120, P13, DOI 10.1016/j.jaci.2007.06.005; PANCHAL RG, 1995, J BIOL CHEM, V270, P23072, DOI 10.1074/jbc.270.39.23072; Parker D, 2012, SEMIN IMMUNOPATHOL, V34, P281, DOI 10.1007/s00281-011-0291-7; Ragle BE, 2009, INFECT IMMUN, V77, P2712, DOI 10.1128/IAI.00115-09; Rooijakkers SHM, 2005, TRENDS MICROBIOL, V13, P596, DOI 10.1016/j.tim.2005.10.002; Rose F, 2002, AM J PHYSIOL-LUNG C, V282, pL207, DOI 10.1152/ajplung.00156.2001; Shukla SK, 2010, J CLIN MICROBIOL, V48, P3582, DOI 10.1128/JCM.00657-10; Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859; Tobin GJ, 2008, VACCINE, V26, P6189, DOI 10.1016/j.vaccine.2008.09.080; Wardenburg JB, 2008, J EXP MED, V205, P287, DOI 10.1084/jem.20072208; Wilke GA, 2010, P NATL ACAD SCI USA, V107, P13473, DOI 10.1073/pnas.1001815107	33	75	88	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e38567	10.1371/journal.pone.0038567	http://dx.doi.org/10.1371/journal.pone.0038567			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701668	Green Published, gold, Green Submitted			2022-12-27	WOS:000305348400072
J	de Vere, N; Rich, TCG; Ford, CR; Trinder, SA; Long, C; Moore, CW; Satterthwaite, D; Davies, H; Allainguillaume, J; Ronca, S; Tatarinova, T; Garbett, H; Walker, K; Wilkinson, MJ				de Vere, Natasha; Rich, Tim C. G.; Ford, Col R.; Trinder, Sarah A.; Long, Charlotte; Moore, Chris W.; Satterthwaite, Danielle; Davies, Helena; Allainguillaume, Joel; Ronca, Sandra; Tatarinova, Tatiana; Garbett, Hannah; Walker, Kevin; Wilkinson, Mike J.			DNA Barcoding the Native Flowering Plants and Conifers of Wales	PLOS ONE			English	Article							HERBARIUM SPECIMENS; EXTRACTION; IDENTIFY; IDENTIFICATION; AMPLIFICATION; RESOLUTION; ALIGNMENT	We present the first national DNA barcode resource that covers the native flowering plants and conifers for the nation of Wales (1143 species). Using the plant DNA barcode markers rbcL and matK, we have assembled 97.7% coverage for rbcL, 90.2% for matK, and a dual-locus barcode for 89.7% of the native Welsh flora. We have sampled multiple individuals for each species, resulting in 3304 rbcL and 2419 matK sequences. The majority of our samples (85%) are from DNA extracted from herbarium specimens. Recoverability of DNA barcodes is lower using herbarium specimens, compared to freshly collected material, mostly due to lower amplification success, but this is balanced by the increased efficiency of sampling species that have already been collected, identified, and verified by taxonomic experts. The effectiveness of the DNA barcodes for identification (level of discrimination) is assessed using four approaches: the presence of a barcode gap ( using pairwise and multiple alignments), formation of monophyletic groups using Neighbour- Joining trees, and sequence similarity in BLASTn searches. These approaches yield similar results, providing relative discrimination levels of 69.4 to 74.9% of all species and 98.6 to 99.8% of genera using both markers. Species discrimination can be further improved using spatially explicit sampling. Mean species discrimination using barcode gap analysis (with a multiple alignment) is 81.6% within 10610 km squares and 93.3% for 262 km squares. Our database of DNA barcodes for Welsh native flowering plants and conifers represents the most complete coverage of any national flora, and offers a valuable platform for a wide range of applications that require accurate species identification.	[Rich, Tim C. G.] Natl Museum Wales, Dept Biodivers & Systemat Biol, Cardiff CF1 3NP, S Glam, Wales; [Allainguillaume, Joel] Univ W England, Dept Appl Sci, Bristol BS16 1QY, Avon, England; [Ronca, Sandra; Wilkinson, Mike J.] Aberystwyth Univ, Inst Biol Environm & Rural Sci, Aberystwyth, Dyfed, Wales; [Tatarinova, Tatiana; Garbett, Hannah] Univ Glamorgan, Fac Adv Technol, Pontypridd CF37 1DL, M Glam, Wales; [Walker, Kevin] Bot Soc British Isles, Harrogate, N Yorkshire, England	University of West England; Aberystwyth University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Institute of Biological, Environmental, Rural & Sciences (IBERS); University of South Wales		natasha.devere@gardenofwales.org.uk	Tatarinova, Tatiana/AAH-1915-2020; Tatarinova, Tatiana Valerievna/AAU-4719-2021; Tatarinova, Tatiana V./K-3445-2016	Tatarinova, Tatiana/0000-0003-1787-1112; Tatarinova, Tatiana V./0000-0003-1787-1112; Davies, Helena Susan/0000-0003-2582-7197; de Vere, Natasha/0000-0001-9593-6925; Trinder, Sarah/0000-0002-0767-9912; Wilkinson, Michael/0000-0002-9881-6993	National Botanic Garden of Wales; National Museum Wales; Welsh Government; Countryside Council for Wales; people of Wales	National Botanic Garden of Wales; National Museum Wales; Welsh Government; Countryside Council for Wales; people of Wales	Funded by the National Botanic Garden of Wales (www.gardenofwales.org.uk), National Museum Wales (http://www.museumwales.ac.uk/), Welsh Government (wales.gov.uk), Countryside Council for Wales (http://www.ccw.gov.uk/), and sponsorship from the people of Wales. The National Botanic Garden of Wales and National Museum Wales are the employers of eight of the co-authors. The other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Asahina H, 2010, J NAT MED-TOKYO, V64, P133, DOI 10.1007/s11418-009-0379-8; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Bininda-Emonds ORP, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-156; Blackstock T, 2010, HABITATS WALES COMPR; Bleeker W, 2008, BIOL CONSERV, V141, P692, DOI 10.1016/j.biocon.2007.12.015; Burgess KS, 2011, METHODS ECOL EVOL, V2, P333, DOI 10.1111/j.2041-210X.2011.00092.x; Chase MW, 2009, SCIENCE, V325, P682, DOI 10.1126/science.1176906; Chater A, 2010, FLORA CARDIGANSHIRE; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Cowan RS, 2006, TAXON, V55, P611, DOI 10.2307/25065638; de Groot GA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016371; De Mattia F, 2011, FOOD RES INT, V44, P693, DOI 10.1016/j.foodres.2010.12.032; Dines T, 2008, VASCULAR PLANT RED D; Drabkova L, 2002, PLANT MOL BIOL REP, V20, P161, DOI 10.1007/BF02799431; Ebihara A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015136; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Erkens RHJ, 2008, BLUMEA, V53, P407, DOI 10.3767/000651908X608052; Gao T, 2010, J ETHNOPHARMACOL, V130, P116, DOI 10.1016/j.jep.2010.04.026; Gonzalez MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007483; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hollingsworth PM, 2011, P NATL ACAD SCI USA, V108, P19451, DOI 10.1073/pnas.1116812108; Hollingsworth PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019254; Jaakola L, 2010, FOOD CHEM, V123, P494, DOI 10.1016/j.foodchem.2010.04.069; Kelly LJ, 2011, NEW PHYTOL, V191, P288, DOI 10.1111/j.1469-8137.2011.03677.x; Kesanakurti PR, 2011, MOL ECOL, V20, P1289, DOI 10.1111/j.1365-294X.2010.04989.x; Kress WJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015409; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Kumar S, 2011, FOOD CHEM, V127, P1335, DOI 10.1016/j.foodchem.2011.01.094; Lahaye R, 2008, P NATL ACAD SCI USA, V105, P2923, DOI 10.1073/pnas.0709936105; Li DZ, 2011, P NATL ACAD SCI USA, V108, P19641, DOI 10.1073/pnas.1104551108; Little DP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020552; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Pang XH, 2011, CLADISTICS, V27, P165, DOI 10.1111/j.1096-0031.2010.00328.x; Preston C, 2002, NEW ATLAS BRIT IRISH; Preston CD, 2004, BOT J LINN SOC, V145, P257, DOI 10.1111/j.1095-8339.2004.00284.x; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; ROGERS SO, 1985, PLANT MOL BIOL, V5, P69, DOI 10.1007/BF00020088; Saunders GW, 2009, MOL ECOL RESOUR, V9, P140, DOI 10.1111/j.1755-0998.2009.02639.x; Schnell IB, 2010, ARTHROPOD-PLANT INTE, V4, P107, DOI 10.1007/s11829-010-9089-0; Sonstebo JH, 2010, MOL ECOL RESOUR, V10, P1009, DOI 10.1111/j.1755-0998.2010.02855.x; Stace C., 1997, New flora of the British Isles.; Starr JR, 2009, MOL ECOL RESOUR, V9, P151, DOI 10.1111/j.1755-0998.2009.02640.x; Stevens DP, 2010, GRASSLANDS WALES SUR; Stoeckle MY, 2011, SCI REP-UK, V1, DOI 10.1038/srep00042; Van De Wiel CCM, 2009, MOL ECOL RESOUR, V9, P1086, DOI 10.1111/j.1755-0998.2009.02547.x; Wang WQ, 2010, BMC PLANT BIOL, V10, DOI [10.1186/1471-2229-10-205, 10.1186/1471-2229-10-14]; Xue CY, 2011, J SYST EVOL, V49, P267, DOI 10.1111/j.1759-6831.2011.00127.x	48	125	131	1	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e37945	10.1371/journal.pone.0037945	http://dx.doi.org/10.1371/journal.pone.0037945			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701588	Green Published, gold			2022-12-27	WOS:000305348400026
J	Qi, HP; Qu, ZY; Duan, SR; Wei, SQ; Wen, SR; Bi, S				Qi, Hui-Ping; Qu, Zheng-Yi; Duan, Shu-Rong; Wei, Shu-Qin; Wen, Shi-Rong; Bi, Sheng			IL-6-174 G/C and-572 C/G Polymorphisms and Risk of Alzheimer's Disease	PLOS ONE			English	Article							INTERLEUKIN-6 PROMOTER POLYMORPHISM; C-REACTIVE PROTEIN; GENE POLYMORPHISMS; ONSET; ASSOCIATION; CYTOKINES; DEMENTIA; ALLELE	Associations between interleukin 6 (IL-6) polymorphisms and Alzheimer's disease (AD) remain controversial and ambiguous. The aim of this meta-analysis is to explore more precise estimations for the relationship between IL-6-174 G/C and -572 C/G polymorphisms and risk for AD. Electronic searches for all publications in databases PubMed and EMBASE were conducted on the associations between IL-6 polymorphisms and risk for AD until January 2012. Odds ratio (OR) and 95% confidence intervals (CIs) were calculated using fixed and random effects models. Twenty-seven studies were included with a total of 19,135 individuals, involving 6,632 AD patients and 12,503 controls. For IL-6-174 G/C polymorphism, the combined results showed significant differences in recessive model (CC vs. CG+GG: OR = 0.65, 95% CI = 0.52-0.82). As regards IL-6-572 C/G polymorphism, significant associations were shown in dominant model (CG+GG vs. CC: OR = 0.73, 95% CI = 0.62-0.86) and in additive model (GG vs. CC, OR = 0.66, 95% CI = 0.46-0.96). In conclusion, genotype CC of IL-6-174 G/C and genotype GG plus GC of IL-6-572 C/G could decrease the risk of AD.	[Duan, Shu-Rong; Wen, Shi-Rong; Bi, Sheng] Harbin Med Univ, Affiliated Hosp 1, Dept Neurol, Harbin, Peoples R China; [Qi, Hui-Ping] Harbin Med Univ, Affiliated Hosp 1, Dept Ophthalmol, Harbin, Peoples R China; [Qu, Zheng-Yi] Harbin Med Univ, Affiliated Hosp 4, Dept Neurol, Harbin, Peoples R China; [Wei, Shu-Qin] Univ Montreal, Hop St Justine, Montreal, PQ H3T 1C5, Canada; [Bi, Sheng] Harbin Med Univ, Affiliated Hosp 1, Cent Lab, Harbin, Peoples R China	Harbin Medical University; Harbin Medical University; Harbin Medical University; Universite de Montreal; Harbin Medical University	Bi, S (corresponding author), Harbin Med Univ, Affiliated Hosp 1, Dept Neurol, Harbin, Peoples R China.	bisheng.bi@gmail.com			Harbin Medical University (Harbin Special Funds for Research of Scientific and Technological Innovative Talents) [2011RFQYS092]	Harbin Medical University (Harbin Special Funds for Research of Scientific and Technological Innovative Talents)	This work was supported by Harbin Medical University (Harbin Special Funds for Research of Scientific and Technological Innovative Talents no. 2011RFQYS092). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arosio B, 2004, NEUROBIOL AGING, V25, P1009, DOI 10.1016/j.neurobiolaging.2003.10.009; Bagli M, 2000, NEUROSCI LETT, V283, P109, DOI 10.1016/S0304-3940(00)00917-4; Bhojak TJ, 2000, NEUROSCI LETT, V288, P21, DOI 10.1016/S0304-3940(00)01185-X; Capurso C, 2004, EXP GERONTOL, V39, P1567, DOI 10.1016/j.exger.2004.07.006; Capurso C, 2010, PROG NEURO-PSYCHOPH, V34, P177, DOI 10.1016/j.pnpbp.2009.10.022; Chen SY, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-21; Combarros O, 2005, J NEUROL, V252, P485, DOI 10.1007/s00415-005-0658-6; Dai L, 2011, J NEUROL; Depboylu C, 2004, DEMENT GERIATR COGN, V17, P170, DOI 10.1159/000076352; Eriksson UK, 2011, J ALZHEIMERS DIS, V23, P361, DOI 10.3233/JAD-2010-101671; Faltraco F, 2003, J AM GERIATR SOC, V51, P578, DOI 10.1046/j.1532-5415.2003.51177.x; Fontalba A, 2009, J NEUROL, V256, P1184, DOI 10.1007/s00415-009-5080-z; Ge YW, 2002, ANN NY ACAD SCI, V973, P463, DOI 10.1111/j.1749-6632.2002.tb04684.x; Han XM, 2011, NEUROSCI LETT, V504, P4, DOI 10.1016/j.neulet.2011.06.055; He MX, 2010, NEUROL SCI, V31, P165, DOI 10.1007/s10072-009-0199-3; Infante J, 2004, NEUROLOGY, V63, P1135, DOI 10.1212/01.WNL.0000138570.96291.A8; Klimkowicz-Mrowiec A, 2010, NEUROL NEUROCHIR POL, V44, P537; Koivisto AM, 2005, J NEUROGENET, V19, P155, DOI 10.1080/01677060600569721; Licastro F, 2003, NEUROBIOL AGING, V24, P921, DOI 10.1016/S0197-4580(03)00013-7; Mansoori N, 2010, DEMENT GERIATR COGN, V30, P461, DOI 10.1159/000321666; Mateo I, 2006, J NEUROL NEUROSUR PS, V77, P278, DOI 10.1136/jnnp.2005.075358; Mebane-Sims I, 2009, ALZHEIMERS DEMENT, V5, P234, DOI 10.1016/j.jalz.2009.03.001; Nishimoto N, 2010, CLIN PHARMACOL THER, V87, P483, DOI 10.1038/clpt.2009.313; Nishimura M, 2004, NEUROSCI LETT, V368, P140, DOI 10.1016/j.neulet.2004.06.076; Paik JK, 2007, CLIN CHIM ACTA, V380, P68, DOI 10.1016/j.cca.2006.11.011; Papassotiropoulos A, 1999, ANN NEUROL, V45, P666, DOI 10.1002/1531-8249(199905)45:5<666::AID-ANA18>3.0.CO;2-3; Paradowski B, 2008, NEUROL NEUROCHIR POL, V42, P312; Pola R, 2002, NEUROREPORT, V13, P1645, DOI 10.1097/00001756-200209160-00015; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Serretti A, 2007, J ALZHEIMERS DIS, V12, P73; Shibata N, 2002, AM J MED GENET, V114, P436, DOI 10.1002/ajmg.10417; van Oijen M, 2006, NEUROSCI LETT, V402, P113, DOI 10.1016/j.neulet.2006.03.050; Vural P, 2009, ACTA NEUROL SCAND, V120, P396, DOI 10.1111/j.1600-0404.2009.01230.x; Wang M, 2010, NEUROSCI LETT, V482, P260, DOI 10.1016/j.neulet.2010.07.051; Wong LYF, 2007, J HUM HYPERTENS, V21, P875, DOI 10.1038/sj.jhh.1002233; Zhang Y, 2004, NEUROSCI LETT, V362, P99, DOI 10.1016/j.neulet.2004.03.008	36	23	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e37858	10.1371/journal.pone.0037858	http://dx.doi.org/10.1371/journal.pone.0037858			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701584	Green Published, gold, Green Submitted			2022-12-27	WOS:000305348400022
J	Zhang, S; Cheng, JQ; Qin, YX				Zhang, Shu; Cheng, Jiqi; Qin, Yi-Xian			Mechanobiological Modulation of Cytoskeleton and Calcium Influx in Osteoblastic Cells by Short-Term Focused Acoustic Radiation Force	PLOS ONE			English	Article							LOW-INTENSITY ULTRASOUND; FLUID-FLOW; SHEAR-STRESS; INTRAMEDULLARY PRESSURE; PULSED ULTRASOUND; GENE-EXPRESSION; BONE-CELLS; IN-VITRO; GROWTH; OSCILLATIONS	Mechanotransduction has demonstrated potential for regulating tissue adaptation in vivo and cellular activities in vitro. It is well documented that ultrasound can produce a wide variety of biological effects in biological systems. For example, pulsed ultrasound can be used to noninvasively accelerate the rate of bone fracture healing. Although a wide range of studies has been performed, mechanism for this therapeutic effect on bone healing is currently unknown. To elucidate the mechanism of cellular response to mechanical stimuli induced by pulsed ultrasound radiation, we developed a method to apply focused acoustic radiation force (ARF) (duration, one minute) on osteoblastic MC3T3-E1 cells and observed cellular responses to ARF using a spinning disk confocal microscope. This study demonstrates that the focused ARF induced F-actin cytoskeletal rearrangement in MC3T3-E1 cells. In addition, these cells showed an increase in intracellular calcium concentration following the application of focused ARF. Furthermore, passive bending movement was noted in primary cilium that were treated with focused ARF. Cell viability was not affected. Application of pulsed ultrasound radiation generated only a minimal temperature rise of 0.1 degrees C, and induced a streaming resulting fluid shear stress of 0.186 dyne/cm(2), suggesting that hyperthermia and acoustic streaming might not be the main causes of the observed cell responses. In conclusion, these data provide more insight in the interactions between acoustic mechanical stress and osteoblastic cells. This experimental system could serve as basis for further exploration of the mechanosensing mechanism of osteoblasts triggered by ultrasound.	[Zhang, Shu; Cheng, Jiqi; Qin, Yi-Xian] SUNY Stony Brook, Dept Biomed Engn, Stony Brook, NY 11794 USA; [Zhang, Shu] Chinese Minist Educ, Key Lab Aerosp Med, Xian, Shaanxi, Peoples R China	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Zhang, S (corresponding author), SUNY Stony Brook, Dept Biomed Engn, Stony Brook, NY 11794 USA.	Yi-Xian.Qin@sunysb.edu		Zhang, Shu/0000-0002-4380-1268	China Scholarship Council; National Institutes of Health [AR49286, AR52379]; National Space Biomedical Research Institute through NASA [NCC 9-58]; US Army Medical Research; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052379, R01AR061821, R01AR049286] Funding Source: NIH RePORTER	China Scholarship Council(China Scholarship Council); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Space Biomedical Research Institute through NASA; US Army Medical Research(United States Department of DefenseUS Army Research Laboratory (ARL)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Dr. Shu Zhang thanks the China Scholarship Council for providing partial financial support for his staying in Stony Brook as a visiting scholar. The authors are grateful for the assistance from Dr. Chris Jacobs and Sara Temiyasathit for their help with the primary cilia immunostaining protocol and analysis.; This work was supported by National Institutes of Health grants (AR49286 and AR52379), National Space Biomedical Research Institute through NASA Cooperative Agreement NCC 9-58, and US Army Medical Research to Dr. Qin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnsdorf EJ, 2009, J CELL SCI, V122, P546, DOI 10.1242/jcs.036293; Barnett SB, 1997, ULTRASOUND MED BIOL, V23, P805, DOI 10.1016/S0301-5629(97)00027-6; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Bikle DD, 2008, OSTEOPOROSIS INT, V19, P1237, DOI 10.1007/s00198-008-0597-z; Bloomfield SA, 2001, INT J SPORT NUTR EXE, V11, pS128, DOI 10.1123/ijsnem.11.s1.s128; Chen NX, 2000, AM J PHYSIOL-CELL PH, V278, pC989, DOI 10.1152/ajpcell.2000.278.5.C989; Coakley WT, 2000, ULTRASONICS, V38, P638, DOI 10.1016/S0041-624X(99)00151-1; Cook SD, 1997, CLIN ORTHOP RELAT R, P198; CRUM LA, 1992, J ACOUST SOC AM, V91, P1113, DOI 10.1121/1.402638; Dalecki D, 2004, ANNU REV BIOMED ENG, V6, P229, DOI 10.1146/annurev.bioeng.6.040803.140126; Donahue SW, 2003, J BIOMECH, V36, P35, DOI 10.1016/S0021-9290(02)00318-4; Donahue SW, 2001, AM J PHYSIOL-CELL PH, V281, pC1635, DOI 10.1152/ajpcell.2001.281.5.C1635; DUARTE LR, 1983, ARCH ORTHOP TRAUM SU, V101, P153, DOI 10.1007/BF00436764; FOWLKES JB, 1988, J ACOUST SOC AM, V83, P2190, DOI 10.1121/1.396347; Frenkel V, 2008, ADV DRUG DELIVER REV, V60, P1193, DOI 10.1016/j.addr.2008.03.007; Frohlich M, 2010, TISSUE ENG PT A, V16, P179, DOI [10.1089/ten.tea.2009.0164, 10.1089/ten.TEA.2009.0164]; Giannoudis PV, 2007, INJURY, V38, pS3, DOI 10.1016/S0020-1383(08)70003-2; Hancock HA, 2009, ULTRASOUND MED BIOL, V35, P1722, DOI 10.1016/j.ultrasmedbio.2009.04.020; HECKMAN JD, 1994, J BONE JOINT SURG AM, V76A, P26, DOI 10.2106/00004623-199401000-00004; Hollman KW, 2007, EXP EYE RES, V85, P890, DOI 10.1016/j.exer.2007.09.006; Hsieh YL, 2005, ARCH PHYS MED REHAB, V86, P1311, DOI 10.1016/j.apmr.2004.12.035; Hultstrom J, 2007, ULTRASOUND MED BIOL, V33, P145, DOI 10.1016/j.ultrasmedbio.2006.07.024; HUNG CT, 1995, CLIN ORTHOP RELAT R, P256; INGBER DE, 1994, INT REV CYTOL, V150, P173; Ingber DE, 2006, FASEB J, V20, P811, DOI 10.1096/fj.05-5424rev; Jacobs CR, 1998, J BIOMECH, V31, P969, DOI 10.1016/S0021-9290(98)00114-6; Juffermans LJM, 2009, ULTRASOUND MED BIOL, V35, P1917, DOI 10.1016/j.ultrasmedbio.2009.06.1091; Kimmel Eitan, 2006, Critical Reviews in Biomedical Engineering, V34, P105, DOI 10.1615/CritRevBiomedEng.v34.i2.10; Korstjens CM, 2004, J ORTHOP RES, V22, P495, DOI 10.1016/j.orthres.2003.09.011; Lee J, 2005, J ACOUST SOC AM, V117, P3273, DOI 10.1121/1.1886387; Li DQ, 2009, TISSUE ENG PT A, V15, P2773, DOI [10.1089/ten.tea.2008.0540, 10.1089/ten.TEA.2008.0540]; Liu YY, 2006, ULTRASON SONOCHEM, V13, P232, DOI 10.1016/j.ultsonch.2005.03.005; Lyon R, 2003, J ORTHOPAED RES, V21, P865, DOI 10.1016/S0736-0266(03)00047-0; Maleke C, 2008, PHYS MED BIOL, V53, P1773, DOI 10.1088/0031-9155/53/6/018; Malone AMD, 2007, P NATL ACAD SCI USA, V104, P13325, DOI 10.1073/pnas.0700636104; Malone AMD, 2007, AM J PHYSIOL-CELL PH, V292, pC1830, DOI 10.1152/ajpcell.00352.2005; Miller DL, 2007, PROG BIOPHYS MOL BIO, V93, P314, DOI 10.1016/j.pbiomolbio.2006.07.027; Milowska K, 2005, ULTRASOUND MED BIOL, V31, P1707, DOI 10.1016/j.ultrasmedbio.2005.07.018; Myers KA, 2007, BIOCHEM BIOPH RES CO, V364, P214, DOI 10.1016/j.bbrc.2007.09.109; Naruse K, 2003, J BONE MINER RES, V18, P360, DOI 10.1359/jbmr.2003.18.2.360; Nightingale K, 2002, ULTRASOUND MED BIOL, V28, P227, DOI 10.1016/S0301-5629(01)00499-9; Nolte PA, 2001, J TRAUMA, V51, P693, DOI 10.1097/00005373-200110000-00012; O'Neill BE, 2009, ULTRASOUND MED BIOL, V35, P416, DOI 10.1016/j.ultrasmedbio.2008.09.021; Papachroni KK, 2009, TRENDS MOL MED, V15, P208, DOI 10.1016/j.molmed.2009.03.001; Parvizi J, 1999, J ORTHOPAED RES, V17, P488, DOI 10.1002/jor.1100170405; Pickard JE, 2009, BIOPHYS J, V96, P4249, DOI 10.1016/j.bpj.2009.01.060; Qin YX, 2003, J BIOMECH, V36, P1427, DOI 10.1016/S0021-9290(03)00127-1; Qin YX, 2002, ANN BIOMED ENG, V30, P693, DOI 10.1114/1.1483863; Reher P, 1997, ULTRASOUND MED BIOL, V23, P1251, DOI 10.1016/S0301-5629(97)00031-8; Rubin C, 2001, J BONE JOINT SURG AM, V83A, P259, DOI 10.2106/00004623-200102000-00015; Scaglione S, 2008, J BIOMED MATER RES A, V86A, P411, DOI 10.1002/jbm.a.31607; Scott A, 2008, SPORTS MED, V38, P139, DOI 10.2165/00007256-200838020-00004; Sena K, 2005, ULTRASOUND MED BIOL, V31, P703, DOI 10.1016/j.ultrasmedbio.2005.01.013; Shou WD, 2006, ULTRASONICS, V44, pE17, DOI 10.1016/j.ultras.2006.06.034; Vaezy S, 2001, ULTRASOUND MED BIOL, V27, P33, DOI 10.1016/S0301-5629(00)00279-9; WANG SJ, 1994, J ORTHOP RES, V12, P40, DOI 10.1002/jor.1100120106; WEINBAUM S, 1994, J BIOMECH, V27, P339, DOI 10.1016/0021-9290(94)90010-8; Worthington AE, 1997, ULTRASOUND MED BIOL, V23, P1095, DOI 10.1016/S0301-5629(97)00019-7; Yang KH, 1996, J ORTHOP RES, V14, P802, DOI 10.1002/jor.1100140518; You J, 2000, J BIOMECH ENG-T ASME, V122, P387, DOI 10.1115/1.1287161; Zhou YF, 2006, J ACOUST SOC AM, V120, P676, DOI 10.1121/1.2214131	61	39	41	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e38343	10.1371/journal.pone.0038343	http://dx.doi.org/10.1371/journal.pone.0038343			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701628	Green Submitted, gold, Green Published			2022-12-27	WOS:000305348400052
J	Ni, F; Gong, Y; Li, LL; Abdolmaleky, HM; Zhou, JR				Ni, Feng; Gong, Yi; Li, Linglin; Abdolmaleky, Hamid M.; Zhou, Jin-Rong			Flavonoid Ampelopsin Inhibits the Growth and Metastasis of Prostate Cancer In Vitro and in Mice	PLOS ONE			English	Article							BREAST-CANCER; CHEMOKINE RECEPTORS; TUMOR ANGIOGENESIS; ORTHOTOPIC GROWTH; APOPTOSIS; CELLS; CXCR4; BCL-2; EXPRESSION; RESISTANCE	The objective of this study was to evaluate the chemopreventive effect of a novel flavonoid, ampelopsin (AMP) on the growth and metastasis of prostate cancer cells. AMP showed the more potent activity in inhibiting the proliferation of androgen-sensitive LNCaP and, to less extent, androgen-independent PC-3 human prostate cancer cell lines in vitro, primarily by induction of apoptosis associated with down-regulation of bcl-2. On the other hand, AMP showed much less activity in inhibiting the proliferation of normal prostate epithelial cells than that of prostate cancer cell lines. AMP also inhibited the migration and invasion of PC-3 cells in vitro associated with down-regulation of CXCR4 expression. In the animal study using an orthotopic prostate tumor model, AMP (150 and 300 mg/kg body weight) inhibited the growth of PC-3 tumors and lymph node and lung metastases in a dose-dependent manner. Compared to the control mice, mice treated with AMP at 300 mg/kg BW had reduced final tumor weight by 49.2% (P<0.05), lymph node metastases by 54.5% (P = 0.3) and lung metastases by 93% (P<0.05), but had no apparent alteration on food intake or body weight. The in vivo anti-growth and anti-metastasis activities of AMP were associated with induction of apoptosis and inhibition of proliferation of prostate cancer cells, reduction of prostate tumor angiogenesis, and reduction of CXCR4 expression. Our results provide supporting evidence to warrant further investigation to develop AMP as a novel efficacious and safe candidate agent against progression and metastasis of prostate cancer.	[Ni, Feng] Fujian Hlth Coll, Dept Pharmaceut, Fuzhou, Fujian, Peoples R China; [Ni, Feng; Gong, Yi; Li, Linglin; Abdolmaleky, Hamid M.; Zhou, Jin-Rong] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Nutr Metab Lab,Dept Surg, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Ni, F (corresponding author), Fujian Hlth Coll, Dept Pharmaceut, Fuzhou, Fujian, Peoples R China.	jrzhou@bidmc.harvard.edu	Liu, Deyu/G-5665-2012	Mostafavi Abdolmaleky, Hamid/0000-0002-8872-5174	Foundation of Chinese Ministry of Health & United Fujian Provincial Health and Education [WKJ2008-2-60]; Foundation of Fujian Provincial Department of Science Technology [2011Y0015]; Scientific Research Foundation of Exploitation on Industrial Technology of Fujian Development and Reform Commission [2008-762]; Department of Defense [PC073988]; NCI/NIH [R21 CA133865]; NATIONAL CANCER INSTITUTE [R21CA133865] Funding Source: NIH RePORTER	Foundation of Chinese Ministry of Health & United Fujian Provincial Health and Education; Foundation of Fujian Provincial Department of Science Technology; Scientific Research Foundation of Exploitation on Industrial Technology of Fujian Development and Reform Commission; Department of Defense(United States Department of Defense); NCI/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Foundation of Chinese Ministry of Health & United Fujian Provincial Health and Education (WKJ2008-2-60), Foundation of Fujian Provincial Department of Science & Technology (2011Y0015) and Scientific Research Foundation of Exploitation on Industrial Technology of Fujian Development and Reform Commission (2008-762) to FN, and Department of Defense (PC073988) and NCI/NIH (R21 CA133865) to JRZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the menuscript.	Cao Y, 2010, EXP CELL RES, V316, P1304, DOI 10.1016/j.yexcr.2010.02.031; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Grande F, 2008, CURR PHARM DESIGN, V14, P385; Harvey JR, 2007, CLIN CANCER RES, V13, P1562, DOI 10.1158/1078-0432.CCR-06-1987; Hase K, 1997, BIOL PHARM BULL, V20, P381, DOI 10.1248/bpb.20.381; He Guixia, 2003, Zhong Yao Cai, V26, P338; Krajewska M, 1996, AM J PATHOL, V148, P1567; Liu D, 2001, Zhong Yao Cai, V24, P348; Liu De-yu, 2003, Zhongguo Zhongyao Zazhi, V28, P957; Liu DY, 2004, BIOMED ENVIRON SCI, V17, P153; Luo Gao-qin, 2006, Zhong Yao Cai, V29, P146; McConkey DJ, 1996, CANCER RES, V56, P5594; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Murakami T, 2004, BIOFACTORS, V21, P175, DOI 10.1002/biof.552210136; Perez de Castro I, 2008, CURR OPIN PHARMACOL, V8, P375, DOI 10.1016/j.coph.2008.06.013; Pitts M., 2002, I ANIMAL CARE USE CO, V2; RAFFO AJ, 1995, CANCER RES, V55, P4438; Rubin JB, 2003, P NATL ACAD SCI USA, V100, P13513, DOI 10.1073/pnas.2235846100; Salvucci O, 2006, BREAST CANCER RES TR, V97, P275, DOI 10.1007/s10549-005-9121-8; Scotton CJ, 2001, CANCER RES, V61, P4961; Scotton CJ, 2002, CANCER RES, V62, P5930; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Singh AV, 2006, CANCER RES, V66, P1851, DOI 10.1158/0008-5472.CAN-05-1332; Song R, 2010, PROSTATE, V70, P571, DOI 10.1002/pros.21091; Steel RGD, 1980, PRINCIPLES PROCEDURE; Yang LH, 2007, CANCER RES, V67, P651, DOI 10.1158/0008-5472.CAN-06-2762; Ye Jiantao, 2009, Zhongguo Zhong Yao Za Zhi, V34, P761; Zeng Sa, 2006, Zhong Yao Cai, V29, P260; Zeng Sa, 2004, Zhong Yao Cai, V27, P842; Zheng Hong-Qiang, 2003, Ai Zheng, V22, P363; Zhong Zheng-xian, 2002, Zhongguo Zhongyao Zazhi, V27, P687; Zhou JR, 1999, J NUTR, V129, P1628, DOI 10.1093/jn/129.9.1628; Zhou JR, 2004, INT J CANCER, V110, P800, DOI 10.1002/ijc.20206; Zhou JR, 2002, PROSTATE, V53, P143, DOI 10.1002/pros.10141; Zhou JR, 1998, CANCER RES, V58, P5231	35	50	58	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e38802	10.1371/journal.pone.0038802	http://dx.doi.org/10.1371/journal.pone.0038802			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22693649	Green Submitted, Green Published, gold			2022-12-27	WOS:000305343900066
J	Loganathan, R; Potetz, BR; Rongish, BJ; Little, CD				Loganathan, Rajprasad; Potetz, Brian R.; Rongish, Brenda J.; Little, Charles D.			Spatial Anisotropies and Temporal Fluctuations in Extracellular Matrix Network Texture during Early Embryogenesis	PLOS ONE			English	Article							CELL-SHAPE CHANGES; MOVEMENT; EMBRYO; MORPHOGENESIS; ORGANIZATION; FIBRONECTIN; DIRECTION	Early stages of vertebrate embryogenesis are characterized by a remarkable series of shape changes. The resulting morphological complexity is driven by molecular, cellular, and tissue-scale biophysical alterations. Operating at the cellular level, extracellular matrix (ECM) networks facilitate cell motility. At the tissue level, ECM networks provide material properties required to accommodate the large-scale deformations and forces that shape amniote embryos. In other words, the primordial biomaterial from which reptilian, avian, and mammalian embryos are molded is a dynamic composite comprised of cells and ECM. Despite its central importance during early morphogenesis we know little about the intrinsic micrometer-scale surface properties of primordial ECM networks. Here we computed, using avian embryos, five textural properties of fluorescently tagged ECM networks - (a) inertia, (b) correlation, (c) uniformity, (d) homogeneity, and (e) entropy. We analyzed fibronectin and fibrillin-2 as examples of fibrous ECM constituents. Our quantitative data demonstrated differences in the surface texture between the fibronectin and fibrillin-2 network in Day 1 (gastrulating) embryos, with the fibronectin network being relatively coarse compared to the fibrillin-2 network. Stage-specific regional anisotropy in fibronectin texture was also discovered. Relatively smooth fibronectin texture was exhibited in medial regions adjoining the primitive streak (PS) compared with the fibronectin network investing the lateral plate mesoderm (LPM), at embryonic stage 5. However, the texture differences had changed by embryonic stage 6, with the LPM fibronectin network exhibiting a relatively smooth texture compared with the medial PS-oriented network. Our data identify, and partially characterize, stage-specific regional anisotropy of fibronectin texture within tissues of a warm-blooded embryo. The data suggest that changes in ECM textural properties reflect orderly time-dependent rearrangements of a primordial biomaterial. We conclude that the ECM microenvironment changes markedly in time and space during the most important period of amniote morphogenesis-as determined by fluctuating textural properties.	[Loganathan, Rajprasad; Rongish, Brenda J.; Little, Charles D.] Univ Kansas, Med Ctr, Dept Anat & Cell Biol, Kansas City, KS 66103 USA; [Loganathan, Rajprasad; Potetz, Brian R.] Univ Kansas, Dept Elect Engn & Comp Sci, Lawrence, KS 66045 USA	University of Kansas; University of Kansas Medical Center; University of Kansas	Loganathan, R (corresponding author), Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21218 USA.	rlogana2@jhmi.edu	Rongish, Brenda/G-7637-2016; Loganathan, Rajprasad/V-9993-2018	Rongish, Brenda/0000-0002-1559-2876; Loganathan, Rajprasad/0000-0001-5618-4222	National Institutes of Health [HL068855, HL085694, GM76692]; G Harold & Leila Y Mathers Charitable Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068855, R01HL085694] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076692] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); G Harold & Leila Y Mathers Charitable Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health RO1 grants HL068855 (CDL), HL085694 (BJR), GM76692 (CDL, PI is James A. Glazier, Indiana University); and the G Harold & Leila Y Mathers Charitable Foundation (CDL and BJR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair-Kirk TL, 2008, INT J BIOCHEM CELL B, V40, P1101, DOI 10.1016/j.biocel.2007.12.005; Arroyo AG, 2010, CARDIOVASC RES, V86, P226, DOI 10.1093/cvr/cvq049; Bae E, 2004, J BIOL CHEM, V279, P35749, DOI 10.1074/jbc.M406283200; Bokel C, 2002, DEV CELL, V3, P311, DOI 10.1016/S1534-5807(02)00265-4; Bruce A., 2002, MOL BIOL CELL, V4th ed.; Butusov OB, 2006, THEOR FOUND CHEM EN+, V40, P291, DOI 10.1134/S0040579506030109; CARTER SB, 1965, NATURE, V208, P1183, DOI 10.1038/2081183a0; CARTER SB, 1967, NATURE, V213, P256, DOI 10.1038/213256a0; Chapman SC, 2001, DEV DYNAM, V220, P284, DOI 10.1002/1097-0177(20010301)220:3<284::AID-DVDY1102>3.0.CO;2-5; Czirok A, 2006, J CELL PHYSIOL, V207, P97, DOI 10.1002/jcp.20573; Davidson L, 2009, INT J BIOCHEM CELL B, V41, P2147, DOI 10.1016/j.biocel.2009.04.015; Davidson LA, 2011, CURR TOP DEV BIOL, V95, P215, DOI 10.1016/B978-0-12-385065-2.00007-4; Dobaczewski M, 2010, J MOL CELL CARDIOL, V48, P504, DOI 10.1016/j.yjmcc.2009.07.015; Fleury Vincent, 2007, Organogenesis, V3, P49; GALLAGHER BC, 1993, DEV DYNAM, V196, P70, DOI 10.1002/aja.1001960109; GEORGE EL, 1993, DEVELOPMENT, V119, P1079; Gjorevski N, 2009, CYTOKINE GROWTH F R, V20, P459, DOI 10.1016/j.cytogfr.2009.10.013; Gonzalez RC, 2002, DIGITAL IMAGE PROCES, P643; HAMBURGER V, 1992, DEV DYNAM, V195, P231, DOI 10.1002/dvdy.1001950404; HARALICK RM, 1979, P IEEE, V67, P786, DOI 10.1109/PROC.1979.11328; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Hohenester E, 2002, MATRIX BIOL, V21, P115, DOI 10.1016/S0945-053X(01)00191-3; Koppen M, 2006, DEVELOPMENT, V133, P2671, DOI 10.1242/dev.02439; Krafts KP, 2010, ORGANOGENESIS, V6, P225, DOI 10.4161/org.6.4.12555; Kurpios NA, 2008, P NATL ACAD SCI USA, V105, P8499, DOI 10.1073/pnas.0803578105; Little CD, 2000, METH MOL B, V135, P183; Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5; MOILLIET JL, 1967, NATURE, V213, P260, DOI 10.1038/213260a0; NEW DAT, 1955, J EMBRYOL EXP MORPH, V3, P320; Paluch E, 2009, CURR BIOL, V19, pR790, DOI 10.1016/j.cub.2009.07.029; Pilot F, 2005, DEV DYNAM, V232, P685, DOI 10.1002/dvdy.20334; POOLE TJ, 1982, DEV BIOL, V92, P144, DOI 10.1016/0012-1606(82)90159-2; Ramos JW, 1996, DEVELOPMENT, V122, P2873; Rongish BJ, 1998, DEV DYNAM, V212, P461; Rosenfield A, 1970, VISUAL TEXTURE ANAL, P70; Rozario T, 2010, DEV BIOL, V341, P126, DOI 10.1016/j.ydbio.2009.10.026; Rozario T, 2009, DEV BIOL, V327, P386, DOI 10.1016/j.ydbio.2008.12.025; Skoglund P, 2007, DEV BIOL, V301, P404, DOI 10.1016/j.ydbio.2006.09.005; STERN CD, 2004, GASTRULATION CELLS E, P219; Szabo A, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/4/045006; Thiery JP, 1989, BIOL EXTRACELLULAR M, P181; Tomita F., 1990, COMPUTER ANAL VISUAL; Tsuda T, 1996, DEV BIOL, V173, P39, DOI 10.1006/dbio.1996.0005; Tuceryan M, HDB PATTERN RECOGNIT, P207; Vakonakis L, 2007, CURR OPIN CELL BIOL, V19, P578, DOI 10.1016/j.ceb.2007.09.005; WUNSCH AM, 1994, DEV BIOL, V165, P585, DOI 10.1006/dbio.1994.1278; Zamir EA, 2006, P NATL ACAD SCI USA, V103, P19806, DOI 10.1073/pnas.0606100103; Zamir EA, 2008, PLOS BIOL, V6, P2163, DOI 10.1371/journal.pbio.0060247	48	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38266	10.1371/journal.pone.0038266	http://dx.doi.org/10.1371/journal.pone.0038266			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693609	gold, Green Published, Green Submitted			2022-12-27	WOS:000305338500120
J	Paxton, GA; Sangster, KJ; Maxwell, EL; McBride, CRJ; Drewe, RH				Paxton, Georgia A.; Sangster, Katrina J.; Maxwell, Ellen L.; McBride, Catherine R. J.; Drewe, Ross H.			Post-Arrival Health Screening in Karen Refugees in Australia	PLOS ONE			English	Article							VITAMIN-D DEFICIENCY; PREVENTION; CHILDREN; IMMIGRANTS; WOMEN; UNIT	Objective: To document the prevalence of nutritional deficiencies, infectious diseases and susceptibility to vaccine preventable diseases in Karen refugees in Australia. Design: Retrospective audit of pathology results. Setting: Community based cohort in Melbourne over the period July 2006-October 2009. Participants: 1136 Karen refugee children and adults, representing almost complete local area settlement and 48% of total Victorian Karen humanitarian intake for the time period. Main Outcome Measures: Prevalence of positive test results for refugee health screening, with breakdown by age group (<6 years, 6-11 years, 12-17 years, 18 years and older). Results: Overall prevalence figures were: anaemia 9.2%, microcytosis 19.1%, iron deficiency 13.1%, low vitamin B-12 1.5%, low folate 1.5%, abnormal thyroid function tests 4.4%, vitamin D<50 nmol/L 33.3%, hypocalcaemia 7.4%, raised alkaline phosphatase 5.2%, abnormal liver transaminases 16.1%, hepatitis B surface antigen positive 9.7%, hepatitis B surface antibody positive 49.5%, isolated hepatitis B core antibody positive 9.0%, hepatitis C positive 1.9%, eosinophilia 14.4%, Schistosoma infection 7%, Strongyloides infection 20.8%, malaria 0.2%, faecal parasites 43.4%. Quantiferon-gold screening was positive in 20.9%. No cases of syphilis or HIV were identified. Serological immunity to vaccine preventable diseases was 87.1% for measles, 95% for mumps and 66.4% for rubella; 56.9% of those tested had seroimmunity to all three. Conclusions: Karen refugees have high rates of nutritional deficiencies and infectious diseases and may be susceptible to vaccine preventable diseases. These data support the need for post-arrival health screening and accessible, funded catch-up immunisation.	[Paxton, Georgia A.; Sangster, Katrina J.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Maxwell, Ellen L.] Melbourne Pathol, Melbourne, Vic, Australia; [McBride, Catherine R. J.; Drewe, Ross H.] ISIS Primary Care, Melbourne, Vic, Australia	Murdoch Children's Research Institute; Royal Children's Hospital Melbourne	Paxton, GA (corresponding author), Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic, Australia.	Georgia.paxton@rch.org.au		Paxton, Georgia/0000-0003-2314-9812				Awumey EMK, 1998, J CLIN ENDOCR METAB, V83, P169, DOI 10.1210/jc.83.1.169; Chaves NJ, 2009, EMERG INFECT DIS, V15, P1769, DOI 10.3201/eid1511.090777; Cherian S, 2006, MED J AUSTRALIA, V185, P611, DOI 10.5694/j.1326-5377.2006.tb00728.x; Denburg A, 2007, Can Commun Dis Rep, V33, P16; Department of Immigration and Citizenship, 2011, DEP IMM CIT FORM 107; Department of Immigration and Citizenship, 2011, SETTL REP FAC; Diamond TH, 2005, MED J AUSTRALIA, V182, P281, DOI 10.5694/j.1326-5377.2005.tb06701.x; Foundation House, 2007, PROM REF HLTH GUID D; Geltman PL, 2003, AM J TROP MED HYG, V69, P657, DOI 10.4269/ajtmh.2003.69.657; Gibney KB, 2009, AM J TROP MED HYG, V80, P805, DOI 10.4269/ajtmh.2009.80.805; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Johnson D, 2007, RATES INFECT DIS NUT; Lavanchy D, 2004, J VIRAL HEPATITIS, V11, P97, DOI 10.1046/j.1365-2893.2003.00487.x; Lok ASF, 2009, HEPATOLOGY, V50, P661, DOI 10.1002/hep.23190; Lucas M, 2010, THORAX, V65, P442, DOI 10.1136/thx.2009.127555; MAHONEY FJ, 1995, PEDIATRICS, V96, P1113; Martin JA, 2006, MED J AUSTRALIA, V185, P607, DOI 10.5694/j.1326-5377.2006.tb00726.x; McGillivray G, 2007, ARCH DIS CHILD, V92, P1088, DOI 10.1136/adc.2006.112813; MILLER E, 1987, BRIT MED J, V294, P737, DOI 10.1136/bmj.294.6574.737; Munns C, 2006, MED J AUSTRALIA, V185, P268, DOI 10.5694/j.1326-5377.2006.tb00558.x; Murray R, 2009, DIAGNOSIS MANAGEMENT; Murray RJ, 2009, MED J AUSTRALIA, V190, P421, DOI 10.5694/j.1326-5377.2009.tb02489.x; O'Sullivan BG, 2004, AUST NZ J PUBL HEAL, V28, P212, DOI 10.1111/j.1467-842X.2004.tb00697.x; Plewes K, 2008, INT J STD AIDS, V19, P833, DOI 10.1258/ijsa.2008.008034; Power David V, 2010, Minn Med, V93, P49; Ritchey MD, 2011, CLIN PEDIATR, V50, P648, DOI 10.1177/0009922811398958; Sheikh M, 2009, J PAEDIATR CHILD H, V45, P509, DOI 10.1111/j.1440-1754.2009.01550.x; Shoklo Malaria Research Unit, 2011, MAL TASK FORC MAE LA; Skull SA, 2003, INTERN MED J, V33, P47, DOI 10.1046/j.1445-5994.2003.00344.x; Tiong ACD, 2006, MED J AUSTRALIA, V185, P602, DOI 10.5694/j.1326-5377.2006.tb00724.x; World Health Organization, 2008, INT TRAVEL HLTH SIT	31	39	40	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38194	10.1371/journal.pone.0038194	http://dx.doi.org/10.1371/journal.pone.0038194			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693599	Green Published, gold			2022-12-27	WOS:000305338500107
J	Schwartz, NU; Zhong, LX; Bellemer, A; Tracey, WD				Schwartz, Nicholas U.; Zhong, Lixian; Bellemer, Andrew; Tracey, W. Daniel			Egg Laying Decisions in Drosophila Are Consistent with Foraging Costs of Larval Progeny	PLOS ONE			English	Article							MELANOGASTER; BEHAVIOR; RECEPTORS; TREHALOSE; SELECTION; SIMULANS; GENE	Decision-making is defined as selection amongst options based on their utility, in a flexible and context-dependent manner. Oviposition site selection by the female fly, Drosophila melanogaster, has been suggested to be a simple and genetically tractable model for understanding the biological mechanisms that implement decisions [1]. Paradoxically, female Drosophila have been found to avoid oviposition on sugar which contrasts with known Drosophila feeding preferences [1]. Here we demonstrate that female Drosophila prefer egg laying on sugar, but this preference is sensitive to the size of the egg laying substrate. With larger experimental substrates, females preferred to lay eggs directly on sugar containing media over other (plain, bitter or salty) media. This was in contrast to smaller substrates with closely spaced choices where females preferred non-sweetened media. We show that in small egg laying chambers newly hatched first instar larvae are able to migrate along a diffusion gradient to the sugar side. In contrast, in contexts where females preferred egg laying directly on sugar, larvae were unable to migrate to find the sucrose if released on the sugar free side of the chamber. Thus, where larval foraging costs are high, female Drosophila choose to lay their eggs directly upon the nutritious sugar substrate. Our results offer a powerful model for female decision-making.	[Schwartz, Nicholas U.; Tracey, W. Daniel] Duke Univ, Trinity Coll Arts & Sci, Neurosci Program, Durham, NC 27710 USA; [Zhong, Lixian; Tracey, W. Daniel] Duke Univ, Pharmacol Sci Training Program, Durham, NC USA; [Tracey, W. Daniel] Duke Univ, Dept Neurobiol, Durham, NC USA; [Tracey, W. Daniel] Duke Univ, Dept Cell Biol, Durham, NC USA; [Bellemer, Andrew; Tracey, W. Daniel] Duke Univ, Med Ctr, Dept Anesthesiol, Durham, NC 27710 USA	Duke University; Duke University; Duke University; Duke University; Duke University	Schwartz, NU (corresponding author), Duke Univ, Trinity Coll Arts & Sci, Neurosci Program, Durham, NC 27710 USA.	dan.tracey@duke.edu		Tracey, W. Daniel/0000-0003-4666-8199; Zhong, Lixian/0000-0003-2048-122X	NIGMS NIH HHS [T32 GM008600] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008600] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Amrein H, 2005, CURR BIOL, V15, pR673, DOI 10.1016/j.cub.2005.08.021; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; Chyb S, 2003, P NATL ACAD SCI USA, V100, P14526, DOI 10.1073/pnas.2135339100; Dahanukar A, 2001, NAT NEUROSCI, V4, P1182, DOI 10.1038/nn765; DEBELLE JS, 1989, GENETICS, V123, P157; GRUWEZ G, 1971, EXPERIENTIA, V27, P1414, DOI 10.1007/BF02154262; Joseph RM, 2009, P NATL ACAD SCI USA, V106, P11352, DOI 10.1073/pnas.0901419106; Miller PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016436; Peabody NC, 2009, J NEUROSCI, V29, P3343, DOI 10.1523/JNEUROSCI.4241-08.2009; Scott K, 2001, CELL, V104, P661, DOI 10.1016/S0092-8674(02)02052-4; Slone J, 2007, CURR BIOL, V17, P1809, DOI 10.1016/j.cub.2007.09.027; SOKOLOWSKI MB, 1983, BEHAV GENET, V13, P159, DOI 10.1007/BF01065664; SOKOLOWSKI MB, 1983, BEHAV GENET, V13, P169, DOI 10.1007/BF01065665; Yang CH, 2008, SCIENCE, V319, P1679, DOI 10.1126/science.1151842	14	54	54	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e37910	10.1371/journal.pone.0037910	http://dx.doi.org/10.1371/journal.pone.0037910			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693584	gold, Green Submitted, Green Published			2022-12-27	WOS:000305338500065
J	Nasman, A; Romanitan, M; Nordfors, C; Grun, N; Johansson, H; Hammarstedt, L; Marklund, L; Munck-Wikland, E; Dalianis, T; Ramqvist, T				Nasman, Anders; Romanitan, Mircea; Nordfors, Cecilia; Grun, Nathalie; Johansson, Hemming; Hammarstedt, Lalle; Marklund, Linda; Munck-Wikland, Eva; Dalianis, Tina; Ramqvist, Torbjorn			Tumor Infiltrating CD8(+) and Foxp3(+) Lymphocytes Correlate to Clinical Outcome and Human Papillomavirus (HPV) Status in Tonsillar Cancer	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; REGULATORY T-CELLS; NECK-CANCER; CERVICAL-CANCER; TONGUE CANCER; HEAD; SURVIVAL; RISK; RELAPSE; EXPRESSION	Background: Human papillomavirus (HPV) is a causative factor for tonsillar squamous cell carcinoma (TSCC) and patients with HPV positive (HPV+) TSCC have a better clinical outcome than those with HPV negative (HPV 2) TSCC. However, since not all patients with HPV+TSCC respond to treatment, additional biomarkers are needed together with HPV status to better predict response to therapy and to individualize treatment. For this purpose, we examined whether the number of tumor infiltrating cytotoxic and regulatory T-cells in TSCC correlated to HPV status and to clinical outcome. Methods: Formalin fixed paraffin embedded TSCC, previously analysed for HPV DNA, derived from 83 patients, were divided into four groups depending on the HPV status of the tumor and clinical outcome. Tumors were stained by immunohistochemistry and evaluated for the number of infiltrating cytotoxic (CD8(+)) and regulatory (Foxp3(+)) T-cells. Results: A high CD8(+) T-cell infiltration was significantly positively correlated to a good clinical outcome in both patients with HPV+ and HPV- TSCC patients. Similarly, a high CD8(+)/Foxp3(+) TIL ratio was correlated to a 3-year disease free survival. Furthermore, HPV+ TSCC had in comparison to HPV 2 TSCC, higher numbers of infiltratin(g) CD8(+) and Foxp3(+) T-cells. Conclusions: In conclusion, a positive correlation between a high number of infiltrating CD8(+) cells and clinical outcome indicates that CD8(+) cells may contribute to a beneficial clinical outcome in TSCC patients, and may potentially serve as a biomarker. Likewise, the CD8(+)/Foxp3(+) cell ratio can potentially be used for the same purpose.	[Nasman, Anders; Romanitan, Mircea; Nordfors, Cecilia; Grun, Nathalie; Johansson, Hemming; Dalianis, Tina; Ramqvist, Torbjorn] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden; [Hammarstedt, Lalle; Marklund, Linda; Munck-Wikland, Eva] Karolinska Inst, Karolinska Univ Hosp, Dept Otorhinolaryngol Head & Neck Surg, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Nasman, A (corresponding author), Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden.	torbjorn.ramqvist@ki.se	Marklunf, Linda/L-1913-2015	Nasman, Anders/0000-0003-4602-4297; Hammarstedt-Nordenvall, Lalle/0000-0003-1660-9737; Dalianis, Tina/0000-0001-7022-2424	Swedish Cancer Society [100258]; Swedish Medical Research Council [K2011-56X-15282-07-6]; Stockholm Cancer Society [101081]; Henning and Ida Perssons Foundation; Karolinska Institutet; Stockholm City Council [2010067]	Swedish Cancer Society(Swedish Cancer Society); Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Stockholm Cancer Society; Henning and Ida Perssons Foundation; Karolinska Institutet(Karolinska Institutet); Stockholm City Council	This work was supported by the Swedish Cancer Society (TD, 100258), the Swedish Medical Research Council (TD, TR, K2011-56X-15282-07-6), the Stockholm Cancer Society (TD, 101081), the Henning and Ida Perssons Foundation (TD), the Karolinska Institutet (TD, TR) and the Stockholm City Council (TD, TR, EMW, 2010067). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attner P, 2011, INT J CANC; Attner P, 2011, INT J CANCER, V128, P2892, DOI 10.1002/ijc.25625; Attner P, 2010, INT J CANCER, V126, P2879, DOI 10.1002/ijc.24994; Babu JM, 2011, BBA-REV CANCER, V1816, P67, DOI 10.1016/j.bbcan.2011.04.003; Badoual C, 2006, CLIN CANCER RES, V12, P465, DOI 10.1158/1078-0432.CCR-05-1886; Bates GJ, 2006, J CLIN ONCOL, V24, P5373, DOI 10.1200/JCO.2006.05.9584; Bontkes HJ, 2000, INT J CANCER, V88, P92, DOI 10.1002/1097-0215(20001001)88:1&lt;92::AID-IJC15&gt;3.0.CO;2-E; Carreras J, 2006, BLOOD, V108, P2957, DOI 10.1182/blood-2006-04-018218; Chaturvedi AK, 2011, J CLIN ONCOL; Fakhry C, 2008, JNCI-J NATL CANCER I, V100, P261, DOI 10.1093/jnci/djn011; Ferreira MBA, 2011, CURR OPIN ONCOL, V23, P259, DOI 10.1097/CCO.0b013e328344f53a; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Hammarstedt L, 2006, INT J CANCER, V119, P2620, DOI 10.1002/ijc.22177; Heusinkveld M, 2011, INT J CANC; HILDERS CGJM, 1994, INT J CANCER, V57, P805, DOI 10.1002/ijc.2910570608; Ichihara F, 2003, CLIN CANCER RES, V9, P4404; Lallemant B, 2010, HEAD NECK-J SCI SPEC, V32, P1712, DOI 10.1002/hed.21491; Leemans CR, 2011, NAT REV CANCER, V11, P9, DOI 10.1038/nrc2982; Lindquist D, 2007, MOL ONCOL, V1, P350, DOI 10.1016/j.molonc.2007.08.005; Mellin H, 2000, INT J CANCER, V89, P300, DOI 10.1002/1097-0215(20000520)89:3<300::AID-IJC14>3.0.CO;2-G; Mougiakakos D, 2010, ADV CANCER RES, V107, P57, DOI 10.1016/S0065-230X(10)07003-X; Nasman A, 2009, INT J CANCER, V125, P362, DOI 10.1002/ijc.24339; Nedergaard BS, 2007, BRIT J CANCER, V97, P1135, DOI 10.1038/sj.bjc.6604001; Ogino T, 2006, CANCER RES, V66, P9281, DOI 10.1158/0008-5472.CAN-06-0488; Piersma SJ, 2007, CANCER RES, V67, P354, DOI 10.1158/0008-5472.CAN-06-3388; Ramqvist T, 2010, EMERG INFECT DIS, V16, P1671, DOI 10.3201/eid1611.100452; Salama P, 2009, J CLIN ONCOL, V27, P186, DOI 10.1200/JCO.2008.18.7229; Sato E, 2005, P NATL ACAD SCI USA, V102, P18538, DOI 10.1073/pnas.0509182102; Shah W, 2011, CELL MOL IMMUNOL, V8, P59, DOI 10.1038/cmi.2010.56; Smeets SJ, 2007, INT J CANCER, V121, P2465, DOI 10.1002/ijc.22980; Spanos WC, 2009, ARCH OTOLARYNGOL, V135, P1137, DOI 10.1001/archoto.2009.159; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Talmadge JE, 2007, CANCER METAST REV, V26, P373, DOI 10.1007/s10555-007-9072-0; Welters MJP, 2006, INT J CANCER, V118, P950, DOI 10.1002/ijc.21459; Zackrisson B, 2011, RADIOTHER ONCOL, V100, P41, DOI 10.1016/j.radonc.2010.12.010	35	137	143	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2012	7	6							e38711	10.1371/journal.pone.0038711	http://dx.doi.org/10.1371/journal.pone.0038711			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UJ	22701698	Green Published, Green Submitted, gold			2022-12-27	WOS:000305340000040
J	Tulp, I; Schekkerman, H; de Leeuw, J				Tulp, Ingrid; Schekkerman, Hans; de Leeuw, Joep			Eggs in the Freezer: Energetic Consequences of Nest Site and Nest Design in Arctic Breeding Shorebirds	PLOS ONE			English	Article							MATING SYSTEM; HEAT-LOSS; INCUBATION; PREDATION; EXPENDITURE; INSULATION; SANDPIPERS; SELECTION; CLUTCH; TUNDRA	Birds construct nests for several reasons. For species that breed in the Arctic, the insulative properties of nests are very important. Incubation is costly there and due to an increasing surface to volume ratio, more so in smaller species. Small species are therefore more likely to place their nests in thermally favourable microhabitats and/or to invest more in nest insulation than large species. To test this hypothesis, we examined characteristics of nests of six Arctic breeding shorebird species. All species chose thermally favourable nesting sites in a higher proportion than expected on the basis of habitat availability. Site choice did not differ between species. Depth to frozen ground, measured near the nests, decreased in the course of the season at similar non-species-specific speeds, but this depth increased with species size. Nest cup depth and nest scrape depth (nest cup without the lining) were unrelated to body mass (we applied an exponent of 0.73, to account for metabolic activity of the differently sized species). Cup depth divided by diameter 2 was used as a measure of nest cup shape. Small species had narrow and deep nests, while large species had wide shallow nests. The thickness of nest lining varied between 0.1 cm and 7.6 cm, and decreased significantly with body mass. We reconstruct the combined effect of different nest properties on the egg cooling coefficient using previously published quantitative relationships. The predicted effect of nest cup depth and lining depth on heat loss to the frozen ground did not correlate with body mass, but the sheltering effect of nest cup diameter against wind and the effects of lining material on the cooling coefficient increased with body mass. Our results suggest that small arctic shorebirds invest more in the insulation of their nests than large species.	[Tulp, Ingrid] Inst Marine Resources & Ecosyst Studies, Ijmuiden, Netherlands; [Schekkerman, Hans] Sovon Dutch Ctr Field Ornithol, Nijmegen, Netherlands; [de Leeuw, Joep] Swedish Univ Agr Sci, Inst Freshwater Res, Drottningholm, Sweden	Wageningen University & Research; Swedish University of Agricultural Sciences	Tulp, I (corresponding author), Inst Marine Resources & Ecosyst Studies, Ijmuiden, Netherlands.	ingrid.tulp@wur.nl		Schekkerman, Hans/0000-0003-3127-4832				Ar A, 2002, OX ORN SER, V13, P143; Aschoff J, 1970, J. Orn., Berl., V111, P38, DOI 10.1007/BF01668180; BIEBACH H, 1986, PHYSIOL ZOOL, V59, P69, DOI 10.1086/physzool.59.1.30156092; BUTTEMER WA, 1987, AUK, V104, P531, DOI 10.2307/4087558; BYRKJEDAL I, 1980, ORNIS SCAND, V11, P249, DOI 10.2307/3676131; CHERNOV YUI, 1985, LIVING TUNDRA; Cramp S., 1983, BIRDS W PALEARCTIC, VIII; Cresswell W, 2003, BEHAV ECOL, V14, P97, DOI 10.1093/beheco/14.1.97; Cresswell W, 2004, BEHAV ECOL, V15, P498, DOI 10.1093/beheco/arh042; De Heij ME., 2006, THESIS U GRONINGEN G; Drent R., 1975, AVIAN BIOL, P333; Grubbauer P, 1996, ECOSCIENCE, V3, P274, DOI 10.1080/11956860.1996.11682342; Hansell M.H., 2000, BIRD NESTS CONSTRUCT, DOI [10.1017/CBO9781139106788, DOI 10.1017/CBO9781139106788]; Hansell MH, 2002, OX ORN SER, V13, P8; Heenan CB, 2011, P ROY SOC B-BIOL SCI, V278, P2924, DOI 10.1098/rspb.2010.2798; Hilden O., 1978, Anser Supplement, P96; Hilton GM, 2004, AUK, V121, P777, DOI 10.1642/0004-8038(2004)121[0777:UANTTI]2.0.CO;2; Lamprecht I, 2004, THERMOCHIM ACTA, V415, P141, DOI 10.1016/j.tca.2003.08.029; Liebezeit JR, 2007, CONDOR, V109, P32, DOI 10.1650/0010-5422(2007)109[32:ATDOSE]2.0.CO;2; Lombardo MP, 1995, AUK, V112, P973, DOI 10.2307/4089028; McCracken KG, 1997, AUK, V114, P610, DOI 10.2307/4089280; McGowan A, 2004, FUNCT ECOL, V18, P578, DOI 10.1111/j.0269-8463.2004.00883.x; MOLLER AP, 1987, OIKOS, V50, P91, DOI 10.2307/3565404; NORTON DW, 1972, CONDOR, V74, P164, DOI 10.2307/1366280; Piersma T, 2003, FUNCT ECOL, V17, P356, DOI 10.1046/j.1365-2435.2003.00741.x; Piersma T., 1996, HDB BIRDS WORLD, P384; Pinowski J, 2006, J THERM BIOL, V31, P573, DOI 10.1016/j.jtherbio.2006.05.007; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Reid JM, 2002, FUNCT ECOL, V16, P305, DOI 10.1046/j.1365-2435.2002.00632.x; Reneerkens J, 2007, THESIS U GRONINGEN G; Reneerkens J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016834; REYNOLDS JD, 1987, IBIS, V129, P225, DOI 10.1111/j.1474-919X.1987.tb03203.x; Sanchez-Lafuente AM, 1998, J FIELD ORNITHOL, V69, P563; Schekkerman H, 2004, STUDIES BREEDING SHO, P922; Szentirmai I, 2005, ACTA ZOOL ACAD SCI H, V51, P59; Szentirmai I, 2002, BEHAVIOUR, V139, P847, DOI 10.1163/156853902320262844; Tinbergen JM, 2002, OX ORN SER, V13, P299; TOIEN O, 1993, J COMP PHYSIOL B, V163, P182; Tomkovich P.S., 2006, International Wader Studies, V19, P19; Tulp I, 2006, J AVIAN BIOL, V37, P207, DOI 10.1111/j.2006.0908-8857.03519.x; Tulp I, 2007, ARCTIC PULSE TIMING; Tulp I, 2008, ARCTIC, V61, P48; Tulp I, 2009, AUK, V126, P155, DOI 10.1525/auk.2009.07181; Turner JS, 2002, OX ORN SER, V13, P119; VLECK CM, 1981, CONDOR, V83, P229, DOI 10.2307/1367313; Whitfield DP, 1996, BIOL J LINN SOC, V57, P277, DOI 10.1111/j.1095-8312.1996.tb00313.x; Whittingham MJ, 2002, J AVIAN BIOL, V33, P184, DOI 10.1034/j.1600-048X.2002.330210.x; Williams Joseph B., 1996, P375	48	19	19	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2012	7	6							e38041	10.1371/journal.pone.0038041	http://dx.doi.org/10.1371/journal.pone.0038041			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UJ	22701596	Green Published, Green Accepted, gold			2022-12-27	WOS:000305340000009
J	Brandt, AU; Zimmermann, H; Kaufhold, F; Promesberger, J; Schippling, S; Finis, D; Aktas, O; Geis, C; Ringelstein, M; Ringelstein, EB; Hartung, HP; Paul, F; Kleffner, I; Dorr, J				Brandt, Alexander U.; Zimmermann, Hanna; Kaufhold, Falko; Promesberger, Julia; Schippling, Sven; Finis, David; Aktas, Orhan; Geis, Christian; Ringelstein, Marius; Ringelstein, E. Bernd; Hartung, Hans-Peter; Paul, Friedemann; Kleffner, Ilka; Doerr, Jan			Patterns of Retinal Damage Facilitate Differential Diagnosis between Susac Syndrome and MS	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; MULTIPLE-SCLEROSIS; RETINOCOCHLEOCEREBRAL VASCULOPATHY; ARTERY-OCCLUSION; HEARING-LOSS; MICROANGIOPATHY; BRAIN; ENDOTHELIOPATHY; ANTIBODIES	Susac syndrome, a rare but probably underdiagnosed combination of encephalopathy, hearing loss, and visual deficits due to branch retinal artery occlusion of unknown aetiology has to be considered as differential diagnosis in various conditions. Particularly, differentiation from multiple sclerosis is often challenging since both clinical presentation and diagnostic findings may overlap. Optical coherence tomography is a powerful and easy to perform diagnostic tool to analyse the morphological integrity of retinal structures and is increasingly established to depict characteristic patterns of retinal pathology in multiple sclerosis. Against this background we hypothesised that differential patterns of retinal pathology facilitate a reliable differentiation between Susac syndrome and multiple sclerosis. In this multicenter cross-sectional observational study optical coherence tomography was performed in nine patients with a definite diagnosis of Susac syndrome. Data were compared with age-, sex-, and disease duration-matched relapsing remitting multiple sclerosis patients with and without a history of optic neuritis, and with healthy controls. Using generalised estimating equation models, Susac patients showed a significant reduction in either or both retinal nerve fibre layer thickness and total macular volume in comparison to both healthy controls and relapsing remitting multiple sclerosis patients. However, in contrast to the multiple sclerosis patients this reduction was not distributed over the entire scanning area but showed a distinct sectorial loss especially in the macular measurements. We therefore conclude that patients with Susac syndrome show distinct abnormalities in optical coherence tomography in comparison to multiple sclerosis patients. These findings recommend optical coherence tomography as a promising tool for differentiating Susac syndrome from MS.	[Brandt, Alexander U.; Zimmermann, Hanna; Kaufhold, Falko; Paul, Friedemann; Doerr, Jan] Charite, NeuroCure Clin Res Ctr, D-13353 Berlin, Germany; [Promesberger, Julia] Univ Munster, Dept Ophthalmol, Munster, Germany; [Schippling, Sven] Univ Med Ctr Hamburg Eppendorf, Inst Neuroimmunol & Clin Multiple Sclerosis Res I, Hamburg, Germany; [Finis, David] Univ Dusseldorf, Univ Med Ctr, Dept Ophthalmol, D-40225 Dusseldorf, Germany; [Aktas, Orhan; Ringelstein, Marius; Hartung, Hans-Peter] Univ Dusseldorf, Univ Med Ctr, Dept Neurol, D-40225 Dusseldorf, Germany; [Geis, Christian] Univ Wurzburg, Dept Neurol, D-8700 Wurzburg, Germany; [Ringelstein, E. Bernd; Kleffner, Ilka] Univ Munster, Dept Neurol, D-4400 Munster, Germany; [Paul, Friedemann; Doerr, Jan] Charite, Dept Neurol, Clin & Expt Res Ctr Multiple Sclerosis, D-13353 Berlin, Germany; [Paul, Friedemann] Max Delbruck Ctr Mol Med, Expt & Clin Res Ctr, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Munster; University of Hamburg; University Medical Center Hamburg-Eppendorf; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; University of Wurzburg; University of Munster; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Brandt, AU (corresponding author), Charite, NeuroCure Clin Res Ctr, D-13353 Berlin, Germany.	jan-markus.doerr@charite.de	Paul, Friedemann/ABF-9415-2020; Aktas, Orhan/B-7623-2009	Aktas, Orhan/0000-0002-2020-9210; Zimmermann, Hanna/0000-0002-0276-8051; paul, friedemann/0000-0002-6378-0070	Deutsche Forschungsgemeinschaft (DFG) [257]; Walter-and-Ilse-Rose Stiftung; Hertie Stiftung	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Walter-and-Ilse-Rose Stiftung; Hertie Stiftung(Austrian Science Fund (FWF))	This study was supported in part by Deutsche Forschungsgemeinschaft (DFG Exc. 257). The MS Center at the Department of Neurology, Heinrich-Heine-University Dusseldorf, is supported in part by the Walter-and-Ilse-Rose Stiftung. The Institute for Neuroimmunology and Clinical Multiple Sclerosis Research (inims), University Medical Center Hamburg Eppendorf, Hamburg, is supported in part by Hertie Stiftung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Asefzadeh Baharak, 2008, Optometry, V79, P85, DOI 10.1016/j.optm.2007.08.021; Aubart-Cohen F, 2007, MEDICINE, V86, P93, DOI 10.1097/MD.0b013e3180404c99; Bock M, 2010, CLIN NEUROL NEUROSUR, V112, P647, DOI 10.1016/j.clineuro.2010.04.014; Cettomai D, 2008, ARCH NEUROL-CHICAGO, V65, P1218, DOI 10.1001/archneur.65.9.1218; Cheung CYL, 2008, OPHTHALMOLOGY, V115, P1347, DOI 10.1016/j.ophtha.2007.11.027; Dorr J, 2009, NAT REV NEUROL, V5, P683, DOI 10.1038/nrneurol.2009.176; Egan RA, 2010, J NEUROL SCI, V299, P97, DOI 10.1016/j.jns.2010.08.043; Frohman E, 2006, LANCET NEUROL, V5, P853, DOI 10.1016/S1474-4422(06)70573-7; Frohman EM, 2008, NAT CLIN PRACT NEURO, V4, P664, DOI 10.1038/ncpneuro0950; Jarius S, 2009, J NEUROL SCI, V285, P259, DOI 10.1016/j.jns.2009.07.002; Kleffner I, 2008, NEUROLOGY, V70, P1867, DOI 10.1212/01.wnl.0000280580.95671.01; Kleffner I, 2010, J NEUROL SCI, V299, P92, DOI 10.1016/j.jns.2010.08.028; Magro CM, 2011, AM J CLIN PATHOL, V136, P903, DOI 10.1309/AJCPERI7LC4VNFYK; McLeod DS, 2011, OPHTHALMOLOGY, V118, P548, DOI 10.1016/j.ophtha.2010.07.012; Naismith RT, 2009, NEUROLOGY, V72, P1077, DOI 10.1212/01.wnl.0000345042.53843.d5; O'Halloran HS, 1998, OPHTHALMOLOGY, V105, P1038, DOI 10.1016/S0161-6420(98)96005-5; Outteryck O, 2009, ARCH NEUROL-CHICAGO, V66, P1373, DOI 10.1001/archneurol.2009.265; Petty GW, 1998, MEDICINE, V77, P12, DOI 10.1097/00005792-199801000-00003; Petty GW, 2001, MAYO CLIN PROC, V76, P958; Petzold A, 2010, LANCET NEUROL, V9, P921, DOI 10.1016/S1474-4422(10)70168-X; Rennebohm R, 2010, J NEUROL SCI, V299, P86, DOI 10.1016/j.jns.2010.08.032; Rennebohm RM, 2008, CURR TREAT OPTION NE, V10, P67, DOI 10.1007/s11940-008-0008-y; Rennebohm RM, 2007, J NEUROL SCI, V257, P215, DOI 10.1016/j.jns.2007.01.031; Saidha S, 2011, BRAIN, V134, P518, DOI 10.1093/brain/awq346; Shah VA, 2010, INDIAN J OPHTHALMOL, V58, P523, DOI 10.4103/0301-4738.71703; Susac JO, 2003, NEUROLOGY, V61, P1783, DOI 10.1212/01.WNL.0000103880.29693.48; SUSAC JO, 1979, NEUROLOGY, V29, P313, DOI 10.1212/WNL.29.3.313; SUSAC JO, 1994, NEUROLOGY, V44, P591, DOI 10.1212/WNL.44.4.591; Susac JO, 2007, J NEUROL SCI, V257, P270, DOI 10.1016/j.jns.2007.01.036; Takahashi H, 2009, JPN J OPHTHALMOL, V53, P494, DOI 10.1007/s10384-009-0714-3	30	48	48	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2012	7	6							e38741	10.1371/journal.pone.0038741	http://dx.doi.org/10.1371/journal.pone.0038741			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TU	22701702	gold, Green Published, Green Accepted			2022-12-27	WOS:000305337600039
J	Jordan, KW; Craver, KL; Magwire, MM; Cubilla, CE; Mackay, TFC; Anholt, RRH				Jordan, Katherine W.; Craver, Kyle L.; Magwire, Michael M.; Cubilla, Carmen E.; Mackay, Trudy F. C.; Anholt, Robert R. H.			Genome-Wide Association for Sensitivity to Chronic Oxidative Stress in Drosophila melanogaster	PLOS ONE			English	Article							LIFE-SPAN; SUPEROXIDE-DISMUTASE; LOCOMOTOR BEHAVIOR; SUBSTANTIA-NIGRA; RESISTANCE; GENE; EXPRESSION; OVEREXPRESSION; MECHANISMS; EXTENSION	Reactive oxygen species (ROS) are a common byproduct of mitochondrial energy metabolism, and can also be induced by exogenous sources, including UV light, radiation, and environmental toxins. ROS generation is essential for maintaining homeostasis by triggering cellular signaling pathways and host defense mechanisms. However, an imbalance of ROS induces oxidative stress and cellular death and is associated with human disease, including age-related locomotor impairment. To identify genes affecting sensitivity and resistance to ROS-induced locomotor decline, we assessed locomotion of aged flies of the sequenced, wild-derived lines from the Drosophila melanogaster Genetics Reference Panel on standard medium and following chronic exposure to medium supplemented with 3 mM menadione sodium bisulfite (MSB). We found substantial genetic variation in sensitivity to oxidative stress with respect to locomotor phenotypes. We performed genome-wide association analyses to identify candidate genes associated with variation in sensitivity to ROS-induced decline in locomotor performance, and confirmed the effects for 13 of 16 mutations tested in these candidate genes. Candidate genes associated with variation in sensitivity to MSB-induced oxidative stress form networks of genes involved in neural development, immunity, and signal transduction. Many of these genes have human orthologs, highlighting the utility of genome-wide association in Drosophila for studying complex human disease.	[Jordan, Katherine W.; Magwire, Michael M.; Cubilla, Carmen E.; Mackay, Trudy F. C.; Anholt, Robert R. H.] N Carolina State Univ, Dept Genet, Raleigh, NC 27695 USA; [Jordan, Katherine W.; Magwire, Michael M.; Mackay, Trudy F. C.; Anholt, Robert R. H.] N Carolina State Univ, WM Keck Ctr Behav Biol, Raleigh, NC 27695 USA; [Craver, Kyle L.; Anholt, Robert R. H.] N Carolina State Univ, Dept Biol, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	Jordan, KW (corresponding author), N Carolina State Univ, Dept Genet, Box 7614, Raleigh, NC 27695 USA.	anholt@ncsu.edu	Anholt, Robert/S-5977-2019		National Institutes of Health [GM 45146, ES18255]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [RC1ES018255] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045146] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants GM 45146 and ES18255. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonov A.V., 2010, NUCLEIC ACIDS RES, V38, pW118; Ayroles JF, 2009, NAT GENET, V41, P299, DOI 10.1038/ng.332; Barnham KJ, 2004, NAT REV DRUG DISCOV, V3, P205, DOI 10.1038/nrd1330; Bellen HJ, 2004, GENETICS, V167, P761, DOI 10.1534/genetics.104.026427; Chaudhuri A, 2007, J NEUROSCI, V27, P2457, DOI 10.1523/JNEUROSCI.4239-06.2007; Coulom H, 2004, J NEUROSCI, V24, P10993, DOI 10.1523/JNEUROSCI.2993-04.2004; Davey KM, 2006, J MED GENET, V43, P385, DOI 10.1136/jmg.2005.036657; Falconer D. S., 1996, INTRO QUANTITATIVE G; FALCONER DS, 1990, GENET RES, V56, P57, DOI 10.1017/S0016672300028883; Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074; Finkel T, 2005, NAT REV MOL CELL BIO, V6, P971, DOI 10.1038/nrm1763; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Ortega-Arellano HF, 2011, NEUROCHEM RES, V36, P1073, DOI 10.1007/s11064-011-0451-0; Ghersi E, 2004, J ALZHEIMERS DIS, V6, P67; Ginsberg SD, 2012, NEUROBIOL DIS, V45, P99, DOI 10.1016/j.nbd.2011.07.013; Girardot F, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-74; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jordan KW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r172; Jordan KW, 2006, GENETICS, V174, P271, DOI 10.1534/genetics.106.058099; Landis GN, 2004, P NATL ACAD SCI USA, V101, P7663, DOI 10.1073/pnas.0307605101; LARSEN PL, 1993, P NATL ACAD SCI USA, V90, P8905, DOI 10.1073/pnas.90.19.8905; Lavara-Culebras E, 2010, GENE, V462, P26, DOI 10.1016/j.gene.2010.04.009; Lee WS, 2011, ARCH BIOCHEM BIOPHYS, V514, P57, DOI 10.1016/j.abb.2011.07.014; Lin YJ, 1998, SCIENCE, V282, P943, DOI 10.1126/science.282.5390.943; Loor G, 2010, FREE RADICAL BIO MED, V49, P1925, DOI 10.1016/j.freeradbiomed.2010.09.021; Lushchak VI, 2011, AQUAT TOXICOL, V101, P13, DOI 10.1016/j.aquatox.2010.10.006; Mackay TFC, 2012, NATURE, V482, P173, DOI 10.1038/nature10811; Madamanchi NR, 2005, J THROMB HAEMOST, V3, P254, DOI 10.1111/j.1538-7836.2004.01085.x; Magwere T, 2006, MECH AGEING DEV, V127, P356, DOI 10.1016/j.mad.2005.12.009; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Mattson MP, 2003, NEUROMOL MED, V3, P65, DOI 10.1385/NMM:3:2:65; Nishioka K, 2010, PARKINSONISM RELAT D, V16, P686, DOI 10.1016/j.parkreldis.2010.09.007; ORR EC, 1990, NUCLEIC ACIDS RES, V18, P3663, DOI 10.1093/nar/18.12.3663; ORR WC, 1994, SCIENCE, V263, P1128, DOI 10.1126/science.8108730; Park J, 2005, GENE, V361, P133, DOI 10.1016/j.gene.2005.06.040; Parkes TL, 1998, NAT GENET, V19, P171, DOI 10.1038/534; Rains JL, 2011, FREE RADICAL BIO MED, V50, P567, DOI 10.1016/j.freeradbiomed.2010.12.006; SETO NOL, 1987, NUCLEIC ACIDS RES, V15, P10601, DOI 10.1093/nar/15.24.10601; SOFIC E, 1992, NEUROSCI LETT, V142, P128, DOI 10.1016/0304-3940(92)90355-B; Sun JT, 1999, MOL CELL BIOL, V19, P216; Venkateshappa C, 2012, NEUROCHEM RES, V37, P358, DOI 10.1007/s11064-011-0619-7; Weber AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034745; Yoshida T, 2011, J NEUROSCI, V31, P13485, DOI 10.1523/JNEUROSCI.2136-11.2011; Zhao HW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011701	46	59	59	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2012	7	6							e38722	10.1371/journal.pone.0038722	http://dx.doi.org/10.1371/journal.pone.0038722			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TQ	22715409	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336800051
J	Dobrin, SE; Fahrbach, SE				Dobrin, Scott E.; Fahrbach, Susan E.			Visual Associative Learning in Restrained Honey Bees with Intact Antennae	PLOS ONE			English	Article							EXPERIENCE-DEPENDENT PLASTICITY; APIS-MELLIFERA L.; MUSHROOM BODIES; SOCIAL-ROLE; BRAIN; DISCRIMINATION; MODULATION; RECEPTORS; NEURONS; REWARD	A restrained honey bee can be trained to extend its proboscis in response to the pairing of an odor with a sucrose reward, a form of olfactory associative learning referred to as the proboscis extension response (PER). Although the ability of flying honey bees to respond to visual cues is well-established, associative visual learning in restrained honey bees has been challenging to demonstrate. Those few groups that have documented vision-based PER have reported that removing the antennae prior to training is a prerequisite for learning. Here we report, for a simple visual learning task, the first successful performance by restrained honey bees with intact antennae. Honey bee foragers were trained on a differential visual association task by pairing the presentation of a blue light with a sucrose reward and leaving the presentation of a green light unrewarded. A negative correlation was found between age of foragers and their performance in the visual PER task. Using the adaptations to the traditional PER task outlined here, future studies can exploit pharmacological and physiological techniques to explore the neural circuit basis of visual learning in the honey bee.	[Dobrin, Scott E.; Fahrbach, Susan E.] Wake Forest Univ, Grad Sch Arts & Sci, Neurosci Program, Winston Salem, NC 27109 USA; [Dobrin, Scott E.; Fahrbach, Susan E.] Wake Forest Univ, Dept Biol, Winston Salem, NC 27109 USA	Wake Forest University; Wake Forest University	Dobrin, SE (corresponding author), Wake Forest Univ, Grad Sch Arts & Sci, Neurosci Program, Winston Salem, NC 27109 USA.	dobrinse@wfu.edu	Dobrin, Scott/ABF-3541-2020		National Institute of Health Award [GM073644]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073644] Funding Source: NIH RePORTER	National Institute of Health Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	SED was supported by National Institute of Health Award GM073644 to SEF. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avargues-Weber A, 2010, J EXP BIOL, V213, P593, DOI 10.1242/jeb.039263; Behrends A, 2007, EXP GERONTOL, V42, P1146, DOI 10.1016/j.exger.2007.09.003; Fahrbach S.E., 2009, COGNITIVE ECOLOGY, P27; Fahrbach SE, 2006, ANNU REV ENTOMOL, V51, P209, DOI 10.1146/annurev.ento.51.110104.150954; Farris SM, 2001, J NEUROSCI, V21, P6395, DOI 10.1523/JNEUROSCI.21-16-06395.2001; Gerber B, 1998, J EXP BIOL, V201, P2213; Giurfa M, 2003, CURR OPIN NEUROBIOL, V13, P726, DOI 10.1016/j.conb.2003.10.015; Hori S, 2007, J COMP PHYSIOL A, V193, P825, DOI 10.1007/s00359-007-0234-x; Hori S, 2006, J COMP PHYSIOL A, V192, P691, DOI 10.1007/s00359-005-0091-4; Ismail N, 2006, P NATL ACAD SCI USA, V103, P207, DOI 10.1073/pnas.0508318102; Jancke L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004785; Kuwabara M., 1957, Journal of the Faculty of Science Hokkaido University Zoology, V13, P458; Letzkus P, 2008, BIOL LETTERS, V4, P16, DOI 10.1098/rsbl.2007.0466; Maguire EA, 2003, HIPPOCAMPUS, V13, P250, DOI 10.1002/hipo.10087; MENZEL R, 1976, J COMP PHYSIOL, V108, P11, DOI 10.1007/BF00625437; Menzel R, 2001, LEARN MEMORY, V8, P198, DOI 10.1101/lm.40001; Mota T, 2011, LEARN MEMORY, V18, P144, DOI 10.1101/lm.2073511; Niggebrugge C, 2009, J EXP BIOL, V212, P1344, DOI 10.1242/jeb.021881; Pankiw T, 2001, J COMP PHYSIOL A, V187, P293, DOI 10.1007/s003590100201; Park IS, 2009, CEREBELLUM, V8, P334, DOI 10.1007/s12311-009-0100-1; PEITSCH D, 1992, J COMP PHYSIOL A, V170, P23, DOI 10.1007/BF00190398; Riveros Andre J., 2009, Communicative & Integrative Biology, V2, P437; Rueppell O, 2007, CURR BIOL, V17, pR274, DOI 10.1016/j.cub.2007.02.015; Scheiner R, 1999, J COMP PHYSIOL A, V185, P1, DOI 10.1007/s003590050360; Scheiner R, 2005, LEARN MEMORY, V12, P626, DOI 10.1101/lm.98105; Scheiner R, 2009, J EXP BIOL, V212, P994, DOI 10.1242/jeb.021188; Schippers MP, 2006, J EXP BIOL, V209, P3828, DOI 10.1242/jeb.02450; Schippers MP, 2010, J COMP PHYSIOL B, V180, P45, DOI 10.1007/s00360-009-0386-9; Strube-Bloss MF, 2011, J NEUROSCI, V31, P3129, DOI 10.1523/JNEUROSCI.2583-10.2011; Toda NRT, 2009, NATURWISSENSCHAFTEN, V96, P1185, DOI 10.1007/s00114-009-0582-1; Winston M.L., 1991, BIOL HONEY BEE	31	25	25	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e37666	10.1371/journal.pone.0037666	http://dx.doi.org/10.1371/journal.pone.0037666			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701575	gold, Green Published, Green Submitted			2022-12-27	WOS:000305348400016
J	Keats, E; Khan, ZA				Keats, Emily; Khan, Zia A.			Unique Responses of Stem Cell-Derived Vascular Endothelial and Mesenchymal Cells to High Levels of Glucose	PLOS ONE			English	Article							TYPE-2 DIABETES-MELLITUS; NETWORKS IN-VIVO; PROGENITOR CELLS; ADIPOCYTE DIFFERENTIATION; COMPLICATIONS; NEOVASCULARIZATION; BINDING; ADULT; PROLIFERATION	Diabetes leads to complications in selected organ systems, and vascular endothelial cell (EC) dysfunction and loss is the key initiating and perpetuating step in the development of these complications. Experimental and clinical studies have shown that hyperglycemia leads to EC dysfunction in diabetes. Vascular stem cells that give rise to endothelial progenitor cells (EPCs) and mesenchymal progenitor cells (MPCs) represent an attractive target for cell therapy for diabetic patients. Whether these vascular stem/progenitor cells succumb to the adverse effects of high glucose remains unknown. We sought to determine whether adult vascular stem/progenitor cells display cellular activation and dysfunction upon exposure to high levels of glucose as seen in diabetic complications. Mononuclear cell fraction was prepared from adult blood and bone marrow. EPCs and MPCs were derived, characterized, and exposed to either normal glucose (5 mmol/L) or high glucose levels (25 mmol/L). We then assayed for cell activity and molecular changes following both acute and chronic exposure to high glucose. Our results show that high levels of glucose do not alter the derivation of either EPCs or MPCs. The adult blood-derived EPCs were also resistant to the effects of glucose in terms of growth. Acute exposure to high glucose levels increased caspase-3 activity in EPCs (1.4x increase) and mature ECs (2.3x increase). Interestingly, MPCs showed a transient reduction in growth upon glucose challenge. Our results also show that glucose skews the differentiation of MPCs towards the adipocyte lineage while suppressing other mesenchymal lineages. In summary, our studies show that EPCs are resistant to the effects of high levels of glucose, even following chronic exposure. The findings further show that hyperglycemia may have detrimental effects on the MPCs, causing reduced growth and altering the differentiation potential.	[Keats, Emily; Khan, Zia A.] Univ Western Ontario, Dept Pathol, London, ON, Canada; [Khan, Zia A.] Lawson Hlth Res Inst, Metab & Diabet Program, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario)	Keats, E (corresponding author), Univ Western Ontario, Dept Pathol, London, ON, Canada.	zia.khan@schulich.uwo.ca	Khan, Zia A./G-8348-2011	Khan, Zia A./0000-0003-1682-5720	Canadian Diabetes Association; Lawson Health Research Institute; New Investigator Award from the Heart and Stroke Foundation of Canada	Canadian Diabetes Association; Lawson Health Research Institute; New Investigator Award from the Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada)	The authors would like to acknowledge support from the Canadian Diabetes Association (Z.K.) and the Lawson Health Research Institute (Z.K. and E.K.). Z.K. is a recipient of a New Investigator Award from the Heart and Stroke Foundation of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers JW, 2010, DIABETES CARE, V33, P1090, DOI 10.2337/dc09-1941; Aronson D, 2008, ADV CARDIOL, V45, P1, DOI 10.1159/000115118; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Asahara T, 1999, CIRC RES, V85, P221, DOI 10.1161/01.RES.85.3.221; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; CAGLIERO E, 1988, J CLIN INVEST, V82, P735, DOI 10.1172/JCI113655; Capla JM, 2007, PLAST RECONSTR SURG, V119, P59, DOI 10.1097/01.prs.0000244830.16906.3f; CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504; Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200; Chung SS, 2012, OBESITY, V20, P482, DOI 10.1038/oby.2011.212; ENGERMAN R, 1977, DIABETES, V26, P760, DOI 10.2337/diabetes.26.8.760; Fadini GP, 2005, J AM COLL CARDIOL, V45, P1449, DOI 10.1016/j.jacc.2004.11.067; Ferreira LS, 2007, CIRC RES, V101, P286, DOI 10.1161/CIRCRESAHA.107.150201; GOLDSTEIN JL, 1979, P NATL ACAD SCI USA, V76, P333, DOI 10.1073/pnas.76.1.333; JACKSON CJ, 1990, J CELL SCI, V96, P257; Khan ZA, 2004, INVEST OPHTH VIS SCI, V45, P287, DOI 10.1167/iovs.03-0540; Khan ZA, 2003, CAN J PHYSIOL PHARM, V81, P622, DOI 10.1139/Y03-053; Khan Zia A., 2006, Current Vascular Pharmacology, V4, P45, DOI 10.2174/157016106775203081; Khan ZA, 2006, BLOOD, V108, P915, DOI 10.1182/blood-2006-03-006478; Khan ZA, 2006, EXP BIOL MED, V231, P1022; Khan Zia A, 2006, Recent Pat Cardiovasc Drug Discov, V1, P167, DOI 10.2174/157489006777442531; Kusuyama T, 2006, J PHARMACOL SCI, V102, P96, DOI 10.1254/jphs.FP0060256; Leung VYL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002356; Loomans CJM, 2004, DIABETES, V53, P195, DOI 10.2337/diabetes.53.1.195; Lopez-Holgado N, 2007, CYTOTHERAPY, V9, P14, DOI 10.1080/14653240601047726; MacArthur BD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003086; Melero-Martin JM, 2008, CIRC RES, V103, P194, DOI 10.1161/CIRCRESAHA.108.178590; Murohara T, 2000, J CLIN INVEST, V105, P1527, DOI 10.1172/JCI8296; Muruganandan S, 2009, CELL MOL LIFE SCI, V66, P236, DOI 10.1007/s00018-008-8429-z; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Ratner R E, 2001, Clin Cornerstone, V4, P24, DOI 10.1016/S1098-3597(01)90027-4; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Takahashi T, 1999, NAT MED, V5, P434, DOI 10.1038/7434; Tepper OM, 2002, CIRCULATION, V106, P2781, DOI 10.1161/01.CIR.0000039526.42991.93; Walter DH, 2002, HERZ, V27, P579, DOI 10.1007/s00059-002-2427-y; Yamashita J, 2000, NATURE, V408, P92, DOI 10.1038/35040568; Yang K, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-66; Yue WS, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-113	38	45	46	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e38752	10.1371/journal.pone.0038752	http://dx.doi.org/10.1371/journal.pone.0038752			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701703	gold, Green Submitted, Green Published			2022-12-27	WOS:000305348400092
J	Nishimune, H; Numata, T; Chen, J; Aoki, Y; Wang, YH; Starr, MP; Mori, Y; Stanford, JA				Nishimune, Hiroshi; Numata, Tomohiro; Chen, Jie; Aoki, Yudai; Wang, Yonghong; Starr, Miranda P.; Mori, Yasuo; Stanford, John A.			Active Zone Protein Bassoon Co-Localizes with Presynaptic Calcium Channel, Modifies Channel Function, and Recovers from Aging Related Loss by Exercise	PLOS ONE			English	Article							CA2+ CHANNEL; NEUROTRANSMITTER RELEASE; NEUROMUSCULAR-JUNCTIONS; TRANSMITTER RELEASE; MICE LACKING; MUSCLE; LOCALIZATION; AGE; TRANSMISSION; MICRODOMAINS	The P/Q-type voltage-dependent calcium channels (VDCCs) are essential for synaptic transmission at adult mammalian neuromuscular junctions (NMJs); however, the subsynaptic location of VDCCs relative to active zones in rodent NMJs, and the functional modification of VDCCs by the interaction with active zone protein Bassoon remain unknown. Here, we show that P/Q-type VDCCs distribute in a punctate pattern within the NMJ presynaptic terminals and align in three dimensions with Bassoon. This distribution pattern of P/Q-type VDCCs and Bassoon in NMJs is consistent with our previous study demonstrating the binding of VDCCs and Bassoon. In addition, we now show that the interaction between P/Q-type VDCCs and Bassoon significantly suppressed the inactivation property of P/Q-type VDCCs, suggesting that the Ca2+ influx may be augmented by Bassoon for efficient synaptic transmission at NMJs. However, presynaptic Bassoon level was significantly attenuated in aged rat NMJs, which suggests an attenuation of VDCC function due to a lack of this interaction between VDCC and Bassoon. Importantly, the decreased Bassoon level in aged NMJs was ameliorated by isometric strength training of muscles for two months. The training increased Bassoon immunoreactivity in NMJs without affecting synapse size. These results demonstrated that the P/Q-type VDCCs preferentially accumulate at NMJ active zones and play essential role in synaptic transmission in conjunction with the active zone protein Bassoon. This molecular mechanism becomes impaired by aging, which suggests altered synaptic function in aged NMJs. However, Bassoon level in aged NMJs can be improved by muscle exercise.	[Nishimune, Hiroshi; Chen, Jie] Univ Kansas, Sch Med, Dept Anat & Cell Biol, Kansas City, KS 66103 USA; [Wang, Yonghong; Starr, Miranda P.; Stanford, John A.] Univ Kansas, Sch Med, Dept Mol & Integrat Physiol, Kansas City, KS USA; [Numata, Tomohiro; Aoki, Yudai; Mori, Yasuo] Kyoto Univ, Dept Synthet Chem & Biol Chem, Grad Sch Engn, Kyoto, Japan	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; Kyoto University	Nishimune, H (corresponding author), Univ Kansas, Sch Med, Dept Anat & Cell Biol, Kansas City, KS 66103 USA.	hnishimune@kumc.edu; mori@sbchem.kyoto-u.ac.jp; JSTANFORD@kumc.edu	Nishimune, Hiroshi/B-7226-2013; Numata, Tomohiro/AAW-2453-2020; Numata, Tomohiro/AAC-2330-2021	Numata, Tomohiro/0000-0002-5719-4884; Numata, Tomohiro/0000-0002-5719-4884; Stanford, John/0000-0002-4667-4057	Whitehall foundation; Japan Society for the Promotion of Science; National Institutes of Health (NIH) [AG023549, AG026491, HD02528]; NICHD; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD002528] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS078214] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K02AG026491, R01AG023549] Funding Source: NIH RePORTER	Whitehall foundation; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from the Whitehall foundation to HN; the Japan Society for the Promotion of Science to YM; National Institutes of Health (NIH) AG023549, AG026491 to JAS; and NIH HD02528. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank B. Yoo and D. Warn for technical assistance on image analysis. The monoclonal SV2 antibody developed by K. M. Buckley was obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the NICHD and maintained by the University of Iowa, Department of Biological Sciences, Iowa City, IA 52242.	BaliceGordon RJ, 1997, MUSCLE NERVE, pS83; BANKER BQ, 1983, J PHYSIOL-LONDON, V339, P355, DOI 10.1113/jphysiol.1983.sp014721; Billings SE, 2012, NEUROREPORT, V23, P49, DOI 10.1097/WNR.0b013e32834e7deb; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Carlson SS, 2010, J NEUROCHEM, V115, P654, DOI 10.1111/j.1471-4159.2010.06965.x; Chakkalakal JV, 2010, DEVELOPMENT, V137, P3489, DOI 10.1242/dev.053348; Chen J, 2012, J COMP NEUROL, V520, P434, DOI 10.1002/cne.22764; Chen J, 2011, J NEUROSCI, V31, P512, DOI 10.1523/JNEUROSCI.3771-10.2011; Cote MP, 2011, J NEUROTRAUM, V28, P299, DOI 10.1089/neu.2010.1594; Day NC, 1997, J NEUROSCI, V17, P6226; De Laet A, 2002, NEUROGASTROENT MOTIL, V14, P173, DOI 10.1046/j.1365-2982.2002.00320.x; Dupont-Versteegden EE, 2004, MUSCLE NERVE, V29, P73, DOI 10.1002/mus.10511; Fahim MA, 1997, J APPL PHYSIOL, V83, P59, DOI 10.1152/jappl.1997.83.1.59; FAHIM MA, 1982, J NEUROCYTOL, V11, P641, DOI 10.1007/BF01262429; Fouquet W, 2009, J CELL BIOL, V186, P129, DOI 10.1083/jcb.200812150; Frank T, 2010, NEURON, V68, P724, DOI 10.1016/j.neuron.2010.10.027; Fregosi RF, 1997, RESP PHYSIOL, V110, P295, DOI 10.1016/S0034-5687(97)00095-9; Guggenmos DJ, 2009, BEHAV BRAIN RES, V201, P229, DOI 10.1016/j.bbr.2009.02.020; GUTMANN E, 1971, J PHYSIOL-LONDON, V216, P331, DOI 10.1113/jphysiol.1971.sp009528; Hallermann S, 2010, NEURON, V68, P710, DOI 10.1016/j.neuron.2010.10.026; HAYDON PG, 1994, NEURON, V13, P1275, DOI 10.1016/0896-6273(94)90414-6; HEUSER JE, 1979, J CELL BIOL, V81, P275, DOI 10.1083/jcb.81.2.275; Hodges SH, 2004, ANN OTO RHINOL LARYN, V113, P175, DOI 10.1177/000348940411300301; Hubert MF, 2000, TOXICOL SCI, V58, P195, DOI 10.1093/toxsci/58.1.195; Jun K, 1999, P NATL ACAD SCI USA, V96, P15245, DOI 10.1073/pnas.96.26.15245; Kaeser PS, 2011, CELL, V144, P282, DOI 10.1016/j.cell.2010.12.029; Kiyonaka S, 2007, NAT NEUROSCI, V10, P691, DOI 10.1038/nn1904; Knight D, 2003, J PHYSIOL-LONDON, V546, P789, DOI 10.1113/jphysiol.2002.030924; Liu KSY, 2011, SCIENCE, V334, P1565, DOI 10.1126/science.1212991; LLINAS R, 1992, SCIENCE, V256, P677, DOI 10.1126/science.1350109; Maselli RA, 2009, J MED GENET, V46, P203, DOI 10.1136/jmg.2008.063693; McCullough MJ, 2011, NEUROSCIENCE, V174, P234, DOI 10.1016/j.neuroscience.2010.11.016; Muller CS, 2010, P NATL ACAD SCI USA, V107, P14950, DOI 10.1073/pnas.1005940107; Mukherjee K, 2010, P NATL ACAD SCI USA, V107, P6504, DOI 10.1073/pnas.1002307107; NARUSAWA M, 1987, J CELL BIOL, V104, P447, DOI 10.1083/jcb.104.3.447; Neher E, 1998, NEURON, V20, P389, DOI 10.1016/S0896-6273(00)80983-6; Nishimune H, 2004, NATURE, V432, P580, DOI 10.1038/nature03112; Prakash YS, 1996, J NEUROCYTOL, V25, P88, DOI 10.1007/BF02284788; PUMPLIN DW, 1981, P NATL ACAD SCI-BIOL, V78, P7210, DOI 10.1073/pnas.78.11.7210; ROBITAILLE R, 1990, NEURON, V5, P773, DOI 10.1016/0896-6273(90)90336-E; Rowley KL, 2007, J NEUROPHYSIOL, V98, P478, DOI 10.1152/jn.00251.2006; Salemme S, 2007, CELL PHYSIOL BIOCHEM, V20, P55, DOI 10.1159/000104153; Santafe MM, 2005, ANN NEUROL, V57, P396, DOI 10.1002/ana.20403; Schaser AJ, 2012, BEHAV BRAIN RES, V226, P235, DOI 10.1016/j.bbr.2011.09.027; Shibasaki T, 2004, DIABETES, V53, pS59, DOI 10.2337/diabetes.53.suppl_3.S59; Shibasaki T, 2004, J BIOL CHEM, V279, P7956, DOI 10.1074/jbc.M309068200; Siri MDR, 1999, J PHYSIOL-LONDON, V514, P533, DOI 10.1111/j.1469-7793.1999.533ae.x; SMITH DO, 1984, J PHYSIOL-LONDON, V347, P161, DOI 10.1113/jphysiol.1984.sp015059; Smittkamp SE, 2010, BEHAV BRAIN RES, V211, P48, DOI 10.1016/j.bbr.2010.03.007; UCHITEL OD, 1992, P NATL ACAD SCI USA, V89, P3330, DOI 10.1073/pnas.89.8.3330; Udina E, 2011, MUSCLE NERVE, V43, P500, DOI 10.1002/mus.21912; Urbano FJ, 2003, P NATL ACAD SCI USA, V100, P3491, DOI 10.1073/pnas.0437991100; Uriu Y, 2010, J BIOL CHEM, V285, P21750, DOI 10.1074/jbc.M110.101311; Valdez G, 2010, P NATL ACAD SCI USA, V107, P14863, DOI 10.1073/pnas.1002220107; Westenbroek RE, 1998, J NEUROSCI, V18, P6319	55	39	40	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e38029	10.1371/journal.pone.0038029	http://dx.doi.org/10.1371/journal.pone.0038029			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701595	gold, Green Published, Green Submitted			2022-12-27	WOS:000305348400030
J	Shah, S; Lowery, E; Braun, RK; Martin, A; Huang, N; Medina, M; Sethupathi, P; Seki, Y; Takami, M; Byrne, K; Wigfield, C; Love, RB; Iwashima, M				Shah, Shivanee; Lowery, Erin; Braun, Rudolf K.; Martin, Alicia; Huang, Nick; Medina, Melissa; Sethupathi, Periannan; Seki, Yoichi; Takami, Mariko; Byrne, Kathryn; Wigfield, Christopher; Love, Robert B.; Iwashima, Makio			Cellular Basis of Tissue Regeneration by Omentum	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; GASTROOMENTAL FREE-FLAP; BONE-MARROW; STROMAL CELLS; SUPPRESSOR-CELLS; GREATER OMENTUM; DIFFERENTIATION; INFLAMMATION; RAT; BRAIN	The omentum is a sheet-like tissue attached to the greater curvature of the stomach and contains secondary lymphoid organs called milky spots. The omentum has been used for its healing potential for over 100 years by transposing the omental pedicle to injured organs (omental transposition), but the mechanism by which omentum helps the healing process of damaged tissues is not well understood. Omental transposition promotes expansion of pancreatic islets, hepatocytes, embryonic kidney, and neurons. Omental cells (OCs) can be activated by foreign bodies in vivo. Once activated, they become a rich source for growth factors and express pluripotent stem cell markers. Moreover, OCs become engrafted in injured tissues suggesting that they might function as stem cells. Omentum consists of a variety of phenotypically and functionally distinctive cells. To understand the mechanism of tissue repair support by the omentum in more detail, we analyzed the cell subsets derived from the omentum on immune and inflammatory responses. Our data demonstrate that the omentum contains at least two groups of cells that support tissue repair, immunomodulatory myeloid derived suppressor cells and omnipotent stem cells that are indistinguishable from mesenchymal stem cells. Based on these data, we propose that the omentum is a designated organ for tissue repair and healing in response to foreign invasion and tissue damage.	[Shah, Shivanee; Huang, Nick; Seki, Yoichi; Takami, Mariko; Iwashima, Makio] Loyola Univ, Dept Microbiol & Immunol, Stritch Sch Med, Chicago, IL 60611 USA; [Lowery, Erin] Loyola Univ, Dept Med, Stritch Sch Med, Chicago, IL 60611 USA; [Braun, Rudolf K.; Martin, Alicia; Medina, Melissa; Sethupathi, Periannan; Byrne, Kathryn; Wigfield, Christopher; Love, Robert B.] Loyola Univ, Dept Thorac & Cardiovasc Surg, Stritch Sch Med, Chicago, IL 60611 USA	Loyola University Chicago; Loyola University Chicago; Loyola University Chicago	Shah, S (corresponding author), Loyola Univ, Dept Microbiol & Immunol, Stritch Sch Med, Chicago, IL 60611 USA.	miwashima@lumc.edu		Braun, Rudolf/0000-0002-1778-9613	NIH [R01 AI055022]; Van Kampen cardiovascular research fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI055022] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Van Kampen cardiovascular research fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH R01 AI055022 (MI) and Van Kampen cardiovascular research fund (RBL). Funders provided financial support for supplies and personnel involved in this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asai S, 2004, ANN PLAS SURG, V52, P144, DOI 10.1097/01.sap.0000100898.68014.6f; Athanassiadi Kalliopi, 2007, Asian Cardiovasc Thorac Ann, V15, P200; Augello A, 2010, EUR CELLS MATER, V20, P121; Avouac J, ARTHRITIS RHEUM, V63, P800; Bayles SW, 2008, ARCH FACIAL PLAST S, V10, P255, DOI 10.1001/archfaci.10.4.255; Braun RK, 2008, INFLAMMATION, V31, P167, DOI 10.1007/s10753-008-9062-6; Bronte V, 2009, EUR J IMMUNOL, V39, P2670, DOI 10.1002/eji.200939892; Burlingham WJ, 2007, J CLIN INVEST, V117, P3498, DOI 10.1172/JCI28031; CANNADAY JE, 1948, AM J SURG, V76, P502, DOI 10.1016/S0002-9610(48)90236-0; Cao YA, 2004, P NATL ACAD SCI USA, V101, P221, DOI 10.1073/pnas.2637010100; Christensen LH, 2008, DERMATOL SURG, V34, pS68, DOI 10.1111/j.1524-4725.2008.34246.x; Collins D, 2009, J GASTROINTEST SURG, V13, P1138, DOI 10.1007/s11605-009-0855-1; Crabtree JH, 1999, SURG LAPARO ENDO PER, V9, P228, DOI 10.1097/00019509-199906000-00018; DELATORRE JC, 1994, BRAIN RES BULL, V35, P413, DOI 10.1016/0361-9230(94)90153-8; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Falagas Matthew E, 2006, J Infect, V52, pe151, DOI 10.1016/j.jinf.2005.08.007; FRIEDENSTEIN AJ, 1968, TRANSPLANTATION, V6, P230, DOI 10.1097/00007890-196803000-00009; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Garcia-Gomez I, 2005, NEUROL RES, V27, P807, DOI 10.1179/016164105X63674; GIN H, 1990, BIOMATER ARTIF CELL, V18, P25, DOI 10.3109/10731199009117287; GOLDSMITH HS, 1994, NEUROL RES, V16, P159; GOLDSMITH HS, 1973, ARCH SURG-CHICAGO, V106, P695; GOLDSMITH HS, 1992, BRAIN RES, V589, P217, DOI 10.1016/0006-8993(92)91280-R; Hammerman MR, 2004, J AM SOC NEPHROL, V15, P1126, DOI 10.1097/01.ASN.0000106020.64930.64; Hocking AM, 2010, EXP CELL RES, V316, P2213, DOI 10.1016/j.yexcr.2010.05.009; Kin T, 2003, AM J TRANSPLANT, V3, P281, DOI 10.1034/j.1600-6143.2003.00049.x; KRIST LFG, 1995, ANAT REC, V241, P163, DOI 10.1002/ar.1092410204; Lee HM, 2003, TISSUE ENG, V9, P1227, DOI 10.1089/10763270360728134; Liebermann-Meffert D, 2000, SURG CLIN N AM, V80, P275, DOI 10.1016/S0039-6109(05)70406-0; Litbarg NO, 2007, CELL TISSUE RES, V328, P487, DOI 10.1007/s00441-006-0356-4; Liu TJ, 2011, J IMMUNOL, V187, P450, DOI 10.4049/jimmunol.1000964; Makino S, 1999, J CLIN INVEST, V103, P697, DOI 10.1172/JCI5298; Maloney CT, 2003, PLAST RECONSTR SURG, V111, P1899, DOI 10.1097/01.PRS.0000056874.31920.7D; Mazzoni A, 2002, J IMMUNOL, V168, P689, DOI 10.4049/jimmunol.168.2.689; Mohammadi R, MUSCLE NERVE, V43, P157; Moreschi Alexandre Heitor, 2008, J. bras. pneumol., V34, P654, DOI 10.1590/S1806-37132008000900004; Moriscot C, 2005, STEM CELLS, V23, P594, DOI 10.1634/stemcells.2004-0123; Morison R, 1906, Br Med J, V1, P76; Munoz JR, 2005, P NATL ACAD SCI USA, V102, P18171, DOI 10.1073/pnas.0508945102; NAKASHIMA JM, 1986, AM J PATHOL, V124, P528; Oh K, 2011, J EXP MED, V208, P1707, DOI 10.1084/jem.20101457; Oh SH, 2004, LAB INVEST, V84, P607, DOI 10.1038/labinvest.3700074; Ostrand-Rosenberg S, 2009, J IMMUNOL, V182, P4499, DOI 10.4049/jimmunol.0802740; Pancholi N, 2010, TRANSL RES, V156, P358, DOI 10.1016/j.trsl.2010.09.002; Patel RS, 2009, CURR OPIN OTOLARYNGO, V17, P258, DOI 10.1097/MOO.0b013e32832cba42; Peister A, 2004, BLOOD, V103, P1662, DOI 10.1182/blood-2003-09-3070; Peranzoni E, 2010, CURR OPIN IMMUNOL, V22, P238, DOI 10.1016/j.coi.2010.01.021; Pond CM, 2003, TRENDS IMMUNOL, V24, P13, DOI 10.1016/S1471-4906(02)00004-2; Rajesh RV, COMP BIOCH PHYSL D, V5, P234; Ray P, 2011, IMMUNOL RES, V50, P153, DOI 10.1007/s12026-011-8230-1; Rippon HJ, 2006, STEM CELLS, V24, P1389, DOI 10.1634/stemcells.2005-0465; Rogers SA, 2004, AM J PHYSIOL-ENDOC M, V286, pE502, DOI 10.1152/ajpendo.00445.2003; Salem HK, 2010, STEM CELLS, V28, P585, DOI 10.1002/stem.269; Sanchez-Ramos J, 2000, EXP NEUROL, V164, P247, DOI 10.1006/exnr.2000.7389; Sato Y, 2005, BLOOD, V106, P756, DOI 10.1182/blood-2005-02-0572; Schwartz RE, 2002, J CLIN INVEST, V109, P1291, DOI 10.1172/JCI200215182; Sigrist S, 2003, J VASC RES, V40, P359, DOI 10.1159/000072700; Singh AK, 2008, CELL TISSUE RES, V332, P81, DOI 10.1007/s00441-007-0560-x; Singh AK, 2009, WORLD J GASTROENTERO, V15, P1057, DOI 10.3748/wjg.15.1057; Singh N, 2010, J IMMUNOL, V184, P94, DOI 10.4049/jimmunol.0900753; Spees JL, 2003, P NATL ACAD SCI USA, V100, P2397, DOI 10.1073/pnas.0437997100; Sueblinvong V, 2008, AM J RESP CRIT CARE, V177, P701, DOI 10.1164/rccm.200706-859OC; Toma C, 2002, CIRCULATION, V105, P93, DOI 10.1161/hc0102.101442; Ugel S, 2009, CURR OPIN PHARMACOL, V9, P470, DOI 10.1016/j.coph.2009.06.014; Vatansev C, 2003, EUR SURG RES, V35, P388, DOI 10.1159/000070612; Vernik J, 2007, INT J ARTIF ORGANS, V30, P95, DOI 10.1177/039139880703000203; VINEBERG AM, 1966, AM HEART J, V72, P79, DOI 10.1016/0002-8703(66)90630-2; Wang GS, 2005, P NATL ACAD SCI USA, V102, P186, DOI 10.1073/pnas.0406266102; Wang WJ, 2009, BIOMATERIALS, V30, P2705, DOI 10.1016/j.biomaterials.2009.01.030; Weiss Daniel J, 2006, Proc Am Thorac Soc, V3, P193, DOI 10.1513/pats.200601-013MS; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	71	56	61	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e38368	10.1371/journal.pone.0038368	http://dx.doi.org/10.1371/journal.pone.0038368			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701632	Green Published, Green Submitted, gold			2022-12-27	WOS:000305348400053
J	Chegou, NN; Essone, PN; Loxton, AG; Stanley, K; Black, GF; van der Spuy, GD; van Helden, PD; Franken, KL; Parida, SK; Klein, MR; Kaufmann, SHE; Ottenhoff, THM; Walzl, G				Chegou, Novel N.; Essone, Paulin N.; Loxton, Andre G.; Stanley, Kim; Black, Gillian F.; van der Spuy, Gian D.; van Helden, Paul D.; Franken, Kees L.; Parida, Shreemanta K.; Klein, Michel R.; Kaufmann, Stefan H. E.; Ottenhoff, Tom H. M.; Walzl, Gerhard			Potential of Host Markers Produced by Infection Phase-Dependent Antigen-Stimulated Cells for the Diagnosis of Tuberculosis in a Highly Endemic Area	PLOS ONE			English	Article							GAMMA RELEASE ASSAYS; HUMORAL IMMUNE-RESPONSES; LATERAL FLOW ASSAY; MYCOBACTERIUM-TUBERCULOSIS; INTERFERON-GAMMA; WHOLE-BLOOD; T-CELLS; DISEASE; BURDEN; HIV	Background: Recent interferon gamma (IFN-gamma)-based studies have identified novel Mycobacterium tuberculosis (M.tb) infection phase-dependent antigens as diagnostic candidates. In this study, the levels of 11 host markers other than IFN-gamma, were evaluated in whole blood culture supernatants after stimulation with M.tb infection phase-dependent antigens, for the diagnosis of TB disease. Methodology and Principal Findings: Five M.tb infection phase-dependent antigens, comprising of three DosR-regulon-encoded proteins (Rv2032, Rv0081, Rv1737c), and two resucitation promoting factors (Rv0867c and Rv2389c), were evaluated in a case-control study with 15 pulmonary TB patients and 15 household contacts that were recruited from a high TB incidence setting in Cape Town, South Africa. After a 7-day whole blood culture, supernatants were harvested and the levels of the host markers evaluated using the Luminex platform. Multiple antigen-specific host markers were identified with promising diagnostic potential. Rv0081-specific levels of IL-12(p40), IP-10, IL-10 and TNF-alpha were the most promising diagnostic candidates, each ascertaining TB disease with an accuracy of 100%, 95% confidence interval for the area under the receiver operating characteristics plots, (1.0 to 1.0). Conclusions: Multiple cytokines other than IFN-gamma in whole blood culture supernatants after stimulation with M.tb infection phase-dependent antigens show promise as diagnostic markers for active TB. These preliminary findings should be verified in well-designed diagnostic studies employing short-term culture assays.	[Chegou, Novel N.; Essone, Paulin N.; Loxton, Andre G.; Stanley, Kim; Black, Gillian F.; van der Spuy, Gian D.; van Helden, Paul D.; Walzl, Gerhard] Univ Stellenbosch, Fac Hlth Sci, DST NRF Ctr Excellence Biomed TB Res, ZA-7505 Tygerberg, South Africa; [Chegou, Novel N.; Essone, Paulin N.; Loxton, Andre G.; Stanley, Kim; Black, Gillian F.; van der Spuy, Gian D.; van Helden, Paul D.; Walzl, Gerhard] Univ Stellenbosch, Fac Hlth Sci, MRC Ctr Mol & Cellular Biol, Div Mol Biol & Human Genet,Dept Biomed Sci, ZA-7505 Tygerberg, South Africa; [Franken, Kees L.; Klein, Michel R.; Ottenhoff, Tom H. M.] Leiden Univ, Med Ctr, Dept Infect Dis, Leiden, Netherlands; [Parida, Shreemanta K.; Kaufmann, Stefan H. E.] Max Planck Inst Infect Biol, Dept Immunol, Berlin, Germany	National Research Foundation - South Africa; Stellenbosch University; Stellenbosch University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Max Planck Society	Chegou, NN (corresponding author), Univ Stellenbosch, Fac Hlth Sci, DST NRF Ctr Excellence Biomed TB Res, ZA-7505 Tygerberg, South Africa.	novel@sun.ac.za	Franken, Kees/ABA-7095-2021; van der Spuy, Gian/AAY-7701-2020; Walzl, Gerhard/N-6371-2016; Kaufmann, Stefan HE/I-5454-2014	Franken, Kees/0000-0002-4747-6060; van der Spuy, Gian/0000-0002-9067-5903; Walzl, Gerhard/0000-0003-2487-125X; Kaufmann, Stefan HE/0000-0001-9866-8268; Parida, Shreemanta K/0000-0003-2129-6691; Black, Gillian/0000-0002-5081-274X; Chegou, Novel N/0000-0002-8690-1699; Loxton, Andre/0000-0003-0659-9803	Bill & Melinda Gates Foundation through Grand Challenge 6 (BMGFGC6) [37772]; Claude Leon Foundation; South African Medical Research Council	Bill & Melinda Gates Foundation through Grand Challenge 6 (BMGFGC6); Claude Leon Foundation; South African Medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Bill & Melinda Gates Foundation through Grand Challenge 6 (BMGFGC6, grant no 37772). Dr. Chegou received financial support from the Claude Leon Foundation and the South African Medical Research Council during the writing up of this manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Black GF, 2009, CLIN VACCINE IMMUNOL, V16, P1203, DOI 10.1128/CVI.00111-09; Chaisson RE, 2008, NEW ENGL J MED, V358, P1089, DOI 10.1056/NEJMp0800809; Chegou NN, 2008, RESPIRATION, V76, P131, DOI 10.1159/000128575; Chegou NN, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-10; Chegou NN, 2011, EXPERT REV ANTI-INFE, V9, P457, DOI [10.1586/eri.11.23, 10.1586/ERI.11.23]; Chegou Novel N, 2009, BMC Pulm Med, V9, P21, DOI 10.1186/1471-2466-9-21; Chiacchio T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027539; Commandeur S, 2011, EUR J IMMUNOL, V41, P2925, DOI 10.1002/eji.201141602; Commandeur S, 2011, CLIN VACCINE IMMUNOL, V18, P676, DOI 10.1128/CVI.00492-10; Connell TG, 2007, CLIN VACCINE IMMUNOL, V14, P847, DOI 10.1128/CVI.00041-07; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Corstjens PLAM, 2008, CLIN BIOCHEM, V41, P440, DOI 10.1016/j.clinbiochem.2007.12.015; Corstjens PLAM, 2008, J CLIN MICROBIOL, V46, P171, DOI 10.1128/JCM.00877-07; Corstjens PLAM, 2007, ANN NY ACAD SCI, V1098, P437, DOI 10.1196/annals.1384.016; Corstjens PLAM, 2011, CLIN BIOCHEM, V44, P1241, DOI 10.1016/j.clinbiochem.2011.06.983; Dheda K, 2009, CURR OPIN PULM MED, V15, P188, DOI 10.1097/MCP.0b013e32832a0adc; Diel R, 2011, EUR RESPIR J, V37, P88, DOI 10.1183/09031936.00115110; Feske M, 2008, CLIN VACCINE IMMUNOL, V15, P1616, DOI 10.1128/CVI.00185-08; Frahm M, 2011, TUBERCULOSIS, V91, P250, DOI 10.1016/j.tube.2011.02.006; Franken KLMC, 2000, PROTEIN EXPRES PURIF, V18, P95, DOI 10.1006/prep.1999.1162; Geluk A, 2010, CLIN VACCINE IMMUNOL, V17, P993, DOI 10.1128/CVI.00046-10; GOIN JE, 1982, PATTERN RECOGN, V15, P263, DOI 10.1016/0031-3203(82)90077-2; Goletti D, 2010, EUR RESPIR J, V36, P135, DOI 10.1183/09031936.00140009; Harari A, 2011, NAT MED, V17, P372, DOI 10.1038/nm.2299; Hesseling AC, 2009, THORAX, V64, P840, DOI 10.1136/thx.2007.085340; Honaker RW, 2008, INFECT IMMUN, V76, P2587, DOI 10.1128/IAI.01235-07; Jones GJ, 2010, CLIN VACCINE IMMUNOL, V17, P1946, DOI 10.1128/CVI.00377-10; Kellar KL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026545; Kritzinger FE, 2009, TROP MED INT HEALTH, V14, P136, DOI 10.1111/j.1365-3156.2008.02213.x; Leyten EMS, 2006, MICROBES INFECT, V8, P2052, DOI 10.1016/j.micinf.2006.03.018; Lighter-Fisher J, 2010, INT J TUBERC LUNG D, V14, P1548; Lin MY, 2007, INFECT IMMUN, V75, P3523, DOI 10.1128/IAI.01999-06; Lu CY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024290; Mandalakas AM, 2008, INT J TUBERC LUNG D, V12, P417; Munk ME, 2001, J INFECT DIS, V183, P175, DOI 10.1086/317663; Palma C, 2008, VACCINE, V26, P4237, DOI 10.1016/j.vaccine.2008.05.050; Raja A, 2004, INDIAN J MED RES, V120, P213; Roy RB, 2012, CURR OPIN INFECT DIS, V25, P250, DOI 10.1097/QCO.0b013e3283529af9; Rubbo PA, 2012, J CLIN MICROBIOL, V50, P1711, DOI 10.1128/JCM.00117-12; Ruhwald M, 2008, EUR RESPIR J, V32, P1607, DOI 10.1183/09031936.00055508; Ruhwald M, 2007, MICROBES INFECT, V9, P806, DOI 10.1016/j.micinf.2007.02.021; Ruhwald M, 2012, EXPERT REV MOL DIAGN, V12, P175, DOI [10.1586/ERM.11.97, 10.1586/erm.11.97]; Ruhwald M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002858; Schoenborn JR, 2007, ADV IMMUNOL, V96, P41, DOI 10.1016/S0065-2776(07)96002-2; Schuck SD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005590; Su WL, 2010, CLIN VACCINE IMMUNOL, V17, P771, DOI 10.1128/CVI.00526-09; Sutherland JS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012365; Sutherland JS, 2009, EUR J IMMUNOL, V39, P723, DOI 10.1002/eji.200838693; Tanaka T, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-71; Trebucq A, 2011, INT J TUBERC LUNG D, V15, P1567, DOI 10.5588/ijtld.11.0392; Ulrichs T, 2004, TUBERCULOSIS, P251	51	54	57	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e38501	10.1371/journal.pone.0038501	http://dx.doi.org/10.1371/journal.pone.0038501			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22693640	Green Published, gold, Green Submitted			2022-12-27	WOS:000305343900050
J	Carr, AC; Moore, SD				Carr, Ana C.; Moore, Sean D.			Robust Quantification of Polymerase Chain Reactions Using Global Fitting	PLOS ONE			English	Article							REAL-TIME PCR; ENZYMATIC AMPLIFICATION; DNA INVITRO; EFFICIENCY	Background: Quantitative polymerase chain reactions (qPCR) are used to monitor relative changes in very small amounts of DNA. One drawback to qPCR is reproducibility: measuring the same sample multiple times can yield data that is so noisy that important differences can be dismissed. Numerous analytical methods have been employed that can extract the relative template abundance between samples. However, each method is sensitive to baseline assignment and to the unique shape profiles of individual reactions, which gives rise to increased variance stemming from the analytical procedure itself. Principal Findings: We developed a simple mathematical model that accurately describes the entire PCR reaction profile using only two reaction variables that depict the maximum capacity of the reaction and feedback inhibition. This model allows quantification that is more accurate than existing methods and takes advantage of the brighter fluorescence signals from later cycles. Because the model describes the entire reaction, the influences of baseline adjustment errors, reaction efficiencies, template abundance, and signal loss per cycle could be formalized. We determined that the common cycle-threshold method of data analysis introduces unnecessary variance because of inappropriate baseline adjustments, a dynamic reaction efficiency, and also a reliance on data with a low signal-to-noise ratio. Significance: Using our model, fits to raw data can be used to determine template abundance with high precision, even when the data contains baseline and signal loss defects. This improvement reduces the time and cost associated with qPCR and should be applicable in a variety of academic, clinical, and biotechnological settings.	[Carr, Ana C.; Moore, Sean D.] Univ Cent Florida, Burnett Sch Biomed Sci, Coll Med, Orlando, FL 32816 USA	State University System of Florida; University of Central Florida	Carr, AC (corresponding author), Univ Cent Florida, Burnett Sch Biomed Sci, Coll Med, Orlando, FL 32816 USA.	sean.moore@ucf.edu			Burnett School of Biomedical Sciences	Burnett School of Biomedical Sciences	This work was supported by Burnett School of Biomedical Sciences start-up lab support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boggy GJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012355; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Goldman S., 1968, INFORM THEORY; HIGUCHI R, 1993, BIO-TECHNOL, V11, P1026, DOI 10.1038/nbt0993-1026; HOLLAND PM, 1991, P NATL ACAD SCI USA, V88, P7276, DOI 10.1073/pnas.88.16.7276; Kim YJ, 2008, APPL MICROBIOL BIOT, V79, P571, DOI 10.1007/s00253-008-1467-5; Liu WH, 2002, BIOCHEM BIOPH RES CO, V294, P347, DOI 10.1016/S0006-291X(02)00478-3; MULLIS K, 1986, COLD SPRING HARB SYM, V51, P263, DOI 10.1101/SQB.1986.051.01.032; MULLIS KB, 1987, METHOD ENZYMOL, V155, P335; Page RB, 2011, THESCIENTIFICWORLDJO, V11, P1383, DOI 10.1100/tsw.2011.124; Park SY, 2010, APPL MICROBIOL BIOT, V85, P807, DOI 10.1007/s00253-009-2314-z; Peccoud J, 1996, BIOPHYS J, V71, P101, DOI 10.1016/S0006-3495(96)79205-6; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Rutledge RG, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh177; Rutledge RG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009731; Rutledge RG, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-96; Rutledge RG, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-47; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; Spiess AN, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-221; Stolovitzky G, 1996, P NATL ACAD SCI USA, V93, P12947, DOI 10.1073/pnas.93.23.12947	21	43	44	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e37640	10.1371/journal.pone.0037640	http://dx.doi.org/10.1371/journal.pone.0037640			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22701526	gold, Green Published, Green Submitted			2022-12-27	WOS:000305338500047
J	Champagne, CD; Houser, DS; Costa, DP; Crocker, DE				Champagne, Cory D.; Houser, Dorian S.; Costa, Daniel P.; Crocker, Daniel E.			The Effects of Handling and Anesthetic Agents on the Stress Response and Carbohydrate Metabolism in Northern Elephant Seals	PLOS ONE			English	Article							HEPATIC GLUCOSE-PRODUCTION; PLASMA-CORTISOL; HEART-RATE; FORAGING BEHAVIOR; HARBOR SEAL; BASE-LINE; KETAMINE; MECHANISMS; ENERGETICS; LACTATION	Free-ranging animals often cope with fluctuating environmental conditions such as weather, food availability, predation risk, the requirements of breeding, and the influence of anthropogenic factors. Consequently, researchers are increasingly measuring stress markers, especially glucocorticoids, to understand stress, disturbance, and population health. Studying free-ranging animals, however, comes with numerous difficulties posed by environmental conditions and the particular characteristics of study species. Performing measurements under either physical restraint or chemical sedation may affect the physiological variable under investigation and lead to values that may not reflect the standard functional state of the animal. This study measured the stress response resulting from different handling conditions in northern elephant seals and any ensuing influences on carbohydrate metabolism. Endogenous glucose production (EGP) was measured using [6(-3) H] glucose and plasma cortisol concentration was measured from blood samples drawn during three-hour measurement intervals. These measurements were conducted in weanlings and yearlings with and without the use of chemical sedatives-under chemical sedation, physical restraint, or unrestrained. We compared these findings with measurements in adult seals sedated in the field. The method of handling had a significant influence on the stress response and carbohydrate metabolism. Physically restrained weanlings and yearlings transported to the lab had increased concentrations of circulating cortisol (F-11,F- (46) = 25.2, p < 0.01) and epinephrine (F-3,F- (12) = 5.8, p = 0.01). Physical restraint led to increased EGP (t = 3.1, p = 0.04) and elevated plasma glucose levels (t = 8.2, p < 0.01). Animals chemically sedated in the field typically did not exhibit a cortisol stress response. The combination of anesthetic agents (Telazol, ketamine, and diazepam) used in this study appeared to alleviate a cortisol stress response due to handling in the field without altering carbohydrate metabolism. Measures of hormone concentrations and metabolism made under these conditions are more likely to reflect basal values.	[Champagne, Cory D.; Costa, Daniel P.] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA; [Houser, Dorian S.; Crocker, Daniel E.] Sonoma State Univ, Dept Biol, Rohnert Pk, CA 94928 USA	University of California System; University of California Santa Cruz; California State University System; Sonoma State University	Champagne, CD (corresponding author), Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA.	champagn@biology.ucsc.edu	Houser, Dorian/AAG-6359-2020; Costa, Daniel/E-2616-2013	Costa, Daniel/0000-0002-0233-5782; Houser, Dorian/0000-0002-0960-8528	National Science Foundation (NSF) [0818018]	National Science Foundation (NSF)(National Science Foundation (NSF))	This research was supported by National Science Foundation (NSF) grant #0818018. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amagai S, 1999, J ACOUST SOC AM, V105, P2029, DOI 10.1121/1.426736; Ambrisko TD, 2005, AM J VET RES, V66, P406, DOI 10.2460/ajvr.2005.66.406; Andrews MT, 2009, AM J PHYSIOL-REG I, V296, pR383, DOI 10.1152/ajpregu.90795.2008; Atkinson S, 2011, GEN COMP ENDOCR, V172, P277, DOI 10.1016/j.ygcen.2011.03.014; Baker JD, 2002, MAR MAMMAL SCI, V18, P500, DOI 10.1111/j.1748-7692.2002.tb01051.x; Bennett KA, 2012, COMP BIOCHEM PHYS A, V161, P69, DOI 10.1016/j.cbpa.2011.09.003; BHAT GK, 1995, NEUROENDOCRINOLOGY, V62, P178, DOI 10.1159/000127003; Boyd IL, 1999, AM J PHYSIOL-HEART C, V276, pH844, DOI 10.1152/ajpheart.1999.276.3.H844; BUTLER PC, 1989, ENDOCRIN METAB CLIN, V18, P1; CASTRO MI, 1981, P SOC EXP BIOL MED, V168, P389; Champagne CD, 2005, J EXP BIOL, V208, P859, DOI 10.1242/jeb.01476; Champagne CD, 2006, AM J PHYSIOL-REG I, V291, pR1129, DOI 10.1152/ajpregu.00570.2005; Charmandari E, 2005, ANNU REV PHYSIOL, V67, P259, DOI 10.1146/annurev.physiol.67.040403.120816; Cooke SJ, 2004, TRENDS ECOL EVOL, V19, P334, DOI 10.1016/j.tree.2004.04.003; COSTA DP, 1986, J ZOOL, V209, P21, DOI 10.1111/j.1469-7998.1986.tb03563.x; COSTA DP, 1988, CAN J ZOOL, V66, P45, DOI 10.1139/z88-006; Costa DP, 2004, ANNU REV PHYSIOL, V66, P209, DOI 10.1146/annurev.physiol.66.032102.114245; Creel S, 2002, CONSERV BIOL, V16, P809, DOI 10.1046/j.1523-1739.2002.00554.x; DAVIS RW, 1983, J COMP PHYSIOL, V153, P275, DOI 10.1007/BF00689631; DAVIS RW, 1991, J COMP PHYSIOL B, V160, P627, DOI 10.1007/BF00571260; Dickens MJ, 2010, BIOL CONSERV, V143, P1329, DOI 10.1016/j.biocon.2010.02.032; Engelhard GH, 2002, J COMP PHYSIOL B, V172, P315, DOI 10.1007/s00360-002-0257-0; Exton J H, 1979, Monogr Endocrinol, V12, P535; Fowler MA, 2008, J EXP BIOL, V211, P2943, DOI 10.1242/jeb.018176; Green JA, 2007, PHYSIOL BIOCHEM ZOOL, V80, P551, DOI 10.1086/519961; Harcourt RG, 2010, J COMP PHYSIOL A, V196, P147, DOI 10.1007/s00359-009-0501-0; Hassrick JL, 2007, DEEP-SEA RES PT II, V54, P369, DOI 10.1016/j.dsr2.2006.12.001; HECHTER O, 1965, ANNU REV PHYSIOL, V27, P133, DOI 10.1146/annurev.ph.27.030165.001025; Heinrichs M, 2002, STRESS, V5, P195, DOI 10.1080/1025389021000010530; Hergovich N, 2001, NEUROPSYCHOPHARMACOL, V24, P590, DOI 10.1016/S0893-133X(00)00194-9; Houser DS, 2007, AM J PHYSIOL-REG I, V293, pR2376, DOI 10.1152/ajpregu.00403.2007; Houser DS, 2001, J COMP PHYSIOL B, V171, P635, DOI 10.1007/s003600100214; JEZOVA D, 1991, NEUROENDOCRINOLOGY, V54, P488; Kelso EJ, J EXP BIOL IN PRESS; KEMNITZ JW, 1982, AM J PRIMATOL, V3, P201, DOI 10.1002/ajp.1350030118; Kitaysky AS, 2007, MAR ECOL PROG SER, V352, P245, DOI 10.3354/meps07074; Kjaer M, 1998, ADV EXP MED BIOL, V441, P117; KRYSTAL JH, 1994, ARCH GEN PSYCHIAT, V51, P199, DOI 10.1001/archpsyc.1994.03950030035004; Lam CKL, 2009, PHYSIOLOGY, V24, P159, DOI 10.1152/physiol.00003.2009; Landys MM, 2006, GEN COMP ENDOCR, V148, P132, DOI 10.1016/j.ygcen.2006.02.013; Langsjo JW, 2005, ANESTHESIOLOGY, V103, P258; Lehmann R, 1997, J MED PRIMATOL, V26, P312, DOI 10.1111/j.1600-0684.1997.tb00060.x; LEMAHO Y, 1992, AM J PHYSIOL, V263, pR775, DOI 10.1152/ajpregu.1992.263.4.R775; LENINAN F, 1988, J COMP PHYSIOL B, V158, P395, DOI 10.1007/BF00691136; Lidgard DC, 2008, HORM BEHAV, V53, P241, DOI 10.1016/j.yhbeh.2007.10.003; LIGHTMAN SL, 1992, ANN NY ACAD SCI, V652, P340, DOI 10.1111/j.1749-6632.1992.tb34365.x; Maestripieri D, 2008, HORM BEHAV, V53, P170, DOI 10.1016/j.yhbeh.2007.09.013; Mateo JM, 2005, PHYSIOL BIOCHEM ZOOL, V78, P1069, DOI 10.1086/432855; McMahon C, 2005, AMBIO, V34, P426, DOI 10.1639/0044-7447(2005)034[0426:HIATSA]2.0.CO;2; MCMAHON M, 1988, DIABETES METAB REV, V4, P17, DOI 10.1002/dmr.5610040105; Meir JU, 2008, J EXP BIOL, V211, P1169, DOI 10.1242/jeb.013235; Mellish Jo-Ann E., 2006, Aquatic Mammals, V32, P58, DOI 10.1578/AM.32.1.2006.58; MORTON DJ, 1995, VET REC, V136, P60, DOI 10.1136/vr.136.3.60; Morton GJ, 2011, PHYSIOL REV, V91, P389, DOI 10.1152/physrev.00007.2010; Mourtzakis M, 2006, J APPL PHYSIOL, V100, P1822, DOI 10.1152/japplphysiol.00571.2005; Nagy KA, 1999, ANNU REV NUTR, V19, P247, DOI 10.1146/annurev.nutr.19.1.247; NORDOY ES, 1991, ACTA PHYSIOL SCAND, V141, P565, DOI 10.1111/j.1748-1716.1991.tb09118.x; Noren DP, 2003, J COMP PHYSIOL B, V173, P443, DOI 10.1007/s00360-003-0353-9; Opazo JC, 2004, COMP BIOCHEM PHYS A, V137, P57, DOI 10.1016/j.cbpb.2003.09.007; Ortiz RM, 2003, GEN COMP ENDOCR, V130, P78, DOI 10.1016/S0016-6480(02)00572-5; Ortiz RM, 2001, AM J PHYSIOL-REG I, V280, pR790, DOI 10.1152/ajpregu.2001.280.3.R790; Petrauskas L, 2008, J EXP ZOOL PART A, V309A, P73, DOI 10.1002/jez.435; Polakof S, 2011, COMP BIOCHEM PHYS B, V160, P123, DOI 10.1016/j.cbpb.2011.07.006; Pride RE, 2005, BIOL LETT-UK, V1, P60, DOI 10.1098/rsbl.2004.0245; Robinson PW, PLOS ONE IN PRESS; Romano MC, 2010, NEUROIMMUNOMODULAT, V17, P209, DOI 10.1159/000258726; Romero LM, 2004, TRENDS ECOL EVOL, V19, P249, DOI 10.1016/j.tree.2004.03.008; Romero LM, 2001, P NATL ACAD SCI USA, V98, P7366, DOI 10.1073/pnas.131091498; Romero LM, 2005, COMP BIOCHEM PHYS A, V140, P73, DOI 10.1016/j.cbpb.2004.11.004; Saha JK, 2005, EXP BIOL MED, V230, P777, DOI 10.1177/153537020523001012; Saha PK, 2004, J BIOL CHEM, V279, P35150, DOI 10.1074/jbc.M405499200; Sandoval D, 2008, ANNU REV PHYSIOL, V70, P513, DOI 10.1146/annurev.physiol.70.120806.095256; Sapolsky, 1996, Stress, V1, P1, DOI 10.3109/10253899609001092; Simmons SE, 2007, MAR ECOL PROG SER, V346, P265, DOI 10.3354/meps07014; Slattery DA, 2008, J PHYSIOL-LONDON, V586, P377, DOI 10.1113/jphysiol.2007.145896; Spee M, 2011, AM J PHYSIOL-REG I, V300, pR1241, DOI 10.1152/ajpregu.00762.2010; Stevenson RD, 2005, INTEGR COMP BIOL, V45, P1, DOI 10.1093/icb/45.1.1; UMMINGER BL, 1975, COMP BIOCHEM PHYS A, V52, P455, DOI 10.1016/S0300-9629(75)80065-X; van Berckel BNM, 1998, PSYCHOPHARMACOLOGY, V137, P271, DOI 10.1007/s002130050620; Viscarra JA, 2011, J ENDOCRINOL, V209, P317, DOI 10.1530/JOE-11-0017; Viscarra JA, 2011, AM J PHYSIOL-REG I, V300, pR150, DOI 10.1152/ajpregu.00478.2010; Walker BG, 2005, INTEGR COMP BIOL, V45, P12, DOI 10.1093/icb/45.1.12; Wasser SK, 1997, CONSERV BIOL, V11, P1019, DOI 10.1046/j.1523-1739.1997.96240.x; Wasserman DH, 2009, AM J PHYSIOL-ENDOC M, V296, pE11, DOI 10.1152/ajpendo.90563.2008; Wenzel B, 2008, GLUCOSE TURNOVER FAS; Wikelski M, 2006, TRENDS ECOL EVOL, V21, P38, DOI 10.1016/j.tree.2005.10.018; Wilson RP, 2006, J ANIM ECOL, V75, P1081, DOI 10.1111/j.1365-2656.2006.01127.x; Wingfield J.C., 2001, HANDBK PHYSL, P211, DOI [10.1002/cphy.cp070411, DOI 10.1002/CPHY.CP070411]; Wolfe RR., 2005, ISOTOPE TRACERS META, V2; WORTHY GAJ, 1992, J ZOOL, V227, P257, DOI 10.1111/j.1469-7998.1992.tb04821.x; Zeno RL, 2008, J ZOOL, V274, P180, DOI 10.1111/j.1469-7998.2007.00371.x	91	45	46	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38442	10.1371/journal.pone.0038442	http://dx.doi.org/10.1371/journal.pone.0038442			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693622	Green Submitted, gold, Green Published			2022-12-27	WOS:000305338500148
J	Chen, HY; Yao, K; Nadas, J; Bode, AM; Malakhova, M; Oi, N; Li, HT; Lubet, RA; Dong, ZG				Chen, Hanyong; Yao, Ke; Nadas, Janos; Bode, Ann M.; Malakhova, Margarita; Oi, Naomi; Li, Haitao; Lubet, Ronald A.; Dong, Zigang			Prediction of Molecular Targets of Cancer Preventing Flavonoid Compounds Using Computational Methods	PLOS ONE			English	Article							RIBOSOMAL S6 KINASE; LIGAND DOCKING; PROTEIN; INHIBITOR; MYRICETIN; PHYTOCHEMICALS; PHYTOESTROGENS; TRANSFORMATION; PROLIFERATION; RESVERATROL	Plant-based polyphenols (i.e., phytochemicals) have been used as treatments for human ailments for centuries. The mechanisms of action of these plant-derived compounds are now a major area of investigation. Thousands of phytochemicals have been isolated, and a large number of them have shown protective activities or effects in different disease models. Using conventional approaches to select the best single or group of best chemicals for studying the effectiveness in treating or preventing disease is extremely challenging. We have developed and used computational-based methodologies that provide efficient and inexpensive tools to gain further understanding of the anticancer and therapeutic effects exerted by phytochemicals. Computational methods involving virtual screening, shape and pharmacophore analysis and molecular docking have been used to select chemicals that target a particular protein or enzyme and to determine potential protein targets for well-characterized as well as for novel phytochemicals.	[Chen, Hanyong; Yao, Ke; Nadas, Janos; Bode, Ann M.; Malakhova, Margarita; Oi, Naomi; Li, Haitao; Dong, Zigang] Univ Minnesota, Hormel Inst, Austin, MN 55912 USA; [Lubet, Ronald A.] NCI, Bethesda, MD 20892 USA	University of Minnesota System; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Chen, HY (corresponding author), Univ Minnesota, Hormel Inst, 801 16th Ave NE, Austin, MN 55912 USA.	zgdong@hi.umn.edu			Hormel Foundation; National Institutes of Health [R37 CA081064, CA120388, ES016548, CA0227501]; National Cancer Institute [HHSN-261200533001C-NO1-CN-53301]; NATIONAL CANCER INSTITUTE [R37CA081064, R01CA120388] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016548] Funding Source: NIH RePORTER	Hormel Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the Hormel Foundation and National Institutes of Health grants R37 CA081064, CA120388, ES016548, CA0227501 and National Cancer Institute Contract No. HHSN-261200533001C-NO1-CN-53301. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIYAMA T, 1987, J BIOL CHEM, V262, P5592; [Anonymous], 2011, GLIDE V5 6 SCHRODING; [Anonymous], 2011, PHASE V3 3 SCHRODING; [Anonymous], 2011, SCHRODINGER SUITE; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Birt DF, 2001, PHARMACOL THERAPEUT, V90, P157, DOI 10.1016/S0163-7258(01)00137-1; Bravo L, 1998, NUTR REV, V56, P317, DOI 10.1111/j.1753-4887.1998.tb01670.x; Cavasotto CN, 2004, J MOL BIOL, V337, P209, DOI 10.1016/j.jmb.2004.01.003; Chen X, 2004, CURR CANCER DRUG TAR, V4, P267, DOI 10.2174/1568009043333041; Cho YY, 2007, CANCER RES, V67, P8104, DOI 10.1158/0008-5472.CAN-06-4668; Cho YY, 2009, CANCER RES, V69, P4398, DOI 10.1158/0008-5472.CAN-08-4959; Cho YY, 2004, CANCER RES, V64, P3855, DOI 10.1158/0008-5472.CAN-04-0201; Clark DE, 2005, CANCER RES, V65, P3108; Cui Y, 2008, CANCER-AM CANCER SOC, V112, P2241, DOI 10.1002/cncr.23398; David JP, 2005, J CLIN INVEST, V115, P664, DOI 10.1172/JCI200522877; DOWNS GM, 1994, J CHEM INF COMP SCI, V34, P1094, DOI 10.1021/ci00021a011; Fitch BG, 2006, LECT NOTES COMPUT SC, V3992, P846, DOI 10.1007/11758525_113; Germain RS, 2005, 2005 International Conference on Hardware/Software Codesign and System Synthesis, P207; Harborne JB, 2000, PHYTOCHEMISTRY, V55, P481, DOI 10.1016/S0031-9422(00)00235-1; Hartshorn MJ, 2007, J MED CHEM, V50, P726, DOI 10.1021/jm061277y; Holder S, 2007, MOL CANCER THER, V6, P163, DOI 10.1158/1535-7163.MCT-06-0397; Hollman PCH, 1999, FOOD CHEM TOXICOL, V37, P937, DOI 10.1016/S0278-6915(99)00079-4; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218; Jeong CH, 2009, CANCER RES, V69, P5584, DOI 10.1158/0008-5472.CAN-09-0491; Jung SK, 2008, CANCER RES, V68, P6021, DOI 10.1158/0008-5472.CAN-08-0899; Jung SK, 2010, CARCINOGENESIS, V31, P911, DOI 10.1093/carcin/bgp221; Jung SK, 2010, BIOCHEM PHARMACOL, V79, P1455, DOI 10.1016/j.bcp.2010.01.004; Kang NJ, 2011, CARCINOGENESIS, V32, P921, DOI 10.1093/carcin/bgr022; Kang NJ, 2009, CARCINOGENESIS, V30, P321, DOI 10.1093/carcin/bgn282; Kim JE, 2011, CANCER PREV RES, V4, P582, DOI 10.1158/1940-6207.CAPR-11-0032; Kinoshita T, 2006, BIOFACTORS, V26, P179, DOI 10.1002/biof.5520260303; Kwon JY, 2009, CARCINOGENESIS, V30, P1932, DOI 10.1093/carcin/bgp216; Lee DE, 2011, CARCINOGENESIS, V32, P629, DOI 10.1093/carcin/bgr008; Lee DE, 2010, J BIOL CHEM, V285, P21458, DOI 10.1074/jbc.M109.094797; Lee KW, 2008, CANCER RES, V68, P946, DOI 10.1158/0008-5472.CAN-07-3140; Lee KW, 2011, NAT REV CANCER, V11, P211, DOI 10.1038/nrc3017; Lee KM, 2010, BIOCHEM PHARMACOL, V80, P2042, DOI 10.1016/j.bcp.2010.06.042; Liu KD, 2011, J BIOL CHEM, V286, P2057, DOI 10.1074/jbc.M110.147306; Lyne PD, 2002, DRUG DISCOV TODAY, V7, P1047, DOI 10.1016/S1359-6446(02)02483-2; Malakhova M, 2008, NAT STRUCT MOL BIOL, V15, P112, DOI 10.1038/nsmb1347; Malakhova M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008044; Oi N, 2010, CANCER RES, V70, P9755, DOI 10.1158/0008-5472.CAN-10-2858; Ososki AL, 2003, PHYTOTHER RES, V17, P845, DOI 10.1002/ptr.1364; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pietta PG, 2000, J NAT PROD, V63, P1035, DOI 10.1021/np9904509; Rester U, 2008, CURR OPIN DRUG DISC, V11, P559; Reynaud J, 2005, NAT PROD REP, V22, P504, DOI 10.1039/b416248j; Rolo-Naranjo A, 2010, J CHEM INF MODEL, V50, P924, DOI 10.1021/ci900358z; Smith JA, 2005, CANCER RES, V65, P1027; Suetsugi M, 2003, MOL CANCER RES, V1, P981; Urusova D, 2011, CANC PREV R IN PRESS; Ververidis Filippos, 2007, Biotechnology Journal, V2, P1214, DOI 10.1002/biot.200700084; Walker EH, 2000, MOL CELL, V6, P909, DOI 10.1016/S1097-2765(05)00089-4; Willett P, 1998, J CHEM INF COMP SCI, V38, P983, DOI 10.1021/ci9800211	55	32	32	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38261	10.1371/journal.pone.0038261	http://dx.doi.org/10.1371/journal.pone.0038261			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693608	Green Published, Green Submitted, gold			2022-12-27	WOS:000305338500119
J	Kuypers, E; Collins, JJP; Jellema, RK; Wolfs, TGAM; Kemp, MW; Nitsos, I; Pillow, JJ; Polglase, GR; Newnham, JP; Germeraad, WTV; Kallapur, SG; Jobe, AH; Kramer, BW				Kuypers, Elke; Collins, Jennifer J. P.; Jellema, Reint K.; Wolfs, Tim G. A. M.; Kemp, Matthew W.; Nitsos, Ilias; Pillow, J. Jane; Polglase, Graeme R.; Newnham, John P.; Germeraad, Wilfred T. V.; Kallapur, Suhas G.; Jobe, Alan H.; Kramer, Boris W.			Ovine Fetal Thymus Response to Lipopolysaccharide-Induced Chorioamnionitis and Antenatal Corticosteroids	PLOS ONE			English	Article							NEONATAL DEXAMETHASONE TREATMENT; T-CELL DEVELOPMENT; HYPOTHALAMOPITUITARY-ADRENAL AXIS; PRETERM LAMBS; INTRAAMNIOTIC ENDOTOXIN; CORD BLOOD; BRONCHOPULMONARY DYSPLASIA; THYMOCYTE DIFFERENTIATION; IMMUNE-SYSTEM; BETAMETHASONE	Rationale: Chorioamnionitis is associated with preterm delivery and involution of the fetal thymus. Women at risk of preterm delivery receive antenatal corticosteroids which accelerate fetal lung maturation and improve neonatal outcome. However, the effects of antenatal corticosteroids on the fetal thymus in the settings of chorioamnionitis are largely unknown. We hypothesized that intra-amniotic exposure to lipopolysaccharide (LPS) causes involution of the fetal thymus resulting in persistent effects on thymic structure and cell populations. We also hypothesized that antenatal corticosteroids may modulate the effects of LPS on thymic development. Methods: Time-mated ewes with singleton fetuses received an intra-amniotic injection of LPS 7 or 14 days before preterm delivery at 120 days gestational age (term = 150 days). LPS and corticosteroid treatment groups received intra-amniotic LPS either preceding or following maternal intra-muscular betamethasone. Gestation matched controls received intra-amniotic and maternal intra-muscular saline. The fetal intra-thoracic thymus was evaluated. Results: Intra-amniotic LPS decreased the cortico-medullary (C/M) ratio of the thymus and increased Toll-like receptor (TLR) 4 mRNA and CD3 expression indicating involution and activation of the fetal thymus. Increased TLR4 and CD3 expression persisted for 14 days but Foxp3 expression decreased suggesting a change in regulatory T-cells. Sonic hedgehog and bone morphogenetic protein 4 mRNA, which are negative regulators of T-cell development, decreased in response to intra-amniotic LPS. Betamethasone treatment before LPS exposure attenuated some of the LPS-induced thymic responses but increased cleaved caspase-3 expression and decreased the C/M ratio. Betamethasone treatment after LPS exposure did not prevent the LPS-induced thymic changes. Conclusion: Intra-amniotic exposure to LPS activated the fetal thymus which was accompanied by structural changes. Treatment with antenatal corticosteroids before LPS partially attenuated the LPS-induced effects but increased apoptosis in the fetal thymus. Corticosteroid administration after the inflammatory stimulus did not inhibit the LPS effects on the fetal thymus.	[Kuypers, Elke; Collins, Jennifer J. P.; Jellema, Reint K.; Wolfs, Tim G. A. M.; Kramer, Boris W.] Maastricht Univ Med Ctr, Dept Pediat, Maastricht, Netherlands; [Kemp, Matthew W.; Nitsos, Ilias; Pillow, J. Jane; Polglase, Graeme R.; Newnham, John P.; Kallapur, Suhas G.; Jobe, Alan H.] Univ Western Australia, Sch Womens & Infants Hlth, Perth, WA 6009, Australia; [Germeraad, Wilfred T. V.] Maastricht Univ Med Ctr, Div Haematol, Dept Internal Med, Maastricht, Netherlands; [Kallapur, Suhas G.; Jobe, Alan H.] Univ Cincinnati, Div Pulm Biol, Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH USA	Maastricht University; Maastricht University Medical Centre (MUMC); University of Western Australia; Maastricht University; Maastricht University Medical Centre (MUMC); Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Kuypers, E (corresponding author), Maastricht Univ Med Ctr, Dept Pediat, Maastricht, Netherlands.	b.kramer@mumc.nl	Pillow, Jane/A-3335-2009; Kramer, Boris/AAO-3183-2021; Jellema, Reint/AAW-1214-2020	Pillow, Jane/0000-0002-6500-0138; Jellema, Reint/0000-0002-6918-0930; Collins, Jennifer/0000-0002-7556-0526; Wolfs, Tim/0000-0003-4417-4144; Polglase, Graeme/0000-0002-8906-614X; Newnham, John/0000-0001-9983-7457	National Institutes of Health (NIH), United States of America [NIH HD-57869]; National Health and Medical Research Council of Australia; Women and Infants Research Foundation, Western Australia; Dutch Scientific Research Organization [Veni BWK 016.096.141]; Research School for Oncology and Developmental Biology (GROW), Maastricht University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD057869] Funding Source: NIH RePORTER	National Institutes of Health (NIH), United States of America(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Women and Infants Research Foundation, Western Australia; Dutch Scientific Research Organization; Research School for Oncology and Developmental Biology (GROW), Maastricht University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Supported by NIH HD-57869 (SGK) from the National Institutes of Health (NIH), United States of America, the National Health and Medical Research Council of Australia, the Women and Infants Research Foundation, Western Australia, Veni BWK 016.096.141 from the Dutch Scientific Research Organization and the Research School for Oncology and Developmental Biology (GROW), Maastricht University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakker JM, 2000, J IMMUNOL, V165, P5932, DOI 10.4049/jimmunol.165.10.5932; Bakker JM, 1995, J NEUROIMMUNOL, V63, P183, DOI 10.1016/0165-5728(95)00152-2; Bakker JM, 2001, J NEUROIMMUNOL, V112, P47, DOI 10.1016/S0165-5728(00)00406-9; Bakker JM, 1997, J NEUROIMMUNOL, V74, P69, DOI 10.1016/S0165-5728(96)00207-X; BALLARD PL, 1995, AM J OBSTET GYNECOL, V173, P254, DOI 10.1016/0002-9378(95)90210-4; Been JV, 2010, BJOG, V118, P113; Cejalvo T, 2007, IMMUNOLOGY, V121, P94, DOI 10.1111/j.1365-2567.2007.02541.x; Chabra S, 1998, BIOL NEONATE, V74, P200, DOI 10.1159/000014025; Crompton T, 2007, NAT REV IMMUNOL, V7, P726, DOI 10.1038/nri2151; Crowther CA, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003935.pub2; Dave VP, 2009, IMMUNOL REV, V232, P22, DOI 10.1111/j.1600-065X.2009.00835.x; De Felice C, 1999, J PEDIATR-US, V135, P384, DOI 10.1016/S0022-3476(99)70140-X; Gantert M, 2010, J PERINATOL, V30, pS21, DOI 10.1038/jp.2010.96; Getahun D, 2010, ARCH PEDIAT ADOL MED, V164, P187, DOI 10.1001/archpediatrics.2009.238; Goldenberg RL, 2000, NEW ENGL J MED, V342, P1500, DOI 10.1056/NEJM200005183422007; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Graf D, 2002, J EXP MED, V196, P163, DOI 10.1084/jem.20020276; Gutierrez-Frias C, 2004, J IMMUNOL, V173, P5046, DOI 10.4049/jimmunol.173.8.5046; Hager-Theodorides AL, 2002, J IMMUNOL, V169, P5496, DOI 10.4049/jimmunol.169.10.5496; Hanson ML, 2010, TOXICOL APPL PHARM, V242, P136, DOI 10.1016/j.taap.2009.09.023; Hartling L, 2012, ARCH DIS CHILD-FETAL, V97, pF8, DOI 10.1136/adc.2010.210187; Kallapur SG, 2001, AM J PHYSIOL-LUNG C, V280, pL527, DOI 10.1152/ajplung.2001.280.3.L527; Kallapur SG, 2003, AM J PHYSIOL-LUNG C, V284, pL633, DOI 10.1152/ajplung.00344.2002; Kavelaars A, 1999, PEDIATR RES, V45, P306, DOI 10.1203/00006450-199903000-00003; Kemp MW, 2011, REPROD SCI, V18, P88, DOI 10.1177/1933719110380470; Kramer BW, 2009, INNATE IMMUN-LONDON, V15, P101, DOI 10.1177/1753425908100455; Kramer BW, 2004, PEDIATR RES, V55, P764, DOI 10.1203/01.PDR.0000120678.72485.19; Kramer BW, 2005, AM J RESP CRIT CARE, V171, P73, DOI 10.1164/rccm.200406-745OC; Kramer BW, 2001, AM J RESP CRIT CARE, V164, P982, DOI 10.1164/ajrccm.164.6.2103061; Kramer BW, 2009, AM J OBSTET GYNECOL, V202, P77; Kumar R, 2008, J ALLERGY CLIN IMMUN, V121, p[878, e876]; Kunzmann S, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.02.035; Kuypers E, 2012, AM J PHYSIOL-LUNG C, V302, pL380, DOI 10.1152/ajplung.00338.2011; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lowrey JA, 2002, J IMMUNOL, V169, P1869, DOI 10.4049/jimmunol.169.4.1869; Michie CA, 1998, ARCH DIS CHILD-FETAL, V79, pF159, DOI 10.1136/fn.79.2.F159a; Newnham JP, 2003, AM J OBSTET GYNECOL, V189, P1458, DOI 10.1067/S0002-9378(03)00758-0; Outram SV, 2000, IMMUNITY, V13, P187, DOI 10.1016/S1074-7613(00)00019-4; Pearse G, 2006, TOXICOL PATHOL, V34, P504, DOI 10.1080/01926230600865549; Quinlivan J A, 1998, J Obstet Gynaecol Res, V24, P173; Rosen D, 2006, AM J RESP CRIT CARE, V174, P75, DOI 10.1164/rccm.200511-1784OC; Sacedon R, 2003, J HISTOCHEM CYTOCHEM, V51, P1557, DOI 10.1177/002215540305101115; Shatrov JG, 2010, OBSTET GYNECOL, V116, P387, DOI 10.1097/AOG.0b013e3181e90046; Sloboda DM, 2000, J ENDOCRINOL, V165, P79, DOI 10.1677/joe.0.1650079; SMOLDERSDEHAAS H, 1990, PEDIATRICS, V86, P65; Tonomura N, 2003, J IMMUNOL, V170, P2469, DOI 10.4049/jimmunol.170.5.2469; Toti P, 2000, HUM PATHOL, V31, P1121, DOI 10.1053/hupa.2000.16676; Wang XX, 2008, LIFE SCI, V83, P671, DOI 10.1016/j.lfs.2008.09.003; Wolfs TGAM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005837; WU FF, 1993, FETAL DIAGN THER, V8, P89, DOI 10.1159/000263754; Yinon Y, 2007, ULTRASOUND OBST GYN, V29, P639, DOI 10.1002/uog.4022	51	19	20	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38257	10.1371/journal.pone.0038257	http://dx.doi.org/10.1371/journal.pone.0038257			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693607	gold, Green Published, Green Submitted			2022-12-27	WOS:000305338500118
J	Meyer-Rath, G; Schnippel, K; Long, L; MacLeod, W; Sanne, I; Stevens, W; Pillay, S; Pillay, Y; Rosen, S				Meyer-Rath, Gesine; Schnippel, Kathryn; Long, Lawrence; MacLeod, William; Sanne, Ian; Stevens, Wendy; Pillay, Sagie; Pillay, Yogan; Rosen, Sydney			The Impact and Cost of Scaling up GeneXpert MTB/RIF in South Africa	PLOS ONE			English	Article							TUBERCULOSIS; DIAGNOSIS; IMPLEMENTATION; RESISTANCE	Objective: We estimated the incremental cost and impact on diagnosis and treatment uptake of national rollout of Xpert MTB/RIF technology (Xpert) for the diagnosis of pulmonary TB above the cost of current guidelines for the years 2011 to 2016 in South Africa. Methods: We parameterised a population-level decision model with data from national-level TB databases (n = 199,511) and implementation studies. The model follows cohorts of TB suspects from diagnosis to treatment under current diagnostic guidelines or an algorithm that includes Xpert. Assumptions include the number of TB suspects, symptom prevalence of 5.5%, annual suspect growth rate of 10%, and 2010 public-sector salaries and drug and service delivery costs. Xpert test costs are based on data from an in-country pilot evaluation and assumptions about when global volumes allowing cartridge discounts will be reached. Results: At full scale, Xpert will increase the number of TB cases diagnosed per year by 30%-37% and the number of MDR-TB cases diagnosed by 69%-71%. It will diagnose 81% of patients after the first visit, compared to 46% currently. The cost of TB diagnosis per suspect will increase by 55% to USD 60-61 and the cost of diagnosis and treatment per TB case treated by 8% to USD 797-873. The incremental capital cost of the Xpert scale-up will be USD 22 million and the incremental recurrent cost USD 287-316 million over six years. Conclusion: Xpert will increase both the number of TB cases diagnosed and treated and the cost of TB diagnosis. These results do not include savings due to reduced transmission of TB as a result of earlier diagnosis and treatment initiation.	[Meyer-Rath, Gesine; Schnippel, Kathryn; Long, Lawrence; MacLeod, William; Sanne, Ian; Rosen, Sydney] Univ Witwatersrand, Dept Med, Fac Hlth Sci, HE2RO, ZA-2001 Johannesburg, South Africa; [Meyer-Rath, Gesine; MacLeod, William; Sanne, Ian; Rosen, Sydney] Boston Univ, Ctr Global Hlth & Dev, Boston, MA 02215 USA; [Stevens, Wendy; Pillay, Sagie] Natl Hlth Lab Serv, Johannesburg, South Africa; [Stevens, Wendy] Univ Witwatersrand, Dept Mol Med & Haematol, Johannesburg, South Africa; [Pillay, Yogan] Natl Dept Hlth, Pretoria, South Africa	University of Witwatersrand; Boston University; National Health Laboratory Service; University of Witwatersrand	Meyer-Rath, G (corresponding author), Univ Witwatersrand, Dept Med, Fac Hlth Sci, HE2RO, ZA-2001 Johannesburg, South Africa.	gesine@bu.edu	Sanne, Ian/ABH-2231-2020	Long, Lawrence/0000-0003-4986-4988; Rosen, Sydney/0000-0002-6560-2964; Meyer-Rath, Gesine/0000-0003-0439-381X; MacLeod, William/0000-0001-8003-8874; Schnippel, Kathryn/0000-0003-0757-4325	South Africa Mission of the US Agency for International Development (USAID) [674-A-00-09-00018-00, GHS-A-00-03-00020, 674-A-00-08-0007-00]; Fogarty International Center/National Institutes of Health, ICOHRTA AIDS/TB [U2RTW007373]; FOGARTY INTERNATIONAL CENTER [U2RTW007373] Funding Source: NIH RePORTER	South Africa Mission of the US Agency for International Development (USAID)(United States Agency for International Development (USAID)); Fogarty International Center/National Institutes of Health, ICOHRTA AIDS/TB; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	Funding for this study was provided by the South Africa Mission of the US Agency for International Development (USAID) under the terms of Associate Cooperative Agreement No. 674-A-00-09-00018-00 under Country Research Activity Leader Award No. GHS-A-00-03-00020 (GMR, KB, LL, WM and SR) and under Agreement No. 674-A-00-08-0007-00 to Right to Care (IS). KB received additional training support from Fogarty International Center/National Institutes of Health, ICOHRTA AIDS/TB Grant No. U2RTW007373. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boehme CC, 2011, LANCET, V377, P1495, DOI 10.1016/S0140-6736(11)60438-8; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Chihota VN, 2010, INT J TUBERC LUNG D, V14, P1024; Dowdy DW, 2008, INT J TUBERC LUNG D, V12, P1021; Dowdy DW, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001063; Erasmus LK, 2011, INT J TUBERC LUNG S3, V15, pS61; Getahun H, 2007, LANCET, V369, P2042, DOI 10.1016/S0140-6736(07)60284-0; Mann GH, 2011, INT J TUBERC LUNG D, V15, P715, DOI 10.5588/ijtld.10.0749; Matsoso L. G., 2010, Southern African Journal of Epidemiology & Infection, V25, P12; Meyer-Rath G, 2011, 42 UN WORLD C LUNG H; Motsoaledi A., 2011, COMMUNICATION   0531; National Department of Health Republic of South Africa, 2009, NAT TUB MAN GUID; National Department of Health Republic of South Africa, 2011, MULT RES TUB POL FRA; National Department of Health Republic of South Africa, 2011, NAT STRAT PLAN HIV A, P2012; Parsons LM, 2011, CLIN MICROBIOL REV, V24, P314, DOI 10.1128/CMR.00059-10; Scott LE, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001061; Sinanovic E, 2003, INT J TUBERC LUNG D, V7, pS56; Sohn H, 2006, EXPERT REV ANTI-INFE, V7, P723; [TB Control Programme National Department of Health Republic of South Africa], 2010, PROV Q TB PROGR REP; UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases/Foundation for Innovative New Diagnostics, 2006, DIAGN TUB GLOB DEM M; WHO, STOPTB PLANN BUDG TB; WHO, 2011, GLOB TUB CONTR REP; WHO, 2010, TUB DIAGN XPERT MTB; World Health Organization, 2010, ROADM ROL XPERT MTB	24	119	119	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e36966	10.1371/journal.pone.0036966	http://dx.doi.org/10.1371/journal.pone.0036966			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693561	Green Published, gold, Green Submitted			2022-12-27	WOS:000305338500023
J	Roy, S; Brownell, WE; Spector, AA				Roy, Sitikantha; Brownell, William E.; Spector, Alexander A.			Modeling Electrically Active Viscoelastic Membranes	PLOS ONE			English	Article							OUTER HAIR CELL; LIVING CELLS; ELECTROMECHANICAL PROPERTIES; FORCE GENERATION; PRESTIN; VOLTAGE; MOTOR; PIEZOELECTRICITY; ELECTROMOTILITY; DEPENDENCE	The membrane protein prestin is native to the cochlear outer hair cell that is crucial to the ear's amplification and frequency selectivity throughout the whole acoustic frequency range. The outer hair cell exhibits interrelated dimensional changes, force generation, and electric charge transfer. Cells transfected with prestin acquire unique active properties similar to those in the native cell that have also been useful in understanding the process. Here we propose a model describing the major electromechanical features of such active membranes. The model derived from thermodynamic principles is in the form of integral relationships between the history of voltage and membrane resultants as independent variables and the charge density and strains as dependent variables. The proposed model is applied to the analysis of an active force produced by the outer hair cell in response to a harmonic electric field. Our analysis reveals the mechanism of the outer hair cell active (isometric) force having an almost constant amplitude and phase up to 80 kHz. We found that the frequency-invariance of the force is a result of interplay between the electrical filtering associated with prestin and power law viscoelasticity of the surrounding membrane. Paradoxically, the membrane viscoelasticity boosts the force balancing the electrical filtering effect. We also consider various modes of electromechanical coupling in membrane with prestin associated with mechanical perturbations in the cell. We consider pressure or strains applied step-wise or at a constant rate and compute the time course of the resulting electric charge. The results obtained here are important for the analysis of electromechanical properties of membranes, cells, and biological materials as well as for a better understanding of the mechanism of hearing and the role of the protein prestin in this mechanism.	[Roy, Sitikantha; Spector, Alexander A.] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA; [Brownell, William E.] Baylor Coll Med, Bobby R Alford Dept Otolaryngol Head & Neck Surg, Houston, TX 77030 USA	Johns Hopkins University; Baylor College of Medicine	Roy, S (corresponding author), Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA.	aspector@jhu.edu	Spector, Alexander/A-3330-2010; ROY, SITIKANTHA/AAT-2836-2021		National Institute on Deafness and Other Communication Disorders, National Institutes of Health [R01 DC 002775, R01 DC 000354]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000354, R01DC002775] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work is supported by research grants R01 DC 002775 and R01 DC 000354 from National Institute on Deafness and Other Communication Disorders, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashmore J, 2010, HEARING RES, V266, P1, DOI 10.1016/j.heares.2010.05.001; Bett GCL, 2000, J MEMBRANE BIOL, V173, P237, DOI 10.1007/s002320001023; BROWNELL WE, 1985, SCIENCE, V227, P194, DOI 10.1126/science.3966153; Brownell WE, 2001, ANNU REV BIOMED ENG, V3, P169, DOI 10.1146/annurev.bioeng.3.1.169; Cady WG., 1964, PIEZOELECTRICITY, V1; Chakrapani S, 2010, P NATL ACAD SCI USA, V107, P5435, DOI 10.1073/pnas.0914109107; Christensen R.M., 1982, THEORY VISCOELASTICI; DALLOS P, 1993, J NEUROPHYSIOL, V70, P299, DOI 10.1152/jn.1993.70.1.299; Dallos P, 2008, NEURON, V58, P333, DOI 10.1016/j.neuron.2008.02.028; Deng LH, 2006, NAT MATER, V5, P636, DOI 10.1038/nmat1685; Deo N, 2004, BIOPHYS J, V86, P3519, DOI 10.1529/biophysj.103.026658; Dong XX, 2004, BIOPHYS J, V86, P1201, DOI 10.1016/S0006-3495(04)74194-6; Dong XX, 2002, BIOPHYS J, V82, P1254, DOI 10.1016/S0006-3495(02)75481-7; Fabry B, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.041914; Frank G, 1999, P NATL ACAD SCI USA, V96, P4420, DOI 10.1073/pnas.96.8.4420; GALE JE, 1994, P ROY SOC B-BIOL SCI, V255, P243, DOI 10.1098/rspb.1994.0035; Haddad YM, 1995, VISCOELASTICIY ENG M; HALLWORTH R, 1993, J NEUROPHYSIOL, V70, P549, DOI 10.1152/jn.1993.70.2.549; Hoffman BD, 2006, P NATL ACAD SCI USA, V103, P10259, DOI 10.1073/pnas.0510348103; Iwasa KH, 1997, BIOPHYS J, V73, P546, DOI 10.1016/S0006-3495(97)78092-5; KAKEHATA S, 1995, BIOPHYS J, V68, P2190, DOI 10.1016/S0006-3495(95)80401-7; Kennedy HJ, 2005, NATURE, V433, P880, DOI 10.1038/nature03367; Kim KS, 1998, BIOPHYS J, V75, P2274, DOI 10.1016/S0006-3495(98)77672-6; Lai WM, 2002, BIORHEOLOGY, V39, P39; Liberman MC, 2002, NATURE, V419, P300, DOI 10.1038/nature01059; Liu YW, 2009, J ACOUST SOC AM, V126, P751, DOI 10.1121/1.3158919; Luckey M., 2008, MEMBRANE STRUCTURAL; Ludwig J, 2001, P NATL ACAD SCI USA, V98, P4178, DOI 10.1073/pnas.071613498; Martin P, 1999, P NATL ACAD SCI USA, V96, P14306, DOI 10.1073/pnas.96.25.14306; Mountain DC, 1994, J ACOUST SOC AM, V97, P3006; Nobili R, 1996, J ACOUST SOC AM, V99, P2244, DOI 10.1121/1.415412; Petrov A.G., 1999, LYOTROPIC STATE MATT; Rabbitt RD, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000444; Rawicz W, 2000, BIOPHYS J, V79, P328, DOI 10.1016/S0006-3495(00)76295-3; Sachs F, 1998, REV PHYSIOL BIOCH P, V132, P1, DOI 10.1007/BFb0004985; SALZSTEIN RA, 1987, J BIOMECH, V20, P271, DOI 10.1016/0021-9290(87)90294-6; Spector AA, 2003, J ACOUST SOC AM, V113, P453, DOI 10.1121/1.1526493; Spector AA, 2001, INT J SOLIDS STRUCT, V38, P2115, DOI 10.1016/S0020-7683(00)00156-6; Spector AA, 1998, J ACOUST SOC AM, V103, P1007, DOI 10.1121/1.421217; Stamenovic D, 2007, BIOPHYS J, V93, pL39, DOI 10.1529/biophysj.107.116582; Sun DD, 2004, J BIOMECH ENG-T ASME, V126, P6, DOI 10.1115/1.1644562; Sun SX, 2009, J THEOR BIOL, V260, P137, DOI 10.1016/j.jtbi.2009.05.019; Tolomeo JA, 1995, J ACOUST SOC AM, V95, P350; Villalba-Galea CA, 2009, BIOPHYS J, V96, pL19, DOI 10.1016/j.bpj.2008.11.003; Weitzel EK, 2003, J ACOUST SOC AM, V114, P1462, DOI 10.1121/1.1596172; Yamada S, 2000, BIOPHYS J, V78, P1736, DOI 10.1016/S0006-3495(00)76725-7; Zheng J, 2000, NATURE, V405, P149, DOI 10.1038/35012009; Zimmerberg J, 2006, CURR BIOL, V16, pR272, DOI 10.1016/j.cub.2006.03.050	48	7	7	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e37667	10.1371/journal.pone.0037667	http://dx.doi.org/10.1371/journal.pone.0037667			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22701528	Green Published, Green Submitted, gold			2022-12-27	WOS:000305338500049
J	Tang, L; Sun, J; Zhang, HC; Zhang, CS; Yu, LN; Bi, J; Zhu, F; Liu, SF; Yang, QL				Tang, Lin; Sun, Jie; Zhang, Hui Cui; Zhang, Chu Shu; Yu, Li Na; Bi, Jie; Zhu, Feng; Liu, Shao Fang; Yang, Qing Li			Evaluation of Physicochemical and Antioxidant Properties of Peanut Protein Hydrolysate	PLOS ONE			English	Article							FUNCTIONAL-PROPERTIES; GELATION; PH	Peanut protein and its hydrolysate were compared with a view to their use as food additives. The effects of pH, temperature and protein concentration on some of their key physicochemical properties were investigated. Compared with peanut protein, peanut peptides exhibited a significantly higher solubility and significantly lower turbidity at pH values 2-12 and temperature between 30 and 80 degrees C. Peanut peptide showed better emulsifying capacity, foam capacity and foam stability, but had lower water holding and fat adsorption capacities over a wide range of protein concentrations (2-5 g/100 ml) than peanut protein isolate. In addition, peanut peptide exhibited in vitro antioxidant properties measured in terms of reducing power, scavenging of hydroxyl radical, and scavenging of DPPH radical. These results suggest that peanut peptide appeared to have better functional and antioxidant properties and hence has a good potential as a food additive.	[Tang, Lin; Zhang, Hui Cui] Shandong Normal Univ, Jinan, Peoples R China; [Sun, Jie; Zhang, Hui Cui; Zhang, Chu Shu; Yu, Li Na; Bi, Jie; Zhu, Feng; Liu, Shao Fang; Yang, Qing Li] Shandong Peanut Res Inst, Qingdao, Peoples R China	Shandong Normal University	Tang, L (corresponding author), Shandong Normal Univ, Jinan, Peoples R China.	rice407@sohu.com			National Natural Science Foundation of China [31100205, 31000728]; China Agriculture Research System [CARS-14]; Promotive Research Fund for Young and Middle-aged Scientists of Shandong Province [BS2010NY023]; Natural Science Fund of Shangdong Province [ZR2009DQ004, ZR2011CQ036]; Qingdao Municipal Science and Technology Plan Project [11-2-3-26-nsh, 11-2-3-25-nsh, 11-2-4-9-(3)-jch]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Agriculture Research System; Promotive Research Fund for Young and Middle-aged Scientists of Shandong Province; Natural Science Fund of Shangdong Province; Qingdao Municipal Science and Technology Plan Project	This study was supported by grants from the National Natural Science Foundation of China (31100205; 31000728), the China Agriculture Research System (CARS-14), the Promotive Research Fund for Young and Middle-aged Scientists of Shandong Province (BS2010NY023), the Natural Science Fund of Shangdong Province (ZR2009DQ004; ZR2011CQ036), Qingdao Municipal Science and Technology Plan Project (11-2-3-26-nsh; 11-2-3-25-nsh; 11-2-4-9-(3)-jch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agyare KK, 2009, FOOD HYDROCOLLOID, V23, P72, DOI 10.1016/j.foodhyd.2007.11.012; Ahmedna M, 1999, J AGR FOOD CHEM, V47, P1340, DOI 10.1021/jf981098s; Akintayo ET, 1999, FOOD CHEM, V66, P51, DOI 10.1016/S0308-8146(98)00155-1; Arogundade LA, 2006, FOOD HYDROCOLLOID, V20, P831, DOI 10.1016/j.foodhyd.2005.07.012; Benjakul S, 2001, J SCI FOOD AGR, V81, P1039, DOI 10.1002/jsfa.887; Carrasco-Castilla J, 2012, FOOD CHEM, V131, P1157, DOI 10.1016/j.foodchem.2011.09.084; Cumby N, 2008, FOOD CHEM, V109, P144, DOI 10.1016/j.foodchem.2007.12.039; DAMAME SV, 1990, PLANT FOOD HUM NUTR, V40, P143, DOI 10.1007/BF02193772; Dong XH, 2011, INNOV FOOD SCI EMERG, V12, P478, DOI 10.1016/j.ifset.2011.07.002; Hettiarachchy NS, 1996, CEREAL CHEM, V73, P364; Hwang JY, 2010, LWT-FOOD SCI TECHNOL, V43, P285, DOI 10.1016/j.lwt.2009.08.020; LUSAS EW, 1979, J AM OIL CHEM SOC, V56, P425, DOI 10.1007/BF02671530; Nielsen PM, 2001, J FOOD SCI, V66, P642, DOI 10.1111/j.1365-2621.2001.tb04614.x; PATIL UG, 1993, PLANT FOOD HUM NUTR, V43, P157, DOI 10.1007/BF01087919; PEARCE KN, 1978, J AGR FOOD CHEM, V26, P716, DOI 10.1021/jf60217a041; Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3; SHIMADA K, 1992, J AGR FOOD CHEM, V40, P945, DOI 10.1021/jf00018a005; Siddhuraju P, 2007, FOOD CHEM, V101, P10, DOI 10.1016/j.foodchem.2006.01.004; Tang CH, 2007, J FOOD ENG, V82, P568, DOI 10.1016/j.jfoodeng.2007.01.029; Tomotake H, 2002, J AGR FOOD CHEM, V50, P2125, DOI 10.1021/jf011248q; Yin Y. R., 1996, Food Science, China, V17, P3; Zhang YuHao, 2007, Transactions of the Chinese Society of Agricultural Engineering, V23, P258; Zhao GL, 2011, FOOD CHEM, V127, P1438, DOI 10.1016/j.foodchem.2011.01.046	23	22	26	4	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e37863	10.1371/journal.pone.0037863	http://dx.doi.org/10.1371/journal.pone.0037863			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693580	Green Published, gold, Green Submitted			2022-12-27	WOS:000305338500061
J	Xia, ZL; Sun, KL; Wang, MP; Wu, K; Zhang, H; Wu, JY				Xia, Zongliang; Sun, Kaile; Wang, Meiping; Wu, Ke; Zhang, Hua; Wu, Jianyu			Overexpression of a Maize Sulfite Oxidase Gene in Tobacco Enhances Tolerance to Sulfite Stress via Sulfite Oxidation and CAT-Mediated H2O2 Scavenging	PLOS ONE			English	Article							CYTOCHROME C OXIDOREDUCTASE; THIOBACILLUS-NOVELLUS; MOLYBDENUM-COFACTOR; CHICKEN LIVER; PURIFICATION; IDENTIFICATION; METABOLISM; EXPRESSION; ENZYME; PLANTS	Sulfite oxidase (SO) plays an important role in sulfite metabolism. To date, the molecular mechanisms of sulfite metabolism in plants are largely unknown. Previously, a full-length cDNA of the putative sulfite oxidase gene from maize (ZmSO) was cloned, and its response to SO2/sulfite stress at the transcriptional level was characterized. In this study, the recombinant ZmSO protein was purified from E. coli. It exhibited sulfite-dependent activity and had strong affinity for the substrate sulfite. Over-expression (OE) of ZmSO in tobacco plants enhanced their tolerance to sulfite stress. The plants showed much less damage, less sulfite accumulation, but greater amounts of sulfate. This suggests that tolerance of transgenic plants to sulfite was enhanced by increasing SO expression levels. Interestingly, H2O2 accumulation levels by histochemical detection and quantitative determination in the OE plants were much less than those in the wild-type upon sulfite stress. Furthermore, reductions of catalase levels detected in the OE lines were considerably less than in the wild-type plants. This indicates that SO may play an important role in protecting CAT from inhibition by excess sulfite. Collectively, these data demonstrate that transgenic tobacco plants over-expressing ZmSO enhance tolerance to excess sulfite through sulfite oxidation and catalase-mediated hydrogen peroxide scavenging. This is the first SO gene from monocots to be functionally characterized.	[Xia, Zongliang; Sun, Kaile; Wang, Meiping; Wu, Ke; Zhang, Hua; Wu, Jianyu] Henan Agr Univ, Coll Life Sci, Zhengzhou, Peoples R China; [Xia, Zongliang; Wu, Jianyu] Key Lab Physiol Ecol & Genet Improvement Food Cro, Zhengzhou, Peoples R China	Henan Agricultural University	Xia, ZL (corresponding author), Henan Agr Univ, Coll Life Sci, Zhengzhou, Peoples R China.	xiazl08@163.com; wujianyu40@126.com		Wu, Jianyu/0000-0002-9090-2512	National Natural Science Foundation of China [30971548]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by the National Natural Science Foundation of China (30971548). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AEBI H, 1984, METHOD ENZYMOL, V105, P121; ANDERSON MD, 1995, PLANT PHYSIOL, V109, P1247, DOI 10.1104/pp.109.4.1247; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brody MS, 1999, BIOCHEMISTRY-US, V38, P6668, DOI 10.1021/bi9902539; Brychkova G, 2007, PLANT J, V50, P696, DOI 10.1111/j.1365-313X.2007.03080.x; Byrne RS, 2009, J BIOL CHEM, V284, P35479, DOI 10.1074/jbc.M109.067355; COHEN HJ, 1971, J BIOL CHEM, V246, P367; COHEN HJ, 1972, J BIOL CHEM, V247, P7759; COHEN HJ, 1971, J BIOL CHEM, V246, P359; D'Errico G, 2006, J BACTERIOL, V188, P694, DOI 10.1128/JB.188.2.694-701.2006; de Jong GAH, 2000, J MOL CATAL B-ENZYM, V8, P61, DOI 10.1016/S1381-1177(99)00067-3; Eilers T, 2001, J BIOL CHEM, V276, P46989, DOI 10.1074/jbc.M108078200; FERGUSON IB, 1983, PLANT PHYSIOL, V71, P182, DOI 10.1104/pp.71.1.182; GARRETT RM, 1994, J BIOL CHEM, V269, P272; Garrett RM, 1998, P NATL ACAD SCI USA, V95, P6394, DOI 10.1073/pnas.95.11.6394; GLEAVE AP, 1992, PLANT MOL BIOL, V20, P1203, DOI 10.1007/BF00028910; Hansch R, 2007, PLANT BIOLOGY, V9, P589, DOI 10.1055/s-2007-965433; Hansch R, 2006, J BIOL CHEM, V281, P6884, DOI 10.1074/jbc.M513054200; Hille R, 1996, CHEM REV, V96, P2757, DOI 10.1021/cr950061t; Kappler U, 2000, J BIOL CHEM, V275, P13202, DOI 10.1074/jbc.275.18.13202; KESSLER DL, 1972, J BIOL CHEM, V247, P6566; Kisker C, 1997, ANNU REV BIOCHEM, V66, P233, DOI 10.1146/annurev.biochem.66.1.233; Kisker C, 1997, CELL, V91, P973, DOI 10.1016/S0092-8674(00)80488-2; Lang C, 2007, PLANT CELL ENVIRON, V30, P447, DOI 10.1111/j.1365-3040.2006.01632.x; Liu L, 1996, ENV SCI, V17, P16; LYRIC RM, 1970, CAN J BIOCHEM CELL B, V48, P334, DOI 10.1139/o70-056; Mendel RR, 1999, CRIT REV PLANT SCI, V18, P33, DOI 10.1016/S0735-2689(99)00386-X; Nowak K, 2004, PLANT CELL PHYSIOL, V45, P1889, DOI 10.1093/pcp/pch212; Pasqualini S, 2007, PLANT CELL ENVIRON, V30, P1545, DOI 10.1111/j.1365-3040.2007.01730.x; Purnell MP, 2005, PLANTA, V222, P167, DOI 10.1007/s00425-005-1510-z; Randewig D, 2012, PLANT CELL ENVIRON, V35, P100, DOI 10.1111/j.1365-3040.2011.02420.x; Rea G, 2004, PLANT PHYSIOL, V134, P1414, DOI 10.1104/pp.103.036764; Schrader N, 2003, STRUCTURE, V11, P1251, DOI 10.1016/j.str.2003.09.001; TOGHROL F, 1983, J BIOL CHEM, V258, P6762; Xia ZL, 2012, MOL BIOL REP, V39, P2429, DOI 10.1007/s11033-011-0993-x; Xia ZongLiang, 2009, Scientia Agricultura Sinica, V42, P2643	37	25	27	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e37383	10.1371/journal.pone.0037383	http://dx.doi.org/10.1371/journal.pone.0037383			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693572	Green Published, Green Submitted, gold			2022-12-27	WOS:000305338500035
J	Poole, KES; Treece, GM; Mayhew, PM; Vaculik, J; Dungl, P; Horak, M; Stepan, JJ; Gee, AH				Poole, Kenneth E. S.; Treece, Graham M.; Mayhew, Paul M.; Vaculik, Jan; Dungl, Pavel; Horak, Martin; Stepan, Jan J.; Gee, Andrew H.			Cortical Thickness Mapping to Identify Focal Osteoporosis in Patients with Hip Fracture	PLOS ONE			English	Article							PROXIMAL FEMUR STRENGTH; FEMORAL-NECK; IN-VITRO; PREDICTION; POROSITY; BONE; MODELS; WOMEN; RISK; AGE	Background: Individuals with osteoporosis are predisposed to hip fracture during trips, stumbles or falls, but half of all hip fractures occur in those without generalised osteoporosis. By analysing ordinary clinical CT scans using a novel cortical thickness mapping technique, we discovered patches of markedly thinner bone at fracture-prone regions in the femurs of women with acute hip fracture compared with controls. Methods: We analysed CT scans from 75 female volunteers with acute fracture and 75 age-and sex-matched controls. We classified the fracture location as femoral neck or trochanteric before creating bone thickness maps of the outer 'cortical' shell of the intact contra-lateral hip. After registration of each bone to an average femur shape and statistical parametric mapping, we were able to visualise and quantify statistically significant foci of thinner cortical bone associated with each fracture type, assuming good symmetry of bone structure between the intact and fractured hip. The technique allowed us to pinpoint systematic differences and display the results on a 3D average femur shape model. Findings: The cortex was generally thinner in femoral neck fracture cases than controls. More striking were several discrete patches of statistically significant thinner bone of up to 30%, which coincided with common sites of fracture initiation (femoral neck or trochanteric). Interpretation: Femoral neck fracture patients had a thumbnail-sized patch of focal osteoporosis at the upper head-neck junction. This region coincided with a weak part of the femur, prone to both spontaneous 'tensile' fractures of the femoral neck, and as a site of crack initiation when falling sideways. Current hip fracture prevention strategies are based on case finding: they involve clinical risk factor estimation to determine the need for single-plane bone density measurement within a standard region of interest (ROI) of the femoral neck. The precise sites of focal osteoporosis that we have identified are overlooked by current 2D bone densitometry methods.	[Poole, Kenneth E. S.; Mayhew, Paul M.] Univ Cambridge, Dept Med, Cambridge CB2 2QQ, England; [Treece, Graham M.; Gee, Andrew H.] Univ Cambridge, Dept Engn, Cambridge CB2 1PZ, England; [Vaculik, Jan; Dungl, Pavel] Charles Univ Prague, Fac Med, Dept Orthopaed, Prague, Czech Republic; [Vaculik, Jan; Dungl, Pavel] Bulovka Hosp, Prague, Czech Republic; [Horak, Martin] Homolka Hosp, Dept Radiol, Prague, Czech Republic; [Stepan, Jan J.] Charles Univ Prague, Dept Rheumatol, Fac Med 1, Prague, Czech Republic; [Stepan, Jan J.] Inst Rheumatol, Prague, Czech Republic	University of Cambridge; University of Cambridge; Charles University Prague; Bulovka University Hospital; Na Homolce Hospital; Charles University Prague; Institute of Rheumatology	Poole, KES (corresponding author), Univ Cambridge, Dept Med, Cambridge CB2 2QQ, England.	kp254@nhs.net	Dungl, Pavel/J-4115-2017; Stepan, Jan/A-7280-2013; Vacullík, Jan/J-3999-2017	Dungl, Pavel/0000-0001-6018-7362; Stepan, Jan/0000-0003-1541-8306; Vacullík, Jan/0000-0003-4850-9490	Arthritis Research UK via a Clinician Scientist Fellowship; Cambridge National Institute for Health Research Biomedical Research Centre; The Evelyn Trust; Versus Arthritis [20109] Funding Source: researchfish	Arthritis Research UK via a Clinician Scientist Fellowship; Cambridge National Institute for Health Research Biomedical Research Centre(National Institute for Health Research (NIHR)); The Evelyn Trust; Versus Arthritis(Versus Arthritis)	This analysis was funded by Arthritis Research UK via a Clinician Scientist Fellowship award to KESP. Cambridge National Institute for Health Research Biomedical Research Centre funded PMM. The Evelyn Trust funded GMT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell KL, 1999, BONE, V24, P57, DOI 10.1016/S8756-3282(98)00143-4; Bessho M, 2009, BONE, V45, P226, DOI 10.1016/j.bone.2009.04.241; Borggrefe J, 2010, J BONE MINER RES, V25, P472, DOI 10.1359/jbmr.090820; Cristofolini L, 2010, PHILOS T R SOC A, V368, P2725, DOI 10.1098/rsta.2010.0046; Cristofolinial L, 2007, J BIOMECH, V40, P2837, DOI 10.1016/j.jbiomech.2007.03.015; de Bakker PM, 2009, J BIOMECH, V42, P1917, DOI 10.1016/j.jbiomech.2009.05.001; Feik SA, 1997, J ANAT, V191, P407, DOI 10.1046/j.1469-7580.1997.19130407.x; FREEMAN MAR, 1974, J BONE JOINT SURG BR, VB 56, P698, DOI 10.1302/0301-620X.56B4.698; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; GLUER CC, 1994, J BONE MINER RES, V9, P671; Hansen S, 2011, CALCIFIED TISSUE INT, V89, P335, DOI 10.1007/s00223-011-9523-z; Holzer G, 2009, J BONE MINER RES, V24, P468, DOI 10.1359/JBMR.081108; Johannesdottir F, 2011, BONE, V48, P1268, DOI 10.1016/j.bone.2011.03.776; Kaptoge S, 2008, J BONE MINER RES, V23, P1892, DOI [10.1359/jbmr.080802, 10.1359/JBMR.080802]; Li WJ, 2009, BONE, V44, P596, DOI 10.1016/j.bone.2008.12.008; Mayhew PM, 2005, LANCET, V366, P129, DOI 10.1016/S0140-6736(05)66870-5; Odgers PNB, 1931, J ANAT, V65, P352; Panzer S, 2010, SKELETAL RADIOL, V39, P645, DOI 10.1007/s00256-009-0792-9; Parker MJ, 1997, ACTA ORTHOP SCAND, V68, P325, DOI 10.3109/17453679708996170; PITT MJ, 1982, AM J ROENTGENOL, V138, P1115, DOI 10.2214/ajr.138.6.1115; Poole KES, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016190; Poole KES, 2010, J BONE MINER RES, V25, P482, DOI 10.1359/jbmr.090734; Pulkkinen P, 2011, BONE, V49, P600, DOI 10.1016/j.bone.2011.07.022; Rueckert D, 2003, IEEE T MED IMAGING, V22, P1014, DOI 10.1109/TMI.2003.815865; Sievanen H, 2007, PLOS MED, V4, P407, DOI 10.1371/journal.pmed.0040027; Treece GM, 2010, MED IMAGE ANAL, V14, P276, DOI 10.1016/j.media.2010.01.003; VACULIK J, 2007, ORTOPEDIE, V1, P62; Wainwright SA, 2005, J CLIN ENDOCR METAB, V90, P2787, DOI 10.1210/jc.2004-1568; Worsley K., 2009, NEUROIMAGE, V47, pS102, DOI [10.1016/s1053-8119(09)70882-1, DOI 10.1016/S1053-8119(09)70882-1, 10.1016/S1053-8119(09)70882-1]; Yang KH, 1996, J BIOMECH ENG-T ASME, V118, P575, DOI 10.1115/1.2796045; Yli-Kyyny T, 2011, LANCET, V377, P2248, DOI 10.1016/S0140-6736(11)60549-7; Zebaze RMD, 2010, LANCET, V375, P1729, DOI 10.1016/S0140-6736(10)60320-0	32	89	94	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2012	7	6							e38466	10.1371/journal.pone.0038466	http://dx.doi.org/10.1371/journal.pone.0038466			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TU	22701648	gold, Green Published, Green Submitted			2022-12-27	WOS:000305337600025
J	Cady, NC; McKean, KA; Behnke, J; Kubec, R; Mosier, AP; Kasper, SH; Burz, DS; Musah, RA				Cady, Nathaniel C.; McKean, Kurt A.; Behnke, Jason; Kubec, Roman; Mosier, Aaron P.; Kasper, Stephen H.; Burz, David S.; Musah, Rabi A.			Inhibition of Biofilm Formation, Quorum Sensing and Infection in Pseudomonas aeruginosa by Natural Products-Inspired Organosulfur Compounds	PLOS ONE			English	Article							PETIVERIA-ALLIACEA; BACTERIAL BIOFILMS; MICROBIAL BIOFILMS; IN-VITRO; SULFOXIDE; CYSTEINE; GENES; EXPRESSION; MODEL; DERIVATIVES	Using a microplate-based screening assay, the effects on Pseudomonas aeruginosa PAO1 biofilm formation of several S-substituted cysteine sulfoxides and their corresponding disulfide derivatives were evaluated. From our library of compounds, S-phenyl-L-cysteine sulfoxide and its breakdown product, diphenyl disulfide, significantly reduced the amount of biofilm formation by P. aeruginosa at levels equivalent to the active concentration of 4-nitropyridine-N-oxide (NPO) (1 mM). Unlike NPO, which is an established inhibitor of bacterial biofilms, our active compounds did not reduce planktonic cell growth and only affected biofilm formation. When used in a Drosophila-based infection model, both S-phenyl-L-cysteine sulfoxide and diphenyl disulfide significantly reduced the P. aeruginosa recovered 18 h post infection (relative to the control), and were non-lethal to the fly hosts. The possibility that the observed biofilm inhibitory effects were related to quorum sensing inhibition (QSI) was investigated using Escherichia coli-based reporters expressing P. aeruginosa lasR or rhIR response proteins, as well as an endogenous P. aeruginosa reporter from the lasI/lasR QS system. Inhibition of quorum sensing by S-phenyl-L-cysteine sulfoxide was observed in all of the reporter systems tested, whereas diphenyl disulfide did not exhibit QSI in either of the E. coli reporters, and showed very limited inhibition in the P. aeruginosa reporter. Since both compounds inhibit biofilm formation but do not show similar QSI activity, it is concluded that they may be functioning by different pathways. The hypothesis that biofilm inhibition by the two active compounds discovered in this work occurs through QSI is discussed.	[Cady, Nathaniel C.; Behnke, Jason; Mosier, Aaron P.; Kasper, Stephen H.] SUNY Albany, Coll Nanoscale Sci & Engn, Albany, NY 12222 USA; [McKean, Kurt A.] SUNY Albany, Dept Biol Sci, Albany, NY 12222 USA; [Kubec, Roman] Univ S Bohemia, Dept Appl Chem, Bohemia, Czech Republic; [Burz, David S.; Musah, Rabi A.] SUNY Albany, Dept Chem, Albany, NY 12222 USA	State University of New York (SUNY) System; State University of New York (SUNY) Albany; SUNY Polytechnic Institute; State University of New York (SUNY) System; State University of New York (SUNY) Albany; University of South Bohemia Ceske Budejovice; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Cady, NC (corresponding author), SUNY Albany, Coll Nanoscale Sci & Engn, Albany, NY 12222 USA.	musah@albany.edu	Kubec, Roman/P-7507-2019	Kubec, Roman/0000-0002-2934-4443	National Science Foundation [0239755]; Div Of Biological Infrastructure [1062963] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The work reported here was supported by a grant to RAM from the National Science Foundation under award number 0239755. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Apidianakis Y, 2009, NAT PROTOC, V4, P1285, DOI 10.1038/nprot.2009.124; Bjarnsholt T, 2005, MICROBIOL-SGM, V151, P3873, DOI 10.1099/mic.0.27955-0; Block E, 2010, J AGR FOOD CHEM, V58, P4617, DOI 10.1021/jf1000106; Brackman G, 2011, ANTIMICROB AGENTS CH, V55, P2655, DOI 10.1128/AAC.00045-11; Brenner K, 2007, P NATL ACAD SCI USA, V104, P17300, DOI 10.1073/pnas.0704256104; Christensen LD, 2012, J ANTIMICROB CHEMOTH, V67, P1198, DOI 10.1093/jac/dks002; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431; Dasgupta MK, 1996, J AM SOC NEPHROL, V7, P877; Davies D, 2003, NAT REV DRUG DISCOV, V2, P114, DOI 10.1038/nrd1008; Davies DG, 2009, J BACTERIOL, V191, P1393, DOI 10.1128/JB.01214-08; Davies DG, 1998, SCIENCE, V280, P295, DOI 10.1126/science.280.5361.295; De Kievit TR, 2001, APPL ENVIRON MICROB, V67, P1865, DOI 10.1128/AEM.67.4.1865-1873.2001; Estin ML, 2010, ADV EXP MED BIOL, V660, P183, DOI 10.1007/978-1-60761-350-3_17; Harjai K, 2010, FEMS IMMUNOL MED MIC, V58, P161, DOI 10.1111/j.1574-695X.2009.00614.x; Hentzer M, 2002, MICROBIOL-SGM, V148, P87, DOI 10.1099/00221287-148-1-87; Heydorn A, 2002, APPL ENVIRON MICROB, V68, P2008, DOI 10.1128/AEM.68.4.2008-2017.2002; Jakobsen TH, 2012, ANTIMICROB AGENTS CH, V56, P2314, DOI 10.1128/AAC.05919-11; JENSEN ET, 1993, MICROB PATHOGENESIS, V15, P377, DOI 10.1006/mpat.1993.1087; Junker LM, 2007, ANTIMICROB AGENTS CH, V51, P3582, DOI 10.1128/AAC.00506-07; Kaufmann GF, 2008, EXPERT OPIN BIOL TH, V8, P719, DOI 10.1517/14712598.8.6.719 ; Kolodkin-Gal I, 2010, SCIENCE, V328, P627, DOI 10.1126/science.1188628; Kovaleva J, 2010, J HOSP INFECT, V76, P345, DOI 10.1016/j.jhin.2010.07.008; Krom BP, 2007, J MICROBIOL METH, V68, P421, DOI 10.1016/j.mimet.2006.08.003; Kubec R, 2002, J NAT PROD, V65, P960, DOI 10.1021/np020064i; Kubec R, 2002, PHYTOCHEMISTRY, V60, P21, DOI 10.1016/S0031-9422(02)00065-1; Kubec R, 2002, PHYTOCHEMISTRY, V61, P675, DOI 10.1016/S0031-9422(02)00328-X; Kubec R, 2001, PHYTOCHEMISTRY, V58, P981, DOI 10.1016/S0031-9422(01)00304-1; MELULENI GJ, 1995, J IMMUNOL, V155, P2029; Miyamoto CM, 1996, MOL MICROBIOL, V19, P767, DOI 10.1046/j.1365-2958.1996.417948.x; Montazerozohori M, 2007, MOLECULES, V12, P694, DOI 10.3390/12030694; Muh U, 2006, ANTIMICROB AGENTS CH, V50, P3674, DOI 10.1128/AAC.00665-06; Mulcahy H, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002299; Musah RA, 2009, PLANT PHYSIOL, V151, P1304, DOI 10.1104/pp.109.142430; NOMURA J, 1963, J BIOL CHEM, V238, P1441; Parsek MR, 2003, ANNU REV MICROBIOL, V57, P677, DOI 10.1146/annurev.micro.57.030502.090720; Persson T, 2005, ORG BIOMOL CHEM, V3, P253, DOI 10.1039/b415761c; Pesci EC, 1999, P NATL ACAD SCI USA, V96, P11229, DOI 10.1073/pnas.96.20.11229; Purevdorj B, 2002, APPL ENVIRON MICROB, V68, P4457, DOI 10.1128/AEM.68.9.4457-4464.2002; Reen FJ, FEMS MICROBIOL ECOL, V77, P413; Rogers FP, 1994, FEMS IMMUNOL MED MIC, V9, P109; Sakuragi Y, 2007, J BACTERIOL, V189, P5383, DOI 10.1128/JB.00137-07; Schaber JA, 2007, J MED MICROBIOL, V56, P738, DOI 10.1099/jmm.0.47031-0; Smyth AR, 2010, PEDIATR PULM, V45, P356, DOI 10.1002/ppul.21193; Vanoyan N, 2010, LANGMUIR, V26, P12089, DOI 10.1021/la101319e; Walencka Elzbieta, 2005, Polish Journal of Microbiology, V54, P191	47	135	144	1	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2012	7	6							e38492	10.1371/journal.pone.0038492	http://dx.doi.org/10.1371/journal.pone.0038492			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TQ	22715388	Green Submitted, gold, Green Published			2022-12-27	WOS:000305336800030
J	Liu, ZJ; Li, Y; Tan, YR; Xiao, M; Zhang, JL; Radtke, F; Velazquez, OC				Liu, Zhao-Jun; Li, Yan; Tan, Yurong; Xiao, Min; Zhang, Jialin; Radtke, Freddy; Velazquez, Omaida C.			Inhibition of Fibroblast Growth by Notch1 Signaling Is Mediated by Induction of Wnt11-Dependent WISP-1	PLOS ONE			English	Article							MELANOMA PROGRESSION; EXTRACELLULAR-MATRIX; STROMAL FIBROBLASTS; WNT/BETA-CATENIN; DOWN-REGULATION; CANCER; CELLS; TUMOR; ACTIVATION; WNT11	Fibroblasts are an integral component of stroma and important source of growth factors and extracellular matrix (ECM). They play a prominent role in maintaining tissue homeostasis and in wound healing and tumor growth. Notch signaling regulates biological function in a variety of cells. To elucidate the physiological function of Notch signaling in fibroblasts, we ablated Notch1 in mouse (Notch1(Flox/Flox)) embryonic fibroblasts (MEFs). Notch1-deficient (Notch1(-/-)) MEFs displayed faster growth and motility rate compared to Notch1(Flox/Flox) MEFs. Such phenotypic changes, however, were reversible by reconstitution of Notch1 activation via overexpression of the intracellular domain of Notch1 (NICD1) in Notch1-deficient MEFs. In contrast, constitutive activation of Notch1 signaling by introducing NICD1 into primary human dermal fibroblasts (FF2441), which caused pan-Notch activation, inhibited cell growth and motility, whereas cellular inhibition was relievable when the Notch activation was countered with dominant-negative mutant of Master-mind like 1 (DN-MAML-1). Functionally, "Notch-activated" stromal fibroblasts could inhibit tumor cell growth/invasion. Moreover, Notch activation induced expression of Wnt-induced secreted proteins-1 (WISP-1/CCN4) in FF2441 cells while deletion of Notch1 in MEFs resulted in an opposite effect. Notably, WISP-1 suppressed fibroblast proliferation, and was responsible for mediating Notch1's inhibitory effect since siRNA-mediated blockade of WISP-1 expression could relieve cell growth inhibition. Notch1-induced WISP-1 expression appeared to be Wnt11-dependent, but Wnt1-independent. Blockade of Wnt11 expression resulted in decreased WISP-1 expression and liberated Notch-induced cell growth inhibition. These findings indicated that inhibition of fibroblast proliferation by Notch pathway activation is mediated, at least in part, through regulating Wnt1-independent, but Wnt11-dependent WISP-1 expression.	[Liu, Zhao-Jun; Li, Yan; Tan, Yurong; Zhang, Jialin; Velazquez, Omaida C.] Univ Miami, Miller Sch Med, Dept Surg, Miami, FL 33136 USA; [Liu, Zhao-Jun; Velazquez, Omaida C.] Univ Miami, Sylvester Comprehens Canc Ctr, Miami, FL USA; [Xiao, Min] Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA; [Radtke, Freddy] Ecole Polytech Fed Lausanne, Swiss Inst Expt Canc Res, CH-1015 Lausanne, Switzerland	University of Miami; University of Miami; The Wistar Institute; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research	Liu, ZJ (corresponding author), Univ Miami, Miller Sch Med, Dept Surg, Miami, FL 33136 USA.	ovelazquez@med.miami.edu	Radtke, Freddy/Q-3198-2017	Radtke, Freddy/0000-0003-4315-4045	National Institutes of Health [R01DK-071084, R01GM081570]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071084] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081570] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institutes of Health (R01DK-071084 and R01GM081570). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Balint K, 2005, J CLIN INVEST, V115, P3166, DOI 10.1172/JCI25001; Becker V, 1998, CLIN EXP NEPHROL, V2, P295; Desnoyers L, 2001, J BIOL CHEM, V276, P47599, DOI 10.1074/jbc.M108339200; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Fukunaga-Kalabis M, 2008, ONCOGENE, V27, P2552, DOI 10.1038/sj.onc.1210896; Fukunaga-Kalabis M, 2006, J CELL BIOL, V175, P563, DOI 10.1083/jcb.200602132; Hogan B., 1994, MANIPULATING MOUSE E; Hsu MY, 1998, AM J PATHOL, V153, P1435, DOI 10.1016/S0002-9440(10)65730-6; Ingber DE, 2002, DIFFERENTIATION, V70, P547, DOI 10.1046/j.1432-0436.2002.700908.x; Ishii G, 2003, BIOCHEM BIOPH RES CO, V309, P232, DOI 10.1016/S0006-291X(03)01544-4; Ishikawa Y, 2008, ONCOGENE, V27, P6164, DOI 10.1038/onc.2008.216; Kalluri R, 2003, J CLIN INVEST, V112, P1776, DOI 10.1172/JCI200320530; Kirikoshi H, 2001, INT J MOL MED, V8, P651; Lin ZH, 2007, CANCER RES, V67, P5017, DOI 10.1158/0008-5472.CAN-06-3696; Liu ZJ, 2006, FASEB J, V20, P1009, DOI 10.1096/fj.05-4880fje; Lynch CC, 2002, DIFFERENTIATION, V70, P561, DOI 10.1046/j.1432-0436.2002.700909.x; Maillard I, 2003, CANCER CELL, V3, P203, DOI 10.1016/S1535-6108(03)00052-7; Majumdar A, 2003, DEVELOPMENT, V130, P3175, DOI 10.1242/dev.00520; Meier F, 2000, AM J PATHOL, V156, P193, DOI 10.1016/S0002-9440(10)64719-0; Midwood KS, 2004, INT J BIOCHEM CELL B, V36, P1031, DOI 10.1016/j.biocel.2003.12.003; Mumm JS, 2000, DEV BIOL, V228, P151, DOI 10.1006/dbio.2000.9960; Orimo A, 2006, CELL CYCLE, V5, P1597, DOI 10.4161/cc.5.15.3112; Ouko L, 2004, J BIOL CHEM, V279, P26707, DOI 10.1074/jbc.M402877200; Pandur P, 2002, NATURE, V418, P636, DOI 10.1038/nature00921; Pennica D, 1998, P NATL ACAD SCI USA, V95, P14717, DOI 10.1073/pnas.95.25.14717; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Radtke F, 2003, NAT REV CANCER, V3, P756, DOI 10.1038/nrc1186; Railo A, 2008, EXP CELL RES, V314, P2389, DOI 10.1016/j.yexcr.2008.04.010; Ross DA, 2004, EXP CELL RES, V296, P173, DOI 10.1016/j.yexcr.2004.02.003; Sakamoto K, 2002, J BIOL CHEM, V277, P29399, DOI 10.1074/jbc.M203727200; SAPPINO AP, 1988, INT J CANCER, V41, P707, DOI 10.1002/ijc.2910410512; Sarmento LM, 2005, J EXP MED, V202, P157, DOI 10.1084/jem.20050559; Shao H, 2011, ONCOGENE, V30, P4316, DOI 10.1038/onc.2011.142; Tanaka S, 2001, ONCOGENE, V20, P5525, DOI 10.1038/sj.onc.1204723; Ueno S, 2007, P NATL ACAD SCI USA, V104, P9685, DOI 10.1073/pnas.0702859104; Urs S, 2008, AM J PATHOL, V173, P865, DOI 10.2353/ajpath.2008.080006; Venkatachalam K, 2009, J BIOL CHEM, V284, P14414, DOI 10.1074/jbc.M809757200; Xu LF, 2000, GENE DEV, V14, P585; Zhou WL, 2007, NAT GENET, V39, P1225, DOI 10.1038/ng2112; Zhu HN, 2004, CANCER RES, V64, P7918, DOI 10.1158/0008-5472.CAN-04-2704	41	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2012	7	6							e38811	10.1371/journal.pone.0038811	http://dx.doi.org/10.1371/journal.pone.0038811			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TQ	22715413	Green Submitted, Green Published, gold			2022-12-27	WOS:000305336800055
J	Seo, J; Kim, SH; Kim, YT; Song, HJ; Lee, JJ; Kim, SH; Han, SW; Nam, EJ; Kim, SK; Lee, HJ; Lee, SJ; Chang, Y				Seo, Jeehye; Kim, Seong-Ho; Kim, Yang-Tae; Song, Hui-jin; Lee, Jae-jun; Kim, Sang-Hyon; Han, Seung Woo; Nam, Eon Jeong; Kim, Seong-Kyu; Lee, Hui Joong; Lee, Seung-Jae; Chang, Yongmin			Working Memory Impairment in Fibromyalgia Patients Associated with Altered Frontoparietal Memory Network	PLOS ONE			English	Article							PREFRONTAL CORTEX; BRAIN CONNECTIVITY; PAIN; DEPRESSION; FMRI; ABNORMALITIES; PERFORMANCE; THRESHOLD; IMPACT; MRI	Background: Fibromyalgia (FM) is a disorder characterized by chronic widespread pain and frequently associated with other symptoms. Patients with FM commonly report cognitive complaints, including memory problem. The objective of this study was to investigate the differences in neural correlates of working memory between FM patients and healthy subjects, using functional magnetic resonance imaging (MRI). Methodology/Principal Findings: Nineteen FM patients and 22 healthy subjects performed an n-back memory task during MRI scan. Functional MRI data were analyzed using within- and between-group analysis. Both activated and deactivated brain regions during n-back task were evaluated. In addition, to investigate the possible effect of depression and anxiety, group analysis was also performed with depression and anxiety level in terms of Beck depression inventory (BDI) and Beck anxiety inventory (BAI) as a covariate. Between-group analyses, after controlling for depression and anxiety level, revealed that within the working memory network, inferior parietal cortex was strongly associated with the mild (r = 0.309, P = 0.049) and moderate (r = 0.331, P = 0.034) pain ratings. In addition, between-group comparison revealed that within the working memory network, the left DLPFC, right VLPFC, and right inferior parietal cortex were associated with the rating of depression and anxiety? Conclusions/Significance: Our results suggest that the working memory deficit found in FM patients may be attributable to differences in neural activation of the frontoparietal memory network and may result from both pain itself and depression and anxiety associated with pain.	[Seo, Jeehye; Song, Hui-jin] Kyungpook Natl Univ, Dept Med & Biol Engn, Taegu, South Korea; [Kim, Seong-Ho] Haeundae Paik Hosp, Div Rheumatol, Inje Univ, Coll Med, Pusan, South Korea; [Kim, Yang-Tae] Keimyung Univ, Dept Psychiat, Sch Med, Taegu, South Korea; [Lee, Jae-jun] Korea Basic Sci Inst, Div Magnet Resonance, Cheongwon, Chungbuk, South Korea; [Kim, Sang-Hyon] Keimyung Univ, Dept Internal Med, Sch Med, Dong San Dong, Daegu, South Korea; [Han, Seung Woo] Daegu Fatima Hosp, Div Rheumatol, Dept Internal Med, Shin Am Dong, Daegu, South Korea; [Nam, Eon Jeong] Kyungpook Natl Univ, Dept Internal Med, Coll Med, Taegu, South Korea; [Kim, Seong-Kyu] Catholic Univ, Dept Internal Med, Arthrit & Autoimmun Res Ctr, Daegu Sch Med, Taegu, South Korea; [Lee, Hui Joong; Chang, Yongmin] Kyungpook Natl Univ, Dept Radiol, Coll Med, Taegu, South Korea; [Lee, Seung-Jae] Kyungpook Natl Univ, Dept Psychiat, Coll Med, Taegu, South Korea; [Chang, Yongmin] Kyungpook Natl Univ, Dept Mol Med, Coll Med, Taegu, South Korea	Kyungpook National University; Inje University; Keimyung University; Korea Basic Science Institute (KBSI); Keimyung University; Daegu Fatima Hospital; Kyungpook National University; Catholic University of Korea; Kyungpook National University; Kyungpook National University; Kyungpook National University	Seo, J (corresponding author), Kyungpook Natl Univ, Dept Med & Biol Engn, Taegu, South Korea.	ychang@knu.ac.kr	Han, Seungwoo/R-5326-2019		Korean Health Technology Research and Development Project, Ministry for Health, Welfare and Family Affairs, Republic of Korea [A092106]	Korean Health Technology Research and Development Project, Ministry for Health, Welfare and Family Affairs, Republic of Korea	This study was supported by a grant of the Korean Health Technology Research and Development Project, Ministry for Health, Welfare and Family Affairs, Republic of Korea (A092106). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold LM, 2008, PATIENT EDUC COUNS, V73, P114, DOI 10.1016/j.pec.2008.06.005; Baliki MN, 2008, J NEUROSCI, V28, P1398, DOI 10.1523/JNEUROSCI.4123-07.2008; Bangert AS, 2003, ARTHRITIS RHEUM, V48, pS90; Bennett RM, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-27; Braver TS, 1997, NEUROIMAGE, V5, P49, DOI 10.1006/nimg.1996.0247; Coghill RC, 1999, J NEUROPHYSIOL, V82, P1934, DOI 10.1152/jn.1999.82.4.1934; Cook DB, 2004, J RHEUMATOL, V31, P364; Dick BD, 2008, PAIN, V139, P610, DOI 10.1016/j.pain.2008.06.017; Drevets WC, 1998, ANNU REV MED, V49, P341, DOI 10.1146/annurev.med.49.1.341; EVANS AC, 1993, NUCLEAR SCIENCE SYMPOSIUM & MEDICAL IMAGING CONFERENCE, VOLS 1-3, P1813, DOI 10.1109/NSSMIC.1993.373602; Fox AS, 2010, J NEUROSCI, V30, P7023, DOI 10.1523/JNEUROSCI.5952-09.2010; Glass JM, 2008, J CLIN PSYCHIAT, V69, P20; Glass JM, 2009, RHEUM DIS CLIN N AM, V35, P299, DOI 10.1016/j.rdc.2009.06.002; Gracely RH, 2002, ARTHRITIS RHEUM-US, V46, P1333, DOI 10.1002/art.10225; Guedj E, 2008, J NUCL MED, V49, P1798, DOI 10.2967/jnumed.108.053264; Hampson M, 2010, MAGN RESON IMAGING, V28, P1051, DOI 10.1016/j.mri.2010.03.021; Hampson M, 2006, J NEUROSCI, V26, P13338, DOI 10.1523/JNEUROSCI.3408-06.2006; Harris Richard E, 2008, Ther Clin Risk Manag, V4, P1331; Harvey PO, 2005, NEUROIMAGE, V26, P860, DOI 10.1016/j.neuroimage.2005.02.048; Jo SA, 2007, INT J GERIATR PSYCH, V22, P218, DOI 10.1002/gps.1664; Kim YA, 2002, J KOREAN MED SCI, V17, P220, DOI 10.3346/jkms.2002.17.2.220; Kim ZS., 1997, KOREAN J CLIN PSYCHO, V16, P185; Koenigs M, 2009, BEHAV BRAIN RES, V201, P239, DOI 10.1016/j.bbr.2009.03.004; Kuchinad A, 2007, J NEUROSCI, V27, P4004, DOI 10.1523/JNEUROSCI.0098-07.2007; Leavitt F, 2006, J RHEUMATOL, V33, P127; Luerding R, 2008, BRAIN, V131, P3222, DOI 10.1093/brain/awn229; Lutz J, 2008, ARTHRITIS RHEUM-US, V58, P3960, DOI 10.1002/art.24070; Mathew SJ, 2004, AM J PSYCHIAT, V161, P1119, DOI 10.1176/appi.ajp.161.6.1119; Mease PJ, 2008, J RHEUMATOL, V35, P502; Meyer-Lindenberg A, 2008, NEUROIMAGE, V40, P655, DOI 10.1016/j.neuroimage.2007.11.058; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Napadow V, 2010, ARTHRITIS RHEUM-US, V62, P2545, DOI 10.1002/art.27497; Okifuji A, 1997, J RHEUMATOL, V24, P377; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Ravizza SM, 2004, NEUROIMAGE, V22, P562, DOI 10.1016/j.neuroimage.2004.01.039; Seidman LJ, 2006, SCHIZOPHR RES, V85, P58, DOI 10.1016/j.schres.2006.03.019; Tomasi D, 2006, HUM BRAIN MAPP, V27, P694, DOI 10.1002/hbm.20211; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Wagner G, 2006, BIOL PSYCHIAT, V59, P958, DOI 10.1016/j.biopsych.2005.10.025; Wang L, 2010, NEUROIMAGE, V51, P910, DOI 10.1016/j.neuroimage.2010.02.046; WOLFE F, 1995, J RHEUMATOL, V22, P151; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203; Zachrisson O, 2002, J PSYCHOSOM RES, V52, P501, DOI 10.1016/S0022-3999(01)00315-4	43	45	45	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2012	7	6							e37808	10.1371/journal.pone.0037808	http://dx.doi.org/10.1371/journal.pone.0037808			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TQ	22715371	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336800012
J	Tozzi, A; de Iure, A; Marsili, V; Romano, R; Tantucci, M; Di Filippo, M; Costa, C; Napolitano, F; Mercuri, NB; Borsini, F; Giampa, C; Fusco, FR; Picconi, B; Usiello, A; Calabresi, P				Tozzi, Alessandro; de Iure, Antonio; Marsili, Valentina; Romano, Rosaria; Tantucci, Michela; Di Filippo, Massimiliano; Costa, Cinzia; Napolitano, Francesco; Mercuri, Nicola Biagio; Borsini, Franco; Giampa, Carmen; Fusco, Francesca Romana; Picconi, Barbara; Usiello, Alessandro; Calabresi, Paolo			A2A Adenosine Receptor Antagonism Enhances Synaptic and Motor Effects of Cocaine via CB1 Cannabinoid Receptor Activation	PLOS ONE			English	Article							DOPAMINE D2 RECEPTORS; LONG-TERM DEPRESSION; MEDIUM SPINY NEURONS; CHOLINERGIC INTERNEURONS; BASAL GANGLIA; ENDOCANNABINOID RELEASE; NUCLEUS-ACCUMBENS; GENE-EXPRESSION; NEURAL BASIS; STRIATUM	Background: Cocaine increases the level of endogenous dopamine (DA) in the striatum by blocking the DA transporter. Endogenous DA modulates glutamatergic inputs to striatal neurons and this modulation influences motor activity. Since D2 DA and A2A-adenosine receptors (A2A-Rs) have antagonistic effects on striatal neurons, drugs targeting adenosine receptors such as caffeine-like compounds, could enhance psychomotor stimulant effects of cocaine. In this study, we analyzed the electrophysiological effects of cocaine and A2A-Rs antagonists in striatal slices and the motor effects produced by this pharmacological modulation in rodents. Principal Findings: Concomitant administration of cocaine and A2A-Rs antagonists reduced glutamatergic synaptic transmission in striatal spiny neurons while these drugs failed to produce this effect when given in isolation. This inhibitory effect was dependent on the activation of D2-like receptors and the release of endocannabinoids since it was prevented by L-sulpiride and reduced by a CB1 receptor antagonist. Combined application of cocaine and A2A-R antagonists also reduced the firing frequency of striatal cholinergic interneurons suggesting that changes in cholinergic tone might contribute to this synaptic modulation. Finally, A2A-Rs antagonists, in the presence of a sub-threshold dose of cocaine, enhanced locomotion and, in line with the electrophysiological experiments, this enhanced activity required activation of D2-like and CB1 receptors. Conclusions: The present study provides a possible synaptic mechanism explaining how caffeine-like compounds could enhance psychomotor stimulant effects of cocaine.	[Tozzi, Alessandro; de Iure, Antonio; Tantucci, Michela; Di Filippo, Massimiliano; Costa, Cinzia; Calabresi, Paolo] Univ Perugia, Neurol Clin, Osped S Maria della Misericordia, I-06100 Perugia, Italy; [Tozzi, Alessandro; de Iure, Antonio; Tantucci, Michela; Mercuri, Nicola Biagio; Giampa, Carmen; Fusco, Francesca Romana; Picconi, Barbara; Calabresi, Paolo] Fdn Santa Lucia IRCCS, Rome, Italy; [Marsili, Valentina; Romano, Rosaria; Napolitano, Francesco; Usiello, Alessandro] CEINGE Biotecnol Avanzate, Naples, Italy; [Borsini, Franco] Sigma Tau Ind Riunite, Pomezia, Italy; [Usiello, Alessandro] SUN, Naples, Italy	Hospital Santa Maria della Misericordia; University of Perugia; IRCCS Santa Lucia; CEINGE Biotecnologie Avanzate	Tozzi, A (corresponding author), Univ Perugia, Neurol Clin, Osped S Maria della Misericordia, I-06100 Perugia, Italy.	calabre@unipg.it	usiello, alessandro/B-2368-2012; Fusco, Francesca R/K-1080-2018; Costa, Cinzia/K-8485-2016; Picconi, Barbara/G-8299-2011; Tozzi, Alessandro/AAB-8707-2022; Calabresi, Paolo/G-8496-2011; Tozzi, Alessandro/G-7254-2011; Napolitano, Francesco/F-8691-2012; Mercuri, Nicola Biagio/K-5348-2016; de iure, Antonio/B-1084-2019	Fusco, Francesca R/0000-0003-2226-523X; Costa, Cinzia/0000-0002-4862-4221; Picconi, Barbara/0000-0001-6020-1021; Calabresi, Paolo/0000-0003-0326-5509; Mercuri, Nicola Biagio/0000-0001-6700-7491; Napolitano, Francesco/0000-0003-0884-1851; de iure, Antonio/0000-0002-7672-7068; Usiello, Alessandro/0000-0001-9203-853X; , Giampa/0000-0002-1763-5665; Tozzi, Alessandro/0000-0003-3153-2424	European Community (EC) [222918 (REPLACES)]; Italian Ministery of Health "Progetto Strategico 2007"; Italian Ministery of Health "Progetti Finalizzati 2006-2008"; Fondazione Cassa di Risparmio di Perugia; Progetti Finalizzati Multicentrici Programma Neuroscienze Compagnia di San Paolo; Bayer Schering; Biogen; Boehringer Ingelheim; Eisai; Novartis; Lundbeck; Sanofi-Aventis; Sigma-Tau; UCB Pharma; Ricerca Corrente IRCCS; Ricerca Finalizzata IRCCS; European Community [SYNSCAFF, REPLACES]; Italian Minister of Health and AIFA (Agenzia Italiana del Farmaco)	European Community (EC)(European CommissionEuropean Commission Joint Research Centre); Italian Ministery of Health "Progetto Strategico 2007"; Italian Ministery of Health "Progetti Finalizzati 2006-2008"; Fondazione Cassa di Risparmio di Perugia(Fondazione Cassa Risparmio Perugia); Progetti Finalizzati Multicentrici Programma Neuroscienze Compagnia di San Paolo(Compagnia di San Paolo); Bayer Schering(Bayer AG); Biogen(Biogen); Boehringer Ingelheim(Boehringer Ingelheim); Eisai(Eisai Co Ltd); Novartis(Novartis); Lundbeck(Lundbeck Corporation); Sanofi-Aventis(Sanofi-Aventis); Sigma-Tau; UCB Pharma(UCB Pharma SA); Ricerca Corrente IRCCS(Ministry of Health, ItalyMinistry of Health Italy - Ricerca Corrente (MOH-RC)); Ricerca Finalizzata IRCCS(Ministry of Health, ItalyMinistry of Health Italy - Ricerca Finalizzata (MOH-RF)); European Community(European Commission); Italian Minister of Health and AIFA (Agenzia Italiana del Farmaco)	This work was supported by grants from: European Community (EC) contract number 222918 (REPLACES) FP7 - Thematic priority HEALTH (PC), Italian Ministery of Health "Progetto Strategico 2007" (PC, BP), Italian Ministery of Health "Progetti Finalizzati 2006-2008" (PC, BP), Fondazione Cassa di Risparmio di Perugia (PC) and Progetti Finalizzati Multicentrici Programma Neuroscienze Compagnia di San Paolo (PC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Dr. Calabresi serves as an editorial board member of Lancet Neurology, the Journal of Neuroscience, Movement Disorders and Synapse; receives research support from Bayer Schering, Biogen, Boehringer Ingelheim, Eisai, Novartis, Lundbeck, Sanofi-Aventis, Sigma-Tau, and UCB Pharma; and from Ricerca Corrente IRCCS, Ricerca Finalizzata IRCCS [European Community Grants SYNSCAFF and REPLACES], the Italian Minister of Health and AIFA (Agenzia Italiana del Farmaco). Dr. Franco Borsini is employed by Sigma-tau Industrie Riunite, Pomezia, Italy. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. All other authors reported no biomedical financial interests or potential conflicts of interest.	ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; Alcantara AA, 2003, BRAIN RES, V986, P22, DOI 10.1016/S0006-8993(03)03165-2; Aliane V, 2011, BRAIN, V134, P110, DOI 10.1093/brain/awq285; Aliane V, 2009, EUR J NEUROSCI, V30, P1269, DOI 10.1111/j.1460-9568.2009.06907.x; AMALRIC M, 1993, PROG BRAIN RES, V99, P209; Bagetta V, 2011, J NEUROSCI IN PRESS, V31; BECKSTEAD RM, 1985, J COMP NEUROL, V232, P481, DOI 10.1002/cne.902320406; Bennett BD, 1998, J NEUROSCI, V18, P8539; Bennett BD, 1999, J NEUROSCI, V19, P5586; Berke JD, 2000, NEURON, V25, P515, DOI 10.1016/S0896-6273(00)81056-9; Bhide PG, 2009, SEMIN CELL DEV BIOL, V20, P395, DOI 10.1016/j.semcdb.2009.01.006; Bradberry CW, 2008, REV NEUROSCIENCE, V19, P113; Calabresi P, 1998, ANN NEUROL, V43, P586, DOI 10.1002/ana.410430506; CALABRESI P, 1992, J NEUROSCI, V12, P4224; Carey RJ, 2008, PROG BRAIN RES, V172, P347, DOI 10.1016/S0079-6123(08)00917-5; Centonze D, 2004, NEUROPSYCHOPHARMACOL, V29, P1488, DOI 10.1038/sj.npp.1300458; Cheer JF, 2007, J NEUROSCI, V27, P791, DOI 10.1523/JNEUROSCI.4152-06.2007; Costa C, 2008, J NEUROSCI, V28, P8040, DOI 10.1523/JNEUROSCI.1947-08.2008; DELONG MR, 1990, TRENDS NEUROSCI, V13, P281, DOI 10.1016/0166-2236(90)90110-V; Deng YP, 2006, J CHEM NEUROANAT, V32, P101, DOI 10.1016/j.jchemneu.2006.07.001; Ferre S, 1997, PSYCHOPHARMACOLOGY, V133, P107, DOI 10.1007/s002130050380; Ferre S, 2010, J ALZHEIMERS DIS, V20, pS35, DOI 10.3233/JAD-2010-1400; Ferre S, 2010, BRIT J PHARMACOL, V160, P443, DOI 10.1111/j.1476-5381.2010.00723.x; Ferre S, 2009, NEUROPHARMACOLOGY, V56, P226, DOI 10.1016/j.neuropharm.2008.06.076; Fisone G, 2004, CELL MOL LIFE SCI, V61, P857, DOI 10.1007/s00018-003-3269-3; Fuxe K., 2003, Neurology, V61, pS19; Fuxe K, 2007, PHYSIOL BEHAV, V92, P210, DOI 10.1016/j.physbeh.2007.05.034; Gerdeman GL, 2002, NAT NEUROSCI, V5, P446, DOI 10.1038/nn832; GERFEN CR, 1990, SCIENCE, V250, P1429, DOI 10.1126/science.2147780; Giuffrida A, 1999, NAT NEUROSCI, V2, P358, DOI 10.1038/7268; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Higley MJ, 2009, NAT NEUROSCI, V12, P1121, DOI 10.1038/nn.2368; Kalivas PW, 2005, AM J PSYCHIAT, V162, P1403, DOI 10.1176/appi.ajp.162.8.1403; Kalivas PW, 1998, J PSYCHOPHARMACOL, V12, P49, DOI 10.1177/026988119801200107; KAWAGUCHI Y, 1993, J NEUROSCI, V13, P4908; Kelley AE, 2002, J NEUROSCI, V22, P3306; Kreitzer AC, 2005, J NEUROSCI, V25, P10537, DOI 10.1523/JNEUROSCI.2959-05.2005; Lerner TN, 2010, J NEUROSCI, V30, P2160, DOI 10.1523/JNEUROSCI.5844-09.2010; Letchworth SR, 2001, J NEUROSCI, V21, P2799, DOI 10.1523/JNEUROSCI.21-08-02799.2001; Nader MA, 2006, NAT NEUROSCI, V9, P1050, DOI 10.1038/nn1737; Napolitano F, 2010, J NEUROSCI, V30, P11043, DOI 10.1523/JNEUROSCI.1682-10.2010; Penberthy Jennifer K, 2010, Curr Drug Abuse Rev, V3, P49; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; Porrino LJ, 2007, PROG NEURO-PSYCHOPH, V31, P1593, DOI 10.1016/j.pnpbp.2007.08.040; Riegel AC, 2004, J NEUROSCI, V24, P11070, DOI 10.1523/JNEUROSCI.3695-04.2004; RITZ MC, 1987, SCIENCE, V237, P1219, DOI 10.1126/science.2820058; RITZ MC, 1990, LIFE SCI, V46, P635, DOI 10.1016/0024-3205(90)90132-B; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; Roitman MF, 2008, NAT NEUROSCI, V11, P1376, DOI 10.1038/nn.2219; Schiffmann SN, 2007, PROG NEUROBIOL, V83, P277, DOI 10.1016/j.pneurobio.2007.05.001; Schwarzschild MA, 2006, TRENDS NEUROSCI, V29, P647, DOI 10.1016/j.tins.2006.09.004; Shen HY, 2008, J NEUROSCI, V28, P2970, DOI 10.1523/JNEUROSCI.5255-07.2008; Singla S, 2007, J NEUROSCI, V27, P5260, DOI 10.1523/JNEUROSCI.0018-07.2007; Song WJ, 2000, J NEUROPHYSIOL, V83, P322, DOI 10.1152/jn.2000.83.1.322; Svenningsson P, 2005, AAPS J, V7, DOI 10.1208/aapsj070235; Tozzi A, 2007, NEUROPHARMACOLOGY, V53, P783, DOI 10.1016/j.neuropharm.2007.08.006; Tozzi A, 2011, J NEUROSCI, V31, P1850, DOI 10.1523/JNEUROSCI.4082-10.2011; Wang ZF, 2006, NEURON, V50, P443, DOI 10.1016/j.neuron.2006.04.010; Yin HH, 2006, P NATL ACAD SCI USA, V103, P8251, DOI 10.1073/pnas.0510797103; Zhang Y, 2001, ANN NY ACAD SCI, V937, P93	60	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2012	7	6							e38312	10.1371/journal.pone.0038312	http://dx.doi.org/10.1371/journal.pone.0038312			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TQ	22715379	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336800020
J	Gianoli, E; Saldana, A; Jimenez-Castillo, M				Gianoli, Ernesto; Saldana, Alfredo; Jimenez-Castillo, Mylthon			Ecophysiological Traits May Explain the Abundance of Climbing Plant Species across the Light Gradient in a Temperate Rainforest	PLOS ONE			English	Article							TROPICAL FOREST; LARGE LIANAS; AVAILABILITY; SHADE; TREES; EVOLUTION; RESPONSES; PATTERNS; HISTORY; VINES	Climbing plants are a key component of rainforests, but mechanistic approaches to their distribution and abundance are scarce. In a southern temperate rainforest, we addressed whether the dominance of climbing plants across light environments is associated with the expression of ecophysiological traits. In mature forest and canopy gaps, we measured leaf size, specific leaf area, photosynthetic rate, and dark respiration in six of the most abundant woody vines. Mean values of traits and their phenotypic change (%) between mature forest and canopy gaps were predictor variables. Leaf size and specific leaf area were not significantly associated with climbing plant dominance. Variation in gas-exchange traits between mature forest and canopy gaps explained, at least partly, the dominance of climbers in this forest. A greater increase in photosynthetic rate and a lower increase in dark respiration rate when canopy openings occur were related to the success of climbing plant species. Dominant climbers showed a strategy of maximizing exploitation of resource availability but minimizing metabolic costs. Results may reflect phenotypic plasticity or genetic differentiation in ecophysiological traits between light environments. It is suggested that the dominant climbers in this temperate rainforest would be able to cope with forest clearings due to human activities.	[Gianoli, Ernesto] Univ La Serena, Dept Biol, La Serena, Chile; [Gianoli, Ernesto; Saldana, Alfredo] Univ Concepcion, Dept Bot, Concepcion, Chile; [Gianoli, Ernesto] Pontificia Univ Catolica Chile, Ctr Adv Studies Ecol & Biodivers, Santiago, Chile; [Jimenez-Castillo, Mylthon] Univ Austral Chile, Inst Ciencias Ambientales & Evolutivas, Valdivia, Chile	Universidad de La Serena; Universidad de Concepcion; Pontificia Universidad Catolica de Chile; Universidad Austral de Chile	Gianoli, E (corresponding author), Univ La Serena, Dept Biol, La Serena, Chile.	egianoli@userena.cl	Saldaña, Alfredo/C-8826-2011; Gianoli, Ernesto/A-7984-2015	Gianoli, Ernesto/0000-0003-4246-8640; Jimenez-Castillo, Mylthon/0000-0003-4328-3904; Saldana, Alfredo/0000-0001-5161-5150	FONDECYT-Chile (Fondo Nacional de Desarrollo Cientifico y Tecnologico) [1070503]	FONDECYT-Chile (Fondo Nacional de Desarrollo Cientifico y Tecnologico)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This study was funded by FONDECYT-Chile (Fondo Nacional de Desarrollo Cientifico y Tecnologico) grant number 1070503. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen BP, 2007, FOREST ECOL MANAG, V242, P17, DOI 10.1016/j.foreco.2007.01.027; Babyak MA, 2004, PSYCHOSOM MED, V66, P411, DOI 10.1097/01.psy.0000127692.23278.a9; Cai ZQ, 2007, ANN BOT-LONDON, V100, P831, DOI 10.1093/aob/mcm179; Carrasco-Urra F, 2009, J VEG SCI, V20, P1155, DOI 10.1111/j.1654-1103.2009.01115.x; CARTER GA, 1988, AM J BOT, V75, P1011, DOI 10.2307/2443769; Denslow JS, 1998, J ECOL, V86, P597, DOI 10.1046/j.1365-2745.1998.00295.x; Domingues TF, 2007, PLANT ECOL, V193, P101, DOI 10.1007/s11258-006-9251-z; Dorsch K., 2003, THESIS LUDWIG MAXIMI; Gentry A.H., 1991, BIOL VINES, P3; Gianoli E, 2004, P ROY SOC B-BIOL SCI, V271, P2011, DOI 10.1098/rspb.2004.2827; Gianoli E, 2010, J VEG SCI, V21, P66, DOI 10.1111/j.1654-1103.2009.01124.x; Gilbert B, 2006, ECOLOGY, V87, P1281, DOI 10.1890/0012-9658(2006)87[1281:LHTITT]2.0.CO;2; GIVNISH TJ, 1988, AUST J PLANT PHYSIOL, V15, P63, DOI 10.1071/PP9880063; Londre RA, 2006, ECOLOGY, V87, P2973, DOI 10.1890/0012-9658(2006)87[2973:TDOLAT]2.0.CO;2; Lusk CH, 2006, OIKOS, V112, P131, DOI 10.1111/j.0030-1299.2006.13922.x; Lusk CH, 2002, OECOLOGIA, V132, P188, DOI 10.1007/s00442-002-0974-9; Malhi Y, 2004, PHILOS T R SOC B, V359, P311, DOI 10.1098/rstb.2003.1433; Matesanz S, 2010, ANN NY ACAD SCI, V1206, P35, DOI 10.1111/j.1749-6632.2010.05704.x; Munoz AA, 2003, AUST J BOT, V51, P381, DOI 10.1071/BT02070; Phillips OL, 2005, ECOLOGY, V86, P1250, DOI 10.1890/04-1446; Phillips OL, 2002, NATURE, V418, P770, DOI 10.1038/nature00926; Poorter L, 1999, FUNCT ECOL, V13, P396, DOI 10.1046/j.1365-2435.1999.00332.x; PUTZ FE, 1984, ECOLOGY, V65, P1713, DOI 10.2307/1937767; Rowe N, 2005, NEW PHYTOL, V166, P61, DOI 10.1111/j.1469-8137.2004.01309.x; Saldana A, 2003, REV CHIL HIST NAT, V76, P639; Saldana A, 2005, OECOLOGIA, V145, P251, DOI 10.1007/s00442-005-0116-2; Schnitzer SA, 2002, TRENDS ECOL EVOL, V17, P223, DOI 10.1016/S0169-5347(02)02491-6; Schnitzer SA, 2005, AM NAT, V166, P262, DOI 10.1086/431250; Swaine MD, 2007, PLANT ECOL, V192, P271, DOI 10.1007/s11258-007-9319-4; Teramura A.H., 1991, PHYSL ECOLOGY MESIC, P245; Valladares F, 2000, ECOLOGY, V81, P1925, DOI 10.1890/0012-9658(2000)081[1925:PPRTLO]2.0.CO;2; Valladares F, 2008, ANNU REV ECOL EVOL S, V39, P237, DOI 10.1146/annurev.ecolsys.39.110707.173506; Valladares F, 2011, ANN BOT-LONDON, V108, P231, DOI 10.1093/aob/mcr132; van der Heijden GMF, 2008, GLOBAL ECOL BIOGEOGR, V17, P372, DOI 10.1111/j.1466-8238.2007.00376.x; van der Heijden GMF, 2008, J VEG SCI, V19, P747, DOI 10.3170/2008-8-18459; Wright SJ, 2004, ECOLOGY, V85, P484, DOI 10.1890/02-0757	36	21	23	3	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e38831	10.1371/journal.pone.0038831	http://dx.doi.org/10.1371/journal.pone.0038831			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685611	Green Published, Green Submitted, gold			2022-12-27	WOS:000305351700075
J	Arora, PK; Jain, RK				Arora, Pankaj Kumar; Jain, Rakesh Kumar			Metabolism of 2-Chloro-4-Nitrophenol in a Gram Negative Bacterium, Burkholderia sp RKJ 800	PLOS ONE			English	Article							CHLORINATED NITROAROMATIC COMPOUNDS; REDUCTIVE DECHLORINATION; DEGRADATION; PATHWAY; 4-CHLORO-2-NITROPHENOL; BIODEGRADATION; 4-CHLORONITROBENZENE; INVOLVEMENT	A 2-Chloro-4-nitrophenol (2C4NP) degrading bacterial strain designated as RKJ 800 was isolated from a pesticide contaminated site of India by enrichment method and utilized 2C4NP as sole source of carbon and energy. The stoichiometric amounts of nitrite and chloride ions were detected during the degradation of 2C4NP. On the basis of thin layer chromatography, high performance liquid chromatography and gas chromatography-mass spectrometry, chlorohydroquinone (CHQ) and hydroquinone (HQ) were identified as major metabolites of the degradation pathway of 2C4NP. Manganese dependent HQ dioxygenase activity was observed in the crude extract of 2C4NP induced cells of the strain RKJ 800 that suggested the cleavage of the HQ to gamma-hydroxymuconic semialdehyde. On the basis of the 16S rRNA gene sequencing, strain RKJ 800 was identified as a member of genus Burkholderia. Our studies clearly showed that Burkholderia sp. RKJ 800 degraded 2-chloro-4-nitrophenol via hydroquinone pathway. The pathway identified in a gram negative bacterium, Burkholderia sp. strain RKJ 800 was differed from previously reported 2C4NP degradation pathway in another gram-negative Burkholderia sp. SJ98. This is the first report of the formation of CHQ and HQ in the degradation of 2C4NP by any gram-negative bacteria. Laboratory-scale soil microcosm studies showed that strain RKJ 800 is a suitable candidate for bioremediation of 2C4NP contaminated sites.	[Arora, Pankaj Kumar; Jain, Rakesh Kumar] Inst Microbial Technol CSIR, Chandigarh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Arora, PK (corresponding author), Univ Hyderabad, Sch Life Sci, Dept Plant Sci, PO Cent Univ, Hyderabad 500134, Andhra Pradesh, India.	arora484@gmail.com	ARORA, PANKAJ K/F-9418-2014	ARORA, PANKAJ K/0000-0002-4106-8859				Arora PK, 2013, 3 BIOTECH, V3, P29, DOI 10.1007/s13205-012-0066-4; Arora PK, 2012, BIODEGRADATION, V23, P325, DOI 10.1007/s10532-011-9512-y; Arora PK, 2012, APPL MICROBIOL BIOT, V93, P2265, DOI 10.1007/s00253-012-3927-1; Arora PK, 2011, CURR MICROBIOL, V63, P568, DOI 10.1007/s00284-011-0022-2; Arora PK, 2011, INT J SYST EVOL MICR, V61, P1859, DOI 10.1099/ijs.0.023184-0; Arora PK, 2010, J BIOREMED BIODEGRAD, V1, P110; BEUNINK J, 1990, APPL MICROBIOL BIOT, V34, P108, DOI 10.1007/BF00170933; BRUHN C, 1988, ARCH MICROBIOL, V150, P171, DOI 10.1007/BF00425158; Ghosh A, 2010, ENVIRON SCI TECHNOL, V44, P1069, DOI 10.1021/es9034123; Hayatsu M, 2000, APPL ENVIRON MICROB, V66, P1737, DOI 10.1128/AEM.66.4.1737-1740.2000; Ju KS, 2010, MICROBIOL MOL BIOL R, V74, P250, DOI 10.1128/MMBR.00006-10; Katsivela E, 1999, APPL ENVIRON MICROB, V65, P1405; Kolvenbach BA, 2011, AMB EXPRESS, V1, DOI 10.1186/2191-0855-1-8; Li BZ, 2010, J ZHEJIANG UNIV-SC B, V11, P177, DOI 10.1631/jzus.B0900291; Miyauchi K, 1998, J BACTERIOL, V180, P1354, DOI 10.1128/JB.180.6.1354-1359.1998; Ohtsubo Y, 1999, FEBS LETT, V459, P395, DOI 10.1016/S0014-5793(99)01305-8; Pandey J, 2011, APPL MICROBIOL BIOT, V92, P597, DOI 10.1007/s00253-011-3254-y; Prakash D, 2011, APPL ENVIRON MICROB, V77, P6606, DOI 10.1128/AEM.00685-11; Reddy GVB, 1998, J BACTERIOL, V180, P5159, DOI 10.1128/JB.180.19.5159-5164.1998; Schenzle A, 1999, APPL ENVIRON MICROB, V65, P2317; SPAIN JC, 1991, APPL ENVIRON MICROB, V57, P812, DOI 10.1128/AEM.57.3.812-819.1991; Wu HZ, 2009, J ENVIRON SCI-CHINA, V21, P89, DOI 10.1016/S1001-0742(09)60016-4; Wu JF, 2006, APPL ENVIRON MICROB, V72, P1759, DOI 10.1128/AEM.72.3.1759-1765.2006; Zhen D, 2006, APPL MICROBIOL BIOT, V72, P797, DOI 10.1007/s00253-006-0345-2	24	38	38	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e38676	10.1371/journal.pone.0038676	http://dx.doi.org/10.1371/journal.pone.0038676			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701692	Green Submitted, gold, Green Published			2022-12-27	WOS:000305348400084
J	Gu, ML; Dong, XQ; Zhang, XZ; Wang, XM; Qi, Y; Yu, J; Niu, WQ				Gu, Mingliang; Dong, Xiaoqun; Zhang, Xuezhi; Wang, Xumin; Qi, Yue; Yu, Jun; Niu, Wenquan			Strong Association between Two Polymorphisms on 15q25.1 and Lung Cancer Risk: A Meta-Analysis	PLOS ONE			English	Article							SUSCEPTIBILITY LOCUS; GENETIC-VARIANTS; CHROMOSOME 15Q25; HETEROGENEITY; SNPS	Background: The association between polymorphisms on 15q25.1 and lung cancer has been widely evaluated; however, the studies have yielded contradictory results. We sought to investigate this inconsistency by performing a comprehensive meta-analysis on two polymorphisms (CHRNA3 gene: rs1051730 and AGPHD1 gene: rs8034191) on 15q25.1. Methods: Data were extracted from 15 and 14 studies on polymorphisms rs1051730 and rs8034191 involving 12301/14000 and 14075/12873 lung cancer cases/controls, respectively. The random-effects model was applied, addressing heterogeneity and publication bias. Results: The two polymorphisms followed Hardy-Weinberg equilibrium for all studies (P>0.05). For rs1051730-G/A, carriers of A allele had a 36% increased risk for lung cancer (95% confidence interval [CI]: 1.27-1.46; P<0.0005), without heterogeneity (P = 0.258) or publication bias (P-Egger = 0.462). For rs8034191-T/C, the allelic contrast indicated that C allele conferred a 23% increased risk for lung cancer (95% CI: 1.08-1.4; P = 0.002), with significant heterogeneity (P < 0.0005), without publication bias (P-Egger = 0.682). Subgroup analyses suggested that the between-study heterogeneity was derived from ethnicity, study design, matched information, and lung cancer subtypes. For example, the association of polymorphisms rs1051730 and rs8034191 with lung cancer was heterogeneous between Caucasians (OR = 1.32 and 1.22; 95% CI: 1.25-1.44 and 1.05-1.42; P < 0.0005 and 0.008, respectively) and East Asians (OR = 1.51 and 1.03; 95% CI: 0.76-3 and 0.47-2.27; P = 0.237 and 0.934, respectively) under the allelic model, and this association was relatively strengthened under the dominant model. There was no observable publication bias for both polymorphisms. Conclusions: Our findings demonstrated that CHRNA3 gene rs1051730-A allele and AGPHD1 gene rs8034191-T allele might be risk-conferring factors for the development of lung cancer in Caucasians, but not in East-Asians.	[Gu, Mingliang; Wang, Xumin; Yu, Jun] Chinese Acad Sci, Beijing Inst Genom, Beijing, Peoples R China; [Dong, Xiaoqun] Univ Rhode Isl, Coll Pharm, Dept Biomed & Pharmaceut Sci, Kingston, RI 02881 USA; [Gu, Mingliang; Wang, Xumin; Yu, Jun] Chinese Acad Sci, Key Lab Genome Sci & Informat, Beijing, Peoples R China; [Zhang, Xuezhi] China Petrochem Corp, Cent Hosp Shengli Oil Field, Clin Lab Biochem, Dongying, Shandong, Peoples R China; [Qi, Yue] Capital Med Univ, Dept Epidemiol, Beijing Inst Heart Lung & Blood Vessel Dis, Beijing Anzhen Hosp, Beijing, Peoples R China; [Niu, Wenquan] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, State Key Lab Med Genom, Shanghai 200030, Peoples R China	Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; University of Rhode Island; Chinese Academy of Sciences; Sinopec; Capital Medical University; Chinese Academy of Sciences; Shanghai Jiao Tong University	Gu, ML (corresponding author), Chinese Acad Sci, Beijing Inst Genom, Beijing, Peoples R China.	niuwenquan@yahoo.cn	wang, xumin/HII-8627-2022; Qi, Yue/HGT-8175-2022		Shanghai Rising Star Program [11QA1405500]; National Science Foundation for Young Scientists of China [30900808]	Shanghai Rising Star Program; National Science Foundation for Young Scientists of China	This work was supported by the Shanghai Rising Star Program (11QA1405500) and National Science Foundation for Young Scientists of China (30900808). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; Amos CI, 2010, J NATL CANCER I, V102, P1199, DOI 10.1093/jnci/djq232; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Biesalski HK, 1998, CA-CANCER J CLIN, V48, P167, DOI 10.3322/canjclin.48.3.167; Broderick P, 2009, CANCER RES, V69, P6633, DOI 10.1158/0008-5472.CAN-09-0680; Cohn LD, 2003, PSYCHOL METHODS, V8, P243, DOI 10.1037/1082-989X.8.3.243; Girard N, 2010, CLIN CANCER RES, V16, P755, DOI 10.1158/1078-0432.CCR-09-2437; Heller G, 2010, CANCER METAST REV, V29, P95, DOI 10.1007/s10555-010-9203-x; Hemminki K, 2006, NAT REV GENET, V7, P958, DOI 10.1038/nrg2009; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; Kohno T, 2011, J THORAC ONCOL, V6, P813, DOI 10.1097/JTO.0b013e3181ee80ef; Lau J, 2006, BMJ-BRIT MED J, V333, P597, DOI 10.1136/bmj.333.7568.597; Liu PY, 2008, JNCI-J NATL CANCER I, V100, P1326, DOI 10.1093/jnci/djn268; McClellan J, 2010, CELL, V141, P210, DOI 10.1016/j.cell.2010.03.032; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Ruano-Ravina A, 2008, GAC SANIT, V22, P609, DOI 10.1016/S0213-9111(08)75363-9; Sakoda LC, 2011, CANCER CAUSE CONTROL, V22, P449, DOI 10.1007/s10552-010-9716-1; Salanti G, 2005, GENET MED, V7, P13, DOI 10.1097/01.GIM.0000151839.12032.1A; Schwartz AG, 2009, J THORAC ONCOL, V4, P1195, DOI 10.1097/JTO.0b013e3181b244ef; Shibuya K, 2002, BMC CANCER, V2, DOI 10.1186/1471-2407-2-37; Shiraishi K, 2009, CARCINOGENESIS, V30, P65, DOI 10.1093/carcin/bgn257; Spitz Margaret R, 2008, J Natl Cancer Inst, V100, P1552, DOI 10.1093/jnci/djn363; Thakkinstian A, 2005, AM J EPIDEMIOL, V162, P201, DOI 10.1093/aje/kwi184; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Tseng RC, 2009, CANCER-AM CANCER SOC, V115, P2939, DOI 10.1002/cncr.24327; Wu C, 2009, CANCER RES, V69, P5065, DOI 10.1158/0008-5472.CAN-09-0081; Xu HY, 2005, HUM GENET, V116, P121, DOI 10.1007/s00439-004-1212-9; Yu K, 2010, EUR J HUM GENET, V18, P370, DOI 10.1038/ejhg.2009.131; Zienolddiny S, 2009, CARCINOGENESIS, V30, P1368, DOI 10.1093/carcin/bgp131	32	35	35	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e37970	10.1371/journal.pone.0037970	http://dx.doi.org/10.1371/journal.pone.0037970			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701590	Green Published, Green Submitted, gold			2022-12-27	WOS:000305348400027
J	Reamon-Buettner, SM; Borlak, J				Reamon-Buettner, Stella Marie; Borlak, Juergen			Dissecting Epigenetic Silencing Complexity in the Mouse Lung Cancer Suppressor Gene Cadm1	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; NUCLEOSOME-FREE REGIONS; HISTONE VARIANT H2A.Z; DNA METHYLATION; ADHESION MOLECULE; EUKARYOTIC GENOME; HUMAN-DISEASE; IN-VIVO; CHROMATIN; MARKS	Disease-oriented functional analysis of epigenetic factors and their regulatory mechanisms in aberrant silencing is a prerequisite for better diagnostics and therapy. Yet, the precise mechanisms are still unclear and complex, involving the interplay of several effectors including nucleosome positioning, DNA methylation, histone variants and histone modifications. We investigated the epigenetic silencing complexity in the tumor suppressor gene Cadm1 in mouse lung cancer progenitor cell lines, exhibiting promoter hypermethylation associated with transcriptional repression, but mostly unresponsive to demethylating drug treatments. After predicting nucleosome positions and transcription factor binding sites along the Cadm1 promoter, we carried out single-molecule mapping with DNA methyltransferase M. SssI, which revealed in silent promoters high nucleosome occupancy and occlusion of transcription factor binding sites. Furthermore, M. SssI maps of promoters varied within and among the different lung cancer cell lines. Chromatin analysis with micrococcal nuclease also indicated variations in nucleosome positioning to have implications in the binding of transcription factors near nucleosome borders. Chromatin immunoprecipitation showed that histone variants (H2A.Z and H3.3), and opposing histone modification marks (H3K4me3 and H3K27me3) all colocalized in the same nucleosome positions that is reminiscent of epigenetic plasticity in embryonic stem cells. Altogether, epigenetic silencing complexity in the promoter region of Cadm1 is not only defined by DNA hypermethylation, but high nucleosome occupancy, altered nucleosome positioning, and 'bivalent' histone modifications, also likely contributed in the transcriptional repression of this gene in the lung cancer cells. Our results will help define therapeutic intervention strategies using epigenetic drugs in lung cancer.	[Reamon-Buettner, Stella Marie; Borlak, Juergen] Fraunhofer Inst Toxicol & Expt Med, Hannover, Germany	Fraunhofer Gesellschaft	Reamon-Buettner, SM (corresponding author), Fraunhofer Inst Toxicol & Expt Med, Hannover, Germany.	reamon-buettner@item.fraunhofer.de			Ministry of Science and Culture, Lower Saxony, Germany [25A 5-7251-99/00]	Ministry of Science and Culture, Lower Saxony, Germany	This work was supported by the Ministry of Science and Culture, Lower Saxony, Germany 25A 5-7251-99/00. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of manuscript.	Andrews AJ, 2011, ANNU REV BIOPHYS, V40, P99, DOI 10.1146/annurev-biophys-042910-155329; Araki Y, 2009, IMMUNITY, V30, P912, DOI 10.1016/j.immuni.2009.05.006; Arya G, 2010, J BIOMOL STRUCT DYN, V27, P803, DOI 10.1080/07391102.2010.10508585; Bai L, 2010, TRENDS GENET, V26, P476, DOI 10.1016/j.tig.2010.08.003; Bapat SA, 2010, EPIGENETICS-US, V5, P716, DOI 10.4161/epi.5.8.13014; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bartke T, 2010, CELL, V143, P470, DOI 10.1016/j.cell.2010.10.012; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Carey Michael, 2007, CSH Protoc, V2007, DOI 10.1101/pdb.prot4890; Chi P, 2010, NAT REV CANCER, V10, P457, DOI 10.1038/nrc2876; Chodavarapu RK, 2010, NATURE, V466, P388, DOI 10.1038/nature09147; Choy JS, 2010, J AM CHEM SOC, V132, P1782, DOI 10.1021/ja910264z; Clark DJ, 2010, J BIOMOL STRUCT DYN, V27, P781, DOI 10.1080/073911010010524945; Conerly ML, 2010, GENOME RES, V20, P1383, DOI 10.1101/gr.106542.110; Creyghton MP, 2008, CELL, V135, P649, DOI 10.1016/j.cell.2008.09.056; Draker R, 2009, BIOCHEM CELL BIOL, V87, P19, DOI 10.1139/O08-117; Fatemi M, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni180; Felle M, 2011, NUCLEIC ACIDS RES, V39, P8355, DOI 10.1093/nar/gkr528; Field Y, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000216; Fullgrabe J, 2011, ONCOGENE, V30, P3391, DOI 10.1038/onc.2011.121; Gal-Yam EN, 2006, PLOS GENET, V2, P1451, DOI 10.1371/journal.pgen.0020160; Gaulton KJ, 2010, NAT GENET, V42, P255, DOI 10.1038/ng.530; Gevry N, 2009, GENE DEV, V23, P1522, DOI 10.1101/gad.1787109; Gomperts BN, 2011, SEMIN RESP CRIT CARE, V32, P32, DOI 10.1055/s-0031-1272867; Haring M, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-11; Henikoff S, 2009, NAT GENET, V41, P865, DOI 10.1038/ng0809-865; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Jiang X, 2008, CANCER CELL, V13, P529, DOI 10.1016/j.ccr.2008.04.019; Jin CY, 2009, NAT GENET, V41, P941, DOI 10.1038/ng.409; Jurkowska RZ, 2011, CHEMBIOCHEM, V12, P206, DOI 10.1002/cbic.201000195; Kaplan N, 2010, NAT STRUCT MOL BIOL, V17, P918, DOI 10.1038/nsmb0810-918; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; Kelly TK, 2010, MOL CELL, V39, P901, DOI 10.1016/j.molcel.2010.08.026; Kerkhoff E, 2000, CELL GROWTH DIFFER, V11, P185; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Liang QL, 2011, CANCER INVEST, V29, P107, DOI 10.3109/07357907.2010.543211; Lin JC, 2007, CANCER CELL, V12, P432, DOI 10.1016/j.ccr.2007.10.014; Marques M, 2010, EPIGENETICS-US, V5, P267, DOI 10.4161/epi.5.4.11520; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Murakami Y, 2005, CANCER SCI, V96, P543, DOI 10.1111/j.1349-7006.2005.00089.x; Muratovska A, 2003, ONCOGENE, V22, P7989, DOI 10.1038/sj.onc.1206766; Niehof M, 2005, MOL PHARMACOL, V67, P604, DOI 10.1124/mol.104.008672; Pan GJ, 2007, CELL STEM CELL, V1, P299, DOI 10.1016/j.stem.2007.08.003; Pondugula S, 2008, J CELL BIOCHEM, V105, P330, DOI 10.1002/jcb.21849; Portela A, 2010, NAT BIOTECHNOL, V28, P1057, DOI 10.1038/nbt.1685; Raisner RM, 2005, CELL, V123, P233, DOI 10.1016/j.cell.2005.10.002; Reamon-Buettner SM, 2008, CANCER RES, V68, P7587, DOI 10.1158/0008-5472.CAN-08-0967; Reka AK, 2011, LUNG CANCER, V72, P154, DOI 10.1016/j.lungcan.2011.01.019; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Rodriguez J, 2008, P NATL ACAD SCI USA, V105, P19809, DOI 10.1073/pnas.0810133105; Rodriguez-Paredes M, 2011, NAT MED, V17, P330, DOI 10.1038/nm.2305; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Segal E, 2009, TRENDS GENET, V25, P335, DOI 10.1016/j.tig.2009.06.002; Sharma S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001286; Sharma S, 2010, CARCINOGENESIS, V31, P27, DOI 10.1093/carcin/bgp220; Sikes ML, 2009, J IMMUNOL METHODS, V344, P58, DOI 10.1016/j.jim.2009.03.007; Steward Nicolas, 2004, Methods Mol Biol, V287, P65; Stolz RC, 2010, NUCLEIC ACIDS RES, V38, pW254, DOI 10.1093/nar/gkq496; Suganuma T, 2011, ANNU REV BIOCHEM, V80, P473, DOI 10.1146/annurev-biochem-061809-175347; Svotelis A, 2009, BIOCHEM CELL BIOL, V87, P179, DOI 10.1139/O08-138; Szenker E, 2011, CELL RES, V21, P421, DOI 10.1038/cr.2011.14; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Talbert PB, 2010, NAT REV MOL CELL BIO, V11, P264, DOI 10.1038/nrm2861; Thakar A, 2010, BIOCHEMISTRY-US, V49, P4018, DOI 10.1021/bi1001618; Thakar A, 2009, BIOCHEMISTRY-US, V48, P10852, DOI 10.1021/bi901129e; Weber CM, 2010, NAT STRUCT MOL BIOL, V17, P1500, DOI 10.1038/nsmb.1926; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Xi LQ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-346; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178; Yun MY, 2011, CELL RES, V21, P564, DOI 10.1038/cr.2011.42; Zemach A, 2010, SCIENCE, V328, P916, DOI 10.1126/science.1186366; Zhang Y, 2009, NAT STRUCT MOL BIOL, V16, P847, DOI 10.1038/nsmb.1636; Zhang ZH, 2011, SCIENCE, V332, P977, DOI 10.1126/science.1200508; Zhao XD, 2007, CELL STEM CELL, V1, P286, DOI 10.1016/j.stem.2007.08.004; Zilberman D, 2008, NATURE, V456, P125, DOI 10.1038/nature07324; Zlatanova J, 2008, STRUCTURE, V16, P166, DOI 10.1016/j.str.2007.12.008	77	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e38531	10.1371/journal.pone.0038531	http://dx.doi.org/10.1371/journal.pone.0038531			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701659	Green Published, gold, Green Submitted			2022-12-27	WOS:000305348400069
J	McBerry, C; Gonzalez, RMS; Shryock, N; Dias, A; Aliberti, J				McBerry, Cortez; Gonzalez, Rosa Maria Salazar; Shryock, Nathaniel; Dias, Alexandra; Aliberti, Julio			SOCS2-Induced Proteasome-Dependent TRAF6 Degradation: A Common Anti-Inflammatory Pathway for Control of Innate Immune Responses	PLOS ONE			English	Article							PLASMACYTOID DENDRITIC CELLS; LIPOXIN A(4); INDOLEAMINE 2,3-DIOXYGENASE; TOXOPLASMA-GONDII; MYCOBACTERIUM-TUBERCULOSIS; IL-12 PRODUCTION; DIOXIN RECEPTOR; EXPRESSION; INFECTION; INFLAMMATION	Pattern recognition receptors and receptors for pro-inflammatory cytokines provide critical signals to drive the development of protective immunity to infection. Therefore, counter-regulatory pathways are required to ensure that overwhelming inflammation harm host tissues. Previously, we showed that lipoxins modulate immune response during infection, restraining inflammation during infectious diseases in an Aryl hydrocarbon receptor (AhR)/suppressors of cytokine signaling (SOCS)2-dependent-manner. Recently, Indoleamine-pyrrole 2,3-dioxygenase (IDO)-derived tryptophan metabolites, including L-kynurenine, were also shown to be involved in several counter-regulatory mechanisms. Herein, we addressed whether the intracellular molecular events induced by lipoxins mediating control of innate immune signaling are part of a common regulatory pathway also shared by L-kynurenine exposure. We demonstrate that Tumor necrosis factor receptor-associated factor (TRAF)6 - member of a family of adapter molecules that couple the TNF receptor and interleukin-1 receptor/Toll-like receptor families to intracellular signaling events essential for the development of immune responses - is targeted by both lipoxins and L-kynurenine via an AhR/SOCS2-dependent pathway. Furthermore, we show that LXA(4)- and L-kynurenine-induced AhR activation, its subsequent nuclear translocation, leading SOCS2 expression and TRAF6 Lys47-linked poly-ubiquitination and proteosome-mediated degradation of the adapter proteins. The in vitro consequences of such molecular interactions included inhibition of TLR- and cytokine receptor-driven signal transduction and cytokine production. Subsequently, in vivo proteosome inhibition led to unresponsiveness to lipoxins, as well as to uncontrolled pro-inflammatory reactions and elevated mortality during toxoplasmosis. In summary, our results establish proteasome degradation of TRAF6 as a key molecular target for the anti-inflammatory pathway triggered by lipoxins and L-kynurenine, critical counter-regulatory mediators in the innate and adaptive immune systems.	[McBerry, Cortez] Cincinnati Childrens Hosp Med Ctr, Div Mol Immunol, Cincinnati, OH USA; Cincinnati Childrens Hosp Med Ctr, Div Pulm Med, Cincinnati, OH USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center	McBerry, C (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Mol Immunol, Cincinnati, OH USA.	julio.aliberti@cchmc.org	Aliberti, Julio/I-7354-2013; Aliberti, Julio/G-4565-2012	Aliberti, Julio/0000-0003-3420-8478; 	National Institutes of Health (NIH) [AI075038, AI078969]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI078969, R01AI075038] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The research results presented here were funded by National Institutes of Health (NIH) grants AI075038 and AI078969 and by a supplement for C.M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliberti J, 2002, NAT IMMUNOL, V3, P76, DOI 10.1038/ni745; Aliberti J, 2000, NAT IMMUNOL, V1, P83, DOI 10.1038/76957; Aliberti J, 2005, NAT REV IMMUNOL, V5, P162, DOI 10.1038/nri1547; Aliberti J, 2002, J EXP MED, V196, P1253, DOI 10.1084/jem.20021183; Anbanandam A, 2008, J MOL BIOL, V384, P219, DOI 10.1016/j.jmb.2008.09.021; Bafica A, 2005, J CLIN INVEST, V115, P1601, DOI 10.1172/JCI23949; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Bergander L, 2003, DRUG METAB DISPOS, V31, P233, DOI 10.1124/dmd.31.2.233; BERGHARD A, 1993, MOL CELL BIOL, V13, P677, DOI 10.1128/MCB.13.1.677; Boasso A, 2007, BLOOD, V109, P3351, DOI 10.1182/blood-2006-07-034785; Celik GE, 2007, CLIN EXP ALLERGY, V37, P1494, DOI 10.1111/j.1365-2222.2007.02806.x; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; DENIS M, 1988, BIOCHEM BIOPH RES CO, V155, P801, DOI 10.1016/S0006-291X(88)80566-7; Divanovic S, 2012, J INFECT DIS, V205, P152, DOI 10.1093/infdis/jir621; DURRIN LK, 1987, J CELL BIOCHEM, V35, P153, DOI 10.1002/jcb.240350208; Floto RA, 2006, SCIENCE, V314, P454, DOI 10.1126/science.1133515; Golding H, 2003, BLOOD, V102, P3280, DOI 10.1182/blood-2003-04-1096; Karp CL, 2004, NAT IMMUNOL, V5, P388, DOI 10.1038/ni1056; Khader SA, 2006, J EXP MED, V203, P1805, DOI 10.1084/jem.20052545; Kieran NE, 2004, KIDNEY INT, V65, P1145, DOI 10.1111/j.1523-1755.2004.00487.x; Machado FS, 2006, NAT MED, V12, P330, DOI 10.1038/nm1355; Mandi Y, 2012, J NEURAL TRANSM, V119, P197, DOI 10.1007/s00702-011-0681-y; Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457; Mezrich JD, J IMMUNOL, V185, P3190; Munn DH, 2004, J CLIN INVEST, V114, P280, DOI 10.1172/JCI200421583; Nguyen NT, P NATL ACAD SCI US, V107, P19961; Odemuyiwa SO, 2009, ALLERGY, V64, P488, DOI 10.1111/j.1398-9995.2008.01809.x; SAMUELSSON B, 1991, Z RHEUMATOL, V50, P3; Schaldach CM, 1999, BIOCHEMISTRY-US, V38, P7594, DOI 10.1021/bi982861e; Serhan CN, 2007, ANNU REV IMMUNOL, V25, P101, DOI 10.1146/annurev.immunol.25.022106.141647; Uyttenhove C, 2003, NAT MED, V9, P1269, DOI 10.1038/nm934; Van Dyke TE, 2003, J DENT RES, V82, P82, DOI 10.1177/154405910308200202; Wei YD, 1998, CHEM-BIOL INTERACT, V110, P39, DOI 10.1016/S0009-2797(97)00111-7; Willey JJ, 1998, TOXICOL APPL PHARM, V151, P33, DOI 10.1006/taap.1998.8444; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093	35	33	35	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e38384	10.1371/journal.pone.0038384	http://dx.doi.org/10.1371/journal.pone.0038384			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22693634	Green Published, Green Submitted, gold			2022-12-27	WOS:000305343900034
J	Unmack, PJ; Bagley, JC; Adams, M; Hammer, MP; Johnson, JB				Unmack, Peter J.; Bagley, Justin C.; Adams, Mark; Hammer, Michael P.; Johnson, Jerald B.			Molecular Phylogeny and Phylogeography of the Australian Freshwater Fish Genus Galaxiella, with an Emphasis on Dwarf Galaxias (G. pusilla)	PLOS ONE			English	Article							TELEOSTEI PERCICHTHYIDAE; MAXIMUM-LIKELIHOOD; STATISTICAL-METHOD; PISCES GALAXIIDAE; BASS BASIN; BIOGEOGRAPHY; VICARIANCE; EVOLUTION; RECONSTRUCTION; BIODIVERSITY	The freshwater fauna of Southern Australia is primarily restricted to the southwestern and southeastern corners of the continent, and is separated by a large, arid region that is inhospitable to this biota. This geographic phenomenon has attracted considerable interest from biogeographers looking to explain evolutionary diversification in this region. Here, we employed phylogenetic and phylogeographic approaches to evaluate the effect of this barrier on a group of four galaxiid fish species (Galaxiella) endemic to temperate Southern Australia. We also tested if continental shelf width has influenced connectivity among populations during low sea levels when rivers, now isolated, could have been connected. We addressed these questions by sampling each species across its range using multiple molecular markers (mitochondrial cytochrome b sequences, nuclear S7 intron sequences, and 49 allozyme loci). These data also allowed us to assess species boundaries, to refine phylogenetic affinities, and to estimate species ages. Interestingly, we found compelling evidence for cryptic species in G. pusilla, manifesting as allopatric eastern and western taxa. Our combined phylogeny and dating analysis point to an origin for the genus dating to the early Cenozoic, with three of the four species originating during the Oligocene-Miocene. Each Galaxiella species showed high levels of genetic divergences between all but the most proximate populations. Despite extensive drainage connections during recent low sea levels in southeastern Australia, populations of both species within G. pusilla maintained high levels of genetic structure. All populations experienced Late Pleistocene-Holocene population growth, possibly in response to the relaxation of arid conditions after the last glacial maximum. High levels of genetic divergence and the discovery of new cryptic species have important implications for the conservation of this already threatened group of freshwater species.	[Unmack, Peter J.] Natl Evolutionary Synth Ctr, Durham, NC USA; [Unmack, Peter J.; Bagley, Justin C.; Johnson, Jerald B.] Brigham Young Univ, Dept Biol, Evolutionary Ecol Labs, Provo, UT 84602 USA; [Adams, Mark; Hammer, Michael P.] S Australian Museum, Evolutionary Biol Unit, Adelaide, SA 5000, Australia; [Adams, Mark] Univ Adelaide, Sch Earth & Environm Sci, Australian Ctr Evolutionary Biol & Biodivers, Adelaide, SA, Australia; [Hammer, Michael P.] Museum & Art Gallery No Terr, Darwin, NT, Australia; [Johnson, Jerald B.] Brigham Young Univ, Monte L Bean Life Sci Museum, Provo, UT 84602 USA	The National Evolutionary Synthesis Center; Brigham Young University; University of Adelaide; Northern Territory Government; Brigham Young University	Unmack, PJ (corresponding author), Natl Evolutionary Synth Ctr, Durham, NC USA.	peter.pub@unmack.net	Unmack, Peter J./AAU-3023-2020; Bagley, Justin C./N-9654-2019; Bagley, Justin/D-3982-2011; Johnson, Jerald/AAN-5574-2020	Unmack, Peter J./0000-0003-1175-1152; Bagley, Justin C./0000-0001-6737-8380; Bagley, Justin/0000-0001-6737-8380; Hammer, Michael/0000-0002-0981-4647	National Evolutionary Synthesis Center (NESCent); NSF [EF-0905606]; Brigham Young University's Department of Biology	National Evolutionary Synthesis Center (NESCent)(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NSF(National Science Foundation (NSF)); Brigham Young University's Department of Biology	We thank the many people who helped with field work and other aspects relative to obtaining specimens, in particular C. Burridge, D. Galeotti, G. Knowles, T. Raadik, R. Remington. We also thank R. Arriagades, S. Beatty, D. Galeotti, E. Habit, J. Jackson, D. Morgan, D. Neely, T. Raadik and P. Victoriano for supplying collection records and/or specimens from their local jurisdictions. We thank E. White for help collecting sequence data, J. Heled for enabling us to complete our *BEAST analysis, C. Burridge for discussion of our dating results and other help, and R. Coleman for carefully reading our final draft. PJU was supported by the National Evolutionary Synthesis Center (NESCent) and NSF #EF-0905606; JCB received stipend support from Brigham Young University's Department of Biology.	Allen G.R., 2002, FIELD GUIDE FRESHWAT; ASFB, 2011, AUSTR SOC FISH BIOL, V41, P94; Backhouse G.N., 1978, Victorian Naturalist (Blackburn), V95, P128; Bagley JC, 2011, BIOL J LINN SOC, V104, P346, DOI 10.1111/j.1095-8312.2011.01720.x; BECK R G, 1985, South Australian Naturalist, V60, P12; Benbow M.C., 1995, GEOLOGY S AUSTR, V2, P208; BERRA T M, 1989, Records of the Western Australian Museum, V14, P293; BLOM WM, 1988, SEDIMENT GEOL, V60, P269, DOI 10.1016/0037-0738(88)90124-8; BLOM WM, 1988, SEARCH, V19, P94; Brown B, 2006, PALAEOGEOGR PALAEOCL, V231, P158, DOI 10.1016/j.palaeo.2005.07.033; Burns EL, 2006, MOL PHYLOGENET EVOL, V39, P573, DOI 10.1016/j.ympev.2005.11.017; Burridge CP, 2008, MOL BIOL EVOL, V25, P624, DOI 10.1093/molbev/msm271; Burridge CP, 2012, J BIOGEOGR, V39, P306, DOI 10.1111/j.1365-2699.2011.02600.x; Cadwallader PL, 1983, GUIDE FRESHWATER FIS; Chow S, 1998, FISHERIES SCI, V64, P397, DOI 10.2331/fishsci.64.397; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Coleman RA, 2010, CONSERV GENET, V11, P1911, DOI 10.1007/s10592-010-0082-z; CRANDALL KA, 1994, SYST BIOL, V43, P222, DOI 10.2307/2413463; Crisp MD, 2007, MOL PHYLOGENET EVOL, V43, P1106, DOI 10.1016/j.ympev.2007.02.030; Currey D.T., 1964, P R SOC VIC, V77, P377; DEGLIESPOSTI M, 1993, BIOCHIM BIOPHYS ACTA, V1143, P243, DOI 10.1016/0005-2728(93)90197-N; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; EIGENMANN CARL H., 1928, MEM NATION ACAD SCI U S A, V22, P1; ESRI, 1993, DIG CHART WORLD 1 1; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Frankham R., 2002, INTRO CONSERVATION G, DOI 10.1017/CBO9780511808999; Fu YX, 1997, GENETICS, V147, P915; Funk DJ, 2003, ANNU REV ECOL EVOL S, V34, P397, DOI 10.1146/annurev.ecolsys.34.011802.132421; Galeotti D. M., 2010, Journal of the Royal Society of Western Australia, V93, P13; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hammer MP, 2007, MAR FRESHWATER RES, V58, P327, DOI 10.1071/MF05258; Hammer MP, 2010, CONSERV GENET, V11, P213, DOI 10.1007/s10592-009-0024-9; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; HUMPHRIES P, 1986, Proceedings of the Royal Society of Victoria, V98, P133; IUCN, 2011, IUCN RED LIST THREAT, DOI [10.2305/IUCN.UK.2021-3.RLTS.T168474749A169378348.en, DOI 10.2305/IUCN.UK.2021-3.RLTS.T168474749A169378348.EN]; Jennings WB, 2003, SYST BIOL, V52, P757, DOI 10.1080/10635150390250974; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Katoh Kazutaka, 2010, Bioinformatics, V26, P1899, DOI 10.1093/bioinformatics/btq224; Knowles LL, 2002, MOL ECOL, V11, P2623, DOI 10.1046/j.1365-294X.2002.01637.x; Kumazawa Y, 1999, BIOL BIODIVERSITY, P35; Lawver LA, 2003, PALAEOGEOGR PALAEOCL, V198, P11, DOI 10.1016/S0031-0182(03)00392-4; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Littlejohn MJ, 1967, AUSTR INLAND WATERS, P150; Mack G., 1936, Memoirs of the National Museum Melbourne, V9, P98; Martin Helene A., 1998, Proceedings of the Linnean Society of New South Wales, V119, P115; MCDOWALL R M, 1973, Journal of the Royal Society of New Zealand, V3, P193; McDowall R.M., 1981, Records of the Australian Museum, V33, P443; MCDOWALL RM, 1978, J ROY SOC NEW ZEAL, V8, P115, DOI 10.1080/03036758.1978.10419420; McDowall RM, 2004, J ROY SOC NEW ZEAL, V34, P23, DOI 10.1080/03014223.2004.9517762; Miller M.A., 2010, P GAT COMP ENV WORKS; Morgan D.L., 1998, RECORDS W AUSTR MU S, V56, P1; Morgan MJ, 2007, MOL PHYLOGENET EVOL, V44, P371, DOI 10.1016/j.ympev.2006.12.009; Munasinghe DHN, 2004, BIOL J LINN SOC, V81, P553, DOI 10.1111/j.1095-8312.2003.00299.x; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; NEI M, 1974, GENETICS, V76, P379; PEN LJ, 1991, J FISH BIOL, V39, P717, DOI 10.1111/j.1095-8649.1991.tb04401.x; PEN LJ, 1993, J FISH BIOL, V43, P847, DOI 10.1111/j.1095-8649.1993.tb01160.x; Phillips N, 2007, EVOLUTIONARY S UNPUB; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; PUSEY BJ, 1990, AUST J MAR FRESH RES, V41, P721; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Richardson BJ, 1990, ALLOZYME ELECTROPHOR; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Saddlier S, 2010, NATL RECOVERY PLAN D; Schultz MB, 2008, MOL ECOL, V17, P5291, DOI 10.1111/j.1365-294X.2008.03996.x; Scott E. O. G., 1942, Records of the Queen Victoria Museum, V1, P51; SHIPWAY BRUCE, 1953, WEST AUSTRALIAN NAT, V3, P173; Smith Kimberly D., 2002, Records of the Western Australian Museum, V21, P285; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Suchard MA, 2001, MOL BIOL EVOL, V18, P1001, DOI 10.1093/oxfordjournals.molbev.a003872; Swofford DL., 2003, PAUP PHYLOGENETIC AN; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thacker CE, 2008, BIOL J LINN SOC, V95, P175, DOI 10.1111/j.1095-8312.2008.01000.x; Unmack PJ, 2011, SYST BIOL, V60, P797, DOI 10.1093/sysbio/syr042; Unmack PJ, 2001, J BIOGEOGR, V28, P1053, DOI 10.1046/j.1365-2699.2001.00615.x; Wallman JF, 2001, J FORENSIC SCI, V46, P681; Waters JM, 2000, SYST BIOL, V49, P777, DOI 10.1080/106351500750049824; Waters JM, 1999, MOL PHYLOGENET EVOL, V11, P1, DOI 10.1006/mpev.1998.0554; Waters JM, 2011, MOL ECOL, V20, P4388, DOI 10.1111/j.1365-294X.2011.05286.x; White S, 2003, GEOLOGY VICTORIA, P563	86	35	35	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e38433	10.1371/journal.pone.0038433	http://dx.doi.org/10.1371/journal.pone.0038433			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22693638	Green Submitted, gold, Green Published			2022-12-27	WOS:000305343900043
J	Bates, JG; Salzman, J; May, D; Garcia, PB; Hogan, GJ; McIntosh, M; Schlissel, MS; Brown, PO				Bates, Jamie G.; Salzman, Julia; May, Damon; Garcia, Patty B.; Hogan, Gregory J.; McIntosh, Martin; Schlissel, Mark S.; Brown, Pat O.			Extensive Gene-Specific Translational Reprogramming in a Model of B Cell Differentiation and Abl-Dependent Transformation	PLOS ONE			English	Article							CHRONIC MYELOGENOUS LEUKEMIA; BCR-ABL; PHILADELPHIA-CHROMOSOME; TYROSINE KINASE; HEMATOPOIETIC-CELLS; STATISTICAL-MODEL; INTEGRIN FUNCTION; MAMMALIAN TARGET; BINDING-PROTEIN; IN-VIVO	To what extent might the regulation of translation contribute to differentiation programs, or to the molecular pathogenesis of cancer? Pre-B cells transformed with the viral oncogene v-Abl are suspended in an immortalized, cycling state that mimics leukemias with a BCR-ABL1 translocation, such as Chronic Myelogenous Leukemia (CML) and Acute Lymphoblastic Leukemia (ALL). Inhibition of the oncogenic Abl kinase with imatinib reverses transformation, allowing progression to the next stage of B cell development. We employed a genome-wide polysome profiling assay called Gradient Encoding to investigate the extent and potential contribution of translational regulation to transformation and differentiation in v-Abl-transformed pre-B cells. Over half of the significantly translationally regulated genes did not change significantly at the level of mRNA abundance, revealing biology that might have been missed by measuring changes in transcript abundance alone. We found extensive, gene-specific changes in translation affecting genes with known roles in B cell signaling and differentiation, cancerous transformation, and cytoskeletal reorganization potentially affecting adhesion. These results highlight a major role for gene-specific translational regulation in remodeling the gene expression program in differentiation and malignant transformation.	[Bates, Jamie G.; Salzman, Julia; Hogan, Gregory J.; Brown, Pat O.] Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA; [Bates, Jamie G.; Salzman, Julia; Hogan, Gregory J.; Brown, Pat O.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [May, Damon; McIntosh, Martin] Fred Hutchinson Canc Res Ctr, Computat Prote Lab, Seattle, WA 98104 USA; [Garcia, Patty B.; Schlissel, Mark S.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	Stanford University; Howard Hughes Medical Institute; Stanford University; Fred Hutchinson Cancer Center; University of California System; University of California Berkeley	Bates, JG (corresponding author), Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA.	pbrown@stanford.edu		May, Damon/0000-0001-6902-3153	PHS by the National Cancer Institute DHHS [T32 CA09151]; National Cancer Institute [CA07797]; National Institutes of Health (NIH) [RO1CA111487, RO1HL48702, RO1CA150974]; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [R01CA111487, T32CA009151] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL048702] Funding Source: NIH RePORTER	PHS by the National Cancer Institute DHHS; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	JGB acknowledges PHS Grant Number T32 CA09151, awarded by the National Cancer Institute DHHS. POB acknowledges National Cancer Institute grant CA07797, National Institutes of Health (NIH) grant RO1CA111487, and the Howard Hughes Medical Institute. POB is an investigator of the Howard Hughes Medical Institute. MSS acknowledges NIH grants RO1HL48702 and RO1CA150974. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABELSON HT, 1970, CANCER RES, V30, P2213; An WG, 2000, CELL GROWTH DIFFER, V11, P355; Avni D, 1997, NUCLEIC ACIDS RES, V25, P995, DOI 10.1093/nar/25.5.995; Bassermann F, 2002, J BIOL CHEM, V277, P12437, DOI 10.1074/jbc.M112397200; Bazzoni G, 1996, J CLIN INVEST, V98, P521, DOI 10.1172/JCI118820; Bendall SC, 2008, MOL CELL PROTEOMICS, V7, P1587, DOI 10.1074/mcp.M800113-MCP200; Bhaskar PT, 2007, DEV CELL, V12, P487, DOI 10.1016/j.devcel.2007.03.020; CHEN YY, 1994, GENE DEV, V8, P688, DOI 10.1101/gad.8.6.688; Cousin H, 2008, DEV BIOL, V319, P86, DOI 10.1016/j.ydbio.2008.04.007; de Pooter RF, 2010, IMMUNOL REV, V238, P93, DOI 10.1111/j.1600-065X.2010.00957.x; Druker BJ, 1996, NAT MED, V2, P561, DOI 10.1038/nm0596-561; Druker BJ, 2008, BLOOD, V112, P4808, DOI 10.1182/blood-2008-07-077958; Duy C, 2010, J EXP MED, V207, P1209, DOI 10.1084/jem.20091299; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Feldhahn N, 2005, J EXP MED, V201, P1837, DOI 10.1084/jem.20042101; Fogal V, 2010, MOL CELL BIOL, V30, P1303, DOI 10.1128/MCB.01101-09; Geier JK, 2006, SEMIN IMMUNOL, V18, P31, DOI 10.1016/j.smim.2005.11.001; Gibbons James J, 2009, Semin Oncol, V36 Suppl 3, pS3, DOI 10.1053/j.seminoncol.2009.10.011; Goebel P, 2002, J IMMUNOL, V169, P2477, DOI 10.4049/jimmunol.169.5.2477; Gomez TS, 2008, ADV IMMUNOL, V97, P1, DOI 10.1016/S0065-2776(08)00001-1; Gorre ME, 2002, BLOOD, V100, P3041, DOI 10.1182/blood-2002-05-1361; Green M, 2009, LEUKEMIA RES, V33, P731, DOI 10.1016/j.leukres.2008.09.007; Hakansson P, 2004, EXP HEMATOL, V32, P476, DOI 10.1016/j.exphem.2004.02.012; Hamilton TL, 2006, BIOCHEM SOC T, V34, P12, DOI 10.1042/BST0340012; Han DK, 2001, NAT BIOTECHNOL, V19, P946, DOI 10.1038/nbt1001-946; Hendrickson DG, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000238; Hsieh AC, 2012, NATURE; Hsu LY, 2003, IMMUNITY, V19, P105, DOI 10.1016/S1074-7613(03)00181-X; Hu H, 2006, NAT IMMUNOL, V7, P819, DOI 10.1038/ni1358; Hu JS, 2008, FRONT BIOSCI-LANDMRK, V13, P7123, DOI 10.2741/3215; Iervolino A, 2002, MOL CELL BIOL, V22, P2255, DOI 10.1128/MCB.22.7.2255-2266.2002; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Janes MR, 2010, NAT MED, V16, P205, DOI 10.1038/nm.2091; Jin ZX, 2002, J IMMUNOL, V169, P3783, DOI 10.4049/jimmunol.169.7.3783; Jongen-Lavrencic M, 2005, LEUKEMIA, V19, P373, DOI 10.1038/sj.leu.2403626; KANTARJIAN HM, 1993, BLOOD, V82, P691; Kaul-Ghanekar R, 2004, NUCLEIC ACIDS RES, V32, P4862, DOI 10.1093/nar/gkh807; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Keller A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-552; Kim JH, 2005, BLOOD, V105, P1717, DOI 10.1182/blood-2004-03-0849; Klein F, 2004, J EXP MED, V199, P673, DOI 10.1084/jem.20031637; KLUG CA, 1994, GENE DEV, V8, P678, DOI 10.1101/gad.8.6.678; Krecic AM, 1999, CURR OPIN CELL BIOL, V11, P363, DOI 10.1016/S0955-0674(99)80051-9; Kurzrock R, 2003, ANN INTERN MED, V138, P819, DOI 10.7326/0003-4819-138-10-200305200-00010; Lazorchak AS, 2006, MOL CELL BIOL, V26, P810, DOI 10.1128/MCB.26.3.810-821.2006; Li YZ, 2007, J CELL SCI, V120, P1436, DOI 10.1242/jcs.03430; Lundell BI, 1996, BLOOD, V87, P2450, DOI 10.1182/blood.V87.6.2450.bloodjournal8762450; Lundell BI, 1997, LEUKEMIA, V11, P822, DOI 10.1038/sj.leu.2400653; Ly C, 2003, CANCER RES, V63, P5716; MacLean B, 2006, BIOINFORMATICS, V22, P2830, DOI 10.1093/bioinformatics/btl379; Madan V, 2009, BLOOD, V113, P1444, DOI 10.1182/blood-2008-02-142638; Mamane Y, 2006, ONCOGENE, V25, P6416, DOI 10.1038/sj.onc.1209888; May D, 2009, J PROTEOME RES, V8, P3212, DOI 10.1021/pr900169w; Mayne M, 2004, EUR J IMMUNOL, V34, P1217, DOI 10.1002/eji.200324726; Mcgee AM, 2011, BIOCHEM J, V433, P119, DOI 10.1042/BJ20101431; Meng XB, 2007, J PROTEOME RES, V6, P744, DOI 10.1021/pr060382t; Meric F, 2002, MOL CANCER THER, V1, P971; Miller SL, 2007, ONCOGENE, V26, P4668, DOI 10.1038/sj.onc.1210264; Miller SL, 2005, MOL ENDOCRINOL, V19, P939, DOI 10.1210/me.2004-0443; Muljo SA, 2003, NAT IMMUNOL, V4, P31, DOI 10.1038/ni870; Muto A, 1998, EMBO J, V17, P5734, DOI 10.1093/emboj/17.19.5734; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Nilsson J, 2004, EMBO REP, V5, P1137, DOI 10.1038/sj.embor.7400291; Notari M, 2006, BLOOD, V107, P2507, DOI 10.1182/blood-2005-09-3732; Nottrott S, 2006, NAT STRUCT MOL BIOL, V13, P1108, DOI 10.1038/nsmb1173; NOWELL PC, 1960, SCIENCE, V132, P1497; Ochiai K, 2006, J BIOL CHEM, V281, P38226, DOI 10.1074/jbc.M607592200; Ohya K, 1999, P NATL ACAD SCI USA, V96, P11976, DOI 10.1073/pnas.96.21.11976; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Perrotti D, 2004, ONCOGENE, V23, P3222, DOI 10.1038/sj.onc.1207543; Perrotti D, 2002, ONCOGENE, V21, P8577, DOI 10.1038/sj.onc.1206085; Prabhu S, 2007, ONCOGENE, V26, P1188, DOI 10.1038/sj.onc.1209901; Psatha MI, 2007, CELL CALCIUM, V41, P593, DOI 10.1016/j.ceca.2006.10.009; Raj L, 2011, NATURE, V475, P231, DOI 10.1038/nature10167; Renshaw MW, 1996, CURR BIOL, V6, P76, DOI 10.1016/S0960-9822(02)00424-4; ROSENBERG N, 1975, P NATL ACAD SCI USA, V72, P1932, DOI 10.1073/pnas.72.5.1932; ROWLEY JD, 1973, NATURE, V243, P290, DOI 10.1038/243290a0; Salesse S, 2002, ONCOGENE, V21, P8605, DOI 10.1038/sj.onc.1206088; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Schieke SM, 2006, J BIOL CHEM, V281, P27643, DOI 10.1074/jbc.M603536200; Schlissel MS, 2004, IMMUNOL REV, V200, P215, DOI 10.1111/j.0105-2896.2004.00157.x; SCHLISSEL MS, 1991, J EXP MED, V173, P711, DOI 10.1084/jem.173.3.711; Schwanhausser B, 2009, PROTEOMICS, V9, P205, DOI 10.1002/pmic.200800275; Seipel K, 2001, J CELL SCI, V114, P389; Sengupta A, 2010, BLOOD, V116, P81, DOI 10.1182/blood-2009-10-247437; Shaffer AL, 2000, IMMUNITY, V13, P199, DOI 10.1016/S1074-7613(00)00020-0; Shiotsu Y, 2000, BLOOD, V96, P2284, DOI 10.1182/blood.V96.6.2284; SHTIVELMAN E, 1985, NATURE, V315, P550, DOI 10.1038/315550a0; SKLAR MD, 1975, NATURE, V253, P550, DOI 10.1038/253550a0; SKORSKI T, 1995, BLOOD, V86, P726, DOI 10.1182/blood.V86.2.726.bloodjournal862726; Skorski T, 1998, P NATL ACAD SCI USA, V95, P11858, DOI 10.1073/pnas.95.20.11858; Skorski T, 1997, EMBO J, V16, P6151, DOI 10.1093/emboj/16.20.6151; Spaargaren M, 2003, J EXP MED, V198, P1539, DOI 10.1084/jem.20011866; Spencer S, 1997, J CELL BIOL, V138, P845, DOI 10.1083/jcb.138.4.845; Su IH, 2003, NAT IMMUNOL, V4, P124, DOI 10.1038/ni876; Svitkin YV, 1996, EMBO J, V15, P7147, DOI 10.1002/j.1460-2075.1996.tb01106.x; Trageser D, 2009, J EXP MED, V206, P1739, DOI 10.1084/jem.20090004; Tsai IC, 2007, DEV CELL, V12, P335, DOI 10.1016/j.devcel.2007.02.009; Wang Y, 2010, ONCOGENE, V29, P3044, DOI 10.1038/onc.2010.78; Wang ZR, 1999, MOL CELL BIOL, V19, P4552; Wang ZY, 1999, MOL CELL BIOL, V19, P284; Weisberg E, 2007, NAT REV CANCER, V7, P345, DOI 10.1038/nrc2126; Yap TA, 2011, CA-CANCER J CLIN, V61, P31, DOI 10.3322/caac.20095; Zhang M, 2008, MOL CELL BIOL, V28, P6496, DOI 10.1128/MCB.00477-08	105	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e37108	10.1371/journal.pone.0037108	http://dx.doi.org/10.1371/journal.pone.0037108			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693568	Green Submitted, Green Published, gold			2022-12-27	WOS:000305338500030
J	Choi, NM; Boss, JM				Choi, Nancy M.; Boss, Jeremy M.			Multiple Histone Methyl and Acetyltransferase Complex Components Bind the HLA-DRA Gene	PLOS ONE			English	Article							CLASS-II TRANSACTIVATOR; COOPERATIVE BINDING; COACTIVATORS P300; X-BOX; ACETYLATION; CIITA; TRANSCRIPTION; EXPRESSION; PROMOTERS; CREB	Major histocompatibility complex class II (MHC-II) genes are fundamental components that contribute to adaptive immune responses. While characterization of the chromatin features at the core promoter region of these genes has been studied, the scope of histone modifications and the modifying factors responsible for activation of these genes are less well defined. Using the MHC-II gene HLA-DRA as a model, the extent and distribution of major histone modifications associated with active expression were defined in interferon-c induced epithelial cells, B cells, and B-cell mutants for MHC-II expression. With active transcription, nucleosome density around the proximal regulatory region was diminished and histone acetylation and methylation modifications were distributed throughout the gene in distinct patterns that were dependent on the modification examined. Irrespective of the location, the majority of these modifications were dependent on the binding of either the X-box binding factor RFX or the class II transactivator (CIITA) to the proximal regulatory region. Importantly, once established, the modifications were stable through multiple cell divisions after the activating stimulus was removed, suggesting that activation of this system resulted in an epigenetic state. A dual crosslinking chromatin immunoprecipitation method was used to detect histone modifying protein components that interacted across the gene. Components of the MLL methyltransferase and GCN5 acetyltransferase complexes were identified. Some MLL complex components were found to be CIITA independent, including MLL1, ASH2L and RbBP5. Likewise, GCN5 containing acetyltransferase complex components belonging to the ATAC and STAGA complexes were also identified. These results suggest that multiple complexes are either used or are assembled as the gene is activated for expression. Together the results define and illustrate a complex network of histone modifying proteins and multisubunit complexes participating in MHC-II transcription.	[Choi, Nancy M.; Boss, Jeremy M.] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA	Emory University	Choi, NM (corresponding author), Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA.	jmboss@emory.edu			National Institutes of Health [GM47310, AI43000]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043000] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047310] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institutes of Health, GM47310 and AI43000. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACCOLLA RS, 1983, J EXP MED, V157, P1053, DOI 10.1084/jem.157.3.1053; ALLFREY VG, 1964, P NATL ACAD SCI USA, V51, P786, DOI 10.1073/pnas.51.5.786; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; BAXTERLOWE LA, 1989, J CLIN INVEST, V84, P613, DOI 10.1172/JCI114206; Beresford GW, 2001, NAT IMMUNOL, V2, P652, DOI 10.1038/89810; Briggs SD, 2001, GENE DEV, V15, P3286, DOI 10.1101/gad.940201; Brown JA, 1998, NUCLEIC ACIDS RES, V26, P4128, DOI 10.1093/nar/26.18.4128; BROWNELL JE, 1995, P NATL ACAD SCI USA, V92, P6364, DOI 10.1073/pnas.92.14.6364; CASPER JT, 1990, J PEDIATR-US, V116, P262, DOI 10.1016/S0022-3476(05)82885-9; Choi NM, 2010, CURRENT OPINION IMMU; Chou SD, 2008, MOL IMMUNOL, V45, P971, DOI 10.1016/j.molimm.2007.07.039; COLLINS T, 1984, P NATL ACAD SCI-BIOL, V81, P4917, DOI 10.1073/pnas.81.15.4917; Dou YL, 2005, CELL, V121, P873, DOI 10.1016/j.cell.2005.04.031; Eissenberg JC, 2010, DEV BIOL, V339, P240, DOI 10.1016/j.ydbio.2009.08.017; EPSTEIN MA, 1965, J NATL CANCER I, V34, P231, DOI 10.1093/jnci/34.2.231; Fontes JD, 1999, MOL CELL BIOL, V19, P941; Fossati A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017220; Gamper AM, 2009, MOL CELL BIOL, V29, P266, DOI 10.1128/MCB.00315-08; Gialitakis M, 2006, NUCLEIC ACIDS RES, V34, P765, DOI 10.1093/nar/gkj462; Gialitakis M, 2010, MOL CELL BIOL, V30, P2046, DOI 10.1128/MCB.00906-09; Gobin SJP, 1998, IMMUNITY, V9, P531, DOI 10.1016/S1074-7613(00)80636-6; Gomez JA, 2005, J IMMUNOL, V175, P1030, DOI 10.4049/jimmunol.175.2.1030; Govind CK, 2007, MOL CELL, V25, P31, DOI 10.1016/j.molcel.2006.11.020; Grant PA, 1999, J BIOL CHEM, V274, P5895, DOI 10.1074/jbc.274.9.5895; Guelman S, 2009, MOL CELL BIOL, V29, P1176, DOI 10.1128/MCB.01599-08; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Horwitz GA, 2008, SCIENCE, V321, P1084, DOI 10.1126/science.1155544; JACKSON V, 1978, CELL, V15, P945, DOI 10.1016/0092-8674(78)90278-7; Jin Q, 2010, EMBO J; Johnsson A, 2009, EMBO REP, V10, P1009, DOI 10.1038/embor.2009.127; KARA CJ, 1991, SCIENCE, V252, P709, DOI 10.1126/science.1902592; Kasper LH, 2010, EMBO J, V29, P3660, DOI 10.1038/emboj.2010.235; Koues OI, 2008, MOL CELL BIOL, V28, P5837, DOI 10.1128/MCB.00535-08; Koues OI, 2010, EPIGENET CHROMATIN, V3, DOI 10.1186/1756-8935-3-5; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Krebs AR, 2011, MOL CELL, V44, P410, DOI 10.1016/j.molcel.2011.08.037; Kretsovali A, 1998, MOL CELL BIOL, V18, P6777, DOI 10.1128/MCB.18.11.6777; Kuo MH, 1996, NATURE, V383, P269, DOI 10.1038/383269a0; Leimgruber E, 2009, NUCLEIC ACIDS RES, V37, P2514, DOI 10.1093/nar/gkp116; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lochamy J, 2007, MOL IMMUNOL, V44, P837, DOI 10.1016/j.molimm.2006.04.004; Masternak K, 2000, GENE DEV, V14, P1156; Masternak K, 2003, NAT IMMUNOL, V4, P132, DOI 10.1038/ni883; Miller T, 2001, P NATL ACAD SCI USA, V98, P12902, DOI 10.1073/pnas.231473398; Moreno CS, 1999, IMMUNITY, V10, P143, DOI 10.1016/S1074-7613(00)80015-1; MuhlethalerMOttet A, 1997, EMBO J, V16, P2851, DOI 10.1093/emboj/16.10.2851; NOCERA A, 1993, HUM IMMUNOL, V38, P231, DOI 10.1016/0198-8859(93)90547-E; Nowak DE, 2005, BIOTECHNIQUES, V39, P715, DOI 10.2144/000112014; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Patel A, 2011, J BIOL CHEM, V286, P3359, DOI 10.1074/jbc.M110.174524; Patel A, 2009, J BIOL CHEM, V284, P24242, DOI 10.1074/jbc.M109.014498; Reith W, 2005, NAT REV IMMUNOL, V5, P793, DOI 10.1038/nri1708; REITH W, 1994, J BIOL CHEM, V269, P20020; REITH W, 1994, P NATL ACAD SCI USA, V91, P554, DOI 10.1073/pnas.91.2.554; Reith W, 2001, ANNU REV IMMUNOL, V19, P331, DOI 10.1146/annurev.immunol.19.1.331; ROSENTHA.AS, 1973, J EXP MED, V138, P1194, DOI 10.1084/jem.138.5.1194; Rybtsova N, 2007, NUCLEIC ACIDS RES, V35, P3431, DOI 10.1093/nar/gkm214; Schiltz RL, 1999, J BIOL CHEM, V274, P1189, DOI 10.1074/jbc.274.3.1189; Sisk TJ, 2000, J IMMUNOL, V165, P2511, DOI 10.4049/jimmunol.165.5.2511; Spilianakis C, 2003, EMBO J, V22, P5125, DOI 10.1093/emboj/cdg496; Spilianakis C, 2000, MOL CELL BIOL, V20, P8489; STEIMLE V, 1993, CELL, V75, P135, DOI 10.1016/0092-8674(93)90685-J; Villard J, 1999, INT IMMUNOL, V11, P461, DOI 10.1093/intimm/11.3.461; WANG Y, 1987, J EXP MED, V166, P625, DOI 10.1084/jem.166.3.625; Wang YL, 2008, J BIOL CHEM, V283, P33808, DOI 10.1074/jbc.M806936200; Wang ZB, 2009, CURR OPIN GENET DEV, V19, P127, DOI 10.1016/j.gde.2009.02.001; Xu WT, 1998, MOL CELL BIOL, V18, P5659, DOI 10.1128/MCB.18.10.5659; Zika E, 2005, P NATL ACAD SCI USA, V102, P16321, DOI 10.1073/pnas.0505045102; Zsindely N, 2009, NUCLEIC ACIDS RES, V37, P6665, DOI 10.1093/nar/gkp722	69	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e37554	10.1371/journal.pone.0037554	http://dx.doi.org/10.1371/journal.pone.0037554			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22701520	Green Published, gold, Green Submitted			2022-12-27	WOS:000305338500042
J	Fu, LZ; Sun, GH; Fiorentino, M; Shi, YB				Fu, Liezhen; Sun, Guihong; Fiorentino, Maria; Shi, Yun-Bo			Characterization of Xenopus Tissue Inhibitor of Metalloproteinases-2: A Role in Regulating Matrix Metalloproteinase Activity during Development	PLOS ONE			English	Article							DUPLICATED MATRIX-METALLOPROTEINASE-9 GENES; IMPLICATES DISTINCT FUNCTIONS; HORMONE RESPONSE GENES; THYROID-HORMONE; AMPHIBIAN METAMORPHOSIS; TRANSCRIPTIONAL REGULATION; ANURAN METAMORPHOSIS; EXPRESSION PROFILES; STROMELYSIN-3 GENE; FROG METAMORPHOSIS	Background: Frog metamorphosis is totally dependent on thyroid hormone (T3) and mimics the postembryonic period around birth in mammals. It is an excellent model to study the molecular basis of postembryonic development in vertebrate. We and others have shown that many, if not all, matrix metalloproteinases (MMPs), which cleave proteins of the extracellular matrix as well as other substrates, are induced by T3 and important for metamorphosis. MMP activity can be inhibited by tissue inhibitors of metalloproteinase (TIMPs). There are 4 TIMPs in vertebrates and their roles in postembryonic development are poorly studied. Methodology/Principal Findings: We analyzed the TIMP2 genes in Xenopus laevis and the highly related species Xenopus tropicalis and discovered that TIMP2 is a single copy gene in Xenopus tropicalis as in mammals but is duplicated in Xenopus laevis. Furthermore, the TIMP2 locus in Xenopus tropicalis genome is different from that in human, suggesting an evolutionary reorganization of the locus. More importantly, we found that the duplicated TIMP2 genes were similarly regulated in the developing limb, remodeling intestine, resorbing tail during metamorphosis. Unexpectedly, like its MMP target genes, the TIMP2 genes were upregulated by T3 during both natural and T3-induced metamorphosis. Conclusions/Significance: Our results indicate that TIMP2 is highly conserved among vertebrates and that the TIMP2 locus underwent a chromosomal reorganization during evolution. Furthermore, the unexpected upregulation of TIMP2 genes during metamorphosis suggests that proper balance of MMP activity is important for metamorphosis.	[Fu, Liezhen; Sun, Guihong; Fiorentino, Maria; Shi, Yun-Bo] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Mol Morphogenesis, PCRM, NIH, Bethesda, MD USA; [Sun, Guihong] Wuhan Univ, Sch Med, Key Lab Allergy & Immune Related Dis, Wuhan 430072, Peoples R China; [Sun, Guihong] Wuhan Univ, Sch Med, Med Res Ctr, Wuhan 430072, Peoples R China	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Wuhan University; Wuhan University	Fu, LZ (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Mol Morphogenesis, PCRM, NIH, Bethesda, MD USA.	Shi@helix.nih.gov	Fiorentino, Maria/AAV-9514-2020	Fiorentino, Maria R/0000-0001-5318-7313; Shi, Yun-Bo/0000-0002-6330-0639	Intramural Research Program of National Institute of Child Health and Human Development, National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001901] Funding Source: NIH RePORTER	Intramural Research Program of National Institute of Child Health and Human Development, National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was supported by the Intramural Research Program of National Institute of Child Health and Human Development, National Institutes of Health. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander CM, 1991, CELL BIOL EXTRACELLU, P255; Amano T, 2005, CELL RES, V15, P150, DOI 10.1038/sj.cr.7290280; BARRETT J, 1998, HDB PROTEOLYTIC ENZY; Berry DL, 1998, DEV BIOL, V203, P12, DOI 10.1006/dbio.1998.8974; Berry DL, 1998, DEV BIOL, V203, P24, DOI 10.1006/dbio.1998.8975; BIRKEDALHANSEN H, 1993, CRIT REV ORAL BIOL M, V4, P197, DOI 10.1177/10454411930040020401; Bourboulia D, 2010, SEMIN CANCER BIOL, V20, P161, DOI 10.1016/j.semcancer.2010.05.002; Brew K, 2010, BBA-MOL CELL RES, V1803, P55, DOI 10.1016/j.bbamcr.2010.01.003; Buchholz DR, 2003, MOL CELL BIOL, V23, P6750, DOI 10.1128/MCB.23.19.6750-6758.2003; Buchholz DR, 2006, GEN COMP ENDOCR, V145, P1, DOI 10.1016/j.ygcen.2005.07.009; Damjanovski S, 1999, CELL RES, V9, P91, DOI 10.1038/sj.cr.7290009; Damjanovski S, 2000, FASEB J, V14, P503, DOI 10.1096/fasebj.14.3.503; Damjanovski S, 2001, DEV DYNAM, V221, P37, DOI 10.1002/dvdy.1123; Friedle H, 1998, EMBO J, V17, P2298, DOI 10.1093/emboj/17.8.2298; Frisch SM, 1997, CURR OPIN CELL BIOL, V9, P701, DOI 10.1016/S0955-0674(97)80124-X; Fu Liezhen, 2007, Organogenesis, V3, P14; Fu LZ, 2006, J BIOL CHEM, V281, P16870, DOI 10.1074/jbc.M603041200; Fu LZ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-81; Fu LZ, 2005, J BIOL CHEM, V280, P27856, DOI 10.1074/jbc.M413275200; Fujimoto K, 2006, DEV GROWTH DIFFER, V48, P223, DOI 10.1111/j.1440-169x.2006.00859.x; Fujimoto K, 2007, DEV GROWTH DIFFER, V49, P131, DOI 10.1111/j.1440-169x.2007.00916.x; Hammoud L, 2006, BIOCHEM CELL BIOL, V84, P167, DOI 10.1139/O05-175; Hasebe T, 2006, CELL TISSUE RES, V324, P105, DOI 10.1007/s00441-005-0099-7; Hasebe T, 2007, DEV DYNAM, V236, P2338, DOI 10.1002/dvdy.21252; Hasebe T, 2007, MECH DEVELOP, V124, P11, DOI 10.1016/j.mod.2006.09.001; Ishizuya-Oka A, 2000, J CELL BIOL, V150, P1177, DOI 10.1083/jcb.150.5.1177; IshizuyaOka A, 1996, CELL TISSUE RES, V283, P325, DOI 10.1007/s004410050542; Jung JC, 2002, DEV DYNAM, V223, P402, DOI 10.1002/dvdy.10069; Li JW, 1998, NUCLEIC ACIDS RES, V26, P3018, DOI 10.1093/nar/26.12.3018; McCawley LJ, 2001, CURR OPIN CELL BIOL, V13, P534, DOI 10.1016/S0955-0674(00)00248-9; Mott JD, 2004, CURR OPIN CELL BIOL, V16, P558, DOI 10.1016/j.ceb.2004.07.010; Murphy G, 1999, APMIS, V107, P38, DOI 10.1111/j.1699-0463.1999.tb01524.x; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; Nagase H, 1998, Cell Res, V8, P179; Noel A, 2000, ONCOGENE, V19, P1605, DOI 10.1038/sj.onc.1203465; Oofusa K, 1996, ROUX ARCH DEV BIOL, V205, P243, DOI 10.1007/BF00365802; OOFUSA K, 1994, INT J DEV BIOL, V38, P345; Overall CM, 2002, MOL BIOTECHNOL, V22, P51, DOI 10.1385/MB:22:1:051; PATTERTON D, 1995, DEV BIOL, V167, P252, DOI 10.1006/dbio.1995.1021; Sato H, 1996, J BIOCHEM-TOKYO, V119, P209; Seiki M, 1999, APMIS, V107, P137, DOI 10.1111/j.1699-0463.1999.tb01536.x; Shi Y.-B., 1999, AMPHIBIAN METAMORPHO; Shi YB, 2001, CELL RES, V11, P245, DOI 10.1038/sj.cr.7290093; Shi YB, 1998, INT J MOL MED, V2, P273; SHI YB, 1993, J BIOL CHEM, V268, P20312; SHI YB, 1994, BBA-GENE STRUCT EXPR, V1217, P227, DOI 10.1016/0167-4781(94)90042-6; Shi YB, 2009, THYROID, V19, P987, DOI 10.1089/thy.2009.0041; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Stetler-Stevenson WG, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.127re6; Stolow MA, 1996, MOL BIOL CELL, V7, P1471, DOI 10.1091/mbc.7.10.1471; VANWART HE, 1990, P NATL ACAD SCI USA, V87, P5578, DOI 10.1073/pnas.87.14.5578; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Walsh LA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001000; WANG Z, 1993, J BIOL CHEM, V268, P16270; Werb Z, 1996, KIDNEY INT, V49, pS68; Woessner JF, 2004, HDB PROTEOLYTIC ENZY; Zhou ZJ, 2000, P NATL ACAD SCI USA, V97, P4052, DOI 10.1073/pnas.060037197	57	4	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e36707	10.1371/journal.pone.0036707	http://dx.doi.org/10.1371/journal.pone.0036707			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693555	Green Published, gold, Green Submitted			2022-12-27	WOS:000305338500016
J	Shirtcliffe, NJ; McHale, G; Newton, MI				Shirtcliffe, Neil J.; McHale, Glen; Newton, Michael I.			Wet Adhesion and Adhesive Locomotion of Snails on Anti-Adhesive Non-Wetting Surfaces	PLOS ONE			English	Article							GASTROPOD PEDAL MUCUS; CONTACT-ANGLE	Creating surfaces capable of resisting liquid-mediated adhesion is extremely difficult due to the strong capillary forces that exist between surfaces. Land snails use this to adhere to and traverse across almost any type of solid surface of any orientation (horizontal, vertical or inverted), texture (smooth, rough or granular) or wetting property (hydrophilic or hydrophobic) via a layer of mucus. However, the wetting properties that enable snails to generate strong temporary attachment and the effectiveness of this adhesive locomotion on modern super-slippy superhydrophobic surfaces are unclear. Here we report that snail adhesion overcomes a wide range of these microscale and nanoscale topographically structured non-stick surfaces. For the one surface which we found to be snail resistant, we show that the effect is correlated with the wetting response of the surface to a weak surfactant. Our results elucidate some critical wetting factors for the design of anti-adhesive and bio-adhesion resistant surfaces.	[Shirtcliffe, Neil J.; McHale, Glen; Newton, Michael I.] Nottingham Trent Univ, Sch Sci & Technol, Nottingham, England	Nottingham Trent University	Shirtcliffe, NJ (corresponding author), Hsch Rhein Waal, Fac Technol & Bion, Kleve, Germany.	Neil.Shirtcliffe@hochschule-rhein-waal.de	Shirtcliffe, Neil J/A-3846-2008; Shirtcliffe, Neil/K-7724-2017; Newton, Michael I/B-8866-2008; McHale, Glen/B-6397-2016	Shirtcliffe, Neil J/0000-0003-3877-3474; Shirtcliffe, Neil/0000-0003-3877-3474; Newton, Michael I/0000-0003-4231-1002; McHale, Glen/0000-0002-8519-7986	EPSRC (Engineering and Physical Sciences Research Council) [EP/E063489/1]; EPSRC [EP/E063489/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/E063489/1] Funding Source: researchfish	EPSRC (Engineering and Physical Sciences Research Council)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	Funded by EPSRC (Engineering and Physical Sciences Research Council) platform grant EP/E063489/1 Exploiting the Solid-Liquid Interface (http://gow.epsrc.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson A. W., 1967, PHYS CHEM SURFACES; Chan B, 2005, PHYS FLUIDS, V17, DOI 10.1063/1.2102927; Chan B, 2007, J INTEL MAT SYST STR, V18, P111, DOI 10.1177/1045389X06063464; Chang FM, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2779092; De Souza EJ, 2008, LANGMUIR, V24, P1391, DOI 10.1021/la702188t; DENNY M, 1980, NATURE, V285, P160, DOI 10.1038/285160a0; DENNY M, 1980, SCIENCE, V208, P1288, DOI 10.1126/science.208.4449.1288; DENNY MW, 1981, J EXP BIOL, V91, P195; DUSSAN EB, 1983, J FLUID MECH, V137, P1, DOI 10.1017/S002211208300227X; Ewoldt RH, 2007, SOFT MATTER, V3, P634, DOI 10.1039/b615546d; Ewoldt RH, 2009, INTEGR COMP BIOL, V49, P40, DOI 10.1093/icb/icp010; Ferrari M, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2226771; Ferrari M, 2010, ADV COLLOID INTERFAC, V161, P22, DOI 10.1016/j.cis.2010.09.002; Gao LC, 2008, LANGMUIR, V24, P9183, DOI 10.1021/la8014578; GOOD RJ, 1992, J ADHES SCI TECHNOL, V6, P1269, DOI 10.1163/156856192X00629; Kobayashi A, 2003, TRIBOLOGICAL RESEARCH AND DESIGN FOR ENGINEERING SYSTEMS, P429; MCFARLANE JS, 1950, PROC R SOC LON SER-A, V202, P224, DOI 10.1098/rspa.1950.0096; Mohammadi R, 2004, LANGMUIR, V20, P9657, DOI 10.1021/la049268k; Pawlicki JM, 2004, J EXP BIOL, V207, P1127, DOI 10.1242/jeb.00859; Quere D, 2003, NANOTECHNOLOGY, V14, P1109, DOI 10.1088/0957-4484/14/10/307; Roach P, 2008, SOFT MATTER, V4, P224, DOI 10.1039/b712575p; Shirtcliffe NJ, 2007, MATER CHEM PHYS, V103, P112, DOI 10.1016/j.matchemphys.2007.01.018; Shirtcliffe NJ, 2011, J POLYM SCI POL PHYS, V49, P1203, DOI 10.1002/polb.22286; Smith AM, 2002, BIOL BULL-US, V203, P338, DOI 10.2307/1543576; 't Mannetje DJCM, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3533362	25	17	19	7	99	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e36983	10.1371/journal.pone.0036983	http://dx.doi.org/10.1371/journal.pone.0036983			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693563	gold, Green Submitted, Green Accepted, Green Published			2022-12-27	WOS:000305338500025
J	Vidal-Petiot, E; Cheval, L; Faugeroux, J; Malard, T; Doucet, A; Jeunemaitre, X; Hadchouel, J				Vidal-Petiot, Emmanuelle; Cheval, Lydie; Faugeroux, Julie; Malard, Thierry; Doucet, Alain; Jeunemaitre, Xavier; Hadchouel, Juliette			A New Methodology for Quantification of Alternatively Spliced Exons Reveals a Highly Tissue-Specific Expression Pattern of WNK1 Isoforms	PLOS ONE			English	Article							PROTEIN-KINASE; GENE-EXPRESSION; BLOOD-PRESSURE; HUMAN BREAST; MUTATIONS; KIDNEY; HYPERTENSION; SCREEN; PCR	Mutations in the WNK1 gene, encoding a serine-threonine kinase of the WNK (With No lysine (K)) family, have been implicated in two rare human diseases, Familial Hyperkalemic Hypertension (FHHt) and Hereditary Sensory and Autonomic Neuropathy type 2 (HSAN2). Alternative promoters give rise to a ubiquitous isoform, L-WNK1, and a kidney-specific isoform, KS-WNK1. Several other isoforms are generated through alternative splicing of exons 9, 11 and 12 but their precise tissue distribution is not known. Two additional exons, 8b and HSN2, involved in HSAN2, are thought to be specifically expressed in the nervous system. The purpose of this study was to establish an exhaustive description of all WNK1 isoforms and to quantify their relative level of expression in a panel of human and mouse tissues and in mouse nephron segments. For the latter purpose, we developed a new methodology allowing the determination of the proportions of the different isoforms generated by alternative splicing. Our results evidenced a striking tissue-specific distribution of the different isoforms and the unexpected presence of exon HSN2 in many tissues other than the nervous system. We also found exon 26 to be alternatively spliced in human and identified two new exons, 26a and 26b, within intron 26, specifically expressed in nervous tissues both in humans and mice. WNK1 should therefore no longer be designated as a 28-but as a 32-exon gene, with 8 of them - 8b, HSN2, 9, 11, 12, 26, 26a and 26b - alternatively spliced in a tissue-specific manner. These tissue-specific isoforms must be considered when studying the different roles of this ubiquitous kinase.	[Vidal-Petiot, Emmanuelle; Faugeroux, Julie; Jeunemaitre, Xavier; Hadchouel, Juliette] INSERM UMR970 Paris Cardiovasc Res Ctr Paris, Paris, France; [Vidal-Petiot, Emmanuelle; Cheval, Lydie; Faugeroux, Julie; Doucet, Alain; Jeunemaitre, Xavier; Hadchouel, Juliette] Univ Paris 05, Fac Med, Paris, France; [Cheval, Lydie; Doucet, Alain] Univ Paris 06, F-75252 Paris 05, France; [Cheval, Lydie; Doucet, Alain] INSERM UMRS 872, Paris, France; [Cheval, Lydie; Doucet, Alain] CNRS ERL726 Cordeliers Res Ctr Paris, Paris, France; [Malard, Thierry] CNRS, LCTS, UMR5801, Pessac, France; [Jeunemaitre, Xavier] Hop Europeen Georges Pompidou, AP HP, Dept Genet, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite de Bordeaux; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite	Vidal-Petiot, E (corresponding author), INSERM UMR970 Paris Cardiovasc Res Ctr Paris, Paris, France.	juliette.hadchouel@inserm.fr	JEUNEMAITRE, Xavier/AAQ-4853-2021; Hadchouel, Juliette/K-4593-2016	JEUNEMAITRE, Xavier/0000-0001-5925-381X; CHEVAL, LYDIE/0000-0003-2957-6487; Vidal-Petiot, Emmanuelle/0000-0001-9356-7302	INSERM the European Community [HEALTH-F2-2007-201590]; Fondation Leducq Transatlantic Network on Hypertension; Agence Nationale pour la Recherche [ANR-05-MRAR-010-01]	INSERM the European Community; Fondation Leducq Transatlantic Network on Hypertension(Leducq Foundation); Agence Nationale pour la Recherche(French National Research Agency (ANR))	This work was supported by INSERM the European Community's 7th Framework Program (HEALTH-F2-2007-201590, EUNEFRON program), the Fondation Leducq Transatlantic Network on Hypertension, and the Agence Nationale pour la Recherche (ANR-05-MRAR-010-01). E.V-P. was a recipient of a "Poste d'accueil Inserm". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergaya S, 2011, HYPERTENSION; Boutros M, 2004, SCIENCE, V303, P832, DOI 10.1126/science.1091266; Cheval L, 2011, PHYSIOL GENOMICS, V43, P161, DOI 10.1152/physiolgenomics.00093.2010; Choate KA, 2003, P NATL ACAD SCI USA, V100, P663, DOI 10.1073/pnas.242728499; Cruz-Rangel S, 2011, AM J PHYSIOL-CELL PH, V301, pC601, DOI 10.1152/ajpcell.00070.2011; Delaloy C, 2003, MOL CELL BIOL, V23, P9208, DOI 10.1128/MCB.23.24.9208-9221.2003; Delaloy C, 2006, AM J PATHOL, V169, P105, DOI 10.2353/ajpath.2006.051290; Fleige S, 2006, BIOTECHNOL LETT, V28, P1601, DOI 10.1007/s10529-006-9127-2; FRIEDMAN PA, 1995, KIDNEY INT, V48, P1427, DOI 10.1038/ki.1995.432; Glover M, 2009, J AM SOC NEPHROL, V20, P1314, DOI 10.1681/ASN.2008050542; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Kahle KT, 2008, ANNU REV PHYSIOL, V70, P329, DOI 10.1146/annurev.physiol.70.113006.100651; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McCormick JA, 2011, PHYSIOL REV, V91, P177, DOI 10.1152/physrev.00017.2010; Min XS, 2004, STRUCTURE, V12, P1303, DOI 10.1016/j.str.2004.04.014; Morla L, 2008, J BIOL CHEM, V283, P28020, DOI 10.1074/jbc.M804399200; Nissant A, 2004, AM J PHYSIOL-RENAL, V287, pF1233, DOI 10.1152/ajprenal.00155.2004; O'Reilly M, 2003, J AM SOC NEPHROL, V14, P2447, DOI 10.1097/01.ASN.0000089830.97681.3B; Picard N, 2008, J BIOL CHEM, V283, P4602, DOI 10.1074/jbc.M705664200; Shekarabi M, 2008, J CLIN INVEST, V118, P2496, DOI 10.1172/JCI34088; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Stephens P, 2005, NAT GENET, V37, P590, DOI 10.1038/ng1571; Sun XT, 2006, J NEUROCHEM, V99, P1114, DOI 10.1111/j.1471-4159.2006.04159.x; Verissimo F, 2001, ONCOGENE, V20, P5562, DOI 10.1038/sj.onc.1204726; Wilson FH, 2001, SCIENCE, V293, P1107, DOI 10.1126/science.1062844; Xie J, 2009, AM J PATHOL; Xu BE, 2004, J BIOL CHEM, V279, P7826, DOI 10.1074/jbc.M313465200; Xu BE, 2000, J BIOL CHEM, V275, P16795, DOI 10.1074/jbc.275.22.16795; Zambrowicz BP, 2003, P NATL ACAD SCI USA, V100, P14109, DOI 10.1073/pnas.2336103100	29	50	51	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e37751	10.1371/journal.pone.0037751	http://dx.doi.org/10.1371/journal.pone.0037751			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22701532	Green Published, Green Submitted, gold			2022-12-27	WOS:000305338500053
J	Wang, SP; Dorsey, TH; Terunuma, A; Kittles, RA; Ambs, S; Kwabi-Addo, B				Wang, Songping; Dorsey, Tiffany H.; Terunuma, Atsushi; Kittles, Rick A.; Ambs, Stefan; Kwabi-Addo, Bernard			Relationship between Tumor DNA Methylation Status and Patient Characteristics in African-American and European-American Women with Breast Cancer	PLOS ONE			English	Article							RACIAL DISPARITIES; SURVIVAL; CARCINOMA; SUBTYPES; HYPERMETHYLATION; BIOLOGY; RACE; PROGNOSIS; PATTERNS; CAROLINA	Aberrant DNA methylation is critical for development and progression of breast cancer. We investigated the association of CpG island methylation in candidate genes and clinicopathological features in 65 African-American (AA) and European-American (EA) breast cancer patients. Quantitative methylation analysis was carried out on bisulfite modified genomic DNA and sequencing (pyrosequencing) for promoter CpG islands of p16, ESR1, RASSF1A, RAR beta 2, CDH13, HIN1, SFRP1 genes and the LINE1 repetitive element using matched paired non-cancerous and breast tumor specimen (32 AA and 33 EA women). Five of the genes, all known tumor suppressor genes (RASSF1A, RAR beta 2, CDH13, HIN1 and SFRP1), were found to be frequently hypermethylated in breast tumor tissues but not in the adjacent non-cancerous tissues. Significant differences in the CDH13 methylation status were observed by comparing DNA methylation between AA and EA patients, with more obvious CDH13 methylation differences between the two patient groups in the ER-disease and among young patients (age<50). In addition, we observed associations between CDH13, SFRP1, and RASSF1A methylation and breast cancer subtypes and between SFRP1 methylation and patient's age. Furthermore, tumors that received neoadjuvant therapy tended to have reduced RASSF1A methylation when compared with chemotherapy naive tumors. Finally, Kaplan Meier survival analysis showed a significant association between methylation at 3 loci (RASSF1A, RAR beta 2 and CDH13) and reduced overall disease survival. In conclusion, the DNA methylation status of breast tumors was found to be significantly associated with clinicopathological features and race/ethnicity of the patients.	[Wang, Songping; Kwabi-Addo, Bernard] Howard Univ, Dept Biochem & Mol Biol, Washington, DC 20059 USA; [Dorsey, Tiffany H.; Terunuma, Atsushi; Ambs, Stefan] NCI, Human Carcinogenesis Lab, Ctr Canc Res & Epidemiol, NIH, Bethesda, MD 20892 USA; [Dorsey, Tiffany H.; Terunuma, Atsushi; Ambs, Stefan] NCI, Genet Res Program, NIH, Bethesda, MD 20892 USA; [Kittles, Rick A.] Univ Illinois, Dept Med, Chicago, IL USA	Howard University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Wang, SP (corresponding author), Howard Univ, Dept Biochem & Mol Biol, Washington, DC 20059 USA.	bkwabi-addo@howard.edu	; Kwabi-Addo, Bernard/A-6993-2016	Ambs, Stefan/0000-0001-7651-9309; Kwabi-Addo, Bernard/0000-0003-3692-6350	Department of Defense Program Idea Award [PC073828]; NATIONAL CANCER INSTITUTE [ZIABC010887] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003048] Funding Source: NIH RePORTER	Department of Defense Program Idea Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by grant PC073828 from the Department of Defense Program Idea Award to BKA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amend K, 2006, CANCER RES, V66, P8327, DOI 10.1158/0008-5472.CAN-06-1927; American Cancer Society, 2009, BREAST CANC SOURCEBO; Bae YK, 2004, CLIN CANCER RES, V10, P5998, DOI 10.1158/1078-0432.CCR-04-0667; Bowen RL, 2006, PHARMACOGENOMICS, V7, P935, DOI 10.2217/14622416.7.6.935; Carey LA, 2006, JAMA-J AM MED ASSOC, V295, P2492, DOI 10.1001/jama.295.21.2492; Celebiler A, 2009, CANCER SCI, V100, P2341, DOI 10.1111/j.1349-7006.2009.01333.x; Chan TA, 2008, PLOS MED, V5, P823, DOI 10.1371/journal.pmed.0050114; CHEN VW, 1994, CANCER EPIDEM BIOMAR, V3, P127; Chlebowski RT, 2005, JNCI-J NATL CANCER I, V97, P439, DOI 10.1093/jnci/dji064; Colella S, 2003, BIOTECHNIQUES, V35, P146, DOI 10.2144/03351md01; Cunningham JE, 2004, BREAST CANCER RES TR, V88, P161, DOI 10.1007/s10549-004-0592-9; Demicheli R, 2007, CANCER-AM CANCER SOC, V110, P1880, DOI 10.1002/cncr.22998; Fackler MJ, 2003, INT J CANCER, V107, P970, DOI 10.1002/ijc.11508; Feng W, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1762; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Glynn SA, 2010, J CLIN INVEST, V120, P3843, DOI 10.1172/JCI42059; Issa JP, 2002, J NUTR, V132, p2388S, DOI 10.1093/jn/132.8.2388S; Joe AK, 2001, ANTICANCER RES, V21, P3535; Konishi K, 2007, GASTROENTEROLOGY, V132, P1254, DOI 10.1053/j.gastro.2007.01.035; Kwabi-Addo B, 2007, CLIN CANCER RES, V13, P3796, DOI 10.1158/1078-0432.CCR-07-0085; Kwabi-Addo B, 2010, CLIN CANCER RES, V16, P3539, DOI 10.1158/1078-0432.CCR-09-3342; Lehmann U, 2002, CANCER RES, V62, P6634; Li CI, 2003, ARCH INTERN MED, V163, P49, DOI 10.1001/archinte.163.1.49; Loo LWM, 2011, BREAST CANCER RES TR, V127, P297, DOI 10.1007/s10549-010-1297-x; Lund MJ, 2009, BREAST CANCER RES TR, V113, P357, DOI 10.1007/s10549-008-9926-3; Malone KE, 2006, CANCER RES, V66, P8297, DOI 10.1158/0008-5472.CAN-06-0503; Martin DN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004531; Mehrotra J, 2004, CLIN CANCER RES, V10, P2052, DOI 10.1158/1078-0432.CCR-03-0514; Nimmrich I, 2008, BREAST CANCER RES TR, V111, P429, DOI 10.1007/s10549-007-9800-8; O'Malley CD, 2003, CANCER, V97, P1303, DOI 10.1002/cncr.11160; Olopade Olufunmilayo I., 2003, Cancer, V97, P236, DOI 10.1002/cncr.11019; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Ries L, 2011, SEER CANC STAT REV 1; Rose DP, 2001, CANCER DETECT PREV, V25, P16; Selhub J, 2002, J Nutr Health Aging, V6, P39; Shu JM, 2006, CANCER RES, V66, P5077, DOI 10.1158/0008-5472.CAN-05-2629; Smid M, 2008, CANCER RES, V68, P3108, DOI 10.1158/0008-5472.CAN-07-5644; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Tisserand P, 2003, CANCER BIOL THER, V2, P559, DOI 10.4161/cbt.2.5.511; Wendt MK, 2008, ONCOGENE, V27, P1461, DOI 10.1038/sj.onc.1210751; Weston A, 1997, ENVIRON HEALTH PERSP, V105, P919, DOI 10.2307/3433304; Yu K, 2004, CLIN CANCER RES, V10, P5508, DOI 10.1158/1078-0432.CCR-04-0085	42	43	46	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e37928	10.1371/journal.pone.0037928	http://dx.doi.org/10.1371/journal.pone.0037928			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22701537	Green Published, Green Submitted, gold			2022-12-27	WOS:000305338500067
J	Coluzza, I; MacDonald, JT; Sadowski, MI; Taylor, WR; Goldstein, RA				Coluzza, Ivan; MacDonald, James T.; Sadowski, Michael I.; Taylor, William R.; Goldstein, Richard A.			Analytic Markovian Rates for Generalized Protein Structure Evolution	PLOS ONE			English	Article							SEQUENCE SPACE; POTENTIALS; MODEL	A general understanding of the complex phenomenon of protein evolution requires the accurate description of the constraints that define the sub-space of proteins with mutations that do not appreciably reduce the fitness of the organism. Such constraints can have multiple origins, in this work we present a model for constrained evolutionary trajectories represented by a Markovian process throughout a set of protein-like structures artificially constructed to be topological intermediates between the structure of two natural occurring proteins. The number and type of intermediate steps defines how constrained the total evolutionary process is. By using a coarse-grained representation for the protein structures, we derive an analytic formulation of the transition rates between each of the intermediate structures. The results indicate that compact structures with a high number of hydrogen bonds are more probable and have a higher likelihood to arise during evolution. Knowledge of the transition rates allows for the study of complex evolutionary pathways represented by trajectories through a set of intermediate structures.	[Coluzza, Ivan] Univ Vienna, Dept Phys, Vienna, Austria; [MacDonald, James T.] Univ London Imperial Coll Sci Technol & Med, Div Mol Biosci, London, England; [MacDonald, James T.] Univ London Imperial Coll Sci Technol & Med, Ctr Synthet Biol & Innovat, London, England; [Sadowski, Michael I.; Taylor, William R.; Goldstein, Richard A.] Natl Inst Med Res, Ridgeway, London NW7 1AA, England	University of Vienna; Imperial College London; Imperial College London	Coluzza, I (corresponding author), Univ Vienna, Dept Phys, Vienna, Austria.	ivan.coluzza@univie.ac.at	Sadowski, Michael/F-4475-2010; Coluzza, Ivan/I-4170-2015	Sadowski, Michael/0000-0002-4546-2159; Coluzza, Ivan/0000-0001-7728-6033; Goldstein, Richard/0000-0001-5148-4672; MacDonald, James/0000-0001-9675-4429	Medical Research Council (National Institute for Medical Research), United Kingdom [U117581331]; Medical Research Council [MC_U117573805] Funding Source: researchfish; MRC [MC_U117573805] Funding Source: UKRI	Medical Research Council (National Institute for Medical Research), United Kingdom; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funding was provided by the Medical Research Council (National Institute for Medical Research), United Kingdom. (U117581331). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babajide A, 2001, J THEOR BIOL, V212, P35, DOI 10.1006/jtbi.2001.2343; Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BornbergBauer E, 1997, BIOPHYS J, V73, P2393, DOI 10.1016/S0006-3495(97)78268-7; Coluzza I, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.051917; Coluzza I, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.046703; Coluzza I, 2005, CHEMPHYSCHEM, V6, P1779, DOI 10.1002/cphc.200400629; Coluzza I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020853; Deeds EJ, 2007, P NATL ACAD SCI USA, V104, P14952, DOI 10.1073/pnas.0702766104; Dokholyan NV, 2001, J MOL BIOL, V312, P289, DOI 10.1006/jmbi.2001.4949; Drummond DA, 2005, P NATL ACAD SCI USA, V102, P14338, DOI 10.1073/pnas.0504070102; Frenkel D, 2004, P NATL ACAD SCI USA, V101, P17571, DOI 10.1073/pnas.0407950101; Heizer EM, 2006, MOL BIOL EVOL, V23, P1670, DOI 10.1093/molbev/msl029; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; James LC, 2003, TRENDS BIOCHEM SCI, V28, P361, DOI 10.1016/S0968-0004(03)00135-X; Kinch LN, 2002, CURR OPIN STRUC BIOL, V12, P400, DOI 10.1016/S0959-440X(02)00338-X; Koehl P, 2002, P NATL ACAD SCI USA, V99, P1280, DOI 10.1073/pnas.032405199; Lobkovsky AE, 2010, P NATL ACAD SCI USA, V107, P2983, DOI 10.1073/pnas.0910445107; MacDonald JT, 2010, PROTEINS, V78, P1311, DOI 10.1002/prot.22651; Meyerguz L, 2007, P NATL ACAD SCI USA, V104, P11627, DOI 10.1073/pnas.0701393104; Pal C, 2006, NAT REV GENET, V7, P337, DOI 10.1038/nrg1838; Taylor WR, 2008, PROTEINS, V70, P1610, DOI 10.1002/prot.21913; Taylor WR, 2007, CURR OPIN STRUC BIOL, V17, P354, DOI 10.1016/j.sbi.2007.06.002; Viksna J, 2007, BIOINFORMATICS, V23, P832, DOI 10.1093/bioinformatics/btm022; Wroe R, 2007, HFSP J, V1, P79, DOI [10.2976/1.2739116, 10.2976/1.2739116/10.2976/1]	25	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e34228	10.1371/journal.pone.0034228	http://dx.doi.org/10.1371/journal.pone.0034228			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22693543	Green Published, gold, Green Submitted			2022-12-27	WOS:000305335800004
J	Stengel, KR; Zheng, Y				Stengel, Kristy R.; Zheng, Yi			Essential Role of Cdc42 in Ras-Induced Transformation Revealed by Gene Targeting	PLOS ONE			English	Article							CELL-POLARITY; RHO-GTPASES; ACTIVATION; KINASE; PHOSPHORYLATION; INVOLVEMENT; PROGRESSION; GROWTH	The ras proto-oncogene is one of the most frequently mutated genes in human cancer. However, given the prevalence of activating mutations in Ras and its association with aggressive forms of cancer, attempts to therapeutically target aberrant Ras signaling have been largely disappointing. This lack of progress highlights the deficiency in our understanding of cellular pathways required for Ras-mediated tumorigenesis and suggests the importance of identifying new molecular pathways associated with Ras-driven malignancies. Cdc42 is a Ras-related small GTPase that is known to play roles in oncogenic processes such as cell growth, survival, invasion, and migration. A pan-dominant negative mutant overexpression approach to suppress Cdc42 and related pathways has previously shown a requirement for Cdc42 in Ras-induced anchorage-independent cell growth, however the lack of specificity of such approaches make it difficult to determine if effects are directly related to changes in Cdc42 activity or other Rho family members. Therefore, in order to directly and unambiguously address the role of Cdc42 in Ras-mediated transformation, tumor formation and maintenance, we have developed a model of conditional cdc42 gene in Ras-transformed cells. Loss of Cdc42 drastically alters the cell morphology and inhibits proliferation, cell cycle progression and tumorigenicity of Ras-transformed cells, while non-transformed cells or c-Myc transformed cells are largely unaffected. The loss of Cdc42 in Ras-transformed cells results in reduced Akt signaling, restoration of which could partially rescues the proliferation defects associated with Cdc42 loss. Moreover, disruption of Cdc42 function in established tumors inhibited continued tumor growth. These studies implicate Cdc42 in Ras-driven tumor growth and suggest that targeting Cdc42 is beneficial in Ras-mediated malignancies.	[Stengel, Kristy R.] Univ Cincinnati, Div Expt Hematol & Canc Biol, Childrens Res Fdn, Cincinnati, OH 45221 USA; Univ Cincinnati, Coll Med, Dept Canc & Cell Biol, Cincinnati, OH USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Stengel, KR (corresponding author), Univ Cincinnati, Div Expt Hematol & Canc Biol, Childrens Res Fdn, Cincinnati, OH 45221 USA.	yi.zheng@cchmc.org	Zheng, Yi/J-7235-2015	Zheng, Yi/0000-0001-7089-6074; Stengel, Kristy/0000-0002-8330-5744	National Institutes of Health [R01CA150547, T32CA117846]; NATIONAL CANCER INSTITUTE [T32CA117846, R01CA150547] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work is supported by National Institutes of Health grants R01CA150547 and T32CA117846. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albiges-Rizo C, 2009, J CELL SCI, V122, P3037, DOI 10.1242/jcs.052704; Appledorn DM, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-13; Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Beeser A, 2005, J BIOL CHEM, V280, P36609, DOI 10.1074/jbc.M502306200; Bosco EE, 2010, BLOOD, V115, P3320, DOI 10.1182/blood-2009-02-202440; Cerione RA, 2004, TRENDS CELL BIOL, V14, P127, DOI 10.1016/j.tcb.2004.01.008; Chen L, 2006, P NATL ACAD SCI USA, V103, P16520, DOI 10.1073/pnas.0603533103; Cheng CM, 2011, MOL CELL BIOL, V31, P983, DOI 10.1128/MCB.00137-10; Chiu VK, 2002, NAT CELL BIOL, V4, P343, DOI 10.1038/ncb783; Cox Adrienne D, 2010, Small GTPases, V1, P2; Del Pulgar TG, 2008, INT J ONCOL, V33, P185; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; Etienne-Manneville S, 2001, CELL, V106, P489, DOI 10.1016/S0092-8674(01)00471-8; Fehrenbacher N, 2009, MOL ONCOL, V3, P297, DOI 10.1016/j.molonc.2009.06.004; Feig LA, 1999, NAT CELL BIOL, V1, pE25, DOI 10.1038/10018; Fritz G, 2002, BRIT J CANCER, V87, P635, DOI 10.1038/sj.bjc.6600510; Fritz G, 1999, INT J CANCER, V81, P682, DOI 10.1002/(SICI)1097-0215(19990531)81:5<682::AID-IJC2>3.0.CO;2-B; Joberty G, 2000, NAT CELL BIOL, V2, P531, DOI 10.1038/35019573; King AJ, 1998, NATURE, V396, P180, DOI 10.1038/24184; Li WQ, 2001, J BIOL CHEM, V276, P34728, DOI 10.1074/jbc.M103496200; Lin R, 1997, CURR BIOL, V7, P794, DOI 10.1016/S0960-9822(06)00338-1; Luo J, 2009, CELL, V137, P835, DOI 10.1016/j.cell.2009.05.006; McCormick F, 2011, J SURG ONCOL, V103, P464, DOI 10.1002/jso.21749; Melendez J, 2011, J BIOL CHEM, V286, P2375, DOI 10.1074/jbc.R110.200329; METZ T, 1995, CELL, V82, P29, DOI 10.1016/0092-8674(95)90049-7; MINDEN A, 1995, CELL, V81, P1147, DOI 10.1016/S0092-8674(05)80019-4; OLSON MF, 1995, SCIENCE, V269, P1270, DOI 10.1126/science.7652575; Qiu RG, 1997, MOL CELL BIOL, V17, P3449, DOI 10.1128/MCB.17.6.3449; Saxena N, 2008, CANCER INVEST, V26, P948, DOI 10.1080/07357900802087275; Scholl C, 2009, CELL, V137, P821, DOI 10.1016/j.cell.2009.03.017; Schubbert S, 2007, NAT REV CANCER, V7, P295, DOI 10.1038/nrc2109; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; Stengel K, 2011, CELL SIGNAL, V23, P1415, DOI 10.1016/j.cellsig.2011.04.001; TRAHEY M, 1987, SCIENCE, V238, P542, DOI 10.1126/science.2821624; Tucci MG, 2007, BRIT J DERMATOL, V157, P1212, DOI 10.1111/j.1365-2133.2007.08246.x; Wang RW, 2006, CELL SIGNAL, V18, P1722, DOI 10.1016/j.cellsig.2006.01.020; Wu WJ, 2003, CELL, V114, P715, DOI 10.1016/S0092-8674(03)00688-3; Yang L, 2007, P NATL ACAD SCI USA, V104, P5091, DOI 10.1073/pnas.0610819104; Yang L, 2006, MOL BIOL CELL, V17, P4675, DOI 10.1091/mbc.E06-05-0466; ZHENG Y, 1994, J BIOL CHEM, V269, P18727; Zheng YH, 2009, MOL CELL, V35, P11, DOI 10.1016/j.molcel.2009.06.013	41	32	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e37317	10.1371/journal.pone.0037317	http://dx.doi.org/10.1371/journal.pone.0037317			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22719838	gold, Green Submitted, Green Published			2022-12-27	WOS:000305583300006
J	Beacher, FDCC; Radulescu, E; Minati, L; Baron-Cohen, S; Lombardo, MV; Lai, MC; Walker, A; Howard, D; Gray, MA; Harrison, NA; Critchley, HD				Beacher, Felix D. C. C.; Radulescu, Eugenia; Minati, Ludovico; Baron-Cohen, Simon; Lombardo, Michael V.; Lai, Meng-Chuan; Walker, Anne; Howard, Dawn; Gray, Marcus A.; Harrison, Neil A.; Critchley, Hugo D.			Sex Differences and Autism: Brain Function during Verbal Fluency and Mental Rotation	PLOS ONE			English	Article							SPECTRUM QUOTIENT AQ; ACTIVATION PATTERN; ASPERGER-SYNDROME; VISUAL-SEARCH; FMRI; DISORDERS; INTELLIGENCE; PERFORMANCE; EMPATHY; CORTEX	Autism spectrum conditions (ASC) affect more males than females. This suggests that the neurobiology of autism: 1) may overlap with mechanisms underlying typical sex-differentiation or 2) alternately reflect sex-specificity in how autism is expressed in males and females. Here we used functional magnetic resonance imaging (fMRI) to test these alternate hypotheses. Fifteen men and fourteen women with Asperger syndrome (AS), and sixteen typically developing men and sixteen typically developing women underwent fMRI during performance of mental rotation and verbal fluency tasks. All groups performed the tasks equally well. On the verbal fluency task, despite equivalent task-performance, both males and females with AS showed enhanced activation of left occipitoparietal and inferior prefrontal activity compared to controls. During mental rotation, there was a significant diagnosis-by-sex interaction across occipital, temporal, parietal, middle frontal regions, with greater activation in AS males and typical females compared to AS females and typical males. These findings suggest a complex relationship between autism and sex that is differentially expressed in verbal and visuospatial domains.	[Beacher, Felix D. C. C.; Radulescu, Eugenia; Minati, Ludovico; Gray, Marcus A.; Harrison, Neil A.; Critchley, Hugo D.] Brighton & Sussex Med Sch, Brighton, E Sussex, England; [Radulescu, Eugenia; Gray, Marcus A.; Harrison, Neil A.; Critchley, Hugo D.] Univ Sussex, Sackler Ctr Consciousness Sci, Brighton, E Sussex, England; [Beacher, Felix D. C. C.] SUNY Stony Brook, Sch Med, Dept Biomed Engn, Stony Brook, NY 11794 USA; [Minati, Ludovico] Fdn IRCCS Ist Neurol Carlo Besta, Dept Sci, Milan, Italy; [Minati, Ludovico] Fdn IRCCS Ist Neurol Carlo Besta, Neuroradiol Unit, Milan, Italy; [Baron-Cohen, Simon; Lombardo, Michael V.; Lai, Meng-Chuan] Univ Cambridge, Dept Psychiat, Autism Res Ctr, Cambridge, England; [Walker, Anne; Howard, Dawn; Harrison, Neil A.; Critchley, Hugo D.] Sussex Partnership NHS Fdn Trust, Neurobehav Clin, Sussex Educ Ctr, Hove, England; [Gray, Marcus A.] Monash Univ, Expt Neuropsychol Res Unit, Sch Psychol, Psychiat Fac Med Nursing & Hlth Sci, Clayton, Vic, Australia	University of Brighton; University of Sussex; University of Sussex; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; IRCCS Istituto Neurologico Besta; Italfarmaco; IRCCS Istituto Neurologico Besta; University of Cambridge; Monash University	Beacher, FDCC (corresponding author), Brighton & Sussex Med Sch, Brighton, E Sussex, England.	e.radulescu@bsms.ac.uk	Gray, Marcus/F-6521-2013; Minati, Ludovico/R-1076-2017; Lai, Meng-Chuan/K-7407-2016; critchley, hugo d/G-9267-2011; Lombardo, Michael V/J-1773-2012	Gray, Marcus/0000-0001-8671-6939; Minati, Ludovico/0000-0002-2532-1674; Lai, Meng-Chuan/0000-0002-9593-5508; critchley, hugo d/0000-0002-2445-9284; Lombardo, Michael V/0000-0001-6780-8619; beacher, felix/0000-0002-4130-4073; Baron-Cohen, Simon/0000-0001-9217-2544; Harrison, Neil/0000-0002-9584-3769	Dr. Mortimer and Theresa Sackler Foundation; Wellcome Trust Programme Grant; Medical Research Council [G0600977] Funding Source: researchfish; MRC [G0600977] Funding Source: UKRI	Dr. Mortimer and Theresa Sackler Foundation; Wellcome Trust Programme Grant(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	ER and partly HDC were supported by the Dr. Mortimer and Theresa Sackler Foundation. HDC was supported by a Wellcome Trust Programme Grant and LM was supported by the Shirley Foundation during the acquisition of these data. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral DG, 2008, TRENDS NEUROSCI, V31, P137, DOI 10.1016/j.tins.2007.12.005; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Astur RS, 2004, BEHAV BRAIN RES, V151, P103, DOI 10.1016/j.bbr.2003.08.024; Badre D, 2005, NEURON, V47, P907, DOI 10.1016/j.neuron.2005.07.023; Baker SC, 1997, PSYCHOL MED, V27, P565, DOI 10.1017/S0033291797004856; Baron-Cohen S, 2003, PHILOS T ROY SOC B, V358, P361, DOI 10.1098/rstb.2002.1206; Baron-Cohen S, 2001, J AUTISM DEV DISORD, V31, P5, DOI 10.1023/A:1005653411471; Baron-Cohen S, 2004, J AUTISM DEV DISORD, V34, P163, DOI 10.1023/B:JADD.0000022607.19833.00; Baron-Cohen S, 2005, SCIENCE, V310, P819, DOI 10.1126/science.1115455; Baron-Cohen S, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001081; Baron-Cohen S, 2009, ANN NY ACAD SCI, V1156, P68, DOI 10.1111/j.1749-6632.2009.04467.x; Beacher FD, 2012, AM J NEURORADIOL, V33, P83, DOI 10.3174/ajnr.A2880; Bejerot S, 2012, BRIT J PSYCHIAT, V201, P116, DOI 10.1192/bjp.bp.111.097899; Brosnan M, 2010, J AUTISM DEV DISORD, V40, P1, DOI 10.1007/s10803-009-0815-3; Cahill L, 2006, NAT REV NEUROSCI, V7, P477, DOI 10.1038/nrn1909; Clements-Stephens AM, 2009, NEUROSCI LETT, V449, P155, DOI 10.1016/j.neulet.2008.10.094; Cosgrove KP, 2007, BIOL PSYCHIAT, V62, P847, DOI 10.1016/j.biopsych.2007.03.001; Critchley HD, 2005, NEUROIMAGE, V24, P751, DOI 10.1016/j.neuroimage.2004.10.013; Crucian GP, 1998, BRAIN COGNITION, V36, P377, DOI 10.1006/brcg.1998.0999; Deary IJ, 2010, NAT REV NEUROSCI, V11, P201, DOI 10.1038/nrn2793; Decety J, 2011, ANN NY ACAD SCI, V1231, P35, DOI 10.1111/j.1749-6632.2011.06027.x; Dehaene S, 2002, NEUROREPORT, V13, P321, DOI 10.1097/00001756-200203040-00015; Deichmann R, 2002, NEUROIMAGE, V15, P120, DOI 10.1006/nimg.2001.0985; Filipek PA, 1999, J AUTISM DEV DISORD, V29, P439, DOI 10.1023/A:1021943802493; Friston KJ, 2000, NEUROIMAGE, V12, P196, DOI 10.1006/nimg.2000.0609; Gauthier CT, 2009, CORTEX, V45, P164, DOI 10.1016/j.cortex.2007.09.006; Golestani N, 2006, NEUROPSYCHOLOGIA, V44, P1029, DOI 10.1016/j.neuropsychologia.2005.11.009; Halari R, 2006, EXP BRAIN RES, V169, P1, DOI 10.1007/s00221-005-0118-7; Harris GJ, 2006, BRAIN COGNITION, V61, P54, DOI 10.1016/j.bandc.2005.12.015; Hugdahl K, 2006, NEUROPSYCHOLOGIA, V44, P1575, DOI 10.1016/j.neuropsychologia.2006.01.026; Jordan K, 2002, NEUROPSYCHOLOGIA, V40, P2397, DOI 10.1016/S0028-3932(02)00076-3; Josephs O, 1999, PHILOS T R SOC B, V354, P1215, DOI 10.1098/rstb.1999.0475; Kaiser A, 2009, BRAIN RES REV, V61, P49, DOI 10.1016/j.brainresrev.2009.03.005; Keehn B, 2008, J INT NEUROPSYCH SOC, V14, P990, DOI 10.1017/S1355617708081356; Kleinhans NM, 2008, BRAIN, V131, P1000, DOI 10.1093/brain/awm334; Kozaki T, 2009, INT J NEUROSCI, V119, P59, DOI 10.1080/00207450802480101; Lai G, 2012, BRAIN, V135, P961, DOI 10.1093/brain/awr335; Lai MC, 2011, THESIS U CAMBRIDGE; Lai MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020835; Lawrence EJ, 2004, PSYCHOL MED, V34, P911, DOI 10.1017/S0033291703001624; Leekam SR, 2002, J CHILD PSYCHOL PSYC, V43, P327, DOI 10.1111/1469-7610.00024; Liederman J, 2012, ARCH SEXUAL BEH 0321; Lissek S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002023; Manjaly ZM, 2007, NEUROIMAGE, V35, P283, DOI 10.1016/j.neuroimage.2006.11.036; Materna S, 2008, NEUROPSYCHOLOGIA, V46, P2759, DOI 10.1016/j.neuropsychologia.2008.05.016; Mayes SD, 2001, AUTISM, V5, P81, DOI 10.1177/1362361301005001008; Mechelli A, 2007, HUM BRAIN MAPP, V28, P205, DOI 10.1002/hbm.20272; Minshew NJ, 2007, ARCH NEUROL-CHICAGO, V64, P945, DOI 10.1001/archneur.64.7.945; Murty VP, 2011, NEUROIMAGE, V57, P1264, DOI 10.1016/j.neuroimage.2011.05.006; NELSON HE, 1978, CORTEX, V14, P234, DOI 10.1016/S0010-9452(78)80049-5; Parsons LM, 2003, TRENDS COGN SCI, V7, P515, DOI 10.1016/j.tics.2003.10.002; Parsons TD, 2004, NEUROPSYCHOLOGIA, V42, P555, DOI 10.1016/j.neuropsychologia.2003.08.014; Perani D, 2001, NEUROIMAGE, V14, P749, DOI 10.1006/nimg.2001.0872; Price CJ, 2010, ANN NY ACAD SCI, V1191, P62, DOI 10.1111/j.1749-6632.2010.05444.x; Radulescu E, 2012, PHARMACOGENOMIC 0214; Schwarz E, 2011, MOL PSYCHIATR, V16, P1213, DOI 10.1038/mp.2010.102; Scott-Van Zeeland AA, 2010, BIOL PSYCHIAT, V68, P345, DOI 10.1016/j.biopsych.2010.01.011; Silk TJ, 2006, AM J PSYCHIAT, V163, P1440, DOI 10.1176/appi.ajp.163.8.1440; Simon SR, 2002, J NEUROPHYSIOL, V88, P2047, DOI 10.1152/jn.2002.88.4.2047; Slotnick SD, 2003, COGNITIVE BRAIN RES, V17, P75, DOI 10.1016/S0926-6410(03)00082-X; Soulieres I, 2009, HUM BRAIN MAPP, V30, P4082, DOI 10.1002/hbm.20831; Steinmetz KRM, 2010, PSYCHOL AGING, V25, P239, DOI 10.1037/a0018297; Tang J, 2006, J COGNITIVE NEUROSCI, V18, P2049, DOI 10.1162/jocn.2006.18.12.2049; Tesink CMJY, 2011, NEUROPSYCHOLOGIA, V49, P1095, DOI 10.1016/j.neuropsychologia.2011.01.018; Thomsen T, 2000, Med Sci Monit, V6, P1186; Turner MA, 1999, J CHILD PSYCHOL PSYC, V40, P189, DOI 10.1111/1469-7610.00432; Volkmar FR, 2000, KAPLAN SADOCKS COMPR; Vollm BA, 2006, NEUROIMAGE, V29, P90, DOI 10.1016/j.neuroimage.2005.07.022; Wakabayashi A, 2006, J AUTISM DEV DISORD, V36, P263, DOI 10.1007/s10803-005-0061-2; Wallace GL, 2010, BRAIN, V133, P3745, DOI 10.1093/brain/awq279; Weiss E, 2003, NEUROSCI LETT, V344, P169, DOI 10.1016/S0304-3940(03)00406-3; Weiss EM, 2003, NEUROSCI LETT, V352, P191, DOI 10.1016/j.neulet.2003.08.071; Wing L, 2011, RES DEV DISABIL 0103; Zacks JM, 2008, J COGNITIVE NEUROSCI, V20, P1, DOI 10.1162/jocn.2008.20013	75	54	56	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2012	7	6							e38355	10.1371/journal.pone.0038355	http://dx.doi.org/10.1371/journal.pone.0038355			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UJ	22701630	gold, Green Accepted, Green Published			2022-12-27	WOS:000305340000018
J	Sutrave, S; Scoglio, C; Isard, SA; Hutchinson, JMS; Garrett, KA				Sutrave, Sweta; Scoglio, Caterina; Isard, Scott A.; Hutchinson, J. M. Shawn; Garrett, Karen A.			Identifying Highly Connected Counties Compensates for Resource Limitations when Evaluating National Spread of an Invasive Pathogen	PLOS ONE			English	Article							SOYBEAN RUST; PHAKOPSORA-PACHYRHIZI; CLIMATE-CHANGE; PLANT-DISEASE; CROP PEST; NETWORKS; MANAGEMENT; INFECTION; DYNAMICS; RISK	Surveying invasive species can be highly resource intensive, yet near-real-time evaluations of invasion progress are important resources for management planning. In the case of the soybean rust invasion of the United States, a linked monitoring, prediction, and communication network saved U. S. soybean growers approximately $200 M/yr. Modeling of future movement of the pathogen (Phakopsora pachyrhizi) was based on data about current disease locations from an extensive network of sentinel plots. We developed a dynamic network model for U. S. soybean rust epidemics, with counties as nodes and link weights a function of host hectarage and wind speed and direction. We used the network model to compare four strategies for selecting an optimal subset of sentinel plots, listed here in order of increasing performance: random selection, zonal selection (based on more heavily weighting regions nearer the south, where the pathogen overwinters), frequency-based selection (based on how frequently the county had been infected in the past), and frequency-based selection weighted by the node strength of the sentinel plot in the network model. When dynamic network properties such as node strength are characterized for invasive species, this information can be used to reduce the resources necessary to survey and predict invasion progress.	[Sutrave, Sweta; Garrett, Karen A.] Kansas State Univ, Dept Plant Pathol, Manhattan, KS 66506 USA; [Sutrave, Sweta; Scoglio, Caterina] Kansas State Univ, Dept Elect & Comp Engn, Manhattan, KS 66506 USA; [Isard, Scott A.] Penn State Univ, Dept Plant Pathol, University Pk, PA 16802 USA; [Isard, Scott A.] Penn State Univ, Dept Meteorol, University Pk, PA 16802 USA; [Hutchinson, J. M. Shawn] Kansas State Univ, Dept Geog, Manhattan, KS 66506 USA	Kansas State University; Kansas State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Kansas State University	Sutrave, S (corresponding author), Kansas State Univ, Dept Plant Pathol, Throckmorton Hall, Manhattan, KS 66506 USA.	kgarrett@ksu.edu		Scoglio, Caterina/0000-0003-4486-9229; Hutchinson, J.M. Shawn/0000-0002-7667-8446	United States Department of Agriculture North Central Regional Integrated Pest Management Grant [2010-34103-20964]; United States Department of Agriculture Animal and Plant Health Inspection Service Grant [11-8453-1483-CA]; United States Department of Agriculture Animal and Plant Health Inspection Service Grant for spatial modeling; National Science Foundation, joint National Science Foundation-National Institute of Health Ecology of Infectious Disease program [EF-0525712]; National Science Foundation [DEB-0516046, SBE-0244984]; Kansas Agricultural Experiment Station [12-197-J]	United States Department of Agriculture North Central Regional Integrated Pest Management Grant; United States Department of Agriculture Animal and Plant Health Inspection Service Grant; United States Department of Agriculture Animal and Plant Health Inspection Service Grant for spatial modeling; National Science Foundation, joint National Science Foundation-National Institute of Health Ecology of Infectious Disease program; National Science Foundation(National Science Foundation (NSF)); Kansas Agricultural Experiment Station	The authors appreciate support of this work by United States Department of Agriculture North Central Regional Integrated Pest Management Grant 2010-34103-20964, United States Department of Agriculture Animal and Plant Health Inspection Service Grant 11-8453-1483-CA, a United States Department of Agriculture Animal and Plant Health Inspection Service Grant for spatial modeling, National Science Foundation Grant EF-0525712 as part of the joint National Science Foundation-National Institute of Health Ecology of Infectious Disease program, National Science Foundation Grant DEB-0516046, National Science Foundation Grant SBE-0244984 (R. A. Dyer, PI), and the Kansas Agricultural Experiment Station (Contribution No. 12-197-J). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Anderson CB, 2010, REV CHIL HIST NAT, V83, P1; [Anonymous], 2006, VALUE PLANT DIS EARL; Balcan D, 2009, P NATL ACAD SCI USA, V106, P21484, DOI 10.1073/pnas.0906910106; Bonde MR, 2008, PLANT DIS, V92, P30, DOI 10.1094/PDIS-92-1-0030; Borer ET, 2010, ECOL LETT, V13, P810, DOI 10.1111/j.1461-0248.2010.01475.x; Brooks CP, 2008, AM NAT, V172, P149, DOI 10.1086/589451; Chades I, 2011, P NATL ACAD SCI USA, V108, P8323, DOI 10.1073/pnas.1016846108; Cheatham MR, 2009, PHYTOPATHOLOGY, V99, P1228, DOI 10.1094/PHYTO-99-11-1228; Chen YP, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.058701; Claffy KC, 1993, SIGCOMM C P COMM ARC; Cohen R, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.247901; Cox CM, 2004, PHYTOPATHOLOGY, V94, P961, DOI 10.1094/PHYTO.2004.94.9.961; Crowl TA, 2008, FRONT ECOL ENVIRON, V6, P238, DOI 10.1890/070151; Demon I, 2011, PHYTOPATHOLOGY, V101, P725, DOI 10.1094/PHYTO-05-09-0120; Dorrance A. E., 2007, USING FOLIAR FUNGICI; Ellis AM, 2010, OIKOS, V119, P485, DOI 10.1111/j.1600-0706.2009.17918.x; Epanchin-Niell RS, 2010, FRONT ECOL ENVIRON, V8, P210, DOI 10.1890/090029; Epanchin-Niell RS, 2010, ECOL LETT, V13, P528, DOI 10.1111/j.1461-0248.2010.01440.x; Fabiszewski AM, 2010, ECOL APPL, V20, P582, DOI 10.1890/08-0820.1; Fischer M, 2010, BASIC APPL ECOL, V11, P473, DOI 10.1016/j.baae.2010.07.009; FITT BDL, 1987, J PHYTOPATHOL, V118, P227, DOI 10.1111/j.1439-0434.1987.tb00452.x; Floerl O, 2009, J APPL ECOL, V46, P37, DOI 10.1111/j.1365-2664.2008.01540.x; Florance D, 2011, P ROY SOC B-BIOL SCI, V278, P2900, DOI 10.1098/rspb.2011.0032; Forster GA, 2007, P NATL ACAD SCI USA, V104, P4984, DOI 10.1073/pnas.0607900104; Gallos LK, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.045104; Garrett KA, 2013, AGR FOREST METEOROL, V170, P216, DOI 10.1016/j.agrformet.2012.04.018; Garrett KA, 2012, EUR J PLANT PATHOL, V133, P75, DOI 10.1007/s10658-012-9963-y; Garrett KA, 2011, PLANT PATHOL, V60, P15, DOI 10.1111/j.1365-3059.2010.02409.x; Garrett KA, 2009, ECOL APPL, V19, P1868, DOI 10.1890/08-0942.1; Gent DH, 2011, PHYTOPATHOLOGY, V101, P640, DOI 10.1094/PHYTO-04-10-0124; Giesler L. J., 2007, 2 NAT SBR S AM PHYT; Gilbert M, 2010, ECOGRAPHY, V33, P809, DOI 10.1111/j.1600-0587.2009.06018.x; Gottwald TR, 2010, ANNU REV PHYTOPATHOL, V48, P119, DOI 10.1146/annurev-phyto-073009-114418; Harwood TD, 2009, ECOL MODEL, V220, P3353, DOI 10.1016/j.ecolmodel.2009.08.014; Hulme PE, 2009, J APPL ECOL, V46, P10, DOI 10.1111/j.1365-2664.2008.01600.x; Irwin ME, 1999, AGR FOREST METEOROL, V97, P235, DOI 10.1016/S0168-1923(99)00069-6; Isard SA, 2006, PLANT DIS, V90, P941, DOI 10.1094/PD-90-0941; Isard SA, 2011, PLANT DIS, V95, P1346, DOI 10.1094/PDIS-01-11-0034; Isard SA, 2005, BIOSCIENCE, V55, P851, DOI 10.1641/0006-3568(2005)055[0851:POTAPF]2.0.CO;2; Isard SA, 2007, AEROBIOLOGIA, V23, P271, DOI 10.1007/s10453-007-9073-z; Jeger MJ, 2007, NEW PHYTOL, V174, P279, DOI 10.1111/j.1469-8137.2007.02028.x; Jeger MJ, 1999, AGR FOREST METEOROL, V97, P331, DOI 10.1016/S0168-1923(99)00076-3; Kampe TU, 2010, J APPL REMOTE SENS, V4, DOI 10.1117/1.3361375; Keller M, 2008, FRONT ECOL ENVIRON, V6, P282, DOI 10.1890/1540-9295(2008)6[282:ACSFTN]2.0.CO;2; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; KO CW, 1995, OPER RES, V43, P684, DOI 10.1287/opre.43.4.684; KOCHMAN JK, 1979, AUST J AGR RES, V30, P273, DOI 10.1071/AR9790273; Lamour A, 2007, FEMS MICROBIOL ECOL, V62, P222, DOI 10.1111/j.1574-6941.2007.00358.x; Legendre P, 2002, ECOGRAPHY, V25, P601, DOI 10.1034/j.1600-0587.2002.250508.x; Li X, 2010, PLANT DIS, V94, P796, DOI 10.1094/PDIS-94-7-0796; Lowman M, 2009, SCIENCE, V323, P1172, DOI 10.1126/science.1166945; Madar N, 2004, EUR PHYS J B, V38, P269, DOI 10.1140/epjb/e2004-00119-8; Malmstrom CM, 2006, J ECOL, V94, P264, DOI 10.1111/j.1365-2745.2006.01101.x; MARCHETTI MA, 1976, PHYTOPATHOLOGY, V66, P461, DOI 10.1094/Phyto-66-461; Margosian ML, 2009, BIOSCIENCE, V59, P141, DOI 10.1525/bio.2009.59.2.7; Marshall JD, 2008, FRONT ECOL ENVIRON, V6, P273, DOI 10.1890/070165; Masuda N, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.036108; McRoberts N, 2011, PHYTOPATHOLOGY, V101, P654, DOI 10.1094/PHYTO-04-10-0126; Minor ES, 2011, ECOL APPL, V21, P739, DOI 10.1890/10-0321.1; Moslonka-Lefebvre M, 2011, PHYTOPATHOLOGY, V101, P392, DOI 10.1094/PHYTO-07-10-0192; Muirhead JR, 2005, J APPL ECOL, V42, P80, DOI 10.1111/j.1365-2664.2004.00988.x; Mundt CC, 2009, AM NAT, V173, P456, DOI 10.1086/597220; Newman MEJ, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.016128; Pastor-Satorras R, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.035108; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; Pautasso M, 2008, ECOL COMPLEX, V5, P1, DOI 10.1016/j.ecocom.2007.07.001; Pfender WF, 2011, PHYTOPATHOLOGY, V101, P644, DOI 10.1094/PHYTO-05-10-0131; Reynolds AM, 2011, PHYTOPATHOLOGY, V101, P1465, DOI 10.1094/PHYTO-01-11-0001; Richardson AD, 2009, ECOL APPL, V19, P1417, DOI 10.1890/08-2022.1; Rothlisberger JD, 2011, CONSERV BIOL, V25, P64, DOI 10.1111/j.1523-1739.2010.01589.x; Saleh AA, 2010, MOL ECOL, V19, P79, DOI 10.1111/j.1365-294X.2009.04433.x; Schneider CM, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.061911; Schneider RW, 2005, PLANT DIS, V89, P774, DOI 10.1094/PD-89-0774A; Schumm P, 2007, P IEEE ACM BION; Shaw MW, 2011, PLANT PATHOL, V60, P31, DOI 10.1111/j.1365-3059.2010.02407.x; Singh RP, 2011, ANNU REV PHYTOPATHOL, V49, P465, DOI 10.1146/annurev-phyto-072910-095423; Skelsey P, 2005, PHYTOPATHOLOGY, V95, P328, DOI 10.1094/PHYTO-95-0328; Sparks AH, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00128.1; Urban DL, 2009, ECOL LETT, V12, P260, DOI 10.1111/j.1461-0248.2008.01271.x; Van Mieghem P, 2009, IEEE ACM T NETWORK, V17, P1, DOI 10.1109/TNET.2008.925623; Wang Y, 2003, SYM REL DIST SYST, P25; WHITTLE P, 1955, BIOMETRIKA, V42, P116, DOI 10.2307/2333427; With KA, 2002, CONSERV BIOL, V16, P1192, DOI 10.1046/j.1523-1739.2002.01064.x; Xia YC, 2004, AM NAT, V164, P267, DOI 10.1086/422341; Xu XM, 2009, ECOGRAPHY, V32, P504, DOI 10.1111/j.1600-0587.2008.05597.x; YANG XB, 1992, J PHYTOPATHOL, V136, P46, DOI 10.1111/j.1439-0434.1992.tb01280.x; YANG XB, 1991, J PHYTOPATHOL, V133, P187, DOI 10.1111/j.1439-0434.1991.tb00153.x; Yorinori JT, 2005, PLANT DIS, V89, P675, DOI 10.1094/PD-89-0675; Youssef M, 2011, J COMPUT SCI-NETH, V2, P286, DOI 10.1016/j.jocs.2011.03.001; Zacharias S, 2011, VADOSE ZONE J, V10, P955, DOI 10.2136/vzj2010.0139	91	35	35	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2012	7	6							e37793	10.1371/journal.pone.0037793	http://dx.doi.org/10.1371/journal.pone.0037793			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UJ	22701580	Green Published, gold			2022-12-27	WOS:000305340000006
J	Felline, S; Caricato, R; Cutignano, A; Gorbi, S; Lionetto, MG; Mollo, E; Regoli, F; Terlizzi, A				Felline, Serena; Caricato, Roberto; Cutignano, Adele; Gorbi, Stefania; Lionetto, Maria Giulia; Mollo, Ernesto; Regoli, Francesco; Terlizzi, Antonio			Subtle Effects of Biological Invasions: Cellular and Physiological Responses of Fish Eating the Exotic Pest Caulerpa racemosa	PLOS ONE			English	Article							VAR. CYLINDRACEA; MYTILUS-GALLOPROVINCIALIS; REPRODUCTIVE-BIOLOGY; DIPLODUS-SARGUS; MEDITERRANEAN SEA; OXIDATIVE STRESS; BROWN BULLHEADS; TRACE-METALS; ASSEMBLAGES; BIOMARKERS	The green alga Caulerpa racemosa var. cylindracea has invaded Mediterranean seabed including marine reserves, modifying the structure of habitats and altering the distributional patterns of associated organisms. However, the understanding of how such invasion can potentially affect functional properties of Mediterranean subtidal systems is yet to be determined. In this study, we show that C. racemosa changes foraging habit of the native white seabream, Diplodus sargus. In invaded areas, we found a high frequency of occurrence of C. racemosa in the stomach contents of this omnivorous fish (72.7 and 85.7%), while the alga was not detected in fish from a control area. We also found a significant accumulation of caulerpin, one of the main secondary metabolites of C. racemosa, in fish tissues. The level of caulerpin in fish tissues was used here as an indicator of the trophic exposure to the invasive pest and related with observed cellular and physiological alterations. Such effects included activation of some enzymatic pathways (catalase, glutathione peroxidases, glutathione S-transferases, total glutathione and the total oxyradical scavenging capacity, 7-ethoxy resorufin O-deethylase), the inhibition of others (acetylcholinesterase and acylCoA oxidase), an increase of hepatosomatic index and decrease of gonadosomatic index. The observed alterations might lead to a detrimental health status and altered behaviours, potentially preventing the reproductive success of fish populations. Results of this study revealed that the entering of alien species in subtidal systems can alter trophic webs and can represent an important, indirect mechanism which might contribute to influence fluctuations of fish stocks and, also, the effectiveness of protection regimes.	[Felline, Serena; Caricato, Roberto; Lionetto, Maria Giulia; Terlizzi, Antonio] Univ Salento, Dipartimento Sci & Tecnol Biol & Ambientali, CoNISMa, Lecce, Italy; [Cutignano, Adele; Mollo, Ernesto] CNR, Ist Chim Biomol, I-80125 Naples, Italy; [Gorbi, Stefania; Regoli, Francesco] Univ Politecn Marche, Dipartimento Sci Vita & Ambiente, Ancona, Italy	CoNISMa; University of Salento; Consiglio Nazionale delle Ricerche (CNR); Istituto di Chimica Biomolecolare (ICB-CNR); Marche Polytechnic University	Felline, S (corresponding author), Univ Salento, Dipartimento Sci & Tecnol Biol & Ambientali, CoNISMa, Lecce, Italy.	antonio.terlizzi@unisalento.it	Terlizzi, Antonio/B-6131-2015; Gorbi, Stefania/K-5662-2016; Lionetto, Maria Giulia/H-1356-2011; Regoli, Francesco/K-2719-2018; Cutignano, Adele/C-3343-2012; Mollo, Ernesto/F-7842-2013	Terlizzi, Antonio/0000-0001-5968-4548; Gorbi, Stefania/0000-0002-4232-2652; Lionetto, Maria Giulia/0000-0003-3752-0192; Regoli, Francesco/0000-0001-6084-6188; Cutignano, Adele/0000-0003-3035-9252; Mollo, Ernesto/0000-0001-7379-1788; Felline, Serena/0000-0003-1221-7306; caricato, roberto/0000-0002-7928-4573	MIUR (The Ministry of Education, Universities and Research) (PRIN, CAUDIP project); EU FP7 PERSEUS Project	MIUR (The Ministry of Education, Universities and Research) (PRIN, CAUDIP project)(Ministry of Education, Universities and Research (MIUR)); EU FP7 PERSEUS Project	Financial support provided by MIUR (The Ministry of Education, Universities and Research) (PRIN 2009, CAUDIP project), and by the EU FP7 PERSEUS Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS SM, 1985, J FISH BIOL, V26, P111, DOI 10.1111/j.1095-8649.1985.tb04248.x; Allison GW, 1998, ECOL APPL, V8, pS79, DOI 10.1890/1051-0761(1998)8[S79:MRANBN]2.0.CO;2; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Anderson MJ, 2003, AUST NZ J STAT, V45, P301, DOI 10.1111/1467-842X.00285; Anderson MJ, 2003, ECOLOGY, V84, P511, DOI 10.1890/0012-9658(2003)084[0511:CAOPCA]2.0.CO;2; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Benedetti M, 2007, AQUAT TOXICOL, V85, P167, DOI 10.1016/j.aquatox.2007.08.009; Bocchetti R, 2006, CHEMOSPHERE, V65, P913, DOI 10.1016/j.chemosphere.2006.03.049; Bocquene Gilles, 1998, ICES Techniques in Marine Environmental Sciences, V22, P1; Box A, 2009, J EXP MAR BIOL ECOL, V380, P11, DOI 10.1016/j.jembe.2009.08.010; Brunelli M, 2000, PROG NEURO-PSYCHOPH, V24, P939, DOI 10.1016/S0278-5846(00)00112-3; Bulleri F, 2009, OIKOS, V118, P269, DOI 10.1111/j.1600-0706.2008.16955.x; Bulleri F, 2011, MAR ECOL PROG SER, V431, P55, DOI 10.3354/meps09137; Bulleri F, 2010, ECOLOGY, V91, P2205, DOI 10.1890/09-1857.1; Byrnes JE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000295; Cnubben NHP, 2001, ENVIRON TOXICOL PHAR, V10, P141, DOI 10.1016/S1382-6689(01)00077-1; DIGIULIO RT, 1995, MAR ENVIRON RES, V39, P175, DOI 10.1016/0141-1136(94)00021-G; DOTY MS, 1970, PAC SCI, V24, P351; EVERAARTS JM, 1993, MAR ENVIRON RES, V35, P101, DOI 10.1016/0141-1136(93)90021-Q; FABACHER DL, 1985, ENVIRON TOXICOL CHEM, V4, P703, DOI 10.1897/1552-8618(1985)4[703:ELAHMM]2.0.CO;2; Fraschetti S, 2005, MAR ENVIRON RES, V59, P309, DOI 10.1016/j.marenvres.2004.05.007; Frasco MF, 2005, BIOMARKERS, V10, P360, DOI 10.1080/13547500500264660; GALLAGHER EP, 1989, ENVIRON POLLUT, V62, P113, DOI 10.1016/0269-7491(89)90182-6; Gorley C.K., 2006, GETTING STARTED PRIM; Grigorakis K, 2007, AQUACULTURE, V272, P55, DOI 10.1016/j.aquaculture.2007.04.062; Guilhermino L, 1998, BIOMARKERS, V3, P157, DOI 10.1080/135475098231318; Halliwell B, 1996, ANNU REV NUTR, V16, P33, DOI 10.1146/annurev.nu.16.070196.000341; HAYSE JW, 1990, FISH B-NOAA, V88, P67; Hoey AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025824; Kopecka-Pilarczyk J, 2011, B ENVIRON CONTAM TOX, V86, P379, DOI 10.1007/s00128-011-0234-y; Kruskal J, 1978, MULTIDIMENSIONAL SCA; KURELEC B, 1993, MAR ENVIRON RES, V35, P341, DOI 10.1016/0141-1136(93)90101-5; Lionetto MG, 2003, MAR POLLUT BULL, V46, P324, DOI 10.1016/S0025-326X(02)00403-4; Lionetto MG, 2001, AQUAT CONSERV, V11, P305, DOI 10.1002/aqc.458; Longepierre S, 2005, BIODIVERS CONSERV, V14, P365, DOI [10.1007/s10531-004-5356-7, 10.1007/s10531-004-5056-7]; LYNCH M, 1995, AM NAT, V146, P489, DOI 10.1086/285812; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Mann BQ, 1998, CYBIUM, V22, P31; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:FMMTCD]2.0.CO;2; Medina MH, 2007, CHEMOSPHERE, V67, P2105, DOI 10.1016/j.chemosphere.2006.12.024; MICALE V, 1994, J FISH BIOL, V45, P661, DOI 10.1006/jfbi.1994.1165; Miralto A, 1999, NATURE, V402, P173, DOI 10.1038/46023; Morato T, 2003, J FISH BIOL, V63, P59, DOI 10.1046/j.1095-8649.2003.00129.x; Mouine N, 2007, SCI MAR, V71, P461, DOI 10.3989/scimar.2007.71n3461; Mozzachiodi R, 2001, NEUROSCIENCE, V107, P519, DOI 10.1016/S0306-4522(01)00365-7; Parvez M, 2000, Acta Crystallogr C, V56, pE96; Piazzi L, 2005, ESTUAR COAST SHELF S, V64, P467, DOI 10.1016/j.ecss.2005.03.010; Piazzi L, 2008, MAR ENVIRON RES, V65, P50, DOI 10.1016/j.marenvres.2007.07.002; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Piva F, 2011, CHEMOSPHERE, V83, P475, DOI 10.1016/j.chemosphere.2010.12.064; Raniello R, 2007, BIOL INVASIONS, V9, P361, DOI 10.1007/s10530-006-9044-2; Regoli F, 2005, ENVIRON TOXICOL CHEM, V24, P1475, DOI 10.1897/04-514R.1; Regoli F, 2002, MAR ENVIRON RES, V54, P419, DOI 10.1016/S0141-1136(02)00146-0; Regoli F, 2011, AQUAT TOXICOL, V105, P56, DOI 10.1016/j.aquatox.2011.06.014; Rocha FD, 2007, PHYTOTHER RES, V21, P170, DOI 10.1002/ptr.2038; Sala E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032742; Santos MA, 2004, ENVIRON INT, V30, P301, DOI 10.1016/S0160-4120(03)00178-8; Schroder HC, 1998, ENVIRON TOXICOL PHAR, V5, P119, DOI 10.1016/S1382-6689(97)10067-9; Sibley P. K., 2000, Journal of Aquatic Ecosystem Stress and Recovery, V7, P117, DOI 10.1023/A:1009967213300; SLOOFF W, 1983, AQUAT TOXICOL, V4, P1, DOI 10.1016/0166-445X(83)90057-7; Stefania G, 2009, ENVIRON POLLUT, V157, P3166, DOI 10.1016/j.envpol.2009.05.021; Sureda A, 2006, COMP BIOCHEM PHYS C, V144, P191, DOI 10.1016/j.cbpc.2006.08.001; Terlizzi A, 2004, MAR POLLUT BULL, V48, P188, DOI 10.1016/j.marpolbul.2003.10.019; Terlizzi A, 2002, MAR POLLUT BULL, V44, P544, DOI 10.1016/S0025-326X(01)00282-X; Terlizzi A, 2011, AQUAT BIOL, V12, P109, DOI 10.3354/ab00330; Uchimura M, 1999, ENVIRON SCI TECHNOL, V33, P1671, DOI 10.1021/es980444j; UEDA T, 1992, WATER SCI TECHNOL, V25, P235, DOI 10.2166/wst.1992.0297; van der Oost R, 2003, ENVIRON TOXICOL PHAR, V13, P57, DOI 10.1016/S1382-6689(02)00126-6; Vazquez-Luis M, 2008, MAR ENVIRON RES, V65, P416, DOI 10.1016/j.marenvres.2008.01.006; Vazquez-Luis M, 2009, HELGOLAND MAR RES, V63, P107, DOI 10.1007/s10152-008-0129-4; Vazquez-Luis M, 2010, HYDROBIOLOGIA, V654, P147, DOI 10.1007/s10750-010-0378-5; Vazquez-Luis M, 2009, ESTUAR COAST SHELF S, V84, P161, DOI 10.1016/j.ecss.2009.04.016; VIDAL JP, 1984, BOT MAR, V27, P533, DOI 10.1515/botm.1984.27.12.533; Wallentinus I, 2007, MAR POLLUT BULL, V55, P323, DOI 10.1016/j.marpolbul.2006.11.010; WEST G, 1990, AUST J MAR FRESH RES, V41, P199, DOI 10.1071/MF9900199; Zenetos A, 2010, MEDITERR MAR SCI, V11, P381, DOI 10.12681/mms.87; Zhan ZJ, 2010, BIOORG MED CHEM LETT, V20, P6185, DOI 10.1016/j.bmcl.2010.08.123	77	35	37	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2012	7	6							e38763	10.1371/journal.pone.0038763	http://dx.doi.org/10.1371/journal.pone.0038763			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TU	22701707	gold, Green Submitted, Green Published			2022-12-27	WOS:000305337600040
J	Vassilieva, S; Goh, HN; Lau, KX; Hughes, JN; Familari, M; Rathjen, PD; Rathjen, J				Vassilieva, Svetlana; Goh, Hwee Ngee; Lau, Kevin X.; Hughes, James N.; Familari, Mary; Rathjen, Peter D.; Rathjen, Joy			A System to Enrich for Primitive Streak-Derivatives, Definitive Endoderm and Mesoderm, from Pluripotent Cells in Culture	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; MOUSE ES CELLS; VISCERAL ENDODERM; EXTRAEMBRYONIC LINEAGES; EXPRESSION ANALYSIS; GERM LAYERS; EPL CELLS; IN-VITRO; DIFFERENTIATION; ECTODERM	Two lineages of endoderm develop during mammalian embryogenesis, the primitive endoderm in the pre-implantation blastocyst and the definitive endoderm at gastrulation. This complexity of endoderm cell populations is mirrored during pluripotent cell differentiation in vitro and has hindered the identification and purification of the definitive endoderm for use as a substrate for further differentiation. The aggregation and differentiation of early primitive ectoderm-like (EPL) cells, resulting in the formation of EPL-cell derived embryoid bodies (EPLEBs), is a model of gastrulation that progresses through the sequential formation of primitive streak-like intermediates to nascent mesoderm and more differentiated mesoderm populations. EPL cell-derived EBs have been further analysed for the formation of definitive endoderm by detailed morphological studies, gene expression and a protein uptake assay. In comparison to embryoid bodies derived from ES cells, which form primitive and definitive endoderm, the endoderm compartment of embryoid bodies formed from EPL cells was comprised almost exclusively of definitive endoderm. Definitive endoderm was defined as a population of squamous cells that expressed Sox17, CXCR4 and Trh, which formed without the prior formation of primitive endoderm and was unable to endocytose horseradish peroxidase from the medium. Definitive endoderm formed in EPLEBs provides a substrate for further differentiation into specific endoderm lineages; these lineages can be used as research tools for understanding the mechanisms controlling lineage establishment and the nature of the transient intermediates formed. The similarity between mouse EPL cells and human ES cells suggests EPLEBs can be used as a model system for the development of technologies to enrich for the formation of human ES cell-derived definitive endoderm in the future.	[Vassilieva, Svetlana; Hughes, James N.; Rathjen, Peter D.] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA, Australia; [Goh, Hwee Ngee; Lau, Kevin X.; Familari, Mary; Rathjen, Peter D.; Rathjen, Joy] Univ Melbourne, Dept Zool, Parkville, Vic 3052, Australia; [Rathjen, Peter D.; Rathjen, Joy] Univ Tasmania, Menzies Res Inst Tasmania, Hobart, Tas, Australia	University of Adelaide; University of Melbourne; University of Tasmania	Vassilieva, S (corresponding author), Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA, Australia.	joy.rathjen@utas.edu.au		Familari, Mary/0000-0002-2275-9582	Australian Stem Cell Centre; ARC SRC (Australian Research Council Special Research Centre) Molecular Genetics of Development; University of Melbourne	Australian Stem Cell Centre; ARC SRC (Australian Research Council Special Research Centre) Molecular Genetics of Development(Australian Research Council); University of Melbourne(University of Melbourne)	Funding was received from the Australian Stem Cell Centre, the ARC SRC (Australian Research Council Special Research Centre) Molecular Genetics of Development and the University of Melbourne. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANG SL, 1993, DEVELOPMENT, V119, P1301; BATTEN BE, 1979, ANAT REC, V194, P125, DOI 10.1002/ar.1091940109; Bernardo AS, 2011, CELL STEM CELL, V9, P144, DOI 10.1016/j.stem.2011.06.015; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chazaud C, 2006, DEV CELL, V10, P615, DOI 10.1016/j.devcel.2006.02.020; Ciruna B, 2001, DEV CELL, V1, P37, DOI 10.1016/S1534-5807(01)00017-X; COUCOUVANIS E, 1995, CELL, V83, P279, DOI 10.1016/0092-8674(95)90169-8; CSERJESI P, 1995, DEV BIOL, V170, P664, DOI 10.1006/dbio.1995.1245; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; DOETSCHMAN TC, 1985, J EMBRYOL EXP MORPH, V87, P27; ENDERS AC, 1978, ANAT REC, V190, P65, DOI 10.1002/ar.1091900107; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Fujikura J, 2002, GENE DEV, V16, P784, DOI 10.1101/gad.968802; GARDNER RL, 1985, PHILOS T R SOC B, V312, P163, DOI 10.1098/rstb.1985.0186; GARDNER RL, 1985, J EMBRYOL EXP MORPH, V88, P303; Gaunt SJ, 2005, INT J DEV BIOL, V49, P901, DOI 10.1387/ijdb.052021sg; GREEN RP, 1992, DNA CELL BIOL, V11, P31, DOI 10.1089/dna.1992.11.31; Hancock SN, 1999, MECH DEVELOP, V81, P205, DOI 10.1016/S0925-4773(98)00244-5; Hart AH, 2004, DEV DYNAM, V230, P187, DOI 10.1002/dvdy.20034; Harvey NT, 2010, J CELL SCI, V123, P1796, DOI 10.1242/jcs.047530; HIRATANI I, 2009, GENOME RES; HOGAN BLM, 1981, NATURE, V291, P235, DOI 10.1038/291235a0; HOGAN BLM, 1981, J EMBRYOL EXP MORPH, V62, P379; Hughes JN, 2009, STEM CELLS, V27, P2941, DOI 10.1002/stem.218; Hughes JN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005579; Kanai-Azuma M, 2002, DEVELOPMENT, V129, P2367; Kehler J, 2005, SEMIN REPROD MED, V23, P222, DOI 10.1055/s-2005-872450; Kubo A, 2004, DEVELOPMENT, V131, P1651, DOI 10.1242/dev.01044; Kwon GS, 2008, DEV CELL, V15, P509, DOI 10.1016/j.devcel.2008.07.017; Lake JA, 2000, J CELL SCI, V113, P555; LevinsonDushnik M, 1997, MOL CELL BIOL, V17, P3817, DOI 10.1128/MCB.17.7.3817; Li L, 2004, DEVELOPMENT, V131, P5277, DOI 10.1242/dev.01415; Lim SM, 2009, STEM CELLS, V27, P363, DOI 10.1634/stemcells.2008-1008; Liu PT, 1999, NAT GENET, V22, P361, DOI 10.1038/11932; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Maye P, 2000, MECH DEVELOP, V94, P117, DOI 10.1016/S0925-4773(00)00304-X; McGrath KE, 1999, DEV BIOL, V213, P442, DOI 10.1006/dbio.1999.9405; McKnight KD, 2007, DEV DYNAM, V236, P2909, DOI 10.1002/dvdy.21313; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Mohamed OA, 2004, DEV DYNAM, V231, P416, DOI 10.1002/dvdy.20135; MONAGHAN AP, 1993, DEVELOPMENT, V119, P567; Morrisey EE, 1998, GENE DEV, V12, P3579, DOI 10.1101/gad.12.22.3579; Morrison GM, 2008, CELL STEM CELL, V3, P402, DOI 10.1016/j.stem.2008.07.021; Murray P, 2001, DIFFERENTIATION, V68, P227, DOI 10.1046/j.1432-0436.2001.680410.x; Pearce JJH, 1999, MECH DEVELOP, V87, P189, DOI 10.1016/S0925-4773(99)00135-5; Pelton TA, 2002, J CELL SCI, V115, P329; Pera MF, 2010, NATURE, V465, P713, DOI 10.1038/nature09228; Rathjen J, 1999, J CELL SCI, V112, P601; Rathjen J, 2003, METHOD ENZYMOL, V365, P3; Rathjen J, 2002, DEVELOPMENT, V129, P2649; Rathjen J, 2001, CURR OPIN GENET DEV, V11, P587, DOI 10.1016/S0959-437X(00)00237-9; SASAKI H, 1993, DEVELOPMENT, V118, P47; Schroeder IS, 2011, CELLS TISSUE ORGANS, VCells Tissues Organs; SOUDAIS C, 1995, DEVELOPMENT, V121, P3877; TAM PPL, 1992, CIBA F SYMP, V165, P27; TAM PPL, 1993, MICROSC RES TECHNIQ, V26, P301, DOI 10.1002/jemt.1070260405; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Thomas T, 1998, DEV BIOL, V196, P228, DOI 10.1006/dbio.1998.8849; Wells JM, 2000, DEVELOPMENT, V127, P1563; Wells JM, 1999, ANNU REV CELL DEV BI, V15, P393, DOI 10.1146/annurev.cellbio.15.1.393; Yasunaga M, 2005, NAT BIOTECHNOL, V23, P1542, DOI 10.1038/nbt1167; Zheng ZQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012555	63	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2012	7	6							e38645	10.1371/journal.pone.0038645	http://dx.doi.org/10.1371/journal.pone.0038645			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TU	22701686	Green Published, gold			2022-12-27	WOS:000305337600036
J	Han, Y; Zhang, W; Tang, Y; Bai, WL; Yang, F; Xie, LP; Li, XZ; Zhou, SM; Pan, SY; Chen, Q; Ferro, A; Ji, Y				Han, Yi; Zhang, Wen; Tang, Yan; Bai, Wenli; Yang, Fan; Xie, Liping; Li, Xiaozhen; Zhou, Suming; Pan, Shiyang; Chen, Qi; Ferro, Albert; Ji, Yong			l-Tetrahydropalmatine, an Active Component of Corydalis yanhusuo W.T. Wang, Protects against Myocardial Ischaemia-Reperfusion Injury in Rats	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; NF-KAPPA-B; CARDIOVASCULAR-DISEASE; SEPTIC SHOCK; CYTOCHROME-C; TNF-ALPHA; PEROXYNITRITE; ACTIVATION; EXPRESSION; APOPTOSIS	l-Tetrahydropalmatine (l-THP) is an active ingredients of Corydalis yanhusuo W.T. Wang, which protects against acute global cerebral ischaemia-reperfusion injury. In this study, we show that l-THP is cardioprotective in myocardial ischaemia-reperfusion injury and examined the mechanism. Rats were treated with l-THP (0, 10, 20, 40 mg/kg b.w.) for 20 min before occlusion of the left anterior descending coronary artery and subjected to myocardial ischaemia-reperfusion (30 min/6 h). Compared with vehicle-treated animals, the infarct area/risk area (IA/RA) of l-THP (20, 40 mg/kg b.w.) treated rats was reduced, whilst l-THP (10 mg/kg b.w.) had no significant effect. Cardiac function was improved in l-THP-treated rats whilst plasma creatine kinase activity declined. Following treatment with l-THP (20 mg/kg b.w.), subunit of phosphatidylinositol 3-kinase p85, serine(473) phosphorylation of Akt and serine(1177) phosphorylation of endothelial NO synthase (eNOS) increased in myocardium, whilst expression of inducible NO synthase (iNOS) decreased. However, the expression of HIF-1 alpha and VEGF were increased in I30 minR6 (h), but decreased to normal level in I30 minR24 (h), while treatment with l-THP (20 mg/kg b.w.) enhanced the levels of these two genes in I30 minR24 h. Production of NO in myocardium and plasma, activity of myeloperoxidase (MPO) in plasma and the expression of tumour necrosis factor-alpha (TNF-alpha) in myocardium were decreased by l-THP. TUNEL assay revealed that l-THP (20 mg/kg b.w.) reduced apoptosis in myocardium. Thus, we show that l-THP activates the PI3K/Akt/eNOS/NO pathway and increases expression of HIF-1 alpha and VEGF, whilst depressing iNOS-derived NO production in myocardium. This effect may decrease the accumulation of inflammatory factors, including TNF-alpha and MPO, and lessen the extent of apoptosis, therefore contributing to the cardioprotective effects of l-THP in myocardial ischaemia-reperfusion injury.	[Han, Yi; Zhou, Suming] Nanjing Med Univ, Affiliated Hosp 1, Dept Geriatr, Nanjing, Jiangsu, Peoples R China; [Zhang, Wen; Tang, Yan; Bai, Wenli; Yang, Fan; Xie, Liping; Li, Xiaozhen; Chen, Qi; Ji, Yong] Nanjing Med Univ, Key Lab Cardiovasc Dis & Mol Intervent, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China; [Pan, Shiyang] Nanjing Med Univ, Affiliated Hosp 1, Dept Lab Med, Nanjing, Jiangsu, Peoples R China; [Ferro, Albert] Kings Coll London, Sch Med, Dept Clin Pharmacol, Div Cardiovasc, London WC2R 2LS, England	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; University of London; King's College London	Ji, Y (corresponding author), Nanjing Med Univ, Key Lab Cardiovasc Dis & Mol Intervent, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China.	yongji@njmu.edu.cn		Ferro, Albert/0000-0002-5486-9145	National Basic Research Program (973) [2010CB535010, 2011CB503903, 2012CB517503]; National Natural Science Foundation of China [30971256, 81170083]; PAPD; Universities Natural Science Research Project of Jiangsu Province [10KJA310033]	National Basic Research Program (973)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); PAPD; Universities Natural Science Research Project of Jiangsu Province	This work was supported by grants from National Basic Research Program (973) (Nos. 2010CB535010, 2011CB503903 and 2012CB517503), the National Natural Science Foundation of China (Nos. 30971256 and 81170083), PAPD and Universities Natural Science Research Project of Jiangsu Province (No. 10KJA310033). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arstall MA, 1999, CIRC RES, V85, P829, DOI 10.1161/01.RES.85.9.829; BJORKMAN JA, 1991, BASIC RES CARDIOL, V86, P236, DOI 10.1007/BF02190603; Borutaite V, 1999, BBA-MOL BASIS DIS, V1453, P41, DOI 10.1016/S0925-4439(98)00082-9; Brown GC, 2007, CARDIOVASC RES, V75, P283, DOI 10.1016/j.cardiores.2007.03.022; Chu HY, 2008, CELL MOL NEUROBIOL, V28, P491, DOI 10.1007/s10571-007-9179-4; Davidson SM, 2006, CARDIOVASC RES, V71, P10, DOI 10.1016/j.cardiores.2006.01.019; DECATERINA R, 1995, J CLIN INVEST, V96, P60, DOI 10.1172/JCI118074; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; DINERMAN JL, 1993, CIRC RES, V73, P217, DOI 10.1161/01.RES.73.2.217; Freeman BD, 2000, EXPERT OPIN INV DRUG, V9, P1651, DOI 10.1517/13543784.9.7.1651; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Gao F, 2002, CIRCULATION, V105, P1497, DOI 10.1161/01.CIR.0000012529.00367.0F; Gao F, 2002, CARDIOVASC RES, V53, P414, DOI 10.1016/S0008-6363(01)00488-6; Griendling KK, 1997, CIRCULATION, V96, P3264; Hong ZY, 2006, BIOPHARM DRUG DISPOS, V27, P111, DOI 10.1002/bdd.489; Jiang BH, 1996, J BIOL CHEM, V271, P17771, DOI 10.1074/jbc.271.30.17771; Jurgensen JS, 2004, FASEB J, V18, P1415, DOI 10.1096/fj.04-1605fje; Kaminski A, 2004, AM J PATHOL, V164, P2241, DOI 10.1016/S0002-9440(10)63780-7; Kido M, 2005, J AM COLL CARDIOL, V46, P2116, DOI 10.1016/j.jacc.2005.08.045; KUBES P, 1991, P NATL ACAD SCI USA, V88, P4651, DOI 10.1073/pnas.88.11.4651; Li CF, 2001, AM J PHYSIOL-HEART C, V280, pH1264, DOI 10.1152/ajpheart.2001.280.3.H1264; Li J, 2008, CRIT CARE MED, V36, P1551, DOI 10.1097/CCM.0b013e3181782335; Li JR, 2005, P NATL ACAD SCI USA, V102, P9936, DOI 10.1073/pnas.0502552102; Liang F, 2004, CARDIOVASC RES, V62, P568, DOI 10.1016/j.cardiores.2004.01.025; Liang J, 1999, CHINESE PHARMACOL B, V15, P167; Liu Bin, 2004, J Huazhong Univ Sci Technolog Med Sci, V24, P445; Lu MJ, 2005, J FORMOS MED ASSOC, V104, P707; Ma HD, 2009, J PHARMACEUT BIOMED, V49, P440, DOI 10.1016/j.jpba.2008.11.019; MA XL, 1993, CIRC RES, V72, P403, DOI 10.1161/01.RES.72.2.403; Matsuhisa S, 2008, AM J PHYSIOL-HEART C, V294, pH2473, DOI 10.1152/ajpheart.91533.2007; MCCORD JM, 1985, NEW ENGL J MED, V312, P159; Merla R, 2007, AM HEART J, V154, P391, DOI 10.1016/j.ahj.2007.04.029; Nian M, 2004, CIRC RES, V94, P1543, DOI 10.1161/01.RES.0000130526.20854.fa; Otani H, 2009, ANTIOXID REDOX SIGN, V11, P1913, DOI [10.1089/ars.2009.2453, 10.1089/ARS.2009.2453]; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; PARK E, 1995, J IMMUNOL, V154, P4778; RADI R, 1993, BIOCHEM J, V290, P51, DOI 10.1042/bj2900051; RADOMSKI MW, 1987, LANCET, V2, P1057, DOI 10.1016/S0140-6736(87)91481-4; Sheeba MS, 2009, J ETHNOPHARMACOL, V124, P39, DOI 10.1016/j.jep.2009.04.020; Shiva S, 2005, FREE RADICAL BIO MED, V38, P297, DOI 10.1016/j.freeradbiomed.2004.10.037; Titheradge MA, 1999, BBA-BIOENERGETICS, V1411, P437, DOI 10.1016/S0005-2728(99)00031-6; Uchiyama T, 2002, J MOL CELL CARDIOL, V34, P1049, DOI 10.1006/jmcc.2002.2045; Wang T., 2003, CHINA REHAB, V18, P135; Wang XL, 2007, APOPTOSIS, V12, P1209, DOI 10.1007/s10495-007-0055-y; Wu LM, 2007, J PHARM PHARMACOL, V59, P695, DOI 10.1211/jpp.59.5.0010; Yang G, 2000, J Tongji Med Univ, V20, P106; Ye YM, 2008, AM J PHYSIOL-HEART C, V295, pH2436, DOI 10.1152/ajpheart.00690.2008; ZHU XZ, 1991, MEM I OSWALDO CRUZ, V86, P173, DOI 10.1590/S0074-02761991000600039; Zingarelli B, 2002, FASEB J, V16, DOI 10.1096/fj.01-0533com	49	45	51	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2012	7	6							e38627	10.1371/journal.pone.0038627	http://dx.doi.org/10.1371/journal.pone.0038627			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TQ	22715398	gold, Green Published, Green Submitted			2022-12-27	WOS:000305336800040
J	Yang, CR; Wei, YC; Qi, ST; Chen, L; Zhang, QH; Ma, JY; Luo, YB; Wang, YP; Hou, Y; Schatten, H; Liu, ZH; Sun, QY				Yang, Cai-Rong; Wei, Yanchang; Qi, Shu-Tao; Chen, Lei; Zhang, Qing-Hua; Ma, Jun-Yu; Luo, Yi-Bo; Wang, Ya-Peng; Hou, Yi; Schatten, Heide; Liu, Zhong-Hua; Sun, Qing-Yuan			The G Protein Coupled Receptor 3 Is Involved in cAMP and cGMP Signaling and Maintenance of Meiotic Arrest in Porcine Oocytes	PLOS ONE			English	Article							MOUSE OOCYTES; KINASE-A; MAMMALIAN OOCYTES; PROPHASE ARREST; XENOPUS OOCYTES; G(S) PROTEIN; CYCLIC-AMP; MATURATION; RESUMPTION; GPR3	The arrest of meiotic prophase in mammalian oocytes within fully grown follicles is dependent on cyclic adenosine monophosphate (cAMP) regulation. A large part of cAMP is produced by the Gs-linked G-protein-coupled receptor (GPR) pathway. In the present study, we examined whether GPR3 is involved in the maintenance of meiotic arrest in porcine oocytes. Expression and distribution of GPR3 were examined by western blot and immunofluorescence microscopy, respectively. The results showed that GPR3 was expressed at various stages during porcine oocyte maturation. At the germinal vesicle (GV) stage, GPR3 displayed a maximal expression level, and its expression remained stable from prometaphase I (MI) to metaphase II (MII). Immunofluorescence staining showed that GPR3 was mainly distributed at the nuclear envelope during the GV stage and localized to the plasma membrane at pro-MI, MI and MII stages. RNA interference (RNAi) was used to knock down the GPR3 expression within oocytes. Injection of small interfering double-stranded RNA (siRNA) targeting GPR3 stimulated meiotic resumption of oocytes. On the other hand, overexpression of GPR3 inhibited meiotic maturation of porcine oocytes, which was caused by increase of cGMP and cAMP levels and inhibition of cyclin B accumulation. Furthermore, incubation of porcine oocytes with the GPR3 ligand sphingosylphosphorylcholine (SPC) inhibited oocyte maturation. We propose that GPR3 is required for maintenance of meiotic arrest in porcine oocytes through pathways involved in the regulation of cAMP and cGMP.	[Yang, Cai-Rong; Ma, Jun-Yu; Liu, Zhong-Hua] NE Agr Univ China, Coll Life Sci, Harbin, Peoples R China; [Yang, Cai-Rong; Wei, Yanchang; Qi, Shu-Tao; Chen, Lei; Zhang, Qing-Hua; Ma, Jun-Yu; Luo, Yi-Bo; Wang, Ya-Peng; Hou, Yi; Sun, Qing-Yuan] Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing, Peoples R China; [Schatten, Heide] Univ Missouri, Dept Vet Pathobiol, Columbia, MO USA	Northeast Agricultural University - China; Chinese Academy of Sciences; Institute of Zoology, CAS; University of Missouri System; University of Missouri Columbia	Yang, CR (corresponding author), NE Agr Univ China, Coll Life Sci, Harbin, Peoples R China.	sunqy@ioz.ac.cn	Yang, Cairong/AAB-1440-2021	Yang, Cairong/0000-0001-9594-0529; Chen, Lei/0000-0002-9993-0894; Qi, Shutao/0000-0002-4073-1161	National Basic Research Program of China [2012CB944404, 2011CB944501]; National Natural Science Foundation of China [30930065]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Basic Research Program of China(2012CB944404, 2011CB944501) and National Natural Science Foundation of China (No. 30930065) to QYS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1986, RES REPROD, V18, P1; Conti M, 2002, MOL CELL ENDOCRINOL, V187, P153, DOI 10.1016/S0303-7207(01)00686-4; DAAR I, 1993, J CELL BIOL, V120, P1197, DOI 10.1083/jcb.120.5.1197; Daly CJ, 2003, PHARMACOL THERAPEUT, V100, P101, DOI 10.1016/j.pharmthera.2003.08.001; DiLuigi A, 2008, BIOL REPROD, V78, P667, DOI 10.1095/biolreprod.107.066019; Duckworth BC, 2002, P NATL ACAD SCI USA, V99, P16794, DOI 10.1073/pnas.222661299; Eppig J J, 1989, J Reprod Fertil Suppl, V38, P3; Eppig J. J., 2004, OVARY, P113, DOI DOI 10.1016/B978-012444562-8/50008-2; Fan HY, 2002, MOL REPROD DEV, V63, P480, DOI 10.1002/mrd.10194; Freudzon L, 2005, J CELL BIOL, V171, P255, DOI 10.1083/jcb.200506194; Haccard O, 2006, CELL CYCLE, V5, P1152, DOI 10.4161/cc.5.11.2800; Han SJ, 2006, CELL CYCLE, V5, P227, DOI 10.4161/cc.5.3.2395; Hinckley M, 2005, DEV BIOL, V287, P249, DOI 10.1016/j.ydbio.2005.08.019; Juilfs D M, 1999, Rev Physiol Biochem Pharmacol, V135, P67, DOI 10.1007/BFb0033670; Kalinowski RR, 2004, DEV BIOL, V267, P1, DOI 10.1016/j.ydbio.2003.11.011; Kostenis E, 2004, PHARMACOL THERAPEUT, V102, P243, DOI 10.1016/j.pharmthera.2004.04.005; Kostenis E, 2004, J CELL BIOCHEM, V92, P923, DOI 10.1002/jcb.20092; Kuroda T, 2004, BIOL REPROD, V70, P154, DOI 10.1095/biolreprod.103.021519; Laforest MF, 2005, MOL REPROD DEV, V70, P361, DOI 10.1002/mrd.20203; Ledent C, 2005, P NATL ACAD SCI USA, V102, P8922, DOI 10.1073/pnas.0503840102; Li M, 2008, BIOL REPROD, V79, P897, DOI 10.1095/biolreprod.108.069245; Lincoln AJ, 2002, NAT GENET, V30, P446, DOI 10.1038/ng856; Masciarelli S, 2004, J CLIN INVEST, V114, P196, DOI 10.1172/JCI2004210804; MEHLMANN LM, 1994, BIOL REPROD, V51, P1088, DOI 10.1095/biolreprod51.6.1088; Mehlmann LM, 2002, SCIENCE, V297, P1343, DOI 10.1126/science.1073978; Mehlmann LM, 2004, SCIENCE, V306, P1947, DOI 10.1126/science.1103974; Mehlmann LM, 2005, DEV BIOL, V288, P397, DOI 10.1016/j.ydbio.2005.09.030; Miao YL, 2009, ENVIRON MOL MUTAGEN, V50, P666, DOI 10.1002/em.20506; Morikawa M, 2007, J REPROD DEVELOP, V53, P1151, DOI 10.1262/jrd.19055; Morrill GA, 1999, STEROIDS, V64, P157, DOI 10.1016/S0039-128X(98)00093-2; NAITO K, 1991, J REPROD FERTIL, V93, P467, DOI 10.1530/jrf.0.0930467; Nogueira D, 2003, BIOL REPROD, V69, P2045, DOI 10.1095/biolreprod.103.021105; Norris RP, 2009, DEVELOPMENT, V136, P1869, DOI 10.1242/dev.035238; Pirino G, 2009, CELL CYCLE, V8, P665, DOI 10.4161/cc.8.4.7846; Richard FJ, 2007, J ANIM SCI, V85, pE4, DOI 10.2527/jas.2006-475; Rios-Cardona D, 2008, DEV BIOL, V317, P380, DOI 10.1016/j.ydbio.2008.02.047; SCHULTZ RM, 1983, DEV BIOL, V95, P294, DOI 10.1016/0012-1606(83)90030-1; Solc P, 2010, MOL HUM REPROD, V16, P654, DOI 10.1093/molehr/gaq034; STRUM JC, 1995, J BIOL CHEM, V270, P13541, DOI 10.1074/jbc.270.22.13541; Sun QY, 2009, CELL CYCLE, V8, P2741, DOI 10.4161/cc.8.17.9471; TORNELL J, 1990, ACTA PHYSIOL SCAND, V139, P511, DOI 10.1111/j.1748-1716.1990.tb08953.x; Tsafriri A., 1994, MOL BIOL FEMALE REPR, P207; Uhlenbrock K, 2002, CELL SIGNAL, V14, P941, DOI 10.1016/S0898-6568(02)00041-4; Vaccari S, 2008, DEV BIOL, V316, P124, DOI 10.1016/j.ydbio.2008.01.018; VIVARELLI E, 1983, CELL DIFFER DEV, V12, P271, DOI 10.1016/0045-6039(83)90023-4; Wang J, 2006, CELL CYCLE, V5, P213, DOI 10.4161/cc.5.2.2365; Wang S, 2008, FRONT BIOSCI, V13, P7087, DOI 10.2741/3212; Xu BZ, 2009, ANIM REPROD SCI, V111, P17, DOI 10.1016/j.anireprosci.2008.02.010; Yang CR, PLOS ONE, V5	49	20	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e38807	10.1371/journal.pone.0038807	http://dx.doi.org/10.1371/journal.pone.0038807			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685609	Green Published, Green Submitted, gold			2022-12-27	WOS:000305351700073
J	Lasry, A; Sansom, SL; Hicks, KA; Uzunangelov, V				Lasry, Arielle; Sansom, Stephanie L.; Hicks, Katherine A.; Uzunangelov, Vladislav			Allocating HIV Prevention Funds in the United States: Recommendations from an Optimization Model	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED-DISEASES; COST-EFFECTIVENESS; AFRICAN-AMERICAN; PERSONS AWARE; RISK BEHAVIOR; INTERVENTION; TRANSMISSION; VIRUS; WOMEN; CARE	The Centers for Disease Control and Prevention (CDC) had an annual budget of approximately $327 million to fund health departments and community-based organizations for core HIV testing and prevention programs domestically between 2001 and 2006. Annual HIV incidence has been relatively stable since the year 2000 [1] and was estimated at 48,600 cases in 2006 and 48,100 in 2009 [2]. Using estimates on HIV incidence, prevalence, prevention program costs and benefits, and current spending, we created an HIV resource allocation model that can generate a mathematically optimal allocation of the Division of HIV/AIDS Prevention's extramural budget for HIV testing, and counseling and education programs. The model's data inputs and methods were reviewed by subject matter experts internal and external to the CDC via an extensive validation process. The model projects the HIV epidemic for the United States under different allocation strategies under a fixed budget. Our objective is to support national HIV prevention planning efforts and inform the decision-making process for HIV resource allocation. Model results can be summarized into three main recommendations. First, more funds should be allocated to testing and these should further target men who have sex with men and injecting drug users. Second, counseling and education interventions ought to provide a greater focus on HIV positive persons who are aware of their status. And lastly, interventions should target those at high risk for transmitting or acquiring HIV, rather than lower-risk members of the general population. The main conclusions of the HIV resource allocation model have played a role in the introduction of new programs and provide valuable guidance to target resources and improve the impact of HIV prevention efforts in the United States.	[Lasry, Arielle; Sansom, Stephanie L.] Centers Dis Control & Prevent, Div HIV AIDS Prevent, Atlanta, GA 30329 USA; [Hicks, Katherine A.; Uzunangelov, Vladislav] RTI Int, Res Triangle Pk, NC USA	Centers for Disease Control & Prevention - USA; Research Triangle Institute	Lasry, A (corresponding author), Centers Dis Control & Prevent, Div HIV AIDS Prevent, Atlanta, GA 30329 USA.	alasry@cdc.gov		Hicks, Katherine/0000-0002-1058-3401				Anderson John E, 2006, Adv Data, P1; [Anonymous], 2010, NAT HIV AIDS STRAT U; Brady JE, 2008, J URBAN HEALTH, V85, P323, DOI 10.1007/s11524-007-9248-5; Brandeau ML, 2009, HEALTH CARE MANAG SC, V12, P27, DOI 10.1007/s10729-008-9074-7; Campsmith ML, 2010, JAIDS-J ACQ IMM DEF, V53, P619, DOI 10.1097/QAI.0b013e3181bf1c45; CAPASSO V, 1978, MATH BIOSCI, V42, P43, DOI 10.1016/0025-5564(78)90006-8; Centers for Disease Control and Prevention, 2008, HIV SURV REP 2006, V18; Centers for Disease Control and Prevention (Database accessed May 2008), HIV COUNS TEST SYST, P2002; Chesson HW, 2002, BMC INFECT DIS, V2, DOI 10.1186/1471-2334-2-24; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Cooper HL, 2007, 2007 ANN M AM PUBL H; Crosby R, 2009, AM J PUBLIC HEALTH, V99, pS96, DOI 10.2105/AJPH.2007.123893; Farnham PG, 2008, PUBLIC HEALTH REP, V123, P51, DOI 10.1177/00333549081230S307; Fisher JD, 2006, JAIDS-J ACQ IMM DEF, V41, P44, DOI 10.1097/01.qai.0000192000.15777.5c; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Guinness Lorna, 2007, Cost Eff Resour Alloc, V5, P13, DOI 10.1186/1478-7547-5-13; Hall HI, 2008, JAMA-J AM MED ASSOC, V300, P520, DOI 10.1001/jama.300.5.520; Hall HI, 2006, AM J EPIDEMIOL, V164, P391, DOI 10.1093/aje/kwj216; Hutchinson AB, 2012, JAIDS-J ACQ IMM DEF, V59, P281, DOI 10.1097/QAI.0b013e31823e5bee; Jemmott LS, 2007, AM J PUBLIC HEALTH, V97, P1034, DOI 10.2105/AJPH.2003.020271; Kalichman SC, 2001, AM J PREV MED, V21, P84, DOI 10.1016/S0749-3797(01)00324-5; Lasry A, 2011, HEALTH CARE MANAG SC, V14, P115, DOI 10.1007/s10729-010-9147-2; Lasry A, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-S1-S8; Marks G, 2005, JAIDS-J ACQ IMM DEF, V39, P446, DOI 10.1097/01.qai.0000151079.33935.79; Marks G, 2006, AIDS, V20, P1447, DOI 10.1097/01.aids.0000233579.79714.8d; Marks G, 2009, AIDS BEHAV, V13, P682, DOI 10.1007/s10461-008-9380-6; Morin SF, 2007, JAIDS-J ACQ IMM DEF, V44, P213, DOI 10.1097/QAI.0b013e31802c0cae; NASTAD and the Kaiser Family Foundation, 2009, NAT HIV PREV INV STA; National Compensation Survey, 2006, NAT COMP SURV; Prejean J., 2008, Morbidity and Mortality Weekly Report, V57, P985; Prejean J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017502; Rotheram-Borus MJ, 2004, JAIDS-J ACQ IMM DEF, V37, pS68, DOI 10.1097/01.qai.0000140604.57478.67; Schackman BR, 2006, MED CARE, V44, P990, DOI 10.1097/01.mlr.0000228021.89490.2a; Scholes D, 2003, AIDS, V17, P1547, DOI 10.1097/00002030-200307040-00016; Shrestha RK, 2008, PUBLIC HEALTH REP, V123, P94, DOI 10.1177/00333549081230S312; Shrestha RK, 2012, J PUBLIC HEALTH MAN, V18, P259, DOI 10.1097/PHH.0b013e31822b2077; Siegfried N, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003362.pub2; Silva A, 2007, ANN EMERG MED, V49, P564, DOI 10.1016/j.annemergmed.2006.09.028; Smith A., 2010, Morbidity and Mortality Weekly Report, V59, P1201; Sweat M, 2001, AIDS, V15, P781, DOI 10.1097/00002030-200104130-00014; Weinhardt LS, 1999, AM J PUBLIC HEALTH, V89, P1397, DOI 10.2105/AJPH.89.9.1397; Wingood GM, 2004, JAIDS-J ACQ IMM DEF, V37, pS58, DOI 10.1097/01.qai.0000140603.57478.a9; YORKE JA, 1978, SEX TRANSM DIS, V5, P51, DOI 10.1097/00007435-197804000-00003	43	24	24	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e37545	10.1371/journal.pone.0037545	http://dx.doi.org/10.1371/journal.pone.0037545			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959WK	22701571	Green Published, Green Submitted, gold			2022-12-27	WOS:000305348400013
J	Cloutier, S; Laverdiere, M; Chou, MN; Boilard, N; Chow, C; Papadopoulou, B				Cloutier, Serge; Laverdiere, Maxime; Chou, Marie-Noelle; Boilard, Nathalie; Chow, Conan; Papadopoulou, Barbara			Translational Control through eIF2alpha Phosphorylation during the Leishmania Differentiation Process	PLOS ONE			English	Article							IN-VITRO CULTIVATION; GENE-EXPRESSION; AXENIC AMASTIGOTES; DONOVANI; STAGE; INITIATION; STRESS; MODEL; PROMASTIGOTE; KINASES	The parasitic protozoan Leishmania alternates between an invertebrate and a mammalian host. Upon their entry to mammalian macrophages, Leishmania promastigotes differentiate into amastigote forms within the harsh environment of the phagolysosomal compartment. Here, we provide evidence for the importance of translational control during the Leishmania differentiation process. We find that exposure of promastigotes to a combined elevated temperature and acidic pH stress, a key signal triggering amastigote differentiation, leads to a marked decrease in global translation initiation, which is associated with eIF2 alpha phosphorylation. Interestingly, we show that amastigotes adapted to grow in a cell-free medium exhibit lower levels of protein synthesis in comparison to promastigotes, suggesting that amastigotes have to enter a slow growth state to adapt to the stressful conditions encountered inside macrophages. Reconversion of amastigotes back to promastigote growth results in upregulation of global translation and a decrease in eIF2 alpha phosphorylation. In addition, we show that while general translation is reduced during amastigote differentiation, translation of amastigote-specific transcripts such as A2 is preferentially upregulated. We find that A2 developmental gene regulation is triggered by temperature changes in the environment and that occurs mainly at the level of translation. Upon elevated temperature, the A2 transcript is stabilized through its association with polyribosomes leading to high levels of translation. When temperature decreases during amastigote to promastigote differentiation, the A2 transcript is not longer associated with translating polyribosomes and is being gradually degraded. Overall, these findings contribute to our better understanding of the adaptive responses of Leishmania to stress during its development and highlight the importance of translational control in promastigote to amastigote differentiation and vice-versa.	[Papadopoulou, Barbara] Univ Laval, CHUL Res Ctr, Infect Dis Res Ctr, Quebec City, PQ, Canada; Univ Laval, Fac Med, Dept Microbiol & Immunol, Quebec City, PQ G1K 7P4, Canada	Laval University; Laval University	Cloutier, S (corresponding author), Univ Laval, CHUL Res Ctr, Infect Dis Res Ctr, Quebec City, PQ, Canada.	barbara.papadopoulou@crchul.ulaval.ca			Canadian Institutes of Health Research (CIHR) [MOP-12182]; CIHR Research Doctoral Fellowship; Centre for Host-Parasite Interactions of the "Fonds Quebecois de la Recherche sur la Nature et les Technologies"; CIHR [STP-53924]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR Research Doctoral Fellowship(Canadian Institutes of Health Research (CIHR)); Centre for Host-Parasite Interactions of the "Fonds Quebecois de la Recherche sur la Nature et les Technologies"; CIHR(Canadian Institutes of Health Research (CIHR))	This work was supported by an operating grant from the Canadian Institutes of Health Research (CIHR) (MOP-12182) awarded to BP. SC was awarded by a CIHR Research Doctoral Fellowship and by a doctoral research bridging award from the Centre for Host-Parasite Interactions of the "Fonds Quebecois de la Recherche sur la Nature et les Technologies". CC was awarded by a postdoctoral fellowship from the CIHR STP-53924 Strategic Training Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcolea Pedro J, 2010, BMC Genomics, V11, P31, DOI 10.1186/1471-2164-11-31; Barak E, 2005, MOL BIOCHEM PARASIT, V141, P99, DOI 10.1016/j.molbiopara.2005.02.004; BATES PA, 1994, EXP PARASITOL, V79, P215, DOI 10.1006/expr.1994.1084; BATES PA, 1992, PARASITOLOGY, V105, P193, DOI 10.1017/S0031182000074102; CHAREST H, 1994, MOL CELL BIOL, V14, P2975, DOI 10.1128/MCB.14.5.2975; Chow C, 2011, CELL MICROBIOL, V13, P1059, DOI 10.1111/j.1462-5822.2011.01602.x; Clayton C, 2007, MOL BIOCHEM PARASIT, V156, P93, DOI 10.1016/j.molbiopara.2007.07.007; Cohen-Freue G, 2007, INT J PARASITOL, V37, P1077, DOI 10.1016/j.ijpara.2007.04.011; Debrabant A, 2004, INT J PARASITOL, V34, P205, DOI 10.1016/j.ijpara.2003.10.011; Desjeux P, 2004, COMP IMMUNOL MICROB, V27, P305, DOI 10.1016/j.cimid.2004.03.004; Dever TE, 2002, CELL, V108, P545, DOI 10.1016/S0092-8674(02)00642-6; Goyard S, 2003, MOL BIOCHEM PARASIT, V130, P31, DOI 10.1016/S0166-6851(03)00142-7; Gupta N, 2001, TRENDS PARASITOL, V17, P150, DOI 10.1016/S1471-4922(00)01811-0; Haile S, 2007, CURR OPIN MICROBIOL, V10, P569, DOI 10.1016/j.mib.2007.10.001; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Hem S, 2010, PROTEOMICS, V10, P3868, DOI 10.1002/pmic.201000305; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Joyce BR, 2010, P NATL ACAD SCI USA, V107, P17200, DOI 10.1073/pnas.1007610107; Kramer S, 2008, J CELL SCI, V121, P3002, DOI 10.1242/jcs.031823; Lahav T, 2011, FASEB J, V25, P515, DOI 10.1096/fj.10-157529; McCall LI, 2010, MOL MICROBIOL, V77, P518, DOI 10.1111/j.1365-2958.2010.07229.x; MCCONVILLE MJ, 1991, J BIOL CHEM, V266, P15170; McConville MJ, 2011, ANN REV MICROBIOL; McNicoll F, 2005, J BIOL CHEM, V280, P35238, DOI 10.1074/jbc.M507511200; McNicoll F, 2006, PROTEOMICS, V6, P3567, DOI 10.1002/pmic.200500853; Moraes MCS, 2007, EUKARYOT CELL, V6, P1979, DOI 10.1128/EC.00249-07; Morales MA, 2008, PROTEOMICS, V8, P350, DOI 10.1002/pmic.200700697; Morales MA, 2010, P NATL ACAD SCI USA, V107, P8381, DOI 10.1073/pnas.0914768107; Narasimhan J, 2008, J BIOL CHEM, V283, P16591, DOI 10.1074/jbc.M800681200; Paape D, 2008, MOL CELL PROTEOMICS, V7, P1688, DOI 10.1074/mcp.M700343-MCP200; RAINEY PM, 1991, MOL BIOCHEM PARASIT, V49, P111, DOI 10.1016/0166-6851(91)90134-R; Rochette Annie, 2008, BMC Genomics, V9, P255, DOI 10.1186/1471-2164-9-255; Rochette A, 2009, MOL BIOCHEM PARASIT, V165, P32, DOI 10.1016/j.molbiopara.2008.12.012; Ron D, 2007, TRANSLATIONAL CONTRO, P345; Rosenzweig D, 2008, FASEB J, V22, P590, DOI 10.1096/fj.07-9254com; Saar Y, 1998, MOL BIOCHEM PARASIT, V95, P9, DOI 10.1016/S0166-6851(98)00062-0; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Saxena A, 2007, MOL BIOCHEM PARASIT, V152, P53, DOI 10.1016/j.molbiopara.2006.11.011; Sereno D, 1998, ANTIMICROB AGENTS CH, V42, P3097, DOI 10.1128/AAC.42.12.3097; Sereno D, 1997, ANTIMICROB AGENTS CH, V41, P972, DOI 10.1128/AAC.41.5.972; Somanna A, 2002, ACTA TROP, V83, P37, DOI 10.1016/S0001-706X(02)00054-2; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Tonelli RR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027904; TURCO SJ, 1991, MOL BIOCHEM PARASIT, V45, P91, DOI 10.1016/0166-6851(91)90030-A; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Wu Y, 2000, MOL BIOCHEM PARASIT, V110, P345, DOI 10.1016/S0166-6851(00)00290-5; Yaman I, 2003, CELL, V113, P519, DOI 10.1016/S0092-8674(03)00345-3; ZILBERSTEIN D, 1994, ANNU REV MICROBIOL, V48, P449, DOI 10.1146/annurev.mi.48.100194.002313	50	41	41	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e35085	10.1371/journal.pone.0035085	http://dx.doi.org/10.1371/journal.pone.0035085			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693545	gold, Green Published, Green Submitted			2022-12-27	WOS:000305338500006
J	Liu, Y; Wang, L; Long, ZY; Zeng, L; Wu, YM				Liu, Yuan; Wang, Li; Long, Zaiyun; Zeng, Lin; Wu, Yamin			Protoplasmic Astrocytes Enhance the Ability of Neural Stem Cells to Differentiate into Neurons In Vitro	PLOS ONE			English	Article							NEUROTROPHIC FACTOR; GROWTH-FACTORS; PROLIFERATION; REPAIR; CNS; PROGENITORS; ROLES	Protoplasmic astrocytes have been reported to exhibit neuroprotective effects on neurons, but there has been no direct evidence for a functional relationship between protoplasmic astrocytes and neural stem cells (NSCs). In this study, we examined neuronal differentiation of NSCs induced by protoplasmic astrocytes in a co-culture model. Protoplasmic astrocytes were isolated from new-born and NSCs from the E13-15 cortex of rats respectively. The differentiated cells labeled with neuron-specific marker beta-tubulin III, were dramatically increased at 7 days in the co-culture condition. Blocking the effects of brain-derived neurotrophic factor (BDNF) with an anti-BDNF antibody reduced the number of neurons differentiated from NSCs when co-cultured with protoplasmic astrocytes. In fact, the content of BDNF in the supernatant obtained from protoplasmic astrocytes and NSCs co-culture media was significantly greater than that from control media conditions. These results indicate that protoplasmic astrocytes promote neuronal differentiation of NSCs, which is driven, at least in part, by BDNF.	[Liu, Yuan; Wang, Li; Long, Zaiyun; Zeng, Lin; Wu, Yamin] Third Mil Med Univ, State Key Lab Trauma Burns & Combined Injury, Daping Hosp, Inst Surg,Dept Res 3, Chongqing, Peoples R China	Army Medical University	Liu, Y (corresponding author), Third Mil Med Univ, State Key Lab Trauma Burns & Combined Injury, Daping Hosp, Inst Surg,Dept Res 3, Chongqing, Peoples R China.	yaminwu65@hotmail.com			National Natural Science Foundation of China [81000682]; Chongqing National Natural Science Fund [2008BB5276]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chongqing National Natural Science Fund	This work was supported by a grant from the National Natural Science Foundation of China (#81000682) and Chongqing National Natural Science Fund (#2008BB5276). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barkho BZ, 2006, STEM CELLS DEV, V15, P407, DOI 10.1089/scd.2006.15.407; Barnabe-Heider F, 2008, CELL STEM CELL, V3, P16, DOI 10.1016/j.stem.2008.06.011; CATTANEO E, 1990, NATURE, V347, P762, DOI 10.1038/347762a0; Deleyrolle L, 2006, STEM CELLS, V24, P748, DOI 10.1634/stemcells.2005-0138; Emsley JG, 2005, PROG NEUROBIOL, V75, P321, DOI 10.1016/j.pneurobio.2005.04.002; Emsley JG, 2004, TRENDS NEUROSCI, V27, P238, DOI 10.1016/j.tins.2004.02.008; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Itami C, 2007, J NEUROSCI, V27, P2241, DOI 10.1523/JNEUROSCI.3345-06.2007; Kang SK, 2003, DEV BRAIN RES, V145, P141, DOI 10.1016/S0165-3806(03)00224-4; Konagaya S, 2011, BIOMATERIALS, V32, P5015, DOI 10.1016/j.biomaterials.2011.03.066; Leng J, 2009, BRAIN RES, V1272, P14, DOI 10.1016/j.brainres.2009.03.048; Lepore AC, 2006, NEUROSCIENCE, V142, P285, DOI 10.1016/j.neuroscience.2005.12.068; Li XG, 2009, BIOMATERIALS, V30, P4978, DOI 10.1016/j.biomaterials.2009.05.047; Lu HX, 2008, BRAIN RES BULL, V77, P158, DOI 10.1016/j.brainresbull.2008.02.037; Meng XT, 2007, CELL BIOL INT, V31, P691, DOI 10.1016/j.cellbi.2006.11.038; Moyse E, 2008, CURR STEM CELL RES T, V3, P163, DOI 10.2174/157488808785740334; Nakayama T, 2003, NEUROSCI RES, V46, P241, DOI 10.1016/S0168-0102(03)00063-4; Naoko K, 2010, NEURON, V67, P213; Petrova PS, 2003, J MOL NEUROSCI, V20, P173, DOI 10.1385/JMN:20:2:173; ROSEWATER K, 1994, BRAIN RES, V636, P73, DOI 10.1016/0006-8993(94)90177-5; Sasaki R, 2010, NEUROSCI LETT, V479, P126, DOI 10.1016/j.neulet.2010.05.042; SHEHAB SAS, 1990, BRAIN RES, V518, P347, DOI 10.1016/0006-8993(90)90996-O; Tarasenko YI, 2004, J NEUROSCI RES, V78, P625, DOI 10.1002/jnr.20316; Vaillant AR, 2002, NEURON, V34, P985, DOI 10.1016/S0896-6273(02)00717-1; Wang FW, 2011, STEM CELL RES, V7, P41, DOI 10.1016/j.scr.2011.03.004; Wang L, 2011, J NEUROSCI METH, V194, P274, DOI 10.1016/j.jneumeth.2010.10.025; Wang Y, 2010, NEUROSCI LETT, V476, P74, DOI 10.1016/j.neulet.2010.04.006; Willerth SM, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt58; Xuan AG, 2008, NEUROSCI LETT, V440, P331, DOI 10.1016/j.neulet.2008.05.107; Zeng WR, 2011, NEUROCHEM INT, V59, P394, DOI 10.1016/j.neuint.2011.04.002; Zhu ZH, 2006, BRAIN RES, V1114, P1, DOI 10.1016/j.brainres.2006.07.070	31	10	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38243	10.1371/journal.pone.0038243	http://dx.doi.org/10.1371/journal.pone.0038243			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693605	Green Published, gold, Green Submitted			2022-12-27	WOS:000305338500116
J	Tweedie-Cullen, RY; Brunner, AM; Grossmann, J; Mohanna, S; Sichau, D; Nanni, P; Panse, C; Mansuy, IM				Tweedie-Cullen, Ry Y.; Brunner, Andrea M.; Grossmann, Jonas; Mohanna, Safa; Sichau, David; Nanni, Paolo; Panse, Christian; Mansuy, Isabelle M.			Identification of Combinatorial Patterns of Post-Translational Modifications on Individual Histones in the Mouse Brain	PLOS ONE			English	Article							DISSOCIATION MASS-SPECTROMETRY; LONG-TERM-MEMORY; PROTEIN-PHOSPHORYLATION; LYSINE-METHYLATION; H3 VARIANTS; CHROMATIN; ACETYLATION; CODE; H4; COGNITION	Post-translational modifications (PTMs) of proteins are biochemical processes required for cellular functions and signalling that occur in every sub-cellular compartment. Multiple protein PTMs exist, and are established by specific enzymes that can act in basal conditions and upon cellular activity. In the nucleus, histone proteins are subjected to numerous PTMs that together form a histone code that contributes to regulate transcriptional activity and gene expression. Despite their importance however, histone PTMs have remained poorly characterised in most tissues, in particular the brain where they are thought to be required for complex functions such as learning and memory formation. Here, we report the comprehensive identification of histone PTMs, of their combinatorial patterns, and of the rules that govern these patterns in the adult mouse brain. Based on liquid chromatography, electron transfer, and collision-induced dissociation mass spectrometry, we generated a dataset containing a total of 10,646 peptides from H1, H2A, H2B, H3, H4, and variants in the adult brain. 1475 of these peptides carried one or more PTMs, including 141 unique sites and a total of 58 novel sites not described before. We observed that these PTMs are not only classical modifications such as serine/threonine (Ser/Thr) phosphorylation, lysine (Lys) acetylation, and Lys/arginine (Arg) methylation, but also include several atypical modifications such as Ser/Thr acetylation, and Lys butyrylation, crotonylation, and propionylation. Using synthetic peptides, we validated the presence of these atypical novel PTMs in the mouse brain. The application of data-mining algorithms further revealed that histone PTMs occur in specific combinations with different ratios. Overall, the present data newly identify a specific histone code in the mouse brain and reveal its level of complexity, suggesting its potential relevance for higher-order brain functions.	[Tweedie-Cullen, Ry Y.; Brunner, Andrea M.; Mohanna, Safa; Sichau, David; Mansuy, Isabelle M.] Univ Zurich, Brain Res Inst, Fac Med, Zurich, Switzerland; [Tweedie-Cullen, Ry Y.; Brunner, Andrea M.; Mohanna, Safa; Sichau, David; Mansuy, Isabelle M.] ETH, Dept Biol, Zurich, Switzerland; [Grossmann, Jonas; Nanni, Paolo; Panse, Christian] Univ Zurich, ETH Zurich, Funct Genom Ctr Zurich, Zurich, Switzerland	University of Geneva; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich	Tweedie-Cullen, RY (corresponding author), Harvard Univ, Sch Med, FM Kirby Neurobiol Ctr, Childrens Hosp Boston, Boston, MA 02115 USA.	mansuy@hifo.uzh.ch	Mansuy, Isabelle M/N-3042-2015	Mansuy, Isabelle M/0000-0001-7785-5371; Brunner, Andrea Mizzi/0000-0002-2801-1751; Nanni, Paolo/0000-0001-8429-3557	University Zurich; Swiss Federal Institute of Technology; Swiss National Foundation; The National Centre for Competence in Research "Neural Plasticity and Repair"; Slack-Gyr Foundation; Bitterlin Foundation	University Zurich; Swiss Federal Institute of Technology; Swiss National Foundation(Swiss National Science Foundation (SNSF)); The National Centre for Competence in Research "Neural Plasticity and Repair"; Slack-Gyr Foundation; Bitterlin Foundation	The lab of IMM is funded by the University Zurich, the Swiss Federal Institute of Technology, the Swiss National Foundation, The National Centre for Competence in Research "Neural Plasticity and Repair", the Slack-Gyr Foundation, and the Bitterlin Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal R., 1993, P 1993 ACM SIGMOD IN, P207, DOI [10.1145/170035.170072, DOI 10.1145/170035.170072]; Baker M, 2011, NAT METHODS, V8, P717, DOI 10.1038/nmeth.1673; Basu A, 2009, P NATL ACAD SCI USA, V106, P13785, DOI 10.1073/pnas.0906801106; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Bode AM, 2005, INDUCIBLE COVALENT P, pre4; Bodon F, 2006, SURVEY FREQUENT ITEM; Brunner AM, 2012, EPIGENETIC IN PRESS; Campos EI, 2009, ANNU REV GENET, V43, P559, DOI 10.1146/annurev.genet.032608.103928; Chen Y, 2007, MOL CELL PROTEOMICS, V6, P812, DOI 10.1074/mcp.M700021-MCP200; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Chwang WB, 2007, J NEUROSCI, V27, P12732, DOI 10.1523/JNEUROSCI.2522-07.2007; CRICK F, 1984, NATURE, V312, P101, DOI 10.1038/312101a0; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Danielsen JMR, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.003590; Day JJ, 2011, NEURON, V70, P813, DOI 10.1016/j.neuron.2011.05.019; Garcia BA, 2005, BIOCHEMISTRY-US, V44, P13202, DOI 10.1021/bi050906n; Garcia BA, 2008, J PROTEOME RES, V7, P4225, DOI 10.1021/pr800044q; Garcia BA, 2007, NAT METHODS, V4, P487, DOI 10.1038/nmeth1052; Garcia Benjamin A, 2009, Front Biosci (Schol Ed), V1, P142, DOI 10.2741/s14; Garske AL, 2008, BIOCHEMISTRY-US, V47, P8094, DOI 10.1021/bi800766k; Genoux D, 2002, NATURE, V418, P970, DOI 10.1038/nature00928; Graff J, 2008, BEHAV BRAIN RES, V192, P70, DOI 10.1016/j.bbr.2008.01.021; Graeff J, 2011, PHYSIOL REV, V91, P603, DOI 10.1152/physrev.00012.2010; Graff J, 2010, LEARN MEMORY, V17, P355, DOI 10.1101/lm.1766510; Gupta S, 2010, J NEUROSCI, V30, P3589, DOI 10.1523/JNEUROSCI.3732-09.2010; Han JH, 2007, SCIENCE, V316, P457, DOI [10.1126/science.1139438, 10.1126/science.1134697]; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Koshibu K, 2009, J NEUROSCI, V29, P13079, DOI 10.1523/JNEUROSCI.3610-09.2009; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Latham JA, 2007, NAT STRUCT MOL BIOL, V14, P1017, DOI 10.1038/nsmb1307; Lieber DS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014444; Lin YX, 2008, NATURE, V455, P1198, DOI 10.1038/nature07319; Liu B, 2009, J BIOL CHEM, V284, P32288, DOI 10.1074/jbc.M109.045856; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Mukherjee S, 2007, TRENDS BIOCHEM SCI, V32, P210, DOI 10.1016/j.tibs.2007.03.007; Munton RP, 2007, MOL CELL PROTEOMICS, V6, P283, DOI 10.1074/mcp.M600046-MCP200; Pang CNI, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-92; Phanstiel D, 2008, P NATL ACAD SCI USA, V105, P4093, DOI 10.1073/pnas.0710515105; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; ROEPSTORFF P, 1984, BIOMED MASS SPECTROM, V11, P601, DOI 10.1002/bms.1200111109; Schwartz D, 2005, NAT BIOTECHNOL, V23, P1391, DOI 10.1038/nbt1146; Schwartz D, 2009, MOL CELL PROTEOMICS, V8, P365, DOI 10.1074/mcp.M800332-MCP200; Siuti N, 2007, NAT METHODS, V4, P817, DOI 10.1038/NMETH1097; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Syka JEP, 2004, P NATL ACAD SCI USA, V101, P9528, DOI 10.1073/pnas.0402700101; Tan MJ, 2011, CELL, V146, P1015, DOI 10.1016/j.cell.2011.08.008; Thomas T, 2008, MOL CELL BIOL, V28, P5093, DOI 10.1128/MCB.02202-07; THORNE AW, 1990, EUR J BIOCHEM, V193, P701, DOI 10.1111/j.1432-1033.1990.tb19390.x; Tweedie-Cullen R. Y., 2009, POSTTRANSLATIONAL MO, P233; Tweedie-Cullen RY, 2010, AMINO ACIDS, V39, P1117, DOI 10.1007/s00726-010-0723-z; Tweedie-Cullen RY, 2009, J PROTEOME RES, V8, P4966, DOI 10.1021/pr9003739; Udeshi ND, 2008, NAT PROTOC, V3, P1709, DOI 10.1038/nprot.2008.159; Wisniewski JR, 2007, MOL CELL PROTEOMICS, V6, P72, DOI 10.1074/mcp.M600255-MCP200; Wooderchak WL, 2008, BIOCHEMISTRY-US, V47, P9456, DOI 10.1021/bi800984s; Yang HB, 2009, BIOCHEM CELL BIOL, V87, P151, DOI 10.1139/O08-131; Zhang KL, 2002, MOL CELL PROTEOMICS, V1, P500, DOI 10.1074/mcp.M200031-MCP200	56	111	112	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e36980	10.1371/journal.pone.0036980	http://dx.doi.org/10.1371/journal.pone.0036980			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693562	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000305338500024
J	Li, H; Qian, WW; Weng, XS; Wu, ZH; Li, HH; Zhuang, QY; Feng, B; Bian, YY				Li, Hui; Qian, Wenwei; Weng, Xisheng; Wu, Zhihong; Li, Huihua; Zhuang, Qianyu; Feng, Bin; Bian, Yanyan			Glucocorticoid Receptor and Sequential P53 Activation by Dexamethasone Mediates Apoptosis and Cell Cycle Arrest of Osteoblastic MC3T3-E1 Cells	PLOS ONE			English	Article							DNA-BINDING COOPERATIVITY; TUMOR-SUPPRESSOR PROTEIN; LEUCINE-ZIPPER GILZ; MULTIPLE-MYELOMA; GRANZYME-A; MECHANISMS; BONE; IDENTIFICATION; INHIBITION; EXPRESSION	Glucocorticoids play a pivotal role in the proliferation of osteoblasts, but the underlying mechanism has not been successfully elucidated. In this report, we have investigated the molecular mechanism which elucidates the inhibitory effects of dexamethasone on murine osteoblastic MC3T3-E1 cells. It was found that the inhibitory effects were largely attributed to apoptosis and G1 phase arrest. Both the cell cycle arrest and apoptosis were dependent on glucocorticoid receptor (GR), as they were abolished by GR blocker RU486 pre-treatment and GR interference. G1 phase arrest and apoptosis were accompanied with a p53-dependent up-regulation of p21 and pro-apoptotic genes NOXA and PUMA. We also proved that dexamethasone can't induce apoptosis and cell cycle arrest when p53 was inhibited by p53 RNA interference. These data demonstrate that proliferation of MC3T3-E1 cell was significantly and directly inhibited by dexamethasone treatment via aberrant GR activation and subsequently P53 activation.	[Li, Hui] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Orthopaed Surg, Beijing 100730, Peoples R China; Peking Union Med Coll, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Li, H (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Orthopaed Surg, Beijing 100730, Peoples R China.	xshweng@medmail.com.cn	wu, zhi/GXH-3041-2022	Weng, Xisheng/0000-0002-6021-1462	National Natural Science Foundation of P.R. China [30973042]	National Natural Science Foundation of P.R. China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of P.R. China (Grant Number: 30973042). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayroldi E, 2009, FASEB J, V23, P3649, DOI 10.1096/fj.09-134684; Civitelli R, 2008, J Endocrinol Invest, V31, P2; Crochemore C, 2002, FASEB J, V16, DOI 10.1096/fj.01-0577com; de Late PL, 2010, J BIOL CHEM, V285, P5594, DOI 10.1074/jbc.M109.068346; Espina B, 2008, J CELL PHYSIOL, V215, P488, DOI 10.1002/jcp.21335; Fukushima W, 2010, CLIN ORTHOP RELAT R, V468, P2715, DOI 10.1007/s11999-010-1292-x; Grugan KD, 2008, J STEROID BIOCHEM, V110, P244, DOI 10.1016/j.jsbmb.2007.11.003; Lowenberg M, 2008, STEROIDS, V73, P1025, DOI 10.1016/j.steroids.2007.12.002; Lu NZ, 2007, MOL CELL BIOL, V27, P7143, DOI 10.1128/MCB.00253-07; Murphy SH, 2011, P NATL ACAD SCI USA, V108, P17117, DOI 10.1073/pnas.1114420108; Myoumoto A, 2007, J HUM GENET, V52, P328, DOI 10.1007/s10038-007-0119-4; O'Brien CA, 2004, ENDOCRINOLOGY, V145, P1835, DOI 10.1210/en.2003-0990; Ruike Y, 2007, J HUM GENET, V52, P172, DOI 10.1007/s10038-006-0099-9; Sasson R, 2002, BIOCHEM BIOPH RES CO, V294, P51, DOI 10.1016/S0006-291X(02)00431-X; Schacke H, 2002, PHARMACOL THERAPEUT, V96, P23, DOI 10.1016/S0163-7258(02)00297-8; Schlereth K, 2010, CELL CYCLE, V9, P4068, DOI 10.4161/cc.9.20.13595; Schlereth K, 2010, MOL CELL, V38, P356, DOI 10.1016/j.molcel.2010.02.037; Sengupta S, 2001, GENE DEV, V15, P2367, DOI 10.1101/gad.202201; Sengupta S, 2000, EMBO J, V19, P6051, DOI 10.1093/emboj/19.22.6051; Shen L, 2004, LEUKEMIA, V18, P1850; Smith E, 2000, J BIOL CHEM, V275, P19992, DOI 10.1074/jbc.M001758200; Smith E, 2002, J BIOL CHEM, V277, P18191, DOI 10.1074/jbc.M109708200; Soundararajan R, 2010, J BIOL CHEM, V285, P39905, DOI 10.1074/jbc.M110.161133; Urban G, 2003, J BIOL CHEM, V278, P9747, DOI 10.1074/jbc.M210993200; Wang DP, 2006, J IMMUNOL, V176, P1695, DOI 10.4049/jimmunol.176.3.1695; Weinstein RS, 1998, J CLIN INVEST, V102, P274, DOI 10.1172/JCI2799; Wu W, 2005, J BIOL CHEM, V280, P4117, DOI 10.1074/jbc.M411200200; Xie H, 2010, AMINO ACIDS, V38, P1145, DOI 10.1007/s00726-009-0325-9; Yan HJ, 2006, CANCER RES, V66, P2305, DOI 10.1158/0008-5472.CAN-05-2447; Yun SI, 2009, J BONE MINER METAB, V27, P140, DOI 10.1007/s00774-008-0019-5	30	70	78	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2012	7	6							e37030	10.1371/journal.pone.0037030	http://dx.doi.org/10.1371/journal.pone.0037030			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WG	22719835	Green Submitted, Green Published, gold			2022-12-27	WOS:000305347800002
J	Zhang, TY; DeSimone, RA; Jiao, XM; Rohlf, FJ; Zhu, W; Gong, QQ; Hunt, SR; Dassopoulos, T; Newberry, RD; Sodergren, E; Weinstock, G; Robertson, CE; Frank, DN; Li, E				Zhang, Tianyi; DeSimone, Robert A.; Jiao, Xiangmin; Rohlf, F. James; Zhu, Wei; Gong, Qing Qing; Hunt, Steven R.; Dassopoulos, Themistocles; Newberry, Rodney D.; Sodergren, Erica; Weinstock, George; Robertson, Charles E.; Frank, Daniel N.; Li, Ellen			Host Genes Related to Paneth Cells and Xenobiotic Metabolism Are Associated with Shifts in Human Ileum-Associated Microbial Composition	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; ILEAL CROHNS-DISEASE; CLOSTRIDIUM-DIFFICILE; DEFENSIN EXPRESSION; ULCERATIVE-COLITIS; NOD2; ATG16L1; PATHOGENESIS; IMBALANCES; PHENOTYPE	The aim of this study was to integrate human clinical, genotype, mRNA microarray and 16 S rRNA sequence data collected on 84 subjects with ileal Crohn's disease, ulcerative colitis or control patients without inflammatory bowel diseases in order to interrogate how host-microbial interactions are perturbed in inflammatory bowel diseases (IBD). Ex-vivo ileal mucosal biopsies were collected from the disease unaffected proximal margin of the ileum resected from patients who were undergoing initial intestinal surgery. Both RNA and DNA were extracted from the mucosal biopsy samples. Patients were genotyped for the three major NOD2 variants (Leufs1007, R702W, and G908R) and the ATG16L1T300A variant. Whole human genome mRNA expression profiles were generated using Agilent microarrays. Microbial composition profiles were determined by 454 pyrosequencing of the V3-V5 hypervariable region of the bacterial 16 S rRNA gene. The results of permutation based multivariate analysis of variance and covariance (MANCOVA) support the hypothesis that host mucosal Paneth cell and xenobiotic metabolism genes play an important role in host microbial interactions.	[Zhang, Tianyi; Jiao, Xiangmin; Zhu, Wei] SUNY Stony Brook, Dept Appl Math & Stat, Stony Brook, NY 11794 USA; [Zhang, Tianyi; DeSimone, Robert A.; Li, Ellen] SUNY Stony Brook, Dept Med, Stony Brook, NY 11794 USA; [Rohlf, F. James] SUNY Stony Brook, Dept Ecol & Evolut, Stony Brook, NY 11794 USA; [Gong, Qing Qing; Dassopoulos, Themistocles; Newberry, Rodney D.; Li, Ellen] Washington Univ, Dept Med, St Louis Sch Med, St Louis, MO USA; [Hunt, Steven R.] Washington Univ, St Louis Sch Med, Dept Surg, St Louis, MO USA; [Sodergren, Erica; Weinstock, George] Washington Univ, St Louis Sch Med, Genome Inst, St Louis, MO USA; [Robertson, Charles E.] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA; [Frank, Daniel N.] Univ Colorado, Dept Med, Aurora, CO 80309 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Saint Louis University; Washington University (WUSTL); Saint Louis University; Washington University (WUSTL); Saint Louis University; Washington University (WUSTL); University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Anschutz Medical Campus	Zhang, TY (corresponding author), SUNY Stony Brook, Dept Appl Math & Stat, Stony Brook, NY 11794 USA.	Ellen.Li@stonybrook.edu	Rohlf, F./AAR-6717-2021; Weinstock, George M/C-6314-2013	Rohlf, F./0000-0003-0522-3679; Weinstock, George M/0000-0002-2997-4592; ROBERTSON, CHARLES/0000-0002-4136-4121; DeSimone, Robert/0000-0002-3484-790X; Jiao, Xiangmin/0000-0002-7111-9813; Newberry, Rodney/0000-0002-4152-5191	National Institutes of Health (NIH) [UH2DK083994]; Crohn's and Colitis Foundation of America; Simons Foundation; Leona M. and Harry B. Helmsley charitable trust through the Sinai-Helmsley Alliance for Research Excellence (SHARE) Network; NIH [R21HG005964]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R21HG005964] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK052574, UH2DK083994] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation of America; Simons Foundation; Leona M. and Harry B. Helmsley charitable trust through the Sinai-Helmsley Alliance for Research Excellence (SHARE) Network; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported partially by National Institutes of Health (NIH) UH2DK083994, the Crohn's and Colitis Foundation of America, the Simons Foundation and by the Leona M. and Harry B. Helmsley charitable trust through the Sinai-Helmsley Alliance for Research Excellence (SHARE) Network and NIH R21HG005964. The authors acknowledge use of the Washington University Digestive Diseases Research Core Center Tissue Procurement Facility (P30 DK52574). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham C, 2009, NEW ENGL J MED, V361, P2066, DOI 10.1056/NEJMra0804647; Aitchison J, 2003, STAT ANAL COMPOSITIO; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Bevins CL, 2009, GUT, V58, P882; Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; Cadwell K, 2010, CELL, V141, P1135, DOI 10.1016/j.cell.2010.05.009; Chen HY, 2011, DIS COLON RECTUM, V54, P1020, DOI 10.1007/DCR.0b013e31821b94b3; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; COLLINS MD, 1994, INT J SYST BACTERIOL, V44, P812, DOI 10.1099/00207713-44-4-812; Cuthbert AP, 2002, GASTROENTEROLOGY, V122, P867, DOI 10.1053/gast.2002.32415; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dieckgraefe BK, 2000, PHYSIOL GENOMICS, V4, P1; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Frank DN, 2011, TRENDS MICROBIOL, V19, P427, DOI 10.1016/j.tim.2011.06.005; Frank DN, 2011, INFLAMM BOWEL DIS, V17, P179, DOI 10.1002/ibd.21339; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Hamm CM, 2010, INFLAMM BOWEL DIS, V16, P1649, DOI 10.1002/ibd.21208; Hancock L, 2008, INFLAMM BOWEL DIS, V14, P1667, DOI 10.1002/ibd.20517; Hartupee JC, 2001, BBA-GENE STRUCT EXPR, V1518, P287, DOI 10.1016/S0167-4781(00)00284-0; Hooper LV, 2001, SCIENCE, V291, P881, DOI 10.1126/science.291.5505.881; Issa M, 2007, CLIN GASTROENTEROL H, V5, P345, DOI 10.1016/j.cgh.2006.12.028; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; Langmann T, 2004, GASTROENTEROLOGY, V127, P26, DOI 10.1053/j.gastro.2004.04.019; Lawrance IC, 2001, HUM MOL GENET, V10, P445, DOI 10.1093/hmg/10.5.445; Lepage P, 2011, GASTROENTEROLOGY, V141, P227, DOI 10.1053/j.gastro.2011.04.011; Lesage S, 2002, AM J HUM GENET, V70, P845, DOI 10.1086/339432; Li E, 2011, PLOS ONE IN PRESS; Nawrocki EP, 2009, BIOINFORMATICS, V25, P1335, DOI 10.1093/bioinformatics/btp157; Nelson RL, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001181.pub3; Ng SC, 2012, INFLAMM BOWEL DIS, V18, P725, DOI 10.1002/ibd.21747; Ogura Y, 2003, GUT, V52, P1591, DOI 10.1136/gut.52.11.1591; Ott RL, 2001, INTRO STAT METHODS D; Peterson DA, 2008, CELL HOST MICROBE, V3, P417, DOI 10.1016/j.chom.2008.05.001; Peterson J, 2009, GENOME RES, V19, P2317, DOI 10.1101/gr.096651.109; Petrosino JF, 2009, CLIN CHEM, V55, P856, DOI 10.1373/clinchem.2008.107565; Prescott NJ, 2007, GASTROENTEROLOGY, V132, P1665, DOI 10.1053/j.gastro.2007.03.034; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rodemann JF, 2007, CLIN GASTROENTEROL H, V5, P339, DOI 10.1016/j.cgh.2006.12.027; Salzman NH, 2010, NAT IMMUNOL, V11, P76, DOI 10.1038/ni.1825; Simms LA, 2008, GUT, V57, P903, DOI 10.1136/gut.2007.142588; Singh W., 2008, THESIS U ICELAND; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Sokol H, 2008, INFLAMM BOWEL DIS, V14, P858, DOI 10.1002/ibd.20392; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Sun JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011351; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vaughan IP, 2005, J APPL ECOL, V42, P487, DOI 10.1111/j.1365-2664.2005.01038.x; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; WARD RF, 1963, SCIENCE, V140, P978, DOI 10.1126/science.140.3570.978; Waterman M, 2011, INFLAMM BOWEL DIS, V17, P1936, DOI 10.1002/ibd.21579; Wehkamp J, 2005, P NATL ACAD SCI USA, V102, P18129, DOI 10.1073/pnas.0505256102; Willing B, 2009, INFLAMM BOWEL DIS, V15, P653, DOI 10.1002/ibd.20783; Willing BP, 2010, GASTROENTEROLOGY, V139, P1844, DOI 10.1053/j.gastro.2010.08.049; Wu F, 2007, INFLAMM BOWEL DIS, V13, P807, DOI 10.1002/ibd.20110; Yoo SM, 2005, VIROLOGY, V343, P47, DOI 10.1016/j.virol.2005.08.018	58	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e30044	10.1371/journal.pone.0030044	http://dx.doi.org/10.1371/journal.pone.0030044			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22719822	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341900005
J	Indic, P; Murray, G; Maggini, C; Amore, M; Meschi, T; Borghi, L; Baldessarini, RJ; Salvatore, P				Indic, Premananda; Murray, Greg; Maggini, Carlo; Amore, Mario; Meschi, Tiziana; Borghi, Loris; Baldessarini, Ross J.; Salvatore, Paola			Multi-Scale Motility Amplitude Associated with Suicidal Thoughts in Major Depression	PLOS ONE			English	Article							BIPOLAR-II DISORDER; SEROTONIN TRANSPORTER; PSYCHOMOTOR ACTIVITY; AFFECTIVE-ILLNESS; PHASE DELAY; RISK-FACTOR; UNIPOLAR; BEHAVIOR; NEUROBIOLOGY; RHYTHMS	Major depression occurs at high prevalence in the general population, often starts in juvenile years, recurs over a lifetime, and is strongly associated with disability and suicide. Searches for biological markers in depression may have been hindered by assuming that depression is a unitary and relatively homogeneous disorder, mainly of mood, rather than addressing particular, clinically crucial features or diagnostic subtypes. Many studies have implicated quantitative alterations of motility rhythms in depressed human subjects. Since a candidate feature of great public-health significance is the unusually high risk of suicidal behavior in depressive disorders, we studied correlations between a measure (vulnerability index [VI]) derived from multi-scale characteristics of daily-motility rhythms in depressed subjects (n = 36) monitored with noninvasive, wrist-worn, electronic actigraphs and their self-assessed level of suicidal thinking operationalized as a wish to die. Patient-subjects had a stable clinical diagnosis of bipolar-I, bipolar-II, or unipolar major depression (n = 12 of each type). VI was associated inversely with suicidal thinking (r = -0.61 with all subjects and r = -0.73 with bipolar disorder subjects; both p<0.0001) and distinguished patients with bipolar versus unipolar major depression with a sensitivity of 91.7% and a specificity of 79.2%. VI may be a useful biomarker of characteristic features of major depression, contribute to differentiating bipolar and unipolar depression, and help to detect risk of suicide. An objective biomarker of suicide-risk could be advantageous when patients are unwilling or unable to share suicidal thinking with clinicians.	[Indic, Premananda] Univ Massachusetts, Sch Med, Dept Neurol, Worcester, MA 01605 USA; [Murray, Greg] Swinburne Univ Technol, Fac Life & Social Sci, Hawthorn, Vic 3122, Australia; [Maggini, Carlo; Amore, Mario; Salvatore, Paola] Univ Parma, Sect Psychiat, Dept Neurosci, I-43100 Parma, Italy; [Meschi, Tiziana; Borghi, Loris] Univ Parma, Dept Clin Sci, Sect Internal Med, I-43100 Parma, Italy; [Baldessarini, Ross J.; Salvatore, Paola] McLean Hosp, Int Consortium Psychot & Bipolar Disorders Res, Belmont, MA 02178 USA; [Baldessarini, Ross J.; Salvatore, Paola] Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA; [Baldessarini, Ross J.; Salvatore, Paola] McLean Hosp, Boston, MA USA	University of Massachusetts System; University of Massachusetts Worcester; Swinburne University of Technology; University of Parma; University of Parma; Harvard University; McLean Hospital; Harvard University; Harvard Medical School; Harvard University; McLean Hospital	Indic, P (corresponding author), Univ Massachusetts, Sch Med, Dept Neurol, Worcester, MA 01605 USA.	psalvatore@mclean.harvard.edu	Murray, Greg/N-8933-2017; Meschi, Tiziana/K-5032-2016	Murray, Greg/0000-0001-7208-5603; Meschi, Tiziana/0000-0002-7538-6863	Swinburne University of Technology and Beyond Blue: National Depression Initiative; Bruce J. Anderson Foundation; McLean Private Donors Bipolar Disorder Research Fund; Italian Ministry of Education and Research University Endowment for Faculty Professors	Swinburne University of Technology and Beyond Blue: National Depression Initiative; Bruce J. Anderson Foundation; McLean Private Donors Bipolar Disorder Research Fund; Italian Ministry of Education and Research University Endowment for Faculty Professors	This research was supported, in part, by grants from Swinburne University of Technology and Beyond Blue: National Depression Initiative (to GM), a grant from the Bruce J. Anderson Foundation and by the McLean Private Donors Bipolar Disorder Research Fund (to RJB), and by the Italian Ministry of Education and Research University Endowment for Faculty Professors (to PS). Funding entities had no role in the design, data collection and analysis, or reporting of this study. No additional external funding received for this study.	Almeida JRC, 2010, BIOL PSYCHIAT, V67, P414, DOI 10.1016/j.biopsych.2009.09.027; Amsterdam JD, 2007, NEUROPSYCHOBIOLOGY, V55, P167, DOI 10.1159/000106476; Anguelova M, 2003, MOL PSYCHIATR, V8, P574, DOI 10.1038/sj.mp.4001328; Asberg M, 1997, ANN NY ACAD SCI, V836, P158, DOI 10.1111/j.1749-6632.1997.tb52359.x; Ayd FJ., 1961, RECOGNIZING DEPRESSE; Baldessarini RJ, 2010, HARVARD REV PSYCHIAT, V18, P143, DOI 10.3109/10673221003747955; BEIGEL A, 1971, ARCH GEN PSYCHIAT, V24, P215; Benazzi F, 2008, PROG NEURO-PSYCHOPH, V32, P1022, DOI 10.1016/j.pnpbp.2008.01.015; Bertani M, 2011, PSYCHOL MED, P1; Brown GK, 2005, AM J PSYCHIAT, V162, P1977, DOI 10.1176/appi.ajp.162.10.1977; Cannon DM, 2007, BIOL PSYCHIAT, V62, P870, DOI 10.1016/j.biopsych.2007.03.016; Charlson FJ, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-47; Courtet P, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.6; Gottesman II, 2003, AM J PSYCHIAT, V160, P636, DOI 10.1176/appi.ajp.160.4.636; Gross G, 1992, BONNER SKALA FUER BE; Indic P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020650; Ivanov PC, 1996, NATURE, V383, P323, DOI 10.1038/383323a0; Judd LL, 2000, ARCH GEN PSYCHIAT, V57, P375, DOI 10.1001/archpsyc.57.4.375; KUHS H, 1992, PSYCHOPATHOLOGY, V25, P109, DOI 10.1159/000284760; Lee BH, 2011, PROG NEURO-PSYCHOPH, V35, P842, DOI 10.1016/j.pnpbp.2010.08.001; Maggini C, 1982, DEPRESSIONE ASPETTI, P151; Mann JJ, 2010, EUR PSYCHIAT, V25, P268, DOI 10.1016/j.eurpsy.2010.01.009; Mann JJ, 2009, BIOL PSYCHIAT, V65, P556, DOI 10.1016/j.biopsych.2008.11.021; Mann JJ, 2003, NAT REV NEUROSCI, V4, P819, DOI 10.1038/nrn1220; MONK TH, 1989, PSYCHIAT RES, V27, P89, DOI 10.1016/0165-1781(89)90013-9; Murray G, 2003, J AFFECT DISORDERS, V76, P15, DOI 10.1016/S0165-0327(02)00059-9; Novick DM, 2010, BIPOLAR DISORD, V12, P1, DOI 10.1111/j.1399-5618.2009.00786.x; Oquendo MA, 2011, AM J PSYCHIAT, V168, P1050, DOI 10.1176/appi.ajp.2011.11010163; Parker G, 2000, AM J PSYCHIAT, V157, P1195, DOI 10.1176/appi.ajp.157.8.1195; Parker G, 2009, PSYCHOL MED, V39, P989, DOI 10.1017/S0033291708004339; Rao U, 2002, J AFFECT DISORDERS, V70, P273, DOI 10.1016/S0165-0327(01)00396-2; ROBINS E, 1970, AM J PSYCHIAT, V126, P983, DOI 10.1176/ajp.126.7.983; Salvatore P, 2002, HARVARD REV PSYCHIAT, V10, P255, DOI 10.1080/10673220216283; Salvatore P, 2008, BIPOLAR DISORD, V10, P256, DOI 10.1111/j.1399-5618.2007.00505.x; Salvatore P, 2011, J CLIN PSYCHIAT, V72, P183, DOI 10.4088/JCP.09m05311yel; Scheler M., 1973, FORMALISM ETHICS NON; Schmidt HD, 2011, NEUROPSYCHOPHARMACOL, V36, P2375, DOI 10.1038/npp.2011.151; Siever LJ, 2008, AM J PSYCHIAT, V165, P429, DOI 10.1176/appi.ajp.2008.07111774; SOUETRE E, 1989, PSYCHIAT RES, V28, P263, DOI 10.1016/0165-1781(89)90207-2; SUPPRIAN U, 1975, PHARMAKOPSYCH NEURO, V8, P8, DOI 10.1055/s-0028-1094439; TEICHER MH, 1995, HARVARD REV PSYCHIAT, V3, P18, DOI 10.3109/10673229509017161; TEICHER MH, 1988, ARCH GEN PSYCHIAT, V45, P913; Versace A, 2010, BIOL PSYCHIAT, V68, P560, DOI 10.1016/j.biopsych.2010.04.036; WEHR TA, 1980, ARCH GEN PSYCHIAT, V37, P257; Weinstock LM, 2010, J PSYCHIATR RES, V44, P979, DOI 10.1016/j.jpsychires.2010.03.010; WEISS BL, 1974, ARCH GEN PSYCHIAT, V31, P379; WOLFF EA, 1985, ARCH GEN PSYCHIAT, V42, P288	47	22	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2012	7	6							e38761	10.1371/journal.pone.0038761	http://dx.doi.org/10.1371/journal.pone.0038761			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UJ	22701706	Green Published, gold			2022-12-27	WOS:000305340000043
J	Kappen, C; Kruger, C; MacGowan, J; Salbaum, JM				Kappen, Claudia; Kruger, Claudia; MacGowan, Jacalyn; Salbaum, J. Michael			Maternal Diet Modulates Placenta Growth and Gene Expression in a Mouse Model of Diabetic Pregnancy	PLOS ONE			English	Article							PROSTAGLANDIN E-2-MEDIATED MIGRATION; AIRWAY HYPERRESPONSIVENESS; EXTRAVILLOUS TROPHOBLAST; BIRTH-DEFECTS; FETAL-GROWTH; MICE; RISK; MTOR; TERATOGENESIS; PREECLAMPSIA	Unfavorable maternal diet during pregnancy can predispose the offspring to diseases later in life, such as hypertension, metabolic syndrome, and obesity. However, the molecular basis for this phenomenon of "developmental programming'' is poorly understood. We have recently shown that a diet nutritionally optimized for pregnancy can nevertheless be harmful in the context of diabetic pregnancy in the mouse, associated with a high incidence of neural tube defects and intrauterine growth restriction. We hypothesized that placental abnormalities may contribute to impaired fetal growth in these pregnancies, and therefore investigated the role of maternal diet in the placenta. LabDiet 5015 diet was associated with reduced placental growth, commencing at midgestation, when compared to pregnancies in which the diabetic dam was fed LabDiet 5001 maintenance chow. Furthermore, by quantitative RT-PCR we identify 34 genes whose expression in placenta at midgestation is modulated by diet, diabetes, or both, establishing biomarkers for gene-environment interactions in the placenta. These results implicate maternal diet as an important factor in pregnancy complications and suggest that the early phases of placenta development could be a critical time window for developmental origins of adult disease.	[Kappen, Claudia; Kruger, Claudia; MacGowan, Jacalyn] Louisiana State Univ Syst, Dept Dev Biol, Pennington Biomed Res Ctr, Baton Rouge, LA USA; [MacGowan, Jacalyn; Salbaum, J. Michael] Louisiana State Univ Syst, Pennington Biomed Res Ctr, Lab Regulat Gene Express, Baton Rouge, LA USA	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Kappen, C (corresponding author), Louisiana State Univ Syst, Dept Dev Biol, Pennington Biomed Res Ctr, Baton Rouge, LA USA.	Claudia.Kappen@pbrc.edu			National Institutes of Health, Eunice Kennedy Shriver Institute of Child Health and Development [RO1-HD37804, RO1-HD055528]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD055528, R01HD037804] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072476] Funding Source: NIH RePORTER	National Institutes of Health, Eunice Kennedy Shriver Institute of Child Health and Development; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding for this study came from the National Institutes of Health, Eunice Kennedy Shriver Institute of Child Health and Development RO1-HD37804 to C. Kappen and RO1-HD055528 to J. Michael Salbaum. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blomberg MI, 2010, BIRTH DEFECTS RES A, V88, P35, DOI 10.1002/bdra.20620; Clausen T, 2001, AM J OBSTET GYNECOL, V185, P451, DOI 10.1067/mob.2001.116687; Coan PM, 2010, J PHYSIOL-LONDON, V588, P527, DOI 10.1113/jphysiol.2009.181214; Gheorghe CP, 2009, PLACENTA, V30, P411, DOI 10.1016/j.placenta.2009.03.002; Godfrey KM, 2002, PLACENTA, V23, pS20, DOI 10.1053/plac.2002.0773; Hietakangas V, 2009, ANNU REV GENET, V43, P389, DOI 10.1146/annurev-genet-102108-134815; Horita H, 2007, HUM REPROD, V22, P1801, DOI 10.1093/humrep/dem125; Kaliberova LN, 2009, MOL CANCER THER, V8, P3130, DOI 10.1158/1535-7163.MCT-09-0270; Kappen C, 2011, REPROD TOXICOL, V31, P41, DOI 10.1016/j.reprotox.2010.09.002; Kruger C, 2006, BIRTH DEFECTS RES A, V76, P216, DOI 10.1002/bdra.20245; Laplante M, 2009, CURR BIOL, V19, pR1046, DOI 10.1016/j.cub.2009.09.058; Lee J, 2011, MOL CELL ENDOCRINOL, V332, P306, DOI 10.1016/j.mce.2010.11.022; Mao J, 2010, P NATL ACAD SCI USA, V107, P5557, DOI 10.1073/pnas.1000440107; MCCARTHY JC, 1968, GENET RES, V11, P43, DOI 10.1017/S0016672300011186; MCLAREN A, 1965, J REPROD FERTIL, V9, P79, DOI 10.1530/jrf.0.0090079; Munoz NM, 2007, J IMMUNOL, V179, P4800, DOI 10.4049/jimmunol.179.7.4800; Munoz NM, 1997, AM J RESP CRIT CARE, V155, P1398, DOI 10.1164/ajrccm.155.4.9105085; Myou S, 2001, NAT IMMUNOL, V2, P145, DOI 10.1038/84244; Nicola C, 2008, BIOL REPROD, V78, P976, DOI 10.1095/biolreprod.107.065433; Nicola C, 2008, ENDOCRINOLOGY, V149, P1243, DOI 10.1210/en.2007-1136; Pavlinkova G, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-274; Plagemann A, 2004, J PERINAT MED, V32, P297, DOI 10.1515/JPM.2004.055; Roberts JM, 2003, J NUTR, V133, p1684S, DOI 10.1093/jn/133.5.1684S; Roos S, 2009, BIOCHEM SOC T, V37, P295, DOI 10.1042/BST0370295; Salbaum JM, 2011, DIABETOLOGIA, V54, P1909, DOI 10.1007/s00125-011-2132-6; SCODRAS JM, 1990, CELL IMMUNOL, V127, P352, DOI 10.1016/0008-8749(90)90138-H; Simeoni U, 2009, SEMIN FETAL NEONAT M, V14, P119, DOI 10.1016/j.siny.2009.01.002; Tanaka M, 1997, DEV BIOL, V190, P55, DOI 10.1006/dbio.1997.8685; Waller DK, 2007, ARCH PEDIAT ADOL MED, V161, P745, DOI 10.1001/archpedi.161.8.745; Wen HY, 2005, PLACENTA, V26, pS63, DOI 10.1016/j.placenta.2005.02.004; Werler MM, 1996, JAMA-J AM MED ASSOC, V275, P1089, DOI 10.1001/jama.275.14.1089; Zabihi S, 2010, BIRTH DEFECTS RES A, V88, P779, DOI 10.1002/bdra.20704	32	24	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2012	7	6							e38445	10.1371/journal.pone.0038445	http://dx.doi.org/10.1371/journal.pone.0038445			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TU	22701643	gold, Green Submitted, Green Published			2022-12-27	WOS:000305337600024
J	Rossmeisl, M; Jilkova, ZM; Kuda, O; Jelenik, T; Medrikova, D; Stankova, B; Kristinsson, B; Haraldsson, GG; Svensen, H; Stoknes, I; Sjovall, P; Magnusson, Y; Balvers, MGJ; Verhoeckx, KCM; Tvrzicka, E; Bryhn, M; Kopecky, J				Rossmeisl, Martin; Jilkova, Zuzana Macek; Kuda, Ondrej; Jelenik, Tomas; Medrikova, Dasa; Stankova, Barbora; Kristinsson, Bjorn; Haraldsson, Gudmundur G.; Svensen, Harald; Stoknes, Iren; Sjovall, Peter; Magnusson, Ylva; Balvers, Michiel G. J.; Verhoeckx, Kitty C. M.; Tvrzicka, Eva; Bryhn, Morten; Kopecky, Jan			Metabolic Effects of n-3 PUFA as Phospholipids Are Superior to Triglycerides in Mice Fed a High-Fat Diet: Possible Role of Endocannabinoids	PLOS ONE			English	Article							KRILL OIL SUPPLEMENTATION; TOF-SIMS ANALYSIS; FISH-OIL; ADIPOSE-TISSUE; EICOSAPENTAENOIC ACID; INSULIN SENSITIVITY; INDUCED OBESITY; CB1 ANTAGONISM; SERUM-LIPIDS; WEIGHT-LOSS	Background: n-3 polyunsaturated fatty acids, namely docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), reduce the risk of cardiovascular disease and can ameliorate many of obesity-associated disorders. We hypothesised that the latter effect will be more pronounced when DHA/EPA is supplemented as phospholipids rather than as triglycerides. Methodology/Principal Findings: In a 'prevention study', C57BL/6J mice were fed for 9 weeks on either a corn oil-based high-fat obesogenic diet (cHF; lipids similar to 35% wt/wt), or cHF-based diets in which corn oil was partially replaced by DHA/EPA, admixed either as phospholipids or triglycerides from marine fish. The reversal of obesity was studied in mice subjected to the preceding cHF-feeding for 4 months. DHA/EPA administered as phospholipids prevented glucose intolerance and tended to reduce obesity better than triglycerides. Lipemia and hepatosteatosis were suppressed more in response to dietary phospholipids, in correlation with better bioavailability of DHA and EPA, and a higher DHA accumulation in the liver, white adipose tissue (WAT), and muscle phospholipids. In dietary obese mice, both DHA/EPA concentrates prevented a further weight gain, reduced plasma lipid levels to a similar extent, and tended to improve glucose tolerance. Importantly, only the phospholipid form reduced plasma insulin and adipocyte hypertrophy, while being more effective in reducing hepatic steatosis and low-grade inflammation of WAT. These beneficial effects were correlated with changes of endocannabinoid metabolome in WAT, where phospholipids reduced 2-arachidonoylglycerol, and were more effective in increasing anti-inflammatory lipids such as N-docosahexaenoylethanolamine. Conclusions/Significance: Compared with triglycerides, dietary DHA/EPA administered as phospholipids are superior in preserving a healthy metabolic profile under obesogenic conditions, possibly reflecting better bioavalability and improved modulation of the endocannabinoid system activity in WAT.	[Rossmeisl, Martin; Jilkova, Zuzana Macek; Kuda, Ondrej; Jelenik, Tomas; Medrikova, Dasa; Kopecky, Jan] Acad Sci Czech Republ, Inst Physiol, Dept Adipose Tissue Biol, Vvi, Prague, Czech Republic; [Stankova, Barbora; Tvrzicka, Eva] Charles Univ Prague, Dept Internal Med 4, Fac Med 1, Prague, Czech Republic; [Kristinsson, Bjorn; Haraldsson, Gudmundur G.] Univ Iceland, Inst Sci, IS-107 Reykjavik, Iceland; [Svensen, Harald; Stoknes, Iren] EPAX AS, Alesund, Norway; [Sjovall, Peter] SP Tech Res Inst Sweden, Boras, Sweden; [Magnusson, Ylva] Univ Gothenburg, Wallenberg Lab, Sahlgrenska Acad, Gothenburg, Sweden; [Magnusson, Ylva] Univ Gothenburg, Univ Hosp, Gothenburg, Sweden; [Balvers, Michiel G. J.] Wageningen Univ, Div Human Nutr, Wageningen, Netherlands; [Balvers, Michiel G. J.; Verhoeckx, Kitty C. M.] TNO, Res Grp Qual & Safety, NL-3700 AJ Zeist, Netherlands; [Bryhn, Morten] Silentia AS, Svelvik, Norway	Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences; Charles University Prague; University of Iceland; SP Technical Research Institute of Sweden; University of Gothenburg; University of Gothenburg; Wageningen University & Research; Netherlands Organization Applied Science Research	Rossmeisl, M (corresponding author), Acad Sci Czech Republ, Inst Physiol, Dept Adipose Tissue Biol, Vvi, Prague, Czech Republic.	kopecky@biomed.cas.cz	Kopecky, Jan/B-8244-2012; Kuda, Ondrej/B-7990-2012; Tvrzicka, Eva/Q-6300-2016; Rossmeisl, Martin/C-1892-2012; Macek Jílková, Zuzana/N-4051-2014; Sjovall, Peter/ABA-7172-2020; Rossmeisl, Martin/CAF-0060-2022; Stankova, Barbora/L-7933-2016	Kopecky, Jan/0000-0001-8072-2035; Kuda, Ondrej/0000-0001-7034-4536; Tvrzicka, Eva/0000-0003-0794-8454; Rossmeisl, Martin/0000-0001-8534-4002; Macek Jílková, Zuzana/0000-0002-2553-5971; Sjovall, Peter/0000-0002-2696-7215; Rossmeisl, Martin/0000-0001-8534-4002; Haraldsson, Gudmundur G./0000-0002-5664-2745; Stankova, Barbora/0000-0002-6184-4878; Balvers, Michiel/0000-0003-4308-3160; Verhoeckx, Kitty/0000-0002-6557-3198	Czech Science Foundation [P301/10/1420]; Ministry of Health of the Czech Republic [NS/10528-3]; Swedish Governmental Agency for Innovation Systems (VINNOVA)	Czech Science Foundation(Grant Agency of the Czech Republic); Ministry of Health of the Czech Republic(Ministry of Health, Czech Republic); Swedish Governmental Agency for Innovation Systems (VINNOVA)(Vinnova)	The research leading to these results has received funding from the Czech Science Foundation (P301/10/1420), the Ministry of Health of the Czech Republic (NS/10528-3), and the Swedish Governmental Agency for Innovation Systems (VINNOVA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvheim AR, 2012, OBESITY, V20, P1984, DOI 10.1038/oby.2012.38; Amate L, 2001, J NUTR, V131, P1250, DOI 10.1093/jn/131.4.1250; Arterburn LM, 2006, AM J CLIN NUTR, V83, p1467S, DOI 10.1093/ajcn/83.6.1467S; Balvers MGJ, 2010, BBA-MOL CELL BIOL L, V1801, P1107, DOI 10.1016/j.bbalip.2010.06.006; Banni S, 2010, MOL NUTR FOOD RES, V54, P82, DOI 10.1002/mnfr.200900516; Batetta B, 2009, J NUTR, V139, P1495, DOI 10.3945/jn.109.104844; Blasbalg TL, 2011, AM J CLIN NUTR, V93, P950, DOI 10.3945/ajcn.110.006643; Bluher M, 2006, DIABETES, V55, P3053, DOI 10.2337/db06-0812; Butler H, 2009, EUR J ENDOCRINOL, V161, P655, DOI 10.1530/EJE-09-0511; Calder PC, 2006, AM J CLIN NUTR, V83, p1505S, DOI 10.1093/ajcn/83.6.1505S; Cansell M, 2003, LIPIDS, V38, P551, DOI 10.1007/s11745-003-1341-0; Cansell MS, 2009, LIPIDS, V44, P237, DOI 10.1007/s11745-008-3279-x; Chakravarthy MV, 2009, CELL, V138, P476, DOI 10.1016/j.cell.2009.05.036; Flachs P, 2006, DIABETOLOGIA, V49, P394, DOI 10.1007/s00125-005-0053-y; Flachs P, 2011, DIABETOLOGIA, V54, P2626, DOI 10.1007/s00125-011-2233-2; Flachs P, 2009, CLIN SCI, V116, P1, DOI 10.1042/CS20070456; Friedberg CE, 1998, DIABETES CARE, V21, P494, DOI 10.2337/diacare.21.4.494; Hao Q, 2012, AM J PHYSIOL-ENDOC M, V302, pE1097, DOI 10.1152/ajpendo.00524.2011; Jelenik T, 2010, DIABETES, V59, P2737, DOI 10.2337/db09-1716; Jourdan T, 2010, DIABETES, V59, P926, DOI 10.2337/db09-1482; Kopecky J, 2009, P NUTR SOC, V68, P361, DOI 10.1017/S0029665109990231; Kromhout D, 2011, DIABETES CARE, V34, P2515, DOI 10.2337/dc11-0896; Kromhout D, 2010, NEW ENGL J MED, V363, P2015, DOI 10.1056/NEJMoa1003603; Kuda O, 2009, DIABETOLOGIA, V52, P941, DOI 10.1007/s00125-009-1305-z; Kunesova M, 2006, PHYSIOL RES, V55, P63, DOI 10.33549/physiolres.930770; Kus V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027126; Lambert DM, 2007, CURR OPIN CLIN NUTR, V10, P735, DOI 10.1097/MCO.0b013e3282f00061; Lankinen M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005258; Li Y, 2005, MOL CELL, V17, P491, DOI 10.1016/j.molcel.2005.02.002; Madsen L, 2005, BBA-MOL BASIS DIS, V1740, P266, DOI 10.1016/j.bbadis.2005.03.001; Magnusson YK, 2008, OBESITY, V16, P2745, DOI 10.1038/oby.2008.424; Maki KC, 2009, NUTR RES, V29, P609, DOI 10.1016/j.nutres.2009.09.004; Medrikova D, 2012, INT J OBESITY, V36, P262, DOI 10.1038/ijo.2011.87; Meijerink J., 2011, BR J NUTR, V4, P1, DOI DOI 10.1017/S0007114510005635; Miranville A, 2010, OBESITY, V18, P2247, DOI 10.1038/oby.2010.81; Mori TA, 1999, AM J CLIN NUTR, V70, P817; Neschen S, 2006, DIABETES, V55, P924, DOI 10.2337/diabetes.55.04.06.db05-0985; Nettleton JA, 2005, J AM DIET ASSOC, V105, P428, DOI 10.1016/j.jada.2004.11.029; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Osei-Hyiaman D, 2008, J CLIN INVEST, V118, P3160, DOI 10.1172/JCI34827; Pacetti D, 2005, J CHROMATOGR A, V1097, P66, DOI 10.1016/j.chroma.2005.08.016; Pacetti D, 2005, J SCI FOOD AGR, V85, P1703, DOI 10.1002/jsfa.2174; Piscitelli F, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-51; RAMPONE AJ, 1977, BIOCHIM BIOPHYS ACTA, V486, P500, DOI 10.1016/0005-2760(77)90100-X; Rossmeisl M, 2009, OBESITY, V17, P1023, DOI 10.1038/oby.2008.602; RUSTAN AC, 1992, BIOCHEM J, V283, P333, DOI 10.1042/bj2830333; Ruzickova J, 2004, LIPIDS, V39, P1177, DOI 10.1007/s11745-004-1345-9; Saravanan P, 2010, LANCET, V376, P540, DOI 10.1016/S0140-6736(10)60445-X; Sato A, 2010, DIABETES, V59, P2495, DOI 10.2337/db09-1554; Schuchardt JP, 2011, PROSTAG LEUKOTR ESS, V85, P381, DOI 10.1016/j.plefa.2011.07.006; Schuchardt JP, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-145; Serhan CN, 2005, PHARMACOL THERAPEUT, V105, P7, DOI 10.1016/j.pharmthera.2004.09.002; Sjovall P, 2008, APPL SURF SCI, V255, P1177, DOI 10.1016/j.apsusc.2008.05.011; STORLIEN LH, 1987, SCIENCE, V237, P885, DOI 10.1126/science.3303333; Tandy S, 2009, J AGR FOOD CHEM, V57, P9339, DOI 10.1021/jf9016042; Todoric J, 2006, DIABETOLOGIA, V49, P2109, DOI 10.1007/s00125-006-0300-x; Tvrzicka E, 2002, ANAL CHIM ACTA, V465, P337, DOI 10.1016/S0003-2670(02)00396-3; Ulven SM, 2011, LIPIDS, V46, P37, DOI 10.1007/s11745-010-3490-4; Vaitheesvaran B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033717; Van Gaal LF, 2006, NATURE, V444, P875, DOI 10.1038/nature05487; ZIERENBERG O, 1982, J LIPID RES, V23, P1136	61	167	170	5	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2012	7	6							e38834	10.1371/journal.pone.0038834	http://dx.doi.org/10.1371/journal.pone.0038834			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TU	22701720	Green Published, gold, Green Submitted			2022-12-27	WOS:000305337600048
J	Seeger-Nukpezah, T; Liebau, MC; Hopker, K; Lamkemeyer, T; Benzing, T; Golemis, EA; Schermer, B				Seeger-Nukpezah, Tamina; Liebau, Max C.; Hoepker, Katja; Lamkemeyer, Tobias; Benzing, Thomas; Golemis, Erica A.; Schermer, Bernhard			The Centrosomal Kinase Plk1 Localizes to the Transition Zone of Primary Cilia and Induces Phosphorylation of Nephrocystin-1	PLOS ONE			English	Article							POLO-LIKE KINASES; AURORA-A; PROTEIN; DISEASE; CILIOGENESIS; ACTIVATION; REVEALS; MECHANISMS; MUTATIONS; P130(CAS)	Polo-like kinase (Plk1) plays a central role in regulating the cell cycle. Plk1-mediated phosphorylation is essential for centrosome maturation, and for numerous mitotic events. Although Plk1 localizes to multiple subcellular sites, a major site of action is the centrosomes, which supports mitotic functions in control of bipolar spindle formation. In G0 or G1 untransformed cells, the centriolar core of the centrosome differentiates into the basal body of the primary cilium. Primary cilia are antenna-like sensory organelles dynamically regulated during the cell cycle. Whether Plk1 has a role in ciliary biology has never been studied. Nephrocystin-1 (NPHP1) is a ciliary protein; loss of NPHP1 in humans causes nephronophthisis (NPH), an autosomal-recessive cystic kidney disease. We here demonstrate that Plk1 colocalizes with nephrocystin-1 to the transition zone of primary cilia in epithelial cells. Plk1 co-immunoprecipitates with NPHP1, suggesting it is part of the nephrocystin protein complex. We identified a candidate Plk1 phosphorylation motif (D/E-X-S/T-phi-X-D/E) in nephrocystin-1, and demonstrated in vitro that Plk1 phosphorylates the nephrocystin N-terminus, which includes the specific PLK1 phosphorylation motif. Further, induced disassembly of primary cilia rapidly evoked Plk1 kinase activity, while small molecule inhibition of Plk1 activity or RNAi-mediated downregulation of Plk1 limited the first and second phase of ciliary disassembly. These data identify Plk1 as a novel transition zone signaling protein, suggest a function of Plk1 in cilia dynamics, and link Plk1 to the pathogenesis of NPH and potentially other cystic kidney diseases.	[Seeger-Nukpezah, Tamina; Golemis, Erica A.] Fox Chase Canc Ctr, Dept Dev Therapeut, Philadelphia, PA 19111 USA; [Seeger-Nukpezah, Tamina; Liebau, Max C.; Hoepker, Katja; Benzing, Thomas; Schermer, Bernhard] Univ Cologne, Dept Internal Med 2, D-50931 Cologne, Germany; [Seeger-Nukpezah, Tamina; Liebau, Max C.; Hoepker, Katja; Benzing, Thomas; Schermer, Bernhard] Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany; [Liebau, Max C.] Univ Cologne, Dept Pediat, D-50931 Cologne, Germany	Fox Chase Cancer Center; University of Cologne; University of Cologne; University of Cologne	Seeger-Nukpezah, T (corresponding author), Fox Chase Canc Ctr, Dept Dev Therapeut, 7701 Burholme Ave, Philadelphia, PA 19111 USA.	bernhard.schermer@uk-koeln.de	Liebau, Max Christoph/K-3470-2019; Benzing, Thomas/X-5476-2019; Schermer, Bernhard/E-9972-2014	Liebau, Max Christoph/0000-0003-0494-9080; Schermer, Bernhard/0000-0002-5194-9000; Golemis, Erica/0000-0003-3618-3673	German Research foundation (DFG) grants [SCHE1562, SFB832, SFB829]; National Institutes of Health core grant [CA-06927]; Pew Charitable Fund;  [R01s CA63366];  [CA113342]; NATIONAL CANCER INSTITUTE [R01CA113342, P30CA006927, R01CA063366] Funding Source: NIH RePORTER	German Research foundation (DFG) grants(German Research Foundation (DFG)); National Institutes of Health core grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pew Charitable Fund; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the German Research foundation (DFG) grants SCHE1562 and SFB832 to BS and SFB829 to TB. EAG was supported by R01s CA63366 and CA113342, and National Institutes of Health core grant CA-06927, and the Pew Charitable Fund (to Fox Chase Cancer Center). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archambault V, 2009, NAT REV MOL CELL BIO, V10, P265, DOI 10.1038/nrm2653; Astier A, 1997, J BIOL CHEM, V272, P19719, DOI 10.1074/jbc.272.32.19719; Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Barr MM, 1999, NATURE, V401, P386, DOI 10.1038/43916; Benzing T, 2011, NAT GENET, V43, P723, DOI 10.1038/ng.896; Bettencourt-Dias M, 2011, TRENDS GENET, V27, P307, DOI 10.1016/j.tig.2011.05.004; Cao MQ, 2009, METHOD CELL BIOL, V94, P333, DOI 10.1016/S0091-679X(08)94017-6; Craige B, 2010, J CELL BIOL, V190, P927, DOI 10.1083/jcb.201006105; Dafinger C, 2011, J CLIN INVEST, V121, P2662, DOI 10.1172/JCI43639; De Luca M, 2006, CELL CYCLE, V5, P296; Elia AEH, 2003, SCIENCE, V299, P1228, DOI 10.1126/science.1079079; Fliegauf M, 2006, J AM SOC NEPHROL, V17, P2424, DOI 10.1681/ASN.2005121351; Grosstessner-Hain K, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.008540; Habbig S, 2011, J CELL BIOL, V193, P633, DOI 10.1083/jcb.201009069; Hanisch A, 2006, MOL BIOL CELL, V17, P448, DOI 10.1091/mbc.E05-08-0801; Hildebrandt F, 2011, NEW ENGL J MED, V364, P1533, DOI 10.1056/NEJMra1010172; Hildebrandt F, 2009, J AM SOC NEPHROL, V20, P23, DOI 10.1681/ASN.2008050456; Ishikawa H, 2011, NAT REV MOL CELL BIO, V12, P222, DOI 10.1038/nrm3085; Jauregui AR, 2008, J CELL BIOL, V180, P973, DOI 10.1083/jcb.200707090; Jiang ST, 2009, HUM MOL GENET, V18, P1566, DOI 10.1093/hmg/ddp068; Johmura Y, 2011, P NATL ACAD SCI USA, V108, P11446, DOI 10.1073/pnas.1106223108; Kim S, 2011, CELL CYCLE, V10, P2683, DOI 10.4161/cc.10.16.17009; Kishi K, 2009, MOL CELL BIOL, V29, P3134, DOI 10.1128/MCB.01663-08; Lane HA, 1996, J CELL BIOL, V135, P1701, DOI 10.1083/jcb.135.6.1701; Lens SMA, 2010, NAT REV CANCER, V10, P825, DOI 10.1038/nrc2964; Li J, 2011, CELL CYCLE, V10, P2946, DOI 10.4161/cc.10.17.15922; Liebau MC, 2011, J BIOL CHEM, V286, P14237, DOI 10.1074/jbc.M110.165464; Liu XS, 2010, PROTEIN CELL, V1, P999, DOI 10.1007/s13238-010-0131-x; Lowery DM, 2007, EMBO J, V26, P2262, DOI 10.1038/sj.emboj.7601683; Macurek L, 2008, NATURE, V455, P119, DOI 10.1038/nature07185; Manie SN, 1997, J BIOL CHEM, V272, P4230, DOI 10.1074/jbc.272.7.4230; Nakajima H, 2003, J BIOL CHEM, V278, P25277, DOI 10.1074/jbc.C300126200; Otto EA, 2003, NAT GENET, V34, P413, DOI 10.1038/ng1217; Pan JM, 2011, J PROTEOME RES, V10, P3830, DOI 10.1021/pr200428n; Petronczki M, 2008, DEV CELL, V14, P646, DOI 10.1016/j.devcel.2008.04.014; Plotnikova OV, 2008, CANCER RES, V68, P2058, DOI 10.1158/0008-5472.CAN-07-5838; Plotnikova OV, 2011, J CELL BIOL, V193, P1021, DOI 10.1083/jcb.201012061; Plotnikova OV, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1061; Pugacheva EN, 2007, CELL, V129, P1351, DOI 10.1016/j.cell.2007.04.035; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Sang LY, 2011, CELL, V145, P513, DOI 10.1016/j.cell.2011.04.019; Santamaria A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.004457; Santos N, 2008, DEV DYNAM, V237, P1972, DOI 10.1002/dvdy.21540; Satir P, 2007, ANNU REV PHYSIOL, V69, P377, DOI 10.1146/annurev.physiol.69.040705.141236; Schermer B, 2005, EMBO J, V24, P4415, DOI 10.1038/sj.emboj.7600885; Schermer B, 2006, J CELL BIOL, V175, P547, DOI 10.1083/jcb.200605092; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Soung NK, 2009, DEV CELL, V16, P539, DOI 10.1016/j.devcel.2009.02.004; Strebhardt K, 2010, NAT REV DRUG DISCOV, V9, P643, DOI 10.1038/nrd3184; van Leuken R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005282; Vazquez-Martin A, 2011, CELL CYCLE, V10, P1295, DOI 10.4161/cc.10.8.15342; Wheatley DN, 1996, CELL BIOL INT, V20, P73, DOI 10.1006/cbir.1996.0011; Williams CL, 2011, J CELL BIOL, V192, P1023, DOI 10.1083/jcb.201012116; Yuan K, 2011, CELL SIGNAL, V23, P1, DOI 10.1016/j.cellsig.2010.07.003	55	34	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2012	7	6							e38838	10.1371/journal.pone.0038838	http://dx.doi.org/10.1371/journal.pone.0038838			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TU	22701722	Green Submitted, Green Published, gold			2022-12-27	WOS:000305337600049
J	Sabatel, H; Di Valentin, E; Gloire, G; Dequiedt, F; Piette, J; Habraken, Y				Sabatel, Helene; Di Valentin, Emmanuel; Gloire, Geoffrey; Dequiedt, Franck; Piette, Jacques; Habraken, Yvette			Phosphorylation of p65(RelA) on Ser(547) by ATM Represses NF-kappa B-Dependent Transcription of Specific Genes after Genotoxic Stress	PLOS ONE			English	Article							DNA-DAMAGE RESPONSE; DOUBLE-STRAND BREAKS; POSTTRANSLATIONAL MODIFICATIONS; SIGNALING PATHWAY; TUMOR-SUPPRESSOR; OXIDATIVE STRESS; IKK ACTIVATION; KINASE; ALPHA; P65	The NF-kappa B pathway is involved in immune and inflammation responses, proliferation, differentiation and cell death or survival. It is activated by many external stimuli including genotoxic stress. DNA double-strand breaks activate NF-kappa B in an ATM-dependent manner. In this manuscript, a direct interaction between p65(RelA) and the N-terminal extremity of ATM is reported. We also report that only one of the five potential ATM-(S/T)Q target sites present in p65, namely Ser(547), is specifically phosphorylated by ATM in vitro. A comparative transcriptomic analysis performed in HEK-293 cells expressing either wild-type HA-p65 or a non-phosphorylatable mutant HA-p65(S547A) identified several differentially transcribed genes after an etoposide treatment (e.g. IL8, A20, SELE). The transcription of these genes is increased in cells expressing the mutant. Substitution of Ser(547) to alanine does not affect p65 binding abilities on the kappa B site of the IL8 promoter but reduces p65 interaction with HDAC1. Cells expressing p65(S547A) have a higher level of histone H3 acetylated on Lys(9) at the IL8 promoter, which is in agreement with the higher gene induction observed. These results indicate that ATM regulates a subset of NF-kappa B dependent genes after a genotoxic stress by direct phosphorylation of p65.	[Sabatel, Helene; Di Valentin, Emmanuel; Gloire, Geoffrey; Piette, Jacques; Habraken, Yvette] Univ Liege, Lab Virol & Immunol, GIGA R, Signal Transduct Unit, Liege, Belgium; [Gloire, Geoffrey] Interface Entreprises Univ Liege Sci Pk, Angleur, Belgium; [Dequiedt, Franck] Univ Liege, Lab Signalisat & Prot Interact, GIGA R, Signal Transduct Unit, Liege, Belgium	University of Liege; University of Liege; University of Liege	Sabatel, H (corresponding author), Univ Liege, Lab Virol & Immunol, GIGA R, Signal Transduct Unit, Liege, Belgium.	yvette.habraken@ulg.ac.be		Dequiedt, Franck/0000-0003-1234-7477	Belgian "Fonds National de la Recherche Scientifique" (FNRS) [1.A227.08]; TELEVIE [7.4514.10]; Interuniversity Attraction Poles (IAP) [6/18]; Belgian FNRS [3.4543.08]; University of Liege; Federal Scientific Policy [IAP6/18]; "Centre anticancereux aupres de l'ULg";  [CR.CH.08.09.1.5.023.09]	Belgian "Fonds National de la Recherche Scientifique" (FNRS)(Fonds de la Recherche Scientifique - FNRS); TELEVIE; Interuniversity Attraction Poles (IAP)(Belgian Federal Science Policy Office); Belgian FNRS(Fonds de la Recherche Scientifique - FNRS); University of Liege(University of Liege); Federal Scientific Policy; "Centre anticancereux aupres de l'ULg"; 	HS was supported by research fellow grants from the Belgian "Fonds National de la Recherche Scientifique" (FNRS) [grant number 1.A227.08] and the TELEVIE [grant number 7.4514.10]. EDV, a research scientist, is paid by the Interuniversity Attraction Poles (IAP) [grant number 6/18]. FD, YH and JP are a research scientist, a senior research scientist and a research director respectively from the Belgian FNRS. Financial support was provided by the Belgian FNRS [grant number 3.4543.08] and the associate fund [grant number CR.CH.08.09.1.5.023.09], the University of Liege, the Federal Scientific Policy IAP6/18, and the "Centre anticancereux aupres de l'ULg". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barre B, 2010, CELL CYCLE, V9, P4795, DOI 10.4161/cc.9.24.14245; Baud V, 2009, NAT REV DRUG DISCOV, V8, P33, DOI 10.1038/nrd2781; Bohuslav J, 2004, J BIOL CHEM, V279, P26115, DOI 10.1074/jbc.M313509200; Campbell KJ, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-101; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Choudhary S, 2011, J BIOL CHEM, V286, P37187, DOI 10.1074/jbc.M111.224923; Courtois G, 2006, ONCOGENE, V25, P6831, DOI 10.1038/sj.onc.1209939; DEJARDIN E, 1995, ONCOGENE, V11, P1835; Dunn GP, 2004, IMMUNITY, V21, P137, DOI 10.1016/j.immuni.2004.07.017; EMI N, 1991, J VIROL, V65, P1202, DOI 10.1128/JVI.65.3.1202-1207.1991; Fernandes N, 2005, J BIOL CHEM, V280, P15158, DOI 10.1074/jbc.M412065200; Frank AK, 2011, MOL CELL BIOL, V31, P1201, DOI 10.1128/MCB.01136-10; Guo Z, 2010, SCIENCE, V330, P517, DOI 10.1126/science.1192912; Habraken Y, 2006, BIOCHEM PHARMACOL, V72, P1132, DOI 10.1016/j.bcp.2006.07.015; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hinz M, 2010, MOL CELL, V40, P63, DOI 10.1016/j.molcel.2010.09.008; Hoberg JE, 2006, MOL CELL BIOL, V26, P457, DOI 10.1128/MCB.26.2.457-471.2006; Horion J, 2007, J BIOL CHEM, V282, P15383, DOI 10.1074/jbc.M609166200; Hu J, 2005, MOL CANCER RES, V3, P100, DOI 10.1158/1541-7786.MCR-04-0070; Huang B, 2010, CELL SIGNAL, V22, P1282, DOI 10.1016/j.cellsig.2010.03.017; Huang TT, 2003, CELL, V115, P565, DOI 10.1016/S0092-8674(03)00895-X; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Karin M, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000141; Khanna KK, 1998, NAT GENET, V20, P398, DOI 10.1038/3882; Kim ST, 1999, J BIOL CHEM, V274, P37538, DOI 10.1074/jbc.274.53.37538; Lawrence T, 2005, NATURE, V434, P1138, DOI 10.1038/nature03491; Li NX, 2001, J BIOL CHEM, V276, P8898, DOI 10.1074/jbc.M009809200; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Miyamoto S, 2011, CELL RES, V21, P116, DOI 10.1038/cr.2010.179; O'Shea JM, 2008, BIOCHEM SOC T, V36, P603, DOI 10.1042/BST0360603; O'Shea JM, 2010, BIOCHEM J, V426, P345, DOI 10.1042/BJ20091630; Oeckinghaus A, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000034; Owen HR, 2005, J PROTEOME RES, V4, P1381, DOI 10.1021/pr0500713; Perkins ND, 2006, ONCOGENE, V25, P6717, DOI 10.1038/sj.onc.1209937; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Piret B, 1999, ONCOGENE, V18, P2261, DOI 10.1038/sj.onc.1202541; Place RF, 2005, BIOCHEM PHARMACOL, V70, P394, DOI 10.1016/j.bcp.2005.04.030; Rocha S, 2003, MOL CELL, V12, P15, DOI 10.1016/S1097-2765(03)00223-5; Sabatel H, 2011, BIOCHEM PHARMACOL, V82, P1371, DOI 10.1016/j.bcp.2011.07.105; Schneider G, 2010, ONCOGENE, V29, P2795, DOI 10.1038/onc.2010.46; Schoonbroodt S, 2000, J IMMUNOL, V164, P4292, DOI 10.4049/jimmunol.164.8.4292; Shiloh Y, 2006, TRENDS BIOCHEM SCI, V31, P402, DOI 10.1016/j.tibs.2006.05.004; Takaesu G, 2003, J MOL BIOL, V326, P105, DOI 10.1016/S0022-2836(02)01404-3; Wu ZH, 2006, SCIENCE, V311, P1141, DOI 10.1126/science.1121513; Wu ZH, 2010, MOL CELL, V40, P75, DOI 10.1016/j.molcel.2010.09.010; WUERZBERGERDAVI.SM, 2007, DNADAMAGE ONCOGENE, V26, P641; Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0	49	32	33	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2012	7	6							e38246	10.1371/journal.pone.0038246	http://dx.doi.org/10.1371/journal.pone.0038246			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TQ	22715377	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336800018
J	Yang, CW				Yang, Chu-Wen			A Comparative Study of Short Linear Motif Compositions of the Influenza A Virus Ribonucleoproteins	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERACTIONS; TERMINAL DOMAIN; PB2 PROTEIN; AMINO-ACID; POLYMERASE; IDENTIFICATION; REPLICATION; ADAPTATION; PEPTIDE; MOUSE	Protein-protein interactions through short linear motifs (SLiMs) are an emerging concept that is different from interactions between globular domains. The SLiMs encode a functional interaction interface in a short (three to ten residues) poorly conserved sequence. This characteristic makes them much more likely to arise/disappear spontaneously via mutations, and they may be more evolutionarily labile than globular domains. The diversity of SLiM composition may provide functional diversity for a viral protein from different viral strains. This study is designed to determine the different SLiM compositions of ribonucleoproteins (RNPs) from influenza A viruses (IAVs) from different hosts and with different levels of virulence. The 96 consensus sequences (regular expressions) of SLiMs from the ELM server were used to conduct a comprehensive analysis of the 52,513 IAV RNP sequences. The SLiM compositions of RNPs from IAVs from different hosts and with different levels of virulence were compared. The SLiM compositions of 845 RNPs from highly virulent/pandemic IAVs were also analyzed. In total, 292 highly conserved SLiMs were found in RNPs regardless of the IAV host range. These SLiMs may be basic motifs that are essential for the normal functions of RNPs. Moreover, several SLiMs that are rare in seasonal IAV RNPs but are present in RNPs from highly virulent/pandemic IAVs were identified. The SLiMs identified in this study provide a useful resource for experimental virologists to study the interactions between IAV RNPs and host intracellular proteins. Moreover, the SLiM compositions of IAV RNPs also provide insights into signal transduction pathways and protein interaction networks with which IAV RNPs might be involved. Information about SLiMs might be useful for the development of anti-IAV drugs.	Soochow Univ, Dept Microbiol, Taipei 11102, Taiwan	Soochow University	Yang, CW (corresponding author), Soochow Univ, Dept Microbiol, Taipei 11102, Taiwan.	ycw6861@scu.edu.tw			National Science Council Taiwan ROC [NSC 98-2321-B-031-001]	National Science Council Taiwan ROC(Ministry of Science and Technology, Taiwan)	This work was supported by grants from the National Science Council Taiwan ROC (NSC 98-2321-B-031-001) to Dr. Yang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Moneim AS, 2011, ARCH VIROL, V156, P1257, DOI 10.1007/s00705-011-0966-3; Batista MVA, 2011, INFECT GENET EVOL, V11, P2026, DOI 10.1016/j.meegid.2011.09.013; Brown EG, 2001, P NATL ACAD SCI USA, V98, P6883, DOI 10.1073/pnas.111165798; Bussey KA, 2011, J VIROL, V85, P7020, DOI 10.1128/JVI.00522-11; Chen GW, 2006, EMERG INFECT DIS, V12, P1353, DOI 10.3201/eid1209.060276; Chen GW, 2009, EMERG INFECT DIS, V15, P1897, DOI 10.3201/eid1512.090845; Dankar SK, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-13; Davey NE, 2011, TRENDS BIOCHEM SCI, V36, P159, DOI 10.1016/j.tibs.2010.10.002; Deng QJ, 2011, J VIROL METHODS, V176, P108, DOI 10.1016/j.jviromet.2011.04.028; Diella F, 2008, FRONT BIOSCI-LANDMRK, V13, P6580, DOI 10.2741/3175; Dinkel H, 2012, NUCLEIC ACIDS RES, V40, pD242, DOI 10.1093/nar/gkr1064; ElSawy KM, 2012, J CHEM INF MODEL, V52, P770, DOI 10.1021/ci200467s; Finkelstein DB, 2007, J VIROL, V81, P10292, DOI 10.1128/JVI.00921-07; Foeglein A, 2011, J GEN VIROL, V92, P1650, DOI 10.1099/vir.0.031492-0; Forbes NE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031839; Gabriel G, 2005, P NATL ACAD SCI USA, V102, P18590, DOI 10.1073/pnas.0507415102; Geiss BJ, 2009, FUTURE MED CHEM, V1, P327, DOI 10.4155/FMC.09.27; Ghanem A, 2007, J VIROL, V81, P7801, DOI 10.1128/JVI.00724-07; Hatta M, 2007, PLOS PATHOG, V3, P1374, DOI 10.1371/journal.ppat.0030133; Hemerka JN, 2009, J VIROL, V83, P3944, DOI 10.1128/JVI.02300-08; Hutchinson EC, 2011, J GEN VIROL, V92, P1859, DOI 10.1099/vir.0.032813-0; Jiang S, 2009, BIOORG MED CHEM LETT, V19, P2693, DOI 10.1016/j.bmcl.2009.03.134; Kadaveru K, 2008, FRONT BIOSCI, V13, P6455, DOI 10.2741/3166; Konig R, 2010, NATURE, V463, P813, DOI 10.1038/nature08699; Koo QY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005352; Li H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019562; Li J, 2011, J GEN VIROL, V92, P1435, DOI 10.1099/vir.0.030718-0; Li ZJ, 2005, J VIROL, V79, P12058, DOI 10.1128/JVI.79.18.12058-12064.2005; Liu Qinfang, 2009, J Mol Genet Med, V3, P225; Loregian A, 2002, REV MED VIROL, V12, P239, DOI 10.1002/rmv.356; Manz B, 2011, J BIOL CHEM, V286, P8414, DOI 10.1074/jbc.M110.205534; Massin P, 2001, J VIROL, V75, P5398, DOI 10.1128/JVI.75.11.5398-5404.2001; Matrosovich M, 2009, REV SCI TECH OIE, V28, P203, DOI 10.20506/rst.28.1.1870; Miotto O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009025; Mok CKP, 2011, J VIROL, V85, P9641, DOI 10.1128/JVI.00702-11; Muratore G, 2012, P NATL ACAD SCI USA, V109, P6247, DOI 10.1073/pnas.1119817109; Naffakh N, 2008, ANNU REV MICROBIOL, V62, P403, DOI 10.1146/annurev.micro.62.081307.162746; Nistal-Villan E, 2009, NAT MED, V15, P1253, DOI 10.1038/nm1109-1253; Pan K, 2011, J R SOC INTERFACE, V8, P1644, DOI 10.1098/rsif.2011.0105; Sarge KD, 2009, METHODS MOL BIOL, V590, P265, DOI 10.1007/978-1-60327-378-7_17; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Shapira SD, 2009, CELL, V139, P1255, DOI 10.1016/j.cell.2009.12.018; Shinya K, 2007, J GEN VIROL, V88, P547, DOI 10.1099/vir.0.82411-0; Song MS, 2011, J VIROL, V85, P6275, DOI 10.1128/JVI.02125-10; Song MS, 2009, J VIROL, V83, P12325, DOI 10.1128/JVI.01373-09; SUBBARAO EK, 1993, J VIROL, V67, P1761, DOI 10.1128/JVI.67.4.1761-1764.1993; Suzuki T, 2011, BIOCHEM BIOPH RES CO, V414, P719, DOI 10.1016/j.bbrc.2011.09.142; Tamuri AU, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000564; Tarendeau F, 2007, NAT STRUCT MOL BIOL, V14, P229, DOI 10.1038/nsmb1212; Tatham MH, 2009, NAT PROTOC, V4, P1363, DOI 10.1038/nprot.2009.128; Wang NX, 2008, DRUG NEWS PERSPECT, V21, P137, DOI 10.1358/dnp.2008.21.3.1203409; Wang S, 2008, J VIROL METHODS, V151, P74, DOI 10.1016/j.jviromet.2008.03.020; Wunderlich K, 2011, ANTIMICROB AGENTS CH, V55, P696, DOI 10.1128/AAC.01419-10; Wunderlich K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007517; Yamada S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001034; Yao YX, 2001, J VIROL, V75, P5410, DOI 10.1128/JVI.75.11.5410-5415.2001; Zar JH., 2010, BIOSTAT ANAL, V5th; Zhan P, 2010, CURR MED CHEM, V17, P3393, DOI 10.2174/092986710793176357	58	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2012	7	6							e38637	10.1371/journal.pone.0038637	http://dx.doi.org/10.1371/journal.pone.0038637			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TQ	22715401	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336800043
J	Smit, LAM; van der Sman-de Beer, F; Opstal-van Winden, AWJ; Hooiveld, M; Beekhuizen, J; Wouters, IM; Yzermans, J; Heederik, D				Smit, Lidwien A. M.; van der Sman-de Beer, Femke; Opstal-van Winden, Annemieke W. J.; Hooiveld, Mariette; Beekhuizen, Johan; Wouters, Inge M.; Yzermans, Joris; Heederik, Dick			Q Fever and Pneumonia in an Area with a High Livestock Density: A Large Population-Based Study	PLOS ONE			English	Article							ANIMAL FEEDING OPERATIONS; NETHERLANDS; OUTBREAK; HEALTH; EPIDEMIOLOGY; EXPOSURE; HISTORY; SYSTEM	Concerns about public health risks of intensive animal production in the Netherlands continue to rise, in particular related to outbreaks of infectious diseases. The aim was to investigate associations between the presence of farm animals around the home address and Q fever and pneumonia. Electronic medical record data for the year 2009 of all patients of 27 general practitioners (GPs) in a region with a high density of animal farms were used. Density of farm animals around the home address was calculated using a Geographic Information System. During the study period, a large Q fever outbreak occurred in this region. Associations between farm exposure variables and pneumonia or 'other infectious disease', the diagnosis code used by GPs for registration of Q fever, were analyzed in 22,406 children (0-17 y) and 70,142 adults (18-70 y), and adjusted for age and sex. In adults, clear exposure-response relationships between the number of goats within 5 km of the home address and pneumonia and 'other infectious disease' were observed. The association with 'other infectious disease' was particularly strong, with an OR [95% CI] of 12.03 [8.79-16.46] for the fourth quartile (>17,190 goats) compared with the first quartile (<2,251 goats). The presence of poultry within 1 km was associated with an increased incidence of pneumonia among adults (OR [95% CI] 1.25 [1.06-1.47]). A high density of goats in a densely populated region was associated with human Q fever. The use of GP records combined with individual exposure estimates using a Geographic Information System is a powerful approach to assess environmental health risks.	[Smit, Lidwien A. M.; Opstal-van Winden, Annemieke W. J.; Beekhuizen, Johan; Wouters, Inge M.; Heederik, Dick] Univ Utrecht, Div Environm Epidemiol, Inst Risk Assessment Sci, Utrecht, Netherlands; [van der Sman-de Beer, Femke; Hooiveld, Mariette; Yzermans, Joris] Netherlands Inst Hlth Serv Res, Utrecht, Netherlands	Utrecht University; Netherlands Institute for Health Services Research	Smit, LAM (corresponding author), Univ Utrecht, Div Environm Epidemiol, Inst Risk Assessment Sci, Utrecht, Netherlands.	L.A.Smit@uu.nl	Smit, Lidwien AM/AFC-8689-2022	Smit, Lidwien AM/0000-0003-0292-0946; Wouters, Inge M./0000-0001-7834-9390; Heederik, Dick/0000-0002-4550-1437	Dutch Ministry of Economic Affairs, Agriculture and Innovation; Dutch Ministry of Health, Welfare and Sport	Dutch Ministry of Economic Affairs, Agriculture and Innovation; Dutch Ministry of Health, Welfare and Sport	Funding for this study was provided by the Dutch Ministry of Economic Affairs, Agriculture and Innovation, and the Dutch Ministry of Health, Welfare and Sport. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayres JG, 1998, QJM-MON J ASSOC PHYS, V91, P105, DOI 10.1093/qjmed/91.2.105; Bamberg WM, 2007, VECTOR-BORNE ZOONOT, V7, P394, DOI 10.1089/vbz.2007.0104; Biermans MCJ, 2008, INT J MED INFORM, V77, P431, DOI 10.1016/j.ijmedinf.2007.08.002; Dijkstra F, 2012, FEMS IMMUNOL MED MIC, V64, P3, DOI 10.1111/j.1574-695X.2011.00876.x; Dutch Federation of Biomedical Scientific Societies, 2004, COD COND US DAT HLTH; Hawker J I, 1998, Commun Dis Public Health, V1, P180; Heederik D, 2007, ENVIRON HEALTH PERSP, V115, P298, DOI 10.1289/ehp.8835; Heederik DJJ, 2011, POTENTIAL EFFECTS IN; Hellenbrand W, 2001, EMERG INFECT DIS, V7, P789, DOI 10.3201/eid0705.010504; Hofhuis A, 2010, INFECTIEZIEKTEN B, V3, P84; Hogerwerf L, 2011, EMERG INFECT DIS, V17, P379, DOI 10.3201/eid1703.101157; Karagiannis I, 2009, EPIDEMIOL INFECT, V137, P1283, DOI 10.1017/S0950268808001908; Lamberts H., 1987, ICPC INT CLASSIFICAT; Maurin M, 1999, CLIN MICROBIOL REV, V12, P518, DOI 10.1128/CMR.12.4.518; Morroy G, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-97; Muskens J, 2011, Vet Rec, V168, P79, DOI 10.1136/vr.c6106; Neupane B, 2010, AM J RESP CRIT CARE, V181, P47, DOI [10.1164/rccm.200901-0160oc, 10.1164/rccm.200901-0160OC]; Portengen L, 2005, J ALLERGY CLIN IMMUN, V115, P797, DOI 10.1016/j.jaci.2004.11.046; Radon K, 2007, EPIDEMIOLOGY, V18, P300, DOI 10.1097/01.ede.0000259966.62137.84; Raoult D, 2005, LANCET INFECT DIS, V5, P219, DOI 10.1016/S1473-3099(05)70052-9; Roest HIJ, 2011, EPIDEMIOL INFECT, V139, P1, DOI 10.1017/S0950268810002268; Schimmer B, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-69; Schinasi L, 2011, EPIDEMIOLOGY, V22, P208, DOI 10.1097/EDE.0b013e3182093c8b; Steenland K, 2004, EPIDEMIOLOGY, V15, P63, DOI 10.1097/01.ede.0000100287.45004.e7; Stirbu-Wagner I, 2010, NATL INFORM NETWORK; Van Den Wijngaard CC, 2011, EPIDEMIOL INFECT, V139, P19, DOI 10.1017/S0950268810001032; van der Hoek W, 2010, EUROSURVEILLANCE, V15, P4; van der Hoek W, 2011, INT J ENVIRON HEAL R, V21, P441, DOI 10.1080/09603123.2011.574270; Wallensten A, 2010, EUROSURVEILLANCE, V15, P16; Wouters IM, EPIDEMIOLOG IN PRESS; Zelikoff JT, 2003, INHAL TOXICOL, V15, P131, DOI 10.1080/08958370304478	31	55	55	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e38843	10.1371/journal.pone.0038843	http://dx.doi.org/10.1371/journal.pone.0038843			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685612	Green Submitted, Green Published, gold			2022-12-27	WOS:000305351700076
J	Bjorkgren, I; Saastamoinen, L; Krutskikh, A; Huhtaniemi, I; Poutanen, M; Sipila, P				Bjorkgren, Ida; Saastamoinen, Lauri; Krutskikh, Anton; Huhtaniemi, Ilpo; Poutanen, Matti; Sipila, Petra			Dicer1 Ablation in the Mouse Epididymis Causes Dedifferentiation of the Epithelium and Imbalance in Sex Steroid Signaling	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-ALPHA; FIBROBLAST-GROWTH-FACTOR; MALE REPRODUCTIVE-TRACT; WILD-TYPE MICE; POSTNATAL-DEVELOPMENT; KNOCKOUT MICE; RAT EPIDIDYMIS; MESSENGER-RNA; MICRORNA EXPRESSION; INITIAL SEGMENT	Background: The postnatal development of the epididymis is a complex process that results in a highly differentiated epithelium, divided into several segments. Recent studies indicate a role for RNA interference (RNAi) in the development of the epididymis, however, the actual requirement for RNAi has remained elusive. Here, we present the first evidence of a direct need for RNAi in the differentiation of the epididymal epithelium. Methodology/Principal Findings: By utilizing the Cre-LoxP system we have generated a conditional knock-out of Dicer1 in the two most proximal segments of the mouse epididymis. Recombination of Dicer1, catalyzed by Defb41(iCre/wt), took place before puberty, starting from 12 days postpartum. Shortly thereafter, downregulation of the expression of two genes specific for the most proximal epididymis (lipocalin 8 and cystatin 8) was observed. Following this, segment development continued until week 5 at which age the epithelium started to regress back to an undifferentiated state. The dedifferentiated epithelium also showed an increase in estrogen receptor 1 expression while the expression of androgen receptor and its target genes; glutathione peroxidase 5, lipocalin 5 and cysteine-rich secretory protein 1 was downregulated, indicating imbalanced sex steroid signaling. Conclusions/Significance: At the time of the final epididymal development, Dicer1 acts as a regulator of signaling pathways essential for maintaining epithelial cell differentiation.	[Bjorkgren, Ida; Saastamoinen, Lauri; Poutanen, Matti; Sipila, Petra] Univ Turku, Dept Physiol, Inst Biomed, Turku, Finland; [Bjorkgren, Ida] Turku Grad Sch Biomed Sci, Turku, Finland; [Krutskikh, Anton; Huhtaniemi, Ilpo] Univ London Imperial Coll Sci Technol & Med, Inst Reprod & Dev Biol, London, England; [Poutanen, Matti; Sipila, Petra] Univ Turku, Turku Ctr Dis Modeling, TCDM, Turku, Finland	University of Turku; University of Turku; Imperial College London; University of Turku	Bjorkgren, I (corresponding author), Univ Turku, Dept Physiol, Inst Biomed, Turku, Finland.	petra.sipila@utu.fi	Sipilä, Petra/GYE-3323-2022; Poutanen, Matti/I-1700-2018	Poutanen, Matti/0000-0002-8953-1734; Bjorkgren, Ida/0000-0001-6678-2672; Sipila, Petra/0000-0001-8187-7143	Academy of Finland [138561]; Sigrid Juselius Foundation; Turku Doctoral Programme of Biomedical Sciences	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Turku Doctoral Programme of Biomedical Sciences	This work was supported by research grants from The Academy of Finland (project number 138561, http://www.aka.fi), and Sigrid Juselius Foundation (http://www.sigridjuselius.fi/foundation). IB is supported by the Turku Doctoral Programme of Biomedical Sciences (http://www.tubs.utu.fi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd-Elmaksoud A, 2009, J MOL HISTOL, V40, P407, DOI 10.1007/s10735-010-9254-x; Adams BD, 2007, MOL ENDOCRINOL, V21, P1132, DOI 10.1210/me.2007-0022; Alkafafy M, 2011, ACTA HISTOCHEM, V113, P96, DOI 10.1016/j.acthis.2009.08.004; Avram CE, 2004, CELL TISSUE RES, V317, P23, DOI 10.1007/s00441-004-0892-8; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Carreau S, 1999, INT J ANDROL, V22, P211, DOI 10.1046/j.1365-2605.1999.00172.x; Carthew RW, 2006, CURR OPIN GENET DEV, V16, P203, DOI 10.1016/j.gde.2006.02.012; Clulow J, 1998, J REPROD FERTIL, P1; Cornwall GA, 2009, HUM REPROD UPDATE, V15, P213, DOI 10.1093/humupd/dmn055; Cotton LM, 2008, ENDOCR REV, V29, P193, DOI 10.1210/er.2007-0028; Crocoll A, 1998, MECH DEVELOP, V72, P175, DOI 10.1016/S0925-4773(98)00007-0; Delic D, 2010, STEROIDS, V75, P998, DOI 10.1016/j.steroids.2010.06.010; Egger GF, 2009, ACTA VET BRNO, V78, P3, DOI 10.2754/avb200978010003; Fibbi B, 2009, J SEX MED, V6, P2173, DOI 10.1111/j.1743-6109.2009.01282.x; Harfe BD, 2005, P NATL ACAD SCI USA, V102, P10898, DOI 10.1073/pnas.0504834102; HERMO L, 1992, ANAT RECORD, V233, P205, DOI 10.1002/ar.1092330205; Hess RA, 2000, J ANDROL, V21, P107; Hoshii T, 2007, BIOL REPROD, V76, P303, DOI 10.1095/biolreprod.106.054619; Huang Y, 2011, J PHYSIOL BIOCHEM, V67, P129, DOI 10.1007/s13105-010-0050-6; Joseph A, 2010, BIOL REPROD, V82, P948, DOI 10.1095/biolreprod.109.079889; Joseph A, 2010, BIOL REPROD, V82, P958, DOI 10.1095/biolreprod.109.080366; Joseph A, 2009, DEV BIOL, V325, P6, DOI 10.1016/j.ydbio.2008.10.012; Keilhack H, 2001, J CELL BIOL, V152, P325, DOI 10.1083/jcb.152.2.325; Kirby JL, 2003, BIOL REPROD, V68, P2314, DOI 10.1095/biolreprod.102.011270; Kirchhoff C, 1999, INT REV CYTOL, V188, P133; Krutskikh A, 2011, ENDOCRINOLOGY, V152, P689, DOI 10.1210/en.2010-0768; Lan ZJ, 1998, BIOL REPROD, V58, P197, DOI 10.1095/biolreprod58.1.197; Lareyre JJ, 2001, ENDOCRINOLOGY, V142, P1296, DOI 10.1210/en.142.3.1296; Lynn FC, 2007, DIABETES, V56, P2938, DOI 10.2337/db07-0175; McKenna LB, 2010, GASTROENTEROLOGY, V139, P1654, DOI 10.1053/j.gastro.2010.07.040; McKinnell C, 2001, J ANDROL, V22, P323; McManus MT, 2002, NAT REV GENET, V3, P737, DOI 10.1038/nrg908; Mendive F, 2006, DEV BIOL, V290, P421, DOI 10.1016/j.ydbio.2005.11.043; Morani A, 2008, J INTERN MED, V264, P128, DOI 10.1111/j.1365-2796.2008.01976.x; Muljo SA, 2005, J EXP MED, V202, P261, DOI 10.1084/jem.20050678; Murashima A, 2011, ENDOCRINOLOGY, V152, P1640, DOI 10.1210/en.2010-1121; Narayanan R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013637; O'Hara L, 2011, ENDOCRINOLOGY, V152, P718, DOI 10.1210/en.2010-0928; Pandey DP, 2010, CURR OPIN PHARMACOL, V10, P637, DOI 10.1016/j.coph.2010.08.009; Ribas J, 2009, CANCER RES, V69, P7165, DOI 10.1158/0008-5472.CAN-09-1448; Robaire B, 2000, E SCHERING RES FDN W, P229; Rosenfeld CS, 1998, ENDOCRINOLOGY, V139, P2982, DOI 10.1210/en.139.6.2982; Sekine S, 2009, J PATHOL, V219, P365, DOI 10.1002/path.2606; Shayu D, 2006, MOL CELL ENDOCRINOL, V249, P40, DOI 10.1016/j.mce.2006.01.016; Shi XB, 2007, P NATL ACAD SCI USA, V104, P19983, DOI 10.1073/pnas.0706641104; Shum WW, 2011, J ANDROL; Simanainen U, 2008, ENDOCRINOLOGY, V149, P3330, DOI 10.1210/en.2007-1805; Sipila P, 2002, MOL ENDOCRINOL, V16, P2603, DOI 10.1210/me.2002-0100; SonnenbergRiethmacher E, 1996, GENE DEV, V10, P1184, DOI 10.1101/gad.10.10.1184; Soukup GA, 2009, DEV BIOL, V328, P328, DOI 10.1016/j.ydbio.2009.01.037; SUN EL, 1979, AM J ANAT, V154, P27, DOI 10.1002/aja.1001540104; Takagi-Morishita Y, 2002, ENDOCR J, V49, P75, DOI 10.1507/endocrj.49.75; Tomaszewski J, 2007, P NATL ACAD SCI USA, V104, P11322, DOI 10.1073/pnas.0703445104; Wang JF, 2010, BIOCHEM BIOPH RES CO, V402, P222, DOI 10.1016/j.bbrc.2010.10.002; Welsh M, 2007, ENDOCRINOLOGY, V148, P3185, DOI 10.1210/en.2007-0028; Williams K, 2001, HUM REPROD UPDATE, V7, P236, DOI 10.1093/humupd/7.3.236; Yeung CH, 1999, BIOL REPROD, V61, P1062, DOI 10.1095/biolreprod61.4.1062; Yuan Q, 2007, ASIAN J ANDROL, V9, P305, DOI 10.1111/j.1745-7262.2007.00260.x; Zhang JS, 2010, ACTA BIOCH BIOPH SIN, V42, P145, DOI 10.1093/abbs/gmp116; Zhou Q, 2002, J ANDROL, V23, P870	61	53	54	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e38457	10.1371/journal.pone.0038457	http://dx.doi.org/10.1371/journal.pone.0038457			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701646	Green Published, Green Submitted, gold			2022-12-27	WOS:000305348400061
J	Garcia-Santisteban, I; Zorroza, K; Rodriguez, JA				Garcia-Santisteban, Iraia; Zorroza, Kerman; Antonio Rodriguez, Jose			Two Nuclear Localization Signals in USP1 Mediate Nuclear Import of the USP1/UAF1 Complex	PLOS ONE			English	Article							FANCONI-ANEMIA PATHWAY; UBIQUITIN SYSTEM; PROTEIN; EXPORT; CANCER; REPAIR; DEUBIQUITINATION; IDENTIFICATION; SEQUENCE; REVERSE	The human deubiquitinase USP1 plays important roles in cancer-related processes, such as the DNA damage response, and the maintenance of the undifferentiated state of osteosarcoma cells. USP1 deubiquitinase activity is critically regulated by its interaction with the WD40 repeat-containing protein UAF1. Inhibiting the function of the USP1/UAF1 complex sensitizes cancer cells to chemotherapy, suggesting that this complex is a relevant anticancer target. Intriguingly, whereas UAF1 has been reported to locate in the cytoplasm, USP1 is a nuclear protein, although the sequence motifs that mediate its nuclear import have not been functionally characterized. Here, we identify two nuclear localization signals (NLSs) in USP1 and show that these NLSs mediate the nuclear import of the USP1/UAF1 complex. Using a cellular relocation assay based on these results, we map the UAF1-binding site to a highly conserved 100 amino acid motif in USP1. Our data support a model in which USP1 and UAF1 form a complex in the cytoplasm that subsequently translocates to the nucleus through import mediated by USP1 NLSs. Importantly, our findings have practical implications for the development of USP1-directed therapies. First, the UAF1-interacting region of USP1 identified here might be targeted to disrupt the USP1/UAF1 interaction with therapeutic purposes. On the other hand, we describe a cellular relocation assay that can be easily implemented in a high throughput setting to search for drugs that may dissociate the USP1/UAF1 complex.	[Garcia-Santisteban, Iraia; Antonio Rodriguez, Jose] Univ Basque Country UPV EHU, Dept Genet Phys Anthropol & Anim Physiol, Leioa, Spain; [Zorroza, Kerman] Basque Fdn Hlth Innovat & Res, BioEF, Bilbao, Spain	University of Basque Country	Garcia-Santisteban, I (corresponding author), Univ Basque Country UPV EHU, Dept Genet Phys Anthropol & Anim Physiol, Leioa, Spain.	josean.rodriguez@ehu.es	Garcia-Santisteban, Iraia/AAS-1463-2020; Rodriguez, Jose Antonio/AAA-1125-2019	Rodriguez, Jose Antonio/0000-0002-2823-3733; GARCIA SANTISTEBAN, IRAIA/0000-0002-7912-385X	Basque Country Government Department of Industry [ETORTEK BioGUNE2010]; Spanish Government MICINN (Ministerio de Ciencia e Innovacion) [BFU2009-13245]; University of the Basque Country [UFI11/20]; Department of Education of the Basque Country Government	Basque Country Government Department of Industry; Spanish Government MICINN (Ministerio de Ciencia e Innovacion); University of the Basque Country; Department of Education of the Basque Country Government	This work was supported by the Basque Country Government Department of Industry (grant number ETORTEK BioGUNE2010 to JAR), the Spanish Government MICINN (Ministerio de Ciencia e Innovacion) (grant number BFU2009-13245 to JAR), the University of the Basque Country (UFI11/20), and a fellowship from the Department of Education of the Basque Country Government (to IG-S). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergink S, 2009, NATURE, V458, P461, DOI 10.1038/nature07963; Chen JJ, 2011, CHEM BIOL, V18, P1390, DOI 10.1016/j.chembiol.2011.08.014; Cohen P, 2010, CELL, V143, P686, DOI 10.1016/j.cell.2010.11.016; Cohn MA, 2007, MOL CELL, V28, P786, DOI 10.1016/j.molcel.2007.09.031; Cohn MA, 2009, J BIOL CHEM, V284, P5343, DOI 10.1074/jbc.M808430200; Cote-Martin A, 2008, J VIROL, V82, P1271, DOI 10.1128/JVI.01405-07; Fraile JM, 2012, ONCOGENE, V31, P2373, DOI 10.1038/onc.2011.443; Garcia-Santisteban I, 2012, BIOCHEM J, V441, P209, DOI 10.1042/BJ20111300; Grabbe C, 2011, NAT REV MOL CELL BIO, V12, P295, DOI 10.1038/nrm3099; Henderson BR, 2000, EXP CELL RES, V256, P213, DOI 10.1006/excr.2000.4825; Hoeller D, 2009, NATURE, V458, P438, DOI 10.1038/nature07960; Huang TT, 2006, NAT CELL BIOL, V8, P339, DOI 10.1038/ncb1378; Joo HY, 2011, J BIOL CHEM, V286, P7190, DOI 10.1074/jbc.M110.158311; Kim JM, 2009, DEV CELL, V16, P314, DOI 10.1016/j.devcel.2009.01.001; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Kosugi S, 2009, P NATL ACAD SCI USA, V106, P10171, DOI 10.1073/pnas.0900604106; Kudo N, 1998, EXP CELL RES, V242, P540, DOI 10.1006/excr.1998.4136; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Murai J, 2011, MOL CELL BIOL, V31, P2462, DOI 10.1128/MCB.05058-11; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Nijman SMB, 2005, MOL CELL, V17, P331, DOI 10.1016/j.molcel.2005.01.008; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Oestergaard VH, 2007, MOL CELL, V28, P798, DOI 10.1016/j.molcel.2007.09.020; Park J, 2002, IMMUNITY, V17, P221, DOI 10.1016/S1074-7613(02)00368-0; Ramakrishna S, 2011, CELL MOL LIFE SCI, V68, P15, DOI 10.1007/s00018-010-0504-6; Rodriguez JA, 2000, J BIOL CHEM, V275, P38589, DOI 10.1074/jbc.M003851200; Song L, 2008, CURR OPIN CELL BIOL, V20, P156, DOI 10.1016/j.ceb.2008.01.012; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Williams SA, 2011, CELL, V146, P917, DOI 10.1016/j.cell.2011.07.040	30	28	31	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e38570	10.1371/journal.pone.0038570	http://dx.doi.org/10.1371/journal.pone.0038570			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701671	Green Published, Green Submitted, gold			2022-12-27	WOS:000305348400074
J	Wajnberg, E; Coquillard, P; Vet, LEM; Hoffmeister, T				Wajnberg, Eric; Coquillard, Patrick; Vet, Louise E. M.; Hoffmeister, Thomas			Optimal Resource Allocation to Survival and Reproduction in Parasitic Wasps Foraging in Fragmented Habitats	PLOS ONE			English	Article							PATCH-LEAVING STRATEGIES; RANDOM ARRIVAL TIMES; EGG LIMITATION; LIFE-HISTORY; GENETIC ALGORITHMS; EVOLUTIONARY ARGUMENT; LANDSCAPE STRUCTURE; BEHAVIORAL ECOLOGY; OVIPOSITION; CONSEQUENCES	Expansion and intensification of human land use represents the major cause of habitat fragmentation. Such fragmentation can have dramatic consequences on species richness and trophic interactions within food webs. Although the associated ecological consequences have been studied by several authors, the evolutionary effects on interacting species have received little research attention. Using a genetic algorithm, we quantified how habitat fragmentation and environmental variability affect the optimal reproductive strategies of parasitic wasps foraging for hosts. As observed in real animal species, the model is based on the existence of a negative trade-off between survival and reproduction resulting from competitive allocation of resources to either somatic maintenance or egg production. We also asked to what degree plasticity along this trade-off would be optimal, when plasticity is costly. We found that habitat fragmentation can indeed have strong effects on the reproductive strategies adopted by parasitoids. With increasing habitat fragmentation animals should invest in greater longevity with lower fecundity; yet, especially in unpredictable environments, some level of phenotypic plasticity should be selected for. Other consequences in terms of learning ability of foraging animals were also observed. The evolutionary consequences of these results are discussed.	[Wajnberg, Eric; Coquillard, Patrick] INRA, Sophia Antipolis, France; [Vet, Louise E. M.] Netherlands Inst Ecol NIOO KNAW, Wageningen, Netherlands; [Hoffmeister, Thomas] Univ Bremen, Inst Ecol, D-28359 Bremen, Germany	INRAE; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); University of Bremen	Wajnberg, E (corresponding author), INRA, Sophia Antipolis, France.	wajnberg@sophia.inra.fr	Vet, Louise E.M./B-1342-2009; Wajnberg, Eric/A-4862-2009; Hoffmeister, Thomas S/E-2804-2013; Hoffmeister, Thomas S./AAH-7796-2020; KNAW, NIOO-KNAW/A-4320-2012	Vet, Louise E.M./0000-0002-2287-1128; Wajnberg, Eric/0000-0002-6700-7114; Hoffmeister, Thomas S/0000-0003-2840-7278; Hoffmeister, Thomas S./0000-0003-2840-7278; KNAW, NIOO-KNAW/0000-0002-3835-159X				Barta Z, 1997, P ROY SOC B-BIOL SCI, V264, P1233, DOI 10.1098/rspb.1997.0170; Bernstein Carlos, 2008, P129, DOI 10.1002/9780470696200.ch7; Blumstein DT, 1996, OIKOS, V77, P569, DOI 10.2307/3545948; Bonsall MB, 2004, SCIENCE, V306, P111, DOI 10.1126/science.1100680; Burger JMS, 2004, OIKOS, V106, P117, DOI 10.1111/j.0030-1299.2004.12908.x; Casas J, 2000, J ANIM ECOL, V69, P185, DOI 10.1046/j.1365-2656.2000.00376.x; Casas J, 2009, ECOLOGY, V90, P537, DOI 10.1890/08-0507.1; CHARNOV EL, 1995, P NATL ACAD SCI USA, V92, P1446, DOI 10.1073/pnas.92.5.1446; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; DEJONG G, 1992, AM NAT, V139, P749, DOI 10.1086/285356; DeWitt TJ, 1998, TRENDS ECOL EVOL, V13, P77, DOI 10.1016/S0169-5347(97)01274-3; Ellers J, 2000, AM NAT, V156, P650, DOI 10.1086/316990; Ellers J, 1997, J EVOLUTION BIOL, V10, P771, DOI 10.1007/s000360050053; Ellers J, 2000, NETH J ZOOL, V50, P29, DOI 10.1163/156854200505784; Evans EW, 2011, BIOCONTROL, V56, P395, DOI 10.1007/s10526-011-9375-5; Ewers RM, 2006, BIOL REV, V81, P117, DOI 10.1017/S1464793105006949; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Fischer B, 2011, OIKOS, V120, P258, DOI 10.1111/j.1600-0706.2010.18642.x; FORREST S, 1993, SCIENCE, V261, P872, DOI 10.1126/science.8346439; Green DM, 2009, POPUL ECOL, V51, P253, DOI 10.1007/s10144-008-0131-3; Hamelin F, 2007, ANN INT SOC DYN GAME, V9, P327, DOI 10.1007/978-0-8176-4553-3_16; Hamelin F, 2007, ANN INT SOC DYN GAME, V9, P349, DOI 10.1007/978-0-8176-4553-3_17; Harvey JA, 2008, EVOL ECOL, V22, P153, DOI 10.1007/s10682-007-9164-x; HASSELL MP, 1978, ANNU REV ECOL SYST, V9, P75, DOI 10.1146/annurev.es.09.110178.000451; Heimpel GE, 1996, ECOLOGY, V77, P2410, DOI 10.2307/2265742; Heimpel GE, 1998, AM NAT, V152, P273, DOI 10.1086/286167; Heimpel GE, 1998, BIOL CONTROL, V11, P160, DOI 10.1006/bcon.1997.0587; Hoffmeister Thomas S., 2008, P384, DOI 10.1002/9780470696200.ch17; Hoffmeister TS, 2005, ECOSYSTEMS, V8, P657, DOI 10.1007/s10021-003-0138-8; Hoffmeister TS, 1998, ECOSCIENCE, V5, P312, DOI 10.1080/11956860.1998.11682470; Hovestadt T, 2011, J ANIM ECOL, V80, P1070, DOI 10.1111/j.1365-2656.2011.01848.x; Hunt J, 2004, BEHAV ECOL SOCIOBIOL, V55, P302, DOI 10.1007/s00265-003-0705-1; Hunter MD, 2002, AGR FOREST ENTOMOL, V4, P159, DOI 10.1046/j.1461-9563.2002.00152.x; Huse G, 1999, EVOL ECOL, V13, P469, DOI 10.1023/A:1006746727151; Jervis MA, 2004, OIKOS, V107, P449, DOI 10.1111/j.0030-1299.2004.13453.x; Jervis MA, 2008, ANNU REV ENTOMOL, V53, P361, DOI 10.1146/annurev.ento.53.103106.093433; Krivan V, 1997, THEOR POPUL BIOL, V51, P201, DOI 10.1006/tpbi.1997.1300; KRUESS A, 1994, SCIENCE, V264, P1581, DOI 10.1126/science.264.5165.1581; MCNAMARA JM, 1987, J THEOR BIOL, V125, P385, DOI 10.1016/S0022-5193(87)80209-6; MINKENBERG OPJM, 1992, OIKOS, V65, P134, DOI 10.2307/3544896; MURDOCH WW, 1994, ECOLOGY, V75, P271, DOI 10.2307/1939533; Nonacs P, 2001, BEHAV ECOL, V12, P71, DOI 10.1093/oxfordjournals.beheco.a000381; OLLASON JG, 1980, THEOR POPUL BIOL, V18, P44, DOI 10.1016/0040-5809(80)90039-8; Papaj DR, 2000, ANNU REV ENTOMOL, V45, P423, DOI 10.1146/annurev.ento.45.1.423; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Richard R, 2009, ECOL MONOGR, V79, P465, DOI 10.1890/08-1566.1; Rivero A, 1999, RES POPUL ECOL, V41, P39, DOI 10.1007/PL00011981; RiveroLynch AP, 1997, FUNCT ECOL, V11, P184, DOI 10.1046/j.1365-2435.1997.00076.x; Roff DA, 2007, J EVOLUTION BIOL, V20, P433, DOI 10.1111/j.1420-9101.2006.01255.x; Roff Derek A., 1992; Rosenheim JA, 1999, EVOL ECOL, V13, P141, DOI 10.1023/A:1006612519265; Rosenheim JA, 2000, P ROY SOC B-BIOL SCI, V267, P1565, DOI 10.1098/rspb.2000.1179; Rosenheim JA, 1996, EVOLUTION, V50, P2089, DOI 10.1111/j.1558-5646.1996.tb03595.x; Rosenheim JA, 1999, EVOLUTION, V53, P376, DOI 10.1111/j.1558-5646.1999.tb03773.x; Rosenheim JA, 2008, AM NAT, V172, P486, DOI 10.1086/591677; Rosenheim JA, 2011, EVOLUTION, V65, P2300, DOI 10.1111/j.1558-5646.2011.01305.x; Russell RE, 2003, OIKOS, V103, P142, DOI 10.1034/j.1600-0706.2003.12418.x; Ruxton GD, 2008, J THEOR BIOL, V250, P435, DOI 10.1016/j.jtbi.2007.10.022; SAUNDERS DA, 1991, CONSERV BIOL, V5, P18, DOI 10.1111/j.1523-1739.1991.tb00384.x; Sevenster JG, 1998, EVOLUTION, V52, P1241, DOI [10.2307/2411256, 10.1111/j.1558-5646.1998.tb01853.x]; Shea K, 1996, J ANIM ECOL, V65, P743, DOI 10.2307/5673; Stephens D.W., 1986, pi; Strand E, 2002, AM NAT, V159, P624, DOI 10.1086/339997; SUMIDA BH, 1990, J THEOR BIOL, V147, P59, DOI 10.1016/S0022-5193(05)80252-8; Swift TL, 2010, BIOL REV, V85, P35, DOI 10.1111/j.1469-185X.2009.00093.x; TATAR M, 1993, EVOLUTION, V47, P1302, DOI [10.1111/j.1558-5646.1993.tb02156.x, 10.2307/2410149]; Thies C, 1999, SCIENCE, V285, P893, DOI 10.1126/science.285.5429.893; Toquenaga Y, 1996, TRENDS ECOL EVOL, V11, P478, DOI 10.1016/0169-5347(96)20075-8; Tully T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003207; Valone TJ, 2006, OIKOS, V112, P252; Van Buskirk J, 2009, J EVOLUTION BIOL, V22, P852, DOI 10.1111/j.1420-9101.2009.01685.x; VAN NOORDWIJK AJ, 1986, AM NAT, V128, P137, DOI 10.1086/284547; van Nouhuys S, 2005, ANN ZOOL FENN, V42, P433; Vet Louise E.M., 1995, P65; Wajnberg E, 2006, BEHAV ECOL SOCIOBIOL, V60, P1, DOI 10.1007/s00265-005-0131-7; Wajnberg E, 2004, J ANIM ECOL, V73, P1179, DOI 10.1111/j.0021-8790.2004.00892.x; Wajnberg E, 2006, BEHAV ECOL SOCIOBIOL, V60, P589, DOI 10.1007/s00265-006-0198-9; WHITLEY D, 1989, PROCEEDINGS OF THE THIRD INTERNATIONAL CONFERENCE ON GENETIC ALGORITHMS, P116	79	16	17	1	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e38227	10.1371/journal.pone.0038227	http://dx.doi.org/10.1371/journal.pone.0038227			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701614	Green Published, gold			2022-12-27	WOS:000305348400041
J	Mikalsen, AB; Haugland, O; Rode, M; Solbakk, IT; Evensen, O				Mikalsen, Aase B.; Haugland, Oyvind; Rode, Marit; Solbakk, Inge Tom; Evensen, Oystein			Atlantic Salmon Reovirus Infection Causes a CD8 T Cell Myocarditis in Atlantic Salmon (Salmo salar L.)	PLOS ONE			English	Article							SKELETAL-MUSCLE INFLAMMATION; TROUT ONCORHYNCHUS-MYKISS; DICENTRARCHUS-LABRAX L.; EXPRESSION ANALYSIS; MOLECULAR-CLONING; RAINBOW-TROUT; DIFFERENTIAL EXPRESSION; CARDIOMYOPATHY SYNDROME; TCR CORECEPTOR; COMMON CARP	Heart and skeletal inflammation (HSMI) of farmed Atlantic salmon (Salmo salar L.) is a disease characterized by a chronic myocarditis involving the epicardium and the compact and spongious part of the heart ventricle. Chronic myositis of the red skeletal muscle is also a typical finding of HSMI. Piscine reovirus (PRV) has been detected by real-time PCR from farmed and wild salmon with and without typical changes of HSMI and thus the causal relationship between presence of virus and the disease has not been fully determined [1]. In this study we show that the Atlantic salmon reovirus (ASRV), identical to PRV, can be passaged in GF-1 cells and experimental challenge of naive Atlantic salmon with cell culture passaged reovirus results in cardiac and skeletal muscle pathology typical of HSMI with onset of pathology from 6 weeks, peaking by 9 weeks post challenge. ASRV replicates in heart tissue and the peak level of virus replication coincides with peak of heart lesions. We further demonstrate mRNA transcript assessment and in situ characterization that challenged fish develop a CD8(+) T cell myocarditis.	[Mikalsen, Aase B.; Haugland, Oyvind; Evensen, Oystein] Norwegian Sch Vet Sci, Dept Basic Sci & Aquat Med, Oslo, Norway; [Rode, Marit; Solbakk, Inge Tom] PHARMAQ AS, Oslo, Norway	Norwegian University of Life Sciences	Mikalsen, AB (corresponding author), Norwegian Sch Vet Sci, Dept Basic Sci & Aquat Med, Oslo, Norway.	oystein.evensen@nvh.no	Evensen, Øystein/O-3011-2015	Evensen, Øystein/0000-0002-4856-3043; Mikalsen, Aase B./0000-0001-6367-9629	Research Council of Norway [190473]	Research Council of Norway(Research Council of Norway)	This work was performed with financial support from the Research Council of Norway, project no. 190473. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afanasyeva M, 2004, AUTOIMMUN REV, V3, P476, DOI 10.1016/j.autrev.2004.08.009; Araki K, 2008, DEV COMP IMMUNOL, V32, P850, DOI 10.1016/j.dci.2007.12.005; Bakke-McKellep AM, 2007, J FISH DIS, V30, P13, DOI 10.1111/j.1365-2761.2007.00769.x; Buonocore F, 2006, FISH SHELLFISH IMMUN, V20, P637, DOI 10.1016/j.fsi.2005.08.006; Cheroutre H, 2008, IMMUNITY, V28, P149, DOI 10.1016/j.immuni.2008.01.005; Chi SC, 1999, J FISH DIS, V22, P173, DOI 10.1046/j.1365-2761.1999.00152.x; Djikeng A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-5; Djikeng A, 2009, FUTURE VIROL, V4, P47, DOI 10.2217/17460794.4.1.47; Evans Donald L., 1992, Annual Review of Fish Diseases, V2, P109, DOI 10.1016/0959-8030(92)90059-7; Evensen O., 2008, ENCY VIROLOGY, P83, DOI DOI 10.1016/B978-012374410-4.00772-X; Feldman AM, 2000, NEW ENGL J MED, V343, P1388, DOI 10.1056/NEJM200011093431908; Fischer U, 2006, FISH SHELLFISH IMMUN, V20, P209, DOI 10.1016/j.fsi.2005.03.013; Forlenza M, 2008, MOL IMMUNOL, V45, P1531, DOI 10.1016/j.molimm.2007.10.010; GRIMHOLT U, 1993, IMMUNOGENETICS, V37, P469, DOI 10.1007/BF00222473; Grimholt U, 2000, DEV COMP IMMUNOL, V24, P751, DOI 10.1016/S0145-305X(00)00034-3; Haller O, 2007, CYTOKINE GROWTH F R, V18, P425, DOI 10.1016/j.cytogfr.2007.06.001; Hansen JD, 2000, J IMMUNOL, V164, P3132, DOI 10.4049/jimmunol.164.6.3132; Haugland O, 2005, VACCINE, V23, P5488, DOI 10.1016/j.vaccine.2005.07.034; Haugland O, 2011, J VIROL, V85, P5275, DOI 10.1128/JVI.02154-10; Hetland DL, 2010, FISH SHELLFISH IMMUN, V28, P30, DOI 10.1016/j.fsi.2009.09.011; HORDVIK I, 1993, IMMUNOGENETICS, V37, P437, DOI 10.1007/BF00222467; Ingerslev HC, 2009, SCAND J IMMUNOL, V69, P90, DOI 10.1111/j.1365-3083.2008.02201.x; Inoue Y, 2005, FISH SHELLFISH IMMUN, V18, P335, DOI 10.1016/j.fsi.2004.08.004; Kawai C, 1999, CIRCULATION, V99, P1091, DOI 10.1161/01.CIR.99.8.1091; Kongtorp RT, 2006, J FISH DIS, V29, P233, DOI 10.1111/j.1365-2761.2006.00710.x; Kongtorp RT, 2004, DIS AQUAT ORGAN, V59, P217, DOI 10.3354/dao059217; Kongtorp RT, 2004, J FISH DIS, V27, P351, DOI 10.1111/j.1365-2761.2004.00549.x; Larsen R, 2004, J VIROL, V78, P7938, DOI 10.1128/JVI.78.15.7938-7944.2004; Lilleeng E, 2009, FISH SHELLFISH IMMUN, V27, P65, DOI 10.1016/j.fsi.2009.04.007; Lovoll M, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-309; Martin SAM, 2007, PHYSIOL GENOMICS, V32, P33, DOI 10.1152/physiolgenomics.00064.2007; MOEBIUS U, 1991, EUR J IMMUNOL, V21, P1793, DOI 10.1002/eji.1830210803; Moore LJ, 2009, FISH SHELLFISH IMMUN, V26, P10, DOI 10.1016/j.fsi.2008.09.019; Moore LJ, 2005, MOL IMMUNOL, V42, P1225, DOI 10.1016/j.molimm.2004.11.017; Palacios G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011487; Pinto RD, 2007, MOL IMMUNOL, V44, P2056, DOI 10.1016/j.molimm.2006.09.014; Praveen K, 2006, MOL IMMUNOL, V43, P1152, DOI 10.1016/j.molimm.2005.07.027; Praveen K, 2004, J MOL EVOL, V58, P449, DOI 10.1007/s00239-003-2566-7; Randelli E, 2006, AQUACULTURE, V256, P631, DOI 10.1016/j.aquaculture.2006.02.013; Robertsen B, 2008, FISH SHELLFISH IMMUN, V25, P351, DOI 10.1016/j.fsi.2008.02.004; Saint-Jean SR, 2007, FISH SHELLFISH IMMUN, V23, P390, DOI 10.1016/j.fsi.2006.11.012; Savan R, 2003, EUR J BIOCHEM, V270, P4647, DOI 10.1046/j.1432-1033.2003.03854.x; Schoenborn JR, 2007, ADV IMMUNOL, V96, P41, DOI 10.1016/S0065-2776(07)96002-2; Seppola M, 2008, MOL IMMUNOL, V45, P887, DOI 10.1016/j.molimm.2007.08.003; Somamoto T, 2005, DEV COMP IMMUNOL, V29, P693, DOI 10.1016/j.dci.2004.11.006; Somamoto T, 2006, VIROLOGY, V348, P370, DOI 10.1016/j.virol.2006.01.019; Suetake H, 2004, IMMUNOGENETICS, V56, P368, DOI 10.1007/s00251-004-0694-x; Takizawa F, 2011, DEV COMP IMMUNOL, V35, P752, DOI 10.1016/j.dci.2011.02.008; TERRY LA, 1990, TISSUE ANTIGENS, V35, P82, DOI 10.1111/j.1399-0039.1990.tb01761.x; Toda H, 2009, DEV COMP IMMUNOL, V33, P646, DOI 10.1016/j.dci.2008.11.008; Utke K, 2007, FISH SHELLFISH IMMUN, V22, P182, DOI 10.1016/j.fsi.2006.04.008; Wen Y, 2011, CELL MOL LIFE SCI, V68, P2615, DOI 10.1007/s00018-010-0574-5; Zhang DC, 2005, J BIOCHEM MOL BIOL, V38, P571; Zou J, 2005, J IMMUNOL, V175, P2484, DOI 10.4049/jimmunol.175.4.2484; Zou J, 2003, IMMUNOGENETICS, V55, P325, DOI 10.1007/s00251-003-0580-y	55	49	54	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e37269	10.1371/journal.pone.0037269	http://dx.doi.org/10.1371/journal.pone.0037269			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22693625	gold, Green Published, Green Submitted			2022-12-27	WOS:000305343900006
J	Bagrow, JP; Lin, YR				Bagrow, James P.; Lin, Yu-Ru			Mesoscopic Structure and Social Aspects of Human Mobility	PLOS ONE			English	Article							PREDICTABILITY; NETWORKS; DEMAND; TRAVEL	The individual movements of large numbers of people are important in many contexts, from urban planning to disease spreading. Datasets that capture human mobility are now available and many interesting features have been discovered, including the ultra-slow spatial growth of individual mobility. However, the detailed substructures and spatiotemporal flows of mobility - the sets and sequences of visited locations - have not been well studied. We show that individual mobility is dominated by small groups of frequently visited, dynamically close locations, forming primary "habitats" capturing typical daily activity, along with subsidiary habitats representing additional travel. These habitats do not correspond to typical contexts such as home or work. The temporal evolution of mobility within habitats, which constitutes most motion, is universal across habitats and exhibits scaling patterns both distinct from all previous observations and unpredicted by current models. The delay to enter subsidiary habitats is a primary factor in the spatiotemporal growth of human travel. Interestingly, habitats correlate with non-mobility dynamics such as communication activity, implying that habitats may influence processes such as information spreading and revealing new connections between human mobility and social networks.	[Bagrow, James P.] Northwestern Univ, Evanston, IL 60208 USA; [Bagrow, James P.] Northeastern Univ, Ctr Complex Network Res, Boston, MA 02115 USA; [Lin, Yu-Ru] Northeastern Univ, Coll Comp & Informat Sci, Boston, MA 02115 USA; [Lin, Yu-Ru] Harvard Univ, Inst Quantitat Social Sci, Cambridge, MA 02138 USA	Northwestern University; Northeastern University; Northeastern University; Harvard University	Bagrow, JP (corresponding author), Northwestern Univ, Evanston, IL 60208 USA.	james.bagrow@northwestern.edu	Bagrow, James/E-1701-2016	Bagrow, James/0000-0002-4614-0792	Center for Complex Network Research; James S. McDonnell Foundation; National Science Foundation [DMR-0426737, IIS-0513650]; Defense Threat Reduction Agency [HDTRA1-08-1-0027, HDTRA1-10-1-0100]; Network Science Collaborative Technology Alliance by the United States Army Research Laboratory [W911NF-09-2-0053]; U.S. Office of Naval Research [N000141010968]; MURI [G00003585]	Center for Complex Network Research; James S. McDonnell Foundation; National Science Foundation(National Science Foundation (NSF)); Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); Network Science Collaborative Technology Alliance by the United States Army Research Laboratory; U.S. Office of Naval Research(Office of Naval Research); MURI(MURI)	This work was supported by the Center for Complex Network Research supported by the James S. McDonnell Foundation 21st Century Initiative in Studying Complex Systems (http://www.jsmf.org/programs/cs/index.htm), the National Science Foundation within the Information Technology Research (DMR-0426737) and IIS-0513650 programs (http://www.nsf.gov/funding/pgm_summ.jsp?pims_id = 5524&from = fund), the Defense Threat Reduction Agency award HDTRA1-08-1-0027 and HDTRA1-10-1-0100 (http://www.dtrasubmission.net/portal/), the Network Science Collaborative Technology Alliance sponsored by the United States Army Research Laboratory under agreement number W911NF-09-2-0053 (http://www.arl.army.mil/www/default.cfm?page = 391), and the U.S. Office of Naval Research Award (N000141010968) (http://www.onr.navy.mil/Contracts-Grants.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank F. Simini, J. Menche, J.-P. Onnela, S. Lehmann, W.-T. Chung, D. Brockmann, B. Uzzi, and D. Lazer for many useful discussions and A.-L. Barabasi, D. Lazer, B. Uzzi and D. Brockmann for support. We gratefully acknowledge the hospitality of the LazerLab at Northeastern University, supported by MURI grant #G00003585. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the funding source.	Backstrom L., 2011, P 5 INT C WEBL SOC M; Bagrow James P., 2009, 2009 International Conference on Computational Science and Engineering (CSE), P944, DOI 10.1109/CSE.2009.283; Bagrow JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017680; Brockmann D, 2006, NATURE, V439, P462, DOI 10.1038/nature04292; Brons M, 2002, J AIR TRANSP MANAG, V8, P165, DOI 10.1016/S0969-6997(01)00050-3; Calabrese F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020814; Colizza V, 2006, P NATL ACAD SCI USA, V103, P2015, DOI 10.1073/pnas.0510525103; Crandall DJ, 2010, P NATL ACAD SCI USA, V107, P22436, DOI 10.1073/pnas.1006155107; Eagle N, 2009, P NATL ACAD SCI USA, V106, P15274, DOI 10.1073/pnas.0900282106; Expert P, 2011, P NATL ACAD SCI USA, V108, P7663, DOI 10.1073/pnas.1018962108; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Horner MW., 2001, J TRANSP GEOGR, V9, P255, DOI DOI 10.1016/S0966-6923(01)00019-9; Hufnagel L, 2004, P NATL ACAD SCI USA, V101, P15124, DOI 10.1073/pnas.0308344101; Hui P, 2005, P 2005 ACM SIGCOMM W, P244, DOI DOI 10.1145/1080139.1080142; Jain AK, 1999, ACM COMPUT SURV, V31, P264, DOI 10.1145/331499.331504; Kendall M.G., 1990, RANK CORRELATION MET, V5th; Kitamura R, 2000, TRANSPORTATION, V27, P25, DOI 10.1023/A:1005259324588; Kleinberg JM, 2000, NATURE, V406, P845, DOI 10.1038/35022643; Onnela JP, 2007, P NATL ACAD SCI USA, V104, P7332, DOI 10.1073/pnas.0610245104; Onnela JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016939; Park J, 2010, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2010/11/P11021; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; Ratti C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014248; Rosvall M, 2008, P NATL ACAD SCI USA, V105, P1118, DOI 10.1073/pnas.0706851105; Simini F, 2012, NATURE, V484, P96, DOI 10.1038/nature10856; Song C., 2010, NATURE PHYS; Stouffer SA, 1940, AM SOCIOL REV, V5, P845, DOI 10.2307/2084520; Thiemann C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015422; Wang D., 2011, P 17 ACM SIGKDD INT, P1100, DOI DOI 10.1145/2020408.2020581	30	72	72	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e37676	10.1371/journal.pone.0037676	http://dx.doi.org/10.1371/journal.pone.0037676			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22701529	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000305338500050
J	Lo, CC; Schwartz, JA; Johnson, DJ; Yu, MC; Aidarus, N; Mujib, S; Benko, E; Hyrcza, M; Kovacs, C; Ostrowski, MA				Lo, Calvin C.; Schwartz, Jordan A.; Johnson, Dylan J.; Yu, Monica; Aidarus, Nasra; Mujib, Shariq; Benko, Erika; Hyrcza, Martin; Kovacs, Colin; Ostrowski, Mario A.			HIV Delays IFN-alpha Production from Human Plasmacytoid Dendritic Cells and Is Associated with SYK Phosphorylation	PLOS ONE			English	Article							INHIBITS TLR9-MEDIATED ACTIVATION; INTERFERON-ALPHA; SIMIAN IMMUNODEFICIENCY; CHEMOKINE PRODUCTION; AIDS VIRUS; CPG DNA; INFLUENZA; INFECTION; TLR7; EXPRESSION	Plasmacytoid dendritic cells (pDC) are the major producers of type I interferons (IFNs) in humans and rapidly produce IFN-alpha in response to virus exposure. Although HIV infection is associated with pDC activation, it is unclear why the innate immune response is unable to effectively control viral replication. We systematically compared the effect of HIV, Influenza, Sendai, and HSV-2 at similar target cell multiplicity of infection (M.O.I.) on human pDC function. We found that Influenza, Sendai, HSV-2 and imiquimod are able to rapidly induce IFN-alpha production within 4 hours to maximal levels, whereas HIV had a delayed induction that was maximal only after 24 hours. In addition, maximal IFN-alpha induction by HIV was at least 10 fold less than that of the other viruses in the panel. HIV also induced less TNF-alpha and MIP-1 beta but similar levels of IP-10 compared to other viruses, which was also mirrored by delayed upregulation of pDC activation markers CD83 and CD86. BDCA-2 has been identified as an inhibitory receptor on pDC, signaling through a pathway that involves SYK phosphorylation. We find that compared to Influenza, HIV induces the activation of the SYK pathway. Thus, HIV delays pDC IFN-alpha production and pDC activation via SYK phosphorylation, allowing establishment of viral populations.	[Lo, Calvin C.; Schwartz, Jordan A.; Johnson, Dylan J.; Yu, Monica; Mujib, Shariq; Ostrowski, Mario A.] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Aidarus, Nasra; Mujib, Shariq; Benko, Erika; Hyrcza, Martin; Kovacs, Colin; Ostrowski, Mario A.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Benko, Erika; Kovacs, Colin] Maple Leaf Med Clin, Toronto, ON, Canada; [Ostrowski, Mario A.] St Michaels Hosp, Li Ka Shing Inst, Toronto, ON M5B 1W8, Canada	University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Lo, CC (corresponding author), Univ Toronto, Dept Immunol, Toronto, ON, Canada.	mario.ostrowski@gmail.com		Mujib, Shariq/0000-0002-6206-5622; Lo, Calvin/0000-0002-0743-8895; Schwartz, Jordan/0000-0001-9658-5282	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Institutes of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asselin-Paturel C, 2005, J EXP MED, V202, P461, DOI 10.1084/jem.20051395; Baccam P, 2006, J VIROL, V80, P7590, DOI 10.1128/JVI.01623-05; Baeten JM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001888; Beignon AS, 2005, J CLIN INVEST, V115, P3265, DOI 10.1172/JCI26032; Beignon AS, 2005, J CLIN INVEST; Benlahrech A, 2011, CURR OPIN HIV AIDS, V6, P373, DOI 10.1097/COH.0b013e328349592a; Cao W, 2007, PLOS BIOL, V5, P2190, DOI 10.1371/journal.pbio.0050248; Cao W, 2006, J EXP MED, V203, P1399, DOI 10.1084/jem.20052454; Cao W, 2009, J EXP MED, V206, P1603, DOI 10.1084/jem.20090547; Cohen MS, 2011, NEW ENGL J MED, V364, P1943, DOI 10.1056/NEJMra1011874; Cox K, 2005, J LEUKOCYTE BIOL, V78, P1142, DOI 10.1189/jlb.1103-532; Dai JH, 2004, J IMMUNOL, V173, P1535, DOI 10.4049/jimmunol.173.3.1535; Der SD, 1998, P NATL ACAD SCI USA, V95, P15623, DOI 10.1073/pnas.95.26.15623; Di Domizio J, 2009, BLOOD, V114, P1794, DOI 10.1182/blood-2009-04-216770; Dobson-Belaire WN, 2010, CELL MICROBIOL; Donhauser N, 2010, AIDS RES HUM RETROV, V26, P161, DOI 10.1089/aid.2008.0278; Dufour JH, 2002, J IMMUNOL, V168, P3195, DOI 10.4049/jimmunol.168.7.3195; Dzionek A, 2001, J EXP MED, V194, P1823, DOI 10.1084/jem.194.12.1823; Fonteneau JF, 2004, J VIROL, V78, P5223, DOI 10.1128/JVI.78.10.5223-5232.2004; Ghedin E, 2005, NATURE, V437, P1162, DOI 10.1038/nature04239; Gibson SJ, 2002, CELL IMMUNOL, V218, P74, DOI 10.1016/S0008-8749(02)00517-8; Gilliet M, 2008, NAT REV IMMUNOL, V8, P594, DOI 10.1038/nri2358; Gondois-Rey F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004319; Guiducci C, 2009, J INTERN MED, V265, P43, DOI 10.1111/j.1365-2796.2008.02050.x; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Izaguirre A, 2003, J LEUKOCYTE BIOL, V74, P1125, DOI 10.1189/jlb.0603255; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Kawai T, 2004, NAT IMMUNOL, V5, P1061, DOI 10.1038/ni1118; Krug A, 2001, EUR J IMMUNOL, V31, P3026, DOI 10.1002/1521-4141(2001010)31:10<3026::AID-IMMU3026>3.0.CO;2-H; Lane BR, 2003, VIROLOGY, V307, P122, DOI 10.1016/S0042-6822(02)00045-4; Li QS, 2009, NATURE, V458, P1034, DOI 10.1038/nature07831; Liu YJ, 2005, ANNU REV IMMUNOL, V23, P275, DOI 10.1146/annurev.immunol.23.021704.115633; Manches O, 2008, J CLIN INVEST, V118, P3431, DOI 10.1172/JCI34823; Mandl JN, 2008, NAT MED, V14, P1077, DOI 10.1038/nm.1871; Markowitz M, 2003, J VIROL, V77, P5037, DOI 10.1128/JVI.77.8.5037-5038.2003; Martinelli E, 2007, P NATL ACAD SCI USA, V104, P3396, DOI 10.1073/pnas.0611353104; Matsui T, 2009, J IMMUNOL, V182, P6815, DOI 10.4049/jimmunol.0802008; Megjugorac NJ, 2004, J LEUKOCYTE BIOL, V75, P504, DOI 10.1189/jlb.0603291; Meier A, 2007, J VIROL, V81, P8180, DOI 10.1128/JVI.00421-07; Miller CJ, 2005, J VIROL, V79, P9217, DOI 10.1128/JVI.79.14.9217-9227.2005; O'Brien M, 2011, J CLIN INVEST, V121, P1088, DOI 10.1172/JCI44960; Osawa Y, 2006, J IMMUNOL, V177, P4841, DOI 10.4049/jimmunol.177.7.4841; Pal R, 2002, J VIROL, V76, P292, DOI 10.1128/JVI.76.1.292-302.2002; Penna G, 2002, J IMMUNOL, V169, P6673, DOI 10.4049/jimmunol.169.12.6673; Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582; Porcu P, 1998, P NATL ACAD SCI USA, V95, P4538, DOI 10.1073/pnas.95.8.4538; RATNER L, 1985, NATURE, V313, P277, DOI 10.1038/313277a0; Ribeiro RM, 2010, J VIROL, V84, P6096, DOI 10.1128/JVI.00127-10; Rock J, 2007, EUR J IMMUNOL, V37, P3564, DOI 10.1002/eji.200737711; Sadaka C, 2009, BLOOD, V113, P2127, DOI 10.1182/blood-2008-10-178152; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Sato M, 1998, FEBS LETT, V441, P106, DOI 10.1016/S0014-5793(98)01514-2; Sheth PM, 2006, J INFECT DIS, V193, P45, DOI 10.1086/498576; Spackman Erica, 2008, V436, P19, DOI 10.1007/978-1-59745-279-3_4; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Xu Y, 2009, MOL IMMUNOL, V46, P2640, DOI 10.1016/j.molimm.2009.04.031; Zhang ZQ, 1999, SCIENCE, V286, P1353, DOI 10.1126/science.286.5443.1353	57	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e37052	10.1371/journal.pone.0037052	http://dx.doi.org/10.1371/journal.pone.0037052			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693567	gold, Green Published, Green Submitted			2022-12-27	WOS:000305338500029
J	Qi, JJ; Guo, AZ; Cui, P; Chen, YY; Mustafa, R; Ba, XL; Hu, CM; Bai, ZD; Chen, X; Shi, L; Chen, HC				Qi, Jingjing; Guo, Aizhen; Cui, Peng; Chen, Yingyu; Mustafa, Riaz; Ba, Xiaoliang; Hu, Changmin; Bai, Zhidi; Chen, Xi; Shi, Lei; Chen, Huanchun			Comparative Geno-Plasticity Analysis of Mycoplasma bovis HB0801 (Chinese Isolate)	PLOS ONE			English	Article							SEQUENCE; ALIGNMENT; IDENTIFICATION; ALGORITHM; ARTEMIS; FAMILY	Mycoplasma bovis pneumonia in cattle has been epidemic in China since 2008. To investigate M. bovis pathogenesis, we completed genome sequencing of strain HB0801 isolated from a lesioned bovine lung from Hubei, China. The genomic plasticity was determined by comparing HB0801 with M. bovis strain ATCCH(R) 25523(TM)/PG45 from cow mastitis milk, Chinese strain Hubei-1 from lesioned lung tissue, and 16 other Mycoplasmas species. Compared to PG45, the genome size of HB0801 was reduced by 11.7 kb. Furthermore, a large chromosome inversion (580 kb) was confirmed in all Chinese isolates including HB0801, HB1007, a strain from cow mastitis milk, and Hubei-1. In addition, the variable surface lipoproteins (vsp) gene cluster existed in HB0801, but contained less than half of the genes, and had poor identity to that in PG45, but they had conserved structures. Further inter-strain comparisons revealed other mechanisms of gene acquisition and loss in HB0801 that primarily involved insertion sequence (IS) elements, integrative conjugative element, restriction and modification systems, and some lipoproteins and transmembrane proteins. Subsequently, PG45 and HB0801 virulence in cattle was compared. Results indicated that both strains were pathogenic to cattle. The scores of gross pathological assessment for the control group, and the PG45- and HB0801-infected groups were 3, 13 and 9, respectively. Meanwhile the scores of lung lesion for these three groups were 36, 70, and 69, respectively. In addition, immunohistochemistry detection demonstrated that both strains were similarly distributed in lungs and lymph nodes. Although PG45 showed slightly higher virulence in calves than HB0801, there was no statistical difference between the strains (P>0.05). Compared to Hubei-1, a total of 122 SNP loci were disclosed in HB0801. In conclusion, although genomic plasticity was thought to be an evolutionary advantage, it did not apparently affect virulence of M. bovis strains in cattle.	[Qi, Jingjing; Guo, Aizhen; Cui, Peng; Chen, Yingyu; Mustafa, Riaz; Ba, Xiaoliang; Hu, Changmin; Bai, Zhidi; Chen, Xi; Shi, Lei; Chen, Huanchun] Huazhong Agr Univ, Natl Key Lab Agr Microbiol, Wuhan, Peoples R China; [Qi, Jingjing; Guo, Aizhen; Cui, Peng; Chen, Yingyu; Mustafa, Riaz; Ba, Xiaoliang; Hu, Changmin; Bai, Zhidi; Chen, Xi; Shi, Lei; Chen, Huanchun] Huazhong Agr Univ, Coll Vet Med, Wuhan, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University	Qi, JJ (corresponding author), Huazhong Agr Univ, Natl Key Lab Agr Microbiol, Wuhan, Peoples R China.	aizhen@mail.hzau.edu.cn	chen, ying/HHS-8254-2022	Shi, Lei/0000-0003-4027-2396; Ba, Xiaoliang/0000-0002-3882-3585	Special Fund for Agro-Scientific Research in the Public Interest [201003060]; Special Fund for Modern Agricultural Technology System (Beef Cattle) [CARS-38]	Special Fund for Agro-Scientific Research in the Public Interest; Special Fund for Modern Agricultural Technology System (Beef Cattle)	This work was supported by Special Fund for Agro-Scientific Research in the Public Interest (201003060) and Special Fund for Modern Agricultural Technology System (Beef Cattle, CARS-38). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Cabezon E, 1997, MOL GEN GENET, V254, P400, DOI 10.1007/s004380050432; Calcutt MJ, 2002, J BACTERIOL, V184, P6929, DOI 10.1128/JB.184.24.6929-6941.2002; Cao TB, 2001, MICROBIOL-SGM, V147, P3201, DOI 10.1099/00221287-147-12-3201; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Caswell JL, 2010, VET CLIN N AM-FOOD A, V26, P365, DOI 10.1016/j.cvfa.2010.03.003; Caswell Jeff L., 2007, Animal Health Research Reviews, V8, P161, DOI 10.1017/S1466252307001351; Creevey CJ, 2005, BIOINFORMATICS, V21, P390, DOI 10.1093/bioinformatics/bti020; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Fadiel A, 2007, FRONT BIOSCI-LANDMRK, V12, P2020, DOI 10.2741/2207; Glew MD, 2002, J BACTERIOL, V184, P5987, DOI 10.1128/JB.184.21.5987-5998.2002; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Kovacs-Simon A, 2011, INFECT IMMUN, V79, P548, DOI 10.1128/IAI.00682-10; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lefebure T, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r71; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Li Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020999; Lysnyansky I, 1999, J BACTERIOL, V181, P5734, DOI 10.1128/JB.181.18.5734-5741.1999; Lysnyansky I, 2009, FEMS MICROBIOL LETT, V294, P172, DOI 10.1111/j.1574-6968.2009.01562.x; Medigue C, 1999, GENOME RES, V9, P1116, DOI 10.1101/gr.9.11.1116; Nicholas RAJ, 2002, VACCINE, V20, P3569, DOI 10.1016/S0264-410X(02)00340-7; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Perrodou E, 2006, NUCLEIC ACIDS RES, V34, pD338, DOI 10.1093/nar/gkj060; Rabel C, 2003, J BACTERIOL, V185, P1045, DOI 10.1128/JB.185.3.1045-1058.2003; Ragan MA, 1992, MOL PHYLOGENET EVOL, V1, P53, DOI 10.1016/1055-7903(92)90035-F; Ren Z, 2012, CHINA ANIMAL HUSBAND; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Shi Lei, 2008, Journal of Huazhong Agricultural University, V27, P629; Sirand-Pugnet P, 2007, PLOS GENET, V3, P744, DOI 10.1371/journal.pgen.0030075; Spalding MD, 2010, MICROBIOL MOL BIOL R, V74, P200, DOI 10.1128/MMBR.00008-10; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vordermeier HM, 2002, INFECT IMMUN, V70, P3026, DOI 10.1128/IAI.70.6.3026-3032.2002; White BJ, 2010, CAN VET J, V51, P1016; Wise KS, 2011, INFECT IMMUN, V79, P982, DOI 10.1128/IAI.00726-10	38	47	55	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38239	10.1371/journal.pone.0038239	http://dx.doi.org/10.1371/journal.pone.0038239			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693604	Green Published, Green Submitted, gold			2022-12-27	WOS:000305338500115
J	Tang, F; Zhang, R; He, YM; Zou, MJ; Guo, L; Xi, T				Tang, Feng; Zhang, Rui; He, Yunmian; Zou, Meijuan; Guo, Le; Xi, Tao			MicroRNA-125b Induces Metastasis by Targeting STARD13 in MCF-7 and MDA-MB-231 Breast Cancer Cells	PLOS ONE			English	Article							MESENCHYMAL TRANSITION; RHO-GTPASES; STEM-CELLS; EXPRESSION AFFECTS; INHIBITS INVASION; PROLIFERATION; GROWTH; MIGRATION; PROTEIN; DIFFERENTIATION	MicroRNAs (miRNAs) are a class of small noncoding RNAs that regulate gene expression by targeting mRNAs to trigger either translation repression or mRNA degradation. miR-125b is down-regulated in human breast cancer cells compared with the normal ones except highly metastatic tumor cells MDA-MB-231. However, few functional studies were designed to investigate metastatic potential of miR-125b. In this study, the effects of miR-125b on metastasis in human breast cancer cells were studied, and the targets of miR-125b were also explored. Transwell migration assay, cell wound healing assay, adhesion assay and nude mice model of metastasis were utilized to investigate the effects of miR-125b on metastasis potential in vitro and in vivo. In addition, it was implied STARD13 (DLC2) was a direct target of miR-125b by Target-Scan analysis, luciferase reporter assay and western blot. Furthermore, activation of STARD13 was identified responsible for metastasis induced by miR-125b through alpha a siRNA targeting STARD13. qRT-PCR, immunofluorescent assay and western blot was used to observe the variation of Vimentin and alpha-SMA in breast cancer cells. In summary, our study provided new insights into the function of miR-125b during the metastasis of breat cancer cells and also suggested the role of miR-125b in pro-metastasis by targeting STARD13.	[Tang, Feng; Zhang, Rui; He, Yunmian; Zou, Meijuan; Guo, Le; Xi, Tao] China Pharmaceut Univ, Sch Life Sci & Technol, Nanjing, Jiangsu, Peoples R China; [Tang, Feng; Zhang, Rui; He, Yunmian; Zou, Meijuan; Guo, Le; Xi, Tao] China Pharmaceut Univ, Jiangsu Key Lab Carcinogenesis & Intervent, Nanjing, Jiangsu, Peoples R China	China Pharmaceutical University; China Pharmaceutical University	Tang, F (corresponding author), China Pharmaceut Univ, Sch Life Sci & Technol, Nanjing, Jiangsu, Peoples R China.	leileitang1984@163.com; xi_tao18@sina.com		Xi, Tao/0000-0001-8065-2639	Fundamental Research Funds for the Central Universities [JYK2011029]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the Fundamental Research Funds for the Central Universities (Program No. JYK2011029). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bloomston M, 2007, JAMA-J AM MED ASSOC, V297, P1901, DOI 10.1001/jama.297.17.1901; Bockmeyer CL, 2011, BREAST CANC RES TREA; Bousquet M, 2008, J EXP MED, V205, P2499, DOI 10.1084/jem.20080285; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chen PN, 2006, J DENT RES, V85, P220, DOI 10.1177/154405910608500303; Ching YP, 2003, J BIOL CHEM, V278, P10824, DOI 10.1074/jbc.M208310200; Cordes KR, 2009, CIRC RES, V104, P724, DOI 10.1161/CIRCRESAHA.108.192872; Croce CM, 2005, CELL, V122, P6, DOI 10.1016/j.cell.2005.06.036; Dykxhoorn DM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007181; Foulkes WD, 2010, NEW ENGL J MED, V363, P1938, DOI 10.1056/NEJMra1001389; Galardi S, 2007, J BIOL CHEM, V282, P23716, DOI 10.1074/jbc.M701805200; Guan Y, 2010, INT J CANC, V23; Huang L, 2011, INT J CANCER, V128, P1758, DOI 10.1002/ijc.25509; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Kim VN, 2006, TRENDS GENET, V22, P165, DOI 10.1016/j.tig.2006.01.003; Lee YS, 2009, ANNU REV PATHOL-MECH, V4, P199, DOI 10.1146/annurev.pathol.4.110807.092222; Leung THY, 2010, LIVER INT, V30, P1315, DOI 10.1111/j.1478-3231.2010.02307.x; Leung THY, 2005, P NATL ACAD SCI USA, V102, P15207, DOI 10.1073/pnas.0504501102; Liu F, 2010, MOL IMAGING BIOL, V12, P595, DOI 10.1007/s11307-010-0305-1; May CD, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2789; Nagaraja GM, 2004, BIOCHEM BIOPH RES CO, V313, P654, DOI 10.1016/j.bbrc.2003.12.001; Nock Nora L, 2009, BMC Proc, V3 Suppl 7, pS50; Paradiso A, 2004, BREAST CANCER RES, V6, pR616, DOI 10.1186/bcr922; Rajabi Hasan, 2010, Genes Cancer, V1, P62; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Scott GK, 2007, J BIOL CHEM, V282, P1479, DOI 10.1074/jbc.M609383200; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Sequeira L, 2008, CLIN EXP METASTAS, V25, P569, DOI 10.1007/s10585-008-9173-3; Shi XB, 2007, P NATL ACAD SCI USA, V104, P19983, DOI 10.1073/pnas.0706641104; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Song JG, 2007, CELL RES, V17, P289, DOI 10.1038/cr.2007.25; Struckhoff AP, 2011, FRONT BIOSCI-LANDMRK, V16, P1915, DOI 10.2741/3830; Tang Y, 2008, FRONT BIOSCI-LANDMRK, V13, P759, DOI 10.2741/2718; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Togawa H, 2011, AM J PHYSIOL-RENAL, V300, pF511, DOI 10.1152/ajprenal.00038.2010; Tomaskovic-Crook E, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2416; Ventura A, 2009, CELL, V136, P586, DOI 10.1016/j.cell.2009.02.005; Virtanen SS, 2002, CANCER RES, V62, P2708; Voss MJ, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-158; Wilbert ML, 2010, WILEY INTERDISCIP RE; Xia HF, 2009, CELL PHYSIOL BIOCHEM, V23, P347, DOI 10.1159/000218181; Xu LJ, 2006, J BIOL CHEM, V281, P4457, DOI 10.1074/jbc.M510721200; Yamaguchi N, 2008, CANCER RES, V68, P1881, DOI 10.1158/0008-5472.CAN-07-1597; Yan LX, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2803; Yang BF, 2009, CLIN EXP PHARMACOL P, V36, P951, DOI 10.1111/j.1440-1681.2009.05245.x; Zhang Y, 2011, CANCER RES, V71, P3552, DOI 10.1158/0008-5472.CAN-10-2435; Zhou M, 2010, J BIOL CHEM, V285, P21496, DOI 10.1074/jbc.M109.083337	50	104	115	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e35435	10.1371/journal.pone.0035435	http://dx.doi.org/10.1371/journal.pone.0035435			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693547	gold, Green Published, Green Submitted			2022-12-27	WOS:000305338500008
J	Sepulveda, D; Cardenas, C; Carmona, M; Marshall, SH				Sepulveda, Dagoberto; Cardenas, Constanza; Carmona, Marisela; Marshall, Sergio H.			Novel Strategy to Evaluate Infectious Salmon Anemia Virus Variants by High Resolution Melting	PLOS ONE			English	Article							ORTHOMYXO-LIKE VIRUS; INFLUENZA-A VIRUS; ATLANTIC SALMON; HEMAGGLUTININ GENE; ISAV; IDENTIFICATION; SEQUENCE; VIRULENCE; SALAR; PATHOGENICITY	Genetic variability is a key problem in the prevention and therapy of RNA-based virus infections. Infectious Salmon Anemia virus (ISAv) is an RNA virus which aggressively attacks salmon producing farms worldwide and in particular in Chile. Just as with most of the Orthomyxovirus, ISAv displays high variability in its genome which is reflected by a wider infection potential, thus hampering management and prevention of the disease. Although a number of widely validated detection procedures exist, in this case there is a need of a more complex approach to the characterization of virus variability. We have adapted a procedure of High Resolution Melting (HRM) as a fine-tuning technique to fully differentiate viral variants detected in Chile and projected to other infective variants reported elsewhere. Out of the eight viral coding segments, the technique was adapted using natural Chilean variants for two of them, namely segments 5 and 6, recognized as virulence-associated factors. Our work demonstrates the versatility of the technique as well as its superior resolution capacity compared with standard techniques currently in use as key diagnostic tools.	[Sepulveda, Dagoberto; Carmona, Marisela; Marshall, Sergio H.] Pontificia Univ Catolica Valparaiso, Lab Patogenos Acuicolas, Nucleo Biotecnol Curauma, Valparaiso, Chile; [Sepulveda, Dagoberto; Carmona, Marisela; Marshall, Sergio H.] Pontificia Univ Catolica Valparaiso, Lab Genet & Inmunol Mol, Inst Biol, Fac Ciencias, Valparaiso, Chile	Pontificia Universidad Catolica de Valparaiso; Pontificia Universidad Catolica de Valparaiso	Sepulveda, D (corresponding author), Pontificia Univ Catolica Valparaiso, Lab Patogenos Acuicolas, Nucleo Biotecnol Curauma, Campus Curauma, Valparaiso, Chile.	smarshal@ucv.cl	Cárdenas, Constanza/ABA-6477-2021	Cardenas Carvajal, Constanza/0000-0002-3673-9320; marshall, sergio/0000-0003-0438-8252; Sepulveda, Dagoberto/0000-0001-8553-5861	Chilean Government Grant CORFO-Innova Chile [09MCSS-6725]	Chilean Government Grant CORFO-Innova Chile	This work was funded by the Chilean Government Grant CORFO-Innova Chile 09MCSS-6725. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; Aspehaug V, 2005, J VIROL, V79, P12544, DOI 10.1128/JVI.79.19.12544-12553.2005; BALDINO F, 1989, METHOD ENZYMOL, V168, P761; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Bouchard D, 1999, DIS AQUAT ORGAN, V35, P131, DOI 10.3354/dao035131; Bouchard DA, 2001, BULL EUR ASSN FISH P, V21, P86; BRESLAUER KJ, 1986, P NATL ACAD SCI USA, V83, P3746, DOI 10.1073/pnas.83.11.3746; Brown EG, 2000, BIOMED PHARMACOTHER, V54, P196, DOI 10.1016/S0753-3322(00)89026-5; Cheng JC, 2006, CLIN CHEM, V52, P1997, DOI 10.1373/clinchem.2006.069286; Christiansen DH, 2011, J GEN VIROL, V92, P909, DOI 10.1099/vir.0.027094-0; Coleman JR, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-9; Cunningham CO, 2000, DIS AQUAT ORGAN, V41, P1, DOI 10.3354/dao041001; Devold M, 2006, J GEN VIROL, V87, P2031, DOI 10.1099/vir.0.81687-0; Devold M, 2001, DIS AQUAT ORGAN, V47, P119, DOI 10.3354/dao047119; Erali M, 2008, EXP MOL PATHOL, V85, P50, DOI 10.1016/j.yexmp.2008.03.012; Erali M, 2010, METHODS, V50, P250, DOI 10.1016/j.ymeth.2010.01.013; Falk K, 2004, J VIROL, V78, P3063, DOI 10.1128/JVI.78.6.3063-3071.2004; Falk K, 1997, J VIROL, V71, P9016, DOI 10.1128/JVI.71.12.9016-9023.1997; Fortini D, 2007, CLIN CHEM, V53, P1377, DOI 10.1373/clinchem.2007.085993; Ghorashi SA, 2011, J VIROL METHODS, V171, P264, DOI 10.1016/j.jviromet.2010.11.013; Godoy MG, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-28; Goto H, 2001, J VIROL, V75, P9297, DOI 10.1128/JVI.75.19.9297-9301.2001; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Jackson D, 2008, P NATL ACAD SCI USA, V105, P4381, DOI 10.1073/pnas.0800482105; Kawaoka Y., 2005, 8 INT COMM TAX VIR, P681; Kibbe WA, 2007, NUCLEIC ACIDS RES, V35, pW43, DOI 10.1093/nar/gkm234; Kibenge FSB, 2007, J GEN VIROL, V88, P3100, DOI 10.1099/vir.0.83097-0; Kibenge FSB, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-88; Kibenge FSB, 2001, J GEN VIROL, V82, P2869, DOI 10.1099/0022-1317-82-12-2869; Kibenge FSB, 2001, DIS AQUAT ORGAN, V45, P9, DOI 10.3354/dao045009; Krossoy B, 2001, J GEN VIROL, V82, P1757, DOI 10.1099/0022-1317-82-7-1757; Krossoy B, 1999, J VIROL, V73, P2136; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Liew M, 2004, CLIN CHEM, V50, P1156, DOI 10.1373/clinchem.2004.032136; Lin JH, 2008, J CLIN MICROBIOL, V46, P1090, DOI 10.1128/JCM.02015-07; Lovely JE, 1999, DIS AQUAT ORGAN, V35, P145, DOI 10.3354/dao035145; Markussen T, 2008, VIROLOGY, V374, P515, DOI 10.1016/j.virol.2008.01.019; McBeath AJA, 2009, DIS AQUAT ORGAN, V87, P161, DOI 10.3354/dao02128; Mjaaland S, 1997, J VIROL, V71, P7681, DOI 10.1128/JVI.71.10.7681-7686.1997; Mjaaland S, 2002, VIROLOGY, V304, P379, DOI 10.1006/viro.2002.1658; Mullins J.E., 1998, Bulletin of the European Association of Fish Pathologists, V18, P110; Naze F, 2010, J CLIN MICROBIOL, V48, P3146, DOI 10.1128/JCM.00402-10; Neron B, 2009, BIOINFORMATICS, V25, P3005, DOI 10.1093/bioinformatics/btp493; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rimstad E, 2001, J VIROL, V75, P5352, DOI 10.1128/JVI.75.11.5352-5356.2001; Rodger H.D., 1998, Bulletin of the European Association of Fish Pathologists, V18, P115; Rozen S, 2000, Methods Mol Biol, V132, P365; Rumschlag-Booms E, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-76; Snow M, 2006, DEV BIOLOGICALS, V126, P133; Tajiri-Utagawa E, 2009, J CLIN MICROBIOL, V47, P435, DOI 10.1128/JCM.01247-08; Taylor CF, 2009, BIOCHEM SOC T, V37, P433, DOI 10.1042/BST0370433; Thorud K., 1988, Bulletin of the European Association of Fish Pathologists, V8, P109; Ugo V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008893; Vossen RHAM, 2009, HUM MUTAT, V30, P860, DOI 10.1002/humu.21019; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wittwer CT, 2009, HUM MUTAT, V30, P857, DOI 10.1002/humu.20951; Wittwer CT, 2003, CLIN CHEM, V49, P853, DOI 10.1373/49.6.853	57	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2012	7	6							e37265	10.1371/journal.pone.0037265	http://dx.doi.org/10.1371/journal.pone.0037265			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UJ	22719837	Green Submitted, Green Published, gold			2022-12-27	WOS:000305340000002
J	Soekmadji, C; Angkawidjaja, C; Kelly, LE				Soekmadji, Carolina; Angkawidjaja, Clement; Kelly, Leonard E.			Ca2+ Regulates the Drosophila Stoned-A and Stoned-B Proteins Interaction with the C2B Domain of Synaptotagmin-1	PLOS ONE			English	Article							NEUROTRANSMITTER RELEASE; IN-VIVO; NEUROMUSCULAR-JUNCTIONS; SYNAPTIC TRANSMISSION; PHOSPHOLIPID-BINDING; MOLECULAR-DYNAMICS; AP-2 BINDING; MUTANTS; LOCUS; MOTIF	The dicistronic Drosophila stoned gene is involved in exocytosis and/or endocytosis of synaptic vesicles. Mutations in either stonedA or stonedB cause a severe disruption of neurotransmission in fruit flies. Previous studies have shown that the coiled-coil domain of the Stoned-A and the mu-homology domain of the Stoned-B protein can interact with the C2B domain of Synaptotagmin-1. However, very little is known about the mechanism of interaction between the Stoned proteins and the C2B domain of Synaptotagmin-1. Here we report that these interactions are increased in the presence of Ca2+. The Ca2+-dependent interaction between the m-homology domain of Stoned-B and C2B domain of Synaptotagmin-1 is affected by phospholipids. The C-terminal region of the C2B domain, including the tryptophan-containing motif, and the Ca2+-binding loop region that modulate the Ca2+-dependent oligomerization, regulates the binding of the Stoned-A and Stoned-B proteins to the C2B domain. Stoned-B, but not Stoned-A, interacts with the Ca2+-binding loop region of C2B domain. The results indicate that Ca2+-induced self-association of the C2B domain regulates the binding of both Stoned-A and Stoned-B proteins to Synaptotagmin-1. The Stoned proteins may regulate sustainable neurotransmission in vivo by binding to Ca-(2+)bound Synaptotagmin-1 associated synaptic vesicles.	[Soekmadji, Carolina; Kelly, Leonard E.] Univ Melbourne, Dept Genet, Parkville, Vic 3052, Australia; [Angkawidjaja, Clement] Osaka Univ, Dept Mat & Life Sci, Suita, Osaka, Japan	University of Melbourne; Osaka University	Soekmadji, C (corresponding author), Univ Melbourne, Dept Genet, Parkville, Vic 3052, Australia.	carolina.soekmadji@qut.edu.au	Soekmadji, Carolina/M-2757-2016	Soekmadji, Carolina/0000-0002-6920-6627; Angkawidjaja, Clement/0000-0002-5019-2536				Andrews J, 1996, GENETICS, V143, P1699; Arac D, 2006, NAT STRUCT MOL BIOL, V13, P209, DOI 10.1038/nsmb1056; Chapman ER, 1996, J BIOL CHEM, V271, P5844, DOI 10.1074/jbc.271.10.5844; Chapman ER, 1998, J BIOL CHEM, V273, P32966, DOI 10.1074/jbc.273.49.32966; Cheng Y, 2004, PROTEIN SCI, V13, P2665, DOI 10.1110/ps.04832604; Davis AF, 1999, NEURON, V24, P363, DOI 10.1016/S0896-6273(00)80850-8; Desai RC, 2000, J CELL BIOL, V150, P1125, DOI 10.1083/jcb.150.5.1125; DIANTONIO A, 1994, NEURON, V12, P909, DOI 10.1016/0896-6273(94)90342-5; Estes PS, 2003, GENETICS, V165, P185; FABIATO A, 1981, J GEN PHYSIOL, V78, P457, DOI 10.1085/jgp.78.5.457; Fergestad T, 2001, J NEUROSCI, V21, P1218; Fergestad T, 1999, J NEUROSCI, V19, P5847, DOI 10.1523/JNEUROSCI.19-14-05847.1999; Fernandez I, 2001, NEURON, V32, P1057, DOI 10.1016/S0896-6273(01)00548-7; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; Gerona RRL, 2000, J BIOL CHEM, V275, P6328, DOI 10.1074/jbc.275.9.6328; Grass I, 2004, J BIOL CHEM, V279, P54872, DOI 10.1074/jbc.M409995200; Haucke V, 2000, EMBO J, V19, P6011, DOI 10.1093/emboj/19.22.6011; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jarousse N, 2003, TRAFFIC, V4, P468, DOI 10.1034/j.1600-0854.2003.00101.x; Jarousse N, 2001, CURR OPIN CELL BIOL, V13, P461, DOI 10.1016/S0955-0674(00)00237-4; Jung N, 2007, J CELL BIOL, V179, P1497, DOI 10.1083/jcb.200708107; Kelly LE, 2005, BIOCHEM J, V388, P195, DOI 10.1042/BJ20041797; LI C, 1995, NATURE, V375, P594, DOI 10.1038/375594a0; Littleton JT, 2001, J NEUROSCI, V21, P1421, DOI 10.1523/JNEUROSCI.21-05-01421.2001; LITTLETON JT, 1993, CELL, V74, P1125, DOI 10.1016/0092-8674(93)90733-7; LITTLETON JT, 1994, P NATL ACAD SCI USA, V91, P10888, DOI 10.1073/pnas.91.23.10888; Loewen CA, 2006, MOL BIOL CELL, V17, P5211, DOI 10.1091/mbc.E06-07-0622; Mackler JM, 2002, NATURE, V418, P340, DOI 10.1038/nature00846; Mackler JM, 2001, J COMP NEUROL, V436, P4, DOI 10.1002/cne.1049; Martens S, 2007, SCIENCE, V316, P1205, DOI 10.1126/science.1142614; Martina JA, 2001, J CELL BIOL, V153, P1111, DOI 10.1083/jcb.153.5.1111; Mohrmann R, 2008, NEUROSCIENCE, V153, P1048, DOI 10.1016/j.neuroscience.2008.02.060; NONET ML, 1993, CELL, V73, P1291, DOI 10.1016/0092-8674(93)90357-V; Pedretti A, 2004, J COMPUT AID MOL DES, V18, P167, DOI 10.1023/B:JCAM.0000035186.90683.f2; PETROVICH TZ, 1993, GENETICS, V133, P955; Phillips AM, 2010, TRAFFIC, V11, P16, DOI 10.1111/j.1600-0854.2009.00999.x; Phillips AM, 2000, J NEUROSCI, V20, P8254, DOI 10.1523/JNEUROSCI.20-22-08254.2000; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Poskanzer KE, 2006, NEURON, V50, P49, DOI 10.1016/j.neuron.2006.02.021; Schiavo G, 1997, P NATL ACAD SCI USA, V94, P997, DOI 10.1073/pnas.94.3.997; Stimson DT, 2001, J NEUROSCI, V21, P3034, DOI 10.1523/JNEUROSCI.21-09-03034.2001; Stimson DT, 1998, J NEUROSCI, V18, P9638; Tamura T, 2007, J NEUROPHYSIOL, V97, P540, DOI 10.1152/jn.00905.2006; Ubach J, 1998, EMBO J, V17, P3921, DOI 10.1093/emboj/17.14.3921; Ubach J, 2001, BIOCHEMISTRY-US, V40, P5854, DOI 10.1021/bi010340c; Vrljic M, 2011, BIOCHEMISTRY-US, V50, P9998, DOI 10.1021/bi200998y; Wu Y, 2003, P NATL ACAD SCI USA, V100, P2082, DOI 10.1073/pnas.0435872100; ZHANG JZ, 1994, CELL, V78, P751, DOI 10.1016/S0092-8674(94)90442-1; Zhang XY, 1998, BIOCHEMISTRY-US, V37, P12395, DOI 10.1021/bi9807512	50	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2012	7	6							e38822	10.1371/journal.pone.0038822	http://dx.doi.org/10.1371/journal.pone.0038822			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UJ	22701718	Green Published, gold			2022-12-27	WOS:000305340000049
J	Hu, ZZ; Du, J; Yang, L; Zhu, YC; Yang, Y; Zheng, DT; Someya, A; Gu, L; Lu, X				Hu, ZhenZhen; Du, Jun; Yang, Ling; Zhu, YiChao; Yang, Yu; Zheng, DaTong; Someya, Akimasa; Gu, Luo; Lu, Xiang			GEP100/Arf6 Is Required for Epidermal Growth Factor-Induced ERK/Rac1 Signaling and Cell Migration in Human Hepatoma HepG2 Cells	PLOS ONE			English	Article							RIBOSYLATION FACTOR 6; INHIBITOR ZD1839 IRESSA; BREAST-CANCER INVASION; ADP-RIBOSYLATION; ARF6 ACTIVATION; FACTOR RECEPTOR; DOWNSTREAM ACTIVATION; DEPENDENT MECHANISM; ACTIN CYTOSKELETON; PLASMA-MEMBRANE	Background: Epidermal growth factor (EGF) signaling is implicated in the invasion and metastasis of hepatoma cells. However, the signaling pathways for EGF-induced motility of hepatoma cells remain undefined. Methodology/Principal Findings: We found that EGF dose-dependently stimulated the migration of human hepatoma cells HepG2, with the maximal effect at 10 ng/mL. Additionally, EGF increased Arf6 activity, and ectopic expression of Arf6 T27N, a dominant negative Arf6 mutant, largely abolish EGF-induced cell migration. Blocking GEP100 with GEP100 siRNA or GEP100-Delta PH, a pleckstrin homology (PH) domain deletion mutant of GEP100, blocked EGF-induced Arf6 activity and cell migration. EGF also increased ERK and Rac1 activity. Ectopic expression GEP100 siRNA, GEP100-Delta PH, or Arf6-T27N suppressed EGF-induced ERK and Rac1 activity. Furthermore, blocking ERK signaling with its inhibitor U0126 remarkably inhibited both EGF-induced Rac1 activation as well as cell migration, and ectopic expression of inactive mutant form of Rac1 (Rac1-T17N) also largely abolished EGF-induced cell migration. Conclusions/Significance: Taken together, this study highlights the function of the PH domain of GEP100 and its regulated Arf6/ERK/Rac1 signaling cascade in EGF-induced hepatoma cell migration. These findings could provide a rationale for designing new therapy based on inhibition of hepatoma metastasis.	[Hu, ZhenZhen; Zhu, YiChao; Yang, Yu] Nanjing Med Univ, Dept Physiol, Nanjing, Jiangsu, Peoples R China; [Hu, ZhenZhen; Zheng, DaTong] Nanjing Med Univ, Affiliated Hosp 2, Dept Pediat, Nanjing, Jiangsu, Peoples R China; [Du, Jun] Nanjing Med Univ, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China; [Yang, Ling] Suzhou Univ, Affiliated Hosp 3, Dept Cardiol, Suzhou 215006, Peoples R China; [Someya, Akimasa] Juntendo Univ, Sch Med, Dept Host Def & Biochem Res, Tokyo 113, Japan; [Gu, Luo] Nanjing Med Univ, Ctr Canc, Nanjing, Jiangsu, Peoples R China; [Lu, Xiang] Nanjing Med Univ, Affiliated Hosp 2, Dept Geriatr, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Soochow University - China; Juntendo University; Nanjing Medical University; Nanjing Medical University	Hu, ZZ (corresponding author), Nanjing Med Univ, Dept Physiol, Nanjing, Jiangsu, Peoples R China.	lgu@njmu.edu.cn; Luxiang66@njmu.edu.cn		Hu, Zhenzhen/0000-0002-9892-6068	National Natural Science Foundation of China [30872926, 81172002]; Postdoctoral Science Foundation of Jiangsu Province; Postdoctoral Science Foundation of China [2011M501254]; Jiangsu Key Laboratory of Cancer Biomarkers, Prevention and Treatment, Cancer Center, Nanjing Medical University; State Key Laboratory of Reproductive Medicine, China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Postdoctoral Science Foundation of Jiangsu Province(China Postdoctoral Science Foundation); Postdoctoral Science Foundation of China(China Postdoctoral Science Foundation); Jiangsu Key Laboratory of Cancer Biomarkers, Prevention and Treatment, Cancer Center, Nanjing Medical University; State Key Laboratory of Reproductive Medicine, China	This work was supported by grants from the National Natural Science Foundation of China (No. 30872926, 81172002) to Dr. Luo Gu, the Postdoctoral Science Foundation of Jiangsu Province and the Postdoctoral Science Foundation of China (2011M501254) to Dr. Jun Du. This work was also partially supported by the research grants from Jiangsu Key Laboratory of Cancer Biomarkers, Prevention and Treatment, Cancer Center, Nanjing Medical University, and State Key Laboratory of Reproductive Medicine, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Barnes CJ, 2003, MOL CANCER THER, V2, P345; Beier I, 2008, ATHEROSCLEROSIS, V196, P92, DOI 10.1016/j.atherosclerosis.2007.02.003; BORNANCIN F, 1993, J BIOL CHEM, V268, P17026; Cotton M, 2007, MOL BIOL CELL, V18, P501, DOI 10.1091/mbc.E06-06-0567; Cox R, 2004, MOL BIOL CELL, V15, P1487, DOI 10.1091/mbc.E03-06-0443; Criss AK, 2001, J CELL SCI, V114, P1331; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Donaldson JG, 2003, J BIOL CHEM, V278, P41573, DOI 10.1074/jbc.R300026200; Donaldson JG, 2011, NAT REV MOL CELL BIO, V12, P362, DOI 10.1038/nrm3117; Du J, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0025213, 10.1371/journal.pone.0026204]; Du J, 2010, CELL PHYSIOL BIOCHEM, V25, P501, DOI 10.1159/000303055; Dunphy JL, 2006, CURR BIOL, V16, P315, DOI 10.1016/j.cub.2005.12.032; GRAY A, 1983, NATURE, V303, P722, DOI 10.1038/303722a0; Hakoshima T, 2003, J BIOCHEM, V134, P327, DOI 10.1093/jb/mvg149; Hashimoto A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023359; Henson ES, 2006, CELL SIGNAL, V18, P2089, DOI 10.1016/j.cellsig.2006.05.015; Hiroi T, 2006, P NATL ACAD SCI USA, V103, P10672, DOI 10.1073/pnas.0604091103; Hu B, 2009, CANCER RES, V69, P794, DOI 10.1158/0008-5472.CAN-08-2110; Ikeda S, 2005, CIRC RES, V96, P467, DOI 10.1161/01.RES.0000158286.51045.16; Jing J, 2009, EUR J CELL BIOL, V88, P325, DOI 10.1016/j.ejcb.2009.02.186; LaMarca HL, 2008, HUM REPROD, V23, P1733, DOI 10.1093/humrep/den178; Lee EJ, 2007, ANN NY ACAD SCI, V1095, P113, DOI 10.1196/annals.1397.015; Li M, 2009, CANCER-AM CANCER SOC, V115, P4959, DOI 10.1002/cncr.24550; Lurje G, 2009, ONCOLOGY-BASEL, V77, P400, DOI 10.1159/000279388; Morishige M, 2008, NAT CELL BIOL, V10, P85, DOI 10.1038/ncb1672; Muralidharan-Chari V, 2009, CANCER RES, V69, P2201, DOI 10.1158/0008-5472.CAN-08-1301; Palacios F, 2003, J BIOL CHEM, V278, P17395, DOI 10.1074/jbc.M300998200; Parri M, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-23; Price JT, 1999, CANCER RES, V59, P5475; Rathinam R, 2011, FRONT BIOSCI, V17, P2561; Ray RM, 2007, CELL MOTIL CYTOSKEL, V64, P143, DOI 10.1002/cm.20172; Sabe H, 2003, J BIOCHEM, V134, P485, DOI 10.1093/jb/mvg181; Sabe H, 2008, CELL ADHES MIGR, V2, P71, DOI 10.4161/cam.2.2.6191; Sabe H, 2009, TRAFFIC, V10, P982, DOI 10.1111/j.1600-0854.2009.00917.x; Saif MW, 2010, EXPERT OPIN INV DRUG, V19, P357, DOI 10.1517/13543781003593962; Sakurai A, 2011, J BIOL CHEM, V286, P34335, DOI 10.1074/jbc.M111.259499; Santy LC, 2001, J CELL BIOL, V154, P599, DOI 10.1083/jcb.200104019; Santy LC, 2005, CURR BIOL, V15, P1749, DOI 10.1016/j.cub.2005.08.052; Someya A, 2001, P NATL ACAD SCI USA, V98, P2413, DOI 10.1073/pnas.051634798; Tague SE, 2004, P NATL ACAD SCI USA, V101, P9671, DOI 10.1073/pnas.0403531101; Turbov JM, 2002, J SURG ONCOL, V79, P17, DOI 10.1002/jso.10033; Tushir JS, 2007, EMBO J, V26, P1806, DOI 10.1038/sj.emboj.7601644; Valderrama F, 2008, NAT CELL BIOL, V10, P16, DOI 10.1038/ncb0108-16; Venkateswarlu K, 2007, J CELL SCI, V120, P792, DOI 10.1242/jcs.03373; Vial E, 2003, CANCER CELL, V4, P67, DOI 10.1016/S1535-6108(03)00162-4; Wang R., 2011, LUNG CANC; Woo CH, 2002, BIOCHEM BIOPH RES CO, V298, P392, DOI 10.1016/S0006-291X(02)02432-4; Wyckoff J, 2004, CANCER RES, V64, P7022, DOI 10.1158/0008-5472.CAN-04-1449; Zhang Q, 1999, MOL CELL BIOL, V19, P8158	49	20	25	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2012	7	6							e38777	10.1371/journal.pone.0038777	http://dx.doi.org/10.1371/journal.pone.0038777			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TU	22701712	Green Published, Green Submitted, gold			2022-12-27	WOS:000305337600044
J	Martino, F; Lorenzen, J; Schmidt, J; Schmidt, M; Broll, M; Gorzig, Y; Kielstein, JT; Thum, T				Martino, Filippo; Lorenzen, Johan; Schmidt, Julius; Schmidt, Mascha; Broll, Michael; Goerzig, Yvonne; Kielstein, Jan T.; Thum, Thomas			Circulating MicroRNAs Are Not Eliminated by Hemodialysis	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; MIR-210; CANCER; ACTIVATION; EXPRESSION; REVEALS	Background: Circulating microRNAs are stably detectable in serum/plasma and other body fluids. In patients with acute kidney injury on dialysis therapy changes of miRNA patterns had been detected. It remains unclear if and how the dialysis procedure itself affects circulating microRNA level. Methods: We quantified miR-21 and miR-210 by quantitative RT-PCR in plasma of patients with acute kidney injury requiring dialysis and measured pre- and post-dialyser miRNA levels as well as their amount in the collected spent dialysate. Single treatments using the following filters were studied: F60 S (1.3 m(2), Molecular Weight Cut Off (MWCO): 30 kDa, n = 8), AV 1000 S (1.8 m(2), MWCO: 30 kDa, n = 6) and EMiC 2 (1.8 m(2), MWCO: 40 kDa, n = 6). Results: Circulating levels of miR-21 or -210 do not differ between pre- and post-dialyzer blood samples independently of the used filter surface and pore size: miR-21: F60S: p = 0.35, AV 1000 S p = 1.0, EMiC2 p = 1.0; miR-210: F60S: p = 0.91, AV 1000 S p = 0.09, EMiC2 p = 0.31. Correspondingly, only traces of both miRNAs could be found in the collected spent dialysate and ultrafiltrate. Conclusions: In patients with acute kidney injury circulating microRNAs are not removed by dialysis. As only traces of miR-21 and -210 are detected in dialysate and ultrafiltrate, microRNAs in the circulation are likely to be transported by larger structures such as proteins and/or microvesicles. As miRNAs are not affected by dialysis they might be more robust biomarkers of acute kidney injury.	[Martino, Filippo; Lorenzen, Johan; Schmidt, Mascha; Goerzig, Yvonne; Thum, Thomas] Hannover Med Sch, IMTTS, D-3000 Hannover, Germany; [Lorenzen, Johan; Schmidt, Julius; Broll, Michael; Kielstein, Jan T.] Hannover Med Sch, Dept Med, Div Nephrol & Hypertens, D-3000 Hannover, Germany; [Thum, Thomas] IRCCS San Raffaele, Ctr Clin & Basic Res, Rome, Italy	Hannover Medical School; Hannover Medical School; Center Clinical & Basic Research; IRCCS San Raffaele Pisana; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Martino, F (corresponding author), Hannover Med Sch, IMTTS, D-3000 Hannover, Germany.	Thum.Thomas@mh-hannover.de	Kielstein, Jan T./I-2956-2019	Kielstein, Jan T./0000-0001-8110-9064; Lorenzen, Johan/0000-0002-9132-948X; Thum, Thomas/0000-0003-4360-1511	German Federal Ministry of Education and Research [IFB-Tx: 01EO0802]; Deutsche Forschungsgemeinschaft (DFG) [903/7-2]; Fresenius Medical Care	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Fresenius Medical Care	This work was supported by a grant from the German Federal Ministry of Education and Research (IFB-Tx: 01EO0802 to T.T.) and by Deutsche Forschungsgemeinschaft (DFG 903/7-2 to T.T.) as well as by an unrestricted grant of Fresenius Medical Care to JTK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Bihrer V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026971; Chau BN, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003205; Delaloy C, 2010, CELL STEM CELL, V6, P323, DOI 10.1016/j.stem.2010.02.015; Emilian C, 2012, CLIN J AM SOC NEPHRO, V7, P619, DOI 10.2215/CJN.10471011; Fliser D, 2006, NAT CLIN PRACT NEPHR, V2, P32, DOI 10.1038/ncpneph0060; Gupta SK, 2010, CIRC-CARDIOVASC GENE, V3, P484, DOI 10.1161/CIRCGENETICS.110.958363; Kumarswamy R, 2011, RNA BIOL, V8, P706, DOI 10.4161/rna.8.5.16154; Liu G, 2010, J EXP MED, V207, P1589, DOI 10.1084/jem.20100035; Lorenzen JM, 2011, AM J TRANSPLANT, V11, P2221, DOI 10.1111/j.1600-6143.2011.03679.x; Lorenzen JM, 2012, CLIN J AM S IN PRESS; Lorenzen JM, 2012, CLIN J AM SOC NEPHRO, V7, P385, DOI 10.2215/CJN.05690611; Lorenzen JM, 2011, CLIN J AM SOC NEPHRO, V6, P1540, DOI 10.2215/CJN.00430111; McDonald JS, 2011, CLIN CHEM, V57, P833, DOI 10.1373/clinchem.2010.157198; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Nana-Sinkam SP, 2011, MOL ONCOL, V5, P483, DOI 10.1016/j.molonc.2011.10.003; Neal CS, 2011, NEPHROL DIAL TRANSPL, V26, P3794, DOI 10.1093/ndt/gfr485; Sayed D, 2011, PHYSIOL REV, V91, P827, DOI 10.1152/physrev.00006.2010; Shen J, 2011, LAB INVEST, V91, P579, DOI 10.1038/labinvest.2010.194; Taylor DD, 2011, METHODS MOL BIOL, V728, P235, DOI 10.1007/978-1-61779-068-3_15; Thum T, 2007, CIRCULATION, V116, P258, DOI 10.1161/CIRCULATIONAHA.107.687947; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; Turchinovich A, 2011, NUCLEIC ACIDS RES, V39, P7223, DOI 10.1093/nar/gkr254; Valera VA, 2011, J CANCER, V2, P515, DOI 10.7150/jca.2.515; van der Fits L, 2011, J INVEST DERMATOL, V131, P762, DOI 10.1038/jid.2010.349; van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105; Volinia S, 2010, GENOME RES, V20, P589, DOI 10.1101/gr.098046.109; Wu HQ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001020; Xiong YJ, 2010, HEPATOLOGY, V51, P836, DOI 10.1002/hep.23380; Zaman MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031060; Zampetaki A, 2011, CARDIOVASC RES  1109; Zampetaki A, 2010, CIRC RES, V107, P810, DOI 10.1161/CIRCRESAHA.110.226357; Zarjou A, 2011, AM J PHYSIOL-RENAL, V301, pF793, DOI 10.1152/ajprenal.00273.2011; Zhao XH, 2010, NEURON, V65, P612, DOI 10.1016/j.neuron.2010.02.018	36	40	51	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2012	7	6							e38269	10.1371/journal.pone.0038269	http://dx.doi.org/10.1371/journal.pone.0038269			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TQ	22715378	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336800019
J	Muller-Borer, B; Esch, G; Aldina, R; Woon, W; Fox, R; Bursac, N; Hiller, S; Maeda, N; Shepherd, N; Jin, JP; Hutson, M; Anderson, P; Kirby, ML; Malouf, NN				Muller-Borer, Barbara; Esch, Gwyn; Aldina, Rob; Woon, Woohyun; Fox, Raymond; Bursac, Nenad; Hiller, Sylvia; Maeda, Nobuyuo; Shepherd, Neal; Jin, Jian Ping; Hutson, Mary; Anderson, Page; Kirby, Margaret L.; Malouf, Nadia N.			Calcium Dependent CAMTA1 in Adult Stem Cell Commitment to a Myocardial Lineage	PLOS ONE			English	Article							BINDING TRANSCRIPTION ACTIVATORS; MARROW STROMAL CELLS; GENE-EXPRESSION; CARDIAC-HYPERTROPHY; DIRECT CONVERSION; HUMAN FIBROBLASTS; PROGENITOR CELLS; SMOOTH-MUSCLE; UP-REGULATION; SIGNALS	The phenotype of somatic cells has recently been found to be reversible. Direct reprogramming of one cell type into another has been achieved with transduction and over expression of exogenous defined transcription factors emphasizing their role in specifying cell fate. To discover early and novel endogenous transcription factors that may have a role in adult-derived stem cell acquisition of a cardiomyocyte phenotype, mesenchymal stem cells from human and mouse bone marrow and rat liver were co-cultured with neonatal cardiomyocytes as an in vitro cardiogenic microenvironment. Cell-cell communications develop between the two cell types as early as 24 hrs in co-culture and are required for elaboration of a myocardial phenotype in the stem cells 8-16 days later. These intercellular communications are associated with novel Ca2+ oscillations in the stem cells that are synchronous with the Ca2+ transients in adjacent cardiomyocytes and are detected in the stem cells as early as 24-48 hrs in co-culture. Early and significant up-regulation of Ca2+-dependent effectors, CAMTA1 and RCAN1 ensues before a myocardial program is activated. CAMTA1 loss-of-function minimizes the activation of the cardiac gene program in the stem cells. While the expression of RCAN1 suggests involvement of the well-characterized calcineurin-NFAT pathway as a response to a Ca2+ signal, the CAMTA1 up-regulated expression as a response to such a signal in the stem cells was unknown. Cell-cell communications between the stem cells and adjacent cardiomyocytes induce Ca2+ signals that activate a myocardial gene program in the stem cells via a novel and early Ca2+-dependent intermediate, up-regulation of CAMTA1.	[Muller-Borer, Barbara] E Carolina Univ, Dept Cardiovasc Sci, Greenville, NC 27858 USA; [Esch, Gwyn; Fox, Raymond; Hiller, Sylvia; Maeda, Nobuyuo; Malouf, Nadia N.] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC USA; [Esch, Gwyn; Aldina, Rob; Shepherd, Neal; Hutson, Mary; Anderson, Page; Kirby, Margaret L.] Duke Univ, Dept Pediat, Durham, NC 27706 USA; [Kirby, Margaret L.] Duke Univ, Dept Cell Biol, Durham, NC USA; [Woon, Woohyun; Bursac, Nenad; Shepherd, Neal] Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA; [Jin, Jian Ping] Univ N Carolina, Ctr Bioinformat, Chapel Hill, NC USA	University of North Carolina; East Carolina University; University of North Carolina; University of North Carolina Chapel Hill; Duke University; Duke University; Duke University; University of North Carolina; University of North Carolina Chapel Hill	Muller-Borer, B (corresponding author), E Carolina Univ, Dept Cardiovasc Sci, Greenville, NC 27858 USA.	mullerborerb@ecu.edu	Jin, Jian-Ping/AAD-1149-2020; Bursac, Nenad/AAU-5548-2021	Bursac, Nenad/0000-0002-5688-6061	U.S. Department of Health & Human Services, National Institutes of Health, National Heart, Lung and Blood Institute [R01HL091348, R01HL42630, T32HL069768]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL069768, R01HL042630, R01HL091348] Funding Source: NIH RePORTER	U.S. Department of Health & Human Services, National Institutes of Health, National Heart, Lung and Blood Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by the U.S. Department of Health & Human Services, National Institutes of Health, National Heart, Lung and Blood Institute, R01HL091348 (MLK, NNM, BMB, NB), R01HL42630 (NM) and T32HL069768 (RF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts B., 1989, MOL BIOL CELL; Anderson PAW, 2007, CELL CYCLE, V6, P1565, DOI 10.4161/cc.6.13.4454; BADING H, 1993, SCIENCE, V260, P181, DOI 10.1126/science.8097060; Battaglia A, 2008, PEDIATRICS, V121, P404, DOI 10.1542/peds.2007-0929; Berridge MJ, 2006, CELL CALCIUM, V40, P405, DOI 10.1016/j.ceca.2006.09.002; Bers DM, 2008, ANNU REV PHYSIOL, V70, P23, DOI 10.1146/annurev.physiol.70.113006.100455; Bouche N, 2002, J BIOL CHEM, V277, P21851, DOI 10.1074/jbc.M200268200; Canellada A, 2008, GLIA, V56, P709, DOI 10.1002/glia.20647; Cesselli D, 2009, CIRC RES, V104, P1225, DOI 10.1161/CIRCRESAHA.109.195859; CHOI J, 1990, P NATL ACAD SCI USA, V87, P7988, DOI 10.1073/pnas.87.20.7988; Colella M, 2008, P NATL ACAD SCI USA, V105, P2859, DOI 10.1073/pnas.0712316105; Crabtree GR, 2009, CELL, V138, DOI 10.1016/j.cell.2009.06.026; Crabtree GR, 2002, CELL, V109, pS67, DOI 10.1016/S0092-8674(02)00699-2; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; Dawn B, 2005, CARDIOVASC RES, V65, P293, DOI 10.1016/j.cardiores.2004.11.031; De Koninck P, 1998, SCIENCE, V279, P227, DOI 10.1126/science.279.5348.227; Doherty CJ, 2009, PLANT CELL, V21, P972, DOI 10.1105/tpc.108.063958; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; Eckardt NA, 2009, PLANT CELL, V21, P697, DOI 10.1105/tpc.109.210310; Finkler A, 2007, FEBS LETT, V581, P3893, DOI 10.1016/j.febslet.2007.07.051; Frey N, 2000, NAT MED, V6, P1221, DOI 10.1038/81321; Fukuhara S, 2003, J THORAC CARDIOV SUR, V125, P1470, DOI 10.1016/S0022-5223(02)73610-6; Geraerts M, 2009, ADV BIOCHEM ENG BIOT, V114, P1, DOI 10.1007/10_2008_21; Grimm M, 2010, J MOL CELL CARDIOL, V48, P322, DOI 10.1016/j.yjmcc.2009.10.016; Gurdon JB, 2008, SCIENCE, V322, P1811, DOI 10.1126/science.1160810; Hatada S, 2011, EXP HEMATOL, V39, P375, DOI 10.1016/j.exphem.2010.12.007; Henrich KO, 2011, CANCER RES, V71, P3142, DOI 10.1158/0008-5472.CAN-10-3014; Ho L, 2010, NATURE, V463, P474, DOI 10.1038/nature08911; Hochedlinger K, 2002, NATURE, V415, P1035, DOI 10.1038/nature718; Hutson MR, 2006, DEV BIOL, V295, P486, DOI 10.1016/j.ydbio.2006.02.052; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Kattman SJ, 2006, DEV CELL, V11, P723, DOI 10.1016/j.devcel.2006.10.002; Kawano S, 2002, CELL CALCIUM, V32, P165, DOI 10.1016/S0143416002001240; Kidder BL, 2009, STEM CELLS, V27, P317, DOI 10.1634/stemcells.2008-0710; Koche RP, 2011, CELL STEM CELL, V8, P96, DOI 10.1016/j.stem.2010.12.001; Kogler G, 2006, EXP HEMATOL, V34, P1589, DOI 10.1016/j.exphem.2006.07.011; Kubo H, 2009, CTS-CLIN TRANSL SCI, V2, P26, DOI 10.1111/j.1752-8062.2008.00089.x; Labovsky V, 2010, DIFFERENTIATION, V79, P93, DOI 10.1016/j.diff.2009.10.001; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Lessard JA, 2010, ANNU REV CELL DEV BI, V26, P503, DOI 10.1146/annurev-cellbio-051809-102012; Li XA, 2011, CELL STEM CELL, V8, P46, DOI 10.1016/j.stem.2010.11.027; Malouf NN, 2001, AM J PATHOL, V158, P1929, DOI 10.1016/S0002-9440(10)64661-5; Mani SK, 2010, J MOL CELL CARDIOL, V48, P342, DOI 10.1016/j.yjmcc.2009.11.007; Mellstrom B, 2001, CURR OPIN NEUROBIOL, V11, P312, DOI 10.1016/S0959-4388(00)00213-0; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Muller-Borer BJ, 2007, P NATL ACAD SCI USA, V104, P3877, DOI 10.1073/pnas.0700416104; Nadri S, 2007, INT J DEV BIOL, V51, P723, DOI 10.1387/ijdb.072352ns; Noseda M, 2011, CIRC RES, V108, P129, DOI 10.1161/CIRCRESAHA.110.223792; Oh M, 2010, J BIOL CHEM, V285, P16623, DOI 10.1074/jbc.M109.098236; Ohba T, 2007, J MOL CELL CARDIOL, V42, P498, DOI 10.1016/j.yjmcc.2006.10.020; Olson EN, 2004, NAT MED, V10, P467, DOI 10.1038/nm0504-467; Pandya K, 2008, P NATL ACAD SCI USA, V105, P13063, DOI 10.1073/pnas.0805120105; Pandya K, 2006, P NATL ACAD SCI USA, V103, P16864, DOI 10.1073/pnas.0607700103; Pijnappels DA, 2008, CIRC RES, V103, P167, DOI 10.1161/CIRCRESAHA.108.176131; Pittenger MF, 2004, CIRC RES, V95, P9, DOI 10.1161/01.RES.0000135902.99383.6f; Santourlidis S, 2011, STEM CELL RES, V6, P60, DOI 10.1016/j.scr.2010.08.003; Shapria SK, 1997, AM J HUM GENET, V61, P642, DOI 10.1086/515520; Singhal N, 2010, CELL, V141, P943, DOI 10.1016/j.cell.2010.04.037; Slack JMW, 2009, J PATHOL, V217, P161, DOI 10.1002/path.2442; Song K, 2006, CELL, V125, P453, DOI 10.1016/j.cell.2006.02.048; Szabo E, 2010, NATURE, V468, P521, DOI 10.1038/nature09591; Takahashi Jun, 2007, Expert Rev Neurother, V7, P667, DOI 10.1586/14737175.7.6.667; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takeuchi JK, 2009, NATURE, V459, P708, DOI 10.1038/nature08039; Tomida T, 2003, EMBO J, V22, P3825, DOI 10.1093/emboj/cdg381; Vega RB, 2003, P NATL ACAD SCI USA, V100, P669, DOI 10.1073/pnas.0237225100; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; WEINTRAUB H, 1989, P NATL ACAD SCI USA, V86, P5434, DOI 10.1073/pnas.86.14.5434; Williams RS, 2002, COLD SPRING HARB SYM, V67, P339, DOI 10.1101/sqb.2002.67.339; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Wu H, 2007, TRENDS CELL BIOL, V17, P251, DOI 10.1016/j.tcb.2007.04.006; Xu MF, 2004, CIRCULATION, V110, P2658, DOI 10.1161/01.CIR.0000145609.20435.36; Yamanaka S, 2010, NATURE, V465, P704, DOI 10.1038/nature09229; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	77	12	12	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2012	7	6							e38454	10.1371/journal.pone.0038454	http://dx.doi.org/10.1371/journal.pone.0038454			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TQ	22715383	gold, Green Published, Green Submitted			2022-12-27	WOS:000305336800025
J	Beven, L; Charenton, C; Dautant, A; Bouyssou, G; Labroussaa, F; Skollermo, A; Persson, A; Blanchard, A; Sirand-Pugnet, P				Beven, Laure; Charenton, Claire; Dautant, Alain; Bouyssou, Guillaume; Labroussaa, Fabien; Skollermo, Anna; Persson, Anja; Blanchard, Alain; Sirand-Pugnet, Pascal			Specific Evolution of F-1-Like ATPases in Mycoplasmas	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; COMPLETE GENOME SEQUENCE; SUBSP MYCOIDES SC; ESCHERICHIA-COLI; ATP SYNTHASE; MAXIMUM-LIKELIHOOD; ORIC PLASMIDS; F-TYPE; STRAINS; HYOPNEUMONIAE	F1F0 ATPases have been identified in most bacteria, including mycoplasmas which have very small genomes associated with a host-dependent lifestyle. In addition to the typical operon of eight genes encoding genuine F1F0 ATPase (Type 1), we identified related clusters of seven genes in many mycoplasma species. Four of the encoded proteins have predicted structures similar to the alpha, beta, gamma and e subunits of F-1 ATPases and could form an F-1-like ATPase. The other three proteins display no similarity to any other known proteins. Two of these proteins are probably located in the membrane, as they have three and twelve predicted transmembrane helices. Phylogenomic studies identified two types of F-1-like ATPase clusters, Type 2 and Type 3, characterized by a rapid evolution of sequences with the conservation of structural features. Clusters encoding Type 2 and Type 3 ATPases were assumed to originate from the Hominis group of mycoplasmas. We suggest that Type 3 ATPase clusters may spread to other phylogenetic groups by horizontal gene transfer between mycoplasmas in the same host, based on phylogeny and genomic context. Functional analyses in the ruminant pathogen Mycoplasma mycoides subsp. mycoides showed that the Type 3 cluster genes were organized into an operon. Proteomic analyses demonstrated that the seven encoded proteins were produced during growth in axenic media. Mutagenesis and complementation studies demonstrated an association of the Type 3 cluster with a major ATPase activity of membrane fractions. Thus, despite their tendency toward genome reduction, mycoplasmas have evolved and exchanged specific F-1-like ATPases with no known equivalent in other bacteria. We propose a model, in which the F-1-like structure is associated with a hypothetical X-0 sector located in the membrane of mycoplasma cells.	[Beven, Laure; Charenton, Claire; Bouyssou, Guillaume; Labroussaa, Fabien; Blanchard, Alain; Sirand-Pugnet, Pascal] Univ Bordeaux, UMR Biol Fruit & Pathol 1332, Villenave Dornon, France; [Beven, Laure; Charenton, Claire; Bouyssou, Guillaume; Labroussaa, Fabien; Blanchard, Alain; Sirand-Pugnet, Pascal] INRA, UMR Biol Fruit & Pathol 1332, Villenave Dornon, France; [Dautant, Alain] Univ Bordeaux, IBGC, UMR 5095, Bordeaux, France; [Dautant, Alain] IBMC, CNRS, UMR 5095, Bordeaux, France; [Skollermo, Anna; Persson, Anja] AlbaNova Univ Ctr, KTH Royal Inst Technol, Dept Prote, Sch Biotechnol, Stockholm, Sweden	UDICE-French Research Universities; Universite de Bordeaux; INRAE; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Royal Institute of Technology	Beven, L (corresponding author), Univ Bordeaux, UMR Biol Fruit & Pathol 1332, Villenave Dornon, France.	sirand@bordeaux.inra.fr	Beven, Laure/Q-1096-2018; Blanchard, Alain/I-3916-2019; Blanchard, Alain/C-6130-2009; Labroussaa, Fabien/AAN-2833-2021	Beven, Laure/0000-0003-4407-3255; Blanchard, Alain/0000-0003-4223-5185; Blanchard, Alain/0000-0003-4223-5185; Labroussaa, Fabien/0000-0002-8712-3024; SIRAND-PUGNET, Pascal/0000-0003-2613-0762	Institut National de Recherche Agronomique; Region Aquitaine; University Bordeaux Segalen; Agence Nationale pour la Recherche [EVOLMYCO ANR-07-GMGE-001]	Institut National de Recherche Agronomique; Region Aquitaine(Region Nouvelle-Aquitaine); University Bordeaux Segalen; Agence Nationale pour la Recherche(French National Research Agency (ANR))	This work was supported by grants from the Institut National de Recherche Agronomique (http://www.inra.fr/), the Region Aquitaine (http://aquitaine.fr/), the University Bordeaux Segalen (http://www.univ-bordeauxsegalen.fr/fr/index.html) and the Agence Nationale pour la Recherche (grant EVOLMYCO ANR-07-GMGE-001, http://www.agence-nationale-recherche.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Abdo EM, 2000, CLIN DIAGN LAB IMMUN, V7, P588, DOI 10.1128/CDLI.7.4.588-595.2000; Barre A, 2004, NUCLEIC ACIDS RES, V32, pD307, DOI 10.1093/nar/gkh114; Bischof DF, 2008, INFECT IMMUN, V76, P263, DOI 10.1128/IAI.00938-07; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chambaud I, 2001, NUCLEIC ACIDS RES, V29, P2145, DOI 10.1093/nar/29.10.2145; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; Cingolani G, 2011, NAT STRUCT MOL BIOL, V18, P701, DOI 10.1038/nsmb.2058; Del Rizzo PA, 2002, BIOCHEMISTRY-US, V41, P6875, DOI 10.1021/bi025736i; DeLano W. L., 2002, PYMOL MOL GRAPHICS S, DOI DOI 10.1007/S10822-016-9944-X; Dibrova DV, 2010, BIOINFORMATICS, V26, P1473, DOI 10.1093/bioinformatics/btq234; Dybvig K, 2008, INFECT IMMUN, V76, P4000, DOI 10.1128/IAI.00516-08; Dybvig K, 2010, FEMS MICROBIOL LETT, V311, P51, DOI 10.1111/j.1574-6968.2010.02078.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Freestone PPE, 2007, FEMS MICROBIOL LETT, V269, P221, DOI 10.1111/j.1574-6968.2006.00619.x; Freund EA, 1983, METHODS MYCOPLASMOLO, P127, DOI DOI 10.1016/B978-0-12-583801-6.50029-9; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Guindon S, 2009, METHODS MOL BIOL, V537, P113, DOI 10.1007/978-1-59745-251-9_6; Hamsten C, 2009, MOL CELL PROTEOMICS, V8, P2544, DOI 10.1074/mcp.M900009-MCP200; Hara KY, 2001, J BIOL CHEM, V276, P23969, DOI 10.1074/jbc.M009303200; HOFMANN K, 1993, BIOL CHEM HOPPESEYLE, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Hutchison CA, 1999, SCIENCE, V286, P2165, DOI 10.1126/science.286.5447.2165; Ibuki T, 2011, NAT STRUCT MOL BIOL, V18, P277, DOI 10.1038/nsmb.1977; Jaffe JD, 2004, GENOME RES, V14, P1447, DOI 10.1101/gr.2674004; Janis C, 2005, APPL ENVIRON MICROB, V71, P2888, DOI 10.1128/AEM.71.6.2888-2893.2005; Janis C, 2008, MICROBIOL-SGM, V154, P2427, DOI 10.1099/mic.0.2008/017640-0; Kall L, 2007, NUCLEIC ACIDS RES, V35, pW429, DOI 10.1093/nar/gkm256; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; KING KW, 1994, PLASMID, V31, P308, DOI 10.1006/plas.1994.1033; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lartigue C, 2003, NUCLEIC ACIDS RES, V31, P6610, DOI 10.1093/nar/gkg848; Mao FL, 2009, NUCLEIC ACIDS RES, V37, pD459, DOI 10.1093/nar/gkn757; Miyata M, 2008, TRENDS MICROBIOL, V16, P6, DOI 10.1016/j.tim.2007.11.002; Mulkidjanian AY, 2007, NAT REV MICROBIOL, V5, P892, DOI 10.1038/nrmicro1767; Nakane D, 2007, P NATL ACAD SCI USA, V104, P19518, DOI 10.1073/pnas.0704280104; Nilsson P, 2005, PROTEOMICS, V5, P4327, DOI 10.1002/pmic.200500072; Nouvel LX, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-86; Oneal MJ, 2008, MICROBIOL-SGM, V154, P2581, DOI 10.1099/mic.0.2008/020230-0; Papazisi L, 2003, MICROBIOL-SGM, V149, P2307, DOI 10.1099/mic.0.26427-0; Pereyre S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000677; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pinto PM, 2009, PROTEOME SCI, V7, DOI 10.1186/1477-5956-7-45; Pinto PM, 2007, VET MICROBIOL, V121, P83, DOI 10.1016/j.vetmic.2006.11.018; Rastogi VK, 1999, NATURE, V402, P263, DOI 10.1038/46224; Razin S, 1998, MICROBIOL MOL BIOL R, V62, P1094, DOI 10.1128/MMBR.62.4.1094-1156.1998; Rees DM, 2009, P NATL ACAD SCI USA, V106, P21597, DOI 10.1073/pnas.0910365106; Shirvan M H, 1993, Subcell Biochem, V20, P261; Sirand-Pugnet P, 2007, RES MICROBIOL, V158, P754, DOI 10.1016/j.resmic.2007.09.007; Sirand-Pugnet P, 2007, PLOS GENET, V3, P744, DOI 10.1371/journal.pgen.0030075; Szczepanek SM, 2010, INFECT IMMUN, V78, P1760, DOI 10.1128/IAI.01172-09; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Uchiyama I, 2010, NUCLEIC ACIDS RES, V38, pD361, DOI 10.1093/nar/gkp948; Vasconcelos ATR, 2005, J BACTERIOL, V187, P5568, DOI 10.1128/JB.187.16.5568-5577.2005; Vilei EM, 2001, CLIN DIAGN LAB IMMUN, V8, P85, DOI 10.1128/CDLI.8.1.85-92.2001; Voigt W, 2006, J CLIN MICROBIOL, V44, P2247, DOI 10.1128/JCM.00330-05; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033	59	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e38793	10.1371/journal.pone.0038793	http://dx.doi.org/10.1371/journal.pone.0038793			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685606	Green Published, Green Submitted, gold			2022-12-27	WOS:000305351700070
J	Pope, PB; Mackenzie, AK; Gregor, I; Smith, W; Sundset, MA; McHardy, AC; Morrison, M; Eijsink, VGH				Pope, Phillip B.; Mackenzie, Alasdair K.; Gregor, Ivan; Smith, Wendy; Sundset, Monica A.; McHardy, Alice C.; Morrison, Mark; Eijsink, Vincent G. H.			Metagenomics of the Svalbard Reindeer Rumen Microbiome Reveals Abundance of Polysaccharide Utilization Loci	PLOS ONE			English	Article							DATABASE; BACTERIAL; PROTEINS; GENES	Lignocellulosic biomass remains a largely untapped source of renewable energy predominantly due to its recalcitrance and an incomplete understanding of how this is overcome in nature. We present here a compositional and comparative analysis of metagenomic data pertaining to a natural biomass-converting ecosystem adapted to austere arctic nutritional conditions, namely the rumen microbiome of Svalbard reindeer (Rangifer tarandus platyrhynchus). Community analysis showed that deeply-branched cellulolytic lineages affiliated to the Bacteroidetes and Firmicutes are dominant, whilst sequence binning methods facilitated the assemblage of metagenomic sequence for a dominant and novel Bacteroidales clade (SRM-1). Analysis of unassembled metagenomic sequence as well as metabolic reconstruction of SRM-1 revealed the presence of multiple polysaccharide utilization loci-like systems (PULs) as well as members of more than 20 glycoside hydrolase and other carbohydrate-active enzyme families targeting various polysaccharides including cellulose, xylan and pectin. Functional screening of cloned metagenome fragments revealed high cellulolytic activity and an abundance of PULs that are rich in endoglucanases (GH5) but devoid of other common enzymes thought to be involved in cellulose degradation. Combining these results with known and partly re-evaluated metagenomic data strongly indicates that much like the human distal gut, the digestive system of herbivores harbours high numbers of deeply branched and as-yet uncultured members of the Bacteroidetes that depend on PUL-like systems for plant biomass degradation.	[Pope, Phillip B.; Mackenzie, Alasdair K.; Eijsink, Vincent G. H.] Norwegian Univ Life Sci, Dept Chem Biotechnol & Food Sci, As, Norway; [Gregor, Ivan; McHardy, Alice C.] Max Planck Inst Informat, Max Planck Res Grp Computat Genom & Epidemiol, Saarbrucken, Germany; [Gregor, Ivan; McHardy, Alice C.] Univ Dusseldorf, Dept Algorithm Bioinformat, D-40225 Dusseldorf, Germany; [Smith, Wendy; Morrison, Mark] CSIRO Livestock Ind, Queensland Biosci Precinct, St Lucia, Qld, Australia; [Sundset, Monica A.] Univ Tromso, Dept Arct & Marine Biol, Tromso, Norway	Norwegian University of Life Sciences; Max Planck Society; Heinrich Heine University Dusseldorf; Commonwealth Scientific & Industrial Research Organisation (CSIRO); UiT The Arctic University of Tromso	Pope, PB (corresponding author), Norwegian Univ Life Sci, Dept Chem Biotechnol & Food Sci, As, Norway.	phil.pope@umb.no	McHardy, Alice C/K-9377-2018; Morrison, Mark/C-9707-2013; McHardy, Alice/ABF-2322-2020; Pope, Phillip/AAQ-2251-2021	McHardy, Alice C/0000-0003-2370-3430; Morrison, Mark/0000-0001-9257-9133; McHardy, Alice/0000-0003-2370-3430; Pope, Phillip/0000-0002-2067-4059; Sundset, Monica Alterskjaer/0000-0002-4850-262X	Research Council of Norway's Bilateralt forskningssamarbeid - prosjektetablering (BILAT) program; European Commission [PIIF-GA-2010-274303]; Norwegian Research Council [190965/S60]; CSIRO's Livestock Industries, Queensland Bioscience Precinct Office of the Chief Executive (OCE); Max-Planck society; Heinrich-Heine University Dusseldorf	Research Council of Norway's Bilateralt forskningssamarbeid - prosjektetablering (BILAT) program(Research Council of Norway); European Commission(European CommissionEuropean Commission Joint Research Centre); Norwegian Research Council(Research Council of NorwayEuropean Commission); CSIRO's Livestock Industries, Queensland Bioscience Precinct Office of the Chief Executive (OCE); Max-Planck society(Max Planck SocietyFoundation CELLEX); Heinrich-Heine University Dusseldorf	The Svalbard reindeer project is partially supported by The Research Council of Norway's Bilateralt forskningssamarbeid - prosjektetablering (BILAT) program (awarded to VE) and the European Commission Marie Curie International Incoming Fellowship (awarded to PBP; PIIF-GA-2010-274303). AM is supported by a grant from the Norwegian Research Council (190965/S60). This work was performed in part under the auspices of the CSIRO's Livestock Industries, Queensland Bioscience Precinct Office of the Chief Executive (OCE) Science Leader program (awarded to MM). ACM and IG gratefully acknowledge support from the Max-Planck society and Heinrich-Heine University Dusseldorf. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Bayer EA, 2008, CHEM REC, V8, P364, DOI 10.1002/tcr.20160; Borodovsky Mark, 2003, Curr Protoc Bioinformatics, VChapter 4, DOI 10.1002/0471250953.bi0405s01; Brulc JM, 2009, P NATL ACAD SCI USA, V106, P1948, DOI 10.1073/pnas.0806191105; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Ding SY, 2001, J BACTERIOL, V183, P1945, DOI 10.1128/JB.183.6.1945-1953.2001; Dodd D, 2010, J BIOL CHEM, V285, P30261, DOI 10.1074/jbc.M110.141788; Duan CJ, 2009, J APPL MICROBIOL, V107, P245, DOI 10.1111/j.1365-2672.2009.04202.x; Duan CJ, 2010, BIOTECHNOL LETT, V32, P1765, DOI 10.1007/s10529-010-0356-z; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Gomez-Alvarez V, 2009, ISME J, V3, P1314, DOI 10.1038/ismej.2009.72; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Hess M, 2011, SCIENCE, V331, P463, DOI 10.1126/science.1200387; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Markowitz VM, 2008, NUCLEIC ACIDS RES, V36, pD534, DOI 10.1093/nar/gkm869; Markowitz VM, 2006, NUCLEIC ACIDS RES, V34, pD344, DOI 10.1093/nar/gkj024; Martens EC, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001221; Martens EC, 2009, J BIOL CHEM, V284, P24673, DOI 10.1074/jbc.R109.022848; Mello LV, 2010, FEBS LETT, V584, P2421, DOI 10.1016/j.febslet.2010.04.045; Noguchi H, 2006, NUCLEIC ACIDS RES, V34, P5623, DOI 10.1093/nar/gkl723; ORPIN CG, 1985, APPL ENVIRON MICROB, V50, P144, DOI 10.1128/AEM.50.1.144-151.1985; Patil KR, 2011, NAT METHODS, V8, P191, DOI 10.1038/nmeth0311-191; Pope PB, 2010, P NATL ACAD SCI USA, V107, P14793, DOI 10.1073/pnas.1005297107; Popper ZA, 2003, ANN BOT-LONDON, V91, P1, DOI 10.1093/aob/mcg013; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Rosewarne CP, 2011, MICROB ECOL, V61, P448, DOI 10.1007/s00248-010-9745-z; Sekelja M, 2011, ISME J, V5, P519, DOI 10.1038/ismej.2010.129; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shipman JA, 2000, J BACTERIOL, V182, P5365, DOI 10.1128/JB.182.19.5365-5372.2000; Sormo W, 1999, J ZOOL, V247, P247, DOI 10.1017/S0952836999002125; Suen G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018814; Sundset MA, 2007, MICROB ECOL, V54, P424, DOI 10.1007/s00248-007-9254-x; Vogel J, 2008, CURR OPIN PLANT BIOL, V11, P301, DOI 10.1016/j.pbi.2008.03.002; Warnecke F, 2007, NATURE, V450, P560, DOI 10.1038/nature06269	40	127	142	4	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e38571	10.1371/journal.pone.0038571	http://dx.doi.org/10.1371/journal.pone.0038571			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701672	Green Published, Green Submitted, gold			2022-12-27	WOS:000305348400075
J	Ramis, G; Thomas-Moya, E; de Mattos, SF; Rodriguez, J; Villalonga, P				Ramis, Guillem; Thomas-Moya, Elena; Fernandez de Mattos, Silvia; Rodriguez, Jose; Villalonga, Priam			EGFR Inhibition in Glioma Cells Modulates Rho Signaling to Inhibit Cell Motility and Invasion and Cooperates with Temozolomide to Reduce Cell Growth	PLOS ONE			English	Article							DIAGNOSED GLIOBLASTOMA-MULTIFORME; FACTOR RECEPTOR INHIBITORS; KINASE INHIBITORS; CYCLIN D1; RADIATION-THERAPY; EXPRESSION; MIGRATION; ERLOTINIB; GTPASES; PHASE	Enforced EGFR activation upon gene amplification and/or mutation is a common hallmark of malignant glioma. Small molecule EGFR tyrosine kinase inhibitors, such as erlotinib (Tarceva), have shown some activity in a subset of glioma patients in recent trials, although the reported data on the cellular basis of glioma cell responsiveness to these compounds have been contradictory. Here we have used a panel of human glioma cell lines, including cells with amplified or mutant EGFR, to further characterize the cellular effects of EGFR inhibition with erlotinib. Dose-response and cellular growth assays indicate that erlotinib reduces cell proliferation in all tested cell lines without inducing cytotoxic effects. Flow cytometric analyses confirm that EGFR inhibition does not induce apoptosis in glioma cells, leading to cell cycle arrest in G(1). Interestingly, erlotinib also prevents spontaneous multicellular tumour spheroid growth in U87MG cells and cooperates with sub-optimal doses of temozolomide (TMZ) to reduce multicellular tumour spheroid growth. This cooperation appears to be schedule-dependent, since pre-treatment with erlotinib protects against TMZ-induced cytotoxicity whereas concomitant treatment results in a cooperative effect. Cell cycle arrest in erlotinib-treated cells is associated with an inhibition of ERK and Akt signaling, resulting in cyclin D1 downregulation, an increase in p27(kip1) levels and pRB hypophosphorylation. Interestingly, EGFR inhibition also perturbs Rho GTPase signaling and cellular morphology, leading to Rho/ROCK-dependent formation of actin stress fibres and the inhibition of glioma cell motility and invasion.	[Ramis, Guillem; Thomas-Moya, Elena; Fernandez de Mattos, Silvia; Rodriguez, Jose; Villalonga, Priam] Univ Illes Balears, Inst Univ Invest Ciencies Salut IUNICS, Canc Cell Biol Grp, Illes Balears, Spain; [Fernandez de Mattos, Silvia; Villalonga, Priam] Univ Illes Balears, Dept Biol Fonamental, Illes Balears, Spain	Universitat de les Illes Balears; Universitat de les Illes Balears	Ramis, G (corresponding author), Univ Illes Balears, Inst Univ Invest Ciencies Salut IUNICS, Canc Cell Biol Grp, Illes Balears, Spain.	priam.villalonga@uib.es	Villalonga, Priam/K-4350-2014; de Mattos, Silvia Fernández/K-5153-2014	Villalonga, Priam/0000-0002-7190-6884; de Mattos, Silvia Fernández/0000-0003-4144-3687	Direccio General de R+D+I, Govern de les Illes Balears; Junta de Balears-AECC; Roche-Espana	Direccio General de R+D+I, Govern de les Illes Balears; Junta de Balears-AECC; Roche-Espana	This work was supported by funding from the "Direccio General de R+D+I, Govern de les Illes Balears" (PV), "Junta de Balears-AECC" (PV and ET-M) and Roche-Espana (JR and PV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amanatullah DF, 2001, METHOD ENZYMOL, V333, P116; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brandes AA, 2008, CLIN CANCER RES, V14, P957, DOI 10.1158/1078-0432.CCR-07-1810; Brown PD, 2008, J CLIN ONCOL, V26, P5603, DOI 10.1200/JCO.2008.18.0612; Carrasco-Garcia E, 2011, EXP CELL RES, V317, P1476, DOI 10.1016/j.yexcr.2011.03.015; Cemeus C, 2008, J NEURO-ONCOL, V90, P9, DOI 10.1007/s11060-008-9627-0; Cheng H, 2011, CANCER CHEMOTH PHARM, V67, P637, DOI 10.1007/s00280-010-1347-4; Fan QW, 2007, CANCER RES, V67, P7960, DOI 10.1158/0008-5472.CAN-07-2154; Fan QW, 2003, CANCER RES, V63, P8930; Giese A, 2003, J CLIN ONCOL, V21, P1624, DOI 10.1200/JCO.2003.05.063; Goldberg L, 2006, CANCER RES, V66, P11709, DOI 10.1158/0008-5472.CAN-06-1878; Gomez-Manzano C, 2001, INT J ONCOL, V19, P359; Griffero F, 2009, J BIOL CHEM; Haas-Kogan DA, 2005, JNCI-J NATL CANCER I, V97, P880, DOI 10.1093/jnci/dji161; Haas-Koogan DA, 2005, CELL CYCLE, V4, P1369, DOI 10.4161/cc.4.10.2105; Halatsch ME, 2009, J NEUROSURG, V111, P211, DOI 10.3171/2008.9.JNS08551; Halatsch ME, 2006, CANCER TREAT REV, V32, P74, DOI 10.1016/j.ctrv.2006.01.003; Halatsch ME, 2004, J NEUROSURG, V100, P523, DOI 10.3171/jns.2004.100.3.0523; Huang HJS, 1997, J BIOL CHEM, V272, P2927, DOI 10.1074/jbc.272.5.2927; Kolchinsky A, 1997, ANTICANCER RES, V17, P3321; Krakstad C, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-135; Maher EA, 2001, GENE DEV, V15, P1311, DOI 10.1101/gad.891601; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Mellinghoff IK, 2005, NEW ENGL J MED, V353, P2012, DOI 10.1056/NEJMoa051918; NISHIKAWA R, 1994, P NATL ACAD SCI USA, V91, P7727, DOI 10.1073/pnas.91.16.7727; Pan F, 2011, J CANCER RES CLIN, V137, P1397, DOI 10.1007/s00432-011-1009-x; Pawlik TM, 2004, INT J RADIAT ONCOL, V59, P928, DOI 10.1016/j.ijrobp.2004.03.005; Prados MD, 2009, J CLIN ONCOL, V27, P579, DOI 10.1200/JCO.2008.18.9639; Ren XD, 2000, METHOD ENZYMOL, V325, P264; Ridley AJ, 2001, J CELL SCI, V114, P2713; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Ridley AJ, 2001, TRENDS CELL BIOL, V11, P471, DOI 10.1016/S0962-8924(01)02153-5; Riganti C, 2008, MINI-REV MED CHEM, V8, P609, DOI 10.2174/138955708784534436; Sander EE, 1999, J CELL BIOL, V147, P1009, DOI 10.1083/jcb.147.5.1009; Stommel JM, 2007, SCIENCE, V318, P287, DOI 10.1126/science.1142946; Takuwa N, 1999, MOL CELL BIOL, V19, P1346; Thomas C, 2001, ACTA NEUROPATHOL, V101, P605; Wang MY, 2006, CANCER RES, V66, P7864, DOI 10.1158/0008-5472.CAN-04-4392; Weber JD, 1997, BIOCHEM J, V326, P61, DOI 10.1042/bj3260061; Wild-Bode C, 2001, CANCER RES, V61, P2744; Zhai GG, 2006, J NEURO-ONCOL, V76, P227, DOI 10.1007/s11060-005-6499-4	41	47	49	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e38770	10.1371/journal.pone.0038770	http://dx.doi.org/10.1371/journal.pone.0038770			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701710	Green Published, gold			2022-12-27	WOS:000305348400095
J	Gao, Y; Chen, SH; Hu, MY; Hu, QB; Luo, JJ; Li, YA				Gao, Yan; Chen, Shaohua; Hu, Meiying; Hu, Qiongbo; Luo, Jianjun; Li, Yanan			Purification and Characterization of a Novel Chlorpyrifos Hydrolase from Cladosporium cladosporioides Hu-01	PLOS ONE			English	Article							METHYL PARATHION HYDROLASE; DEGRADING BACTERIUM; STRAIN; BIODEGRADATION; BIOREMEDIATION; CLONING; 3,5,6-TRICHLORO-2-PYRIDINOL; GENE; CYPERMETHRIN; DEGRADATION	Chlorpyrifos is of great environmental concern due to its widespread use in the past several decades and its potential toxic effects on human health. Thus, the degradation study of chlorpyrifos has become increasing important in recent years. A fungus capable of using chlorpyrifos as the sole carbon source was isolated from organophosphate-contaminated soil and characterized as Cladosporium cladosporioides Hu-01 (collection number: CCTCC M 20711). A novel chlorpyrifos hydrolase from cell extract was purified 35.6-fold to apparent homogeneity with 38.5% overall recovery by ammoniumsulfate precipitation, gel filtration chromatography and anion-exchange chromatography. It is a monomeric structure with a molecular mass of 38.3 kDa. The pI value was estimated to be 5.2. The optimal pH and temperature of the purified enzyme were 6.5 and 40 degrees C, respectively. No cofactors were required for the chlorpyrifos-hydrolysis activity. The enzyme was strongly inhibited by Hg2+, Fe3+, DTT, beta-mercaptoethanol and SDS, whereas slight inhibitory effects (5-10% inhibition) were observed in the presence of Mn2+, Zn2+, Cu2+, Mg2+, and EDTA. The purified enzyme hydrolyzed various organophosphorus insecticides with P-O and P-S bond. Chlorpyrifos was the preferred substrate. The Km and Vmax values of the enzyme for chlorpyrifos were 6.7974 mu M and 2.6473 mu mol-min(-1), respectively. Both NH2-terminal sequencing and matrix-assisted laser desorption/ionization time-of-flight/time-of-flight mass spectrometer (MALDI-TOF-MS) identified an amino acid sequence MEPDGELSALTQGANS, which shared no similarity with any reported organophosphate-hydrolyzing enzymes. These results suggested that the purified enzyme was a novel hydrolase and might conceivably be developed to fulfill the practical requirements to enable its use in situ for detoxification of chlorpyrifos. Finally, this is the first described chlorpyrifos hydrolase from fungus.	[Gao, Yan; Chen, Shaohua; Hu, Meiying; Hu, Qiongbo; Luo, Jianjun; Li, Yanan] S China Agr Univ, Minist Educ, Key Lab Pesticide & Chem Biol, Guangzhou, Guangdong, Peoples R China; [Gao, Yan] Guangdong Acad Agr Sci, Guangdong Prov Key Lab High Technol Plant Protect, Plant Protect Res Inst, Guangzhou, Guangdong, Peoples R China	South China Agricultural University; Guangdong Academy of Agricultural Sciences	Gao, Y (corresponding author), S China Agr Univ, Minist Educ, Key Lab Pesticide & Chem Biol, Guangzhou, Guangdong, Peoples R China.	humy@scau.edu.cn	Chen, Shaohua/AAQ-9860-2021	Chen, Shaohua/0000-0001-8306-2626	National Natural Science Foundation [30871660]; Project of Scientific Technological Planning of Guangdong Province, People's Republic of China [2009B020310005, 2009B020310003]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Project of Scientific Technological Planning of Guangdong Province, People's Republic of China	The authors gratefully acknowledge the grants from the National Natural Science Foundation (No.30871660) and the Project of Scientific Technological Planning of Guangdong Province (No.2009B020310005, 2009B020310003), People's Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anwar S, 2009, J HAZARD MATER, V168, P400, DOI 10.1016/j.jhazmat.2009.02.059; Bicker W, 2005, TOXICOL LETT, V159, P235, DOI 10.1016/j.toxlet.2005.05.013; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030862; Chen SH, 2012, APPL MICROBIOL BIOT, V94, P505, DOI 10.1007/s00253-011-3640-5; Chen SH, 2012, BIORESOURCE TECHNOL, V110, P97, DOI 10.1016/j.biortech.2012.01.106; Chen SH, 2011, BIORESOURCE TECHNOL, V102, P8110, DOI 10.1016/j.biortech.2011.06.055; Chen SH, 2011, J HAZARD MATER, V187, P433, DOI 10.1016/j.jhazmat.2011.01.049; Chen SH, 2011, APPL MICROBIOL BIOT, V90, P755, DOI 10.1007/s00253-010-3035-z; CHENG TC, 1993, APPL ENVIRON MICROB, V59, P3138, DOI 10.1128/AEM.59.9.3138-3140.1993; COCHRAN RC, 1995, FOOD CHEM TOXICOL, V33, P165, DOI 10.1016/0278-6915(94)00124-7; Cui ZL, 2001, APPL ENVIRON MICROB, V67, P4922; Cycon M, 2009, CHEMOSPHERE, V76, P494, DOI 10.1016/j.chemosphere.2009.03.023; DEFRANK JJ, 1991, J BACTERIOL, V173, P1938, DOI 10.1128/jb.173.6.1938-1943.1991; Dong YJ, 2005, J MOL BIOL, V353, P655, DOI 10.1016/j.jmb.2005.08.057; DUMAS DP, 1989, J BIOL CHEM, V264, P19659; Fang H, 2008, INT BIODETER BIODEGR, V61, P294, DOI 10.1016/j.ibiod.2007.10.001; Guo P, 2009, INT BIODETER BIODEGR, V63, P1107, DOI 10.1016/j.ibiod.2009.09.008; Harms H, 2011, NAT REV MICROBIOL, V9, P177, DOI 10.1038/nrmicro2519; Horne I, 2002, APPL ENVIRON MICROB, V68, P3371, DOI 10.1128/AEM.68.7.3371-3376.2002; Howard PH, 1991, HDB ENV FATE EXPOSUR; Kulshrestha G, 2011, BIOL FERT SOILS, V47, P219, DOI 10.1007/s00374-010-0505-5; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li JQ, 2010, BIORESOURCE TECHNOL, V101, P7479, DOI 10.1016/j.biortech.2010.04.030; Li XH, 2008, INT BIODETER BIODEGR, V62, P331, DOI 10.1016/j.ibiod.2008.03.001; Li XH, 2007, RES MICROBIOL, V158, P143, DOI 10.1016/j.resmic.2006.11.007; Liang WQ, 2005, J AGR FOOD CHEM, V53, P7415, DOI 10.1021/jf051460k; Megharaj M, 2011, ENVIRON INT, V37, P1362, DOI 10.1016/j.envint.2011.06.003; Mohan SV, 2007, ECOTOX ENVIRON SAFE, V68, P252, DOI 10.1016/j.ecoenv.2007.06.002; Oliver GR, 2000, NEUROTOXICOLOGY, V21, P203; Peng Y, 2009, APPL MICROBIOL BIOT, V85, P85, DOI 10.1007/s00253-009-2061-1; Singh BK, 2004, APPL ENVIRON MICROB, V70, P4855, DOI 10.1128/AEM.70.8.4855-4863.2004; Singh BK, 2006, SOIL BIOL BIOCHEM, V38, P2682, DOI 10.1016/j.soilbio.2006.04.019; Singh BK, 2009, NAT REV MICROBIOL, V7, P156, DOI 10.1038/nrmicro2050; Sorensen SR, 2008, APPL ENVIRON MICROB, V74, P2332, DOI 10.1128/AEM.02687-07; Theriot CM, 2011, APPL MICROBIOL BIOT, V89, P35, DOI 10.1007/s00253-010-2807-9; VARGHESE G, 1983, ANAL BIOCHEM, V132, P481, DOI 10.1016/0003-2697(83)90037-4; Wang BZ, 2009, APPL ENVIRON MICROB, V75, P5496, DOI 10.1128/AEM.01298-09; Wu PC, 2006, J AGR FOOD CHEM, V54, P836, DOI 10.1021/jf052691u; Xu GM, 2008, INT BIODETER BIODEGR, V62, P51, DOI 10.1016/j.ibiod.2007.12.001; Yang C, 2006, FEMS MICROBIOL LETT, V265, P118, DOI 10.1111/j.1574-6968.2006.00478.x; Yang L, 2005, FEMS MICROBIOL LETT, V251, P67, DOI 10.1016/j.femsle.2005.07.031; Yang L, 2011, BIOL FERT SOILS, V47, P917, DOI 10.1007/s00374-011-0602-0; Yu YL, 2006, BIODEGRADATION, V17, P487, DOI 10.1007/s10532-005-9020-z; Zhang C, 2011, BIORESOURCE TECHNOL, V102, P7139, DOI 10.1016/j.biortech.2011.03.086	45	64	66	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e38137	10.1371/journal.pone.0038137	http://dx.doi.org/10.1371/journal.pone.0038137			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22693630	Green Published, Green Submitted, gold			2022-12-27	WOS:000305343900018
J	Wang, LL; Li, B; Zhao, XH; Chen, CX; Cao, JJ				Wang, Lili; Li, Bin; Zhao, Xiaohong; Chen, Chunxia; Cao, Jingjing			Effect of Rare Earth Ions on the Properties of Composites Composed of Ethylene Vinyl Acetate Copolymer and Layered Double Hydroxides	PLOS ONE			English	Article							STRUCTURAL-CHARACTERIZATION; THERMAL-DECOMPOSITION; PARTIAL OXIDATION; AL; HYDROTALCITE; MG; INTERCALATION; CATALYSTS; RELEASE; NITRATE	Background: The study on the rare earth (RE)-doped layered double hydroxides (LDHs) has received considerable attention due to their potential applications in catalysts. However, the use of RE-doped LDHs as polymer halogen-free flame retardants was seldom investigated. Furthermore, the effect of rare earth elements on the hydrophobicity of LDHs materials and the compatibility of LDHs/polymer composite has seldom been reported. Methodology/Principal Findings: The stearate sodium surface modified Ni-containing LDHs and RE-doped Ni-containing LDHs were rapidly synthesized by a coprecipitation method coupled with the microwave hydrothermal treatment. The influences of trace amounts of rare earth ions La, Ce and Nd on the amount of water molecules, the crystallinity, the morphology, the hydrophobicity of modified Ni-containing LDHs and the adsorption of modifier in the surface of LDHs were investigated by TGA, XRD, TEM, contact angle and IR, respectively. Moreover, the effects of the rare earth ions on the interfacial compatibility, the flame retardancy and the mechanical properties of ethylene vinyl acetate copolymer (EVA)/LDHs composites were also explored in detail. Conclusions/Significance: S-Ni0.1MgAl-La displayed more uniform dispersion and better interfacial compatibility in EVA matrix compared with other LDHs. Furthermore, the S-Ni0.1MgAl-La/EVA composite showed the best fire retardancy and mechanical properties in all composites.	[Wang, Lili; Li, Bin; Zhao, Xiaohong; Chen, Chunxia; Cao, Jingjing] NE Forestry Univ, Heilongjiang Key Lab Mol Design & Preparat Flame, Coll Sci, Harbin, Peoples R China	Northeast Forestry University - China	Wang, LL (corresponding author), NE Forestry Univ, Heilongjiang Key Lab Mol Design & Preparat Flame, Coll Sci, Harbin, Peoples R China.	libinzh62@163.com			Fundamental Research Funds for the Central Universities [DL10BB04]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This project was supported by the Fundamental Research Funds for the Central Universities (No. DL10BB04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi-Pagano M, 2003, J MATER CHEM, V13, P1988, DOI 10.1039/b302747n; Agroui K, 2006, SOL ENERG MAT SOL C, V90, P2509, DOI 10.1016/j.solmat.2006.03.023; Ardanuy M, 2011, APPL CLAY SCI, V51, P341, DOI 10.1016/j.clay.2010.12.024; Auxilio AR, 2007, POLYHEDRON, V26, P3479, DOI 10.1016/j.poly.2007.03.019; Babizhetskyy V, 2010, J SOLID STATE CHEM, V183, P2343, DOI 10.1016/j.jssc.2010.07.046; Becker CM, 2011, COMPOS PART A-APPL S, V42, P196, DOI 10.1016/j.compositesa.2010.11.005; Benito P, 2006, MICROPOR MESOPOR MAT, V94, P148, DOI 10.1016/j.micromeso.2006.03.038; Benito P, 2006, J SOLID STATE CHEM, V179, P3784, DOI 10.1016/j.jssc.2006.08.010; Arizaga GGC, 2008, J COLLOID INTERF SCI, V320, P238, DOI 10.1016/j.jcis.2007.12.025; Arizaga GGC, 2010, J SOLID STATE CHEM, V183, P2324, DOI 10.1016/j.jssc.2010.07.050; Cecen V, 2008, EUR POLYM J, V44, P3827, DOI 10.1016/j.eurpolymj.2008.07.053; Chen YF, 2011, J LUMIN, V131, P701, DOI 10.1016/j.jlumin.2010.11.021; Chen YF, 2010, J SOLID STATE CHEM, V183, P2222, DOI 10.1016/j.jssc.2010.07.042; Cota I, 2010, APPL CATAL A-GEN, V382, P272, DOI 10.1016/j.apcata.2010.05.006; del Arco M, 2010, J SOLID STATE CHEM, V183, P3002, DOI 10.1016/j.jssc.2010.10.017; Guessoum K, 2011, CORROS SCI, V53, P1639, DOI 10.1016/j.corsci.2011.01.006; Guo K, 2011, CHEM PHYS, V380, P54, DOI 10.1016/j.chemphys.2010.12.006; Guo QH, 2007, J CONTROL RELEASE, V118, P318, DOI 10.1016/j.jconrel.2006.12.030; Ha JU, 2011, INT J PHARMACEUT, V414, P321, DOI 10.1016/j.ijpharm.2011.05.028; He HM, 2010, J COLLOID INTERF SCI, V343, P225, DOI 10.1016/j.jcis.2009.11.004; Herrero M, 2007, J SOLID STATE CHEM, V180, P873, DOI 10.1016/j.jssc.2006.12.011; Hu LH, 2011, MATER RES BULL, V46, P244, DOI 10.1016/j.materresbull.2010.11.002; Jaubertie C, 2006, CHEM MATER, V18, P3114, DOI 10.1021/cm060512y; Kameda T, 2011, J COLLOID INTERF SCI, V362, P497, DOI 10.1016/j.jcis.2011.06.065; Kloprogge JT, 2002, AM MINERAL, V87, P623; Kovanda F, 2010, APPL CLAY SCI, V48, P260, DOI 10.1016/j.clay.2009.11.012; Lezhnina MM, 2010, OPT MATER, V33, P4, DOI 10.1016/j.optmat.2010.07.005; Li QZ, 2010, MATER CHEM PHYS, V120, P676, DOI 10.1016/j.matchemphys.2009.12.025; Lucredio AF, 2010, APPL CATAL A-GEN, V388, P77, DOI 10.1016/j.apcata.2010.08.026; Lucredio AF, 2007, APPL CATAL A-GEN, V333, P90, DOI 10.1016/j.apcata.2007.09.009; Millange F, 2000, J MATER CHEM, V10, P1713, DOI 10.1039/b002827o; Mokhtar M, 2010, J ALLOY COMPD, V493, P376, DOI 10.1016/j.jallcom.2009.12.106; Nguyen HL, 2010, COMP MATER SCI, V50, P2, DOI 10.1016/j.commatsci.2010.03.002; Nyambo C, 2009, POLYM DEGRAD STABIL, V94, P513, DOI 10.1016/j.polymdegradstab.2009.01.028; Ohnishi T, 2010, J ALLOY COMPD, V506, P27, DOI 10.1016/j.jallcom.2010.07.004; Palmer SJ, 2009, J COLLOID INTERF SCI, V329, P404, DOI 10.1016/j.jcis.2008.09.065; Panda HS, 2008, MATER RES BULL, V43, P1448, DOI 10.1016/j.materresbull.2007.06.037; Prasad BE, 2010, J COLLOID INTERF SCI, V348, P216, DOI 10.1016/j.jcis.2010.04.038; Prasanna SV, 2010, J COLLOID INTERF SCI, V344, P508, DOI 10.1016/j.jcis.2010.01.013; Tao RT, 2010, J COLLOID INTERF SCI, V351, P501, DOI 10.1016/j.jcis.2009.12.025; Triantafyllidis KS, 2010, J COLLOID INTERF SCI, V342, P427, DOI 10.1016/j.jcis.2009.10.063; Violante A, 2009, J COLLOID INTERF SCI, V333, P63, DOI 10.1016/j.jcis.2009.01.004; Wang DY, 2011, POLYM DEGRAD STABIL, V96, P285, DOI 10.1016/j.polymdegradstab.2010.03.003; Wang DY, 2011, J ALLOY COMPD, V509, P3497, DOI 10.1016/j.jallcom.2010.12.138; Wang J, 2010, J ALLOY COMPD, V494, P271, DOI 10.1016/j.jallcom.2010.01.007; Wang LL, 2011, J COLLOID INTERF SCI, V356, P519, DOI 10.1016/j.jcis.2011.01.048; Wang LJ, 2010, POLYM DEGRAD STABIL, V95, P572, DOI 10.1016/j.polymdegradstab.2009.12.012; Wang SF, 2004, J APPL POLYM SCI, V91, P1571, DOI 10.1002/app.13265; Wypych F, 2005, J COLLOID INTERF SCI, V283, P130, DOI 10.1016/j.jcis.2004.08.125; Xiang X, 2010, J ALLOY COMPD, V499, P30, DOI 10.1016/j.jallcom.2010.03.125; Ye L, 2008, POLYM DEGRAD STABIL, V93, P918, DOI 10.1016/j.polymdegradstab.2008.02.002; Yuan Y, 2011, APPL CLAY SCI, V53, P608, DOI 10.1016/j.clay.2011.05.010; Zhang G, 2007, POLYM DEGRAD STABIL, V92, P1715, DOI 10.1016/j.polymdegradstab.2007.06.004; Zhang J, 2010, INT J HYDROGEN ENERG, V35, P11776, DOI 10.1016/j.ijhydene.2010.08.025; Zhang M, 2008, MATER CHEM PHYS, V109, P206, DOI 10.1016/j.matchemphys.2007.11.013; Zubitur M, 2009, POLYM DEGRAD STABIL, V94, P804, DOI 10.1016/j.polymdegradstab.2009.01.026	56	18	18	7	108	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e37781	10.1371/journal.pone.0037781	http://dx.doi.org/10.1371/journal.pone.0037781			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22693627	Green Published, Green Submitted, gold			2022-12-27	WOS:000305343900013
J	Austvoll-Dahlgren, A; Bjorndal, A; Odgaard-Jensen, J; Helseth, S				Austvoll-Dahlgren, Astrid; Bjorndal, Arild; Odgaard-Jensen, Jan; Helseth, Solvi			Evaluation of a Web Portal for Improving Public Access to Evidence-Based Health Information and Health Literacy Skills: A Pragmatic Trial	PLOS ONE			English	Article							DECISION-MAKING; INTERNET; PARENTS; PROFESSIONALS; STRATEGIES; ACTIVATION; MEDICINE; BARRIERS; QUALITY	Background: Using the conceptual framework of shared decision-making and evidence-based practice, a web portal was developed to serve as a generic (non disease-specific) tailored intervention to improve the lay public's health literacy skills. Objective: To evaluate the effects of the web portal compared to no intervention in a real-life setting. Methods: A pragmatic randomised controlled parallel trial using simple randomisation of 96 parents who had children aged <4 years. Parents were allocated to receive either access to the portal or no intervention, and assigned three tasks to perform over a three-week period. These included a searching task, a critical appraisal task, and reporting on perceptions about participation. Data were collected from March through June 2011. Results: Use of the web portal was found to improve attitudes towards searching for health information. This variable was identified as the most important predictor of intention to search in both samples. Participants considered the web portal to have good usability, usefulness, and credibility. The intervention group showed slight increases in the use of evidence-based information, critical appraisal skills, and participation compared to the group receiving no intervention, but these differences were not statistically significant. Conclusion: Despite the fact that the study was underpowered, we found that the web portal may have a positive effect on attitudes towards searching for health information. Furthermore, participants considered the web portal to be a relevant tool. It is important to continue experimenting with web-based resources in order to increase user participation in health care decision-making.	[Austvoll-Dahlgren, Astrid; Helseth, Solvi] Fac Hlth Sci, Oslo, Norway; [Austvoll-Dahlgren, Astrid; Helseth, Solvi] Akershus Univ, Coll Appl Sci, Oslo, Norway; [Austvoll-Dahlgren, Astrid; Odgaard-Jensen, Jan] Norwegian Knowledge Ctr Hlth Serv, Oslo, Norway; [Bjorndal, Arild] Reg Ctr Child & Adolescent Mental Hlth, Oslo, Norway; [Bjorndal, Arild] Univ Oslo, Inst Hlth & Soc, Oslo, Norway	Oslo Metropolitan University (OsloMet); Norwegian Knowledge Centre for Health Services; University of Oslo	Austvoll-Dahlgren, A (corresponding author), Fac Hlth Sci, Oslo, Norway.	Astrid.austvoll-dahlgren@nokc.no			Oslo University College	Oslo University College	The project was funded by Oslo University College. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Andreassen Hege, 2002, Tidsskr Nor Laegeforen, V122, P1640; Armitage CJ, 2001, BRIT J SOC PSYCHOL, V40, P471, DOI 10.1348/014466601164939; Austvoll-Dahlgren A, 2011, SCANDINAVIAN J  1215; Austvoll-Dahlgren A, 2012, COGNITIVE FACT UNPUB; Austvoll-Dahlgren A, 2012, COMPLEX INTERV UNPUB; Austvoll-Dahlgren A, 2010, J ADV NURS, V66, P2421, DOI 10.1111/j.1365-2648.2010.05403.x; Berkman ND, 2011, ANN INTERN MED, V155, P97, DOI 10.7326/0003-4819-155-2-201107190-00005; Bjorndal A, 2007, KNOWLEDGE MANAGEMENT; Bugge C, 2006, SOC SCI MED, V63, P2065, DOI 10.1016/j.socscimed.2006.05.010; Bylund CL, 2007, PATIENT EDUC COUNS, V66, P346, DOI 10.1016/j.pec.2007.01.009; Charnock D, 1999, J EPIDEMIOL COMMUN H, V53, P105, DOI 10.1136/jech.53.2.105; Charnock D, 1998, DISCERN HDB QUALITY; Coulter A, 2005, EUR J PUBLIC HEALTH, V15, P355, DOI 10.1093/eurpub/cki004; Coulter A., 2002, AUTONOMOUS PATIENT E; Coulter A, 2006, PATIENT FOCUSED INTE; Dawes M, 2005, BMC MED ED; Detmer D, 2003, INFORM PATIENT STUDY, P53; Dicenso Alba, 2009, Evid Based Nurs, V12, P99, DOI 10.1136/ebn.12.4.99-b; Eccles M, 2006, IMPLEMENTATION SCI; Eysenbach G, 2002, JAMA-J AM MED ASSOC, V287, P2691, DOI 10.1001/jama.287.20.2691; Fox S., 2006, ONLINE HLTH SEARCH; Francis J., 2004, CONSTRUCTING QUESTIO, V5th ed.; Freedman DA, 2009, AM J PREV MED, V36, P446, DOI 10.1016/j.amepre.2009.02.001; Glenton C, 2005, BMC MED INFORM  0315; Glenton Claire, 1998, Health Expect, V1, P14, DOI 10.1046/j.1369-6513.1998.00002.x; Goldacre B, 2007, BRIT MED J, V335, P126, DOI 10.1136/bmj.39280.447419.59; Gordon MM, 2002, RHEUMATOLOGY, V41, P1402, DOI 10.1093/rheumatology/41.12.1402; Haug Charlotte, 2009, Tidsskr Nor Laegeforen, V129, P1619, DOI 10.4045/tidsskr.09.0996; Hibbard JH, 2005, HEALTH SERV RES, V40, P1918, DOI 10.1111/j.1475-6773.2005.00438.x; Hibbard JH, 2004, HEALTH SERV RES, V39, P1005, DOI 10.1111/j.1475-6773.2004.00269.x; Hoye Sigurd, 2002, Tidsskr Nor Laegeforen, V122, P1671; Irwig L, 2008, SMART HLTH CHOICES M, Vxi, P242; Ishikawa H, 2008, HEALTH EXPECT, V11, P113, DOI 10.1111/j.1369-7625.2008.00497.x; Johansen L W, 1996, Tidsskr Nor Laegeforen, V116, P260; Jones S., 2009, GENERATIONS ONLINE 2; Legare F, 2008, PATIENT EDUC COUNS, V73, P526, DOI 10.1016/j.pec.2008.07.018; LLOYD AJ, 2001, QUAL HLTH CARE S1, V10, P14; Mills E, 2005, J CLIN EPIDEMIOL, V58, P1081, DOI 10.1016/j.jclinepi.2005.09.002; Morville P, 2004, USER EXPERIENCE DESI; Murray E, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004274.pub4; Nutbeam D, 2000, HEALTH PROMOT INT, V15, P259, DOI 10.1093/heapro/15.3.259; Nutbeam D., 1998, HLTH PROMOTION GLOSS; Nutbeam D, 2008, SOC SCI MED, V67, P2072, DOI 10.1016/j.socscimed.2008.09.050; Peerson A, 2009, HEALTH PROMOT INT, V24, P285, DOI 10.1093/heapro/dap014; Radosevich D, 2006, UNDERSTANDING HLTH C, P23; Robinson E, 2005, LAY PUBLICS UNDERSTA; Rosenbaum SE, 2008, BMC MED INFORM DECIS, V8, DOI 10.1186/1472-6947-8-34; Sabel MS, 2005, J AM ACAD DERMATOL, V52, P779, DOI 10.1016/j.jaad.2004.10.874; Schwartz KL, 2006, J AM BOARD FAM MED, V19, P39, DOI 10.3122/jabfm.19.1.39; Schwartz LM, 1997, ANN INTERN MED, V127, P966, DOI 10.7326/0003-4819-127-11-199712010-00003; Sillence E, 2007, SOC SCI MED, V64, P1853, DOI 10.1016/j.socscimed.2007.01.012; Statistics Norway, 2009, US HLTH SERV SEX AG; Steinsbekk Aslak, 2008, Tidsskr Nor Laegeforen, V128, P2316; Teasdale E, 2011, PATIENT EDUC COUNS, V85, P413, DOI 10.1016/j.pec.2010.12.026; Tickner S, 2006, VACCINE, V24, P7030, DOI 10.1016/j.vaccine.2006.06.060; Tuffrey C, 2002, ARCH DIS CHILD, V87, P534, DOI 10.1136/adc.87.6.534; Wainstein BK, 2006, J PAEDIATR CHILD H, V42, P528, DOI 10.1111/j.1440-1754.2006.00916.x; Wangberg S, 2009, SCAND J CARING SCI, V23, P691, DOI 10.1111/j.1471-6712.2008.00662.x; Wantland DJ, 2004, J MED INTERNET RES, V6, P67; Weinstein Neil D., 1999, Journal of the National Cancer Institute Monographs, P15; Wolfe RM, 2002, JAMA-J AM MED ASSOC, V287, P3245, DOI 10.1001/jama.287.24.3245; Woloshin S, 2000, ARCH INTERN MED, V160, P1434, DOI 10.1001/archinte.160.10.1434; Zarcadoolas C, 2006, ADV HLTH LITERACY FR	64	15	15	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e37715	10.1371/journal.pone.0037715	http://dx.doi.org/10.1371/journal.pone.0037715			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TY	22701531	gold, Green Published			2022-12-27	WOS:000305338500052
J	Ercsey-Ravasz, M; Toroczkai, Z; Lakner, Z; Baranyi, J				Ercsey-Ravasz, Maria; Toroczkai, Zoltan; Lakner, Zoltan; Baranyi, Jozsef			Complexity of the International Agro-Food Trade Network and Its Impact on Food Safety	PLOS ONE			English	Article							SECURITY	With the world's population now in excess of 7 billion, it is vital to ensure the chemical and microbiological safety of our food, while maintaining the sustainability of its production, distribution and trade. Using UN databases, here we show that the international agro-food trade network (IFTN), with nodes and edges representing countries and import-export fluxes, respectively, has evolved into a highly heterogeneous, complex supply-chain network. Seven countries form the core of the IFTN, with high values of betweenness centrality and each trading with over 77% of all the countries in the world. Graph theoretical analysis and a dynamic food flux model show that the IFTN provides a vehicle suitable for the fast distribution of potential contaminants but unsuitable for tracing their origin. In particular, we show that high values of node betweenness and vulnerability correlate well with recorded large food poisoning outbreaks.	[Ercsey-Ravasz, Maria; Toroczkai, Zoltan] Univ Notre Dame, Interdisciplinary Ctr Network Sci & Applicat iCeN, Notre Dame, IN 46556 USA; [Ercsey-Ravasz, Maria; Toroczkai, Zoltan] Univ Notre Dame, Dept Phys, Notre Dame, IN 46556 USA; [Ercsey-Ravasz, Maria] Univ Babes Bolyai, Fac Phys, RO-400084 Cluj Napoca, Romania; [Lakner, Zoltan] Budapest Corvinus Univ, Dept Food Sci, Budapest, Hungary; [Baranyi, Jozsef] AFRC, Inst Food Res, Norwich NR4 7UA, Norfolk, England	University of Notre Dame; University of Notre Dame; Babes Bolyai University from Cluj; Corvinus University Budapest; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Quadram Institute; University of East Anglia	Ercsey-Ravasz, M (corresponding author), Univ Notre Dame, Interdisciplinary Ctr Network Sci & Applicat iCeN, Notre Dame, IN 46556 USA.	jozsef.baranyi@ifr.ac.uk	Baranyi, Jozsef/A-7531-2008; Toroczkai, Zoltan/AAC-8446-2019; Ravasz, Maria Ercsey/E-2098-2017	Baranyi, Jozsef/0000-0001-8360-6021; Toroczkai, Zoltan/0000-0002-6602-2849; Ravasz, Maria Ercsey/0000-0003-4428-9953	US HDTRA [1-09-1-0039]; US NSF [BCS-0826958]; Romanian Government [PN-II-RU-TE-2011-3-0121]; Hungarian Government OTKA [K81594]; BBSRC [IFR-44405A]; Biotechnology and Biological Sciences Research Council [BBS/E/F/00044405] Funding Source: researchfish; BBSRC [BBS/E/F/00044405] Funding Source: UKRI; Direct For Social, Behav & Economic Scie [0826958] Funding Source: National Science Foundation	US HDTRA; US NSF(National Science Foundation (NSF)); Romanian Government(Romanian Government); Hungarian Government OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	Financial support was provided in part by the US HDTRA 1-09-1-0039 (ZT and MER), the US NSF BCS-0826958 (ZT), the Romanian Government PN-II-RU-TE-2011-3-0121 (MER) and the Hungarian Government OTKA K81594 (ZL). BBSRC core fund (IFR-44405A) supported the work of JB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Baskaran T, 2011, INT REV ECON FINANC, V20, P135, DOI 10.1016/j.iref.2010.11.003; Beddington J, 2010, PHILOS T R SOC B, V365, P2767, DOI 10.1098/rstb.2010.0181; Brandes U, 2008, SOC NETWORKS, V30, P136, DOI 10.1016/j.socnet.2007.11.001; Centers for Disease Control and Prevention Website, 2011, INV UPD MULT OUTBR L; Cowden JM, 2001, EPIDEMIOL INFECT, V126, P335, DOI 10.1017/S0950268801005520; Dall'Asta L, 2006, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2006/P04006; Dilley M, 2001, FOOD POLICY, V26, P229, DOI 10.1016/S0306-9192(00)00046-4; Ercsey-Ravasz M., 2011, RANGE LTD CENTRALITY; FAOSTAT, FAOSTAT FOOD BAL SHE; Gilmore R, 2004, NAT BIOTECHNOL, V22, P1503, DOI 10.1038/nbt1204-1503; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Hidalgo CA, 2009, P NATL ACAD SCI USA, V106, P10570, DOI 10.1073/pnas.0900943106; Holme Petter, 2002, Phys Rev E Stat Nonlin Soft Matter Phys, V65, P066109; Kivi M, 2005, EUROSURVEILLANCE, V10, P2847; Kupferschmidt K, 2011, SCIENCE, V332, P1249, DOI 10.1126/science.332.6035.1249; National Institute of Health and Infectious Diseases Control Division Ministry of Health and Welfare Website, 1997, VER PROD ESH COL ENT; Newman M.E.J., 2010, NETWORKS INTRO; Newman MEJ, 2001, PHYS REV E, V64, DOI [10.1103/PhysRevE.64.016131, 10.1103/PhysRevE.64.016132]; Ontario Public Health Division of the Ministry of Health and Long-term Care Website, 2009, CHIEF MED OFF HLTH R; Parfitt J, 2010, PHILOS T R SOC B, V365, P3065, DOI 10.1098/rstb.2010.0126; Serrano M. A., 2007, J ECON INTERACT COOR, V2, P111, DOI DOI 10.1007/S11403-007-0026-Y; Serrano MA, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.015101; Wilkinson K, 2011, PHILOS T R SOC B, V366, P1933, DOI 10.1098/rstb.2010.0415; Woods J, 2010, PHILOS T R SOC B, V365, P2991, DOI 10.1098/rstb.2010.0172	25	118	124	5	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e37810	10.1371/journal.pone.0037810	http://dx.doi.org/10.1371/journal.pone.0037810			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22701535	Green Published, gold, Green Submitted			2022-12-27	WOS:000305338500057
J	Gao, J; Pan, ZL; Jiao, ZA; Li, F; Zhao, GQ; Wei, QQ; Pan, F; Evangelou, E				Gao, Jin; Pan, Zhenglun; Jiao, Zhian; Li, Feng; Zhao, Guoqing; Wei, Qianqian; Pan, Fang; Evangelou, Evangelos			TPH2 Gene Polymorphisms and Major Depression - A Meta-Analysis	PLOS ONE			English	Article							TRYPTOPHAN HYDROXYLASE-2 GENE; OF-FUNCTION MUTATION; HAPLOTYPE ANALYSIS; CANDIDATE GENES; MOOD DISORDERS; NO ASSOCIATION; UNIPOLAR; POPULATION; EPIDEMIOLOGY; RELATIVES	Background: Tryptophan hydroxylase-2 (TPH2) is the rate-limiting enzyme in the synthetic pathway for brain serotonin and is considered key factor for maintaining normal serotonin transmission in the central neuron system (CNS). Gene-disease association studies have reported a relationship between TPH2 and major depressive disorder (MDD) in different populations, however subsequent studies have produced contradictory results. Objectives: We performed a systematic overview and a meta-analysis with all available data up-to-date. Methods: We scrutinized PubMed, Embase, HuGNet and China National Knowledge Infrastructure (CNKI) and last update was held on October 2011. We also searched the manuscripts and the supplementary documents of the published genome-wide association studies in the field. Effect sizes of independent loci that have been studied in more than 3 articles were synthesized using fixed and random effects models. Results: We found 27 eligible articles that studied a total of 74 single nucleotide polymorphisms (SNPs). Finally, 12 independent loci were included in the meta-analysis. The synthesis of the data shown that two SNPs (rs4570625 and rs17110747) were associated with MDD using fixed effects models. SNP rs4570625 had low heterogeneity and remained significant using the more conservative random effects calculations with a summary OR = 0.83 (95% CI: 0.73-0.96). Conclusion: The current study identified a SNP (rs4570625) with strong epidemiological credibility; however more studies are required to provide robust evidence for other weak associations.	[Gao, Jin; Pan, Fang] Shandong Univ, Sch Med, Dept Med Psychol, Jinan, Shandong, Peoples R China; [Gao, Jin; Jiao, Zhian; Zhao, Guoqing; Wei, Qianqian] Shandong Univ, Prov Hosp, Dept Clin Psychol, Jinan, Shandong, Peoples R China; [Pan, Zhenglun; Li, Feng] Shandong Univ, Prov Hosp, Dept Rheumatol, Jinan, Shandong, Peoples R China; [Evangelou, Evangelos] Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, GR-45110 Ioannina, Greece	Shandong University; Shandong University; Shandong University; University of Ioannina	Gao, J (corresponding author), Shandong Univ, Sch Med, Dept Med Psychol, Jinan, Shandong, Peoples R China.	panfang2003@hotmail.com; vangelis@cc.uoi.gr	Pan, Zhenglun/AIA-2501-2022; Evangelou, Evangelos/C-3033-2013	Evangelou, Evangelos/0000-0002-5488-2999	National Natural Science Foundation of China [30801025]; Excellent Young Scientist Foundation of Shandong Province [2006BS03018]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Excellent Young Scientist Foundation of Shandong Province	This work was supported by grants from National Natural Science Foundation of China (www.nsfc.gov.cn) (No. 30801025) and Excellent Young Scientist Foundation of Shandong Province (http://www.sdstc.gov.cn) (No. 2006BS03018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bicalho MA, 2006, MOL PSYCHIATR, V11, P799, DOI 10.1038/sj.mp.4001861; Bierut LJ, 1999, ARCH GEN PSYCHIAT, V56, P557, DOI 10.1001/archpsyc.56.6.557; BLACKER D, 1993, AM J MED GENET, V48, P192, DOI 10.1002/ajmg.1320480405; [曹静 CAO Jing], 2010, [中华行为医学与脑科学杂志, Chinese Journal of Behavioral Medicine and Brain Science], V19, P140; [曹岚 Cao Lan], 2010, [上海交通大学学报. 医学版, Journal of Shanghai Jiaotong University (Medical Science)], V30, P612; Claes S, 2011, PSYCHIAT RES, V188, P355, DOI 10.1016/j.psychres.2011.03.012; Delorme R, 2006, BIOL PSYCHIAT, V60, P202, DOI 10.1016/j.biopsych.2005.12.014; Garriock HA, 2005, MOL PSYCHIATR, V10, P976, DOI 10.1038/sj.mp.4001712; GERSHON ES, 1982, ARCH GEN PSYCHIAT, V39, P1157; Gizatullin R, 2008, J AFFECT DISORDERS, V107, P175, DOI 10.1016/j.jad.2007.07.005; Glatt CE, 2005, NEURON, V48, P704, DOI 10.1016/j.neuron.2005.11.019; Haghighi F, 2008, MOL PSYCHIATR, V13, P813, DOI 10.1038/sj.mp.4002127; Illi A, 2009, NEUROREPORT, V20, P1125, DOI 10.1097/WNR.0b013e32832eb708; Inoue H, 2010, BRAIN RES, V1331, P51, DOI 10.1016/j.brainres.2010.03.057; Ioannidis JPA, 2008, INT J EPIDEMIOL, V37, P120, DOI 10.1093/ije/dym159; Ioannidis JPA, 2007, BRIT MED J, V335, P914, DOI 10.1136/bmj.39343.408449.80; Ioannidis JPA, 2006, NAT GENET, V38, P3, DOI 10.1038/ng0106-3; Jiang W, 2008, CMJD, V24, P1; KENDLER KS, 1993, ARCH GEN PSYCHIAT, V50, P952; Kendler KS, 2001, PSYCHOL MED, V31, P411, DOI 10.1017/S0033291701003622; Kim YK, 2009, BEHAV GENET, V39, P170, DOI 10.1007/s10519-008-9254-8; Kloiber S, 2010, MOL PSYCHIATR, V15, P736, DOI 10.1038/mp.2008.142; Leppanen JM, 2011, J CHILD PSYCHOL PSYC, V52, P1144, DOI 10.1111/j.1469-7610.2011.02391.x; Lin YMJ, 2009, ARCH WOMEN MENT HLTH, V12, P401, DOI 10.1007/s00737-009-0088-z; MAIER W, 1993, INT CLIN PSYCHOPHARM, V8, P27, DOI 10.1097/00004850-199309001-00004; Malhi G S, 2000, Curr Psychiatry Rep, V2, P165, DOI 10.1007/s11920-000-0062-y; Mann JJ, 2008, J AFFECT DISORDERS, V106, P117, DOI 10.1016/j.jad.2007.05.031; MCGUFFIN P, 1991, ARCH GEN PSYCHIAT, V48, P764; Murray CJL, 1996, SCIENCE, V274, P740, DOI 10.1126/science.274.5288.740; Pereira PD, 2011, AM J GERIAT PSYCHIAT, V19, P825, DOI 10.1097/JGP.0b013e31820eeb21; Serretti A, 2011, PSYCHIAT RES, V189, P26, DOI 10.1016/j.psychres.2011.02.001; Shen XH, 2011, J AFFECT DISORDERS, V133, P619, DOI 10.1016/j.jad.2011.04.037; Soronen P, 2011, AM J MED GENET B, V156B, P435, DOI 10.1002/ajmg.b.31179; Sullivan PF, 2000, AM J PSYCHIAT, V157, P1552, DOI 10.1176/appi.ajp.157.10.1552; TORGERSEN S, 1986, ARCH GEN PSYCHIAT, V43, P502; Tsai SJ, 2009, PROG NEURO-PSYCHOPH, V33, P637, DOI 10.1016/j.pnpbp.2009.02.020; Utge S, 2010, AM J MED GENET B, V153B, P468, DOI 10.1002/ajmg.b.31002; Van den Bogaert A, 2005, NEURON, V48, P704, DOI 10.1016/j.neuron.2005.11.017; Van den Bogaert A, 2006, ARCH GEN PSYCHIAT, V63, P1103, DOI 10.1001/archpsyc.63.10.1103; Walther DJ, 2003, SCIENCE, V299, P76, DOI 10.1126/science.1078197; WEISSMAN MM, 1993, J AFFECT DISORDERS, V29, P77, DOI 10.1016/0165-0327(93)90025-F; WEISSMAN MM, 1984, ARCH GEN PSYCHIAT, V41, P13; Xue K, 2010, CJMD, V26, P1; Yoon HK, 2009, PROG NEURO-PSYCHOPH, V33, P403, DOI 10.1016/j.pnpbp.2008.12.013; Zhang C, 2011, J MOL NEUROSCI, V43, P406, DOI 10.1007/s12031-010-9458-2; Zhang XD, 2005, NEURON, V45, P11, DOI 10.1016/j.neuron.2004.12.014; Zhang YQ, 2011, MODERN PREVENTIVE ME, V38; Zhou ZF, 2005, NEURON, V48, P702, DOI 10.1016/j.neuron.2005.11.018; Zhou ZF, 2005, ARCH GEN PSYCHIAT, V62, P1109, DOI 10.1001/archpsyc.62.10.1109; Zill P, 2004, MOL PSYCHIATR, V9, P1030, DOI 10.1038/sj.mp.4001525	50	66	71	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e36721	10.1371/journal.pone.0036721	http://dx.doi.org/10.1371/journal.pone.0036721			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693556	Green Submitted, Green Published, gold			2022-12-27	WOS:000305338500017
J	Liu, DJ; Huang, LP; Wang, YL; Wang, W; Wehrens, XHT; Belousova, T; Abdelrahim, M; DiMattia, G; Sheikh-Hamad, D				Liu, Dajun; Huang, Luping; Wang, Yanlin; Wang, Wei; Wehrens, Xander H. T.; Belousova, Tatiana; Abdelrahim, Maen; DiMattia, Gabriel; Sheikh-Hamad, David			Human Stanniocalcin-1 Suppresses Angiotensin II-Induced Superoxide Generation in Cardiomyocytes through UCP3-Mediated Anti-Oxidant Pathway	PLOS ONE			English	Article							MITOCHONDRIAL UNCOUPLING PROTEINS; METABOLIC GENE-EXPRESSION; FAILING HUMAN HEART; OXIDATIVE-PHOSPHORYLATION; DILATED CARDIOMYOPATHY; ENERGY-METABOLISM; SKELETAL-MUSCLE; TRANSGENIC MICE; CELLS; MEMBRANE	Rationale: We have previously shown increased cardiac stanniocalcin-1 (STC1) in patients with idiopathic dilated cardiomyopathy. STC1 localizes to the inner mitochondrial membrane and transgenic over-expression of STC1 is associated with increased energy utilization. Objective: We examined the hypothesis that STC1 uncouples mitochondrial oxidative phosphorylation - to suppress superoxide generation and modulate neurohormonal effects on cardiomyocytes. Methods and Results: Compared to WT mouse heart, STC1 Tg heart displays: 2-fold higher uncoupling protein 3 (UCP3) levels, but no effect on UCP2 protein; 40% lower ATP levels; but similar activities of respiratory chain complexes I-IV. In cultured adult rat and freshly-isolated mouse cardiomyocytes, rSTC1 induces UCP3, but not UCP2. Treatment of cardiomyocytes with STC1 decreases mitochondrial membrane potential and suppresses baseline and angiotensin II (Ang II)-induced superoxide generation. Furthermore, baseline superoxide generation is higher in freshly-isolated adult UCP3(-/-) mouse cardiomyocytes compared to WT, suggesting an important role for UCP3 in regulating cardiomyocyte ROS under physiologic conditions. Treatment of UCP3(-/-) cardiomyocytes with rSTC1 failed to suppress superoxide generation, suggesting that the effects of STC1 on superoxide generation in cardiomyocytes are UCP3-dependent. Conclusion: STC1 activates a novel anti-oxidant pathway in cardiac myocytes through induction of UCP3, and may play an important role in suppressing ROS in the heart under normal physiologic conditions and ameliorate the deleterious effects of Ang II-mediated cardiac injury. Importantly, our data point to a critical role for the mitochondria in regulating ROS generation in response to Ang II.	[Liu, Dajun; Huang, Luping; Wang, Yanlin; Belousova, Tatiana; Sheikh-Hamad, David] Baylor Coll Med, Dept Med, Div Nephrol, Houston, TX 77030 USA; [Wang, Wei; Wehrens, Xander H. T.] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA; [Abdelrahim, Maen] Univ Texas MD Anderson Canc Ctr, Canc Res Inst, Orlando, FL USA; [DiMattia, Gabriel] Univ Western Ontario, Dept Oncol, London, ON, Canada; [DiMattia, Gabriel] Univ Western Ontario, Dept Biochem, London, ON, Canada	Baylor College of Medicine; Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center; Western University (University of Western Ontario); Western University (University of Western Ontario)	Liu, DJ (corresponding author), China Med Univ, Sheng Jing Hosp, Shenyang, Peoples R China.	lupingh@bcm.edu; sheikh@bcm.tmc.edu	Wehrens, Xander/AAQ-9574-2020	Wehrens, Xander/0000-0001-5044-672X	National Institute of Health [R01-DK080306, R01-HL089598, T32 DK62703, R01-HL091947]; American Heart Association [0455120Y]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089598, R01HL091947] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080306] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institute of Health grants R01-DK080306, R01-HL089598, T32 DK62703, and R01-HL091947; American Heart Association Grant-in-Aid #0455120Y. Dr. Wehrens is a W.M. Keck Foundation Distinguished Young Scholar in Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arsenijevic D, 2000, NAT GENET, V26, P435, DOI 10.1038/82565; Beer M, 2002, J AM COLL CARDIOL, V40, P1267, DOI 10.1016/S0735-1097(02)02160-5; Brand MD, 2005, CELL METAB, V2, P85, DOI 10.1016/j.cmet.2005.06.002; Clapham JC, 2000, NATURE, V406, P415, DOI 10.1038/35019082; Cline GW, 2001, J BIOL CHEM, V276, P20240, DOI 10.1074/jbc.M102540200; Elkayam U, 1998, CARDIOLOGY, V89, P38, DOI 10.1159/000047278; Ellard JP, 2007, MOL CELL ENDOCRINOL, V264, P90, DOI 10.1016/j.mce.2006.10.008; Filvaroff EH, 2002, ENDOCRINOLOGY, V143, P3681, DOI 10.1210/en.2001-211424; Fosslien E, 2003, ANN CLIN LAB SCI, V33, P371; Gong DW, 2000, J BIOL CHEM, V275, P16251, DOI 10.1074/jbc.M910177199; Huang LP, 2009, AM J PATHOL, V174, P1368, DOI 10.2353/ajpath.2009.080476; Jacobson SL, 1989, ISOLATED ADULT CARDI, P43; James K, 2005, KIDNEY INT, V67, P477, DOI 10.1111/j.1523-1755.2005.67104.x; Jellinek DA, 2000, BIOCHEM J, V350, P453, DOI 10.1042/0264-6021:3500453; Jiang N, 2009, FREE RADICAL BIO MED, V46, P138, DOI 10.1016/j.freeradbiomed.2008.09.026; Kim-Han JS, 2005, ANTIOXID REDOX SIGN, V7, P1173, DOI 10.1089/ars.2005.7.1173; Korshunov SS, 1997, FEBS LETT, V416, P15, DOI 10.1016/S0014-5793(97)01159-9; LI YB, 1995, NAT GENET, V11, P376, DOI 10.1038/ng1295-376; Lu ZJ, 2009, CIRCULATION, V120, P318, DOI 10.1161/CIRCULATIONAHA.109.873380; Luo CW, 2004, MOL ENDOCRINOL, V18, P2085, DOI 10.1210/me.2004-0066; McCudden CR, 2002, J BIOL CHEM, V277, P45249, DOI 10.1074/jbc.M205954200; MOHAZZAB HK, 1997, CIRCULATION, V96, P614; Murray AJ, 2004, LANCET, V364, P1786, DOI 10.1016/S0140-6736(04)17402-3; Neubauer S, 1997, CIRCULATION, V96, P2190; NOHL H, 1987, FEBS LETT, V214, P269, DOI 10.1016/0014-5793(87)80068-6; Poindexter BJ, 2001, CELL CALCIUM, V30, P373, DOI 10.1054/ceca.2001.0249; Razeghi P, 2002, CARDIOLOGY, V97, P203, DOI 10.1159/000063122; Razeghi P, 2001, CIRCULATION, V104, P2923, DOI 10.1161/hc4901.100526; Re RN, 2010, AM J PHYSIOL-HEART C, V299, pH577, DOI 10.1152/ajpheart.00421.2010; Rousset S, 2004, DIABETES, V53, pS130, DOI 10.2337/diabetes.53.2007.S130; Sack MN, 2006, CARDIOVASC RES, V72, P210, DOI 10.1016/j.cardiores.2006.07.010; SAKS VA, 1985, J BIOL CHEM, V260, P7757; Sazonova O, 2008, AM J PHYSIOL-RENAL, V294, pF788, DOI 10.1152/ajprenal.00553.2007; Sheikh-Hamad D, 2003, AM J PHYSIOL-HEART C, V285, pH442, DOI 10.1152/ajpheart.01071.2002; Sheikh-Hamad D, 2010, AM J PHYSIOL-RENAL, V298, pF248, DOI 10.1152/ajprenal.00260.2009; Sorescu Dan, 2002, Congest Heart Fail, V8, P132, DOI 10.1111/j.1527-5299.2002.00717.x; SOTTOCASA GL, 1967, J CELL BIOL, V32, P415, DOI 10.1083/jcb.32.2.415; Taegtmeyer H, 2002, CIRCULATION, V106, P2043, DOI 10.1161/01.CIR.0000036760.42319.3F; Thompson MP, 2004, FEBS LETT, V568, P4, DOI 10.1016/j.febslet.2004.05.011; Varghese R, 1998, ENDOCRINOLOGY, V139, P4714, DOI 10.1210/en.139.11.4714; Varghese R, 2002, ENDOCRINOLOGY, V143, P868, DOI 10.1210/en.143.3.868; Vidal-Puig AJ, 2000, J BIOL CHEM, V275, P16258, DOI 10.1074/jbc.M910179199; Wang YL, 2009, J LEUKOCYTE BIOL, V86, P981, DOI 10.1189/jlb.0708454; Westberg JA, 2007, AM J PHYSIOL-HEART C, V293, pH1766, DOI 10.1152/ajpheart.00017.2007; Wiedemann FR, 2002, J NEUROCHEM, V80, P616, DOI 10.1046/j.0022-3042.2001.00731.x; Wu SL, 2005, FREE RADICAL BIO MED, V39, P1601, DOI 10.1016/j.freeradbiomed.2005.08.006; Zhang JL, 1998, PROTEIN EXPRES PURIF, V12, P390, DOI 10.1006/prep.1997.0857; [No title captured]	48	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e36994	10.1371/journal.pone.0036994	http://dx.doi.org/10.1371/journal.pone.0036994			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693564	Green Published, Green Submitted, gold			2022-12-27	WOS:000305338500026
J	Riegl, BM; Bruckner, AW; Rowlands, GP; Purkis, SJ; Renaud, P				Riegl, Bernhard M.; Bruckner, Andrew W.; Rowlands, Gwilym P.; Purkis, Sam J.; Renaud, Philip			Red Sea Coral Reef Trajectories over 2 Decades Suggest Increasing Community Homogenization and Decline in Coral Size	PLOS ONE			English	Article							QUANTITATIVE-ANALYSIS; CLIMATE-CHANGE; DISTRIBUTIONS; PARAMETERS; GROWTH	Three independent line intercept transect surveys on northern Red Sea reef slopes conducted in 1988/9 and 1997/8 in Egypt and from 2006-9 in Saudi Arabia were used to compare community patterns and coral size. Coral communities showed scale-dependent variability, highest at fine spatial and taxonomic scale (species-specific within and among reef patterns). At coarser scale (generic pattern across regions), patterns were more uniform (regionally consistent generic dominance on differently exposed reef slopes and at different depths). Neither fine-nor coarse-scale patterns aligned along the sampled 1700 km latitudinal gradient. Thus, a latitudinal gradient that had been described earlier from comparable datasets, separating the Red Sea into three faunistic zones, was no longer apparent. This may indicate subtle changes in species distributions. Coral size, measured as corrected average intercept of corals in transects, had decreased from 1997 to 2009, after having remained constant from 1988 to 1997. Recruitment had remained stable (similar to 12 juvenile corals per m(2)). Size distributions had not changed significantly but large corals had declined over 20 years. Thus, data from a wide range of sites taken over two decades support claims by others that climate change is indeed beginning to show clear effects on Red Sea reefs.	[Riegl, Bernhard M.; Rowlands, Gwilym P.; Purkis, Sam J.] Nova SE Univ, Natl Coral Reef Inst, Dania, FL USA; [Bruckner, Andrew W.; Renaud, Philip] Khaled Bin Sultan Living Oceans Fdn, Landover, MD USA	Nova Southeastern University	Riegl, BM (corresponding author), Nova SE Univ, Natl Coral Reef Inst, Dania, FL USA.	rieglb@nova.edu	Purkis, Sam/B-8552-2013	Riegl, Bernhard/0000-0002-6003-9324	Khlaed bin Sultan Living Oceans Foundation	Khlaed bin Sultan Living Oceans Foundation	The previous funding source was the Khlaed bin Sultan Living Oceans Foundation, www.livingoceansfoundation.org. There are no current external funding sources for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronson RB, 2005, ECOLOGY, V86, P2586, DOI 10.1890/05-0045; Cantin NE, 2010, SCIENCE, V329, P322, DOI 10.1126/science.1190182; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; DeVantier L., 2000, P INT WORKSH EXT IMP; DeVantier Lyndon, 2000, Fauna of Arabia, V18, P23; Edwards AJ, 1987, RED SEA KEYS ENV; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hughes TP, 2012, CURR BIOL, V22, P736, DOI 10.1016/j.cub.2012.02.068; Jameson S. C., 2007, Journal of Sustainable Tourism, V15, P309, DOI 10.2167/jost719.0; Jongman RHG, 1995, DATA ANAL COMMUNITY; Klaus R, 2008, P 11 INT COR REEF S, P722; Kleemann K., 1992, Facies, V26, P1, DOI 10.1007/BF02539790; Loya Y, 2004, CORAL HEALTH AND DISEASE, P1; LOYA Y, 1972, MAR BIOL, V13, P100, DOI 10.1007/BF00366561; Loya Y, 1971, S ZOOL SOC LONDON, V28, P117; Loya Y, 1978, UNESCO MONOGRAPHS OC, V5, P197; MARSH LM, 1984, CORAL REEFS, V2, P175; MERGNER H, 1985, HELGOLANDER MEERESUN, V39, P375, DOI 10.1007/BF01987409; Mergner H., 1992, P 7 INT COR REEF S G, V1, P104; Ormond R.F.G., 1984, REPORT DISTRIBUTION; ORMOND RFG, 1973, NATURE, V246, P167, DOI 10.1038/246167a0; Pratchett MS, 2007, PAC SCI, V61, P113, DOI 10.1353/psc.2007.0011; Reinicke GB, 2003, FACIES, V49, P271; RIEGL B, 1991, HYDROBIOLOGIA, V216, P249, DOI 10.1007/BF00026471; Riegl B, 1999, CORAL REEFS, V18, P241, DOI 10.1007/s003380050188; Riegl B, 1997, FACIES, V36, P141, DOI 10.1007/BF02536881; Riegl B, 1998, MAR POLLUT BULL, V37, P488; RIEGL B, 1994, MAR ECOL-P S Z N I, V15, P213, DOI 10.1111/j.1439-0485.1994.tb00054.x; Rowlands G, 2012, MAR POLLUT BULL, V64, P1222, DOI 10.1016/j.marpolbul.2012.03.003; SCHUHMACHER H, 1985, HELGOLANDER MEERESUN, V39, P419, DOI 10.1007/BF01987411; Schuhmacher Helmut, 1995, Beitraege zur Palaeontologie, V20, P89; Sheppard C.R.C., 1985, Fauna of Saudi Arabia, V7, P37; Sheppard C.R.C., 1985, Fauna of Saudi Arabia, V7, P17; Sheppard C. R. C., 1991, FAUNA SAUDI ARABIA, V12, P170; Tilot de Grissac V, 2000, P 9 INT COR REE S, V2, P867; VELIMIROV B, 1974, HELGOLAND WISS MEER, V26, P18, DOI 10.1007/BF01613302; Veron J.E.N., 2000, CORALS WORLD, V1-3; Zvuloni A, 2008, LIMNOL OCEANOGR-METH, V6, P144, DOI 10.4319/lom.2008.6.144; [No title captured]	39	53	53	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38396	10.1371/journal.pone.0038396	http://dx.doi.org/10.1371/journal.pone.0038396			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693620	Green Published, Green Submitted, gold			2022-12-27	WOS:000305338500143
J	Cantarel, BL; Lombard, V; Henrissat, B				Cantarel, Brandi L.; Lombard, Vincent; Henrissat, Bernard			Complex Carbohydrate Utilization by the Healthy Human Microbiome	PLOS ONE			English	Article							GUT MICROBIOME; CLASSIFICATION; METAGENOMICS; CELLULOSOMES; DEGRADATION; BACTERIA; GENOMES	The various ecological habitats in the human body provide microbes a wide array of nutrient sources and survival challenges. Advances in technology such as DNA sequencing have allowed a deeper perspective into the molecular function of the human microbiota than has been achievable in the past. Here we aimed to examine the enzymes that cleave complex carbohydrates (CAZymes) in the human microbiome in order to determine (i) whether the CAZyme profiles of bacterial genomes are more similar within body sites or bacterial families and (ii) the sugar degradation and utilization capabilities of microbial communities inhabiting various human habitats. Upon examination of 493 bacterial references genomes from 12 human habitats, we found that sugar degradation capabilities of taxa are more similar to others in the same bacterial family than to those inhabiting the same habitat. Yet, the analysis of 520 metagenomic samples from five major body sites show that even when the community composition varies the CAZyme profiles are very similar within a body site, suggesting that the observed functional profile and microbial habitation have adapted to the local carbohydrate composition. When broad sugar utilization was compared within the five major body sites, the gastrointestinal track contained the highest potential for total sugar degradation, while dextran and peptidoglycan degradation were highest in oral and vaginal sites respectively. Our analysis suggests that the carbohydrate composition of each body site has a profound influence and probably constitutes one of the major driving forces that shapes the community composition and therefore the CAZyme profile of the local microbial communities, which in turn reflects the microbiome fitness to a body site.	[Cantarel, Brandi L.] Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 21201 USA; [Lombard, Vincent; Henrissat, Bernard] Aix Marseille Univ, Ctr Natl Rech Sci, Marseille, France	University System of Maryland; University of Maryland Baltimore; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Cantarel, BL (corresponding author), Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 21201 USA.	bcantarel@som.umaryland.edu	Henrissat, Bernard/J-2475-2012; Cantarel, Brandi/ABF-5756-2020	Henrissat, Bernard/0000-0002-3434-8588; Cantarel, Brandi/0000-0003-4126-4478; Lombard, Vincent/0000-0002-9684-7067	National Institutes of Health [1U01HG004866-01]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004866] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	The data analysis was funded by National Institutes of Health grant number 1U01HG004866-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abubucker S, 2011, PLOS COMP B IN PRESS; [Anonymous], 1957, KONGELIGE DANSKE VID; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Bayer EA, 2004, ANNU REV MICROBIOL, V58, P521, DOI 10.1146/annurev.micro.57.030502.091022; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Brulc JM, 2009, P NATL ACAD SCI USA, V106, P1948, DOI 10.1073/pnas.0806191105; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Carpita NC, 1996, ANNU REV PLANT PHYS, V47, P445, DOI 10.1146/annurev.arplant.47.1.445; Consortium HMP, 2011, NATURE UNPUB; Fontes CMGA, 2010, ANNU REV BIOCHEM, V79, P655, DOI 10.1146/annurev-biochem-091208-085603; Gilbert HJ, 2010, PLANT PHYSIOL, V153, P444, DOI 10.1104/pp.110.156646; Gorshkova TA, 1996, PLANT PHYSIOL, V110, P721, DOI 10.1104/pp.110.3.721; Hehemann JH, 2010, NATURE, V464, P908, DOI 10.1038/nature08937; Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; HENRISSAT B, 1985, BIO-TECHNOL, V3, P722, DOI 10.1038/nbt0885-722; HENRISSAT B, 1995, P NATL ACAD SCI USA, V92, P7090, DOI 10.1073/pnas.92.15.7090; Hess M, 2011, SCIENCE, V331, P463, DOI 10.1126/science.1200387; Hooper LV, 2002, ANNU REV NUTR, V22, P283, DOI 10.1146/annurev.nutr.22.011602.092259; Hu YN, 2002, CHEM BIOL, V9, P1287, DOI 10.1016/S1074-5521(02)00295-8; Jones BV, 2007, NAT METHODS, V4, P55, DOI 10.1038/NMETH964; LAINE RA, 1994, GLYCOBIOLOGY, V4, P759, DOI 10.1093/glycob/4.6.759; Lozupone CA, 2008, P NATL ACAD SCI USA, V105, P15076, DOI 10.1073/pnas.0807339105; Nelson KE, 2010, SCIENCE, V328, P994, DOI 10.1126/science.1183605; Nomenclature Committee of the International Union of Biochemistry and Molecular Biology (NC-IUBMB), 1999, EUROPEAN J BIOCH, V264, P610; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Roberts AP, 2008, PLASMID, V60, P167, DOI 10.1016/j.plasmid.2008.08.001; Suen G, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001129; Tamames J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-136; Tasse L, 2010, GENOME RES, V20, P1605, DOI 10.1101/gr.108332.110; Topping DL, 2001, PHYSIOL REV, V81, P1031, DOI 10.1152/physrev.2001.81.3.1031; Turnbaugh PJ, 2010, ACTA CRYSTALLOGR F, V66, P1261, DOI 10.1107/S1744309110029088; Turnbaugh PJ, 2010, P NATL ACAD SCI USA, V107, P7503, DOI 10.1073/pnas.1002355107; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Varki A, 2009, HIST BACKGROUND OVER; Varki Ajit, 1999; WANG TCV, 1991, BIOCHIMIE, V73, P335, DOI 10.1016/0300-9084(91)90221-L; Warnecke F, 2007, NATURE, V450, P560, DOI 10.1038/nature06269; White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352; Xu J, 2003, SCIENCE, V299, P2074, DOI 10.1126/science.1080029; Xu J, 2007, PLOS BIOL, V5, P1574, DOI 10.1371/journal.pbio.0050156	42	214	225	5	109	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e28742	10.1371/journal.pone.0028742	http://dx.doi.org/10.1371/journal.pone.0028742			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22719820	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341900003
J	Catarino, R; Coelho, A; Araujo, A; Gomes, M; Nogueira, A; Lopes, C; Medeiros, R				Catarino, Raquel; Coelho, Ana; Araujo, Antonio; Gomes, Monica; Nogueira, Augusto; Lopes, Carlos; Medeiros, Rui			Circulating DNA: Diagnostic Tool and Predictive Marker for Overall Survival of NSCLC Patients	PLOS ONE			English	Article							CELL LUNG-CANCER; MESSENGER-RNA EXPRESSION; PLASMA DNA; NUCLEIC-ACIDS; TUMOR DNA; QUANTITATIVE-ANALYSIS; PROGNOSTIC VALUE; FOLLOW-UP; QUANTIFICATION; SERUM	Purpose: The purpose of our study was to determine whether the amounts of circulating DNA (cDNA) could discriminate between NSCLC patients and healthy individuals and assess its value as a prognostic marker of this disease. Methods: We conducted a study of 309 individuals and the cDNA levels were assessed through real-time PCR methodology. Results: We found increased cDNA levels in NSCLC patients compared to control individuals. We also found a decreased overall survival time in patients presenting high cDNA levels, when compared to lower cDNA concentrations. Conclusions: Quantification of cDNA may be a good tool for NSCLC detection with potential for clinical applicability.	[Catarino, Raquel; Coelho, Ana; Gomes, Monica; Nogueira, Augusto; Lopes, Carlos; Medeiros, Rui] Portuguese Inst Oncol, Mol Oncol Grp Invest Ctr, Oporto, Portugal; [Araujo, Antonio] Portuguese Inst Oncol, Dept Med Oncol, Oporto, Portugal; [Lopes, Carlos; Medeiros, Rui] Abel Salazar Inst Biomed Sci, Oporto, Portugal; [Medeiros, Rui] Portuguese League Canc N, Res Dept, Oporto, Portugal; [Medeiros, Rui] Fernando Pessoa Univ, CEBIMED, Fac Hlth Sci, Oporto, Portugal	Universidade de Coimbra; Universidade de Coimbra; Universidade do Porto; Universidade Fernando Pessoa	Catarino, R (corresponding author), Portuguese Inst Oncol, Mol Oncol Grp Invest Ctr, Oporto, Portugal.	raquelcatarino@yahoo.com	Medeiros, Rui/C-7938-2009; Araújo, António/B-5047-2008	Medeiros, Rui/0000-0003-3010-8373; Araújo, António/0000-0002-7267-3584; Lopes, Carlos/0000-0003-3209-8447; Catarino, Raquel/0000-0001-6320-0788; Gomes, Monica/0000-0001-9947-5775	Ministry of Health of Portugal; Ministery of Science, Technology and Superior Education-FCT (Fundacao para a Ciencia e Tecnologia) [SFRH/BPD/72932/2010]	Ministry of Health of Portugal; Ministery of Science, Technology and Superior Education-FCT (Fundacao para a Ciencia e Tecnologia)	The authors acknowledge funding of this work by the Ministry of Health of Portugal. The authors also gratefully acknowledge the financial support of an individual post-doctoral grant of the first author from the Ministery of Science, Technology and Superior Education-FCT (Fundacao para a Ciencia e Tecnologia: SFRH/BPD/72932/2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anker P, 1999, CANCER METAST REV, V18, P65, DOI 10.1023/A:1006260319913; Beau-Faller M, 2003, INT J CANCER, V105, P361, DOI 10.1002/ijc.11079; Bremnes RM, 2005, LUNG CANCER, V49, P1, DOI 10.1016/j.lungcan.2004.12.008; Brundage MD, 2002, CHEST, V122, P1037, DOI 10.1378/chest.122.3.1037; Bunn PA, 2003, J CLIN ONCOL, V21, P3891, DOI 10.1200/JCO.2003.07.976; BURKI E, 1948, OPHTHALMOLOGICA, V115, P241; Catarino R, 2008, BIOCHEM BIOPH RES CO, V370, P118, DOI 10.1016/j.bbrc.2008.03.039; Catarino R, 2007, EJC SUPPL, V5, P184; de Geus-Oei LF, 2007, CANCER-AM CANCER SOC, V110, P1654, DOI 10.1002/cncr.22979; Diehl F, 2005, P NATL ACAD SCI USA, V102, P16368, DOI 10.1073/pnas.0507904102; Esteller M, 1999, CANCER RES, V59, P67; Fleischhacker M, 2007, BBA-REV CANCER, V1775, P181, DOI 10.1016/j.bbcan.2006.10.001; Frattini M, 2005, J CLIN ONCOL, V23, P3163, DOI 10.1200/JCO.2005.05.430; Gal S, 2004, BRIT J CANCER, V90, P1211, DOI 10.1038/sj.bjc.6601609; Gautschi O, 2004, J CLIN ONCOL, V22, P4157, DOI 10.1200/JCO.2004.11.123; Gormally E, 2007, MUTAT RES-REV MUTAT, V635, P105, DOI 10.1016/j.mrrev.2006.11.002; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Herrera LJ, 2005, CLIN CHEM, V51, P113, DOI 10.1373/clinchem.2004.039263; Huang ZH, 2006, CANCER LETT, V243, P64, DOI 10.1016/j.canlet.2005.11.027; Jackman DM, 2005, LANCET, V366, P1385, DOI 10.1016/S0140-6736(05)67569-1; Johnson PJ, 2002, CLIN CHEM, V48, P1186; Laktionov PP, 2004, NUCLEOS NUCLEOT NUCL, V23, P879, DOI 10.1081/NCN-200026035; LEON SA, 1977, CANCER RES, V37, P646; Lo YMD, 1999, AM J HUM GENET, V64, P218, DOI 10.1086/302205; MAO L, 1994, CANCER RES, V54, P1634; Metzger R, 2009, ANTICANCER RES, V29, P1157; Paci M, 2009, LUNG CANCER, V64, P92, DOI 10.1016/j.lungcan.2008.07.012; Pathak AK, 2006, CLIN CHEM, V52, P1833, DOI 10.1373/clinchem.2005.062893; Sethi T, 2002, THORAX, V57, P992, DOI 10.1136/thorax.57.11.992; Silva JM, 2002, CLIN CANCER RES, V8, P3761; Silva JM, 2002, GUT, V50, P530, DOI 10.1136/gut.50.4.530; Skvortsova TE, 2006, BRIT J CANCER, V94, P1492, DOI 10.1038/sj.bjc.6603117; Sozzi G, 2005, J NATL CANCER I, V97, P1848, DOI 10.1093/jnci/dji432; Sozzi G, 2003, J CLIN ONCOL, V21, P3902, DOI 10.1200/JCO.2003.02.006; Sozzi G, 2001, CANCER RES, V61, P4675; Sozzi G, 2009, AM J RESP CRIT CARE, V179, P69, DOI 10.1164/rccm.200807-1068OC; Van den Berg RM, 2010, INT J ONCOL, V37, P455, DOI 10.3892/ijo_00000694; van der Drift MA, 2010, LUNG CANCER, V68, P283, DOI 10.1016/j.lungcan.2009.06.021; Wakelee HA, 2006, CANCER-AM CANCER SOC, V106, P2208, DOI 10.1002/cncr.21869; Xie GS, 2004, CHINESE MED J-PEKING, V117, P1485; Zhang RF, 2010, LUNG CANCER, V69, P225, DOI 10.1016/j.lungcan.2009.11.009; Ziegler A, 2002, CANCER TREAT REV, V28, P255, DOI 10.1016/S0305-7372(02)00077-4	42	53	57	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2012	7	6							e38559	10.1371/journal.pone.0038559	http://dx.doi.org/10.1371/journal.pone.0038559			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UJ	22701665	gold, Green Published, Green Submitted			2022-12-27	WOS:000305340000032
J	Menzaghi, C; Salvemini, L; Fini, G; Thompson, R; Mangiacotti, D; Di Paola, R; Morini, E; Giorelli, M; De Bonis, C; De Cosmo, S; Doria, A; Trischitta, V				Menzaghi, Claudia; Salvemini, Lucia; Fini, Grazia; Thompson, Ryan; Mangiacotti, Davide; Di Paola, Rosa; Morini, Eleonora; Giorelli, Maddalena; De Bonis, Concetta; De Cosmo, Salvatore; Doria, Alessandro; Trischitta, Vincenzo			Serum Resistin and Kidney Function: A Family-Based Study in Non-Diabetic, Untreated Individuals	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; INSULIN-RESISTANCE; RENAL-FUNCTION; CARDIOVASCULAR-DISEASE; CIRCULATING RESISTIN; ADIPONECTIN; ASSOCIATION; CAUCASIANS; INFLAMMATION; LEPTIN	Background: High serum resistin levels have been associated with kidney dysfunction. Most of these studies have been carried out in individuals with severe kidney impairment, diabetes, cardiovascular disease and related treatments. Thus, the observed association might have been influenced by these confounders. Our aim was to study the relationship between serum resistin, urinary albumin/creatinine ratio (ACR) and glomerular filtration rate (GFR) in a family-based sample, the Gargano Family Study (GFS) of 635 non diabetic, untreated Whites. Methods: A linear mixed effects model and bivariate analyses were used to evaluate the phenotypic and genetic relations between serum resistin and both ACR and eGFR. All analyses were adjusted for sex, age, age squared, BMI, systolic blood pressure, smoking habits and physical exercise. Results: After adjustments, resistin levels were slightly positively associated with ACR (beta +/- SE = 0.049 +/- 0.023, p = 0.035) and inversely related to eGFR (beta +/- SE = 21.43 +/- 0.61, p = 0.018) levels. These associations remained significant when either eGFR or ACR were, reciprocally, added as covariates. A genetic correlation (rho g = -0.31 +/- 0.12; adjusted p = 0.013) was observed between resistin and eGFR (but not ACR) levels. Conclusion: Serum resistin levels are independently associated with ACR and eGFR in untreated non-diabetic individuals. Serum resistin and eGFR share also some common genetic background. Our data strongly suggest that resistin plays a role in modulating kidney function.	[Menzaghi, Claudia; Salvemini, Lucia; Fini, Grazia; Mangiacotti, Davide; Di Paola, Rosa; Morini, Eleonora; Giorelli, Maddalena; De Bonis, Concetta; Trischitta, Vincenzo] IRCCS Casa Sollievo Sofferenza San Giovanni Roton, Res Unit Diabet & Endocrine Dis, San Giovanni Rotondo, Italy; [Thompson, Ryan; Doria, Alessandro] Joslin Diabet Ctr, Div Res, Boston, MA 02215 USA; [De Cosmo, Salvatore] IRCCS Casa Sollievo Sofferenza, Unit Endocrinol, San Giovanni Rotondo, Italy; [Doria, Alessandro] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Trischitta, Vincenzo] IRCSS Casa Sollievo Sofferenza,Rome, Mendel Lab, Rome, Italy; [Trischitta, Vincenzo] Univ Roma La Sapienza, Dept Expt Med, I-00185 Rome, Italy	IRCCS Casa Sollievo Della Sofferenza; Harvard University; Joslin Diabetes Center, Inc.; IRCCS Casa Sollievo Della Sofferenza; Harvard University; Harvard Medical School; IRCCS Casa Sollievo Della Sofferenza; Istituto CSS Mendel; Sapienza University Rome	Menzaghi, C (corresponding author), IRCCS Casa Sollievo Sofferenza San Giovanni Roton, Res Unit Diabet & Endocrine Dis, San Giovanni Rotondo, Italy.	c.menzaghi@operapadrepio.it; v.trischitta@operapadrepio.it	Salvemini, Lucia/K-2121-2016; De Cosmo, Salvatore/J-7420-2016; Trischitta, Vincenzo/K-1487-2016; mangiacotti, davide/AAM-8142-2020; fini, grazia/AAM-3320-2020; DE BONIS, CONCETTA/AAM-8146-2020; Menzaghi, Claudia/J-7210-2016; Di Paola, Rosa/G-7813-2011; Doria, Alessandro/H-9157-2018	Salvemini, Lucia/0000-0001-8776-9477; De Cosmo, Salvatore/0000-0001-8787-8286; Trischitta, Vincenzo/0000-0003-1174-127X; Menzaghi, Claudia/0000-0002-7438-8955; Di Paola, Rosa/0000-0001-5837-9111; Doria, Alessandro/0000-0002-3830-4304	Accordo Programma Quadro in Materia di Ricerca Scientifica nella Regione Puglia-PST; Italian Ministry of Health [RC2011]; EFSD/Pfizer; National Institutes of Health [HL073168]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073168] Funding Source: NIH RePORTER	Accordo Programma Quadro in Materia di Ricerca Scientifica nella Regione Puglia-PST; Italian Ministry of Health(Ministry of Health, Italy); EFSD/Pfizer(Pfizer); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by Accordo Programma Quadro in Materia di Ricerca Scientifica nella Regione Puglia-PST 2006, an Italian Ministry of Health grant (RC2011), a EFSD/Pfizer grant (C. M.) and National Institutes of Health grant HL073168 (A. D.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; Almasy L., 2010, COLD SPRING HARB PRO; Axelsson J, 2006, KIDNEY INT, V69, P596, DOI 10.1038/sj.ki.5000089; Chen CY, 2010, AM J PHYSIOL-HEART C, V299, pH193, DOI 10.1152/ajpheart.00431.2009; COMUZZIE AG, 1994, INT J OBESITY, V18, P413; De Cosmo S, 2006, DIABETES CARE, V29, P432, DOI 10.2337/diacare.29.02.06.dc05-1841; Diez JJ, 2005, CLIN ENDOCRINOL, V62, P242, DOI 10.1111/j.1365-2265.2005.02207.x; Ellington AA, 2007, HYPERTENSION, V50, P708, DOI 10.1161/HYPERTENSIONAHA.107.095257; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Kawamura R, 2010, NEPHROL DIAL TRANSPL, V25, P3236, DOI 10.1093/ndt/gfq155; Koh KK, 2010, INT J CARDIOL, V140, P73, DOI 10.1016/j.ijcard.2008.11.017; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Ma XW, 2002, J CLIN ENDOCR METAB, V87, P4407, DOI 10.1210/jc.2002-020109; Menzaghi C, 2010, J INTERN MED, V267, P287, DOI 10.1111/j.1365-2796.2009.02141.x; Menzaghi C, 2010, DIABETOLOGIA, V53, P226, DOI 10.1007/s00125-009-1589-z; Menzaghi C, 2011, DIABETOLOGIA; Menzaghi C, 2006, J CLIN ENDOCR METAB, V91, P2792, DOI 10.1210/jc.2005-2715; Nusken KD, 2006, NEPHROL DIAL TRANSPL, V21, P107, DOI 10.1093/ndt/gfi084; Osawa H, 2004, AM J HUM GENET, V75, P678, DOI 10.1086/424761; Ott J, 2011, NAT REV GENET, V12, P465, DOI 10.1038/nrg2989; Pajvani UB, 2004, J BIOL CHEM, V279, P12152, DOI 10.1074/jbc.M311113200; Reilly MP, 2005, CIRCULATION, V111, P932, DOI 10.1161/01.CIR.0000155620.10387.43; Risch L, 2007, CLIN CHIM ACTA, V376, P108, DOI 10.1016/j.cca.2006.07.026; Scherer PE, 2006, DIABETES, V55, P1537, DOI 10.2337/db06-0263; Stenvinkel P, 2010, J INTERN MED, V268, P456, DOI 10.1111/j.1365-2796.2010.02269.x; Tsioufis C, 2010, AM J HYPERTENS, V23, P681, DOI 10.1038/ajh.2010.34; von Eynatten M, 2005, DIABETES CARE, V28, P754, DOI 10.2337/diacare.28.3.754; Yilmaz MI, 2007, CLIN NEPHROL, V68, P1; Zoccali C, 2008, NEPHROL DIAL TRANSPL, V23, P783, DOI 10.1093/ndt/gfm924; Zoccali C, 2008, NEPHROL DIAL TRANSPL, V23, P3767, DOI 10.1093/ndt/gfn517	30	24	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2012	7	6							e38414	10.1371/journal.pone.0038414	http://dx.doi.org/10.1371/journal.pone.0038414			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UJ	22701635	Green Submitted, gold, Green Published			2022-12-27	WOS:000305340000021
J	Casellas, J; Varona, L				Casellas, Joaquim; Varona, Luis			Modeling Skewness in Human Transcriptomes	PLOS ONE			English	Article							GENE-EXPRESSION DATA; MICROARRAY DATA; DIFFERENTIAL EXPRESSION; DISTRIBUTIONS; CELLS	Gene expression data are influenced by multiple biological and technological factors leading to a wide range of dispersion scenarios, although skewed patterns are not commonly addressed in microarray analyses. In this study, the distribution pattern of several human transcriptomes has been studied on free-access microarray gene expression data. Our results showed that, even in previously normalized gene expression data, probe and differential expression within probe effects suffer from substantial departures from the commonly assumed symmetric Gaussian distribution. We developed a flexible mixed model for non-competitive microarray data analysis that accounted for asymmetric and heavy-tailed (Student's t distribution) dispersion processes. Random effects for gene expression data were modeled under asymmetric Student's t distributions where the asymmetry parameter (lambda) took values from perfect symmetry (lambda = 0) to right-(lambda > 0) or left-side (lambda > 0) over-expression patterns. This approach was applied to four free-access human data sets and revealed clearly better model performance when comparing with standard approaches accounting for traditional symmetric Gaussian distribution patterns. Our analyses on human gene expression data revealed a substantial degree of right-hand asymmetry for probe effects, whereas differential gene expression addressed both symmetric and left-hand asymmetric patterns. Although these results cannot be extrapolated to all microarray experiments, they highlighted the incidence of skew dispersion patterns in human transcriptome; moreover, we provided a new analytical approach to appropriately address this biological phenomenon. The source code of the program accommodating these analytical developments and additional information about practical aspects on running the program are freely available by request to the corresponding author of this article.	[Casellas, Joaquim; Varona, Luis] Univ Autonoma Barcelona, Dept Ciencia Anim & Dels Aliments, Bellaterra, Spain; [Varona, Luis] Univ Zaragoza, Dept Anat Embriol & Geneti Anim, Zaragoza, Spain	Autonomous University of Barcelona; University of Zaragoza	Casellas, J (corresponding author), Univ Autonoma Barcelona, Dept Ciencia Anim & Dels Aliments, Bellaterra, Spain.	joaquim.casellas@uab.cat	Varona, Luis/C-2744-2012	Varona, Luis/0000-0001-6256-5478; Casellas, Joaquim/0000-0002-4982-3556	Spain's Ministerio de Ciencia e Innovacion [RYC-2009-04049]	Spain's Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	The research contract of JC was partially funded by Spain's Ministerio de Ciencia e Innovacion (reference, RYC-2009-04049). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Angelini C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-415; Beyene Joseph, 2007, BMC Proc, V1 Suppl 1, pS150; Bhowmick D, 2006, BIOSTATISTICS, V7, P630, DOI 10.1093/biostatistics/kxj032; Bonferroni C., 1930, ELMENTI STAT GEN; Bull TM, 2004, AM J RESP CRIT CARE, V170, P911, DOI 10.1164/rccm.200312-1686OC; Casellas J, 2008, ANIM GENET, V39, P89, DOI 10.1111/j.1365-2052.2007.01670.x; Chen DT, 2004, BIOINFORMATICS, V20, P854, DOI 10.1093/bioinformatics/btg493; Cui XQ, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-210; Gilks WR, 1996, MARKOV CHAIN MONTE C; Gottardo R, 2006, BIOMETRICS, V62, P10, DOI 10.1111/j.1541-0420.2005.00397.x; Hardin J, 2009, BIOSTATISTICS, V10, P446, DOI 10.1093/biostatistics/kxp003; Heguy A, 2006, J MOL MED, V84, P318, DOI 10.1007/s00109-005-0008-2; Hoeschele I, 2005, BIOSTATISTICS, V6, P183, DOI 10.1093/biostatistics/kxi001; Kendziorski CM, 2003, STAT MED, V22, P3899, DOI 10.1002/sim.1548; Khondoker MR, 2006, BIOINFORMATICS, V22, P215, DOI 10.1093/bioinformatics/bti790; Kuznetsov VA, 2002, GENETICS, V161, P1321; LANGE KL, 1989, J AM STAT ASSOC, V84, P881, DOI 10.2307/2290063; Model Fabian, 2002, Bioinformatics, V18 Suppl 1, pS155; Platts AE, 2007, HUM MOL GENET, V16, P763, DOI 10.1093/hmg/ddm012; Posekany A, 2011, BIOINFORMATICS, V27, P807, DOI 10.1093/bioinformatics/btr018; Purdom E, 2005, STAT APPL GENET MOL, V4; Sahu SK, 2003, CAN J STAT, V31, P129, DOI 10.2307/3316064; Salas-Gonzalez D, 2009, COMPUT STAT DATA AN, V53, P1535, DOI 10.1016/j.csda.2008.08.008; Searle S. R., 1982, MATRIX ALGEBRA USEFU; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Stranden I, 1999, GENET SEL EVOL, V31, P25, DOI 10.1051/gse:19990102; Varona L, 2008, GENET RES, V90, P179, DOI 10.1017/S0016672308009233; Wolfinger RD, 2001, J COMPUT BIOL, V8, P625, DOI 10.1089/106652701753307520	29	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2012	7	6							e38919	10.1371/journal.pone.0038919	http://dx.doi.org/10.1371/journal.pone.0038919			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TU	22701729	Green Submitted, Green Published, gold			2022-12-27	WOS:000305337600056
J	Elling, L; Schupp, H; Bayer, J; Brockelmann, AK; Steinberg, C; Dobel, C; Junghofer, M				Elling, Ludger; Schupp, Harald; Bayer, Janine; Broeckelmann, Ann-Kathrin; Steinberg, Christian; Dobel, Christian; Junghofer, Markus			The Impact of Acute Psychosocial Stress on Magnetoencephalographic Correlates of Emotional Attention and Exogenous Visual Attention	PLOS ONE			English	Article							SALIVARY ALPHA-AMYLASE; SELF-REPORTED STRESS; BLOOD-BRAIN-BARRIER; SEX-DIFFERENCES; WORKING-MEMORY; COGNITIVE FLEXIBILITY; PSYCHOLOGICAL STRESS; PREFRONTAL CORTEX; NEURAL MECHANISMS; SPATIAL ATTENTION	Stress-induced acute activation of the cerebral catecholaminergic systems has often been found in rodents. However, little is known regarding the consequences of this activation on higher cognitive functions in humans. Theoretical inferences would suggest increased distractibility in the sense of increased exogenous attention and emotional attention. The present study investigated the influence of acute stress responses on magnetoencephalographic (MEG) correlates of visual attention. Healthy male subjects were presented emotional and neutral pictures in three subsequent MEG recording sessions after being exposed to a TSST-like social stressor, intended to trigger a HPA-response. The subjects anticipation of another follow-up stressor was designed to sustain the short-lived central catecholaminergic stress reactions throughout the ongoing MEG recordings. The heart rate indicates a stable level of anticipatory stress during this time span, subsequent cortisol concentrations and self-report measures of stress were increased. With regard to the MEG correlates of attentional functions, we found that the N1m amplitude remained constantly elevated during stressor anticipation. The magnetic early posterior negativity (EPNm) was present but, surprisingly, was not at all modulated during stressor anticipation. This suggests that a general increase of the influence of exogenous attention but no specific effect regarding emotional attention in this time interval. Regarding the time course of the effects, an influence of the HPA on these MEG correlates of attention seems less likely. An influence of cerebral catecholaminergic systems is plausible, but not definite.	[Elling, Ludger; Broeckelmann, Ann-Kathrin; Steinberg, Christian; Dobel, Christian; Junghofer, Markus] Univ Hosp Muenster, Inst Biomagnetism & Biosignalanal, Munster, Germany; [Schupp, Harald] Univ Konstanz, Dept Psychol, Constance, Germany; [Bayer, Janine] Univ Hosp Hamburg Eppendorf, Dept Syst Neurosci, Hamburg, Germany	University of Munster; University of Konstanz; University of Hamburg; University Medical Center Hamburg-Eppendorf	Elling, L (corresponding author), Univ Hosp Muenster, Inst Biomagnetism & Biosignalanal, Munster, Germany.	ellingl@uni-muenster.de	Bayer, Janine/AAS-1939-2021; Junghoefer, Markus/AAA-2892-2021	Bayer, Janine/0000-0003-4681-4571; Junghoefer, Markus/0000-0002-8532-2986	Deutsche Forschungsgemeinschaft [DFG-FOR 751-JU445/4.2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This research was funded by the Deutsche Forschungsgemeinschaft (DFG-FOR 751-JU445/4.2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams RA, 2006, PERCEPT PSYCHOPHYS, V68, P114, DOI 10.3758/BF03193661; Al'Absi M, 2002, PSYCHOPHYSIOLOGY, V39, P95, DOI 10.1017/S0048577202001543; Alexander JK, 2007, J COGNITIVE NEUROSCI, V19, P468, DOI 10.1162/jocn.2007.19.3.468; Arnsten AFT, 1998, SCIENCE, V280, P1711, DOI 10.1126/science.280.5370.1711; Arnsten AFT, 2009, NAT REV NEUROSCI, V10, P410, DOI 10.1038/nrn2648; Aston-Jones G, 2005, ANNU REV NEUROSCI, V28, P403, DOI 10.1146/annurev.neuro.28.061604.135709; BANKS WA, 1995, PEPTIDES, V16, P1157, DOI 10.1016/0196-9781(95)00043-J; Benarroch EE, 2009, NEUROLOGY, V73, P1699, DOI 10.1212/WNL.0b013e3181c2937c; Bradley MM, 2007, PSYCHOPHYSIOLOGY, V44, P364, DOI 10.1111/j.1469-8986.2007.00520.x; Braunstein-Bercovitz H, 2003, ANXIETY STRESS COPIN, V16, P345, DOI 10.1080/10615800310000112560; Bublatzky F, SOC COGN AF IN PRESS; Calvo MG, 2007, J EXP PSYCHOL GEN, V136, P347, DOI 10.1037/0096-3445.136.3.347; Carretie L, 2003, PSYCHOPHYSIOLOGY, V40, P381, DOI 10.1111/1469-8986.00041; Chrousos GP, 2009, NAT REV ENDOCRINOL, V5, P374, DOI 10.1038/nrendo.2009.106; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Cousijn H, 2010, P NATL ACAD SCI USA, V107, P9867, DOI 10.1073/pnas.1003514107; COX T, 1985, BRIT J PSYCHOL, V76, P183, DOI 10.1111/j.2044-8295.1985.tb01941.x; de Kloet ER, 2008, FRONT NEUROENDOCRIN, V29, P268, DOI 10.1016/j.yfrne.2007.10.002; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; Dedovic K, 2005, J PSYCHIATR NEUROSCI, V30, P319; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Desimone R, 1998, PHILOS T R SOC B, V353, P1245, DOI 10.1098/rstb.1998.0280; Doallo S, 2007, NEUROSCI LETT, V418, P111, DOI 10.1016/j.neulet.2007.03.009; Ellenbogen MA, 2009, BEHAV RES THER, V47, P128, DOI 10.1016/j.brat.2008.10.021; Elling L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018009; Goldstein JM, 2005, J NEUROSCI, V25, P9309, DOI 10.1523/JNEUROSCI.2239-05.2005; Grech R, 2008, J NEUROENG REHABIL, V5, DOI 10.1186/1743-0003-5-25; HAMALAINEN MS, 1994, MED BIOL ENG COMPUT, V32, P35, DOI 10.1007/BF02512476; Hauk O, 2004, NEUROIMAGE, V21, P1612, DOI 10.1016/j.neuroimage.2003.12.018; Herman JP, 1997, TRENDS NEUROSCI, V20, P78, DOI 10.1016/S0166-2236(96)10069-2; Herrmann CS, 2001, NEUROSCI BIOBEHAV R, V25, P465, DOI 10.1016/S0149-7634(01)00027-6; Hoffman R, 2004, ARCH CLIN NEUROPSYCH, V19, P497, DOI 10.1016/j.acn.2003.07.005; Holmes A, 2003, COGNITIVE BRAIN RES, V16, P174, DOI 10.1016/S0926-6410(02)00268-9; Joels M, 2009, NAT REV NEUROSCI, V10, P459, DOI 10.1038/nrn2632; Junghofer M, 2006, PROG BRAIN RES, V156, P123, DOI 10.1016/S0079-6123(06)56007-8; Junghofer M, 2000, PSYCHOPHYSIOLOGY, V37, P523, DOI 10.1111/1469-8986.3740523; Junghofer M, 2001, PSYCHOPHYSIOLOGY, V38, P175, DOI 10.1017/S0048577201000762; Keil A, 2001, CLIN NEUROPHYSIOL, V112, P2057, DOI 10.1016/S1388-2457(01)00654-X; Kirschbaum C, 1999, PSYCHOSOM MED, V61, P154, DOI 10.1097/00006842-199903000-00006; KIRSCHBAUM C, 1994, PSYCHONEUROENDOCRINO, V19, P313, DOI 10.1016/0306-4530(94)90013-2; KIRSCHBAUM C, 1992, PSYCHOSOM MED, V54, P648, DOI 10.1097/00006842-199211000-00004; KIRSCHBAUM C, 1993, NEUROPSYCHOBIOLOGY, V28, P76, DOI 10.1159/000119004; KIRSCHBAUM C, 1989, NEUROPSYCHOBIOLOGY, V22, P150, DOI 10.1159/000118611; Kudielka BM, 2005, BIOL PSYCHOL, V69, P113, DOI 10.1016/j.biopsycho.2004.11.009; Kudielka BM, 2009, PSYCHONEUROENDOCRINO, V34, P2, DOI 10.1016/j.psyneuen.2008.10.004; Lang P. J., 2005, A6 U FLOR, DOI DOI 10.1027/0269-8803/A000147; Lang P. J., 1997, NIMH CTR STUDY EMOTI, P39; LAVIE N, 1994, PERCEPT PSYCHOPHYS, V56, P183, DOI 10.3758/BF03213897; Lithari C, 2010, BRAIN TOPOGR, V23, P27, DOI 10.1007/s10548-009-0130-5; Luck SJ, 2000, TRENDS COGN SCI, V4, P432, DOI 10.1016/S1364-6613(00)01545-X; MACKAY C, 1978, BRIT J SOC CLIN PSYC, V17, P283, DOI 10.1111/j.2044-8260.1978.tb00280.x; Martins JM, 1996, NEUROENDOCRINOLOGY, V63, P338; Muller MM, 2008, CEREB CORTEX, V18, P1892, DOI 10.1093/cercor/bhm215; Natale E, 2006, EUR J NEUROSCI, V23, P2511, DOI 10.1111/j.1460-9568.2006.04756.x; Nater UM, 2005, INT J PSYCHOPHYSIOL, V55, P333, DOI 10.1016/j.ijpsycho.2004.09.009; Oei NYL, 2006, STRESS, V9, P133, DOI 10.1080/10253890600965773; Oei NYL, 2011, SOCIAL COGNITIVE AFF; Olofsson JK, 2008, BIOL PSYCHOL, V77, P247, DOI 10.1016/j.biopsycho.2007.11.006; PARDRIDGE WM, 1983, ANNU REV PHYSIOL, V45, P73, DOI 10.1146/annurev.ph.45.030183.000445; Pessoa L, 2002, COGNITIVE BRAIN RES, V15, P31, DOI 10.1016/S0926-6410(02)00214-8; Pessoa L, 2002, P NATL ACAD SCI USA, V99, P11458, DOI 10.1073/pnas.172403899; Pessoa L, 2003, J NEUROSCI, V23, P3990; Peyk P, 2008, BRAIN TOPOGR, V20, P205, DOI 10.1007/s10548-008-0052-7; Peyk P, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/861705; Phillips ML, 2003, BIOL PSYCHIAT, V54, P504, DOI 10.1016/S0006-3223(03)00168-9; Plessow F, 2011, J COGNITIVE NEUROSCI, V23, P3218, DOI 10.1162/jocn_a_00024; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; REMINGTON RW, 1992, PERCEPT PSYCHOPHYS, V51, P279, DOI 10.3758/BF03212254; Rohleder N, 2006, PSYCHOPHYSIOLOGY, V43, P645, DOI 10.1111/j.1469-8986.2006.00457.x; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Schimmack U, 1998, DIAGNOSTICA, V44, P166; Schoofs D, 2008, PSYCHONEUROENDOCRINO, V33, P643, DOI 10.1016/j.psyneuen.2008.02.004; Schupp HT, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-16; Schupp HT, 2006, PROG BRAIN RES, V156, P31, DOI 10.1016/S0079-6123(06)56002-9; Schupp HT, 2007, J NEUROSCI, V27, P1082, DOI 10.1523/JNEUROSCI.3223-06.2007; Schupp HT, 2004, PSYCHOPHYSIOLOGY, V41, P441, DOI 10.1111/j.1469-8986.2004.00174.x; Schupp HT, 2003, NEUROREPORT, V14, P1107, DOI 10.1097/00001756-200306110-00002; Schupp HT, 2003, PSYCHOL SCI, V14, P7, DOI 10.1111/1467-9280.01411; Shackman AJ, 2011, J NEUROSCI, V31, P1156, DOI 10.1523/JNEUROSCI.3384-10.2011; Simoens VL, 2007, PSYCHOPHYSIOLOGY, V44, P30, DOI 10.1111/j.1469-8986.2006.00476.x; Skosnik PD, 2000, INT J PSYCHOPHYSIOL, V36, P59, DOI 10.1016/S0167-8760(99)00100-2; Southwick SM, 1999, BIOL PSYCHIAT, V46, P1192, DOI 10.1016/S0006-3223(99)00219-X; Stark R, 2006, NEUROIMAGE, V32, P1290, DOI 10.1016/j.neuroimage.2006.05.046; Steyer, 1997, MEHRDIMENSIONALE BEF; Strawn JR, 2008, DEPRESS ANXIETY, V25, P260, DOI 10.1002/da.20292; Taylor VA, 2011, BIOL PSYCHOL, V86, P17, DOI 10.1016/j.biopsycho.2010.10.001; Valentino RJ, 2008, EUR J PHARMACOL, V583, P194, DOI 10.1016/j.ejphar.2007.11.062; van Marle HJF, 2009, BIOL PSYCHIAT, V66, P649, DOI 10.1016/j.biopsych.2009.05.014; Veer IM, 2011, NEUROIMAGE, V57, P1534, DOI 10.1016/j.neuroimage.2011.05.074; Vuilleumier P, 2005, TRENDS COGN SCI, V9, P585, DOI 10.1016/j.tics.2005.10.011; Vuilleumier P, 2009, CURR DIR PSYCHOL SCI, V18, P148, DOI 10.1111/j.1467-8721.2009.01626.x; WEWERS ME, 1990, RES NURS HEALTH, V13, P227, DOI 10.1002/nur.4770130405; Wittchen H.-U., 1997, SKID STRUKTURIERTES; ZLOKOVIC BV, 1990, BIOCHIM BIOPHYS ACTA, V1025, P191, DOI 10.1016/0005-2736(90)90097-8	94	16	16	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2012	7	6							e35767	10.1371/journal.pone.0035767	http://dx.doi.org/10.1371/journal.pone.0035767			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TU	22701552	Green Published, Green Submitted, gold			2022-12-27	WOS:000305337600002
J	Nishimura, S; Uno, M; Kaneta, Y; Fukuchi, K; Nishigohri, H; Hasegawa, J; Komori, H; Takeda, S; Enomoto, K; Nara, F; Agatsuma, T				Nishimura, Satoko; Uno, Makiko; Kaneta, Yasuyuki; Fukuchi, Keisuke; Nishigohri, Haruyuki; Hasegawa, Jun; Komori, Hironobu; Takeda, Shigeki; Enomoto, Katsuhiko; Nara, Futoshi; Agatsuma, Toshinori			MRGD, a MAS-related G-protein Coupled Receptor, Promotes Tumorigenisis and Is Highly Expressed in Lung Cancer	PLOS ONE			English	Article							BREAST CARCINOMAS; ES CELLS; C-MYC; ONCOGENE; OVEREXPRESSION; IDENTIFICATION; INVOLVEMENT; PROGNOSIS; SUBSETS; FAMILY	To elucidate the function of MAS-related GPCR, member D (MRGD) in cancers, we investigated the in vitro and in vivo oncogenic function of MRGD using murine fibroblast cell line NIH3T3 in which MRGD is stably expressed. The expression pattern of MRGD in clinical samples was also analyzed. We found that overexpression of MRGD in NIH3T3 induced focus formation and multi-cellular spheroid formation, and promoted tumors in nude mice. In other words, overexpression of MRGD in NIH3T3 induced the loss of contact inhibition, anchorage-independent growth and in vivo tumorigenesis. Furthermore, it was found that the ligand of MRGD, beta-alanine, enhanced spheroid formation in MRGD-expressing NIH3T3 cells. From investigation of clinical cancer tissues, we found high expression of MRGD in several lung cancers by immunohistochemistry as well as real time PCR. Based on these results, MRGD could be involved in tumorigenesis and could also be a novel anticancer drug target.	[Nishimura, Satoko; Kaneta, Yasuyuki; Fukuchi, Keisuke; Nishigohri, Haruyuki; Hasegawa, Jun; Agatsuma, Toshinori] Daiichi Sankyo Co Ltd, Biol Res Labs, Shinagawa Ku, Tokyo, Japan; [Uno, Makiko] Daiichi Sankyo Co Ltd, Exploratory Res Labs 2, Shinagawa Ku, Tokyo, Japan; [Komori, Hironobu] Daiichi Sankyo Co Ltd, Oncol Res Labs, Edogawa Ku, Tokyo, Japan; [Takeda, Shigeki] Gunma Univ, Grad Sch Engn, Dept Chem & Chem Biol, Gunma, Japan; [Enomoto, Katsuhiko] Akita Univ, Grad Sch Med, Dept Mol Pathol & Tumor Pathol, Akita 010, Japan; [Nara, Futoshi] Daiichi Sankyo Co Ltd, Cardiovasc Metabol Res Labs, Shinagawa Ku, Tokyo, Japan	Daiichi Sankyo Company Limited; Daiichi Sankyo Company Limited; Daiichi Sankyo Company Limited; Gunma University; Akita University; Daiichi Sankyo Company Limited	Nishimura, S (corresponding author), Daiichi Sankyo Co Ltd, Biol Res Labs, Shinagawa Ku, Tokyo, Japan.	agatsuma.toshinori.v7@daiichisankyo.co.jp		Takeda, Shigeki/0000-0001-8979-1133	Daiichi Sankyo Co. Ltd.	Daiichi Sankyo Co. Ltd.(Daiichi Sankyo Company Limited)	This study was funded by Daiichi Sankyo Co. Ltd. The funders had role in study design, data collection and analysis, decision to publish and preparation of the manuscript.	Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Cavanaugh DJ, 2009, P NATL ACAD SCI USA, V106, P9075, DOI 10.1073/pnas.0901507106; DeWire SM, 2011, CIRC RES, V109, P205, DOI 10.1161/CIRCRESAHA.110.231308; DIFIORE PP, 1987, SCIENCE, V237, P178, DOI 10.1126/science.2885917; Dong XZ, 2001, CELL, V106, P619, DOI 10.1016/S0092-8674(01)00483-4; Gembardt F, 2008, MOL CELL BIOCHEM, V319, P115, DOI 10.1007/s11010-008-9884-4; GUERIN M, 1988, ONCOGENE RES, V3, P21; KAWAKAMI T, 1988, P NATL ACAD SCI USA, V85, P3870, DOI 10.1073/pnas.85.11.3870; Kostenis E, 2005, CIRCULATION, V111, P1806, DOI 10.1161/01.CIR.0000160867.23556.7D; Kumar R, 1996, CLIN CANCER RES, V2, P1215; Lappano R, 2011, NAT REV DRUG DISCOV, V10, P47, DOI 10.1038/nrd3320; Li SY, 2005, INT J ONCOL, V27, P1329; MARKS N, 1970, J NEUROCHEM, V17, P53, DOI 10.1111/j.1471-4159.1970.tb00501.x; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; PARMENTIER M, 1989, SCIENCE, V246, P1620, DOI 10.1126/science.2556796; PINE MJ, 1982, J NATL CANCER I, V69, P729; Pylayeva-Gupta Y, 2011, NAT REV CANCER, V11, P761, DOI 10.1038/nrc3106; Qiao JB, 2008, P NATL ACAD SCI USA, V105, P12891, DOI 10.1073/pnas.0711861105; Santos EL, 2007, REGUL PEPTIDES, V141, P159, DOI 10.1016/j.regpep.2006.12.030; Shinohara T, 2004, J BIOL CHEM, V279, P23559, DOI 10.1074/jbc.M314240200; Stroomer AEM, 2004, BIOCHEM J, V379, P119; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takeda S, 2002, FEBS LETT, V520, P97, DOI 10.1016/S0014-5793(02)02775-8; TALLAN HH, 1954, J BIOL CHEM, V211, P927; VARLEY JM, 1987, ONCOGENE, V1, P423; YOKOTA J, 1986, LANCET, V1, P765; YOUNG D, 1986, CELL, V45, P711, DOI 10.1016/0092-8674(86)90785-3	29	18	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2012	7	6							e38618	10.1371/journal.pone.0038618	http://dx.doi.org/10.1371/journal.pone.0038618			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TQ	22715397	Green Submitted, gold, Green Published			2022-12-27	WOS:000305336800039
J	Singh, VP; Lakshmi, BJ; Singh, S; Shah, V; Goel, S; Sarathi, DP; Kumar, S				Singh, Vijay Pratap; Lakshmi, B. Jyothi; Singh, Shalu; Shah, Vanya; Goel, Sandeep; Sarathi, D. Partha; Kumar, Satish			Lack of Wdr13 Gene in Mice Leads to Enhanced Pancreatic Beta Cell Proliferation, Hyperinsulinemia and Mild Obesity	PLOS ONE			English	Article							WD-REPEAT; GLUCOSE-INTOLERANCE; INSULIN-SECRETION; ADIPOSE-TISSUE; DIABETIC-RATS; GROWTH-FACTOR; CYCLE ARREST; MASS; PROTEINS; REPLICATION	WD-repeat proteins are very diverse, yet these are structurally related proteins that participate in a wide range of cellular functions. WDR13, a member of this family, is conserved from fishes to humans and localizes into the nucleus. To understand the in vivo function(s) of Wdr13 gene, we have created and characterized a mutant mouse strain lacking this gene. The mutant mice had higher serum insulin levels and increased pancreatic islet mass as a result of enhanced beta cell proliferation. While a known cell cycle inhibitor, p21, was downregulated in the mutant islets, over expression of WDR13 in the pancreatic beta cell line (MIN6) resulted in upregulation of p21, accompanied by retardation of cell proliferation. We suggest that WDR13 is a novel negative regulator of the pancreatic beta cell proliferation. Given the higher insulin levels and better glucose clearance in Wdr13 gene deficient mice, we propose that this protein may be a potential candidate drug target for ameliorating impaired glucose metabolism in diabetes.	[Singh, Vijay Pratap; Lakshmi, B. Jyothi; Singh, Shalu; Shah, Vanya; Goel, Sandeep; Sarathi, D. Partha; Kumar, Satish] CSIR, Ctr Cellular & Mol Biol, Hyderabad, Andhra Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Singh, VP (corresponding author), CSIR, Ctr Cellular & Mol Biol, Hyderabad, Andhra Pradesh, India.	satishk@ccmb.res.in	Singh, Vijay/AAH-9906-2020; singh, shalu/GYD-6110-2022; Goel, Sandeep/C-5985-2009	Singh, Vijay/0000-0002-6803-7585; Goel, Sandeep/0000-0001-7485-5392; Singh, Shalu/0000-0002-5884-4850	Council of Scientific and Industrial Research, New Delhi; Department of Science and Technology, Government of India, New Delhi; Department of Biotechnology, Government of India, New Delhi	Council of Scientific and Industrial Research, New Delhi(Council of Scientific & Industrial Research (CSIR) - India); Department of Science and Technology, Government of India, New Delhi(Department of Science & Technology (India)); Department of Biotechnology, Government of India, New Delhi(Department of Biotechnology (DBT) India)	The first author was supported by a fellowship from the Council of Scientific and Industrial Research, New Delhi. This manuscript is an outcome of the research funds provided by the Council of Scientific and Industrial Research, New Delhi, Department of Science and Technology, Government of India, New Delhi and Department of Biotechnology, Government of India, New Delhi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariyama Y, 2007, OBESITY, V15, P1647, DOI 10.1038/oby.2007.197; Bluher M, 2002, DEV CELL, V3, P25, DOI 10.1016/S1534-5807(02)00199-5; Bonner-Weir S, 2000, ENDOCRINOLOGY, V141, P1926, DOI 10.1210/en.141.6.1926; Bouwens L, 2005, PHYSIOL REV, V85, P1255, DOI 10.1152/physrev.00025.2004; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; Cinti S, 1998, DIABETOLOGIA, V41, P171, DOI 10.1007/s001250050886; Cozar-Castellano I, 2006, DIABETES, V55, P70, DOI 10.2337/diabetes.55.01.06.db05-0632; Cozar-Castellano I, 2006, DIABETES, V55, P3271, DOI 10.2337/db06-0627; D'Agata V, 2003, GENES BRAIN BEHAV, V2, P231, DOI 10.1034/j.1601-183X.2003.00029.x; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; El-Hattab A, 2010, CLIN GENET; FINEGOOD DT, 1995, DIABETES, V44, P249, DOI 10.2337/diabetes.44.3.249; Gerich JE, 1998, ENDOCR REV, V19, P491, DOI 10.1210/er.19.4.491; GIRARD J, 1994, FASEB J, V8, P36, DOI 10.1096/fasebj.8.1.7905448; Gupta RK, 2007, GENE DEV, V21, P756, DOI 10.1101/gad.1535507; Hanley SC, 2010, ENDOCRINOLOGY, V151, P1462, DOI 10.1210/en.2009-1277; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Heit JJ, 2006, ANNU REV CELL DEV BI, V22, P311, DOI 10.1146/annurev.cellbio.22.010305.104425; Heit JJ, 2006, NATURE, V443, P345, DOI 10.1038/nature05097; Honore B, 2002, ONCOGENE, V21, P1123, DOI 10.1038/sj.onc.1205186; Lee YC, 2009, MOL CELL ENDOCRINOL, V297, P18, DOI 10.1016/j.mce.2008.08.033; Loftus TM, 1998, P NATL ACAD SCI USA, V95, P14168, DOI 10.1073/pnas.95.24.14168; Lustig RH, 2004, INT J OBESITY, V28, P1344, DOI 10.1038/sj.ijo.0802753; Mauvais-Jarvis F, 2011, TRENDS ENDOCRIN MET, V22, P24, DOI 10.1016/j.tem.2010.10.002; Meng ZX, 2009, DIABETOLOGIA, V52, P125, DOI 10.1007/s00125-008-1174-x; Muoio DM, 2008, NAT REV MOL CELL BIO, V9, P193, DOI 10.1038/nrm2327; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Nielsen JH, 2001, DIABETES, V50, pS25, DOI 10.2337/diabetes.50.2007.S25; Nikolova G, 2006, DEV CELL, V10, P397, DOI 10.1016/j.devcel.2006.01.015; Podcheko A, 2007, MOL CELL BIOL, V27, P6484, DOI 10.1128/MCB.02409-06; Price M, 2003, MOL BRAIN RES, V117, P58, DOI 10.1016/S0169-328X(03)00285-7; Rhodes CJ, 2005, SCIENCE, V307, P380, DOI 10.1126/science.1104345; Ritzel RA, 2006, DIABETES CARE, V29, P717, DOI 10.2337/diacare.29.03.06.dc05-1538; ROHNERJEANRENAUD F, 1985, ENDOCRINOLOGY, V116, P830, DOI 10.1210/endo-116-2-830; Rosen ED, 2000, ANNU REV CELL DEV BI, V16, P145, DOI 10.1146/annurev.cellbio.16.1.145; Rulifson IC, 2007, P NATL ACAD SCI USA, V104, P6247, DOI 10.1073/pnas.0701509104; SIMON J, 1985, AM J PHYSIOL, V249, pR393, DOI 10.1152/ajpregu.1985.249.4.R393; Singh BN, 2003, GENOMICS, V81, P315, DOI 10.1016/S0888-7543(02)00036-8; Smith Temple F., 2008, V48, P20, DOI 10.1007/978-0-387-09595-0_3; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; Song BB, 2008, J CLIN INVEST, V118, P3378, DOI 10.1172/JCI34587; Suarez-Pinzon WL, 2005, DIABETES, V54, P2596, DOI 10.2337/diabetes.54.9.2596; Suresh A, 2005, MOL REPROD DEV, V72, P299, DOI 10.1002/mrd.20362; Thorel F, 2010, NATURE, V464, P1149, DOI 10.1038/nature08894; Wen T, 2009, MOL ENDOCRINOL, V23, P671, DOI 10.1210/me.2008-0345; Whibley AC, 2010, AM J HUM GENET, V87, P173, DOI 10.1016/j.ajhg.2010.06.017; WILLING AE, 1990, PHYSIOL BEHAV, V48, P893, DOI 10.1016/0031-9384(90)90245-Y; Xu G, 1999, DIABETES, V48, P2270, DOI 10.2337/diabetes.48.12.2270	48	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2012	7	6							e38685	10.1371/journal.pone.0038685	http://dx.doi.org/10.1371/journal.pone.0038685			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TQ	22715406	gold, Green Published, Green Submitted			2022-12-27	WOS:000305336800048
J	Smolinska, A; Blanchet, L; Coulier, L; Ampt, KAM; Luider, T; Hintzen, RQ; Wijmenga, SS; Buydens, LMC				Smolinska, Agnieszka; Blanchet, Lionel; Coulier, Leon; Ampt, Kirsten A. M.; Luider, Theo; Hintzen, Rogier Q.; Wijmenga, Sybren S.; Buydens, Lutgarde M. C.			Interpretation and Visualization of Non-Linear Data Fusion in Kernel Space: Study on Metabolomic Characterization of Progression of Multiple Sclerosis	PLOS ONE			English	Article							SUPPORT VECTOR MACHINES; CEREBROSPINAL-FLUID; PATTERN-RECOGNITION; VALIDATION; SELECTION; MODELS; DISCRIMINATION; CLASSIFICATION; SPECTROMETRY; PROTEOMICS	Background: In the last decade data fusion has become widespread in the field of metabolomics. Linear data fusion is performed most commonly. However, many data display non-linear parameter dependences. The linear methods are bound to fail in such situations. We used proton Nuclear Magnetic Resonance and Gas Chromatography-Mass Spectrometry, two well established techniques, to generate metabolic profiles of Cerebrospinal fluid of Multiple Sclerosis (MScl) individuals. These datasets represent non-linearly separable groups. Thus, to extract relevant information and to combine them a special framework for data fusion is required. Methodology: The main aim is to demonstrate a novel approach for data fusion for classification; the approach is applied to metabolomics datasets coming from patients suffering from MScl at a different stage of the disease. The approach involves data fusion in kernel space and consists of four main steps. The first one is to extract the significant information per data source using Support Vector Machine Recursive Feature Elimination. This method allows one to select a set of relevant variables. In the next step the optimized kernel matrices are merged by linear combination. In step 3 the merged datasets are analyzed with a classification technique, namely Kernel Partial Least Square Discriminant Analysis. In the final step, the variables in kernel space are visualized and their significance established. Conclusions: We find that fusion in kernel space allows for efficient and reliable discrimination of classes (MScl and early stage). This data fusion approach achieves better class prediction accuracy than analysis of individual datasets and the commonly used mid-level fusion. The prediction accuracy on an independent test set (8 samples) reaches 100%. Additionally, the classification model obtained on fused kernels is simpler in terms of complexity, i.e. just one latent variable was sufficient. Finally, visualization of variables importance in kernel space was achieved.	[Smolinska, Agnieszka; Blanchet, Lionel; Ampt, Kirsten A. M.; Wijmenga, Sybren S.; Buydens, Lutgarde M. C.] Radboud Univ Nijmegen, Inst Mol & Mat, NL-6525 ED Nijmegen, Netherlands; [Coulier, Leon] TNO Qual Life, Zeist, Netherlands; [Luider, Theo; Hintzen, Rogier Q.] Erasmus Univ, Dept Neurol, Med Ctr, Rotterdam, Netherlands	Radboud University Nijmegen; Netherlands Organization Applied Science Research; Erasmus University Rotterdam; Erasmus MC	Smolinska, A (corresponding author), Radboud Univ Nijmegen, Inst Mol & Mat, NL-6525 ED Nijmegen, Netherlands.	A.Smolinska@science.ru.nl	Blanchet, Lionel/H-3150-2019; Buydens, Lutgarde M.C./D-4338-2012; Blanchet, Lionel/C-8829-2011	Blanchet, Lionel/0000-0003-2284-8101; Blanchet, Lionel/0000-0003-2284-8101	TI Pharma [D4-102]; TI Pharma	TI Pharma; TI Pharma	This study was funded by TI Pharma, project number D4-102, www.tipharma.com. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; LC is employed by TNO quality of Life and our study was funded by TI Pharma. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Bach F. R., 2004, P 21 INT C MACH LEAR; Ben-Hur A, 2005, BIOINFORMATICS, V21, pI38, DOI 10.1093/bioinformatics/bti1016; Blanchet L, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-254; Cao DS, 2011, CHEMOMETR INTELL LAB, V107, P106, DOI 10.1016/j.chemolab.2011.02.004; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Constantinou MA, 2005, ANAL CHIM ACTA, V542, P169, DOI 10.1016/j.aca.2005.03.059; Cristianini N, 2000, INTRO SUPPORT VECTOR; Croux C, 2005, J MULTIVARIATE ANAL, V95, P206, DOI 10.1016/j.jmva.2004.08.002; Czekaj T, 2005, J CHEMOMETR, V19, P341, DOI 10.1002/cem.937; Daszykowski M, 2002, ANAL CHIM ACTA, V468, P91, DOI 10.1016/S0003-2670(02)00651-7; de Haan JR, 2007, BIOINFORMATICS, V23, P184, DOI 10.1093/bioinformatics/btl572; De Meyer T, 2008, ANAL CHEM, V80, P3783, DOI 10.1021/ac7025964; Eilers PHC, 2003, ANAL CHEM, V75, P3631, DOI 10.1021/ac034173t; Forshed J, 2007, CHEMOMETR INTELL LAB, V85, P102, DOI 10.1016/j.chemolab.2006.05.002; Galvao RKH, 2005, TALANTA, V67, P736, DOI 10.1016/j.talanta.2005.03.025; Garcia-Perez I, 2010, ANAL CHEM, V82, P203, DOI 10.1021/ac901728w; GHAURI FYK, 1993, NMR BIOMED, V6, P163, DOI 10.1002/nbm.1940060210; Gidskehaug L, 2008, CHEMOMETR INTELL LAB, V93, P1, DOI 10.1016/j.chemolab.2008.01.005; Golbraikh A, 2002, J COMPUT AID MOL DES, V16, P357, DOI 10.1023/A:1020869118689; Golbraikh A, 2003, J COMPUT AID MOL DES, V17, P241, DOI 10.1023/A:1025386326946; GOWER JC, 1988, BIOMETRIKA, V75, P445, DOI 10.1093/biomet/75.3.445; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; KENNARD RW, 1968, TECHNOMETRICS, V10, P423; Koek MM, 2006, ANAL CHEM, V78, P1272, DOI 10.1021/ac051683+; Krooshof PWT, 2010, ANAL CHEM, V82, P7000, DOI 10.1021/ac101338y; Kuncheva LI, 2004, COMBINING PETTERNS C; Lanckriet GRG, 2004, J MACH LEARN RES, V5, P27; Pekalska E, 2009, IEEE T PATTERN ANAL, V31, P1017, DOI 10.1109/TPAMI.2008.290; Postma GJ, 2011, ANAL CHIM ACTA, V705, P123, DOI 10.1016/j.aca.2011.04.025; Richards SE, 2010, CHEMOMETR INTELL LAB, V104, P121, DOI 10.1016/j.chemolab.2010.07.006; Roussel S, 2003, CHEMOMETR INTELL LAB, V65, P209, DOI 10.1016/S0169-7439(02)00111-9; Rubingh CM, 2006, METABOLOMICS, V2, P53, DOI 10.1007/s11306-006-0022-6; Sinclair AJ, 2010, NMR BIOMED, V23, P123, DOI 10.1002/nbm.1428; Smilde AK, 2005, ANAL CHEM, V77, P6729, DOI 10.1021/ac051080y; Sord M, 2005, ISBMDA LNBI, V3745, P193; Stanimirova I, 2008, ANAL BIOANAL CHEM, V390, P1273, DOI 10.1007/s00216-007-1648-6; Steinmetz V, 1999, J AGR ENG RES, V74, P21, DOI 10.1006/jaer.1999.0428; Stoop MP, 2010, MOL CELL PROTEOMICS, V9, P2063, DOI 10.1074/mcp.M900877-MCP200; Tomasi G, 2004, J CHEMOMETR, V18, P231, DOI 10.1002/cem.859; Van der Greef J, 2006, PHARMACOGENOMICS, V7, P1087, DOI 10.2217/14622416.7.7.1087; van der Kloet FM, 2009, J PROTEOME RES, V8, P5132, DOI 10.1021/pr900499r; Weljie AM, 2006, ANAL CHEM, V78, P4430, DOI 10.1021/ac060209g; Westerhuis JA, 2008, METABOLOMICS, V4, P81, DOI 10.1007/s11306-007-0099-6; Yu S, 2011, STUDIES COMPUTATIONA	44	53	54	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2012	7	6							e38163	10.1371/journal.pone.0038163	http://dx.doi.org/10.1371/journal.pone.0038163			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TQ	22715376	Green Published, gold			2022-12-27	WOS:000305336800017
J	He, H; Sui, J; Yu, QB; Turner, JA; Ho, BC; Sponheim, SR; Manoach, DS; Clark, VP; Calhoun, VD				He, Hao; Sui, Jing; Yu, Qingbao; Turner, Jessica A.; Ho, Beng-Choon; Sponheim, Scott R.; Manoach, Dara S.; Clark, Vincent P.; Calhoun, Vince D.			Altered Small-World Brain Networks in Schizophrenia Patients during Working Memory Performance	PLOS ONE			English	Article							DORSOLATERAL PREFRONTAL CORTEX; INDEPENDENT COMPONENT ANALYSIS; FUNCTIONAL CONNECTIVITY; COGNITIVE CONTROL; MOTION CORRECTION; LOW-FREQUENCY; DYSFUNCTION; ACTIVATION; INEFFICIENCY; COEFFICIENT	Impairment of working memory (WM) performance in schizophrenia patients (SZ) is well-established. Compared to healthy controls (HC), SZ patients show aberrant blood oxygen level dependent (BOLD) activations and disrupted functional connectivity during WM performance. In this study, we examined the small-world network metrics computed from functional magnetic resonance imaging (fMRI) data collected as 35 HC and 35 SZ performed a Sternberg Item Recognition Paradigm (SIRP) at three WM load levels. Functional connectivity networks were built by calculating the partial correlation on preprocessed time courses of BOLD signal between task-related brain regions of interest (ROIs) defined by group independent component analysis (ICA). The networks were then thresholded within the small-world regime, resulting in undirected binarized small-world networks at different working memory loads. Our results showed: 1) at the medium WM load level, the networks in SZ showed a lower clustering coefficient and less local efficiency compared with HC; 2) in SZ, most network measures altered significantly as the WM load level increased from low to medium and from medium to high, while the network metrics were relatively stable in HC at different WM loads; and 3) the altered structure at medium WM load in SZ was related to their performance during the task, with longer reaction time related to lower clustering coefficient and lower local efficiency. These findings suggest brain connectivity in patients with SZ was more diffuse and less strongly linked locally in functional network at intermediate level of WM when compared to HC. SZ show distinctly inefficient and variable network structures in response to WM load increase, comparing to stable highly clustered network topologies in HC.	[He, Hao; Sui, Jing; Yu, Qingbao; Turner, Jessica A.; Clark, Vincent P.; Calhoun, Vince D.] Mind Res Network, Albuquerque, NM USA; [He, Hao; Calhoun, Vince D.] Univ New Mexico, Dept Elect & Comp Engn, Albuquerque, NM 87131 USA; [Ho, Beng-Choon] Univ Iowa, Dept Psychiat, Iowa City, IA 52242 USA; [Sponheim, Scott R.] Univ Minnesota, Dept Psychiat, Minneapolis, MN 55455 USA; [Sponheim, Scott R.] Univ Minnesota, Minneapolis VA Hlth Care Syst, Minneapolis, MN USA; [Manoach, Dara S.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Psychiat, Charlestown, MA USA; [Clark, Vincent P.] Univ New Mexico, Dept Psychol, Albuquerque, NM 87131 USA; [Calhoun, Vince D.] Yale Univ, Dept Psychiat, New Haven, CT 06520 USA; [Calhoun, Vince D.] Yale Univ, Dept Neurobiol, New Haven, CT USA; [Calhoun, Vince D.] Olin Neuropsychiat Res Ctr, Hartford, CT USA	Lovelace Respiratory Research Institute; University of New Mexico; University of Iowa; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; Harvard University; Massachusetts General Hospital; University of New Mexico; Yale University; Yale University	He, H (corresponding author), Mind Res Network, Albuquerque, NM USA.	vcalhoun@unm.edu	Sponheim, Scott/J-3857-2017; Clark, Vincent P/B-3343-2010; Yu, Qingbao/I-2244-2013; Turner, Jessica A/H-7282-2015; Ho, Beng-Choon/D-6959-2011; Sui, Jing/B-3455-2018; He, Hao/H-9618-2014; Calhoun, Vince D./ACN-9399-2022; Turner, Jessica A/N-2228-2017	Sponheim, Scott/0000-0002-2782-0856; Clark, Vincent P/0000-0002-9151-2102; Yu, Qingbao/0000-0003-4166-3102; Turner, Jessica A/0000-0003-0076-8434; Ho, Beng-Choon/0000-0003-3976-1555; Sui, Jing/0000-0001-6837-5966; He, Hao/0000-0002-9382-998X; Calhoun, Vince D./0000-0001-9058-0747; Turner, Jessica A/0000-0003-0076-8434	Department of Energy [DE-FG02-99ER62764]; National Institutes of Health [R01 EB000840, 5P20RR021938]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021938] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000840] Funding Source: NIH RePORTER	Department of Energy(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	The data collection was funded by the Department of Energy, grant DE-FG02-99ER62764. This work was supported by the National Institutes of Health grants R01 EB000840 (PI: VDC) and 5P20RR021938 (PI: VDC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Alexander-Bloch AF, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00147; Andreasen N., 1984, SCALE ASSESSMENT POS; Andreasen N. C., 1984, SCALE ASSESSMENT POS; Ashburner J, 1999, HUM BRAIN MAPP, V7, P254, DOI 10.1002/(SICI)1097-0193(1999)7:4<254::AID-HBM4>3.0.CO;2-G; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Bassett DS, 2009, P NATL ACAD SCI USA, V106, P11747, DOI 10.1073/pnas.0903641106; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; Bassettt DS, 2006, P NATL ACAD SCI USA, V103, P19518, DOI 10.1073/pnas.0606005103; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bluhm RL, 2007, SCHIZOPHRENIA BULL, V33, P1004, DOI 10.1093/schbul/sbm052; Brown GG, 2009, SCHIZOPHRENIA BULL, V35, P32, DOI 10.1093/schbul/sbn149; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Callicott JH, 2000, CEREB CORTEX, V10, P1078, DOI 10.1093/cercor/10.11.1078; Callicott JH, 1999, CEREB CORTEX, V9, P20, DOI 10.1093/cercor/9.1.20; Callicott JH, 2003, AM J PSYCHIAT, V160, P2209, DOI 10.1176/appi.ajp.160.12.2209; Camchong J, 2011, SCHIZOPHRENIA BULL, V37, P640, DOI 10.1093/schbul/sbp131; Cohen JD, 1996, PHILOS T R SOC B, V351, P1515, DOI 10.1098/rstb.1996.0138; Ehrlich S, 2012, PSYCHOL MED, V42, P267, DOI 10.1017/S003329171100119X; Ehrlich S, 2012, SCHIZOPHRENIA BULL, V38, P1050, DOI 10.1093/schbul/sbr018; First M.B., 2014, STRUCTURED CLIN INTE; Fisher RA, 1914, BIOMETRIKA, V10, P507; Fornito A, 2011, BIOL PSYCHIAT, V70, P64, DOI 10.1016/j.biopsych.2011.02.019; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Freire L, 2002, IEEE T MED IMAGING, V21, P470, DOI 10.1109/TMI.2002.1009383; Freire L, 2001, NEUROIMAGE, V14, P709, DOI 10.1006/nimg.2001.0869; Ginestet CE, 2011, NEUROIMAGE, V55, P688, DOI 10.1016/j.neuroimage.2010.11.030; GOLDMANRAKIC PS, 1994, J NEUROPSYCH CLIN N, V6, P348; Hampson M, 2002, HUM BRAIN MAPP, V15, P247, DOI 10.1002/hbm.10022; Hampson M, 2006, J NEUROSCI, V26, P13338, DOI 10.1523/JNEUROSCI.3408-06.2006; He Y, 2007, CEREB CORTEX, V17, P2407, DOI 10.1093/cercor/bhl149; He Y, 2009, NEUROSCIENTIST, V15, P333, DOI 10.1177/1073858409334423; Humphries MD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002051; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Kaiser M, 2004, NEUROCOMPUTING, V58, P297, DOI 10.1016/j.neucom.2004.01.059; Kang SS, 2011, NEUROPSYCHOLOGIA, V49, P2836, DOI 10.1016/j.neuropsychologia.2011.06.009; Karlsgodt KH, 2007, SCHIZOPHR RES, V89, P191, DOI 10.1016/j.schres.2006.08.016; Kim DI, 2010, NEUROINFORMATICS, V8, P213, DOI 10.1007/s12021-010-9077-7; Kim DI, 2009, HUM BRAIN MAPP, V30, P3795, DOI 10.1002/hbm.20807; Kim MA, 2010, SCHIZOPHR RES, V117, P42, DOI 10.1016/j.schres.2009.12.014; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Latora V, 2003, EUR PHYS J B, V32, P249, DOI 10.1140/epjb/e2003-00095-5; Lauritzen SL, 1996, GRAPHICAL MODELS, Vx; Liao W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008525; Liu Y, 2008, BRAIN, V131, P945, DOI 10.1093/brain/awn018; Lynall ME, 2010, J NEUROSCI, V30, P9477, DOI 10.1523/JNEUROSCI.0333-10.2010; Manoach DS, 1999, BIOL PSYCHIAT, V45, P1128, DOI 10.1016/S0006-3223(98)00318-7; Manoach DS, 2000, BIOL PSYCHIAT, V48, P99, DOI 10.1016/S0006-3223(00)00227-4; Manoach DS, 2003, SCHIZOPHR RES, V60, P285, DOI 10.1016/S0920-9964(02)00294-3; Marrelec G, 2006, NEUROIMAGE, V32, P228, DOI 10.1016/j.neuroimage.2005.12.057; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; MCCARTHY G, 1994, P NATL ACAD SCI USA, V91, P8690, DOI 10.1073/pnas.91.18.8690; Michael AM, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00071; Micheloyannis S, 2006, SCHIZOPHR RES, V87, P60, DOI 10.1016/j.schres.2006.06.028; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Moussa MN, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00083; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Pachou E, 2008, BRAIN TOPOGR, V21, P128, DOI 10.1007/s10548-008-0062-5; Palva S, 2010, NEUROIMAGE, V49, P3257, DOI 10.1016/j.neuroimage.2009.11.031; PARK S, 1992, ARCH GEN PSYCHIAT, V49, P975; Perlstein WM, 2001, AM J PSYCHIAT, V158, P1105, DOI 10.1176/appi.ajp.158.7.1105; PETRIDES M, 1993, P NATL ACAD SCI USA, V90, P878, DOI 10.1073/pnas.90.3.878; Potkin SG, 2009, SCHIZOPHRENIA BULL, V35, P19, DOI 10.1093/schbul/sbn162; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Roffman JL, 2008, P NATL ACAD SCI USA, V105, P17573, DOI 10.1073/pnas.0803727105; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Rubinov M, 2009, HUM BRAIN MAPP, V30, P403, DOI 10.1002/hbm.20517; Salvador R, 2008, NEUROIMAGE, V39, P279, DOI 10.1016/j.neuroimage.2007.08.018; SAWAGUCHI T, 1991, SCIENCE, V251, P947, DOI 10.1126/science.1825731; SAYKIN AJ, 1991, ARCH GEN PSYCHIAT, V48, P618; Sporns O, 2004, NEUROINFORMATICS, V2, P145, DOI 10.1385/NI:2:2:145; Stam CJ, 2007, CEREB CORTEX, V17, P92, DOI 10.1093/cercor/bhj127; STERNBERG S, 1966, SCIENCE, V153, P652, DOI 10.1126/science.153.3736.652; Sui J, 2010, NEUROIMAGE, V51, P123, DOI 10.1016/j.neuroimage.2010.01.069; van den Heuvel MP, 2010, EUR NEUROPSYCHOPHARM, V20, P519, DOI 10.1016/j.euroneuro.2010.03.008; van den Heuvel MP, 2009, J NEUROSCI, V29, P7619, DOI 10.1523/JNEUROSCI.1443-09.2009; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Wang H, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.021924; Wang LA, 2010, J NEUROSCI, V30, P13171, DOI 10.1523/JNEUROSCI.3514-10.2010; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; White T, 2011, CEREB CORTEX, V21, P510, DOI 10.1093/cercor/bhq114; Whittaker J, 1990, GRAPHICAL MODELS APP, Vxiv; Yu QB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025423; Yu QB, 2011, FRONT SYST NEUROSCI, V5, DOI [10.3389/fnsys.2011.00007, 10.3389/fnsys.2011.00103]; Zhao QB, 2008, PHYSICA A, V387, P5952, DOI 10.1016/j.physa.2008.07.002	89	57	57	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e38195	10.1371/journal.pone.0038195	http://dx.doi.org/10.1371/journal.pone.0038195			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701611	Green Submitted, Green Published, gold			2022-12-27	WOS:000305348400039
J	Owens, GC; Walcott, EC				Owens, Geoffrey C.; Walcott, Elisabeth C.			Extensive Fusion of Mitochondria in Spinal Cord Motor Neurons	PLOS ONE			English	Article							AXONAL MITOCHONDRIA; TRANSPORT; MECHANISMS; DENDRITES; TURNOVER; DYNAMICS; DATABASE; DOCKING; CULTURE; GTPASE	The relative roles played by trafficking, fission and fusion in the dynamics of mitochondria in neurons have not been fully elucidated. In the present study, a slow widespread redistribution of mitochondria within cultured spinal cord motor neurons was observed as a result of extensive organelle fusion. Mitochondria were labeled with a photoconvertible fluorescent protein (mitoKaede) that is red-shifted following brief irradiation with blue light. The behavior of these selectively labeled mitochondria was followed by live fluorescence imaging. Marking mitochondria within the cell soma revealed a complete mixing, within 18 hours, of these organelles with mitochondria coming from the surrounding neurites. Fusion of juxtaposed mitochondria was directly observed in neuritic processes at least 200 microns from the cell body. Within 24 hours, photoconverted mitoKaede was dispersed to all of the mitochondria in the portion of neurite under observation. When time lapse imaging over minutes was combined with long-term observation of marked mitochondria, moving organelles that traversed the field of view did not initially contain photoconverted protein, but after several hours organelles in motion contained both fluorescent proteins, coincident with widespread fusion of all of the mitochondria within the length of neurite under observation. These observations suggest that there is a widespread exchange of mitochondrial components throughout a neuron as a result of organelle fusion.	[Owens, Geoffrey C.; Walcott, Elisabeth C.] Inst Neurosci, San Diego, CA USA		Owens, GC (corresponding author), Inst Neurosci, San Diego, CA USA.	owens@nsi.edu			Neurosciences Research Foundation; G. Harold & Leila Y. Mathers Foundation	Neurosciences Research Foundation; G. Harold & Leila Y. Mathers Foundation	Funded by The Neurosciences Research Foundation and The G. Harold & Leila Y. Mathers Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944; Amiri M, 2008, DEV NEUROBIOL, V68, P1348, DOI 10.1002/dneu.20668; Ando R, 2002, P NATL ACAD SCI USA, V99, P12651, DOI 10.1073/pnas.202320599; Andreoli C, 2004, NUCLEIC ACIDS RES, V32, pD459, DOI 10.1093/nar/gkh137; Attwell D, 2001, J CEREBR BLOOD F MET, V21, P1133, DOI 10.1097/00004647-200110000-00001; BEATTIE DS, 1967, J BIOL CHEM, V242, P4584; Cai Q, 2009, EXP NEUROL, V218, P257, DOI 10.1016/j.expneurol.2009.03.024; Carriedo SG, 1996, J NEUROSCI, V16, P4069; Chang DTW, 2006, J NEUROSCI, V26, P7035, DOI 10.1523/JNEUROSCI.1012-06.2006; Chen HC, 2005, HUM MOL GENET, V14, pR283, DOI 10.1093/hmg/ddi270; Chen HC, 2007, CELL, V130, P548, DOI 10.1016/j.cell.2007.06.026; Chen S, 2007, MOL CELL NEUROSCI, V36, P472, DOI 10.1016/j.mcn.2007.08.004; Cotter D, 2004, NUCLEIC ACIDS RES, V32, pD463, DOI 10.1093/nar/gkh048; CUZNER ML, 1966, BIOCHEM J, V101, P618, DOI 10.1042/bj1010618; Desai NS, 2006, J NEUROSCI, V26, P2215, DOI 10.1523/JNEUROSCI.4310-05.2006; Edelman DB, 2011, JOVE-J VIS EXP, DOI 10.3791/2599; EVANS MJ, 1989, J BIOL CHEM, V264, P14361; Feissner RF, 2009, FRONT BIOSCI-LANDMRK, V14, P1197, DOI 10.2741/3303; Frederick RL, 2007, TRAFFIC, V8, P1668, DOI 10.1111/j.1600-0854.2007.00644.x; Gumy LF, 2010, EXP NEUROL, V223, P28, DOI 10.1016/j.expneurol.2009.06.004; Haastert K, 2005, J NEUROSCI METH, V142, P275, DOI 10.1016/j.jneumeth.2004.09.003; Hollenbeck PJ, 2005, J CELL SCI, V118, P5411, DOI 10.1242/jcs.053850; Hoppins S, 2007, ANNU REV BIOCHEM, V76, P751, DOI 10.1146/annurev.biochem.76.071905.090048; Kang JS, 2008, CELL, V132, P137, DOI 10.1016/j.cell.2007.11.024; Kann O, 2007, AM J PHYSIOL-CELL PH, V292, pC641, DOI 10.1152/ajpcell.00222.2006; Knott AB, 2008, NAT REV NEUROSCI, V9, P505, DOI 10.1038/nrn2417; MacAskill AF, 2010, TRENDS CELL BIOL, V20, P102, DOI 10.1016/j.tcb.2009.11.002; MacAskill AF, 2009, NEURON, V61, P541, DOI 10.1016/j.neuron.2009.01.030; Magrane J, 2012, J NEUROSCI, V32, P229, DOI 10.1523/JNEUROSCI.1233-11.2012; Mattenberger Y, 2003, FEBS LETT, V538, P53, DOI 10.1016/S0014-5793(03)00124-8; McKinney SA, 2009, NAT METHODS, V6, P131, DOI [10.1038/NMETH.1296, 10.1038/nmeth.1296]; Miller KE, 2004, J CELL SCI, V117, P2791, DOI 10.1242/jcs.01130; Misko A, 2010, J NEUROSCI, V30, P4232, DOI 10.1523/JNEUROSCI.6248-09.2010; Overly CC, 1996, J CELL SCI, V109, P971; Pathak D, 2010, J NEUROSCI, V30, P8984, DOI 10.1523/JNEUROSCI.1621-10.2010; Popov V, 2005, J COMP NEUROL, V492, P50, DOI 10.1002/cne.20682; Quintero OA, 2009, CURR BIOL, V19, P2008, DOI 10.1016/j.cub.2009.10.026; RANSOM BR, 1977, J NEUROPHYSIOL, V40, P1132, DOI 10.1152/jn.1977.40.5.1132; Reis K, 2009, FEBS LETT, V583, P1391, DOI 10.1016/j.febslet.2009.04.015; Richter JD, 2009, GENE DEV, V23, P1, DOI 10.1101/gad.1735809; SALAMANCA MC, 1987, DEV NEUROSCI-BASEL, V9, P174, DOI 10.1159/000111620; Saotome M, 2008, P NATL ACAD SCI USA, V105, P20728, DOI 10.1073/pnas.0808953105; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Wagner OI, 2003, J NEUROSCI, V23, P9046; Walcott EC, 2011, J NEUROSCI, V31, P13097, DOI 10.1523/JNEUROSCI.1341-11.2011; Wang XN, 2009, CELL, V136, P163, DOI 10.1016/j.cell.2008.11.046; WESTBURY DR, 1982, J PHYSIOL-LONDON, V325, P79, DOI 10.1113/jphysiol.1982.sp014137; Zuchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341	48	6	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e38435	10.1371/journal.pone.0038435	http://dx.doi.org/10.1371/journal.pone.0038435			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701641	gold, Green Published, Green Submitted			2022-12-27	WOS:000305348400057
J	Angus, D; Watson, B; Smith, A; Gallois, C; Wiles, J				Angus, Daniel; Watson, Bernadette; Smith, Andrew; Gallois, Cindy; Wiles, Janet			Visualising Conversation Structure across Time: Insights into Effective Doctor-Patient Consultations	PLOS ONE			English	Article							COMMUNICATION	Effective communication between healthcare professionals and patients is critical to patients' health outcomes. The doctor/patient dialogue has been extensively researched from different perspectives, with findings emphasising a range of behaviours that lead to effective communication. Much research involves self-reports, however, so that behavioural engagement cannot be disentangled from patients' ratings of effectiveness. In this study we used a highly efficient and time economic automated computer visualisation measurement technique called Discursis to analyse conversational behaviour in consultations. Discursis automatically builds an internal language model from a transcript, mines the transcript for its conceptual content, and generates an interactive visual account of the discourse. The resultant visual account of the whole consultation can be analysed for patterns of engagement between interactants. The findings from this study show that Discursis is effective at highlighting a range of consultation techniques, including communication accommodation, engagement and repetition.	[Angus, Daniel; Watson, Bernadette; Smith, Andrew; Gallois, Cindy; Wiles, Janet] Univ Queensland, St Lucia, Qld, Australia	University of Queensland	Angus, D (corresponding author), Univ Queensland, St Lucia, Qld, Australia.	d.angus@uq.edu.au	Watson, Bernadette/H-1146-2014; Gallois, Cindy/F-9546-2014; Angus, Daniel/C-8163-2009; Wiles, Janet/C-1989-2008	Watson, Bernadette/0000-0003-2419-7752; Gallois, Cindy/0000-0002-7938-7839; Angus, Daniel/0000-0002-1412-5096; Smith, Andrew/0000-0002-4037-4010; Wiles, Janet/0000-0002-4051-4116	Australian Research Council [TS0669699]	Australian Research Council(Australian Research Council)	This work was funded by the Australian Research Council Thinking Systems Grant TS0669699. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angus D, 2012, IEEE T AUDIO SPEECH, V20, P1795, DOI 10.1109/TASL.2012.2189566; Angus D, 2012, IEEE T VIS COMPUT GR, V18, P988, DOI 10.1109/TVCG.2011.100; [Anonymous], 1950, AM SOCIOL REV; Atkinson J., 1985, STRUCTURES SOCIAL AC; Boon H, 1998, PATIENT EDUC COUNS, V35, P161, DOI 10.1016/S0738-3991(98)00063-9; Cegala DJ, 1996, HEALTH COMMUN, V8, P1, DOI 10.1207/s15327027hc0801_1; Cretchley J, 2010, CONVERSATIONS CARERS; ECKMANN JP, 1987, EUROPHYS LETT, V4, P973, DOI 10.1209/0295-5075/4/9/004; Gallois C., 2005, THEORIZING INTERCULT, P121; Graugaard PK, 2005, PATIENT EDUC COUNS, V57, P22, DOI 10.1016/j.pec.2004.03.014; Heritage J, COMMUNICATION MED CA; Hewett DG, 2009, SOC SCI MED, V69, P1732, DOI 10.1016/j.socscimed.2009.09.048; Leach Matthew J, 2005, Complement Ther Clin Pract, V11, P262, DOI 10.1016/j.ctcp.2005.05.005; Leonard M, 2004, QUAL SAF HEALTH CARE, V13, pI85, DOI 10.1136/qshc.2004.010033; Moore SD, 2009, HEALTH COMMUN, V24, P285, DOI 10.1080/10410230902889225; Platt FW, 2004, FIELD GUIDE DIFFICUL; Risch J, 2008, LECT NOTES COMPUT SC, V4404, P154; Roter D, 2002, PATIENT EDUC COUNS, V46, P243, DOI 10.1016/S0738-3991(02)00012-5; Sandvik M, 2002, PATIENT EDUC COUNS, V46, P235, DOI 10.1016/S0738-3991(02)00014-9; Smith AE, 2000, MACHINE MAPPING DOCU, P39; Smith AE, 2006, BEHAV RES METHODS, V38, P262, DOI 10.3758/BF03192778; Street Jr R, 2001, NEW HDB LANGUAGE SOC, P541; Street RL, 2009, PATIENT EDUC COUNS, V74, P295, DOI 10.1016/j.pec.2008.11.015; Street RL, 2003, LEA COMMUN SER, P63; Street RL, 2001, HEALTH COMMUN, V13, P61, DOI 10.1207/S15327027HC1301_06; Watson B, 2002, J LANG SOC PSYCHOL, V21, P32, DOI 10.1177/0261927X02021001003; Watson B. M., 2004, LANGUAGE MATTERS COM, P63; Watson B, 2007, PALGRAVE ADV, P108	28	51	52	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e38014	10.1371/journal.pone.0038014	http://dx.doi.org/10.1371/journal.pone.0038014			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959VI	22693629	Green Published, gold, Green Submitted			2022-12-27	WOS:000305343900017
J	Vandecandelaere, I; Matthijs, N; Van Nieuwerburgh, F; Deforce, D; Vosters, P; De Bus, L; Nelis, HJ; Depuydt, P; Coenye, T				Vandecandelaere, Ilse; Matthijs, Nele; Van Nieuwerburgh, Filip; Deforce, Dieter; Vosters, Peter; De Bus, Liesbet; Nelis, Hans J.; Depuydt, Pieter; Coenye, Tom			Assessment of Microbial Diversity in Biofilms Recovered from Endotracheal Tubes Using Culture Dependent and Independent Approaches	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; SURVEILLANCE CULTURES; NOSOCOMIAL PNEUMONIA; ORAL CAVITY; BACTERIA; IMPACT; INFECTION; RISK	Ventilator-associated pneumonia (VAP) is a common nosocomial infection in mechanically ventilated patients. Biofilm formation is one of the mechanisms through which the endotracheal tube (ET) facilitates bacterial contamination of the lower airways. In the present study, we analyzed the composition of the ET biofilm flora by means of culture dependent and culture independent (16 S rRNA gene clone libraries and pyrosequencing) approaches. Overall, the microbial diversity was high and members of different phylogenetic lineages were detected (Actinobacteria, beta-Proteobacteria, Candida spp., Clostridia, epsilon-Proteobacteria, Firmicutes, Fusobacteria and gamma-Proteobacteria). Culture dependent analysis, based on the use of selective growth media and conventional microbiological tests, resulted in the identification of typical aerobic nosocomial pathogens which are known to play a role in the development of VAP, e. g. Staphylococcus aureus and Pseudomonas aeruginosa. Other opportunistic pathogens were also identified, including Staphylococcus epidermidis and Kocuria varians. In general, there was little correlation between the results obtained by sequencing 16 S rRNA gene clone libraries and by cultivation. Pyrosequencing of PCR amplified 16 S rRNA genes of four selected samples resulted in the identification of a much wider variety of bacteria. The results from the pyrosequencing analysis suggest that these four samples were dominated by members of the normal oral flora such as Prevotella spp., Peptostreptococcus spp. and lactic acid bacteria. A combination of methods is recommended to obtain a complete picture of the microbial diversity of the ET biofilm.	[Vandecandelaere, Ilse; Matthijs, Nele; Nelis, Hans J.; Coenye, Tom] Univ Ghent, Lab Pharmaceut Microbiol, B-9000 Ghent, Belgium; [Van Nieuwerburgh, Filip; Deforce, Dieter] Univ Ghent, Lab Pharmaceut Biotechnol, B-9000 Ghent, Belgium; [Vosters, Peter; De Bus, Liesbet; Depuydt, Pieter] Ghent Univ Hosp, Dept Intens Care, Ghent, Belgium	Ghent University; Ghent University; Ghent University; Ghent University Hospital	Vandecandelaere, I (corresponding author), Univ Ghent, Lab Pharmaceut Microbiol, B-9000 Ghent, Belgium.	Ilse.Vandecandelaere@UGent.be	Van Nieuwerburgh, Filip/H-9697-2015; Coenye, Tom/Z-1928-2019; Coenye, Tom/A-6291-2014; Deforce, Dieter LD/J-4725-2013	Van Nieuwerburgh, Filip/0000-0001-8815-5485; Coenye, Tom/0000-0002-6407-0601; Coenye, Tom/0000-0002-6407-0601; Deforce, Dieter LD/0000-0002-0635-661X	'Fonds voor Wetenschappelijk Onderzoek-Vlaanderen' (FWO-Vlaanderen) [3G001211]	'Fonds voor Wetenschappelijk Onderzoek-Vlaanderen' (FWO-Vlaanderen)(FWO)	This work was funded by 'Fonds voor Wetenschappelijk Onderzoek-Vlaanderen' (FWO-Vlaanderen; project number: 3G001211). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott S.L., 2011, MANUAL CLIN MICROBIO; Adair CG, 1999, INTENS CARE MED, V25, P1072, DOI 10.1007/s001340051014; ALBERTSON D, 1978, ARCH INTERN MED, V138, P487, DOI 10.1001/archinte.138.3.487; [Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; Argimon S, 2011, J CLIN MICROBIOL, V49, P984, DOI 10.1128/JCM.01993-10; Augustyn B, 2007, CRIT CARE NURSE, V27, P32; Bahrani-Mougeot FK, 2007, J CLIN MICROBIOL, V45, P1588, DOI 10.1128/JCM.01963-06; Baron EJ, 2011, MANUAL CLIN MICROBIO; Bauer T T, 2002, Monaldi Arch Chest Dis, V57, P84; Becker K., 2011, MANUAL CLIN MICROBIO; Blot S, 2008, CLIN INFECT DIS, V46, P481, DOI 10.1086/526349; Blot S, 2008, INTENS CARE MED, V34, P2130, DOI 10.1007/s00134-008-1249-7; Bouza E, 2009, CURR OPIN INFECT DIS, V22, P345, DOI 10.1097/QCO.0b013e32832d8910; Cairns S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014759; Carbon C, 2000, CLIN MICROBIOL INFEC, V6, P17, DOI 10.1046/j.1469-0691.2000.00005.x; Chang EP, 2009, J MICROBIOL IMMUNOL, V42, P329; Coenye T, 1999, INT J SYST BACTERIOL, V49, P405, DOI 10.1099/00207713-49-2-405; Conville PS, 2011, MANUAL CLIN MICROBIO; Costerton JW, 2011, FEMS IMMUNOL MED MIC, V61, P133, DOI 10.1111/j.1574-695X.2010.00766.x; Czosnowski QA, 2011, PHARMACOTHERAPY, V31, P338, DOI 10.1592/phco.31.4.338; Decraene V, 2008, J GEN APPL MICROBIOL, V54, P195, DOI 10.2323/jgam.54.195; Decre D, 2011, J CLIN MICROBIOL, V49, P3012, DOI 10.1128/JCM.00676-11; Depuydt P, 2008, INTENS CARE MED, V34, P675, DOI 10.1007/s00134-007-0953-z; Depuydt P, 2006, CURR OPIN PULM MED, V12, P192; Depuydt P, 2006, INTENS CARE MED, V32, P1773, DOI 10.1007/s00134-006-0354-8; Dewhirst FE, 2010, J BACTERIOL, V192, P5002, DOI 10.1128/JB.00542-10; Edwards C, 2000, MOL BIOTECHNOL, V15, P211, DOI 10.1385/MB:15:3:211; Esteban J, 2010, ACTA ORTHOP, V81, P674, DOI 10.3109/17453674.2010.537810; Funke G, 1997, CLIN MICROBIOL REV, V10, P125, DOI 10.1128/CMR.10.1.125; GOOD IJ, 1953, BIOMETRIKA, V40, P237, DOI 10.2307/2333344; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Heo SM, 2008, CLIN INFECT DIS, V47, P1562, DOI 10.1086/593193; INGLIS TJJ, 1989, J CLIN MICROBIOL, V27, P2014, DOI 10.1128/JCM.27.9.2014-2018.1989; Joly E, 1996, METHOD MOL BIOL, V58, P256; Joseph NM, 2010, EUR J INTERN MED, V21, P360, DOI 10.1016/j.ejim.2010.07.006; Lazarevic V, 2009, J MICROBIOL METH, V79, P266, DOI 10.1016/j.mimet.2009.09.012; Luna CM, 2009, EUR RESPIR J, V33, P182, DOI 10.1183/09031936.00046308; Mahenthiralingam E, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-251; Mancini F, 2009, EMERG INFECT DIS, V15, P1874, DOI 10.3201/eid1511.090126; Narayan SA, 2009, INFECT CONT HOSP EP, V30, P797, DOI 10.1086/598240; Nseir S, 2007, INTENS CARE MED, V33, P137, DOI 10.1007/s00134-006-0422-0; Oudiz RJ, 2004, CHEST, V126, P90, DOI 10.1378/chest.126.1.90; Palatinszky M, 2011, J MICROBIOL METH, V85, P131, DOI 10.1016/j.mimet.2011.02.007; Park David R, 2005, Respir Care, V50, P742; Pereira EM, 2010, MICROBIOL RES, V165, P243, DOI 10.1016/j.micres.2009.03.003; Perkins SD, 2010, INT J MED MICROBIOL, V300, P503, DOI 10.1016/j.ijmm.2010.02.005; Ruoff KL, 2011, MANUAL CLIN MICROBIO; Ryan MP, 2010, J HOSP INFECT, V75, P153, DOI 10.1016/j.jhin.2010.03.007; Savini V, 2010, J MED MICROBIOL, V59, P1395, DOI 10.1099/jmm.0.021709-0; Schloss PD, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000844; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Song EH, 2010, DIAGN MICR INFEC DIS, V66, P436, DOI 10.1016/j.diagmicrobio.2009.11.007; Sookkhee S, 2001, J APPL MICROBIOL, V90, P172, DOI 10.1046/j.1365-2672.2001.01229.x; SOTTILE FD, 1986, CRIT CARE MED, V14, P265, DOI 10.1097/00003246-198604000-00001; Takeshita T, 2010, J AM GERIATR SOC, V58, P1050, DOI 10.1111/j.1532-5415.2010.02867.x; Toyoshima Mikio, 2010, Respirology, V15, P867, DOI 10.1111/j.1440-1843.2010.01780.x; Tunney MM, 2008, AM J RESP CRIT CARE, V177, P995, DOI 10.1164/rccm.200708-1151OC; Vaneechoutte ML, 2011, MANUAL CLIN MICROBIO; WATANABE T, 1986, J CLIN MICROBIOL, V23, P1034, DOI 10.1128/JCM.23.6.1034-1038.1986; Zemanick ET, 2011, CURR OPIN PEDIATR, V23, P319, DOI 10.1097/MOP.0b013e32834604f2; Zhao JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033127; Ziebuhr W, 2006, INT J ANTIMICROB AG, V28, pS14, DOI 10.1016/j.ijantimicag.2006.05.012	64	50	50	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e38401	10.1371/journal.pone.0038401	http://dx.doi.org/10.1371/journal.pone.0038401			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22693635	Green Published, gold, Green Submitted			2022-12-27	WOS:000305343900035
J	Athavale, SS; Petrov, AS; Hsiao, C; Watkins, D; Prickett, CD; Gossett, JJ; Lie, L; Bowman, JC; O'Neill, E; Bernier, CR; Hud, NV; Wartell, RM; Harvey, SC; Williams, LD				Athavale, Shreyas S.; Petrov, Anton S.; Hsiao, Chiaolong; Watkins, Derrick; Prickett, Caitlin D.; Gossett, J. Jared; Lie, Lively; Bowman, Jessica C.; O'Neill, Eric; Bernier, Chad R.; Hud, Nicholas V.; Wartell, Roger M.; Harvey, Stephen C.; Williams, Loren Dean			RNA Folding and Catalysis Mediated by Iron (II)	PLOS ONE			English	Article							ENERGY DECOMPOSITION ANALYSIS; MOLECULAR-INTERACTIONS; TERTIARY STRUCTURE; METAL-IONS; BINDING; MAGNESIUM; MANGANESE; RIBOZYME; MINERALOGY; FRAMEWORK	Mg2+ shares a distinctive relationship with RNA, playing important and specific roles in the folding and function of essentially all large RNAs. Here we use theory and experiment to evaluate Fe2+ in the absence of free oxygen as a replacement for Mg2+ in RNA folding and catalysis. We describe both quantum mechanical calculations and experiments that suggest that the roles of Mg2+ in RNA folding and function can indeed be served by Fe2+. The results of quantum mechanical calculations show that the geometry of coordination of Fe2+ by RNA phosphates is similar to that of Mg2+. Chemical footprinting experiments suggest that the conformation of the Tetrahymena thermophila Group I intron P4-P6 domain RNA is conserved between complexes with Fe2+ or Mg2+. The catalytic activities of both the L1 ribozyme ligase, obtained previously by in vitro selection in the presence of Mg2+, and the hammerhead ribozyme are enhanced in the presence of Fe2+ compared to Mg2+. All chemical footprinting and ribozyme assays in the presence of Fe2+ were performed under anaerobic conditions. The primary motivation of this work is to understand RNA in plausible early earth conditions. Life originated during the early Archean Eon, characterized by a non-oxidative atmosphere and abundant soluble Fe2+. The combined biochemical and paleogeological data are consistent with a role for Fe2+ in an RNA World. RNA and Fe2+ could, in principle, support an array of RNA structures and catalytic functions more diverse than RNA with Mg2+ alone.	[Athavale, Shreyas S.; Petrov, Anton S.; Gossett, J. Jared; Lie, Lively; Wartell, Roger M.; Harvey, Stephen C.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Hsiao, Chiaolong; Watkins, Derrick; Prickett, Caitlin D.; Bowman, Jessica C.; O'Neill, Eric; Bernier, Chad R.; Hud, Nicholas V.; Wartell, Roger M.; Harvey, Stephen C.; Williams, Loren Dean] Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA; [Athavale, Shreyas S.; Petrov, Anton S.; Hsiao, Chiaolong; Watkins, Derrick; Prickett, Caitlin D.; Gossett, J. Jared; Lie, Lively; Bowman, Jessica C.; O'Neill, Eric; Bernier, Chad R.; Hud, Nicholas V.; Harvey, Stephen C.; Williams, Loren Dean] Georgia Inst Technol, NAI Ctr Ribosomal Origins & Evolut, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Athavale, SS (corresponding author), Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA.	loren.williams@chemistry.gatech.edu	Hud, Nicholas V/T-7017-2017	Hud, Nicholas/0000-0001-7711-6472; Bowman, Jessica/0000-0002-6219-2680	NASA Astrobiology Institute [NNA09DA78A]	NASA Astrobiology Institute	Funding provided by NASA Astrobiology Institute Grant number: NNA09DA78A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre JD, 2012, J BIOL CHEM, V287, P13541, DOI 10.1074/jbc.R111.312181; Anbar AD, 2008, SCIENCE, V322, P1481, DOI 10.1126/science.1163100; Athavale SS, 2012, RNA, V18, P752, DOI 10.1261/rna.030692.111; Atkins J. F., 2011, RNA WORLDS LIFES ORI; Auffinger P, 2011, METAL IONS LIFE SCI, V9, P1, DOI 10.1039/978184973251200001; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; BECKE AD, 1988, PHYS REV A, V38, P3098, DOI 10.1103/PhysRevA.38.3098; Bock CW, 2006, THEOR CHEM ACC, V115, P100, DOI 10.1007/s00214-005-0056-2; BOYS SF, 1970, MOL PHYS, V19, P553, DOI 10.1080/00268977000101561; Brion P, 1997, ANNU REV BIOPH BIOM, V26, P113, DOI 10.1146/annurev.biophys.26.1.113; BROWN ID, 1992, ACTA CRYSTALLOGR B, V48, P553, DOI 10.1107/S0108768192002453; Butcher SE, 2011, METAL IONS LIFE SCI, V9, P235, DOI 10.1039/978184973251200235; Cate JH, 1997, NAT STRUCT BIOL, V4, P553, DOI 10.1038/nsb0797-553; Chiancone E, 2004, BIOMETALS, V17, P197, DOI 10.1023/B:BIOM.0000027692.24395.76; Coale KH, 1996, NATURE, V383, P495, DOI 10.1038/383495a0; Condie KC, 2007, EARTHS OLDEST ROCKS; Condie KC, 2008, GEOL SOC AM SPEC PAP, V440, P281, DOI 10.1130/2008.2440(14); DAVIES GF, 1992, GEOLOGY, V20, P963, DOI 10.1130/0091-7613(1992)020<0963:OTEOPT>2.3.CO;2; Draper DE, 2008, BIOPHYS J, V95, P5489, DOI 10.1529/biophysj.108.131813; Frisch G. W., 2013, GAUSSIAN 09; Glendening ED, 1996, J AM CHEM SOC, V118, P2473, DOI 10.1021/ja951834y; GLENDENING ED, 1994, J CHEM PHYS, V100, P2900, DOI 10.1063/1.466432; Gordon MS, 2005, THEORY AND APPLICATIONS OF COMPUTATIONAL CHEMISTRY: THE FIRST FORTY YEARS, P1167, DOI 10.1016/B978-044451719-7/50084-6; Goss DJ, 2011, ACCOUNTS CHEM RES, V44, P1320, DOI 10.1021/ar2001149; Hanson S, 2005, RNA, V11, P503, DOI 10.1261/rna.7251305; Hazen RM, 2008, AM MINERAL, V93, P1693, DOI 10.2138/am.2008.2955; Hazen RM, 2010, ELEMENTS, V6, P9, DOI 10.2113/gselements.6.1.9; Holland H.D., 1984, CHEM EVOLUTION ATMOS; Hsiao CL, 2009, NUCLEIC ACIDS RES, V37, P3134, DOI 10.1093/nar/gkp119; Hsiao Chiaolong, 2009, P1; Johnson CM, 2008, ANNU REV EARTH PL SC, V36, P457, DOI 10.1146/annurev.earth.36.031207.124139; Johnson-Buck AE, 2011, METAL IONS LIFE SCI, V9, P175, DOI 10.1039/978184973251200175; Kell DB, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-2; Klein C, 2005, AM MINERAL, V90, P1473, DOI 10.2138/am.2005.1871; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; LINDAHL T, 1966, P NATL ACAD SCI USA, V55, P941, DOI 10.1073/pnas.55.4.941; LYNCH DC, 1974, BIOCHEMISTRY-US, V13, P1841, DOI 10.1021/bi00706a012; Merino EJ, 2005, J AM CHEM SOC, V127, P4223, DOI 10.1021/ja043822v; Misra VK, 2001, P NATL ACAD SCI USA, V98, P12456, DOI 10.1073/pnas.221234598; Moore J.K., 2007, BIOGEOSCIENCES, V4, P1241, DOI [10.5194/bgd-4-1241-2007, DOI 10.5194/BGD-4-1241-2007, DOI 10.5194/bgd-4-1241-2007]; Mortimer SA, 2007, J AM CHEM SOC, V129, P4144, DOI 10.1021/ja0704028; Mortimer SA, 2008, J AM CHEM SOC, V130, P16178, DOI 10.1021/ja8061216; Peers G, 2004, LIMNOL OCEANOGR, V49, P1774, DOI 10.4319/lo.2004.49.5.1774; Petrov AS, 2011, RNA, V17, P291, DOI 10.1261/rna.2390311; RASHIN AA, 1985, J PHYS CHEM-US, V89, P5588, DOI 10.1021/j100272a006; Robertson MP, 2007, SCIENCE, V315, P1549, DOI 10.1126/science.1136231; Rosing MT, 2010, NATURE, V464, P744, DOI 10.1038/nature08955; Schenter GK, 1996, J PHYS CHEM-US, V100, P17152, DOI 10.1021/jp9612994; Scott WG, 2007, CURR OPIN STRUC BIOL, V17, P280, DOI 10.1016/j.sbi.2007.05.003; Seehafer C, 2011, RNA, V17, P21, DOI 10.1261/rna.2429911; SNOW JE, 1995, GEOCHIM COSMOCHIM AC, V59, P4219, DOI 10.1016/0016-7037(95)00239-V; Stage-Zimmermann TK, 2001, NAT STRUCT BIOL, V8, P863, DOI 10.1038/nsb1001-863; STEIN A, 1976, BIOCHEMISTRY-US, V15, P160, DOI 10.1021/bi00646a025; SUNDA WG, 1995, MAR CHEM, V50, P189, DOI 10.1016/0304-4203(95)00035-P; TAJIKA E, 1992, EARTH PLANET SC LETT, V113, P251, DOI 10.1016/0012-821X(92)90223-I; Takamoto K, 2004, J MOL BIOL, V343, P1195, DOI 10.1016/j.jmb.2004.08.080; Theil EC, 2009, CHEM REV, V109, P4568, DOI 10.1021/cr900052g; Tomasi J, 1999, J MOL STRUC-THEOCHEM, V464, P211, DOI 10.1016/S0166-1280(98)00553-3; Toor N, 2008, SCIENCE, V320, P77, DOI 10.1126/science.1153803; Van duijneveldt-Van de Rijdt JGCM, 1997, WILEY THEOR CHEM, P13; VARY CPH, 1984, P NATL ACAD SCI-BIOL, V81, P6978, DOI 10.1073/pnas.81.22.6978; Vicens Q, 2007, RNA, V13, P536, DOI 10.1261/rna.400207; WANG JF, 1992, SCIENCE, V256, P526, DOI 10.1126/science.1315076; Ward WL, 2012, RNA, V18, P16, DOI 10.1261/rna.030239.111; Whitfield M, 2001, ADV MAR BIOL, V41, P1, DOI 10.1016/S0065-2881(01)41002-9; Wilkinson KA, 2005, J AM CHEM SOC, V127, P4659, DOI 10.1021/ja0436749; Wilkinson KA, 2008, PLOS BIOL, V6, P883, DOI 10.1371/journal.pbio.0060096; Wolfe-Simon F, 2006, PLANT PHYSIOL, V142, P1701, DOI 10.1104/pp.106.088963	69	63	66	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38024	10.1371/journal.pone.0038024	http://dx.doi.org/10.1371/journal.pone.0038024			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22701543	gold, Green Published, Green Submitted			2022-12-27	WOS:000305338500074
J	Cui, W; Wang, K; Ruan, JS; Qi, Z; Feng, Y; Shao, YM; Tuszynski, JA				Cui, Wei; Wang, Kui; Ruan, Jishou; Qi, Zhi; Feng, Yi; Shao, Yiming; Tuszynski, Jack A.			The Molecular Mechanism of Action of the CR6261-Azichromycin Combination Found through Computational Analysis	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; AUTOMATED DOCKING; MONOCLONAL-ANTIBODIES; FLEXIBLE LIGANDS; INDUCTION; PROTEINS	Background: CR6261 was found in 2008 and F10 was found in 2009. In 2010 Friesen et al experimentally showed that Oseltamivir/Zanamivir may improve the therapeutic efficacy of CR6261. As a result, the use of CR6261 combined with a drug to provide an antibody-based therapy against all influenza A viruses was proposed. Although CR8020 may neutralize group 2 influenza viruses and FI6 may neutralize both group 1 and group 2 influenza viruses as determined in 2011, the insight of Friesen et al is still interesting. Here, we address the following questions: how to uncover the molecular mechanism of a drug, which improves the therapeutic efficacy of mAbs and how to find drugs that enable CR6261 (CR8020, F10) to become a universal mAb. Methods and Findings: Using the 3D structures of 3 gbn, 3 gbm, 3 ztn, 3 ztj, 3 fku and 3 sdy, we separate the 3D structures of CR6261, F10, CR8020 and FI6, and the 3D structures of trimer HAs of H3N2 and H5N1. Based on the experimental result of Friesen et al, we have found many clues, which reveal the molecular mechanism of action for a drug and an HA-mAb complex. Conclusions: Oseltamivir/Zanamivir may congruously improve the therapeutic efficacies of CR6261, F10, CR8020 and FI6 by providing an additional affinity to compensate for the loss of affinity between HA and mAb resulting from mutations. However, Oseltamivir or Zanamivir are not expected to generally widen the spectrum of these mAbs. In order to enhance CR6261, CR8020, or for F10 to become universal, we may select Azichromycin, Oseltamivir, or the combination of Azichromycin and Oseltamivir, respectively.	[Cui, Wei; Wang, Kui; Ruan, Jishou] Nankai Univ, Coll Math Sci, LPMC, Tianjin 300071, Peoples R China; [Qi, Zhi; Feng, Yi; Shao, Yiming] Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China; [Tuszynski, Jack A.] Cross Canc Inst, Div Expt Oncol, Edmonton, AB T6G 1Z2, Canada; [Ruan, Jishou] Nankai Univ, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China	Nankai University; Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention; University of Alberta; Nankai University	Cui, W (corresponding author), Nankai Univ, Coll Math Sci, LPMC, Tianjin 300071, Peoples R China.	jsruan@nankai.edu.cn; yshao08@gmail.com	Tuszynski, Jack/AAA-2073-2020	Tuszynski, Jack/0000-0001-9976-0429	International Development Research Center, Ottawa, Canada [104519-010]; China CDC [2008SKLID203]; National Nature Science Foundation of China; NSFC [10671100, 68075049, 31050110432];  [08ZCHHZ00200]	International Development Research Center, Ottawa, Canada; China CDC; National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); NSFC(National Natural Science Foundation of China (NSFC)); 	This work was carried out with the aid of a grant (No. 104519-010) from the International Development Research Center, Ottawa, Canada. All authors acknowledge the project of the China CDC (2008SKLID203). JRuan group would like to specifically thank for the support received from National Nature Science Foundation of China, NSFC (10671100, 68075049 and 31050110432), the project for the innovative groups administered by China Ministry of Education and 08ZCHHZ00200. Websites: IDRC www.idrc.ca, NSFC www.nsfc.gov.cn, China CDC www.chinacdc.cn, and TSTC www.tstc.gov.cn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrusier N, 2008, PROTEINS, V73, P271, DOI 10.1002/prot.22170; Bourquard T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018541; Bray N, 2003, NUCLEIC ACIDS RES, V31, P3525, DOI 10.1093/nar/gkg623; Bray N, 2003, GENOME RES, V13, P97, DOI 10.1101/gr.789803; Corti D, 2011, SCIENCE, V333, P850, DOI 10.1126/science.1205669; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ekiert DC, 2011, SCIENCE, V333, P843, DOI 10.1126/science.1204839; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Friesen RHE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009106; Goodsell DS, 1996, J MOL RECOGNIT, V9, P1, DOI 10.1002/(SICI)1099-1352(199601)9:1<1::AID-JMR241>3.0.CO;2-6; GOODSELL DS, 1990, PROTEINS, V8, P195, DOI 10.1002/prot.340080302; Huey R, 2007, J COMPUT CHEM, V28, P1145, DOI 10.1002/jcc.20634; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Lyskov S, 2008, NUCLEIC ACIDS RES, V36, pW233, DOI 10.1093/nar/gkn216; Morris GM, 1996, J COMPUT AID MOL DES, V10, P293, DOI 10.1007/BF00124499; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Nabel GJ, 2010, NAT MED, V16, P1389, DOI 10.1038/nm1210-1389; Notredame C, 1996, NUCLEIC ACIDS RES, V24, P1515, DOI 10.1093/nar/24.8.1515; Notredame C, 1998, BIOINFORMATICS, V14, P407, DOI 10.1093/bioinformatics/14.5.407; Ritchie DW, 2008, CURR PROTEIN PEPT SC, V9, P1, DOI 10.2174/138920308783565741; SKEHEL JJ, 1975, P NATL ACAD SCI USA, V72, P93, DOI 10.1073/pnas.72.1.93; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Throsby M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003942; Wei CJ, 2010, SCIENCE, V329, P1060, DOI 10.1126/science.1192517; Zhang M, 2005, COMPUT BIOL CHEM, V29, P175, DOI 10.1016/j.compbiolchem.2004.12.005	27	1	1	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e37790	10.1371/journal.pone.0037790	http://dx.doi.org/10.1371/journal.pone.0037790			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693576	Green Published, Green Submitted, gold			2022-12-27	WOS:000305338500056
J	Hladik, W; Barker, J; Ssenkusu, JM; Opio, A; Tappero, JW; Hakim, A; Serwadda, D; Grp, CS				Hladik, Wolfgang; Barker, Joseph; Ssenkusu, John M.; Opio, Alex; Tappero, Jordan W.; Hakim, Avi; Serwadda, David; Grp, Crane Survey			HIV Infection among Men Who Have Sex with Men in Kampala, Uganda-A Respondent Driven Sampling Survey	PLOS ONE			English	Article							INCOME; RISK; GAY	Background: Uganda's generalized HIV epidemic is well described, including an estimated adult male HIV prevalence in Kampala of 4.5%, but no data are available on the prevalence of and risk factors for HIV infection among men who have sex with men (MSM). Methodology/Principal Findings: From May 2008 to February 2009, we used respondent-driven sampling to recruit MSM >= 18 years old in Kampala who reported anal sex with another man in the previous three months. We collected demographic and HIV-related behavioral data through audio computer-assisted self-administered interviews. Laboratory testing included biomarkers for HIV and other sexually transmitted infections. We obtained population estimates adjusted for the non-random sampling frame using RDSAT and STATA. 300 MSM were surveyed over 11 waves; median age was 25 years (interquartile range, 21-29 years). Overall HIV prevalence was 13.7% (95% confidence interval [CI] 7.9%-20.1%), and was higher among MSM >= 25 years (22.4%) than among MSM aged 18-24 years (3.9%, odds ratio [OR] 5.69, 95% CI 2.02-16.02). In multivariate analysis, MSM >= 25 years (adjusted OR [aOR] 4.32, 95% CI 1.33-13.98) and those reporting ever having been exposed to homophobic abuse (verbal, moral, sexual, or physical abuse; aOR 5.38, 95% CI 1.95-14.79) were significantly more likely to be HIV infected. Conclusions/Significance: MSM in Kampala are at substantially higher risk for HIV than the general adult male population. MSM reporting a lifetime history of homophobic abuse are at increased risk of being HIV infected. Legal challenges and stigma must be overcome to provide access to tailored HIV prevention and care services.	[Hladik, Wolfgang; Barker, Joseph; Ssenkusu, John M.; Tappero, Jordan W.] Ctr Dis Control & Prevent CDC, Ctr Global Hlth, Div Global HIV AIDS, Entebbe, Uganda; [Hladik, Wolfgang] Univ Amsterdam, Dept Clin Epidemiol, Acad Med Ctr, Amsterdam, Netherlands; [Opio, Alex] Minist Hlth, Kampala, Uganda; [Hakim, Avi] Ctr Dis Control & Prevent CDC, Div Global HIV AIDS, Ctr Global Hlth, Entebbe, Uganda; [Serwadda, David] Makerere Univ, Sch Publ Hlth, Kampala, Uganda	University of Amsterdam; Academic Medical Center Amsterdam; Makerere University	Hladik, W (corresponding author), Ctr Dis Control & Prevent CDC, Ctr Global Hlth, Div Global HIV AIDS, Entebbe, Uganda.	wfh3@cdc.gov		Ssenkusu, John/0000-0003-0499-5642	US President's Emergency Plan for AIDS Relief	US President's Emergency Plan for AIDS Relief(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This study was funded by the US President's Emergency Plan for AIDS Relief. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baral S, 2007, PLOS MED, V4, P1901, DOI 10.1371/journal.pmed.0040339; Baral S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004997; Beyrer C, 2010, EPIDEMIOL REV, V32, P137, DOI 10.1093/epirev/mxq011; Beyrer C, 2010, CLIN INFECT DIS, V50, pS108, DOI 10.1086/651481; Caceres C, 2006, SEX TRANSM INFECT, V82, pIII3, DOI 10.1136/sti.2005.019489; Friedman MS, 2008, AIDS BEHAV, V12, P891, DOI 10.1007/s10461-007-9319-3; Glick SN, 2010, JAIDS-J ACQ IMM DEF, V55, P516, DOI 10.1097/QAI.0b013e3181f275e0; Goel S, 2010, P NATL ACAD SCI USA, V107, P6743, DOI 10.1073/pnas.1000261107; HECKATHORN D, 2004, SOCIAL METHODS, V34, P208; Heckathorn DD, 2002, SOC PROBL, V49, P11, DOI 10.1525/sp.2002.49.1.11; Heckathorn DD, 1997, SOC PROBL, V44, P174, DOI 10.1525/sp.1997.44.2.03x0221m; International Gay and Lesbian Human Rights Commission, 2008, UG LGBT ARR INT HIV; International Gay and Lesbian Human Rights Commission, 2008, UG DEM END OFF HAR L; Kajubi P, 2008, AIDS BEHAV, V12, P492, DOI 10.1007/s10461-007-9323-7; Makerere University School of Public Health, 2010, CRAN SURV REP HIGH R; Malekinejad M, 2008, AIDS BEHAV, V12, pS105, DOI 10.1007/s10461-008-9421-1; Ministry of Health (MoH) STD/AIDS Control Programme, 2011, HIV AIDS SER SURV FI; Ministry of Health (MOH) [Uganda] ORC Macro, 2006, UG HIV AIDS SER SURV; Sanders EJ, 2007, AIDS, V21, P2513, DOI 10.1097/QAD.0b013e3282f2704a; van Griensven F, 2007, AIDS, V21, P1361, DOI 10.1097/QAD.0b013e328017f868; Wade AS, 2005, AIDS, V19, P2133, DOI 10.1097/01.aids.0000194128.97640.07	21	97	98	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38143	10.1371/journal.pone.0038143	http://dx.doi.org/10.1371/journal.pone.0038143			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693590	Green Published, gold			2022-12-27	WOS:000305338500093
J	Pathania, M; Torres-Reveron, J; Yan, L; Kimura, T; Lin, TV; Gordon, V; Teng, ZQ; Zhao, XY; Fulga, TA; Van Vactor, D; Bordey, A				Pathania, Manavendra; Torres-Reveron, Juan; Yan, Lily; Kimura, Tomoki; Lin, Tiffany V.; Gordon, Valerie; Teng, Zhao-Qian; Zhao, Xinyu; Fulga, Tudor A.; Van Vactor, David; Bordey, Angelique			miR-132 Enhances Dendritic Morphogenesis, Spine Density, Synaptic Integration, and Survival of Newborn Olfactory Bulb Neurons	PLOS ONE			English	Article							ADULT NEUROGENESIS; MICRORNAS; TRANSCRIPTION	An array of signals regulating the early stages of postnatal subventricular zone (SVZ) neurogenesis has been identified, but much less is known regarding the molecules controlling late stages. Here, we investigated the function of the activity-dependent and morphogenic microRNA miR-132 on the synaptic integration and survival of olfactory bulb (OB) neurons born in the neonatal SVZ. In situ hybridization revealed that miR-132 expression occurs at the onset of synaptic integration in the OB. Using in vivo electroporation we found that sequestration of miR-132 using a sponge-based strategy led to a reduced dendritic complexity and spine density while overexpression had the opposite effects. These effects were mirrored with respective changes in the frequency of GABAergic and glutamatergic synaptic inputs reflecting altered synaptic integration. In addition, timely directed overexpression of miR-132 at the onset of synaptic integration using an inducible approach led to a significant increase in the survival of newborn neurons. These data suggest that miR-132 forms the basis of a structural plasticity program seen in SVZ-OB postnatal neurogenesis. miR-132 overexpression in transplanted neurons may thus hold promise for enhancing neuronal survival and improving the outcome of transplant therapies.	[Pathania, Manavendra; Torres-Reveron, Juan; Yan, Lily; Kimura, Tomoki; Lin, Tiffany V.; Gordon, Valerie; Bordey, Angelique] Yale Univ, Sch Med, Dept Neurosurg, New Haven, CT 06520 USA; [Pathania, Manavendra; Torres-Reveron, Juan; Yan, Lily; Kimura, Tomoki; Lin, Tiffany V.; Gordon, Valerie; Bordey, Angelique] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA; [Teng, Zhao-Qian; Zhao, Xinyu] Univ New Mexico, Dept Neurosci, Sch Med, Albuquerque, NM 87131 USA; [Fulga, Tudor A.; Van Vactor, David] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA USA	Yale University; Yale University; University of New Mexico; Harvard University; Harvard Medical School	Pathania, M (corresponding author), Yale Univ, Sch Med, Dept Neurosurg, New Haven, CT 06520 USA.	angelique.bordey@yale.edu	Yan, Lily/AAR-6163-2021; Teng, Zhao-Qian/AAD-1033-2021; Teng, Zhao-Qian/J-6260-2015	Yan, Lily/0000-0001-6363-7920; Teng, Zhao-Qian/0000-0002-7232-3381; Teng, Zhao-Qian/0000-0002-7232-3381; Fulga, Tudor/0000-0002-1056-0082; Torres-Reveron, Juan/0000-0002-3269-1067; Van Vactor, Jr., David L./0000-0001-8156-9482; Pathania, Manav/0000-0001-5635-5028	National Institutes of Health (NIH) [R01 DC007681, P30 NS-052519]; McKnight disorder award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003352] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH078972, R01MH080434] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS069695, P30NS052519] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC007681] Funding Source: NIH RePORTER; Medical Research Council [G0902418] Funding Source: researchfish; MRC [G0902418] Funding Source: UKRI	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McKnight disorder award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by grants from the National Institutes of Health (NIH) R01 DC007681 and McKnight disorder award (AB), and NIH P30 NS-052519 (FH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bordey A, 2006, CELL CYCLE, V5, P722, DOI 10.4161/cc.5.7.2614; Cheng LC, 2009, NAT NEUROSCI, V12, P399, DOI 10.1038/nn.2294; Deo M, 2006, DEV DYNAM, V235, P2538, DOI 10.1002/dvdy.20847; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Edbauer D, 2010, NEURON, V65, P373, DOI 10.1016/j.neuron.2010.01.005; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Feliciano DM, 2012, HUM MOL GENET, V21, P799, DOI 10.1093/hmg/ddr511; Giachino C, 2005, J NEUROSCI, V25, P10105, DOI 10.1523/JNEUROSCI.3512-05.2005; Hansen KF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015497; Herranz H, 2010, GENE DEV, V24, P1339, DOI 10.1101/gad.1937010; Impey S, 2010, MOL CELL NEUROSCI, V43, P146, DOI 10.1016/j.mcn.2009.10.005; Kawashima H, 2010, NEUROSCIENCE, V165, P1301, DOI 10.1016/j.neuroscience.2009.11.057; Kosik KS, 2006, NAT REV NEUROSCI, V7, P911, DOI 10.1038/nrn2037; Lacar B, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00043; Loya CM, 2009, NAT METHODS, V6, P897, DOI 10.1038/nmeth.1402; Luikart BW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019077; Magill ST, 2010, P NATL ACAD SCI USA, V107, P20382, DOI 10.1073/pnas.1015691107; Nudelman AS, 2010, HIPPOCAMPUS, V20, P492, DOI 10.1002/hipo.20646; Obernosterer G, 2007, NAT PROTOC, V2, P1508, DOI 10.1038/nprot.2007.153; Pathania M, 2010, NEUROPHARMACOLOGY, V58, P865, DOI 10.1016/j.neuropharm.2010.01.010; Petreanu L, 2002, J NEUROSCI, V22, P6106; Pignatelli A., 2010, NEUROBIOLOGY OLFACTI; Platel JC, 2010, NEURON, V65, P859, DOI 10.1016/j.neuron.2010.03.009; Sanai N, 2011, NATURE, V478, P382, DOI 10.1038/nature10487; Shibata M, 2011, J NEUROSCI, V31, P3407, DOI 10.1523/JNEUROSCI.5085-10.2011; Tonelli DDP, 2006, BIOTECHNIQUES, V41, P727, DOI 10.2144/000112296; Ventura A, 2004, P NATL ACAD SCI USA, V101, P10380, DOI 10.1073/pnas.0403954101; Vo N, 2005, P NATL ACAD SCI USA, V102, P16426, DOI 10.1073/pnas.0508448102; Wayman GA, 2008, P NATL ACAD SCI USA, V105, P9093, DOI 10.1073/pnas.0803072105	29	100	102	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38174	10.1371/journal.pone.0038174	http://dx.doi.org/10.1371/journal.pone.0038174			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693596	gold, Green Published, Green Submitted			2022-12-27	WOS:000305338500102
J	Ballard, C; Jones, E; Gauge, N; Aarsland, D; Nilsen, OB; Saxby, BK; Lowery, D; Corbett, A; Wesnes, K; Katsaiti, E; Arden, J; Amaoko, D; Prophet, N; Purushothaman, B; Green, D				Ballard, Clive; Jones, Emma; Gauge, Nathan; Aarsland, Dag; Nilsen, Odd Bjarte; Saxby, Brian K.; Lowery, David; Corbett, Anne; Wesnes, Keith; Katsaiti, Eirini; Arden, James; Amaoko, Derek; Prophet, Nicholas; Purushothaman, Balaji; Green, David			Optimised Anaesthesia to Reduce Post Operative Cognitive Decline (POCD) in Older Patients Undergoing Elective Surgery, a Randomised Controlled Trial	PLOS ONE			English	Article							MAJOR ABDOMINAL-SURGERY; TRAUMATIC BRAIN-INJURY; GENERAL-ANESTHESIA; ELDERLY-PATIENTS; NONCARDIAC SURGERY; BISPECTRAL INDEX; DYSFUNCTION; IMPAIRMENT; DEMENTIA; PREDICTION	Background: The study determined the one year incidence of post operative cognitive decline (POCD) and evaluated the effectiveness of an intra-operative anaesthetic intervention in reducing post-operative cognitive impairment in older adults (over 60 years of age) undergoing elective orthopaedic or abdominal surgery. Methods and Trial Design: The design was a prospective cohort study with a nested randomised, controlled intervention trial, using intra-operative BiSpectral index and cerebral oxygen saturation monitoring to enable optimisation of anaesthesia depth and cerebral oxygen saturation in older adults undergoing surgery. Results: In the 52 week prospective cohort study (192 surgical patients and 138 controls), mild (chi(2) = 17.9 p<0.0001), moderate (chi(2) = 7.8 p = 0.005) and severe (chi(2) = 5.1 p = 0.02) POCD were all significantly higher after 52 weeks in the surgical patients than among the age matched controls. In the nested RCT, 81 patients were randomized, 73 contributing to the data analysis (34 intervention, 39 control). In the intervention group mild POCD was significantly reduced at 1, 12 and 52 weeks (Fisher's Exact Test p = 0.018, chi(2) = 5.1 p = 0.02 and chi(2) = 5.9 p = 0.015), and moderate POCD was reduced at 1 and 52 weeks (chi(2) = 4.4 p = 0.037 and chi(2) = 5.4 p = 0.02). In addition there was significant improvement in reaction time at all time-points (Vigilance Reaction Time MWU Z = -2.1 p = 0.03, MWU Z = -2.7 p = 0.004, MWU Z = -3.0 p = 0.005), in MMSE at one and 52 weeks (MWU Z = -2.9 p = 0.003, MWU Z = -3.3 p = 0.001), and in executive function at 12 and 52 weeks (Trail Making MWU Z = -2.4 p =.0.018, MWU Z = -2.4 p = 0.019). Conclusion: POCD is common and persistent in older adults following surgery. The results of the nested RCT indicate the potential benefits of intra-operative monitoring of anaesthetic depth and cerebral oxygenation as a pragmatic intervention to reduce post-operative cognitive impairment.	[Ballard, Clive; Jones, Emma; Gauge, Nathan; Katsaiti, Eirini] Kings Coll London, Wolfson Ctr Age Related Dis, London WC2R 2LS, England; [Aarsland, Dag] Karolinska Inst, Dept Neurobiol Ward & Soc, Stockholm, Sweden; [Aarsland, Dag; Nilsen, Odd Bjarte] Stavanger Univ Hosp, Fac Sci & Technol, Stavanger, Norway; [Saxby, Brian K.] Univ Newcastle, Inst Ageing & Hlth, Newcastle, England; [Lowery, David] Univ London Univ Coll, Res Dept Primary Care & Populat Hlth, London, England; [Corbett, Anne] Alzheimers Soc UK, Res Directorate, London, England; [Wesnes, Keith] Swinburne Univ, Ctr Human Psychopharmacol, Melbourne, Vic, Australia; [Arden, James; Amaoko, Derek; Prophet, Nicholas; Purushothaman, Balaji; Green, David] Kings Coll Hosp London, Dept Anaesthet, London, England	University of London; King's College London; Karolinska Institutet; Stavanger University Hospital; Newcastle University - UK; University of London; University College London; King's College Hospital NHS Foundation Trust; King's College Hospital	Ballard, C (corresponding author), Kings Coll London, Wolfson Ctr Age Related Dis, London WC2R 2LS, England.	Clive.ballard@kcl.ac.uk	Saxby, Brian K/A-9903-2010; Wesnes, Keith A/D-7148-2018; Corbett, Anne/B-3223-2014	Saxby, Brian K/0000-0003-2912-5176; Corbett, Anne/0000-0003-2015-0316; Wesnes, Keith/0000-0002-4498-8511; Ballard, Clive/0000-0003-0022-5632; Aarsland, Dag/0000-0001-6314-216X	BUPA foundation	BUPA foundation	The authors would like to thank the BUPA foundation for supporting the project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avidan MS, 2011, J ALZHEIMERS DIS, V24, P201, DOI 10.3233/JAD-2011-101680; Ballard C, 2003, INT PSYCHOGERIATR, V15, P123, DOI 10.1017/S1041610203009074; BEDFORD PD, 1955, LANCET, V2, P259; Casati A, 2005, ANESTH ANALG, V101, P740, DOI 10.1213/01.ane.0000166974.96219.cd; Culley DJ, 2007, CURR OPIN ANESTHESIO, V20, P408, DOI 10.1097/ACO.0b013e3282efd18b; Farag E, 2006, ANESTH ANALG, V103, P633, DOI 10.1213/01.ane.0000228870.48028.b5; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Green DW, 2007, EUR J ANAESTH, V24, P230, DOI 10.1017/S0265021506001645; Howard R, 2011, INT J GERIATR PSYCH, V26, P812, DOI 10.1002/gps.2607; Johnson T, 2002, ANESTHESIOLOGY, V96, P1351, DOI 10.1097/00000542-200206000-00014; Kojima Y, 2006, ACTA ANAESTH SCAND, V50, P19, DOI 10.1111/j.1399-6576.2005.00882.x; Linstedt U, 2002, ACTA ANAESTH SCAND, V46, P384, DOI 10.1034/j.1399-6576.2002.460409.x; Lowery DP, 2007, DEMENT GERIATR COGN, V23, P390, DOI 10.1159/000101453; Lowery DP, 2008, INT J GERIATR PSYCH, V23, P1253, DOI 10.1002/gps.2059; Mitchell J, 2009, J NEUROL, V256, P1500, DOI 10.1007/s00415-009-5152-0; Moller JT, 1998, LANCET, V351, P857, DOI 10.1016/S0140-6736(97)07382-0; Myles PS, 2009, ANESTHESIOLOGY, V110, P1106, DOI 10.1097/ALN.0b013e31819daef6; Newman S, 2007, ANESTHESIOLOGY, V106, P572, DOI 10.1097/00000542-200703000-00023; Nylen K, 2008, ACTA NEUROCHIR, V150, P221, DOI 10.1007/s00701-007-1489-2; Perouansky M, 2009, ANESTHESIOLOGY, V111, P1365, DOI 10.1097/ALN.0b013e3181bf1d61; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Price CC, 2008, ANESTHESIOLOGY, V108, P8, DOI 10.1097/01.anes.0000296072.02527.18; Punjasawadwong Y, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003843.pub2; Rasmussen LS, 2003, ACTA ANAESTH SCAND, V47, P260, DOI 10.1034/j.1399-6576.2003.00057.x; Ritchie K, 2001, NEUROLOGY, V56, P37, DOI 10.1212/WNL.56.1.37; Sanders RD, 2005, BEST PRACT RES-CLIN, V19, P461, DOI 10.1016/j.bpa.2005.01.005; Schneider G, 1997, EUR J ANAESTH, V14, P21, DOI 10.1097/00003643-199705001-00005; SIMPSON PM, 1991, INT J GERIATR PSYCH, V6, P95, DOI 10.1002/gps.930060208; Slater JP, 2009, ANN THORAC SURG, V87, P36, DOI 10.1016/j.athoracsur.2008.08.070; Steinmetz J, 2009, ANESTHESIOLOGY, V110, P548, DOI 10.1097/ALN.0b013e318195b569; Terrando N, 2010, P NATL ACAD SCI USA, V107, P20518, DOI 10.1073/pnas.1014557107; van Dijk D, 2000, J THORAC CARDIOV SUR, V120, P632, DOI 10.1067/mtc.2000.108901; Wan YJ, 2007, ANESTHESIOLOGY, V106, P436, DOI 10.1097/00000542-200703000-00007; Wan YJ, 2010, CRIT CARE MED, V38, P2190, DOI 10.1097/CCM.0b013e3181f17bcb; Wiesmann M, 2010, ACTA NEUROL SCAND, V121, P178, DOI 10.1111/j.1600-0404.2009.01196.x	35	234	244	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2012	7	6							e37410	10.1371/journal.pone.0037410	http://dx.doi.org/10.1371/journal.pone.0037410			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WX	22719840	Green Published, Green Submitted, gold			2022-12-27	WOS:000305350000006
J	de Oliveira, AS; Melo, FL; Inoue-Nagata, AK; Nagata, T; Kitajima, EW; Resende, RO				de Oliveira, Athos Silva; Melo, Fernando Lucas; Inoue-Nagata, Alice Kazuko; Nagata, Tatsuya; Kitajima, Elliot Watanabe; Resende, Renato Oliveira			Characterization of Bean Necrotic Mosaic Virus: A Member of a Novel Evolutionary Lineage within the Genus Tospovirus	PLOS ONE			English	Article							SPOTTED WILT VIRUS; INSECT VECTOR; S-RNA; NUCLEOTIDE-SEQUENCE; IDENTIFICATION; PROTEIN; THYSANOPTERA; PHYLOGENY; THRIPIDAE; SEGMENT	Background: Tospoviruses (Genus Tospovirus, Family Bunyaviridae) are phytopathogens responsible for significant worldwide crop losses. They have a tripartite negative and ambisense RNA genome segments, termed S (Small), M (Medium) and L (Large) RNA. The vector-transmission is mediated by thrips in a circulative-propagative manner. For new tospovirus species acceptance, several analyses are needed, e. g., the determination of the viral protein sequences for enlightenment of their evolutionary history. Methodology/Principal Findings: Biological (host range and symptomatology), serological, and molecular (S and M RNA sequencing and evolutionary studies) experiments were performed to characterize and differentiate a new tospovirus species, Bean necrotic mosaic virus (BeNMV), which naturally infects common beans in Brazil. Based upon the results, BeNMV can be classified as a novel species and, together with Soybean vein necrosis-associated virus (SVNaV), they represent members of a new evolutionary lineage within the genus Tospovirus. Conclusion/Significances: Taken together, these evidences suggest that two divergent lineages of tospoviruses are circulating in the American continent and, based on the main clades diversity (American and Eurasian lineages), new tospovirus species related to the BeNMV-SVNaV clade remain to be discovered. This possible greater diversity of tospoviruses may be reflected in a higher number of crops as natural hosts, increasing the economic impact on agriculture. This idea also is supported since BeNMV and SVNaV were discovered naturally infecting atypical hosts (common bean and soybean, respectively), indicating, in this case, a preference for leguminous species. Further studies, for instance a survey focusing on crops, specifically of leguminous plants, may reveal a greater tospovirus diversity not only in the Americas (where both viruses were reported), but throughout the world.	[de Oliveira, Athos Silva; Melo, Fernando Lucas; Nagata, Tatsuya; Resende, Renato Oliveira] Univ Brasilia, Dept Cell Biol, Brasilia, DF, Brazil; [Inoue-Nagata, Alice Kazuko] Embrapa Vegetables, Brasilia, DF, Brazil; [Kitajima, Elliot Watanabe] Univ Sao Paulo, Sao Paulo, Brazil	Universidade de Brasilia; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade de Sao Paulo	de Oliveira, AS (corresponding author), Univ Brasilia, Dept Cell Biol, Brasilia, DF, Brazil.	rresende@unb.br	Citros, Inct/I-2442-2013; de Oliveira, Athos S./AAC-4106-2019; Nagata, Tatsuya/I-4031-2013; Inoue-Nagata, Alice/H-3775-2012; Melo, Fernando Lucas/U-6535-2017	de Oliveira, Athos S./0000-0003-2715-8898; Nagata, Tatsuya/0000-0002-7114-017X; Inoue-Nagata, Alice/0000-0002-8355-9269; Melo, Fernando Lucas/0000-0002-9591-0239; Resende, Renato/0000-0003-3852-1576	CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico); Capes (Conselho de Aperfeicoamento de Pessoal de Nivel Superior); FAP-DF (Fundacao de Apoio a Pesquisa do Distrito Federal)	CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Capes (Conselho de Aperfeicoamento de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAP-DF (Fundacao de Apoio a Pesquisa do Distrito Federal)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Financial support by CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico), Capes (Conselho de Aperfeicoamento de Pessoal de Nivel Superior) and FAP-DF (Fundacao de Apoio a Pesquisa do Distrito Federal). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Bezerra IC, 1999, PHYTOPATHOLOGY, V89, P823, DOI 10.1094/PHYTO.1999.89.9.823; Chen CC, 1995, ACTA HORTIC, P57; Chu FH, 2001, PHYTOPATHOLOGY, V91, P856, DOI 10.1094/PHYTO.2001.91.9.856; Cortez I, 2001, ARCH VIROL, V146, P265, DOI 10.1007/s007050170174; de Oliveira AS, 2011, VIRUS GENES, V43, P385, DOI 10.1007/s11262-011-0639-z; DEAVILA AC, 1993, J GEN VIROL, V74, P153, DOI 10.1099/0022-1317-74-2-153; DEAVILA AC, 1993, ARCH VIROL, V128, P211, DOI 10.1007/BF01309435; DEHAAN P, 1990, J GEN VIROL, V71, P1001, DOI 10.1099/0022-1317-71-5-1001; DEHAAN P, 1991, J GEN VIROL, V72, P2207, DOI 10.1099/0022-1317-72-9-2207; Dong JH, 2008, ARCH VIROL, V153, P855, DOI 10.1007/s00705-008-0054-5; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Hassani-Mehraban A, 2010, ARCH VIROL, V155, P423, DOI 10.1007/s00705-010-0590-7; Inoue T, 2007, APPL ENTOMOL ZOOL, V42, P71, DOI 10.1303/aez.2007.71; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; King AM, 2012, 9 REPORT INT COMMITT, P770; Knierim D, 2006, ARCH VIROL, V151, P1761, DOI 10.1007/s00705-006-0749-4; KORMELINK R, 1992, J GEN VIROL, V73, P2795, DOI 10.1099/0022-1317-73-11-2795; Kosakovsky Pond SL, 2011, MOL BIOL EVOL; Lopez C, 2011, J GEN VIROL, V92, P210, DOI 10.1099/vir.0.026708-0; Medeiros RB, 2004, J VIROL, V78, P4976, DOI 10.1128/JVI.78.10.4976-4982.2004; Miller M.A., 2010, P GAT COMP ENV WORKS; Mound L. A, 2002, THRIPS TOSPOVIRUSES, P379; Nakahara S, 1999, P ENTOMOL SOC WASH, V101, P290; Nakahara S, 1997, ANNOTATED LIST FRANK; Pappu HR, 2009, VIRUS RES, V141, P219, DOI 10.1016/j.virusres.2009.01.009; Pond SLK, 2011, MOL BIOL EVOL, V28, P3033, DOI 10.1093/molbev/msr125; Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320; Ribeiro D, 2008, J GEN VIROL, V89, P1811, DOI 10.1099/vir.0.2008/001164-0; Riley DG, 2011, J INTEGR PEST MANAG, V2, DOI 10.1603/IPM10020; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Satyanarayana T, 1998, ARCH VIROL, V143, P353, DOI 10.1007/s007050050291; Seepiban C, 2011, ARCH VIROL, V156, P263, DOI 10.1007/s00705-010-0856-0; Snippe M, 2007, VIROLOGY, V363, P272, DOI 10.1016/j.virol.2006.12.038; Staden R, 1996, MOL BIOTECHNOL, V5, P233, DOI 10.1007/BF02900361; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Storms MMH, 1998, PLANT J, V13, P131, DOI 10.1046/j.1365-313X.1998.00007.x; Takeda A, 2002, FEBS LETT, V532, P75, DOI 10.1016/S0014-5793(02)03632-3; ULLMAN DE, 1993, PHYTOPATHOLOGY, V83, P456, DOI 10.1094/Phyto-83-456; Whitfield AE, 2005, ANNU REV PHYTOPATHOL, V43, P459, DOI 10.1146/annurev.phyto.43.040204.140017; WIJKAMP I, 1993, J GEN VIROL, V74, P341, DOI 10.1099/0022-1317-74-3-341; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Xia XH, 2003, MOL PHYLOGENET EVOL, V26, P1, DOI 10.1016/S1055-7903(02)00326-3; Yang ZH, 2011, MOL BIOL EVOL, V28, P1217, DOI 10.1093/molbev/msq303; Zhou J, 2011, VIRUS GENES, V43, P289, DOI 10.1007/s11262-011-0621-9	47	41	42	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2012	7	6							e38634	10.1371/journal.pone.0038634	http://dx.doi.org/10.1371/journal.pone.0038634			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TQ	22715400	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336800042
J	Jia, PL; Li, F; Xia, JF; Chen, HQ; Ji, HB; Pao, W; Zhao, ZM				Jia, Peilin; Li, Fei; Xia, Jufeng; Chen, Haiquan; Ji, Hongbin; Pao, William; Zhao, Zhongming			Consensus Rules in Variant Detection from Next-Generation Sequencing Data	PLOS ONE			English	Article							MASSIVELY-PARALLEL DNA; HUMAN GENOME; EXOME; MUTATIONS; CARCINOMA; ALIGNMENT; DISCOVERY; LEUKEMIA	A critical step in detecting variants from next-generation sequencing data is post hoc filtering of putative variants called or predicted by computational tools. Here, we highlight four critical parameters that could enhance the accuracy of called single nucleotide variants and insertions/deletions: quality and deepness, refinement and improvement of initial mapping, allele/strand balance, and examination of spurious genes. Use of these sequence features appropriately in variant filtering could greatly improve validation rates, thereby saving time and costs in next-generation sequencing projects.	[Jia, Peilin; Zhao, Zhongming] Vanderbilt Univ, Sch Med, Dept Biomed Informat, Nashville, TN 37212 USA; [Li, Fei; Xia, Jufeng; Ji, Hongbin] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Cell Biol, Shanghai, Peoples R China; [Chen, Haiquan] Fudan Univ, Shanghai Canc Ctr, Dept Thorac Surg, Shanghai 200433, Peoples R China; [Chen, Haiquan] Shanghai Med Coll, Dept Oncol, Shanghai, Peoples R China; [Pao, William; Zhao, Zhongming] Vanderbilt Univ, Med Ctr, Vanderbilt Ingram Canc Ctr, Nashville, TN USA; [Pao, William] Vanderbilt Univ, Sch Med, Dept Med, Div Hematol Oncol, Nashville, TN 37212 USA; [Zhao, Zhongming] Vanderbilt Univ, Sch Med, Dept Psychiat, Nashville, TN 37212 USA	Vanderbilt University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Fudan University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Jia, PL (corresponding author), Vanderbilt Univ, Sch Med, Dept Biomed Informat, Nashville, TN 37212 USA.	zhongming.zhao@vanderbilt.edu	Xia, Jufeng/AAW-2643-2020; Jia, Peilin/B-4519-2013		Stand Up To Cancer-American Association for Cancer Research [SU2CAACR-IRG0109]; Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America, Cancer Center [P30CA68485]; NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER	Stand Up To Cancer-American Association for Cancer Research; Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America, Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was partially supported by the Stand Up To Cancer-American Association for Cancer Research Innovative Research Grant (SU2CAACR-IRG0109) and the Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America, Cancer Center Core grant P30CA68485. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Hoischen A, 2010, NAT GENET, V42, P483, DOI 10.1038/ng.581; Johnson JO, 2010, AM J HUM GENET, V87, P567, DOI 10.1016/j.ajhg.2010.05.021; Ju YS, 2011, NAT GENET, V43, P745, DOI 10.1038/ng.872; Koboldt DC, 2010, BRIEF BIOINFORM, V11, P484, DOI 10.1093/bib/bbq016; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li H, 2011, BIOINFORMATICS, V27, P1157, DOI 10.1093/bioinformatics/btr076; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Ng SB, 2010, HUM MOL GENET, V19, pR119, DOI 10.1093/hmg/ddq390; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Teer JK, 2010, GENOME RES, V20, P1420, DOI 10.1101/gr.106716.110; Totoki Y, 2011, NAT GENET, V43, P464, DOI 10.1038/ng.804; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; Wei XM, 2011, NAT GENET, V43, P442, DOI 10.1038/ng.810; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; Xia JF, 2012, HUM MUTAT, V33, pE2341, DOI 10.1002/humu.22096; Xu B, 2011, NAT GENET, V43, P864, DOI 10.1038/ng.902; Yan XJ, 2011, NAT GENET, V43, P309, DOI 10.1038/ng.788	26	24	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2012	7	6							e38470	10.1371/journal.pone.0038470	http://dx.doi.org/10.1371/journal.pone.0038470			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TQ	22715385	gold, Green Submitted, Green Published			2022-12-27	WOS:000305336800027
J	Peura, S; Eiler, A; Hiltunen, M; Nykanen, H; Tiirola, M; Jones, RI				Peura, Sari; Eiler, Alexander; Hiltunen, Minna; Nykanen, Hannu; Tiirola, Marja; Jones, Roger I.			Bacterial and Phytoplankton Responses to Nutrient Amendments in a Boreal Lake Differ According to Season and to Taxonomic Resolution	PLOS ONE			English	Article							FRESH-WATER; COMMUNITY COMPOSITION; HUMIC LAKE; TOP-DOWN; LIMITATION; BACTERIOPLANKTON; NITROGEN; PHOSPHORUS; GROWTH; DIVERSITY	Nutrient limitation and resource competition in bacterial and phytoplankton communities may appear different when considering different levels of taxonomic resolution. Nutrient amendment experiments conducted in a boreal lake on three occasions during one open water season revealed complex responses in overall bacterioplankton and phytoplankton abundance and biovolume. In general, bacteria were dominant in spring, while phytoplankton was clearly the predominant group in autumn. Seasonal differences in the community composition of bacteria and phytoplankton were mainly related to changes in observed taxa, while the differences across nutrient treatments within an experiment were due to changes in relative contributions of certain higher-and lower-level phylogenetic groups. Of the main bacterioplankton phyla, only Actinobacteria had a treatment response that was visible even at the phylum level throughout the season. With increasing resolution (from 75 to 99% sequence similarity) major responses to nutrient amendments appeared using 454 pyrosequencing data of 16S rRNA amplicons. This further revealed that OTUs (defined by 97% sequence similarity) annotated to the same highly resolved freshwater groups appeared to occur during different seasons and were showing treatment-dependent differentiation, indicating that OTUs within these groups were not ecologically coherent. Similarly, phytoplankton species from the same genera responded differently to nutrient amendments even though biovolumes of the majority of taxa increased when both nitrogen and phosphorus were added simultaneously. The bacterioplankton and phytoplankton community compositions showed concurrent trajectories that could be seen in synchronous succession patterns over the season. Overall, our data revealed that the response of both communities to nutrient changes was highly dependent on season and that contradictory results may be obtained when using different taxonomic resolutions.	[Peura, Sari; Nykanen, Hannu; Tiirola, Marja; Jones, Roger I.] Univ Jyvaskyla, Dept Biol & Environm Sci, Jyvaskyla, Finland; [Eiler, Alexander] Uppsala Univ, Dept Ecol & Genet, Uppsala, Sweden; [Hiltunen, Minna] Univ Eastern Finland, Dept Biol, Joensuu, Finland	University of Jyvaskyla; Uppsala University; University of Eastern Finland	Peura, S (corresponding author), Univ Jyvaskyla, Dept Biol & Environm Sci, Jyvaskyla, Finland.	sari.peura@jyu.fi	Eiler, Alexander/V-9220-2017; Jones, Roger I/C-7703-2011	Eiler, Alexander/0000-0001-9916-9567; Jones, Roger I/0000-0002-0835-8264; Peura, Sari/0000-0003-3892-8157; Hiltunen, Minna/0000-0002-0003-3000; Tiirola, Marja/0000-0001-5589-3748	Academy of Finland [114604]; University of Jyvaskyla; Swedish foundation of strategic research; Nordic Environmental NUcleotide Network (NENUN)	Academy of Finland(Academy of Finland); University of Jyvaskyla; Swedish foundation of strategic research(Swedish Foundation for Strategic Research); Nordic Environmental NUcleotide Network (NENUN)	This work was supported by Academy of Finland grant 114604 to RIJ. SP was also partly funded by a Rectors grant from the University of Jyvaskyla. AE was partly funded by the Swedish foundation of strategic research. Nordic Environmental NUcleotide Network (NENUN) is acknowledged for travel grant to SP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allgaier M, 2007, ENVIRON MICROBIOL, V9, P2728, DOI 10.1111/j.1462-2920.2007.01385.x; Anderson M. J., 2001, AUSTRAL ECOL, V26, P2; Anderson MJ, 2004, ECOL LETT, V6, P683; ARVOLA L, 1986, HYDROBIOLOGIA, V137, P125, DOI 10.1007/BF00004208; Barlett MA, 2010, CAN J MICROBIOL, V56, P32, DOI [10.1139/W09-099, 10.1139/w09-099]; Bergstrom AK, 2008, AQUAT BIOL, V4, P55, DOI 10.3354/ab00099; Brett Michael T., 1999, Aquatic Ecology, V33, P135, DOI 10.1023/A:1009998915078; Burkert U, 2003, APPL ENVIRON MICROB, V69, P6550, DOI 10.1128/AEM.69.11.6550-6559.2003; CHAO A, 1984, SCAND J STAT, V11, P265; COLE JJ, 1982, ANNU REV ECOL SYST, V13, P291, DOI 10.1146/annurev.es.13.110182.001451; Danger M, 2008, OIKOS, V117, P1741, DOI 10.1111/j.1600-0706.2008.16793.x; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; EDWARDS U, 1989, NUCLEIC ACIDS RES, V17, P7843, DOI 10.1093/nar/17.19.7843; Eiler A, 2012, ISME J, V6, P330, DOI 10.1038/ismej.2011.113; Elser JJ, 2007, ECOL LETT, V10, P1135, DOI 10.1111/j.1461-0248.2007.01113.x; Gilbert JA, 2009, ENVIRON MICROBIOL, V11, P3132, DOI 10.1111/j.1462-2920.2009.02017.x; Griffiths RI, 2000, APPL ENVIRON MICROB, V66, P5488, DOI 10.1128/AEM.66.12.5488-5491.2000; Grossart HP, 2008, ENVIRON MICROBIOL, V10, P635, DOI 10.1111/j.1462-2920.2007.01487.x; Grossart HP, 2007, AQUAT MICROB ECOL, V47, P163, DOI 10.3354/ame047163; Haukka K, 2006, MICROB ECOL, V51, P137, DOI 10.1007/s00248-005-0049-7; Herlemann DPR, 2011, ISME J, V5, P1571, DOI 10.1038/ismej.2011.41; Hessen DO, 1994, ENVIRON INT, V20, P7; HORN HS, 1966, AM NAT, V100, P419, DOI 10.1086/282436; HOWARTH RW, 1988, ANNU REV ECOL SYST, V19, P89, DOI 10.1146/annurev.es.19.110188.000513; Hutalle-Schmelzer KML, 2010, FEMS MICROBIOL ECOL, V72, P58, DOI 10.1111/j.1574-6941.2009.00831.x; ILMAVIRTA V, 1982, HYDROBIOLOGIA, V86, P11, DOI 10.1007/BF00005782; Jansson M, 1996, LIMNOL OCEANOGR, V41, P1552, DOI 10.4319/lo.1996.41.7.1552; Jansson M, 2007, TRENDS ECOL EVOL, V22, P316, DOI 10.1016/j.tree.2007.02.015; Jezbera J, 2006, ENVIRON MICROBIOL, V8, P1330, DOI 10.1111/j.1462-2920.2006.01026.x; Jezbera J, 2011, ENVIRON MICROBIOL, V13, P922, DOI 10.1111/j.1462-2920.2010.02396.x; Johnson John L., 1994, P655; Kankaala P, 2010, FUND APPL LIMNOL, V177, P161, DOI 10.1127/1863-9135/2010/0177-0161; Kent AD, 2007, ISME J, V1, P38, DOI 10.1038/ismej.2007.6; Kent AD, 2006, ENVIRON MICROBIOL, V8, P1448, DOI 10.1111/j.1462-2920.2006.01039.x; Keskitalo Jorma, 1998, Boreal Environment Research, V3, P251; Krebs C.J., 1999, ECOLOGICAL METHODOLO; Legendre P., 2012, NUMERICAL ECOLOGY; Lewitus AJ, 1998, LIMNOL OCEANOGR, V43, P636, DOI 10.4319/lo.1998.43.4.0636; Maberly SC, 2002, FRESHWATER BIOL, V47, P2136, DOI 10.1046/j.1365-2427.2002.00962.x; Massana R, 2009, ISME J, V3, P588, DOI 10.1038/ismej.2008.130; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:FMMTCD]2.0.CO;2; Mills DK, 2003, J MICROBIOL METH, V54, P57, DOI 10.1016/S0167-7012(03)00007-1; NEEFS JM, 1990, NUCLEIC ACIDS RES, V18, P2237, DOI 10.1093/nar/18.suppl.2237; Newton RJ, 2011, ENVIRON MICROBIOL, V13, P887, DOI 10.1111/j.1462-2920.2010.02387.x; Newton RJ, 2011, MICROBIOL MOL BIOL R, V75, P14, DOI 10.1128/MMBR.00028-10; Peres-Neto PR, 2001, OECOLOGIA, V129, P169, DOI 10.1007/s004420100720; Peura S, 2012, ISME J, V6, P1640, DOI 10.1038/ismej.2012.21; PIELOU EC, 1966, AM NAT, V100, P463, DOI 10.1086/282439; Ptacnik R, 2010, ECOSYSTEMS, V13, P1201, DOI 10.1007/s10021-010-9380-z; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; REDFIELD AC, 1958, AM SCI, V46, P205; SCHANZ F, 1983, HYDROBIOLOGIA, V102, P187, DOI 10.1007/BF00006346; Schauer M, 2005, APPL ENVIRON MICROB, V71, P5900, DOI 10.1128/AEM.71.10.5900-5907.2005; Selinummi J, 2005, BIOTECHNIQUES, V39, P859, DOI 10.2144/000112018; Shade A, 2007, LIMNOL OCEANOGR, V52, P487, DOI 10.4319/lo.2007.52.2.0487; Simek K, 2005, APPL ENVIRON MICROB, V71, P2381, DOI 10.1128/AEM.71.5.2381-2390.2005; Simek K, 2006, ENVIRON MICROBIOL, V8, P1613, DOI 10.1111/j.1462-2920.2006.01053.x; Suzuki M, 1998, APPL ENVIRON MICROB, V64, P4522; Taipale S, 2009, AQUAT MICROB ECOL, V55, P1, DOI 10.3354/ame01277; Tessier JT, 2003, J APPL ECOL, V40, P523, DOI 10.1046/j.1365-2664.2003.00820.x; Thomsen TR, 2007, FEMS MICROBIOL ECOL, V60, P370, DOI 10.1111/j.1574-6941.2007.00309.x; Tiirola MA, 2002, APPL ENVIRON MICROB, V68, P173, DOI 10.1128/AEM.68.1.173-180.2002; van der Ploeg RR, 1999, SOIL SCI SOC AM J, V63, P1055, DOI 10.2136/sssaj1999.6351055x; van Hannen EJ, 1999, APPL ENVIRON MICROB, V65, P795; VANNI MJ, 1990, LIMNOL OCEANOGR, V35, P697, DOI 10.4319/lo.1990.35.3.0697; Vrede K, 1999, LIMNOL OCEANOGR, V44, P1616, DOI 10.4319/lo.1999.44.7.1616; Vrede K, 2005, MICROB ECOL, V49, P245, DOI 10.1007/s00248-004-0259-4; WOLDA H, 1981, OECOLOGIA, V50, P296, DOI 10.1007/BF00344966; Wu LQ, 2009, MICROB ECOL, V57, P58, DOI 10.1007/s00248-008-9403-x	70	23	23	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2012	7	6							e38552	10.1371/journal.pone.0038552	http://dx.doi.org/10.1371/journal.pone.0038552			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TQ	22715392	gold, Green Submitted, Green Published			2022-12-27	WOS:000305336800034
J	Zhuo, SM; Yan, J; Chen, G; Shi, H; Zhu, XQ; Lu, JP; Chen, JX; Xie, SS				Zhuo, Shuangmu; Yan, Jun; Chen, Gang; Shi, Hong; Zhu, Xiaoqin; Lu, Jianping; Chen, Jianxin; Xie, Shusen			Label-Free Imaging of Basement Membranes Differentiates Normal, Precancerous, and Cancerous Colonic Tissues by Second-Harmonic Generation Microscopy	PLOS ONE			English	Article							ENDOMICROSCOPY; PATTERNS; COLLAGEN	Since changes in the basement membranes are the critical indicators for differentiating normal, precancerous, and cancerous colonic tissues, direct visualization of these warning signs is essential for the early diagnosis and treatment of colonic cancer. Here, we present that second harmonic generation (SHG) microscopy can probe the changes of basement membranes in different colonic cancer stages. Our results also show the capability of using the quantitative analyses of images for quantifying these changes in different cancer stages. These results suggest that SHG microscopy has the potential in label-freely imaging the changes of basement membranes for effectively distinguishing between normal, precancerous, and cancerous colonic tissues. To our knowledge, this is the first demonstration of the dynamics of basement membrane changes in different colonic cancer stages using entirely intrinsic source of contrast.	[Zhuo, Shuangmu; Zhu, Xiaoqin; Chen, Jianxin; Xie, Shusen] Fujian Normal Univ, Inst Laser & Optoelect Technol, Fujian Prov Key Lab Photon Technol, Key Lab OptoElect Sci & Technol Med,Minist Educ, Fuzhou, Peoples R China; [Yan, Jun] Fujian Prov Tumor Hosp, Dept Surg, Fuzhou, Peoples R China; [Chen, Gang; Lu, Jianping] Fujian Prov Tumor Hosp, Dept Pathol, Fuzhou, Peoples R China; [Shi, Hong] Fujian Prov Tumor Hosp, Dept Endoscopy, Fuzhou, Peoples R China	Fujian Normal University	Zhuo, SM (corresponding author), Fujian Normal Univ, Inst Laser & Optoelect Technol, Fujian Prov Key Lab Photon Technol, Key Lab OptoElect Sci & Technol Med,Minist Educ, Fuzhou, Peoples R China.	chenjianxin@fjnu.edu.cn; ssxie@fjnu.edu.cn	Zhuo, Shuangmu/F-4826-2012	Zhuo, Shuangmu/0000-0001-5767-5197	Program for Changjiang Scholars and Innovative Research Team in University [IRT1115]; National Natural Science Foundation of China [60908043, 30970783, 81101209]; Natural Science Foundation of Fujian Province [2011J01341, 2010J01136, 2010J01321]	Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Fujian Province(Natural Science Foundation of Fujian Province)	The project was supported by the Program for Changjiang Scholars and Innovative Research Team in University (Grant No. IRT1115), the National Natural Science Foundation of China (Grant Nos. 60908043, 30970783, 81101209), and the Natural Science Foundation of Fujian Province (Grant Nos. 2011J01341, 2010J01136, 2010J01321). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao HC, 2010, OPT EXPRESS, V18, P1255, DOI 10.1364/OE.18.001255; BOSMAN FT, 1994, MICROSC RES TECHNIQ, V28, P216, DOI 10.1002/jemt.1070280306; Brown E, 2003, NAT MED, V9, P796, DOI 10.1038/nm879; Campagnola PJ, 2011, LASER PHOTONICS REV, V5, P13, DOI 10.1002/lpor.200910024; Campagnola PJ, 2003, NAT BIOTECHNOL, V21, P1356, DOI 10.1038/nbt894; Goetz M, 2010, AM J PHYSIOL-GASTR L, V298, pG797, DOI 10.1152/ajpgi.00027.2010; HIDA J, 1994, CANCER, V74, P592, DOI 10.1002/1097-0142(19940715)74:2<592::AID-CNCR2820740210>3.0.CO;2-4; Hovhannisyan VA, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3142864; Jass JR, 2002, GASTROENTEROLOGY, V123, P862, DOI 10.1053/gast.2002.35392; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; LIOTTA LA, 1980, NATURE, V284, P67, DOI 10.1038/284067a0; Matteini P, 2009, OPT EXPRESS, V17, P4868, DOI 10.1364/OE.17.004868; Rivera DR, 2011, P NATL ACAD SCI USA, V108, P17598, DOI 10.1073/pnas.1114746108; Srivastava S, 1998, MOL PATHOLOGY EARLY; VISSER R, 1993, J PATHOL, V170, P285, DOI 10.1002/path.1711700311; Wu YC, 2009, OPT LETT, V34, P953, DOI 10.1364/OL.34.000953; Zhuo SM, 2006, OPT EXPRESS, V14, P7810, DOI 10.1364/OE.14.007810; Zhuo SM, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3505762; Zhuo SM, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3441337; Zipfel WR, 2003, P NATL ACAD SCI USA, V100, P7075, DOI 10.1073/pnas.0832308100	20	25	26	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2012	7	6							e38655	10.1371/journal.pone.0038655	http://dx.doi.org/10.1371/journal.pone.0038655			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TQ	22715404	Green Submitted, gold, Green Published			2022-12-27	WOS:000305336800046
J	Ren, MQ; Tidwell, JA; Sharma, S; Cowell, JK				Ren, MingQiang; Tidwell, Josephine A.; Sharma, Suash; Cowell, John K.			Acute Progression of BCR-FGFR1 Induced Murine B-Lympho/Myeloproliferative Disorder Suggests Involvement of Lineages at the Pro-B Cell Stage	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; CHRONIC MYELOID-LEUKEMIA; MYELOPROLIFERATIVE DISORDER; FUSION; LYMPHOMA; BCR; T(8/22)(P11,Q11); T(8/22); DISEASE; GENES	Constitutive activation of FGFR1, through rearrangement with various dimerization domains, leads to atypical myeloproliferative disorders where, although T cell lymphoma are common, the BCR-FGFR1 chimeric kinase results in CML-like leukemia. As with the human disease, mouse bone marrow transduction/transplantation with BCR-FGFR1 leads to CML-like myeloproliferation as well as B-cell leukemia/ lymphoma. The murine disease described in this report is virtually identical to the human disease in that both showed bi-lineage involvement of myeloid and B-cells, splenomegaly, leukocytosis and bone marrow hypercellularity. A CD19(+) IgM(+) CD43(+) immunophenotype was seen both in primary tumors and two cell lines derived	[Ren, MingQiang; Tidwell, Josephine A.; Cowell, John K.] Georgia Hlth Sci Univ, Sch Med, Ctr Canc, Augusta, GA USA; [Sharma, Suash] Georgia Hlth Sci Univ, Sch Med, Dept Pathol, Augusta, GA USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University	Ren, MQ (corresponding author), Georgia Hlth Sci Univ, Sch Med, Ctr Canc, Augusta, GA USA.	jcowell@georgiahealth.edu		Cowell, John/0000-0002-2079-5950	National Institutes of Health [CA076167]; NATIONAL CANCER INSTITUTE [R01CA076167] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This manuscript was supported in part by a grant from the National Institutes of Health, CA076167. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRUZZO LV, 1992, AM J SURG PATHOL, V16, P236, DOI 10.1097/00000478-199203000-00003; Agerstam H, 2007, GENE CHROMOSOME CANC, V46, P635, DOI 10.1002/gcc.20442; Baldazzi C, 2010, LEUKEMIA RES, V34, pE282, DOI 10.1016/j.leukres.2010.05.009; Barabe F, 2007, SCIENCE, V316, P600, DOI 10.1126/science.1139851; Chen Y, 2009, LEUKEMIA, V23, P1446, DOI 10.1038/leu.2009.52; Cowell JK, 2005, CANCER GENET CYTOGEN, V163, P23, DOI 10.1016/j.cancergencyto.2005.04.019; Demiroglu A, 2001, BLOOD, V98, P3778, DOI 10.1182/blood.V98.13.3778; Fioretos T, 2001, GENE CHROMOSOME CANC, V32, P302, DOI 10.1002/gcc.1195; Jackson CC, 2010, HUM PATHOL, V41, P461, DOI 10.1016/j.humpath.2009.11.003; Kim SY, 2011, LEUKEMIA RES, V35, pE30, DOI 10.1016/j.leukres.2010.12.014; Murati A, 2005, INT J ONCOL, V26, P1485; Pini Massimo, 2002, Hematol J, V3, P315, DOI 10.1038/sj.thj.6200201; Ren MQ, 2011, BLOOD, V117, P6837, DOI 10.1182/blood-2010-07-295725; Ren MQ, 2009, BLOOD, V114, P1576, DOI 10.1182/blood-2009-03-212704; Richebourg S, 2008, GENE CHROMOSOME CANC, V47, P915, DOI 10.1002/gcc.20588; Roumiantsev S, 2004, CANCER CELL, V5, P287, DOI 10.1016/S1535-6108(04)00053-4; Tefferi A, 2008, LEUKEMIA, V22, P14, DOI 10.1038/sj.leu.2404955; Tefferi A, 2009, NAT REV CLIN ONCOL, V6, P627, DOI 10.1038/nrclinonc.2009.149; Wakim JJ, 2011, LEUKEMIA RES, V35, pE151, DOI 10.1016/j.leukres.2011.05.013; Wei J, 2008, CANCER CELL, V13, P483, DOI 10.1016/j.ccr.2008.04.020; Williams DA, 2000, BLOOD, V96, P1646	21	22	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e38265	10.1371/journal.pone.0038265	http://dx.doi.org/10.1371/journal.pone.0038265			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701616	gold, Green Submitted, Green Published			2022-12-27	WOS:000305348400042
J	Theodoratou, E; Palmer, T; Zgaga, L; Farrington, SM; McKeigue, P; Din, FVN; Tenesa, A; Davey-Smith, G; Dunlop, MG; Campbell, H				Theodoratou, Evropi; Palmer, Tom; Zgaga, Lina; Farrington, Susan M.; McKeigue, Paul; Din, Farhat V. N.; Tenesa, Albert; Davey-Smith, George; Dunlop, Malcolm G.; Campbell, Harry			Instrumental Variable Estimation of the Causal Effect of Plasma 25-Hydroxy-Vitamin D on Colorectal Cancer Risk: A Mendelian Randomization Analysis	PLOS ONE			English	Article							VITAMIN-D INTAKE; 25-HYDROXYVITAMIN D; D SUPPLEMENTATION; D DEFICIENCY; CALCIUM; ASSOCIATION; HEALTH; METAANALYSIS; PREVENTION; ASPIRIN	Vitamin D deficiency has been associated with several common diseases, including cancer and is being investigated as a possible risk factor for these conditions. We reported the striking prevalence of vitamin D deficiency in Scotland. Previous epidemiological studies have reported an association between low dietary vitamin D and colorectal cancer (CRC). Using a case-control study design, we tested the association between plasma 25-hydroxy-vitamin D (25-OHD) and CRC (2,001 cases, 2,237 controls). To determine whether plasma 25-OHD levels are causally linked to CRC risk, we applied the control function instrumental variable (IV) method of the Mendelian randomization (MR) approach using four single nucleotide polymorphisms (rs2282679, rs12785878, rs10741657, rs6013897) previously shown to be associated with plasma 25-OHD. Low plasma 25-OHD levels were associated with CRC risk in the crude model (odds ratio (OR): 0.76, 95% Confidence Interval (CI): 0.71, 0.81, p: 1.4x10(-14)) and after adjusting for age, sex and other confounding factors. Using an allele score that combined all four SNPs as the IV, the estimated causal effect was OR 1.16 (95% CI 0.60, 2.23), whilst it was 0.94 (95% CI 0.46, 1.91) and 0.93 (0.53, 1.63) when using an upstream (rs12785878, rs10741657) and a downstream allele score (rs2282679, rs6013897), respectively. 25-OHD levels were inversely associated with CRC risk, in agreement with recent meta-analyses. The fact that this finding was not replicated when the MR approach was employed might be due to weak instruments, giving low power to demonstrate an effect (<0.35). The prevalence and degree of vitamin D deficiency amongst individuals living in northerly latitudes is of considerable importance because of its relationship to disease. To elucidate the effect of vitamin D on CRC cancer risk, additional large studies of vitamin D and CRC risk are required and/or the application of alternative methods that are less sensitive to weak instrument restrictions.	[Theodoratou, Evropi; Zgaga, Lina; McKeigue, Paul; Campbell, Harry] Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland; [Theodoratou, Evropi; Zgaga, Lina; Farrington, Susan M.; Din, Farhat V. N.; Tenesa, Albert; Dunlop, Malcolm G.] Univ Edinburgh, Western Gen Hosp, Inst Genet & Mol Med, MRC Human Genet Unit,Colon Canc Grp & Acad Colopr, Edinburgh EH8 9YL, Midlothian, Scotland; [Palmer, Tom; Davey-Smith, George] Univ Bristol, Sch Social & Community Med, MRC Ctr Causal Anal Translat Epidemiol, Bristol, Avon, England; [Zgaga, Lina] Univ Zagreb, Sch Med, Andrija Stampar Sch Publ Hlth, Zagreb 41000, Croatia; [Tenesa, Albert] Univ Edinburgh, Roslin Inst, Roslin, Midlothian, Scotland	University of Edinburgh; University of Edinburgh; University of Bristol; University of Zagreb; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh	Theodoratou, E (corresponding author), Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland.	E.Theodoratou@ed.ac.uk	Dunlop, Malcolm G/F-1973-2011; Palmer, Tom Michael/X-6807-2019; Zgaga, Lina/Q-9415-2018; Farrington, Susan M/Q-2710-2019; Theodoratou, Evropi/C-3430-2014; Din, Farhat/A-1944-2015; Davey Smith, George/A-7407-2013; Farrington, Susan M/C-7319-2013; Campbell, Harry/E-2959-2010	Dunlop, Malcolm G/0000-0002-3033-5851; Palmer, Tom Michael/0000-0003-4655-4511; Zgaga, Lina/0000-0003-4089-9703; Farrington, Susan M/0000-0001-5955-7389; Theodoratou, Evropi/0000-0001-5887-9132; Davey Smith, George/0000-0002-1407-8314; Campbell, Harry/0000-0002-6169-6262; Tenesa, Albert/0000-0003-4884-4475; Venkatasubramanian, Siddharth/0000-0002-5860-0768; s, hema/0000-0002-3440-9475	Cancer Research UK Programme grant [C348/A12076]; Medical Research Council [G0000657-53203]; Scottish Executive Chief Scientist's Office [CZH/4/529, CZB/4/449]; Centre Grant from CORE, Digestive Cancer Campaign; Cancer Research UK Fellowship [C31250/A10107]; MRC centre grant [G0600705]; United States National Institute for Health-National Cancer Institute U19 programme grant, CORECT consortium [1U19CA148107-01]; NATIONAL CANCER INSTITUTE [U19CA148107] Funding Source: NIH RePORTER; Cancer Research UK [11378, 12076] Funding Source: researchfish; Medical Research Council [G0600705, MC_U127527198, MC_PC_U127527198, G0800604] Funding Source: researchfish; Chief Scientist Office [CZB/4/449, CZH/4/529] Funding Source: researchfish; MRC [G0600705, MC_U127527198, G0800604, MC_PC_U127527198] Funding Source: UKRI	Cancer Research UK Programme grant(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Scottish Executive Chief Scientist's Office; Centre Grant from CORE, Digestive Cancer Campaign; Cancer Research UK Fellowship(Cancer Research UK); MRC centre grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); United States National Institute for Health-National Cancer Institute U19 programme grant, CORECT consortium; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Chief Scientist Office; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the following grants: Cancer Research UK Programme grant (C348/A12076), Medical Research Council (G0000657-53203) and Scottish Executive Chief Scientist's Office (CZH/4/529, CZB/4/449), and a Centre Grant from CORE as part of the Digestive Cancer Campaign. Dr. Theodoratou is funded by Cancer Research UK Fellowship C31250/A10107. Dr. Palmer is funded by MRC centre grant G0600705. Dr. Zgaga is supported by the United States National Institute for Health-National Cancer Institute U19 programme grant (1U19CA148107-01) as part of the CORECT consortium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benn M, 2011, JNCI-J NATL CANCER I, V103, P508, DOI 10.1093/jnci/djr008; Bischoff-Ferrari HA, 2006, AM J CLIN NUTR, V84, P18, DOI 10.1093/ajcn/84.1.18; Breitling LP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022318; Burleigh E, 2006, SCOT MED J, V51, P27; *COMA, 1991, DIET REF VAL FOOD EN; Dahl M, 2011, THORAX, V66, P197, DOI 10.1136/thx.2009.131193; De Silva NMG, 2011, DIABETES, V60, P1008, DOI 10.2337/db10-1317; Didelez V, 2007, STAT METHODS MED RES, V16, P309, DOI 10.1177/0962280206077743; Din FVN, 2010, GUT, V59, P1670, DOI 10.1136/gut.2009.203000; Ding EL, 2008, INT J CANCER, V122, P1690, DOI 10.1002/ijc.23311; Gross MD, 2005, J NUTR, V135, P326, DOI 10.1093/jn/135.2.326; Jimenez-Lara AM, 2007, INT J BIOCHEM CELL B, V39, P672, DOI 10.1016/j.biocel.2006.10.024; Kivimaki M, 2011, INT J EPIDEMIOL, V40, P470, DOI 10.1093/ije/dyq205; Kivimaki M, 2011, AM J EPIDEMIOL, V173, P421, DOI 10.1093/aje/kwq444; Knox S, 2009, ANN CLIN BIOCHEM, V46, P226, DOI 10.1258/acb.2009.008206; Lawlor DA, 2007, STAT MED; Lawlor DA, 2008, STAT MED, V27, P1133, DOI 10.1002/sim.3034; Lawlor DA, 2011, J INTERN MED, V269, P525, DOI 10.1111/j.1365-2796.2011.02343.x; Lee JE, 2011, CANCER PREV RES, V4, P735, DOI 10.1158/1940-6207.CAPR-10-0289; Lewis SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021689; McKeigue PM, 2010, INT J EPIDEMIOL, V39, P907, DOI 10.1093/ije/dyp397; Mumby HS, 2011, J OBES, V2011, DOI 10.1155/2011/180729; Ng K, 2011, J CLIN ONCOL, V29, P1599, DOI 10.1200/JCO.2010.31.7255; Palmer TM, 2011, AM J EPIDEMIOL, V173, P1392, DOI 10.1093/aje/kwr026; Park SY, 2007, AM J EPIDEMIOL, V165, P784, DOI 10.1093/aje/kwk069; Pearce SHS, 2010, BRIT MED J, V340, DOI 10.1136/bmj.b5664; Pfister R, 2011, DIABETOLOGIA, V54, P2561, DOI 10.1007/s00125-011-2235-0; Pierce BL, 2011, INT J EPIDEMIOL, V40, P740, DOI 10.1093/ije/dyq151; Sivakumaran S, 2011, AM J HUM GE IN PRESS; Slattery ML, 2004, CANCER EPIDEM BIOMAR, V13, P538; Smith GD, 2004, INT J EPIDEMIOL, V33, P30, DOI 10.1093/ije/dyh132; Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070; Smith GD, 2007, PLOS MED, V4, P1985, DOI 10.1371/journal.pmed.0040352; Theodoratou E, 2008, INT J CANCER, V123, P2170, DOI 10.1002/ijc.23769; Theodoratou E, 2007, CANCER EPIDEM BIOMAR, V16, P684, DOI 10.1158/1055-9965.EPI-06-0785; Touvier M, 2011, CANCER EPIDEM BIOMAR, V20, P1003, DOI 10.1158/1055-9965.EPI-10-1141; Trivedi DP, 2003, BMJ-BRIT MED J, V326, P469, DOI 10.1136/bmj.326.7387.469; Vieth R, 2007, AM J CLIN NUTR, V85, P649, DOI 10.1093/ajcn/85.3.649; Wactawski-Wende J, 2006, NEW ENGL J MED, V354, P684, DOI 10.1056/NEJMoa055222; Wagner CL, 2008, PEDIATRICS, V122, P1142, DOI 10.1542/peds.2008-1862; Wallace AM, 2010, STEROIDS, V75, P477, DOI 10.1016/j.steroids.2010.02.012; Wang TJ, 2010, LANCET, V376, P180, DOI 10.1016/S0140-6736(10)60588-0; Wensley F, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d548; Yin L, 2011, PREV MED, V53, P10, DOI 10.1016/j.ypmed.2011.05.013; Zgaga L, 2011, J NUTR	45	43	43	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e37662	10.1371/journal.pone.0037662	http://dx.doi.org/10.1371/journal.pone.0037662			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701574	Green Published, gold, Green Submitted			2022-12-27	WOS:000305348400015
J	Nagel, M; Sprenger, A; Steinlechner, S; Binkofski, F; Lencer, R				Nagel, Matthias; Sprenger, Andreas; Steinlechner, Susanne; Binkofski, Ferdinand; Lencer, Rebekka			Altered Velocity Processing in Schizophrenia during Pursuit Eye Tracking	PLOS ONE			English	Article							ARCUATE FRONTAL-CORTEX; SMOOTH-PURSUIT; MOTION PERCEPTION; CORTICAL MECHANISMS; OCULOMOTOR SYSTEM; VISUAL-PERCEPTION; CEREBELLAR UVULA; TARGET BLANKING; MOVEMENTS; DEFICITS	Smooth pursuit eye movements (SPEM) are needed to keep the retinal image of slowly moving objects within the fovea. Depending on the task, about 50%-80% of patients with schizophrenia have difficulties in maintaining SPEM. We designed a study that comprised different target velocities as well as testing for internal (extraretinal) guidance of SPEM in the absence of a visual target. We applied event-related fMRI by presenting four velocities (5, 10, 15, 20 degrees/s) both with and without intervals of target blanking. 17 patients and 16 healthy participants were included. Eye movements were registered during scanning sessions. Statistical analysis included mixed ANOVAs and regression analyses of the target velocity on the Blood Oxygen Level Dependency (BOLD) signal. The main effect group and the interaction of velocityxgroup revealed reduced activation in V5 and putamen but increased activation of cerebellar regions in patients. Regression analysis showed that activation in supplementary eye field, putamen, and cerebellum was not correlated to target velocity in patients in contrast to controls. Furthermore, activation in V5 and in intraparietal sulcus (putative LIP) bilaterally was less strongly correlated to target velocity in patients than controls. Altered correlation of target velocity and neural activation in the cortical network supporting SPEM (V5, SEF, LIP, putamen) implies impaired transformation of the visual motion signal into an adequate motor command in patients. Cerebellar regions seem to be involved in compensatory mechanisms although cerebellar activity in patients was not related to target velocity.	[Nagel, Matthias; Steinlechner, Susanne; Lencer, Rebekka] Univ Lubeck, Dept Psychiat & Psychotherapy, Lubeck, Germany; [Sprenger, Andreas] Univ Lubeck, Dept Neurol, Lubeck, Germany; [Nagel, Matthias] Univ Clin Hamburg Eppendorf, Dept Syst Neurosci, Hamburg, Germany; [Nagel, Matthias] Clin Psychiat & Psychotherapy, Asklepios Klin Nord Wandsbek, Hamburg, Germany; [Lencer, Rebekka] Univ Munster, Dept Psychiat & Psychotherapy, Munster, Germany; [Binkofski, Ferdinand] Rhein Westfal TH Aachen, Div Cognit Neurol, Dept Neurol, Aachen, Germany	University of Lubeck; University of Lubeck; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Munster; RWTH Aachen University	Nagel, M (corresponding author), Univ Lubeck, Dept Psychiat & Psychotherapy, Lubeck, Germany.	ma.nagel@asklepios.com	Sprenger, Andreas/C-7612-2009; Lencer, Rebekka/A-4994-2009; Binkofski, Ferdinand/S-6997-2017	Sprenger, Andreas/0000-0001-9255-7911; Lencer, Rebekka/0000-0003-4032-7297; Binkofski, Ferdinand/0000-0002-6750-943X	DFG (Deutsche Forschungsgemeinschaft/German Research Foundation) [NA 614/3-1]	DFG (Deutsche Forschungsgemeinschaft/German Research Foundation)(German Research Foundation (DFG))	This work was granted by the DFG (Deutsche Forschungsgemeinschaft/German Research Foundation, grant: NA 614/3-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreasen NC, 2008, BIOL PSYCHIAT, V64, P81, DOI 10.1016/j.biopsych.2008.01.003; BECKER W, 1985, EXP BRAIN RES, V57, P562; Burke MR, 2008, CEREB CORTEX, V18, P126, DOI 10.1093/cercor/bhm038; Butler PD, 2008, BIOL PSYCHIAT, V64, P40, DOI 10.1016/j.biopsych.2008.03.023; Butler PD, 2005, CURR OPIN PSYCHIATR, V18, P151, DOI 10.1097/00001504-200503000-00008; Chen Y, 2004, BIOL PSYCHIAT, V55, P834, DOI 10.1016/j.biopsych.2003.12.024; Chen Y, 1999, ARCH GEN PSYCHIAT, V56, P149, DOI 10.1001/archpsyc.56.2.149; Chen Y, 1999, ARCH GEN PSYCHIAT, V56, P155, DOI 10.1001/archpsyc.56.2.155; Chen Y, 2003, SCHIZOPHR RES, V61, P215, DOI 10.1016/S0920-9964(02)00222-0; Dash S, 2012, CEREB CORTEX, V22, P877, DOI 10.1093/cercor/bhr153; Dieterich M, 2009, ANN NY ACAD SCI, V1164, P282, DOI 10.1111/j.1749-6632.2008.03718.x; Friston KJ, 1995, HUM BRAIN MAPP, V3, P165, DOI 10.1002/hbm.460030303; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Fukushima J, 2004, J NEUROPHYSIOL, V91, P2809, DOI 10.1152/jn.01128.2003; Heinen SJ, 1996, EXP BRAIN RES, V110, P1; HEINEN SJ, 1992, ANN NY ACAD SCI, V656, P775, DOI 10.1111/j.1749-6632.1992.tb25256.x; HOLZMAN PS, 1974, ARCH GEN PSYCHIAT, V31, P143; Hong LE, 2008, BIOL PSYCHIAT, V63, P458, DOI 10.1016/j.biopsych.2007.06.004; Hong LE, 2009, BIOL PSYCHIAT, V65, P1079, DOI 10.1016/j.biopsych.2008.10.021; Hong LE, 2005, BIOL PSYCHIAT, V57, P726, DOI 10.1016/j.biopsych.2004.12.015; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Krauzlis RJ, 2004, J NEUROPHYSIOL, V91, P591, DOI 10.1152/jn.00801.2003; Lencer R, 2000, BIOL PSYCHIAT, V47, P391, DOI 10.1016/S0006-3223(99)00249-8; Lencer R, 2004, EUR J NEUROSCI, V19, P1430, DOI 10.1111/j.1460-9568.2004.03229.x; Lencer R, 2005, NEUROIMAGE, V24, P1256, DOI 10.1016/j.neuroimage.2004.11.013; Lencer R, 2011, PSYCHIAT RES-NEUROIM, V194, P30, DOI 10.1016/j.pscychresns.2011.06.011; Lencer R, 2010, BIOL PSYCHIAT, V67, P217, DOI 10.1016/j.biopsych.2009.08.005; Lynch JC, 2006, PROG BRAIN RES, V151, P461, DOI 10.1016/S0079-6123(05)51015-X; Nagel M, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-89; Nagel M, 2006, NEUROIMAGE, V29, P1319, DOI 10.1016/j.neuroimage.2005.08.050; Nagel M, 2008, NEUROIMAGE, V41, P483, DOI 10.1016/j.neuroimage.2008.02.058; Nagel M, 2007, NEUROIMAGE, V34, P300, DOI 10.1016/j.neuroimage.2006.08.025; Neggers SFW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029517; Nkam I, 2010, BIOL PSYCHIAT, V67, P992, DOI 10.1016/j.biopsych.2009.11.029; ODonnell BF, 1996, AM J PSYCHIAT, V153, P687; RASHBASS C, 1961, J PHYSIOL-LONDON, V159, P326, DOI 10.1113/jphysiol.1961.sp006811; Robinson FR, 2001, ANNU REV NEUROSCI, V24, P981, DOI 10.1146/annurev.neuro.24.1.981; Schmid A, 2001, NEUROREPORT, V12, P1409, DOI 10.1097/00001756-200105250-00023; Schraa-Tam CKL, 2008, EXP BRAIN RES, V185, P535, DOI 10.1007/s00221-007-1176-9; Schultz W, 2006, ANNU REV PSYCHOL, V57, P87, DOI 10.1146/annurev.psych.56.091103.070229; Shadmehr R, 2008, EXP BRAIN RES, V185, P359, DOI 10.1007/s00221-008-1280-5; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Shichinohe N, 2009, NEURON, V62, P717, DOI 10.1016/j.neuron.2009.05.010; Slaghuis WL, 2007, EXP BRAIN RES, V182, P415, DOI 10.1007/s00221-007-1003-3; Slaghuis WL, 2004, EXP BRAIN RES, V156, P196, DOI 10.1007/s00221-003-1771-3; Takagi M, 2000, J NEUROPHYSIOL, V83, P2047, DOI 10.1152/jn.2000.83.4.2047; Tanaka M, 2002, J NEUROPHYSIOL, V87, P2700, DOI 10.1152/jn.2002.87.6.2700; Tanaka M, 2002, J NEUROPHYSIOL, V87, P2684, DOI 10.1152/jn.2002.87.6.2684; Thaker GK, 1998, ARCH GEN PSYCHIAT, V55, P830, DOI 10.1001/archpsyc.55.9.830; Thaker GK, 1999, PSYCHIAT RES, V88, P209, DOI 10.1016/S0165-1781(99)00084-0; Thaker GK, 2008, SCHIZOPHRENIA BULL, V34, P760, DOI 10.1093/schbul/sbn049; Thier P, 2005, CURR OPIN NEUROBIOL, V15, P645, DOI 10.1016/j.conb.2005.10.013; Voogd J, 2012, CEREBELLUM, V11, P392, DOI 10.1007/s12311-010-0204-7	53	14	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e38494	10.1371/journal.pone.0038494	http://dx.doi.org/10.1371/journal.pone.0038494			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22693639	Green Published, Green Submitted, gold			2022-12-27	WOS:000305343900049
J	Bhat, AA; Sharma, A; Pope, J; Krishnan, M; Washington, MK; Singh, AB; Dhawan, P				Bhat, Ajaz A.; Sharma, Ashok; Pope, Jillian; Krishnan, Moorthy; Washington, Mary K.; Singh, Amar B.; Dhawan, Punita			Caudal Homeobox Protein Cdx-2 Cooperates with Wnt Pathway to Regulate Claudin-1 Expression in Colon Cancer Cells	PLOS ONE			English	Article							TIGHT JUNCTION STRANDS; CARBONIC-ANHYDRASE 1; GENE-EXPRESSION; INTESTINAL DIFFERENTIATION; TRANSCRIPTION FACTORS; HOMEODOMAIN PROTEINS; EPITHELIAL-CELLS; PROMOTER; OCCLUDIN; PROLIFERATION	Dysregulation of tight junctions (TJs) is often associated with human diseases including carcinogenesis and recent studies support role of TJ integral proteins in the regulation of Epithelial-to-Mesenchymal Transition (EMT). In this regard, expression of claudin-1, a key constituent of TJs, is highly increased in colon cancer and is causally associated with the tumor growth and progression. However, mechanism/s underlying regulation of claudin-1 expression in intestinal epithelial cells remains poorly understood. In our studies, we have identified putative binding sites for intestinal transcription factors Cdx1, -2 and GATA4 in the 5'-flanking region of the claudin-1 gene. Our further studies using full length and/or deletion mutant constructs in two different human colon cancer cell lines, SW480 and HCT116, showed key role of Cdx1, Cdx2 and GATA4 in the regulation of claudin-1 mRNA expression. However, overexpression of Cdx2 had the most potent effect upon claudin-1 mRNA expression and promoter activity. Also, in colon cancer patient samples, we observed a significant and parallel correlation between claudin-1 and Cdx2 expressions. Chromatin immunoprecipitation (ChIP) assay confirmed the Cdx2 binding with claudin-1 promoter in vivo. Using Cdx2 deletion mutant constructs, we further mapped the Cdx2 C-terminus domain to be important in the regulation of claudin-1 promoter activity. Interestingly, co-expression of activated beta-catenin further induced the Cdx2-dependent upregulation of claudin-1 promoter activity while expression of the dominant negative (dn)-TCF-4 abrogated this activation. Taken together, we conclude that homeodomain transcription factors Cdx1, Cdx2 and GATA4 regulate claudin-1 gene expression in human colon cancer cells. Moreover, a functional crosstalk between Wnt-signaling and transcriptional activation related to caudal-related homeobox (Cdx) proteins and GATA-proteins is demonstrated in the regulation of claudin-1 promoter-activation.	[Bhat, Ajaz A.; Sharma, Ashok; Pope, Jillian; Krishnan, Moorthy; Singh, Amar B.; Dhawan, Punita] Vanderbilt Univ, Sch Med, Dept Surg, Nashville, TN 37212 USA; [Pope, Jillian; Dhawan, Punita] Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37212 USA; [Washington, Mary K.] Vanderbilt Univ, Sch Med, Dept Pathol, Nashville, TN 37212 USA; [Singh, Amar B.] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Bhat, AA (corresponding author), Vanderbilt Univ, Sch Med, Dept Surg, Nashville, TN 37212 USA.	punita.dhawan@vanderbilt.edu2	Sharma, Ashok/AAE-5439-2019; Bhat, Ajaz/V-3642-2019	Sharma, Ashok/0000-0001-7505-6023; Bhat, Ajaz/0000-0003-3640-6275	National Institutes of Health (NIH) [CA124977, DK088902]; NATIONAL CANCER INSTITUTE [R01CA124977] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088902] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM062459] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) grant CA124977 (P. Dhawan) and DK088902 (A.B. Singh). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki K, 2003, NAT GENET, V35, P323, DOI 10.1038/ng1265; Bonhomme C, 2003, GUT, V52, P1465, DOI 10.1136/gut.52.10.1465; Boudreau F, 2002, J BIOL CHEM, V277, P31909, DOI 10.1074/jbc.M204622200; Charite J, 1998, DEVELOPMENT, V125, P4349; Chawengsaksophak K, 1997, NATURE, V386, P84, DOI 10.1038/386084a0; Chun SY, 2007, ONCOGENE, V26, P4725, DOI 10.1038/sj.onc.1210258; Dang LH, 2006, ONCOGENE, V25, P2264, DOI 10.1038/sj.onc.1209247; Dhawan P, 2005, J CLIN INVEST, V115, P1765, DOI 10.1172/JCI24543; Dhawan P, 2011, ONCOGENE, V30, P3234, DOI 10.1038/onc.2011.43; Drummond F, 1996, EUR J BIOCHEM, V236, P670, DOI 10.1111/j.1432-1033.1996.t01-1-00670.x; Drummond FJ, 1998, FEBS LETT, V423, P218, DOI 10.1016/S0014-5793(98)00103-3; DUPREY P, 1988, GENE DEV, V2, P1647, DOI 10.1101/gad.2.12a.1647; Escaffit F, 2005, J CELL PHYSIOL, V203, P15, DOI 10.1002/jcp.20189; Fang RX, 2000, GASTROENTEROLOGY, V118, P115, DOI 10.1016/S0016-5085(00)70420-3; Furuse M, 1998, J CELL BIOL, V143, P391, DOI 10.1083/jcb.143.2.391; Guo RJ, 2010, CARCINOGENESIS, V31, P159, DOI 10.1093/carcin/bgp213; Hellebrekers DMEI, 2009, CLIN CANCER RES, V15, P3990, DOI 10.1158/1078-0432.CCR-09-0055; JAMES R, 1991, J BIOL CHEM, V266, P3246; JAMES R, 1994, J BIOL CHEM, V269, P15229; Kahler RA, 2003, J BIOL CHEM, V278, P11937, DOI 10.1074/jbc.M211443200; Kaimaktchiev V, 2004, MODERN PATHOL, V17, P1392, DOI 10.1038/modpathol.3800205; Krishnan M, 2010, ONCOGENE, V29, P305, DOI 10.1038/onc.2009.324; Lambert M, 1996, EUR J BIOCHEM, V236, P778, DOI 10.1111/j.1432-1033.1996.00778.x; Lickert H, 2000, DEVELOPMENT, V127, P3805; Lynch J, 2000, J BIOL CHEM, V275, P4499, DOI 10.1074/jbc.275.6.4499; Mclin VA, 2007, DEVELOPMENT, V134, P2207, DOI 10.1242/dev.001230; Miller CT, 2003, CLIN CANCER RES, V9, P4819; Mitchelmore C, 2000, BIOCHEM J, V346, P529, DOI 10.1042/0264-6021:3460529; Miwa N, 2001, ONCOL RES, V12, P469, DOI 10.3727/096504001108747477; Morita K, 1999, P NATL ACAD SCI USA, V96, P511, DOI 10.1073/pnas.96.2.511; Moskaluk CA, 2003, MODERN PATHOL, V16, P913, DOI 10.1097/01.MP.0000086073.92773.55; Sakaguchi T, 2002, J BIOL CHEM, V277, P21361, DOI 10.1074/jbc.M110261200; Satake S, 2008, PATHOL INT, V58, P156, DOI 10.1111/j.1440-1827.2007.02204.x; Shiou SR, 2007, CANCER RES, V67, P1571, DOI 10.1158/0008-5472.CAN-06-1680; Silberg DG, 2000, GASTROENTEROLOGY, V119, P961, DOI 10.1053/gast.2000.18142; Singh AB, 2011, GASTROENTEROLOGY, V141, P2140, DOI 10.1053/j.gastro.2011.08.038; Soubeyran P, 1999, GASTROENTEROLOGY, V117, P1326, DOI 10.1016/S0016-5085(99)70283-0; Suh E, 1996, MOL CELL BIOL, V16, P619; SUH E, 1994, MOL CELL BIOL, V14, P7340, DOI 10.1128/MCB.14.11.7340; Tamai Y, 1999, CANCER RES, V59, P2965; Troelsen JT, 1997, BIOCHEM J, V322, P833, DOI 10.1042/bj3220833; Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088; Tsukita S, 2000, J CELL BIOL, V149, P13, DOI 10.1083/jcb.149.1.13; Verzi MP, 2010, P NATL ACAD SCI USA, V107, P15157, DOI 10.1073/pnas.1003822107; Vietor I, 2001, EMBO REP, V2, P306, DOI 10.1093/embo-reports/kve066; Wong V, 1997, J CELL BIOL, V136, P399, DOI 10.1083/jcb.136.2.399	46	52	55	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2012	7	6							e37174	10.1371/journal.pone.0037174	http://dx.doi.org/10.1371/journal.pone.0037174			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WX	22719836	gold, Green Published, Green Submitted			2022-12-27	WOS:000305350000004
J	Cockayne, DA; Cheng, DT; Waschki, B; Sridhar, S; Ravindran, P; Hilton, H; Kourteva, G; Bitter, H; Pillai, SG; Visvanathan, S; Muller, KC; Holz, O; Magnussen, H; Watz, H; Fine, JS				Cockayne, Debra A.; Cheng, Donavan T.; Waschki, Benjamin; Sridhar, Sriram; Ravindran, Palanikumar; Hilton, Holly; Kourteva, Galina; Bitter, Hans; Pillai, Sreekumar G.; Visvanathan, Sudha; Mueller, Kai-Christian; Holz, Olaf; Magnussen, Helgo; Watz, Henrik; Fine, Jay S.			Systemic Biomarkers of Neutrophilic Inflammation, Tissue Injury and Repair in COPD Patients with Differing Levels of Disease Severity	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; OBSTRUCTIVE PULMONARY-DISEASE; EPIDERMAL-GROWTH-FACTOR; SOLUBLE RECEPTOR; METABOLIC SYNDROME; EPITHELIAL REPAIR; PLASMA-FIBRINOGEN; PHYSICAL-ACTIVITY; LUNG-FUNCTION; FACTOR-ALPHA	The identification and validation of biomarkers to support the assessment of novel therapeutics for COPD continues to be an important area of research. The aim of the current study was to identify systemic protein biomarkers correlated with measures of COPD severity, as well as specific protein signatures associated with comorbidities such as metabolic syndrome. 142 protein analytes were measured in serum of 140 patients with stable COPD, 15 smokers without COPD and 30 nonsmoking controls. Seven analytes (sRAGE, EN-RAGE, NGAL, Fibrinogen, MPO, TGF-alpha and HB-EGF) showed significant differences between severe/very severe COPD, mild/moderate COPD, smoking and non-smoking control groups. Within the COPD subjects, univariate and multivariate analyses identified analytes significantly associated with FEV1, FEV1/FVC and DLCO. Most notably, a set of 5 analytes (HB-EGF, Fibrinogen, MCP-4, sRAGE and Sortilin) predicted 21% of the variability in DLCO values. To determine common functions/pathways, analytes were clustered in a correlation network by similarity of expression profile. While analytes related to neutrophil function (EN-RAGE, NGAL, MPO) grouped together to form a cluster associated with FEV1 related parameters, analytes related to the EGFR pathway (HB-EGF, TGF-alpha) formed another cluster associated with both DLCO and FEV1 related parameters. Associations of Fibrinogen with DLCO and MPO with FEV1/FVC were stronger in patients without metabolic syndrome (r = 20.52, p = 0.005 and r = -0.61, p = 0.023, respectively) compared to patients with coexisting metabolic syndrome (r = -0.25, p = 0.47 and r = -0.15, p = 0.96, respectively), and may be driving overall associations in the general cohort. In summary, our study has identified known and novel serum protein biomarkers and has demonstrated specific associations with COPD disease severity, FEV1, FEV1/FVC and DLCO. These data highlight systemic inflammatory pathways, neutrophil activation and epithelial tissue injury/repair processes as key pathways associated with COPD.	[Cockayne, Debra A.; Pillai, Sreekumar G.; Visvanathan, Sudha; Fine, Jay S.] Hoffmann La Roche Inc, Inflammat Dis Therapy Area, Nutley, NJ 07110 USA; [Cheng, Donavan T.; Sridhar, Sriram; Ravindran, Palanikumar; Hilton, Holly; Kourteva, Galina; Bitter, Hans] Hoffmann La Roche Inc, Translat Res Sci, Nutley, NJ 07110 USA; [Waschki, Benjamin; Magnussen, Helgo; Watz, Henrik] Hosp Grosshansdorf, Pulm Res Inst, Grosshansdorf, Germany; [Waschki, Benjamin; Mueller, Kai-Christian; Holz, Olaf] Hosp Grosshandorf, Ctr Pneumol & Thorac Surg, Grosshansdorf, Germany	Roche Holding; Roche Holding; Grosshansdorf Hospital; Grosshansdorf Hospital	Cockayne, DA (corresponding author), Hoffmann La Roche Inc, Inflammat Dis Therapy Area, 340 Kingsland St, Nutley, NJ 07110 USA.	donavan.cheng@roche.com	Waschki, Benjamin/V-4588-2019	Waschki, Benjamin/0000-0002-1070-3661	Hoffmann-La Roche Inc.	Hoffmann-La Roche Inc.(Hoffmann-La Roche)	This study was funded by Hoffmann-La Roche Inc. No current external funding sources for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaron SD, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-41; Alexiou P, 2010, CURR MED CHEM, V17, P2232, DOI 10.2174/092986710791331086; Allahverdian S, 2008, AM J RESP CELL MOL, V38, P153, DOI 10.1165/rcmb.2007-0173OC; Baginski TK, 2006, AM J RESP CELL MOL, V35, P165, DOI 10.1165/rcmb.2005-0259OC; Barnes PJ, 2004, LANCET, V364, P985, DOI 10.1016/S0140-6736(04)17025-6; Baughman RP, 1999, SARCOIDOSIS VASC DIF, V16, P57; BERNARD A, 1992, EUR RESPIR J, V5, P1231; Braido F, 2007, RESP MED, V101, P2119, DOI 10.1016/j.rmed.2007.05.023; Buckley ST, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/917108; Calfee CS, 2008, THORAX, V63, P1083, DOI 10.1136/thx.2008.095588; Cernaro V, 2011, CURR PHARM DESIGN, V17, P844, DOI 10.2174/138161211795428939; CLAUSS A., 1957, ACTA HAEMATOL, V17, P237; COTES JE, 1993, EUR RESPIR J, V6, P41, DOI 10.1183/09041950.041s1693; Crosby LM, 2010, AM J PHYSIOL-LUNG C, V298, pL715, DOI 10.1152/ajplung.00361.2009; Dahl M, 2001, AM J RESP CRIT CARE, V164, P1008, DOI 10.1164/ajrccm.164.6.2010067; de Boer WI, 2006, AM J CLIN PATHOL, V125, P184, DOI 10.1039/W1AXKGT7UA37X257; Demling N, 2006, CELL TISSUE RES, V323, P475, DOI 10.1007/s00441-005-0069-0; Dickens JA, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-146; Eagan TML, 2010, EUR RESPIR J, V35, P540, DOI 10.1183/09031936.00088209; Eagan TM, 2010, CHEST, V138, P888, DOI 10.1378/chest.09-2718; Englert JM, 2008, AM J PATHOL, V172, P583, DOI 10.2353/ajpath.2008.070569; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Ferhani N, 2010, AM J RESP CRIT CARE, V181, P917, DOI 10.1164/rccm.200903-0340OC; Foell D, 2003, RHEUMATOLOGY, V42, P1383, DOI 10.1093/rheumatology/keg385; Foell D, 2007, J LEUKOCYTE BIOL, V81, P28, DOI 10.1189/jlb.0306170; Gan WQ, 2004, THORAX, V59, P574, DOI 10.1136/thx.2003.019588; Han MK, 2010, AM J RESP CRIT CARE, V182, P598, DOI 10.1164/rccm.200912-1843CC; Hasegawa T, 2003, ATHEROSCLEROSIS, V171, P211, DOI 10.1016/j.atherosclerosis.2003.08.021; Hurst JR, 2006, AM J RESP CRIT CARE, V174, P867, DOI 10.1164/rccm.200604-506OC; Kramer EL, 2007, AM J PHYSIOL-LUNG C, V293, pL314, DOI 10.1152/ajplung.00354.2006; Lomas DA, 2008, THORAX, V63, P1058, DOI 10.1136/thx.2008.102574; Lotze MT, 2009, J TRANSLATIONAL MED, V7; MacIntyre N, 2005, EUR RESPIR J, V26, P720, DOI 10.1183/09031936.05.00034905; Magnussen Helgo, 2009, Proc Am Thorac Soc, V6, P648, DOI 10.1513/pats.200906-053DP; Mahajan N, 2010, INT J CARDIOL, V145, P589, DOI 10.1016/j.ijcard.2010.05.075; Maillard-Lefebvre H, 2009, RHEUMATOLOGY, V48, P1190, DOI 10.1093/rheumatology/kep199; Marquis Karine, 2005, J Cardiopulm Rehabil, V25, P226, DOI 10.1097/00008483-200507000-00010; McCawley LJ, 2001, CURR OPIN CELL BIOL, V13, P534, DOI 10.1016/S0955-0674(00)00248-9; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Morbini P, 2006, MODERN PATHOL, V19, P1437, DOI 10.1038/modpathol.3800661; Nah SS, 2007, FEBS LETT, V581, P1928, DOI 10.1016/j.febslet.2007.03.090; Nussbaumer-Ochsner Y, 2011, CHEST, V139, P165, DOI 10.1378/chest.10-1252; Pietzsch J, 2009, AMINO ACIDS, V36, P381, DOI 10.1007/s00726-008-0097-7; Pinto-Plata V, 2007, THORAX, V62, P595, DOI 10.1136/thx.2006.064428; Pinto-Plata VM, 2006, THORAX, V61, P23, DOI 10.1136/thx.2005.042200; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; Queisser MA, 2008, AM J RESP CELL MOL, V39, P337, DOI 10.1165/rcmb.2007-0244OC; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Rasheed Z, 2011, RHEUMATOLOGY, V50, P838, DOI 10.1093/rheumatology/keq380; Rennard Stephen I, 2011, Proc Am Thorac Soc, V8, P368, DOI 10.1513/pats.201102-019RM; Repapi E, 2010, NAT GENET, V42, P36, DOI 10.1038/ng.501; Richter A, 2002, AM J RESP CELL MOL, V27, P85, DOI 10.1165/ajrcmb.27.1.4789; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shijubo N, 1997, EUR RESPIR J, V10, P1108, DOI 10.1183/09031936.97.10051108; Sin DD, 2011, AM J RESP CRIT CARE, V183, P1187, DOI 10.1164/rccm.201008-1220OC; Singh D, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-77; Smith DJ, 2011, EUR RESPIR J, V37, P516, DOI 10.1183/09031936.00029310; STAHLMAN MT, 1989, LAB INVEST, V60, P539; Stockley RA, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-136; Sukkar MB, 2011, EUR RESP J; Sutherland JP, 2004, METAB SYNDR RELAT D, V2, P82, DOI 10.1089/met.2004.2.82; Suzuki M, 1997, J BIOL CHEM, V272, P31730, DOI 10.1074/jbc.272.50.31730; Takeyama K, 2000, J IMMUNOL, V164, P1546, DOI 10.4049/jimmunol.164.3.1546; Thyagarajan B, 2006, INT J EPIDEMIOL, V35, P1001, DOI 10.1093/ije/dyl049; Uchida T, 2006, AM J RESP CRIT CARE, V173, P1008, DOI 10.1164/rccm.200509-1477OC; Vestbo J, 2011, NEW ENGL J MED, V365, P1184, DOI 10.1056/NEJMoa1105482; Vestbo J, 2010, AM J RESP CRIT CARE, V182, P863, DOI 10.1164/rccm.201004-0602ED; Wang Q, 2010, J IMMUNOL, V185, P834, DOI 10.4049/jimmunol.0901490; Waschki B, 2011, CHEST, V140, P331, DOI 10.1378/chest.10-2521; Watz H, 2009, EUR RESPIR J, V33, P262, DOI 10.1183/09031936.00024608; Watz H, 2008, AM J RESP CRIT CARE, V177, P743, DOI 10.1164/rccm.200707-1011OC; Watz H, 2010, CHEST, V138, P32, DOI 10.1378/chest.09-2810; Watz H, 2010, NEW ENGL J MED, V362, P1638, DOI 10.1056/NEJMc1002018; Watz H, 2009, CHEST, V136, P1039, DOI 10.1378/chest.09-0393; Woodruff Prescott G, 2011, Proc Am Thorac Soc, V8, P350, DOI 10.1513/pats.201101-015RM; Wu LA, 2011, RESP MED, V105, P329, DOI 10.1016/j.rmed.2010.11.001; Yamakawa N, 2011, AM J PHYSIOL-LUNG C, V300, pL516, DOI 10.1152/ajplung.00118.2010; Yan SF, 2010, BIOCHEM PHARMACOL, V79, P1379, DOI 10.1016/j.bcp.2010.01.013; Yanbaeva DG, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-23; Yang Z, 2007, J ALLERGY CLIN IMMUN, V119, P106, DOI 10.1016/j.jaci.2006.08.021	82	72	77	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2012	7	6							e38629	10.1371/journal.pone.0038629	http://dx.doi.org/10.1371/journal.pone.0038629			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UJ	22701684	Green Published, gold, Green Submitted			2022-12-27	WOS:000305340000038
J	Neto, JM; Arroyo, JL; Bargain, B; Monros, JS; Matrai, N; Prochazka, P; Zehtindjiev, P				Neto, Julio M.; Arroyo, Jose L.; Bargain, Bruno; Monros, Juan S.; Matrai, Norbert; Prochazka, Petr; Zehtindjiev, Pavel			Phylogeography of a Habitat Specialist with High Dispersal Capability: The Savi's Warbler Locustella luscinioides	PLOS ONE			English	Article							CROSS-SPECIES AMPLIFICATION; EXTRA-PAIR PATERNITY; POPULATION-STRUCTURE; GENETIC DIFFERENTIATION; MICROSATELLITE LOCI; SOFTWARE; MITOCHONDRIAL; DIVERSIFICATION; REFUGIA; COLONIZATION	In order to describe the influence of Pleistocene glaciations on the genetic structure and demography of a highly mobile, but specialized, passerine, the Savi's Warbler (Locustella luscinioides), mitochondrial DNA sequences (ND2) and microsatellites were analysed in c. 330 individuals of 17 breeding and two wintering populations. Phylogenetic, population genetics and coalescent methods were used to describe the genetic structure, determine the timing of the major splits and model the demography of populations. Savi's Warblers split from its sister species c. 8 million years ago and have two major haplotype groups that diverged in the early/middle Pleistocene. One of these clades originated in the Balkans and is currently widespread, showing strong evidence for population expansion; whereas the other is restricted to Iberia and remained stable. Microsatellites agreed with a genetic break around the Pyrenees, but showed considerable introgression and a weaker genetic structure. Both genetic markers showed an isolation-by-distance pattern associated with the population expansion of the eastern clade. Breeding populations seem to be segregated at the wintering sites, but results on migratory connectivity are preliminary. Savi's Warbler is the only known migratory bird species in which Iberian birds did not expand beyond the Pyrenees after the last glaciation. Despite the long period of independent evolution of western and eastern populations, complete introgression occurred when these groups met in Iberia. Mitochondrial sequences indicated the existence of refugia-within-refugia in the Iberian Peninsula during the last glacial period, which is surprising given the high dispersal capacity of this species. Plumage differences of eastern subspecies seemed to have evolved recently through natural selection, in agreement with the glacial expansion hypothesis. This study supports the great importance of the Iberian Peninsula and its role for the conservation of genetic variation.	[Neto, Julio M.] Lund Univ, Dept Biol, Lund, Sweden; [Neto, Julio M.] Univ Porto, CIBIO UP Ctr Invest Biodiversidade & Recursos Gen, Vairao, Portugal; [Arroyo, Jose L.] Fuentes Nava, Grp Iber Anillamiento, Palencia, Spain; [Bargain, Bruno] Bretagne Vivante, Village De Trunvel, Treogat, France; [Monros, Juan S.] Univ Valencia, Inst Cavanilles Biodivers & Evolutionary Biol, Valencia, Spain; [Matrai, Norbert] Szent Istvan Univ, Dept Zool & Anim Ecol, Godollo, Hungary; [Prochazka, Petr] Acad Sci Czech Republ, Inst Vertebrate Biol, Brno, Czech Republic; [Zehtindjiev, Pavel] Bulgarian Acad Sci, Inst Biodivers & Ecosyst Res, Sofia, Bulgaria	Lund University; Universidade do Porto; University of Valencia; Hungarian University of Agriculture & Life Sciences; Czech Academy of Sciences; Institute of Vertebrate Biology of the Czech Academy of Sciences; Bulgarian Academy of Sciences	Neto, JM (corresponding author), Lund Univ, Dept Biol, Ecol Bldg, Lund, Sweden.	julio.m.neto@gmail.com	Neto, Júlio Manuel/D-1853-2009; Zehtidiev, Pavel/K-3236-2012; Monros, Juan S/L-9750-2014; Monros, Juan/AAA-3726-2020; Prochazka, Petr/A-9727-2008; Matos, José Luis Arroyo/H-7074-2019	Neto, Júlio Manuel/0000-0002-4855-3988; Zehtidiev, Pavel/0000-0002-9786-3974; Monros, Juan S/0000-0002-0952-2089; Monros, Juan/0000-0002-0952-2089; Prochazka, Petr/0000-0001-9385-4547; Matos, José Luis Arroyo/0000-0002-7605-5599	Portuguese Foundation for Science and Technology [SFRH/BPD/40667/2007, PTDC/BIA-BDE/64285/2006]; Fundo Social Europeu (FSE) under the Programa Operacional Potencial Humano (POPH) from QREN (Quadro de Referencia Estrategico Nacional)	Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); Fundo Social Europeu (FSE) under the Programa Operacional Potencial Humano (POPH) from QREN (Quadro de Referencia Estrategico Nacional)	JMN was supported financially by the Portuguese Foundation for Science and Technology (grant SFRH/BPD/40667/2007), co-financed by Fundo Social Europeu (FSE) under the Programa Operacional Potencial Humano (POPH) from QREN (Quadro de Referencia Estrategico Nacional). This study was partially financed by the same institution through the project PTDC/BIA-BDE/64285/2006. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alstrom P, 2011, MOL PHYLOGENET EVOL, V58, P513, DOI 10.1016/j.ympev.2010.12.012; Arbogast BS, 2006, EVOLUTION, V60, P370, DOI 10.1111/j.0014-3820.2006.tb01113.x; Avise JC, 2009, J BIOGEOGR, V36, P3, DOI 10.1111/j.1365-2699.2008.02032.x; Bensch S, 2009, MOL ECOL, V18, P3087, DOI 10.1111/j.1365-294X.2009.04210.x; Brito PH, 2007, MOL ECOL, V16, P3423, DOI 10.1111/j.1365-294X.2007.03401.x; Cabral M.J., 2005, LIVRO VERMELHO VERTE; Centeno-Cuadros A, 2009, MOL ECOL, V18, P3652, DOI 10.1111/j.1365-294X.2009.04297.x; Crawford NG, 2010, MOL ECOL RESOUR, V10, P556, DOI 10.1111/j.1755-0998.2009.02801.x; Double MC, 1997, MOL ECOL, V6, P691, DOI 10.1046/j.1365-294X.1997.00228.x; Drovetski SV, 2004, J AVIAN BIOL, V35, P105; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2010, GENEIOUS 5 1; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Earl DA, 2009, STRUCTURE HARVESTER; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2009, ANNU REV ECOL EVOL S, V40, P481, DOI 10.1146/annurev.ecolsys.39.110707.173414; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Ferrero ME, 2011, MOL ECOL, V20, P2628, DOI 10.1111/j.1365-294X.2011.05111.x; Frentiu FD, 2003, MOL ECOL NOTES, V3, P462, DOI 10.1046/j.1471-8286.2003.00484.x; Garcia JT, 2008, MOL PHYLOGENET EVOL, V46, P237, DOI 10.1016/j.ympev.2007.06.022; Gibbs HL, 1999, MOL ECOL, V8, P1551; Goossens B, 1998, MOL ECOL, V7, P1237, DOI 10.1046/j.1365-294x.1998.00407.x; Griffith SC, 1999, BIOL J LINN SOC, V68, P303, DOI 10.1111/j.1095-8312.1999.tb01171.x; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hackett SJ, 1996, MOL PHYLOGENET EVOL, V5, P368, DOI 10.1006/mpev.1996.0032; Hansson B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002794; Helbig AJ, 1996, IBIS, V138, P650, DOI 10.1111/j.1474-919X.1996.tb04767.x; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Johnson KP, 1998, MOL PHYLOGENET EVOL, V10, P82, DOI 10.1006/mpev.1997.0481; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Kennerley P, 2010, REED BUSH WARBLERS; Kvist L, 2011, J ORNITHOL, V152, P681, DOI 10.1007/s10336-011-0646-9; Lerner HRL, 2011, CURR BIOL, V21, P1838, DOI 10.1016/j.cub.2011.09.039; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lovette IJ, 2005, TRENDS ECOL EVOL, V20, P57, DOI 10.1016/j.tree.2004.11.011; Madrono A., 2004, LIBRO ROJO AVES ESPA; Manthey JD, 2011, MOL PHYLOGENET EVOL, V58, P502, DOI 10.1016/j.ympev.2010.12.003; Martinez JG, 1999, EVOLUTION, V53, P269, DOI 10.1111/j.1558-5646.1999.tb05352.x; Mila B, 2007, P R SOC B, V274, P2653, DOI 10.1098/rspb.2007.0852; MORITZ C, 1994, TRENDS ECOL EVOL, V9, P373, DOI 10.1016/0169-5347(94)90057-4; Neto JM, 2006, IBIS, V148, P39, DOI 10.1111/j.1474-919X.2006.00477.x; Neto JM, 2006, BIRD STUDY, V53, P171, DOI 10.1080/00063650609461430; Neto JM, 2010, BEHAVIOUR, V147, P1413, DOI 10.1163/000579510X517217; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Petren K, 1998, MOL ECOL, V7, P1782, DOI 10.1046/j.1365-294x.1998.00518.x; Pons JM, 2011, J BIOGEOGR, V38, P311, DOI 10.1111/j.1365-2699.2010.02401.x; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Pritchard JK, 2000, GENETICS, V155, P945; Prochazka P, 2011, J AVIAN BIOL, V42, P103, DOI 10.1111/j.1600-048X.2010.05161.x; Provan J, 2008, TRENDS ECOL EVOL, V23, P564, DOI 10.1016/j.tree.2008.06.010; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; Richardson DS, 2000, MOL ECOL, V9, P2226; Saetre GP, 2001, IBIS, V143, P494, DOI 10.1111/j.1474-919X.2001.tb04951.x; Schmitt T, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-11; Stewart JR, 2010, P ROY SOC B-BIOL SCI, V277, P661, DOI 10.1098/rspb.2009.1272; TEMPLETON AR, 1992, GENETICS, V132, P619; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Webster MS, 2002, TRENDS ECOL EVOL, V17, P76, DOI 10.1016/S0169-5347(01)02380-1; Weir JT, 2008, MOL ECOL, V17, P2321, DOI 10.1111/j.1365-294X.2008.03742.x; Weiss S, 2007, PHYLOGEOGRAPHY SO EU; Zink RM, 2004, P ROY SOC B-BIOL SCI, V271, P561, DOI 10.1098/rspb.2003.2617; Zink RM, 2010, J AVIAN BIOL, V41, P1, DOI 10.1111/j.1600-048X.2009.04903.x	64	18	20	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2012	7	6							e38497	10.1371/journal.pone.0038497	http://dx.doi.org/10.1371/journal.pone.0038497			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TU	22701653	gold, Green Published			2022-12-27	WOS:000305337600027
J	Semeiks, J; Grishin, NV				Semeiks, Jeremy; Grishin, Nick V.			A Method to Find Longevity-Selected Positions in the Mammalian Proteome	PLOS ONE			English	Article							ANTI-MULLERIAN HORMONE; PHYLOGENETIC ANALYSIS; MESSENGER-RNA; LIFE-SPAN; MENOPAUSE; SEQUENCE; SENESCENCE; PREDICTION; PHYSIOLOGY; STABILITY	Evolutionary theory suggests that the force of natural selection decreases with age. To explore the extent to which this prediction directly affects protein structure and function, we used multiple regression to find longevity-selected positions, defined as the columns of a sequence alignment conserved in long-lived but not short-lived mammal species. We analyzed 7,590 orthologous protein families in 33 mammalian species, accounting for body mass, phylogeny, and species-specific mutation rate. Overall, we found that the number of longevity-selected positions in the mammalian proteome is much higher than would be expected by chance. Further, these positions are enriched in domains of several proteins that interact with one another in inflammation and other aging-related processes, as well as in organismal development. We present as an example the kinase domain of anti-Mullerian hormone type-2 receptor (AMHR2). AMHR2 inhibits ovarian follicle recruitment and growth, and a homology model of the kinase domain shows that its longevity-selected positions cluster near a SNP associated with delayed human menopause. Distinct from its canonical role in development, this region of AMHR2 may function to regulate the protein's activity in a lifespan-specific manner.	[Semeiks, Jeremy] Univ Texas SW Med Ctr Dallas, Mol Biophys Program, Dallas, TX 75390 USA; [Semeiks, Jeremy] Univ Texas SW Med Ctr Dallas, Med Scientist Training Program, Dallas, TX 75390 USA; [Grishin, Nick V.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Grishin, Nick V.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Semeiks, J (corresponding author), Univ Texas SW Med Ctr Dallas, Mol Biophys Program, Dallas, TX 75390 USA.	jeremy.semeiks@utsw.edu			National Institutes of Health [GM094575]; Welch Foundation [I-1505]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094575] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the National Institutes of Health (GM094575 to NVG) and the Welch Foundation (I-1505 to NVG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi J., 1996, COMPUT SCI MONOGR, V28, P1; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Belville C, 2009, HUM MOL GENET, V18, P3002, DOI 10.1093/hmg/ddp238; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095; de Magalhaes JP, 2009, J EVOLUTION BIOL, V22, P1770, DOI 10.1111/j.1420-9101.2009.01783.x; de Magalhaes JP, 2007, J GERONTOL A-BIOL, V62, P149; de Magalhaes JP, 2009, AGING CELL, V8, P65, DOI 10.1111/j.1474-9726.2008.00442.x; Durlinger ALL, 2002, REPRODUCTION, V124, P601, DOI 10.1530/reprod/124.5.601; Finch C. E., 1986, AGING REPROD CLIMACT, P3, DOI DOI 10.1007/978-1-4684-5047-7_1; Finch CE, 1990, LONGEVITY SENESCENCE; Foote AD, 2008, BIOL LETTERS, V4, P189, DOI 10.1098/rsbl.2008.0006; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; Gnerre S, 2011, P NATL ACAD SCI USA, V108, P1513, DOI 10.1073/pnas.1017351108; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Hiramoto-Yamaki N, 2010, J CELL BIOL, V190, P461, DOI 10.1083/jcb.201005141; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; IMBEAUD S, 1995, NAT GENET, V11, P382, DOI 10.1038/ng1295-382; Jobson RW, 2010, MOL BIOL EVOL, V27, P840, DOI 10.1093/molbev/msp293; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kanapuru B, 2009, AM J MED, V122, P605, DOI 10.1016/j.amjmed.2009.01.030; Kevenaar ME, 2007, HUM REPROD, V22, P2382, DOI 10.1093/humrep/dem176; Kim EB, 2011, NATURE, V479, P223, DOI 10.1038/nature10533; KIRKWOOD TBL, 1977, NATURE, V270, P301, DOI 10.1038/270301a0; KNIGHTON DR, 1991, SCIENCE, V253, P407, DOI 10.1126/science.1862342; Li Y, 2013, AGE, V35, P301, DOI 10.1007/s11357-011-9361-y; Manev H, 2000, FASEB J, V14, P1464, DOI 10.1096/fj.14.10.1464; Mason JM, 2004, CHEMBIOCHEM, V5, P170, DOI 10.1002/cbic.200300781; Orme, 2011, CAPER COMP ANAL PHYL; Pei JM, 2001, BIOINFORMATICS, V17, P700, DOI 10.1093/bioinformatics/17.8.700; Perez VI, 2009, P NATL ACAD SCI USA, V106, P3059, DOI 10.1073/pnas.0809620106; Qu TY, 2000, NEUROBIOL AGING, V21, P647, DOI 10.1016/S0197-4580(00)00167-6; Ranwez V, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-241; ROSE MR, 1984, EVOLUTION, V38, P1004, DOI 10.1111/j.1558-5646.1984.tb00370.x; Sempowski GD, 2000, J IMMUNOL, V164, P2180, DOI 10.4049/jimmunol.164.4.2180; Speakman JR, 2005, AGING CELL, V4, P167, DOI 10.1111/j.1474-9726.2005.00162.x; Suhre K, 2003, J BIOL CHEM, V278, P17198, DOI 10.1074/jbc.M301327200; Voorhuis M, 2011, J CLIN ENDOCR METAB, V96, pE473, DOI 10.1210/jc.2010-1799; Walker ML, 2008, BIOL REPROD, V79, P398, DOI 10.1095/biolreprod.108.068536; Ward EJ, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-4; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; WILLIAMS GC, 1957, EVOLUTION, V11, P398, DOI 10.1111/j.1558-5646.1957.tb02911.x; Yang ZH, 2000, TRENDS ECOL EVOL, V15, P496, DOI 10.1016/S0169-5347(00)01994-7; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	45	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2012	7	6							e38595	10.1371/journal.pone.0038595	http://dx.doi.org/10.1371/journal.pone.0038595			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TU	22701678	Green Published, gold, Green Submitted			2022-12-27	WOS:000305337600033
J	Manjerovic, MB; Waterman, JM				Manjerovic, Mary Beth; Waterman, Jane M.			Immunological Sex Differences in Socially Promiscuous African Ground Squirrels	PLOS ONE			English	Article							IMMUNE FUNCTION; BODY CONDITION; MASS; ORGANIZATION; MAMMALS; HOST; AGE	Differences in how males and females respond to foreign antigens are common across taxa. Such sexual differences in the immune system are predicted to be greater in species with high promiscuity and sociality as these factors increase the likelihood of disease transmission. Intense sperm competition is thought to further this sexual dichotomy as increased investment in spermatogenesis likely incurs additional immunological costs. Xerus inauris, a ground squirrel found throughout southern Africa, is extremely social and promiscuous with one of the highest male reproductive investments among rodents. These life-history attributes suggest males and females should demonstrate a large dichotomy in immunity. Contrary to our prediction, we found no difference in spleen mass between the sexes. However, we did find significant biases in leukocyte types and red blood cell counts, possibly reflecting responses to parasite types. Among males, we predicted greater investments in spermatogenesis would result in reduced immunological investments. We found a negative association between testes and spleen size and a positive relationship between testes and number of lice suggesting trade-offs in reproductive investment possibly due to the costs associated with spermatogenesis and immunity. We suggest when measuring sexual differences in immunity it is important to consider the effects of reproductive pressures, parasite types, and life history costs.	[Manjerovic, Mary Beth] Univ Illinois, Dept Anim Sci, Illinois Nat Hist Survey, Urbana, IL 61801 USA; [Waterman, Jane M.] Univ Manitoba, Dept Biol Sci, Winnipeg, MB, Canada	Illinois Natural History Survey; University of Illinois System; University of Illinois Urbana-Champaign; University of Manitoba	Manjerovic, MB (corresponding author), Univ Illinois, Dept Anim Sci, Illinois Nat Hist Survey, 328 Mumford Hall, Urbana, IL 61801 USA.	Jane.Waterman@ad.umanitoba.ca			National Science Foundation [0130600]; Natural Sciences and Engineering Research Council of Canada	National Science Foundation(National Science Foundation (NSF)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	National Science Foundation grant (#0130600) (http://www.nsf.gov/) and a Natural Sciences and Engineering Research Council of Canada Discovery grant (http://www.nserc-crsng.gc.ca/) to JMW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altizer S, 2003, ANNU REV ECOL EVOL S, V34, P517, DOI 10.1146/annurev.ecolsys.34.030102.151725; BEARDSELL PL, 1984, Z PARASITENKD, V70, P337, DOI 10.1007/BF00927820; Bordes F, 2011, OECOLOGIA, V165, P7, DOI 10.1007/s00442-010-1743-9; Christe P, 2002, J AVIAN BIOL, V33, P321, DOI 10.1034/j.1600-048X.2002.330317.x; Corbin E, 2008, MAMMAL REV, V38, P108, DOI 10.1111/j.1365-2907.2007.00112.x; Deerenberg C, 1997, P ROY SOC B-BIOL SCI, V264, P1021, DOI 10.1098/rspb.1997.0141; Ezenwa VO, FUNCTIONAL ECOLOGY, V26, P123; Falcone FH, 2001, TRENDS PARASITOL, V17, P126, DOI 10.1016/S1471-4922(00)01846-8; Fernandez-Llario P, EUROPEAN J WILDLIFE, V50, P13; FOLSTAD I, 1992, AM NAT, V139, P603, DOI 10.1086/285346; Fuxjager MJ, FUNCTIONAL ECOLOGY, V25, P132; GERACI JR, 1975, J FISH RES BOARD CAN, V32, P2559, DOI 10.1139/f75-302; HAMILTON WD, 1982, SCIENCE, V218, P384, DOI 10.1126/science.7123238; Hawlena H, 2008, COMP BIOCHEM PHYS A, V150, P66, DOI 10.1016/j.cbpa.2008.03.004; Hillegass MA, BEHAV ECOLOGY, V21, P696; Hillegass MA, BEHAV ECOLOGY, V19, P1006; Hosken DJ, 2001, ETHOL ECOL EVOL, V13, P173; Klein SL, 2000, BEHAV PROCESS, V51, P149, DOI 10.1016/S0376-6357(00)00125-X; Lochmiller RL, 2000, OIKOS, V88, P87, DOI 10.1034/j.1600-0706.2000.880110.x; Manjerovic MB, J ZOOLOGY, V275, P375; Moller AP, AM NATURALISTTURALIS, V152, P605; Moore SL, 2002, SCIENCE, V297, P2015, DOI 10.1126/science.1074196; Nunn CL, 2000, SCIENCE, V290, P1168, DOI 10.1126/science.290.5494.1168; Nunn CL, PHILOS T ROYAL SOC B, V364, P61; Owen JP, TRENDS PARASITOLOGY, V26, P530; Owens IPF, TRENDS ECOLOGY EVOLU, V14, P170; Pettitt BA, J ZOOLOGY, V276, P291; Post J, 2003, POULTRY SCI, V82, P591, DOI 10.1093/ps/82.4.591; Restif O, P ROYAL SOC B, V277, P2247; Roberts ML, ANIMAL BEHAV, V68, P227; Rolff J, P ROYAL SOC B, V269, P867; Scantlebury M, 2010, J ZOOL, V282, P246, DOI 10.1111/j.1469-7998.2010.00734.x; Scantlebury M, PHYSL BEHAV, V94, P359; Schalk G, 1997, OIKOS, V78, P67, DOI 10.2307/3545801; Schmid-Hempel P, P ROYAL SOC B, V270, P357; Schulte-Hostedde AI, 2005, ECOLOGY, V86, P155, DOI 10.1890/04-0232; Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1; Simmons LW, 2005, SCIENCE, V309, P2031, DOI 10.1126/science.1114500; Sokal RR, 1995, BIOMETRY; Stoehr AM, BEHAV ECOLOGY, V17, P751; Thrall PH, 2000, P ROY SOC B-BIOL SCI, V267, P1555, DOI 10.1098/rspb.2000.1178; Waterman JM, 1996, J MAMMAL, V77, P134, DOI 10.2307/1382715; WATERMAN JM, 1995, ETHOLOGY, V101, P130, DOI 10.1111/j.1439-0310.1995.tb00352.x; Waterman JM, ANIMAL BEHAV, V56, P459; Zuk M, 1996, ECOLOGY, V77, P1037, DOI 10.2307/2265574; Zuk M, INT J PARASITOLOGY, V26, P1009; Zuk M, PARASITOLOGY TODAY, V6, P231	47	7	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2012	7	6							e38524	10.1371/journal.pone.0038524	http://dx.doi.org/10.1371/journal.pone.0038524			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TQ	22715391	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336800033
J	Mundt, AP; Franciskovic, T; Gurovich, I; Heinz, A; Ignatyev, Y; Ismayilov, F; Kalapos, MP; Krasnov, V; Mihai, A; Mir, J; Padruchny, D; Potocan, M; Raboch, J; Taube, M; Welbel, M; Priebe, S				Mundt, Adrian P.; Franciskovic, Tanja; Gurovich, Isaac; Heinz, Andreas; Ignatyev, Yuriy; Ismayilov, Fouad; Kalapos, Miklos Peter; Krasnov, Valery; Mihai, Adriana; Mir, Jan; Padruchny, Dzianis; Potocan, Matej; Raboch, Jiri; Taube, Maris; Welbel, Marta; Priebe, Stefan			Changes in the Provision of Institutionalized Mental Health Care in Post-Communist Countries	PLOS ONE			English	Article							FORENSIC PSYCHIATRY; PRISON POPULATION; SYSTEM; CRIMINALIZATION; INCLUSION; DIVERSION; DISORDER; CUSTODY; ILLNESS; PATIENT	Background: General psychiatric and forensic psychiatric beds, supported housing and the prison population have been suggested as indicators of institutionalized mental health care. According to the Penrose hypothesis, decreasing psychiatric bed numbers may lead to increasing prison populations. The study aimed to assess indicators of institutionalized mental health care in post-communist countries during the two decades following the political change, and to explore whether the data are consistent with the Penrose hypothesis in that historical context. Methodology/Principal Findings: General psychiatric and forensic psychiatric bed numbers, supported housing capacities and the prison population rates were collected in Azerbaijan, Belarus, Croatia, Czech Republic, East Germany, Hungary, Kazakhstan, Latvia, Poland, Romania, Russia and Slovenia. Percentage change of indicators over the decades 1989-1999, 1999-2009 and the whole period of 1989-2009 and correlations between changes of different indicators were calculated. Between 1989 and 2009, the number of general psychiatric beds was reduced in all countries. The decrease ranged from -11% in Croatia to -51% in East Germany. In 2009, the bed numbers per 100,000 population ranged from 44.7 in Azerbaijan to 134.4 in Latvia. Forensic psychiatric bed numbers and supported housing capacities increased in most countries. From 1989-2009, trends in the prison population ranged from a decrease of -58% in East Germany to an increase of 43% in Belarus and Poland. Trends in different indicators of institutionalised care did not show statistically significant associations. Conclusions/Significance: After the political changes in 1989, post-communist countries experienced a substantial reduction in general psychiatric hospital beds, which in some countries may have partly been compensated by an increase in supported housing capacities and more forensic psychiatric beds. Changes in the prison population are inconsistent. The findings do not support the Penrose hypothesis in that historical context as a general rule for most of the countries.	[Mundt, Adrian P.; Heinz, Andreas; Mir, Jan; Potocan, Matej] Univ Med Berlin, Charite Campus Mitte, Dept Psychiat & Psychotherapy, Berlin, Germany; [Franciskovic, Tanja] Univ Rijeka, Sch Med, Dept Psychiat & Psychol Med, Rijeka, Croatia; [Gurovich, Isaac; Krasnov, Valery] Moscow Res Inst Psychiat, Moscow, Russia; [Ignatyev, Yuriy] Kazakh Natl Med Univ, Dept Commun Skills Med Psychol & Psychotherapy, Alma Ata, Kazakhstan; [Ismayilov, Fouad] Azerbaijan Med Univ, Dept Psychiat, Baku, Azerbaijan; [Kalapos, Miklos Peter] Theoret Biol Res Grp, Budapest, Hungary; [Mihai, Adriana] Univ Med & Pharm, Dept Psychiat, Targu Mures, Romania; [Padruchny, Dzianis] Republican Sci & Pract Ctr Mental Hlth, Minsk, BELARUS; [Raboch, Jiri] Charles Univ Prague, Dept Psychiat, Prague, Czech Republic; [Taube, Maris] Riga Stradins Univ, Dept Psychiat, Riga, Latvia; [Welbel, Marta] Inst Psychiat & Neurol, Warsaw, Poland; [Mundt, Adrian P.; Priebe, Stefan] Queen Mary Univ London, Unit Social & Community Psychiat, Barts & London Sch Med & Dent, London, England	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Rijeka; Asfendiyarov Kazakh National Medical University; Ministry of Education of Azerbaijan Republic; Azerbaijan Medical University; George Emil Palade University of Medicine, Pharmacy, Science, & Technology of Targu Mures; Charles University Prague; Riga Stradins University; Institute of Psychiatry & Neurology; University of London; Queen Mary University London	Mundt, AP (corresponding author), Univ Med Berlin, Charite Campus Mitte, Dept Psychiat & Psychotherapy, Berlin, Germany.	adrian.mundt@charite.de	Franciskovic, Tanja/R-8177-2018; Gurovich, Isaak Ya/A-5444-2013; Taube, Maris/AAG-9277-2019; Heinz, Andreas/ABB-7736-2020; Welbel, Marta/A-9089-2016; Krasnov, Valery N/A-5117-2013; Mundt, Adrian/AAN-4641-2020; raboch, jiri/N-7445-2017; Ismayilov, Fuad/S-2177-2019; Mihai, Adriana/C-3299-2011	Franciskovic, Tanja/0000-0003-4106-9461; Taube, Maris/0000-0002-1144-8586; Heinz, Andreas/0000-0001-5405-9065; Welbel, Marta/0000-0002-3395-4850; Mundt, Adrian/0000-0001-8763-4601; raboch, jiri/0000-0001-6667-1497; Ismayilov, Fuad/0000-0001-9850-8977; Mihai, Adriana/0000-0003-1474-0133; Krasnov, Valery/0000-0002-5249-3316; Priebe, Stefan/0000-0001-9864-3394	Deutsche Forschungsgemeinschaft DFG [Mu 3323/1-1]	Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG))	The study was supported by the Deutsche Forschungsgemeinschaft DFG grant number Mu 3323/1-1. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARBOLEDAFLOREZ J, 1988, CAN J PSYCHIAT, V33, P87, DOI 10.1177/070674378803300203; Baillargeon J, 2009, AM J PSYCHIAT, V166, P103, DOI 10.1176/appi.ajp.2008.08030416; Birmingham L, 1999, BRIT J PSYCHIAT, V174, P378, DOI 10.1192/bjp.174.5.378; Bobrik A, 2005, J PUBLIC HEALTH POL, V26, P30, DOI 10.1057/palgrave.jphp.3200002; Ceccherini-Nelli A, 2007, INT J SOC ECON, V34, P788, DOI 10.1108/03068290710826396; Fazel S, 2006, ADDICTION, V101, P181, DOI 10.1111/j.1360-0443.2006.01316.x; Fazel S, 2002, LANCET, V359, P545, DOI 10.1016/S0140-6736(02)07740-1; Furedi J, 2006, ACTA PSYCHIAT SCAND, V114, P223, DOI 10.1111/j.1600-0447.2006.00804.x; Geller JL, 2002, PSYCHIATR SERV, V53, P346, DOI 10.1176/appi.ps.53.3.346; Gluzman Semyon, 2006, Int Psychiatry, V3, P38; Golubeva N, 2006, INT PSYCHIAT, V3, P14; Hamden A, 2011, INT J MENT HLTH NURS; Hartvig P, 2009, NORD J PSYCHIAT, V63, P51, DOI 10.1080/08039480802298697; HOLLEY HL, 1988, CAN J PSYCHIAT, V33, P81, DOI 10.1177/070674378803300202; Jenkins R, 2010, PSYCHIAT SERV, V61, P222, DOI 10.1176/ps.2010.61.3.222; JOSEPH PLA, 1993, BRIT J PSYCHIAT, V162, P330, DOI 10.1192/bjp.162.3.330; JOSEPH PLA, 1993, BRIT J PSYCHIAT, V162, P325, DOI 10.1192/bjp.162.3.325; Kalapos Miklos Peter, 2009, Orvosi Hetilap, V150, P1321, DOI 10.1556/OH.2009.28633; Kalapos Miklos Peter, 2007, Orvosi Hetilap, V148, P1895, DOI 10.1556/OH.2007.28154; Konrad N, 2010, INT J LAW PSYCHIAT, V33, P236, DOI 10.1016/j.ijlp.2010.06.005; Krasnov Valery, 2010, Int Psychiatry, V7, P39; Lamb HR, 1998, PSYCHIATR SERV, V49, P483, DOI 10.1176/ps.49.4.483; Large MM, 2009, PSYCHOL PSYCHOTHER-T, V82, P113, DOI 10.1348/147608308X320099; Malone D, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000270.pub2; Marshall M, 2000, COCHRANE DATABASE SY; Mundt AP, 2012, COMMUNITY MENTAL HLT; Novella EJ, 2010, THEOR MED BIOETH, V31, P411, DOI 10.1007/s11017-010-9155-8; Penrose LS, 1939, BRIT J MED PSYCHOL, V18, P1, DOI 10.1111/j.2044-8341.1939.tb00704.x; Poloshij B, 2001, ACTA PSYCHIAT SCAND, V104, P56, DOI 10.1034/j.1600-0447.2001.1040s2056.x; Priebe S, 2005, BMJ-BRIT MED J, V330, P123, DOI 10.1136/bmj.38296.611215.AE; Priebe S, 2008, PSYCHIAT SERV, V59, P570, DOI 10.1176/ps.2008.59.5.570; Priebe S, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-187; Priebe S, 2009, SOC PSYCH PSYCH EPID, V44, P805, DOI 10.1007/s00127-009-0001-0; Prince JD, 2007, PSYCHIAT SERV, V58, P1173, DOI 10.1176/appi.ps.58.9.1173; Puzynski S, 2001, ACTA PSYCHIAT SCAND, V104, P69, DOI 10.1034/j.1600-0447.2001.1040s2069.x; Raboch J, 2006, INT PSYCHIAT, V3, P15; Rezvyy G, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-128; ROESCH R, 1995, INT J LAW PSYCHIAT, V18, P1, DOI 10.1016/0160-2527(94)00023-9; Ruchkin VV, 2000, INT J LAW PSYCHIAT, V23, P555, DOI 10.1016/S0160-2527(00)00046-7; Schott H., 2006, GESCH PSYCHIAT KRANK; Shaw J, 1999, LANCET, V353, P1053, DOI 10.1016/S0140-6736(98)08094-5; Tataru N, 2010, CURR OPIN PSYCHIATR, V23, P472, DOI 10.1097/YCO.0b013e32833cfc05; Traub HJ, 2008, NERVENARZT, V79, P594, DOI 10.1007/s00115-008-2413-6; van Voren R., 2009, DISSIDENTS MADNESS; van Voren R, 2010, SCHIZOPHRENIA BULL, V36, P33, DOI 10.1093/schbul/sbp119; Vevera J, 2009, EUR PSYCHIAT, V24, P380, DOI 10.1016/j.eurpsy.2009.07.005; Walmsley R, 2015, WORLD PRISON POPULAT; World Health Organization, 2011, MAN LAB DIAGN VIR SU, P1	48	26	29	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2012	7	6							e38490	10.1371/journal.pone.0038490	http://dx.doi.org/10.1371/journal.pone.0038490			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TQ	22715387	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336800029
J	Nakajima, K; Ngouabeu, AMT; Miyashita, S; Goldi, M; Fuchslin, M; Pfeifer, R				Nakajima, Kohei; Ngouabeu, Aubery Marchel Tientcheu; Miyashita, Shuhei; Goeldi, Maurice; Fuechslin, Marcel; Pfeifer, Rolf			Morphology-Induced Collective Behaviors: Dynamic Pattern Formation in Water-Floating Elements	PLOS ONE			English	Article							LATERAL CAPILLARY FORCES; PARTICLES; ENTROPY; OBJECTS; DISKS	Complex systems involving many interacting elements often organize into patterns. Two types of pattern formation can be distinguished, static and dynamic. Static pattern formation means that the resulting structure constitutes a thermodynamic equilibrium whose pattern formation can be understood in terms of the minimization of free energy, while dynamic pattern formation indicates that the system is permanently dissipating energy and not in equilibrium. In this paper, we report experimental results showing that the morphology of elements plays a significant role in dynamic pattern formation. We prepared three different shapes of elements (circles, squares, and triangles) floating in a water-filled container, in which each of the shapes has two types: active elements that were capable of self-agitation with vibration motors, and passive elements that were mere floating tiles. The system was purely decentralized: that is, elements interacted locally, and subsequently elicited global patterns in a process called self-organized segregation. We showed that, according to the morphology of the selected elements, a different type of segregation occurs. Also, we quantitatively characterized both the local interaction regime and the resulting global behavior for each type of segregation by means of information theoretic quantities, and showed the difference for each case in detail, while offering speculation on the mechanism causing this phenomenon.	[Nakajima, Kohei; Goeldi, Maurice; Fuechslin, Marcel; Pfeifer, Rolf] Univ Zurich, Dept Informat, Zurich, Switzerland; [Ngouabeu, Aubery Marchel Tientcheu] Tech Univ Munich, Dept Elect Engn & Informat Technol, Munich, Germany; [Miyashita, Shuhei] Carnegie Mellon Univ, Dept Mech Engn, Pittsburgh, PA 15213 USA; [Fuechslin, Marcel] European Ctr Living Technol, Venice, Italy	University of Zurich; Technical University of Munich; Carnegie Mellon University	Nakajima, K (corresponding author), Univ Zurich, Dept Informat, Zurich, Switzerland.	nakajima@ifi.uzh.ch		Goldi, Maurice/0000-0002-4531-2775; Miyashita, Shuhei/0000-0002-9795-9247	Swiss National Science Foundation Fellowship [PBZHP2-133472]	Swiss National Science Foundation Fellowship(Swiss National Science Foundation (SNSF))	This work was partially supported by a Swiss National Science Foundation Fellowship PBZHP2-133472. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASAKURA S, 1954, J CHEM PHYS, V22, P1255, DOI 10.1063/1.1740347; Balch T, 2000, AUTON ROBOT, V8, P209, DOI 10.1023/A:1008973424594; Boncheva M, 2005, P NATL ACAD SCI USA, V102, P3924, DOI 10.1073/pnas.0500807102; Bowden N, 1999, J AM CHEM SOC, V121, P5373, DOI 10.1021/ja983882z; Bowden N, 1997, SCIENCE, V276, P233, DOI 10.1126/science.276.5310.233; Bowden NB, 2001, ACCOUNTS CHEM RES, V34, P231, DOI 10.1021/ar0000760; Brown D., 2009, TRACKER VIDEO ANAL M; Bruce A., 2002, MOL BIOL CELL, V4th ed.; BUDRENE EO, 1995, NATURE, V376, P49, DOI 10.1038/376049a0; BUDRENE EO, 1991, NATURE, V349, P630, DOI 10.1038/349630a0; Cavagna A, 2010, P NATL ACAD SCI USA, V107, P11865, DOI 10.1073/pnas.1005766107; Clark TD, 2002, J AM CHEM SOC, V124, P18, DOI 10.1021/ja0120633; Cohn M. B., 1991, TRANSDUCERS '91. 1991 International Conference on Solid-State Sensors and Actuators. Digest of Technical Papers (Cat. No.91CH2817-5), P490, DOI 10.1109/SENSOR.1991.148919; COVER T. M., 2012, ELEMENTS INFORM THEO, DOI 10.1002/0471200611; Desiraju G. R., 1989, CRYSTAL ENG DESIGN O; Dickman R, 1997, J CHEM PHYS, V107, P205, DOI 10.1063/1.474367; EMLEN J. T., 1952, AUK, V69, P160; Grzybowski BA, 2000, NATURE, V405, P1033, DOI 10.1038/35016528; Grzybowski BA, 2004, APPL PHYS LETT, V84, P1798, DOI 10.1063/1.1664019; Grzybowski BA, 2003, NAT MATER, V2, P241, DOI 10.1038/nmat860; Grzybowski BA, 2002, J PHYS CHEM B, V106, P1188, DOI 10.1021/jp012819k; Grzybowski BA, 2002, P NATL ACAD SCI USA, V99, P4147, DOI 10.1073/pnas.062036699; Grzybowski BA, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.011603; Grzybowski BA, 2001, J PHYS CHEM B, V105, P8770, DOI 10.1021/jp011187z; Hosokawa K, 1996, SENSOR ACTUAT A-PHYS, V57, P117, DOI 10.1016/S0924-4247(97)80102-1; KVALSETH TO, 1987, IEEE T SYST MAN CYB, V17, P517, DOI 10.1109/TSMC.1987.4309069; LUCASSEN J, 1992, COLLOID SURFACE, V65, P131, DOI 10.1016/0166-6622(92)80268-7; MALVESTUTO FM, 1986, INFORM SYST, V11, P211, DOI 10.1016/0306-4379(86)90029-3; Mao CD, 2002, J AM CHEM SOC, V124, P14508, DOI 10.1021/ja021043d; Miyashita S, 2011, THESIS U ZURICH; Miyashita S., 2009, ARTIF LIFE MODELS HA, P161; Miyashita S, 2008, IEEE INT CONF ROBOT, P3533; Miyashita S, 2011, INT J ROBOT RES, V30, P627, DOI 10.1177/0278364910393288; Miyashita S, 2009, ENTROPY-SWITZ, V11, P643, DOI 10.3390/e11040643; Nelson P., 2003, BIOL PHYS ENERGY INF, V1st; Ngouabeu A.M.T., 2010, P 12 INT C SYNTH SIM, P232; Okubo A., 1986, Advances in Biophysics, V22, P1, DOI 10.1016/0065-227X(86)90003-1; Reynolds C.W., 1987, P 14 ANN C COMPUTER, V21, P25, DOI DOI 10.1145/37402.37406; ROSATO A, 1987, PHYS REV LETT, V58, P1038, DOI 10.1103/PhysRevLett.58.1038; Rothemund PWK, 2000, P NATL ACAD SCI USA, V97, P984, DOI 10.1073/pnas.97.3.984; Sethna JP, 2006, ENTROPY ORDER PARAME; Strehl A., 2003, Journal of Machine Learning Research, V3, P583, DOI 10.1162/153244303321897735; Whitesides GM, 2002, SCIENCE, V295, P2418, DOI 10.1126/science.1070821; Whitesides GM, 2002, P NATL ACAD SCI USA, V99, P4769, DOI 10.1073/pnas.082065899; Wolfe DB, 2003, LANGMUIR, V19, P2206, DOI 10.1021/la0264973; YAMAKI M, 1995, LANGMUIR, V11, P2975, DOI 10.1021/la00008a021; Yao YY, 2003, STUD FUZZ SOFT COMP, V119, P115	47	11	11	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2012	7	6							e37805	10.1371/journal.pone.0037805	http://dx.doi.org/10.1371/journal.pone.0037805			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TQ	22715370	Green Published, Green Accepted, gold			2022-12-27	WOS:000305336800011
J	Pathak, A; Mahadik, K; Dhaneria, SP; Sharma, A; Eriksson, B; Lundborg, CS				Pathak, Ashish; Mahadik, Kalpana; Dhaneria, Surya Prakesh; Sharma, Ashish; Eriksson, Bo; Lundborg, Cecilia Stalsby			Surveillance of Antibiotic Consumption Using the "Focus of Infection" Approach in 2 Hospitals in Ujjain, India	PLOS ONE			English	Article							ANTIMICROBIAL USE; UNITED-STATES; RESISTANCE; GUIDELINES; ADULTS; MANAGEMENT; CHILDREN; SOCIETY; EUROPE	Antibiotic surveillance initiatives are limited in resource-constrained settings. In the present study, a quantitative comparison of antibiotic use rates for suspected infections in 2 hospitals in India was performed using the "focus of infection" approach to identify targets for quality improvement in antibiotic prescription patterns in hospitalized patients. Methods: This observational study was carried out in one teaching and one nonteaching hospital. All the patients with suspected bacterial etiology were included. Data on the prescribed antibiotics and the focus of infection were prospectively collected using a structured questionnaire. Each diagnosis was further reviewed and confirmed by an independent consultant. The prescribed antibiotics were coded according to the World Health Organization Anatomic Therapeutic Classification (ATC) index with the defined daily dose (DDD) methodology. Focus-specific DDDs were calculated per hundred patient days (DDD/HPD). Results: A total of 6026 patients were included from 72 participating physicians out of available 75 physicians. Overall antibiotic prescribing was higher by 5 percentage points in the teaching hospital (95%) than in the nonteaching hospital (90%). Quinolones (ciprofloxacin constituting 86% of DDD/HPD) were the highest prescribed class in the teaching hospital, and third-generation cephalosporins (with ceftriaxone and ceftriaxone/sulbactam constituting 40% and 28% of the DDD/HPD, respectively), in the nonteaching hospital. The targets identified for improvement were the following: longer than recommended duration of prophylaxis and lack of distinction between prophylaxis and therapy among surgical patients; irrational antibiotic prescribing in gastroenteritis; overuse of quinolones and lack of use of penicillin in pneumonia; overuse of quinolones and lack of use of doxycycline and macrolides in genital infections; and overreliance on antibiotics for treating skin and soft tissue infections. Conclusions: Providing a quantitative comparison of antibiotic use rates for suspected infections, using the "focus of infection" approach along with the ATC/DDD methodology, appears appropriate for identifying targets for quality improvement with regards to antibiotic prescribing.	[Pathak, Ashish; Lundborg, Cecilia Stalsby] Karolinska Inst, Dept Publ Hlth Sci, Div Global Hlth IHCAR, Stockholm, Sweden; [Pathak, Ashish] RD Gardi Med Coll, Dept Pediat, Ujjain, Madhya Pradesh, India; [Mahadik, Kalpana] RD Gardi Med Coll, Dept Obstet & Gynaecol, Ujjain, Madhya Pradesh, India; [Dhaneria, Surya Prakesh] RD Gardi Med Coll, Dept Pharmacol, Ujjain, Madhya Pradesh, India; [Sharma, Ashish] RD Gardi Med Coll, Dept Med, Ujjain, Madhya Pradesh, India; [Eriksson, Bo] Nord Sch Publ Hlth, Gothenburg, Sweden	Karolinska Institutet	Pathak, A (corresponding author), Karolinska Inst, Dept Publ Hlth Sci, Div Global Hlth IHCAR, Stockholm, Sweden.	ashish.pathak@ki.se	Pathak, Ashish/N-2303-2019; Sharma, Ashish/AAJ-2955-2021; Mahadik, Kalpana/AAY-2389-2021; Pathak, Ashish/Y-1821-2019	Pathak, Ashish/0000-0002-7576-895X; Stalsby Lundborg, Cecilia/0000-0001-6525-1861	Swedish Research Council, Sweden [K2007-70X-20514-01-3]; Asia Link [348-2006-6633]	Swedish Research Council, Sweden(Swedish Research Council); Asia Link	This study was supported by a grant from the Swedish Research Council, Sweden (grant number K2007-70X-20514-01-3), and the Asia Link (grant number 348-2006-6633). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad Cybele L, 2011, Crit Care Clin, V27, pe1, DOI 10.1016/j.ccc.2010.12.001; Ansari F, 2009, CLIN INFECT DIS, V49, P1496, DOI 10.1086/644617; Ashley EA, 2011, TROP MED INT HEALTH, V16, P1167, DOI 10.1111/j.1365-3156.2011.02822.x; Bager F, 2000, INT J ANTIMICROB AG, V14, P271, DOI 10.1016/S0924-8579(00)00135-7; de With K, 2004, INT J ANTIMICROB AG, V24, P213, DOI 10.1016/j.ijantimicag.2004.03.015; Deshpande K, 2004, HEALTH POLICY, V68, P211, DOI 10.1016/j.healthpol.2003.09.012; Dumartin C, 2010, J ANTIMICROB CHEMOTH, V65, P2028, DOI 10.1093/jac/dkq228; Erntell M, 2004, STRAMA POINT PREVELE; Fridkin SK, 1999, CLIN INFECT DIS, V29, P245, DOI 10.1086/520193; Goossens H, 2005, LANCET, V365, P579, DOI 10.1016/S0140-6736(05)17907-0; Hadi U, 2008, CLIN MICROBIOL INFEC, V14, P698, DOI 10.1111/j.1469-0691.2008.02014.x; Jaiyeoba O, 2011, EXPERT REV ANTI-INFE, V9, P61, DOI [10.1586/eri.10.156, 10.1586/ERI.10.156]; Kritsotakis EI, 2006, CLIN MICROBIOL INFEC, V12, P701, DOI 10.1111/j.1469-0691.2006.01415.x; Levy ML, 2010, PRIM CARE RESP J, V19, P21, DOI 10.4104/pcrj.2010.00014; Liu C, 2011, CLIN INFECT DIS, V52, P285, DOI 10.1093/cid/cir034; Mazuski JE, 2007, EXPERT OPIN PHARMACO, V8, P2933, DOI 10.1517/14656566.8.17.2933; Molstad S, 2008, LANCET INFECT DIS, V8, P125, DOI 10.1016/S1473-3099(08)70017-3; Pakyz A, 2008, PHARMACOTHERAPY, V28, P906, DOI 10.1592/phco.28.7.906; Pathak A, 2011, SCAND J INFECT DIS, V43, P479, DOI 10.3109/00365548.2011.554854; Pathak D, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-32; Pittet D, 2008, J HOSP INFECT, V68, P285, DOI 10.1016/j.jhin.2007.12.013; Ramakrishnan K, 2005, AM FAM PHYSICIAN, V71, P933; Reddy KS, 2011, LANCET, V377, P760, DOI 10.1016/S0140-6736(10)61960-5; Song JH, 2011, INT J ANTIMICROB AG, V38, P108, DOI 10.1016/j.ijantimicag.2011.02.017; The National Policy for Containment of Antimicrobial Resistance India, 2011, NAT POL CONT ANT RES; Verbrugh HA, 2003, NETH J MED, V61, P341; *WHO COLL CTR DRUG, 2009, AN THER CHEM ATC CLA; World Health Organization, 2005, IMPR CONT ANT RES WH; Zarb P, 2011, DRUGS, V71, P745, DOI 10.2165/11591180-000000000-00000	29	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2012	7	6							e38641	10.1371/journal.pone.0038641	http://dx.doi.org/10.1371/journal.pone.0038641			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TQ	22715402	gold, Green Published, Green Submitted			2022-12-27	WOS:000305336800044
J	Gremillet, D; Prudor, A; le Maho, Y; Weimerskirch, H				Gremillet, David; Prudor, Aurelien; le Maho, Yvon; Weimerskirch, Henri			Vultures of the Seas: Hyperacidic Stomachs in Wandering Albatrosses as an Adaptation to Dispersed Food Resources, including Fishery Wastes	PLOS ONE			English	Article							DIOMEDEA-EXULANS; SEABIRDS; PREY; PHYSIOLOGY; PENGUINS; ECOLOGY; WIND	Animals are primarily limited by their capacity to acquire food, yet digestive performance also conditions energy acquisition, and ultimately fitness. Optimal foraging theory predicts that organisms feeding on patchy resources should maximize their food loads within each patch, and should digest these loads quickly to minimize travelling costs between food patches. We tested the prediction of high digestive performance in wandering albatrosses, which can ingest prey of up to 3 kg, and feed on highly dispersed food resources across the southern ocean. GPS-tracking of 40 wandering albatrosses from the Crozet archipelago during the incubation phase confirmed foraging movements of between 475-4705 km, which give birds access to a variety of prey, including fishery wastes. Moreover, using miniaturized, autonomous data recorders placed in the stomach of three birds, we performed the first-ever measurements of gastric pH and temperature in procellariformes. These revealed surprisingly low pH levels (average 1.50 +/- 0.13), markedly lower than in other seabirds, and comparable to those of vultures feeding on carrion. Such low stomach pH gives wandering albatrosses a strategic advantage since it allows them a rapid chemical breakdown of ingested food and therefore a rapid digestion. This is useful for feeding on patchy, natural prey, but also on fishery wastes, which might be an important additional food resource for wandering albatrosses.	[Gremillet, David] CEFE CNRS, UMR5175, Montpellier, France; [Gremillet, David] Univ Cape Town, Percy FitzPatrick Inst, ZA-7700 Rondebosch, South Africa; [Gremillet, David] Univ Cape Town, DST NRF Ctr Excellence, ZA-7700 Rondebosch, South Africa; [Prudor, Aurelien; Weimerskirch, Henri] CEBC CNRS, UPR1934, Villiers En Bois, France; [le Maho, Yvon] Univ Strasbourg, Inst Pluridisciplinaire Hubert Curien, Strasbourg, France; [le Maho, Yvon] CNRS, UMR7178, Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Montpellier; University of Cape Town; National Research Foundation - South Africa; University of Cape Town; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Gremillet, D (corresponding author), CEFE CNRS, UMR5175, Montpellier, France.	david.gremillet@cefe.cnrs.fr	Weimerskirch, Henri/K-7306-2019; Weimerskirch, Henri/F-5562-2013; Gremillet, David/W-1946-2018	Weimerskirch, Henri/0000-0002-0457-586X; Gremillet, David/0000-0002-7711-9398	Centre National de la Recherche Scientifique; French Polar Institute Paul-Emile Victor [109]	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); French Polar Institute Paul-Emile Victor	This study was funded by Centre National de la Recherche Scientifique and by the French Polar Institute Paul-Emile Victor (programme 109). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbraud C, 2012, J ORNITHOL, V153, P375, DOI 10.1007/s10336-011-0752-8; Bost CA, 1997, MAR ECOL PROG SER, V150, P21, DOI 10.3354/meps150021; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Bugoni L, 2010, J EXP MAR BIOL ECOL, V391, P190, DOI 10.1016/j.jembe.2010.06.027; Cherel Y, 1999, MAR ECOL PROG SER, V188, P93, DOI 10.3354/meps188093; CROXALL JP, 1988, POLAR BIOL, V9, P9, DOI 10.1007/BF00441760; DIAMOND JM, 1986, NATURE, V320, P62, DOI 10.1038/320062a0; Duke GE, 1997, P NUTR SOC, V56, P1049, DOI 10.1079/PNS19970109; Ford S, 2010, J EXOT PET MED, V19, P140, DOI 10.1053/j.jepm.2010.05.004; Garthe S, 1996, MAR ECOL PROG SER, V136, P1, DOI 10.3354/meps136001; Gremillet D, 2000, CAN J ZOOL, V78, P1567, DOI 10.1139/cjz-78-9-1567; Gremillet D, 2008, P R SOC B, V275, P1149, DOI 10.1098/rspb.2007.1763; Hammond KA, 1997, NATURE, V386, P457, DOI 10.1038/386457a0; HERPOL C, 1967, Z VERGL PHYSIOL, V57, P209, DOI 10.1007/BF00302996; Hilton GM, 2000, EVOL ECOL RES, V2, P207; HOUSTON D C, 1975, Journal of Wildlife Diseases, V11, P306; IMBER MJ, 1992, J ROY SOC NEW ZEAL, V22, P243, DOI 10.1080/03036758.1992.10420819; JACKSON S, 1992, PHYSIOL ZOOL, V65, P674, DOI 10.1086/physzool.65.3.30157976; KARASOV WH, 1985, SCIENCE, V228, P202, DOI 10.1126/science.3975638; Pennycuick C.J., 1989, BIRD FLIGHT PERFORMA; Peters G, 1997, THESIS KIEL U; Shaffer SA, 2001, J ANIM ECOL, V70, P864, DOI 10.1046/j.0021-8790.2001.00548.x; Speakman JR, 2010, J ANIM ECOL, V79, P726, DOI 10.1111/j.1365-2656.2010.01689.x; Stephens D.W., 1986, pi; Thouzeau C, 2004, J EXP BIOL, V207, P2715, DOI 10.1242/jeb.01074; Weimerskirch H, 2005, ECOLOGY, V86, P2611, DOI 10.1890/04-1866; Weimerskirch H, 2000, P ROY SOC B-BIOL SCI, V267, P1869, DOI 10.1098/rspb.2000.1223; WEIMERSKIRCH H, 1992, MAR ECOL PROG SER, V86, P297, DOI 10.3354/meps086297; WEIMERSKIRCH H, 1995, OECOLOGIA, V102, P37, DOI 10.1007/BF00333308; Weimerskirch H, 2007, AM NAT, V170, P734, DOI 10.1086/522059; Weimerskirch H, 2012, SCIENCE, V335, P211, DOI 10.1126/science.1210270; Whelan CJ, 2005, OIKOS, V110, P481, DOI 10.1111/j.0030-1299.2005.13387.x; WILSON RP, 1992, J EXP BIOL, V167, P267; WILSON RP, 1989, COMP BIOCHEM PHYS A, V94, P461, DOI 10.1016/0300-9629(89)90121-7; WILSON RP, 1984, J FIELD ORNITHOL, V55, P109; Xavier JC, 2004, FISH OCEANOGR, V13, P324, DOI 10.1111/j.1365-2419.2004.00298.x	36	14	14	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e37834	10.1371/journal.pone.0037834	http://dx.doi.org/10.1371/journal.pone.0037834			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701581	Green Published, Green Submitted, gold			2022-12-27	WOS:000305348400020
J	Kanaan, RA; Allin, M; Picchioni, M; Barker, GJ; Daly, E; Shergill, SS; Woolley, J; McGuire, PK				Kanaan, Richard A.; Allin, Matthew; Picchioni, Marco; Barker, Gareth J.; Daly, Eileen; Shergill, Sukhwinder S.; Woolley, James; McGuire, Philip K.			Gender Differences in White Matter Microstructure	PLOS ONE			English	Article							HUMAN CORPUS-CALLOSUM; DIFFUSION-TENSOR MRI; ADULT HUMAN BRAIN; SEX-DIFFERENCES; MAGNETIC-RESONANCE; HEALTHY-INDIVIDUALS; CEREBELLAR VOLUME; MORPHOMETRIC ANALYSIS; SPATIAL STATISTICS; NERVOUS-SYSTEM	Background: Sexual dimorphism in human brain structure is well recognised, but little is known about gender differences in white matter microstructure. We used diffusion tensor imaging to explore differences in fractional anisotropy (FA), an index of microstructural integrity. Methods: A whole brain analysis of 135 matched subjects (90 men and 45 women) using a 1.5 T scanner. A region of interest (ROI) analysis was used to confirm those results where proximity to CSF raised the possibility of partial-volume artefact. Results: Men had higher fractional anisotropy (FA) in cerebellar white matter and in the left superior longitudinal fasciculus; women had higher FA in the corpus callosum, confirmed by ROI. Discussion: The size of the differences was substantial - of the same order as that attributed to some pathology suggesting gender may be a potentially significant confound in unbalanced clinical studies. There are several previous reports of difference in the corpus callosum, though they disagree on the direction of difference; our findings in the cerebellum and the superior longitudinal fasciculus have not previously been noted. The higher FA in women may reflect greater efficiency of a smaller corpus callosum. The relatively increased superior longitudinal fasciculus and cerebellar FA in men may reflect their increased language lateralisation and enhanced motor development, respectively.	[Kanaan, Richard A.] Kings Coll London, Inst Psychiat, Dept Psychol Med, London WC2R 2LS, England; [Allin, Matthew; Picchioni, Marco; Shergill, Sukhwinder S.; Woolley, James; McGuire, Philip K.] Kings Coll London, Inst Psychiat, Dept Psychosis Studies, London WC2R 2LS, England; [Picchioni, Marco] Kings Coll London, St Andrews Acad Ctr, Northampton, England; [Barker, Gareth J.] Kings Coll London, Inst Psychiat, Ctr Neuroimaging Sci, London WC2R 2LS, England; [Daly, Eileen] Kings Coll London, Inst Psychiat, Dept Dev Psychiat, London WC2R 2LS, England	University of London; King's College London; University of London; King's College London; University of London; King's College London; University of London; King's College London; University of London; King's College London	Kanaan, RA (corresponding author), Kings Coll London, Inst Psychiat, Dept Psychol Med, London WC2R 2LS, England.	richard.kanaan@kcl.ac.uk	Barker, Gareth J/C-9616-2009; Picchioni, Marco M/E-3300-2010	Barker, Gareth J/0000-0002-5214-7421; Picchioni, Marco M/0000-0001-6681-147X; McGuire, Philip/0000-0003-4381-0532; Daly, Eileen/0000-0003-3625-3467; Kanaan, Richard/0000-0003-0992-1917; shergill, sukhi/0000-0003-4928-9100	Wellcome Trust [07255]; MRC [G0901868] Funding Source: UKRI; Medical Research Council [G0901868] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	RK received grant support 07255 from the Wellcome Trust (www.wellcome.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe O, 2002, NEUROBIOL AGING, V23, P433, DOI 10.1016/S0197-4580(01)00318-9; Allen JS, 2003, NEUROIMAGE, V18, P880, DOI 10.1016/S1053-8119(03)00034-X; Allen JS, 2002, AM J PHYS ANTHROPOL, V118, P341, DOI 10.1002/ajpa.10092; ANNETT M, 1970, BRIT J PSYCHOL, V61, P303, DOI 10.1111/j.2044-8295.1970.tb01248.x; Barnea-Goraly N, 2005, CEREB CORTEX, V15, P1848, DOI 10.1093/cercor/bhi062; Basser PJ, 1995, NMR BIOMED, V8, P333, DOI 10.1002/nbm.1940080707; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Bava S, 2010, BRAIN RES; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Bengtsson SL, 2005, NAT NEUROSCI, V8, P1148, DOI 10.1038/nn1516; Bishop KM, 1997, NEUROSCI BIOBEHAV R, V21, P581, DOI 10.1016/S0149-7634(96)00049-8; Brun CC, 2009, NEUROREPORT, V20, P930, DOI 10.1097/WNR.0b013e32832c5e65; Catani M, 2007, P NATL ACAD SCI USA, V104, P17163, DOI 10.1073/pnas.0702116104; Chen XH, 2007, NEUROIMAGE, V36, P691, DOI 10.1016/j.neuroimage.2007.03.063; Chung SC, 2005, BRAIN RES, V1042, P233, DOI 10.1016/j.brainres.2005.02.033; Cosgrove KP, 2007, BIOL PSYCHIAT, V62, P847, DOI 10.1016/j.biopsych.2007.03.001; Duarte-Carvajalino JM, 2012, NEUROIMAGE, V59, P3784, DOI 10.1016/j.neuroimage.2011.10.096; ESCALONA PR, 1991, AM J NEURORADIOL, V12, P927; FILIPEK PA, 1994, CEREB CORTEX, V4, P344, DOI 10.1093/cercor/4.4.344; Fjell AM, 2008, NEUROIMAGE, V42, P1654, DOI 10.1016/j.neuroimage.2008.06.005; Foong J, 2000, J NEUROL NEUROSUR PS, V68, P242, DOI 10.1136/jnnp.68.2.242; Goldstein JM, 2001, CEREB CORTEX, V11, P490, DOI 10.1093/cercor/11.6.490; Gong GL, 2009, J NEUROSCI, V29, P15684, DOI 10.1523/JNEUROSCI.2308-09.2009; Good CD, 2001, NEUROIMAGE, V14, P685, DOI 10.1006/nimg.2001.0857; Gur RC, 1999, J NEUROSCI, V19, P4065; Hsu JL, 2008, NEUROIMAGE, V39, P566, DOI 10.1016/j.neuroimage.2007.09.017; Hugenschmidt CE, 2008, CEREB CORTEX, V18, P433, DOI 10.1093/cercor/bhm080; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Huster RJ, 2009, HUM BRAIN MAPP, V30, P383, DOI 10.1002/hbm.20509; Hutchinson S, 2003, CEREB CORTEX, V13, P943, DOI 10.1093/cercor/13.9.943; HYDE JS, 1988, PSYCHOL BULL, V104, P53, DOI 10.1037/0033-2909.104.1.53; Ikezawa S, 2008, INT J PSYCHOPHYSIOL, V68, P41, DOI 10.1016/j.ijpsycho.2008.01.006; Jones DK, 2010, NMR BIOMED, V23, P803, DOI 10.1002/nbm.1543; Jones DK, 2005, NEUROIMAGE, V26, P546, DOI 10.1016/j.neuroimage.2005.02.013; Jones DK, 1999, MAGNET RESON MED, V42, P515, DOI 10.1002/(SICI)1522-2594(199909)42:3<515::AID-MRM14>3.0.CO;2-Q; Kanaan RA, 2006, PSYCHIAT RES-NEUROIM, V146, P73, DOI 10.1016/j.pscychresns.2005.11.002; Kang XJ, 2011, NEUROIMAGE, V56, P2011, DOI 10.1016/j.neuroimage.2011.03.016; Kennedy N, 2005, AM J PSYCHIAT, V162, P257, DOI 10.1176/appi.ajp.162.2.257; Lebel C, 2009, HUM BRAIN MAPP, V30, P3563, DOI 10.1002/hbm.20779; Lee CEC, 2009, NEURORADIOLOGY, V51, P3, DOI 10.1007/s00234-008-0441-3; Lenroot RK, 2010, BRAIN COGNITION, V72, P46, DOI 10.1016/j.bandc.2009.10.008; Luders E, 2005, NEUROIMAGE, V26, P493, DOI 10.1016/j.neuroimage.2005.02.010; Luders E, 2002, NEUROREPORT, V13, P2371, DOI 10.1097/01.wnr.0000049603.85580.da; Luders E, 2010, PROG BRAIN RES, V186, P3, DOI 10.1016/B978-0-444-53630-3.00001-4; Menzler K, 2011, NEUROIMAGE, V54, P2557, DOI 10.1016/j.neuroimage.2010.11.029; Moes PE, 2007, NEUROPSYCHOLOGIA, V45, P2626, DOI 10.1016/j.neuropsychologia.2007.03.017; Nelson H., 1991, NATL ADULT READING T; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Nopoulos P, 2000, PSYCHIAT RES-NEUROIM, V98, P1, DOI 10.1016/S0925-4927(99)00044-X; Oh JS, 2007, NEUROIMAGE, V36, P606, DOI 10.1016/j.neuroimage.2007.03.020; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pal D, 2011, J CLIN NEUROSCI, V18, P193, DOI 10.1016/j.jocn.2010.05.033; Pangelinan MM, 2011, NEUROIMAGE, V54, P3093, DOI 10.1016/j.neuroimage.2010.11.021; Paradiso S, 1997, NEUROPSY NEUROPSY BE, V10, P1; Park J, 2012, ACTA NEUROCHIR, V154, P79, DOI 10.1007/s00701-011-1178-z; Poole Janet L, 2005, J Hand Ther, V18, P348, DOI 10.1197/j.jht.2005.04.003; Powell JL, 2012, NEUROSCIENCE, V207, P227, DOI 10.1016/j.neuroscience.2012.01.016; Price G, 2005, J NEUROL NEUROSUR PS, V76, P585, DOI 10.1136/jnnp.2004.042952; Rabinowicz T, 1999, J CHILD NEUROL, V14, P98, DOI 10.1177/088307389901400207; Raz N, 2001, AM J NEURORADIOL, V22, P1161; Saksena S, 2008, CEREBELLUM, V7, P392, DOI 10.1007/s12311-008-0041-0; Salat DH, 2005, NEUROBIOL AGING, V26, P1215, DOI 10.1016/j.neurobiolaging.2004.09.017; Schulte T, 2005, CEREB CORTEX, V15, P1384, DOI 10.1093/cercor/bhi020; Schulte T, 2004, NEUROPSYCHOLOGIA, V42, P257, DOI 10.1016/S0028-3932(03)00155-6; Shin YW, 2005, NEUROREPORT, V16, P795, DOI 10.1097/00001756-200505310-00003; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Sommer IEC, 2004, BRAIN, V127, P1845, DOI 10.1093/brain/awh207; Sommer IE, 2008, BRAIN RES, V1206, P76, DOI 10.1016/j.brainres.2008.01.003; Studholme C, 1997, MED PHYS, V24, P25, DOI 10.1118/1.598130; Sullivan EV, 2001, NEUROREPORT, V12, P99, DOI 10.1097/00001756-200101220-00027; Szabo CA, 2003, AM J NEURORADIOL, V24, P644; Szeszko PR, 2003, NEUROREPORT, V14, P2469, DOI 10.1097/00001756-200312190-00035; Takao H, 2011, NEUROSCIENCE, V193, P291, DOI 10.1016/j.neuroscience.2011.07.041; THOMAS JR, 1985, PSYCHOL BULL, V98, P260, DOI 10.1037/0033-2909.98.2.260; Vos SB, 2011, NEUROIMAGE, V55, P1566, DOI 10.1016/j.neuroimage.2011.01.048; Wallentin M, 2009, BRAIN LANG, V108, P175, DOI 10.1016/j.bandl.2008.07.001; Wechsler D., 2011, WASI 2 WECHSLER ABBR; Wechsler D., 1997, WECHSLER ADULT INTEL; Werring DJ, 2000, J NEUROL NEUROSUR PS, V69, P269, DOI 10.1136/jnnp.69.2.269; Westerhausen R, 2004, COGNITIVE BRAIN RES, V21, P418, DOI 10.1016/j.cogbrainres.2004.07.002; Westerhausen R, 2003, NEUROSCI LETT, V351, P99, DOI 10.1016/j.neulet.2003.07.011; Westerhausen R, 2011, NEUROIMAGE, V56, P874, DOI 10.1016/j.neuroimage.2011.03.013; Whitford TJ, 2011, NEUROIMAGE, V54, P2318, DOI 10.1016/j.neuroimage.2010.10.048; Whittle S, 2011, BIOL PSYCHOL, V87, P319, DOI 10.1016/j.biopsycho.2011.05.003; WITELSON SF, 1995, J NEUROSCI, V15, P3418; Wu YC, 2011, NEUROIMAGE, V54, P1840, DOI 10.1016/j.neuroimage.2010.09.067	87	88	90	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e38272	10.1371/journal.pone.0038272	http://dx.doi.org/10.1371/journal.pone.0038272			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959WK	22701619	Green Published, gold			2022-12-27	WOS:000305348400044
J	Oda, M; Hashimoto, M; Takahashi, M; Ohmae, Y; Seike, S; Kato, R; Fujita, A; Tsuge, H; Nagahama, M; Ochi, S; Sasahara, T; Hayashi, S; Hirai, Y; Sakurai, J				Oda, Masataka; Hashimoto, Manabu; Takahashi, Masaya; Ohmae, Yuka; Seike, Soshi; Kato, Ryoko; Fujita, Aoi; Tsuge, Hideaki; Nagahama, Masahiro; Ochi, Sadayuki; Sasahara, Teppei; Hayashi, Shunji; Hirai, Yoshikazu; Sakurai, Jun			Role of Sphingomyelinase in Infectious Diseases Caused by Bacillus cereus	PLOS ONE			English	Article							PERFRINGENS ALPHA-TOXIN; STAPHYLOCOCCUS-AUREUS; CLOSTRIDIUM-PERFRINGENS; NEUTRAL SPHINGOMYELINASE; SHEEP ERYTHROCYTES; VIRULENCE FACTOR; PHOSPHOLIPASE-C; HEMOLYSIN BL; CERAMIDE; STRAINS	Bacillus cereus (B. cereus) is a pathogen in opportunistic infections. Here we show that Bacillus cereus sphingomyelinase (Bc-SMase) is a virulence factor for septicemia. Clinical isolates produced large amounts of Bc-SMase, grew in vivo, and caused death among mice, but ATCC strains isolated from soil did not. A transformant of the ATCC strain carrying a recombinant plasmid containing the Bc-SMase gene grew in vivo, but that with the gene for E53A, which has little enzymatic activity, did not. Administration of an anti-Bc-SMase antibody and immunization against Bc-SMase prevented death caused by the clinical isolates, showing that Bc-SMase plays an important role in the diseases caused by B. cereus. Treatment of mouse macrophages with Bc-SMase resulted in a reduction in the generation of H2O2 and phagocytosis of macrophages induced by peptidoglycan (PGN), but no effect on the release of TNF-alpha and little release of LDH under our experimental conditions. Confocal laser microscopy showed that the treatment of mouse macrophages with Bc-SMase resulted in the formation of ceramide-rich domains. A photobleaching analysis suggested that the cells treated with Bc-SMase exhibited a reduction in membrane fluidity. The results suggest that Bc-SMase is essential for the hydrolysis of SM in membranes, leading to a reduction in phagocytosis.	[Oda, Masataka; Hashimoto, Manabu; Takahashi, Masaya; Ohmae, Yuka; Seike, Soshi; Kato, Ryoko; Fujita, Aoi; Nagahama, Masahiro; Sakurai, Jun] Tokushima Bunri Univ, Fac Pharmaceut Sci, Dept Microbiol, Yamashiro, Tokushima 770, Japan; [Tsuge, Hideaki] Tokushima Bunri Univ, Inst Hlth Sci, Yamashiro, Tokushima, Japan; [Tsuge, Hideaki] Kyoto Sangyo Univ, Fac Life Sci, Kamigamo Motoyama Kita Ku, Kyoto 603, Japan; [Ochi, Sadayuki] Fujita Hlth Univ, Sch Med, Toyoake, Aichi 47011, Japan; [Sasahara, Teppei; Hayashi, Shunji; Hirai, Yoshikazu] Jichi Med Univ, Sch Med, Shimono City, Tochigi, Japan	Tokushima Bunri University; Tokushima Bunri University; Kyoto Sangyo University; Fujita Health University; Jichi Medical University	Oda, M (corresponding author), Tokushima Bunri Univ, Fac Pharmaceut Sci, Dept Microbiol, Yamashiro, Tokushima 770, Japan.	sakurai@ph.bunri-u.ac.jp	Tsuge, Hideaki/ABF-6424-2021; Oda, Masataka/ABG-6047-2020	Seike, Soshi/0000-0001-9029-0715; Tsuge, Hideaki/0000-0003-0166-9163	Ministry of Education, Culture, Sports, Science and Technology, Japan. SENRYAKU Fund; Mutual Aid Corporation for Private Schools of Japan; Sumitomo Foundation for Promotion of Science; Tokushima Bunri University	Ministry of Education, Culture, Sports, Science and Technology, Japan. SENRYAKU Fund; Mutual Aid Corporation for Private Schools of Japan; Sumitomo Foundation for Promotion of Science; Tokushima Bunri University	This research was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan. SENRYAKU Fund (2009-2011) for Promotion of Science, the Mutual Aid Corporation for Private Schools of Japan, and the Sumitomo Foundation for Promotion of Science, and funding from Tokushima Bunri University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ago H, 2006, J BIOL CHEM, V281, P16157, DOI 10.1074/jbc.M601089200; Arnesen LPS, 2008, FEMS MICROBIOL REV, V32, P579, DOI 10.1111/j.1574-6976.2008.00112.x; Bottone EJ, 2010, CLIN MICROBIOL REV, V23, P382, DOI 10.1128/CMR.00073-09; Bryant AE, 2000, J INFECT DIS, V182, P799, DOI 10.1086/315756; Cadot C, 2010, J CLIN MICROBIOL, V48, P1358, DOI 10.1128/JCM.02123-09; Callegan MC, 1999, INFECT IMMUN, V67, P3357, DOI 10.1128/IAI.67.7.3357-3366.1999; Callegan MC, 2003, INFECT IMMUN, V71, P3116, DOI 10.1128/IAI.71.6.3116-3124.2003; Callegan MC, 2002, INFECT IMMUN, V70, P5381, DOI 10.1128/IAI.70.10.5381-5389.2002; Collins J, 2008, J CLIN MICROBIOL, V46, P2112, DOI 10.1128/JCM.00156-08; Dohmae S, 2008, J HOSP INFECT, V69, P361, DOI 10.1016/j.jhin.2008.04.014; DROBNIEWSKI FA, 1993, CLIN MICROBIOL REV, V6, P324, DOI 10.1128/CMR.6.4.324-338.1993; Drobnik W, 2003, J LIPID RES, V44, P754, DOI 10.1194/jlr.M200401-JLR200; Duport C, 2004, ARCH MICROBIOL, V182, P90, DOI 10.1007/s00203-004-0688-y; Fagerlund A, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-43; Gaur AH, 2001, PEDIATR INFECT DIS J, V20, P533, DOI 10.1097/00006454-200105000-00013; GIANNELLA RA, 1979, J INFECT DIS, V139, P366, DOI 10.1093/infdis/139.3.366; Gohar M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002793; Goni FM, 2009, BBA-BIOMEMBRANES, V1788, P169, DOI 10.1016/j.bbamem.2008.09.002; Gonzalez-Zorn B, 1999, MOL MICROBIOL, V33, P510, DOI 10.1046/j.1365-2958.1999.01486.x; Guillemet E, 2010, J BACTERIOL, V192, P286, DOI 10.1128/JB.00264-09; Guinebretiere MH, 2002, J CLIN MICROBIOL, V40, P3053, DOI 10.1128/JCM.40.8.3053-3056.2002; Gulbins E, 2004, J MOL MED, V82, P357, DOI 10.1007/s00109-004-0539-y; Heffernan BJ, 2006, INFECT IMMUN, V74, P3756, DOI 10.1128/IAI.00307-06; Huseby M, 2007, J BACTERIOL, V189, P8719, DOI 10.1128/JB.00741-07; IKEZAWA H, 1978, BIOCHIM BIOPHYS ACTA, V528, P247; Klein C, 2003, BRAIN RES PROTOC, V11, P46, DOI 10.1016/S1385-299X(03)00016-3; Lereclus D, 1996, J BACTERIOL, V178, P2749, DOI 10.1128/jb.178.10.2749-2756.1996; Lo CW, 2011, J INVEST DERMATOL, V131, P401, DOI 10.1038/jid.2010.319; MARQUES MB, 1989, J CLIN MICROBIOL, V27, P2451, DOI 10.1128/JCM.27.11.2451-2454.1989; Montes LR, 2008, BIOCHEMISTRY-US, V47, P11222, DOI 10.1021/bi801139z; Nakabo Y, 1997, IMMUNOLOGY, V90, P477, DOI 10.1046/j.1365-2567.1997.d01-2189.x; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Obama T, 2003, J BIOCHEM, V133, P279, DOI 10.1093/jb/mvg038; Ochi S, 2004, J BIOL CHEM, V279, P12181, DOI 10.1074/jbc.M307046200; Oda M, 2008, J LIPID RES, V49, P1039, DOI 10.1194/jlr.M700587-JLR200; Oda M, 2010, BBA-BIOMEMBRANES, V1798, P1073, DOI 10.1016/j.bbamem.2010.03.004; Openshaw AEA, 2005, J BIOL CHEM, V280, P35011, DOI 10.1074/jbc.M506800200; Ramarao N, 2005, CELL MICROBIOL, V7, P1357, DOI 10.1111/j.1462-5822.2005.00562.x; Sasahara T, 2011, EUR J CLIN MICROBIOL, V30, P219, DOI 10.1007/s10096-010-1072-2; Schwan WR, 2003, FEMS IMMUNOL MED MIC, V38, P23, DOI 10.1016/S0928-8244(03)00098-1; TAYLOR AJ, 1975, J MED MICROBIOL, V8, P543, DOI 10.1099/00222615-8-4-543; Tran SL, 2011, CELL MICROBIOL, V13, P92, DOI 10.1111/j.1462-5822.2010.01522.x; Tseng HJ, 2004, BIOCHEM BIOPH RES CO, V314, P513, DOI 10.1016/j.bbrc.2003.12.125; Van der Zwet WC, 2000, J CLIN MICROBIOL, V38, P4131, DOI 10.1128/JCM.38.11.4131-4136.2000	44	43	43	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e38054	10.1371/journal.pone.0038054	http://dx.doi.org/10.1371/journal.pone.0038054			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701599	gold, Green Published, Green Submitted			2022-12-27	WOS:000305348400033
J	Stahl, F				Stahl, Frank			Defining and Detecting Crossover-Interference Mutants in Yeast	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; CROSSING-OVER; MISMATCH REPAIR; GENE CONVERSION; MUTS HOMOLOG; MEIOSIS; RECOMBINATION; ASSURANCE; PATHWAYS	The analysis of crossover interference in many creatures is complicated by the presence of two kinds of crossovers, interfering and noninterfering. In such creatures, the values of the traditional indicators of interference are subject not only to the strength of interference but also to the relative frequencies of crossing over contributed by the two kinds. We formalize the relationship among these variables and illustrate the possibilities and limitations of classical interference analysis with meiotic tetrad data from wild-type Saccharomyces cerevisiae and from mlh1 and ndj1 mutants.	Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA	University of Oregon	Stahl, F (corresponding author), Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA.	fstahl@uoregon.edu						Abdullah MFF, 2004, CYTOGENET GENOME RES, V107, P180, DOI 10.1159/000080596; Argueso JL, 2004, GENETICS, V168, P1805, DOI 10.1534/genetics.104.032912; Cole F, 2012, NAT CELL BIOL, V14, P424, DOI 10.1038/ncb2451; Falque M, 2009, PLANT CELL, V21, P3915, DOI 10.1105/tpc.109.071514; FOSS E, 1993, GENETICS, V133, P681; Gauthier F, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-27; Getz TJ, 2008, GENETICS, V178, P1251, DOI 10.1534/genetics.106.067603; HOLLINGSWORTH NM, 1995, GENE DEV, V9, P1728, DOI 10.1101/gad.9.14.1728; Housworth EA, 2003, AM J HUM GENET, V73, P188, DOI 10.1086/376610; Malkova A, 2004, GENETICS, V168, P49, DOI 10.1534/genetics.104.027961; Martini E, 2006, CELL, V126, P285, DOI 10.1016/j.cell.2006.05.044; Muller HJ, 1916, AM NAT, V50, P194; PAPAZIAN HP, 1952, GENETICS, V37, P175; PERKINS DD, 1949, GENETICS, V34, P607; ROSSMACDONALD P, 1994, CELL, V79, P1069, DOI 10.1016/0092-8674(94)90037-X; Rosu S, 2011, SCIENCE, V334, P1286, DOI 10.1126/science.1212424; Shinohara M, 2008, NAT GENET, V40, P299, DOI 10.1038/ng.83; Stahl F, 2008, GENETICS, V180, P1, DOI 10.1534/genetics.104.95596; Stahl FW, 2008, GENETICS, V179, P701, DOI 10.1534/genetics.108.086918; Stahl FW, 2010, GENETICS, V186, P515, DOI 10.1534/genetics.110.121194; Stahl FW, 2009, METHODS MOL BIOL, V557, P35, DOI 10.1007/978-1-59745-527-5_4; Stahl FW, 2004, GENETICS, V168, P35, DOI 10.1534/genetics.104.027789; Sturtevant A. H., 1915, Zs indukt Abstamm Berlin, V13, DOI 10.1007/BF01792906; Viswanath L, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-297; Wanat JJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000188	25	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e38476	10.1371/journal.pone.0038476	http://dx.doi.org/10.1371/journal.pone.0038476			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701650	Green Published, Green Submitted, gold			2022-12-27	WOS:000305348400064
J	Ahveninen, J; Jaaskelainen, IP; Belliveau, JW; Hamalainen, M; Lin, FH; Raij, T				Ahveninen, Jyrki; Jaaskelainen, Iiro P.; Belliveau, John W.; Hamalainen, Matti; Lin, Fa-Hsuan; Raij, Tommi			Dissociable Influences of Auditory Object vs. Spatial Attention on Visual System Oscillatory Activity	PLOS ONE			English	Article							PARIETOOCCIPITAL ALPHA-RHYTHM; PARIETAL REACH REGION; OCCIPITAL CORTEX; SELECTIVE ATTENTION; CORTICAL ACTIVITY; NEURONAL-ACTIVITY; HEAD-DIRECTION; BAND; MODULATION; EEG	Given that both auditory and visual systems have anatomically separate object identification ("what") and spatial ("where") pathways, it is of interest whether attention-driven cross-sensory modulations occur separately within these feature domains. Here, we investigated how auditory "what" vs. "where" attention tasks modulate activity in visual pathways using cortically constrained source estimates of magnetoencephalograpic (MEG) oscillatory activity. In the absence of visual stimuli or tasks, subjects were presented with a sequence of auditory-stimulus pairs and instructed to selectively attend to phonetic ("what") vs. spatial ("where") aspects of these sounds, or to listen passively. To investigate sustained modulatory effects, oscillatory power was estimated from time periods between sound-pair presentations. In comparison to attention to sound locations, phonetic auditory attention was associated with stronger alpha (7-13 Hz) power in several visual areas (primary visual cortex; lingual, fusiform, and inferior temporal gyri, lateral occipital cortex), as well as in higher-order visual/multisensory areas including lateral/medial parietal and retrosplenial cortices. Region-of-interest (ROI) analyses of dynamic changes, from which the sustained effects had been removed, suggested further power increases during Attend Phoneme vs. Location centered at the alpha range 400-600 ms after the onset of second sound of each stimulus pair. These results suggest distinct modulations of visual system oscillatory activity during auditory attention to sound object identity ("what") vs. sound location ("where"). The alpha modulations could be interpreted to reflect enhanced crossmodal inhibition of feature-specific visual pathways and adjacent audiovisual association areas during "what" vs. "where" auditory attention.	[Ahveninen, Jyrki; Belliveau, John W.; Hamalainen, Matti; Lin, Fa-Hsuan; Raij, Tommi] Harvard Univ, Sch Med, Athinoula A Martinos Ctr Biomed Imaging, Dept Radiol,Massachusetts Gen Hosp, Charlestown, MA USA; [Belliveau, John W.; Hamalainen, Matti] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Jaaskelainen, Iiro P.] Aalto Univ, Dept Biomed Engn & Computat Sci BECS, Espoo, Finland; [Lin, Fa-Hsuan] Natl Taiwan Univ, Inst Biomed Engn, Taipei 10764, Taiwan	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Aalto University; National Taiwan University	Ahveninen, J (corresponding author), Harvard Univ, Sch Med, Athinoula A Martinos Ctr Biomed Imaging, Dept Radiol,Massachusetts Gen Hosp, Charlestown, MA USA.	jyrki@nmr.mgh.harvard.edu	Hamalainen, Matti S/C-8507-2013; Lin, Fa-Hsuan/G-6988-2012; Jaaskelainen, Iiro P/C-7392-2012	Lin, Fa-Hsuan/0000-0002-9539-1731; Jaaskelainen, Iiro P/0000-0001-6001-6950; Hamalainen, Matti/0000-0001-6841-112X; Raij, Tommi/0000-0001-7439-7491	National Institutes of Health [R01MH083744, R21DC010060, R01HD040712, R01NS037462, R01NS057500, R01NS048279, 5R01EB009048, P41RR14075]; National Science Foundation [NSF 0351442]; Mental Illness and Neuroscience Discovery Institute; American Heart Association; Ella and Georg Ehrnrooth Foundation; Emil Aaltonen Foundation; Finnish Cultural Foundation; Sigrid Juselius Foundation; Academy of Finland;  [S10RR14798];  [S10RR023401];  [S10RR019307];  [S10RR023043]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD040712] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR014075, S10RR023401, S10RR023043, S10RR019307, S10RR014798] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB009048] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH083744] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037462, R01NS048279, R56NS057500, R01NS057500] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R21DC010060] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Mental Illness and Neuroscience Discovery Institute; American Heart Association(American Heart Association); Ella and Georg Ehrnrooth Foundation; Emil Aaltonen Foundation; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Academy of Finland(Academy of Finland); ; ; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by National Institutes of Health Awards R01MH083744, R21DC010060, R01HD040712, R01NS037462, R01NS057500, R01NS048279, 5R01EB009048, and P41RR14075; Shared Instrumentation Grants S10RR14798, S10RR023401, S10RR019307, and S10RR023043; National Science Foundation Grant NSF 0351442; the Mental Illness and Neuroscience Discovery Institute, the American Heart Association, the Ella and Georg Ehrnrooth Foundation, the Emil Aaltonen Foundation, the Finnish Cultural Foundation, the Sigrid Juselius Foundation, and the Academy of Finland. The funding organizations had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrian ED, 1934, J PHYSIOL-LONDON, V81, P440, DOI 10.1113/jphysiol.1934.sp003147; Ahveninen J, 2000, NEUROSCI LETT, V292, P29, DOI 10.1016/S0304-3940(00)01429-4; Ahveninen J, 2007, NEUROIMAGE, V35, P577, DOI 10.1016/j.neuroimage.2006.12.033; Ahveninen J, 2006, P NATL ACAD SCI USA, V103, P14608, DOI 10.1073/pnas.0510480103; Ahveninen J, 2011, P NATL ACAD SCI USA, V108, P4182, DOI 10.1073/pnas.1016134108; Alain C, 2001, P NATL ACAD SCI USA, V98, P12301, DOI 10.1073/pnas.211209098; Anderson KL, 2011, NEUROSCIENCE, V180, P165, DOI 10.1016/j.neuroscience.2011.02.004; Arnott SR, 2011, NEUROSCI BIOBEHAV R, V35, P2162, DOI 10.1016/j.neubiorev.2011.04.005; Astafiev SV, 2003, J NEUROSCI, V23, P4689; Banerjee S, 2011, J NEUROSCI, V31, P9923, DOI 10.1523/JNEUROSCI.4660-10.2011; Bar M, 2003, NEURON, V38, P347, DOI 10.1016/S0896-6273(03)00167-3; Bauer M, 2006, J NEUROSCI, V26, P490, DOI 10.1523/JNEUROSCI.5228-04.2006; Baumann O, 2010, J NEUROSCI, V30, P12897, DOI 10.1523/JNEUROSCI.3077-10.2010; Bernier PM, 2010, NEURON, V68, P776, DOI 10.1016/j.neuron.2010.11.002; Bichot NP, 2005, SCIENCE, V308, P529, DOI 10.1126/science.1109676; Budinger E, 2008, BRAIN RES, V1220, P2, DOI 10.1016/j.brainres.2007.07.084; Bushara KO, 1999, NAT NEUROSCI, V2, P759, DOI 10.1038/11239; CHEN LL, 1994, EXP BRAIN RES, V101, P8, DOI 10.1007/BF00243212; Cho JW, 2001, BEHAV NEUROSCI, V115, P3, DOI 10.1037//0735-7044.115.1.3; Cohen YE, 2000, NEURON, V27, P647, DOI 10.1016/S0896-6273(00)00073-8; Collignon O, 2011, P NATL ACAD SCI USA, V108, P4435, DOI 10.1073/pnas.1013928108; Connolly JD, 2003, EXP BRAIN RES, V153, P140, DOI 10.1007/s00221-003-1587-1; Cooper NR, 2003, INT J PSYCHOPHYSIOL, V47, P65, DOI 10.1016/S0167-8760(02)00107-1; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Diaconescu AO, 2011, J COGNITIVE NEUROSCI, V23, P1609, DOI 10.1162/jocn.2010.21465; Doehrmann O, 2010, J NEUROSCI, V30, P3370, DOI 10.1523/JNEUROSCI.5074-09.2010; Driver J, 1998, PHILOS T R SOC B, V353, P1319, DOI 10.1098/rstb.1998.0286; Epstein RA, 2008, TRENDS COGN SCI, V12, P388, DOI 10.1016/j.tics.2008.07.004; Fernandez-Ruiz J, 2007, CEREB CORTEX, V17, P2283, DOI 10.1093/cercor/bhl137; Fox MD, 2006, P NATL ACAD SCI USA, V103, P10046, DOI 10.1073/pnas.0604187103; Foxe JJ, 1998, NEUROREPORT, V9, P3929, DOI 10.1097/00001756-199812010-00030; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; Fu KMG, 2001, COGNITIVE BRAIN RES, V12, P145, DOI 10.1016/S0926-6410(01)00034-9; Green JJ, 2005, EXP BRAIN RES, V166, P358, DOI 10.1007/s00221-005-2377-8; Gruber T, 1999, CLIN NEUROPHYSIOL, V110, P2074, DOI 10.1016/S1388-2457(99)00176-5; Halgren E, 2000, CEREB CORTEX, V10, P69, DOI 10.1093/cercor/10.1.69; HAMALAINEN M, 1993, REV MOD PHYS, V65, P413, DOI 10.1103/RevModPhys.65.413; HAMALAINEN MS, 1989, IEEE T BIO-MED ENG, V36, P165, DOI 10.1109/10.16463; Handel BF, 2011, J COGNITIVE NEUROSCI, V23, P2494, DOI 10.1162/jocn.2010.21557; Ingle D, ANAL VISUAL BEHAV; JACK CE, 1973, PERCEPT MOTOR SKILL, V37, P967, DOI 10.2466/pms.1973.37.3.967; Kincade JM, 2005, J NEUROSCI, V25, P4593, DOI 10.1523/JNEUROSCI.0236-05.2005; Klimesch W, 2007, BRAIN RES REV, V53, P63, DOI 10.1016/j.brainresrev.2006.06.003; Koelewijn T, 2010, ACTA PSYCHOL, V134, P372, DOI 10.1016/j.actpsy.2010.03.010; Lenz D, 2007, INT J PSYCHOPHYSIOL, V64, P31, DOI 10.1016/j.ijpsycho.2006.07.008; Lin FH, 2006, HUM BRAIN MAPP, V27, P1, DOI 10.1002/hbm.20155; Lin FH, 2004, NEUROIMAGE, V23, P582, DOI 10.1016/j.neuroimage.2004.04.027; Macaluso E, 2010, CORTEX, V46, P282, DOI 10.1016/j.cortex.2009.05.010; Maeder PP, 2001, NEUROIMAGE, V14, P802, DOI 10.1006/nimg.2001.0888; Maier JX, 2009, HEARING RES, V258, P106, DOI 10.1016/j.heares.2009.05.008; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; MCGURK H, 1976, NATURE, V264, P746, DOI 10.1038/264746a0; MISHKIN M, 1983, TRENDS NEUROSCI, V6, P414, DOI 10.1016/0166-2236(83)90190-X; Mo J, 2011, J NEUROSCI, V31, P878, DOI 10.1523/JNEUROSCI.5295-10.2011; Molholm S, 2007, EUR J NEUROSCI, V26, P499, DOI 10.1111/j.1460-9568.2007.05668.x; Mosher JC, 1999, IEEE T BIO-MED ENG, V46, P245, DOI 10.1109/10.748978; Mozolic JL, 2008, BMC NEUROL, V8, DOI 10.1186/1471-2377-8-35; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Palva S, 2005, J NEUROSCI, V25, P5248, DOI 10.1523/JNEUROSCI.0141-05.2005; Palva S, 2007, TRENDS NEUROSCI, V30, P150, DOI 10.1016/j.tins.2007.02.001; Pfurtscheller G, 2003, EPILEPSIA, V44, P2, DOI 10.1111/j.0013-9580.2003.12001.x; Raij T, 1999, J COGNITIVE NEUROSCI, V11, P282, DOI 10.1162/089892999563391; Rauschecker JP, 2000, P NATL ACAD SCI USA, V97, P11800, DOI 10.1073/pnas.97.22.11800; RAY WJ, 1985, SCIENCE, V228, P750, DOI 10.1126/science.3992243; Romanski LM, 1999, NAT NEUROSCI, V2, P1131, DOI 10.1038/16056; ROUILLER EM, 1990, EXP BRAIN RES, V80, P501, DOI 10.1007/BF00227991; Salenius S, 1995, ELECTROEN CLIN NEURO, V95, P453, DOI 10.1016/0013-4694(95)00155-7; Schroeder CE, 2005, CURR OPIN NEUROBIOL, V15, P454, DOI 10.1016/j.conb.2005.06.008; SELEMON LD, 1988, J NEUROSCI, V8, P4049; Shams L, 2002, COGNITIVE BRAIN RES, V14, P147, DOI 10.1016/S0926-6410(02)00069-1; Shinn-Cunningham BG, 2005, J ACOUST SOC AM, V117, P3100, DOI 10.1121/1.1872572; Shomstein S, 2006, J NEUROSCI, V26, P435, DOI 10.1523/JNEUROSCI.4408-05.2006; Smith DV, 2010, J COGNITIVE NEUROSCI, V22, P347, DOI 10.1162/jocn.2009.21241; SUMBY WH, 1954, J ACOUST SOC AM, V26, P212, DOI 10.1121/1.1907309; Tadel F, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/879716; Tallon-Baudry C, 2005, CEREB CORTEX, V15, P654, DOI 10.1093/cercor/bhh167; TallonBaudry C, 1997, J NEUROSCI, V17, P722; Thut G, 2006, J NEUROSCI, V26, P9494, DOI 10.1523/JNEUROSCI.0875-06.2006; TIITINEN H, 1993, NATURE, V364, P59, DOI 10.1038/364059a0; Van der Burg E, 2011, NEUROIMAGE, V55, P1208, DOI 10.1016/j.neuroimage.2010.12.068; Vanni S, 1997, J NEUROSCI, V17, P7141; Wolbers T, 2008, NAT NEUROSCI, V11, P1223, DOI 10.1038/nn.2189; Worden MS, 2000, J NEUROSCI, V20; Wu CT, 2007, BRAIN RES, V1134, P187, DOI 10.1016/j.brainres.2006.11.088; YAMAMOTO T, 1988, P NATL ACAD SCI USA, V85, P8732, DOI 10.1073/pnas.85.22.8732; Zhang Y, 2008, J COGNITIVE NEUROSCI, V20, P1915, DOI 10.1162/jocn.2008.20132; Zimmer U, 2010, NEUROIMAGE, V52, P606, DOI 10.1016/j.neuroimage.2010.04.245	92	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e38511	10.1371/journal.pone.0038511	http://dx.doi.org/10.1371/journal.pone.0038511			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22693642	Green Published, Green Submitted, gold			2022-12-27	WOS:000305343900052
J	Kottgen, A; Yang, Q; Shimmin, LC; Tin, A; Schaeffer, C; Coresh, J; Liu, X; Rampoldi, L; Hwang, SJ; Boerwinkle, E; Hixson, JE; Kao, WHL; Fox, CS				Koettgen, Anna; Yang, Qiong; Shimmin, Lawrence C.; Tin, Adrienne; Schaeffer, Celine; Coresh, Josef; Liu, Xuan; Rampoldi, Luca; Hwang, Shih-Jen; Boerwinkle, Eric; Hixson, James E.; Kao, W. H. Linda; Fox, Caroline S.			Association of Estimated Glomerular Filtration Rate and Urinary Uromodulin Concentrations with Rare Variants Identified by UMOD Gene Region Sequencing	PLOS ONE			English	Article							COLLABORATIVE METAANALYSIS; HIGHER ALBUMINURIA; SERUM CREATININE; KIDNEY-FUNCTION; ALL-CAUSE; RISK; MORTALITY; DISEASE; PROTEIN; DESIGN	Background: Recent genome-wide association studies (GWAS) have identified common variants in the UMOD region associated with kidney function and disease in the general population. To identify novel rare variants as well as common variants that may account for this GWAS signal, the exons and 4 kb upstream region of UMOD were sequenced. Methodology/Principal Findings: Individuals (n = 485) were selected based on presence of the GWAS risk haplotype and chronic kidney disease (CKD) in the ARIC Study and on the extremes of of the UMOD gene product, uromodulin, in urine (Tamm Horsfall protein, THP) in the Framingham Heart Study (FHS). Targeted sequencing was conducted using capillary based Sanger sequencing (3730 DNA Analyzer). Variants were tested for association with THP concentrations and estimated glomerular filtration rate (eGFR), and identified non-synonymous coding variants were genotyped in up to 22,546 follow-up samples. Twenty-four and 63 variants were identified in the 285 ARIC and 200 FHS participants, respectively. In both studies combined, there were 33 common and 54 rare (MAF<0.05) variants. Five non-synonymous rare variants were identified in FHS; borderline enrichment of rare variants was found in the extremes of THP (SKAT p-value = 0.08). Only V458L was associated with THP in the FHS general-population validation sample (p = 9* 10(-3), n = 2,522), but did not show directionconsistent and significant association with eGFR in both the ARIC (n = 14,635) and FHS (n = 7,520) validation samples. Pooling all non-synonymous rare variants except V458L together showed non-significant associations with THP and eGFR in the FHS validation sample. Functional studies of V458L revealed no alternations in protein trafficking. Conclusions/Significance: Multiple novel rare variants in the UMOD region were identified, but none were consistently associated with eGFR in two independent study samples. Only V458L had modest association with THP levels in the general population and thus could not account for the observed GWAS signal.	[Koettgen, Anna; Tin, Adrienne; Coresh, Josef; Kao, W. H. Linda] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; [Koettgen, Anna] Freiburg Univ Clin, Div Renal, Freiburg, Germany; [Yang, Qiong; Liu, Xuan] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Shimmin, Lawrence C.; Boerwinkle, Eric; Hixson, James E.] UT Houston Sch Publ Hlth, Div Epidemiol & Dis Control, Ctr Human Genet, Houston, TX USA; [Schaeffer, Celine; Rampoldi, Luca] Ist Sci San Raffaele, Dulbecco Telethon Inst, I-20132 Milan, Italy; [Schaeffer, Celine; Rampoldi, Luca] Ist Sci San Raffaele, Div Genet & Cell Biol, I-20132 Milan, Italy; [Coresh, Josef; Kao, W. H. Linda] Johns Hopkins Med Inst, Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD 21205 USA; [Hwang, Shih-Jen; Fox, Caroline S.] NHLBI, Framingham Heart Study, Framingham, MA USA; [Hwang, Shih-Jen; Fox, Caroline S.] Ctr Populat Studies, Framingham, MA USA; [Fox, Caroline S.] Brigham & Womens Hosp, Div Endocrinol, Boston, MA 02115 USA; [Fox, Caroline S.] Harvard Univ, Sch Med, Boston, MA USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Freiburg; Boston University; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Fondazione Telethon; Dulbecco Telethon Institute (DTI); Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Johns Hopkins University; Johns Hopkins Medicine; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Kottgen, A (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA.	foxca@nhlbi.nih.gov	Hwang, Shih-Jen/HGU-5826-2022; Schaeffer, Celine/AAU-5713-2020; Yang, Qiong/G-5438-2014; Rampoldi, Luca/AAN-6228-2020; Schaeffer, Celine/AAC-5208-2022; Rampoldi, Luca/L-3639-2018	Schaeffer, Celine/0000-0001-5883-3951; Rampoldi, Luca/0000-0002-0544-7042; Schaeffer, Celine/0000-0001-5883-3951; Rampoldi, Luca/0000-0002-0544-7042; Hixson, James/0000-0002-0849-9315	National Heart, Lung, and Blood Institute [HHSN268201100005C, HHSN268201100006C, HSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, HHSN268201100012C]; National Institute of Diabetes and Digestive and Kidney Diseases [1 R01 DK076770-01]; Emmy Noether Programme of the German Research Foundation [KO 3598/2-1]; National Human Genome Research Institute [RC2 HG005697]; National Institutes of Health/National Heart, Lung, and Blood Institute [N01-HC-25195]; NHLBI; Fondazione Telethon Italy [TCR08006]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006094, R01HL105756] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [RC2HG005697] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076770] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Emmy Noether Programme of the German Research Foundation(German Research Foundation (DFG)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institutes of Health/National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Fondazione Telethon Italy(Fondazione Telethon); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	ARIC: The Atherosclerosis Risk in Communities Study is carried out as a collaborative study supported by National Heart, Lung, and Blood Institute contracts (HHSN268201100005C, HHSN268201100006C, HSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, and HHSN268201100012C). The authors thank the staff and participants of the ARIC study for their important contributions. This study was additionally funded by the National Institute of Diabetes and Digestive and Kidney Diseases (1 R01 DK076770-01), the Emmy Noether Programme of the German Research Foundation (KO 3598/2-1 to A.K.), and the National Human Genome Research Institute (RC2 HG005697 to JEH). FHS: This work was supported through National Institutes of Health/National Heart, Lung, and Blood Institute Contract N01-HC-25195 and the NHLBI division of intra- mural research. Functional studies: This work was supported by the Fondazione Telethon Italy (TCR08006 to LR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Astor BC, 2011, KIDNEY INT, V79, P1331, DOI 10.1038/ki.2010.550; Bernascone I, 2006, TRAFFIC, V7, P1567, DOI 10.1111/j.1600-0854.2006.00481.x; Bollee G, 2011, CLIN J AM SOC NEPHRO, V6, P2429, DOI 10.2215/CJN.01220211; DAWBER TR, 1963, ANN NY ACAD SCI, V107, P539, DOI 10.1111/j.1749-6632.1963.tb13299.x; FEINLEIB M, 1975, PREV MED, V4, P518, DOI 10.1016/0091-7435(75)90037-7; Gansevoort RT, 2011, KIDNEY INT, V80, P93, DOI 10.1038/ki.2010.531; Gudbjartsson DF, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001039; Hart TC, 2002, J MED GENET, V39, P882, DOI 10.1136/jmg.39.12.882; Kottgen A, 2010, NAT GENET, V42, P376, DOI 10.1038/ng.568; Kottgen A, 2010, J AM SOC NEPHROL, V21, P337, DOI 10.1681/ASN.2009070725; Kottgen A, 2009, NAT GENET, V41, P712, DOI 10.1038/ng.377; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Li BS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000481; Manjunath G, 2003, J AM COLL CARDIOL, V41, P47, DOI 10.1016/S0735-1097(02)02663-3; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Padmanabhan S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001177; Pattaro C, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-41; Rampoldi L, 2003, HUM MOL GENET, V12, P3369, DOI 10.1093/hmg/ddg353; Rampoldi L, 2011, KIDNEY INT, V80, P338, DOI 10.1038/ki.2011.134; Rivas MA, 2011, NAT GENET, V43, P1066, DOI 10.1038/ng.952; Schaeffer C, 2009, MOL BIOL CELL, V20, P589, DOI 10.1091/mbc.E08-08-0876; Shea J, 2011, NAT GENET, V43, P801, DOI 10.1038/ng.871; Shlipak MG, 2011, BMC NEPHROL, V12, DOI 10.1186/1471-2369-12-2; Splansky GL, 2007, AM J EPIDEMIOL, V165, P1328, DOI 10.1093/aje/kwm021; Sulem P, 2011, NAT GENET, V43, P1127, DOI 10.1038/ng.972; TAMM I, 1950, P SOC EXP BIOL MED, V74, P108, DOI 10.3181/00379727-74-17825; van der Velde M, 2011, KIDNEY INT, V79, P1341, DOI 10.1038/ki.2010.536; Vylet'al P, 2006, KIDNEY INT, V70, P1155, DOI 10.1038/sj.ki.5001728; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Zhang QL, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-117	35	23	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38311	10.1371/journal.pone.0038311	http://dx.doi.org/10.1371/journal.pone.0038311			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693617	Green Published, gold, Green Submitted			2022-12-27	WOS:000305338500128
J	Leshikar, ED; Duarte, A; Hertzog, C				Leshikar, Eric D.; Duarte, Audrey; Hertzog, Christopher			Task-Selective Memory Effects for Successfully Implemented Encoding Strategies	PLOS ONE			English	Article							MEDIAL TEMPORAL-LOBE; PREFRONTAL CORTEX; EPISODIC SIMULATION; HIPPOCAMPAL SYSTEM; RELATIONAL MEMORY; PARIETAL CORTEX; MENTAL-IMAGERY; RETRIEVAL; ITEM; RECOLLECTION	Previous behavioral evidence suggests that instructed strategy use benefits associative memory formation in paired associate tasks. Two such effective encoding strategies-visual imagery and sentence generation-facilitate memory through the production of different types of mediators (e. g., mental images and sentences). Neuroimaging evidence suggests that regions of the brain support memory reflecting the mental operations engaged at the time of study. That work, however, has not taken into account self-reported encoding task success (i.e., whether participants successfully generated a mediator). It is unknown, therefore, whether task-selective memory effects specific to each strategy might be found when encoding strategies are successfully implemented. In this experiment, participants studied pairs of abstract nouns under either visual imagery or sentence generation encoding instructions. At the time of study, participants reported their success at generating a mediator. Outside of the scanner, participants further reported the quality of the generated mediator (e. g., images, sentences) for each word pair. We observed task-selective memory effects for visual imagery in the left middle occipital gyrus, the left precuneus, and the lingual gyrus. No such task-selective effects were observed for sentence generation. Intriguingly, activity at the time of study in the left precuneus was modulated by the self-reported quality (vividness) of the generated mental images with greater activity for trials given higher ratings of quality. These data suggest that regions of the brain support memory in accord with the encoding operations engaged at the time of study.	[Leshikar, Eric D.] Brandeis Univ, Dept Psychol, Waltham, MA 02254 USA; [Duarte, Audrey; Hertzog, Christopher] Georgia Inst Technol, Sch Psychol, Atlanta, GA 30332 USA	Brandeis University; University System of Georgia; Georgia Institute of Technology	Leshikar, ED (corresponding author), Brandeis Univ, Dept Psychol, Waltham, MA 02254 USA.	leshikar@Brandeis.edu		Duarte, Audrey/0000-0001-5293-4049	National Institutes of Health [T32 AG00175]; Center for Advanced Brain Imaging at the Georgia Institute of Technology [S091001]; NATIONAL INSTITUTE ON AGING [T32AG000175] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Advanced Brain Imaging at the Georgia Institute of Technology; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by National Institutes of Health Grant T32 AG00175 to E. D. Leshikar and by Grant S091001 from the Center for Advanced Brain Imaging at the Georgia Institute of Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addis DR, 2006, NEUROIMAGE, V33, P1194, DOI 10.1016/j.neuroimage.2006.07.039; Addis DR, 2009, NEUROPSYCHOLOGIA, V47, P2660, DOI 10.1016/j.neuropsychologia.2009.05.018; Addis DR, 2009, NEUROPSYCHOLOGIA, V47, P2222, DOI 10.1016/j.neuropsychologia.2008.10.026; Badre D, 2007, NEUROPSYCHOLOGIA, V45, P2883, DOI 10.1016/j.neuropsychologia.2007.06.015; Blumenfeld RS, 2011, J COGNITIVE NEUROSCI, V23, P257, DOI 10.1162/jocn.2010.21459; BOWER GH, 1970, PSYCHON SCI, V20, P119, DOI 10.3758/BF03335632; BOWER GH, 1970, J VERB LEARN VERB BE, V9, P529, DOI 10.1016/S0022-5371(70)80096-2; Cohen NJ, 1999, HIPPOCAMPUS, V9, P83, DOI 10.1002/(SICI)1098-1063(1999)9:1<83::AID-HIPO9>3.0.CO;2-7; Craik FIM, 2002, MEMORY, V10, P305, DOI 10.1080/09658210244000135; Davachi L, 2003, P NATL ACAD SCI USA, V100, P2157, DOI 10.1073/pnas.0337195100; DEsposito M, 1997, NEUROPSYCHOLOGIA, V35, P725, DOI 10.1016/S0028-3932(96)00121-2; Dobbins IG, 2005, CEREB CORTEX, V15, P1768, DOI 10.1093/cercor/bhi054; Dunlosky J, 2005, DEV PSYCHOL, V41, P389, DOI 10.1037/0012-1649.41.2.389; Dunlosky J, 1998, PSYCHOL AGING, V13, P597, DOI 10.1037/0882-7974.13.4.597; Dunlosky J, 2000, PSYCHOL AGING, V15, P462, DOI 10.1037//0882-7974.15.3.462; Eichenbaum H, 2007, ANNU REV NEUROSCI, V30, P123, DOI 10.1146/annurev.neuro.30.051606.094328; Eichenbaum H, 2000, NAT REV NEUROSCI, V1, P41, DOI 10.1038/35036213; Eichenbaum H, 1997, ANNU REV PSYCHOL, V48, P547, DOI 10.1146/annurev.psych.48.1.547; FLETCHER PC, 1995, NEUROIMAGE, V2, P195, DOI 10.1006/nimg.1995.1025; Friston K, 2007, STATISTICAL PARAMETRIC MAPPING: THE ANALYSIS OF FUNCTIONAL BRAIN IMAGES, P1; Friston KJ, 2002, NEUROIMAGE, V16, P484, DOI 10.1006/nimg.2002.1091; Gold BT, 2005, CEREB CORTEX, V15, P1438, DOI 10.1093/cercor/bhi024; Gold BT, 2002, NEURON, V35, P803, DOI 10.1016/S0896-6273(02)00800-0; Hassabis D, 2007, TRENDS COGN SCI, V11, P299, DOI 10.1016/j.tics.2007.05.001; Hassabis D, 2009, PHILOS T R SOC B, V364, P1263, DOI 10.1098/rstb.2008.0296; Hertzog C, 2006, ADV CONSC RES, V66, P259; Hertzog C, 2009, Q J EXP PSYCHOL, V62, P155, DOI 10.1080/17470210701855520; Huijbers W, 2011, NEUROPSYCHOLOGIA, V6; Johnson JD, 2007, CEREB CORTEX, V17, P2507, DOI 10.1093/cercor/bhl156; Kan IP, 2003, COGN NEUROPSYCHOL, V20, P525, DOI 10.1080/02643290244000257; Kausler D. H., 1994, LEARNING MEMORY NORM; Kirchhoff BA, 2000, J NEUROSCI, V20, P6173, DOI 10.1523/JNEUROSCI.20-16-06173.2000; Kirchhoff BA, 2006, NEURON, V51, P263, DOI 10.1016/j.neuron.2006.06.006; Kosslyn SM, 2001, NAT REV NEUROSCI, V2, P635, DOI 10.1038/35090055; KOSSLYN SM, 1977, COGNITIVE PSYCHOL, V9, P52, DOI 10.1016/0010-0285(77)90004-4; Kosslyn SM, 1997, NEUROIMAGE, V6, P320, DOI 10.1006/nimg.1997.0295; Lepage M, 2000, COGNITIVE BRAIN RES, V9, P271, DOI 10.1016/S0926-6410(00)00005-7; Leshikar ED, 2012, SOC NEUROSCI-UK, V7, P126, DOI 10.1080/17470919.2011.585242; Leshikar ED, 2010, CORTEX, V46, P507, DOI 10.1016/j.cortex.2009.07.011; Logan JM, 2002, NEURON, V33, P827, DOI 10.1016/S0896-6273(02)00612-8; Mandzia JL, 2004, HUM BRAIN MAPP, V21, P1, DOI 10.1002/hbm.10140; Martin C. J., 1965, PSYCHONOMIC SCI, V3, P455; Moscovitch M., 2002, PRINCIPLES FRONTAL L, P188, DOI [10.1093/acprof:oso/9780195134971.003.0012, DOI 10.1093/ACPROF:OSO/9780195134971.003.0012]; Otten LJ, 2002, NAT NEUROSCI, V5, P1339, DOI 10.1038/nn967; Otten LJ, 2001, CEREB CORTEX, V11, P1150, DOI 10.1093/cercor/11.12.1150; PAIVIO A, 1973, COGNITIVE PSYCHOL, V5, P176, DOI 10.1016/0010-0285(73)90032-7; PAIVIO A, 1969, PSYCHOL REV, V76, P241, DOI 10.1037/h0027272; Paivio A, 1971, IMAGERY VERBAL PROCE; Park H, 2008, LEARN MEMORY, V15, P417, DOI 10.1101/lm.878908; Parks CM, 2007, J MEM LANG, V57, P81, DOI 10.1016/j.jml.2007.03.003; Richardson JTE, 1998, PSYCHON B REV, V5, P597, DOI 10.3758/BF03208837; Rugg MD, 2008, PROG BRAIN RES, V169, P339, DOI 10.1016/S0079-6123(07)00021-0; Staresina BP, 2008, J COGNITIVE NEUROSCI, V20, P1478, DOI 10.1162/jocn.2008.20104; Uncapher MR, 2009, J NEUROSCI, V29, P8270, DOI 10.1523/JNEUROSCI.1043-09.2009; Vilberg KL, 2008, NEUROPSYCHOLOGIA, V46, P1787, DOI 10.1016/j.neuropsychologia.2008.01.004; Vilberg KL, 2009, NEUROREPORT, V20, P1295, DOI 10.1097/WNR.0b013e3283306798	56	30	31	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38160	10.1371/journal.pone.0038160	http://dx.doi.org/10.1371/journal.pone.0038160			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TY	22693593	Green Submitted, Green Published, gold			2022-12-27	WOS:000305338500097
J	Wang, GH; Wang, CF; Hou, R; Zhou, XY; Li, GT; Zhang, SJ; Xu, JR				Wang, Guanghui; Wang, Chenfang; Hou, Rui; Zhou, Xiaoying; Li, Guotian; Zhang, Shijie; Xu, Jin-Rong			The AMT1 Arginine Methyltransferase Gene Is Important for Plant Infection and Normal Hyphal Growth in Fusarium graminearum	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; NUCLEAR EXPORT; PROTEIN; YEAST; METHYLATION; KINASE; WHEAT; PATHOGENICITY; PATHOGENESIS; SUBSTRATE	Arginine methylation of non-histone proteins by protein arginine methyltransferase (PRMT) has been shown to be important for various biological processes from yeast to human. Although PRMT genes are well conserved in fungi, none of them have been functionally characterized in plant pathogenic ascomycetes. In this study, we identified and characterized all of the four predicted PRMT genes in Fusarium graminearum, the causal agent of Fusarium head blight of wheat and barley. Whereas deletion of the other three PRMT genes had no obvious phenotypes, the Delta amt1 mutant had pleiotropic defects. AMT1 is a predicted type I PRMT gene that is orthologous to HMT1 in Saccharomyces cerevisiae. The Delta amt1 mutant was slightly reduced in vegetative growth but normal in asexual and sexual reproduction. It had increased sensitivities to oxidative and membrane stresses. DON mycotoxin production and virulence on flowering wheat heads also were reduced in the Delta amt1 mutant. The introduction of the wild-type AMT1 allele fully complemented the defects of the Delta amt1 mutant and Amt1-GFP fusion proteins mainly localized to the nucleus. Hrp1 and Nab2 are two hnRNPs in yeast that are methylated by Hmt1 for nuclear export. In F. graminearum, AMT1 is required for the nuclear export of FgHrp1 but not FgNab2, indicating that yeast and F. graminearum differ in the methylation and nucleo-cytoplasmic transport of hnRNP components. Because AMT2 also is a predicted type I PRMT with limited homology to yeast HMT1, we generated the Delta amt1 Delta amt2 double mutants. The Delta amt1 single and Delta amt1 Delta amt2 double mutants had similar defects in all the phenotypes assayed, including reduced vegetative growth and virulence. Overall, data from this systematic analysis of PRMT genes suggest that AMT1, like its ortholog in yeast, is the predominant PRMT gene in F. graminearum and plays a role in hyphal growth, stress responses, and plant infection.	[Wang, Guanghui; Wang, Chenfang; Hou, Rui; Zhang, Shijie] NW A&F Univ, Coll Plant Protect, Yangling, Shaanxi, Peoples R China; [Wang, Guanghui; Zhou, Xiaoying; Li, Guotian; Xu, Jin-Rong] Purdue Univ, Dept Bot & Plant Pathol, W Lafayette, IN 47907 USA	Northwest A&F University - China; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Xu, JR (corresponding author), Purdue Univ, Dept Bot & Plant Pathol, W Lafayette, IN 47907 USA.	jinrong@purdue.edu	zhang, shijie/HGF-0836-2022; zhang, shijie/AAA-3351-2019		National Major Project of Breeding for New Transgenic Organisms [2012ZX08009003]; National Research Initiative of the United States Department of Agriculture (USDA) CSREES [2007-35319-102681]; China Scholarship Council fellowships	National Major Project of Breeding for New Transgenic Organisms; National Research Initiative of the United States Department of Agriculture (USDA) CSREES; China Scholarship Council fellowships	This work was supported by the National Major Project of Breeding for New Transgenic Organisms (2012ZX08009003) and a grant from the National Research Initiative of the United States Department of Agriculture (USDA) CSREES (#2007-35319-102681). Dr. Wang and Dr. Li were partially supported by China Scholarship Council fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachand F, 2007, EUKARYOT CELL, V6, P889, DOI 10.1128/EC.00099-07; Bauer I, 2010, FUNGAL GENET BIOL, V47, P551, DOI 10.1016/j.fgb.2010.03.006; Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; Ben Lovely C, 2011, EUKARYOT CELL, V10, P869, DOI 10.1128/EC.00237-10; Bluhm BH, 2007, MOL PLANT MICROBE IN, V20, P627, DOI 10.1094/MPMI-20-6-0627; Boisvert F, 2005, SCI STKE, V2005, pre2; Bolwell GP, 2002, J EXP BOT, V53, P1367, DOI 10.1093/jexbot/53.372.1367; Bruno KS, 2004, EUKARYOT CELL, V3, P1525, DOI 10.1128/EC.3.6.1525-1532.2004; Catlett N.L., 2003, FUNGAL GENET NEWSL, V50, P9, DOI DOI 10.4148/1941-4765.1150; Chern MK, 2002, J BIOL CHEM, V277, P15345, DOI 10.1074/jbc.M111379200; Cimato TR, 2002, J NEUROSCI RES, V67, P435, DOI 10.1002/jnr.10123; Cuomo CA, 2007, SCIENCE, V317, P1400, DOI 10.1126/science.1143708; Ding SL, 2010, PLANT CELL, V22, P2495, DOI 10.1105/tpc.110.074302; Ding SL, 2009, EUKARYOT CELL, V8, P867, DOI 10.1128/EC.00048-09; Gale LR, 2002, PHYTOPATHOLOGY, V92, P1315, DOI 10.1094/PHYTO.2002.92.12.1315; Gonzalez CI, 2000, MOL CELL, V5, P489, DOI 10.1016/S1097-2765(00)80443-8; Goswami RS, 2004, MOL PLANT PATHOL, V5, P515, DOI 10.1111/J.1364-3703.2004.00252.X; Green DM, 2002, J BIOL CHEM, V277, P7752, DOI 10.1074/jbc.M110053200; Gross S, 2001, MOL CELL BIOL, V21, P8045, DOI 10.1128/MCB.21.23.8045-8055.2001; Harris LJ, 1999, PLANT DIS, V83, P954, DOI 10.1094/PDIS.1999.83.10.954; Hector RE, 2002, EMBO J, V21, P1800, DOI 10.1093/emboj/21.7.1800; Hou ZM, 2002, MOL PLANT MICROBE IN, V15, P1119, DOI 10.1094/MPMI.2002.15.11.1119; Jenczmionka NJ, 2003, CURR GENET, V43, P87, DOI 10.1007/s00294-003-0379-2; Kang ZS, 2008, EUR J PLANT PATHOL, V120, P383, DOI 10.1007/s10658-007-9230-9; Kessler MM, 1997, GENE DEV, V11, P2545, DOI 10.1101/gad.11.19.2545; Krause CD, 2007, PHARMACOL THERAPEUT, V113, P50, DOI 10.1016/j.pharmthera.2006.06.007; Kucharczyk R, 1999, YEAST, V15, P987, DOI 10.1002/(SICI)1097-0061(199907)15:10B<987::AID-YEA403>3.0.CO;2-5; Lee J, 2005, J BIOL CHEM, V280, P32890, DOI 10.1074/jbc.M506944200; Li YM, 2011, MOL PLANT MICROBE IN, V24, P487, DOI 10.1094/MPMI-10-10-0233; Liu WD, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001261; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McBride AE, 2000, J BIOL CHEM, V275, P3128, DOI 10.1074/jbc.275.5.3128; McBride AE, 2007, EUKARYOT CELL, V6, P1119, DOI 10.1128/EC.00074-07; McMullen M, 1997, PLANT DIS, V81, P1340, DOI 10.1094/PDIS.1997.81.12.1340; Niewmierzycka A, 1999, J BIOL CHEM, V274, P814, DOI 10.1074/jbc.274.2.814; Ochiai N, 2007, BIOCHEM BIOPH RES CO, V363, P639, DOI 10.1016/j.bbrc.2007.09.027; Pandolfi V, 2010, GENET MOL RES, V9, P1298, DOI 10.4238/vol9-3gmr828; Pei YX, 2007, PLANT PHYSIOL, V144, P1913, DOI 10.1104/pp.107.099531; PROCTOR RH, 1995, MOL PLANT MICROBE IN, V8, P593, DOI 10.1094/MPMI-8-0593; Sayegh J, 2008, BIOCHEM BIOPH RES CO, V372, P811, DOI 10.1016/j.bbrc.2008.05.121; Scott HS, 1998, GENOMICS, V48, P330, DOI 10.1006/geno.1997.5190; Seong K, 2006, FUNGAL GENET BIOL, V43, P34, DOI 10.1016/j.fgb.2005.10.002; Seong K, 2005, PHYTOPATHOLOGY, V95, P744, DOI 10.1094/PHYTO-95-0744; Shen EC, 1998, GENE DEV, V12, P679, DOI 10.1101/gad.12.5.679; Torres MA, 2006, PLANT PHYSIOL, V141, P373, DOI 10.1104/pp.106.079467; Urban M, 2003, MOL PLANT PATHOL, V4, P347, DOI 10.1046/J.1364-3703.2003.00183.X; Wang CF, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002460; Wang Y, 2011, MOL PLANT MICROBE IN, V24, P118, DOI 10.1094/MPMI-06-10-0129; Wong CM, 2010, NUCLEIC ACIDS RES, V38, P2217, DOI 10.1093/nar/gkp1133; Yu MC, 2004, GENE DEV, V18, P2024, DOI 10.1101/gad.1223204; Yu MC, 2006, GENE DEV, V20, P3249, DOI 10.1101/gad.1495206; Yun CY, 2000, J CELL BIOL, V150, P707, DOI 10.1083/jcb.150.4.707; Zhou X, 2011, METHOD MOL BIOL, P199; Zhou XY, 2010, FUNGAL GENET BIOL, V47, P143, DOI 10.1016/j.fgb.2009.11.001; Zobel-Thropp P, 1998, J BIOL CHEM, V273, P29283, DOI 10.1074/jbc.273.45.29283	55	13	18	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38324	10.1371/journal.pone.0038324	http://dx.doi.org/10.1371/journal.pone.0038324			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693618	Green Published, Green Submitted, gold			2022-12-27	WOS:000305338500130
J	Zhang, M; Zhang, HW; Zhang, T; Ji, YX; Jiao, YM; Wu, H				Zhang, Mei; Zhang, Hongwei; Zhang, Tong; Ji, Yunxia; Jiao, Yanmei; Wu, Hao			Longitudinal Changes of Peripheral Blood DC Subsets and Regulatory T Cells in Chinese Chronic HIV-1-Infected Patients during Antiretroviral Therapy	PLOS ONE			English	Article							PLASMACYTOID DENDRITIC CELL; INTERFERON-PRODUCING CELLS; HIV-INFECTION; IMMUNE ACTIVATION; INNATE; RECONSTITUTION; FREQUENCY; DECREASE; NUMBERS; TYPE-1	It has been emphasized that chronic generalized immune dysfunction is the leading event in the pathogenesis of HIV infection, in which the contribution of dendritic cells (DCs) and regulatory T cells (Tregs) should not be underestimated. In current study, we assessed the longitudinal changes of peripheral blood DC subsets and Tregs in chronically asymptomatic treatment-naive HIV-1-infected patients during 60 weeks of antiretroviral therapy (ART), and compared with those in healthy controls and long term non-progressors (LTNPs). Blood samples were collected at week 0, 4, 12, 24, 48 and 60 of treatment to measure the counts of DC subsets and Tregs by flow cytometry and IFN-a plasma levels by ELISA. The counts of myeloid dendritic cells (mDCs) increased during ART, reaching similar levels to healthy controls at week 60 post ART but still lower than those of LTNPs. In HIV-1-infected patients, the mDCs counts were directly correlated with CD4 counts during ART. Changes in mDCs at week 8 were positively correlated with the changes in CD4 counts at week 60 post ART. However, the counts and function of plasmacytoid dendritic cells (pDCs) remained relatively stable during ART, and similar to those in healthy controls and LTNPs. The percentage of Tregs increased before ART and normalized after ART. Importantly, we found pDCs counts were associated with percentage of Tregs during ART, which may help in understanding of the role of these cells in HIV infection.	[Zhang, Mei; Zhang, Hongwei; Zhang, Tong; Ji, Yunxia; Jiao, Yanmei; Wu, Hao] Capital Med Univ, Beijing Youan Hosp, Ctr Infect Dis, Beijing, Peoples R China	Capital Medical University	Zhang, M (corresponding author), Capital Med Univ, Beijing Youan Hosp, Ctr Infect Dis, Beijing, Peoples R China.	jiaoyanmei@sina.com; wuhd2002@yahoo.com.cn	Zhang, Tong/HGC-1090-2022		Key Project of the National Twelfth-Five Year Research Program of China [2012ZX10001-003, 2012ZX10001-006, 2012ZX10001-008]; Beijing Municipal Science and Technology Commission [D09050703590901]; Beijing Key Laboratory [BZ0089]	Key Project of the National Twelfth-Five Year Research Program of China; Beijing Municipal Science and Technology Commission(Beijing Municipal Science & Technology Commission); Beijing Key Laboratory	This work was supported by grants from Key Project of the National Twelfth-Five Year Research Program of China (2012ZX10001-003,2012ZX10001-006, 2012ZX10001-008), Project of Beijing Municipal Science and Technology Commission (D09050703590901) and Beijing Key Laboratory (BZ0089). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azzoni L, 2007, AIDS, V21, P293, DOI 10.1097/QAD.0b013e328012b85f; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Barratt-Boyes SM, 2011, J MED PRIMATOL, V40, P206, DOI 10.1111/j.1600-0684.2011.00484.x; Barron MA, 2003, J INFECT DIS, V187, P26, DOI 10.1086/345957; Bi X, 2009, EUR J IMMUNOL, V39, P301, DOI 10.1002/eji.200838667; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Chatila TA, 2005, J ALLERGY CLIN IMMUN, V116, P949, DOI 10.1016/j.jaci.2005.08.047; Chehimi J, 2002, J IMMUNOL, V168, P4796, DOI 10.4049/jimmunol.168.9.4796; Chehimi J, 2007, J IMMUNOL, V179, P2642, DOI 10.4049/jimmunol.179.4.2642; Donaghy H, 2001, BLOOD, V98, P2574, DOI 10.1182/blood.V98.8.2574; Epple HJ, 2006, BLOOD, V108, P3072, DOI 10.1182/blood-2006-04-016923; Fazekas de St Groth B, 2008, AIDS, V22, P671, DOI 10.1097/QAD.0b013e3282f466da; Finke JS, 2004, J CLIN IMMUNOL, V24, P647, DOI 10.1007/s10875-004-6250-5; Fitzgerald-Bocarsly P, 2010, J LEUKOCYTE BIOL, V87, P609, DOI 10.1189/jlb.0909635; Fontaine J, 2009, J INFECT DIS, V199, P1007, DOI 10.1086/597278; Ford ES, 2009, CURR OPIN HIV AIDS, V4, P206, DOI 10.1097/COH.0b013e328329c68c; Gaardbo JC, 2008, CLIN EXP IMMUNOL, V154, P80, DOI 10.1111/j.1365-2249.2008.03725.x; Geng WQ, 2011, J CLIN IMMUNOL, V31, P882, DOI 10.1007/s10875-011-9556-0; Hubert P, 2007, J LEUKOCYTE BIOL, V82, P781, DOI 10.1189/jlb.1106694; Hunt PW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015924; Jiao YM, 2009, IMMUNOLOGY, V128, pe366, DOI 10.1111/j.1365-2567.2008.02978.x; Killian MS, 2006, AIDS, V20, P1247, DOI 10.1097/01.aids.0000232231.34253.bd; Krathwohl MD, 2006, J INFECT DIS, V193, P494, DOI 10.1086/499597; Liu YJ, 2005, ANNU REV IMMUNOL, V23, P275, DOI 10.1146/annurev.immunol.23.021704.115633; Lore K, 2003, APMIS, V111, P776, DOI 10.1034/j.1600-0463.2003.11107809.x; Mahnke K, 2007, CELL IMMUNOL, V250, P1, DOI 10.1016/j.cellimm.2008.01.004; Manches O, 2008, J CLIN INVEST, V118, P3431, DOI 10.1172/JCI34823; Ndhlovu LC, 2008, J LEUKOCYTE BIOL, V83, P254, DOI 10.1189/jlb.0507281; Pacanowski J, 2001, BLOOD, V98, P3016, DOI 10.1182/blood.V98.10.3016; Presicce P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028118; Robertson SJ, 2006, SPRINGER SEMIN IMMUN, V28, P51, DOI 10.1007/s00281-006-0019-2; Sabado RL, 2010, BLOOD, V116, P3839, DOI 10.1182/blood-2010-03-273763; Sachdeva N, 2008, J IMMUNOL, V181, P2887, DOI 10.4049/jimmunol.181.4.2887; Schmidt B, 2006, J CLIN IMMUNOL, V26, P55, DOI 10.1007/s10875-006-8401-3; Smed-Sorensen A, 2011, CURR OPIN HIV AIDS, V6, P405, DOI 10.1097/COH.0b013e328349b06b; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Weiss L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011659; Wijewardana V, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001235; Yonezawa A, 2003, J VIROL, V77, P3777, DOI 10.1128/JVI.77.6.3777-3784.2003; Zhang ZN, 2008, JPN J INFECT DIS, V61, P391	40	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e37966	10.1371/journal.pone.0037966	http://dx.doi.org/10.1371/journal.pone.0037966			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22701538	Green Submitted, Green Published, gold			2022-12-27	WOS:000305338500068
J	Zhang, X; Xiao, YN; Ran, Q; Liu, Y; Duan, QB; Duan, HL; Ye, XD; Li, ZJ				Zhang, Xi; Xiao, Yanni; Ran, Qian; Liu, Yao; Duan, Qianbi; Duan, Huiling; Ye, Xingde; Li, Zhongjun			Clinical Observation of Factors in the Efficacy of Blood Component Transfusion in Patients following Hematopoietic Stem Cell Transplantation	PLOS ONE			English	Article							PROPHYLACTIC PLATELET TRANSFUSION; ABO INCOMPATIBILITY; BONE-MARROW; IMPACT; DONOR; REFRACTORINESS; REQUIREMENTS; THRESHOLD; CHILDREN; ANTIGENS	Background: Factors affecting the efficacy of platelet and red blood cell (RBC) transfusion in patients undergoing hematopoietic stem cell transplantation (HSCT) have not been studied extensively. We aimed to evaluate platelet and RBC transfusion efficacy by measuring the platelet corrected count increment and the hemoglobin increment, respectively, 24 h after transfusion in 105 patients who received HSCT. Methodology/Principal Findings: Using retrospective analysis, we studied whether factors, including gender, time of transplantation, the compatibility of ABO group between HSC donors and recipients, and autologous or allogenic transplantation, influence the efficacy of blood component transfusion. We found that the infection rate of HSCT patients positively correlated with the transfusion amount, and the length of stay in the laminar flow room was associated with transfusion. We found that platelet transfusion performed during HSCT showed significantly better efficacy than that performed before HSCT. The effect of platelet transfusion in auto-transplantation was significantly better than that in allotransplantation. The efficacy of RBC transfusion during HSCT was significantly lower than that performed before HSCT. The efficacy of RBC transfusion in auto-transplantation was significantly higher than that in allo-transplantation. Allotransplantation patients who received HSCs from compatible ABO groups showed significantly higher efficacy during both platelet and RBC transfusion. Conclusions: We conclude that the efficacy of platelet and RBC transfusions does not correlate with the gender of patients, while it significantly correlates with the time of transplantation, type of transplantation, and ABO compatibility between HSC donors and recipients. During HSCT, the infection rate of patients positively correlates with the transfusion amount of RBCs and platelets. The total volume of RBC units transfused positively correlates with the length of the patients' stay in the laminar flow room.	[Zhang, Xi; Liu, Yao] Third Mil Med Univ, Dept Hematol, Xinqiao Affiliated Hosp, Chongqing, Peoples R China; [Xiao, Yanni; Ran, Qian; Duan, Qianbi; Duan, Huiling; Ye, Xingde; Li, Zhongjun] Third Mil Med Univ, Dept Blood Transfus, Xinqiao Affiliated Hosp, Chongqing, Peoples R China	Army Medical University; Army Medical University	Zhang, X (corresponding author), Third Mil Med Univ, Dept Hematol, Xinqiao Affiliated Hosp, Chongqing, Peoples R China.	lizhungjun@yahoo.com.cn	Liu, Y/AAK-4063-2021		Third Military Medical University of Chinese PLA [2010XLC26, 2010XLC27]; Natural Science Fund Project of Chongqing (Key Project) [cstc2012jjB10029]	Third Military Medical University of Chinese PLA; Natural Science Fund Project of Chongqing (Key Project)	This work was supported by the Scientific Researching Fund Projects of the Third Military Medical University of Chinese PLA (No. 2010XLC26, No. 2010XLC27) and the Natural Science Fund Project of Chongqing (Key Project, No. cstc2012jjB10029). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar BMAM, 1995, BONE MARROW TRANSPL, V16, P793; Benjamin R J, 1998, Biol Blood Marrow Transplant, V4, P151; BENSON K, 1993, SEMIN ONCOL, V20, P102; Bilgin YM, 2011, NETH J MED, V69, P441; Burt RK, 2008, J AUTOIMMUN, V30, P116, DOI 10.1016/j.jaut.2007.12.010; Canals C, 2004, TRANSFUSION, V44, P1603, DOI 10.1111/j.1537-2995.2004.04106.x; Cognasse F, 2008, BLOOD, V112, P4779, DOI 10.1182/blood-2008-05-157578; Copelan EA, 2006, NEW ENGL J MED, V354, P1813, DOI 10.1056/NEJMra052638; Crudele V, 2011, IMMUNOL LETT, V141, P18, DOI 10.1016/j.imlet.2011.07.004; Gajewski JL, 2008, BLOOD, V112, P3036, DOI 10.1182/blood-2007-10-118372; Gunsilius E, 2001, BIOMED PHARMACOTHER, V55, P186, DOI 10.1016/S0753-3322(01)00051-8; Hod E, 2008, BRIT J HAEMATOL, V142, P348, DOI 10.1111/j.1365-2141.2008.07189.x; Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159; Kanda Y, 2002, BRIT J HAEMATOL, V118, P128, DOI 10.1046/j.1365-2141.2002.03693.x; Lawrence JB, 2001, LEUKEMIA LYMPHOMA, V41, P67, DOI 10.3109/10428190109057955; Li ZJ, 2009, TRANSFUS APHER SCI, V41, P179, DOI 10.1016/j.transci.2009.09.015; Lightdale JR, 2012, BIOL BLOOD MARROW TR, V18, P813, DOI 10.1016/j.bbmt.2011.10.043; Marktel S, 2010, PEDIATR TRANSPLANT, V14, P393, DOI 10.1111/j.1399-3046.2009.01282.x; Milland J, 2006, TISSUE ANTIGENS, V68, P459, DOI 10.1111/j.1399-0039.2006.00721.x; OGASAWARA K, 1993, BLOOD, V82, P993; Pietersz RNI, 2009, TRANSFUS APHER SCI, V41, P115, DOI 10.1016/j.transci.2009.07.003; Rabitsch W, 2003, BONE MARROW TRANSPL, V32, P1015, DOI 10.1038/sj.bmt.1704264; Leal-Noval SR, 2011, TRANSFUSION, V51, P1957, DOI 10.1111/j.1537-2995.2011.03091.x; Rebulla P, 1997, NEW ENGL J MED, V337, P1870, DOI 10.1056/NEJM199712253372602; Rozman P, 2005, TRANSPL IMMUNOL, V14, P159, DOI 10.1016/j.trim.2005.03.005; Schiffer CA, 2001, J CLIN ONCOL, V19, P1519, DOI 10.1200/JCO.2001.19.5.1519; Semple JW, 2011, NAT REV IMMUNOL, V11, P264, DOI 10.1038/nri2956; Slichter Sherrill J, 2007, Hematology Am Soc Hematol Educ Program, P172, DOI 10.1182/asheducation-2007.1.172; Tay J, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-207; Tobias Joseph D, 2003, Pediatr Crit Care Med, V4, P49, DOI 10.1097/00130478-200301000-00009; Tormey CA, 2009, TRANSFUSION, V49, P1242, DOI 10.1111/j.1537-2995.2009.02128.x; Wang ZJ, 2010, BRIT J HAEMATOL, V149, P101, DOI 10.1111/j.1365-2141.2009.08073.x; Weissinger F, 2001, BLOOD, V98, P3584, DOI 10.1182/blood.V98.13.3584; Worel N, 2000, TRANSFUSION, V40, P543, DOI 10.1046/j.1537-2995.2000.40050543.x; Zumberg MS, 2002, BIOL BLOOD MARROW TR, V8, P569, DOI 10.1053/bbmt.2002.v8.pm12434952	35	4	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e36912	10.1371/journal.pone.0036912	http://dx.doi.org/10.1371/journal.pone.0036912			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22701516	gold, Green Submitted, Green Published			2022-12-27	WOS:000305343500036
J	Pittet, F; Coignard, M; Houdelier, C; Richard-Yris, MA; Lumineau, S				Pittet, Florent; Coignard, Maud; Houdelier, Cecilia; Richard-Yris, Marie-Annick; Lumineau, Sophie			Age Affects the Expression of Maternal Care and Subsequent Behavioural Development of Offspring in a Precocial Bird	PLOS ONE			English	Article							LONG-LIVED BIRD; JAPANESE-QUAIL; REPRODUCTIVE EFFORT; EMOTIONAL REACTIVITY; TERMINAL INVESTMENT; PARENTAL EXPERIENCE; COTURNIX-JAPONICA; GENE-EXPRESSION; CALIFORNIA GULL; MOTHERS	Variations of breeding success with age have been studied largely in iteroparous species and particularly in birds: survival of offspring increases with parental age until senescence. Nevertheless, these results are from observations of free-living individuals and therefore, it remains impossible to determine whether these variations result from parental investment or efficiency or both, and whether these variations occur during the prenatal or the postnatal stage or during both. Our study aimed first, to determine whether age had an impact on the expression of maternal breeding care by comparing inexperienced female birds of two different ages, and second, to define how these potential differences impact chicks' growth and behavioural development. We made 22 2-month-old and 22 8-month-old female Japanese quail foster 1-day-old chicks. We observed their maternal behaviour until the chicks were 11 days old and then tested these chicks after separation from their mothers. Several behavioural tests estimated their fearfulness and their sociality. We observed first that a longer induction was required for young females to express maternal behaviour. Subsequently as many young females as elder females expressed maternal behaviour, but young females warmed chicks less, expressed less covering postures and rejected their chicks more. Chicks brooded by elder females presented higher growth rates and more fearfulness and sociality. Our results reveal that maternal investment increased with age independently of maternal experience, suggesting modification of hormone levels implied in maternal behaviour. Isolated effects of maternal experience should now be assessed in females of the same age. In addition, our results show, for first time in birds, that variations in maternal care directly induce important differences in the behavioural development of chicks. Finally, our results confirm that Japanese quail remains a great laboratory model of avian maternal behaviour and that the way we sample maternal behaviour is highly productive.	[Pittet, Florent; Coignard, Maud; Houdelier, Cecilia; Richard-Yris, Marie-Annick; Lumineau, Sophie] Univ Rennes 1, UMR Ethol Anim & Humaine 6552, CNRS, Rennes, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Rennes	Pittet, F (corresponding author), Univ Rennes 1, UMR Ethol Anim & Humaine 6552, CNRS, Rennes, France.	florent.pittet@univ-rennes1.fr	Pittet, Florent/Q-2100-2015	Lumineau, Sophie/0000-0002-2076-9947	CNRS, the French Ministry of Research	CNRS, the French Ministry of Research(Centre National de la Recherche Scientifique (CNRS))	This work was supported by grants from the CNRS, the French Ministry of Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER G, 1993, AUST J EXP AGR, V33, P721, DOI 10.1071/EA9930721; Angelier F, 2007, BEHAV ECOL SOCIOBIOL, V61, P611, DOI 10.1007/s00265-006-0290-1; Angelier F, 2006, GEN COMP ENDOCR, V149, P1, DOI 10.1016/j.ygcen.2006.04.006; Archer J, 1976, PERSPECTIVES ETHOLOG, P231; Avery ML, 1996, ANIM BEHAV, V51, P1279, DOI 10.1006/anbe.1996.0132; Beamonte-Barrientos R, 2010, AM NAT, V175, P469, DOI 10.1086/650726; Bertin A, 2005, J EXP ZOOL PART A, V303A, P792, DOI 10.1002/jez.a.202; Bertin A, 2004, APPL ANIM BEHAV SCI, V89, P215, DOI 10.1016/j.applanim.2004.06.004; Boguszewski P, 2002, BEHAV BRAIN RES, V133, P323, DOI 10.1016/S0166-4328(02)00018-9; Boos M, 2007, BEHAV PROCESS, V76, P206, DOI 10.1016/j.beproc.2007.05.003; Cameron EZ, 2000, BEHAV ECOL SOCIOBIOL, V47, P243, DOI 10.1007/s002650050661; Cameron NM, 2005, NEUROSCI BIOBEHAV R, V29, P843, DOI 10.1016/j.neubiorev.2005.03.022; Chiu SF, 1996, J GERONTOL A-BIOL, V51, pB220, DOI 10.1093/gerona/51A.3.B220; Clarke JA, 2010, ANIM BEHAV, V79, P25, DOI 10.1016/j.anbehav.2009.09.021; CLUTTONBROCK TH, 1984, AM NAT, V123, P212, DOI 10.1086/284198; Cote SD, 2001, ANIM BEHAV, V62, P173, DOI 10.1006/anbe.2001.1719; CURIO E, 1983, IBIS, V125, P400, DOI 10.1111/j.1474-919X.1983.tb03130.x; Forkman B, 2007, PHYSIOL BEHAV, V92, P340, DOI 10.1016/j.physbeh.2007.03.016; Formanek L, 2008, ETHOLOGY, V114, P817, DOI 10.1111/j.1439-0310.2008.01536.x; FORSLUND P, 1995, TRENDS ECOL EVOL, V10, P374, DOI 10.1016/S0169-5347(00)89141-7; Green WCH, 1990, BEHAV ECOL, V1, P148, DOI 10.1093/beheco/1.2.148; Guibert F, 2012, PHYSIOL BEHAV, V105, P242, DOI 10.1016/j.physbeh.2011.08.009; Hoffman CL, 2010, BEHAV ECOL, V21, P972, DOI 10.1093/beheco/arq098; Holmes WG, 1998, ANIM BEHAV, V55, P1555, DOI 10.1006/anbe.1997.0700; JONES RB, 1986, WORLD POULTRY SCI J, V42, P82, DOI 10.1079/WPS19860008; JONES RB, 1983, BEHAV PROCESS, V8, P243; Krijgsveld KL, 2003, PHYSIOL BEHAV, V79, P311, DOI 10.1016/S0031-9384(03)00117-3; Krpan KM, 2005, HORM BEHAV, V47, P112, DOI 10.1016/j.yhbeh.2004.08.006; LEVINE L, 1985, PEDIATRICS, V75, P23; Mauck RA, 2004, EVOLUTION, V58, P880, DOI 10.1554/03-147; Meaney MJ, 2001, NEUROSCIENCE, V24; MILLS A D, 1990, Medical Science Research, V18, P179; Mills AD, 1997, NEUROSCI BIOBEHAV R, V21, P261, DOI 10.1016/S0149-7634(96)00028-0; Moretti M, 2011, PHYSIOL BEHAV, V102, P115, DOI 10.1016/j.physbeh.2010.09.019; ORCUTT FS, 1976, AUK, V93, P135; Pflanz T, 2002, ANIM BEHAV, V63, P613, DOI 10.1006/anbe.2001.1930; PIANKA ER, 1975, AM NAT, V109, P453, DOI 10.1086/283013; PUGESEK BH, 1995, ANIM BEHAV, V49, P641; PUGESEK BH, 1983, BEHAV ECOL SOCIOBIOL, V13, P161, DOI 10.1007/BF00299919; Richard-Yris M. A., 1994, COMPORTEMENT ADAPTAT, P61; Richard-Yris MA, 2005, DEV PSYCHOBIOL, V46, P1, DOI 10.1002/dev.20040; RICHARDYRIS MA, 1988, BEHAVIOUR, V104, P126, DOI 10.1163/156853988X00638; Ruscio MG, 2004, HORM BEHAV, V46, P19, DOI 10.1016/j.yhbeh.2004.02.002; Salchner P, 2004, BEHAV BRAIN RES, V151, P1, DOI 10.1016/j.bbr.2003.07.002; Schino G, 2001, DEV PSYCHOBIOL, V38, P186, DOI 10.1002/dev.1012; Simpson MJA, 1985, PRIMATES, V26, P57; TENCATE C, 1989, ETHOLOGY, V82, P287; THORNHILL R, 1989, ETHOLOGY, V83, P31, DOI 10.1111/j.1439-0310.1989.tb00517.x; Wauters AM, 2002, DEV PSYCHOBIOL, V41, P25, DOI 10.1002/dev.10042; Wyss JM, 2000, NEUROBIOL AGING, V21, P671, DOI 10.1016/S0197-4580(00)00132-9	50	23	23	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e36835	10.1371/journal.pone.0036835	http://dx.doi.org/10.1371/journal.pone.0036835			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TW	22701515	Green Published, gold, Green Submitted			2022-12-27	WOS:000305338200048
J	Bouvier, T; Venail, P; Pommier, T; Bouvier, C; Barbera, C; Mouquet, N				Bouvier, Thierry; Venail, Patrick; Pommier, Thomas; Bouvier, Corinne; Barbera, Claire; Mouquet, Nicolas			Contrasted Effects of Diversity and Immigration on Ecological Insurance in Marine Bacterioplankton Communities	PLOS ONE			English	Article							GRADIENT GEL-ELECTROPHORESIS; 16S RIBOSOMAL-RNA; BACTERIAL COMMUNITIES; FRESH-WATER; BIODIVERSITY; STABILITY; METACOMMUNITIES; DISPERSAL; PREDICTABILITY; PRODUCTIVITY	The ecological insurance hypothesis predicts a positive effect of species richness on ecosystem functioning in a variable environment. This effect stems from temporal and spatial complementarity among species within metacommunities coupled with optimal levels of dispersal. Despite its importance in the context of global change by human activities, empirical evidence for ecological insurance remains scarce and controversial. Here we use natural aquatic bacterial communities to explore some of the predictions of the spatial and temporal aspects of the ecological insurance hypothesis. Addressing ecological insurance with bacterioplankton is of strong relevance given their central role in fundamental ecosystem processes. Our experimental set up consisted of water and bacterioplankton communities from two contrasting coastal lagoons. In order to mimic environmental fluctuations, the bacterioplankton community from one lagoon was successively transferred between tanks containing water from each of the two lagoons. We manipulated initial bacterial diversity for experimental communities and immigration during the experiment. We found that the abundance and production of bacterioplankton communities was higher and more stable (lower temporal variance) for treatments with high initial bacterial diversity. Immigration was only marginally beneficial to bacterial communities, probably because microbial communities operate at different time scales compared to the frequency of perturbation selected in this study, and of their intrinsic high physiologic plasticity. Such local "physiological insurance" may have a strong significance for the maintenance of bacterial abundance and production in the face of environmental perturbations.	[Bouvier, Thierry; Pommier, Thomas; Bouvier, Corinne] Univ Montpellier 2, Lab Ecol Syst Marins Cotiers ECOSYM, CNRS IRD IFREMER, UMR5119, Montpellier, France; [Venail, Patrick; Barbera, Claire; Mouquet, Nicolas] Univ Montpellier 2, Inst Sci Evolut ISEM, CNRS, UMR 5554, Montpellier, France; [Venail, Patrick] Univ Michigan, Sch Nat Resources & Environm, Ann Arbor, MI 48109 USA; [Pommier, Thomas] Univ Lyon 1, UMR Ecol Microbienne CNRS 5557, USC INRA 1193, F-69622 Villeurbanne, France	Ifremer; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; University of Michigan System; University of Michigan; INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Bouvier, T (corresponding author), Univ Montpellier 2, Lab Ecol Syst Marins Cotiers ECOSYM, CNRS IRD IFREMER, UMR5119, Pl E Bataillon, Montpellier, France.	thierry.bouvier@univ-montp2.fr	Venail, Patrick/D-2968-2018; Pommier, Thomas/AAR-1115-2021; Bouvier, Thierry/A-1895-2013; MOUQUET, Nicolas/AAL-1440-2021	Venail, Patrick/0000-0003-1126-280X; Pommier, Thomas/0000-0003-2986-5326; Mouquet, Nicolas/0000-0003-1840-6984; bouvier, thierry/0000-0002-7151-5680	French grant ANR [BACH-09-JCJC-0110-01]; fellowship within the postdoctoral program of the French National Center for Scientific Research (CNRS)	French grant ANR(French National Research Agency (ANR)); fellowship within the postdoctoral program of the French National Center for Scientific Research (CNRS)	Research funding was provided by the French grant ANR # BACH-09-JCJC-0110-01 (to NM and TB). TP was supported by a fellowship within the postdoctoral program of the French National Center for Scientific Research (CNRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amann R, 2008, NAT REV MICROBIOL, V6, P339, DOI 10.1038/nrmicro1888; Azam F, 2007, NAT REV MICROBIOL, V5, P782, DOI 10.1038/nrmicro1747; Baas-Becking L.G.M., 1934, GEOBIOLOGIE INLEIDIN, P263; Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Bec B, 2011, AQUAT MICROB ECOL, V63, P29, DOI 10.3354/ame01480; Bernhard AE, 2005, FEMS MICROBIOL ECOL, V52, P115, DOI 10.1016/j.femsec.2004.10.016; Boles BR, 2004, P NATL ACAD SCI USA, V101, P16630, DOI 10.1073/pnas.0407460101; Bostrom KH, 2004, LIMNOL OCEANOGR-METH, V2, P365, DOI 10.4319/lom.2004.2.365; Bowen JL, 2011, ISME J, V5, P1540, DOI 10.1038/ismej.2011.22; Campbell V, 2011, OIKOS, V120, P399, DOI 10.1111/j.1600-0706.2010.18768.x; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; Cardinale BJ, 2011, NATURE, V472, P86, DOI 10.1038/nature09904; Cissoko M, 2008, FRESHWATER BIOL, V53, P1154, DOI 10.1111/j.1365-2427.2007.01930.x; Cottingham KL, 2001, ECOL LETT, V4, P72, DOI 10.1046/j.1461-0248.2001.00189.x; Covert JS, 2001, AQUAT MICROB ECOL, V25, P127, DOI 10.3354/ame025127; de Wit R, 2006, ENVIRON MICROBIOL, V8, P755, DOI 10.1111/j.1462-2920.2006.01017.x; Forrest J, 2007, ECOSCIENCE, V14, P137, DOI 10.2980/1195-6860(2007)14[137:VAPIAZ]2.0.CO;2; France KE, 2006, NATURE, V441, P1139, DOI 10.1038/nature04729; Gasol JM, 2002, LIMNOL OCEANOGR, V47, P62, DOI 10.4319/lo.2002.47.1.0062; Gasol JM, 2000, SCI MAR, V64, P197, DOI 10.3989/scimar.2000.64n2197; Girvan MS, 2005, ENVIRON MICROBIOL, V7, P301, DOI 10.1111/j.1462-2920.2005.00695.x; Hector A, 2010, ECOLOGY, V91, P2213, DOI 10.1890/09-1162.1; Howeth JG, 2010, ECOLOGY, V91, P2727, DOI 10.1890/09-1004.1; Jiang L, 2009, AM NAT, V174, P651, DOI 10.1086/605961; Kaiser E, 1997, APPL ENVIRON MICROB, V63, P4026, DOI 10.1128/AEM.63.10.4026-4031.1997; Kettler GC, 2007, PLOS GENET, V3, P2515, DOI 10.1371/journal.pgen.0030231; Kirchman D.L., 2008, MICROBIAL ECOLOGY OC, Vsecond; Langenheder S, 2005, LIMNOL OCEANOGR, V50, P957, DOI 10.4319/lo.2005.50.3.0957; Langenheder S, 2007, ECOLOGY, V88, P2154, DOI 10.1890/06-2098.1; Lavik G, 2009, NATURE, V457, P581, DOI 10.1038/nature07588; Leary DJ, 2009, J ANIM ECOL, V78, P1143, DOI 10.1111/j.1365-2656.2009.01586.x; Lehman CL, 2000, AM NAT, V156, P534, DOI 10.1086/303402; Leibold MA, 2004, LIMNOL OCEANOGR, V49, P1278, DOI 10.4319/lo.2004.49.4_part_2.1278; Lindstrom ES, 2011, PLOS ONE, DOI [10.1371/journal.-pone.0025883, DOI 10.1371/JOURNAL.-PONE.0025883]; Logue JB, 2011, TRENDS ECOL EVOL, V26, P482, DOI 10.1016/j.tree.2011.04.009; Logue Jurg Brendan, 2008, Freshwater Reviews, V1, P99, DOI 10.1608/FRJ-1.1.9; Loreau M, 2003, P NATL ACAD SCI USA, V100, P12765, DOI 10.1073/pnas.2235465100; Martiny JBH, 2006, NAT REV MICROBIOL, V4, P102, DOI 10.1038/nrmicro1341; McGradySteed J, 1997, NATURE, V390, P162, DOI 10.1038/36561; MORITA RY, 1982, ADV MICROB ECOL, V6, P171; Muyzer G, 1998, ANTON LEEUW INT J G, V73, P127, DOI 10.1023/A:1000669317571; Ovreas L, 1997, APPL ENVIRON MICROB, V63, P3367; PAINCHAUD J, 1995, APPL ENVIRON MICROB, V61, P205, DOI 10.1128/AEM.61.1.205-208.1995; Peter H, 2011, ISME J, V5, P351, DOI 10.1038/ismej.2010.119; Pommier T, 2007, MOL ECOL, V16, P867, DOI 10.1111/j.1365-294X.2006.03189.x; Reche I, 2005, ECOLOGY, V86, P1715, DOI 10.1890/04-1587; Reed HE, 2007, FEMS MICROBIOL ECOL, V62, P161, DOI 10.1111/j.1574-6941.2007.00386.x; Reinthaler T, 2005, APPL ENVIRON MICROB, V71, P2260, DOI 10.1128/AEM.71.5.2260-2266.2005; Shade A, 2011, ENVIRON MICROBIOL, V13, P2752, DOI 10.1111/j.1462-2920.2011.02546.x; Sloan WT, 2006, ENVIRON MICROBIOL, V8, P732, DOI 10.1111/j.1462-2920.2005.00956.x; Smith David C., 1992, Marine Microbial Food Webs, V6, P107; Steiner CF, 2011, AM NAT, V178, P159, DOI 10.1086/660835; VASCONCELOS GJ, 1976, APPL ENVIRON MICROB, V31, P913, DOI 10.1128/AEM.31.6.913-920.1976; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Yachi S, 1999, P NATL ACAD SCI USA, V96, P1463, DOI 10.1073/pnas.96.4.1463; YENTSCH CS, 1963, DEEP-SEA RES, V10, P221, DOI 10.1016/0011-7471(63)90358-9	56	12	12	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2012	7	6							e37620	10.1371/journal.pone.0037620	http://dx.doi.org/10.1371/journal.pone.0037620			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UJ	22701572	Green Published, Green Submitted, gold			2022-12-27	WOS:000305340000004
J	Tomlinson, DC; Baxter, EW; Loadman, PM; Hull, MA; Knowles, MA				Tomlinson, Darren C.; Baxter, Euan W.; Loadman, Paul M.; Hull, Mark A.; Knowles, Margaret A.			FGFR1-Induced Epithelial to Mesenchymal Transition through MAPK/PLC gamma/COX-2-Mediated Mechanisms	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; PHOSPHOLIPASE-C-GAMMA; RAT BLADDER-CARCINOMA; CELL CARCINOMA; URINARY-BLADDER; CYCLOOXYGENASE-2 EXPRESSION; TUMOR PROGRESSION; DEPENDENT MECHANISM; CANCER CELLS; PPAR-GAMMA	Tumour invasion and metastasis is the most common cause of death from cancer. For epithelial cells to invade surrounding tissues and metastasise, an epithelial-mesenchymal transition (EMT) is required. We have demonstrated that FGFR1 expression is increased in bladder cancer and that activation of FGFR1 induces an EMT in urothelial carcinoma (UC) cell lines. Here, we created an in vitro FGFR1-inducible model of EMT, and used this model to identify regulators of urothelial EMT. FGFR1 activation promoted EMT over a period of 72 hours. Initially a rapid increase in actin stress fibres occurred, followed by an increase in cell size, altered morphology and increased migration and invasion. By using site-directed mutagenesis and small molecule inhibitors we demonstrated that combined activation of the mitogen activated protein kinase (MAPK) and phospholipase C gamma (PLC gamma) pathways regulated this EMT. Actin stress fibre formation was regulated by PLC gamma activation, and was also important for the increase in cell size, migration and altered morphology. MAPK activation regulated migration and E-cadherin expression, indicating that combined activation of PLC gamma and MAPK is required for a full EMT. We used expression microarrays to assess changes in gene expression downstream of these signalling cascades. COX-2 was transcriptionally upregulated by FGFR1 and caused increased intracellular prostaglandin E-2 levels, which promoted migration. In conclusion, we have demonstrated that FGFR1 activation in UC cells lines promotes EMT via coordinated activation of multiple signalling pathways and by promoting activation of prostaglandin synthesis.	[Tomlinson, Darren C.; Baxter, Euan W.; Knowles, Margaret A.] St James Univ Hosp, Sect Expt Oncol, Leeds Inst Mol Med, Leeds, W Yorkshire, England; [Loadman, Paul M.] Univ Bradford, Inst Canc Therapeut, Bradford BD7 1DP, W Yorkshire, England; [Hull, Mark A.] St James Univ Hosp, Sect Mol Gastroenterol, Leeds Inst Mol Med, Leeds, W Yorkshire, England	Saint James's University Hospital; University of Leeds; University of Bradford; Saint James's University Hospital; University of Leeds	Tomlinson, DC (corresponding author), St James Univ Hosp, Sect Expt Oncol, Leeds Inst Mol Med, Leeds, W Yorkshire, England.	m.a.knowles@leeds.ac.uk		Tomlinson, Darren/0000-0003-4134-7484; Loadman, Paul/0000-0002-4259-8616; Knowles, Margaret/0000-0002-9363-8657	Yorkshire Cancer Research [L346]; Cancer Research UK [C6228/A5437]; Medical Research Council [G116/146] Funding Source: researchfish; MRC [G116/146] Funding Source: UKRI	Yorkshire Cancer Research; Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by grants from Yorkshire Cancer Research (L346) and Cancer Research UK (C6228/A5437). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo VD, 2007, CANCER CELL, V12, P559, DOI 10.1016/j.ccr.2007.11.004; ARTEAGA CL, 1991, P NATL ACAD SCI USA, V88, P10435, DOI 10.1073/pnas.88.23.10435; Bakin AV, 2000, J BIOL CHEM, V275, P36803, DOI 10.1074/jbc.M005912200; Bakin AV, 2002, J CELL SCI, V115, P3193; Bernard-Pierrot I, 2006, CARCINOGENESIS, V27, P740, DOI 10.1093/carcin/bgi290; Bhowmick NA, 2001, MOL BIOL CELL, V12, P27, DOI 10.1091/mbc.12.1.27; BOYER B, 1993, J CELL BIOL, V120, P767, DOI 10.1083/jcb.120.3.767; Cappellen D, 1999, NAT GENET, V23, P18, DOI 10.1038/12615; Carpenter G, 1999, EXP CELL RES, V253, P15, DOI 10.1006/excr.1999.4671; Chapman EJ, 2006, ONCOGENE, V25, P5037, DOI 10.1038/sj.onc.1209513; Chen LF, 2007, DEV CELL, V12, P603, DOI 10.1016/j.devcel.2007.03.005; Ciruna B, 2001, DEV CELL, V1, P37, DOI 10.1016/S1534-5807(01)00017-X; CLYMAN RI, 1994, CELL ADHES COMMUN, V1, P333, DOI 10.3109/15419069409097264; di Martino E, 2009, ONCOGENE, V28, P4306, DOI 10.1038/onc.2009.280; Ellenrieder V, 2001, CANCER RES, V61, P4222; Gotzmann J, 2004, MUTAT RES-REV MUTAT, V566, P9, DOI 10.1016/S1383-5742(03)00033-4; Gotzmann J, 2002, J CELL SCI, V115, P1189; Grunert S, 2003, NAT REV MOL CELL BIO, V4, P657, DOI 10.1038/nrm1175; Inoue H, 2000, J BIOL CHEM, V275, P28028; Janda E, 2002, J CELL BIOL, V156, P299, DOI 10.1083/jcb.200109037; Jang TJ, 2010, VIRCHOWS ARCH, V457, P319, DOI 10.1007/s00428-010-0943-3; Jouanneau J, 1999, ONCOGENE, V18, P327, DOI 10.1038/sj.onc.1202285; Knowles MA, 2006, CARCINOGENESIS, V27, P361, DOI 10.1093/carcin/bgi310; Kolsch V, 2008, J CELL SCI, V121, P551, DOI 10.1242/jcs.023333; Komhoff M, 2000, AM J PATHOL, V157, P29, DOI 10.1016/S0002-9440(10)64513-0; Mbonye UR, 2009, BMB REP, V42, P552, DOI 10.5483/BMBRep.2009.42.9.552; MIETTINEN PJ, 1994, J CELL BIOL, V127, P2021, DOI 10.1083/jcb.127.6.2021; MOHAMMADI M, 1992, NATURE, V358, P681, DOI 10.1038/358681a0; Munro NP, 2003, J UROLOGY, V169, P675, DOI 10.1016/S0022-5347(05)63991-2; NOMOTO K, 1995, MOL CARCINOGEN, V12, P146, DOI 10.1002/mc.2940120306; Oft M, 1996, GENE DEV, V10, P2462, DOI 10.1101/gad.10.19.2462; OTOOLE C, 1978, BRIT J CANCER, V38, P64, DOI 10.1038/bjc.1978.164; Piek E, 1999, J CELL SCI, V112, P4557; Price JT, 1999, CANCER RES, V59, P5475; Qing J, 2009, J CLIN INVEST, V119, P1216, DOI 10.1172/JCI38017; Ristimaki A, 2001, AM J PATHOL, V158, P849, DOI 10.1016/S0002-9440(10)64033-3; Sarkar S, 2000, CANCER RES, V60, P3862; Savagner P, 1997, J CELL BIOL, V137, P1403, DOI 10.1083/jcb.137.6.1403; Shirahama T, 2001, CANCER, V92, P188, DOI 10.1002/1097-0142(20010701)92:1<188::AID-CNCR1308>3.0.CO;2-W; Shirahama T, 2000, CLIN CANCER RES, V6, P2424; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Thiery JP, 1999, CANCER METAST REV, V18, P31, DOI 10.1023/A:1006256219004; Thomas SM, 2003, CANCER RES, V63, P5629; Tomlinson DC, 2007, J PATHOL, V213, P91, DOI 10.1002/path.2207; Tomlinson DC, 2010, AM J PATHOL, V177, P2379, DOI 10.2353/ajpath.2010.100354; Tomlinson DC, 2009, CANCER RES, V69, P4613, DOI 10.1158/0008-5472.CAN-08-2816; Turner T, 1996, CLIN EXP METASTAS, V14, P409, DOI 10.1007/BF00123400; Varley CL, 2004, J CELL SCI, V117, P2029, DOI 10.1242/jcs.01042; Wild PJ, 2005, INT J ONCOL, V27, P385; WILLIAMS RD, 1980, INVEST UROL, V17, P359; Wu XR, 2005, NAT REV CANCER, V5, P713, DOI 10.1038/nrc1697; Xian W, 2005, J CELL BIOL, V171, P663, DOI 10.1083/jcb.200505098; Yang WL, 2001, CARCINOGENESIS, V22, P1379, DOI 10.1093/carcin/22.9.1379; Yang YN, 2006, CANCER RES, V66, P8617, DOI 10.1158/0008-5472.CAN-06-1308; Yeager TR, 1998, GENE DEV, V12, P163, DOI 10.1101/gad.12.2.163; Zuo W, 2009, MOL BIOL CELL, V20, P1020, DOI 10.1091/mbc.E08-09-0898	58	63	69	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2012	7	6							e38972	10.1371/journal.pone.0038972	http://dx.doi.org/10.1371/journal.pone.0038972			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UJ	22701738	Green Published, Green Submitted, gold			2022-12-27	WOS:000305340000058
J	Yue, GH; Xia, JH; Liu, F; Lin, GC				Yue, Gen Hua; Xia, Jun Hong; Liu, Feng; Lin, Grace			Evidence for Female-Biased Dispersal in the Protandrous Hermaphroditic Asian Seabass, Lates calcarifer	PLOS ONE			English	Article							EARLY LIFE-HISTORY; INBREEDING AVOIDANCE; POPULATION-STRUCTURE; GENETIC-STRUCTURE; NATAL DISPERSAL; BARRAMUNDI; BLOCH; EVOLUTION; DIFFERENTIATION; MIGRATION	Movement of individuals influences individual reproductive success, fitness, genetic diversity and relationships among individuals within populations and gene exchange among populations. Competition between males or females for mating opportunities and/or local resources predicts a female bias in taxa with monogamous mating systems and a male-biased dispersal in polygynous species. In birds and mammals, the patterns of dispersal between sexes are well explored, while dispersal patterns in protandrous hermaphroditic fish species have not been studied. We collected 549 adult individuals of Asian seabass (Lates calcarifer) from four locations in the South China Sea. To assess the difference in patterns of dispersal between sexes, we genotyped all individuals with 18 microsatellites. Significant genetic differentiation was detected among and within sampling locations. The parameters of population structure (F-ST), relatedness (r) and the mean assignment index (mAIC), in combination with data on tagging-recapture, supplied strong evidences for female-biased dispersal in the Asian seabass. This result contradicts our initial hypothesis of no sex difference in dispersal. We suggest that inbreeding avoidance of females, female mate choice under the condition of low mate competition among males, and male resource competition create a female-biased dispersal. The bigger body size of females may be a cause of the female-biased movement. Studies of dispersal using data from DNA markers and tagging-recapture in hermaphroditic fish species could enhance our understanding of patterns of dispersal in fish.	[Yue, Gen Hua; Xia, Jun Hong; Liu, Feng; Lin, Grace] Natl Univ Singapore, Mol Populat Genet Grp, Temasek Life Sci Lab, Singapore 117548, Singapore	National University of Singapore	Yue, GH (corresponding author), Natl Univ Singapore, Mol Populat Genet Grp, Temasek Life Sci Lab, Singapore 117548, Singapore.	genhua@tll.org.sg	Yue, GH/F-4801-2015	Yue, GH/0000-0002-3537-2248	National Research Foundation of Singapore	National Research Foundation of Singapore(National Research Foundation, Singapore)	This research is funded by the National Research Foundation of Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews AH, 1999, CAN J FISH AQUAT SCI, V56, P1339, DOI 10.1139/cjfas-56-8-1339; Austin JD, 2003, MOL ECOL, V12, P3165, DOI 10.1046/j.1365-294X.2003.01948.x; Avise J, 2004, MOL MARKERS NATURAL; Avise JC, 2009, SEX DEV, V3, P152, DOI 10.1159/000223079; Berg EC, 2009, MOL ECOL, V18, P3486, DOI 10.1111/j.1365-294X.2009.04284.x; Bird C, 1992, TRIAL BARRAMUNDI TRA; Blaber SJM, 2009, DEV EARTH ENV SCI, V9, P411, DOI 10.1016/S1571-9197(08)00411-4; Cano JM, 2008, MOL ECOL, V17, P3234, DOI 10.1111/j.1365-294X.2008.03837.x; CHARNOV E L, 1982; Chenoweth SF, 1998, HEREDITY, V80, P187, DOI 10.1046/j.1365-2540.1998.00292.x; Chopelet J, 2009, FISH FISH, V10, P329, DOI 10.1111/j.1467-2979.2009.00329.x; Clutton-Brock T, 2010, TRENDS ECOL EVOL, V25, P562, DOI 10.1016/j.tree.2010.08.002; Costello CM, 2008, MOL ECOL, V17, P4713, DOI 10.1111/j.1365-294X.2008.03930.x; Croft DP, 2003, OECOLOGIA, V137, P62, DOI 10.1007/s00442-003-1268-6; DAVIS TLO, 1986, FISH RES, V4, P243, DOI 10.1016/0165-7836(86)90006-8; DAVIS TLO, 1982, AUST J MAR FRESH RES, V33, P529; De Meester N, 2010, BEHAV ECOL, V21, P992, DOI 10.1093/beheco/arq088; Devlin RH, 2002, AQUACULTURE, V208, P191, DOI 10.1016/S0044-8486(02)00057-1; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Favre L, 1997, P ROY SOC B-BIOL SCI, V264, P127, DOI 10.1098/rspb.1997.0019; Fishbase, 2011, FISHBASE GLOB INF SY; GARCIA LMB, 1992, J FISH BIOL, V40, P359, DOI 10.1111/j.1095-8649.1992.tb02583.x; Goudet J, 2002, MOL ECOL, V11, P1103, DOI 10.1046/j.1365-294X.2002.01496.x; Goudet J., 2002, FSTAT PROGRAM ESTIMA; GREENWOOD PJ, 1980, ANIM BEHAV, V28, P1140, DOI 10.1016/S0003-3472(80)80103-5; Handley LJL, 2007, MOL ECOL, V16, P1559, DOI 10.1111/j.1365-294X.2006.03152.x; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Hutchings JA, 2002, P ROY SOC B-BIOL SCI, V269, P2487, DOI 10.1098/rspb.2002.2176; Itaya K, 2006, HOKKAIDO FISHERIES S, V70, P89; Ito M, 2008, MARINE FISHERIES STO, P774; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Johns R, 2010, OECOLOGIA, V163, P935, DOI 10.1007/s00442-010-1632-2; JOHNSON ML, 1990, ANNU REV ECOL SYST, V21, P449, DOI 10.1146/annurev.ecolsys.21.1.449; JONSSON B, 1993, REV FISH BIOL FISHER, V3, P348, DOI 10.1007/BF00043384; KEENAN CP, 1994, AUST J MAR FRESH RES, V45, P1123, DOI 10.1071/MF9941123; KLIMLEY AP, 1987, ENVIRON BIOL FISH, V18, P27, DOI 10.1007/BF00002325; Knight ME, 1999, MOL ECOL, V8, P1521, DOI 10.1046/j.1365-294x.1999.00740.x; Koizumi I, 2006, J FISH BIOL, V68, P1513, DOI 10.1111/j.0022-1112.2006.001038.x; Lebigre C, 2010, MOL ECOL, V19, P1929, DOI 10.1111/j.1365-294X.2010.04614.x; Lewis P, 2000, GENETIC DATA ANAL GD; Long ES, 2008, BEHAV ECOL, V19, P1235, DOI 10.1093/beheco/arn082; Mank JE, 2009, SEX DEV, V3, P60, DOI 10.1159/000223071; Mc Dougall A, 2004, FISH RES, V67, P129, DOI 10.1016/j.fishres.2003.09.044; McCulloch M, 2005, MAR FRESHWATER RES, V56, P637, DOI 10.1071/MF04184; Milton DA, 2005, MAR ECOL PROG SER, V301, P279, DOI 10.3354/meps301279; MOORE R, 1982, AUST J MAR FRESH RES, V33, P647; MOORE R, 1979, AUST J MAR FRESH RES, V30, P803, DOI 10.1071/MF9790803; MOORE R, 1982, AUST J MAR FRESH RES, V33, P671, DOI 10.1071/MF9820671; Morita SH, 2012, ENVIRON BIOL FISH, V94, P505, DOI 10.1007/s10641-010-9613-1; Perrin N, 1999, AM NAT, V154, P282, DOI 10.1086/303236; Perrin N, 2000, AM NAT, V155, P116, DOI 10.1086/303296; Pritchard JK, 2000, GENETICS, V155, P945; Pritchard JK, 2010, STRUCTURE 2 3 3; PUSEY AE, 1987, TRENDS ECOL EVOL, V2, P295, DOI 10.1016/0169-5347(87)90081-4; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.2307/2409206; Randall DA, 2007, BEHAV ECOL, V18, P579, DOI 10.1093/beheco/arm010; Roff Derek, 2002, pi; ROSS RM, 1990, ENVIRON BIOL FISH, V29, P81, DOI 10.1007/BF00005025; RUSSELL DJ, 1988, AUST J MAR FRESH RES, V39, P117; RUSSELL DJ, 1985, AUST J MAR FRESH RES, V36, P191, DOI 10.1071/MF9850191; SALINI J, 1988, AUST J MAR FRESH RES, V39, P317, DOI 10.1071/MF9880317; SHAKLEE JB, 1993, T AM FISH SOC, V122, P685, DOI 10.1577/1548-8659(1993)122&lt;0685:ECOMGS&gt;2.3.CO;2; SHAPIRO DY, 1987, BIOSCIENCE, V37, P490, DOI 10.2307/1310421; Stiver KA, 2007, MOL ECOL, V16, P2974, DOI 10.1111/j.1365-294X.2007.03350.x; Tamate T, 2004, ECOL FRESHW FISH, V13, P96, DOI 10.1111/j.1600-0633.2004.00043.x; Ulrich Y, 2009, MOL ECOL, V18, P1791, DOI 10.1111/j.1365-294X.2009.04154.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Wahlund S, 1928, HEREDITAS, V11, P65, DOI 10.1111/j.1601-5223.1928.tb02483.x; Wang CM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-174; Waples RS, 1998, J HERED, V89, P438, DOI 10.1093/jhered/89.5.438; WARD RD, 1994, J FISH BIOL, V44, P213, DOI 10.1111/j.1095-8649.1994.tb01200.x; WARNER RR, 1988, ENVIRON BIOL FISH, V22, P81, DOI 10.1007/BF00001539; WAUTERS L, 1994, BEHAV ECOL SOCIOBIOL, V34, P197, DOI 10.1007/s002650050033; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Williams DA, 2007, ETHOLOGY, V113, P534, DOI 10.1111/j.1439-0310.2007.01353.x; Yue GH, 2005, ELECTROPHORESIS, V26, P3081, DOI 10.1002/elps.200410411; Yue GH, 2002, MAR BIOTECHNOL, V4, P503, DOI 10.1007/s10126-002-0037-6; Zhu ZY, 2010, ANIM GENET, V41, P208, DOI 10.1111/j.1365-2052.2009.01973.x	80	14	14	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2012	7	6							e37976	10.1371/journal.pone.0037976	http://dx.doi.org/10.1371/journal.pone.0037976			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UJ	22701591	Green Published, gold, Green Submitted			2022-12-27	WOS:000305340000007
J	Svensson, L; Stanley, P; Willenbrock, F; Hogg, N				Svensson, Lena; Stanley, Paula; Willenbrock, Frances; Hogg, Nancy			The G alpha q/11 Proteins Contribute to T Lymphocyte Migration by Promoting Turnover of Integrin LFA-1 through Recycling	PLOS ONE			English	Article							PLASMA-MEMBRANE; RAP1-INDUCED ADHESION; ALPHA-SUBUNITS; UP-REGULATION; CELL; ACTIVATION; RAPL; STIMULATION; TRAFFICKING; NEUTROPHILS	The role of G alpha i proteins coupled to chemokine receptors in directed migration of immune cells is well understood. In this study we show that the separate class of G alpha q/11 proteins is required for the underlying ability of T cells to migrate both randomly and in a directed chemokine-dependent manner. Interfering with G alpha q or G alpha 11 using dominant negative cDNA constructs or siRNA for G alpha q causes accumulation of LFA-1 adhesions and stalled migration. G alpha q/11 has an impact on LFA-1 expression at plasma membrane level and also on its internalization. Additionally G alpha q co-localizes with LFA-1- and EEA1-expressing intracellular vesicles and partially with Rap1- but not Rab11-expressing vesicles. However the influence of G alpha q is not confined to the vesicles that express it, as its reduction alters intracellular trafficking of other vesicles involved in recycling. In summary vesicle-associated G alpha q/11 is required for the turnover of LFA-1 adhesion that is necessary for migration. These G proteins participate directly in the initial phase of recycling and this has an impact on later stages of the endo-exocytic pathway.	[Svensson, Lena; Stanley, Paula; Willenbrock, Frances; Hogg, Nancy] Canc Res UK London Res Inst, Leukocyte Adhes Lab, London, England	Cancer Research UK	Svensson, L (corresponding author), Lund Univ, Immunol Sect, Dept Expt Med Sci, Lund, Sweden.	nancy.hogg@cancer.org.uk			Cancer Research UK; EC Marie Curie Fellowship; Career Re-entry Fellowship from the Wellcome Trust	Cancer Research UK(Cancer Research UK); EC Marie Curie Fellowship(European CommissionEuropean Commission Joint Research Centre); Career Re-entry Fellowship from the Wellcome Trust	This work was supported by Cancer Research UK; LS was partially supported by an individual EC Marie Curie Fellowship; FW was supported by a Career Re-entry Fellowship from the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon R, 2010, CELL ADHES MIGR, V4, P211, DOI 10.4161/cam.4.2.11133; Bivona TG, 2004, J CELL BIOL, V164, P461, DOI 10.1083/jcb.200311093; Christoforidis S, 1999, NATURE, V397, P621, DOI 10.1038/17618; DRANSFIELD I, 1989, EMBO J, V8, P3759, DOI 10.1002/j.1460-2075.1989.tb08552.x; Ebisuno Y, 2010, BLOOD, V115, P804, DOI 10.1182/blood-2009-03-211979; Evans R, 2011, BLOOD, V117, P3331, DOI 10.1182/blood-2010-06-289140; Fabbri M, 2005, MOL BIOL CELL, V16, P5793, DOI 10.1091/mbc.E05-05-0413; Fabbri M, 1999, EMBO J, V18, P4915, DOI 10.1093/emboj/18.18.4915; Herroeder S, 2009, IMMUNITY, V30, P708, DOI 10.1016/j.immuni.2009.02.010; Hogg N, 2011, NAT REV IMMUNOL, V11, P416, DOI 10.1038/nri2986; Hubbard KB, 2006, CELL SIGNAL, V18, P135, DOI 10.1016/j.cellsig.2005.08.004; Hwang IY, 2007, J IMMUNOL, V179, P439, DOI 10.4049/jimmunol.179.1.439; Katagiri K, 2003, NAT IMMUNOL, V4, P741, DOI 10.1038/ni950; Katagiri K, 2006, NAT IMMUNOL, V7, P919, DOI 10.1038/ni1374; Kinashi T, 2005, NAT REV IMMUNOL, V5, P546, DOI 10.1038/nri1646; Kumar A, 2011, J IMMUNOL, V186, P951, DOI 10.4049/jimmunol.1002019; Kunkel EJ, 2002, IMMUNITY, V16, P1, DOI 10.1016/S1074-7613(01)00261-8; LAWSON MA, 1995, NATURE, V377, P75, DOI 10.1038/377075a0; Mellado M, 2001, ANNU REV IMMUNOL, V19, P397, DOI 10.1146/annurev.immunol.19.1.397; Mor A, 2009, MOL CELL BIOL, V29, P3297, DOI 10.1128/MCB.00366-09; Moser B, 2004, TRENDS IMMUNOL, V25, P75, DOI 10.1016/j.it.2003.12.005; Ngai J, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-27; Pierini LM, 2000, BLOOD, V95, P2471; Raab M, 2010, IMMUNITY, V32, P541, DOI 10.1016/j.immuni.2010.03.007; REID PA, 1990, NATURE, V346, P655, DOI 10.1038/346655a0; Shi GX, 2007, J EXP MED, V204, P2705, DOI 10.1084/jem.20071267; Smith A, 2005, J CELL BIOL, V170, P141, DOI 10.1083/jcb.200412032; Smith A, 2003, J CELL SCI, V116, P3123, DOI 10.1242/jcs.00606; Soede RDM, 2001, J IMMUNOL, V166, P4293, DOI 10.4049/jimmunol.166.7.4293; Soede RDM, 2000, BLOOD, V96, P691; Stanley P, 2008, EMBO J, V27, P62, DOI 10.1038/sj.emboj.7601959; Svensson L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015090; Tohyama Y, 2003, MOL BIOL CELL, V14, P2570, DOI 10.1091/mbc.E02-09-0615; Wettschureck N, 2005, PHYSIOL REV, V85, P1159, DOI 10.1152/physrev.00003.2005; WINITZ S, 1994, J BIOL CHEM, V269, P1889; WRIGHT DD, 1994, MOL CELL BIOL, V14, P2429, DOI 10.1128/MCB.14.4.2429; Yu B, 2000, J BIOL CHEM, V275, P71, DOI 10.1074/jbc.275.1.71; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	38	20	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2012	7	6							e38517	10.1371/journal.pone.0038517	http://dx.doi.org/10.1371/journal.pone.0038517			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TU	22701657	Green Submitted, gold, Green Published			2022-12-27	WOS:000305337600028
J	Tanic, M; Yanowsky, K; Rodriguez-Antona, C; Andres, R; Marquez-Rodas, I; Osorio, A; Benitez, J; Martinez-Delgado, B				Tanic, Miljana; Yanowsky, Kira; Rodriguez-Antona, Cristina; Andres, Raquel; Marquez-Rodas, Ivan; Osorio, Ana; Benitez, Javier; Martinez-Delgado, Beatriz			Deregulated miRNAs in Hereditary Breast Cancer Revealed a Role for miR-30c in Regulating KRAS Oncogene	PLOS ONE			English	Article							SIGNAL-TRANSDUCTION PATHWAY; MALIGNANT-TRANSFORMATION; RAS ACTIVATION; GENE; TUMORS; RESISTANCE; MICRORNAS; GROWTH	Aberrant miRNA expression has been previously established in breast cancer and has clinical relevance. However, no studies so far have defined miRNAs deregulated in hereditary breast tumors. In this study we investigated the role of miRNAs in hereditary breast tumors comparing with normal breast tissue. Global miRNA expression profiling using Exiqon microarrays was performed on 22 hereditary breast tumors and 15 non-tumoral breast tissues. We identified 19 miRNAs differentially expressed, most of them down-regulated in tumors. An important proportion of deregulated miRNAs in hereditary tumors were previously identified commonly deregulated in sporadic breast tumors. Under-expression of these miRNAs was validated by qRT-PCR in additional 18 sporadic breast tumors and their normal breast tissue counterparts. Pathway enrichment analysis revealed that deregulated miRNAs collectively targeted a number of genes belonging to signaling pathways such as MAPK, ErbB, mTOR, and those regulating cell motility or adhesion. In silico prediction detected KRAS oncogene as target of several deregulated miRNAs. In particular, we experimentally validated KRAS as a miR-30c target. Luciferase assays confirmed that miR-30c binds the 39UTR of KRAS transcripts and expression of pre-miR-30c down-regulated KRAS mRNA and protein. Furthermore, miR-30c overexpression inhibited proliferation of breast cancer cells. Our results identify miRNAs associated to hereditary breast cancer, as well as miRNAs commonly miss-expressed in hereditary and sporadic tumors, suggesting common underlying mechanisms of tumor progression. In addition, we provide evidence that KRAS is a target of miR-30c, and that this miRNA suppresses breast cancer cell growth potentially through inhibition of KRAS signaling.	[Tanic, Miljana; Yanowsky, Kira; Osorio, Ana; Benitez, Javier; Martinez-Delgado, Beatriz] Spanish Natl Canc Res Ctr CNIO, Human Genet Grp, Madrid, Spain; [Yanowsky, Kira; Osorio, Ana; Benitez, Javier; Martinez-Delgado, Beatriz] CIBERER, Madrid, Spain; [Rodriguez-Antona, Cristina] CNIO, Hereditary Endocrine Canc Grp, Madrid, Spain; [Andres, Raquel] Univ Lozano Blesa, Hosp Clin, Med Oncol Serv, Zaragoza, Spain; [Marquez-Rodas, Ivan] Hosp Gregorio Maranon, Med Oncol Serv, Madrid, Spain	Centro Nacional de Investigaciones Oncologicas (CNIO); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Centro Nacional de Investigaciones Oncologicas (CNIO); Lozano Blesa University Clinical Hospital; General University Gregorio Maranon Hospital	Tanic, M (corresponding author), Spanish Natl Canc Res Ctr CNIO, Human Genet Grp, Madrid, Spain.	bmartinez@cnio.es	Tanic, Miljana/M-6650-2019; Tanic, Miljana/A-5458-2014; Osorio, Ana/I-4324-2014; Martinez-Delgado, Beatriz/B-6833-2013; Rodriguez-Antona, Cristina/E-1073-2011; Marquez-Rodas, Ivan/ABD-5532-2021	Tanic, Miljana/0000-0003-3102-776X; Tanic, Miljana/0000-0003-3102-776X; Osorio, Ana/0000-0001-8124-3984; Martinez-Delgado, Beatriz/0000-0001-6834-350X; Rodriguez-Antona, Cristina/0000-0001-8750-7338; Marquez-Rodas, Ivan/0000-0002-2476-668X	Asociacion Espanola contra el cancer (AECC); Fundacion La Caixa	Asociacion Espanola contra el cancer (AECC); Fundacion La Caixa(La Caixa Foundation)	This study was supported by grants from the Asociacion Espanola contra el cancer (AECC). MT has financial support from Fundacion La Caixa. The CIBER de Enfermedades Raras is an initiative of the ISCIII, Instituto de Salud Carlos III. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGNANTIS NJ, 1994, ANTICANCER RES, V14, P2135; Atanaskova N, 2002, ONCOGENE, V21, P4000, DOI 10.1038/sj.onc.1205506; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Blenkiron C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r214; Bradbury AR, 2007, REV ENDOCR METAB DIS, V8, P255, DOI 10.1007/s11154-007-9038-0; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Calin GA, 2006, CANCER RES, V66, P7390, DOI 10.1158/0008-5472.CAN-06-0800; Chen CZ, 2005, NEW ENGL J MED, V353, P1768, DOI 10.1056/NEJMp058190; Chen X, 2009, ONCOGENE, V28, P1385, DOI 10.1038/onc.2008.474; CLARK GJ, 1995, BREAST CANCER RES TR, V35, P133, DOI 10.1007/BF00694753; Dunn KL, 2005, BIOCHEM CELL BIOL, V83, P1, DOI 10.1139/O04-121; Eckert LB, 2004, CANCER RES, V64, P4585, DOI 10.1158/0008-5472.CAN-04-0396; Enerly E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016915; Haagenson KK, 2010, CANCER METAST REV, V29, P143, DOI 10.1007/s10555-010-9208-5; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hedenfalk I, 2001, NEW ENGL J MED, V344, P539, DOI 10.1056/NEJM200102223440801; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kent OA, 2010, GENE DEV, V24, P2754, DOI 10.1101/gad.1950610; KOFFA M, 1994, INT J ONCOL, V4, P573; Lee CH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007314; Liu CG, 2004, P NATL ACAD SCI USA, V101, P9740, DOI 10.1073/pnas.0403293101; Lo HW, 2006, BREAST CANCER RES TR, V95, P211, DOI 10.1007/s10549-005-9011-0; McCubrey JA, 2007, BBA-MOL CELL RES, V1773, P1263, DOI 10.1016/j.bbamcr.2006.10.001; Morrissey ER, 2009, NUCLEIC ACIDS RES, V37, pW581, DOI 10.1093/nar/gkp366; Palacios J, 2008, PATHOBIOLOGY, V75, P85, DOI 10.1159/000123846; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Rodriguez-Gonzalez FG, 2011, BREAST CANCER RES TR, V127, P43, DOI 10.1007/s10549-010-0940-x; Salh B, 1999, ANTICANCER RES, V19, P731; SPANDIDOS DA, 1987, ANTICANCER RES, V7, P991; Ventura A, 2009, CELL, V136, P586, DOI 10.1016/j.cell.2009.02.005; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; von Lintig FC, 2000, BREAST CANCER RES TR, V62, P51, DOI 10.1023/A:1006491619920; Yu F, 2010, ONCOGENE, V29, P4194, DOI 10.1038/onc.2010.167; Yu SN, 2010, CANCER RES, V70, P6015, DOI 10.1158/0008-5472.CAN-09-4531; Zajac M, 2008, MOL CANCER THER, V7, P2358, DOI 10.1158/1535-7163.MCT-08-0327	37	70	75	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2012	7	6							e38847	10.1371/journal.pone.0038847	http://dx.doi.org/10.1371/journal.pone.0038847			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TU	22701724	Green Submitted, gold, Green Published			2022-12-27	WOS:000305337600051
J	Waduthantri, S; Yong, SS; Tan, CH; Shen, L; Lee, MX; Nagarajan, S; Hla, MH; Tong, L				Waduthantri, Samanthila; Yong, Siew Sian; Tan, Chien Hua; Shen, Liang; Lee, Man Xin; Nagarajan, Sangeetha; Hla, Mynt Htoon; Tong, Louis			Cost of Dry Eye Treatment in an Asian Clinic Setting	PLOS ONE			English	Article							POPULATION; SYMPTOMS; EFFICACY; IMPACT	Objectives: To estimate the cost and patterns of expenditure of dry eye treatment. Methodology: We retrieved data on the type and cost of dry eye treatment in Singapore National Eye Centre from pharmacy and clinic inventory databases over a 2 year period (2008-2009) retrospectively. According to the type of treatment, data were sorted into 7 groups; meibomien gland disease (MGD) treatment, preservative free lubricant eye drops, preserved lubricant eye drops, lubricant ointments and gels, cyclosporine eye drops, oral supplements and non-pharmacological treatments/procedures. Each recorded entry was considered as one patient episode (PE). Comparisons in each group between two years were carried out using Pearson Chi-Square test. Significance level was set at alpha = 0.05. Results: Cost data from 54,052 patients were available for analysis. Total number of recorded PEs was 132,758. Total annual expenditure on dry eye treatment for year 2008 and 2009 were US$1,509,372.20 and US$1,520,797.80 respectively. Total expenditure per PE in year 2008 and 2009 were US$22.11 and US$23.59 respectively. From 2008 to 2009, there was a 0.8% increase in total annual expenditure and 6.69% increase in expenditure per PE. Pharmacological treatment attributes to 99.2% of the total expenditure with lubricants accounting for 79.3% of the total pharmacological treatment expenditure. Total number of units purchased in preservative free lubricants, cyclosporine eye drops and MGD therapy have increased significantly (p < 0.001) whereas number of units purchased in preserved lubricants and ointments/gels have reduced significantly (p < 0.001) from 2008 to 2009. Conclusion: Dry Eye imposes a significant direct burden to health care expenditure even without considering indirect costs. Health care planners should be aware that these direct costs appear to increase over the time and more so for particular types of medications. Given the limitations of socio-economic data, true societal costs of Dry eye syndrome are likely to be much higher than estimated.	[Waduthantri, Samanthila; Yong, Siew Sian; Tan, Chien Hua; Lee, Man Xin; Nagarajan, Sangeetha; Hla, Mynt Htoon; Tong, Louis] Singapore Eye Res Inst, Singapore, Singapore; [Waduthantri, Samanthila; Tong, Louis] Singapore Natl Eye Ctr, Singapore, Singapore; [Shen, Liang] Natl Univ Singapore, Singapore 117548, Singapore; [Tong, Louis] Duke NUS Grad Med Sch, Singapore, Singapore	National University of Singapore; Singapore National Eye Center; Singapore National Eye Center; National University of Singapore; National University of Singapore	Waduthantri, S (corresponding author), Singapore Eye Res Inst, Singapore, Singapore.	samanthila@hotmail.com		Tong, Louis/0000-0002-3986-6552	National Medical Research Council (NMRC) [NMRC/1206/2009, NMRC/0808/2003, NMRC/CPG/002/2003, NMRC/0982/2005]	National Medical Research Council (NMRC)(National Medical Research Council, Singapore)	This work received grant support NMRC/1206/2009, NMRC/0808/2003, NMRC/CPG/002/2003, NMRC/0982/2005 and NMRC/1206/2009 from National Medical Research Council (NMRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASBELL PA, 2007, DRY EYE DIS CLIN GUI; Balaram M, 2001, AM J OPHTHALMOL, V131, P30, DOI 10.1016/S0002-9394(00)00620-6; Brown MM, 2009, ARCH OPHTHALMOL-CHIC, V127, P146, DOI 10.1001/archophthalmol.2008.608; Clegg JP, 2006, OPHTHAL EPIDEMIOL, V13, P263, DOI 10.1080/09286580600801044; Ellwein LB, 2002, ARCH OPHTHALMOL-CHIC, V120, P804; Hirsch JD, 2007, SURV OPHTHALMOL, V52, P618, DOI 10.1016/j.survophthal.2007.08.017; Hirsch Jan D, 2003, Manag Care, V12, P33; Kozma CM, 2000, INVEST OPHTH VIS SCI, V41, pS928; Lemp Michael A, 2008, Am J Manag Care, V14, pS88; Pflugfelder Stephen C, 2008, Am J Manag Care, V14, pS102; Rand AL, 2011, CURR OPIN OPHTHALMOL, V22, P279, DOI 10.1097/ICU.0b013e3283477d23; Reddy P, 2004, CORNEA, V23, P751, DOI 10.1097/01.ico.0000134183.47687.75; Shimmura S, 1999, CORNEA, V18, P408, DOI 10.1097/00003226-199907000-00003; Smeeding JE, 2001, VALUE HEALTH, V4, P117; Tai MC, 2002, CORNEA, V21, P135, DOI 10.1097/00003226-200203000-00001; Tong L, 2010, EYE, V24, P1486, DOI 10.1038/eye.2010.67; Yu JH, 2011, CORNEA, V30, P379, DOI 10.1097/ICO.0b013e3181f7f363	17	34	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2012	7	6							e37711	10.1371/journal.pone.0037711	http://dx.doi.org/10.1371/journal.pone.0037711			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TU	22701577	Green Published, gold, Green Submitted			2022-12-27	WOS:000305337600010
J	Young, AMH; Campbell, EC; Lynch, S; Dunn, MH; Powis, SJ; Suckling, J				Young, Adam M. H.; Campbell, Elaine C.; Lynch, Sarah; Dunn, Malcolm H.; Powis, Simon J.; Suckling, John			Regional Susceptibility to TNF-alpha Induction of Murine Brain Inflammation via Classical IKK/NF-kappa B Signalling	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; IN-VITRO; AUTISM; ACTIVATION; MICROGLIA; PATHWAY; MOUSE	It is becoming clear that inflammation plays a significant role in a number of neurological and psychiatric conditions. Post mortem brain samples in Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, multiple sclerosis, schizophrenia and most recently autism spectrum condition, all exhibit neuroglial activation and inflammatory markers within the CSF. Many questions remain about the underlying molecular mechanisms. By adding the pro-inflammatory cytokine, TNF-alpha, to mouse brain tissue we demonstrated that the frontal lobes and temporal region, areas involved in higher functions such as memory and learning, are most susceptible to cytokine-induced inflammation via the NF-kappa B signalling pathway. We observed direct correlations between the volumetric increase and molecular expression indicating that therapeutic targets in these lobes may require different approaches when treating conditions with a central neuroinflammatory component.	[Young, Adam M. H.; Campbell, Elaine C.; Lynch, Sarah; Powis, Simon J.] Univ St Andrews, Sch Med, St Andrews KY16 9AJ, Fife, Scotland; [Young, Adam M. H.; Suckling, John] Univ Cambridge, Sch Clin Med, Cambridge, England; [Dunn, Malcolm H.] Univ St Andrews, Sch Phys & Astron, St Andrews KY16 9AJ, Fife, Scotland; [Suckling, John] Univ Cambridge, Dept Psychiat, Cambridge, England	University of St Andrews; University of Cambridge; University of St Andrews; University of Cambridge	Young, AMH (corresponding author), Univ St Andrews, Sch Med, St Andrews KY16 9AJ, Fife, Scotland.	js369@cam.ac.uk	Suckling, John/ABD-7246-2021	Suckling, John/0000-0002-5098-1527; Powis, Simon/0000-0003-4218-2984; Williams, Sarah/0000-0003-1574-3328	University of St Andrews & Archimedes Pharmaceuticals	University of St Andrews & Archimedes Pharmaceuticals	This study received financial support from the University of St Andrews & Archimedes Pharmaceuticals (www.archimedespharma.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIYAMA H, 1994, TOHOKU J EXP MED, V174, P295, DOI 10.1620/tjem.174.295; Alcamo E, 2001, J IMMUNOL, V167, P1592, DOI 10.4049/jimmunol.167.3.1592; Anderson SW, 1999, NAT NEUROSCI, V2, P1032, DOI 10.1038/14833; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Block ML, 2005, PROG NEUROBIOL, V76, P77, DOI 10.1016/j.pneurobio.2005.06.004; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Cruz-Machado SD, 2010, J PINEAL RES, V49, P183, DOI 10.1111/j.1600-079X.2010.00785.x; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Hagihara Hideo, 2009, J Vis Exp, DOI 10.3791/1543; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Herbert MR, 2008, ALTERN THER HEALTH M, V14, P28; Hollander E, 2009, PSYCHIAT RES, V170, P43, DOI 10.1016/j.psychres.2008.07.014; Kim WG, 2000, J NEUROSCI, V20, P6309, DOI 10.1523/JNEUROSCI.20-16-06309.2000; Konradi C, 2012, NEUROBIOL DIS, V45, P37, DOI 10.1016/j.nbd.2011.01.025; LAWSON LJ, 1990, NEUROSCIENCE, V39, P151, DOI 10.1016/0306-4522(90)90229-W; Meyer U, 2011, PEDIATR RES, V69, p26R, DOI 10.1203/PDR.0b013e318212c196; Oldreive CE, 2010, J MOL NEUROSCI, V42, P44, DOI 10.1007/s12031-010-9370-9; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Pardo CA, 2006, INT REV PSYCHIATR, V17, P485, DOI 10.1080/02646830500381930; Perkins ND, 2004, TRENDS CELL BIOL, V14, P64, DOI 10.1016/j.tcb.2003.12.004; SCHMIDT EL, 1965, APPL MICROBIOL, V13, P673, DOI 10.1128/AEM.13.5.673-679.1965; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; Terada T, 2011, J NEUROL SCI, V309, P136, DOI 10.1016/j.jns.2011.06.049; Vargas DL, 2005, ANN NEUROL, V57, P67, DOI 10.1002/ana.20315; Viel TA, 2011, CURR ALZHEIMER RES, V8, P59; Widera D, 2006, EUR CELLS MATER, V11, P76, DOI 10.22203/eCM.v011a08; WING L, 1979, J AUTISM DEV DISORD, V9, P11, DOI 10.1007/BF01531288; Young Adam M H, 2011, Front Psychiatry, V2, P27, DOI 10.3389/fpsyt.2011.00027; Zilbovicius M, 2000, AM J PSYCHIAT, V157, P1988, DOI 10.1176/appi.ajp.157.12.1988; Zimmerman AW, 2005, PEDIATR NEUROL, V33, P195, DOI 10.1016/j.pediatrneurol.2005.03.014; Zindler E, 2010, BEST PRACT RES-CLIN, V24, P551, DOI 10.1016/j.bpa.2010.11.001	32	22	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2012	7	6							e39049	10.1371/journal.pone.0039049	http://dx.doi.org/10.1371/journal.pone.0039049			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TU	22701747	Green Accepted, gold, Green Published			2022-12-27	WOS:000305337600067
J	Sidhaye, VK; Chau, E; Srivastava, V; Sirimalle, S; Balabhadrapatruni, C; Aggarwal, NR; D'Alessio, FR; Robinson, DN; King, LS				Sidhaye, Venkataramana K.; Chau, Eric; Srivastava, Vasudha; Sirimalle, Srinivas; Balabhadrapatruni, Chinmayee; Aggarwal, Neil R.; D'Alessio, Franco R.; Robinson, Douglas N.; King, Landon S.			A Novel Role for Aquaporin-5 in Enhancing Microtubule Organization and Stability	PLOS ONE			English	Article							EPITHELIAL BARRIER FUNCTION; CELL-MIGRATION; WATER PERMEABILITY; EXPRESSION; AQP5; INVOLVEMENT; TUBULIN; PROTEIN; MICE; PROLIFERATION	Aquaporin-5 (AQP5) is a water-specific channel located on the apical surface of airway epithelial cells. In addition to regulating transcellular water permeability, AQP5 can regulate paracellular permeability, though the mechanisms by which this occurs have not been determined. Microtubules also regulate paracellular permeability. Here, we report that AQP5 promotes microtubule assembly and helps maintain the assembled microtubule steady state levels with slower turnover dynamics in cells. Specifically, reduced levels of AQP5 correlated with lower levels of assembled microtubules and decreased paracellular permeability. In contrast, overexpression of AQP5 increased assembly of microtubules, with evidence of increased MT stability, and promoted the formation of long straight microtubules in the apical domain of the epithelial cells. These findings indicate that AQP5-mediated regulation of microtubule dynamics modulates airway epithelial barrier properties and epithelial function.	[Sidhaye, Venkataramana K.; Chau, Eric; Sirimalle, Srinivas; Balabhadrapatruni, Chinmayee; Aggarwal, Neil R.; D'Alessio, Franco R.; King, Landon S.] Johns Hopkins Univ, Sch Med, Dept Med, Div Pulm & Crit Care Med, Baltimore, MD 21205 USA; [Srivastava, Vasudha; Robinson, Douglas N.] Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD USA; [King, Landon S.] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Sidhaye, VK (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Div Pulm & Crit Care Med, Baltimore, MD 21205 USA.	vsidhay1@jhmi.edu	Sidhaye, Venkataramana/AAC-3930-2019	Sidhaye, Venkataramana/0000-0002-4506-8549; , Neil/0000-0002-0922-8824; Srivastava, Vasudha/0000-0001-8845-9518; Robinson, Douglas/0000-0003-1236-4891	FAMRI (Flight Attendants Medical Research Institute); Johns Hopkins Bayview Scholars Program; NIH [GM66817];  [K08HL085763]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL085763] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066817] Funding Source: NIH RePORTER	FAMRI (Flight Attendants Medical Research Institute); Johns Hopkins Bayview Scholars Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the FAMRI (Flight Attendants Medical Research Institute) (FAMRI Young Investigator Award) Young Investigator Award and K08HL085763 (VKS), the Johns Hopkins Bayview Scholars Program (LSK), and an NIH grant GM66817 (DNR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belmadani S, 2004, MOL CELL BIOCHEM, V258, P35, DOI 10.1023/B:MCBI.0000012834.43990.b6; Birukova AA, 2005, J CELL PHYSIOL, V204, P934, DOI 10.1002/jcp.20359; Birukova AA, 2005, AM J PHYSIOL-LUNG C, V289, pL75, DOI 10.1152/ajplung.00447.2004; BLACK MM, 1984, BRAIN RES, V295, P255, DOI 10.1016/0006-8993(84)90974-0; Blagosklonny MV, 2002, MOL CANCER THER, V1, P937; Chae YK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002162; Chae YK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002594; Dobbs LG, 1998, P NATL ACAD SCI USA, V95, P2991, DOI 10.1073/pnas.95.6.2991; GUMBINER B, 1987, AM J PHYSIOL, V253, pC749, DOI 10.1152/ajpcell.1987.253.6.C749; GUMBINER B, 1991, P NATL ACAD SCI USA, V88, P3460, DOI 10.1073/pnas.88.8.3460; Herrlich A, 2004, P NATL ACAD SCI USA, V101, P15799, DOI 10.1073/pnas.0406853101; Hoffert JD, 2000, J BIOL CHEM, V275, P9070, DOI 10.1074/jbc.275.12.9070; Horsefield R, 2008, P NATL ACAD SCI USA, V105, P13327, DOI 10.1073/pnas.0801466105; Hwang SM, 2002, EXP MOL MED, V34, P69, DOI 10.1038/emm.2002.10; Ivanov AI, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-12; Ivanov AI, 2010, AM J PATHOL, V177, P512, DOI 10.2353/ajpath.2010.100168; Jiao GY, 2002, CHINESE MED J-PEKING, V115, P963; Kannarkat GT, 2006, J HEPATOL, V44, P963, DOI 10.1016/j.jhep.2005.07.007; Kawedia JD, 2007, P NATL ACAD SCI USA, V104, P3621, DOI 10.1073/pnas.0608384104; Kawkitinarong K, 2004, AM J RESP CELL MOL, V31, P517, DOI 10.1165/rcmb.2003-0432OC; King LS, 2004, NAT REV MOL CELL BIO, V5, P687, DOI 10.1038/nrm1469; Kouzarides T, 2000, EMBO J, V19, P1176, DOI 10.1093/emboj/19.6.1176; Kozono D, 2002, J CLIN INVEST, V109, P1395, DOI 10.1172/JCI200215851; Krane CM, 2001, J BIOL CHEM, V276, P23413, DOI 10.1074/jbc.M008760200; Kumari SS, 2009, BIOCHEM BIOPH RES CO, V390, P1034, DOI 10.1016/j.bbrc.2009.10.103; Levin MH, 2006, INVEST OPHTH VIS SCI, V47, P4365, DOI 10.1167/iovs.06-0335; Liu JL, 2011, J CELL SCI, V124, P198, DOI 10.1242/jcs.072652; Liu XB, 2006, J BIOL CHEM, V281, P15485, DOI 10.1074/jbc.M600549200; Lorenowicz MJ, 2007, AM J PHYSIOL-LUNG C, V293, pL1321, DOI 10.1152/ajplung.00443.2006; Ma TH, 1999, J BIOL CHEM, V274, P20071, DOI 10.1074/jbc.274.29.20071; Milewski MI, 2005, FEBS LETT, V579, P483, DOI 10.1016/j.febslet.2004.11.106; Nicchia GP, 2005, FASEB J, V19, P1674, DOI 10.1096/fj.04-3281fje; Ochoa CD, 2011, AM J PHYSIOL-LUNG C, V300, pL132, DOI 10.1152/ajplung.00185.2010; Papadopoulos MC, 2008, PFLUG ARCH EUR J PHY, V456, P693, DOI 10.1007/s00424-007-0357-5; Perez-Moreno M, 2003, CELL, V112, P535, DOI 10.1016/S0092-8674(03)00108-9; Petrache I, 2003, AM J RESP CELL MOL, V28, P574, DOI 10.1165/rcmb.2002-0075OC; Poruchynsky MS, 2004, BIOCHEMISTRY-US, V43, P13944, DOI 10.1021/bi049300+; Ross AJ, 2007, AM J RESP CELL MOL, V37, P169, DOI 10.1165/rcmb.2006-0466OC; Saadoun S, 2005, NATURE, V434, P786, DOI 10.1038/nature03460; Saadoun S, 2005, J CELL SCI, V118, P5691, DOI 10.1242/jcs.02680; Saadoun S, 2009, NEUROSCIENCE, V161, P764, DOI 10.1016/j.neuroscience.2009.03.069; Schneider A, 2011, GASTROENTEROLOGY, V140, P162, DOI 10.1053/j.gastro.2010.10.045; Shankardas J, 2010, MOL VIS, V16, P1538; Shen Y, 2010, RESP PHYSIOL NEUROBI, V171, P212, DOI 10.1016/j.resp.2010.03.021; Sidhaye V, 2005, J BIOL CHEM, V280, P3590, DOI 10.1074/jbc.M411038200; Sidhaye VK, 2008, P NATL ACAD SCI USA, V105, P3345, DOI 10.1073/pnas.0712287105; Sidhaye VK, 2011, AM J RESP CELL MOL, V45, P120, DOI 10.1165/rcmb.2010-0235OC; Sidhaye VK, 2006, P NATL ACAD SCI USA, V103, P4747, DOI 10.1073/pnas.0511211103; Sidhaye VK, 2011, AM J RESP CELL MOL B; Steinfeld S, 2001, LAB INVEST, V81, P143, DOI 10.1038/labinvest.3780221; TASHIRO T, 1991, J NEUROSCI RES, V30, P192, DOI 10.1002/jnr.490300120; Towne JE, 2001, J BIOL CHEM, V276, P18657, DOI 10.1074/jbc.M100322200; Varadaraj K, 2010, EXP EYE RES, V91, P393, DOI 10.1016/j.exer.2010.06.013; Wang Z, 2011, INVEST OPHTH VIS SCI, V52, P5079, DOI 10.1167/iovs.10-6998; Woo J, 2008, BIOCHEM BIOPH RES CO, V366, P321, DOI 10.1016/j.bbrc.2007.11.078; Yan Xia, 2007, Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, V19, P214; Yang F, 2003, J BIOL CHEM, V278, P32173, DOI 10.1074/jbc.M305149200; Yu XS, 2005, J BIOL CHEM, V280, P22081, DOI 10.1074/jbc.M414377200; Zhang H, 2008, J MOL BIOL, V382, P1136, DOI 10.1016/j.jmb.2008.07.089; Zhang ZQ, 2010, J PATHOL, V221, P210, DOI 10.1002/path.2702	60	20	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2012	7	6							e38717	10.1371/journal.pone.0038717	http://dx.doi.org/10.1371/journal.pone.0038717			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TQ	22715407	gold, Green Submitted, Green Published			2022-12-27	WOS:000305336800049
J	van Agtmaal, EL; Bierings, R; Dragt, BS; Leyen, TA; Fernandez-Borja, M; Horrevoets, AJG; Voorberg, J				van Agtmaal, Ellen L.; Bierings, Ruben; Dragt, Bieuwke S.; Leyen, Thomas A.; Fernandez-Borja, Mar; Horrevoets, Anton J. G.; Voorberg, Jan			The Shear Stress-Induced Transcription Factor KLF2 Affects Dynamics and Angiopoietin-2 Content of Weibel-Palade Bodies	PLOS ONE			English	Article							VON-WILLEBRAND-FACTOR; HUMAN-ENDOTHELIAL-CELLS; KRUPPEL-LIKE FACTOR-2; FLOW-DEPENDENT REGULATION; P-SELECTIN; REGULATED SECRETION; INTERLEUKIN-8; ANGIOGENESIS; EXPRESSION; PROTEIN	Background: The shear-stress induced transcription factor KLF2 has been shown to induce an atheroprotective phenotype in endothelial cells (EC) that are exposed to prolonged laminar shear. In this study we characterized the effect of the shear stress-induced transcription factor KLF2 on regulation and composition of Weibel-Palade bodies (WPBs) using peripheral blood derived ECs. Methodology and Principal Findings: Lentiviral expression of KLF2 resulted in a 4.5 fold increase in the number of WPBs per cell when compared to mock-transduced endothelial cells. Unexpectedly, the average length of WPBs was significantly reduced: in mock-transduced endothelial cells WPBs had an average length of 1.7 mu m versus 1.3 mu m in KLF2 expressing cells. Expression of KLF2 abolished the perinuclear clustering of WPBs observed following stimulation with cAMP-raising agonists such as epinephrine. Immunocytochemistry revealed that WPBs of KLF2 expressing ECs were positive for IL-6 and IL-8 (after their upregulation with IL-1 beta) but lacked angiopoietin-2 (Ang2), a regular component of WPBs. Stimulus-induced secretion of Ang2 in KLF2 expressing ECs was greatly reduced and IL-8 secretion was significantly lower. Conclusions and Significance: These data suggest that KLF2 expression leads to a change in size and composition of the regulated secretory compartment of endothelial cells and alters its response to physiological stimuli.	[van Agtmaal, Ellen L.; Bierings, Ruben; Dragt, Bieuwke S.; Voorberg, Jan] Univ Amsterdam, Dept Plasma Prot, Sanquin AMC Landsteiner Lab, Amsterdam, Netherlands; [Bierings, Ruben] Natl Inst Med Res, Dept Phys Biochem, London NW7 1AA, England; [Leyen, Thomas A.; Horrevoets, Anton J. G.] Vrije Univ Amsterdam Med Ctr, Dept Mol Cell Biol & Immunol, Amsterdam, Netherlands; [Fernandez-Borja, Mar] Sanquin AMC Landsteiner Lab, Dept Mol Cell Biol, Amsterdam, Netherlands	University of Amsterdam; MRC National Institute for Medical Research; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of Amsterdam	van Agtmaal, EL (corresponding author), Univ Amsterdam, Dept Plasma Prot, Sanquin AMC Landsteiner Lab, Amsterdam, Netherlands.	j.voorberg@sanquin.nl	van Agtmaal, Ellen/G-4489-2016; Bierings, Ruben/AAQ-8854-2020	Bierings, Ruben/0000-0002-1205-9689; Voorberg, Jan/0000-0003-4585-2621	Netherlands Heart Foundation [2002.187]; Netherlands Thrombosis Foundation [TSN2007.01]; Netherlands Organization for Scientific Research (NWO) [91209006]	Netherlands Heart Foundation(Netherlands Heart Foundation); Netherlands Thrombosis Foundation; Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was supported in part by grants from the Netherlands Heart Foundation (Grant 2002.187), the Netherlands Thrombosis Foundation (TSN2007.01) and the Netherlands Organization for Scientific Research (NWO, grant no. 91209006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augustin HG, 2009, NAT REV MOL CELL BIO, V10, P165, DOI 10.1038/nrm2639; Bhattacharya R, 2005, J BIOL CHEM, V280, P28848, DOI 10.1074/jbc.C500200200; Bierings R, 2007, J THROMB HAEMOST, V5, P2512, DOI 10.1111/j.1538-7836.2007.02768.x; BONFANTI R, 1989, BLOOD, V73, P1109; Boon RA, 2009, HAMOSTASEOLOGIE, V29, P39, DOI 10.1055/s-0037-1616937; Chiu JJ, 2011, PHYSIOL REV, V91, P327, DOI 10.1152/physrev.00047.2009; Das H, 2006, P NATL ACAD SCI USA, V103, P6653, DOI 10.1073/pnas.0508235103; Davids N, 1981, Neurol Res, V3, P83; de Wit TR, 2003, ARTERIOSCL THROM VAS, V23, P755, DOI 10.1161/01.ATV.0000069847.72001.E8; Dekker RJ, 2002, BLOOD, V100, P1689, DOI 10.1182/blood-2002-01-0046; Dekker RJ, 2005, AM J PATHOL, V167, P609, DOI 10.1016/S0002-9440(10)63002-7; Dekker RJ, 2006, BLOOD, V107, P4354, DOI 10.1182/blood-2005-08-3465; Denis CV, 2001, P NATL ACAD SCI USA, V98, P4072, DOI 10.1073/pnas.061307098; Fang Y, 2012, ARTERIOSCLER THROMB; Fiedler U, 2004, BLOOD, V103, P4150, DOI 10.1182/blood-2003-10-3685; Fiedler U, 2006, NAT MED, V12, P235, DOI 10.1038/nm1351; Fiedler U, 2006, TRENDS IMMUNOL, V27, P552, DOI 10.1016/j.it.2006.10.004; Goettsch W, 2008, J CELL PHYSIOL, V214, P491, DOI 10.1002/jcp.21229; Gracia-Sancho J, 2011, GUT, V60, P517, DOI 10.1136/gut.2010.220913; Haberichter SL, 2005, BLOOD, V105, P145, DOI 10.1182/blood-2004-02-0464; Harrison-Lavoie KJ, 2006, TRAFFIC, V7, P647, DOI 10.1111/j.1600-0854.2006.00415.x; Jain MK, 2005, NAT REV DRUG DISCOV, V4, P977, DOI 10.1038/nrd1901; Kumar A, 2005, MOL CELL BIOL, V25, P5893, DOI 10.1128/MCB.25.14.5893-5903.2005; Lui-Roberts WWY, 2005, J CELL BIOL, V170, P627, DOI 10.1083/jcb.200503054; MCEVER RP, 1989, J CLIN INVEST, V84, P92, DOI 10.1172/JCI114175; Michaux G, 2006, BLOOD, V107, P3922, DOI 10.1182/blood-2005-09-3635; Oynebraten I, 2004, BLOOD, V104, P314, DOI 10.1182/blood-2003-08-2891; Parmar KM, 2006, J CLIN INVEST, V116, P49, DOI 10.1172/JCI24787; RAINES G, 1990, THROMB RES, V60, P201, DOI 10.1016/0049-3848(90)90181-B; Rondaij MG, 2008, BLOOD, V112, P56, DOI 10.1182/blood-2007-07-099309; Rondaij MG, 2006, ARTERIOSCL THROM VAS, V26, P49, DOI 10.1161/01.ATV.0000191639.08082.04; SAKAMOTO Y, 1993, ANAT REC, V237, P482, DOI 10.1002/ar.1092370407; Starke RD, 2011, BLOOD, V117, P1071, DOI 10.1182/blood-2010-01-264507; Tzima E, 2003, J BIOL CHEM, V278, P31020, DOI 10.1074/jbc.M301179200; Utgaard JO, 1998, J EXP MED, V188, P1751, DOI 10.1084/jem.188.9.1751; Valentijn KM, 2011, BLOOD; van den Biggelaar M, 2009, HAEMATOL-HEMATOL J, V94, P670, DOI 10.3324/haematol.13427; van Thienen JV, 2006, CARDIOVASC RES, V72, P231, DOI 10.1016/j.cardiores.2006.07.008; VISCHER UM, 1993, BLOOD, V82, P1184, DOI 10.1182/blood.V82.4.1184.1184; WAGNER DD, 1982, J CELL BIOL, V95, P355, DOI 10.1083/jcb.95.1.355; WEIBEL ER, 1964, J CELL BIOL, V23, P101, DOI 10.1083/jcb.23.1.101; Wolff B, 1998, J EXP MED, V188, P1757, DOI 10.1084/jem.188.9.1757; Wu W, 2011, CIRCULATION, V124, P633, DOI 10.1161/CIRCULATIONAHA.110.005108; Zannettino ACW, 2005, J CELL PHYSIOL, V204, P714, DOI 10.1002/jcp.20354; ZARINS CK, 1983, CIRC RES, V53, P502, DOI 10.1161/01.RES.53.4.502	45	28	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2012	7	6							e38399	10.1371/journal.pone.0038399	http://dx.doi.org/10.1371/journal.pone.0038399			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TQ	22715381	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336800022
J	Buchwald, ZS; Kiesel, JR; DiPaolo, R; Pagadala, MS; Aurora, R				Buchwald, Zachary S.; Kiesel, Jennifer R.; DiPaolo, Richard; Pagadala, Meghana S.; Aurora, Rajeev			Osteoclast Activated FoxP3(+) CD8(+) T-Cells Suppress Bone Resorption in vitro	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; HEMATOPOIETIC STEM-CELL; TGF-BETA; AUTOIMMUNE-DISEASE; OSTEOBLASTIC CELLS; RECEPTOR ACTIVATOR; INTERFERON-GAMMA; IMMUNE-RESPONSE; CD4(+) CD25(+); CUTTING EDGE	Background: Osteoclasts are the body's sole bone resorbing cells. Cytokines produced by pro-inflammatory effector T-cells (T-EFF) increase bone resorption by osteoclasts. Prolonged exposure to the T-EFF produced cytokines leads to bone erosion diseases such as osteoporosis and rheumatoid arthritis. The crosstalk between T-cells and osteoclasts has been termed osteoimmunology. We have previously shown that under non-inflammatory conditions, murine osteoclasts can recruit naive CD8 T-cells and activate these T-cells to induce CD25 and FoxP3 (Tc-REG). The activation of CD8 T-cells by osteoclasts also induced the cytokines IL-2, IL-6, IL-10 and IFN-gamma. Individually, these cytokines can activate or suppress osteoclast resorption. Principal Findings: To determine the net effect of Tc-REG on osteoclast activity we used a number of in vitro assays. We found that Tc-REG can potently and directly suppress bone resorption by osteoclasts. Tc-REG could suppress osteoclast differentiation and resorption by mature osteoclasts, but did not affect their survival. Additionally, we showed that Tc-REG suppress cytoskeletal reorganization in mature osteoclasts. Whereas induction of Tc-REG by osteoclasts is antigen-dependent, suppression of osteoclasts by Tc-REG does not require antigen or re-stimulation. We demonstrated that antibody blockade of IL-6, IL-10 or IFN-gamma relieved suppression. The suppression did not require direct contact between the Tc-REG and osteoclasts. Significance: We have determined that osteoclast-induced Tc-REG can suppress osteoclast activity, forming a negative feedback system. As the CD8 T-cells are activated in the absence of inflammatory signals, these observations suggest that this regulatory loop may play a role in regulating skeletal homeostasis. Our results provide the first documentation of suppression of osteoclast activity by CD8 regulatory T-cells and thus, extend the purview of osteoimmunology.	[Buchwald, Zachary S.; Kiesel, Jennifer R.; DiPaolo, Richard; Pagadala, Meghana S.; Aurora, Rajeev] St Louis Univ, Sch Med, Dept Mol Microbiol & Immunol, St Louis, MO 63103 USA	Saint Louis University	Buchwald, ZS (corresponding author), St Louis Univ, Sch Med, Dept Mol Microbiol & Immunol, St Louis, MO 63103 USA.	aurorar@slu.edu		Aurora, Rajeev/0000-0002-6609-6055	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR057235] Funding Source: NIH RePORTER; NIAMS NIH HHS [P30 AR057235] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Aandahl EM, 2008, HUM IMMUNOL, V69, P696, DOI 10.1016/j.humimm.2008.08.291; Ablamunits V, 2008, HUM IMMUNOL, V69, P732, DOI 10.1016/j.humimm.2008.08.290; Adams GB, 2006, NAT IMMUNOL, V7, P333, DOI 10.1038/ni1331; Allez M, 2002, GASTROENTEROLOGY, V123, P1516, DOI 10.1053/gast.2002.36588; Arai F, 1999, J EXP MED, V190, P1741, DOI 10.1084/jem.190.12.1741; Arai F, 2005, INT J HEMATOL, V82, P371, DOI 10.1532/IJH97.05100; Arron JR, 2000, NATURE, V408, P535, DOI 10.1038/35046196; Asseman C, 2003, J IMMUNOL, V171, P971, DOI 10.4049/jimmunol.171.2.971; Axmann R, 2008, ANN RHEUM DIS, V67, P1603, DOI 10.1136/ard.2007.080713; Badillo AT, 2006, STEM CELL REV, V2, P241, DOI 10.1007/s12015-006-0052-5; Banham AH, 2006, EUR J IMMUNOL, V36, P2832, DOI 10.1002/eji.200636459; Bonewald LF, 1997, ENDOCRINOLOGY, V138, P657, DOI 10.1210/en.138.2.657; Brimnes J, 2005, J IMMUNOL, V174, P5814, DOI 10.4049/jimmunol.174.9.5814; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Caetano-Lopes J, 2009, AUTOIMMUN REV, V8, P250, DOI 10.1016/j.autrev.2008.07.038; CENTRELLA M, 1989, CONNECT TISSUE RES, V20, P267, DOI 10.3109/03008208909023896; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Cheung J, 2003, J ENDOCRINOL, V177, P423, DOI 10.1677/joe.0.1770423; Collison LW, 2007, NATURE, V450, P566, DOI 10.1038/nature06306; Colovai AI, 2003, HUM IMMUNOL, V64, P31, DOI 10.1016/S0198-8859(02)00742-5; Correale J, 2010, ANN NEUROL, V67, P625, DOI 10.1002/ana.21944; Corthay A, 2009, SCAND J IMMUNOL, V70, P326, DOI 10.1111/j.1365-3083.2009.02308.x; Dallas SL, 2002, J BIOL CHEM, V277, P21352, DOI 10.1074/jbc.M111663200; DASCH JR, 1989, J IMMUNOL, V142, P1536; David JP, 2007, ADV IMMUNOL, V95, P149, DOI 10.1016/S0065-2776(07)95005-1; Davidson TS, 2007, J IMMUNOL, V178, P4022, DOI 10.4049/jimmunol.178.7.4022; Fantini MC, 2004, J IMMUNOL, V172, P5149, DOI 10.4049/jimmunol.172.9.5149; Filgueira L, 2004, J HISTOCHEM CYTOCHEM, V52, P411, DOI 10.1177/002215540405200312; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Fox SW, 2000, BIOCHEM BIOPH RES CO, V276, P868, DOI 10.1006/bbrc.2000.3577; Fuller K, 2000, J CELL SCI, V113, P2445; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Haribhai D, 2007, J IMMUNOL, V178, P2961, DOI 10.4049/jimmunol.178.5.2961; Haylock DN, 2005, CELL CYCLE, V4, P1353, DOI 10.4161/cc.4.10.2056; Henriksen K, 2009, BONE, V44, P1026, DOI 10.1016/j.bone.2009.03.671; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Huang X, 2011, J DENT RES, V90, P981, DOI 10.1177/0022034511408613; Huter EN, 2008, EUR J IMMUNOL, V38, P1814, DOI 10.1002/eji.200838346; Jiang H, 2008, HUM IMMUNOL, V69, P721, DOI 10.1016/j.humimm.2008.08.279; Kared H, 2006, IMMUNITY, V25, P823, DOI 10.1016/j.immuni.2006.09.008; Kezuka T, 2000, INVEST OPHTH VIS SCI, V41, P1803; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Kiesel J, 2007, DEV DYNAM, V236, P2181, DOI 10.1002/dvdy.21206; Kiesel JR, 2009, J IMMUNOL, V182, P5477, DOI 10.4049/jimmunol.0803897; Kiniwa Y, 2007, CLIN CANCER RES, V13, P6947, DOI 10.1158/1078-0432.CCR-07-0842; Kohara H, 2011, IMMUNOL LETT, V137, P53, DOI 10.1016/j.imlet.2011.02.017; Kollet O, 2007, ANNU REV IMMUNOL, V25, P51, DOI 10.1146/annurev.immunol.25.022106.141631; Kollet O, 2006, NAT MED, V12, P657, DOI 10.1038/nm1417; Konya C, 2009, EXPERT OPIN BIOL TH, V9, P951, DOI 10.1517/14712590903020759; Krause CD, 2000, J BIOL CHEM, V275, P22995, DOI 10.1074/jbc.M909607199; Li HY, 2010, BLOOD, V116, P210, DOI 10.1182/blood-2009-11-255026; Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737; Li MO, 2006, IMMUNITY, V25, P455, DOI 10.1016/j.immuni.2006.07.011; Lin W, 2007, NAT IMMUNOL, V8, P359, DOI 10.1038/ni1445; Lorenzo J, 2005, IMMUNOL REV, V208, P5, DOI 10.1111/j.0105-2896.2005.00340.x; Luxenburg C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000179; Martin TJ, 2008, BEST PRACT RES CL EN, V22, P701, DOI 10.1016/j.beem.2008.07.006; Matsuo K, 2008, ARCH BIOCHEM BIOPHYS, V473, P201, DOI 10.1016/j.abb.2008.03.027; Mayer CT, 2011, EUR J IMMUNOL, V41, P716, DOI 10.1002/eji.201040913; Meloni F, 2006, HUM IMMUNOL, V67, P1, DOI 10.1016/j.humimm.2005.11.005; Mossetti G, 2005, BONE, V36, P549, DOI 10.1016/j.bone.2004.11.004; Nagahama K, 2004, BONE, V35, P1059, DOI 10.1016/j.bone.2004.06.018; Niederkorn JY, 2008, CURR OPIN IMMUNOL, V20, P327, DOI 10.1016/j.coi.2008.02.003; Novack DV, 2008, ANNU REV PATHOL-MECH, V3, P457, DOI 10.1146/annurev.pathmechdis.3.121806.151431; Novack DV, 2011, AGEING RES REV, V10, P54, DOI 10.1016/j.arr.2009.09.005; OURSLER MJ, 1994, J BONE MINER RES, V9, P443; Pacifici R, 2008, CELL IMMUNOL, V252, P68, DOI 10.1016/j.cellimm.2007.06.008; Pandiyan P, 2007, NAT IMMUNOL, V8, P1353, DOI 10.1038/ni1536; Paterson AM, 2010, NAT IMMUNOL, V11, P109, DOI 10.1038/ni0210-109; Pillai MR, 2011, J IMMUNOL, V187, P4987, DOI 10.4049/jimmunol.1102173; Rodan GA, 2000, SCIENCE, V289, P1508, DOI 10.1126/science.289.5484.1508; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; Sato K, 2006, J EXP MED, V203, P2673, DOI 10.1084/jem.20061775; Sato Kojiro, 2008, Allergol Int, V57, P109, DOI 10.2332/allergolint.R-07-158; Schubert LA, 2001, J BIOL CHEM, V276, P37672, DOI 10.1074/jbc.M104521200; Sharabi A, 2008, J IMMUNOL, V181, P3243, DOI 10.4049/jimmunol.181.5.3243; Shevach EM, 2006, IMMUNITY, V25, P195, DOI 10.1016/j.immuni.2006.08.003; Shevach EM, 2006, IMMUNOL REV, V212, P60, DOI 10.1111/j.0105-2896.2006.00415.x; Singh RP, 2007, J IMMUNOL, V178, P7649, DOI 10.4049/jimmunol.178.12.7649; Soysa Niroshani Surangika, 2009, Journal of Medical and Dental Sciences, V56, P107; Stephens GL, 2007, J IMMUNOL, V178, P6901, DOI 10.4049/jimmunol.178.11.6901; Suda T, 1999, ENDOCR REV, V20, P345, DOI 10.1210/er.20.3.345; Suzuki M, 2008, HUM IMMUNOL, V69, P781, DOI 10.1016/j.humimm.2008.08.283; Takahashi T, 1998, INT IMMUNOL, V10, P1969, DOI 10.1093/intimm/10.12.1969; Takami M, 1999, CELL TISSUE RES, V298, P327, DOI 10.1007/s004419900092; Takayanagi Hiroshi, 2005, Mod Rheumatol, V15, P225; Takayanagi H, 2007, NAT REV IMMUNOL, V7, P292, DOI 10.1038/nri2062; Takayanagi H, 2002, ARTHRITIS RES THER, V4, pS227, DOI 10.1186/ar581; Taubman MA, 2005, J PERIODONTOL, V76, P2033, DOI 10.1902/jop.2005.76.11-S.2033; Teng YTA, 2006, J DENT RES, V85, P209, DOI 10.1177/154405910608500302; Theill LE, 2002, ANNU REV IMMUNOL, V20, P795, DOI 10.1146/annurev.immunol.20.100301.064753; Tomimori Y, 2009, J BONE MINER RES, V24, P1194, DOI [10.1359/JBMR.090217, 10.1359/jbmr.090217]; Tsai SE, 2010, IMMUNITY, V32, P568, DOI 10.1016/j.immuni.2010.03.015; Udagawa N, 1999, BONE, V25, P517, DOI 10.1016/S8756-3282(99)00210-0; van der Vliet HJJ, 2007, CLIN DEV IMMUNOL, DOI 10.1155/2007/89017; VantHof RJ, 1997, J BONE MINER RES, V12, P1797, DOI 10.1359/jbmr.1997.12.11.1797; Walsh MC, 2006, ANNU REV IMMUNOL, V24, P33, DOI 10.1146/annurev.immunol.24.021605.090646; Waschbisch A, 2010, J NEUROIMMUNOL, V225, P137, DOI 10.1016/j.jneuroim.2010.03.013; Zaiss MM, 2007, ARTHRITIS RHEUM, V56, P4104, DOI 10.1002/art.23138; Zhang HJ, 2011, AM J PHYSIOL-RENAL, V301, pF171, DOI 10.1152/ajprenal.00339.2010; Zheng SG, 2004, J IMMUNOL, V172, P5213, DOI 10.4049/jimmunol.172.9.5213	101	55	57	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e38199	10.1371/journal.pone.0038199	http://dx.doi.org/10.1371/journal.pone.0038199			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701612	Green Published, Green Submitted, gold			2022-12-27	WOS:000305348400040
J	Rosa, R; Pimentel, MS; Boavida-Portugal, J; Teixeira, T; Trubenbach, K; Diniz, M				Rosa, Rui; Pimentel, Marta S.; Boavida-Portugal, Joana; Teixeira, Tatiana; Truebenbach, Katja; Diniz, Mario			Ocean Warming Enhances Malformations, Premature Hatching, Metabolic Suppression and Oxidative Stress in the Early Life Stages of a Keystone Squid	PLOS ONE			English	Article							THERMAL TOLERANCE; LOLIGO-VULGARIS; CLIMATE-CHANGE; EMBRYONIC-DEVELOPMENT; ELEVATED-TEMPERATURE; FOOD AVAILABILITY; MARINE; GROWTH; FISH; HISTORY	Background: The knowledge about the capacity of organisms' early life stages to adapt to elevated temperatures is very limited but crucial to understand how marine biota will respond to global warming. Here we provide a comprehensive and integrated view of biological responses to future warming during the early ontogeny of a keystone invertebrate, the squid Loligo vulgaris. Methodology/Principal Findings: Recently-spawned egg masses were collected and reared until hatching at present day and projected near future (+2 degrees C)temperatures, to investigate the ability of early stages to undergo thermal acclimation, namely phenotypic altering of morphological, behavioural, biochemical and physiological features. Our findings showed that under the projected near-future warming, the abiotic conditions inside the eggs promoted metabolic suppression, which was followed by premature hatching. Concomitantly, the less developed newborns showed greater incidence of malformations. After hatching, the metabolic burst associated with the transition from an encapsulated embryo to a planktonic stage increased linearly with temperature. However, the greater exposure to environmental stress by the hatchlings seemed to be compensated by physiological mechanisms that reduce the negative effects on fitness. Heat shock proteins (HSP70/HSC70) and antioxidant enzymes activities constituted an integrated stress response to ocean warming in hatchlings (but not in embryos). Conclusions/Significance: The stressful abiotic conditions inside eggs are expected to be aggravated under the projected near-future ocean warming, with deleterious effects on embryo survival and growth. Greater feeding challenges and the lower thermal tolerance limits of the hatchlings are strictly connected to high metabolic demands associated with the planktonic life strategy. Yet, we found some evidence that, in the future, the early stages might support higher energy demands by adjusting some cellular functional properties to increase their thermal tolerance windows.	[Rosa, Rui; Pimentel, Marta S.; Boavida-Portugal, Joana; Teixeira, Tatiana; Truebenbach, Katja] Univ Lisbon, Fac Ciencias, Lab Maritimo Guia, Ctr Oceanog, Cascais, Portugal; [Diniz, Mario] Univ Nova Lisboa, REQUIMTE, Dept Quim, Ctr Quim Fina & Biotecnol,Fac Ciencias & Tecnol, Caparica, Portugal	Universidade de Lisboa; Universidade Nova de Lisboa	Rosa, R (corresponding author), Univ Lisbon, Fac Ciencias, Lab Maritimo Guia, Ctr Oceanog, Cascais, Portugal.	rrosa@fc.ul.pt	Rosa, Rui/A-4580-2009; Pimentel, Marta S/H-3229-2014; Pimentel, Marta S./I-4844-2012; Diniz, Mário/C-7849-2013; REQUIMTE, C4O/M-5599-2013; Boavida-Portugal, Joana/I-4525-2012; Trubenbach, Katja/I-4841-2012	Rosa, Rui/0000-0003-2801-5178; Pimentel, Marta S/0000-0003-3248-4479; Diniz, Mário/0000-0003-1571-0366; Boavida-Portugal, Joana/0000-0001-5101-227X; Trubenbach, Katja/0000-0002-1824-608X	Portuguese Foundation for Science and Technology (FCT) [PTDC/BIA-BEC/103266/2008, PTDC/MAR/0908066/2008]	Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology)	The Portuguese Foundation for Science and Technology (FCT) supported this study through project grants PTDC/BIA-BEC/103266/2008 and PTDC/MAR/0908066/2008 to RR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartol IK, 2009, J EXP BIOL, V212, P1506, DOI 10.1242/jeb.026948; Boavida-Portugal J, 2010, FISH RES, V106, P193, DOI 10.1016/j.fishres.2010.06.002; Boyle P, 2005, CEPHALOPODS: ECOLOGY AND FISHERIES, P1, DOI 10.1002/9780470995310; Burt JM, 2011, REV FISH BIOL FISHER, V21, P377, DOI 10.1007/s11160-010-9179-1; Byrne M, 2011, OCEANOGR MAR BIOL, V49, P1; Cooper RU, 2002, J EXP MAR BIOL ECOL, V279, P1, DOI 10.1016/S0022-0981(02)00329-5; Cronin ER, 2000, MAR BIOL, V136, P863, DOI 10.1007/s002270000274; de Oliveira UO, 2005, COMP BIOCHEM PHYS B, V140, P51, DOI 10.1016/j.cbpc.2004.09.026; Donelson JM, 2010, MAR ECOL PROG SER, V401, P233, DOI 10.3354/meps08366; Donelson JM, 2011, GLOBAL CHANGE BIOL, V17, P1712, DOI 10.1111/j.1365-2486.2010.02339.x; Edwards M, 2004, NATURE, V430, P881, DOI 10.1038/nature02808; Grieshaber M K, 1994, Rev Physiol Biochem Pharmacol, V125, P43, DOI 10.1007/BFb0030909; Gutowska MA, 2009, MAR BIOL, V156, P515, DOI 10.1007/s00227-008-1096-7; Helmuth B, 2006, ANNU REV ECOL EVOL S, V37, P373, DOI 10.1146/annurev.ecolsys.37.091305.110149; Hu MY, 2011, AM J PHYSIOL-REG I, V301, pR1700, DOI 10.1152/ajpregu.00107.2011; Hu MY, 2010, CELL TISSUE RES, V339, P571, DOI 10.1007/s00441-009-0921-8; Jordaan A, 2003, BIG FISH BANG, P45; Kamler E, 2008, REV FISH BIOL FISHER, V18, P143, DOI 10.1007/s11160-007-9070-x; Lesser MP, 2006, ANNU REV PHYSIOL, V68, P253, DOI 10.1146/annurev.physiol.68.040104.110001; Levitus S, 2005, GEOPHYS RES LETT, V32; Mackenzie BR, 2007, GLOBAL CHANGE BIOL, V13, P1335, DOI 10.1111/j.1365-2486.2007.01360.x; Meehl GA, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P747; Moreno A, 2009, J PLANKTON RES, V31, P73, DOI 10.1093/plankt/fbn103; Munday PL, 2008, CORAL REEFS, V27, P927, DOI 10.1007/s00338-008-0393-4; Munday PL, 2009, MAR ECOL PROG SER, V388, P235, DOI 10.3354/meps08137; Naef A, 1928, MONOGRAPHIA, V35, P194; Njemini R, 2005, J IMMUNOL METHODS, V306, P176, DOI 10.1016/j.jim.2005.08.012; Oosthuizen A, 2002, S AFR J MARINE SCI, V24, P379, DOI 10.2989/025776102784528367; Oyarzun FX, 2011, INTEGR COMP BIOL, V51, P81, DOI 10.1093/icb/icr009; Pechenik J.A., 1987, P551; Pechenik JA, 1999, MAR ECOL PROG SER, V177, P269, DOI 10.3354/meps177269; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; Portner HO, 2007, SCIENCE, V315, P95, DOI 10.1126/science.1135471; Portner HO, 2002, COMP BIOCHEM PHYS A, V132, P739, DOI 10.1016/S1095-6433(02)00045-4; Portner HO, 2004, RESP PHYSIOL NEUROBI, V141, P243, DOI 10.1016/j.resp.2004.03.011; Prosser CL, 1994, ENV METABOLIC ANIMAL; Przeslawski Rachel, 2004, Molluscan Research, V24, P43, DOI 10.1071/MR04001; Rosa R, 2008, P NATL ACAD SCI USA, V105, P20776, DOI 10.1073/pnas.0806886105; Rosa R, 2010, PROG OCEANOGR, V86, P72, DOI 10.1016/j.pocean.2010.04.004; Rosa R, 2009, PHYSIOL BIOCHEM ZOOL, V82, P419, DOI 10.1086/591950; Rosa R, 2008, ECOLOGY, V89, P3449, DOI 10.1890/08-0638.1; Santos F. D., 2002, CLIMATE CHANGE PORTU; Sokolova IM, 2012, OXIDATIVE STRESS IN AQUATIC ECOSYSTEMS, P263; Stillman JH, 2000, PHYSIOL BIOCHEM ZOOL, V73, P200, DOI 10.1086/316738; STRATHMANN RR, 1985, ANNU REV ECOL SYST, V16, P339, DOI 10.1146/annurev.es.16.110185.002011; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Vidal EAG, 2002, B MAR SCI, V71, P915; Villanueva R, 2000, MAR BIOL, V136, P449, DOI 10.1007/s002270050704; Villanueva R, 2003, MAR ECOL PROG SER, V253, P197, DOI 10.3354/meps253197; Villanueva R, 2007, REV FISH BIOL FISHER, V17, P101, DOI 10.1007/s11160-006-9022-x	50	68	69	0	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e38282	10.1371/journal.pone.0038282	http://dx.doi.org/10.1371/journal.pone.0038282			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701620	Green Submitted, Green Published, gold			2022-12-27	WOS:000305348400045
J	Wang, N; Leung, HT; Mazalouskas, MD; Watkins, GR; Gomez, RJ; Wadzinski, BE				Wang, Ning; Leung, Hung-Tat; Mazalouskas, Matthew D.; Watkins, Guy R.; Gomez, Rey J.; Wadzinski, Brian E.			Essential Roles of the Tap42-Regulated Protein Phosphatase 2A (PP2A) Family in Wing Imaginal Disc Development of Drosophila melanogaster	PLOS ONE			English	Article							ALPHA4 PROTEIN; SIGNALING PATHWAY; PERIPODIAL CELLS; THORAX CLOSURE; JNK PATHWAY; GAL4 SYSTEM; TAP42; DORSAL; PHOSPHORYLATION; MORPHOGENESIS	Protein ser/thr phosphatase 2A family members (PP2A, PP4, and PP6) are implicated in the control of numerous biological processes, but our understanding of the in vivo function and regulation of these enzymes is limited. In this study, we investigated the role of Tap42, a common regulatory subunit for all three PP2A family members, in the development of Drosophila melanogaster wing imaginal discs. RNAi-mediated silencing of Tap42 using the binary Gal4/UAS system and two disc drivers, pnr- and ap-Gal4, not only decreased survival rates but also hampered the development of wing discs, resulting in a remarkable thorax cleft and defective wings in adults. Silencing of Tap42 also altered multiple signaling pathways (HH, JNK and DPP) and triggered apoptosis in wing imaginal discs. The Tap42(RNAi)-induced defects were the direct result of loss of regulation of Drosophila PP2A family members (MTS, PP4, and PPV), as enforced expression of wild type Tap42, but not a phosphatase binding defective Tap42 mutant, rescued fly survivorship and defects. The experimental platform described herein identifies crucial roles for Tap42 center dot phosphatase complexes in governing imaginal disc and fly development.	[Wang, Ning; Mazalouskas, Matthew D.; Watkins, Guy R.; Gomez, Rey J.; Wadzinski, Brian E.] Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN 37232 USA; [Leung, Hung-Tat] Grambling State Univ, Dept Biol Sci, Grambling, LA USA	Vanderbilt University; University of Louisiana System; Grambling State University	Wang, N (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN 37232 USA.	brian.wadzinski@vanderbilt.edu			National Institutes of Health [GM051366, DK070787]; Minority Biomedical Research Support-Research Initiative for Scientific Enhancement (MBRS-RISE) Program [5R25GM066714-07]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070787] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R56GM051366, R25GM066714, R01GM051366] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Minority Biomedical Research Support-Research Initiative for Scientific Enhancement (MBRS-RISE) Program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM051366 and DK070787 (to B. E. W.) and 5R25GM066714-07, Minority Biomedical Research Support-Research Initiative for Scientific Enhancement (MBRS-RISE) Program to Grambling State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi-Yamada T, 1999, NATURE, V400, P166, DOI 10.1038/22112; Agnes F, 1999, CR ACAD SCI III-VIE, V322, P5, DOI 10.1016/S0764-4469(99)80012-2; Agnes F, 1999, DEVELOPMENT, V126, P5453; Alcedo J, 2000, MOL CELL, V6, P457, DOI 10.1016/S1097-2765(00)00044-7; BATE M, 1991, DEVELOPMENT, V112, P755; Bielinski VA, 2007, EXP CELL RES, V313, P3117, DOI 10.1016/j.yexcr.2007.05.008; Calleja M, 2000, DEVELOPMENT, V127, P3971; Chen J, 1998, BIOCHEM BIOPH RES CO, V247, P827, DOI 10.1006/bbrc.1998.8792; Chen LP, 2011, ONCOGENE, V30, P2943, DOI 10.1038/onc.2011.20; Cygnar KD, 2005, GENETICS, V170, P733, DOI 10.1534/genetics.104.039909; DIAZBENJUMEA FJ, 1993, CELL, V75, P741, DOI 10.1016/0092-8674(93)90494-B; DiComo CJ, 1996, GENE DEV, V10, P1904, DOI 10.1101/gad.10.15.1904; Duffy JB, 2002, GENESIS, V34, P1, DOI 10.1002/gene.10150; Elliott David A., 2008, V420, P79, DOI 10.1007/978-1-59745-583-1_5; Gibson MC, 2000, CELL, V103, P343, DOI 10.1016/S0092-8674(00)00125-2; Gibson MC, 2002, DEV CELL, V3, P451, DOI 10.1016/S1534-5807(02)00264-2; Gibson MC, 2001, BIOESSAYS, V23, P691, DOI 10.1002/bies.1098; Gotz J, 1998, P NATL ACAD SCI USA, V95, P12370, DOI 10.1073/pnas.95.21.12370; Harlow E., 1999, USING ANTIBODIES LAB; Huangfu D, 2006, DEVELOPMENT, V133, P3, DOI 10.1242/dev.02169; Jacinto E, 2001, MOL CELL, V8, P1017, DOI 10.1016/S1097-2765(01)00386-0; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Jia H, 2009, DEVELOPMENT, V136, P307, DOI 10.1242/dev.030015; Kloeker S, 2003, PROTEIN EXPRES PURIF, V31, P19, DOI 10.1016/S1046-5928(03)00141-4; Kong M, 2004, SCIENCE, V306, P695, DOI 10.1126/science.1100537; Kong M, 2007, J BIOL CHEM, V282, P29712, DOI 10.1074/jbc.M703159200; Kong M, 2009, MOL CELL, V36, P51, DOI 10.1016/j.molcel.2009.09.025; LeNoue-Newton M, 2011, J BIOL CHEM, V286, P17665, DOI 10.1074/jbc.M111.222414; LUNDGREN SE, 1995, DEVELOPMENT, V121, P1769; Maeda K, 1999, EUR J BIOCHEM, V264, P702, DOI 10.1046/j.1432-1327.1999.00571.x; Martin-Blanco E, 2000, P NATL ACAD SCI USA, V97, P7888, DOI 10.1073/pnas.97.14.7888; MartinBlanco E, 1997, CURR OPIN GENET DEV, V7, P666, DOI 10.1016/S0959-437X(97)80015-9; McConnell JL, 2010, BIOCHEMISTRY-US, V49, P1713, DOI 10.1021/bi901837h; Nanahoshi M, 1998, BIOCHEM BIOPH RES CO, V251, P520, DOI 10.1006/bbrc.1998.9493; Nybakken K, 2005, NAT GENET, V37, P1323, DOI 10.1038/ng1682; Pallavi SK, 2003, DEVELOPMENT, V130, P4931, DOI 10.1242/dev.00719; Pallavi SK, 2005, J CELL SCI, V118, P3363, DOI 10.1242/jcs.02464; Sato M, 1999, DEVELOPMENT, V126, P1457; Su Y, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001747; Tanimoto H, 2000, MOL CELL, V5, P59, DOI 10.1016/S1097-2765(00)80403-7; Tripura C, 2011, INT J DEV BIOL, V55, P583, DOI 10.1387/ijdb.103275ct; Umemori M, 2009, GENE REGUL SYST BIO, V3, P11; Virshup DM, 2000, CURR OPIN CELL BIOL, V12, P180, DOI 10.1016/S0955-0674(99)00074-5; Wang HM, 2003, MOL CELL BIOL, V23, P3116, DOI 10.1128/MCB.23.9.3116-3125.2003; Wang N, 2008, J NEUROSCI, V28, P1444, DOI 10.1523/JNEUROSCI.5134-07.2008; Yamashita T, 2006, BRAIN RES, V1082, P1, DOI 10.1016/j.brainres.2006.01.101; Yang J, 2007, BIOCHEMISTRY-US, V46, P8807, DOI 10.1021/bi7007118; Zeitlinger J, 1999, DEVELOPMENT, V126, P3947; Zolnierowicz S, 2000, BIOCHEM PHARMACOL, V60, P1225, DOI 10.1016/S0006-2952(00)00424-X	49	6	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e38569	10.1371/journal.pone.0038569	http://dx.doi.org/10.1371/journal.pone.0038569			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701670	Green Published, Green Submitted, gold			2022-12-27	WOS:000305348400073
J	Gao, S; Hu, JH; Gong, DK; Chen, SF; Kendrick, KM; Yao, DZ				Gao, Shan; Hu, Jiehui; Gong, Diankun; Chen, Sifan; Kendrick, Keith M.; Yao, Dezhong			Integration of Consonant and Pitch Processing as Revealed by the Absence of Additivity in Mismatch Negativity	PLOS ONE			English	Article							AUDITORY CHANGE-DETECTION; SPEECH-PERCEPTION; DIFFERENT REFERENCES; INFINITY REFERENCE; SENSORY MEMORY; HUMAN BRAIN; MUSIC; EEG; LANGUAGE; CORTEX	Consonants, unlike vowels, are thought to be speech specific and therefore no interactions would be expected between consonants and pitch, a basic element for musical tones. The present study used an electrophysiological approach to investigate whether, contrary to this view, there is integrative processing of consonants and pitch by measuring additivity of changes in the mismatch negativity (MMN) of evoked potentials. The MMN is elicited by discriminable variations occurring in a sequence of repetitive, homogeneous sounds. In the experiment, event-related potentials (ERPs) were recorded while participants heard frequently sung consonant-vowel syllables and rare stimuli deviating in either consonant identity only, pitch only, or in both dimensions. Every type of deviation elicited a reliable MMN. As expected, the two single-deviant MMNs had similar amplitudes, but that of the double-deviant MMN was also not significantly different from them. This absence of additivity in the double-deviant MMN suggests that consonant and pitch variations are processed, at least at a pre-attentive level, in an integrated rather than independent way. Domain-specificity of consonants may depend on higher-level processes in the hierarchy of speech perception.	[Gao, Shan; Hu, Jiehui; Gong, Diankun; Chen, Sifan; Kendrick, Keith M.; Yao, Dezhong] Univ Elect Sci & Technol China, Sch Life Sci & Technol, Minist Educ, Key Lab NeuroInformat, Chengdu 610054, Peoples R China; [Gao, Shan; Hu, Jiehui] Univ Elect Sci & Technol China, Sch Foreign Languages, Chengdu 610054, Peoples R China; [Chen, Sifan] Univ Elect Sci & Technol China, Mental Hlth Educ & Counseling Ctr, Chengdu 610054, Peoples R China	University of Electronic Science & Technology of China; University of Electronic Science & Technology of China; University of Electronic Science & Technology of China	Gao, S (corresponding author), Univ Elect Sci & Technol China, Sch Life Sci & Technol, Minist Educ, Key Lab NeuroInformat, Chengdu 610054, Peoples R China.	kkendrick@uestc.edu.cn; dyao@uestc.edu.cn	Gao, Shan/AAI-1589-2019	Yao, Dezhong/0000-0002-8042-879X; Gong, Diankun/0000-0001-5598-3778; Kendrick, Keith/0000-0002-0371-5904	973 Project [2011CB707803]; NSFC [60736029]; PCSIRT; 111 Project; doctor Training Fund of MOE [20100185110016]; Chinese Ministry of Education Social Science Funding [11YJC880079]; Chinese National Educational Research Key Project [GPA115005]; Chinese Fundamental Research Funding for Central Universities [ZYGX2010J143, ZYGX2010J137]; Sichuan Provincial Research Funding of Sichuan Applied Psychological Research Center [CXSL-01002014]	973 Project(National Basic Research Program of China); NSFC(National Natural Science Foundation of China (NSFC)); PCSIRT(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); 111 Project(Ministry of Education, China - 111 Project); doctor Training Fund of MOE; Chinese Ministry of Education Social Science Funding; Chinese National Educational Research Key Project; Chinese Fundamental Research Funding for Central Universities; Sichuan Provincial Research Funding of Sichuan Applied Psychological Research Center	This work is supported by the 973 Project No. 2011CB707803, the NSFC No. 60736029 (http://www.nsfc.gov.cn/Portal0/default106.htm), the PCSIRT and 111 Project, the doctor Training Fund of MOE No. 20100185110016, Chinese Ministry of Education Social Science Funding (11YJC880079), Chinese National Educational Research Key Project (GPA115005), Chinese Fundamental Research Funding for Central Universities (ZYGX2010J143, ZYGX2010J137), and Sichuan Provincial Research Funding (CXSL-01002014) of Sichuan Applied Psychological Research Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alain C, 1997, PSYCHOPHYSIOLOGY, V34, P534, DOI 10.1111/j.1469-8986.1997.tb01740.x; ALHO K, 1995, EAR HEARING, V16, P38, DOI 10.1097/00003446-199502000-00004; Bigand E, 2001, COGNITION, V81, pB11, DOI 10.1016/S0010-0277(01)00117-2; Binder JR, 2000, CEREB CORTEX, V10, P512, DOI 10.1093/cercor/10.5.512; Czigler I, 1996, NEUROREPORT, V7, P2413, DOI 10.1097/00001756-199611040-00002; Di Carlo N.S., 2007, J SING, V63, P1; Fry DB, 1956, R JAKOBSON; Garner W. R., 1974, PROCESSING INFORM ST; GIARD MH, 1995, J COGNITIVE NEUROSCI, V7, P133, DOI 10.1162/jocn.1995.7.2.133; Guitton MJ, 2010, COMPUT HUM BEHAV, V26, P1772, DOI 10.1016/j.chb.2010.07.004; Hickok G, 2000, TRENDS COGN SCI, V4, P131, DOI 10.1016/S1364-6613(00)01463-7; Jancke L, 2002, NEUROIMAGE, V15, P733, DOI 10.1006/nimg.2001.1027; Knosche TR, 2002, NEUROIMAGE, V17, P1493, DOI 10.1006/nimg.2002.1262; Koelsch S, 2004, NAT NEUROSCI, V7, P302, DOI 10.1038/nn1197; Kolinsky R, 2009, COGNITION, V112, P1, DOI 10.1016/j.cognition.2009.02.014; Lei X, 2011, HUM BRAIN MAPP, V32, P1141, DOI 10.1002/hbm.21098; LEVANEN S, 1993, EXP BRAIN RES, V97, P177; LIBERMAN AM, 1989, SCIENCE, V243, P489, DOI 10.1126/science.2643163; Lidji P, 2010, CLIN NEUROPHYSIOL, V121, P533, DOI 10.1016/j.clinph.2009.12.018; Maess B, 2001, NAT NEUROSCI, V4, P540, DOI 10.1038/87502; May P, 1999, J COMPUT NEUROSCI, V6, P99, DOI 10.1023/A:1008896417606; Naatanen R, 2007, CLIN NEUROPHYSIOL, V118, P2544, DOI 10.1016/j.clinph.2007.04.026; Naatanen R., 1995, Brain Topography, V7, P315, DOI 10.1007/BF01195257; Paavilainen P, 2001, NEUROSCI LETT, V301, P179, DOI 10.1016/S0304-3940(01)01635-4; Patel AD, 2003, NAT NEUROSCI, V6, P674, DOI 10.1038/nn1082; Patel AD, 2003, COGNITION, V87, pB35, DOI 10.1016/S0010-0277(02)00187-7; Peretz I, 2006, COGNITION, V100, P1, DOI 10.1016/j.cognition.2005.11.004; Qin Y, 2010, CLIN NEUROPHYSIOL, V121, P1981, DOI 10.1016/j.clinph.2010.03.056; Schroger E, 1997, PSYCHOPHYSIOLOGY, V34, P245, DOI 10.1111/j.1469-8986.1997.tb02395.x; Scotto di Carlo N., 2007, J SINGING, V63, P559; SHARMA A, 1993, ELECTROEN CLIN NEURO, V88, P64, DOI 10.1016/0168-5597(93)90029-O; Sharma Mridula, 2004, J Am Acad Audiol, V15, P616, DOI 10.3766/jaaa.15.9.3; Shtyrov Y, 2005, NEUROIMAGE, V27, P37, DOI 10.1016/j.neuroimage.2005.02.003; Steinbeis N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002226; STUDDERT.M, 1972, COGNITIVE PSYCHOL, V3, P455, DOI 10.1016/0010-0285(72)90017-5; Studdert-Kennedy M., 1974, CURR TRENDS LINGUIST, P2349; Takegata R, 1999, NEUROSCI LETT, V266, P109, DOI 10.1016/S0304-3940(99)00267-0; Vouloumanos A, 2001, J COGNITIVE NEUROSCI, V13, P994, DOI 10.1162/089892901753165890; Wolff C, 2001, NEUROSCI LETT, V311, P37, DOI 10.1016/S0304-3940(01)02135-8; WOOD CC, 1974, PERCEPT PSYCHOPHYS, V15, P501, DOI 10.3758/BF03199292; Wood CC, 1975, J EXPT PSYCHOLOGY HU, V1, P3; Xu P, 2007, IEEE T BIO-MED ENG, V54, P400, DOI 10.1109/TBME.2006.886640; Yao DZ, 2000, IEEE T BIO-MED ENG, V47, P964, DOI 10.1109/10.846691; Yao DZ, 2005, PHYSIOL MEAS, V26, P173, DOI 10.1088/0967-3334/26/3/003; Yao DZ, 2001, PHYSIOL MEAS, V22, P693, DOI 10.1088/0967-3334/22/4/305; Ylinen S, 2005, NEUROREPORT, V16, P1857, DOI 10.1097/01.wnr.0000185959.11465.9b; Zatorre RJ, 2002, TRENDS COGN SCI, V6, P37, DOI 10.1016/S1364-6613(00)01816-7	47	5	5	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38289	10.1371/journal.pone.0038289	http://dx.doi.org/10.1371/journal.pone.0038289			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TY	22693614	Green Published, Green Submitted, gold			2022-12-27	WOS:000305338500125
J	Hanel, R; Pochacker, M; Scholling, M; Thurner, S				Hanel, Rudolf; Poechacker, Manfred; Schoelling, Manuel; Thurner, Stefan			A Self-Organized Model for Cell-Differentiation Based on Variations of Molecular Decay Rates	PLOS ONE			English	Article							GENETIC REGULATORY NETWORKS; FOXO TRANSCRIPTION FACTORS; QUALITATIVE SIMULATION; PROTEIN-DEGRADATION; ESCHERICHIA-COLI; BOOLEAN NETWORKS; SYSTEMS BIOLOGY; EXPRESSION; DYNAMICS; OSCILLATIONS	Systemic properties of living cells are the result of molecular dynamics governed by so-called genetic regulatory networks (GRN). These networks capture all possible features of cells and are responsible for the immense levels of adaptation characteristic to living systems. At any point in time only small subsets of these networks are active. Any active subset of the GRN leads to the expression of particular sets of molecules (expression modes). The subsets of active networks change over time, leading to the observed complex dynamics of expression patterns. Understanding of these dynamics becomes increasingly important in systems biology and medicine. While the importance of transcription rates and catalytic interactions has been widely recognized in modeling genetic regulatory systems, the understanding of the role of degradation of biochemical agents (mRNA, protein) in regulatory dynamics remains limited. Recent experimental data suggests that there exists a functional relation between mRNA and protein decay rates and expression modes. In this paper we propose a model for the dynamics of successions of sequences of active subnetworks of the GRN. The model is able to reproduce key characteristics of molecular dynamics, including homeostasis, multi-stability, periodic dynamics, alternating activity, differentiability, and self-organized critical dynamics. Moreover the model allows to naturally understand the mechanism behind the relation between decay rates and expression modes. The model explains recent experimental observations that decay-rates (or turnovers) vary between differentiated tissue-classes at a general systemic level and highlights the role of intracellular decay rate control mechanisms in cell differentiation.	[Hanel, Rudolf; Poechacker, Manfred; Schoelling, Manuel; Thurner, Stefan] Med Univ Vienna, Sect Sci Complex Syst, CeMSIIS, Vienna, Austria; [Thurner, Stefan] Santa Fe Inst, Santa Fe, NM 87501 USA	Medical University of Vienna; The Santa Fe Institute	Hanel, R (corresponding author), Med Univ Vienna, Sect Sci Complex Syst, CeMSIIS, Vienna, Austria.	stefan.thurner@meduniwien.ac.at		Hanel, Rudolf/0000-0002-4045-9532	"Forum Integrativmedizin" (FIM) an initiative of the "Hilde Umdasch Privatstiftung"	"Forum Integrativmedizin" (FIM) an initiative of the "Hilde Umdasch Privatstiftung"	This work has been funded by the "Forum Integrativmedizin" (FIM) an initiative of the "Hilde Umdasch Privatstiftung" (http://www.integrativemedizin.at). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amorim MJ, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.38; Beer MA, 2004, CELL, V117, P185, DOI 10.1016/S0092-8674(04)00304-6; Bhattacharjya A, 1996, PHYS REV LETT, V77, P1644, DOI 10.1103/PhysRevLett.77.1644; Bossi A, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.17; Bratsun D, 2005, P NATL ACAD SCI USA, V102, P14593, DOI 10.1073/pnas.0503858102; Burg MB, 1996, FASEB J, V10, P1598, DOI 10.1096/fasebj.10.14.9002551; Burkard TR, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-17; Capaldi AP, 2008, NAT GENET, V40, P1300, DOI 10.1038/ng.235; Casey R, 2006, J MATH BIOL, V52, P27, DOI 10.1007/s00285-005-0338-2; Church GM, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100007; Ciechanover A, 2006, EXP BIOL MED, V231, P1197; Das D, 2004, P NATL ACAD SCI USA, V101, P16234, DOI 10.1073/pnas.0407365101; de Chassey B, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.66; de Jong H, 2003, BIOINFORMATICS, V19, P336, DOI 10.1093/bioinformatics/btf851; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Gertz J, 2009, NATURE, V457, P215, DOI 10.1038/nature07521; Glass L, 1998, EUROPHYS LETT, V41, P599, DOI 10.1209/epl/i1998-00199-0; GLASS L, 1973, J THEOR BIOL, V39, P103, DOI 10.1016/0022-5193(73)90208-7; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Gsponer J, 2008, SCIENCE, V322, P1365, DOI 10.1126/science.1163581; Guet CC, 2002, SCIENCE, V296, P1466, DOI 10.1126/science.1067407; Hanel R, 2010, PHILOS T R SOC A, V368, P5583, DOI 10.1098/rsta.2010.0267; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Hood L, 2004, SCIENCE, V306, P640, DOI 10.1126/science.1104635; Jothi R, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.52; Kashtan N, 2005, P NATL ACAD SCI USA, V102, P13773, DOI 10.1073/pnas.0503610102; Kauffman S.A., 1993, ORIGINS ORDER; Kitano H, 2002, NATURE, V420, P206, DOI 10.1038/nature01254; LANGTON CG, 1990, PHYSICA D, V42, P12, DOI 10.1016/0167-2789(90)90064-V; Lee JE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011201; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Luscombe NM, 2004, NATURE, V431, P308, DOI 10.1038/nature02782; Metivier R, 2004, EMBO J, V23, P3653, DOI 10.1038/sj.emboj.7600377; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Mitchell M., 1993, Complex Systems, V7, P89; Ozbudak EM, 2004, LETT NATURE, V427, P237; Park JH, 2000, P NATL ACAD SCI USA, V97, P3608, DOI 10.1073/pnas.070036197; Paulsson J, 2000, P NATL ACAD SCI USA, V97, P7148, DOI 10.1073/pnas.110057697; Pigolotti S, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.088701; Pirkkala L, 2001, FASEB J, V15, P1118, DOI 10.1096/fj00-0294rev; Ptashne M, 1992, GENETIC SWITCH PHAGE; Qian XN, 2010, BIOINFORMATICS, V26, P3098, DOI 10.1093/bioinformatics/btq575; Rewienski M, 2003, IEEE ACM T COMP AIDE, P252; Ropers D, 2006, BIOSYSTEMS, V84, P124, DOI 10.1016/j.biosystems.2005.10.005; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Semsey S, 2006, NUCLEIC ACIDS RES, V34, P4960, DOI 10.1093/nar/gkl627; Shmulevich I, 2003, P NATL ACAD SCI USA, V100, P10734, DOI 10.1073/pnas.1534782100; Smolen P, 1998, AM J PHYSIOL-CELL PH, V274, pC531, DOI 10.1152/ajpcell.1998.274.2.C531; Stokic D, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.061917; Tothova Z, 2007, CELL STEM CELL, V1, P140, DOI 10.1016/j.stem.2007.07.017; Turner TE, 2004, COMPUT BIOL CHEM, V28, P165, DOI 10.1016/j.compbiolchem.2004.05.001; Viretta AU, 2004, BIOTECHNOL PROGR, V20, P670, DOI 10.1021/bp034323l; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Vokes SA, 2008, GENE DEV, V22, P2651, DOI 10.1101/gad.1693008; YAGIL G, 1971, BIOPHYS J, V11, P11, DOI 10.1016/S0006-3495(71)86192-1; Zinzen RP, 2009, NATURE, V462, P65, DOI 10.1038/nature08531	56	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e36679	10.1371/journal.pone.0036679	http://dx.doi.org/10.1371/journal.pone.0036679			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693554	Green Published, gold, Green Submitted			2022-12-27	WOS:000305338500015
J	Ishii, H; Iwamoto, Y; Tajima, N				Ishii, Hitoshi; Iwamoto, Yasuhiko; Tajima, Naoko			An Exploration of Barriers to Insulin Initiation for Physicians in Japan: Findings from the Diabetes Attitudes, Wishes and Needs (DAWN) JAPAN Study	PLOS ONE			English	Article							PATIENTS FEARS; TYPE-2; THERAPY; CARE	Objective: Insulin is recommended as an appropriate treatment in type 2 diabetes patients with suboptimal glycemic control; however, its initiation is often delayed. We therefore conducted the DAWN (Diabetes Attitudes, Wishes and Needs) JAPAN study in an attempt to identify specific patient- and physician-related factors which contribute to delay of insulin initiation among Japanese patients with diabetes. In this report, we explored barriers for physicians which prevent timely insulin initiation. Methods: The DAWN JAPAN study is a multicenter, questionnaire-based survey, conducted between 2004 and 2005. Participating physicians were categorized as follows based on their expertise: Japan Diabetes Society (JDS) certified specialists (n = 77), JDS-affiliated physicians (n = 30), and non-JDS-affiliated physicians (n = 27). To assess physician barriers to insulin initiation, we have used a newly developed 27- item questionnaire. Results: The mean age of patients (n = 11,656) treated by participating physicians was 64.1 years. The mean duration of diabetes was 121.6 months, and their mean HbA1c was 7.5%. Insulin was used in 27.4% of total patients. With regard to physician barriers to insulin initiation, the biggest differences in concerns expressed by JDS-certified specialists and non-JDS-affiliated physicians were observed in the following items with statistical significance: "I do not have staff (nurse, pharmacists) who can assist with explanations" (1.3% vs 55.5%, respectively), "I have concerns about the use of insulin therapy in elderly patients" (38.1% vs 81.5%), and "It is difficult to provide guidance and education on insulin injection to patients" (16.9% vs 55.5%). The mean HbA1c at which physicians responded they would recommend insulin to their patients was 8.7%; however, they would reduce this level to 8.2% if they themselves required insulin. Conclusions: Our results demonstrated that physicians have concerns about insulin use, and suggested that their concerns can lead to delay of insulin initiation.	[Ishii, Hitoshi] Tenri Hosp, Dept Endocrinol, Tenri, Nara 632, Japan; [Iwamoto, Yasuhiko] Tokyo Womens Med Univ, Shinjuku Ku, Tokyo, Japan; [Tajima, Naoko] Jikei Univ, Sch Med, Minato Ku, Tokyo, Japan	Tenri Hospital; Tokyo Women's Medical University; Jikei University	Ishii, H (corresponding author), Tenri Hosp, Dept Endocrinol, Tenri, Nara 632, Japan.	hit@tenriyorozu.jp			Novo Nordisk A/S	Novo Nordisk A/S(Novo Nordisk)	This study was funded by Novo Nordisk A/S. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti G., 2002, PRACT DIABETES INT, V19, P22, DOI [DOI 10.1002/pdi.305, DOI 10.1002/PDI.305/PDF]; Bogatean MP, 2004, PRACT DIABETES INT, V21, P247, DOI DOI 10.1002/PDI.670; Cuddihy RM, 2011, DIABETES EDUCATOR, V37, P111, DOI 10.1177/0145721710388426; Funnell MM, 2007, CLIN DIABETES, V25, P36, DOI DOI 10.2337/DIACLIN.25.1.36; Gavin JR, 2010, DIABETES EDUCATOR, V36, p26S, DOI 10.1177/0145721710369637; Haque M, 2005, SAMJ S AFR MED J, V95, P798; Hermanns N, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-113; Hunt LM, 1997, DIABETES CARE, V20, P292, DOI 10.2337/diacare.20.3.292; Karter AJ, 2010, DIABETES CARE, V33, P733, DOI 10.2337/dc09-1184; Kobayashi M, 2006, DIABETES RES CLIN PR, V73, P198, DOI 10.1016/j.diabres.2006.01.013; Korytkowski M, 2002, INT J OBESITY, V26, pS18, DOI 10.1038/sj.ijo.0802173; Kunt T, 2009, INT J CLIN PRACT, V63, P6, DOI 10.1111/j.1742-1241.2009.02176.x; Lauritzen T, 2001, BARRIERS INSULIN THE, P36; Meece J, 2006, DIABETES EDUCATOR, V32, p9S, DOI 10.1177/0145721705285638; Ministry of Education Culture Sports Science and Technology Ministry of Health Labour and Welfare of Japan, 2002, ETH GUID EP RES; Ministry of Welfare Japan, 2002, REP NAT SURV DIAB; Nakar S, 2007, J DIABETES COMPLICAT, V21, P220, DOI 10.1016/j.jdiacomp.2006.02.004; Peyrot M, 2005, DIABETES CARE, V28, P2673, DOI 10.2337/diacare.28.11.2673; Peyrot Mark, 2010, Prim Care Diabetes, V4 Suppl 1, pS11, DOI 10.1016/S1751-9918(10)60004-6; Phillips LS, 2001, ANN INTERN MED, V135, P825, DOI 10.7326/0003-4819-135-9-200111060-00012; Seino Y, 2010, J DIABETES INVEST, V1, P212, DOI 10.1111/j.2040-1124.2010.00074.x; Shichiri M, 2000, DIABETES CARE, V23, pB21; Skovlund SE., 2005, DIABETES SPECTRUM, V18, P136, DOI [10.2337/diaspect.18.3.136, DOI 10.2337/DIASPECT.18.3.136]; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; WOLFFENBUTTEL BHR, 1993, PATIENT EDUC COUNS, V22, P117, DOI 10.1016/0738-3991(93)90091-A; World Medical Association, 2000, 52 GEN ASS ED WORLD; Wright A, 2002, DIABETES CARE, V25, P330, DOI 10.2337/diacare.25.2.330; Zambanini A, 1999, DIABETES RES CLIN PR, V46, P239, DOI 10.1016/S0168-8227(99)00099-6	28	46	47	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2012	7	6							e36361	10.1371/journal.pone.0036361	http://dx.doi.org/10.1371/journal.pone.0036361			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WG	22719830	gold, Green Published, Green Submitted			2022-12-27	WOS:000305347800001
J	Hass, J; Blaschke, S; Herrmann, JM				Hass, Joachim; Blaschke, Stefan; Herrmann, J. Michael			Cross-Modal Distortion of Time Perception: Demerging the Effects of Observed and Performed Motion	PLOS ONE			English	Article							PURSUIT TRACKING; INTEGRATION; MOVEMENT; DISCRIMINATION; INFORMATION; MECHANISMS; INTERVALS; MODEL; LAW	Temporal information is often contained in multi-sensory stimuli, but it is currently unknown how the brain combines e. g. visual and auditory cues into a coherent percept of time. The existing studies of cross-modal time perception mainly support the "modality appropriateness hypothesis", i.e. the domination of auditory temporal cues over visual ones because of the higher precision of audition for time perception. However, these studies suffer from methodical problems and conflicting results. We introduce a novel experimental paradigm to examine cross-modal time perception by combining an auditory time perception task with a visually guided motor task, requiring participants to follow an elliptic movement on a screen with a robotic manipulandum. We find that subjective duration is distorted according to the speed of visually observed movement: The faster the visual motion, the longer the perceived duration. In contrast, the actual execution of the arm movement does not contribute to this effect, but impairs discrimination performance by dual-task interference. We also show that additional training of the motor task attenuates the interference, but does not affect the distortion of subjective duration. The study demonstrates direct influence of visual motion on auditory temporal representations, which is independent of attentional modulation. At the same time, it provides causal support for the notion that time perception and continuous motor timing rely on separate mechanisms, a proposal that was formerly supported by correlational evidence only. The results constitute a counterexample to the modality appropriateness hypothesis and are best explained by Bayesian integration of modality-specific temporal information into a centralized "temporal hub".	[Hass, Joachim] Heidelberg Univ, Res Grp Computat Neurosci, Cent Inst Mental Hlth, Med Fac Mannheim, D-6800 Mannheim, Germany; [Hass, Joachim] Bernstein Ctr Computat Neurosci Heidelberg Mannhe, Mannheim, Germany; [Blaschke, Stefan] FH Arnstadt Balingen, Balingen, Germany; [Herrmann, J. Michael] Univ Edinburgh, Inst Percept Act & Behav, Sch Informat, Edinburgh, Midlothian, Scotland; [Herrmann, J. Michael] Bernstein Ctr Gottingen, Gottingen, Germany	Central Institute of Mental Health; Ruprecht Karls University Heidelberg; University of Edinburgh	Hass, J (corresponding author), Heidelberg Univ, Res Grp Computat Neurosci, Cent Inst Mental Hlth, Med Fac Mannheim, D-6800 Mannheim, Germany.	joachim.hass@zi-mannheim.de		Hass, Joachim/0000-0001-6802-7718	German Bundesministerium fur Bildung und Forschung (BMBF) in the framework of the Bernstein Center for Computational Neuroscience Gottingen project C3 [01GQ0432, 01GQ1005B]	German Bundesministerium fur Bildung und Forschung (BMBF) in the framework of the Bernstein Center for Computational Neuroscience Gottingen project C3(Federal Ministry of Education & Research (BMBF))	This work was funded by the German Bundesministerium fur Bildung und Forschung (BMBF) in the framework of the Bernstein Center for Computational Neuroscience Gottingen project C3, grant numbers 01GQ0432 and 01GQ1005B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biess A, 2007, J NEUROSCI, V27, P13045, DOI 10.1523/JNEUROSCI.4334-06.2007; Brown JF, 1931, PSYCHOL FORSCH, V14, P233, DOI 10.1007/BF00403874; Brown SW, 2008, PSYCHOLOGY OF TIME, P111, DOI 10.1016/B978-0-08046-977-5.00004-1; Brown SW, 1997, PERCEPT PSYCHOPHYS, V59, P1118, DOI 10.3758/BF03205526; BROWN SW, 1995, PERCEPT PSYCHOPHYS, V57, P105, DOI 10.3758/BF03211853; Brown SW, 2002, PSYCHOL RES-PSYCH FO, V66, P80, DOI 10.1007/s004260100076; Buonomano DV, 2010, TRENDS COGN SCI, V14, P520, DOI 10.1016/j.tics.2010.09.002; Burr D, 2009, EXP BRAIN RES, V198, P49, DOI 10.1007/s00221-009-1933-z; Chen KM, 2009, ACTA PSYCHOL, V130, P225, DOI 10.1016/j.actpsy.2008.12.008; CREELMAN CD, 1962, J ACOUST SOC AM, V34, P582, DOI 10.1121/1.1918172; Deneve S, 2004, J PHYSIOLOGY-PARIS, V98, P249, DOI 10.1016/j.jphysparis.2004.03.011; Eagleman DM, 2008, CURR OPIN NEUROBIOL, V18, P131, DOI 10.1016/j.conb.2008.06.002; Fraisse P, 1963, PSYCHOL TIME; Gamache PL, 2010, EUR J NEUROSCI, V31, P1908, DOI 10.1111/j.1460-9568.2010.07197.x; GIBBON J, 1977, PSYCHOL REV, V84, P279, DOI 10.1037/0033-295X.84.3.279; Grondin S, 2001, PSYCHOL BULL, V127, P22, DOI 10.1037//0033-2909.127.1.22; Grondin S, 2010, ATTEN PERCEPT PSYCHO, V72, P561, DOI 10.3758/APP.72.3.561; Guttman SE, 2005, PSYCHOL SCI, V16, P228, DOI 10.1111/j.0956-7976.2005.00808.x; Hass J, 2008, J COMPUT NEUROSCI, V25, P449, DOI 10.1007/s10827-008-0088-4; Hass J, 2012, NEURAL COMPUT, V24, P1519, DOI 10.1162/NECO_a_00280; Hass J, 2009, PROG NEURAL PROCESS, V18, P167, DOI 10.1142/9789812834232_0014; IVRY RB, 1995, J EXP PSYCHOL HUMAN, V21, P3, DOI 10.1037/0096-1523.21.1.3; Ivry RB, 2008, TRENDS COGN SCI, V12, P273, DOI 10.1016/j.tics.2008.04.002; Jazayeri M, 2010, NAT NEUROSCI, V13, P1020, DOI 10.1038/nn.2590; Johnston A, 2006, CURR BIOL, V16, P472, DOI 10.1016/j.cub.2006.01.032; KAERNBACH C, 1991, PERCEPT PSYCHOPHYS, V49, P227, DOI 10.3758/BF03214307; Kanai R, 2006, J VISION, V6, P1421, DOI 10.1167/16.12.8; KEELE SW, 1985, ACTA PSYCHOL, V60, P173, DOI 10.1016/0001-6918(85)90054-X; Klink PC, 2011, ATTEN PERCEPT PSYCHO, V73, P219, DOI 10.3758/s13414-010-0010-9; Lewis PA, 2003, CURR OPIN NEUROBIOL, V13, P250, DOI 10.1016/S0959-4388(03)00036-9; Ley I, 2009, J EXP PSYCHOL HUMAN, V35, P1005, DOI 10.1037/a0015021; Morrone MC, 2005, NAT NEUROSCI, V8, P950, DOI 10.1038/nn1488; Pariyadath V, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001264; Rammsayer T, 2005, ACTA PSYCHOL, V120, P141, DOI 10.1016/j.actpsy.2005.03.005; RAMMSAYER TH, 1991, PERCEPT PSYCHOPHYS, V50, P565, DOI 10.3758/BF03207541; Recanzone GH, 2003, J NEUROPHYSIOL, V89, P1078, DOI 10.1152/jn.00706.2002; Recanzone GH, 2009, HEARING RES, V258, P89, DOI 10.1016/j.heares.2009.04.009; Robertson SD, 1999, J EXP PSYCHOL HUMAN, V25, P1316, DOI 10.1037/0096-1523.25.5.1316; van Wassenhove V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001437; VIVIANI P, 1990, J MOTOR BEHAV, V22, P407; VIVIANI P, 1987, J EXP PSYCHOL HUMAN, V13, P62, DOI 10.1037/0096-1523.13.1.62; VIVIANI P, 1995, J EXP PSYCHOL HUMAN, V21, P32, DOI 10.1037/0096-1523.21.1.32; Wada Y, 2003, INT J PSYCHOPHYSIOL, V50, P117, DOI 10.1016/S0167-8760(03)00128-4; WELCH RB, 1980, PSYCHOL BULL, V88, P638, DOI 10.1037/0033-2909.88.3.638; Wuerger S, 2010, INFORM FUSION, V11, P45, DOI 10.1016/j.inffus.2009.04.005; Zakay D, 1997, CURR DIR PSYCHOL SCI, V6, P12, DOI 10.1111/1467-8721.ep11512604; Zelaznik HN, 2002, J EXP PSYCHOL HUMAN, V28, P575, DOI 10.1037//0096-1523.28.3.575; Zelaznik HN, 2008, PSYCHOLOGY OF TIME, P233, DOI 10.1016/B978-0-08046-977-5.00007-7	48	13	13	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2012	7	6							e38092	10.1371/journal.pone.0038092	http://dx.doi.org/10.1371/journal.pone.0038092			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UJ	22701603	Green Published, Green Submitted, gold			2022-12-27	WOS:000305340000011
J	Zhang, YW; Staal, B; Dykema, KJ; Furge, KA; Vande Woude, GF				Zhang, Yu-Wen; Staal, Ben; Dykema, Karl J.; Furge, Kyle A.; Vande Woude, George F.			Cancer-Type Regulation of MIG-6 Expression by Inhibitors of Methylation and Histone Deacetylation	PLOS ONE			English	Article							MITOGEN-INDUCIBLE GENE-6; NEGATIVE REGULATOR; EGF RECEPTOR; APOPTOSIS; DELETION; BINDING; PROTEIN; DRUGS	Epigenetic silencing is one of the mechanisms leading to inactivation of a tumor suppressor gene, either by DNA methylation or histone modification in a promoter regulatory region. Mitogen inducible gene 6 (MIG-6), mainly known as a negative feedback inhibitor of the epidermal growth factor receptor (EGFR) family, is a tumor suppressor gene that is associated with many human cancers. To determine if MIG-6 is inactivated by epigenetic alteration, we identified a group of human lung cancer and melanoma cell lines in which its expression is either low or undetectable and studied the effects of methylation and of histone deacetylation on its expression. The DNA methyltransferase (DNMT) inhibitor 5-aza-2'-deoxycytidine (5-aza-dC) induced MIG-6 expression in melanoma cell lines but little in lung cancer lines. By contrast, the histone deacetylase (HDAC) inhibitor trichostatin A (TSA) induced MIG-6 expression in lung cancer lines but had little effect in melanoma lines. However, the MIG-6 promoter itself did not appear to be directly affected by either methylation or histone deacetylation, indicating an indirect regulatory mechanism. Luciferase reporter assays revealed that a short segment of exon 1 in the MIG-6 gene is responsible for TSA response in the lung cancer cells; thus, the MIG-6 gene can be epigenetically silenced through an indirect mechanism without having a physical alteration in its promoter. Furthermore, our data also suggest that MIG-6 gene expression is differentially regulated in lung cancer and melanoma.	[Zhang, Yu-Wen; Staal, Ben; Vande Woude, George F.] Van Andel Res Inst, Mol Oncol Lab, Grand Rapids, MI USA; [Dykema, Karl J.; Furge, Kyle A.] Van Andel Res Inst, Lab Computat Biol, Grand Rapids, MI USA	Van Andel Institute; Van Andel Institute	Zhang, YW (corresponding author), Van Andel Res Inst, Mol Oncol Lab, Grand Rapids, MI USA.	YuWen.Zhang@vai.org; George.VandeWoude@vai.org			Van Andel Foundation	Van Andel Foundation	This work was supported by funding from the Van Andel Foundation. The funders had no role in study design, data collection and manuscript.	Amatschek S, 2004, CANCER RES, V64, P844, DOI 10.1158/0008-5472.CAN-03-2361; Anastasi S, 2005, ONCOGENE, V24, P4540, DOI 10.1038/sj.onc.1208658; Anastasi S, 2003, ONCOGENE, V22, P4221, DOI 10.1038/sj.onc.1206516; Caren H, 2007, BRIT J CANCER, V97, P1416, DOI 10.1038/sj.bjc.6604032; Duncan CG, 2010, ONCOTARGET, V1, P265, DOI 10.18632/oncotarget.137; Ferby I, 2006, NAT MED, V12, P568, DOI 10.1038/nm1401; Frosi Y, 2010, J CELL BIOL, V189, P557, DOI 10.1083/jcb.201002032; Girard L, 2000, CANCER RES, V60, P4894; Hackel PO, 2001, BIOL CHEM, V382, P1649, DOI 10.1515/BC.2001.200; Hilger-Eversheim K, 2000, GENE, V260, P1, DOI 10.1016/S0378-1119(00)00454-6; Jeong JW, 2009, P NATL ACAD SCI USA, V106, P8677, DOI 10.1073/pnas.0903632106; Jin N, 2009, DEVELOPMENT, V136, P3347, DOI 10.1242/dev.032979; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Li Z, 2011, MOL CARCINOG; Lin CI, 2011, J CLIN ENDOCR METAB, V96, pE554, DOI 10.1210/jc.2010-1800; Mai A, 2009, INT J BIOCHEM CELL B, V41, P199, DOI 10.1016/j.biocel.2008.08.020; Makkinje A, 2000, J BIOL CHEM, V275, P17838, DOI 10.1074/jbc.M909735199; Nomoto S, 2000, GENE CHROMOSOME CANC, V28, P342, DOI 10.1002/1098-2264(200007)28:3<342::AID-GCC13>3.0.CO;2-A; Orso F, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-355; Pante G, 2005, J CELL BIOL, V171, P337, DOI 10.1083/jcb.200502013; Poetsch M, 1999, VIRCHOWS ARCH, V435, P105, DOI 10.1007/s004280050406; Reschke M, 2010, HEPATOLOGY, V51, P1383, DOI 10.1002/hep.23428; Ruan DT, 2008, SURGERY, V144, P908, DOI 10.1016/j.surg.2008.07.028; Schmelz K, 2005, LEUKEMIA, V19, P103, DOI 10.1038/sj.leu.2403552; Sigalotti L, 2007, J CELL PHYSIOL, V212, P330, DOI 10.1002/jcp.21066; Taddei A, 2005, EMBO REP, V6, P520, DOI 10.1038/sj.embor.7400441; Thiel G, 2002, J CELL PHYSIOL, V193, P287, DOI 10.1002/jcp.10178; Tseng RC, 2005, INT J CANCER, V117, P241, DOI 10.1002/ijc.21178; VanBrocklin MW, 2009, CANCER RES, V69, P1985, DOI 10.1158/0008-5472.CAN-08-3934; Yoo CB, 2006, NAT REV DRUG DISCOV, V5, P37, DOI 10.1038/nrd1930; Zhang XW, 2007, NATURE, V450, P741, DOI 10.1038/nature05998; Zhang YW, 2007, ONCOGENE, V26, P269, DOI 10.1038/sj.onc.1209790; Zhang YW, 2007, CELL CYCLE, V6, P507, DOI 10.4161/cc.6.5.3928; Zhang YW, 2005, P NATL ACAD SCI USA, V102, P11740, DOI 10.1073/pnas.0505171102	34	41	43	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2012	7	6							e38955	10.1371/journal.pone.0038955	http://dx.doi.org/10.1371/journal.pone.0038955			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UJ	22701735	Green Submitted, Green Published, gold			2022-12-27	WOS:000305340000056
J	Carraher, C; Authier, A; Steinwender, B; Newcomb, RD				Carraher, Colm; Authier, Astrid; Steinwender, Bernd; Newcomb, Richard D.			Sequence Comparisons of Odorant Receptors among Tortricid Moths Reveal Different Rates of Molecular Evolution among Family Members	PLOS ONE			English	Article							DROSOPHILA; IDENTIFICATION; GENES; SPECIALIZATION; CTENOPSEUSTIS; LEPIDOPTERA; RESPONSES; SELECTION; TOPOLOGY; SITES	In insects, odorant receptors detect volatile cues involved in behaviours such as mate recognition, food location and oviposition. We have investigated the evolution of three odorant receptors from five species within the moth genera Ctenopseustis and Planotrotrix, family Tortricidae, which fall into distinct clades within the odorant receptor multigene family. One receptor is the orthologue of the co-receptor Or83b, now known as Orco (OR2), and encodes the obligate ion channel subunit of the receptor complex. In comparison, the other two receptors, OR1 and OR3, are ligand-binding receptor subunits, activated by volatile compounds produced by plants - methyl salicylate and citral, respectively. Rates of sequence evolution at non-synonymous sites were significantly higher in OR1 compared with OR2 and OR3. Within the dataset OR1 contains 109 variable amino acid positions that are distributed evenly across the entire protein including transmembrane helices, loop regions and termini, while OR2 and OR3 contain 18 and 16 variable sites, respectively. OR2 shows a high level of amino acid conservation as expected due to its essential role in odour detection; however we found unexpected differences in the rate of evolution between two ligand-binding odorant receptors, OR1 and OR3. OR3 shows high sequence conservation suggestive of a conserved role in odour reception, whereas the higher rate of evolution observed in OR1, particularly at non-synonymous sites, may be suggestive of relaxed constraint, perhaps associated with the loss of an ancestral role in sex pheromone reception.	[Carraher, Colm; Authier, Astrid; Steinwender, Bernd; Newcomb, Richard D.] New Zealand Inst Plant & Food Res Ltd, Auckland, New Zealand; [Carraher, Colm; Steinwender, Bernd; Newcomb, Richard D.] Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand; [Steinwender, Bernd; Newcomb, Richard D.] Allan Wilson Ctr Mol Ecol & Evolut, Auckland, New Zealand	New Zealand Institute for Plant & Food Research Ltd; University of Auckland; Massey University	Carraher, C (corresponding author), New Zealand Inst Plant & Food Res Ltd, Auckland, New Zealand.	Richard.Newcomb@plantandfood.co.nz	Newcomb, Richard/C-2067-2009; Carraher, Colm/A-3975-2019	Newcomb, Richard/0000-0002-7307-9755; Carraher, Colm/0000-0001-5341-116X	Foundation for Research, Science and Technology of New Zealand [C06x701]; Allan Wilson Centre for Molecular Ecology and Evolution	Foundation for Research, Science and Technology of New Zealand(New Zealand Foundation for Research, Science and Technology); Allan Wilson Centre for Molecular Ecology and Evolution	The work was funded by the Foundation for Research, Science and Technology of New Zealand (contract no C06x701) and the Allan Wilson Centre for Molecular Ecology and Evolution. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albre J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002489; Anderson AR, 2009, INSECT BIOCHEM MOLEC, V39, P189, DOI 10.1016/j.ibmb.2008.11.002; Barker FK, 2002, SYST BIOL, V51, P625, DOI 10.1080/10635150290102302; Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; Brigaud I, 2009, FEBS J, V276, P6537, DOI 10.1111/j.1742-4658.2009.07351.x; de Bruyne M, 2010, J COMP PHYSIOL A, V196, P97, DOI 10.1007/s00359-009-0496-6; DRUMMOND AJ, 2009, GENEIOUS V4 7; Gardiner A, 2008, MOL ECOL, V17, P1648, DOI 10.1111/j.1365-294X.2008.03713.x; Gardiner A, 2009, BIOL LETTERS, V5, P244, DOI 10.1098/rsbl.2008.0723; Grosse-Wilde E, 2011, P NATL ACAD SCI USA, V108, P7449, DOI 10.1073/pnas.1017963108; Grosse-Wilde E, 2010, FRONT CELL NEUROSCI, V4, DOI 10.3389/fncel.2010.00022; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guo S, 2007, MOL BIOL EVOL, V24, P1198, DOI 10.1093/molbev/msm038; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; HOFMANN K, 1993, BIOL CHEM HOPPESEYLE, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; JOHNS SJ, 2005, TOPO2 TRANSMEMBRANE; Jordan MD, 2009, CHEM SENSES, V34, P383, DOI 10.1093/chemse/bjp010; Krieger J, 2004, P NATL ACAD SCI USA, V101, P11845, DOI 10.1073/pnas.0403052101; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Langhoff P, 2009, MOL ECOL RESOUR, V9, P691, DOI 10.1111/j.1755-0998.2009.02537.x; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Lundin C, 2007, FEBS LETT, V581, P5601, DOI 10.1016/j.febslet.2007.11.007; McBride CS, 2007, GENETICS, V177, P1395, DOI 10.1534/genetics.107.078683; Mitsuno H, 2008, EUR J NEUROSCI, V28, P893, DOI 10.1111/j.1460-9568.2008.06429.x; Nakagawa T, 2005, SCIENCE, V307, P1638, DOI 10.1126/science.1106267; Nakagawa T, 2009, CURR OPIN NEUROBIOL, V19, P284, DOI 10.1016/j.conb.2009.07.015; Newcomb RD, 1998, BIOCHEM SYST ECOL, V26, P473, DOI 10.1016/S0305-1978(98)00015-5; Nozawa M, 2007, P NATL ACAD SCI USA, V104, P7122, DOI 10.1073/pnas.0702133104; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Sakurai T, 2004, P NATL ACAD SCI USA, V101, P16653, DOI 10.1073/pnas.0407596101; Sanchez-Gracia A, 2009, HEREDITY, V103, P208, DOI 10.1038/hdy.2009.55; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Smart R, 2008, INSECT BIOCHEM MOLEC, V38, P770, DOI 10.1016/j.ibmb.2008.05.002; Suckling DM, 1996, NEW ZEAL J CROP HORT, V24, P323, DOI 10.1080/01140671.1996.9513969; Swanson WJ, 2003, MOL BIOL EVOL, V20, P18, DOI 10.1093/oxfordjournals.molbev.a004233; Tanaka K, 2009, CURR BIOL, V19, P881, DOI 10.1016/j.cub.2009.04.035; Tunstall NE, 2007, J MOL EVOL, V64, P628, DOI 10.1007/s00239-006-0151-6; Vosshall LB, 2011, CHEM SENSES, V36, P497, DOI 10.1093/chemse/bjr022; Wanner KW, 2007, INSECT MOL BIOL, V16, P107, DOI 10.1111/j.1365-2583.2007.00708.x; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861; Yang ZH, 2000, MOL BIOL EVOL, V17, P32, DOI 10.1093/oxfordjournals.molbev.a026236; Yang ZH, 2000, GENETICS, V155, P431; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	45	13	13	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2012	7	6							e38391	10.1371/journal.pone.0038391	http://dx.doi.org/10.1371/journal.pone.0038391			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TU	22701634	gold, Green Published, Green Submitted			2022-12-27	WOS:000305337600021
J	Ruan, GX; Gamble, KL; Risner, ML; Young, LA; McMahon, DG				Ruan, Guo-Xiang; Gamble, Karen L.; Risner, Michael L.; Young, Laurel A.; McMahon, Douglas G.			Divergent Roles of Clock Genes in Retinal and Suprachiasmatic Nucleus Circadian Oscillators	PLOS ONE			English	Article							MAMMALIAN RETINA; MOUSE RETINA; DOPAMINE; PHOTORECEPTOR; RHYTHMS; POLYMORPHISM; SYSTEM; PER3	The retina is both a sensory organ and a self-sustained circadian clock. Gene targeting studies have revealed that mammalian circadian clocks generate molecular circadian rhythms through coupled transcription/translation feedback loops which involve 6 core clock genes, namely Period (Per) 1 and 2, Cryptochrome (Cry) 1 and 2, Clock, and Bmal1 and that the roles of individual clock genes in rhythms generation are tissue-specific. However, the mechanisms of molecular circadian rhythms in the mammalian retina are incompletely understood and the extent to which retinal neural clocks share mechanisms with the suprachiasmatic nucleus (SCN), the central neural clock, is unclear. In the present study, we examined the rhythmic amplitude and period of real-time bioluminescence rhythms in explants of retina from Per1-, Per2-, Per3-, Cry1-, Cry2-, and Clock-deficient mice that carried transgenic PERIOD2:: LUCIFERASE (PER2::LUC) or Period1::luciferase (Per1::luc) circadian reporters. Per1-, Cry1- and Clock-deficient retinal and SCN explants showed weakened or disrupted rhythms, with stronger effects in retina compared to SCN. Per2, Per3, and Cry2 were individually dispensable for sustained rhythms in both tissues. Retinal and SCN explants from double knockouts of Cry1 and Cry2 were arrhythmic. Gene effects on period were divergent with reduction in the number of Per1 alleles shortening circadian period in retina, but lengthening it in SCN, and knockout of Per3 substantially shortening retinal clock period, but leaving SCN unaffected. Thus, the retinal neural clock has a unique pattern of clock gene dependence at the tissue level that it is similar in pattern, but more severe in degree, than the SCN neural clock, with divergent clock gene regulation of rhythmic period.	[Ruan, Guo-Xiang; Gamble, Karen L.; Risner, Michael L.; Young, Laurel A.; McMahon, Douglas G.] Vanderbilt Univ, Dept Biol Sci, Nashville, TN USA	Vanderbilt University	Ruan, GX (corresponding author), Harvard Univ, Schepens Eye Res Inst, Massachusetts Eye & Ear Infirm, Sch Med, Boston, MA 02114 USA.	douglas.g.mcmahon@vanderbilt.edu	Risner, Michael L. L/L-6751-2018	Risner, Michael L. L/0000-0002-8399-5036; Gamble, Karen/0000-0003-3813-8577	National Eye Institute [R01 EY15815]; NATIONAL EYE INSTITUTE [R01EY015815] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The work was funded by the National Eye Institute (R01 EY15815), www.nei.nih.gov/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer SN, 2003, SLEEP, V26, P413, DOI 10.1093/sleep/26.4.413; Bae K, 2001, NEURON, V30, P525, DOI 10.1016/S0896-6273(01)00302-6; Cameron MA, 2008, J BIOL RHYTHM, V23, P489, DOI 10.1177/0748730408325874; DeBruyne JP, 2007, CURR BIOL, V17, pR538, DOI 10.1016/j.cub.2007.05.067; DeBruyne JP, 2007, NAT NEUROSCI, V10, P543, DOI 10.1038/nn1884; DeBruyne JP, 2006, NEURON, V50, P465, DOI 10.1016/j.neuron.2006.03.041; Dmitriev AV, 2001, J NEUROSCI, V21, P2897, DOI 10.1523/JNEUROSCI.21-08-02897.2001; Doyle SE, 2002, VISUAL NEUROSCI, V19, P593, DOI 10.1017/S0952523802195058; Doyle SE, 2002, J NEUROCHEM, V83, P211, DOI 10.1046/j.1471-4159.2002.01149.x; Ebisawa T, 2001, EMBO REP, V2, P342, DOI 10.1093/embo-reports/kve070; Granados-Fuentes D, 2006, J NEUROSCI, V26, P12219, DOI 10.1523/JNEUROSCI.3445-06.2006; Green CB, 2004, J BIOL RHYTHM, V19, P91, DOI 10.1177/0748730404263002; Herzog ED, 2004, J BIOL RHYTHM, V19, P35, DOI 10.1177/0748730403260776; IUVONE PM, 1991, INVEST OPHTH VIS SCI, V32, P1674; Jaliffa CO, 2001, BRAIN RES, V912, P195, DOI 10.1016/S0006-8993(01)02736-6; Liu AC, 2007, CELL, V129, P605, DOI 10.1016/j.cell.2007.02.047; Nir I, 2000, BRAIN RES, V870, P118, DOI 10.1016/S0006-8993(00)02409-4; Ogilvie JM, 2002, NEUROBIOL DIS, V10, P33, DOI 10.1006/nbdi.2002.0489; Organisciak DT, 2000, INVEST OPHTH VIS SCI, V41, P3694; Pendergast JS, 2009, J NEUROSCI, V29, P14681, DOI 10.1523/JNEUROSCI.3261-09.2009; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Ribelayga C, 2008, NEURON, V59, P790, DOI 10.1016/j.neuron.2008.07.017; Ruan GX, 2006, P NATL ACAD SCI USA, V103, P9703, DOI 10.1073/pnas.0601940103; Ruan GX, 2008, PLOS BIOL, V6, P2248, DOI 10.1371/journal.pbio.0060249; Storch KF, 2007, CELL, V130, P730, DOI 10.1016/j.cell.2007.06.045; Styles CJ, 2007, CLIN EXP OPHTHALMOL, V35, P18, DOI 10.1111/j.1442-9071.2007.01416.x; Tanoue S, 2004, CURR BIOL, V14, P638, DOI 10.1016/j.cub.2004.04.009; TEIRSTEIN PS, 1980, INVEST OPHTH VIS SCI, V19, P1268; Thresher RJ, 1998, SCIENCE, V282, P1490, DOI 10.1126/science.282.5393.1490; Tosini G, 1996, SCIENCE, V272, P419, DOI 10.1126/science.272.5260.419; Tosini G, 1998, BRAIN RES, V789, P221, DOI 10.1016/S0006-8993(97)01446-7; Tosini G, 2007, FASEB J, V21, P3866, DOI 10.1096/fj.07-8371com; Tosini G, 2007, BRAIN RES, V1159, P134, DOI 10.1016/j.brainres.2007.05.023; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; van der Veen DR, 2010, J BIOL RHYTHM, V25, P3, DOI 10.1177/0748730409356680; Viola AU, 2007, CURR BIOL, V17, P613, DOI 10.1016/j.cub.2007.01.073; Vitaterna MH, 1999, P NATL ACAD SCI USA, V96, P12114, DOI 10.1073/pnas.96.21.12114; Von Schantz M, 2008, J GENET, V87, P513, DOI 10.1007/s12041-008-0074-7; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101	39	40	42	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2012	7	6							e38985	10.1371/journal.pone.0038985	http://dx.doi.org/10.1371/journal.pone.0038985			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TU	22701739	Green Submitted, gold, Green Published			2022-12-27	WOS:000305337600063
J	Xiao, L; Yu, SX; Li, MG; Wang, YF				Xiao, Lin; Yu, Shixiao; Li, Mingguang; Wang, Yongfan			Community Compensatory Trend Prevails from Tropical to Temperate Forest	PLOS ONE			English	Article							DENSITY-DEPENDENCE; PROMOTES COEXISTENCE; PLANT DIVERSITY; RECRUITMENT; NEIGHBORHOOD; MORTALITY; PATTERNS; GROWTH	Community compensatory trend (CCT) is thought to facilitate persistence of rare species and thus stabilize species composition in tropical forests. However, whether CCT acts over broad geographical ranges is still in question. In this study, we tested for the presence of negative density dependence (NDD) and CCT in three forests along a tropical-temperate gradient. Inventory data were collected from forest communities located in three different latitudinal zones in China. Two widely used methods were used to test for NDD at the community level. The first method considered relationships between the relative abundance ratio and adult abundance. The second method emphasized the effect of adult abundance on abundance of established younger trees. Evidence for NDD acting on different growth forms was tested by using the first method, and the presence of CCT was tested by checking whether adult abundance of rare species affected that of established younger trees less than did abundance of common species. Both analyses indicated that NDD existed in seedling, sapling and pole stages in all three plant communities and that this effect increased with latitude. However, the extent of NDD varied among understory, midstory and canopy trees in the three communities along the gradient. Additionally, despite evidence of NDD for almost all common species, only a portion of rare species showed NDD, supporting the action of CCT in all three communities. So, we conclude that NDD and CCT prevail in the three recruitment stages of the tree communities studied; rare species achieve relative advantage through CCT and thus persist in these communities; CCT clearly facilitates newly established species and maintains tree diversity within communities across our latitudinal gradient.	[Xiao, Lin; Yu, Shixiao; Li, Mingguang; Wang, Yongfan] Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Xiao, L (corresponding author), Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China.	lsslmg@mail.sysu.edu.cn		Xiao, Lin/0000-0001-9806-6881; Yu, Shixiao/0000-0003-1943-0185	Key Foundation Projects of the National Natural Science Foundation of China [30730021]; Zhang-Hongda Science Foundation of Sun Yat-sen University; administrations of Bawangling National Nature Reserve; administrations of Heishiding Nature Reserve; administrations of Changbai Mountain National Nature Reserves	Key Foundation Projects of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhang-Hongda Science Foundation of Sun Yat-sen University; administrations of Bawangling National Nature Reserve; administrations of Heishiding Nature Reserve; administrations of Changbai Mountain National Nature Reserves	This study was funded by the Key Foundation Projects of the National Natural Science Foundation of China (grant numbers: 30730021, http://www.nsfc.gov.cn/) and by the Zhang-Hongda Science Foundation of Sun Yat-sen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to the administrations of Bawangling National Nature Reserve, Heishiding Nature Reserve and Changbai Mountain National Nature Reserves for their support. We also thank Qing Chen, Weinan Ye, Ruyan Sun, Wen Zhen, Gang Hu, Zongbo Peng and Yinghua Luo for their assistance in data collection. We thank Professor John R Spence and two anonymous referees for their insightful comments that much improved our study.	[Anonymous], 1971, DYNAMICS POPULATIONS; Augspurger CK, 2007, BIOTROPICA, V39, P702, DOI 10.1111/j.1744-7429.2007.00326.x; Bell T, 2006, ECOL LETT, V9, P569, DOI 10.1111/j.1461-0248.2006.00905.x; Bevill RL, 1999, CONSERV BIOL, V13, P493, DOI 10.1046/j.1523-1739.1999.97369.x; Bradley DJ, 2008, ECOL LETT, V11, P461, DOI 10.1111/j.1461-0248.2008.01162.x; Chen L, 2010, ECOL LETT, V13, P695, DOI 10.1111/j.1461-0248.2010.01468.x; CHESSON PL, 1981, AM NAT, V117, P923, DOI 10.1086/283778; Comita LS, 2007, J VEG SCI, V18, P163, DOI 10.1658/1100-9233(2007)18[163:POWPSA]2.0.CO;2; Comita LS, 2010, SCIENCE, V329, P330, DOI 10.1126/science.1190772; Comita LS, 2009, ECOLOGY, V90, P328, DOI 10.1890/08-0451.1; CONNELL JH, 1984, ECOL MONOGR, V54, P141, DOI 10.2307/1942659; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; Givnish TJ, 1999, J ECOL, V87, P193, DOI 10.1046/j.1365-2745.1999.00333.x; Harms KE, 2000, NATURE, V404, P493, DOI 10.1038/35006630; He FL, 1997, J VEG SCI, V8, P105, DOI 10.2307/3237248; HilleRisLambers J, 2002, NATURE, V417, P732, DOI 10.1038/nature00809; HU YJ, 1992, TROPICAL RAIN FOREST; Hubbell SP, 1986, CONSERVATION BIOL SC, P205; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; JIANG YX, 2002, BIODIVERSITY ITS FOR; Kiers ET, 2000, ECOL LETT, V3, P106, DOI 10.1046/j.1461-0248.2000.00126.x; Klironomos JN, 2002, NATURE, V417, P67, DOI 10.1038/417067a; Li J.D., 2001, JILIN VEGETATION; Metz MR, 2010, ECOLOGY, V91, P3675, DOI 10.1890/08-2323.1; Queenborough SA, 2007, ECOLOGY, V88, P2248, DOI 10.1890/06-0737.1; Richards P.W., 1996, TROPICAL RAIN FOREST, VSecond edition; van Gelder HA, 2006, NEW PHYTOL, V171, P367, DOI 10.1111/j.1469-8137.2006.01757.x; Webb CO, 1999, ECOLOGY, V80, P2006, DOI 10.1890/0012-9658(1999)080[2006:SDDPCO]2.0.CO;2; WELDEN CW, 1991, ECOLOGY, V72, P35, DOI 10.2307/1938900; Wright SJ, 2005, ECOLOGY, V86, P848, DOI 10.1890/03-0750; Wright SJ, 2002, OECOLOGIA, V130, P1, DOI 10.1007/s004420100809; Zhou Xianye, 2004, Yingyong Shengtai Xuebao, V15, P367; Zhu Y, 2010, OIKOS, V119, P109, DOI 10.1111/j.1600-0706.2009.17758.x	33	5	5	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2012	7	6							e38621	10.1371/journal.pone.0038621	http://dx.doi.org/10.1371/journal.pone.0038621			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TU	22701682	gold, Green Published, Green Submitted			2022-12-27	WOS:000305337600034
J	Kilembe, W; Keeling, M; Karita, E; Lakhi, S; Chetty, P; Price, MA; Makkan, H; Latka, M; Likoti, M; Ilukui, K; Hurlston, M; Allen, S; Stevens, G; Hunter, E				Kilembe, William; Keeling, Michelle; Karita, Etienne; Lakhi, Shabir; Chetty, Paramesh; Price, Matt A.; Makkan, Heeran; Latka, Mary; Likoti, Morongwe; Ilukui, Kenneth; Hurlston, Mackenzie; Allen, Susan; Stevens, Gwynn; Hunter, Eric			Failure of A Novel, Rapid Antigen and Antibody Combination Test to Detect Antigen-Positive HIV Infection in African Adults with Early HIV Infection	PLOS ONE			English	Article							DISCORDANT COUPLES; P24 ANTIGEN	Background: Acute HIV infection (prior to antibody seroconversion) represents a high-risk window for HIV transmission. Development of a test to detect acute infection at the point-of-care is urgent. Methods: Volunteers enrolled in a prospective study of HIV incidence in four African cities, Kigali in Rwanda and Ndola, Kitwe and Lusaka in Zambia, were tested regularly for HIV by rapid antibody test and p24 antigen ELISA. Five subgroups of samples were also tested by the Determine Ag/Ab Combo test 1) Antigen positive, antibody negative (acute infection); 2) Antigen positive, antibody positive; 3) Antigen negative, antibody positive; 4) Antigen negative, antibody negative; and 5) Antigen false positive, antibody negative (HIV uninfected). A sixth group included serial dilutions from a p24 antigen-positive control sample. Combo test results were reported as antigen positive, antibody positive, or both. Results: Of 34 group 1 samples with VL between 5x105 and >1.5x107 copies/mL (median 3.5x106), 1 (2.9%) was detected by the Combo antigen component, 7 (20.6%) others were positive by the Combo antibody component. No group 2 samples were antigen positive by the Combo test (0/18). Sensitivity of the Combo antigen test was therefore 1.9% (1/52, 95% CI 0.0, 9.9). One false positive Combo antibody result (1/30, 3.3%) was observed in group 4. No false-positive Combo antigen results were observed. The Combo antigen test was positive in group 6 at concentrations of 80 pg/mL, faintly positive at 40 and 20 pg/mL, and negative thereafter. The p24 ELISA antigen test remained positive at 5 pg/mL. Conclusions: Although the antibody component of the Combo test detected antibodies to HIV earlier than the comparison antibody tests used, less than 2% of the cases of antigen-positive HIV infection were detected by the Combo antigen component. The development of a rapid point-of-care test to diagnose acute HIV infection remains an urgent goal.	[Kilembe, William; Karita, Etienne; Lakhi, Shabir; Ilukui, Kenneth; Hurlston, Mackenzie; Allen, Susan; Hunter, Eric] Rwanda Zambia HIV Res Grp, Kigali, Rwanda; [Kilembe, William; Karita, Etienne; Lakhi, Shabir; Ilukui, Kenneth; Hurlston, Mackenzie; Allen, Susan; Hunter, Eric] Rwanda Zambia HIV Res Grp, Lusaka, Zambia; [Kilembe, William; Karita, Etienne; Lakhi, Shabir; Ilukui, Kenneth; Hurlston, Mackenzie; Allen, Susan; Hunter, Eric] Rwanda Zambia HIV Res Grp, Kitwe, Zambia; [Kilembe, William; Karita, Etienne; Lakhi, Shabir; Ilukui, Kenneth; Hurlston, Mackenzie; Allen, Susan; Hunter, Eric] Rwanda Zambia HIV Res Grp, Ndola, Zambia; [Kilembe, William; Keeling, Michelle; Karita, Etienne; Lakhi, Shabir; Ilukui, Kenneth; Hurlston, Mackenzie; Allen, Susan; Hunter, Eric] Emory Univ, Atlanta, GA 30322 USA; [Chetty, Paramesh; Price, Matt A.; Stevens, Gwynn] Int AIDS Vaccine Initiat, New York, NY USA; [Makkan, Heeran; Latka, Mary; Likoti, Morongwe] Aurum Inst Hlth Res, Johannesburg, South Africa	Emory University; International AIDS Vaccine Initiative	Kilembe, W (corresponding author), Rwanda Zambia HIV Res Grp, Kigali, Rwanda.	wkilembe@rzhrg-mail.org; mkeelin@emory.edu	Makkan, Heeran/GXI-0465-2022; Price, Matt/AAK-6881-2021	Price, Matt/0000-0002-2918-1373; Makkan, Heeran/0000-0002-4737-7804	Center for AIDS Research Virology Core [P30 AI-050409]; National Institutes of Health [R37 AI-51231, R01 AI-64060]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050409, R01AI064060, R37AI051231, R01AI051231] Funding Source: NIH RePORTER	Center for AIDS Research Virology Core; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by the Center for AIDS Research Virology Core (P30 AI-050409), by grants from the National Institutes of Health (R37 AI-51231, R01 AI-64060), and in part by the generous support of the American people through the United States Agency for International Development (USAID). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beelaert G, 2010, J VIROL METHODS, V168, P218, DOI 10.1016/j.jviromet.2010.06.002; Boeras DI, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-18; BROOKMEYER R, 1995, AM J EPIDEMIOL, V141, P166, DOI 10.1093/oxfordjournals.aje.a117404; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P329; Cohen MS, 2011, NEW ENGL J MED, V364, P1943, DOI 10.1056/NEJMra1011874; Dunkle KL, 2008, LANCET, V371, P2183, DOI 10.1016/S0140-6736(08)60953-8; Fideli OS, 2001, AIDS RES HUM RETROV, V17, P901, DOI 10.1089/088922201750290023; Fiscus SA, 2006, PLOS MED, V3, P1743, DOI 10.1371/journal.pmed.0030417; Inverness Medical, DET HIV 1 2 AG AB CO; Kamanga G, 2011, POOR PERFORMANCE DET; Kempf MC, 2008, JAIDS-J ACQ IMM DEF, V47, P116, DOI 10.1097/QAI.0b013e31815d2f3f; Keren T, 2009, PERFORMANCE EVALUATI; Mulenga J, 2006, P24 ANTIGEN SCREENIN; Pavie J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011581; PETERSEN LR, 1994, TRANSFUSION, V34, P283, DOI 10.1046/j.1537-2995.1994.34494233574.x; Pilcher CD, 2009, CLIN STUDY ANTIGEN A; Pilcher CD, 2010, J INFECT DIS, V201, pS7, DOI 10.1086/650393; Powers KA, 2007, AIDS, V21, P2237, DOI 10.1097/QAD.0b013e3282f08b4d; Schupbach J, 2003, INT ARCH ALLERGY IMM, V132, P196, DOI 10.1159/000074552; Sullivan PS, 2011, AIDS IN PRESS; Trask SA, 2002, J VIROL, V76, P397, DOI 10.1128/JVI.76.1.397-405.2002; Zetola NM, 2007, INFECT DIS CLIN N AM, V21, P19, DOI 10.1016/j.idc.2007.01.008	22	33	34	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2012	7	6							e37154	10.1371/journal.pone.0037154	http://dx.doi.org/10.1371/journal.pone.0037154			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TQ	22715363	gold, Green Published, Green Submitted			2022-12-27	WOS:000305336800004
J	Gordts, PLSM; Bartelt, A; Nilsson, SK; Annaert, W; Christoffersen, C; Nielsen, LB; Heeren, J; Roebroek, AJM				Gordts, Philip L. S. M.; Bartelt, Alexander; Nilsson, Stefan K.; Annaert, Wim; Christoffersen, Christina; Nielsen, Lars Bo; Heeren, Joerg; Roebroek, Anton J. M.			Impaired LDL Receptor-Related Protein 1 Translocation Correlates with Improved Dyslipidemia and Atherosclerosis in apoE-Deficient Mice	PLOS ONE			English	Article							TRIGLYCERIDE-RICH LIPOPROTEINS; HEPARAN-SULFATE PROTEOGLYCANS; APOLIPOPROTEIN-E; CHYLOMICRON REMNANTS; LRP1 EXPRESSION; APOPROTEIN-E; IN-VITRO; CLEARANCE; BINDING; DYSBETALIPOPROTEINEMIA	Objective: Determination of the in vivo significance of LDL receptor-related protein 1 (LRP1) dysfunction on lipid metabolism and atherosclerosis development in absence of its main ligand apoE. Methods and Results: LRP1 knock-in mice carrying an inactivating mutation in the NPxYxxL motif were crossed with apoE-deficient mice. In the absence of apoE, relative to LRP1 wild-type animals, LRP1 mutated mice showed an increased clearance of postprandial lipids despite a compromised LRP1 endocytosis rate and inefficient insulin-mediated translocation of the receptor to the plasma membrane, likely due to inefficient slow recycling of the mutated receptor. Postprandial lipoprotein improvement was explained by increased hepatic clearance of triglyceride-rich remnant lipoproteins and accompanied by a compensatory 1.6-fold upregulation of LDLR expression in hepatocytes. One year-old apoE-deficient mice having the dysfunctional LRP1 revealed a 3-fold decrease in spontaneous atherosclerosis development and a 2-fold reduction in LDL-cholesterol levels. Conclusion: These findings demonstrate that the NPxYxxL motif in LRP1 is important for insulin-mediated translocation and slow perinuclear endosomal recycling. These LRP1 impairments correlated with reduced atherogenesis and cholesterol levels in apoE-deficient mice, likely via compensatory LDLR upregulation.	[Gordts, Philip L. S. M.; Roebroek, Anton J. M.] Katholieke Univ Leuven, Lab Expt Mouse Genet, Ctr Human Genet, Louvain, Belgium; [Bartelt, Alexander; Heeren, Joerg] Univ Med Ctr Hamburg Eppendorf, Dept Biochem & Mol Cell Biol, Hamburg, Germany; [Bartelt, Alexander] Univ Med Ctr Hamburg Eppendorf, Dept Orthoped, Hamburg, Germany; [Nilsson, Stefan K.] Umea Univ, Dept Med Biosci Physiol Chem, Umea, Sweden; [Annaert, Wim] VIB, Lab Membrane Trafficking, Dept Mol & Dev Genet, Louvain, Belgium; [Annaert, Wim] Katholieke Univ Leuven, Lab Membrane Trafficking, Ctr Human Genet, Louvain, Belgium; [Christoffersen, Christina; Nielsen, Lars Bo] Rigshosp, Dept Clin Biochem, DK-2100 Copenhagen, Denmark; [Nielsen, Lars Bo] Univ Copenhagen, Dept Biomed Sci, Copenhagen, Denmark	KU Leuven; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Umea University; Flanders Institute for Biotechnology (VIB); KU Leuven; Rigshospitalet; University of Copenhagen; University of Copenhagen	Gordts, PLSM (corresponding author), Katholieke Univ Leuven, Lab Expt Mouse Genet, Ctr Human Genet, Louvain, Belgium.	heeren@uke.uni-hamburg.de; anton.roebroek@med.kuleuven.be	Nilsson, Stefan/K-5555-2012; Bartelt, Alexander/ABC-2525-2020	Christoffersen, Christina/0000-0003-3751-5203; Gordts, Philip/0000-0001-7224-4328	"Fonds voor Wetenschappelijk Onderzoek Vlaanderen" (FWO-Vlaanderen) [G.0529.08, G.0689.10]; KU Leuven [GOA/12/016]; Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen); European Atherosclerosis Society; BMBF ANCYLOSS project;  [GRK1459]	"Fonds voor Wetenschappelijk Onderzoek Vlaanderen" (FWO-Vlaanderen)(FWO); KU Leuven(KU Leuven); Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); European Atherosclerosis Society; BMBF ANCYLOSS project(Federal Ministry of Education & Research (BMBF)); 	This work was supported by grants from the "Fonds voor Wetenschappelijk Onderzoek Vlaanderen" (FWO-Vlaanderen G.0529.08 and G.0689.10) and from the KU Leuven (GOA/12/016) to Anton Roebroek. The research was also funded by a PhD grant of the Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen) to Philip Gordts. Alexander Bartelt is supported by a Postdoctoral Fellowship Award from the European Atherosclerosis Society and the BMBF ANCYLOSS project. Joerg Heeren is supported by the GRK1459. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartelt A, 2011, NAT MED, V17, P200, DOI 10.1038/nm.2297; Basford JE, 2011, J BIOL CHEM, V286, P13079, DOI 10.1074/jbc.M111.229369; BEISIEGEL U, 1989, NATURE, V341, P162, DOI 10.1038/341162a0; BEISIEGEL U, 1991, P NATL ACAD SCI USA, V88, P8342, DOI 10.1073/pnas.88.19.8342; Boucher P, 2011, BIOCHEM PHARMACOL, V81, P1, DOI 10.1016/j.bcp.2010.09.018; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Dedieu S, 2008, MOL CELL BIOL, V28, P2980, DOI 10.1128/MCB.02238-07; Donoso M, 2009, MOL BIOL CELL, V20, P481, DOI 10.1091/mbc.E08-08-0805; ERICSSON S, 1991, J CLIN INVEST, V87, P591, DOI 10.1172/JCI115034; Field PA, 2000, METABOLISM, V49, P492, DOI 10.1016/S0026-0495(00)80014-1; Gordts PLSM, 2009, ARTERIOSCL THROM VAS, V29, P1258, DOI 10.1161/ATVBAHA.109.192211; Heeren J, 2002, J MOL MED-JMM, V80, P576, DOI 10.1007/s00109-002-0351-5; HERZ J, 1991, J BIOL CHEM, V266, P21232; Hui DY, 2005, NEUROBIOL AGING, V26, P317, DOI 10.1016/j.neurobiolaging.2004.02.030; Johnson AO, 1998, J BIOL CHEM, V273, P17968, DOI 10.1074/jbc.273.28.17968; Knisely Jane M., 2008, V457, P319, DOI 10.1007/978-1-59745-261-8_24; KOWAL RC, 1989, P NATL ACAD SCI USA, V86, P5810, DOI 10.1073/pnas.86.15.5810; Laatsch A, 2009, ATHEROSCLEROSIS, V204, P105, DOI 10.1016/j.atherosclerosis.2008.07.046; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Llorente-Cortes V, 2007, CARDIOVASC RES, V74, P526, DOI 10.1016/j.cardiores.2007.02.020; MacArthur JM, 2007, J CLIN INVEST, V117, P153, DOI 10.1172/JCI29154; Mahley RW, 2007, J CLIN INVEST, V117, P94, DOI 10.1172/JCI30889; Mahley RW, 1999, J LIPID RES, V40, P1933; Mahley RW, 2000, ANNU REV GENOM HUM G, V1, P507, DOI 10.1146/annurev.genom.1.1.507; Mahley RW, 1999, J LIPID RES, V40, P1; Melman L, 2002, MOL BIOL CELL, V13, P3325, DOI 10.1091/mbc.E02-03-0152; MEREDITH MJ, 1988, CELL BIOL TOXICOL, V4, P405, DOI 10.1007/BF00117769; Merkel M, 2005, J BIOL CHEM, V280, P21553, DOI 10.1074/jbc.M411412200; Moon JH, 2011, METABOLISM, V60, P930, DOI 10.1016/j.metabol.2010.08.013; Niemeier A, 2005, J BONE MINER RES, V20, P283, DOI 10.1359/JBMR.041102; Niemeier A, 1996, J LIPID RES, V37, P1733; Nilsson SK, 2007, BIOCHEMISTRY-US, V46, P3896, DOI 10.1021/bi7000533; OTWAY S, 1967, J PHYSIOL-LONDON, V190, P321, DOI 10.1113/jphysiol.1967.sp008211; PIEDRAHITA JA, 1992, P NATL ACAD SCI USA, V89, P4471, DOI 10.1073/pnas.89.10.4471; PLUMP AS, 1992, CELL, V71, P343, DOI 10.1016/0092-8674(92)90362-G; Reekmans SM, 2010, CELL MOL LIFE SCI, V67, P135, DOI 10.1007/s00018-009-0171-7; Roebroek AJM, 2006, MOL CELL BIOL, V26, P605, DOI 10.1128/MCB.26.2.605-616.2006; Rohlmann A, 1998, J CLIN INVEST, V101, P689, DOI 10.1172/JCI1240; Schaefer JR, 2009, EUR J HUM GENET, V17, P541, DOI 10.1038/ejhg.2008.222; Schapiro FB, 2004, MOL BIOL CELL, V15, P2884, DOI 10.1091/mbc.E03-09-0653; SCHNEIDER WJ, 1981, J CLIN INVEST, V68, P1075, DOI 10.1172/JCI110330; Stanford KI, 2009, J CLIN INVEST, V119, P3236, DOI 10.1172/JCI38251; Tabas I, 2007, CIRCULATION, V116, P1832, DOI 10.1161/CIRCULATIONAHA.106.676890; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Tuma P L, 2001, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0302s02; Willnow TE, 1996, BIOCHEM J, V313, P71, DOI 10.1042/bj3130071; Yancey PG, 2011, CIRCULATION, V124, P454, DOI 10.1161/CIRCULATIONAHA.111.032268; Yancey PG, 2010, ARTERIOSCL THROM VAS, V30, P787, DOI 10.1161/ATVBAHA.109.202051; Zhou L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006853	49	21	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e38330	10.1371/journal.pone.0038330	http://dx.doi.org/10.1371/journal.pone.0038330			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701627	Green Published, Green Submitted, gold			2022-12-27	WOS:000305348400051
J	Wucherer, MF; Michiels, NK				Wucherer, Matthias F.; Michiels, Nico K.			A Fluorescent Chromatophore Changes the Level of Fluorescence in a Reef Fish	PLOS ONE			English	Article							MELANOPHORES; PATTERNS; PIGMENT; COLOR; COMMUNICATION; TRANSPORT; EVOLUTION; SYSTEMS	Body coloration plays a major role in fish ecology and is predominantly generated using two principles: a) absorbance combined with reflection of the incoming light in pigment colors and b) scatter, refraction, diffraction and interference in structural colors. Poikilotherms, and especially fishes possess several cell types, so-called chromatophores, which employ either of these principles. Together, they generate the dynamic, multi-color patterns used in communication and camouflage. Several chromatophore types possess motile organelles, which enable rapid changes in coloration. Recently, we described red fluorescence in a number of marine fish and argued that it may be used for private communication in an environment devoid of red. Here, we describe the discovery of a chromatophore in fishes that regulates the distribution of fluorescent pigments in parts of the skin. These cells have a dendritic shape and contain motile fluorescent particles. We show experimentally that the fluorescent particles can be aggregated or dispersed through hormonal and nervous control. This is the first description of a stable and natural cytoskeleton-related fluorescence control mechanism in vertebrate cells. Its nervous control supports suggestions that fluorescence could act as a context-dependent signal in some marine fish species and encourages further research in this field. The fluorescent substance is stable under different chemical conditions and shows no discernible bleaching under strong, constant illumination.	[Wucherer, Matthias F.; Michiels, Nico K.] Univ Tubingen, Tubingen, Germany	Eberhard Karls University of Tubingen	Wucherer, MF (corresponding author), Univ Tubingen, Tubingen, Germany.	matthias.wucherer@uni-tuebingen.de	Michiels, Nico K/A-2045-2009	Michiels, Nico K/0000-0001-9873-3111	German Science Foundation (DFG) [Mi 482/13-1]; Hanns-Seidel-Foundation, Munich, Germany	German Science Foundation (DFG)(German Research Foundation (DFG)); Hanns-Seidel-Foundation, Munich, Germany	This study was part of the "Koselleck Grant Mi 482/13-1" funded by the German Science Foundation (DFG, http://www.dfg.de). The main author was supported by a stipend from the Hanns-Seidel-Foundation, Munich, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott F, 1973, INTEGR COMP BIOL, V13, P885; Aspengren S, 2003, PIGM CELL RES, V16, P59, DOI 10.1034/j.1600-0749.2003.00003.x; Aspengren S, 2009, DIFFERENT STRATEGIES; Aspengren S, 2007, J NEUROSCI RES, V85, P2591, DOI 10.1002/jnr.21132; Bagnara JT, 2007, PIGM CELL RES, V20, P14, DOI 10.1111/j.1600-0749.2006.00360.x; Bagnara JT., 2006, PIGMENTARY SYSTEM PH, P11, DOI [10.1002/9780470987100.ch2, DOI 10.1002/9780470987100.CH2]; Burton D, 2000, J FISH BIOL; Cheney KL, 2008, P R SOC B, V275, P117, DOI 10.1098/rspb.2007.0966; Cott H.B., 1940, ADAPTIVE COLORATION; Endler J, 2008, BIOL J LINN SOC, V41, P315; ENDLER JA, 1993, PHILOS T R SOC B, V340, P215, DOI 10.1098/rstb.1993.0060; ENDLER JA, 1999, ANIMAL SIGNALS SIGNA, P11; Fujii R, 2000, PIGM CELL RES, V13, P300, DOI 10.1034/j.1600-0749.2000.130502.x; Fujishige A, 2000, COMP BIOCHEM PHYS A, V127, P167, DOI 10.1016/S1095-6433(00)00252-X; Goda M, 1995, ZOOL SCI, V12, P811, DOI 10.2108/zsj.12.811; HAROSI FI, 1983, SCIENCE, V222, P1021, DOI 10.1126/science.6648514; KASUKAWA H, 1987, PIGM CELL RES, V1, P152, DOI 10.1111/j.1600-0749.1987.tb00406.x; Kawauchi H, 2004, PEPTIDES, V25, P1577, DOI 10.1016/j.peptides.2004.03.025; Kelsh RN, 2004, PIGM CELL RES, V17, P326, DOI 10.1111/j.1600-0749.2004.00174.x; Leclercq E, 2010, FISH FISH, V11, P159, DOI 10.1111/j.1467-2979.2009.00346.x; Loew E.R., 1990, P1; Losey GS, 1999, J FISH BIOL, V54, P921, DOI 10.1111/j.1095-8649.1999.tb00848.x; Lythgoe J.N., 1979, ECOLOGY VISION; Marshall NJ, 2003, COPEIA, P455, DOI 10.1643/01-055; Marshall NJ, 2000, PHILOS T ROY SOC B, V355, P1243, DOI 10.1098/rstb.2000.0676; Marshall NJ, 2010, COLOUR DESIGN CREATI, V5, P1; Michiels Nico K., 2008, BMC Ecology, V8, P16, DOI 10.1186/1472-6785-8-16; Miyata S, 2005, J EXPT ZOOLOGY, V241, P31; Nakajima M, 1999, ZOOLOGICAL SCI; Price AC, 2008, ZEBRAFISH, V5, P297, DOI 10.1089/zeb.2008.0551; Quigley AK, 2004, DEVELOPMENT, V131, P6053, DOI 10.1242/dev.01526; Raposo G, 2007, NAT REV MOL CELL BIO, V8, P786, DOI 10.1038/nrm2258; Siebeck UE, 2010, CURR BIOL, V20, P407, DOI 10.1016/j.cub.2009.12.047; Sugimoto M, 2002, MICROSCOPY RES TECHN; Turner JR, 2009, DEEP-SEA RES PT I, V56, P1003, DOI 10.1016/j.dsr.2009.01.007; Zhang C, 2010, P NATL ACAD SCI US	36	20	20	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e37913	10.1371/journal.pone.0037913	http://dx.doi.org/10.1371/journal.pone.0037913			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701587	gold, Green Submitted, Green Published			2022-12-27	WOS:000305348400025
J	Lyke, KE; Wang, A; Dabo, A; Arama, C; Daou, M; Diarra, I; Plowe, CV; Doumbo, OK; Sztein, MB				Lyke, Kirsten E.; Wang, Amy; Dabo, Abdoulaye; Arama, Charles; Daou, Modibo; Diarra, Issa; Plowe, Christopher V.; Doumbo, Ogobara K.; Sztein, Marcelo B.			Antigen-Specific B Memory Cell Responses to Plasmodium falciparum Malaria Antigens and Schistosoma haematobium Antigens in Co-Infected Malian Children	PLOS ONE			English	Article							INFLAMMATORY MARKERS; INTERFERON-GAMMA; IMMUNE-COMPLEXES; REINFECTION; COINFECTION; C3D; ASSOCIATION; ACQUISITION; ACTIVATION; PROTECTION	Polyparasitism is common in the developing world. We have previously demonstrated that schistosomiasis-positive (SP) Malian children have age-dependent protection from malaria compared to matched schistosomiasis-negative (SN) children. Evidence of durable immunologic memory to malaria antigens is conflicting, particularly in young children and the effect of concomitant schistomiasis upon acquisition of memory is unknown. We examined antigen-specific B memory cell (MBC) frequencies (expressed as percentage of total number of IgG-secreting cells) in 84 Malian children aged 4-14 to malaria blood-stage antigens, apical membrane antigen 1 (AMA-1) and merozoite surface protein 1 (MSP-1) and to schistosomal antigens, Soluble Worm Antigenic Preparation (SWAP) and Schistosoma Egg Antigen (SEA), at a time point during the malaria transmission season and a follow-up dry season visit. We demonstrate, for the first time, MBC responses to S. haematobium antigens in Malian children with urinary egg excretion and provide evidence of seasonal acquisition of immunologic memory, age-associated differences in MBC acquisition, and correlation with circulating S. haematobium antibody. Moreover, the presence of a parasitic co-infection resulted in older children, aged 9-14 years, with underlying S. haematobium infection having significantly more MBC response to malaria antigens (AMA1 and MSP1) than their age-matched SN counterparts. We conclude that detectable MBC response can be measured against both malaria and schistosomal antigens and that the presence of S. haematobium may be associated with enhanced MBC induction in an age-specific manner.	[Lyke, Kirsten E.; Wang, Amy; Plowe, Christopher V.; Sztein, Marcelo B.] Univ Maryland, Sch Med, Ctr Vaccine Dev, Baltimore, MD 21201 USA; [Dabo, Abdoulaye; Arama, Charles; Daou, Modibo; Diarra, Issa; Doumbo, Ogobara K.] Univ Bamako, Malaria Res & Training Ctr, Bamako, Mali; [Arama, Charles] Univ Stockholm, Dept Immunol, S-10691 Stockholm, Sweden; [Plowe, Christopher V.] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA	University System of Maryland; University of Maryland Baltimore; University of Bamako; Stockholm University; Howard Hughes Medical Institute; Johns Hopkins University	Lyke, KE (corresponding author), Univ Maryland, Sch Med, Ctr Vaccine Dev, Baltimore, MD 21201 USA.	KLyke@medicine.umaryland.edu			National Institute of Allergy and Infectious Diseases (NIAID/National Institutes of Health (NIH) [AI49203]; Doris Duke Clinical Development Award; NIAID/NIH [AI067954]; National Institute of Allergy and Infectious Disease; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI049203, R01AI067954] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID/National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Doris Duke Clinical Development Award; NIAID/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The clinical portion of the study was funded by a K23 award awarded by the National Institute of Allergy and Infectious Diseases (NIAID/National Institutes of Health (NIH) (AI49203). Immunologic assays were funded in part by a Doris Duke Clinical Development Award as well as an R-01 (AI067954) from NIAID/NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to acknowledge the population of Bandiagara, Mali for their support and participation in this and many other trials. This abstract has been presented in part to the American Society of Tropical Medicine and Hygiene, Atlanta, GA, November 2010, abstract #1288. Dr. William Blackwelder kindly provided advice in regards to statistical analyses. S. haematobium proteins were obtained through the Schistosome Related Reagent Repository (SR3) sponsored by the National Institute of Allergy and Infectious Disease with special thanks to Dr. Fred Lewis. Apical membrane antigen 1 was kindly donated by Drs. David Lanar and Sheetij Dutta, and merozoite surface protein 1 (42) by Dr. Evelina Angov, of Walter Reed Army Institute of Research (WRAIR).	Amanna IJ, 2010, IMMUNOL REV, V236, P125, DOI 10.1111/j.1600-065X.2010.00912.x; Bernasconi NL, 2002, SCIENCE, V298, P2199, DOI 10.1126/science.1076071; Brabin B., 1990, Tropical Diseases Bulletin, V87, pR1; Briand V, 2005, AM J TROP MED HYG, V72, P702, DOI 10.4269/ajtmh.2005.72.702; CAPRON A, 1992, ANNU REV MED, V43, P209, DOI 10.1146/annurev.me.43.020192.001233; CHANDIWANA SK, 1991, PARASITOLOGY, V102, P73, DOI 10.1017/S0031182000060364; Coulibaly D, 2002, AM J TROP MED HYG, V67, P604; Crompton PD, 2009, J IMMUNOL, V182, P3318, DOI 10.4049/jimmunol.0803596; Crotty S, 2004, J IMMUNOL METHODS, V286, P111, DOI 10.1016/j.jim.2003.12.015; Dempsey PW, 1996, SCIENCE, V271, P348, DOI 10.1126/science.271.5247.348; Diallo TO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012764; Diallo TO, 2004, PARASITE IMMUNOL, V26, P365, DOI 10.1111/j.0141-9838.2004.00719.x; Dorfman JR, 2005, J INFECT DIS, V191, P1623, DOI 10.1086/429671; Dutta S, 2002, INFECT IMMUN, V70, P3101, DOI 10.1128/IAI.70.6.3101-3110.2002; ETARD JF, 1995, AM J TROP MED HYG, V52, P549, DOI 10.4269/ajtmh.1995.52.549; Franklin BS, 2009, P NATL ACAD SCI USA, V106, P5789, DOI 10.1073/pnas.0809742106; GRAU GE, 1994, RES IMMUNOL, V145, P441, DOI 10.1016/S0923-2494(94)80175-4; Grogan JL, 1998, J INFECT DIS, V177, P1433, DOI 10.1086/517832; GRZYCH JM, 1991, J IMMUNOL, V146, P1322; HAGAN P, 1991, NATURE, V349, P243, DOI 10.1038/349243a0; Joshi AD, 2008, J LEUKOCYTE BIOL, V83, P314, DOI 10.1189/jlb.1007689; King CL, 1996, J IMMUNOL, V156, P4715; Lyke KE, 2005, AM J TROP MED HYG, V73, P1124, DOI 10.4269/ajtmh.2005.73.1124; Lyke KE, 2005, INFECT IMMUN, V73, P5799, DOI 10.1128/IAI.73.9.5799-5808.2005; Lyke KE, 2006, INFECT IMMUN, V74, P5718, DOI 10.1128/IAI.01822-05; Lyke KE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031647; Macdonald G., 1950, Tropical Diseases Bulletin, V47, P915; McCall MBB, 2007, J IMMUNOL, V179, P162, DOI 10.4049/jimmunol.179.1.162; McGregor I, 1986, CLIN TROP MED COMMUN, V1986, P1; McGREGOR I. A., 1963, TRANS ROY SOC TROP MED AND HYG, V57, P170, DOI 10.1016/0035-9203(63)90058-0; MURPHY JR, 1989, J CLIN MICROBIOL, V27, P1434, DOI 10.1128/JCM.27.7.1434-1437.1989; Ndungu FM, 2002, PARASITE IMMUNOL, V24, P77, DOI 10.1046/j.0141-9838.2001.00440.x; PEARCE EJ, 1991, J EXP MED, V173, P159, DOI 10.1084/jem.173.1.159; Perry JA, 2005, J IMMUNOL, V174, P5921, DOI 10.4049/jimmunol.174.10.5921; Remoue F, 2003, T ROY SOC TROP MED H, V97, P361, DOI 10.1016/S0035-9203(03)90170-2; SANTORO F, 1980, CLIN EXP IMMUNOL, V42, P219; Simon JK, 2009, VACCINE, V27, P565, DOI 10.1016/j.vaccine.2008.10.081; Traore B, 2009, VACCINE, V27, P7299, DOI 10.1016/j.vaccine.2009.08.023; van der Kleij D, 2004, J INFECT DIS, V189, P1044, DOI 10.1086/382089; VERROUST PJ, 1979, KIDNEY INT, V16, P9, DOI 10.1038/ki.1979.97; Wahid R, 2011, CLIN IMMUNOL, V138, P187, DOI 10.1016/j.clim.2010.11.006; Weiss GE, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000912; Wipasa J, 2002, IMMUNOL CELL BIOL, V80, P401, DOI 10.1046/j.1440-1711.2002.01107.x; Wipasa J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000770; WYLER AR, 1972, J NEUROSURG, V37, P185, DOI 10.3171/jns.1972.37.2.0185; Wyler D J, 1979, Bull World Health Organ, V57 Suppl 1, P239	46	10	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e37868	10.1371/journal.pone.0037868	http://dx.doi.org/10.1371/journal.pone.0037868			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22693628	Green Published, gold, Green Submitted			2022-12-27	WOS:000305343900014
J	Cao, DS; Zhong, LL; Hsieh, TH; Abooj, M; Bishnoi, M; Hughes, L; Premkumar, LS				Cao, De-Shou; Zhong, Linlin; Hsieh, Tsung-han; Abooj, Mruvil; Bishnoi, Mahendra; Hughes, Lauren; Premkumar, Louis S.			Expression of Transient Receptor Potential Ankyrin 1 (TRPA1) and Its Role in Insulin Release from Rat Pancreatic Beta Cells	PLOS ONE			English	Article							SENSITIVE K+ CHANNELS; SENSORY NEURONS; DIABETIC COMPLICATIONS; COVALENT MODIFICATION; COLD HYPERALGESIA; CATION CHANNELS; CA2+ RELEASE; ION CHANNELS; LINE RIN-5F; ADP-RIBOSE	Objective: Several transient receptor potential (TRP) channels are expressed in pancreatic beta cells and have been proposed to be involved in insulin secretion. However, the endogenous ligands for these channels are far from clear. Here, we demonstrate the expression of the transient receptor potential ankyrin 1 (TRPA1) ion channel in the pancreatic beta cells and its role in insulin release. TRPA1 is an attractive candidate for inducing insulin release because it is calcium permeable and is activated by molecules that are produced during oxidative glycolysis. Methods: Immunohistochemistry, RT-PCR, and Western blot techniques were used to determine the expression of TRPA1 channel. Ca2+ fluorescence imaging and electrophysiology (voltage-and current-clamp) techniques were used to study the channel properties. TRPA1-mediated insulin release was determined using ELISA. Results: TRPA1 is abundantly expressed in a rat pancreatic beta cell line and freshly isolated rat pancreatic beta cells, but not in pancreatic alpha cells. Activation of TRPA1 by allyl isothiocyanate (AITC), hydrogen peroxide (H2O2), 4-hydroxynonenal (4-HNE), and cyclopentenone prostaglandins (PGJ(2)) and a novel agonist methylglyoxal (MG) induces membrane current, depolarization, and Ca2+ influx leading to generation of action potentials in a pancreatic beta cell line and primary cultured pancreatic beta cells. Activation of TRPA1 by agonists stimulates insulin release in pancreatic beta cells that can be inhibited by TRPA1 antagonists such as HC030031 or AP-18 and by RNA interference. TRPA1-mediated insulin release is also observed in conditions of voltage-gated Na+ and Ca2+ channel blockade as well as ATP sensitive potassium (K-ATP) channel activation. Conclusions: We propose that endogenous and exogenous ligands of TRPA1 cause Ca2+ influx and induce basal insulin release and that TRPA1-mediated depolarization acts synergistically with K-ATP channel blockade to facilitate insulin release.	[Cao, De-Shou; Zhong, Linlin; Hsieh, Tsung-han; Abooj, Mruvil; Bishnoi, Mahendra; Hughes, Lauren; Premkumar, Louis S.] So Illinois Univ, Sch Med, Dept Pharmacol, Springfield, IL 62794 USA	Southern Illinois University System; Southern Illinois University	Cao, DS (corresponding author), So Illinois Univ, Sch Med, Dept Pharmacol, Springfield, IL 62794 USA.	dcao@ucsd.edu; lpremkumar@siumed.edu	Bishnoi, Mahendra/CAG-3229-2022; Cao, Deshou/G-8697-2014	Bishnoi, Mahendra/0000-0002-7785-1204	National Institutes of Health [NS042296, DK065742, DA028017]; Southern Illinois University School of Medicine; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK065742, R01DK065742] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042296] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA028017] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Southern Illinois University School of Medicine; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by grants from National Institutes of Health (NS042296 and DK065742 and DA028017) and an Excellence in Academic Medicine (EAM) award from Southern Illinois University School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiba Y, 2004, BIOCHEM BIOPH RES CO, V321, P219, DOI 10.1016/j.bbrc.2004.06.149; Andersson DA, 2008, J NEUROSCI, V28, P2485, DOI 10.1523/JNEUROSCI.5369-07.2008; ASHCROFT FM, 1984, NATURE, V312, P446, DOI 10.1038/312446a0; Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; Barbasa M, 2008, ETHNICITY DIS S1, V18, P62; Bautista DM, 2005, P NATL ACAD SCI USA, V102, P12248, DOI 10.1073/pnas.0505356102; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Bessac BF, 2008, J CLIN INVEST, V118, P1899, DOI 10.1172/JCI34192; BRITSCH S, 1995, BIOCHEM BIOPH RES CO, V207, P33, DOI 10.1006/bbrc.1995.1149; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615; Casas S, 2008, DIABETOLOGIA, V51, P2252, DOI 10.1007/s00125-008-1111-z; Ceppa E, 2010, AM J PHYSIOL-GASTR L, V299, pG556, DOI 10.1152/ajpgi.00433.2009; Cheng H, 2007, CELL CALCIUM, V41, P51, DOI 10.1016/j.ceca.2006.04.032; Colsoul B, 2010, P NATL ACAD SCI USA, V107, P5208, DOI 10.1073/pnas.0913107107; Cook LJ, 1998, BIOCHEM PHARMACOL, V55, P1361, DOI 10.1016/S0006-2952(97)00619-9; Drews G, 2010, ADV EXP MED BIOL, V654, P115, DOI 10.1007/978-90-481-3271-3_7; Gram DX, 2007, EUR J NEUROSCI, V25, P213, DOI 10.1111/j.1460-9568.2006.05261.x; Henquin JC, 2000, DIABETES, V49, P1751, DOI 10.2337/diabetes.49.11.1751; Hinman A, 2006, P NATL ACAD SCI USA, V103, P19564, DOI 10.1073/pnas.0609598103; Hisanaga E, 2009, DIABETES, V58, P174, DOI 10.2337/db08-0862; Ishii M, 2006, J PHARMACOL SCI, V101, P174, DOI 10.1254/jphs.SCJ06001X; Ishii M, 2006, CELL CALCIUM, V39, P487, DOI 10.1016/j.ceca.2006.01.013; Islam MS, 2011, ADV EXP MED BIOL, V704, P811, DOI 10.1007/978-94-007-0265-3_42; Jacobson D. A., 2007, V179, P409; Jan CR, 2005, CELL SIGNAL, V17, P847, DOI 10.1016/j.cellsig.2004.11.007; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Katsura H, 2006, EXP NEUROL, V200, P112, DOI 10.1016/j.expneurol.2006.01.031; Kerstein PC, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-19; Komatsu M, 2001, ENDOCR J, V48, P275, DOI 10.1507/endocrj.48.275; Krippeit-Drews P, 1999, J PHYSIOL-LONDON, V514, P471, DOI 10.1111/j.1469-7793.1999.471ae.x; KRIPPEITDREWS P, 1994, PFLUG ARCH EUR J PHY, V426, P552, DOI 10.1007/BF00378534; Kwan KY, 2009, J NEUROSCI, V29, P4808, DOI 10.1523/JNEUROSCI.5380-08.2009; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; Leech CA, 1997, J BIOL CHEM, V272, P17987, DOI 10.1074/jbc.272.29.17987; Li F, 2009, WORLD J GASTROENTERO, V15, P3046, DOI 10.3748/wjg.15.3046; MacDonald MJ, 2006, ARCH BIOCHEM BIOPHYS, V447, P118, DOI 10.1016/j.abb.2006.01.019; Macpherson LJ, 2007, NATURE, V445, P541, DOI 10.1038/nature05544; Miura Y, 2003, AM J PHYSIOL-ENDOC M, V285, pE1001, DOI 10.1152/ajpendo.00005.2003; Nagata K, 2005, J NEUROSCI, V25, P4052, DOI 10.1523/JNEUROSCI.0013-05.2005; NAKAZAKI M, 1995, DIABETES, V44, P878, DOI 10.2337/diabetes.44.8.878; Nilius B, 2007, PHYSIOL REV, V87, P165, DOI 10.1152/physrev.00021.2006; Numazawa S, 2012, BIOL PHARM BULL, V35, P346, DOI 10.1248/bpb.35.346; Obata K, 2005, J CLIN INVEST, V115, P2393, DOI 10.1172/JCI23437; Pi JB, 2007, DIABETES, V56, P1783, DOI 10.2337/db06-1601; Qian F, 2002, DIABETES, V51, pS183, DOI 10.2337/diabetes.51.2007.S183; Ravier MA, 2010, DIABETOLOGIA, V53, P1947, DOI 10.1007/s00125-010-1775-z; Razavi R, 2006, CELL, V127, P1123, DOI 10.1016/j.cell.2006.10.038; Roe MW, 1998, J BIOL CHEM, V273, P10402, DOI 10.1074/jbc.273.17.10402; Sakura H, 1997, DIABETOLOGIA, V40, P528, DOI 10.1007/s001250050711; Sato Y, 1999, ENDOCRINOLOGY, V140, P2252, DOI 10.1210/en.140.5.2252; Sawada Y, 2008, EUR J NEUROSCI, V27, P1131, DOI 10.1111/j.1460-9568.2008.06093.x; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Straub SG, 1998, DIABETES, V47, P758, DOI 10.2337/diabetes.47.5.758; Togashi K, 2006, EMBO J, V25, P1804, DOI 10.1038/sj.emboj.7601083; Trevisani M, 2007, P NATL ACAD SCI USA, V104, P13519, DOI 10.1073/pnas.0705923104; Uchida K, 2011, DIABETES, V60, P119, DOI 10.2337/db10-0276; Vennekens R, 2007, NAT IMMUNOL, V8, P312, DOI 10.1038/ni1441; Wagner TFJ, 2008, NAT CELL BIOL, V10, P1421, DOI 10.1038/ncb1801; Wang H, 2007, CLIN BIOCHEM, V40, P1232, DOI 10.1016/j.clinbiochem.2007.07.016	60	84	90	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38005	10.1371/journal.pone.0038005	http://dx.doi.org/10.1371/journal.pone.0038005			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22701540	Green Submitted, Green Published, gold			2022-12-27	WOS:000305338500071
J	Hartsock, A; Nelson, WJ				Hartsock, Andrea; Nelson, W. James			Competitive Regulation of E-Cadherin JuxtaMembrane Domain Degradation by p120-Catenin Binding and Hakai-Mediated Ubiquitination	PLOS ONE			English	Article							CELL-CELL ADHESION; PROTEASOME PATHWAY; P120 CATENIN; VE-CADHERIN; ENDOCYTOSIS; PROTEIN; RECEPTOR; CYTOSKELETON; MECHANISMS; EXPRESSION	p120-Catenin binding to, and Hakai-mediated ubiquitination of the E-cadherin juxtamembrane domain (JMD) are thought to be involved in regulating E-cadherin internalization and degradation. However, the relationship between these two pathways is not understood. We targeted the E-cadherin JMD to mitochondria (WT-JMD) to isolate this domain from the plasma membrane and internalization, and to examine protein modifications and degradation. WT-JMD localized to mitochondria, but did not accumulate there except when proteasome activity was inhibited. We found WT-JMD was ubiquitinated, and arginine substitution of lysines at position 5 (K5R) and 83 (K83R) resulted in the stable accumulation of mutant JMD at mitochondria. p120-Catenin did not localize, or bind to WT-JMD even upon proteasome inhibition, whereas the K5,83R-JMD mutant bound and localized p120-catenin to mitochondria. Mutation of the p120-catenin binding site in combination with these lysine mutations inhibited p120-catenin binding, but did not decrease JMD stability or its accumulation at mitochondria. Thus, increased stability of JMD lysine mutants was due to inhibition of ubiquitination and not to p120-catenin binding. Finally, mutation of these critical lysines in full length E-cadherin had similar effects on protein stability as WT-JMD. Our results indicate that ubiquitination of the JMD inhibits p120-catenin binding, and targets E-cadherin for degradation.	[Hartsock, Andrea; Nelson, W. James] Stanford Univ, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Nelson, W. James] Stanford Univ, Dept Biol, Stanford, CA 94305 USA	Stanford University; Stanford University	Hartsock, A (corresponding author), Stanford Univ, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA.	wjnelson@stanford.edu			National Institutes of Health (NIH) [GM035527]; Research Supplement to Promote Diversity in Health-Related Research [GM035527-25S2]; Stanford University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM035527, R01GM035527] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Supplement to Promote Diversity in Health-Related Research; Stanford University(Stanford University); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) grant GM035527 to WJN, a Research Supplement to Promote Diversity in Health-Related Research (GM035527-25S2) to AH, and a D.A.R.E. Fellowship from Stanford University to AH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benjamin JM, 2010, J CELL BIOL, V189, P339, DOI 10.1083/jcb.200910041; Chen YT, 1999, J CELL BIOL, V144, P687, DOI 10.1083/jcb.144.4.687; Davis MA, 2003, J CELL BIOL, V163, P525, DOI 10.1083/jcb.200307111; Ferber A, 2002, EXP CELL RES, V274, P35, DOI 10.1006/excr.2001.5436; Fujita Y, 2002, NAT CELL BIOL, V4, P222, DOI 10.1038/ncb758; Halbleib JM, 2006, GENE DEV, V20, P3199, DOI 10.1101/gad.1486806; Harris ES, 2010, CURR OPIN CELL BIOL, V22, P651, DOI 10.1016/j.ceb.2010.07.006; Hartsock A, 2008, BBA-BIOMEMBRANES, V1778, P660, DOI 10.1016/j.bbamem.2007.07.012; Ishiyama N, 2010, CELL, V141, P117, DOI 10.1016/j.cell.2010.01.017; Jeffers M, 1997, MOL CELL BIOL, V17, P799, DOI 10.1128/MCB.17.2.799; Maeda M, 2006, ONCOGENE, V25, P4595, DOI 10.1038/sj.onc.1209396; Marmor MD, 2004, ONCOGENE, V23, P2057, DOI 10.1038/sj.onc.1207390; MARRS JA, 1993, J CELL BIOL, V123, P149, DOI 10.1083/jcb.123.1.149; Martinez-Moczygemba M, 2001, J CLIN INVEST, V108, P1797, DOI 10.1172/JCI200113877; MAYS RW, 1995, J CELL BIOL, V130, P1105, DOI 10.1083/jcb.130.5.1105; Mimnaugh EG, 1999, ELECTROPHORESIS, V20, P418, DOI 10.1002/(SICI)1522-2683(19990201)20:2<418::AID-ELPS418>3.0.CO;2-N; Niebuhr K, 1997, EMBO J, V16, P5433, DOI 10.1093/emboj/16.17.5433; REYNOLDS AB, 1989, MOL CELL BIOL, V9, P629, DOI 10.1128/MCB.9.2.629; REYNOLDS AB, 1992, ONCOGENE, V7, P2439; Staub O, 1997, EMBO J, V16, P6325, DOI 10.1093/emboj/16.21.6325; Thoreson MA, 2000, J CELL BIOL, V148, P189, DOI 10.1083/jcb.148.1.189; Troyanovsky RB, 2007, MOL BIOL CELL, V18, P4343, DOI 10.1091/mbc.E07-01-0084; van Kerkhof P, 2000, J BIOL CHEM, V275, P1575, DOI 10.1074/jbc.275.3.1575; Xiao KY, 2005, MOL BIOL CELL, V16, P5141, DOI 10.1091/mbc.E05-05-0440; Xiao KY, 2003, J CELL BIOL, V163, P535, DOI 10.1083/jcb.200306001; Yen CH, 2000, J IMMUNOL, V165, P6372, DOI 10.4049/jimmunol.165.11.6372	26	31	32	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e37476	10.1371/journal.pone.0037476	http://dx.doi.org/10.1371/journal.pone.0037476			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693575	Green Published, gold, Green Submitted			2022-12-27	WOS:000305338500038
J	Lavelle, D; Vaitkus, K; Ruiz, MA; Ibanez, V; Kouznetsova, T; Saunthararajah, Y; Mahmud, N; DeSimone, J				Lavelle, Donald; Vaitkus, Kestutis; Ruiz, Maria Armila; Ibanez, Vinzon; Kouznetsova, Tatiana; Saunthararajah, Yogen; Mahmud, Nadim; DeSimone, Joseph			Effect of AGM and Fetal Liver-Derived Stromal Cell Lines on Globin Expression in Adult Baboon (P. anubis) Bone Marrow-Derived Erythroid Progenitors	PLOS ONE			English	Article							SERUM-FREE CULTURE; HEMOGLOBIN-SYNTHESIS; GAMMA; ERYTHROPOIETIN; DIFFERENTIATE; STIMULATION; MATURATION; NICHES	This study was performed to investigate the hypothesis that the erythroid micro-environment plays a role in regulation of globin gene expression during adult erythroid differentiation. Adult baboon bone marrow and human cord blood CD34+ progenitors were grown in methylcellulose, liquid media, and in co-culture with stromal cell lines derived from different developmental stages in identical media supporting erythroid differentiation to examine the effect of the microenvironment on globin gene expression. Adult progenitors express high levels of gamma-globin in liquid and methylcellulose media but low, physiological levels in stromal cell co-cultures. In contrast, gamma-globin expression remained high in cord blood progenitors in stromal cell line co-cultures. Differences in gamma-globin gene expression between adult progenitors in stromal cell line co-cultures and liquid media required cell-cell contact and were associated with differences in rate of differentiation and gamma-globin promoter DNA methylation. We conclude that gamma-globin expression in adult-derived erythroid cells can be influenced by the micro-environment, suggesting new potential targets for HbF induction.	[Lavelle, Donald; Vaitkus, Kestutis; Ruiz, Maria Armila; Ibanez, Vinzon; Kouznetsova, Tatiana; Saunthararajah, Yogen; Mahmud, Nadim; DeSimone, Joseph] Univ Illinois, Dept Med, Chicago, IL 60607 USA; [Lavelle, Donald; Vaitkus, Kestutis; Ruiz, Maria Armila; Ibanez, Vinzon; Kouznetsova, Tatiana; DeSimone, Joseph] Jesse Brown VA Med Ctr, Chicago, IL USA; [Saunthararajah, Yogen] Cleveland Clin, Cleveland, OH 44106 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center; Cleveland Clinic Foundation	Lavelle, D (corresponding author), Univ Illinois, Dept Med, Chicago, IL 60607 USA.	dlavelle@uic.edu			National Heart, Lung, and Blood Institute (NHLBI) [U54HL090513]; State of Illinois Sickle Cell Center funds; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U54HL090513, R01HL114561] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); State of Illinois Sickle Cell Center funds; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Heart, Lung, and Blood Institute (NHLBI) (U54HL090513) and State of Illinois Sickle Cell Center funds. The funders had no role in study design, data collection and analysis, or preparation of the manuscript.	ALKHATTI A, 1987, NEW ENGL J MED, V317, P415, DOI 10.1056/NEJM198708133170704; Araki H, 2006, EXP HEMATOL, V34, P140, DOI 10.1016/j.exphem.2005.10.002; Atweh G, 2010, HEMATOL ONCOL CLIN N, V24, P1131, DOI 10.1016/j.hoc.2010.08.001; Banzon V, 2011, EXP HEMATOL, V39, P26, DOI 10.1016/j.exphem.2010.10.003; Bhanu NV, 2005, BLOOD, V105, P387, DOI 10.1182/blood-2004-04-1599; Chang CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025761; Chasis JA, 2008, BLOOD, V112, P470, DOI 10.1182/blood-2008-03-077883; Chin J, 2009, EXP HEMATOL, V37, P1131, DOI 10.1016/j.exphem.2009.06.007; DERON AT, 1985, EXP HEMATOL, V13, P919; DESIMONE J, 1979, BLOOD, V54, P1176; Dev A, 2010, BLOOD, V116, P5991; Eshghi S, 2007, J CELL BIOL, V177, P871, DOI 10.1083/jcb.200702080; FUJIMORI Y, 1990, BLOOD, V75, P1718; Kusadasi N, 2002, LEUKEMIA, V16, P1782, DOI 10.1038/sj.leu.2402615; Lavelle D, 2001, EXP HEMATOL, V29, P156, DOI 10.1016/S0301-472X(00)00654-8; Lee KY, 2011, STEM CELLS DEV, V20, P31, DOI 10.1089/scd.2010.0196; LEONE L, 1985, J CHROMATOGR, V321, P407, DOI 10.1016/S0021-9673(01)90459-5; MIGLIACCIO AR, 1990, BLOOD, V76, P1150; Moore KA, 1997, BLOOD, V89, P4337, DOI 10.1182/blood.V89.12.4337; NAKANO T, 1994, SCIENCE, V265, P1098, DOI 10.1126/science.8066449; Neildez-Nguyen TMA, 2002, NAT BIOTECHNOL, V20, P467, DOI 10.1038/nbt0502-467; Ni H, 1999, EXP HEMATOL, V27, P46, DOI 10.1016/S0301-472X(98)00010-1; PAPAYANNOPOULOU T, 1981, BLOOD, V57, P531; PAPAYANNOPOULOU T, 1982, P NATL ACAD SCI-BIOL, V79, P6579, DOI 10.1073/pnas.79.21.6579; PAPAYANNOPOULOU T, 1976, P NATL ACAD SCI USA, V73, P2033, DOI 10.1073/pnas.73.6.2033; PAPAYANNOPOULOU T, 1986, CELL, V46, P469, DOI 10.1016/0092-8674(86)90667-7; PESCHLE C, 1993, BLOOD, V81, P328; Qiu CH, 2008, BLOOD, V111, P2400, DOI 10.1182/blood-2007-07-102087; Sankaran VG, 2009, NATURE, V460, P1093, DOI 10.1038/nature08243; Saunthararajah Y, 2004, BRIT J HAEMATOL, V126, P629, DOI 10.1111/j.1365-2141.2004.05064.x; Singh M, 2007, EXP HEMATOL, V35, P48, DOI 10.1016/j.exphem.2006.09.001; Stamatoyannopoulos G, 2001, DISORDERS HEMOGLOBIN, P131; TAGLE DA, 1988, J MOL BIOL, V203, P439, DOI 10.1016/0022-2836(88)90011-3; WOOD WG, 1985, NATURE, V313, P320, DOI 10.1038/313320a0; ZANJANI ED, 1982, NATURE, V295, P244, DOI 10.1038/295244a0	35	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e36846	10.1371/journal.pone.0036846	http://dx.doi.org/10.1371/journal.pone.0036846			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693559	Green Submitted, gold, Green Published			2022-12-27	WOS:000305338500021
J	Ragonnet-Cronin, M; Aris-Brosou, S; Joanisse, I; Merks, H; Vallee, D; Caminiti, K; Sandstrom, P; Brooks, J				Ragonnet-Cronin, Manon; Aris-Brosou, Stephane; Joanisse, Isabelle; Merks, Harriet; Vallee, Dominic; Caminiti, Kyna; Sandstrom, Paul; Brooks, James			Adaptive Evolution of HIV at HLA Epitopes Is Associated with Ethnicity in Canada	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; T-LYMPHOCYTE ESCAPE; GENETIC-VARIATION; CLASS-I; ADAPTATION; HAPLOTYPES; POLYMORPHISMS; POPULATIONS; RESPONSES; SELECTION	Host immune selection pressure influences the development of mutations that allow for HIV escape. Mutation patterns induced in HIV by the human leukocyte antigen (HLA) are HLA-allele specific. As ethnic groups have distinct and characteristic HLA allele frequencies, we can expect divergent viral evolution within ethnicities. Here, we have sequenced and analyzed the HIV pol gene from 1248 subtype B infected, treatment-naive individuals in Canada. Phylogenetic analysis showed no separation between pol sequences from five self-identified ethnic groups, yet fixation index (F-ST) values showed significant divergence between ethnicities. A total of 17 amino acid sites showed an ethnic-specific fixation pattern (0.015<F-ST <0.060, p<0.01), and 27 codons were inferred to be under positive selection (p<0.01), with each set of sites strongly associated with HLA sites (p = 1.78x10(-6) and p = 1.91x10(-7), respectively). Within the pol gene, eight sites under HLA selective pressure were correlated with ethnicity, indicating 'adaptive divergence' between the groups studied. Our findings highlight challenges in HIV vaccine design in ethnically diverse countries with subtype B epidemics.	[Ragonnet-Cronin, Manon; Joanisse, Isabelle; Merks, Harriet; Vallee, Dominic; Caminiti, Kyna; Sandstrom, Paul; Brooks, James] Publ Hlth Agcy Canada, Natl HIV & Retrovirol Labs, Ottawa, ON, Canada; [Ragonnet-Cronin, Manon; Aris-Brosou, Stephane] Univ Ottawa, Dept Biol, Ottawa, ON, Canada; [Brooks, James] Univ Ottawa, Dept Med, Ottawa, ON, Canada	Public Health Agency of Canada; University of Ottawa; University of Ottawa	Ragonnet-Cronin, M (corresponding author), Univ Edinburgh, Inst Evolutionary Biol, Edinburgh, Midlothian, Scotland.	James.Brooks@phac-aspc.gc.ca	Ragonnet-Cronin, Manon/L-5394-2019	Aris-Brosou, Stephane/0000-0003-4987-0296; Ragonnet-Cronin, Manon/0000-0002-4879-2209	Canada Memorial Foundation; Natural Sciences Research Council of Canada; Canada Foundation for Innovation; Federal Initiative on HIV/AIDS in Canada	Canada Memorial Foundation; Natural Sciences Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Federal Initiative on HIV/AIDS in Canada	This work was supported by the Canada Memorial Foundation (MRC), the Natural Sciences Research Council of Canada (SAB), the Canada Foundation for Innovation (SAB), and the Federal Initiative on HIV/AIDS in Canada (JB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2010, NUCLEIC ACIDS RES, V38, pW7, DOI 10.1093/nar/gkq291; Allen TM, 2005, J VIROL, V79, P12952, DOI 10.1128/JVI.79.20.12952-12960.2005; Avila-Rios S, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-72; Bhattacharya T, 2007, SCIENCE, V315, P1583, DOI 10.1126/science.1131528; Brumme ZL, 2007, PLOS PATHOG, V3, P913, DOI 10.1371/journal.ppat.0030094; Brumme ZL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006687; Cao K, 2001, HUM IMMUNOL, V62, P1009, DOI 10.1016/S0198-8859(01)00298-1; Carlson JM, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000225; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Gonzalez-Galarza FF, 2011, NUCLEIC ACIDS RES, V39, pD913, DOI 10.1093/nar/gkq1128; HAHN BH, 1986, SCIENCE, V232, P1548, DOI 10.1126/science.3012778; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hartl D, 2007, PRINCIPLES POPULATIO, P288; ITESCU S, 1992, J ACQ IMMUN DEF SYND, V5, P37; John M, 2010, J IMMUNOL, V184, P4368, DOI 10.4049/jimmunol.0903745; Kawashima Y, 2009, NATURE, V458, P641, DOI 10.1038/nature07746; Pond SLK, 2006, PLOS COMPUT BIOL, V2, P530, DOI 10.1371/journal.pcbi.0020062; Leslie AJ, 2004, NAT MED, V10, P282, DOI 10.1038/nm992; Matthews PC, 2009, J VIROL, V83, P4605, DOI 10.1128/JVI.02017-08; MEIER UC, 1995, SCIENCE, V270, P1360, DOI 10.1126/science.270.5240.1360; Monsalve MV, 1998, HUM IMMUNOL, V59, P48, DOI 10.1016/S0198-8859(97)00251-6; Moore CB, 2002, SCIENCE, V296, P1439, DOI 10.1126/science.1069660; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Parekh BS, 2002, AIDS RES HUM RETROV, V18, P295, DOI 10.1089/088922202753472874; Parker J, 2008, INFECT GENET EVOL, V8, P239, DOI 10.1016/j.meegid.2007.08.001; Perez-Sweeney B, 2010, INFECT GENET EVOL, V10, P1155, DOI 10.1016/j.meegid.2010.07.010; PHILLIPS RE, 1991, NATURE, V354, P453, DOI 10.1038/354453a0; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Price DA, 1997, P NATL ACAD SCI USA, V94, P1890, DOI 10.1073/pnas.94.5.1890; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Public Health Agency of Canada, 2010, HIV AIDS CAN; R Core Team, 2018, R LANG ENV STAT COMP; Ragonnet-Cronin M, 2010, JAIDS-J ACQ IMM DEF, V55, P102, DOI 10.1097/QAI.0b013e3181e8c7b0; Salzano FN, 2002, AN ACAD BRAS CIENC, V74, P223, DOI 10.1590/S0001-37652002000200005; SPSS Inc, 2009, SPSS WIND VERS 18 0; Vina MAF, 2012, PHILOS T R SOC B, V367, P820, DOI 10.1098/rstb.2011.0320	40	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e36933	10.1371/journal.pone.0036933	http://dx.doi.org/10.1371/journal.pone.0036933			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693560	Green Submitted, Green Published, gold			2022-12-27	WOS:000305338500022
J	Rodriguez-Franco, EJ; Cantres-Rosario, YM; Plaud-Valentin, M; Romeu, R; Rodriguez, Y; Skolasky, R; Melendez, V; Cadilla, CL; Melendez, LM				Rodriguez-Franco, Eillen J.; Cantres-Rosario, Yisel M.; Plaud-Valentin, Marines; Romeu, Rafael; Rodriguez, Yolanda; Skolasky, Richard; Melendez, Viviana; Cadilla, Carmen L.; Melendez, Loyda M.			Dysregulation of Macrophage-Secreted Cathepsin B Contributes to HIV-1-Linked Neuronal Apoptosis	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HIV-ASSOCIATED DEMENTIA; LYSOSOMAL CYSTEINE PROTEASES; CENTRAL-NERVOUS-SYSTEM; CYSTATIN-C; HIV-1-INFECTED MACROPHAGES; HIV-1-ASSOCIATED DEMENTIA; CEREBROSPINAL-FLUID; ALZHEIMERS-DISEASE; APOLIPOPROTEIN-E	Chronic HIV infection leads to the development of cognitive impairments, designated as HIV-associated neurocognitive disorders (HAND). The secretion of soluble neurotoxic factors by HIV-infected macrophages plays a central role in the neuronal dysfunction and cell death associated with HAND. One potentially neurotoxic protein secreted by HIV-1 infected macrophages is cathepsin B. To explore the potential role of cathepsin B in neuronal cell death after HIV infection, we cultured HIV-1ADA infected human monocyte-derived macrophages (MDM) and assayed them for expression and activity of cathepsin B and its inhibitors, cystatins B and C. The neurotoxic activity of the secreted cathepsin B was determined by incubating cells from the neuronal cell line SK-N-SH with MDM conditioned media (MCM) from HIV-1 infected cultures. We found that HIV-1 infected MDM secreted significantly higher levels of cathepsin B than did uninfected cells. Moreover, the activity of secreted cathepsin B was significantly increased in HIV-infected MDM at the peak of viral production. Incubation of neuronal cells with supernatants from HIV-infected MDM resulted in a significant increase in the numbers of apoptotic neurons, and this increase was reversed by the addition of either the cathepsin B inhibitor CA-074 or a monoclonal antibody to cathepsin B. In situ proximity ligation assays indicated that the increased neurotoxic activity of the cathepsin B secreted by HIV-infected MDM resulted from decreased interactions between the enzyme and its inhibitors, cystatins B and C. Furthermore, preliminary in vivo studies of human post-mortem brain tissue suggested an upregulation of cathepsin B immunoreactivity in the hippocampus and basal ganglia in individuals with HAND. Our results demonstrate that HIV-1 infection upregulates cathepsin B in macrophages, increases cathepsin B activity, and reduces cystatin-cathepsin interactions, contributing to neuronal apoptosis. These findings provide new evidence for the role of cathepsin B in neuronal cell death induced by HIV-infected macrophages.	[Rodriguez-Franco, Eillen J.; Cantres-Rosario, Yisel M.; Plaud-Valentin, Marines; Rodriguez, Yolanda; Melendez, Loyda M.] Univ Puerto Rico Med Sci Campus, Dept Microbiol & Med Zool, San Juan, PR 00936 USA; [Cadilla, Carmen L.] Univ Puerto Rico Med Sci Campus, Dept Biochem, San Juan, PR USA; [Romeu, Rafael] Univ Puerto Rico, Dept Biol, San Juan, PR 00936 USA; [Melendez, Viviana] Univ Puerto Rico, Dept Biotechnol, Mayaguez, PR USA; [Skolasky, Richard] Johns Hopkins Univ, Dept Orthoped Surg, Baltimore, MD USA	University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico; University of Puerto Rico Mayaguez; Johns Hopkins University	Rodriguez-Franco, EJ (corresponding author), Univ Puerto Rico Med Sci Campus, Dept Microbiol & Med Zool, San Juan, PR 00936 USA.	loyda.melendez@upr.edu		Cantres-Rosario, Yisel/0000-0002-0630-5695; Skolasky, Richard/0000-0002-2598-4427	National Institutes of Health [R01MH083516, U54NS043011, R25GM061838, S06GM08224, ISI0 RR-13705-01, DBI-0923132]; Translational Proteomics Center [NCRR-2G12-RR003051/NIMHHD 8G12-MD007600]; Department of Defense [52680-LS-ISP]; National Science Foundation [DBI-0115825]; University of Puerto Rico School of Medicine; Associate Deanship of Biomedical Sciences institutional funds; National Institutes of Mental Health; National Institute of Neurological Disorders and Stroke [U01MH083501, R24MH59724, 5U01MH083500, NS 38841, U01MH083506, R24MH59745, U01MH083545, N01MH32002]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR013705] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [S06GM008224, R25GM061838] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH083501, R24MH059724, R01MH083516, U01MH083500, U01MH083506, R24MH059745, U01MH083507, U01MH083545] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R24NS045491, R24NS038841, U54NS043011] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007600] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Translational Proteomics Center; Department of Defense(United States Department of Defense); National Science Foundation(National Science Foundation (NSF)); University of Puerto Rico School of Medicine; Associate Deanship of Biomedical Sciences institutional funds; National Institutes of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported in part by grants from the National Institutes of Health R01MH083516, U54NS043011, R25GM061838, S06GM08224, ISI0 RR-13705-01 and DBI-0923132 to establish and upgrade the Confocal Microscopy Facility at the University of Puerto Rico (CIF-UPR) and the NCRR-2G12-RR003051/NIMHHD 8G12-MD007600 Translational Proteomics Center and Confocal Facility at the at the UPR Medical Sciences Campus. This work was also supported in part by Department of Defense Grant 52680-LS-ISP, National Science Foundation Grant DBI-0115825, and University of Puerto Rico School of Medicine and the Associate Deanship of Biomedical Sciences institutional funds. This publication was also supported in part by the National Institutes of Mental Health and National Institute of Neurological Disorders and Stroke by the following grants: Manhattan HIV Brain Bank: U01MH083501, R24MH59724; Texas NeuroAIDS Research Center U01MH083507, R24 NS45491; National Neurological AIDS Bank 5U01MH083500, NS 38841; California NeuroAIDS Tissue Network U01MH083506, R24MH59745; Statistics and Data Coordinating Center U01MH083545, N01MH32002. Its contents are solely the responsibility of the authors and do not necessarily represent the official view of the National NeuroAIDS Tissue Consortium or National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson DC, 1996, SCIENCE, V274, P1917, DOI 10.1126/science.274.5294.1917; ADLEBIASSETTE H, 1995, NEUROPATH APPL NEURO, V21, P218, DOI 10.1111/j.1365-2990.1995.tb01053.x; Akache B, 2007, MOL THER, V15, P330, DOI 10.1038/sj.mt.6300053; Altiok O, 2006, AM J RESP CRIT CARE, V173, P318, DOI 10.1164/rccm.200503-425OC; Anthony IC, 2005, J NEUROPATH EXP NEUR, V64, P529, DOI 10.1093/jnen/64.6.529; Aquaro S, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-76; Barber SA, 2004, AM J PATHOL, V164, P355, DOI 10.1016/S0002-9440(10)63125-2; BARRETT AJ, 1981, METHOD ENZYMOL, V80, P535; Brabers NACH, 2006, EUR J CLIN INVEST, V36, P447, DOI 10.1111/j.1365-2362.2006.01657.x; Brix K, 2008, BIOCHIMIE, V90, P194, DOI 10.1016/j.biochi.2007.07.024; Burster T, 2007, INT IMMUNOL, V19, P645, DOI 10.1093/intimm/dxm030; BUTTLE DJ, 1992, ARCH BIOCHEM BIOPHYS, V299, P377, DOI 10.1016/0003-9861(92)90290-D; Ciborowski P, 2007, VIROLOGY, V363, P198, DOI 10.1016/j.virol.2007.01.013; Cirman T, 2004, J BIOL CHEM, V279, P3578, DOI 10.1074/jbc.M308347200; Dore GJ, 1999, AIDS, V13, P1249, DOI 10.1097/00002030-199907090-00015; Dubin G, 2005, CELL MOL LIFE SCI, V62, P653, DOI 10.1007/s00018-004-4445-9; Fischer-Smith Tracy, 2005, Expert Reviews in Molecular Medicine, V7, P1, DOI 10.1017/S1462399405010239; Furman LM, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-139; Gan L, 2004, J BIOL CHEM, V279, P5565, DOI 10.1074/jbc.M306183200; Garcia R, 2004, J BIOL CHEM, V279, P15183, DOI 10.1074/jbc.M312954200; Geeraerts T, 2006, NEUROSCI LETT, V399, P115, DOI 10.1016/j.neulet.2006.01.033; GELBARD HA, 1994, J VIROL, V68, P4628, DOI 10.1128/JVI.68.7.4628-4635.1994; Gelman BB, 1997, AM J PATHOL, V151, P1437; GENDELMAN HE, 1988, J EXP MED, V167, P1428, DOI 10.1084/jem.167.4.1428; Ghafouri M, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-28; Ghidoni R, 2007, NEUROBIOL AGING, V28, P371, DOI 10.1016/j.neurobiolaging.2006.01.007; Gisolf EH, 2000, AIDS, V14, P1583, DOI 10.1097/00002030-200007280-00014; GLASS JD, 1995, ANN NEUROL, V38, P755, DOI 10.1002/ana.410380510; Gonzalez RG, 2000, AIDS, V14, P2841, DOI 10.1097/00002030-200012220-00005; Gonzalez-Scarano F, 2005, NAT REV IMMUNOL, V5, P69, DOI 10.1038/nri1527; Govindaraj J, 2010, INDIAN J EXP BIOL, V48, P133; Guicciardi ME, 2000, J CLIN INVEST, V106, P1127, DOI 10.1172/JCI9914; Heyes MP, 1998, FASEB J, V12, P881, DOI 10.1096/fasebj.12.10.881; Honey K, 2003, NAT REV IMMUNOL, V3, P472, DOI 10.1038/nri1110; Hook V, 2005, BIOL CHEM, V386, P931, DOI 10.1515/BC.2005.108; Hook VYH, 2008, J BIOL CHEM, V283, P7745, DOI 10.1074/jbc.M708362200; Houseweart MK, 2003, CELL DEATH DIFFER, V10, P1329, DOI 10.1038/sj.cdd.4401309; Irani DN, 2006, ANN NEUROL, V59, P237, DOI 10.1002/ana.20786; Ishimaru H, 1996, BRAIN RES, V709, P155, DOI 10.1016/0006-8993(95)01232-X; Jiang ZG, 2001, J NEUROIMMUNOL, V117, P97, DOI 10.1016/S0165-5728(01)00315-0; Kadiu I, 2009, CELL IMMUNOL, V258, P44, DOI 10.1016/j.cellimm.2009.03.012; Katakai K, 1997, J NEUROENDOCRINOL, V9, P247, DOI 10.1046/j.1365-2826.1997.t01-1-00566.x; Kaul M, 2001, NATURE, V410, P988, DOI 10.1038/35073667; Kaul M, 2005, CELL DEATH DIFFER, V12, P878, DOI 10.1038/sj.cdd.4401623; Kaznelson DW, 2004, VIROLOGY, V320, P301, DOI 10.1016/j.virol.2003.12.018; Kingham PJ, 2001, J NEUROCHEM, V76, P1475, DOI 10.1046/j.1471-4159.2001.00146.x; KOENIG S, 1986, SCIENCE, V233, P1089, DOI 10.1126/science.3016903; Kopitar-Jerala N, 2006, FEBS LETT, V580, P6295, DOI 10.1016/j.febslet.2006.10.055; Laforge M, 2007, J VIROL, V81, P11426, DOI 10.1128/JVI.00597-07; Laspiur JP, 2007, J NEUROIMMUNOL, V192, P157, DOI 10.1016/j.jneuroim.2007.08.004; Leist M, 2001, CELL DEATH DIFFER, V8, P324, DOI 10.1038/sj.cdd.4400859; Li JH, 2005, J IMMUNOL, V175, P1858, DOI 10.4049/jimmunol.175.3.1858; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Castejon G, 2010, J IMMUNOL, V185, P2611, DOI 10.4049/jimmunol.1000436; Luciano-Montalvo C, 2008, PLACENTA, V29, P1016, DOI 10.1016/j.placenta.2008.09.005; Lukasiuk K, 2002, EPILEPSIA, V43, P137, DOI 10.1046/j.1528-1157.43.s.5.20.x; Major EO, 2000, SCIENCE, V288, P440; McArthur JC, 2004, J NEUROIMMUNOL, V157, P3, DOI 10.1016/j.jneuroim.2004.08.042; McArthur JC, 1999, SEMIN NEUROL, V19, P129, DOI 10.1055/s-2008-1040831; MCARTHUR JC, 1993, NEUROLOGY, V43, P2245, DOI 10.1212/WNL.43.11.2245; Mehle A, 2004, J BIOL CHEM, V279, P7792, DOI 10.1074/jbc.M313093200; Melendez LM, 2011, J NEUROIMMUNE PHARM, V6, P89, DOI 10.1007/s11481-010-9253-4; MELENDEZGUERRERO LM, 1990, AIDS RES HUM RETROV, V6, P731, DOI 10.1089/aid.1990.6.731; Mollace V, 2001, TRENDS NEUROSCI, V24, P411, DOI 10.1016/S0166-2236(00)01819-1; Nagaraj NS, 2006, J CANCER RES CLIN, V132, P171, DOI 10.1007/s00432-005-0053-9; Nixon RA, 2000, NEUROCHEM RES, V25, P1161, DOI 10.1023/A:1007675508413; NOTTET HSLM, 1995, IMMUNOL TODAY, V16, P441, DOI 10.1016/0167-5699(95)80022-0; Noursadeghi M, 2009, J IMMUNOL, V182, P319, DOI 10.4049/jimmunol.182.1.319; Persidsky Y, 2000, J LEUKOCYTE BIOL, V68, P413; Prince PSM, 2009, EUR J PHARMACOL, V615, P139, DOI 10.1016/j.ejphar.2009.05.003; Reiners JJ, 2002, CELL DEATH DIFFER, V9, P934, DOI 10.1038/sj.cdd.4401048; Sacktor N, 2001, NEUROLOGY, V56, P257, DOI 10.1212/WNL.56.2.257; SARDAR AM, 1995, J NEUROCHEM, V64, P932; Schurigt Uta, 2005, Arthritis Res Ther, V7, pR174, DOI 10.1186/ar1466; Shi B, 1996, J CLIN INVEST, V98, P1979, DOI 10.1172/JCI119002; Skerget K, 2010, J BIOL CHEM, V285, P3201, DOI 10.1074/jbc.M109.024620; Stoka V, 2001, J BIOL CHEM, V276, P3149, DOI 10.1074/jbc.M008944200; Toro-Nieves DM, 2009, J NEUROVIROL, V15, P36, DOI 10.1080/13550280802385505; Trillo-Pazos G, 2000, BRAIN RES, V864, P315, DOI 10.1016/S0006-8993(00)02213-7; Tsai HT, 2009, FERTIL STERIL, V91, P549, DOI 10.1016/j.fertnstert.2007.12.076; Turk V, 2001, EMBO J, V20, P4629, DOI 10.1093/emboj/20.17.4629; Valcour Victor, 2011, Curr HIV/AIDS Rep, V8, P54, DOI 10.1007/s11904-010-0070-4; Velazquez I, 2009, J NEUROIMMUNOL, V206, P106, DOI 10.1016/j.jneuroim.2008.10.013; Wang CF, 2008, TOXICOL LETT, V181, P196, DOI 10.1016/j.toxlet.2008.05.013; Wang T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002507; Werneburg NW, 2007, J BIOL CHEM, V282, P28960, DOI 10.1074/jbc.M705671200; WESTERVELT P, 1991, P NATL ACAD SCI USA, V88, P3097, DOI 10.1073/pnas.88.8.3097; Williams KC, 2001, J EXP MED, V193, P905, DOI 10.1084/jem.193.8.905; Yeung MC, 1998, AIDS, V12, P349, DOI 10.1097/00002030-199804000-00002; YEUNG MC, 1995, AIDS, V9, P137, DOI 10.1097/00002030-199509020-00004	90	43	43	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e36571	10.1371/journal.pone.0036571	http://dx.doi.org/10.1371/journal.pone.0036571			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693552	Green Published, gold, Green Submitted			2022-12-27	WOS:000305338500013
J	Shao, LY; Wang, LS; Wei, ZY; Xiong, YY; Wang, Y; Tang, KF; Li, Y; Feng, GY; Xing, QH; He, L				Shao, Liyan; Wang, Lishan; Wei, Zhiyun; Xiong, Yuyu; Wang, Yang; Tang, Kefu; Li, Yang; Feng, Guoyin; Xing, Qinghe; He, Lin			Dynamic Network of Transcription and Pathway Crosstalk to Reveal Molecular Mechanism of MGd-Treated Human Lung Cancer Cells	PLOS ONE			English	Article							ACTIVATED RECEPTOR-GAMMA; C-MYC; REGULATORY NETWORK; EXPRESSION; GROWTH; CARCINOMA; ALPHA; SP1; CONTRIBUTES; SENESCENCE	Recent research has revealed various molecular markers in lung cancer. However, the organizational principles underlying their genetic regulatory networks still await investigation. Here we performed Network Component Analysis (NCA) and Pathway Crosstalk Analysis (PCA) to construct a regulatory network in human lung cancer (A549) cells which were treated with 50 uM motexafin gadolinium (MGd), a metal cation-containing chemotherapeutic drug for 4, 12, and 24 hours. We identified a set of key TFs, known target genes for these TFs, and signaling pathways involved in regulatory networks. Our work showed that putative interactions between these TFs (such as ESR1/Sp1, E2F1/Sp1, c-MYC-ESR, Smad3/c-Myc, and NFKB1/RELA), between TFs and their target genes (such as BMP41/Est1, TSC2/Myc, APE1/Sp1/p53, RARA/HOXA1, and SP1/USF2), and between signaling pathways (such as PPAR signaling pathway and Adipocytokines signaling pathway). These results will provide insights into the regulatory mechanism of MGd-treated human lung cancer cells.	[Shao, Liyan; Wang, Lishan; Wei, Zhiyun; Xiong, Yuyu; Wang, Yang; Tang, Kefu; Li, Yang; Feng, Guoyin; He, Lin] Shanghai Jiao Tong Univ, Minist Educ, Key Lab Genet Dev & Neuropsychiat Disorders, Bio X Inst, Shanghai 200030, Peoples R China; [He, Lin] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Shanghai, Peoples R China; [Xing, Qinghe; He, Lin] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China	Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Fudan University	Shao, LY (corresponding author), Shanghai Jiao Tong Univ, Minist Educ, Key Lab Genet Dev & Neuropsychiat Disorders, Bio X Inst, Shanghai 200030, Peoples R China.	xingqinghesjtu@gmail.com; helin@bio-x.cn	Wei, Zhiyun/E-2008-2016; Wang, Yang/HCG-9543-2022; Li, Yang/R-9468-2018	Wei, Zhiyun/0000-0002-3554-4142; Li, Yang/0000-0002-1914-5598	973 Program [2010CB529600]; 863 Program [2009AA022701]; National Nature Science Foundation of China [81121001]; Shanghai Municipal Commission of Science and Technology Program [09DJ1400601]; National Key Technology Research & Devolopment Program [2006BAI05A09]; Shanghai Leading Academic Discipline Project [B205]	973 Program(National Basic Research Program of China); 863 Program(National High Technology Research and Development Program of China); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Commission of Science and Technology Program; National Key Technology Research & Devolopment Program; Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project)	This work was supported by the 973 Program (2010CB529600), the 863 Program (2009AA022701), the National Nature Science Foundation of China (81121001), the Shanghai Municipal Commission of Science and Technology Program (09DJ1400601), the National Key Technology Research & Devolopment Program (2006BAI05A09), and the Shanghai Leading Academic Discipline Project (B205). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borczuk AC, 2005, AM J RESP CRIT CARE, V172, P729, DOI 10.1164/rccm.200504-615OC; Boyle P, 2011, ANN ONCOL, V22, P383, DOI 10.1093/annonc/mdq361; Buckley S, 2004, AM J PHYSIOL-LUNG C, V286, pL81, DOI 10.1152/ajplung.00160.2003; Bushel PR, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-93; Chang TH, 2000, CANCER RES, V60, P1129; Chen PH, 2011, ONCOGENE; Chen SF, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-110; Cheng ASL, 2006, MOL CELL, V21, P393, DOI 10.1016/j.molcel.2005.12.016; Choi KC, 2005, BIOCHEM BIOPH RES CO, V336, P747, DOI 10.1016/j.bbrc.2005.08.203; Coulson JM, 1999, BIOCHEM J, V344, P961, DOI 10.1042/0264-6021:3440961; Cui X, 2007, ONCOGENE, V26, P4253, DOI 10.1038/sj.onc.1210222; Elena C, 2010, BBA-MOL CELL BIOL L, V1801, P537, DOI 10.1016/j.bbalip.2010.01.005; Feng XH, 2002, MOL CELL, V9, P133, DOI 10.1016/S1097-2765(01)00430-0; Flagiello D, 1997, FEBS LETT, V415, P263, DOI 10.1016/S0014-5793(97)01118-6; Fung H, 2001, J BIOL CHEM, V276, P42011, DOI 10.1074/jbc.M106423200; Garcia-Martinez J, 2004, MOL CELL, V15, P303, DOI 10.1016/j.molcel.2004.06.004; Gorgoulis VG, 2002, J PATHOL, V198, P142, DOI 10.1002/path.1121; Han SW, 2006, MOL CANCER THER, V5, P430, DOI 10.1158/1535-7163.MCT-05-0347; Hansson SR, 2006, MOL HUM REPROD, V12, P169, DOI 10.1093/molehr/gal011; Hayles B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009908; Hsu TI, 2011, ONCOGENE; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ji HB, 2007, CANCER RES, V67, P4933, DOI 10.1158/0008-5472.CAN-06-4592; Jiang C, 2007, NUCLEIC ACIDS RES, V35, pD137, DOI 10.1093/nar/gkl1041; Kanehisa M, 2002, NOVART FDN SYMP, V247, P91; Keshamouni VG, 2004, ONCOGENE, V23, P100, DOI 10.1038/sj.onc.1206885; Kim K, 2005, MOL ENDOCRINOL, V19, P843, DOI 10.1210/me.2004-0326; Kim TK, 2001, LUNG CANCER-J IASLC, V31, P181, DOI 10.1016/S0169-5002(00)00169-0; Li Y, 2008, BIOINFORMATICS, V24, P1442, DOI 10.1093/bioinformatics/btn200; Liao JC, 2003, P NATL ACAD SCI USA, V100, P15522, DOI 10.1073/pnas.2136632100; Lin Q, 2009, J CANCER RES CLIN, V135, P1675, DOI 10.1007/s00432-009-0614-4; Liu HC, 1999, J BIOL CHEM, V274, P23617, DOI 10.1074/jbc.274.33.23617; Liu ZP, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-S2-S11; Maegdefrau U, 2009, J PATHOL, V218, P520, DOI 10.1002/path.2563; Magda D, 2005, CANCER RES, V65, P3837, DOI 10.1158/0008-5472.CAN-04-4099; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; Nguyen DX, 2009, CELL, V138, P51, DOI 10.1016/j.cell.2009.04.030; Ocejo-Garcia M, 2005, J PATHOL, V206, P151, DOI 10.1002/path.1775; PERKINS ND, 1994, MOL CELL BIOL, V14, P6570, DOI 10.1128/MCB.14.10.6570; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Ravitz MJ, 2007, CANCER RES, V67, P11209, DOI 10.1158/0008-5472.CAN-06-4351; Sato T, 2007, J BIOL CHEM, V282, P27702, DOI 10.1074/jbc.M611862200; Schmidt EV, 2009, CELL CYCLE, V8, P1344, DOI 10.4161/cc.8.9.8215; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Stark C, 2011, NUCLEIC ACIDS RES, V39, pD698, DOI 10.1093/nar/gkq1116; Su DM, 2011, BIOCHEM J, V433, P333, DOI 10.1042/BJ20100404; Tsou JH, 2008, NUCLEIC ACIDS RES, V36, P217, DOI 10.1093/nar/gkm1027; Vettor R, 2005, ALIMENT PHARM THER, V22, P3, DOI 10.1111/j.1365-2036.2005.02587.x; Wang LS, 2010, NUCLEIC ACIDS RES, V38, pD665, DOI 10.1093/nar/gkp945; Yao M, 1999, ACTA MED OKAYAMA, V53, P245; Zaky A, 2008, NUCLEIC ACIDS RES, V36, P1555, DOI 10.1093/nar/gkm1173	51	10	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e31984	10.1371/journal.pone.0031984	http://dx.doi.org/10.1371/journal.pone.0031984			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693540	gold, Green Published, Green Submitted			2022-12-27	WOS:000305338500002
J	Fior, J				Fior, Jonathan			An Initial In Vitro Investigation into the Potential Therapeutic Use of SupT1 Cells to Prevent AIDS in HIV-Seropositive Individuals	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; T-CELLS; SOLUBLE CD4; MULTIPLE-SCLEROSIS; LINES; VIF; DNA; REPLICATION; VACCINATION; INHIBITION	HIV infection usually leads to a progressive decline in number and functionality of CD4+ T lymphocytes, resulting in AIDS development. In this study, I investigated the strategy of using inoculated SupT1 cells to move infection from HIV-1 X4 strains toward the inoculated cells, which should theoretically prevent infection and depletion of normal CD4+ T cells, preventing the development of AIDS-related pathologies. Interestingly, the persistent in vitro replication in SupT1 cells renders the virus less cytopathic and more sensitive to antibody-mediated neutralization, suggesting that replication of the virus in the inoculated SupT1 cells may have a vaccination effect in the long run. In order to mimic the scenario of a therapy in which SupT1 cells are inoculated in an HIV-seropositive patient, I used infected SupT1/PBMC cocultures and a series of control experiments. Infections were done with equal amounts of the wild type HIV-1 LAI virus. The SupT1 CD4+ CD8+ T cell population was distinguished from the PBMC CD4+ CD8-T cell population by FACS analysis. The results of this study show that the virus-mediated killing of primary CD4+ T cells in the SupT1/PBMC cocultures was significantly delayed, suggesting that the preferential infection of SupT1 cells can induce the virus to spare primary CD4+ T cells from infection and depletion. The preferential infection of SupT1 cells can be explained by the higher viral tropism for the SupT1 cell line. In conclusion, this study demonstrates that it's possible in an in vitro system to use SupT1 cells to prevent HIV infection of primary CD4+ T cells, suggesting that further exploration of the SupT1 cell line as a cell-based therapy against HIV-1 may prove worthwhile.	Univ Milan, Sect Infect Dis & Immunopathol, Dept Clin Sci, Luigi Sacco Hosp, Milan, Italy	University of Milan; Luigi Sacco Hospital	Fior, J (corresponding author), Univ Milan, Sect Infect Dis & Immunopathol, Dept Clin Sci, Luigi Sacco Hosp, Milan, Italy.	jonathan.fior82@gmail.com		Fior, Jonathan/0000-0002-5283-407X	University of Mila	University of Mila	This study was supported by the University of Mila. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUERSPERG N, 1964, J NATL CANCER I, V32, P135; Badley AD, 2000, BLOOD, V96, P2951, DOI 10.1182/blood.V96.9.2951.h8002951_2951_2964; Brenner MK, 2010, CURR OPIN IMMUNOL, V22, P251, DOI 10.1016/j.coi.2010.01.020; Chinnaiyan AM, 1997, NAT MED, V3, P333, DOI 10.1038/nm0397-333; DAAR ES, 1990, P NATL ACAD SCI USA, V87, P6574, DOI 10.1073/pnas.87.17.6574; Das AT, 1999, VIROLOGY, V263, P55, DOI 10.1006/viro.1999.9898; GABUZDA DH, 1992, J VIROL, V66, P6489, DOI 10.1128/JVI.66.11.6489-6495.1992; Glynn JM, 1996, J IMMUNOL, V157, P2754; Jeeninga RE, 2005, CANCER RES, V65, P3347, DOI 10.1158/0008-5472.CAN-04-4280; MOORE JP, 1993, AIDS RES HUM RETROV, V9, P529, DOI 10.1089/aid.1993.9.529; Rosenberg SA, 2008, NAT REV CANCER, V8, P299, DOI 10.1038/nrc2355; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; SMITH SD, 1984, CANCER RES, V44, P5657; Thielen BK, 2007, PLOS PATHOG, V3, P1320, DOI 10.1371/journal.ppat.0030135; TURNER S, 1992, P NATL ACAD SCI USA, V89, P1335, DOI 10.1073/pnas.89.4.1335; Van der AA A, 2003, CLIN EXP IMMUNOL, V131, P155, DOI 10.1046/j.1365-2249.2003.02019.x; VONSCHWEDLER U, 1993, J VIROL, V67, P4945, DOI 10.1128/JVI.67.8.4945-4955.1993; Xin KQ, 1999, VACCINE, V17, P858, DOI 10.1016/S0264-410X(98)00271-0; Zhang H, 2003, NATURE, V424, P94, DOI 10.1038/nature01707; Zhang JZ, 2002, J NEUROL, V249, P212, DOI 10.1007/PL00007867	20	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e37511	10.1371/journal.pone.0037511	http://dx.doi.org/10.1371/journal.pone.0037511			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22701517	gold, Green Published, Green Submitted			2022-12-27	WOS:000305335800050
J	Park, YN; Morales, D; Rubinson, EH; Masison, D; Eisenberg, E; Greene, LE				Park, Yang-Nim; Morales, David; Rubinson, Emily H.; Masison, Daniel; Eisenberg, Evan; Greene, Lois E.			Differences in the Curing of [PSI+] Prion by Various Methods of Hsp104 Inactivation	PLOS ONE			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; GUANIDINE-HYDROCHLORIDE; PROTEIN AGGREGATION; CELL-DIVISION; LIVING CELLS; PROPAGATION; CHAPERONE; PSI(+); OVEREXPRESSION; SUP35	[PSI+] yeast, containing the misfolded amyloid conformation of Sup35 prion, is cured by inactivation of Hsp104. There has been controversy as to whether inactivation of Hsp104 by guanidine treatment or by overexpression of the dominant negative Hsp104 mutant, Hsp104-2KT, cures [PSI+] by the same mechanism- inhibition of the severing of the prion seeds. Using live cell imaging of Sup35-GFP, overexpression of Hsp104-2KT caused the foci to increase in size, then decrease in number, and finally disappear when the cells were cured, similar to that observed in cells cured by depletion of Hsp104. In contrast, guanidine initially caused an increase in foci size but then the foci disappeared before the cells were cured. By starving the yeast to make the foci visible in cells grown with guanidine, the number of cells with foci was found to correlate exactly with the number of [PSI+] cells, regardless of the curing method. Therefore, the fluorescent foci are the prion seeds required for maintenance of [PSI+] and inactivation of Hsp104 cures [PSI+] by preventing severing of the prion seeds. During curing with guanidine, the reduction in seed size is an Hsp104-dependent effect that cannot be explained by limited severing of the seeds. Instead, in the presence of guanidine, Hsp104 retains an activity that trims or reduces the size of the prion seeds by releasing Sup35 molecules that are unable to form new prion seeds. This Hsp104 activity may also occur in propagating yeast.	[Park, Yang-Nim; Morales, David; Rubinson, Emily H.; Eisenberg, Evan; Greene, Lois E.] NHLBI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA; [Masison, Daniel] NIDDKD, Lab Biochem & Genet, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Park, YN (corresponding author), NHLBI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA.	greenel@helix.nih.gov			National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL000516] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK024953] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was entirely funded by the "National Institutes of Health," through the employment of YP, D. Morales, ER, LG, D. Masison and EE, who designed and performed the experiments, analyzed the data and wrote the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagriantsev SN, 2008, MOL BIOL CELL, V19, P2433, DOI 10.1091/mbc.E08-01-0078; Borchsenius AS, 2001, EMBO J, V20, P6683, DOI 10.1093/emboj/20.23.6683; Byrne LJ, 2007, P NATL ACAD SCI USA, V104, P11688, DOI 10.1073/pnas.0701392104; Byrne LJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004670; Chernoff YO, 2004, PRIONS AND PRION DISEASES: CURRENT PERSPECTIVES, P257; CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; Cox B, 2003, GENETICS, V165, P23; DePace AH, 1998, CELL, V93, P1241, DOI 10.1016/S0092-8674(00)81467-1; Derdowski A, 2010, SCIENCE, V330, P680, DOI 10.1126/science.1197785; Eaglestone SS, 2000, P NATL ACAD SCI USA, V97, P240, DOI 10.1073/pnas.97.1.240; Elsner M, 2003, EMBO REP, V4, P1000, DOI 10.1038/sj.embor.embor942; Erjavec N, 2007, GENE DEV, V21, P2410, DOI 10.1101/gad.439307; Ferreira PC, 2001, MOL MICROBIOL, V40, P1357, DOI 10.1046/j.1365-2958.2001.02478.x; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Gietz RD, 2007, NAT PROTOC, V2, P38, DOI 10.1038/nprot.2007.15; Greene LE, 2009, PROTEIN PEPTIDE LETT, V16, P635, DOI 10.2174/092986609788490221; Grimminger V, 2004, J BIOL CHEM, V279, P7378, DOI 10.1074/jbc.M312403200; Hung GC, 2006, GENETICS, V173, P611, DOI 10.1534/genetics.106.056820; Jung G, 2000, GENETICS, V156, P559; Jung GM, 2001, CURR MICROBIOL, V43, P7, DOI 10.1007/s002840010251; Kawai-Noma S, 2006, GENES CELLS, V11, P1085, DOI 10.1111/j.1365-2443.2006.01004.x; Kawai-Noma S, 2009, GENES CELLS, V14, P1045, DOI 10.1111/j.1365-2443.2009.01333.x; Lee S, 2004, J STRUCT BIOL, V146, P99, DOI 10.1016/j.jsb.2003.11.016; Mathur V, 2009, J MOL BIOL, V390, P155, DOI 10.1016/j.jmb.2009.04.063; Moriyama H, 2000, MOL CELL BIOL, V20, P8916, DOI 10.1128/MCB.20.23.8916-8922.2000; Ness F, 2002, MOL CELL BIOL, V22, P5593, DOI 10.1128/MCB.22.15.5593-5605.2002; Newnam GP, 1999, MOL CELL BIOL, V19, P1325; Park YN, 2011, YEAST, V28, P673, DOI 10.1002/yea.1895; Patino MM, 1996, SCIENCE, V273, P622, DOI 10.1126/science.273.5275.622; Paushkin SV, 1996, EMBO J, V15, P3127, DOI 10.1002/j.1460-2075.1996.tb00675.x; Roll-Mecak A, 2008, NATURE, V451, P363, DOI 10.1038/nature06482; Satpute-Krishnan P, 2005, NATURE, V437, P262, DOI 10.1038/nature03981; Satpute-Krishnan P, 2007, PLOS BIOL, V5, P251, DOI 10.1371/journal.pbio.0050024; Schirmer EC, 2001, P NATL ACAD SCI USA, V98, P914, DOI 10.1073/pnas.031568098; Song YT, 2005, EUKARYOT CELL, V4, P289, DOI 10.1128/EC.4.2.289-297.2005; Tanaka M, 2006, NATURE, V442, P585, DOI 10.1038/nature04922; TUITE MF, 1981, GENETICS, V98, P691; Wang ZF, 2004, J BIOMED OPT, V9, P395, DOI 10.1117/1.1646416; Wegrzyn RD, 2001, MOL CELL BIOL, V21, P4656, DOI 10.1128/MCB.21.14.4656-4669.2001; Wickner RB, 1999, J BIOL CHEM, V274, P555, DOI 10.1074/jbc.274.2.555; Wu YX, 2005, P NATL ACAD SCI USA, V102, P12789, DOI 10.1073/pnas.0506384102; Zhou P, 2001, MOL MICROBIOL, V39, P37, DOI 10.1046/j.1365-2958.2001.02224.x	42	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e37692	10.1371/journal.pone.0037692	http://dx.doi.org/10.1371/journal.pone.0037692			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22719845	Green Published, Green Submitted, gold			2022-12-27	WOS:000305583300011
J	Senatore, A; Spafford, JD				Senatore, Adriano; Spafford, J. David			Gene Transcription and Splicing of T-Type Channels Are Evolutionarily-Conserved Strategies for Regulating Channel Expression and Gating	PLOS ONE			English	Article							I-II LOOP; CALCIUM-CHANNEL; SURFACE EXPRESSION; SODIUM-CHANNELS; NERVOUS-SYSTEM; MUSCLE CELLS; LYMNAEA; ALPHA(1G); ISOFORMS; VARIANTS	T-type calcium channels operate within tightly regulated biophysical constraints for supporting rhythmic firing in the brain, heart and secretory organs of invertebrates and vertebrates. The snail T-type gene, LCa(v)3 from Lymnaea stagnalis, possesses alternative, tandem donor splice sites enabling a choice of a large exon 8b (201 aa) or a short exon 25c (9 aa) in cytoplasmic linkers, similar to mammalian homologs. Inclusion of optional 25c exons in the III-IV linker of T-type channels speeds up kinetics and causes hyperpolarizing shifts in both activation and steady-state inactivation of macroscopic currents. The abundant variant lacking exon 25c is the workhorse of embryonic Ca(v)3 channels, whose high density and right-shifted activation and availability curves are expected to increase pace-making and allow the channels to contribute more significantly to cellular excitation in prenatal tissue. Presence of brain-enriched, optional exon 8b conserved with mammalian Ca(v)3.1 and encompassing the proximal half of the I-II linker, imparts a similar to 50% reduction in total and surface-expressed LCa(v)3 channel protein, which accounts for reduced whole-cell calcium currents of +8b variants in HEK cells. Evolutionarily conserved optional exons in cytoplasmic linkers of Ca(v)3 channels regulate expression (exon 8b) and a battery of biophysical properties (exon 25c) for tuning specialized firing patterns in different tissues and throughout development.	[Senatore, Adriano; Spafford, J. David] Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada	University of Waterloo	Senatore, A (corresponding author), Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada.	spafford@uwaterloo.ca			Natural Sciences and Engineering Research Council (NSERC) Discovery grant; NSERC Canada Graduate Scholarship award	Natural Sciences and Engineering Research Council (NSERC) Discovery grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC Canada Graduate Scholarship award	This work was funded through a Natural Sciences and Engineering Research Council (NSERC) Discovery grant to JDS and a NSERC Canada Graduate Scholarship award to AS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altier C, 2011, NAT NEUROSCI, V14, P173, DOI 10.1038/nn.2712; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Anderson D, 2010, NAT NEUROSCI, V13, P333, DOI 10.1038/nn.2493; Arias-Olguin II, 2008, J BIOL CHEM, V283, P8136, DOI 10.1074/jbc.M708761200; Astori S, 2011, P NATL ACAD SCI USA, V108, P13823, DOI 10.1073/pnas.1105115108; Baumgart JP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002976; Broicher T, 2007, MOL CELL NEUROSCI, V36, P132, DOI 10.1016/j.mcn.2007.05.013; Chemin J, 2002, J PHYSIOL-LONDON, V540, P3, DOI 10.1113/jphysiol.2001.013269; Chemin J, 2001, BIOPHYS J, V80, P1238, DOI 10.1016/S0006-3495(01)76100-0; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Crandall SR, 2010, J NEUROSCI, V30, P15419, DOI 10.1523/JNEUROSCI.3636-10.2010; David LS, 2010, CHANNELS, V4, P375, DOI 10.4161/chan.4.5.12874; Di Biase V, 2005, J CELL BIOL, V171, P695, DOI 10.1083/jcb.200503077; EAHOLTZ G, 1994, NEURON, V12, P1041, DOI 10.1016/0896-6273(94)90312-3; Emerick MC, 2006, PROTEINS, V64, P320, DOI 10.1002/prot.20877; Groome JR, 2007, BIOPHYS J, V93, P1519, DOI 10.1529/biophysj.106.102079; Hertel KJ, 2008, J BIOL CHEM, V283, P1211, DOI 10.1074/jbc.R700035200; Hildebrand ME, 2009, J NEUROSCI, V29, P9668, DOI 10.1523/JNEUROSCI.0362-09.2009; Kalsotra A, 2011, NAT REV GENET, V12, P715, DOI 10.1038/nrg3052; Kang HW, 2008, BBA-BIOMEMBRANES, V1778, P2740, DOI 10.1016/j.bbamem.2008.08.002; Kim T, 2009, BIOCHEM BIOPH RES CO, V378, P15, DOI 10.1016/j.bbrc.2008.09.034; Latour I, 2004, GLIA, V48, P112, DOI 10.1002/glia.20063; Liebeskind BJ, 2011, P NATL ACAD SCI USA, V108, P9154, DOI 10.1073/pnas.1106363108; Lin YCJ, 2001, J EXP BIOL, V204, P3717; Liu JH, 2003, DEVELOPMENT, V130, P3437, DOI 10.1242/dev.00562; MACKIE GO, 1985, NATURE, V313, P791, DOI 10.1038/313791a0; MAROIS R, 1992, J COMP NEUROL, V322, P255, DOI 10.1002/cne.903220211; McComb C, 2005, J EXP BIOL, V208, P1459, DOI 10.1242/jeb.01544; McKay BE, 2006, EUR J NEUROSCI, V24, P2581, DOI 10.1111/j.1460-9568.2006.05136.x; McRory JE, 2001, J BIOL CHEM, V276, P3999, DOI 10.1074/jbc.M008215200; Mezghrani A, 2008, J NEUROSCI, V28, P4501, DOI 10.1523/JNEUROSCI.2844-07.2008; Monteil A, 2000, J BIOL CHEM, V275, P6090, DOI 10.1074/jbc.275.9.6090; Ohkubo T, 2005, CELL PHYSIOL BIOCHEM, V16, P245, DOI 10.1159/000089850; Ono K, 2010, J MOL CELL CARDIOL, V48, P65, DOI 10.1016/j.yjmcc.2009.08.021; Perez-Reyes E, 2003, PHYSIOL REV, V83, P117, DOI 10.1152/physrev.00018.2002; Perez-Reyes E, 2010, MOL PHARMACOL, V77, P136, DOI 10.1124/mol.109.062133; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Senatore A., 2012, WIRES MEMBR TRANSP S, V1, P467, DOI DOI 10.1002/WMTS.41; Senatore A, 2011, JOVE-J VIS EXP, DOI 10.3791/2314; Senatore A, 2010, J BIOL CHEM, V285, P7447, DOI 10.1074/jbc.M109.090753; Shcheglovitov A, 2008, FEBS LETT, V582, P3765, DOI 10.1016/j.febslet.2008.10.013; Spafford JD, 2006, J NEUROPHYSIOL, V95, P42, DOI 10.1152/jn.00658.2005; Spafford JD, 2003, J BIOL CHEM, V278, P21178, DOI 10.1074/jbc.M302212200; Steger KA, 2005, J EXP BIOL, V208, P2191, DOI 10.1242/jeb.01616; Taylor JT, 2008, WORLD J GASTROENTERO, V14, P4984, DOI 10.3748/wjg.14.4984; Tscherter A, 2011, J PHYSIOL-LONDON, V589, P1707, DOI 10.1113/jphysiol.2010.203836; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Yeoman MS, 1999, J NEUROPHYSIOL, V82, P2428, DOI 10.1152/jn.1999.82.5.2428; Zhong XL, 2006, HUM MOL GENET, V15, P1497, DOI 10.1093/hmg/ddl068	49	22	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2012	7	6							e37409	10.1371/journal.pone.0037409	http://dx.doi.org/10.1371/journal.pone.0037409			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WX	22719839	Green Published, Green Submitted, gold			2022-12-27	WOS:000305350000005
J	Wylie, KM; Truty, RM; Sharpton, TJ; Mihindukulasuriya, KA; Zhou, YJ; Gao, HY; Sodergren, E; Weinstock, GM; Pollard, KS				Wylie, Kristine M.; Truty, Rebecca M.; Sharpton, Thomas J.; Mihindukulasuriya, Kathie A.; Zhou, Yanjiao; Gao, Hongyu; Sodergren, Erica; Weinstock, George M.; Pollard, Katherine S.			Novel Bacterial Taxa in the Human Microbiome	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; HUMAN GUT; MAXIMUM-LIKELIHOOD; FAST PROGRAM; SP NOV.; SEQUENCES; PROJECT; GENERATION; PROTEIN; SPACE	The human gut harbors thousands of bacterial taxa. A profusion of metagenomic sequence data has been generated from human stool samples in the last few years, raising the question of whether more taxa remain to be identified. We assessed metagenomic data generated by the Human Microbiome Project Consortium to determine if novel taxa remain to be discovered in stool samples from healthy individuals. To do this, we established a rigorous bioinformatics pipeline that uses sequence data from multiple platforms (Illumina GAIIX and Roche 454 FLX Titanium) and approaches (whole-genome shotgun and 16S rDNA amplicons) to validate novel taxa. We applied this approach to stool samples from 11 healthy subjects collected as part of the Human Microbiome Project. We discovered several low-abundance, novel bacterial taxa, which span three major phyla in the bacterial tree of life. We determined that these taxa are present in a larger set of Human Microbiome Project subjects and are found in two sampling sites (Houston and St. Louis). We show that the number of false-positive novel sequences (primarily chimeric sequences) would have been two orders of magnitude higher than the true number of novel taxa without validation using multiple datasets, highlighting the importance of establishing rigorous standards for the identification of novel taxa in metagenomic data. The majority of novel sequences are related to the recently discovered genus Barnesiella, further encouraging efforts to characterize the members of this genus and to study their roles in the microbial communities of the gut. A better understanding of the effects of less-abundant bacteria is important as we seek to understand the complex gut microbiome in healthy individuals and link changes in the microbiome to disease.	[Wylie, Kristine M.; Mihindukulasuriya, Kathie A.; Zhou, Yanjiao; Gao, Hongyu; Sodergren, Erica; Weinstock, George M.] Washington Univ, Sch Med, Genome Inst, St Louis, MO 63130 USA; [Truty, Rebecca M.; Sharpton, Thomas J.; Pollard, Katherine S.] Univ Calif San Francisco, Gladstone Inst, San Francisco, CA 94143 USA; [Pollard, Katherine S.] Univ Calif San Francisco, Inst Human Genet, Div Biostat, San Francisco, CA 94143 USA	Washington University (WUSTL); University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco	Wylie, KM (corresponding author), Washington Univ, Sch Med, Genome Inst, St Louis, MO 63130 USA.	kwylie@genome.wustl.edu; rebecca.truty@gladstone.ucsf.edu	Weinstock, George M/C-6314-2013	Weinstock, George M/0000-0002-2997-4592; Sharpton, Thomas/0000-0002-5996-7764; Mihindukulasuriya, Kathie/0000-0001-9372-3758	National Institutes of Health [NIH-NHGRI U54HG004968]; Gordon & Betty Moore Foundation; J. David Gladstone Institutes; Direct For Mathematical & Physical Scien [1069303] Funding Source: National Science Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004968] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gordon & Betty Moore Foundation(Gordon and Betty Moore Foundation); J. David Gladstone Institutes(University of California System); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by National Institutes of Health grant NIH-NHGRI U54HG004968 to George M. Weinstock and funding from the Gordon & Betty Moore Foundation and the J. David Gladstone Institutes to Katherine S. Pollard. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ARONSSON B, 1981, MED MICROBIOL IMMUN, V170, P27, DOI 10.1007/BF02123794; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Berger SA, 2011, SYST BIOL, V60, P291, DOI 10.1093/sysbio/syr010; Cole JR, 2007, NUCLEIC ACIDS RES, V35, pD169, DOI 10.1093/nar/gkl889; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Goldstein EJC, 2003, J CLIN MICROBIOL, V41, P2752, DOI 10.1128/JCM.41.6.2752-2754.2003; Green P, 1994, CROSS MATCH UNPUB; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Hajishengallis G, 2011, CELL HOST MICROBE; Han MV, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-356; Hugenholtz P, 2003, INT J SYST EVOL MICR, V53, P289, DOI 10.1099/ijs.0.02441-0; Kurokawa K, 2007, DNA RES, V14, P169, DOI 10.1093/dnares/dsm018; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Milne I, 2010, BIOINFORMATICS, V26, P401, DOI 10.1093/bioinformatics/btp666; Morgulis A, 2006, J COMPUT BIOL, V13, P1028, DOI 10.1089/cmb.2006.13.1028; Morotomi M, 2008, INT J SYST EVOL MICR, V58, P2716, DOI 10.1099/ijs.0.2008/000810-0; Peterson J, 2009, GENOME RES, V19, P2317, DOI 10.1101/gr.096651.109; Sakamoto M, 2007, INT J SYST EVOL MICR, V57, P342, DOI 10.1099/ijs.0.64709-0; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sharpton TJ, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001061; Shen XJ, 2010, GUT MICROBES, V1, P138, DOI 10.4161/gmic.1.3.12360; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; Suau A, 1999, APPL ENVIRON MICROB, V65, P4799; Sun YJ, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp285; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Walker AW, 2011, ISME J, V5, P220, DOI 10.1038/ISMEJ.2010.118; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wylie TN, REFCOV VERSION 2 0	34	63	66	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e35294	10.1371/journal.pone.0035294	http://dx.doi.org/10.1371/journal.pone.0035294			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22719826	Green Submitted, Green Published, gold			2022-12-27	WOS:000305341900008
J	Osterholt, HCD; Dannevig, I; Wyckoff, MH; Liao, J; Akgul, Y; Ramgopal, M; Mija, DS; Cheong, N; Longoria, C; Mahendroo, M; Nakstad, B; Saugstad, OD; Savani, RC				Osterholt, Helene C. D.; Dannevig, Ingrid; Wyckoff, Myra H.; Liao, Jie; Akgul, Yucel; Ramgopal, Mrithyunjay; Mija, Dan S.; Cheong, Naeun; Longoria, Christopher; Mahendroo, Mala; Nakstad, Britt; Saugstad, Ola D.; Savani, Rashmin C.			Antioxidant Protects against Increases in Low Molecular Weight Hyaluronan and Inflammation in Asphyxiated Newborn Pigs Resuscitated with 100% Oxygen	PLOS ONE			English	Article							BRONCHOALVEOLAR LAVAGE FLUID; N-ACETYLCYSTEINE IMPROVES; ROOM-AIR RESUSCITATION; LESS OXIDATIVE STRESS; NITRIC-OXIDE; NEONATAL RESUSCITATION; SUPEROXIDE-DISMUTASE; PEROXYNITRITE; INJURY; ACID	Background: Newborn resuscitation with 100% oxygen is associated with oxidative-nitrative stresses and inflammation. The mechanisms are unclear. Hyaluronan (HA) is fragmented to low molecular weight (LMW) by oxidative-nitrative stresses and can promote inflammation. We examined the effects of 100% oxygen resuscitation and treatment with the antioxidant, N-acetylcysteine (NAC), on lung 3-nitrotyrosine (3-NT), LMW HA, inflammation, TNF alpha and IL1 beta in a newborn pig model of resuscitation. Methods & Principal Findings: Newborn pigs (n = 40) were subjected to severe asphyxia, followed by 30 min ventilation with either 21% or 100% oxygen, and were observed for the subsequent 150 minutes in 21% oxygen. One 100% oxygen group was treated with NAC. Serum, bronchoalveolar lavage (BAL), lung sections, and lung tissue were obtained. Asphyxia resulted in profound hypoxia, hypercarbia and metabolic acidosis. In controls, HA staining was in airway subepithelial matrix and no 3-NT staining was seen. At the end of asphyxia, lavage HA decreased, whereas serum HA increased. At 150 minutes after resuscitation, exposure to 100% oxygen was associated with significantly higher BAL HA, increased 3NT staining, and increased fragmentation of lung HA. Lung neutrophil and macrophage contents, and serum TNF alpha and IL1 beta were higher in animals with LMW than those with HMW HA in the lung. Treatment of 100% oxygen animals with NAC blocked nitrative stress, preserved HMW HA, and decreased inflammation. In vitro, peroxynitrite was able to fragment HA, and macrophages stimulated with LMW HA increased TNF alpha and IL1 beta expression. Conclusions & Significance: Compared to 21%, resuscitation with 100% oxygen resulted in increased peroxynitrite, fragmentation of HA, inflammation, as well as TNF alpha and IL1 beta expression. Antioxidant treatment prevented the expression of peroxynitrite, the degradation of HA, and also blocked increases in inflammation and inflammatory cytokines. These findings provide insight into potential mechanisms by which exposure to hyperoxia results in systemic inflammation.	[Osterholt, Helene C. D.; Dannevig, Ingrid; Nakstad, Britt] Akershus Univ Hosp, Dept Pediat, Lorenskog, Norway; [Osterholt, Helene C. D.; Dannevig, Ingrid; Nakstad, Britt] Univ Oslo, Inst Clin Med, Oslo, Norway; [Osterholt, Helene C. D.; Dannevig, Ingrid] Univ Oslo, Rikshosp, Oslo Univ Hosp, Inst Surg Res, N-0027 Oslo, Norway; [Saugstad, Ola D.] Univ Oslo, Rikshosp, Oslo Univ Hosp, Dept Pediat Res, N-0027 Oslo, Norway; [Akgul, Yucel; Mahendroo, Mala] Univ Texas SW Med Ctr Dallas, Dept Obstet & Gynecol, Dallas, TX 75390 USA; [Wyckoff, Myra H.; Liao, Jie; Ramgopal, Mrithyunjay; Mija, Dan S.; Cheong, Naeun; Longoria, Christopher; Savani, Rashmin C.] Univ Texas SW Med Ctr Dallas, Div Pulm & Vasc Biol, Dept Pediat, Dallas, TX 75390 USA; [Wyckoff, Myra H.; Liao, Jie; Ramgopal, Mrithyunjay; Mija, Dan S.; Cheong, Naeun; Longoria, Christopher; Savani, Rashmin C.] Univ Texas SW Med Ctr Dallas, Div Neonatal Perinatal Med, Dept Pediat, Dallas, TX 75390 USA	University of Oslo; University of Oslo; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Osterholt, HCD (corresponding author), Akershus Univ Hosp, Dept Pediat, Lorenskog, Norway.	rashmin.savani@utsouthwestern.edu	Rashmin C. Savani, MBChB/AAG-2041-2021; Akgul, Yucel/M-1745-2013; Saugstad, Ola/AAS-9041-2021	Rashmin C. Savani, MBChB/0000-0002-9533-5422; Saugstad, Ola/0000-0002-3166-5254; akgul, yucel/0000-0001-8880-9821	Norwegian South East Health Trust; William Buchanan Chair awarded; Ikaria Therapeutics	Norwegian South East Health Trust; William Buchanan Chair awarded; Ikaria Therapeutics	This project was funded by the Norwegian South East Health Trust, The William Buchanan Chair awarded to RCS and a research grant award to MHW and RCS from Ikaria Therapeutics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKATSUKA M, 1993, J PHARM PHARMACOL, V45, P110, DOI 10.1111/j.2042-7158.1993.tb03693.x; Akgul Y, 2012, ENDOCRINOLO IN PRESS; Alonso-Spilsbury M, 2005, ANIM REPROD SCI, V90, P1, DOI 10.1016/j.anireprosci.2005.01.007; ANDERSON B, 1991, AM REV RESPIR DIS, V143, P284, DOI 10.1164/ajrccm/143.2.284; Andresen JH, 2008, NEONATOLOGY, V94, P279, DOI 10.1159/000151647; Ara J, 1998, P NATL ACAD SCI USA, V95, P7659, DOI 10.1073/pnas.95.13.7659; Banks BA, 1998, PEDIATRICS, V101, P870, DOI 10.1542/peds.101.5.870; Beckman JS, 2000, SEMIN PERINATOL, V24, P37, DOI 10.1016/S0146-0005(00)80053-1; BECKMAN JS, 1993, BIOCHEM SOC T, V21, P330, DOI 10.1042/bst0210330; BJERMER L, 1987, BRIT MED J, V295, P803, DOI 10.1136/bmj.295.6602.803; Bryce J, 2005, LANCET, V365, P1147, DOI 10.1016/S0140-6736(05)71877-8; Chan Emily, 2007, Proc West Pharmacol Soc, V50, P53; Cheung PY, 2011, JOVE-J VIS EXP, DOI 10.3791/3166; CROSS CE, 1994, LANCET, V344, P930, DOI 10.1016/S0140-6736(94)92275-6; Deguine V, 1998, INT J BIOL MACROMOL, V22, P17, DOI 10.1016/S0141-8130(97)00084-6; Doroszko A, 2010, SHOCK, V34, P592, DOI 10.1097/SHK.0b013e3181e14f1d; Ducrocq C, 1999, CELL MOL LIFE SCI, V55, P1068, DOI 10.1007/s000180050357; Ezaki S, 2009, J CLIN BIOCHEM NUTR, V44, P111, DOI 10.3164/jcbn.08-221; FREEMAN BA, 1982, LAB INVEST, V47, P412; Gao F, 2008, J BIOL CHEM, V283, P6058, DOI 10.1074/jbc.M709273200; Gow AJ, 2001, J CELL PHYSIOL, V187, P277, DOI 10.1002/jcp.1085; Gow AJ, 1996, FEBS LETT, V385, P63, DOI 10.1016/0014-5793(96)00347-X; HADDAD IY, 1993, AM J PHYSIOL, V265, pL555, DOI 10.1152/ajplung.1993.265.6.L555; HALLGREN R, 1985, BRIT MED J, V290, P1778, DOI 10.1136/bmj.290.6484.1778; HALLGREN R, 1989, AM REV RESPIR DIS, V139, P682; HELLSTROM S, 1987, ACTA OTO-LARYNGOL, P54; Hrabarova E, 2011, GEN PHYSIOL BIOPHYS, V30, P223, DOI 10.4149/gpb_2011_03_223; ISCHIROPOULOS H, 1992, ARCH BIOCHEM BIOPHYS, V298, P446, DOI 10.1016/0003-9861(92)90433-W; Jiang D, 2007, ANNU REV CELL DEV BI, V23, P435, DOI 10.1146/annurev.cellbio.23.090506.123337; Johnson ST, 2007, SHOCK, V28, P484, DOI 10.1097/shk.0b013e31804f775d; Johnson ST, 2009, NEONATOLOGY, V96, P162, DOI 10.1159/000210089; Kattwinkel J, 2010, CIRCULATION, V122, pS909, DOI 10.1161/CIRCULATIONAHA.110.971119; KING SR, 1991, SURGERY, V109, P76; Lee TF, 2011, SHOCK, V35, P428, DOI 10.1097/SHK.0b013e3181fffec2; LEVINE S, 1990, CRIT CARE CLIN, V6, P505; Li M, 1997, ARCH BIOCHEM BIOPHYS, V341, P245, DOI 10.1006/abbi.1997.9970; Liu JQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015322; Liu JQ, 2010, J NEUROTRAUM, V27, P1865, DOI 10.1089/neu.2010.1325; MACLEAN D, 1976, SCIENCE, V194, P199, DOI 10.1126/science.959848; MacMillanCrow LA, 1996, P NATL ACAD SCI USA, V93, P11853, DOI 10.1073/pnas.93.21.11853; Manzanares D, 2007, AM J RESP CELL MOL, V37, P160, DOI 10.1165/rcmb.2006-0413OC; Marnett LJ, 2000, CARCINOGENESIS, V21, P361, DOI 10.1093/carcin/21.3.361; McKee CM, 1997, J BIOL CHEM, V272, P8013, DOI 10.1074/jbc.272.12.8013; McKee CM, 1996, J CLIN INVEST, V98, P2403, DOI 10.1172/JCI119054; Moseley R, 1997, BBA-MOL BASIS DIS, V1362, P221, DOI 10.1016/S0925-4439(97)00083-5; Munkeby BH, 2005, PEDIATR RES, V58, P542, DOI 10.1203/01.PDR.0000179407.46810.2D; Munkeby BH, 2004, PEDIATR RES, V56, P783, DOI 10.1203/01.PDR.0000141988.89820.E3; NETTELBLADT O, 1989, AM REV RESPIR DIS, V140, P1028, DOI 10.1164/ajrccm/140.4.1028; NETTELBLADT O, 1989, AM REV RESPIR DIS, V139, P759, DOI 10.1164/ajrccm/139.3.759; NOBLE PW, 1993, J CLIN INVEST, V91, P2368, DOI 10.1172/JCI116469; Obladen M, 2009, NEONATOLOGY, V95, P91, DOI 10.1159/000151761; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Richmond S, 2008, SEMIN FETAL NEONAT M, V13, P368, DOI 10.1016/j.siny.2008.04.002; RIPELLINO JA, 1985, J HISTOCHEM CYTOCHEM, V33, P1060, DOI 10.1177/33.10.4045184; Royall J A, 1995, New Horiz, V3, P113; Saugstad OD, 1998, PEDIATRICS, V102, DOI 10.1542/peds.102.1.e1; Saugstad OD, 2003, PEDIATRICS, V112, P296, DOI 10.1542/peds.112.2.296; Saugstad OD, 2008, NEONATOLOGY, V94, P176, DOI 10.1159/000143397; Savani RC, 2000, AM J RESP CELL MOL, V23, P475, DOI 10.1165/ajrcmb.23.4.3944; Savani RC, 2000, AM J PHYSIOL-LUNG C, V279, pL743, DOI 10.1152/ajplung.2000.279.4.L743; SAVANI RC, 1995, P W PHARMACOL SOC, V38, P131; SAVANI RC, 2003, LUNG BIOL HEALTH DIS, V168, P73; Solberg R, 2010, PEDIATR RES, V67, P250, DOI 10.1203/PDR.0b013e3181cde843; Souza JM, 1999, ARCH BIOCHEM BIOPHYS, V371, P169, DOI 10.1006/abbi.1999.1480; STRACHAN RK, 1990, ANN RHEUM DIS, V49, P949, DOI 10.1136/ard.49.11.949; Sugiura H, 2011, NITRIC OXIDE-BIOL CH, V25, P138, DOI 10.1016/j.niox.2011.03.079; SUZUKI Y, 1993, AGENTS ACTIONS, V38, P32, DOI 10.1007/BF02027210; Tabima DM, 2012, FREE RADICAL BIOL ME; TAMOTO K, 1994, MICROBIOL IMMUNOL, V38, P73, DOI 10.1111/j.1348-0421.1994.tb01746.x; Taylor KR, 2007, J BIOL CHEM, V282, P18265, DOI 10.1074/jbc.M606352200; Teder P, 1997, AM J RESP CELL MOL, V17, P376, DOI 10.1165/ajrcmb.17.3.2698; Turanlahti M, 2000, ACTA PAEDIATR, V89, P966, DOI 10.1080/080352500750043440; Tyree MM, 2006, PEDIATR RES, V59, P423, DOI 10.1203/01.pdr.0000199908.30751.ef; URMAN B, 1991, FERTIL STERIL, V56, P563; Vento M, 2005, AM J RESP CRIT CARE, V172, P1393, DOI 10.1164/rccm.200412-1740OC; Vento M, 2009, PEDIATRICS, V124, pE439, DOI 10.1542/peds.2009-0434; WALDENSTROM A, 1991, J CLIN INVEST, V88, P1622, DOI 10.1172/JCI115475; WELLS AF, 1990, TRANSPLANTATION, V50, P240, DOI 10.1097/00007890-199008000-00014; WELLS AF, 1992, ARTHRITIS RHEUM, V35, P391, DOI 10.1002/art.1780350405; Wyckoff M, 2007, PEDIATR RES, V61, P415, DOI 10.1203/pdr.0b013e3180332c45; Yamasaki K, 2009, J BIOL CHEM, V284, P12762, DOI 10.1074/jbc.M806084200	82	22	23	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2012	7	6							e38839	10.1371/journal.pone.0038839	http://dx.doi.org/10.1371/journal.pone.0038839			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TU	22701723	Green Published, Green Submitted, gold			2022-12-27	WOS:000305337600050
J	de Jong, IGM; Reinders-Messelink, HA; Janssen, WGM; Poelma, MJ; van Wijk, I; van der Sluis, CK				de Jong, Ingrid G. M.; Reinders-Messelink, Heleen A.; Janssen, Wim G. M.; Poelma, Margriet J.; van Wijk, Iris; van der Sluis, Corry K.			Mixed Feelings of Children and Adolescents with Unilateral Congenital Below Elbow Deficiency: An Online Focus Group Study	PLOS ONE			English	Article							PERCEIVED PHYSICAL APPEARANCE; BODY-IMAGE; PSYCHOLOGICAL ADJUSTMENT; SOCIAL SUPPORT; SELF-ESTEEM; LIMB; DISABILITY; IMPACT; PARENT	The existing literature is inconsistent about the psychosocial functioning of children and adolescents with Unilateral Congenital Below Elbow Deficiency (UCBED). The objective of this qualitative study was to explore the psychosocial functioning of children and adolescents with UCBED in terms of their feelings about the deficiency and what helps them to cope with those feelings. Additionally, the perspectives of prosthesis wearers and non-wearers were compared, as were the perspectives of children, adolescents, parents and health professionals. Online focus group interviews were carried out with 42 children and adolescents (aged 8-12, 13-16 and 17-20), 16 parents and 19 health professionals. Questions were asked about psychosocial functioning, activities, participation, prosthetic use or non-use, and rehabilitation care. This study concerned remarks about psychosocial functioning. Children and adolescents with UCBED had mixed feelings about their deficiency. Both negative and positive feelings were often felt simultaneously and mainly depended on the way people in the children's environment reacted to the deficiency. People staring affected the children negatively, while support from others helped them to cope with the deficiency. Wearing a prosthesis and peer-to-peer contact were also helpful. Non-wearers tended to be more resilient than prosthesis wearers. Wearers wore their prosthesis for cosmetic reasons and to prevent them from negative reactions from the environment. We recommend that rehabilitation teams make parents aware of their great influence on the psychosocial functioning of their child with UCBED, to adjust or extend the currently available psychosocial help, and to encourage peer-to-peer contact.	[de Jong, Ingrid G. M.; Reinders-Messelink, Heleen A.; van der Sluis, Corry K.] Univ Groningen, Univ Med Ctr Groningen, Dept Rehabil Med, NL-9713 AV Groningen, Netherlands; [Janssen, Wim G. M.] Erasmus MC, Dept Rehabil Med, Rotterdam, Netherlands; [Poelma, Margriet J.] Rehabil Ctr Sint Maartensklin, Dept Rehabil Med, Nijmegen, Netherlands; [van Wijk, Iris] Rehabil Ctr Hoogstr, Dept Rehabil Med, Utrecht, Netherlands	University of Groningen; Erasmus University Rotterdam; Erasmus MC; Sint Maartens Clinic	de Jong, IGM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Rehabil Med, NL-9713 AV Groningen, Netherlands.	c.k.van.der.sluis@umcg.nl		de Jong, Igle J./0000-0002-3444-5548	Stichting Beatrixoord Noord-Nederland; De Gratama Stichting; OIM Stichting; Orthopedietechniek De Hoogstraat	Stichting Beatrixoord Noord-Nederland; De Gratama Stichting; OIM Stichting; Orthopedietechniek De Hoogstraat	This study was funded by Stichting Beatrixoord Noord-Nederland (http://www.stichtingbeatrixoord.nl/), De Gratama Stichting (http://www.gratama.net/), OIM Stichting (http://www.oim.nl/over-oim/organisatie/oim-stichting/), and Orthopedietechniek De Hoogstraat (http://www.orthopedietechniek.info/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CADMAN D, 1987, PEDIATRICS, V79, P805; Carroll P, 1999, J BEHAV MED, V22, P59, DOI 10.1023/A:1018799618864; CASH TF, 1995, SEX ROLES, V33, P19, DOI 10.1007/BF01547933; Cohen E, 2008, J DEV PHYS DISABIL, V20, P415, DOI 10.1007/s10882-008-9106-8; De Jong IGM, ACTIVITY PA IN PRESS; Delfabbro PH, 2011, J GENET PSYCHOL, V172, P67, DOI 10.1080/00221325.2010.517812; DIMDI, 2005, INT CLASS FUNCT DIS; Drotar D, 1997, J PEDIATR PSYCHOL, V22, P149; Duffy ME, 2002, J NURS SCHOLARSHIP, V34, P83, DOI 10.1111/j.1547-5069.2002.00083.x; Frisen A, 2009, EDUC STUD-UK, V35, P337, DOI 10.1080/03055690802648200; Gaiser TJ, 1997, SOC SCI COMPUT REV, V15, P135, DOI 10.1177/089443939701500202; Green SE, 2003, SOC SCI MED, V57, P1361, DOI 10.1016/S0277-9536(02)00511-7; Hermansson L, 2005, ACTA PAEDIATR, V94, P479, DOI 10.1080/08035250410022512; James MA, 2006, J BONE JOINT SURG AM, V88A, P2356, DOI 10.2106/JBJS.E.01146; Kerr SM, 2000, CHILD CARE HLTH DEV, V26, P309, DOI 10.1046/j.1365-2214.2000.00149.x; Mann C., 2000, INTERNET COMMUNICATI; Montoya-Weiss M.M., 1998, EUR J MARKETING, V32, P713, DOI DOI 10.1108/03090569810224100; MURRAY C, 2007, FAMILIES SYSTEMS HLT, V25, P276, DOI DOI 10.1037/1091-7527.25.3.276; Pope C, 2006, QUALITATIVE RES HLTH; Rosenblum GD, 1999, CHILD DEV, V70, P50, DOI 10.1111/1467-8624.00005; Shakespeare Tom, 1996, SEXUAL POLITICS DISA; Taleporos G, 2002, SOC SCI MED, V54, P971, DOI 10.1016/S0277-9536(01)00069-7; Tates K, 2010, KWALON, V15, P40; Tates K, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-15; VARNI JW, 1989, PEDIATRICS, V84, P323; VARNI JW, 1991, J DEV BEHAV PEDIATR, V12, P171; VARNI JW, 1989, J DEV BEHAV PEDIATR, V10, P13; Varni JW, 1996, J CLIN CHILD PSYCHOL, V25, P201, DOI 10.1207/s15374424jccp2502_9; VARNI JW, 1992, J BEHAV MED, V15, P31, DOI 10.1007/BF00848376; VARNI JW, 1989, J PEDIATR PSYCHOL, V14, P515, DOI 10.1093/jpepsy/14.4.515; WALLANDER JL, 1988, J PEDIATR PSYCHOL, V13, P197, DOI 10.1093/jpepsy/13.2.197; Ylimainen K, 2010, ACTA PAEDIATR, V99, P1550, DOI 10.1111/j.1651-2227.2010.01855.x; Zwaanswijk Marieke, 2007, BMC Pediatr, V7, P35, DOI 10.1186/1471-2431-7-35	33	14	14	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2012	7	6							e37099	10.1371/journal.pone.0037099	http://dx.doi.org/10.1371/journal.pone.0037099			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TQ	22715362	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336800003
J	Giolo, SR; Krieger, JE; Mansur, AJ; Pereira, AC				Giolo, Suely Ruiz; Krieger, Jose Eduardo; Mansur, Alfredo Jose; Pereira, Alexandre Costa			Survival Analysis of Patients with Heart Failure: Implications of Time-Varying Regression Effects in Modeling Mortality	PLOS ONE			English	Article							VENTRICULAR ASSIST DEVICE; IN-HOSPITAL MORTALITY; RESIDUALS; TRENDS; RISK	Background: Several models have been designed to predict survival of patients with heart failure. These, while available and widely used for both stratifying and deciding upon different treatment options on the individual level, have several limitations. Specifically, some clinical variables that may influence prognosis may have an influence that change over time. Statistical models that include such characteristic may help in evaluating prognosis. The aim of the present study was to analyze and quantify the impact of modeling heart failure survival allowing for covariates with time-varying effects known to be independent predictors of overall mortality in this clinical setting. Methodology: Survival data from an inception cohort of five hundred patients diagnosed with heart failure functional class III and IV between 2002 and 2004 and followed-up to 2006 were analyzed by using the proportional hazards Cox model and variations of the Cox's model and also of the Aalen's additive model. Principal Findings: One-hundred and eighty eight (188) patients died during follow-up. For patients under study, age, serum sodium, hemoglobin, serum creatinine, and left ventricular ejection fraction were significantly associated with mortality. Evidence of time-varying effect was suggested for the last three. Both high hemoglobin and high LV ejection fraction were associated with a reduced risk of dying with a stronger initial effect. High creatinine, associated with an increased risk of dying, also presented an initial stronger effect. The impact of age and sodium were constant over time. Conclusions: The current study points to the importance of evaluating covariates with time-varying effects in heart failure models. The analysis performed suggests that variations of Cox and Aalen models constitute a valuable tool for identifying these variables. The implementation of covariates with time-varying effects into heart failure prognostication models may reduce bias and increase the specificity of such models.	[Giolo, Suely Ruiz; Krieger, Jose Eduardo; Pereira, Alexandre Costa] Univ Sao Paulo, Lab Genet & Mol Cardiol, Inst Heart, Sao Paulo, Brazil; [Giolo, Suely Ruiz] Univ Fed Parana, Dept Stat, BR-80060000 Curitiba, Parana, Brazil; [Mansur, Alfredo Jose] Univ Sao Paulo, Dept Clin Cardiol, Inst Heart, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Federal do Parana; Universidade de Sao Paulo	Giolo, SR (corresponding author), Univ Sao Paulo, Lab Genet & Mol Cardiol, Inst Heart, Sao Paulo, Brazil.	giolo@ufpr.br; alexandre.pereira@incor.usp.br	Giolo, Suely R/C-2780-2012; Pereira, Alexandre/HHN-1038-2022; Krieger, Jose E/C-3117-2011	Krieger, Jose E/0000-0001-5464-1792; Giolo, Suely/0000-0003-1185-7483	CNPq - Brazilian Foundation for Scientific and Technological Development [150653/2008-5]	CNPq - Brazilian Foundation for Scientific and Technological Development	The first author was partially support by CNPq - Brazilian Foundation for Scientific and Technological Development (Grant 150653/2008-5). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Aalen O. O., 1980, LECT NOTES STAT, V2, P1; AALEN OO, 1989, STAT MED, V8, P907, DOI 10.1002/sim.4780080803; AALEN OO, 1993, STAT MED, V12, P1569, DOI 10.1002/sim.4780121705; Aaronson KD, 1997, CIRCULATION, V95, P2660, DOI 10.1161/01.CIR.95.12.2660; Abraham WT, 2008, J AM COLL CARDIOL, V52, P347, DOI 10.1016/j.jacc.2008.04.028; Bleumink GS, 2004, EUR HEART J, V25, P1614, DOI 10.1016/j.ehj.2004.06.038; Chen J, 2011, JAMA-J AM MED ASSOC, V306, P1669, DOI 10.1001/jama.2011.1474; Cortese G, 2010, STAT METHODS MED RES, V19, P5, DOI 10.1177/0962280209105022; COX DR, 1968, J ROY STAT SOC B, V30, P248, DOI 10.1111/j.2517-6161.1968.tb00724.x; COX DR, 1972, J R STAT SOC B, V34, P187; Fonarow GC, 2005, JAMA-J AM MED ASSOC, V293, P572, DOI 10.1001/jama.293.5.572; Goldraich Livia, 2009, Expert Rev Cardiovasc Ther, V7, P985, DOI 10.1586/erc.09.68; Gottlieb SS, 2009, J AM COLL CARDIOL, V53, P343, DOI 10.1016/j.jacc.2008.09.044; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Hunt Sharon Ann, 2005, J Am Coll Cardiol, V46, pe1, DOI 10.1016/j.jacc.2005.08.022; Jhund PS, 2009, CIRCULATION, V119, P515, DOI 10.1161/CIRCULATIONAHA.108.812172; Kalogeropoulos AP, 2009, J AM COLL CARDIOL, V53, P334, DOI 10.1016/j.jacc.2008.10.023; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Leiden University Medical Center Department of Medical Statistics and BioInformatics website, R PACK COXVC VERS 1; Levy WC, 2006, CIRCULATION, V113, P1424, DOI 10.1161/CIRCULATIONAHA.105.584102; Lietz K, 2007, CIRCULATION, V116, P497, DOI 10.1161/CIRCULATIONAHA.107.691972; Maller RA., 1996, SURVIVAL ANAL LONG T; MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163; Martinussem T, 2006, DYNAMIC REGRESSION M; MCKEAGUE IW, 1994, BIOMETRIKA, V81, P501; MCKEE PA, 1971, NEW ENGL J MED, V285, P1441, DOI 10.1056/NEJM197112232852601; Slaughter MS, 2009, NEW ENGL J MED, V361, P2241, DOI 10.1056/NEJMoa0909938; Team R. D. C, 2011, R LANG ENV STAT COMP; Volinsky CT, 2000, BIOMETRICS, V56, P256, DOI 10.1111/j.0006-341X.2000.00256.x	29	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2012	7	6							e37392	10.1371/journal.pone.0037392	http://dx.doi.org/10.1371/journal.pone.0037392			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TQ	22715367	Green Submitted, Green Published, gold			2022-12-27	WOS:000305336800008
J	Kaplan, F; Alborn, HT; von Reuss, SH; Ajredini, R; Ali, JG; Akyazi, F; Stelinski, LL; Edison, AS; Schroeder, FC; Teal, PE				Kaplan, Fatma; Alborn, Hans T.; von Reuss, Stephan H.; Ajredini, Ramadan; Ali, Jared G.; Akyazi, Faruk; Stelinski, Lukasz L.; Edison, Arthur S.; Schroeder, Frank C.; Teal, Peter E.			Interspecific Nematode Signals Regulate Dispersal Behavior	PLOS ONE			English	Article							DAUER PHEROMONE COMPONENT; SMALL-MOLECULE SIGNALS; CAENORHABDITIS-ELEGANS; ENTOMOPATHOGENIC NEMATODES; TEMPERATURE; EVOLUTION; PATTERNS; MODE	Background: Dispersal is an important nematode behavior. Upon crowding or food depletion, the free living bacteriovorus nematode Caenorhabditis elegans produces stress resistant dispersal larvae, called dauer, which are analogous to second stage juveniles (J2) of plant parasitic Meloidogyne spp. and infective juveniles (IJ)s of entomopathogenic nematodes (EPN), e.g., Steinernema feltiae. Regulation of dispersal behavior has not been thoroughly investigated for C. elegans or any other nematode species. Based on the fact that ascarosides regulate entry in dauer stage as well as multiple behaviors in C. elegans adults including mating, avoidance and aggregation, we hypothesized that ascarosides might also be involved in regulation of dispersal behavior in C. elegans and for other nematodes such as IJ of phylogenetically related EPNs. Methodology/Principal Findings: Liquid chromatography-mass spectrometry analysis of C. elegans dauer conditioned media, which shows strong dispersing activity, revealed four known ascarosides (ascr#2, ascr#3, ascr#8, icas#9). A synthetic blend of these ascarosides at physiologically relevant concentrations dispersed C. elegans dauer in the presence of food and also caused dispersion of IJs of S. feltiae and J2s of plant parasitic Meloidogyne spp. Assay guided fractionation revealed structural analogs as major active components of the S. feltiae (ascr#9) and C. elegans (ascr#2) dispersal blends. Further analysis revealed ascr#9 in all Steinernema spp. and Heterorhabditis spp. infected insect host cadavers. Conclusions/Significance: Ascaroside blends represent evolutionarily conserved, fundamentally important communication systems for nematodes from diverse habitats, and thus may provide sustainable means for control of parasitic nematodes.	[Kaplan, Fatma; Alborn, Hans T.; Teal, Peter E.] ARS, Ctr Med Agr & Vet Entomol, USDA, Gainesville, FL USA; [von Reuss, Stephan H.; Schroeder, Frank C.] Cornell Univ, Boyce Thompson Inst, Ithaca, NY USA; [von Reuss, Stephan H.; Schroeder, Frank C.] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY USA; [Ajredini, Ramadan; Edison, Arthur S.] Univ Florida, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA; [Ajredini, Ramadan; Edison, Arthur S.] Univ Florida, Natl High Magnet Field Lab, Gainesville, FL USA; [Ali, Jared G.; Stelinski, Lukasz L.] Univ Florida, Dept Entomol & Nematol, Citrus Res & Educ Ctr, Lake Alfred, FL USA; [Akyazi, Faruk] Univ Florida, Dept Entomol & Nematol, Gainesville, FL 32611 USA; [Akyazi, Faruk] Ordu Univ, Dept Plant Protect, Ordu, Turkey	United States Department of Agriculture (USDA); Cornell University; Boyce Thompson Institute for Plant Research; Cornell University; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Ordu University	Kaplan, F (corresponding author), ARS, Ctr Med Agr & Vet Entomol, USDA, Gainesville, FL USA.	fkaplan@ufl.edu	Kaplan, Fatma/AAJ-7666-2020; Schroeder, Frank/H-5026-2012	Kaplan, Fatma/0000-0002-9565-0211; Edison, Arthur/0000-0002-5686-2350; Schroeder, Frank/0000-0002-4420-0237; Ali, Jareg/0000-0002-5794-9554; von Reuss, Stephan/0000-0003-4325-5495; Ali, Jared/0000-0001-9870-0299	National Institutes of Health [R01 GM085285]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085285, R01GM088290] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work is partially supported by the National Institutes of Health R01 GM085285. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barriere A, 2005, CURR BIOL, V15, P1176, DOI 10.1016/j.cub.2005.06.022; Brito JA, 2008, NEMATOLOGY, V10, P757, DOI 10.1163/156854108785787253; Butcher RA, 2008, P NATL ACAD SCI USA, V105, P14288, DOI 10.1073/pnas.0806676105; Butcher RA, 2007, NAT CHEM BIOL, V3, P420, DOI 10.1038/nchembio.2007.3; Butcher RA, 2009, ORG LETT, V11, P3100, DOI 10.1021/ol901011c; Campos-Herrera R, 2011, ANN APPL BIOL, V158, P55, DOI 10.1111/j.1744-7348.2010.00433.x; De Ley P., 2006, COMMUNITY TCER, P1, DOI [10.1895/wormbook.1.41.1, DOI 10.1895/WORMBOOK.1.41.1]; Eisenback J. D., 1985, An advanced treatise on Meloidogyne. Volume 1: Biology and control., P95; Esbenshade P. R., 1985, An advanced treatise on Meloidogyne.Volume II: Methodology., P115; GOLDEN JW, 1984, P NATL ACAD SCI-BIOL, V81, P819, DOI 10.1073/pnas.81.3.819; GOLDEN JW, 1982, SCIENCE, V218, P578, DOI 10.1126/science.6896933; GOLDEN JW, 1984, DEV BIOL, V102, P368, DOI 10.1016/0012-1606(84)90201-X; HUSSEY RS, 1973, PLANT DIS REP, V57, P1025; Jeong PY, 2005, NATURE, V433, P541, DOI 10.1038/nature03201; Kaplan F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017804; Kaya Harry K., 1997, P281, DOI 10.1016/B978-012432555-5/50016-6; KAYA HK, 1993, ANNU REV ENTOMOL, V38, P181, DOI 10.1146/annurev.en.38.010193.001145; Kiontke KC, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-339; Macosko EZ, 2009, NATURE, V458, P1171, DOI 10.1038/nature07886; Pungaliya C, 2009, P NATL ACAD SCI USA, V106, P7708, DOI 10.1073/pnas.0811918106; Rolston AN, 2006, J NEMATOL, V38, P221; Shapiro-Ilan DI, 2003, J INVERTEBR PATHOL, V83, P270, DOI 10.1016/S0022-2011(03)00101-0; Srinivasan J, 2008, NATURE, V454, P1115, DOI 10.1038/nature07168; Srinivasan J, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001237; Symonds MRE, 2005, J EVOLUTION BIOL, V18, P1253, DOI 10.1111/j.1420-9101.2005.00971.x; Symonds MRE, 2004, P ROY SOC B-BIOL SCI, V271, P839, DOI 10.1098/rspb.2003.2647; von Reuss SH, 2011, J AM CHEM SOC UNPUB; von Reuss SH, 2012, J AM CHEM SOC, V134, P1817, DOI 10.1021/ja210202y; Yamada K, 2010, SCIENCE, V329, P1647, DOI 10.1126/science.1192020	29	64	69	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e38735	10.1371/journal.pone.0038735	http://dx.doi.org/10.1371/journal.pone.0038735			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701701	Green Published, Green Submitted, gold			2022-12-27	WOS:000305348400091
J	Kawamori, A; Shimaji, K; Yamaguchi, M				Kawamori, Akihito; Shimaji, Kouhei; Yamaguchi, Masamitsu			Dynamics of Endoreplication during Drosophila Posterior Scutellar Macrochaete Development	PLOS ONE			English	Article							CELL-CYCLE CONTROL; GLIAL-CELL; S-PHASE; MICROCHAETE LINEAGE; DNA-REPLICATION; ENDOCYCLE; NOTUM; POLYPLOIDY; EMERGENCE; DIVISION	Endoreplication is a variant type of DNA replication, consisting only of alternating G1 and S phases. Many types of Drosophila tissues undergo endoreplication. However, the timing and the extent to which a single endocycling macrochaete undergoes temporally programmed endoreplication during development are unclear. Here, we focused on the dynamics of endoreplication during posterior scutellar (pSC) macrochaete development. Quantitative analyses of C values in shaft cells and socket cells revealed a gradual rise from 8C and 4C at 8 hours after pupal formation (APF) to 72C and 24C at 29 hours APF, respectively. The validity of the values was further confirmed by the measurement of DNA content with a confocal laser microscope. BrdU incorporation assays demonstrated that shaft cells undergo four rounds of endoreplication from 18 to 29.5 hours APF. In contrast, socket cells undergo two rounds of endoreplication during the same period. Statistical analyses showed that the theoretical C values, based on BrdU assays, nearly coincide with the actually measured C values in socket cells, but not in shaft cells after 22 hours APF. These analyses suggest that socket cells undergo two rounds of endoreplication. However, the mechanism of endoreplication in the shaft cells may change from 22 hours APF, suggesting the possibility that shaft cells undergo two or four rounds of endoreplication during the periods. We also found that the timing of endoreplication differs, depending on the type of macrochaete. Moreover, endocycling in shaft cells of both the left and right sides of pSC bristle lineages occurs in the same pattern, indicating that the process is synchronized for specific types of macrochaete. Our findings suggest that endocycling in macrochaete cell lineages can be a model for understanding mechanisms of endoreplication at the single-cell level.	[Kawamori, Akihito; Shimaji, Kouhei; Yamaguchi, Masamitsu] Kyoto Inst Technol, Dept Appl Biol, Sakyo Ku, Kyoto 606, Japan; [Kawamori, Akihito; Shimaji, Kouhei; Yamaguchi, Masamitsu] Kyoto Inst Technol, Insect Biomed Res Ctr, Sakyo Ku, Kyoto 606, Japan	Kyoto Institute of Technology; Kyoto Institute of Technology	Kawamori, A (corresponding author), Kyoto Inst Technol, Dept Appl Biol, Sakyo Ku, Kyoto 606, Japan.	myamaguc@kit.ac.jp		Yamaguchi, Masamitsu/0000-0002-6321-9750; Shimaji, Kouhei/0000-0002-8121-7257	JSPS; Ministry of Education, Culture, Sports, Science and Technology of Japan	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by Grants-in-Aid from JSPS and the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asano M, 2009, FLY, V3, P173, DOI 10.4161/fly.8087; Audibert A, 2005, DEVELOPMENT, V132, P2287, DOI 10.1242/dev.01797; Calvi BR, 1998, GENE DEV, V12, P734, DOI 10.1101/gad.12.5.734; Edgar BA, 2001, CELL, V105, P297, DOI 10.1016/S0092-8674(01)00334-8; FEGER G, 1995, EMBO J, V14, P5387, DOI 10.1002/j.1460-2075.1995.tb00223.x; Fichelson P, 2003, DEVELOPMENT, V130, P123, DOI 10.1242/dev.00198; Follette PJ, 1998, CURR BIOL, V8, P235, DOI 10.1016/S0960-9822(98)70089-2; Gho M, 1999, DEVELOPMENT, V126, P3573; HARTENSTEIN V, 1989, DEVELOPMENT, V107, P389; HUANG F, 1991, DEVELOPMENT, V111, P1087; Jacobs HW, 1998, GENE DEV, V12, P3741, DOI 10.1101/gad.12.23.3741; Kawamori A, 2011, CELL STRUCT FUNCT, V36, P103, DOI 10.1247/csf.11004; Klusza S, 2011, BIOESSAYS, V33, P124, DOI 10.1002/bies.201000089; Lee HO, 2009, GENE DEV, V23, P2461, DOI 10.1101/gad.1829209; LEHNER CF, 1990, EMBO J, V9, P3573, DOI 10.1002/j.1460-2075.1990.tb07568.x; Lilly MA, 2005, ONCOGENE, V24, P2765, DOI 10.1038/sj.onc.1208610; Lilly MA, 1996, GENE DEV, V10, P2514, DOI 10.1101/gad.10.19.2514; Park SY, 2008, P NATL ACAD SCI USA, V105, P12343, DOI 10.1073/pnas.0805189105; Reddy GV, 1999, DEVELOPMENT, V126, P4617; Salle J, 2012, DEVELOPMENT, V139, P547, DOI 10.1242/dev.069823; Shermoen AW, 2010, CURR BIOL, V20, P2067, DOI 10.1016/j.cub.2010.10.021; Simpson P, 1999, DEVELOPMENT, V126, P1349; SIMPSON P, 1990, DEVELOPMENT, V109, P509; SMITH J M, 1961, J Embryol Exp Morphol, V9, P661; STERN B, 1993, DEVELOPMENT, V117, P219; URATA Y, 1995, J CELL BIOL, V131, P279, DOI 10.1083/jcb.131.2.279; USUI K, 1993, ROUX ARCH DEV BIOL, V203, P151, DOI 10.1007/BF00365054; Weiss A, 1998, CURR BIOL, V8, P239, DOI 10.1016/S0960-9822(98)70090-9; WHITFIELD WGF, 1990, EMBO J, V9, P2563, DOI 10.1002/j.1460-2075.1990.tb07437.x; Zimmet J, 2000, EXP HEMATOL, V28, P3, DOI 10.1016/S0301-472X(99)00124-1	30	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e38714	10.1371/journal.pone.0038714	http://dx.doi.org/10.1371/journal.pone.0038714			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701699	Green Published, gold, Green Submitted			2022-12-27	WOS:000305348400089
J	Mileyko, Y; Edelsbrunner, H; Price, CA; Weitz, JS				Mileyko, Yuriy; Edelsbrunner, Herbert; Price, Charles A.; Weitz, Joshua S.			Hierarchical Ordering of Reticular Networks	PLOS ONE			English	Article							COMMUNITY STRUCTURE; GENERAL-MODEL; SCALING LAWS; LEAF; VENATION; EXTRACTION; DESIGN; LEAVES; ORIGIN; TREES	The structure of hierarchical networks in biological and physical systems has long been characterized using the Horton-Strahler ordering scheme. The scheme assigns an integer order to each edge in the network based on the topology of branching such that the order increases from distal parts of the network (e. g., mountain streams or capillaries) to the "root" of the network (e. g., the river outlet or the aorta). However, Horton-Strahler ordering cannot be applied to networks with loops because they they create a contradiction in the edge ordering in terms of which edge precedes another in the hierarchy. Here, we present a generalization of the Horton-Strahler order to weighted planar reticular networks, where weights are assumed to correlate with the importance of network edges, e. g., weights estimated from edge widths may correlate to flow capacity. Our method assigns hierarchical levels not only to edges of the network, but also to its loops, and classifies the edges into reticular edges, which are responsible for loop formation, and tree edges. In addition, we perform a detailed and rigorous theoretical analysis of the sensitivity of the hierarchical levels to weight perturbations. In doing so, we show that the ordering of the reticular edges is more robust to noise in weight estimation than is the ordering of the tree edges. We discuss applications of this generalized Horton-Strahler ordering to the study of leaf venation and other biological networks.	[Mileyko, Yuriy] Duke Univ, Dept Math, Durham, NC 27706 USA; [Edelsbrunner, Herbert] IST Austria, Klosterneuburg, Austria; [Edelsbrunner, Herbert] Duke Univ, Dept Comp Sci, Durham, NC 27706 USA; [Edelsbrunner, Herbert] Geomagic, Res Triangle Pk, NC USA; [Price, Charles A.] Univ Western Australia, Sch Plant Biol, Crawley, WA, Australia; [Weitz, Joshua S.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Weitz, Joshua S.] Georgia Inst Technol, Sch Phys, Atlanta, GA 30332 USA	Duke University; Institute of Science & Technology - Austria; Duke University; University of Western Australia; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Mileyko, Y (corresponding author), Duke Univ, Dept Math, Durham, NC 27706 USA.	yury@math.duke.edu; jsweitz@gatech.edu	Price, Chuck A/HIK-1431-2022; Weitz, Joshua S/I-6696-2012; Price, Charles A/B-1171-2011	Weitz, Joshua S/0000-0002-3433-8312; 	National Science Foundation Plant Genome Research Program [0820624]; Defense Advanced Projects Research Agency [HR0011-09-1-0055]; European Science Foundation (under the Research Networking Programme on "Applied and Computational Algebraic Topology" run); Scientific Interface from the Burroughs Wellcome Fund	National Science Foundation Plant Genome Research Program(National Science Foundation (NSF)NSF - Office of the Director (OD)); Defense Advanced Projects Research Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); European Science Foundation (under the Research Networking Programme on "Applied and Computational Algebraic Topology" run); Scientific Interface from the Burroughs Wellcome Fund(Burroughs Wellcome Fund)	This work was supported by the National Science Foundation Plant Genome Research Program (grant 0820624 to H. E. and J.S.W.), the Defense Advanced Projects Research Agency (grant HR0011-09-1-0055 to H. E. and J.S.W.), and the European Science Foundation (under the Research Networking Programme on "Applied and Computational Algebraic Topology" run by H. E.). Joshua S. Weitz, Ph.D., holds a Career Award at the Scientific Interface from the Burroughs Wellcome Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Allesina S, 2008, SCIENCE, V320, P658, DOI 10.1126/science.1156269; Alon U, 2007, INTRO SYSTEMS BIOL D; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Banavar JR, 2010, P NATL ACAD SCI USA, V107, P15816, DOI 10.1073/pnas.1009974107; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barthelemy Marc, 2011, Physics Reports, V499, P1, DOI 10.1016/j.physrep.2010.11.002; Blonder B, 2011, ECOL LETT, V14, P91, DOI 10.1111/j.1461-0248.2010.01554.x; Bollobas B, 1998, MODERN GRAPH THEORY; Brodribb TJ, 2007, PLANT PHYSIOL, V144, P1890, DOI 10.1104/pp.107.101352; Brodribb TJ, 2010, FUNCT PLANT BIOL, V37, P488, DOI 10.1071/FP10010; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Chartrand G, 1985, INTRO GRAPH THEORY; Christakis NA, 2007, NEW ENGL J MED, V357, P370, DOI 10.1056/NEJMsa066082; Cochard H, 2004, PLANT CELL ENVIRON, V27, P1257, DOI 10.1111/j.1365-3040.2004.01233.x; Corson F, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.048703; Dodds PS, 2001, J THEOR BIOL, V209, P9, DOI 10.1006/jtbi.2000.2238; Dodds PS, 2003, SCIENCE, V301, P827, DOI 10.1126/science.1081058; Dodds PS, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.016117; Dodds PS, 2000, ANNU REV EARTH PL SC, V28, P571, DOI 10.1146/annurev.earth.28.1.571; Duarte NC, 2007, P NATL ACAD SCI USA, V104, P1777, DOI 10.1073/pnas.0610772104; Enquist BJ, 1998, NATURE, V395, P163, DOI 10.1038/25977; Flores CO, 2011, P NATL ACAD SCI USA, V108, pE288, DOI 10.1073/pnas.1101595108; Gastner MT, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.016117; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; HORTON RE, 1945, GEOL SOC AM BULL, V56, P275, DOI 10.1130/0016-7606(1945)56[275:edosat]2.0.co;2; Kassab GS, 2006, AM J PHYSIOL-HEART C, V290, pH894, DOI 10.1152/ajpheart.00579.2005; Katifori E, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.048704; Kolokotrones T, 2010, NATURE, V464, P753, DOI 10.1038/nature08920; LABARBERA M, 1990, SCIENCE, V249, P992, DOI 10.1126/science.2396104; Lafferty KD, 2006, P NATL ACAD SCI USA, V103, P11211, DOI 10.1073/pnas.0604755103; Latty T, 2011, J R SOC INTERFACE, V8, P1298, DOI 10.1098/rsif.2010.0612; Masucci AP, 2009, EUR PHYS J B, V71, P259, DOI 10.1140/epjb/e2009-00290-4; Meyers LA, 2005, J THEOR BIOL, V232, P71, DOI 10.1016/j.jtbi.2004.07.026; Nardini A, 2001, PLANT PHYSIOL, V125, P1700, DOI 10.1104/pp.125.4.1700; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Newman MEJ, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.016128; PASCUAL M, 2006, ECOLOGICAL NETWORKS; PECKHAM SD, 1995, WATER RESOUR RES, V31, P1023, DOI 10.1029/94WR03155; Pelletier JD, 2000, PHILOS T ROY SOC B, V355, P307, DOI 10.1098/rstb.2000.0566; Price CA, 2007, ECOLOGY, V88, P1132, DOI 10.1890/06-1158; Price CA, 2011, PLANT PHYSIOL, V155, P236, DOI 10.1104/pp.110.162834; Rashevsky N, 1962, PHYSICOMATHEMATICAL, P493; Rodriguez-Iturbe I., 1997, FRACTAL RIVER NETWOR; Sack L, 2008, P NATL ACAD SCI USA, V105, P1567, DOI 10.1073/pnas.0709333105; Sack L, 2006, ANNU REV PLANT BIOL, V57, P361, DOI 10.1146/annurev.arplant.56.032604.144141; Savage VM, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000171; Strahler A.N., 1957, EOS T AM GEOPHYS UN, V38, P913, DOI [DOI 10.1029/TR038I006P00913, 10.1029/TR038i006p00913]; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; TARBOTON DG, 1991, HYDROL PROCESS, V5, P81, DOI 10.1002/hyp.3360050107; Tokunaga E, 1978, GEOGRAPHICAL REPORTS, V13, P1; Turcotte DL, 1998, J THEOR BIOL, V193, P577, DOI 10.1006/jtbi.1998.0723; Waisel Y, 2002, PLANT ROOTS HIDDEN H, P157, DOI DOI 10.1201/9780203909423; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; West GB, 1997, SCIENCE, V276, P122, DOI 10.1126/science.276.5309.122; Zhang K, 2000, P NATL ACAD SCI USA, V97, P5621, DOI 10.1073/pnas.090504197	59	35	35	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e36715	10.1371/journal.pone.0036715	http://dx.doi.org/10.1371/journal.pone.0036715			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701559	Green Published, gold, Green Submitted			2022-12-27	WOS:000305348400006
J	Pereyre, S; Charron, A; Hidalgo-Grass, C; Touati, A; Moses, AE; Nir-Paz, R; Bebear, C				Pereyre, Sabine; Charron, Alain; Hidalgo-Grass, Carlos; Touati, Arabella; Moses, Allon E.; Nir-Paz, Ran; Bebear, Cecile			The Spread of Mycoplasma pneumoniae Is Polyclonal in Both an Endemic Setting in France and in an Epidemic Setting in Israel	PLOS ONE			English	Article							REAL-TIME PCR; P1 CYTADHESIN GENE; MACROLIDE-RESISTANT STRAINS; RESOLUTION MELT ANALYSIS; TANDEM-REPEAT ANALYSIS; MOLECULAR ANALYSIS; SUSCEPTIBILITY; INFECTIONS; SPECIMENS; SEQUENCES	Mycoplasma pneumoniae infections occur both endemically and epidemically, and macrolide resistance has been spreading for 10 years worldwide. A substantial increased incidence of M. pneumoniae infections has been reported in several countries since 2010. Whether this increased incidence is attributed to different or to the same M. pneumoniae genotype is unknown. We have developed a multilocus variable-number tandem-repeat ( VNTR) analysis ( MLVA) for the molecular typing of M. pneumoniae isolates. In this study, the MLVA typing method was modified and validated to be applicable directly to respiratory tract specimens without culture. This method was applied to 34 M. pneumoniae-positive specimens received at the Bordeaux Hospital, France, between 2007 and 2010 in an endemic setting, and to 63 M. pneumoniae-positive specimens collected during an epidemic surge of M. pneumoniae infections in 2010 in Jerusalem, Israel. The M. pneumoniae endemic spread was shown to be polyclonal in France, with 15 MLVA types identified. Strikingly, the Israeli epidemic surge was also a multi-clonal phenomenon, with 18 circulating MLVA types. The macrolide resistance-associated substitution, A2058G, was found in 22% of the Israeli patients. Macrolide-resistant M. pneumoniae belonged to four MLVA types, the MLVA type Z being the most frequent one. An association between the MLVA type Z and macrolide resistance might exist since macrolide resistance was present or generated during the course of illness in all patients infected with this MLVA type. In conclusion, the discriminatory power of the MLVA showed that the spread of M. pneumoniae strains in France in an endemic setting was polyclonal as well as the surge of M. pneumoniae infections in Israel in 2010.	[Pereyre, Sabine; Charron, Alain; Touati, Arabella; Bebear, Cecile] Univ Bordeaux, USC Infect Humaines Mycoplasmes & Chlamydiae, Bordeaux, France; [Pereyre, Sabine; Charron, Alain; Touati, Arabella; Bebear, Cecile] INRA, USC Infect Humaines Mycoplasmes & Chlamydiae, Bordeaux, France; [Pereyre, Sabine; Bebear, Cecile] Ctr Hosp Univ Bordeaux, Bacteriol Lab, Bordeaux, France; [Hidalgo-Grass, Carlos; Moses, Allon E.; Nir-Paz, Ran] Hadassah Hebrew Univ, Med Ctr, Jerusalem, Israel	UDICE-French Research Universities; Universite de Bordeaux; INRAE; CHU Bordeaux; Hebrew University of Jerusalem; Hadassah University Medical Center	Pereyre, S (corresponding author), Univ Bordeaux, USC Infect Humaines Mycoplasmes & Chlamydiae, Bordeaux, France.	sabine.pereyre@u-bordeaux2.fr	Bébéar, Cécile/A-6596-2016; Hidalgo-Grass, Carlos J/J-6488-2016; Nir-Paz, Ran/Q-6244-2019; Nir-Paz, Ran/I-5003-2012; Nir-Paz, Ran/GYA-4148-2022; , Pereyre/B-5815-2016	Nir-Paz, Ran/0000-0002-1567-2550; , Pereyre/0000-0003-1757-4206; Bebear, Cecile/0000-0001-6065-2332	Hadassah-Hebrew University Medical Center development fund	Hadassah-Hebrew University Medical Center development fund	This study was supported by internal fundings and by a Hadassah-Hebrew University Medical Center development fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson TP, 2008, FEMS MICROBIOL REV, V32, P956, DOI 10.1111/j.1574-6976.2008.00129.x; Averbuch D, 2011, EMERG INFECT DIS, V17, P1079, DOI [10.3201/eid1706.101558, 10.3201/eid/1706.101558]; Bebear C, 2011, FUTURE MICROBIOL, V6, P423, DOI [10.2217/fmb.11.18, 10.2217/FMB.11.18]; Chalker V, 2012, EUROSURVEILL, V17; Chalker V, 2011, EUROSURVEILLANCE, V16; Cousin-Allery A, 2000, EPIDEMIOL INFECT, V124, P103, DOI 10.1017/S0950268899003313; Degrange S, 2009, J CLIN MICROBIOL, V47, P914, DOI 10.1128/JCM.01935-08; Dorigo-Zetsma JW, 2001, INFECT IMMUN, V69, P5612, DOI 10.1128/IAI.69.9.5612-5618.2001; Dumke R, 2003, INT J MED MICROBIOL, V292, P513, DOI 10.1078/1438-4221-00231; Dumke R, 2006, J CLIN MICROBIOL, V44, P2567, DOI 10.1128/JCM.00495-06; Dumke R, 2011, J MICROBIOL METH, V86, P393, DOI 10.1016/j.mimet.2011.06.008; Kenri T, 1999, INFECT IMMUN, V67, P4557, DOI 10.1128/IAI.67.9.4557-4562.1999; Lenglet A, 2012, EUROSURVEILL, V17; Liu Y, 2009, ANTIMICROB AGENTS CH, V53, P2160, DOI 10.1128/AAC.01684-08; Nir-Paz R, 2012, EUROSURVEILL, V17; Pereyre S, 2007, J CLIN MICROBIOL, V45, P3534, DOI 10.1128/JCM.01345-07; Peuchant O, 2009, J ANTIMICROB CHEMOTH, V64, P52, DOI 10.1093/jac/dkp160; Sasaki T, 1996, J CLIN MICROBIOL, V34, P447, DOI 10.1128/JCM.34.2.447-449.1996; Schwartz SB, 2009, CLIN MICROBIOL INFEC, V15, P756, DOI 10.1111/j.1469-0691.2009.02814.x; Spuesens EBM, 2010, J MICROBIOL METH, V82, P214, DOI 10.1016/j.mimet.2010.06.004; Touati A, 2009, J CLIN MICROBIOL, V47, P2269, DOI 10.1128/JCM.00326-09; WAITES KB, 2001, CUMITECH, V34; Wolff BJ, 2008, ANTIMICROB AGENTS CH, V52, P3542, DOI 10.1128/AAC.00582-08; Zhao F, 2012, ANTIMICROB AGENTS CH, V56, P1108, DOI 10.1128/AAC.05627-11	24	50	57	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e38585	10.1371/journal.pone.0038585	http://dx.doi.org/10.1371/journal.pone.0038585			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701675	Green Submitted, Green Published, gold			2022-12-27	WOS:000305348400077
J	Collin, GB; Marshall, JD; King, BL; Milan, G; Maffei, P; Jagger, DJ; Naggert, JK				Collin, Gayle B.; Marshall, Jan D.; King, Benjamin L.; Milan, Gabriella; Maffei, Pietro; Jagger, Daniel J.; Naggert, Jurgen K.			The Alstrom Syndrome Protein, ALMS1, Interacts with alpha-Actinin and Components of the Endosome Recycling Pathway	PLOS ONE			English	Article							MYOSIN VB; CLEAVAGE FURROW; CYTOKINESIS; CILIOGENESIS; RAB11; LOCALIZATION; TRAFFICKING; CENTROSOME; MECHANISMS; OBESITY	Alstrom syndrome (ALMS) is a progressive multi-systemic disorder characterized by cone-rod dystrophy, sensorineural hearing loss, childhood obesity, insulin resistance and cardiac, renal, and hepatic dysfunction. The gene responsible for Alstrom syndrome, ALMS1, is ubiquitously expressed and has multiple splice variants. The protein encoded by this gene has been implicated in ciliary function, cell cycle control, and intracellular transport. To gain better insight into the pathways through which ALMS1 functions, we carried out a yeast two hybrid (Y2H) screen in several mouse tissue libraries to identify ALMS1 interacting partners. The majority of proteins found to interact with the murine carboxy-terminal end (19/32) of ALMS1 were alpha-actinin isoforms. Interestingly, several of the identified ALMS1 interacting partners (alpha-actinin 1, alpha-actinin 4, myosin Vb, rad50 interacting 1 and huntingtin associated protein1A) have been previously associated with endosome recycling and/or centrosome function. We examined dermal fibroblasts from human subjects bearing a disruption in ALMS1 for defects in the endocytic pathway. Fibroblasts from these patients had a lower uptake of transferrin and reduced clearance of transferrin compared to controls. Antibodies directed against ALMS1 N- and C-terminal epitopes label centrosomes and endosomal structures at the cleavage furrow of dividing MDCK cells, respectively, suggesting isoform-specific cellular functions. Our results suggest a role for ALMS1 variants in the recycling endosome pathway and give us new insights into the pathogenesis of a subset of clinical phenotypes associated with ALMS.	[Collin, Gayle B.; Marshall, Jan D.; King, Benjamin L.; Naggert, Jurgen K.] Jackson Lab, Bar Harbor, ME 04609 USA; [King, Benjamin L.] Mt Desert Isl Biol Lab, Salisbury, ME USA; [Milan, Gabriella; Maffei, Pietro] Univ Padua, Dept Med & Surg Sci, Padua, Italy; [Jagger, Daniel J.] UCL, UCL Ear Inst, London, England	Jackson Laboratory; Mount Desert Island Biological Laboratory; University of Padua; University of London; University College London	Collin, GB (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.	juergen.naggert@jax.org	King, Benjamin/AAI-1492-2019; Jagger, Daniel/Q-3466-2019; Milan, Gabriella/AAB-6234-2022; Maffei, Pietro/O-1878-2013	Jagger, Daniel/0000-0003-2796-5526; Milan, Gabriella/0000-0001-8987-5310; King, Benjamin/0000-0001-6463-1336; Maffei, Pietro/0000-0002-1717-263X; Johnson, Colin/0000-0002-2979-8234	National Institutes of Health [HD036878]; Royal Society University Research Fellowship [516002.K5746.KK]; Executive Agency for Health and Consumer (EAHC), EURO-WABB [2010 12 05];  [CA34196]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD036878] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA034196] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Royal Society University Research Fellowship(Royal Society of London); Executive Agency for Health and Consumer (EAHC), EURO-WABB; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	JKN, GBC, and JDM were supported by a grant from the National Institutes of Health (HD036878). DJ was supported by a Royal Society University Research Fellowship (Grant 516002.K5746.KK). PM and GM were funded by Executive Agency for Health and Consumer (EAHC), EURO-WABB, agreement number 2010 12 05. Core services at The Jackson Laboratory were supported by an institutional grant CA34196. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai Erkang, 2009, Communicative & Integrative Biology, V2, P444; Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; Araki N, 2000, J CELL SCI, V113, P3329; Chi RJ, 2008, J BIOL CHEM, V283, P20959, DOI 10.1074/jbc.M709621200; Chi RJ, 2005, INT J BIOCHEM CELL B, V37, P1470, DOI 10.1016/j.biocel.2005.02.014; Collin GB, 2005, HUM MOL GENET, V14, P2323, DOI 10.1093/hmg/ddi235; Collin GB, 2002, NAT GENET, V31, P74, DOI 10.1038/ng867; De Matteis MA, 2011, NEW ENGL J MED, V365, P927, DOI 10.1056/NEJMra0910494; Fan GH, 2004, MOL BIOL CELL, V15, P2456, DOI 10.1091/mbc.E03-09-0706; FUJIWARA K, 1978, J CELL BIOL, V79, P268, DOI 10.1083/jcb.79.1.268; Grant BD, 2009, NAT REV MOL CELL BIO, V10, P597, DOI 10.1038/nrm2755; Hales CM, 2002, J BIOL CHEM, V277, P50415, DOI 10.1074/jbc.M209270200; Hearn T, 2005, DIABETES, V54, P1581, DOI 10.2337/diabetes.54.5.1581; Hearn T, 2002, NAT GENET, V31, P79, DOI 10.1038/ng874; Jagger D, 2011, HUM MOL GENET, V20, P466, DOI 10.1093/hmg/ddq493; Kim J, 2010, NATURE, V464, P1048, DOI 10.1038/nature08895; Knodler A, 2010, P NATL ACAD SCI USA, V107, P6346, DOI 10.1073/pnas.1002401107; Knorz VJ, 2010, MOL BIOL CELL, V21, P3617, DOI 10.1091/mbc.E10-03-0246; Kremerskothen J, 2002, BIOCHEM BIOPH RES CO, V295, P678, DOI 10.1016/S0006-291X(02)00734-9; Li GC, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030008; Li XY, 2009, MOL CELL BIOL, V29, P6106, DOI 10.1128/MCB.00420-09; Lim YS, 2011, BIOL CELL, V103, P209, DOI 10.1042/BC20100150; Marshall JD, 2007, HUM MUTAT, V28, P1114, DOI 10.1002/humu.20577; Marshall JD, 2005, ARCH INTERN MED, V165, P675, DOI 10.1001/archinte.165.6.675; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Mayle KM, 2012, BBA-GEN SUBJECTS, V1820, P264, DOI 10.1016/j.bbagen.2011.09.009; Mellman I, 1996, ANNU REV CELL DEV BI, V12, P575, DOI 10.1146/annurev.cellbio.12.1.575; Millman EE, 2008, TRAFFIC, V9, P1958, DOI 10.1111/j.1600-0854.2008.00813.x; Montagnac G, 2008, BIOCHEM SOC T, V36, P442, DOI 10.1042/BST0360442; Mukhina S, 2007, DEV CELL, V13, P554, DOI 10.1016/j.devcel.2007.08.003; Murphy JE, 2009, P NATL ACAD SCI USA, V106, P17615, DOI 10.1073/pnas.0906541106; Nedvetsky PI, 2007, TRAFFIC, V8, P110, DOI 10.1111/j.1600-0854.2006.00508.x; Roland JT, 2011, P NATL ACAD SCI USA, V108, P2789, DOI 10.1073/pnas.1010754108; Rong J, 2007, J NEUROSCI RES, V85, P3025, DOI 10.1002/jnr.21326; SAGER PR, 1984, CELL, V39, P275, DOI 10.1016/0092-8674(84)90005-9; Suchy SF, 2002, AM J HUM GENET, V71, P1420, DOI 10.1086/344517; Talior-Volodarsky I, 2008, J BIOL CHEM, V283, P25115, DOI 10.1074/jbc.M801750200; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; Wilson GM, 2005, MOL BIOL CELL, V16, P849, DOI 10.1091/mbc.e04-10-0927; Yan Q, 2005, MOL BIOL CELL, V16, P2470, DOI 10.1091/mbc.e04-11-1014; Zulato E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019081	41	58	61	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e37925	10.1371/journal.pone.0037925	http://dx.doi.org/10.1371/journal.pone.0037925			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693585	Green Published, Green Submitted, gold			2022-12-27	WOS:000305338500066
J	Brunialti, MKC; Santos, MC; Rigato, O; Machado, FR; Silva, E; Salomao, R				Colo Brunialti, Milena Karina; Santos, Michelle Carolina; Rigato, Otelo; Machado, Flavia Ribeiro; Silva, Eliezer; Salomao, Reinaldo			Increased Percentages of T Helper Cells Producing IL-17 and Monocytes Expressing Markers of Alternative Activation in Patients with Sepsis	PLOS ONE			English	Article							WHOLE-BLOOD; CYTOKINE PRODUCTION; SERUM MARKERS; SEPTIC SHOCK; REQUIREMENT; NEUTROPHILS; BACTEREMIA; GENERATION; MORTALITY; APOPTOSIS	Background: A shift from Th1 to Th2 as well as an increase in Treg CD4+T cell subsets has been reported in septic patients (SP). Furthermore, these patients display modulation of monocyte function, with reduced production of pro-inflammatory cytokines upon LPS stimulus, which resembles the phenotype of alternatively activated macrophages. In this study, we evaluated the percentages of T cells differentiated into Th1, Th17 and Treg subsets, as well as the percentage of monocytes expressing markers of alternatively activated monocytes/macrophages (AAM) in SP. Methodology/Principal Findings: Peripheral blood mononuclear cells (PBMC) were obtained from 32 healthy volunteers (HV) and from SP at admission (D0, n=67) and after 7 days of therapy (D7, n=33). Th1 and Th17 (CD3+CD8-) lymphocytes were identified by the intracellular detection of IFN-gamma and IL-17, respectively, spontaneously and after PMA/Io stimulation, and Treg cells were identified by Foxp3+CD127-expression. Monocytes were evaluated for CD206 and CD163 expression. Absolute numbers of CD4+T lymphocytes were measured in whole blood samples by flow cytometry. The Mann-Whitney or Wilcoxon test was applied, as appropriate. The percentage of Th1 cells was lower in SP than in HV at admission after PMA/Io stimulation, whereas the percentage of Th17 cells was higher. In patients' follow-up samples, a higher percentage of Th1 cells and a lower percentage of Th17 cells were observed on D7 compared with the D0 samples. Treg cells remained unchanged. Septic patients showed a markedly increased proportion of monocytes expressing CD163 and CD206. Conclusions/Significance: Upon in vitro stimulus, the percentage of T helper lymphocytes producing IL-17 was higher in SP than in HV at admission, and the percentage producing IFN-gamma was lower, a pattern that was reversed during follow-up. The increased expression of CD163 and CD206 indicates that monocytes may acquire the AAM phenotype during sepsis.	[Colo Brunialti, Milena Karina; Santos, Michelle Carolina; Rigato, Otelo; Salomao, Reinaldo] Univ Fed Sao Paulo, Div Infect Dis, Dept Med, Escola Paulista Med,Hosp Sao Paulo, Sao Paulo, Brazil; [Rigato, Otelo] Hosp Sirio Libanes, Crit Care Unit, Sao Paulo, Brazil; [Machado, Flavia Ribeiro] Univ Fed Sao Paulo, Div Anesthesiol, Dept Surg, Escola Paulista Med,Hosp Sao Paulo, Sao Paulo, Brazil; [Silva, Eliezer] Hosp Albert Einstein, Crit Care Unit, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Hospital Sirio Libanes; Universidade Federal de Sao Paulo (UNIFESP); Hospital Israelita Albert Einstein	Brunialti, MKC (corresponding author), Univ Fed Sao Paulo, Div Infect Dis, Dept Med, Escola Paulista Med,Hosp Sao Paulo, Sao Paulo, Brazil.	rsalomao@unifesp.br	Machado, Flavia R/G-4651-2012; Brunialti, Milena K C/C-4905-2012; Salomao, Reinaldo/C-6419-2013	Machado, Flavia R/0000-0002-2356-4867; Brunialti, Milena K C/0000-0003-2874-520X; Salomao, Reinaldo/0000-0003-1149-4598	Fundacao de Amparo a Pesquisa de Estado de Sao Paulo (FAPESP) [2006/58744-1, 2008/07511-2]	Fundacao de Amparo a Pesquisa de Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Fundacao de Amparo a Pesquisa de Estado de Sao Paulo (FAPESP - grants 2006/58744-1 and 2008/07511-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bettelli E, 2008, NATURE, V453, P1051, DOI 10.1038/nature07036; Beyer M, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/734036; Bingold TM, 2010, SHOCK, V34, P337, DOI 10.1097/SHK.0b013e3181dc07b1; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Brunialti MKC, 2006, SHOCK, V25, P351, DOI 10.1097/01.shk.0000217815.57727.29; Cavaillon JM, 2006, CRIT CARE, V10, DOI 10.1186/cc5055; ERTEL W, 1995, BLOOD, V85, P1341, DOI 10.1182/blood.V85.5.1341.bloodjournal8551341; Fernandes ML, 2010, BRAZ J MED BIOL RES, V43, P860, DOI 10.1590/S0100-879X2010000900008; Flierl MA, 2008, FASEB J, V22, P2198, DOI 10.1096/fj.07-105221; Gaini S, 2008, CLIN EXP IMMUNOL, V151, P423, DOI 10.1111/j.1365-2249.2007.03586.x; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Groselj-Grenc M, 2008, MEDIAT INFLAMM, V2008, DOI 10.1155/2008/202646; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Heidecke CD, 1999, AM J SURG, V178, P288, DOI 10.1016/S0002-9610(99)00183-X; Hein F, 2010, CRIT CARE, V14, DOI 10.1186/cc8876; Heuer JG, 2005, J IMMUNOL, V174, P7141, DOI 10.4049/jimmunol.174.11.7141; Hotchkiss RS, 2001, J IMMUNOL, V166, P6952, DOI 10.4049/jimmunol.166.11.6952; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Huang WT, 2004, J INFECT DIS, V190, P624, DOI 10.1086/422329; LIN RY, 1993, CHEST, V104, P847, DOI 10.1378/chest.104.3.847; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Martins PS, 2008, CRIT CARE, V12, DOI 10.1186/cc6801; Martins PS, 2003, SHOCK, V20, P208, DOI 10.1097/01.shk.0000079425.52617.db; Mendes ME, 2011, IMMUNOBIOLOGY, V216, P285, DOI 10.1016/j.imbio.2010.07.008; Moller HJ, 2006, CRIT CARE MED, V34, P2561, DOI 10.1097/01.CCM.0000239120.32490.AB; Monneret G, 2003, CRIT CARE MED, V31, P2068, DOI 10.1097/01.CCM.0000069345.78884.0F; Monneret G, 2006, INTENS CARE MED, V32, P1175, DOI 10.1007/s00134-006-0204-8; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; MUNOZ C, 1991, J CLIN INVEST, V88, P1747, DOI 10.1172/JCI115493; OSULLIVAN ST, 1995, ANN SURG, V222, P482; PASSLICK B, 1989, BLOOD, V74, P2527, DOI 10.1182/blood.V74.7.2527.2527; Pesce J, 2006, J CLIN INVEST, V116, P2044, DOI 10.1172/JCI27727; PICKER LJ, 1995, BLOOD, V86, P1408, DOI 10.1182/blood.V86.4.1408.bloodjournal8641408; Rigato O, 2003, SHOCK, V19, P113, DOI 10.1097/00024382-200302000-00004; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Salomao R, 2002, J ENDOTOXIN RES, V8, P371, DOI 10.1179/096805102125000704; Salomao R, 2009, CRIT CARE MED, V37, P132, DOI 10.1097/CCM.0b013e318192fbaf; Salomao R, 2008, SHOCK, V30, P73, DOI 10.1097/SHK.0b013e318181af2a; Scumpia PO, 2006, J IMMUNOL, V177, P7943, DOI 10.4049/jimmunol.177.11.7943; Serbina NV, 2008, ANNU REV IMMUNOL, V26, P421, DOI 10.1146/annurev.immunol.26.021607.090326; STEIN M, 1992, J EXP MED, V176, P287, DOI 10.1084/jem.176.1.287; Stockinger B, 2007, SEMIN IMMUNOL, V19, P353, DOI 10.1016/j.smim.2007.10.008; Tiemessen MM, 2007, P NATL ACAD SCI USA, V104, P19446, DOI 10.1073/pnas.0706832104; Tippett E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019968; van de Veerdonk FL, 2009, CELL HOST MICROBE, V5, P329, DOI 10.1016/j.chom.2009.02.006; Van Gorp H, 2010, MOL IMMUNOL, V47, P1650, DOI 10.1016/j.molimm.2010.02.008; Venet F, 2004, CRIT CARE MED, V32, P2329, DOI 10.1097/01.CCM.0000145999.42971.4B; Venet F, 2010, SHOCK, V34, P358, DOI 10.1097/SHK.0b013e3181dc0977; Venet F, 2009, INTENS CARE MED, V35, P678, DOI 10.1007/s00134-008-1337-8; Ye P, 2001, J EXP MED, V194, P519, DOI 10.1084/jem.194.4.519	53	33	40	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e37393	10.1371/journal.pone.0037393	http://dx.doi.org/10.1371/journal.pone.0037393			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693573	Green Published, Green Submitted, gold			2022-12-27	WOS:000305338500036
J	Lienhard, D; Lauterburg, M; Escher, G; Frey, FJ; Frey, BM				Lienhard, Daniel; Lauterburg, Meret; Escher, Genevieve; Frey, Felix J.; Frey, Brigitte M.			High Salt Intake Down-Regulates Colonic Mineralocorticoid Receptors, Epithelial Sodium Channels and 11 beta-Hydroxysteroid Dehydrogenase Type 2	PLOS ONE			English	Article							BETA-HYDROXYSTEROID DEHYDROGENASE; GLUCOCORTICOID-INDUCED KINASE; NA+ CHANNEL; RAT COLON; MESSENGER-RNA; DISTAL COLON; SUBCELLULAR-LOCALIZATION; DIFFERENTIAL REGULATION; GENE-EXPRESSION; ENAC SUBUNITS	Besides the kidneys, the gastrointestinal tract is the principal organ responsible for sodium homeostasis. For sodium transport across the cell membranes the epithelial sodium channel (ENaC) is of pivotal relevance. The ENaC is mainly regulated by mineralocorticoid receptor mediated actions. The MR activation by endogenous 11 beta-hydroxy-glucocorticoids is modulated by the 11 beta-hydroxysteroid dehydrogenase type 2 (11 beta-HSD2). Here we present evidence for intestinal segment specific 11 beta-HSD2 expression and hypothesize that a high salt intake and/or uninephrectomy (UNX) affects colonic 11 beta-HSD2, MR and ENaC expression. The 11 beta-HSD2 activity was measured by means of 3H-corticosterone conversion into 3H-11-dehydrocorticosterone in Sprague Dawley rats on a normal and high salt diet. The activity increased steadily from the ileum to the distal colon by a factor of about 3, an observation in line with the relevance of the distal colon for sodium handling. High salt intake diminished mRNA and protein of 11 beta-HSD2 by about 50% (p<0.001) and reduced the expression of the MR (p<0.01). The functionally relevant ENaC-beta and ENaC-gamma expression, a measure of mineralocorticoid action, diminished by more than 50% by high salt intake (p<0.001). The observed changes were present in rats with and without UNX. Thus, colonic epithelial cells appear to contribute to the protective armamentarium of the mammalian body against salt overload, a mechanism not modulated by UNX.	[Lienhard, Daniel; Lauterburg, Meret; Escher, Genevieve; Frey, Felix J.; Frey, Brigitte M.] Univ Hosp Bern, Dept Hypertens & Nephrol, CH-3010 Bern, Switzerland; [Frey, Brigitte M.] Univ Hosp Bern, Dept Clin Res, CH-3010 Bern, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern	Lienhard, D (corresponding author), Univ Hosp Bern, Dept Hypertens & Nephrol, CH-3010 Bern, Switzerland.	brigitte.frey@dkf.unibe.ch		Escher, Genevieve/0000-0002-5125-2262	Swiss National Foundations for Scientific Research [320030-122135]	Swiss National Foundations for Scientific Research	This work was supported by the Swiss National Foundations for Scientific Research, No 320030-122135 (FJF and BMF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBISTON AL, 1994, MOL CELL ENDOCRINOL, V105, pR11, DOI 10.1016/0303-7207(94)90176-7; Audige A, 2002, EUR J CLIN INVEST, V32, P411, DOI 10.1046/j.1365-2362.2002.01003.x; Bergann T, 2009, BIOCHEM BIOPH RES CO, V382, P280, DOI 10.1016/j.bbrc.2009.03.006; Bhargava A, 2001, ENDOCRINOLOGY, V142, P1587, DOI 10.1210/en.142.4.1587; Coric T, 2004, AM J PHYSIOL-GASTR L, V286, pG663, DOI 10.1152/ajpgi.00364.2003; Debonneville C, 2001, EMBO J, V20, P7052, DOI 10.1093/emboj/20.24.7052; Epple HJ, 2000, AM J PHYSIOL-GASTR L, V278, pG718, DOI 10.1152/ajpgi.2000.278.5.G718; EPPLE HJ, 1995, AM J PHYSIOL-GASTR L, V269, pG42, DOI 10.1152/ajpgi.1995.269.1.G42; Escher G, 1998, ENDOCRINOLOGY, V139, P1533, DOI 10.1210/en.139.4.1533; Farese S, 2009, KIDNEY INT, V76, P877, DOI 10.1038/ki.2009.269; Ferrari P, 2001, HYPERTENSION, V38, P1330, DOI 10.1161/hy1101.096112; Frey FJ, 2004, CURR OPIN NEPHROL HY, V13, P451, DOI 10.1097/01.mnh.0000133976.32559.b0; Fukushima K, 2005, SCAND J GASTROENTERO, V40, P850, DOI 10.1080/00365520510015700; Fuller PJ, 2000, PFLUG ARCH EUR J PHY, V441, P94, DOI 10.1007/s004240000366; FUNDER JW, 1988, SCIENCE, V242, P583, DOI 10.1126/science.2845584; Greig ER, 2002, PFLUG ARCH EUR J PHY, V444, P476, DOI 10.1007/s00424-002-0828-7; Hatch M, 2008, AM J PHYSIOL-GASTR L, V295, pG348, DOI 10.1152/ajpgi.00079.2008; Hundertmark S, 2001, HORM METAB RES, V33, P78, DOI 10.1055/s-2001-12429; Ikuma M, 1999, AM J PHYSIOL-GASTR L, V276, pG539, DOI 10.1152/ajpgi.1999.276.2.G539; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loffing J, 2000, AM J PHYSIOL-RENAL, V279, pF252, DOI 10.1152/ajprenal.2000.279.2.F252; Norregaard R, 2003, AM J PHYSIOL-RENAL, V285, pF348, DOI 10.1152/ajprenal.00061.2003; Odermatt A, 1999, J BIOL CHEM, V274, P28762, DOI 10.1074/jbc.274.40.28762; Ono S, 1997, PFLUG ARCH EUR J PHY, V434, P756, DOI 10.1007/s004240050462; PACHA J, 1994, LIFE SCI, V54, P745, DOI 10.1016/0024-3205(94)90164-3; Pacha J, 1997, LIFE SCI, V61, P2391, DOI 10.1016/S0024-3205(97)00956-9; Pearce D, 2007, J CLIN INVEST, V117, P592, DOI 10.1172/JCI31538; Petrelli MD, 1997, ENDOCRINOLOGY, V138, P3077, DOI 10.1210/en.138.7.3077; RENARD S, 1995, PFLUG ARCH EUR J PHY, V430, P299, DOI 10.1007/BF00373903; SCHAEFER L, 1995, NEPHROL DIAL TRANSPL, V10, P801; Serra A, 2002, J AM SOC NEPHROL, V13, P191, DOI 10.1681/ASN.V131191; Sheppard KE, 1999, AM J PHYSIOL-GASTR L, V277, pG541, DOI 10.1152/ajpgi.1999.277.3.G541; Sheppard KE, 1998, AM J PHYSIOL-ENDOC M, V275, pE124, DOI 10.1152/ajpendo.1998.275.1.E124; Shigaev A, 2000, AM J PHYSIOL-RENAL, V278, pF613, DOI 10.1152/ajprenal.2000.278.4.F613; Smith RE, 1997, ENDOCRINOLOGY, V138, P540, DOI 10.1210/en.138.2.540; Soundararajan R, 2010, J BIOL CHEM, V285, P39905, DOI 10.1074/jbc.M110.161133; Stokes JB, 1998, AM J PHYSIOL-CELL PH, V274, pC1699, DOI 10.1152/ajpcell.1998.274.6.C1699; TOMKINS AM, 1975, GUT, V16, P277, DOI 10.1136/gut.16.4.277; TURNAMIAN SG, 1989, J CLIN INVEST, V84, P1924, DOI 10.1172/JCI114380; White PC, 1997, ENDOCR REV, V18, P135, DOI 10.1210/er.18.1.135; WHITEHEAD RH, 1987, IN VITRO CELL DEV B, V23, P436; WHITEHEAD RH, 1993, P NATL ACAD SCI USA, V90, P587, DOI 10.1073/pnas.90.2.587; WHORWOOD CB, 1994, ENDOCRINOLOGY, V135, P2533, DOI 10.1210/en.135.6.2533; Wiemuth D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012163; WILL PC, 1985, AM J PHYSIOL, V248, pG124, DOI 10.1152/ajpgi.1985.248.1.G124	45	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e37898	10.1371/journal.pone.0037898	http://dx.doi.org/10.1371/journal.pone.0037898			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693583	Green Published, gold, Green Submitted			2022-12-27	WOS:000305338500064
J	van Hasselt, FN; de Visser, L; Tieskens, JM; Cornelisse, S; Baars, AM; Lavrijsen, M; Krugers, HJ; van den Bos, R; Joels, M				van Hasselt, Felisa N.; de Visser, Leonie; Tieskens, Jacintha M.; Cornelisse, Sandra; Baars, Annemarie M.; Lavrijsen, Marla; Krugers, Harm J.; van den Bos, Ruud; Joels, Marian			Individual Variations in Maternal Care Early in Life Correlate with Later Life Decision-Making and c-Fos Expression in Prefrontal Subregions of Rats	PLOS ONE			English	Article							IOWA GAMBLING TASK; PITUITARY-ADRENAL RESPONSES; AGRANULAR INSULAR CORTEX; EARLY PARENTAL LOSS; ORBITOFRONTAL CORTEX; DENDRITIC MORPHOLOGY; NUCLEUS-ACCUMBENS; SEX-DIFFERENCES; BASOLATERAL AMYGDALA; UNIPOLAR DEPRESSION	Early life adversity affects hypothalamus-pituitary-adrenal axis activity, alters cognitive functioning and in humans is thought to increase the vulnerability to psychopathology-e. g. depression, anxiety and schizophrenia-later in life. Here we investigated whether subtle natural variations among individual rat pups in the amount of maternal care received, i.e. differences in the amount of licking and grooming (LG), correlate with anxiety and prefrontal cortex-dependent behavior in young adulthood. Therefore, we examined the correlation between LG received during the first postnatal week and later behavior in the elevated plus maze and in decision-making processes using a rodent version of the Iowa Gambling Task (rIGT). In our cohort of male and female animals a high degree of LG correlated with less anxiety in the elevated plus maze and more advantageous choices during the last 10 trials of the rIGT. In tissue collected 2 hrs after completion of the task, the correlation between LG and c-fos expression (a marker of neuronal activity) was established in structures important for IGT performance. Negative correlations existed between rIGT performance and c-fos expression in the lateral orbitofrontal cortex, prelimbic cortex, infralimbic cortex and insular cortex. The insular cortex correlations between c-fos expression and decision-making performance depended on LG background; this was also true for the lateral orbitofrontal cortex in female rats. Dendritic complexity of insular or infralimbic pyramidal neurons did not or weakly correlate with LG background. We conclude that natural variations in maternal care received by pups may significantly contribute to later-life decision-making and activity of underlying brain structures.	[de Visser, Leonie; Cornelisse, Sandra; van den Bos, Ruud; Joels, Marian] UMC Utrecht, Rudolf Magnus Inst, Dept Neurosci & Pharmacol, Utrecht, Netherlands; [van Hasselt, Felisa N.; Tieskens, Jacintha M.; Krugers, Harm J.] Univ Amsterdam, SILS CNS, Amsterdam, Netherlands; [Baars, Annemarie M.; Lavrijsen, Marla] Univ Utrecht, Fac Vet Med, Dept Anim Sci & Soc, Div Behav Neurosci,Rudolf Magnus Inst, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; University of Amsterdam; Utrecht University	Joels, M (corresponding author), UMC Utrecht, Rudolf Magnus Inst, Dept Neurosci & Pharmacol, Utrecht, Netherlands.	m.joels@umcutrecht.nl	Joëls, Marian/P-6415-2016	Tieskens, J.M./0000-0002-6418-4852; Joels, Marian/0000-0002-4826-6209	Hersenstichting [15F07]; Human Frontiers Science Program [RGP0039/2006]	Hersenstichting; Human Frontiers Science Program(Human Frontier Science Program)	This study was supported by Hersenstichting (https://www.hersenstichting.nl/homepage/index.html) grant #15F07 to MJ and HJK and Human Frontiers Science Program (http://www.hfsp.org/) grant #RGP0039/2006 to MJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agid O, 1999, MOL PSYCHIATR, V4, P163, DOI 10.1038/sj.mp.4000473; Arnsten AFT, 2009, NAT REV NEUROSCI, V10, P410, DOI 10.1038/nrn2648; Bagot RC, 2009, NEUROBIOL LEARN MEM, V92, P292, DOI 10.1016/j.nlm.2009.03.004; Balleine BW, 2010, NEUROPSYCHOPHARMACOL, V35, P48, DOI 10.1038/npp.2009.131; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Bechara A, 1999, J NEUROSCI, V19, P5473; Berridge KC, 2008, PSYCHOPHARMACOLOGY, V199, P457, DOI 10.1007/s00213-008-1099-6; Birrell JM, 2000, J NEUROSCI, V20, P4320; Bishop S, 2004, NAT NEUROSCI, V7, P184, DOI 10.1038/nn1173; Bock J, 2005, CEREB CORTEX, V15, P802, DOI 10.1093/cercor/bhh181; Boekhoorn K, 2006, J NEUROSCI, V26, P3514, DOI 10.1523/JNEUROSCI.5425-05.2006; Bolla KI, 2004, CEREB CORTEX, V14, P1226, DOI 10.1093/cercor/bhh083; Brand M, 2006, NEURAL NETWORKS, V19, P1266, DOI 10.1016/j.neunet.2006.03.001; BREIER A, 1988, ARCH GEN PSYCHIAT, V45, P987; Bremner J Douglas, 2002, Curr Psychiatry Rep, V4, P254, DOI 10.1007/s11920-996-0044-9; Caldji C, 1998, P NATL ACAD SCI USA, V95, P5335, DOI 10.1073/pnas.95.9.5335; Cardinal RN, 2003, INT CONGR SER, V1250, P347, DOI 10.1016/S0531-5131(03)01013-6; Champagne DL, 2008, J NEUROSCI, V28, P6037, DOI 10.1523/JNEUROSCI.0526-08.2008; Champagne FA, 2003, PHYSIOL BEHAV, V79, P359, DOI 10.1016/S0031-9384(03)00149-5; Chudasama Y, 2006, BIOL PSYCHOL, V73, P19, DOI 10.1016/j.biopsycho.2006.01.005; Claessens SE, PSYCHOPHARMACOLOGY B, V214, P141; Clark L, 2008, BRAIN, V131, P1311, DOI 10.1093/brain/awn066; Contreras M, 2007, SCIENCE, V318, P655, DOI 10.1126/science.1145590; De Visser L, 2011, NEUROSCIENCE, V184, P97, DOI 10.1016/j.neuroscience.2011.02.025; de Visser L, 2010, NEUROPSYCHOLOGIA, V48, P1598, DOI 10.1016/j.neuropsychologia.2010.01.027; de Visser L, 2011, FRONT NEUROSCI-SWITZ, V5, DOI [10.3389/fnins.2011.00109, 10.3389/fnins.2011.00102]; Dias R, 1996, NATURE, V380, P69, DOI 10.1038/380069a0; DIORIO D, 1993, J NEUROSCI, V13, P3839; Ernst M, 2002, NEUROPSYCHOPHARMACOL, V26, P682, DOI 10.1016/S0893-133X(01)00414-6; Olvera-Cortes ME, 2008, PROG BRAIN RES, V172, P567, DOI 10.1016/S0079-6123(08)00927-8; Fernandes C, 1999, PHARMACOL BIOCHEM BE, V64, P731, DOI 10.1016/S0091-3057(99)00139-2; Floresco SB, 2008, BEHAV BRAIN RES, V190, P85, DOI 10.1016/j.bbr.2008.02.008; Fossati P, 1999, PSYCHIAT RES, V89, P171, DOI 10.1016/S0165-1781(99)00110-9; Fukui H, 2005, NEUROIMAGE, V24, P253, DOI 10.1016/j.neuroimage.2004.08.028; Grachev ID, 2000, MOL PSYCHIATR, V5, P482, DOI 10.1038/sj.mp.4000778; Holmes A, 2009, NEUROSCI BIOBEHAV R, V33, P773, DOI 10.1016/j.neubiorev.2008.11.005; Homberg JR, 2008, NEUROPHARMACOLOGY, V55, P80, DOI 10.1016/j.neuropharm.2008.04.016; Hsu M, 2005, SCIENCE, V310, P1680, DOI 10.1126/science.1115327; Kesner RP, 2007, NEUROBIOL LEARN MEM, V88, P82, DOI 10.1016/j.nlm.2007.02.002; Lapiz-Bluhm MDS, 2008, J NEUROENDOCRINOL, V20, P1115, DOI 10.1111/j.1365-2826.2008.01772.x; Lawrence NS, 2009, CEREB CORTEX, V19, P1134, DOI 10.1093/cercor/bhn154; Li X, HUM BRAIN MAPP, V31, P410; Lin CH, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-72; Liston C, 2006, J NEUROSCI, V26, P7870, DOI 10.1523/JNEUROSCI.1184-06.2006; Liu D, 2000, NAT NEUROSCI, V3, P799, DOI 10.1038/77702; Liu D, 1997, SCIENCE, V277, P1659, DOI 10.1126/science.277.5332.1659; Mainen ZF, 2009, CURR OPIN NEUROBIOL, V19, P84, DOI 10.1016/j.conb.2009.03.010; MANN JJ, 1995, NEUROPSYCHOPHARMACOL, V13, P53, DOI 10.1016/0893-133X(95)00016-7; McClure SM, 2004, SCIENCE, V306, P503, DOI 10.1126/science.1100907; Meaney MJ, 2001, ANNU REV NEUROSCI, V24, P1161, DOI 10.1146/annurev.neuro.24.1.1161; Miu AC, 2008, BIOL PSYCHOL, V77, P353, DOI 10.1016/j.biopsycho.2007.11.010; Monroy E, 2010, J CHEM NEUROANAT, V40, P93, DOI 10.1016/j.jchemneu.2010.05.005; MOORE CL, 1979, J COMP PHYSIOL PSYCH, V93, P677, DOI 10.1037/h0077599; Nagai M, 2007, EUR PSYCHIAT, V22, P387, DOI 10.1016/j.eurpsy.2007.02.006; Naqvi NH, 2009, TRENDS NEUROSCI, V32, P56, DOI 10.1016/j.tins.2008.09.009; Nikolaus S, 2010, REV NEUROSCIENCE, V21, P119; Niwa M, 2010, INT J NEUROPSYCHOPH, P1, DOI DOI 10.1017/S1461145710001239.[; Nutt DJ, 2001, J CLIN PSYCHIAT, V62, P22; Ongur D, 2000, CEREB CORTEX, V10, P206, DOI 10.1093/cercor/10.3.206; Overman WH, 2004, BRAIN COGNITION, V55, P134, DOI 10.1016/s0278-2626(03)00279-3; Overman W, 2006, BEHAV NEUROSCI, V120, P817, DOI 10.1037/0735-7044.120.4.817; Pais-Vieira M, 2007, NEUROSCIENCE, V145, P225, DOI 10.1016/j.neuroscience.2006.11.058; Pascual R, 2007, ACTA NEUROBIOL EXP, V67, P471; Paulus MP, 2003, NEUROIMAGE, V19, P1439, DOI 10.1016/S1053-8119(03)00251-9; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V5th Edn, DOI 10.1016/c2009-0-63235-9; Pechtel P, 2010, PSYCHOPHARMACOLOGY B; Preuschoff K, 2008, J NEUROSCI, V28, P2745, DOI 10.1523/JNEUROSCI.4286-07.2008; Pryce CR, 2001, DEV PSYCHOBIOL, V38, P239, DOI 10.1002/dev.1018; Ragozzino ME, 1999, J NEUROSCI, V19, P4585; Ragozzino ME, 1999, BEHAV BRAIN RES, V98, P103; Reavis R, 2001, BEHAV NEUROSCI, V115, P196, DOI 10.1037//0735-7044.115.1.196; Reynolds SM, 2005, J NEUROSCI, V25, P11757, DOI 10.1523/JNEUROSCI.3432-05.2005; Rivalan M, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00022; Rogers MA, 2004, NEUROSCI RES, V50, P1, DOI 10.1016/j.neures.2004.05.003; Rolls ET, 2008, PROG NEUROBIOL, V86, P216, DOI 10.1016/j.pneurobio.2008.09.001; Salamone JD, 1996, J NEUROSCI METH, V64, P137, DOI 10.1016/0165-0270(95)00125-5; Schoenbaum G, 2003, NEURON, V39, P855, DOI 10.1016/S0896-6273(03)00474-4; Shansky RM, 2009, BRAIN RES, V1293, P108, DOI 10.1016/j.brainres.2009.03.062; Sul JH, 2010, NEURON, V66, P449, DOI 10.1016/j.neuron.2010.03.033; Sullivan RM, 2002, PSYCHONEUROENDOCRINO, V27, P99, DOI 10.1016/S0306-4530(01)00038-5; Takahashi YK, 2009, NEURON, V62, P269, DOI 10.1016/j.neuron.2009.03.005; Tanaka SC, 2004, NAT NEUROSCI, V7, P887, DOI 10.1038/nn1279; Todtenkopf MS, 2006, J NEUROSCI, V26, P11665, DOI 10.1523/JNEUROSCI.3070-06.2006; Tran-Tu-Yen DAS, 2009, EUR J NEUROSCI, V30, P464, DOI 10.1111/j.1460-9568.2009.06834.x; van den Bos R, 2006, BIOL PSYCHOL, V71, P155, DOI 10.1016/j.biopsycho.2005.05.003; Van den Bos R, 2012, HDB PSYCHOL DECISION; Van den Bos R, 2006, BEHAV RES METHODS, V38, P470, DOI 10.3758/BF03192801; van den Bos R, 2009, PSYCHONEUROENDOCRINO, V34, P1449, DOI 10.1016/j.psyneuen.2009.04.016; van Hasselt FN, 2012, J NEUROENDOCRINOL, V24, P331, DOI 10.1111/j.1365-2826.2011.02233.x; van Hasselt FN, 2012, HIPPOCAMPUS, V22, P255, DOI 10.1002/hipo.20892; van Hasselt FN, 2012, PHYSL BEHAV; Weaver ICG, 2006, P NATL ACAD SCI USA, V103, P3480, DOI 10.1073/pnas.0507526103; Weller JA, 2009, SOC NEUROSCI-UK, V4, P347, DOI 10.1080/17470910902934400; Xue G, 2010, NEUROIMAGE, V50, P709, DOI 10.1016/j.neuroimage.2009.12.097; Young JJ, 2009, BEHAV NEUROSCI, V123, P1028, DOI 10.1037/a0016822; Yu RJ, 2010, J NEUROSCI, V30, P14702, DOI 10.1523/JNEUROSCI.3772-10.2010; Zeeb FD, 2011, J NEUROSCI, V31, P2197, DOI 10.1523/JNEUROSCI.5597-10.2011	97	34	34	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e37820	10.1371/journal.pone.0037820	http://dx.doi.org/10.1371/journal.pone.0037820			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693577	Green Submitted, Green Published, gold			2022-12-27	WOS:000305338500058
J	Wu, J; Wu, TH; Han, RP; Chang, SJ; Shih, CT; Sun, JY; Hsu, SM				Wu, Jay; Wu, Tung H.; Han, Rou P.; Chang, Shu J.; Shih, Cheng T.; Sun, Jing Y.; Hsu, Shih M.			Comparison of the Commercial Color LCD and the Medical Monochrome LCD Using Randomized Object Test Patterns	PLOS ONE			English	Article							LIQUID-CRYSTAL DISPLAYS; PERFORMANCE; MONITORS; QUALITY; IMAGES; WORKSTATION; EMERGENCY; CONTRAST; SYSTEMS; GRADE	Workstations and electronic display devices in a picture archiving and communication system (PACS) provide a convenient and efficient platform for medical diagnosis. The performance of display devices has to be verified to ensure that image quality is not degraded. In this study, we designed a set of randomized object test patterns (ROTPs) consisting of randomly located spheres with various image characteristics to evaluate the performance of a 2.5 mega-pixel (MP) commercial color LCD and a 3 MP diagnostic monochrome LCD in several aspects, including the contrast, resolution, point spread effect, and noise. The ROTPs were then merged into 120 abdominal CT images. Five radiologists were invited to review the CT images, and receiver operating characteristic (ROC) analysis was carried out using a five-point rating scale. In the high background patterns of ROTPs, the sensitivity performance was comparable between both monitors in terms of contrast and resolution, whereas, in the low background patterns, the performance of the commercial color LCD was significantly poorer than that of the diagnostic monochrome LCD in all aspects. The average area under the ROC curve (AUC) for reviewing abdominal CT images was 0.717 +/- 0.0200 and 0.740 +/- 0.0195 for the color monitor and the diagnostic monitor, respectively. The observation time (OT) was 145 +/- 27.6 min and 127 +/- 19.3 min, respectively. No significant differences appeared in AUC (p = 0.265) and OT (p = 0.07). The overall results indicate that ROTPs can be implemented as a quality control tool to evaluate the intrinsic characteristics of display devices. Although there is still a gap in technology between different types of LCDs, commercial color LCDs could replace diagnostic monochrome LCDs as a platform for reviewing abdominal CT images after monitor calibration.	[Wu, Jay; Hsu, Shih M.] China Med Univ, Coll Hlth Care, Dept Biomed Imaging & Radiol Sci, Taichung, Taiwan; [Wu, Tung H.; Sun, Jing Y.] Natl Yang Ming Univ, Dept Biomed Imaging & Radiol Sci, Taipei 112, Taiwan; [Han, Rou P.] Cent Taiwan Univ Sci & Technol, Dept Management Informat Syst, Taichung, Taiwan; [Chang, Shu J.] Inst Nucl Energy Res, Div Hlth Phys, Longtan, Taiwan; [Shih, Cheng T.] Natl Tsing Hua Univ, Dept Biomed Engn & Environm Sci, Hsinchu, Taiwan	China Medical University Taiwan; National Yang Ming Chiao Tung University; Central Taiwan University Science & Technology; Institute of Nuclear Energy Research - Taiwan; National Tsing Hua University	Wu, J (corresponding author), China Med Univ, Coll Hlth Care, Dept Biomed Imaging & Radiol Sci, Taichung, Taiwan.	smhsu@mail.cmu.edu.tw	Shih, Cheng-Ting/Q-2842-2019	Shih, Cheng-Ting/0000-0002-8554-9136	National Science Council of Taiwan [NSC 100-2320-B-039-037]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	Funding was received from the National Science Council of Taiwan under Contract no. NSC 100-2320-B-039-037. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACR, 2007, TECHN STAND EL PRACT; Aldrich JE, 2005, J DIGIT IMAGING, V18, P287, DOI 10.1007/s10278-005-6974-7; American Association of Physicists in Medicine (AAPM), 2005, ASS DISPL PERF MED I; Badano A, 2003, MED PHYS, V30, P2602, DOI 10.1118/1.1606449; Brem MH, 2006, EMERG MED J, V23, P850, DOI 10.1136/emj.2006.036822; Chen TJ, 2004, COMPUT MED IMAG GRAP, V28, P167, DOI 10.1016/j.compmedimag.2004.01.003; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; DICOM, 2000, GRAYSC DIPL STAND 14; Doyle AJ, 2002, ACAD RADIOL, V9, P646, DOI 10.1016/S1076-6332(03)80309-4; Geijer H, 2007, J DIGIT IMAGING, V20, P114, DOI 10.1007/s10278-007-9028-5; Huang HK, 2010, PACS IMAGING INFORM; McDonald L, 2006, CAN ASSOC RADIOL J, V57, P30; Ong AHJ, 2011, J MED IMAG RADIAT ON, V55, P153, DOI 10.1111/j.1754-9485.2011.02245.x; Samei E, 2006, MED PHYS, V33, P645, DOI 10.1118/1.2168430; SCOTT WW, 1995, RADIOLOGY, V195, P223, DOI 10.1148/radiology.195.1.7892474; SMPTE, 1991, RP133 SMPTE; Tsalafoutas IA, 2004, BRIT J RADIOL, V77, P52, DOI 10.1259/bjr/62332261; Uemura Masanobu, 2006, Radiat Med, V24, P653, DOI 10.1007/s11604-006-0085-3; Wade C, 2004, BRIT J RADIOL, V77, P465, DOI 10.1259/bjr/18928981; Wang JH, 2003, J DIGIT IMAGING, V16, P185, DOI 10.1007/s10278-003-1657-8; Yamaguchi M, 2005, EUR RADIOL, V15, P2487, DOI 10.1007/s00330-005-2880-0; Yamaguchi M, 2004, EUR RADIOL, V14, P2357, DOI 10.1007/s00330-004-2315-3	22	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e37769	10.1371/journal.pone.0037769	http://dx.doi.org/10.1371/journal.pone.0037769			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22701534	Green Submitted, Green Published, gold			2022-12-27	WOS:000305338500055
J	Wei, H; Kamat, A; Chen, M; Ke, HL; Chang, DW; Yin, JK; Grossman, HB; Dinney, CP; Wu, XF				Wei, Hua; Kamat, Ashish; Chen, Meng; Ke, Hung-Lung; Chang, David W.; Yin, Jikai; Grossman, H. Barton; Dinney, Colin P.; Wu, Xifeng			Association of Polymorphisms in Oxidative Stress Genes with Clinical Outcomes for Bladder Cancer Treated with Bacillus Calmette-Guerin	PLOS ONE			English	Article							TRANSITIONAL-CELL CARCINOMA; HUMAN DNA GLYCOSYLASE; NITRIC-OXIDE; RECURRENCE; SURVIVAL; PATHWAY; DISEASE; REPAIR; DAMAGE; TA	Genetic polymorphisms in oxidative stress pathway genes may contribute to carcinogenesis, disease recurrence, treatment response, and clinical outcomes. We applied a pathway-based approach to determine the effects of multiple single nucleotide polymorphisms (SNPs) within this pathway on clinical outcomes in non-muscle-invasive bladder cancer (NMIBC) patients treated with Bacillus Calmette-Guerin (BCG). We genotyped 276 SNPs in 38 genes and evaluated their associations with clinical outcomes in 421 NMIBC patients. Twenty-eight SNPs were associated with recurrence in the BCG-treated group (P<0.05). Six SNPs, including five in NEIL2 gene from the overall and BCG group remained significantly associated with recurrence after multiple comparison adjustments (q<0.1). Cumulative unfavorable genotype analysis showed that the risk of recurrence increased with increasing number of unfavorable genotypes. In the analysis of risk factors associated with progression to disease, rs3890995 in UNG, remained significant after adjustment for multiple comparison (q<0.1). These results support the hypothesis that genetic variations in host oxidative stress genes in NMIBC patients may affect response to therapy with BCG.	[Wei, Hua; Chen, Meng; Ke, Hung-Lung; Chang, David W.; Yin, Jikai; Wu, Xifeng] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Kamat, Ashish; Grossman, H. Barton; Dinney, Colin P.] Univ Texas MD Anderson Canc Ctr, Dept Urol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Wei, H (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA.	xwu@mdanderson.org	Ke, Hung-Lung/HCH-9079-2022	Dinney, Colin/0000-0002-8969-711X	National Institutes of Health/National Cancer Institute [U01 CA 127615, R01 CA 74880, P50 CA 91846, R01 CA 131335]; NATIONAL CANCER INSTITUTE [U01CA127615, R01CA131335, R01CA074880, P50CA091846] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024148] Funding Source: NIH RePORTER	National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Supported by grants from National Institutes of Health/National Cancer Institute: U01 CA 127615, R01 CA 74880, P50 CA 91846, and R01 CA 131335 (http://www.cancer.gov/researchandfunding). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babjuk M, 2008, EUR UROL, V54, P303, DOI 10.1016/j.eururo.2008.04.051; Bandaru V, 2002, DNA REPAIR, V1, P517, DOI 10.1016/S1568-7864(02)00036-8; Brausi M, 2002, EUR UROL, V41, P523, DOI 10.1016/S0302-2838(02)00068-4; Chen M, 2010, CANC PREV RES PHILA; Chen M, 2010, CANCER PREV RES, V3, P1235, DOI 10.1158/1940-6207.CAPR-10-0035; Chen M, 2009, CARCINOGENESIS, V30, P2047, DOI 10.1093/carcin/bgp258; Chiong E, 2011, CLIN CANCER RES, V17, P2863, DOI 10.1158/1078-0432.CCR-09-3202; Choi JY, 2009, CLIN CANCER RES, V15, P5258, DOI 10.1158/1078-0432.CCR-09-0685; FARIASEISNER R, 1994, P NATL ACAD SCI USA, V91, P9407, DOI 10.1073/pnas.91.20.9407; Hazra TK, 2002, J BIOL CHEM, V277, P30417, DOI 10.1074/jbc.C200355200; Kinslow CJ, 2008, GENE CHROMOSOME CANC, V47, P923, DOI 10.1002/gcc.20594; Kinslow CJ, 2009, MUTAGENESIS; Lamm DL, 2000, J UROLOGY, V163, P1124, DOI 10.1016/S0022-5347(05)67707-5; Lurie G, 2008, CANCER EPIDEM BIOMAR, V17, P2070, DOI 10.1158/1055-9965.EPI-08-0145; Mena S, 2009, MUTAT RES-GEN TOX EN, V674, P36, DOI 10.1016/j.mrgentox.2008.09.017; Mikhak B, 2008, CARCINOGENESIS, V29, P2335, DOI 10.1093/carcin/bgn212; Pearl LH, 2000, MUTAT RES-DNA REPAIR, V460, P165, DOI 10.1016/S0921-8777(00)00025-2; Ropolo M, 2006, INT J CANCER, V118, P1628, DOI 10.1002/ijc.21554; Siegel R., 2011, CA CANC J CLIN; Sylvester RJ, 2006, EUR UROL, V49, P466, DOI 10.1016/j.eururo.2005.12.031; Udler M, 2007, J CLIN ONCOL, V25, P3015, DOI 10.1200/JCO.2006.10.0099; Valavanidis A, 2009, J ENVIRON SCI HEAL C, V27, P120, DOI 10.1080/10590500902885684; van Rhijn BWG, 2009, EUR UROL, V56, P430, DOI 10.1016/j.eururo.2009.06.028; Wellen KE, 2010, MOL CELL, V40, P323, DOI 10.1016/j.molcel.2010.10.004; Winnepenninckx VR, 2006, JNCI-J NATL CANCER I, V98, P472, DOI 10.1093/jnci/djj103; Yue P, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-166	26	24	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2012	7	6							e38533	10.1371/journal.pone.0038533	http://dx.doi.org/10.1371/journal.pone.0038533			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UJ	22701660	gold, Green Published, Green Submitted			2022-12-27	WOS:000305340000029
J	Yun, HY; Engelen, AH; Santos, RO; Molis, M				Yun, Hee Young; Engelen, Aschwin H.; Santos, Rui O.; Molis, Markus			Water-Borne Cues of a Non-Indigenous Seaweed Mediate Grazer-Deterrent Responses in Native Seaweeds, but Not Vice Versa	PLOS ONE			English	Article							INDUCED PLANT-RESPONSES; INDUCED RESISTANCE; CHEMICAL DEFENSE; FUCUS-VESICULOSUS; WILD TOBACCO; HERBIVORES; INDUCTION; EVOLUTION; SAGEBRUSH; ECOLOGY	Plants optimise their resistance to herbivores by regulating deterrent responses on demand. Induction of anti-herbivory defences can occur directly in grazed plants or from emission of risk cues to the environment, which modifies interactions of adjacent plants with, for instance, their consumers. This study confirmed the induction of anti-herbivory responses by water-borne risk cues between adjoining con-specific seaweeds and firstly examined whether plant-plant signalling also exists among adjacent hetero-specific seaweeds. Furthermore, differential abilities and geographic variation in plant-plant signalling by a non-indigenous seaweed as well as native seaweeds were assessed. Twelve-day induction experiments using the non-indigenous seaweed Sargassum muticum were conducted in the laboratory in Portugal and Germany with one local con-familiar (Portugal: Cystoseira humilis, Germany: Halidrys siliquosa) and hetero-familiar native species (Portugal: Fucus spiralis, Germany: F. vesiculosus). All seaweeds were grazed by a local isopod species (Portugal: Stenosoma nadejda, Germany: Idotea baltica) and were positioned upstream of con-and hetero-specific seaweeds. Grazing-induced modification in seaweed traits were tested in three-day feeding assays between cue-exposed and cue-free (= control) pieces of both fresh and reconstituted seaweeds. Both Fucus species reduced their palatability when positioned downstream of isopod-grazed con-specifics. Yet, the palatability of non-indigenous S. muticum remained constant in the presence of upstream grazed con-specifics and native hetero-specifics. In contrast, both con-familiar (but neither hetero-familiar) native species reduced palatability when located downstream of grazed S. muticum. Similar patterns of grazer-deterrent responses to water-borne cues were observed on both European shores, and were almost identical between assays using fresh and reconstituted seaweeds. Hence, seaweeds may use plant-plant signalling to optimise chemical resistance to consumers, though this ability appeared to be species-specific. Furthermore, this study suggests that native species may benefit more than a non-indigenous species from water-borne cue mediated reduction in consumption as only natives responded to signals emitted by hetero-specifics.	[Yun, Hee Young; Molis, Markus] Alfred Wegener Inst Polar & Marine Res, Sect Funct Ecol, Helgoland, Germany; [Engelen, Aschwin H.; Santos, Rui O.] Univ Algarve, Ctr Marine Sci, Marine Plant Ecol Res Grp, Faro, Portugal	Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Universidade do Algarve	Yun, HY (corresponding author), Alfred Wegener Inst Polar & Marine Res, Sect Funct Ecol, Helgoland, Germany.	hyyun77@gmail.com	Engelen, Aschwin H/M-3432-2013; Santos, Rui O P/B-4168-2008	Engelen, Aschwin H/0000-0002-9579-9606; Santos, Rui O P/0000-0002-7861-4366	Portuguese Science Foundation (Fundacao para a Ciencia e a Tecnologia, FCT) under Programa Operacional Ciencia e Inovacao do Quadro Comunitario de Apoio III e comparticipado pelo Fundo Comunitario Europeu FEDER [POCI/MAR/55377/2004]; FCT scholarships [SFRH/BPD/7153/2001, SFRH/BPD/63703/2009]; Fundação para a Ciência e a Tecnologia [POCI/MAR/55377/2004] Funding Source: FCT	Portuguese Science Foundation (Fundacao para a Ciencia e a Tecnologia, FCT) under Programa Operacional Ciencia e Inovacao do Quadro Comunitario de Apoio III e comparticipado pelo Fundo Comunitario Europeu FEDER; FCT scholarships(Portuguese Foundation for Science and Technology); Fundação para a Ciência e a Tecnologia	The Portuguese part of the study was funded by research grant POCI/MAR/55377/2004 of the Portuguese Science Foundation (Fundacao para a Ciencia e a Tecnologia, FCT) financed under the 'Programa Operacional Ciencia e Inovacao 2010 (POCI 2010) do Quadro Comunitario de Apoio III e comparticipado pelo Fundo Comunitario Europeu FEDER'. AHE was supported by FCT scholarships SFRH/BPD/7153/2001 and SFRH/BPD/63703/2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER FR, 1994, AM NAT, V144, P813, DOI 10.1086/285708; Agrawal AA, 2000, OIKOS, V89, P493, DOI 10.1034/j.1600-0706.2000.890308.x; BRAWLEY SH, 1992, SYST ASSOC SPEC VOL, V46, P235; Buschbaum C, 2006, MAR BIOL, V148, P743, DOI 10.1007/s00227-005-0128-9; Cronin G, 2001, CRC MAR SCI, P325; Cronin G, 1996, ECOLOGY, V77, P1531, DOI 10.2307/2265549; CYR H, 1993, NATURE, V361, P148, DOI 10.1038/361148a0; Dolch R, 2000, OECOLOGIA, V125, P504, DOI 10.1007/s004420000482; Domisch S, 2008, THESIS C VONOSSIETZK; Engelberth J, 2004, P NATL ACAD SCI USA, V101, P1781, DOI 10.1073/pnas.0308037100; Engelen A, 2009, J ECOL, V97, P675, DOI 10.1111/j.1365-2745.2009.01501.x; Engelen AH, 2011, HYDROBIOLOGIA, V669, P157, DOI 10.1007/s10750-011-0680-x; Glinwood R, 2004, ECOL ENTOMOL, V29, P188, DOI 10.1111/j.0307-6946.2004.00582.x; Haavisto F, 2010, OECOLOGIA, V162, P685, DOI 10.1007/s00442-009-1494-7; Hay ME, 1996, J EXP MAR BIOL ECOL, V200, P103, DOI 10.1016/S0022-0981(96)02659-7; Hay ME, 2004, ANNU REV ECOL EVOL S, V35, P175, DOI 10.1146/annurev.ecolsys.34.011802.132357; HAY ME, 1994, ECOLOGY, V75, P1714, DOI 10.2307/1939631; HAY ME, 1991, TRENDS ECOL EVOL, V6, P362, DOI 10.1016/0169-5347(91)90227-O; Heil M, 2010, TRENDS ECOL EVOL, V25, P137, DOI 10.1016/j.tree.2009.09.010; Hemmi A, 2004, MAR ECOL PROG SER, V273, P109, DOI 10.3354/meps273109; Karban R, 1999, TRENDS ECOL EVOL, V14, P443, DOI 10.1016/S0169-5347(99)01678-X; Karban R, 2000, OECOLOGIA, V125, P66, DOI 10.1007/PL00008892; Karban R, 2006, ECOLOGY, V87, P922, DOI 10.1890/0012-9658(2006)87[922:DRISVA]2.0.CO;2; Karban R, 2004, ECOLOGY, V85, P1846, DOI 10.1890/03-0593; Karban R, 2004, EVOL ECOL, V18, P283, DOI 10.1023/B:EVEC.0000035063.70344.03; Karban R, 2003, OIKOS, V100, P325, DOI 10.1034/j.1600-0706.2003.12075.x; Karban R., 1997, INDUCED RESPONSES HE, DOI 10.7208/chicago/9780226424972.001.0001; Karban R, 2011, FUNCT ECOL, V25, P339, DOI 10.1111/j.1365-2435.2010.01789.x; Karez R, 2000, MAR ECOL PROG SER, V205, P85, DOI 10.3354/meps205085; KORNMANN P, 1994, HELGOLANDER MEERESUN, V48, P365, DOI 10.1007/BF02366253; Long JD, 2007, ECOLOGY, V88, P1232, DOI 10.1890/06-1585; Macaya EC, 2005, J EXP MAR BIOL ECOL, V325, P214, DOI 10.1016/j.jembe.2005.05.004; Malin G., 2001, Journal of Phycology, V37, P32; Ohgushi T, 2005, ANNU REV ECOL EVOL S, V36, P81, DOI 10.1146/annurev.ecolsys.36.091704.175523; Pavia H, 2000, ECOLOGY, V81, P3212; Rohde S, 2004, J ECOL, V92, P1011, DOI 10.1111/j.0022-0477.2004.00936.x; Rohde S, 2008, J PHYCOL, V44, P85, DOI 10.1111/j.1529-8817.2007.00451.x; Rohde S, 2008, J EXP MAR BIOL ECOL, V367, P227, DOI 10.1016/j.jembe.2008.10.003; SEELEY RH, 1986, P NATL ACAD SCI USA, V83, P6897, DOI 10.1073/pnas.83.18.6897; SOLER M, 1990, NATURE, V343, P748, DOI 10.1038/343748a0; Sotka EE, 2002, J EXP MAR BIOL ECOL, V277, P1, DOI 10.1016/S0022-0981(02)00128-4; Steneck RS, 2002, ENVIRON CONSERV, V29, P436, DOI 10.1017/S0376892902000322; TOLLRIAN R, 1999, ECOLOGY EVOLUTION IN; Toth GB, 2000, P NATL ACAD SCI USA, V97, P14418, DOI 10.1073/pnas.250226997; Toth GB, 2007, J ECOL, V95, P425, DOI 10.1111/j.1365-2745.2007.01224.x; Van Zandt PA, 2004, ECOLOGY, V85, P2616, DOI 10.1890/03-0622; Vandendriessche S, 2006, MAR BIOL, V149, P1499, DOI 10.1007/s00227-006-0292-6; VERMEIJ GJ, 1982, NATURE, V299, P349, DOI 10.1038/299349a0; Wiesemeier T, 2007, AQUAT SCI, V69, P403, DOI 10.1007/s00027-007-0889-y; Wittstock U, 2002, CURR OPIN PLANT BIOL, V5, P300, DOI 10.1016/S1369-5266(02)00264-9; Xavier R, 2009, MOL ECOL, V18, P3283, DOI 10.1111/j.1365-294X.2009.04260.x; Yun HY, 2010, MAR ECOL PROG SER, V408, P47, DOI 10.3354/meps08561	52	8	8	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2012	7	6							e38804	10.1371/journal.pone.0038804	http://dx.doi.org/10.1371/journal.pone.0038804			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UJ	22701715	gold, Green Submitted, Green Published			2022-12-27	WOS:000305340000047
J	Enk, MJ; Silva, GOE; Rodrigues, NB				Enk, Martin Johannes; Oliveira e Silva, Guilherme; Rodrigues, Nilton Barnabe			Diagnostic Accuracy and Applicability of a PCR System for the Detection of Schistosoma mansoni DNA in Human Urine Samples from an Endemic Area	PLOS ONE			English	Article							KATO-KATZ TECHNIQUE; POLYMERASE-CHAIN-REACTION; FECAL EGG COUNTS; DAY-TO-DAY; STOOL SAMPLES; INFECTION; PRAZIQUANTEL; HAEMATOBIUM; JAPONICA; ANTIGENS	Schistosomiasis caused by Schistosoma mansoni, one of the most neglected human parasitoses in Latin America and Africa, is routinely confirmed by microscopic visualization of eggs in stool. The main limitation of this diagnostic approach is its lack of sensitivity in detecting individual low worm burdens and consequently data on infection rates in low transmission settings are little reliable. According to the scientific literature, PCR assays are characterized by high sensitivity and specificity in detecting parasite DNA in biological samples. A simple and cost effective extraction method for DNA of Schistosoma mansoni from urine samples in combination with a conventional PCR assay was developed and applied in an endemic area. This urine based PCR system was tested for diagnostic accuracy among a population of a small village in an endemic area, comparing it to a reference test composed of three different parasitological techniques. The diagnostic parameters revealed a sensitivity of 100%, a specificity of 91.20%, positive and negative predictive values of 86.25% and 100%, respectively, and a test accuracy of 94.33%. Further statistical analysis showed a k index of 0.8806, indicating an excellent agreement between the reference test and the PCR system. Data obtained from the mouse model indicate the infection can be detected one week after cercariae penetration, opening a new perspective for early detection and patient management during this stage of the disease. The data indicate that this innovative PCR system provides a simple to handle and robust diagnostic tool for the detection of S. mansoni DNA from urine samples and a promising approach to overcome the diagnostic obstacles in low transmission settings. Furthermore the principals of this molecular technique, based on the examination of human urine samples may be useful for the diagnosis of other neglected tropical diseases that can be detected by trans-renal DNA.	[Enk, Martin Johannes] Fiocruz MS, Lab Esquistossomose, Ctr Pesquisas Rene Rachou, Belo Horizonte, MG, Brazil; [Enk, Martin Johannes; Rodrigues, Nilton Barnabe] Univ Vale Rio Doce, Lab Parasitol, Governador Valadares, MG, Brazil; [Oliveira e Silva, Guilherme; Rodrigues, Nilton Barnabe] Fiocruz MS, Ctr Pesquisas Rene Rachou, Lab Imunol Celular & Mol, Minas, Gerais, Brazil	Fundacao Oswaldo Cruz; University Vale Rio Doce; Fundacao Oswaldo Cruz	Enk, MJ (corresponding author), Fiocruz MS, Lab Esquistossomose, Ctr Pesquisas Rene Rachou, Belo Horizonte, MG, Brazil.	marenk@cpqrr.fiocruz.br	Enk, Martin Johannes/J-6400-2012	Enk, Martin Johannes/0000-0002-3209-1758	Conselho Nacional de Pesquisa; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais; Fundacao Oswaldo Cruz	Conselho Nacional de Pesquisa; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Fundacao Oswaldo Cruz	This study received financial support from the Conselho Nacional de Pesquisa, Fundacao de Amparo a Pesquisa do Estado de Minas Gerais, and Fundacao Oswaldo Cruz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergquist R, 2009, TRENDS PARASITOL, V25, P151, DOI 10.1016/j.pt.2009.01.004; Berhe N, 2004, ACTA TROP, V92, P205, DOI 10.1016/j.actatropica.2004.06.011; Bligh J, 2010, ANN TROP MED PARASIT, V104, P511, DOI 10.1179/136485910X12786389891245; Booth M, 2003, PARASITOLOGY, V127, P525, DOI 10.1017/S0031182003004128; Cesari IM, 2010, PARASITOL RES, V106, P1225, DOI 10.1007/s00436-010-1798-x; Coelho PMZ, 2009, MEM I OSWALDO CRUZ, V104, P720, DOI 10.1590/S0074-02762009000500010; Corachan M, 2002, CLIN INFECT DIS, V35, P446, DOI 10.1086/341895; Coura JR, 2004, MEM I OSWALDO CRUZ, V99, P13, DOI 10.1590/S0074-02762004000900003; Dean A G, 2010, OPENEPI OPEN SOURCE; DEVLAS SJ, 1992, PARASITOL TODAY, V8, P274, DOI 10.1016/0169-4758(92)90144-Q; Gomes ALD, 2006, MEM I OSWALDO CRUZ, V101, P133, DOI 10.1590/S0074-02762006000900021; Doenhoff MJ, 2004, TRENDS PARASITOL, V20, P35, DOI 10.1016/j.pt.2003.10.019; Engels D, 2002, ACTA TROP, V82, P139, DOI 10.1016/S0001-706X(02)00045-1; Engels D, 1996, AM J TROP MED HYG, V54, P319, DOI 10.4269/ajtmh.1996.54.319; Enk Martin J, 2010, BMC Res Notes, V3, P115, DOI 10.1186/1756-0500-3-115; Enk MJ, 2008, ACTA TROP, V108, P222, DOI 10.1016/j.actatropica.2008.09.016; Enk MJ, 2010, ANN 12 INT S SCHIST; FELDMEIER H, 1993, ACTA TROP, V52, P205, DOI 10.1016/0001-706X(93)90009-Z; FELDMEIER H, 1983, ZBL BAKT-INT J MED M, V255, P413, DOI 10.1016/S0174-3031(83)80185-1; Gomes LI, 2009, MEM I OSWALDO CRUZ, V104, P1194, DOI 10.1590/S0074-02762009000800021; Gomes LI, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000664; Gryseels B, 2006, LANCET, V368, P1106, DOI 10.1016/S0140-6736(06)69440-3; HAMBURGER J, 1991, MOL BIOCHEM PARASIT, V44, P73, DOI 10.1016/0166-6851(91)90222-R; Hotez PJ, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000300; Jurberg AD, 2008, MEM I OSWALDO CRUZ, V103, P112, DOI 10.1590/S0074-02762008005000005; Katz N, 1972, Rev Inst Med Trop Sao Paulo, V14, P397; King CH, 2008, CHRONIC ILLN, V4, P65, DOI 10.1177/1742395307084407; King CH, 2010, ACTA TROP, V113, P95, DOI 10.1016/j.actatropica.2009.11.012; Kongs A, 2001, TROP MED INT HEALTH, V6, P163, DOI 10.1046/j.1365-3156.2001.00687.x; Lambertucci JR, 2007, REV SOC BRAS MED TRO, V40, P574, DOI 10.1590/S0037-86822007000500016; LANDIS JR, 1977, BIOMETRICS, V33, P363, DOI 10.2307/2529786; Luo QL, 2009, ACTA TROP, V112, P91, DOI 10.1016/j.actatropica.2009.06.011; Melkonyan HS, 2008, ANN NY ACAD SCI, V1137, P73, DOI 10.1196/annals.1448.015; Pontes LA, 2003, AM J TROP MED HYG, V68, P652, DOI 10.4269/ajtmh.2003.68.652; Pontes LA, 2002, AM J TROP MED HYG, V66, P157, DOI 10.4269/ajtmh.2002.66.157; Rabello AL, 2005, REPORT SCI WORKING G, P67; RABELLO ALT, 1992, MEM I OSWALDO CRUZ, V87, P325, DOI 10.1590/S0074-02761992000800052; Sandoval N, 2006, PARASITOLOGY, V133, P581, DOI 10.1017/S0031182006000898; Sandoval N, 2006, EXP PARASITOL, V114, P84, DOI 10.1016/j.exppara.2006.02.012; SANGUINETTI CJ, 1994, BIOTECHNIQUES, V17, P914; Steinmann P, 2006, LANCET INFECT DIS, V6, P411, DOI 10.1016/S1473-3099(06)70521-7; ten Hove RJ, 2008, T ROY SOC TROP MED H, V102, P179, DOI 10.1016/j.trstmh.2007.10.011; Umansky SR, 2006, EXPERT REV MOL DIAGN, V6, P153, DOI 10.1586/14737159.6.2.153; Utzinger J, 2000, LANCET, V355, P1320, DOI 10.1016/S0140-6736(00)02114-0; Utzinger J, 2001, PARASITOLOGY, V122, P537, DOI 10.1017/S0031182001007752; Wichmann D, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000422; Yu J, 1998, AM J TROP MED HYG, V59, P370, DOI 10.4269/ajtmh.1998.59.370; Zhong ZR, 2010, ACTA TROP, V116, P1, DOI 10.1016/j.actatropica.2010.04.014; Zhou YB, 2008, ACTA TROP, V107, P251, DOI 10.1016/j.actatropica.2008.06.009	49	60	62	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2012	7	6							e38947	10.1371/journal.pone.0038947	http://dx.doi.org/10.1371/journal.pone.0038947			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TU	22701733	gold, Green Submitted, Green Published			2022-12-27	WOS:000305337600060
J	Tang, YM; Luo, DH; Rong, XM; Shi, XL; Peng, Y				Tang, Yamei; Luo, Donghua; Rong, Xiaoming; Shi, Xiaolei; Peng, Ying			Psychological Disorders, Cognitive Dysfunction and Quality of Life in Nasopharyngeal Carcinoma Patients with Radiation-Induced Brain Injury	PLOS ONE			English	Article							EMOTIONAL STATUS; CANCER-PATIENTS; RADIOTHERAPY; THERAPY; IMPACT; RADIONECROSIS; DEPRESSION; ANXIETY	Purpose: To evaluate factors affecting psychology, cognitive function and quality of life (QOL) of nasopharyngeal carcinoma (NPC) patients with radiation-induced brain injury (RI). Methods and Materials: 46 recurrence-free NPC patients with RI and 46 matched control patients without RI were recruited in our study. Subjective and objective symptoms of RI were evaluated with the LENT/SOMA systems. Psychological assessment was measured with Self-Rating Anxiety Scale (SAS) and Self-Rating Depression Scale (SDS). Montreal Cognitive Assessment (MoCA) was carried out in these patients for assessing their cognitive function. QOL was evaluated by means of WHOQOL BREF. Results: Of the patients with RI, 39(84.8%) had depression and 40(87.0%) had anxiety. The patients with RI got higher scores both in SDS and SAS than those without RI (SDS, 63.48 +/- 8.11vs. 58.67 +/- 7.52, p = 0.008; SAS, 67.36 +/- 10.41vs. 60.34 +/- 9.76, p = 0.005). Score in MoCA of patients with RI was significantly lower than that of patients without RI (21.32 +/- 2.45vs. 25.98 +/- 1.73, p<0.001). SAS was positive correlated with post-radiotherapy interval. Both SAS and SDS had a significantly positive correlation with the rank of SOMA, while MoCA had a significantly negative correlation with SOMA. Chemotherapy was a risk factor for cognitive dysfunction. In addition, patients with RI got significantly lower scores in physical health (16.50 +/- 11.05 vs. 35.02 +/- 10.43, p<0.001), psychological health (17.70 +/- 10.33 vs. 39.48 +/- 12.00, p<0.001) and social relationship (48.00 +/- 18.65 vs. 67.15 +/- 19.70, p<0.001) compared with those in patients without RI. Multiple linear regression analysis revealed that anxiety and cognitive impairment were significant predictors of global QOL. Conclusions: NPC patients with RI exhibit negative emotions, impaired cognitive function and QOL. The severity of clinical symptoms of RI plays an important role in both emotions and cognitive function. Anxiety and cognitive impairment are associated with decreased QOL.	[Tang, Yamei; Rong, Xiaoming; Shi, Xiaolei; Peng, Ying] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Neurol, Guangzhou 510275, Guangdong, Peoples R China; [Tang, Yamei; Rong, Xiaoming; Shi, Xiaolei; Peng, Ying] Sun Yat Sen Univ, Key Lab Malignant Tumor Gene Regulat & Target The, Guangdong Higher Educ Inst, Guangzhou 510275, Guangdong, Peoples R China; [Luo, Donghua] Sun Yat Sen Univ, Ctr Canc, Dept Nasopharyngeal Carcinoma, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Tang, YM (corresponding author), Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Neurol, Guangzhou 510275, Guangdong, Peoples R China.	yameitang@hotmail.com		Tang, Yamei/0000-0002-6353-6107	National Natural Science Foundation of China (NSFC) [30600164, 81072242, NSFC 30973479]; Yat-Sen Scholarship of Sun Yat-Sen Memorial Hospital for Young Scientist	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Yat-Sen Scholarship of Sun Yat-Sen Memorial Hospital for Young Scientist	The current project was supported by the National Natural Science Foundation of China (NSFC No. 30600164, NSFC No. 81072242 to Y.T. and NSFC 30973479 to Y.P.) and Yat-Sen Scholarship of Sun Yat-Sen Memorial Hospital for Young Scientist. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behin A, 2004, SEMIN NEUROL, V24, P405, DOI 10.1055/s-2004-861535; Chang HT, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-70; Chen PR, 2005, INT J RADIAT ONCOL, V61, P466, DOI 10.1016/j.ijrobp.2004.05.016; Cheung MC, 2003, CANCER-AM CANCER SOC, V97, P2019, DOI 10.1002/cncr.11295; Cheung MC, 2000, ARCH NEUROL-CHICAGO, V57, P1347, DOI 10.1001/archneur.57.9.1347; Fang FM, 2002, INT J RADIAT ONCOL, V53, P959, DOI 10.1016/S0360-3016(02)02838-9; Frick E, 2007, EUR J CANCER CARE, V16, P130, DOI 10.1111/j.1365-2354.2006.00720.x; Hammerlid E, 2001, HEAD NECK-J SCI SPEC, V23, P113, DOI 10.1002/1097-0347(200102)23:2<113::AID-HED1006>3.0.CO;2-W; Heinonen H, 2004, QUAL LIFE RES, V13, P1347, DOI 10.1023/B:QURE.0000040788.12947.b9; Hsiao KY, 2010, INT J RADIAT ONCOL, V77, P722, DOI 10.1016/j.ijrobp.2009.06.080; Karasawa Kumiko, 2005, Radiat Med, V23, P478; Ku PKM, 2010, LARYNGOSCOPE, V120, P223, DOI 10.1002/lary.20701; Lam LCW, 2003, J NEUROPSYCH CLIN N, V15, P90, DOI 10.1176/appi.neuropsych.15.1.90; Lee PWH, 2007, CANCER-AM CANCER SOC, V109, P1344, DOI 10.1002/cncr.22539; Lue BH, 2008, INT J RADIAT ONCOL, V70, P28, DOI 10.1016/j.ijrobp.2007.06.053; Mystakidou K, 2005, QUAL LIFE RES, V14, P1825, DOI 10.1007/s11136-005-4324-3; Routledge JA, 2003, INT J RADIAT ONCOL, V56, P502, DOI 10.1016/S0360-3016(02)04578-9; Sehlen S, 2000, ONKOLOGIE, V23, P565, DOI 10.1159/000055007; Shin HR, 2010, ASIAN PAC J CANCER P, V11, P11; Tang Y, 2011, STRAHLENTHER ONKOL, V187, P39, DOI 10.1007/s00066-010-2151-0; Wan LS, 2011, BMC CANCER, V11, P128; World Health Organization (WHO), 1998, WHOQOL US MAN; Young YH, 2004, OTOL NEUROTOL, V25, P366, DOI 10.1097/00129492-200405000-00027; Zhang M, 1998, HDB PSYCHIAT SCALES	24	66	76	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2012	7	6							e36529	10.1371/journal.pone.0036529	http://dx.doi.org/10.1371/journal.pone.0036529			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TU	22701557	gold, Green Submitted, Green Published			2022-12-27	WOS:000305337600004
J	Yu, L; Zhou, YY; Wang, RB; Lou, J; Zhang, LJ; Li, J; Bi, ZQ; Kan, B				Yu, Li; Zhou, Yanyan; Wang, Ruibai; Lou, Jing; Zhang, Lijuan; Li, Jie; Bi, Zhenqiang; Kan, Biao			Multiple Antibiotic Resistance of Vibrio cholerae Serogroup O139 in China from 1993 to 2009	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; SXT ELEMENT; EL-TOR; CALCUTTA; STRAINS; BENGAL; EMERGENCE; EVOLUTION; RIBOTYPES; OUTBREAK	Regarded as an emerging diarrheal micropathogen, Vibrio cholerae serogroup O139 was first identified in 1992 and has become an important cause of cholera epidemics over the last two decades. O139 strains have been continually isolated since O139 cholera appeared in China in 1993, from sporadic cases and dispersed foodborne outbreaks, which are the common epidemic types of O139 cholera in China. Antibiotic resistance profiles of these epidemic strains are required for development of clinical treatments, epidemiological studies and disease control. In this study, a comprehensive investigation of the antibiotic resistance of V. cholerae O139 strains isolated in China from 1993 to 2009 was conducted. The initial O139 isolates were resistant to streptomycin, trimethoprim-sulfamethoxazole and polymyxin B only, while multidrug resistance increased suddenly and became common in strains isolated after 1998. Different resistance profiles were observed in the isolates from different years. In contrast, most V. cholerae O1 strains isolated in the same period were much less resistant to these antibiotics and no obvious multidrug resistance patterns were detected. Most of the non-toxigenic strains isolated from the environment and seafood were resistant to four antibiotics or fewer, although a few multidrug resistant strains were also identified. These toxigenic O139 strains exhibited a high prevalence of the class I integron and the SXT element, which were rare in the non-toxigenic strains. Molecular subtyping of O139 strains showed highly diverse pulsed-field gel electrophoresis patterns, which may correspond to the epidemic state of sporadic cases and small-scale outbreaks and complex resistance patterns. Severe multidrug resistance, even resistance transfers based on mobile antibiotic resistance elements, increases the probability of O139 cholera as a threat to public health. Therefore, continual epidemiological and antibiotic sensitivity surveillance should focus on the occurrence of multidrug resistance and frequent microbial population shifts in O139 strains.	[Yu, Li; Zhou, Yanyan; Wang, Ruibai; Lou, Jing; Zhang, Lijuan; Li, Jie; Kan, Biao] Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, Dept Diarrheal Dis, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Yu, Li; Bi, Zhenqiang] Shandong Ctr Dis Control & Prevent, Shandong Prov Key Lab Infect Dis Control & Preven, Jinan, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Yu, L (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, Dept Diarrheal Dis, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China.	bzq63@163.com; kanbiao@icdc.cn	Zhang, Li/GWM-7501-2022		National Basic Research Priorities Program [2009CB522604]; Natural Science Foundation key project [30830008]; National Science and Technology Major Project on Infectious Disease Control and Prevention [2012ZX10004-215]	National Basic Research Priorities Program(National Basic Research Program of China); Natural Science Foundation key project; National Science and Technology Major Project on Infectious Disease Control and Prevention	This work was supported by the National Basic Research Priorities Program 2009CB522604, Natural Science Foundation key project 30830008, and National Science and Technology Major Project on Infectious Disease Control and Prevention 2012ZX10004-215 (URLs of funders: www.973.gov.cn, www.nsfc.gov.cn, www.nmp.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERT MJ, 1993, LANCET, V341, P704; Amita, 2003, EMERG INFECT DIS, V9, P500; Basu A, 2000, EMERG INFECT DIS, V6, P139, DOI 10.3201/eid0602.000206; Beaber JW, 2004, NATURE, V427, P72, DOI 10.1038/nature02241; Chakraborty S, 2001, J MED MICROBIOL, V50, P879, DOI 10.1099/0022-1317-50-10-879; Cooper KLF, 2006, FOODBORNE PATHOG DIS, V3, P51, DOI 10.1089/fpd.2006.3.51; Dalsgaard A, 2000, J CLIN MICROBIOL, V38, P3774, DOI 10.1128/JCM.38.10.3774-3779.2000; Faruque SM, 2003, P NATL ACAD SCI USA, V100, P1304, DOI 10.1073/pnas.0337468100; Faruque SM, 2003, EMERG INFECT DIS, V9, P1116; Garg P, 2000, EPIDEMIOL INFECT, V124, P393, DOI 10.1017/S0950268899003957; Hochhut B, 2000, J BACTERIOL, V182, P2043, DOI 10.1128/JB.182.7.2043-2047.2000; Kam KM, 1999, EMERG INFECT DIS, V5, P595, DOI 10.3201/eid0504.990431; Kimsey HH, 1998, LANCET, V352, P457, DOI 10.1016/S0140-6736(05)79193-5; Kitaoka M, 2011, J MED MICROBIOL, V60, P397, DOI 10.1099/jmm.0.023051-0; Krishna BVS, 2006, T ROY SOC TROP MED H, V100, P224, DOI 10.1016/j.trstmh.2005.07.007; Mitra R, 1996, LANCET, V348, P1181, DOI 10.1016/S0140-6736(05)65326-3; Mukhopadhyay AK, 1998, J CLIN MICROBIOL, V36, P2149, DOI 10.1128/JCM.36.7.2149-2152.1998; Mukhopadhyay AK, 1996, J CLIN MICROBIOL, V34, P2537, DOI 10.1128/JCM.34.10.2537-2543.1996; Pan JC, 2008, ANTIMICROB AGENTS CH, V52, P3829, DOI 10.1128/AAC.00375-08; Pang B, 2007, J BACTERIOL, V189, P4837, DOI 10.1128/JB.01959-06; Qu M, 2003, J CLIN MICROBIOL, V41, P2306, DOI 10.1128/JCM.41.6.2306-2310.2003; Ramachandran D, 2007, J MED MICROBIOL, V56, P346, DOI 10.1099/jmm.0.46655-0; RAMAMURTHY T, 1993, LANCET, V341, P703, DOI 10.1016/0140-6736(93)90480-5; Rawlings TK, 2007, APPL ENVIRON MICROB, V73, P7926, DOI 10.1128/AEM.01238-07; Saha D, 2006, NEW ENGL J MED, V354, P2452, DOI 10.1056/NEJMoa054493; Sciortino CV, 1996, J CLIN MICROBIOL, V34, P897, DOI 10.1128/JCM.34.4.897-900.1996; Sharma C, 1997, J CLIN MICROBIOL, V35, P3348, DOI 10.1128/JCM.35.12.3348-3350.1997; THRELFALL EJ, 1982, LANCET, V1, P42; Waldor MK, 1996, J BACTERIOL, V178, P4157, DOI 10.1128/jb.178.14.4157-4165.1996	29	26	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2012	7	6							e38633	10.1371/journal.pone.0038633	http://dx.doi.org/10.1371/journal.pone.0038633			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TU	22701685	Green Published, gold, Green Submitted			2022-12-27	WOS:000305337600035
J	Hasemann, MS; Schuster, MB; Frank, AK; Theilgaard-Monch, K; Pedersen, TA; Nerlov, C; Porse, BT				Hasemann, Marie S.; Schuster, Mikkel B.; Frank, Anne-Katrine; Theilgaard-Monch, Kim; Pedersen, Thomas A.; Nerlov, Claus; Porse, Bo T.			Phosphorylation of Serine 248 of C/EBP alpha Is Dispensable for Myelopoiesis but Its Disruption Leads to a Low Penetrant Myeloid Disorder with Long Latency	PLOS ONE			English	Article							BINDING PROTEIN-ALPHA; HEMATOPOIETIC STEM-CELLS; GRANULOCYTIC DIFFERENTIATION; TRANSCRIPTION FACTORS; GENE-EXPRESSION; SELF-RENEWAL; PROLIFERATION; LEUKEMIA; PU.1; MUTATION	Background: Transcription factors play a key role in lineage commitment and differentiation of stem cells into distinct mature cells. In hematopoiesis, they regulate lineage-specific gene expression in a stage-specific manner through various physical and functional interactions with regulatory proteins that are simultanously recruited and activated to ensure timely gene expression. The transcription factor CCAAT/enhancer binding protein alpha (C/EBP alpha) is such a factor and is essential for the development of granulocytic/monocytic cells. The activity of C/EBP alpha is regulated on several levels including gene expression, alternative translation, protein interactions and posttranslational modifications, such as phosphorylation. In particular, the phosphorylation of serine 248 of the transactivation domain has been shown to be of crucial importance for granulocytic differentiation of 32Dcl3 cells in vitro. Methodology/Principal Findings: Here, we use mouse genetics to investigate the significance of C/EBP alpha serine 248 in vivo through the construction and analysis of Cebpa(S248A/S248A) knock-in mice. Surprisingly, 8-week old Cebpa(S248A/S248A) mice display normal steady-state hematopoiesis including unaltered development of mature myeloid cells. However, over time some of the animals develop a hematopoietic disorder with accumulation of multipotent, megakaryocytic and erythroid progenitor cells and a mild impairment of differentiation along the granulocytic-monocytic lineage. Furthermore, BM cells from Cebpa(S248A/S248A) animals display a competitive advantage compared to wild type cells in a transplantation assay. Conclusions/Significance: Taken together, our data shows that the substitution of C/EBP alpha serine 248 to alanine favors the selection of the megakaryocytic/erythroid lineage over the monocytic/granulocytic compartment in old mice and suggests that S248 phosphorylation may be required to maintain proper hematopoietic homeostasis in response to changes in the wiring of cellular signalling networks. More broadly, the marked differences between the phenotype of the S248A variant in vivo and in vitro highlight the need to exert caution when extending in vitro phenotypes to the more appropriate in vivo context.	[Hasemann, Marie S.; Schuster, Mikkel B.; Frank, Anne-Katrine; Theilgaard-Monch, Kim; Porse, Bo T.] Univ Copenhagen, Rigshosp, Fac Hlth Sci, Finsen Lab, DK-2100 Copenhagen, Denmark; [Hasemann, Marie S.; Schuster, Mikkel B.; Frank, Anne-Katrine; Theilgaard-Monch, Kim; Porse, Bo T.] Univ Copenhagen, BRIC, Copenhagen, Denmark; [Hasemann, Marie S.; Schuster, Mikkel B.; Frank, Anne-Katrine; Porse, Bo T.] Univ Copenhagen, Fac Hlth Sci, Danish Stem Cell Ctr DanStem, Copenhagen, Denmark; [Theilgaard-Monch, Kim] Lund Univ, Skanes Univ Hosp, Deptartment Hematol, Lund, Sweden; [Pedersen, Thomas A.; Nerlov, Claus] Mouse Biol Unit, EMBL, Monterotondo, Italy; [Nerlov, Claus] Univ Edinburgh, Inst Stem Cell Res, Ctr Regenerat Med, MRC, Edinburgh, Midlothian, Scotland	Rigshospitalet; University of Copenhagen; University of Copenhagen; University of Copenhagen; Lund University; European Molecular Biology Laboratory (EMBL); University of Edinburgh	Hasemann, MS (corresponding author), Univ Copenhagen, Rigshosp, Fac Hlth Sci, Finsen Lab, DK-2100 Copenhagen, Denmark.	bo.porse@finsenlab.dk		Frank, Anne-Katrine/0000-0001-6635-6104; Porse, Bo/0000-0001-6043-0844; Schuster, Mikkel Bruhn/0000-0003-1742-5550; Theilgaard-Monch, Kim/0000-0002-4239-4939	Lundbeck Foundation; The NovoNordisk Foundation; Danish Cancer Society; Lundbeck Foundation [R34-2009-3620, R19-2007-830] Funding Source: researchfish; Medical Research Council [G0700711B] Funding Source: researchfish; Novo Nordisk Fonden [NNF12OC1015986] Funding Source: researchfish	Lundbeck Foundation(Lundbeckfonden); The NovoNordisk Foundation(Novo Nordisk Foundation); Danish Cancer Society(Danish Cancer Society); Lundbeck Foundation(Lundbeckfonden); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by the Lundbeck Foundation, The NovoNordisk Foundation and the Danish Cancer Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behre G, 2002, J BIOL CHEM, V277, P26293, DOI 10.1074/jbc.M202301200; Bereshchenko O, 2009, CANCER CELL, V16, P390, DOI 10.1016/j.ccr.2009.09.036; Bryder D, 2006, AM J PATHOL, V169, P338, DOI 10.2353/ajpath.2006.060312; Dahl R, 2003, NAT IMMUNOL, V4, P1029, DOI 10.1038/ni973; Fukuchi Y, 2006, EMBO J, V25, P3398, DOI 10.1038/sj.emboj.7601199; Fukuchi Y, 2008, STEM CELLS, V26, P3172, DOI 10.1634/stemcells.2008-0320; Guchhait P, 2003, J IMMUNOL METHODS, V283, P195, DOI 10.1016/j.jim.2003.09.013; Hasemann MS, 2008, BLOOD, V111, P4309, DOI 10.1182/blood-2007-06-097790; Hattori T, 2003, ONCOGENE, V22, P1273, DOI 10.1038/sj.onc.1206204; Iakova P, 2003, CELL, V113, P495, DOI 10.1016/S0092-8674(03)00318-0; Johnson PF, 2005, J CELL SCI, V118, P2545, DOI 10.1242/jcs.02459; Kirstetter P, 2008, CANCER CELL, V13, P299, DOI 10.1016/j.ccr.2008.02.008; LIN FT, 1993, P NATL ACAD SCI USA, V90, P9606, DOI 10.1073/pnas.90.20.9606; MAHONEY CW, 1992, J BIOL CHEM, V267, P19396; McKnight SL, 2001, CELL, V107, P259, DOI 10.1016/S0092-8674(01)00543-8; Pedersen TA, 2001, GENE DEV, V15, P3208, DOI 10.1101/gad.209901; Pedersen TA, 2007, EMBO J, V26, P1081, DOI 10.1038/sj.emboj.7601563; Porse BT, 2006, MOL CELL BIOL, V26, P1028, DOI 10.1128/MCB.26.3.1028-1037.2006; Porse BT, 2005, J EXP MED, V202, P85, DOI 10.1084/jem.20050067; Porse BT, 2001, CELL, V107, P247, DOI 10.1016/S0092-8674(01)00516-5; Pronk CJH, 2007, CELL STEM CELL, V1, P428, DOI 10.1016/j.stem.2007.07.005; Reddy VA, 2002, BLOOD, V100, P483, DOI 10.1182/blood.V100.2.483; Rosenbauer F, 2007, NAT REV IMMUNOL, V7, P105, DOI 10.1038/nri2024; Ross SE, 2004, MOL CELL BIOL, V24, P675, DOI 10.1128/MCB.24.2.675-686.2004; Ross SE, 1999, MOL CELL BIOL, V19, P8433; Schuster MB, 2006, BBA-REV CANCER, V1766, P88, DOI 10.1016/j.bbcan.2006.02.003; Singh SM, 2008, BIOCHEM BIOPH RES CO, V369, P692, DOI 10.1016/j.bbrc.2008.02.090; Subramanian L, 2003, J BIOL CHEM, V278, P9134, DOI 10.1074/jbc.M210440200; Suh HC, 2006, BLOOD, V107, P4308, DOI 10.1182/blood-2005-06-2216; Twu YC, 2010, BLOOD, V115, P2491, DOI 10.1182/blood-2009-07-231993; Wang GL, 2006, MOL CELL BIOL, V26, P2570, DOI 10.1128/MCB.26.7.2570-2582.2006; Wang GL, 2005, MOL CELL BIOL, V25, P1325, DOI 10.1128/MCB.25.4.1325-1338.2005; Wang XP, 1999, BLOOD, V94, P560, DOI 10.1182/blood.V94.2.560.414k41_560_571; Warren LA, 2009, MECH AGEING DEV, V130, P46, DOI 10.1016/j.mad.2008.03.010; Zhang DE, 1997, P NATL ACAD SCI USA, V94, P569, DOI 10.1073/pnas.94.2.569; Zhang P, 2004, IMMUNITY, V21, P853, DOI 10.1016/j.immuni.2004.11.006	36	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2012	7	6							e38841	10.1371/journal.pone.0038841	http://dx.doi.org/10.1371/journal.pone.0038841			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TQ	22715416	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336800058
J	Parasa, VRR; Sikhamani, R; Raja, A				Parasa, Venkata Ramana Rao; Sikhamani, Rajasekaran; Raja, Alamelu			Effect of Recombinant Cytokines on the Expression of Natural Killer Cell Receptors from Patients with TB or/and HIV Infection	PLOS ONE			English	Article							NK CELLS; INHIBITORY RECEPTORS; PULMONARY TUBERCULOSIS; HIV-1-INFECTED PATIENTS; CYTOTOXICITY RECEPTORS; ACTIVATING RECEPTORS; IMMUNODEFICIENCY; NKP44; LYMPHOCYTES; NKP30	Background: NK cells express several specialized receptors through which they recognize and discriminate virally-infected/tumor cells efficiently from healthy cells and kill them. This ability to lyse is regulated by an array of inhibitory or activating receptors. The present study investigated the frequency of various NK receptors expressed by NK cell subsets from HIV-infected TB patients. The effect of IL-15+IL-12 stimulation on the expression of NK receptors was also studied. Methodology/Principal Findings: The study included 15 individuals each from normal healthy subjects, pulmonary tuberculosis patients, HIV-infected individuals and patients with HIV and tuberculosis co-infection. The expression of NK cell receptors was analyzed on two NK cell subsets within the peripheral blood: CD16+CD3- and CD56+CD3- using flow cytometry. The expression of inhibitory receptors (CD158a, CD158b, KIRp70, CD85j and NKG2A) on NK subsets was increased in HIV, when compared to NHS. But the response in HIV-TB was not uniform. Stimulation with IL-15+IL-12 dropped (p<0.05) the expression of CD85j and NKG2A in HIV. The basal expression of natural cytotoxicity receptors (NKp30 and NKp46) on NK cell subsets was lowered (p<0.05) in HIV and HIV-TB as compared to NHS. However, the expression of NKp44 and NKG2D was elevated in HIV. Enhanced NKp46 and NKG2D expression was observed in HIV with IL-15+IL-12 stimulation. The coreceptor NKp80 was found to be expressed in higher numbers on NK subsets from HIV compared to NHS, which elevated with IL-15+IL-12 stimulation. The expression of NK receptors and response to stimulation was primarily on CD56+CD3- subset. Conclusions/Significance: IL-15+IL-12 has an immunomodulatory effect on NK cell subsets from HIV-infected individuals viz down-regulation of iNKRs, elevation of activatory receptors NKp46 and NKG2D, and induction of coreceptor NKp80. IL-15+IL-12 is not likely to be of value when co-infected with TB probably due to the influence of tuberculosis.	[Parasa, Venkata Ramana Rao; Raja, Alamelu] Natl Inst Res TB ICMR, Dept Immunol, Madras, Tamil Nadu, India; [Sikhamani, Rajasekaran] Govt Hosp Thorac Med, Madras, Tamil Nadu, India	Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT)	Parasa, VRR (corresponding author), Natl Inst Res TB ICMR, Dept Immunol, Madras, Tamil Nadu, India.	alameluraja@gmail.com		Parasa, Venkata Ramanarao/0000-0003-1506-7446	Lady Tata Memorial Trust (LTMT), Mumbai, India	Lady Tata Memorial Trust (LTMT), Mumbai, India	VRP thanks the Lady Tata Memorial Trust (LTMT), Mumbai, India for providing Senior Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlenstiel G, GASTROENTEROLOGY, V138, P325; Ahmad R, 2001, J MED VIROL, V65, P431, DOI 10.1002/jmv.2053.abs; Andre P, 2004, EUR J IMMUNOL, V34, P961, DOI 10.1002/eji.200324705; Bertone S, 1999, EUR J IMMUNOL, V29, P23, DOI 10.1002/(SICI)1521-4141(199901)29:01<23::AID-IMMU23>3.0.CO;2-Y; Biassoni R, 1999, EUR J IMMUNOL, V29, P1014, DOI 10.1002/(SICI)1521-4141(199903)29:03<1014::AID-IMMU1014>3.0.CO;2-O; Biassoni R, 2001, IMMUNOL REV, V181, P203, DOI 10.1034/j.1600-065X.2001.1810117.x; Biron CA, 1999, ANNU REV IMMUNOL, V17, P189, DOI 10.1146/annurev.immunol.17.1.189; Bozzano F, 2011, INT IMMUNOL, V23, P109, DOI 10.1093/intimm/dxq462; Bozzano F, 2009, INT IMMUNOL, V21, P779, DOI 10.1093/intimm/dxp046; Cambiaggi A, 1996, BLOOD, V87, P2369, DOI 10.1182/blood.V87.6.2369.bloodjournal8762369; Cantoni C, 1999, J EXP MED, V189, P787, DOI 10.1084/jem.189.5.787; Castriconi R, 2003, P NATL ACAD SCI USA, V100, P4120, DOI 10.1073/pnas.0730640100; CAUDA R, 1994, CLIN IMMUNOL IMMUNOP, V70, P198, DOI 10.1006/clin.1994.1029; Cohen GB, 1999, IMMUNITY, V10, P661, DOI 10.1016/S1074-7613(00)80065-5; De Maria A, 2003, EUR J IMMUNOL, V33, P2410, DOI 10.1002/eji.200324141; De Maria A, 2000, HUM IMMUNOL, V61, P74, DOI 10.1016/S0198-8859(99)00169-X; De Maria A, 2007, EUR J IMMUNOL, V37, P445, DOI 10.1002/eji.200635989; Esin S, 2008, INFECT IMMUN, V76, P1719, DOI 10.1128/IAI.00870-07; Fresno M, 1997, IMMUNOL TODAY, V18, P56, DOI 10.1016/S0167-5699(96)30069-8; Fu GF, 2009, VIRAL IMMUNOL, V22, P105, DOI 10.1089/vim.2008.0081; Hershkovitz O, 2009, J IMMUNOL, V183, P2610, DOI 10.4049/jimmunol.0802806; Houchins JP, 1997, J IMMUNOL, V158, P3603; Kottilil S, 2004, J INFECT DIS, V189, P1193, DOI 10.1086/382090; Lanier LL, 1996, IMMUNOL TODAY, V17, P86, DOI 10.1016/0167-5699(96)80585-8; Lieberman J, 2001, BLOOD, V98, P1667, DOI 10.1182/blood.V98.6.1667; Linnemeyer P A, 1995, STEP Perspect, V7, P6; Mantegani P, 2010, IMMUNOLOGY, V129, P220, DOI 10.1111/j.1365-2567.2009.03171.x; Mason D, 2002, BLOOD, V99, P3877, DOI 10.1182/blood.V99.10.3877; Mavilio D, 2003, P NATL ACAD SCI USA, V100, P15011, DOI 10.1073/pnas.2336091100; Mingari MC, 1997, EUR J IMMUNOL, V27, P1374, DOI 10.1002/eji.1830270612; Moretta A, 2001, ANNU REV IMMUNOL, V19, P197, DOI 10.1146/annurev.immunol.19.1.197; Moretta A, 1996, ANNU REV IMMUNOL, V14, P619, DOI 10.1146/annurev.immunol.14.1.619; Moretta L, 2004, EMBO J, V23, P255, DOI 10.1038/sj.emboj.7600019; Moretta L, 2001, TRANSPLANT P, V33, P60, DOI 10.1016/S0041-1345(00)02790-1; Natarajan K, 2002, ANNU REV IMMUNOL, V20, P853, DOI 10.1146/annurev.immunol.20.100301.064812; Oliva A, 1998, J CLIN INVEST, V102, P223, DOI 10.1172/JCI2323; Ostrowski SR, 2005, CLIN EXP IMMUNOL, V141, P526, DOI 10.1111/j.1365-2249.2005.02869.x; Parato KG, 2002, AIDS, V16, P1251, DOI 10.1097/00002030-200206140-00007; Pende D, 1999, J EXP MED, V190, P1505, DOI 10.1084/jem.190.10.1505; Radaev S, 2003, ANNU REV BIOPH BIOM, V32, P93, DOI 10.1146/annurev.biophys.32.110601.142347; Ramana Rao PV, 2010, J CLIN IMMU IN PRESS; Rao PVR, 2010, J INTERF CYTOK RES, V30, P33, DOI 10.1089/jir.2009.0018; Rao PVR, 2008, AIDS RES HUM RETROV, V24, P1435, DOI 10.1089/aid.2008.0126; Stevenson M, 2003, NAT MED, V9, P853, DOI 10.1038/nm0703-853; ULLUM H, 1995, J EXP MED, V182, P789, DOI 10.1084/jem.182.3.789; Vance RE, 1998, CURR TOP MICROBIOL, V230, P135; Vankayalapati R, 2002, J IMMUNOL, V168, P3451, DOI 10.4049/jimmunol.168.7.3451; Yokoyama WM, 1998, P NATL ACAD SCI USA, V95, P4791, DOI 10.1073/pnas.95.9.4791	48	48	49	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2012	7	6							e37448	10.1371/journal.pone.0037448	http://dx.doi.org/10.1371/journal.pone.0037448			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TQ	22715368	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000305336800009
J	Hamacher, K; Greiner, T; Ogata, H; Van Etten, JL; Gebhardt, M; Villarreal, LP; Cosentino, C; Moroni, A; Thiel, G				Hamacher, Kay; Greiner, Timo; Ogata, Hiroyuki; Van Etten, James L.; Gebhardt, Manuela; Villarreal, Luis P.; Cosentino, Cristian; Moroni, Anna; Thiel, Gerhard			Phycodnavirus Potassium Ion Channel Proteins Question the Virus Molecular Piracy Hypothesis	PLOS ONE			English	Article							ECTOCARPUS-SILICULOSUS VIRUS; MULTIPLE SEQUENCE ALIGNMENT; VIRAL K+ CHANNELS; CHLORELLA VIRUSES; HOST-CELLS; KCV; INFECTION; GENOME; NC64A; EUKARYOTES	Phycodnaviruses are large dsDNA, algal-infecting viruses that encode many genes with homologs in prokaryotes and eukaryotes. Among the viral gene products are the smallest proteins known to form functional K+ channels. To determine if these viral K+ channels are the product of molecular piracy from their hosts, we compared the sequences of the K+ channel pore modules from seven phycodnaviruses to the K+ channels from Chlorella variabilis and Ectocarpus siliculosus, whose genomes have recently been sequenced. C. variabilis is the host for two of the viruses PBCV-1 and NY-2A and E. siliculosus is the host for the virus EsV-1. Systematic phylogenetic analyses consistently indicate that the viral K+ channels are not related to any lineage of the host channel homologs and that they are more closely related to each other than to their host homologs. A consensus sequence of the viral channels resembles a protein of unknown function from a proteobacterium. However, the bacterial protein lacks the consensus motif of all K+ channels and it does not form a functional channel in yeast, suggesting that the viral channels did not come from a proteobacterium. Collectively, our results indicate that the viruses did not acquire their K+ channel-encoding genes from their current algal hosts by gene transfer; thus alternative explanations are required. One possibility is that the viral genes arose from ancient organisms, which served as their hosts before the viruses developed their current host specificity. Alternatively the viral proteins could be the origin of K+ channels in algae and perhaps even all cellular organisms.	[Hamacher, Kay] Tech Univ Darmstadt, Computat Biol Grp, Darmstadt, Germany; [Greiner, Timo; Gebhardt, Manuela; Thiel, Gerhard] Tech Univ Darmstadt, Membrane Biophys Grp, Darmstadt, Germany; [Ogata, Hiroyuki] Aix Marseille Univ, Struct & Genom Informat Lab, Marseille, France; [Van Etten, James L.] Univ Nebraska, Dept Plant Pathol, Lincoln, NE 68583 USA; [Van Etten, James L.] Univ Nebraska, Nebraska Ctr Virol, Lincoln, NE USA; [Villarreal, Luis P.] Univ Calif Irvine, Ctr Virus Res, Irvine, CA USA; [Cosentino, Cristian; Moroni, Anna] Univ Milan, Dept Biol, Milan, Italy	Technical University of Darmstadt; Technical University of Darmstadt; UDICE-French Research Universities; Aix-Marseille Universite; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; University of California System; University of California Irvine; University of Milan	Hamacher, K (corresponding author), Tech Univ Darmstadt, Computat Biol Grp, Darmstadt, Germany.	thiel@bio.tu-darmstadt.de	moroni, anna/H-2097-2014; Greiner, Timo/Y-1900-2019; Cosentino, Cristian/F-2604-2010	moroni, anna/0000-0002-1860-406X; Greiner, Timo/0000-0002-0909-570X; Cosentino, Cristian/0000-0002-2784-0048; Hamacher, Kay/0000-0002-6921-8345; Thiel, Gerhard/0000-0002-2335-1351	Deutsche Forschungsgemeinschaft [DFG GrK-1657]; Public Health Service Grant [GM32441]; Fonds der Chemischen Industrie; National Institutes of Health grant from the COBRE program of the National Center for Research Resources [P20RR15635]; European Drug Initiative on Channels and Transporters (EDICT) project EU FP7 [201924]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015635] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032441] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Public Health Service Grant(United States Department of Health & Human ServicesUnited States Public Health Service); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); National Institutes of Health grant from the COBRE program of the National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Drug Initiative on Channels and Transporters (EDICT) project EU FP7; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Study was supported by: 1) Deutsche Forschungsgemeinschaft (DFG GrK-1657: GT, and KH), 2) Public Health Service Grant GM32441 (JLVE), 3) Fonds der Chemischen Industrie (KH), 4) National Institutes of Health grant P20RR15635 from the COBRE program of the National Center for Research Resources (JLVE) 5) European Drug Initiative on Channels and Transporters (EDICT) project EU FP7 (201924) (AM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Balss J, 2008, P NATL ACAD SCI USA, V105, P12313, DOI 10.1073/pnas.0805709105; Blanc G, 2010, PLANT CELL, V22, P2943, DOI 10.1105/tpc.110.076406; Chen J, 2005, BIOCHEM BIOPH RES CO, V326, P887, DOI 10.1016/j.bbrc.2004.11.125; Ciampor F., 2003, Acta Microbiologica et Immunologica Hungarica, V50, P433, DOI 10.1556/AMicr.50.2003.4.9; Cock JM, 2010, NATURE, V465, P617, DOI 10.1038/nature09016; Delaroque N, 1999, J GEN VIROL, V80, P1367, DOI 10.1099/0022-1317-80-6-1367; Delaroque N, 2001, VIROLOGY, V287, P112, DOI 10.1006/viro.2001.1028; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fischer WB, 2002, BBA-BIOMEMBRANES, V1561, P27, DOI 10.1016/S0304-4157(01)00009-0; Fitzgerald LA, 2007, VIROLOGY, V362, P350, DOI 10.1016/j.virol.2006.12.028; Fitzgerald LA, 2007, VIROLOGY, V358, P459, DOI 10.1016/j.virol.2006.08.034; Fitzgerald LA, 2007, VIROLOGY, V358, P472, DOI 10.1016/j.virol.2006.08.033; Frohns F, 2006, J VIROL, V80, P2437, DOI 10.1128/JVI.80.5.2437-2444.2006; Gazzarrini S, 2006, P NATL ACAD SCI USA, V103, P5355, DOI 10.1073/pnas.0600848103; Gazzarrini S, 2004, J BIOL CHEM, V279, P28443, DOI 10.1074/jbc.M401184200; Gazzarrini S, 2003, FEBS LETT, V552, P12, DOI 10.1016/S0014-5793(03)00777-4; Gazzarrini S, 2009, BIOCHEM J, V420, P295, DOI 10.1042/BJ20090095; Gonzalez ME, 2003, FEBS LETT, V552, P28, DOI 10.1016/S0014-5793(03)00780-4; Greiner T, 2011, PLANT J, V68, P977, DOI 10.1111/j.1365-313X.2011.04748.x; Greiner T, 2009, J GEN VIROL, V90, P2033, DOI 10.1099/vir.0.010629-0; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HEGINBOTHAM L, 1994, BIOPHYS J, V66, P1061, DOI 10.1016/S0006-3495(94)80887-2; Hsu K, 2004, MOL CELL, V14, P259, DOI 10.1016/S1097-2765(04)00183-2; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Kang M, 2004, P NATL ACAD SCI USA, V101, P5318, DOI 10.1073/pnas.0307824100; Kwan T, 2005, P NATL ACAD SCI USA, V102, P5174, DOI 10.1073/pnas.0501140102; Lesage F, 1996, EMBO J, V15, P1004, DOI 10.1002/j.1460-2075.1996.tb00437.x; Moreira D, 2009, NAT REV MICROBIOL, V7, P306, DOI 10.1038/nrmicro2108; Neupartl M, 2008, VIROLOGY, V372, P340, DOI 10.1016/j.virol.2007.10.024; Ogata H, 2007, GENOME RES, V17, P1353, DOI 10.1101/gr.6358607; Ogata H, 2011, ISME J, V5, P1143, DOI 10.1038/ismej.2010.210; Pagliuca C, 2007, BIOCHEMISTRY-US, V46, P1079, DOI 10.1021/bi061530w; Plugge B, 2000, SCIENCE, V287, P1641, DOI 10.1126/science.287.5458.1641; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Shim JW, 2007, FEBS LETT, V581, P1027, DOI 10.1016/j.febslet.2007.02.005; Tayefeh S, 2009, BIOPHYS J, V96, P485, DOI 10.1016/j.bpj.2008.09.050; Thiel G, 2011, BBA-BIOMEMBRANES, V1808, P580, DOI 10.1016/j.bbamem.2010.04.008; Thiel G, 2010, PROG BOT, V71, P169, DOI 10.1007/978-3-642-02167-1_7; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Van Etten JL, 2002, ARCH VIROL, V147, P1479, DOI 10.1007/s00705-002-0822-6; Van Etten JL, TRENDS PL SCI, V17, P1; Villarreal LP, 2008, ORIGIN AND EVOLUTION OF VIRUSES, 2ND EDITION, P477, DOI 10.1016/B978-0-12-374153-0.00021-7; Wang K., 2010, BIOCHIM BIOPHYS ACTA, V29, P2059; Wilson WH, 2009, CURR TOP MICROBIOL, V328, P1; Yin YB, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-24; Yoon HS, 2004, MOL BIOL EVOL, V21, P809, DOI 10.1093/molbev/msh075; Yoshida T, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-427	50	13	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e38826	10.1371/journal.pone.0038826	http://dx.doi.org/10.1371/journal.pone.0038826			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685610	Green Published, gold			2022-12-27	WOS:000305351700074
J	Lindgren, D; Sjodahl, G; Lauss, M; Staaf, J; Chebil, G; Lovgren, K; Gudjonsson, S; Liedberg, F; Patschan, O; Mansson, W; Ferno, M; Hoglund, M				Lindgren, David; Sjodahl, Gottfrid; Lauss, Martin; Staaf, Johan; Chebil, Gunilla; Lovgren, Kristina; Gudjonsson, Sigurdur; Liedberg, Fredrik; Patschan, Oliver; Mansson, Wiking; Ferno, Marten; Hoglund, Mattias			Integrated Genomic and Gene Expression Profiling Identifies Two Major Genomic Circuits in Urothelial Carcinoma	PLOS ONE			English	Article							TRANSITIONAL-CELL CARCINOMA; BLADDER-CANCER; COPY NUMBER; ARRAY-CGH; HYBRIDIZATION; TUMORS; INACTIVATION; IMBALANCES; SIGNATURES; MUTATIONS	Similar to other malignancies, urothelial carcinoma (UC) is characterized by specific recurrent chromosomal aberrations and gene mutations. However, the interconnection between specific genomic alterations, and how patterns of chromosomal alterations adhere to different molecular subgroups of UC, is less clear. We applied tiling resolution array CGH to 146 cases of UC and identified a number of regions harboring recurrent focal genomic amplifications and deletions. Several potential oncogenes were included in the amplified regions, including known oncogenes like E2F3, CCND1, and CCNE1, as well as new candidate genes, such as SETDB1 (1q21), and BCL2L1 (20q11). We next combined genome profiling with global gene expression, gene mutation, and protein expression data and identified two major genomic circuits operating in urothelial carcinoma. The first circuit was characterized by FGFR3 alterations, overexpression of CCND1, and 9q and CDKN2A deletions. The second circuit was defined by E3F3 amplifications and RB1 deletions, as well as gains of 5p, deletions at PTEN and 2q36, 16q, 20q, and elevated CDKN2A levels. TP53/MDM2 alterations were common for advanced tumors within the two circuits. Our data also suggest a possible RAS/RAF circuit. The tumors with worst prognosis showed a gene expression profile that indicated a keratinized phenotype. Taken together, our integrative approach revealed at least two separate networks of genomic alterations linked to the molecular diversity seen in UC, and that these circuits may reflect distinct pathways of tumor development.	[Lindgren, David] Lund Univ, Dept Mol Pathol, Malmo, Sweden; [Sjodahl, Gottfrid; Lauss, Martin; Staaf, Johan; Hoglund, Mattias] Lund Univ, Dept Oncol, Canc Branch, Lund, Sweden; [Chebil, Gunilla; Lovgren, Kristina; Ferno, Marten] Lund Univ, Skane Univ Hosp, Dept Oncol, Lund, Sweden; [Gudjonsson, Sigurdur; Liedberg, Fredrik; Patschan, Oliver; Mansson, Wiking] Skane Univ Hosp, Dept Urol, Malmo, Sweden	Lund University; Lund University; Lund University; Skane University Hospital; Lund University; Skane University Hospital	Lindgren, D (corresponding author), Lund Univ, Dept Mol Pathol, Malmo, Sweden.	mattias.hoglund@med.lu.se	Gudjonsson, S./K-6878-2015	Gudjonsson, S./0000-0002-5147-595X; Sjodahl, Gottfrid/0000-0002-7869-0473; Hoglund, Mattias/0000-0001-9283-4421; Patschan, Oliver/0000-0001-5788-794X	Swedish Cancer Society [10 0517]; Swedish Research Council [2011-17816-83790-87]; Crafoord Foundation; Gunnar Nilsson Foundation; Medical Faculty of Lund University Hospital; Swedish Society for Medical Research	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Crafoord Foundation; Gunnar Nilsson Foundation; Medical Faculty of Lund University Hospital; Swedish Society for Medical Research	This work was supported by the Swedish Cancer Society (http://www.vr.se) (grant number 10 0517), the Swedish Research Council (www.cancerfonden.se/) (grant number 2011-17816-83790-87), the Crafoord Foundation (http://www.crafoord.se/vetenskaplig_forskning.asp), the Gunnar Nilsson Foundation (http://www.cancerstiftelsen.com/), the Medical Faculty of Lund University Hospital (http://www.med.lu.se/), and the Swedish Society for Medical Research (http://www.ssmf.se/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Billerey C, 2001, AM J PATHOL, V158, P1955, DOI 10.1016/S0002-9440(10)64665-2; Blaveri E, 2005, CLIN CANCER RES, V11, P7012, DOI 10.1158/1078-0432.CCR-05-0177; Ceol CJ, 2011, NATURE, V471, P513, DOI 10.1038/nature09806; Fadl-Elmula Imad, 2005, Cell Chromosome, V4, P1, DOI 10.1186/1475-9268-4-1; Goebell PJ, 2010, UROL ONCOL-SEMIN ORI, V28, P409, DOI 10.1016/j.urolonc.2010.04.003; Gui YT, 2011, NAT GENET, V43, P875, DOI 10.1038/ng.907; Haigis KM, 2011, NAT GENET, V43, P177, DOI 10.1038/ng0311-177; Heidenblad M, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-3; Hoglund M, 2001, CANCER RES, V61, P8241; Hurst CD, 2008, ONCOGENE, V27, P2716, DOI 10.1038/sj.onc.1210934; Hurst CD, 2004, ONCOGENE, V23, P2250, DOI 10.1038/sj.onc.1207260; Lindgren D, 2010, CANCER RES, V70, P3463, DOI 10.1158/0008-5472.CAN-09-4213; Majewski T, 2008, LAB INVEST, V88, P694, DOI 10.1038/labinvest.2008.27; Puzio-Kuter AM, 2009, GENE DEV, V23, P675, DOI 10.1101/gad.1772909; Richter J, 1998, AM J PATHOL, V153, P1615, DOI 10.1016/S0002-9440(10)65750-1; Richter J, 1997, CANCER RES, V57, P2860; Schvartzman JM, 2010, NAT REV CANCER, V10, P102, DOI 10.1038/nrc2781; Sjodahl G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018583; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Staaf J, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-382; Vallon-Christersson J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-330; Veltman JA, 2003, CANCER RES, V63, P2872; Williams SV, 2002, GENE CHROMOSOME CANC, V34, P86, DOI 10.1002/gcc.10050; Wu XR, 2005, NAT REV CANCER, V5, P713, DOI 10.1038/nrc1697	25	150	152	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e38863	10.1371/journal.pone.0038863	http://dx.doi.org/10.1371/journal.pone.0038863			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685613	Green Published, Green Submitted, gold			2022-12-27	WOS:000305351700077
J	Doi, H; Vander Zanden, MJ; Hillebrand, H				Doi, Hideyuki; Vander Zanden, M. Jake; Hillebrand, Helmut			Shorter Food Chain Length in Ancient Lakes: Evidence from a Global Synthesis	PLOS ONE			English	Article							STABLE-ISOTOPE ANALYSES; ECOSYSTEM SIZE; WEB STRUCTURE; EAST-AFRICA; RAPID EVOLUTION; NITROGEN; BAIKAL; CARBON; AVAILABILITY; PRODUCTIVITY	Food webs may be affected by evolutionary processes, and effective evolutionary time ultimately affects the probability of species evolving to fill the niche space. Thus, ecosystem history may set important evolutionary constraints on community composition and food web structure. Food chain length (FCL) has long been recognized as a fundamental ecosystem attribute. We examined historical effects on FCL in large lakes spanning >6 orders of magnitude in age. We found that food chains in the world's ancient lakes (n = 8) were significantly shorter than in recently formed lakes (n = 10) and reservoirs (n = 3), despite the fact that ancient lakes harbored much higher species richness, including many endemic species. One potential factor leading to shorter FCL in ancient lakes is an increasing diversity of trophic omnivores and herbivores. Speciation could simply broaden the number of species within a trophic group, particularly at lower trophic levels and could also lead to a greater degree of trophic omnivory. Our results highlight a counter-intuitive and poorly-understood role of evolutionary history in shaping key food web properties such as FCL.	[Doi, Hideyuki; Hillebrand, Helmut] Carl von Ossietzky Univ Oldenburg, Inst Chem & Biol Marine Environm, Wilhelmshaven, Germany; [Doi, Hideyuki] Hiroshima Univ, Inst Sustainable Sci & Dev, Higashihiroshima 724, Japan; [Vander Zanden, M. Jake] Univ Wisconsin, Ctr Limnol, Madison, WI 53706 USA	Carl von Ossietzky Universitat Oldenburg; Hiroshima University; University of Wisconsin System; University of Wisconsin Madison	Doi, H (corresponding author), Carl von Ossietzky Univ Oldenburg, Inst Chem & Biol Marine Environm, Schleusenstr 1, Wilhelmshaven, Germany.	doih@hiroshima-u.ac.jp	Hillebrand, Helmut/I-1717-2014; Doi, Hideyuki/D-2012-2010	Hillebrand, Helmut/0000-0001-7449-1613; Doi, Hideyuki/0000-0002-2701-3982; Vander Zanden, Jake/0000-0002-8122-1416	Japanese Society for the Promotion of Science	Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Funding provided by the Japanese Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertson RC, 2006, HEREDITY, V97, P211, DOI 10.1038/sj.hdy.6800864; Black AR, 2003, NORTHWEST SCI, V77, P1; Campbell L, 2008, SCI TOTAL ENVIRON, V402, P184, DOI 10.1016/j.scitotenv.2008.04.017; Campbell LM, 2005, ENVIRON BIOL FISH, V74, P247, DOI 10.1007/s10641-005-3190-8; Campbell LM, 2003, J GREAT LAKES RES, V29, P243, DOI 10.1016/S0380-1330(03)70552-8; Chao BF, 2008, SCIENCE, V320, P212, DOI 10.1126/science.1154580; Clarke LR, 2005, ECOL FRESHW FISH, V14, P267, DOI 10.1111/j.1600-0633.2005.00103.x; COHEN JE, 1991, AM NAT, V138, P1542, DOI 10.1086/285299; Doi H, 2004, HYDROBIOLOGIA, V529, P225, DOI 10.1007/s10750-004-6418-2; Doi H, 2009, OIKOS, V118, P138, DOI 10.1111/j.1600-0706.2008.17171.x; Elton C., 1927, ANIMAL ECOLOGY; FORDYCE RE, 1994, ANNU REV EARTH PL SC, V22, P419, DOI 10.1146/annurev.ea.22.050194.002223; Fukami T, 2003, NATURE, V424, P423, DOI 10.1038/nature01785; Gewurtz SB, 2006, J GREAT LAKES RES, V32, P712, DOI 10.3394/0380-1330(2006)32[712:DOPITF]2.0.CO;2; Hecky RE, 1995, J N AM BENTHOL SOC, V14, P631, DOI 10.2307/1467546; Hunt DM, 1997, MOL PHYLOGENET EVOL, V8, P415, DOI 10.1006/mpev.1997.0428; Iacumin P, 1998, J ARCHAEOL SCI, V25, P293, DOI 10.1006/jasc.1997.0206; JENKINS B, 1992, OIKOS, V65, P249, DOI 10.2307/3545016; Johnson TC, 1996, SCIENCE, V273, P1091, DOI 10.1126/science.273.5278.1091; Keough JR, 1996, LIMNOL OCEANOGR, V41, P136, DOI 10.4319/lo.1996.41.1.0136; Kidd KA, 2003, J GREAT LAKES RES, V29, P258, DOI 10.1016/S0380-1330(03)70553-X; Kikuchi E, 2004, RES REPORT RES ED CT, V2, P21; Lennon JT, 2008, ECOL LETT, V11, P1178, DOI 10.1111/j.1461-0248.2008.01225.x; Loeuille N, 2005, P NATL ACAD SCI USA, V102, P5761, DOI 10.1073/pnas.0408424102; May RM, 2001, STABILITY COMPLEXITY; Pimm S., 1982, FOOD WEB; PIMM SL, 1978, NATURE, V275, P542, DOI 10.1038/275542a0; Post DM, 2007, OIKOS, V116, P775, DOI 10.1111/j.2007.0030-1299.15552.x; Post DM, 2000, NATURE, V405, P1047, DOI 10.1038/35016565; Power M, 2005, ENVIRON BIOL FISH, V73, P263, DOI 10.1007/s10641-005-2137-4; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Saito L, 2001, ECOSYSTEMS, V4, P105, DOI 10.1007/s100210000062; SCHOENER TW, 1989, ECOLOGY, V70, P1559, DOI 10.2307/1938088; Stapleton HM, 2001, ENVIRON SCI TECHNOL, V35, P3287, DOI 10.1021/es0019225; Takai N, 1999, CAN J ZOOL, V77, P258, DOI 10.1139/cjz-77-2-258; Takimoto G, 2008, ECOLOGY, V89, P3001, DOI 10.1890/07-1990.1; Thompson RM, 2005, OIKOS, V108, P137, DOI 10.1111/j.0030-1299.2005.11600.x; Vander Zanden MJ, 2007, OIKOS, V116, P1378, DOI 10.1111/j.2007.0030-1299.16036.x; Vander Zanden MJ, 2003, ECOSYSTEMS, V6, P274, DOI 10.1007/s10021-002-0204-7; Vander Zanden MJ, 1999, AM NAT, V154, P406, DOI 10.1086/303250; Yoshii K, 1999, LIMNOL OCEANOGR, V44, P502, DOI 10.4319/lo.1999.44.3.0502; Yoshii K, 1999, HYDROBIOLOGIA, V411, P145, DOI 10.1023/A:1003810004451; Zimmerman MS, 2009, CAN J FISH AQUAT SCI, V66, P1007, DOI 10.1139/F09-060	43	12	12	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e37856	10.1371/journal.pone.0037856	http://dx.doi.org/10.1371/journal.pone.0037856			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701583	Green Published, gold			2022-12-27	WOS:000305348400021
J	Lepage, JF; Morin-Moncet, O; Beaule, V; de Beaumont, L; Champoux, F; Theoret, H				Lepage, Jean-Francois; Morin-Moncet, Olivier; Beaule, Vincent; de Beaumont, Louis; Champoux, Francois; Theoret, Hugo			Occlusion of LTP-Like Plasticity in Human Primary Motor Cortex by Action Observation	PLOS ONE			English	Article							CORTICAL PLASTICITY; MODULATION; FACILITATION; EXCITABILITY; MEMORY; STIMULATION; CONNECTIONS; ACQUISITION; MUSCLE	Passive observation of motor actions induces cortical activity in the primary motor cortex (M1) of the onlooker, which could potentially contribute to motor learning. While recent studies report modulation of motor performance following action observation, the neurophysiological mechanism supporting these behavioral changes remains to be specifically defined. Here, we assessed whether the observation of a repetitive thumb movement - similarly to active motor practice - would inhibit subsequent long-term potentiation-like (LTP) plasticity induced by paired-associative stimulation (PAS). Before undergoing PAS, participants were asked to either 1) perform abductions of the right thumb as fast as possible; 2) passively observe someone else perform thumb abductions; or 3) passively observe a moving dot mimicking thumb movements. Motor evoked potentials (MEP) were used to assess cortical excitability before and after motor practice (or observation) and at two time points following PAS. Results show that, similarly to participants in the motor practice group, individuals observing repeated motor actions showed marked inhibition of PAS-induced LTP, while the "moving dot" group displayed the expected increase in MEP amplitude, despite differences in baseline excitability. Interestingly, LTP occlusion in the action-observation group was present even if no increase in cortical excitability or movement speed was observed following observation. These results suggest that mere observation of repeated hand actions is sufficient to induce LTP, despite the absence of motor learning.	[Lepage, Jean-Francois; Morin-Moncet, Olivier; Beaule, Vincent; Theoret, Hugo] Univ Montreal, Dept Psychol, Montreal, PQ H3C 3J7, Canada; [Lepage, Jean-Francois; Theoret, Hugo] Hop St Justine, Res Ctr, Montreal, PQ H3T 1C5, Canada; [de Beaumont, Louis] McGill Univ, Douglas Mental Hlth Univ Hopsital, Montreal, PQ, Canada; [Champoux, Francois] Univ Montreal, Dept Audiol, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal; McGill University; Universite de Montreal	Lepage, JF (corresponding author), Univ Montreal, Dept Psychol, CP 6128, Montreal, PQ H3C 3J7, Canada.	hugo.theoret@umontreal.ca		Lepage, Jean-Francois/0000-0002-1181-6043; Theoret, Hugo/0000-0002-7458-8797	National Sciences and Engineering Research Council of Canada; Fonds de la Recherche en Sante du Quebec (FRSQ); FRSQ	National Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Fonds de la Recherche en Sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); FRSQ(Fonds de la Recherche en Sante du Quebec)	This work was supported by grants from the National Sciences and Engineering Research Council of Canada and the Fonds de la Recherche en Sante du Quebec (FRSQ) awarded to HT; JFL is supported by a postdoctoral fellowship from FRSQ; VB is supported by a scholarship from FRSQ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaerts K, 2009, CORTEX, V45, P1148, DOI 10.1016/j.cortex.2008.10.005; Avenanti A, 2007, CURR BIOL, V17, P2129, DOI 10.1016/j.cub.2007.11.045; Avenanti A, 2013, CEREB CORTEX, V23, P570, DOI 10.1093/cercor/bhs040; Aziz-Zadeh L, 2002, EXP BRAIN RES, V144, P127, DOI 10.1007/s00221-002-1037-5; BrashersKrug T, 1996, NATURE, V382, P252, DOI 10.1038/382252a0; Brass M, 2000, BRAIN COGNITION, V44, P124, DOI 10.1006/brcg.2000.1225; Brass M, 2001, ACTA PSYCHOL, V106, P3, DOI 10.1016/S0001-6918(00)00024-X; Cantarero G, 2011, J COGNITIVE NEUROSCI, V23, P3757, DOI 10.1162/jocn_a_00051; Celnik P, 2006, NEUROIMAGE, V29, P677, DOI 10.1016/j.neuroimage.2005.07.039; Celnik P, 2008, STROKE, V39, P1814, DOI 10.1161/STROKEAHA.107.508184; Classen J, 1998, J NEUROPHYSIOL, V79, P1117, DOI 10.1152/jn.1998.79.2.1117; Delvendahl I, 2010, CLIN NEUROPHYSIOL, V121, P594, DOI 10.1016/j.clinph.2009.09.034; Dum RP, 2002, PHYSIOL BEHAV, V77, P677, DOI 10.1016/S0031-9384(02)00929-0; FADIGA L, 1995, J NEUROPHYSIOL, V73, P2608, DOI 10.1152/jn.1995.73.6.2608; Gangitano M, 2001, NEUROREPORT, V12, P1489, DOI 10.1097/00001756-200105250-00038; Heyes CM, 2002, Q J EXP PSYCHOL-A, V55, P593, DOI 10.1080/02724980143000389; Karni A, 1998, P NATL ACAD SCI USA, V95, P861, DOI 10.1073/pnas.95.3.861; Koch G, 2010, NEUROPSYCHOLOGIA, V48, P3513, DOI 10.1016/j.neuropsychologia.2010.07.037; Maeda F, 2002, J NEUROPHYSIOL, V87, P1329, DOI 10.1152/jn.00773.2000; Mattar AAG, 2005, NEURON, V46, P153, DOI 10.1016/j.neuron.2005.02.009; Meunier S, 2007, J NEUROPHYSIOL, V97, P3131, DOI 10.1152/jn.01086.2006; Muellbacher W, 2002, NATURE, V415, P640, DOI 10.1038/nature712; Muellbacher W, 2001, EXP BRAIN RES, V136, P431, DOI 10.1007/s002210000614; PASCUALLEONE A, 1995, J NEUROPHYSIOL, V74, P1037, DOI 10.1152/jn.1995.74.3.1037; Press C, 2011, J NEUROSCI, V31, P2792, DOI 10.1523/JNEUROSCI.1595-10.2011; Rioult-Pedotti MS, 1998, NAT NEUROSCI, V1, P230, DOI 10.1038/678; Rioult-Pedotti MS, 2000, SCIENCE, V290, P533, DOI 10.1126/science.290.5491.533; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Rosenkranz K, 2007, J NEUROSCI, V27, P12058, DOI 10.1523/JNEUROSCI.2663-07.2007; Rossi S, 2011, CLIN NEUROPHYSIOL, V122, P1686, DOI 10.1016/j.clinph.2010.12.037; Sanes JN, 2000, ANNU REV NEUROSCI, V23, P393, DOI 10.1146/annurev.neuro.23.1.393; Shimazu H, 2004, J NEUROSCI, V24, P1200, DOI 10.1523/JNEUROSCI.4731-03.2004; Small SL, 2012, DEV PSYCHOBIOL, V54, P293, DOI 10.1002/dev.20504; Stefan K, 2008, EUR J NEUROSCI, V27, P730, DOI 10.1111/j.1460-9568.2008.06035.x; Stefan K, 2004, J NEUROPHYSIOL, V92, P66, DOI 10.1152/jn.00383.2003; Stefan K, 2002, J PHYSIOL-LONDON, V543, P699, DOI 10.1113/jphysiol.2002.023317; Stefan K, 2006, CEREB CORTEX, V16, P376, DOI 10.1093/cercorbhi116; Stefan K, 2005, J NEUROSCI, V25, P9339, DOI 10.1523/JNEUROSCI.2282-05.2005; Stefan K, 2000, BRAIN, V123, P572, DOI 10.1093/brain/123.3.572; Strafella AP, 2000, NEUROREPORT, V11, P2289, DOI 10.1097/00001756-200007140-00044; Urgesi C, 2006, EUR J NEUROSCI, V23, P2522, DOI 10.1111/j.1460-9568.2006.04772.x; Urgesi C, 2010, CEREB CORTEX, V20, P2511, DOI 10.1093/cercor/bhp292; Wolters A, 2003, J NEUROPHYSIOL, V89, P2339, DOI 10.1152/jn.00900.2002; Ziemann U, 2004, J NEUROSCI, V24, P1666, DOI 10.1523/JNEUROSCI.5016-03.2004; Ziemann U, 2001, BRAIN, V124, P1171, DOI 10.1093/brain/124.6.1171	45	14	14	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e38754	10.1371/journal.pone.0038754	http://dx.doi.org/10.1371/journal.pone.0038754			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701704	gold, Green Published, Green Submitted			2022-12-27	WOS:000305348400093
J	Ludt, WB; Bernal, MA; Bowen, BW; Rocha, LA				Ludt, William B.; Bernal, Moises A.; Bowen, Brian W.; Rocha, Luiz A.			Living in the Past: Phylogeography and Population Histories of Indo-Pacific Wrasses (Genus Halichoeres) in Shallow Lagoons versus Outer Reef Slopes	PLOS ONE			English	Article							DNA; MITOCHONDRIAL; SEA; FISHES; CONNECTIVITY; PERCIFORMES; HAPLOTYPES; DIVERSITY; GROWTH	Sea level fluctuations during glacial cycles affect the distribution of shallow marine biota, exposing the continental shelf on a global scale, and displacing coral reef habitat to steep slopes on oceanic islands. In these circumstances we expect that species inhabiting lagoons should show shallow genetic architecture relative to species inhabiting more stable outer reefs. Here we test this expectation on an ocean-basin scale with four wrasses (genus Halichoeres): H. claudia (N = 194, with oceanwide distribution) and H. ornatissimus (N = 346, a Hawaiian endemic) inhabit seaward reef slopes, whereas H. trimaculatus (N = 239) and H. margaritaceus (N = 118) inhabit lagoons and shallow habitats throughout the Pacific. Two mitochondrial markers (cytochrome oxidase I and control region) were sequenced to resolve population structure and history of each species. Haplotype and nucleotide diversity were similar among all four species. The outer reef species showed significantly less population structure, consistent with longer pelagic larval durations. Mismatch distributions and significant negative Fu's F values indicate Pleistocene population expansion for all species, and (contrary to expectations) shallower histories in the outer slope species. We conclude that lagoonal wrasses may persist through glacial habitat disruptions, but are restricted to refugia during lower sea level stands. In contrast, outer reef slope species have homogeneous and well-connected populations through their entire ranges regardless of sea level fluctuations. These findings contradict the hypothesis that shallow species are less genetically diverse as a consequence of glacial cycles.	[Ludt, William B.; Bernal, Moises A.] Univ Texas Austin, Dept Marine Sci, Austin, TX 78712 USA; [Bowen, Brian W.] Univ Hawaii, Hawaiian Inst Marine Biol, Kaneohe, HI USA; [Rocha, Luiz A.] Calif Acad Sci, Dept Ichthyol, San Francisco, CA 94118 USA	University of Texas System; University of Texas Austin; University of Hawaii System; California Academy of Sciences	Ludt, WB (corresponding author), Univ Texas Austin, Dept Marine Sci, Austin, TX 78712 USA.	wbludt@gmail.com	Rocha, Luiz/C-5107-2011; Rocha, Luiz/T-6326-2019	Rocha, Luiz/0000-0003-4011-569X; Ludt, William/0000-0002-0599-9699; Bernal, Moises/0000-0002-3236-8403	University of Texas Marine Science Institute, US National Science Foundation [OCE-0454873, OCE-0453167, OCE-0623678, OCE-0929031]; UH EECB program [OCE-0232016]	University of Texas Marine Science Institute, US National Science Foundation; UH EECB program	Financial support was provided by the University of Texas Marine Science Institute, US National Science Foundation Grants to B.W.B. and R.J.T. (OCE-0454873, OCE-0453167, OCE-0623678, and OCE-0929031) and to the UH EECB program (OCE-0232016), in conjunction with the HIMB-NWHI Coral Reef Research Partnership (NMSP MOA 2005-008/6682) and Cocos and Christmas Island collection support from National Geographic Society grant to M. Craig and L.A. Rocha (8208-07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen G.R., 2003, REEF FISH IDENTIFICA; Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x; Bay LK, 2004, MAR BIOL, V144, P757, DOI 10.1007/s00227-003-1224-3; Beerli P, 2010, GENETICS, V185, P313, DOI 10.1534/genetics.109.112532; Bellwood David R., 2002, P5, DOI 10.1016/B978-012615185-5/50003-7; Bowen BW, 2006, J HERED, V97, P1, DOI 10.1093/jhered/esj006; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Craig MT, 2007, MAR ECOL PROG SER, V334, P245, DOI 10.3354/meps334245; Crandall ED, 2008, MOL ECOL, V17, P611, DOI 10.1111/j.1365-294X.2007.03600.x; DiBattista Joseph D., 2011, Journal of Marine Biology, V2011, P1, DOI 10.1155/2011/839134; DOHERTY PJ, 1995, ECOLOGY, V76, P2373, DOI 10.2307/2265814; Drummond AJ, 2002, GENETICS, V161, P1307; Eble Jeff A., 2011, Journal of Marine Biology, V2011, P1; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; FAIRBANKS RG, 1989, NATURE, V342, P637, DOI 10.1038/342637a0; Fauvelot C, 2003, EVOLUTION, V57, P1571; Fu YX, 1997, GENETICS, V147, P915; Gaither MR, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-189; Gaither MR, 2010, J BIOGEOGR, V37, P133, DOI 10.1111/j.1365-2699.2009.02188.x; GOSLINE WA, 1965, ECOLOGY, V46, P823, DOI 10.2307/1934015; Grant WS, 1998, J HERED, V89, P415, DOI 10.1093/jhered/89.5.415; HARPENDING HC, 1994, HUM BIOL, V66, P591; He LJ, 2010, J EXP MAR BIOL ECOL, V385, P20, DOI 10.1016/j.jembe.2010.01.019; Horne JB, 2008, MOL PHYLOGENET EVOL, V49, P629, DOI 10.1016/j.ympev.2008.08.023; Janko K, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-220; Karl SA, 2012, MOL ECOL IN PRESS; Klanten OS, 2007, MAR BIOL, V150, P659, DOI 10.1007/s00227-006-0372-7; LEE WJ, 1995, J MOL EVOL, V41, P54; Lessios HA, 2008, ANNU REV ECOL EVOL S, V39, P63, DOI 10.1146/annurev.ecolsys.38.091206.095815; Meeker ND, 2007, BIOTECHNIQUES, V43, P610, DOI 10.2144/000112619; Molengraaff GAF, 1921, P K AKAD WET-AMSTERD, V23, P395; Nei M., 1987, MOL EVOLUTIONARY GEN; PAULAY G, 1990, PALEOBIOLOGY, V16, P415, DOI 10.1017/S0094837300010162; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Randall JE, 1997, FISHES GREAT BARRIER; Randall JE, 2009, ZOOL STUD, V48, P709; Reece JS, 2011, MAR ECOL PROG SER, V437, P269, DOI 10.3354/meps09248; ROGERS AR, 1995, EVOLUTION, V49, P608, DOI 10.1111/j.1558-5646.1995.tb02297.x; SEUTIN G, 1991, CAN J ZOOL, V69, P82, DOI 10.1139/z91-013; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TEMPLETON AR, 1992, GENETICS, V132, P619; Thacker CE, 2004, CORAL REEFS, V23, P357, DOI 10.1007/s00338-004-0391-0; Toonen Robert J, 2011, J Mar Biol, V2011, DOI 10.1155/2011/460173; VICTOR BC, 1986, MAR BIOL, V90, P317, DOI 10.1007/BF00428555; Voris HK, 2000, J BIOGEOGR, V27, P1153, DOI 10.1046/j.1365-2699.2000.00489.x; Wallace A. R., 1880; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Weersing K, 2009, MAR ECOL PROG SER, V393, P1, DOI 10.3354/meps08287; Winters KL, 2010, MAR BIOL, V157, P1679, DOI 10.1007/s00227-010-1442-4; Woodroffe CD, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044067	52	32	32	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e38042	10.1371/journal.pone.0038042	http://dx.doi.org/10.1371/journal.pone.0038042			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701597	gold, Green Published, Green Submitted			2022-12-27	WOS:000305348400031
J	Schlaak, JF; Trippler, M; Hoyo-Becerra, C; Erim, Y; Kis, B; Wang, B; Scherbaum, N; Gerken, G				Schlaak, Joerg F.; Trippler, Martin; Hoyo-Becerra, Carolina; Erim, Yesim; Kis, Bernhard; Wang, Bo; Scherbaum, Norbert; Gerken, Guido			Selective Hyper-responsiveness of the Interferon System in Major Depressive Disorders and Depression Induced by Interferon Therapy	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; NONPARENCHYMAL LIVER-CELLS; VIRUS-INFECTION; PLUS RIBAVIRIN; GENE-EXPRESSION; RECEPTOR GENE; RISK-FACTORS; ALPHA; SYMPTOMS; DISC1	Background: Though an important percentage of patients with chronic hepatitis C virus (HCV) undergoing interferon (IFN) therapy develop depressive symptoms, the role of the IFN system in the pathogenesis of depressive disorders is not well understood. Methods: 50 patients with HCV infection were treated with standard combination therapy (pegylated IFN-alpha 2a/ribavirin). IFN-induced gene expression was analyzed to identify genes which are differentially regulated in patients with or without IFN-induced depression. For validation, PBMC from 22 psychiatric patients with a severe depressive episode (SDE) and 11 controls were cultivated in vitro with pegylated IFN-alpha 2a and gene expression was analyzed. Results: IFN-induced depression in HCV patients was associated with selective upregulation of 15 genes, including 6 genes that were previously described to be relevant for major depressive disorders or neuronal development. In addition, increased endogenous IFN-production and selective hyper-responsiveness of these genes to IFN stimulation were observed in SDE patients. Conclusions: Our data suggest that selective hyper-responsiveness to exogenous (IFN therapy) or endogenous (depressive disorders) type I IFNs may lead to the development of depressive symptoms. These data could lead to the discovery of novel therapeutic approaches to treat IFN-induced and major depressive disorders.	[Schlaak, Joerg F.; Trippler, Martin; Hoyo-Becerra, Carolina; Wang, Bo; Gerken, Guido] Univ Hosp Essen, Dept Gastroenterol & Hepatol, Essen, Germany; [Erim, Yesim] Rhein Kliniken, Dept Psychosomat, Essen, Germany; [Scherbaum, Norbert] LVR Klinikum, Addict Res Grp, Dept Psychiat & Psychotherapy, Essen, Germany	University of Duisburg Essen	Schlaak, JF (corresponding author), Univ Hosp Essen, Dept Gastroenterol & Hepatol, Essen, Germany.	joerg.schlaak@uni-due.de	Kis, Bernhard/A-8731-2008	Kis, Bernhard/0000-0003-3244-9737; Schlaak, Joerg/0000-0002-9499-1014; Gerken, Guido/0000-0001-6734-5001				Asnis GM, 2006, J CLIN GASTROENTEROL, V40, P322, DOI 10.1097/01.mcg.0000210099.36500.fe; Bezemer G, 2012, NEUROPSYCHOBIOLOGY, V65, P126, DOI 10.1159/000330585; Bigger CB, 2004, J VIROL, V78, P13779, DOI 10.1128/JVI.78.24.13779-13792.2004; Blackwood DHR, 2001, AM J HUM GENET, V69, P428, DOI 10.1086/321969; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Broering R, 2008, J HEPATOL, V48, P914, DOI 10.1016/j.jhep.2008.01.028; Broering R, 2011, CLIN SCI, V121, P415, DOI 10.1042/CS20110065; Bull SJ, 2009, MOL PSYCHIATR, V14, P1095, DOI 10.1038/mp.2008.48; Callicott JH, 2005, P NATL ACAD SCI USA, V102, P8627, DOI 10.1073/pnas.0500515102; Capuron L, 2003, AM J PSYCHIAT, V160, P1342, DOI 10.1176/appi.ajp.160.7.1342; Chen LM, 2005, GASTROENTEROLOGY, V128, P1437, DOI 10.1053/j.gastro.2005.01.059; Chuang JZ, 2005, DEV CELL, V9, P75, DOI 10.1016/j.devcel.2005.04.003; Elomaa AP, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-2; Felger JC, 2007, BIOL PSYCHIAT, V62, P1324, DOI 10.1016/j.biopsych.2007.05.026; Flavell SW, 2006, SCIENCE, V311, P1008, DOI 10.1126/science.1122511; Forton DM, 2004, J VIROL, V78, P5170, DOI 10.1128/JVI.78.10.5170-5183.2004; Forton DM, 2002, HEPATOLOGY, V35, P433, DOI 10.1053/jhep.2002.30688; Forton DM, 2001, LANCET, V358, P38, DOI 10.1016/S0140-6736(00)05270-3; Foster GR, 1998, HEPATOLOGY, V27, P209, DOI 10.1002/hep.510270132; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; GASTL G, 1986, IMMUNOBIOLOGY, V172, P262, DOI 10.1016/S0171-2985(86)80107-3; Hahn H, 2001, ARCH NEUROL-CHICAGO, V58, P749, DOI 10.1001/archneur.58.5.749; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Heiman GA, 2004, NEUROLOGY, V63, P631, DOI 10.1212/01.WNL.0000137113.39225.FA; Hennah W, 2003, HUM MOL GENET, V12, P3151, DOI 10.1093/hmg/ddg341; Howren MB, 2009, PSYCHOSOM MED, V71, P171, DOI 10.1097/PSY.0b013e3181907c1b; Hu X., 2011, J CLIN PHARM; HUBER C, 1984, J EXP MED, V160, P310, DOI 10.1084/jem.160.1.310; HUBER C, 1983, J IMMUNOL, V130, P1047; Kamata M, 2000, EUR NEUROPSYCHOPHARM, V10, P129, DOI 10.1016/S0924-977X(99)00067-X; Kamiya A, 2005, NAT CELL BIOL, V7, P1167, DOI 10.1038/ncb1328; Kanda T, 2007, J VIROL, V81, P12375, DOI 10.1128/JVI.01695-07; Kaneko N, 2006, NEUROPSYCHOPHARMACOL, V31, P2619, DOI 10.1038/sj.npp.1301137; Kato T, 2001, NEUROSCI RES, V40, P105, DOI 10.1016/S0168-0102(01)00221-8; Kealey C, 2005, AM J MED GENET B, V136B, P75, DOI 10.1002/ajmg.b.30192; Kitagami T, 2003, BRAIN RES, V978, P104, DOI 10.1016/S0006-8993(03)02776-8; Konakova M, 2001, ARCH NEUROL-CHICAGO, V58, P921, DOI 10.1001/archneur.58.6.921; Kraus MR, 2007, GASTROENTEROLOGY, V132, P1279, DOI 10.1053/j.gastro.2007.02.053; Laskus T, 2002, J VIROL, V76, P10064, DOI 10.1128/JVI.76.19.10064-10068.2002; Lee PY, 2009, AM J PATHOL, V175, P2023, DOI 10.2353/ajpath.2009.090328; Li Y, 2008, NEURON, V59, P399, DOI 10.1016/j.neuron.2008.06.023; Liang T. Jake, 2000, Annals of Internal Medicine, V132, P296; Loftis JM, 2008, NEUROSCI LETT, V430, P264, DOI 10.1016/j.neulet.2007.11.001; Maes M, 2009, METAB BRAIN DIS, V24, P27, DOI 10.1007/s11011-008-9118-1; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Mao ZX, 1999, SCIENCE, V286, P785, DOI 10.1126/science.286.5440.785; Miller AH, 2009, BRAIN BEHAV IMMUN, V23, P149, DOI 10.1016/j.bbi.2008.08.006; Morikawa O, 1998, EUR J PHARMACOL, V349, P317, DOI 10.1016/S0014-2999(98)00187-3; Myint AM, 2005, J AFFECT DISORDERS, V88, P167, DOI 10.1016/j.jad.2005.07.008; O'Connor JC, 2009, MOL PSYCHIATR, V14, P511, DOI 10.1038/sj.mp.4002148; O'Connor JC, 2009, J NEUROSCI, V29, P4200, DOI 10.1523/JNEUROSCI.5032-08.2009; O'Connor JC, 2009, J IMMUNOL, V182, P3202, DOI 10.4049/jimmunol.0802722; Pasquali S, 2010, CURR MED CHEM, V17, P3327, DOI 10.2174/092986710793176393; Perera TD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017600; Raison CL, 2006, TRENDS IMMUNOL, V27, P24, DOI 10.1016/j.it.2005.11.006; Raison CL, 2005, J CLIN PSYCHIAT, V66, P41, DOI 10.4088/JCP.v66n0106; Raison CL, 2005, BRAIN BEHAV IMMUN, V19, P23, DOI 10.1016/j.bbi.2004.05.001; Sawamura N, 2005, P NATL ACAD SCI USA, V102, P1187, DOI 10.1073/pnas.0406543102; SCHLAAK JF, 1994, J INVEST DERMATOL, V102, P145, DOI 10.1111/1523-1747.ep12371752; Shalizi A, 2006, SCIENCE, V311, P1012, DOI 10.1126/science.1122513; SHIMIZU H, 1995, ENDOCR J, V42, P551, DOI 10.1507/endocrj.42.551; Smith A.K., 2011, MOL PSYCHIAT; Smith KJ, 2011, NEUROPSYCH DIS TREAT, V7, P275, DOI 10.2147/NDT.S13917; Sohn H, 2006, FASEB J, V20, P1248, DOI 10.1096/fj.05-4911fje; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Uher R, 2011, HARVARD REV PSYCHIAT, V19, P109, DOI 10.3109/10673229.2011.586551; Wang J, 2008, MOL PSYCHIATR, V13, P293, DOI 10.1038/sj.mp.4002013; Wichers MC, 2007, J PSYCHOSOM RES, V62, P207, DOI 10.1016/j.jpsychores.2006.09.007; Wong ML, 2008, MOL PSYCHIATR, V13, P800, DOI 10.1038/mp.2008.59; Wu J, 2007, HEPATOLOGY, V46, P1769, DOI 10.1002/hep.21897; Yoshida K, 2005, NEUROPSYCHOBIOLOGY, V52, P55, DOI 10.1159/000086605; Zhang P, 2008, MOL PHYLOGENET EVOL, V49, P586, DOI 10.1016/j.ympev.2008.08.020; Zhao LJ, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-157; Zoller H, 2011, J INTERFERON CYTOKIN	75	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e38668	10.1371/journal.pone.0038668	http://dx.doi.org/10.1371/journal.pone.0038668			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701688	Green Published, Green Submitted, gold			2022-12-27	WOS:000305348400082
J	Wang, HJ; Giambini, H; Zhang, WJ; Ye, GH; Zhao, CF; An, KN; Li, YK; Lan, WR; Li, JY; Jiang, XS; Zou, QL; Zhang, XY; Chen, C				Wang, Hua-Jun; Giambini, Hugo; Zhang, Wen-Jun; Ye, Gan-Hu; Zhao, Chunfeng; An, Kai-Nan; Li, Yi-Kai; Lan, Wen-Rui; Li, Jian-You; Jiang, Xue-Sheng; Zou, Qiu-Lan; Zhang, Xiao-Ying; Chen, Chao			A Modified Sagittal Spine Postural Classification and Its Relationship to Deformities and Spinal Mobility in a Chinese Osteoporotic Population	PLOS ONE			English	Article							QUALITY-OF-LIFE; BACK EXTENSOR STRENGTH; VERTEBRAL FRACTURES; KYPHOSIS; ALIGNMENT; BALANCE; PAIN; IMPACT; WOMEN; RISK	Background: Abnormal posture and spinal mobility have been demonstrated to cause functional impairment in the quality of life, especially in the postmenopausal osteoporotic population. Most of the literature studies focus on either thoracic kyphosis or lumbar lordosis, but not on the change of the entire spinal alignment. Very few articles reported the spinal alignment of Chinese people. The purpose of this study was threefold: to classify the spinal curvature based on the classification system defined by Satoh consisting of the entire spine alignment; to identify the change of trunk mobility; and to relate spinal curvature to balance disorder in a Chinese population. Methodology/Principal Findings: 450 osteoporotic volunteers were recruited for this study. Spinal range of motion and global curvature were evaluated noninvasively using the Spinal-Mouse (R) system and sagittal postural deformities were characterized. Results: We found a new spine postural alignment consisting of an increased thoracic kyphosis and decreased lumbar lordosis which we classified as our modified round back. We did not find any of Satoh's type 5 classification in our population. Type 2 sagittal alignment was the most common spinal deformity (38.44%). In standing, thoracic kyphosis angles in types 2 (58.34 degrees) and 3 (58.03 degrees) were the largest and lumbar lordosis angles in types 4 (13.95 degrees) and 5 (-8.61 degrees) were the smallest. The range of flexion (ROF) and range of flexion-extension (ROFE) of types 2 and 3 were usually greater than types 4 and 5, with type 1 being the largest. Conclusions/Significance: The present study classified and compared for the first time the mobility, curvature and balance in a Chinese population based on the entire spine alignment and found types 4 and 5 to present the worst balance and mobility. This study included a new spine postural alignment classification that should be considered in future population studies.	[Wang, Hua-Jun; Zhang, Wen-Jun; Li, Yi-Kai; Lan, Wen-Rui; Chen, Chao] So Med Univ, Sch Tradit Chinese Med, Dept Orthoped, Guangzhou, Guangdong, Peoples R China; [Wang, Hua-Jun; Giambini, Hugo; Zhao, Chunfeng; An, Kai-Nan] Mayo Clin, Div Orthoped Res, Biomech Lab, Rochester, MN USA; [Ye, Gan-Hu] Chang Ping Hosp, Dongguan, Peoples R China; [Li, Jian-You; Jiang, Xue-Sheng] Huzhou Cent Hosp, Dept Orthoped, Huzhou, Peoples R China; [Zou, Qiu-Lan; Zhang, Xiao-Ying] You Hao Residential Care Home, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Mayo Clinic; Huzhou University	Wang, HJ (corresponding author), So Med Univ, Sch Tradit Chinese Med, Dept Orthoped, Guangzhou, Guangdong, Peoples R China.	chenchao@smu.edu.cn			National Natural Science Foundation of China [30700893, 31171024]; Huzhou Science and Technology RD Fund [2009YS04, 2010GS01]; third phase of important subject construction programme of "211 Project" of Guangdong province	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Huzhou Science and Technology RD Fund; third phase of important subject construction programme of "211 Project" of Guangdong province	This study is funded by the grant from National Natural Science Foundation of China (30700893 and 31171024), Huzhou Science and Technology R&D Fund (2009YS04 and 2010GS01) and the third phase of important subject construction programme of "211 Project" of Guangdong province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrey C, 2007, EUR SPINE J, V16, P1459, DOI 10.1007/s00586-006-0294-6; Berthonnaud E, 2011, EUR SPINE J, V20, pS572; Briggs AM, 2007, OSTEOPOROSIS INT, V18, P575, DOI 10.1007/s00198-006-0304-x; Cheung E, 2011, MATURITAS, V69, P50, DOI 10.1016/j.maturitas.2011.01.010; de Boer J, 2002, SCIENCE, V296, P1276, DOI 10.1126/science.1070174; Hinman Martha R, 2004, Spine J, V4, P413, DOI 10.1016/j.spinee.2004.01.002; Hongo M, 2007, OSTEOPOROSIS INT, V18, P1389, DOI 10.1007/s00198-007-0398-9; Hongo M, 2012, OSTEOPOROSIS INT, V23, P1029, DOI 10.1007/s00198-011-1624-z; Huang MH, 2006, J BONE MINER RES, V21, P419, DOI 10.1359/JBMR.051201; Imagama S, 2011, EUR SPINE J, V20, P954, DOI 10.1007/s00586-010-1606-4; Ishikawa Y, 2009, OSTEOPOROSIS INT, V20, P2049, DOI 10.1007/s00198-009-0919-9; ITOI E, 1991, SPINE, V16, P750, DOI 10.1097/00007632-199107000-00011; JACKSON RP, 1994, SPINE, V19, P1611, DOI 10.1097/00007632-199407001-00010; Jang JS, 2007, J NEUROSURG-SPINE, V7, P387, DOI 10.3171/SPI-07/10/387; Kado DM, 2009, ANN INTERN MED, V150, P681, DOI 10.7326/0003-4819-150-10-200905190-00005; Kalfopulos Baron Zarate-, 2012, J NEUROSURG-SPINE, V2, P1; Kasukawa Y, 2010, J BONE MINER METAB, V28, P82, DOI 10.1007/s00774-009-0107-1; Katzman WB, 2011, OSTEOPOROSIS INT, V22, P85, DOI 10.1007/s00198-010-1265-7; Lee CS, 2011, SPINE, V36, pE1648, DOI 10.1097/BRS.0b013e318216b0fd; Legaye J, 2005, EUR SPINE J, V71, P213; Lynn SG, 1997, ARCH PHYS MED REHAB, V78, P273, DOI 10.1016/S0003-9993(97)90033-2; Mannion AF, 2004, EUR SPINE J, V13, P122, DOI 10.1007/s00586-003-0618-8; Martin AR, 2002, BONE, V31, P32, DOI 10.1016/S8756-3282(02)00787-1; Mendoza-Lattes S, 2010, SPINE, V35, pE792, DOI 10.1097/BRS.0b013e3181d35ca9; Mika A, 2005, SPINE, V30, P241, DOI 10.1097/01.brs.0000150521.10071.df; Miyakoshi N, 2007, OSTEOPOROSIS INT, V18, P1397, DOI 10.1007/s00198-007-0383-3; Miyakoshi N, 2005, OSTEOPOROSIS INT, V16, P1871, DOI 10.1007/s00198-005-1953-x; Miyakoshi N, 2003, OSTEOPOROSIS INT, V14, P1007, DOI 10.1007/s00198-003-1510-4; Nevitt MC, 1998, ANN INTERN MED, V128, P793, DOI 10.7326/0003-4819-128-10-199805150-00001; Obeid Ibrahim, 2011, Eur Spine J, V20 Suppl 5, P681, DOI 10.1007/s00586-011-1936-x; Post RB, 2004, ARCH ORTHOP TRAUM SU, V124, P187, DOI 10.1007/s00402-004-0641-1; Reginster JY, 2006, BONE, V38, P4, DOI 10.1016/j.bone.2005.11.024; Roussouly P, 2005, SPINE, V30, P346, DOI 10.1097/01.brs.0000152379.54463.65; Ryan SD, 1997, J AM GERIATR SOC, V45, P1479, DOI 10.1111/j.1532-5415.1997.tb03199.x; Satoh K, 1988, CONT ORTHOP, V16, P23; Schneider DL, 2004, J RHEUMATOL, V31, P747; Sinaki M, 1996, MAYO CLIN PROC, V71, P951, DOI 10.4065/71.10.951; Sinaki M, 2005, OSTEOPOROSIS INT, V16, P1004, DOI 10.1007/s00198-004-1791-2; Sinaki M, 2005, MAYO CLIN PROC, V80, P849, DOI 10.4065/80.7.849; Smith A, 2008, SPINE, V33, P2101, DOI 10.1097/BRS.0b013e31817ec3b0; Staffel F., 1889, MENSCHLICHEN HALTUNG; STAGNARA P, 1982, SPINE, V7, P335, DOI 10.1097/00007632-198207000-00003; Takahashi T, 2005, OSTEOPOROSIS INT, V16, P273, DOI 10.1007/s00198-004-1669-3; TAKEMITSU Y, 1988, SPINE, V13, P1317, DOI 10.1097/00007632-198811000-00019; Tuzun C, 1999, CLIN RHEUMATOL, V18, P308, DOI 10.1007/s100670050107; Wiles P., 1937, LANCET, V229, P911, DOI [10.1016/S0140-6736(00)82825-1, DOI 10.1016/S0140-6736(00)82825-1]	46	16	17	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e38560	10.1371/journal.pone.0038560	http://dx.doi.org/10.1371/journal.pone.0038560			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22693647	Green Published, Green Submitted, gold			2022-12-27	WOS:000305343900059
J	Jagai, JS; Sarkar, R; Castronovo, D; Kattula, D; McEntee, J; Ward, H; Kang, G; Naumova, EN				Jagai, Jyotsna S.; Sarkar, Rajiv; Castronovo, Denise; Kattula, Deepthi; McEntee, Jesse; Ward, Honorine; Kang, Gagandeep; Naumova, Elena N.			Seasonality of Rotavirus in South Asia: A Meta-Analysis Approach Assessing Associations with Temperature, Precipitation, and Vegetation Index	PLOS ONE			English	Article							HOSPITAL-BASED SURVEILLANCE; AGED LESS-THAN-5 YEARS; ACUTE WATERY DIARRHEA; TIME-SERIES ANALYSIS; GLOBAL SEASONALITY; CHILDHOOD DIARRHEA; GENOMIC DIVERSITY; NORTHERN INDIA; DISEASE BURDEN; BIRTH COHORT	Background: Rotavirus infection causes a significant proportion of diarrhea in infants and young children worldwide leading to dehydration, hospitalization, and in some cases death. Rotavirus infection represents a significant burden of disease in developing countries, such as those in South Asia. Methods: We conducted a meta-analysis to examine how patterns of rotavirus infection relate to temperature and precipitation in South Asia. Monthly rotavirus data were abstracted from 39 published epidemiological studies and related to monthly aggregated ambient temperature and cumulative precipitation for each study location using linear mixed-effects models. We also considered associations with vegetation index, gathered from remote sensing data. Finally, we assessed whether the relationship varied in tropical climates and humid mid-latitude climates. Results: Overall, as well as in tropical and humid mid-latitude climates, low temperature and precipitation levels are significant predictors of an increased rate of rotaviral diarrhea. A 1 degrees C decrease in monthly ambient temperature and a decrease of 10 mm in precipitation are associated with 1.3% and 0.3% increase above the annual level in rotavirus infections, respectively. When assessing lagged relationships, temperature and precipitation in the previous month remained significant predictors and the association with temperature was stronger in the tropical climate. The same association was seen for vegetation index; a seasonal decline of 0.1 units results in a 3.8% increase in rate of rotavirus. Conclusions: In South Asia the highest rate of rotavirus was seen in the colder, drier months. Meteorological characteristics can be used to better focus and target public health prevention programs.	[Jagai, Jyotsna S.] US EPA, Natl Hlth & Environm Effects Res Lab, Off Res & Dev, Res Triangle Pk, NC 27711 USA; [Jagai, Jyotsna S.; Ward, Honorine; Naumova, Elena N.] Tufts Univ, Sch Med, Dept Publ Hlth & Community Med, Boston, MA 02111 USA; [Sarkar, Rajiv; Kattula, Deepthi; Ward, Honorine; Kang, Gagandeep; Naumova, Elena N.] Christian Med Coll & Hosp, Vellore, Tamil Nadu, India; [Castronovo, Denise] Mapping Sustainabil LLC, Jupiter, FL USA; [McEntee, Jesse] Cardiff Univ, ESRC Ctr Business Relationships Accountabil Susta, Cardiff, S Glam, Wales; [Naumova, Elena N.] Tufts Univ, Dept Civil & Environm Engn, Sch Engn, Medford, MA 02155 USA	United States Environmental Protection Agency; Massachusetts Department of Public Health; Tufts University; Christian Medical College & Hospital (CMCH) Vellore; Cardiff University; UK Research & Innovation (UKRI); Economic & Social Research Council (ESRC); Tufts University	Jagai, JS (corresponding author), US EPA, Natl Hlth & Environm Effects Res Lab, Off Res & Dev, Res Triangle Pk, NC 27711 USA.	jagai.jyotsna@epa.gov; elena.naumova@tufts.edu	Sarkar, Rajiv/AAU-7203-2021; Naumova, Elena/AAP-3395-2020	Sarkar, Rajiv/0000-0003-0616-3129; Naumova, Elena/0000-0002-9562-4734; Kang, Gagandeep/0000-0002-3656-564X	National Institute of Environmental Health Sciences [NIEHS ES 013171]; CDC/IMCR; National Institutes of Health (NIH); Ruth L. Kirschstein NIH National Research Trainee Fellowship [T90-DK070117-05]; FIC Global Infectious Disease Research Training grant [D43 TW007392]; PHS grant "Molecular epidemiology of cryptosporidiosis in India" [R03 TW2711]; PHS grant "Immune Response to Cryptosporidium in a Birth Cohort of Children of South India" [NIAID R01 AI072222]; CDC/Indo-US Concept "Environmental Indicators for Diarrheal Infections in South India"; Global Infectious Disease Research Training Grant [D43TW007392]; FOGARTY INTERNATIONAL CENTER [D43TW007392] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072222] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T90DK070117] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES013171] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); CDC/IMCR; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirschstein NIH National Research Trainee Fellowship; FIC Global Infectious Disease Research Training grant; PHS grant "Molecular epidemiology of cryptosporidiosis in India"; PHS grant "Immune Response to Cryptosporidium in a Birth Cohort of Children of South India"; CDC/Indo-US Concept "Environmental Indicators for Diarrheal Infections in South India"; Global Infectious Disease Research Training Grant; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was funded in part by the National Institute of Environmental Health Sciences (NIEHS ES 013171, ENN); CDC/IMCR, National Institutes of Health (NIH), Ruth L. Kirschstein NIH National Research Trainee Fellowship (T90-DK070117-05, JSJ); FIC Global Infectious Disease Research Training grant (D43 TW007392, RS); PHS grants "Molecular epidemiology of cryptosporidiosis in India" (R03 TW2711, GK) and "Immune Response to Cryptosporidium in a Birth Cohort of Children of South India" (NIAID R01 AI072222, HW); CDC/Indo-US Concept "Environmental Indicators for Diarrheal Infections in South India" (ENN); and the Global Infectious Disease Research Training Grant (D43TW007392; GK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed K, 2010, VIRUS GENES, V40, P347, DOI 10.1007/s11262-010-0463-x; Ahmed K, 2010, ARCH VIROL, V155, P71, DOI 10.1007/s00705-009-0552-0; Ananthan S, 2000, INDIAN J MED RES, V111, P50; ANSARI SA, 1991, REV INFECT DIS, V13, P448; Armah GE, 2010, LANCET, V376, P606, DOI 10.1016/S0140-6736(10)60889-6; Atchison CJ, 2009, EPIDEMIOL INFECT, V137, P957, DOI 10.1017/S0950268808001933; Bahl R, 2005, J INFECT DIS, V192, pS114, DOI 10.1086/431497; Banerjee I, 2006, J CLIN MICROBIOL, V44, P2468, DOI 10.1128/JCM.01882-05; Bavia M. E., 2005, Parassitologia (Rome), V47, P165; BHAT P, 1985, INDIAN J MED RES, V82, P105; BINGNAN F, 1991, Journal of Clinical Microbiology, V29, P1359; BLACK RE, 1982, AM J EPIDEMIOL, V115, P315, DOI 10.1093/oxfordjournals.aje.a113308; Bobak M, 2001, HUM REPROD, V16, P1512, DOI 10.1093/humrep/16.7.1512; Bresee J, 2004, EMERG INFECT DIS, V10, P988, DOI 10.3201/eid1006.030519; BROOR S, 1993, J DIARRHOEAL DIS RES, V11, P14; BROWN DWG, 1988, J CLIN MICROBIOL, V26, P2410, DOI 10.1128/JCM.26.11.2410-2414.1988; Brownstein JS, 2002, VECTOR-BORNE ZOONOT, V2, P157, DOI 10.1089/15303660260613729; Buttery JP, 2007, CURR OPIN INFECT DIS, V20, P253, DOI 10.1097/QCO.0b013e32813aeaac; Chakravarti A, 2010, SE ASIAN J TROP MED, V41, P1145; COOK SM, 1990, B WORLD HEALTH ORGAN, V68, P171; Cringoli G., 2005, Parassitologia (Rome), V47, P51; Cunliffe NA, 1998, B WORLD HEALTH ORGAN, V76, P525; D'Souza RM, 2008, EPIDEMIOL INFECT, V136, P56, DOI 10.1017/S0950268807008229; Deering D.W., 1975, PROC 10 INT S REMOTE, V2, P1169; Gebre-Michael T., 2005, Parassitologia (Rome), V47, P135; Glass RI, 2006, ADV EXP MED BIOL, V582, P45; Global Land Cover Facilty GLCF, 2011, GLOB INV MOD MAPP ST; GOWARD SN, 1985, VEGETATIO, V64, P3, DOI 10.1007/BF00033449; Jagai JS, 2009, ENVIRON RES, V109, P465, DOI 10.1016/j.envres.2009.02.008; Kang G, 2009, J INFECT DIS, V200, pS147, DOI 10.1086/605031; KHAN MU, 1988, T ROY SOC TROP MED H, V82, P485, DOI 10.1016/0035-9203(88)90172-1; Lam D A, 1991, Adv Exp Med Biol, V286, P73; LAM DA, 1991, SOC BIOL, V38, P51; Levy K, 2009, INT J EPIDEMIOL, V38, P1487, DOI 10.1093/ije/dyn260; Lipsitch M, 2009, P NATL ACAD SCI USA, V106, P3645, DOI 10.1073/pnas.0900933106; LIU HQ, 1995, IEEE T GEOSCI REMOTE, V33, P457, DOI 10.1109/36.377946; Mishra V, 2010, CLIN MICROBIOL INFEC, V16, P45, DOI 10.1111/j.1469-0691.2009.02772.x; Moe K, 2005, J INFECT DIS, V192, pS111, DOI 10.1086/431509; Nair GB, 2010, GUT PATHOG, V2, DOI 10.1186/1757-4749-2-4; NATH G, 1992, INDIAN J MED RES-A, V95, P259; National Aeronautics and Space Administration Earth Observatory, 2011, MEAS VEG NDVI EVI; Naumova EN, 2007, EPIDEMIOL INFECT, V135, P281, DOI 10.1017/S0950268806006698; Naumova EN, 2007, STAT IND TECHNOL, P437, DOI 10.1007/978-0-8176-4542-7_28; Nishio O, 2000, PEDIATR INT, V42, P425, DOI 10.1046/j.1442-200x.2000.01256.x; Nyambat B, 2009, J INFECT DIS, V200, pS160, DOI 10.1086/605030; PANIKER CKJ, 1982, B WORLD HEALTH ORGAN, V60, P123; Parashar UD, 2003, EMERG INFECT DIS, V9, P565, DOI 10.3201/eid0905.020562; Parashar UD, 1998, EMERG INFECT DIS, V4, P561, DOI 10.3201/eid0404.980406; Parashar UD, 2006, EMERG INFECT DIS, V12, P304; Parashar UD, 2009, J INFECT DIS, V200, pS9, DOI 10.1086/605025; PATWARI AK, 1994, J TROP PEDIATRICS, V40, P214, DOI 10.1093/tropej/40.4.214; Peel MC, 2007, HYDROL EARTH SYST SC, V11, P1633, DOI 10.5194/hess-11-1633-2007; Phukan Anil C, 2003, Indian J Pathol Microbiol, V46, P274; Pitzer VE, 2011, J R SOC INTERFACE, V8, P1584, DOI 10.1098/rsif.2011.0062; Pitzer VE, 2009, SCIENCE, V325, P290, DOI 10.1126/science.1172330; Purohit SG, 1998, J DIARRHOEAL DIS RES, V16, P74; Qadri F, 2007, INFECT IMMUN, V75, P3961, DOI 10.1128/IAI.00459-07; Qazi R, 2009, VACCINE, V27, pF25, DOI 10.1016/j.vaccine.2009.08.064; Rahman M, 2007, EMERG INFECT DIS, V13, P18, DOI 10.3201/eid1301.060910; RAM S, 1990, INDIAN J MED RES-A, V91, P167; Rouse JW, 1974, MONITORING VEGETATIO, P3010; SAHA MR, 1984, T ROY SOC TROP MED H, V78, P818, DOI 10.1016/0035-9203(84)90031-2; Sarkar R, 2008, EPIDEMIOLOGY, V19, pS307; Shaman J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000316; Sharma S, 2008, J CLIN MICROBIOL, V46, P1343, DOI 10.1128/JCM.02358-07; Sherchand JB, 2009, J INFECT DIS, V200, pS182, DOI 10.1086/605046; Shi PY, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-778; Singh V, 1989, Indian J Gastroenterol, V8, P23; STOLL BJ, 1982, BRIT MED J, V285, P1185, DOI 10.1136/bmj.285.6349.1185; TABASSUM S, 1994, J MED VIROL, V43, P50, DOI 10.1002/jmv.1890430110; Tanaka G, 2007, PEDIATR INFECT DIS J, V26, P1014, DOI 10.1097/INF.0b013e318125721c; Tate JE, 2009, VACCINE, V27, pF18, DOI 10.1016/j.vaccine.2009.08.098; Tate JE, 2009, PEDIATRICS, V124, P465, DOI 10.1542/peds.2008-3528; Tatte VS, 2010, J MED VIROL, V82, P519, DOI 10.1002/jmv.21708; Torok TJ, 1997, PEDIATR INFECT DIS J, V16, P941, DOI 10.1097/00006454-199710000-00007; U.S. Geological Survey USGS, 2011, WHAT IS NDVI; UNICOMB LE, 1993, ARCH VIROL, V132, P201, DOI 10.1007/BF01309854; Unicomb LE, 1997, PEDIATR INFECT DIS J, V16, P947, DOI 10.1097/00006454-199710000-00008; Viboud C, 2006, SCIENCE, V312, P447, DOI 10.1126/science.1125237; Wenger JB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010187; Yachha S K, 1994, Indian Pediatr, V31, P27; Zaman K, 2009, VACCINE, V27, pF31, DOI 10.1016/j.vaccine.2009.08.063	82	84	88	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38168	10.1371/journal.pone.0038168	http://dx.doi.org/10.1371/journal.pone.0038168			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693594	gold, Green Published, Green Submitted			2022-12-27	WOS:000305338500098
J	Rana, S; Nissen, F; Marr, A; Markert, A; Altmann, A; Mier, W; Debus, J; Haberkorn, U; Askoxylakis, V				Rana, Shoaib; Nissen, Felix; Marr, Annabell; Markert, Annette; Altmann, Annette; Mier, Walter; Debus, Juergen; Haberkorn, Uwe; Askoxylakis, Vasileios			Optimization of a Novel Peptide Ligand Targeting Human Carbonic Anhydrase IX	PLOS ONE			English	Article							RENAL-CELL CARCINOMA; CANCER-THERAPY; EXPRESSION; HYPOXIA; MARKER; ANTIGEN; MATU	Background: Carbonic anhydrase IX (CA IX) is a hypoxia-regulated transmembrane protein over-expressed in various types of human cancer. Recently, a new peptide with affinity for human carbonic anhydrase IX (CaIX-P1) was identified using the phage display technology. Aim of the present study is to characterize the binding site in the sequence of CaIX-P1, in order to optimize the binding and metabolic properties and use it for targeting purposes. Methodology/Principal Findings: Various fragments of CaIX-P1 were synthesized on solid support using Fmoc chemistry. Alanine scanning was performed for identification of the amino acids crucial for target binding. Derivatives with increased binding affinity were radiolabeled and in vitro studies were carried out on the CA IX positive human renal cell carcinoma cell line SKRC 52 and the CA IX negative human pancreatic carcinoma cell line BxPC3. Metabolic stability was investigated in cell culture medium and human serum. Organ distribution and planar scintigraphy studies were performed in Balb/c nu/nu mice carrying subcutaneously transplanted SKRC 52 tumors. The results of our studies clearly identified amino acids that are important for target binding. Among various fragments and derivatives the ligand CaIX-P1-4-10 (NHVPLSPy) was found to possess increased binding potential in SKRC 52 cells, whereas no binding capacity for BxPC3 cells was observed. Binding of radiolabeled CaIX-P1-4-10 on CA IX positive cells could be inhibited by both the unlabeled and the native CaIX-P1 peptide but not by control peptides. Stability experiments indicated the degradation site in the sequence of CaIX-P1-4-10. Biodistribution studies showed a higher in vivo accumulation in the tumor than in most healthy tissues. Conclusions: Our data reveal modifications in the sequence of the CA IX affine ligand CaIX-P1 that might be favorable for improvement of target affinity and metabolic stability, which are necessary prior to the use of the ligand in clinical approaches.	[Rana, Shoaib; Debus, Juergen; Askoxylakis, Vasileios] Univ Heidelberg, Dept Radiat Oncol, Heidelberg, Germany; [Rana, Shoaib; Marr, Annabell; Markert, Annette; Altmann, Annette; Haberkorn, Uwe; Askoxylakis, Vasileios] German Canc Res Ctr, Clin Cooperat Unit Nucl Med, D-6900 Heidelberg, Germany; [Nissen, Felix; Marr, Annabell; Markert, Annette; Altmann, Annette; Mier, Walter; Haberkorn, Uwe] Univ Heidelberg, Dept Nucl Med, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Rana, S (corresponding author), Univ Heidelberg, Dept Radiat Oncol, Heidelberg, Germany.	v.askoxylakis@dkfz.de			Tumorzentrum Heidelberg/Mannheim; Postdoc Program of the Medical Faculty of the University of Heidelberg	Tumorzentrum Heidelberg/Mannheim; Postdoc Program of the Medical Faculty of the University of Heidelberg	This project has been financially supported by the Tumorzentrum Heidelberg/Mannheim. VA received financial support from the Postdoc Program of the Medical Faculty of the University of Heidelberg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Askoxylakis V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015962; Boy RG, 2010, MOL IMAGING BIOL, V12, P377, DOI 10.1007/s11307-009-0287-z; Choschzick M, 2011, VIRCHOWS ARCH, V459, P193, DOI 10.1007/s00428-011-1105-y; Chrastina A, 2003, INT J CANCER, V105, P873, DOI 10.1002/ijc.11142; Fischer PM, 2003, CURR PROTEIN PEPT SC, V4, P339, DOI 10.2174/1389203033487054; Grabmaier K, 2004, ONCOGENE, V23, P5624, DOI 10.1038/sj.onc.1207764; Hilvo M, 2008, J BIOL CHEM, V283, P27799, DOI 10.1074/jbc.M800938200; Hockel M, 2001, JNCI-J NATL CANCER I, V93, P266, DOI 10.1093/jnci/93.4.266; Li G, 2010, UROL ONCOL; Li GR, 2001, CLIN CANCER RES, V7, P89; Li GR, 2007, CLIN EXP METASTAS, V24, P149, DOI 10.1007/s10585-007-9064-z; Li Peng, 2002, Current Topics in Medicinal Chemistry, V2, P325, DOI 10.2174/1568026023394209; LIAO SY, 1994, AM J PATHOL, V145, P598; Marr A, 2011, METHODS, V55, P215, DOI 10.1016/j.ymeth.2011.05.002; PASTOREKOVA S, 1992, VIROLOGY, V187, P620, DOI 10.1016/0042-6822(92)90464-Z; Potter CPS, 2003, BRIT J CANCER, V89, P2, DOI 10.1038/sj.bjc.6600936; Saarnio J, 1998, AM J PATHOL, V153, P279, DOI 10.1016/S0002-9440(10)65569-1; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Siebels M, 2011, WORLD J UROL, V29, P121, DOI 10.1007/s00345-010-0570-2; Supuran C.T., 2009, DRUG DESIGN ZINC ENZ, DOI [10.1002/9780470508169.ch22, DOI 10.1002/9780470508169]; Thiry A, 2006, TRENDS PHARMACOL SCI, V27, P566, DOI 10.1016/j.tips.2006.09.002; Tran L, 2011, J PHARMACEUT BIOMED, V56, P609, DOI 10.1016/j.jpba.2011.05.026; Vaupel P, 2007, CANCER METAST REV, V26, P225, DOI 10.1007/s10555-007-9055-1; Wykoff CC, 2000, CANCER RES, V60, P7075; ZAVADA J, 1993, INT J CANCER, V54, P268, DOI 10.1002/ijc.2910540218	25	13	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38279	10.1371/journal.pone.0038279	http://dx.doi.org/10.1371/journal.pone.0038279			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693612	Green Submitted, gold, Green Published			2022-12-27	WOS:000305338500123
J	Reynolds, PL; Bruno, JF				Reynolds, Pamela L.; Bruno, John F.			Effects of Trophic Skewing of Species Richness on Ecosystem Functioning in a Diverse Marine Community	PLOS ONE			English	Article							FOOD-CHAIN LENGTH; PREDATOR DIVERSITY; PLANT DIVERSITY; TOP-DOWN; BIODIVERSITY; HERBIVORE; SEAGRASS; AMPHIPOD; PRODUCTIVITY; CONSEQUENCES	Widespread overharvesting of top consumers of the world's ecosystems has "skewed" food webs, in terms of biomass and species richness, towards a generally greater domination at lower trophic levels. This skewing is exacerbated in locations where exotic species are predominantly low-trophic level consumers such as benthic macrophytes, detritivores, and filter feeders. However, in some systems where numerous exotic predators have been added, sometimes purposefully as in many freshwater systems, food webs are skewed in the opposite direction toward consumer dominance. Little is known about how such modifications to food web topology, e.g., changes in the ratio of predator to prey species richness, affect ecosystem functioning. We experimentally measured the effects of trophic skew on production in an estuarine food web by manipulating ratios of species richness across three trophic levels in experimental mesocosms. After 24 days, increasing macroalgal richness promoted both plant biomass and grazer abundance, although the positive effect on plant biomass disappeared in the presence of grazers. The strongest trophic cascade on the experimentally stocked macroalgae emerged in communities with a greater ratio of prey to predator richness (bottom-rich food webs), while stronger cascades on the accumulation of naturally colonizing algae (primarily microalgae with some early successional macroalgae that recruited and grew in the mesocosms) generally emerged in communities with greater predator to prey richness (the more top-rich food webs). These results suggest that trophic skewing of species richness and overall changes in food web topology can influence marine community structure and food web dynamics in complex ways, emphasizing the need for multitrophic approaches to understand the consequences of marine extinctions and invasions.	[Reynolds, Pamela L.; Bruno, John F.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27515 USA; [Reynolds, Pamela L.] Coll William & Mary, Virginia Inst Marine Sci, Dept Biol Sci, Gloucester Point, VA USA	University of North Carolina; University of North Carolina Chapel Hill; William & Mary; Virginia Institute of Marine Science	Reynolds, PL (corresponding author), Univ N Carolina, Dept Biol, Chapel Hill, NC 27515 USA.	reynolds@vims.edu		Reynolds, Pamela/0000-0002-0177-3537	University of North Carolina's Institute of Marine Sciences; National Science Foundation [OCE-30623736]; University of North Carolina Wilson Award	University of North Carolina's Institute of Marine Sciences; National Science Foundation(National Science Foundation (NSF)); University of North Carolina Wilson Award	Funding support came from University of North Carolina's Institute of Marine Sciences, National Science Foundation grant OCE-30623736 to Bruno, and a University of North Carolina Wilson Award to Reynolds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albins MA, 2008, MAR ECOL PROG SER, V367, P233, DOI 10.3354/meps07620; Aquilino KM, 2005, OIKOS, V108, P275, DOI 10.1111/j.0030-1299.2005.13418.x; Bardgett R.D., 2010, ABOVEGROUND BELOWGRO; Boyer KE, 2009, OIKOS, V118, P1062, DOI 10.1111/j.1600-0706.2009.17252.x; Bruno JF, 2005, ECOL LETT, V8, P1165, DOI 10.1111/j.1461-0248.2005.00823.x; Bruno JF, 2005, ECOL LETT, V8, P1048, DOI 10.1111/j.1461-0248.2005.00808.x; Bruno JF, 2008, ECOLOGY, V89, P2518, DOI 10.1890/07-1345.1; Bruno JF, 2008, FRONT ECOL ENVIRON, V6, P539, DOI 10.1890/070136; Burkepile DE, 2008, P NATL ACAD SCI USA, V105, P16201, DOI 10.1073/pnas.0801946105; Byrnes J, 2006, ECOL LETT, V9, P61, DOI 10.1111/j.1461-0248.2005.00842.x; Byrnes JE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000295; Byrnes JE, 2009, ECOLOGY, V90, P2879, DOI 10.1890/08-1073.1; Cardillo M, 2005, SCIENCE, V309, P1239, DOI 10.1126/science.1116030; Cardinale Bradley, 2009, P105; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; Cardinale BJ, 2011, AM J BOT, V98, P572, DOI 10.3732/ajb.1000364; CARPENTER SR, 1986, AQUAT BOT, V26, P341, DOI 10.1016/0304-3770(86)90031-8; Collette BB, 2011, SCIENCE, V333, P291, DOI 10.1126/science.1208730; Cruz-Rivera E, 2003, ECOL MONOGR, V73, P483, DOI 10.1890/0012-9615(2003)073[0483:PNQIWC]2.0.CO;2; Cruz-Rivera E, 2001, MAR ECOL PROG SER, V218, P249, DOI 10.3354/meps218249; DeMott WR, 1998, ECOLOGY, V79, P2463, DOI 10.2307/176836; Dobson A, 2006, ECOLOGY, V87, P1915, DOI 10.1890/0012-9658(2006)87[1915:HLTCAT]2.0.CO;2; Douglass JG, 2008, ECOL LETT, V11, P598, DOI 10.1111/j.1461-0248.2008.01175.x; Downing AL, 2002, NATURE, V416, P837, DOI 10.1038/416837a; Duffy JE, 2006, MAR ECOL PROG SER, V311, P233, DOI 10.3354/meps311233; Duffy JE, 2002, OIKOS, V99, P201, DOI 10.1034/j.1600-0706.2002.990201.x; Duffy JE, 2005, ECOL LETT, V8, P301, DOI 10.1111/j.1461-0248.2005.00725.x; Duffy JE, 2003, ECOL LETT, V6, P680, DOI 10.1046/j.1461-0248.2003.00494.x; Duffy JE, 2003, ECOL LETT, V6, P637; DUFFY JE, 1994, ECOLOGY, V75, P1304, DOI 10.2307/1937456; Duffy JE, 2000, ECOL MONOGR, V70, P237, DOI 10.1890/0012-9615(2000)070[0237:SIOGAO]2.0.CO;2; Duffy JE, 1989, ECOLOGY EVOLUTION HE; Dyer LA, 2003, ECOL LETT, V6, P60, DOI 10.1046/j.1461-0248.2003.00398.x; Eby LA, 2006, TRENDS ECOL EVOL, V21, P576, DOI 10.1016/j.tree.2006.06.016; EDGAR GJ, 1992, J EXP MAR BIOL ECOL, V157, P225, DOI 10.1016/0022-0981(92)90164-6; Edwards KF, 2010, ECOL LETT, V13, P194, DOI 10.1111/j.1461-0248.2009.01417.x; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; FAITH DP, 1987, VEGETATIO, V69, P57, DOI 10.1007/BF00038687; Ferriter A., 2004, 2004 EV CONS REP, P11; Finke DL, 2004, NATURE, V429, P407, DOI 10.1038/nature02554; Fodrie FJ, 2010, GLOBAL CHANGE BIOL, V16, P48, DOI 10.1111/j.1365-2486.2009.01889.x; Fox JW, 2004, ECOLOGY, V85, P549, DOI 10.1890/03-0095; Gamfeldt L, 2005, ECOL LETT, V8, P696, DOI 10.1111/j.1461-0248.2005.00765.x; Gido KB, 1999, FRESHWATER BIOL, V42, P387, DOI 10.1046/j.1365-2427.1999.444490.x; Griffin JN, 2008, ECOLOGY, V89, P298, DOI 10.1890/07-1220.1; Griffin JN, 2009, OIKOS, V118, P1335, DOI 10.1111/j.1600-0706.2009.17572.x; Haddad NM, 2001, AM NAT, V158, P17, DOI 10.1086/320866; Hairston NG, 1960, AM NAT, V94, P425; Halpern BS, 2005, ECOL LETT, V8, P189, DOI 10.1111/j.1461-0248.2004.00712.x; Hay ME, 1988, ECOLOGY RUBBLE STRUC; Hoffmann M, 2010, SCIENCE, V330, P1503, DOI 10.1126/science.1194442; HOLMLUND MB, 1990, J EXP MAR BIOL ECOL, V139, P65, DOI 10.1016/0022-0981(90)90039-F; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Hunter MD, 1992, ECOLOGY, V73; Jernakoff P, 1996, OCEANOGR MAR BIOL, V34, P109; Jolliffe PA, 2000, J ECOL, V88, P371, DOI 10.1046/j.1365-2745.2000.00470.x; KRUSKAL JB, 1964, PSYCHOMETRIKA, V29, P1, DOI 10.1007/BF02289565; Krysko KL, 2011, ZOOTAXA, P1; Lee SC, 2009, P NATL ACAD SCI USA, V106, P7052, DOI 10.1073/pnas.0809284106; LEIBOLD MA, 1989, AM NAT, V134, P922, DOI 10.1086/285022; Lesser MP, 2011, BIOL INVASIONS, V13, P1855, DOI 10.1007/s10530-011-0005-z; Levene H., 1960, CONTRIBUTIONS PROBAB, P278; Long ZT, 2007, ECOLOGY, V88, P2821, DOI 10.1890/06-1977.1; Long ZT, 2011, J ANIM ECOL, V80, P586, DOI 10.1111/j.1365-2656.2010.01800.x; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Lotze HK, 2004, ECOL APPL, V14, P1428, DOI 10.1890/03-5027; MA, 2005, ECOSYSTEMS HUMAN WEL; McKinney ML, 1997, ANNU REV ECOL SYST, V28, P495, DOI 10.1146/annurev.ecolsys.28.1.495; Moran ER, 2010, MAR ECOL PROG SER, V400, P277, DOI 10.3354/meps08406; Mulder CPH, 1999, ECOL LETT, V2, P237; Muncy RJ, 1984, ER827 US ARM CORPS E; Naeem S, 2000, OIKOS, V91, P97, DOI 10.1034/j.1600-0706.2000.910108.x; NAEEM S, 1994, NATURE, V368, P734, DOI 10.1038/368734a0; NELSON WG, 1979, J EXP MAR BIOL ECOL, V39, P231, DOI 10.1016/0022-0981(79)90129-1; NELSON WG, 1979, J EXP MAR BIOL ECOL, V38, P225, DOI 10.1016/0022-0981(79)90069-8; O'Connor MI, 2009, J ANIM ECOL, V78, P732, DOI 10.1111/j.1365-2656.2009.01533.x; Oksanen J., 2016, R PACKAG; Pereira HM, 2010, SCIENCE, V330, P1496, DOI 10.1126/science.1196624; Petchey OL, 2004, OIKOS, V104, P467, DOI 10.1111/j.0030-1299.2004.13257.x; Pinsky ML, 2011, P NATL ACAD SCI USA, V108, P8317, DOI 10.1073/pnas.1015313108; Pitt William C., 2007, P265, DOI 10.1007/978-3-540-46046-6_12; Powers SP, 2005, MAR ECOL PROG SER, V302, P233, DOI 10.3354/meps302233; Powers SP, 2002, J EXP MAR BIOL ECOL, V273, P171, DOI 10.1016/S0022-0981(02)00162-4; Ray J. C., 2005, LARGE CARNIVORES CON; Reynolds PL, 2011, J ECOL, V99, P1272, DOI 10.1111/j.1365-2745.2011.01837.x; ROOT RB, 1973, ECOL MONOGR, V43, P95, DOI 10.2307/1942161; Ruzycki JR, 2003, ECOL APPL, V13, P23, DOI 10.1890/1051-0761(2003)013[0023:EOILTO]2.0.CO;2; Sax D. F., 2005, SPECIES INVASIONS IN; Sax DF, 2003, TRENDS ECOL EVOL, V18, P561, DOI 10.1016/S0169-5347(03)00224-6; Scherber C, 2006, J ECOL, V94, P922, DOI 10.1111/j.1365-2745.2006.01144.x; Schmid Bernhard, 2009, P14; Searle SR., 1992, VARIANCE COMPONENTS; Siemann E, 1998, AM NAT, V152, P738, DOI 10.1086/286204; Sih A, 1998, TRENDS ECOL EVOL, V13, P350, DOI 10.1016/S0169-5347(98)01437-2; Simberloff D, 2011, ENCY BIOL INVASIONS; Sotka EE, 2011, EVOL ECOL, V25, P1335, DOI 10.1007/s10682-011-9473-y; Srivastava DS, 2009, ECOLOGY, V90, P1073, DOI 10.1890/08-0439.1; Stachowicz JJ, 2007, ANNU REV ECOL EVOL S, V38, P739, DOI 10.1146/annurev.ecolsys.38.091206.095659; Stachowicz JJ, 2008, P NATL ACAD SCI USA, V105, P18842, DOI 10.1073/pnas.0806425105; Stachowicz JJ, 2008, ECOLOGY, V89, P3008, DOI 10.1890/07-1873.1; STONER AW, 1979, MAR BIOL, V55, P201, DOI 10.1007/BF00396819; Terborgh J, 2001, SCIENCE, V294, P1923, DOI 10.1126/science.1064397; Thebault E, 2006, ECOL RES, V21, P17, DOI 10.1007/s11284-005-0127-9; Tilman D, 1997, OIKOS, V80, P185, DOI 10.2307/3546532; Tilman D, 2001, SCIENCE, V294, P843, DOI 10.1126/science.1060391; TRACY CR, 1992, AM NAT, V139, P102, DOI 10.1086/285315; Underwood A.J., 1997, EXPT ECOLOGY THEIR L, DOI DOI 10.1017/CBO9780511806407; VIRNSTEIN RW, 1986, MAR ECOL PROG SER, V29, P279, DOI 10.3354/meps029279; Wardle DA, 2011, SCIENCE, V332, P1273, DOI 10.1126/science.1197479	109	12	13	2	94	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e36196	10.1371/journal.pone.0036196	http://dx.doi.org/10.1371/journal.pone.0036196			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693549	Green Submitted, gold, Green Published			2022-12-27	WOS:000305338500010
J	Mefford, D; Mefford, J				Mefford, Dwain; Mefford, Joel			Stromal Genes Add Prognostic Information to Proliferation and Histoclinical Markers: A Basis for the Next Generation of Breast Cancer Gene Signatures	PLOS ONE			English	Article							EXPRESSION SIGNATURES; IMMUNE-RESPONSE; MICROARRAY DATA; PREDICTS; CLASSIFICATION; CARCINOMA; SUBTYPES; THERAPY; SURVIVAL; INDEX	Background: First-generation gene signatures that identify breast cancer patients at risk of recurrence are confined to estrogen-positive cases and are driven by genes involved in the cell cycle and proliferation. Previously we induced sets of stromal genes that are prognostic for both estrogen-positive and estrogen-negative samples. Creating risk-management tools that incorporate these stromal signatures, along with existing proliferation-based signatures and established clinicopathological measures such as lymph node status and tumor size, should better identify women at greatest risk for metastasis and death. Methodology/Principal Findings: To investigate the strength and independence of the stromal and proliferation factors in estrogen-positive and estrogen-negative patients we constructed multivariate Cox proportional hazards models along with tree-based partitions of cancer cases for four breast cancer cohorts. Two sets of stromal genes, one consisting of DCN and FBLN1, and the other containing LAMA2, add substantial prognostic value to the proliferation signal and to clinical measures. For estrogen receptor-positive patients, the stromal-decorin set adds prognostic value independent of proliferation for three of the four datasets. For estrogen receptor-negative patients, the stromal-laminin set significantly adds prognostic value in two datasets, and marginally in a third. The stromal sets are most prognostic for the unselected population studies and may depend on the age distribution of the cohorts. Conclusion: The addition of stromal genes would measurably improve the performance of proliferation-based first-generation gene signatures, especially for older women. Incorporating indicators of the state of stromal cell types would mark a conceptual shift from epithelial-centric risk assessment to assessment based on the multiple cell types in the cancer-altered tissue.	[Mefford, Joel] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco		dwainmefford@gmail.com						Abba MC, 2004, BREAST CANCER RES, V6, pR499, DOI 10.1186/bcr899; Alexe G, 2007, CANCER RES, V67, P10669, DOI 10.1158/0008-5472.CAN-07-0539; Allinen M, 2004, CANCER CELL, V6, P17, DOI 10.1016/j.ccr.2004.06.010; [Anonymous], ARRAYEXPRESS; Beck AH, 2008, LAB INVEST, V88, P591, DOI 10.1038/labinvest.2008.31; Beck AH, 2009, CLIN CANCER RES, V15, P778, DOI 10.1158/1078-0432.CCR-08-1283; Bergamaschi A, 2008, J PATHOL, V214, P357, DOI 10.1002/path.2278; Bianchini G, 2010, J CLIN ONCOL, V28, P4316, DOI 10.1200/JCO.2009.27.2419; Cheang MCU, 2009, JNCI-J NATL CANCER I, V101, P736, DOI 10.1093/jnci/djp082; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Colombo PE, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2890; Cuzick J, 2011, J CLIN ONCOL, V29, P4273, DOI 10.1200/JCO.2010.31.2835; Dai HY, 2005, CANCER RES, V65, P4059, DOI 10.1158/0008-5472.CAN-04-3953; Desmedt C, 2008, CLIN CANCER RES, V14, P5158, DOI 10.1158/1078-0432.CCR-07-4756; Desmedt C, 2007, CLIN CANCER RES, V13, P3207, DOI 10.1158/1078-0432.CCR-06-2765; Desmedt C, 2006, CELL CYCLE, V5, P2198, DOI 10.4161/cc.5.19.3254; Drier Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017795; Dunkler D, 2007, EUR J CANCER, V43, P745, DOI 10.1016/j.ejca.2006.11.018; Eden P, 2004, EUR J CANCER, V40, P1837, DOI 10.1016/j.ejca.2004.02.025; Farmer P, 2009, NAT MED, V15, P68, DOI 10.1038/nm.1908; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Fournier MV, 2006, CANCER RES, V66, P7095, DOI 10.1158/0008-5472.CAN-06-0515; Gene Expression Omnibus, GENE EXPRESSION OMNI; Geyer FC, 2012, ADV ANAT PATHOL, V19, P39, DOI 10.1097/PAP.0b013e31823fafa0; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Haibe-Kains B, 2008, BIOINFORMATICS, V24, P2200, DOI 10.1093/bioinformatics/btn374; Haibe-Kains B, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-394; Harris L, 2007, J CLIN ONCOL, V25, P5287, DOI 10.1200/JCO.2007.14.2364; Karn T, 2010, BREAST CANCER RES TR, V120, P567, DOI 10.1007/s10549-009-0416-z; Loi S, 2007, CRIT REV ONCOL HEMAT, V61, P187, DOI 10.1016/j.critrevonc.2006.09.005; Martin KJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002994; Mefford D, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-482; Meng SD, 2004, CLIN CANCER RES, V10, P8152, DOI 10.1158/1078-0432.CCR-04-1110; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; Myhre S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014002; Pawitan Y, 2005, BREAST CANCER RES, V7, pR953, DOI 10.1186/bcr1325; Perou CM, 2010, LANCET ONCOL, V11, P718, DOI 10.1016/S1470-2045(10)70176-5; Reyal F, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2192; Ringner M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017911; Rody A, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2234; Ross JS, 2008, ONCOLOGIST, V13, P477, DOI 10.1634/theoncologist.2007-0248; Schmidt M, 2008, CANCER RES, V68, P5405, DOI 10.1158/0008-5472.CAN-07-5206; Sorlie T, 2010, LANCET ONCOL, V11, P719, DOI 10.1016/S1470-2045(10)70174-1; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Sotiriou C, 2009, NEW ENGL J MED, V360, P790, DOI 10.1056/NEJMra0801289; Symmans WF, 2010, J CLIN ONCOL, V28, P4111, DOI 10.1200/JCO.2010.28.4273; Teschendorff AE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r157; van 't Veer LJ, 2008, NATURE, V452, P564, DOI 10.1038/nature06915; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Weigelt B, 2010, LANCET ONCOLOGY; Weigelt B, 2012, NAT REV CLIN ONCOL, V9, P58, DOI 10.1038/nrclinonc.2011.125; Weigelt B, 2010, J PATHOL, V220, P263, DOI 10.1002/path.2648; West RB, 2005, PLOS BIOL, V3, P1101, DOI 10.1371/journal.pbio.0030187; West RB, 2007, LAB INVEST, V87, P967, DOI 10.1038/labinvest.3700666; Wirapati P, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2124; Zhao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017845	57	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e37646	10.1371/journal.pone.0037646	http://dx.doi.org/10.1371/journal.pone.0037646			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22719844	Green Published, gold, Green Submitted			2022-12-27	WOS:000305583300009
J	Meltzer, L; Blinick, NS; Fleishman, AB				Meltzer, Lorayne; Blinick, Naomi S.; Fleishman, Abram B.			Management Implications of the Biodiversity and Socio-Economic Impacts of Shrimp Trawler By-Catch in Bahia de Kino, Sonora, Mexico	PLOS ONE			English	Article							GULF-OF-CALIFORNIA; FISHERY; BYCATCH	The shrimp fishery is the most economically important fishery in Mexico. The trawler-based portion of this fishery results in high rates of by-catch. This study quantifies and describes the biodiversity of by-catch associated with trawling in the Bahia de Kino region of Sonora, Mexico. Data were collected from 55 trawls, on six boats, over 14 nights, during November of 2003, 2004, 2006-2009. By-catch rates within trawl samples averaged 85.9% measured by weight. A total of 183 by-catch species were identified during the course of this study, including 97 species of bony fish from 43 families, 19 species of elasmobranchs from 12 families, 66 species of invertebrates from eight phyla, and one species of marine turtle; seven of the documented by-catch species are listed on the IUCN Red List, CITES, or the Mexican NOM-059-ECOL-2010; 35 species documented in the by-catch are also targeted by local artisanal fishers. Some of the species frequently captured as juveniles in the by-catch are economically important to small-scale fishers in the region, and are particularly sensitive to overexploitation due to their life histories. This study highlights the need for further research quantifying the impacts of high levels of by-catch upon small-scale fishing economies in the region and presents strong ecological and economic rationale for by-catch management within the shrimp fishery of the Gulf of California. Site-specific by-catch management plans should be piloted in the Bahia de Kino region to address the growing momentum in national and international fisheries policy regimes toward the reduction of by-catch in shrimp fisheries.	[Meltzer, Lorayne] Prescott Coll, Environm Studies Fac, Prescott, AZ USA; [Meltzer, Lorayne; Blinick, Naomi S.; Fleishman, Abram B.] Prescott Coll, Res & Conservat Program, Kino Bay Ctr Cultural & Ecol Studies, Bahia De Kino, Sonora, Mexico		Meltzer, L (corresponding author), Prescott Coll, Environm Studies Fac, Prescott, AZ USA.	lmeltzer@prescott.edu			David and Lucile Packard Foundation; Prescott College	David and Lucile Packard Foundation(The David & Lucile Packard Foundation); Prescott College	The David and Lucile Packard Foundation and Prescott College fund the program that conducted this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balton DA, 2010, FED REGISTER, V75, P27855; Beck MW, 2001, BIOSCIENCE, V51, P633, DOI 10.1641/0006-3568(2001)051[0633:TICAMO]2.0.CO;2; Brusca R. C., 2004, SEA SHORE GUIDE NO G; [CITES] Convention on the International Trade of Endangered Species of Wild Flora and Fauna, UNEP WCMC SPEC DAT C; [CONAPESCA] Comision Nacional de Acuacultura y Pesca, 2011, DISM CON NUM EMB CAM; Davies RWD, 2009, MAR POLICY, V33, P661, DOI 10.1016/j.marpol.2009.01.003; FAO, 2010, 934 FAO; Garcia-Caudillo JM, 2000, BIOL CONSERV, V92, P199, DOI 10.1016/S0006-3207(99)00053-1; Garcia-Caudillo JM, 2005, PESCA IND CAMERON GO; Gillet R., 2008, FAO FISH TECH PAP, V475, P331; Glenn EP, 2006, AQUAT CONSERV, V16, P5, DOI 10.1002/aqc.681; Heredia Quevedo JA, 2001, THESIS UN U REYKJAVI; Rabago-Quiroz CH, 2011, REV BIOL TROP, V59, P255; [INP] Instituto Nacional de la Pesca, 2000, CAT SIST CAPT PRINC; Kelleher Kieran, 2005, FAO FISHERIES TECHNI; Lopez-Martinez J, 2010, REV BIOL TROP, V58, P925; Madrid-Vera J, 2007, FISH RES, V83, P81, DOI 10.1016/j.fishres.2006.08.026; Madrid-Vera J, 2010, MAR ECOL PROG SER, V403, P145, DOI 10.3354/meps08434; MAGALLON-BARAJAS F J, 1987, California Cooperative Oceanic Fisheries Investigations Reports, V28, P43; Mark Freeberg J.G.Pope, 1994, GLOBAL ASSESSMENT FI; Marquez F, 2006, IUCN 2010 IUCN RED L; Marquez-Farias JF, 2007, MAR BIOL, V151, P1445, DOI 10.1007/s00227-006-0599-3; Meltzer L, 2006, OCEAN COAST MANAGE, V49, P222, DOI 10.1016/j.ocecoaman.2006.02.009; Moreno C., 2005, DIAGNOSTICO AMBIENTA; Moreno-Baez M, 2010, THESIS U ARIZONA TUC; Nava Romero JM, 1994, THESIS I TECNOLOGICO; Perez-Mellado J, 1985, RECURSOS PESQUERAS P, V5, P201; Rivera M., 2021, IUCN RED LIST THREAT, DOI DOI 10.2305/IUCN.UK.2020-3.RLTS.T22678711A183481909.EN; [SAGARPA] Secretaria de Agricultura Ganaderia Desarrollo Rural Pesca y Alimentacion, 2009, AN EST PESC 2009; Salomon-Aguilar CA, 2009, CIENC MAR, V35, P369, DOI 10.7773/cm.v35i4.1435; [SEMARNAT] Secretaria de Medio Ambiente y Recursos Naturales, 2010, DIARIO OFICIAL  1230, V2, P1; [WRI] World Resources Institute, 2004, FISH ANSW MAK SENS G; Young RH, 1979, TROP SCI, V21, P249	33	9	9	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e35609	10.1371/journal.pone.0035609	http://dx.doi.org/10.1371/journal.pone.0035609			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22719827	Green Published, Green Submitted, gold			2022-12-27	WOS:000305583300003
J	Banfield, S; Pascoe, E; Thambiran, A; Siafarikas, A; Burgner, D				Banfield, Sally; Pascoe, Elaine; Thambiran, Aesen; Siafarikas, Aris; Burgner, David			Factors Associated with the Performance of a Blood-Based Interferon-gamma Release Assay in Diagnosing Tuberculosis	PLOS ONE			English	Article							VITAMIN-D DEFICIENCY; MYCOBACTERIUM-TUBERCULOSIS; LATENT TUBERCULOSIS; INFECTION; REFUGEES; MALARIA; PREVENTION; MANAGEMENT; CHILDREN; IMMUNITY	Background: Indeterminate results are a recognised limitation of interferon-c release assays (IGRA) in the diagnosis of latent tuberculosis (TB) infection (LTBI) and TB disease, especially in children. We investigated whether age and common comorbidities were associated with IGRA performance in an unselected cohort of resettled refugees. Methods: A retrospective cross-sectional study of refugees presenting for their post-resettlement health assessment during 2006 and 2007. Refugees were investigated for prevalent infectious diseases, including TB, and for common nutritional deficiencies and haematological abnormalities as part of standard clinical screening protocols. Tuberculosis screening was performed by IGRA; QuantiFERON-TB Gold in 2006 and QuantiFERON-TBGold In-Tube in 2007. Results: Complete data were available on 1130 refugees, of whom 573 (51%) were children less than 17 years and 1041 (92%) were from sub-Saharan Africa. All individuals were HIV negative. A definitive IGRA result was obtained in 1004 (89%) refugees, 264 (26%) of which were positive; 256 (97%) had LTBI and 8 (3%) had TB disease. An indeterminate IGRA result was obtained in 126 (11%) refugees (all failed positive mitogen control). In multivariate analysis, younger age (linear OR = 0.93 [95% CI 0.91-0.95], P<0.001), iron deficiency anaemia (2.69 [1.51-4.80], P = 0.001), malaria infection (3.04 [1.51-6.09], P = 0.002), and helminth infection (2.26 [1.48-3.46], P<0.001), but not vitamin D deficiency or insufficiency, were associated with an indeterminate IGRA result. Conclusions: Younger age and a number of common co-morbidities are significantly and independently associated with indeterminate IGRA results in resettled predominantly African refugees.	[Banfield, Sally; Pascoe, Elaine; Siafarikas, Aris; Burgner, David] Univ Western Australia, Sch Paediat & Child Hlth, Perth, WA 6009, Australia; [Siafarikas, Aris] Princess Margaret Hosp Children, Perth, WA, Australia; [Siafarikas, Aris] Univ Notre Dame, Inst Hlth & Rehabil Res, Fremantle, WA, Australia; [Thambiran, Aesen] Migrant Hlth Unit, Perth, WA, Australia; [Pascoe, Elaine] Univ Queensland, Sch Med, Brisbane, Qld 4072, Australia; [Burgner, David] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia	University of Western Australia; University of Western Australia; University of Notre Dame Australia; University of Queensland; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne	Banfield, S (corresponding author), Univ Western Australia, Sch Paediat & Child Hlth, Perth, WA 6009, Australia.	david.burgner@mcri.edu.au		Burgner, David/0000-0002-8304-4302; Pascoe, Elaine/0000-0003-1653-5803	National Health and Medical Research Council, Australia	National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia)	No specific funding was sourced for this research. DB is supported by a Career Development Award from the National Health and Medical Research Council, Australia (www.nhmrc.gov.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, Commun Dis Intell Q Rep, V26, P238; Babu S, 2009, J INFECT DIS, V200, P288, DOI 10.1086/599797; Baeke F, 2010, CURR OPIN PHARMACOL, V10, P482, DOI 10.1016/j.coph.2010.04.001; Bergamini BM, 2009, PEDIATRICS, V123, pe419, DOI 10.1542/peds.2008-1722; Cain KP, 2007, AM J RESP CRIT CARE, V175, P75, DOI 10.1164/rccm.200608-1178OC; Centers for Disease Control (CDC), 1989, MMWR Morb Mortal Wkly Rep, V38, P269; Cherian S, 2007, ARCH DIS CHILD, V92, P983, DOI 10.1136/adc.2006.114801; Cherian S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004030; Chih DT, 2006, MED J AUSTRALIA, V185, P598, DOI 10.5694/j.1326-5377.2006.tb00723.x; Co DO, 2006, J IMMUNOL, V177, P8456, DOI 10.4049/jimmunol.177.12.8456; Connell TG, 2006, THORAX, V61, P616, DOI 10.1136/thx.2005.048033; Connell TG, 2010, PEDIATR INFECT DIS J, V29, P285, DOI 10.1097/INF.0b013e3181c4822f; Connell TG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002624; DHUR A, 1989, COMP BIOCHEM PHYS A, V94, P11, DOI 10.1016/0300-9629(89)90776-7; Elias D, 2008, VACCINE, V26, P3897, DOI 10.1016/j.vaccine.2008.04.083; Enwere GC, 1999, ANN TROP MED PARASIT, V93, P669, DOI 10.1080/00034989957907; Gauvain S, 1948, TUBERCLE, P259; Glaziou P, 2011, B WORLD HEALTH ORGAN, V89, P573, DOI 10.2471/BLT.11.087510; Haustein T, 2009, PEDIATR INFECT DIS J, V28, P669, DOI 10.1097/INF.0b013e3181a16394; Herrera V, 2011, CLIN INFECT DIS, V52, P1031, DOI 10.1093/cid/cir068; Holick Michael F, 2011, J Clin Endocrinol Metab, V96, P1; Jia Zhongwei, 2011, J Evid Based Med, V4, P48, DOI 10.1111/j.1756-5391.2011.01116.x; Khanh VQL, 2011, AM J MED SCI, V341, P493, DOI 10.1097/MAJ.0b013e3182070f47; Lucas M, 2010, THORAX, V65, P442, DOI 10.1136/thx.2009.127555; Mant D, 2007, LANCET, V369, P1493, DOI 10.1016/S0140-6736(07)60684-9; Marks GB, 2000, AM J RESP CRIT CARE, V162, P1851, DOI 10.1164/ajrccm.162.5.2004154; Martineau AR, 2010, EUR RESPIR J, V35, P1106, DOI 10.1183/09031936.00087009; Martineau AR, 2007, AM J RESP CRIT CARE, V176, P208, DOI 10.1164/rccm.200701-007OC; McPherson ME, 2008, COMMUN DIS INTELL, V32, P237; MULLER K, 1993, IMMUNOL LETT, V35, P177, DOI 10.1016/0165-2478(93)90088-J; Murray RJ, 2009, MED J AUSTRALIA, V190, P421, DOI 10.5694/j.1326-5377.2009.tb02489.x; Mutch RC, 2011, J PAEDIAT C IN PRESS; Newton SM, 2008, LANCET INFECT DIS, V8, P498, DOI 10.1016/S1473-3099(08)70182-8; Pai M, 2004, LANCET INFECT DIS, V4, P761, DOI 10.1016/S1473-3099(04)01206-X; Pearce EJ, 2004, IMMUNOL REV, V201, P117, DOI 10.1111/j.0105-2896.2004.00187.x; Potian JA, 2011, J EXP MED, V208, P1863, DOI 10.1084/jem.20091473; Rook GAW, 2009, IMMUNOLOGY, V126, P3, DOI 10.1111/j.1365-2567.2008.03007.x; Rowe J, 2001, J INFECT DIS, V184, P80, DOI 10.1086/320996; Schafer JL, 1997, ANAL INCOMPLETE MULT, V1st, DOI 10.1201/9781439821862; Stephan C, 2008, AIDS, V22, P2471, DOI 10.1097/QAD.0b013e3283188415; Verver S, 2001, INT J TUBERC LUNG D, V5, P419; White GP, 2002, J IMMUNOL, V168, P2820, DOI 10.4049/jimmunol.168.6.2820; Wilkinson RJ, 2000, LANCET, V355, P618, DOI 10.1016/S0140-6736(99)02301-6	43	43	46	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2012	7	6							e38556	10.1371/journal.pone.0038556	http://dx.doi.org/10.1371/journal.pone.0038556			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UJ	22701664	gold, Green Published, Green Submitted			2022-12-27	WOS:000305340000031
J	Humbert, S; Zhong, SH; Deng, Y; Howell, SH; Rothstein, SJ				Humbert, Sabrina; Zhong, Sihui; Deng, Yan; Howell, Stephen H.; Rothstein, Steven J.			Alteration of the bZIP60/IRE1 Pathway Affects Plant Response to ER Stress in Arabidopsis thaliana	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; TRANSCRIPTION FACTOR; GENE-EXPRESSION; BIP; IRE1; ATBZIP60; ACCUMULATION; TOLERANCE; EFFICIENT	The Unfolded Protein Response (UPR) is elicited under cellular and environmental stress conditions that disrupt protein folding in the endoplasmic reticulum (ER). Through the transcriptional induction of genes encoding ER resident chaperones and proteins involved in folding, the pathway contributes to alleviating ER stress by increasing the folding capacity in the ER. Similarly to other eukaryotic systems, one arm of the UPR in Arabidopsis is set off by a non-conventional splicing event mediated by ribonuclease kinase IRE1b. The enzyme specifically targets mature bZIP60 RNA for cleavage, which results in a novel splice variant encoding a nuclear localized transcription factor. Although it is clear that this molecular switch widely affects the transcriptome, its exact role in overall plant response to stress has not been established and mutant approaches have not provided much insight. In this study, we took a transgenic approach to manipulate the pathway in positive and negative fashions. Our data show that the ER-resident chaperone BiP accumulates differentially depending on the level of activation of the pathway. In addition, phenotypes of the transgenic lines suggest that BiP accumulation is positively correlated with plant tolerance to chronic ER stress.	[Humbert, Sabrina; Zhong, Sihui; Rothstein, Steven J.] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada; [Deng, Yan; Howell, Stephen H.] Iowa State Univ, Inst Plant Sci, Ames, IA USA	University of Guelph; Iowa State University	Humbert, S (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada.	shumbert@uoguelph.ca	Rothstein, Steven J/A-4947-2013	Rothstein, Steven J/0000-0003-0737-1878				Alvim FC, 2001, PLANT PHYSIOL, V126, P1042, DOI 10.1104/pp.126.3.1042; Chen Y, 2011, PLANT J; Cheng NH, 2003, PLANT CELL, V15, P347, DOI 10.1105/tpc.007385; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Deng Y, 2011, P NATL ACAD SCI USA, V108, P7247, DOI 10.1073/pnas.1102117108; Gillikin JW, 1997, PLANT PHYSIOL, V114, P345, DOI 10.1104/pp.114.1.345; GLEAVE AP, 1992, PLANT MOL BIOL, V20, P1203, DOI 10.1007/BF00028910; Iwata Y, 2005, P NATL ACAD SCI USA, V102, P5280, DOI 10.1073/pnas.0408941102; Iwata Y, 2008, PLANT BIOTECHNOL, V25, P397, DOI 10.5511/plantbiotechnology.25.397; Iwata Y, 2009, BIOSCI BIOTECH BIOCH, V73, P865, DOI 10.1271/bbb.80779; Iwata Y, 2008, PLANT CELL, V20, P3107, DOI 10.1105/tpc.108.061002; Iwawaki T, 2009, P NATL ACAD SCI USA, V106, P16657, DOI 10.1073/pnas.0903775106; Jin H, 2009, P NATL ACAD SCI USA, V106, P13612, DOI 10.1073/pnas.0906144106; Kamauchi S, 2005, FEBS J, V272, P3461, DOI 10.1111/j.1742-4658.2005.04770.x; Koiwa H, 2003, PLANT CELL, V15, P2273, DOI 10.1105/tpc.013862; Koizumi N, 2001, PLANT PHYSIOL, V127, P949, DOI 10.1104/pp.010636; Liu JX, 2008, PLANT CELL ENVIRON, V31, P1735, DOI 10.1111/j.1365-3040.2008.01873.x; Lu DP, 2008, PHYSIOL PLANTARUM, V134, P360, DOI 10.1111/j.1399-3054.2008.01133.x; Lu DP, 2008, MOL GENET GENOMICS, V280, P199, DOI 10.1007/s00438-008-0356-z; Martinez IM, 2003, PLANT CELL, V15, P561, DOI 10.1105/tpc.007609; Maruyama D, 2010, P NATL ACAD SCI USA, V107, P1684, DOI 10.1073/pnas.0905795107; Mori K, 2009, J BIOCHEM, V146, P743, DOI 10.1093/jb/mvp166; Morris J, 2008, PLANT PHYSIOL, V148, P1474, DOI 10.1104/pp.108.118810; NIKAWA JI, 1992, MOL MICROBIOL, V6, P1441, DOI 10.1111/j.1365-2958.1992.tb00864.x; Noh SJ, 2003, GENE, V311, P81, DOI 10.1016/S0378-1119(03)00559-6; Noh SJ, 2002, BBA-GENE STRUCT EXPR, V1575, P130, DOI 10.1016/S0167-4781(02)00237-3; Pontier D, 2002, PLANT J, V30, P499, DOI 10.1046/j.1365-313X.2002.01307.x; Sung DY, 2001, PLANT PHYSIOL, V126, P789, DOI 10.1104/pp.126.2.789; Tajima H, 2008, BIOCHEM BIOPH RES CO, V374, P242, DOI 10.1016/j.bbrc.2008.07.021; Valente MAS, 2009, J EXP BOT, V60, P533, DOI 10.1093/jxb/ern296; Wesley SV, 2001, PLANT J, V27, P581, DOI 10.1046/j.1365-313X.2001.01105.x; Yasuda H, 2009, PLANT CELL PHYSIOL, V50, P1532, DOI 10.1093/pcp/pcp098; Ye CM, 2011, PLANT PHYSIOL, V156, P741, DOI 10.1104/pp.111.174110; Yoshida H, 2006, J CELL BIOL, V172, P565, DOI 10.1083/jcb.200508145	34	34	38	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2012	7	6							e39023	10.1371/journal.pone.0039023	http://dx.doi.org/10.1371/journal.pone.0039023			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UJ	22701744	Green Published, Green Submitted, gold			2022-12-27	WOS:000305340000061
J	O'Brien, SP; DeLisa, MP				O'Brien, Sean P.; DeLisa, Matthew P.			Functional Reconstitution of a Tunable E3-Dependent Sumoylation Pathway in Escherichia coli	PLOS ONE			English	Article							SUMO E3 LIGASE; MASS-SPECTROMETRY; UBIQUITIN; NUCLEAR; PROTEIN; SMAD4; UBC9; CONJUGATION; SITES; PIASX	SUMO (small ubiquitin-related modifier) is a reversible post-translational protein modifier that alters the localization, activity, or stability of proteins to which it is attached. Many enzymes participate in regulated SUMO-conjugation and SUMO-deconjugation pathways. Hundreds of SUMO targets are currently known, with the majority being nuclear proteins. However, the dynamic and reversible nature of this modification and the large number of natively sumoylated proteins in eukaryotic proteomes makes molecular dissection of sumoylation in eukaryotic cells challenging. Here, we have reconstituted a complete mammalian SUMO-conjugation cascade in Escherichia coli cells that involves a functional SUMO E3 ligase, which effectively biases the sumoylation of both native and engineered substrate proteins. Our sumo-engineered E. coli cells have several advantages including efficient protein conjugation and physiologically relevant sumoylation patterns. Overall, this system provides a rapid and controllable platform for studying the enzymology of the entire sumoylation cascade directly in living cells.	[O'Brien, Sean P.; DeLisa, Matthew P.] Cornell Univ, Sch Chem & Biomol Engn, Ithaca, NY 14853 USA	Cornell University	O'Brien, SP (corresponding author), Cornell Univ, Sch Chem & Biomol Engn, Ithaca, NY 14853 USA.	md255@cornell.edu	DeLisa, Matthew/AAE-7361-2019	DeLisa, Matthew/0000-0003-3226-1566	National Science Foundation Career Award [CBET-0449080]; New York State Office of Science, Technology and Academic Research Distinguished Faculty Award; Cornell Genomics Fellowship	National Science Foundation Career Award(National Science Foundation (NSF)); New York State Office of Science, Technology and Academic Research Distinguished Faculty Award; Cornell Genomics Fellowship	This work was supported by the National Science Foundation Career Award CBET-0449080 (to M. P. D.); the New York State Office of Science, Technology and Academic Research Distinguished Faculty Award (to M. P. D.); and a Cornell Genomics Fellowship (to S.P.O.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora T, 2003, J BIOL CHEM, V278, P21327, DOI 10.1074/jbc.C300119200; Bernier-Villamor V, 2002, CELL, V108, P345, DOI 10.1016/S0092-8674(02)00630-X; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Hochstrasser M, 2001, CELL, V107, P5, DOI 10.1016/S0092-8674(01)00519-0; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Johnson ES, 2001, CELL, V106, P735, DOI 10.1016/S0092-8674(01)00491-3; Kahyo T, 2001, MOL CELL, V8, P713, DOI 10.1016/S1097-2765(01)00349-5; Knipscheer P, 2007, EMBO J, V26, P2797, DOI 10.1038/sj.emboj.7601711; Lee PSW, 2003, J BIOL CHEM, V278, P27853, DOI 10.1074/jbc.M301755200; Lennon G, 1996, GENOMICS, V33, P151, DOI 10.1006/geno.1996.0177; Liang M, 2004, J BIOL CHEM, V279, P22857, DOI 10.1074/jbc.M401554200; Lin X, 2003, J BIOL CHEM, V278, P31043, DOI 10.1074/jbc.C300112200; Lin X, 2003, J BIOL CHEM, V278, P18714, DOI 10.1074/jbc.M302243200; Liu B, 2004, NAT IMMUNOL, V5, P891, DOI 10.1038/ni1104; Liu B, 2001, P NATL ACAD SCI USA, V98, P3203, DOI 10.1073/pnas.051489598; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; Matic I, 2008, MOL CELL PROTEOMICS, V7, P132, DOI 10.1074/mcp.M700173-MCP200; Melchior F, 2000, ANNU REV CELL DEV BI, V16, P591, DOI 10.1146/annurev.cellbio.16.1.591; Mencia M, 2004, PROTEIN EXPRES PURIF, V37, P409, DOI 10.1016/j.pep.2004.07.001; Ohshima T, 2003, J BIOL CHEM, V278, P50833, DOI 10.1074/jbc.M307533200; Okada S, 2009, PLANT CELL PHYSIOL, V50, P1049, DOI 10.1093/pcp/pcp056; Pedrioli PGA, 2006, NAT METHODS, V3, P533, DOI 10.1038/NMETH891; Pfander B, 2005, NATURE, V436, P428, DOI 10.1038/nature03665; Reindle A, 2006, J CELL SCI, V119, P4749, DOI 10.1242/jcs.03243; Reverter D, 2005, NATURE, V435, P687, DOI 10.1038/nature03588; Rodriguez MS, 2001, J BIOL CHEM, V276, P12654, DOI 10.1074/jbc.M009476200; Roth W, 2004, J IMMUNOL, V173, P6189, DOI 10.4049/jimmunol.173.10.6189; Sachdev S, 2001, GENE DEV, V15, P3088, DOI 10.1101/gad.944801; Sampson DA, 2001, J BIOL CHEM, V276, P21664, DOI 10.1074/jbc.M100006200; Santti H, 2005, J MOL ENDOCRINOL, V34, P645, DOI 10.1677/jme.1.01666; Schmidt D, 2002, P NATL ACAD SCI USA, V99, P2872, DOI 10.1073/pnas.052559499; Seeler JS, 2003, NAT REV MOL CELL BIO, V4, P690, DOI 10.1038/nrm1200; Takahashi K, 2001, J BIOL CHEM, V276, P37556, DOI 10.1074/jbc.M101730200; Takahashi Y, 2005, J BIOL CHEM, V280, P35822, DOI 10.1074/jbc.M506794200; Tatham MH, 2001, J BIOL CHEM, V276, P35368, DOI 10.1074/jbc.M104214200; Uchimura Y, 2004, FEBS LETT, V564, P85, DOI 10.1016/S0014-5793(04)00321-7; Ulrich HD, 2008, MOL CELL, V32, P301, DOI 10.1016/j.molcel.2008.10.010; Wang YG, 2009, J CELL SCI, V122, P4249, DOI 10.1242/jcs.050542; Wilson VG, 2009, SUMO REGULATION OF CELLULAR PROCESSES, P1, DOI 10.1007/978-90-481-2649-1_1; Yang Y, 2007, ELECTROPHORESIS, V28, P2080, DOI 10.1002/elps.200600524; Yunus AA, 2009, MOL CELL, V35, P669, DOI 10.1016/j.molcel.2009.07.013	42	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2012	7	6							e38671	10.1371/journal.pone.0038671	http://dx.doi.org/10.1371/journal.pone.0038671			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UJ	22701689	Green Published, Green Submitted, gold			2022-12-27	WOS:000305340000039
J	Roxby, AC; Drake, AL; Ongecha-Owuor, F; Kiarie, JN; Richardson, B; Matemo, DN; Overbaugh, J; Emery, S; John-Stewart, GC; Wald, A; Farquhar, C				Roxby, Alison C.; Drake, Alison L.; Ongecha-Owuor, Francisca; Kiarie, James N.; Richardson, Barbra; Matemo, Daniel N.; Overbaugh, Julie; Emery, Sandra; John-Stewart, Grace C.; Wald, Anna; Farquhar, Carey			Effects of Valacyclovir on Markers of Disease Progression in Postpartum Women Co-Infected with HIV-1 and Herpes Simplex Virus-2	PLOS ONE			English	Article							TO-CHILD TRANSMISSION; CD4 CELL COUNT; SUPPRESSIVE THERAPY; TYPE-2 INFECTION; VIRAL LOAD; RNA LEVELS; PLASMA; ACYCLOVIR; IMPACT; PREVENTION	Objective: Herpes simplex virus type 2 (HSV-2) suppression has been shown to reduce HIV-1 disease progression in nonpregnant women and men, but effects on pregnant and postpartum women have not been described. Methods: We analyzed data from a cohort of Kenyan women participating in a randomized clinical trial of HSV-2 suppression. Pregnant HIV-1-seropositive, HSV-2-seropositive women who were not eligible for antiretroviral therapy (WHO stage 1-2, CD4>250 cells/mu l) were randomized to either 500 mg valacyclovir or placebo twice daily from 34 weeks gestation through 12 months postpartum. Women received zidovudine and single-dose nevirapine for prevention of mother-to-child HIV-1 transmission. HIV-1 progression markers, including CD4 count and plasma HIV-1 RNA levels, were measured serially. Multivariate linear regression was used to compare progression markers between study arms. Results: Of 148 women randomized, 136 (92%) completed 12 months of postpartum follow-up. While adjusted mean CD4 count at 12 months (565 cells/mu l placebo arm, 638 cells/mu l valacyclovir arm) increased from antenatal levels in both arms, the mean CD4 count increase was 73 cells/ml higher in the valacyclovir arm than placebo arm (p = 0.03). Mean increase in CD4 count was 154 cells/mu l in the valacyclovir arm, almost double the increase of 78 cells/mu l in the placebo arm. At 12 months, adjusted HIV-1 RNA levels in the placebo arm increased by 0.66 log(10) copies/ml from baseline, and increased by only 0.21 log(10) copies/ml in the valacyclovir arm (0.40 log(10) copies/ml difference, p = 0.001). Conclusion: Women randomized to valacyclovir suppressive therapy during pregnancy and postpartum had greater increases in CD4 counts and smaller increases in plasma HIV-1 RNA levels than women in the placebo arm. Valacyclovir suppression during pregnancy and breastfeeding may improve outcomes and delay antiretroviral therapy for HIV-1/HSV-2 co-infected women.	[Roxby, Alison C.; John-Stewart, Grace C.; Wald, Anna; Farquhar, Carey] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Drake, Alison L.; Richardson, Barbra; John-Stewart, Grace C.; Farquhar, Carey] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [John-Stewart, Grace C.; Wald, Anna; Farquhar, Carey] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Richardson, Barbra] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [John-Stewart, Grace C.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Wald, Anna] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; [Overbaugh, Julie] Univ Nairobi, Dept Obstet & Gynaecol, Nairobi, Kenya; [Overbaugh, Julie] Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98104 USA; [Emery, Sandra; Wald, Anna] Fred Hutchinson Canc Res Ctr, Div Vaccine & Infect Dis, Seattle, WA 98104 USA; [Ongecha-Owuor, Francisca] Kenyatta Univ, Dept Med Therapeut & Psychiat, Nairobi, Kenya	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Nairobi; Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; Kenyatta University	Roxby, AC (corresponding author), Univ Washington, Dept Med, Seattle, WA 98195 USA.	aroxby@u.washington.edu	Wald, Anna/B-6272-2012; John-Stewart, Grace/L-3650-2019; John-Stewart, Grace/U-3351-2019	Wald, Anna/0000-0003-3486-6438; John-Stewart, Grace/0000-0002-4301-1573; kiarie, james/0000-0003-4180-7858; Ongecha, Francisca/0000-0002-3425-9841; Roxby, Alison/0000-0001-9449-8062	US National Institutes of Health (NIH) [R03 HD 057773, R03 HD 057773-02S1, R01 AI076105, K24 AI087399, K24 AI071113, PO1 AI30731]; University of Washington Center for AIDS Research (CFAR) [P30 AI027757]; Puget Sound Partners for Global Health Research and Technology Grant; University of Washington Royalty Research Fund Grant; NIH [T32AI07140-32]; Fogarty International Center, NIH [D43-TW000007, R24 TW007988]; GlaxoSmithKline; Antigenics; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD057773] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [R24TW007988, D43TW000007] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI030731, K24AI071113, R01AI076105, T32AI007140, P30AI027757, K24AI087399] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Washington Center for AIDS Research (CFAR); Puget Sound Partners for Global Health Research and Technology Grant; University of Washington Royalty Research Fund Grant(University of Washington); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fogarty International Center, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); GlaxoSmithKline(GlaxoSmithKline); Antigenics; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by US National Institutes of Health (NIH) research grants [R03 HD 057773, R03 HD 057773-02S1, R01 AI076105; K24 AI087399 to C.F., K24 AI071113 and PO1 AI30731 to A. W.]; the University of Washington Center for AIDS Research (CFAR) (P30 AI027757), a Puget Sound Partners for Global Health Research and Technology Grant, and a University of Washington Royalty Research Fund Grant. GlaxoSmithKline donated study drug and matched placebo, but had no other role in the study. A.L.D. was supported by NIH-funded University of Washington CFAR Training Grant (T32AI07140-32), A.C.R. and D.M. were scholars in the International AIDS Research and Training Program, funded by the Fogarty International Center, NIH (D43-TW000007); A.C.R. and F.O.O. were Fogarty International Clinical Research Fellows funded by the Fogarty International Center, NIH (R24 TW007988). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Dr. Wald has the following conflicts: she has received grant support from GlaxoSmithKline and Antigenics and has consulted for AiCuris and Agenus. All other authors have declared that no competing interests exist. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Baeten JM, 2011, J INFECT DIS, V203, P117, DOI 10.1093/infdis/jiq013; Baeten JM, 2008, J INFECT DIS, V198, P1804, DOI 10.1086/593214; Baggaley RF, 2009, AIDS, V23, P1005, DOI 10.1097/QAD.0b013e32832aadf2; Boyles TH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019201; Brown ER, 2009, J INFECT DIS, V199, P1292, DOI 10.1086/597617; Celum C, 2010, NEW ENGL J MED, V362, P427, DOI 10.1056/NEJMoa0904849; Chibwesha CJ, 2011, JAIDS-J ACQ IMM DEF, V58, P224, DOI 10.1097/QAI.0b013e318229147e; Delany S, 2009, AIDS, V23, P461, DOI 10.1097/QAD.0b013e32831db217; Drake AL, 2007, OBSTET GYNECOL, V109, P403, DOI 10.1097/01.AOG.0000251511.27725.5c; Drake AL, 2012, J INFECT DIS, V205, P366, DOI 10.1093/infdis/jir766; Duffus WA, 2005, INT J STD AIDS, V16, P733, DOI 10.1258/095646205774763298; Dunne EF, 2008, JAIDS-J ACQ IMM DEF, V49, P77, DOI 10.1097/QAI.0b013e3181831832; Emery S, 2000, J CLIN MICROBIOL, V38, P2688, DOI 10.1128/JCM.38.7.2688-2695.2000; Katubulushi M, 2005, AIDS, V19, P102, DOI 10.1097/00002030-200501030-00016; Lingappa JR, 2010, LANCET, V375, P824, DOI 10.1016/S0140-6736(09)62038-9; Modjarrad K, 2008, AIDS, V22, P2179, DOI 10.1097/QAD.0b013e328312c756; Morrow RA, 2006, J CLIN VIROL, V36, P141, DOI 10.1016/j.jcv.2006.02.006; Mugwanya K, 2011, J INFECT DIS, V204, P1912, DOI 10.1093/infdis/jir649; Nagot N, 2007, NEW ENGL J MED, V356, P790, DOI 10.1056/NEJMoa062607; Ouedraogo A, 2006, AIDS, V20, P2305, DOI 10.1097/QAD.0b013e328010238d; Reynolds SJ, 2012, LANCET INFECT DIS; Schouten EJ, 2011, LANCET, V378, P282, DOI 10.1016/S0140-6736(10)62303-3; Serwadda D, 2003, J INFECT DIS, V188, P1492, DOI 10.1086/379333; Tanton C, 2010, J INFECT DIS, V201, P1285, DOI 10.1086/651696; Thomson KA, 2011, T ROY SOC TROP MED H, V105, P320, DOI 10.1016/j.trstmh.2011.02.011; Urassa W, 2004, AIDS, V18, P433, DOI 10.1097/00002030-200402200-00009; Vickerman P, 2011, SEX TRANSM DIS, V38, P401, DOI 10.1097/OLQ.0b013e31820b8bc8; Watson-Jones D, 2010, J CLIN MICROBIOL, V48, P3496, DOI 10.1128/JCM.01263-10; Wolbers M, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000239; World Health Organization, 2021, ANT DRUGS TREAT PREG; Zuckerman RA, 2007, J INFECT DIS, V196, P1500, DOI 10.1086/522523	31	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2012	7	6							e38622	10.1371/journal.pone.0038622	http://dx.doi.org/10.1371/journal.pone.0038622			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UJ	22701683	gold, Green Published, Green Submitted			2022-12-27	WOS:000305340000036
J	Bonnefond, A; Philippe, J; Durand, E; Dechaume, A; Huyvaert, M; Montagne, L; Marre, M; Balkau, B; Fajardy, I; Vambergue, A; Vatin, V; Delplanque, J; Le Guilcher, D; De Graeve, F; Lecoeur, C; Sand, O; Vaxillaire, M; Froguel, P				Bonnefond, Amelie; Philippe, Julien; Durand, Emmanuelle; Dechaume, Aurelie; Huyvaert, Marlene; Montagne, Louise; Marre, Michel; Balkau, Beverley; Fajardy, Isabelle; Vambergue, Anne; Vatin, Vincent; Delplanque, Jerome; Le Guilcher, David; De Graeve, Franck; Lecoeur, Cecile; Sand, Olivier; Vaxillaire, Martine; Froguel, Philippe			Whole-Exome Sequencing and High Throughput Genotyping Identified KCNJ11 as the Thirteenth MODY Gene	PLOS ONE			English	Article							NEONATAL DIABETES-MELLITUS; INSULIN GENE; YOUNG MODY; RARE CAUSE; MUTATIONS; ONSET; CHILDHOOD; ADULTHOOD; FAMILIES; INS	Background: Maturity-onset of the young (MODY) is a clinically heterogeneous form of diabetes characterized by an autosomal-dominant mode of inheritance, an onset before the age of 25 years, and a primary defect in the pancreatic beta-cell function. Approximately 30% of MODY families remain genetically unexplained (MODY-X). Here, we aimed to use whole-exome sequencing (WES) in a four-generation MODY-X family to identify a new susceptibility gene for MODY. Methodology: WES (Agilent-SureSelect capture/Illumina-GAIIx sequencing) was performed in three affected and one non-affected relatives in the MODY-X family. We then performed a high-throughput multiplex genotyping (Illumina-GoldenGate assay) of the putative causal mutations in the whole family and in 406 controls. A linkage analysis was also carried out. Principal Findings: By focusing on variants of interest (i.e. gains of stop codon, frameshift, non-synonymous and splice-site variants not reported in dbSNP130) present in the three affected relatives and not present in the control, we found 69 mutations. However, as WES was not uniform between samples, a total of 324 mutations had to be assessed in the whole family and in controls. Only one mutation (p. Glu227Lys in KCNJ11) co-segregated with diabetes in the family (with a LOD-score of 3.68). No KCNJ11 mutation was found in 25 other MODY-X unrelated subjects. Conclusions/Significance: Beyond neonatal diabetes mellitus (NDM), KCNJ11 is also a MODY gene ('MODY13'), confirming the wide spectrum of diabetes related phenotypes due to mutations in NDM genes (i.e. KCNJ11, ABCC8 and INS). Therefore, the molecular diagnosis of MODY should include KCNJ11 as affected carriers can be ideally treated with oral sulfonylureas.	[Bonnefond, Amelie; Philippe, Julien; Durand, Emmanuelle; Dechaume, Aurelie; Huyvaert, Marlene; Montagne, Louise; Vatin, Vincent; Delplanque, Jerome; Le Guilcher, David; De Graeve, Franck; Lecoeur, Cecile; Sand, Olivier; Vaxillaire, Martine; Froguel, Philippe] Lille Pasteur Inst, CNRS UMR8199, Lille, France; [Bonnefond, Amelie; Philippe, Julien; Durand, Emmanuelle; Dechaume, Aurelie; Huyvaert, Marlene; Montagne, Louise; Fajardy, Isabelle; Vambergue, Anne; Vatin, Vincent; Delplanque, Jerome; Le Guilcher, David; De Graeve, Franck; Lecoeur, Cecile; Sand, Olivier; Vaxillaire, Martine; Froguel, Philippe] Lille Nord France Univ, Lille, France; [Montagne, Louise] Catholic Univ Lille, St Vincent de Paul Hosp, St Antoine Pediat Hosp, Dept Pediat, Lille, France; [Marre, Michel] Bichat Claude Bernard Univ Hosp, AP HP, Dept Endocrinol Diabetol & Nutr, Paris, France; [Marre, Michel] Univ Paris 07, Inserm U695, Paris, France; [Balkau, Beverley] Ctr Res Epidemiol & Populat Hlth, Inserm U1018, Villejuif, France; [Balkau, Beverley] Univ Paris 11, Villejuif, France; [Vambergue, Anne] Huriez Hosp, CHRU Lille, Dept Diabetol, EA Perinatal Environm & Fetal Growth 4489, Lille, France; [Froguel, Philippe] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Sch Publ Hlth, Dept Genom Common Dis, London, England	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Universite de Lille - ISITE; CHU Lille; Imperial College London	Bonnefond, A (corresponding author), Lille Pasteur Inst, CNRS UMR8199, Lille, France.	p.froguel@imperial.ac.uk	Philippe, Julien/R-5183-2019; FROGUEL, Philippe/O-6799-2017; Bonnefond, Amélie/O-2784-2017	FROGUEL, Philippe/0000-0003-2972-0784; Bonnefond, Amélie/0000-0001-9976-3005; Marre, Michel/0000-0002-3071-1837; Philippe, Julien/0000-0003-1906-7259; Sand, Olivier/0000-0003-1465-1640	transnational European research grant on Rare Diseases [ERANET-09-RARE-005]; French Agence Nationale de la Recherche [ANR-10-LABX-46, ANR-10-EQPX-07-01]	transnational European research grant on Rare Diseases; French Agence Nationale de la Recherche(French National Research Agency (ANR))	The study was supported by the transnational European research grant on Rare Diseases (ERANET-09-RARE-005) and by the French Agence Nationale de la Recherche (ANR-10-LABX-46 and ANR-10-EQPX-07-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-Bryan L, 2008, ENDOCR REV, V29, P265, DOI 10.1210/er.2007-0029; Babenko AP, 2006, NEW ENGL J MED, V355, P456, DOI 10.1056/NEJMoa055068; Babenko AP, 1998, ANNU REV PHYSIOL, V60, P667, DOI 10.1146/annurev.physiol.60.1.667; Balkau B, 1996, REV EPIDEMIOL SANTE, V44, P373; Bamshad MJ, 2011, NAT REV GENET, V12, P745, DOI 10.1038/nrg3031; Boesgaard TW, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-42; Bonnefond A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013630; Bonnefond A, 2010, TRENDS MOL MED, V16, P407, DOI 10.1016/j.molmed.2010.06.004; Bowman P, 2012, DIABETOLOGIA, V55, P123, DOI 10.1007/s00125-011-2319-x; Chevre JC, 1998, DIABETOLOGIA, V41, P1017, DOI 10.1007/s001250051025; D'Amato E, 2008, DIABETIC MED, V25, P651, DOI 10.1111/j.1464-5491.2008.02443.x; Edghill EL, 2008, DIABETES, V57, P1034, DOI 10.2337/db07-1405; Edghill EL, 2007, J CLIN ENDOCR METAB, V92, P1773, DOI 10.1210/jc.2006-2817; Fajans SS, 2011, DIABETES CARE, V34, P1878, DOI 10.2337/dc11-0035; Flanagan SE, 2007, DIABETES, V56, P1930, DOI 10.2337/db07-0043; Frayling TM, 2003, DIABETES, V52, P872, DOI 10.2337/diabetes.52.3.872; Girard CAJ, 2006, PFLUG ARCH EUR J PHY, V453, P323, DOI 10.1007/s00424-006-0112-3; Gudbjartsson DF, 2005, NAT GENET, V37, P1015, DOI 10.1038/ng1005-1015; Iafusco D, 2011, DIABETOLOGIA, V54, P2736, DOI 10.1007/s00125-011-2273-7; Kochar IPS, 2010, INDIAN PEDIATR, V47, P359; Landau Z, 2007, J PEDIATR-US, V150, P553, DOI 10.1016/j.jpeds.2007.03.004; Meur G, 2010, DIABETES, V59, P653, DOI 10.2337/db09-1091; Molven A, 2008, DIABETES, V57, P1131, DOI 10.2337/db07-1467; Murphy R, 2008, NAT CLIN PRACT ENDOC, V4, P200, DOI 10.1038/ncpendmet0778; Pearson ER, 2006, NEW ENGL J MED, V355, P467, DOI 10.1056/NEJMoa061759; Rica I, 2007, DIABETIC MED, V24, P707, DOI 10.1111/j.1464-5491.2007.02140.x; Riveline JP, 2012, DIABETES CARE, V35, P248, DOI 10.2337/dc11-1469; Stoy J, 2008, PEDIATR DIABETES, V9, P450, DOI 10.1111/j.1399-5448.2008.00433.x; VAXILLAIRE M, 1995, NAT GENET, V9, P418, DOI 10.1038/ng0495-418; Vaxillaire M, 2006, ENDOCRIN METAB CLIN, V35, P371, DOI 10.1016/j.ecl.2006.02.009; Yorifuji T, 2005, J CLIN ENDOCR METAB, V90, P3174, DOI 10.1210/jc.2005-0096	31	138	149	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2012	7	6							e37423	10.1371/journal.pone.0037423	http://dx.doi.org/10.1371/journal.pone.0037423			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TU	22701567	Green Submitted, Green Published, gold			2022-12-27	WOS:000305337600008
J	Boudjenah, R; Molina-Gomes, D; Torre, A; Bergere, M; Bailly, M; Boitrelle, F; Taieb, S; Wainer, R; Benahmed, M; de Mazancourt, P; Selva, J; Vialard, F				Boudjenah, Radia; Molina-Gomes, Denise; Torre, Antoine; Bergere, Marianne; Bailly, Marc; Boitrelle, Florence; Taieb, Stephane; Wainer, Robert; Benahmed, Mohamed; de Mazancourt, Philippe; Selva, Jacqueline; Vialard, Francois			Genetic Polymorphisms Influence the Ovarian Response to rFSH Stimulation in Patients Undergoing In Vitro Fertilization Programs with ICSI	PLOS ONE			English	Article							ANTI-MULLERIAN HORMONE; ESTROGEN-RECEPTOR-BETA; LEUKEMIA INHIBITORY FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; ENDOTHELIAL GROWTH-FACTOR; HUMAN OOCYTES INVITRO; IMPLANTATION FAILURE; EMBRYO IMPLANTATION; REDUCTASE MTHFR; WOMEN	Introduction: Obtaining an adequate number of high-quality oocytes is a major challenge in controlled ovarian hyperstimulation (COH). To date, a range of hormonal and clinical parameters have been used to optimize COH but none have significant predictive value. This variability could be due to the genetic predispositions of single-nucleotide polymorphisms (SNPs). Here, we assessed the individual and combined impacts of thirteen SNPs that reportedly influence the outcome of in vitro fertilisation (IVF) on the ovarian response to rFSH stimulation for patients undergoing intracytoplasmic sperm injection program (ICSI). Results: Univariate analysis revealed that only FSHR, ESR2 and p53 SNPs influenced the number of mature oocytes. The association was statistically significant for FSHR (p = 0.0047) and ESR2 (0.0017) in the overall study population and for FSHR (p = 0.0009) and p53 (p = 0.0048) in subgroup that was more homogeneous in terms of clinical variables. After Bonferroni correction and a multivariate analysis, only the differences for FSHR and ESR2 polymorphisms were still statistically significant. In a multilocus analysis, only the FSHR and AMH SNP combination significantly influenced oocyte numbers in both population (p < 0.01). Discussion: We confirmed the impact of FSHR and ESR2 polymorphisms on the IVF outcome. Furthermore, we showed for the first time that a p53 polymorphism (which is already known to impact embryo implantation) could influence the ovarian response. However, given that this result lost its statistical significance after multivariate analysis, more data are needed to draw firm conclusions. Only the FSHR and AMH polymorphism combination appears to influence mature oocyte numbers but this finding also needs to be confirmed. Materials and Methods: A 13 gene polymorphisms: FSHR(Asn680Ser), p53(Arg72Pro), AMH(Ile49Ser), ESR2(+1730G>A), ESR1(-397T>C), BMP15(-9C>G), MTHFR1(677C>T), MTHFR2(1298A>C), HLA-G(-725C>G), VEGF(+405G>C), TNF alpha(-308A>G), AMHR(-482 A>G), PAI-1 (4 G/5 G), multiplex PCR assay was designed to genotype women undergoing ICSI program. We analyzed the overall study population (n = 427) and a subgroup with homogeneous characteristics (n = 112).	[Boudjenah, Radia; Molina-Gomes, Denise; Torre, Antoine; Bergere, Marianne; Bailly, Marc; Boitrelle, Florence; Wainer, Robert; Selva, Jacqueline; Vialard, Francois] Poissy St Germain Med Ctr, Dept Reprod Biol Cytogenet Gynaecol & Obstet, Poissy, France; [Boudjenah, Radia; Molina-Gomes, Denise; Torre, Antoine; Bergere, Marianne; Bailly, Marc; Boitrelle, Florence; Taieb, Stephane; Wainer, Robert; de Mazancourt, Philippe; Selva, Jacqueline; Vialard, Francois] Versailles St Quentin Univ, EA 2493, Versailles, France; [Benahmed, Mohamed] Nice Univ Hosp, Dept Reprod Biol, Nice, France	UDICE-French Research Universities; Universite Paris Saclay; CHU Nice	Boudjenah, R (corresponding author), Poissy St Germain Med Ctr, Dept Reprod Biol Cytogenet Gynaecol & Obstet, Poissy, France.	boudjenahradia@yahoo.fr; fvialard@chi-psg.com		BOITRELLE, Florence/0000-0002-5322-0141; Vialard, Francois/0000-0002-5774-2756	FARO (Fonds d'Aide a la Recherche Organon); AMMR-PSG (Association Maternite et Medecine de la Reproduction-Poissy St Germain en Laye)	FARO (Fonds d'Aide a la Recherche Organon); AMMR-PSG (Association Maternite et Medecine de la Reproduction-Poissy St Germain en Laye)	Grants have been obtained by Radia Boudjenah for her PhD and the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Grants were obtained from the FARO (Fonds d'Aide a la Recherche Organon) and AMMR-PSG (Association Maternite et Medecine de la Reproduction-Poissy St Germain en Laye). No additional external funding was received for this study.	Achrekar SK, 2009, FERTIL STERIL, V91, P432, DOI 10.1016/j.fertnstert.2007.11.093; Aghajanova L, 2004, ANN NY ACAD SCI, V1034, P176, DOI 10.1196/annals.1335.020; Altmae S, 2011, HUM REPROD UPDATE, V17, P813, DOI 10.1093/humupd/dmr034; Altmae S, 2007, MOL HUM REPROD, V13, P521, DOI 10.1093/molehr/gam035; Anagnostou E, CURR PHARM BIOTECHNO; Azem F, 2004, HUM REPROD, V19, P368, DOI 10.1093/humrep/deh069; Behre HM, 2005, PHARMACOGENET GENOM, V15, P451, DOI 10.1097/01.fpc.0000167330.92786.5e; BOTERORUIZ W, 1984, FERTIL STERIL, V41, P820; Byers M, 1997, MOL ENDOCRINOL, V11, P172, DOI 10.1210/me.11.2.172; Carlsson IB, 2006, HUM REPROD, V21, P2223, DOI 10.1093/humrep/del165; Conway GS, 1999, CLIN ENDOCRINOL, V51, P97, DOI 10.1046/j.1365-2265.1999.00745.x; Coulam CB, 2006, AM J REPROD IMMUNOL, V55, P360, DOI 10.1111/j.1600-0897.2006.00376.x; Daelemans C, 2004, J CLIN ENDOCR METAB, V89, P6310, DOI 10.1210/jc.2004-1044; de Castro F, 2004, PHARMACOGENETICS, V14, P285, DOI 10.1097/00008571-200405000-00003; de Castro F, 2003, FERTIL STERIL, V80, P571, DOI 10.1016/S0015-0282(03)00795-7; Derry WB, 2001, SCIENCE, V294, P591, DOI 10.1126/science.1065486; Drummond AE, 1999, MOL CELL ENDOCRINOL, V151, P57, DOI 10.1016/S0303-7207(99)00038-6; Durlinger ALL, 2002, REPRODUCTION, V124, P601, DOI 10.1530/reprod/124.5.601; Durlinger ALL, 2001, ENDOCRINOLOGY, V142, P4891, DOI 10.1210/en.142.11.4891; Ficicioglu C, 2006, FERTIL STERIL, V85, P592, DOI 10.1016/j.fertnstert.2005.09.019; FISHEL SB, 1983, J ENDOCRINOL, V99, P335, DOI 10.1677/joe.0.0990335; Gigli I, 2005, MOL REPROD DEV, V71, P480, DOI 10.1002/mrd.20338; Goodman C, 2008, REPROD BIOMED ONLINE, V16, P720, DOI 10.1016/S1472-6483(10)60487-7; Grady R, 2012, FERTIL STERIL, V97, P324, DOI 10.1016/j.fertnstert.2011.11.033; Greb RR, 2005, REPROD BIOMED ONLINE, V11, P589, DOI 10.1016/S1472-6483(10)61167-4; Greb RR, 2005, J CLIN ENDOCR METAB, V90, P4866, DOI 10.1210/jc.2004-2268; Haggarty P, 2006, LANCET, V367, P1513, DOI 10.1016/S0140-6736(06)68651-0; Hanevik HI, REPROD BIOMED ONLINE, V21, P616; Hegele-Hartung C, 2004, P NATL ACAD SCI USA, V101, P5129, DOI 10.1073/pnas.0306720101; Hendriks DJ, 2005, FERTIL STERIL, V83, P291, DOI 10.1016/j.fertnstert.2004.10.011; Hofmann GE, 1998, FERTIL STERIL, V69, P474, DOI 10.1016/S0015-0282(97)00531-1; HOLM S, 1979, SCAND J STAT, V6, P65; IRELAND JJ, 1978, ENDOCRINOLOGY, V102, P876, DOI 10.1210/endo-102-3-876; Jun JK, 2006, J HUM GENET, V51, P665, DOI 10.1007/s10038-006-0005-5; Kang HJ, 2008, FERTIL STERIL, V92, pS21; Kay C, 2006, REPROD BIOMED ONLINE, V13, P492, DOI 10.1016/S1472-6483(10)60635-9; Kevenaar ME, 2008, J CLIN ENDOCR METAB, V93, P1310, DOI 10.1210/jc.2007-2205; Kevenaar ME, 2007, HUM REPROD, V22, P1547, DOI 10.1093/humrep/dem036; Klinkert ER, 2006, REPROD BIOMED ONLINE, V13, P687, DOI 10.1016/S1472-6483(10)60660-8; Krege JH, 1998, P NATL ACAD SCI USA, V95, P15677, DOI 10.1073/pnas.95.26.15677; Laird SM, 1997, HUM REPROD, V12, P569; Laven JSE, 2003, FERTIL STERIL, V80, P986, DOI 10.1016/S0015-0282(03)01115-4; LICCIARDI FL, 1995, FERTIL STERIL, V64, P991, DOI 10.1016/S0015-0282(16)57916-3; Loutradis D, 2006, GYNECOL OBSTET INVES, V61, P56, DOI 10.1159/000088658; Martinelli I, 2003, HAEMATOLOGICA, V88, P789; Mayorga MP, 2000, J CLIN ENDOCR METAB, V85, P3365, DOI 10.1210/jc.85.9.3365; Mikolajczyk M, 2007, AM J REPROD IMMUNOL, V58, P65, DOI 10.1111/j.1600-0897.2007.00492.x; Moron FJ, 2006, PHARMACOGENET GENOM, V16, P485, DOI 10.1097/01.fpc.0000215073.44589.96; Ocal P, 2004, EUR J OBSTET GYN R B, V115, P194, DOI 10.1016/j.ejogrb.2004.01.034; Ollmann M, 2000, CELL, V101, P91, DOI 10.1016/S0092-8674(00)80626-1; Putnik M, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-55; Rosen MP, 2007, FERTIL STERIL, V88, P632, DOI 10.1016/j.fertnstert.2006.11.165; Roussev RG, 2007, J ASSIST REPROD GEN, V24, P288, DOI 10.1007/s10815-007-9148-3; SCHWARTZ D, 1982, NEW ENGL J MED, V306, P404, DOI 10.1056/NEJM198202183060706; SCOTT RT, 1989, FERTIL STERIL, V51, P651; SCOTT RT, 1990, FERTIL STERIL, V54, P297; Scully KM, 1997, MOL ENDOCRINOL, V11, P674, DOI 10.1210/me.11.6.674; Simoni M, 2002, HUM REPROD UPDATE, V8, P413, DOI 10.1093/humupd/8.5.413; Srouji SS, 2005, FERTIL STERIL, V84, P795, DOI 10.1016/j.fertnstert.2005.02.042; Sudo S, 2002, MOL HUM REPROD, V8, P893, DOI 10.1093/molehr/8.10.893; Sundarrajan C, 2001, J CLIN ENDOCR METAB, V86, P135, DOI 10.1210/jc.86.1.135; Sundarrajan C, 1999, MOL HUM REPROD, V5, P797, DOI 10.1093/molehr/5.9.797; Thaler CJ, 2006, AM J REPROD IMMUNOL, V55, P251, DOI 10.1111/j.1600-0897.2005.00357.x; Vialard F, INCREASED EMBR UNPUB; Visser JA, 2007, ENDOCRINOLOGY, V148, P2301, DOI 10.1210/en.2006-1265; Windahl SH, 2002, TRENDS ENDOCRIN MET, V13, P195, DOI 10.1016/S1043-2760(02)00594-5	66	54	74	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2012	7	6							e38700	10.1371/journal.pone.0038700	http://dx.doi.org/10.1371/journal.pone.0038700			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TU	22701696	Green Published, Green Submitted, gold			2022-12-27	WOS:000305337600038
J	Urasaki, Y; Johlfs, MG; Fiscus, RR; Le, TT				Urasaki, Yasuyo; Johlfs, Mary G.; Fiscus, Ronald R.; Le, Thuc T.			Imaging Immune and Metabolic Cells of Visceral Adipose Tissues with Multimodal Nonlinear Optical Microscopy	PLOS ONE			English	Article							LIPID DROPLETS; OBESITY; INFLAMMATION; FLUORESCENCE; MACROPHAGES; LIPOLYSIS; PROTEINS; CANCER	Visceral adipose tissue (VAT) inflammation is recognized as a mechanism by which obesity is associated with metabolic diseases. The communication between adipose tissue macrophages (ATMs) and adipocytes is important to understanding the interaction between immunity and energy metabolism and its roles in obesity-induced diseases. Yet visualizing adipocytes and macrophages in complex tissues is challenging to standard imaging methods. Here, we describe the use of a multimodal nonlinear optical (NLO) microscope to characterize the composition of VATs of lean and obese mice including adipocytes, macrophages, and collagen fibrils in a label-free manner. We show that lipid metabolism processes such as lipid droplet formation, lipid droplet microvesiculation, and free fatty acids trafficking can be dynamically monitored in macrophages and adipocytes. With its versatility, NLO microscopy should be a powerful imaging tool to complement molecular characterization of the immunity-metabolism interface.	[Urasaki, Yasuyo; Le, Thuc T.] Desert Res Inst, Human Hlth & Environm Program, Las Vegas, NV USA; [Urasaki, Yasuyo; Le, Thuc T.] Nevada Canc Inst, Dept Drug Dev, Las Vegas, NV USA; [Johlfs, Mary G.; Fiscus, Ronald R.] Roseman Univ Hlth Sci, Ctr Diabet & Obes Prevent Treatment Res & Educ, Henderson, NV USA; [Johlfs, Mary G.; Fiscus, Ronald R.] Roseman Univ Hlth Sci, Coll Pharm, Henderson, NV USA	Nevada System of Higher Education (NSHE); Desert Research Institute NSHE; University of California System; University of California San Diego	Urasaki, Y (corresponding author), Desert Res Inst, Human Hlth & Environm Program, Las Vegas, NV USA.	thuc.le@dri.edu			Nevada INBRE Program of the National Center for Research Resources [P20RR-016464]; American Cancer Society [IRG-08-062-04]; Vons Breast Cancer Research Award; Roseman University of Health Sciences; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016464] Funding Source: NIH RePORTER	Nevada INBRE Program of the National Center for Research Resources; American Cancer Society(American Cancer Society); Vons Breast Cancer Research Award; Roseman University of Health Sciences; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by a Nevada INBRE Program of the National Center for Research Resources (P20RR-016464, TTL), the American Cancer Society (IRG-08-062-04, TTL), the Vons Breast Cancer Research Award (TTL), and startup funding from Roseman University of Health Sciences (RRF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariotti N, 2012, MOL BIOL CELL, V23, P1826, DOI 10.1091/mbc.E11-10-0847; Bensinger SJ, 2008, NATURE, V454, P470, DOI 10.1038/nature07202; Calle EE, 2004, NAT REV CANCER, V4, P579, DOI 10.1038/nrc1408; Campagnola PJ, 2003, NAT BIOTECHNOL, V21, P1356, DOI 10.1038/nbt894; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Engeli S, 2004, J LIPID RES, V45, P1640, DOI 10.1194/jlr.M300322-JLR200; Fiscus RR, 2012, PROTEIN KIN IN PRESS, V68; Fiscus RR, 2012, OVARIAN CANC BASIC S, P315; Fukumura D, 2003, CIRC RES, V93, pE88, DOI 10.1161/01.RES.0000099243.20096.FA; Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589; Helmchen F, 2005, NAT METHODS, V2, P932, DOI 10.1038/NMETH818; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hotamisligil GS, 2008, NAT REV IMMUNOL, V8, P923, DOI 10.1038/nri2449; Huang SH, 2002, BIOPHYS J, V82, P2811, DOI 10.1016/S0006-3495(02)75621-X; JEFFERIES WA, 1985, J EXP MED, V162, P117, DOI 10.1084/jem.162.1.117; KNOWLES RG, 1994, BIOCHEM J, V298, P249, DOI 10.1042/bj2980249; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Le TT, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2795437; Le TT, 2007, MOL IMAGING, V6, P205, DOI 10.2310/7290.2007.00018; Le TT, 2010, J LIPID RES, V51, P3091, DOI 10.1194/jlr.R008730; Le TT, 2010, J LIPID RES, V51, P672, DOI 10.1194/jlr.D000638; Le TT, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-42; Lumeng CN, 2007, DIABETES, V56, P16, DOI 10.2337/db06-1076; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lumeng CN, 2008, DIABETES, V57, P3239, DOI 10.2337/db08-0872; Marcinkiewicz A, 2006, J BIOL CHEM, V281, P11901, DOI 10.1074/jbc.M600171200; Paar M, 2012, J BIOL CHEM, V287, P11164, DOI 10.1074/jbc.M111.316794; Slipchenko MN, 2009, J PHYS CHEM B, V113, P7681, DOI 10.1021/jp902231y; SMITH MJ, 1987, J CELL SCI, V87, P113; Stahl A, 2001, TRENDS ENDOCRIN MET, V12, P266, DOI 10.1016/S1043-2760(01)00427-1; Sul HS, 2009, MOL ENDOCRINOL, V23, P1717, DOI 10.1210/me.2009-0160; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Yamaguchi T, 2007, J LIPID RES, V48, P1078, DOI 10.1194/jlr.M600493-JLR200; Yan HY, 2002, J LIPID RES, V43, P2123, DOI 10.1194/jlr.M200305-JLR200; Yen K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012810; Zhu JB, 2009, J LIPID RES, V50, P1080, DOI 10.1194/jlr.M800555-JLR200; Zipfel WR, 2003, P NATL ACAD SCI USA, V100, P7075, DOI 10.1073/pnas.0832308100	37	15	15	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2012	7	6							e38418	10.1371/journal.pone.0038418	http://dx.doi.org/10.1371/journal.pone.0038418			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TU	22701636	Green Published, gold, Green Submitted			2022-12-27	WOS:000305337600022
J	Claus, J; Chavarria-Krauser, A				Claus, Juliane; Chavarria-Krauser, Andres			Modeling Regulation of Zinc Uptake via ZIP Transporters in Yeast and Plant Roots	PLOS ONE			English	Article							ZAP1 TRANSCRIPTIONAL ACTIVATOR; MOLECULAR-MECHANISMS; HIGH-AFFINITY; GENE ENCODES; ARABIDOPSIS; HOMEOSTASIS; ADAPTATION; HYPERACCUMULATION; TOLERANCE; SENSORS	In yeast (Saccharomyces cerevisiae) and plant roots (Arabidopsis thaliana) zinc enters the cells via influx transporters of the ZIP family. Since zinc is both essential for cell function and toxic at high concentrations, tight regulation is essential for cell viability. We provide new insight into the underlying mechanisms, starting from a general model based on ordinary differential equations and adapting it to the specific cases of yeast and plant root cells. In yeast, zinc is transported by the transporters ZRT1 and ZRT2, which are both regulated by the zinc-responsive transcription factor ZAP1. Using biological data, parameters were estimated and analyzed, confirming the different affinities of ZRT1 and ZRT2 reported in the literature. Furthermore, our model suggests that the positive feedback in ZAP1 production has a stabilizing function at high influx rates. In plant roots, various ZIP transporters play a role in zinc uptake. Their regulation is largely unknown, but bZIP transcription factors are thought to be involved. We set up three putative models based on: an activator only, an activator with dimerization and an activator-inhibitor pair. These were fitted to measurements and analyzed. Simulations show that the activator-inhibitor model outperforms the other two in providing robust and stable homeostasis at reasonable parameter ranges.	[Claus, Juliane; Chavarria-Krauser, Andres] Heidelberg Univ, Ctr Modelling & Simulat Biosci, Heidelberg, Germany; [Claus, Juliane; Chavarria-Krauser, Andres] Heidelberg Univ, Interdisciplinary Ctr Sci Comp, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Claus, J (corresponding author), Heidelberg Univ, Ctr Modelling & Simulat Biosci, Heidelberg, Germany.	andres.chavarria@bioquant.uni-heidelberg.de			German Research Foundation [CH 958/1-1]	German Research Foundation(German Research Foundation (DFG))	This work was funded by the German Research Foundation grant number CH 958/1-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assuncao AGL, 2010, PLANT SIGNAL BEHAV, V5, P1553, DOI 10.4161/psb.5.12.13469; Assuncao AGL, 2010, P NATL ACAD SCI USA, V107, P10296, DOI 10.1073/pnas.1004788107; Bevington P.R., 2003, DATA REDUCTION ERROR, V3th; Bird AJ, 2004, EMBO J, V23, P1123, DOI 10.1038/sj.emboj.7600122; Broadley MR, 2007, NEW PHYTOL, V173, P677, DOI 10.1111/j.1469-8137.2007.01996.x; Bruce A., 2002, MOL BIOL CELL, V4th ed.; Cakmak I, 2000, NEW PHYTOL, V146, P185, DOI 10.1046/j.1469-8137.2000.00630.x; Chaney RL, 1997, CURR OPIN BIOTECH, V8, P279, DOI 10.1016/S0958-1669(97)80004-3; Clemens S, 2001, PLANTA, V212, P475, DOI 10.1007/s004250000458; Cook DL, 1998, P NATL ACAD SCI USA, V95, P15641, DOI 10.1073/pnas.95.26.15641; Deppmann CD, 2006, MOL BIOL EVOL, V23, P1480, DOI 10.1093/molbev/msl022; Dittmer PJ, 2009, J BIOL CHEM, V284, P16289, DOI 10.1074/jbc.M900501200; Eide DJ, 2003, J NUTR, V133, p1532S, DOI 10.1093/jn/133.5.1532S; GEGENFURTNER KR, 1992, BEHAV RES METH INSTR, V24, P560, DOI 10.3758/BF03203605; Gitan RS, 2003, J BIOL CHEM, V278, P39558, DOI 10.1074/jbc.M302760200; Grotz N, 1998, P NATL ACAD SCI USA, V95, P7220, DOI 10.1073/pnas.95.12.7220; Guerinot ML, 2000, BBA-BIOMEMBRANES, V1465, P190, DOI 10.1016/S0005-2736(00)00138-3; Hacisalihoglu G, 2001, PLANT PHYSIOL, V125, P456, DOI 10.1104/pp.125.1.456; Jakoby M, 2002, TRENDS PLANT SCI, V7, P106, DOI 10.1016/S1360-1385(01)02223-3; Jolma IW, 2010, BIOPHYS J, V98, P743, DOI 10.1016/j.bpj.2009.11.013; Keener J., 2009, MATH PHYSL, V1; Macnair MR, 1999, P ROY SOC B-BIOL SCI, V266, P2175, DOI 10.1098/rspb.1999.0905; Ni XY, 2009, BIOPHYS J, V97, P1244, DOI 10.1016/j.bpj.2009.06.030; Outten CE, 2001, SCIENCE, V292, P2488, DOI 10.1126/science.1060331; Palmer CM, 2009, NAT CHEM BIOL, V5, P333, DOI 10.1038/nchembio.166; Schutze K, 2008, TRENDS PLANT SCI, V13, P247, DOI 10.1016/j.tplants.2008.03.002; Sommer AL, 1926, PLANT PHYSIOL, V1, P231, DOI 10.1104/pp.1.3.231; Talke IN, 2006, PLANT PHYSIOL, V142, P148, DOI 10.1104/pp.105.076232; Vinkenborg JL, 2009, NAT METHODS, V6, P737, DOI [10.1038/NMETH.1368, 10.1038/nmeth.1368]; Yamasaki S, 2007, J CELL BIOL, V177, P637, DOI 10.1083/jcb.200702081; Zhao FJ, 2000, PLANT CELL ENVIRON, V23, P507, DOI 10.1046/j.1365-3040.2000.00569.x; Zhao H, 1998, J BIOL CHEM, V273, P28713, DOI 10.1074/jbc.273.44.28713; Zhao H, 1996, J BIOL CHEM, V271, P23203, DOI 10.1074/jbc.271.38.23203; Zhao H, 1996, P NATL ACAD SCI USA, V93, P2454, DOI 10.1073/pnas.93.6.2454	34	16	16	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2012	7	6							e37193	10.1371/journal.pone.0037193	http://dx.doi.org/10.1371/journal.pone.0037193			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TQ	22715365	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336800006
J	Dupuis, L; Dengler, R; Heneka, MT; Meyer, T; Zierz, S; Kassubek, J; Fischer, W; Steiner, F; Lindauer, E; Otto, M; Dreyhaupt, J; Grehl, T; Hermann, A; Winkler, AS; Bogdahn, U; Benecke, R; Schrank, B; Wessig, C; Grosskreutz, J; Ludolph, AC				Dupuis, Luc; Dengler, Reinhard; Heneka, Michael T.; Meyer, Thomas; Zierz, Stephan; Kassubek, Jan; Fischer, Wilhelm; Steiner, Franziska; Lindauer, Eva; Otto, Markus; Dreyhaupt, Jens; Grehl, Torsten; Hermann, Andreas; Winkler, Andrea S.; Bogdahn, Ulrich; Benecke, Reiner; Schrank, Bertold; Wessig, Carsten; Grosskreutz, Julian; Ludolph, Albert C.		GERP ALS Study Grp	A Randomized, Double Blind, Placebo-Controlled Trial of Pioglitazone in Combination with Riluzole in Amyotrophic Lateral Sclerosis	PLOS ONE			English	Article							TRANSGENIC MOUSE MODEL; CENTRAL-NERVOUS-SYSTEM; NONALCOHOLIC STEATOHEPATITIS; PPAR-GAMMA; HEXANUCLEOTIDE REPEAT; DISEASE PROGRESSION; DELAYS PROGRESSION; SOD1 MUTATIONS; ALS; MINOCYCLINE	Background: Pioglitazone, an oral anti-diabetic that stimulates the PPAR-gamma transcription factor, increased survival of mice with amyotrophic lateral sclerosis (ALS). Methods/Principal Findings: We performed a phase II, double blind, multicentre, placebo controlled trial of pioglitazone in ALS patients under riluzole. 219 patients were randomly assigned to receive 45 mg/day of pioglitazone or placebo (one: one allocation ratio). The primary endpoint was survival. Secondary endpoints included incidence of non-invasive ventilation and tracheotomy, and slopes of ALS-FRS, slow vital capacity, and quality of life as assessed using EUROQoL EQ-5D. The study was conducted under a two-stage group sequential test, allowing to stop for futility or superiority after interim analysis. Shortly after interim analysis, 30 patients under pioglitazone and 24 patients under placebo had died. The trial was stopped for futility; the hazard ratio for primary endpoint was 1.21 (95% CI: 0.71-2.07, p = 0.48). Secondary endpoints were not modified by pioglitazone treatment. Pioglitazone was well tolerated. Conclusion/Significance: Pioglitazone has no beneficial effects on the survival of ALS patients as add-on therapy to riluzole.	[Dupuis, Luc; Kassubek, Jan; Fischer, Wilhelm; Steiner, Franziska; Lindauer, Eva; Otto, Markus; Ludolph, Albert C.] Univ Ulm, Dept Neurol, D-7900 Ulm, Germany; [Dupuis, Luc] INSERM, U692, Lab Signalisat Mol & Neurodegenerescence, Strasbourg, France; [Dupuis, Luc] Univ Strasbourg, UMRS692, Fac Med, Strasbourg, France; [Dengler, Reinhard] Hannover Med Sch, Dept Neurol, D-3000 Hannover, Germany; [Heneka, Michael T.] Univ Bonn, Dept Neurol, Bonn, Germany; [Meyer, Thomas] Charite, Dept Neurol, Berlin, Germany; [Zierz, Stephan] Univ Halle Wittenberg, Dept Neurol, Halle, Germany; [Dreyhaupt, Jens] Univ Ulm, Inst Epidemiol & Med Biometry, Ulm, Germany; [Grehl, Torsten] Ruhr Univ Bochum, Dept Neurol, Bochum, Germany; [Hermann, Andreas] Tech Univ Dresden, Dept Neurol, Dresden, Germany; [Winkler, Andrea S.] Tech Univ Munich, Dept Neurol, Munich, Germany; [Bogdahn, Ulrich] Univ Regensburg, Dept Neurol, Regensburg, Germany; [Benecke, Reiner] Univ Rostock, Neurol Clin, Rostock, Germany; [Schrank, Bertold] Deutsch Klin Diagnost, D-6200 Wiesbaden, Germany; [Wessig, Carsten] Univ Wurzburg, Dept Neurol, D-8700 Wurzburg, Germany; [Grosskreutz, Julian] Univ Hosp, Dept Neurol, Jena, Germany	Ulm University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Hannover Medical School; University of Bonn; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Martin Luther University Halle Wittenberg; Ulm University; Ruhr University Bochum; Technische Universitat Dresden; Technical University of Munich; University of Regensburg; University of Rostock; University of Wurzburg; Friedrich Schiller University of Jena	Dupuis, L (corresponding author), Univ Ulm, Dept Neurol, D-7900 Ulm, Germany.	Albert.Ludolph@rku.de	Heneka, Michael/AAE-8011-2019; Kassubek, Jan/GPX-0910-2022; Kassubek, Jan/O-1740-2019; Hermann, Andreas/D-4213-2017; Otto, Markus/F-4304-2015; Kassubek, Jan/F-2774-2015; Dupuis, Luc/A-6981-2012; Grosskreutz, Julian/G-2293-2010; Heneka, Michael/E-8072-2015	Kassubek, Jan/0000-0002-7106-9270; Kassubek, Jan/0000-0002-7106-9270; Hermann, Andreas/0000-0002-7364-7791; Otto, Markus/0000-0003-4273-4267; Kassubek, Jan/0000-0002-7106-9270; Grosskreutz, Julian/0000-0001-9525-1424; Meyer, Thomas/0000-0002-2736-7350; Borasio, Gian Domenico/0000-0002-2737-3662; Heneka, Michael/0000-0003-4996-1630	Takeda Pharma GmbH (Germany); DFG Mercator; "contrat d'interface" INSERM AP-HP; Takeda Pharma GmbH	Takeda Pharma GmbH (Germany); DFG Mercator; "contrat d'interface" INSERM AP-HP; Takeda Pharma GmbH	The study was partly supported by Takeda Pharma GmbH (Germany). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The principal investigator (ACL) had full access to the data, and took the final decision to publication. LD is supported by a DFG Mercator professorship and a "contrat d'interface" INSERM AP-HP.; Takeda Pharma GmbH partly funded this study. The trial used Pioglitazone which is a Takeda product. There are no other patents, products in development or marketed products to disclose. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Belfort R, 2006, NEW ENGL J MED, V355, P2297, DOI 10.1056/NEJMoa060326; Ceriello A, 2008, DIABETES-METAB RES, V24, P14, DOI 10.1002/dmrr.790; Cudkowicz M, 2011, NAT MED, V17, P1652, DOI 10.1038/nm.2579; DeFronzo RA, 2011, NEW ENGL J MED, V364, P1104, DOI 10.1056/NEJMoa1010949; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Deng HX, 2011, ARCH NEUROL-CHICAGO, V68, P1057, DOI 10.1001/archneurol.2011.178; Deng HX, 2010, ANN NEUROL, V67, P739, DOI 10.1002/ana.22051; Dobrowolny G, 2005, J CELL BIOL, V168, P193, DOI 10.1083/jcb.200407021; Dorst J, 2011, J NEUROL, V258, P613, DOI 10.1007/s00415-010-5805-z; Dupuis L, 2008, NEUROLOGY, V70, P1004, DOI 10.1212/01.wnl.0000285080.70324.27; Dupuis L, 2004, P NATL ACAD SCI USA, V101, P11159, DOI 10.1073/pnas.0402026101; Dupuis L, 2011, LANCET NEUROL, V10, P75, DOI 10.1016/S1474-4422(10)70224-6; Fornai F, 2008, P NATL ACAD SCI USA, V105, P2052, DOI 10.1073/pnas.0708022105; Gill A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006489; Glass CK, 2010, NAT REV IMMUNOL, V10, P365, DOI 10.1038/nri2748; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Gordon PH, 2007, LANCET NEUROL, V6, P1045, DOI 10.1016/S1474-4422(07)70270-3; Kaspar BK, 2003, SCIENCE, V301, P839, DOI 10.1126/science.1086137; Kiaei M, 2005, EXP NEUROL, V191, P331, DOI 10.1016/j.expneurol.2004.10.007; Klivenyi P, 2004, J NEUROCHEM, V88, P576, DOI 10.1046/j.1471-4159.2003.02160.x; Klivenyi P, 1999, NAT MED, V5, P347, DOI 10.1038/6568; Kriz J, 2002, NEUROBIOL DIS, V10, P268, DOI 10.1006/nbdi.2002.0487; Lacomblez L, 1996, LANCET, V347, P1425, DOI 10.1016/S0140-6736(96)91680-3; Lu M, 2011, NAT MED, V17, P618, DOI 10.1038/nm.2332; Ludolph Albert C, 2007, Amyotroph Lateral Scler, V8, P217, DOI 10.1080/17482960701292837; Mackenzie IRA, 2007, ANN NEUROL, V61, P427, DOI 10.1002/ana.21147; Maeshiba Y, 1997, ARZNEIMITTEL-FORSCH, V47, P29; Meininger V, 2006, NEUROLOGY, V66, P88, DOI 10.1212/01.wnl.0000191326.40772.62; Messi ML, 2007, EXP NEUROL, V207, P52, DOI 10.1016/j.expneurol.2007.05.016; Milane A, 2009, J PHARM PHARM SCI, V12, P209, DOI 10.18433/J36C78; Paganoni S, 2011, MUSCLE NERVE, V44, P20, DOI 10.1002/mus.22114; Philips T, 2011, LANCET NEUROL, V10, P253, DOI 10.1016/S1474-4422(11)70015-1; Pizzasegola C, 2009, AMYOTROPH LATERAL SC, V10, P221, DOI 10.1080/17482960902803440; Promrat K, 2004, HEPATOLOGY, V39, P188, DOI 10.1002/hep.20012; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Ryan KK, 2011, NAT MED, V17, P623, DOI 10.1038/nm.2349; Sanyal AJ, 2010, NEW ENGL J MED, V362, P1675, DOI 10.1056/NEJMoa0907929; Schutz B, 2005, J NEUROSCI, V25, P7805, DOI 10.1523/JNEUROSCI.2038-05.2005; Scott S, 2008, AMYOTROPH LATERAL SC, V9, P4, DOI 10.1080/17482960701856300; Shibata N, 2008, NEUROPATHOLOGY, V28, P387, DOI 10.1111/j.1440-1789.2008.00890.x; Van Den Bosch L, 2002, NEUROREPORT, V13, P1067, DOI 10.1097/00001756-200206120-00018; WANG SK, 1987, BIOMETRICS, V43, P193, DOI 10.2307/2531959; Zhu S, 2002, NATURE, V417, P74, DOI 10.1038/417074a	43	98	104	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2012	7	6							e37885	10.1371/journal.pone.0037885	http://dx.doi.org/10.1371/journal.pone.0037885			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TQ	22715372	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336800013
J	Cardanobile, S; Pernice, V; Deger, M; Rotter, S				Cardanobile, Stefano; Pernice, Volker; Deger, Moritz; Rotter, Stefan			Inferring General Relations between Network Characteristics from Specific Network Ensembles	PLOS ONE			English	Article							SMALL-WORLD; SYNCHRONIZATION	Different network models have been suggested for the topology underlying complex interactions in natural systems. These models are aimed at replicating specific statistical features encountered in real-world networks. However, it is rarely considered to which degree the results obtained for one particular network class can be extrapolated to real-world networks. We address this issue by comparing different classical and more recently developed network models with respect to their ability to generate networks with large structural variability. In particular, we consider the statistical constraints which the respective construction scheme imposes on the generated networks. After having identified the most variable networks, we address the issue of which constraints are common to all network classes and are thus suitable candidates for being generic statistical laws of complex networks. In fact, we find that generic, not model-related dependencies between different network characteristics do exist. This makes it possible to infer global features from local ones using regression models trained on networks with high generalization power. Our results confirm and extend previous findings regarding the synchronization properties of neural networks. Our method seems especially relevant for large networks, which are difficult to map completely, like the neural networks in the brain. The structure of such large networks cannot be fully sampled with the present technology. Our approach provides a method to estimate global properties of under-sampled networks in good approximation. Finally, we demonstrate on three different data sets (C. elegans neuronal network, R. prowazekii metabolic network, and a network of synonyms extracted from Roget's Thesaurus) that real-world networks have statistical relations compatible with those obtained using regression models.	[Cardanobile, Stefano; Pernice, Volker; Deger, Moritz; Rotter, Stefan] Univ Freiburg, Bernstein Ctr Freiburg, D-79106 Freiburg, Germany; [Cardanobile, Stefano; Pernice, Volker; Deger, Moritz; Rotter, Stefan] Univ Freiburg, Fac Biol, D-79106 Freiburg, Germany	University of Freiburg; University of Freiburg	Cardanobile, S (corresponding author), Univ Freiburg, Bernstein Ctr Freiburg, Hugstetter Str 55, D-79106 Freiburg, Germany.	stefan.rotter@biologie.uni-freiburg.de		Deger, Moritz/0000-0002-2775-2611	German Federal Ministry of Education and Research (BMBF) [01GQ0420, 01GQ0830, 01GW0730]; German Research Foundation (DFG) [CRC 780]	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); German Research Foundation (DFG)(German Research Foundation (DFG))	Supported by the German Federal Ministry of Education and Research (BMBF; grant 01GQ0420 "BCCN Freiburg", grant 01GQ0830 "BFNT Freiburg*Tubingen", grant 01GW0730 "Impulse Control"), and the German Research Foundation (DFG; CRC 780, subproject C4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Arenas A, 2008, PHYS REP, V469, P93, DOI 10.1016/j.physrep.2008.09.002; Artzy-Randrup Yael, 2004, Science, V305, P1107; Atay FM, 2006, PHYSICA D, V224, P35, DOI 10.1016/j.physd.2006.09.018; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Batagelj V., PAJEK DATASETS; Bianconi G, 2008, EPL-EUROPHYS LETT, V81, DOI 10.1209/0295-5075/81/28005; Bogacz L, 2006, PHYSICA A; Boguna M, 2009, NAT PHYS, V5, P74, DOI 10.1038/NPHYS1130; Chen WL, 2011, FRONT COMPUT NEUROSC, V5, DOI 10.3389/fncom.2011.00014; Chung F., 2002, ANN COMB, V6, P125, DOI [10.1007/PL00012580, 10.1007/PL00012580.pdf, DOI 10.1007/PL00012580.PDF]; Gerhard F, 2011, FRONT COMPUT NEUROSC, V5, P1, DOI [10.3389/fncom.2011.00004, 10.3389/fncom.2011.00023]; Grabow C, 2010, EPL-EUROPHYS LETT, V90, DOI 10.1209/0295-5075/90/48002; Jarvis Sarah, 2010, Front Neuroinform, V4, DOI 10.3389/fninf.2010.00011; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Kitsak M, 2010, NAT PHYS, V6, P888, DOI [10.1038/nphys1746, 10.1038/NPHYS1746]; Kotter R, 2000, PHILOS T ROY SOC B, V355, P127, DOI 10.1098/rstb.2000.0553; Leicht EA, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.118703; Liu YY, 2011, NATURE, V473, P167, DOI 10.1038/nature10011; Lovasz L, 2006, J COMB THEORY B, V96, P933, DOI 10.1016/j.jctb.2006.05.002; Maki-Marttunen T, 2011, FRONT COMPUT NEUROSC, V5, P1; McGraw P, 2005, PHYS REV E, V72, P1; Milo R, 2004, SCIENCE, V305; Milo R, 2004, SCIENCE, V303, P1538, DOI 10.1126/science.1089167; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Palla G, 2011, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2011/02/P02003; Palla G, 2010, P NATL ACAD SCI USA, V107, P7640, DOI 10.1073/pnas.0912983107; Prettejohn BJ, 2011, FRONT COMPUT NEUROSC, V5, P1, DOI 10.3389/fncom.2011.00011; Renyi A., 1959, PUBL MATH-DEBRECEN, V6, P290, DOI DOI 10.2307/1999405; Rocha LEC, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001109; Roxin A, 2011, FRONT COMPUT NEUROSC, V5, P1, DOI 10.3389/fncom.2011.00008; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Sporns O, 2011, FRONT COMPUT NEUROSC, V5, DOI 10.3389/fncom.2011.00005; Tarjan R., 1972, SIAM Journal on Computing, V1, P146, DOI 10.1137/0201010; Varshney LR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001066; Wagner A, 2001, P ROY SOC B-BIOL SCI, V268, P1803, DOI 10.1098/rspb.2001.1711; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wu XY, 2008, PHYSICA A, V387, P623, DOI 10.1016/j.physa.2007.09.039; Zhan CJ, 2010, PHYSICA A, V389, P1779, DOI 10.1016/j.physa.2009.12.005; Zhao L, 2011, FRONT COMPUT NEUROSC, V5	43	5	5	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e37911	10.1371/journal.pone.0037911	http://dx.doi.org/10.1371/journal.pone.0037911			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701586	gold, Green Published, Green Submitted			2022-12-27	WOS:000305348400024
J	Degrelle, SA; Jaffrezic, F; Campion, E; Le Cao, KA; Le Bourhis, D; Richard, C; Rodde, N; Fleurot, R; Everts, RE; Lecardonnel, J; Heyman, Y; Vignon, X; Yang, XZ; Tian, XCC; Lewin, HA; Renard, JP; Hue, I				Degrelle, Severine A.; Jaffrezic, Florence; Campion, Evelyne; Le Cao, Kim-Anh; Le Bourhis, Daniel; Richard, Christophe; Rodde, Nathalie; Fleurot, Renaud; Everts, Robin E.; Lecardonnel, Jerome; Heyman, Yvan; Vignon, Xavier; Yang, Xiangzhong; Tian, Xiuchun C.; Lewin, Harris A.; Renard, Jean-Paul; Hue, Isabelle			Uncoupled Embryonic and Extra-Embryonic Tissues Compromise Blastocyst Development after Somatic Cell Nuclear Transfer	PLOS ONE			English	Article							EPIBLAST STEM-CELLS; EXPRESSION ANALYSIS; GENE-EXPRESSION; MYOSIN VI; IN-VIVO; PLURIPOTENCY; OVINE; TROPHOBLAST; PREIMPLANTATION; DIFFERENTIATION	Somatic cell nuclear transfer (SCNT) is the most efficient cell reprogramming technique available, especially when working with bovine species. Although SCNT blastocysts performed equally well or better than controls in the weeks following embryo transfer at Day 7, elongation and gastrulation defects were observed prior to implantation. To understand the developmental implications of embryonic/extra-embryonic interactions, the morphological and molecular features of elongating and gastrulating tissues were analysed. At Day 18, 30 SCNT conceptuses were compared to 20 controls (AI and IVP: 10 conceptuses each); one-half of the SCNT conceptuses appeared normal while the other half showed signs of atypical elongation and gastrulation. SCNT was also associated with a high incidence of discordance in embryonic and extra embryonic patterns, as evidenced by morphological and molecular "uncoupling''. Elongation appeared to be secondarily affected; only 3 of 30 conceptuses had abnormally elongated shapes and there were very few differences in gene expression when they were compared to the controls. However, some of these differences could be linked to defects in microvilli formation or extracellular matrix composition and could thus impact extra-embryonic functions. In contrast to elongation, gastrulation stages included embryonic defects that likely affected the hypoblast, the epiblast, or the early stages of their differentiation. When taking into account SCNT conceptus somatic origin, i.e. the reprogramming efficiency of each bovine ear fibroblast (Low: 0029, Med: 7711, High: 5538), we found that embryonic abnormalities or severe embryonic/extra-embryonic uncoupling were more tightly correlated to embryo loss at implantation than were elongation defects. Alternatively, extra-embryonic differences between SCNT and control conceptuses at Day 18 were related to molecular plasticity (high efficiency/high plasticity) and subsequent pregnancy loss. Finally, because it alters redifferentiation processes in vivo, SCNT reprogramming highlights temporally and spatially restricted interactions among cells and tissues in a unique way.	[Degrelle, Severine A.; Campion, Evelyne; Le Bourhis, Daniel; Rodde, Nathalie; Fleurot, Renaud; Heyman, Yvan; Vignon, Xavier; Renard, Jean-Paul; Hue, Isabelle] INRA, UMR Biol Dev & Reprod 1198, Jouy En Josas, France; [Degrelle, Severine A.; Campion, Evelyne; Le Bourhis, Daniel; Rodde, Nathalie; Fleurot, Renaud; Heyman, Yvan; Vignon, Xavier; Renard, Jean-Paul; Hue, Isabelle] ENVA, Maisons Alfort, France; [Jaffrezic, Florence] INRA, UMR1313, Jouy En Josas, France; [Le Cao, Kim-Anh] INRA, UR631, Stn Ameliorat Genet Anim, Castanet Tolosan, France; [Le Bourhis, Daniel] UNCEIA, R&D Dept, Maisons Alfort, France; [Richard, Christophe] INRA, UCEA Bressonvilliers UE331, Leudeville, France; [Everts, Robin E.; Lewin, Harris A.] Univ Illinois, Dept Anim Sci, Urbana, IL USA; [Lecardonnel, Jerome] INRA, Ctr Ressources Biol, Jouy En Josas, France; [Yang, Xiangzhong; Tian, Xiuchun C.] Univ Connecticut, Dept Anim Sci, Storrs, CT USA; [Yang, Xiangzhong; Tian, Xiuchun C.] Univ Connecticut, Ctr Regenerat Biol, Storrs, CT USA; [Lewin, Harris A.] Univ Illinois, Inst Genom Biol, Urbana, IL USA	INRAE; UDICE-French Research Universities; Universite Paris Saclay; Ecole Nationale Veterinaire d'Alfort (ENVA); INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; Ecole Nationale Veterinaire d'Alfort (ENVA); INRAE; University of Illinois System; University of Illinois Urbana-Champaign; INRAE; UDICE-French Research Universities; Universite Paris Saclay; University of Connecticut; University of Connecticut; University of Illinois System; University of Illinois Urbana-Champaign	Degrelle, SA (corresponding author), INSERM, U1016, Inst Cochin, Dept Immunol, Paris, France.	isabelle.hue@jouy.inra.fr	richard, christophe/E-9529-2015; LEWIN, HARRIS/HGC-6543-2022; Le Cao, Kim-Anh/B-6637-2013; Degrelle, Severine/AAC-1726-2020; Hue, Isabelle/AAD-2341-2020	LEWIN, HARRIS/0000-0002-1043-7287; Le Cao, Kim-Anh/0000-0003-3923-1116; Degrelle, Severine/0000-0001-6263-4875; Hue, Isabelle/0000-0002-3873-9738; Fleurot, Renaud/0000-0003-2015-0738	French Ministry of Research [20085]; EU; USDA CSREES National Research Initiative [2002-35205-11548]; USDA ARS [AG 58-1265-2-018, 58-1265-2-020]; CNRS/INRA (PHASE-GA); EMBIC European network of excellence	French Ministry of Research(Ministry of Research, FranceEuropean Commission); EU(European Commission); USDA CSREES National Research Initiative(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); USDA ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); CNRS/INRA (PHASE-GA); EMBIC European network of excellence	This work was supported by awards from the French Ministry of Research (no. 20085 to IH and J-PR), the EU (SABRE to J-PR), the USDA CSREES National Research Initiative Grant 2002-35205-11548 and USDA ARS contracts (AG 58-1265-2-018 to XY and XCT and 58-1265-2-020 to HAL). SAD was a MNERT fellow, KALC was a PhD student with a shared CNRS/INRA (PHASE-GA) fellowship, and NR was a technical assistant supported by the EMBIC European network of excellence headed at the INRA by O. Sandra. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams HA, 2011, FUNCT INTEGR GENOMIC, V11, P139, DOI 10.1007/s10142-010-0189-9; Akaogi K, 2009, ONCOGENE, V28, P2894, DOI 10.1038/onc.2009.151; Alberio R, 2010, STEM CELLS DEV, V19, P1627, DOI 10.1089/scd.2010.0012; Alexopoulos NI, 2008, REPRODUCTION, V136, P433, DOI 10.1530/REP-07-0392; Alves BCA, 2003, THERIOGENOLOGY, V59, P1415, DOI 10.1016/S0093-691X(02)01191-3; Ameen N, 2007, TRAFFIC, V8, P998, DOI 10.1111/j.1600-0854.2007.00587.x; Bauersachs S, 2009, P NATL ACAD SCI USA, V106, P5681, DOI 10.1073/pnas.0811841106; Berg DK, 2010, THERIOGENOLOGY, V73, P250, DOI 10.1016/j.theriogenology.2009.09.005; Bertocchini F, 2002, DEV CELL, V3, P735, DOI 10.1016/S1534-5807(02)00318-0; BETTERIDGE KJ, 1988, THERIOGENOLOGY, V29, P155, DOI 10.1016/0093-691X(88)90038-6; Bui LC, 2009, REPRODUCTION, V138, P289, DOI 10.1530/REP-09-0042; Chavatte-Palmer P, 2011, PLACENTA, V2011, P13; Chesne P, 2002, NAT BIOTECHNOL, V20, P366, DOI 10.1038/nbt0402-366; Dai XP, 2010, J BIOL CHEM, V285, P31002, DOI 10.1074/jbc.M110.136085; Degrelle SA, 2011, PLACENTA, V32, P917, DOI 10.1016/j.placenta.2011.08.014; Degrelle SA, 2005, DEV BIOL, V288, P448, DOI 10.1016/j.ydbio.2005.09.043; Degrelle SA, 2011, REPRODUCTION, V141, P79, DOI 10.1530/REP-10-0174; Degrelle SA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-46; Everts RE, 2005, VET IMMUNOL IMMUNOP, V105, P235, DOI 10.1016/j.vetimm.2005.02.003; Fitzpatrick E, 2009, MOL HUM REPROD, V15, P195, DOI 10.1093/molehr/gap001; Flechon JE, 2007, GENESIS, V45, P709, DOI 10.1002/dvg.20347; Flechon JE, 2004, GENESIS, V38, P13, DOI 10.1002/gene.10244; Fujii T, 2010, CELL REPROGRAM, V12, P617, DOI 10.1089/cell.2010.0017; Gaspar-Maia A, 2011, NAT REV MOL CELL BIO, V12, P36, DOI 10.1038/nrm3036; GREENSTEIN JS, 1958, ANAT REC, V132, P321, DOI 10.1002/ar.1091320308; GUILLOMOT M, 1995, J REPROD FERTIL, P39; Guillomot M, 2004, REPRODUCTION, V127, P491, DOI 10.1530/rep.1.00057; Hai T, 2011, CELL REPROGRAM, V13, P47, DOI 10.1089/cell.2010.0042; Hanna JH, 2010, CELL, V143, P508, DOI 10.1016/j.cell.2010.10.008; HASLER JF, 1995, THERIOGENOLOGY, V43, P141, DOI 10.1016/0093-691X(94)00020-U; HEYMAN Y, 1984, J REPROD FERTIL, V70, P533, DOI 10.1530/jrf.0.0700533; Heyman Y, 2005, REPROD NUTR DEV, V45, P353, DOI 10.1051/rnd:2005026; Hochedlinger K, 2009, DEVELOPMENT, V136, P509, DOI 10.1242/dev.020867; Hue I, 2007, Soc Reprod Fertil Suppl, V64, P365; Hue I, 2001, DEV GENES EVOL, V211, P157, DOI 10.1007/s004270100138; Idkowiak J, 2004, DEV GENES EVOL, V214, P591, DOI 10.1007/s00427-004-0436-y; Jaffrezic F, 2007, GENET RES, V89, P19, DOI 10.1017/S0016672307008646; Jouneau A, 2006, DEVELOPMENT, V133, P1597, DOI 10.1242/dev.02317; Jullien J, 2011, NAT REV MOL CELL BIO, V12, P453, DOI 10.1038/nrm3140; Kato Y, 2007, CLONING STEM CELLS, V9, P495, DOI 10.1089/clo.2007.0014; Kee HJ, 2009, J MOL CELL CARDIOL, V47, P770, DOI 10.1016/j.yjmcc.2009.08.022; Khan DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034110; Kim JY, 2011, BIOL REPROD, V84, P62, DOI 10.1095/biolreprod.110.085738; King WA, 2006, THERIOGENOLOGY, V65, P166, DOI 10.1016/j.theriogenology.2005.09.031; Loi P, 2008, BIOESSAYS, V30, P66, DOI 10.1002/bies.20684; Longo-Guess CM, 2005, P NATL ACAD SCI USA, V102, P7894, DOI 10.1073/pnas.0500760102; Lucifero D, 2006, BIOL REPROD, V75, P531, DOI 10.1095/biolreprod.106.051722; Maddox-Hyttel P, 2003, REPRODUCTION, V125, P607, DOI 10.1530/rep.0.1250607; Mansouri-Attia N, 2009, P NATL ACAD SCI USA, V106, P5687, DOI 10.1073/pnas.0812722106; Martin L, 2007, MOL REPROD DEV, V74, P952, DOI 10.1002/mrd.20692; Maruotti J, 2012, MOL REPROD DEV, V79, P461, DOI 10.1002/mrd.22051; Maruotti J, 2010, INT J DEV BIOL, V54, P1609, DOI 10.1387/ijdb.103195jm; Maruotti J, 2010, STEM CELLS, V28, P743, DOI 10.1002/stem.400; Matoba S, 2011, P NATL ACAD SCI USA, V108, P20621, DOI 10.1073/pnas.1112664108; Miki H, 2009, PLACENTA, V30, P543, DOI 10.1016/j.placenta.2009.03.006; Nadra K, 2006, MOL CELL BIOL, V26, P3266, DOI 10.1128/MCB.26.8.3266-3281.2006; Niemann H, 2008, REPRODUCTION, V135, P151, DOI 10.1530/REP-07-0397; Perea-Gomez A, 2002, DEV CELL, V3, P745, DOI 10.1016/S1534-5807(02)00321-0; REICHENBACH HD, 1992, J REPROD FERTIL, V95, P363, DOI 10.1530/jrf.0.0950363; Renard JP, 2007, THERIOGENOLOGY, V68, pS196, DOI 10.1016/j.theriogenology.2007.05.060; Rodriguez-Alvarez L, 2010, ZYGOTE, V18, P269, DOI 10.1017/S0967199409990323; Rodriguez-Alvarez L, 2010, THERIOGENOLOGY, V74, P45, DOI 10.1016/j.theriogenology.2009.12.018; Roten LT, 2009, EUR J HUM GENET, V17, P250, DOI 10.1038/ejhg.2008.158; Rozario T, 2009, DEV BIOL, V327, P386, DOI 10.1016/j.ydbio.2008.12.025; Sawai K, 2007, J REPROD DEVELOP, V53, P77, DOI 10.1262/jrd.18056; Sawai K, 2009, J REPROD DEVELOP, V55, P11, DOI 10.1262/jrd.20131; Schuettengruber B, 2009, DEVELOPMENT, V136, P3531, DOI 10.1242/dev.033902; Self T, 1999, DEV BIOL, V214, P331, DOI 10.1006/dbio.1999.9424; Smith CS, 2010, CELL REPROGRAM, V12, P699, DOI 10.1089/cell.2010.0040; Soares MJ, 2009, P NATL ACAD SCI USA, V106, P16014, DOI 10.1073/pnas.0908646106; Suzuki J, 2011, BIOL REPROD, V84, P947, DOI 10.1095/biolreprod.110.087833; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tian XC, 2003, REPROD BIOL ENDOCRIN, V1, P1; Tveden-Nyborg P, 2005, REPRODUCTION, V130, P681, DOI 10.1530/rep.1.00850; Ushizawa K, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-9; Ushizawa K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005814; van Dijk M, 2011, J PREGNANCY, V2011, DOI 10.1155/2011/521826; Vignon X., 2000, Theriogenology, V53, P245; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Whitworth KM, 2010, MOL REPROD DEV, V77, P1001, DOI 10.1002/mrd.21242; Wilmut I, 2006, METH MOL B, V348, P307; Yang XZ, 2007, NAT GENET, V39, P295, DOI 10.1038/ng1973; Yu F, 2011, ONCOGENE, V30, P2161, DOI 10.1038/onc.2010.591; Zhao JG, 2010, CELL TISSUE RES, V341, P13, DOI 10.1007/s00441-010-1000-x	84	25	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e38309	10.1371/journal.pone.0038309	http://dx.doi.org/10.1371/journal.pone.0038309			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701625	Green Published, gold			2022-12-27	WOS:000305348400049
J	Mongeau, JM; McRae, B; Jusufi, A; Birkmeyer, P; Hoover, AM; Fearing, R; Full, RJ				Mongeau, Jean-Michel; McRae, Brian; Jusufi, Ardian; Birkmeyer, Paul; Hoover, Aaron M.; Fearing, Ronald; Full, Robert J.			Rapid Inversion: Running Animals and Robots Swing like a Pendulum under Ledges	PLOS ONE			English	Article							ROTATIONAL INERTIA; LOCOMOTION; WALKING; MODEL; BEHAVIOR; MECHANICS; MOVEMENTS; MANEUVERS; DYNAMICS; COST	Escaping from predators often demands that animals rapidly negotiate complex environments. The smallest animals attain relatively fast speeds with high frequency leg cycling, wing flapping or body undulations, but absolute speeds are slow compared to larger animals. Instead, small animals benefit from the advantages of enhanced maneuverability in part due to scaling. Here, we report a novel behavior in small, legged runners that may facilitate their escape by disappearance from predators. We video recorded cockroaches and geckos rapidly running up an incline toward a ledge, digitized their motion and created a simple model to generalize the behavior. Both species ran rapidly at 12-15 body lengths-per-second toward the ledge without braking, dove off the ledge, attached their feet by claws like a grappling hook, and used a pendulum-like motion that can exceed one meter-per-second to swing around to an inverted position under the ledge, out of sight. We discovered geckos in Southeast Asia can execute this escape behavior in the field. Quantification of these acrobatic behaviors provides biological inspiration toward the design of small, highly mobile search-and-rescue robots that can assist us during natural and human-made disasters. We report the first steps toward this new capability in a small, hexapedal robot.	[Mongeau, Jean-Michel] Univ Calif Berkeley, Biophys Grad Grp, Berkeley, CA 94720 USA; [McRae, Brian] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Jusufi, Ardian; Full, Robert J.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Birkmeyer, Paul; Fearing, Ronald] Univ Calif Berkeley, Dept Elect Engn & Comp Sci, Berkeley, CA 94720 USA; [Hoover, Aaron M.] Univ Calif Berkeley, Dept Mech Engn, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Mongeau, JM (corresponding author), Univ Calif Berkeley, Biophys Grad Grp, Berkeley, CA 94720 USA.	jmmongeau@berkeley.edu		Fearing, Ronald/0000-0001-6242-5379; Jusufi, Ardian/0000-0003-4250-2984	National Science Foundation (NSF) [EF-0425878]; Micro Autonomous Systems and Technology Collaborative Technology Alliance Grant [W911NF-08-2-0004]; NSF Graduate Research Fellowship; Integrative Graduate Education and Research Traineeship (IGERT) [0903711]; NSF Center of Integrated Nanomechanical Systems [EEC-0304730]; Swiss NSF Fellowship	National Science Foundation (NSF)(National Science Foundation (NSF)); Micro Autonomous Systems and Technology Collaborative Technology Alliance Grant; NSF Graduate Research Fellowship(National Science Foundation (NSF)); Integrative Graduate Education and Research Traineeship (IGERT)(National Science Foundation (NSF)); NSF Center of Integrated Nanomechanical Systems; Swiss NSF Fellowship	Research supported by a National Science Foundation (NSF) Frontiers in Integrative Biological Research Grant to RJF (EF-0425878), Micro Autonomous Systems and Technology Collaborative Technology Alliance Grant to RF, RJF and AMH (W911NF-08-2-0004), a NSF Graduate Research Fellowship and Integrative Graduate Education and Research Traineeship (IGERT) to JMM (0903711), NSF Center of Integrated Nanomechanical Systems support to PB (EEC-0304730) and a Swiss NSF Fellowship to AJ supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER RM, 1985, J EXP BIOL, V115, P231; Asbeck AT, 2006, INT J ROBOT RES, V25, P1165, DOI 10.1177/0278364906072511; Autumn K, 2006, J EXP BIOL, V209, P260, DOI 10.1242/jeb.01980; Bassler U, 1998, BRAIN RES REV, V27, P65, DOI 10.1016/S0165-0173(98)00006-X; Bertram JEA, 1999, J EXP BIOL, V202, P2609; Bertram JEA, 2004, YEARB PHYS ANTHROPOL, V47, P100, DOI 10.1002/ajpa.20156; Birkmeyer P, 2009, IEEE INT C INTELLIGE; BLICKHAN R, 1987, J EXP BIOL, V130, P155; Brackenbury J, 1999, J INSECT PHYSIOL, V45, P525, DOI 10.1016/S0022-1910(98)00157-7; Brackenbury J, 1997, NATURE, V390, P453, DOI 10.1038/37253; Carrier DR, 2001, J EXP BIOL, V204, P3917; Dickinson MH, 2005, INTEGR COMP BIOL, V45, P274, DOI 10.1093/icb/45.2.274; Evangelista C, 2010, J EXP BIOL, V213, P262, DOI 10.1242/jeb.037465; Farley CT, 1997, J EXP BIOL, V200, P2177; Frazier SF, 1999, J COMP PHYSIOL A, V185, P157, DOI 10.1007/s003590050374; FULL RJ, 1995, J EXP BIOL, V198, P2441; Goldman DI, 2006, J EXP BIOL, V209, P2990, DOI 10.1242/jeb.02322; Gomes MW, 2005, J THEOR BIOL, V237, P265, DOI 10.1016/j.jtbi.2005.04.014; Higham TE, 2001, J EXP BIOL, V204, P4141; Hoover A, 2008, IEEE INT C INTELLIGE; Hoover AM, 2008, IEEE INT C ROBOTICS; HYZER WG, 1962, SCIENCE, V137, P609, DOI 10.1126/science.137.3530.609; Jusufi A, 2008, P NATL ACAD SCI USA, V105, P4215, DOI 10.1073/pnas.0711944105; Jusufi A, 2011, INTEGR COMP BIOL, V51, P937, DOI 10.1093/icb/icr114; Kohlsdorf T, 2006, J ZOOL, V270, P359, DOI 10.1111/j.1469-7998.2006.00150.x; Kral K, 2010, PHYSIOL ENTOMOL, V35, P240, DOI 10.1111/j.1365-3032.2010.00735.x; LARSEN GS, 1995, J COMP PHYSIOL A, V176, P229, DOI 10.1007/BF00239925; Libby T, 2012, NATURE, V481, P181, DOI 10.1038/nature10710; Moya-Larano J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001841; Ruina A, 2005, J THEOR BIOL, V237, P170, DOI 10.1016/j.jtbi.2005.04.004; Spagna JC, 2007, BIOINSPIR BIOMIM, V2, P9, DOI 10.1088/1748-3182/2/1/002; Srinivasan M, 2006, NATURE, V439, P72, DOI 10.1038/nature04113; TING LH, 1994, J EXP BIOL, V197, P251; Walter RM, 2002, J EXP BIOL, V205, P2135; Wood RJ, 2008, J MECH DESIGN, V130, DOI 10.1115/1.2885509; Zug George R., 2007, Proceedings of the California Academy of Sciences, V58, P387	36	20	20	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e38003	10.1371/journal.pone.0038003	http://dx.doi.org/10.1371/journal.pone.0038003			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701594	Green Published, Green Submitted, gold			2022-12-27	WOS:000305348400029
J	van de Sande, WWJ				van de Sande, Wendy W. J.			Phylogenetic Analysis of the Complete Mitochondrial Genome of Madurella mycetomatis Confirms Its Taxonomic Position within the Order Sordariales	PLOS ONE			English	Article							TRANSFER-RNA GENES; IN-VITRO SUSCEPTIBILITIES; DNA-SEQUENCE; PODOSPORA-ANSERINA; TRNASCAN-SE; NEUROSPORA; IDENTIFICATION; INTRONS; PROGRAM; AGENTS	Background: Madurella mycetomatis is the most common cause of human eumycetoma. The genus Madurella has been characterized by overall sterility on mycological media. Due to this sterility and the absence of other reliable morphological and ultrastructural characters, the taxonomic classification of Madurella has long been a challenge. Mitochondria are of monophyletic origin and mitochondrial genomes have been proven to be useful in phylogenetic analyses. Results: he first complete mitochondrial DNA genome of a mycetoma-causative agent was sequenced using 454 sequencing. The mitochondrial genome of M. mycetomatis is a circular DNA molecule with a size of 45,590 bp, encoding for the small and the large subunit rRNAs, 27 tRNAs, 11 genes encoding subunits of respiratory chain complexes, 2 ATP synthase subunits, 5 hypothetical proteins, 6 intronic proteins including the ribosomal protein rps3. In phylogenetic analyses using amino acid sequences of the proteins involved in respiratory chain complexes and the 2 ATP synthases it appeared that M. mycetomatis clustered together with members of the order Sordariales and that it was most closely related to Chaetomium thermophilum. Analyses of the gene order showed that within the order Sordariales a similar gene order is found. Furthermore also the tRNA order seemed mostly conserved. Conclusion: Phylogenetic analyses of fungal mitochondrial genomes confirmed that M. mycetomatis belongs to the order of Sordariales and that it was most closely related to Chaetomium thermophilum, with which it also shared a comparable gene and tRNA order.	Erasmus MC, Dept Med Microbiol & Infect Dis, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	van de Sande, WWJ (corresponding author), Erasmus MC, Dept Med Microbiol & Infect Dis, Rotterdam, Netherlands.	w.vandesande@erasmusmc.nl	van de Sande, Wendy/AAS-4545-2021	van de Sande, Wendy/0000-0002-8652-8783	VENI grant of the Netherlands Organisation of Scientific Research (NWO) [91611178]	VENI grant of the Netherlands Organisation of Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This research was financially supported by VENI grant 91611178 of the Netherlands Organisation of Scientific Research (NWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed A, 2003, J CLIN MICROBIOL, V41, P4537, DOI 10.1128/JCM.41.10.4537-4541.2003; Ahmed A, 2002, J CLIN MICROBIOL, V40, P1031, DOI 10.1128/JCM.40.3.1031-1036.2002; Ahmed AO, 2003, FEMS IMMUNOL MED MIC, V37, P29, DOI 10.1016/S0928-8244(03)00096-8; Ahmed AOA, 2004, LANCET INFECT DIS, V4, P566, DOI 10.1016/S1473-3099(04)01131-4; Ahmed AOA, 2004, ANTIMICROB AGENTS CH, V48, P2742, DOI 10.1128/AAC.48.7.2742-2746.2004; Ahmed AOA, 1999, J CLIN MICROBIOL, V37, P3175, DOI 10.1128/JCM.37.10.3175-3178.1999; Amlacher S, 2011, CELL, V146, P277, DOI 10.1016/j.cell.2011.06.039; Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x; Basse CW, 2010, CURR OPIN MICROBIOL, V13, P712, DOI 10.1016/j.mib.2010.09.003; Bullerwell CE, 2005, CURR OPIN MICROBIOL, V8, P362, DOI 10.1016/j.mib.2005.06.009; Cardoso MAG, 2007, YEAST, V24, P607, DOI 10.1002/yea.1500; COLLINS RA, 1983, PLASMID, V9, P53, DOI 10.1016/0147-619X(83)90031-8; CUMMINGS DJ, 1990, CURR GENET, V17, P375, DOI 10.1007/BF00334517; CUMMINGS DJ, 1985, J MOL BIOL, V185, P659, DOI 10.1016/0022-2836(85)90052-X; de Hoog GS, 2012, J CLIN MICROBIOL, V50, P988, DOI 10.1128/JCM.05477-11; de Hoog GS, 2004, MYCOSES, V47, P121, DOI 10.1111/j.1439-0507.2004.00964.x; Edgell DR, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-22; Foury F, 1998, FEBS LETT, V440, P325, DOI 10.1016/S0014-5793(98)01467-7; Gautheret D, 2001, J MOL BIOL, V313, P1003, DOI 10.1006/jmbi.2001.5102; Jacobson DJ, 2006, MYCOLOGIA, V98, P550, DOI 10.3852/mycologia.98.4.550; Kleidon J, 2003, MITOCHONDRION, V2, P345, DOI 10.1016/S1567-7249(03)00002-3; Kouvelis VN, 2004, FUNGAL GENET BIOL, V41, P930, DOI 10.1016/j.fgb.2004.07.003; KUBELIK AR, 1990, J BIOL CHEM, V265, P4515; Laforest MJ, 1997, NUCLEIC ACIDS RES, V25, P626, DOI 10.1093/nar/25.3.626; Lang BF, 1999, ANNU REV GENET, V33, P351, DOI 10.1146/annurev.genet.33.1.351; Laslett D, 2004, NUCLEIC ACIDS RES, V32, P11, DOI 10.1093/nar/gkh152; Laslett D, 2008, BIOINFORMATICS, V24, P172, DOI 10.1093/bioinformatics/btm573; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; MICHEL F, 1990, J MOL BIOL, V216, P585, DOI 10.1016/0022-2836(90)90386-Z; Nowrousian M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000891; Paoletti M, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-223; Paquin B, 1996, J MOL BIOL, V255, P688, DOI 10.1006/jmbi.1996.0056; Pramateftaki PV, 2008, FEMS YEAST RES, V8, P311, DOI 10.1111/j.1567-1364.2007.00332.x; Pramateftaki PV, 2006, FEMS YEAST RES, V6, P77, DOI 10.1111/j.1567-1364.2005.00018.x; Prochazka E, 2010, FEMS YEAST RES, V10, P545, DOI 10.1111/j.1567-1364.2010.00644.x; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; SEKITO T, 1995, CURR GENET, V28, P39, DOI 10.1007/BF00311880; Sethuraman J, 2009, MOL BIOL EVOL, V26, P2299, DOI 10.1093/molbev/msp145; SILLIKER ME, 1990, GENETICS, V125, P775; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TAYLOR JW, 1985, CURR GENET, V9, P597, DOI 10.1007/BF00381173; Torriani SFF, 2008, FUNGAL GENET BIOL, V45, P628, DOI 10.1016/j.fgb.2007.12.005; van de Sande WWJ, 2011, MOLECULAR DETECTION OF HUMAN FUNGAL PATHOGENS, P117; van de Sande WWJ, 2005, ANTIMICROB AGENTS CH, V49, P1364, DOI 10.1128/AAC.49.4.1364-1368.2005; van Diepeningen AD, 2010, MECH AGEING DEV, V131, P315, DOI 10.1016/j.mad.2010.03.001; Woo PCY, 2003, FEBS LETT, V555, P469, DOI 10.1016/S0014-5793(03)01307-3; Wu Y, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-238; Zhang N, 2006, MYCOLOGIA, V98, P1076, DOI 10.3852/mycologia.98.6.1076	48	26	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e38654	10.1371/journal.pone.0038654	http://dx.doi.org/10.1371/journal.pone.0038654			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701687	Green Published, gold			2022-12-27	WOS:000305348400081
J	Zhao, CJ; Saul, MC; Driessen, T; Gammie, SC				Zhao, Changjiu; Saul, Michael C.; Driessen, Terri; Gammie, Stephen C.			Gene Expression Changes in the Septum: Possible Implications for MicroRNAs in Sculpting the Maternal Brain	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; LATERAL SEPTUM; ARCUATE NUCLEUS; PARAVENTRICULAR NUCLEUS; REPRODUCTIVE FUNCTION; BEHAVIORAL-RESPONSES; VASOPRESSIN RELEASE; SOCIAL RECOGNITION; STRIA TERMINALIS; NEUROPEPTIDE-Y	The transition from the non-maternal to the maternal state is characterized by a variety of CNS alterations that support the care of offspring. The septum (including lateral and medial portions) is a brain region previously linked to various emotional and motivational processes, including maternal care. In this study, we used microarrays (PLIER algorithm) to examine gene expression changes in the septum of postpartum mice and employed gene set enrichment analysis (GSEA) to identify possible regulators of altered gene expression. Genes of interest identified as differentially regulated with microarray analysis were validated with quantitative real-time PCR. We found that fatty acid binding protein 7 (Fabp7) and galanin (Gal) were downregulated, whereas insulin-like growth factor binding protein 3 (Igfbp3) was upregulated in postpartum mice compared to virgin females. These genes were previously found to be differentially regulated in other brain regions during lactation. We also identified altered expression of novel genes not previously linked to maternal behavior, but that could play a role in postpartum processes, including glutamate-ammonia ligase (Glul) and somatostatin receptor 1 (Sstr1) (both upregulated in postpartum). Genes implicated in metabolism, cell differentiation, or proliferation also exhibited altered expression. Unexpectedly, enrichment analysis revealed a high number of microRNAs, transcription factors, or conserved binding sites (177 with corrected P-value <0.05) that were significantly linked to maternal upregulated genes, while none were linked to downregulated genes. MicroRNAs have been linked to placenta and mammary gland development, but this is the first indication they may also play a key role in sculpting the maternal brain. Together, this study provides new insights into genes (along with possible mechanisms for their regulation) that are involved in septum-mediated adaptations during the postpartum period.	[Zhao, Changjiu; Saul, Michael C.; Driessen, Terri; Gammie, Stephen C.] Univ Wisconsin, Dept Zool, Madison, WI 53706 USA; [Gammie, Stephen C.] Univ Wisconsin, Neurosci Training Program, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Zhao, CJ (corresponding author), Univ Wisconsin, Dept Zool, Madison, WI 53706 USA.	czhao23@wisc.edu	Zhao, Changjiu/M-8263-2014; Saul, Michael C./N-9303-2019	Saul, Michael C./0000-0002-4916-8619	National Institutes of Health Grant [R01 MH 085642]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085642] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institutes of Health Grant R01 MH 085642 to S.G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai Y, 2005, J NEUROSCI, V25, P9752, DOI 10.1523/JNEUROSCI.2512-05.2005; Bonefeld BE, 2008, SYNAPSE, V62, P302, DOI 10.1002/syn.20496; BROAD KD, 1993, J NEUROENDOCRINOL, V5, P435, DOI 10.1111/j.1365-2826.1993.tb00505.x; Butler ST, 2003, J ENDOCRINOL, V176, P205, DOI 10.1677/joe.0.1760205; Caldwell KK, 2008, PHARMACOL BIOCHEM BE, V90, P614, DOI 10.1016/j.pbb.2008.05.004; Cammalleri M, 2004, EUR J NEUROSCI, V20, P2711, DOI 10.1111/j.1460-9568.2004.03741.x; Chen PL, 1999, ENDOCRINOLOGY, V140, P2645, DOI 10.1210/en.140.6.2645; CLEMMONS DR, 1991, ANNU REV NUTR, V11, P393, DOI 10.1146/annurev.nu.11.070191.002141; Cremer CM, 2010, EPILEPSIA, V51, P1446, DOI 10.1111/j.1528-1167.2010.02562.x; D'Anna KL, 2009, BEHAV NEUROSCI, V123, P356, DOI 10.1037/a0014987; daCosta APC, 1996, BRAIN RES, V742, P177, DOI 10.1016/S0006-8993(96)00962-6; Drazen DL, 1999, NITRIC OXIDE-BIOL CH, V3, P366, DOI 10.1006/niox.1999.0251; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Everts HGJ, 1999, BEHAV BRAIN RES, V99, P7, DOI 10.1016/S0166-4328(98)00004-7; FLEISCHER S, 1978, PHYSIOL BEHAV, V21, P189, DOI 10.1016/0031-9384(78)90041-0; FONNUM F, 1990, J NEUROCHEM, V54, P1253, DOI 10.1111/j.1471-4159.1990.tb01956.x; Gammie SC, 2005, MOL BRAIN RES, V139, P201, DOI 10.1016/j.molbrainres.2005.05.011; Gerstner JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015890; GIORDANO AL, 1989, NEUROENDOCRINOLOGY, V50, P248, DOI 10.1159/000125230; GLUCKMAN P, 1992, BIOCHEM BIOPH RES CO, V182, P593, DOI 10.1016/0006-291X(92)91774-K; Gross Liza, 2007, PLoS Biol, V5, pe320, DOI 10.1371/journal.pbio.0050320; Hokfelt T, 1999, HORM METAB RES, V31, P330, DOI 10.1055/s-2007-978748; Jakab Robert L., 1995, P405; Kalluri HSG, 2011, NEUROCHEM RES, V36, P406, DOI 10.1007/s11064-010-0349-2; Karlsson RM, 2006, AMINO ACIDS, V31, P231, DOI 10.1007/s00726-006-0336-8; Kinsley CH, 2011, J NEUROENDOCRINOL, V23, P974, DOI 10.1111/j.1365-2826.2011.02194.x; Klein RL, 2000, BRAIN RES, V875, P144, DOI 10.1016/S0006-8993(00)02634-2; Kuroda KO, 2011, PROG NEURO-PSYCHOPH, V35, P1205, DOI 10.1016/j.pnpbp.2011.02.008; LAUTERIO TJ, 1987, PHYSIOL BEHAV, V40, P755, DOI 10.1016/0031-9384(87)90279-4; Lee G, 2009, BEHAV NEUROSCI, V123, P1169, DOI 10.1037/a0017535; Levy F, 2011, J NEUROENDOCRINOL, V23, P984, DOI 10.1111/j.1365-2826.2011.02203.x; LIGHTMAN SL, 1992, ANN NY ACAD SCI, V652, P340, DOI 10.1111/j.1749-6632.1992.tb34365.x; Lukas M, 2011, PSYCHONEUROENDOCRINO, V36, P843, DOI 10.1016/j.psyneuen.2010.11.007; MAKINO S, 1994, BRAIN RES, V657, P141, DOI 10.1016/0006-8993(94)90961-X; Mann PE, 2002, MOL BRAIN RES, V105, P136, DOI 10.1016/S0169-328X(02)00401-1; Mann PE, 1997, MOL BRAIN RES, V46, P9, DOI 10.1016/S0169-328X(96)00267-7; MARCONDES F. K., 2002, Braz. J. Biol., V62, P609, DOI 10.1590/S1519-69842002000400008; Mercer JG, 1996, MOL BRAIN RES, V43, P202, DOI 10.1016/S0169-328X(96)00174-X; Mills JL, 2007, CLIN ENDOCRINOL, V67, P230, DOI 10.1111/j.1365-2265.2007.02868.x; MONTAGNESE CM, 1987, J ENDOCRINOL, V115, P97, DOI 10.1677/joe.0.1150097; Moss EG, 2003, DEV BIOL, V258, P432, DOI 10.1016/S0012-1606(03)00126-X; Nelissen K, 2010, J NEUROSCI METH, V187, P78, DOI 10.1016/j.jneumeth.2009.12.018; Neumann I D, 2001, Prog Brain Res, V133, P143; Numan M, 1999, BRAIN RES, V830, P358, DOI 10.1016/S0006-8993(99)01424-9; Olias G, 2004, J NEUROCHEM, V89, P1057, DOI 10.1111/j.1471-4159.2004.02402.x; OTTINGER MA, 1995, J NEUROENDOCRINOL, V7, P341, DOI 10.1111/j.1365-2826.1995.tb00767.x; Owada Y, 2006, EUR J NEUROSCI, V24, P175, DOI 10.1111/j.1460-9568.2006.04855.x; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Prieto DMM, 2011, J REPROD IMMUNOL, V88, P106, DOI 10.1016/j.jri.2011.01.004; Renn SCP, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-42; Risold PY, 1997, BRAIN RES REV, V24, P115, DOI 10.1016/S0165-0173(97)00009-X; Risold PY, 1997, BRAIN RES REV, V24, P91, DOI 10.1016/S0165-0173(97)00008-8; ROMANO GJ, 1989, MOL BRAIN RES, V5, P51, DOI 10.1016/0169-328X(89)90017-X; Rosati B, 2004, BIOTECHNIQUES, V36, P316, DOI 10.2144/04362MT03; Rosenblatt J., 1963, MATERNAL BEHAVIOR MA, P8; Rudick CN, 2003, J NEUROSCI, V23, P4479; Russell J A, 2001, Prog Brain Res, V133, P1; Schaffhauser AO, 2002, OBES RES, V10, P1188, DOI 10.1038/oby.2002.161; Schumer M, 2011, J EXP BIOL, V214, P3269, DOI 10.1242/jeb.055467; Seo J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-395; Sheehan TP, 2004, BRAIN RES REV, V46, P71, DOI 10.1016/j.brainresrev.2004.04.009; Shenouda SK, 2009, CANCER METAST REV, V28, P369, DOI 10.1007/s10555-009-9188-5; Silveri L, 2006, REPROD NUTR DEV, V46, P549, DOI 10.1051/rnd:2006026; SMITH MS, 1993, ENDOCRINOLOGY, V133, P1258, DOI 10.1210/en.133.3.1258; Smith MS, 2002, FRONT NEUROENDOCRIN, V23, P225, DOI 10.1016/S0091-3022(02)00002-X; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Stroh T, 2009, J NEUROSCI, V29, P8198, DOI 10.1523/JNEUROSCI.0336-09.2009; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Uriguen L, 2008, GENES BRAIN BEHAV, V7, P649, DOI 10.1111/j.1601-183X.2008.00402.x; Veenema AH, 2010, HORM BEHAV, V58, P273, DOI 10.1016/j.yhbeh.2010.03.006; Windle RJ, 1997, J NEUROENDOCRINOL, V9, P407, DOI 10.1046/j.1365-2826.1997.00587.x; Wrenn CC, 2001, PROG NEURO-PSYCHOPH, V25, P283, DOI 10.1016/S0278-5846(00)00156-1; Xiao XQ, 2005, ENDOCRINOLOGY, V146, P4391, DOI 10.1210/en.2005-0561; Zhao C, 2010, NEUROSCIENCE, V166, P1043, DOI 10.1016/j.neuroscience.2010.01.023	74	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e38602	10.1371/journal.pone.0038602	http://dx.doi.org/10.1371/journal.pone.0038602			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701680	gold, Green Published, Green Submitted			2022-12-27	WOS:000305348400079
J	Gabizon, R; Brandt, T; Sukenik, S; Lahav, N; Lebendiker, M; Shalev, DE; Veprintsev, D; Friedler, A				Gabizon, Ronen; Brandt, Tobias; Sukenik, Shahar; Lahav, Noa; Lebendiker, Mario; Shalev, Deborah E.; Veprintsev, Dmitry; Friedler, Assaf			Specific Recognition of p53 Tetramers by Peptides Derived from p53 Interacting Proteins	PLOS ONE			English	Article							TUMOR-SUPPRESSOR; HIV-1 INTEGRASE; BINDING DOMAIN; S100 FAMILY; DNA-BINDING; KINASE-C; THERMODYNAMIC ANALYSIS; COOPERATIVE BINDING; CRYSTAL-STRUCTURE; OLIGOMERIZATION	Oligomerization plays a major role in regulating the activity of many proteins, and in modulating their interactions. p53 is a homotetrameric transcription factor that has a pivotal role in tumor suppression. Its tetramerization domain is contained within its C-terminal domain, which is a site for numerous protein-protein interactions. Those can either depend on or regulate p53 oligomerization. Here we screened an array of peptides derived from proteins known to bind the tetrameric p53 C-terminal domain (p53CTD) and identified ten binding peptides. We quantitatively characterized their binding to p53CTD using fluorescence anisotropy. The peptides bound tetrameric p53CTD with micromolar affinities. Despite the high charge of the binding peptides, electrostatics contributed only mildly to the interactions. NMR studies indicated that the peptides bound p53CTD at defined sites. The most significant chemical shift deviations were observed for the peptides WS100B(81-92), which bound directly to the p53 tetramerization domain, and PKC alpha(281-295), which stabilized p53CTD in circular dichroism thermal denaturation studies. Using analytical ultracentrifugation, we found that several of the peptides bound preferentially to p53 tetramers. Our results indicate that the protein-protein interactions of p53 are dependent on the oligomerization state of p53. We conclude that peptides may be used to regulate the oligomerization of p53.	[Gabizon, Ronen; Sukenik, Shahar; Lahav, Noa; Friedler, Assaf] Hebrew Univ Jerusalem, Inst Chem, IL-91904 Jerusalem, Israel; [Brandt, Tobias; Veprintsev, Dmitry] MRC Lab Mol Biol, Cambridge, England; [Lebendiker, Mario; Shalev, Deborah E.] Hebrew Univ Jerusalem, Wolfson Ctr Appl Struct Biol, Jerusalem, Israel; [Veprintsev, Dmitry] Paul Scherrer Inst, Lab Biomol Res, Villigen, Switzerland; [Veprintsev, Dmitry] Swiss Fed Inst Technol, Dept Biol, Zurich, Switzerland	Hebrew University of Jerusalem; MRC Laboratory Molecular Biology; Hebrew University of Jerusalem; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Swiss Federal Institutes of Technology Domain; ETH Zurich	Gabizon, R (corresponding author), Hebrew Univ Jerusalem, Inst Chem, IL-91904 Jerusalem, Israel.	dmitry.veprintsev@psi.ch; assaf.friedler@mail.huji.ac.il	Shalev, Deborah E/AAY-2873-2021; Veprintsev, Dmitry B/H-2228-2012; Sukenik, Shahar/J-4438-2013	Veprintsev, Dmitry B/0000-0002-3583-5409; Sukenik, Shahar/0000-0003-3855-9574; Gabizon, Ronen/0000-0002-3626-5073	European Research Council under the European Community's Seventh Framework Programme [203413]; Adams Fellowship Program of the Israel Academy of Sciences and Humanities; Cambridge European Trust; Medical Research Council	European Research Council under the European Community's Seventh Framework Programme(European Commission); Adams Fellowship Program of the Israel Academy of Sciences and Humanities; Cambridge European Trust; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	AF is supported by a starting grant from the European Research Council under the European Community's Seventh Framework Programme (FP7/2007-2013)/ERC Grant agreement no 203413. RG is supported by the Adams Fellowship Program of the Israel Academy of Sciences and Humanities. TB is supported by the Cambridge European Trust and the Medical Research Council. This research was supported by the Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews P, 2006, ONCOGENE, V25, P4534, DOI 10.1038/sj.onc.1209490; Brandt T, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-628; Chen YH, 2010, STRUCTURE, V18, P246, DOI 10.1016/j.str.2009.11.011; Chene P, 2001, ONCOGENE, V20, P2611, DOI 10.1038/sj.onc.1204373; Dehner A, 2005, ANGEW CHEM INT EDIT, V44, P5247, DOI 10.1002/anie.200501887; Delphin C, 1997, EUR J BIOCHEM, V245, P684, DOI 10.1111/j.1432-1033.1997.t01-1-00684.x; Dobner T, 1996, SCIENCE, V272, P1470, DOI 10.1126/science.272.5267.1470; Fernandez-Fernandez MR, 2008, PROTEIN SCI, V17, P1663, DOI 10.1110/ps.035527.108; Fernandez-Fernandez MR, 2005, P NATL ACAD SCI USA, V102, P4735, DOI 10.1073/pnas.0501459102; Friedler A, 2005, J BIOL CHEM, V280, P8051, DOI 10.1074/jbc.M411176200; Friedler A, 2005, STRUCTURE, V13, P629, DOI 10.1016/j.str.2005.01.020; Gabizon R, 2008, BIOPOLYMERS, V90, P105, DOI 10.1002/bip.20919; Gordo S, 2008, P NATL ACAD SCI USA, V105, P16426, DOI 10.1073/pnas.0805658105; Gotz C, 1999, MOL CELL BIOCHEM, V191, P111, DOI 10.1023/A:1006886727248; Hayouka Z, 2008, BIOPOLYMERS, V90, P481, DOI 10.1002/bip.20930; Hayouka Z, 2007, P NATL ACAD SCI USA, V104, P8316, DOI 10.1073/pnas.0700781104; Hayouka Z, 2010, BIOORGAN MED CHEM, V18, P8388, DOI 10.1016/j.bmc.2010.09.046; Hayouka Z, 2010, BIOCHEM BIOPH RES CO, V394, P260, DOI 10.1016/j.bbrc.2010.02.100; Jaffe EK, 2005, TRENDS BIOCHEM SCI, V30, P490, DOI 10.1016/j.tibs.2005.07.003; JEFFREY PD, 1995, SCIENCE, V267, P1498, DOI 10.1126/science.7878469; JOHNSON CR, 1995, BIOCHEMISTRY-US, V34, P5309, DOI 10.1021/bi00016a002; Kaustov L, 2007, J BIOL CHEM, V282, P11300, DOI 10.1074/jbc.M611297200; LEE WT, 1994, NAT STRUCT BIOL, V1, P877, DOI 10.1038/nsb1294-877; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Maes M, 2009, BIOORGAN MED CHEM, V17, P7635, DOI 10.1016/j.bmc.2009.09.053; Martinell M, 2006, CHEMBIOCHEM, V7, P1105, DOI 10.1002/cbic.200500555; Menendez D, 2009, NAT REV CANCER, V9, P724, DOI 10.1038/nrc2730; Michael D, 2002, CURR OPIN GENET DEV, V12, P53, DOI 10.1016/S0959-437X(01)00264-7; Natan E, 2009, P NATL ACAD SCI USA, V106, P14327, DOI 10.1073/pnas.0907840106; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; Nikolaev AY, 2003, CELL, V112, P29, DOI 10.1016/S0092-8674(02)01255-2; Nikolova PV, 1998, P NATL ACAD SCI USA, V95, P14675, DOI 10.1073/pnas.95.25.14675; Oh J, 2008, J BIOL CHEM, V283, P11924, DOI 10.1074/jbc.M705401200; Politi Laura, 2009, Archaea, V2, P221, DOI 10.1155/2009/280317; Poyurovsky MV, 2010, NAT STRUCT MOL BIOL, V17, P982, DOI 10.1038/nsmb.1872; Rajagopalan S, 2008, NUCLEIC ACIDS RES, V36, P5983, DOI 10.1093/nar/gkn598; RECORD MT, 1978, Q REV BIOPHYS, V11, P103, DOI 10.1017/S003358350000202X; Robinson R. A., 1970, ELECTROLYTE SOLUTION, V2nd; Robinson R.A., 1959, ELECTROLYTE SOLUTION, DOI DOI 10.1073?PNAS.0305836101; Rustandi RR, 1998, BIOCHEMISTRY-US, V37, P1951, DOI 10.1021/bi972701n; Ryan KM, 2001, CURR OPIN CELL BIOL, V13, P332, DOI 10.1016/S0955-0674(00)00216-7; Schneider-Merck T, 2006, J BIOL CHEM, V281, P269, DOI 10.1074/jbc.M503459200; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Steinberg SF, 2008, PHYSIOL REV, V88, P1341, DOI 10.1152/physrev.00034.2007; Stommel JM, 1999, EMBO J, V18, P1660, DOI 10.1093/emboj/18.6.1660; Takahasi K, 2010, GENES CELLS, V15, P901, DOI 10.1111/j.1365-2443.2010.01427.x; Teufel DP, 2007, P NATL ACAD SCI USA, V104, P7009, DOI 10.1073/pnas.0702010104; van Dieck J, 2009, J BIOL CHEM, V284, P13804, DOI 10.1074/jbc.M901351200; Veprintsev DB, 2006, P NATL ACAD SCI USA, V103, P2115, DOI 10.1073/pnas.0511130103; Verdaguer N, 1999, EMBO J, V18, P6329, DOI 10.1093/emboj/18.22.6329; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wadhwa R, 2002, EXP CELL RES, V274, P246, DOI 10.1006/excr.2002.5468; Wagner P, 1998, ONCOGENE, V16, P105, DOI 10.1038/sj.onc.1201510; Weber PJA, 1998, BIOORG MED CHEM LETT, V8, P597, DOI 10.1016/S0960-894X(98)00084-5; Weinberg RL, 2004, J MOL BIOL, V341, P1145, DOI 10.1016/j.jmb.2004.06.071; Zhang HB, 1998, ONCOGENE, V16, P1713, DOI 10.1038/sj.onc.1201932	56	16	16	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38060	10.1371/journal.pone.0038060	http://dx.doi.org/10.1371/journal.pone.0038060			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693587	Green Published, gold, Green Submitted			2022-12-27	WOS:000305338500083
J	Simoes, SD; da Cunha, SS; Cruz, AA; Dias, KC; Alcantara-Neves, NM; Amorim, LD; Rodrigues, LC; Barreto, ML				Simoes, Silvia de Magalhaes; da Cunha, Sergio S.; Cruz, Alvaro A.; Dias, Karen Conceicao; Alcantara-Neves, Neuza M.; Amorim, Leila D.; Rodrigues, Laura C.; Barreto, Mauricio L.			A Community Study of Factors Related to Poorly Controlled Asthma among Brazilian Urban Children	PLOS ONE			English	Article							ALLERGIC RHINITIS; MEDICATION USE; SEVERITY; HEALTH; SYMPTOMS; INSIGHTS; EXPOSURE; REALITY; FUNGI	Background: Asthma constitutes a serious public health problem in many regions of the world, including the city of Salvador, State of Bahia - Brazil. The purpose of this study was to analyse the factors associated with poor asthma control. Methodology/Principal Findings: Two definitions were used for asthma: 1) wheezing in the last 12 months; 2) wheezing in the last 12 months plus other asthma symptoms or asthma diagnosis ever. The definition of poorly controlled asthma was: at least one reported hospitalisation due to asthma and/or high frequency of symptoms, in the last year. Children with poorly controlled asthma (N = 187/374) were compared with wheezing children with controlled asthma regarding age, gender, atopy, parental asthma, rhinitis, eczema, exposure to second hand tobacco smoke, presence of moulds, pets and pests in the house, helminth infections and body mass index. Crude and logistic regression adjusted odds ratios were used as measures of association. There was a higher proportion of poorly controlled asthma among children with eczema (OR = 1.55; 95% CI 1.02; 2.37). The strength of the association was greater among children with eczema and rhinitis (42.6%, 53.4% and 57.7%, respectively, in children who had no rhinitis nor eczema, had only one of those, and had both (p = 0.02 for trend test). The presence of mould in the houses was inversely associated with poorly controlled asthma (OR = 0.54; 95% CI 0.34; 0.87). Conclusions/Significance: Our results indicate an association between eczema and poor asthma control in this environment, but emphasize the role of various other individual and environmental factors as determinants of poor control.	[Simoes, Silvia de Magalhaes] Univ Fed Sergipe, Ctr Ciencias Biol & Saude, Aracaju, Brazil; [Simoes, Silvia de Magalhaes; da Cunha, Sergio S.; Cruz, Alvaro A.; Dias, Karen Conceicao; Alcantara-Neves, Neuza M.; Amorim, Leila D.; Rodrigues, Laura C.; Barreto, Mauricio L.] SCAALA Social Change Asthma & Allergy Latin Amer, Recife, PE, Brazil; [da Cunha, Sergio S.] Univ Fed Pernambuco, Dept Med Social, Recife, PE, Brazil; [Cruz, Alvaro A.] Univ Fed Bahia, ProAR Nucleo Excelencia Asma, PRONEX CNPq FAPESB, Salvador, BA, Brazil; [Dias, Karen Conceicao; Barreto, Mauricio L.] Univ Fed Bahia, Inst Saude Colet, Salvador, BA, Brazil; [Alcantara-Neves, Neuza M.] Univ Fed Bahia, Inst Ciencias Saude, Salvador, BA, Brazil; [Rodrigues, Laura C.] London Sch Hyg & Trop Med, London WC1, England; [Amorim, Leila D.] Univ Fed Bahia, Inst Matemat, Salvador, BA, Brazil	Universidade Federal de Sergipe; Universidade Federal de Pernambuco; Universidade Federal da Bahia; Universidade Federal da Bahia; Universidade Federal da Bahia; University of London; London School of Hygiene & Tropical Medicine; Universidade Federal da Bahia	Simoes, SD (corresponding author), Univ Fed Sergipe, Ctr Ciencias Biol & Saude, Aracaju, Brazil.	silvia@alergia.org	Amorim, Leila/ABG-9480-2021; Cruz, Alvaro A/I-1676-2012; Amorim, Leila/B-4508-2015; Barreto, Mauricio L/B-1752-2008; RODRIGUES, LAURA CUNHA/AAO-4130-2021	Amorim, Leila/0000-0002-1112-2332; Cruz, Alvaro A/0000-0002-7403-3871; Amorim, Leila/0000-0002-1112-2332; Barreto, Mauricio L/0000-0002-0215-4930; Souza da Cunha, Sergio/0000-0002-4926-3827	Welcome Trust UK [072405/Z/03/Z]; Foundation for Research of the State of Bahia (FAPESB) [1941/2006, SUS0028/2009]; Brazilian Council for Development of Science and Technology (CNPq)	Welcome Trust UK(Wellcome Trust); Foundation for Research of the State of Bahia (FAPESB); Brazilian Council for Development of Science and Technology (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study is part of the SCAALA programme (Social Change, Asthma and Allergy in Latin America), which is funded by The Welcome Trust UK, Ref 072405/Z/03/Z. SMS was supported by a scholarship of the Foundation for Research of the State of Bahia (FAPESB) grant 1941/2006. AAC has scientist award of the Brazilian Council for Development of Science and Technology (CNPq), and a grant from FAPESB (SUS0028/2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo MI, 2000, INT ARCH ALLERGY IMM, V123, P145, DOI 10.1159/000024433; Asher MI, 2006, LANCET, V368, P733, DOI 10.1016/S0140-6736(06)69283-0; Barreto ML, 2006, BMC PULM MED; Bousquet J, 2005, B WORLD HEALTH ORGAN, V83, P548; Cassol VE, 2006, J ASTHMA, V43, P57, DOI 10.1080/02770900500448597; Crane J, 2003, EUR RESPIR J, V21, P455, DOI 10.1183/09031936.03.00041403; Denning DW, 2006, EUR RESPIR J, V27, P615, DOI 10.1183/09031936.06.00074705; Downs SH, 2001, AM J RESP CRIT CARE, V164, P455, DOI 10.1164/ajrccm.164.3.2008042; Gent JF, 2009, ENVIRON RES, V109, P768, DOI 10.1016/j.envres.2009.04.010; Halpern MT, 2004, J ASTHMA, V41, P117, DOI 10.1081/JAS-120026069; Heinrich J, 2003, J EXPO ANAL ENV EPID, V13, P152, DOI 10.1038/sj.jea.7500267; HIMES JH, 1994, AM J CLIN NUTR, V59, P307, DOI 10.1093/ajcn/59.2.307; Hoffman W. A., 1934, PUERTO RICO J PUBLIC, V9, P281, DOI DOI 10.1590/S0037-86822012000300024; Katz N, 1972, Rev Inst Med Trop Sao Paulo, V14, P397; Kyllonen H, 2006, CLIN EXP ALLERGY, V36, P192, DOI 10.1111/j.1365-2222.2006.02419.x; Mannino DM, 2002, CHEST, V122, P409, DOI 10.1378/chest.122.2.409; Medeiros M, 2003, J ALLERGY CLIN IMMUN, V111, P947, DOI 10.1067/mai.2003.1381; Neffen H, 2005, REV PANAM SALUD PUBL, V17, P191, DOI 10.1590/S1020-49892005000300007; O'Driscoll BR, BMC PULM MED; Ponte EV, 2008, ALLERGY, V63, P564, DOI 10.1111/j.1398-9995.2007.01624.x; Ponte EV, 2006, ANN ALLERG ASTHMA IM, V96, P713, DOI 10.1016/S1081-1206(10)61070-8; Rabe KF, 2004, J ALLERGY CLIN IMMUN, V114, P40, DOI 10.1016/j.jaci.2004.04.042; Rosenstreich DL, 1997, NEW ENGL J MED, V336, P1356, DOI 10.1056/NEJM199705083361904; Santos DB, 2012, EUR J CLIN PHARMACOL, V68, P73, DOI 10.1007/s00228-011-1092-6; Simons FER, 1999, J ALLERGY CLIN IMMUN, V104, P534, DOI 10.1016/S0091-6749(99)70320-9; Sole D, 2005, PEDIAT ALLERG IMM-UK, V16, P121, DOI 10.1111/j.1399-3038.2005.00227.x; STRACHAN DP, 1995, BRIT MED J, V311, P1053, DOI 10.1136/bmj.311.7012.1053; Weissman DN, 2002, CHEST, V121, P6, DOI 10.1378/chest.121.1.6; Zureik M, 2002, BMJ-BRIT MED J, V325, P411, DOI 10.1136/bmj.325.7361.411	29	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e37050	10.1371/journal.pone.0037050	http://dx.doi.org/10.1371/journal.pone.0037050			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693565	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000305338500027
J	Springer, SA; Qiu, JJ; Saber-Tehrani, AS; Altice, FL				Springer, Sandra A.; Qiu, Jingjun; Saber-Tehrani, Ali Shabahang; Altice, Frederick L.			Retention on Buprenorphine Is Associated with High Levels of Maximal Viral Suppression among HIV-Infected Opioid Dependent Released Prisoners	PLOS ONE			English	Article							ADMINISTERED ANTIRETROVIRAL THERAPY; MEDICATION-ASSISTED TREATMENT; ALCOHOL-USE DISORDERS; DRUG-ABUSE TREATMENT; METHADONE-MAINTENANCE; TREATMENT OUTCOMES; PUBLIC-HEALTH; CLINICAL CARE; PREVENTION; ADDICTION	Introduction: HIV-infected prisoners lose viral suppression within the 12 weeks after release to the community. This prospective study evaluates the use of buprenorphine/naloxone (BPN/NLX) as a method to reduce relapse to opioid use and sustain viral suppression among released HIV-infected prisoners meeting criteria for opioid dependence (OD). Methods: From 2005-2010, 94 subjects meeting DSM-IV criteria for OD were recruited from a 24-week prospective trial of directly administered antiretroviral therapy (DAART) for released HIV-infected prisoners; 50 (53%) selected BPN/NLX and were eligible to receive it for 6 months; the remaining 44 (47%) selected no BPN/NLX therapy. Maximum viral suppression (MVS), defined as HIV-1 RNA<50 copies/mL, was compared for the BPN/NLX and non-BPN/NLX (N = 44) groups. Results: The two groups were similar, except the BPN/NLX group was significantly more likely to be Hispanic (56.0% v 20.4%), from Hartford (74.4% v 47.7%) and have higher mean global health quality of life indicator scores (54.18 v 51.40). MVS after 24 weeks of being released was statistically correlated with 24-week retention on BPN/NLX [AOR = 5.37 (1.15, 25.1)], having MVS at the time of prison-release [AOR = 10.5 (3.21, 34.1)] and negatively with being Black [AOR = 0.13 (0.03, 0.68)]. Receiving DAART or methadone did not correlate with MVS. Conclusions: In recognition that OD is a chronic relapsing disease, strategies that initiate and retain HIV-infected prisoners with OD on BPN/NLX is an important strategy for improving HIV treatment outcomes as a community transition strategy.	[Springer, Sandra A.; Qiu, Jingjun; Saber-Tehrani, Ali Shabahang; Altice, Frederick L.] Yale Univ, Sch Med, AIDS Program, Infect Dis Sect, New Haven, CT 06520 USA; [Altice, Frederick L.] Yale Univ, Sch Publ Hlth, Div Epidemiol Microbial Dis, New Haven, CT USA; [Altice, Frederick L.] Univ Malaya, Fac Med, Ctr Excellence Res AIDS, Kuala Lumpur, Malaysia	Yale University; Yale University; Universiti Malaya	Springer, SA (corresponding author), Yale Univ, Sch Med, AIDS Program, Infect Dis Sect, New Haven, CT 06520 USA.	Sandra.springer@yale.edu	Springer, Sandra/ABC-4569-2020	springer, sandra/0000-0002-6318-1000	National Institutes of Health, National Institutes on Drug Abuse for research [R21 DA019843, R01 DA017059, K24 DA017072, K02 DA032322, K23 DA019381]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA017059, K23DA019381, K02DA032322, R21DA019843, K24DA017072] Funding Source: NIH RePORTER	National Institutes of Health, National Institutes on Drug Abuse for research; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Funding for this work was provided by the National Institutes of Health, National Institutes on Drug Abuse for research (R21 DA019843, R01 DA017059 for FLA), and career development (K24 DA017072 for FLA, K02 DA032322 and K23 DA019381 for SAS) support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altice F, 2011, 18 C RETR OPP INF BO; Altice FL, 2011, JAIDS-J ACQ IMM DEF, V56, pS22, DOI 10.1097/QAI.0b013e318209751e; Altice FL, 2010, LANCET, V376, P367, DOI 10.1016/S0140-6736(10)60829-X; Azar MM, 2010, DRUG ALCOHOL DEPEN, V112, P178, DOI 10.1016/j.drugalcdep.2010.06.014; Bae JW, 2011, AIDS, V25, P279, DOI 10.1097/QAD.0b013e328340feb0; Baillargeon J, 2010, AIDS PATIENT CARE ST, V24, P389, DOI 10.1089/apc.2009.0303; Baillargeon J, 2009, JAMA-J AM MED ASSOC, V301, P848, DOI 10.1001/jama.2009.202; Barta WD, 2009, J STUD ALCOHOL DRUGS, V70, P735, DOI 10.15288/jsad.2009.70.735; Binswanger IA, 2007, NEW ENGL J MED, V356, P157, DOI 10.1056/NEJMsa064115; Chandler RK, 2009, JAMA-J AM MED ASSOC, V301, P183, DOI 10.1001/jama.2008.976; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Copenhaver MM, 2007, AM J DRUG ALCOHOL AB, V33, P643, DOI 10.1080/00952990701522674; Das M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011068; Fang CT, 2004, J INFECT DIS, V190, P879, DOI 10.1086/422601; Friedmann PD, 2012, SUBST ABUS, V33, P9, DOI 10.1080/08897077.2011.611460; Gardner EM, 2011, CLIN INFECT DIS, V52, P793, DOI 10.1093/cid/ciq243; Gordon MS, 2011, BEHAV SCI LAW, V29, P829, DOI 10.1002/bsl.1015; Hammer SM, 1996, AIDS, V10, pS1; Ing EC, 2011, AIDS BEHAV      1122; KARBERG JENNIFER C., 2002, SUBSTANCE DEPENDENCE, P1; Kinlock TW, 2010, J OFFENDER REHABIL, V49, P91, DOI 10.1080/10509670903534951; Kinlock TW, 2009, J SUBST ABUSE TREAT, V37, P277, DOI 10.1016/j.jsat.2009.03.002; Kinlock TW, 2002, J SUBST ABUSE TREAT, V22, P141, DOI 10.1016/S0740-5472(02)00226-X; Krupitsky E, 2011, LANCET, V377, P1506, DOI 10.1016/S0140-6736(11)60358-9; Lucas GM, 2006, CLIN INFECT DIS, V42, P1628, DOI 10.1086/503905; Magura S, 2009, DRUG ALCOHOL DEPEN, V99, P222, DOI 10.1016/j.drugalcdep.2008.08.006; Maruschak LM, 2009, HIV PRISONS 2008; Mattick RP, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002207.pub3; MCLELLAN AT, 1992, J SUBST ABUSE TREAT, V9, P199, DOI 10.1016/0740-5472(92)90062-S; Montaner JSG, 2010, LANCET, V376, P532, DOI 10.1016/S0140-6736(10)60936-1; Mumola C, 1999, SUBSTANCE ABUSE TREA, P1; Nunn A, 2009, DRUG ALCOHOL DEPEN, V105, P83, DOI 10.1016/j.drugalcdep.2009.06.015; Rich JD, 2005, J URBAN HEALTH, V82, P411, DOI 10.1093/jurban/jti072; Rich Josiah D, 2011, Curr HIV/AIDS Rep, V8, P288, DOI 10.1007/s11904-011-0095-3; Rosen CS, 2000, ADDICTION, V95, P419, DOI 10.1046/j.1360-0443.2000.95341912.x; Saber-Tehrani AS, 2012, CONTEMP CLIN TRIALS, V33, P436, DOI 10.1016/j.cct.2011.11.002; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Sheehan DV, 1997, EUR PSYCHIAT, V12, P232, DOI 10.1016/S0924-9338(97)83297-X; Smith-Rohrberg D, 2004, J DRUG ISSUES, V34, P451, DOI 10.1177/002204260403400210; Spaulding AC, 2009, PLOS ONE, V4, pA16, DOI 10.1371/journal.pone.0007558; Springer SA, 2004, CLIN INFECT DIS, V38, P1754, DOI 10.1086/421392; Springer SA, 2011, CLIN INFECT DIS, V53, P469, DOI 10.1093/cid/cir446; Springer SA, 2011, AM J DRUG ALCOHOL AB, V37, P12, DOI 10.3109/00952990.2010.540280; Springer SA, 2010, ADDICTION, V105, P224, DOI 10.1111/j.1360-0443.2009.02893.x; Springer Sandra A, 2008, J Opioid Manag, V4, P81; Springer SA, 2010, J URBAN HEALTH, V87, P592, DOI 10.1007/s11524-010-9438-4; Stephenson BL, 2006, INT J STD AIDS, V17, P103, DOI 10.1258/095646206775455775; Stephenson BL, 2005, PUBLIC HEALTH REP, V120, P84, DOI 10.1177/003335490512000114; Sullivan LE, 2006, CLIN INFECT DIS, V43, pS184, DOI 10.1086/508182; Sullivan LE, 2011, JAIDS-J ACQ IMM DEF, V56, pS54, DOI 10.1097/QAI.0b013e3182097576; Thompson MA, 2012, ANN INTERNAL ME 0305; Wexler HK, 2007, PRISON J, V87, P9, DOI 10.1177/0032885506299036; Zaccarelli M, 2009, INFECTION, V37, P203, DOI 10.1007/s15010-008-8142-8	53	96	97	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38335	10.1371/journal.pone.0038335	http://dx.doi.org/10.1371/journal.pone.0038335			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22719814	Green Published, Green Submitted, gold			2022-12-27	WOS:000305338500133
J	Van Deun, K; Van Mechelen, I; Thorrez, L; Schouteden, M; De Moor, B; van der Werf, MTJ; De Lathauwer, L; Smilde, AK; Kiers, HAL				Van Deun, Katrijn; Van Mechelen, Iven; Thorrez, Lieven; Schouteden, Martijn; De Moor, Bart; van der Werf, Mariet J.; De Lathauwer, Lieven; Smilde, Age K.; Kiers, Henk A. L.			DISCO-SCA and Properly Applied GSVD as Swinging Methods to Find Common and Distinctive Processes	PLOS ONE			English	Article							METABOLOMICS; PLATFORM; MODULES; MODELS	Background: In systems biology it is common to obtain for the same set of biological entities information from multiple sources. Examples include expression data for the same set of orthologous genes screened in different organisms and data on the same set of culture samples obtained with different high-throughput techniques. A major challenge is to find the important biological processes underlying the data and to disentangle therein processes common to all data sources and processes distinctive for a specific source. Recently, two promising simultaneous data integration methods have been proposed to attain this goal, namely generalized singular value decomposition (GSVD) and simultaneous component analysis with rotation to common and distinctive components (DISCO-SCA). Results: Both theoretical analyses and applications to biologically relevant data show that: (1) straightforward applications of GSVD yield unsatisfactory results, (2) DISCO-SCA performs well, (3) provided proper pre-processing and algorithmic adaptations, GSVD reaches a performance level similar to that of DISCO-SCA, and (4) DISCO-SCA is directly generalizable to more than two data sources. The biological relevance of DISCO-SCA is illustrated with two applications. First, in a setting of comparative genomics, it is shown that DISCO-SCA recovers a common theme of cell cycle progression and a yeast-specific response to pheromones. The biological annotation was obtained by applying Gene Set Enrichment Analysis in an appropriate way. Second, in an application of DISCO-SCA to metabolomics data for Escherichia coli obtained with two different chemical analysis platforms, it is illustrated that the metabolites involved in some of the biological processes underlying the data are detected by one of the two platforms only; therefore, platforms for microbial metabolomics should be tailored to the biological question. Conclusions: Both DISCO-SCA and properly applied GSVD are promising integrative methods for finding common and distinctive processes in multisource data. Open source code for both methods is provided.	[Van Deun, Katrijn; Van Mechelen, Iven; Schouteden, Martijn] Katholieke Univ Leuven, Dept Psychol, Louvain, Belgium; [Thorrez, Lieven] Katholieke Univ Leuven, Stem Cell Inst Leuven, Dept Dev & Regenerat, Louvain, Belgium; [Thorrez, Lieven; De Moor, Bart; De Lathauwer, Lieven] Katholieke Univ Leuven, Dept Elect Engn ESAT SCD, IBBT Future Hlth Dept, Louvain, Belgium; [Thorrez, Lieven] Katholieke Univ Leuven, Interdisciplinary Res Ctr, B-8500 Kortrijk, Belgium; [van der Werf, Mariet J.] TNO, NL-3700 AJ Zeist, Netherlands; [Smilde, Age K.] Univ Amsterdam, Swammerdam Inst Life Sci, Amsterdam, Netherlands; [Kiers, Henk A. L.] Univ Groningen, Heymans Inst, Groningen, Netherlands	KU Leuven; KU Leuven; KU Leuven; KU Leuven; Netherlands Organization Applied Science Research; University of Amsterdam; University of Groningen	Van Deun, K (corresponding author), Katholieke Univ Leuven, Dept Psychol, Louvain, Belgium.	katrijn.vandeun@ppw.kuleuven.be	Kiers, Henk/D-2900-2012; Thorrez, Lieven/A-2583-2011	Thorrez, Lieven/0000-0002-5896-6823; Smilde, Age/0000-0002-3052-4644; Kiers, Henk/0000-0002-4995-9349	Research Fund of Katholieke Universiteit Leuven [SymBioSys: CoE EF/05/007, OPTEC: CoE EF/05/006, GOA/2005/04, GOA-MaNet, CIF1, STRT1/08/023]; IWT-Flanders [IWT/060045/SBO Bioframe]; Fund for Scientific Research - Flanders [G.0321.06]; Research Community (ICCoS); Research Community (ANMMM); Research Community (MLDM); Belgian Federal Science Policy Office [IUAP P6/03, P6/04]; European Union (ERNSI)	Research Fund of Katholieke Universiteit Leuven; IWT-Flanders(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Fund for Scientific Research - Flanders(FWO); Research Community (ICCoS); Research Community (ANMMM); Research Community (MLDM); Belgian Federal Science Policy Office(Belgian Federal Science Policy Office); European Union (ERNSI)	LT is a Postdoctoral Fellow of the Research Foundation - Flanders (FWO). This work was supported by the Research Fund of Katholieke Universiteit Leuven (SymBioSys: CoE EF/05/007, OPTEC: CoE EF/05/006, GOA/2005/04, GOA-MaNet, CIF1, STRT1/08/023), by IWT-Flanders (IWT/060045/SBO Bioframe), by the Fund for Scientific Research - Flanders (G.0321.06), by Research Communities (ICCoS, ANMMM, and MLDM), by the Belgian Federal Science Policy Office (IUAP P6/03 and P6/04), and by the European Union (ERNSI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter O, 2003, P NATL ACAD SCI USA, V100, P3351, DOI 10.1073/pnas.0530258100; Bai Z, 1992, IMA PREPRINT SERIES; Bergmann S, 2004, PLOS BIOL, V2, P85, DOI 10.1371/journal.pbio.0020009; Bernstein KA, 2007, MOL BIOL CELL, V18, P953, DOI 10.1091/mbc.E06-06-0512; Browne MW, 2007, J MATH STAT PSYCHOL, V25, P115; Dahl T, 2006, COMPUT STAT DATA AN, V50, P3086, DOI 10.1016/j.csda.2005.06.016; Devarajan K, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000029; Friedland S, 2005, SIAM J MATRIX ANAL A, V27, P434, DOI 10.1137/S0895479804439791; Hageman JA, 2008, METABOLOMICS, V4, P141, DOI 10.1007/s11306-008-0105-7; Hennig C, 2010, PACKAGE FPC; Holter NS, 2000, P NATL ACAD SCI USA, V97, P8409, DOI 10.1073/pnas.150242097; Howland P, 2004, IEEE T PATTERN ANAL, V26, P995, DOI 10.1109/TPAMI.2004.46; Ihmels J, 2004, BIOINFORMATICS, V20, P1993, DOI 10.1093/bioinformatics/bth166; Jolliffe I., 2005, SPRINGERLINK PRINCIP, DOI 10.1007/b98835; Kiers HAL, 2000, J CHEMOMETR, V14, P105, DOI 10.1002/1099-128X(200005/06)14:3<105::AID-CEM582>3.0.CO;2-I; Kiers HAL, 1997, PSYCHOMETRIKA, V62, P251, DOI 10.1007/BF02295279; KIERS HAL, 1994, BRIT J MATH STAT PSY, V47, P109, DOI 10.1111/j.2044-8317.1994.tb01027.x; Lemmens K, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r37; Lofstedt T, 2011, J CHEMOMETR, V25, P441, DOI 10.1002/cem.1388; Lorenzo-Seva U., 2006, METHODOLOGY, V2, P57, DOI [10.1027/1614-2241.2.2.57, DOI 10.1027/1614-2241.2.2.57]; Mage I, 2008, J CHEMOMETR, V22, P443, DOI 10.1002/cem.1169; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; PAIGE CC, 1981, SIAM J NUMER ANAL, V18, P398, DOI 10.1137/0718026; Ponnapalli SP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028072; Schouteden M, 2009, IFCS 2009 11 C INT F; Smilde AK, 2005, ANAL CHEM, V77, P6729, DOI 10.1021/ac051080y; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tamayo P, 2007, P NATL ACAD SCI USA, V104, P5959, DOI 10.1073/pnas.0701068104; Tanay A, 2005, P NATL ACAD SCI USA, V102, P7203, DOI 10.1073/pnas.0502521102; Timmerman ME, 2003, PSYCHOMETRIKA, V68, P105, DOI 10.1007/BF02296656; van den Berg RA, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-142; van der Werf MJ, 2007, ANAL BIOCHEM, V370, P17, DOI 10.1016/j.ab.2007.07.022; Van Deun K, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-246; VANLOAN CF, 1976, SIAM J NUMER ANAL, V13, P76, DOI 10.1137/0713009; Westerhuis JA, 2007, J CHEMOMETR, V21, P474, DOI 10.1002/cem.1072	36	28	28	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e37840	10.1371/journal.pone.0037840	http://dx.doi.org/10.1371/journal.pone.0037840			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693578	Green Published, gold, Green Submitted			2022-12-27	WOS:000305338500059
J	Wan, OW; Chung, KKK				Wan, Oi Wan; Chung, Kenny K. K.			The Role of Alpha-Synuclein Oligomerization and Aggregation in Cellular and Animal Models of Parkinson's Disease	PLOS ONE			English	Article							INCLUSION FORMATION; ALZHEIMERS-DISEASE; IN-VITRO; PROTEIN; MUTATION; FIBRILLIZATION; MUTANT; NACP; E46K	alpha-synuclein (alpha-syn) is a synaptic protein in which four mutations (A53T, A30P, E46K and gene triplication) have been found to cause an autosomal dominant form of Parkinson's disease (PD). It is also the major component of intraneuronal protein aggregates, designated as Lewy bodies (LBs), a prominent pathological hallmark of PD. How alpha-syn contributes to LB formation and PD is still not well-understood. It has been proposed that aggregation of alpha-syn contributes to the formation of LBs, which then leads to neurodegeneration in PD. However, studies have also suggested that aggregates formation is a protective mechanism against more toxic alpha-syn oligomers. In this study, we have generated alpha-syn mutants that have increased propensity to form aggregates by attaching a CL1 peptide to the C-terminal of alpha-syn. Data from our cellular study suggest an inverse correlation between cell viability and the amount of alpha-syn aggregates formed in the cells. In addition, our animal model of PD indicates that attachment of CL1 to alpha-syn enhanced its toxicity to dopaminergic neurons in an age-dependent manner and induced the formation of Lewy body-like alpha-syn aggregates in the substantia nigra. These results provide new insights into how alpha-syn-induced toxicity is related to its aggregation.	[Wan, Oi Wan; Chung, Kenny K. K.] Hong Kong Univ Sci & Technol, Div Life Sci, State Key Lab Mol Neurosci, Hong Kong, Hong Kong, Peoples R China	Hong Kong University of Science & Technology	Wan, OW (corresponding author), Hong Kong Univ Sci & Technol, Div Life Sci, State Key Lab Mol Neurosci, Hong Kong, Hong Kong, Peoples R China.	bckchung@ust.hk			Research Grants Council of Hong Kong [HIA05/06.SC04, AoE/B-15/01, SBI09/10.SC01]	Research Grants Council of Hong Kong(Hong Kong Research Grants Council)	This work is supported by Research Grants Council of Hong Kong (HIA05/06.SC04, AoE/B-15/01, SBI09/10.SC01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartels T, 2011, NATURE, V477, P107, DOI 10.1038/nature10324; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Bodner RA, 2006, P NATL ACAD SCI USA, V103, P4246, DOI 10.1073/pnas.0511256103; Breydo L, 2011, BIOCH BIOPHYS ACTA; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Chen L, 2005, NAT NEUROSCI, V8, P657, DOI 10.1038/nn1443; Chen L, 2009, J CLIN INVEST, V119, P3257, DOI 10.1172/JCI39088; Conway KA, 2000, BIOCHEMISTRY-US, V39, P2552, DOI 10.1021/bi991447r; Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571; Conway KA, 2000, ANN NY ACAD SCI, V920, P42; Dawson TM, 2010, NEURON, V66, P646, DOI 10.1016/j.neuron.2010.04.034; Devine MJ, 2011, MOV DISORD; FAUVET B, 2012, J BIOL CHEM; Fredenburg RA, 2007, BIOCHEMISTRY-US, V46, P7107, DOI 10.1021/bi7000246; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; Galvin J E, 1999, Adv Neurol, V80, P313; Gao HM, 2008, J NEUROSCI, V28, P7687, DOI 10.1523/JNEUROSCI.0143-07.2008; Giasson BI, 2000, SCIENCE, V290, P985, DOI 10.1126/science.290.5493.985; Giasson BI, 1999, J BIOL CHEM, V274, P7619, DOI 10.1074/jbc.274.12.7619; Giasson BI, 2003, SCIENCE, V300, P636, DOI 10.1126/science.1082324; Hong DP, 2009, BBA-PROTEINS PROTEOM, V1794, P282, DOI 10.1016/j.bbapap.2008.09.026; Hoyer W, 2002, J MOL BIOL, V322, P383, DOI 10.1016/S0022-2836(02)00775-1; Hoyer WG, 2004, J MOL BIOL, V340, P127, DOI 10.1016/j.jmb.2004.04.051; Jin WY, 2006, J NEUROSCI, V26, P2380, DOI 10.1523/JNEUROSCI.3503-05.2006; Kahle PJ, 2002, EMBO REP, V3, P583, DOI 10.1093/embo-reports/kvf109; Kim J, 1997, MOL CELLS, V7, P78; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Li J, 2001, BIOCHEMISTRY-US, V40, P11604, DOI 10.1021/bi010616g; Link CD, 2006, J BIOL CHEM, V281, P1808, DOI 10.1074/jbc.M505581200; Lou HY, 2010, J BIOL CHEM, V285, P17648, DOI 10.1074/jbc.M110.100867; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; Narhi L, 1999, J BIOL CHEM, V274, P9843, DOI 10.1074/jbc.274.14.9843; Outeiro TF, 2007, SCIENCE, V317, P516, DOI 10.1126/science.1143780; POLLANEN MS, 1993, J NEUROPATH EXP NEUR, V52, P183, DOI 10.1097/00005072-199305000-00001; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Savitt JM, 2006, J CLIN INVEST, V116, P1744, DOI 10.1172/JCI29178; Sharon R, 2003, NEURON, V37, P583, DOI 10.1016/S0896-6273(03)00024-2; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Thomas B, 2007, HUM MOL GENET, V16, pR183, DOI 10.1093/hmg/ddm159; Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37; Wang J, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.05.004; Waxman EA, 2009, BBA-MOL BASIS DIS, V1792, P616, DOI 10.1016/j.bbadis.2008.09.013; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; Winner B, 2011, P NATL ACAD SCI USA, V108, P4194, DOI 10.1073/pnas.1100976108; Xie WL, 2010, BBA-MOL BASIS DIS, V1802, P935, DOI 10.1016/j.bbadis.2010.07.014; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795	48	64	66	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2012	7	6							e38545	10.1371/journal.pone.0038545	http://dx.doi.org/10.1371/journal.pone.0038545			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UJ	22701661	Green Published, Green Submitted, gold			2022-12-27	WOS:000305340000030
J	White, JR; Patel, J; Ottesen, A; Arce, G; Blackwelder, P; Lopez, JV				White, James R.; Patel, Jignasa; Ottesen, Andrea; Arce, Gabriela; Blackwelder, Patricia; Lopez, Jose V.			Pyrosequencing of Bacterial Symbionts within Axinella corrugata Sponges: Diversity and Seasonal Variability	PLOS ONE			English	Article							SULFUR-OXIDIZING BACTERIA; MARINE SPONGE; DEEP-SEA; EMENDED DESCRIPTION; GEN. NOV.; CELL; ECTOTHIORHODOSPIRACEAE; AMPLIFICATION; PORIBACTERIA; DEMOSPONGIAE	Background: Marine sponge species are of significant interest to many scientific fields including marine ecology, conservation biology, genetics, host-microbe symbiosis and pharmacology. One of the most intriguing aspects of the sponge "holobiont" system is the unique physiology, interaction with microbes from the marine environment and the development of a complex commensal microbial community. However, intraspecific variability and temporal stability of sponge-associated bacterial symbionts remain relatively unknown. Methodology/Principal Findings: We have characterized the bacterial symbiont community biodiversity of seven different individuals of the Caribbean reef sponge Axinella corrugata, from two different Florida reef locations during variable seasons using multiplex 454 pyrosequencing of 16 S rRNA amplicons. Over 265,512 high-quality 16 S rRNA sequences were generated and analyzed. Utilizing versatile bioinformatics methods and analytical software such as the QIIME and CloVR packages, we have identified 9,444 distinct bacterial operational taxonomic units (OTUs). Approximately 65,550 rRNA sequences (24%) could not be matched to bacteria at the class level, and may therefore represent novel taxa. Differentially abundant classes between seasonal Axinella communities included Gammaproteobacteria, Flavobacteria, Alphaproteo-bacteria, Cyanobacteria, Acidobacter and Nitrospira. Comparisons with a proximal outgroup sponge species (Amphimedon compressa), and the growing sponge symbiont literature, indicate that this study has identified approximately 330 A. corrugata-specific symbiotic OTUs, many of which are related to the sulfur-oxidizing Ectothiorhodospiraceae. This family appeared exclusively within A. corrugata, comprising >34.5% of all sequenced amplicons. Other A. corrugata symbionts such as Deltaproteobacteria, Bdellovibrio, and Thiocystis among many others are described. Conclusions/Significance: Slight shifts in several bacterial taxa were observed between communities sampled during spring and fall seasons. New 16 S rDNA sequences and concomitant identifications greatly expand the microbial community profile for this model reef sponge, and will likely be useful as a baseline for any future comparisons regarding sponge microbial community dynamics.	[White, James R.; Patel, Jignasa; Blackwelder, Patricia; Lopez, Jose V.] Nova SE Univ, Oceanog Ctr, Dania, FL USA; [Ottesen, Andrea; Arce, Gabriela] US FDA, Off Regulatory Sci, Div Microbiol, College Pk, MD USA; [Blackwelder, Patricia] Univ Miami, Ctr Adv Microscopy & Marine Geol & Geophys, Rosenstiel Sch Marine & Atmospher Sci, Miami, FL USA	Nova Southeastern University; US Food & Drug Administration (FDA); University of Miami	White, JR (corresponding author), Nova SE Univ, Oceanog Ctr, Dania, FL USA.	joslo@nova.edu	Lopez, Jose V/F-8809-2011	Lopez, Jose V/0000-0002-1637-4125; Blackwelder, Patricia/0000-0003-0989-2976	National Science Foundation [DEB-0829271]; NSU President's Faculty Research Development Grant; Direct For Biological Sciences [0829791] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); NSU President's Faculty Research Development Grant; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	PI Lopez is funded through National Science Foundation grant DEB-0829271, and an internal NSU President's Faculty Research Development Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelzaher AM, 2010, APPL ENVIRON MICROB, V76, P724, DOI 10.1128/AEM.02127-09; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Alvarez B, 1998, SMITHSONIAN CONTRIBU, P598; Andrade P, 1999, TETRAHEDRON LETT, V40, P4775, DOI 10.1016/S0040-4039(99)00881-3; Angiuoli SV, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-356; [Anonymous], 2002, HIST PHIL LIFE SCI; Banks Kenneth W., 2008, V1, P175, DOI 10.1007/978-1-4020-6847-8_5; Benjamini Y., 1995, J R STAT SOC B, V57, P289, DOI DOI 10.1111/J.2517-6161.1995.TB02031.X; Bernardet JF, 2002, INT J SYST EVOL MICR, V52, P1049, DOI 10.1099/00207713-52-3-1049; BRAEKMAN JC, 1989, PURE APPL CHEM, V61, P509, DOI 10.1351/pac198961030509; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cassler M, 2008, MICROB ECOL, V55, P384, DOI 10.1007/s00248-007-9283-5; Chen VB, 2009, PROTEIN SCI, V18, P2403, DOI 10.1002/pro.250; Cho JC, 2003, INT J SYST EVOL MICR, V53, P1031, DOI 10.1099/ijs.0.02566-0; Diaz MC, 2004, B MUS I BIOL U GEN, V68, P279; Duckworth AR, 2003, MAR BIOTECHNOL, V5, P519, DOI 10.1007/s10126-002-0111-0; Fieseler L, 2004, APPL ENVIRON MICROB, V70, P3724, DOI 10.1128/aem.70.6.3724-3732.2004; Foti M, 2006, FEMS MICROBIOL ECOL, V56, P95, DOI 10.1111/j.1574-6941.2006.00068.x; Galkiewicz JP, 2008, APPL ENVIRON MICROB, V74, P7828, DOI 10.1128/AEM.01303-08; Hazen TC, 2010, SCIENCE, V330, P204, DOI 10.1126/science.1195979; Hill M, 2006, MAR BIOL, V148, P1221, DOI 10.1007/s00227-005-0164-5; Hill R, 2004, MICROBIAL DIVERSITY; Hoffmann F, 2009, ENVIRON MICROBIOL, V11, P2228, DOI 10.1111/j.1462-2920.2009.01944.x; Hooper John N. A., 1993, Invertebrate Taxonomy, V7, P1395, DOI 10.1071/IT9931395; IMHOFF JF, 1984, INT J SYST BACTERIOL, V34, P338, DOI 10.1099/00207713-34-3-338; Imhoff JF, 1996, ARCH MICROBIOL, V165, P106, DOI 10.1007/s002030050304; Knowlton N, 2001, P NATL ACAD SCI USA, V98, P5419, DOI 10.1073/pnas.091092998; Lafi FF, 2009, APPL ENVIRON MICROB, V75, P5695, DOI 10.1128/AEM.00035-09; Lopez JV, 2002, J HERED, V93, P27, DOI 10.1093/jhered/93.1.27; Lopez JV, 1999, MEMOIRS QUEENSLAND M, P44; Lopez JV, 2010, P 11 INT COR REEF S, P1362; Lu Z, 2011, ISME J; Messing CG, 2010, TAXON PAGE AXINELLA; Middelburg JJ, 1996, GLOBAL BIOGEOCHEM CY, V10, P661, DOI 10.1029/96GB02562; Mohamed NM, 2008, ENVIRON MICROBIOL, V10, P2910, DOI 10.1111/j.1462-2920.2008.01704.x; Montoya JM, 2006, NATURE, V442, P259, DOI 10.1038/nature04927; Moran NA, 2007, P NATL ACAD SCI USA, V104, P8627, DOI 10.1073/pnas.0611659104; Munro MHG, 1994, SEABED SICKBED WHAT; Negandhi K, 2010, SYMBIOSIS, V51, P117, DOI 10.1007/s13199-010-0059-1; Pile AJ, 1996, MAR ECOL PROG SER, V141, P95, DOI 10.3354/meps141095; Pomponi S, 1997, DEV TECHNIQUES IN VI; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; REISWIG HM, 1971, MAR BIOL, V9, P38, DOI 10.1007/BF00348816; Ruetzler K., 2004, BOLL MUS IST BIOL UN, V68, P85; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Sambrook J., 2001, MOL CLONING LAB MANU; SANTAVY DL, 1990, APPL ENVIRON MICROB, V56, P1750, DOI 10.1128/AEM.56.6.1750-1762.1990; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schmitt S, 2011, ISME J; Sfanos K, 2005, SYST APPL MICROBIOL, V28, P242, DOI 10.1016/j.syapm.2004.12.002; Simpson T., 1984, CELL BIOL SPONGES; Sipkema D, 2005, BIOTECHNOL BIOENG, V90, P201, DOI 10.1002/bit.20404; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Sorokin DY, 2005, FEMS MICROBIOL REV, V29, P685, DOI 10.1016/j.femsre.2004.10.005; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Taylor MW, 2007, MICROBIOL MOL BIOL R, V71, P295, DOI 10.1128/MMBR.00040-06; Tsuihij H, 2006, J BIOSCI BIOENG, V101, P263, DOI 10.1263/jbb.101.263; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; van Wilderen LJGW, 2006, P NATL ACAD SCI USA, V103, P15050, DOI 10.1073/pnas.0603476103; VOGEL S, 1977, P NATL ACAD SCI USA, V74, P2069, DOI 10.1073/pnas.74.5.2069; Walters WA, 2011, BIOINFORMATICS, V27, P1159, DOI 10.1093/bioinformatics/btr087; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Webster NS, 2010, ENVIRON MICROBIOL, V12, P2070, DOI 10.1111/j.1462-2920.2009.02065.x; Webster NS, 2009, ISME J, V3, P1, DOI 10.1038/ismej.2008.102; Webster NS, 2011, ENV MICROBIOLOGY; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352; WILKINSON CR, 1981, MICROBIAL ECOL, V7, P13, DOI 10.1007/BF02010474; Willoughby R, 2000, IN VITRO CELL DEV-AN, V36, P194; Wilson DM, 1999, J CHEM ECOL, V25, P2811, DOI 10.1023/A:1020811810223; WRIGHT AE, 1991, J NAT PROD, V54, P1684, DOI 10.1021/np50078a034; Ying JY, 2007, INT J SYST EVOL MICR, V57, P1711, DOI 10.1099/ijs.0.64825-0	72	61	61	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2012	7	6							e38204	10.1371/journal.pone.0038204	http://dx.doi.org/10.1371/journal.pone.0038204			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UJ	22701613	Green Published, gold			2022-12-27	WOS:000305340000013
J	Fung, ICH; Antia, R; Handel, A				Fung, Isaac Chun-Hai; Antia, Rustom; Handel, Andreas			How to Minimize the Attack Rate during Multiple Influenza Outbreaks in a Heterogeneous Population	PLOS ONE			English	Article							PANDEMIC INFLUENZA; SCHOOL CLOSURE; ANTIVIRAL RESISTANCE; DRUG-RESISTANCE; TRANSMISSION; STRATEGIES; SPREAD; INFECTION; VIRUS; MODEL	Background: If repeated interventions against multiple outbreaks are not feasible, there is an optimal level of control during the first outbreak. Any control measures above that optimal level will lead to an outcome that may be as sub-optimal as that achieved by an intervention that is too weak. We studied this scenario in more detail. Method: An age-stratified ordinary-differential-equation model was constructed to study infectious disease outbreaks and control in a population made up of two groups, adults and children. The model was parameterized using influenza as an example. This model was used to simulate two consecutive outbreaks of the same infectious disease, with an intervention applied only during the first outbreak, and to study how cumulative attack rates were influenced by population composition, strength of inter-group transmission, and different ways of triggering and implementing the interventions. We assumed that recovered individuals are fully immune and the intervention does not confer immunity. Results/Conclusion: The optimal intervention depended on coupling between the two population sub-groups, the length, strength and timing of the intervention, and the population composition. Population heterogeneity affected intervention strategies only for very low cross-transmission between groups. At more realistic values, coupling between the groups led to synchronization of outbreaks and therefore intervention strategies that were optimal in reducing the attack rates for each subgroup and the population overall coincided. For a sustained intervention of low efficacy, early intervention was found to be best, while at high efficacies, a delayed start was better. For short interventions, a delayed start was always advantageous, independent of the intervention efficacy. For most scenarios, starting the intervention after a certain cumulative proportion of children were infected seemed more robust in achieving close to optimal outcomes compared to a strategy that used a specified duration after an outbreak's beginning as the trigger.	[Fung, Isaac Chun-Hai; Handel, Andreas] Univ Georgia, Dept Epidemiol & Biostat, Coll Publ Hlth, Athens, GA 30602 USA; [Antia, Rustom] Emory Univ, Dept Biol, Atlanta, GA 30322 USA	University System of Georgia; University of Georgia; Emory University	Fung, ICH (corresponding author), Univ Georgia, Dept Epidemiol & Biostat, Coll Publ Hlth, Athens, GA 30602 USA.	ichfung@gmail.com	Handel, Andreas/F-6056-2012	Handel, Andreas/0000-0002-4622-1146; Fung, Isaac Chun-Hai/0000-0001-5496-2529	National Institute of General Medical Sciences MIDAS [U01-GM070749]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM070749] Funding Source: NIH RePORTER	National Institute of General Medical Sciences MIDAS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Rustom Antia was partially supported by the National Institute of General Medical Sciences MIDAS grant U01-GM070749. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Alexander ME, 2007, P R SOC B, V274, P1675, DOI 10.1098/rspb.2007.0422; Alexander ME, 2009, J THEOR BIOL, V259, P253, DOI 10.1016/j.jtbi.2009.03.029; ANDERSON R M, 1991; Boelle PY, 2009, EUROSURVEILLANCE, V14, P10; Brown ST, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-353; Camacho A, 2011, P BIOL SCI; Carrat F, 2008, AM J EPIDEMIOL, V167, P775, DOI 10.1093/aje/kwm375; Cauchemez S, 2008, NATURE, V452, P750, DOI 10.1038/nature06732; Cauchemez S, 2009, LANCET INFECT DIS, V9, P473, DOI 10.1016/S1473-3099(09)70176-8; Coburn BJ, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-30; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Ferguson NM, 2003, J ANTIMICROB CHEMOTH, V51, P977, DOI 10.1093/jac/dkg136; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; FRANK AL, 1981, J INFECT DIS, V144, P433, DOI 10.1093/infdis/144.5.433; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; Hahne S., 2009, EUROSURVEILLANCE, V14; Halloran ME, 2008, P NATL ACAD SCI USA, V105, P4639, DOI 10.1073/pnas.0706849105; Handel A, 2007, P ROY SOC B-BIOL SCI, V274, P833, DOI 10.1098/rspb.2006.0015; Handel A, 2009, J THEOR BIOL, V256, P117, DOI 10.1016/j.jtbi.2008.09.021; Hansen Elsa, 2010, Can J Infect Dis Med Microbiol, V21, pe28; Hollingsworth TD, 2006, NAT MED, V12, P497, DOI 10.1038/nm0506-497; Horby P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016965; House T, 2009, PLOS CURR, V1, DOI DOI 10.1371/CURRENTS.RRN1119; House T, 2011, P BIOL SCI; Keeling MJ, 2005, J R SOC INTERFACE, V2, P295, DOI 10.1098/rsif.2005.0051; Keeling MJ., 2008, MODELING INFECT DIS, DOI DOI 10.1515/9781400841035; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; Lee BY, 2010, J PUBLIC HEALTH MAN, V16, P252, DOI 10.1097/PHH.0b013e3181ce594e; Lipsitch M, 2006, SCIENCE, V312, P845; Lipsitch M, 2007, PLOS MED, V4, P111, DOI 10.1371/journal.pmed.0040015; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; Mathews JD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001220; Mills CE, 2006, PLOS MED, V3, P769, DOI 10.1371/journal.pmed.0030135; Moghadas SM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001839; Moghadas SM, 2008, P ROY SOC B-BIOL SCI, V275, P1163, DOI 10.1098/rspb.2008.0016; Munayco CV, 2009, EUROSURVEILLANCE, V14, P6; Nishiura H, 2009, EUROSURVEILLANCE, V14; Nishiura H, 2009, NEW ZEAL MED J, V122, P73; Perez CM, 2010, EMERG INFECT DIS, V16, P156, DOI 10.3201/eid1601.091420; Pourbohloul B, 2009, INFLUENZA OTHER RESP, V3, P215, DOI 10.1111/j.1750-2659.2009.00100.x; Read JM, 2008, J R SOC INTERFACE, V5, P1001, DOI 10.1098/rsif.2008.0013; Sadique MZ, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-135; Wessel L, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S1-S2; White LF, 2009, INFLUENZA OTHER RESP, V3, P267, DOI 10.1111/j.1750-2659.2009.00106.x; Wu JT, 2010, EMERG INFECT DIS, V16, P538, DOI 10.3201/eid1603.091216; Wu JT, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000085; Yang Y, 2009, SCIENCE, V326, P729, DOI 10.1126/science.1177373	48	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2012	7	6							e36573	10.1371/journal.pone.0036573	http://dx.doi.org/10.1371/journal.pone.0036573			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TU	22701558	Green Submitted, Green Published, gold			2022-12-27	WOS:000305337600005
J	Grommes, J; Vijayan, S; Drechsler, M; Hartwig, H; Morgelin, M; Dembinski, R; Jacobs, M; Koeppel, TA; Binnebosel, M; Weber, C; Soehnlein, O				Grommes, Jochen; Vijayan, Santosh; Drechsler, Maik; Hartwig, Helene; Moergelin, Matthias; Dembinski, Rolf; Jacobs, Michael; Koeppel, Thomas Andreas; Binneboesel, Marcel; Weber, Christian; Soehnlein, Oliver			Simvastatin Reduces Endotoxin-Induced Acute Lung Injury by Decreasing Neutrophil Recruitment and Radical Formation	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; PULMONARY INFLAMMATION; NADPH OXIDASE; ADHESION; REDUCTASE; STATINS; PROTEIN; INHIBITION; MONOCYTES; BARRIER	Introduction: Treatment of acute lung injury (ALI) remains an unsolved problem in intensive care medicine. As simvastatin exerts protective effects in inflammatory diseases we explored its effects on development of ALI and due to the importance of neutrophils in ALI also on neutrophil effector functions. Methods: C57Bl/6 mice were exposed to aerosolized LPS (500 mg/ml) for 30 min. The count of alveolar, interstitial, and intravasal neutrophils were assessed 4 h later by flow cytometry. Lung permeability changes were assessed by FITC-dextran clearance and albumin content in the BAL fluid. In vitro, we analyzed the effect of simvastatin on neutrophil adhesion, degranulation, apoptosis, and formation of reactive oxygen species. To monitor effects of simvastatin on bacterial clearance we performed phagocytosis and bacterial killing studies in vitro as well as sepsis experiments in mice. Results: Simvastatin treatment before and after onset of ALI reduces neutrophil influx into the lung as well as lung permeability indicating the protective role of simvastatin in ALI. Moreover, simvastatin reduces the formation of ROS species and adhesion of neutrophils without affecting apoptosis, bacterial phagocytosis and bacterial clearance. Conclusion: Simvastatin reduces recruitment and activation of neutrophils hereby protecting from LPS-induced ALI. Our results imply a potential role for statins in the management of ALI.	[Grommes, Jochen; Vijayan, Santosh; Weber, Christian; Soehnlein, Oliver] Rhein Westfal TH Aachen, IMCAR, D-52062 Aachen, Germany; [Grommes, Jochen; Jacobs, Michael; Koeppel, Thomas Andreas] Rhein Westfal TH Aachen, European Vasc Ctr Aachen Maastricht, D-52062 Aachen, Germany; [Grommes, Jochen; Jacobs, Michael; Koeppel, Thomas Andreas] Maastricht Univ, Med Ctr, Maastricht, Netherlands; [Hartwig, Helene; Weber, Christian; Soehnlein, Oliver] Univ Munich, Inst Cardiovasc Prevent, Munich, Germany; [Moergelin, Matthias] Lund Univ, Dept Clin Sci, Div Infect Med, Lund, Sweden; [Dembinski, Rolf] Rhein Westfal TH Aachen, Dept Intens Care Med, D-52062 Aachen, Germany; [Binneboesel, Marcel] Rhein Westfal TH Aachen, Dept Gen Visceral & Transplantat Surg, D-52062 Aachen, Germany; [Weber, Christian; Soehnlein, Oliver] Maastricht Univ, Cardiovasc Res Inst Maastricht, Maastricht, Netherlands	RWTH Aachen University; Maastricht University; RWTH Aachen University; Maastricht University; University of Munich; Lund University; RWTH Aachen University; RWTH Aachen University; Maastricht University	Grommes, J (corresponding author), Rhein Westfal TH Aachen, IMCAR, D-52062 Aachen, Germany.	jgrommes@ukaachen.de; oliver.soehnlein@med.uni-muenchen.de	Dembinski, Rolf/Q-3060-2019; Weber, Christian/AAW-2153-2020; Drechsler, Maik/C-3829-2008	Weber, Christian/0000-0003-4610-8714; Grommes, Jochen/0000-0002-6419-6802	Deutsche Forschungsgemeinschaft [SO876/3-1, FOR809 TP2, TP9]; German Heart Foundation; Else-Kroner-Fresenius Foundation; B. Braun Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Heart Foundation; Else-Kroner-Fresenius Foundation; B. Braun Foundation	This study was supported by the Deutsche Forschungsgemeinschaft (SO876/3-1, FOR809 TP2, TP9), the German Heart Foundation, the Else-Kroner-Fresenius Foundation, and the B. Braun Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auten RL, 2002, AM J RESP CELL MOL, V26, P391, DOI 10.1165/ajrcmb.26.4.4708; Auten RL, 2001, J PHARMACOL EXP THER, V299, P90; Bdeir K, 2010, AM J RESP CRIT CARE, V181, P935, DOI 10.1164/rccm.200907-1128OC; Belperio JA, 2002, J CLIN INVEST, V110, P1703, DOI 10.1172/JCI200215849; Carnesecchi S, 2009, AM J RESP CRIT CARE, V180, P972, DOI 10.1164/rccm.200902-0296OC; Chen WG, 2008, AM J PHYSIOL-LUNG C, V295, pL575, DOI 10.1152/ajplung.00428.2007; Chiarugi P, 2003, J CELL BIOL, V161, P933, DOI 10.1083/jcb.200211118; Chow OA, 2010, CELL HOST MICROBE, V8, P445, DOI 10.1016/j.chom.2010.10.005; Craig TR, 2010, AM J RESP CRIT CARE; DiStasi MR, 2009, TRENDS IMMUNOL, V30, P539, DOI 10.1016/j.it.2009.07.012; Fessler MB, 2005, AM J RESP CRIT CARE, V171, P606, DOI 10.1164/rccm.200406-729OC; Gautam N, 2001, NAT MED, V7, P1123, DOI 10.1038/nm1001-1123; Grommes J, 2012, EUR RESP J; Grommes J, 2012, AM J RESP CRIT CARE; Grommes J, 2011, MOL MED, V17, P293, DOI 10.2119/molmed.2010.00138; Herwald H, 2004, CELL, V116, P367, DOI 10.1016/S0092-8674(04)00057-1; Jacobson JR, 2005, AM J PHYSIOL-LUNG C, V288, pL1026, DOI 10.1152/ajplung.00354.2004; Jacobson JR, 2004, AM J RESP CELL MOL, V30, P662, DOI 10.1165/rcmb.2003-0267OC; Kopterides P, 2009, CLIN MICROBIOL INFEC, V15, P325, DOI 10.1111/j.1469-0691.2009.02750.x; Kubo H, 1996, J CLIN INVEST, V97, P2680, DOI 10.1172/JCI118718; Kureishi Y, 2000, NAT MED, V6, P1004, DOI 10.1038/79510; Laudanna C, 1996, SCIENCE, V271, P981, DOI 10.1126/science.271.5251.981; LAUFE MD, 1986, AM J MED, V80, P1022, DOI 10.1016/0002-9343(86)90659-5; Looney MR, 2006, J CLIN INVEST, V116, P1615, DOI 10.1172/JCI27238; Maher BM, 2009, J LEUKOCYTE BIOL, V85, P186, DOI 10.1189/jlb.0608382; MARTIN MA, 1992, CLIN INFECT DIS, V14, P1213, DOI 10.1093/clinids/14.6.1213; Massberg S, 2010, NAT MED; Matute-Bello G, 2008, AM J PHYSIOL-LUNG C, V295, pL379, DOI 10.1152/ajplung.00010.2008; Matute-Bello G, 2011, AM J RESP CELL MOL, V44, P725, DOI 10.1165/rcmb.2009-0210ST; Moreland JG, 2002, AM J RESP CELL MOL, V27, P474, DOI 10.1165/rcmb.4694; OGNIBENE FP, 1986, NEW ENGL J MED, V315, P547, DOI 10.1056/NEJM198608283150904; Pham CTN, 2006, NAT REV IMMUNOL, V6, P541, DOI 10.1038/nri1841; Reutershan J, 2005, AM J PHYSIOL-LUNG C, V289, pL807, DOI 10.1152/ajplung.00477.2004; Shyamsundar M, 2009, AM J RESP CRIT CARE, V179, P1107, DOI 10.1164/rccm.200810-1584OC; Soehnlein O, 2008, EUR RESPIR J, V32, P405, DOI 10.1183/09031936.00173207; Soehnlein O, 2008, CLIN EXP IMMUNOL, V151, P139, DOI 10.1111/j.1365-2249.2007.03532.x; Soehnlein O, 2008, J CLIN INVEST, V118, P3491, DOI 10.1172/JCI35740; Soehnlein O, 2008, BLOOD, V112, P1461, DOI 10.1182/blood-2008-02-139634; Soehnlein O, 2009, J MOL MED-JMM, V87, P1157, DOI 10.1007/s00109-009-0508-6; Soehnlein O, 2009, TRENDS IMMUNOL, V30, P546, DOI 10.1016/j.it.2009.06.006; Terblanche M, 2007, LANCET INFECT DIS, V7, P358, DOI 10.1016/S1473-3099(07)70111-1; Walter T, 2010, IN VIVO, V24, P189; Wang CY, 2008, TRENDS MOL MED, V14, P37, DOI 10.1016/j.molmed.2007.11.004; WANG XZ, 1994, AM J RESP CRIT CARE, V150, P1449, DOI 10.1164/ajrccm.150.5.7952574; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Weber C, 1997, J AM COLL CARDIOL, V30, P1212, DOI 10.1016/S0735-1097(97)00324-0; Zeng LX, 2005, FASEB J, V19, P1845, DOI 10.1096/fj.05-4240fje; Zhang S, 2011, AM J PHYSL LUNG CELL	48	64	66	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2012	7	6							e38917	10.1371/journal.pone.0038917	http://dx.doi.org/10.1371/journal.pone.0038917			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TU	22701728	Green Submitted, Green Published, gold			2022-12-27	WOS:000305337600055
J	Kurushima, J; Kuwae, A; Abe, A				Kurushima, Jun; Kuwae, Asaomi; Abe, Akio			The Type III Secreted Protein BspR Regulates the Virulence Genes in Bordetella bronchiseptica	PLOS ONE			English	Article							ENTEROPATHOGENIC ESCHERICHIA-COLI; PSEUDOMONAS-AERUGINOSA; SIGNAL-TRANSDUCTION; SIGMA-FACTOR; PERTUSSIS; SYSTEM; EXPRESSION; 2-COMPONENT; PERSPECTIVE; STARVATION	Bordetella bronchiseptica is closely related with B. pertussis and B. parapertussis, the causative agents of whooping cough. These pathogenic species share a number of virulence genes, including the gene locus for the type III secretion system (T3SS) that delivers effector proteins. To identify unknown type III effectors in Bordetella, secreted proteins in the bacterial culture supernatants of wild-type B. bronchiseptica and an isogenic T3SS-deficient mutant were compared with iTRAQ-based, quantitative proteomic analysis method. BB1639, annotated as a hypothetical protein, was identified as a novel type III secreted protein and was designated BspR (Bordetella secreted protein regulator). The virulence of a BspR mutant (Delta bspR) in B. bronchiseptica was significantly attenuated in a mouse infection model. BspR was also highly conserved in B. pertussis and B. parapertussis, suggesting that BspR is an essential virulence factor in these three Bordetella species. Interestingly, the BspR-deficient strain showed hyper-secretion of T3SS-related proteins. Furthermore, T3SS-dependent host cell cytotoxicity and hemolytic activity were also enhanced in the absence of BspR. By contrast, the expression of filamentous hemagglutinin, pertactin, and adenylate cyclase toxin was completely abolished in the BspR-deficient strain. Finally, we demonstrated that BspR is involved in the iron-responsive regulation of T3SS. Thus, Bordetella virulence factors are coordinately but inversely controlled by BspR, which functions as a regulator in response to iron starvation.	[Kurushima, Jun; Kuwae, Asaomi; Abe, Akio] Kitasato Univ, Grad Sch Infect Control Sci, Lab Bacterial Infect, Tokyo, Japan	Kitasato University	Kurushima, J (corresponding author), Kitasato Univ, Grad Sch Infect Control Sci, Lab Bacterial Infect, Tokyo, Japan.	abe@lisci.kitasato-u.ac.jp	Abe, Akio/AAQ-2464-2020	Kurushima, Jun/0000-0002-8573-6169	Ministry of Education, Culture, Sports, Science, and Technology of Japan [21390133, 23790484, 21022045]; Japan Society for the Promotion of Science (JSPS) [23-7356]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by the Ministry of Education, Culture, Sports, Science, and Technology of Japan through Grants-in-Aid for Scientific Research (B, 21390133; C, 23790484) and for Scientific Research on Priority Areas (21022045) and by Japan Society for the Promotion of Science (JSPS) Fellows (23-7356). JK is a Research Fellow of the JSPS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe A, 2005, CR BIOL, V328, P413, DOI 10.1016/j.crvi.2005.02.008; Abe A, 2008, MICROBIOL IMMUNOL, V52, P128, DOI 10.1111/j.1348-0421.2008.00028.x; AKERLEY BJ, 1992, J BACTERIOL, V174, P980, DOI 10.1128/jb.174.3.980-990.1992; Boucher PE, 1997, J BACTERIOL, V179, P1755, DOI 10.1128/jb.179.5.1755-1763.1997; Brickman TJ, 2011, J BACTERIOL, V193, P4798, DOI 10.1128/JB.05136-11; Brickman T, 2009, BIOMETALS, V22, P33, DOI 10.1007/s10534-008-9189-9; Campbell EA, 2008, CURR OPIN MICROBIOL, V11, P121, DOI 10.1016/j.mib.2008.02.016; Cotter PA, 1997, MOL MICROBIOL, V24, P671, DOI 10.1046/j.1365-2958.1997.3821741.x; Cotter PA, 2003, TRENDS MICROBIOL, V11, P367, DOI 10.1016/S0966-842X(03)00156-2; COTTER PA, 1994, INFECT IMMUN, V62, P3381, DOI 10.1128/IAI.62.8.3381-3390.1994; Cotter PA, 2000, ANNU REV MICROBIOL, V54, P519, DOI 10.1146/annurev.micro.54.1.519; Deora R, 2001, MOL MICROBIOL, V40, P669, DOI 10.1046/j.1365-2958.2001.02415.x; DONNENBERG MS, 1991, INFECT IMMUN, V59, P4310, DOI 10.1128/IAI.59.12.4310-4317.1991; Enninga J, 2009, CELL MICROBIOL, V11, P1462, DOI 10.1111/j.1462-5822.2009.01360.x; Finlay BB, 1997, SCIENCE, V276, P718, DOI 10.1126/science.276.5313.718; GOODNOW RA, 1980, MICROBIOL REV, V44, P722, DOI 10.1128/MMBR.44.4.722-738.1980; Hoch JA, 2000, CURR OPIN MICROBIOL, V3, P165, DOI 10.1016/S1369-5274(00)00070-9; Hughes KT, 1998, ANNU REV MICROBIOL, V52, P231, DOI 10.1146/annurev.micro.52.1.231; Kodama T, FEMS MICROBIOL LETT, V311, P10; Kozak NA, 2005, J BACTERIOL, V187, P5665, DOI 10.1128/JB.187.16.5665-5676.2005; Kuwae A, 2006, J BIOL CHEM, V281, P6589, DOI 10.1074/jbc.M512711200; Kuwae A, 2003, CELL MICROBIOL, V5, P973, DOI 10.1046/j.1462-5822.2003.00341.x; Lee JW, 2007, BIOMETALS, V20, P485, DOI 10.1007/s10534-006-9070-7; Martinez de Tejada G. M., 1996, MOL MICROBIOL, V22, P895; Mattoo S, 2005, CLIN MICROBIOL REV, V18, P326, DOI 10.1128/CMR.18.2.326-382.2005; Mattoo S, 2004, MOL MICROBIOL, V52, P1201, DOI 10.1111/j.1365-2958.2004.04053.x; Medhekar B, 2009, MOL MICROBIOL, V71, P492, DOI 10.1111/j.1365-2958.2008.06543.x; Nagamatsu K, 2009, J EXP MED, V206, P3073, DOI 10.1084/jem.20090494; Nogawa H, 2004, J BACTERIOL, V186, P3806, DOI 10.1128/JB.186.12.3806-3813.2004; Noguchi H, 2008, DNA RES, V15, P387, DOI 10.1093/dnares/dsn027; Panina EM, 2005, MOL MICROBIOL, V58, P267, DOI 10.1111/j.1365-2958.2005.04823.x; Parkhill J, 2003, NAT GENET, V35, P32, DOI 10.1038/ng1227; Rietsch A, 2005, P NATL ACAD SCI USA, V102, P8006, DOI 10.1073/pnas.0503005102; Sekiya K, 2001, P NATL ACAD SCI USA, V98, P11638, DOI 10.1073/pnas.191378598; Shilov IV, 2007, MOL CELL PROTEOMICS, V6, P1638, DOI 10.1074/mcp.T600050-MCP200; Sorenson MK, 2004, MOL CELL, V14, P127, DOI 10.1016/S1097-2765(04)00150-9; Soscia C, 2007, J BACTERIOL, V189, P3124, DOI 10.1128/JB.01677-06; STIBITZ S, 1989, NATURE, V338, P266, DOI 10.1038/338266a0; Stockbauer KE, 2001, MOL MICROBIOL, V39, P65, DOI 10.1046/j.1365-2958.2001.02191.x; UHL MA, 1994, P NATL ACAD SCI USA, V91, P1163, DOI 10.1073/pnas.91.3.1163; Urbanowski ML, 2005, P NATL ACAD SCI USA, V102, P9930, DOI 10.1073/pnas.0504405102; VanderZee A, 1997, J BACTERIOL, V179, P6609, DOI 10.1128/jb.179.21.6609-6617.1997; Watanabe M, 2000, VACCINE, V19, P1199, DOI 10.1016/S0264-410X(00)00308-X; Williams CL, 2005, MOL MICROBIOL, V56, P175, DOI 10.1111/j.1365-2958.2004.04526.x; Yuk MH, 1998, MOL MICROBIOL, V28, P945, DOI 10.1046/j.1365-2958.1998.00850.x	45	21	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2012	7	6							e38925	10.1371/journal.pone.0038925	http://dx.doi.org/10.1371/journal.pone.0038925			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TU	22701731	Green Submitted, gold, Green Published			2022-12-27	WOS:000305337600058
J	Liu, S; Fu, R; Zhou, LH; Chen, SP				Liu, Shu; Fu, Rao; Zhou, Li-Hua; Chen, Sheng-Ping			Application of Consensus Scoring and Principal Component Analysis for Virtual Screening against beta-Secretase (BACE-1)	PLOS ONE			English	Article							PROTEIN-LIGAND INTERACTIONS; STRUCTURE-BASED DESIGN; X-RAY CRYSTALLOGRAPHY; BINDING FREE-ENERGIES; APP CLEAVING ENZYME; MOLECULAR DOCKING; AUTOMATED DOCKING; FLEXIBLE DOCKING; CHEMICAL DATABASES; ACCURATE DOCKING	Background: In order to identify novel chemical classes of beta-secretase (BACE-1) inhibitors, an alternative scoring protocol, Principal Component Analysis (PCA), was proposed to summarize most of the information from the original scoring functions and re-rank the results from the virtual screening against BACE-1. Method: Given a training set (50 BACE-1 inhibitors and 9950 inactive diverse compounds), three rank-based virtual screening methods, individual scoring, conventional consensus scoring and PCA, were judged by the hit number in the top 1% of the ranked list. The docking poses were generated by Surflex, five scoring functions (Surflex_Score, D_Score, G_Score, ChemScore, and PMF_Score) were used for pose extraction. For each pose group, twelve scoring functions (Surflex_Score, D_Score, G_Score, ChemScore, PMF_Score, LigScore1, LigScore2, PLP1, PLP2, jain, Ludi_1, and Ludi_2) were used for the pose rank. For a test set, 113,228 chemical compounds (Sigma-Aldrich (R) corporate chemical directory) were docked by Surflex, then ranked by the same three ranking methods motioned above to select the potential active compounds for experimental test. Results: For the training set, the PCA approach yielded consistently superior rankings compared to conventional consensus scoring and single scoring. For the test set, the top 20 compounds according to conventional consensus scoring were experimentally tested, no inhibitor was found. Then, we relied on PCA scoring protocol to test another different top 20 compounds and two low micromolar inhibitors (S450588 and 276065) were emerged through the BACE-1 fluorescence resonance energy transfer (FRET) assay. Conclusion: The PCA method extends the conventional consensus scoring in a quantitative statistical manner and would appear to have considerable potential for chemical screening applications.	[Liu, Shu; Fu, Rao; Zhou, Li-Hua] Sun Yat Sen Univ, Zhong Shan Sch Med, Dept Anat, Guangzhou 510275, Guangdong, Peoples R China; [Chen, Sheng-Ping] Sun Yat Sen Univ, Zhong Shan Sch Med, Guangdong Prov Key Lab Funct Mol Ocean Microorgan, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Liu, S (corresponding author), Sun Yat Sen Univ, Zhong Shan Sch Med, Dept Anat, Guangzhou 510275, Guangdong, Peoples R China.	chenshp@mail.sysu.edu.cn		Liu, Shu/0000-0002-6072-6036	National Natural Science Foundation of China [31171290, 41176128, 81070995]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The present work was supported by the National Natural Science Foundation of China. Number of foundation: 31171290; 41176128; 81070995 (http://159.226.244.22/portal/Proj_List.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], SYBYL VERS 8 1; [Anonymous], DISC STUD VERS 2 1; Ballester PJ, 2010, BIOINFORMATICS, V26, P1169, DOI 10.1093/bioinformatics/btq112; Baxter EW, 2007, J MED CHEM, V50, P4261, DOI 10.1021/jm0705408; Bea I, 2006, J ORG CHEM, V71, P2056, DOI 10.1021/jo052469o; Belyaev ND, 2010, J BIOL CHEM, V285, P41443, DOI 10.1074/jbc.M110.141390; BEVERIDGE DL, 1989, ANNU REV BIOPHYS BIO, V18, P431, DOI 10.1146/annurev.bb.18.060189.002243; Bissantz C, 2003, PROTEINS, V50, P5, DOI 10.1002/prot.10237; Bissantz C, 2000, J MED CHEM, V43, P4759, DOI 10.1021/jm001044l; Bohm HJ, 1998, J COMPUT AID MOL DES, V12, P309, DOI 10.1023/A:1007999920146; BOHM HJ, 1994, J COMPUT AID MOL DES, V8, P243, DOI 10.1007/BF00126743; Bortolato A, 2007, J CHEM INF MODEL, V47, P572, DOI 10.1021/ci600369n; Charifson PS, 1999, J MED CHEM, V42, P5100, DOI 10.1021/jm990352k; Chen LL, 2006, J BIOMOL SCREEN, V11, P915, DOI 10.1177/1087057106293295; Cheng TJ, 2009, J CHEM INF MODEL, V49, P1079, DOI 10.1021/ci9000053; Coburn CA, 2004, J MED CHEM, V47, P6117, DOI 10.1021/jm049388p; Eldridge MD, 1997, J COMPUT AID MOL DES, V11, P425, DOI 10.1023/A:1007996124545; Eriksson MAL, 1999, J MED CHEM, V42, P868, DOI 10.1021/jm980277y; Ewig CS, 2001, J COMPUT CHEM, V22, P1782, DOI 10.1002/jcc.1131; Ewing TJA, 2001, J COMPUT AID MOL DES, V15, P411, DOI 10.1023/A:1011115820450; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; GEHLHAAR DK, 1995, CHEM BIOL, V2, P317, DOI 10.1016/1074-5521(95)90050-0; Ghosh AK, 2008, NEUROTHERAPEUTICS, V5, P399, DOI 10.1016/j.nurt.2008.05.007; Goodsell DS, 1996, J MOL RECOGNIT, V9, P1, DOI 10.1002/(SICI)1099-1352(199601)9:1<1::AID-JMR241>3.0.CO;2-6; Guo JX, 2004, J MED CHEM, V47, P5492, DOI 10.1021/jm049695v; Halgren TA, 2004, J MED CHEM, V47, P1750, DOI 10.1021/jm030644s; Halperin I, 2002, PROTEINS, V47, P409, DOI 10.1002/prot.10115; Heberger K, 2003, J AGR FOOD CHEM, V51, P8055, DOI 10.1021/jf034851c; Heberger K, 1999, LIPIDS, V34, P83, DOI 10.1007/s11745-999-341-4; Hou TJ, 2011, J CHEM INF MODEL, V51, P69, DOI 10.1021/ci100275a; Huang DZ, 2006, J AM CHEM SOC, V128, P5436, DOI 10.1021/ja0573108; Jacobsson M, 2003, J MED CHEM, V46, P5781, DOI 10.1021/jm030896t; Jain AN, 2007, J COMPUT AID MOL DES, V21, P281, DOI 10.1007/s10822-007-9114-2; Jain AN, 1996, J COMPUT AID MOL DES, V10, P427, DOI 10.1007/BF00124474; Jain AN, 2003, J MED CHEM, V46, P499, DOI 10.1021/jm020406h; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; Kaden D, 2008, J BIOL CHEM, V283, P7271, DOI 10.1074/jbc.M708046200; Konstantinou-Kirtay C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-27; Krammer A, 2005, J MOL GRAPH MODEL, V23, P395, DOI 10.1016/j.jmgm.2004.11.007; Lyne PD, 2002, DRUG DISCOV TODAY, V7, P1047, DOI 10.1016/S1359-6446(02)02483-2; Malnar M, 2010, BBA-MOL BASIS DIS, V1802, P682, DOI 10.1016/j.bbadis.2010.05.006; Mancini F, 2011, ANAL BIOANAL CHEM, V400, P1979, DOI 10.1007/s00216-011-4963-x; McGovern SL, 2003, J MED CHEM, V46, P4265, DOI 10.1021/jm030266r; MENG EC, 1992, J COMPUT CHEM, V13, P505, DOI 10.1002/jcc.540130412; Mooij WTM, 2005, PROTEINS, V61, P272, DOI 10.1002/prot.20588; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Muegge I, 1999, J MED CHEM, V42, P2498, DOI 10.1021/jm990073x; Muegge I, 1999, J MED CHEM, V42, P791, DOI 10.1021/jm980536j; Murray CW, 2007, J MED CHEM, V50, P1116, DOI 10.1021/jm0611962; Owens J, 2003, DRUG DISCOV TODAY, V8, P12, DOI 10.1016/S1359-6446(02)02556-4; Patel S, 2004, J MOL BIOL, V343, P407, DOI 10.1016/j.jmb.2004.08.018; Polgar T, 2005, J MED CHEM, V48, P3749, DOI 10.1021/jm049133b; Polgar T, 2007, J CHEM INF MODEL, V47, P2366, DOI 10.1021/ci700223p; Polgar T, 2006, J CHEM INF MODEL, V46, P1795, DOI 10.1021/ci050412x; Prakash MK, 2011, J AM CHEM SOC, V133, P9976, DOI 10.1021/ja201500z; Prathipati P, 2006, J CHEM INF MODEL, V46, P39, DOI 10.1021/ci050120w; Rahaman O, 2011, J CHEM INF MODEL; Rarey M, 1996, J MOL BIOL, V261, P470, DOI 10.1006/jmbi.1996.0477; Rastelli G, 2010, J COMPUT CHEM, V31, P797, DOI 10.1002/jcc.21372; Rosenfeld RJ, 2003, J COMPUT AID MOL DES, V17, P525, DOI 10.1023/B:JCAM.0000004604.87558.02; Ryan AJ, 2003, J MED CHEM, V46, P3448, DOI 10.1021/jm0340896; Seeliger D, 2010, BIOPHYS J, V98, P2309, DOI 10.1016/j.bpj.2010.01.051; Skrbic B, 2005, J AGR FOOD CHEM, V53, P2171, DOI 10.1021/jf0402577; Spitzer R., 2012, J COMPUT AIDED MOL D; Terp GE, 2001, J MED CHEM, V44, P2333, DOI 10.1021/jm001090l; Tuccinardi T, 2009, COMB CHEM HIGH T SCR, V12, P303, DOI 10.2174/138620709787581666; Vassar R, 2011, ALZHEIMERS RES THER, V3, DOI 10.1186/alzrt82; Verdonk ML, 2004, J CHEM INF COMP SCI, V44, P793, DOI 10.1021/ci034289q; Vilar S, 2011, J MOL GRAPH MODEL, V29, P614, DOI 10.1016/j.jmgm.2010.11.005; Wang RX, 2001, J CHEM INF COMP SCI, V41, P1422, DOI 10.1021/ci010025x; Wang RX, 2003, J MED CHEM, V46, P2287, DOI 10.1021/jm0203783; Wang RX, 2002, J COMPUT AID MOL DES, V16, P11, DOI 10.1023/A:1016357811882; Wang YS, 2010, J MED CHEM, V53, P942, DOI 10.1021/jm901472u; Wilton D, 2003, J CHEM INF COMP SCI, V43, P469, DOI 10.1021/ci025586i; Wilton DJ, 2006, J CHEM INF MODEL, V46, P471, DOI 10.1021/ci050397w; Xie QQ, 2011, EUR J MED CHEM, V46, P3675, DOI 10.1016/j.ejmech.2011.05.031; Xing L, 2004, J COMPUT AID MOL DES, V18, P333, DOI 10.1023/B:JCAM.0000047812.39758.ab	77	28	30	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2012	7	6							e38086	10.1371/journal.pone.0038086	http://dx.doi.org/10.1371/journal.pone.0038086			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TU	22701601	Green Submitted, gold, Green Published			2022-12-27	WOS:000305337600014
J	Stradling, C; Chen, YF; Russell, T; Connock, M; Thomas, GN; Taheri, S				Stradling, Clare; Chen, Yen-Fu; Russell, Tracy; Connock, Martin; Thomas, G. Neil; Taheri, Shahrad			The Effects of Dietary Intervention on HIV Dyslipidaemia: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; POLYUNSATURATED FATTY-ACIDS; ACTIVE ANTIRETROVIRAL THERAPY; CHOLESTEROL-LOWERING FOODS; INFECTED PATIENTS; FISH-OIL; CARDIOVASCULAR-DISEASE; AEROBIC EXERCISE; SERUM-LIPIDS; DOUBLE-BLIND	Background: Efficacy of dietary intervention for treatment and prevention of HIV-related lipid disturbances has not been well established. Methods: We conducted a systematic search of electronic databases supplemented with manual searches and conference abstracts, without language restriction. All randomised controlled trials (RCTs) with blood lipid outcomes, involving dietary intervention or supplementation for the treatment or prevention of adult HIV dyslipidaemia, versus no or other intervention were included. Two authors using predefined data fields, including study quality indicators, extracted data independently. Results: Eighteen studies (n = 873) met our inclusion criteria. Seven RCTs for omega-3 supplementation (n = 372), and four RCTs for dietary intervention (n = 201) were meta-analysed using random-effects models. Mild statistical heterogeneity was observed. Dietary intervention reduced triglyceride levels by -0.46 mmol/l (95% CI: -0.85 to -0.07 mmol/l) compared to control. Omega-3 supplementation reduced triglyceride levels by 21.12 mmol/l, (95% CI: -1.57 to -0.67 mmol/l) and total cholesterol, -0.36 mmol/l (95% CI: -0.67 to -0.05 mmol/l) compared to placebo/control. Conclusions: Both omega-3 supplementation and dietary intervention reduced triglyceride level, with the latter possibly to a smaller extent. While dietary interventions are beneficial, more stringent dietary approaches may be necessary to fully address lipid disturbances in HIV patients. Registration:	[Stradling, Clare; Taheri, Shahrad] Heart England NHS Fdn Trust, HIV Metab Clin, Birmingham, W Midlands, England; [Stradling, Clare; Chen, Yen-Fu; Taheri, Shahrad] Univ Birmingham, Birmingham & Black Country NIHR CLAHRC, Birmingham, W Midlands, England; [Russell, Tracy] Western Gen Hosp, Dietet Dept, Edinburgh EH4 2XU, Midlothian, Scotland; [Connock, Martin] Univ Warwick, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England; [Thomas, G. Neil] Univ Birmingham, Sch Publ Hlth Epidemiol & Biostat, Birmingham, W Midlands, England; [Taheri, Shahrad] Univ Birmingham, Sch Clin & Expt Med, Birmingham, W Midlands, England	Heart of England NHS Foundation Trust; University of Birmingham; University of Edinburgh; University of Warwick; University of Birmingham; University of Birmingham	Stradling, C (corresponding author), Heart England NHS Fdn Trust, HIV Metab Clin, Birmingham, W Midlands, England.	clare.stradling@heartofengland.nhs.uk; S.Taheri@bham.ac.uk	Thomas, G. Neil/A-1879-2013; Stradling, Clare/O-6333-2015; Chen, Yen-Fu/AAD-2825-2019; Taheri, Shahrad/O-9721-2016; Chen, Yen-Fu/A-1086-2008	Thomas, G. Neil/0000-0002-2777-1847; Stradling, Clare/0000-0002-1869-6451; Taheri, Shahrad/0000-0001-8314-1500; Chen, Yen-Fu/0000-0002-9446-2761	National Institute for Health Research (NIHR) through Collaborations for Leadership in Applied Health Research and Care for Birmingham and Black Country (CLAHRC-BBC) programme; Research Training Award from Developing Research Leadership, Capability and Capacity amongst Nurses, Midwives and Allied Health Professionals in the West Midlands; National Institute for Health Research [DRF-2012-05-204] Funding Source: researchfish	National Institute for Health Research (NIHR) through Collaborations for Leadership in Applied Health Research and Care for Birmingham and Black Country (CLAHRC-BBC) programme(National Institute for Health Research (NIHR)); Research Training Award from Developing Research Leadership, Capability and Capacity amongst Nurses, Midwives and Allied Health Professionals in the West Midlands; National Institute for Health Research(National Institute for Health Research (NIHR))	CS, YFC, and ST are supported by the National Institute for Health Research (NIHR) through the Collaborations for Leadership in Applied Health Research and Care for Birmingham and Black Country (CLAHRC-BBC) programme. The views expressed in this publication are not necessarily those of the NIHR, the Department of Health, NHS South Birmingham, University of Birmingham or the CLAHRC-BBC Theme 8 Management/Steering group. CS was supported by a Research Training Award from Developing Research Leadership, Capability and Capacity amongst Nurses, Midwives and Allied Health Professionals in the West Midlands. For the remaining authors none were declared. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghdassi E, 2010, CURR HIV RES, V8, P113, DOI 10.2174/157016210790442687; Almeida LB, 2009, ARQ BRAS ENDOCRINOL, V53, P519, DOI 10.1590/S0004-27302009000500005; Astrup A, 2011, AM J CLIN NUTR, V93, P684, DOI 10.3945/ajcn.110.004622; Balasubramanyam A, 2011, J CLIN ENDOCR METAB, V96, P2236, DOI 10.1210/jc.2010-3067; Balk E, 2004, EFFECTS OMEGA 3 FATT; Baril JG, 2007, HIV CLIN TRIALS, V8, P400, DOI 10.1310/hct0806-400; Barrios A, 2002, AIDS, V16, P2079, DOI 10.1097/00002030-200210180-00014; Brunner EJ, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002128.pub3; Carter V M, 2006, Sex Health, V3, P287, DOI 10.1071/SH06001; Chow DC, 2010, AIDS, V24, P1019, DOI 10.1097/QAD.0b013e3283383016; Cochrane Collaboration, 2008, REV MAN REVMAN COMP; De Truchis P, 2007, JAIDS-J ACQ IMM DEF, V44, P278, DOI 10.1097/QAI.0b013e31802c2f3d; Dolan SE, 2006, ARCH INTERN MED, V166, P1225, DOI 10.1001/archinte.166.11.1225; Dube MP, 2003, CLIN INFECT DIS, V37, P613, DOI 10.1086/378131; Eckel RH, 2010, CIRCULATION, V122, P2110, DOI 10.1161/CIRCULATIONAHA.110.986976; Eslick GD, 2009, INT J CARDIOL, V136, P4, DOI 10.1016/j.ijcard.2008.03.092; Filion KB, 2010, BMC CARDIOVASC DISOR, V10, DOI 10.1186/1471-2261-10-24; Fitch KV, 2006, AIDS, V20, P1843, DOI 10.1097/01.aids.0000244203.95758.db; Gazzard BG, 2008, HIV MED, V9, P563, DOI 10.1111/j.1468-1293.2008.00636.x; Gerber JG, 2008, JAIDS-J ACQ IMM DEF, V47, P459, DOI 10.1097/QAI.0b013e31815bace2; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Hadigan C, 2006, J CLIN ENDOCR METAB, V91, P4438, DOI 10.1210/jc.2006-1174; Hartweg J, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003205.pub2; Heaney RP, 2008, J NUTR, V138, P1591, DOI 10.1093/jn/138.9.1591; Hjerkinn EM, 2004, J INTERN MED, V255, P68, DOI 10.1046/j.0954-6820.2003.01248.x; Hooper L, 2006, BMJ-BRIT MED J, V332, P752, DOI 10.1136/bmj.38755.366331.2F; Jenkins DJA, 2011, JAMA-J AM MED ASSOC, V306, P831, DOI 10.1001/jama.2011.1202; Jenkins DJA, 2003, JAMA-J AM MED ASSOC, V290, P502, DOI 10.1001/jama.290.4.502; Kelley GA, 2004, J WOMENS HEALTH, V13, P1148, DOI 10.1089/jwh.2004.13.1148; Kelley George A, 2006, J Mens Health Gend, V3, P61, DOI 10.1016/j.jmhg.2005.09.003; Kelley GA, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-74; Lazzaretti RK, 2012, J AM COLL CARDIOL, V59, P979, DOI 10.1016/j.jacc.2011.11.038; Leon H., 2009, BMJ-BRIT MED J, V338, P2931; Leyes P, 2008, ANTIVIR THER, V13, P149; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Lundgren JD, 2008, HIV MED, V9, P72, DOI 10.1111/j.1468-1293.2007.00534.x; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Marik PE, 2009, CLIN CARDIOL, V32, P365, DOI 10.1002/clc.20604; McGoldrick C, 2007, HIV MED, V8, P325, DOI 10.1111/j.1468-1293.2007.00480.x; Miller M, 2011, CIRCULATION, V123, P2292, DOI 10.1161/CIR.0b013e3182160726; Mutimura E, 2008, AIDS RES HUM RETROV, V24, P15, DOI 10.1089/aid.2007.0023; Ng GWB, 2011, SEX HEALTH, V8, P43, DOI 10.1071/SH09065; Peabody D, 2002, 14 WORLD AIDS C; Peters BS, 2012, CLIN THER, V34, P67, DOI 10.1016/j.clinthera.2011.12.001; Saha SA, 2007, AM HEART J, V154, P943, DOI 10.1016/j.ahj.2007.07.011; Sanchez M, 2006, 16 INT AIDS C; Sofi F., 2008, BMJ-BRIT MED J, V337, pa1334; Sterne JAC, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4002; Studer M, 2005, ARCH INTERN MED, V165, P725, DOI 10.1001/archinte.165.7.725; Terry L, 2006, MED SCI SPORT EXER, V38, P411, DOI 10.1249/01.mss.0000191347.73848.80; Thanasilp S, 2009, 5 IAS C HIV PATH TRE; Thusgaard M, 2009, SCAND J INFECT DIS, V41, P760, DOI 10.1080/00365540903168056; Van Horn L, 2008, J AM DIET ASSOC, V108, P287, DOI 10.1016/j.jada.2007.10.050; Wohl DA, 2005, CLIN INFECT DIS, V41, P1498, DOI 10.1086/497273; Woods MN, 2009, AM J CLIN NUTR, V90, P1566, DOI 10.3945/ajcn.2009.28137; Worm SW, 2011, AIDS, V25, P1497, DOI 10.1097/QAD.0b013e32834917c6; Yu-Poth S, 1999, AM J CLIN NUTR, V69, P632; Zhao YT, 2009, ANN MED, V41, P301, DOI 10.1080/07853890802698834	58	25	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2012	7	6							e38121	10.1371/journal.pone.0038121	http://dx.doi.org/10.1371/journal.pone.0038121			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TU	22701607	Green Published, gold, Green Submitted			2022-12-27	WOS:000305337600016
J	He, JJ; Gu, H; Liu, WQ				He, Jianjun; Gu, Hong; Liu, Wenqi			Imbalanced Multi-Modal Multi-Label Learning for Subcellular Localization Prediction of Human Proteins with Both Single and Multiple Sites	PLOS ONE			English	Article							AMINO-ACID-COMPOSITION; PROTEASE CLEAVAGE SITES; LOCATION PREDICTION; FUNCTIONAL DOMAIN; WEB SERVER; FUSION CLASSIFIER; EUK-MPLOC; VIRUS; SCALE; ENSEMBLE	It is well known that an important step toward understanding the functions of a protein is to determine its subcellular location. Although numerous prediction algorithms have been developed, most of them typically focused on the proteins with only one location. In recent years, researchers have begun to pay attention to the subcellular localization prediction of the proteins with multiple sites. However, almost all the existing approaches have failed to take into account the correlations among the locations caused by the proteins with multiple sites, which may be the important information for improving the prediction accuracy of the proteins with multiple sites. In this paper, a new algorithm which can effectively exploit the correlations among the locations is proposed by using Gaussian process model. Besides, the algorithm also can realize optimal linear combination of various feature extraction technologies and could be robust to the imbalanced data set. Experimental results on a human protein data set show that the proposed algorithm is valid and can achieve better performance than the existing approaches.	[He, Jianjun; Gu, Hong; Liu, Wenqi] Dalian Univ Technol, Sch Control Sci & Engn, Dalian, Liaoning, Peoples R China	Dalian University of Technology	He, JJ (corresponding author), Dalian Univ Technol, Sch Control Sci & Engn, Dalian, Liaoning, Peoples R China.	guhong@dlut.edu.cn			National Major Project of China [2009ZX09306-005, 2009ZX10004-701]; Liaoning Provincial Natural Science Foundation of China [20102025]	National Major Project of China; Liaoning Provincial Natural Science Foundation of China	This work is supported by National Major Project during the 11st Five-Year Plan Period of China (Grant No. 2009ZX09306-005, 2009ZX10004-701), and Liaoning Provincial Natural Science Foundation of China (Grant No. 20102025). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Briesemeister S, 2010, BIOINFORMATICS, V26, P1232, DOI 10.1093/bioinformatics/btq115; Chen L, 2010, MOLECULES, V15, P8177, DOI 10.3390/molecules15118177; Chen L, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-293; Chen YL, 2007, J THEOR BIOL, V248, P377, DOI 10.1016/j.jtbi.2007.05.019; Chen YL, 2007, J THEOR BIOL, V245, P775, DOI 10.1016/j.jtbi.2006.11.010; Chou K.-C., 2010, NAT SCI IRVINE, V2, P1090, DOI [10.4236/ns.2010.210136, DOI 10.4236/NS.2010.210136]; Chou KC, 2005, BIOINFORMATICS, V21, P944, DOI 10.1093/bioinformatics/bti104; Chou KC, 2004, CURR MED CHEM, V11, P2105, DOI 10.2174/0929867043364667; Chou KC, 1996, ANAL BIOCHEM, V233, P1, DOI 10.1006/abio.1996.0001; Chou KC, 2002, J BIOL CHEM, V277, P45765, DOI 10.1074/jbc.M204161200; Chou KC, 1999, PROTEIN ENG, V12, P107, DOI 10.1093/protein/12.2.107; CHOU KC, 1995, CRIT REV BIOCHEM MOL, V30, P275, DOI 10.3109/10409239509083488; CHOU KC, 1993, J BIOL CHEM, V268, P16938; Chou KC, 2001, PROTEINS, V43, P246, DOI 10.1002/prot.1035; CHOU KC, 2009, NAT SCI, V2, P63, DOI DOI 10.4236/NS.2009.12011; Chou KC, 2008, BIOCHEM BIOPH RES CO, V376, P321, DOI 10.1016/j.bbrc.2008.08.125; Chou KC, 2008, NAT PROTOC, V3, P153, DOI 10.1038/nprot.2007.494; Chou KC, 2007, ANAL BIOCHEM, V370, P1, DOI 10.1016/j.ab.2007.07.006; Chou KC, 2007, BIOCHEM BIOPH RES CO, V360, P339, DOI 10.1016/j.bbrc.2007.06.027; Chou KC, 2007, BIOCHEM BIOPH RES CO, V357, P633, DOI 10.1016/j.bbrc.2007.03.162; Chou KC, 2007, J PROTEOME RES, V6, P1728, DOI 10.1021/pr060635i; Chou KC, 2012, MOL BIOSYST, V8, P629, DOI 10.1039/c1mb05420a; Chou KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018258; Chou KC, 2011, J THEOR BIOL, V273, P236, DOI 10.1016/j.jtbi.2010.12.024; Chou KC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011335; Chou KC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009931; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Esmaeili M, 2010, J THEOR BIOL, V263, P203, DOI 10.1016/j.jtbi.2009.11.016; Foster LJ, 2006, CELL, V125, P187, DOI 10.1016/j.cell.2006.03.022; Georgiou DN, 2009, J THEOR BIOL, V257, P17, DOI 10.1016/j.jtbi.2008.11.003; He ZS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009603; Hoglund A, 2006, BIOINFORMATICS, V22, P1158, DOI 10.1093/bioinformatics/btl002; Hu LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014556; Hua SJ, 2001, BIOINFORMATICS, V17, P721, DOI 10.1093/bioinformatics/17.8.721; Huang T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025297; Huang T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022940; Huang T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010972; Imai K, 2010, PROTEOMICS, V10, P3970, DOI 10.1002/pmic.201000274; Jiang XY, 2008, PROTEIN PEPTIDE LETT, V15, P392, DOI 10.2174/092986608784246443; Lee K, 2006, NUCLEIC ACIDS RES, V34, P4655, DOI 10.1093/nar/gkl638; Li FM, 2008, PROTEIN PEPTIDE LETT, V15, P612, DOI 10.2174/092986608784966930; Liao B, 2011, PROTEIN PEPTIDE LETT, V18, P1086, DOI 10.2174/092986611797200931; Lin HN, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S15-S8; Lin WZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024756; Liu T, 2010, PROTEIN PEPTIDE LETT, V17, P1263, DOI 10.2174/092986610792231528; Lu Z, 2004, BIOINFORMATICS, V20, P547, DOI 10.1093/bioinformatics/btg447; Ma JW, 2010, INT J INNOV COMPUT I, V6, P5093; Ma JW, 2010, BMB REP, V43, P670, DOI [10.3858/BMBRep.2010.43.10.670, 10.5483/BMBRep.2010.43.10.670]; Mei SY, 2012, J THEOR BIOL, V293, P121, DOI 10.1016/j.jtbi.2011.10.015; Mei SY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-44; Mohabatkar H, 2011, J THEOR BIOL, V281, P18, DOI 10.1016/j.jtbi.2011.04.017; Mohabatkar H, 2010, PROTEIN PEPTIDE LETT, V17, P1207, DOI 10.2174/092986610792231564; NAKASHIMA H, 1994, J MOL BIOL, V238, P54, DOI 10.1006/jmbi.1994.1267; Schapire RE, 2000, MACH LEARN, V39, P135, DOI 10.1023/A:1007649029923; Scott MS, 2004, GENOME RES, V14, P1957, DOI 10.1101/gr.2650004; Shen HB, 2008, ANAL BIOCHEM, V373, P386, DOI 10.1016/j.ab.2007.10.012; Shen HB, 2007, BIOCHEM BIOPH RES CO, V355, P1006, DOI 10.1016/j.bbrc.2007.02.071; Shen HB, 2010, J BIOMOL STRUCT DYN, V28, P175, DOI 10.1080/07391102.2010.10507351; Shen HB, 2009, ANAL BIOCHEM, V394, P269, DOI 10.1016/j.ab.2009.07.046; Shi JY, 2008, AMINO ACIDS, V35, P321, DOI 10.1007/s00726-007-0623-z; Tian J, 2011, COMPUT BIOL MED, V41, P648, DOI 10.1016/j.compbiomed.2011.05.016; Tsoumakas G., 2007, INT J DATA WAREHOUS, V3, P1; Wang P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018476; Wang P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023505; Wu ZC, 2011, PROTEIN PEPTIDE LETT, DOI BSP/PPL/E pub/0380; Wu ZC, 2011, MOL BIOSYST, V7, P3287, DOI 10.1039/c1mb05232b; Xiao X, 2011, J THEOR BIOL, V284, P42, DOI 10.1016/j.jtbi.2011.06.005; Xiao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020592; Xiao XA, 2011, MOL BIOSYST, V7, P911, DOI 10.1039/c0mb00170h; Yin JB, 2011, NEUROCOMPUTING, V74, P3816, DOI 10.1016/j.neucom.2011.07.017; Zeng YH, 2009, J THEOR BIOL, V259, P366, DOI 10.1016/j.jtbi.2009.03.028; Zhang S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-127; Zhou GP, 2003, PROTEINS, V50, P44, DOI 10.1002/prot.10251	74	25	28	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2012	7	6							e37155	10.1371/journal.pone.0037155	http://dx.doi.org/10.1371/journal.pone.0037155			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TQ	22715364	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336800005
J	Cesar, KR; Romero, EC; de Braganca, AC; Blanco, RM; Abreu, PAE; Magaldi, AJ				Cesar, Katia Regina; Romero, Eliete Calo; de Braganca, Ana Carolina; Blanco, Roberta Morozetti; Estima Abreu, Patricia Antonia; Magaldi, Antonio Jose			Renal Involvement in Leptospirosis: The Effect of Glycolipoprotein on Renal Water Absorption	PLOS ONE			English	Article							INTERROGANS SEROVAR COPENHAGENI; KIDNEY; ACTIVATION; LIVER; EXPRESSION; TUBULES; BLOOD; LUNG	Background: Leptospirotic renal lesions frequently produce a polyuric form of acute kidney injury with a urinary concentration defect. Our study investigated a possible effect of the glycolipoprotein, (GLPc) extracted from L. interrogans, on vasopressin (Vp) action in the guinea pig inner medullary collecting duct (IMCD). Methods: The osmotic water permeability (Pf mu m/s) was measured by the microperfusion in vitro technique. AQP2 protein abundance was determined by Western Blot. Three groups were established for study as follows: Group I, IMCD from normal (ngp, n = 5) and from leptospirotic guinea-pigs (lgp-infected with L. interrogans serovar Copenhageni, GLPc, n = 5); Group II, IMCD from normal guinea-pigs in the presence of GLPc (GLPc group, n = 54); Group III, IMCD from injected animals with GLPc ip (n = 8). Results: In Group I, Pfs were: ngp-61.8 +/- 22.1 and lgp-8.8 +/- 12.4, p<0.01 and the urinary osmolalities were: lgp-735 +/- 64 mOsm/Kg and ngp-1,632 +/- 120 mOsm/Kg. The lgp BUN was higher (176 +/- 36 mg%) than the ngp (56 +/- 9 mg%). In Group II, the Pf was measured under GLPc (250 mu g/ml) applied directly to the bath solution of the microperfused normal guinea-pig IMCDs. GLPc blocked Vp (200 pg/ml, n = 5) action, did not block cAMP (10(-4) M,) and Forskolin (Fors-10(-9) M) action, but partially blocked Cholera Toxin (ChT-10(-9) M) action. GLP from L. biflexa serovar patoc (GLPp, non pathogenic, 250 mu g) did not alter Vp action. In Group III, GLPc (250 mg) injected intraperitoneally produced a decrease of about 20% in IMCD Aquaporin 2 expression. Conclusion: The IMCD Pf decrease caused by GLP is evidence, at least in part, towards explaining the urinary concentrating incapacity observed in infected guinea-pigs.	[Cesar, Katia Regina; de Braganca, Ana Carolina; Magaldi, Antonio Jose] Nephrol HCFMUSP, Basic Res Lab LIM, Sao Paulo, SP, Brazil; [Romero, Eliete Calo; Blanco, Roberta Morozetti] Adolfo Lutz Inst, Sao Paulo, SP, Brazil; [Estima Abreu, Patricia Antonia] Inst Butantan, Bacteriol Lab, Sao Paulo, SP, Brazil	Instituto Adolfo Lutz; Instituto Butantan	Cesar, KR (corresponding author), Nephrol HCFMUSP, Basic Res Lab LIM, Sao Paulo, SP, Brazil.	biomag@usp.br	Abreu, Patricia/C-4682-2012; Blanco, Roberta M/H-7254-2012; de Braganca, Ana Carolina/E-7892-2014; Romero, Eliete C/H-6976-2012	Abreu, Patricia/0000-0002-7541-0341; Blanco, Roberta M/0000-0002-8853-6795; Romero, Eliete C/0000-0002-8635-439X; de Braganca, Ana Carolina/0000-0002-1398-2512	CNPq (National Counsel for Scientific and Technological Development); FAPESP (Foundation for the Support of Research in the State of Sao Paulo); FFM (School of Medicine Foundation); LIM-HCFMUSP (Clinic Hospital Medical Investigation Laboratories-University of Sao Paulo); FAPESP fellowships	CNPq (National Counsel for Scientific and Technological Development); FAPESP (Foundation for the Support of Research in the State of Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FFM (School of Medicine Foundation); LIM-HCFMUSP (Clinic Hospital Medical Investigation Laboratories-University of Sao Paulo); FAPESP fellowships(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was sponsored by the CNPq (National Counsel for Scientific and Technological Development), the FAPESP (Foundation for the Support of Research in the State of Sao Paulo), the FFM (School of Medicine Foundation) and the LIM-HCFMUSP (Clinic Hospital Medical Investigation Laboratories-University of Sao Paulo). AJM was the recipient of CNPq and FAPESP fellowships. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALZAHID G, 1977, J MEMBRANE BIOL, V31, P103, DOI 10.1007/BF01869401; Andrade L, 2007, AM J PHYSIOL-RENAL, V292, pF586, DOI 10.1152/ajprenal.00102.2006; Araujo ER, 2010, VIRCHOWS ARCH, V456, P367, DOI 10.1007/s00428-010-0894-8; AREAN VM, 1962, LAB INVEST, V11, P273; Arriaga AJD, 1982, J PATHOL, V138, P145; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; Daher ED, 2004, NEPHRON CLIN PRACT, V98, pC8, DOI 10.1159/000079922; De Brito T, 2006, VIRCHOWS ARCH, V448, P576, DOI 10.1007/s00428-006-0163-z; DEBRITO T, 1966, VIRCHOWS ARCH A, V341, P64; Diament D, 2002, INFECT IMMUN, V70, P1677, DOI 10.1128/IAI.70.4.1677-1683.2002; Dorigatti F, 2005, BRAZ J MED BIOL RES, V38, P909, DOI 10.1590/S0100-879X2005000600013; Faine S, 1957, BRIT J EXPT PATHOLOG, V37, P1; Faine S, 1999, LEPTOSPIRA LEPTOSPIR, P11; HOLT SC, 1978, MICROBIOL REV, V42, P114, DOI 10.1128/MMBR.42.1.114-160.1978; MAGALDI AJ, 1992, NEPHRON, V62, P332, DOI 10.1159/000187069; MARSHALL RB, 1974, J MED MICROBIOL, V7, P505, DOI 10.1099/00222615-7-4-505; Nascimento ALTO, 2004, BRAZ J MED BIOL RES, V37, P459, DOI 10.1590/S0100-879X2004000400003; Pereira MM, 1997, EXP TOXICOL PATHOL, V49, P505, DOI 10.1016/S0940-2993(97)80155-8; POH SC, 1970, THORAX, V25, P751, DOI 10.1136/thx.25.6.751; ROCHA AS, 1974, KIDNEY INT, V6, P379, DOI 10.1038/ki.1974.123; SANTOS RTM, 1989, REV I MED TROP, V31, P235; SEGURO AC, 1990, NEPHRON, V55, P146, DOI 10.1159/000185943; SITPRIJA V, 1970, American Journal of Medicine, V49, P780, DOI 10.1016/S0002-9343(70)80059-6; STALHEIM OH, 1968, J BACTERIOL, V95, P465, DOI 10.1128/JB.95.2.465-468.1968; VINH T, 1986, J GEN MICROBIOL, V132, P111; Wu MS, 2004, NEPHROL DIAL TRANSPL, V19, P2472, DOI 10.1093/ndt/gfh452; Yang CW, 2007, KIDNEY INT, V72, P918, DOI 10.1038/sj.ki.5002393; YOUNESIBRAHIM M, 1995, CR ACAD SCI III-VIE, V318, P619	29	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e37625	10.1371/journal.pone.0037625	http://dx.doi.org/10.1371/journal.pone.0037625			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701573	Green Submitted, Green Published, gold			2022-12-27	WOS:000305348400014
J	Downs, I; Liu, JF; Aw, TY; Adegboyega, PA; Ajuebor, MN				Downs, Isaac; Liu, Jianfeng; Aw, Tak Yee; Adegboyega, Patrick A.; Ajuebor, Maureen N.			The ROS Scavenger, NAC, Regulates Hepatic V alpha 14iNKT Cells Signaling during Fas mAb-Dependent Fulminant Liver Failure	PLOS ONE			English	Article							KILLER T-CELLS; MITOCHONDRIAL PERMEABILITY TRANSITION; INDUCED APOPTOSIS; NKT CELLS; IMMUNE-SYSTEM; GLUTATHIONE DEPLETION; MICROBIAL INFECTION; CELLULAR REDOX; CUTTING EDGE; PC-12 CELLS	Uncontrolled systemic activation of the immune system is an early initiating event that leads to development of acute fulminant liver failure (FLF) in mice after treatment with agonistic Fas mAb. In this study, we demonstrate that treatment of mice with N-acetylcysteine (NAC), an ROS scavenger and glutathione (GSH) precursor, almost completely abolished Fas mAb-induced FLF through suppression of V alpha 14iNKT cell activation, IFN-gamma signaling, apoptosis and nitrotyrosine formation in liver. In addition, enrichment of the liver with GSH due to V alpha 14iNKT cells deficiency, induced an anti-inflammatory response in the liver of J alpha 18(-/-) mice that inhibited apoptosis, nitrotyrosine formation, IFN-gamma signaling and effector functions. In summary, we propose a novel and previously unrecognized pro-inflammatory and pro-apoptotic role for endogenous ROS in stimulating Th1 signaling in V alpha 14iNKT cells to promote the development of FLF. Therefore, our study provides critical new insights into how NAC, a ROS scavenger, regulates Th1 signaling in intrahepatic V alpha 14iNKT cells to impact inflammatory and pathological responses.	[Downs, Isaac; Liu, Jianfeng; Aw, Tak Yee; Ajuebor, Maureen N.] Louisiana State Univ, Hlth Sci Ctr Shreveport, Dept Mol & Cellular Physiol, Shreveport, LA 71105 USA; [Adegboyega, Patrick A.] Louisiana State Univ, Hlth Sci Ctr Shreveport, Dept Pathol, Shreveport, LA 71105 USA	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport	Downs, I (corresponding author), Louisiana State Univ, Hlth Sci Ctr Shreveport, Dept Mol & Cellular Physiol, Shreveport, LA 71105 USA.	majueb@lsuhsc.edu			NIH [NIAID R56AI085150]; TYA [NIDDK DK44510]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI085150] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK044510] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); TYA; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by NIH grants to MNA (NIAID R56AI085150) and TYA (NIDDK DK44510). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajuebor MN, 2008, J VIROL, V82, P9564, DOI 10.1128/JVI.00927-08; Ajuebor MN, 2007, AM J PATHOL, V170, P1975, DOI 10.2353/ajpath.2007.060690; Ajuebor MN, 2010, J VIROL, V84, P8520, DOI 10.1128/JVI.00605-10; Ajuebor MN, 2005, J IMMUNOL, V174, P8027, DOI 10.4049/jimmunol.174.12.8027; Atkuri KR, 2007, CURR OPIN PHARMACOL, V7, P355, DOI 10.1016/j.coph.2007.04.005; Brigl M, 2003, NAT IMMUNOL, V4, P1230, DOI 10.1038/ni1002; Brutkiewicz RR, 2006, J IMMUNOL, V177, P769, DOI 10.4049/jimmunol.177.2.769; Carnaud C, 1999, J IMMUNOL, V163, P4647; Cazanave S, 2008, TOXICOL APPL PHARM, V231, P336, DOI 10.1016/j.taap.2008.05.010; Cazanave S, 2007, J HEPATOL, V46, P858, DOI 10.1016/j.jhep.2006.11.015; Chiba A, 2008, J IMMUNOL, V181, P2292, DOI 10.4049/jimmunol.181.4.2292; Cobb D, J LEUKOC BIOL, V88, P965; Crowe NY, 2003, J IMMUNOL, V171, P4020, DOI 10.4049/jimmunol.171.8.4020; Cui JQ, 1997, SCIENCE, V278, P1623, DOI 10.1126/science.278.5343.1623; Ding WX, 2004, HEPATOLOGY, V40, P403, DOI 10.1002/hep.20310; Faouzi S, 2001, J BIOL CHEM, V276, P49077, DOI 10.1074/jbc.M109791200; Gardner TR, 2010, AM J PATHOL, V176, P1779, DOI 10.2353/ajpath.2010.090738; Godfrey DI, 2004, NAT REV IMMUNOL, V4, P231, DOI 10.1038/nri1309; Gumperz JE, 2000, IMMUNITY, V12, P211, DOI 10.1016/S1074-7613(00)80174-0; Haouzi D, 2001, HEPATOLOGY, V33, P1181, DOI 10.1053/jhep.2001.24235; Harada M, 2004, INT IMMUNOL, V16, P241, DOI 10.1093/intimm/dxh023; Hatano E, 2000, J BIOL CHEM, V275, P11814, DOI 10.1074/jbc.275.16.11814; Hobbs JA, 2001, J VIROL, V75, P10746, DOI 10.1128/JVI.75.22.10746-10754.2001; Johansson S, 2005, TRENDS IMMUNOL, V26, P613, DOI 10.1016/j.it.2005.08.008; Kinjo Y, 2005, NATURE, V434, P520, DOI 10.1038/nature03407; Kinjo Y, 2006, NAT IMMUNOL, V7, P978, DOI 10.1038/ni1380; Malassagne B, 2001, GASTROENTEROLOGY, V121, P1451, DOI 10.1053/gast.2001.29590; Matsuda JL, 2008, CURR OPIN IMMUNOL, V20, P358, DOI 10.1016/j.coi.2008.03.018; Matsuda JL, 2000, J EXP MED, V192, P741, DOI 10.1084/jem.192.5.741; Matsuda JL, 2003, P NATL ACAD SCI USA, V100, P8395, DOI 10.1073/pnas.1332805100; Matsuda JL, 2001, P NATL ACAD SCI USA, V98, P12636, DOI 10.1073/pnas.221445298; Matute-Bello G, 2001, AM J PATHOL, V158, P153, DOI 10.1016/S0002-9440(10)63953-3; Minagawa M, 2004, GASTROENTEROLOGY, V126, P1387, DOI 10.1053/j.gastro.2004.01.022; Musallam L, 2002, AM J PHYSIOL-GASTR L, V283, pG709, DOI 10.1152/ajpgi.00013.2002; Nagarajan NA, 2007, J IMMUNOL, V178, P2706, DOI 10.4049/jimmunol.178.5.2706; OGASAWARA J, 1993, NATURE, V364, P806, DOI 10.1038/364806a0; Okouchi M, 2005, CURR NEUROVASC RES, V2, P375, DOI 10.2174/156720205774962665; Okouchi M, 2005, CURR NEUROVASC RES, V2, P13, DOI 10.2174/1567202052773535; Porubsky S, 2007, P NATL ACAD SCI USA, V104, P5977, DOI 10.1073/pnas.0611139104; REED DJ, 1980, ANAL BIOCHEM, V106, P55, DOI 10.1016/0003-2697(80)90118-9; RENSINGEHL A, 1995, J INFLAMM, V45, P161; Robinson RT, 2009, J IMMUNOL, V182, P3278, DOI 10.4049/jimmunol.0803417; Ryo K, 2000, AM J GASTROENTEROL, V95, P2047; Saas P, 1999, J IMMUNOL, V162, P2326; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Seino K, 2004, FRONT BIOSCI-LANDMRK, V9, P2577, DOI 10.2741/1418; Sironi JJ, 2004, J BIOL CHEM, V279, P4066, DOI 10.1074/jbc.M307774200; Song EW, 2003, NAT MED, V9, P347, DOI 10.1038/nm828; Speak AO, 2007, P NATL ACAD SCI USA, V104, P5971, DOI 10.1073/pnas.0607285104; Taieb J, 1998, LANCET, V351, P1930, DOI 10.1016/S0140-6736(05)78614-1; Tyznik AJ, 2008, J IMMUNOL, V181, P4452, DOI 10.4049/jimmunol.181.7.4452; Van Kaer L, 2005, NAT REV IMMUNOL, V5, P31, DOI 10.1038/nri1531; vandenDobbelsteen DJ, 1996, J BIOL CHEM, V271, P15420, DOI 10.1074/jbc.271.26.15420; Wang XD, 2005, HEPATOLOGY, V42, P400, DOI 10.1002/hep.20792; Wesley JD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000106; Wilson MT, 2003, P NATL ACAD SCI USA, V100, P10913, DOI 10.1073/pnas.1833166100	57	32	34	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e38051	10.1371/journal.pone.0038051	http://dx.doi.org/10.1371/journal.pone.0038051			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701598	Green Submitted, Green Published, gold			2022-12-27	WOS:000305348400032
J	Bade, VN; Nickels, J; Keusekotten, K; Praefcke, GJK				Bade, Veronika N.; Nickels, Jochen; Keusekotten, Kirstin; Praefcke, Gerrit J. K.			Covalent Protein Modification with ISG15 via a Conserved Cysteine in the Hinge Region	PLOS ONE			English	Article							POLYUBIQUITIN CHAINS; CONJUGATING ENZYME; 15-KDA PROTEIN; PML/RAR-ALPHA; NS1 PROTEIN; HUMAN-CELLS; DNA-REPAIR; UBIQUITIN; ISGYLATION; INFLUENZA	The ubiquitin-like protein ISG15 (interferon-stimulated gene of 15 kDa) is strongly induced by type I interferons and displays antiviral activity. As other ubiquitin-like proteins (Ubls), ISG15 is post-translationally conjugated to substrate proteins by an isopeptide bond between the C-terminal glycine of ISG15 and the side chains of lysine residues in the substrates (ISGylation). ISG15 consists of two ubiquitin-like domains that are separated by a hinge region. In many orthologs, this region contains a single highly reactive cysteine residue. Several hundred potential substrates for ISGylation have been identified but only a few of them have been rigorously verified. In order to investigate the modification of several ISG15 substrates, we have purified ISG15 conjugates from cell extracts by metal-chelate affinity purification and immunoprecipitations. We found that the levels of proteins modified by human ISG15 can be decreased by the addition of reducing agents. With the help of thiol blocking reagents, a mutational analysis and miRNA mediated knock-down of ISG15 expression, we revealed that this modification occurs in living cells via a disulphide bridge between the substrates and Cys78 in the hinge region of ISG15. While the ISG15 activating enzyme UBE1L is conjugated by ISG15 in the classical way, we show that the ubiquitin conjugating enzyme Ubc13 can either be classically conjugated by ISG15 or can form a disulphide bridge with ISG15 at the active site cysteine 87. The latter modification would interfere with its function as ubiquitin conjugating enzyme. However, we found no evidence for an ISG15 modification of the dynamin-like GTPases MxA and hGBP1. These findings indicate that the analysis of potential substrates for ISG15 conjugation must be performed with great care to distinguish between the two types of modification since many assays such as immunoprecipitation or metal-chelate affinity purification are performed with little or no reducing agent present.	[Bade, Veronika N.; Nickels, Jochen; Keusekotten, Kirstin; Praefcke, Gerrit J. K.] Univ Cologne, Inst Genet, CMMC, Cologne, Germany	University of Cologne	Bade, VN (corresponding author), Univ Cologne, Inst Genet, CMMC, Weyertal 121, Cologne, Germany.	gpraefck@uni-koeln.de		Praefcke, Gerrit/0000-0001-8818-1499; bade, Veronika/0000-0002-9877-5220	Deutsche Forschungsgemeinschaft (German Research Foundation) [SFB635]	Deutsche Forschungsgemeinschaft (German Research Foundation)(German Research Foundation (DFG))	This research was supported by a grant of the Deutsche Forschungsgemeinschaft (German Research Foundation) (SFB635). The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; Bothos J, 2003, ONCOGENE, V22, P7101, DOI 10.1038/sj.onc.1206831; Brusky J, 2000, CURR GENET, V37, P168, DOI 10.1007/s002940050515; Dastur A, 2006, J BIOL CHEM, V281, P4334, DOI 10.1074/jbc.M512830200; DCunha J, 1996, J IMMUNOL, V157, P4100; Durfee LA, 2010, MOL CELL, V38, P722, DOI 10.1016/j.molcel.2010.05.002; FARRELL PJ, 1979, NATURE, V279, P523, DOI 10.1038/279523a0; Flohr F, 1999, FEBS LETT, V463, P24, DOI 10.1016/S0014-5793(99)01598-7; Giannakopoulos NV, 2005, BIOCHEM BIOPH RES CO, V336, P496, DOI 10.1016/j.bbrc.2005.08.132; GREGORY JD, 1955, J AM CHEM SOC, V77, P3922, DOI 10.1021/ja01619a073; Guenzi E, 2001, EMBO J, V20, P5568, DOI 10.1093/emboj/20.20.5568; Guo YL, 2010, CANCER RES, V70, P9875, DOI 10.1158/0008-5472.CAN-10-1100; HAAS AL, 1987, J BIOL CHEM, V262, P11315; HERSH LB, 1979, J BIOL CHEM, V254, P1988; Hochrainer K, 2008, CELL MOL LIFE SCI, V65, P2105, DOI 10.1007/s00018-008-8148-5; Hofmann RM, 1999, CELL, V96, P645, DOI 10.1016/S0092-8674(00)80575-9; Kim KI, 2004, MOL CELL BIOL, V24, P9592, DOI 10.1128/MCB.24.21.9592-9600.2004; Kim MJ, 2008, J VIROL, V82, P1474, DOI 10.1128/JVI.01650-07; KNIGHT E, 1991, J IMMUNOL, V146, P2280; Knobeloch KP, 2005, MOL CELL BIOL, V25, P11030, DOI 10.1128/MCB.25.24.11030-11034.2005; Lai C, 2009, J VIROL, V83, P1147, DOI 10.1128/JVI.00105-08; Leaman DW, 2003, J INTERF CYTOK RES, V23, P745, DOI 10.1089/107999003772084860; Lenschow DJ, 2007, P NATL ACAD SCI USA, V104, P1371, DOI 10.1073/pnas.0607038104; LOEB KR, 1992, J BIOL CHEM, V267, P7806; Malakhov MP, 2002, J BIOL CHEM, V277, P9976, DOI 10.1074/jbc.M109078200; Malakhov MP, 2003, J BIOL CHEM, V278, P16608, DOI 10.1074/jbc.M208435200; Malakhova OA, 2008, J BIOL CHEM, V283, P8783, DOI 10.1074/jbc.C800030200; McKenna S, 2001, J BIOL CHEM, V276, P40120, DOI 10.1074/jbc.M102858200; Narasimhan J, 2005, J BIOL CHEM, V280, P27356, DOI 10.1074/jbc.M502814200; Nyman TA, 2000, EUR J BIOCHEM, V267, P4011, DOI 10.1046/j.1432-1327.2000.01433.x; Okumura A, 2008, P NATL ACAD SCI USA, V105, P3974, DOI 10.1073/pnas.0710629105; Okumura F, 2007, GENE DEV, V21, P255, DOI 10.1101/gad.1521607; Okumura F, 2008, J BIOL CHEM, V283, P24484, DOI 10.1074/jbc.M803795200; Owhashi M, 2003, BIOCHEM BIOPH RES CO, V309, P533, DOI 10.1016/j.bbrc.2003.08.038; Padovan E, 2002, CANCER RES, V62, P3453; PAVLOVIC J, 1990, J VIROL, V64, P3370, DOI 10.1128/JVI.64.7.3370-3375.1990; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; REICH N, 1987, P NATL ACAD SCI USA, V84, P6394, DOI 10.1073/pnas.84.18.6394; Ritchie KJ, 2004, SEMIN CELL DEV BIOL, V15, P237, DOI 10.1016/j.semcdb.2003.12.005; Schnellhardt M, 2012, METHODS MOL BIOL, V832, P81, DOI 10.1007/978-1-61779-474-2_4; Schulz JB, 2000, EUR J BIOCHEM, V267, P4904, DOI 10.1046/j.1432-1327.2000.01595.x; Shah SJ, 2008, MOL CANCER THER, V7, P905, DOI 10.1158/1535-7163.MCT-07-0515; Sorensen CM, 2007, BIOCHEMISTRY-US, V46, P772, DOI 10.1021/bi061408x; Takeuchi T, 2005, BIOCHEM BIOPH RES CO, V336, P9, DOI 10.1016/j.bbrc.2005.08.034; Takeuchi T, 2006, BIOCHEM BIOPH RES CO, V348, P473, DOI 10.1016/j.bbrc.2006.07.076; Weisshaar SR, 2008, FEBS LETT, V582, P3174, DOI 10.1016/j.febslet.2008.08.008; Wong JJY, 2006, P NATL ACAD SCI USA, V103, P10735, DOI 10.1073/pnas.0600397103; Yuan WM, 2001, EMBO J, V20, P362, DOI 10.1093/emboj/20.3.362; Zhao C, 2005, P NATL ACAD SCI USA, V102, P10200, DOI 10.1073/pnas.0504754102; Zhao C, 2010, P NATL ACAD SCI USA, V107, P2253, DOI 10.1073/pnas.0909144107; Zou WG, 2006, J BIOL CHEM, V281, P3989, DOI 10.1074/jbc.M510787200; Zou WG, 2005, BIOCHEM BIOPH RES CO, V336, P61, DOI 10.1016/j.bbrc.2005.08.038	52	8	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e38294	10.1371/journal.pone.0038294	http://dx.doi.org/10.1371/journal.pone.0038294			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22693631	gold, Green Submitted, Green Published			2022-12-27	WOS:000305343900027
J	Innocenti, A; De Stefani, E; Bernardi, NF; Campione, GC; Gentilucci, M				Innocenti, Alessandro; De Stefani, Elisa; Bernardi, Nicolo Francesco; Campione, Giovanna Cristina; Gentilucci, Maurizio			Gaze Direction and Request Gesture in Social Interactions	PLOS ONE			English	Article							MIRROR-NEURON SYSTEM; VISUAL CUES; MECHANISMS; PERCEPTION; PREHENSION; ATTENTION; MOVEMENTS; BEHAVIOR; OTHERS; GRASP	One of the most important faculties of humans is to understand the behaviour of other conspecifics. The present study aimed at determining whether, in a social context, request gesture and gaze direction of an individual are enough to infer his/her intention to communicate, by searching for their effects on the kinematics of another individual's arm action. In four experiments participants reached, grasped and lifted a bottle filled of orange juice in presence of an empty glass. In experiment 1, the further presence of a conspecific not producing any request with a hand and gaze did not modify the kinematics of the sequence. Conversely, experiments 2 and 3 showed that the presence of a conspecific producing only a request of pouring by holding the glass with his/her right hand, or only a request of comunicating with the conspecific, by using his/her gaze, affected lifting and grasping of the sequence, respectively. Experiment 4 showed that hand gesture and eye contact simultaneously produced affected the entire sequence. The results suggest that the presence of both request gesture and direct gaze produced by an individual changes the control of a motor sequence executed by another individual. We propose that a social request activates a social affordance that interferes with the control of whatever sequence and that the gaze of the potential receiver who held the glass with her hand modulates the effectiveness of the manual gesture. This paradigm if applied to individuals affected by autism disorder can give new insight on the nature of their impairment in social interaction and communication.	[Innocenti, Alessandro; De Stefani, Elisa; Bernardi, Nicolo Francesco; Campione, Giovanna Cristina; Gentilucci, Maurizio] Univ Parma, Dept Neurosci, I-43100 Parma, Italy; [Gentilucci, Maurizio] Ist Italiano Tecnol, Parma, Italy; [Bernardi, Nicolo Francesco] Univ Milano Bicocca, Dept Psychol, Milan, Italy	University of Parma; Istituto Italiano di Tecnologia - IIT; University of Milano-Bicocca	Innocenti, A (corresponding author), Univ Parma, Dept Neurosci, I-43100 Parma, Italy.	maurizio.gentilucci@unipr.it	De Stefani, Elisa/C-3154-2018	De Stefani, Elisa/0000-0003-4492-3926; Bernardi, Nicolo Francesco/0000-0002-1250-1916; Campione, Giovanna Cristina/0000-0003-0410-5400	Ministero dell'Istruzione; dell'Universita e della Ricerca; Istituto Italiano della Tecnologia	Ministero dell'Istruzione(Ministry of Education, Universities and Research (MIUR)); dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); Istituto Italiano della Tecnologia	The work was supported by grants Ministero dell'Istruzione, dell'Universita e della Ricerca and Istituto Italiano della Tecnologia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 2009, ANNU REV PSYCHOL, V60, P693, DOI 10.1146/annurev.psych.60.110707.163514; Allison T, 2000, TRENDS COGN SCI, V4, P267, DOI 10.1016/S1364-6613(00)01501-1; Barten S., 1979, SYMBOLIC FUNCTIONING, P126; Ferri F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015855; Ferri F, 2010, EXP BRAIN RES, V203, P637, DOI 10.1007/s00221-010-2271-x; Frischen A, 2007, PSYCHOL BULL, V133, P694, DOI 10.1037/0033-2909.133.4.694; Gangitano M, 1998, EXP BRAIN RES, V122, P441, DOI 10.1007/s002210050532; Gentilucci M, 1997, PARIETAL LOBE CONTRI, P339; Gentilucci M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019793; George N, 2008, NEUROPHYSIOL CLIN, V38, P197, DOI 10.1016/j.neucli.2008.03.001; George N, 2001, NEUROIMAGE, V13, P1102, DOI 10.1006/nimg.2001.0769; Georgiou I, 2007, COGNITION, V102, P415, DOI 10.1016/j.cognition.2006.01.008; Glover S, 2004, BEHAV BRAIN SCI, V27, P3; Greene DJ, 2011, NEUROIMAGE, V56, P354, DOI 10.1016/j.neuroimage.2011.02.031; Hari R, 2009, PHYSIOL REV, V89, P453, DOI 10.1152/physrev.00041.2007; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Howard LA, 1997, EXP BRAIN RES, V113, P144, DOI 10.1007/BF02454150; Jeannerod M., 1988, NEURAL BEHAV ORG GOA; Johnson MH, 2005, DEV PSYCHOPATHOL, V17, P599, DOI 10.1017/S0954579405050297; Kampe KKW, 2001, NATURE, P413; KANNER L, 1971, J AUTISM CHILD SCHIZ, V1, P119, DOI 10.1007/BF01537953; Mason MF, 2005, PSYCHOL SCI, V16, P236, DOI 10.1111/j.0956-7976.2005.00809.x; Mon-Williams M, 2001, EXP BRAIN RES, V137, P497; Mon-Williams M, 2000, EXP BRAIN RES, V134, P268, DOI 10.1007/s002210000479; Newman-Norlund RD, 2007, NAT NEUROSCI, V10, P817, DOI 10.1038/nn1911; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pelphrey KA, 2006, CURR DIR PSYCHOL SCI, V15, P136, DOI 10.1111/j.0963-7214.2006.00423.x; Pierno AC, 2008, SOC NEUROSCI-UK, V3, P51, DOI 10.1080/17470910701563269; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Sartori L, 2009, J EXP PSYCHOL HUMAN, V35, P1490, DOI 10.1037/a0015777; Schilbach L, 2011, AUTISM IN PRESS; Sebanz N, 2006, TRENDS COGN SCI, V10, P70, DOI 10.1016/j.tics.2005.12.009; Senju A, 2009, TRENDS COGN SCI, V13, P127, DOI 10.1016/j.tics.2008.11.009; Tipper SP, 1997, VIS COGN, V4, P1, DOI 10.1080/713756749; TIPPER SP, 1991, BRIT J PSYCHOL, V82, P507, DOI 10.1111/j.2044-8295.1991.tb02416.x; Tresilian JR, 1998, EXP BRAIN RES, V120, P352, DOI 10.1007/s002210050409; Vivanti G, 2011, DEV PSYCHOL, V47, P841, DOI 10.1037/a0023105; Vlainic E, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00208	38	36	36	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e36390	10.1371/journal.pone.0036390	http://dx.doi.org/10.1371/journal.pone.0036390			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TY	22693550	Green Published, Green Submitted, gold			2022-12-27	WOS:000305338500011
J	Litchfield, LM; Riggs, KA; Hockenberry, AM; Oliver, LD; Barnhart, KG; Cai, J; Pierce, WM; Ivanova, MM; Bates, PJ; Appana, SN; Datta, S; Kulesza, P; McBryan, J; Young, LS; Klinge, CM				Litchfield, Lacey M.; Riggs, Krista A.; Hockenberry, Alyson M.; Oliver, Laura D.; Barnhart, Katelyn G.; Cai, Jian; Pierce, William M., Jr.; Ivanova, Margarita M.; Bates, Paula J.; Appana, Savitri N.; Datta, Susmita; Kulesza, Piotr; McBryan, Jean; Young, Leonie S.; Klinge, Carolyn M.			Identification and Characterization of Nucleolin as a COUP-TFII Coactivator of Retinoic Acid Receptor beta Transcription in Breast Cancer Cells	PLOS ONE			English	Article							HUMAN MICROGLIAL CELLS; BCL-2 MESSENGER-RNA; ESTROGEN-RECEPTOR; GENE-EXPRESSION; FACTOR-I; GLUCOCORTICOID-RECEPTOR; HORMONE-RECEPTOR; FACTOR INTERACTS; PROMOTER; PROTEIN	Introduction: The orphan nuclear receptor COUP-TFII plays an undefined role in breast cancer. Previously we reported lower COUP-TFII expression in tamoxifen/endocrine-resistant versus sensitive breast cancer cell lines. The identification of COUP-TFII-interacting proteins will help to elucidate its mechanism of action as a transcriptional regulator in breast cancer. Results: FLAG-affinity purification and multidimensional protein identification technology (MudPIT) identified nucleolin among the proteins interacting with COUP-TFII in MCF-7 tamoxifen-sensitive breast cancer cells. Interaction of COUP-TFII and nucleolin was confirmed by coimmunoprecipitation of endogenous proteins in MCF-7 and T47D breast cancer cells. In vitro studies revealed that COUP-TFII interacts with the C-terminal arginine-glycine repeat (RGG) domain of nucleolin. Functional interaction between COUP-TFII and nucleolin was indicated by studies showing that siRNA knockdown of nucleolin and an oligonucleotide aptamer that targets nucleolin, AS1411, inhibited endogenous COUP-TFII-stimulated RARB2 expression in MCF-7 and T47D cells. Chromatin immunoprecipitation revealed COUP-TFII occupancy of the RARB2 promoter was increased by all-trans retinoic acid (atRA). RAR beta 2 regulated gene RRIG1 was increased by atRA and COUP-TFII transfection and inhibited by siCOUP-TFII. Immunohistochemical staining of breast tumor microarrays showed nuclear COUP-TFII and nucleolin staining was correlated in invasive ductal carcinomas. COUP-TFII staining correlated with ER alpha, SRC1, AIB1, Pea3, MMP2, and phospho-Src and was reduced with increased tumor grade. Conclusions: Our data indicate that nucleolin plays a coregulatory role in transcriptional regulation of the tumor suppressor RARB2 by COUP-TFII.	[Litchfield, Lacey M.; Riggs, Krista A.; Hockenberry, Alyson M.; Oliver, Laura D.; Barnhart, Katelyn G.; Ivanova, Margarita M.; Klinge, Carolyn M.] Dept Biochem & Mol Biol, Louisville, KY USA; [Litchfield, Lacey M.; Riggs, Krista A.; Hockenberry, Alyson M.; Oliver, Laura D.; Barnhart, Katelyn G.; Ivanova, Margarita M.; Klinge, Carolyn M.] Ctr Genet & Mol Med, Louisville, KY USA; [Cai, Jian; Pierce, William M., Jr.] Univ Louisville, Sch Med, Dept Pharmacol & Toxicol, Louisville, KY 40292 USA; [Bates, Paula J.] Univ Louisville, James Graham Brown Canc Ctr, Louisville, KY 40292 USA; [Appana, Savitri N.; Datta, Susmita] Univ Louisville, Dept Bioinformat & Biostat, Sch Publ Hlth & Informat Sci, Louisville, KY 40292 USA; [Kulesza, Piotr] Northwestern Univ, Dept Pathol, Feinberg Sch Med, Chicago, IL 60611 USA; [McBryan, Jean; Young, Leonie S.] Royal Coll Surgeons Ireland, Dept Surg, Endocrine Oncol Res Grp, Dublin 2, Ireland	University of Louisville; University of Louisville; University of Louisville; Northwestern University; Feinberg School of Medicine; Royal College of Surgeons - Ireland	Litchfield, LM (corresponding author), Dept Biochem & Mol Biol, Louisville, KY USA.	carolyn.klinge@louisville.edu	Ivanova, Margarita/AAM-4510-2021	Klinge, Carolyn/0000-0002-3358-4378; McBryan, Jean/0000-0002-7568-2208; Bates, Paula/0000-0002-4622-4152; Ivanova, Margarita/0000-0002-6197-8606; Hockenberry, Alyson/0000-0003-0828-1428; Young, Leonie/0000-0002-4904-0367	Komen for the Cure [KG080365]; NIEHS [T32 ES011564]; Health Research Board; Science Foundation Ireland; Breast Cancer Ireland; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES011564] Funding Source: NIH RePORTER	Komen for the Cure(Susan G. Komen Breast Cancer Foundation); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Health Research Board; Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Breast Cancer Ireland; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by a Komen for the Cure grant KG080365 to C. M. K. L. M. L. and K. A. R. were supported by NIEHS T32 ES011564. J.M. and L.S.Y. were supported by grants from the Health Research Board, Science Foundation Ireland, and Breast Cancer Ireland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almendro V, 2011, CLIN TRANSL ONCOL, V13, P767, DOI 10.1007/s12094-011-0731-9; Bates PJ, 2009, EXP MOL PATHOL, V86, P151, DOI 10.1016/j.yexmp.2009.01.004; Bates PJ, 1999, J BIOL CHEM, V274, P26369, DOI 10.1074/jbc.274.37.26369; Berns EMJJ, 1998, BREAST CANCER RES TR, V48, P87, DOI 10.1023/A:1005903226483; Conzen SD, 2008, MOL ENDOCRINOL, V22, P2215, DOI 10.1210/me.2007-0421; De Martino MU, 2004, ANN NY ACAD SCI, V1024, P72, DOI 10.1196/annals.1321.006; De Martino MU, 2004, MOL ENDOCRINOL, V18, P820, DOI 10.1210/me.2003-0341; Desai D, 1996, J BIOL CHEM, V271, P15153, DOI 10.1074/jbc.271.25.15153; Faria TN, 1999, J BIOL CHEM, V274, P26783, DOI 10.1074/jbc.274.38.26783; Girvan AC, 2006, MOL CANCER THER, V5, P1790, DOI 10.1158/1535-7163.MCT-05-0361; Gonzalez V, 2009, J BIOL CHEM, V284, P23622, DOI 10.1074/jbc.M109.018028; Greene FL, 2008, CA-CANCER J CLIN, V58, P180, DOI 10.3322/CA.2008.0001; Hanakahi LA, 2000, BIOCHEMISTRY-US, V39, P15493, DOI 10.1021/bi001683y; Ishimaru D, 2010, J BIOL CHEM, V285, P27182, DOI 10.1074/jbc.M109.098830; Jensen EV, 2001, P NATL ACAD SCI USA, V98, P15197, DOI 10.1073/pnas.211556298; JORDAN VC, 2011, BREAST S1, V20, pS1; Ju BG, 2006, SCIENCE, V312, P1798, DOI 10.1126/science.1127196; Keen JC, 2003, CANCER-AM CANCER SOC, V97, P825, DOI 10.1002/cncr.11126; Klinge CM, 1999, J STEROID BIOCHEM, V71, P1, DOI 10.1016/S0960-0760(99)00124-7; Klinge CM, 1997, J BIOL CHEM, V272, P31465, DOI 10.1074/jbc.272.50.31465; Klinge CM, 2000, ARCH BIOCHEM BIOPHYS, V373, P163, DOI 10.1006/abbi.1999.1552; Kraus WL, 2008, CURR OPIN CELL BIOL, V20, P294, DOI 10.1016/j.ceb.2008.03.006; Kruse SW, 2008, PLOS BIOL, V6, P2002, DOI 10.1371/journal.pbio.0060227; Liang ZD, 2006, CANCER RES, V66, P7111, DOI 10.1158/0008-5472.CAN-06-0812; Lin BZ, 2000, MOL CELL BIOL, V20, P957, DOI 10.1128/MCB.20.3.957-970.2000; Lin F, 2002, J BIOL CHEM, V277, P21414, DOI 10.1074/jbc.M201885200; Malanga M, 2008, J BIOL CHEM, V283, P19991, DOI 10.1074/jbc.M709495200; Marcus SL, 1996, J BIOL CHEM, V271, P27197, DOI 10.1074/jbc.271.44.27197; Masiuk M, 2004, ANTICANCER RES, V24, P963; Mattingly KA, 2008, MOL ENDOCRINOL, V22, P609, DOI 10.1210/me.2007-0029; McBryan J, 2012, CANCER RES, V72, P548, DOI 10.1158/0008-5472.CAN-11-2073; Mi YC, 2003, J BIOL CHEM, V278, P8572, DOI 10.1074/jbc.M207637200; Mongelard F, 2007, TRENDS CELL BIOL, V17, P80, DOI 10.1016/j.tcb.2006.11.010; More E, 2003, J ENDOCRINOL, V176, P83, DOI 10.1677/joe.0.1760083; Nagasaki S, 2009, CANCER SCI, V13, P13; Nakshatri H, 2000, BIOCHEM BIOPH RES CO, V270, P1144, DOI 10.1006/bbrc.2000.2562; Navab R, 2004, CANCER RES, V64, P5097, DOI 10.1158/0008-5472.CAN-03-1185; Pereira FA, 1999, GENE DEV, V13, P1037, DOI 10.1101/gad.13.8.1037; Petit FG, 2004, MECH AGEING DEV, V125, P719, DOI 10.1016/j.mad.2004.03.009; Qin J, 2010, P NATL ACAD SCI USA, V107, P3687, DOI 10.1073/pnas.0914619107; Qin L, 2008, MOL CELL BIOL, V28, P5937, DOI 10.1128/MCB.00579-08; QIU Y, 1995, GENOMICS, V29, P240, DOI 10.1006/geno.1995.1237; Qiu YH, 1997, GENE DEV, V11, P1925, DOI 10.1101/gad.11.15.1925; Redmond AM, 2009, CLIN CANCER RES, V15, P2098, DOI 10.1158/1078-0432.CCR-08-1649; Reyes-Reyes EM, 2010, CANCER RES, V70, P8617, DOI 10.1158/0008-5472.CAN-10-0920; Riggs KA, 2006, CANCER RES, V66, P10188, DOI 10.1158/0008-5472.CAN-05-3937; Rohr O, 2000, J BIOL CHEM, V275, P2654, DOI 10.1074/jbc.275.4.2654; Rohr O, 1997, J BIOL CHEM, V272, P31149, DOI 10.1074/jbc.272.49.31149; Rousseau C, 2003, J STEROID BIOCHEM, V86, P1, DOI 10.1016/S0960-0760(03)00255-3; Russo J, 2006, J STEROID BIOCHEM, V102, P89, DOI 10.1016/j.jsbmb.2006.09.004; Santen RJ, 2009, ENDOCR REV, V30, P343, DOI 10.1210/er.2008-0016; Senawong T, 2003, J BIOL CHEM, V278, P43041, DOI 10.1074/jbc.M307477200; Shibata H, 2004, ENDOCR RES, V30, P795, DOI 10.1081/ERC-200044042; Shibata H, 1997, MOL ENDOCRINOL, V11, P714, DOI 10.1210/me.11.6.714; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Soundararajan S, 2008, CANCER RES, V68, P2358, DOI 10.1158/0008-5472.CAN-07-5723; Storck Sebastien, 2007, Subcell Biochem, V41, P125; Tamimi RM, 2009, CANCER RES, V69, P9323, DOI 10.1158/0008-5472.CAN-09-1018; Tediose T, 2010, NUCLEIC ACIDS RES, V38, P2799, DOI 10.1093/nar/gkq013; Teng Y, 2007, CANCER RES, V67, P10491, DOI 10.1158/0008-5472.CAN-06-4206; TH-M Huang, 2010, COLD SPRING HARBOR P, P2; THEODOSIOU M, 2010, CELL MOL LIFE SCI; Tsai SY, 1997, ENDOCR REV, V18, P229, DOI 10.1210/er.18.2.229; Tsou JH, 2008, NUCLEIC ACIDS RES, V36, P217, DOI 10.1093/nar/gkm1027; Uribe DJ, 2011, BIOCHEMISTRY-US, V50, P3796, DOI 10.1021/bi101633b; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; WAKELING AE, 1992, J STEROID BIOCHEM, V43, P173, DOI 10.1016/0960-0760(92)90204-V; Xie X, 2011, P NATL ACAD SCI USA, V108, P14843, DOI 10.1073/pnas.1110236108; Xu XC, 2007, CANCER LETT, V253, P14, DOI 10.1016/j.canlet.2006.11.019; Yang QF, 2002, BREAST CANCER RES TR, V76, P167, DOI 10.1023/A:1020576606004; Ying GG, 2000, J BIOL CHEM, V275, P4152, DOI 10.1074/jbc.275.6.4152; Zhang LJ, 2009, J BIOL CHEM, V284, P6156, DOI 10.1074/jbc.M807713200	72	33	35	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38278	10.1371/journal.pone.0038278	http://dx.doi.org/10.1371/journal.pone.0038278			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693611	Green Published, Green Submitted, gold			2022-12-27	WOS:000305338500122
J	Litvinov, J; Nasrullah, A; Sherlock, T; Wang, YJ; Ruchhoeft, P; Willson, RC				Litvinov, Julia; Nasrullah, Azeem; Sherlock, Timothy; Wang, Yi-Ju; Ruchhoeft, Paul; Willson, Richard C.			High-Throughput Top-Down Fabrication of Uniform Magnetic Particles	PLOS ONE			English	Article							ENGINEERED DRUG THERAPIES; PRINT	Ion Beam Aperture Array Lithography was applied to top-down fabrication of large dense (10(8)-10(9) particles/cm(2)) arrays of uniform micron-scale particles at rates hundreds of times faster than electron beam lithography. In this process, a large array of helium ion beamlets is formed when a stencil mask containing an array of circular openings is illuminated by a broad beam of energetic (5-8 keV) ions, and is used to write arrays of specific repetitive patterns. A commercial 5-micrometer metal mesh was used as a stencil mask; the mesh size was adjusted by shrinking the stencil openings using conformal sputter-deposition of copper. Thermal evaporation from multiple sources was utilized to form magnetic particles of varied size and thickness, including alternating layers of gold and permalloy. Evaporation of permalloy layers in the presence of a magnetic field allowed creation of particles with uniform magnetic properties and pre-determined magnetization direction. The magnetic properties of the resulting particles were characterized by Vibrating Sample Magnetometry. Since the orientation of the particles on the substrate before release into suspension is known, the orientation-dependent magnetic properties of the particles could be determined.	[Litvinov, Julia] Univ Houston, Dept Biomed Engn, Houston, TX 77004 USA; [Nasrullah, Azeem; Sherlock, Timothy; Ruchhoeft, Paul] Univ Houston, Dept Elect & Comp Engn, Houston, TX USA; [Wang, Yi-Ju; Willson, Richard C.] Univ Houston, Dept Chem & Biomol Engn, Houston, TX USA; [Willson, Richard C.] Methodist Hosp, Res Inst, Houston, TX 77030 USA	University of Houston System; University of Houston; University of Houston System; University of Houston; University of Houston System; University of Houston; The Methodist Hospital System; The Methodist Hospital - Houston	Litvinov, J (corresponding author), Univ Houston, Dept Biomed Engn, Houston, TX 77004 USA.	julialitvinov@gmail.com	Willson, richard/AAD-4832-2019		National Institute of Allergy and Infectious Diseases/National Institutes of Health (NIAID/NIH) [U54 AI057156]; National Science Foundation [CMMI-0900743]; Alliance for Nanohealth grant [W81XWH-09-2-0139]; NIH RC1 grant [1RC1RR028465-01]; CPRIT grant [RP110360]; ARP grant [003652-0186-2009]; Welch Foundation grant [E-1264]; Center for Integrated Bio and Nanosystems and the University of Houston; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057156] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases/National Institutes of Health (NIAID/NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Science Foundation(National Science Foundation (NSF)); Alliance for Nanohealth grant; NIH RC1 grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CPRIT grant; ARP grant; Welch Foundation grant(The Welch Foundation); Center for Integrated Bio and Nanosystems and the University of Houston; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The project described was supported by Grant Number U54 AI057156 from National Institute of Allergy and Infectious Diseases/National Institutes of Health (NIAID/NIH). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the RCE Programs Office, NIAID, or NIH. Support was also provided by the National Science Foundation under Grant Number CMMI-0900743, and by Alliance for Nanohealth grant W81XWH-09-2-0139, NIH RC1 grant 1RC1RR028465-01, CPRIT grant RP110360, ARP grant 003652-0186-2009, and Welch Foundation grant E-1264. The authors thank the Center for Integrated Bio and Nanosystems and the University of Houston Nanofabrication Facility for providing excellent facilities and support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Canelas DA, 2009, WIRES NANOMED NANOBI, V1, P391, DOI 10.1002/wnan.40; DeSimone JN, 2005, ABSTR PAP AM CHEM S, V230, pU3727; Doshi N, 2009, ADV FUNCT MATER, V19, P3843, DOI 10.1002/adfm.200901538; Gratton SEA, 2007, J CONTROL RELEASE, V121, P10, DOI 10.1016/j.jconrel.2007.05.027; Gratton SEA, 2008, ACCOUNTS CHEM RES, V41, P1685, DOI 10.1021/ar8000348; Gratton SEA, 2008, PHARM RES-DORDR, V25, P2845, DOI 10.1007/s11095-008-9654-8; Hartling T, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3425670; Ikeda S, 2002, IEEE T MAGN, V38, P2219, DOI 10.1109/TMAG.2002.802664; Kraus T, 2007, NAT NANOTECHNOL, V2, P570, DOI 10.1038/nnano.2007.262; Lee BH, 2005, J MATER PROCESS TECH, V169, P54, DOI 10.1016/j.jmatprotec.2005.02.259; Lili L, 2010, J NANOSCI NANOTECHNO, V10, P4875; MCGUIRE TR, 1975, IEEE T MAGN, V11, P1018, DOI 10.1109/TMAG.1975.1058782; Mills P, 2009, EUR PHYS J E, V30, P309, DOI 10.1140/epje/i2009-10530-7; Nasrullah A, 2009, J VAC SCI TECHNOL B, V27, P2674, DOI 10.1116/1.3265462; Parekh VA, 2007, NANO LETT, V7, P3246, DOI 10.1021/nl071793r; Petros RA, 2008, J AM CHEM SOC, V130, P5008, DOI 10.1021/ja801436j; Rozhkova EA, 2009, J APPL PHYS, V105, DOI 10.1063/1.3061685; Sherlock T, 2011, J VAC SCI TECHNOL B, V29, DOI 10.1116/1.3656801; Shore MS, 2011, SMALL, V7, P230, DOI 10.1002/smll.201001138; Shukla A, 2010, AICHE J, V56, P2825, DOI 10.1002/aic.12182; Song L, 2010, J NANOSCI NANOTECHNO, V10, P5282; van Megen W, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.258302; Wang DZ, 2005, REV SCI INSTRUM, V76, DOI 10.1063/1.1942531; Wang DZ, 2005, J NANOPART RES, V7, P301, DOI 10.1007/s11051-004-7772-8; Xu MH, 2010, J ALLOY COMPD, V495, P200, DOI 10.1016/j.jallcom.2010.01.121; Zhang H, 2009, NEW J PHYS, V11	26	4	4	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e37440	10.1371/journal.pone.0037440	http://dx.doi.org/10.1371/journal.pone.0037440			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693574	Green Published, Green Submitted, gold			2022-12-27	WOS:000305338500037
J	Wang, HC; Tsai, YL; Wu, YC; Chang, FR; Liu, MH; Chen, WY; Wu, CC				Wang, Hui-Chun; Tsai, Yi-Ling; Wu, Yang-Chang; Chang, Fang-Rong; Liu, Mei-Hsin; Chen, Wen-Ying; Wu, Chin-Chung			Withanolides-Induced Breast Cancer Cell Death Is Correlated with Their Ability to Inhibit Heat Protein 90	PLOS ONE			English	Article							NF-KAPPA-B; COMPOUND WITHAFERIN-A; APOPTOSIS; ACTIVATION; HSP90; PROLIFERATION; EXPRESSION; THERAPY; TARGET; GROWTH	Withanolides are a large group of steroidal lactones found in Solanaceae plants that exhibit potential anticancer activities. We have previously demonstrated that a withanolide, tubocapsenolide A, induced cycle arrest and apoptosis in human breast cancer cells, which was associated with the inhibition of heat shock protein 90 (Hsp90). To investigate whether other withanolides are also capable of inhibiting Hsp90 and to analyze the structure-activity relationships, nine withanolides with different structural properties were tested in human breast cancer cells MDA-MB-231 and MCF-7 in the present study. Our data show that the 2,3-unsaturated double bond-containing withanolides inhibited Hsp90 function, as evidenced by selective depletion of Hsp90 client proteins and induction of Hsp70. The inhibitory effect of the withanolides on Hsp90 chaperone activity was further confirmed using in vivo heat shock luciferase activity recovery assays. Importantly, Hsp90 inhibition by the withanolides was correlated with their ability to induce cancer cell death. In addition, the withanolides reduced constitutive NF-kappa B activation by depleting I kappa B kinase complex (IKK) through inhibition of Hsp90. In estrogen receptor (ER)-positive MCF-7 cells, the withanolides also reduced the expression of ER, and this may be partly due to Hsp90 inhibition. Taken together, our results suggest that Hsp90 inhibition is a general feature of cytotoxic withanolides and plays an important role in their anticancer activity.	[Wang, Hui-Chun; Tsai, Yi-Ling; Chang, Fang-Rong; Liu, Mei-Hsin; Wu, Chin-Chung] Kaohsiung Med Univ, Grad Inst Nat Prod, Kaohsiung, Taiwan; [Wu, Yang-Chang] China Med Univ, Sch Chinese Med, Coll Chinese Med, Taichung, Taiwan; [Wu, Yang-Chang; Chang, Fang-Rong] Kaohsiung Med Univ Hosp, Ctr Canc, Kaohsiung, Taiwan; [Chen, Wen-Ying] Fooyin Univ, Basic Med Sci Educ Ctr, Kaohsiung, Taiwan	Kaohsiung Medical University; China Medical University Taiwan; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Fooyin University	Wang, HC (corresponding author), Kaohsiung Med Univ, Grad Inst Nat Prod, Kaohsiung, Taiwan.	ccwu@kmu.edu.tw	Wang, Hui-Chun/C-5680-2009; Wu, Yang-Chang/C-5682-2009	Wu, Yang-Chang/0000-0001-7815-2686; Wu, Chin-Chung/0000-0003-4203-4084; Chang, Fang-Rong/0000-0003-2549-4193; Wang, Hui-Chun/0000-0003-1414-1595	National Science Council of Taiwan	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by grants from National Science Council of Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagatell R, 2001, CLIN CANCER RES, V7, P2076; Bharti AC, 2002, BIOCHEM PHARMACOL, V64, P883, DOI 10.1016/S0006-2952(02)01154-1; Biswas DK, 2000, P NATL ACAD SCI USA, V97, P8542, DOI 10.1073/pnas.97.15.8542; Biswas DK, 2004, P NATL ACAD SCI USA, V101, P10137, DOI 10.1073/pnas.0403621101; Broemer M, 2004, ONCOGENE, V23, P5378, DOI 10.1038/sj.onc.1207705; Castoria G, 2010, STEROIDS, V75, P524, DOI 10.1016/j.steroids.2009.10.007; Chen LX, 2011, NAT PROD REP, V28, P705, DOI 10.1039/c0np00045k; Chen WY, 2008, J BIOL CHEM, V283, P17184, DOI 10.1074/jbc.M709447200; Chen WY, 2011, INVEST NEW DRUG, V29, P1347, DOI 10.1007/s10637-010-9497-0; Cumming RC, 2004, J BIOL CHEM, V279, P21749, DOI 10.1074/jbc.M312267200; Falsey RR, 2006, NAT CHEM BIOL, V2, P33, DOI 10.1038/nchembio755; FUSKA J, 1984, NEOPLASMA, V31, P31; Grover A, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S1-S30; Guo F, 2005, CANCER RES, V65, P10536, DOI 10.1158/0008-5472.CAN-05-1799; Hernandez A, 2008, MOL CANCER THER, V7, P474, DOI 10.1158/1535-7163.MCT-07-0457; Hertlein E, 2010, BLOOD, V116, P45, DOI 10.1182/blood-2010-01-263756; Hsieh PW, 2007, J NAT PROD, V70, P747, DOI 10.1021/np0605541; Ichikawa H, 2006, MOL CANCER THER, V5, P1434, DOI 10.1158/1535-7163.MCT-06-0096; Kaileh M, 2007, J BIOL CHEM, V282, P4253, DOI 10.1074/jbc.M606728200; Kreuz S, 2001, MOL CELL BIOL, V21, P3964, DOI 10.1128/MCB.21.12.3964-3973.2001; LEE YC, 1995, J CELL BIOCHEM, V57, P150, DOI 10.1002/jcb.240570115; Malik F, 2007, APOPTOSIS, V12, P2115, DOI 10.1007/s10495-007-0129-x; Mirjalili MH, 2009, MOLECULES, V14, P2373, DOI 10.3390/molecules14072373; Mishra L C, 2000, Altern Med Rev, V5, P334; Mitsiades CS, 2006, BLOOD, V107, P1092, DOI 10.1182/blood-2005-03-1158; Nakshatri H, 1997, MOL CELL BIOL, V17, P3629, DOI 10.1128/MCB.17.7.3629; Pan MR, 2009, J BIOL CHEM, V284, P2746, DOI 10.1074/jbc.M806223200; Park BK, 2007, NAT MED, V13, P62, DOI 10.1038/nm1519; Powers MV, 2008, CANCER CELL, V14, P250, DOI 10.1016/j.ccr.2008.08.002; Prasad S, 2010, MOL CELL BIOCHEM, V336, P25, DOI 10.1007/s11010-009-0267-2; Sabzevari O, 2004, CHEM-BIOL INTERACT, V148, P57, DOI 10.1016/j.cbi.2004.04.004; Schneider C, 1996, P NATL ACAD SCI USA, V93, P14536, DOI 10.1073/pnas.93.25.14536; Segnitz B, 1997, J BIOL CHEM, V272, P18694, DOI 10.1074/jbc.272.30.18694; Sovak MA, 1997, J CLIN INVEST, V100, P2952, DOI 10.1172/JCI119848; Srinivasan S, 2007, CANCER RES, V67, P246, DOI 10.1158/0008-5472.CAN-06-2430; Van Waes C, 2007, CLIN CANCER RES, V13, P1076, DOI 10.1158/1078-0432.CCR-06-2221; Wang XB, 2007, NAT CELL BIOL, V9, P470, DOI 10.1038/ncb1559; Yang HJ, 2007, MOL PHARMACOL, V71, P426, DOI 10.1124/mol.106.030015; Yen CY, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-46; Yu YK, 2010, BIOCHEM PHARMACOL, V79, P542, DOI 10.1016/j.bcp.2009.09.017	40	28	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e37764	10.1371/journal.pone.0037764	http://dx.doi.org/10.1371/journal.pone.0037764			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22701533	Green Published, gold, Green Submitted			2022-12-27	WOS:000305338500054
J	Huebner, GM; Gegenfurtner, KR				Huebner, Gesche M.; Gegenfurtner, Karl R.			Conceptual and Visual Features Contribute to Visual Memory for Natural Images	PLOS ONE			English	Article							LONG-TERM-MEMORY; RECOGNITION MEMORY; OBJECT RECOGNITION; SCENE MEMORY; PICTURES; WORLD; RECOLLECTION; PICTORIAL; REPRESENTATION; FAMILIARITY	We examined the role of conceptual and visual similarity in a memory task for natural images. The important novelty of our approach was that visual similarity was determined using an algorithm [1] instead of being judged subjectively. This similarity index takes colours and spatial frequencies into account. For each target, four distractors were selected that were (1) conceptually and visually similar, (2) only conceptually similar, (3) only visually similar, or (4) neither conceptually nor visually similar to the target image. Participants viewed 219 images with the instruction to memorize them. Memory for a subset of these images was tested subsequently. In Experiment 1, participants performed a two-alternative forced choice recognition task and in Experiment 2, a yes/no-recognition task. In Experiment 3, testing occurred after a delay of one week. We analyzed the distribution of errors depending on distractor type. Performance was lowest when the distractor image was conceptually and visually similar to the target image, indicating that both factors matter in such a memory task. After delayed testing, these differences disappeared. Overall performance was high, indicating a large-capacity, detailed visual long-term memory.	[Huebner, Gesche M.; Gegenfurtner, Karl R.] Univ Giessen, Dept Psychol, Giessen, Germany	Justus Liebig University Giessen	Huebner, GM (corresponding author), Univ Giessen, Dept Psychol, Giessen, Germany.	gesche.huebner@gmail.com		Gegenfurtner, Karl/0000-0001-5390-0684; Huebner, Gesche/0000-0002-1304-4366	DFG Graduate School "NeuroACt"	DFG Graduate School "NeuroACt"	This work was supported by a scholarship of the DFG Graduate School "NeuroACt" to Gesche M. Huebner (http://www.dfg.de/en/index.jsp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brady TF, 2008, P NATL ACAD SCI USA, V105, P14325, DOI 10.1073/pnas.0803390105; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brockmole JR, 2006, VIS COGN, V13, P99, DOI 10.1080/13506280500165188; BULTHOFF HH, 1992, P NATL ACAD SCI USA, V89, P60, DOI 10.1073/pnas.89.1.60; BUSEY TA, 1994, PSYCHOL REV, V101, P446, DOI 10.1037/0033-295X.101.3.446; Castelhano MS, 2005, VIS COGN, V12, P1017, DOI 10.1080/13506280444000634; Cook GI, 2005, PSYCHON B REV, V12, P720, DOI 10.3758/BF03196763; DEWHURST SA, 1994, J EXP PSYCHOL LEARN, V20, P1088, DOI 10.1037/0278-7393.20.5.1088; GOLDSTEIN AG, 1974, J GEN PSYCHOL, V90, P69, DOI 10.1080/00221309.1974.9920745; Grimes J., 1996, PERCEPTION, P89; Hayward WG, 1997, J EXP PSYCHOL HUMAN, V23, P1511, DOI 10.1037/0096-1523.23.5.1511; Henderson JM, 2003, PSYCHOL SCI, V14, P493, DOI 10.1111/1467-9280.02459; Henderson JM, 1999, PSYCHOL SCI, V10, P438, DOI 10.1111/1467-9280.00183; Hollingworth A, 2005, J EXP PSYCHOL LEARN, V31, P396, DOI 10.1037/0278-7393.31.3.396; Hollingworth A, 2004, J EXP PSYCHOL HUMAN, V30, P519, DOI 10.1037/0096-1523.30.3.519; Hollingworth A, 2002, J EXP PSYCHOL HUMAN, V28, P113, DOI 10.1037//0096-1523.28.1.113; Khoe W, 2000, NEUROPSYCHOLOGIA, V38, P1333, DOI 10.1016/S0028-3932(00)00055-5; Konkle T, 2010, PSYCHOL SCI, V21, P1551, DOI 10.1177/0956797610385359; Konkle T, 2010, J EXP PSYCHOL GEN, V139, P558, DOI 10.1037/a0019165; Mandler G, 2008, PERSPECT PSYCHOL SCI, V3, P390, DOI 10.1111/j.1745-6924.2008.00087.x; McConkie GW, 1996, J EXP PSYCHOL HUMAN, V22, P563, DOI 10.1037/0096-1523.22.3.563; NELSON DL, 1976, J EXP PSYCHOL-HUM L, V2, P523, DOI 10.1037/0278-7393.2.5.523; NELSON DL, 1976, J EXP PSYCHOL-HUM L, V2, P49; Neumann D., 2006, ACM T APPL PERCEPT, V3, P31, DOI [10.1145/1119766. 1119769, DOI 10.1145/1119766]; NICKERSON RS, 1965, CAN J PSYCHOLOGY, V19, P155, DOI 10.1037/h0082899; O'Regan JK, 2001, BEHAV BRAIN SCI, V24, P939, DOI 10.1017/S0140525X01000115; OREGAN JK, 1992, CAN J PSYCHOL, V46, P461, DOI 10.1037/h0084327; PAIVIO A, 1991, CAN J PSYCHOL, V45, P255, DOI 10.1037/h0084295; PAIVIO A, 1969, PSYCHOL REV, V76, P241, DOI 10.1037/h0027272; Paivio A, 1971, IMAGERY VERBAL PROCE; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Potter MC, 2004, J EXP PSYCHOL HUMAN, V30, P478, DOI 10.1037/0096-1523.30.3.478; Rasche C, 2010, INT J COMPUT VISION, V87, P337, DOI 10.1007/s11263-009-0286-1; Rensink RA, 1997, PSYCHOL SCI, V8, P368, DOI 10.1111/j.1467-9280.1997.tb00427.x; SHEPARD RN, 1967, J VERB LEARN VERB BE, V6, P156, DOI 10.1016/S0022-5371(67)80067-7; Simons DJ, 1998, PSYCHON B REV, V5, P644, DOI 10.3758/BF03208840; STANDING L, 1973, Q J EXP PSYCHOL, V25, P207, DOI 10.1080/14640747308400340; Standing L., 1970, PSYCHON SCI, V19, P169; Tarr MJ, 1998, NAT NEUROSCI, V1, P275, DOI 10.1038/1089; Tatler BW, 2005, Q J EXP PSYCHOL-A, V58, P931, DOI 10.1080/02724980443000430; Vogt S, 2007, EXP PSYCHOL, V54, P298, DOI 10.1027/1618-3169.54.4.298; Yonelinas AP, 2005, J NEUROSCI, V25, P3002, DOI 10.1523/JNEUROSCI.5295-04.2005	42	19	20	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e37575	10.1371/journal.pone.0037575	http://dx.doi.org/10.1371/journal.pone.0037575			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UV	22719842	Green Submitted, Green Published, gold			2022-12-27	WOS:000305341900011
J	Koster, A; Caserotti, P; Patel, KV; Matthews, CE; Berrigan, D; Van Domelen, DR; Brychta, RJ; Chen, KY; Harris, TB				Koster, Annemarie; Caserotti, Paolo; Patel, Kushang V.; Matthews, Charles E.; Berrigan, David; Van Domelen, Dane R.; Brychta, Robert J.; Chen, Kong Y.; Harris, Tamara B.			Association of Sedentary Time with Mortality Independent of Moderate to Vigorous Physical Activity	PLOS ONE			English	Article							TELEVISION VIEWING TIME; CARDIOVASCULAR-DISEASE; METABOLIC SYNDROME; UNITED-STATES; LIFE-STYLE; ALL-CAUSE; RISK; OBESITY; BEHAVIORS; AUSDIAB	Background: Sedentary behavior has emerged as a novel health risk factor independent of moderate to vigorous physical activity (MVPA). Previous studies have shown self-reported sedentary time to be associated with mortality; however, no studies have investigated the effect of objectively measured sedentary time on mortality independent of MVPA. The objective our study was to examine the association between objectively measured sedentary time and all-cause mortality. Methods: 7-day accelerometry data of 1906 participants aged 50 and over from the U. S. nationally representative National Health and Nutrition Examination Survey (NHANES) 2003-2004 were analyzed. All-cause mortality was assessed from the date of examination through December 31, 2006. Results: Over an average follow-up of 2.8 years, there were 145 deaths reported. In a model adjusted for sociodemographic factors, lifestyle factors, multiple morbidities, mobility limitation, and MVPA, participants in third quartile (hazard ratio (HR):4.05; 95% CI:1.55-10.60) and fourth quartile (HR:5.94; 95% CI: 2.49-14.15) of having higher percent sedentary time had a significantly increased risk of death compared to those in the lowest quartile. Conclusions: Our study suggests that sedentary behavior is a risk factor for mortality independent of MVPA. Further investigation, including studies with longer follow-up, is needed to address the health consequences of sedentary behavior.	[Koster, Annemarie; Caserotti, Paolo; Patel, Kushang V.; Van Domelen, Dane R.; Harris, Tamara B.] NIA, Intramural Res Program, Lab Epidemiol Demog & Biometry, Bethesda, MD 20892 USA; [Koster, Annemarie] Maastricht Univ, CAPHRI Sch Publ Hlth & Primary Care, Dept Social Med, Maastricht, Netherlands; [Caserotti, Paolo] Univ So Denmark, Inst Sports Sci & Clin Biomech, Odense, Denmark; [Matthews, Charles E.] NCI, Div Canc Epidemiol & Genet Nutrit Epidemiol, Rockville, MD USA; [Berrigan, David] NCI, Div Canc Control & Populat Sci, Appl Res Program, Bethesda, MD USA; [Brychta, Robert J.; Chen, Kong Y.] NIDDKD, Bethesda, MD 20892 USA; [Brychta, Robert J.; Chen, Kong Y.] Obes Branch, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Maastricht University; University of Southern Denmark; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Koster, A (corresponding author), NIA, Intramural Res Program, Lab Epidemiol Demog & Biometry, Bethesda, MD 20892 USA.	a.koster@maastrichtuniversity.nl	Chen, Kong/P-1685-2019; Berrigan, David/AAF-1576-2020; Koster, Annemarie/E-7438-2010; Chen, Kong Y/L-6972-2017; matthews, Charles e/E-8073-2015	Chen, Kong/0000-0002-0306-1904; Koster, Annemarie/0000-0003-1583-7391; Chen, Kong Y/0000-0002-0306-1904; matthews, Charles e/0000-0001-8037-3103; Berrigan, David/0000-0002-5333-179X; Van Domelen, Dane/0000-0003-0051-7790	NATIONAL CANCER INSTITUTE [ZIACP010197] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000732] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZICDK071013, ZIADK071014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG006020] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Bankoski A, 2011, DIABETES CARE, V34, P497, DOI 10.2337/dc10-0987; Dunstan DW, 2010, CIRCULATION, V121, P384, DOI 10.1161/CIRCULATIONAHA.109.894824; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; Hamilton MT, 2007, DIABETES, V56, P2655, DOI 10.2337/db07-0882; Healy GN, 2008, DIABETES CARE, V31, P369, DOI 10.2337/dc07-1795; Healy GN, 2008, DIABETES CARE, V31, P661, DOI 10.2337/dc07-2046; Katzmarzyk PT, 2009, MED SCI SPORT EXER, V41, P998, DOI 10.1249/MSS.0b013e3181930355; Kujala UM, 1998, JAMA-J AM MED ASSOC, V279, P440, DOI 10.1001/jama.279.6.440; Leitzmann MF, 2007, ARCH INTERN MED, V167, P2453, DOI 10.1001/archinte.167.22.2453; Lollgen H, 2009, INT J SPORTS MED, V30, P213, DOI 10.1055/s-0028-1128150; Matthews CE, 2008, AM J EPIDEMIOL, V167, P875, DOI 10.1093/aje/kwm390; National Cancer Institute, RISK FACT MON METH S; NHANES, 1999, LINK MORT FIL; Owen N, 2010, MAYO CLIN PROC, V85, P1138, DOI 10.4065/mcp.2010.0444; Patel AV, 2010, AM J EPIDEMIOL, V172, P419, DOI 10.1093/aje/kwq155; Physical Activity Guidelines Advisory Committee, 2008, PHYS ACT GUID AM; Safdar A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010778; Sallis JF, 2000, RES Q EXERCISE SPORT, V71, pS1, DOI 10.1080/02701367.2000.11082780; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Warren TY, 2010, MED SCI SPORT EXER, V42, P879, DOI 10.1249/MSS.0b013e3181c3aa7e; Wijndaele K, 2011, INT J EPIDEMIOL, V40, P150, DOI 10.1093/ije/dyq105	21	204	208	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e37696	10.1371/journal.pone.0037696	http://dx.doi.org/10.1371/journal.pone.0037696			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22719846	gold, Green Published, Green Submitted			2022-12-27	WOS:000305341900012
J	Meyerhardt, JA; Ancukiewicz, M; Abrams, TA; Schrag, D; Enzinger, PC; Chan, JA; Kulke, MH; Wolpin, BM; Goldstein, M; Blaszkowsky, L; Zhu, AX; Elliott, M; Regan, E; Jain, RK; Duda, DG				Meyerhardt, Jeffrey A.; Ancukiewicz, Marek; Abrams, Thomas A.; Schrag, Deborah; Enzinger, Peter C.; Chan, Jennifer A.; Kulke, Matthew H.; Wolpin, Brian M.; Goldstein, Michael; Blaszkowsky, Lawrence; Zhu, Andrew X.; Elliott, Meaghan; Regan, Eileen; Jain, Rakesh K.; Duda, Dan G.			Phase I Study of Cetuximab, Irinotecan, and Vandetanib (ZD6474) as Therapy for Patients with Previously Treated Metastastic Colorectal Cancer	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; TYROSINE KINASE INHIBITOR; ERLOTINIB OSI-774; PTK787/ZK 222584; PLUS IRINOTECAN; BEVACIZUMAB; LEUCOVORIN; TRIAL; OXALIPLATIN; GEFITINIB	Background: To determine the maximum tolerated dose (MTD) and safety, and explore efficacy and biomarkers of vandetanib with cetuximab and irinotecan in second-line metastatic colorectal cancer. Methods: Vandetanib (an orally bioavailable VEGFR-2 and EGFR tyrosine kinases inhibitor) was combined at 100 mg, 200 mg, or 300 mg daily with standard dosed cetuximab and irinotecan (3+3 dose-escalation design). Ten patients were treated at the MTD and plasma angiogenesis biomarkers (VEGF, PlGF, bFGF, sVEGFR1, sVEGFR2, IL-1 beta, IL-6, IL-8, TNF-alpha, SDF1 alpha) were measured before and after treatment. Results: Twenty-seven patients were enrolled at 4 dose levels and the MTD. Two dose-limiting toxicities (grade 3 QTc prolongation and diarrhea) were detected at 300 mg of vandetanib with cetuximab and irinotecan resulting in 200 mg being the MTD. Seven percent of patients had a partial response, 59% stable disease and 34% progressed. Median progression-free survival was 3.6 months (95% CI, 3.2-5.6) and median overall survival was 10.5 months (95% CI, 5.1-20.7). Toxicities were fairly manageable with grade 3 or 4 diarrhea being most prominent (30%). Vandetanib and cetuximab treatment induced a sustained increase in plasma PlGF and a transient decrease in plasma sVEGFR1, but no changes in plasma VEGF and sVEGFR2. Conclusions: Vandetanib can be safely combined with cetuximab and irinotecan for metastatic colorectal cancer. Exploratory biomarker analyses suggest differential effects on certain plasma biomarkers for VEGFR inhibition when combined with EGFR blockade and a potential correlation between baseline sVEGFR1 and response. However, while the primary endpoint was safety, the observed efficacy raises concern for moving forward with this combination.	[Meyerhardt, Jeffrey A.; Abrams, Thomas A.; Schrag, Deborah; Enzinger, Peter C.; Chan, Jennifer A.; Kulke, Matthew H.; Wolpin, Brian M.; Elliott, Meaghan; Regan, Eileen] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Ancukiewicz, Marek; Jain, Rakesh K.; Duda, Dan G.] Massachusetts Gen Hosp, Steele Lab Tumor Biol, Dept Radiat Oncol, Boston, MA 02114 USA; [Goldstein, Michael] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Blaszkowsky, Lawrence; Zhu, Andrew X.] Massachusetts Gen Hosp, Div Med Oncol, Boston, MA 02114 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts General Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Massachusetts General Hospital	Meyerhardt, JA (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.	jmeyerhardt@partners.org	Jain, Rakesh K/I-1384-2017; Duda, Dan G/H-8523-2014	Jain, Rakesh K/0000-0001-7571-3548; Duda, Dan G/0000-0001-7065-8797	Astra-Zeneca; Federal Share/National Cancer Institute Proton Beam Program Income Grants [P01-CA080124]; GI SPORE grant [P50CA127003]; National Foundation for Cancer Research (NFCR); NATIONAL CANCER INSTITUTE [P01CA080124, P50CA127003, K07CA140790] Funding Source: NIH RePORTER	Astra-Zeneca(AstraZeneca); Federal Share/National Cancer Institute Proton Beam Program Income Grants; GI SPORE grant; National Foundation for Cancer Research (NFCR); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by Astra-Zeneca and in part by P01-CA080124 (to RKJ), Federal Share/National Cancer Institute Proton Beam Program Income Grants (to RKJ and DGD), and GI SPORE grant P50CA127003. RKJ is funded by the National Foundation for Cancer Research (NFCR) as a NFCR Project Director. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allegra CJ, 2009, J CLIN ONCOL, V27, P2091, DOI 10.1200/JCO.2009.21.9170; Bibeau F, 2008, J CLIN ONCOL, V26, DOI 10.1200/jco.2008.26.15_suppl.11004; Bozec A, 2006, CURR OPIN ONCOL, V18, P330, DOI 10.1097/01.cco.0000228737.78003.06; Carlomagno F, 2002, CANCER RES, V62, P7284; Cercek A, 2010, CURR ONCOL REP, V12, P153, DOI 10.1007/s11912-010-0096-1; Cho CD, 2006, INVEST NEW DRUG, V24, P117, DOI 10.1007/s10637-006-2032-7; Ciardiello F, 2004, CLIN CANCER RES, V10, P784, DOI 10.1158/1078-0432.CCR-1100-03; Commander H, 2011, DRUGS, V71, P1355, DOI 10.2165/11595310-000000000-00000; Cunningham D, 2004, NEW ENGL J MED, V351, P337, DOI 10.1056/NEJMoa033025; De Roock W, 2010, LANCET ONCOL, V11, P753, DOI 10.1016/S1470-2045(10)70130-3; Duda DG, 2010, ONCOLOGIST, V15, P577, DOI 10.1634/theoncologist.2010-0029; Duda DG, 2010, J CLIN ONCOL, V28, P183, DOI 10.1200/JCO.2009.24.8021; Genovese CR, 2006, BIOMETRIKA, V93, P509, DOI 10.1093/biomet/93.3.509; Giantonio BJ, 2007, J CLIN ONCOL, V25, P1539, DOI 10.1200/JCO.2006.09.6305; Hanrahan EO, 2010, J CLIN ONCOL, V28, P193, DOI 10.1200/JCO.2009.22.4279; Hecht JR, 2007, CANCER-AM CANCER SOC, V110, P980, DOI 10.1002/cncr.22915; Hecht JR, 2011, J CLIN ONCOL, V29, P1997, DOI 10.1200/JCO.2010.29.4496; Hecht JR, 2009, J CLIN ONCOL, V27, P672, DOI 10.1200/JCO.2008.19.8135; Herbst RS, 2010, LANCET ONCOL, V11, P619, DOI 10.1016/S1470-2045(10)70132-7; Huang SM, 2004, CANCER RES, V64, P5355, DOI 10.1158/0008-5472.CAN-04-0562; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Jain RK, 2009, NAT REV CLIN ONCOL, V6, P327, DOI 10.1038/nrclinonc.2009.63; Jain RK, 2006, NAT CLIN PRACT ONCOL, V3, P24, DOI 10.1038/ncponc0403; Jung YD, 2002, EUR J CANCER, V38, P1133, DOI 10.1016/S0959-8049(02)00013-8; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Keilholz U, 2005, J CLIN ONCOLOGY 2005, V23; Lindsey H, 2006, LANCET ONCOL, V7, P15, DOI 10.1016/S1470-2045(05)70521-0; Matar P, 2004, CLIN CANCER RES, V10, P6487, DOI 10.1158/1078-0432.CCR-04-0870; McCarty MF, 2004, MOL CANCER THER, V3, P1041; Messersmith WA, 2004, CLIN CANCER RES, V10, P6522, DOI 10.1158/1078-0432.CCR-04-0746; Meyerhardt JA, 2007, ANN ONCOL, V18, P1185, DOI 10.1093/annonc/mdm124; Meyerhardt JA, 2006, J CLIN ONCOL, V24, P1892, DOI 10.1200/JCO.2005.05.3728; Meyerhardt JA, 2007, CANC CHEMOTHER PHARM; Midgley R, 2001, EXPERT OPIN INV DRUG, V10, P1011; Regales L, 2009, J CLIN INVEST, V119, P3000, DOI 10.1172/JCI38746; Ries LAG, 2003, SEER CANC STAT REV 1; Rothenberg ML, 2005, J CLIN ONCOL, V23, P9265, DOI 10.1200/JCO.2005.03.0536; Saltz LB, 2004, J CLIN ONCOL, V22, P1201, DOI 10.1200/JCO.2004.10.182; Saltz LB, 2007, J CLIN ONCOL, V25, P4557, DOI 10.1200/JCO.2007.12.0949; Sandler A, 2006, CLIN CANCER RES, V12, p4421S, DOI 10.1158/1078-0432.CCR-06-0796; Sargent DJ, 2009, J CLIN ONCOL, V27, P1948, DOI 10.1200/JCO.2008.20.2879; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Spigel DR, 2006, PHASE 2 STUDY FOLFOX; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Tol J, 2009, NEW ENGL J MED, V360, P563, DOI 10.1056/NEJMoa0808268; Townsley CA, 2006, BRIT J CANCER, V94, P1136, DOI 10.1038/sj.bjc.6603055; Van Cutsem E, 2011, J CLIN ONCOL, V29, P2004, DOI 10.1200/JCO.2010.29.5436; Veronese ML, 2005, BRIT J CANCER, V92, P1846, DOI 10.1038/sj.bjc.6602569; Vincenzi B, 2007, PHARMACOGENOMICS, V8, P319, DOI 10.2217/14622416.8.4.319; Wedge SR, 2002, CANCER RES, V62, P4645; Wells Jr. SA, 2011, J CLIN ONCOL; Willett CG, 2009, J CLIN ONCOL, V27, P3020, DOI 10.1200/JCO.2008.21.1771; Wolpin BM, 2006, CLIN COLORECTAL CANC, V6, P208, DOI 10.3816/CCC.2006.n.037	53	42	42	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2012	7	6							e38231	10.1371/journal.pone.0038231	http://dx.doi.org/10.1371/journal.pone.0038231			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UJ	22701615	Green Published, gold, Green Submitted			2022-12-27	WOS:000305340000015
J	Pillai, AG; de Jong, D; Kanatsou, S; Krugers, H; Knapman, A; Heinzmann, JM; Holsboer, F; Landgraf, R; Joels, M; Touma, C				Pillai, Anup G.; de Jong, Danielle; Kanatsou, Sofia; Krugers, Harm; Knapman, Alana; Heinzmann, Jan-Michael; Holsboer, Florian; Landgraf, Rainer; Joels, Marian; Touma, Chadi			Dendritic Morphology of Hippocampal and Amygdalar Neurons in Adolescent Mice Is Resilient to Genetic Differences in Stress Reactivity	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING HORMONE; RECURRENT MAJOR DEPRESSION; PITUITARY-ADRENAL AXIS; CHRONIC PSYCHOSOCIAL STRESS; CA3 PYRAMIDAL NEURONS; HIGH FAMILIAL RISK; AFFECTIVE-DISORDERS; MUNICH VULNERABILITY; JUVENILE STRESS; ADRENOCORTICAL REGULATION	Many studies have shown that chronic stress or corticosterone over-exposure in rodents leads to extensive dendritic remodeling, particularly of principal neurons in the CA3 hippocampal area and the basolateral amygdala. We here investigated to what extent genetic predisposition of mice to high versus low stress reactivity, achieved through selective breeding of CD-1 mice, is also associated with structural plasticity in Golgi-stained neurons. Earlier, it was shown that the highly stress reactive (HR) compared to the intermediate (IR) and low (LR) stress reactive mice line presents a phenotype, with respect to neuroendocrine parameters, sleep architecture, emotional behavior and cognition, that recapitulates some of the features observed in patients suffering from major depression. In late adolescent males of the HR, IR, and LR mouse lines, we observed no significant differences in total dendritic length, number of branch points and branch tips, summated tip order, number of primary dendrites or dendritic complexity of either CA3 pyramidal neurons (apical as well as basal dendrites) or principal neurons in the basolateral amygdala. Apical dendrites of CA1 pyramidal neurons were also unaffected by the differences in stress reactivity of the animals; marginally higher length and complexity of the basal dendrites were found in LR compared to IR but not HR mice. In the same CA1 pyramidal neurons, spine density of distal apical tertiary dendrites was significantly higher in LR compared to IR or HR animals. We tentatively conclude that the dendritic complexity of principal hippocampal and amygdala neurons is remarkably stable in the light of a genetic predisposition to high versus low stress reactivity, while spine density seems more plastic. The latter possibly contributes to the behavioral phenotype of LR versus HR animals.	[Pillai, Anup G.; Kanatsou, Sofia; Joels, Marian] Univ Med Ctr, Dept Neurosci & Pharmacol, RMI, Utrecht, Netherlands; [Knapman, Alana; Heinzmann, Jan-Michael; Holsboer, Florian; Landgraf, Rainer; Touma, Chadi] Max Planck Inst Psychiat, D-80804 Munich, Germany; [Pillai, Anup G.; de Jong, Danielle; Kanatsou, Sofia; Krugers, Harm; Joels, Marian] Univ Amsterdam, Swammerdam Inst Life Sci, Ctr Neurosci, NL-1012 WX Amsterdam, Netherlands	Utrecht University; Utrecht University Medical Center; Max Planck Society; University of Amsterdam	Pillai, AG (corresponding author), Univ Med Ctr, Dept Neurosci & Pharmacol, RMI, Utrecht, Netherlands.	A.G.Pillai@umcutrecht.nl	Touma, Chadi/G-4677-2011; de Jong - Bolm, Danielle/AAT-6112-2020; Joëls, Marian/P-6415-2016	de Jong - Bolm, Danielle/0000-0002-7422-1725; Pillai, Anup/0000-0001-9788-1286; Joels, Marian/0000-0002-4826-6209	Max Planck society	Max Planck society(Max Planck Society)	The research was supported by a grant from Max Planck society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam EK, 2008, DEV PSYCHOPATHOL, V20, P975, DOI 10.1017/S0954579408000461; Adam EK, 2010, PSYCHONEUROENDOCRINO, V35, P921, DOI 10.1016/j.psyneuen.2009.12.007; Alfarez DN, 2009, HIPPOCAMPUS, V19, P828, DOI 10.1002/hipo.20566; Avital A, 2005, INT J NEUROPSYCHOPH, V8, P163, DOI 10.1017/S1461145704004808; Bersani G, 2010, EUR PSYCHIAT, V25, P461, DOI 10.1016/j.eurpsy.2010.01.002; Bremner JD, 2000, AM J PSYCHIAT, V157, P115, DOI 10.1176/ajp.157.1.115; Checkley S, 1996, BRIT MED BULL, V52, P597; Choi SJ, 1997, DEV BRAIN RES, V98, P134, DOI 10.1016/S0165-3806(96)00179-4; Coplan JD, 1996, P NATL ACAD SCI USA, V93, P1619, DOI 10.1073/pnas.93.4.1619; Dallmann R, 2006, J COMP PHYSIOL A, V192, P769, DOI 10.1007/s00359-006-0114-9; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; DEBELLIS MD, 1993, AM J PSYCHIAT, V150, P656; DEBELLIS MD, 1994, J CLIN ENDOCR METAB, V78, P249, DOI 10.1210/jc.78.2.249; Deuschle M, 1997, J CLIN ENDOCR METAB, V82, P234, DOI 10.1210/jc.82.1.234; Donohue HS, 2006, NEUROSCIENCE, V140, P597, DOI 10.1016/j.neuroscience.2006.02.072; Engeland WC, 2005, ENDOCRINE, V28, P325, DOI 10.1385/ENDO:28:3:325; Fenzl T, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-29; Friess E, 2008, EUR ARCH PSY CLIN N, V258, P285, DOI 10.1007/s00406-007-0795-2; Frodl T, 2002, BIOL PSYCHIAT, V51, P708, DOI 10.1016/S0006-3223(01)01359-2; Frodl T, 2010, J PSYCHIATR RES, V44, P799, DOI 10.1016/j.jpsychires.2010.01.006; HALBERG F, 1959, AM J PHYSIOL, V197, P1083, DOI 10.1152/ajplegacy.1959.197.5.1083; Heim C, 2008, PSYCHONEUROENDOCRINO, V33, P693, DOI 10.1016/j.psyneuen.2008.03.008; Heinzmann JM, 2010, J NEUROENDOCRINOL, V22, P1187, DOI 10.1111/j.1365-2826.2010.02062.x; Heuser IJE, 1996, AM J PSYCHIAT, V153, P93; HOLSBOER F, 1995, NEUROENDOCRINOLOGY, V62, P340, DOI 10.1159/000127023; Holsboer F, 2000, NEUROPSYCHOPHARMACOL, V23, P477, DOI 10.1016/S0893-133X(00)00159-7; Holsboer F, 1996, ENDOCR REV, V17, P187, DOI 10.1210/er.17.2.187; HOLSBOER F, 1987, BIOL PSYCHIAT, V22, P228, DOI 10.1016/0006-3223(87)90237-X; HOLSBOERTRACHSLER E, 1994, J PSYCHIATR RES, V28, P381, DOI 10.1016/0022-3956(94)90020-5; HORNER CH, 1991, J ANAT, V177, P179; Ising M, 2005, J PSYCHIATR RES, V39, P21, DOI 10.1016/j.jpsychires.2004.04.009; Ising M, 2005, PROG NEURO-PSYCHOPH, V29, P1085, DOI 10.1016/j.pnpbp.2005.03.014; Johnson SA, 2009, NEUROSCIENCE, V163, P34, DOI 10.1016/j.neuroscience.2009.06.005; Keller J, 2008, AM J PSYCHIAT, V165, P872, DOI 10.1176/appi.ajp.2008.07081257; Keller J, 2006, BIOL PSYCHIAT, V60, P275, DOI 10.1016/j.biopsych.2005.10.014; Kellogg CK, 1998, NEUROSCIENCE, V83, P681, DOI 10.1016/S0306-4522(97)00408-9; Knapman A, 2010, NEUROBIOL LEARN MEM, V94, P145, DOI 10.1016/j.nlm.2010.04.010; Knapman A, 2010, J PSYCHIATR RES, V44, P566, DOI 10.1016/j.jpsychires.2009.11.014; Lauer CJ, 1998, J PSYCHIAT RES, V32, P393, DOI 10.1016/S0022-3956(98)00026-0; Lenze SN, 2008, PSYCHIAT RES-NEUROIM, V162, P39, DOI 10.1016/j.pscychresns.2007.04.004; Lupien SJ, 1998, NAT NEUROSCI, V1, P69, DOI 10.1038/271; Magarinos AM, 1996, J NEUROSCI, V16, P3534; Manji HK, 2003, BIOL PSYCHIAT, V53, P707, DOI 10.1016/S0006-3223(03)00117-3; McEwen BS, 1999, ANNU REV NEUROSCI, V22, P105, DOI 10.1146/annurev.neuro.22.1.105; Mervaala E, 2000, PSYCHOL MED, V30, P117, DOI 10.1017/S0033291799001567; Mitra R, 2008, P NATL ACAD SCI USA, V105, P5573, DOI 10.1073/pnas.0705615105; Modell S, 1998, NEUROPSYCHOPHARMACOL, V18, P253; Modell S, 1997, NEUROENDOCRINOLOGY, V65, P216, DOI 10.1159/000127275; Morales-Medina JC, 2009, J CHEM NEUROANAT, V38, P266, DOI 10.1016/j.jchemneu.2009.05.009; Ohl F, 2000, PSYCHONEUROENDOCRINO, V25, P357, DOI 10.1016/S0306-4530(99)00062-1; Pawlak R, 2005, P NATL ACAD SCI USA, V102, P18201, DOI 10.1073/pnas.0509232102; Peleg-Raibstein D, 2011, PSYCHOPHARMACOLOGY, V214, P339, DOI 10.1007/s00213-010-1991-8; Rao U, 2010, BIOL PSYCHIAT, V67, P357, DOI 10.1016/j.biopsych.2009.10.017; RUBIN RT, 1987, ARCH GEN PSYCHIAT, V44, P328; Sheline YI, 2000, BIOL PSYCHIAT, V48, P791, DOI 10.1016/S0006-3223(00)00994-X; Sheline YI, 1998, NEUROREPORT, V9, P2023, DOI 10.1097/00001756-199806220-00021; Sheline YI, 1996, P NATL ACAD SCI USA, V93, P3908, DOI 10.1073/pnas.93.9.3908; Sheline YI, 2003, BIOL PSYCHIAT, V54, P338, DOI 10.1016/S0006-3223(03)00347-0; Sheline YI, 1999, J NEUROSCI, V19, P5034; Sousa N, 2000, NEUROSCIENCE, V97, P253, DOI 10.1016/S0306-4522(00)00050-6; Touma C, 2008, PSYCHONEUROENDOCRINO, V33, P839, DOI 10.1016/j.psyneuen.2008.03.013; Touma C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004325; Tsoory M, 2007, EUR NEUROPSYCHOPHARM, V17, P245, DOI 10.1016/j.euroneuro.2006.06.007; Vazquez DM, 1998, PSYCHONEUROENDOCRINO, V23, P663; Vyas A, 2004, NEUROSCIENCE, V128, P667, DOI 10.1016/j.neuroscience.2004.07.013; Vyas A, 2002, J NEUROSCI, V22, P6810; WATANABE Y, 1992, BRAIN RES, V588, P341, DOI 10.1016/0006-8993(92)91597-8; Wong ML, 2000, P NATL ACAD SCI USA, V97, P325, DOI 10.1073/pnas.97.1.325; Zobel AW, 1999, AM J PSYCHIAT, V156, P949, DOI 10.1176/ajp.156.6.949	69	63	63	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2012	7	6							e38971	10.1371/journal.pone.0038971	http://dx.doi.org/10.1371/journal.pone.0038971			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UJ	22701737	Green Published, Green Submitted, gold			2022-12-27	WOS:000305340000057
J	Zhao, YL; Wang, H; Gustafsson, M; Muraro, A; Bruhn, S; Benson, M				Zhao, Yelin; Wang, Hui; Gustafsson, Mika; Muraro, Antonella; Bruhn, Soren; Benson, Mikael			Combined Multivariate and Pathway Analyses Show That Allergen-Induced Gene Expression Changes in CD4(+) T Cells Are Reversed by Glucocorticoids	PLOS ONE			English	Article							RHINITIS; APOPTOSIS; RESPONSES; MECHANISM; CYTOKINES; PROTEIN	Background: Glucocorticoids (GCs) play a key role in the treatment of allergy. However, the genome-wide effects of GCs on gene expression in allergen-challenged CD4(+) T cells have not been described. The aim of this study was to perform a genome-wide analysis to investigate whether allergen-induced gene expression changes in CD4(+) T cells could be reversed by GCs. Methodology/Principal Findings: Gene expression microarray analysis was performed to profile gene expression in diluent( D), allergen- (A), and allergen + hydrocortisone- (T) challenged CD4(+) T cells from patients with seasonal allergic rhinitis. Principal component analysis (PCA) showed good separation of the three groups. To identify the correlation between changes in gene expression in allergen-challenged CD4(+) T cells before and after GC treatment, we performed orthogonal partial least squares discriminant analysis (OPLS-DA) followed by Pearson correlation analysis. This revealed that allergen-induced genes were widely reversed by GC treatment (r = -0.77, P<0.0001). We extracted 547 genes reversed by GC treatment from OPLS-DA models based on their high contribution to the discrimination and found that those genes belonged to several different inflammatory pathways including TNFR2 Signalling, Interferon Signalling, Glucocorticoid Receptor Signalling and T Helper Cell Differentiation. The results were supported by gene expression microarray analyses of two independent materials. Conclusions/Significance: Allergen-induced gene expression changes in CD4(+) T cells were reversed by treatment with glucocorticoids. The top allergen-induced genes that reversed by GC treatment belonged to several inflammatory pathways and genes of known or potential relevance for allergy.	[Zhao, Yelin; Wang, Hui; Gustafsson, Mika; Bruhn, Soren; Benson, Mikael] Linkoping Univ, Fac Hlth Sci, Dept Clin & Expt Med, Linkoping, Sweden; [Wang, Hui] Univ Gothenburg, Dept Pediat, Gothenburg, Sweden; [Muraro, Antonella] Univ Padua, Dept Pediat, Ctr Food Allergy Diag & Treatment, Padua, Italy	Linkoping University; University of Gothenburg; University of Padua	Zhao, YL (corresponding author), Linkoping Univ, Fac Hlth Sci, Dept Clin & Expt Med, Linkoping, Sweden.	mikael.benson@liu.se			European Commission [223367]; Swedish Medical Research Council	European Commission(European CommissionEuropean Commission Joint Research Centre); Swedish Medical Research Council(Swedish Medical Research Council (SMRC))	This research has been supported by the European Commission under the Seventh Framework Programme, grant agreement number 223367, MultiMod, the Swedish Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akdis M, 2004, J EXP MED, V199, P1567, DOI 10.1084/jem.20032058; Barnes Peter J, 2009, Lancet, V373, P1905, DOI 10.1016/S0140-6736(09)60326-3; Barrenas F, 2008, CYTOKINE, V42, P325, DOI 10.1016/j.cyto.2008.03.004; Benson M, 2004, J ALLERGY CLIN IMMUN, V113, P1137, DOI 10.1016/j.jaci.2004.02.028; Benson M, 2000, J ALLERGY CLIN IMMUN, V106, P307, DOI 10.1067/mai.2000.108111; Bosco A, 2009, J IMMUNOL, V182, P6011, DOI 10.4049/jimmunol.0804125; Bousquet J, 2010, ALLERGY, V65, P1212, DOI [10.1111/j.1398-9995.2010.02439.x, 10.1111/j.1398-9995.2010.02480.x]; Cohen J.E., 1988, STAT POWER ANAL BEHA; Damsted SK, 2011, EUR J PAEDIATR NEURO, V15, P465, DOI 10.1016/j.ejpn.2011.05.002; Eriksson L, 2008, J CHEMOMETR, V22, P594, DOI 10.1002/cem.1187; Erin EM, 2005, CLIN EXP ALLERGY, V35, P1608, DOI 10.1111/j.1365-2222.2005.02381.x; Frohlich A, 2007, BLOOD, V109, P2023, DOI 10.1182/blood-2006-05-021600; Goleva E, 2012, J ALLERGY CLIN IMMUN; Greiner AN, 2011, LANCET, V378, P2112, DOI 10.1016/S0140-6736(11)60130-X; Hattori H, 2006, AM J RHINOL, V20, P165, DOI 10.1177/194589240602000208; Ishida A, 2010, AURIS NASUS LARYNX, V37, P584, DOI 10.1016/j.anl.2009.12.002; Ito K, 2006, J ALLERGY CLIN IMMUN, V117, P522, DOI 10.1016/j.jaci.2006.01.032; Jin HL, 2009, J CLIN INVEST, V119, P47, DOI 10.1172/JCI32310; KleinJan A, 2006, J ALLERGY CLIN IMMUN, V118, P1117, DOI 10.1016/j.jaci.2006.05.030; Malmhall C, 2007, ALLERGY, V62, P1007, DOI 10.1111/j.1398-9995.2007.01420.x; Maurer M, 2001, HORM METAB RES, V33, P691, DOI 10.1055/s-2001-19142; Moazzami AA, 2010, NMR BIOMED; Niinuma T, 2012, CANC RES; Obexer P, 2001, ONCOGENE, V20, P4324, DOI 10.1038/sj.onc.1204573; Okano M, 2000, ALLERGY, V55, P723, DOI 10.1034/j.1398-9995.2000.00429.x; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; Sokol CL, 2008, NAT IMMUNOL, V9, P310, DOI 10.1038/ni1558; Thysell E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014175; Tonko M, 2001, FASEB J, V15, P693, DOI 10.1096/fj.00-0327com; Venge P, 2009, MONITORING ALLERGIC, P453; Wang H, 2011, ALLERGY, V66, P132, DOI 10.1111/j.1398-9995.2010.02444.x; Wang H, 2010, CLIN EXP ALLERGY, V40, P1194, DOI 10.1111/j.1365-2222.2010.03542.x; Wang H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023563; Wang H, 2009, J ALLERGY CLIN IMMUN, V124, P1360, DOI 10.1016/j.jaci.2009.09.037; Webster JC, 2002, ENDOCRINOLOGY, V143, P3866, DOI 10.1210/en.2002-220188; Whelehan OP, 2006, CHEMOMETR INTELL LAB, V84, P82, DOI 10.1016/j.chemolab.2006.03.008; Yoshida NL, 2002, BIOCHEM BIOPH RES CO, V293, P1254; Ziegler SF, 2009, MICROBES INFECT, V11, P594, DOI 10.1016/j.micinf.2009.04.002	38	10	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2012	7	6							e39016	10.1371/journal.pone.0039016	http://dx.doi.org/10.1371/journal.pone.0039016			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UJ	22701743	Green Published, gold, Green Submitted			2022-12-27	WOS:000305340000060
J	Di Paola, S; Micaroni, M; Di Tullio, G; Buccione, R; Di Girolamo, M				Di Paola, Simone; Micaroni, Massimo; Di Tullio, Giuseppe; Buccione, Roberto; Di Girolamo, Maria			PARP16/ARTD15 Is a Novel Endoplasmic-Reticulum-Associated Mono-ADP-Ribosyltransferase That Interacts with, and Modifies Karyopherin-beta 1	PLOS ONE			English	Article							39-KDA POLY(ADP-RIBOSE) GLYCOHYDROLASE; NUCLEAR-PROTEIN IMPORT; NUCLEOCYTOPLASMIC TRANSPORT; RIBOSYLATING TOXINS; POLYMERASE-ACTIVITY; FAMILY; BETA; RIBOSE; CELLS; PARP	Background: Protein mono-ADP-ribosylation is a reversible post-translational modification that modulates the function of target proteins. The enzymes that catalyze this reaction in mammalian cells are either bacterial pathogenic toxins or endogenous cellular ADP-ribosyltransferases. The latter include members of three different families of proteins: the well characterized arginine-specific ecto-enzymes ARTCs, two sirtuins and, more recently, novel members of the poly(ADPribose) polymerase (PARP/ARTD) family that have been suggested to act as cellular mono-ADP-ribosyltransferases. Here, we report on the characterisation of human ARTD15, the only known ARTD family member with a putative C-terminal transmembrane domain. Methodology/Principal Findings: Immunofluorescence and electron microscopy were performed to characterise the subcellular localisation of ARTD15, which was found to be associated with membranes of the nuclear envelope and endoplasmic reticulum. The orientation of ARTD15 was determined using protease protection assay, and is shown to be a tail-anchored protein with a cytosolic catalytic domain. Importantly, by combining immunoprecipitation with mass spectrometry and using cell lysates from cells over-expressing FLAG-ARTD15, we have identified karyopherin-beta 1, a component of the nuclear trafficking machinery, as a molecular partner of ARTD15. Finally, we demonstrate that ARTD15 is a mono-ADP-ribosyltransferase able to induce the ADP-ribosylation of karyopherin-beta 1, thus defining the first substrate for this enzyme. Conclusions/Significance: Our data reveal that ARTD15 is a novel ADP-ribosyltransferase enzyme with a new intracellular location. Finally, the identification of karyopherin-beta 1 as a target of ARTD15-mediated ADP-ribosylation, hints at a novel regulatory mechanism of karyopherin-beta 1 functions.	[Di Paola, Simone; Micaroni, Massimo; Di Tullio, Giuseppe; Buccione, Roberto; Di Girolamo, Maria] Consorzio Mario Negri Sud, Chieti, Italy	Consorzio Mario Negri Sud	Di Paola, S (corresponding author), Consorzio Mario Negri Sud, Chieti, Italy.	mdigirolamo@negrisud.it	Di Paola, Simone/GYU-0514-2022	Di Paola, Simone/0000-0003-3753-5722; Buccione, Roberto/0000-0001-9210-5261; Micaroni, Massimo/0000-0001-6405-0451	Fondazione Negri Sud; Italian Association for Cancer Research (AIRC)	Fondazione Negri Sud; Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro)	We gratefully acknowledge the financial support of the Fondazione Negri Sud and the Italian Association for Cancer Research (AIRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar RCT, 2005, J BIOL CHEM, V280, P33756, DOI 10.1074/jbc.M505408200; Ame JC, 2004, BIOESSAYS, V26, P882, DOI 10.1002/bies.20085; Boehler C, 2011, CELL CYCLE, V10, P1023, DOI 10.4161/cc.10.7.15169; Borgese N, 2011, BBA-BIOMEMBRANES, V1808, P937, DOI 10.1016/j.bbamem.2010.07.010; CERVANTESLAUREAN D, 1995, J BIOL CHEM, V270, P7929, DOI 10.1074/jbc.270.14.7929; Chang P, 2005, NAT CELL BIOL, V7, P1133, DOI 10.1038/ncb1322; Chou HYE, 2006, J BIOL CHEM, V281, P15201, DOI 10.1074/jbc.M506745200; Cingolani G, 1999, NATURE, V399, P221, DOI 10.1038/20367; Conti E, 2001, CURR OPIN CELL BIOL, V13, P310, DOI 10.1016/S0955-0674(00)00213-1; Corda D, 2003, EMBO J, V22, P1953, DOI 10.1093/emboj/cdg209; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; Dani N, 2011, J BIOL CHEM, V286, P5995, DOI 10.1074/jbc.M110.112466; Dania N, 2009, P NATL ACAD SCI USA, V106, P4243, DOI 10.1073/pnas.0900066106; Deng Q, 2008, ANNU REV MICROBIOL, V62, P271, DOI 10.1146/annurev.micro.62.081307.162848; Di Girolamo M, 2005, FEBS J, V272, P4565, DOI 10.1111/j.1742-4658.2005.04876.x; DOMENIGHINI M, 1994, MOL MICROBIOL, V14, P41, DOI 10.1111/j.1365-2958.1994.tb01265.x; Fried H, 2003, CELL MOL LIFE SCI, V60, P1659, DOI 10.1007/s00018-003-3070-3; Frye RA, 2000, BIOCHEM BIOPH RES CO, V273, P793, DOI 10.1006/bbrc.2000.3000; Glowacki G, 2002, PROTEIN SCI, V11, P1657, DOI 10.1110/ps.0200602; Goenka S, 2006, P NATL ACAD SCI USA, V103, P4210, DOI 10.1073/pnas.0506981103; Gorlich D, 1995, COLD SPRING HARB SYM, V60, P695, DOI 10.1101/SQB.1995.060.01.075; GORLICH D, 1994, CELL, V79, P767, DOI 10.1016/0092-8674(94)90067-1; GORLICH D, 1995, CURR BIOL, V5, P383, DOI 10.1016/S0960-9822(95)00079-0; Haigis MC, 2006, CELL, V126, P941, DOI 10.1016/j.cell.2006.06.057; Harel A, 2004, MOL CELL, V16, P319, DOI 10.1016/S1097-2765(04)00647-1; Hassa PO, 2008, FRONT BIOSCI-LANDMRK, V13, P3046, DOI 10.2741/2909; Hassa PO, 2006, MICROBIOL MOL BIOL R, V70, P789, DOI 10.1128/MMBR.00040-05; Herrero-Yraola A, 2001, EMBO J, V20, P2404, DOI 10.1093/emboj/20.10.2404; Hottiger MO, 2010, UNIFIED NOMENCLATURE; HSIA JA, 1985, J BIOL CHEM, V260, P6187; JUST I, 1995, BIOCHEMISTRY-US, V34, P326, DOI 10.1021/bi00001a040; Kalbfleisch T, 2007, TRAFFIC, V8, P1687, DOI 10.1111/j.1600-0854.2007.00661.x; Kanai M, 2007, NAT CELL BIOL, V9, P1175, DOI 10.1038/ncb1638; Kerns JA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040021; Kickhoefer VA, 1999, J CELL BIOL, V146, P917, DOI 10.1083/jcb.146.5.917; Kleine H, 2008, MOL CELL, V32, P57, DOI 10.1016/j.molcel.2008.08.009; KOZLOWSKI JM, 1984, J NATL CANCER I, V72, P913; KRUEGER KM, 1995, CLIN MICROBIOL REV, V8, P34, DOI 10.1128/CMR.8.1.34; LENO GH, 1989, EUR J BIOCHEM, V186, P205, DOI 10.1111/j.1432-1033.1989.tb15196.x; Leung AKL, 2011, MOL CELL, V42, P489, DOI 10.1016/j.molcel.2011.04.015; LOESBERG C, 1990, BIOCHIM BIOPHYS ACTA, V1037, P92, DOI 10.1016/0167-4838(90)90106-P; Lupi R, 2000, J BIOL CHEM, V275, P9418, DOI 10.1074/jbc.275.13.9418; Ma Q, 2001, BIOCHEM BIOPH RES CO, V289, P499, DOI 10.1006/bbrc.2001.5987; Malanga M, 2011, METHODS MOL BIOL, V780, P67, DOI 10.1007/978-1-61779-270-0_5; Merdes A, 1996, CELL, V87, P447, DOI 10.1016/S0092-8674(00)81365-3; Moss J, 1997, ADV EXP MED BIOL, V419, P25; Nachury MV, 2001, CELL, V104, P95, DOI 10.1016/S0092-8674(01)00194-5; Oka S, 2006, J BIOL CHEM, V281, P705, DOI 10.1074/jbc.M510290200; Ono T, 2006, P NATL ACAD SCI USA, V103, P16687, DOI 10.1073/pnas.0607911103; Otto H, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-139; PANZETER PL, 1990, NUCLEIC ACIDS RES, V18, P2194, DOI 10.1093/nar/18.8.2194; Paone G, 2002, P NATL ACAD SCI USA, V99, P8231, DOI 10.1073/pnas.122238899; PAYNE DM, 1985, BIOCHEMISTRY-US, V24, P7540, DOI 10.1021/bi00347a006; PIRON KJ, 1990, BIOCHEM J, V270, P591, DOI 10.1042/bj2700591; Polishchuk R S, 2001, Curr Protoc Cell Biol, VChapter 4, DOI 10.1002/0471143030.cb0408s11; Polishchuk V P, 2000, Mikrobiol Z, V62, P40; Raval-Fernandes S, 2005, CANCER RES, V65, P8846, DOI 10.1158/0008-5472.CAN-05-0770; Schreiber V, 2002, J BIOL CHEM, V277, P23028, DOI 10.1074/jbc.M202390200; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Seman M, 2004, CURR MED CHEM, V11, P857, DOI 10.2174/0929867043455611; Seman M, 2003, IMMUNITY, V19, P571, DOI 10.1016/S1074-7613(03)00266-8; Stilla A, 2011, EUR J CELL BIOL, V90, P665, DOI 10.1016/j.ejcb.2011.03.007; Tanner KG, 2000, P NATL ACAD SCI USA, V97, P14178, DOI 10.1073/pnas.250422697; Terry LJ, 2007, SCIENCE, V318, P1412, DOI 10.1126/science.1142204; WADA I, 1991, J BIOL CHEM, V266, P19599; Wiese C, 2001, SCIENCE, V291, P653, DOI 10.1126/science.1057661; Wittmann T, 2000, J CELL BIOL, V149, P1405, DOI 10.1083/jcb.149.7.1405; Yates SP, 2005, BIOCHEM J, V385, P667, DOI 10.1042/BJ20041480; Yu M, 2005, ONCOGENE, V24, P1982, DOI 10.1038/sj.onc.1208410; Zhang J, 1997, METHOD ENZYMOL, V280, P255; Zhong YW, 2011, J BIOL CHEM, V286, P33921, DOI 10.1074/jbc.M111.272906; ZOLKIEWSKA A, 1993, J BIOL CHEM, V268, P25273	72	69	70	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2012	7	6							e37352	10.1371/journal.pone.0037352	http://dx.doi.org/10.1371/journal.pone.0037352			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TU	22701565	gold, Green Published, Green Submitted			2022-12-27	WOS:000305337600007
J	Gu, XR; Neric, NJ; Crabb, JS; Crabb, JW; Bhattacharya, SK; Rayborn, ME; Hollyfield, JG; Bonilha, VL				Gu, Xiaorong; Neric, Nikolas J.; Crabb, John S.; Crabb, John W.; Bhattacharya, Sanjoy K.; Rayborn, Mary E.; Hollyfield, Joe G.; Bonilha, Vera L.			Age-Related Changes in the Retinal Pigment Epithelium (RPE)	PLOS ONE			English	Article							RAT RETINA; LYSOSOMAL-ENZYMES; OXIDATIVE DAMAGE; COLLECTRIN; DJ-1; EXPRESSION; COMPLEX; PROTEIN; MICROVILLI; MEMBRANE	Background: Age-related changes in the retina are often accompanied by visual impairment but their mechanistic details remain poorly understood. Methodology: Proteomic studies were pursued toward a better molecular understanding of retinal pigment epithelium (RPE) aging mechanisms. RPE cells were isolated from young adults (3-4 month-old) and old (24-25 month-old) F344BN rats, and separated into subcellular fractions containing apical microvilli (MV) and RPE cell bodies (CB) lacking their apical microvilli. Proteins were extracted in detergent, separated by SDS-PAGE, digested in situ with trypsin and analyzed by LC MS/MS. Select proteins detected in young and old rat RPE were further studied using immunofluorescence and Western blot analysis. Principal Findings: A total of 356 proteins were identified in RPE MV from young and 378 in RPE MV from old rats, 48% of which were common to each age group. A total of 897 proteins were identified in RPE CB from young rats and 675 in old CB, 56% of which were common to each age group. Several of the identified proteins, including proteins involved in response to oxidative stress, displayed both quantitative and qualitative changes in overall abundance during RPE aging. Numerous proteins were identified for the first time in the RPE. One such protein, collectrin, was localized to the apical membrane of apical brush border of proximal tubules where it likely regulates several amino acid transporters. Elsewhere, collectrin is involved in pancreatic beta cell proliferation and insulin secretion. In the RPE, collectrin expression was significantly modulated during RPE aging. Another age-regulated, newly described protein was DJ-1, a protein extensively studied in brain where oxidative stress-related functions have been described. Conclusions/Significance: The data presented here reveals specific changes in the RPE during aging, providing the first protein database of RPE aging, which will facilitate future studies of age-related retinal diseases.	[Gu, Xiaorong; Neric, Nikolas J.; Crabb, John S.; Crabb, John W.; Rayborn, Mary E.; Hollyfield, Joe G.; Bonilha, Vera L.] Cleveland Clin, Dept Ophthalm Res, Cole Eye Inst, Cleveland, OH 44106 USA; [Bhattacharya, Sanjoy K.] Univ Miami, Bascom Palmer Eye Inst, Miami, FL USA	Cleveland Clinic Foundation; Bascom Palmer Eye Institute; University of Miami	Gu, XR (corresponding author), Cleveland Clin, Lerner Res Inst, Cleveland, OH 44106 USA.	bonilhav@ccf.org	Bonilha, Vera/AAS-8566-2020	Bonilha, Vera/0000-0002-6166-5124	NIH [EY017153, EY014240, EY016112]; Research Center Grants from The Foundation Fighting Blindness and Research to Prevent Blindness; Cleveland Clinic Foundation; NATIONAL EYE INSTITUTE [R01EY016112, R01EY014240, R56EY014240, R21EY017153] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Center Grants from The Foundation Fighting Blindness and Research to Prevent Blindness; Cleveland Clinic Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Supported by NIH grants EY017153 (VLB), EY014240 (JGH), and EY016112 (SKB), Research Center Grants from The Foundation Fighting Blindness and Research to Prevent Blindness and funds from the Cleveland Clinic Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balazy M, 2003, AGEING RES REV, V2, P191, DOI 10.1016/S1568-1637(02)00065-X; BERMAN ER, 1994, BRIT J OPHTHALMOL, V78, P82, DOI 10.1136/bjo.78.2.82; BOK D, 1993, J CELL SCI, P189; Bonilha VL, 2008, CLIN OPHTHALMOL, V2, P413; Bonilha VL, 2004, MOL CELL PROTEOMICS, V3, P1119, DOI 10.1074/mcp.M400106-MCP200; Bonilha VL, 2004, EXP EYE RES, V79, P419, DOI 10.1016/j.exer.2004.04.001; BOULTON M, 1994, BRIT J OPHTHALMOL, V78, P125, DOI 10.1136/bjo.78.2.125; Boulton M, 2001, EYE, V15, P384, DOI 10.1038/eye.2001.141; Bousette N, 2008, PROTEOM CLIN APPL, V2, P638, DOI 10.1002/prca.200780043; Cai JY, 2000, PROG RETIN EYE RES, V19, P205, DOI 10.1016/S1350-9462(99)00009-9; COOPER NGF, 1987, CURR EYE RES, V6, P969, DOI 10.3109/02713688709034868; Danilczyk U, 2006, NATURE, V444, P1088, DOI 10.1038/nature05475; DILORETO DA, 1995, BRAIN RES, V698, P1, DOI 10.1016/0006-8993(95)00647-9; Frank R N, 1998, Trans Am Ophthalmol Soc, V96, P635; Fukui K, 2005, CELL METAB, V2, P373, DOI 10.1016/j.cmet.2005.11.003; Garcia GG, 2007, J IMMUNOL, V179, P6403, DOI 10.4049/jimmunol.179.10.6403; Garron L K, 1963, Trans Am Ophthalmol Soc, V61, P545; Guymer R, 1999, PROG RETIN EYE RES, V18, P59, DOI 10.1016/S1350-9462(98)00012-3; Ida H, 2003, PHYSIOL GENOMICS, V15, P258, DOI 10.1152/physiolgenomics.00126.2003; KATZ ML, 1984, EXP EYE RES, V38, P137, DOI 10.1016/0014-4835(84)90098-8; LAI YL, 1980, INVEST OPHTH VIS SCI, V19, P849; LAI YL, 1978, INVEST OPHTH VIS SCI, V17, P634; LAI YL, 1986, P SOC EXP BIOL MED, V181, P371; Malakauskas SM, 2007, AM J PHYSIOL-RENAL, V292, pF533, DOI 10.1152/ajprenal.00325.2006; MARMOR MF, 1990, EYE, V4, P340, DOI 10.1038/eye.1990.46; Marshall J., 1998, RETINAL PIGMENT EPIT, P669; Nyska A, 2002, TOXICOL PATHOL, V30, P620, DOI 10.1080/01926230290166724; Panahian N, 1999, BRAIN RES, V850, P1, DOI 10.1016/S0006-8993(99)01726-6; Roper K, 2000, NAT CELL BIOL, V2, P582, DOI 10.1038/35023524; Scalera F, 2008, HYPERTENSION, V51, P696, DOI 10.1161/HYPERTENSIONAHA.107.104570; Taira T, 2004, EMBO REP, V5, P213, DOI 10.1038/sj.embor.7400074; Takahashi K, 2001, J BIOL CHEM, V276, P37556, DOI 10.1074/jbc.M101730200; Van Remmen H, 2003, EXERC SPORT SCI REV, V31, P149, DOI 10.1097/00003677-200307000-00009; WEISSE I, 1995, OPHTHALMIC RES, V27, P154, DOI 10.1159/000267862; Xu J, 2005, HUM MOL GENET, V14, P1231, DOI 10.1093/hmg/ddi134; Yoshida S, 2002, INVEST OPHTH VIS SCI, V43, P2554; Zhang H, 2001, J BIOL CHEM, V276, P17132, DOI 10.1074/jbc.M006723200; Zhong N, 2006, J BIOL CHEM, V281, P20940, DOI 10.1074/jbc.M601935200	38	48	51	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2012	7	6							e38673	10.1371/journal.pone.0038673	http://dx.doi.org/10.1371/journal.pone.0038673			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TU	22701690	Green Published, Green Submitted, gold			2022-12-27	WOS:000305337600037
J	Lancaster, GI; Kowalski, GM; Estevez, E; Kraakman, MJ; Grigoriadis, G; Febbraio, MA; Gerondakis, S; Banerjee, A				Lancaster, Graeme I.; Kowalski, Greg M.; Estevez, Emma; Kraakman, Michael J.; Grigoriadis, George; Febbraio, Mark A.; Gerondakis, Steve; Banerjee, Ashish			Tumor Progression Locus 2 (Tpl2) Deficiency Does Not Protect against Obesity-Induced Metabolic Disease	PLOS ONE			English	Article							INDUCED INSULIN-RESISTANCE; ADIPOSE-TISSUE; CELLS; STRESS; INFLAMMATION; INDUCTION; PATHWAYS; ERK	Obesity is associated with a state of chronic low grade inflammation that plays an important role in the development of insulin resistance. Tumor progression locus 2 (Tpl2) is a serine/threonine mitogen activated protein kinase kinase kinase (MAP3K) involved in regulating responses to specific inflammatory stimuli. Here we have used mice lacking Tpl2 to examine its role in obesity-associated insulin resistance. Wild type (wt) and tpl2(-/-) mice accumulated comparable amounts of fat and lean mass when fed either a standard chow diet or two different high fat (HF) diets containing either 42% or 59% of energy content derived from fat. No differences in glucose tolerance were observed between wt and tpl2(-/-) mice on any of these diets. Insulin tolerance was similar on both standard chow and 42% HF diets, but was slightly impaired in tpl2(-/-) mice fed the 59% HFD. While gene expression markers of macrophage recruitment and inflammation were increased in the white adipose tissue of HF fed mice compared with standard chow fed mice, no differences were observed between wt and tpl2(-/-) mice. Finally, a HF diet did not increase Tpl2 expression nor did it activate Extracellular Signal-Regulated Kinase 1/2 (ERK1/2), the MAPK downstream of Tpl2. These findings argue that Tpl2 does not play a non-redundant role in obesity-associated metabolic dysfunction.	[Lancaster, Graeme I.; Kowalski, Greg M.; Estevez, Emma; Kraakman, Michael J.; Febbraio, Mark A.] BakerIDI Heart & Diabet Inst, Cellular & Mol Metab Lab, Melbourne, Vic, Australia; [Kowalski, Greg M.; Kraakman, Michael J.] Monash Univ, Dept Biochem & Mol Biol, Melbourne, Vic 3004, Australia; [Grigoriadis, George; Gerondakis, Steve; Banerjee, Ashish] Burnet Inst, Intracellular Signalling & Gene Express Lab, Melbourne, Vic, Australia; [Grigoriadis, George; Gerondakis, Steve; Banerjee, Ashish] Monash Univ, Cent Clin Sch, Dept Clin Haematol, Melbourne, Vic 3004, Australia	Monash University; Burnet Institute; Monash University	Lancaster, GI (corresponding author), BakerIDI Heart & Diabet Inst, Cellular & Mol Metab Lab, Melbourne, Vic, Australia.	graeme.lancaster@bakeridi.edu.au; banerjee@burnet.edu.au	Febbraio, Mark/AAE-9632-2019	Estevez, Emma/0000-0002-5125-2190; Febbraio, Mark/0000-0002-9296-4418; Kraakman, Michael/0000-0002-5755-0447; Kowalski, Greg/0000-0002-1599-017X	National Health and Research Council of Australia (NHMRC) [526619, 586636, 257502, 543141]; Leukemia and Lymphoma Society [SCOR 7015]	National Health and Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society)	This study was supported in part by grants from The National Health and Research Council of Australia (NHMRC Project Grant No's 526619 and 586636) to GIL and MAF, (Program 257502 and Project 543141) to SG and from the Leukemia and Lymphoma Society (SCOR 7015) to SG. SG and MAF are Principal Research Fellows of the NHMRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; Banerjee A, 2006, P NATL ACAD SCI USA, V103, P3274, DOI 10.1073/pnas.0511113103; Banerjee A, 2007, IMMUNOL CELL BIOL, V85, P420, DOI 10.1038/sj.icb.7100098; Banerjee A, 2008, BLOOD, V112, P5063, DOI 10.1182/blood-2007-10-120832; Dumitru CD, 2000, CELL, V103, P1071, DOI 10.1016/S0092-8674(00)00210-5; Eliopoulos AG, 2003, EMBO J, V22, P3855, DOI 10.1093/emboj/cdg386; Erion DM, 2010, NAT MED, V16, P400, DOI 10.1038/nm0410-400; Handoyo H, 2009, BIOCHEM J, V424, P109, DOI 10.1042/BJ20091271; Holland WL, 2007, CELL METAB, V5, P167, DOI 10.1016/j.cmet.2007.01.002; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Jager J, 2010, DIABETES, V59, P61, DOI 10.2337/db09-0470; Kowalski GM, 2011, DIABETOLOGIA, V54, P888, DOI 10.1007/s00125-010-2020-5; Matthews VB, 2010, DIABETOLOGIA, V53, P2431, DOI 10.1007/s00125-010-1865-y; Nguyen MTA, 2007, J BIOL CHEM, V282, P35279, DOI 10.1074/jbc.M706762200; Nicholls HT, 2011, DIABETES, V60, P1100, DOI 10.2337/db10-1353; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Patsouris D, 2008, CELL METAB, V8, P301, DOI 10.1016/j.cmet.2008.08.015; Perfield JW, 2011, DIABETES, V60, P1168, DOI 10.2337/db10-0715; Sabio G, 2008, SCIENCE, V322, P1539, DOI 10.1126/science.1160794; Sabio G, 2010, MOL CELL BIOL, V30, P106, DOI 10.1128/MCB.01162-09; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Stafford MJ, 2006, FEBS LETT, V580, P4010, DOI 10.1016/j.febslet.2006.06.004	24	4	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2012	7	6							e39100	10.1371/journal.pone.0039100	http://dx.doi.org/10.1371/journal.pone.0039100			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TU	22701749	Green Published, gold, Green Submitted			2022-12-27	WOS:000305337600069
J	Roestenberg, M; O'Hara, GA; Duncan, CJA; Epstein, JE; Edwards, NJ; Scholzen, A; van der Ven, AJAM; Hermsen, CC; Hill, AVS; Sauerwein, RW				Roestenberg, Meta; O'Hara, Geraldine A.; Duncan, Christopher J. A.; Epstein, Judith E.; Edwards, Nick J.; Scholzen, Anja; van der Ven, Andre J. A. M.; Hermsen, Cornelus C.; Hill, Adrian V. S.; Sauerwein, Robert W.			Comparison of Clinical and Parasitological Data from Controlled Human Malaria Infection Trials	PLOS ONE			English	Article							VACCINIA VIRUS ANKARA; PLASMODIUM-FALCIPARUM MALARIA; ANOPHELES-STEPHENSI; CIRCUMSPOROZOITE PROTEIN; HUMAN VOLUNTEERS; CHALLENGE; MOSQUITOS; EFFICACY; IMMUNOGENICITY; SAFETY	Background: Exposing healthy human volunteers to Plasmodium falciparum-infected mosquitoes is an accepted tool to evaluate preliminary efficacy of malaria vaccines. To accommodate the demand of the malaria vaccine pipeline, controlled infections are carried out in an increasing number of centers worldwide. We assessed their safety and reproducibility. Methods: We reviewed safety and parasitological data from 128 malaria-naive subjects participating in controlled malaria infection trials conducted at the University of Oxford, UK, and the Radboud University Nijmegen Medical Center, The Netherlands. Results were compared to a report from the US Military Malaria Vaccine Program. Results: We show that controlled human malaria infection trials are safe and demonstrate a consistent safety profile with minor differences in the frequencies of arthralgia, fatigue, chills and fever between institutions. But prepatent periods show significant variation. Detailed analysis of Q-PCR data reveals highly synchronous blood stage parasite growth and multiplication rates. Conclusions: Procedural differences can lead to some variation in safety profile and parasite kinetics between institutions. Further harmonization and standardization of protocols will be useful for wider adoption of these cost-effective small-scale efficacy trials. Nevertheless, parasite growth rates are highly reproducible, illustrating the robustness of controlled infections as a valid tool for malaria vaccine development.	[Roestenberg, Meta; Scholzen, Anja; Hermsen, Cornelus C.; Sauerwein, Robert W.] Radboud Univ Nijmegen, Med Ctr, Dept Med Microbiol, NL-6525 ED Nijmegen, Netherlands; [O'Hara, Geraldine A.; Duncan, Christopher J. A.; Edwards, Nick J.; Hill, Adrian V. S.] Univ Oxford, Ctr Clin Vaccinol & Trop Med, Churchill Hosp, Oxford, England; [O'Hara, Geraldine A.; Duncan, Christopher J. A.; Edwards, Nick J.; Hill, Adrian V. S.] Univ Oxford, Jenner Inst, Churchill Hosp, Oxford, England; [van der Ven, Andre J. A. M.] Radboud Univ Nijmegen, Dept Gen Internal Med, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Epstein, Judith E.] USN, US Mil Malaria Vaccine Program, Med Res Ctr, Silver Spring, MD USA	Radboud University Nijmegen; University of Oxford; University of Oxford; Jenner Institute; Radboud University Nijmegen; United States Department of Defense; United States Navy	Roestenberg, M (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Med Microbiol, NL-6525 ED Nijmegen, Netherlands.	M.Roestenberg@lumc.nl	Sauerwein, Robert/C-8519-2013; Roestenberg, Meta/AAP-9413-2021; Scholzen, Anja/D-1046-2013; Hermsen, C.C./L-4368-2015; van der Ven, A.J.A.M./H-8102-2014; Duncan, Christopher/A-2018-2012	Roestenberg, Meta/0000-0002-5052-2830; Scholzen, Anja/0000-0001-6481-6090; van der Ven, A.J.A.M./0000-0003-1833-3391; Edwards, Nick/0000-0002-7030-7839; Duncan, Christopher/0000-0003-4181-2315	Top Institute Pharma [T4-102]; Dioraphte Foundation; UK Medical Research Council; Wellcome Trust; European Commission; European Vaccine Initiative; PATH Malaria Vaccine Initiative; UK National Institute for Health Research; MRC [G0700735, G0502018, G0500634] Funding Source: UKRI; Medical Research Council [G0502018, G0500634, G0700735] Funding Source: researchfish; National Institute for Health Research [NF-SI-0509-10233] Funding Source: researchfish	Top Institute Pharma; Dioraphte Foundation; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); European Vaccine Initiative; PATH Malaria Vaccine Initiative; UK National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by Top Institute Pharma (grant number T4-102) and Dioraphte Foundation. The UK trials were supported by the UK Medical Research Council, the Wellcome Trust, the European Commission framework programmes, the European Vaccine Initiative, the PATH Malaria Vaccine Initiative, and the UK National Institute for Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali H, 2008, JCPSP-J COLL PHYSICI, V18, P362, DOI 06.2008/JCPSP.362368; Andrews L, 2005, AM J TROP MED HYG, V73, P191, DOI 10.4269/ajtmh.2005.73.191; BEIER JC, 1991, AM J TROP MED HYG, V44, P564, DOI 10.4269/ajtmh.1991.44.564; Bousema JT, 2006, AM J TROP MED HYG, V74, P425; Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3; de Mast Q, 2007, J INFECT DIS, V196, P622, DOI 10.1086/519844; de Mast Q, 2010, BRIT J HAEMATOL, V151, P495, DOI 10.1111/j.1365-2141.2010.08399.x; Dunachie SJ, 2006, INFECT IMMUN, V74, P5933, DOI 10.1128/IAI.00590-06; Epstein JE, 2007, J INFECT DIS, V196, P145, DOI 10.1086/518510; Felger I, 2003, TRENDS PARASITOL, V19, P60, DOI 10.1016/S1471-4922(02)00066-1; Frischknecht F, 2004, CELL MICROBIOL, V6, P687, DOI 10.1111/j.1462-5822.2004.00395.x; Genton B, 2010, VACCINE, V28, P6573, DOI 10.1016/j.vaccine.2010.07.067; Hermsen CC, 2001, MOL BIOCHEM PARASIT, V118, P247, DOI 10.1016/S0166-6851(01)00379-6; Hoffman SL, 2010, HUM VACCINES, V6, P97, DOI 10.4161/hv.6.1.10396; JEFFERY G. M., 1959, ANN TROP MED AND PARASITOL, V53, P51; Jinj Y, 2007, INFECT IMMUN, V75, P5532, DOI 10.1128/IAI.00600-07; McCall MBB, 2007, J IMMUNOL, V179, P162, DOI 10.4049/jimmunol.179.1.162; McCall MBB, 2006, T ROY SOC TROP MED H, V100, P1098, DOI 10.1016/j.trstmh.2006.02.017; McConkey SJ, 2003, NAT MED, V9, P729, DOI 10.1038/nm881; Moorthy V S, 2009, Vaccine, V27, P5719, DOI 10.1016/j.vaccine.2009.07.049; Nieman AE, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-277; PONNUDURAI T, 1991, T ROY SOC TROP MED H, V85, P175, DOI 10.1016/0035-9203(91)90012-N; PONNUDURAI T, 1989, PARASITOLOGY, V98, P165, DOI 10.1017/S0031182000062065; Porter DW, 2011, VACCINE, V29, P7514, DOI 10.1016/j.vaccine.2011.03.083; Pumpuni CB, 1997, J PARASITOL, V83, P652, DOI 10.2307/3284242; RICKMAN LS, 1990, AM J TROP MED HYG, V43, P441, DOI 10.4269/ajtmh.1990.43.441; Roestenberg M, 2011, LANCET; Roestenberg M, 2009, NEW ENGL J MED, V361, P468, DOI 10.1056/NEJMoa0805832; ROSENBERG R, 1990, T ROY SOC TROP MED H, V84, P209, DOI 10.1016/0035-9203(90)90258-G; Sauerwein RW, 2011, NAT REV IMMUNOL, V11, P57, DOI 10.1038/nri2902; Thompson FM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001493; TRAPE JF, 1987, T ROY SOC TROP MED H, V81, P10, DOI 10.1016/0035-9203(87)90472-X; Verhage DF, 2005, NETH J MED, V63, P52; Visser HKA, 2005, NETH J MED, V63, P41; Walther M, 2006, INFECT IMMUN, V74, P2706, DOI 10.1128/IAI.74.5.2706-2716.2006; Walther M, 2005, VACCINE, V23, P857, DOI 10.1016/j.vaccine.2004.08.020; Webster DP, 2005, P NATL ACAD SCI USA, V102, P4836, DOI 10.1073/pnas.0406381102	37	57	57	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2012	7	6							e38434	10.1371/journal.pone.0038434	http://dx.doi.org/10.1371/journal.pone.0038434			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TU	22701640	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000305337600023
J	Thornbrough, JM; Hundley, T; Valdivia, R; Worley, MJ				Thornbrough, Joshua M.; Hundley, Tom; Valdivia, Raphael; Worley, Micah J.			Human Genome-Wide RNAi Screen for Host Factors That Modulate Intracellular Salmonella Growth	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; PATHOGENICITY ISLAND 2; III SECRETION SYSTEM; EPITHELIAL-CELLS; MYCOBACTERIUM-TUBERCULOSIS; VIRULENCE PROTEIN; APEE GENE; MACROPHAGES; SURVIVAL; NETWORK	Salmonella enterica is a bacterial pathogen of humans that can proliferate within epithelial cells as well as professional phagocytes of the immune system. While much has been learned about the microbial genes that influence the infectious process through decades of intensive research, relatively little is known about the host factors that affect infection. We performed a genome-wide siRNA screen to identify host genes that Salmonella enterica serovar Typhimurium (S. typhimurium) utilizes to facilitate growth within human epithelial cells. In this screen, with siRNAs targeting every predicted gene in the human genome, we identified 252 new human-host-susceptibility factors (HSFs) for S. typhimurium. We also identified 39 genes whose silencing results in increased intracellular growth of S. typhimurium. The HSFs identified are regulated most centrally by NFkB and associate with each other through an extremely dense network of interactions that center around a group of kinases. Most genes identified were not previously appreciated as playing roles in the intracellular lifecycle of S. enterica. Numerous HSFs identified with interesting characteristics that could play plausible roles in mediating intracellular microbial growth are discussed. Importantly, this study reveals significant overlap between the host network that supports S. typhimurium growth within human epithelial cells and the one that promotes the growth of Mycobacterium tuberculosis within human macrophages. In addition to providing much new information about the molecular mechanisms underlying S. enterica-host cell interplay, all 252 HSFs identified are candidates for new anti-microbial targets for controlling S. enterica infections, and some may provide broad-spectrum anti-microbial activity.	[Thornbrough, Joshua M.; Hundley, Tom; Worley, Micah J.] Univ Louisville, Dept Biol, Louisville, KY 40292 USA; [Worley, Micah J.] Univ Louisville, Dept Microbiol & Immunol, Louisville, KY 40292 USA; [Valdivia, Raphael] Duke Univ, Dept Mol Genet & Microbiol, Durham, NC USA	University of Louisville; University of Louisville; Duke University	Thornbrough, JM (corresponding author), Univ Louisville, Dept Biol, Louisville, KY 40292 USA.	micah.worley@louisville.edu	Valdivia, Raphael/R-5377-2019	Valdivia, Raphael/0000-0003-0961-073X	National Institutes of Health grant from Southeastern Regional Center of Excellence for Emerging Infections and Biodefense [U54 AI057157]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057157] Funding Source: NIH RePORTER	National Institutes of Health grant from Southeastern Regional Center of Excellence for Emerging Infections and Biodefense; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was supported by National Institutes of Health grant #U54 AI057157 from the Southeastern Regional Center of Excellence for Emerging Infections and Biodefense. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audia JP, 2006, J BACTERIOL, V188, P6261, DOI 10.1128/JB.00371-06; Bach H, 2008, CELL HOST MICROBE, V3, P316, DOI 10.1016/j.chom.2008.03.008; Baldwin SA, 2005, J BIOL CHEM, V280, P15880, DOI 10.1074/jbc.M414337200; Barr FA, 1999, CURR BIOL, V9, P381, DOI 10.1016/S0960-9822(99)80167-5; Becker D, 2006, NATURE, V440, P303, DOI 10.1038/nature04616; Bhan MK, 2005, LANCET, V366, P749, DOI 10.1016/S0140-6736(05)67181-4; Birmingham CL, 2006, J BIOL CHEM, V281, P11374, DOI 10.1074/jbc.M509157200; Boyle EC, 2007, J BACTERIOL, V189, P1489, DOI 10.1128/JB.01730-06; Carinato ME, 1998, J BACTERIOL, V180, P3517, DOI 10.1128/JB.180.14.3517-3521.1998; Chen Y, 2008, MOL CELLS, V26, P415; Cirillo DM, 1998, MOL MICROBIOL, V30, P175, DOI 10.1046/j.1365-2958.1998.01048.x; Conlin CA, 2001, J BACTERIOL, V183, P1784, DOI 10.1128/JB.183.5.1784-1786.2001; Das P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015466; Deiwick J, 1999, MOL MICROBIOL, V31, P1759, DOI 10.1046/j.1365-2958.1999.01312.x; Dorer MS, 2006, PLOS PATHOG, V2, P315, DOI 10.1371/journal.ppat.0020034; Faherty CS, 2008, TRENDS MICROBIOL, V16, P173, DOI 10.1016/j.tim.2008.02.001; FIELDS PI, 1986, P NATL ACAD SCI USA, V83, P5189, DOI 10.1073/pnas.83.14.5189; Gaind R, 2006, J ANTIMICROB CHEMOTH, V58, P1139, DOI 10.1093/jac/dkl391; Galyov EE, 1997, MOL MICROBIOL, V25, P903, DOI 10.1111/j.1365-2958.1997.mmi525.x; GROISMAN EA, 1993, EMBO J, V12, P3779, DOI 10.1002/j.1460-2075.1993.tb06056.x; Hensel M, 1998, MOL MICROBIOL, V30, P163, DOI 10.1046/j.1365-2958.1998.01047.x; Hernandez LD, 2004, SCIENCE, V304, P1805, DOI 10.1126/science.1098188; Hobbie S, 1997, J IMMUNOL, V159, P5550; Janakiraman A, 2000, MOL MICROBIOL, V35, P1146, DOI 10.1046/j.1365-2958.2000.01783.x; Janecek S, 2002, BIOINFORMATICS, V18, P1534, DOI 10.1093/bioinformatics/18.11.1534; Jiang SX, 2010, J BIOL CHEM, V285, P34960, DOI 10.1074/jbc.M110.150839; Kagan JC, 2004, J EXP MED, V199, P1201, DOI 10.1084/jem.20031706; Keestra AM, 2011, MBIO, V2; Kuhle V, 2006, TRAFFIC, V7, P716, DOI 10.1111/j.1600-0854.2006.00422.x; Kuijl C, 2007, NATURE, V450, P725, DOI 10.1038/nature06345; Kumar D, 2010, CELL, V140, P731, DOI 10.1016/j.cell.2010.02.012; Leonard AE, 2000, BIOCHEM J, V350, P765, DOI 10.1042/0264-6021:3500765; Campoy EM, 2011, INFECT IMMUN, V79, P402, DOI 10.1128/IAI.00688-10; McClelland M, 2001, NATURE, V413, P852, DOI 10.1038/35101614; McLaughlin LM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000671; Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966; Ochman H, 1996, P NATL ACAD SCI USA, V93, P7800, DOI 10.1073/pnas.93.15.7800; Ohno Y, 2010, P NATL ACAD SCI USA, V107, P18439, DOI 10.1073/pnas.1005572107; Okazaki H, 2008, J BIOL CHEM, V283, P33357, DOI 10.1074/jbc.M802686200; Oswald E, 2005, CURR OPIN MICROBIOL, V8, P83, DOI 10.1016/j.mib.2004.12.011; PANG T, 1995, TRENDS MICROBIOL, V3, P253, DOI 10.1016/S0966-842X(00)88937-4; Patel JC, 2009, CELL, V137, P283, DOI 10.1016/j.cell.2009.01.056; Ray K, 2009, NAT REV MICROBIOL, V7, P333, DOI 10.1038/nrmicro2112; RIKIHISA Y, 1984, ANAT REC, V208, P319, DOI 10.1002/ar.1092080302; Rowe B, 1997, CLIN INFECT DIS, V24, pS106, DOI 10.1093/clinids/24.Supplement_1.S106; Rudge SA, 2004, MOL BIOL CELL, V15, P24, DOI 10.1091/mbc.E03-05-0297; Rytkonen A, 2007, P NATL ACAD SCI USA, V104, P3502, DOI 10.1073/pnas.0610095104; Salcedo SP, 2003, EMBO J, V22, P5003, DOI 10.1093/emboj/cdg517; Schroder B, 2007, TRAFFIC, V8, P1676, DOI 10.1111/j.1600-0854.2007.00643.x; Smith AC, 2007, J CELL BIOL, V176, P263, DOI 10.1083/jcb.200611056; Steele-Mortimer O, 2000, INFECT IMMUN, V68, P5401, DOI 10.1128/IAI.68.9.5401-5404.2000; Thomas M, 2009, CELL HOST MICROBE, V5, P309, DOI 10.1016/j.chom.2009.03.010; van der Velden AWM, 2000, INFECT IMMUN, V68, P5702, DOI 10.1128/IAI.68.10.5702-5709.2000; Walker DH, 1997, LAB INVEST, V76, P129; Walker DM, 2001, CURR BIOL, V11, P1600, DOI 10.1016/S0960-9822(01)00501-2; Weinrauch Y, 1999, ANNU REV MICROBIOL, V53, P155, DOI 10.1146/annurev.micro.53.1.155; Winter SE, 2010, NATURE, V467, P426, DOI 10.1038/nature09415; Worley MJ, 2006, P NATL ACAD SCI USA, V103, P17915, DOI 10.1073/pnas.0604054103; Worley MJ, 2000, MOL MICROBIOL, V36, P749, DOI 10.1046/j.1365-2958.2000.01902.x	59	15	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2012	7	6							e38097	10.1371/journal.pone.0038097	http://dx.doi.org/10.1371/journal.pone.0038097			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TU	22701604	gold, Green Submitted, Green Published			2022-12-27	WOS:000305337600015
J	Hudelson, P; Perneger, T; Kolly, V; Perron, NJ				Hudelson, Patricia; Perneger, Thomas; Kolly, Veronique; Perron, Noelle Junod			Self-Assessed Competency at Working with a Medical Interpreter Is Not Associated with Knowledge of Good Practice	PLOS ONE			English	Article							OVERCOMING LANGUAGE BARRIERS; LIMITED ENGLISH PROFICIENCY; CULTURAL COMPETENCE; RESIDENT PHYSICIANS; HEALTH-CARE; SERVICES; STUDENTS; PREPAREDNESS; ATTITUDES; QUALITY	Background: Specific knowledge and skills are needed to work effectively with an interpreter, but most doctors have received limited training. Self-assessed competency may not accurately identify training needs. Purposes: The purpose of this study is to explore the association between self-assessed competency at working with an interpreter and the ability to identify elements of good practice, using a written vignette. Methods: A mailed questionnaire was sent to 619 doctors and medical students in Geneva, Switzerland. Results: 58.6% of respondents considered themselves to be highly competent at working with a professional interpreter, but 22% failed to mention even one element of good practice in response to the vignette, and only 39% could name more than one. There was no association between self-rated competency and number of elements mentioned. Conclusions: Training efforts should challenge the assumption that working with an interpreter is intuitive. Evaluation of clinicians' ability to work with an interpreter should not be limited to self-ratings. In the context of large-scale surveys, written vignettes may provide a simple method for identifying knowledge of good practice and topics requiring further training.	[Hudelson, Patricia; Perron, Noelle Junod] Univ Hosp Geneva, Dept Community Med Primary Care & Emergency Med, Geneva, Switzerland; [Perneger, Thomas] Univ Geneva, Fac Med, Dept Community Hlth & Med, Geneva, Switzerland; [Kolly, Veronique] Univ Hosp Geneva, Espace Mediat, Geneva, Switzerland	University of Geneva; University of Geneva; University of Geneva	Hudelson, P (corresponding author), Univ Hosp Geneva, Dept Community Med Primary Care & Emergency Med, Geneva, Switzerland.	Patricia.Hudelson@hcuge.ch		Hudelson, Patricia/0000-0003-2601-7479	Swiss Federal Public Health Office [04.000929]	Swiss Federal Public Health Office	The study was funded by the Swiss Federal Public Health Office, contract 04.000929. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], NAT HLTH LAW PROGR L; Bischoff A, 1998, MOTS OUVERTS GUIDE E; Bischoff A, 2010, J TRAVEL MED, V17, P15, DOI 10.1111/j.1708-8305.2009.00314.x; Davis DA, 2006, JAMA-J AM MED ASSOC, V296, P1094, DOI 10.1001/jama.296.9.1094; Diamond LC, 2009, J GEN INTERN MED, V24, P256, DOI 10.1007/s11606-008-0875-7; Divi C, 2007, INT J QUAL HEALTH C, V19, P60, DOI 10.1093/intqhc/mzl069; Flores G, 2005, MED CARE RES REV, V62, P255, DOI 10.1177/1077558705275416; Greater New York Hospital Association, NYS DOH REL FIN HOSP; Ho MJ, 2008, MED EDUC, V42, P525, DOI 10.1111/j.1365-2923.2008.03048.x; Hudelson P, 2011, SURVEY CARE IMMIGRAN; Hudelson P, 2011, BMC MED EDUC, V11, DOI 10.1186/1472-6920-11-63; Hudelson P, 2010, EVAL HEALTH PROF, V33, P452, DOI 10.1177/0163278710370157; Hudelson P, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-187; ISM Interpretariat, COMM TRAV AV INT; Jacobs EA, 2004, AM J PUBLIC HEALTH, V94, P866, DOI 10.2105/AJPH.94.5.866; Jacobs EA, 2010, PATIENT EDUC COUNS, V78, P149, DOI 10.1016/j.pec.2009.12.001; Kalet Adina, 2002, Acad Med, V77, P927, DOI 10.1097/00001888-200209000-00029; Karliner LS, 2007, HEALTH SERV RES, V42, P727, DOI 10.1111/j.1475-6773.2006.00629.x; Kumas-Tan Z, 2007, ACAD MED, V82, P548, DOI 10.1097/ACM.0b013e3180555a2d; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lee KC, 2006, JAMA-J AM MED ASSOC, V296, P1050, DOI 10.1001/jama.296.9.1050; Lie D, 2009, ACAD MED, V84, P643, DOI 10.1097/ACM.0b013e31819faec8; McEvoy Mimi, 2009, Med Educ Online, V14, P12, DOI 10.3885/meo.2009.Res00309; Ngo-Metzger Q, 2007, J GEN INTERN MED, V22, P324, DOI 10.1007/s11606-007-0340-z; Nokes KM, 2005, J NURS EDUC, V44, P65; O'Leary SCB, 2003, PEDIATRICS, V111, pE569, DOI 10.1542/peds.111.5.e569; PHELAN M, 1995, BRIT MED J, V311, P555, DOI 10.1136/bmj.311.7004.555; Phillips C, 2010, AUST FAM PHYSICIAN, V39, P188; Queensland Health Interpreter Service, 2007, WORK INT GUID; Rodriguez F, 2011, BMC MED EDUC, V11, DOI 10.1186/1472-6920-11-26; Schenker Y, 2011, J GEN INTERN MED, V26, P712, DOI 10.1007/s11606-010-1619-z; Smith-Campbell Betty, 2005, J Allied Health, V34, P56; The Joint Commission, JOINT COMM 2009 REQ JOINT COMM 2009 REQ; Thompson B, 2008, STUDENT PERCEPTIONS; Weissman JS, 2005, JAMA-J AM MED ASSOC, V294, P1058, DOI 10.1001/jama.294.9.1058; Woloshin S, 1997, J GEN INTERN MED, V12, P472, DOI 10.1046/j.1525-1497.1997.00085.x	36	14	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2012	7	6							e38973	10.1371/journal.pone.0038973	http://dx.doi.org/10.1371/journal.pone.0038973			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TQ	22715421	Green Submitted, Green Published, gold			2022-12-27	WOS:000305336800063
J	Kruizinga, I; Jansen, W; de Haan, CL; van der Ende, J; Carter, AS; Raat, H				Kruizinga, Ingrid; Jansen, Wilma; de Haan, Carolien L.; van der Ende, Jan; Carter, Alice S.; Raat, Hein			Reliability and Validity of the Dutch Version of the Brief Infant-Toddler Social and Emotional Assessment (BITSEA)	PLOS ONE			English	Article							QUALITY-OF-LIFE; ASSESSMENT ITSEA; BEHAVIORAL-PROBLEMS; IMMIGRANT CHILDREN; MENTAL-HEALTH; CRITERIA	Background: The Brief Infant-Toddler Social and Emotional Assessment (BITSEA) is a relatively new and short (42-item) questionnaire that measures psychosocial problems in toddlers and consists of a Problem and a Competence scale. In this study the reliability and validity of the Dutch version of the BITSEA were examined for the whole group and for gender and ethnicity subgroups. Methods: Parents of 7140 two-year-old children were invited in the study, of which 3170 (44.4%) parents completed the BITSEA. For evaluation of the score distribution, the presence of floor/ceiling effects was determined. The internal consistency (Cronbach's alpha) was evaluated and in subsamples the test-retest, parent-childcare provider interrater reliability and concurrent validity with regard to the Child Behavioral Checklist (CBCL). Discriminative validity was evaluated by comparing scores of parents that worry and parents that do not worry about their child's development. Results: The BITSEA showed no floor or ceiling effects. Psychometric properties of the BITSEA Problem and Competence scale were respectively: Cronbach's alphas were 0.76 and 0.63. Test-retest correlations were 0.75 and 0.61. Interrater reliability correlations were 0.30 and 0.17. Concurrent validity was as hypothesised. The BITSEA was able to discriminate between parents that worry about their child and parents that do not worry. The psychometric properties of the BITSEA were comparable across gender and ethnic background. Conclusion: The results in this large-scale study of a diverse sample support the reliability and validity of the BITSEA Problem scale. The BITSEA Competence scale needs further study. The performance of the BITSEA appears to be similar in subgroups by gender and ethnic background.	[Kruizinga, Ingrid; Raat, Hein] Erasmus Univ, Med Ctr, Dept Publ Hlth, Rotterdam, Netherlands; [Jansen, Wilma; de Haan, Carolien L.] Rotterdam Municipal Hlth Serv GGD Rotterdam Rijnm, Dept Youth Policy, Rotterdam, Netherlands; [van der Ende, Jan] Erasmus Univ, Med Ctr, Sophia Childrens Hosp, Dept Child & Adolescent Psychiat, Rotterdam, Netherlands; [Carter, Alice S.] Univ Massachusetts, Dept Psychol, Boston, MA 02125 USA	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital; University of Massachusetts System; University of Massachusetts Boston	Kruizinga, I (corresponding author), Erasmus Univ, Med Ctr, Dept Publ Hlth, Rotterdam, Netherlands.	h.raat@erasmusmc.nl	Carter, Alice/AAF-4694-2020; Jansen, Wilma/ABD-5066-2020	Jansen, Wilma/0000-0002-4453-9054; Carter, Alice/0000-0001-9861-1560	funding body ZonMw, The Netherlands Organization for Health Research and Development [80-82435-98-8058]; BITSEA	funding body ZonMw, The Netherlands Organization for Health Research and Development; BITSEA	This study is funded by a grant from the funding body ZonMw, The Netherlands Organization for Health Research and Development (www.zonmw.nl), project number: 80-82435-98-8058. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: A.S. Carter receives royalties from Pearson Assessment on the sale of the BITSEA, however not in the context of this study. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors. The other authors have declared that they have no competing interests.	Aaronson N, 2002, QUAL LIFE RES, V11, P193; Achenbach T. M., 2000, MANUAL ASEBA PRESCHO; ACHENBACH TM, 1987, PSYCHOL BULL, V101, P213, DOI 10.1037/0033-2909.101.2.213; [Anonymous], 2012, DEFINITIONS NATIVE I; Bornstein MH, 2010, DEV PSYCHOPATHOL, V22, P717, DOI 10.1017/S0954579410000416; Briggs-Gowan M.J., 2002, BRIEF INFANT TODDLER; Briggs-Gowan MJ, 2007, INFANT MENT HEALTH J, V28, P564, DOI 10.1002/imhj.20154; Briggs-Gowan MJ, 1998, INF MENTAL HLTH J, V19, P422, DOI 10.1002/(SICI)1097-0355(199824)19:4<422::AID-IMHJ5>3.0.CO;2-U; Briggs-Gowan MJ, 2004, J PEDIATR PSYCHOL, V29, P143, DOI 10.1093/jpepsy/jsh017; Briggs-Gowan MJ, 2001, J AM ACAD CHILD PSY, V40, P811, DOI 10.1097/00004583-200107000-00016; Carter AS, 2003, J ABNORM CHILD PSYCH, V31, P495, DOI 10.1023/A:1025449031360; Cohen J.E., 1988, STAT POWER ANAL BEHA; Durlak JA, 1998, AM J COMMUN PSYCHOL, V26, P775, DOI 10.1023/A:1022162015815; Elliot J, 2002, J PAEDIATR CHILD H, V38, P41, DOI 10.1046/j.1440-1754.2002.00713.x; Glanz S, 1992, PRIMER BIOSTATISTICS; Glascoe F P, 2000, Pediatr Rev, V21, P272, DOI 10.1542/pir.21-8-272; Glascoe FP, 2005, MENT RETARD DEV D R, V11, P173, DOI 10.1002/mrdd.20068; Glascoe FP, 1997, PEDIATRICS, V99, P522, DOI 10.1542/peds.99.4.522; Haapsamo H, 2009, INT J CIRCUMPOL HEAL, V68, P386, DOI 10.3402/ijch.v68i4.17365; Karabekiroglu K, 2009, INFANT BEHAV DEV, V32, P291, DOI 10.1016/j.infbeh.2009.03.003; Kraemer S, 2000, BRIT MED J, V321, P1609, DOI 10.1136/bmj.321.7276.1609; Kruizinga I, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-494; Lavigne JV, 1998, J AM ACAD CHILD PSY, V37, P1246, DOI 10.1097/00004583-199812000-00007; Mesman J, 2001, J AM ACAD CHILD PSY, V40, P1029, DOI 10.1097/00004583-200109000-00011; MoutonSimien P, 1997, J ABNORM CHILD PSYCH, V25, P59, DOI 10.1023/A:1025759408417; Nunnally JC, 1994, PSYCHOMETRIC THEORY, V3rd, DOI DOI 10.1037/018882; Ohan JL, 2005, CHILD PSYCHIAT HUM D, V35, P359, DOI 10.1007/s10578-005-2694-y; Reijneveld S, 2005, EUR CHILD ADOLES PSY, V14, P145, DOI 10.1007/s00787-005-0454-y; ROBINSON EA, 1980, J CLIN CHILD PSYCHOL, V9, P22, DOI 10.1080/15374418009532938; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012; Theunissen NCM, 1998, QUAL LIFE RES, V7, P387, DOI 10.1023/A:1008801802877; Visser JC, 2010, INFANT MENT HEALTH J, V31, P611, DOI 10.1002/imhj.20273; Vogels T, 1998, QUAL LIFE RES, V7, P457, DOI 10.1023/A:1008848218806; Vollebergh WAM, 2005, SOC PSYCH PSYCH EPID, V40, P489, DOI 10.1007/s00127-005-0906-1; Warnecke RB, 1997, ANN EPIDEMIOL, V7, P334, DOI 10.1016/S1047-2797(97)00030-6; Wild D, 2005, VALUE HEALTH, V8, P94, DOI 10.1111/j.1524-4733.2005.04054.x	36	24	24	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2012	7	6							e38762	10.1371/journal.pone.0038762	http://dx.doi.org/10.1371/journal.pone.0038762			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TQ	22715411	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336800053
J	Sivakumar, L; Dehmer, M				Sivakumar, Lavanya; Dehmer, Matthias			Towards Information Inequalities for Generalized Graph Entropies	PLOS ONE			English	Article							COMPLEX NETWORKS; BOUNDS	In this article, we discuss the problem of establishing relations between information measures for network structures. Two types of entropy based measures namely, the Shannon entropy and its generalization, the Renyi entropy have been considered for this study. Our main results involve establishing formal relationships, by means of inequalities, between these two kinds of measures. Further, we also state and prove inequalities connecting the classical partition-based graph entropies and partition-independent entropy measures. In addition, several explicit inequalities are derived for special classes of graphs.	[Sivakumar, Lavanya] Inst Math Sci, Madras 600113, Tamil Nadu, India; [Dehmer, Matthias] UMIT, Inst Bioinformat & Translat Res, Hall In Tirol, Austria	Institute of Mathematical Sciences (IMSc) India	Sivakumar, L (corresponding author), Inst Math Sci, Madras 600113, Tamil Nadu, India.	matthias.dehmer@umit.at	Selvaganesh, Lavanya/AAX-8445-2021	Selvaganesh, Lavanya/0000-0002-8208-5372	FWF (Austrian Sciences Fund) [PN22029-N13]; Austrian Science Fund (FWF) [P 22029] Funding Source: researchfish	FWF (Austrian Sciences Fund); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	Matthias Dehmer and Lavanya Sivakumar thank the FWF (Austrian Sciences Fund) (Project No. PN22029-N13) for supporting this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand K, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.045102; [Anonymous], 2005, COMPLEXITY CHEM BIOL, DOI DOI 10.1007/B136300; Arndt C., 2004, INFORM MEASURES INFO; BALABAN AT, 1991, J MATH CHEM, V8, P383, DOI 10.1007/BF01166951; BASAK SC, 1988, DISCRETE APPL MATH, V19, P17, DOI 10.1016/0166-218X(88)90004-2; Bertz SH, 1983, CHEM APPL TOPOLOGY G, P206; BONCHEV D, 1977, J CHEM PHYS, V67, P4517, DOI 10.1063/1.434593; Bonchev D., 2003, COMPLEXITY CHEM INTR, V7; Bonchev D, 2009, ENCY COMPLEXITY SYST, V5, P4820, DOI [10.1007/978-0-387-30440-3_285, DOI 10.1007/978-0-387-30440-3_285]; Bonchev D, 1983, INFORM THEORETIC IND; Butts CT, 2001, SOC NETWORKS, V23, P31, DOI 10.1016/S0378-8733(01)00030-2; Claussen JC, 2007, PHYSICA A, V375, P365, DOI 10.1016/j.physa.2006.08.067; Costa LD, 2007, ADV PHYS, V56, P167, DOI 10.1080/00018730601170527; Cover TM., 2006, WILEY SERIES TELECOM; DAROCZY Z, 1979, ACTA MATH ACAD SCI H, V34, P105, DOI 10.1007/BF01902599; Dehmer M, 2008, APPL ARTIF INTELL, V22, P684, DOI 10.1080/08839510802164101; Dehmer M, 2008, APPL MATH COMPUT, V201, P82, DOI 10.1016/j.amc.2007.12.010; Dehmer M, 2008, COMPUT BIOL CHEM, V32, P131, DOI 10.1016/j.compbiolchem.2007.09.007; Dehmer M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031395; Dehmer M, 2011, COMPLEXITY, V17, P45, DOI 10.1002/cplx.20379; Dehmer M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015733; Dehmer M, 2011, INFORM SCIENCES, V181, P57, DOI 10.1016/j.ins.2010.08.041; Dehmer M, 2010, APPL MATH COMPUT, V215, P4263, DOI 10.1016/j.amc.2009.12.051; Dehmer M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008057; Dehmer M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003079; Delgado-Soler L, 2009, J CHEM INF MODEL, V49, P2457, DOI 10.1021/ci900275w; DEMBO A, 1991, IEEE T INFORM THEORY, V37, P1501, DOI 10.1109/18.104312; Dragomir SS, 1997, APPL MATH LETT, V10, P23, DOI 10.1016/S0893-9659(97)00028-1; Harary F., 1969, GRAPH THEORY; HARDY G. H., 1988, CAMBRIDGE MATH LIB; Kim J, 2008, PHYSICA A, V387, P2637, DOI 10.1016/j.physa.2008.01.015; Korner J., 1973, T 6 PRAG C INF THEOR, P411; MOWSHOWITZ A, 1968, B MATH BIOPHYS, V30, P175, DOI 10.1007/BF02476948; RASHEVSKY N., 1955, BULL MATH BIOPHYS, V17, P229, DOI 10.1007/BF02477860; Renyi A, 1961, P 4 BERK S MATH STAT, V1; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Shannon CE, 1997, MATH THEORY COMMUNIC; Skorobogatov VA, 1988, MATCH-COMMUN MATH CO, V23, P105; Yeung RW, 1997, IEEE T INFORM THEORY, V43, P1924, DOI 10.1109/18.641556	40	4	4	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2012	7	6							e38159	10.1371/journal.pone.0038159	http://dx.doi.org/10.1371/journal.pone.0038159			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TQ	22715375	gold, Green Submitted, Green Published			2022-12-27	WOS:000305336800016
J	Threlfall, CG; Law, B; Banks, PB				Threlfall, Caragh G.; Law, Bradley; Banks, Peter B.			Influence of Landscape Structure and Human Modifications on Insect Biomass and Bat Foraging Activity in an Urban Landscape	PLOS ONE			English	Article							AERIAL INSECTIVOROUS BATS; NET PRIMARY PRODUCTIVITY; NEW-SOUTH-WALES; SPECIES RICHNESS; FOREST; HABITAT; URBANIZATION; COMMUNITY; VEGETATION; ABUNDANCE	Urban landscapes are often located in biologically diverse, productive regions. As such, urbanization may have dramatic consequences for this diversity, largely due to changes in the structure and function of urban communities. We examined the influence of landscape productivity (indexed by geology), housing density and vegetation clearing on the spatial distribution of nocturnal insect biomass and the foraging activity of insectivorous bats in the urban landscape of Sydney, Australia. Nocturnal insect biomass (g) and bat foraging activity were sampled from 113 sites representing backyard, open space, bushland and riparian landscape elements, across urban, suburban and vegetated landscapes within 60 km of Sydney's Central Business District. We found that insect biomass was at least an order of magnitude greater within suburban landscapes in bushland and backyard elements located on the most fertile shale influenced geologies (both p<0.001) compared to nutrient poor sandstone landscapes. Similarly, the feeding activity of bats was greatest in bushland, and riparian elements within suburbs on fertile geologies (p = 0.039). Regression tree analysis indicated that the same three variables explained the major proportion of the variation in insect biomass and bat foraging activity. These were ambient temperature (positive), housing density (negative) and the percent of fertile shale geologies (positive) in the landscape; however variation in insect biomass did not directly explain bat foraging activity. We suggest that prey may be unavailable to bats in highly urbanized areas if these areas are avoided by many species, suggesting that reduced feeding activity may reflect under-use of urban habitats by bats. Restoration activities to improve ecological function and maintain the activity of a diversity of bat species should focus on maintaining and restoring bushland and riparian habitat, particularly in areas with fertile geology as these were key bat foraging habitats.	[Threlfall, Caragh G.; Banks, Peter B.] Univ New S Wales, Evolut & Ecol Res Ctr, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia; [Law, Bradley] NSW Primary Ind, Forest Sci Ctr, Beecroft, NSW, Australia; [Banks, Peter B.] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia	University of New South Wales Sydney; NSW Department of Primary Industries; University of Sydney	Threlfall, CG (corresponding author), Univ Melbourne, Dept Resource Management & Geog, Melbourne, Vic 3010, Australia.	caragh.threlfall@unimelb.edu.au	Threlfall, Caragh G/Y-2292-2018; Vazquez-Dominguez, Guillermo GVD/L-7818-2014	Threlfall, Caragh G/0000-0002-4197-8588; Banks, Peter/0000-0002-4340-6495; Law, Bradley/0000-0002-3991-3865	student grants by the Royal Zoological Society of NSW; Ecological Society of Australia	student grants by the Royal Zoological Society of NSW; Ecological Society of Australia	This research was supported by student grants to C. T. provided by the Royal Zoological Society of NSW and the Ecological Society of Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott IM, 2009, BIOL CONSERV, V142, P2904, DOI 10.1016/j.biocon.2009.07.012; ADAMS M, 1988, AUST J BIOL SCI, V41, P315, DOI 10.1071/BI9880315; Adams MD, 2010, ACTA CHIROPTEROL, V12, P231, DOI 10.3161/150811010X504725; Adams MD, 2009, FOREST ECOL MANAG, V258, P2090, DOI 10.1016/j.foreco.2009.08.002; Adams MD, 2005, WILDLIFE RES, V32, P173, DOI 10.1071/WR04060; ALDRIDGE HDJN, 1987, J ANIM ECOL, V56, P763, DOI 10.2307/4947; Avila-Flores R, 2005, J MAMMAL, V86, P1193, DOI 10.1644/04-MAMM-A-085R1.1; Basham R, 2011, AUSTRAL ECOL, V36, P663, DOI 10.1111/j.1442-9993.2010.02202.x; Benson D, 1996, MOUNTAIN DEVIL MANGR; Benson D. H., 1995, TAKEN GRANTED BUSHLA; BRAITHWAITE LW, 1984, AUST WILDLIFE RES, V11, P41; BRAITHWAITE LW, 1989, BIOL CONSERV, V50, P33, DOI 10.1016/0006-3207(89)90004-9; Christie Fiona J., 2010, Urban Ecosystems, V13, P169, DOI 10.1007/s11252-009-0115-x; Churchill S, 2008, AUSTR BATS, V2nd; Conrad KF, 2006, BIOL CONSERV, V132, P279, DOI 10.1016/j.biocon.2006.04.020; Corben C, 2010, AUSTRALASIAN BAT SOC, V35, P40; De'ath G, 2000, ECOLOGY, V81, P3178, DOI 10.2307/177409; Ellis EC, 2008, FRONT ECOL ENVIRON, V6, P439, DOI 10.1890/070062; Erkert H.G., 1982, P201; Faeth SH, 2005, BIOSCIENCE, V55, P399, DOI 10.1641/0006-3568(2005)055[0399:TDIUC]2.0.CO;2; Fischer J, 2010, BIOL CONSERV, V143, P1564, DOI 10.1016/j.biocon.2010.03.030; Frazier MR, 2006, AM NAT, V168, P512, DOI 10.1086/506977; GEGGIE JF, 1985, CAN J ZOOL, V63, P263, DOI 10.1139/z85-040; Griffin D. R., 1960, Animal Behaviour, V8, P141, DOI 10.1016/0003-3472(60)90022-1; Grimm NB, 2008, SCIENCE, V319, P756, DOI 10.1126/science.1150195; Haberl H, 2004, LAND USE POLICY, V21, P279, DOI 10.1016/j.landusepol.2003.10.008; Haddad NM, 2000, OECOLOGIA, V124, P73, DOI 10.1007/s004420050026; Hecker KR, 1999, J MAMMAL, V80, P1196, DOI 10.2307/1383170; Hourigan C. L., 2006, Urban Ecosystems, V9, P67, DOI 10.1007/s11252-006-7902-4; Hoye Glenn, 2004, P138; Imhoff ML, 2004, NATURE, V429, P870, DOI 10.1038/nature02619; Imhoff ML, 2004, REMOTE SENS ENVIRON, V89, P434, DOI 10.1016/j.rse.2003.10.015; Jung K, 2011, DIVERS DISTRIB, V17, P262, DOI 10.1111/j.1472-4642.2010.00738.x; Jung K, 2010, J MAMMAL, V91, P144, DOI [10.1644/08-MAMM-A-313R.1, 10.1644/08-MAMM-A-313R.1.]; Kalcounis-Rueppell MC, 2007, BIOL CONSERV, V138, P120, DOI 10.1016/j.biocon.2007.04.009; KAVANAGH RP, 1990, AUST WILDLIFE RES, V17, P285; Kunz TH, 2003, BAT ECOLOGY, P3; LANDSBERG J, 1995, AUST J ECOL, V20, P299, DOI 10.1111/j.1442-9993.1995.tb00542.x; Lassau SA, 2005, AUSTRAL ECOL, V30, P179, DOI 10.1111/j.1442-9993.2005.01435.x; Lassau SA, 2007, AUSTRAL ECOL, V32, P656, DOI 10.1111/j.1442-9993.2007.01751.x; Law B, 2002, J APPL ECOL, V39, P605, DOI 10.1046/j.1365-2664.2002.00739.x; Law Bradley, 1998, Australian Zoologist, V30, P467; Law BS, 2011, WILDLIFE RES, V38, P173, DOI 10.1071/WR10204; Law BS, 1999, BIOL CONSERV, V88, P333, DOI 10.1016/S0006-3207(98)00118-9; Leishman MR, 2007, NEW PHYTOL, V176, P635, DOI 10.1111/j.1469-8137.2007.02189.x; Lesinski G, 2000, Z SAUGETIERKD, V65, P129; Luck GW, 2007, J BIOGEOGR, V34, P201, DOI 10.1111/j.1365-2699.2006.01575.x; Lumsden LF, 2005, BIOL CONSERV, V122, P205, DOI 10.1016/j.biocon.2004.07.006; McIntyre NE, 2001, LANDSCAPE URBAN PLAN, V52, P257, DOI 10.1016/S0169-2046(00)00122-5; Mittelbach GG, 2010, ECOLOGY, V91, P2540, DOI 10.1890/09-1029.1; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; NORBERG U M, 1987, Philosophical Transactions of the Royal Society of London B Biological Sciences, V316, P335, DOI 10.1098/rstb.1987.0030; Ober HK, 2008, FOREST ECOL MANAG, V256, P1124, DOI 10.1016/j.foreco.2008.06.010; ONEILL MG, 1989, AUST J ECOL, V14, P19; Pyke G.H., 1985, P65; R Development Core Team, 2007, R LANG ENV STAT COMP; Rainho A, 2010, J APPL ECOL, V47, P850, DOI 10.1111/j.1365-2664.2010.01820.x; Recher H.F., 1985, P283; Recher HF, 1996, FOREST ECOL MANAG, V85, P177, DOI 10.1016/S0378-1127(96)03758-9; Ripley B R-Project Website, TREE CLASS REGR TREE; ROSENZWEIG ML, 1992, J MAMMAL, V73, P715, DOI 10.2307/1382191; Schnitzler HU, 2001, BIOSCIENCE, V51, P557, DOI 10.1641/0006-3568(2001)051[0557:EBIEB]2.0.CO;2; Shochat E, 2006, TRENDS ECOL EVOL, V21, P186, DOI 10.1016/j.tree.2005.11.019; Shochat E, 2004, ECOL APPL, V14, P268, DOI 10.1890/02-5341; Smith DA, 2010, RESTOR ECOL, V18, P914, DOI 10.1111/j.1526-100X.2009.00538.x; Smith RM, 2006, BIODIVERS CONSERV, V15, P2415, DOI 10.1007/s10531-004-5014-0; Stone EL, 2009, CURR BIOL, V19, P1123, DOI 10.1016/j.cub.2009.05.058; Threlfall C, 2011, ECOGRAPHY, V34, P814, DOI 10.1111/j.1600-0587.2010.06939.x; Threlfall CG, 2012, BIOL CONSERV, V146, P41, DOI 10.1016/j.biocon.2011.11.026; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Walker PH, 1960, SOIL SURVEY COUNTY C; Walsh AL, 1996, J APPL ECOL, V33, P508, DOI 10.2307/2404980; WHITE TCR, 1984, OECOLOGIA, V63, P90, DOI 10.1007/BF00379790; Wickramasinghe LP, 2004, CONSERV BIOL, V18, P1283, DOI 10.1111/j.1523-1739.2004.00152.x; Yela JL, 1997, ENVIRON ENTOMOL, V26, P1283, DOI 10.1093/ee/26.6.1283; Zoborowski P, 2003, FIELD GUIDE INSECTS; Zurcher AA, 2010, ACTA CHIROPTEROL, V12, P337, DOI 10.3161/150811010X537918	77	42	48	0	139	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e38800	10.1371/journal.pone.0038800	http://dx.doi.org/10.1371/journal.pone.0038800			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685608	gold, Green Published			2022-12-27	WOS:000305351700072
J	Frank, MG; Waldrop, RH; Dumoulin, M; Aton, S; Boal, JG				Frank, Marcos G.; Waldrop, Robert H.; Dumoulin, Michelle; Aton, Sara; Boal, Jean G.			A Preliminary Analysis of Sleep-Like States in the Cuttlefish Sepia officinalis	PLOS ONE			English	Article							BEHAVIORAL EVIDENCE; CEPHALOPODA; DROSOPHILA; EVOLUTION; PHARAONIS; BRAIN; REST; EYE	Sleep has been observed in several invertebrate species, but its presence in marine invertebrates is relatively unexplored. Rapid-eye-movement (REM) sleep has only been observed in vertebrates. We investigated whether the cuttlefish Sepia officinalis displays sleep-like states. We find that cuttlefish exhibit frequent quiescent periods that are homeostatically regulated, satisfying two criteria for sleep. In addition, cuttlefish transiently display a quiescent state with rapid eye movements, changes in body coloration and twitching of the arms, that is possibly analogous to REM sleep. Our findings thus suggest that at least two different sleep-like states may exist in Sepia officinalis.	[Frank, Marcos G.; Dumoulin, Michelle; Aton, Sara] Univ Penn, Perelman Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA; [Waldrop, Robert H.; Boal, Jean G.] Millersville Univ, Dept Biol, Lancaster, PA USA	University of Pennsylvania; Pennsylvania Medicine; Pennsylvania State System of Higher Education (PASSHE); Millersville University of Pennsylvania	Frank, MG (corresponding author), Univ Penn, Perelman Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA.	mgf@mail.med.upenn.edu; Jean.Boal@millersville.edu		Aton, Sara/0000-0002-2921-0509; Bridi, Michelle/0000-0001-5533-5092	NEI NIH HHS [T32 EY007143, F32 EY017766] Funding Source: Medline; NATIONAL EYE INSTITUTE [T32EY007143, F32EY017766] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ABBOT NJ, 1995, CEPHALOPOD NEUROBIOL; Adamo SA, 2006, BIOL BULL-US, V210, P192, DOI 10.2307/4134557; Alves C, 2007, ANIM COGN, V10, P29, DOI 10.1007/s10071-006-0027-6; Boal JG, 2004, BEHAVIOUR, V141, P837, DOI 10.1163/1568539042265662; Brown ER, 2006, BEHAV BRAIN RES, V172, P355, DOI 10.1016/j.bbr.2006.05.009; Budelmann B, 1994, MICROSCOPIC ANATOMY, P119; Cajochen C, 2006, CHRONOBIOL INT, V23, P461, DOI 10.1080/07420520500545813; CHICHERY MP, 1992, BRAIN RES, V574, P77, DOI 10.1016/0006-8993(92)90802-G; Crook AC, 2002, PHILOS T ROY SOC B, V357, P1617, DOI 10.1098/rstb.2002.1070; Duntley SP, 2004, ANN NEUROL, V56, pS68; Duntley SP, 2003, SLEEP, V26, pA118; Duntley SP, 2002, SLEEP, V25, pA159; Frank MG, 1999, RAPID EYE MOVEMENT SLEEP, P17; Guibe M, 2008, ETUDE FONCTIONS COGN; HANLON RT, 1988, PHILOS T ROY SOC B, V320, P437, DOI 10.1098/rstb.1988.0087; Hanlon RT, 1996, CEPHALOPOD BEHAV; Hendricks JC, 2000, NEURON, V25, P129, DOI 10.1016/S0896-6273(00)80877-6; Hvorecny LM, 2007, ANIM COGN, V10, P449, DOI 10.1007/s10071-007-0085-4; Jouvet-Mounier D, 1970, Dev Psychobiol, V2, P216; Langridge KV, 2009, ANIM BEHAV, V77, P847, DOI 10.1016/j.anbehav.2008.11.023; Lesku JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023203; Mahowald MW, 2004, ARCH ITAL BIOL, V142, P469; MATHER JA, 1995, ADV STUD BEHAV, V24, P317, DOI 10.1016/S0065-3454(08)60398-8; MESSENGER JB, 1973, BRAIN RES, V58, P519, DOI 10.1016/0006-8993(73)90025-5; Raizen DM, 2008, NATURE, V451, P569, DOI 10.1038/nature06535; Ramon F, 2004, P NATL ACAD SCI USA, V101, P11857, DOI 10.1073/pnas.0402015101; SASTRE JP, 1979, PHYSIOL BEHAV, V22, P979; Shashar N, 1998, BIOL BULL, V195, P187, DOI 10.2307/1542830; Shaw PJ, 2000, SCIENCE, V287, P1834, DOI 10.1126/science.287.5459.1834; Shaw PJ, 2003, J NEUROBIOL, V54, P179, DOI 10.1002/neu.10167; Siegel JA, 2005, METH NE FRO NEUROSCI, P163; Siegel JM, 1998, PHILOS T ROY SOC B, V353, P1147, DOI 10.1098/rstb.1998.0272; Stephenson R, 2011, J EXP BIOL, V214, P747, DOI 10.1242/jeb.050591; Tobler I., 2005, PRINCIPLES PRACTICE, P77, DOI [10.1016/B0-72-160797-7/50014-8, DOI 10.1016/B0-72-160797-7/50014-8]	34	32	32	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e38125	10.1371/journal.pone.0038125	http://dx.doi.org/10.1371/journal.pone.0038125			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701609	gold, Green Published			2022-12-27	WOS:000305348400038
J	Freundlieb, N; Ridder, V; Dobel, C; Enriquez-Geppert, S; Baumgaertner, A; Zwitserlood, P; Gerloff, C; Hummel, FC; Liuzzi, G				Freundlieb, Nils; Ridder, Volker; Dobel, Christian; Enriquez-Geppert, Stefanie; Baumgaertner, Annette; Zwitserlood, Pienie; Gerloff, Christian; Hummel, Friedhelm C.; Liuzzi, Gianpiero			Associative Vocabulary Learning: Development and Testing of Two Paradigms for the (Re-) Acquisition of Action- and Object-Related Words	PLOS ONE			English	Article							CONSTRAINT-INDUCED APHASIA; MOTOR CORTEX; BROCAS AREA; LANGUAGE; THERAPY; STROKE; VERB; STIMULATION; RECOVERY; ERRORLESS	Despite a growing number of studies, the neurophysiology of adult vocabulary acquisition is still poorly understood. One reason is that paradigms that can easily be combined with neuroscientfic methods are rare. Here, we tested the efficiency of two paradigms for vocabulary (re-) acquisition, and compared the learning of novel words for actions and objects. Cortical networks involved in adult native-language word processing are widespread, with differences postulated between words for objects and actions. Words and what they stand for are supposed to be grounded in perceptual and sensorimotor brain circuits depending on their meaning. If there are specific brain representations for different word categories, we hypothesized behavioural differences in the learning of action-related and object-related words. Paradigm A, with the learning of novel words for body-related actions spread out over a number of days, revealed fast learning of these new action words, and stable retention up to 4 weeks after training. The single-session Paradigm B employed objects and actions. Performance during acquisition did not differ between action-related and object-related words (time*word category: p = 0.01), but the translation rate was clearly better for object-related (79%) than for action-related words (53%, p = 0.002). Both paradigms yielded robust associative learning of novel action-related words, as previously demonstrated for object-related words. Translation success differed for action-and object-related words, which may indicate different neural mechanisms. The paradigms tested here are well suited to investigate such differences with neuroscientific means. Given the stable retention and minimal requirements for conscious effort, these learning paradigms are promising for vocabulary re-learning in brain-lesioned people. In combination with neuroimaging, neuro-stimulation or pharmacological intervention, they may well advance the understanding of language learning to optimize therapeutic strategies.	[Freundlieb, Nils; Ridder, Volker; Gerloff, Christian; Hummel, Friedhelm C.; Liuzzi, Gianpiero] Univ Hosp Hamburg Eppendorf, Dept Neurol, Hamburg, Germany; [Dobel, Christian; Enriquez-Geppert, Stefanie; Zwitserlood, Pienie] Univ Munster, Psychol Inst 2, Munster, Germany; [Baumgaertner, Annette] Univ Appl Sci Fresenius, Hamburg, Germany; [Liuzzi, Gianpiero] Univ Zurich Hosp, Dept Neurosurg, CH-8091 Zurich, Switzerland	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Munster; University of Zurich; University Zurich Hospital	Freundlieb, N (corresponding author), Univ Hosp Hamburg Eppendorf, Dept Neurol, Hamburg, Germany.	f.hummel@uke.uni-hamburg.de; liuzzi@ganglion.de		Gerloff, Christian/0000-0002-6484-8882; Hummel, Friedhelm/0000-0002-4746-4633	Deutsche Forschungsgemeinschaft [DFG LI 1892/1-1]; Forschungsforderungsfonds Medizin of the University of Hamburg [NWF08/07]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Forschungsforderungsfonds Medizin of the University of Hamburg	This research was supported by the Deutsche Forschungsgemeinschaft (DFG LI 1892/1-1 to G. L.; www.dfg.de) and by the Forschungsforderungsfonds Medizin of the University of Hamburg (NWF08/07 to G. L., www.uke.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aschenbrenner S., 2000, REGENSBURGER WORTFLU; Beck AT, 1995, BECK DEPRESSIONS INV; Berthier ML, 2009, ANN NEUROL, V65, P577, DOI 10.1002/ana.21597; Bird H, 2000, BRAIN LANG, V72, P246, DOI 10.1006/brln.2000.2292; Breitenstein C, 2005, NEUROIMAGE, V25, P958, DOI 10.1016/j.neuroimage.2004.12.019; Breitenstein C, 2004, RESTOR NEUROL NEUROS, V22, P445; Breitenstein C, 2002, J NEUROSCI METH, V114, P173, DOI 10.1016/S0165-0270(01)00525-8; Breitenstein C, 2009, NERVENARZT, V80, P149, DOI 10.1007/s00115-008-2571-6; Brickenkamp R., 1981, HDB PSYCHOL PADAGOGI, P270; Conroy P, 2009, APHASIOLOGY, V23, P1311, DOI 10.1080/02687030902756439; de Vries MH, 2010, J COGNITIVE NEUROSCI, V22, P2427, DOI 10.1162/jocn.2009.21385; Dienes Z, 2008, PROG BRAIN RES, V168, P49, DOI 10.1016/S0079-6123(07)68005-4; Dobel C, 2010, J COGNITIVE NEUROSCI, V22, P1251, DOI 10.1162/jocn.2009.21297; Enticott PG, 2010, NEUROPSYCHOLOGIA, V48, P2675, DOI 10.1016/j.neuropsychologia.2010.05.014; Fillingham JK, 2003, NEUROPSYCHOL REHABIL, V13, P337, DOI 10.1080/09602010343000020; FLOEL A, 2008, J COGN NEUROSCI; Floel A, 2010, NEUROBIOL DIS, V37, P243, DOI 10.1016/j.nbd.2009.05.027; Hauk O, 2004, NEURON, V41, P301, DOI 10.1016/S0896-6273(03)00838-9; Hebb D. O., 1949, ORG BEHAV NEUROPHYSI; Helmstaedter C, 2001, VERBALER LERN MERKFA, V1; Horn W., 1983, L P S LEISTUNGSPR FS, V2; Hummel FC, 2006, LANCET NEUROL, V5, P708, DOI 10.1016/S1474-4422(06)70525-7; Kelly-Hayes Margaret, 2003, J Stroke Cerebrovasc Dis, V12, P119, DOI 10.1016/S1052-3057(03)00042-9; Knecht S, 2004, ANN NEUROL, V56, P20, DOI 10.1002/ana.20125; Liuzzi G, 2008, NEUROPSYCHOLOGIA, V46, P2824, DOI 10.1016/j.neuropsychologia.2008.05.015; Liuzzi G, 2010, CURR BIOL, V20, P1745, DOI 10.1016/j.cub.2010.08.034; Matzig S, 2009, CORTEX, V45, P738, DOI 10.1016/j.cortex.2008.10.003; MILLER GA, 1991, COGNITION, V41, P197, DOI 10.1016/0010-0277(91)90036-4; Musso M, 2003, NAT NEUROSCI, V6, P774, DOI 10.1038/nn1077; Nickels L, 2002, APHASIOLOGY, V16, P1047, DOI 10.1080/02687040143000618; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; PEDERSEN PM, 1995, ANN NEUROL, V38, P659, DOI 10.1002/ana.410380416; Pulvermuller F, 1999, BEHAV BRAIN SCI, V22, P253, DOI 10.1017/S0140525X9900182X; Pulvermuller F, 2000, NEUROREPORT, V11, P2789, DOI 10.1097/00001756-200008210-00036; Pulvermuller F, 2005, NAT REV NEUROSCI, V6, P576, DOI 10.1038/nrn1706; Pulvermuller F, 2001, STROKE, V32, P1621, DOI 10.1161/01.STR.32.7.1621; Pulvermuller F, 2001, BRAIN LANG, V78, P143, DOI 10.1006/brln.2000.2390; Pulvermuller F, 2008, APHASIOLOGY, V22, P563, DOI 10.1080/02687030701612213; REBER AS, 1967, J VERB LEARN VERB BE, V6, P855, DOI 10.1016/S0022-5371(67)80149-X; Rey A., 1959, MANUEL TEST COPIE FI; Rizzolatti G, 1998, TRENDS NEUROSCI, V21, P188, DOI 10.1016/S0166-2236(98)01260-0; SCHWARTZ RG, 1984, J SPEECH HEAR RES, V27, P119, DOI 10.1044/jshr.2701.119; Szaflarski JP, 2008, MED SCI MONITOR, V14, pCR243	43	8	8	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e37033	10.1371/journal.pone.0037033	http://dx.doi.org/10.1371/journal.pone.0037033			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959WK	22701562	Green Published, gold, Green Submitted			2022-12-27	WOS:000305348400009
J	Khapare, N; Kundu, ST; Sehgal, L; Sawant, M; Priya, R; Gosavi, P; Gupta, N; Alam, H; Karkhanis, M; Naik, N; Vaidya, MM; Dalal, SN				Khapare, Nileema; Kundu, Samrat T.; Sehgal, Lalit; Sawant, Mugdha; Priya, Rashmi; Gosavi, Prajakta; Gupta, Neha; Alam, Hunain; Karkhanis, Madhura; Naik, Nishigandha; Vaidya, Milind M.; Dalal, Sorab N.			Plakophilin3 Loss Leads to an Increase in PRL3 Levels Promoting K8 Dephosphorylation, Which Is Required for Transformation and Metastasis	PLOS ONE			English	Article							O-LINKED GLYCOSYLATION; CANCER-CELL MIGRATION; INTERMEDIATE-FILAMENTS; EPITHELIAL-CELLS; CULTURED-CELLS; PLAQUE PROTEIN; EXPRESSION; KERATIN-8; PHOSPHORYLATION; INVASION	The desmosome anchors keratin filaments in epithelial cells leading to the formation of a tissue wide IF network. Loss of the desmosomal plaque protein plakophilin3 (PKP3) in HCT116 cells, leads to an increase in neoplastic progression and metastasis, which was accompanied by an increase in K8 levels. The increase in levels was due to an increase in the protein levels of the Phosphatase of Regenerating Liver 3 (PRL3), which results in a decrease in phosphorylation on K8. The increase in PRL3 and K8 protein levels could be reversed by introduction of an shRNA resistant PKP3 cDNA. Inhibition of K8 expression in the PKP3 knockdown clone S10, led to a decrease in cell migration and lamellipodia formation. Further, the K8 PKP3 double knockdown clones showed a decrease in colony formation in soft agar and decreased tumorigenesis and metastasis in nude mice. These results suggest that a stabilisation of K8 filaments leading to an increase in migration and transformation may be one mechanism by which PKP3 loss leads to tumor progression and metastasis.	[Khapare, Nileema; Kundu, Samrat T.; Sehgal, Lalit; Sawant, Mugdha; Priya, Rashmi; Gosavi, Prajakta; Gupta, Neha; Alam, Hunain; Vaidya, Milind M.; Dalal, Sorab N.] Tata Mem Hosp, KS215, ACTREC, Navi Mumbai, Maharashtra, India; [Karkhanis, Madhura; Naik, Nishigandha] Piramal Life Sci Ltd, Dept Pharmacol, Mumbai, Maharashtra, India	Tata Memorial Centre (TMC); Advance Centre for Treatment, Research & Education in Cancer (ACTREC); Tata Memorial Hospital; Piramal Life Sciences Ltd	Khapare, N (corresponding author), Tata Mem Hosp, KS215, ACTREC, Navi Mumbai, Maharashtra, India.	sdalal@actrec.gov.in	Alam, Hunain/H-2984-2019	Alam, Hunain/0000-0002-6183-3677; Sehgal, lalit/0000-0002-1151-5427; Priya, Rashmi/0000-0002-0510-7515; Kundu, Samrat/0000-0002-0117-6986	Department of Biotechnology [BT/PR11537/BRB/10/661/2008]; Advanced Centre for Treatment Reserach and Education in Cancer (ACTREC); Council for Scientific and Industrial Research; University Grants Commission	Department of Biotechnology; Advanced Centre for Treatment Reserach and Education in Cancer (ACTREC); Council for Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); University Grants Commission(University Grants Commission, India)	This work was supported by grants from the Department of Biotechnology (grant BT/PR11537/BRB/10/661/2008) and Advanced Centre for Treatment Reserach and Education in Cancer (ACTREC) (SND) and fellowships from Council for Scientific and Industrial Research (HA) and the University Grants Commission (PG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aigner K, 2007, FEBS LETT; Alam H, 2011, PLOS ONE UNPUB; Alam H, 2011, J CELL SCI, V124, P2096, DOI 10.1242/jcs.073585; Bardelli A, 2003, CLIN CANCER RES, V9, P5607; BARIBAULT H, 1993, GENE DEV, V7, P1191, DOI 10.1101/gad.7.7a.1191; Bonne S, 2003, J CELL BIOL, V161, P403, DOI 10.1083/jcb.200303036; Bonne S, 1999, J CELL SCI, V112, P2265; Chan TA, 1999, NATURE, V401, P616, DOI 10.1038/44188; Chidgey M, 2007, BRIT J CANCER, V96, P1783, DOI 10.1038/sj.bjc.6603808; CHOU CF, 1993, J BIOL CHEM, V268, P4465; CHOU CF, 1992, J BIOL CHEM, V267, P3901; CLAUSEN H, 1986, J INVEST DERMATOL, V86, P249, DOI 10.1111/1523-1747.ep12285369; Dalal SN, 1999, MOL CELL BIOL, V19, P4465; Fillies T, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-10; FRANKE WW, 1983, P NATL ACAD SCI-BIOL, V80, P7113, DOI 10.1073/pnas.80.23.7113; Garrod D, 2007, BIOCH BIOPHYS ACTA; Garrod DR, 2002, MOL MEMBR BIOL, V19, P81, DOI 10.1080/09687680210132476; Getsios S, 2009, J CELL BIOL, V185, P1243, DOI 10.1083/jcb.200809044; Gillio-Tos A, 2007, PATHOLOGY, V39, P345, DOI 10.1080/00313020701329757; Gosavi P, 2011, CELL MOL LIFE SCI, V68, P1439, DOI 10.1007/s00018-010-0531-3; Green KJ, 2000, NAT REV MOL CELL BIO, V1, P208, DOI 10.1038/35043032; Hendrix MJC, 1996, CANCER METAST REV, V15, P507, DOI 10.1007/BF00054016; Hesse M, 2004, EUR J CELL BIOL, V83, P19, DOI 10.1078/0171-9335-00354; Hofmann I, 2006, MOL BIOL CELL, V17, P1388, DOI 10.1091/mbc.e05-08-0708; Ihrie RA, 2005, CELL, V120, P843, DOI 10.1016/j.cell.2005.01.008; Jaitovich A, 2008, J BIOL CHEM, V283, P25348, DOI 10.1074/jbc.M801635200; Jiang YJ, 2011, CANCER RES, V71, P234, DOI 10.1158/0008-5472.CAN-10-1487; Just L, 2003, J NEUROSCI METH, V126, P69, DOI 10.1016/S0165-0270(03)00065-7; Karpova Tatiana, 2006, Curr Protoc Cytom, VChapter 12, DOI 10.1002/0471142956.cy1207s35; Krubasik D, 2006, BRIT J CANCER, V94, P1326, DOI 10.1038/sj.bjc.6603101; Ku NO, 1996, CANCER METAST REV, V15, P429, DOI 10.1007/BF00054011; Ku NO, 2000, J CELL BIOL, V149, P547, DOI 10.1083/jcb.149.3.547; Ku NO, 2002, J BIOL CHEM, V277, P10775, DOI 10.1074/jbc.M107623200; Kundu ST, 2008, INT J CANCER, V123, P2303, DOI 10.1002/ijc.23797; LARCHER F, 1992, MOL CARCINOGEN, V6, P112, DOI 10.1002/mc.2940060206; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mizuuchi E, 2009, INT J CANCER, V124, P1802, DOI 10.1002/ijc.24111; MOLL R, 1982, CELL, V31, P11, DOI 10.1016/0092-8674(82)90400-7; Oshima RG, 1996, CANCER METAST REV, V15, P445, DOI 10.1007/BF00054012; Papagerakis S, 2003, HUM PATHOL, V34, P565, DOI 10.1016/S0046-8177(03)00174-6; Potiron VA, 2007, CANCER RES, V67, P8708, DOI 10.1158/0008-5472.CAN-06-3612; Raul U, 2004, INT J CANCER, V111, P662, DOI 10.1002/ijc.20349; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Roger L, 2010, J CELL SCI, V123, P1295, DOI 10.1242/jcs.061002; Saha S, 2001, SCIENCE, V294, P1343, DOI 10.1126/science.1065817; SCHAAFSMA HE, 1993, J PATHOL, V170, P77, DOI 10.1002/path.1711700113; Schmidt A, 1999, DIFFERENTIATION, V64, P291, DOI 10.1046/j.1432-0436.1999.6450291.x; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schwarz J, 2006, HUM PATHOL, V37, P613, DOI 10.1016/j.humpath.2006.01.013; Schweizer J, 2006, J CELL BIOL, V174, P169, DOI 10.1083/jcb.200603161; Spector D. L., 1998, CELLS LAB MANUAL; Srikanth B, 2010, J BIOL CHEM, V285, P34062, DOI 10.1074/jbc.M109.098996; STEINERT PM, 1976, J MOL BIOL, V108, P547, DOI 10.1016/S0022-2836(76)80136-2; STEINERT PM, 1976, BIOCHEM BIOPH RES CO, V70, P221, DOI 10.1016/0006-291X(76)91131-1; Tao GZ, 2003, J CELL SCI, V116, P4629, DOI 10.1242/jcs.00782; Vaidya MM, 1996, ORAL ONCOL, V32B, P333, DOI 10.1016/0964-1955(96)00012-7; Vignjevic D, 2008, SEMIN CANCER BIOL, V18, P12, DOI 10.1016/j.semcancer.2007.08.001; Wang HH, 2007, CANCER RES, V67, P2922, DOI 10.1158/0008-5472.CAN-06-3598; Wang HH, 2010, CANCER CELL, V18, P52, DOI 10.1016/j.ccr.2010.04.028; Woll S, 2007, J CELL BIOL, V177, P795, DOI 10.1083/jcb.200703174; Wolf A, 2010, J CELL BIOL, V188, P463, DOI 10.1083/jcb.200908135; Xiang RH, 2002, CANCER RES, V62, P2637; Yamaguchi H, 2007, BBA-MOL CELL RES, V1773, P642, DOI 10.1016/j.bbamcr.2006.07.001; ZALVIDE J, 1995, MOL CELL BIOL, V15, P5800	64	33	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e38561	10.1371/journal.pone.0038561	http://dx.doi.org/10.1371/journal.pone.0038561			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701666	gold, Green Published			2022-12-27	WOS:000305348400071
J	Scorza, FB; Colucci, AM; Maggiore, L; Sanzone, S; Rossi, O; Ferlenghi, I; Pesce, I; Caboni, M; Norais, N; Di Cioccio, V; Saul, A; Gerke, C				Scorza, Francesco Berlanda; Colucci, Anna Maria; Maggiore, Luana; Sanzone, Silvia; Rossi, Omar; Ferlenghi, Ilaria; Pesce, Isabella; Caboni, Mariaelena; Norais, Nathalie; Di Cioccio, Vito; Saul, Allan; Gerke, Christiane			High Yield Production Process for Shigella Outer Membrane Particles	PLOS ONE			English	Article							NEISSERIA-MENINGITIDIS; PROTECTIVE IMMUNITY; NUCLEOTIDE-SEQUENCE; CHROMOSOMAL GENES; VESICLES; VACCINE; FLEXNERI; IMMUNIZATION; VIRULENCE; PROTEINS	Gram-negative bacteria naturally shed particles that consist of outer membrane lipids, outer membrane proteins, and soluble periplasmic components. These particles have been proposed for use as vaccines but the yield has been problematic. We developed a high yielding production process of genetically derived outer membrane particles from the human pathogen Shigella sonnei. Yields of approximately 100 milligrams of membrane-associated proteins per liter of fermentation were obtained from cultures of S. sonnei Delta tolR Delta galU at optical densities of 30-45 in a 5 L fermenter. Proteomic analysis of the purified particles showed the preparation to primarily contain predicted outer membrane and periplasmic proteins. These were highly immunogenic in mice. The production of these outer membrane particles from high density cultivation of bacteria supports the feasibility of scaling up this approach as an affordable manufacturing process. Furthermore, we demonstrate the feasibility of using this process with other genetic manipulations e. g. abolition of O antigen synthesis and modification of the lipopolysaccharide structure in order to modify the immunogenicity or reactogenicity of the particles. This work provides the basis for a large scale manufacturing process of Generalized Modules of Membrane Antigens (GMMA) for production of vaccines from Gram-negative bacteria.	[Ferlenghi, Ilaria; Norais, Nathalie] Novartis Vaccines & Diagnost, Siena, Italy; [Scorza, Francesco Berlanda; Colucci, Anna Maria; Maggiore, Luana; Sanzone, Silvia; Rossi, Omar; Pesce, Isabella; Caboni, Mariaelena; Di Cioccio, Vito; Saul, Allan; Gerke, Christiane] Novartis Vaccines Inst Global Hlth, Siena, Italy	Novartis; Novartis	Scorza, FB (corresponding author), Novartis Vaccines & Diagnost, Siena, Italy.	christiane.gerke@novartis.com	Saul, Allan/ABH-2091-2020; Di Cioccio, Vito/N-1296-2013; Saul, Allan J/I-6968-2013; Rossi, Omar/AAT-6743-2020	Saul, Allan/0000-0003-0665-4091; Di Cioccio, Vito/0000-0002-8063-9650; Saul, Allan J/0000-0003-0665-4091; Caboni, Mariaelena/0000-0002-9742-0022; Berlanda Scorza, Francesco/0000-0003-2307-7855; Maggiore, Luana/0000-0002-2147-5780; Gerke, Christiane/0000-0001-9446-8031	Bill & Melinda Gates Foundation through the Grant Challenges Explorations Initiative [51833]; Novartis Vaccines Institute for Global Health (NVGH)	Bill & Melinda Gates Foundation through the Grant Challenges Explorations Initiative; Novartis Vaccines Institute for Global Health (NVGH)	The work was funded in part by a grant (#51833) from the Bill & Melinda Gates Foundation through the Grant Challenges Explorations Initiative and in part by Novartis Vaccines Institute for Global Health (NVGH). Several of the authors are or were employed by NVGH and, as such, NVGH played a role in study design, data collection and analysis, decision to publish, and preparation of the manuscript. The B&M Gates Foundation had no role in these activities.	Adu-Bobie J, 2004, INFECT IMMUN, V72, P1914, DOI 10.1128/IAI.72.4.1914-1919.2004; Alaniz RC, 2007, J IMMUNOL, V179, P7692, DOI 10.4049/jimmunol.179.11.7692; Bergman MA, 2005, INFECT IMMUN, V73, P1350, DOI 10.1128/IAI.73.3.1350-1356.2005; Bernadac A, 1998, J BACTERIOL, V180, P4872, DOI 10.1128/JB.180.18.4872-4878.1998; Berven FD, 2006, ARCH MICROBIOL, V184, P362, DOI 10.1007/s00203-005-0055-7; Beveridge TJ, 1999, J BACTERIOL, V181, P4725, DOI 10.1128/JB.181.16.4725-4733.1999; Camacho AI, 2011, VACCINE, V29, P8222, DOI 10.1016/j.vaccine.2011.08.121; Chaveroche MK, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.22.e97; Chen DJ, 2010, P NATL ACAD SCI USA, V107, P3099, DOI 10.1073/pnas.0805532107; Cohen D, 1996, Adv Exp Med Biol, V397, P159; d'Hauteville H, 2002, J IMMUNOL, V168, P5240, DOI 10.4049/jimmunol.168.10.5240; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Derbise A, 2003, FEMS IMMUNOL MED MIC, V38, P113, DOI 10.1016/S0928-8244(03)00181-0; Doherty NS, 1998, ELECTROPHORESIS, V19, P355, DOI 10.1002/elps.1150190234; Ferrari G, 2006, PROTEOMICS, V6, P1856, DOI 10.1002/pmic.200500164; FORMAL SB, 1966, J BACTERIOL, V92, P17, DOI 10.1128/JB.92.1.17-22.1966; GILMOUR NJL, 1991, VACCINE, V9, P137, DOI 10.1016/0264-410X(91)90271-7; Henry T, 2004, RES MICROBIOL, V155, P437, DOI 10.1016/j.resmic.2004.04.007; Jiang Y, 2005, PLASMID, V54, P149, DOI 10.1016/j.plasmid.2005.03.002; Kaminski RW, 2009, EXPERT REV VACCINES, V8, P1693, DOI 10.1586/ERV.09.127; Kaneshige T, 2009, AVIAN DIS, V53, P563, DOI 10.1637/8925-051309-Reg.1; Keenan JI, 2003, FEMS IMMUNOL MED MIC, V36, P199, DOI 10.1016/S0928-8244(03)00091-9; Koeberling O, 2008, J INFECT DIS, V198, P262, DOI 10.1086/589308; Kotloff KL, 1999, B WORLD HEALTH ORGAN, V77, P651; Kuehn MJ, 2005, GENE DEV, V19, P2645, DOI 10.1101/gad.1299905; Kulp A, 2010, ANNU REV MICROBIOL, V64, P163, DOI 10.1146/annurev.micro.091208.073413; Kweon MN, 2008, CURR OPIN INFECT DIS, V21, P313, DOI 10.1097/QCO.0b013e3282f88b92; Levine MM, 2007, NAT REV MICROBIOL, V5, P540, DOI 10.1038/nrmicro1662; Maxson ME, 2004, J BACTERIOL, V186, P4199, DOI 10.1128/JB.186.13.4199-4208.2004; Nichols WA, 1997, J ENDOTOXIN RES, V4, P163, DOI 10.1177/096805199700400301; Passwell JH, 2010, VACCINE, V28, P2231, DOI 10.1016/j.vaccine.2009.12.050; Pizza M, 2000, SCIENCE, V287, P1816, DOI 10.1126/science.287.5459.1816; SANDLIN RC, 1995, INFECT IMMUN, V63, P229, DOI 10.1128/IAI.63.1.229-237.1995; Schild S, 2009, INFECT IMMUN, V77, P472, DOI 10.1128/IAI.01139-08; Schild S, 2008, INFECT IMMUN, V76, P4554, DOI 10.1128/IAI.00532-08; Scorza FB, 2008, MOL CELL PROTEOMICS, V7, P473, DOI 10.1074/mcp.M700295-MCP200; Somerville JE, 1999, INFECT IMMUN, V67, P6583; Somerville JE, 1996, J CLIN INVEST, V97, P359, DOI 10.1172/JCI118423; Sprong T, 2011, INNATE IMMUN-LONDON, V17, P517, DOI 10.1177/1753425910383999; TAYLOR LA, 1988, NUCLEIC ACIDS RES, V16, P358, DOI 10.1093/nar/16.1.358; TRIEUCUOT P, 1990, NUCLEIC ACIDS RES, V18, P3660, DOI 10.1093/nar/18.12.3660; van der Ley P, 2001, INFECT IMMUN, V69, P5981, DOI 10.1128/IAI.69.10.5981-5990.2001; Ying TY, 2005, PROTEOMICS, V5, P4777, DOI 10.1002/pmic.200401326; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249	44	77	86	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e35616	10.1371/journal.pone.0035616	http://dx.doi.org/10.1371/journal.pone.0035616			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701551	gold, Green Published, Green Submitted			2022-12-27	WOS:000305348400002
J	Zamora, S; Rahman, IA; Smith, AB				Zamora, Samuel; Rahman, Imran A.; Smith, Andrew B.			Plated Cambrian Bilaterians Reveal the Earliest Stages of Echinoderm Evolution	PLOS ONE			English	Article							DEUTEROSTOME PHYLOGENY; CTENOCYSTOIDEA; ONTOGENY	Echinoderms are unique in being pentaradiate, having diverged from the ancestral bilaterian body plan more radically than any other animal phylum. This transformation arises during ontogeny, as echinoderm larvae are initially bilateral, then pass through an asymmetric phase, before giving rise to the pentaradiate adult. Many fossil echinoderms are radial and a few are asymmetric, but until now none have been described that show the original bilaterian stage in echinoderm evolution. Here we report new fossils from the early middle Cambrian of southern Europe that are the first echinoderms with a fully bilaterian body plan as adults. Morphologically they are intermediate between two of the most basal classes, the Ctenocystoidea and Cincta. This provides a root for all echinoderms and confirms that the earliest members were deposit feeders not suspension feeders.	[Zamora, Samuel; Smith, Andrew B.] Nat Hist Museum, Dept Palaeontol, London SW7 5BD, England; [Rahman, Imran A.] Univ Birmingham, Sch Geog Earth & Environm Sci, Birmingham, W Midlands, England	Natural History Museum London; University of Birmingham	Zamora, S (corresponding author), Nat Hist Museum, Dept Palaeontol, Cromwell Rd, London SW7 5BD, England.	a.smith@nhm.ac.uk	Zamora, Samuel/ABC-9333-2021; Rahman, Imran Alexander/F-4224-2012; Smith, Andrew B/B-9849-2009	Rahman, Imran Alexander/0000-0001-6598-6534; Zamora, Samuel/0000-0002-3917-4628	Spanish Ministry of Science and Education MEC-FEDER-EU [CGL2006-12975/BTE]; Post Doctoral grant [EX2009-0815]; Natural Environment Research Council [NE/H015817/1]; Caja de Ahorros de la Inmaculada (CAI); Direccion General de Aragon (DGA); bank Caja de Ahorros de la Inmaculada, Aragon, Spain; Natural Environment Research Council [NE/H015817/2] Funding Source: researchfish; NERC [NE/H015817/1, NE/H015817/2] Funding Source: UKRI	Spanish Ministry of Science and Education MEC-FEDER-EU(German Research Foundation (DFG)); Post Doctoral grant; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Caja de Ahorros de la Inmaculada (CAI); Direccion General de Aragon (DGA)(Gobierno de Aragon); bank Caja de Ahorros de la Inmaculada, Aragon, Spain; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Samuel Zamora was funded by the Spanish Ministry of Science and Education MEC-FEDER-EU (project CGL2006-12975/BTE) and a Post Doctoral grant (EX2009-0815). Imran Rahman was funded by the Natural Environment Research Council (grant number NE/H015817/1). Excavations in Purujosa were supported by the Caja de Ahorros de la Inmaculada (CAI) and Direccion General de Aragon (DGA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors received financial support for excavations from the bank Caja de Ahorros de la Inmaculada, Aragon, Spain. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Alvaro JJ, 2008, GEOL SOC AM BULL, V120, P962, DOI 10.1130/B26243.1; BATHER F. A., 1930, ARCH ZOOL ITAL, V14, P431; Bottjer DJ, 2006, SCIENCE, V314, P956, DOI 10.1126/science.1132310; Cameron CB, 2002, BIOL BULL, V202, P192, DOI 10.2307/1543655; Cannon JT, 2009, MOL PHYLOGENET EVOL, V52, P17, DOI 10.1016/j.ympev.2009.03.027; David B, 2000, PALEOBIOLOGY, V26, P529, DOI 10.1666/0094-8373(2000)026<0529:AHEAAF>2.0.CO;2; Dominguez-Alonso P, 1999, THESIS U COMPLUTENSE; Dunn CW, 2008, NATURE, V452, P745, DOI 10.1038/nature06614; Esteve J, 2011, GEOLOGY, V39, P575, DOI 10.1130/G31985.1; FATKA O, 1985, Vestnik Ustredniho Ustavu Geologickeho, V60, P225; Janies DA, 2011, SYST BIOL, V60, P420, DOI 10.1093/sysbio/syr044; Lartillot N, 2008, PHILOS T R SOC B, V363, P1463, DOI 10.1098/rstb.2007.2236; Littlewood DTJ, 1997, BIOL J LINN SOC, V61, P409, DOI 10.1006/bijl.1996.0131; Mallatt J, 2007, MOL PHYLOGENET EVOL, V43, P1005, DOI 10.1016/j.ympev.2006.11.023; Mooi R, 2008, ANNU REV ECOL EVOL S, V39, P43, DOI 10.1146/annurev.ecolsys.39.110707.173521; Osborn KJ, 2012, P ROY SOC B-BIOL SCI, V279, P1646, DOI 10.1098/rspb.2011.1916; PAUL CRC, 1984, BIOL REV, V59, P443, DOI 10.1111/j.1469-185X.1984.tb00411.x; Perseke M, 2010, MOL PHYLOGENET EVOL, V56, P201, DOI 10.1016/j.ympev.2010.01.035; Peterson KJ, 2000, EVOL DEV, V2, P93, DOI 10.1046/j.1525-142x.2000.00042.x; Pisani D, 2012, MOL PHYLOGENET EVOL, V62, P27, DOI 10.1016/j.ympev.2011.08.028; Rahman IA, 2009, J SYST PALAEONTOL, V7, P413, DOI 10.1017/S1477201909990046; ROBINSON RA, 1969, SCIENCE, V166, P1512, DOI 10.1126/science.166.3912.1512; Sdzuy Klaus, 1993, Beringeria, V8, P189; Smith AB, 2004, ASSEMBLING THE TREE OF LIFE, P365; Smith AB, 2005, GEOL J, V40, P255, DOI 10.1002/gj.1018; Smith AB, 2008, EVOL DEV, V10, P493, DOI 10.1111/j.1525-142X.2008.00260.x; Smith AB, 2009, PALAEONTOLOGY, V52, P803, DOI 10.1111/j.1475-4983.2009.00880.x; Sprinkle J, 1978, TREATISE INVERTEBR T, pT998; Sumrall CD, 2007, PALEOBIOLOGY, V33, P149, DOI 10.1666/06053.1; Sutton MD, PALAEONTOLO IN PRESS; Swalla BJ, 2008, PHILOS T R SOC B, V363, P1557, DOI 10.1098/rstb.2007.2246; UBAGHS G, 1975, ANNU REV EARTH PL SC, V3, P79, DOI 10.1146/annurev.ea.03.050175.000455; Zamora S, CAMBRIAN EC IN PRESS; Zamora S, 2010, GEOLOGY, V38, P507, DOI 10.1130/G30657.1	34	43	45	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e38296	10.1371/journal.pone.0038296	http://dx.doi.org/10.1371/journal.pone.0038296			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701623	gold, Green Published, Green Submitted			2022-12-27	WOS:000305348400047
J	Wu, YB; Punta, M; Xiao, R; Acton, TB; Sathyamoorthy, B; Dey, F; Fischer, M; Skerra, A; Rost, B; Montelione, GT; Szyperski, T				Wu, Yibing; Punta, Marco; Xiao, Rong; Acton, Thomas B.; Sathyamoorthy, Bharathwaj; Dey, Fabian; Fischer, Markus; Skerra, Arne; Rost, Burkhard; Montelione, Gaetano T.; Szyperski, Thomas			NMR Structure of Lipoprotein YxeF from Bacillus subtilis Reveals a Calycin Fold and Distant Homology with the Lipocalin Blc from Escherichia coli	PLOS ONE			English	Article							TORSION ANGLE DYNAMICS; PRODUCTION PLATFORM; BINDING PROTEINS; DATABASE; ASSIGNMENTS; PROGRAM; FAMILY; RECOGNITION; STABILITY; ALGORITHM	The soluble monomeric domain of lipoprotein YxeF from the Gram positive bacterium B. subtilis was selected by the Northeast Structural Genomics Consortium (NESG) as a target of a biomedical theme project focusing on the structure determination of the soluble domains of bacterial lipoproteins. The solution NMR structure of YxeF reveals a calycin fold and distant homology with the lipocalin Blc from the Gram-negative bacterium E. coli. In particular, the characteristic beta-barrel, which is open to the solvent at one end, is extremely well conserved in YxeF with respect to Blc. The identification of YxeF as the first lipocalin homologue occurring in a Gram-positive bacterium suggests that lipocalins emerged before the evolutionary divergence of Gram positive and Gram negative bacteria. Since YxeF is devoid of the alpha-helix that packs in all lipocalins with known structure against the beta-barrel to form a second hydrophobic core, we propose to introduce a new lipocalin sub-family named 'slim lipocalins', with YxeF and the other members of Pfam family PF11631 to which YxeF belongs constituting the first representatives. The results presented here exemplify the impact of structural genomics to enhance our understanding of biology and to generate new biological hypotheses.	[Wu, Yibing; Sathyamoorthy, Bharathwaj; Szyperski, Thomas] SUNY Buffalo, Dept Chem, Buffalo, NY 14260 USA; [Punta, Marco; Rost, Burkhard] Tech Univ Munich, Dept Comp Sci, Munich, Germany; [Punta, Marco; Rost, Burkhard] Tech Univ Munich, Inst Adv Study, Munich, Germany; [Xiao, Rong; Acton, Thomas B.; Montelione, Gaetano T.] State Univ New Jersey, Robert Wood Johnson Med Sch, Dept Mol Biol & Biochem, Ctr Adv Biotechnol & Med, Piscataway, NJ USA; [Dey, Fabian; Fischer, Markus] Columbia Univ, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, Ctr Computat Biol & Bioinformat, New York, NY 10032 USA; [Skerra, Arne] Tech Univ Munich, Munich Ctr Integrated Prot Sci, Freising Weihenstephan, Germany; [Skerra, Arne] Tech Univ Munich, Lehrstuhl Biol Chem, Freising Weihenstephan, Germany	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Technical University of Munich; Technical University of Munich; Rutgers State University New Brunswick; Rutgers State University Medical Center; Columbia University; Howard Hughes Medical Institute; Technical University of Munich; Technical University of Munich	Wu, YB (corresponding author), Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA.	szypersk@buffalo.edu	Punta, Marco/ABH-4698-2020; Rost, Burkhard/A-1908-2016; Sathyamoorthy, Bharathwaj/ABG-2715-2020; Skerra, Arne/A-2269-2013	Punta, Marco/0000-0002-0050-0676; Rost, Burkhard/0000-0003-0179-8424; Sathyamoorthy, Bharathwaj/0000-0002-1568-2599; Montelione, Gaetano/0000-0002-9440-3059; Skerra, Arne/0000-0002-5717-498X	National Institutes of Health [U54 GM094597]; National Science Foundation [MCB 0817857]; Technische Universitat Munchen, Institute for Advanced Study; German Excellence Initiative; University at Buffalo's Center for Computational Research; Div Of Molecular and Cellular Bioscience [0817857] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094597] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Technische Universitat Munchen, Institute for Advanced Study; German Excellence Initiative; University at Buffalo's Center for Computational Research; Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health (U54 GM094597 to TS and GTM), the National Science Foundation (MCB 0817857 to TS) and the Technische Universitat Munchen, Institute for Advanced Study, funded by the German Excellence Initiative (to BR and MP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank R. Shastry, C. Ciccosanti, H. Janjua, and G.V.T. Swapna for contributions in sample preparation, and Dr. Masayori Inouye, Rutgers University, for advice regarding the biology and biochemistry of bacterial lipoproteins. Support was also obtained from the University at Buffalo's Center for Computational Research.	Acton TB, 2005, METHOD ENZYMOL, V394, P210, DOI 10.1016/S0076-6879(05)94008-1; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andreeva A, 2008, NUCLEIC ACIDS RES, V36, pD419, DOI 10.1093/nar/gkm993; Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Atreya HS, 2004, P NATL ACAD SCI USA, V101, P9642, DOI 10.1073/pnas.0403529101; Babu MM, 2006, J BACTERIOL, V188, P2761, DOI 10.1128/JB.188.8.2761-2773.2006; BARTELS C, 1995, J BIOMOL NMR, V6, P1, DOI 10.1007/BF00417486; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Beste G, 1999, P NATL ACAD SCI USA, V96, P1898, DOI 10.1073/pnas.96.5.1898; Bhattacharya A, 2007, PROTEINS, V66, P778, DOI 10.1002/prot.21165; Bishop R, 2000, BACTERIAL LIPOCALINS; Bishop RE, 2000, BBA-PROTEIN STRUCT M, V1482, P73, DOI 10.1016/S0167-4838(00)00138-2; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Campanacci V, 2006, FEBS LETT, V580, P4877, DOI 10.1016/j.febslet.2006.07.086; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Delfosse V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004712; du Penhoat Catherine Herve, 2005, Journal of Structural and Functional Genomics, V6, P51, DOI 10.1007/s10969-005-5277-z; FLOWER DR, 1993, PROTEIN SCI, V2, P753, DOI 10.1002/pro.5560020507; Flower DR, 1996, BIOCHEM J, V318, P1; Flower DR, 2000, BBA-PROTEIN STRUCT M, V1482, P9, DOI 10.1016/S0167-4838(00)00148-5; Ganfornina MD, 2000, MOL BIOL EVOL, V17, P114, DOI 10.1093/oxfordjournals.molbev.a026224; Greene LH, 2007, NUCLEIC ACIDS RES, V35, pD291, DOI 10.1093/nar/gkl959; Greene LH, 2001, PROTEIN SCI, V10, P2301, DOI 10.1110/ps.22901; Grzyb J, 2006, J PLANT PHYSIOL, V163, P895, DOI 10.1016/j.jplph.2005.12.007; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Hasegawa H, 2009, CURR OPIN STRUC BIOL, V19, P341, DOI 10.1016/j.sbi.2009.04.003; Heinig M, 2004, NUCLEIC ACIDS RES, V32, pW500, DOI 10.1093/nar/gkh429; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Huang YJ, 2006, PROTEINS, V62, P587, DOI 10.1002/prot.20820; Huang YJ, 2005, J AM CHEM SOC, V127, P1665, DOI 10.1021/ja047109h; Jansson M, 1996, J BIOMOL NMR, V7, P131; KATAKURA Y, 1994, BBA-PROTEIN STRUCT M, V1207, P58, DOI 10.1016/0167-4838(94)90051-5; Kersey PJ, 2010, NUCLEIC ACIDS RES, V38, pD563, DOI 10.1093/nar/gkp871; Kim HJ, 2009, J AM CHEM SOC, V131, P3565, DOI 10.1021/ja806857r; Kim S, 2003, J AM CHEM SOC, V125, P1385, DOI 10.1021/ja028197d; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Liu GH, 2005, P NATL ACAD SCI USA, V102, P10487, DOI 10.1073/pnas.0504338102; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Mans BJ, 2008, J BIOL CHEM, V283, P18721, DOI 10.1074/jbc.M800188200; Mills JL, 2009, BIOCHEMISTRY-US, V48, P7411, DOI 10.1021/bi900535j; NERI D, 1989, BIOCHEMISTRY-US, V28, P7510, DOI 10.1021/bi00445a003; Paesen GC, 1999, MOL CELL, V3, P661, DOI 10.1016/S1097-2765(00)80359-7; Petrey D, 2003, METHOD ENZYMOL, V374, P492, DOI 10.1016/S0076-6879(03)74021-X; Petrey D, 2009, P NATL ACAD SCI USA, V106, P17377, DOI 10.1073/pnas.0907971106; Rzychon M, 2003, PROTEIN SCI, V12, P2252, DOI 10.1110/ps.03247703; Sadreyev RI, 2009, CURR OPIN STRUC BIOL, V19, P321, DOI 10.1016/j.sbi.2009.04.009; Schiefner A, 2010, ACTA CRYSTALLOGR D, V66, P1308, DOI 10.1107/S0907444910039375; Schlehuber S, 2002, BIOPHYS CHEM, V96, P213, DOI 10.1016/S0301-4622(02)00026-1; Schonfeld D, 2009, P NATL ACAD SCI USA, V106, P8198, DOI 10.1073/pnas.0813399106; Shen Y, 2005, J AM CHEM SOC, V127, P9085, DOI 10.1021/ja0501870; SIPPL MJ, 1993, PROTEINS, V17, P355, DOI 10.1002/prot.340170404; Skerra A, 2000, BBA-PROTEIN STRUCT M, V1482, P337, DOI 10.1016/S0167-4838(00)00145-X; Tokuda H, 2004, BBA-MOL CELL RES, V1693, P5, DOI 10.1016/j.bbamcr.2004.02.005; Ulrich EL, 2008, NUCLEIC ACIDS RES, V36, pD402, DOI 10.1093/nar/gkm957; Vernikos GS, 2006, BIOINFORMATICS, V22, P2196, DOI 10.1093/bioinformatics/btl369; WOESE CR, 1987, MICROBIOL REV, V51, P221, DOI 10.1128/MMBR.51.2.221-271.1987; Xiao R, 2010, J STRUCT BIOL, V172, P21, DOI 10.1016/j.jsb.2010.07.011; Yang AS, 2000, J MOL BIOL, V301, P665, DOI 10.1006/jmbi.2000.3973; Zimmerman DE, 1997, J MOL BIOL, V269, P592, DOI 10.1006/jmbi.1997.1052	64	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e37404	10.1371/journal.pone.0037404	http://dx.doi.org/10.1371/journal.pone.0037404			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22693626	Green Published, Green Submitted, gold			2022-12-27	WOS:000305343900007
J	Masaki, H; Murphy, TI; Kamijo, K; Yamazaki, K; Sommer, W				Masaki, Hiroaki; Murphy, Timothy I.; Kamijo, Keita; Yamazaki, Katuo; Sommer, Werner			Foreshadowing of Performance Accuracy by Event-Related Potentials: Evidence from a Minimal-Conflict Task	PLOS ONE			English	Article							COGNITIVE CONTROL; CINGULATE CORTEX; ERROR-DETECTION; CORRECT TRIALS; BRAIN ACTIVITY; COMPATIBILITY; INFORMATION; RESPONSES; ACTIVATION; COMPONENTS	Background: Recent studies employing stimulus-response compatibility tasks suggest that an increase in the amplitude of the positive deflection of the response-locked event-related potential (ERP) foreshadows errors on forthcoming trials. However, no studies have tested the generalizability of error-foreshadowing positivity to tasks without stimulus-response interference. Methodology/Principal Findings: The present study adopted an alternating-response task, in which the participants responded to the pointing direction of an arrowhead (up or down). Although the arrowhead direction alternated for the majority of trials (95%), occasionally this pattern was broken by a repeated stimulus, termed a lure trial. We compared the matched-reaction-time correct-preceding ERP with the error-preceding ERP on lure-preceding trials. There was no evidence that errors are foreshadowed by the increase of a positive electroencephalogram (EEG) deflection. To the contrary, analyses of ERPs time-locked to electromyogram (EMG) onset on the five consecutive lure-preceding trials showed larger positive deflections on correct-preceding than error-preceding trials. The post-response negativity did not differ between correct-preceding and error-preceding trials. Conclusions/Significance: These results suggest that in minimal conflict tasks a decreased positivity may foreshadow incorrect performance several trials prior to the error, possibly reflecting the waning of task-related efforts. Therefore, error-foreshadowing brain signals may be task-specific.	[Masaki, Hiroaki; Kamijo, Keita; Yamazaki, Katuo] Waseda Univ, Fac Sport Sci, Tokorozawa, Saitama, Japan; [Murphy, Timothy I.] Brock Univ, Dept Psychol, St Catharines, ON L2S 3A1, Canada; [Sommer, Werner] Humboldt Univ, Inst Psychol, D-10099 Berlin, Germany	Waseda University; Brock University; Humboldt University of Berlin	Masaki, H (corresponding author), Waseda Univ, Fac Sport Sci, Tokorozawa, Saitama, Japan.	masaki@waseda.jp	Sommer, Werner/H-4672-2011; Sommer, Werner/N-1945-2019; Kamijo, Keita/H-4530-2013	Sommer, Werner/0000-0001-5266-3445; Sommer, Werner/0000-0001-5266-3445; Kamijo, Keita/0000-0001-8828-4930	Japan Society for the Promotion of Science [21530774]; Ministry of Education, Culture, Sports, Science and Technology; Waseda University [2008A-505]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Waseda University	This study was supported by a Grant-in-Aid for Scientific Research(C) 21530774 from Japan Society for the Promotion of Science, two Grants-in-Aid [the Global Center of Excellence program and Kibankeisei (2010)] from the Ministry of Education, Culture, Sports, Science and Technology, and a Grant for Special Research Projects from Waseda University Projects (2008A-505) to H. Masaki. URLs: http://www.jsps.go.jp/english/e-grants/index.html. http://www.jsps.go.jp/english/e-globalcoe/. http://www.waseda.jp/rps/en/manual/tokutei.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allain S, 2004, NEUROSCI LETT, V372, P161, DOI 10.1016/j.neulet.2004.09.036; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Burle B, 2005, J EXP PSYCHOL HUMAN, V31, P831, DOI 10.1037/0096-1523.31.4.831; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Casini L, 1996, NEUROSCI LETT, V219, P71, DOI 10.1016/S0304-3940(96)13188-8; Coles MGH, 2001, BIOL PSYCHOL, V56, P173, DOI 10.1016/S0301-0511(01)00076-X; Eichele T, 2008, P NATL ACAD SCI USA, V105, P6173, DOI 10.1073/pnas.0708965105; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; FALKENSTEIN M, 1991, ELECTROEN CLIN NEURO, V78, P447, DOI 10.1016/0013-4694(91)90062-9; Ford JM, 1999, PSYCHOPHYSIOLOGY, V36, P667, DOI 10.1111/1469-8986.3660667; FREUDE G, 1989, J PSYCHOPHYSIOL, V3, P377; GEHRING WJ, 1993, PSYCHOL SCI, V4, P385, DOI 10.1111/j.1467-9280.1993.tb00586.x; GRATTON G, 1992, J EXP PSYCHOL GEN, V121, P480, DOI 10.1037/0096-3445.121.4.480; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Hajcak G, 2005, BIOL PSYCHOL, V70, P67, DOI 10.1016/j.biopsycho.2004.12.001; Hoffmann S, 2010, HUM BRAIN MAPP, V31, P1305, DOI 10.1002/hbm.20937; Jentzsch I, 2001, PSYCHOPHYSIOLOGY, V38, P607, DOI 10.1017/S0048577201000531; Kawabe S, 1982, JAPANESE J PHYS ED, V27, P217; Masaki H, 2000, PSYCHOPHYSIOLOGY, V37, P464, DOI 10.1017/S0048577200981976; Notebaert W, 2009, COGNITION, V111, P275, DOI 10.1016/j.cognition.2009.02.002; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Padilla ML, J COGNITIVE NEUROSCI, V18, P1477; Ridderinkhof KR, 2003, NEUROSCI LETT, V348, P1, DOI 10.1016/S0304-3940(03)00566-4; Scheffers MK, 2000, J EXP PSYCHOL HUMAN, V26, P141, DOI 10.1037/0096-1523.26.1.141; SIMON JR, 1967, J APPL PSYCHOL, V51, P300, DOI 10.1037/h0020586; SMID HGOM, 1992, J EXP PSYCHOL HUMAN, V18, P1101, DOI 10.1037/0096-1523.18.4.1101; Sommer W, 1999, PERCEPT PSYCHOPHYS, V61, P342, DOI 10.3758/BF03206892; Sturmer B, 2002, J EXP PSYCHOL HUMAN, V28, P1345, DOI 10.1037//0096-1523.28.6.1345; Vidal F, 2003, BIOL PSYCHOL, V64, P265, DOI 10.1016/S0301-0511(03)00097-8	29	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38006	10.1371/journal.pone.0038006	http://dx.doi.org/10.1371/journal.pone.0038006			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TY	22701541	Green Submitted, gold, Green Published			2022-12-27	WOS:000305338500072
J	Croak, BM; Pike, DA; Webb, JK; Shine, R				Croak, Benjamin M.; Pike, David A.; Webb, Jonathan K.; Shine, Richard			Habitat Selection in a Rocky Landscape: Experimentally Decoupling the Influence of Retreat Site Attributes from That of Landscape Features	PLOS ONE			English	Article							HOPLOCEPHALUS-BUNGAROIDES SERPENTES; HOT ROCKS; ENDANGERED SNAKE; SANDSTONE OUTCROPS; ARTIFICIAL ROCKS; CLIMATE-CHANGE; LIZARD; THERMOREGULATION; CONSEQUENCES; MICROCLIMATE	Organisms selecting retreat sites may evaluate not only the quality of the specific shelter, but also the proximity of that site to resources in the surrounding area. Distinguishing between habitat selection at these two spatial scales is complicated by co-variation among microhabitat factors (i.e., the attributes of individual retreat sites often correlate with their proximity to landscape features). Disentangling this co-variation may facilitate the restoration or conservation of threatened systems. To experimentally examine the role of landscape attributes in determining retreat-site quality for saxicolous ectotherms, we deployed 198 identical artificial rocks in open (sun-exposed) sites on sandstone outcrops in southeastern Australia, and recorded faunal usage of those retreat sites over the next 29 months. Several landscape-scale attributes were associated with occupancy of experimental rocks, but different features were important for different species. For example, endangered broad-headed snakes (Hoplocephalus bungaroides) preferred retreat sites close to cliff edges, flat rock spiders (Hemicloea major) preferred small outcrops, and velvet geckos (Oedura lesueurii) preferred rocks close to the cliff edge with higher-than-average sun exposure. Standardized retreat sites can provide robust experimental data on the effects of landscape-scale attributes on retreat site selection, revealing interspecific divergences among sympatric taxa that use similar habitats.	[Croak, Benjamin M.; Shine, Richard] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia; [Pike, David A.] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld, Australia; [Webb, Jonathan K.] Univ Technol Sydney, Sch Environm, Sydney, NSW 2007, Australia	University of Sydney; James Cook University; University of Technology Sydney	Croak, BM (corresponding author), Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia.	benjamin.croak@sydney.edu.au	Pike, David A/B-2032-2012	Webb, Jonathan/0000-0003-4822-6829; Croak, Benjamin/0000-0003-4191-5891	a linkage grant (ARC) [LP0776647]; Australian research council; Australian National Parks and Wildlife Service; Australian Reptile Park; Forestry New South Wales; Hawksbury/Nepean Catchment Authority; Zoos Victoria	a linkage grant (ARC)(Australian Research Council); Australian research council(Australian Research Council); Australian National Parks and Wildlife Service; Australian Reptile Park; Forestry New South Wales; Hawksbury/Nepean Catchment Authority; Zoos Victoria	Funding was provided by a linkage grant (ARC grant number: LP0776647) between the following institutions: The Australian research council URL - http://www.arc.gov.au/, Australian National Parks and Wildlife Service URL - http://www.environment.nsw.gov.au/, the Australian Reptile Park URL - http://www.reptilepark.com.au/, Forestry New South Wales http://www.dpi.nsw.gov.au/forests, the Hawksbury/Nepean Catchment Authority http://www.hn.cma.nsw.gov.au/, and Zoos Victoria http://www.zoo.org.au/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAUER A M, 1990, Herpetological Review, V21, P83; Bell TP, 2009, HERPETOL CONSERV BIO, V4, P415; Briones-Fourzan P, 2007, OECOLOGIA, V151, P401, DOI 10.1007/s00442-006-0595-9; Clark RW, 2004, J CHEM ECOL, V30, P607, DOI 10.1023/B:JOEC.0000018632.27010.1e; Cogger H, 2000, REPTILES AMPHIBIANS; Crawley M. J., 2009, R BOOK; Croak BM, 2010, RESTOR ECOL, V18, P428, DOI 10.1111/j.1526-100X.2008.00476.x; Croak BM, 2008, ANIM BEHAV, V76, P1875, DOI 10.1016/j.anbehav.2008.08.011; Doody J. Sean, 2006, Herpetological Review, V37, P49; Downes S, 1998, ANIM BEHAV, V55, P1387, DOI 10.1006/anbe.1997.0705; Downes S, 1998, ANIM BEHAV, V55, P1373, DOI 10.1006/anbe.1997.0704; Downes S, 1999, J HERPETOL, V33, P156, DOI 10.2307/1565560; Du Weiguo, 2009, Current Zoology, V55, P266; Dunlap KD, 2002, J COMP PHYSL, V188, P496; Frazer G.W., 2000, B ECOL SOC AM, V81, P191, DOI DOI 10.1890/0012-9623(2000)081[0190:TT]2.0.CO;2; Goldsbrough CL, 2006, AUSTRAL ECOL, V31, P326, DOI 10.1111/j.1442-9993.2006.01561.x; Goldsbrough CL, 2003, BIOL CONSERV, V109, P85, DOI 10.1016/S0006-3207(02)00139-8; Goldsrough CL, 2004, ECOLOGY, V85, P1635, DOI 10.1890/02-0770; Head ML, 2002, J CHEM ECOL, V28, P541, DOI 10.1023/A:1014592028693; Hersey F, 1980, ENDANGERED ANIMALS N, P30; HUEY RB, 1981, ECOLOGY, V62, P991, DOI 10.2307/1936998; HUEY RB, 1989, ECOLOGY, V70, P931, DOI 10.2307/1941360; HUEY RB, 1991, AM NAT, V137, pS91, DOI 10.1086/285141; Indermaur L, 2009, ECOLOGY, V90, P3430, DOI 10.1890/08-0886.1; Isaac JL, 2008, ANIM CONSERV, V11, P281, DOI 10.1111/j.1469-1795.2008.00177.x; Isaia M, 2006, ENVIRON ENTOMOL, V35, P1654, DOI 10.1603/0046-225X(2006)35[1654:COPBWA]2.0.CO;2; Jones J, 2001, AUK, V118, P557, DOI 10.1642/0004-8038(2001)118[0557:HSSIAE]2.0.CO;2; Kearney M, 2002, J THERM BIOL, V27, P205, DOI 10.1016/S0306-4565(01)00085-7; Kearney M, 2000, ECOLOGY, V81, P2984, DOI 10.1890/0012-9658(2000)081[2984:DNETAS]2.0.CO;2; Krefft G., 1869, SNAKES AUSTR ILLUSTR; Lettink Marieke, 2006, New Zealand Entomologist, V29, P99; Martin TE, 2001, ECOLOGY, V82, P175, DOI 10.2307/2680095; Penman TD, 2010, DIVERS DISTRIB, V16, P109, DOI 10.1111/j.1472-4642.2009.00619.x; Pike DA, 2012, FUNCT ECOL, V26, P469, DOI 10.1111/j.1365-2435.2011.01946.x; Pike DA, 2011, ECOL APPL, V21, P274, DOI 10.1890/09-2394.1; Pike DA, 2010, BEHAVIOUR, V147, P397, DOI 10.1163/000579509X12578482408448; Pringle RM, 2003, ECOLOGY, V84, P2668, DOI 10.1890/02-0482; Quinn GP, 2003, EXPT DESIGN DATA ANA; R Core Team, 2020, R LANG ENV STAT COMP; ROSENZWEIG ML, 1991, AM NAT, V137, pS5, DOI 10.1086/285137; Rudolf VHW, 2005, OECOLOGIA, V142, P316, DOI 10.1007/s00442-004-1668-2; Sabo JL, 2003, OECOLOGIA, V136, P329, DOI 10.1007/s00442-003-1292-6; Scharf I, 2006, J INSECT BEHAV, V19, P197, DOI 10.1007/s10905-006-9017-4; SCHLESINGER CA, 1994, BIOL CONSERV, V67, P49, DOI 10.1016/0006-3207(94)90008-6; SCHLESINGER CA, 1994, HERPETOLOGICA, V50, P156; SHINE R, 1989, Australian Zoologist, V25, P65; Shine R, 1998, WILDLIFE RES, V25, P285, DOI 10.1071/WR97022; Smith BW, 2001, J WILDLIFE MANAGE, V65, P318, DOI 10.2307/3802911; Souter NJ, 2004, BIOL CONSERV, V116, P403, DOI 10.1016/S0006-3207(03)00232-5; Uraguchi Kohji, 1998, Mammal Study, V23, P31, DOI 10.3106/mammalstudy.23.31; Webb JK, 2004, COPEIA, P919, DOI 10.1643/CH-04-039R1; Webb JK, 1998, PHYSIOL ZOOL, V71, P680, DOI 10.1086/515979; Webb JK, 2000, BIOL CONSERV, V92, P93, DOI 10.1016/S0006-3207(99)00056-7; Webb JK, 1998, BIOL CONSERV, V86, P233, DOI 10.1016/S0006-3207(97)00180-8; Webb JK, 1998, ANIM CONSERV, V1, P185, DOI 10.1111/j.1469-1795.1998.tb00028.x; Webb JK, 2009, BEHAV ECOL, V20, P271, DOI 10.1093/beheco/arp011; Wilson S., 2021, COMPLETE GUIDE REPTI, V6th	57	19	19	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2012	7	6							e37982	10.1371/journal.pone.0037982	http://dx.doi.org/10.1371/journal.pone.0037982			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UJ	22701592	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000305340000008
J	Kim, CY; Breiman, RF; Cosmas, L; Audi, A; Aura, B; Bigogo, G; Njuguna, H; Lebo, E; Waiboci, L; Njenga, MK; Feikin, DR; Katz, MA				Kim, Clara Y.; Breiman, Robert F.; Cosmas, Leonard; Audi, Allan; Aura, Barrack; Bigogo, Godfrey; Njuguna, Henry; Lebo, Emmaculate; Waiboci, Lilian; Njenga, M. Kariuki; Feikin, Daniel R.; Katz, Mark A.			Secondary Household Transmission of 2009 Pandemic Influenza A (H1N1) Virus among an Urban and Rural Population in Kenya, 2009-2010	PLOS ONE			English	Article							1-ADAMANTANAMINE HYDROCHLORIDE; FAMILY ENVIRONMENT; OUTBREAK; OSELTAMIVIR; INFECTIONS; RISK	Background: In Kenya, >1,200 laboratory-confirmed 2009 pandemic influenza A (H1N1) (pH1N1) cases occurred since June 2009. We used population-based infectious disease surveillance (PBIDS) data to assess household transmission of pH1N1 in urban Nairobi (Kibera) and rural Lwak. Methods: We defined a pH1N1 patient as laboratory-confirmed pH1N1 infection among PBIDS participants during August 1, 2009-February 5, 2010, in Kibera, or August 1, 2009-January 20, 2010, in Lwak, and a case household as a household with a laboratory-confirmed pH1N1 patient. Community interviewers visited PBIDS-participating households to inquire about illnesses among household members. We randomly selected 4 comparison households per case household matched by number of children aged <5. Comparison households had a household visit 10 days before or after the matched patient symptom onset date. We defined influenza-like illnesses (ILI) as self-reported cough or sore throat, and a self-reported fever <= 8 days after the pH1N1 patient's symptom onset in case households and <= 8 days before selected household visit in comparison households. We used the Cochran-Mantel-Haenszel test to compare proportions of ILIs among case and comparison households, and log binomial-model to compare that of Kibera and Lwak. Results: Among household contacts of patients with confirmed pH1N1 in Kibera, 4.6% had ILI compared with 8.2% in Lwak (risk ratio [RR], 0.5; 95% confidence interval [CI], 0.3-0.9). Household contacts of patients were more likely to have ILIs than comparison-household members in both Kibera (RR, 1.8; 95% CI, 1.1-2.8) and Lwak (RR, 2.6; 95% CI, 1.6-4.3). Overall, ILI was not associated with patient age. However, ILI rates among household contacts were higher among children aged <5 years than persons aged >= 5 years in Lwak, but not Kibera. Conclusions: Substantial pH1N1 household transmission occurred in urban and rural Kenya. Household transmission rates were higher in the rural area.	[Kim, Clara Y.] Ctr Dis Control & Prevent, Epidem Intelligence Serv, Off Workforce & Career Dev, Atlanta, GA 30329 USA; [Kim, Clara Y.] Ohio Dept Hlth, State Epidemiol Off, Columbus, OH 43266 USA; [Breiman, Robert F.; Cosmas, Leonard; Audi, Allan; Aura, Barrack; Bigogo, Godfrey; Njuguna, Henry; Lebo, Emmaculate; Waiboci, Lilian; Njenga, M. Kariuki; Feikin, Daniel R.; Katz, Mark A.] Ctr Dis Control & Prevent Kenya, Kenya Med Res Inst, Global Dis Detect Div, Kisumu, Kenya; [Breiman, Robert F.; Cosmas, Leonard; Audi, Allan; Aura, Barrack; Bigogo, Godfrey; Njuguna, Henry; Lebo, Emmaculate; Waiboci, Lilian; Njenga, M. Kariuki; Feikin, Daniel R.; Katz, Mark A.] Ctr Dis Control & Prevent Kenya, Kenya Med Res Inst, Global Dis Detect Div, Nairobi, Kenya; [Katz, Mark A.] Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Kenya Medical Research Institute; Kenya Medical Research Institute; Centers for Disease Control & Prevention - USA	Kim, CY (corresponding author), Ctr Dis Control & Prevent, Epidem Intelligence Serv, Off Workforce & Career Dev, Atlanta, GA 30329 USA.	clara_kim@alumni.upenn.edu	Bigogo, Godfrey/W-3591-2019	Audi, Allan/0000-0003-1683-554X				Bridges CB, 2000, JAMA-J AM MED ASSOC, V284, P1655, DOI 10.1001/jama.284.13.1655; Carcione D, 2011, EUROSURVEILLANCE, V16, P32; Carneiro I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008988; Carrat F, 2002, ARCH INTERN MED, V162, P1842, DOI 10.1001/archinte.162.16.1842; Cauchemez S, 2004, STAT MED, V23, P3469, DOI 10.1002/sim.1912; Cauchemez S, 2011, P NATL ACAD SCI USA, V108, P2825, DOI 10.1073/pnas.1008895108; Cauchemez S, 2009, NEW ENGL J MED, V361, P2619, DOI 10.1056/NEJMoa0905498; Centers for Disease Control and Prevention, 2009, CDC PROT REALT RT PC; Cowling BJ, 2010, NEW ENGL J MED, V362, P2175, DOI 10.1056/NEJMoa0911530; Feikin DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016085; Feikin DR, 2010, INT J EPIDEMIOL, V39, P450, DOI 10.1093/ije/dyp374; France AM, 2010, J INFECT DIS, V201, P984, DOI 10.1086/651145; GALBRAIT.AW, 1969, B WORLD HEALTH ORGAN, V41, P677; GALBRAITH AW, 1969, LANCET, V2, P1026; Ghani AC, 2009, PLOS CURR INFLU 1116; Hayden FG, 2000, NEW ENGL J MED, V343, P1282, DOI 10.1056/NEJM200011023431801; Hayden FG, 2004, J INFECT DIS, V189, P440, DOI 10.1086/381128; Leung YH, 2011, EPIDEMIOL INFECT, V139, P41, DOI 10.1017/S0950268810001445; Looker C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013702; McNutt LA, 2003, AM J EPIDEMIOL, V157, P940, DOI 10.1093/aje/kwg074; Morales KF, 2010, TALE 2 FEVERS EXPLOR; Morgan OW, 2010, EMERG INFECT DIS, V16, P631, DOI 10.3201/eid1604.091658; Papenburg J, 2010, CLIN INFECT DIS, V51, P1033, DOI 10.1086/656582; Sikora C, 2010, J CLIN VIROL, V49, P90, DOI 10.1016/j.jcv.2010.06.015; Sugimoto JD, 2011, EPIDEMIOLOGY, V22, P180, DOI 10.1097/EDE.0b013e3182060ca5; Tabu C., 2009, Morbidity and Mortality Weekly Report, V58, P1143; Viboud C, 2004, BRIT J GEN PRACT, V54, P684; Waiboci LW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020320; WHO, 2008, INT MAN CHILDH ILLN; World Health Organization, 2010, PAND H1N1 2009 UPD 1	30	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2012	7	6							e38166	10.1371/journal.pone.0038166	http://dx.doi.org/10.1371/journal.pone.0038166			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TU	22701610	Green Published, gold, Green Submitted			2022-12-27	WOS:000305337600017
J	Lima, VLA; Dias, F; Nunes, RD; Pereira, LO; Santos, TSR; Chiarini, LB; Ramos, TD; Silva-Mendes, BJ; Perales, J; Valente, RH; Oliveira, PL				Lima, Vitor L. A.; Dias, Felipe; Nunes, Rodrigo D.; Pereira, Luiza O.; Santos, Tiago S. R.; Chiarini, Luciana B.; Ramos, Tadeu D.; Silva-Mendes, Bernardo J.; Perales, Jonas; Valente, Richard H.; Oliveira, Pedro L.			The Antioxidant Role of Xanthurenic Acid in the Aedes aegypti Midgut during Digestion of a Blood Meal	PLOS ONE			English	Article							PERITROPHIC MATRIX; HEME; EXPRESSION; IDENTIFICATION; ALPHA; IRON	In the midgut of the mosquito Aedes aegypti, a vector of dengue and yellow fever, an intense release of heme and iron takes place during the digestion of a blood meal. Here, we demonstrated via chromatography, light absorption and mass spectrometry that xanthurenic acid (XA), a product of the oxidative metabolism of tryptophan, is produced in the digestive apparatus after the ingestion of a blood meal and reaches milimolar levels after 24 h, the period of maximal digestive activity. XA formation does not occur in the White Eye (WE) strain, which lacks kynurenine hydroxylase and accumulates kynurenic acid. The formation of XA can be diminished by feeding the insect with 3,4-dimethoxy-N-[ 4-(3-nitrophenyl) thiazol-2-yl] benzenesulfonamide (Ro-61-8048), an inhibitor of XA biosynthesis. Moreover, XA inhibits the phospholipid oxidation induced by heme or iron. A major fraction of this antioxidant activity is due to the capacity of XA to bind both heme and iron, which occurs at a slightly alkaline pH (7.5-8.0), a condition found in the insect midgut. The midgut epithelial cells of the WE mosquito has a marked increase in occurrence of cell death, which is reversed to levels similar to the wild type mosquitoes by feeding the insects with blood supplemented with XA, confirming the protective role of this molecule. Collectively, these results suggest a new role for XA as a heme and iron chelator that provides protection as an antioxidant and may help these animals adapt to a blood feeding habit.	[Lima, Vitor L. A.] Univ Fed Alagoas, Inst Quim & Biotecnol, Maceio, Alagoas, Brazil; [Dias, Felipe; Nunes, Rodrigo D.; Santos, Tiago S. R.; Ramos, Tadeu D.; Silva-Mendes, Bernardo J.; Oliveira, Pedro L.] Univ Fed Rio de Janeiro, Inst Bioquim Med, Programa Biol Mol & Biotecnol, Rio De Janeiro, Brazil; [Pereira, Luiza O.] Inst Oswaldo Cruz, Lab Interdisciplinar Pesquisas Med, BR-20001 Rio De Janeiro, Brazil; [Chiarini, Luciana B.] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Rio De Janeiro, Brazil; [Perales, Jonas; Valente, Richard H.] Inst Oswaldo Cruz, Lab Toxinol, BR-20001 Rio De Janeiro, Brazil; [Oliveira, Pedro L.] Inst Nacl Ciencia & Tecnol Entomol Mol, Rio De Janeiro, Brazil	Universidade Federal de Alagoas; Universidade Federal do Rio de Janeiro; Fundacao Oswaldo Cruz; Universidade Federal do Rio de Janeiro; Fundacao Oswaldo Cruz	Lima, VLA (corresponding author), Univ Fed Alagoas, Inst Quim & Biotecnol, Maceio, Alagoas, Brazil.	pedro@bioqmed.ufrj.br	Nunes, Rodrigo/J-6859-2012; Pereira, Luiza O R/P-7606-2018; Dias, Felipe/L-7390-2013; Chiarini, Luciana B/J-3644-2015; Valente, Richard Hemmi/I-5300-2012; L. Oliveira, Pedro/A-9438-2010	Nunes, Rodrigo/0000-0003-1346-291X; Pereira, Luiza O R/0000-0002-8132-1724; Dias, Felipe/0000-0003-2074-1052; L. Oliveira, Pedro/0000-0003-0307-354X; Diniz Ramos, Tadeu/0000-0002-8523-4361; Valente, Richard Hemmi/0000-0002-6562-7571	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, INCT de Entomologia Molecular); Fundacao de Coordenacao de Aperfeicoamento do Pessoal de nivel Superior (CAPES); Fundacao de Amparo a Pesquisa de Estado do Rio de Janeiro (FAPERJ); Howard Hughes Medical Institute (HHMI)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, INCT de Entomologia Molecular)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Coordenacao de Aperfeicoamento do Pessoal de nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa de Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute)	This work was supported by grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, INCT de Entomologia Molecular), Fundacao de Coordenacao de Aperfeicoamento do Pessoal de nivel Superior (CAPES), Fundacao de Amparo a Pesquisa de Estado do Rio de Janeiro (FAPERJ) and the Howard Hughes Medical Institute (HHMI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BHALLA SC, 1968, MOSQ NEWS, V28, P380; Billker O, 1998, NATURE, V392, P289, DOI 10.1038/32667; Britan A, 2006, CELL TISSUE RES, V324, P301, DOI 10.1007/s00441-005-0151-7; CHRISTEN S, 1990, P NATL ACAD SCI USA, V87, P2506, DOI 10.1073/pnas.87.7.2506; Devenport M, 2006, BIOCHEMISTRY-US, V45, P9540, DOI 10.1021/bi0605991; Dunkov Boris C, 2002, J Insect Sci, V2, P7; Gobaille S, 2008, J NEUROCHEM, V105, P982, DOI 10.1111/j.1471-4159.2008.05219.x; Graca-Souza AV, 2006, INSECT BIOCHEM MOLEC, V36, P322, DOI 10.1016/j.ibmb.2006.01.009; GUTTERIDGE JMC, 1988, BIOCHEM J, V256, P861, DOI 10.1042/bj2560861; Halliwell B., 2007, FREE RADICALS BIOL M; Han Q, 2007, J INSECT PHYSIOL, V53, P254, DOI 10.1016/j.jinsphys.2006.09.004; Harizanova N, 2005, INSECT MOL BIOL, V14, P79, DOI 10.1111/j.1365-2583.2004.00533.x; Hazan R, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000810; Kayser H., 1985, P367; Kremer N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000630; Lopez-Burillo S, 2003, J PINEAL RES, V34, P269, DOI 10.1034/j.1600-079X.2003.00041.x; MACKLIS JD, 1990, J NEUROSCI METH, V31, P43, DOI 10.1016/0165-0270(90)90007-3; MILLER EC, 1945, J BIOL CHEM, V157, P551; Mossialos D, 2000, APPL ENVIRON MICROB, V66, P487, DOI 10.1128/AEM.66.2.487-492.2000; Munn DH, 1999, J EXP MED, V189, P1363, DOI 10.1084/jem.189.9.1363; Murakami K, 2001, J NUTR SCI VITAMINOL, V47, P306, DOI 10.3177/jnsv.47.306; NORIEGA FG, 1994, INSECT BIOCHEM MOLEC, V24, P627, DOI 10.1016/0965-1748(94)90099-X; Okuda S, 1998, J NEUROCHEM, V70, P299; Oliveira JHM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001320; Pascoa V, 2002, INSECT BIOCHEM MOLEC, V32, P517, DOI 10.1016/S0965-1748(01)00130-8; Pereira LOR, 2007, BIOCHEMISTRY-US, V46, P6822, DOI 10.1021/bi700011d; Raabe AC, 2011, CELL MICROBIOL, V13, P955, DOI 10.1111/j.1462-5822.2011.01591.x; Rover S, 1997, J MED CHEM, V40, P4378, DOI 10.1021/jm970467t; SCHMITT TH, 1993, ARCH BIOCHEM BIOPHYS, V307, P96, DOI 10.1006/abbi.1993.1566; Shahabuddin M, 1995, EXP PARASITOL, V81, P386, DOI 10.1006/expr.1995.1129; Suzuki S, 2001, BIOCHEM J, V355, P425, DOI 10.1042/0264-6021:3550425; TAPPEL AL, 1955, J BIOL CHEM, V217, P721; VINCENT SH, 1989, SEMIN HEMATOL, V26, P105; Watson RJ, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-177; Zhou GL, 2007, J INSECT PHYSIOL, V53, P1169, DOI 10.1016/j.jinsphys.2007.06.009	35	41	42	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2012	7	6							e38349	10.1371/journal.pone.0038349	http://dx.doi.org/10.1371/journal.pone.0038349			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TU	22701629	gold, Green Submitted, Green Published			2022-12-27	WOS:000305337600020
J	Greenlee, JJ; Smith, JD; Greenlee, MHW; Nicholson, EM				Greenlee, Justin J.; Smith, Jodi D.; Greenlee, M. Heather West; Nicholson, Eric M.			Clinical and Pathologic Features of H-Type Bovine Spongiform Encephalopathy Associated with E211K Prion Protein Polymorphism	PLOS ONE			English	Article							SUFFOLK SHEEP; ATYPICAL BSE; SCRAPIE; CATTLE; IDENTIFICATION; TRANSMISSION; ACCUMULATION; VARIANT; SIMILARITIES; DISEASE	The majority of bovine spongiform encephalopathy (BSE) cases have been ascribed to the classical form of the disease. H-type and L-type BSE cases have atypical molecular profiles compared to classical BSE and are thought to arise spontaneously. However, one case of H-type BSE was associated with a heritable E211K mutation in the prion protein gene. The purpose of this study was to describe transmission of this unique isolate of H-type BSE when inoculated into a calf of the same genotype by the intracranial route. Electroretinograms were used to demonstrate preclinical deficits in retinal function, and optical coherence tomography was used to demonstrate an antemortem decrease in retinal thickness. The calf rapidly progressed to clinical disease (9.4 months) and was necropsied. Widespread distribution of abnormal prion protein was demonstrated within neural tissues by western blot and immunohistochemistry. While this isolate is categorized as BSE-H due to a higher molecular mass of the unglycosylated PrPSc isoform, a strong labeling of all 3 PrPSc bands with monoclonal antibodies 6H4 and P4, and a second unglycosylated band at approximately 14 kDa when developed with antibodies that bind in the C-terminal region, it is unique from other described cases of BSE-H because of an additional band 23 kDa demonstrated on western blots of the cerebellum. This work demonstrates that this isolate is transmissible, has a BSE-H phenotype when transmitted to cattle with the K211 polymorphism, and has molecular features that distinguish it from other cases of BSE-H described in the literature.	[Greenlee, Justin J.; Smith, Jodi D.; Nicholson, Eric M.] Agr Res Serv, Natl Anim Dis Ctr, USDA, Ames, IA USA; [Greenlee, M. Heather West] Iowa State Univ, Ames, IA USA	United States Department of Agriculture (USDA); Iowa State University	Greenlee, JJ (corresponding author), Agr Res Serv, Natl Anim Dis Ctr, USDA, Ames, IA USA.	justin.greenlee@ars.usda.gov	Greenlee, Justin/Y-5732-2019	Greenlee, Justin/0000-0003-2202-3054; Smith, Jodi/0000-0001-7952-8024	congressionally appropriated funds	congressionally appropriated funds	This research was funded in its entirety by congressionally appropriated funds to the United States Department of Agriculture, Agriculture Research Service. The funders of the work did not influence study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Balkema-Buschmann A, 2011, PREV VET MED, V102, P112, DOI 10.1016/j.prevetmed.2011.04.006; Balkema-Buschmann A, 2011, J TOXICOL ENV HEAL A, V74, P103, DOI 10.1080/15287394.2011.529060; Balkema-Buschmann A, 2011, J GEN VIROL, V92, P467, DOI 10.1099/vir.0.025387-0; Baron T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015839; Beringue V, 2006, PLOS PATHOG, V2, P956, DOI 10.1371/journal.ppat.0020112; Biacabe AG, 2004, EMBO REP, V5, P110, DOI 10.1038/sj.embor.7400054; Biacabe AG, 2008, EMERG INFECT DIS, V14, P298, DOI 10.3201/eid1402.071141; Biacabe AG, 2007, PRION, V1, P61, DOI 10.4161/pri.1.1.3828; Bruce ME, 1997, NATURE, V389, P498, DOI 10.1038/39057; Brunelle BW, 2007, J ANIM SCI, V85, P3142, DOI 10.2527/jas.2007-0208; Buschmann A, 2006, VET MICROBIOL, V117, P103, DOI 10.1016/j.vetmic.2006.06.016; Capobianco R, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030031; Casalone C, 2004, P NATL ACAD SCI USA, V101, P3065, DOI 10.1073/pnas.0305777101; Collinge J, 1999, LANCET, V354, P317, DOI 10.1016/S0140-6736(99)05128-4; CUTLIP RC, 1994, J INFECT DIS, V169, P814, DOI 10.1093/infdis/169.4.814; Cutlip RC, 2001, CAN J VET RES, V65, P131; Donnelly CA, 1997, NATURE, V389, P903, DOI 10.1038/39982; Dudas S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010638; Gavier-Widen D, 2008, J VET DIAGN INVEST, V20, P2, DOI 10.1177/104063870802000102; Gonzalez L, 2002, J COMP PATHOL, V126, P17, DOI 10.1053/jcpa.2001.0516; Greenlee JJ, 2006, VET PATHOL, V43, P733, DOI 10.1354/vp.43-5-733; Hamir AN, 2006, VET PATHOL, V43, P118, DOI 10.1354/vp.43-2-118; Hamir AN, 2005, J VET DIAGN INVEST, V17, P3, DOI 10.1177/104063870501700103; Hortells P, 2006, BRAIN RES, V1108, P188, DOI 10.1016/j.brainres.2006.06.021; Jacobs JG, 2007, J CLIN MICROBIOL, V45, P1821, DOI 10.1128/JCM.00160-07; Konold T, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-22; Nicholson EM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002912; O'Rourke KI, 2000, J CLIN MICROBIOL, V38, P3254, DOI 10.1128/JCM.38.9.3254-3259.2000; Okada H, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-79; Polak MP, 2012, VET J; Regnier A, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-25; Richt JA, 2007, J VET DIAGN INVEST, V19, P142, DOI 10.1177/104063870701900202; Richt JA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000156; Smith JD, 2008, J COMP PATHOL, V138, P12, DOI 10.1016/j.jcpa.2007.09.002; Smith JD, 2009, VET PATHOL, V46, P810, DOI 10.1354/vp.08-VP-0206-W-FL; Smith JD, 2009, VET REC, V165, P179, DOI 10.1136/vr.165.6.179; Stack M, 2009, ZOONOSES PUBLIC HLTH, V56, P376, DOI 10.1111/j.1863-2378.2008.01202.x; Sugiura K, 2009, REV SCI TECH OIE, V28, P945; Tester S, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-64; Torres JM, 2011, EMERG INFECT DIS, V17, P1636, DOI 10.3201/eid1709.101403; Torres M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015658; WILESMITH JW, 1991, VET REC, V128, P199, DOI 10.1136/vr.128.9.199; WILESMITH JW, 1988, VET REC, V123, P638; Will RG, 1996, LANCET, V347, P921, DOI 10.1016/S0140-6736(96)91412-9	44	27	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2012	7	6							e38678	10.1371/journal.pone.0038678	http://dx.doi.org/10.1371/journal.pone.0038678			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TQ	22715405	Green Submitted, Green Published, gold			2022-12-27	WOS:000305336800047
J	Takata, Y; Kristal, AR; Santella, RM; King, IB; Duggan, DJ; Lampe, JW; Rayman, MP; Blount, PL; Reid, BJ; Vaughan, TL; Peters, U				Takata, Yumie; Kristal, Alan R.; Santella, Regina M.; King, Irena B.; Duggan, David J.; Lampe, Johanna W.; Rayman, Margaret P.; Blount, Patricia L.; Reid, Brian J.; Vaughan, Thomas L.; Peters, Ulrike			Selenium, Selenoenzymes, Oxidative Stress and Risk of Neoplastic Progression from Barrett's Esophagus: Results from Biomarkers and Genetic Variants	PLOS ONE			English	Article							VITAMIN MINERAL SUPPLEMENTATION; GLUTATHIONE-PEROXIDASE; SELENOPROTEIN-P; NITRIC-OXIDE; CANCER; SERUM; EXPRESSION; ASSOCIATIONS; POLYMORPHISM; PREDICTORS	Clinical trials have suggested a protective effect of selenium supplementation on the risk of esophageal cancer, which may be mediated through the antioxidant activity of selenoenzymes. We investigated whether serum selenium concentrations, selenoenzyme activity, oxidative stress and genetic variation in selenoenzymes were associated with the risk of neoplastic progression to esophageal adenocarcinoma (EA) and two intermediate endpoints, aneuploidy and tetraploidy. In this prospective cohort study, during an average follow-up of 7.3 years, 47 EA cases, 41 aneuploidy cases and 51 tetraploidy cases accrued among 361 participants from the Seattle Barrett's Esophagus Research Study who were free of EA at the time of blood draw and had at least one follow-up visit. Development to EA was assessed histologically and aneuploidy and tetraploidy by DNA content flow cytometry. Serum selenium concentrations were measured using atomic absorption spectrometry, activity of glutathione peroxidase (GPX) 1 and GPX3 by substrate-specific coupled test procedures, selenoprotein P (SEPP1) concentrations and protein carbonyl content by ELISA method and malondialdehyde concentrations by HPLC. Genetic variants in GPX1-4 and SEPP1 were genotyped. Serum selenium was not associated with the risk of neoplastic progression to EA, aneuploidy or tetraploidy (P for trend = 0.25 to 0.85). SEPP1 concentrations were positively associated with the risk of EA [hazard ratio (HR) = 3.95, 95% confidence intervals (CI) = 1.42-10.97 comparing the third tertile with the first] and with aneuploidy (HR = 6.53, 95% CI = 1.31-32.58), but not selenoenzyme activity or oxidative stress markers. No genetic variants, overall, were associated with the risk of neoplastic progression to EA (global p = 0.12-0.69). Our results do not support a protective effect of selenium on risk of neoplastic progression to EA. Our study is the first to report positive associations of plasma SEPP1 concentrations with the risk of EA and aneuploidy, which warrants further investigation.	[Takata, Yumie; Kristal, Alan R.; King, Irena B.; Lampe, Johanna W.; Reid, Brian J.; Vaughan, Thomas L.; Peters, Ulrike] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA; [Santella, Regina M.] Columbia Univ, Dept Environm Hlth Sci, New York, NY USA; [King, Irena B.] Univ New Mexico, Dept Internal Med, Albuquerque, NM 87131 USA; [Duggan, David J.] Translat Genom Res Inst, Div Genet Basis Human Dis, Phoenix, AZ USA; [Rayman, Margaret P.] Univ Surrey, Fac Hlth & Med Sci, Guildford GU2 5XH, Surrey, England; [Blount, Patricia L.; Reid, Brian J.] Fred Hutchinson Canc Res Ctr, Human Biol Div, Seattle, WA 98104 USA	Fred Hutchinson Cancer Center; Columbia University; University of New Mexico; Translational Genomics Research Institute; University of Surrey; Fred Hutchinson Cancer Center	Takata, Y (corresponding author), Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, 1124 Columbia St, Seattle, WA 98104 USA.	upeters@fhcrc.org	Reid, Brian John/AFT-8587-2022	Reid, Brian John/0000-0002-9613-979X; Kristal, Alan/0000-0002-7329-1617	National Cancer Institute [P01 CA91955, K22 CA118421, K05CA124911]; National Institute of Health [DK58763]; NATIONAL CANCER INSTITUTE [P30CA015704, K22CA118421, K05CA124911, P01CA091955] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058763] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by the National Cancer Institute (grant number: P01 CA91955 and K22 CA118421 and K05CA124911) and by the National Institute of Health (grant number: DK58763). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 2002, J CHROMATOGR B, V775, P121, DOI 10.1016/S1570-0232(02)00273-8; Arsova-Sarafinovska Z, 2009, INT UROL NEPHROL, V41, P63, DOI 10.1007/s11255-008-9407-y; Arteel GE, 1999, FEBS LETT, V445, P226, DOI 10.1016/S0014-5793(99)00073-3; BLOT WJ, 2006, CANC EPIDEMIOLOGY PR, P697, DOI DOI 10.1093/ACPROF:OSO/9780195149616.003.0036; Brigelius-Flohe R, 1999, FREE RADICAL BIO MED, V27, P951, DOI 10.1016/S0891-5849(99)00173-2; Burk RF, 2005, ANNU REV NUTR, V25, P215, DOI 10.1146/annurev.nutr.24.012003.132120; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; Chapman JM, 2003, HUM HERED, V56, P18, DOI 10.1159/000073729; Clark LC, 1996, JAMA-J AM MED ASSOC, V276, P1957, DOI 10.1001/jama.276.24.1957; Clemons NJ, 2007, GASTROENTEROLOGY, V133, P1198, DOI 10.1053/j.gastro.2007.06.061; Clemons NJ, 2010, CARCINOGENESIS, V31, P1669, DOI 10.1093/carcin/bgq130; Duffield AJ, 1999, AM J CLIN NUTR, V70, P896; Early DS, 2002, AM J GASTROENTEROL, V97, P745, DOI 10.1111/j.1572-0241.2002.05558.x; ERICSON SP, 1986, CLIN CHEM, V32, P1350; Foster CB, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-56; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Galipeau PC, 2007, PLOS MED, V4, P342, DOI 10.1371/jourmal.pmed.0040067; GARLAND M, 1995, J NATL CANCER I, V87, P497, DOI 10.1093/jnci/87.7.497; Hansen RD, 2009, MUTAT RES-FUND MOL M, V664, P13, DOI 10.1016/j.mrfmmm.2009.01.009; Jimenez P, 2005, WORLD J GASTROENTERO, V11, P2697, DOI 10.3748/wjg.v11.i18.26; KRISHNASWAMY K, 1993, INDIAN J MED RES-B, V98, P124; Lee OJ, 2005, NEOPLASIA, V7, P854, DOI 10.1593/neo.05328; LI JY, 1993, J NATL CANCER I, V85, P1492, DOI 10.1093/jnci/85.18.1492; Longnecker MP, 1996, EPIDEMIOLOGY, V7, P384, DOI 10.1097/00001648-199607000-00008; Mark SD, 2000, J NATL CANCER I, V92, P1753, DOI 10.1093/jnci/92.21.1753; McColl KEL, 2005, GUT, V54, P1, DOI 10.1136/gut.2004.047126; Mork H, 1998, NUTR CANCER, V32, P64, DOI 10.1080/01635589809514720; Mork H, 2003, INT J CANCER, V105, P300, DOI 10.1002/ijc.11087; Murphy SJ, 2007, CARCINOGENESIS, V28, P1323, DOI 10.1093/carcin/bgm007; PAGLIA DE, 1967, J LAB CLIN MED, V70, P158; Peng T, 2007, CANCER SCI, V98, P140, DOI 10.1111/j.1349-7006.2006.00380.x; Rabinovitch PS, 2001, AM J GASTROENTEROL, V96, P3071, DOI 10.1111/j.1572-0241.2001.05261.x; Ravn-Haren G, 2006, CARCINOGENESIS, V27, P820, DOI 10.1093/carcin/bgi267; Reid BJ, 2000, AM J GASTROENTEROL, V95, P1669, DOI 10.1111/j.1572-0241.2000.02196.x; Reid BJ, 2010, NAT REV CANCER, V10, P87, DOI 10.1038/nrc2773; Rudolph RE, 2000, ANN INTERN MED, V132, P612, DOI 10.7326/0003-4819-132-8-200004180-00003; Rudolph RE, 2003, J NATL CANCER I, V95, P750, DOI 10.1093/jnci/95.10.750; Saito Y, 1999, J BIOL CHEM, V274, P2866, DOI 10.1074/jbc.274.5.2866; Steevens J, 2010, CANCER CAUSE CONTROL, V21, P2259, DOI 10.1007/s10552-010-9651-1; Steevens J, 2010, GASTROENTEROLOGY, V138, P1704, DOI 10.1053/j.gastro.2009.12.004; Takata Y, 2012, J NUTR, V142, P419, DOI 10.3945/jn.111.151845; TAYLOR PR, 1994, CANCER RES, V54, pS2029; Tham DM, 1998, AM J PHYSIOL-GASTR L, V275, pG1463, DOI 10.1152/ajpgi.1998.275.6.G1463; THOMSON CD, 1993, BRIT J NUTR, V69, P577, DOI 10.1079/BJN19930057; Ujiie S, 2002, TOHOKU J EXP MED, V196, P99, DOI 10.1620/tjem.196.99; Vaughan TL, 2005, LANCET ONCOL, V6, P945, DOI 10.1016/S1470-2045(05)70431-9; WANG GQ, 1994, CANCER EPIDEM BIOMAR, V3, P161; Yang SJ, 2011, J CLIN ENDOCR METAB, V96, pE1325, DOI 10.1210/jc.2011-0620	48	22	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2012	7	6							e38612	10.1371/journal.pone.0038612	http://dx.doi.org/10.1371/journal.pone.0038612			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TQ	22715394	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336800036
J	Wachter, B; Blanc, AS; Melzheimer, J; Honer, OP; Jago, M; Hofer, H				Wachter, Bettina; Blanc, Anne-Sophie; Melzheimer, Joerg; Hoener, Oliver P.; Jago, Mark; Hofer, Heribert			An Advanced Method to Assess the Diet of Free-Ranging Large Carnivores Based on Scats	PLOS ONE			English	Article							BIALOWIEZA PRIMEVAL FOREST; WOLF SCATS; FEEDING ECOLOGY; AFRICAN SAVANNA; CANIS-ADUSTUS; FOOD-HABITS; PREY; WOLVES; PREDATION; POLAND	Background: The diet of free-ranging carnivores is an important part of their ecology. It is often determined from prey remains in scats. In many cases, scat analyses are the most efficient method but they require correction for potential biases. When the diet is expressed as proportions of consumed mass of each prey species, the consumed prey mass to excrete one scat needs to be determined and corrected for prey body mass because the proportion of digestible to indigestible matter increases with prey body mass. Prey body mass can be corrected for by conducting feeding experiments using prey of various body masses and fitting a regression between consumed prey mass to excrete one scat and prey body mass (correction factor 1). When the diet is expressed as proportions of consumed individuals of each prey species and includes prey animals not completely consumed, the actual mass of each prey consumed by the carnivore needs to be controlled for (correction factor 2). No previous study controlled for this second bias. Methodology/Principal Findings: Here we use an extended series of feeding experiments on a large carnivore, the cheetah (Acinonyx jubatus), to establish both correction factors. In contrast to previous studies which fitted a linear regression for correction factor 1, we fitted a biologically more meaningful exponential regression model where the consumed prey mass to excrete one scat reaches an asymptote at large prey sizes. Using our protocol, we also derive correction factor 1 and 2 for other carnivore species and apply them to published studies. We show that the new method increases the number and proportion of consumed individuals in the diet for large prey animals compared to the conventional method. Conclusion/Significance: Our results have important implications for the interpretation of scat-based studies in feeding ecology and the resolution of human-wildlife conflicts for the conservation of large carnivores.	[Wachter, Bettina; Melzheimer, Joerg; Hoener, Oliver P.; Hofer, Heribert] Leibniz Inst Zoo & Wildlife Res, Berlin, Germany; [Blanc, Anne-Sophie] Univ Neuchatel, Inst Zool, CH-2007 Neuchatel, Switzerland; [Jago, Mark] AfriCat Fdn, Otjiwarongo, Namibia	Leibniz Institut fur Zoo und Wildtierforschung; University of Neuchatel	Wachter, B (corresponding author), Leibniz Inst Zoo & Wildlife Res, Berlin, Germany.	wachter@izw-berlin.de	Hofer, Heribert/AAF-7854-2021; Wachter, Bettina/AAJ-9663-2020; Höner, Oliver P./N-3224-2014	Hofer, Heribert/0000-0002-2813-7442; Höner, Oliver P./0000-0002-0658-3417; Wachter, Bettina/0000-0002-0414-2298	Messerli Stiftung; Universite Neuchatel; Fond Wuthrich et Mathey-Dupraz (all Switzerland); Leibniz Institute for Zoo and Wildlife Research, Germany	Messerli Stiftung; Universite Neuchatel; Fond Wuthrich et Mathey-Dupraz (all Switzerland); Leibniz Institute for Zoo and Wildlife Research, Germany	This study was financed by the Messerli Stiftung, the Universite Neuchatel, the Fond Wuthrich et Mathey-Dupraz (all Switzerland) and the Leibniz Institute for Zoo and Wildlife Research, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKERMAN BB, 1984, J WILDLIFE MANAGE, V48, P147, DOI 10.2307/3808462; Andheria AP, 2007, J ZOOL, V273, P169, DOI 10.1111/j.1469-7998.2007.00310.x; Ansorge H, 2006, ACTA THERIOL, V51, P99, DOI 10.1007/BF03192661; Atkinson RPD, 2002, J ZOOL, V257, P129, DOI 10.1017/S0952836902000729; Caro T., 1994, CHEETAHS SERENGETI P; Ciucci P, 1996, WILDLIFE BIOL, V2, P37, DOI 10.2981/wlb.1996.006; Eaton R.L., 1974, CHEETAH BIOL ECOLOGY; FLOYD TJ, 1978, J WILDLIFE MANAGE, V42, P528, DOI 10.2307/3800814; Godbois IA, 2005, WILDLIFE SOC B, V33, P149, DOI 10.2193/0091-7648(2005)33[149:EODOML]2.0.CO;2; GOSZCZYNSKI J, 1974, Acta Theriologica, V19, P1; JDuP Bothma, 1989, GAME RANCH MANAGEMEN; Jedrzejewski W, 2002, ECOLOGY, V83, P1341, DOI 10.2307/3071948; Jedrzejewski W, 2000, J MAMMAL, V81, P197, DOI 10.1644/1545-1542(2000)081&lt;0197:PSAPBW&gt;2.0.CO;2; Jethva BD, 2004, ZOO BIOL, V23, P513, DOI 10.1002/zoo.20030; Kingdom J, 1997, KINGDON FIELD GUIDE; LOCKIE J. D., 1959, JOUR WILDLIFE MANAGEMENT, V23, P224, DOI 10.2307/3797647; Loveridge AJ, 2003, J ZOOL, V259, P143, DOI 10.1017/S0952836902003114; Marker LL, 2003, S AFR J WILDL RES, V33, P43; Marker-Kraus L., 1996, CHEETAH SURVIVAL NAM; Mech LD., 1970, WOLF ECOLOGY BEHAV E; Meza AD, 2002, AM MIDL NAT, V148, P146; Mills M.G.L., 1984, Koedoe, V27, P281; Mills MGL, 2004, WILDLIFE BIOL, V10, P177, DOI 10.2981/wlb.2004.024; Napolitano C, 2008, MOL ECOL, V17, P678, DOI 10.1111/j.1365-294X.2007.03606.x; Pienaar U. de V., 1969, Koedoe, VNo. 12, P108; Radloff FGT, 2004, J ANIM ECOL, V73, P410, DOI 10.1111/j.0021-8790.2004.00817.x; REYNOLDS JC, 1991, MAMMAL REV, V21, P97, DOI 10.1111/j.1365-2907.1991.tb00113.x; Robbins CT, 1993, WILDLIFE FEEDING NUT, P288; Ruehe F, 2003, ACTA THERIOL, V48, P527, DOI 10.1007/BF03192498; Ruhe F, 2007, ACTA THERIOL, V52, P317, DOI 10.1007/BF03194228; Ruhe F, 2008, WILDLIFE BIOL, V14, P500, DOI 10.2981/0909-6396-14.4.500; Wachter Bettina, 2006, Cat News, V44, P8; WEAVER JL, 1993, J WILDLIFE MANAGE, V57, P534, DOI 10.2307/3809278	33	44	46	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2012	7	6							e38066	10.1371/journal.pone.0038066	http://dx.doi.org/10.1371/journal.pone.0038066			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TQ	22715373	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336800014
J	Guo, YY; Luo, YB; Liu, ZJ; Wang, XQ				Guo, Yan-Yan; Luo, Yi-Bo; Liu, Zhong-Jian; Wang, Xiao-Quan			Evolution and Biogeography of the Slipper Orchids: Eocene Vicariance of the Conduplicate Genera in the Old and New World Tropics	PLOS ONE			English	Article							ESTIMATING DIVERGENCE TIMES; QINGHAI-TIBETAN PLATEAU; CHLOROPLAST GENOME; MOLECULAR PHYLOGENY; NORTHERN-HEMISPHERE; HISTORICAL BIOGEOGRAPHY; ECOLOGICAL SPECIATION; PLANT DISJUNCTIONS; GENETIC DIVERSITY; GONDWANA BREAKUP	Intercontinental disjunctions between tropical regions, which harbor two-thirds of the flowering plants, have drawn great interest from biologists and biogeographers. Most previous studies on these distribution patterns focused on woody plants, and paid little attention to herbs. The Orchidaceae is one of the largest families of angiosperms, with a herbaceous habit and a high species diversity in the Tropics. Here we investigate the evolutionary and biogeographical history of the slipper orchids, which represents a monophyletic subfamily (Cypripedioideae) of the orchid family and comprises five genera that are disjunctly distributed in tropical to temperate regions. A relatively well-resolved and highly supported phylogeny of slipper orchids was reconstructed based on sequence analyses of six maternally inherited chloroplast and two low-copy nuclear genes (LFY and ACO). We found that the genus Cypripedium with a wide distribution in the northern temperate and subtropical zones diverged first, followed by Selenipedium endemic to South America, and finally conduplicate-leaved genera in the Tropics. Mexipedium and Phragmipedium from the neotropics are most closely related, and form a clade sister to Paphiopedilum from tropical Asia. According to molecular clock estimates, the genus Selenipedium originated in Palaeocene, while the most recent common ancestor of conduplicate-leaved slipper orchids could be dated back to the Eocene. Ancestral area reconstruction indicates that vicariance is responsible for the disjunct distribution of conduplicate slipper orchids in palaeotropical and neotropical regions. Our study sheds some light on mechanisms underlying generic and species diversification in the orchid family and tropical disjunctions of herbaceous plant groups. In addition, we suggest that the biogeographical study should sample both regional endemics and their widespread relatives.	[Guo, Yan-Yan; Luo, Yi-Bo; Wang, Xiao-Quan] Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing, Peoples R China; [Guo, Yan-Yan] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Liu, Zhong-Jian] Orchid Conservat & Res Ctr Shenzhen, Shenzhen, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Guo, YY (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing, Peoples R China.	xiaoq_wang@ibcas.ac.cn		Wang, Xiao-Quan/0000-0003-3978-0828; Luo, Yi-bo/0000-0002-2824-8011; Liu, Zhong-Jian/0000-0003-4390-3878	National Natural Science Foundation of China [30730010]; Chinese Academy of Sciences (the 100-Talent Project)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences (the 100-Talent Project)	This work was supported by the National Natural Science Foundation of China (Grant No. 30730010), and the Chinese Academy of Sciences (the 100-Talent Project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott RJ, 2000, SCIENCE, V289, P1343, DOI 10.1126/science.289.5483.1343; Albert Victor A., 1994, Lindleyana, V9, P115; Albert Victor A., 1992, Lindleyana, V7, P172; Antonelli A, 2010, BIOL J LINN SOC, V100, P597, DOI 10.1111/j.1095-8312.2010.01438.x; Arditti J, 2000, NEW PHYTOL, V145, P367, DOI 10.1046/j.1469-8137.2000.00587.x; Atwood J.T., 1984, SELBYANA, V7, P129; Averyanov L.V., 2003, SLIPPER ORCHIDS VIET; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Azuma H, 2001, AM J BOT, V88, P2275, DOI 10.2307/3558389; Bittkau C, 2009, J BIOGEOGR, V36, P1346, DOI 10.1111/j.1365-2699.2008.02003.x; Bouetard A, 2010, MOL PHYLOGENET EVOL, V55, P621, DOI 10.1016/j.ympev.2010.01.021; Bream GJ, 1988, PAPHIOPEDILUM; Cameron Kenneth M., 2006, Aliso, V22, P447; Cameron KM, 2004, MOL PHYLOGENET EVOL, V31, P1157, DOI 10.1016/j.ympev.2003.10.010; Cameron KM, 1999, AM J BOT, V86, P208, DOI 10.2307/2656938; Cameron KM, 2000, MONOCOTS SYSTEMATICS, P457; Chang CC, 2006, MOL BIOL EVOL, V23, P279, DOI 10.1093/molbev/msj029; Conran JG, 2009, AM J BOT, V96, P466, DOI 10.3732/ajb.0800269; Couvreur TLP, 2011, J BIOGEOGR, V38, P664, DOI 10.1111/j.1365-2699.2010.02434.x; Cox AV, 1997, PLANT SYST EVOL, V208, P197, DOI 10.1007/BF00985442; Cozzolino S, 2005, TRENDS ECOL EVOL, V20, P487, DOI 10.1016/j.tree.2005.06.004; Cribb P., 2009, Curtis's Botanical Magazine, V26, P5, DOI 10.1111/j.1467-8748.2009.01632.x; Cribb P., 1998, GENUS PAPHIOPEDILUM; Cribb P, 1997, GENUS CYPRIPEDIUM; Crisp MD, 2011, TRENDS ECOL EVOL, V26, P66, DOI 10.1016/j.tree.2010.11.005; Cuenca A, 2008, MOL PHYLOGENET EVOL, V46, P760, DOI 10.1016/j.ympev.2007.10.010; Cun YZ, 2010, MOL PHYLOGENET EVOL, V56, P972, DOI 10.1016/j.ympev.2010.05.007; Davis CC, 2002, P NATL ACAD SCI USA, V99, P6833, DOI 10.1073/pnas.102175899; Delannoy E, 2011, MOL BIOL EVOL, V28, P2077, DOI 10.1093/molbev/msr028; Donoghue MJ, 2008, P NATL ACAD SCI USA, V105, P11549, DOI 10.1073/pnas.0801962105; Dressler R.L., 1981, ORCHIDS NATURAL HIST; Dressler RL, 1993, PHYLOGENY CLASSIFICA; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Duarte JM, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-61; Ducousso M, 2004, MOL ECOL, V13, P231, DOI 10.1046/j.1365-294X.2003.02032.x; Fan J, 2009, TAXON, V58, P849, DOI 10.1002/tax.583013; Farris JS, 1995, CLADISTICS, V10, P315, DOI [DOI 10.1111/J.1096-0031.1994.TB00181.X, DOI 10.1111/J.1096-0031.1996.TB00196.X]; FELSENSTEIN J, 1988, ANNU REV GENET, V22, P521, DOI 10.1146/annurev.ge.22.120188.002513; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Feng CM, 2009, MOL PHYLOGENET EVOL, V51, P201, DOI 10.1016/j.ympev.2009.01.017; Freudenstein JV, 2004, AM J BOT, V91, P149, DOI 10.3732/ajb.91.1.149; Freudenstein JV, 2001, SYST BOT, V26, P643; Freudenstein JV, 2000, MONOCOTS SYSTEMATICS, P421; Freudensteinia JV, 2008, AM J BOT, V95, P498, DOI 10.3732/ajb.95.4.498; Friis EM, 2004, P NATL ACAD SCI USA, V101, P16565, DOI 10.1073/pnas.0407174101; Givnish TJ, 2004, INT J PLANT SCI, V165, pS1, DOI 10.1086/424022; Goremykin VV, 2005, MOL BIOL EVOL, V22, P1813, DOI 10.1093/molbev/msi173; Goremykin VV, 2004, MOL BIOL EVOL, V21, P1445, DOI 10.1093/molbev/msh147; Goremykin VV, 2003, MOL BIOL EVOL, V20, P1499, DOI 10.1093/molbev/msg159; Gorniak M, 2010, MOL PHYLOGENET EVOL, V56, P784, DOI 10.1016/j.ympev.2010.03.003; Gravendeel B, 2004, PHILOS T ROY SOC B, V359, P1523, DOI 10.1098/rstb.2004.1529; Grob GBJ, 2004, MOL PHYLOGENET EVOL, V30, P13, DOI 10.1016/S1055-7903(03)00183-0; Guan ZJ, 2011, J PLANT RES, V124, P289, DOI 10.1007/s10265-010-0372-z; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Gustafsson ALS, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-177; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hallam A, 1995, OUTLINE PHANEROZOIC; Haston E, 2009, BOT J LINN SOC, V161, P128, DOI 10.1111/j.1095-8339.2009.00996.x; HEANEY LR, 1991, CLIMATIC CHANGE, V19, P53, DOI 10.1007/BF00142213; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; HIRATSUKA J, 1989, MOL GEN GENET, V217, P185, DOI 10.1007/BF02464880; Huang JL, 2010, J SYST EVOL, V48, P240, DOI 10.1111/j.1759-6831.2010.00080.x; Hughes C, 2006, P NATL ACAD SCI USA, V103, P10334, DOI 10.1073/pnas.0601928103; Ickert-Bond SM, 2006, MOL PHYLOGENET EVOL, V39, P512, DOI 10.1016/j.ympev.2005.12.003; Iturralde-Vinent MA, 1999, B AM MUS NAT HIST, P1; Jakob SS, 2007, MOL ECOL, V16, P1713, DOI 10.1111/j.1365-294X.2007.03228.x; John P, 1997, PHYSIOL PLANTARUM, V100, P583, DOI 10.1034/j.1399-3054.1997.1000321.x; Jokat W, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2002JB001802; Karasawa K, 2005, B HIROSHIMA BOT GARD, V22/ 23, P1; Kershaw P, 2001, ANNU REV ECOL SYST, V32, P397, DOI 10.1146/annurev.ecolsys.32.081501.114059; Kim ST, 2008, P NATL ACAD SCI USA, V105, P12370, DOI 10.1073/pnas.0805141105; Kocyan A, 2008, MOL PHYLOGENET EVOL, V48, P422, DOI 10.1016/j.ympev.2008.02.017; Koopowitz H, 2008, TROPICAL SLIPPER ORC; Kores P.J., 2000, MONOCOTS SYSTEMATIC; Lan TY, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-126; LAVIN M, 1993, AM J BOT, V80, P1, DOI 10.2307/2445114; Li JH, 2011, MOL PHYLOGENET EVOL, V61, P308, DOI 10.1016/j.ympev.2011.06.006; Li L, 2011, AM J BOT, V98, P1520, DOI 10.3732/ajb.1100006; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; LIDGARD S, 1990, PALEOBIOLOGY, V16, P77, DOI 10.1017/S009483730000974X; Lin ZF, 2009, J EXP BOT, V60, P3311, DOI 10.1093/jxb/erp204; Lindley J, 1840, GENERA SPECIES ORCHI; Liu ZJ, 2009, GENUS PAPHIOPEDILUM; Logacheva MD, 2011, GENOME BIOL EVOL, V3, P1296, DOI 10.1093/gbe/evr102; Maizel A, 2005, SCIENCE, V308, P260, DOI 10.1126/science.1108229; McKenna M.C., 1983, STRUCTURE DEV GREENL, P351, DOI DOI 10.1007/978-1-4613-3485-9_19; MCKENNA MC, 1983, ANN MO BOT GARD, V70, P459, DOI 10.2307/2992083; Merckx V, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-178; Michalak I, 2010, J BIOGEOGR, V37, P1214, DOI 10.1111/j.1365-2699.2010.02306.x; Milne RI, 2002, ADV BOT RES, V38, P281, DOI 10.1016/S0065-2296(02)38033-9; Milne RI, 2006, ANN BOT-LONDON, V98, P465, DOI 10.1093/aob/mcl148; Moles AT, 2005, SCIENCE, V307, P576, DOI 10.1126/science.1104863; Molvary M, 1999, GENERA ORCHIDACEARUM, P59; Mondragon-Palomino M, 2009, ANN BOT-LONDON, V104, P583, DOI 10.1093/aob/mcn258; Moore MJ, 2010, P NATL ACAD SCI USA, V107, P4623, DOI 10.1073/pnas.0907801107; Moyroud E, 2010, TRENDS PLANT SCI, V15, P346, DOI 10.1016/j.tplants.2010.03.007; Nathan R, 2006, SCIENCE, V313, P786, DOI 10.1126/science.1124975; Neubig KM, 2010, AM J BOT, V97, pE52, DOI 10.3732/ajb.1000128; Neubig KM, 2009, PLANT SYST EVOL, V277, P75, DOI 10.1007/s00606-008-0105-0; Nie ZL, 2008, MOL PHYLOGENET EVOL, V48, P1027, DOI 10.1016/j.ympev.2008.06.004; Nie ZL, 2010, AM J BOT, V97, P1342, DOI 10.3732/ajb.1000085; Nilsson O, 1998, GENETICS, V150, P403; Nylander J.A.A, 2004, MRMODELTEST V2; Oh SH, 2005, AM J BOT, V92, P179, DOI 10.3732/ajb.92.1.179; Oh SH, 2003, MOL PHYLOGENET EVOL, V29, P203, DOI 10.1016/S1055-7903(03)00093-9; Otero JT, 2006, TRENDS ECOL EVOL, V21, P64, DOI 10.1016/j.tree.2005.11.016; Parks M, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-84; Peng D, 2008, MOL PHYLOGENET EVOL, V47, P1190, DOI 10.1016/j.ympev.2008.02.001; Pennington RT, 2004, PHILOS T R SOC B, V359, P1611, DOI 10.1098/rstb.2004.1532; Petit RJ, 2003, SCIENCE, V300, P1563, DOI 10.1126/science.1083264; Pfitzer EHH, 1903, PFLANZENREICH, P1; Phillips RD, 2009, AUST J BOT, V57, P259, DOI 10.1071/BT08157; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; PRANCE GT, 1977, ANN MO BOT GARD, V64, P659, DOI 10.2307/2395293; Ramirez SR, 2007, NATURE, V448, P1042, DOI 10.1038/nature06039; RAVEN PH, 1988, TAXON, V37, P549, DOI 10.2307/1221098; Ree RH, 2005, EVOLUTION, V59, P2299; Ree RH, 2008, SYSTEMATIC BIOL, V57, P4, DOI 10.1080/10635150701883881; Renner SS, 2005, TRENDS PLANT SCI, V10, P550, DOI 10.1016/j.tplants.2005.09.010; Repetur CP, 1997, SYST BOT, V22, P465, DOI 10.2307/2419821; Roberts DL, 2008, CURR BIOL, V18, pR325, DOI 10.1016/j.cub.2008.02.026; Rogers SO, 1988, PLANT MOL BIOL MAN A, VA6, P1, DOI DOI 10.1007/978-94-017-5294-7_; Rokas A, 2005, MOL BIOL EVOL, V22, P1337, DOI 10.1093/molbev/msi121; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rundle HD, 2005, ECOL LETT, V8, P336, DOI 10.1111/j.1461-0248.2004.00715.x; Russell A, 2010, TAXON, V59, P389, DOI 10.1002/tax.592005; Ryan PG, 2007, SCIENCE, V315, P1420, DOI 10.1126/science.1138829; Sanderson MJ, 2002, MOL BIOL EVOL, V19, P101, DOI 10.1093/oxfordjournals.molbev.a003974; Sanderson MJ, 1997, MOL BIOL EVOL, V14, P1218, DOI 10.1093/oxfordjournals.molbev.a025731; Sanderson MJ, 2003, BIOINFORMATICS, V19, P301, DOI 10.1093/bioinformatics/19.2.301; Sang T, 2002, CRIT REV BIOCHEM MOL, V37, P121, DOI 10.1080/10409230290771474; Sapir Y, 2007, MOL ECOL, V16, P5017, DOI 10.1111/j.1365-294X.2007.03557.x; Schluter D, 2009, SCIENCE, V323, P737, DOI 10.1126/science.1160006; Silvera K, 2009, PLANT PHYSIOL, V149, P1838, DOI 10.1104/pp.108.132555; Small RL, 2004, AUST SYST BOT, V17, P145, DOI 10.1071/SB03015; Smedmark JEE, 2010, J BIOGEOGR, V37, P2260, DOI 10.1111/j.1365-2699.2010.02366.x; Sorhannus U, 1999, MOL BIOL EVOL, V16, P849, DOI 10.1093/oxfordjournals.molbev.a026169; Soto MA, 1990, ORQUIDEA MEX, V12, P1; Spicer RA, 2003, NATURE, V421, P622, DOI 10.1038/nature01356; Swofford DL, 2002, PAUP 4 0B10 PHYLOGEN; Thorne R, 2004, INT J PLANT SCI, V165, pS137, DOI 10.1086/424023; TIFFNEY BH, 1985, J ARNOLD ARBORETUM, V66, P73, DOI 10.5962/bhl.part.13179; TIFFNEY BH, 1985, J ARNOLD ARBORETUM, V66, P243, DOI 10.5962/bhl.part.13183; Trejo-Torres JC, 2001, J BIOGEOGR, V28, P775, DOI 10.1046/j.1365-2699.2001.00576.x; Upchurch P, 2008, TRENDS ECOL EVOL, V23, P229, DOI 10.1016/j.tree.2007.11.006; Valiente-Banuet A, 2006, P NATL ACAD SCI USA, V103, P16812, DOI 10.1073/pnas.0604933103; Wang HC, 2009, P NATL ACAD SCI USA, V106, P3853, DOI 10.1073/pnas.0813376106; Wei XX, 2010, MOL PHYLOGENET EVOL, V55, P776, DOI 10.1016/j.ympev.2010.03.007; WEIGEL D, 1992, CELL, V69, P843, DOI 10.1016/0092-8674(92)90295-N; Wen J, 1999, ANNU REV ECOL SYST, V30, P421, DOI 10.1146/annurev.ecolsys.30.1.421; Whittall JB, 2006, MOL PHYLOGENET EVOL, V39, P124, DOI 10.1016/j.ympev.2005.10.010; WING SL, 1987, ANN MO BOT GARD, V74, P748, DOI 10.2307/2399449; WOLFE JA, 1975, ANN MO BOT GARD, V62, P264, DOI 10.2307/2395198; WOLFE KH, 1987, P NATL ACAD SCI USA, V84, P9054, DOI 10.1073/pnas.84.24.9054; Wu FH, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-68; Yang FS, 2008, MOL ECOL, V17, P5135, DOI 10.1111/j.1365-294X.2008.03976.x; Yang ZH, 2003, SYST BIOL, V52, P705, DOI 10.1080/10635150390235557; Yoder AD, 2006, ANNU REV ECOL EVOL S, V37, P405, DOI 10.1146/annurev.ecolsys.37.091305.110239; Young ND, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-6; Yu Y, S DIVA STAT DISPERSA; Yu Y, 2010, MOL PHYLOGENET EVOL, V56, P848, DOI 10.1016/j.ympev.2010.04.011; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; Zachos JC, 2003, SCIENCE, V302, P1551, DOI 10.1126/science.1090110; Zanazzi A, 2007, NATURE, V445, P639, DOI 10.1038/nature05551	164	52	58	2	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e38788	10.1371/journal.pone.0038788	http://dx.doi.org/10.1371/journal.pone.0038788			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685605	Green Published, Green Submitted, gold			2022-12-27	WOS:000305351700069
J	Aguilar-Mahecha, A; Kuzyk, MA; Domanski, D; Borchers, CH; Basik, M				Aguilar-Mahecha, Adriana; Kuzyk, Michael A.; Domanski, Dominik; Borchers, Christoph H.; Basik, Mark			The Effect of Pre-Analytical Variability on the Measurement of MRM-MS-Based Mid- to High-Abundance Plasma Protein Biomarkers and a Panel of Cytokines	PLOS ONE			English	Article							ADVIA-120 HEMATOLOGY SYSTEM; HUMAN PLATELETS; PROTEOMIC BIOMARKER; MASS-SPECTROMETRY; HUMAN BLOOD; COLLECTION; CANCER; SERUM; ANTICOAGULANTS; ACTIVATION	Blood sample processing and handling can have a significant impact on the stability and levels of proteins measured in biomarker studies. Such pre-analytical variability needs to be well understood in the context of the different proteomics platforms available for biomarker discovery and validation. In the present study we evaluated different types of blood collection tubes including the BD P100 tube containing protease inhibitors as well as CTAD tubes, which prevent platelet activation. We studied the effect of different processing protocols as well as delays in tube processing on the levels of 55 mid and high abundance plasma proteins using novel multiple-reaction monitoring-mass spectrometry (MRM-MS) assays as well as 27 low abundance cytokines using a commercially available multiplexed bead-based immunoassay. The use of P100 tubes containing protease inhibitors only conferred proteolytic protection for 4 cytokines and only one MRM-MS-measured peptide. Mid and high abundance proteins measured by MRM are highly stable in plasma left unprocessed for up to six hours although platelet activation can also impact the levels of these proteins. The levels of cytokines were elevated when tubes were centrifuged at cold temperature, while low levels were detected when samples were collected in CTAD tubes. Delays in centrifugation also had an impact on the levels of cytokines measured depending on the type of collection tube used. Our findings can help in the development of guidelines for blood collection and processing for proteomic biomarker studies.	[Aguilar-Mahecha, Adriana; Basik, Mark] McGill Univ, Dept Oncol, Lady Davis Inst, Montreal, PQ, Canada; [Kuzyk, Michael A.; Domanski, Dominik; Borchers, Christoph H.] Univ Victoria, Genome BC Prote Ctr, Victoria, BC, Canada; [Borchers, Christoph H.] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC, Canada	Lady Davis Institute; McGill University; University of Victoria; University of Victoria	Aguilar-Mahecha, A (corresponding author), McGill Univ, Dept Oncol, Lady Davis Inst, Montreal, PQ, Canada.	mark.basik@mcgill.ca	BORCHERS, Christoph/U-5964-2019; Aguilar, Adriana/GRF-2369-2022	Domanski, Dominik/0000-0003-2549-1064	Jewish General Hospital Foundation; Weekend to end breast cancer; Fondation de Recherche en Sante du Quebec (FRSQ) Reseau Cancer; Genome BC; Genome Canada	Jewish General Hospital Foundation; Weekend to end breast cancer; Fondation de Recherche en Sante du Quebec (FRSQ) Reseau Cancer; Genome BC; Genome Canada(Genome Canada)	This work was supported by the Jewish General Hospital Foundation, The Weekend to end breast cancer and Fondation de Recherche en Sante du Quebec (FRSQ) Reseau Cancer. The University of Victoria-Genome BC Proteomics Centre is partially supported by platform grants from Genome BC and Genome Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahnadi CE, 2003, THROMB HAEMOSTASIS, V90, P940, DOI 10.1160/TH03-02-0097; Anderson NL, 2002, MOL CELL PROTEOMICS, V1, P845, DOI 10.1074/mcp.R200007-MCP200; Banks RE, 2005, CLIN CHEM, V51, P1637, DOI 10.1373/clinchem.2005.051417; Banks RE, 1998, BRIT J CANCER, V77, P956, DOI 10.1038/bjc.1998.158; Blair P, 2009, BLOOD REV, V23, P177, DOI 10.1016/j.blre.2009.04.001; de Jager W, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-52; Fu Q, 2010, CLIN CHEM, V56, P314, DOI 10.1373/clinchem.2009.135087; Hanash SM, 2011, NAT REV CLIN ONCOL, V8, P142, DOI 10.1038/nrclinonc.2010.220; Hanash SM, 2007, BIOMARK INSIGHTS, V1, P1; Hsu J., 1996, MULTIPLE COMP THEORY; Jackson DH, 2010, PROTEOM CLIN APPL, V4, P250, DOI 10.1002/prca.200900220; Kuzyk MA, 2009, MOL CELL PROTEOMICS, V8, P1860, DOI 10.1074/mcp.M800540-MCP200; Macey M, 2002, CLIN CHEM, V48, P891; Oliver AE, 1999, BBA-BIOMEMBRANES, V1416, P349, DOI 10.1016/S0005-2736(98)00239-9; Proc JL, 2010, J PROTEOME RES, V9, P5422, DOI 10.1021/pr100656u; Qureshi AH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007627; Rai AJ, 2005, PROTEOMICS, V5, P3262, DOI 10.1002/pmic.200401245; Rai AJ, 2006, EXPERT REV PROTEOMIC, V3, P409, DOI 10.1586/14789450.3.4.409; Randall SA, 2010, PROTEOMICS, V10, P2050, DOI 10.1002/pmic.200900517; Rifai N, 2006, NAT BIOTECHNOL, V24, P971, DOI 10.1038/nbt1235; Rodriguez H, 2010, PROTEOM CLIN APPL, V4, P904, DOI 10.1002/prca.201000057; Tammen H, 2005, PROTEOMICS, V5, P3414, DOI 10.1002/pmic.200401219; Tuck MK, 2009, J PROTEOME RES, V8, P113, DOI 10.1021/pr800545q; Wildes D, 2010, P NATL ACAD SCI USA, V107, P4561, DOI 10.1073/pnas.0914495107; WINOKUR R, 1995, BLOOD, V85, P1796, DOI 10.1182/blood.V85.7.1796.bloodjournal8571796; Yi JZ, 2007, J PROTEOME RES, V6, P1768, DOI 10.1021/pr060550h; Yi JZ, 2008, J PROTEOME RES, V7, P5112, DOI 10.1021/pr800396c; Zimmermann R, 2005, CLIN CHEM, V51, P2365, DOI 10.1373/clinchem.2005.055558; Zimmermann R, 2009, J IMMUNOL METHODS, V347, P91, DOI 10.1016/j.jim.2009.04.010	29	49	49	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e38290	10.1371/journal.pone.0038290	http://dx.doi.org/10.1371/journal.pone.0038290			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701622	gold, Green Published, Green Submitted			2022-12-27	WOS:000305348400046
J	Buchser, WJ; Smith, RP; Pardinas, JR; Haddox, CL; Hutson, T; Moon, L; Hoffman, SR; Bixby, JL; Lemmon, VP				Buchser, William J.; Smith, Robin P.; Pardinas, Jose R.; Haddox, Candace L.; Hutson, Thomas; Moon, Lawrence; Hoffman, Stanley R.; Bixby, John L.; Lemmon, Vance P.			Peripheral Nervous System Genes Expressed in Central Neurons Induce Growth on Inhibitory Substrates	PLOS ONE			English	Article							CHONDROITIN SULFATE PROTEOGLYCAN; AXON REGENERATION; PROTEIN-SYNTHESIS; NEURITE OUTGROWTH; SERINE-PROTEASE; MYELIN; BRAIN; CNS; DIFFERENTIATION; RECEPTOR	Trauma to the spinal cord and brain can result in irreparable loss of function. This failure of recovery is in part due to inhibition of axon regeneration by myelin and chondroitin sulfate proteoglycans (CSPGs). Peripheral nervous system (PNS) neurons exhibit increased regenerative ability compared to central nervous system neurons, even in the presence of inhibitory environments. Previously, we identified over a thousand genes differentially expressed in PNS neurons relative to CNS neurons. These genes represent intrinsic differences that may account for the PNS's enhanced regenerative ability. Cerebellar neurons were transfected with cDNAs for each of these PNS genes to assess their ability to enhance neurite growth on inhibitory (CSPG) or permissive (laminin) substrates. Using high content analysis, we evaluated the phenotypic profile of each neuron to extract meaningful data for over 1100 genes. Several known growth associated proteins potentiated neurite growth on laminin. Most interestingly, novel genes were identified that promoted neurite growth on CSPGs (GPX3, EIF2B5, RBMX). Bioinformatic approaches also uncovered a number of novel gene families that altered neurite growth of CNS neurons.	[Buchser, William J.; Smith, Robin P.; Haddox, Candace L.; Bixby, John L.; Lemmon, Vance P.] Univ Miami, Miller Sch Med, Miami Project Cure Paralysis, Dept Pharmacol, Miami, FL 33136 USA; [Buchser, William J.; Smith, Robin P.; Haddox, Candace L.; Bixby, John L.; Lemmon, Vance P.] Univ Miami, Miller Sch Med, Neurosci Program, Dept Neurol Surg, Miami, FL 33136 USA; [Pardinas, Jose R.] Egea Biosci, La Jolla, CA USA; [Hoffman, Stanley R.] Med Univ S Carolina, Div Rheumatol & Immunol, Charleston, SC 29425 USA; [Hutson, Thomas; Moon, Lawrence] Kings Coll London, Wolfson Ctr Age Related Dis, London WC2R 2LS, England	University of Miami; University of Miami; Medical University of South Carolina; University of London; King's College London	Buchser, WJ (corresponding author), Univ Miami, Miller Sch Med, Miami Project Cure Paralysis, Dept Pharmacol, Miami, FL 33136 USA.	jbixby@miami.edu; vlemmon@miami.edu	Lemmon, Vance/A-7410-2010; Moon, Lawrence/C-4906-2008	Lemmon, Vance/0000-0003-3550-7576; Moon, Lawrence/0000-0001-9622-0312; Haddox, Candace/0000-0003-4223-0632; Buchser, William/0000-0002-6675-6359; Bixby, John/0000-0003-1633-5318	National Institutes of Health [HD057632, NS059866]; U.S. Army [W81XWH-05-1-0061]; Paralyzed Veterans of America; Henry Smith Charity; Buoniconti Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD057632] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059866] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Army; Paralyzed Veterans of America; Henry Smith Charity; Buoniconti Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health (HD057632), (NS059866), U.S. Army (W81XWH-05-1-0061), Paralyzed Veterans of America, Henry Smith Charity, and the Buoniconti Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araki T, 1998, J NEUROSCI RES, V53, P7, DOI 10.1002/(SICI)1097-4547(19980701)53:1<7::AID-JNR2>3.3.CO;2-H; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bishop AC, 2002, J BIOL CHEM, V277, P25090, DOI 10.1074/jbc.M203208200; Blackmore MG, 2010, MOL CELL NEUROSCI, V44, P43, DOI 10.1016/j.mcn.2010.02.002; Bolliger MF, 2010, J CELL SCI, V123, P3944, DOI 10.1242/jcs.072090; Bonaldo MDF, 1996, GENOME RES, V6, P791, DOI 10.1101/gr.6.9.791; Bonilla IE, 2002, J NEUROSCI, V22, P1303, DOI 10.1523/JNEUROSCI.22-04-01303.2002; Brittis PA, 2002, CELL, V110, P223, DOI 10.1016/S0092-8674(02)00813-9; Broude E, 1997, EXP NEUROL, V148, P367, DOI 10.1006/exnr.1997.6665; Bryan B, 2005, FEBS LETT, V579, P1015, DOI 10.1016/j.febslet.2004.12.074; Buchser WJ, 2006, BIOTECHNIQUES, V41, P619, DOI 10.2144/000112279; Buchser WJ, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.52; Cai DM, 1999, NEURON, V22, P89, DOI 10.1016/S0896-6273(00)80681-9; Cajal S., 1928, DEGENERATION REGENER; Camps M, 1998, FEBS LETT, V425, P271, DOI 10.1016/S0014-5793(98)00250-6; Chakravarti IM, 1967, HDB METHODS APPL STA, V1, P392; Chaudhry N, 2007, J CEREBR BLOOD F MET, V27, P1096, DOI 10.1038/sj.jcbfm.9600407; Chen ZL, 2007, ANNU REV NEUROSCI, V30, P209, DOI 10.1146/annurev.neuro.30.051606.094337; Chivatakarn O, 2007, J NEUROSCI, V27, P7117, DOI 10.1523/JNEUROSCI.1541-07.2007; Collinet C, 2010, NATURE, V464, P243, DOI 10.1038/nature08779; Crack PJ, 2001, J NEUROCHEM, V78, P1389, DOI 10.1046/j.1471-4159.2001.00535.x; Davies SJA, 1997, NATURE, V390, P680, DOI 10.1038/37776; Dey N, 2005, EXP CELL RES, V307, P1, DOI 10.1016/j.yexcr.2005.02.029; Dichmann DS, 2008, DEV DYNAM, V237, P1755, DOI 10.1002/dvdy.21590; Dill J, 2008, J NEUROSCI, V28, P8914, DOI 10.1523/JNEUROSCI.1178-08.2008; Drinjakovic J, 2010, NEURON, V65, P341, DOI 10.1016/j.neuron.2010.01.017; Efron B., 1994, CHAPMAN HALL CRC MON; ERNST H, 1995, J CELL SCI, V108, P3807; Fitch MT, 1999, J NEUROSCI, V19, P8182; FREDERICKSON RM, 1992, MOL CELL BIOL, V12, P1239, DOI 10.1128/MCB.12.3.1239; Frischknecht R, 2008, J NEUROSCI, V28, P1568, DOI 10.1523/JNEUROSCI.3398-07.2008; Gerhard DS, 2004, GENOME RES, V14, P2121, DOI 10.1101/gr.2596504; Giuliano KA, 1997, J BIOMOL SCREEN, V2, P249, DOI 10.1177/108705719700200410; Goldberg JL, 2002, SCIENCE, V296, P1860, DOI 10.1126/science.1068428; Gutierrez H, 2008, J NEUROSCI, V28, P8246, DOI 10.1523/JNEUROSCI.1941-08.2008; Hafezparast M, 2003, SCIENCE, V300, P808, DOI 10.1126/science.1083129; Herdegen T, 1997, TRENDS NEUROSCI, V20, P227, DOI 10.1016/S0166-2236(96)01000-4; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang YF, 2007, P NATL ACAD SCI USA, V104, P4194, DOI 10.1073/pnas.0611609104; Inman DM, 2003, J COMP NEUROL, V462, P431, DOI 10.1002/cne.10768; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kawabe H, 2010, NEURON, V65, P358, DOI 10.1016/j.neuron.2010.01.007; Kleijn M, 1998, J BIOL CHEM, V273, P5536, DOI 10.1074/jbc.273.10.5536; Koprivica V, 2005, SCIENCE, V310, P106, DOI 10.1126/science.1115462; Langton JT, 2007, PROC SPIE, V6495, DOI 10.1117/12.706110; Lee JK, 2010, NEURON, V66, P663, DOI 10.1016/j.neuron.2010.05.002; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lein ES, 2004, J NEUROSCI, V24, P3879, DOI 10.1523/JNEUROSCI.4710-03.2004; LI D, 1995, EUR J NEUROSCI, V7, P1164, DOI 10.1111/j.1460-9568.1995.tb01106.x; Lin AC, 2008, CURR OPIN NEUROBIOL, V18, P60, DOI 10.1016/j.conb.2008.05.004; MCKEON RJ, 1991, J NEUROSCI, V11, P3398; MEYERFRANKE A, 1995, NEURON, V15, P805, DOI 10.1016/0896-6273(95)90172-8; Moon LDF, 2001, NAT NEUROSCI, V4, P465, DOI 10.1038/87415; Moore DL, 2009, SCIENCE, V326, P298, DOI 10.1126/science.1175737; MUKHOPADHYAY G, 1994, NEURON, V13, P757, DOI 10.1016/0896-6273(94)90042-6; Ng L, 2007, IEEE ACM T COMPUT BI, V4, P382, DOI 10.1109/TCBB.2007.1035; Numajiri T, 2006, J PLAST RECONSTR AES, V59, P393, DOI 10.1016/j.bjps.2005.04.018; Omura Y, 2009, BMB REP, V42, P232, DOI 10.5483/BMBRep.2009.42.4.232; Park KK, 2010, EXP NEUROL, V223, P45, DOI 10.1016/j.expneurol.2009.12.032; Park KK, 2008, SCIENCE, V322, P963, DOI 10.1126/science.1161566; Peeters PJ, 2006, PHYSIOL GENOMICS, V24, P252, DOI 10.1152/physiolgenomics.00169.2005; Poluha W, 1997, J BIOL CHEM, V272, P24002, DOI 10.1074/jbc.272.38.24002; Power JHT, 2009, ACTA NEUROPATHOL, V117, P63, DOI 10.1007/s00401-008-0438-3; REIER PJ, 1979, BRAIN RES, V164, P61, DOI 10.1016/0006-8993(79)90006-4; SCHECTERSON LC, 1992, NEURON, V9, P449, DOI 10.1016/0896-6273(92)90183-E; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shen YJ, 2009, SCIENCE, V326, P592, DOI 10.1126/science.1178310; Shu XK, 2006, BIOCHEMISTRY-US, V45, P9639, DOI 10.1021/bi060773l; Sivasankaran R, 2004, NAT NEUROSCI, V7, P261, DOI 10.1038/nn1193; Smith J, 2000, P NATL ACAD SCI USA, V97, P10032, DOI 10.1073/pnas.170209797; Smith PD, 2009, NEURON, V64, P617, DOI 10.1016/j.neuron.2009.11.021; Smith RP, 2011, MOL CELL NEUROSCI, V46, P32, DOI 10.1016/j.mcn.2010.07.015; SNOW DM, 1990, EXP NEUROL, V109, P111, DOI 10.1016/S0014-4886(05)80013-5; Tcherkezian J, 2010, CELL, V141, P632, DOI 10.1016/j.cell.2010.04.008; Thompson CL, 2008, NEURON, V60, P1010, DOI 10.1016/j.neuron.2008.12.008; Tsend-Ayush E, 2005, DEV DYNAM, V234, P682, DOI 10.1002/dvdy.20432; Usher LC, 2010, J NEUROSCI, V30, P4693, DOI 10.1523/JNEUROSCI.0302-10.2010; WICTORIN K, 1990, NATURE, V347, P556, DOI 10.1038/347556a0; Zhang XHD, 2009, BIOINFORMATICS, V25, P841, DOI 10.1093/bioinformatics/btp082	79	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e38101	10.1371/journal.pone.0038101	http://dx.doi.org/10.1371/journal.pone.0038101			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701605	Green Published, Green Submitted, gold			2022-12-27	WOS:000305348400035
J	Garcia-Rua, V; Otero, MF; Lear, PV; Rodriguez-Penas, D; Feijoo-Bandin, S; Noguera-Moreno, T; Calaza, M; Alvarez-Barred, M; Mosquera-Leal, A; Parrington, J; Brugada, J; Portoles, M; Rivera, M; Gonzalez-Juanatey, JR; Lago, F				Garcia-Rua, Vanessa; Otero, Manuel Francisco; Lear, Pamela Virginia; Rodriguez-Penas, Diego; Feijoo-Bandin, Sandra; Noguera-Moreno, Teresa; Calaza, Manuel; Alvarez-Barred, Maria; Mosquera-Leal, Ana; Parrington, John; Brugada, Josep; Portoles, Manuel; Rivera, Miguel; Gonzalez-Juanatey, Jose Ramon; Lago, Francisca			Increased Expression of Fatty-Acid and Calcium Metabolism Genes in Failing Human Heart	PLOS ONE			English	Article							ACTIVATED RECEPTOR-ALPHA; ENDOPLASMIC-RETICULUM STRESS; OXIDATIVE CAPACITY; SKELETAL-MUSCLE; MITOCHONDRIAL; FAILURE; PROTEIN; TRANSPORTERS; DEFICIENCY; PROMOTER	Background: Heart failure (HF) involves alterations in metabolism, but little is known about cardiomyopathy-(CM)-specific or diabetes-independent alterations in gene expression of proteins involved in fatty-acid (FA) uptake and oxidation or in calcium-(Ca2+)-handling in the human heart. Methods: RT-qPCR was used to quantify mRNA expression and immunoblotting to confirm protein expression in left-ventricular myocardium from patients with HF (n = 36) without diabetes mellitus of ischaemic (ICM, n = 16) or dilated (DCM, n = 20) cardiomyopathy aetiology, and non-diseased donors (CTL, n = 6). Results: Significant increases in mRNA of genes regulating FA uptake (CD36) and intracellular transport (Heart-FA-Binding Protein (HFABP)) were observed in HF patients vs CTL. Significance was maintained in DCM and confirmed at protein level, but not in ICM. mRNA was higher in DCM than ICM for peroxisome-proliferator-activated-receptor-alpha (PPARA), PPARgamma coactivator-1-alpha (PGC1A) and CD36, and confirmed at the protein level for PPARA and CD36. Transcript and protein expression of Ca2+-handling genes (Two-Pore-Channel 1 (TPCN1), Two-Pore-Channel 2 (TPCN2), and Inositol 1,4,5-triphosphate Receptor type-1 (IP3R1)) increased in HF patients relative to CTL. Increases remained significant for TPCN2 in all groups but for TPCN1 only in DCM. There were correlations between FA metabolism and Ca2+-handling genes expression. In ICM there were six correlations, all distinct from those found in CTL. In DCM there were also six (all also different from those found in CTL): three were common to and three distinct from ICM. Conclusion: DCM-specific increases were found in expression of several genes that regulate FA metabolism, which might help in the design of aetiology-specific metabolic therapies in HF. Ca2+-handling genes TPCN1 and TPCN2 also showed increased expression in HF, while HF- and CM-specific positive correlations were found among several FA and Ca2+-handling genes.	[Garcia-Rua, Vanessa; Otero, Manuel Francisco; Lear, Pamela Virginia; Rodriguez-Penas, Diego; Feijoo-Bandin, Sandra; Alvarez-Barred, Maria; Rivera, Miguel; Gonzalez-Juanatey, Jose Ramon] Univ Santiago de Compostela, Clin Hosp CHUS, Santiago Inst Biomed Res IDIS, Lab Cellular & Mol Cardiol, Santiago De Compostela, Spain; [Noguera-Moreno, Teresa] Univ Santiago Compostela, Clin Hosp CHUS, Lab 10, Santiago Inst Biomed Res IDIS, Santiago De Compostela, Spain; [Otero, Manuel Francisco] Univ Santiago Compostela, Dept Clin Chem, Clin Hosp CHUS, Santiago De Compostela, Spain; [Calaza, Manuel; Rivera, Miguel] Univ Santiago Compostela, Dept Cardiol, Clin Hosp CHUS, Santiago De Compostela, Spain; [Noguera-Moreno, Teresa] Univ Santiago Compostela, Unit Biostat Res, Santiago De Compostela, Spain; [Parrington, John] Univ Oxford, Dept Pharmacol, Oxford, England; [Brugada, Josep] Hosp Clin Barcelona, Thorax Inst, Dept Cardiol, Barcelona, Spain; [Portoles, Manuel; Rivera, Miguel] La Fe Univ Hosp, Valencia, Spain	Universidade de Santiago de Compostela; Universidade de Santiago de Compostela; Universidade de Santiago de Compostela; Universidade de Santiago de Compostela; Universidade de Santiago de Compostela; University of Oxford; University of Barcelona; Hospital Clinic de Barcelona	Garcia-Rua, V (corresponding author), Univ Santiago de Compostela, Clin Hosp CHUS, Santiago Inst Biomed Res IDIS, Lab Cellular & Mol Cardiol, Santiago De Compostela, Spain.	francisca.lago.paz@sergas.es	PORTOLES, MANUEL/B-4789-2009; Feijóo-Bandín, Sandra/AAL-6787-2020	PORTOLES, MANUEL/0000-0002-4415-7160; Feijóo-Bandín, Sandra/0000-0002-3739-5806; Gonzalez Juanatey, Jose Ramon/0000-0001-9681-3388; Lear, Pamela/0000-0002-4297-5995; Calaza Cabanas, Manuel/0000-0003-3082-525X; BRUGADA, JOSEP/0000-0002-5662-8302	Health Research Fund of Instituto de Salud Carlos III (ISCIII) [FIS08/0044, FIS11/00497]; University Professional Development Program (FPU) of the Spanish Ministry of Education; Rio Hortega Program of the Spanish Ministry of Economy and Competitiveness; Spanish Network of Collaborative Cardiological Research (REDINSCOR); IDICHUS Research Foundation; University of Santiago de Compostela Clinical Hospital; Xunta de Galicia (SERGAS); Wellcome Trust UK; SERGAS	Health Research Fund of Instituto de Salud Carlos III (ISCIII); University Professional Development Program (FPU) of the Spanish Ministry of Education(German Research Foundation (DFG)); Rio Hortega Program of the Spanish Ministry of Economy and Competitiveness; Spanish Network of Collaborative Cardiological Research (REDINSCOR); IDICHUS Research Foundation; University of Santiago de Compostela Clinical Hospital; Xunta de Galicia (SERGAS)(Xunta de Galicia); Wellcome Trust UK(Wellcome Trust); SERGAS	This work was funded by the Health Research Fund of Instituto de Salud Carlos III (ISCIII, FIS08/0044 and FIS11/00497); VG-R is funded by the University Professional Development Program (FPU) of the Spanish Ministry of Education; MFO is funded by the Rio Hortega Program of the Spanish Ministry of Economy and Competitiveness; PVL is funded by the Spanish Network of Collaborative Cardiological Research (REDINSCOR); DR-P, SF-B, MA-B, AM are funded by IDICHUS Research Foundation, University of Santiago de Compostela Clinical Hospital; MC is funded by Xunta de Galicia (SERGAS); JP is funded by the Wellcome Trust UK; and FL is funded by SERGAS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayer JD, 2010, HEART RHYTHM, V7, P1093, DOI 10.1016/j.hrthm.2010.04.008; Calcraft PJ, 2009, NATURE, V459, P596, DOI 10.1038/nature08030; Cortes R, 2009, TRANSPL P, V41, P2227, DOI 10.1016/j.transproceed.2009.06.013; Cortes R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030915; Cortes R, 2010, CARDIOVASC RES, V85, P464, DOI 10.1093/cvr/cvp336; Crossman DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017901; Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649; Dulhunty AF, 2011, CURR DRUG TARGETS, V12, P709; Duncan JG, 2011, PEDIATR CARDIOL, V32, P323, DOI 10.1007/s00246-011-9889-8; Duncan JG, 2010, CIRCULATION, V121, P426, DOI 10.1161/CIRCULATIONAHA.109.888735; Finck BN, 2007, CIRCULATION, V115, P2540, DOI 10.1161/CIRCULATIONAHA.107.670588; Fu HY, 2010, CIRCULATION, V122, P361, DOI 10.1161/CIRCULATIONAHA.109.917914; Fu SN, 2011, NATURE, V473, P528, DOI 10.1038/nature09968; Galione A, 2011, COLD SPRING HARB PER, V3; Galione A, 2009, PFLUG ARCH EUR J PHY, V458, P869, DOI 10.1007/s00424-009-0682-y; Garnier A, 2003, J PHYSIOL-LONDON, V551, P491, DOI 10.1113/jphysiol.2003.045104; Garnier A, 2009, CIRC-HEART FAIL, V2, P342, DOI 10.1161/CIRCHEARTFAILURE.108.812099; Glatz JFC, 2006, CARDIOVASC DRUG THER, V20, P471, DOI 10.1007/s10557-006-0582-8; Glatz JFC, 2002, CURR OPIN CLIN NUTR, V5, P365, DOI 10.1097/00075197-200207000-00003; GO LO, 1995, J CLIN INVEST, V95, P888, DOI 10.1172/JCI117739; Goikoetxea MJ, 2006, CARDIOVASC RES, V69, P899, DOI 10.1016/j.cardiores.2005.11.016; Harzheim D, 2009, P NATL ACAD SCI USA, V106, P11406, DOI 10.1073/pnas.0905485106; Heather LC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026326; Heather LC, 2011, J MOL CELL CARDIOL, V50, P598, DOI 10.1016/j.yjmcc.2011.01.007; Holloway GP, 2011, J PHYSIOL-LONDON, V589, P169, DOI 10.1113/jphysiol.2010.198663; Holloway GP, 2009, AM J CLIN NUTR, V89, p455S, DOI 10.3945/ajcn.2008.26717B; Hooper R, 2011, J BIOL CHEM, V286, P9141, DOI 10.1074/jbc.M110.189985; Huang BL, 2002, DIABETES, V51, P276, DOI 10.2337/diabetes.51.2.276; Jaswal JS, 2011, BBA-MOL CELL RES, V1813, P1333, DOI 10.1016/j.bbamcr.2011.01.015; Karamanlidis G, 2010, CIRC RES, V106, P1541, DOI 10.1161/CIRCRESAHA.109.212753; Karbowska J, 2003, CELL MOL BIOL LETT, V8, P49; Kato T, 2010, CIRC-HEART FAIL, V3, P420, DOI 10.1161/CIRCHEARTFAILURE.109.888479; Lionetti V, 2011, CARDIOVASC RES, V90, P202, DOI 10.1093/cvr/cvr038; Luciani DS, 2009, DIABETES, V58, P422, DOI 10.2337/db07-1762; Macgregor A, 2007, J BIOL CHEM, V282, P15302, DOI 10.1074/jbc.M611167200; Mettaure B, 2001, J AM COLL CARDIOL, V38, P947, DOI 10.1016/S0735-1097(01)01460-7; Minamino T, 2010, CIRC RES, V107, P1071, DOI 10.1161/CIRCRESAHA.110.227819; Murray AJ, 2005, DIABETES, V54, P3496, DOI 10.2337/diabetes.54.12.3496; Murray AJ, 2004, LANCET, V364, P1786, DOI 10.1016/S0140-6736(04)17402-3; Nakata T, 2003, CARDIOLOGY, V99, P96, DOI 10.1159/000069726; Opie LH, 2011, J AM COLL CARDIOL, V54, P1637; Pelsers MMAL, 2005, CLIN CHIM ACTA, V352, P15, DOI 10.1016/j.cccn.2004.09.001; Pohl J, 2000, Eur J Med Res, V5, P438; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Razeghi P, 2001, CIRCULATION, V104, P2923, DOI 10.1161/hc4901.100526; Rennison JH, 2008, CARDIOVASC RES, V79, P331, DOI 10.1093/cvr/cvn066; Rosello-Lleti E, 2012, BIOCHEM BIOPH RES CO, V418, P222, DOI 10.1016/j.bbrc.2011.12.151; Sack MN, 1996, CIRCULATION, V94, P2837, DOI 10.1161/01.CIR.94.11.2837; Sato O, 2002, J BIOL CHEM, V277, P15703, DOI 10.1074/jbc.M110158200; Schupp M, 2006, EUR J HEART FAIL, V8, P290, DOI 10.1016/j.ejheart.2005.09.003; Schwenk RW, 2008, CARDIOVASC RES, V79, P249, DOI 10.1093/cvr/cvn116; Sebastiani M, 2007, J AM COLL CARDIOL, V50, P1362, DOI 10.1016/j.jacc.2007.06.035; Sharma V, 2009, EUR J PHARMACOL, V607, P156, DOI 10.1016/j.ejphar.2009.02.016; Sihag S, 2009, J MOL CELL CARDIOL, V46, P201, DOI 10.1016/j.yjmcc.2008.10.025; Son NH, 2010, J CLIN INVEST, V120, P3443, DOI 10.1172/JCI40905; Stanley WC, 2005, PHYSIOL REV, V85, P1093, DOI 10.1152/physrev.00006.2004; Teboul L, 2001, BIOCHEM J, V360, P305, DOI 10.1042/0264-6021:3600305; Turer AT, 2010, CURR OPIN CLIN NUTR, V13, P458, DOI 10.1097/MCO.0b013e32833a55a5; Uray IP, 2003, CARDIOVASC RES, V59, P57, DOI 10.1016/S0008-6363(03)00352-3; van Bilsen M, 2009, CARDIOVASC RES, V81, P420, DOI 10.1093/cvr/cvn282; Wu PF, 2001, BIOCHEM BIOPH RES CO, V287, P391, DOI 10.1006/bbrc.2001.5608; Yang J, 2007, CIRC RES, V100, P1208, DOI 10.1161/01.RES.0000264104.25265.b6; Yano M, 2005, J CLIN INVEST, V115, P556, DOI 10.1172/JCI200524159; Zong XG, 2009, PFLUG ARCH EUR J PHY, V458, P891, DOI 10.1007/s00424-009-0690-y	64	37	39	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e37505	10.1371/journal.pone.0037505	http://dx.doi.org/10.1371/journal.pone.0037505			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701570	Green Published, Green Submitted, gold			2022-12-27	WOS:000305348400012
J	Massaoka, MH; Matsuo, AL; Figueiredo, CR; Farias, CF; Girola, N; Arruda, DC; Scutti, JAB; Romoff, P; Favero, OA; Ferreira, MJP; Lago, JHG; Travassos, LR				Massaoka, Mariana H.; Matsuo, Alisson L.; Figueiredo, Carlos R.; Farias, Camyla F.; Girola, Natalia; Arruda, Denise C.; Scutti, Jorge A. B.; Romoff, Paulete; Favero, Oriana A.; Ferreira, Marcelo J. P.; Lago, Joao H. G.; Travassos, Luiz R.			Jacaranone Induces Apoptosis in Melanoma Cells via ROS-Mediated Downregulation of Akt and p38 MAPK Activation and Displays Antitumor Activity In Vivo	PLOS ONE			English	Article							MITOCHONDRIAL-MEMBRANE PERMEABILIZATION; CANCER-CELLS; PROTEIN-KINASE; CASPASE ACTIVATION; STRESS; PATHWAYS; GROWTH; LEADS; PHOSPHORYLATION; MECHANISMS	Background: Malignant melanoma is a deadly type of metastatic skin cancer with increased incidence over the past 30 years. Despite the advanced knowledge on the biology, immunobiology and molecular genetics of melanoma, the alternatives of treatment are limited with poor prognosis. On clinical trials, natural products and among them redox-active quinones have been tested in the attempt to control the growth of cancer cells. Recently, we isolated jacaranone from Pentacalia desiderabilis, a benzoquinone derivative that showed a broad antitumor activity and protective anti-melanoma effect in a syngeneic model. The purified substance is active at micromolar concentrations, is not hemolytic, and is not toxic in naive mice. Methodology/Principal Findings: The jacaranone antitumor activity was shown against several human cancer cell lines in vitro. Moreover, the induction of apoptosis in murine melanoma cells and jacaranone antitumor activity in vivo, in a melanoma experimental model, were also shown. Jacaranone renders antiproliferative and proapoptotic responses in tumor cells, by acting on Akt and p38 MAPK signaling pathways through generation of reactive oxygen species (ROS). The free radical scavenger N-acetyl-cysteine (NAC) was able to completely suppress cell death induced by jacaranone as it blocked Akt downregulation, p38 MAPK activation as well as upregulation of proapoptotic Bax. Notably, treatment of melanoma growing subcutaneously in mice with jacaranone significantly extended the mean survival times in a dose-dependent manner. Conclusions/Significance: The results provide evidence for the mechanisms of action of jacaranone and emphasize the potential use of this quinone for the treatment of melanoma.	[Massaoka, Mariana H.; Matsuo, Alisson L.; Figueiredo, Carlos R.; Farias, Camyla F.; Girola, Natalia; Arruda, Denise C.; Scutti, Jorge A. B.; Travassos, Luiz R.] Univ Fed Sao Paulo, Unidade Oncol Expt, Sao Paulo, Brazil; [Romoff, Paulete; Favero, Oriana A.; Ferreira, Marcelo J. P.] Univ Presbiteriana Mackenzie, Ctr Ciencias & Humanidades, Sao Paulo, Brazil; [Romoff, Paulete; Favero, Oriana A.; Ferreira, Marcelo J. P.] Univ Presbiteriana Mackenzie, Ctr Ciencias Biol & Saude, Sao Paulo, Brazil; [Lago, Joao H. G.] Univ Fed Sao Paulo, Inst Ciencias Ambientais Quim & Farmaceut, Diadema, SP, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Presbiteriana Mackenzie; Universidade Presbiteriana Mackenzie; Universidade Federal de Sao Paulo (UNIFESP)	Massaoka, MH (corresponding author), Univ Fed Sao Paulo, Unidade Oncol Expt, Sao Paulo, Brazil.	luiztravassos@gmail.com	Travassos, Luiz R/J-3631-2012; Lago, Joao/W-5238-2019; Romoff, Paulete/AAD-3638-2021; Figueiredo, Carlos Rogerio de/H-1236-2014; Arruda, Denise C/E-2184-2013; Travassos, Luiz/V-2467-2019; , Denise/AAD-1162-2022; Girola, Natalia/L-9060-2017; Fapesp, Biota/F-8655-2017; Ferreira, Marcelo JP/G-6002-2014	Lago, Joao/0000-0002-1193-8374; Figueiredo, Carlos Rogerio de/0000-0003-3680-4070; Arruda, Denise C/0000-0002-8807-8835; Fapesp, Biota/0000-0002-9887-8449; Ferreira, Marcelo JP/0000-0003-1877-1762	State of Sao Paulo Research Support Foundation (FAPESP), Brazil [2010/51423-0]; Brazilian National Research Council (CNPq)	State of Sao Paulo Research Support Foundation (FAPESP), Brazil(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Brazilian National Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The State of Sao Paulo Research Support Foundation (FAPESP), Brazil, supported this work through grant 2010/51423-0 as well as the Brazilian National Research Council (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berra E, 1998, J BIOL CHEM, V273, P10792, DOI 10.1074/jbc.273.17.10792; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cai BB, 2006, J BIOL CHEM, V281, P25215, DOI 10.1074/jbc.M512627200; Chang CW, 2009, J BIOL CHEM, V284, P33195, DOI 10.1074/jbc.M109.020586; Chang F, 2003, LEUKEMIA, V17, P590, DOI 10.1038/sj.leu.2402824; Chaudhuri L, 2010, ENVIRON INT, V36, P924, DOI 10.1016/j.envint.2010.01.001; Dai DL, 2005, J CLIN ONCOL, V23, P1473, DOI 10.1200/JCO.2005.07.168; Demain AL, 2011, MICROB BIOTECHNOL, V4, P687, DOI 10.1111/j.1751-7915.2010.00221.x; Dhawan P, 2002, CANCER RES, V62, P7335; Doughan AK, 2007, ANTIOXID REDOX SIGN, V9, P1825, DOI 10.1089/ars.2007.1693; FLUCKIGER R, 1995, METHOD ENZYMOL, V258, P140; Fulda S, 2011, ANTIOXID REDOX SIGN, V15, P2937, DOI 10.1089/ars.2011.4078; Garbe C, 2009, CLIN DERMATOL, V27, P3, DOI 10.1016/j.clindermatol.2008.09.001; Gogas HJ, 2007, CANCER-AM CANCER SOC, V109, P455, DOI 10.1002/cncr.22427; Govindarajan B, 2007, J CLIN INVEST, V117, P719, DOI 10.1172/JCI30102; Gratton JP, 2001, J BIOL CHEM, V276, P30359, DOI 10.1074/jbc.M009698200; Grossman D, 2001, CANCER METAST REV, V20, P3, DOI 10.1023/A:1013123532723; Guo Y, 2002, J BIOL CHEM, V277, P13430, DOI 10.1074/jbc.M108029200; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Izeradjene K, 2005, CANCER RES, V65, P7436, DOI 10.1158/0008-5472.CAN-04-2628; Jerant AF, 2000, AM FAM PHYSICIAN, V62, P357; Jia YT, 2007, J IMMUNOL, V179, P7808, DOI 10.4049/jimmunol.179.11.7808; Jo Y, 2005, ARCH PHARM RES, V28, P885, DOI 10.1007/BF02973871; Kim BJ, 2006, J BIOL CHEM, V281, P21256, DOI 10.1074/jbc.M510644200; Kim BM, 2011, APOPTOSIS, V16, P184, DOI 10.1007/s10495-010-0557-x; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Kuida K, 1998, CELL, V94, P325, DOI 10.1016/S0092-8674(00)81476-2; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Liao Y, 2003, MOL CELL BIOL, V23, P6836, DOI 10.1128/MCB.23.19.6836-6848.2003; Lin CF, 2004, J BIOL CHEM, V279, P40755, DOI 10.1074/jbc.M404726200; Loizzo MR, 2005, J PHARM PHARMACOL, V57, P897, DOI 10.1211/0022357056398; Lopez-Bergami P, 2011, PIGM CELL MELANOMA R, V24, P902, DOI 10.1111/j.1755-148X.2011.00908.x; Matsuo AL, 2011, BIOCHEM BIOPH RES CO, V411, P449, DOI 10.1016/j.bbrc.2011.06.176; Morais TR, 2012, PARASITOL RES, V110, P95, DOI 10.1007/s00436-011-2454-9; Nagy G, 2003, J IMMUNOL, V171, P5188, DOI 10.4049/jimmunol.171.10.5188; Ollinger Karin, 2002, Subcell Biochem, V36, P151; Park KR, 2011, CANCER LETT, V312, P178, DOI 10.1016/j.canlet.2011.08.001; Pasciu V, 2010, TOXICOL SCI, V114, P101, DOI 10.1093/toxsci/kfp301; PAZ MA, 1991, J BIOL CHEM, V266, P689; Pelicano H, 2004, DRUG RESIST UPDATE, V7, P97, DOI 10.1016/j.drup.2004.01.004; Pfisterer PH, 2010, CURR PHARM DESIGN, V16, P1718; Porras A, 2004, MOL BIOL CELL, V15, P922, DOI 10.1091/mbc.E03-08-0592; POWIS G, 1989, FREE RADICAL BIO MED, V6, P63, DOI 10.1016/0891-5849(89)90162-7; Prasad V, 2006, FREE RADICAL BIO MED, V41, P431, DOI 10.1016/j.freeradbiomed.2006.03.009; Saraste A, 2000, CARDIOVASC RES, V45, P528, DOI 10.1016/S0008-6363(99)00384-3; Shin SW, 2009, CLIN CANCER RES, V15, P5414, DOI 10.1158/1078-0432.CCR-08-3101; Squadrito GL, 2001, FREE RADICAL BIO MED, V31, P1132, DOI 10.1016/S0891-5849(01)00703-1; Testa JR, 2001, P NATL ACAD SCI USA, V98, P10983, DOI 10.1073/pnas.211430998; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Valko M, 2006, CHEM-BIOL INTERACT, V160, P1, DOI 10.1016/j.cbi.2005.12.009; Verrax J, 2011, ANTI-CANCER AGENT ME, V11, P213, DOI 10.2174/187152011795255902; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Woldemichael GM, 2011, CANCER RES, V71, P134, DOI 10.1158/0008-5472.CAN-10-0757; Xavier CPR, 2009, CANCER LETT, V281, P162, DOI 10.1016/j.canlet.2009.02.041; Xu J, 2002, J BIOL CHEM, V277, P35561, DOI 10.1074/jbc.M203805200; Yin XM, 2000, CELL RES, V10, P161, DOI 10.1038/sj.cr.7290045; Yu DS, 2002, CHEM RES TOXICOL, V15, P832, DOI 10.1021/tx010177m; Zorov DB, 2006, BBA-BIOENERGETICS, V1757, P509, DOI 10.1016/j.bbabio.2006.04.029; Zuo Y, 2009, CELL RES, V19, P449, DOI 10.1038/cr.2009.19	60	44	47	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e38698	10.1371/journal.pone.0038698	http://dx.doi.org/10.1371/journal.pone.0038698			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701695	Green Published, gold, Green Submitted			2022-12-27	WOS:000305348400087
J	Payen, D; Lukaszewicz, AC; Legrand, M; Gayat, E; Faivre, V; Megarbane, B; Azoulay, E; Fieux, F; Charron, D; Loiseau, P; Busson, M				Payen, Didier; Lukaszewicz, Anne-Claire; Legrand, Matthieu; Gayat, Etienne; Faivre, Valerie; Megarbane, Bruno; Azoulay, Elie; Fieux, Fabienne; Charron, Dominique; Loiseau, Pascale; Busson, Marc			A Multicentre Study of Acute Kidney Injury in Severe Sepsis and Septic Shock: Association with Inflammatory Phenotype and HLA Genotype	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; CRITICALLY-ILL PATIENTS; LEUKOCYTE ANTIGEN-DR; INTERNATIONAL CONSENSUS CONFERENCE; MAJOR HISTOCOMPATIBILITY COMPLEX; CLASS-II; MEMBRANOUS NEPHROPATHY; PREDICTIVE-VALUE; ORGAN FAILURE; EXPRESSION	Background: To investigate the association between severity of acute kidney injury (AKI) and outcome, systemic inflammatory phenotype and HLA genotype in severe sepsis. Methodology/Principal Findings: Prospective multicenter observational study done in 4 intensive care units in two university hospitals. Severe sepsis and septic shock patients with at least 2 organ failures based on the SOFA score were classified: 1) "no AKI", 2) "mild AKI" (grouping stage 1 and 2 of AKIN score) and 3) "severe AKI" (stage 3 of AKIN score). Sequential measurements: The vasopressor dependency index (VDI; dose and types of drugs) to evaluate the association between hemodynamic status and the development of early AKI; plasma levels of IL-10, macrophage migration inhibitory factor (MIF), IL-6 and HLA-DR monocyte expression. Genotyping of the 13 HLA-DRB1 alleles with deduction of presence of HLA-DRB3, -DRB4 and -DRB5 genes. We used multivariate analysis with competitive risk model to study associations. Overall, 176 study patients (146 with septic shock) were classified from AKIN score as "no AKI" (n = 43), "mild AKI" (n = 74) or "severe AKI" (n = 59). The VDI did not differ between groups of AKI. After adjustment, "mild and severe AKI" were an independent risk factor for mortality (HR 2.42 95% CI[1.01-5.83], p = 0.048 and HR 1.99 95% CI[1.30-3.03], p = 0.001 respectively). "Severe AKI" had higher levels of plasma IL-10, MIF and IL-6 compared to "no AKI" and mild AKI (p<0.05 for each), with no difference in mHLA-DR at day 0. HLA-DRB genotyping showed a significantly lower proportion of 4 HLA-DRB alleles among patients requiring renal replacement therapy (RRT) (58%) than in patients with severe AKI who did not receive RRT (84%) (p = 0.004). Conclusions: AKI severity is independently associated with mortality and plasma IL-10, MIF or IL-6 levels. Presence of 4 alleles of HLA-DRB in severe AKI patients seems associated with a lower need of RRT.	[Payen, Didier; Lukaszewicz, Anne-Claire; Legrand, Matthieu; Gayat, Etienne; Faivre, Valerie] Lariboisiere Hosp, AP HP, Dept Anesthesiol & Crit Care, Paris, France; [Megarbane, Bruno] Lariboisiere Hosp, AP HP, Med Intens Care Unit, Paris, France; [Fieux, Fabienne] AP HP, Surg Intens Care Unit, Paris, France; [Charron, Dominique; Loiseau, Pascale; Busson, Marc] Hop St Louis, AP HP, INSERM UMR 940, Paris, France; [Payen, Didier; Lukaszewicz, Anne-Claire; Legrand, Matthieu; Gayat, Etienne; Faivre, Valerie; Megarbane, Bruno; Azoulay, Elie; Fieux, Fabienne; Charron, Dominique; Loiseau, Pascale; Busson, Marc] Univ Paris 07, Sorbonne Paris Cite, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Payen, D (corresponding author), Lariboisiere Hosp, AP HP, Dept Anesthesiol & Crit Care, Paris, France.	dpayen1234@orange.fr	Lukaszewicz, Anne-Claire/GXG-4590-2022; Gayat, Etienne/ABG-5308-2021	Megarbane, Bruno/0000-0002-2522-2764; GAYAT, Etienne/0000-0002-3334-3849	Programme Hospitalier Recherche Clinique (PHRC) AORO2006; Quadrienal plan for research from the French Ministry of Research [EA 3509]	Programme Hospitalier Recherche Clinique (PHRC) AORO2006; Quadrienal plan for research from the French Ministry of Research	This work was supported in part by "Programme Hospitalier Recherche Clinique (PHRC) AORO2006" and by "Quadrienal plan for research from the French Ministry of Research" EA 3509. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No aditional external funding was received for this study.	Albert M, 2004, CRIT CARE MED, V32, P1891, DOI 10.1097/01.CCM.0000139708.10718.E3; ANDERSSON G, 1987, J BIOL CHEM, V262, P8748; Bagshaw SM, 2008, CRIT CARE, V12, DOI [10.1186/cc6863, 10.1186/cc6268]; Bagshaw SM, 2008, NEPHROL DIAL TRANSPL, V23, P1569, DOI 10.1093/ndt/gfn009; Bagshaw SM, 2009, INTENS CARE MED, V35, P871, DOI 10.1007/s00134-008-1367-2; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; Bhimma R, 2002, KIDNEY INT, V61, P1510, DOI 10.1046/j.1523-1755.2002.00287.x; BONE RC, 1992, CHEST, V101, P1481, DOI 10.1378/chest.101.6.1481; BRENNER M, 1990, CHEST, V98, P170, DOI 10.1378/chest.98.1.170; Brochard L, 2010, AM J RESP CRIT CARE, V181, P1128, DOI 10.1164/rccm.200711-1664ST; Coppo P, 2010, J THROMB HAEMOST, V8, P856, DOI 10.1111/j.1538-7836.2010.03772.x; Cordovado SK, 2008, DIABETES, V57, P518, DOI 10.2337/db07-0826; Cruz DN, 2009, JAMA-J AM MED ASSOC, V301, P2445, DOI 10.1001/jama.2009.856; Cunningham PN, 2002, J IMMUNOL, V168, P5817, DOI 10.4049/jimmunol.168.11.5817; Emonts M, 2007, CLIN INFECT DIS, V44, P1321, DOI 10.1086/514344; FARGE D, 1995, CHEST, V107, P1095, DOI 10.1378/chest.107.4.1095; Feehally J, 2010, J AM SOC NEPHROL, V21, P1791, DOI 10.1681/ASN.2010010076; Fisher M, 1997, KIDNEY INT, V51, P222, DOI 10.1038/ki.1997.27; Grigoryev DN, 2008, J AM SOC NEPHROL, V19, P547, DOI 10.1681/ASN.2007040469; Hynninen M, 2003, SHOCK, V20, P1, DOI 10.1097/01.shk.0000068322.08268.b4; Jo SK, 2002, NEPHRON, V91, P406, DOI 10.1159/000064280; Landelle C, 2010, INTENS CARE MED, V36, P1859, DOI 10.1007/s00134-010-1962-x; Le Dorze M, 2009, CURR OPIN CRIT CARE, V15, P503, DOI 10.1097/MCC.0b013e328332f6cf; Legrand M, 2010, ANESTHESIOLOGY, V112, P119, DOI 10.1097/ALN.0b013e3181c4a5e2; Lekkou A, 2004, CLIN DIAGN LAB IMMUN, V11, P161, DOI 10.1128/CDLI.11.1.161-167.2004; Lerolle N, 2009, INTENSIVE CARE MED; Lerolle N, 2006, INTENS CARE MED, V32, P1553, DOI 10.1007/s00134-006-0360-x; Lukaszewicz AC, 2009, CRIT CARE MED, V37, P2746, DOI 10.1097/CCM.0b013e3181ab858a; Marshall JC, 2003, CRIT CARE MED, V31, P1560, DOI 10.1097/01.CCM.0000065186.67848.3A; Monneret G, 2006, INTENS CARE MED, V32, P1175, DOI 10.1007/s00134-006-0204-8; Muczynski KA, 2003, J AM SOC NEPHROL, V14, P1336, DOI 10.1097/01.ASN.0000061778.08085.9F; Muczynski KA, 2001, KIDNEY INT, V59, P488, DOI 10.1046/j.1523-1755.2001.059002488.x; MULLER CA, 1989, KIDNEY INT, V35, P116, DOI 10.1038/ki.1989.16; Murugan R, 2010, KIDNEY INT, V77, P527, DOI 10.1038/ki.2009.502; Nickolas TL, 2008, ANN INTERN MED, V148, P810, DOI 10.7326/0003-4819-148-11-200806030-00003; Payen D, 2009, MINERVA ANESTESIOL, V75, P484; Payen D, 2008, CRIT CARE, V12, DOI 10.1186/cc6916; Reith W, 2001, ANNU REV IMMUNOL, V19, P331, DOI 10.1146/annurev.immunol.19.1.331; Rogus JJ, 2008, DIABETES, V57, P2519, DOI 10.2337/db07-1086; Schrier RW, 2004, NEW ENGL J MED, V351, P159, DOI 10.1056/NEJMra032401; Stanescu HC, 2011, NEW ENGL J MED, V364, P616, DOI 10.1056/NEJMoa1009742; STOCKEL J, 1994, J BIOL CHEM, V269, P29571; Uchino S, 2005, JAMA-J AM MED ASSOC, V294, P813, DOI 10.1001/jama.294.7.813; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Wan L, 2008, CRIT CARE MED, V36, pS198, DOI 10.1097/CCM.0b013e318168ccd5	45	83	99	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e35838	10.1371/journal.pone.0035838	http://dx.doi.org/10.1371/journal.pone.0035838			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701553	Green Submitted, Green Published, gold			2022-12-27	WOS:000305348400003
J	Ladiwala, U; Basu, H; Mathur, D				Ladiwala, Uma; Basu, Himanish; Mathur, Deepak			Assembling Neurospheres: Dynamics of Neural Progenitor/Stem Cell Aggregation Probed Using an Optical Trap	PLOS ONE			English	Article							RED-BLOOD-CELLS; NEURONAL GROWTH; IN-VITRO; ADHESION; INTEGRIN; FORCE; ASSAY; CYTOCHALASIN; ELONGATION; PHASE	Optical trapping (tweezing) has been used in conjunction with fluid flow technology to dissect the mechanics and spatio-temporal dynamics of how neural progenitor/stem cells (NSCs) adhere and aggregate. Hitherto unavailable information has been obtained on the most probable minimum time (similar to 5 s) and most probable minimum distance of approach (4-6 mu m) required for irreversible adhesion of proximate cells to occur. Our experiments also allow us to study and quantify the spatial characteristics of filopodial- and membrane-mediated adhesion, and to probe the functional dynamics of NSCs to quantify a lower limit of the adhesive force by which NSCs aggregate (similar to 18 pN). Our findings, which we also validate by computational modeling, have important implications for the neurosphere assay: once aggregated, neurospheres cannot disassemble merely by being subjected to shaking or by thermal effects. Our findings provide quantitative affirmation to the notion that the neurosphere assay may not be a valid measure of clonality and "stemness". Post-adhesion dynamics were also studied and oscillatory motion in filopodia-mediated adhesion was observed. Furthermore, we have also explored the effect of the removal of calcium ions: both filopodia-mediated as well as membrane-membrane adhesion were inhibited. On the other hand, F-actin disrupted the dynamics of such adhesion events such that filopodia-mediated adhesion was inhibited but not membrane-membrane adhesion.	[Ladiwala, Uma] Univ Mumbai, UM DAE Ctr Excellence Basic Sci, Bombay, Maharashtra, India; [Basu, Himanish; Mathur, Deepak] Tata Inst Fundamental Res, Bombay 400005, Maharashtra, India	UM-DAE Centre for Excellence in Basic Sciences; University of Mumbai; Tata Institute of Fundamental Research (TIFR)	Ladiwala, U (corresponding author), Univ Mumbai, UM DAE Ctr Excellence Basic Sci, Kalina Campus, Bombay, Maharashtra, India.	brainwave@cbs.ac.in; atmol1@tifr.res.in	Mathur, Deepak/K-5000-2019	Mathur, Deepak/0000-0002-2322-6331; Basu, Himanish/0000-0001-8236-1157	Tata Institute of Fundamental Research, Mumbai; Centre for Excellence in Basic Sciences, Mumbai	Tata Institute of Fundamental Research, Mumbai; Centre for Excellence in Basic Sciences, Mumbai	The research has been funded from Institutional funds of the Tata Institute of Fundamental Research, Mumbai and the Centre for Excellence in Basic Sciences, Mumbai. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramovici H, 2007, CELL MOTIL CYTOSKEL, V64, P549, DOI 10.1002/cm.20204; Alberts B, 2002, CELL CELL ADHESION M; Aplin AE, 1998, PHARMACOL REV, V50, P197; Bambardekar K, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3430732; Bambardekar K, 2008, J BIOMED OPT, V13, DOI 10.1117/1.3037342; Bankapur A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035075; Bankapur A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010427; Basu H, 2011, BIOPHYS J, V101, P1604, DOI 10.1016/j.bpj.2011.08.043; Baumgartner W, 2000, P NATL ACAD SCI USA, V97, P4005, DOI 10.1073/pnas.070052697; Campos LS, 2004, J NEUROSCI RES, V78, P761, DOI 10.1002/jnr.20333; Cavey M, 2008, NATURE, V453, P751, DOI 10.1038/nature06953; Chang HP, 1999, LEARN MEMORY, V6, P448, DOI 10.1101/lm.6.5.448; Chu YS, 2004, J CELL BIOL, V167, P1183, DOI 10.1083/jcb.200403043; Clarke RJ, 2008, MOL VIS, V14, P706; Coles-Takabe BLK, 2008, STEM CELLS, V26, P2938, DOI 10.1634/stemcells.2008-0558; Dharmadhikari JA, 2004, CURR SCI INDIA, V86, P1432; Dharmadhikari JA, 2004, OPT EXPRESS, V12, P1179, DOI 10.1364/OPEX.12.001179; Dictus C, 2007, J NEUROSCI METH, V161, P250, DOI 10.1016/j.jneumeth.2006.11.012; Difato F, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3560268; Ehrlicher A, 2002, P NATL ACAD SCI USA, V99, P16024, DOI 10.1073/pnas.252631899; Erasmus J, 2010, BIOL CELL, V102, P13, DOI 10.1042/BC20090048; Fasen K, 2003, ACTA NEUROPATHOL, V106, P319, DOI 10.1007/s00401-003-0733-y; Foty RA, 2005, DEV BIOL, V278, P255, DOI 10.1016/j.ydbio.2004.11.012; Hall PE, 2006, STEM CELLS, V24, P2078, DOI 10.1634/stemcells.2005-0595; Hoffmann B, 2010, CELL ADHES MIGR, V4, P190, DOI 10.4161/cam.4.2.10899; Husainy AN, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-86; Jacinto A, 2000, CURR BIOL, V10, P1420, DOI 10.1016/S0960-9822(00)00796-X; Jessberger S, 2007, STEM CELLS, V25, P871, DOI 10.1634/stemcells.2006-0620; Karpowicz P, 2009, J NEUROSCI, V29, P3885, DOI 10.1523/JNEUROSCI.0037-09.2009; Le Clainche C, 2008, PHYSIOL REV, V88, P489, DOI 10.1152/physrev.00021.2007; Leone DP, 2005, J CELL SCI, V118, P2589, DOI 10.1242/jcs.02396; Liebau S, 2007, J NEUROCHEM, V101, P1338, DOI 10.1111/j.1471-4159.2006.04437.x; Liebau S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018148; Lobo MVT, 2003, J HISTOCHEM CYTOCHEM, V51, P89, DOI 10.1177/002215540305100111; Marshall GP, 2007, CURR PHARM BIOTECHNO, V8, P141; Millard TH, 2008, DEVELOPMENT, V135, P621, DOI 10.1242/dev.014001; Mori H, 2006, J NEUROSCI RES, V84, P1682, DOI 10.1002/jnr.21082; Mori H, 2007, J BIOSCI BIOENG, V104, P231, DOI 10.1263/jbb.104.231; PALMER TD, 1995, MOL CELL NEUROSCI, V6, P474, DOI 10.1006/mcne.1995.1035; Panorchan P, 2006, J CELL SCI, V119, P66, DOI 10.1242/jcs.02719; Park Y, 2010, P NATL ACAD SCI USA, V107, P6731, DOI 10.1073/pnas.0909533107; Pastrana E, 2011, CELL STEM CELL, V8, P486, DOI 10.1016/j.stem.2011.04.007; Patla I, 2010, NAT CELL BIOL, V12, P909, DOI 10.1038/ncb2095; Pinkstaff JK, 1999, J NEUROSCI, V19, P1541; Raich WB, 1999, CURR BIOL, V9, P1139, DOI 10.1016/S0960-9822(00)80015-9; SAMPATH P, 1991, BIOCHEMISTRY-US, V30, P1973, DOI 10.1021/bi00221a034; Schafer C, 2011, CELL ADHES MIGR, V5, P431, DOI 10.4161/cam.5.5.17400; Singec I, 2006, NAT METHODS, V3, P801, DOI 10.1038/nmeth926; TAKEICHI M, 1995, CURR OPIN CELL BIOL, V7, P619, DOI 10.1016/0955-0674(95)80102-2; Tamada A, 2010, J CELL BIOL, V188, P429, DOI 10.1083/jcb.200906043; TSUI HCT, 1985, P NATL ACAD SCI USA, V82, P8256, DOI 10.1073/pnas.82.23.8256; Vasioukhin V, 2000, CELL, V100, P209, DOI 10.1016/S0092-8674(00)81559-7; Wakatsuki T, 2001, J CELL SCI, V114, P1025; Wu X, 2012, PHARMACOL THERAPEUT, V134, P68, DOI 10.1016/j.pharmthera.2011.12.008; YONEMURA S, 1995, J CELL SCI, V108, P127; Zachariah E, 2010, J PHOTOCH PHOTOBIO B, V100, P113, DOI 10.1016/j.jphotobiol.2010.05.009; Zhuravlev PI, 2009, P NATL ACAD SCI USA, V106, P11570, DOI 10.1073/pnas.0812746106	57	24	26	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e38613	10.1371/journal.pone.0038613	http://dx.doi.org/10.1371/journal.pone.0038613			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22693648	Green Published, gold, Green Submitted			2022-12-27	WOS:000305343900061
J	Hagemann, TL; Jobe, EM; Messing, A				Hagemann, Tracy L.; Jobe, Emily M.; Messing, Albee			Genetic Ablation of Nrf2/Antioxidant Response Pathway in Alexander Disease Mice Reduces Hippocampal Gliosis but Does Not Impact Survival	PLOS ONE			English	Article							FIBRILLARY ACIDIC PROTEIN; TRANSCRIPTION FACTOR NRF2; COMPLEX-II INHIBITION; ALPHA-B-CRYSTALLIN; OXIDATIVE STRESS; IN-VIVO; PROTEASOME PATHWAY; GFAP ACCUMULATION; ACTIVATION; AUTOPHAGY	In Alexander disease (AxD) the presence of mutant glial fibrillary acidic protein (GFAP), the major intermediate filament of astrocytes, triggers protein aggregation, with marked induction of a stress response mediated by the transcription factor, Nrf2. To clarify the role of Nrf2 in AxD, we have crossed Gfap mutant and transgenic mouse models into an Nrf2 null background. Deletion of Nrf2 eliminates the phase II stress response normally present in mouse models of AxD, but causes no change in body weight or lifespan, even in a severe lethal model. AxD astrocytes without Nrf2 retain features of reactivity, such as expression of the endothelin-B receptor, but have lower Gfap levels, a decrease in p62 protein and reduced iron accumulation, particularly in hippocampus. Microglial activation, indicated by Iba1 expression, is also diminished. Although the Nrf2 response is generally considered beneficial, these results show that in the context of AxD, loss of the antioxidant pathway has no obvious negative effects, while actually decreasing Gfap accumulation and pathology. Given the attention Nrf2 is receiving as a potential therapeutic target in AxD and other neurodegenerative diseases, it will be interesting to see whether induction of Nrf2, beyond the endogenous response, is beneficial or not in these same models.	[Hagemann, Tracy L.; Jobe, Emily M.; Messing, Albee] Univ Wisconsin, Waisman Ctr, Madison, WI 53705 USA; [Jobe, Emily M.] Univ Wisconsin, Grad Program Cellular & Mol Biol, Madison, WI 53705 USA; [Messing, Albee] Univ Wisconsin, Dept Comparat Biosci, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Hagemann, TL (corresponding author), Univ Wisconsin, Waisman Ctr, Madison, WI 53705 USA.	hagemann@waisman.wisc.edu		Jobe, Emily/0000-0001-8712-4767	National Institutes of Health [R01-NS060120, P30-HD03352]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003352] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007215] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS042803, R01NS060120] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the National Institutes of Health: R01-NS060120 (AM) and P30-HD03352 (Waisman Center). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER WS, 1949, BRAIN, V72, P373, DOI 10.1093/brain/72.3.373; BAILEY MS, 1993, J COMP NEUROL, V328, P501, DOI 10.1002/cne.903280405; Brenner M, 2001, NAT GENET, V27, P117, DOI 10.1038/83679; Calkins MJ, 2010, TOXICOL SCI, V115, P557, DOI 10.1093/toxsci/kfq072; Calkins MJ, 2005, P NATL ACAD SCI USA, V102, P244, DOI 10.1073/pnas.0408487101; Chan JY, 1998, EMBO J, V17, P1779, DOI 10.1093/emboj/17.6.1779; Chan KM, 1996, P NATL ACAD SCI USA, V93, P13943, DOI 10.1073/pnas.93.24.13943; Chen PC, 2009, P NATL ACAD SCI USA, V106, P2933, DOI 10.1073/pnas.0813361106; Connor JR, 1996, GLIA, V17, P83, DOI 10.1002/(SICI)1098-1136(199606)17:2<83::AID-GLIA1>3.0.CO;2-7; Eggler AL, 2005, P NATL ACAD SCI USA, V102, P10070, DOI 10.1073/pnas.0502402102; Emsley JG, 2006, NEURON GLIA BIOL, V2, P175, DOI 10.1017/S1740925X06000202; Fahey JW, 1997, P NATL ACAD SCI USA, V94, P10367, DOI 10.1073/pnas.94.19.10367; Hagemann TL, 2005, HUM MOL GENET, V14, P2443, DOI 10.1093/hmg/ddi248; Hagemann TL, 2006, J NEUROSCI, V26, P11162, DOI 10.1523/JNEUROSCI.3260-06.2006; HILL JM, 1984, NEUROSCIENCE, V11, P595, DOI 10.1016/0306-4522(84)90046-0; Hubbs AF, 2007, AM J PATHOL, V170, P2068, DOI 10.2353/ajpath.2007.060898; Ishii T, 2000, J BIOL CHEM, V275, P16023, DOI 10.1074/jbc.275.21.16023; IWAKI T, 1989, CELL, V57, P71, DOI 10.1016/0092-8674(89)90173-6; Jain A, 2010, J BIOL CHEM, V285, P22576, DOI 10.1074/jbc.M110.118976; Jakel RJ, 2007, BRAIN RES, V1144, P192, DOI 10.1016/j.brainres.2007.01.131; Johnson DA, 2002, J NEUROCHEM, V81, P1233, DOI 10.1046/j.1471-4159.2002.00913.x; Johnson DA, 2010, TOXICOL SCI, V114, P237, DOI 10.1093/toxsci/kfp274; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Komatsu M, 2010, NAT CELL BIOL, V12, P213, DOI 10.1038/ncb2021; Kraft AD, 2006, J NEUROCHEM, V98, P1852, DOI 10.1111/j.1471-4159.2006.04019.x; Lee JM, 2003, J BIOL CHEM, V278, P12029, DOI 10.1074/jbc.M211558200; Lee JM, 2003, J BIOL CHEM, V278, P37948, DOI 10.1074/jbc.M305204200; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li R, 2005, ANN NEUROL, V57, P310, DOI 10.1002/ana.20406; McMahon M, 2004, J BIOL CHEM, V279, P31556, DOI 10.1074/jbc.M403061200; Messing A, 1998, AM J PATHOL, V152, P391; Messing A, 2011, ARCH NEUROL; Messing A, 2010, NEUROTHERAPEUTICS, V7, P507, DOI 10.1016/j.nurt.2010.05.013; Nguyen T, 2004, FREE RADICAL BIO MED, V37, P433, DOI 10.1016/j.freeradbiomed.2004.04.033; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Petzold A, 2004, J IMMUNOL METHODS, V287, P169, DOI 10.1016/j.jim.2004.01.015; Prust M, 2011, NEUROLOGY, V77, P1287, DOI 10.1212/WNL.0b013e3182309f72; Qian ZM, 2001, TRENDS MOL MED, V7, P103, DOI 10.1016/S1471-4914(00)01910-9; Quinlan RA, 2007, EXP CELL RES, V313, P2077, DOI 10.1016/j.yexcr.2007.04.004; Rada P, 2011, MOL CELL BIOL, V31, P1121, DOI 10.1128/MCB.01204-10; Rajasekaran NS, 2011, ANTIOXID REDOX SIGN, V14, P957, DOI 10.1089/ars.2010.3587; Rouault Tracey A, 2006, Semin Pediatr Neurol, V13, P142, DOI 10.1016/j.spen.2006.08.002; Rouault TA, 2006, NAT CHEM BIOL, V2, P406, DOI 10.1038/nchembio807; Shih AY, 2005, J NEUROSCI, V25, P10321, DOI 10.1523/JNEUROSCI.4014-05.2005; Shih AY, 2005, J BIOL CHEM, V280, P22925, DOI 10.1074/jbc.M414635200; Shiihara T, 2004, J NEUROL SCI, V225, P125, DOI 10.1016/j.jns.2004.07.008; Stewart D, 2003, J BIOL CHEM, V278, P2396, DOI 10.1074/jbc.M209195200; Stumpf E, 2003, ARCH NEUROL-CHICAGO, V60, P1307, DOI 10.1001/archneur.60.9.1307; Tang GM, 2008, HUM MOL GENET, V17, P1540, DOI 10.1093/hmg/ddn042; Tang GM, 2006, J BIOL CHEM, V281, P38634, DOI 10.1074/jbc.M604942200; Tang GM, 2010, J BIOL CHEM, V285, P10527, DOI 10.1074/jbc.M109.067975; Tian RJ, 2006, AM J PATHOL, V168, P888, DOI 10.2353/ajpath.2006.051028; Tsuji Y, 2000, MOL CELL BIOL, V20, P5818, DOI 10.1128/MCB.20.16.5818-5827.2000; Vargas MR, 2008, J NEUROSCI, V28, P13574, DOI 10.1523/JNEUROSCI.4099-08.2008; Wakabayashi N, 2003, NAT GENET, V35, P238, DOI 10.1038/ng1248; Wang LQ, 2011, J NEUROSCI, V31, P2868, DOI 10.1523/JNEUROSCI.3410-10.2011; Wasserman WW, 1997, P NATL ACAD SCI USA, V94, P5361, DOI 10.1073/pnas.94.10.5361; Zatloukal K, 2002, AM J PATHOL, V160, P255, DOI 10.1016/S0002-9440(10)64369-6; Zhang Y, 2010, CURR OPIN NEUROBIOL, V20, P588, DOI 10.1016/j.conb.2010.06.005	59	16	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e37304	10.1371/journal.pone.0037304	http://dx.doi.org/10.1371/journal.pone.0037304			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693571	gold, Green Submitted, Green Published			2022-12-27	WOS:000305338500034
J	Madai, VI; von Samson-Himmelstjerna, FC; Bauer, M; Stengl, KL; Mutke, MA; Tovar-Martinez, E; Wuerfel, J; Endres, M; Niendorf, T; Sobesky, J				Madai, Vince I.; von Samson-Himmelstjerna, Federico C.; Bauer, Miriam; Stengl, Katharina L.; Mutke, Matthias A.; Tovar-Martinez, Elena; Wuerfel, Jens; Endres, Matthias; Niendorf, Thoralf; Sobesky, Jan			Ultrahigh-Field MRI in Human Ischemic Stroke - a 7 Tesla Study	PLOS ONE			English	Article							MAGNETIC-RESONANCE ANGIOGRAPHY; VIRCHOW-ROBIN SPACES; DISEASE; IMAGES; BRAIN	Introduction: Magnetic resonance imaging (MRI) using field strengths up to 3 Tesla (T) has proven to be a powerful tool for stroke diagnosis. Recently, ultrahigh-field (UHF) MRI at 7 T has shown relevant diagnostic benefits in imaging of neurological diseases, but its value for stroke imaging has not been investigated yet. We present the first evaluation of a clinically feasible stroke imaging protocol at 7 T. For comparison an established stroke imaging protocol was applied at 3 T. Methods: In a prospective imaging study seven patients with subacute and chronic stroke were included. Imaging at 3 T was immediately followed by 7 T imaging. Both protocols included T1-weighted 3D Magnetization-Prepared Rapid-Acquired Gradient-Echo (3D-MPRAGE), T2-weighted 2D Fluid Attenuated Inversion Recovery (2D-FLAIR), T2-weighted 2D Fluid Attenuated Inversion Recovery (2D-T2-TSE), T2* weighted 2D Fast Low Angle Shot Gradient Echo (2D-HemoFLASH) and 3D Time-of-Flight angiography (3D-TOF). Results: The diagnostic information relevant for clinical stroke imaging obtained at 3 T was equally available at 7 T. Higher spatial resolution at 7 T revealed more anatomical details precisely depicting ischemic lesions and periinfarct alterations. A clear benefit in anatomical resolution was also demonstrated for vessel imaging at 7 T. RF power deposition constraints induced scan time prolongation and reduced brain coverage for 2D-FLAIR, 2D-T2-TSE and 3D-TOF at 7 T versus 3 T. Conclusions: The potential of 7 T MRI for human stroke imaging is shown. Our pilot study encourages a further evaluation of the diagnostic benefit of stroke imaging at 7 T in a larger study.	[Madai, Vince I.; von Samson-Himmelstjerna, Federico C.; Bauer, Miriam; Stengl, Katharina L.; Mutke, Matthias A.; Endres, Matthias; Sobesky, Jan] Charite, Dept Neurol, D-13353 Berlin, Germany; [Madai, Vince I.; von Samson-Himmelstjerna, Federico C.; Bauer, Miriam; Stengl, Katharina L.; Mutke, Matthias A.; Endres, Matthias; Sobesky, Jan] Charite, Ctr Stroke Res Berlin CSB, D-13353 Berlin, Germany; [von Samson-Himmelstjerna, Federico C.; Tovar-Martinez, Elena; Wuerfel, Jens; Niendorf, Thoralf] Max Delbruck Ctr Mol Med MDC, Berlin Ultra High Field Facil BUFF, Berlin, Germany; [Niendorf, Thoralf; Sobesky, Jan] Charite, ECRC, D-13353 Berlin, Germany; [Wuerfel, Jens] Charite, NeuroCure Clin Res Ctr, D-13353 Berlin, Germany; [Wuerfel, Jens] Univ Lubeck, Inst Neuroradiol, Lubeck, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Lubeck	Madai, VI (corresponding author), Charite, Dept Neurol, D-13353 Berlin, Germany.	jan.sobesky@charite.de	Niendorf, Thoralf/H-7738-2013; Madai, Vince/GYD-7365-2022; Madai, Vince/AAF-5525-2020	Niendorf, Thoralf/0000-0001-7584-6527; Madai, Vince/0000-0002-8552-6954; Madai, Vince/0000-0002-8552-6954; Endres, Matthias/0000-0001-6520-3720; Wuerfel, Jens/0000-0002-0034-8053; Sobesky, Jan/0000-0001-5459-3655	German Federal Ministry of Education and Research via "Center for Stroke Research Berlin'' [01 EO 0801]; German Research Foundation (DFG) (Excellence cluster NeuroCure) [SFB TR 43, KFO 247, KFO 213]; Federal Ministry of Education and Research (BMBF) (Centre for Stroke Research Berlin); EU (Eustroke, ARISE, WakeUp); Volkswagen Foundation (Lichtenberg Program); Corona Foundation	German Federal Ministry of Education and Research via "Center for Stroke Research Berlin''; German Research Foundation (DFG) (Excellence cluster NeuroCure); Federal Ministry of Education and Research (BMBF) (Centre for Stroke Research Berlin); EU (Eustroke, ARISE, WakeUp); Volkswagen Foundation (Lichtenberg Program); Corona Foundation	The research leading to these results has received funding from the German Federal Ministry of Education and Research via the grant "Center for Stroke Research Berlin'' (01 EO 0801; http://www.bmbf.de). M.E. receives funding from the German Research Foundation (DFG) (Excellence cluster NeuroCure; SFB TR 43, KFO 247, KFO 213; http://www.dfg.de), Federal Ministry of Education and Research (BMBF) (Centre for Stroke Research Berlin; http://www.bmbf.de), EU (Eustroke, ARISE, WakeUp), Volkswagen Foundation (Lichtenberg Program; http://www.volkswagenstiftung.de), Corona Foundation (http://www.stifterverband.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bokura H, 2011, STROKE, V42, P1867, DOI 10.1161/STROKEAHA.110.601922; Brundel M, 2012, J CEREB BLOOD FLOW M; Busse RF, 2004, MAGN RESON MED, V51, P1031, DOI 10.1002/mrm.20056; Chen W, 2011, AM J NEURORADIOL, V32, P1490, DOI 10.3174/ajnr.A2541; Cizek J, 2004, NEUROIMAGE, V22, P434, DOI 10.1016/j.neuroimage.2004.01.016; Dammann P, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.6.FOCUS10130; de Graaf WL, 2012, EUR RADIOL, V22, P221, DOI 10.1007/s00330-011-2242-z; Hennig J, 2001, MAGNET RESON MED, V46, P6, DOI 10.1002/mrm.1153; Heverhagen JT, 2008, INVEST RADIOL, V43, P568, DOI 10.1097/RLI.0b013e31817e9b2c; Kang CK, 2010, INT J STROKE, V5, P374, DOI 10.1111/j.1747-4949.2010.00464.x; Kwon DH, 2012, ANN NEUROL, V71, P267, DOI 10.1002/ana.22592; Lupo JM, 2011, CURR OPIN NEUROL, V24, P605, DOI 10.1097/WCO.0b013e32834cd495; Merino JG, 2010, NAT REV NEUROL, V6, P560, DOI 10.1038/nrneurol.2010.129; Novak V, 2005, MAGN RESON IMAGING, V23, P539, DOI 10.1016/j.mri.2005.02.010; Nyberg E, 2012, AM J NEURORADIOL, V33, P77, DOI 10.3174/ajnr.A2737; Pipe JG, 1999, MAGNET RESON MED, V42, P963, DOI 10.1002/(SICI)1522-2594(199911)42:5<963::AID-MRM17>3.0.CO;2-L; Qian YX, 2012, MAGN RESON MED, V68, P227, DOI 10.1002/mrm.23225; Tallantyre EC, 2011, NEUROLOGY, V76, P534, DOI 10.1212/WNL.0b013e31820b7630; van der Kolk AG, 2011, STROKE, V42, P2478, DOI 10.1161/STROKEAHA.111.620443; Weber R, 2005, MAGN RESON MED, V54, P59, DOI 10.1002/mrm.20532; Wiggins G. C., 2011, MAGNETOM FLASH, V46, P32; Zhu YC, 2011, AM J NEURORADIOL, V32, P709, DOI 10.3174/ajnr.A2366; Zhu YC, 2010, STROKE, V41, P2483, DOI 10.1161/STROKEAHA.110.591586	23	42	42	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e37631	10.1371/journal.pone.0037631	http://dx.doi.org/10.1371/journal.pone.0037631			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22701525	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000305338500046
J	Muller, E; Dunstheimer, D; Klammt, J; Friebe, D; Kiess, W; Kratzsch, J; Kruis, T; Laue, S; Pfaffle, R; Wallborn, T; Heidemann, PH				Mueller, Eva; Dunstheimer, Desiree; Klammt, Juergen; Friebe, Daniela; Kiess, Wieland; Kratzsch, Juergen; Kruis, Tassilo; Laue, Sandy; Pfaeffle, Roland; Wallborn, Tillmann; Heidemann, Peter H.			Clinical and Functional Characterization of a Patient Carrying a Compound Heterozygous Pericentrin Mutation and a Heterozygous IGF1 Receptor Mutation	PLOS ONE			English	Article							GROWTH-FACTOR-I; DWARFISM TYPE-II; PRIMORDIAL DWARFISM; SHORT-STATURE; MOPD-II; SECKEL-SYNDROME; PDZ DOMAIN; G-PROTEIN; INTRAUTERINE; CHILD	Intrauterine and postnatal longitudinal growth is controlled by a strong genetic component that regulates a complex network of endocrine factors integrating them with cellular proliferation, differentiation and apoptotic processes in target tissues, particularly the growth centers of the long bones. Here we report on a patient born small for gestational age (SGA) with severe, proportionate postnatal growth retardation, discreet signs of skeletal dysplasia, microcephaly and moyamoya disease. Initial genetic evaluation revealed a novel heterozygous IGF1R p. Leu1361Arg mutation affecting a highly conserved residue with the insulin-like growth factor type 1 receptor suggestive for a disturbance within the somatotropic axis. However, because the mutation did not co-segregate with the phenotype and functional characterization did not reveal an obvious impairment of the ligand depending major IGF1R signaling capabilities a second-site mutation was assumed. Mutational screening of components of the somatotropic axis, constituents of the IGF signaling system and factors involved in cellular proliferation, which are described or suggested to provoke syndromic dwarfism phenotypes, was performed. Two compound heterozygous PCNT mutations (p.[Arg585X];[Glu1774X]) were identified leading to the specification of the diagnosis to MOPD II. These investigations underline the need for careful assessment of all available information to derive a firm diagnosis from a sequence aberration.	[Mueller, Eva; Klammt, Juergen; Friebe, Daniela; Kruis, Tassilo; Laue, Sandy; Wallborn, Tillmann] Univ Hosp Children & Adolescents, Pediat Res Ctr, Leipzig, Germany; [Kiess, Wieland; Pfaeffle, Roland] Univ Hosp Children & Adolescents, Dept Pediat, Leipzig, Germany; [Kratzsch, Juergen] Inst Lab Med & Mol Diagnost, Leipzig, Germany; [Dunstheimer, Desiree; Heidemann, Peter H.] Klinikum Augsburg, Dept Pediat 1, Augsburg, Germany	Leipzig University; Leipzig University; Klinikum Augsburg	Muller, E (corresponding author), Univ Hosp Children & Adolescents, Pediat Res Ctr, Leipzig, Germany.	Wieland.Kiess@medizin.uni-leipzig.de		Klammt, Jurgen/0000-0003-2293-9193	Pfizer; Novo Nordisk; Sandoz; Ipsen; Merck Serono; Eli Lilly; Medical Faculty of the University of Leipzig; Deutsche Forschungsgemeinschaft (Bonn, Germany) [PF 225/3]; LIFE program of the Medical Faculty, University of Leipzig; IFB Adiposity Diseases; BMBF; Deutsche Forschungsgemeinschaft [KFO 152]	Pfizer(Pfizer); Novo Nordisk(Novo Nordisk); Sandoz(Novartis); Ipsen(Ipsen); Merck Serono(Merck & Company); Eli Lilly(Eli Lilly); Medical Faculty of the University of Leipzig; Deutsche Forschungsgemeinschaft (Bonn, Germany)(German Research Foundation (DFG)); LIFE program of the Medical Faculty, University of Leipzig; IFB Adiposity Diseases; BMBF(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	WK has received research grants from Pfizer, Novo Nordisk, Sandoz, Ipsen and Merck Serono. RP has received research grants from Eli Lilly and Merck Serono and serves on an Ipsen advisory board. This work is supported by grants of the Medical Faculty of the University of Leipzig (to EM) and the Deutsche Forschungsgemeinschaft (Bonn, Germany; project PF 225/3 to J. Klammt, WK, and RP). WK is also supported by the LIFE program of the Medical Faculty, University of Leipzig, the IFB Adiposity Diseases, BMBF and Deutsche Forschungsgemeinschaft (KFO 152). PHH, J. Kratzsch, DD, TK, TW, DF, and SL have nothing to disclose.	Abuzzahab MJ, 2003, NEW ENGL J MED, V349, P2211, DOI 10.1056/NEJMoa010107; Badano JL, 2002, NAT REV GENET, V3, P779, DOI 10.1038/nrg910; Bober MB, 2010, AM J MED GENET A, V152A, P960, DOI 10.1002/ajmg.a.33252; Booth RA, 2002, J BIOL CHEM, V277, P6719, DOI 10.1074/jbc.M108033200; Brancati F, 2005, AM J MED GENET A, V139A, P212, DOI 10.1002/ajmg.a.31009; Choi JS, 2010, CANCER LETT, V294, P254, DOI 10.1016/j.canlet.2010.02.007; Delaval B, 2010, J CELL BIOL, V188, P181, DOI 10.1083/jcb.200908114; Di Bartolomeo R, 2003, EUR J PEDIATR, V162, P860, DOI 10.1007/s00431-003-1310-z; Ducos B, 2001, J CLIN ENDOCR METAB, V86, P5516, DOI 10.1210/jc.86.11.5516; Dumitrescu C, 2010, ACTA ENDOCRINOL-BUCH, V6, P361, DOI 10.4183/aeb.2010.361; Faivre L, 2002, AM J MED GENET, V112, P379, DOI 10.1002/ajmg.10677; Fang P, 2012, J CLIN ENDOCR METAB, V97, pE243, DOI 10.1210/jc.2011-2142; Fang P, 2009, J CLIN ENDOCR METAB, V94, P1740, DOI 10.1210/jc.2008-1903; Hall JG, 2004, AM J MED GENET A, V130A, P55, DOI 10.1002/ajmg.a.30203; Huang-Doran I, 2011, DIABETES, V60, P925, DOI 10.2337/db10-1334; Inagaki K, 2007, J CLIN ENDOCR METAB, V92, P1542, DOI 10.1210/jc.2006-2354; Juul A, 2003, GROWTH HORM IGF RES, V13, P113, DOI 10.1016/S1096-6374(03)00038-8; Kannu P, 2004, AM J MED GENET A, V128A, P98, DOI 10.1002/ajmg.a.30086; Kawashima Y, 2005, J CLIN ENDOCR METAB, V90, P4679, DOI 10.1210/jc.2004-1947; Kjaer I, 2001, CLEFT PALATE-CRAN J, V38, P645, DOI 10.1597/1545-1569(2001)038<0645:CMDASM>2.0.CO;2; Klammt J, 2005, BIOCHEM BIOPH RES CO, V327, P557, DOI 10.1016/j.bbrc.2004.12.039; Klammt J, 2011, BEST PRACT RES CL EN, V25, P191, DOI 10.1016/j.beem.2010.09.012; Kotzot D, 2005, AM J MED GENET A, V136A, P287, DOI 10.1002/ajmg.a.30483; Kotzot D, 2004, ANN GENET-PARIS, V47, P251, DOI 10.1016/j.anngen.2004.03.006; Kruis T, 2010, J CLIN ENDOCR METAB, V95, P1137, DOI 10.1210/jc.2009-1433; Larsson O, 2007, Br J Cancer, V96 Suppl, pR2; LeRoith D, 1995, ANN NY ACAD SCI, V766, P402, DOI 10.1111/j.1749-6632.1995.tb26689.x; Ligensa T, 2001, J BIOL CHEM, V276, P33419, DOI 10.1074/jbc.M104509200; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/S0092-8674(05)80084-4; Lou XJ, 2001, MOL BIOL CELL, V12, P615, DOI 10.1091/mbc.12.3.615; Majewski F, 1998, AM J MED GENET, V80, P25, DOI 10.1002/(SICI)1096-8628(19981102)80:1<25::AID-AJMG5>3.0.CO;2-0; MAJEWSKI F, 1982, AM J MED GENET, V12, P23, DOI 10.1002/ajmg.1320120104; Muders MH, 2006, CANCER RES, V66, P10264, DOI 10.1158/0008-5472.CAN-06-2321; Muders MH, 2009, CLIN CANCER RES, V15, P4095, DOI 10.1158/1078-0432.CCR-08-2837; Naccache SN, 2006, P NATL ACAD SCI USA, V103, P12735, DOI 10.1073/pnas.0605317103; Raile K, 2006, J CLIN ENDOCR METAB, V91, P2264, DOI 10.1210/jc.2005-2146; Rauch A, 2008, SCIENCE, V319, P816, DOI 10.1126/science.1151174; Schmidt A, 2002, CLIN ENDOCRINOL, V57, P293, DOI 10.1046/j.1365-2265.2002.01590.x; Sorof JM, 1999, PEDIATR NEPHROL, V13, P343, DOI 10.1007/s004670050623; TARTAREDECKERT S, 1995, J BIOL CHEM, V270, P23456, DOI 10.1074/jbc.270.40.23456; Waldron JS, 2009, J NEUROSURG-PEDIATR, V4, P439, DOI 10.3171/2009.6.PEDS08137; Walenkamp MJE, 2006, J CLIN ENDOCR METAB, V91, P3062, DOI 10.1210/jc.2005-1597; Wallborn T, 2010, J CLIN ENDOCR METAB, V95, P2316, DOI 10.1210/jc.2009-2404; Willems M, 2010, J MED GENET, V47, P797, DOI 10.1136/jmg.2009.067298	44	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38220	10.1371/journal.pone.0038220	http://dx.doi.org/10.1371/journal.pone.0038220			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693602	gold, Green Submitted, Green Published			2022-12-27	WOS:000305338500113
J	Salvaing, J; Aguirre-Lavin, T; Boulesteix, C; Lehmann, G; Debey, P; Beaujean, N				Salvaing, Juliette; Aguirre-Lavin, Tiphaine; Boulesteix, Claire; Lehmann, Gaetan; Debey, Pascale; Beaujean, Nathalie			5-Methylcytosine and 5-Hydroxymethylcytosine Spatiotemporal Profiles in the Mouse Zygote	PLOS ONE			English	Article							DNA METHYLATION; PATERNAL GENOME; TRANSCRIPTIONAL ACTIVITY; ACTIVE DEMETHYLATION; TET PROTEINS; EMBRYOS; REPLICATION; MAINTENANCE; PATTERNS; FERTILIZATION	Background: In the mouse zygote, DNA methylation patterns are heavily modified, and differ between the maternal and paternal pronucleus. Demethylation of the paternal genome has been described as an active and replication-independent process, although the mechanisms responsible for it remain elusive. Recently, 5-hydroxymethylcytosine has been suggested as an intermediate in this demethylation. Methodology/Principal Findings: In this study, we quantified DNA methylation and hydroxymethylation in both pronuclei of the mouse zygote during the replication period and we examined their patterns on the pericentric heterochromatin using 3D immuno-FISH. Our results demonstrate that 5-methylcytosine and 5-hydroxymethylcytosine localizations on the pericentric sequences are not complementary; indeed we observe no enrichment of either marks on some regions and an enrichment of both on others. In addition, we show that DNA demethylation continues during DNA replication, and is inhibited by aphidicolin. Finally, we observe notable differences in the kinetics of demethylation and hydroxymethylation; in particular, a peak of 5-hydroxymethylcytosine, unrelated to any change in 5-methylcytosine level, is observed after completion of replication. Conclusions/Significance: Together our results support the already proposed hypothesis that 5-hydroxymethylcytosine is not a simple intermediate in an active demethylation process and could play a role of its own during early development.	[Salvaing, Juliette; Aguirre-Lavin, Tiphaine; Boulesteix, Claire; Lehmann, Gaetan; Debey, Pascale; Beaujean, Nathalie] INRA, Biol Dev & Reprod UMR1198, Jouy En Josas, France; [Salvaing, Juliette; Aguirre-Lavin, Tiphaine; Boulesteix, Claire; Lehmann, Gaetan; Debey, Pascale; Beaujean, Nathalie] ENVA, Maisons Alfort, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; Ecole Nationale Veterinaire d'Alfort (ENVA)	Salvaing, J (corresponding author), INRA, Biol Dev & Reprod UMR1198, Jouy En Josas, France.	juliette.salvaing@jouy.inra.fr	Beaujean, Nathalie/C-9883-2011	Beaujean, Nathalie/0000-0003-0188-9190	INRA (Institut National de la Recherche Agronomique) "Young Team" research grant; Region Ile-de-France	INRA (Institut National de la Recherche Agronomique) "Young Team" research grant; Region Ile-de-France(Region Ile-de-France)	This work was supported by an INRA (Institut National de la Recherche Agronomique) "Young Team" research grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are indebted to members of Unite Experimentale d'Infectiologie Experimentale des Rongeurs et Poissons (UEIERP) in charge of the mice. The authors wish to thank Justine Auge and Anne Jeandin for their help in initiating this study. They also thank the MIMA2 facility for access to confocal and ApoTome microscopes and the Region Ile-de-France for funding this last system.	Adenot P, 2011, EPIGENETICS OFFICIAL, V6, P1; Adenot PG, 1997, DEVELOPMENT, V124, P4615; [Anonymous], 2010, R LANG ENV STAT COMP; Aoki F, 1997, DEV BIOL, V181, P296, DOI 10.1006/dbio.1996.8466; Beaujean N, 2004, BIOL REPROD, V71, P185, DOI 10.1095/biolreprod.103.026559; BouniolBaly C, 1997, EXP CELL RES, V236, P201, DOI 10.1006/excr.1997.3708; Cirio MC, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-9; Corry GN, 2009, BIRTH DEFECTS RES C, V87, P297, DOI 10.1002/bdrc.20165; Dean W, 2001, P NATL ACAD SCI USA, V98, P13734, DOI 10.1073/pnas.241522698; Farthing CR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000116; Ficz G, 2011, NATURE, V473, P398, DOI 10.1038/nature10008; Fulka H, 2004, REPRODUCTION, V128, P703, DOI 10.1530/rep.1.00217; Gu TP, 2011, NATURE, V477, P606, DOI 10.1038/nature10443; Hajkova P, 2002, MECH DEVELOP, V117, P15, DOI 10.1016/S0925-4773(02)00181-8; Hajkova P, 2010, SCIENCE, V329, P78, DOI 10.1126/science.1187945; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Hirasawa R, 2008, GENE DEV, V22, P1607, DOI 10.1101/gad.1667008; Inoue A, 2011, CELL RES, V21, P1670, DOI 10.1038/cr.2011.189; Inoue A, 2011, SCIENCE, V334, P194, DOI 10.1126/science.1212483; Iqbal K, 2011, P NATL ACAD SCI USA, V108, P3642, DOI 10.1073/pnas.1014033108; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Jeanblanc M, 2008, GYNECOL OBSTET FERTI, V36, P1126, DOI 10.1016/j.gyobfe.2008.07.015; Jin Bilian, 2011, Genes Cancer, V2, P607, DOI 10.1177/1947601910393957; Kurihara Y, 2008, DEV BIOL, V313, P335, DOI 10.1016/j.ydbio.2007.10.033; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Maalouf WE, 2010, METHODS MOL BIOL, V659, P401, DOI 10.1007/978-1-60761-789-1_31; Martin C, 2006, DEV BIOL, V292, P317, DOI 10.1016/j.ydbio.2006.01.009; Mayer W, 2000, NATURE, V403, P501, DOI 10.1038/35000656; Nestor CE, 2011, GENOME RES; Okada Y, 2010, NATURE, V463, P554, DOI 10.1038/nature08732; Oswald J, 2000, CURR BIOL, V10, P475, DOI 10.1016/S0960-9822(00)00448-6; Park JS, 2007, DEV DYNAM, V236, P2523, DOI 10.1002/dvdy.21278; Probst AV, 2007, CHROMOSOMA, V116, P403, DOI 10.1007/s00412-007-0106-8; Romanova L, 2006, BIOL REPROD, V74, P807, DOI 10.1095/biolreprod.105.047340; Rougier N, 1998, GENE DEV, V12, P2108, DOI 10.1101/gad.12.14.2108; Ruzov A, 2011, CELL RES, V21, P1332, DOI 10.1038/cr.2011.113; Santos F, 2002, DEV BIOL, V241, P172, DOI 10.1006/dbio.2001.0501; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tate P, 1996, NAT GENET, V12, P205, DOI 10.1038/ng0296-205; Valinluck V, 2007, CANCER RES, V67, P946, DOI 10.1158/0008-5472.CAN-06-3123; Vassena R, 2005, MOL REPROD DEV, V72, P430, DOI 10.1002/mrd.20375; Williams K, 2011, NATURE, V473, P343, DOI 10.1038/nature10066; Wossidlo M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1240; Wossidlo M, 2010, EMBO J, V29, P1877, DOI 10.1038/emboj.2010.80; Wu H, 2011, NATURE, V473, P389, DOI 10.1038/nature09934; Xu YF, 2011, MOL CELL, V42, P451, DOI 10.1016/j.molcel.2011.04.005; Yamazaki T, 2007, DEV BIOL, V304, P409, DOI 10.1016/j.ydbio.2006.12.046; Zaitseva I, 2007, MOL REPROD DEV, V74, P1255, DOI 10.1002/mrd.20704	49	54	54	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38156	10.1371/journal.pone.0038156	http://dx.doi.org/10.1371/journal.pone.0038156			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693592	Green Published, gold, Green Submitted			2022-12-27	WOS:000305338500096
J	Pepper, DJ; Marais, S; Bhaijee, F; Wilkinson, RJ; De Azevedo, V; Meintjes, G				Pepper, Dominique J.; Marais, Suzaan; Bhaijee, Feriyl; Wilkinson, Robert J.; De Azevedo, Virginia; Meintjes, Graeme			Assessment at Antiretroviral Clinics during TB Treatment Reduces Loss to Follow-Up among HIV-Infected Patients	PLOS ONE			English	Article							CD4 CELL COUNTS; THERAPY; TUBERCULOSIS; INITIATION; OUTCOMES; RATES; START	Setting: A South African township clinic where loss to follow-up during TB treatment may prevent HIV-infected TB patients from receiving life-saving ART. Objective: To determine factors associated with loss to follow-up during TB treatment. Design: Regression analyses of a cohort of ART-eligible TB patients who commenced TB treatment and were followed for 24 weeks. Results: Of 111 ART-eligible TB patients, 15 (14%) died in the ensuing 24 weeks. Of the remaining 96 TB patients, 11 (11%) were lost to follow-up. All TB patients lost to follow-up did not initiate ART. Of 85 TB patients in follow-up, 62 (73%) initiated ART 56 days after TB diagnosis (median, IQR 33-77 days) and 31 days after initial assessment at an ART clinic (median, IQR: 18-55 days). The median duration from TB diagnosis to initial assessment at an ART clinic was 19 days (IQR: 7-48 days). At 24 weeks, 6 of 85 (7%) TB patients who presented to an ART clinic for assessment were lost to follow-up, compared to 5 of 11 (45%) TB patients who did not present to an ART clinic for assessment. Logistic regression analysis (adjusted odds ratio = 0.1, 95% confidence interval [95% CI]: 0.03-0.66) and our Cox proportional hazards model (hazard ratio = 0.2, 95% CI: 0.04-0.68) confirmed that assessment at an ART clinic during TB treatment reduced loss to follow-up. Conclusion: Assessment at antiretroviral clinics for HIV care by trained health-care providers reduces loss to follow-up among HIV-infected patients with TB.	[Pepper, Dominique J.; Marais, Suzaan; Wilkinson, Robert J.; Meintjes, Graeme] Univ Cape Town, Dept Med, Clin Infect Dis Res Initiat, Inst Infect Dis & Mol Med, ZA-7700 Rondebosch, Western Provinc, South Africa; [Pepper, Dominique J.; Bhaijee, Feriyl] Univ Mississippi, Med Ctr, Dept Med, Jackson, MS 39216 USA; [Marais, Suzaan; Wilkinson, Robert J.; Meintjes, Graeme] GF Jooste Hosp, Dept Med, Infect Dis Unit, Cape Town, South Africa; [Wilkinson, Robert J.; Meintjes, Graeme] Univ London Imperial Coll Sci Technol & Med, Div Med, London, England; [De Azevedo, Virginia] City Hlth, Cape Town, South Africa; [Wilkinson, Robert J.] Natl Inst Med Res, MRC, London NW7 1AA, England	University of Cape Town; University of Mississippi; University of Mississippi Medical Center; Imperial College London; MRC National Institute for Medical Research	Pepper, DJ (corresponding author), Univ Cape Town, Dept Med, Clin Infect Dis Res Initiat, Inst Infect Dis & Mol Med, ZA-7700 Rondebosch, Western Provinc, South Africa.	dominiquepepper@gmail.com	Marais, Suzaan/AAG-2750-2019	Marais, Suzaan/0000-0002-8050-9610; Meintjes, Graeme/0000-0003-1196-4414; Wilkinson, Robert/0000-0002-2753-1800	Perinatal HIV Research Unit; US Agency for International Development; President's Emergency Plan for AIDS Relief; Wellcome Trust [WT 081667, 084323, 088316]; Fogarty International Center South Africa [NIH/FIC 1U2RTW007373-01A1, 1U2RTW007370]; European and Developing Countries Clinical Trials Partnership (EDCTP) [IP.07.32080.002]; Medical Research Council of the United Kingdom [U.1175.02.002.00014.01]; Medical Research Council [MC_U117588499] Funding Source: researchfish; MRC [MC_U117588499] Funding Source: UKRI; FOGARTY INTERNATIONAL CENTER [U2RTW007370, U2RTW007373] Funding Source: NIH RePORTER	Perinatal HIV Research Unit; US Agency for International Development(United States Agency for International Development (USAID)); President's Emergency Plan for AIDS Relief(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Wellcome Trust(Wellcome TrustEuropean Commission); Fogarty International Center South Africa(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); European and Developing Countries Clinical Trials Partnership (EDCTP); Medical Research Council of the United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported by The Perinatal HIV Research Unit, the US Agency for International Development, and the President's Emergency Plan for AIDS Relief (to DJP and SM); and Wellcome Trust (RJW and GM, WT 081667, 084323 and 088316). The data analysis was supported by a Fogarty International Center South Africa TB/AIDS Training Award (NIH/FIC 1U2RTW007373-01A1, 1U2RTW007370). RJW also receives support from The European and Developing Countries Clinical Trials Partnership (EDCTP) (IP.07.32080.002) and the Medical Research Council of the United Kingdom (U.1175.02.002.00014.01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blanc FX, 2011, NEW ENGL J MED, V365, P1471, DOI 10.1056/NEJMoa1013911; Boyles TH, 2012, NEW ENGL J MED, V366, P474, DOI 10.1056/NEJMc1113986; Business Trust & dplg, 2007, KHAYE NOD EC DEV PRO; Ciglenecki I, 2007, INT J TUBERC LUNG D, V11, P1121; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; ETR.NET of South Africa, 2010, EL TUB REG; Fox MP, 2010, AIDS, V24, P2041, DOI 10.1097/QAD.0b013e32833c703e; Greig J, 2011, J ACQ IMMUN DEF SYND, V59, pe92; Havlir DV, 2011, NEW ENGL J MED, V365, P1482, DOI 10.1056/NEJMoa1013607; Karim SSA, 2011, NEW ENGL J MED, V365, P1492, DOI 10.1056/NEJMoa1014181; Karim SSA, 2010, NEW ENGL J MED, V362, P697, DOI 10.1056/NEJMoa0905848; MacPherson P, 2009, T ROY SOC TROP MED H, V103, P588, DOI 10.1016/j.trstmh.2008.10.001; Makombe SD, 2007, INT J TUBERC LUNG D, V11, P412; Middelkoop K, 2011, JAIDS-J ACQ IMM DEF, V56, P263, DOI 10.1097/QAI.0b013e31820413b3; Mossdorf E, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-98; Pepper DJ, 2011, PLOS ONE, V6; Pepper DJ, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-83; South African Department of Health, 2004, S AFR NAT TUB CONTR; Varma JK, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-42	19	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e37634	10.1371/journal.pone.0037634	http://dx.doi.org/10.1371/journal.pone.0037634			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22719843	Green Published, Green Submitted, gold			2022-12-27	WOS:000305583300008
J	Yang, XJ; Liu, P; Sun, JB; Wang, GH; Zeng, F; Yuan, K; Liu, JX; Dong, MH; von Deneen, KM; Qin, W; Tian, J				Yang, Xuejuan; Liu, Peng; Sun, Jinbo; Wang, Guihong; Zeng, Fang; Yuan, Kai; Liu, Jixin; Dong, Minghao; von Deneen, Karen M.; Qin, Wei; Tian, Jie			Impact of Brain-Derived Neurotrophic Factor Val66Met Polymorphism on Cortical Thickness and Voxel-Based Morphometry in Healthy Chinese Young Adults	PLOS ONE			English	Article							OLD-WORLD MONKEY; SURFACE-BASED ANALYSIS; AMYGDALA VOLUME; CEREBRAL-CORTEX; RISK-FACTOR; BDNF GENE; SCHIZOPHRENIA; ASSOCIATION; INSULA; MEMORY	Background: Following voxel-based morphometry (VBM), brain-derived neurotrophic factor (BDNF) Val66Met polymorphism (rs6265) has been shown to affect human brain morphology in Caucasians. However, little is known about the specific role of the Met/Met genotype on brain structure. Moreover, the relationship between BDNF Val66Met polymorphism and Chinese brain morphology has not been studied. Methodology/Principal Findings: The present study investigated brain structural differences among three genotypes of BDNF (rs6265) for the first time in healthy young Chinese adults via cortical thickness analysis and VBM. Brain differences in Met carriers using another grouping method (combining Val/Met and Met/Met genotypes into a group of Met carriers as in most previous studies) were also investigated using VBM. Dual-approach analysis revealed less gray matter (GM) in the frontal, temporal, cingulate and insular cortices in the Met/Met group compared with the Val/Val group (corrected, P<0.05). Areas with less GM in the Val/Met group were included in the Met/Met group. VBM differences in Met carriers were only found in the middle cingulate cortex. Conclusions/Significance: The current results indicated a unique pattern of brain morphologic differences caused by BDNF (rs6265) in young Chinese adults, in which the Met/Met genotype markedly affected the frontal, temporal, cingulate, and insular regions. The grouping method with Met carriers was not suitable to detect the genetic effect of BDNF Val66Met polymorphism on brain morphology, at least in the Chinese population, because it may hide some specific roles of Met/Met and Val/Met genotypes on brain structure.	[Yang, Xuejuan; Liu, Peng; Sun, Jinbo; Wang, Guihong; Yuan, Kai; Liu, Jixin; Dong, Minghao; von Deneen, Karen M.; Qin, Wei; Tian, Jie] Xidian Univ, Sch Life Sci & Technol, Life Sci Res Ctr, Xian, Shaanxi, Peoples R China; [Zeng, Fang] Chengdu Univ Tradit Chinese Med, Teaching Hosp 3, Chengdu, Sichuan, Peoples R China; [Tian, Jie] Chinese Acad Sci, Inst Automat, Beijing, Peoples R China	Xidian University; Chengdu University of Traditional Chinese Medicine; Chinese Academy of Sciences; Institute of Automation, CAS	Yang, XJ (corresponding author), Xidian Univ, Sch Life Sci & Technol, Life Sci Res Ctr, Xian, Shaanxi, Peoples R China.	wqin@xidian.edu.cn; tian@ieee.org	秦, 伟/J-9770-2016; Yuan, Kai/M-9403-2013; tian, jie/M-6336-2013; Life, PAM/M-9552-2013; Tian, Jie/H-1190-2011; JinBo, Sun/GLT-2082-2022; Yuan, Kai/I-4150-2016; Dong, Minghao/A-6425-2014	秦, 伟/0000-0003-4583-0406; Tian, Jie/0000-0003-0498-0432; Yuan, Kai/0000-0002-3098-1124; Dong, Minghao/0000-0002-0190-6985	Project for the National Key Basic Research and Development Program (973) [2011CB707702, 2012CB518501]; National Natural Science Foundation of China [30930112, 30970774, 60901064, 30873462, 81000640, 81000641, 81071217, 81101036, 81101108, 31150110171]; Fundamental Research Funds for the Central Universities; Chinese Academy of Sciences [KGCX2-YW-129]	Project for the National Key Basic Research and Development Program (973)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Chinese Academy of Sciences(Chinese Academy of Sciences)	This study was supported by the Project for the National Key Basic Research and Development Program (973) under Grant Nos. 2011CB707702 and 2012CB518501, the National Natural Science Foundation of China under Grant Nos. 30930112, 30970774, 60901064, 30873462, 81000640, 81000641, 81071217, 81101036, 81101108 and 31150110171, the Fundamental Research Funds for the Central Universities and the Knowledge Innovation Program of the Chinese Academy of Sciences under Grant No. KGCX2-YW-129. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2001, NEUROIMAGE, V14, P1238, DOI 10.1006/nimg.2001.0961; Augustine JR, 1996, BRAIN RES REV, V22, P229, DOI 10.1016/S0165-0173(96)00011-2; Bueller JA, 2006, BIOL PSYCHIAT, V59, P812, DOI 10.1016/j.biopsych.2005.09.022; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; Chen QY, 2006, NEUROSCI LETT, V397, P285, DOI 10.1016/j.neulet.2005.12.033; Chen ZY, 2006, SCIENCE, V314, P140, DOI 10.1126/science.1129663; Chen Zhe-Yu, 2008, Novartis Found Symp, V289, P180; Cole J., 2011, GENES BRAIN BEHAV; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Franke B, 2011, MOL PSYCHIAT; Frodl T, 2007, ARCH GEN PSYCHIAT, V64, P410, DOI 10.1001/archpsyc.64.4.410; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Hajek T, 2011, WORLD J BIOL PSYCHIA; Ho BC, 2006, ARCH GEN PSYCHIAT, V63, P731, DOI 10.1001/archpsyc.63.7.731; Hong CJ, 2003, NEUROSCI LETT, V349, P206, DOI 10.1016/S0304-3940(03)00828-0; Hyde KL, 2010, HUM BRAIN MAPP, V31, P556, DOI 10.1002/hbm.20887; Im K, 2008, CEREB CORTEX, V18, P2181, DOI 10.1093/cercor/bhm244; Karnik MS, 2010, PSYCHIAT RES, V178, P425, DOI 10.1016/j.psychres.2009.09.008; Lehmann M, 2011, NEUROBIOL AGING, V32, P1466, DOI 10.1016/j.neurobiolaging.2009.08.017; Liu M SL, 2007, HEREDITAS, V29, P41; Lyoo IK, 2011, ARCH GEN PSYCHIAT, V68, P701, DOI 10.1001/archgenpsychiatry.2011.70; MacDonald D, 2000, NEUROIMAGE, V12, P340, DOI 10.1006/nimg.1999.0534; Matsuo K, 2009, NEUROPSYCHOPHARMACOL, V34, P1904, DOI 10.1038/npp.2009.23; MESULAM MM, 1982, J COMP NEUROL, V212, P1, DOI 10.1002/cne.902120102; MESULAM MM, 1982, J COMP NEUROL, V212, P38, DOI 10.1002/cne.902120104; Montag C, 2009, PSYCHOL MED, V39, P1831, DOI 10.1017/S0033291709005509; MUFSON EJ, 1982, J COMP NEUROL, V212, P23, DOI 10.1002/cne.902120103; Naoe Y, 2007, NEUROSCI LETT, V415, P108, DOI 10.1016/j.neulet.2007.01.006; Neves-Pereira M, 2005, MOL PSYCHIATR, V10, P208, DOI 10.1038/sj.mp.4001575; Pezawas L, 2004, J NEUROSCI, V24, P10099, DOI 10.1523/JNEUROSCI.2680-04.2004; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Qian L, 2007, BIOCHEM BIOPH RES CO, V353, P738, DOI 10.1016/j.bbrc.2006.12.121; Raznahan A, 2009, J NEURODEV DISORD, V1, P215, DOI 10.1007/s11689-009-9012-0; Richter-Schmidinger T, 2011, J NEURAL TRANSM, V118, P249, DOI 10.1007/s00702-010-0539-8; Rosa A, 2006, AM J MED GENET B, V141B, P135, DOI 10.1002/ajmg.b.30266; Schofield PR, 2009, BIOL PSYCHOL, V80, P176, DOI 10.1016/j.biopsycho.2008.09.001; Shimizu E, 2004, AM J MED GENET B, V126B, P122, DOI 10.1002/ajmg.b.20118; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Sublette ME, 2008, PROG NEURO-PSYCHOPH, V32, P1652, DOI 10.1016/j.pnpbp.2008.06.009; Szeszko PR, 2005, MOL PSYCHIATR, V10, P631, DOI 10.1038/sj.mp.4001656; Takahashi T, 2008, NEUROSCI LETT, V435, P34, DOI 10.1016/j.neulet.2008.02.004; Thompson PM, 2010, CURR OPIN NEUROL, V23, P368, DOI 10.1097/WCO.0b013e32833b764c; Voineskos AN, 2011, ARCH GEN PSYCHIAT, V68, P198, DOI 10.1001/archgenpsychiatry.2010.194	49	39	43	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e37777	10.1371/journal.pone.0037777	http://dx.doi.org/10.1371/journal.pone.0037777			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22719849	gold, Green Published, Green Submitted			2022-12-27	WOS:000305341900014
J	Bell, AS; Huijben, S; Paaijmans, KP; Sim, DG; Chan, BHK; Nelson, WA; Read, AF				Bell, Andrew S.; Huijben, Silvie; Paaijmans, Krijn P.; Sim, Derek G.; Chan, Brian H. K.; Nelson, William A.; Read, Andrew F.			Enhanced Transmission of Drug-Resistant Parasites to Mosquitoes following Drug Treatment in Rodent Malaria	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM GAMETOCYTES; REVERSE-TRANSCRIPTION PCR; WITHIN-HOST COMPETITION; TIME QUANTITATIVE PCR; TECHNIQUE VALIDATION; MIXED INFECTIONS; SEX-RATIO; CHABAUDI; EVOLUTION; FITNESS	The evolution of drug resistant Plasmodium parasites is a major challenge to effective malaria control. In theory, competitive interactions between sensitive parasites and resistant parasites within infections are a major determinant of the rate at which parasite evolution undermines drug efficacy. Competitive suppression of resistant parasites in untreated hosts slows the spread of resistance; competitive release following treatment enhances it. Here we report that for the murine model Plasmodium chabaudi, co-infection with drug-sensitive parasites can prevent the transmission of initially rare resistant parasites to mosquitoes. Removal of drug-sensitive parasites following chemotherapy enabled resistant parasites to transmit to mosquitoes as successfully as sensitive parasites in the absence of treatment. We also show that the genetic composition of gametocyte populations in host venous blood accurately reflects the genetic composition of gametocytes taken up by mosquitoes. Our data demonstrate that, at least for this mouse model, aggressive chemotherapy leads to very effective transmission of highly resistant parasites that are present in an infection, the very parasites which undermine the long term efficacy of front-line drugs.	[Bell, Andrew S.; Huijben, Silvie; Paaijmans, Krijn P.; Sim, Derek G.; Chan, Brian H. K.; Read, Andrew F.] Penn State Univ, Dept Biol, Ctr Infect Dis Dynam, University Pk, PA 16802 USA; [Bell, Andrew S.; Huijben, Silvie; Paaijmans, Krijn P.; Sim, Derek G.; Chan, Brian H. K.; Read, Andrew F.] Penn State Univ, Dept Entomol, Ctr Infect Dis Dynam, University Pk, PA 16802 USA; [Nelson, William A.] Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada; [Read, Andrew F.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Queens University - Canada; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC)	Bell, AS (corresponding author), Penn State Univ, Dept Biol, Ctr Infect Dis Dynam, University Pk, PA 16802 USA.	a.read@psu.edu	Paaijmans, Krijn/ABC-9928-2020; Nelson, William A/D-1405-2013; Huijben, Silvie/Q-3837-2019	Huijben, Silvie/0000-0002-3537-1915; Chan, Brian/0000-0002-9451-4621	National Institute of General Medical Sciences [R01GM089932]; National Institute of Allergy And Infectious Diseases [R01AI089819, U19AI089676]; Pennsylvania Department of Health using Tobacco Settlement Funds; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI089676, R01AI089819] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089932] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Allergy And Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Pennsylvania Department of Health using Tobacco Settlement Funds; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported by the National Institute of General Medical Sciences (R01GM089932), the National Institute of Allergy And Infectious Diseases (R01AI089819 and U19AI089676), and the Pennsylvania Department of Health using Tobacco Settlement Funds. The content of this paper is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of General Medical Sciences, the National Institute of Allergy and Infectious Diseases, the National Institutes of Health, or the Pennsylvania Department of Health which specifically disclaims responsibility for any analyses, interpretations or conclusions.	[Anonymous], 2010, R LANG ENV STAT COMP; Arnot D, 1998, T ROY SOC TROP MED H, V92, P580, DOI 10.1016/S0035-9203(98)90773-8; Babiker HA, 1999, T ROY SOC TROP MED H, V93, pS11, DOI 10.1016/S0035-9203(99)90321-8; Baliraine FN, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-283; Barnes KI, 2005, ACTA TROP, V94, P230, DOI 10.1016/j.actatropica.2005.04.014; Baruah S, 2009, INFECT GENET EVOL, V9, P853, DOI 10.1016/j.meegid.2009.05.006; Beale G.H., 1978, P213; Bell AS, 2006, EVOLUTION, V60, P1358, DOI 10.1111/j.0014-3820.2006.tb01215.x; Bell AS, 2009, J INVERTEBR PATHOL, V100, P160, DOI 10.1016/j.jip.2009.01.006; Bousema JT, 2008, AM J TROP MED HYG, V78, P442, DOI 10.4269/ajtmh.2008.78.442; Bruce MC, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-38; Bruce MC, 2000, SCIENCE, V287, P845, DOI 10.1126/science.287.5454.845; Buckling A, 1999, PARASITOLOGY, V118, P339, DOI 10.1017/S0031182099003960; Buckling A, 2001, P ROY SOC B-BIOL SCI, V268, P2325, DOI 10.1098/rspb.2001.1808; Buckling A, 1999, EXP PARASITOL, V93, P45, DOI 10.1006/expr.1999.4429; Buckling AGJ, 1997, P ROY SOC B-BIOL SCI, V264, P553, DOI 10.1098/rspb.1997.0079; Carter R., 1988, MALARIA PRINCIPLES P, P253; Cheesman SJ, 2003, MOL BIOCHEM PARASIT, V131, P83, DOI 10.1016/S0166-6851(03)00195-6; Collins WE, 2003, AM J TROP MED HYG, V68, P366, DOI 10.4269/ajtmh.2003.68.366; Daubersies P, 1996, AM J TROP MED HYG, V54, P18, DOI 10.4269/ajtmh.1996.54.18; de Roode JC, 2005, P NATL ACAD SCI USA, V102, P7624, DOI 10.1073/pnas.0500078102; de Roode JC, 2005, AM NAT, V166, P531, DOI 10.1086/491659; de Roode JC, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-33; de Roode JC, 2004, P ROY SOC B-BIOL SCI, V271, P1073, DOI 10.1098/rspb.2004.2695; Drakeley CJ, 1999, TROP MED INT HEALTH, V4, P131, DOI 10.1046/j.1365-3156.1999.00361.x; Drew DR, 2007, MOL BIOCHEM PARASIT, V156, P199, DOI 10.1016/j.molbiopara.2007.08.004; Durand R, 2008, TROP MED INT HEALTH, V13, P1392, DOI 10.1111/j.1365-3156.2008.02156.x; Enserink M, 2008, SCIENCE, V322, P1776, DOI 10.1126/science.322.5909.1776; Felger I, 2008, TRENDS PARASITOL, V24, P331, DOI 10.1016/j.pt.2008.05.004; Gaillard FO, 2003, PARASITOLOGY, V127, P427, DOI 10.1017/S0031182003004025; Greenwood BM, 2008, J CLIN INVEST, V118, P1266, DOI 10.1172/JCI33996; Harrington WE, 2009, P NATL ACAD SCI USA, V106, P9027, DOI 10.1073/pnas.0901415106; Hastings IA, 2005, DRUG RESIST UPDATE, V8, P43, DOI 10.1016/j.drup.2005.03.003; Hastings IM, 1997, PARASITOLOGY, V115, P133, DOI 10.1017/S0031182097001261; Hastings IM, 2000, PARASITOL TODAY, V16, P340, DOI 10.1016/S0169-4758(00)01707-5; Hastings IM, 2003, TRENDS PARASITOL, V19, P70, DOI 10.1016/S1471-4922(02)00017-X; HILL WG, 1995, GENET RES, V65, P53, DOI 10.1017/S0016672300033000; Huijben S, 2011, J EVOLUTION BIOL, V24, P2410, DOI 10.1111/j.1420-9101.2011.02369.x; Huijben S, 2010, THESIS U EDINBURGH; Huijben S, 2010, EVOLUTION, V64, P2952, DOI 10.1111/j.1558-5646.2010.01068.x; Hyde JE, 2005, TRENDS PARASITOL, V21, P494, DOI 10.1016/j.pt.2005.08.020; JACOBS RL, 1964, EXP PARASITOL, V15, P213, DOI 10.1016/0014-4894(64)90017-7; Jafari S, 2004, J INFECT DIS, V189, P195, DOI 10.1086/380910; JARRA W, 1985, PARASITE IMMUNOL, V7, P595, DOI 10.1111/j.1365-3024.1985.tb00103.x; Liljander A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016940; Mackinnon MJ, 1998, T ROY SOC TROP MED H, V92, P188, DOI 10.1016/S0035-9203(98)90745-3; MercereauPuijalon O, 1996, PARASITE IMMUNOL, V18, P173, DOI 10.1046/j.1365-3024.1996.d01-79.x; Nwakanma D, 2008, INT J PARASITOL, V38, P219, DOI 10.1016/j.ijpara.2007.07.003; Pichon G, 2000, PARASITOLOGY, V121, P115, DOI 10.1017/S0031182099006277; Pollitt LC, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-105; Read AF, 2011, P NATL ACAD SCI USA, V108, P10871, DOI 10.1073/pnas.1100299108; Read AF, 2009, EVOL APPL, V2, P40, DOI 10.1111/j.1752-4571.2008.00066.x; Robert V, 1996, T ROY SOC TROP MED H, V90, P621, DOI 10.1016/S0035-9203(96)90408-3; Smith T, 1999, T ROY SOC TROP MED H, V93, pS59; Soulama I, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-135; Talisuna AO, 2006, INFECT GENET EVOL, V6, P241, DOI 10.1016/j.meegid.2005.06.003; Talisuna AO, 2003, INT J PARASITOL, V33, P1051, DOI 10.1016/S0020-7519(03)00156-5; Taylor LH, 1998, INT J PARASITOL, V28, P719, DOI 10.1016/S0020-7519(98)00032-0; Taylor LH, 1997, P ROY SOC B-BIOL SCI, V264, P927, DOI 10.1098/rspb.1997.0128; Vafa M, 2008, MALARIA J, V7, P9; Vardo-Zalik AM, 2009, INT J PARASITOL, V39, P1573, DOI 10.1016/j.ijpara.2009.05.014; WALLIKER D, 1975, PARASITOLOGY, V70, P19, DOI 10.1017/S0031182000048824; Walliker D, 2005, ACTA TROP, V94, P251, DOI 10.1016/j.actatropica.2005.04.005; Wargo AR, 2007, P NATL ACAD SCI USA, V104, P19914, DOI 10.1073/pnas.0707766104; Wargo AR, 2006, EXP PARASITOL, V112, P13, DOI 10.1016/j.exppara.2005.08.013; WHO, 2010, GUID TREATM MAL, V2nd	66	25	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e37172	10.1371/journal.pone.0037172	http://dx.doi.org/10.1371/journal.pone.0037172			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701563	Green Published, gold			2022-12-27	WOS:000305348400010
J	Ghosh, N; McKillop, TJ; Jowitt, TA; Howard, M; Davies, H; Holmes, DF; Roberts, IS; Bella, J				Ghosh, Neelanjana; McKillop, Thomas J.; Jowitt, Thomas A.; Howard, Marjorie; Davies, Heather; Holmes, David F.; Roberts, Ian S.; Bella, Jordi			Collagen-Like Proteins in Pathogenic E. coli Strains	PLOS ONE			English	Article							ENTEROHEMORRHAGIC ESCHERICHIA-COLI; BACILLUS-ANTHRACIS EXOSPORIUM; HELICAL COILED-COIL; SHORT TAIL FIBER; TRIPLE-HELIX; SHIGA-TOXIN; MOLECULAR-STRUCTURE; CONVERTING BACTERIOPHAGES; CRYSTAL-STRUCTURE; GENOME SEQUENCE	The genome sequences of enterohaemorrhagic E. coli O157:H7 strains show multiple open-reading frames with collagen-like sequences that are absent from the common laboratory strain K-12. These putative collagens are included in prophages embedded in O157: H7 genomes. These prophages carry numerous genes related to strain virulence and have been shown to be inducible and capable of disseminating virulence factors by horizontal gene transfer. We have cloned two collagen-like proteins from E. coli O157: H7 into a laboratory strain and analysed the structure and conformation of the recombinant proteins and several of their constituting domains by a variety of spectroscopic, biophysical, and electron microscopy techniques. We show that these molecules exhibit many of the characteristics of vertebrate collagens, including trimer formation and the presence of a collagen triple helical domain. They also contain a C-terminal trimerization domain, and a trimeric a-helical coiled-coil domain with an unusual amino acid sequence almost completely lacking leucine, valine or isoleucine residues. Intriguingly, these molecules show high thermal stability, with the collagen domain being more stable than those of vertebrate fibrillar collagens, which are much longer and post-translationally modified. Under the electron microscope, collagen-like proteins from E. coli O157: H7 show a dumbbell shape, with two globular domains joined by a hinged stalk. This morphology is consistent with their likely role as trimeric phage side-tail proteins that participate in the attachment of phage particles to E. coli target cells, either directly or through assembly with other phage tail proteins. Thus, collagen-like proteins in enterohaemorrhagic E. coli genomes may have a direct role in the dissemination of virulence-related genes through infection of harmless strains by induced bacteriophages.	[Ghosh, Neelanjana; Bella, Jordi] Univ Manchester, Manchester Interdisciplinary Bioctr, Manchester, Lancs, England; [Ghosh, Neelanjana; McKillop, Thomas J.; Jowitt, Thomas A.; Howard, Marjorie; Davies, Heather; Holmes, David F.; Roberts, Ian S.; Bella, Jordi] Univ Manchester, Fac Life Sci, Manchester, Lancs, England	University of Manchester; University of Manchester	Ghosh, N (corresponding author), Univ Manchester, Manchester Interdisciplinary Bioctr, Manchester, Lancs, England.	jordi.bella@manchester.ac.uk	Bella, Jordi/F-3794-2018	Bella, Jordi/0000-0003-0443-4562; Jowitt, Thomas/0000-0002-4045-0933	Dorothy Hodgkin Postgraduate Award [EP/P500966/1]; Research Councils UK; Masters in Biological Sciences Award [BB/E527355/1]; Biotechnology and Biological Sciences Research Council	Dorothy Hodgkin Postgraduate Award; Research Councils UK(UK Research & Innovation (UKRI)); Masters in Biological Sciences Award(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Neelanjana Ghosh was supported by a Dorothy Hodgkin Postgraduate Award to the University of Manchester (ref. EP/P500966/1), funded by Research Councils UK (http://www.rcuk.ac.uk). Thomas J. McKillop was supported by a Masters in Biological Sciences Award to the University of Manchester (ref. BB/E527355/1), funded by the Biotechnology and Biological Sciences Research Council (http://www.bbsrc.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison HE, 2003, INFECT IMMUN, V71, P3409, DOI 10.1128/IAI.71.6.3409-3418.2003; Armstrong CT, 2011, BIOINFORMATICS, V27, P1908, DOI 10.1093/bioinformatics/btr299; Asadulghani M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000408; BAMFORD JKH, 1990, VIROLOGY, V177, P445, DOI 10.1016/0042-6822(90)90508-O; Bann JG, 2000, FEBS LETT, V473, P237, DOI 10.1016/S0014-5793(00)01493-9; Bansal T, 2007, INFECT IMMUN, V75, P4597, DOI 10.1128/IAI.00630-07; Beck K, 1998, J STRUCT BIOL, V122, P17, DOI 10.1006/jsbi.1998.3965; BELLA J, 1994, SCIENCE, V266, P75, DOI 10.1126/science.7695699; Bella J, 2010, J STRUCT BIOL, V170, P377, DOI 10.1016/j.jsb.2010.02.003; BERG RA, 1973, BIOCHEM BIOPH RES CO, V52, P115, DOI 10.1016/0006-291X(73)90961-3; Bergholz TM, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-97; Blommel PG, 2007, BIOTECHNOL PROGR, V23, P585, DOI 10.1021/bp070011x; Boydston JA, 2005, J BACTERIOL, V187, P5310, DOI 10.1128/JB.187.15.5310-5317.2005; Brodsky B, 2005, ADV PROTEIN CHEM, V70, P301, DOI 10.1016/S0065-3233(05)70009-7; Caswell CC, 2010, FEMS MICROBIOL LETT, V303, P61, DOI 10.1111/j.1574-6968.2009.01864.x; Chen SM, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-320; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Daubenspeck JM, 2004, J BIOL CHEM, V279, P30945, DOI 10.1074/jbc.M401613200; Delorenzi M, 2002, BIOINFORMATICS, V18, P617, DOI 10.1093/bioinformatics/18.4.617; Eppinger M, 2007, ANNOTATION ESCHERICH; Feng P, 1998, J INFECT DIS, V177, P1750, DOI 10.1086/517438; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Greenfield NJ, 2006, NAT PROTOC, V1, P2891, DOI 10.1038/nprot.2006.244; HAGGARDLJUNGQUIST E, 1992, J BACTERIOL, V174, P1462, DOI 10.1128/jb.174.5.1462-1477.1992; Hayashi T, 2001, DNA RES, V8, P11, DOI 10.1093/dnares/8.1.11; HENDRIX RW, 1992, SCIENCE, V258, P1145, DOI 10.1126/science.1439823; Herold S, 2005, ANTIMICROB AGENTS CH, V49, P931, DOI 10.1128/AAC.49.3.931-944.2005; Hulo C, 2011, NUCLEIC ACIDS RES, V39, pD576, DOI 10.1093/nar/gkq901; Humtsoe JO, 2005, J BIOL CHEM, V280, P13848, DOI 10.1074/jbc.M410605200; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Imamovic L, 2010, APPL ENVIRON MICROB, V76, P5693, DOI 10.1128/AEM.00107-10; JIMENEZ S, 1973, BIOCHEM BIOPH RES CO, V52, P106, DOI 10.1016/0006-291X(73)90960-1; Johannes L, 2010, NAT REV MICROBIOL, V8, P105, DOI 10.1038/nrmicro2279; Kadler KE, 2007, J CELL SCI, V120, P1955, DOI 10.1242/jcs.03453; Kammerer RA, 1998, J BIOL CHEM, V273, P10602, DOI 10.1074/jbc.273.17.10602; Karmali MA, 2010, VET MICROBIOL, V140, P360, DOI 10.1016/j.vetmic.2009.04.011; Kuhnel K, 2004, P NATL ACAD SCI USA, V101, P17027, DOI 10.1073/pnas.0403069101; Lee J, 2007, APPL ENVIRON MICROB, V73, P4100, DOI 10.1128/AEM.00360-07; Leikina E, 2002, P NATL ACAD SCI USA, V99, P1314, DOI 10.1073/pnas.032307099; Leiman PG, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-355; Lim JY, 2010, J MICROBIOL BIOTECHN, V20, P5, DOI 10.4014/jmb.0908.08007; Lupas A, 1996, METHOD ENZYMOL, V266, P513; Mane SP, 2011, ESCHERICHIA COLI EC4; Mane SP, 2011, SHIGELLA FLEXNERI CD; McAlinden A, 2003, J BIOL CHEM, V278, P42200, DOI 10.1074/jbc.M302429200; Mitraki A, 2002, J STRUCT BIOL, V137, P236, DOI 10.1006/jsbi.2002.4447; Mohs A, 2007, J BIOL CHEM, V282, P29757, DOI 10.1074/jbc.M703991200; MOULD AP, 1985, J ULTRA MOL STRUCT R, V91, P66, DOI 10.1016/0889-1605(85)90077-1; Muniesa M, 2004, MICROBIOL-SGM, V150, P2959, DOI 10.1099/mic.0.27188-0; Muniesa M, 2003, INFECT IMMUN, V71, P4554, DOI 10.1128/IAI.71.8.4554-4562.2003; Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004; OBRIEN AD, 1989, MICROB PATHOGENESIS, V6, P381, DOI 10.1016/0882-4010(89)90080-6; Ogura Y, 2006, DNA RES, V13, P3, DOI 10.1093/dnares/dsi026; Ogura Y, 2009, P NATL ACAD SCI USA, V106, P17939, DOI 10.1073/pnas.0903585106; Ohnishi M, 2001, TRENDS MICROBIOL, V9, P481, DOI 10.1016/S0966-842X(01)02173-4; Oliva CR, 2008, P NATL ACAD SCI USA, V105, P1261, DOI 10.1073/pnas.0709321105; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Parry DAD, 2008, J STRUCT BIOL, V163, P258, DOI 10.1016/j.jsb.2008.01.016; Pennington H, 2010, LANCET, V376, P1428, DOI 10.1016/S0140-6736(10)60963-4; Perna NT, 2001, NATURE, V409, P529, DOI 10.1038/35054089; Plunkett G, 1999, J BACTERIOL, V181, P1767, DOI 10.1128/JB.181.6.1767-1778.1999; RAMACHANDRAN GN, 1955, NATURE, V176, P593, DOI 10.1038/176593a0; Ramshaw JAM, 1998, J STRUCT BIOL, V122, P86, DOI 10.1006/jsbi.1998.3977; Rasko DA, 2008, COMPLETE SEQUENCE SH; Rasmussen M, 2000, INFECT IMMUN, V68, P6370, DOI 10.1128/IAI.68.11.6370-6377.2000; Rasmussen M, 2003, J BIOL CHEM, V278, P32313, DOI 10.1074/jbc.M304709200; RICH A, 1961, J MOL BIOL, V3, P483, DOI 10.1016/S0022-2836(61)80016-8; RIETRA PJGM, 1989, J GEN MICROBIOL, V135, P2307; Sandt CH, 2000, INFECT IMMUN, V68, P2205, DOI 10.1128/IAI.68.4.2205-2214.2000; Sato T, 2003, GENE, V309, P35, DOI 10.1016/S0378-1119(03)00487-6; Smith DL, 2007, J BACTERIOL, V189, P7223, DOI 10.1128/JB.00824-07; Smith MCM, 1998, SCIENCE, V279, P1834; SREERAMA N, 1994, BIOCHEMISTRY-US, V33, P10022, DOI 10.1021/bi00199a028; Sylvestre P, 2002, MOL MICROBIOL, V45, P169, DOI 10.1046/j.1365-2958.2000.03000.x; Tao YZ, 1997, STRUCTURE, V5, P789, DOI 10.1016/S0969-2126(97)00233-5; Thomassen E, 2003, J MOL BIOL, V331, P361, DOI 10.1016/s0022-2836(03)00755-1; Tobe T, 2006, P NATL ACAD SCI USA, V103, P14941, DOI 10.1073/pnas.0604891103; Touchon M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000344; Uniprot, 2011, NUCLEIC ACIDS RES, V39, pD214; van Raaij MJ, 2001, J MOL BIOL, V314, P1137, DOI 10.1006/jmbi.2000.5204; Weigele PR, 2003, J BACTERIOL, V185, P4022, DOI 10.1128/JB.185.14.4022-4030.2003; Wick LM, 2005, J BACTERIOL, V187, P1783, DOI 10.1128/JB.187.5.1783-1791.2005; WILLSHAW GA, 1987, J GEN MICROBIOL, V133, P1309; Wolf E, 1997, PROTEIN SCI, V6, P1179, DOI 10.1002/pro.5560060606; Xiang Y, 2011, P NATL ACAD SCI USA, V108, P4806, DOI 10.1073/pnas.1018097108; Xu Y, 2002, J BIOL CHEM, V277, P27312, DOI 10.1074/jbc.M201163200; Yamamoto T, 2006, STX2 PHAGE ENTEROHEM; Zhang Y, 2008, ENTEROBACTERIA PHAGE	88	28	29	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e37872	10.1371/journal.pone.0037872	http://dx.doi.org/10.1371/journal.pone.0037872			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701585	gold, Green Submitted, Green Published			2022-12-27	WOS:000305348400023
J	Mennigen, JA; Panserat, S; Larquier, M; Plagnes-Juan, E; Medale, F; Seiliez, I; Skiba-Cassy, S				Mennigen, Jan A.; Panserat, Stephane; Larquier, Melanie; Plagnes-Juan, Elisabeth; Medale, Francoise; Seiliez, Iban; Skiba-Cassy, Sandrine			Postprandial Regulation of Hepatic MicroRNAs Predicted to Target the Insulin Pathway in Rainbow Trout	PLOS ONE			English	Article							IN-VIVO; GENE-EXPRESSION; NUTRITIONAL REGULATION; GLUCOSE-HOMEOSTASIS; SIGNALING PATHWAYS; LIPID-METABOLISM; LIVER; AUTOPHAGY; ACTIVATION; MUSCLE	Rainbow trout are carnivorous fish and poor metabolizers of carbohydrates, which established this species as a model organism to study the comparative physiology of insulin. Following the recent characterisation of key roles of several miRNAs in the insulin action on hepatic intermediary metabolism in mammalian models, we investigated the hypothesis that hepatic miRNA expression is postprandially regulated in the rainbow trout and temporally coordinated in the context of insulin-mediated regulation of metabolic gene expression in the liver. To address this hypothesis, we used a time-course experiment in which rainbow trout were fed a commercial diet after short-term fasting. We investigated hepatic miRNA expression, activation of the insulin pathway, and insulin regulated metabolic target genes at several time points. Several miRNAs which negatively regulate hepatic insulin signaling in mammalian model organisms were transiently increased 4 h after the meal, consistent with a potential role in acute postprandial negative feed-back regulation of the insulin pathway and attenuation of gluconeogenic gene expression. We equally observed a transient increase in omy-miRNA-33 and omy-miRNA-122b 4 h after feeding, whose homologues have potent lipogenic roles in the liver of mammalian model systems. A concurrent increase in the activity of the hepatic insulin signaling pathway and the expression of lipogenic genes (srebp1c, fas, acly) was equally observed, while lipolytic gene expression (cpt1a and cpt1b) decreased significantly 4 h after the meal. This suggests lipogenic roles of omy-miRNA-33 and omy-miRNA-122b may be conserved between rainbow trout and mammals and that these miRNAs may furthermore contribute to acute postprandial regulation of de novo hepatic lipid synthesis in rainbow trout. These findings provide a framework for future research of miRNA regulation of hepatic metabolism in trout and will help to further elucidate the metabolic phenotype of rainbow trout.	[Mennigen, Jan A.; Panserat, Stephane; Larquier, Melanie; Plagnes-Juan, Elisabeth; Medale, Francoise; Seiliez, Iban; Skiba-Cassy, Sandrine] INRA, Nutr UMR1067, St Pee Sur Nivelle, Pyrenees Atlant, France	INRAE; Universite de Pau et des Pays de l'Adour	Mennigen, JA (corresponding author), INRA, Nutr UMR1067, St Pee Sur Nivelle, Pyrenees Atlant, France.	skiba@st.pee.inra.fr		Medale, Francoise/0000-0002-8083-1298; Panserat, Stephane/0000-0002-4479-9868	A Marie-Curie post-doctoral fellowship [273840]	A Marie-Curie post-doctoral fellowship	A Marie-Curie post-doctoral fellowship (project reference 273840, Seventh Framework Programme of the European Commission, http://cordis.europa.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010859; Bizuayehu TT, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-11; Caruso MA, 2011, GEN COMP ENDOCR, V173, P227, DOI 10.1016/j.ygcen.2011.06.014; Chen K, 2007, NAT REV GENET, V8, P93, DOI 10.1038/nrg1990; Chi W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023549; COWEY CB, 1977, BRIT J NUTR, V38, P463, DOI 10.1079/BJN19770111; Cowey DJ, 1993, FISH PHYSIOL BIOCHEM, V11, P421; Davalos A, 2011, P NATL ACAD SCI USA, V108, P9232, DOI 10.1073/pnas.1102281108; Drummond MJ, 2009, J NUTR, V139, P2279, DOI 10.3945/jn.109.112797; Elmen J, 2008, NUCLEIC ACIDS RES, V36, P1153, DOI 10.1093/nar/gkm1113; Enes P, 2009, FISH PHYSIOL BIOCHEM, V35, P519, DOI 10.1007/s10695-008-9259-5; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Ezaki J, 2011, AUTOPHAGY, V7, P727, DOI 10.4161/auto.7.7.15371; Fernandez-Hernando C, 2011, CURR OPIN LIPIDOL, V22, P86, DOI 10.1097/MOL.0b013e3283428d9d; Fu YS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022957; Gao CP, 2010, CANCER-AM CANCER SOC, V116, P41, DOI 10.1002/cncr.24743; Granjon A, 2009, DIABETES, V58, P2555, DOI 10.2337/db09-0165; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Her GM, 2011, BBA-MOL CELL BIOL L, V1811, P536, DOI 10.1016/j.bbalip.2011.06.011; Herrera BM, 2010, DIABETOLOGIA, V53, P1099, DOI 10.1007/s00125-010-1667-2; Hinske LCG, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-533; Iliopoulos D, 2010, J LIPID RES, V51, P1513, DOI 10.1194/jlr.M004812; Jegga AG, 2011, AUTOPHAGY, V7, P477, DOI 10.4161/auto.7.5.14811; Jordan SD, 2011, NAT CELL BIOL, V13, P434, DOI 10.1038/ncb2211; Jung CH, 2010, FEBS LETT, V584, P1287, DOI 10.1016/j.febslet.2010.01.017; Kanazawa T, 2004, J BIOL CHEM, V279, P8452, DOI 10.1074/jbc.M306337200; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Lansard M, 2010, AMINO ACIDS, V39, P801, DOI 10.1007/s00726-010-0533-3; Latasa MJ, 2000, P NATL ACAD SCI USA, V97, P10619, DOI 10.1073/pnas.180306597; Leavens KF, 2011, CRIT REV BIOCHEM MOL, V46, P200, DOI 10.3109/10409238.2011.562481; Leonardi R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011107; Li SJ, 2009, J LIPID RES, V50, P1756, DOI 10.1194/jlr.M800509-JLR200; Lian S, 2009, BIOORGAN MED CHEM, V17, P7085, DOI 10.1016/j.bmc.2009.09.004; Liu HY, 2009, J BIOL CHEM, V284, P31484, DOI 10.1074/jbc.M109.033936; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Minghetti M, 2011, BBA-MOL CELL BIOL L, V1811, P194, DOI 10.1016/j.bbalip.2010.12.008; Muoio DM, 2008, NAT REV MOL CELL BIO, V9, P193, DOI 10.1038/nrm2327; Pandey AK, 2011, MOL CELL ENDOCRINOL, V332, P125, DOI 10.1016/j.mce.2010.10.004; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Plagnes-Juan E, 2008, J EXP BIOL, V211, P2510, DOI 10.1242/jeb.018374; Polakof S, 2011, AM J PHYSIOL-REG I, V300, pR166, DOI 10.1152/ajpregu.00619.2010; Polakof S, 2010, J EXP BIOL, V213, P4151, DOI 10.1242/jeb.050807; Polakof S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020228; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Ramachandra RK, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-41; Rayner KJ, 2011, NATURE, V478, P404, DOI 10.1038/nature10486; Rayner KJ, 2010, SCIENCE, V328, P1570, DOI 10.1126/science.1189862; Ryu HS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017343; Salem M, 2008, MAR BIOTECHNOL NY, V12, P410; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Seiliez I, 2008, AM J PHYSIOL-REG I, V295, pR329, DOI 10.1152/ajpregu.00146.2008; Seiliez I, 2011, GEN COMP ENDOCR, V172, P363, DOI 10.1016/j.ygcen.2011.03.026; Seiliez I, 2011, AM J PHYSIOL-REG I, V300, pR733, DOI 10.1152/ajpregu.00579.2010; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Skiba-Cassy S, 2009, AM J PHYSIOL-REG I, V297, pR1421, DOI 10.1152/ajpregu.00312.2009; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Trajkovski M, 2011, NATURE, V474, P649, DOI 10.1038/nature10112; Tsang J, 2007, MOL CELL, V26, P753, DOI 10.1016/j.molcel.2007.05.018; Xia JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017537; Yecies JL, 2011, CELL METAB, V14, P21, DOI 10.1016/j.cmet.2011.06.002; Zhang WW, 2006, J BIOL CHEM, V281, P10105, DOI 10.1074/jbc.M600272200; Zhang YM, 2007, CHEM BIOL, V14, P291, DOI 10.1016/j.chembiol.2007.01.013; Zhao EP, 2009, MAMM GENOME, V20, P476, DOI 10.1007/s00335-009-9217-2	64	63	69	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e38604	10.1371/journal.pone.0038604	http://dx.doi.org/10.1371/journal.pone.0038604			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701681	Green Submitted, gold, Green Published			2022-12-27	WOS:000305348400080
J	Phillips, NJ; Steichen, CT; Schilling, B; Post, DMB; Niles, RK; Bair, TB; Falsetta, ML; Apicella, MA; Gibson, BW				Phillips, Nancy J.; Steichen, Christopher T.; Schilling, Birgit; Post, Deborah M. B.; Niles, Richard K.; Bair, Thomas B.; Falsetta, Megan L.; Apicella, Michael A.; Gibson, Bradford W.			Proteomic Analysis of Neisseria gonorrhoeae Biofilms Shows Shift to Anaerobic Respiration and Changes in Nutrient Transport and Outermembrane Proteins	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA BIOFILMS; ESCHERICHIA-COLI BIOFILMS; OUTER-MEMBRANE PROTEIN; CELL-CULTURE SILAC; GENE-EXPRESSION; IV PILI; QUANTITATIVE PROTEOMICS; AMINO-ACIDS; GONOCOCCAL BIOFILMS; MICROARRAY ANALYSIS	Neisseria gonorrhoeae, the causative agent of gonorrhea, can form biofilms in vitro and in vivo. In biofilms, the organism is more resistant to antibiotic treatment and can serve as a reservoir for chronic infection. We have used stable isotope labeling by amino acids in cell culture (SILAC) to compare protein expression in biofilm and planktonic organisms. Two parallel populations of N. gonorrhoeae strain 1291, which is an arginine auxotroph, were grown for 48 h in continuous- flow chambers over glass, one supplemented with C-13(6)-arginine for planktonic organisms and the other with unlabeled arginine for biofilm growth. The biofilm and planktonic cells were harvested and lysed separately, and fractionated into three sequential protein extracts. Corresponding heavy ( H) planktonic and light ( L) biofilm protein extracts were mixed and separated by 1D SDS-PAGE gels, and samples were extensively analyzed by liquid chromatography-mass spectrometry. Overall, 757 proteins were identified, and 152 unique proteins met a 1.5-fold cutoff threshold for differential expression with p-values <0.05. Comparing biofilm to planktonic organisms, this set included 73 upregulated and 54 downregulated proteins. Nearly a third of the upregulated proteins were involved in energy metabolism, with cell envelope proteins making up the next largest group. Of the downregulated proteins, the largest groups were involved in protein synthesis and energy metabolism. These proteomics results were compared with our previously reported results from transcriptional profiling of gonococcal biofilms using microarrays. Nitrite reductase and cytochrome c peroxidase, key enzymes required for anaerobic growth, were detected as highly upregulated in both the proteomic and transcriptomic datasets. These and other protein expression changes observed in the present study were consistent with a shift to anaerobic respiration in gonococcal biofilms, although changes in membrane proteins not explicitly related to this shift may have other functions.	[Phillips, Nancy J.; Gibson, Bradford W.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA; [Steichen, Christopher T.; Bair, Thomas B.; Falsetta, Megan L.; Apicella, Michael A.] Univ Iowa, Coll Med, Dept Microbiol, Iowa City, IA 52242 USA; [Schilling, Birgit; Post, Deborah M. B.; Gibson, Bradford W.] Buck Inst Res Aging, Novato, CA USA; [Niles, Richard K.] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Biol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of Iowa; Buck Institute for Research on Aging; University of California System; University of California San Francisco	Phillips, NJ (corresponding author), Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA.	bgibson@buckinstitute.org	Falsetta, Megan L./AAE-1586-2020		NIH [AI045728]; shared instrumentation grant [S10 RR024615]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024615] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045728] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); shared instrumentation grant; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the NIH grant AI045728 (M.A.A.) and by the shared instrumentation grant S10 RR024615. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barken KB, 2008, ENVIRON MICROBIOL, V10, P2331, DOI 10.1111/j.1462-2920.2008.01658.x; Beloin C, 2005, TRENDS MICROBIOL, V13, P16, DOI 10.1016/j.tim.2004.11.008; Beloin C, 2004, MOL MICROBIOL, V51, P659, DOI 10.1046/j.1365-2958.2003.03865.x; Bernardini G, 2011, PROTEOMICS, V11, P1351, DOI 10.1002/pmic.201000406; Cardinale JA, 2000, INFECT IMMUN, V68, P4368, DOI 10.1128/IAI.68.7.4368-4369.2000; Cole MJ, 2010, SEX TRANSM INFECT, V86, P427, DOI 10.1136/sti.2010.044164; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; DORWARD DW, 1989, J BACTERIOL, V171, P4196, DOI 10.1128/JB.171.8.4196-4201.1989; DORWARD DW, 1989, J BACTERIOL, V171, P2499, DOI 10.1128/jb.171.5.2499-2505.1989; Dreisbach A, 2008, PROTEOMICS, V8, P2062, DOI 10.1002/pmic.200701081; Ducey TF, 2005, J BACTERIOL, V187, P4865, DOI 10.1128/JB.187.14.4865-4874.2005; Falsetta ML, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00075; Falsetta ML, 2010, INFECT IMMUN, V78, P2320, DOI 10.1128/IAI.01312-09; Falsetta ML, 2009, INFECT IMMUN, V77, P3522, DOI 10.1128/IAI.00036-09; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Fux CA, 2005, TRENDS MICROBIOL, V13, P34, DOI 10.1016/j.tim.2004.11.010; Goodman SD, 2011, MUCOSAL IMMUNOL, V4, P625, DOI 10.1038/mi.2011.27; Graham Ciaren, 2011, Bioeng Bugs, V2, P17, DOI 10.4161/bbug.2.1.14413; Greiner LL, 2005, INFECT IMMUN, V73, P1964, DOI 10.1128/IAI.73.4.1964-1970.2005; Harshey RM, 2003, ANNU REV MICROBIOL, V57, P249, DOI 10.1146/annurev.micro.57.030502.091014; Hoiby N, 2010, INT J ANTIMICROB AG, V35, P322, DOI 10.1016/j.ijantimicag.2009.12.011; Hook Er., 1999, SEX TRANSM DIS; Hopper A, 2009, FEMS MICROBIOL LETT, V301, P232, DOI 10.1111/j.1574-6968.2009.01824.x; Johnson M, 2008, INFECT IMMUN, V76, P1756, DOI 10.1128/IAI.01635-07; Jurcisek JA, 2007, MOL MICROBIOL, V65, P1288, DOI 10.1111/j.1365-2958.2007.05864.x; Jurcisek JA, 2007, J BACTERIOL, V189, P3868, DOI 10.1128/JB.01935-06; Klausen M, 2003, MOL MICROBIOL, V48, P1511, DOI 10.1046/j.1365-2958.2003.03525.x; Lazazzera BA, 2005, CURR OPIN MICROBIOL, V8, P222, DOI 10.1016/j.mib.2005.02.015; Luke NR, 2007, INFECT IMMUN, V75, P5559, DOI 10.1128/IAI.00946-07; Mann M, 2006, NAT REV MOL CELL BIO, V7, P952, DOI 10.1038/nrm2067; MORSE SA, 1980, CAN J MICROBIOL, V26, P13, DOI 10.1139/m80-003; Mukherjee J, 2011, PROTEOMICS, V11, P339, DOI 10.1002/pmic.201000386; Nigaud Y, 2010, BBA-PROTEINS PROTEOM, V1804, P957, DOI 10.1016/j.bbapap.2010.01.008; Nudleman E, 2004, J MOL MICROB BIOTECH, V7, P52, DOI 10.1159/000077869; O'Dwyer CA, 2009, MICROBIOL-SGM, V155, P1940, DOI 10.1099/mic.0.026559-0; Ohnishi M, 2011, ANTIMICROB AGENTS CH, V55, P3538, DOI 10.1128/AAC.00325-11; Ong SE, 2003, METHODS, V29, P124, DOI 10.1016/S1046-2023(02)00303-1; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Ong SE, 2003, J PROTEOME RES, V2, P173, DOI 10.1021/pr0255708; Ong SE, 2005, NAT CHEM BIOL, V1, P252, DOI 10.1038/nchembio736; Orme R, 2006, PROTEOMICS, V6, P4269, DOI 10.1002/pmic.200600193; Pitcher RS, 2004, BBA-BIOENERGETICS, V1655, P388, DOI 10.1016/j.bbabio.2003.09.017; Resch A, 2006, PROTEOMICS, V6, P1867, DOI 10.1002/pmic.200500531; Resch A, 2005, APPL ENVIRON MICROB, V71, P2663, DOI 10.1128/AEM.71.5.2663-2676.2005; Rey S, 2005, NUCLEIC ACIDS RES, V33, pD164, DOI 10.1093/nar/gki027; Ruiz L, 2009, MICROBIOL-SGM, V155, P957, DOI 10.1099/mic.0.024273-0; Sauer K, 2002, J BACTERIOL, V184, P1140, DOI 10.1128/jb.184.4.1140-1154.2002; Sauer K, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-6-219; Schembri MA, 2003, MOL MICROBIOL, V48, P253, DOI 10.1046/j.1365-2958.2003.03432.x; Schryvers AB, 1999, MOL MICROBIOL, V32, P1117, DOI 10.1046/j.1365-2958.1999.01411.x; Seib KL, 2006, MICROBIOL MOL BIOL R, V70, P344, DOI 10.1128/MMBR.00044-05; Shilov IV, 2007, MOL CELL PROTEOMICS, V6, P1638, DOI 10.1074/mcp.T600050-MCP200; Shin JH, 2009, J MICROBIOL, V47, P728, DOI 10.1007/s12275-009-0158-y; Soufi B, 2010, J PROTEOME RES, V9, P3638, DOI 10.1021/pr100150w; Steichen CT, 2011, INFECT IMMUN, V79, P1504, DOI 10.1128/IAI.01162-10; Steichen CT, 2008, J INFECT DIS, V198, P1856, DOI 10.1086/593336; Stewart PS, 2008, NAT REV MICROBIOL, V6, P199, DOI 10.1038/nrmicro1838; Tang WH, 2008, J PROTEOME RES, V7, P3661, DOI 10.1021/pr070492f; Teal TK, 2006, APPL ENVIRON MICROB, V72, P7324, DOI 10.1128/AEM.01163-06; Unemo M, 2010, EUROPEAN COMMUNICABL, V15; van Alen T, 2010, PROTEOMICS, V10, P4512, DOI 10.1002/pmic.201000267; Vilain S, 2004, ANAL BIOCHEM, V329, P120, DOI 10.1016/j.ab.2004.02.014; Wackwitz B, 1999, MOL GEN GENET, V262, P876, DOI 10.1007/s004380051153; Wall D, 1999, MOL MICROBIOL, V32, P1, DOI 10.1046/j.1365-2958.1999.01339.x; Whiteley M, 2001, NATURE, V413, P860, DOI 10.1038/35101627; Yu NY, 2011, NUCLEIC ACIDS RES, V39, pD241, DOI 10.1093/nar/gkq1093	66	50	50	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e38303	10.1371/journal.pone.0038303	http://dx.doi.org/10.1371/journal.pone.0038303			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701624	Green Published, Green Submitted, gold			2022-12-27	WOS:000305348400048
J	Basmaci, R; Yagupsky, P; Ilharreborde, B; Guyot, K; Porat, N; Chomton, M; Thiberge, JM; Mazda, K; Bingen, E; Bonacorsi, P; Bidet, P				Basmaci, Romain; Yagupsky, Pablo; Ilharreborde, Brice; Guyot, Kathleen; Porat, Nurith; Chomton, Marilyn; Thiberge, Jean-Michel; Mazda, Keyvan; Bingen, Edouard; Bonacorsi, Stephane; Bidet, Philippe			Multilocus Sequence Typing and rtxA Toxin Gene Sequencing Analysis of Kingella kingae Isolates Demonstrates Genetic Diversity and International Clones	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; REAL-TIME PCR; OSTEOARTICULAR INFECTIONS; YOUNG-CHILDREN; SEPTIC ARTHRITIS; DIAGNOSIS; ENDOCARDITIS; PATHOGEN	Background: Kingella kingae, a normal component of the upper respiratory flora, is being increasingly recognized as an important invasive pathogen in young children. Genetic diversity of this species has not been studied. Methods: We analyzed 103 strains from different countries and clinical origins by a new multilocus sequence-typing (MLST) schema. Putative virulence gene rtxA, encoding an RTX toxin, was also sequenced, and experimental virulence of representative strains was assessed in a juvenile-rat model. Results: Thirty-six sequence-types (ST) and nine ST-complexes (STc) were detected. The main STc 6, 14 and 23 comprised 23, 17 and 20 strains respectively, and were internationally distributed. rtxA sequencing results were mostly congruent with MLST, and showed horizontal transfer events. Of interest, all members of the distantly related ST-6 (n = 22) and ST-5 (n = 4) harboured a 33 bp duplication or triplication in their rtxA sequence, suggesting that this genetic trait arose through selective advantage. The animal model revealed significant differences in virulence among strains of the species. Conclusion: MLST analysis reveals international spread of ST-complexes and will help to decipher acquisition and evolution of virulence traits and diversity of pathogenicity among K. kingae strains, for which an experimental animal model is now available.	[Basmaci, Romain; Guyot, Kathleen; Chomton, Marilyn; Bingen, Edouard; Bonacorsi, Stephane; Bidet, Philippe] Univ Paris Diderot, EA 3105, Paris, France; [Basmaci, Romain; Chomton, Marilyn; Bingen, Edouard; Bonacorsi, Stephane; Bidet, Philippe] Hop Robert Debre, AP HP, Microbiol Lab, F-75019 Paris, France; [Yagupsky, Pablo] Ben Gurion Univ Negev, Clin Microbiol Lab, Soroka Univ Med Ctr, IL-84105 Beer Sheva, Israel; [Ilharreborde, Brice; Mazda, Keyvan] Hop Robert Debre, AP HP, Serv Chirurg Orthoped, F-75019 Paris, France; [Porat, Nurith] Ben Gurion Univ Negev, Pediat Infect Dis Unit, Soroka Univ Med Ctr, IL-84105 Beer Sheva, Israel; [Thiberge, Jean-Michel] Inst Pasteur, Paris, France	UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Ben Gurion University; Soroka Medical Center; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Ben Gurion University; Soroka Medical Center; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Basmaci, R (corresponding author), Univ Paris Diderot, EA 3105, Paris, France.	stephane.bonacorsi@rdb.aphp.fr			Academie Nationale de Medecine	Academie Nationale de Medecine	This work was supported in part by the "Academie Nationale de Medecine". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Basmaci R, 2011, PEDIATR INFECT DIS J, V30, P902, DOI 10.1097/INF.0b013e31821fe0f7; Bofinger JJ, 2007, J CLIN MICROBIOL, V45, P3118, DOI 10.1128/JCM.00878-07; Ceroni D, 2010, J PEDIATR ORTHOPED, V30, P301, DOI 10.1097/BPO.0b013e3181d4732f; Cherkaoui A, 2009, Rev Med Suisse, V5, P2235; Chometon S, 2007, PEDIATR INFECT DIS J, V26, P377, DOI 10.1097/01.inf.0000259954.88139.f4; Dubnov-Raz G, 2010, PEDIATR INFECT DIS J, V29, P639, DOI 10.1097/INF.0b013e3181d57a6c; Hay F, 2002, ARCH PEDIATRIE, V9, P37, DOI 10.1016/S0929-693X(01)00692-3; Holmes AA, 2011, ANN PEDIAT CARDIOL, V4, P210, DOI 10.4103/0974-2069.84664; Ilharreborde B, 2009, J CLIN MICROBIOL, V47, P1837, DOI 10.1128/JCM.00144-09; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lehours P, 2011, J CLIN MICROBIOL, V49, P1245, DOI 10.1128/JCM.01657-10; Rosey AL, 2007, J MICROBIOL METH, V68, P88, DOI 10.1016/j.mimet.2006.06.010; Sena AC, 2010, PEDIATR INFECT DIS J, V29, P86, DOI 10.1097/INF.0b013e3181b48cc3; Stahelin J, 1998, CLIN INFECT DIS, V27, P1328, DOI 10.1093/clinids/27.5.1328; TOSHNIWAL R, 1986, DIAGN MICR INFEC DIS, V5, P81, DOI 10.1016/0732-8893(86)90095-7; Verdier I, 2005, PEDIATR INFECT DIS J, V24, P692, DOI 10.1097/01.inf.0000172153.10569.dc; YAGUPSKY P, 1992, J CLIN MICROBIOL, V30, P1278, DOI 10.1128/JCM.30.5.1278-1281.1992; Yagupsky P, 2011, PEDIATRICS, V127, P557, DOI 10.1542/peds.2010-1867; Yagupsky P, 2009, PEDIATR INFECT DIS J, V28, P707, DOI 10.1097/INF.0b013e31819f1f36; Yagupsky PQ, 2004, LANCET INFECT DIS, V4, P358, DOI 10.1016/S1473-3099(04)01046-1; Youssef D, 2010, CARDIOL YOUNG, V20, P448, DOI 10.1017/S1047951110000351	21	34	34	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38078	10.1371/journal.pone.0038078	http://dx.doi.org/10.1371/journal.pone.0038078			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693588	Green Published, Green Submitted, gold			2022-12-27	WOS:000305338500086
J	Gebauer, D; Fink, A; Kargl, R; Reishofer, G; Koschutnig, K; Purgstaller, C; Fazekas, F; Enzinger, C				Gebauer, Daniela; Fink, Andreas; Kargl, Reinhard; Reishofer, Gernot; Koschutnig, Karl; Purgstaller, Christian; Fazekas, Franz; Enzinger, Christian			Differences in Brain Function and Changes with Intervention in Children with Poor Spelling and Reading Abilities	PLOS ONE			English	Article							DEVELOPMENTAL DYSLEXIA; NEURAL MECHANISMS; ACTIVATION; FMRI; RECOLLECTION; DIFFICULTIES; METAANALYSIS; REMEDIATION; FAMILIARITY; EDUCATION	Previous fMRI studies in English-speaking samples suggested that specific interventions may alter brain function in language-relevant networks in children with reading and spelling difficulties, but this research strongly focused on reading impaired individuals. Only few studies so far investigated characteristics of brain activation associated with poor spelling ability and whether a specific spelling intervention may also be associated with distinct changes in brain activity patterns. We here investigated such effects of a morpheme-based spelling intervention on brain function in 20 children with comparatively poor spelling and reading abilities using repeated fMRI. Relative to 10 matched controls, children with comparatively poor spelling and reading abilities showed increased activation in frontal medial and right hemispheric regions and decreased activation in left occipito-temporal regions prior to the intervention, during processing of a lexical decision task. After five weeks of intervention, spelling and reading comprehension significantly improved in the training group, along with increased activation in the left temporal, parahippocampal and hippocampal regions. Conversely, the waiting group showed increases in right posterior regions. Our findings could indicate an increased left temporal activation associated with the recollection of the new learnt morpheme-based strategy related to successful training.	[Gebauer, Daniela; Fazekas, Franz; Enzinger, Christian] Med Univ Graz, Dept Neurol, Graz, Austria; [Gebauer, Daniela; Fink, Andreas; Koschutnig, Karl] Karl Franzens Univ Graz, Dept Psychol, Graz, Austria; [Kargl, Reinhard; Purgstaller, Christian] Inst Reading & Spelling, Graz, Austria; [Reishofer, Gernot; Enzinger, Christian] Med Univ Graz, Dept Radiol, Graz, Austria	Medical University of Graz; University of Graz; Medical University of Graz	Gebauer, D (corresponding author), Med Univ Graz, Dept Neurol, Graz, Austria.	andreas.fink@uni-graz.at	Reishofer, Gernot/E-9215-2011; Koschutnig, Karl/W-3106-2019	Reishofer, Gernot/0000-0002-3068-6475; Koschutnig, Karl/0000-0001-6234-0498; Pinter, Daniela/0000-0003-3138-5225; Fink, Andreas/0000-0001-7316-3140	Styrian government [A27214001062]; Jubilee Fund of the Austrian National Bank [A26E16020013]	Styrian government; Jubilee Fund of the Austrian National Bank	The research presented in this paper was supported by grants from the Styrian government (Nr. A27214001062 - http://www.verwaltung.steiermark.at) and the Jubilee Fund of the Austrian National Bank (Nr. A26E16020013 - http://www.onb.ac.at/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnbak E., 2000, SCAND J EDUC RES, V44, P229, DOI [10.1080/00313830050154485, DOI 10.1080/00313830050154485]; Augst G., 1989, SCHRIFTWORTSCHATZ UN; Aylward EH, 2003, NEUROLOGY, V61, P212, DOI 10.1212/01.WNL.0000068363.05974.64; Bhatt C., 1991, EINFUHRUNG MORPHOLOG; Binder JR, 2009, CEREB CORTEX, V19, P2767, DOI 10.1093/cercor/bhp055; Booth JR, 2004, J COGNITIVE NEUROSCI, V16, P1234, DOI 10.1162/0898929041920496; Booth JR, 2002, NEUROIMAGE, V16, P7, DOI 10.1006/nimg.2002.1081; Brown WE, 2001, NEUROLOGY, V56, P781, DOI 10.1212/WNL.56.6.781; Brunswick N, 1999, BRAIN, V122, P1901, DOI 10.1093/brain/122.10.1901; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Davis KD, 2000, J NEUROPHYSIOL, V83, P3575, DOI 10.1152/jn.2000.83.6.3575; Dehaene S, 2011, TRENDS COGN SCI, V15, P254, DOI 10.1016/j.tics.2011.04.003; Diana RA, 2007, TRENDS COGN SCI, V11, P379, DOI 10.1016/j.tics.2007.08.001; Dilling H, 2005, KLINISCH DIAGNOSTISC; Eckert MA, 2003, BRAIN, V126, P482, DOI 10.1093/brain/awg026; Eden GF, 2004, NEURON, V44, P411, DOI 10.1016/j.neuron.2004.10.019; Fornito A, 2004, CEREB CORTEX, V14, P424, DOI 10.1093/cercor/bhh004; Fulbright RK, 1999, AM J NEURORADIOL, V20, P1925; Gaab N, 2007, RESTOR NEUROL NEUROS, V25, P295; Gabrieli JDE, 2009, SCIENCE, V325, P280, DOI 10.1126/science.1171999; Gimbel SI, 2011, COGN NEUROSCI-UK, V2, P19, DOI 10.1080/17588928.2010.513770; Graves WW, 2010, NEUROIMAGE, V53, P638, DOI 10.1016/j.neuroimage.2010.06.055; Kargl R., 2011, Z HEILPADAGOG, V2, P61; Kargl R., 2010, MORPHEM UNTERSTUTZTE; Kargl R, 2008, HEILPADAGOGISCHE FOR, V31, P147; Krafnick AJ, 2011, NEUROIMAGE, V57, P733, DOI 10.1016/j.neuroimage.2010.10.062; Kronbichler M, 2007, J COGNITIVE NEUROSCI, V19, P1584, DOI 10.1162/jocn.2007.19.10.1584; Kronbichler M, 2006, NEUROPSYCHOLOGIA, V44, P1822, DOI 10.1016/j.neuropsychologia.2006.03.010; Landerl K., 2009, FALLBUCH KLINISCHEN, P193; Lenhard W., 2006, ELFE 1 6 LESEVERSTAN; LYSTER SAH, 2002, READ WRIT, V15, P261, DOI DOI 10.1023/A:1015272516220; Maisog JM, 2008, ANN NY ACAD SCI, V1145, P237, DOI 10.1196/annals.1416.024; MAY P, 2000, HAMBURGER SCHREIBPRO; Mayringer H, 2003, SALZBURGER LESE SCRE; Mayringer H., 2005, SALZBURGER LESE SCRE; Meyler A, 2008, NEUROPSYCHOLOGIA, V46, P2580, DOI 10.1016/j.neuropsychologia.2008.03.012; Moll K, 2009, SCI STUD READ, V13, P359, DOI 10.1080/10888430903162878; Nicolson RI, 1999, LANCET, V353, P1662, DOI 10.1016/S0140-6736(98)09165-X; Nicolson RI, 2001, TRENDS NEUROSCI, V24, P508, DOI 10.1016/S0166-2236(00)01896-8; Nunes T, 2003, SCI STUD READ, V7, P289, DOI 10.1207/S1532799XSSR0703_6; Poldrack RA, 2001, BRAIN, V124, P67, DOI 10.1093/brain/124.1.67; Raven JC, GUIDE STANDARD PROGR; Richards TL, 2006, J NEUROLINGUIST, V19, P56, DOI 10.1016/j.jneuroling.2005.07.003; Richards TL, 2009, J NEUROLINGUIST, V22, P327, DOI 10.1016/j.jneuroling.2008.11.002; Richlan F, 2009, HUM BRAIN MAPP, V30, P3299, DOI 10.1002/hbm.20752; Riva D, 2000, BRAIN, V123, P1051, DOI 10.1093/brain/123.5.1051; Scheerer-Neumann G, 1979, INTERVENTION BEI LES; Scott RB, 2001, DEV MED CHILD NEUROL, V43, P685, DOI 10.1017/S0012162201001232; Shaywitz BA, 2004, BIOL PSYCHIAT, V55, P926, DOI 10.1016/j.biopsych.2003.12.019; Shaywitz SE, 2008, ANNU REV PSYCHOL, V59, P451, DOI 10.1146/annurev.psych.59.103006.093633; Shaywitz SE, 2006, CURR DIR PSYCHOL SCI, V15, P278, DOI 10.1111/j.1467-8721.2006.00452.x; Simos PG, 2006, DEV NEUROPSYCHOL, V30, P591, DOI 10.1207/s15326942dn3001_4; Simos PG, 2002, NEUROLOGY, V58, P1203, DOI 10.1212/WNL.58.8.1203; Steinbrink C, 2012, BRAIN LANG, V121, P1, DOI 10.1016/j.bandl.2011.12.003; Temple E, 2003, P NATL ACAD SCI USA, V100, P2860, DOI 10.1073/pnas.0030098100; Van der Mark S, 2009, NEUROIMAGE, V47, P1940, DOI 10.1016/j.neuroimage.2009.05.021; Wager TD, 2003, NEUROIMAGE, V18, P293, DOI 10.1016/S1053-8119(02)00046-0; Weiss S, 2010, READ WRIT, V23, P645, DOI 10.1007/s11145-009-9177-7; Wimmer H, 2002, J EDUC PSYCHOL, V94, P272, DOI 10.1037//0022-0663.94.2.272	59	24	24	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38201	10.1371/journal.pone.0038201	http://dx.doi.org/10.1371/journal.pone.0038201			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TY	22693600	Green Submitted, gold, Green Published			2022-12-27	WOS:000305338500109
J	Okamoto, N; Horak, A; Keeling, PJ				Okamoto, Noriko; Horak, Ales; Keeling, Patrick J.			Description of Two Species of Early Branching Dinoflagellates, Psammosa pacifica n. g., n. sp and P. atlantica n. sp	PLOS ONE			English	Article							INTRACELLULAR PARASITE; MICROBIAL EUKARYOTES; GENETIC DIVERSITY; OXYRRHIS-MARINA; FINE-STRUCTURE; PHYLOGENETIC POSITION; EVOLUTIONARY HISTORY; PERKINSUS-MARINUS; NOV; ULTRASTRUCTURE	In alveolate evolution, dinoflagellates have developed many unique features, including the cell that has epicone and hypocone, the undulating transverse flagellum. However, it remains unclear how these features evolved. The early branching dinoflagellates so far investigated such as Hematodinium, Amoebophrya and Oxyrrhis marina differ in many ways from of core dinoflagellates, or dinokaryotes. Except those handful of well studied taxa, the vast majority of early branching dinoflagellates are known only by environmental sequences, and remain enigmatic. In this study we describe two new species of the early branching dinoflagellates, Psammosa pacifica n. g., n. sp. and P. atlantica n. sp. from marine intertidal sandy beach. Molecular phylogeny of the small subunit (SSU) ribosomal RNA and Hsp90 gene places Psammosa spp. as an early branch among the dinoflagellates. Morphologically (1) they lack the typical dinoflagellate epicone-hypocone structure, and (2) undulation in either flagella. Instead they display a mosaic c of dinokaryotes traits, i.e. (3) presence of bipartite trychocysts; Oxyrrhis marina-like traits, i.e. (4) presence of flagellar hairs, (5) presence of two-dimensional cobweb scales ornamenting both flagella (6) transversal cell division; a trait shared with some syndineansand Parvilucifera spp. i.e. (7) a nucleus with a conspicuous nucleolus and condensed chromatin distributed beneath the nuclear envelope; as well as Perkinsus marinus -like features i.e. (8) separate ventral grooves where flagella emerge and (9) lacking dinoflagellate-type undulating flagellum. Notably Psammosa retains an apical complex structure, which is shared between perkinsids, colpodellids, chromerids and apicomplexans, but is not found in dinokaryotic dinoflagellates.	[Okamoto, Noriko; Horak, Ales; Keeling, Patrick J.] Univ British Columbia, Dept Bot, Vancouver, BC, Canada; [Horak, Ales] Acad Sci Czech Republ, Inst Parasitol, Lab Mol Taxon, Ctr Biol, CR-37005 Ceske Budejovice, Czech Republic; [Horak, Ales] Univ S Bohemia, Fac Sci, Dept Evolutionary Protistol, Ceske Budejovice, Czech Republic	University of British Columbia; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice	Okamoto, N (corresponding author), Univ British Columbia, Dept Bot, Vancouver, BC, Canada.	okamoton@ubc.mail.ca	Horak, Ales/H-6723-2012; Okamoto, Noriko/J-6570-2012	Horak, Ales/0000-0002-3364-7383; Okamoto, Noriko/0000-0001-5493-8051; Keeling, Patrick/0000-0002-7644-0745	Tula Foundation; Canadian Institutes for Health Research [MOP-42517]; Canadian Institute for Advanced Research; Biology Centre of Academy of Sciences of the Czech Republic, Institute of Parasitology [Z60220518]	Tula Foundation; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Institute for Advanced Research(Canadian Institute for Advanced Research (CIFAR)); Biology Centre of Academy of Sciences of the Czech Republic, Institute of Parasitology	This work was supported by a grant from the Tula Foundation to the Centre for Microbial Diversity and Evolution, and grants from the Canadian Institutes for Health Research (MOP-42517) to PJK. PJK is supported by the Canadian Institute for Advanced Research. AH was partly supported by Biology Centre of Academy of Sciences of the Czech Republic, Institute of Parasitology (Grant Number Z60220518). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Qassab S, 2002, ACTA PROTOZOOL, V41, P91; Alexander E, 2009, ENVIRON MICROBIOL, V11, P360, DOI 10.1111/j.1462-2920.2008.01777.x; Appleton PL, 1998, PARASITOLOGY, V116, P115, DOI 10.1017/S0031182097002096; AZEVEDO C, 1989, J PARASITOL, V75, P627, DOI 10.2307/3282915; Boothroyd JC, 2008, NAT REV MICROBIOL, V6, P79, DOI 10.1038/nrmicro1800; Botte CY, 2011, J BIOL CHEM, V286, P29893, DOI 10.1074/jbc.M111.254979; Brown MV, 2009, ISME J, V3, P1374, DOI 10.1038/ismej.2009.86; Brugerolle G, 2002, EUR J PROTISTOL, V38, P113, DOI 10.1078/0932-4739-00864; Cachon J., 1987, Botanical Monographs (Oxford), V21, P571; Cavalier-Smith T, 2004, EUR J PROTISTOL, V40, P185, DOI 10.1016/j.ejop.2004.01.002; Cavalier-Smith T, 2004, P ROY SOC B-BIOL SCI, V271, P1251, DOI 10.1098/rspb.2004.2705; Clarke K.J, 1972, British phycol J, V7, P357; CLARKE KJ, 1976, BRIT PHYCOL J, V11, P345, DOI 10.1080/00071617600650391; Coats DW, 2012, J EUKARYOT MICROBIOL, V59, P1, DOI 10.1111/j.1550-7408.2011.00588.x; Cuvelier ML, 2008, ENVIRON MICROBIOL, V10, P1621, DOI 10.1111/j.1462-2920.2008.01580.x; DODGE J D, 1971, Protistologica, V7, P399; DODGE JD, 1971, BOT REV, V37, P481, DOI 10.1007/BF02868686; FOISSNER W, 1984, PROTISTOLOGICA, V20, P635; FRITZ L, 1992, J PHYCOL, V28, P312, DOI 10.1111/j.0022-3646.1992.00312.x; Garces E, 2010, HARMFUL ALGAE, V10, P64, DOI 10.1016/j.hal.2010.07.001; Gestal C, 2006, ENVIRON MICROBIOL, V8, P1105, DOI 10.1111/j.1462-2920.2006.01008.x; Gomez F, 2010, PROTIST, V161, P466, DOI 10.1016/j.protis.2009.12.005; Gomez F, 2009, SYST PARASITOL, V74, P65, DOI 10.1007/s11230-009-9199-1; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Green BR, 2004, PROTIST, V155, P23, DOI 10.1078/1434461000161; Groisillier A, 2006, AQUAT MICROB ECOL, V42, P277, DOI 10.3354/ame042277; Guillou L, 2008, ENVIRON MICROBIOL, V10, P3349, DOI 10.1111/j.1462-2920.2008.01731.x; Gunderson JH, 1999, J EUKARYOT MICROBIOL, V46, P194, DOI 10.1111/j.1550-7408.1999.tb04603.x; Hansen G, 1998, EUR J PHYCOL, V33, P281; Hansen G, 2007, PHYCOL RES, V55, P25, DOI 10.1111/j.1440-1835.2006.00442.x; Harada A, 2007, PROTIST, V158, P337, DOI 10.1016/j.protis.2007.03.005; Hoppenrath M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013220; Jackson CJ, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-41; Janouskovec J, 2010, P NATL ACAD SCI USA, V107, P10949, DOI 10.1073/pnas.1003335107; Janson S, 2000, PARASITOL RES, V86, P929, DOI 10.1007/s004360000272; Janssen PH, 2009, NATURE, V458, P831, DOI 10.1038/458831a; Kato KH, 2000, BIOL CELL, V92, P583, DOI 10.1016/S0248-4900(00)01106-0; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Katoh K, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-212; KELLER MD, 1987, J PHYCOL, V23, P633; Kim E, 2006, MOL BIOL EVOL, V23, P2455, DOI 10.1093/molbev/msl120; Kim S, 2008, J EUKARYOT MICROBIOL, V55, P1, DOI 10.1111/j.1550-7408.2007.00295.x; Lartillot N, 2009, BIOINFORMATICS, V25, P2286, DOI 10.1093/bioinformatics/btp368; LEADBEATER BS, 1971, J CELL SCI, V9, P443; Leander BS, 2008, EUR J PROTISTOL, V44, P55, DOI 10.1016/j.ejop.2007.08.004; Leander BS, 2004, J PHYCOL, V40, P341, DOI 10.1111/j.1529-8817.2004.03129.x; Leander BS, 2003, TRENDS ECOL EVOL, V18, P395, DOI 10.1016/S0169-5347(03)00152-6; Lidie KB, 2007, J EUKARYOT MICROBIOL, V54, P427, DOI 10.1111/j.1550-7408.2007.00282.x; Lin SJ, 2011, RES MICROBIOL, V162, P551, DOI 10.1016/j.resmic.2011.04.006; Lin SJ, 2002, J MOL BIOL, V320, P727, DOI 10.1016/S0022-2836(02)00468-0; Lopez-Garcia P, 2001, NATURE, V409, P603, DOI 10.1038/35054537; Lopez-Garcia P, 2007, ENVIRON MICROBIOL, V9, P546, DOI 10.1111/j.1462-2920.2006.01158.x; Lovejoy C, 2006, APPL ENVIRON MICROB, V72, P3085, DOI 10.1128/AEM.72.5.3085-3095.2006; Mangot JF, 2011, HYDROBIOLOGIA, V659, P37, DOI 10.1007/s10750-010-0268-x; Maranda L, 2001, J PHYCOL, V37, P245, DOI 10.1046/j.1529-8817.2001.037002245.x; Massana R, 2008, ENVIRON MICROBIOL, V10, P1335, DOI 10.1111/j.1462-2920.2007.01549.x; Massana R, 2008, CURR OPIN MICROBIOL, V11, P213, DOI 10.1016/j.mib.2008.04.004; Miller JJ, 2011, PROTIST; Moore RB, 2008, NATURE, V451, P959, DOI 10.1038/nature06635; MORRILL L C, 1981, Journal of Plankton Research, V3, P53, DOI 10.1093/plankt/3.1.53; Myl'nikova ZM, 2009, INLAND WATER BIOL, V2, P199, DOI 10.1134/S199508290903002X; Mylnikov AP, 2009, BIOL BULL+, V36, P582, DOI 10.1134/S1062359009060065; Noren F, 1999, EUR J PROTISTOL, V35, P233, DOI 10.1016/S0932-4739(99)80001-7; Obornik M, 2009, INT J PARASITOL, V39, P1, DOI 10.1016/j.ijpara.2008.07.010; Okamoto N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007080; Patterson DJ, 1996, EUR J PROTISTOL, V32, P423, DOI 10.1016/S0932-4739(96)80003-4; PERKINS FO, 1976, J PARASITOL, V62, P959, DOI 10.2307/3279192; Perkins FO, 1996, J SHELLFISH RES, V15, P67; PERKINS FO, 1976, MAR FISH REV, V38, P19; Pfiester L.A., 1987, Botanical Monographs (Oxford), V21, P611; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; ROBERTS KR, 1987, PROTOPLASMA, V137, P65, DOI 10.1007/BF01281178; Saldarriaga JF, 2004, EUR J PROTISTOL, V40, P85, DOI 10.1016/j.ejop.2003.11.003; Saldarriaga JF, 2003, INT J SYST EVOL MICR, V53, P355, DOI 10.1099/ijs.0.02328-0; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Shimodaira H, 2004, ANN STAT, V32, P2616, DOI 10.1214/009053604000000823; Silberman JD, 2004, J EUKARYOT MICROBIOL, V51, P246, DOI 10.1111/j.1550-7408.2004.tb00555.x; Skovgaard A, 2005, PROTIST, V156, P413, DOI 10.1016/j.protis.2005.08.002; Skovgaard A, 2008, PROTIST, V159, P401, DOI 10.1016/j.protis.2008.02.003; Skovgaard A, 2009, ENVIRON MICROBIOL, V11, P2030, DOI 10.1111/j.1462-2920.2009.01924.x; Slamovits CH, 2007, J MOL BIOL, V372, P356, DOI 10.1016/j.jmb.2007.06.085; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stern RF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013991; Stoeck T, 2003, APPL ENVIRON MICROB, V69, P5656, DOI 10.1128/AEM.69.9.5656-5663.2003; Stoeck T, 2003, APPL ENVIRON MICROB, V69, P2657, DOI 10.1128/AEM.69.5.2657-2663.2003; Stoeck T, 2007, MICROB ECOL, V53, P328, DOI 10.1007/s00248-006-9166-1; Stoeck T, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-72; Takishita K, 2010, J EUKARYOT MICROBIOL, V57, P76, DOI 10.1111/j.1550-7408.2009.00457.x; Tamura M, 2009, PHYCOL RES, V57, P304, DOI 10.1111/j.1440-1835.2009.00550.x; Taylor FJR, 2008, BIODIVERS CONSERV, V17, P407, DOI 10.1007/s10531-007-9258-3; Taylor FJR, 2004, PHYCOL RES, V52, P308, DOI 10.1111/j.1440-1835.2004.tb00341.x; TAYLOR FJR, 1980, BIOSYSTEMS, V13, P65, DOI 10.1016/0303-2647(80)90006-4; TIPPIT DH, 1977, J CELL BIOL, V73, P705, DOI 10.1083/jcb.73.3.705; Waller RF, 2009, BIOESSAYS, V31, P237, DOI 10.1002/bies.200800164; WATANABE MM, 1990, J PHYCOL, V26, P741, DOI 10.1111/j.0022-3646.1990.00741.x; Yuasa K, 2007, FISH PATHOL, V42, P59, DOI 10.3147/jsfp.42.59; Zhang H, 2007, P NATL ACAD SCI USA, V104, P4618, DOI 10.1073/pnas.0700258104; Zhang H, 2009, MOL BIOL EVOL, V26, P1757, DOI 10.1093/molbev/msp083; Zhang ZD, 1999, NATURE, V400, P155, DOI 10.1038/22099	99	29	32	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e34900	10.1371/journal.pone.0034900	http://dx.doi.org/10.1371/journal.pone.0034900			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22719825	Green Submitted, gold, Green Published			2022-12-27	WOS:000305583300002
J	Li, E; Hamm, CM; Gulati, AS; Sartor, RB; Chen, HY; Wu, X; Zhang, TY; Rohlf, FJ; Zhu, W; Gu, C; Robertson, CE; Pace, NR; Boedeker, EC; Harpaz, N; Yuan, J; Weinstock, GM; Sodergren, E; Frank, DN				Li, Ellen; Hamm, Christina M.; Gulati, Ajay S.; Sartor, R. Balfour; Chen, Hongyan; Wu, Xiao; Zhang, Tianyi; Rohlf, F. James; Zhu, Wei; Gu, Chi; Robertson, Charles E.; Pace, Norman R.; Boedeker, Edgar C.; Harpaz, Noam; Yuan, Jeffrey; Weinstock, George M.; Sodergren, Erica; Frank, Daniel N.			Inflammatory Bowel Diseases Phenotype, C. difficile and NOD2 Genotype Are Associated with Shifts in Human Ileum Associated Microbial Composition	PLOS ONE			English	Article							ILEAL CROHNS-DISEASE; CLOSTRIDIUM-DIFFICILE; COMMENSAL MICROBIOTA; DEFENSIN EXPRESSION; GENE ATG16L1; PANETH CELLS; SUSCEPTIBILITY; SMOKING; RISK; MUTATION	We tested the hypothesis that Crohn's disease (CD)-related genetic polymorphisms involved in host innate immunity are associated with shifts in human ileum-associated microbial composition in a cross-sectional analysis of human ileal samples. Sanger sequencing of the bacterial 16S ribosomal RNA (rRNA) gene and 454 sequencing of 16S rRNA gene hypervariable regions (V1-V3 and V3-V5), were conducted on macroscopically disease-unaffected ileal biopsies collected from 52 ileal CD, 58 ulcerative colitis and 60 control patients without inflammatory bowel diseases (IBD) undergoing initial surgical resection. These subjects also were genotyped for the three major NOD2 risk alleles (Leu1007fs, R708W, G908R) and the ATG16L1 risk allele (T300A). The samples were linked to clinical metadata, including body mass index, smoking status and Clostridia difficile infection. The sequences were classified into seven phyla/subphyla categories using the Naive Bayesian Classifier of the Ribosome Database Project. Centered log ratio transformation of six predominant categories was included as the dependent variable in the permutation based MANCOVA for the overall composition with stepwise variable selection. Polymerase chain reaction (PCR) assays were conducted to measure the relative frequencies of the Clostridium coccoides - Eubacterium rectales group and the Faecalibacterium prausnitzii spp. Empiric logit transformations of the relative frequencies of these two microbial groups were included in permutation-based ANCOVA. Regardless of sequencing method, IBD phenotype, Clostridia difficile and NOD2 genotype were selected as associated (FDR <= 0.05) with shifts in overall microbial composition. IBD phenotype and NOD2 genotype were also selected as associated with shifts in the relative frequency of the C. coccoides - E. rectales group. IBD phenotype, smoking and IBD medications were selected as associated with shifts in the relative frequency of F. prausnitzii spp. These results indicate that the effects of genetic and environmental factors on IBD are mediated at least in part by the enteric microbiota.	[Li, Ellen; Hamm, Christina M.; Zhang, Tianyi] SUNY Stony Brook, Dept Med, Stony Brook, NY 11794 USA; [Li, Ellen] SUNY Stony Brook, Dept Microbiol & Mol Genet, Stony Brook, NY 11794 USA; [Chen, Hongyan; Wu, Xiao; Zhang, Tianyi; Zhu, Wei] SUNY Stony Brook, Dept Appl Math & Stat, Stony Brook, NY 11794 USA; [Rohlf, F. James] SUNY Stony Brook, Dept Ecol & Evolut, Stony Brook, NY 11794 USA; [Robertson, Charles E.; Pace, Norman R.] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA; [Gulati, Ajay S.] Univ N Carolina, Dept Pediat, Chapel Hill, NC USA; [Sartor, R. Balfour] Univ N Carolina, Dept Med, Chapel Hill, NC USA; [Sartor, R. Balfour] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC USA; [Boedeker, Edgar C.] Univ New Mexico, Dept Med, Albuquerque, NM 87131 USA; [Harpaz, Noam] Mt Sinai Sch Med, Dept Pathol, New York, NY USA; [Li, Ellen; Yuan, Jeffrey] Washington Univ, Dept Med, St Louis, MO USA; [Weinstock, George M.; Sodergren, Erica] Washington Univ, Genome Inst, St Louis, MO USA; [Gu, Chi] Washington Univ, Div Biostat, St Louis, MO USA; [Frank, Daniel N.] Univ Colorado Anschutz Med Campus, Dept Med, Aurora, CO USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Colorado System; University of Colorado Boulder; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of New Mexico; Icahn School of Medicine at Mount Sinai; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of Colorado System; University of Colorado Anschutz Medical Campus	Li, E (corresponding author), SUNY Stony Brook, Dept Med, Stony Brook, NY 11794 USA.	ellen.li@stonybrook.edu; Daniel.frank@ucdenver.edu	Harpaz, Noam/L-3411-2017; Rohlf, F./AAR-6717-2021; Weinstock, George M/C-6314-2013; Gu, C. Charles/A-7934-2010	Harpaz, Noam/0000-0003-4923-2200; Rohlf, F./0000-0003-0522-3679; Weinstock, George M/0000-0002-2997-4592; ROBERTSON, CHARLES/0000-0002-4136-4121; Gu, C. Charles/0000-0002-8527-8145	National Institutes of Health (NIH) [UH2DK083994]; Crohn's and Colitis Foundation of America; Simons Foundation; Leona M. and Harry B. Helmsley charitable trust through the Sinai-Helmsley Alliance for Research Excellence Network; NIH [R21HG005964]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R21HG005964] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [UH2DK083994, P30DK052574] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation of America; Simons Foundation; Leona M. and Harry B. Helmsley charitable trust through the Sinai-Helmsley Alliance for Research Excellence Network; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported partially by National Institutes of Health (NIH) UH2DK083994, the Crohn's and Colitis Foundation of America, the Simons Foundation, and the Leona M. and Harry B. Helmsley charitable trust through the Sinai-Helmsley Alliance for Research Excellence Network and NIH R21HG005964. We acknowledge use of the Washington University Digestive Diseases Research Core Center Tissue Procurement Facility (P30 DK52574). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitchison J, 1986, STAT ANAL COMPOSITIO; Aldhous MC, 2007, AM J GASTROENTEROL, V102, P577, DOI 10.1111/j.1572-0241.2007.01064.x; Anderson CA, 2011, NAT GENET, V43, P246, DOI 10.1038/ng.764; Anderson MJ, 1999, J STAT COMPUT SIM, V62, P271, DOI 10.1080/00949659908811936; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bevins CL, 2009, GUT, V58, P882; Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; Cadwell K, 2010, CELL, V141, P1135, DOI 10.1016/j.cell.2010.05.009; Chang JY, 2008, J INFECT DIS, V197, P435, DOI 10.1086/525047; Chen HY, 2011, DIS COLON RECTUM, V54, P1020, DOI 10.1007/DCR.0b013e31821b94b3; Cohen SH, 2010, INFECT CONT HOSP EP, V31, P431, DOI 10.1086/651706; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; COLLINS MD, 1994, INT J SYST BACTERIOL, V44, P812, DOI 10.1099/00207713-44-4-812; Croswell A, 2009, INFECT IMMUN, V77, P2741, DOI 10.1128/IAI.00006-09; Cuthbert AP, 2002, GASTROENTEROLOGY, V122, P867, DOI 10.1053/gast.2002.32415; Delima SL, 2010, J CLIN MICROBIOL, V48, P2344, DOI 10.1128/JCM.01821-09; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Eckburg PB, 2007, CLIN INFECT DIS, V44, P256, DOI 10.1086/510385; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Frank DN, 2011, TRENDS MICROBIOL, V19, P427, DOI 10.1016/j.tim.2011.06.005; Frank DN, 2011, INFLAMM BOWEL DIS, V17, P179, DOI 10.1002/ibd.21339; Frank JA, 2008, APPL ENVIRON MICROB, V74, P2461, DOI 10.1128/AEM.02272-07; Geboes K, 2009, J CLIN PATHOL, V62, P201, DOI 10.1136/jcp.2008.059311; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Hamm CM, 2010, INFLAMM BOWEL DIS, V16, P1649, DOI 10.1002/ibd.21208; Hancock L, 2008, INFLAMM BOWEL DIS, V14, P1667, DOI 10.1002/ibd.20517; Hopkins MJ, 2002, J MED MICROBIOL, V51, P448, DOI 10.1099/0022-1317-51-5-448; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Issa M, 2007, CLIN GASTROENTEROL H, V5, P345, DOI 10.1016/j.cgh.2006.12.028; Lesage S, 2002, AM J HUM GENET, V70, P845, DOI 10.1086/339432; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Maeda H, 2003, FEMS IMMUNOL MED MIC, V39, P81, DOI 10.1016/S0928-8244(03)00224-4; Maeda S, 2005, SCIENCE, V307, P734, DOI 10.1126/science.1103685; Mahid SS, 2006, MAYO CLIN PROC, V81, P1462, DOI 10.4065/81.11.1462; Manly BFJ, 1997, RANDOMIZATION BOOTST; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:FMMTCD]2.0.CO;2; Nawrocki EP, 2009, BIOINFORMATICS, V25, P1335, DOI 10.1093/bioinformatics/btp157; Nelson RL, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001181.pub3; Ogura Y, 2003, GUT, V52, P1591, DOI 10.1136/gut.52.11.1591; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Peterson DA, 2008, CELL HOST MICROBE, V3, P417, DOI 10.1016/j.chom.2008.05.001; Peterson J, 2009, GENOME RES, V19, P2317, DOI 10.1101/gr.096651.109; Petnicki-Ocwieja T, 2009, P NATL ACAD SCI USA, V106, P15813, DOI 10.1073/pnas.0907722106; Petrosino JF, 2009, CLIN CHEM, V55, P856, DOI 10.1373/clinchem.2008.107565; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Prescott NJ, 2007, GASTROENTEROLOGY, V132, P1665, DOI 10.1053/j.gastro.2007.03.034; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rehman A, 2011, GUT, V60, P1354, DOI 10.1136/gut.2010.216259; Rim SH, 2009, CANCER-AM CANCER SOC, V115, P1967, DOI 10.1002/cncr.24216; Rinttila T, 2004, J APPL MICROBIOL, V97, P1166, DOI 10.1111/j.1365-2672.2004.02409.x; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Rodemann JF, 2007, CLIN GASTROENTEROL H, V5, P339, DOI 10.1016/j.cgh.2006.12.027; Salzman NH, 2007, SEMIN IMMUNOL, V19, P70, DOI 10.1016/j.smim.2007.04.002; Salzman NH, 2010, NAT IMMUNOL, V11, P76, DOI 10.1038/ni.1825; Sartor RB, 2008, GASTROENTEROLOGY, V134, P577, DOI 10.1053/j.gastro.2007.11.059; Satsangi J, 2006, GUT, V55, P749, DOI 10.1136/gut.2005.082909; Simms LA, 2008, GUT, V57, P903, DOI 10.1136/gut.2007.142588; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Sokol H, 2008, INFLAMM BOWEL DIS, V14, P858, DOI 10.1002/ibd.20392; Stange EF, 2006, GUT, V55, DOI 10.1136/gut.2005.081950a; Unkart JT, 2008, DIS COLON RECTUM, V51, P1211, DOI 10.1007/s10350-008-9348-7; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Waterman M, 2011, INFLAMM BOWEL DIS, V17, P1936, DOI 10.1002/ibd.21579; Willing B, 2009, INFLAMM BOWEL DIS, V15, P653, DOI 10.1002/ibd.20783; Willing BP, 2010, GASTROENTEROLOGY, V139, P1844, DOI 10.1053/j.gastro.2010.08.049	67	159	161	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e26284	10.1371/journal.pone.0026284	http://dx.doi.org/10.1371/journal.pone.0026284			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22719818	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341900001
J	Wylie, KM; Mihindukulasuriya, KA; Sodergren, E; Weinstock, GM; Storch, GA				Wylie, Kristine M.; Mihindukulasuriya, Kathie A.; Sodergren, Erica; Weinstock, George M.; Storch, Gregory A.			Sequence Analysis of the Human Virome in Febrile and Afebrile Children	PLOS ONE			English	Article							PNEUMOCOCCAL CONJUGATE VACCINE; METAGENOMIC DETECTION; VIRAL PATHOGENS; VIRUSES; INFANTS; FEVER; ERA	Unexplained fever (UF) is a common problem in children under 3 years old. Although virus infection is suspected to be the cause of most of these fevers, a comprehensive analysis of viruses in samples from children with fever and healthy controls is important for establishing a relationship between viruses and UF. We used unbiased, deep sequencing to analyze 176 nasopharyngeal swabs (NP) and plasma samples from children with UF and afebrile controls, generating an average of 4.6 million sequences per sample. An analysis pipeline was developed to detect viral sequences, which resulted in the identification of sequences from 25 viral genera. These genera included expected pathogens, such as adenoviruses, enteroviruses, and roseoloviruses, plus viruses with unknown pathogenicity. Viruses that were unexpected in NP and plasma samples, such as the astrovirus MLB-2, were also detected. Sequencing allowed identification of virus subtype for some viruses, including roseoloviruses. Highly sensitive PCR assays detected low levels of viruses that were not detected in approximately 5 million sequences, but greater sequencing depth improved sensitivity. On average NP and plasma samples from febrile children contained 1.5- to 5-fold more viral sequences, respectively, than samples from afebrile children. Samples from febrile children contained a broader range of viral genera and contained multiple viral genera more frequently than samples from children without fever. Differences between febrile and afebrile groups were most striking in the plasma samples, where detection of viral sequence may be associated with a disseminated infection. These data indicate that virus infection is associated with UF. Further studies are important in order to establish the range of viral pathogens associated with fever and to understand of the role of viral infection in fever. Ultimately these studies may improve the medical treatment of children with UF by helping avoid antibiotic therapy for children with viral infections.	[Wylie, Kristine M.; Mihindukulasuriya, Kathie A.; Sodergren, Erica; Weinstock, George M.] Washington Univ, Sch Med, Genome Inst, St Louis, MO 63130 USA; [Storch, Gregory A.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Wylie, KM (corresponding author), Washington Univ, Sch Med, Genome Inst, St Louis, MO 63130 USA.	kwylie@genome.wustl.edu	Weinstock, George M/C-6314-2013	Weinstock, George M/0000-0002-2997-4592; Mihindukulasuriya, Kathie/0000-0001-9372-3758	National Institute of Allergy and Infectious Diseases [1UAH2AI083266-01]; Demonstration Project of the Human Microbiome Project; National Institutes of Health (NIH)-National Center for Research Resources [UL1RR024992]; National Institutes of Health-National Human Genome Research Institute (NIH-NHGRI) [U54HG003079]; NIH-NHGRI [U54HG004968]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024992] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003079, U54HG004968] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UH2AI083266] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Demonstration Project of the Human Microbiome Project; National Institutes of Health (NIH)-National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health-National Human Genome Research Institute (NIH-NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIH-NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by grant number 1UAH2AI083266-01 from the National Institute of Allergy and Infectious Diseases, a Demonstration Project of the Human Microbiome Project to GS, grant number UL1RR024992 from the National Institutes of Health (NIH)-National Center for Research Resources to GS, grant number U54HG003079 from the National Institutes of Health-National Human Genome Research Institute (NIH-NHGRI) to The Genome Institute, and grant number U54HG004968 from the NIH-NHGRI to The Genome Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Angly FE, 2006, PLOS BIOL, V4, P2121, DOI 10.1371/journal.pbio.0040368; Baraff LJ, 2000, ANN EMERG MED, V36, P602, DOI 10.1067/mem.2000.110820; Breitbart M, 2005, BIOTECHNIQUES, V39, P729, DOI 10.2144/000112019; Briese T, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000455; Felix MA, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000586; Finkbeiner SR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000011; Finkbeiner SR, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-161; Green P, 1994, CROSS MATCH UNPUB; Holtz LR, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-159; Holtz LR, 2011, EMERG INF D IN PRESS; Hormozdi DJ, 2010, PEDIATR INFECT DIS J, V29, P329, DOI 10.1097/INF.0b013e3181c1795c; KRAUSS B S, 1991, Pediatric Emergency Care, V7, P67, DOI 10.1097/00006565-199104000-00001; Loh J, 2009, J VIROL, V83, P13019, DOI 10.1128/JVI.00638-09; McErlean P, 2007, J CLIN VIROL, V39, P67, DOI 10.1016/j.jcv.2007.03.012; Morgulis A, 2006, J COMPUT BIOL, V13, P1028, DOI 10.1089/cmb.2006.13.1028; Nakamura S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004219; Ninomiya M, 2008, J CLIN MICROBIOL, V46, P507, DOI 10.1128/JCM.01703-07; Reyes A, 2010, NATURE, V466, P334, DOI 10.1038/nature09199; Rudinsky SL, 2009, ACAD EMERG MED, V16, P585, DOI 10.1111/j.1553-2712.2009.00444.x; Sumino KC, 2010, THORAX, V65, P639, DOI 10.1136/thx.2009.132480; Vasilyev EV, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-134; Victoria JG, 2009, J VIROL, V83, P4642, DOI 10.1128/JVI.02301-08; Waddle E, 2009, ARCH DIS CHILD, V94, P144, DOI 10.1136/adc.2007.130583; Wang D, 2002, P NATL ACAD SCI USA, V99, P15687, DOI 10.1073/pnas.242579699; Wang D, 2003, PLOS BIOL, V1, P257, DOI 10.1371/journal.pbio.0000002; Watt K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012448; Wilkinson M, 2009, ACAD EMERG MED, V16, P220, DOI 10.1111/j.1553-2712.2008.00328.x; Willner D, 2011, P NATL ACAD SCI USA, V108, P4547, DOI 10.1073/pnas.1000089107; Willner D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007370	31	130	133	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e27735	10.1371/journal.pone.0027735	http://dx.doi.org/10.1371/journal.pone.0027735			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22719819	Green Published, gold			2022-12-27	WOS:000305341900002
J	Nyholm, SV; Song, PF; Dang, JN; Bunce, C; Girguis, PR				Nyholm, Spencer V.; Song, Pengfei; Dang, Jeanne; Bunce, Corey; Girguis, Peter R.			Expression and Putative Function of Innate Immunity Genes under in situ Conditions in the Symbiotic Hydrothermal Vent Tubeworm Ridgeia piscesae	PLOS ONE			English	Article							RIFTIA-PACHYPTILA JONES; CARBONIC-ANHYDRASE; METABOLITE UPTAKE; SULFIDE BINDING; RECOGNITION; WORM; HOST; TRANSCRIPTOME; LOCALIZATION; ENDOSYMBIONT	The relationships between hydrothermal vent tubeworms and sulfide-oxidizing bacteria have served as model associations for understanding chemoautotrophy and endosymbiosis. Numerous studies have focused on the physiological and biochemical adaptations that enable these symbioses to sustain some of the highest recorded carbon fixation rates ever measured. However, far fewer studies have explored the molecular mechanisms underlying the regulation of host and symbiont interactions, specifically those mediated by the innate immune system of the host. To that end, we conducted a series of studies where we maintained the tubeworm, Ridgeia piscesae, in high-pressure aquaria and examined global and quantitative changes in gene expression via high-throughput transcriptomics and quantitative real-time PCR (qPCR). We analyzed over 32,000 full-length expressed sequence tags as well as 26 Mb of transcript sequences from the trophosome (the organ that houses the endosymbiotic bacteria) and the plume (the gas exchange organ in contact with the free-living microbial community). R. piscesae maintained under conditions that promote chemoautotrophy expressed a number of putative cell signaling and innate immunity genes, including pattern recognition receptors (PRRs), often associated with recognizing microbe-associated molecular patterns (MAMPs). Eighteen genes involved with innate immunity, cell signaling, cell stress and metabolite exchange were further analyzed using qPCR. PRRs, including five peptidoglycan recognition proteins and a Toll-like receptor, were expressed significantly higher in the trophosome compared to the plume. Although PRRs are often associated with mediating host responses to infection by pathogens, the differences in expression between the plume and trophosome also implicate similar mechanisms of microbial recognition in interactions between the host and symbiont. We posit that regulation of this association involves a molecular "dialogue'' between the partners that includes interactions between the host's innate immune system and the symbiont.	[Nyholm, Spencer V.; Bunce, Corey] Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06269 USA; [Song, Pengfei; Dang, Jeanne; Girguis, Peter R.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA	University of Connecticut; Harvard University	Nyholm, SV (corresponding author), Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06269 USA.	spencer.nyholm@uconn.edu; pgirguis@oeb.harvard.edu		Girguis, Peter/0000-0002-3599-8160	National Science Foundation (NSF) [NSF OCE-0732369, NSF OCE-0426109]; University of Connecticut Research Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); University of Connecticut Research Foundation	The sequence data were obtained by the United States Department of Energy Joint Genome Institute (http://www.jgi.doe.gov) in collaboration with the user community. This material is based upon work supported by the National Science Foundation (NSF) under Grant Nos. NSF OCE-0732369 and NSF OCE-0426109 (nsf.gov) to PRG and the University of Connecticut Research Foundation (research.uconn.edu) to SVN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altincicek B, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-18; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Armstrong PB, 1999, DEV COMP IMMUNOL, V23, P375, DOI 10.1016/S0145-305X(99)00018-X; ARP AJ, 1981, SCIENCE, V213, P342, DOI 10.1126/science.213.4505.342; ARP AJ, 1983, SCIENCE, V219, P295, DOI 10.1126/science.219.4582.295; Benson A, 2009, CELL HOST MICROBE, V6, P187, DOI 10.1016/j.chom.2009.06.005; Bettencourt R, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-559; Bischoff V, 2006, PLOS PATHOG, V2, P139, DOI 10.1371/journal.ppat.0020014; Bittel P, 2007, CURR OPIN PLANT BIOL, V10, P335, DOI 10.1016/j.pbi.2007.04.021; Bosch CG, 1984, CR HEBD ACAD SCI, V9, P413; Bosch CG, 1984, CR HEBD ACAD SCI, V9, P371; Bright M, 2000, MAR BIOL, V136, P621, DOI 10.1007/s002270050722; Bright M, 2003, INVERTEBR BIOL, V122, P347; Bright M, 2010, OCEANOGR MAR BIOL, V48, P213; Carney SL, 2007, COMP BIOCHEM PHYS B, V146, P326, DOI 10.1016/j.cbpb.2006.11.002; CAVANAUGH CM, 1981, SCIENCE, V213, P340, DOI 10.1126/science.213.4505.340; Chaput C, 2007, MICROBES INFECT, V9, P637, DOI 10.1016/j.micinf.2007.01.022; CHILDRESS JJ, 1991, BIOL BULL-US, V180, P135, DOI 10.2307/1542437; CHILDRESS JJ, 1984, MAR BIOL, V83, P109, DOI 10.1007/BF00394718; Cooper EL, 2001, ADV EXP MED BIOL, V484, P169; Davidson CR, 2008, DEV COMP IMMUNOL, V32, P608, DOI 10.1016/j.dci.2007.11.004; De Cian MC, 2000, J EXP BIOL, V203, P2907; De Cian MC, 2003, J EXP BIOL, V206, P399, DOI 10.1242/jeb.00074; DEBURGH ME, 1989, MAR BIOL, V101, P97, DOI 10.1007/BF00393482; Dethlefsen L, 2007, NATURE, V449, P811, DOI 10.1038/nature06245; Dubilier N, 2008, NAT REV MICROBIOL, V6, P725, DOI 10.1038/nrmicro1992; Dunn SR, 2009, ENVIRON MICROBIOL, V11, P268, DOI 10.1111/j.1462-2920.2008.01774.x; Dziarski R, 2010, INNATE IMMUN-LONDON, V16, P168, DOI 10.1177/1753425910366059; Felbeck H, 1998, PHYSIOL ZOOL, V71, P294, DOI 10.1086/515931; FELBECK H, 1981, SCIENCE, V213, P336, DOI 10.1126/science.213.4505.336; FISHER CR, 1988, DEEP-SEA RES, V35, P1745, DOI 10.1016/0198-0149(88)90047-7; FISHER CR, 1989, BIOL BULL, V177, P372, DOI 10.2307/1541597; Fitt WK, 2000, BIOL BULL, V198, P110, DOI 10.2307/1542809; Flores JF, 2005, P NATL ACAD SCI USA, V102, P2713, DOI 10.1073/pnas.0407455102; Gagniere N, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-634; Girguis PR, 2006, J EXP BIOL, V209, P3516, DOI 10.1242/jeb.02404; Girguis PR, 2000, APPL ENVIRON MICROB, V66, P2783, DOI 10.1128/AEM.66.7.2783-2790.2000; Girguis PR, 2002, J EXP BIOL, V205, P3055; Goffredi SK, 1999, PHYSIOL BIOCHEM ZOOL, V72, P296, DOI 10.1086/316664; Goffredi SK, 1999, BIOL BULL-US, V196, P257, DOI 10.2307/1542950; Goodson MS, 2005, APPL ENVIRON MICROB, V71, P6934, DOI 10.1128/AEM.71.11.6934-6946.2005; Govenar B, 2005, MAR ECOL PROG SER, V305, P67, DOI 10.3354/meps305067; HEARD J, 1995, P NATL ACAD SCI USA, V92, P5273, DOI 10.1073/pnas.92.12.5273; Henry MS, 2008, DEEP-SEA RES PT I, V55, P679, DOI 10.1016/j.dsr.2008.02.001; HENTSCHEL U, 1993, NATURE, V366, P338, DOI 10.1038/366338a0; Hessler R, 1983, DISTRIBUTION COMMUNI, P735; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Hurtado LA, 2004, MOL ECOL, V13, P2603, DOI 10.1111/j.1365-294X.2004.02287.x; Jeanthon C, 2000, ANTON LEEUW INT J G, V77, P117, DOI 10.1023/A:1002463825025; Kochevar RE, 1996, MAR BIOL, V125, P375, DOI 10.1007/BF00346318; Koropatnick TA, 2004, SCIENCE, V306, P1186, DOI 10.1126/science.1102218; Kurata S, 2010, INT IMMUNOL, V22, P143, DOI 10.1093/intimm/dxp128; Kvennefors ECE, 2010, DEV COMP IMMUNOL, V34, P1219, DOI 10.1016/j.dci.2010.06.016; Laue BE, 1997, MOL MAR BIOL BIOTECH, V6, P180; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Macagno ER, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-407; Markert S, 2007, SCIENCE, V315, P247, DOI 10.1126/science.1132913; Marsh AG, 2001, NATURE, V411, P77, DOI 10.1038/35075063; McFall-Ngai M, 2010, SEMIN IMMUNOL, V22, P48, DOI 10.1016/j.smim.2009.11.003; Messenguy F, 2003, GENE, V316, P1, DOI 10.1016/S0378-1119(03)00747-9; Miyake K, 2006, J ENDOTOXIN RES, V12, P195, DOI 10.1179/096805106X118807; Moharikar S, 2007, J BIOSCIENCES, V32, P261, DOI 10.1007/s12038-007-0026-z; Murphy TD, 2003, J CELL SCI, V116, P2321, DOI 10.1242/jcs.00463; Nurnberger T, 2004, IMMUNOL REV, V198, P249, DOI 10.1111/j.0105-2896.2004.0119.x; Nussbaumer AD, 2006, NATURE, V441, P345, DOI 10.1038/nature04793; Nyholm SV, 2008, BIOL BULL-US, V214, P255, DOI 10.2307/25470667; Nyholm SV, 2004, NAT REV MICROBIOL, V2, P632, DOI 10.1038/nrmicro957; Pal S, 2009, ADV EXP MED BIOL, V653, P162; Peng XT, 2009, BIOMETALS, V22, P723, DOI 10.1007/s10534-009-9216-5; Pflugfelder B, 2009, CELL TISSUE RES, V337, P149, DOI 10.1007/s00441-009-0811-0; Reid R.G., 2007, BIOL EMERGENCES EVOL; Robidart JC, 2008, ENVIRON MICROBIOL, V10, P727, DOI 10.1111/j.1462-2920.2007.01496.x; Robidart JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021692; Rosenstiel P, 2009, J INNATE IMMUN, V1, P291, DOI 10.1159/000211193; Royet J, 2011, NAT REV IMMUNOL, V11, P837, DOI 10.1038/nri3089; Ruan LW, 2008, EXTREMOPHILES, V12, P735, DOI 10.1007/s00792-008-0172-8; Sanchez S, 2007, FEBS J, V274, P5311, DOI 10.1111/j.1742-4658.2007.06050.x; Shank TM, 1998, DEEP-SEA RES PT II, V45, P465, DOI 10.1016/S0967-0645(97)00089-1; Stewart Frank J., 2006, V41, P197; Troll JV, 2010, ENVIRON MICROBIOL, V12, P2190, DOI 10.1111/j.1462-2920.2009.02121.x; Troll JV, 2009, CELL MICROBIOL, V11, P1114, DOI 10.1111/j.1462-5822.2009.01315.x; Tsuchiya A, 2007, FEBS J, V274, P1818, DOI 10.1111/j.1742-4658.2007.05730.x; Wells JM, 2011, P NATL ACAD SCI USA, V108, P4607, DOI 10.1073/pnas.1000092107; Young CR, 2008, MOL ECOL, V17, P1718, DOI 10.1111/j.1365-294X.2008.03609.x	86	16	16	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2012	7	6							e38267	10.1371/journal.pone.0038267	http://dx.doi.org/10.1371/journal.pone.0038267			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TU	22701617	gold, Green Submitted, Green Published			2022-12-27	WOS:000305337600018
J	Jambo, KC; Sepako, E; Glennie, SJ; Mzinza, D; Williams, NA; Gordon, SB; Heyderman, RS				Jambo, Kondwani C.; Sepako, Enoch; Glennie, Sarah J.; Mzinza, David; Williams, Neil A.; Gordon, Stephen B.; Heyderman, Robert S.			Naturally-Acquired Influenza-Specific CD4(+) T-Cell Proliferative Responses Are Impaired in HIV-Infected African Adults	PLOS ONE			English	Article							VIRUS-INFECTION; CD154; SUSCEPTIBILITY; VACCINATION; INDUCTION; VACCINES; MEMORY	Background: Seasonal influenza has been associated with greater morbidity and mortality in AIDS patients. Highly-active antiretroviral therapy (HAART) has led to some reduction in influenza-related complications but the nature of naturally-acquired T-cell immunity to influenza virus in an African setting, and how this changes with immune reconstitution following HAART is unknown. We measured influenza-specific CD4(+) T-cell immunity in unimmunized HIV-infected Malawian adults and then investigated immune reconstitution following HAART. Methods: Peripheral blood mononuclear cells were isolated from HIV-infected and HIV-uninfected Malawian adults. CFSE proliferation and CD154 expression flow cytometry-based assays were used to measure influenza-specific CD4(+) T-cell immunity. Results: We found lower naturally-acquired proliferative influenza-specific CD4(+) T-cell responses in AIDS patients that was also present in asymptomatic HIV-infected adults with relatively high CD4 counts (>350 cells/mu l). Influenza-specific CD4(+) T-cell immune reconstitution in HIV-infected patients on HAART for 12 months was poor despite a marked reduction in viral load and an increase in CD4 count. This poor immune reconstitution was characterised by a low influenza-specific proliferative CD4(+) T-cell response and reduced proportions of CD154-expressing influenza-specific CD4(+) T-cells in peripheral blood. Conclusion: Our data suggest that asymptomatic HIV-infected adults may also be at risk of influenza-related complications and that HAART alone may not circumvent this risk in AIDS patients. This study highlights the need to identify possible interventions early in HIV infection to reduce the risk of influenza and to intensify influenza surveillance in these susceptible African populations.	[Jambo, Kondwani C.; Sepako, Enoch; Mzinza, David; Heyderman, Robert S.] Univ Malawi, Coll Med, Malawi Liverpool Wellcome Trust Clin Res Programm, Blantyre, Malawi; [Glennie, Sarah J.; Gordon, Stephen B.] Univ Liverpool, Liverpool Sch Trop Med, Resp Infect Grp, Liverpool L3 5QA, Merseyside, England; [Williams, Neil A.] Univ Bristol, Bristol, Avon, England	University of Malawi; Liverpool School of Tropical Medicine; University of Liverpool; University of Bristol	Jambo, KC (corresponding author), Univ Malawi, Coll Med, Malawi Liverpool Wellcome Trust Clin Res Programm, Blantyre, Malawi.	kjambo@liv.ac.uk		Mzinza, David/0000-0002-5999-8616; Gordon, Stephen/0000-0001-6576-1116; Jambo, Kondwani/0000-0002-3195-2210	Wellcome Trust (United Kingdom) [083603/A/07/Z, 084679/Z/08/Z]	Wellcome Trust (United Kingdom)(Wellcome Trust)	This work was supported by a grant to NAW and RSH by the Wellcome Trust 083603/A/07/Z (United Kingdom) and a core programme grant to RSH by the Wellcome Trust 084679/Z/08/Z (United Kingdom). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anonymous, 2009, Morbidity and Mortality Weekly Report, V58, P453; Belz GT, 2002, J VIROL, V76, P12388, DOI 10.1128/JVI.76.23.12388-12393.2002; Cagigi A, 2010, LANCET INFECT DIS, V10, P499, DOI 10.1016/S1473-3099(10)70117-1; Chattopadhyay PK, 2006, NAT PROTOC, V1, P1, DOI 10.1038/nprot.2006.1; Cooper CL, 2012, CURR OPIN INFECT DIS, V25, P26, DOI 10.1097/QCO.0b013e32834ef56c; Crum-Cianflone NF, 2011, VACCINE, V29, P3183, DOI 10.1016/j.vaccine.2011.02.040; Crum-Cianflone NF, 2011, CLIN INFECT DIS, V52, P138, DOI 10.1093/cid/ciq019; Nuorti J. Pekka, 2010, Morbidity and Mortality Weekly Report, V59, P1; Florence E, 2003, HIV Med, V4, P255, DOI 10.1046/j.1468-1293.2003.00156.x; Geldmacher C, 2010, J EXP MED, V207, P2869, DOI 10.1084/jem.20100090; Glennie SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025610; Guthrie T, 2004, J INFECT DIS, V190, P1927, DOI 10.1086/425517; Jambo KC, 2011, THORAX; Lee N, 2011, J INFECT DIS, V203, P1739, DOI 10.1093/infdis/jir187; Mayer KH, 2011, CLIN INFECT DIS, V52, pS205, DOI 10.1093/cid/ciq043; McNamee LA, 2006, INFECT IMMUN, V74, P6707, DOI 10.1128/IAI.00789-06; Montufar-Solis D, 2007, IMMUNOL REV, V215, P189, DOI 10.1111/j.1600-065X.2006.00471.x; Mozdzanowska K, 2005, J VIROL, V79, P5943, DOI 10.1128/JVI.79.10.5943-5951.2005; Ormsby CE, 2011, AIDS, V25, P435, DOI 10.1097/QAD.0b013e3283434844; Richards KA, 2010, J IMMUNOL, V185, P4998, DOI 10.4049/jimmunol.1001395; Roti M, 2008, J IMMUNOL, V180, P1758, DOI 10.4049/jimmunol.180.3.1758; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Schoub Barry D, 2010, Expert Rev Respir Med, V4, P167, DOI 10.1586/ers.10.10; Stumptner-Cuvelette P, 2001, P NATL ACAD SCI USA, V98, P12144, DOI 10.1073/pnas.221256498; Subauste CS, 2007, J IMMUNOL, V178, P1645, DOI 10.4049/jimmunol.178.3.1645; Subauste CS, 2004, J INFECT DIS, V189, P61, DOI 10.1086/380510; UNAIDS, 2009, AIDS EP UPD NOV 2009; Wilkinson TM, 2012, NAT MED, V18, P274, DOI 10.1038/nm.2612; World Health Organization, 2008, GLOB BURD DIS 2004 U	29	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2012	7	6							e38628	10.1371/journal.pone.0038628	http://dx.doi.org/10.1371/journal.pone.0038628			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TQ	22715399	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000305336800041
J	Smyth, D; Leung, G; Fernando, M; McKay, DM				Smyth, David; Leung, Gabriella; Fernando, Maria; McKay, Derek M.			Reduced Surface Expression of Epithelial E-Cadherin Evoked by Interferon-Gamma Is Fyn Kinase-Dependent	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; BARRIER FUNCTION; ESCHERICHIA-COLI; PROINFLAMMATORY CYTOKINES; ADHERENS JUNCTIONS; INDUCED INCREASES; P120 CATENIN; SRC; PHOSPHORYLATION; BINDING	Interferon gamma (IFN gamma) is an important regulatory cytokine that can exert a pro-inflammatory effect in the gut, where it has been shown to increase epithelial permeability via disruption of the tight junctions. Here we investigated the potential for IFN gamma to regulate the adherens junction protein E-cadherin, an important mediator of normal epithelial tissue function, using the model T84 human colonic epithelial cell line. IFN gamma (10 ng/ml) stimulated increased internalization of E-cadherin as assessed by immunofluorescence microscopy; internalization was reversed when cells were treated with PP1 (125 nM), a Src kinase-selective inhibitor. Immunoprecipitation studies demonstrated loss of E-cadherin from membrane fractions following IFN gamma treatment and a corresponding increase in cytosolic E-cadherin and its binding partners, p120-catenin and beta-catenin: effects that were Src-kinase dependent. E-cadherin and p120-catenin phosphorylation was increased by IFN gamma treatment and siRNA studies showed this was dependent upon the Src-kinase isoform Fyn. E-cadherin ubiquitinylation and subsequent proteasomal degradation stimulated by IFN gamma was found to be dependent upon Fyn and the E-cadherin-selective ubiquitin ligase, Hakai. Use of Fyn and Hakai siRNA inhibited the internalization of E-cadherin as shown by immunoblotting and confocal fluorescence microscopy. Finally, IFN gamma treatment resulted in a more fragile T84 cell monolayer with increased cell detachment in response to physical stress, which was prevented by PP1 and siRNA targeting Fyn or Hakai. Collectively, these results demonstrate a Fyn kinase-dependent mechanism through which IFN gamma regulates E-cadherin stability and suggest a novel mechanism of disruption of epithelial cell contact, which could contribute to perturbed epithelial barrier function.	[Smyth, David] Univ Calgary, Gastrointestinal Res Grp, Dept Physiol & Pharmacol, Calgary, AB, Canada; Univ Calgary, Calvin Phoebe & Joan Snyder Inst Chron Dis, Calgary, AB, Canada	University of Calgary; University of Calgary	Smyth, D (corresponding author), Univ Calgary, Gastrointestinal Res Grp, Dept Physiol & Pharmacol, Calgary, AB, Canada.	dmckay@ucalgary.ca	McKay, Derek/HCH-3240-2022	Leung, Gabriella/0000-0002-8754-1621	CIHR/Crohn's and Colitis Foundation of Canada (CCFC)/Canadian Association of Gastroenterology (CAG); Alberta Innovates-Health Solutions (AI-HS); AI-HS Graduate Studentships; CIHR M.Sc. Studentship; Canada Research Chair (Tier 1)	CIHR/Crohn's and Colitis Foundation of Canada (CCFC)/Canadian Association of Gastroenterology (CAG)(Canadian Institutes of Health Research (CIHR)); Alberta Innovates-Health Solutions (AI-HS); AI-HS Graduate Studentships; CIHR M.Sc. Studentship(Canadian Institutes of Health Research (CIHR)); Canada Research Chair (Tier 1)(Canada Research Chairs)	D. Smyth was awarded post-doctoral research fellowships from CIHR/Crohn's and Colitis Foundation of Canada (CCFC)/Canadian Association of Gastroenterology (CAG) and the Alberta Innovates-Health Solutions (AI-HS). G. Leung and M. Fernando are recipients of AI-HS Graduate Studentships and a CIHR M.Sc. Studentship (M. Fernando). D. McKay is an AI-HS Scientist and recipient of a Canada Research Chair (Tier 1) in Intestinal Immunophysiology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilleos A, 2010, DEVELOPMENT, V137, P1833, DOI 10.1242/dev.047647; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Avizienyte E, 2005, CELLS TISSUES ORGANS, V179, P73, DOI 10.1159/000084511; Avizienyte E, 2005, CURR OPIN CELL BIOL, V17, P542, DOI 10.1016/j.ceb.2005.08.007; Beaurepaire C, 2009, J INTERF CYTOK RES, V29, P133, DOI 10.1089/jir.2008.0057; Benati D, 2008, CURR MED CHEM, V15, P1154, DOI 10.2174/092986708784310404; Boivin MA, 2009, J INTERF CYTOK RES, V29, P45, DOI 10.1089/jir.2008.0128; Bonazzi M, 2008, CELL MICROBIOL, V10, P2208, DOI 10.1111/j.1462-5822.2008.01200.x; Bruewer M, 2003, J IMMUNOL, V171, P6164, DOI 10.4049/jimmunol.171.11.6164; Castano J, 2007, MOL CELL BIOL, V27, P1745, DOI 10.1128/MCB.01974-06; Chen Y, 2009, J CELL BIOCHEM, V108, P851, DOI 10.1002/jcb.22313; Clark E, 2005, GASTROENTEROLOGY, V128, P1258, DOI 10.1053/j.gastro.2005.01.046; Daniel JM, 1997, BIOESSAYS, V19, P883, DOI 10.1002/bies.950191008; Dorman SE, 2000, CYTOKINE GROWTH F R, V11, P321, DOI 10.1016/S1359-6101(00)00010-1; Feng W, 2008, J BIOL CHEM, V283, P23440, DOI 10.1074/jbc.M802482200; Ferber EC, 2008, J BIOL CHEM, V283, P12691, DOI 10.1074/jbc.M708887200; Figueroa A, 2009, CELL CYCLE, V8, P3648, DOI 10.4161/cc.8.22.9909; Fujita Y, 2002, NAT CELL BIOL, V4, P222, DOI 10.1038/ncb758; Fukumoto Y, 2008, EXP CELL RES, V314, P52, DOI 10.1016/j.yexcr.2007.07.024; Harris TJC, 2010, NAT REV MOL CELL BIO, V11, P502, DOI 10.1038/nrm2927; Ishiyama N, 2010, CELL, V141, P117, DOI 10.1016/j.cell.2010.01.017; Ito R, 2006, CLIN EXP IMMUNOL, V146, P330, DOI 10.1111/j.1365-2249.2006.03214.x; Janda E, 2006, ONCOGENE, V25, P7117, DOI 10.1038/sj.onc.1209701; Kaser A, 2011, GASTROENTEROLOGY, V140, P1738, DOI 10.1053/j.gastro.2011.02.048; Kim AN, 2011, BIOCHEM BIOPH RES CO, V407, P181, DOI 10.1016/j.bbrc.2011.02.134; Kotelevets L, 2004, FASEB J, V18, P115, DOI 10.1096/fj.04-1942fje; Lewis K, 2008, AM J PHYSIOL-GASTR L, V294, pG669, DOI 10.1152/ajpgi.00382.2007; Lugli A, 2007, HISTOPATHOLOGY, V50, P453, DOI 10.1111/j.1365-2559.2007.02620.x; Lukas M, 2010, DIGEST DIS, V28, P619, DOI 10.1159/000320276; MADARA JL, 1989, J CLIN INVEST, V83, P724, DOI 10.1172/JCI113938; Marchiando AM, 2010, ANNU REV PATHOL-MECH, V5, P119, DOI 10.1146/annurev.pathol.4.110807.092135; Mariner DJ, 2001, J BIOL CHEM, V276, P28006, DOI 10.1074/jbc.M102443200; Mashukova A, 2011, MOL CELL BIOL, V31, P756, DOI 10.1128/MCB.00811-10; Matter K, 2003, NAT REV MOL CELL BIO, V4, P225, DOI 10.1038/nrm1055; McKay DM, 2007, J PHARMACOL EXP THER, V320, P1013, DOI 10.1124/jpet.106.113639; Medema JP, 2011, NATURE, V474, P318, DOI 10.1038/nature10212; Muise AM, 2009, GUT, V58, P1121, DOI 10.1136/gut.2008.175117; Ngan CY, 2007, J SURG ONCOL, V95, P652, DOI 10.1002/jso.20638; Pizarro-Cerda J, 2006, J PATHOL, V208, P215, DOI 10.1002/path.1888; Pories SE, 1998, GASTROENTEROLOGY, V114, P1287, DOI 10.1016/S0016-5085(98)70435-4; Posadas EM, 2009, BJU INT, V103, P171, DOI 10.1111/j.1464-410X.2008.08009.x; Rovedatti L, 2009, GUT, V58, P1629, DOI 10.1136/gut.2009.182170; Saito YD, 2010, CANCER-AM CANCER SOC, V116, P1629, DOI 10.1002/cncr.24879; Smyth D, 2011, LAB INVEST, V91, P764, DOI 10.1038/labinvest.2010.208; Strauman MC, 2010, INFECT IMMUN, V78, P4958, DOI 10.1128/IAI.00580-10; Strober W, 2011, GASTROENTEROLOGY, V140, P1756, DOI 10.1053/j.gastro.2011.02.016; Tunggal JA, 2005, EMBO J, V24, P1146, DOI 10.1038/sj.emboj.7600605; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Yu D, 2010, P NATL ACAD SCI USA, V107, P8237, DOI 10.1073/pnas.0908869107	49	29	29	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2012	7	6							e38441	10.1371/journal.pone.0038441	http://dx.doi.org/10.1371/journal.pone.0038441			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TQ	22715382	Green Submitted, Green Published, gold			2022-12-27	WOS:000305336800024
J	Ayres, KL; Booth, RK; Hempelmann, JA; Koski, KL; Emmons, CK; Baird, RW; Balcomb-Bartok, K; Hanson, MB; Ford, MJ; Wasser, SK				Ayres, Katherine L.; Booth, Rebecca K.; Hempelmann, Jennifer A.; Koski, Kari L.; Emmons, Candice K.; Baird, Robin W.; Balcomb-Bartok, Kelley; Hanson, M. Bradley; Ford, Michael J.; Wasser, Samuel K.			Distinguishing the Impacts of Inadequate Prey and Vessel Traffic on an Endangered Killer Whale (Orcinus orca) Population	PLOS ONE			English	Article							BRITISH-COLUMBIA; THYROID-HORMONE; CHINOOK SALMON; GROWTH-HORMONE; DETECTION DOGS; DIVERSE ARRAY; PACIFIC; STRESS; SEX; MANAGEMENT	Managing endangered species often involves evaluating the relative impacts of multiple anthropogenic and ecological pressures. This challenge is particularly formidable for cetaceans, which spend the majority of their time underwater. Noninvasive physiological approaches can be especially informative in this regard. We used a combination of fecal thyroid (T3) and glucocorticoid (GC) hormone measures to assess two threats influencing the endangered southern resident killer whales (SRKW; Orcinus orca) that frequent the inland waters of British Columbia, Canada and Washington, U. S. A. Glucocorticoids increase in response to nutritional and psychological stress, whereas thyroid hormone declines in response to nutritional stress but is unaffected by psychological stress. The inadequate prey hypothesis argues that the killer whales have become prey limited due to reductions of their dominant prey, Chinook salmon (Oncorhynchus tshawytscha). The vessel impact hypothesis argues that high numbers of vessels in close proximity to the whales cause disturbance via psychological stress and/or impaired foraging ability. The GC and T3 measures supported the inadequate prey hypothesis. In particular, GC concentrations were negatively correlated with short-term changes in prey availability. Whereas, T3 concentrations varied by date and year in a manner that corresponded with more long-term prey availability. Physiological correlations with prey overshadowed any impacts of vessels since GCs were lowest during the peak in vessel abundance, which also coincided with the peak in salmon availability. Our results suggest that identification and recovery of strategic salmon populations in the SRKW diet are important to effectively promote SRKW recovery.	[Ayres, Katherine L.; Booth, Rebecca K.; Wasser, Samuel K.] Univ Washington, Ctr Conservat Biol, Despartment Biol, Seattle, WA 98195 USA; [Hempelmann, Jennifer A.; Emmons, Candice K.; Hanson, M. Bradley; Ford, Michael J.] NOAA, Natl Marine Fisheries Serv, NW Fisheries Sci Ctr, Seattle, WA 98112 USA; [Koski, Kari L.] Whale Museum, Soundwatch Boater Educ Program, Friday Harbor, WA USA; [Baird, Robin W.] Cascadia Res Collect, Olympia, WA USA	University of Washington; University of Washington Seattle; National Oceanic Atmospheric Admin (NOAA) - USA	Ayres, KL (corresponding author), HT Harvey & Associates, Fresno, CA USA.	kayres@harveyecology.com	Wasser, Samuel K/I-5542-2015; Baird, Robin/Y-8230-2019	Baird, Robin/0000-0002-9419-6336	National Oceanic and Atmospheric Administration-Northwest Fisheries Science Center; Joint Institute for the Study of the Atmosphere and Ocean, Washington Sea Grant [NA10OAR417005]; Canadian Consulate General, Northwest Science Association; University of Washington Department of Biology; Center for Conservation Biology; Northwest Fisheries Science Center; NOAA	National Oceanic and Atmospheric Administration-Northwest Fisheries Science Center; Joint Institute for the Study of the Atmosphere and Ocean, Washington Sea Grant; Canadian Consulate General, Northwest Science Association; University of Washington Department of Biology(University of Washington); Center for Conservation Biology; Northwest Fisheries Science Center; NOAA(National Oceanic Atmospheric Admin (NOAA) - USA)	This work has been funded by the National Oceanic and Atmospheric Administration-Northwest Fisheries Science Center, the Joint Institute for the Study of the Atmosphere and Ocean, Washington Sea Grant No. NA10OAR417005, the Canadian Consulate General, Northwest Science Association, University of Washington Department of Biology, Lynn Riddiford and Jim Truman, Elizabeth Welch and the Center for Conservation Biology. M.J. Ford, M. B. Hanson, J. Hempelmann, and C. Emmons are employees of Northwest Fisheries Science Center. All authors were involved in the preparation of the manuscript. M. B. Hanson, J. Hempelmann, and C. Emmons were involved in data collection and analysis. K. L. Ayres, R. K. Booth are employees with the Center for Conservation Biology, a nonprofit directed by S. K. Wasser. K. L. Ayres and S. K. Wasser designed the study, applied for funding, collected data and did most of the analysis, decision to publish and preparation of the manuscript. R. K. Booth was involved in study design/methods and data analysis. The other funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Authors Michael J. Ford and M. Bradley Hanson were partially responsible for funding decisions from Northwest Fisheries Science Center. Washington SeaGrant is also administered by NOAA, however the NOAA employees that are authors on this paper were not directly involved with SeaGrant funding decisions. Funding from this agency was a major part of funding this research. Authors Katherine Ayres, Rebecca Booth and Samuel Wasser work for the Center for Conservation Biology, which also partially funded this work. Author Kari Koski is an employee for the Soundwatch Boater Education program that provided the vessel traffic data for this research. Soundwatch is a boater education program that often consults on vessel regulations decisions based on their monitoring research. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Aguilar A., 1999, Journal of Cetacean Research and Management Special Issue, V1, P83; Baird RW, 2001, CAN FIELD NAT, V115, P676; Baird RW, 2000, CETACEAN SOCIETIES, P127; Balcomb III KC, 1980, MM1300731 US MAR MAM; Barrett-Lennard LG, 2001, 2001065 CAN SCI ADV; Bigg M., 1982, REP INT WHALING COMM, V32, P655; Bigg M.A., 1990, Reports of the International Whaling Commission Special Issue, P383; BIGG MA, 1975, J FISH RES BOARD CAN, V32, P1213, DOI 10.1139/f75-140; Brett J.R., 1995, P3; Diamandis E.P., 1996, IMMUNOASSAY; Douyon L, 2002, ENDOCRIN METAB CLIN, V31, P173, DOI 10.1016/S0889-8529(01)00023-8; EALES JG, 1988, AM ZOOL, V28, P351; Ellifrit D, 2006, OFFICIAL ORCA SURVEY; Ellifrit D, 2008, OFFICIAL ORCA SURVEY; Felleman F.L., 1991, P113; *FISH OC CAN, 2008, REC STRAT NO SO RES; Flier JS, 2000, J CLIN INVEST, V105, P859, DOI 10.1172/JCI9725; Ford J. K. B., 2000, KILLER WHALES NATURA; Ford J.K.B., 2002, ENCY MARINE MAMMALS, P669; Ford J.K.B., 1999, TRANSIENTS MAMMAL HU; Ford JKB, 1998, CAN J ZOOL, V76, P1456, DOI 10.1139/cjz-76-8-1456; Ford JKB, 2006, MAR ECOL PROG SER, V316, P185, DOI 10.3354/meps316185; Ford JKB, 2010, BIOL LETTERS, V6, P139, DOI 10.1098/rsbl.2009.0468; Ford MJ, 2011, J HERED, V102, P537, DOI 10.1093/jhered/esr067; Foster EA, 2012, ANIM BEHAV, V83, P731, DOI 10.1016/j.anbehav.2011.12.021; Geris KL, 1999, DOMEST ANIM ENDOCRIN, V16, P231, DOI 10.1016/S0739-7240(99)00016-8; Gustafson RG, 2007, CONSERV BIOL, V21, P1009, DOI 10.1111/j.1523-1739.2007.00693.x; Hanson M. Bradley, 2010, Endangered Species Research, V11, P69, DOI 10.3354/esr00263; Hayward LS, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00199.1; Hayward LS, 2010, GEN COMP ENDOCR, V169, P117, DOI 10.1016/j.ygcen.2010.08.004; Heimlich-Boran J.R., 1986, Zoo Biology Monographs, V1, P113; Hoelzel AR, 1998, J HERED, V89, P121, DOI 10.1093/jhered/89.2.121; Holt MM, 2009, J ACOUST SOC AM, V125, pEL27, DOI 10.1121/1.3040028; HURVICH CM, 1989, BIOMETRIKA, V76, P297, DOI 10.2307/2336663; JEFFERSON TA, 1991, MAMMAL REV, V21, P151, DOI 10.1111/j.1365-2907.1991.tb00291.x; Kitaysky AS, 2005, HORM BEHAV, V47, P606, DOI 10.1016/j.yhbeh.2005.01.005; Koski K, 2010, SOUNDWATCH PROGRAM A; Krahn MM, 2007, MAR POLLUT BULL, V54, P1903, DOI 10.1016/j.marpolbul.2007.08.015; Krahn MM, 2009, MAR POLLUT BULL, V58, P1522, DOI 10.1016/j.marpolbul.2009.05.014; Levine S, 1972, Ciba Found Symp, V8, P281; Mesa MG, 2006, RIVER RES APPL, V22, P1085, DOI 10.1002/rra.955; Millspaugh JJ, 2004, GEN COMP ENDOCR, V138, P189, DOI 10.1016/j.ygcen.2004.07.002; Myers JM, 1998, NMESNWFSC35 NOAA; National Marine Fisheries Service, 2008, REC PLAN SO RES KILL; Nelson RJ., 2005, INTRO BEHAV ENDOCRIN; Noren D. P., 2009, Endangered Species Research, V8, P179, DOI 10.3354/esr00205; O'Shea Thomas J., 1999, P485; Olesiuk P.F., 1990, Reports of the International Whaling Commission Special Issue, P209; Ortiz RM, 2010, MAR MAMMAL SCI, V26, P409, DOI 10.1111/j.1748-7692.2009.00309.x; Pacific Fishery Management Council, 2011, REV 2010 OC SALM FIS; Parken CK, 2008, N AM J FISH MANAGE, V28, P328, DOI 10.1577/M06-110.1; Parsons KM, 2009, ANIM BEHAV, V77, P963, DOI 10.1016/j.anbehav.2009.01.018; Pilot M, 2010, J EVOLUTION BIOL, V23, P20, DOI 10.1111/j.1420-9101.2009.01887.x; Quinn TP, 1999, CAN J ZOOL, V1169, P1161; Rolland Rosalind M., 2006, Journal of Cetacean Research and Management, V8, P121; Romero LM, 2004, TRENDS ECOL EVOL, V19, P249, DOI 10.1016/j.tree.2004.03.008; Rosel PE, 2003, CONSERV GENET, V4, P647, DOI 10.1023/A:1025666212967; Ross PS, 2006, CAN J FISH AQUAT SCI, V63, P224, DOI 10.1139/F05-244; Ross PS, 2000, MAR POLLUT BULL, V40, P504, DOI 10.1016/S0025-326X(99)00233-7; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Schew WA, 1996, GEN COMP ENDOCR, V101, P304, DOI 10.1006/gcen.1996.0033; StAubin DJ, 1996, MAR MAMMAL SCI, V12, P1, DOI 10.1111/j.1748-7692.1996.tb00301.x; Taylor M., 2004, SC56E32 INT WHAL COM; Walpita CN, 2007, GEN COMP ENDOCR, V150, P18, DOI 10.1016/j.ygcen.2006.07.002; Ward EJ, 2009, J APPL ECOL, V46, P632, DOI 10.1111/j.1365-2664.2009.01647.x; Wasser SK, 2011, FRONT ECOL ENVIRON, V9, P546, DOI 10.1890/100071; Wasser SK, 2010, GEN COMP ENDOCR, V168, P1, DOI 10.1016/j.ygcen.2010.04.004; WASSER SK, 1994, J REPROD FERTIL, V101, P213; Wasser SK, 2004, CAN J ZOOL, V82, P475, DOI 10.1139/Z04-020; Wasser SK, 2000, GEN COMP ENDOCR, V120, P260, DOI 10.1006/gcen.2000.7557; WASSER SK, 1993, J REPROD FERTIL, V97, P569, DOI 10.1530/jrf.0.0970569; WEISS JM, 1968, J COMP PHYSIOL PSYCH, V65, P251, DOI 10.1037/h0025562; Weitkamp LA, 2010, T AM FISH SOC, V139, P147, DOI 10.1577/T08-225.1; Wikelski M, 2006, TRENDS ECOL EVOL, V21, P38, DOI 10.1016/j.tree.2005.10.018; WILES GJ, 2004, WASHINGTON STATE STA; Williams R, 2007, J ZOOL, V272, P390, DOI 10.1111/j.1469-7998.2006.00280.x; Williams R, 2006, BIOL CONSERV, V133, P301, DOI 10.1016/j.biocon.2006.06.010; Williams R, 2009, MAR MAMMAL SCI, V25, P327, DOI 10.1111/j.1748-7692.2008.00255.x; Williams Rob, 2009, Endangered Species Research, V6, P199, DOI 10.3354/esr00150; Zamon Jeannette E., 2007, Northwestern Naturalist, V88, P193, DOI 10.1898/1051-1733(2007)88[193:WOOSRK]2.0.CO;2	80	98	100	2	178	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e36842	10.1371/journal.pone.0036842	http://dx.doi.org/10.1371/journal.pone.0036842			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701560	Green Published, Green Submitted, gold			2022-12-27	WOS:000305348400007
J	Staropoli, JF; Haliw, L; Biswas, S; Garrett, L; Holter, SM; Becker, L; Skosyrski, S; Da Silva-Buttkus, P; Calzada-Wack, J; Neff, F; Rathkolb, B; Rozman, J; Schrewe, A; Adler, T; Puk, O; Sun, MX; Favor, J; Racz, I; Bekeredjian, R; Busch, DH; Graw, J; Klingenspor, M; Klopstock, T; Wolf, E; Wurst, W; Zimmer, A; Lopez, E; Harati, H; Hill, E; Krause, DS; Guide, J; Dragileva, E; Gale, E; Wheeler, VC; Boustany, RM; Brown, DE; Breton, S; Ruether, K; Gailus-Durner, V; Fuchs, H; de Angelis, MH; Cotman, SL				Staropoli, John F.; Haliw, Larissa; Biswas, Sunita; Garrett, Lillian; Hoelter, Sabine M.; Becker, Lore; Skosyrski, Sergej; Da Silva-Buttkus, Patricia; Calzada-Wack, Julia; Neff, Frauke; Rathkolb, Birgit; Rozman, Jan; Schrewe, Anja; Adler, Thure; Puk, Oliver; Sun, Minxuan; Favor, Jack; Racz, Ildiko; Bekeredjian, Raffi; Busch, Dirk H.; Graw, Jochen; Klingenspor, Martin; Klopstock, Thomas; Wolf, Eckhard; Wurst, Wolfgang; Zimmer, Andreas; Lopez, Edith; Harati, Hayat; Hill, Eric; Krause, Daniela S.; Guide, Jolene; Dragileva, Ella; Gale, Evan; Wheeler, Vanessa C.; Boustany, Rose-Mary; Brown, Diane E.; Breton, Sylvie; Ruether, Klaus; Gailus-Durner, Valerie; Fuchs, Helmut; de Angelis, Martin Hrabe; Cotman, Susan L.			Large-Scale Phenotyping of an Accurate Genetic Mouse Model of JNCL Identifies Novel Early Pathology Outside the Central Nervous System	PLOS ONE			English	Article							NEURONAL CEROID-LIPOFUSCINOSIS; ATRIAL-NATRIURETIC-PEPTIDE; BATTEN-DISEASE GENE; KNOCK-IN MICE; INDEPENDENT MECHANISMS; BETA-HEXOSAMINIDASE; V-ATPASE; JUVENILE; PROTEIN; MITOCHONDRIAL	Cln3(Delta ex7/8) mice harbor the most common genetic defect causing juvenile neuronal ceroid lipofuscinosis (JNCL), an autosomal recessive disease involving seizures, visual, motor and cognitive decline, and premature death. Here, to more thoroughly investigate the manifestations of the common JNCL mutation, we performed a broad phenotyping study of Cln3(Delta ex7/8) mice. Homozygous Cln3(Delta ex7/8) mice, congenic on a C57BL/6N background, displayed subtle deficits in sensory and motor tasks at 10-14 weeks of age. Homozygous Cln3(Delta ex7/8) mice also displayed electroretinographic changes reflecting cone function deficits past 5 months of age and a progressive decline of retinal post- receptoral function. Metabolic analysis revealed increases in rectal body temperature and minimum oxygen consumption in 12- 13 week old homozygous Cln3(Delta ex7/8) mice, which were also seen to a lesser extent in heterozygous Cln3(Delta ex7/8) mice. Heart weight was slightly increased at 20 weeks of age, but no significant differences were observed in cardiac function in young adults. In a comprehensive blood analysis at 15-16 weeks of age, serum ferritin concentrations, mean corpuscular volume of red blood cells (MCV), and reticulocyte counts were reproducibly increased in homozygous Cln3(Delta ex7/8) mice, and male homozygotes had a relative T- cell deficiency, suggesting alterations in hematopoiesis. Finally, consistent with findings in JNCL patients, vacuolated peripheral blood lymphocytes were observed in homozygous Cln3(Delta ex7/8) neonates, and to a greater extent in older animals. Early onset, severe vacuolation in clear cells of the epididymis of male homozygous Cln3(Delta ex7/8) mice was also observed. These data highlight additional organ systems in which to study CLN3 function, and early phenotypes have been established in homozygous Cln3(Delta ex7/8) mice that merit further study for JNCL biomarker development.	[Staropoli, John F.; Haliw, Larissa; Biswas, Sunita; Lopez, Edith; Harati, Hayat; Guide, Jolene; Dragileva, Ella; Gale, Evan; Wheeler, Vanessa C.; Cotman, Susan L.] Massachusetts Gen Hosp, Mol Neurogenet Unit, Ctr Human Genet Res, Boston, MA 02114 USA; [Staropoli, John F.; Krause, Daniela S.; Brown, Diane E.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Garrett, Lillian; Hoelter, Sabine M.; Puk, Oliver; Sun, Minxuan; Graw, Jochen; Wurst, Wolfgang] Helmholtz Zentrum Munchen, Inst Dev Genet, Neuherberg, Germany; [Becker, Lore; Klopstock, Thomas] Univ Munich, Dept Neurol, Friedrich Baur Inst, D-80804 Munich, Germany; [Becker, Lore; Rathkolb, Birgit; Rozman, Jan; Schrewe, Anja; Adler, Thure; Gailus-Durner, Valerie; Fuchs, Helmut; de Angelis, Martin Hrabe] Helmholtz Zentrum Munchen, German Mouse Clin, Inst Expt Genet, Neuherberg, Germany; [Skosyrski, Sergej] Campus Virchow Klinikum, Charite Eye Hosp, Berlin, Germany; [Da Silva-Buttkus, Patricia; Calzada-Wack, Julia; Neff, Frauke] Helmholtz Zentrum Munchen, Inst Pathol, Neuherberg, Germany; [Rathkolb, Birgit; Wolf, Eckhard] Univ Munich, Chair Mol Anim Breeding & Biotechnol, Gene Ctr, Munich, Germany; [Rozman, Jan; Klingenspor, Martin] TUM, Else Kroner Fresenius Ctr, Freising Weihenstephan, Germany; [Adler, Thure; Busch, Dirk H.] TUM, Inst Med Microbiol Immunol & Hyg, Munich, Germany; [Favor, Jack] Helmholtz Zentrum Munchen, Inst Human Genet, Neuherberg, Germany; [Racz, Ildiko; Zimmer, Andreas] Univ Bonn, Inst Mol Psychiat, Bonn, Germany; [Bekeredjian, Raffi] Heidelberg Univ, Dept Med 3, Div Cardiol, Otto Meyerhof Zentrum, Heidelberg, Germany; [Wurst, Wolfgang] TUM, Lehrstuhl Entwicklungsgenet, Freising Weihenstephan, Germany; [Wurst, Wolfgang] Max Planck Inst Psychiat, D-80804 Munich, Germany; [Wurst, Wolfgang] Deutsch Zentrum Neurodegenerat Erkrankungen eV Si, Munich, Germany; [Harati, Hayat; Boustany, Rose-Mary] Amer Univ Beirut, Neurogenet Program, Beirut, Lebanon; [Harati, Hayat; Boustany, Rose-Mary] Amer Univ Beirut, Div Pediat Neurol, Dept Pediat, Beirut, Lebanon; [Harati, Hayat; Boustany, Rose-Mary] Amer Univ Beirut, Div Pediat Neurol, Dept Biochem, Beirut, Lebanon; [Hill, Eric; Breton, Sylvie] Massachusetts Gen Hosp, Ctr Syst Biol, Program Membrane Biol, Div Nephrol, Boston, MA 02114 USA; [Brown, Diane E.] Massachusetts Gen Hosp, Ctr Comparat Med, Boston, MA 02114 USA; [Ruether, Klaus] Augenabt Sankt Gertrauden Krankenhaus, Berlin, Germany; [de Angelis, Martin Hrabe] TUM, Lehrstuhl Expt Genet, Freising Weihenstephan, Germany	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Technical University of Munich; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Bonn; Ruprecht Karls University Heidelberg; Technical University of Munich; Max Planck Society; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); American University of Beirut; American University of Beirut; American University of Beirut; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Technical University of Munich	Staropoli, JF (corresponding author), Massachusetts Gen Hosp, Mol Neurogenet Unit, Ctr Human Genet Res, Boston, MA 02114 USA.	cotman@helix.mgh.harvard.edu	Gailus-Durner, Valerie/M-7337-2014; Puk, Oliver/E-1443-2013; Rozman, Jan/A-2540-2010; Klingenspor, Martin/D-6930-2011; Becker, Lore/E-3717-2010; Becker, Lore/AAJ-1203-2020; de Angelis, Martin Hrabe/F-5531-2012; Racz, I./C-3074-2009; Fuchs, Helmut/M-7347-2014; Graw, Jochen/D-9336-2013; Hölter, Sabine M./N-5868-2014; Klingenspor, Martin/K-5033-2019; Rathkolb, Birgit/F-7041-2013; Zimmer, Andreas/B-8357-2009	Rozman, Jan/0000-0002-8035-8904; Klingenspor, Martin/0000-0002-4502-6664; Becker, Lore/0000-0002-6890-4984; de Angelis, Martin Hrabe/0000-0002-7898-2353; Racz, I./0000-0002-1549-3616; Fuchs, Helmut/0000-0002-5143-2677; Hölter, Sabine M./0000-0003-4878-5241; Calzada, Julia/0000-0003-0816-9305; Garrett, Lillian/0000-0003-4880-7076; Graw, Jochen/0000-0003-0298-9660; Wolf, Eckhard/0000-0002-0430-9510; Wurst, Wolfgang/0000-0003-4422-7410	Dubai-Harvard Foundation for Medical Research; NCL Stiftung; Batten Disease Support and Research Association; National Institutes of Health: National1380 Institute of Neurological Disorders Stroke [NS073813, NS049206]; German Federal Ministry of Education and Research [01GS0850, 01GS0851, 01GS0852, 01GS0853, 01GS0854, GS0868, 01GS0869]; EU [LSHG-2006-037188]; Initiative and Networking Fund of the Helmholtz Association [T(HA-215]; National Institute of Diabetes and Digestive and Kidney Diseases in the form of an Inflammatory Bowel Disease [DK43351]; Boston Area Diabetes and Endocrinology Research Center (BADERC) [DK57521]; NATIONAL CANCER INSTITUTE [K08CA138916] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351, P30DK057521] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073813, R01NS049206] Funding Source: NIH RePORTER	Dubai-Harvard Foundation for Medical Research; NCL Stiftung; Batten Disease Support and Research Association; National Institutes of Health: National1380 Institute of Neurological Disorders Stroke; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); EU(European Commission); Initiative and Networking Fund of the Helmholtz Association; National Institute of Diabetes and Digestive and Kidney Diseases in the form of an Inflammatory Bowel Disease; Boston Area Diabetes and Endocrinology Research Center (BADERC); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Dubai-Harvard Foundation for Medical Research [to SLC and R-MB]; NCL Stiftung [to KR]; the Batten Disease Support and Research Association [to JFS]; the National Institutes of Health: National1380 Institute of Neurological Disorders & Stroke [NS073813 to SLC and NS049206 to VCW]; the German Federal Ministry of Education and Research [DZD E.V. to the German Center for Diabetes Research and NGFN-Plus grants 01GS0850, 01GS0851, 01GS0852, 01GS0853, 01GS0854, GS0868, 01GS0869 to the German Mouse Clinic]; EU grant [EUMODIC, LSHG-2006-037188 to the German Mouse Clinic]; and by the Initiative and Networking Fund of the Helmholtz Association in the framework of the Helmholtz Alliance for Mental Research in an Ageing Society [T(HA-215) to Systems Biology/Program in Membrane Biology is partially supported National Institute of Diabetes and Digestive and Kidney Diseases in the form of an Inflammatory Bowel Disease Grant [DK43351] and a Boston Area Diabetes and Endocrinology Research Center (BADERC) Award [DK57521]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbruzzese G, 2003, MOVEMENT DISORD, V18, P231, DOI 10.1002/mds.10327; Adamali HI, 1999, J ANDROL, V20, P803; Adamali HI, 1999, J ANDROL, V20, P779; Adams HR, 2007, J CHILD NEUROL, V22, P621, DOI 10.1177/0883073807302603; Ahtiainen L, 2007, NEUROBIOL DIS, V28, P52, DOI 10.1016/j.nbd.2007.06.012; Aleman TS, 2011, INVEST OPHTH VIS SCI, V52, P6898, DOI 10.1167/iovs.11-7701; Anderson G, 2005, J CLIN PATHOL, V58, P1305, DOI 10.1136/jcp.2005.027045; [Anonymous], 1995, Cell, V82, P949; Asano T, 2011, MOL CELL BIOL, V31, P2040, DOI 10.1128/MCB.01437-10; Backman ML, 2005, J INTELL DISABIL RES, V49, P25, DOI 10.1111/j.1365-2788.2005.00659.x; Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204; Bronson RT, 1998, AM J MED GENET, V77, P289, DOI 10.1002/(SICI)1096-8628(19980526)77:4<289::AID-AJMG8>3.0.CO;2-I; Brown DE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009441; Cao Y, 2006, J BIOL CHEM, V281, P20483, DOI 10.1074/jbc.M602180200; Cao Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017118; Castaneda JA, 2008, NEUROBIOL DIS, V29, P92, DOI 10.1016/j.nbd.2007.08.007; Chattopadhyay S, 2002, HUM MOL GENET, V11, P1421, DOI 10.1093/hmg/11.12.1421; Cialone J, 2012, J INHERIT METAB DIS, V35, P549, DOI 10.1007/s10545-011-9421-6; Codlin S, 2008, J CELL SCI, V121, P2860, DOI 10.1242/jcs.030122; Codlin S, 2009, J CELL SCI, V122, P1163, DOI 10.1242/jcs.038323; Cooper JD, 2006, BBA-MOL BASIS DIS, V1762, P873, DOI 10.1016/j.bbadis.2006.08.002; Cotman SL, 2002, HUM MOL GENET, V11, P2709, DOI 10.1093/hmg/11.22.2709; Cotman SL, 2012, CLIN LIPIDOL, V7, P79, DOI 10.2217/CLP.11.70; Da Silva N, 2007, AM J PHYSIOL-CELL PH, V293, pC199, DOI 10.1152/ajpcell.00596.2006; EDDY NB, 1953, J PHARMACOL EXP THER, V107, P385; Eliason SL, 2007, J NEUROSCI, V27, P9826, DOI 10.1523/JNEUROSCI.1710-07.2007; FAVOR J, 1983, MUTAT RES, V110, P367, DOI 10.1016/0027-5107(83)90153-7; Finn R, 2011, NEUROCHEM INT, V58, P648, DOI 10.1016/j.neuint.2011.02.003; Fox J.G., MOUSE BIOMEDICAL RES; Fuchs H, 2009, CURR PHARM BIOTECHNO, V10, P236, DOI 10.2174/138920109787315051; Fuchs H, 2011, METHODS, V53, P120, DOI 10.1016/j.ymeth.2010.08.006; GADOTH N, 1975, J NEUROL SCI, V25, P197, DOI 10.1016/0022-510X(75)90140-9; Gailus-Durner V, 2005, NAT METHODS, V2, P403, DOI 10.1038/nmeth0605-403; Gailus-Durner Valerie, 2009, V530, P463, DOI 10.1007/978-1-59745-471-1_25; Gao HL, 2002, AM J HUM GENET, V70, P324, DOI 10.1086/338190; Hanninen A, 2011, EUR J IMMUNOL, V41, P634, DOI 10.1002/eji.201040760; Herrmann P, 2008, J NEUROSCI RES, V86, P1857, DOI 10.1002/jnr.21630; Hofman I L, 2001, Eur J Paediatr Neurol, V5 Suppl A, P213; Jalanko A, 2009, BBA-MOL CELL RES, V1793, P697, DOI 10.1016/j.bbamcr.2008.11.004; Kama R, 2011, J CELL BIOL, V195, P203, DOI 10.1083/jcb.201102115; Katz M L, 2001, Eur J Paediatr Neurol, V5 Suppl A, P109, DOI 10.1053/ejpn.2000.0445; Katz ML, 2008, NEUROBIOL DIS, V29, P242, DOI 10.1016/j.nbd.2007.08.017; KETTUNEN RVJ, 1994, AM HEART J, V127, P1449, DOI 10.1016/0002-8703(94)90369-7; Kielar C, 2009, HUM MOL GENET, V18, P4066, DOI 10.1093/hmg/ddp355; Knutson M, 2003, CRIT REV BIOCHEM MOL, V38, P61, DOI 10.1080/713609210; Kohlschutter A, 2009, BRAIN DEV-JPN, V31, P499, DOI 10.1016/j.braindev.2008.12.008; KOHLSCHUTTER A, 1988, ACTA PAEDIATR SCAND, V77, P867, DOI 10.1111/j.1651-2227.1988.tb10770.x; Kyttala A, 2006, BBA-MOL BASIS DIS, V1762, P920, DOI 10.1016/j.bbadis.2006.05.007; Lebrun AH, 2011, MOL MED, V17, P1253, DOI 10.2119/molmed.2010.00241; LERMAN A, 1993, LANCET, V341, P1105, DOI 10.1016/0140-6736(93)93125-K; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Luiro K, 2001, HUM MOL GENET, V10, P2123, DOI 10.1093/hmg/10.19.2123; Luiro K, 2006, J NEUROSCI RES, V84, P1124, DOI 10.1002/jnr.21015; Mandillo S, 2008, PHYSIOL GENOMICS, V34, P243, DOI 10.1152/physiolgenomics.90207.2008; Marshall FJ, 2005, NEUROLOGY, V65, P275, DOI 10.1212/01.wnl.0000169019.41332.8a; Mattapallil MJ, 2012, INVESTIGATIVE OPHTHA; Mitchison HM, 1999, NEUROBIOL DIS, V6, P321, DOI 10.1006/nbdi.1999.0267; Mole S., 2011, NEURONAL CEROID LIPO, DOI DOI 10.1093/MED/9780199590018.003.0018; Mole SE, 2005, NEUROGENETICS, V6, P107, DOI 10.1007/s10048-005-0218-3; Molkentin JD, 2004, CARDIOVASC RES, V63, P467, DOI 10.1016/j.cardiores.2004.01.021; Moran JL, 2006, GENOME RES, V16, P436, DOI 10.1101/gr.4563306; Munroe PB, 1997, AM J HUM GENET, V61, P310, DOI 10.1086/514846; Narayan SB, 2006, ANN NEUROL, V60, P570, DOI 10.1002/ana.20975; Osorio NS, 2009, GENES BRAIN BEHAV, V8, P337, DOI 10.1111/j.1601-183X.2009.00478.x; Ostergaard JR, 2011, NEUROLOGY, V76, P1245, DOI 10.1212/WNL.0b013e31821435bd; PALMER DN, 1992, AM J MED GENET, V42, P561, DOI 10.1002/ajmg.1320420428; Partanen S, 2008, J NEUROPATH EXP NEUR, V67, P16, DOI 10.1097/nen.0b013e31815f3899; Pasche B, 2005, INFECT IMMUN, V73, P5952, DOI 10.1128/IAI.73.9.5952-5960.2005; Pearce DA, 1999, MOL GENET METAB, V66, P320, DOI 10.1006/mgme.1999.2819; Perlman I, 2011, ORG RETINA VISUAL SY; Petkova SB, 2008, PHYSIOL GENOMICS, V34, P304, DOI 10.1152/physiolgenomics.00185.2007; Pettitt SJ, 2009, NAT METHODS, V6, P493, DOI 10.1038/nmeth.1342; Pietrement C, 2006, BIOL REPROD, V74, P185, DOI 10.1095/biolreprod.105.043752; Pietrement C, 2008, J BIOL CHEM, V283, P2986, DOI 10.1074/jbc.M704678200; Poet M, 2006, P NATL ACAD SCI USA, V103, P13854, DOI 10.1073/pnas.0606137103; Pontikis CC, 2005, NEUROBIOL DIS, V20, P823, DOI 10.1016/j.nbd.2005.05.018; Pontikis CC, 2004, BRAIN RES, V1023, P231, DOI 10.1016/j.brainres.2004.07.030; Pouretemad HR, 1998, EPILEPSY RES, V31, P1, DOI 10.1016/S0920-1211(98)00014-X; Rogers DC, 1997, MAMM GENOME, V8, P711, DOI 10.1007/s003359900551; Rusyn E, 2008, PEDIATR RES, V63, P625, DOI 10.1203/PDR.0b013e31816fdc17; SAFTIG P, 1995, EMBO J, V14, P3599, DOI 10.1002/j.1460-2075.1995.tb00029.x; SAHN DJ, 1978, CIRCULATION, V58, P1072, DOI 10.1161/01.CIR.58.6.1072; Schmucker C, 2004, VISION RES, V44, P2445, DOI 10.1016/j.visres.2004.05.018; Schneider I, 2006, J NEUROSCI METH, V157, P82, DOI 10.1016/j.jneumeth.2006.04.002; Shum WWC, 2009, J EXP BIOL, V212, P1753, DOI 10.1242/jeb.027284; Siintola E, 2006, BRAIN, V129, P1438, DOI 10.1093/brain/awl107; Song JW, 2008, J NEUROSCI, V28, P8993, DOI 10.1523/JNEUROSCI.0720-08.2008; Stephenson LM, 2009, AUTOPHAGY, V5, P625, DOI 10.4161/auto.5.5.8133; Stiedl O, 1999, BEHAV BRAIN RES, V104, P1, DOI 10.1016/S0166-4328(99)00047-9; SWERDLOW NR, 1995, J NEUROL NEUROSUR PS, V58, P192, DOI 10.1136/jnnp.58.2.192; TEICHHOLZ LE, 1974, NEW ENGL J MED, V291, P1220, DOI 10.1056/NEJM197412052912304; Virmani T, 2005, NEUROBIOL DIS, V20, P314, DOI 10.1016/j.nbd.2005.03.012; Weimer JM, 2006, NEUROBIOL DIS, V22, P284, DOI 10.1016/j.nbd.2005.11.008; Weleber RG, 1998, EYE, V12, P580, DOI 10.1038/eye.1998.148; Wheeler RB, 2002, AM J HUM GENET, V70, P537, DOI 10.1086/338708; Woloszynek JC, 2007, J BIOL CHEM, V282, P35765, DOI 10.1074/jbc.M705124200; Zhang J, 2009, BLOOD, V114, P157, DOI 10.1182/blood-2008-04-151639	97	48	48	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e38310	10.1371/journal.pone.0038310	http://dx.doi.org/10.1371/journal.pone.0038310			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701626	Green Published, Green Submitted, gold			2022-12-27	WOS:000305348400050
J	Ueki, Y; Reh, TA				Ueki, Yumi; Reh, Thomas A.			Activation of BMP-Smad1/5/8 Signaling Promotes Survival of Retinal Ganglion Cells after Damage In Vivo	PLOS ONE			English	Article							CILIARY NEUROTROPHIC FACTOR; BONE MORPHOGENETIC PROTEIN; LEUKEMIA INHIBITORY FACTOR; FIBROBLAST-GROWTH-FACTOR; FACTOR PREVENTS DEGENERATION; LONG-TERM SURVIVAL; SPINAL-CORD-INJURY; RAT RETINA; NERVOUS-SYSTEM; UP-REGULATION	While the essential role of bone morphogenetic protein (BMP) signaling in nervous system development is well established, its function in the adult CNS is poorly understood. We investigated the role of BMP signaling in the adult mouse retina following damage in vivo. Intravitreal injection of N-Methyl-D-aspartic acid (NMDA) induced extensive retinal ganglion cell death by 2 days. During this period, BMP2, -4 and -7 were upregulated, leading to phosphorylation of the downstream effector, Smad1/5/8 in the inner retina, including in retinal ganglion cells. Expression of Inhibitor of differentiation 1 (Id1; a known BMP-Smad1/5/8 target) was also upregulated in the retina. This activation of BMP-Smad1/5/8 signaling was also observed following light damage, suggesting that it is a general response to retinal injuries. Co-injection of BMP inhibitors with NMDA effectively blocked the damage-induced BMP-Smad1/5/8 activation and led to further cell death of retinal ganglion cells, when compared with NMDA injection alone. Moreover, treatment of the retina with exogenous BMP4 along with NMDA damage led to a significant rescue of retinal ganglion cells. These data demonstrate that BMP-Smad1/5/8 signaling is neuroprotective for retinal ganglion cells after damage, and suggest that stimulation of this pathway can serve as a potential target for neuroprotective therapies in retinal ganglion cell diseases, such as glaucoma.	[Ueki, Yumi; Reh, Thomas A.] Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Ueki, Y (corresponding author), Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA.	tomreh@uw.edu			 [1R01EY021482]; NATIONAL EYE INSTITUTE [P30EY001730, R01EY021482] Funding Source: NIH RePORTER	; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The authors are grateful to the imaging core of the Vision Core Grant to the University of Washington, P30EY01730. This work was supported by 1R01EY021482 to TAR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson KD, 1996, P NATL ACAD SCI USA, V93, P7346, DOI 10.1073/pnas.93.14.7346; Basak O, 2007, EUR J NEUROSCI, V25, P1006, DOI 10.1111/j.1460-9568.2007.05370.x; Behesti H, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-62; Blanco RE, 2008, J NEUROSCI RES, V86, P3382, DOI 10.1002/jnr.21793; Burgi S, 2009, MOL VIS, V15, P1631; Cao W, 1997, EXP EYE RES, V65, P241, DOI 10.1006/exer.1997.0328; Cayouette M, 1998, J NEUROSCI, V18, P9282; Chang B, 2001, BMC GENET, V2, DOI 10.1186/1471-2156-2-18; Charytoniuk DA, 2000, NEUROSCIENCE, V100, P33, DOI 10.1016/S0306-4522(00)00246-3; CHEEMA SS, 1994, J NEUROSCI RES, V37, P213, DOI 10.1002/jnr.490370207; Crews L, 2010, J NEUROSCI, V30, P12252, DOI 10.1523/JNEUROSCI.1305-10.2010; Du Y, 2010, INVEST OPHTH VIS SCI, V51, P3764, DOI 10.1167/iovs.09-4906; DUDLEY AT, 1995, GENE DEV, V9, P2795, DOI 10.1101/gad.9.22.2795; Dudley AT, 1997, DEV DYNAM, V208, P349; EISENFELD AJ, 1984, INVEST OPHTH VIS SCI, V25, P1321; Ekstrom P, 2003, DEV BRAIN RES, V145, P1, DOI 10.1016/S0165-3806(03)00170-6; FAKTOROVICH EG, 1992, J NEUROSCI, V12, P3554; Fischer AJ, 2004, MOL CELL NEUROSCI, V27, P531, DOI 10.1016/j.mcn.2004.08.007; Franke AG, 2006, J COMP NEUROL, V495, P263, DOI 10.1002/cne.20869; Frasson M, 1999, INVEST OPHTH VIS SCI, V40, P2724; Fukuda S, 2007, MOL CELL BIOL, V27, P4931, DOI 10.1128/MCB.02435-06; Fuller ML, 2007, ANN NEUROL, V62, P288, DOI 10.1002/ana.21179; Furuta Y, 1998, GENE DEV, V12, P3764, DOI 10.1101/gad.12.23.3764; Gadient RA, 1998, BRAIN RES, V798, P140, DOI 10.1016/S0006-8993(98)00236-4; Gao H, 1996, EXP EYE RES, V62, P181, DOI 10.1006/exer.1996.0022; HAGG T, 1993, P NATL ACAD SCI USA, V90, P6315, DOI 10.1073/pnas.90.13.6315; Honjo M, 2000, INVEST OPHTH VIS SCI, V41, P552; Karl MO, 2008, P NATL ACAD SCI USA, V105, P19508, DOI 10.1073/pnas.0807453105; Kawamata T, 1998, NEUROREPORT, V9, P1441, DOI 10.1097/00001756-199805110-00035; LAVAIL MM, 1992, P NATL ACAD SCI USA, V89, P11249, DOI 10.1073/pnas.89.23.11249; LaVail MM, 1998, INVEST OPHTH VIS SCI, V39, P592; Leaver SG, 2006, GENE THER, V13, P1328, DOI 10.1038/sj.gt.3302791; Lin SZ, 1999, STROKE, V30, P126, DOI 10.1161/01.STR.30.1.126; Liu J, 2003, DEV BIOL, V256, P34, DOI 10.1016/S0012-1606(02)00115-X; Lopez-Rovira T, 2002, J BIOL CHEM, V277, P3176, DOI 10.1074/jbc.M106826200; MacLaren RE, 2006, EXP EYE RES, V83, P1118, DOI 10.1016/j.exer.2006.05.019; Mehler MF, 1997, TRENDS NEUROSCI, V20, P309, DOI 10.1016/S0166-2236(96)01046-6; MEY J, 1993, BRAIN RES, V602, P304, DOI 10.1016/0006-8993(93)90695-J; Miyazono K, 2010, J BIOCHEM, V147, P35, DOI 10.1093/jb/mvp148; Murali D, 2005, DEVELOPMENT, V132, P913, DOI 10.1242/dev.01673; Murali D, 2011, INVEST OPHTH VIS SCI, V52, P2930, DOI 10.1167/iovs.10-5940; Nakashima K, 1999, SCIENCE, V284, P479, DOI 10.1126/science.284.5413.479; Nelson BR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022817; Nonner D, 2001, J NEUROCHEM, V77, P691, DOI 10.1046/j.1471-4159.2001.00273.x; Qi XA, 2010, EXP NEUROL, V221, P353, DOI 10.1016/j.expneurol.2009.12.003; Sahni V, 2010, J NEUROSCI, V30, P1839, DOI 10.1523/JNEUROSCI.4459-09.2010; Samanta J, 2004, DEVELOPMENT, V131, P4131, DOI 10.1242/dev.01273; Samardzija M, 2006, FASEB J, V20, P2411, DOI 10.1096/fj.06-5895fje; SENDTNER M, 1992, NATURE, V358, P502, DOI 10.1038/358502a0; Setoguchi T, 2001, BRAIN RES, V921, P219, DOI 10.1016/S0006-8993(01)03123-7; Soto I, 2006, J NEUROCHEM, V96, P82, DOI 10.1111/j.1471-4159.2005.03510.x; Sucher NJ, 1997, VISION RES, V37, P3483, DOI 10.1016/S0042-6989(97)00047-3; Takahata K, 2003, INVEST OPHTH VIS SCI, V44, P1760, DOI 10.1167/iovs.02-0471; Trousse F, 2001, J NEUROSCI, V21, P1292; Ueki Y, 2008, J NEUROCHEM, V105, P784, DOI 10.1111/j.1471-4159.2007.05180.x; UNOKI K, 1994, INVEST OPHTH VIS SCI, V35, P907; Vaccari JPD, 2009, NEUROSCI LETT, V465, P226, DOI 10.1016/j.neulet.2009.09.013; van Adel BA, 2005, J NEUROBIOL, V63, P215, DOI 10.1002/neu.20117; WEN R, 1995, J NEUROSCI, V15, P7377	59	37	37	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e38690	10.1371/journal.pone.0038690	http://dx.doi.org/10.1371/journal.pone.0038690			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701694	Green Published, Green Submitted, gold			2022-12-27	WOS:000305348400086
J	Adam, C; Picard, M; Dequard-Chablat, M; Sellem, CH; Hermann-Le Denmat, S; Contamine, V				Adam, Celine; Picard, Marguerite; Dequard-Chablat, Michelle; Sellem, Carole H.; Hermann-Le Denmat, Sylvie; Contamine, Veronique			Biological Roles of the Podospora anserina Mitochondrial Lon Protease and the Importance of Its N-Domain	PLOS ONE			English	Article							ATP-DEPENDENT PROTEASE; REAL-TIME PCR; NUCLEAR MUTATIONS; CELLS; MAINTENANCE; PROTEOLYSIS; EXPRESSION; SEQUENCE; DNA; BACTERIAL	Mitochondria have their own ATP-dependent proteases that maintain the functional state of the organelle. All multicellular eukaryotes, including filamentous fungi, possess the same set of mitochondrial proteases, unlike in unicellular yeasts, where ClpXP, one of the two matricial proteases, is absent. Despite the presence of ClpXP in the filamentous fungus Podospora anserina, deletion of the gene encoding the other matricial protease, PaLon1, leads to lethality at high and low temperatures, indicating that PaLON1 plays a main role in protein quality control. Under normal physiological conditions, the PaLon1 deletion is viable but decreases life span. PaLon1 deletion also leads to defects in two steps during development, ascospore germination and sexual reproduction, which suggests that PaLON1 ensures important regulatory functions during fungal development. Mitochondrial Lon proteases are composed of a central ATPase domain flanked by a large non-catalytic N-domain and a C-terminal protease domain. We found that three mutations in the N-domain of PaLON1 affected fungal life cycle, PaLON1 protein expression and mitochondrial proteolytic activity, which reveals the functional importance of the N-domain of the mitochondrial Lon protease. All PaLon1 mutations affected the C-terminal part of the N-domain. Considering that the C-terminal part is predicted to have an alpha helical arrangement in which the number, length and position of the helices are conserved with the solved structure of its bacterial homologs, we propose that this all-helical structure participates in Lon substrate interaction.	[Adam, Celine; Picard, Marguerite; Dequard-Chablat, Michelle; Hermann-Le Denmat, Sylvie; Contamine, Veronique] Univ Paris Sud, Inst Genet & Microbiol, UMR 8621, Orsay, France; [Adam, Celine; Picard, Marguerite; Dequard-Chablat, Michelle; Hermann-Le Denmat, Sylvie; Contamine, Veronique] CNRS, F-91405 Orsay, France; [Sellem, Carole H.] CNRS, Ctr Genet Mol, UPR 3404, Gif Sur Yvette, France; [Hermann-Le Denmat, Sylvie] Ecole Normale Super, F-75231 Paris, France	UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Adam, C (corresponding author), Univ Paris Sud, Inst Genet & Microbiol, UMR 8621, Orsay, France.	sylvie.hermann-ledenmat@igmors.u-psud.fr; veronique.contamine@igmors.u-psud.fr			Association Francaise contre les Myopathies	Association Francaise contre les Myopathies(Association Francaise contre les Myopathies)	This work was supported by research projects granted by the Association Francaise contre les Myopathies [http://www.afm-telethon.fr/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert A, 2002, CURR GENET, V40, P365, DOI 10.1007/s00294-002-0275-1; Aldridge JE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000874; Bidard F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021476; Bota DA, 2005, FREE RADICAL BIO MED, V38, P665, DOI 10.1016/j.freeradbiomed.2004.11.017; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chir JL, 2009, BIOCHEM BIOPH RES CO, V382, P762, DOI 10.1016/j.bbrc.2009.03.109; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; Contamine V, 1998, FUNGAL GENET BIOL, V23, P223, DOI 10.1006/fgbi.1998.1040; Contamine W, 2004, GENETICS, V166, P135, DOI 10.1534/genetics.166.1.135; Dequard-Chablat M, 2011, MOL BIOL EVOL, V28, P2063, DOI 10.1093/molbev/msr025; Duman RE, 2010, J MOL BIOL, V401, P653, DOI 10.1016/j.jmb.2010.06.030; Ebel W, 1999, J BACTERIOL, V181, P2236, DOI 10.1128/JB.181.7.2236-2243.1999; El-Khoury R, 2008, CURR GENET, V53, P249, DOI 10.1007/s00294-008-0180-3; El-Khoury R, 2009, GENETICS, V183, P861, DOI 10.1534/genetics.109.107813; Espagne E, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r77; Gerdes F, 2012, BBA-MOL CELL RES, V1823, P49, DOI 10.1016/j.bbamcr.2011.09.015; GOLDBERG AL, 1992, EUR J BIOCHEM, V203, P9, DOI 10.1111/j.1432-1033.1992.tb19822.x; GOTTESMAN S, 1992, MICROBIOL REV, V56, P592, DOI 10.1128/MMBR.56.4.592-621.1992; Guha S, 2011, J MOL BIOL, V408, P222, DOI 10.1016/j.jmb.2011.02.044; Guillon B, 2009, FEBS J, V276, P1036, DOI 10.1111/j.1742-4658.2008.06847.x; Gur E, 2009, P NATL ACAD SCI USA, V106, P18503, DOI 10.1073/pnas.0910392106; HAFFTER P, 1992, GENETICS, V131, P255; Hansen J, 2008, NEUROSCIENCE, V153, P474, DOI 10.1016/j.neuroscience.2008.01.070; Hori O, 2002, J CELL BIOL, V157, P1151, DOI 10.1083/jcb.200108103; LECELLIER G, 1994, CURR GENET, V25, P122, DOI 10.1007/BF00309536; Lee AYL, 2004, J BIOL CHEM, V279, P34903, DOI 10.1074/jbc.M403562200; Li M, 2010, ACTA CRYSTALLOGR D, V66, P865, DOI 10.1107/S0907444910019554; Lu B, 2007, J BIOL CHEM, V282, P17363, DOI 10.1074/jbc.M611540200; Luce K, 2009, NAT CELL BIOL, V11, P852, DOI 10.1038/ncb1893; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Melnikov EE, 2008, ACTA BIOCHIM POL, V55, P281, DOI 10.18388/abp.2008_3075; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Rep M, 1996, SCIENCE, V274, P103, DOI 10.1126/science.274.5284.103; Rigas S, 2009, NEW PHYTOL, V181, P588, DOI 10.1111/j.1469-8137.2008.02701.x; Roudiak SG, 1998, BIOCHEMISTRY-US, V37, P11255, DOI 10.1021/bi980945h; Sellem CH, 2005, GENETICS, V169, P1379, DOI 10.1534/genetics.104.033837; SUZUKI CK, 1994, SCIENCE, V264, P273, DOI 10.1126/science.8146662; VANDYCK L, 1994, J BIOL CHEM, V269, P238; Venkatesh S, 2012, BBA-MOL CELL RES, V1823, P56, DOI 10.1016/j.bbamcr.2011.11.003; WANG N, 1993, P NATL ACAD SCI USA, V90, P11247, DOI 10.1073/pnas.90.23.11247; Zhao Q, 2002, EMBO J, V21, P4411, DOI 10.1093/emboj/cdf445	41	30	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38138	10.1371/journal.pone.0038138	http://dx.doi.org/10.1371/journal.pone.0038138			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693589	Green Published, Green Submitted, gold			2022-12-27	WOS:000305338500092
J	Coppinger, JA; Hutt, DM; Razvi, A; Koulov, AV; Pankow, S; Yates, JR; Balch, WE				Coppinger, Judith A.; Hutt, Darren M.; Razvi, Abbas; Koulov, Atanas V.; Pankow, Sandra; Yates, John R., III; Balch, William E.			A Chaperone Trap Contributes to the Onset of Cystic Fibrosis	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; RETICULUM-ASSOCIATED DEGRADATION; HEAT-SHOCK PROTEINS; ENDOPLASMIC-RETICULUM; DELTA-F508 CFTR; MOLECULAR CHAPERONES; SHOTGUN PROTEOMICS; HSP70 CHAPERONES; HSP90; DISEASE	Protein folding is the primary role of proteostasis network (PN) where chaperone interactions with client proteins determine the success or failure of the folding reaction in the cell. We now address how the Phe508 deletion in the NBD1 domain of the cystic fibrosis (CF) transmembrane conductance regulator (CFTR) protein responsible for cystic fibrosis (CF) impacts the binding of CFTR with cellular chaperones. We applied single ion reaction monitoring mass spectrometry (SRM-MS) to quantitatively characterize the stoichiometry of the heat shock proteins (Hsps) in CFTR folding intermediates in vivo and mapped the sites of interaction of the NBD1 domain of CFTR with Hsp90 in vitro. Unlike folding of WT-CFTR, we now demonstrate the presence of Delta F508-CFTR in a stalled folding intermediate in stoichiometric association with the core Hsps 40, 70 and 90, referred to as a 'chaperone trap'. Culturing cells at 30 C resulted in correction of Delta F508-CFTR trafficking and function, restoring the sub-stoichiometric association of core Hsps observed for WT-CFTR. These results support the interpretation that Delta F508-CFTR is restricted to a chaperone-bound folding intermediate, a state that may contribute to its loss of trafficking and increased targeting for degradation. We propose that stalled folding intermediates could define a critical proteostasis pathway branch-point(s) responsible for the loss of function in misfolding diseases as observed in CF.	[Coppinger, Judith A.; Hutt, Darren M.; Razvi, Abbas; Koulov, Atanas V.; Pankow, Sandra; Yates, John R., III; Balch, William E.] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [Balch, William E.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Yates, John R., III; Balch, William E.] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Balch, William E.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Balch, William E.] Scripps Res Inst, Inst Childhood & Neglected Dis, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Coppinger, JA (corresponding author), Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA.	jyates@scripps.edu; webalch@scripps.edu		coppinger, judith/0000-0001-6813-9840; Pankow, Sandra/0000-0003-3213-9886; Koulov, Atanas/0000-0003-0262-7002	National Institute of Health (NIH) [HL 079442, GM42336, DK785483, P41 RR011823]; Cystic Fibrosis Foundation (CFF); Cystic Fibrosis Consortium (CFC); Canadian Cystic Fibrosis Foundation (CCFF); Canadian Institutes for Health Research (CIHR); NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095524, R01HL079442] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042336] Funding Source: NIH RePORTER	National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation (CFF); Cystic Fibrosis Consortium (CFC); Canadian Cystic Fibrosis Foundation (CCFF); Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institute of Health (NIH) (HL 079442 (WEB/JRY), GM42336 (WEB), DK785483 (WEB), P41 RR011823 (JRY), by fellowships from the Cystic Fibrosis Foundation (CFF) and funding from the Cystic Fibrosis Consortium (CFC). DMH was supported by fellowships from the Canadian Cystic Fibrosis Foundation (CCFF) and the Canadian Institutes for Health Research (CIHR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahner A, 2007, MOL BIOL CELL, V18, P806, DOI 10.1091/mbc.E06-05-0458; Akerfelt M, 2010, NAT REV MOL CELL BIO, V11, P545, DOI 10.1038/nrm2938; Aleksandrov AA, 2010, J MOL BIOL, V401, P194, DOI 10.1016/j.jmb.2010.06.019; Andreasson C, 2010, J BIOL CHEM, V285, P12445, DOI 10.1074/jbc.M109.096735; Balch W. E., 2011, COLD SPRING HARB PER, V3; Balch WE, 2011, COLD SPRING IN PRESS; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Bannykh SI, 2000, TRAFFIC, V1, P852, DOI 10.1034/j.1600-0854.2000.011105.x; Bourgault S, 2011, BIOCHEM BIOPH RES CO, V410, P707, DOI 10.1016/j.bbrc.2011.04.133; Broadley SA, 2009, FEBS LETT, V583, P2647, DOI 10.1016/j.febslet.2009.04.029; Brodsky JL, 2009, CURR OPIN CELL BIOL, V21, P516, DOI 10.1016/j.ceb.2009.04.006; Calamini B, 2012, NAT CHEM BIOL, V8, P185, DOI 10.1038/nchembio.763; Carra S, 2009, J BIOL CHEM, V284, P5523, DOI 10.1074/jbc.M807440200; Chang XB, 2008, J CELL SCI, V121, P2814, DOI 10.1242/jcs.028951; Connelly S, 2010, CURR OPIN STRUC BIOL, V20, P54, DOI 10.1016/j.sbi.2009.12.009; Cui LY, 2007, J MOL BIOL, V365, P981, DOI 10.1016/j.jmb.2006.10.086; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; Du K, 2005, NAT STRUCT MOL BIOL, V12, P17, DOI 10.1038/nsmb882; Du K, 2009, MOL BIOL CELL, V20, P1903, DOI 10.1091/mbc.E08-09-0950; Elschenbroich S, 2011, MOL BIOSYST, V7, P292, DOI 10.1039/c0mb00159g; Evans CG, 2010, J MED CHEM, V53, P4585, DOI 10.1021/jm100054f; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Garrido C., 2012, INT J BIOCH CELL BIO; Gelman MS, 2002, J BIOL CHEM, V277, P11709, DOI 10.1074/jbc.M111958200; Gerber SA, 2003, P NATL ACAD SCI USA, V100, P6940, DOI 10.1073/pnas.0832254100; Gidalevitz T., 2011, COLD SPRING HARB PER, V3; Grove DE, 2011, MOL BIOL CELL, V22, P301, DOI 10.1091/mbc.E10-09-0760; Hageman J, 2011, BIOCHEM J, V435, P127, DOI 10.1042/BJ20101247; Hageman J, 2010, MOL CELL, V37, P355, DOI 10.1016/j.molcel.2010.01.001; Hoelen H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015458; Huang SY, 2009, J MOL GRAPH MODEL, V27, P822, DOI 10.1016/j.jmgm.2008.12.005; Hutt DM, 2009, FEBS LETT, V583, P2639, DOI 10.1016/j.febslet.2009.07.014; Hutt DH, 2010, NAT CHEM BI IN PRESS; Jinwal UK, 2009, J NEUROSCI, V29, P12079, DOI 10.1523/JNEUROSCI.3345-09.2009; Johnson SM, 2012, J MOL BIOL; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; KARTNER N, 1992, NAT GENET, V1, P321, DOI 10.1038/ng0892-321; Klaic L, 2012, ACS CHEM BIOL; Koulov AV, 2010, MOL BIOL CELL; Lee MJ, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.R110.003871; Lewis HA, 2010, J MOL BIOL, V396, P406, DOI 10.1016/j.jmb.2009.11.051; Lewis HA, 2005, J BIOL CHEM, V280, P1346, DOI 10.1074/jbc.M410968200; Loo MA, 1998, EMBO J, V17, P6879, DOI 10.1093/emboj/17.23.6879; Lukacs GL, 2012, TRENDS MOL MED, V18, P81, DOI 10.1016/j.molmed.2011.10.003; MacCoss MJ, 2003, ANAL CHEM, V75, P6912, DOI 10.1021/ac034790h; MacCoss MJ, 2002, ANAL CHEM, V74, P5593, DOI 10.1021/ac025826t; Marozkina NV, 2010, P NATL ACAD SCI USA, V107, P11393, DOI 10.1073/pnas.0909128107; Mendoza JL, 2007, J BIOENERG BIOMEMBR, V39, P499, DOI 10.1007/s10863-007-9117-7; Mendoza JL, 2012, CELL, V148, P164, DOI 10.1016/j.cell.2011.11.023; Mendoza JL, 2011, METHODS MOL BIOL, V741, P321, DOI 10.1007/978-1-61779-117-8_21; Miyata Y, 2011, FUTURE MED CHEM, V3, P1523, DOI [10.4155/FMC.11.88, 10.4155/fmc.11.88]; Morimoto RI, 2012, COLD SPRING HARB S Q; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Morito D, 2008, MOL BIOL CELL, V19, P1328, DOI 10.1091/mbc.E07-06-0601; Mornon JP, 2009, CELL MOL LIFE SCI, V66, P3469, DOI 10.1007/s00018-009-0133-0; Okiyoneda T, 2010, SCIENCE, V329, P805, DOI 10.1126/science.1191542; Ong DST, 2011, CURR OPIN CELL BIOL, V23, P231, DOI 10.1016/j.ceb.2010.11.002; Park SK, 2010, CURR PROTOC BIOINFOR, DOI 10.1002/0471250953.bi1312s29; Patrick AE, 2011, MOL BIOL CELL, V22, P4461, DOI 10.1091/mbc.E11-05-0396; Powers ET, 2009, ANNU REV BIOCHEM, V78, P959, DOI 10.1146/annurev.biochem.052308.114844; Prahlad V, 2009, TRENDS CELL BIOL, V19, P52, DOI 10.1016/j.tcb.2008.11.002; Pratt WB, 2008, J BIOL CHEM, V283, P22885, DOI 10.1074/jbc.R800023200; Qu BH, 1997, J BIOENERG BIOMEMBR, V29, P483, DOI 10.1023/A:1022439108101; Qu BH, 1997, J BIOL CHEM, V272, P15739, DOI 10.1074/jbc.272.25.15739; Rabeh WM, 2012, CELL, V148, P150, DOI 10.1016/j.cell.2011.11.024; Riordan JR, 2008, ANNU REV BIOCHEM, V77, P701, DOI 10.1146/annurev.biochem.75.103004.142532; Rodriguez F, 2008, MOL CELL, V32, P347, DOI 10.1016/j.molcel.2008.09.016; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rosser MFN, 2008, MOL BIOL CELL, V19, P4570, DOI 10.1091/mbc.E08-04-0357; Rousaki A, 2011, J MOL BIOL, V411, P614, DOI 10.1016/j.jmb.2011.06.003; Schlecht R, 2011, NAT STRUCT MOL BIOL, V18, P345, DOI 10.1038/nsmb.2006; Schmidt A, 2011, METHODS MOL BIOL, V741, P365, DOI 10.1007/978-1-61779-117-8_24; Serohijos AWR, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000008; Serohijos AWR, 2008, P NATL ACAD SCI USA, V105, P3256, DOI 10.1073/pnas.0800254105; Sun F, 2008, FASEB J, V22, P3255, DOI 10.1096/fj.07-105338; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Thibodeau PH, 2010, J BIOL CHEM, V285, P35825, DOI 10.1074/jbc.M110.131623; Thibodeau PH, 2005, NAT STRUCT MOL BIOL, V12, P10, DOI 10.1038/nsmb881; THOMAS PJ, 1995, TRENDS BIOCHEM SCI, V20, P456, DOI 10.1016/S0968-0004(00)89100-8; Turnbull EL, 2007, BMC BIOCHEM, V8, DOI 10.1186/1471-2091-8-S1-S11; Vabulas RM, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a004390; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Vos MJ, 2011, AUTOPHAGY, V7, P101, DOI 10.4161/auto.7.1.13935; Vos MJ, 2010, HUM MOL GENET, V19, P4677, DOI 10.1093/hmg/ddq398; Walter GM, 2011, J BIOL CHEM, V286, P40486, DOI 10.1074/jbc.M111.284448; Wandinger SK, 2008, J BIOL CHEM, V283, P18473, DOI 10.1074/jbc.R800007200; Wang AM, 2010, J BIOL CHEM, V285, P15714, DOI 10.1074/jbc.M109.098806; Wang XD, 2004, J CELL BIOL, V167, P65, DOI 10.1083/jcb.200401035; Wang XD, 2008, TRAFFIC, V9, P1878, DOI 10.1111/j.1600-0854.2008.00806.x; Wang XD, 2006, CELL, V127, P803, DOI 10.1016/j.cell.2006.09.043; Weissman AM, 2011, NAT REV MOL CELL BIO, V12, P605, DOI 10.1038/nrm3173; Westerheide SD, 2009, SCIENCE, V323, P1063, DOI 10.1126/science.1165946; Wiseman RL, 2007, CELL, V131, P809, DOI 10.1016/j.cell.2007.10.025; Wisen S, 2010, ACS CHEM BIOL, V5, P611, DOI 10.1021/cb1000422; Wolf-Yadlin A, 2007, P NATL ACAD SCI USA, V104, P5860, DOI 10.1073/pnas.0608638104; Yates JR, 2009, ANNU REV BIOMED ENG, V11, P49, DOI 10.1146/annurev-bioeng-061008-124934; Yoo JS, 2002, J BIOL CHEM, V277, P11401, DOI 10.1074/jbc.M110263200; Youker RT, 2004, MOL BIOL CELL, V15, P4787, DOI 10.1091/mbc.E04-07-0584; Younger JM, 2006, CELL, V126, P571, DOI 10.1016/j.cell.2006.06.041; Zijlstra MP, 2010, EUR J NEUROSCI, V32, P760, DOI 10.1111/j.1460-9568.2010.07352.x	101	48	49	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e37682	10.1371/journal.pone.0037682	http://dx.doi.org/10.1371/journal.pone.0037682			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22701530	gold, Green Published, Green Submitted			2022-12-27	WOS:000305338500051
J	Yedid, G; Stredwick, J; Ofria, CA; Agapow, PM				Yedid, Gabriel; Stredwick, Jason; Ofria, Charles A.; Agapow, Paul-Michael			A Comparison of the Effects of Random and Selective Mass Extinctions on Erosion of Evolutionary History in Communities of Digital Organisms	PLOS ONE			English	Article							NONRANDOM EXTINCTION; RECOVERY; DIVERSIFICATION; PHYLOGENIES; RATES; ROBUSTNESS; SIGNATURES; RADIATION; DYNAMICS; SURVIVAL	The effect of mass extinctions on phylogenetic diversity and branching history of clades remains poorly understood in paleobiology. We examined the phylogenies of communities of digital organisms undergoing open-ended evolution as we subjected them to instantaneous "pulse'' extinctions, choosing survivors at random, and to prolonged "press'' extinctions involving a period of low resource availability. We measured age of the phylogenetic root and tree stemminess, and evaluated how branching history of the phylogenetic trees was affected by the extinction treatments. We found that strong random (pulse) and strong selective extinction (press) both left clear long-term signatures in root age distribution and tree stemminess, and eroded deep branching history to a greater degree than did weak extinction and control treatments. The widely-used Pybus-Harvey gamma statistic showed a clear short-term response to extinction and recovery, but differences between treatments diminished over time and did not show a long-term signature. The characteristics of post-extinction phylogenies were often affected as much by the recovery interval as by the extinction episode itself.	[Yedid, Gabriel] Univ Oslo, Dept Biol, Ctr Ecol & Evolutionary Synth, Oslo, Norway; [Stredwick, Jason] uTest, Southborough, MA USA; [Ofria, Charles A.] Michigan State Univ, Dept Comp Sci & Engn, E Lansing, MI 48824 USA; [Agapow, Paul-Michael] Hlth Protect Agcy, Ctr Infect, London, England	University of Oslo; Michigan State University; Health Protection Agency	Yedid, G (corresponding author), Univ Oslo, Dept Biol, Ctr Ecol & Evolutionary Synth, Oslo, Norway.	gyedid02@gmail.com		Ofria, Charles/0000-0003-2924-1732	Research Council of Norway [179569/V40]; U.S. National Science Foundation [DBI-0939454, CCF-0643952, CNS-0751155]	Research Council of Norway(Research Council of Norway); U.S. National Science Foundation(National Science Foundation (NSF))	This work was supported by the Research Council of Norway grant #179569/V40 (www.forskningsradet.no/english/) and the U.S. National Science Foundation grants #DBI-0939454, #CCF-0643952, #CNS-0751155. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1995, GLOBAL BIODIVERSITY; [Anonymous], MATLAB R2010B V7 11; Bambach RK, 2006, ANNU REV EARTH PL SC, V34, P127, DOI 10.1146/annurev.earth.33.092203.122654; Bambach RK, 2004, PALEOBIOLOGY, V30, P522, DOI 10.1666/0094-8373(2004)030<0522:OEAMDO>2.0.CO;2; Barraclough TG, 2003, EVOLUTION, V57, P2166; Benton MJ, 2003, TRENDS ECOL EVOL, V18, P358, DOI 10.1016/S0169-5347(03)00093-4; Carlson SJ, 2008, FOSS STRATA, P167; Chow SS, 2004, SCIENCE, V305, P84, DOI 10.1126/science.1096307; Cooper T., 2003, P INT C ARTIFICIAL L, P227; Crisp MD, 2009, EVOLUTION, V63, P2257, DOI 10.1111/j.1558-5646.2009.00728.x; Elena SF, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-284; Erwin DH, 1998, TRENDS ECOL EVOL, V13, P344, DOI 10.1016/S0169-5347(98)01436-0; Erwin DH, 2008, P NATL ACAD SCI USA, V105, P11520, DOI 10.1073/pnas.0801913105; Fritz SA, 2010, P ROY SOC B-BIOL SCI, V277, P2435, DOI 10.1098/rspb.2010.0030; Goldstein DB, 1999, BIOESSAYS, V21, P148, DOI 10.1002/(SICI)1521-1878(199902)21:2<148::AID-BIES8>3.0.CO;2-5; Hang DH, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-94; Harcourt-Brown KG, 2002, SYST BIOL, V51, P908, DOI 10.1080/10635150290155962; HARVEY PH, 1994, EVOLUTION, V48, P523, DOI 10.1111/j.1558-5646.1994.tb01341.x; Heard SB, 2000, P ROY SOC B-BIOL SCI, V267, P613, DOI 10.1098/rspb.2000.1046; Heard SB, 2002, SYST BIOL, V51, P889, DOI 10.1080/10635150290155917; Jablonski D, 2005, PALEOBIOLOGY, V31, P192, DOI 10.1666/0094-8373(2005)031[0192:MEAM]2.0.CO;2; Jablonski D, 2002, P NATL ACAD SCI USA, V99, P8139, DOI 10.1073/pnas.102163299; Jablonski D, 2001, P NATL ACAD SCI USA, V98, P5393, DOI 10.1073/pnas.101092598; Lenski RE, 1999, NATURE, V400, P661, DOI 10.1038/23245; Lenski RE, 2003, NATURE, V423, P139, DOI 10.1038/nature01568; Liow LH, 2010, SYST BIOL, V59, P646, DOI 10.1093/sysbio/syq052; McGhee GR, 2004, PALAEOGEOGR PALAEOCL, V211, P289, DOI 10.1016/j.palaeo.2004.05.010; McGowan AJ, 2004, PALEOBIOLOGY, V30, P369, DOI 10.1666/0094-8373(2004)030<0369:TEOTPB>2.0.CO;2; McKinney ML, 1997, ANNU REV ECOL SYST, V28, P495, DOI 10.1146/annurev.ecolsys.28.1.495; McPeek MA, 2008, AM NAT, V172, pE270, DOI 10.1086/593137; Misevic D, 2010, J HERED, V101, pS46, DOI 10.1093/jhered/esq017; Nee S, 2005, CONSERV BIOL SER, V8, P387; Nee S, 1997, SCIENCE, V278, P692, DOI 10.1126/science.278.5338.692; Nee Sean, 1995, P164; Ofria C, 2004, ARTIF LIFE, V10, P191, DOI 10.1162/106454604773563612; Ostrowski EA, 2007, AM NAT, V169, pE1, DOI 10.1086/510211; Phillimore AB, 2008, PLOS BIOL, V6, P483, DOI 10.1371/journal.pbio.0060071; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; Purvis A, 2000, SCIENCE, V288, P328, DOI 10.1126/science.288.5464.328; Pybus OG, 2000, P ROY SOC B-BIOL SCI, V267, P2267, DOI 10.1098/rspb.2000.1278; Quental TB, 2009, EVOLUTION, V63, P3158, DOI 10.1111/j.1558-5646.2009.00794.x; ROHLF FJ, 1990, EVOLUTION, V44, P1671, DOI 10.1111/j.1558-5646.1990.tb03855.x; Roopnarine PD, 2006, PALEOBIOLOGY, V32, P1; Roopnarine PD, 2007, P ROY SOC B-BIOL SCI, V274, P2077, DOI 10.1098/rspb.2007.0515; Roopnarine Peter D., 2009, Paleontological Society Papers, V15, P195; Russell GJ, 1998, CONSERV BIOL, V12, P1365, DOI 10.1046/j.1523-1739.1998.96332.x; Sahney S, 2008, P ROY SOC B-BIOL SCI, V275, P759, DOI 10.1098/rspb.2007.1370; SIMPSON GG, 1951, EVOLUTION, V5, P285, DOI 10.2307/2405675; Sole RV, 2010, J THEOR BIOL, V267, P193, DOI 10.1016/j.jtbi.2010.08.015; Sole RV, 2002, PHILOS T R SOC B, V357, P697, DOI 10.1098/rstb.2001.0987; Vamosi JC, 2008, ECOL LETT, V11, P1047, DOI 10.1111/j.1461-0248.2008.01215.x; Vamosi JC, 2005, DIVERS DISTRIB, V11, P25, DOI 10.1111/j.1366-9516.2005.00119.x; von Euler F, 2001, P ROY SOC B-BIOL SCI, V268, P127, DOI 10.1098/rspb.2000.1340; Wilke CO, 2001, NATURE, V412, P331, DOI 10.1038/35085569; Yedid G, 2008, J EVOLUTION BIOL, V21, P1335, DOI 10.1111/j.1420-9101.2008.01564.x; Yedid G, 2009, AM NAT, V173, pE139, DOI 10.1086/597228	56	13	13	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e37233	10.1371/journal.pone.0037233	http://dx.doi.org/10.1371/journal.pone.0037233			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693570	gold, Green Published, Green Submitted			2022-12-27	WOS:000305338500033
J	Aagaard, K; Riehle, K; Ma, J; Segata, N; Mistretta, TA; Coarfa, C; Raza, S; Rosenbaum, S; Van den Veyver, I; Milosavljevic, A; Gevers, D; Huttenhower, C; Petrosino, J; Versalovic, J				Aagaard, Kjersti; Riehle, Kevin; Ma, Jun; Segata, Nicola; Mistretta, Toni-Ann; Coarfa, Cristian; Raza, Sabeen; Rosenbaum, Sean; Van den Veyver, Ignatia; Milosavljevic, Aleksandar; Gevers, Dirk; Huttenhower, Curtis; Petrosino, Joseph; Versalovic, James			A Metagenomic Approach to Characterization of the Vaginal Microbiome Signature in Pregnancy	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; INTESTINAL MICROBIOTA; BODY HABITATS; COMMUNITIES; DIVERSITY; BACTERIAL; EVOLUTION; DELIVERY; INSIGHTS; TOOLS	While current major national research efforts (i.e., the NIH Human Microbiome Project) will enable comprehensive metagenomic characterization of the adult human microbiota, how and when these diverse microbial communities take up residence in the host and during reproductive life are unexplored at a population level. Because microbial abundance and diversity might differ in pregnancy, we sought to generate comparative metagenomic signatures across gestational age strata. DNA was isolated from the vagina (introitus, posterior fornix, midvagina) and the V5V3 region of bacterial 16S rRNA genes were sequenced (454FLX Titanium platform). Sixty-eight samples from 24 healthy gravidae (18 to 40 confirmed weeks) were compared with 301 non-pregnant controls (60 subjects). Generated sequence data were quality filtered, taxonomically binned, normalized, and organized by phylogeny and into operational taxonomic units (OTU); principal coordinates analysis (PCoA) of the resultant beta diversity measures were used for visualization and analysis in association with sample clinical metadata. Altogether, 1.4 gigabytes of data containing >2.5 million reads (averaging 6,837 sequences/sample of 493 nt in length) were generated for computational analyses. Although gravidae were not excluded by virtue of a posterior fornix pH >4.5 at the time of screening, unique vaginal microbiome signature encompassing several specific OTUs and higher-level clades was nevertheless observed and confirmed using a combination of phylogenetic, non-phylogenetic, supervised, and unsupervised approaches. Both overall diversity and richness were reduced in pregnancy, with dominance of Lactobacillus species (L. iners crispatus, jensenii and johnsonii, and the orders Lactobacillales (and Lactobacillaceae family), Clostridiales, Bacteroidales, and Actinomycetales. This intergroup comparison using rigorous standardized sampling protocols and analytical methodologies provides robust initial evidence that the vaginal microbial 16S rRNA gene catalogue uniquely differs in pregnancy, with variance of taxa across vaginal subsite and gestational age.	[Aagaard, Kjersti; Ma, Jun; Rosenbaum, Sean; Van den Veyver, Ignatia] Baylor Coll Med, Div Maternal Fetal Med, Dept Obstet & Gynecol, Houston, TX 77030 USA; [Aagaard, Kjersti; Riehle, Kevin; Ma, Jun; Mistretta, Toni-Ann; Coarfa, Cristian; Raza, Sabeen; Rosenbaum, Sean; Van den Veyver, Ignatia; Milosavljevic, Aleksandar; Petrosino, Joseph; Versalovic, James] Texas Childrens Hosp, Houston, TX 77030 USA; [Mistretta, Toni-Ann; Raza, Sabeen; Versalovic, James] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Aagaard, Kjersti; Riehle, Kevin; Ma, Jun; Coarfa, Cristian; Milosavljevic, Aleksandar] Baylor Coll Med, Bioinformat Res Lab, Houston, TX 77030 USA; [Segata, Nicola; Huttenhower, Curtis] Harvard Univ, Sch Publ Hlth, Cambridge, MA 02138 USA; [Gevers, Dirk] MIT, Broad Inst, Cambridge, MA 02139 USA; [Petrosino, Joseph] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Baylor College of Medicine	Aagaard, K (corresponding author), Baylor Coll Med, Div Maternal Fetal Med, Dept Obstet & Gynecol, Houston, TX 77030 USA.	aagaardt@bcm.edu	Gevers, Dirk/C-1451-2009; Van den Veyver, Ignatia B/AAF-4510-2021; Petrosino, Joseph F./AAF-1621-2019; Segata, Nicola/AAB-2980-2019; Segata, Nicola/K-7240-2016	Van den Veyver, Ignatia B/0000-0002-0651-5924; Riehle, Kevin/0000-0003-4888-2404; Huttenhower, Curtis/0000-0002-1110-0096; Segata, Nicola/0000-0002-1583-5794	National Institutes of Health [DP2120OD001500-01]; NICHD/NIDDK [R01DK080558-01, UH3 DK083990l]; NIH [1R01HG005969]; NIH Common Fund Human Microbiome-HMP [NIHU54HG004969]; Burroughs Welcome Fund (Burroughs Welcome Fund Preterm Birth Initiative); NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004969, R01HG005969] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080558] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD001500] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NICHD/NIDDK; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Common Fund Human Microbiome-HMP; Burroughs Welcome Fund (Burroughs Welcome Fund Preterm Birth Initiative); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by the National Institutes of Health (NIH Director New Innovator Award (DP2120OD001500-01 K.A.), NICHD/NIDDK #R01DK080558-01 (K.A.), UH3 DK083990l (J.V.), NIH 1R01HG005969 (C.H.), and the NIH Common Fund Human Microbiome-HMP (K.A., J.V., J.P., C.H., (NIHU54HG004969 D.G.)), and the Burroughs Welcome Fund (Burroughs Welcome Fund Preterm Birth Initiative (K.A. and J.V.)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard KJ, 2011, SCI TRANSL MED UNPUB; [Anonymous], 1986, MULTIVARIATE STAT ME; Brown CJ, 2007, J MED MICROBIOL, V56, P271, DOI 10.1099/jmm.0.46607-0; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; CHAO A, 1984, SCAND J STAT, V11, P265; Charlson ES, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015216; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Dominguez-Bello MG, 2011, GASTROENTEROLOGY, V140, P1713, DOI 10.1053/j.gastro.2011.02.011; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Favier CF, 2003, ANAEROBE, V9, P219, DOI 10.1016/j.anaerobe.2003.07.001; Favier CF, 2002, APPL ENVIRON MICROB, V68, P219, DOI 10.1128/AEM.68.1.219-226.2002; Fierer N, 2010, P NATL ACAD SCI USA, V107, P6477, DOI 10.1073/pnas.1000162107; Forney LJ, 2006, J INFECT DIS, V194, P1468, DOI 10.1086/508497; Forney LJ, 2010, J CLIN MICROBIOL, V48, P1741, DOI 10.1128/JCM.01710-09; Gavin DG, 2003, QUATERNARY RES, V60, P356, DOI 10.1016/S0033-5894(03)00088-7; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Gronlund MM, 1999, J PEDIATR GASTR NUTR, V28, P19, DOI 10.1097/00005176-199901000-00007; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Hamady M, 2009, GENOME RES, V19, P1141, DOI 10.1101/gr.085464.108; Hooper LV, 2001, SCIENCE, V291, P881, DOI 10.1126/science.291.5505.881; Kim TK, 2009, J CLIN MICROBIOL, V47, P1181, DOI 10.1128/JCM.00854-08; Kindt R., 2005, WORLD; Knights D, 2011, ISME J, V5, P570, DOI 10.1038/ismej.2010.148; Knights D, 2011, FEMS MICROBIOL REV, V35, P343, DOI 10.1111/j.1574-6976.2010.00251.x; Kurokawa K, 2006, DNA RES, V14, P169; Kursa MB, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i11; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Ley RE, 2008, NAT REV MICROBIOL, V6, P776, DOI 10.1038/nrmicro1978; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Li M, 2008, P NATL ACAD SCI USA, V105, P2117, DOI 10.1073/pnas.0712038105; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone CA, 2007, APPL ENVIRON MICROB, V73, P1576, DOI 10.1128/AEM.01996-06; Mackie RI, 1999, AM J CLIN NUTR, V69, p1035S, DOI 10.1093/ajcn/69.5.1035s; Oksanen J., 2007, VEGAN COMMUNITY ECOL; Oswald WW, 2003, J ECOL, V91, P1022, DOI 10.1046/j.1365-2745.2003.00823.x; Penders J, 2006, PEDIATRICS, V118, P511, DOI 10.1542/peds.2005-2824; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Pridmore RD, 2004, P NATL ACAD SCI USA, V101, P2512, DOI 10.1073/pnas.0307327101; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; R Core Team, 2016, R FDN STAT COMP; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Reeder J, 2010, NAT METHODS, V7, P668, DOI 10.1038/nmeth0910-668b; Reinhardt C, 2009, J PEDIATR GASTR NUTR, V48, P249, DOI 10.1097/MPG.0b013e318183187c; Renyi A, 1961, P 4 BERK S MATH STAT, V1; Riehle KP, 2011, BMC BIOINFO IN PRESS; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; TOTHMERESZ B, 1995, J VEG SCI, V6, P283, DOI 10.2307/3236223; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; WHITTAKER R H, 1972, Taxon, V21, P213, DOI 10.2307/1218190; Xhou X, 2010, INFECT DIS OBSTET GY; Ye YZ, 2010, IEEE INT C BIOINFORM, P153, DOI 10.1109/BIBM.2010.5706555; Zoetendal EG, 1998, APPL ENVIRON MICROB, V64, P3854	61	419	451	0	120	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e36466	10.1371/journal.pone.0036466	http://dx.doi.org/10.1371/journal.pone.0036466			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22719832	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341900010
J	Bensafi, M; Iannilli, E; Poncelet, J; Seo, HS; Gerber, J; Rouby, C; Hummel, T				Bensafi, Moustafa; Iannilli, Emilia; Poncelet, Johan; Seo, Han-Seok; Gerber, Johannes; Rouby, Catherine; Hummel, Thomas			Dissociated Representations of Pleasant and Unpleasant Olfacto-Trigeminal Mixtures: An fMRI Study	PLOS ONE			English	Article							HUMAN BRAIN; NEURAL REPRESENTATION; ODOR PERCEPTION; ACTIVATION; RESPONSES; VALENCE; HUMANS; STIMULATION; INTEGRATION; CORTEX	How the pleasantness of chemosensory stimuli such as odorants or intranasal trigeminal compounds is processed in the human brain has been the focus of considerable recent interest. Yet, so far, only the unimodal form of this hedonic processing has been explored, and not its bimodal form during crossmodal integration of olfactory and trigeminal stimuli. The main purpose of the present study was to investigate this question. To this end, functional magnetic resonance imaging (fMRI) was used in an experiment comparing brain activation related to a pleasant and a relatively unpleasant olfacto-trigeminal mixture, and to their individual components (CO2 alone, Orange alone, Rose alone). Results revealed first common neural activity patterns in response to both mixtures in a number of regions: notably the superior temporal gyrus and the caudate nucleus. Common activations were also observed in the insula, although the pleasant mixture activated the right insula whereas the unpleasant mixture activated the left insula. However, specific activations were observed in anterior cingulate gyrus and the ventral tegmental area only during the perception of the pleasant mixture. These findings emphasized for the firs time the involvement of the latter structures in processing of pleasantness during crossmodal integration of chemosensory stimuli.	[Bensafi, Moustafa; Poncelet, Johan; Rouby, Catherine] Univ Lyon, Lyon Neurosci Res Ctr, CNRS, UMR5292, Lyon, France; [Iannilli, Emilia; Seo, Han-Seok; Hummel, Thomas] Univ Dresden, Dept Otorhinolaryngol, Smell & Taste Clin, Sch Med, Dresden, Germany; [Gerber, Johannes] Univ Dresden, Dept Neuroradiol, Sch Med, Dresden, Germany	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); Technische Universitat Dresden; Technische Universitat Dresden	Bensafi, M (corresponding author), Univ Lyon, Lyon Neurosci Res Ctr, CNRS, UMR5292, Lyon, France.	bensafi@olfac.univ-lyon1.fr	Iannilli, Emilia/H-6776-2019; Bensafi, Moustafa/H-6618-2017; Gerber, Johannes/U-4918-2019	Iannilli, Emilia/0000-0001-6871-3769; Bensafi, Moustafa/0000-0002-2991-3036; Gerber, Johannes/0000-0001-7465-8700; Rouby, Catherine/0000-0002-5683-5491; Seo, Han-Seok/0000-0001-9845-8199	French Research National Agency (ANR)	French Research National Agency (ANR)(French National Research Agency (ANR))	This work was funded by a grant from the French Research National Agency (ANR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht J, 2009, HUM BRAIN MAPP, V30, P699, DOI 10.1002/hbm.20535; Anderson AK, 2003, NAT NEUROSCI, V6, P196, DOI 10.1038/nn1001; Ashburner J., 2003, HUMAN BRAIN FUNCTION; Ashby FG, 1999, PSYCHOL REV, V106, P529, DOI 10.1037/0033-295X.106.3.529; Bensafi M, 2008, NEUROSCIENCE, V154, P832, DOI 10.1016/j.neuroscience.2008.03.079; Bensafi M, 2007, CLIN NEUROPHYSIOL, V118, P696, DOI 10.1016/j.clinph.2006.10.022; Bensafi M, 2002, NEUROSCI LETT, V328, P309, DOI 10.1016/S0304-3940(02)00548-7; Bensafi M, 2007, J NEUROPHYSIOL, V98, P3254, DOI 10.1152/jn.00349.2007; Boyle JA, 2007, NEUROSCIENCE, V149, P223, DOI 10.1016/j.neuroscience.2007.06.045; Calvert GA, 2001, CEREB CORTEX, V11, P1110, DOI 10.1093/cercor/11.12.1110; Cometto-Muniz JE, 2005, CHEM SENSES, V30, P627, DOI 10.1093/chemse/bji056; Croy I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009362; de Araujo IE, 2005, NEURON, V46, P671, DOI 10.1016/j.neuron.2005.04.021; Doty R. L., 2003, HDB OLFACTION GUSTAT, P981, DOI DOI 10.1201/9780203911457; DOTY RL, 1978, PHYSIOL BEHAV, V20, P175, DOI 10.1016/0031-9384(78)90070-7; Frasnelli J, 2007, CEREB CORTEX, V17, P2268, DOI 10.1093/cercor/bhl135; Gottfried JA, 2002, J NEUROSCI, V22, P10829; Gottfried JA, 2002, J NEUROSCI, V22, P10819; Hummel T, 1997, CHEM SENSES, V22, P39, DOI 10.1093/chemse/22.1.39; Keller A, 2007, NATURE, V449, P468, DOI 10.1038/nature06162; KOBAL G, 1992, CHEM SENSES, V17, P233, DOI 10.1093/chemse/17.3.233; Kobal G, 1981, ELEKTROPHYSIOLOGISCH; Lombion S, 2009, HUM BRAIN MAPP, V30, P821, DOI 10.1002/hbm.20548; Lundstrom JN, 2006, CHEM SENSES, V31, P705, DOI 10.1093/chemse/bjl012; Mai JK, 2004, ATLAS HUMAN BRAIN; Nagy A, 2006, EUR J NEUROSCI, V24, P917, DOI 10.1111/j.1460-9568.2006.04942.x; Penny W., 2003, HUMAN BRAIN FUNCTION; Rolls ET, 2003, EUR J NEUROSCI, V18, P695, DOI 10.1046/j.1460-9568.2003.02779.x; Royet JP, 2003, NEUROIMAGE, V20, P713, DOI 10.1016/S1053-8119(03)00388-4; ROZIN P, 1982, APPETITE, V3, P13, DOI 10.1016/S0195-6663(82)80033-0; Sabri M, 2005, NEUROIMAGE, V25, P969, DOI 10.1016/j.neuroimage.2004.12.033; Sela L, 2009, J NEUROSCI, V29, P12059, DOI 10.1523/JNEUROSCI.2114-09.2009; Small DM, 2003, NEURON, V39, P701, DOI 10.1016/S0896-6273(03)00467-7; Small DM, 2005, NEURON, V47, P593, DOI 10.1016/j.neuron.2005.07.022; Small DM, 2004, J NEUROPHYSIOL, V92, P1892, DOI 10.1152/jn.00050.2004; Vogt BA, 2005, NAT REV NEUROSCI, V6, P533, DOI 10.1038/nrn1704; WYSOCKI CJ, 1989, ANN NY ACAD SCI, V561, P12, DOI 10.1111/j.1749-6632.1989.tb20966.x; Zald DH, 1997, P NATL ACAD SCI USA, V94, P4119, DOI 10.1073/pnas.94.8.4119; Zelano C, 2007, J NEUROPHYSIOL, V97, P1969, DOI 10.1152/jn.01122.2006	39	32	33	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2012	7	6							e38358	10.1371/journal.pone.0038358	http://dx.doi.org/10.1371/journal.pone.0038358			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UJ	22701631	gold, Green Submitted, Green Published			2022-12-27	WOS:000305340000019
J	Guo, J; Han, B; Qin, LJ; Li, B; You, HH; Yang, JW; Liu, DD; Wei, CX; Nanberg, E; Bornehag, CG; Yang, X				Guo, Jing; Han, Bing; Qin, Longjuan; Li, Bing; You, Huihui; Yang, Jiwen; Liu, Dandan; Wei, Chenxi; Nanberg, Eewa; Bornehag, Carl-Gustaf; Yang, Xu			Pulmonary Toxicity and Adjuvant Effect of Di-(2-exylhexyl) Phthalate in Ovalbumin-Immunized BALB/c Mice	PLOS ONE			English	Article							SUBCUTANEOUS INJECTION MODEL; DI-(2-ETHYLHEXYL) PHTHALATE; ASTHMA; CHILDREN; EXPOSURE; DISEASES; ASSOCIATION; ALLERGIES; DUST; HOME	Background: Asthma is a complex pulmonary inflammatory disease, which is characterized by airway hyperresponsiveness, variable airflow obstruction and inflammation in the airways. The majority of asthma is allergic asthma, which is a disease caused by type I hypersensitivity mediated by IgE. Exposures to a number of environmental chemicals are suspected to lead to asthma, one such pollutant is di-(2-ethylheyl) phthalate (DEHP). DEHP is a manufactured chemical that is commonly added in plastic products to make them flexible. Epidemiological studies have revealed a positive association between DEHP exposure and asthma prevalence. Methodology/Principal Findings: The present study was aimed to determine the underlying role of DEHP exposure in airway reactivity, especially when combined with allergen exposure. The biomarkers include pulmonary histopathology, airway hyperresponsiveness (lung function), IgE, IL-4, IFN-gamma and eosinophils. Healthy balb/c mice were randomly divided into eight exposure groups (n = 8 each): (1) saline control, (2) 30 mu g/(kg.d) DEHP, (3) 300 mu g/(kg.d) DEHP, (4) 3000 mu g/(kg.d) DEHP, and (5) ovalbumin (OVA)-sensitized group, (6) OVA-combined with 30 mu g/(kg.d) DEHP, (7) OVA-combined with 300 mu g/(kg.d) DEHP, and (8) OVA-combined with 3000 mu g/(kg.d) DEHP. Experimental tests were conducted after 52-day DEHP exposure and subsequently one week of challenge with aerosolized OVA. The principal findings include: (1) Strong postive associations exist between OVA-combined DEHP exposure and serum total IgE (T-IgE), as well as histological findings. These positive associations show a dose-dependent low dose sensitive effect of DEHP. (2) IL-4, eosinophil recruitment and lung function are also indicators for adjuvant effect of DEHP. Conclusions/Significance: Our results suggest that except the significant changes of immunological and inflammatory biomarkers (T-IgE, IL-4, IFN-gamma and eosinophils), the pulmonary histological (histopathological examination) and physiological (lung function) data also support that DEHP may promote and aggravate allergic asthma by adjuvant effect.	[Guo, Jing; Han, Bing; Qin, Longjuan; Li, Bing; You, Huihui; Yang, Jiwen; Liu, Dandan; Wei, Chenxi; Yang, Xu] Huazhong Normal Univ, Hubei Key Lab Genet Regulat & Integrat Biol, Wuhan, Peoples R China; [You, Huihui; Nanberg, Eewa] Karlstad Univ, Dept Chem & Biomed Sci, Karlstad, Sweden; [Bornehag, Carl-Gustaf] Karlstad Univ, Dept Hlth & Environm, Karlstad, Sweden	Central China Normal University; Karlstad University; Karlstad University	Guo, J (corresponding author), Huazhong Normal Univ, Hubei Key Lab Genet Regulat & Integrat Biol, Wuhan, Peoples R China.	carl-gustaf.bornehag@kau.se; yangxu@mail.ccnu.edu.cn	Wei, Chenxi/C-8630-2016	Wei, Chenxi/0000-0002-3837-1881; Bornehag, Carl-Gustaf/0000-0003-0417-1686	China National Natural Science Foundation [51136002, 51076079]; National Key Technologies R&D Program of China [2012BAJ02B03]	China National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Key Technologies R&D Program of China(National Key Technology R&D Program)	This work was supported by the China National Natural Science Foundation (grant ID: 51136002, 51076079) and National Key Technologies R&D Program of China (grant ID: 2012BAJ02B03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anandan C, 2010, ALLERGY, V65, P152, DOI 10.1111/j.1398-9995.2009.02244.x; ATSDR(AgencyforToxicSubstancesandDiseaseRegistry), 2002, TOX PROF DI 2 ETH PH; Bornehag CG, 2010, INT J ANDROL, V33, P333, DOI 10.1111/j.1365-2605.2009.01023.x; Bornehag CG, 2004, ENVIRON HEALTH PERSP, V112, P1393, DOI 10.1289/ehp.7187; Butala JH, 2004, TOXICOLOGY, V201, P77, DOI 10.1016/j.tox.2004.04.004; Dearman RJ, 2008, TOXICOLOGY, V244, P231, DOI 10.1016/j.tox.2007.11.017; Drazen JM, 1999, ANNU REV PHYSIOL, V61, P593, DOI 10.1146/annurev.physiol.61.1.593; Hansen JS, 2007, TOXICOLOGY, V232, P79, DOI 10.1016/j.tox.2006.12.011; Hirota JA, 2009, PULM PHARMACOL THER, V22, P370, DOI 10.1016/j.pupt.2008.12.004; Hirvonen A, 2009, MUTAT RES-FUND MOL M, V667, P132, DOI 10.1016/j.mrfmmm.2008.12.013; Jaakkola JJK, 2000, AM J PUBLIC HEALTH, V90, P797, DOI 10.2105/AJPH.90.5.797; Jaakkola JJK, 2004, AM J PUBLIC HEALTH, V94, P560, DOI 10.2105/AJPH.94.4.560; Jaakkola JJK, 2008, ENVIRON HEALTH PERSP, V116, P845, DOI 10.1289/ehp.10846; Kolarik B, 2008, ENVIRON HEALTH PERSP, V116, P98, DOI 10.1289/ehp.10498; Larsen Soren T, 2009, BMC Res Notes, V2, P225, DOI 10.1186/1756-0500-2-225; Larsen ST, 2007, TOXICOL LETT, V170, P223, DOI 10.1016/j.toxlet.2007.03.009; Larsen ST, 2007, TOXICOLOGY, V235, P119, DOI 10.1016/j.tox.2007.03.010; Larsen ST, 2001, TOXICOL LETT, V125, P11, DOI 10.1016/S0378-4274(01)00419-2; Larsen ST, 2001, TOXICOLOGY, V169, P37, DOI 10.1016/S0300-483X(01)00484-X; Lee MH, 2004, INT ARCH ALLERGY IMM, V134, P213, DOI 10.1159/000078768; Liu YJ, 2007, ANNU REV IMMUNOL, V25, P193, DOI 10.1146/annurev.immunol.25.022106.141718; Nagata Y, 2007, INT ARCH ALLERGY IMM, V144, P305, DOI 10.1159/000106319; *NTP CERHR, 2000, NTP CERHR EXP PAN RE; Qiao Y, 2009, INHAL TOXICOL, V21, P1200, DOI 10.3109/08958370902806159; Simpson JL, 2009, PHARMACOL THERAPEUT, V124, P86, DOI 10.1016/j.pharmthera.2009.06.004; Subbarao P, 2009, CAN MED ASSOC J, V181, pE181, DOI 10.1503/cmaj.080612; Swindle EJ, 2009, J ALLERGY CLIN IMMUN, V124, P23, DOI 10.1016/j.jaci.2009.05.037; Tuomainen A, 2006, ENVIRON HEALTH PERSP, V114, P1409, DOI 10.1289/ehp.8965; US Food and Drug Administration, 2001, SAF ASS DI 2 ETH PHT; Yang GT, 2008, FOOD AGR IMMUNOL, V19, P351, DOI 10.1080/09540100802545869; You HH, 2011, J YULIN NORMAL U, V32, P15	31	69	69	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2012	7	6							e39008	10.1371/journal.pone.0039008	http://dx.doi.org/10.1371/journal.pone.0039008			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UJ	22701742	Green Published, gold, Green Submitted			2022-12-27	WOS:000305340000059
J	Sanchez-Donoso, I; Vila, C; Puigcerver, M; Butkauskas, D; de la Calle, JRC; Morales-Rodriguez, PA; Rodriguez-Teijeiro, JD				Sanchez-Donoso, Ines; Vila, Carles; Puigcerver, Manel; Butkauskas, Dalius; Caballero de la Calle, Jose Ramon; Antonio Morales-Rodriguez, Pablo; Domingo Rodriguez-Teijeiro, Jose			Are Farm-Reared Quails for Game Restocking Really Common Quails (Coturnix coturnix)?: A Genetic Approach	PLOS ONE			English	Article							JAPANESE-QUAIL; LINKAGE MAP; A-GRAECA; HYBRIDIZATION; POPULATIONS; INDIVIDUALS	The common quail (Coturnix coturnix) is a popular game species for which restocking with farm-reared individuals is a common practice. In some areas, the number of released quails greatly surpasses the number of wild breeding common quail. However, common quail are difficult to raise in captivity and this casts suspicion about a possible hybrid origin of the farmed individuals from crosses with domestic Japanese quail (C. japonica). In this study we used a panel of autosomal microsatellite markers to characterize the genetic origin of quails reared for hunting purposes in game farms in Spain and of quails from an experimental game farm which was founded with hybrids that have been systematically backcrossed with wild common quails. The genotypes of these quail were compared to those of wild common quail and domestic strains of Japanese quail. Our results show that more than 85% of the game farm birds were not common quail but had domestic Japanese quail ancestry. In the experimental farm a larger proportion of individuals could not be clearly separated from pure common quails. We conclude that the majority of quail sold for restocking purposes were not common quail. Genetic monitoring of individuals raised for restocking is indispensable as the massive release of farm-reared hybrids could represent a severe threat for the long term survival of the native species.	[Sanchez-Donoso, Ines; Vila, Carles] EBD CSIC, Conservat & Evolutionary Genet Grp, Donana Biol Stn, Seville, Spain; [Sanchez-Donoso, Ines; Domingo Rodriguez-Teijeiro, Jose] Univ Barcelona, Dept Anim Biol, Barcelona, Spain; [Puigcerver, Manel] Univ Barcelona, Expt Sci & Math Didact Dept, Barcelona, Spain; [Butkauskas, Dalius] Nat Res Ctr, Lab Mol Ecol, Vilnius, Lithuania; [Caballero de la Calle, Jose Ramon; Antonio Morales-Rodriguez, Pablo] Univ Castilla La Mancha, Sci Agroforestry Technol & Genet Dept, E-13071 Ciudad Real, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); University of Barcelona; University of Barcelona; Nature Research Center - Lithuania; Universidad de Castilla-La Mancha	Sanchez-Donoso, I (corresponding author), EBD CSIC, Conservat & Evolutionary Genet Grp, Donana Biol Stn, Seville, Spain.	ines.sanchezdonoso@gmail.com	Rodríguez-Teijeiro, José Domingo/AAV-7830-2021; Rodriguez-Teijeiro, Jose D/G-2768-2016; Morales-Rodríguez, Pablo Antonio/ABA-5545-2020; Vila, Carles/H-4893-2013; Sanchez-Donoso, Ines/L-7478-2014	Rodríguez-Teijeiro, José Domingo/0000-0001-7787-9293; Rodriguez-Teijeiro, Jose D/0000-0001-7787-9293; Morales-Rodríguez, Pablo Antonio/0000-0002-2909-1992; Vila, Carles/0000-0002-4206-5246; Sanchez-Donoso, Ines/0000-0003-2773-9844	Direccion General de Investigacion y Gestion del plan nacional de I+D+i [CGL2004-05308/BOS, CGL2007-63199/BOS]; Direccio General de Recerca [2009-SGR-481]; Departament d'Universitats, Investigacio i Societat de la Informacio of the "Generalitat de Catalunya"; Ajuts per a la formacio i contractacio de personal investigador novell of the "Generalitat de Catalunya"; Proyecto Regional de la Junta de Comunidades de Castilla-La Mancha [PII1I09-0174-0915]; Programa de captacion del conocimiento para Andalucia of the "Junta de Andalucia"	Direccion General de Investigacion y Gestion del plan nacional de I+D+i; Direccio General de Recerca; Departament d'Universitats, Investigacio i Societat de la Informacio of the "Generalitat de Catalunya"; Ajuts per a la formacio i contractacio de personal investigador novell of the "Generalitat de Catalunya"; Proyecto Regional de la Junta de Comunidades de Castilla-La Mancha(Junta de Comunidades de Castilla-La Mancha); Programa de captacion del conocimiento para Andalucia of the "Junta de Andalucia"(Junta de Andalucia)	The work has been supported by the following funders: "Direccion General de Investigacion y Gestion del plan nacional de I+D+i" (CGL2004-05308/BOS and CGL2007-63199/BOS projects); "Direccio General de Recerca" (2009-SGR-481 project); "Departament d'Universitats, Investigacio i Societat de la Informacio of the "Generalitat de Catalunya"; "Ajuts per a la formacio i contractacio de personal investigador novell" (FI grant) of the "Generalitat de Catalunya" (http://www.gencat.cat/); "Proyecto Regional de la Junta de Comunidades de Castilla-La Mancha" (PII1I09-0174-0915 project); grant from the "Programa de captacion del conocimiento para Andalucia" of the "Junta de Andalucia" (http://www.juntadeandalucia.es/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral AJ, 2007, FOLIA ZOOL, V56, P285; Anderson EC, 2002, GENETICS, V160, P1217; Bagliacca M, 2008, ITAL J ANIM SCI, V7, P321; Barilani M, 2005, BIOL CONSERV, V126, P445, DOI 10.1016/j.biocon.2005.06.027; Barilani M, 2007, BIOL CONSERV, V137, P57, DOI 10.1016/j.biocon.2007.01.014; Belkhir K., 2004, GENETIX 4 05 LOGICIE; Blanco-Aguiar JA, 2008, ANIM CONSERV, V11, P535, DOI 10.1111/j.1469-1795.2008.00212.x; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; BURFIELD IJ, 2004, BIRDS EUROPE POPULAT; Butkauskas Dalius, 2006, Acta Zoologica Lituanica, V16, P177; Caballero de la Calle J.R., 1997, PRODUCCIONES CINEG T, V12, P109; Champagnon Jocelyn, 2009, Wildfowl, P184; Chazara O., 2006, ACTES BRG, V6, P317; Chazara O, 2010, CONSERV GENET, V11, P1051, DOI 10.1007/s10592-009-9951-8; Deregnaucourt S, 2005, APPL ANIM BEHAV SCI, V94, P303, DOI 10.1016/j.applanim.2005.03.002; Deregnaucourt S, 2002, ARDEA, V90, P15; Deregnaucourt S., 2000, THESIS U RENNES 1 RE, V2381; DeYoung RW, 2003, MOL ECOL, V12, P3237, DOI 10.1046/j.1365-294X.2003.01996.x; Earl DA, 2011, CONSERV GENET RESOUR, V4, P359, DOI DOI 10.1007/S12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Fischer J, 2000, BIOL CONSERV, V96, P1, DOI 10.1016/S0006-3207(00)00048-3; Galli L, 2003, THESIS U GENOVA GENO; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Guyomarc'h J. C., 2003, Game & Wildlife Science, V20, P1; Hamilton M.B., 2009, POPULATION GENETICS; Johnsgard PA, 1988, QUAILS PARTRIDGES FR; Kayang BB, 2004, ANIM GENET, V35, P195, DOI 10.1111/j.1365-2052.2004.01135.x; Kayang BB, 2002, GENET SEL EVOL, V34, P233, DOI [10.1051/gse:2002006, 10.1186/1297-9686-34-2-233]; Kruckenhauser L, 2004, J ZOOL SYST EVOL RES, V42, P19; Lamont Myles M., 2009, International Journal of Galliformes Conservation, V1, P63; Leberg PL, 2002, MOL ECOL, V11, P2445, DOI 10.1046/j.1365-294X.2002.01612.x; Mank JE, 2004, CONSERV GENET, V5, P395, DOI 10.1023/B:COGE.0000031139.55389.b1; Martinez-Fresno M, 2008, CONSERV GENET, V9, P1223, DOI 10.1007/s10592-007-9449-1; Negro JJ, 2001, BIOL CONSERV, V98, P19, DOI 10.1016/S0006-3207(00)00129-4; Nei M., 1987, MOL EVOLUTIONARY GEN; Park S.D.E., 2001, THESIS; Perez y Perez F., 1974, COTURNICULTURA TRATA, V2nd; Pritchard JK, 2000, GENETICS, V155, P945; Puigcerver M, 2007, BIOL CONSERV, V136, P628, DOI 10.1016/j.biocon.2007.01.007; Randi E, 2003, MOL ECOL, V12, P2201, DOI 10.1046/j.1365-294X.2003.01899.x; Rizzoni R, 1957, QUAGLIA DOMESTICA; Rodriguez-Teijeiro J. D., 1992, Gibier Faune Sauvage, V9, P377; Rodriguez-Teijeiro J. D, 2004, ATLES OCELLS NIDIFIC, P112; Rodriguez-Teijeiro J.D., 1993, TROFEO, V277, P48; Sevane N, 2011, J BIOL RES-THESSALON, V16, P266; Sokos CK, 2008, WILDLIFE BIOL, V14, P412, DOI 10.2981/0909-6396-14.4.412; Tsiompanoudis A., 2011, INT J GALLIFORMES CO, V2, P36; Vaha JP, 2006, MOL ECOL, V15, P63, DOI 10.1111/j.1365-294X.2005.02773.x; Vernesi C, 2003, MOL ECOL, V12, P585, DOI 10.1046/j.1365-294X.2003.01763.x; Yamashina Y., 1961, Journal of the Bombay Natural History Society, V58, P216; [No title captured]	51	27	28	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2012	7	6							e39031	10.1371/journal.pone.0039031	http://dx.doi.org/10.1371/journal.pone.0039031			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UJ	22701745	Green Published, gold			2022-12-27	WOS:000305340000062
J	Monteleone, MC; Wusener, AEG; Burdisso, JE; Conde, C; Caceres, A; Arregui, CO				Monteleone, Melisa C.; Gonzalez Wusener, Ana E.; Burdisso, Juan E.; Conde, Cecilia; Caceres, Alfredo; Arregui, Carlos O.			ER-Bound Protein Tyrosine Phosphatase PTP1B Interacts with Src at the Plasma Membrane/Substrate Interface	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM; CELL-ADHESION; C-SRC; INSULIN-RECEPTOR; N-CADHERIN; FAMILY; MEMBRANE; 1B; KINASE; ACTIN	PTP1B is an endoplasmic reticulum (ER) anchored enzyme whose access to substrates is partly dependent on the ER distribution and dynamics. One of these substrates, the protein tyrosine kinase Src, has been found in the cytosol, endosomes, and plasma membrane. Here we analyzed where PTP1B and Src physically interact in intact cells, by bimolecular fluorescence complementation (BiFC) in combination with temporal and high resolution microscopy. We also determined the structural basis of this interaction. We found that BiFC signal is displayed as puncta scattered throughout the ER network, a feature that was enhanced when the substrate trapping mutant PTP1B-D181A was used. Time-lapse and co-localization analyses revealed that BiFC puncta did not correspond to vesicular carriers; instead they localized at the tip of dynamic ER tubules. BiFC puncta were retained in ventral membrane preparations after cell unroofing and were also detected within the evanescent field of total internal reflection fluorescent microscopy (TIRFM) associated to the ventral membranes of whole cells. Furthermore, BiFC puncta often colocalized with dark spots seen by surface reflection interference contrast (SRIC). Removal of Src myristoylation and polybasic motifs abolished BiFC. In addition, PTP1B active site and negative regulatory tyrosine 529 on Src were primary determinants of BiFC occurrence, although the SH3 binding motif on PTP1B also played a role. Our results suggest that ER-bound PTP1B dynamically interacts with the negative regulatory site at the C-terminus of Src at random puncta in the plasma membrane/ substrate interface, likely leading to Src activation and recruitment to adhesion complexes. We postulate that this functional ER/plasma membrane crosstalk could apply to a wide array of protein partners, opening an exciting field of research.	[Monteleone, Melisa C.; Gonzalez Wusener, Ana E.; Burdisso, Juan E.; Arregui, Carlos O.] Univ San Martin, Inst Invest Biotecnol, Buenos Aires, DF, Argentina; [Conde, Cecilia; Caceres, Alfredo] Inst Invest Med Mercedes & Martin Ferreya INIMEC, Cordoba, Argentina		Monteleone, MC (corresponding author), Univ San Martin, Inst Invest Biotecnol, Buenos Aires, DF, Argentina.	carregui@iib.unsam.edu.ar		Arregui, Carlos/0000-0003-0704-3321; Monteleone, Melisa Carolina/0000-0002-6282-4019; Conde, Cecilia/0000-0002-5103-6391	Agencia Nacional para la Promocion Cientifica y Tecnologica, Argentina	Agencia Nacional para la Promocion Cientifica y Tecnologica, Argentina(ANPCyT)	This work was supported by grants from Agencia Nacional para la Promocion Cientifica y Tecnologica, Argentina http://www.agencia.gov.ar/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderie I, 2007, CELL SIGNAL, V19, P582, DOI 10.1016/j.cellsig.2006.08.007; Arias-Romero LE, 2009, CANCER RES, V69, P4582, DOI 10.1158/0008-5472.CAN-08-4001; Arias-Salgado EG, 2005, J CELL BIOL, V170, P837, DOI 10.1083/jcb.200503125; Arregui CO, 2000, NEUROCHEM RES, V25, P95, DOI 10.1023/A:1007595617447; Arregui CO, 1998, J CELL BIOL, V143, P861, DOI 10.1083/jcb.143.3.861; AVNUR Z, 1981, J MOL BIOL, V153, P361, DOI 10.1016/0022-2836(81)90283-7; Axelrod D, 2008, METHOD CELL BIOL, V89, P169, DOI 10.1016/S0091-679X(08)00607-9; Balsamo J, 1998, J CELL BIOL, V143, P523, DOI 10.1083/jcb.143.2.523; Bjorge JD, 2000, J BIOL CHEM, V275, P41439, DOI 10.1074/jbc.M004852200; Boggon TJ, 2004, ONCOGENE, V23, P7918, DOI 10.1038/sj.onc.1208081; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Boute N, 2003, EMBO REP, V4, P313, DOI 10.1038/sj.embor.embor767; Burridge K, 2006, J BIOL CHEM, V281, P15593, DOI 10.1074/jbc.R500030200; Chacon PJ, 2010, MOL CELL NEUROSCI, V43, P384, DOI 10.1016/j.mcn.2010.01.005; Cheng A, 2001, J BIOL CHEM, V276, P25848, DOI 10.1074/jbc.M009734200; Chong YP, 2005, BBA-PROTEINS PROTEOM, V1754, P210, DOI 10.1016/j.bbapap.2005.07.027; Cortesio CL, 2008, J CELL BIOL, V180, P957, DOI 10.1083/jcb.200708048; Dadke S, 2002, BIOCHEM J, V364, P377, DOI 10.1042/BJ20011372; Drees Frauke, 2004, V294, P303; Eden ER, 2010, NAT CELL BIOL, V12, P267, DOI 10.1038/ncb2026; FEIGUIN F, 1994, J CELL BIOL, V127, P1021, DOI 10.1083/jcb.127.4.1021; Fincham VJ, 1996, J CELL BIOL, V135, P1551, DOI 10.1083/jcb.135.6.1551; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; Frame MC, 2002, NAT REV MOL CELL BIO, V3, P233, DOI 10.1038/nrm779; FRANGIONI JV, 1992, CELL, V68, P545, DOI 10.1016/0092-8674(92)90190-N; Fuentes F, 2009, MOL BIOL CELL, V20, P1878, DOI 10.1091/mbc.E08-07-0675; Haj FG, 2002, SCIENCE, V295, P1708, DOI 10.1126/science.1067566; Hernandez MV, 2010, MOL BIOL CELL, V21, P1387, DOI 10.1091/mbc.E09-10-0880; Hernandez MV, 2006, J CELL SCI, V119, P1233, DOI 10.1242/jcs.02846; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; KAPLAN KB, 1992, J CELL BIOL, V118, P321, DOI 10.1083/jcb.118.2.321; KAPLAN KB, 1994, EMBO J, V13, P4745, DOI 10.1002/j.1460-2075.1994.tb06800.x; Kasahara K, 2007, EXP CELL RES, V313, P2651, DOI 10.1016/j.yexcr.2007.05.001; Kay BK, 2000, FASEB J, V14, P231, DOI 10.1096/fasebj.14.2.231; Kerppola TK, 2008, ANNU REV BIOPHYS, V37, P465, DOI 10.1146/annurev.biophys.37.032807.125842; Kostic A, 2006, MOL BIOL CELL, V17, P2684, DOI 10.1091/mbc.E05-12-1161; Krylyshkina O, 2003, J CELL BIOL, V161, P853, DOI 10.1083/jcb.200301102; LEE C, 1988, CELL, V54, P37, DOI 10.1016/0092-8674(88)90177-8; Lessard L, 2010, BBA-PROTEINS PROTEOM, V1804, P613, DOI 10.1016/j.bbapap.2009.09.018; Liang FB, 2005, J BIOL CHEM, V280, P24857, DOI 10.1074/jbc.M502780200; Lilien J, 2002, DEV DYNAM, V224, P18, DOI 10.1002/dvdy.10087; Liu F, 1996, J BIOL CHEM, V271, P31290, DOI 10.1074/jbc.271.49.31290; Mertins P, 2008, MOL CELL PROTEOMICS, V7, P1763, DOI 10.1074/mcp.M800196-MCP200; Nievergall E, 2010, J CELL BIOL, V191, P1189, DOI 10.1083/jcb.201005035; Parsons SJ, 2004, ONCOGENE, V23, P7906, DOI 10.1038/sj.onc.1208160; RESH MD, 1994, CELL, V76, P411, DOI 10.1016/0092-8674(94)90104-X; Romsicki Y, 2004, J BIOL CHEM, V279, P12868, DOI 10.1074/jbc.M309600200; Roskoski R, 2005, BIOCHEM BIOPH RES CO, V331, P1, DOI 10.1016/j.bbrc.2005.03.012; Sallee JL, 2006, J BIOL CHEM, V281, P16189, DOI 10.1074/jbc.R600003200; Sandilands E, 2004, DEV CELL, V7, P855, DOI 10.1016/j.devcel.2004.09.019; Sandilands E, 2008, TRENDS CELL BIOL, V18, P322, DOI 10.1016/j.tcb.2008.05.004; SHENOYSCARIA AM, 1994, J CELL BIOL, V126, P353, DOI 10.1083/jcb.126.2.353; Shibata Y, 2009, ANNU REV CELL DEV BI, V25, P329, DOI 10.1146/annurev.cellbio.042308.113324; Shvartsman DE, 2007, J CELL BIOL, V178, P675, DOI 10.1083/jcb.200701133; Sicheri F, 1997, CURR OPIN STRUC BIOL, V7, P777, DOI 10.1016/S0959-440X(97)80146-7; Songyang Zhou, 2004, Cell, V116, pS41, DOI 10.1016/S0092-8674(04)00041-8; Stephens DJ, 2000, J CELL SCI, V113, P2177; Tonks NK, 2003, FEBS LETT, V546, P140, DOI 10.1016/S0014-5793(03)00603-3; vantHof W, 1997, J CELL BIOL, V136, P1023, DOI 10.1083/jcb.136.5.1023; Vedrenne C, 2006, TRAFFIC, V7, P639, DOI 10.1111/j.1600-0854.2006.00419.x; Waterman-Storer CM, 1998, CURR BIOL, V8, P798, DOI 10.1016/S0960-9822(98)70321-5; Weber I, 2003, METHOD ENZYMOL, V361, P34; Wolven A, 1997, MOL BIOL CELL, V8, P1159, DOI 10.1091/mbc.8.6.1159; Xie LP, 2002, BIOCHEMISTRY-US, V41, P4032, DOI 10.1021/bi015904r; Zhang X, 2010, J CELL SCI, V123, P3901, DOI 10.1242/jcs.069153	65	20	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2012	7	6							e38948	10.1371/journal.pone.0038948	http://dx.doi.org/10.1371/journal.pone.0038948			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TU	22701734	gold, Green Submitted, Green Published			2022-12-27	WOS:000305337600061
J	Oldekop, JA; Bebbington, AJ; Truelove, NK; Tysklind, N; Villamarin, S; Preziosi, RF				Oldekop, Johan A.; Bebbington, Anthony J.; Truelove, Nathan K.; Tysklind, Niklas; Villamarin, Santiago; Preziosi, Richard F.			Co-Occurrence Patterns of Common and Rare Leaf-Litter Frogs, Epiphytic Ferns and Dung Beetles across a Gradient of Human Disturbance	PLOS ONE			English	Article							BIODIVERSITY INDICATORS; SPECIES RICHNESS; VASCULAR EPIPHYTES; RESERVE SELECTION; TROPICAL PRIMARY; CONSERVATION; DIVERSITY; FOREST; LANDSCAPE; TAXA	Indicator taxa are commonly used to identify priority areas for conservation or to measure biological responses to environmental change. Despite their widespread use, there is no general consensus about the ability of indicator taxa to predict wider trends in biodiversity. Many studies have focused on large-scale patterns of species co-occurrence to identify areas of high biodiversity, threat or endemism, but there is much less information about patterns of species co-occurrence at local scales. In this study, we assess fine-scale co-occurrence patterns of three indicator taxa (epiphytic ferns, leaf litter frogs and dung beetles) across a remotely sensed gradient of human disturbance in the Ecuadorian Amazon. We measure the relative contribution of rare and common species to patterns of total richness in each taxon and determine the ability of common and rare species to act as surrogate measures of human disturbance and each other. We find that the species richness of indicator taxa changed across the human disturbance gradient but that the response differed among taxa, and between rare and common species. Although we find several patterns of co-occurrence, these patterns differed between common and rare species. Despite showing complex patterns of species co-occurrence, our results suggest that species or taxa can act as reliable indicators of each other but that this relationship must be established and not assumed.	[Oldekop, Johan A.; Truelove, Nathan K.; Preziosi, Richard F.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Bebbington, Anthony J.] Univ Manchester, Inst Dev Policy & Management, Manchester, Lancs, England; [Bebbington, Anthony J.] Clark Univ, Grad Sch Geog, Worcester, MA 01610 USA; [Tysklind, Niklas] Bangor Univ, Coll Nat Sci, Bangor, Gwynedd, Wales; [Villamarin, Santiago] Museo Ecuatoriano Ciencias Natur, Quito, Ecuador	University of Manchester; University of Manchester; Clark University; Bangor University	Oldekop, JA (corresponding author), Washington State Univ, Sch Environm, Vancouver, WA 98686 USA.	j.oldekop@gmx.net	Tysklind, Niklas/A-5275-2017; Preziosi, Richard F/A-8626-2010	Tysklind, Niklas/0000-0002-6617-7875; Preziosi, Richard F/0000-0003-0468-6655; Oldekop, Johan/0000-0003-0565-812X	GIZ GmbH through their internship programme; Wingate Foundation scholarship	GIZ GmbH through their internship programme; Wingate Foundation scholarship	Johan A. Oldekop and Niklas Tysklind thank the GIZ GmbH for financial support through their internship programme. Johan A. Oldekop acknowledges the support of a Wingate Foundation scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Andelman SJ, 2000, P NATL ACAD SCI USA, V97, P5954, DOI 10.1073/pnas.100126797; Arponen A, 2005, CONSERV BIOL, V19, P2009, DOI 10.1111/j.1523-1739.2005.00218.x; Balmford A, 1995, CONSERV BIOL, V9, P1539, DOI 10.1046/j.1523-1739.1995.09061539.x; Barlow J, 2007, P NATL ACAD SCI USA, V104, P18555, DOI 10.1073/pnas.0703333104; Barlow J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009609; Buckling A, 2000, NATURE, V408, P961, DOI 10.1038/35050080; Butchart SHM, 2006, CONSERV BIOL, V20, P579, DOI 10.1111/j.1523-1739.2006.00410.x; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Chazdon RL, 2003, PERSPECT PLANT ECOL, V6, P51, DOI 10.1078/1433-8319-00042; Chazdon RL, 1998, MAN BIOSPH, V20, P285; COLWELL RK, 1994, PHILOS T R SOC B, V345, P101, DOI 10.1098/rstb.1994.0091; Gardner TA, 2008, ECOL LETT, V11, P139, DOI 10.1111/j.1461-0248.2007.01133.x; Gregory RD, 2005, PHILOS T R SOC B, V360, P269, DOI 10.1098/rstb.2004.1602; Grenyer R, 2006, NATURE, V444, P93, DOI 10.1038/nature05237; Harvey CA, 2006, ECOL APPL, V16, P1986, DOI 10.1890/1051-0761(2006)016[1986:POADID]2.0.CO;2; Hess GR, 2006, BIOL CONSERV, V132, P448, DOI 10.1016/j.biocon.2006.04.037; Hopkins GW, 2002, ANIM CONSERV, V5, P245, DOI 10.1017/S1367943002002299; Howard PC, 1998, NATURE, V394, P472, DOI 10.1038/28843; INRA, 2007, CAN EYE V6 2; Kati V, 2004, CONSERV BIOL, V18, P667, DOI 10.1111/j.1523-1739.2004.00465.x; Kessler M, 2011, J APPL ECOL, V48, P330, DOI 10.1111/j.1365-2664.2010.01932.x; Kessler M, 2009, ECOL APPL, V19, P2142, DOI 10.1890/08-1074.1; Kluge J, 2011, PLANT ECOL, V212, P1109, DOI 10.1007/s11258-010-9891-x; Kromer T, 2007, PLANT ECOL, V189, P261, DOI 10.1007/s11258-006-9182-8; Lamoreux JF, 2006, NATURE, V440, P212, DOI 10.1038/nature04291; Lawler JJ, 2003, CONSERV BIOL, V17, P875, DOI 10.1046/j.1523-1739.2003.01638.x; Lawton JH, 1998, NATURE, V391, P72, DOI 10.1038/34166; Lennon JJ, 2004, ECOL LETT, V7, P81, DOI 10.1046/j.1461-0248.2004.00548.x; Lewandowski AS, 2010, CONSERV BIOL, V24, P1367, DOI 10.1111/j.1523-1739.2010.01513.x; Lwanga JS, 1998, BIODIVERS CONSERV, V7, P1387, DOI 10.1023/A:1008865518378; Mace GM, 2007, CONSERV BIOL, V21, P1406, DOI 10.1111/j.1523-1739.2007.00830.x; Maes D, 2005, BIODIVERS CONSERV, V14, P1345, DOI 10.1007/s10531-004-9662-x; Maes D, 2005, BIOL CONSERV, V123, P177, DOI 10.1016/j.biocon.2004.11.005; Magurran AE, 2003, NATURE, V422, P714, DOI 10.1038/nature01547; Mazaris A, 2008, BIODIVERS CONSERV, V17, P3567, DOI 10.1007/s10531-008-9480-7; McMorrow J, 2001, INT J REMOTE SENS, V22, P2243, DOI 10.1080/01431160117188; Mucunguzi P, 2007, AFR J ECOL, V45, P120, DOI 10.1111/j.1365-2028.2007.00868.x; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Navarrete D, 2008, BIODIVERS CONSERV, V17, P2869, DOI 10.1007/s10531-008-9402-8; Navarrete H, 2001, HELECHOS COMUNES AMA; Nichols E, 2009, OIKOS, V118, P481, DOI 10.1111/j.1600-0706.2009.17268.x; Oldekop JA, 2012, HUM ECOL, V40, P101, DOI 10.1007/s10745-011-9455-2; Oldekop JA, 2011, BIODIVERS CONSERV, V20, P2615, DOI 10.1007/s10531-011-0094-0; Orme CDL, 2005, NATURE, V436, P1016, DOI 10.1038/nature03850; Paciencia MLB, 2005, PLANT ECOL, V180, P87, DOI 10.1007/s11258-005-3025-x; Pardini R, 2009, BIOL CONSERV, V142, P1178, DOI 10.1016/j.biocon.2009.02.010; Parody JM, 2001, GLOBAL ECOL BIOGEOGR, V10, P305, DOI 10.1046/j.1466-822X.2001.00233.x; Pearman PB, 1997, CONSERV BIOL, V11, P1211, DOI 10.1046/j.1523-1739.1997.96202.x; Pearman PB, 2007, BIOL CONSERV, V138, P109, DOI 10.1016/j.biocon.2007.04.005; Pineda E, 2005, CONSERV BIOL, V19, P400, DOI 10.1111/j.1523-1739.2005.00531.x; PRENDERGAST JR, 1993, NATURE, V365, P335, DOI 10.1038/365335a0; Rodrigues ASL, 2007, ANNU REV ECOL EVOL S, V38, P713, DOI 10.1146/annurev.ecolsys.38.091206.095737; Rodriguez L. O., 1994, SPECIAL PUBLICATION; Rosenberg MS, 2011, METHODS ECOL EVOL, V2, P229, DOI 10.1111/j.2041-210X.2010.00081.x; Roxburgh JR, 1995, NEW ZEAL J ECOL, V19, P213; Roxburgh SH, 2004, ECOLOGY, V85, P359, DOI 10.1890/03-0266; Spector S, 2006, COLEOPTS BULL, V60, P71, DOI 10.1649/0010-065X(2006)60[71:SDBCSS]2.0.CO;2; Tognelli MF, 2005, BIOL CONSERV, V121, P409, DOI 10.1016/j.biocon.2004.05.013; Tscharntke T, 2008, ECOLOGY, V89, P944, DOI 10.1890/07-0455.1; Valencia J. H., 2008, GUIA CAMPO ANFIBIOS; van Jaarsveld AS, 1998, SCIENCE, V279, P2106, DOI 10.1126/science.279.5359.2106; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Werner FA, 2011, BASIC APPL ECOL, V12, P172, DOI 10.1016/j.baae.2010.11.002; Williams-Linera G, 2005, BIODIVERS CONSERV, V14, P119, DOI 10.1007/s10531-005-4053-5; Zotz G, 2007, J VEG SCI, V18, P123, DOI 10.1111/j.1654-1103.2007.tb02522.x; Zotz G, 2003, J TROP ECOL, V19, P81, DOI 10.1017/S0266467403003092	66	8	9	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2012	7	6							e38922	10.1371/journal.pone.0038922	http://dx.doi.org/10.1371/journal.pone.0038922			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TU	22701730	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000305337600057
J	Song, F; Poljak, A; Crawford, J; Kochan, NA; Wen, W; Cameron, B; Lux, O; Brodaty, H; Mather, K; Smythe, GA; Sachdev, PS				Song, Fei; Poljak, Anne; Crawford, John; Kochan, Nicole A.; Wen, Wei; Cameron, Barbara; Lux, Ora; Brodaty, Henry; Mather, Karen; Smythe, George A.; Sachdev, Perminder S.			Plasma Apolipoprotein Levels Are Associated with Cognitive Status and Decline in a Community Cohort of Older Individuals	PLOS ONE			English	Article							ALZHEIMERS-DISEASE PATIENTS; CARDIOVASCULAR RISK-FACTORS; GENOME-WIDE ASSOCIATION; MINI-MENTAL-STATE; CEREBROSPINAL-FLUID; A-I; DENSITY-LIPOPROTEIN; IDENTIFIES VARIANTS; SERUM CONCENTRATION; VASCULAR DEMENTIA	Objectives: Apolipoproteins have recently been implicated in the etiology of Alzheimer's disease (AD). In particular, Apolipoprotein J (ApoJ or clusterin) has been proposed as a biomarker of the disease at the pre-dementia stage. We examined a group of apolipoproteins, including ApoA1, ApoA2, ApoB, ApoC3, ApoE, ApoH and ApoJ, in the plasma of a longitudinal community based cohort. Methods: 664 subjects (257 with Mild Cognitive Impairment [MCI] and 407 with normal cognition), mean age 78 years, from the Sydney Memory and Aging Study (MAS) were followed up over two years. Plasma apolipoprotein levels at baseline (Wave 1) were measured using a multiplex bead fluorescence immunoassay technique. Results: At Wave 1, MCI subjects had lower levels of ApoA1, ApoA2 and ApoH, and higher levels of ApoE and ApoJ, and a higher ApoB/ApoA1 ratio. Carriers of the apolipoprotein E epsilon 4 allele had significantly lower levels of plasma ApoE, ApoC3 and ApoH and a significantly higher level of ApoB. Global cognitive scores were correlated positively with ApoH and negatively with ApoJ levels. ApoJ and ApoE levels were correlated negatively with grey matter volume and positively with cerebrospinal fluid (CSF) volume on MRI. Lower ApoA1, ApoA2 and ApoH levels, and higher ApoB/ApoA1 ratio, increased the risk of cognitive decline over two years in cognitively normal individuals. ApoA1 was the most significant predictor of decline. These associations remained after statistically controlling for lipid profile. Higher ApoJ levels predicted white matter atrophy over two years. Conclusions: Elderly individuals with MCI have abnormal apolipoprotein levels, which are related to cognitive function and volumetric MRI measures cross-sectionally and are predictive of cognitive impairment in cognitively normal subjects. ApoA1, ApoH and ApoJ are potential plasma biomarkers of cognitive decline in non-demented elderly individuals.	[Song, Fei; Poljak, Anne; Crawford, John; Kochan, Nicole A.; Wen, Wei; Lux, Ora; Brodaty, Henry; Mather, Karen; Sachdev, Perminder S.] Univ New S Wales, Brain & Aging Res Program, Sydney, NSW, Australia; [Song, Fei; Crawford, John; Kochan, Nicole A.; Wen, Wei; Brodaty, Henry; Mather, Karen; Sachdev, Perminder S.] Univ New S Wales, Sch Psychiat, Sydney, NSW, Australia; [Song, Fei; Poljak, Anne; Smythe, George A.] Univ New S Wales, Bioanalyt Mass Spectrometry Facil, Sydney, NSW, Australia; [Poljak, Anne; Cameron, Barbara; Smythe, George A.] Univ New S Wales, Sch Med Sci, Sydney, NSW, Australia; [Brodaty, Henry] Univ New S Wales, Dementia Collaborat Res Ctr, Sydney, NSW, Australia	University of New South Wales Sydney; University of New South Wales Sydney; University of New South Wales Sydney; University of New South Wales Sydney; University of New South Wales Sydney	Song, F (corresponding author), Univ New S Wales, Brain & Aging Res Program, Sydney, NSW, Australia.	p.sachdev@unsw.edu.au	Sachdev, Perminder/ABC-1137-2020; Karen, Mather A/O-9795-2016	Sachdev, Perminder/0000-0002-9595-3220; Karen, Mather A/0000-0003-4143-8941; Poljak, Anne/0000-0001-9953-1984; Wen, Wei/0000-0003-2753-3870	Australian National Health and Medical Research Council [350833, 568940]; Rebecca L Cooper Medical Research Foundation	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Rebecca L Cooper Medical Research Foundation	This work was facilitated by the Australian National Health and Medical Research Council Program Grant 350833 and Capacity Building Grant 568940, and the generous financial support of the Rebecca L Cooper Medical Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso A, 2009, J NEUROL SCI, V280, P79, DOI 10.1016/j.jns.2009.02.004; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Anderson TM, 2007, AM J GERIAT PSYCHIAT, V15, P467, DOI 10.1097/JGP.0b013e3180547053; [Anonymous], 2010, WORLD ALZHEIMER REPO; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bereczki E, 2008, J PROTEOME RES, V7, P2246, DOI 10.1021/pr7006329; Boyle PA, 2006, NEUROLOGY, V67, P441, DOI 10.1212/01.wnl.0000228244.10416.20; Caramelli P, 1999, ACTA NEUROL SCAND, V100, P61, DOI 10.1111/j.1600-0404.1999.tb00724.x; Castro A, 2010, ATHEROSCLEROSIS, V209, P201, DOI 10.1016/j.atherosclerosis.2009.09.072; CHOIMIURA NH, 1992, ACTA NEUROPATHOL, V83, P260, DOI 10.1007/BF00296787; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; Darreh-Shori T, 2012, J ALZHEIMERS DIS, V28, P443, DOI 10.3233/JAD-2011-111088; Darreh-Shori T, 2011, NEUROBIOL AGING, V32, P1236, DOI 10.1016/j.neurobiolaging.2009.07.015; Darreh-Shori T, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.04.028; de Laat B, 2006, BLOOD, V107, P1916, DOI 10.1182/blood-2005-05-1943; DESILVA HV, 1990, BIOCHEMISTRY-US, V29, P5380, DOI 10.1021/bi00474a025; Dieterle F, 2010, NAT BIOTECHNOL, V28, P463, DOI 10.1038/nbt.1622; Dufouil C, 2005, NEUROLOGY, V64, P1531, DOI 10.1212/01.WNL.0000160114.42643.31; Eichner JE, 2002, AM J EPIDEMIOL, V155, P487, DOI 10.1093/aje/155.6.487; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Ganguli M, 2004, NEUROLOGY, V63, P115, DOI 10.1212/01.WNL.0000132523.27540.81; George D, 2009, PROG CARDIOVASC DIS, V52, P115, DOI 10.1016/j.pcad.2009.06.005; GHISO J, 1993, BIOCHEM J, V293, P27, DOI 10.1042/bj2930027; Giannakopoulos P, 1998, ACTA NEUROPATHOL, V95, P387, DOI 10.1007/s004010050815; Gupta VB, 2011, NEUROLOGY, V76, P1091, DOI 10.1212/WNL.0b013e318211c352; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Hesse C, 2000, NEUROCHEM RES, V25, P511, DOI 10.1023/A:1007516210548; Hindmarch I, 1998, DEMENT GERIATR COGN, V9, P20, DOI 10.1159/000051195; Jellinger KA, 2003, J NEUROL, V250, P1050, DOI 10.1007/s00415-003-0142-0; JORDANSTARCK TC, 1994, J LIPID RES, V35, P194; Jorm AF, 2007, NEUROPSYCHOLOGY, V21, P1, DOI 10.1037/0894-4105.21.1.1; Katzav A, 2011, NEUROBIOL AGING, V32, P272, DOI 10.1016/j.neurobiolaging.2009.02.007; KAWANO M, 1995, CLIN CHIM ACTA, V239, P209, DOI 10.1016/0009-8981(95)06115-T; Kivipelto M, 2001, BMJ-BRIT MED J, V322, P1447, DOI 10.1136/bmj.322.7300.1447; Kullberg S, 2001, BRAIN RES, V899, P169, DOI 10.1016/S0006-8993(01)02222-3; Kuo YM, 1998, BIOCHEM BIOPH RES CO, V252, P711, DOI 10.1006/bbrc.1998.9652; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Laukka EJ, 2010, DEMENT GERIATR COGN, V29, P498, DOI 10.1159/000313978; Leduc MS, 2008, J LIPID RES, V49, P2648, DOI 10.1194/jlr.M800155-JLR200; Lewis TL, 2010, J BIOL CHEM, V285, P36958, DOI 10.1074/jbc.M110.127829; Lidstrom AM, 1998, EXP NEUROL, V154, P511, DOI 10.1006/exnr.1998.6892; Lindh M, 1997, NEUROSCI LETT, V229, P85, DOI 10.1016/S0304-3940(97)00429-1; Liu HC, 2006, DEMENT GERIATR COGN, V21, P155, DOI 10.1159/000090676; Martins IJ, 2006, MOL PSYCHIATR, V11, P721, DOI 10.1038/sj.mp.4001854; Martins IJ, 2009, J NEUROCHEM, V111, P1275, DOI 10.1111/j.1471-4159.2009.06408.x; Merched A, 2000, NEUROBIOL AGING, V21, P27, DOI 10.1016/S0197-4580(99)00103-7; Millan J, 2009, VASC HEALTH RISK MAN, V5, P757; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Nilselid AM, 2006, NEUROCHEM INT, V48, P718, DOI 10.1016/j.neuint.2005.12.005; Nuutinen T, 2009, BRAIN RES REV, V61, P89, DOI 10.1016/j.brainresrev.2009.05.007; O'Bryant SE, 2010, ARCH NEUROL-CHICAGO, V67, P1077, DOI 10.1001/archneurol.2010.215; Ohrfelt A, 2011, DEMENT GER COGN D EX, V1, P31, DOI 10.1159/000323417; PETERSEN RC, 1995, JAMA-J AM MED ASSOC, V273, P1274, DOI 10.1001/jama.273.16.1274; Petersen RC, 2001, ARCH NEUROL-CHICAGO, V58, P1985, DOI 10.1001/archneur.58.12.1985; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Pirttila T, 1998, NEUROSCI LETT, V249, P21, DOI 10.1016/S0304-3940(98)00381-4; Roher AE, 2009, BIOMARKERS; Rountree SD, 2007, DEMENT GERIATR COGN, V24, P476, DOI 10.1159/000110800; Ruiz-Irastorza Guillermo, 2002, Autoimmunity Reviews, V1, P43, DOI 10.1016/S1568-9972(01)00005-2; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; Scacchi R, 1998, DEMENT GERIATR COGN, V9, P186, DOI 10.1159/000017045; Sherman CB, 2010, CARDIOL REV, V18, P141, DOI 10.1097/CRD.0b013e3181c4b508; Siest G, 2000, CLIN CHEM LAB MED, V38, P721, DOI 10.1515/CCLM.2000.102; Sihlbom C, 2008, NEUROCHEM RES, V33, P1332, DOI 10.1007/s11064-008-9588-x; Slooter AJC, 1998, NEUROSCI LETT, V248, P21, DOI 10.1016/S0304-3940(98)00339-5; Sparks DL, 2005, ARCH NEUROL-CHICAGO, V62, P753, DOI 10.1001/archneur.62.5.753; Takechi R, 2010, BRIT J NUTR, V103, P652, DOI 10.1017/S0007114509992194; Takechi R, 2009, HISTOCHEM CELL BIOL, V131, P661, DOI 10.1007/s00418-009-0567-3; Thambisetty M, 2010, ARCH GEN PSYCHIAT, V67, P739, DOI 10.1001/archgenpsychiatry.2010.78; van Dijk KW, 2004, CURR OPIN LIPIDOL, V15, P239, DOI [10.1097/01.mol.00001300096.77252.1f, 10.1097/00041433-200406000-00002]; Whitmer RA, 2005, NEUROLOGY, V64, P277, DOI 10.1212/01.WNL.0000149519.47454.F2; Winblad B, 2004, J INTERN MED, V256, P240, DOI 10.1111/j.1365-2796.2004.01380.x; Zhang RL, 2004, PROTEOMICS, V4, P244, DOI 10.1002/pmic.200300495; Zlokovic BV, 1996, P NATL ACAD SCI USA, V93, P4229, DOI 10.1073/pnas.93.9.4229; [No title captured], DOI DOI 10.1017/S1041610210001067	75	125	132	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2012	7	6							e34078	10.1371/journal.pone.0034078	http://dx.doi.org/10.1371/journal.pone.0034078			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TU	22701550	gold, Green Published, Green Submitted			2022-12-27	WOS:000305337600001
J	Lawlor, KT; O'Keefe, LV; Samaraweera, SE; van Eyk, CL; Richards, RI				Lawlor, Kynan T.; O'Keefe, Louise V.; Samaraweera, Saumya E.; van Eyk, Clare L.; Richards, Robert I.			Ubiquitous Expression of CUG or CAG Trinucleotide Repeat RNA Causes Common Morphological Defects in a Drosophila Model of RNA-Mediated Pathology	PLOS ONE			English	Article							MYOTONIC-DYSTROPHY; TRIPLET REPEAT; NUCLEAR FOCI; RCGG REPEATS; TOXICITY; NEURODEGENERATION; MUSCLEBLIND; EXPANSION; POLYGLUTAMINE; PROTEIN	Expanded DNA repeat sequences are known to cause over 20 diseases, including Huntington's disease, several types of spinocerebellar ataxia and myotonic dystrophy type 1 and 2. A shared genetic basis, and overlapping clinical features for some of these diseases, indicate that common pathways may contribute to pathology. Multiple mechanisms, mediated by both expanded homopolymeric proteins and expanded repeat RNA, have been identified by the use of model systems, that may account for shared pathology. The use of such animal models enables identification of distinct pathways and their 'molecular hallmarks' that can be used to determine the contribution of each pathway in human pathology. Here we characterise a tergite disruption phenotype in adult flies, caused by ubiquitous expression of either untranslated CUG or CAG expanded repeat RNA. Using the tergite phenotype as a quantitative trait we define a new genetic system in which to examine 'hairpin' repeat RNA-mediated cellular perturbation. Further experiments use this system to examine whether pathways involving Muscleblind sequestration or Dicer processing, which have been shown to mediate repeat RNA-mediated pathology in other model systems, contribute to cellular perturbation in this model.	[Lawlor, Kynan T.] Univ Adelaide, Discipline Genet, Sch Mol & Biomed Sci, Adelaide, SA, Australia; Univ Adelaide, Australian Res Council, Special Res Ctr Mol Genet Dev, Adelaide, SA, Australia	University of Adelaide; University of Adelaide	Lawlor, KT (corresponding author), Univ Adelaide, Discipline Genet, Sch Mol & Biomed Sci, Adelaide, SA, Australia.	robert.richards@adelaide.edu.au	van Eyk, Clare L/P-8334-2019; Richards, Robert/ABE-6423-2020; O'Keefe, Louise V/B-9856-2008; Lawlor, Kynan/AAC-2407-2021	van Eyk, Clare L/0000-0003-0345-9944; Samaraweera, Saumya/0000-0002-9619-0624; Richards, Robert Ian/0000-0002-5978-6453; Lawlor, Kynan/0000-0003-4080-5439	Australian Postgraduate Awards; National Health and Medical Research Council Peter Doherty Fellowship [207830]; National Health and Medical Research Council [453674, 627183]; Australian Research Council Special Research Centre for the Molecular Genetics of Development	Australian Postgraduate Awards(Australian Government); National Health and Medical Research Council Peter Doherty Fellowship(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council Special Research Centre for the Molecular Genetics of Development(Australian Research Council)	This work was supported by Australian Postgraduate Awards (to KTL, SES and CLvE); a National Health and Medical Research Council Peter Doherty Fellowship (fellowship number 207830 to LVO); project grants from the National Health and Medical Research Council (grant numbers 453674, 627183 to RIR and LVO); and the Australian Research Council Special Research Centre for the Molecular Genetics of Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batra R, 2010, HUM MOL GENET, V19, pR77, DOI 10.1093/hmg/ddq132; Begemann G, 1997, DEVELOPMENT, V124, P4321; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; BRAND AH, 1993, DEVELOPMENT, V118, P401; Cho DH, 2005, MOL CELL, V20, P483, DOI 10.1016/j.molcel.2005.09.002; Daughters RS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000600; Davis BM, 1997, P NATL ACAD SCI USA, V94, P7388, DOI 10.1073/pnas.94.14.7388; de Haro M, 2006, HUM MOL GENET, V15, P2138, DOI 10.1093/hmg/ddl137; de Mezer M, 2011, NUCLEIC ACIDS RES, V39, P3852, DOI 10.1093/nar/gkq1323; FU YH, 1992, SCIENCE, V255, P1256, DOI 10.1126/science.1546326; Garcia-Lopez A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001595; HARRISON DA, 1995, EMBO J, V14, P2857, DOI 10.1002/j.1460-2075.1995.tb07285.x; Houseley JM, 2005, HUM MOL GENET, V14, P873, DOI 10.1093/hmg/ddi080; Hsu RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016417; Ito K, 1997, DEVELOPMENT, V124, P761; Iwahashi CK, 2006, BRAIN, V129, P256, DOI 10.1093/brain/awh650; Jin P, 2003, NEURON, V39, P739, DOI 10.1016/S0896-6273(03)00533-6; Jin P, 2007, NEURON, V55, P556, DOI 10.1016/j.neuron.2007.07.020; Kiliszek A, 2010, NUCLEIC ACIDS RES, V38, P8370, DOI 10.1093/nar/gkq700; Kino Y, 2004, HUM MOL GENET, V13, P495, DOI 10.1093/hmg/ddh056; Krol J, 2007, MOL CELL, V25, P575, DOI 10.1016/j.molcel.2007.01.031; La Spada AR, 2010, NAT REV GENET, V11, P247, DOI 10.1038/nrg2748; Ladd PD, 2007, HUM MOL GENET, V16, P3174, DOI 10.1093/hmg/ddm293; Lawlor KT, 2011, HUM MOL GENET, V20, P3757, DOI 10.1093/hmg/ddr292; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Li LB, 2008, NATURE, V453, P1107, DOI 10.1038/nature06909; Li LB, 2010, TRENDS NEUROSCI, V33, P292, DOI 10.1016/j.tins.2010.03.004; Liquori CL, 2001, SCIENCE, V293, P864, DOI 10.1126/science.1062125; MADHAVAN K, 1995, ROUX ARCH DEV BIOL, V204, P330, DOI 10.1007/BF02179501; Mankodi A, 2000, SCIENCE, V289, P1769, DOI 10.1126/science.289.5485.1769; Mankodi A, 2001, HUM MOL GENET, V10, P2165, DOI 10.1093/hmg/10.19.2165; Marsh JL, 2000, HUM MOL GENET, V9, P13, DOI 10.1093/hmg/9.1.13; McLeod CJ, 2005, HUM MOL GENET, V14, P1041, DOI 10.1093/hmg/ddi096; Miller JW, 2000, EMBO J, V19, P4439, DOI 10.1093/emboj/19.17.4439; Minakuchi C, 2008, MECH DEVELOP, V125, P91, DOI 10.1016/j.mod.2007.10.002; Moseley ML, 2006, NAT GENET, V38, P758, DOI 10.1038/ng1827; Mutsuddi M, 2004, CURR BIOL, V14, P302, DOI 10.1016/j.cub.2004.01.034; Ninov N, 2007, DEVELOPMENT, V134, P367, DOI 10.1242/dev.02728; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Pascual M, 2006, DIFFERENTIATION, V74, P65, DOI 10.1111/j.1432-0436.2006.00060.x; PIERETTI M, 1991, CELL, V66, P817, DOI 10.1016/0092-8674(91)90125-I; Ranum LPW, 2006, ANNU REV NEUROSCI, V29, P259, DOI 10.1146/annurev.neuro.29.051605.113014; Ranum LPW, 2004, TRENDS GENET, V20, P506, DOI 10.1016/j.tig.2004.08.004; Richards RI, 2001, HUM MOL GENET, V10, P2187, DOI 10.1093/hmg/10.20.2187; Rudnicki DD, 2007, ANN NEUROL, V61, P272, DOI 10.1002/ana.21081; Sakamoto N, 2001, J BIOL CHEM, V276, P27171, DOI 10.1074/jbc.M101879200; Sellier C, 2010, EMBO J, V29, P1248, DOI 10.1038/emboj.2010.21; Shieh SY, 2011, HUM MOL GENET, V20, P4810, DOI 10.1093/hmg/ddr420; Sobczak K, 2010, J BIOL CHEM, V285, P12755, DOI 10.1074/jbc.M109.078790; Sofola OA, 2007, NEURON, V55, P565, DOI 10.1016/j.neuron.2007.07.021; Sopher BL, 2011, NEURON, V70, P1071, DOI 10.1016/j.neuron.2011.05.027; TANEJA KL, 1995, J CELL BIOL, V128, P995, DOI 10.1083/jcb.128.6.995; Timchenko LT, 1996, NUCLEIC ACIDS RES, V24, P4407, DOI 10.1093/nar/24.22.4407; Todd PK, 2010, ANN NEUROL, V67, P291, DOI 10.1002/ana.21948; van Eyk CL, 2012, HUM MOL GENET, V21, P536, DOI 10.1093/hmg/ddr487; van Eyk CL, 2011, HUM MOL GENET, V20, P2783, DOI 10.1093/hmg/ddr177; Wang LC, 2011, CELL MOL LIFE SCI, V68, P1255, DOI 10.1007/s00018-010-0522-4; Wells R.D., 2006, GENETIC INSTABILITIE; White MC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000984; Wilburn B, 2011, NEURON, V70, P427, DOI 10.1016/j.neuron.2011.03.021; WODARZ A, 1995, CELL, V82, P67, DOI 10.1016/0092-8674(95)90053-5; Wojciechowska M, 2011, HUM MOL GENET, V20, P3811, DOI 10.1093/hmg/ddr299; Yu ZM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001340; Yuan Y, 2007, NUCLEIC ACIDS RES, V35, P5474, DOI 10.1093/nar/gkm601; Zu T, 2011, P NATL ACAD SCI USA, V108, P260, DOI 10.1073/pnas.1013343108	65	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2012	7	6							e38516	10.1371/journal.pone.0038516	http://dx.doi.org/10.1371/journal.pone.0038516			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TQ	22715390	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336800032
J	Bik, HM; Halanych, KM; Sharma, J; Thomas, WK				Bik, Holly M.; Halanych, Kenneth M.; Sharma, Jyotsna; Thomas, W. Kelley			Dramatic Shifts in Benthic Microbial Eukaryote Communities following the Deepwater Horizon Oil Spill	PLOS ONE			English	Article							BIODIVERSITY	Benthic habitats harbour a significant (yet unexplored) diversity of microscopic eukaryote taxa, including metazoan phyla, protists, algae and fungi. These groups are thought to underpin ecosystem functioning across diverse marine environments. Coastal marine habitats in the Gulf of Mexico experienced visible, heavy impacts following the Deepwater Horizon oil spill in 2010, yet our scant knowledge of prior eukaryotic biodiversity has precluded a thorough assessment of this disturbance. Using a marker gene and morphological approach, we present an intensive evaluation of microbial eukaryote communities prior to and following oiling around heavily impacted shorelines. Our results show significant changes in community structure, with pre-spill assemblages of diverse Metazoa giving way to dominant fungal communities in post-spill sediments. Post-spill fungal taxa exhibit low richness and are characterized by an abundance of known hydrocarbon-degrading genera, compared to prior communities that contained smaller and more diverse fungal assemblages. Comparative taxonomic data from nematodes further suggests drastic impacts; while pre-spill samples exhibit high richness and evenness of genera, post-spill communities contain mainly predatory and scavenger taxa alongside an abundance of juveniles. Based on this community analysis, our data suggest considerable (hidden) initial impacts across Gulf beaches may be ongoing, despite the disappearance of visible surface oil in the region.	[Bik, Holly M.; Thomas, W. Kelley] Univ New Hampshire, Hubbard Ctr Genome Studies, Durham, NH 03824 USA; [Bik, Holly M.] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA; [Halanych, Kenneth M.] Auburn Univ, Dept Biol Sci, Auburn, AL 36849 USA; [Sharma, Jyotsna] Univ Texas San Antonio, Dept Biol, San Antonio, TX USA	University System Of New Hampshire; University of New Hampshire; University of California System; University of California Davis; Auburn University System; Auburn University; University of Texas System; University of Texas at San Antonio (UTSA)	Bik, HM (corresponding author), Univ New Hampshire, Hubbard Ctr Genome Studies, Durham, NH 03824 USA.	holly.bik@gmail.com	Halanych, Ken M/A-9480-2009	Halanych, Ken M/0000-0002-8658-9674; Bik, Holly/0000-0002-4356-3837	National Science Foundation RAPID award [DEB-1058458, DEB-1058489, DEB-1058461]; Direct For Computer & Info Scie & Enginr [0808624] Funding Source: National Science Foundation	National Science Foundation RAPID award; Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This work was supported by a National Science Foundation RAPID award (DEB-1058458, DEB-1058489, DEB-1058461). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atalla M. M., 2010, Agriculture and Biology Journal of North America, V1, P591; Bartha R, 1977, Adv Appl Microbiol, V22, P225, DOI 10.1016/S0065-2164(08)70164-3; Blaxter ML, 1998, NATURE, V392, P71, DOI 10.1038/32160; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Colfone L, 1973, J GEN MICROBIOL, V76, P243; Creer S, 2010, MOL ECOL, V19, P4, DOI 10.1111/j.1365-294X.2009.04473.x; Danovaro R, 2009, NEMATODES AS ENVIRONMENTAL INDICATORS, P146, DOI 10.1079/9781845933852.0146; FLEEGER JW, 1985, T AM MICROSC SOC, V104, P321, DOI 10.2307/3226485; Fonseca VG, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1095; Gorley C.K., 2006, GETTING STARTED PRIM; Kiiskinen LL, 2004, J APPL MICROBIOL, V97, P640, DOI 10.1111/j.1365-2672.2004.02348.x; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Moens T, 1999, MAR BIOL, V134, P585, DOI 10.1007/s002270050573; Mtui G, 2008, AFR J BIOTECHNOL, V7, P3066; Obire O., 2008, J AGR TECH, V4, P81; OKPOKWASILI GC, 1988, TRIBOL INT, V21, P215, DOI 10.1016/0301-679X(88)90020-5; Porazinska DL, 2009, MOL ECOL RESOUR, V9, P1439, DOI 10.1111/j.1755-0998.2009.02611.x; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Quince C, 2008, ISME J, V2, P997, DOI 10.1038/ismej.2008.69; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Snelgrove P, 1997, AMBIO, V26, P578; Somerfield P.J., 2005, P229, DOI 10.1002/9780470995129.ch6; Yoder M, 2006, NEMATOLOGY, V8, P367, DOI 10.1163/156854106778493448	25	120	124	1	104	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e38550	10.1371/journal.pone.0038550	http://dx.doi.org/10.1371/journal.pone.0038550			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701662	Green Submitted, Green Published, gold			2022-12-27	WOS:000305348400070
J	Ye, F; Wang, HJ; Huntington, D; Zhou, H; Li, Y; You, FZ; Li, JH; Cui, WL; Yao, ML; Wang, Y				Ye, Fang; Wang, Haijun; Huntington, Dale; Zhou, Hong; Li, Yan; You, Fengzhi; Li, Jinhua; Cui, Wenlong; Yao, Meiling; Wang, Yan		Team Economic Impact Maternal	The Immediate Economic Impact of Maternal Deaths on Rural Chinese Households	PLOS ONE			English	Article							OBSTETRIC CARE; TUBERCULOSIS; INDIA; COST	Objective: To identify the immediate economic impact of maternal death on rural Chinese households. Methods: Results are reported from a study that matched 195 households who had suffered a maternal death to 384 households that experienced a childbirth without maternal death in rural areas of three provinces in China, using quantitative questionnaire to compare differences of direct and indirect costs between two groups. Findings: The direct costs of a maternal death were significantly higher than the costs of a childbirth without a maternal death (US$4,119 vs. $370, p<0.001). More than 40% of the direct costs were attributed to funeral expenses. Hospitalization and emergency care expenses were the largest proportion of non-funeral direct costs and were higher in households with maternal death than the comparison group (US$2,248 vs. $305, p<0.001). To cover most of the high direct costs, 44.1% of affected households utilized compensation from hospitals, and the rest affected households (55.9%) utilized borrowing money or taking loans as major source of money to offset direct costs. The median economic burden of the direct (and non-reimbursed) costs of a maternal death was quite high - 37.0% of the household's annual income, which was approximately 4 times as high as the threshold for an expense being considered catastrophic. Conclusion: The immediate direct costs of maternal deaths are extremely catastrophic for the rural Chinese households in three provinces studied.	[Ye, Fang; Wang, Haijun; Zhou, Hong; Wang, Yan] Peking Univ, Div Maternal & Child Hlth, Sch Publ Hlth, Beijing 100871, Peoples R China; [Huntington, Dale] World Hlth Org, Dept Reprod Hlth & Res, Geneva, Switzerland; [Li, Yan; Cui, Wenlong] Kunming Med Coll, Sch Publ Hlth, Kunming, Yunnan, Peoples R China; [You, Fengzhi; Yao, Meiling] Zhengzhou Univ, Womens Healthcare Sect, Affiliated Hosp Zhengzhou 3, Zhengzhou, Henan, Peoples R China; [Li, Jinhua] Hebei Women & Children Hlth Ctr, Shijiazhuang, Hebei, Peoples R China	Peking University; World Health Organization; Kunming Medical University; Zhengzhou University	Ye, F (corresponding author), Peking Univ, Div Maternal & Child Hlth, Sch Publ Hlth, Beijing 100871, Peoples R China.	wangyan@bjmu.edu.cn	Wang, Haijun/AAD-1302-2021	Wang, Haijun/0000-0003-0849-2903	UNDP/UNFPA/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP), World Health Organization, Geneva, Switzerland [A65403]	UNDP/UNFPA/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP), World Health Organization, Geneva, Switzerland	The study was supported by a grant from the UNDP/UNFPA/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP), World Health Organization, Geneva, Switzerland (http://www.who.int/reproductivehealth/en/). The Grant number is A65403. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou Zahr C., 2004, MATERNAL MORTALITY 2; Afsana K, 2004, REPROD HEALTH MATTER, V12, P171, DOI 10.1016/S0968-8080(04)24142-8; [Anonymous], 2008, HLTH STAT YB; [Anonymous], 2008, CHIN STAT YB; [Anonymous], C SOC PROT POV; Borghi J, 2003, HEALTH POLICY PLANN, V18, P383, DOI 10.1093/heapol/czg046; Department of comprehensive statistics of national bureau of statistics, 2009, CHIN STAT YB REG EC; Fillippi V., 2004, NUMBERS REV MATERNAL, P103; Greene M.E., 2005, POVERTY REDUCTION DO; Guo JL, 2006, CHINESE HLTH EC, V25, P48; Islam MK, 2006, COSTS MATERNAL NEWBO; Levin A, 2000, 22 ABT ASS INC PARTN; Luo Hao, 2009, Maternal and Child Health Care of China, V24, P3773; Ministry of Health, 2007, HLTH STAT YB; Ministry of Health, 2009, HLTH STAT YB; Ministry of Health, 2010, HLTH STAT YB; Needham DM, 1998, INT J TUBERC LUNG D, V2, P811; Pattinson RC, 2003, BJOG-INT J OBSTET GY, V110, P889, DOI 10.1111/j.1471-0528.2003.03044.x; Rajeswari R, 1999, INT J TUBERC LUNG D, V3, P869; Ranson MK, 2002, B WORLD HEALTH ORGAN, V80, P613; Rural Survey Department of National Bureau of Statistics, 2006, POV MON REP RUR CHIN; Russell S, 2004, AM J TROP MED HYG, V71, P147, DOI 10.4269/ajtmh.2004.71.147; State Statistical Bureau, 2006, CHIN STAT YB; State Statistical Bureau, 2009, CHIN STAT YB; State Statistical Bureau, 2007, CHIN STAT YB; State Statistical Bureau, 2010, CHIN STAT YB; Storeng KT, 2008, SOC SCI MED, V66, P545, DOI 10.1016/j.socscimed.2007.10.001; The Ministry of Health, 2006, HLTH STAT YB; WHO, 2010, MAT DEATHS WORLDW DR; WHO, 2010, TRENDS MAT MORT 1990; Xu K, 2003, LANCET, V362, P111, DOI 10.1016/S0140-6736(03)13861-5; Xu K., 2005, 2 WHO; 王临虹, 2004, [实用妇产科杂志, Journal of Practical Obstetrics and Gynecology], V20, P193	33	14	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e38467	10.1371/journal.pone.0038467	http://dx.doi.org/10.1371/journal.pone.0038467			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701649	Green Published, Green Submitted, gold			2022-12-27	WOS:000305348400063
J	Liu, ZL; Myers, LC				Liu, Zhongle; Myers, Lawrence C.			Med5(Nut1) and Med17(Srb4) Are Direct Targets of Mediator Histone H4 Tail Interactions	PLOS ONE			English	Article							RNA-POLYMERASE-II; SACCHAROMYCES-CEREVISIAE; YEAST MEDIATOR; TRANSCRIPTIONAL REGULATION; GENE DELETION; COMPLEX; PROTEIN; MODULE; SIN4; GENOME	The Mediator complex transmits activation signals from DNA bound transcription factors to the core transcription machinery. In addition to its canonical role in transcriptional activation, recent studies have demonstrated that S. cerevisiae Mediator can interact directly with nucleosomes, and their histone tails. Mutations in Mediator subunits have shown that Mediator and certain chromatin structures mutually impact each other structurally and functionally in vivo. We have taken a UV photo cross-linking approach to further delineate the molecular basis of Mediator chromatin interactions and help determine whether the impact of certain Mediator mutants on chromatin is direct. Specifically, by using histone tail peptides substituted with an amino acid analog that is a UV activatible crosslinker, we have identified specific subunits within Mediator that participate in histone tail interactions. Using Mediator purified from mutant yeast strains we have evaluated the impact of these subunits on histone tail binding. This analysis has identified the Med5 subunit of Mediator as a target for histone tail interactions and suggests that the previously observed effect of med5 mutations on telomeric heterochromatin and silencing is direct.	[Liu, Zhongle; Myers, Lawrence C.] Dartmouth Med Sch, Dept Biochem, Hanover, NH USA	Dartmouth College	Liu, ZL (corresponding author), Dartmouth Med Sch, Dept Biochem, Hanover, NH USA.	larry.myers@dartmouth.edu			National Institute of General Medical Sciences [R01 GM62483]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062483] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institute of General Medical Sciences grant R01 GM62483 (LCM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrau JC, 2006, MOL CELL, V22, P179, DOI 10.1016/j.molcel.2006.03.023; Baidoobonso SM, 2007, J BIOL CHEM, V282, P5551, DOI 10.1074/jbc.M609484200; Beve J, 2005, J BIOL CHEM, V280, P41366, DOI 10.1074/jbc.M511181200; Bjorklund S, 2005, TRENDS BIOCHEM SCI, V30, P240, DOI 10.1016/j.tibs.2005.03.008; Borggrefe T, 2002, J BIOL CHEM, V277, P44202, DOI 10.1074/jbc.M207195200; Bourbon HM, 2008, NUCLEIC ACIDS RES, V36, P3993, DOI 10.1093/nar/gkn349; Braunstein M, 1996, MOL CELL BIOL, V16, P4349; Chadick JZ, 2005, TRENDS BIOCHEM SCI, V30, P264, DOI 10.1016/j.tibs.2005.03.001; Conaway RC, 2005, TRENDS BIOCHEM SCI, V30, P250, DOI 10.1016/j.tibs.2005.03.002; Conaway RC, 2011, CURR OPIN GENET DEV, V21, P225, DOI 10.1016/j.gde.2011.01.013; de Bruin D, 2000, MOL CELL BIOL, V20, P7991, DOI 10.1128/MCB.20.21.7991-8000.2000; DORMAN G, 1994, BIOCHEMISTRY-US, V33, P5661, DOI 10.1021/bi00185a001; Guglielmi B, 2004, NUCLEIC ACIDS RES, V32, P5379, DOI 10.1093/nar/gkh878; Han SJ, 2001, J BIOL CHEM, V276, P37020, DOI 10.1074/jbc.M105596200; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Howard SC, 2001, GENETICS, V159, P77; Imasaki T, 2011, NATURE, V475, P240, DOI 10.1038/nature10162; Jiang YW, 1996, GENE DEV, V10, P604, DOI 10.1101/gad.10.5.604; JIANG YW, 1995, GENETICS, V140, P47; KIM YJ, 1994, CELL, V77, P599, DOI 10.1016/0092-8674(94)90221-6; Lee YC, 1999, MOL CELL BIOL, V19, P2967; Li LH, 2005, GENETICS, V171, P477, DOI 10.1534/genetics.105.043893; LI Y, 1995, P NATL ACAD SCI USA, V92, P10864, DOI 10.1073/pnas.92.24.10864; Linder T, 2004, J BIOL CHEM, V279, P49455, DOI 10.1074/jbc.M409046200; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lorch Y, 2000, MOL CELL, V6, P197, DOI 10.1016/S1097-2765(00)00021-6; Macatee T, 1997, NUCLEIC ACIDS RES, V25, P1240, DOI 10.1093/nar/25.6.1240; Myers LC, 1997, METHODS, V12, P212, DOI 10.1006/meth.1997.0473; Myers LC, 1999, P NATL ACAD SCI USA, V96, P67, DOI 10.1073/pnas.96.1.67; Myers LC, 1998, GENE DEV, V12, P45, DOI 10.1101/gad.12.1.45; Myers LC, 2000, ANNU REV BIOCHEM, V69, P729, DOI 10.1146/annurev.biochem.69.1.729; Peng J, 2012, NUCLEIC ACIDS RES, V40, P581, DOI 10.1093/nar/gkr757; Poux AN, 2003, BIOCHEMISTRY-US, V42, P14366, DOI 10.1021/bi035632n; Rani PG, 2004, MOL CELL BIOL, V24, P1709, DOI 10.1128/MCB.24.4.1709-1720.2004; Samuelsen CO, 2003, P NATL ACAD SCI USA, V100, P6422, DOI 10.1073/pnas.1030497100; Sato S, 2004, MOL CELL, V14, P685, DOI 10.1016/j.molcel.2004.05.006; Singh H, 2006, GENETICS, V172, P2169, DOI 10.1534/genetics.105.052738; Song WJ, 1996, MOL CELL BIOL, V16, P115; THOMPSON CM, 1993, CELL, V73, P1361, DOI 10.1016/0092-8674(93)90362-T; van de Peppel J, 2005, MOL CELL, V19, P511, DOI 10.1016/j.molcel.2005.06.033; Wang X, 2004, GENETICS, V168, P747, DOI 10.1534/genetics.104.029611; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Yu YX, 2000, MOL CELL BIOL, V20, P2350, DOI 10.1128/MCB.20.7.2350-2357.2000; Zhu XF, 2006, MOL CELL, V22, P169, DOI 10.1016/j.molcel.2006.03.032; Zhu XF, 2011, NUCLEIC ACIDS RES, V39, P8342, DOI 10.1093/nar/gkr551; Zhu XF, 2011, MOL CELL BIOL, V31, P2413, DOI 10.1128/MCB.05242-11	46	15	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e38416	10.1371/journal.pone.0038416	http://dx.doi.org/10.1371/journal.pone.0038416			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22693636	gold, Green Published, Green Submitted			2022-12-27	WOS:000305343900038
J	Muller, II; Muller, KAL; Schonleber, H; Karathanos, A; Schneider, M; Jorbenadze, R; Bigalke, B; Gawaz, M; Geisler, T				Mueller, Iris I.; Mueller, Karin A. L.; Schoenleber, Heiko; Karathanos, Athanasios; Schneider, Martina; Jorbenadze, Rezo; Bigalke, Boris; Gawaz, Meinrad; Geisler, Tobias			Macrophage Migration Inhibitory Factor Is Enhanced in Acute Coronary Syndromes and Is Associated with the Inflammatory Response	PLOS ONE			English	Article							ATHEROSCLEROTIC PLAQUES; PLATELET INHIBITION; FACTOR MIF; MECHANISMS; DISEASE; ATHEROGENESIS; EXPRESSION	Background: Chronic inflammation promotes atherosclerosis in cardiovascular disease and is a major prognostic factor for patients undergoing percutaneous coronary intervention (PCI). Macrophage migration inhibitory factor (MIF) is involved in the progress of atherosclerosis and plaque destabilization and plays a pivotal role in the development of acute coronary syndromes (ACS). Little is known to date about the clinical impact of MIF in patients with symptomatic coronary artery disease (CAD). Methods and Results: In a pilot study, 286 patients with symptomatic CAD (n = 119 ACS, n = 167 stable CAD) undergoing PCI were consecutively evaluated. 25 healthy volunteers served as control. Expression of MIF was consecutively measured in patients at the time of PCI. Baseline levels of interleukin 6 (IL-6), "regulated upon activation, normal T-cell expressed, and secreted" (RANTES) and monocyte chemoattractant protein-1 (MCP-1) were measured by Bio-Plex Cytokine assay. C-reactive protein (CRP) was determined by Immunoassay. Patients with ACS showed higher plasma levels of MIF compared to patients with stable CAD and control subjects (median 2.85 ng/mL, interquartile range (IQR) 3.52 versus median 1.22 ng/mL, IQR 2.99, versus median 0.1, IQR 0.09, p<0.001). Increased MIF levels were associated with CRP and IL-6 levels and correlated with troponin I (TnI) release (spearman rank coefficient: 0.31, p<0.001). Patients with ACS due to plaque rupture showed significantly higher plasma levels of MIF than patients with flow limiting stenotic lesions (p = 0.002). Conclusion: To our knowledge this is the first study, demonstrating enhanced expression of MIF in ACS. It is associated with established inflammatory markers, correlates with the extent of cardiac necrosis marker release after PCI and is significantly increased in ACS patients with "culprit" lesions. Further attempts should be undertaken to characterize the role of MIF for risk assessment in the setting of ACS.	[Mueller, Iris I.; Mueller, Karin A. L.; Schoenleber, Heiko; Karathanos, Athanasios; Schneider, Martina; Jorbenadze, Rezo; Bigalke, Boris; Gawaz, Meinrad; Geisler, Tobias] Univ Tubingen, Med Klin 3, Tubingen, Germany	Eberhard Karls University of Tubingen	Muller, II (corresponding author), Univ Tubingen, Med Klin 3, Tubingen, Germany.	meinrad.gawaz@med.uni-tuebingen.de; tobias.geisler@med.uni-tuebingen.de	Geisler, Tobias/AAO-4472-2020; Mondy, William L/G-4883-2012		Deutsche Forschungsgemeinschaft [Transregio-SFB19]; Klinische Forschergruppe: Platelets-Molecular Mechanisms and Translational Implications [KFO 274]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Klinische Forschergruppe: Platelets-Molecular Mechanisms and Translational Implications	Material for platelet aggregation studies with the Multiplate device was kindly provided free of charge by Dynabyte (Munich, Germany). The company had no influence on design, conduct of the study, interpretation of the data and the whole manuscript process. The study was in part funded by the Deutsche Forschungsgemeinschaft (Transregio-SFB19), and the Klinische Forschergruppe (KFO 274): Platelets-Molecular Mechanisms and Translational Implications. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	BERNHAGEN J, 1993, NATURE, V365, P756, DOI 10.1038/365756a0; Calandra T, 2003, NAT REV IMMUNOL, V3, P791, DOI 10.1038/nri1200; Gawaz M, 2005, J CLIN INVEST, V115, P3378, DOI 10.1172/JCI27196; Geisler T, 2004, MED SCI MONITOR, V10, pRA308; Gresele P, 2011, EUR HEART J, V32, P316, DOI 10.1093/eurheartj/ehq390; Lin SG, 2000, CIRC RES, V87, P1202, DOI 10.1161/01.RES.87.12.1202; Lue HQ, 2002, MICROBES INFECT, V4, P449, DOI 10.1016/S1286-4579(02)01560-5; May AE, 2002, CIRCULATION, V106, P2111, DOI 10.1161/01.CIR.0000033597.45947.0F; Muller K, 2010, ATHEROSCLEROSIS, V213, P256, DOI 10.1016/j.atherosclerosis.2010.07.023; Ouertatani-Sakouhi H, 2010, J BIOL CHEM, V285, P26581, DOI 10.1074/jbc.M110.113951; Roger T, 2001, NATURE, V414, P920, DOI 10.1038/414920a; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Saltzman AJ, 2010, J INVASIVE CARDIOL, V22, P2; Schmeisser A, 2005, ATHEROSCLEROSIS, V178, P83, DOI 10.1016/j.atherosclerosis.2004.08.038; Schober A, 2008, J MOL MED, V86, P761, DOI 10.1007/s00109-008-0334-2; Soehnlein O, 2009, BLOOD, V114, P4613, DOI 10.1182/blood-2009-06-221630; VANDERWAL AC, 1994, CIRCULATION, V89, P36, DOI 10.1161/01.CIR.89.1.36; Yang Li-xia, 2008, Zhonghua Xinxueguanbing Zazhi, V36, P912; Zernecke A, 2008, ARTERIOSCL THROM VAS, V28, P1897, DOI 10.1161/ATVBAHA.107.161174	19	49	53	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e38376	10.1371/journal.pone.0038376	http://dx.doi.org/10.1371/journal.pone.0038376			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22693633	gold, Green Published, Green Submitted			2022-12-27	WOS:000305343900031
J	Frydrychowski, AF; Szarmach, A; Czaplewski, B; Winklewski, PJ				Frydrychowski, Andrzej F.; Szarmach, Arkadiusz; Czaplewski, Bartosz; Winklewski, Pawel J.			Subarachnoid Space: New Tricks by an Old Dog	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; SEXUAL-DIMORPHISM; CEREBROVASCULAR PULSATION; NONINVASIVE MEASUREMENT; HEMISPHERIC-ASYMMETRY; WIDTH; BRAIN; FOUNDATIONS; HANDEDNESS; PRESSURE	Purpose: The purpose of the study was to: (1) evaluate the subarachnoid space (SAS) width and pial artery pulsation in both hemispheres, and (2) directly compare magnetic resonance imaging (MRI) to near-infrared transillumination/backscattering sounding (NIR-T/BSS) measurements of SAS width changes in healthy volunteers. Methods: The study was performed on three separate groups of volunteers, consisting in total of 62 subjects (33 women and 29 men) aged from 16 to 39 years. SAS width was assessed by MRI and NIR-T/BSS, and pial artery pulsation by NIR-T/BSS. Results: In NIR-T/BSS, the right frontal SAS was 9.1% wider than the left (p<0.01). The SAS was wider in men (p<0.01), while the pial artery pulsation was higher in women (p<0.01). Correlation and regression analysis of SAS width changes between the back-and abdominal-lying positions measured with MRI and NIRT-B/SS demonstrated high interdependence between both methods (r = 0.81, p<0.001). Conclusions: NIR-T/BSS and MRI were comparable and gave equivalent modalities for the SAS width change measurements. The SAS width and pial artery pulsation results obtained with NIR-T/BSS are consistent with the MRI data in the literature related to sexual dimorphism and morphological asymmetries between the hemispheres. NIR-T/BSS is a potentially cheap and easy-to-use method for early screening in patients with brain tumours, increased intracranial pressures and other abnormalities. Further studies in patients with intracranial pathologies are warranted.	[Frydrychowski, Andrzej F.; Winklewski, Pawel J.] Med Univ Gdansk, Inst Human Physiol, Gdansk, Poland; [Szarmach, Arkadiusz] Med Univ Gdansk, Dept Radiol, Gdansk, Poland; [Czaplewski, Bartosz] Gdansk Univ Technol, Dept Teleinformat Networks, Gdansk, Poland	Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; Gdansk University of Technology	Frydrychowski, AF (corresponding author), Med Univ Gdansk, Inst Human Physiol, Gdansk, Poland.	pawelwinklewski@wp.pl	Winklewski, Pawel/E-9307-2013; Czaplewski, Bartosz/AFQ-1291-2022	Szarmach, Arkadiusz/0000-0003-3118-014X; Winklewski, Pawel/0000-0002-1671-2163; Czaplewski, Bartosz/0000-0001-7904-5567	Medical University of Gdansk; NIRT sp. z o. o., Wierzbice, Poland	Medical University of Gdansk(Medical University Gdansk); NIRT sp. z o. o., Wierzbice, Poland	Funding came from the Medical University of Gdansk and NIRT sp. z o. o., Wierzbice, Poland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boucher Y, 1997, BRIT J CANCER, V75, P829, DOI 10.1038/bjc.1997.148; Cipolla MJ, 2007, HYPERTENSION, V50, P14, DOI 10.1161/HYPERTENSIONAHA.106.079442; Frydrychowski AE, 2002, IEEE T BIO-MED ENG, V49, P887, DOI 10.1109/TBME.2002.800786; Frydrychowski AF, 2001, OPTO-ELECTRON REV, V9, P397; Frydrychowski AF, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2753756; Frydrychowski AF, 2012, MICROVASC RES, V83, P229, DOI 10.1016/j.mvr.2011.08.005; Frydrychowski AF, 2011, ACTA NEUROBIOL EXP, V71, P313; Frydrychowski AF, 2011, MICROVASC RES, V82, P156, DOI 10.1016/j.mvr.2011.05.005; Frydrychowski AF, 2009, J ECT, V25, P99, DOI 10.1097/YCT.0b013e31818b1328; Gilmore JH, 2007, J NEUROSCI, V27, P1255, DOI 10.1523/JNEUROSCI.3339-06.2007; Good CD, 2001, NEUROIMAGE, V14, P685, DOI 10.1006/nimg.2001.0857; Gravendeel J, 2010, PEDIATR RADIOL, V40, P1651, DOI 10.1007/s00247-010-1687-6; GUR RC, 1982, SCIENCE, V217, P659, DOI 10.1126/science.217.4560.657; Klingelhofer J, 1997, J CEREBR BLOOD F MET, V17, P577, DOI 10.1097/00004647-199705000-00013; Krause DN, 2006, J APPL PHYSIOL, V101, P1252, DOI 10.1152/japplphysiol.01095.2005; Lam WW, 2003, PEDIATR NEUROL, V25, P380; Li ZY, 2011, MICROVASC RES, V81, P81, DOI 10.1016/j.mvr.2010.09.011; Li ZY, 2010, MICROVASC RES, V80, P142, DOI 10.1016/j.mvr.2010.02.004; LIBICHER M, 1992, RADIOLOGY, V184, P749, DOI 10.1148/radiology.184.3.1509061; Maes M, 2000, ALCOHOL, V20, P117, DOI 10.1016/S0741-8329(99)00066-X; MAIER SE, 1994, RADIOLOGY, V193, P477, DOI 10.1148/radiology.193.2.7972766; MEYER JS, 1978, STROKE, V9, P195, DOI 10.1161/01.STR.9.3.195; Mills SJ, 2006, AM J NEURORADIOL, V27, P853; Nopoulos P, 2000, PSYCHIAT RES-NEUROIM, V98, P1, DOI 10.1016/S0925-4927(99)00044-X; PIVEN J, 1995, AM J PSYCHIAT, V152, P1145; Plucinski J, 2000, J BIOMED OPT, V5, P291, DOI 10.1117/1.429999; Plucinski J, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2757603; Raz N, 2004, NEUROBIOL AGING, V25, P377, DOI 10.1016/S0197-4580(03)00118-0; RODRIGUEZ G, 1988, J CEREBR BLOOD F MET, V8, P783, DOI 10.1038/jcbfm.1988.133; Sanderson TL, 1999, LANCET, V354, P1867, DOI 10.1016/S0140-6736(99)01049-1; Wagner BP, 2003, INTENS CARE MED, V29, P196, DOI 10.1007/s00134-002-1592-z; Wszedybyl-Winklewska M, 2012, ACTA NEUROBIOL EXP, V72, P80; Wszedybyl-Winklewska M, 2011, MICROVASC RES, V82, P369, DOI 10.1016/j.mvr.2011.08.003	33	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e37529	10.1371/journal.pone.0037529	http://dx.doi.org/10.1371/journal.pone.0037529			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22701518	Green Published, gold, Green Submitted			2022-12-27	WOS:000305338500040
J	Liu, MF; Boulouis, HJ; Biville, F				Liu, MaFeng; Boulouis, Henri-Jean; Biville, Francis			Heme Degrading Protein HemS Is Involved in Oxidative Stress Response of Bartonella henselae	PLOS ONE			English	Article							GRAM-NEGATIVE BACTERIA; PSEUDOMONAS-AERUGINOSA; ESCHERICHIA-COLI; IRON UPTAKE; CORYNEBACTERIUM-DIPHTHERIAE; HUMAN ERYTHROCYTES; YERSINIA-PESTIS; BINDING; OXYGENASE; GENE	Bartonellae are hemotropic bacteria, agents of emerging zoonoses. These bacteria are heme auxotroph Alphaproteobacteria which must import heme for supporting their growth, as they cannot synthesize it. Therefore, Bartonella genome encodes for a complete heme uptake system allowing the transportation of this compound across the outer membrane, the periplasm and the inner membranes. Heme has been proposed to be used as an iron source for Bartonella since these bacteria do not synthesize a complete system required for iron Fe3+ uptake. Similarly to other bacteria which use heme as an iron source, Bartonellae must transport this compound into the cytoplasm and degrade it to allow the release of iron from the tetrapyrrole ring. For Bartonella, the gene cluster devoted to the synthesis of the complete heme uptake system also contains a gene encoding for a polypeptide that shares homologies with heme trafficking or degrading enzymes. Using complementation of an E. coli mutant strain impaired in heme degradation, we demonstrated that HemS from Bartonella henselae expressed in E. coli allows the release of iron from heme. Purified HemS from B. henselae binds heme and can degrade it in the presence of a suitable electron donor, ascorbate or NADPH-cytochrome P450 reductase. Knocking down the expression of HemS in B. henselae reduces its ability to face H2O2 induced oxidative stress.	[Liu, MaFeng; Boulouis, Henri-Jean; Biville, Francis] Univ Paris Est, Ecole Natl Vet Alfort, UMR BIPAR INRA Anses UPEC ENVA, Maisons Alfort, France; [Liu, MaFeng] Jilin Univ, Minist Educ, Inst Zoonosis, Key Lab Zoonosis, Changchun 130023, Peoples R China; [Biville, Francis] Inst Pasteur, Dept Microbiol, Paris, France	Ecole Nationale Veterinaire d'Alfort (ENVA); INRAE; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Jilin University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Liu, MF (corresponding author), Univ Paris Est, Ecole Natl Vet Alfort, UMR BIPAR INRA Anses UPEC ENVA, Maisons Alfort, France.	fbiville@pasteur.fr			Pasteur Institute; Centre National de la Recherche Scientifique [URA2172]; Agence Nationale pour la Recherche [ANR-06-MIME-019-01]; China Scholarship Council	Pasteur Institute; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale pour la Recherche(French National Research Agency (ANR)); China Scholarship Council(China Scholarship Council)	This work was supported by the Pasteur Institute, the Centre National de la Recherche Scientifique (URA2172), the Agence Nationale pour la Recherche[ANR-06-MIME-019-01]. MFL was supported by the grant of China Scholarship Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsmark CM, 2004, P NATL ACAD SCI USA, V101, P9716, DOI 10.1073/pnas.0305659101; Anzaldi LL, 2010, INFECT IMMUN, V78, P4977, DOI 10.1128/IAI.00613-10; Breitschwerdt EB, 2010, J VET EMERG CRIT CAR, V20, P8, DOI 10.1111/j.1476-4431.2009.00496.x; Bruggemann H, 2004, ARCH MICROBIOL, V182, P259, DOI 10.1007/s00203-004-0721-1; Carroll JA, 2000, INFECT IMMUN, V68, P6750, DOI 10.1128/IAI.68.12.6750-6757.2000; Chaveroche MK, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.22.e97; Coleman SA, 2003, MICROB PATHOGENESIS, V34, P179, DOI 10.1016/S0882-4010(03)00005-6; Dailey HA, MBIO, V2; Derbise A, 2003, FEMS IMMUNOL MED MIC, V38, P113, DOI 10.1016/S0928-8244(03)00181-0; Derrick SC, 2001, BLOOD CELL MOL DIS, V27, P1013, DOI 10.1006/bcmd.2001.0475; Edouard S, 2010, MED MALADIES INFECT, V40, P319, DOI 10.1016/j.medmal.2009.11.004; Gillaspie D, 2009, APPL ENVIRON MICROB, V75, P5434, DOI 10.1128/AEM.00949-09; Guptill L, 2010, VET MICROBIOL, V140, P347, DOI 10.1016/j.vetmic.2009.11.011; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Imlay JA, 2008, ANNU REV BIOCHEM, V77, P755, DOI 10.1146/annurev.biochem.77.061606.161055; Kaur AP, 2009, J BIOL CHEM, V284, P56, DOI 10.1074/jbc.M806068200; Klotz SA, 2011, AM FAM PHYSICIAN, V83, P152; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lansky IB, 2006, J BIOL CHEM, V281, P13652, DOI 10.1074/jbc.M600824200; Letoffe S, 2003, MOL MICROBIOL, V50, P77, DOI 10.1046/j.1365-2958.2003.03686.x; Letoffe S, 2006, P NATL ACAD SCI USA, V103, P12891, DOI 10.1073/pnas.0605440103; Letoffe S, 2009, P NATL ACAD SCI USA, V106, P11719, DOI 10.1073/pnas.0903842106; Liu MF, 2012, MICROBIOL-SGM, V158, P886, DOI 10.1099/mic.0.054619-0; Maniatis T., 1989, MOL CLONING LAB MANU; Miller J.H., 1972, EXPT MOL GENETICS; MITCHELL SJ, 1995, INFECT IMMUN, V63, P1552, DOI 10.1128/IAI.63.4.1552-1562.1995; Oshima T, 2006, MICROBIOL-SGM, V152, P2129, DOI 10.1099/mic.0.28753-0; Parrow NL, 2009, INFECT IMMUN, V77, P307, DOI 10.1128/IAI.01194-08; Perrotte-Piquemal M, 1999, BIOCHIMIE, V81, P245, DOI 10.1016/S0300-9084(99)80058-3; Perry RD, 2007, BIOMETALS, V20, P699, DOI 10.1007/s10534-006-9051-x; Puri S, 2006, J BACTERIOL, V188, P6476, DOI 10.1128/JB.00737-06; Ratliff M, 2001, J BACTERIOL, V183, P6394, DOI 10.1128/JB.183.21.6394-6403.2001; Riess T, 2003, GENE, V313, P103, DOI 10.1016/S0378-1119(03)00636-X; Riess T, 2008, APPL ENVIRON MICROB, V74, P5224, DOI 10.1128/AEM.00621-08; Sander A, 2000, FEMS MICROBIOL LETT, V189, P55, DOI 10.1111/j.1574-6968.2000.tb09205.x; SCHERER DC, 1993, INFECT IMMUN, V61, P4962, DOI 10.1128/IAI.61.12.4962-4971.1993; Schmitt MP, 1997, J BACTERIOL, V179, P838, DOI 10.1128/jb.179.3.838-845.1997; Seubert A, 2003, MOL MICROBIOL, V49, P1253, DOI 10.1046/j.1365-2958.2003.03650.x; Silver GM, 2002, ARCH INSECT BIOCHEM, V51, P136, DOI 10.1002/arch.10059; Skaar EP, 2004, J BIOL CHEM, V279, P436, DOI 10.1074/jbc.M307952200; Skaar EP, 2006, J BACTERIOL, V188, P1071, DOI 10.1128/JB.188.3.1071-1080.2006; STOJILJKOVIC I, 1994, MOL MICROBIOL, V13, P719, DOI 10.1111/j.1365-2958.1994.tb00465.x; Suits MDL, 2005, P NATL ACAD SCI USA, V102, P16955, DOI 10.1073/pnas.0504289102; Thompson JM, 1999, INFECT IMMUN, V67, P3879, DOI 10.1128/IAI.67.8.3879-3892.1999; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VARGAS C, 1993, ANAL BIOCHEM, V209, P323, DOI 10.1006/abio.1993.1127; Vayssier-Taussat M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000946; Watson RJ, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-177; Wilks A, 1998, J BIOL CHEM, V273, P837, DOI 10.1074/jbc.273.2.837; Wyckoff EE, 2005, J BACTERIOL, V187, P5658, DOI 10.1128/JB.187.16.5658-5664.2005; Wyckoff EE, 2004, J BACTERIOL, V186, P4142, DOI 10.1128/JB.186.13.4142-4151.2004; Zhu WM, 2000, J BACTERIOL, V182, P6783, DOI 10.1128/JB.182.23.6783-6790.2000	52	10	12	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e37630	10.1371/journal.pone.0037630	http://dx.doi.org/10.1371/journal.pone.0037630			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22701524	Green Published, gold, Green Submitted			2022-12-27	WOS:000305338500045
J	Mandal, K; Balland, M; Bureau, L				Mandal, Kalpana; Balland, Martial; Bureau, Lionel			Thermoresponsive Micropatterned Substrates for Single Cell Studies	PLOS ONE			English	Article							POLYMER BRUSHES; SURFACES; DIFFERENTIATION; ORGANIZATION; DETACHMENT; INTERFACES; ANISOTROPY; COLLAPSE	We describe the design of micropatterned surfaces for single cell studies, based on thermoresponsive polymer brushes. We show that brushes made of poly(N-isopropylacrylamide) grafted at high surface density display excellent protein and cell anti-adhesive properties. Such brushes are readily patterned at the micron scale via deep UV photolithography. A proper choice of the adhesive pattern shapes, combined with the temperature-dependent swelling properties of PNIPAM, allow us to use the polymer brush as a microactuator which induces cell detachment when the temperature is reduced below 32 degrees C.	[Mandal, Kalpana; Balland, Martial; Bureau, Lionel] Univ Grenoble 1, CNRS, Lab Interdisciplinaire Phys, UMR 5588, Grenoble, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Mandal, K (corresponding author), Univ Grenoble 1, CNRS, Lab Interdisciplinaire Phys, UMR 5588, Grenoble, France.	martial.balland@ujf-grenoble.fr; lionel.bureau@ujf-grenoble.fr		Balland, martial/0000-0002-6585-9735	Fondation Nanosciences aux limites de la nanoelectronique [FCSN-2008-11JE]	Fondation Nanosciences aux limites de la nanoelectronique	Kalpana Mandal has a PhD grant from the "Fondation Nanosciences aux limites de la nanoelectronique" (contract number FCSN-2008-11JE; http://http://www.fondation-nanosciences.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Competing	Azioune A, 2009, LAB CHIP, V9, P1640, DOI 10.1039/b821581m; Cole MA, 2009, BIOMATERIALS, V30, P1827, DOI 10.1016/j.biomaterials.2008.12.026; DEGENNES PG, 1980, MACROMOLECULES, V13, P1069, DOI 10.1021/ma60077a009; Destaing O, 2010, MOL BIOL CELL, V21, P4108, DOI 10.1091/mbc.E10-07-0580; Falconnet D, 2006, BIOMATERIALS, V27, P3044, DOI 10.1016/j.biomaterials.2005.12.024; Gautrot JE, 2010, BIOMATERIALS, V31, P5030, DOI 10.1016/j.biomaterials.2010.02.066; Halperin A, 2011, MACROMOLECULES, V44, P6986, DOI 10.1021/ma201006h; Huang JH, 2009, NANO LETT, V9, P1111, DOI 10.1021/nl803548b; Ishida N, 2007, LANGMUIR, V23, P11083, DOI 10.1021/la701461b; Iwanaga S, 2005, BIOMATERIALS, V26, P5395, DOI 10.1016/j.biomaterials.2005.01.021; Liu HC, 2002, LAB CHIP, V2, P175, DOI 10.1039/b204944a; Ma HW, 2004, ADV MATER, V16, P338, DOI 10.1002/adma.200305830; Malham IB, 2010, LANGMUIR, V26, P4762, DOI 10.1021/la9035387; Mizutani A, 2008, BIOMATERIALS, V29, P2073, DOI 10.1016/j.biomaterials.2008.01.004; Nagase K, 2011, MACROMOL BIOSCI, V11, P400, DOI 10.1002/mabi.201000312; Nagase K, 2009, J R SOC INTERFACE, V6, pS293, DOI 10.1098/rsif.2008.0499.focus; OKANO T, 1995, BIOMATERIALS, V16, P297, DOI 10.1016/0142-9612(95)93257-E; Pan Z, 2012, BIOMATERIALS, V33, P1730, DOI 10.1016/j.biomaterials.2011.11.023; Peng R, 2011, BIOMATERIALS, V32, P8048, DOI 10.1016/j.biomaterials.2011.07.035; Plunkett KN, 2006, LANGMUIR, V22, P4259, DOI 10.1021/la0531502; Racine J, 2011, BIOTECHNOL BIOENG, V108, P983, DOI 10.1002/bit.22997; Schmaljohann D, 2003, BIOMACROMOLECULES, V4, P1733, DOI 10.1021/bm034160p; SINGHVI R, 1994, SCIENCE, V264, P696, DOI 10.1126/science.8171320; Takahashi H, 2011, BIOMACROMOLECULES, V12, P1414, DOI 10.1021/bm2000956; Tang J, 2010, BIOMATERIALS, V31, P2470, DOI 10.1016/j.biomaterials.2009.12.006; Thery M, 2006, P NATL ACAD SCI USA, V103, P19771, DOI 10.1073/pnas.0609267103; Thery M, 2010, J CELL SCI, V123, P4201, DOI 10.1242/jcs.075150; Williams C, 2009, ADV MATER, V21, P2161, DOI 10.1002/adma.200801027; Yamato M, 2002, BIOMATERIALS, V23, P561, DOI 10.1016/S0142-9612(01)00138-7; Yan C, 2011, BIOMATERIALS, V32, P3931, DOI 10.1016/j.biomaterials.2011.01.078	30	48	48	0	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e37548	10.1371/journal.pone.0037548	http://dx.doi.org/10.1371/journal.pone.0037548			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22701519	Green Submitted, Green Published, gold			2022-12-27	WOS:000305338500041
J	Wang, ZL; Parker, D; Meng, H; Wu, LO; Li, J; Zhao, Z; Zhang, RP; Fan, Q; Wang, HY; Cui, LW; Yang, ZQ				Wang, Zenglei; Parker, Daniel; Meng, Hao; Wu, Lanou; Li, Jia; Zhao, Zhen; Zhang, Rongping; Fan, Qi; Wang, Haiyan; Cui, Liwang; Yang, Zhaoqing			In Vitro Sensitivity of Plasmodium falciparum from China-Myanmar Border Area to Major ACT Drugs and Polymorphisms in Potential Target Genes	PLOS ONE			English	Article							ARTEMISININ-RESISTANT MALARIA; PFMDR1 COPY NUMBER; ARTEMETHER-LUMEFANTRINE; MEFLOQUINE RESISTANCE; ARTESUNATE-MEFLOQUINE; MOLECULAR ANALYSIS; CHLOROQUINE RESISTANCE; COMBINATION THERAPY; TYROSINE-86 ALLELE; QUININE RESISTANCE	Drug resistance has always been one of the most important impediments to global malaria control. Artemisinin resistance has recently been confirmed in the Greater Mekong Subregion (GMS) and efforts for surveillance and containment are intensified. To determine potential mechanisms of artemisinin resistance and monitor the emergence and spread of resistance in other regions of the GMS, we investigated the in vitro sensitivity of 51 culture-adapted parasite isolates from the China-Myanmar border area to four drugs. The 50% inhibitory concentrations (IC(50)s) of dihydroartemisinin, mefloquine and lumefantrine were clustered in a relatively narrow, 3- to 6-fold range, whereas the IC50 range of artesunate was 12-fold. We assessed the polymorphisms of candidate resistance genes pfcrt, pfmdr1, pfATP6, pfmdr6 and pfMT (a putative metabolite/drug transporter). The K76T mutation in pfcrt reached fixation in the study parasite population, whereas point mutations in pfmdr1 and pfATP6 had low levels of prevalence. In addition, pfmdr1 gene amplification was not detected. None of the mutations in pfmdr1 and pfATP6 was associated significantly with in vitro sensitivity to artemisinin derivatives. The ABC transporter gene pfmdr6 harbored two point mutations, two indels, and number variations in three simple repeats. Only the length variation in a microsatellite repeat appeared associated with altered sensitivity to dihydroartemisinin. The PfMT gene had two point mutations and one codon deletion; the I30N and N496-both reached high levels of prevalence. However, none of the SNPs or haplotypes in PfMT were correlated significantly with resistance to the four tested drugs. Compared with other parasite populations from the GMS, our studies revealed drastically different genotype and drug sensitivity profiles in parasites from the China-Myanmar border area, where artemisinins have been deployed extensively for over 30 years.	[Wang, Zenglei; Parker, Daniel; Meng, Hao; Cui, Liwang] Penn State Univ, Dept Entomol, University Pk, PA 16802 USA; [Meng, Hao; Li, Jia; Zhao, Zhen; Yang, Zhaoqing] Kunming Med Univ, Dept Parasitol, Kunming, Yunnan, Peoples R China; [Wu, Lanou] Kunming Med Univ, Dept Pharmacol, Kunming, Yunnan, Peoples R China; [Zhang, Rongping] Kunming Med Univ, Dept Pharmaceut Chem, Kunming, Yunnan, Peoples R China; [Fan, Qi] Dalian Inst Biotechnol, Dalian, Liaoning, Peoples R China; [Wang, Haiyan] Kansas State Univ, Dept Stat, Manhattan, KS 66506 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Kunming Medical University; Kunming Medical University; Kunming Medical University; Kansas State University	Wang, ZL (corresponding author), Penn State Univ, Dept Entomol, University Pk, PA 16802 USA.	luc2@psu.edu; zhaoqingy92@hotmail.com	Parker, Daniel M./B-5471-2013	Parker, Daniel M./0000-0002-5352-7338	National Institutes of Health (NIH) [1R01AI075429]; National Natural Science Foundation of China [30960050]; National Institute of Allergy and Infectious Diseases, NIH [U19AI089672]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI089672, R01AI075429] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institute of Allergy and Infectious Diseases, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by National Institutes of Health (NIH) international grant (1R01AI075429) to Z. Yang, National Natural Science Foundation of China (no. 30960050), and U19AI089672 from National Institute of Allergy and Infectious Diseases, NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alker AP, 2007, AM J TROP MED HYG, V76, P641, DOI 10.4269/ajtmh.2007.76.641; Arnou B, 2011, BIOCHEM SOC T, V39, P823, DOI 10.1042/BST0390823; Bacon DJ, 2009, ANTIMICROB AGENTS CH, V53, P2042, DOI 10.1128/AAC.01677-08; Beez D, 2011, ANTIMICROB AGENTS CH, V55, P50, DOI 10.1128/AAC.00916-10; Bosman A, 2007, AM J TROP MED HYG, V77, P193, DOI 10.4269/ajtmh.2007.77.193; Cardi D, 2010, J BIOL CHEM, V285, P26406, DOI 10.1074/jbc.M109.090340; Carrara VI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004551; Chaijaroenkul W, 2010, ACTA TROP, V113, P190, DOI 10.1016/j.actatropica.2009.10.016; Chavchich M, 2010, ANTIMICROB AGENTS CH, V54, P2455, DOI 10.1128/AAC.00947-09; Chen NH, 2010, ANTIMICROB AGENTS CH, V54, P3395, DOI 10.1128/AAC.01421-09; Cojean S, 2006, EMERG INFECT DIS, V12, P1798, DOI 10.3201/eid1211.060903; COWMAN AF, 1994, P NATL ACAD SCI USA, V91, P1143, DOI 10.1073/pnas.91.3.1143; Crespo MD, 2008, ANTIMICROB AGENTS CH, V52, P98, DOI 10.1128/AAC.00609-07; Cui L, 2012, ANTIMICROB IN PRESS; Cui LW, 2012, ACTA TROP, V121, P227, DOI 10.1016/j.actatropica.2011.02.016; Cui LW, 2009, EXPERT REV ANTI-INFE, V7, P999, DOI [10.1586/eri.09.68, 10.1586/ERI.09.68]; Cui LW, 2002, NUCLEIC ACIDS RES, V30, P4607, DOI 10.1093/nar/gkf600; Dahlstrom S, 2008, INFECT GENET EVOL, V8, P340, DOI 10.1016/j.meegid.2008.02.002; Delacollette C, 2009, SE ASIAN J TROP MED, V40, P674; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Duraisingh MT, 2000, MOL BIOCHEM PARASIT, V108, P13, DOI 10.1016/S0166-6851(00)00201-2; Duraisingh MT, 2005, ACTA TROP, V94, P181, DOI 10.1016/j.actatropica.2005.04.008; Duraisingh MT, 1997, PARASITOLOGY, V114, P205, DOI 10.1017/S0031182096008487; Eckstein-Ludwig U, 2003, NATURE, V424, P957, DOI 10.1038/nature01813; Ferdig MT, 2004, MOL MICROBIOL, V52, P985, DOI 10.1111/j.1365-2958.2004.04035.x; Ferreira ID, 2007, TROP MED INT HEALTH, V12, P353, DOI 10.1111/j.1365-3156.2006.01789.x; FOOTE SJ, 1990, NATURE, V345, P255, DOI 10.1038/345255a0; Happi CT, 2009, ANTIMICROB AGENTS CH, V53, P888, DOI 10.1128/AAC.00968-08; Huttinger F, 2010, WIEN KLIN WOCHENSCHR, V122, P52, DOI 10.1007/s00508-010-1438-6; Hunt P, 2007, MOL MICROBIOL, V65, P27, DOI 10.1111/j.1365-2958.2007.05753.x; Ibrahim ML, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-28; Imwong M, 2010, ANTIMICROB AGENTS CH, V54, P2886, DOI 10.1128/AAC.00032-10; Jambou R, 2005, LANCET, V366, P1960, DOI 10.1016/S0140-6736(05)67787-2; Jambou R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009424; Kaneko O, 1997, EXP PARASITOL, V86, P45, DOI 10.1006/expr.1997.4147; Kavishe RA, 2006, AM J TROP MED HYG, V75, P827, DOI 10.4269/ajtmh.2006.75.827; Krishna S, 2006, TRENDS MOL MED, V12, P200, DOI 10.1016/j.molmed.2006.03.005; Lim P, 2010, ANTIMICROB AGENTS CH, V54, P2135, DOI 10.1128/AAC.01304-09; Lim P, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-11; Maude RJ, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-31; Meng H, 2010, ANTIMICROB AGENTS CH, V54, P4306, DOI 10.1128/AAC.00321-10; Meshnick SR, 2002, INT J PARASITOL, V32, P1655, DOI 10.1016/S0020-7519(02)00194-7; Mu JB, 2003, MOL MICROBIOL, V49, P977, DOI 10.1046/j.1365-2958.2003.03627.x; Mu JB, 2010, NAT GENET, V42, P268, DOI 10.1038/ng.528; Mugittu K, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-126; Mungthin M, 2010, AM J TROP MED HYG, V83, P1005, DOI 10.4269/ajtmh.2010.10-0339; Noedl H, 2010, CLIN INFECT DIS, V51, pE82, DOI 10.1086/657120; Noedl H, 2008, NEW ENGL J MED, V359, P2619, DOI 10.1056/NEJMc0805011; Noedl H, 2009, NEW ENGL J MED, V361, P540, DOI 10.1056/NEJMc0900231; Phompradit P, 2011, ACTA TROP, V120, P130, DOI 10.1016/j.actatropica.2011.07.003; Pickard AL, 2003, ANTIMICROB AGENTS CH, V47, P2418, DOI 10.1128/AAC.47.8.2418-2423.2003; Preechapornkul P, 2009, ANTIMICROB AGENTS CH, V53, P1509, DOI 10.1128/AAC.00241-08; Price RN, 1999, ANTIMICROB AGENTS CH, V43, P2943, DOI 10.1128/AAC.43.12.2943; Price RN, 2006, CLIN INFECT DIS, V42, P1570, DOI 10.1086/503423; Price RN, 2004, LANCET, V364, P438, DOI 10.1016/S0140-6736(04)16767-6; Rathod PK, 1997, P NATL ACAD SCI USA, V94, P9389, DOI 10.1073/pnas.94.17.9389; Reed MB, 2000, NATURE, V403, P906, DOI 10.1038/35002615; Roper C, 1998, PARASITOLOGY, V116, P501, DOI 10.1017/S0031182098002650; Roper C, 2004, SCIENCE, V305, P1124, DOI 10.1126/science.1098876; Sanchez CP, 2010, INT J PARASITOL, V40, P1109, DOI 10.1016/j.ijpara.2010.04.001; Shah NK, 2008, EMERG INFECT DIS, V14, P1637, DOI 10.3201/eid1410.080080; Sidhu ABS, 2005, MOL MICROBIOL, V57, P913, DOI 10.1111/j.1365-2958.2005.04729.x; Sidhu ABS, 2006, J INFECT DIS, V194, P528, DOI 10.1086/507115; Sisowath C, 2005, J INFECT DIS, V191, P1014, DOI 10.1086/427997; Smilkstein M, 2004, ANTIMICROB AGENTS CH, V48, P1803, DOI 10.1128/AAC.48.5.1803-1806.2004; Snounou G, 1999, T ROY SOC TROP MED H, V93, P369, DOI 10.1016/S0035-9203(99)90120-7; Tanabe K, 2011, ANTIMICROB AGENTS CH, V55, P94, DOI 10.1128/AAC.01156-10; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Uhlemann AC, 2005, NAT STRUCT MOL BIOL, V12, P628, DOI 10.1038/nsmb947; Valderramos SG, 2010, ANTIMICROB AGENTS CH, V54, P3842, DOI 10.1128/AAC.00121-10; Veiga MI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020212; Wellems TE, 2001, J INFECT DIS, V184, P770, DOI 10.1086/322858; White NJ, 2008, SCIENCE, V320, P330, DOI 10.1126/science.1155165; WHO, 2009, WHO TECH REP SER, V958, P1; WILSON CM, 1993, MOL BIOCHEM PARASIT, V57, P151, DOI 10.1016/0166-6851(93)90252-S; Wongsrichanalai C, 2008, EMERG INFECT DIS, V14, P716, DOI 10.3201/eid1405.071601; Yang HL, 2003, T ROY SOC TROP MED H, V97, P226, DOI 10.1016/S0035-9203(03)90127-1; Yang ZQ, 2007, TROP MED INT HEALTH, V12, P1051, DOI 10.1111/j.1365-3156.2007.01882.x; Yang ZQ, 2011, EMERG INFECT DIS, V17, P498, DOI 10.3201/eid1703.100870; Zarocostas J, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c6558; Zhang GQ, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-122	81	32	37	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e30927	10.1371/journal.pone.0030927	http://dx.doi.org/10.1371/journal.pone.0030927			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22701513	Green Published, Green Submitted, gold			2022-12-27	WOS:000305338500001
J	Xu, P; Chen, JC; Chen, Z; Zhou, SY; Hu, P; Chen, XY; Huang, MD				Xu, Peng; Chen, Jincan; Chen, Zhuo; Zhou, Shanyong; Hu, Ping; Chen, Xueyuan; Huang, Mingdong			Receptor-Targeting Phthalocyanine Photosensitizer for Improving Antitumor Photocytotoxicity	PLOS ONE			English	Article							GONADOTROPIN-RELEASING-HORMONE; PHOTODYNAMIC ACTIVITY; IN-VITRO; PHOTOCHEMICAL PROPERTIES; BASIC PRINCIPLES; CANCER-CELLS; THERAPY; BREAST; ANALOGS; ZINC	Photodynamic therapy (PDT) is a promising therapeutic modality which uses a photosensitizer to capture visible light resulting in phototoxicity in the irradiated region. PDT has been used in a number of pathological indications, including tumor. A key desirable feature of the photosensitizer is the high phototoxicity on tumor cells but not on normal cells. In this study, we conjugate a gonadotropin-releasing hormone (GnRH) to a photosensitizer, Zinc phthalocyanine (ZnPc), in order to enhance its specificity to breast cancer, which over-expresses GnRH receptor. ZnPc has unique advantages over other photosensitizers, but is difficult to derivatize and purify as a single isomer. We previously developed a straight-forward way to synthesize mono-substituted beta-carboxy-phthalocyanine zinc (ZnPc-COOH). Photophysical and photochemical parameters of this ZnPc-GnRH conjugate including fluorescence quantum yield (Phi(f)), fluorescence decay time (tau(s)) and singlet oxygen quantum yield (Phi(Delta)) were evaluated and found comparable with that of ZnPc, indicating that addition of a GnRH peptide does not significantly alter the generation of singlet oxygen from ZnPc. Cellular uptakes and phototoxicities of this conjugate were tested and found significantly enhanced on human breast cancer cell lines overexpressing GnRH receptors (MDA-MB-231 and MCF-7 cells) compared to cells with low levels of GnRH receptors, such as human embryonic lung fibroblast (HELF) and human liver carcinoma (HepG2) cells. In addition, the cellular uptake of this conjugate toward MCF-7 cells were found clearly alleviated by a GnRH receptor blocker Cetrorelix, suggesting that the cellular uptake of this conjugate was GnRH receptor-mediated. Put together, these findings revealed that coupling ZnPc with GnRH analogue was an effective way to improve the selectivity of ZnPc towards tumors with over-expressed GnRH receptors.	[Xu, Peng; Chen, Jincan; Chen, Zhuo; Zhou, Shanyong; Hu, Ping; Huang, Mingdong] Chinese Acad Sci, Fujian Inst Res Struct Matter, State Key Lab Struct Chem, Danish Chinese Ctr Proteases & Canc, Fuzhou 350002, Fujian, Peoples R China; [Xu, Peng; Chen, Jincan; Chen, Zhuo; Chen, Xueyuan; Huang, Mingdong] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Chen, Xueyuan] Chinese Acad Sci, Fujian Inst Res Struct Matter, Key Lab Optoelect Mat Chem & Phys, Fuzhou 350002, Fujian, Peoples R China	Chinese Academy of Sciences; Fujian Institute of Research on the Structure of Matter, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Fujian Institute of Research on the Structure of Matter, CAS	Xu, P (corresponding author), Chinese Acad Sci, Fujian Inst Res Struct Matter, State Key Lab Struct Chem, Danish Chinese Ctr Proteases & Canc, Fuzhou 350002, Fujian, Peoples R China.	zchen@fjirsm.ac.cn; mhuang@fjirsm.ac.cn	Chen, Zhuo/O-2928-2019; Chen, Zhuo/A-6144-2011; Chen, Xueyuan/C-5613-2012; Xu, Peng/GXF-8681-2022; Huang, Mingdong/J-4278-2017	Chen, Zhuo/0000-0002-6351-8689; Chen, Zhuo/0000-0002-6351-8689; Chen, Xueyuan/0000-0003-0493-839X; Xu, Peng/0000-0003-3968-7279; Huang, Mingdong/0000-0003-0085-9141	Fujian Province Natural Science Foundation [2009I0029]; National Natural Science Foundation [30973567, 30811130467]; Chinese Ministry of Science and Technology [2006AA02A313]	Fujian Province Natural Science Foundation(Natural Science Foundation of Fujian Province); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Science and Technology(Ministry of Science and Technology, China)	This work was supported by Fujian Province Natural Science Foundation (2009I0029), National Natural Science Foundation (30973567 and 30811130467) and the Chinese Ministry of Science and Technology (2006AA02A313). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen CM, 2001, J PORPHYR PHTHALOCYA, V5, P161, DOI 10.1002/jpp.324; Allen Cynthia M., 2002, P329; Avetisov S E, 2007, Vestn Oftalmol, V123, P3; Bai M, 2011, ORG BIOMOL CHEM, V9, P7028, DOI 10.1039/c1ob05955f; BAJUSZ S, 1989, P NATL ACAD SCI USA, V86, P6318, DOI 10.1073/pnas.86.16.6318; Biyiklioglu Z, 2010, J PHOTOCH PHOTOBIO A, V211, P32, DOI 10.1016/j.jphotochem.2010.01.018; Brasseur N, 1999, PHOTOCHEM PHOTOBIOL, V69, P345, DOI 10.1562/0031-8655(1999)069<0345:RMTOPT>2.3.CO;2; Carcenac M, 1999, PHOTOCHEM PHOTOBIOL, V70, P930, DOI 10.1111/j.1751-1097.1999.tb08304.x; Chen JC, 2008, CHEM J CHINESE U, V29, P2131; Chen JC, 2006, INORG CHEM COMMUN, V9, P313, DOI 10.1016/j.inoche.2005.12.002; Chen JC, 2011, J PORPHYR PHTHALOCYA, V15, P293, DOI 10.1142/S1088424611003276; Chen Z, 2010, CHEMMEDCHEM, V5, P890, DOI 10.1002/cmdc.201000042; Choi Y, 2006, CHEMMEDCHEM, V1, P458, DOI 10.1002/cmdc.200500036; DOUGHERTY TJ, 1993, PHOTOCHEM PHOTOBIOL, V58, P895, DOI 10.1111/j.1751-1097.1993.tb04990.x; EIDNE KA, 1987, J CLIN ENDOCR METAB, V64, P425, DOI 10.1210/jcem-64-3-425; Ethirajan M, 2011, CHEM SOC REV, V40, P340, DOI 10.1039/b915149b; Harrison GS, 2004, ENDOCR-RELAT CANCER, V11, P725, DOI 10.1677/erc.1.00777; Huang D, 2000, SPECTROSC SPECT ANAL, V20, P95; JANAKY T, 1992, P NATL ACAD SCI USA, V89, P972, DOI 10.1073/pnas.89.3.972; Kakar SS, 2008, ADV EXP MED BIOL, V614, P285, DOI 10.1007/978-0-387-74911-2_32; Kakar SS, 2004, VITAM HORM, V69, P151, DOI 10.1016/S0083-6729(04)69006-6; KAKAR SS, 1994, MOL CELL ENDOCRINOL, V106, P145, DOI 10.1016/0303-7207(94)90196-1; Keller G, 2005, CANCER RES, V65, P5857, DOI 10.1158/0008-5472.CAN-04-3816; Kovacs M, 1997, P NATL ACAD SCI USA, V94, P1420, DOI 10.1073/pnas.94.4.1420; Kuznetsova NA, 2000, RUSS J GEN CHEM, V70, P133; Leuschner C, 2003, BREAST CANCER RES TR, V78, P17, DOI 10.1023/A:1022169525521; Leuschner C, 2006, BREAST CANCER RES TR, V99, P163, DOI 10.1007/s10549-006-9199-7; Liu JY, 2009, ORG BIOMOL CHEM, V7, P1583, DOI 10.1039/b822128f; Lo PC, 2007, BIOORG MED CHEM LETT, V17, P1073, DOI 10.1016/j.bmcl.2006.11.017; Morgan K, 2008, CANCER RES, V68, P6331, DOI 10.1158/0008-5472.CAN-08-0197; Nagy A, 2005, BIOL REPROD, V73, P851, DOI 10.1095/biolreprod.105.043489; Nagy A, 1996, P NATL ACAD SCI USA, V93, P7269, DOI 10.1073/pnas.93.14.7269; Nyk M, 2010, J LUMIN, V130, P2487, DOI 10.1016/j.jlumin.2010.08.017; Ogunsipe A, 2004, NEW J CHEM, V28, P822, DOI 10.1039/b315319c; Rahimipour S, 2003, J MED CHEM, V46, P3965, DOI 10.1021/jm020535y; Sharman WM, 2005, BIOCONJUGATE CHEM, V16, P1166, DOI 10.1021/bc0500241; Sharman WM, 2004, ADV DRUG DELIVER REV, V56, P53, DOI 10.1016/j.addr.2003.08.015; Sharman WM, 1999, DRUG DISCOV TODAY, V4, P507, DOI 10.1016/S1359-6446(99)01412-9; Smirnova Z. S., 2005, Khimiko-Farmatsevticheskii Zhurnal, V39, P3; Stefflova K, 2006, J MED CHEM, V49, P3850, DOI 10.1021/jm060146u; Taquet JP, 2007, CURR MED CHEM, V14, P1673, DOI 10.2174/092986707780830970; Tirand L, 2006, J CONTROL RELEASE, V111, P153, DOI 10.1016/j.jconrel.2005.11.017; Vrouenraets MB, 2003, ANTICANCER RES, V23, P505; World Health Organization, 2011, FACT SHEET 297; Xu CJ, 2009, J AM CHEM SOC, V131, P15346, DOI 10.1021/ja905938a	45	27	27	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e37051	10.1371/journal.pone.0037051	http://dx.doi.org/10.1371/journal.pone.0037051			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693566	gold, Green Submitted, Green Published			2022-12-27	WOS:000305338500028
J	Conti, L; Crisafulli, L; Caldera, V; Tortoreto, M; Brilli, E; Conforti, P; Zunino, F; Magrassi, L; Schiffer, D; Cattaneo, E				Conti, Luciano; Crisafulli, Laura; Caldera, Valentina; Tortoreto, Monica; Brilli, Elisa; Conforti, Paola; Zunino, Franco; Magrassi, Lorenzo; Schiffer, Davide; Cattaneo, Elena			REST Controls Self-Renewal and Tumorigenic Competence of Human Glioblastoma Cells	PLOS ONE			English	Article							BREAST-CANCER; STEM-CELLS; IN-VIVO; GENE; TUMOR; TRANSCRIPTION; REST/NRSF; REPRESSOR; DIFFERENTIATION; PROTEIN	The Repressor Element 1 Silencing Transcription factor (REST/NRSF) is a master repressor of neuronal programs in non-neuronal lineages shown to function as a central regulator of developmental programs and stem cell physiology. Aberrant REST function has been associated with a number of pathological conditions. In cancer biology, REST has been shown to play a tumor suppressor activity in epithelial cancers but an oncogenic role in brain childhood malignancies such as neuroblastoma and medulloblastoma. Here we examined REST expression in human glioblastoma multiforme (GBM) specimens and its role in GBM cells carrying self-renewal and tumorigenic competence. We found REST to be expressed in GBM specimens, its presence being particularly enriched in tumor cells in the perivascular compartment. Significantly, REST is highly expressed in self-renewing tumorigenic-competent GBM cells and its knock down strongly reduces their self-renewal in vitro and tumor-initiating capacity in vivo and affects levels of miR-124 and its downstream targets. These results indicate that REST contributes to GBM maintenance by affecting its self-renewing and tumorigenic cellular component and that, hence, a better understanding of these circuitries in these cells might lead to new exploitable therapeutic targets.	[Conti, Luciano; Crisafulli, Laura; Brilli, Elisa; Conforti, Paola; Cattaneo, Elena] Univ Milan, Dept Pharmacol Sci, Milan, Italy; [Conti, Luciano; Crisafulli, Laura; Brilli, Elisa; Conforti, Paola; Cattaneo, Elena] Univ Milan, Ctr Stem Cell Res, Milan, Italy; [Caldera, Valentina; Schiffer, Davide] Policlin Monza Fdn, Neurobiooncol Ctr, Vercelli, Italy; [Tortoreto, Monica; Zunino, Franco] Fdn IRCCS Ist Nazl Tumori, Milan, Italy; [Magrassi, Lorenzo] Univ Pavia, Fdn IRCCS Policlin S Matteo, Dipartimento Sci Chirurg, I-27100 Pavia, Italy	University of Milan; University of Milan; Fondazione IRCCS Istituto Nazionale Tumori Milan; IRCCS Fondazione San Matteo; University of Pavia	Conti, L (corresponding author), Univ Milan, Dept Pharmacol Sci, Milan, Italy.	Luciano.Conti@unimi.it	Crisafulli, Laura/Q-2271-2018; Crisafulli, Laura/ABI-1447-2020; Conti, Luciano/H-4184-2012; Magrassi, Lorenzo/AAJ-3105-2020	Crisafulli, Laura/0000-0002-1393-5652; Crisafulli, Laura/0000-0002-1393-5652; Conti, Luciano/0000-0002-2050-9846; Magrassi, Lorenzo/0000-0002-8308-2720; CATTANEO, ELENA/0000-0002-0755-4917	NeuroScreen (FP6, European Union Health) [2007-B-222943]; Progetto Giovani Ricercatori (Italian Ministry of Health); Progetto Oncologico "Characterization of the molecular mechanisms regulating brain tumors growth and chemioresistance'' (Italian Ministry of Health); NeuroStemcell (European Community's Seventh Framework Programme grant) [222943]	NeuroScreen (FP6, European Union Health); Progetto Giovani Ricercatori (Italian Ministry of Health); Progetto Oncologico "Characterization of the molecular mechanisms regulating brain tumors growth and chemioresistance'' (Italian Ministry of Health); NeuroStemcell (European Community's Seventh Framework Programme grant)	This work was supported by NeuroScreen (FP6, European Union Health-2007-B-222943) and Progetto Giovani Ricercatori (Italian Ministry of Health) to Luciano Conti and by Progetto Oncologico "Characterization of the molecular mechanisms regulating brain tumors growth and chemioresistance'' (Italian Ministry of Health, 2008-2011) and partially by NeuroStemcell (European Community's Seventh Framework Programme grant agreement nr. 222943) to EC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballas N, 2005, CELL, V121, P645, DOI 10.1016/j.cell.2005.03.013; Blom T, 2006, ACTA NEUROPATHOL, V112, P483, DOI 10.1007/s00401-006-0102-8; Bruce AW, 2004, P NATL ACAD SCI USA, V101, P10458, DOI 10.1073/pnas.0401827101; Calderone A, 2003, J NEUROSCI, V23, P2112; Chen ZF, 1998, NAT GENET, V20, P136, DOI 10.1038/2431; CHONG JHA, 1995, CELL, V80, P949, DOI 10.1016/0092-8674(95)90298-8; Conaco C, 2006, P NATL ACAD SCI USA, V103, P2422, DOI 10.1073/pnas.0511041103; Coulson JM, 2000, CANCER RES, V60, P1840; Fowler A, 2011, EUR J CANCER, V47, P953, DOI 10.1016/j.ejca.2010.11.026; Gao ZL, 2011, J NEUROSCI, V31, P9772, DOI 10.1523/JNEUROSCI.1604-11.2011; Garriga-Canut M, 2006, NAT NEUROSCI, V9, P1382, DOI 10.1038/nn1791; Gilbertson RJ, 2007, NAT REV CANCER, V7, P733, DOI 10.1038/nrc2246; Huang Z, 2011, NAT CELL BIOL, V13, P142, DOI 10.1038/ncb2153; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Jones FS, 1999, BIOESSAYS, V21, P372, DOI 10.1002/(SICI)1521-1878(199905)21:5<372::AID-BIES3>3.0.CO;2-3; Kamal MM, 2012, STEM CELLS, V30, P405, DOI 10.1002/stem.1020; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lawinger P, 2000, NAT MED, V6, P826, DOI 10.1038/77565; Lunyak VV, 2002, SCIENCE, V298, P1747, DOI 10.1126/science.1076469; Madhavan S, 2009, MOL CANCER RES, V7, P157, DOI 10.1158/1541-7786.MCR-08-0435; Mandel G, 2011, P NATL ACAD SCI USA, V108, P16789, DOI 10.1073/pnas.1113486108; Ooi L, 2007, NAT REV GENET, V8, P544, DOI 10.1038/nrg2100; Palm K, 1999, MOL BRAIN RES, V72, P30, DOI 10.1016/S0169-328X(99)00196-5; Pellegatta S, 2006, CANCER RES, V66, P10247, DOI 10.1158/0008-5472.CAN-06-2048; Pollard SM, 2009, CELL STEM CELL, V4, P568, DOI 10.1016/j.stem.2009.03.014; Qureshi IA, 2009, NEUROSCI LETT, V466, P73, DOI 10.1016/j.neulet.2009.07.093; Reddy BY, 2009, P NATL ACAD SCI USA, V106, P4408, DOI 10.1073/pnas.0809130106; SCHOENHERR CJ, 1995, CURR OPIN NEUROBIOL, V5, P566, DOI 10.1016/0959-4388(95)80060-3; Silber J, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-14; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Soldati C, 2011, STEM CELLS; Sun TT, 2011, CELL, V144, P703, DOI 10.1016/j.cell.2011.02.003; Sun Y, 2008, MOL CELL NEUROSCI, V38, P245, DOI 10.1016/j.mcn.2008.02.014; Sun YM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003656; Venere M, 2011, GLIA, V59, P1148, DOI 10.1002/glia.21185; Visvanathan J, 2007, GENE DEV, V21, P744, DOI 10.1101/gad.1519107; Westbrook TF, 2005, CELL, V121, P837, DOI 10.1016/j.cell.2005.03.033; Westbrook TF, 2008, NATURE, V452, P370, DOI 10.1038/nature06780; Wu J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-r85; Zhang P, 2011, P NATL ACAD SCI US; Zhang P, 2008, CURR BIOL, V18, P1489, DOI 10.1016/j.cub.2008.08.048; Zhang PS, 2009, TRENDS NEUROSCI, V32, P559, DOI 10.1016/j.tins.2009.07.005; Zuccato C, 2003, NAT GENET, V35, P76, DOI 10.1038/ng1219	44	71	73	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2012	7	6							e38486	10.1371/journal.pone.0038486	http://dx.doi.org/10.1371/journal.pone.0038486			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TU	22701651	Green Submitted, Green Published, gold			2022-12-27	WOS:000305337600026
J	Ong, RH; King, AJC; Mullins, BJ; Cooper, TF; Caley, MJ				Ong, Robert H.; King, Andrew J. C.; Mullins, Benjamin J.; Cooper, Timothy F.; Caley, M. Julian			Development and Validation of Computational Fluid Dynamics Models for Prediction of Heat Transfer and Thermal Microenvironments of Corals	PLOS ONE			English	Article							GREAT-BARRIER-REEF; MASSIVE CORALS; TEMPERATURE; FLOW; IRRADIANCE; PATTERNS; SURVIVAL; GROWTH; LIMITS	We present Computational Fluid Dynamics (CFD) models of the coupled dynamics of water flow, heat transfer and irradiance in and around corals to predict temperatures experienced by corals. These models were validated against controlled laboratory experiments, under constant and transient irradiance, for hemispherical and branching corals. Our CFD models agree very well with experimental studies. A linear relationship between irradiance and coral surface warming was evident in both the simulation and experimental result agreeing with heat transfer theory. However, CFD models for the steady state simulation produced a better fit to the linear relationship than the experimental data, likely due to experimental error in the empirical measurements. The consistency of our modelling results with experimental observations demonstrates the applicability of CFD simulations, such as the models developed here, to coral bleaching studies. A study of the influence of coral skeletal porosity and skeletal bulk density on surface warming was also undertaken, demonstrating boundary layer behaviour, and interstitial flow magnitude and temperature profiles in coral cross sections. Our models compliment recent studies showing systematic changes in these parameters in some coral colonies and have utility in the prediction of coral bleaching.	[Ong, Robert H.; King, Andrew J. C.; Mullins, Benjamin J.] Curtin Univ, Fluid Dynam Res Grp, Perth, WA, Australia; [Mullins, Benjamin J.] Griffith Univ, Atmospher Environm Res Ctr, Brisbane, Qld 4111, Australia; [Mullins, Benjamin J.] Curtin Univ, Curtin Hlth Innovat Res Inst, Perth, WA, Australia; [Cooper, Timothy F.] Australian Inst Marine Sci, UWA Oceans Inst, Perth, WA, Australia; [Caley, M. Julian] Australian Inst Marine Sci, Townsville, Qld 4810, Australia	Curtin University; Griffith University; Curtin University; Australian Institute of Marine Science; Australian Institute of Marine Science	Ong, RH (corresponding author), Curtin Univ, Fluid Dynam Res Grp, Perth, WA, Australia.	robert.ong@postgrad.curtin.edu.au	; Caley, Julian/A-4042-2008	King, Andrew/0000-0003-0517-3712; Mullins, Benjamin/0000-0002-6722-1073; Caley, Julian/0000-0001-5739-749X	Western Australia Supercomputing Hub (iVEC); Society for Underwater Technology (SUT)	Western Australia Supercomputing Hub (iVEC); Society for Underwater Technology (SUT)	The authors acknowledge both the Western Australia Supercomputing Hub (iVEC) and the Society for Underwater Technology (SUT) for external funding sources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, OPENFOAM US GUID VER; Anthony K, 2002, LIMNOLOGY OCEANOGRAP, P1417; BARNES DJ, 1992, J EXP MAR BIOL ECOL, V159, P113, DOI 10.1016/0022-0981(92)90261-8; Berkelmans R, 1999, CORAL REEFS, V18, P55, DOI 10.1007/s003380050154; Berkelmans R, 1999, CORAL REEFS, V18, P219, DOI 10.1007/s003380050186; Brown BE, 1997, CORAL REEFS, V16, P129; Chang S, 2009, LIMNOL OCEANOGR, V54, P1819, DOI DOI 10.4319/LO.2009.54.5.1819; COLES SL, 1991, CORAL REEFS, V9, P231, DOI 10.1007/BF00290427; Cooper TF, 2012, SCIENCE, V335, P593, DOI 10.1126/science.1214570; Davies JM, 1997, MAR FRESHWATER RES, V48, P513, DOI 10.1071/MF96128; De'ath G, 2009, SCIENCE, V323, P116, DOI 10.1126/science.1165283; Fabricius KE, 2006, LIMNOL OCEANOGR, V51, P30, DOI 10.4319/lo.2006.51.1.0030; Ferziger J.H., 1999, COMPUTATIONAL METHOD; GLYNN PW, 1993, CORAL REEFS, V12, P1, DOI 10.1007/BF00303779; HIGHSMITH RC, 1983, MAR ECOL PROG SER, V13, P261, DOI 10.3354/meps013261; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; HOEGHGULDBERG O, 1989, J EXP MAR BIOL ECOL, V129, P279, DOI 10.1016/0022-0981(89)90109-3; HUBBARD DK, 1986, CORAL REEFS, V5, P117, DOI 10.1007/BF00298179; HUTCHINGS PA, 1988, P 6 INT COR REEF S A, V3, P263; Jell J.S., 1978, PAPERS DEP GEOLOGY U, V8, P1; Jimenez IM, 2008, LIMNOL OCEANOGR, V53, P1548, DOI 10.4319/lo.2008.53.4.1548; Jimenez IM, 2011, J R SOC INTERFACE, V8, P1785, DOI 10.1098/rsif.2011.0144; Kaandorp JA, 2003, PHILOS T R SOC B, V358, P1551, DOI 10.1098/rstb.2003.1339; KOBLUK DR, 1994, B MAR SCI, V54, P142; Laine J, 2008, MATER CHARACT, V59, P1522, DOI 10.1016/j.matchar.2007.12.002; LESSER MP, 1990, CORAL REEFS, V8, P225, DOI 10.1007/BF00265015; MUSCATINE L, 1991, MAR ECOL PROG SER, V77, P233, DOI 10.3354/meps077233; Nakamura T, 2001, MAR ECOL PROG SER, V212, P301, DOI 10.3354/meps212301; Patankar S., 2018, NUMERICAL HEAT TRANS, DOI DOI 10.1201/9781482234213; Roche R, 2010, J EXPT MARINE BIOL E; Shen CY, 2001, J GEOPHYS RES-OCEANS, V106, P6973, DOI 10.1029/2000JC000267; VanWoesik R, 1995, MAR ECOL PROG SER, V128, P261, DOI 10.3354/meps128261; Versteeg H.K., 2007, INTRO COMPUTATIONAL; Wu JS, 2007, INT J HEAT MASS TRAN, V50, P3925, DOI 10.1016/j.ijheatmasstransfer.2007.02.009	34	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2012	7	6							e37842	10.1371/journal.pone.0037842	http://dx.doi.org/10.1371/journal.pone.0037842			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TU	22701582	Green Published, gold, Green Submitted			2022-12-27	WOS:000305337600011
J	Cao, GY; Liu, YJ; Zhang, SX; Yang, XW; Chen, RR; Zhang, YW; Lu, W; Liu, Y; Wang, JH; Lin, M; Wang, GY				Cao, Gaoyi; Liu, Yunjun; Zhang, Shengxue; Yang, Xuewen; Chen, Rongrong; Zhang, Yuwen; Lu, Wei; Liu, Yan; Wang, Jianhua; Lin, Min; Wang, Guoying			A Novel 5-Enolpyruvylshikimate-3-Phosphate Synthase Shows High Glyphosate Tolerance in Escherichia coli and Tobacco Plants	PLOS ONE			English	Article							HERBICIDE GLYPHOSATE; 3-PHOSPHATE SYNTHASE; 5-ENOPYRUVYLSHIKIMATE-3-PHOSPHATE SYNTHASE; CONFERS RESISTANCE; DIRECTED EVOLUTION; STRUCTURAL BASIS; MOLECULAR-BASIS; AROA GENE; IDENTIFICATION; EXPRESSION	A key enzyme in the shikimate pathway, 5-enolpyruvylshikimate-3-phosphate synthase (EPSPS) is the primary target of the broad-spectrum herbicide glyphosate. Identification of new aroA genes coding for EPSPS with a high level of glyphosate tolerance is essential for the development of glyphosate-tolerant crops. In the present study, the glyphosate tolerance of five bacterial aroA genes was evaluated in the E. coli aroA-defective strain ER2799 and in transgenic tobacco plants. All five aroA genes could complement the aroA-defective strain ER2799, and AM79 aroA showed the highest glyphosate tolerance. Although glyphosate treatment inhibited the growth of both WT and transgenic tobacco plants, transgenic plants expressing AM79 aroA tolerated higher concentration of glyphosate and had a higher fresh weight and survival rate than plants expressing other aroA genes. When treated with high concentration of glyphosate, lower shikimate content was detected in the leaves of transgenic plants expressing AM79 aroA than transgenic plants expressing other aroA genes. These results suggest that AM79 aroA could be a good candidate for the development of transgenic glyphosate-tolerant crops.	[Cao, Gaoyi; Zhang, Yuwen; Wang, Jianhua] China Agr Univ, Coll Agr & Biotechnol, Beijing 100094, Peoples R China; [Cao, Gaoyi; Liu, Yunjun; Zhang, Shengxue; Yang, Xuewen; Chen, Rongrong; Liu, Yan; Wang, Guoying] Chinese Acad Agr Sci, Inst Crop Sci, Beijing 100193, Peoples R China; [Lu, Wei; Lin, Min] Chinese Acad Agr Sci, Biotechnol Res Inst, Beijing 100193, Peoples R China	China Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Chinese Academy of Agricultural Sciences; Biotechnology Research Institute, CAAS	Cao, GY (corresponding author), China Agr Univ, Coll Agr & Biotechnol, Beijing 100094, Peoples R China.	gywang604@gmail.com	min, lin/AAJ-7325-2020		National Major Project for Transgenic Organism Breeding [2008ZX08003-001]; Scientific Research Foundation for Returned Overseas Chinese Scholars of the Ministry of Education of China	National Major Project for Transgenic Organism Breeding; Scientific Research Foundation for Returned Overseas Chinese Scholars of the Ministry of Education of China	This work was supported by the National Major Project for Transgenic Organism Breeding (2008ZX08003-001) and by the Scientific Research Foundation for Returned Overseas Chinese Scholars of the Ministry of Education of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baerson SR, 2002, PLANT PHYSIOL, V129, P1265, DOI 10.1104/pp.001560; Barry G.F., 1992, World Patent, Patent No. [9204449, WO 9. 204: 449]; Belfiore NM, 2001, MUTAT RES-REV MUTAT, V489, P97, DOI 10.1016/S1383-5742(01)00065-5; BINAROVA P, 1994, BIOL PLANTARUM, V36, P65, DOI 10.1007/BF02921271; Bradshaw LD, 1997, WEED TECHNOL, V11, P189, DOI 10.1017/S0890037X00041567; Castle LA, 2004, SCIENCE, V304, P1151, DOI 10.1126/science.1096770; Chang HS, 2003, MOL CELLS, V15, P20; Chen LX, 2001, GENE, V263, P39, DOI 10.1016/S0378-1119(00)00568-0; COMAI L, 1985, NATURE, V317, P741, DOI 10.1038/317741a0; COMAI L, 1983, SCIENCE, V221, P370, DOI 10.1126/science.221.4608.370; DELLACIOPPA G, 1987, BIO-TECHNOL, V5, P579, DOI 10.1038/nbt0687-579; DELLACIOPPA G, 1986, P NATL ACAD SCI USA, V83, P6873, DOI 10.1073/pnas.83.18.6873; Du WS, 2000, EUR J BIOCHEM, V267, P222, DOI 10.1046/j.1432-1327.2000.00994.x; Dun BQ, 2007, APPL ENVIRON MICROB, V73, P7997, DOI 10.1128/AEM.00956-07; DYER WE, 1988, PLANT PHYSIOL, V88, P661, DOI 10.1104/pp.88.3.661; FITZGIBBON JE, 1990, APPL ENVIRON MICROB, V56, P3382, DOI 10.1128/AEM.56.11.3382-3388.1990; Foster PL, 2000, BIOESSAYS, V22, P1067, DOI 10.1002/1521-1878(200012)22:12<1067::AID-BIES4>3.0.CO;2-Q; Funke T, 2006, P NATL ACAD SCI USA, V103, P13010, DOI 10.1073/pnas.0603638103; Funke T, 2009, J BIOL CHEM, V284, P9854, DOI 10.1074/jbc.M809771200; He M, 2001, BBA-GEN SUBJECTS, V1568, P1, DOI 10.1016/S0304-4165(01)00181-7; Healy-Fried ML, 2007, J BIOL CHEM, V282, P32949, DOI 10.1074/jbc.M705624200; HORSCH RB, 1985, SCIENCE, V227, P1229, DOI 10.1126/science.227.4691.1229; Howe AR, 2002, MOL BREEDING, V10, P153, DOI 10.1023/A:1020396708088; Jin D, 2007, CURR MICROBIOL, V55, P350, DOI 10.1007/s00284-007-0268-x; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; Liang AM, 2008, BIOTECHNOL LETT, V30, P1397, DOI 10.1007/s10529-008-9703-8; Lin M, 2007, World Patent, Patent No. [WO/2009/059485, 2009059485]; Liu Z, 2006, DNA SEQUENCE, V17, P208, DOI 10.1080/10425170600824186; Lopez-Rodas V, 2007, EVOL ECOL, V21, P535, DOI 10.1007/s10682-006-9134-8; PADGETTE SR, 1995, CROP SCI, V35, P1451, DOI 10.2135/cropsci1995.0011183X003500050032x; Pedotti M, 2009, J BIOL CHEM, V284, P36415, DOI 10.1074/jbc.M109.051631; POWELL HA, 1991, NEW PHYTOL, V119, P421, DOI 10.1111/j.1469-8137.1991.tb00042.x; Priestman MA, 2005, FEBS LETT, V579, P5773, DOI 10.1016/j.febslet.2005.09.066; Priestman MA, 2005, FEBS LETT, V579, P728, DOI 10.1016/j.febslet.2004.12.057; Schonbrunn E, 2001, P NATL ACAD SCI USA, V98, P1376, DOI 10.1073/pnas.98.4.1376; Shimizu M, 2002, APPL ENVIRON MICROB, V68, P4061, DOI 10.1128/AEM.68.8.4061-4066.2002; STALKER DM, 1985, J BIOL CHEM, V260, P4724; STEINRUCKEN HC, 1980, BIOCHEM BIOPH RES CO, V94, P1207, DOI 10.1016/0006-291X(80)90547-1; Stenoien HK, 2005, J MOL EVOL, V61, P306, DOI 10.1007/s00239-004-0271-9; Tian YS, 2010, APPL ENVIRON MICROB, V76, P6001, DOI 10.1128/AEM.00770-10; Wang HY, 2003, J PLANT RES, V116, P455, DOI 10.1007/s10265-003-0120-8; Ye GN, 2001, PLANT J, V25, P261, DOI 10.1046/j.1365-313x.2001.00958.x; Zhou M, 2006, PLANT PHYSIOL, V140, P184, DOI 10.1104/pp.105.068577	43	36	47	3	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2012	7	6							e38718	10.1371/journal.pone.0038718	http://dx.doi.org/10.1371/journal.pone.0038718			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TQ	22715408	Green Submitted, Green Published, gold			2022-12-27	WOS:000305336800050
J	Kim, YW; Bae, SM; Battogtokh, G; Bang, HJ; Ahn, WS				Kim, Yong-Wan; Bae, Su Mi; Battogtokh, Gantumur; Bang, Hyo Joo; Ahn, Woong Shick			Synergistic Anti-Tumor Effects of Combination of Photodynamic Therapy and Arsenic Compound in Cervical Cancer Cells: In Vivo and In Vitro Studies	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; OXIDATIVE STRESS; TETRAARSENIC OXIDE; CYCLE PROGRESSION; DRUG-COMBINATION; TUMOR RESPONSE; APOPTOSIS; EXPRESSION; TRIOXIDE; DEATH	The effects of As4O6 as adjuvant on photodynamic therapy (PDT) were studied. As4O6 is considered to have anticancer activity via several biological actions, such as free radical production and inhibition of VEGF expression. PDT or As4O6 significantly inhibited TC-1 cell proliferation in a dose-dependent manner (P<0.05) by MTT assay. The anti-proliferative effect of the combination treatment was significantly higher than in TC-1 cells treated with either photodynamic therapy or As4O6 alone (62.4 and 52.5% decrease compared to vehicle-only treated TC-1 cells, respectively, P<0.05). In addition, cell proliferation in combination of photodynamic therapy and As4O6 treatment significantly decreased by 77.4% (P<0.05). Cell survival pathway (Naip1, Tert and Aip1) and p53-dependent pathway (Bax, p21(Cip1), Fas, Gadd45, IGFBP-3 and Mdm-2) were markedly increased by combination treatment of photodynamic therapy and As4O6. In addition, the immune response in the NEAT pathway (Ly-12, CD178 and IL-2) was also modulated after combination treatment, suggesting improved antitumor effects by controlling unwanted growth-stimulatory pathways. The combination effect apparently reflected concordance with in vitro data, in restricting tumor growth in vivo and in relation to some common signaling pathways to those observed in vitro. These findings suggest the benefit of combinatory treatment with photodynamic therapy and As4O6 for inhibition of cervical cancer cell growth.	[Kim, Yong-Wan; Bae, Su Mi; Battogtokh, Gantumur; Bang, Hyo Joo] Catholic Univ Korea, Catholic Res Inst Med Sci, Seoul, South Korea; [Ahn, Woong Shick] Catholic Univ Korea, Coll Med, Dept Obstet & Gynecol, Seoul, South Korea	Catholic University of Korea; Catholic University of Korea	Kim, YW (corresponding author), Catholic Univ Korea, Catholic Res Inst Med Sci, Seoul, South Korea.	ahnlab1@catholic.ac.kr			Catholic Harvard Wellman Photomedicine Core Technique Development Center, Seoul, Republic of Korea [5-2012-A0154-00001]	Catholic Harvard Wellman Photomedicine Core Technique Development Center, Seoul, Republic of Korea	The study was supported by The Catholic Harvard Wellman Photomedicine Core Technique Development Center, Seoul, Republic of Korea (Grant #5-2012-A0154-00001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn WS, 2004, ONCOL REP, V12, P573; Al-Waili NS, 2005, MED SCI MONITOR, V11, pRA279; Banerjee N, 2008, TOXICOLOGY, V246, P101, DOI 10.1016/j.tox.2007.12.029; Buytaert E, 2007, BBA-REV CANCER, V1776, P86, DOI 10.1016/j.bbcan.2007.07.001; Castano AP, 2006, NAT REV CANCER, V6, P535, DOI 10.1038/nrc1894; Chen GQ, 1996, BLOOD, V88, P1052; Cheung WMW, 2007, CANCER LETT, V246, P122, DOI 10.1016/j.canlet.2006.02.009; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Corti L, 1996, J PHOTOCH PHOTOBIO B, V36, P193, DOI 10.1016/S1011-1344(96)07371-X; Ferrario A, 2000, CANCER RES, V60, P4066; Ferrario A, 2005, CANCER RES, V65, P9473, DOI 10.1158/0008-5472.CAN-05-1659; Ferrario A, 2004, CANCER RES, V64, P2328, DOI 10.1158/0008-5472.CAN-04-0071; Ferrario A, 2002, CANCER RES, V62, P3956; Gao JJ, 2005, P NATL ACAD SCI USA, V102, P17207, DOI 10.1073/pnas.0506893102; Germolec DR, 1996, TOXICOL APPL PHARM, V141, P308, DOI 10.1016/S0041-008X(96)80037-8; Gomer CJ, 2006, LASER SURG MED, V38, P516, DOI 10.1002/lsm.20339; GOMER CJ, 1989, RADIAT RES, V120, P1, DOI 10.2307/3577632; Goodwin Scott C, 2003, J Vasc Interv Radiol, V14, pS467; Kammerer R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021834; Laparra JM, 2008, TOXICOL IN VITRO, V22, P444, DOI 10.1016/j.tiv.2007.11.004; Lew YS, 1999, CANCER RES, V59, P6033; Liu LZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020858; Moserova I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032972; Nakagawa H, 2007, ORAL ONCOL, V43, P544, DOI 10.1016/j.oraloncology.2006.03.020; Pletcher SD, 2002, CURR BIOL, V12, P712, DOI 10.1016/S0960-9822(02)00808-4; Reynolds CP, 2005, METH MOLEC MED, V110, P173; Rigas B, 2008, BRIT J CANCER, V98, P1157, DOI 10.1038/sj.bjc.6604225; Rigas B, 2007, CURR OPIN GASTROEN, V23, P55, DOI 10.1097/MOG.0b013e32801145b0; Sagawa Y, 2001, CANCER LETT, V168, P45, DOI 10.1016/S0304-3835(01)00501-8; Separovic D, 2009, BRIT J CANCER, V100, P626, DOI 10.1038/sj.bjc.6604896; Shao WL, 1998, J NATL CANCER I, V90, P124, DOI 10.1093/jnci/90.2.124; Solban N, 2006, CANCER RES, V66, P5633, DOI 10.1158/0008-5472.CAN-06-0604; Sun Y, 2008, CANCER RES, V68, P8269, DOI 10.1158/0008-5472.CAN-08-2010; TOMAYKO MM, 1989, CANCER CHEMOTH PHARM, V24, P148, DOI 10.1007/BF00300234; Tozer GM, 1999, CANCER RES, V59, P1626; Wang JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022566; Wei YQ, 2007, PHOTOCHEM PHOTOBIOL, V83, P1319, DOI 10.1111/j.1751-1097.2007.00160.x; Woo SH, 2005, J CELL BIOCHEM, V95, P120, DOI 10.1002/jcb.20329; Yoo MH, 2004, J VET MED SCI, V66, P1091, DOI 10.1292/jvms.66.1091	40	14	15	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2012	7	6							e38583	10.1371/journal.pone.0038583	http://dx.doi.org/10.1371/journal.pone.0038583			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TQ	22715393	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336800035
J	Bordeleau, F; Lapierre, MEM; Sheng, YL; Marceau, N				Bordeleau, Francois; Lapierre, Marie-Eve Myrand; Sheng, Yunlong; Marceau, Normand			Keratin 8/18 Regulation of Cell Stiffness-Extracellular Matrix Interplay through Modulation of Rho-Mediated Actin Cytoskeleton Dynamics	PLOS ONE			English	Article							INTERMEDIATE-FILAMENTS; MECHANICAL-STRESS; EPITHELIAL-CELLS; FOCAL ADHESIONS; PROGRESSION; SUBSTRATE; KINASE; ELASTICITY; INTEGRINS; APOPTOSIS	Cell mechanical activity generated from the interplay between the extracellular matrix (ECM) and the actin cytoskeleton is essential for the regulation of cell adhesion, spreading and migration during normal and cancer development. Keratins are the intermediate filament (IF) proteins of epithelial cells, expressed as pairs in a lineage/differentiation manner. Hepatic epithelial cell IFs are made solely of keratins 8/18 (K8/K18), hallmarks of all simple epithelia. Notably, our recent work on these epithelial cells has revealed a key regulatory function for K8/K18 IFs in adhesion/migration, through modulation of integrin interactions with ECM, actin adaptors and signaling molecules at focal adhesions. Here, using K8-knockdown rat H4 hepatoma cells and their K8/K18-containing counterparts seeded on fibronectin-coated substrata of different rigidities, we show that the K8/K18 IF-lacking cells lose their ability to spread and exhibit an altered actin fiber organization, upon seeding on a low-rigidity substratum. We also demonstrate a concomitant reduction in local cell stiffness at focal adhesions generated by fibronectin-coated microbeads attached to the dorsal cell surface. In addition, we find that this K8/K18 IF modulation of cell stiffness and actin fiber organization occurs through RhoA-ROCK signaling. Together, the results uncover a K8/K18 IF contribution to the cell stiffness-ECM rigidity interplay through a modulation of Rho-dependent actin organization and dynamics in simple epithelial cells.	[Bordeleau, Francois; Lapierre, Marie-Eve Myrand; Marceau, Normand] Ctr hosp Quebec, Ctr Rech Cancerol, Quebec City, PQ, Canada; [Bordeleau, Francois; Lapierre, Marie-Eve Myrand; Marceau, Normand] Ctr Hosp Quebec, Ctr Rech, Quebec City, PQ, Canada; [Bordeleau, Francois; Sheng, Yunlong] Univ Laval, Ctr Opt Photon & Laser, Quebec City, PQ G1K 7P4, Canada	Laval University	Bordeleau, F (corresponding author), Ctr hosp Quebec, Ctr Rech Cancerol, Quebec City, PQ, Canada.	Normand.Marceau@crhdq.ulaval.ca			grants from the National Sciences and Engineering Council of Canada [312270]; Canadian Institutes of Health Research [MOP15529]	grants from the National Sciences and Engineering Council of Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by grants from the National Sciences and Engineering Council of Canada (312270) and the Canadian Institutes of Health Research (MOP15529). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam H, 2011, J CELL SCI, V124, P2096, DOI 10.1242/jcs.073585; Amano M, 2010, CYTOSKELETON, V67, P545, DOI 10.1002/cm.20472; Asparuhova MB, 2009, SCAND J MED SCI SPOR, V19, P490, DOI 10.1111/j.1600-0838.2009.00928.x; Barnes SL, 2007, MED PHYS, V34, P4439, DOI 10.1118/1.2795665; Bausch AR, 1999, BIOPHYS J, V76, P573, DOI 10.1016/S0006-3495(99)77225-5; BLOUIN R, 1992, DIFFERENTIATION, V52, P45, DOI 10.1111/j.1432-0436.1992.tb00498.x; Bordeleau F, 2008, BIOCHEM CELL BIOL, V86, P352, DOI [10.1139/O08-076, 10.1139/o08-076]; Bordeleau F, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3626864; Bordeleau F, 2010, MOL BIOL CELL, V21, P1698, DOI 10.1091/mbc.E09-05-0373; Brandt D, 2002, J BIOL CHEM, V277, P20903, DOI 10.1074/jbc.M200946200; Butcher DT, 2009, NAT REV CANCER, V9, P108, DOI 10.1038/nrc2544; Chen EJ, 1996, IEEE T ULTRASON FERR, V43, P191, DOI 10.1109/58.484478; Coulombe PA, 2004, NAT CELL BIOL, V6, P699, DOI 10.1038/ncb0804-699; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; ENGVALL E, 1977, INT J CANCER, V20, P1, DOI 10.1002/ijc.2910200102; Fereol S, 2009, BIOPHYS J, V96, P2009, DOI 10.1016/j.bpj.2008.10.072; Fung Y.C., 1993, BIOMECHANICS MECH PR; Galarneau L, 2007, EXP CELL RES, V313, P179, DOI 10.1016/j.yexcr.2006.10.007; Galbraith CG, 2002, J CELL BIOL, V159, P695, DOI 10.1083/jcb.200204153; Gilbert S, 2001, J CELL BIOL, V154, P763, DOI 10.1083/jcb.200102130; Guck J, 2005, BIOPHYS J, V88, P3689, DOI 10.1529/biophysj.104.045476; Huveneers S, 2009, J CELL SCI, V122, P1059, DOI 10.1242/jcs.039446; Huynh J, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002761; Jiang GY, 2003, NATURE, V424, P334, DOI 10.1038/nature01805; Jung KS, 2011, HEPATOLOGY, V53, P885, DOI 10.1002/hep.24121; Katoh K, 2001, AM J PHYSIOL-CELL PH, V280, pC1669, DOI 10.1152/ajpcell.2001.280.6.C1669; Kocgozlu L, 2010, J CELL SCI, V123, P29, DOI 10.1242/jcs.053520; Kuo YH, 2010, HEPATOL INT, V4, P700, DOI 10.1007/s12072-010-9223-1; Lamarche N, 1996, CELL, V87, P519, DOI 10.1016/S0092-8674(00)81371-9; Lim Y, 2008, J CELL BIOL, V180, P187, DOI 10.1083/jcb.200708194; Lopez JI, 2008, ONCOGENE, V27, P6981, DOI 10.1038/onc.2008.348; Mamidipudi V, 2004, MOL CELL BIOL, V24, P6788, DOI 10.1128/MCB.24.15.6788-6798.2004; Marceau N, 2001, BIOCHEM CELL BIOL, V79, P543, DOI 10.1139/bcb-79-5-543; Matthews BD, 2006, J CELL SCI, V119, P508, DOI 10.1242/jcs.02760; Matthews BD, 2004, BIOCHEM BIOPH RES CO, V313, P758, DOI 10.1016/j.bbrc.2003.12.005; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; Omary MB, 2009, J CLIN INVEST, V119, P1794, DOI 10.1172/JCI37762; Omary MB, 1997, HEPATOLOGY, V25, P1043, DOI 10.1002/hep.510250537; Oshima RG, 1996, CANCER METAST REV, V15, P445, DOI 10.1007/BF00054012; Oshima RG, 2002, CELL DEATH DIFFER, V9, P486, DOI 10.1038/sj.cdd.4400988; Pajerowski JD, 2007, P NATL ACAD SCI USA, V104, P15619, DOI 10.1073/pnas.0702576104; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Pekny M, 2007, EXP CELL RES, V313, P2244, DOI 10.1016/j.yexcr.2007.04.023; Pertz O, 2010, J CELL SCI, V123, P1841, DOI 10.1242/jcs.064345; Robert A, 2006, MOL BIOL CELL, V17, P3329, DOI 10.1091/mbc.E05-12-1146; Roca-Cusachs P, 2009, P NATL ACAD SCI USA, V106, P16245, DOI 10.1073/pnas.0902818106; Schweizer J, 2006, J CELL BIOL, V174, P169, DOI 10.1083/jcb.200603161; Solon J, 2007, BIOPHYS J, V93, P4453, DOI 10.1529/biophysj.106.101386; Steinbock FA, 1999, BIOL CHEM, V380, P151, DOI 10.1515/BC.1999.023; Subramanian A, 2005, J BIOMED MATER RES A, V75A, P742, DOI 10.1002/jbm.a.30489; Tee SY, 2011, BIOPHYS J, V100, pL25, DOI 10.1016/j.bpj.2010.12.3744; Wang Yi, 2011, AJR Am J Roentgenol, V196, P553, DOI 10.2214/AJR.10.4580; Wang YL, 1998, METHOD ENZYMOL, V298, P489, DOI 10.1016/S0076-6879(98)98041-7; Wei WC, 2008, AM J PHYSIOL-CELL PH, V295, pC1579, DOI 10.1152/ajpcell.00223.2008; Wu M, 2010, CANCER-AM CANCER SOC, V116, P2768, DOI 10.1002/cncr.25181; Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041	56	50	52	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e38780	10.1371/journal.pone.0038780	http://dx.doi.org/10.1371/journal.pone.0038780			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685604	Green Published, gold, Green Submitted			2022-12-27	WOS:000305351700068
J	Eischer, L; Tscholl, V; Heinze, G; Traby, L; Kyrle, PA; Eichinger, S				Eischer, Lisbeth; Tscholl, Verena; Heinze, Georg; Traby, Ludwig; Kyrle, Paul A.; Eichinger, Sabine			Hematocrit and the Risk of Recurrent Venous Thrombosis: A Prospective Cohort Study	PLOS ONE			English	Article							THROMBOEMBOLISM; ERYTHROCYTES; MEN	Background: Venous thromboembolism (VTE) is a multicausal disease which recurs. Hematocrit is associated with a thrombotic risk. We aimed to investigate if hematocrit is associated with the recurrence risk. Methods: Patients with a first VTE were followed after anticoagulation. Patients with VTE provoked by a transient risk factor, natural inhibitor deficiency, lupus anticoagulant, homozygous or double heterozygous defects, cancer, or long-term antithrombotic treatment were excluded. The study endpoint was recurrent VTE. Results: 150 (23%) of 653 patients had recurrence. Only high hematocrit was significantly associated with recurrence risk [hazard ratio (HR) for 1% hematocrit increase with the third tertile 1.08; 95% CI 1.01-1.15]. No or only a weak association for hematocrits within the first and second tertile was seen (HR 1.03; 95% CI 0.97-1.09, and 1.07; 95% CI 1.00-1.13). Hematocrit was associated with recurrence risk only among women. After five years, the probability of recurrence was 9.9% (95% CI 3.7%-15.7%), 15.6% (95% CI 9.7%-21.2%) and 25.5% (95% CI 15.1%-34.6%) in women, and was 29.2% (95% CI 21.1%-36.5%), 30.1% (95% CI 24.1%-35.7%) and 30.8% (95% CI 22.0%-38.7%) in men for hematocrits in the first, second and third tertile, respectively. Men had a higher recurrence risk (1.9; 95% CI 1.1-2.7; p = 0.03), which dropped by 23.5% after adjustment for hematocrit. Hematocrit was not a significant mediator of the sex-difference in recurrence risk (p = 0.223). Conclusions: High hematocrit is associated with the recurrence only in women. The different recurrence risk between men and women is possibly partly explained by hematocrit.	[Eischer, Lisbeth; Tscholl, Verena; Traby, Ludwig; Kyrle, Paul A.; Eichinger, Sabine] Med Univ Vienna, Dept Med 1, Vienna, Austria; [Heinze, Georg] Med Univ Vienna, Core Unit Med Stat & Informat, Vienna, Austria	Medical University of Vienna; Medical University of Vienna	Eischer, L (corresponding author), Med Univ Vienna, Dept Med 1, Vienna, Austria.	sabine.eichinger@meduniwien.ac.at	Traby, Ludwig/ABC-2338-2020	Traby, Ludwig/0000-0003-2861-5771; , Verena/0000-0003-2748-2540; Heinze, Georg/0000-0003-1147-8491	Medizinisch-Wissenschaftlicher Fond des Burgermeisters der Bundeshauptstadt Wien [10019]	Medizinisch-Wissenschaftlicher Fond des Burgermeisters der Bundeshauptstadt Wien	This work was supported by "Medizinisch-Wissenschaftlicher Fond des Burgermeisters der Bundeshauptstadt Wien" - Project Number 10019 (http://www.wien.gv.at/gesundheit/einrichtungen/med-wiss-fonds/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bloom ALCDF, 1994, EGD HAEMOSTASIS THRO, V2, P1169; Braekkan SK, 2010, HAEMATOL-HEMATOL J, V95, P270, DOI 10.3324/haematol.2009.008417; BRANDT JT, 1995, THROMB HAEMOSTASIS, V74, P1185; Douketis J, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d813; Eichinger S, 2010, CIRCULATION, V121, P1630, DOI 10.1161/CIRCULATIONAHA.109.925214; Heinze G, 2001, BIOMETRICS, V57, P114, DOI 10.1111/j.0006-341X.2001.00114.x; Kalbfleisch J. D., 1980, WILEY SERIES PROBABI; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kyrle PA, 2004, NEW ENGL J MED, V350, P2558, DOI 10.1056/NEJMoa032959; Kyrle PA, 2010, LANCET, V376, P2032, DOI 10.1016/S0140-6736(10)60962-2; Lin DY, 1997, STAT MED, V16, P1515, DOI 10.1002/(SICI)1097-0258(19970715)16:13<1515::AID-SIM572>3.3.CO;2-T; Mcrae S, 2006, LANCET, V368, P371, DOI 10.1016/S0140-6736(06)69110-1; RIUNITI O, 1995, ANN INTERN MED, V123, P656, DOI 10.7326/0003-4819-123-9-199511010-00003; Rodger MA, 2008, CAN MED ASSOC J, V179, P417, DOI 10.1503/cmaj.080493; Royston P., 2008, MULTIVARIABLE MODEL; SANTOS MT, 1991, J CLIN INVEST, V87, P571, DOI 10.1172/JCI115032; SCHAFER AI, 1984, BLOOD, V64, P1; VALLES J, 1991, BLOOD, V78, P154; Vaya A, 2002, CLIN HEMORHEOL MICRO, V26, P41	19	25	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e38705	10.1371/journal.pone.0038705	http://dx.doi.org/10.1371/journal.pone.0038705			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701697	gold, Green Published, Green Submitted			2022-12-27	WOS:000305348400088
J	Katifori, E; Magnasco, MO				Katifori, Eleni; Magnasco, Marcelo O.			Quantifying Loopy Network Architectures	PLOS ONE			English	Article							LEAF VENATION PATTERNS; COMPLEX NETWORKS; CHANNEL NETWORKS; ORIGIN; SYSTEMS; TREES	Biology presents many examples of planar distribution and structural networks having dense sets of closed loops. An archetype of this form of network organization is the vasculature of dicotyledonous leaves, which showcases a hierarchicallynested architecture containing closed loops at many different levels. Although a number of approaches have been proposed to measure aspects of the structure of such networks, a robust metric to quantify their hierarchical organization is still lacking. We present an algorithmic framework, the hierarchical loop decomposition, that allows mapping loopy networks to binary trees, preserving in the connectivity of the trees the architecture of the original graph. We apply this framework to investigate computer generated graphs, such as artificial models and optimal distribution networks, as well as natural graphs extracted from digitized images of dicotyledonous leaves and vasculature of rat cerebral neocortex. We calculate various metrics based on the asymmetry, the cumulative size distribution and the Strahler bifurcation ratios of the corresponding trees and discuss the relationship of these quantities to the architectural organization of the original graphs. This algorithmic framework decouples the geometric information (exact location of edges and nodes) from the metric topology (connectivity and edge weight) and it ultimately allows us to perform a quantitative statistical comparison between predictions of theoretical models and naturally occurring loopy graphs.	[Katifori, Eleni; Magnasco, Marcelo O.] Rockefeller Univ, Ctr Studies Phys & Biol, New York, NY 10021 USA	Rockefeller University	Katifori, E (corresponding author), Rockefeller Univ, Ctr Studies Phys & Biol, 1230 York Ave, New York, NY 10021 USA.	ekatifori@rockefeller.edu	Liu, Andrea/K-3968-2017	Liu, Andrea/0000-0002-2295-2729; Katifori, Eleni/0000-0002-7332-4749	National Science Foundation [PHY-1058899]; Burroughs-Wellcome Career at Scientific Interface Award; Raymond and Beverly Sackler Fellowship; Direct For Mathematical & Physical Scien [1058899] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Burroughs-Wellcome Career at Scientific Interface Award; Raymond and Beverly Sackler Fellowship; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported in part by the National Science Foundation under Grant PHY-1058899. http://www.nsf.gov/.EK would like to acknowledge support from the Burroughs-Wellcome Career at the Scientific Interface Award and the Raymond and Beverly Sackler Fellowship. http://www.bwfund.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Ang WK, 2005, ENG OPTIMIZ, V37, P277, DOI 10.1080/0305215512331328259; Barrat A, 2004, P NATL ACAD SCI USA, V101, P3747, DOI 10.1073/pnas.0400087101; Blinder P, 2010, P NATL ACAD SCI USA, V107, P12670, DOI 10.1073/pnas.1007239107; Blonder B, 2011, ECOL LETT, V14, P91, DOI 10.1111/j.1461-0248.2010.01554.x; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Corson F, 2009, J THEOR BIOL, V259, P440, DOI 10.1016/j.jtbi.2009.05.002; Corson F, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.048703; Costa LD, 2007, ADV PHYS, V56, P167, DOI 10.1080/00018730601170527; Couder Y, 2002, EUR PHYS J B, V28, P135, DOI 10.1140/epjb/e2002-00211-1; Dimitrov P, 2006, P NATL ACAD SCI USA, V103, P9363, DOI 10.1073/pnas.0603559103; Fujita H, 2006, DEV DYNAM, V235, P2710, DOI 10.1002/dvdy.20908; Horton RE, 1945, GEOL SOC AM BULL, V56, P275; Katifori E, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.048704; KIRCHNER JW, 1993, GEOLOGY, V21, P591, DOI 10.1130/0091-7613(1993)021<0591:SIOHSL>2.3.CO;2; MELVILLE R, 1969, NATURE, V224, P121, DOI 10.1038/224121a0; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Paik K, 2007, EUR PHYS J B, V60, P247, DOI 10.1140/epjb/e2007-00332-y; Perna A, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.066106; Rinaldo A, 2006, WATER RESOUR RES, V42, DOI 10.1029/2005WR004108; Rinaldo A, 1998, ANNU REV EARTH PL SC, V26, P289, DOI 10.1146/annurev.earth.26.1.289; Rolland-Lagan AG, 2009, PLANT J, V57, P195, DOI 10.1111/j.1365-313X.2008.03678.x; Roth-Nebelsick A, 2001, ANN BOT-LONDON, V87, P553, DOI 10.1006/anbo.2001.1391; Sales-Pardo M, 2007, P NATL ACAD SCI USA, V104, P15224, DOI 10.1073/pnas.0703740104; Shao J, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.036105; STRAHLER AN, 1952, GEOL SOC AM BULL, V63, P1117, DOI 10.1130/0016-7606(1952)63[1117:HAAOET]2.0.CO;2; TAKAYASU H, 1988, PHYS REV A, V37, P3110, DOI 10.1103/PhysRevA.37.3110; Tero A, 2010, SCIENCE, V327, P439, DOI 10.1126/science.1177894; VANPELT J, 1992, B MATH BIOL, V54, P759, DOI 10.1016/S0092-8240(05)80142-9	30	47	47	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e37994	10.1371/journal.pone.0037994	http://dx.doi.org/10.1371/journal.pone.0037994			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701593	Green Published, Green Submitted, gold			2022-12-27	WOS:000305348400028
J	Miller, EF; Vaish, S; Maier, RJ				Miller, Erica F.; Vaish, Soumya; Maier, Robert J.			Efficiency of Purine Utilization by Helicobacter pylori: Roles for Adenosine Deaminase and a NupC Homolog	PLOS ONE			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; COMPLETE GENOME SEQUENCE; NUTRITIONAL-REQUIREMENTS; NUCLEOTIDE BIOSYNTHESIS; PYRIMIDINE METABOLISM; BACILLUS-SUBTILIS; ESCHERICHIA-COLI; DEFINED MEDIUM; HUMAN-BLOOD; GROWTH	The ability to synthesize and salvage purines is crucial for colonization by a variety of human bacterial pathogens. Helicobacter pylori colonizes the gastric epithelium of humans, yet its specific purine requirements are poorly understood, and the transport mechanisms underlying purine uptake remain unknown. Using a fully defined synthetic growth medium, we determined that H. pylori 26695 possesses a complete salvage pathway that allows for growth on any biological purine nucleobase or nucleoside with the exception of xanthosine. Doubling times in this medium varied between 7 and 14 hours depending on the purine source, with hypoxanthine, inosine and adenosine representing the purines utilized most efficiently for growth. The ability to grow on adenine or adenosine was studied using enzyme assays, revealing deamination of adenosine but not adenine by H. pylori 26695 cell lysates. Using mutant analysis we show that a strain lacking the gene encoding a NupC homolog (HP1180) was growth-retarded in a defined medium supplemented with certain purines. This strain was attenuated for uptake of radiolabeled adenosine, guanosine, and inosine, showing a role for this transporter in uptake of purine nucleosides. Deletion of the GMP biosynthesis gene guaA had no discernible effect on mouse stomach colonization, in contrast to findings in numerous bacterial pathogens. In this study we define a more comprehensive model for purine acquisition and salvage in H. pylori that includes purine uptake by a NupC homolog and catabolism of adenosine via adenosine deaminase.	[Miller, Erica F.; Vaish, Soumya; Maier, Robert J.] Univ Georgia, Dept Microbiol, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Miller, EF (corresponding author), Univ Georgia, Dept Microbiol, Athens, GA 30602 USA.	rmaier@uga.edu			University of Georgia Research Foundation	University of Georgia Research Foundation	The University of Georgia Research Foundation supported this work, but the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baltrus DA, 2009, J BACTERIOL, V191, P447, DOI 10.1128/JB.01416-08; Chiang SL, 1998, MOL MICROBIOL, V27, P797, DOI 10.1046/j.1365-2958.1998.00726.x; COLONNA A, 1983, ANAL BIOCHEM, V130, P19, DOI 10.1016/0003-2697(83)90644-9; Duckworth M, 2006, HELICOBACTER, V11, P287, DOI 10.1111/j.1523-5378.2006.00409.x; HAM RG, 1965, P NATL ACAD SCI USA, V53, P288, DOI 10.1073/pnas.53.2.288; HAMMOND DJ, 1984, MOL BIOCHEM PARASIT, V13, P243, DOI 10.1016/0166-6851(84)90117-8; HARTWICK RA, 1979, J CHROMATOGR, V186, P659, DOI 10.1016/S0021-9673(00)95286-5; HOFFMEYE.I, 1971, J BACTERIOL, V106, P14, DOI 10.1128/JB.106.1.14-24.1971; IVANOVIC.G, 1968, J GEN MICROBIOL, V53, P147, DOI 10.1099/00221287-53-2-147; Jewett MW, 2009, J BACTERIOL, V191, P6231, DOI 10.1128/JB.00450-09; Kilstrup M, 2005, FEMS MICROBIOL REV, V29, P555, DOI 10.1016/j.femsre.2005.04.006; Kleanthous H., 1995, Gut, V37, pA94; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Liechti G, 2012, J BACTERIOL, V194, P839, DOI 10.1128/JB.05757-11; Linz B, 2007, NATURE, V445, P915, DOI 10.1038/nature05562; Loewen SK, 1999, J BIOL CHEM, V274, P24475, DOI 10.1074/jbc.274.35.24475; Loewen SK, 2004, MOL MEMBR BIOL, V21, P1, DOI 10.1080/0968768031000140836; Makola D, 2007, J CLIN GASTROENTEROL, V41, P548, DOI 10.1097/MCG.0b013e318030e3c3; Martinussen J, 2003, J BACTERIOL, V185, P1503, DOI 10.1128/JB.185.5.1503-1508.2003; MCCLARTY G, 1993, J BACTERIOL, V175, P4652, DOI 10.1128/JB.175.15.4652-4661.1993; Mehta NS, 2005, INFECT IMMUN, V73, P5311, DOI 10.1128/IAI.73.9.5311-5318.2005; MENDZ GL, 1994, J APPL BACTERIOL, V77, P674, DOI 10.1111/j.1365-2672.1994.tb02818.x; Mendz GL, 1997, ARCH MICROBIOL, V168, P448, DOI 10.1007/s002030050521; NEDENSKOV P, 1994, APPL ENVIRON MICROB, V60, P3450, DOI 10.1128/AEM.60.9.3450-3453.1994; Nygaard P, 1996, J BACTERIOL, V178, P846, DOI 10.1128/jb.178.3.846-853.1996; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Patching SG, 2005, ORG BIOMOL CHEM, V3, P462, DOI 10.1039/b414739a; Pettersson J, 2007, INFECT IMMUN, V75, P3877, DOI 10.1128/IAI.00199-07; REYNOLDS DJ, 1994, MICROBIOL-UK, V140, P2649, DOI 10.1099/00221287-140-10-2649; Ritzel MWL, 2001, J BIOL CHEM, V276, P2914, DOI 10.1074/jbc.M007746200; Roodveldt C, 2005, BIOCHEMISTRY-US, V44, P12728, DOI 10.1021/bi051021e; Russo TA, 1996, MOL MICROBIOL, V22, P217, DOI 10.1046/j.1365-2958.1996.00096.x; Samant S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040037; Saxild HH, 1996, J BACTERIOL, V178, P424, DOI 10.1128/jb.178.2.424-434.1996; Schreiber S, 2004, P NATL ACAD SCI USA, V101, P5024, DOI 10.1073/pnas.0308386101; Seffernick JL, 2001, BIOCHEMISTRY-US, V40, P12747, DOI 10.1021/bi011293r; STRALEY SC, 1984, INFECT IMMUN, V45, P649, DOI 10.1128/IAI.45.3.649-654.1984; Tan SM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000407; Testerman TL, 2001, J CLIN MICROBIOL, V39, P3842, DOI 10.1128/JCM.39.11.3842-3850.2001; Testerman TL, 2006, J CLIN MICROBIOL, V44, P1650, DOI 10.1128/JCM.44.5.1650-1658.2006; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Wang JY, 2001, INFECT IMMUN, V69, P4734, DOI 10.1128/IAI.69.8.4734-4741.2001; WEATHERBURN MW, 1967, ANAL CHEM, V39, P971, DOI 10.1021/ac60252a045; White RH, 1997, J BACTERIOL, V179, P563, DOI 10.1128/jb.179.2.563-566.1997; ZALKIN H, 1996, BIOSYNTHESIS PURINE	46	11	12	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e38727	10.1371/journal.pone.0038727	http://dx.doi.org/10.1371/journal.pone.0038727			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701700	Green Published, Green Submitted, gold			2022-12-27	WOS:000305348400090
J	Amraoui, F; Krida, G; Bouattour, A; Rhim, A; Daaboub, J; Harrat, Z; Boubidi, SC; Tijane, M; Sarih, M; Failloux, AB				Amraoui, Fadila; Krida, Ghazi; Bouattour, Ali; Rhim, Adel; Daaboub, Jabeur; Harrat, Zoubir; Boubidi, Said-Chawki; Tijane, Mhamed; Sarih, Mhammed; Failloux, Anna-Bella			Culex pipiens, an Experimental Efficient Vector of West Nile and Rift Valley Fever Viruses in the Maghreb Region	PLOS ONE			English	Article							ATTENUATED AVIRULENT ISOLATE; MOSQUITOS; COMPETENCE; CULICIDAE; DIPTERA; AFRICA; AEDES; TRANSCRIPTION; EPIDEMIOLOGY; REPLICATION	West Nile fever (WNF) and Rift Valley fever (RVF) are emerging diseases causing epidemics outside their natural range of distribution. West Nile virus (WNV) circulates widely and harmlessly in the old world among birds as amplifying hosts, and horses and humans as accidental dead-end hosts. Rift Valley fever virus (RVFV) re-emerges periodically in Africa causing massive outbreaks. In the Maghreb, eco-climatic and entomologic conditions are favourable for WNV and RVFV emergence. Both viruses are transmitted by mosquitoes belonging to the Culex pipiens complex. We evaluated the ability of different populations of Cx. pipiens from North Africa to transmit WNV and the avirulent RVFV Clone 13 strain. Mosquitoes collected in Algeria, Morocco, and Tunisia during the summer 2010 were experimentally infected with WNV and RVFV Clone 13 strain at titers of 10(7.8) and 10(8.5) plaque forming units/mL, respectively. Disseminated infection and transmission rates were estimated 14-21 days following the exposure to the infectious blood-meal. We show that 14 days after exposure to WNV, all mosquito st developed a high disseminated infection and were able to excrete infectious saliva. However, only 69.2% of mosquito strains developed a disseminated infection with RVFV Clone 13 strain, and among them, 77.8% were able to deliver virus through saliva. Thus, Cx. pipiens from the Maghreb are efficient experimental vectors to transmit WNV and to a lesser extent, RVFV Clone 13 strain. The epidemiologic importance of our findings should be considered in the light of other parameters related to mosquito ecology and biology.	[Amraoui, Fadila; Sarih, Mhammed] Inst Pasteur Maroc, Lab Malad Vectorielles, Casablanca, Morocco; [Krida, Ghazi; Bouattour, Ali; Rhim, Adel] Univ Tunis El Manar, Inst Pasteur Tunis, Lab Epidemiol & Microbiol Vet, Serv Entomol Med, Tunis, Tunisia; [Krida, Ghazi] Univ Carthage, Inst Natl Agron Tunisie, Tunis, Tunisia; [Daaboub, Jabeur] Minist Sante Publ Tunisie, Direct Hyg Milieu & Protect Environm, Tunis, Tunisia; [Harrat, Zoubir; Boubidi, Said-Chawki] Inst Pasteur Alger, Unite Entomol Med, Serv Ecoepidemiol Parasitaire & Genet Populat, Algiers, Algeria; [Amraoui, Fadila; Tijane, Mhamed] Fac Sci Rabat, Lab Biochim & Immunol, Rabat, Morocco; [Failloux, Anna-Bella] Inst Pasteur, Dept Virol Arboviruses & Insect Vectors, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Universite de Tunis-El-Manar; Institut Pasteur Tunis; Universite de Carthage; Mohammed V University in Rabat; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Amraoui, F (corresponding author), Inst Pasteur Maroc, Lab Malad Vectorielles, Casablanca, Morocco.	anna-bella.failloux@pasteur.fr			Institut Pasteur (ACIP) [A-08-2009]; European Commission [228421]; "Division International" of the Institut Pasteur	Institut Pasteur (ACIP); European Commission(European CommissionEuropean Commission Joint Research Centre); "Division International" of the Institut Pasteur	This work was funded by the Institut Pasteur (ACIP grant A-08-2009) and the European Commission Framework Program Seven Award "InfraVec" (n 228421). FA was supported by the "Division International" of the Institut Pasteur. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd El-Rahim IHA, 1999, REV SCI TECH OIE, V18, P741, DOI 10.20506/rst.18.3.1195; Ahmad K, 2000, LANCET, V356, P1422, DOI 10.1016/S0140-6736(05)74068-X; Anderson SL, 2010, J AM MOSQUITO CONTR, V26, P103, DOI 10.2987/09-5926.1; Ben Hassine T, 2011, Bull Soc Pathol Exot, V104, P266, DOI 10.1007/s13149-011-0173-1; Billecocq A, 2004, J VIROL, V78, P9798, DOI 10.1128/JVI.78.18.9798-9806.2004; Boshra H, 2011, J VIROL, V85, P6098, DOI 10.1128/JVI.02641-10; Bouloy MB, 1998, LANCET, V352, P1596, DOI 10.1016/S0140-6736(05)61043-4; Dancesco P, 1975, Bull Soc Pathol Exot Filiales, V68, P503; Daubney R, 1931, J PATHOL BACTERIOL, V34, P545, DOI 10.1002/path.1700340418; El Mamy ABO, 2011, EMERG INFECT DIS, V17, P1894, DOI 10.3201/eid1710.110397; El-Harrak M., 1997, VIROLOGIE, V1, P248; Farajollahi A, 2011, INFECT GENET EVOL, V11, P1577, DOI 10.1016/j.meegid.2011.08.013; FARAN ME, 1988, AM J TROP MED HYG, V39, P206, DOI 10.4269/ajtmh.1988.39.206; FARAN ME, 1987, AM J TROP MED HYG, V37, P403, DOI 10.4269/ajtmh.1987.37.403; Fontenille D, 1998, EMERG INFECT DIS, V4, P289, DOI 10.3201/eid0402.980218; FONTENILLE D, 1995, AM J TROP MED HYG, V52, P403, DOI 10.4269/ajtmh.1995.52.403; Garbouj M., 2003, B EPIDEMIOLOGIQUE, V3, P4; HARDY JL, 1983, ANNU REV ENTOMOL, V28, P229, DOI 10.1146/annurev.en.28.010183.001305; IGARASHI A, 1978, J GEN VIROL, V40, P531, DOI 10.1099/0022-1317-40-3-531; Kilpatrick AM, 2010, AM J TROP MED HYG, V83, P607, DOI 10.4269/ajtmh.2010.10-0005; Kramer LD, 2008, ANNU REV ENTOMOL, V53, P61, DOI 10.1146/annurev.ento.53.103106.093258; Kramer LD, 2003, ADV VIRUS RES, V60, P187, DOI 10.1016/S0065-3527(03)60006-0; Krida G, 2012, ANN SOC ENT IN PRESS; Krida Ghazi, 1997, Bulletin de la Societe Entomologique de France, V102, P143; KUBERSKI TT, 1977, AM J TROP MED HYG, V26, P533, DOI 10.4269/ajtmh.1977.26.533; Le May N, 2004, CELL, V116, P541, DOI 10.1016/S0092-8674(04)00132-1; LeGuenno B, 1996, LANCET, V348, P1315, DOI 10.1016/S0140-6736(05)65799-6; Moutailler S, 2008, VECTOR-BORNE ZOONOT, V8, P749, DOI 10.1089/vbz.2008.0009; Moutailler S, 2010, VECTOR-BORNE ZOONOT, V10, P681, DOI 10.1089/vbz.2009.0246; MULLER R, 1995, AM J TROP MED HYG, V53, P405, DOI 10.4269/ajtmh.1995.53.405; Murgue B, 2001, EMERG INFECT DIS, V7, P692; OIE, 9515 OIE; Reisen WK, 2008, J MED ENTOMOL, V45, P1126, DOI 10.1603/0022-2585(2008)45[1126:DVICDC]2.0.CO;2; Reisen WK, 2006, J MED ENTOMOL, V43, P309, DOI 10.1603/0022-2585(2006)043[0309:EOTOTT]2.0.CO;2; RIOUX J.-A., 1965, ARCH INST PASTEUR TUNIS, V42, P1; Rioux J. A., 1958, CULICIDES MIDI MEDIT; Roubaud E., 1939, B SOC PATHOL EXOT, V36, P172; Roubaud E, 1933, ANN SCI NAT ZOOL, V16, P5; Schuffenecker I, 2005, EMERG INFECT DIS, V11, P306, DOI 10.3201/eid1102.040817; Senevet G., 1958, Arch Inst Pasteur Alger Algiers, V36, P70; Senevet G, 1959, ORTHOPODOMYIA MANSON; SENEVET GEORGES, 1963, ARCH INST PASTEUR ALGERIE, V41, P115; Smithburn KC., 1940, AM J TROP MED HYG, V1, P471, DOI 10.4269/ajtmh.1940.s1-20.471; Traore-Lamizana M, 2001, J MED ENTOMOL, V38, P480, DOI 10.1603/0022-2585-38.4.480; Triki H, 2001, Med Trop (Mars), V61, P487; Turell MJ, 2000, AM J TROP MED HYG, V62, P413, DOI 10.4269/ajtmh.2000.62.413; TURELL MJ, 1984, AM J TROP MED HYG, V33, P176, DOI 10.4269/ajtmh.1984.33.176; Vaidyanathan R, 2007, VECTOR-BORNE ZOONOT, V7, P193, DOI 10.1089/vbz.2006.0589; Vazeille-Falcoz M, 1999, AM J TROP MED HYG, V60, P292, DOI 10.4269/ajtmh.1999.60.292; VERMEIL C., 1954, BULL SOC PATHOL EXOT, V47, P841; Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008; Zeller HG, 1997, AM J TROP MED HYG, V56, P265, DOI 10.4269/ajtmh.1997.56.265	52	74	81	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e36757	10.1371/journal.pone.0036757	http://dx.doi.org/10.1371/journal.pone.0036757			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693557	Green Published, gold			2022-12-27	WOS:000305338500018
J	Iwamaru, Y; Takenouchi, T; Murayama, Y; Okada, H; Imamura, M; Shimizu, Y; Hashimoto, M; Mohri, S; Yokoyama, T; Kitani, H				Iwamaru, Yoshifumi; Takenouchi, Takato; Murayama, Yuichi; Okada, Hiroyuki; Imamura, Morikazu; Shimizu, Yoshihisa; Hashimoto, Makoto; Mohri, Shirou; Yokoyama, Takashi; Kitani, Hiroshi			Anti-Prion Activity of Brilliant Blue G	PLOS ONE			English	Article							PURINERGIC P2X(7) RECEPTOR; CREUTZFELDT-JAKOB-DISEASE; MICROGLIAL CELL-LINE; PROTEIN ACCUMULATION; CULTURED-CELLS; IN-VITRO; 2-ARACHIDONOYLGLYCEROL PRODUCTION; CHRONIC NEURODEGENERATION; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE	Background: Prion diseases are fatal neurodegenerative disorders with no effective therapy currently available. Accumulating evidence has implicated over-activation of P2X7 ionotropic purinergic receptor (P2X7R) in the progression of neuronal loss in several neurodegenerative diseases. This has led to the speculation that simultaneous blockade of this receptor and prion replication can be an effective therapeutic strategy for prion diseases. We have focused on Brilliant Blue G (BBG), a well-known P2X7R antagonist, possessing a chemical structure expected to confer anti-prion activity and examined its inhibitory effect on the accumulation of pathogenic isoforms of prion protein (PrPres) in a cellular and a mouse model of prion disease in order to determine its therapeutic potential. Principal Findings: BBG prevented PrPres accumulation in infected MG20 microglial and N2a neural cells at 50% inhibitory concentrations of 14.6 and 3.2 mu M, respectively. Administration of BBG in vivo also reduced PrPres accumulation in the brains of mice with prion disease. However, it did not appear to alleviate the disease progression compared to the vehicle-treated controls, implying a complex role of P2X7R on the neuronal degeneration in prion diseases. Significance: These results provide novel insights into the pathophysiology of prion diseases and have important implications for the treatment.	[Iwamaru, Yoshifumi; Murayama, Yuichi; Okada, Hiroyuki; Imamura, Morikazu; Shimizu, Yoshihisa; Mohri, Shirou; Yokoyama, Takashi] Natl Inst Anim Hlth, Prion Dis Res Ctr, Tsukuba, Ibaraki 305, Japan; [Takenouchi, Takato; Kitani, Hiroshi] Natl Inst Agrobiol Sci, Anim Immune & Cell Biol Res Unit, Tsukuba, Ibaraki, Japan; [Hashimoto, Makoto] Tokyo Metropolitan Inst Med Sci, Div Sensory & Motor Syst, Setagaya Ku, Tokyo 113, Japan	National Agriculture & Food Research Organization - Japan; National Institute of Animal Health - Japan; National Institute of Agrobiological Sciences - Japan; Tokyo Metropolitan Institute of Medical Science	Iwamaru, Y (corresponding author), Natl Inst Anim Hlth, Prion Dis Res Ctr, Tsukuba, Ibaraki 305, Japan.	kitani@affrc.go.jp	Mohri, Shirou/AAK-1281-2020		BSE; Ministry of Agriculture, Forestry, and Fisheries of Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan [23780313, 22580389]	BSE; Ministry of Agriculture, Forestry, and Fisheries of Japan(Ministry of Agriculture Forestry & Fisheries - Japan); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-Aid from the BSE and other Prion 20 Disease Control Project of the Ministry of Agriculture, Forestry, and Fisheries of Japan and by a Grant-in-Aid for Young Scientists (Category B: Grant# 23780313) and Scientific Research (Category C: Grant# 22580389) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballerini P, 1996, NEUROREPORT, V7, P2533, DOI 10.1097/00001756-199611040-00026; Boche D, 2006, NEUROBIOL DIS, V22, P638, DOI 10.1016/j.nbd.2006.01.004; Bolognesi ML, 2010, CHEMMEDCHEM, V5, P1324, DOI 10.1002/cmdc.201000133; BORCHELT DR, 1992, J BIOL CHEM, V267, P16188; Brown AR, 2003, J GEN VIROL, V84, P2605, DOI 10.1099/vir.0.19137-0; Brown DR, 2001, MICROSC RES TECHNIQ, V54, P71, DOI 10.1002/jemt.1122; Cabral GA, 2001, ADV EXP MED BIOL, V493, P207; CAUGHEY B, 1991, J BIOL CHEM, V266, P18217; Caughey B, 2003, J VIROL, V77, P5499, DOI 10.1128/JVI.77.9.5499-5502.2003; CAUGHEY B, 1992, J NEUROCHEM, V59, P768, DOI 10.1111/j.1471-4159.1992.tb09437.x; COMPTON SJ, 1985, ANAL BIOCHEM, V151, P369, DOI 10.1016/0003-2697(85)90190-3; Cunningham C, 2003, EUR J NEUROSCI, V17, P2147, DOI 10.1046/j.1460-9568.2003.02662.x; Daude N, 2003, J CELL SCI, V116, P2775, DOI 10.1242/jcs.00494; Depino AM, 2003, EUR J NEUROSCI, V18, P2731, DOI 10.1111/j.1460-9568.2003.03014.x; Deuchars SA, 2001, J NEUROSCI, V21, P7143, DOI 10.1523/JNEUROSCI.21-18-07143.2001; Diaz-Hernandez M, 2009, FASEB J, V23, P1893, DOI 10.1096/fj.08-122275; Dirikoc S, 2007, J NEUROSCI, V27, P9537, DOI 10.1523/JNEUROSCI.1942-07.2007; Ferrari D, 1996, J IMMUNOL, V156, P1531; Ferrari D, 1997, J EXP MED, V185, P579, DOI 10.1084/jem.185.3.579; Gilch S, 2001, EMBO J, V20, P3957, DOI 10.1093/emboj/20.15.3957; Goold R, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1282; Heiseke A, 2009, J NEUROCHEM, V109, P25, DOI 10.1111/j.1471-4159.2009.05906.x; Hracsko Z, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-28; Iriyama A, 2012, RETINA-J RET VIT DIS, V32, P613, DOI 10.1097/IAE.0b013e31822091df; Iwamaru Y, 2008, J NEUROCHEM, V107, P636, DOI 10.1111/j.1471-4159.2008.05628.x; Iwamaru Y, 2007, J VIROL, V81, P1524, DOI 10.1128/JVI.01379-06; Jeffrey M, 2000, NEUROPATH APPL NEURO, V26, P41, DOI 10.1046/j.1365-2990.2000.00216.x; Kang SW, 2006, CELL, V127, P999, DOI 10.1016/j.cell.2006.10.032; Khaspekov LG, 2004, EUR J NEUROSCI, V19, P1691, DOI 10.1111/j.1460-9568.2004.03285.x; Kordek R, 1999, ACTA NEUROPATHOL, V98, P597, DOI 10.1007/s004010051124; Marcoli M, 2008, J NEUROCHEM, V105, P2330, DOI 10.1111/j.1471-4159.2008.05322.x; Marijanovic Z, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000426; Marsicano G, 2003, SCIENCE, V302, P84, DOI 10.1126/science.1088208; Matute C, 2007, J NEUROSCI, V27, P9525, DOI 10.1523/JNEUROSCI.0579-07.2007; McLarnon JG, 2006, J NEUROPATH EXP NEUR, V65, P1090, DOI 10.1097/01.jnen.0000240470.97295.d3; Monif M, 2010, INT J BIOCHEM CELL B, V42, P1753, DOI 10.1016/j.biocel.2010.06.021; Murayama Y, 2007, NEUROSCI LETT, V413, P270, DOI 10.1016/j.neulet.2006.11.056; Nagaoka K, 2010, BIOCHEM BIOPH RES CO, V397, P626, DOI 10.1016/j.bbrc.2010.06.013; Ortega F, 2011, NEUROPHARMACOLOGY; Papp L, 2004, NEUROREPORT, V15, P2387, DOI 10.1097/00001756-200410250-00017; Parvathenani LK, 2003, J BIOL CHEM, V278, P13309, DOI 10.1074/jbc.M209478200; PRUSINER SB, 1991, SCIENCE, V252, P1515, DOI 10.1126/science.1675487; Quaglio E, 2001, J BIOL CHEM, V276, P11432, DOI 10.1074/jbc.M009666200; Rambold AS, 2008, J NEUROCHEM, V107, P218, DOI 10.1111/j.1471-4159.2008.05611.x; Remy M, 2008, BRIT J OPHTHALMOL, V92, P1142, DOI 10.1136/bjo.2008.138164; Ryu JK, 2008, NEUROREPORT, V19, P1715, DOI 10.1097/WNR.0b013e3283179333; SAKAGUCHI S, 1995, J VIROL, V69, P7586, DOI 10.1128/JVI.69.12.7586-7592.1995; Schultz J, 2004, AM J PATHOL, V165, P671, DOI 10.1016/S0002-9440(10)63331-7; Shimizu Y, 2010, MICROBIOL IMMUNOL, V54, P112, DOI 10.1111/j.1348-0421.2009.00190.x; SHYNG SL, 1995, J BIOL CHEM, V270, P30221; Skaper SD, 2006, GLIA, V54, P234, DOI 10.1002/glia.20379; Sperlagh B, 2002, J NEUROCHEM, V81, P1196, DOI 10.1046/j.1471-4159.2002.00920.x; Takenouchi T, 2007, FEBS LETT, V581, P3019, DOI 10.1016/j.febslet.2007.05.057; Takenouchi T, 2010, ARCH IMMUNOL THER EX, V58, P91, DOI 10.1007/s00005-010-0069-y; Takenouchi T, 2009, CRIT REV IMMUNOL, V29, P335, DOI 10.1615/CritRevImmunol.v29.i4.40; TARABOULOS A, 1992, MOL BIOL CELL, V3, P851, DOI 10.1091/mbc.3.8.851; Tribouillard-Tanvier D, 2009, J VIROL, V83, P11244, DOI 10.1128/JVI.01413-09; Walsh DT, 2001, J NEUROPATH EXP NEUR, V60, P173, DOI 10.1093/jnen/60.2.173; Walter L, 2004, J NEUROSCI, V24, P8068, DOI 10.1523/JNEUROSCI.2419-04.2004; Wang XH, 2004, NAT MED, V10, P821, DOI 10.1038/nm1082; Witting A, 2004, P NATL ACAD SCI USA, V101, P3214, DOI 10.1073/pnas.0306707101; Yamasaki T, 2012, J GEN VIROL, V93, P668, DOI 10.1099/vir.0.037101-0; Yiangou Y, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-12	63	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e37896	10.1371/journal.pone.0037896	http://dx.doi.org/10.1371/journal.pone.0037896			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693582	gold, Green Published, Green Submitted			2022-12-27	WOS:000305338500063
J	Lebon, F; Lotze, M; Stinear, CM; Byblow, WD				Lebon, Florent; Lotze, Martin; Stinear, Cathy M.; Byblow, Winston D.			Task-Dependent Interaction between Parietal and Contralateral Primary Motor Cortex during Explicit versus Implicit Motor Imagery	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; MENTAL ROTATION; CORTICOSPINAL EXCITABILITY; HAND MOVEMENTS; INVOLVEMENT; TMS; SYSTEM; BRAIN; FMRI; REPRESENTATIONS	Both mental rotation (MR) and motor imagery (MI) involve an internalization of movement within motor and parietal cortex. Transcranial magnetic stimulation (TMS) techniques allow for a task-dependent investigation of the interhemispheric interaction between these areas. We used image-guided dual-coil TMS to investigate interactions between right inferior parietal lobe (rIPL) and left primary motor cortex (M1) in 11 healthy participants. They performed MI (right index-thumb pinching in time with a 1 Hz metronome) or hand MR tasks, while motor evoked potentials (MEPs) were recorded from right first dorsal interosseous. At rest, rIPL conditioning 6 ms prior to M1 stimulation facilitated MEPs in all participants, whereas this facilitation was abolished during MR. While rIPL conditioning 12 ms prior to M1 stimulation had no effect on MEPs at rest, it suppressed corticomotor excitability during MI. These results support the idea that rIPL forms part of a distinct inhibitory network that may prevent unwanted movement during imagery tasks.	[Lebon, Florent; Stinear, Cathy M.] Univ Auckland, Dept Med, Neurol Res Grp, Auckland, New Zealand; [Lebon, Florent; Stinear, Cathy M.] Ernst Moritz Arndt Univ Greifswald, Greifswald, Germany; [Stinear, Cathy M.; Byblow, Winston D.] Univ Auckland, Ctr Brain Res, Auckland 1, New Zealand; [Byblow, Winston D.] Univ Auckland, Movement Neurosci Lab, Dept Sport & Exercise Sci, Auckland 1, New Zealand	University of Auckland; Ernst Moritz Arndt Universitat Greifswald; University of Auckland; University of Auckland	Lebon, F (corresponding author), Univ Auckland, Dept Med, Neurol Res Grp, Auckland, New Zealand.	w.byblow@auckland.ac.nz	Lebon, Florent/W-4065-2017; Lotze, Martin/D-2964-2012; Byblow, Winston/D-3579-2009	Lebon, Florent/0000-0003-0096-9762; Lotze, Martin/0000-0003-4519-4956; Byblow, Winston/0000-0001-8347-6730; Stinear, Cathy/0000-0002-9404-1959	Federal Ministry of Education and Research Germany (BMBF); Royal Society of New Zealand International Mobility Fund	Federal Ministry of Education and Research Germany (BMBF)(Federal Ministry of Education & Research (BMBF)); Royal Society of New Zealand International Mobility Fund(Royal Society of New Zealand)	ML was supported by the Federal Ministry of Education and Research Germany (BMBF). WDB was supported by the Royal Society of New Zealand International Mobility Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Binkofski F, 2000, HUM BRAIN MAPP, V11, P273, DOI 10.1002/1097-0193(200012)11:4<273::AID-HBM40>3.0.CO;2-0; Bode S, 2007, BEHAV BRAIN FUNCT, V3, DOI 10.1186/1744-9081-3-38; Choi HJ, 2006, J COMP NEUROL, V495, P53, DOI 10.1002/cne.20849; Danckert J, 2002, NEUROCASE, V8, P194, DOI 10.1076/neur.8.2.194.16204; de Lange FP, 2008, CORTEX, V44, P494, DOI 10.1016/j.cortex.2007.09.002; de Lange FP, 2005, J COGNITIVE NEUROSCI, V17, P97, DOI 10.1162/0898929052880039; Deftereos SN, 2008, FUNCT NEUROL, V23, P137; Eisenegger C, 2007, EUR J NEUROSCI, V25, P1240, DOI 10.1111/j.1460-9568.2007.05354.x; Fleming MK, 2010, EXP BRAIN RES, V201, P499, DOI 10.1007/s00221-009-2062-4; Ganis G, 2000, CEREB CORTEX, V10, P175, DOI 10.1093/cercor/10.2.175; Gao Q, 2011, NEUROIMAGE, V54, P1280, DOI 10.1016/j.neuroimage.2010.08.071; Gerardin E, 2000, CEREB CORTEX, V10, P1093, DOI 10.1093/cercor/10.11.1093; Gogos A, 2010, NEUROPSYCHOLOGIA, V48, P529, DOI 10.1016/j.neuropsychologia.2009.10.013; Harris IM, 2003, J COGNITIVE NEUROSCI, V15, P315, DOI 10.1162/089892903321593054; Herwig U, 2003, BRAIN TOPOGR, V16, P95, DOI 10.1023/B:BRAT.0000006333.93597.9d; JEANNEROD M, 1995, NEUROPSYCHOLOGIA, V33, P1419, DOI 10.1016/0028-3932(95)00073-C; Jeannerod M, 1999, CURR OPIN NEUROBIOL, V9, P735, DOI 10.1016/S0959-4388(99)00038-0; Koch G, 2007, J NEUROSCI, V27, P6815, DOI 10.1523/JNEUROSCI.0598-07.2007; Koch G, 2009, J PHYSIOL-LONDON, V587, P4281, DOI 10.1113/jphysiol.2009.174086; Kosslyn S.M., 2010, NEUROPHYSIOLOGICAL F, P3, DOI [DOI 10.1093/ACPR0F:0S0/9780199546251.003.0001, DOI 10.1093/ACPROF:OSO/9780199546251.003.0001]; Kosslyn SM, 1998, PSYCHOPHYSIOLOGY, V35, P151, DOI 10.1017/S0048577298001516; Kuhtz-Buschbeck JP, 2003, EUR J NEUROSCI, V18, P3375, DOI 10.1111/j.1460-9568.2003.03066.x; Lacourse MG, 2005, NEUROIMAGE, V27, P505, DOI 10.1016/j.neuroimage.2005.04.025; Lebon F, 2012, EUR J NEUROSCI, V35, P323, DOI 10.1111/j.1460-9568.2011.07938.x; Lotze M, 2010, RESTOR NEUROL NEUROS, V28, P469, DOI 10.3233/RNN-2010-0563; Mink JW, 1996, PROG NEUROBIOL, V50, P381, DOI 10.1016/S0301-0082(96)00042-1; Nambu A, 2002, NEUROSCI RES, V43, P111, DOI 10.1016/S0168-0102(02)00027-5; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; PARSONS LM, 1994, J EXP PSYCHOL HUMAN, V20, P709, DOI 10.1037/0096-1523.20.4.709; PARSONS LM, 1995, NATURE, V375, P54, DOI 10.1038/375054a0; ROSSINI PM, 1994, ELECTROEN CLIN NEURO, V91, P79, DOI 10.1016/0013-4694(94)90029-9; Sauner D, 2006, EUR J NEUROSCI, V23, P2215, DOI 10.1111/j.1460-9568.2006.04731.x; Schwoebel J, 2002, BRAIN COGNITION, V50, P1, DOI 10.1016/S0278-2626(02)00005-2; Seurinck R, 2011, J COGNITIVE NEUROSCI, V23, P1395, DOI 10.1162/jocn.2010.21525; Sharma N, 2008, NEUROIMAGE, V41, P92, DOI 10.1016/j.neuroimage.2008.02.009; Sirigu A, 1996, SCIENCE, V273, P1564, DOI 10.1126/science.273.5281.1564; Stinear CM, 2009, NEUROSCI BIOBEHAV R, V33, P662, DOI 10.1016/j.neubiorev.2008.08.013; Stinear CM, 2006, EXP BRAIN RES, V168, P157, DOI 10.1007/s00221-005-0078-y; Stinear CM, 2004, EXP BRAIN RES, V157, P351, DOI 10.1007/s00221-004-1851-z; Stinear CM, 2003, CLIN NEUROPHYSIOL, V114, P909, DOI 10.1016/S1388-2457(02)00373-5; Stinear CM, 2010, NEUROPHYSIOLOGICAL F; Vargas CD, 2004, CEREB CORTEX, V14, P1200, DOI 10.1093/cercor/bhh080; Vingerhoets G, 2002, NEUROIMAGE, V17, P1623, DOI 10.1006/nimg.2002.1290; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931; Wraga M, 2003, BRAIN COGNITION, V52, P135, DOI 10.1016/S0278-2626(03)00033-2; Zarei M, 2006, J ANAT, V209, P311, DOI 10.1111/j.1469-7580.2006.00615.x	46	28	28	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e37850	10.1371/journal.pone.0037850	http://dx.doi.org/10.1371/journal.pone.0037850			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693579	Green Submitted, Green Published, gold			2022-12-27	WOS:000305338500060
J	Mokhonov, VV; Theendakara, VP; Gribanova, YE; Ahmedli, NB; Farber, DB				Mokhonov, Vladislav V.; Theendakara, Veena P.; Gribanova, Yekaterina E.; Ahmedli, Novruz B.; Farber, Debora B.			Sequence-Specific Binding of Recombinant Zbed4 to DNA: Insights into Zbed4 Participation in Gene Transcription and Its Association with Other Proteins	PLOS ONE			English	Article							ZINC-FINGER; SECONDARY STRUCTURE; GC-BOX; ELEMENT; IDENTIFICATION; EXPRESSION; INTERACTS; DOMAIN; VISUALIZATION; LYSOZYME	Zbed4, a member of the BED subclass of Zinc-finger proteins, is expressed in cone photoreceptors and glial Muller cells of human retina whereas it is only present in Muller cells of mouse retina. To characterize structural and functional properties of Zbed4, enough amounts of purified protein were needed. Thus, recombinant Zbed4 was expressed in E. coli and its refolding conditions optimized for the production of homogenous and functionally active protein. Zbed4's secondary structure, determined by circular dichroism spectroscopy, showed that this protein contains 32% alpha-helices, 18% beta-sheets, 20% turns and 30% unordered structures. CASTing was used to identify the target sites of Zbed4 in DNA. The majority of the DNA fragments obtained contained poly-Gs and some of them had, in addition, the core signature of GC boxes; a few clones had only GC-boxes. With electrophoretic mobility shift assays we demonstrated that Zbed4 binds both not only to DNA and but also to RNA oligonucleotides with very high affinity, interacting with poly-G tracts that have a minimum of 5 Gs; its binding to and GC-box consensus sequences. However, the latter binding depends on the GC-box flanking nucleotides. We also found that Zbed4 interacts in Y79 retinoblastoma cells with nuclear and cytoplasmic proteins Scaffold Attachment Factor B1 (SAFB1), estrogen receptor alpha (ER alpha), and cellular myosin 9 (MYH9), as shown with immunoprecipitation and mass spectrometry studies as well as gel overlay assays. In addition, immunostaining corroborated the co-localization of Zbed4 with these proteins. Most importantly, in vitro experiments using constructs containing promoters of genes directing expression of the luciferase gene, showed that Zbed4 transactivates the transcription of those promoters with poly-G tracts.	[Mokhonov, Vladislav V.; Theendakara, Veena P.; Gribanova, Yekaterina E.; Ahmedli, Novruz B.; Farber, Debora B.] Univ Calif Los Angeles, David Geffen Sch Med, Jules Stein Eye Inst, Los Angeles, CA 90095 USA; [Mokhonov, Vladislav V.; Theendakara, Veena P.; Gribanova, Yekaterina E.; Ahmedli, Novruz B.; Farber, Debora B.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Ophthalmol, Los Angeles, CA 90095 USA; [Farber, Debora B.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA; [Farber, Debora B.] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Mokhonov, VV (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Jules Stein Eye Inst, Los Angeles, CA 90095 USA.	Akhmedov@jsei.ucla.edu; farber@jsei.ucla.edu	Mokhonov, Vladislav/K-2006-2015; Mokhonov, Vladislav/E-9186-2017	Farber, Debora/0000-0002-3207-697X; Mokhonov, Vladislav/0000-0002-8542-5723	National Institutes of Health [EY008285]; Hope for Vision; NATIONAL EYE INSTITUTE [R01EY008285] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hope for Vision; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by grants from National Institutes of Health (EY008285) and Hope for Vision. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravind L, 2000, TRENDS BIOCHEM SCI, V25, P421, DOI 10.1016/S0968-0004(00)01620-0; Baneyx F, 1999, CURR OPIN BIOTECH, V10, P411, DOI 10.1016/S0958-1669(99)00003-8; Bowers PW, 1999, NAT STRUCT BIOL, V6, P478; Chen SM, 1996, J BIOL CHEM, V271, P28549, DOI 10.1074/jbc.271.45.28549; Chen T, 2009, J BIOL CHEM, V284, P6683, DOI 10.1074/jbc.M807753200; CLARK DV, 1995, MOL GEN GENET, V247, P367, DOI 10.1007/BF00293205; Clark ED, 1999, METHOD ENZYMOL, V309, P217; Coupe SA, 1997, PLANT J, V11, P1207, DOI 10.1046/j.1365-313X.1997.11061207.x; FRANKEL AD, 1987, P NATL ACAD SCI USA, V84, P4841, DOI 10.1073/pnas.84.14.4841; Garee JP, 2010, J CELL BIOCHEM, V109, P312, DOI 10.1002/jcb.22420; Garnier J, 1996, METHOD ENZYMOL, V266, P540; Gu ZY, 2002, PROTEIN EXPRES PURIF, V25, P174, DOI 10.1006/prep.2002.1624; Gu ZY, 2001, J CHROMATOGR A, V918, P311, DOI 10.1016/S0021-9673(01)00766-X; HARLEY VR, 1994, NUCLEIC ACIDS RES, V22, P1500, DOI 10.1093/nar/22.8.1500; Hellman LM, 2007, NAT PROTOC, V2, P1849, DOI 10.1038/nprot.2007.249; Htun H, 1999, MOL BIOL CELL, V10, P471, DOI 10.1091/mbc.10.2.471; IMATAKA H, 1992, EMBO J, V11, P3663, DOI 10.1002/j.1460-2075.1992.tb05451.x; Iuchi S, 2005, MOL B INT U, P7; JANKOWSKI JM, 1987, BIOSCIENCE REP, V7, P955, DOI 10.1007/BF01122129; Jiang L, 2009, MOL CELL BIOCHEM, V328, P137, DOI 10.1007/s11010-009-0083-8; Kallenbach N. R., 1996, CIRCULAR DICHROISM C, P201; Katoh S, 2000, PROCESS BIOCHEM, V35, P1119, DOI 10.1016/S0032-9592(00)00145-X; KLUG A, 1995, FASEB J, V9, P597, DOI 10.1096/fasebj.9.8.7768350; Kushner PJ, 2003, PURE APPL CHEM, V75, P1757, DOI 10.1351/pac200375111757; Laity JH, 2001, CURR OPIN STRUC BIOL, V11, P39, DOI 10.1016/S0959-440X(00)00167-6; LAM E, 1990, PLANT CELL, V2, P857, DOI 10.1105/tpc.2.9.857; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lerner LE, 2005, J BIOL CHEM, V280, P20642, DOI 10.1074/jbc.M500957200; Lerner LE, 2001, J BIOL CHEM, V276, P34999, DOI 10.1074/jbc.M103301200; Lerner LE, 2000, METHOD ENZYMOL, V315, P617; Li WF, 2008, J AM CHEM SOC, V130, P892, DOI 10.1021/ja075302g; Lu D, 2003, NATURE, V426, P96, DOI 10.1038/nature02088; Mackay JP, 1998, TRENDS BIOCHEM SCI, V23, P1, DOI 10.1016/S0968-0004(97)01168-7; Madej T, 2012, NUCLEIC ACIDS RES, V40, pD461, DOI 10.1093/nar/gkr1162; Mahajan MA, 2002, MOL CELL BIOL, V22, P6883, DOI 10.1128/MCB.22.19.6883-6894.2002; Markljung E, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000256; Matthews JM, 2002, IUBMB LIFE, V54, P351, DOI 10.1080/15216540216035; Novy R., 2001, INNOVATIONS, V12, P1; Ohshima N, 2003, J BIOL CHEM, V278, P22928, DOI 10.1074/jbc.M303109200; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Saghizadeh M, 2011, MOL VIS, V17, P2011; Saghizadeh M, 2009, INVEST OPHTH VIS SCI, V50, P3580, DOI 10.1167/iovs.08-2751; SANCHEZGARCIA I, 1994, TRENDS GENET, V10, P315, DOI 10.1016/0168-9525(94)90034-5; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Sreerama N, 1999, PROTEIN SCI, V8, P370; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; Togo T, 2004, MOL BIOL CELL, V15, P688, DOI 10.1091/mbc.E03-06-0430; Townson SM, 2004, J BIOL CHEM, V279, P26074, DOI 10.1074/jbc.M313726200; Ullman CG, 1996, BIOCHEM J, V319, P229, DOI 10.1042/bj3190229; Vallejo LF, 2004, BIOTECHNOL BIOENG, V85, P601, DOI 10.1002/bit.10906; WRIGHT WE, 1991, MOL CELL BIOL, V11, P4104, DOI 10.1128/MCB.11.8.4104; Wu WJ, 2007, FEBS J, V274, P390, DOI 10.1111/j.1742-4658.2006.05587.x	52	8	8	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e35317	10.1371/journal.pone.0035317	http://dx.doi.org/10.1371/journal.pone.0035317			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693546	Green Published, gold, Green Submitted			2022-12-27	WOS:000305338500007
J	Schartl, M; Kneitz, S; Wilde, B; Wagner, T; Henkel, CV; Spaink, HP; Meierjohann, S				Schartl, Manfred; Kneitz, Susanne; Wilde, Brigitta; Wagner, Toni; Henkel, Christiaan V.; Spaink, Herman P.; Meierjohann, Svenja			Conserved Expression Signatures between Medaka and Human Pigment Cell Tumors	PLOS ONE			English	Article							GENE-EXPRESSION; MALIGNANT-MELANOMA; CUTANEOUS MELANOMA; REACTIVE OXYGEN; PROLIFERATION; XIPHOPHORUS; ZEBRAFISH; PHENOTYPE; ONCOGENE; MODEL	Aberrations in gene expression are a hallmark of cancer cells. Differential tumor-specific transcript levels of single genes or whole sets of genes may be critical for the neoplastic phenotype and important for therapeutic considerations or useful as biomarkers. As an approach to filter out such relevant expression differences from the plethora of changes noted in global expression profiling studies, we searched for changes of gene expression levels that are conserved. Transcriptomes from massive parallel sequencing of different types of melanoma from medaka were generated and compared to microarray datasets from zebrafish and human melanoma. This revealed molecular conservation at various levels between fish models and human tumors providing a useful strategy for identifying expression signatures strongly associated with disease phenotypes and uncovering new melanoma molecules.	[Schartl, Manfred; Kneitz, Susanne; Wilde, Brigitta; Wagner, Toni; Meierjohann, Svenja] Univ Wurzburg, Bioctr, Wurzburg, Germany; [Henkel, Christiaan V.] ZF Screens BV, Leiden, Netherlands; [Spaink, Herman P.] Leiden Univ, Inst Biol, Leiden, Netherlands	University of Wurzburg; Leiden University; Leiden University - Excl LUMC	Schartl, M (corresponding author), Univ Wurzburg, Bioctr, Wurzburg, Germany.	phch1@biozentrum.uni-wuerzburg.de	Spaink, Herman P./S-3586-2017	Spaink, Herman P./0000-0003-4128-9501; Schartl, Manfred/0000-0001-9882-5948; Henkel, Christiaan/0000-0001-9838-8215	German Research Foundation (DFG) [SFB-Transregio 17]; Melanoma Research Network of the Deutsche Krebshilfe e.V.; DFG; University of Wuerzburg	German Research Foundation (DFG)(German Research Foundation (DFG)); Melanoma Research Network of the Deutsche Krebshilfe e.V.; DFG(German Research Foundation (DFG)); University of Wuerzburg	This work was supported by the German Research Foundation (DFG) through SFB-Transregio 17 (no specific grant number; URL: http://www.imt.uni-marburg.de/tr17/) and by the Melanoma Research Network of the Deutsche Krebshilfe e.V. (German Cancer Aid) (no specific grant number; URL: http://www.melanomverbund.de/), as well as the funding programme Open Access Publishing by the DFG and the University of Wuerzburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders Simon, 2010, Genome Biol, V11, pR106, DOI 10.1186/gb-2010-11-10-r106; Anelli V, 2009, ZEBRAFISH, V6, P417, DOI 10.1089/zeb.2009.0612; Berger MF, 2010, GENOME RES, V20, P413, DOI 10.1101/gr.103697.109; Bittner M, 2000, NATURE, V406, P536, DOI 10.1038/35020115; Bogenrieder T, 2011, CANCER BIOMARK, V9, P267, DOI 10.3233/CBM-2011-0164; Bogunovic D, 2009, P NATL ACAD SCI USA, V106, P20429, DOI 10.1073/pnas.0905139106; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Carreira S, 2006, GENE DEV, V20, P3426, DOI 10.1101/gad.406406; Ceol CJ, 2011, NATURE, V471, P513, DOI 10.1038/nature09806; Ceol CJ, 2008, ZEBRAFISH, V5, P247, DOI 10.1089/zeb.2008.0544; Chien AJ, 2009, P NATL ACAD SCI USA, V106, P1193, DOI 10.1073/pnas.0811902106; Dovey M, 2009, ZEBRAFISH, V6, P397, DOI 10.1089/zeb.2009.0606; Fernandez L, 2008, HUM MUTAT, V29, P1161, DOI 10.1002/humu.20804; Fried L, 2008, PIGM CELL MELANOMA R, V21, P117, DOI 10.1111/j.1755-148X.2008.00451.x; Herlyn M, 2011, PIGM CELL MELANOMA R, V24, P975, DOI 10.1111/j.1755-148X.2011.00906.x; Hoek KS, 2006, PIGM CELL RES, V19, P290, DOI 10.1111/j.1600-0749.2006.00322.x; Hoek KS, 2010, PIGM CELL MELANOMA R, V23, P746, DOI 10.1111/j.1755-148X.2010.00757.x; Ibarrola-Villava M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019271; Jonsson G, 2010, CLIN CANCER RES, V16, P3356, DOI 10.1158/1078-0432.CCR-09-2509; Kuphal S, 2011, ARCH BIOCHEM BIOPHYS; Lam SH, 2006, CELL CYCLE, V5, P573, DOI 10.4161/cc.5.6.2550; Leikam C, 2008, ONCOGENE, V27, P7070, DOI 10.1038/onc.2008.323; Lokaj K, 2009, J PROTEOME RES, V8, P1818, DOI 10.1021/pr800578a; Meierjohann S, 2006, TRENDS GENET, V22, P654, DOI 10.1016/j.tig.2006.09.013; Mitra D, 2009, HEMATOL ONCOL CLIN N, V23, P447, DOI 10.1016/j.hoc.2009.03.003; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nazarian RM, 2010, J CUTAN PATHOL, V37, P41, DOI 10.1111/j.1600-0560.2010.01505.x; Palmieri G, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-86; Patton EE, 2010, PIGM CELL MELANOMA R, V23, P314, DOI 10.1111/j.1755-148X.2010.00693.x; Patton EE, 2005, CURR BIOL, V15, P249, DOI 10.1016/j.cub.2005.01.031; Perez AN, 2011, COMP BIOCH PHYSL C; Platz A, 2008, MOL ONCOL, V1, P395, DOI 10.1016/j.molonc.2007.12.003; Purdue MP, 2008, J INVEST DERMATOL, V128, P2905, DOI 10.1038/jid.2008.159; Ray ME, 1997, P NATL ACAD SCI USA, V94, P3229, DOI 10.1073/pnas.94.7.3229; Rodolfo M, 2005, J INVEST DERMATOL, V125, pXII, DOI 10.1111/j.0022-202X.2005.23965.x; Sauter ER, 2002, CANCER RES, V62, P3200; Schartl M, 2010, J INVEST DERMATOL, V130, P249, DOI 10.1038/jid.2009.213; Simpson D, 2000, MOL VIS, V6, P178; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Sokal R.R., 2012, BIOMETRY; Talantov D, 2005, CLIN CANCER RES, V11, P7234, DOI 10.1158/1078-0432.CCR-05-0683; Teutschbein J, 2009, COMP BIOCHEM PHYS C, V149, P168, DOI 10.1016/j.cbpc.2008.09.013; Timar J, 2010, CLIN EXP METASTAS, V27, P371, DOI 10.1007/s10585-010-9307-2; Vance KW, 2004, PIGM CELL RES, V17, P318, DOI 10.1111/j.1600-0749.2004.00164.x; Wagner TU, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028990; Wellbrock C, 2005, J CELL BIOL, V170, P703, DOI 10.1083/jcb.200505059; WELLBROCK C, 1995, ONCOGENE, V10, P2135; White RM, 2011, NATURE, V471, P518, DOI 10.1038/nature09882; Winnepenninckx VR, 2006, JNCI-J NATL CANCER I, V98, P472, DOI 10.1093/jnci/djj103; Yang GA, 2005, J INVEST DERMATOL, V125, P1242, DOI 10.1111/j.0022-202X.2005.23931.x	50	30	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e37880	10.1371/journal.pone.0037880	http://dx.doi.org/10.1371/journal.pone.0037880			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693581	Green Published, Green Submitted, gold			2022-12-27	WOS:000305338500062
J	Li, K; Bihan, M; Yooseph, S; Methe, BA				Li, Kelvin; Bihan, Monika; Yooseph, Shibu; Methe, Barbara A.			Analyses of the Microbial Diversity across the Human Microbiome	PLOS ONE			English	Article							RIBOSOMAL-RNA SEQUENCES; COMMUNITIES; SOIL; COVERAGE; EVENNESS	Analysis of human body microbial diversity is fundamental to understanding community structure, biology and ecology. The National Institutes of Health Human Microbiome Project (HMP) has provided an unprecedented opportunity to examine microbial diversity within and across body habitats and individuals through pyrosequencing-based profiling of 16 S rRNA gene sequences (16 S) from habits of the oral, skin, distal gut, and vaginal body regions from over 200 healthy individuals enabling the application of statistical techniques. In this study, two approaches were applied to elucidate the nature and extent of human microbiome diversity. First, bootstrap and parametric curve fitting techniques were evaluated to estimate the maximum number of unique taxa, S-max, and taxa discovery rate for habitats across individuals. Next, our results demonstrated that the variation of diversity within low abundant taxa across habitats and individuals was not sufficiently quantified with standard ecological diversity indices. This impact from low abundant taxa motivated us to introduce a novel rank-based diversity measure, the Tail statistic, ("tau"), based on the standard deviation of the rank abundance curve if made symmetric by reflection around the most abundant taxon. Due to tau's greater sensitivity to low abundant taxa, its application to diversity estimation of taxonomic units using taxonomic dependent and independent methods revealed a greater range of values recovered between individuals versus body habitats, and different patterns of diversity within habitats. The greatest range of tau values within and across individuals was found in stool, which also exhibited the most undiscovered taxa. Oral and skin habitats revealed variable diversity patterns, while vaginal habitats were consistently the least diverse. Collectively, these results demonstrate the importance, and motivate the introduction, of several visualization and analysis methods tuned specifically for next-generation sequence data, further revealing that low abundant taxa serve as an important reservoir of genetic diversity in the human microbiome.	[Li, Kelvin; Bihan, Monika; Yooseph, Shibu; Methe, Barbara A.] J Craig Venter Inst, Rockville, MD USA	J. Craig Venter Institute	Li, K (corresponding author), J Craig Venter Inst, Rockville, MD USA.	bmethe@jcvi.org	Bihan, Monika/C-7469-2014	Yooseph, Shibu/0000-0001-5581-5002	National Institute of Allergy and Infectious Diseases [AI084844]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI084844] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a grant from the National Institute of Allergy and Infectious Diseases #AI084844. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; [Anonymous], 1958, STAT EXTREMES, DOI DOI 10.7312/GUMB92958; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Belda-Ferre P, 2012, ISME J, V6, P46, DOI 10.1038/ismej.2011.85; BULMER MG, 1974, BIOMETRICS, V30, P101, DOI 10.2307/2529621; Bunge J, 2011, BIOCOMPUT-PAC SYM, P121; Campbell BJ, 2010, ENVIRON MICROBIOL, V12, P1842, DOI 10.1111/j.1462-2920.2010.02189.x; Caporaso JG, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r50; Cilia V, 1996, MOL BIOL EVOL, V13, P451, DOI 10.1093/oxfordjournals.molbev.a025606; CLAYTON RA, 1995, INT J SYST BACTERIOL, V45, P595, DOI 10.1099/00207713-45-3-595; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Crielaard W, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-22; DeSantis TZ, 2006, NUCLEIC ACIDS RES, V34, pW394, DOI 10.1093/nar/gkl244; Fortunato CS, 2011, MICROB ECOL, V62, P374, DOI 10.1007/s00248-011-9805-z; Gilbert JA, 2012, ISME J, V6, P298, DOI 10.1038/ismej.2011.107; GOOD IJ, 1956, BIOMETRIKA, V43, P45; Goodman AL, 2010, CELL METAB, V12, P111, DOI 10.1016/j.cmet.2010.07.001; Gottel NR, 2011, APPL ENVIRON MICROB, V77, P5934, DOI 10.1128/AEM.05255-11; HILL MO, 1973, ECOLOGY, V54, P427, DOI 10.2307/1934352; Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213; Lozupone CA, 2008, FEMS MICROBIOL REV, V32, P557, DOI 10.1111/j.1574-6976.2008.00111.x; Mager DL, 2003, J CLIN PERIODONTOL, V30, P644, DOI 10.1034/j.1600-051X.2003.00376.x; Mirmonsef P, 2011, AM J REPROD IMMUNOL, V65, P190, DOI 10.1111/j.1600-0897.2010.00943.x; Morales SE, 2009, APPL ENVIRON MICROB, V75, P668, DOI 10.1128/AEM.01757-08; Myshrall KL, 2010, GEOBIOLOGY, V8, P337, DOI 10.1111/j.1472-4669.2010.00245.x; Nasidze I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023352; Ordovas JM, 2006, CURR OPIN LIPIDOL, V17, P157, DOI 10.1097/01.mol.0000217897.75068.ba; Peterson J, 2009, GENOME RES, V19, P2317, DOI 10.1101/gr.096651.109; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Ramos-Padron E, 2011, ENVIRON SCI TECHNOL, V45, P439, DOI 10.1021/es1028487; Rappe MS, 2003, ANNU REV MICROBIOL, V57, P369, DOI 10.1146/annurev.micro.57.030502.090759; Renyi A, 1961, P 4 BERK S MATH STAT, V1; Roling WFM, 2010, CURR OPIN BIOTECH, V21, P532, DOI 10.1016/j.copbio.2010.06.007; Schloss PD, 2011, APPL ENVIRON MICROB, V77, P3219, DOI 10.1128/AEM.02810-10; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Tamhane AC, 2000, STAT DATA ANAL ELEME; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wasserman L., 2004, ALL STAT CONCISE COU, V26	38	118	126	1	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e32118	10.1371/journal.pone.0032118	http://dx.doi.org/10.1371/journal.pone.0032118			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22719823	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341900006
J	Reinhardt, JD; von Elm, E; Fekete, C; Siegrist, J				Reinhardt, Jan D.; von Elm, Erik; Fekete, Christine; Siegrist, Johannes			Social Inequalities of Functioning and Perceived Health in Switzerland-A Representative Cross-Sectional Analysis	PLOS ONE			English	Article							INTERNATIONAL CLASSIFICATION; DISABILITY; OUTCOMES; MODELS	Many people worldwide live with a disability, i.e. limitations in functioning. The prevalence is expected to increase due to demographic change and the growing importance of non-communicable disease and injury. To date, many epidemiological studies have used simple dichotomous measures of disability, even though the WHO's International Classification of Functioning, Disability, and Health (ICF) provides a multi-dimensional framework of functioning. We aimed to examine associations of socio-economic status (SES) and social integration in 3 core domains of functioning (impairment, pain, limitations in activity and participation) and perceived health. We conducted a secondary analysis of representative cross-sectional data of the Swiss Health Survey 2007 including 10,336 female and 8,424 male Swiss residents aged 15 or more. Guided by a theoretical ICF-based model, 4 mixed effects Poisson regressions were fitted in order to explain functioning and perceived health by indicators of SES and social integration. Analyses were stratified by age groups (15-30, 31-54, >= 55 years). In all age groups, SES and social integration were significantly associated with functional and perceived health. Among the functional domains, impairment and pain were closely related, and both were associated with limitations in activity and participation. SES, social integration and functioning were related to perceived health. We found pronounced social inequalities in functioning and perceived health, supporting our theoretical model. Social factors play a significant role in the experience of health, even in a wealthy country such as Switzerland. These findings await confirmation in other, particularly lower resourced settings.	[Reinhardt, Jan D.; Fekete, Christine] Swiss Parapleg Res SPF, Nottwil, Switzerland; [Reinhardt, Jan D.] Univ Lucerne, Dept Hlth Sci & Hlth Policy, Luzern, Switzerland; [von Elm, Erik] Univ Lausanne, Inst Social & Prevent Med, Lausanne, Switzerland; [Siegrist, Johannes] Univ Dusseldorf, Inst Med Sociol, D-40225 Dusseldorf, Germany	Swiss Paraplegic Research; University of Lucerne; University of Lausanne; Heinrich Heine University Dusseldorf	Reinhardt, JD (corresponding author), Swiss Parapleg Res SPF, Nottwil, Switzerland.	jan.reinhardt@paranet.ch	Siegrist, Johannes/AAL-6814-2021	Siegrist, Johannes/0000-0002-7530-4178; Fekete, Christine/0000-0002-3753-3017; von Elm, Erik/0000-0002-7412-0406				Altmets K, 2011, EUR J PUBLIC HEALTH, V21, P49, DOI 10.1093/eurpub/ckp239; [Anonymous], 1984, DISTINCTION SOCIAL C; Bickenbach JE, 1999, SOC SCI MED, V48, P1173, DOI 10.1016/S0277-9536(98)00441-9; Black D, 1982, INEQUALITIES HLTH BL; Brekke M, 2002, SOC SCI MED, V54, P221, DOI 10.1016/S0277-9536(01)00018-1; Dale C, 2012, J EPIDEMIOL COMMUN H, V66, P170, DOI 10.1136/jech-2011-200078; Dans A, 2011, LANCET, V377, P680, DOI 10.1016/S0140-6736(10)61506-1; Fellinghauer B, 2012, COMPUTATION IN PRESS; Gould W, 2001, PSEUDO R2 PROBIT; Graf E, 2010, RAPPORT METHODES ENQ; Hagenaars A., 1994, POVERTY STAT LATE 19; Huisman M, 2003, SOC SCI MED, V57, P861, DOI 10.1016/S0277-9536(02)00454-9; Huwiler K, 2002, SCHWEIZERISCHE GESUN; Kolenikov S, 2009, STATA J, V9, P329, DOI 10.1177/1536867X0900900301; Koukouli S, 2002, BMC HEALTH SERV RES, V2, DOI 10.1186/1472-6963-2-20; Lafortune G., 2007, TRENDS SEVERE DISABI; Minkler M, 2006, NEW ENGL J MED, V355, P695, DOI 10.1056/NEJMsa044316; Nilsson CJ, 2010, ARCH GERONTOL GERIAT, V51, P152, DOI 10.1016/j.archger.2009.09.043; OECD, 2017, OECD REV HLTH SYSTEM, DOI [10.1787/9789264269453-en, DOI 10.1787/146D0DEA-EN, 10.1787/9789264120914-en]; Phalkey R, 2011, GLOBAL HEALTH ACTION, V4, DOI [10.3402/gha.v4i0.7196, 10.3402/gha.v4i0.7191]; Rabe-Hesketh S., 2008, MULTILEVEL LONGITUDI; Ramsay SE, 2008, ANN EPIDEMIOL, V18, P896, DOI 10.1016/j.annepidem.2008.09.006; Rautio N, 2005, SOC SCI MED, V60, P2405, DOI 10.1016/j.socscimed.2004.11.029; Reinhardt JD, 2011, INT J PUBLIC HEALTH, V56, P341, DOI 10.1007/s00038-010-0222-8; Reinhardt JD, 2010, DISABIL REHABIL, V32, P1000, DOI 10.3109/09638281003775410; Sandel ME, 2010, PM&R, V2, P881, DOI 10.1016/j.pmrj.2010.08.012; Schoeni RF, 2005, AM J PUBLIC HEALTH, V95, P2065, DOI 10.2105/AJPH.2004.048744; Sharma BR, 2008, PUBLIC HEALTH, V122, P1399, DOI 10.1016/j.puhe.2008.06.009; Skrondal A., 2004, GEN LATENT VARIABLE; StataCorp LP, 2006, STAT 12 HELP MARG; Stekhoven DJ, 2011, BIOINFORMATICS; UNESCO, 2006, INT STAND CLASS ED I; United Nations Convention on the Rights of Persons with Disabilities (UNCRPD), 2006, CONV RIGHTS PERS DIS; United Nations Statstics Division, 2010, WASH GROUP DIS STAT; Wang PP, 2006, DISABIL REHABIL, V28, P135, DOI 10.1080/09638280500167761; WHO, 2011, WORLD REPORT ON DISABILITY, P1; WILSON IB, 1995, JAMA-J AM MED ASSOC, V273, P59, DOI 10.1001/jama.273.1.59; World Health Organisation (WHO), 2001, INT CLASS FUNCT DIS	38	8	8	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2012	7	6							e38782	10.1371/journal.pone.0038782	http://dx.doi.org/10.1371/journal.pone.0038782			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UJ	22701713	Green Published, Green Submitted, gold			2022-12-27	WOS:000305340000044
J	Anamika, K; Gyenis, A; Poidevin, L; Poch, O; Tora, L				Anamika, Krishanpal; Gyenis, Akos; Poidevin, Laetitia; Poch, Olivier; Tora, Laszlo			RNA Polymerase II Pausing Downstream of Core Histone Genes Is Different from Genes Producing Polyadenylated Transcripts	PLOS ONE			English	Article							PRE-MESSENGER-RNA; HUMAN-COMPLEMENT GENES; POLY(A) SIGNAL; 3' END; C-MYC; DROSOPHILA-MELANOGASTER; TERMINATION MACHINERIES; PROCESSING FACTORS; EXONUCLEASE XRN2; NUCLEAR-RNA	Recent genome-wide chromatin immunoprecipitation coupled high throughput sequencing (ChIP-seq) analyses performed in various eukaryotic organisms, analysed RNA Polymerase II (Pol II) pausing around the transcription start sites of genes. In this study we have further investigated genome-wide binding of Pol II downstream of the 3' end of the annotated genes (EAGs) by ChIP-seq in human cells. At almost all expressed genes we observed Pol II occupancy downstream of the EAGs suggesting that Pol II pausing 39 from the transcription units is a rather common phenomenon. Downstream of EAGs Pol II transcripts can also be detected by global run-on and sequencing, suggesting the presence of functionally active Pol II. Based on Pol II occupancy downstream of EAGs we could distinguish distinct clusters of Pol II pause patterns. On core histone genes, coding for non-polyadenylated transcripts, Pol II occupancy is quickly dropping after the EAG. In contrast, on genes, whose transcripts undergo polyA tail addition [poly(A)(+)], Pol II occupancy downstream of the EAGs can be detected up to 4-6 kb. Inhibition of polyadenylation significantly increased Pol II occupancy downstream of EAGs at poly(A)(+) genes, but not at the EAGs of core histone genes. The differential genome-wide Pol II occupancy profiles 3' of the EAGs have also been confirmed in mouse embryonic stem (mES) cells, indicating that Pol II pauses genome-wide downstream of the EAGs in mammalian cells. Moreover, in mES cells the sharp drop of Pol II signal at the EAG of core histone genes seems to be independent of the phosphorylation status of the C-terminal domain of the large subunit of Pol II. Thus, our study uncovers a potential link between different mRNA 39 end processing mechanisms and consequent Pol II transcription termination processes.	[Anamika, Krishanpal; Gyenis, Akos; Tora, Laszlo] Univ Strasbourg, Dept Funct Genom & Canc, Inst Genet & Biol Mol & Cellulaire IGBMC, CNRS,UMR 7104,INSERM,U964, Illkirch Graffenstaden, France; [Anamika, Krishanpal; Poidevin, Laetitia; Poch, Olivier] Univ Strasbourg, Dept Struct Biol & Genom, Inst Genet & Biol Mol & Cellulaire IGBMC, CNRS,UMR 7104,INSERM,U964, Illkirch Graffenstaden, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Anamika, K (corresponding author), Univ Strasbourg, Dept Funct Genom & Canc, Inst Genet & Biol Mol & Cellulaire IGBMC, CNRS,UMR 7104,INSERM,U964, Illkirch Graffenstaden, France.	laszlo@igbmc.fr	Tora, Laszlo/E-9999-2018	Tora, Laszlo/0000-0001-7398-2250; Gyenis, Akos/0000-0002-8104-7681	Fondation pour la Recherche Medicale (FRM) France; EU (European Transcriptome Regulome & Cellular Commitment Consortium EUTRACC) [LSHG-CT-2007-037445, EPIDIACAN]; SkinChroma-CNRS; Institut National du Cancer (INCA); Agence nationale de la recherche [ANR-09-BLAN-0266]	Fondation pour la Recherche Medicale (FRM) France(Fondation pour la Recherche Medicale); EU (European Transcriptome Regulome & Cellular Commitment Consortium EUTRACC); SkinChroma-CNRS; Institut National du Cancer (INCA)(Institut National du Cancer (INCA) France); Agence nationale de la recherche(French National Research Agency (ANR))	AG is supported by a fellowship from Fondation pour la Recherche Medicale (FRM) France. This work was supported by grants from the EU (European Transcriptome Regulome & Cellular Commitment Consortium EUTRACC, LSHG-CT-2007-037445 and EPIDIACAN), SkinChroma-CNRS and the Institut National du Cancer (INCA; 2008 Ubican) to LT and Agence nationale de la recherche (ANR-09-BLAN-0266) to LT and OP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHFIELD R, 1994, EMBO J, V13, P5656, DOI 10.1002/j.1460-2075.1994.tb06904.x; ASHFIELD R, 1991, EMBO J, V10, P4197, DOI 10.1002/j.1460-2075.1991.tb04998.x; Bentley DL, 2005, CURR OPIN CELL BIOL, V17, P251, DOI 10.1016/j.ceb.2005.04.006; Brookes E, 2012, CELL STEM CELL, V10, P157, DOI 10.1016/j.stem.2011.12.017; Buratowski S, 2005, CURR OPIN CELL BIOL, V17, P257, DOI 10.1016/j.ceb.2005.04.003; Calvo O, 2001, MOL CELL, V7, P1013, DOI 10.1016/S1097-2765(01)00236-2; CHODCHOY N, 1991, MOL CELL BIOL, V11, P497, DOI 10.1128/MCB.11.1.497; CONNELLY S, 1988, GENE DEV, V2, P440, DOI 10.1101/gad.2.4.440; Core LJ, 2008, SCIENCE, V319, P1791, DOI 10.1126/science.1150843; Dantonel JC, 1997, NATURE, V389, P399, DOI 10.1038/38763; Dominski Z, 1999, GENE, V239, P1, DOI 10.1016/S0378-1119(99)00367-4; Dominski Z, 2007, GENE, V396, P373, DOI 10.1016/j.gene.2007.04.021; Dye MJ, 2001, CELL, V105, P669, DOI 10.1016/S0092-8674(01)00372-5; Dye MJ, 1999, MOL CELL, V3, P371, DOI 10.1016/S1097-2765(00)80464-5; El Kaderi B, 2009, J BIOL CHEM, V284, P25015, DOI 10.1074/jbc.M109.007948; ENRIQUEZHARRIS P, 1991, EMBO J, V10, P1833, DOI 10.1002/j.1460-2075.1991.tb07709.x; Eskiw CH, 2011, J CELL SCI, V124, P3676, DOI 10.1242/jcs.087981; GICK O, 1986, EMBO J, V5, P1319, DOI 10.1002/j.1460-2075.1986.tb04362.x; Glover-Cutter K, 2008, NAT STRUCT MOL BIOL, V15, P71, DOI 10.1038/nsmb1352; Glover-Cutter K, 2009, MOL CELL BIOL, V29, P5455, DOI 10.1128/MCB.00637-09; Gromak N, 2006, MOL CELL BIOL, V26, P3986, DOI 10.1128/MCB.26.10.3986-3996.2006; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; HAGENBUCHLE O, 1984, CELL, V38, P737, DOI 10.1016/0092-8674(84)90269-1; Hah N, 2011, CELL, V145, P622, DOI 10.1016/j.cell.2011.03.042; Hampsey M, 2011, ADV ENZYME REGUL, V51, P118, DOI 10.1016/j.advenzreg.2010.10.001; Hochheimer A, 2003, GENE DEV, V17, P1309, DOI 10.1101/gad.1099903; Ioannidis P, 1999, ONCOGENE, V18, P117, DOI 10.1038/sj.onc.1202255; Kaneko S, 2007, GENE DEV, V21, P1779, DOI 10.1101/gad.1565207; Kazerouninia A, 2010, RNA, V16, P197, DOI 10.1261/rna.1622010; Kim M, 2004, NATURE, V432, P517, DOI 10.1038/nature03041; Krishnamurthy S, 2009, MOL CELL BIOL, V29, P2925, DOI 10.1128/MCB.01655-08; Lee CY, 2008, MOL CELL BIOL, V28, P3290, DOI 10.1128/MCB.02224-07; Lian Z, 2008, GENOME RES, V18, P1224, DOI 10.1101/gr.075804.107; Lis J, 1998, COLD SPRING HARB SYM, V63, P347, DOI 10.1101/sqb.1998.63.347; LOGAN J, 1987, P NATL ACAD SCI USA, V84, P8306, DOI 10.1073/pnas.84.23.8306; Luo WF, 2006, GENE DEV, V20, P954, DOI 10.1101/gad.1409106; Lykke-Andersen S, 2011, CELL CYCLE, V10, P863, DOI 10.4161/cc.10.6.14931; Mapendano CK, 2010, MOL CELL, V40, P410, DOI 10.1016/j.molcel.2010.10.012; Marzluff WF, 2008, NAT REV GENET, V9, P843, DOI 10.1038/nrg2438; Mukundan B, 2011, J BIOL CHEM, V286, P37053, DOI 10.1074/jbc.C111.295915; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; Nag A, 2006, RNA, V12, P1534, DOI 10.1261/rna.103206; Nechaev S, 2010, SCIENCE, V327, P335, DOI 10.1126/science.1181421; Neugebauer KM, 2002, J CELL SCI, V115, P3865, DOI 10.1242/jcs.00073; Orozco IJ, 2002, J BIOL CHEM, V277, P42899, DOI 10.1074/jbc.M207415200; Orphanides G, 1996, GENE DEV, V10, P2657, DOI 10.1101/gad.10.21.2657; Park NJ, 2004, MOL CELL BIOL, V24, P4092, DOI 10.1128/MCB.24.10.4092-4103.2004; Proudfoot N, 2004, CURR OPIN CELL BIOL, V16, P272, DOI 10.1016/j.ceb.2004.03.007; Proudfoot NJ, 2011, GENE DEV, V25, P1770, DOI 10.1101/gad.17268411; Proudfoot NJ, 2002, CELL, V108, P501, DOI 10.1016/S0092-8674(02)00617-7; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Ptashne M, 1997, NATURE, V386, P569, DOI 10.1038/386569a0; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Richard P, 2009, GENE DEV, V23, P1247, DOI 10.1101/gad.1792809; ROUGVIE AE, 1988, CELL, V54, P795, DOI 10.1016/S0092-8674(88)91087-2; SCHAUFELE F, 1986, NATURE, V323, P777, DOI 10.1038/323777a0; SCHUMPERLI D, 1988, TRENDS GENET, V4, P187, DOI 10.1016/0168-9525(88)90074-1; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Skourti-Stathaki K, 2011, MOL CELL, V42, P794, DOI 10.1016/j.molcel.2011.04.026; Spies N, 2009, MOL CELL, V36, P245, DOI 10.1016/j.molcel.2009.10.008; Sullivan KD, 2009, MOL CELL, V34, P322, DOI 10.1016/j.molcel.2009.04.024; TANTRAVAHI J, 1993, MOL CELL BIOL, V13, P578, DOI 10.1128/MCB.13.1.578; Tran DP, 2001, MOL CELL BIOL, V21, P7495, DOI 10.1128/MCB.21.21.7495-7508.2001; Wang YM, 2010, CURR BIOL, V20, P548, DOI 10.1016/j.cub.2010.01.052; West S, 2004, NATURE, V432, P522, DOI 10.1038/nature03035; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Ye T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1287; Yonaha M, 1999, MOL CELL, V3, P593, DOI 10.1016/S1097-2765(00)80352-4; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475	70	36	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2012	7	6							e38769	10.1371/journal.pone.0038769	http://dx.doi.org/10.1371/journal.pone.0038769			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TU	22701709	gold, Green Published, Green Submitted			2022-12-27	WOS:000305337600042
J	Andrews, J; D'Aguiar, C; Pruessner, JC				Andrews, Julie; D'Aguiar, Catherine; Pruessner, Jens C.			The Combined Dexamethasone/TSST Paradigm - A New Method for Psychoneuroendocrinology	PLOS ONE			English	Article							SALIVARY ALPHA-AMYLASE; RAT-BRAIN; CORTISOL RESPONSES; STRESS RESPONSES; HEART-RATE; GLUCOCORTICOIDS; RECEPTOR; SYSTEM; SUPPRESSION; DISORDERS	The two main physiological systems involved in the regulation of the stress response are the hypothalamus-pituitary-adrenal (HPA) axis and the sympathetic nervous system (SNS). However, the interaction of these systems on the stress response remains poorly understood. To better understand the cross-regulatory effects of the different systems involved in stress regulation, we developed a new stress paradigm that keeps the activity of the HPA constant when exposing subjects to psychosocial stress. Thirty healthy male participants were recruited and randomly assigned to either a dexamethasone (DEX; n = 15) or placebo (PLC; n = 15) group. All subjects were instructed to take the Dexamethasone (2 mg) or Placebo pill the night before coming to the laboratory to undergo the Trier Social Stress Task (TSST). Salivary cortisol, salivary alpha amylase (sAA), heart rate, blood pressure and subjective stress were assessed throughout the protocol. As expected, the DEX group presented with suppressed cortisol levels. In comparison, their heart rate was elevated by approximately ten base points compared to the PLC group, with increases throughout the protocol and during the TSST. Neither sAA, nor systolic or diastolic blood pressures showed significant group differences. Subjective stress levels significantly increased from baseline, and were found to be higher before and after the TSST after DEX compared to placebo. These results demonstrate a significant interaction between the HPA and the SNS during acute stress. The SNS activity was found to be elevated in the presence of a suppressed HPA axis, with some further effects on subjective levels of stress. The method to suppress the HPA prior to inducing stress was found to completely reliable, without any adverse side effects. Therefore, we propose this paradigm as a new method to investigate the interaction of the two major stress systems in the regulation of the stress response.	[Andrews, Julie] McGill Univ, Douglas Mental Hlth Univ Inst, Montreal, PQ, Canada; [D'Aguiar, Catherine; Pruessner, Jens C.] McGill Univ, Fac Med, McGill Ctr Studies Aging, Montreal, PQ, Canada	McGill University; McGill University	Andrews, J (corresponding author), McGill Univ, Douglas Mental Hlth Univ Inst, Montreal, PQ, Canada.	jens.pruessner@mcgill.ca		Pruessner, Jens/0000-0002-8582-2980	Canadian Institute of Health Research (CIHR); Natural Sciences and Engineering Research Council of Canada (NSERC)	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This study was funded by grants from The Canadian Institute of Health Research (CIHR) and Natural Sciences and Engineering Research Council of Canada (NSERC) to Dr. Jens C. Pruessner. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXIS MN, 1983, J BIOL CHEM, V258, P4710; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Bosch JA, 2011, PSYCHONEUROENDOCRINO, V36, P449, DOI 10.1016/j.psyneuen.2010.12.019; Brotman DJ, 2005, J CLIN ENDOCR METAB, V90, P3202, DOI 10.1210/jc.2004-2379; CARVER CS, 1989, J PERS SOC PSYCHOL, V56, P267, DOI 10.1037/0022-3514.56.2.267; Chrousos GP, 2009, NAT REV ENDOCRINOL, V5, P374, DOI 10.1038/nrendo.2009.106; CHROUSOS GP, 1992, JAMA-J AM MED ASSOC, V267, P1244, DOI 10.1001/jama.267.9.1244; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cole MA, 2000, PSYCHONEUROENDOCRINO, V25, P151, DOI 10.1016/S0306-4530(99)00045-1; Dallman MF, 2006, PROG BRAIN RES, V153, P75, DOI 10.1016/S0079-6123(06)53004-3; DEKLOET ER, 1974, ENDOCRINOLOGY, V94, P61, DOI 10.1210/endo-94-1-61; DEKLOET R, 1975, ENDOCRINOLOGY, V96, P598, DOI 10.1210/endo-96-3-598; Dickerson SS, 2004, PSYCHOL BULL, V130, P355, DOI 10.1037/0033-2909.130.3.355; DRESSENDORFER RA, 1992, J STEROID BIOCHEM, V43, P683, DOI 10.1016/0960-0760(92)90294-S; Engert V, 2011, PSYCHONEUROENDOCRINO, V36, P1294, DOI 10.1016/j.psyneuen.2011.02.018; Engert V, 2010, J PSYCHIATR NEUROSCI, V35, P370, DOI 10.1503/jpn.100022; Foley P, 2010, NEUROSCI BIOBEHAV R, V35, P91, DOI 10.1016/j.neubiorev.2010.01.010; Gaab J, 2005, PSYCHONEUROENDOCRINO, V30, P599, DOI 10.1016/j.psyneuen.2005.02.001; Granger DA, 2007, ANN NY ACAD SCI, V1098, P122, DOI 10.1196/annals.1384.008; Hellhammer J, 2011, PSYCHONEUROENDOCRINO; Karssen AM, 2005, ENDOCRINOLOGY, V146, P5587, DOI 10.1210/en.2005-0501; KIRSCHBAUM C, 1993, NEUROPSYCHOBIOLOGY, V28, P76, DOI 10.1159/000119004; KIRSCHBAUM C, 1989, NEUROPSYCHOBIOLOGY, V22, P150, DOI 10.1159/000118611; KIRSCHBAUM C, 1995, PSYCHOSOM MED, V57, P468, DOI 10.1097/00006842-199509000-00009; Krampen G, 1991, COMPETENCE CONTROL Q; LEARY MR, 1983, PERS SOC PSYCHOL B, V9, P371, DOI 10.1177/0146167283093007; LEUNG K, 1975, ANNU REV PHYSIOL, V37, P245, DOI 10.1146/annurev.ph.37.030175.001333; Maheu FS, 2005, J CLIN ENDOCR METAB, V90, P1697, DOI 10.1210/jc.2004-0009; MILLER AH, 1992, BIOL PSYCHIAT, V32, P850, DOI 10.1016/0006-3223(92)90175-Y; Nater UM, 2009, PSYCHONEUROENDOCRINO, V34, P486, DOI 10.1016/j.psyneuen.2009.01.014; Nater UM, 2006, PSYCHONEUROENDOCRINO, V31, P49, DOI 10.1016/j.psyneuen.2005.05.010; Palatini P, 1997, J HYPERTENS, V15, P3, DOI 10.1097/00004872-199715010-00001; PARKER G, 1979, BRIT J PSYCHIAT, V134, P138, DOI 10.1192/bjp.134.2.138; Pruessner JC, 2005, NEUROIMAGE, V28, P815, DOI 10.1016/j.neuroimage.2005.06.014; Rosenberg M., 1965, SOC ADOLESCENT SELF, DOI 10.1515/9781400876136; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Schommer NC, 2003, PSYCHOSOM MED, V65, P450, DOI 10.1097/01.PSY.0000035721.12441.17; Seckl JR, 2004, ANN NY ACAD SCI, V1032, P63, DOI 10.1196/annals.1314.006; Strohmayer EA, 2011, ENDOCRIN METAB CLIN, V40, P409, DOI 10.1016/j.ecl.2011.01.011; Suzuki T, 2003, MICROSC RES TECHNIQ, V60, P76, DOI 10.1002/jemt.10246; Tjugen TB, 2010, CURR HYPERTENS REP, V12, P162, DOI 10.1007/s11906-010-0104-8; Yamaguchi N, 2009, AUTON NEUROSCI-BASIC, V151, P82, DOI 10.1016/j.autneu.2009.06.009	42	29	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2012	7	6							e38994	10.1371/journal.pone.0038994	http://dx.doi.org/10.1371/journal.pone.0038994			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TU	22701740	gold, Green Published, Green Submitted			2022-12-27	WOS:000305337600064
J	Chandonnet, N; Saey, D; Almeras, N; Marc, I				Chandonnet, Nadia; Saey, Didier; Almeras, Natalie; Marc, Isabelle			French Pregnancy Physical Activity Questionnaire Compared with an Accelerometer Cut Point to Classify Physical Activity among Pregnant Obese Women	PLOS ONE			English	Article							ENERGY-EXPENDITURE; EXERCISE; VALIDATION; VALIDITY; CALIBRATION; ACTIGRAPH; MONITOR; WEIGHT; BIRTH	Given the high risk for inactivity during pregnancy in obese women, validated questionnaires for physical activity (PA) assessment in this specific population is required before evaluating the effect of PA on perinatal outcomes. No questionnaire was validated in pregnant obese women. The Pregnancy Physical Activity Questionnaire (PPAQ) has been designed based on activities reported during pregnancy and validated in pregnant women. We translated the PPAQ to French and assessed reliability and accuracy of this French version among pregnant obese women. In this cross-sectional study, pregnant obese women were evenly recruited at the end of each trimester of pregnancy. They completed the PPAQ twice, with an interval of 7 days in-between, to recall PA of the last three months. Between PPAQ assessments, participants wore an accelerometer (Actigraph GT1M) during 7 consecutive days. Fourty-nine (49) pregnant obese women (29.8 +/- 4.2 yrs, 34.7 +/- 5.1 kg.m(-2)) participated to the study. The intraclass correlation coefficients (ICCs) between the two PPAQ assessments were 0.90 for total activity, 0.86 for light and for moderate intensity, and 0.81 for vigorous intensity activities. It ranged from 0.59 for "Transportation'' to 0.89 for "Household and Caregiving'' activities. Spearman correlation coefficients (SCCs) between the PPAQ and the Matthews' cut point used to classify an activity of moderate and above intensity were 0.50 for total activity, 0.25 for vigorous intensity and 0.40 for moderate intensity. The correlations between the PPAQ and the accelerometer counts were 0.58 for total activity, 0.39 for vigorous intensity and 0.49 for moderate intensity. The highest SCCs were for "Occupation'' and "Household and Caregiving'' activities. Comparisons with other standard cutpoints were presented in files S1, S2, S3, S4, S5, S6, S7. The PPAQ is reliable and moderately accurate for the measure of PA of various intensities and types among pregnant obese women.	[Chandonnet, Nadia; Marc, Isabelle] Univ Laval, Ctr Hosp Univ Quebec, Res Ctr, Dept Paediat, Quebec City, PQ, Canada; [Saey, Didier] Univ Laval, Fac Med, Rehabil Dept, Quebec City, PQ G1K 7P4, Canada; [Saey, Didier; Almeras, Natalie] Univ Laval, Inst Univ Cardiol & Pneumol Quebec, Res Ctr, Quebec City, PQ, Canada	Laval University; Laval University; Laval University	Chandonnet, N (corresponding author), Univ Laval, Ctr Hosp Univ Quebec, Res Ctr, Dept Paediat, Quebec City, PQ, Canada.	isabelle.marc@crchul.ulaval.ca	Saey, Didier/F-7963-2014	Marc, Isabelle/0000-0001-6060-8550	Fondation des Etoiles, Quebec, Canada [F45641]; Canadian Institute of Health Research (CIHR)-Quebec Training Network in Perinatal Research (QTNPR), Canada [TGF53899]; Fonds de recherche en sante du Quebec (FRSQ), Canada [22510]	Fondation des Etoiles, Quebec, Canada; Canadian Institute of Health Research (CIHR)-Quebec Training Network in Perinatal Research (QTNPR), Canada(Canadian Institutes of Health Research (CIHR)); Fonds de recherche en sante du Quebec (FRSQ), Canada	This research was supported by a grant from the Fondation des Etoiles, Quebec, Canada, to Isabelle Marc grant #F45641, http://www.fondationdesetoiles.ca/.N.Chandonnet is a recipient of a MSc grant #TGF53899 from the Canadian Institute of Health Research (CIHR)-Quebec Training Network in Perinatal Research (QTNPR), Canada www.qtnpr.ca/ .I. Marc, clinician researcher, is a scholar from the Fonds de recherche en sante du Quebec (FRSQ) #22510, Canada www.frsq.gouv.qc.ca/ The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth BE, 2000, MED SCI SPORT EXER, V32, P1327, DOI 10.1097/00005768-200007000-00022; Borodulin KM, 2008, MED SCI SPORT EXER, V40, P1901, DOI 10.1249/MSS.0b013e31817f1957; Cai ZJ, 1999, WHO TECH REP SER, V887, P1; Caspersen CJ, 2008, MED SCI SPORT EXER, V40, pS519, DOI 10.1249/MSS.0b013e31817c6737; Chasan-Taber L, 2004, MED SCI SPORT EXER, V36, P1750, DOI 10.1249/01.MSS.0000142303.49306.0D; Chasan-Taber L, 2007, WOMEN HEALTH, V45, P85, DOI 10.1300/J013v45n04_05; Clapp James F. III, 2006, Metabolic Syndrome and Related Disorders, V4, P84, DOI 10.1089/met.2006.4.84; Comm Obstetric Practice, 2002, INT J GYNECOL OBSTET, V77, P79; Evenson KR, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-21; Freedson PS, 1998, MED SCI SPORT EXER, V30, P777, DOI 10.1097/00005768-199805000-00021; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; Gavard JA, 2008, CLIN OBSTET GYNECOL, V51, P467, DOI 10.1097/GRF.0b013e31816feb1d; Guelinckx I, 2010, AM J CLIN NUTR, V91, P373, DOI 10.3945/ajcn.2009.28166; Haakstad LAH, 2010, ACTA OBSTET GYN SCAN, V89, P749, DOI 10.3109/00016349.2010.484482; Harrison CL, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-19; Hendelman D, 2000, MED SCI SPORT EXER, V32, pS442, DOI 10.1097/00005768-200009001-00002; JACOBS DR, 1993, MED SCI SPORT EXER, V25, P81, DOI 10.1249/00005768-199301000-00012; Johnson RK, 1998, INT J OBESITY, V22, P1046, DOI 10.1038/sj.ijo.0800723; Juhl M, 2008, AM J EPIDEMIOL, V167, P859, DOI 10.1093/aje/kwm364; Kozey SL, 2010, MED SCI SPORT EXER, V42, P971, DOI 10.1249/MSS.0b013e3181c29e90; Kramer MS, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000180.pub2; Masse LC, 2004, J APPL PHYSIOL, V96, P1357, DOI 10.1152/japplphysiol.00901.2003; Matsuzaki M, 2010, BIOSCI TRENDS, V4, P170; Matthews CE, 2005, MED SCI SPORT EXER, V37, pS512, DOI 10.1249/01.mss.0000185659.11982.3d; Matthews CE, 2012, MED SCI SPORT EXER, V44, pS68, DOI 10.1249/MSS.0b013e3182399e5b; Melzer K, 2004, CURR OPIN CLIN NUTR, V7, P641, DOI 10.1097/00075197-200411000-00009; Montoye HJ, 1996, MEASURING PHYS ACTIV; Mottola Michelle F, 2007, Curr Sports Med Rep, V6, P381, DOI 10.1007/s11932-007-0056-1; *NAT AC SCI I MED, 1990, NUTR PREGN; Ota Erika, 2008, Southeast Asian Journal of Tropical Medicine and Public Health, V39, P562; Owe KM, 2009, SCAND J MED SCI SPOR, V19, P637, DOI 10.1111/j.1600-0838.2008.00840.x; Poudevigne MS, 2006, SPORTS MED, V36, P19, DOI 10.2165/00007256-200636010-00003; Rasmussen KM, 2009, WEIGHT GAIN DURING PREGNANCY: REEXAMINING THE GUIDELINES, P1; Schmidt MD, 2006, MED SCI SPORT EXER, V38, P42, DOI 10.1249/01.mss.0000181301.07516.d6; Swartz AM, 2000, MED SCI SPORT EXER, V32, pS450, DOI 10.1097/00005768-200009001-00003; US Department of Health and Human Services, 2008, PHYS ACT GUID AM; Welk GJ, 2007, OBESITY, V15, P918, DOI 10.1038/oby.2007.624; World Health Organization, 2000, WHO TECH REP SER, V894, p[i, 1]; Zavorsky GS, 2011, SPORTS MED, V41, P345, DOI 10.2165/11583930-000000000-00000	39	60	60	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2012	7	6							e38818	10.1371/journal.pone.0038818	http://dx.doi.org/10.1371/journal.pone.0038818			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TU	22701717	Green Published, gold, Green Submitted			2022-12-27	WOS:000305337600046
J	Sharmin, S; Guan, HY; Williams, AS; Yang, KP				Sharmin, Saina; Guan, Haiyan; Williams, Andrew Scott; Yang, Kaiping			Caffeine Reduces 11 beta-Hydroxysteroid Dehydrogenase Type 2 Expression in Human Trophoblast Cells through the Adenosine A(2B) Receptor	PLOS ONE			English	Article							INTRAUTERINE GROWTH RESTRICTION; DEVELOPMENTAL ORIGINS; UMBILICAL-CORD; MESSENGER-RNA; METABOLITES; CONSUMPTION; PREGNANCY; EXPOSURE; BLOOD; DIFFERENTIATION	Maternal caffeine consumption is associated with reduced fetal growth, but the underlying molecular mechanisms are unknown. Since there is evidence that decreased placental 11 beta-hydroxysteroid dehydrogenase type 2 (11 beta-HSD2) is linked to fetal growth restriction, we hypothesized that caffeine may inhibit fetal growth partly through down regulating placental 11 beta-HSD2. As a first step in examining this hypothesis, we studied the effects of caffeine on placental 11 beta-HSD2 activity and expression using our established primary human trophoblast cells as an in vitro model system. Given that maternal serum concentrations of paraxanthine (the primary metabolite of caffeine) were greater in women who gave birth to small-forgestational age infants than to appropriately grown infants, we also studied the effects of paraxanthine. Our main findings were: (1) both caffeine and paraxanthine decreased placental 11 beta-HSD2 activity, protein and mRNA in a concentration-dependent manner; (2) this inhibitory effect was mediated by the adenosine A(2B) receptor, since siRNA-mediated knockdown of this receptor prevented caffeine-and paraxanthine-induced inhibition of placental 11 beta-HSD2; and (3) forskolin (an activator of adenyl cyclase and a known stimulator of 11 beta-HSD2) abrogated the inhibitory effects of both caffeine and paraxanthine, which provides evidence for a functional link between exposure to caffeine and paraxanthine, decreased intracellular levels of cAMP and reduced placental 11 beta-HSD2. Taken together, these findings reveal that placental 11 beta-HSD2 is a novel molecular target through which caffeine may adversely affect fetal growth. They also uncover a previously unappreciated role for the adenosine A(2B) receptor signaling in regulating placental 11 beta-HSD2, and consequently fetal development.	[Sharmin, Saina] Univ Western Ontario, Childrens Hlth Res Inst, London, ON, Canada; Univ Western Ontario, Dept Obstet, Lawson Hlth Res Inst, London, ON, Canada; Univ Western Ontario, Dept Gynaecol, Lawson Hlth Res Inst, London, ON, Canada; Univ Western Ontario, Lawson Hlth Res Inst, Dept Physiol, London, ON, Canada; Univ Western Ontario, Lawson Hlth Res Inst, Dept Pharmacol, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Sharmin, S (corresponding author), Univ Western Ontario, Childrens Hlth Res Inst, London, ON, Canada.	kyang@uwo.ca	Williams, Andrew S/AAD-9720-2019	Williams, Andrew S/0000-0001-5287-4496	Canadian Institutes of Health Research [MOP-79484]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Institutes of Health Research (Operating Grant #MOP-79484). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDI F, 1993, XENOBIOTICA, V23, P449, DOI 10.3109/00498259309057033; Bakker R, 2010, AM J CLIN NUTR, V91, P1691, DOI 10.3945/ajcn.2009.28792; Balat O, 2003, Clin Exp Obstet Gynecol, V30, P57; Biaggioni I, 2002, DIABETES CARE, V25, P399, DOI 10.2337/diacare.25.2.399; Boylan S, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2332; Bracken MB, 2003, AM J EPIDEMIOL, V157, P456, DOI 10.1093/aje/kwf220; Brent RL, 2011, BIRTH DEFECTS RES B, V92, P152, DOI 10.1002/bdrb.20288; Brodsky Dara, 2004, J Intensive Care Med, V19, P307, DOI 10.1177/0885066604269663; Cook DG, 1996, BRIT MED J, V313, P1358, DOI 10.1136/bmj.313.7069.1358; Desai M, 2011, SEMIN REPROD MED, V29, P237, DOI 10.1055/s-0031-1275517; Dy J, 2008, PLACENTA, V29, P193, DOI 10.1016/j.placenta.2007.10.010; Fredholm BB, 1999, PHARMACOL REV, V51, P83; Fredholm BB, 2010, EXP CELL RES, V316, P1284, DOI 10.1016/j.yexcr.2010.02.004; Ghidini A, 1996, Obstet Gynecol Surv, V51, P376, DOI 10.1097/00006254-199606000-00023; GILBERT SG, 1991, FUND APPL TOXICOL, V17, P454, DOI 10.1016/0272-0590(91)90197-C; Grosso LM, 2006, AM J EPIDEMIOL, V163, P1035, DOI 10.1093/aje/kwj125; Grosso LM, 2005, ANN EPIDEMIOL, V15, P460, DOI 10.1016/j.annepidem.2004.12.011; Guan HY, 2005, AM J PHYSIOL-ENDOC M, V288, pE663, DOI 10.1152/ajpendo.00461.2004; Hardy DB, 2002, J CLIN ENDOCR METAB, V87, P3696, DOI 10.1210/jc.87.8.3696; Hentges CR, 2010, J PEDIAT-BRAZIL, V86, P137, DOI [10.1590/S0021-75572010000200010, 10.2223/JPED.1990]; Infante-Rivard C, 2007, PAEDIATR PERINAT EP, V21, P300, DOI 10.1111/j.1365-3016.2007.00825.x; Joss-Moore LA, 2009, CURR OPIN PEDIATR, V21, P230, DOI 10.1097/MOP.0b013e328326773b; Kim YH, 2008, REPROD SCI, V15, P939, DOI 10.1177/1933719108322431; KIRKINEN P, 1983, AM J OBSTET GYNECOL, V147, P939, DOI 10.1016/0002-9378(83)90250-8; Klebanoff MA, 2002, AM J EPIDEMIOL, V155, P32, DOI 10.1093/aje/155.1.32; KLIMAN HJ, 1986, ENDOCRINOLOGY, V118, P1567, DOI 10.1210/endo-118-4-1567; Knutti R, 1982, Arch Toxicol Suppl, V5, P187; KROZOWSKI Z, 1995, J CLIN ENDOCR METAB, V80, P2203, DOI 10.1210/jc.80.7.2203; Kuczkowski KM, 2009, ARCH GYNECOL OBSTET, V280, P695, DOI 10.1007/s00404-009-0991-6; Langley-Evans SC, 2010, MED PRIN PRACT, V19, P87, DOI 10.1159/000273066; Mandruzzato G, 2008, J PERINAT MED, V36, P277, DOI 10.1515/JPM.2008.050; McTernan CL, 2001, J CLIN ENDOCR METAB, V86, P4979, DOI 10.1210/jc.86.10.4979; Miller J, 2008, SEMIN PERINATOL, V32, P274, DOI 10.1053/j.semperi.2008.04.010; Momoi N, 2008, AM J PHYSIOL-HEART C, V294, pH2248, DOI 10.1152/ajpheart.91469.2007; NEERHOF MG, 1995, CLIN PERINATOL, V22, P375; Neitzke U, 2011, MICROCIRCULATION, V18, P304, DOI 10.1111/j.1549-8719.2011.00089.x; Pasquarette MM, 1996, J MOL ENDOCRINOL, V16, P269, DOI 10.1677/jme.0.0160269; Peck JD, 2010, FOOD CHEM TOXICOL, V48, P2549, DOI 10.1016/j.fct.2010.06.019; PUFFINBARGER NK, 1995, MOL PHARMACOL, V47, P1126; Sankaran S, 2009, BEST PRACT RES CL OB, V23, P765, DOI 10.1016/j.bpobgyn.2009.05.003; Shams M, 1998, HUM REPROD, V13, P799, DOI 10.1093/humrep/13.4.799; Sharma A, 2009, ENDOCRINOLOGY, V150, P4278, DOI 10.1210/en.2009-0479; SMITH SE, 1987, FOOD CHEM TOXICOL, V25, P125, DOI 10.1016/0278-6915(87)90145-1; Stewart A, 2010, J CELL PHYSIOL, V223, P658, DOI 10.1002/jcp.22064; Sun K, 1998, BIOL REPROD, V58, P1379, DOI 10.1095/biolreprod58.6.1379; van Beek JP, 2004, J CLIN ENDOCR METAB, V89, P5614, DOI 10.1210/jc.2004-0113; Vik T, 2003, PAEDIATR PERINAT EP, V17, P324, DOI 10.1046/j.1365-3016.2003.00507.x; von Versen-Hoynck F, 2009, PLACENTA, V30, P434, DOI 10.1016/j.placenta.2009.02.004; Wyrwoll CS, 2009, ENDOCRINOLOGY, V150, P1287, DOI 10.1210/en.2008-1100	49	17	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2012	7	6							e38082	10.1371/journal.pone.0038082	http://dx.doi.org/10.1371/journal.pone.0038082			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TU	22701600	gold, Green Published, Green Submitted			2022-12-27	WOS:000305337600013
J	Zheng, Y; Wang, Q; Xiao, B; Lu, QJ; Wang, YZ; Wang, XM				Zheng, Yan; Wang, Qi; Xiao, Bing; Lu, Qingjun; Wang, Yizheng; Wang, Xiaomin			Involvement of Receptor Tyrosine Kinase Tyro3 in Amyloidogenic APP Processing and beta-Amyloid Deposition in Alzheimer's Disease Models	PLOS ONE			English	Article							LONG-TERM POTENTIATION; TRANSGENIC MICE; HIPPOCAMPAL-NEURONS; PRECURSOR PROTEIN; INDUCED APOPTOSIS; FAMILY RECEPTORS; MEMORY DEFICITS; NERVOUS-SYSTEM; MOUSE MODELS; PC12 CELLS	Alzheimer's disease (AD) is the most common progressive neurodegenerative disease known to humankind. It is characterized by brain atrophy, extracellular amyloid plaques, and intracellular neurofibril tangles. beta-amyloid cascade is considered the major causative player in AD. Up until now, the mechanisms underlying the process of A beta generation and accumulation in the brain have not been well understood. Tyro3 receptor belongs to the TAM receptor subfamily of receptor protein tyrosine kinases (RPTKs). It is specifically expressed in the neurons of the neocortex and hippocampus. In this study, we established a cell model stably expressing APPswe mutants and producing A beta. We found that overexpression of Tyro3 receptor in the cell model significantly decreased A beta generation and also down-regulated the expression of beta-site amyloid precursor protein cleaving enzyme (BACE1). However, the effects of Tyro3 were inhibited by its natural ligand, Gas6, in a concentration-dependent manner. In order to confirm the role of Tyro3 in the progression of AD development, we generated an AD transgenic mouse model accompanied by Tyro3 knockdown. We observed a significant increase in the number of amyloid plaques in the hippocampus in the mouse model. More plaque-associated clusters of astroglia were also detected. The present study may help researchers determine the role of Tyro3 receptor in the neuropathology of AD.	[Zheng, Yan; Wang, Qi; Xiao, Bing; Lu, Qingjun; Wang, Yizheng; Wang, Xiaomin] Capital Med Univ, Dept Physiol, Key Lab Neurodegenerat Disorders, Minist Educ, Beijing, Peoples R China	Capital Medical University	Zheng, Y (corresponding author), Capital Med Univ, Dept Physiol, Key Lab Neurodegenerat Disorders, Minist Educ, Beijing, Peoples R China.	xmwang@ccmu.edu.cn			National Basic Research Program of China [2011CB504100]; NSFC of China [30900421/c090201, 81030062]	National Basic Research Program of China(National Basic Research Program of China); NSFC of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (Xiaomin Wang, 2011CB504100) and the NSFC of China (Yan Zheng, 30900421/c090201; Xiaomin Wang, 81030062). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen MP, 1999, MOL ENDOCRINOL, V13, P191, DOI 10.1210/me.13.2.191; Babic T, 1999, J NEUROL NEUROSUR PS, V67, P558, DOI 10.1136/jnnp.67.4.558; Binder MD, 2008, J NEUROSCI, V28, P5195, DOI 10.1523/JNEUROSCI.1180-08.2008; Citron M, 2004, TRENDS PHARMACOL SCI, V25, P92, DOI 10.1016/j.tips.2003.12.004; Cuello AC, 2007, CURR ALZHEIMER RES, V4, P351, DOI 10.2174/156720507781788774; Funakoshi H, 2002, J NEUROSCI RES, V68, P150, DOI 10.1002/jnr.10211; Gandy S, 2005, J CLIN INVEST, V115, P1121, DOI 10.1172/JCI200525100; GNAHN H, 1983, DEV BRAIN RES, V9, P45, DOI 10.1016/0165-3806(83)90107-4; Goedert M, 1986, Brain Res, V387, P85; Goedert M, 2006, SCIENCE, V314, P777, DOI 10.1126/science.1132814; Grommes C, 2008, J NEUROIMMUNE PHARM, V3, P130, DOI 10.1007/s11481-007-9090-2; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hogan DB, 2002, CAN J NEUROL SCI, V29, P306, DOI 10.1017/S031716710000216X; Hsia AY, 1998, J NEUROPHYSIOL, V79, P2013, DOI 10.1152/jn.1998.79.4.2013; JANSSEN JWG, 1991, ONCOGENE, V6, P2113; LAI C, 1994, ONCOGENE, V9, P2567; LAI C, 1991, NEURON, V6, P691, DOI 10.1016/0896-6273(91)90167-X; Lemke G, 2003, CURR OPIN IMMUNOL, V15, P31, DOI 10.1016/S0952-7915(02)00016-X; Li CY, 2011, CURR ALZHEIMER RES, V8, P67; Lu QX, 1999, NATURE, V398, P723, DOI 10.1038/19554; Lu QX, 2001, SCIENCE, V293, P306, DOI 10.1126/science.1061663; Lynch MA, 2004, PHYSIOL REV, V84, P87, DOI 10.1152/physrev.00014.2003; Ma GZM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016964; McGowan E, 2006, TRENDS GENET, V22, P281, DOI 10.1016/j.tig.2006.03.007; Michaelis ML, 2003, J PHARMACOL EXP THER, V304, P897, DOI 10.1124/jpet.102.035840; Nussbaum RL, 2003, NEW ENGL J MED, V348, P1356, DOI 10.1056/NEJM2003ra020003; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; OBRYAN JP, 1991, MOL CELL BIOL, V11, P5016, DOI 10.1128/MCB.11.10.5016; Ohno M, 2006, EUR J NEUROSCI, V23, P251, DOI 10.1111/j.1460-9568.2005.04551.x; Ohno M, 2007, NEUROBIOL DIS, V26, P134, DOI 10.1016/j.nbd.2006.12.008; Prasad D, 2006, MOL CELL NEUROSCI, V33, P96, DOI 10.1016/j.mcn.2006.06.011; Prieto AL, 2007, NEUROSCIENCE, V150, P319, DOI 10.1016/j.neuroscience.2007.09.047; Prieto AL, 2000, J COMP NEUROL, V425, P295; RESCIGNO J, 1991, ONCOGENE, V6, P1909; Roberson ED, 2006, SCIENCE, V314, P781, DOI 10.1126/science.1132813; Selkoe DJ, 1996, J BIOL CHEM, V271, P18295, DOI 10.1074/jbc.271.31.18295; SELKOE DJ, 1993, TRENDS NEUROSCI, V16, P403, DOI 10.1016/0166-2236(93)90008-A; Shankar SL, 2006, J NEUROSCI, V26, P5638, DOI 10.1523/JNEUROSCI.5063-05.2006; Shankar SL, 2003, J NEUROSCI, V23, P4208; Sinha S, 1999, P NATL ACAD SCI USA, V96, P11049, DOI 10.1073/pnas.96.20.11049; STITT TN, 1995, CELL, V80, P661, DOI 10.1016/0092-8674(95)90520-0; SturchlerPierrat C, 1997, P NATL ACAD SCI USA, V94, P13287, DOI 10.1073/pnas.94.24.13287; Suh YH, 2002, PHARMACOL REV, V54, P469, DOI 10.1124/pr.54.3.469; Vassar R, 2002, ADV DRUG DELIVER REV, V54, P1589, DOI 10.1016/S0169-409X(02)00157-6; Verkhratsky A, 2010, NEUROTHERAPEUTICS, V7, P399, DOI 10.1016/j.nurt.2010.05.017; Wang Q, 2011, NEUROSCI BULL, V27, P15, DOI 10.1007/s12264-011-1042-4; Weinger JG, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-49; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134; Wolfe MS, 2002, NAT REV DRUG DISCOV, V1, P859, DOI 10.1038/nrd938; Yagami T, 2002, NEUROPHARMACOLOGY, V43, P1289, DOI 10.1016/S0028-3908(02)00333-7; Ye F, 2011, INVEST OPHTH VIS SCI, V52, P4239, DOI 10.1167/iovs.10-6700; Zheng Y, 2009, BIOCHEM BIOPH RES CO, V378, P371, DOI 10.1016/j.bbrc.2008.11.049	52	23	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2012	7	6							e39035	10.1371/journal.pone.0039035	http://dx.doi.org/10.1371/journal.pone.0039035			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TU	22701746	gold, Green Published, Green Submitted			2022-12-27	WOS:000305337600066
J	Pendyala, G; Ninemire, C; Fox, HS				Pendyala, Gurudutt; Ninemire, Carly; Fox, Howard S.			Protective Role for the Disulfide Isomerase PDIA3 in Methamphetamine Neurotoxicity	PLOS ONE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; ENDOPLASMIC-RETICULUM; DOPAMINERGIC DEFICITS; STRIATAL DOPAMINE; INFECTED MONKEYS; SUBSTANTIA-NIGRA; RHESUS-MONKEYS; BRAIN; EXPRESSION; ENRICHMENT	Methamphetamine abuse continues to be a worldwide problem, damaging the individual user as well as society. Only minimal information exists on molecular changes in the brain that result from methamphetamine administered in patterns typical of human abusers. In order to investigate such changes, we examined the effect of methamphetamine on the transcriptional profile in brains of monkeys. Gene expression profiling of caudate and hippocampus identified protein disulfide isomerase family member A3 (PDIA3) to be significantly up-regulated in the animals treated with methamphetamine as compared to saline treated control monkeys. Methamphetamine treatment of mice also increased striatal PDIA3 expression. Treatment of primary striatal neurons with methamphetamine revealed an up-regulation of PDIA3, showing a direct effect of methamphetamine on neurons to increase PDIA3. In vitro studies using a neuroblastoma cell line demonstrated that PDIA3 expression protects against methamphetamine-induced cell toxicity and methamphetamine-induced intracellular reactive oxygen species production, revealing a neuroprotective role for PDIA3. The current study implicates PDIA3 to be an important cellular neuroprotective mechanism against a toxic drug, and as a potential target for therapeutic investigations.	[Pendyala, Gurudutt; Ninemire, Carly; Fox, Howard S.] Univ Nebraska Med Ctr, Dept Pharmacol & Expt Neurosci, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center	Pendyala, G (corresponding author), Univ Nebraska Med Ctr, Dept Pharmacol & Expt Neurosci, Omaha, NE 68198 USA.	hfox@unmc.edu		Fox, Howard/0000-0003-2032-374X	NIH [P30 MH062261, R01 MH073490, P01 DA026146, P20 RR16469, P20 RR018788]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018788, P20RR016469] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH073490, P30MH062261] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA026146] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by NIH grants P30 MH062261, R01 MH073490 and P01 DA026146. The UNMC Microarray Core Facility receives partial support from NIH grants P20 RR16469 and P20 RR018788. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berman S, 2008, ANN NY ACAD SCI, V1141, P195, DOI 10.1196/annals.1441.031; Burdo TH, 2005, AIDS, V19, P1704, DOI 10.1097/01.aids.0000186823.76230.33; Cadet JL, 2009, INT REV NEUROBIOL, V88, P101, DOI 10.1016/S0074-7742(09)88005-7; Degenhardt L, 2010, INT J DRUG POLICY, V21, P347, DOI 10.1016/j.drugpo.2009.11.007; Erickson RR, 2005, BIOCHEM BIOPH RES CO, V332, P50, DOI 10.1016/j.bbrc.2005.04.090; Harvey DC, 2000, EXP BRAIN RES, V133, P349, DOI 10.1007/s002210000386; Harvey DC, 2000, BRAIN RES, V871, P259, DOI 10.1016/S0006-8993(00)02439-2; Hetz C, 2005, J NEUROSCI, V25, P2793, DOI 10.1523/JNEUROSCI.4090-04.2005; HIRANO N, 1995, EUR J BIOCHEM, V234, P336, DOI 10.1111/j.1432-1033.1995.336_c.x; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jayanthi S, 2004, FASEB J, V18, P238, DOI 10.1096/fj.03-0295com; Jayanthi S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006092; Kuroda KO, 2010, NEUROPSYCHOPHARMACOL, V35, P641, DOI 10.1038/npp.2009.169; Marcondes MCG, 2007, J IMMUNOL, V178, P5812, DOI 10.4049/jimmunol.178.9.5812; Marcondes MCG, 2010, AM J PATHOL, V177, P355, DOI 10.2353/ajpath.2010.090953; MAZZARELLA RA, 1994, ARCH BIOCHEM BIOPHYS, V308, P454, DOI 10.1006/abbi.1994.1064; Melega WP, 2008, NEUROPSYCHOPHARMACOL, V33, P1441, DOI 10.1038/sj.npp.1301502; WATRY D, 1995, AM J PATHOL, V146, P914; Wilson JM, 1996, NAT MED, V2, P699, DOI 10.1038/nm0696-699; Wilson JM, 1996, ANN NEUROL, V40, P428, DOI 10.1002/ana.410400312; WOOLVERTON WL, 1989, BRAIN RES, V486, P73, DOI 10.1016/0006-8993(89)91279-1; Xie T, 2002, J NEUROSCI, V22, P274, DOI 10.1523/JNEUROSCI.22-01-00274.2002; Yamamoto BK, 2010, ANN NY ACAD SCI, V1187, P101, DOI 10.1111/j.1749-6632.2009.05141.x	23	18	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2012	7	6							e38909	10.1371/journal.pone.0038909	http://dx.doi.org/10.1371/journal.pone.0038909			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TQ	22715419	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336800061
J	Ferramosca, A; Conte, A; Burri, L; Berge, K; De Nuccio, F; Giudetti, AM; Zara, V				Ferramosca, Alessandra; Conte, Annalea; Burri, Lena; Berge, Kjetil; De Nuccio, Francesco; Giudetti, Anna Maria; Zara, Vincenzo			A Krill Oil Supplemented Diet Suppresses Hepatic Steatosis in High-Fat Fed Rats	PLOS ONE			English	Article							CONJUGATED LINOLEIC-ACID; MITOCHONDRIAL CITRATE CARRIER; DOCOSAHEXAENOIC ACID; INSULIN SENSITIVITY; ADIPOSE-TISSUE; FISH-OIL; MICE; BRAIN; LIVER; PURIFICATION	Krill oil (KO) is a dietary source of n-3 polyunsaturated fatty acids, mainly represented by eicosapentaenoic acid and docosahexaenoic acid bound to phospholipids. The supplementation of a high-fat diet with 2.5% KO efficiently prevented triglyceride and cholesterol accumulation in liver of treated rats. This effect was accompanied by a parallel reduction of the plasma levels of triglycerides and glucose and by the prevention of a plasma insulin increase. The investigation of the molecular mechanisms of KO action in high-fat fed animals revealed a strong decrease in the activities of the mitochondrial citrate carrier and of the cytosolic acetyl-CoA carboxylase and fatty acid synthetase, which are both involved in hepatic de novo lipogenesis. In these animals a significant increase in the activity of carnitine palmitoyl-transferase I and in the levels of carnitine was also observed, suggesting a concomitant stimulation of hepatic fatty acid oxidation. The KO supplemented animals also retained an efficient mitochondrial oxidative phosphorylation, most probably as a consequence of a KO-induced arrest of the uncoupling effects of a high-fat diet. Lastly, the KO supplementation prevented an increase in body weight, as well as oxidative damage of lipids and proteins, which is often found in high-fat fed animals.	[Ferramosca, Alessandra; Conte, Annalea; De Nuccio, Francesco; Giudetti, Anna Maria; Zara, Vincenzo] Univ Salento, Dept Biol & Environm Sci & Technol, Lecce, Italy; [Burri, Lena; Berge, Kjetil] Aker BioMarine ASA, Oslo, Norway	University of Salento	Ferramosca, A (corresponding author), Univ Salento, Dept Biol & Environm Sci & Technol, Lecce, Italy.	vincenzo.zara@unisalento.it	Ferramosca, Alessandra/B-8801-2015; Giudetti, Anna Maria/ABF-4049-2021; Zara, Vincenzo/AAC-2900-2019; De Nuccio, Francesco/GSD-5516-2022	Ferramosca, Alessandra/0000-0002-8251-9652; Zara, Vincenzo/0000-0001-6592-4501; Conte, Annalea/0000-0002-2833-506X; De Nuccio, Francesco/0000-0003-2041-0149; GIUDETTI, ANNA MARIA/0000-0002-9204-040X	Aker BioMarine ASA	Aker BioMarine ASA	This research was supported by Aker BioMarine ASA and by 5x1000 contribution to Univeristy of Salento. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amate L, 2001, J NUTR, V131, P1250, DOI 10.1093/jn/131.4.1250; BIEBER LL, 1972, ANAL BIOCHEM, V50, P509, DOI 10.1016/0003-2697(72)90061-9; Bisschop PH, 2001, AM J CLIN NUTR, V73, P554; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Bunea Ruxandra, 2004, Altern Med Rev, V9, P420; Burri Lena, 2011, Frontiers in Genetics, V2, P45, DOI 10.3389/fgene.2011.00045; Cole MA, 2011, BASIC RES CARDIOL, V106, P447, DOI 10.1007/s00395-011-0156-1; Deutsch L, 2007, J AM COLL NUTR, V26, P39, DOI 10.1080/07315724.2007.10719584; Di Marzo V, 2010, INT DAIRY J, V20, P231, DOI 10.1016/j.idairyj.2009.11.015; Eslick GD, 2009, INT J CARDIOL, V136, P4, DOI 10.1016/j.ijcard.2008.03.092; Fedor D, 2009, CURR OPIN CLIN NUTR, V12, P138, DOI 10.1097/MCO.0b013e3283218299; Ferramosca A, 2012, J ANIM PHYSIOL AN N, V96, P295, DOI 10.1111/j.1439-0396.2011.01135.x; Ferramosca A, 2008, J AGR FOOD CHEM, V56, P8148, DOI 10.1021/jf8010728; Ferramosca A, 2008, BIOSCI BIOTECH BIOCH, V72, P62, DOI 10.1271/bbb.70369; Ferramosca A, 2006, J LIPID RES, V47, P1994, DOI 10.1194/jlr.M600138-JLR200; Ferramosca A, 2012, UROLOGY, V79, P809, DOI 10.1016/j.urology.2011.12.042; Galgani JE, 2008, BRIT J NUTR, V100, P471, DOI 10.1017/S0007114508894408; Gnoni GV, 2009, IUBMB LIFE, V61, P987, DOI 10.1002/iub.249; Graf BA, 2010, PROSTAG LEUKOTR ESS, V83, P89, DOI 10.1016/j.plefa.2010.05.004; HODGE J, 1993, LIPIDS, V28, P525, DOI 10.1007/BF02536084; Huang PL, 2009, DIS MODEL MECH, V2, P231, DOI 10.1242/dmm.001180; Ide T, 2005, DIABETES, V54, P412, DOI 10.2337/diabetes.54.2.412; Ikemoto S, 1996, METABOLISM, V45, P1539, DOI 10.1016/S0026-0495(96)90185-7; Jump DB, 2008, CURR OPIN LIPIDOL, V19, P242, DOI 10.1097/MOL.0b013e3282ffaf6a; Jump DB, 2011, CURR OPIN CLIN NUTR, V14, P115, DOI 10.1097/MCO.0b013e328342991c; KOLAKOWSKA A, 1994, NAHRUNG, V38, P128, DOI 10.1002/food.19940380204; Kowaltowski AJ, 2009, FREE RADICAL BIO MED, V47, P333, DOI 10.1016/j.freeradbiomed.2009.05.004; Lagarde M, 2001, J MOL NEUROSCI, V16, P201, DOI 10.1385/JMN:16:2-3:201; LINN TC, 1981, ARCH BIOCHEM BIOPHYS, V209, P613, DOI 10.1016/0003-9861(81)90320-9; LONG CS, 1982, NEUROLOGY, V32, P663, DOI 10.1212/WNL.32.6.663; MUCI MR, 1992, INT J VITAM NUTR RES, V62, P330; NAKAMURA GR, 1952, ANAL CHEM, V24, P1372, DOI 10.1021/ac60068a036; Postic C, 2008, J CLIN INVEST, V118, P829, DOI 10.1172/JCI34275; Riediger ND, 2009, J AM DIET ASSOC, V109, P668, DOI 10.1016/j.jada.2008.12.022; Riserus U, 2008, CURR OPIN CLIN NUTR, V11, P100, DOI 10.1097/MCO.0b013e3282f52708; RUBEN B, 2003, J FOOD ENG, V56, P289; Tandy S, 2009, J AGR FOOD CHEM, V57, P9339, DOI 10.1021/jf9016042; Tou JC, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-179; Vial G, 2011, J HEPATOL, V54, P348, DOI 10.1016/j.jhep.2010.06.044; Wagner EM, 2004, J LIPID RES, V45, P356, DOI 10.1194/jlr.M300293-JLR200; Wijendran V, 2002, PEDIATR RES, V51, P265, DOI 10.1203/00006450-200203000-00002; Zara V, 2009, BBA-MOL CELL RES, V1793, P89, DOI 10.1016/j.bbamcr.2008.04.011; Zhu JJ, 2008, LIPIDS HEALTH DIS, V7, DOI 10.1186/1476-511X-7-30; Zuliani G, 2009, CURR PHARM DESIGN, V15, P4087, DOI 10.2174/138161209789909773	46	63	65	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e38797	10.1371/journal.pone.0038797	http://dx.doi.org/10.1371/journal.pone.0038797			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685607	Green Published, gold, Green Submitted			2022-12-27	WOS:000305351700071
J	Chen, CT; Peng, HP; Jian, JW; Tsai, KC; Chang, JY; Yang, EW; Chen, JB; Ho, SY; Hsu, WL; Yang, AS				Chen, Ching-Tai; Peng, Hung-Pin; Jian, Jhih-Wei; Tsai, Keng-Chang; Chang, Jeng-Yih; Yang, Ei-Wen; Chen, Jun-Bo; Ho, Shinn-Ying; Hsu, Wen-Lian; Yang, An-Suei			Protein-Protein Interaction Site Predictions with Three-Dimensional Probability Distributions of Interacting Atoms on Protein Surfaces	PLOS ONE			English	Article							INTERACTION PARTNERS; HOT-SPOTS; RECOGNITION; INTERFACES; PREFERENCES; CLASSIFIER; PRINCIPLES; IDENTIFY; REGIONS	Protein-protein interactions are key to many biological processes. Computational methodologies devised to predict protein-protein interaction (PPI) sites on protein surfaces are important tools in providing insights into the biological functions of proteins and in developing therapeutics targeting the protein-protein interaction sites. One of the general features of PPI sites is that the core regions from the two interacting protein surfaces are complementary to each other, similar to the interior of proteins in packing density and in the physicochemical nature of the amino acid composition. In this work, we simulated the physicochemical complementarities by constructing three-dimensional probability density maps of non-covalent interacting atoms on the protein surfaces. The interacting probabilities were derived from the interior of known structures. Machine learning algorithms were applied to learn the characteristic patterns of the probability density maps specific to the PPI sites. The trained predictors for PPI sites were cross-validated with the training cases (consisting of 432 proteins) and were tested on an independent dataset (consisting of 142 proteins). The residue-based Matthews correlation coefficient for the independent test set was 0.423; the accuracy, precision, sensitivity, specificity were 0.753, 0.519, 0.677, and 0.779 respectively. The benchmark results indicate that the optimized machine learning models are among the best predictors in identifying PPI sites on protein surfaces. In particular, the PPI site prediction accuracy increases with increasing size of the PPI site and with increasing hydrophobicity in amino acid composition of the PPI interface; the core interface regions are more likely to be recognized with high prediction confidence. The results indicate that the physicochemical complementarity patterns on protein surfaces are important determinants in PPIs, and a substantial portion of the PPI sites can be predicted correctly with the physicochemical complementarity features based on the non-covalent interaction data derived from protein interiors.	[Chen, Ching-Tai; Peng, Hung-Pin; Jian, Jhih-Wei; Tsai, Keng-Chang; Chang, Jeng-Yih; Yang, Ei-Wen; Chen, Jun-Bo; Yang, An-Suei] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Peng, Hung-Pin; Jian, Jhih-Wei] Natl Yang Ming Univ, Inst Biomed Informat, Taipei 112, Taiwan; [Chen, Jun-Bo] Natl Tsing Hua Univ, Dept Comp Sci, Hsinchu 30043, Taiwan; [Chen, Ching-Tai; Ho, Shinn-Ying] Natl Chiao Tung Univ, Inst Bioinformat & Syst Biol, Hsinchu, Taiwan; [Chen, Ching-Tai; Peng, Hung-Pin; Jian, Jhih-Wei] Acad Sinica, Inst Informat Sci, Taiwan Int Grad Program, Bioinformat Program, Taipei, Taiwan	Academia Sinica - Taiwan; National Yang Ming Chiao Tung University; National Tsing Hua University; National Yang Ming Chiao Tung University; Academia Sinica - Taiwan	Chen, CT (corresponding author), Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan.	hsu@iis.sinica.edu.tw; yangas@gate.sinica.edu.tw	Ho, Shinn-Ying/AAE-9394-2022; Ho, Shinn-Ying/AFD-8402-2022; Hsu, Wen-Lian/ABB-2851-2020	Ho, Shinn-Ying/0000-0002-1901-8353; Ho, Shinn-Ying/0000-0002-1901-8353; Hsu, Wen-Lian/0000-0001-7061-3513; Tsai, Keng-Chang/0000-0001-8277-9174; Yang, An-Suei/0000-0002-4699-873X	National Health Research Institutes [NHRI-EX98-9802EI]; National Science Council [NSC 99-2311-B-001-014-MY3]; Genomics Research Center at Academia Sinica [AS-100-TP2-B01]; NRPB program, NSC [NSC 100-2325-B-001-009, 100IDP006-3]	National Health Research Institutes(National Health Research Institutes, Japan); National Science Council(Ministry of Science and Technology, Taiwan); Genomics Research Center at Academia Sinica(Academia Sinica - Taiwan); NRPB program, NSC	This work was supported by National Health Research Institutes [NHRI-EX98-9802EI to A-S. Y.], National Science Council [NSC 99-2311-B-001-014-MY3 to A-S. Y.], Genomics Research Center at Academia Sinica [AS-100-TP2-B01 to A-S. Y.], and NRPB program, NSC. [NSC 100-2325-B-001-009; 100IDP006-3 to A-S. Y.] The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Burges CJC, 1998, DATA MIN KNOWL DISC, V2, P121, DOI 10.1023/A:1009715923555; Chakrabarti P, 2002, PROTEINS, V47, P334, DOI 10.1002/prot.10085; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chang DTH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S3; Chen CT, 2008, BIOINFORMATICS, V24, P2691, DOI 10.1093/bioinformatics/btn538; de Vries SJ, 2008, CURR PROTEIN PEPT SC, V9, P394, DOI 10.2174/138920308785132712; Elkins JM, 2002, BIOCHEMISTRY-US, V41, P5185, DOI 10.1021/bi016014e; Engelen S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000267; Ezkurdia L, 2009, BRIEF BIOINFORM, V10, P233, DOI 10.1093/bib/bbp021; Gallet X, 2000, J MOL BIOL, V302, P917, DOI 10.1006/jmbi.2000.4092; Glaser F, 2001, PROTEINS, V43, P89, DOI 10.1002/1097-0134(20010501)43:2<89::AID-PROT1021>3.3.CO;2-8; Henrick K, 1998, TRENDS BIOCHEM SCI, V23, P358, DOI 10.1016/S0968-0004(98)01253-5; Hubbard S. J., 1993, NACCESS; Janin J, 2008, Q REV BIOPHYS, V41, P133, DOI 10.1017/S0033583508004708; Jiang L, 2005, PROTEINS, V58, P893, DOI 10.1002/prot.20347; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Keskin O, 2008, CHEM REV, V108, P1225, DOI 10.1021/cr040409x; Koike A, 2004, PROTEIN ENG DES SEL, V17, P165, DOI 10.1093/protein/gzh020; Kufareva I, 2007, PROTEINS, V67, P400, DOI 10.1002/prot.21233; Kundrotas PJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000727; Laskowski RA, 1996, J MOL BIOL, V259, P175, DOI 10.1006/jmbi.1996.0311; Levy ED, 2010, J MOL BIOL, V403, P660, DOI 10.1016/j.jmb.2010.09.028; Li MH, 2007, BIOINFORMATICS, V23, P597, DOI 10.1093/bioinformatics/btl660; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Manning CD, 2007, INTRO INFORM RETRIEV; MATTHEWS BW, 1975, BIOCHIM BIOPHYS ACTA, V405, P442, DOI 10.1016/0005-2795(75)90109-9; McConkey BJ, 2003, P NATL ACAD SCI USA, V100, P3215, DOI 10.1073/pnas.0535768100; Moont G, 1999, PROTEINS, V35, P364, DOI 10.1002/(SICI)1097-0134(19990515)35:3<364::AID-PROT11>3.0.CO;2-4; Moreira IS, 2007, PROTEINS, V68, P803, DOI 10.1002/prot.21396; Murakami Y, 2006, BIOINFORMATICS, V22, P1794, DOI 10.1093/bioinformatics/btl171; Murakami Y, 2010, BIOINFORMATICS, V26, P1841, DOI 10.1093/bioinformatics/btq302; Negi SS, 2007, J MOL MODEL, V13, P1157, DOI 10.1007/s00894-007-0237-0; Neuvirth H, 2004, J MOL BIOL, V338, P181, DOI 10.1016/j.jmb.2004.02.040; Newman W S, 1993, Q APPL MATH, V2, P160; Wass MN, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.3; Ofran Y, 2003, J MOL BIOL, V325, P377, DOI 10.1016/S0022-2836(02)01223-8; Ofran Y, 2003, FEBS LETT, V544, P236, DOI 10.1016/S0014-5793(03)00456-3; Ofran Y, 2007, BIOINFORMATICS, V23, pE13, DOI 10.1093/bioinformatics/btl303; Porollo A, 2007, PROTEINS, V66, P630, DOI 10.1002/prot.21248; Res I, 2005, BIOINFORMATICS, V21, P2496, DOI 10.1093/bioinformatics/bti340; RIEDMILLER M, 1993, 1993 IEEE INTERNATIONAL CONFERENCE ON NEURAL NETWORKS, VOLS 1-3, P586, DOI 10.1109/ICNN.1993.298623; Riedmiller M., 1994, RPROP DESCRIPTION IM; Rodier F, 2005, PROTEINS, V60, P36, DOI 10.1002/prot.20478; Sacquin-Mora S, 2008, J MOL BIOL, V382, P1276, DOI 10.1016/j.jmb.2008.08.002; Sheinerman FB, 2000, CURR OPIN STRUC BIOL, V10, P153, DOI 10.1016/S0959-440X(00)00065-8; Sikic M, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000278; Tuncbag N, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/3/035006; Wass MN, 2011, CURR OPIN STRUC BIOL, V21, P382, DOI 10.1016/j.sbi.2011.03.013; Yu CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033340; Zhang QC, 2011, NUCLEIC ACIDS RES, V39, pW283, DOI 10.1093/nar/gkr311; Zhang QC, 2010, P NATL ACAD SCI USA, V107, P10896, DOI 10.1073/pnas.1005894107; Zhou HX, 2007, BIOINFORMATICS, V23, P2203, DOI 10.1093/bioinformatics/btm323	55	23	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e37706	10.1371/journal.pone.0037706	http://dx.doi.org/10.1371/journal.pone.0037706			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701576	Green Submitted, Green Published, gold			2022-12-27	WOS:000305348400017
J	Freudenberg, J; Gregersen, PK; Freudenberg-Hua, Y				Freudenberg, Jan; Gregersen, Peter K.; Freudenberg-Hua, Yun			A Simple Method for Analyzing Exome Sequencing Data Shows Distinct Levels of Nonsynonymous Variation for Human Immune and Nervous System Genes	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; NATURAL-SELECTION; CANDIDATE GENES; EVOLUTIONARY; SPECTRUM; DISEASES; REGIONS; EXCESS; RATES	To measure the strength of natural selection that acts upon single nucleotide variants (SNVs) in a set of human genes, we calculate the ratio between nonsynonymous SNVs (nsSNVs) per nonsynonymous site and synonymous SNVs (sSNVs) per synonymous site. We transform this ratio with a respective factor f that corrects for the bias of synonymous sites towards transitions in the genetic code and different mutation rates for transitions and transversions. This method approximates the relative density of nsSNVs (rdnsv) in comparison with the neutral expectation as inferred from the density of sSNVs. Using SNVs from a diploid genome and 200 exomes, we apply our method to immune system genes (ISGs), nervous system genes (NSGs), randomly sampled genes (RSGs), and gene ontology annotated genes. The estimate of rdnsv in an individual exome is around 20% for NSGs and 30-40% for ISGs and RSGs. This smaller rdnsv of NSGs indicates overall stronger purifying selection. To quantify the relative shift of nsSNVs towards rare variants, we next fit a linear regression model to the estimates of rdnsv over different SNV allele frequency bins. The obtained regression models show a negative slope for NSGs, ISGs and RSGs, supporting an influence of purifying selection on the frequency spectrum of segregating nsSNVs. The y-intercept of the model predicts rdnsv for an allele frequency close to 0. This parameter can be interpreted as the proportion of nonsynonymous sites where mutations are tolerated to segregate with an allele frequency notably greater than 0 in the population, given the performed normalization of the observed nsSNV to sSNV ratio. A smaller y-intercept is displayed by NSGs, indicating more nonsynonymous sites under strong negative selection. This predicts more monogenically inherited or de-novo mutation diseases that affect the nervous system.	[Freudenberg, Jan; Gregersen, Peter K.] Northshore LIJ Healthsyst, Feinstein Inst Med Res, Robert S Boas Ctr Human Genet & Genom, Manhasset, NY USA; [Freudenberg-Hua, Yun] Northshore LIJ Healthsyst, Div Geriatr Psychiat, Dept Psychiat, Glen Oaks, NY USA; [Freudenberg-Hua, Yun] Northshore LIJ Healthsyst, Feinstein Inst Med Res, Litwin Zucker Ctr Alzheimers Dis & Memory Disorde, Manhasset, NY USA	Northwell Health; Northwell Health; Northwell Health	Freudenberg, J (corresponding author), Northshore LIJ Healthsyst, Feinstein Inst Med Res, Robert S Boas Ctr Human Genet & Genom, Manhasset, NY USA.	jan.freudenberg@nshs.edu			Young Investigator Award of the National Alliance for Research in Schizophrenia and Depression (NARSAD); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR063340] Funding Source: NIH RePORTER	Young Investigator Award of the National Alliance for Research in Schizophrenia and Depression (NARSAD); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Part of this research has been supported by a Young Investigator Award of the National Alliance for Research in Schizophrenia and Depression (NARSAD) to JF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Ahituv N, 2007, AM J HUM GENET, V80, P779, DOI 10.1086/513471; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Bargmann CI, 1998, SCIENCE, V282, P2028, DOI 10.1126/science.282.5396.2028; Barreiro LB, 2010, NAT REV GENET, V11, P17, DOI 10.1038/nrg2698; Boyko AR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000083; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; Coventry A, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1130; Dorus S, 2004, CELL, V119, P1027, DOI 10.1016/j.cell.2004.11.040; Emes RD, 2008, NAT NEUROSCI, V11, P799, DOI 10.1038/nn.2135; Flajnik MF, 2010, NAT REV GENET, V11, P47, DOI 10.1038/nrg2703; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Freudenberg J, 2007, EUR J HUM GENET, V15, P1071, DOI 10.1038/sj.ejhg.5201876; Freudenberg J, 2007, NEUROGENETICS, V8, P159, DOI 10.1007/s10048-007-0082-4; Freudenberg-Hua Y, 2003, GENOME RES, V13, P2271, DOI 10.1101/gr.1299703; Freudenberg-Hua Y, 2005, PHARMACOGENOMICS J, V5, P183, DOI 10.1038/sj.tpj.6500306; Fumagalli M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002355; Gahl WA, 2011, JAMA-J AM MED ASSOC, V305, P1904, DOI 10.1001/jama.2011.613; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; Gilad Y, 2003, P NATL ACAD SCI USA, V100, P3324, DOI 10.1073/pnas.0535697100; Girard SL, 2011, NAT GENET, V43, P860, DOI 10.1038/ng.886; Halushka MK, 1999, NAT GENET, V22, P239, DOI 10.1038/10297; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hughes AL, 2005, IMMUNOGENETICS, V57, P821, DOI 10.1007/s00251-005-0052-7; Hughes AL, 2003, P NATL ACAD SCI USA, V100, P15754, DOI 10.1073/pnas.2536718100; Jiang CZ, 2006, GENOMICS, V88, P527, DOI 10.1016/j.ygeno.2006.06.003; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kryukov GV, 2007, AM J HUM GENET, V80, P727, DOI 10.1086/513473; Leabman MK, 2003, P NATL ACAD SCI USA, V100, P5896, DOI 10.1073/pnas.0730857100; LI WH, 1993, J MOL EVOL, V36, P96, DOI 10.1007/BF02407308; Li YR, 2010, NAT GENET, V42, P969, DOI 10.1038/ng.680; Livingston RJ, 2004, GENOME RES, V14, P1821, DOI 10.1101/gr.2730004; Maglott D, 2007, NUCLEIC ACIDS RES, V35, pD26, DOI 10.1093/nar/gkl993; Marth GT, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r84; McVicker G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000471; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; Ng PC, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000160; Parmley JL, 2007, BIOESSAYS, V29, P515, DOI 10.1002/bies.20592; Piontkivska H, 2003, J MOL EVOL, V56, P277, DOI 10.1007/s00239-002-2399-9; Rhead B, 2010, NUCLEIC ACIDS RES, V38, pD613, DOI 10.1093/nar/gkp939; Roak BJO, 2012, NATURE, V485, P242; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Smith AV, 2005, GENOME RES, V15, P1519, DOI 10.1101/gr.4421405; STRACHAN T, 2003, HUMAN MOL GENETICS; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Vissers LELM, 2010, NAT GENET, V42, P1109, DOI 10.1038/ng.712; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Yang ZH, 1998, J MOL EVOL, V46, P409, DOI 10.1007/PL00006320	52	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e38087	10.1371/journal.pone.0038087	http://dx.doi.org/10.1371/journal.pone.0038087			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701602	Green Submitted, Green Published, gold			2022-12-27	WOS:000305348400034
J	Smathers, RL; Fritz, KS; Galligan, JJ; Shearn, CT; Reigan, P; Marks, MJ; Petersen, DR				Smathers, Rebecca L.; Fritz, Kristofer S.; Galligan, James J.; Shearn, Colin T.; Reigan, Philip; Marks, Michael J.; Petersen, Dennis R.			Characterization of 4-HNE Modified L-FABP Reveals Alterations in Structural and Functional Dynamics	PLOS ONE			English	Article							ACID-BINDING-PROTEIN; LIPID-PEROXIDATION PRODUCTS; ALCOHOLIC LIVER-DISEASE; FATTY-ACID; RAT-LIVER; COVALENT MODIFICATION; PEROXIREDOXIN 6; LIGAND-BINDING; MOUSE MODEL; IN-VITRO	4-Hydroxynonenal (4-HNE) is a reactive alpha, beta-unsaturated aldehyde produced during oxidative stress and subsequent lipid peroxidation of polyunsaturated fatty acids. The reactivity of 4-HNE towards DNA and nucleophilic amino acids has been well established. In this report, using proteomic approaches, liver fatty acid-binding protein (L-FABP) is identified as a target for modification by 4-HNE. This lipid binding protein mediates the uptake and trafficking of hydrophobic ligands throughout cellular compartments. Ethanol caused a significant decrease in L-FABP protein (P<0.001) and mRNA (P<0.05), as well as increased poly-ubiquitinated L-FABP (P, 0.001). Sites of 4-HNE adduction on mouse recombinant L-FABP were mapped using MALDI-TOF/TOF mass spectrometry on apo (Lys57 and Cys69) and holo (Lys6, Lys31, His43, Lys46, Lys57 and Cys69) L-FABP. The impact of 4-HNE adduction was found to occur in a concentration-dependent manner; affinity for the fluorescent ligand, anilinonaphthalene-8-sulfonic acid, was reduced from 0.347 mu M to Kd(1) = 0.395 mu M and Kd(2) = 34.20 mu M. Saturation analyses revealed that capacity for ligand is reduced by approximately 50% when adducted by 4-HNE. Thermal stability curves of apo L-FABP was also found to be significantly affected by 4-HNE adduction (Delta Tm = 5.44 degrees C, P<0.01). Computational-based molecular modeling simulations of adducted protein revealed minor conformational changes in global protein structure of apo and holo L-FABP while more apparent differences were observed within the internal binding pocket, revealing reduced area and structural integrity. New solvent accessible portals on the periphery of the protein were observed following 4-HNE modification in both the apo and holo state, suggesting an adaptive response to carbonylation. The results from this study detail the dynamic process associated with L-FABP modification by 4-HNE and provide insight as to how alterations in structural integrity and ligand binding may a contributing factor in the pathogenesis of ALD.	[Smathers, Rebecca L.; Fritz, Kristofer S.; Shearn, Colin T.; Reigan, Philip; Petersen, Dennis R.] Univ Colorado, Dept Pharmaceut Sci, Skaggs Sch Pharm & Pharmaceut Sci, Aurora, CO 80045 USA; [Galligan, James J.] Univ Colorado, Dept Pharmacol, Sch Med, Aurora, CO USA; [Marks, Michael J.] Univ Colorado, Inst Behav Genet, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Boulder	Smathers, RL (corresponding author), Univ Colorado, Dept Pharmaceut Sci, Skaggs Sch Pharm & Pharmaceut Sci, Anschutz Med Campus, Aurora, CO 80045 USA.	dennis.petersen@ucdenver.edu	Galligan, James/A-5041-2015; McCullough, Rebecca/I-4081-2014	Fritz, Kristofer/0000-0002-1499-6174	National Institutes of Health/National Institutes of Alcoholism and Alcohol Abuse [R37AA09300, R01DK074487-01, F31AA018898-02]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074487] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R37AA009300, F31AA018898] Funding Source: NIH RePORTER	National Institutes of Health/National Institutes of Alcoholism and Alcohol Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Studies were supported by the National Institutes of Health/National Institutes of Alcoholism and Alcohol Abuse under grant numbers R37AA09300 (DRP), R01DK074487-01 (DRP) and F31AA018898-02 (RLS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arteel GE, 2003, GASTROENTEROLOGY, V124, P778, DOI 10.1053/gast.2003.50087; Atshaves BP, 2010, J NUTR BIOCHEM, V21, P1015, DOI 10.1016/j.jnutbio.2010.01.005; Backos DS, 2011, FREE RADICAL BIO MED, V50, P14, DOI 10.1016/j.freeradbiomed.2010.10.694; Beier Juliane I, 2011, Curr Gastroenterol Rep, V13, P56, DOI 10.1007/s11894-010-0157-5; BENEDETTI A, 1984, BIOCHIM BIOPHYS ACTA, V792, P172, DOI 10.1016/0005-2760(84)90219-4; Bennaars-Eiden A, 2002, J BIOL CHEM, V277, P50693, DOI 10.1074/jbc.M209493200; Carbone DL, 2005, J PHARMACOL EXP THER, V315, P8, DOI 10.1124/jpet.105.088088; Carbone DL, 2005, CHEM RES TOXICOL, V18, P1324, DOI 10.1021/tx050078z; Carbone DL, 2004, CHEM RES TOXICOL, V17, P1459, DOI 10.1021/tx049838g; CHAM BE, 1976, J LIPID RES, V17, P176; Chuang S, 2008, J MED CHEM, V51, P3755, DOI 10.1021/jm701192w; Clugston RD, 2011, J LIPID RES; Codreanu SG, 2009, MOL CELL PROTEOMICS, V8, P670, DOI 10.1074/mcp.M800070-MCP200; Comporti MM, 1998, FREE RADICAL RES, V28, P623, DOI 10.3109/10715769809065818; Conde de la Rosa L, 2008, REV ESP ENFERM DIG, V100, P156, DOI 10.4321/s1130-01082008000300006; Dalle-Donne I, 2006, CLIN CHEM, V52, P601, DOI 10.1373/clinchem.2005.061408; Dalle-Donne I, 2006, J CELL MOL MED, V10, P389, DOI 10.1111/j.1582-4934.2006.tb00407.x; Donohue TM, 2003, ALCOHOL RES HEALTH, V27, P317; Doorn JA, 2003, CHEM-BIOL INTERACT, V143, P93, DOI 10.1016/S0009-2797(02)00178-3; Doorn JA, 2002, CHEM RES TOXICOL, V15, P1445, DOI 10.1021/tx025590o; DORMANN P, 1993, J BIOL CHEM, V268, P16286; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Fritz KS, 2011, CHEM RES TOXICOL, V24, P1411, DOI 10.1021/tx200169n; Fritz KS, 2011, CHEM RES TOXICOL, V24, P651, DOI 10.1021/tx100355a; Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589; Galligan JJ, 2011, J PROTEOME RES, V10, P1837, DOI 10.1021/pr101101s; Galligan JJ, 2012, CHEM RES TOXICOL; Grimsrud PA, 2007, MOL CELL PROTEOMICS, V6, P624, DOI 10.1074/mcp.M600120-MCP200; He Y, 2007, BIOCHEMISTRY-US, V46, P12543, DOI 10.1021/bi701092r; HERR FM, 1995, BIOCHEMISTRY-US, V34, P11840, DOI 10.1021/bi00037a023; Kane CD, 1996, ANAL BIOCHEM, V233, P197, DOI 10.1006/abio.1996.0028; KIM HK, 1992, J BIOL CHEM, V267, P77; Koska J, 2008, J CHEM INF MODEL, V48, P1965, DOI 10.1021/ci800081s; LITTLE RG, 1983, COMP BIOCHEM PHYS C, V74, P271, DOI 10.1016/0742-8413(83)90101-9; Long D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006081; LoPachin RM, 2012, CHEM RES TOXICOL, V25, P239, DOI 10.1021/tx2003257; LoPachin RM, 2009, CHEM RES TOXICOL, V22, P1499, DOI 10.1021/tx900147g; Lu YK, 2008, HEPATOLOGY, V47, P1483, DOI 10.1002/hep.22222; Marnett LJ, 2003, J CLIN INVEST, V111, P583, DOI 10.1172/JCI200318022; Martin GG, 2005, BIOCHEM J, V391, P549, DOI 10.1042/BJ20050296; Martin GG, 2003, BIOCHEMISTRY-US, V42, P11520, DOI 10.1021/bi0346749; Martin GG, 2003, J BIOL CHEM, V278, P21429, DOI 10.1074/jbc.M300287200; McIntosh AL, 2009, ARCH BIOCHEM BIOPHYS, V485, P160, DOI 10.1016/j.abb.2009.03.004; Moller M, 2002, BIOCHEM MOL BIOL EDU, V30, P309, DOI 10.1002/bmb.2002.494030050089; Newton BW, 2009, J PROTEOME RES, V8, P1663, DOI 10.1021/pr800905w; OCKNER RK, 1982, J BIOL CHEM, V257, P7872; PALLEROS DR, 1994, J BIOL CHEM, V269, P13107; Paradis V, 1997, HEPATOLOGY, V26, P135; Petersen DR, 2004, FREE RADICAL BIO MED, V37, P937, DOI 10.1016/j.freeradbiomed.2004.06.012; PIGNON JP, 1987, HEPATOLOGY, V7, P865, DOI 10.1002/hep.1840070512; Poli G, 2008, MED RES REV, V28, P569, DOI 10.1002/med.20117; Poli G, 2008, MOL ASPECTS MED, V29, P67, DOI 10.1016/j.mam.2007.09.016; Purohit V, 2004, ALCOHOL, V34, P3, DOI 10.1016/j.alcohol.2004.06.008; Ramaiah SK, 2004, INT J TOXICOL, V23, P217, DOI 10.1080/10915810490502069; Richieri GV, 2000, BIOCHEMISTRY-US, V39, P7197, DOI 10.1021/bi000314z; Richieri GV, 1996, J BIOL CHEM, V271, P31068, DOI 10.1074/jbc.271.49.31068; Roede JR, 2008, CHEM RES TOXICOL, V21, P2289, DOI 10.1021/tx800244u; Roede JR, 2008, FREE RADICAL BIO MED, V45, P1551, DOI 10.1016/j.freeradbiomed.2008.08.032; Sampey BP, 2007, J BIOL CHEM, V282, P1925, DOI 10.1074/jbc.M610602200; Sato T, 1996, J BIOCHEM-TOKYO, V120, P908; Sayre LM, 2006, DRUG METAB REV, V38, P651, DOI 10.1080/03602530600959508; Schroeder F, 2008, LIPIDS, V43, P1, DOI 10.1007/s11745-007-3111-z; SCHULENBERGSCHELL H, 1988, EUR J BIOCHEM, V170, P565, DOI 10.1111/j.1432-1033.1988.tb13735.x; Seitz HK, 2005, ALCOHOL CLIN EXP RES, V29, P1276, DOI 10.1097/01.ALC.0000171896.37022.F7; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Smathers RL, 2011, CHEM-BIOL INTERACT, V192, P107, DOI 10.1016/j.cbi.2011.02.021; Smathers Rebecca L., 2011, Human Genomics, V5, P170; Stewart BJ, 2007, CHEM RES TOXICOL, V20, P1111, DOI 10.1021/tx700106v; Storch J, 2009, J LIPID RES, V50, pS126, DOI 10.1194/jlr.R800084-JLR200; Thompson J, 1999, BBA-MOL CELL BIOL L, V1441, P117, DOI 10.1016/S1388-1981(99)00146-8; Thompson J, 1997, J BIOL CHEM, V272, P7140, DOI 10.1074/jbc.272.11.7140; Toyokuni S, 2000, ANTIOXID REDOX SIGN, V2, P681, DOI 10.1089/ars.2000.2.4-681; TSUKAMOTO H, 1995, J CLIN INVEST, V96, P620, DOI 10.1172/JCI118077; UCHIDA K, 1992, P NATL ACAD SCI USA, V89, P4544, DOI 10.1073/pnas.89.10.4544; Uchida K, 2003, PROG LIPID RES, V42, P318, DOI 10.1016/S0163-7827(03)00014-6; Wang W, 2005, INT J PHARMACEUT, V289, P1, DOI 10.1016/j.ijpharm.2004.11.014; You Q, 2006, HEPATOLOGY, V44, P1421, DOI 10.1002/hep.21425; Zimmerman AW, 2002, CELL MOL LIFE SCI, V59, P1096, DOI 10.1007/s00018-002-8490-y; Zimmerman AW, 2001, INT J BIOCHEM CELL B, V33, P865, DOI 10.1016/S1357-2725(01)00070-X; Zou XQ, 1999, J AM CHEM SOC, V121, P8033, DOI 10.1021/ja984102p	80	42	43	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e38459	10.1371/journal.pone.0038459	http://dx.doi.org/10.1371/journal.pone.0038459			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701647	gold, Green Published, Green Submitted			2022-12-27	WOS:000305348400062
J	Szameitat, AJ; McNamara, A; Shen, S; Sterr, A				Szameitat, Andre J.; McNamara, Adam; Shen, Shan; Sterr, Annette			Neural Activation and Functional Connectivity during Motor Imagery of Bimanual Everyday Actions	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; PREMOTOR CORTEX; HAND MOVEMENTS; MENTAL REPRESENTATION; COORDINATION TASK; FINGER MOVEMENTS; BRAIN ACTIVATION; HEALTHY-SUBJECTS; ACTIONS SHARE; TIME-SERIES	Bimanual actions impose intermanual coordination demands not present during unimanual actions. We investigated the functional neuroanatomical correlates of these coordination demands in motor imagery (MI) of everyday actions using functional magnetic resonance imaging (fMRI). For this, 17 participants imagined unimanual actions with the left and right hand as well as bimanual actions while undergoing fMRI. A univariate fMRI analysis showed no reliable cortical activations specific to bimanual MI, indicating that intermanual coordination demands in MI are not associated with increased neural processing. A functional connectivity analysis based on psychophysiological interactions (PPI), however, revealed marked increases in connectivity between parietal and premotor areas within and between hemispheres. We conclude that in MI of everyday actions intermanual coordination demands are primarily met by changes in connectivity between areas and only moderately, if at all, by changes in the amount of neural activity. These results are the first characterization of the neuroanatomical correlates of bimanual coordination demands in MI. Our findings support the assumed equivalence of overt and imagined actions and highlight the differences between uni- and bimanual actions. The findings extent our understanding of the motor system and may aid the development of clinical neurorehabilitation approaches based on mental practice.	[Szameitat, Andre J.] Univ Munich, Dept Psychol, Munich, Germany; [Szameitat, Andre J.; McNamara, Adam; Shen, Shan; Sterr, Annette] Univ Surrey, Dept Psychol, Guildford GU2 5XH, Surrey, England	University of Munich; University of Surrey	Szameitat, AJ (corresponding author), Univ Munich, Dept Psychol, Munich, Germany.	szameitat@psy.lmu.de		Sterr, Annette/0000-0003-4490-985X	Medical Research Council, UK [CEG 61501]; MRC [G0200128] Funding Source: UKRI; Medical Research Council [G0200128] Funding Source: researchfish	Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was funded by the Medical Research Council, UK (CEG 61501; Dr Sterr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson JLR, 2001, NEUROIMAGE, V13, P903, DOI 10.1006/nimg.2001.0746; Andres FG, 1999, BRAIN, V122, P855, DOI 10.1093/brain/122.5.855; Bakker M, 2008, NEUROIMAGE, V41, P998, DOI 10.1016/j.neuroimage.2008.03.020; Belardinelli MO, 2009, ACTA PSYCHOL, V132, P190, DOI 10.1016/j.actpsy.2009.06.009; Boecker H, 2002, NEUROIMAGE, V17, P999, DOI 10.1006/nimg.2002.1139; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; Cauraugh JH, 2004, RESTOR NEUROL NEUROS, V22, P337; Crammond DJ, 1997, TRENDS NEUROSCI, V20, P54, DOI 10.1016/S0166-2236(96)30019-2; Debaere F, 2004, NEUROIMAGE, V21, P1416, DOI 10.1016/j.neuroimage.2003.12.011; Debaere F, 2004, NEUROPSYCHOLOGIA, V42, P855, DOI 10.1016/j.neuropsychologia.2003.12.010; Decety J, 1996, BEHAV BRAIN RES, V72, P127; Decety J, 1996, COGNITIVE BRAIN RES, V3, P87, DOI 10.1016/0926-6410(95)00033-X; Dechent P, 2004, COGNITIVE BRAIN RES, V19, P138, DOI 10.1016/j.cogbrainres.2003.11.012; Deiber MP, 1998, NEUROIMAGE, V7, P73, DOI 10.1006/nimg.1997.0314; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Ertelt D, 2007, NEUROIMAGE, V36, pT164, DOI 10.1016/j.neuroimage.2007.03.043; Fleming MK, 2010, EXP BRAIN RES, V201, P499, DOI 10.1007/s00221-009-2062-4; Fourkas AD, 2008, CEREB CORTEX, V18, P2382, DOI 10.1093/cercor/bhn005; FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Gao Q, 2011, NEUROIMAGE, V54, P1280, DOI 10.1016/j.neuroimage.2010.08.071; Garrison KA, 2010, NEUROREHAB NEURAL RE, V24, P404, DOI 10.1177/1545968309354536; Gazzola V, 2009, CEREB CORTEX, V19, P1239, DOI 10.1093/cercor/bhn181; Gerardin E, 2000, CEREB CORTEX, V10, P1093, DOI 10.1093/cercor/10.11.1093; Gerloff C, 2002, ACTA PSYCHOL, V110, P161, DOI 10.1016/S0001-6918(02)00032-X; Goldenberg G, 2009, NEUROPSYCHOLOGIA, V47, P1449, DOI 10.1016/j.neuropsychologia.2008.07.014; Gordon AM, 2007, DEV MED CHILD NEUROL, V49, P830, DOI 10.1111/j.1469-8749.2007.00830.x; Grefkes C, 2008, NEUROIMAGE, V41, P1382, DOI 10.1016/j.neuroimage.2008.03.048; GUIARD Y, 1987, J MOTOR BEHAV, V19, P486; HALSBAND U, 1993, BRAIN, V116, P243, DOI 10.1093/brain/116.1.243; Hanakawa T, 2003, J NEUROPHYSIOL, V89, P989, DOI 10.1152/jn.00132.2002; Hou WS, 2005, P ANN INT IEEE EMBS, P3687; JEANNEROD M, 1994, BEHAV BRAIN SCI, V17, P187, DOI 10.1017/S0140525X00034026; Kranczioch C, 2009, HUM BRAIN MAPP, V30, P3275, DOI 10.1002/hbm.20748; Kuhtz-Buschbeck JP, 2003, EUR J NEUROSCI, V18, P3375, DOI 10.1111/j.1460-9568.2003.03066.x; Lorey B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020368; Lotze M, 2006, J PHYSIOL-PARIS, V99, P386, DOI 10.1016/j.jphysparis.2006.03.012; Macuga KL, 2012, NEUROIMAGE, V59, P2798, DOI 10.1016/j.neuroimage.2011.09.083; Malouin F, 2003, HUM BRAIN MAPP, V19, P47, DOI 10.1002/hbm.10103; Michelon P, 2006, J NEUROPHYSIOL, V95, P811, DOI 10.1152/jn.00488.2005; Miller KJ, 2010, P NATL ACAD SCI USA, V107, P4430, DOI 10.1073/pnas.0913697107; Naito E, 2002, J NEUROSCI, V22, P3683; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Olsson CJ, 2010, SCAND J MED SCI SPOR, V20, P711, DOI 10.1111/j.1600-0838.2010.01101.x; PASCUALLEONE A, 1995, J NEUROPHYSIOL, V74, P1037, DOI 10.1152/jn.1995.74.3.1037; PASHLER H, 1994, PSYCHOL BULL, V116, P220, DOI 10.1037/0033-2909.116.2.220; Pfurtscheller G, 1997, NEUROSCI LETT, V239, P65, DOI 10.1016/S0304-3940(97)00889-6; Pomeroy VM, 2005, NEUROREHAB NEURAL RE, V19, P4, DOI 10.1177/1545968304274351; Porro CA, 1996, J NEUROSCI, V16, P7688; Puttemans V, 2005, J NEUROSCI, V25, P4270, DOI 10.1523/JNEUROSCI.3866-04.2005; Renner CIE, 2005, J NEUROL SCI, V239, P25, DOI 10.1016/j.jns.2005.07.005; Sharma N, 2009, ANN NEUROL, V66, P604, DOI 10.1002/ana.21810; Sharma N, 2006, STROKE, V37, P1941, DOI 10.1161/01.STR.0000226902.43357.fc; Sirigu A, 1996, SCIENCE, V273, P1564, DOI 10.1126/science.273.5281.1564; Solodkin A, 2004, CEREB CORTEX, V14, P1246, DOI 10.1093/cercor/bhh086; Stelzel C, 2009, NEUROIMAGE, V48, P237, DOI 10.1016/j.neuroimage.2009.06.064; Stephan KM, 1999, BRAIN, V122, P351, DOI 10.1093/brain/122.2.351; STEPHAN KM, 1995, J NEUROPHYSIOL, V73, P373, DOI 10.1152/jn.1995.73.1.373; Stinear CM, 2007, CLIN NEUROPHYSIOL, V118, P1794, DOI 10.1016/j.clinph.2007.05.008; Stinear CM, 2006, EXP BRAIN RES, V168, P157, DOI 10.1007/s00221-005-0078-y; Stinear JW, 2002, J PHYSIOL-LONDON, V543, P307, DOI 10.1113/jphysiol.2002.023986; Sun FT, 2007, CEREB CORTEX, V17, P1227, DOI 10.1093/cercor/bhl033; Swinnen SP, 2002, NAT REV NEUROSCI, V3, P350, DOI 10.1038/nrn807; Szameitat AJ, 2002, J COGNITIVE NEUROSCI, V14, P1184, DOI 10.1162/089892902760807195; Szameitat AJ, 2007, EUR J NEUROSCI, V26, P3303, DOI 10.1111/j.1460-9568.2007.05920.x; Szameitat AJ, 2007, NEUROIMAGE, V34, P702, DOI 10.1016/j.neuroimage.2006.09.033; Szameitat AJ, 2011, NEUROIMAGE, V54, P1765, DOI 10.1016/j.neuroimage.2010.07.069; Toussaint L, 2010, J SPORT SCI, V28, P497, DOI 10.1080/02640410903555855; van den Berg FE, 2010, CEREB CORTEX, V20, P2842, DOI 10.1093/cercor/bhq034; Wenderoth N, 2006, NEUROIMAGE, V31, P264, DOI 10.1016/j.neuroimage.2005.11.033; Wolbers T, 2003, CEREB CORTEX, V13, P392, DOI 10.1093/cercor/13.4.392; Woldag H, 2004, STROKE, V35, P2556, DOI 10.1161/01.STR.0000144651.07122.da; Yoo SC, 2003, NEUROREPORT, V14, P581, DOI 10.1097/00001756-200303240-00011	74	26	27	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e38506	10.1371/journal.pone.0038506	http://dx.doi.org/10.1371/journal.pone.0038506			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701655	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000305348400066
J	Zhang, T; Bai, JQ; Wang, W; Wang, D; Shen, BZ				Zhang, Tong; Bai, Jinquan; Wang, Wei; Wang, Dan; Shen, Baozhong			Preliminary Study of Prospective ECG-Gated 320-Detector CT Coronary Angiography in Patients with Ventricular Premature Beats	PLOS ONE			English	Article							ROW COMPUTED-TOMOGRAPHY; DOSE-LENGTH PRODUCT; IMAGE QUALITY; METAANALYSIS; EXPERIENCE; ARTERIES	Background: To study the applicability of prospective ECG-gated 320-detector CT coronary angiography (CTCA) in patients with ventricular premature beats(VPB), and determine the scanning mode that best maximizes image quality and reduces radiation dose. Methods: 110 patients were divided into a VPB group (60 cases) and a control group (50 cases) using CTCA. All the patients then underwent coronary angiography (CAG) within one month. CAG served as a reference standard through which the sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of CTCA in diagnosing significant coronary artery stenosis (luminal stenosis >= 50%) could be analyzed. The two radiologists with more than 3 years' experience in cardiac CT each finished the image analysis after consultation. A personalized scanning mode was adopted to compare image quality and radiation dose between the two groups. Methodology/Principal Findings: At the coronary artery segment level, sensitivity, specificity, PPV, and NPV in the premature beat group were 92.55%, 98.21%, 88.51%, and 98.72% respectively. In the control group these values were found to be 95.79%, 98.42%, 90.11%, and 99.28% respectively. Between the two groups, specificity, sensitivity PPV, NPV was no significant difference. The two groups had no significant difference in image quality score (P>0.05). Heart rate (77.20 +/- 12.07 bpm) and radiation dose (14.62 +/- 1.37 mSv) in the premature beat group were higher than heart rate (58.72 +/- 4.73 bpm) and radiation dose (3.08 +/- 2.35 mSv) in the control group. In theVPB group, the radiation dose (34.55 +/- 7.12 mSv) for S-field scanning was significantly higher than the radiation dose (15.10 +/- 1.12 mSv) for M-field scanning. Conclusions/Significance: With prospective ECG-gated scanning for VPB, the diagnostic accuracy of coronary artery stenosis is very high. Scanning field adjustment can reduce radiation dose while maintaining good image quality. For patients with slow heart rates and good rhythm, there was no statistically significant difference in image quality.	[Zhang, Tong; Bai, Jinquan; Wang, Wei; Wang, Dan; Shen, Baozhong] Harbin Med Univ, Dept Radiol, Affiliated Hosp 4, Harbin, Peoples R China; [Wang, Wei] Harbin Med Univ, Dept MRI Room, Affiliated Hosp 1, Harbin, Peoples R China	Harbin Medical University; Harbin Medical University	Zhang, T (corresponding author), Harbin Med Univ, Dept Radiol, Affiliated Hosp 4, Harbin, Peoples R China.	baozhongshen@hotmail.com						Abdulla J, 2007, EUR HEART J, V28, P3042, DOI 10.1093/eurheartj/ehm466; Austen W G, 1975, Circulation, V51, P5; Cademartiri F, 2004, RADIOLOGY, V233, P817, DOI 10.1148/radiol.2333030668; Dewey M, 2009, CIRCULATION, V120, P867, DOI 10.1161/CIRCULATIONAHA.109.859280; Earls JP, 2008, RADIOLOGY, V246, P742, DOI 10.1148/radiol.2463070989; Gutstein Ariel, 2008, J Cardiovasc Comput Tomogr, V2, P81, DOI 10.1016/j.jcct.2007.12.015; Hamon M, 2006, J AM COLL CARDIOL, V48, P1896, DOI 10.1016/j.jacc.2006.08.028; Hoe John, 2009, J Cardiovasc Comput Tomogr, V3, P257, DOI 10.1016/j.jcct.2009.05.013; Huda W, 2008, RADIOLOGY, V248, P995, DOI 10.1148/radiol.2483071964; Husmann L, 2008, EUR HEART J, V29, P191, DOI 10.1093/eurheartj/ehm613; KALENDER WA, 1990, RADIOLOGY, V176, P181, DOI 10.1148/radiology.176.1.2353088; Konen E, 2007, J AM COLL CARDIOL, V49, P587, DOI 10.1016/j.jacc.2006.09.039; Lee AB, 2011, AM J ROENTGENOL, V196, pW729, DOI 10.2214/AJR.10.5252; Matsutani H, 2008, CIRC J, V72, P1071, DOI 10.1253/circj.72.1071; Rankin SC, 1998, EUR J RADIOL, V28, P18, DOI 10.1016/S0720-048X(98)00009-6; Rybicki FJ, 2008, INT J CARDIOVAS IMAG, V24, P535, DOI 10.1007/s10554-008-9308-2; Shrimpton PC, 2009, RADIOLOGY, V250, P604, DOI 10.1148/radiol.2502081340; Steigner ML, 2009, INT J CARDIOVAS IMAG, V25, P85, DOI 10.1007/s10554-008-9347-8; Zhang T, 2011, MINERVA MED, V102, P249	19	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e38430	10.1371/journal.pone.0038430	http://dx.doi.org/10.1371/journal.pone.0038430			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701639	Green Submitted, gold, Green Published			2022-12-27	WOS:000305348400056
J	Capraro, DT; Gosavi, S; Roy, M; Onuchic, JN; Jennings, PA				Capraro, Dominique T.; Gosavi, Shachi; Roy, Melinda; Onuchic, Jose N.; Jennings, Patricia A.			Folding Circular Permutants of IL-1 beta: Route Selection Driven by Functional Frustration	PLOS ONE			English	Article							NATIVE-STATE TOPOLOGY; BETA-TREFOIL PROTEIN; DIHYDROFOLATE-REDUCTASE; IMPROVED SENSITIVITY; ESCHERICHIA-COLI; ENERGY LANDSCAPE; TRANSITION-STATE; INTERLEUKIN-1-BETA; NMR; STABILITY	Interleukin-1 beta (IL-1 beta) is the cytokine crucial to inflammatory and immune response. Two dominant routes are populated in the folding to native structure. These distinct routes are a result of the competition between early packing of the functional loops versus closure of the beta-barrel to achieve efficient folding and have been observed both experimentally and computationally. Kinetic experiments on the WT protein established that the dominant route is characterized by early packing of geometrically frustrated functional loops. However, deletion of one of the functional loops, the beta-bulge, switches the dominant route to an alternative, yet, as accessible, route, where the termini necessary for barrel closure form first. Here, we explore the effect of circular permutation of the WT sequence on the observed folding landscape with a combination of kinetic and thermodynamic experiments. Our experiments show that while the rate of formation of permutant protein is always slower than that observed for the WT sequence, the region of initial nucleation for all permutants is similar to that observed for the WT protein and occurs within a similar timescale. That is, even permutants with significant sequence rearrangement in which the functional-nucleus is placed at opposing ends of the polypeptide chain, fold by the dominant WT "functional loop-packing route", despite the entropic cost of having to fold the N- and C-termini early. Taken together, our results indicate that the early packing of the functional loops dominates the folding landscape in active proteins, and, despite the entropic penalty of coalescing the termini early, these proteins will populate an entropically unfavorable route in order to conserve function. More generally, circular permutation can elucidate the influence of local energetic stabilization of functional regions within a protein, where topological complexity creates a mismatch between energetics and topology in active proteins.	[Capraro, Dominique T.; Onuchic, Jose N.] Rice Univ, Ctr Theoret Biol Phys, Houston, TX 77251 USA; [Gosavi, Shachi] Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bangalore, Karnataka, India; [Roy, Melinda; Jennings, Patricia A.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA	Rice University; Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); University of California System; University of California San Diego	Capraro, DT (corresponding author), Rice Univ, Ctr Theoret Biol Phys, Houston, TX 77251 USA.	pajennings@ucsd.edu			Center for Theoretical Biological Physics; National Science Foundation (NSF) [PHY-0822283, MCB-1051438]; National Institutes of Health (NIH) [GM54038]; Government of India-Department of Atomic Energy through the National Centre for Biological Sciences; Government of India-Department of Science and Technology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054038, R29GM054038] Funding Source: NIH RePORTER; Division Of Physics [1308264] Funding Source: National Science Foundation	Center for Theoretical Biological Physics; National Science Foundation (NSF)(National Science Foundation (NSF)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Government of India-Department of Atomic Energy through the National Centre for Biological Sciences; Government of India-Department of Science and Technology(Department of Science & Technology (India)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Division Of Physics(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	D.T.C. and J.N.O. are supported by the Center for Theoretical Biological Physics sponsored by the National Science Foundation (NSF) Grants PHY-0822283 and MCB-1051438. Additionally, this work was supported in part by National Institutes of Health (NIH) Grants GM54038. S. G. is supported by the Government of India-Department of Atomic Energy through the National Centre for Biological Sciences startup funds and the Government of India-Department of Science and Technology-Ramanujan Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], PYMOL MOL GRAPH SYST; Arai M, 2003, J MOL BIOL, V328, P273, DOI 10.1016/S0022-2836(03)00212-2; BODENHAUSEN G, 1980, CHEM PHYS LETT, V69, P185, DOI 10.1016/0009-2614(80)80041-8; Bulaj G, 2004, PROTEIN SCI, V13, P1182, DOI 10.1110/ps.03563704; Capraro DT, 2012, P NATL ACAD SCI USA, V109, P1490, DOI 10.1073/pnas.1114430109; Capraro DT, 2008, P NATL ACAD SCI USA, V105, P14844, DOI 10.1073/pnas.0807812105; Capraro DT, 2011, P NATL ACAD IN PRESS; Chavez LL, 2006, P NATL ACAD SCI USA, V103, P10254, DOI 10.1073/pnas.0510110103; CHRUNYK BA, 1993, J BIOL CHEM, V268, P18053; Clementi C, 2000, P NATL ACAD SCI USA, V97, P5871, DOI 10.1073/pnas.100547897; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Finke JM, 2001, J BIOL PHYS, V27, P119, DOI 10.1023/A:1013178505077; Finke JM, 2001, THESIS U CALIF, pxvii; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Goddard D., 2008, SPARKY 3; Gosavi S, 2006, J MOL BIOL, V357, P986, DOI 10.1016/j.jmb.2005.11.074; Gosavi S, 2008, P NATL ACAD SCI USA, V105, P10384, DOI 10.1073/pnas.0801343105; GRZESIEK S, 1992, J MAGN RESON, V96, P215, DOI 10.1016/0022-2364(92)90307-S; GRZESIEK S, 1993, J BIOMOL NMR, V3, P185; Haglund E, 2008, J BIOL CHEM, V283, P27904, DOI 10.1074/jbc.M801776200; Heidary DK, 1997, NAT STRUCT BIOL, V4, P725, DOI 10.1038/nsb0997-725; Heidary DK, 2005, J MOL BIOL, V353, P1187, DOI 10.1016/j.jmb.2005.08.072; Heidary DK, 2002, J MOL BIOL, V316, P789, DOI 10.1006/jmbi.2001.5270; Heinemann U, 1995, PROG BIOPHYS MOL BIO, V64, P121, DOI 10.1016/0079-6107(95)00013-5; HORLICK RA, 1992, PROTEIN ENG, V5, P427, DOI 10.1093/protein/5.5.427; JONES BE, 1994, BIOCHEMISTRY-US, V33, P15250, DOI 10.1021/bi00255a005; Klimov DK, 2005, J MOL BIOL, V353, P1171, DOI 10.1016/j.jmb.2005.09.029; Koussounadis AI, 2004, CURR PHARM DESIGN, V10, P3857, DOI 10.2174/1381612043382585; Latypov RF, 2007, J MOL BIOL, V368, P1187, DOI 10.1016/j.jmb.2007.02.031; Li L, 2001, J MOL BIOL, V306, P121, DOI 10.1006/jmbi.2000.4375; Lindberg M, 2002, NAT STRUCT BIOL, V9, P818, DOI 10.1038/nsb847; Lindberg MO, 2006, P NATL ACAD SCI USA, V103, P4083, DOI 10.1073/pnas.0508863103; Lindberg MO, 2001, J MOL BIOL, V314, P891, DOI 10.1006/jmbi.2001.5186; Lo WC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031791; MORI S, 1995, J MAGN RESON SER B, V108, P94, DOI 10.1006/jmrb.1995.1109; MUHANDIRAM DR, 1994, J MAGN RESON SER B, V103, P203, DOI 10.1006/jmrb.1994.1032; Onuchic JN, 2004, CURR OPIN STRUC BIOL, V14, P70, DOI 10.1016/j.sbi.2004.01.009; Rees AR, 1992, PROTEIN ENG PRACTICA, Vxxv, P397; Roy M, 2005, J MOL BIOL, V348, P335, DOI 10.1016/j.jmb.2005.02.059; Roy M, 2003, J MOL BIOL, V328, P693, DOI 10.1016/S0022-2836(03)00340-1; SEMISOTNOV GV, 1991, BIOPOLYMERS, V31, P119, DOI 10.1002/bip.360310111; SEMISOTNOV GV, 1987, FEBS LETT, V224, P9, DOI 10.1016/0014-5793(87)80412-X; Varley CL, 1997, CYTOKINE, V9, P577, DOI 10.1006/cyto.1997.0204; VARLEY P, 1993, SCIENCE, V260, P1110, DOI 10.1126/science.8493553; Vigers GPA, 1997, NATURE, V386, P190, DOI 10.1038/386190a0	45	19	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e38512	10.1371/journal.pone.0038512	http://dx.doi.org/10.1371/journal.pone.0038512			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22693643	Green Published, gold			2022-12-27	WOS:000305343900053
J	Walters, M; Morrison, NI; Claus, J; Tang, GL; Phillips, CE; Young, R; Zink, RT; Alphey, L				Walters, Michelle; Morrison, Neil I.; Claus, John; Tang, Guolei; Phillips, Caroline E.; Young, Robin; Zink, Richard T.; Alphey, Luke			Field Longevity of a Fluorescent Protein Marker in an Engineered Strain of the Pink Bollworm, Pectinophora gossypiella (Saunders)	PLOS ONE			English	Article							LEPIDOPTERA; GELECHIIDAE; FITNESS; GENETICS	The cotton pest, pink bollworm (Pectinophora gossypiella (Saunders)), is a significant pest in most cotton-growing areas around the world. In southwestern USA and northern Mexico, pink bollworm is the target of the sterile insect technique (SIT), which relies on the mass-release of sterile pink bollworm adults to over-flood the wild population and thereby reduce it over time. Sterile moths reared for release are currently marked with a dye provided in their larval diet. There are concerns, however, that this marker fails from time to time, leading to sterile moths being misidentified in monitoring traps as wild moths. This can lead to expensive reactionary releases of sterile moths. We have developed a genetically marked strain that is engineered to express a fluorescent protein, DsRed2, which is easily screened under a specialised microscope. In order to test this marker under field conditions, we placed wild-type and genetically marked moths on traps and placed them in field cages. The moths were then screened, in a double-blind fashion, for DsRed2 fluorescence at regular intervals to determine marker reliability over time. The marker was shown to be robust in very high temperatures and generally proved reliable for a week or longer. More importantly, genotyping of moths on traps by PCR screening of the moths was 100% correct. Our findings indicate that this strain - and fluorescent protein markers in general - could make a valuable contribution to SIT.	[Walters, Michelle; Claus, John; Tang, Guolei; Zink, Richard T.] Anim Plant Hlth & Inspect Serv, Ctr Plant Hlth Sci & Technol, USDA, Phoenix, AZ USA; [Morrison, Neil I.; Phillips, Caroline E.; Alphey, Luke] Oxitec Ltd, Oxford, England; [Young, Robin] Univ Cambridge, Strangeways Res Lab, Cardiovasc Epidemiol Unit, Cambridge, England; [Zink, Richard T.] Anim Plant Hlth & Inspect Serv, Ctr Plant Hlth Sci & Technol, USDA, Ft Collins, CO USA; [Alphey, Luke] Univ Oxford, Dept Zool, Oxford OX1 3PS, England	United States Department of Agriculture (USDA); University of Cambridge; United States Department of Agriculture (USDA); University of Oxford	Walters, M (corresponding author), Anim Plant Hlth & Inspect Serv, Ctr Plant Hlth Sci & Technol, USDA, Phoenix, AZ USA.	luke.alphey@oxitec.com	Tang, Guolei/H-7070-2017	Tang, Guolei/0000-0003-4565-0800; Alphey, Luke/0000-0002-2916-3802				BARTLETT AC, 1979, ANN ENTOMOL SOC AM, V72, P256, DOI 10.1093/aesa/72.2.256; BARTLETT AC, 1978, ANN ENTOMOL SOC AM, V71, P813, DOI 10.1093/aesa/71.6.813; BARTLETT AC, 1984, ENVIRON ENTOMOL, V13, P543, DOI 10.1093/ee/13.2.543; BARTLETT AC, 1980, ANN ENTOMOL SOC AM, V73, P164, DOI 10.1093/aesa/73.2.164; Carpenter JE, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P115, DOI 10.1007/1-4020-4051-2_5; Catteruccia F, 2003, SCIENCE, V299, P1225, DOI 10.1126/science.1081453; Common I. F. B., 1958, Australian Journal of Zoology, V6, P268, DOI 10.1071/ZO9580268; Edwards RH, 1996, T ASAE, V39, P1789, DOI 10.13031/2013.27655; Feldmann U, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P701, DOI 10.1007/1-4020-4051-2_27; GRAHAM HM, 1971, J ECON ENTOMOL, V64, P376, DOI 10.1093/jee/64.2.376; Grefenstette B., 2009, PINK BOLLWORM ERADIC; Hagler JR, 2002, ENTOMOL EXP APPL, V103, P1, DOI 10.1023/A:1019803106330; Henneberry T. J., 1998, Integrated Pest Management Reviews, V3, P31, DOI 10.1023/A:1009673622862; Henneberry T. J., 2007, P567, DOI 10.1007/978-1-4020-6059-5_53; HENNEBERRY TJ, 1981, J ECON ENTOMOL, V74, P19, DOI 10.1093/jee/74.1.19; Irvin N, 2004, P NATL ACAD SCI USA, V101, P891, DOI 10.1073/pnas.0305511101; KNIPLING EF, 1955, J ECON ENTOMOL, V48, P459, DOI 10.1093/jee/48.4.459; Lukyanov KA, 2000, J BIOL CHEM, V275, P25879, DOI 10.1074/jbc.C000338200; Marrelli MT, 2006, TRENDS PARASITOL, V22, P197, DOI 10.1016/j.pt.2006.03.004; Matz MV, 1999, NAT BIOTECHNOL, V17, P969, DOI 10.1038/13657; MILLER E, 1994, J ECON ENTOMOL, V87, P1659, DOI 10.1093/jee/87.6.1659; MOSS JI, 1982, ENVIRON ENTOMOL, V11, P1264, DOI 10.1093/ee/11.6.1264; NCC, 2010, NAT COTT COUNC PINK; Simmons G. S., 2007, P119, DOI 10.1007/978-1-4020-6059-5_10; Simmons GS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024110; Staten R. T., 1999, PROC BELTWIDE COTTON, P985; Tabashnik BE, 2010, NAT BIOTECHNOL, V28, P1304, DOI 10.1038/nbt.1704; VANSTEENWYK RA, 1978, ANN ENTOMOL SOC AM, V71, P81, DOI 10.1093/aesa/71.1.81; WILSON AGL, 1972, J AUST I AGR SCI, V38, P95	29	12	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e38547	10.1371/journal.pone.0038547	http://dx.doi.org/10.1371/journal.pone.0038547			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22693645	Green Published, gold, Green Submitted			2022-12-27	WOS:000305343900056
J	Berthouly-Salazar, C; van Rensburg, BJ; Le Roux, JJ; van Vuuren, BJ; Hui, C				Berthouly-Salazar, Cecile; van Rensburg, Berndt J.; Le Roux, Johannes J.; van Vuuren, Bettine J.; Hui, Cang			Spatial Sorting Drives Morphological Variation in the Invasive Bird, Acridotheris tristis	PLOS ONE			English	Article							CLIMATE-CHANGE; DISPERSAL STRATEGIES; RANGE EXPANSION; SPECIES RANGE; EVOLUTION; SIZE; CONSEQUENCES; DYNAMICS; DISTANCE; BEHAVIOR	The speed of range expansion in many invasive species is often accelerating because individuals with stronger dispersal abilities are more likely to be found at the range front. This 'spatial sorting' of strong dispersers will drive the acceleration of range expansion. In this study, we test whether the process of spatial sorting is at work in an invasive bird population (Common myna, Acridotheris tristis) in South Africa. Specifically, we sampled individuals across its invasive range and compared morphometric measurements relevant and non-relevant to the dispersal ability. Besides testing for signals of spatial sorting, we further examined the effect of environmental factors on morphological variations. Our results showed that dispersal-relevant traits are significantly correlated with distance from the range core, with strong sexual dimorphism, indicative of sex-biased dispersal. Morphological variations were significant in wing and head traits of females, suggesting females as the primary dispersing sex. In contrast, traits not related to dispersal such as those associated with foraging showed no signs of spatial sorting but were significantly affected by environmental variables such as the vegetation and the intensity of urbanisation. When taken together, our results support the role of spatial sorting in facilitating the expansion of Common myna in South Africa despite its low propensity to disperse in the native range.	[Berthouly-Salazar, Cecile; Le Roux, Johannes J.; Hui, Cang] Univ Stellenbosch, Ctr Invas Biol, Dept Bot & Zool, ZA-7600 Stellenbosch, South Africa; [van Rensburg, Berndt J.] Univ Queensland, Sch Biol Sci, Brisbane, Qld 4072, Australia; [van Rensburg, Berndt J.] Univ Pretoria, Ctr Invas Biol, Dept Zool & Entomol, ZA-0002 Pretoria, South Africa; [van Vuuren, Bettine J.] Univ Johannesburg, Ctr Invas Biol, Dept Zool, Johannesburg, South Africa	Stellenbosch University; University of Queensland; University of Pretoria; University of Johannesburg	Berthouly-Salazar, C (corresponding author), Univ Stellenbosch, Ctr Invas Biol, Dept Bot & Zool, ZA-7600 Stellenbosch, South Africa.	c.berthouly@gmail.com	Hui, Cang/A-1781-2008; Jansen van Vuuren, Bettine/E-6227-2013; van Rensburg, Berndt/A-4154-2009; Berthouly-Salazar, Cecile/J-3204-2016	Hui, Cang/0000-0002-3660-8160; Jansen van Vuuren, Bettine/0000-0002-5334-5358; van Rensburg, Berndt/0000-0002-5274-5536; Berthouly-Salazar, Cecile/0000-0002-0685-6745; Le Roux, Johannes/0000-0001-7911-9810	Stellenbosch University Subcommittee B; National Research Foundation (NRF)	Stellenbosch University Subcommittee B; National Research Foundation (NRF)	This study was made possible through the financial support from the Stellenbosch University Subcommittee B and the National Research Foundation (NRF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Araujo MB, 2005, ECOGRAPHY, V28, P693, DOI 10.1111/j.2005.0906-7590.04253.x; Baldwin MW, 2010, J EVOLUTION BIOL, V23, P1050, DOI 10.1111/j.1420-9101.2010.01975.x; Blackburn TM, 2009, OXFORD AVIAN BIOL, P1; Bowler DE, 2005, BIOL REV, V80, P205, DOI 10.1017/S1464793104006645; Bridle JR, 2007, TRENDS ECOL EVOL, V22, P140, DOI 10.1016/j.tree.2006.11.002; Brown JH, 1996, ANNU REV ECOL SYST, V27, P597, DOI 10.1146/annurev.ecolsys.27.1.597; Channell R, 2000, J BIOGEOGR, V27, P169, DOI 10.1046/j.1365-2699.2000.00382.x; Davis MB, 2001, SCIENCE, V292, P673, DOI 10.1126/science.292.5517.673; Dawideit BA, 2009, J ANIM ECOL, V78, P388, DOI 10.1111/j.1365-2656.2008.01504.x; Dray S, 2006, ECOL MODEL, V196, P483, DOI 10.1016/j.ecolmodel.2006.02.015; Duckworth RA, 2008, AM NAT, V172, pS4, DOI 10.1086/588289; Forsman A, 2011, P ROY SOC B-BIOL SCI, V278, P225, DOI 10.1098/rspb.2010.1325; Gaston KJ, 2009, P ROY SOC B-BIOL SCI, V276, P1391, DOI [10.1098/rspb.2009.0100, 10.1098/rspb.2008.1480]; Graham MH, 2003, ECOLOGY, V84, P2809, DOI 10.1890/02-3114; Grant PR, 2006, SCIENCE, V313, P224, DOI 10.1126/science.1128374; GREENWOOD PJ, 1982, ANNU REV ECOL SYST, V13, P1, DOI 10.1146/annurev.es.13.110182.000245; GREENWOOD PJ, 1980, ANIM BEHAV, V28, P1140, DOI 10.1016/S0003-3472(80)80103-5; Harrison JA, 1997, ATLAS SO AFRICAN BIR; Hendry AP, 2006, J EVOLUTION BIOL, V19, P741, DOI 10.1111/j.1420-9101.2005.01061.x; Higgins SI, 2003, ECOLOGY, V84, P1945, DOI 10.1890/01-0616; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hockey P.A.R., 2005, ROBERTSBIRDS SO AFRI, V7th; Holt RD, 2003, EVOL ECOL RES, V5, P159; Hugo S, 2008, GLOBAL ECOL BIOGEOGR, V17, P611, DOI 10.1111/j.1466-8238.2008.00391.x; Jombart T, 2009, ECOGRAPHY, V32, P161, DOI 10.1111/j.1600-0587.2008.05567.x; Kang N, 1992, RADIO TELEMETRY URBA; Kirkpatrick M, 1997, AM NAT, V150, P1, DOI 10.1086/286054; Laiolo P, 2001, IBIS, V143, P602, DOI 10.1111/j.1474-919X.2001.tb04888.x; Lee MSY, 2011, P NATL ACAD SCI USA, V108, pE347, DOI 10.1073/pnas.1105702108; Leisler B, 2003, AVIAN MIGRATION, P175; Lockwood JL, 2007, INVASION ECOLOGY; Malcolm JR, 2006, CONSERV BIOL, V20, P538, DOI 10.1111/j.1523-1739.2006.00364.x; MARCHETTI K, 1995, J AVIAN BIOL, V26, P177, DOI 10.2307/3677316; Moller AP, 2010, J EVOLUTION BIOL, V23, P625, DOI 10.1111/j.1420-9101.2009.01928.x; Mucina K, 2006, VEGETATION S AFRICA; Oufiero CE, 2007, FUNCT ECOL, V21, P676, DOI 10.1111/j.1365-2435.2007.01259.x; Peacock DS, 2007, S AFR J SCI, V103, P465; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Peterson AT, 2003, GLOBAL CHANGE BIOL, V9, P647, DOI 10.1046/j.1365-2486.2003.00616.x; Phillips BL, 2009, BIOL LETTERS, V5, P802, DOI 10.1098/rsbl.2009.0367; Phillips BL, 2008, AM NAT, V172, pS34, DOI 10.1086/588255; Phillips BL, 2010, ECOLOGY, V91, P1617, DOI 10.1890/09-0910.1; Phillips BL, 2006, NATURE, V439, P803, DOI 10.1038/439803a; R Core Development Team, 2006, R LANG ENV STAT COMP; Radford AN, 2003, J ANIM ECOL, V72, P258, DOI 10.1046/j.1365-2656.2003.00697.x; Rao C.R., 1964, SANKHYA A, V26, P329, DOI DOI 10.1214/AOMS/1177704248; RISING JD, 1989, AUK, V106, P666; Saino N, 1997, OECOLOGIA, V110, P186, DOI 10.1007/s004420050148; Sakai AK, 2001, ANNU REV ECOL SYST, V32, P305, DOI 10.1146/annurev.ecolsys.32.081501.114037; Sekercioglu CH, 2007, CONSERV BIOL, V21, P482, DOI 10.1111/j.1523-1739.2007.00655.x; Shine R, 2011, P NATL ACAD SCI USA, V108, pE348, DOI 10.1073/pnas.1108240108; Shine R, 2011, P NATL ACAD SCI USA, V108, P5708, DOI 10.1073/pnas.1018989108; Simmons AD, 2004, AM NAT, V164, P378, DOI 10.1086/423430; Slocum GL, 1995, THESIS AUSTR NATL U; Sol D, 2005, P NATL ACAD SCI USA, V102, P5460, DOI 10.1073/pnas.0408145102; Svenning JC, 2004, ECOL LETT, V7, P565, DOI 10.1111/j.1461-0248.2004.00614.x; Thompson M, 1996, S AFR J SCI, V92, P34; Travis JMJ, 2002, EVOL ECOL RES, V4, P1119; Travis JMJ, 2009, J THEOR BIOL, V259, P151, DOI 10.1016/j.jtbi.2009.03.008; Vaclavik T, 2012, DIVERS DISTRIB, V18, P73, DOI 10.1111/j.1472-4642.2011.00854.x	61	48	49	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38145	10.1371/journal.pone.0038145	http://dx.doi.org/10.1371/journal.pone.0038145			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693591	Green Published, gold			2022-12-27	WOS:000305338500094
J	Huse, SM; Ye, YZ; Zhou, YJ; Fodor, AA				Huse, Susan M.; Ye, Yuzhen; Zhou, Yanjiao; Fodor, Anthony A.			A Core Human Microbiome as Viewed through 16S rRNA Sequence Clusters	PLOS ONE			English	Article								We explore the microbiota of 18 body sites in over 200 individuals using sequences amplified V1-V3 and the V3-V5 small subunit ribosomal RNA (16S) hypervariable regions as part of the NIH Common Fund Human Microbiome Project. The body sites with the greatest number of core OTUs, defined as OTUs shared amongst 95% or more of the individuals, were the oral sites (saliva, tongue, cheek, gums, and throat) followed by the nose, stool, and skin, while the vaginal sites had the fewest number of OTUs shared across subjects. We found that commonalities between samples based on taxonomy could sometimes belie variability at the sub-genus OTU level. This was particularly apparent in the mouth where a given genus can be present in many different oral sites, but the sub-genus OTUs show very distinct site selection, and in the vaginal sites, which are consistently dominated by the Lactobacillus genus but have distinctly different sub-genus V1-V3 OTU populations across subjects. Different body sites show approximately a ten-fold difference in estimated microbial richness, with stool samples having the highest estimated richness, followed by the mouth, throat and gums, then by the skin, nasal and vaginal sites. Richness as measured by the V1-V3 primers was consistently higher than richness measured by V3-V5. We also show that when such a large cohort is analyzed at the genus level, most subjects fit the stool "enterotype" profile, but other subjects are intermediate, blurring the distinction between the enterotypes. When analyzed at the finer-scale, OTU level, there was little or no segregation into stool enterotypes, but in the vagina distinct biotypes were apparent. Finally, we note that even OTUs present in nearly every subject, or that dominate in some samples, showed orders of magnitude variation in relative abundance emphasizing the highly variable nature across individuals.	[Huse, Susan M.] Josephine Bay Paul Ctr, Marine Biol Lab, Woods Hole, MA USA; [Ye, Yuzhen] Indiana Univ, Sch Informat & Comp, Bloomington, IL USA; [Zhou, Yanjiao] Washington Univ, Sch Med, Genome Ctr, St Louis, MO USA; [Fodor, Anthony A.] Univ N Carolina, Dept Bioinformat & Gen, Charlotte, NC 28223 USA	Marine Biological Laboratory - Woods Hole; Indiana University System; Indiana University Bloomington; Washington University (WUSTL); University of North Carolina; University of North Carolina Charlotte	Huse, SM (corresponding author), Josephine Bay Paul Ctr, Marine Biol Lab, Woods Hole, MA USA.	shuse@mbl.edu			National Science Foundation [NSF-BDI 0960626]; National Institutes of Health (NIH) [1UH2DK083993-01]; NIH [1R01HG004908]; NIH-NHGRI [U54HG004968]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004908] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [UH2DK083993] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH-NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the following grants: National Science Foundation NSF-BDI 0960626 to Susan Huse, National Institutes of Health (NIH) 1UH2DK083993-01 to Vincent Young (SMH), NIH 1R01HG004908 to Yuzhen Ye, and NIH-NHGRI U54HG004968 to George Weinstock (YZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aargaard K, NATURE IN PRESS; Arumugam M, 2011, NATURE, V474, DOI 10.1038/nature10187; Bogaert D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017035; Bunge J, 2011, P 2011 PAC S BIOC; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Knights D, 2011, CELL HOST MICROBE, V10, P292, DOI 10.1016/j.chom.2011.09.003; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Office of Portfolio Analysis and Strategic Initiatives NIoH, 2008, NIH ROADM MED RES HU; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Wang Q, 2007, APPL ENVIRON MICROB; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Zhou X, 2010, INFECT DIS OBSTET GY	16	360	386	3	125	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e34242	10.1371/journal.pone.0034242	http://dx.doi.org/10.1371/journal.pone.0034242			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22719824	gold, Green Published			2022-12-27	WOS:000305341900007
J	Assefa, Y; Worku, A; Wouters, E; Koole, O; Mariam, DH; Van Damme, W				Assefa, Yibeltal; Worku, Alemayehu; Wouters, Edwin; Koole, Olivier; Mariam, Damen Haile; Van Damme, Wim			Simplified Tools for Measuring Retention in Care in Antiretroviral Treatment Program in Ethiopia: Cohort and Current Retention in Care	PLOS ONE			English	Article							INITIATION; THERAPY	Introduction: Patient retention in care is a critical challenge for antiretroviral treatment programs. This is mainly because retention in care is related to adherence to treatment and patient survival. It is therefore imperative that health facilities and programs measure patient retention in care. However, the currently available tools, such as Kaplan Meier, for measuring retention in care have a lot of practical limitations. The objective of this study was to develop simplified tools for measuring retention in care. Methods: Retrospective cohort data were collected from patient registers in nine health facilities in Ethiopia. Retention in care was the primary outcome for the study. Tools were developed to measure "current retention'' in care during a specific period of time for a specific "ART-age group'' and "cohort retention'' in care among patients who were followed for the last "Y'' number of years on ART. "Probability of retention'' based on the tool for "cohort retention'' in care was compared with "probability of retention'' based on Kaplan Meier. Results: We found that the new tools enable to measure "current retention'' and "cohort retention'' in care. We also found that the tools were easy to use and did not require advanced statistical skills. Both "current retention'' and "cohort retention'' are lower among patients in the first two "ART-age groups'' and "ART-age cohorts'' than in subsequent "ART-age groups'' and "ART-age cohorts''. The "probability of retention'' based on the new tools were found to be similar to the "probability of retention'' based on Kaplan Meier. Conclusion: The simplified tools for "current retention'' and "cohort retention'' will enable practitioners and program managers to measure and monitor rates of retention in care easily and appropriately. We therefore recommend that health facilities and programs start to use these tools in their efforts to improve retention in care and patient outcomes.	[Assefa, Yibeltal] Fed HIV AIDS Prevent & Control Off, Addis Ababa, Ethiopia; [Worku, Alemayehu; Mariam, Damen Haile] Univ Addis Ababa, Sch Publ Hlth, Addis Ababa, Ethiopia; [Wouters, Edwin] Univ Antwerp, Dept Social Sci, B-2020 Antwerp, Belgium; [Koole, Olivier] Inst Trop Med, Dept Clin Sci, B-2000 Antwerp, Belgium; [Assefa, Yibeltal; Van Damme, Wim] Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium	Addis Ababa University; University of Antwerp; Institute of Tropical Medicine (ITM); Institute of Tropical Medicine (ITM)	Assefa, Y (corresponding author), Fed HIV AIDS Prevent & Control Off, Addis Ababa, Ethiopia.	yibeltalassefa343@gmail.com	Wouters, Edwin/AAE-1649-2021; Assefa, Yibeltal/ABI-8057-2020; Assefa, Yibeltal/N-5984-2016; Van Damme, Wim/F-7404-2011	Wouters, Edwin/0000-0003-2268-3829; Assefa, Yibeltal/0000-0003-2393-1492; Assefa, Yibeltal/0000-0003-2393-1492; Van Damme, Wim/0000-0002-6344-3007; Koole, Olivier/0000-0002-1122-5382	Directorate General for Development and Cooperation of Belgium through the Institute of Tropical Medicine	Directorate General for Development and Cooperation of Belgium through the Institute of Tropical Medicine	The Directorate General for Development and Cooperation of Belgium supported this study through the Institute of Tropical Medicine. The funders had no role in study design, data collection, and analysis, decision to publish, or preparations of the manuscript.	Assefa Yibeltal, 2008, Ethiop Med J, V46, P401; Assefa Y, 2010, AIDS PATIENT CARE ST, V24, P521, DOI 10.1089/apc.2009.0286; Assefa Y, 2010, CURR OPIN HIV AIDS, V5, P78, DOI 10.1097/COH.0b013e328333b87a; Assefa Y, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000056; Berg MB, 2005, AIDS CARE, V17, P902, DOI 10.1080/09540120500101658; Hogg RS, 1998, JAMA-J AM MED ASSOC, V279, P450, DOI 10.1001/jama.279.6.450; Hsiej JJ, 1999, BIOMETRICAL J, V83, P143; Ministry of Health of Ethiopia, SINGL POINT HIV PREV; Pox MP, 2009, TROP MED INT HEALTH, V15, P1; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; Schilder AJ, 2001, SOC SCI MED, V52, P1643, DOI 10.1016/S0277-9536(00)00274-4; Tassie JM, 2010, JAIDS-J ACQ IMM DEF, V54, P437, DOI 10.1097/QAI.0b013e3181d73e1b; *WHO, UN ACC SCAL PRIOR HI; *WHO, TREAT 3 MILL 2005 MA; WHO, COUNTR EXP IMPL PAT	15	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2012	7	6							e38555	10.1371/journal.pone.0038555	http://dx.doi.org/10.1371/journal.pone.0038555			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TU	22701663	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000305337600029
J	Barbosa, HSC; Fernandes, TG; Dias, TP; Diogo, MM; Cabral, JMS				Barbosa, Helder S. C.; Fernandes, Tiago G.; Dias, Tiago P.; Diogo, Maria Margarida; Cabral, Joaquim M. S.			New Insights into the Mechanisms of Embryonic Stem Cell Self-Renewal under Hypoxia: A Multifactorial Analysis Approach	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; BETA-CATENIN; IN-VITRO; PLURIPOTENCY; WNT; ACTIVATION; BIOLOGY; OXYGEN; DIFFERENTIATION; PROLIFERATION	Previous reports have shown that culturing mouse embryonic stem (mES) cells at different oxygen tensions originated different cell proliferation patterns and commitment stages depending on which signaling pathways are activated or inhibited to support the pluripotency state. Herein we provide new insights into the mechanisms by which oxygen is influencing mES cell self-renewal and pluripotency. A multifactorial approach was developed to rationally evaluate the singular and interactive control of MEK/ERK pathway, GSK-3 inhibition, and LIF/STAT3 signaling at physiological and non-physiological oxygen tensions. Collectively, our methodology revealed a significant role of GSK-3-mediated signaling towards maintenance of mES cell pluripotency at lower O-2 tensions. Given the central role of this signaling pathway, future studies will need to focus on the downstream mechanisms involved in ES cell self-renewal under such conditions, and ultimately how these findings impact human models of pluripotency.	[Barbosa, Helder S. C.] Univ Tecn Lisboa, Inst Super Tecn, Ctr Biol & Chem Engn, Dept Bioengn, P-1096 Lisbon, Portugal; Univ Tecn Lisboa, Inst Super Tecn, Ctr Biol & Chem Engn, Inst Biotechnol & Bioengn, P-1096 Lisbon, Portugal	Universidade de Lisboa; Instituto Superior Tecnico; Universidade de Lisboa; Instituto Superior Tecnico	Barbosa, HSC (corresponding author), Univ Tecn Lisboa, Inst Super Tecn, Ctr Biol & Chem Engn, Dept Bioengn, P-1096 Lisbon, Portugal.	joaquim.cabral@ist.utl.pt	Diogo, Maria Margarida/K-6117-2012; Dias, Tiago P./A-3371-2017; Cabral, Joaquim M S/G-2052-2010; Diogo, Margarida/ABF-4341-2020; Pillay, Nischalan/F-9536-2012; Fernandes, Tiago G./C-3865-2009	Dias, Tiago P./0000-0001-9133-8856; Cabral, Joaquim M S/0000-0002-2405-5845; Fernandes, Tiago G./0000-0002-4651-2832; Diogo, Maria Margarida/0000-0002-6270-4455	Fundacao para a Ciencia e a Tecnologia, Portugal [SFRH/BPD/65834/2009, SFRH/BPD/65439/2009, SFRH/BD/78774/2011]; Fundacao para a Ciencia e Tecnologia (FCT) through the Compromisso para a Ciencia Program; MIT-Portugal Program;  [PTDC/EQU-ERQ/105277/2008];  [PTDC/EBB-BIO/101088/2008]	Fundacao para a Ciencia e a Tecnologia, Portugal(Portuguese Foundation for Science and Technology); Fundacao para a Ciencia e Tecnologia (FCT) through the Compromisso para a Ciencia Program; MIT-Portugal Program; ; 	HSCB, TGF and TPD acknowledge support from Fundacao para a Ciencia e a Tecnologia, Portugal (SFRH/BPD/65834/2009, SFRH/BPD/65439/2009 and SFRH/BD/78774/2011, respectively). This work was financially supported by Fundacao para a Ciencia e Tecnologia (FCT) through the Compromisso para a Ciencia 2007 Program, the MIT-Portugal Program and projects PTDC/EQU-ERQ/105277/2008 and PTDC/EBB-BIO/101088/2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade PZ, 2010, MOL BIOSYST, V6, P1207, DOI 10.1039/b922637k; Barker N, 2000, ADV CANCER RES, V77, P1; Bone HK, 2009, CHEM BIOL, V16, P15, DOI 10.1016/j.chembiol.2008.11.003; BOX G.E.P., 2005, STAT EXPT DESIGN INN; Brantjes H, 2002, BIOL CHEM, V383, P255, DOI 10.1515/BC.2002.027; Burdon T, 1999, DEV BIOL, V210, P30, DOI 10.1006/dbio.1999.9265; Cameron CM, 2008, EXP BIOL MED, V233, P1044, DOI 10.3181/0709-RM-263; Cartwright P, 2005, DEVELOPMENT, V132, P885, DOI 10.1242/dev.01670; Cimetta E, 2010, LAB CHIP, V10, P3277, DOI 10.1039/c0lc00033g; Covello KL, 2006, GENE DEV, V20, P557, DOI 10.1101/gad.1399906; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Da Silva CL, 2009, J CELL PHYSIOL, V220, P102, DOI 10.1002/jcp.21736; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Fernandes TG, 2010, STEM CELL RES, V5, P76, DOI 10.1016/j.scr.2010.04.003; Fernandes TG, 2010, BIOTECHNOL BIOENG, V106, P106, DOI 10.1002/bit.22661; Fernandes TG, 2009, TRENDS BIOTECHNOL, V27, P342, DOI 10.1016/j.tibtech.2009.02.009; Gordan JD, 2007, CANCER CELL, V11, P335, DOI 10.1016/j.ccr.2007.02.006; Hanna J, 2009, CELL STEM CELL, V4, P513, DOI 10.1016/j.stem.2009.04.015; Hao J, 2006, DEV BIOL, V290, P81, DOI 10.1016/j.ydbio.2005.11.011; Ivanovic Z, 2009, J CELL PHYSIOL, V219, P271, DOI 10.1002/jcp.21690; Jeong CH, 2007, J BIOL CHEM, V282, P13672, DOI 10.1074/jbc.M700534200; Jung JP, 2011, INTEGR BIOL-UK, V3, P185, DOI 10.1039/c0ib00112k; Kaufman DS, 2010, NAT CELL BIOL, V12, P926, DOI 10.1038/ncb1010-926; Kelly KF, 2011, CELL STEM CELL, V8, P214, DOI 10.1016/j.stem.2010.12.010; Kim JW, 2007, MOL CELL BIOL, V27, P7381, DOI 10.1128/MCB.00440-07; Klimanskaya I, 2008, NAT REV DRUG DISCOV, V7, P131, DOI 10.1038/nrd2403; Kunath T, 2007, DEVELOPMENT, V134, P2895, DOI 10.1242/dev.02880; Lee YM, 2001, DEV DYNAM, V220, P175, DOI 10.1002/1097-0177(20010201)220:2<175::AID-DVDY1101>3.0.CO;2-F; MacArthur BD, 2008, COLD SH Q B, V73, P211, DOI 10.1101/sqb.2008.73.061; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; Maltepe E, 1998, J MOL MED-JMM, V76, P391, DOI 10.1007/s001090050231; Mazumdar J, 2010, NAT CELL BIOL, V12, P1007, DOI 10.1038/ncb2102; Meijer L, 2004, TRENDS PHARMACOL SCI, V25, P471, DOI 10.1016/j.tips.2004.07.006; Mohyeldin A, 2010, CELL STEM CELL, V7, P150, DOI 10.1016/j.stem.2010.07.007; Mottet D, 2003, J BIOL CHEM, V278, P31277, DOI 10.1074/jbc.M300763200; Novak A, 1999, CELL MOL LIFE SCI, V56, P523, DOI 10.1007/s000180050449; Ogawa K, 2006, BIOCHEM BIOPH RES CO, V343, P159, DOI 10.1016/j.bbrc.2006.02.127; Paling NRD, 2004, J BIOL CHEM, V279, P48063, DOI 10.1074/jbc.M406467200; Patel SA, 2008, CELL DEATH DIFFER, V15, P628, DOI 10.1038/cdd.2008.17; Pouton CW, 2005, ADV DRUG DELIVER REV, V57, P1918, DOI 10.1016/j.addr.2005.08.003; Powers DE, 2008, BIOTECHNOL BIOENG, V101, P241, DOI 10.1002/bit.21986; PULVERER BJ, 1994, ONCOGENE, V9, P59; Ring DB, 2003, DIABETES, V52, P588, DOI 10.2337/diabetes.52.3.588; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435; Woodgett J R, 2001, Sci STKE, V2001, pre12, DOI 10.1126/stke.2001.100.re12; Wray J, 2011, NAT CELL BIOL, V13, P838, DOI 10.1038/ncb2267; Wray J, 2010, BIOCHEM SOC T, V38, P1027, DOI 10.1042/BST0381027; Wu DQ, 2010, TRENDS BIOCHEM SCI, V35, P161, DOI 10.1016/j.tibs.2009.10.002; Yi F, 2011, NAT CELL BIOL, V13, P762, DOI 10.1038/ncb2283; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X	53	21	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2012	7	6							e38963	10.1371/journal.pone.0038963	http://dx.doi.org/10.1371/journal.pone.0038963			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TU	22701736	Green Published, gold, Green Submitted			2022-12-27	WOS:000305337600062
J	Maddi, A; Fu, C; Free, SJ				Maddi, Abhiram; Fu, Ci; Free, Stephen J.			The Neurospora crassa dfg5 and dcw1 Genes Encode alpha-1,6-Mannanases That Function in the Incorporation of Glycoproteins into the Cell Wall	PLOS ONE			English	Article							GPI-ANCHORED PROTEINS; SACCHAROMYCES-CEREVISIAE; NEUROSPORA-CRASSA; CANDIDA-ALBICANS; FUNGAL CELL; LINKED OLIGOSACCHARIDES; CROSS-LINKING; OUTER CHAIN; GROWTH; OCH1	The covalent cross-linking of cell wall proteins into the cell wall glucan/chitin matrix is an important step in the biogenesis of the fungal cell wall. We demonstrate that the Neurospora crassa DFG5 (NCU03770) and DCW1 (NCU08127) enzymes function in vivo to cross-link glycoproteins into the cell wall. Mutants lacking DFG5 or DCW1 release slightly elevated levels of cell wall proteins into their growth medium. Mutants lacking both DFG5 and DCW1 have substantially reduced levels of cell wall proteins in their cell walls and release large amounts of known cell wall proteins into the medium. DFG5 and DCW1 are members of the GH76 family of glycosyl hydrolases, which have specificity to recognize and cleave alpha-1,6-mannans. A model for incorporation of glycoproteins into the cell wall through the alpha-1,6-mannan core of the N-linked galactomannan is presented. In this model, DFG5 and DCW1 recognize the N-linked galactomannan present on glycoproteins and cross-link it into the cell wall glucan/chitin matrix.	[Maddi, Abhiram] SUNY Buffalo, Sch Dent Med, Dept Periodont & Endodont, Buffalo, NY 14260 USA; [Fu, Ci; Free, Stephen J.] SUNY Buffalo, Dept Biol Sci, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Maddi, A (corresponding author), SUNY Buffalo, Sch Dent Med, Dept Periodont & Endodont, Buffalo, NY 14260 USA.	free@buffalo.edu	Maddi, Abhiram/L-1696-2019; Maddi, Abhiram/B-3895-2018	Maddi, Abhiram/0000-0001-9565-408X; Maddi, Abhiram/0000-0001-9565-408X	National Institutes of Health [R01 GM078589]; UB Foundation; Department of Energy [DE-FG02-09ER-20097]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078589] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UB Foundation; Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by grant R01 GM078589 from the National Institutes of Health and by funds from the UB Foundation. The research was supported in part by the Department of Energy-funded (DE-FG02-09ER-20097) Center for Plant and Microbial Complex Carbohydrates. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldabbous MS, 2010, MICROBIOL-SGM, V156, P2621, DOI 10.1099/mic.0.040147-0; Bowman SM, 2006, BIOESSAYS, V28, P799, DOI 10.1002/bies.20441; Bowman SM, 2006, EUKARYOT CELL, V5, P587, DOI 10.1128/EC.5.3.587-600.2006; Cabib E, 2007, MOL MICROBIOL, V63, P921, DOI 10.1111/j.1365-2958.2006.05565.x; Colot HV, 2006, P NATL ACAD SCI USA, V103, P10352, DOI 10.1073/pnas.0601456103; Davis R.H., 1970, 789 METHODS ENZYMOLO, VVolume 17, P79, DOI DOI 10.1016/0076-6879(71)17168-6; de Groot PWJ, 2009, FUNGAL GENET BIOL, V46, pS72, DOI 10.1016/j.fgb.2008.07.022; Deshpande N, 2008, GLYCOBIOLOGY, V18, P626, DOI 10.1093/glycob/cwn044; Fujii T, 1999, BBA-GEN SUBJECTS, V1427, P133, DOI 10.1016/S0304-4165(99)00012-4; GOLDMAN RC, 1995, EUR J BIOCHEM, V227, P372, DOI 10.1111/j.1432-1033.1995.tb20399.x; Gonzalez M, 2010, YEAST, V27, P583, DOI 10.1002/yea.1797; Kitagaki H, 2004, EUKARYOT CELL, V3, P1297, DOI 10.1128/EC.3.5.1297-1306.2004; Kitagaki H, 2002, MOL MICROBIOL, V46, P1011, DOI 10.1046/j.1365-2958.2002.03244.x; Klis FM, 2009, FEMS YEAST RES, V9, P1013, DOI 10.1111/j.1567-1364.2009.00541.x; Lambou K, 2010, YEAST, V27, P625, DOI 10.1002/yea.1798; Latge JP, 2007, MOL MICROBIOL, V66, P279, DOI 10.1111/j.1365-2958.2007.05872.x; Lesage G, 2006, MICROBIOL MOL BIOL R, V70, P317, DOI 10.1128/MMBR.00038-05; LU CF, 1995, J CELL BIOL, V128, P333, DOI 10.1083/jcb.128.3.333; Maddi A, 2010, EUKARYOT CELL, V9, P1766, DOI 10.1128/EC.00134-10; Maddi A, 2009, FUNGAL GENET BIOL, V46, P768, DOI 10.1016/j.fgb.2009.06.005; Maniatis T., 1982, MOL CLONING LAB MANU; Margolin BS, 1997, FUNGAL GENET NEWSLET, V44, P34, DOI [10.4148/1941-4765.1281, DOI 10.1128/EC.00244-07]; McCluskey K, 2010, J BIOSCIENCES, V35, P119, DOI 10.1007/s12038-010-0014-6; Mosch HU, 1997, GENETICS, V145, P671; Mouyna I, 2000, J BIOL CHEM, V275, P14882, DOI 10.1074/jbc.275.20.14882; NAKAJIMA T, 1984, J BIOCHEM, V96, P1013, DOI 10.1093/oxfordjournals.jbchem.a134917; NAKANISHISHINDO Y, 1993, J BIOL CHEM, V268, P26338; NAKAYAMA K, 1992, EMBO J, V11, P2511, DOI 10.1002/j.1460-2075.1992.tb05316.x; Plaine A, 2008, FUNGAL GENET BIOL, V45, P1404, DOI 10.1016/j.fgb.2008.08.003; Selker EU, 1999, CELL, V97, P157, DOI 10.1016/S0092-8674(00)80725-4; Spreghini E, 2003, EUKARYOT CELL, V2, P746, DOI 10.1128/EC.2.4.746-755.2003	31	41	41	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2012	7	6							e38872	10.1371/journal.pone.0038872	http://dx.doi.org/10.1371/journal.pone.0038872			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TU	22701726	gold, Green Submitted, Green Published			2022-12-27	WOS:000305337600053
J	Jensen-Smith, HC; Hallworth, R; Nichols, MG				Jensen-Smith, Heather C.; Hallworth, Richard; Nichols, Michael G.			Gentamicin Rapidly Inhibits Mitochondrial Metabolism in High-Frequency Cochlear Outer Hair Cells	PLOS ONE			English	Article							RIBOSOMAL-RNA; DEHYDROGENASE ACTIVITY; INTRACELLULAR ATP; INDUCED APOPTOSIS; IN-VITRO; DEATH; MECHANISMS; SUCCINATE; OTOTOXICITY; ANTIBIOTICS	Aminoglycosides (AG), including gentamicin (GM), are the most frequently used antibiotics in the world and are proposed to cause irreversible cochlear damage and hearing loss (HL) in 1/4 of the patients receiving these life-saving drugs. Akin to the results of AG ototoxicity studies, high-frequency, basal turn outer hair cells (OHCs) preferentially succumb to multiple HL pathologies while inner hair cells (IHCs) are much more resilient. To determine if endogenous differences in IHC and OHC mitochondrial metabolism dictate differential sensitivities to AG-induced HL, IHC- and OHC-specific changes in mitochondrial reduced nicotinamide adenine dinucleotide (NADH) fluorescence during acute (1 h) GM treatment were compared. GM-mediated decreases in NADH fluorescence and succinate dehydrogenase activity were observed shortly after GM application. High-frequency basal turn OHCs were found to be metabolically biased to rapidly respond to alterations in their microenvironment including GM and elevated glucose exposures. These metabolic biases may predispose high-frequency OHCs to preferentially produce cell-damaging reactive oxygen species during traumatic challenge. Noise-induced and age-related HL pathologies share key characteristics with AG ototoxicity, including preferential OHC loss and reactive oxygen species production. Data from this report highlight the need to address the role of mitochondrial metabolism in regulating AG ototoxicity and the need to illuminate how fundamental differences in IHC and OHC metabolism may dictate differences in HC fate during multiple HL pathologies.	[Jensen-Smith, Heather C.; Hallworth, Richard] Creighton Univ, Dept Biomed Sci, Omaha, NE 68178 USA; [Nichols, Michael G.] Creighton Univ, Dept Phys, Omaha, NE 68178 USA	Creighton University; Creighton University	Jensen-Smith, HC (corresponding author), Creighton Univ, Dept Biomed Sci, Omaha, NE 68178 USA.	heathersmith@creighton.edu		Nichols, Michael/0000-0002-6565-6743	NIGM, NIH [R15-GM085776]; National Center for Research Resources [5P20RR016469]; National Institute for General Medical Science (NIGMS), a component of the National Institutes of Health (NIH) [8P20GM103427]; Creighton University Medical School; Nebraska EPSCoR program; National Center for Research Resources, NIH, USA [RR17417-01]; NCRR, NIH [G20 RR024001]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR017417, G20RR024001, P20RR016469] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103427, R15GM085776, P20GM103471] Funding Source: NIH RePORTER	NIGM, NIH; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute for General Medical Science (NIGMS), a component of the National Institutes of Health (NIH); Creighton University Medical School; Nebraska EPSCoR program; National Center for Research Resources, NIH, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	MGN was supported by R15-GM085776 (NIGM, NIH). This publication was also made possible by grants from the National Center for Research Resources (5P20RR016469) and the National Institute for General Medical Science (NIGMS) (8P20GM103427), a component of the National Institutes of Health (NIH). This research was conducted at the Integrated Biomedical Imaging Facility at Creighton University (CUIBIF), Omaha, NE. This facility, supported by the Creighton University Medical School and Nebraska EPSCoR program, is part of a research space that was constructed with support from C06 Grant RR17417-01 from the National Center for Research Resources, NIH, USA. Animal care facilities for this project were supported by G20 RR024001 from the NCRR, NIH. This investigation is solely the responsibility of the author and does not necessarily represent the official views of NIGMS, NCRR or NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abi-Hachem Ralph N, 2010, Recent Pat CNS Drug Discov, V5, P147; Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Alharazneh A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022347; Banfi B, 2004, J BIOL CHEM, V279, P46065, DOI 10.1074/jbc.M403046200; Bindu LH, 2008, INT J AUDIOL, V47, P702, DOI 10.1080/14992020802215862; Bottger EC, 2010, ANTIMICROB AGENTS CH, V54, P3073, DOI 10.1128/AAC.01819-09; CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527; Chen GD, 2000, HEARING RES, V145, P91, DOI 10.1016/S0378-5955(00)00076-9; Cheng AG, 2003, JARO, V4, P91, DOI 10.1007/s10162-002-3016-8; Cunningham LL, 2002, J NEUROSCI, V22, P8532; de Beeck KO, 2011, HEARING RES, V281, P18, DOI 10.1016/j.heares.2011.07.002; Dehne N, 2002, HEARING RES, V169, P47, DOI 10.1016/S0378-5955(02)00338-6; Ding DL, 2010, HEARING RES, V259, P16, DOI 10.1016/j.heares.2009.08.008; Ding DL, 2001, HANDBOOK OF MOUSE AUDITORY RESEARCH: FROM BEHAVIOR TO MOLECULAR BIOLOGY, P189, DOI 10.1201/9781420038736.ch13; Ding DL, 1999, ANN NY ACAD SCI, V884, P152, DOI 10.1111/j.1749-6632.1999.tb08640.x; Eguchi Y, 1997, CANCER RES, V57, P1835; Fischel-Ghodsian N, 1999, HUM MUTAT, V13, P261, DOI 10.1002/(SICI)1098-1004(1999)13:4<261::AID-HUMU1>3.0.CO;2-W; Forge A, 2000, HEARING RES, V139, P97, DOI 10.1016/S0378-5955(99)00177-X; Forkink M, 2010, BBA-BIOENERGETICS, V1797, P1034, DOI 10.1016/j.bbabio.2010.01.022; Fredelius L, 2001, ORL J OTO-RHINO-LARY, V63, P12, DOI 10.1159/000055700; Gropper S.S., 2008, CENGAGE LEARNING; Hashino E, 1995, BRAIN RES, V704, P135, DOI 10.1016/0006-8993(95)01198-6; Heikal AA, 2010, BIOMARK MED, V4, P241, DOI 10.2217/BMM.10.1; Hobbie SN, 2008, P NATL ACAD SCI USA, V105, P3244, DOI 10.1073/pnas.0707265105; Hobbie SN, 2008, P NATL ACAD SCI USA, V105, P20888, DOI 10.1073/pnas.0811258106; HORN KL, 1978, ARCH OTOLARYNGOL, V104, P42; Hu BH, 2008, HEARING RES, V236, P11, DOI 10.1016/j.heares.2007.11.002; Huth ME, 2011, INT J OTOLARYNGOL, V2011, DOI DOI 10.1155/2011/937861; Jiang H, 2006, CELL DEATH DIFFER, V13, P20, DOI 10.1038/sj.cdd.4401706; Jiang H, 2006, J NEUROSCI RES, V83, P1544, DOI 10.1002/jnr.20833; Karnes HE, 2010, J AM ACAD AUDIOL, V21, P204, DOI 10.3766/jaaa.21.3.9; Kim HJ, 2010, J NEUROSCI, V30, P3933, DOI 10.1523/JNEUROSCI.6054-09.2010; Koopman Werner J H, 2010, Antioxid Redox Signal, V12, P1431, DOI 10.1089/ars.2009.2743; Lancaster CRD, 2002, BBA-BIOENERGETICS, V1553, P1, DOI 10.1016/S0005-2728(01)00240-7; Leist M, 1997, J EXP MED, V185, P1481, DOI 10.1084/jem.185.8.1481; Marcotti W, 2005, J PHYSIOL-LONDON, V567, P505, DOI 10.1113/jphysiol.2005.085951; Matsui JI, 2004, J NEUROBIOL, V61, P250, DOI 10.1002/neu.20054; Mayevsky A, 2007, AM J PHYSIOL-CELL PH, V292, pC615, DOI 10.1152/ajpcell.00249.2006; McFadden SL, 2004, BRAIN RES, V997, P40, DOI 10.1016/j.brainres.2003.10.031; Mukherjea D, 2008, J NEUROSCI, V28, P13056, DOI 10.1523/JNEUROSCI.1307-08.2008; Nicotera P, 1998, TOXICOL LETT, V103, P139; Nicotera TM, 2003, JARO-J ASSOC RES OTO, V4, P466, DOI 10.1007/s10162-002-3038-2; Ohlemiller KK, 1999, AUDIOL NEURO-OTOL, V4, P229, DOI 10.1159/000013846; Pandya A, 1993, NONSYNDROMIC HEARING; Poirrier AL, 2010, CURR MED CHEM, V17, P3591; PREZANT TR, 1993, NAT GENET, V4, P289, DOI 10.1038/ng0793-289; Qian YP, 2009, ANTIMICROB AGENTS CH, V53, P4612, DOI 10.1128/AAC.00965-08; Ralph SJ, 2011, PHARM RES-DORDR, V28, P2695, DOI 10.1007/s11095-011-0566-7; Rizzi Mark Douglas, 2007, Curr Opin Otolaryngol Head Neck Surg, V15, P352, DOI 10.1097/MOO.0b013e3282ef772d; Rybak LP, 2007, KIDNEY INT, V72, P931, DOI 10.1038/sj.ki.5002434; Rybak Leonard P, 2005, Int Tinnitus J, V11, P23; Rybak LP, 2005, DRUG DISCOV TODAY, V10, P1313, DOI 10.1016/S1359-6446(05)03552-X; Shadel GS, 2004, TRENDS GENET, V20, P513, DOI 10.1016/j.tig.2004.08.005; Shulman A, 1999, ANN NY ACAD SCI, V884, P433, DOI 10.1111/j.1749-6632.1999.tb08660.x; Sokolova IM, 2004, J EXP BIOL, V207, P3369, DOI 10.1242/jeb.01152; Someya S, 2010, MECH AGEING DEV, V131, P480, DOI 10.1016/j.mad.2010.04.006; Tabuchi K, 2011, CURR MED CHEM; Tiede L, 2009, BRAIN RES, V1277, P37, DOI 10.1016/j.brainres.2009.02.052; Tiede LM, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2714777; Warchol ME, 2010, CURR OPIN OTOLARYNGO, V18, P454, DOI 10.1097/MOO.0b013e32833e05ec; Wirmer J, 2006, METHOD ENZYMOL, V415, P180, DOI 10.1016/S0076-6879(06)15012-0; Wu WJ, 2002, AUDIOL NEURO-OTOL, V7, P171, DOI 10.1159/000058305; Xie J, 2011, HEARING RES, V281, P28, DOI 10.1016/j.heares.2011.05.008; YANG FS, 1991, EUR ARCH OTO-RHINO-L, V248, P195; Yang WP, 2010, CHINESE MED J-PEKING, V123, P1633, DOI 10.3760/cma.j.issn.0366-6999.2010.13.004; Yorgason JG, 2011, EXPERT OPIN DRUG MET, V7, P1521, DOI 10.1517/17425255.2011.614231; Zhao LD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023729; Ziegler M, 2000, EUR J BIOCHEM, V267, P1550, DOI 10.1046/j.1432-1327.2000.01187.x	68	46	46	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2012	7	6							e38471	10.1371/journal.pone.0038471	http://dx.doi.org/10.1371/journal.pone.0038471			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TQ	22715386	gold, Green Published, Green Submitted			2022-12-27	WOS:000305336800028
J	Menoud, A; Welle, M; Tetens, J; Lichtner, P; Drogemuller, C				Menoud, Annie; Welle, Monika; Tetens, Jens; Lichtner, Peter; Droegemueller, Cord			A COL7A1 Mutation Causes Dystrophic Epidermolysis Bullosa in Rotes Hohenvieh Cattle	PLOS ONE			English	Article							VII COLLAGEN GENE; MECHANOBULLOUS DISEASE; ANIMAL-MODEL; CLASSIFICATION; DIAGNOSIS	We identified a congenital mechanobullous skin disorder in six calves on a single farm of an endangered German cattle breed in 2010. The condition presented as a large loss of skin distal to the fetlocks and at the mucosa of the muzzle. All affected calves were euthanized on humane grounds due to the severity, extent and progression of the skin and oral lesions. Examination of skin samples under light microscopy revealed detachment of the epidermis from the dermis at the level of the dermo epidermal junction, leading to the diagnosis of a subepidermal bullous dermatosis such as epidermolysis bullosa. The pedigree was consistent with monogenic autosomal recessive inheritance. We localized the causative mutation to an 18 Mb interval on chromosome 22 by homozygosity mapping. The COL7A1 gene encoding collagen type VII alpha 1 is located within this interval and COL7A1 mutations have been shown to cause inherited dystrophic epidermolysis bullosa (DEB) in humans. A SNP in the bovine COL7A1 exon 49 (c.4756C>T) was perfectly associated with the observed disease. The homozygous mutant T/T genotype was exclusively present in affected calves and their parents were heterozygous C/T confirming the assumed recessive mode of inheritance. All known cases and genotyped carriers were related to a single cow, which is supposed to be the founder animal. The mutant T allele was absent in 63 animals from 24 cattle breeds. The identified mutation causes a premature stop codon which leads to a truncated protein representing a complete loss of COL7A1 function (p.R1586*). We thus have identified a candidate causative mutation for this genetic disease using only three cases to unravel its molecular basis. Selection against this mutation can now be used to eliminate the mutant allele from the Rotes Hohenvieh breed.	[Menoud, Annie; Droegemueller, Cord] Univ Bern, Vetsuisse Fac, Inst Genet, Bern, Switzerland; [Welle, Monika] Univ Bern, Vetsuisse Fac, Inst Anim Pathol, Bern, Switzerland; [Tetens, Jens] Univ Kiel, Inst Anim Breeding & Husb, Kiel, Germany; [Lichtner, Peter] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Human Genet, Neuherberg, Germany; [Welle, Monika; Droegemueller, Cord] Univ Bern, Vetsuisse Fac, DermFocus, Bern, Switzerland	University of Bern; University of Bern; University of Kiel; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Bern	Menoud, A (corresponding author), Univ Bern, Vetsuisse Fac, Inst Genet, Bern, Switzerland.	cord.droegemueller@vetsuisse.unibe.ch	Welle, Monika Maria/ABF-6113-2021; Tetens, Jens/H-5344-2012	Tetens, Jens/0000-0001-5352-464X; Drogemuller, Cord/0000-0001-9773-522X	H.W. Schaumann Stiftung, Hamburg, Germany	H.W. Schaumann Stiftung, Hamburg, Germany	The project and AM were supported by a grant of the H.W. Schaumann Stiftung, Hamburg, Germany. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahr C, 2004, TIERAERZTL PRAX G N, V32, P205; Baldeschi C, 2003, HUM MOL GENET, V12, P1897, DOI 10.1093/hmg/ddg200; BRUCKNERTUDERMAN L, 1991, J INVEST DERMATOL, V96, P452, DOI 10.1111/1523-1747.ep12470130; CHRISTIANO AM, 1993, NAT GENET, V4, P62, DOI 10.1038/ng0593-62; CHRISTIANO AM, 1995, J CLIN INVEST, V95, P1328, DOI 10.1172/JCI117783; Drogemuller C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018931; Fine JD, 2000, J AM ACAD DERMATOL, V42, P1051, DOI 10.1016/S0190-9622(00)90302-5; Fine JD, 2008, J AM ACAD DERMATOL, V58, P931, DOI 10.1016/j.jaad.2008.02.004; Fine JD, 2010, CURR OPIN PEDIATR, V22, P453, DOI 10.1097/MOP.0b013e32833bb74f; Ford CA, 2005, J INVEST DERMATOL, V124, P1170, DOI 10.1111/j.0022-202X.2005.23610.x; Foster AP, 2010, J COMP PATHOL, V142, P336, DOI 10.1016/j.jcpa.2009.10.001; Fritsch A, 2008, J CLIN INVEST, V118, P1669, DOI 10.1172/JCI34292; Guaguere E, 2003, B ACAD VET FRANCE, V157, P47; HOVNANIAN A, 1994, AM J HUM GENET, V55, P289; Kehr C, 2010, ZUCHTUNGSKUNDE, V82, P387; Kern JS, 2009, BRIT J DERMATOL, V161, P1089, DOI 10.1111/j.1365-2133.2009.09333.x; Kern JS, 2006, J INVEST DERMATOL, V126, P1006, DOI 10.1038/sj.jid.5700219; Magnol JP, 2005, B ACAD NAT MED PARIS, V189, P107, DOI 10.1016/S0001-4079(19)33609-X; Medeiros GX, 2012, J VET DIAGN INVEST, V24, P231, DOI 10.1177/1040638711425953; Momke S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018943; Olivry T, 1999, VET PATHOL, V36, P616, DOI 10.1354/vp.36-6-616; Palazzi X, 2000, J INVEST DERMATOL, V115, P135, DOI 10.1046/j.1523-1747.2000.00031-5.x; Spirito F, 2002, J INVEST DERMATOL, V119, P684, DOI 10.1046/j.1523-1747.2002.01852.x; THOMPSON KG, 1985, VET PATHOL, V22, P283, DOI 10.1177/030098588502200311; Uitto J, 2004, J INVEST DERMATOL, V123, pXII, DOI 10.1111/j.0022-202X.2004.23333.x	25	11	11	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2012	7	6							e38823	10.1371/journal.pone.0038823	http://dx.doi.org/10.1371/journal.pone.0038823			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TQ	22715415	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336800057
J	Morgan, B; Terburg, D; Thornton, HB; Stein, DJ; van Honk, J				Morgan, Barak; Terburg, David; Thornton, Helena B.; Stein, Dan J.; van Honk, Jack			Paradoxical Facilitation of Working Memory after Basolateral Amygdala Damage	PLOS ONE			English	Article							URBACH-WIETHE-DISEASE; PREFRONTAL CORTEX; INDIVIDUAL-DIFFERENCES; FUNCTIONAL CONNECTIVITY; PERIAQUEDUCTAL GRAY; EMOTION; BRAIN; COGNITION; FEAR; HUMANS	Working memory is a vital cognitive capacity without which meaningful thinking and logical reasoning would be impossible. Working memory is integrally dependent upon prefrontal cortex and it has been suggested that voluntary control of working memory, enabling sustained emotion inhibition, was the crucial step in the evolution of modern humans. Consistent with this, recent fMRI studies suggest that working memory performance depends upon the capacity of prefrontal cortex to suppress bottom-up amygdala signals during emotional arousal. However fMRI is not well-suited to definitively resolve questions of causality. Moreover, the amygdala is neither structurally or functionally homogenous and fMRI studies do not resolve which amygdala sub-regions interfere with working memory. Lesion studies on the other hand can contribute unique causal evidence on aspects of brain-behaviour phenomena fMRI cannot "see". To address these questions we investigated working memory performance in three adult female subjects with bilateral basolateral amygdala calcification consequent to Urbach-Wiethe Disease and ten healthy controls. Amygdala lesion extent and functionality was determined by structural and functional MRI methods. Working memory performance was assessed using the Wechsler Adult Intelligence Scale-III digit span forward task. State and trait anxiety measures to control for possible emotional differences between patient and control groups were administered. Structural MRI showed bilateral selective basolateral amygdala damage in the three Urbach-Wiethe Disease subjects and fMRI confirmed intact functionality in the remaining amygdala sub-regions. The three Urbach-Wiethe Disease subjects showed significant working memory facilitation relative to controls. Control measures showed no group anxiety differences. Results are provisionally interpreted in terms of a 'cooperation through competition' networks model that may account for the observed paradoxical functional facilitation effect.	[Morgan, Barak] Univ Cape Town, MRC Med Imaging Res Unit, Dept Human Biol, ZA-7925 Cape Town, South Africa; [Terburg, David; van Honk, Jack] Univ Utrecht, Dept Psychol, Utrecht, Netherlands; [Thornton, Helena B.; Stein, Dan J.; van Honk, Jack] Univ Cape Town, Dept Psychiat & Mental Hlth, ZA-7925 Cape Town, South Africa	University of Cape Town; Utrecht University; University of Cape Town	Morgan, B (corresponding author), Univ Cape Town, MRC Med Imaging Res Unit, Dept Human Biol, ZA-7925 Cape Town, South Africa.	barak.morgan@uct.ac.za	Stein, Dan/A-1752-2008	Stein, Dan/0000-0001-7218-7810; Terburg, David/0000-0003-2356-8734; Morgan, Barak/0000-0002-9380-431X	DST/MRC Professional Development Program; Hope For Depression Foundation	DST/MRC Professional Development Program; Hope For Depression Foundation	BM was supported by the DST/MRC Professional Development Program. JvH is supported by the Hope For Depression Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 2005, NAT NEUROSCI, V8, P512, DOI 10.1038/nn1413; Adolphs R, 2005, NATURE, V433, P68, DOI 10.1038/nature03086; ADOLPHS R, 1994, NATURE, V372, P669, DOI 10.1038/372669a0; Amunts K, 2005, ANAT EMBRYOL, V210, P343, DOI 10.1007/s00429-005-0025-5; Anderson AK, 2002, J COGNITIVE NEUROSCI, V14, P709, DOI 10.1162/08989290260138618; [Anonymous], 2000, CROSS CULTURAL NEURO; Anticevic A, 2010, COGN AFFECT BEHAV NE, V10, P159, DOI 10.3758/CABN.10.2.159; Baddeley A. D., 1993, ATTENTION SELECTION, P152; Boes AD, 2012, SOC COGN AFFECT NEUR, V7, P588, DOI 10.1093/scan/nsr047; Bressler SL, 2010, TRENDS COGN SCI, V14, P277, DOI 10.1016/j.tics.2010.04.004; Coolidge FL, 2005, CAMB ARCHAEOL J, V15, P5, DOI 10.1017/S0959774305000016; Crinion J, 2007, NEUROIMAGE, V37, P866, DOI 10.1016/j.neuroimage.2007.04.065; Davis M, 2001, MOL PSYCHIATR, V6, P13, DOI 10.1038/sj.mp.4000812; Dolcos F, 2006, J NEUROSCI, V26, P2072, DOI 10.1523/JNEUROSCI.5042-05.2006; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Eickhoff SB, 2007, NEUROIMAGE, V36, P511, DOI 10.1016/j.neuroimage.2007.03.060; Etkin A, 2009, ARCH GEN PSYCHIAT, V66, P1361, DOI 10.1001/archgenpsychiatry.2009.104; Feinstein JS, 2011, CURR BIOL, V21, P34, DOI 10.1016/j.cub.2010.11.042; Freese JL, 2009, HUMAN AMYGDALA; Friston KJ, 1995, HUM BRAIN MAPP, V3, P165, DOI 10.1002/hbm.460030303; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Ghashghaei HT, 2002, NEUROSCIENCE, V115, P1261, DOI 10.1016/S0306-4522(02)00446-3; Gianaros PJ, 2009, BIOL PSYCHIAT, V65, P943, DOI 10.1016/j.biopsych.2008.10.007; Hampton AN, 2007, NEURON, V55, P545, DOI 10.1016/j.neuron.2007.07.022; Hariri AR, 2002, SCIENCE, V297, P400, DOI 10.1126/science.1071829; Henrich J, 2010, BEHAV BRAIN SCI, V33, P61, DOI 10.1017/S0140525X0999152X; Henrich J, 2010, NATURE, V466, P29, DOI 10.1038/466029a; Hurlemann R, 2007, NEUROPSYCHOLOGIA, V45, P877, DOI 10.1016/j.neuropsychologia.2006.08.027; Hurlemann R, 2010, J NEUROSCI, V30, P4999, DOI 10.1523/JNEUROSCI.5538-09.2010; Hurlemann R, 2009, SOC COGN AFFECT NEUR, V4, P79, DOI 10.1093/scan/nsn039; Jones D, 2010, SCIENCE, V328, P1627, DOI 10.1126/science.328.5986.1627; Kapur N, 1996, BRAIN, V119, P1775, DOI 10.1093/brain/119.5.1775; Kennedy DP, 2009, NAT NEUROSCI, V12, P1226, DOI 10.1038/nn.2381; Knapska E, 2007, PHYSIOL REV, V87, P1113, DOI 10.1152/physrev.00037.2006; Manuck SB, 2007, AM J PSYCHIAT, V164, P1613, DOI 10.1176/appi.ajp.2007.07040609; Martinez RCR, 2006, NEUROBIOL LEARN MEM, V85, P58, DOI 10.1016/j.nlm.2005.08.007; Mobbs D, 2007, SCIENCE, V317, P1079, DOI 10.1126/science.1144298; Muller NG, 2006, NEUROSCIENCE, V139, P51, DOI 10.1016/j.neuroscience.2005.09.018; Murray EA, 2010, CURR OPIN NEUROBIOL, V20, P212, DOI 10.1016/j.conb.2010.02.001; Ochsner KN, 2004, NEUROIMAGE, V23, P483, DOI 10.1016/j.neuroimage.2004.06.030; PORRINO LJ, 1981, J COMP NEUROL, V198, P121, DOI 10.1002/cne.901980111; Postle BR, 2006, NEUROSCIENCE, V139, P23, DOI 10.1016/j.neuroscience.2005.06.005; Postle BR, 2005, J COGNITIVE NEUROSCI, V17, P1679, DOI 10.1162/089892905774589208; Reichle ME, 2010, TRENDS COGN SCI, V14, P180, DOI 10.1016/j.tics.2010.01.008; Roesch MR, 2010, J NEUROSCI, V30, P2464, DOI 10.1523/JNEUROSCI.5781-09.2010; Roy AK, 2009, NEUROIMAGE, V45, P614, DOI 10.1016/j.neuroimage.2008.11.030; Sakai K, 2002, NAT NEUROSCI, V5, P479, DOI 10.1038/nn846; Salzman CD, 2010, ANNU REV NEUROSCI, V33, P173, DOI 10.1146/annurev.neuro.051508.135256; Sander D, 2003, REV NEUROSCIENCE, V14, P303, DOI 10.1515/REVNEURO.2003.14.4.303; Schaefer A, 2007, REV NEUROSCIENCE, V18, P355; Schaefer A, 2006, J NEUROSCI, V26, P10120, DOI 10.1523/JNEUROSCI.2567-06.2006; Schiller D, 2010, TRENDS COGN SCI, V14, P268, DOI 10.1016/j.tics.2010.04.002; Siebert M, 2003, BRAIN, V126, P2627, DOI 10.1093/brain/awg271; Solano-Castiella E, 2010, NEUROIMAGE, V49, P2958, DOI 10.1016/j.neuroimage.2009.11.027; Stalnaker TA, 2007, NEURON, V54, P51, DOI 10.1016/j.neuron.2007.02.014; Statistics South Africa, 2011, Q LAB FORC SURV QUAR; Strange BA, 2003, P NATL ACAD SCI USA, V100, P13626, DOI 10.1073/pnas.1635116100; Thornton HB, 2008, J NEUROPSYCH CLIN N, V20, P86, DOI 10.1176/jnp.2008.20.1.86; Tottenham N, 2009, PSYCHIAT RES, V168, P242, DOI 10.1016/j.psychres.2008.05.006; Wechsler D., 2011, WASI 2 WECHSLER ABBR; Weschler D., 2011, WECHSLER ADULT INTEL, V4; Whalen PJ, 1998, CURR DIR PSYCHOL SCI, V7, P177, DOI 10.1111/1467-8721.ep10836912; Yun RJ, 2010, BRAIN IMAGING BEHAV, V4, P96, DOI 10.1007/s11682-010-9089-9	63	25	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2012	7	6							e38116	10.1371/journal.pone.0038116	http://dx.doi.org/10.1371/journal.pone.0038116			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TQ	22715374	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336800015
J	Tarnowski, LJ; Kowalec, P; Milewski, M; Jurek, M; Plochocka, D; Fronk, J; Kurlandzka, A				Tarnowski, Leszek J.; Kowalec, Piotr; Milewski, Michal; Jurek, Marta; Plochocka, Danuta; Fronk, Jan; Kurlandzka, Anna			Nuclear Import and Export Signals of Human Cohesins SA1/STAG1 and SA2/STAG2 Expressed in Saccharomyces cerevisiae	PLOS ONE			English	Article							NUCLEOCYTOPLASMIC TRANSPORT; DNA-REPLICATION; MESSENGER-RNA; PROTEIN; COMPLEXES; MEIOSIS; YEAST; IDENTIFICATION; TRANSLOCATION; KARYOPHERINS	Background: Human SA/STAG proteins, homologues of the yeast Irr1/Scc3 cohesin, are the least studied constituents of the sister chromatid cohesion complex crucial for proper chromosome segregation. The two SA paralogues, SA1 and SA2, show some specificity towards the chromosome region they stabilize, and SA2, but not SA1, has been shown to participate in transcriptional regulation as well. The molecular basis of this functional divergence is unknown. Methodology/Principal Findings: In silico analysis indicates numerous putative nuclear localization (NLS) and export (NES) signals in the SA proteins, suggesting the possibility of their nucleocytoplasmic shuttling. We studied the functionality of those putative signals by expressing fluorescently tagged SA1 and SA2 in the yeast Saccharomyces cerevisiae. Only the N-terminal NLS turned out to be functional in SA1. In contrast, the SA2 protein has at least two functional NLS and also two functional NES. Depending on the balance between these opposing signals, SA2 resides in the nucleus or is distributed throughout the cell. Validation of the above conclusions in HeLa cells confirmed that the same N-terminal NLS of SA1 is functional in those cells. In contrast, in SA2 the principal NLS functioning in HeLa cells is different from that identified in yeast and is localized to the C-terminus. Conclusions/Significance: This is the first demonstration of the possibility of non-nuclear localization of an SA protein. The reported difference in the organization between the two SA homologues may also be relevant to their partially divergent functions. The mechanisms determining subcellular localization of cohesins are only partially conserved between yeast and human cells.	[Tarnowski, Leszek J.; Kowalec, Piotr; Plochocka, Danuta; Kurlandzka, Anna] Polish Acad Sci, Inst Biochem & Biophys, Warsaw, Poland; [Kowalec, Piotr; Fronk, Jan] Univ Warsaw, Fac Biol, Inst Biochem, Warsaw, Poland; [Milewski, Michal; Jurek, Marta] Inst Mother & Child Hlth, Dept Med Genet, Warsaw, Poland	Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; University of Warsaw	Tarnowski, LJ (corresponding author), Polish Acad Sci, Inst Biochem & Biophys, Warsaw, Poland.	ania218@ibb.waw.pl	Milewski, Michal/C-7144-2012; Milewski, Michał/AAK-4243-2021; , Marta/H-4342-2017	Milewski, Michal/0000-0001-7982-2565; Milewski, Michał/0000-0001-7982-2565; Fronk, Jan/0000-0002-6564-4339; , Marta/0000-0003-2550-5745; Kowalec, Piotr/0000-0002-3301-384X; Tarnowski, Leszek/0000-0001-9673-2780; Kurlandzka, Anna/0000-0002-6395-0746	Ministry of Science and Higher Education, Poland [N N303 456838]	Ministry of Science and Higher Education, Poland(Ministry of Science and Higher Education, Poland)	This work was supported by the Ministry of Science and Higher Education, Poland [grant N N303 456838]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azimzadeh J, 2007, J CELL SCI, V120, P2139, DOI 10.1242/jcs.005231; Butterfield-Gerson KL, 2006, J VIROL, V80, P1798, DOI 10.1128/JVI.80.4.1798-1806.2006; Canudas S, 2009, J CELL BIOL, V187, P165, DOI 10.1083/jcb.200903096; Carramolino L, 1997, GENE, V195, P151, DOI 10.1016/S0378-1119(97)00121-2; Cena A, 2008, EUR J CELL BIOL, V87, P831, DOI 10.1016/j.ejcb.2008.05.002; Chu CT, 2007, J NEUROPATH EXP NEUR, V66, P873, DOI 10.1097/nen.0b013e318156a3d7; Fabbro M, 2003, EXP CELL RES, V282, P59, DOI 10.1016/S0014-4827(02)00019-8; Feldherr C, 2002, J CELL SCI, V115, P2997; Feng WQ, 1999, J CELL SCI, V112, P339; Ferrer M, 2005, HUM MOL GENET, V14, P1271, DOI 10.1093/hmg/ddi138; Fukuda M, 1997, NATURE, V390, P308, DOI 10.1038/36894; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Gerlich D, 2006, CURR BIOL, V16, P1571, DOI 10.1016/j.cub.2006.06.068; Gorlich D, 1996, SCIENCE, V271, P1513, DOI 10.1126/science.271.5255.1513; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Gould CM, 2010, NUCLEIC ACIDS RES, V38, pD167, DOI 10.1093/nar/gkp1016; Groner B, 2008, SEMIN CELL DEV BIOL, V19, P341, DOI 10.1016/j.semcdb.2008.06.005; Gruber S, 2003, CELL, V112, P765, DOI 10.1016/S0092-8674(03)00162-4; Haering CH, 2004, MOL CELL, V15, P951, DOI 10.1016/j.molcel.2004.08.030; Harel A, 2004, MOL CELL, V16, P319, DOI 10.1016/S1097-2765(04)00647-1; Hauf S, 2005, PLOS BIOL, V3, P419, DOI 10.1371/journal.pbio.0030069; HEATH IB, 1980, INT REV CYTOL, V64, P1, DOI 10.1016/S0074-7696(08)60235-1; Henderson BR, 2005, BIOESSAYS, V27, P884, DOI 10.1002/bies.20277; Hirano T, 2005, PHILOS T R SOC B, V360, P507, DOI 10.1098/rstb.2004.1606; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Holzmann J, 2011, J PROTEOME RES, V10, P780, DOI 10.1021/pr100927x; Horton P, 1997, ISMB-97 - FIFTH INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEMS FOR MOLECULAR BIOLOGY, PROCEEDINGS, P147; Kutay U, 2005, TRENDS CELL BIOL, V15, P121, DOI 10.1016/j.tcb.2005.01.005; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; Lara-Pezzi E, 2004, J BIOL CHEM, V279, P6553, DOI 10.1074/jbc.M307663200; Lin WQ, 2011, GENETICS, V187, P1041, DOI 10.1534/genetics.110.122358; Losada A, 2007, CHROMOSOMA, V116, P321, DOI 10.1007/s00412-007-0104-x; Mager WH, 2005, TRENDS PHARMACOL SCI, V26, P265, DOI 10.1016/j.tips.2005.03.004; McNairn AJ, 2009, CHROMOSOME RES, V17, P155, DOI 10.1007/s10577-008-9007-9; MORELAND RB, 1987, MOL CELL BIOL, V7, P4048, DOI 10.1128/MCB.7.11.4048; Mosammaparast N, 2004, TRENDS CELL BIOL, V14, P547, DOI 10.1016/j.tcb.2004.09.004; Mosammaparast N, 2002, EMBO J, V21, P6527, DOI 10.1093/emboj/cdf647; Mosammaparast N, 2001, J CELL BIOL, V153, P251, DOI 10.1083/jcb.153.2.251; Neville M, 1999, EMBO J, V18, P3746, DOI 10.1093/emboj/18.13.3746; Nigg EA, 1997, NATURE, V386, P779, DOI 10.1038/386779a0; Postic C, 2007, ANNU REV NUTR, V27, P179, DOI 10.1146/annurev.nutr.27.061406.093618; Prieto I, 2002, EMBO REP, V3, P543, DOI 10.1093/embo-reports/kvf108; Prieto I, 2001, NAT CELL BIOL, V3, P761, DOI 10.1038/35087082; Sazer S, 2005, CURR BIOL, V15, pR23, DOI 10.1016/j.cub.2004.12.015; Schmidt D, 2010, GENOME RES, V20, P578, DOI 10.1101/gr.100479.109; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Stade K, 1997, CELL, V90, P1041, DOI 10.1016/S0092-8674(00)80370-0; Suja J. A., 2009, V5, P94, DOI 10.1159/000166622; Sun YX, 2006, CELL CYCLE, V5, P2537, DOI 10.4161/cc.5.21.3407; Terry LJ, 2007, SCIENCE, V318, P1412, DOI 10.1126/science.1142204; Waterham HR, 2007, METHOD MICROBIOL, V36, P577, DOI 10.1016/S0580-9517(06)36023-0; Weis K, 1998, TRENDS BIOCHEM SCI, V23, P185, DOI 10.1016/S0968-0004(98)01204-3; Wolff B, 1997, CHEM BIOL, V4, P139, DOI 10.1016/S1074-5521(97)90257-X; Xiao TJ, 2011, MOL CELL BIOL, V31, P2174, DOI 10.1128/MCB.05093-11; Zhang NG, 2008, J CELL BIOL, V183, P1019, DOI 10.1083/jcb.200801157	58	8	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2012	7	6							e38740	10.1371/journal.pone.0038740	http://dx.doi.org/10.1371/journal.pone.0038740			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TQ	22715410	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336800052
J	Bendlin, BB; Carlsson, CM; Johnson, SC; Zetterberg, H; Blennow, K; Willette, AA; Okonkwo, OC; Sodhi, A; Ries, ML; Birdsill, AC; Alexander, AL; Rowley, HA; Puglielli, L; Asthana, S; Sager, MA				Bendlin, Barbara B.; Carlsson, Cynthia M.; Johnson, Sterling C.; Zetterberg, Henrik; Blennow, Kaj; Willette, Auriel A.; Okonkwo, Ozioma C.; Sodhi, Aparna; Ries, Michele L.; Birdsill, Alex C.; Alexander, Andrew L.; Rowley, Howard A.; Puglielli, Luigi; Asthana, Sanjay; Sager, Mark A.			CSF T-Tau/A beta(42) Predicts White Matter Microstructure in Healthy Adults at Risk for Alzheimer's Disease	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; CEREBROSPINAL-FLUID BIOMARKERS; CORPUS-CALLOSUM ATROPHY; BRAIN ATROPHY; IN-VIVO; NEUROFILAMENT PROTEIN; PHOSPHORYLATED-TAU; MYELIN BREAKDOWN; TAU/BETA-AMYLOID(42) RATIO; AXONAL DEGENERATION	Cerebrospinal fluid (CSF) biomarkers T-Tau and A beta(42) are linked with Alzheimer's disease (AD), yet little is known about the relationship between CSF biomarkers and structural brain alteration in healthy adults. In this study we examined the extent to which AD biomarkers measured in CSF predict brain microstructure indexed by diffusion tensor imaging (DTI) and volume indexed by T1-weighted imaging. Forty-three middle-aged adults with parental family history of AD received baseline lumbar puncture and MRI approximately 3.5 years later. Voxel-wise image analysis methods were used to test whether baseline CSF A beta(42), total tau (T-Tau), phosphorylated tau (P-Tau) and neurofilament light protein predicted brain microstructure as indexed by DTI and gray matter volume indexed by T1-weighted imaging. T-Tau and T-Tau/A beta(42) were widely correlated with indices of brain microstructure (mean, axial, and radial diffusivity), notably in white matter regions adjacent to gray matter structures affected in the earliest stages of AD. None of the CSF biomarkers were related to gray matter volume. Elevated P-Tau and P-Tau/A beta(42) levels were associated with lower recognition performance on the Rey Auditory Verbal Learning Test. Overall, the results suggest that CSF biomarkers are related to brain microstructure in healthy adults with elevated risk of developing AD. Furthermore, the results clearly suggest that early pathological changes in AD can be detected with DTI and occur not only in cortex, but also in white matter.	[Bendlin, Barbara B.; Carlsson, Cynthia M.; Johnson, Sterling C.; Willette, Auriel A.; Okonkwo, Ozioma C.; Sodhi, Aparna; Ries, Michele L.; Birdsill, Alex C.; Puglielli, Luigi; Asthana, Sanjay; Sager, Mark A.] William S Middleton Mem Vet Adm Med Ctr, GRECC, Madison, WI USA; [Bendlin, Barbara B.; Carlsson, Cynthia M.; Johnson, Sterling C.; Willette, Auriel A.; Okonkwo, Ozioma C.; Sodhi, Aparna; Ries, Michele L.; Birdsill, Alex C.; Puglielli, Luigi; Asthana, Sanjay; Sager, Mark A.] Univ Wisconsin, Dept Med, Wisconsin Alzheimers Dis Res Ctr, Madison, WI USA; [Zetterberg, Henrik; Blennow, Kaj] Univ Gothenburg, Sahlgrenska Acad, Dept Psychiat & Neurochem, Inst Neurosci & Physiol, Gothenburg, Sweden; [Alexander, Andrew L.] Univ Wisconsin, Dept Med Phys, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Alexander, Andrew L.] Univ Wisconsin, Dept Psychiat, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Alexander, Andrew L.] Waisman Lab Brain Imaging & Behav, Madison, WI USA; [Rowley, Howard A.] Univ Wisconsin, Dept Radiol, Sch Med & Publ Hlth, Madison, WI 53706 USA	Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); William S Middleton Memorial Veterans Hospital; University of Wisconsin System; University of Wisconsin Madison; University of Gothenburg; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Bendlin, BB (corresponding author), William S Middleton Mem Vet Adm Med Ctr, GRECC, Madison, WI USA.	bbb@medicine.wisc.edu	Willette, Auriel/J-2143-2019	Willette, Auriel/0000-0001-5131-8199; Bendlin, Barbara/0000-0002-0580-9875; Birdsill, Alex/0000-0002-3778-9645	National Institute on Aging [R01 AG027161, K23 AG026752, ADRC P50 AG033514]; University of Wisconsin Institute for Clinical and Translational Research; National Center for Research Resources/National Institutes of Health Clinical and Translational Science Award [1UL1RR025011]; program of the National Center for Research Resources, United States National Institutes of Health; Swedish Research Council; Pfizer Inc.; Innogenetics; Vastra Gotalandsregionen, Sweden; Swedish Brain Power Project; Swedish Council for Working Life and Social Research; Swedish Alzheimer Foundation; Stiftelsen for Gamla Tjanarinnor; King Gustaf V and Queen Victoria Foundation; Alzheimer's Association; Royal Swedish Academy of Sciences; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003352] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000427] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025011] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG027161, R01AG021155, P50AG033514, R01AG037639, K23AG026752] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); University of Wisconsin Institute for Clinical and Translational Research; National Center for Research Resources/National Institutes of Health Clinical and Translational Science Award; program of the National Center for Research Resources, United States National Institutes of Health; Swedish Research Council(Swedish Research CouncilEuropean Commission); Pfizer Inc.(Pfizer); Innogenetics; Vastra Gotalandsregionen, Sweden; Swedish Brain Power Project; Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Swedish Alzheimer Foundation; Stiftelsen for Gamla Tjanarinnor; King Gustaf V and Queen Victoria Foundation; Alzheimer's Association(Alzheimer's Association); Royal Swedish Academy of Sciences; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This project was supported in part by the National Institute on Aging (R01 AG027161 [MAS], K23 AG026752 [CMC]; ADRC P50 AG033514 [SA]), the University of Wisconsin Institute for Clinical and Translational Research, funded through a National Center for Research Resources/National Institutes of Health Clinical and Translational Science Award, 1UL1RR025011, a program of the National Center for Research Resources, United States National Institutes of Health, and the Swedish Research Council. The project was also facilitated by the facilities and resources at the Geriatric Research, Education, and Clinical Center (GRECC) of the William S. Middleton Memorial Veterans Hospital, Madison, WI. GRECC MS # 2011-19. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Dr. Blennow has served on scientific advisory boards for Adlyfe Inc., Bayer Schering Pharma, Bristol-Myers Squibb, and Merz Pharmaceuticals GmbH; received a speaker honorarium from Pfizer Inc.; serves as a consultant for Wyeth, AstraZeneca, Bristol-Myers Squibb, and Eli Lilly and Company; and has received research support from Pfizer Inc., Innogenetics, the Swedish Research Council, Vastra Gotalandsregionen, Sweden, the Swedish Brain Power Project, the Swedish Council for Working Life and Social Research, the Swedish Alzheimer Foundation, Stiftelsen for Gamla Tjanarinnor, and the King Gustaf V and Queen Victoria Foundation. Dr. Zetterberg has served on a scientific advisory board for GlaxoSmithKline; serves as an Associate Editor for the Journal of Alzheimer's Disease; and receives research support from the Swedish Research Council, the Alzheimer's Association, and the Royal Swedish Academy of Sciences. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Andersson C, 2007, DEMENT GERIATR COGN, V23, P87, DOI 10.1159/000097354; Andreasen N, 2001, J NEUROL NEUROSUR PS, V71, P557, DOI 10.1136/jnnp.71.4.557; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Balthazar MLF, 2009, EUR J NEUROL, V16, P468, DOI 10.1111/j.1468-1331.2008.02408.x; Bartzokis G, 2004, NEUROBIOL AGING, V25, P843, DOI 10.1016/j.neurobiolaging.2003.09.005; Bartzokis G, 2004, NEUROBIOL AGING, V25, P5, DOI 10.1016/j.neurobiolaging.2003.03.001; Bartzokis G, 2007, BIOL PSYCHIAT, V62, P1380, DOI 10.1016/j.biopsych.2007.03.024; Bartzokis G, 2007, NEUROCHEM RES, V32, P1655, DOI 10.1007/s11064-007-9352-7; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; Baxter LC, 2006, J ALZHEIMERS DIS, V9, P253; Bendlin BB, 2010, DEV NEUROPSYCHOL, V35, P257, DOI 10.1080/87565641003696775; Bendlin BB, 2010, ALZHEIMERS DEMENT, V6, P394, DOI 10.1016/j.jalz.2009.11.003; Benedict R., 1997, BRIEF VISUOSPATIAL M; Benton AL, 1983, MULTILINGUAL APHASIA; Bozzali M, 2002, J NEUROL NEUROSUR PS, V72, P742, DOI 10.1136/jnnp.72.6.742; Braak H, 1997, NEUROBIOL AGING, V18, P351, DOI 10.1016/S0197-4580(97)00056-0; Bronge L, 2002, DEMENT GERIATR COGN, V13, P205, DOI 10.1159/000057698; Budde MD, 2007, NMR BIOMED; Buerger K, 2007, BRAIN, V130, DOI 10.1093/brain/awm140; Canu E, 2009, J ALZHEIMERS DIS; Carlsson CM, 2010, ALZHEIMERS DEMENT S, V6, pS151; Carlsson CM, 2008, J ALZHEIMERS DIS, V13, P187; Chaim TM, 2007, PSYCHIAT RES-NEUROIM, V154, P59, DOI 10.1016/j.pscychresns.2006.04.003; Cho H, 2008, J KOREAN MED SCI, V23, P477, DOI 10.3346/jkms.2008.23.3.477; Davatzikos C, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.05.023; De Meyer G, 2010, ARCH NEUROL-CHICAGO, V67, P949, DOI 10.1001/archneurol.2010.179; DELAMONTE SM, 1989, ANN NEUROL, V25, P450, DOI 10.1002/ana.410250506; Desai MK, 2011, GLIA, V59, P627, DOI 10.1002/glia.21131; Desai MK, 2009, GLIA, V57, P54, DOI 10.1002/glia.20734; Desikan RS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012853; Duan JH, 2006, SURG RADIOL ANAT, V28, P150, DOI 10.1007/s00276-006-0111-2; Fagan AM, 2006, ANN NEUROL, V59, P512, DOI 10.1002/ana.20730; Fagan AM, 2007, ARCH NEUROL-CHICAGO, V64, P343, DOI 10.1001/archneur.64.3.noc60123; Fagan AM, 2009, ANN NEUROL, V65, P176, DOI 10.1002/ana.21559; Fellgiebel A, 2005, NEUROBIOL AGING, V26, P1193, DOI 10.1016/j.neurobiolaging.2004.11.006; Fellgiebel A, 2004, DEMENT GERIATR COGN, V18, P101, DOI 10.1159/000077817; Fellgiebel A, 2008, NEUROPSYCHOLOGIA, V46, P1698, DOI 10.1016/j.neuropsychologia.2007.12.010; Fjell AM, 2010, CEREB CORTEX, V20, P2069, DOI 10.1093/cercor/bhp279; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FRIEDE RL, 1970, ANAT REC, V167, P379, DOI 10.1002/ar.1091670402; Galasko D, 1998, ARCH NEUROL-CHICAGO, V55, P937, DOI 10.1001/archneur.55.7.937; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Glodzik L, 2011, NEUROBIOL AGING; Gotz J, 2001, J BIOL CHEM, V276, P529, DOI 10.1074/jbc.M006531200; Hampel H, 2004, MOL PSYCHIATR, V9, P705, DOI 10.1038/sj.mp.4001473; Hansson O, 2007, DEMENT GERIATR COGN, V23, P316, DOI 10.1159/000100926; Hanyu H, 1999, J NEUROL SCI, V167, P37, DOI 10.1016/S0022-510X(99)00135-5; Harsan LA, 2006, J NEUROSCI RES, V83, P392, DOI 10.1002/jnr.20742; Herukka SK, 2008, J ALZHEIMERS DIS, V14, P51; Herukka SK, 2005, NEUROLOGY, V64, P1294, DOI 10.1212/01.WNL.0000156914.16988.56; Higuchi M, 2002, NEURON, V35, P433, DOI 10.1016/S0896-6273(02)00789-4; Hofling AA, 2009, NMR BIOMED; Hu YY, 2002, NEUROSCI LETT, V320, P156, DOI 10.1016/S0304-3940(02)00047-2; Huang J, 2007, AM J NEURORADIOL, V28, P1943, DOI 10.3174/ajnr.A0700; Im K, 2008, NEUROIMAGE, V43, P103, DOI 10.1016/j.neuroimage.2008.07.016; IWATSUBO T, 1994, ACTA NEUROPATHOL, V88, P129; Kantarci K, 2001, RADIOLOGY, V219, P101, DOI 10.1148/radiology.219.1.r01ap14101; Kester MI, 2009, J ALZHEIMERS DIS, V16, P601, DOI 10.3233/JAD-2009-0999; Li S, 2008, ACTA RADIOL, V49, P84, DOI 10.1080/02841850701627181; Lin WL, 2003, AM J PATHOL, V162, P213, DOI 10.1016/S0002-9440(10)63812-6; Lovblad KO, 2004, NEURORADIOLOGY, V46, P282, DOI 10.1007/s00234-004-1183-5; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; Mattsson N, 2009, JAMA-J AM MED ASSOC, V302, P385, DOI 10.1001/jama.2009.1064; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Medina D, 2006, NEUROBIOL AGING, V27, P663, DOI 10.1016/j.neurobiolaging.2005.03.026; Menzler K, 2011, NEUROIMAGE, V54, P2557, DOI 10.1016/j.neuroimage.2010.11.029; Mielke MM, 2009, NEUROIMAGE, V46, P47, DOI 10.1016/j.neuroimage.2009.01.054; MORRIS JC, 1989, NEUROLOGY, V39, P1159, DOI 10.1212/wnl.43.12.2457; Nierenberg J, 2005, NEUROREPORT, V16, P1369, DOI 10.1097/01.wnr.0000174058.49521.16; NISHIMURA M, 1995, AM J PATHOL, V146, P1052; Norgren N, 2003, BRAIN RES, V987, P25, DOI 10.1016/S0006-8993(03)03219-0; Olsson A, 2005, CLIN CHEM, V51, P336, DOI 10.1373/clinchem.2004.039347; Olsson B, 2011, PROG NEUROBIOL; Ott BR, 2010, J ALZHEIMERS DIS, V20, P647, DOI 10.3233/JAD-2010-1406; Persson J, 2006, NEUROLOGY, V66, P1029, DOI 10.1212/01.wnl.0000204180.25361.48; Pfefferbaum A, 2000, MAGNET RESON MED, V44, P259, DOI 10.1002/1522-2594(200008)44:2<259::AID-MRM13>3.0.CO;2-6; Reitan R.M., 1993, HALSTEAD REITAN NEUR; Rey A, 1964, LEXAMEN CLINIQUE PSY; Richter-Landsberg C, 2008, J MOL NEUROSCI, V35, P55, DOI 10.1007/s12031-007-9017-7; Roher AE, 2002, BIOCHEMISTRY-US, V41, P11080, DOI 10.1021/bi026173d; Rose SE, 2006, J NEUROL NEUROSUR PS, V77, P1122, DOI 10.1136/jnnp.2005.074336; Rose SE, 2008, J MAGN RESON IMAGING, V27, P20, DOI 10.1002/jmri.21231; Rosengren LE, 1999, NEUROLOGY, V52, P1090, DOI 10.1212/WNL.52.5.1090; Rosengren LE, 1996, J NEUROCHEM, V67, P2013, DOI 10.1046/j.1471-4159.1996.67052013.x; Ryan L, 2011, NEUROIMAGE, V54, P1565, DOI 10.1016/j.neuroimage.2010.08.052; Sager MA, 2005, J GERIATR PSYCH NEUR, V18, P245, DOI 10.1177/0891988705281882; Salat DH, 2009, NEUROIMAGE, V44, P1247, DOI 10.1016/j.neuroimage.2008.10.030; Salat DH, 2005, NEUROBIOL AGING, V26, P1215, DOI 10.1016/j.neurobiolaging.2004.09.017; Salat DH, 2008, NEUROBIOL AGING; SCHELTENS P, 1995, NEUROLOGY, V45, P883, DOI 10.1212/WNL.45.5.883; Schott JM, 2010, ANN NEUROL, V68, P825, DOI 10.1002/ana.22315; Shaw LM, 2009, ANN NEUROL, V65, P403, DOI 10.1002/ana.21610; Sjogren M, 2001, J NEUROSCI RES, V66, P510, DOI 10.1002/jnr.1242; Smach MA, 2009, EUR NEUROL, V62, P349, DOI 10.1159/000241881; Smith CD, 2010, NEUROBIOL AGING, V31, P1122, DOI 10.1016/j.neurobiolaging.2008.08.006; Sole-Padulles C, 2011, PSYCHIAT RES-NEUROIM, V192, P140, DOI 10.1016/j.pscychresns.2010.12.001; Song F, 2009, J MAGN RESON IMAGING, V30, P277, DOI 10.1002/jmri.21825; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; Stahl R, 2007, RADIOLOGY, V243, P483, DOI 10.1148/radiol.2432051714; Stenset V, 2009, NEUROBIOL AGING; Stokin GB, 2005, SCIENCE, V307, P1282, DOI 10.1126/science.1105681; Stomrud E, 2010, ARCH NEUROL-CHICAGO, V67, P217, DOI 10.1001/archneurol.2009.316; Stout JC, 1996, ARCH NEUROL-CHICAGO, V53, P742, DOI 10.1001/archneur.1996.00550080056013; Stricker NH, 2009, NEUROIMAGE, V45, P10, DOI 10.1016/j.neuroimage.2008.11.027; Sun SW, 2006, MAGN RESON MED, V55, P302, DOI 10.1002/mrm.20774; Sunderland T, 2003, JAMA-J AM MED ASSOC, V289, P2094, DOI 10.1001/jama.289.16.2094; Sunderland T, 2004, BIOL PSYCHIAT, V56, P670, DOI 10.1016/j.biopsych.2004.07.021; Takahashi S, 2002, NEUROSCI LETT, V332, P45, DOI 10.1016/S0304-3940(02)00914-X; Tapiola T, 2009, ARCH NEUROL-CHICAGO, V66, P382, DOI 10.1001/archneurol.2008.596; Teipel SJ, 1998, NEUROLOGY, V51, P1381, DOI 10.1212/WNL.51.5.1381; Teipel SJ, 2002, ARCH NEUROL-CHICAGO, V59, P243, DOI 10.1001/archneur.59.2.243; Terry RD, 1998, J NEURAL TRANSM-SUPP, P141; Tournier JD, 2011, MAGN RESON MED, V65, P1532, DOI 10.1002/mrm.22924; Umahara T, 2002, NEUROPATHOLOGY, V22, P9, DOI 10.1046/j.0919-6544.2002.00422.x; VANDERMEEREN M, 1993, J NEUROCHEM, V61, P1828, DOI 10.1111/j.1471-4159.1993.tb09823.x; VERMERSCH P, 1994, EUR NEUROL, V34, P83; Wang PJ, 2006, NEUROBIOL AGING, V27, P1613, DOI 10.1016/j.neurobiolaging.2005.09.035; Wechsler D., 1997, WECHSLER ADULT INTEL; Wu QZ, 2007, NEUROIMAGE, V37, P1138, DOI 10.1016/j.neuroimage.2007.06.029; Xie S, 2006, NEUROLOGY, V66, P1845, DOI 10.1212/01.wnl.0000219625.77625.aa; Xiong CJ, 2011, ARCH NEUROL-CHICAGO, V68, P1313, DOI 10.1001/archneurol.2011.208	123	71	71	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e37720	10.1371/journal.pone.0037720	http://dx.doi.org/10.1371/journal.pone.0037720			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701578	Green Published, Green Submitted, gold			2022-12-27	WOS:000305348400018
J	Munoz, RC; Zgliczynski, BJ; Laughlin, JL; Teer, BZ				Munoz, Roldan C.; Zgliczynski, Brian J.; Laughlin, Joseph L.; Teer, Bradford Z.			Extraordinary Aggressive Behavior from the Giant Coral Reef Fish, Bolbometopon muricatum, in a Remote Marine Reserve	PLOS ONE			English	Article							SPAWNING BEHAVIOR; KNOWLEDGE; IMPACTS; SIZE	Human impacts to terrestrial and marine communities are widespread and typically begin with the local extirpation of large-bodied animals. In the marine environment, few pristine areas relatively free of human impact remain to provide baselines of ecosystem function and goals for restoration efforts. Recent comparisons of remote and/or protected coral reefs versus impacted sites suggest remote systems are dominated by apex predators, yet in these systems the ecological role of nonpredatory, large-bodied, highly vulnerable species such as the giant bumphead parrotfish (Bolbometopon muricatum) has received less attention. Overfishing of Bolbometopon has lead to precipitous declines in population density and avoidance of humans throughout its range, contributing to its status as a candidate species under the U. S. Endangered Species Act and limiting opportunities to study unexploited populations. Here we show that extraordinary ecological processes, such as violent headbutting contests by the world's largest parrotfish, can be revealed by studying unexploited ecosystems, such as the coral reefs of Wake Atoll where we studied an abundant population of Bolbometopon. Bolbometopon is among the largest of coral reef fishes and is a well known, charismatic species, yet to our knowledge, no scientific documentation of ritualized headbutting exists for marine fishes. Our observations of aggressive headbutting by Bolbometopon underscore that remote locations and marine reserves, by inhibiting negative responses to human observers and by allowing the persistence of historical conditions, can provide valuable opportunities to study ecosystems in their natural state, thereby facilitating the discovery, conservation, and interpretation of a range of sometimes remarkable behavioral and ecological processes.	[Munoz, Roldan C.; Teer, Bradford Z.] NOAA, Natl Marine Fisheries Serv, Beaufort Lab, Beaufort, NC USA; [Zgliczynski, Brian J.] Univ Calif San Diego, Scripps Inst Oceanog, Ctr Marine Biodivers & Conservat, La Jolla, CA 92093 USA; [Laughlin, Joseph L.] Mariculture Hawaii LLC, Ashland, OR USA	National Oceanic Atmospheric Admin (NOAA) - USA; University of California System; University of California San Diego; Scripps Institution of Oceanography	Munoz, RC (corresponding author), NOAA, Natl Marine Fisheries Serv, Beaufort Lab, Beaufort, NC USA.	roldan.munoz@noaa.gov			NOAA Proactive Species Conservation Program	NOAA Proactive Species Conservation Program	Support was provided by the NOAA Proactive Species Conservation Program to RCM and BJZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, SO SUDAN ODYSSEY DIV; Aswani S, 2004, ENVIRON CONSERV, V31, P69, DOI 10.1017/S037689290400116X; Bellwood DR, 2011, CORAL REEFS, V30, P549, DOI 10.1007/s00338-011-0738-2; Bellwood DR, 2012, P ROY SOC B-BIOL SCI, V279, P1621, DOI 10.1098/rspb.2011.1906; Bellwood DR, 2003, ECOL LETT, V6, P281, DOI 10.1046/j.1461-0248.2003.00432.x; Choat J. Howard, 2002, P57; CLUTTONBROCK TH, 1979, BEHAVIOUR, V69, P145, DOI 10.1163/156853979X00449; Colin PL, 2012, FISH FISH SER, V35, P285, DOI 10.1007/978-94-007-1980-4_9; DeMartini EE, 2008, MAR ECOL PROG SER, V365, P199, DOI 10.3354/meps07501; Domeier ML, 2012, FISH FISH SER, V35, P1, DOI 10.1007/978-94-007-1980-4_1; Donaldson TJ, 2004, ENVIRON BIOL FISH, V70, P373, DOI 10.1023/B:EBFI.0000035509.89614.1e; Dulvy NK, 2004, ANIM CONSERV, V7, P365, DOI 10.1017/S1367943004001519; GLADSTONE W, 1986, JPN J ICHTHYOL, V33, P326, DOI 10.1007/BF02904171; Hamilton R, 2010, NO BOUGAINVILLE MARI; Hamilton RJ, 2008, CORAL REEFS, V27, P153, DOI 10.1007/s00338-007-0304-0; Hamilton RJ, 2012, FISH FISHERIES SERIE, P490; Hamilton RJ, 2004, THESIS U OTAGO NEW Z; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Johannes R.E., 1981, WORDS LAGOON FISHING; Knowlton N, 2008, PLOS BIOL, V6, P215, DOI 10.1371/journal.pbio.0060054; Kortet R, 2004, ETHOLOGY, V110, P591, DOI 10.1111/j.1439-0310.2004.01002.x; Lammers MO, 2008, J ACOUST SOC AM, V123, P1720, DOI 10.1121/1.2836780; Lobel Phillip S., 2004, Pacific Science, V58, P65, DOI 10.1353/psc.2004.0007; Lobel Phillip S., 2008, V1, P655, DOI 10.1007/978-1-4020-6847-8_17; Lusseau D, 2003, J EVOLUTION BIOL, V16, P531, DOI 10.1046/j.1420-9101.2003.00541.x; Miranda A, 2005, J EXP BIOL, V208, P2037, DOI 10.1242/jeb.01584; Morrison JC, 2007, J MAMMAL, V88, P1363, DOI 10.1644/06-MAMM-A-124R2.1; Munoz RC, 2010, B MAR SCI, V86, P93; Myers RF, 1999, MICRONESIAN REEF FIS, V3rd; Nanami A, 2008, MAR BIOL, V153, P1103, DOI 10.1007/s00227-007-0882-y; Phillips CT, 2011, SOUTHWEST NAT, V56, P108, DOI 10.1894/RJE-07.1; Richards BL, 2011, B MAR SCI, V87, P55, DOI 10.5343/bms.2010.1019; Roberts C.M., 1991, Reviews in Fish Biology and Fisheries, V1, P65, DOI 10.1007/BF00042662; Sadovy Y., 2007, W PACIFIC FISHERY SU, V3; Suzuki S, 2008, J ETHOL, V26, P397, DOI 10.1007/s10164-008-0102-3; Terleph TA, 2004, J FISH BIOL, V64, P1373, DOI 10.1111/j.0022-1112.2004.00401.x; WARNER RR, 1980, EVOLUTION, V34, P508, DOI 10.1111/j.1558-5646.1980.tb04840.x; Warner RR., 1978, SMITHSON CONTRIB ZOO, V254, P1, DOI [10.5479/si.00810282.254, DOI 10.5479/SI.00810282.254]; Westneat MW, 2005, MOL PHYLOGENET EVOL, V36, P370, DOI 10.1016/j.ympev.2005.02.001; Zgliczynski BJ, DISTRIBUTIO IN PRESS	40	7	8	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e38120	10.1371/journal.pone.0038120	http://dx.doi.org/10.1371/journal.pone.0038120			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701606	gold, Green Submitted, Green Published			2022-12-27	WOS:000305348400036
J	Ross, JL; Howlett, SE				Ross, Jenna L.; Howlett, Susan E.			Age and Ovariectomy Abolish Beneficial Effects of Female Sex on Rat Ventricular Myocytes Exposed to Simulated Ischemia and Reperfusion	PLOS ONE			English	Article							ADRENERGIC-RECEPTOR BLOCKADE; CORONARY-ARTERY-DISEASE; ISCHEMIA/REPERFUSION INJURY; MYOCARDIAL-ISCHEMIA; HEART-DISEASE; INTRACELLULAR CA2+; ESTROGEN; SUSCEPTIBILITY; GENDER; CONTRACTION	Sex differences in responses to myocardial ischemia have been described, but whether cardiomyocyte function is influenced by sex in the setting of ischemia and reperfusion has not been elucidated. This study compared contractions and intracellular Ca2+ in isolated ventricular myocytes exposed to ischemia and reperfusion. Cells were isolated from anesthetized 3-month-old male and female Fischer 344 rats, paced at 4 Hz (37 degrees C), exposed to simulated ischemia (20 mins) and reperfused. Cell shortening (edge detector) and intracellular Ca2+ (fura-2) were measured simultaneously. Cell viability was assessed with Trypan blue. Ischemia reduced peak contractions and increased Ca2+ levels equally in myocytes from both sexes. However, contraction amplitudes were reduced in reperfusion in male myocytes, while contractions recovered to exceed control levels in females (62.6 +/- 5.1 vs. 140.1 +/- 15.8%; p<0.05). Only 60% of male myocytes excluded trypan blue dye after ischemia and reperfusion, while all female cardiomyocytes excluded the dye (p<0.05). Parallel experiments were conducted in myocytes from similar to 24-month-old female rats or 5-6-month-old rats that had an ovariectomy at 3-4 weeks of age. Beneficial effects of female sex on myocyte viability and contractile dysfunction in reperfusion were abolished in cells from 24-month-old females. Aged female myocytes also exhibited elevated intracellular Ca2+ and alternans in ischemia. Cells from ovariectomized rats displayed increased Ca2+ transients and spontaneous activity in ischemia compared to sham-operated controls. None of the myocytes from ovariectomized rats were viable after 15 minutes of ischemia, while 75% of sham cells remained viable at end of reperfusion (p<0.05). These findings demonstrate that cardiomyocytes from young adult females are more resistant to ischemia and reperfusion injury than cells from males. Age and OVX abolish these beneficial effects and induce Ca2+ dysregulation at the level of the cardiomyocyte. Thus, beneficial effects of estrogen in ischemia and reperfusion are mediated, in part, by effects on cardiomyocytes.	[Ross, Jenna L.; Howlett, Susan E.] Dalhousie Univ, Dept Pharmacol, Halifax, NS B3H 4H7, Canada; [Howlett, Susan E.] Dalhousie Univ, Div Geriatr Med, Halifax, NS, Canada	Dalhousie University; Dalhousie University	Ross, JL (corresponding author), Dalhousie Univ, Dept Pharmacol, Halifax, NS B3H 4H7, Canada.	susan.howlett@dal.ca		Howlett, Susan E/0000-0001-5351-6308	Canadian Institutes for Health Research [MOP 97973]; Nova Scotia Health Research Foundation; Heart and Stroke Foundation of Nova Scotia; Heart and Stroke Foundation of New Brunswick	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Nova Scotia Health Research Foundation; Heart and Stroke Foundation of Nova Scotia; Heart and Stroke Foundation of New Brunswick	This study was supported in part by grants from the Canadian Institutes for Health Research (grant # MOP 97973; http://www.cihr-irsc.gc.ca/e/193.html), the Nova Scotia Health Research Foundation (http://www.nshrf.ca/) and the Heart and Stroke Foundations of Nova Scotia and New Brunswick (http://www.hsf.ca/research/en/home). Jenna Ross was supported by a studentship from the Nova Scotia Health Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison MA, 2008, MENOPAUSE, V15, P639, DOI 10.1097/gme.0b013e31816d5b1c; Bell JR, 2008, AM J PHYSIOL-HEART C, V294, pH1514, DOI 10.1152/ajpheart.01283.2007; Bers DM, 2008, ANNU REV PHYSIOL, V70, P23, DOI 10.1146/annurev.physiol.70.113006.100455; Blum A, 2009, GENDER MED, V6, P410, DOI 10.1016/j.genm.2009.09.005; Booth EA, 2008, CARDIOVASC TOXICOL, V8, P101, DOI 10.1007/s12012-008-9022-2; Brown DA, 2005, J PHYSIOL-LONDON, V564, P619, DOI 10.1113/jphysiol.2004.081323; Chung MT, 2010, MENOPAUSE, V17, P127, DOI 10.1097/gme.0b013e3181b4c4ac; CORDEIRO JM, 1994, CARDIOVASC RES, V28, P1794, DOI 10.1093/cvr/28.12.1794; Cross HR, 1998, CIRC RES, V83, P1215, DOI 10.1161/01.RES.83.12.1215; Cross HR, 1999, CIRC RES, V85, P1077; Cross HR, 2003, AM J PHYSIOL-HEART C, V284, pH683, DOI 10.1152/ajpheart.00567.2002; Cross HR, 2002, AM J PHYSIOL-HEART C, V283, pH481, DOI 10.1152/ajpheart.00790.2001; Curl CL, 2003, CLIN EXP PHARMACOL P, V30, P489, DOI 10.1046/j.1440-1681.2003.03864.x; Curl CL, 2001, PFLUG ARCH EUR J PHY, V441, P709, DOI 10.1007/s004240000473; Czubryt MP, 2006, CAN J PHYSIOL PHARM, V84, P93, DOI 10.1139/Y05-151; Day SM, 2007, J MOL MED, V85, P911, DOI 10.1007/s00109-007-0181-6; Fares E, 2012, J MOL CELL CARDIOL, V52, P32; Farrell SR, 2010, AM J PHYSIOL-HEART C, V299, pH36, DOI 10.1152/ajpheart.00299.2010; Gabel Scott A, 2005, J Mol Cell Cardiol, V38, P289, DOI 10.1016/j.yjmcc.2004.11.013; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Harman S Mitchell, 2006, Gend Med, V3, P254, DOI 10.1016/S1550-8579(06)80214-7; Howlett SE, 2010, AM J PHYSIOL-HEART C, V298, pH659, DOI 10.1152/ajpheart.00214.2009; Jousilahti P, 1999, CIRCULATION, V99, P1165, DOI 10.1161/01.cir.99.9.1165; Kravtsov GM, 2007, AM J PHYSIOL-CELL PH, V292, pC1625, DOI 10.1152/ajpcell.00368.2006; Lagranha CJ, 2010, CIRC RES, V106, P1681, DOI 10.1161/CIRCRESAHA.109.213645; Lloyd-Jones DM, 1999, LANCET, V353, P89, DOI 10.1016/S0140-6736(98)10279-9; Louch WE, 2002, AM J PHYSIOL-HEART C, V283, pH800, DOI 10.1152/ajpheart.00020.2002; Luczak ED, 2009, ANNU REV PHYSIOL, V71, P1, DOI 10.1146/annurev.physiol.010908.163156; Lujan HL, 2008, AM J PHYSIOL-HEART C, V294, pH1523, DOI 10.1152/ajpheart.01241.2007; Lujan HL, 2007, AM J PHYSIOL-HEART C, V293, pH2799, DOI 10.1152/ajpheart.00596.2007; Ma Y, 2009, BRIT J PHARMACOL, V157, P705, DOI 10.1111/j.1476-5381.2009.00212.x; McCully JD, 2006, ANN THORAC SURG, V82, P117, DOI 10.1016/j.athoracsur.2006.03.002; Murph E, 2007, CARDIOVASC RES, V75, P478, DOI 10.1016/j.cardiores.2007.03.025; Murphy E, 2011, CIRC RES, V109, P687, DOI 10.1161/CIRCRESAHA.110.236687; O'Brien JD, 2008, AM J PHYSIOL-HEART C, V295, pH768, DOI 10.1152/ajpheart.00432.2008; Ostadal B, 2009, EXP BIOL MED, V234, P1011, DOI 10.3181/0812-MR-362; Puzianowska-Kuznicka M, 2009, AGEING RES REV, V8, P160, DOI 10.1016/j.arr.2009.05.002; Regitz-Zagrosek V, 2006, NAT REV DRUG DISCOV, V5, P425, DOI 10.1038/nrd2032; Ren J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010085; Ross JL, 2009, EUR J PHARMACOL, V602, P364, DOI 10.1016/j.ejphar.2008.11.034; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Saeedi Ramesh, 2006, BMC Cardiovasc Disord, V6, P8, DOI 10.1186/1471-2261-6-8; Sari FR, 2011, CARDIOVASC PATHOL, V20, P281, DOI 10.1016/j.carpath.2010.07.006; Simpson ER, 2003, J STEROID BIOCHEM, V86, P225, DOI 10.1016/S0960-0760(03)00360-1; Song X, 2003, ACTA PHYSIOL SCAND, V177, P459, DOI 10.1046/j.1365-201X.2003.01068.x; Stoddart MJ, 2011, METHODS MOL BIOL, V740, P1, DOI 10.1007/978-1-61779-108-6_1; Sze SCW, 2009, J ETHNOPHARMACOL, V123, P27, DOI 10.1016/j.jep.2009.02.034; Thorp DB, 2007, AM J PHYSIOL-REG I, V293, pR363, DOI 10.1152/ajpregu.00363.2006; Tomicek NJ, 2013, CARDIOVASC THER, V31, P32, DOI 10.1111/j.1755-5922.2011.00288.x; Wang FF, 2010, HYPERTENSION, V55, P1172, DOI 10.1161/HYPERTENSIONAHA.110.150839; Wang MJ, 2008, SURGERY, V144, P233, DOI 10.1016/j.surg.2008.03.009; Wang MJ, 2009, AM J PHYSIOL-REG I, V296, pR972, DOI 10.1152/ajpregu.00045.2009; Wang MJ, 2005, AM J PHYSIOL-HEART C, V288, pH221, DOI 10.1152/ajpheart.00784.2004; Wasserstrom JA, 2008, AM J PHYSIOL-HEART C, V295, pH1895, DOI 10.1152/ajpheart.00469.2008; Whelan RS, 2010, ANNU REV PHYSIOL, V72, P19, DOI 10.1146/annurev.physiol.010908.163111; Willems Laura, 2005, J Mol Cell Cardiol, V38, P245, DOI 10.1016/j.yjmcc.2004.09.014; Wilson LD, 2006, ANN NY ACAD SCI, V1080, P216, DOI 10.1196/annals.1380.018; Wu Q, 2008, EXP PHYSIOL, V93, P1034, DOI 10.1113/expphysiol.2007.041939; Zhao H, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-6; Zhao W, 2011, J ETHNOPHARMACOL, V134, P122, DOI 10.1016/j.jep.2010.11.073	60	45	46	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e38425	10.1371/journal.pone.0038425	http://dx.doi.org/10.1371/journal.pone.0038425			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701638	Green Published, gold, Green Submitted			2022-12-27	WOS:000305348400055
J	You, YH; He, LH; Zhang, MJ; Fu, JY; Gu, YX; Zhang, BH; Tao, XX; Zhang, JZ				You, Yuanhai; He, Lihua; Zhang, Maojun; Fu, Jianying; Gu, Yixin; Zhang, Binghua; Tao, Xiaoxia; Zhang, Jianzhong			Comparative Genomics of Helicobacter pylori Strains of China Associated with Different Clinical Outcome	PLOS ONE			English	Article							CAG-PATHOGENICITY ISLAND; IV SECRETION SYSTEM; FUNCTIONAL-ANALYSIS; GASTRIC-CANCER; DIVERSITY; SEQUENCE; GENES; RESTRICTION; PATHOGENESIS; MICROARRAY	In this study, a whole-genome CombiMatrix Custom oligonucleotide tiling microarray with 90000 probes covering six sequenced Helicobacter pylori (H. pylori) genomes was designed. This microarray was used to compare the genomic profiles of eight unsequenced strains isolated from patients with different gastroduodenal diseases in Heilongjiang province of China. Since significant genomic variation was found among these strains, an additional 76 H. pylori strains associated with different clinical outcomes were isolated from various provinces of China. These strains were tested by polymerase chain reaction to demonstrate this distinction. We identified several highly variable regions in strains associated with gastritis, gastric ulceration, and gastric cancer. These regions are associated with genes involved in the bacterial type I, type II, and type III R-M systems. They were also associated with the virB gene, which lies on the well-studied cag pathogenic island. While previous studies have reported on the diverse genetic characterization of this pathogenic island, in this study, we find that it is conserved in all strains tested by microarray. Moreover, a number of genes involved in the type IV secretion system, which is related to horizontal DNA transfer between H. pylori strains, were identified in the comparative analysis of the strain-specific genes. These findings may provide insight into new biomarkers for the prediction of gastric diseases.	[You, Yuanhai; He, Lihua; Zhang, Maojun; Fu, Jianying; Gu, Yixin; Zhang, Binghua; Tao, Xiaoxia; Zhang, Jianzhong] Chinese Ctr Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Natl Inst Communicable Dis Control & Prevent, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention	You, YH (corresponding author), Chinese Ctr Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Natl Inst Communicable Dis Control & Prevent, Beijing, Peoples R China.	zhangjianzhong@icdc.cn	Zhang, Jianzhong/AAM-6179-2021	Zhang, Jianzhong/0000-0001-7056-8206	National Key Program for Infectious Diseases of China [2008ZX1004-002]; China Mega-Project for Infectious Disease [2011ZX10004-001]; National Technology R&D Program in the 12th Five year Plan of china [2012BAI06B02]	National Key Program for Infectious Diseases of China; China Mega-Project for Infectious Disease; National Technology R&D Program in the 12th Five year Plan of china	This research was supported by a grant from the National Key Program for Infectious Diseases of China (No.2008ZX1004-002), China Mega-Project for Infectious Disease (No.2011ZX10004-001) and National Technology R&D Program in the 12th Five year Plan of china (No.2012BAI06B02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alm RA, 1999, NATURE, V397, P176, DOI 10.1038/16495; Ando T, 2002, CANCER RES, V62, P2385; Ando T, 2010, J GASTROEN HEPATOL, V25, pS95, DOI 10.1111/j.1440-1746.2009.06211.x; Andres S, 2010, HELICOBACTER, V15, P114, DOI 10.1111/j.1523-5378.2010.00745.x; Avasthi TS, 2011, J BACTERIOL, V193, P3385, DOI 10.1128/JB.05006-11; Backert S, 2004, INFECT IMMUN, V72, P1043, DOI 10.1128/IAI.72.2.1043-1056.2004; Baltrus DA, 2009, J BACTERIOL, V191, P447, DOI 10.1128/JB.01416-08; Chen JJ, 2007, BMC BIOINFORMATICS, V8, P1, DOI 10.1186/1471-2105-8-412; de Jonge R, 2004, FEMS IMMUNOL MED MIC, V41, P161, DOI 10.1016/j.femsim.2004.03.003; Devi SM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-191; Devi SH, 2010, J BACTERIOL, V192, P6488, DOI 10.1128/JB.01110-10; Diaz-Uriarte R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000737; Falush D, 2003, SCIENCE, V299, P1582, DOI 10.1126/science.1080857; Farnbacher M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-335; Fischer W, 2011, FEBS J, V278, P1203, DOI 10.1111/j.1742-4658.2011.08036.x; Fischer W, 2010, NUCLEIC ACIDS RES, V38, P6089, DOI 10.1093/nar/gkq378; Furuta Y, 2011, P NATL ACAD SCI USA, V108, P1501, DOI 10.1073/pnas.1012579108; Garcia-Vallve S, 2002, TRENDS MICROBIOL, V10, P445, DOI 10.1016/S0966-842X(02)02446-0; Gerhard M, 2002, HELICOBACTER, V7, P17, DOI 10.1046/j.1523-5378.7.s1.3.x; Gressmann H, 2005, PLOS GENET, V1, P419, DOI 10.1371/journal.pgen.0010043; Han YH, 2007, J MICROBIOL, V45, P21; Israel DA, 2001, J CLIN INVEST, V107, P611, DOI 10.1172/JCI11450; Janssen PJ, 2001, NUCLEIC ACIDS RES, V29, P4395, DOI 10.1093/nar/29.21.4395; Karnholz A, 2006, J BACTERIOL, V188, P882, DOI 10.1128/JB.188.3.882-893.2006; Kawai M, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-104; Kersulyte D, 2003, J BACTERIOL, V185, P3764, DOI 10.1128/JB.185.13.3764-3772.2003; Kersulyte D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006859; Kong HM, 2000, NUCLEIC ACIDS RES, V28, P3216, DOI 10.1093/nar/28.17.3216; Kraft C, 2005, INT J MED MICROBIOL, V295, P299, DOI 10.1016/j.ijmm.2005.06.002; Lin LF, 2001, P NATL ACAD SCI USA, V98, P2740, DOI 10.1073/pnas.051612298; Linz B, 2007, RES MICROBIOL, V158, P737, DOI 10.1016/j.resmic.2007.09.006; Linz B, 2007, NATURE, V445, P915, DOI 10.1038/nature05562; Lodes MJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000924; Lodes MJ, 2006, J CLIN MICROBIOL, V44, P1209, DOI 10.1128/JCM.44.4.1209-1218.2006; Mane SP, 2010, J BACTERIOL, V192, P3078, DOI 10.1128/JB.00063-10; MARSHALL BJ, 1994, AM J GASTROENTEROL, V89, pS116; McClain MS, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-3; Momynaliev KT, 2003, MOL BIOL+, V37, P529, DOI 10.1023/A:1025179109207; Moodley Y, 2009, SCIENCE, V323, P527, DOI 10.1126/science.1166083; Nilsson C, 2003, INFECT IMMUN, V71, P6573, DOI 10.1128/IAI.71.11.6573-6581.2003; Oh JD, 2006, P NATL ACAD SCI USA, V103, P9999, DOI 10.1073/pnas.0603784103; Olbermann P, 2010, BMC GENOMICS, V11, P368; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Raymond J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002259; Romo-Gonzalez C, 2009, INFECT IMMUN, V77, P2201, DOI 10.1128/IAI.01284-08; Salama N, 2000, P NATL ACAD SCI USA, V97, P14668, DOI 10.1073/pnas.97.26.14668; Salama NR, 2007, J BACTERIOL, V189, P3834, DOI 10.1128/JB.01696-06; Santos A, 2003, J CLIN MICROBIOL, V41, P1651, DOI 10.1128/JCM.41.4.1651-1655.2003; Tegtmeyer N, 2011, FEBS J, V278, P1190, DOI 10.1111/j.1742-4658.2011.08035.x; Terradot L, 2011, FEBS J, V278, P1213, DOI 10.1111/j.1742-4658.2011.08037.x; Thiberge JM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-368; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; Xu Q, 2000, P NATL ACAD SCI USA, V97, P9671, DOI 10.1073/pnas.97.17.9671; Yamaoka Y, 2008, J MED MICROBIOL, V57, P545, DOI 10.1099/jmm.0.2008/000570-0	55	12	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e38528	10.1371/journal.pone.0038528	http://dx.doi.org/10.1371/journal.pone.0038528			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701658	Green Published, Green Submitted, gold			2022-12-27	WOS:000305348400068
J	Chaudhury, S; Perelson, AS; Sinitstyn, NA				Chaudhury, Srabanti; Perelson, Alan S.; Sinitstyn, Nikolai A.			Spontaneous Clearance of Viral Infections by Mesoscopic Fluctuations	PLOS ONE			English	Article							C VIRUS-INFECTION; HIV-1 POPULATION-DYNAMICS; HEPATITIS-B-VIRUS; IN-VIVO; THERAPY; VIREMIA; CHIMPANZEES; INTERFERON; EFFICACY	Spontaneous disease extinction can occur due to a rare stochastic fluctuation. We explore this process, both numerically and theoretically, in two minimal models of stochastic viral infection dynamics. We propose a method that reduces the complexity in models of viral infections so that the remaining dynamics can be studied by previously developed techniques for analyzing epidemiological models. Using this technique, we obtain an expression for the infection clearance time as a function of kinetic parameters. We apply our theoretical results to study stochastic infection clearance for specific stages of HIV and HCV dynamics. Our results show that the typical time for stochastic clearance of a viral infection increases exponentially with the size of the population, but infection still can be cleared spontaneously within a reasonable time interval in a certain population of cells. We also show that the clearance time is exponentially sensitive to the viral decay rate and viral infectivity but only linearly dependent on the lifetime of an infected cell. This suggests that if standard drug therapy fails to clear an infection then intensifying therapy by adding a drug that reduces the rate of cell infection rather than immune modulators that hasten infected cell death may be more useful in ultimately clearing remaining pockets of infection.	[Chaudhury, Srabanti; Sinitstyn, Nikolai A.] Los Alamos Natl Lab, Div Theoret, Los Alamos, NM 87545 USA; [Chaudhury, Srabanti; Sinitstyn, Nikolai A.] New Mexico Consortium, Los Alamos, NM USA	United States Department of Energy (DOE); Los Alamos National Laboratory	Chaudhury, S (corresponding author), Los Alamos Natl Lab, Div Theoret, Los Alamos, NM 87545 USA.	c.srabanti@gmail.com	Perelson, Alan S/Z-1959-2019	Perelson, Alan S/0000-0002-2455-0002	National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH) [P20-RR018754]; National Nuclear Security Administration of the U.S. Department of Energy at Los Alamos National Laboratory [DE-AC52-06NA25396]; NIH [R37-AI028433, R01-RR006555]; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR006555, P20RR018754] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI028433, R01AI028433] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R01OD011095] Funding Source: NIH RePORTER	National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Nuclear Security Administration of the U.S. Department of Energy at Los Alamos National Laboratory(National Nuclear Security Administration); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The project was supported by grant number P20-RR018754 from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH). The work at LANL was carried out under the auspices of the National Nuclear Security Administration of the U.S. Department of Energy at Los Alamos National Laboratory under contract no. DE-AC52-06NA25396 and partially supported by NIH grants R37-AI028433 and R01-RR006555. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assaf M, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.248102; Assaf M, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.021116; Barnes E, 2002, VIRAL IMMUNOL, V15, P285, DOI 10.1089/08828240260066233; Bartlett MS., 1960, STOCHASTIC POPULATIO; Chen HY, 2007, P NATL ACAD SCI USA, V104, P19079, DOI 10.1073/pnas.0707449104; Cohen J, 2011, SCIENCE, V334, P1614, DOI 10.1126/science.334.6063.1614; Dahari H, 2007, J THEOR BIOL, V247, P371, DOI 10.1016/j.jtbi.2007.03.006; Elgart V, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.041106; Forgoston E, 2011, B MATH BIOL, V73, P495, DOI 10.1007/s11538-010-9537-0; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Glynn SA, 2005, TRANSFUSION, V45, P994, DOI 10.1111/j.1537-2995.2005.04390.x; Guedj J, 2011, HEPATOLOGY, V53, P1801, DOI 10.1002/hep.24272; Haase AT, 2010, NATURE, V464, P217, DOI 10.1038/nature08757; Herrmann E, 2003, HEPATOLOGY, V37, P1351, DOI 10.1053/jhep.2003.50218; Jordan AN, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.260604; Kamenev A, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.061107; Kamina A, 2001, MATH BIOSCI, V170, P187, DOI 10.1016/S0025-5564(00)00069-9; Kepler TB, 1998, P NATL ACAD SCI USA, V95, P11514, DOI 10.1073/pnas.95.20.11514; Khasin M, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.068101; LEMON SM, 2007, FIELDS VIROLOGY, P1253; Li QS, 2009, SCIENCE, V323, P1726, DOI 10.1126/science.1168676; Liang YQ, 2009, GASTROENTEROLOGY, V137, P1448, DOI 10.1053/j.gastro.2009.07.050; Maheshwari A, 2008, LANCET, V372, P321, DOI 10.1016/S0140-6736(08)61116-2; Meyer MF, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-58; Murray JM, 2005, P NATL ACAD SCI USA, V102, P17780, DOI 10.1073/pnas.0508913102; Neumann AU, 1998, SCIENCE, V282, P103, DOI 10.1126/science.282.5386.103; Nowak MA., 2000, VIRUS DYNAMICS MATH; Pearson JE, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001058; Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582; Perelson AS, 2002, NAT REV IMMUNOL, V2, P28, DOI 10.1038/nri700; Perelson AS, 1997, NATURE, V387, P188, DOI 10.1038/387188a0; Rehermann B, 2005, NAT REV IMMUNOL, V5, P215, DOI 10.1038/nri1573; Ribeiro RM, 2010, J VIROL, V84, P6096, DOI 10.1128/JVI.00127-10; Rodriguez-Inigo E, 2005, J MOL DIAGN, V7, P535, DOI 10.1016/S1525-1578(10)60585-5; Rong LB, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000544; Rong LB, 2009, J THEOR BIOL, V260, P308, DOI 10.1016/j.jtbi.2009.06.011; Sinitsyn NA, 2009, P NATL ACAD SCI USA, V106, P10546, DOI 10.1073/pnas.0809340106; Stafford MA, 2000, J THEOR BIOL, V203, P285, DOI 10.1006/jtbi.2000.1076; Tan WY, 1998, MATH BIOSCI, V147, P173, DOI 10.1016/S0025-5564(97)00094-1; Thomson M, 2003, J VIROL, V77, P862, DOI 10.1128/JVI.77.2.862-870.2003; Tuckwell HC, 1998, J THEOR BIOL, V195, P451, DOI 10.1006/jtbi.1998.0806; Veerapu NS, 2011, GASTROENTEROLOGY, V140, P676, DOI 10.1053/j.gastro.2010.10.048	42	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e38549	10.1371/journal.pone.0038549	http://dx.doi.org/10.1371/journal.pone.0038549			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22693646	Green Published, Green Submitted, gold			2022-12-27	WOS:000305343900058
J	Clendenning, DE; Mortlock, DP				Clendenning, Dawn E.; Mortlock, Douglas P.			The BMP Ligand Gdf6 Prevents Differentiation of Coronal Suture Mesenchyme in Early Cranial Development	PLOS ONE			English	Article							NEURAL CREST; FACIAL SYNDROME; JOINT FORMATION; BONE; MUTATIONS; MORPHOGENESIS; NOGGIN; MICE; CRANIOSYNOSTOSIS; MICRODELETION	Growth Differentiation Factor-6 (Gdf6) is a member of the Bone Morphogenetic Protein (BMP) family of secreted signaling molecules. Previous studies have shown that Gdf6 plays a role in formation of a diverse subset of skeletal joints. In mice, loss of Gdf6 results in fusion of the coronal suture, the intramembranous joint that separates the frontal and parietal bones. Although the role of GDFs in the development of cartilaginous limb joints has been studied, limb joints are developmentally quite distinct from cranial sutures and how Gdf6 controls suture formation has remained unclear. In this study we show that coronal suture fusion in the Gdf6-/- mouse is due to accelerated differentiation of suture mesenchyme, prior to the onset of calvarial ossification. Gdf6 is expressed in the mouse frontal bone primordia from embryonic day (E) 10.5 through 12.5. In the Gdf6-/- embryo, the coronal suture fuses prematurely and concurrently with the initiation of osteogenesis in the cranial bones. Alkaline phosphatase (ALP) activity and Runx2 expression assays both showed that the suture width is reduced in Gdf6+/- embryos and is completely absent in Gdf6-/- embryos by E12.5. ALP activity is also increased in the suture mesenchyme of Gdf6+/- embryos compared to wild-type. This suggests Gdf6 delays differentiation of the mesenchyme occupying the suture, prior to the onset of ossification. Therefore, although BMPs are known to promote bone formation, Gdf6 plays an inhibitory role to prevent the osteogenic differentiation of the coronal suture mesenchyme.	[Clendenning, Dawn E.; Mortlock, Douglas P.] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Ctr Human Genet Res, Nashville, TN 37212 USA	Vanderbilt University	Clendenning, DE (corresponding author), Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Ctr Human Genet Res, Nashville, TN 37212 USA.	mortlock@chgr.mc.vanderbilt.edu	Morlock, Doug/C-3482-2012; Mortlock, Douglas P/C-9981-2010		United States National Institutes of Health (NIH) [HD047880]; NIH Genetics Training Grant [T32GM080178]; NIH Developmental Biology Training Grant [T32HD07502]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007502] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD047880] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM080178] Funding Source: NIH RePORTER	United States National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Genetics Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Developmental Biology Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	DPM was supported by United States National Institutes of Health (NIH) grant HD047880. DEC was supported by NIH Genetics Training Grant T32GM080178 and NIH Developmental Biology Training Grant T32HD07502. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asai-Coakwell M, 2007, AM J HUM GENET, V80, P306, DOI 10.1086/511280; Bobacz K, 2006, ANN RHEUM DIS, V65, P169, DOI 10.1136/ard.2004.022756; Brunet LJ, 1998, SCIENCE, V280, P1455, DOI 10.1126/science.280.5368.1455; Butler SJ, 2003, NEURON, V38, P389, DOI 10.1016/S0896-6273(03)00254-X; Chai Y, 2000, DEVELOPMENT, V127, P1671; Chandler KJ, 2007, MAMM GENOME, V18, P693, DOI 10.1007/s00335-007-9056-y; Chandler RL, 2007, MOL CELL BIOL, V27, P2934, DOI 10.1128/MCB.01609-06; Chang CB, 1999, DEVELOPMENT, V126, P3347; Cohen MM, 2005, AM J MED GENET A, V136A, P313, DOI 10.1002/ajmg.a.30757; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; den Hollander AI, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-102; Doherty ES, 2007, AM J MED GENET A, V143A, P3204, DOI 10.1002/ajmg.a.32078; Dunn NR, 1997, DEV BIOL, V188, P235, DOI 10.1006/dbio.1997.8664; FURUYA Y, 1984, J NEUROSURG, V61, P53, DOI 10.3171/jns.1984.61.1.0053; Iseki S, 1999, DEVELOPMENT, V126, P5611; Ishii M, 2003, DEVELOPMENT, V130, P6131, DOI 10.1242/dev.00793; Jiang XB, 2002, DEV BIOL, V241, P106, DOI 10.1006/dbio.2001.0487; Kabbani H, 2004, AM FAM PHYSICIAN, V69, P2863; LYONS KM, 1995, MECH DEVELOP, V50, P71, DOI 10.1016/0925-4773(94)00326-I; Mazerbourg S, 2005, J BIOL CHEM, V280, P32122, DOI 10.1074/jbc.M504629200; Merrill AE, 2006, HUM MOL GENET, V15, P1319, DOI 10.1093/hmg/ddl052; Mortlock DP, 2003, GENOME RES, V13, P2069, DOI 10.1101/gr.1306003; Nochi H, 2004, J BONE MINER RES, V19, P111, DOI 10.1359/jbmr.2004.19.1.111; Poliakov A, 2004, DEV CELL, V7, P465, DOI 10.1016/j.devcel.2004.09.006; Raas-Rothschild A, 2009, EUR J MED GENET, V52, P140, DOI 10.1016/j.ejmg.2009.03.011; Rice DPC, 1999, EUR J ORAL SCI, V107, P265, DOI 10.1046/j.0909-8836.1999.eos107406.x; Salpietro CD, 2003, AM J MED GENET A, V121A, P283, DOI 10.1002/ajmg.a.20280; Settle S, 2001, DEV BIOL, V234, P138, DOI 10.1006/dbio.2001.0244; Settle SH, 2003, DEV BIOL, V254, P116, DOI 10.1016/S0012-1606(02)00022-2; Shen BJ, 2009, INT J BIOL SCI, V5, P192; Shieh JTC, 2006, AM J MED GENET A, V140A, P1267, DOI 10.1002/ajmg.a.31262; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Storm EE, 1999, DEV BIOL, V209, P11, DOI 10.1006/dbio.1999.9241; STORM EE, 1994, NATURE, V368, P639, DOI 10.1038/368639a0; Tassabehji M, 2008, HUM MUTAT, V29, P1017, DOI 10.1002/humu.20741; Tsumaki N, 1999, J CELL BIOL, V144, P161, DOI 10.1083/jcb.144.1.161; Warren SM, 2003, NATURE, V422, P625, DOI 10.1038/nature01545; Wilkie AOM, 1997, HUM MOL GENET, V6, P1647, DOI 10.1093/hmg/6.10.1647; Williams LA, 2008, INT J BIOL SCI, V4, P318; Yoshimoto T, 2006, J PERIODONTAL RES, V41, P140, DOI 10.1111/j.1600-0765.2005.00847.x	40	27	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e36789	10.1371/journal.pone.0036789	http://dx.doi.org/10.1371/journal.pone.0036789			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693558	Green Published, gold, Green Submitted			2022-12-27	WOS:000305338500019
J	De Weirdt, R; Crabbe, A; Roos, S; Vollenweider, S; Lacroix, C; van Pijkeren, JP; Britton, RA; Sarker, S; Van de Wiele, T; Nickerson, CA				De Weirdt, Rosemarie; Crabbe, Aurelie; Roos, Stefan; Vollenweider, Sabine; Lacroix, Christophe; van Pijkeren, Jan Peter; Britton, Robert A.; Sarker, Shameema; Van de Wiele, Tom; Nickerson, Cheryl A.			Glycerol Supplementation Enhances L. reuteri's Protective Effect against S. Typhimurium Colonization in a 3-D Model of Colonic Epithelium	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; PATHOGENICITY ISLAND 1; LACTOBACILLUS-REUTERI; SALMONELLA-TYPHIMURIUM; MUCUS LAYERS; 3-HYDROXYPROPIONALDEHYDE; INVASION; TOLERANCE; VIRULENCE; SAFETY	The probiotic effects of Lactobacillus reuteri have been speculated to partly depend on its capacity to produce the antimicrobial substance reuterin during the reduction of glycerol in the gut. In this study, the potential of this process to protect human intestinal epithelial cells against infection with Salmonella enterica serovar Typhimurium was investigated. We used a three-dimensional (3-D) organotypic model of human colonic epithelium that was previously validated and applied to study interactions between S. Typhimurium and the intestinal epithelium that lead to enteric salmonellosis. Using this model system, we show that L. reuteri protects the intestinal cells against the early stages of Salmonella infection and that this effect is significantly increased when L. reuteri is stimulated to produce reuterin from glycerol. More specifically, the reuterin-containing ferment of L. reuteri caused a reduction in Salmonella adherence and invasion (1 log unit), and intracellular survival (2 log units). In contrast, the L. reuteri ferment without reuterin stimulated growth of the intracellular Salmonella population with 1 log unit. The short-term exposure to reuterin or the reuterin-containing ferment had no observed negative impact on intestinal epithelial cell health. However, long-term exposure (24 h) induced a complete loss of cell-cell contact within the epithelial aggregates and compromised cell viability. Collectively, these results shed light on a potential role for reuterin in inhibiting Salmonella-induced intestinal infections and may support the combined application of glycerol and L. reuteri. While future in vitro and in vivo studies of reuterin on intestinal health should fine-tune our understanding of the mechanistic effects, in particular in the presence of a complex gut microbiota, this the first report of a reuterin effect on the enteric infection process in any mammalian cell type.	[De Weirdt, Rosemarie; Van de Wiele, Tom] Univ Ghent, Lab Microbial Ecol & Technol LabMET, B-9000 Ghent, Belgium; [Crabbe, Aurelie; Sarker, Shameema; Nickerson, Cheryl A.] Arizona State Univ, Biodesign Inst, Ctr Infect Dis & Vaccinol, Tempe, AZ USA; [Roos, Stefan] Swedish Univ Agr Sci, Dept Microbiol, Uppsala BioCtr, S-75007 Uppsala, Sweden; [Vollenweider, Sabine; Lacroix, Christophe] ETH, Inst Food Nutr & Hlth, Zurich, Switzerland; [van Pijkeren, Jan Peter; Britton, Robert A.] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA	Ghent University; Arizona State University; Arizona State University-Tempe; Swedish University of Agricultural Sciences; Swiss Federal Institutes of Technology Domain; ETH Zurich; Michigan State University	De Weirdt, R (corresponding author), Univ Ghent, Lab Microbial Ecol & Technol LabMET, B-9000 Ghent, Belgium.	cheryl.nickerson@asu.edu	Van de Wiele, Tom/C-8638-2011; van Pijkeren, Jan-Peter/H-5333-2019; Lacroix, Christophe/B-5139-2016; De Weirdt, Rosemarie/ABI-6298-2020	Van de Wiele, Tom/0000-0001-6854-5689; Lacroix, Christophe/0000-0003-4360-2020; Roos, Stefan/0000-0002-1606-1794; Crabbe, Aurelie/0000-0003-3084-4418	FWO-Vlaanderen [1526012N]; GOA Project [BOF12/GOA/008]; Special Research Fund of Ghent University; National Aeronautics and Space Administration [NCC2-1362]; Strategic Partnership Grant by Michigan State University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI090872] Funding Source: NIH RePORTER	FWO-Vlaanderen(FWO); GOA Project; Special Research Fund of Ghent University(Ghent University); National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA)); Strategic Partnership Grant by Michigan State University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by an FWO-Vlaanderen travel grant (www.fwo.be), an FWO-Vlaanderen research grant 1526012N and a GOA Project (BOF12/GOA/008) (www.ugent.be). RDW was funded by the Special Research Fund of Ghent University (www.ugent.be). CAN was supported by the National Aeronautics and Space Administration Grant NCC2-1362 (www.nasa.gov). TVDW benefits from an FWO-Vlaanderen postdoctoral grant. RB and JPVP were supported by a Strategic Partnership Grant by Michigan State University (http://msufoundation.msu.edu/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arques JL, 2004, INT J FOOD MICROBIOL, V95, P225, DOI 10.1016/j.ijfoodmicro.2004.03.009; Axelsson L.T., 1989, MICROB ECOL HEALTH D, V2, P131, DOI [DOI 10.3109/08910608909140210, 10.3109/08910608909140210]; Barrila J, 2010, NAT REV MICROBIOL, V8, P791, DOI 10.1038/nrmicro2423; Baumler AJ, 1997, INFECT IMMUN, V65, P2254; Becker D, 2006, NATURE, V440, P303, DOI 10.1038/nature04616; Bentrup KHZ, 2006, MICROBES INFECT, V8, P1813, DOI 10.1016/j.micinf.2006.02.020; Bian L, 2011, WORLD J MICROB BIOT, V27, P991, DOI 10.1007/s11274-010-0543-z; Bobik TA, 1997, J BACTERIOL, V179, P6633, DOI 10.1128/jb.179.21.6633-6639.1997; BOYER HW, 1969, J MOL BIOL, V41, P459, DOI 10.1016/0022-2836(69)90288-5; Casas Ivan A., 2000, Microbial Ecology in Health and Disease, V12, P247; Chiu LH, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-86; Cleusix V, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-101; Cleusix V, 2008, FEMS MICROBIOL ECOL, V63, P56, DOI 10.1111/j.1574-6941.2007.00412.x; Coombes BK, 2005, INFECT IMMUN, V73, P7161, DOI 10.1128/IAI.73.11.7161-7169.2005; De Weirdt R, 2010, FEMS MICROBIOL ECOL, V74, P601, DOI 10.1111/j.1574-6941.2010.00974.x; Desin TS, 2009, INFECT IMMUN, V77, P2866, DOI 10.1128/IAI.00039-09; Frese SA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001314; GULIG PA, 1987, INFECT IMMUN, V55, P2891, DOI 10.1128/IAI.55.12.2891-2901.1987; Hobert ME, 2002, J BIOL CHEM, V277, P51025, DOI 10.1074/jbc.M210466200; Hu QH, 2008, J CLIN MICROBIOL, V46, P1330, DOI 10.1128/JCM.01255-07; Hurley BP, 2003, TRENDS MICROBIOL, V11, P562, DOI 10.1016/j.tim.2003.10.002; Jeong JH, 2008, J BACTERIOL, V190, P6340, DOI 10.1128/JB.00385-08; Johansson MEV, 2011, P NATL ACAD SCI USA, V108, P4659, DOI 10.1073/pnas.1006451107; Johansson MEV, 2008, P NATL ACAD SCI USA, V105, P15064, DOI 10.1073/pnas.0803124105; Jones SE, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-35; Kehrer JP, 2000, TOXICOL SCI, V57, P6, DOI 10.1093/toxsci/57.1.6; Kim JY, 2007, FOOD SCI BIOTECHNOL, V16, P778; Lawhon SD, 2002, MOL MICROBIOL, V46, P1451, DOI 10.1046/j.1365-2958.2002.03268.x; Lin YP, 2008, INFLAMM BOWEL DIS, V14, P1068, DOI 10.1002/ibd.20448; Liu YY, 2010, AM J PHYSIOL-GASTR L, V299, pG1087, DOI 10.1152/ajpgi.00124.2010; Luthi-Peng Q, 2002, APPL MICROBIOL BIOT, V60, P73, DOI 10.1007/s00253-002-1099-0; Maassen CBM, 2000, VACCINE, V18, P2613, DOI 10.1016/S0264-410X(99)00378-3; Martinez-Argudo I, 2008, MICROBIOL-SGM, V154, P3887, DOI 10.1099/mic.0.2008/021162-0; Morgan E, 2004, MOL MICROBIOL, V54, P994, DOI 10.1111/j.1365-2958.2004.04323.x; Morita H, 2008, DNA RES, V15, P151, DOI 10.1093/dnares/dsn009; Murray RA, 2000, INFECT IMMUN, V68, P5050, DOI 10.1128/IAI.68.9.5050-5055.2000; Nickerson CA, 2001, INFECT IMMUN, V69, P7106, DOI 10.1128/IAI.69.11.7106-7120.2001; O'Brien PJ, 2005, CRIT REV TOXICOL, V35, P609, DOI 10.1080/10408440591002183; Oh PL, 2010, ISME J, V4, P377, DOI 10.1038/ismej.2009.123; Payne AN, 2012, TRENDS BIOTECHNOL, V30, P17, DOI 10.1016/j.tibtech.2011.06.011; Peran L, 2007, BRIT J NUTR, V97, P96, DOI 10.1017/S0007114507257770; Pullinger GD, 2007, INFECT IMMUN, V75, P5191, DOI 10.1128/IAI.00784-07; Radtke AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015750; Raffatellu M, 2005, INFECT IMMUN, V73, P146, DOI 10.1128/IAI.73.1.146-154.2005; Rosander A, 2008, APPL ENVIRON MICROB, V74, P6032, DOI 10.1128/AEM.00991-08; Schaefer L, 2010, MICROBIOL-SGM, V156, P1589, DOI 10.1099/mic.0.035642-0; Spinler JK, 2008, ANAEROBE, V14, P166, DOI 10.1016/j.anaerobe.2008.02.001; Sriramulu DD, 2008, J BACTERIOL, V190, P4559, DOI 10.1128/JB.01535-07; TALARICO TL, 1988, ANTIMICROB AGENTS CH, V32, P1854, DOI 10.1128/AAC.32.12.1854; Tenor JL, 2004, CURR BIOL, V14, P1018, DOI 10.1016/j.cub.2004.05.050; Thiennimitr P, 2012, CURR OPIN MICROBIOL, V15, P108, DOI 10.1016/j.mib.2011.10.002; Todoriki K, 2001, J APPL MICROBIOL, V91, P154, DOI 10.1046/j.1365-2672.2001.01371.x; Van Immerseel F, 2006, AVIAN PATHOL, V35, P182, DOI 10.1080/03079450600711045; van Pijkeren JP, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks147; Vollenweider S, 2004, APPL MICROBIOL BIOT, V64, P16, DOI 10.1007/s00253-003-1497-y; Vollenweider S, 2003, J AGR FOOD CHEM, V51, P3287, DOI 10.1021/jf021086d; Vollenweider S, 2010, J AGR FOOD CHEM, V58, P10315, DOI 10.1021/jf1010897; Wallis TS, 2000, MOL MICROBIOL, V36, P997, DOI 10.1046/j.1365-2958.2000.01892.x; Walter J, 2011, P NATL ACAD SCI USA, V108, P4645, DOI 10.1073/pnas.1000099107; WATSON PR, 1995, INFECT IMMUN, V63, P2743, DOI 10.1128/IAI.63.7.2743-2754.1995; Weizman Z, 2005, PEDIATRICS, V115, P5, DOI 10.1542/peds.2004-1815; Weizman Z, 2006, J AM COLL NUTR, V25, P415, DOI 10.1080/07315724.2006.10719554; WHO (World Health Organization), 2005, DRUG RES SALM; Wiesner M, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-9; WOLF BW, 1995, MICROB ECOL HEALTH D, V8, P41, DOI 10.3109/08910609509141381; Wolf BW, 1998, FOOD CHEM TOXICOL, V36, P1085, DOI 10.1016/S0278-6915(98)00090-8	66	35	38	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e37116	10.1371/journal.pone.0037116	http://dx.doi.org/10.1371/journal.pone.0037116			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693569	Green Published, Green Submitted, gold			2022-12-27	WOS:000305338500031
J	Yamada, T; Park, CS; Burns, A; Nakada, D; Lacorazza, HD				Yamada, Takeshi; Park, Chun Shik; Burns, Audrea; Nakada, Daisuke; Lacorazza, H. Daniel			The Cytosolic Protein G0S2 Maintains Quiescence in Hematopoietic Stem Cells	PLOS ONE			English	Article							GENE-EXPRESSION; BONE-MARROW; IN-VIVO; RHEUMATOID-ARTHRITIS; MONONUCLEAR-CELLS; PROGENITOR CELLS; MESSENGER-RNA; TARGET GENE; SWITCH GENE; NUCLEOLIN	Bone marrow hematopoietic stem cells (HSCs) balance proliferation and differentiation by integrating complex transcriptional and post-translational mechanisms regulated by cell intrinsic and extrinsic factors. We found that transcripts of G(0)/G(1) switch gene 2 (G0S2) are enriched in lineage(-)Sca-1(+)c-kit(+) (LSK) CD150(+)CD48(-)CD41(-) cells, a population highly enriched for quiescent HSCs, whereas G0S2 expression is suppressed in dividing LSK CD150(+)CD48(-) cells. Gain-of-function analyses using retroviral expression vectors in bone marrow cells showed that G0S2 localizes to the mitochondria, endoplasmic reticulum, and early endosomes in hematopoietic cells. Co-transplantation of bone marrow cells transduced with the control or G0S2 retrovirus led to increased chimerism of G0S2-overexpressing cells in femurs, although their contribution to the blood was reduced. This finding was correlated with increased quiescence in G0S2-overexpressing HSCs (LSK CD150(+)CD48(-)) and progenitor cells (LS-K). Conversely, silencing of endogenous G0S2 expression in bone marrow cells increased blood chimerism upon transplantation and promoted HSC cell division, supporting an inhibitory role for G0S2 in HSC proliferation. A proteomic study revealed that the hydrophobic domain of G0S2 interacts with a domain of nucleolin that is rich in arginine-glycine-glycine repeats, which results in the retention of nucleolin in the cytosol. We showed that this cytosolic retention of nucleolin occurs in resting, but not proliferating, wild-type LSK CD150(+)CD48(-) cells. Collectively, we propose a novel model of HSC quiescence in which elevated G0S2 expression can sequester nucleolin in the cytosol, precluding its pro-proliferation functions in the nucleolus.	[Yamada, Takeshi; Park, Chun Shik; Burns, Audrea; Lacorazza, H. Daniel] Texas Childrens Hosp, Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Nakada, Daisuke] Texas Childrens Hosp, Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Lacorazza, H. Daniel] Texas Childrens Hosp, Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Yamada, T (corresponding author), Texas Childrens Hosp, Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA.	hdl@bcm.edu		Park, Chun Shik/0000-0002-4329-3953; Nakada, Daisuke/0000-0001-6010-7094; Lacorazza, Daniel/0000-0003-0660-617X	National Institutes of Health, National Institute of Allergy and Infectious Diseases [RO1AI077536, R01AI077536-02S1]; Gabrielle's Angel Foundation for Cancer Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077536] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Gabrielle's Angel Foundation for Cancer Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by funds from National Institutes of Health, National Institute of Allergy and Infectious Diseases (RO1AI077536 and R01AI077536-02S1 to HDL) and the Gabrielle's Angel Foundation for Cancer Research (to HDL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmohsen K, 2011, NUCLEIC ACIDS RES, V39, P8513, DOI 10.1093/nar/gkr488; Antonchuk J, 2002, CELL, V109, P39, DOI 10.1016/S0092-8674(02)00697-9; BORER RA, 1989, CELL, V56, P379, DOI 10.1016/0092-8674(89)90241-9; Bouvet P, 1998, J BIOL CHEM, V273, P19025, DOI 10.1074/jbc.273.30.19025; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Coller HA, 2006, PLOS BIOL, V4, P329, DOI 10.1371/journal.pbio.0040083; Colmegna I, 2008, ARTHRITIS RHEUM, V58, P990, DOI 10.1002/art.23287; Cristillo AD, 1997, DNA CELL BIOL, V16, P1449, DOI 10.1089/dna.1997.16.1449; DERENZINI M, 1995, EXP CELL RES, V219, P276, DOI 10.1006/excr.1995.1228; Essers MAG, 2009, NATURE, V458, P904, DOI 10.1038/nature07815; Fahling M, 2005, BBA-GENE STRUCT EXPR, V1731, P32, DOI 10.1016/j.bbaexp.2005.08.005; Foudi A, 2009, NAT BIOTECHNOL, V27, P84, DOI 10.1038/nbt.1517; Grinstein E, 2011, CELL SIGNAL, V23, P1358, DOI 10.1016/j.cellsig.2011.03.018; Hock H, 2004, NATURE, V431, P1002, DOI 10.1038/nature02994; Jerke U, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008302; Jude CD, 2008, CELL CYCLE, V7, P586, DOI 10.4161/cc.7.5.5549; Juntilla MM, 2010, BLOOD, V115, P4030, DOI 10.1182/blood-2009-09-241000; Kao LC, 2003, ENDOCRINOLOGY, V144, P2870, DOI 10.1210/en.2003-0043; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kitareewan S, 2008, INT J ONCOL, V33, P397, DOI 10.3892/ijo_00000021; Kitsos CM, 2005, J BIOL CHEM, V280, P33101, DOI 10.1074/jbc.M505208200; Kobayashi S, 2008, DNA RES, V15, P253, DOI 10.1093/dnares/dsn014; Koczan D, 2005, EUR J DERMATOL, V15, P251; Kusakabe M, 2009, BIOCHEM BIOPH RES CO, V390, P1283, DOI 10.1016/j.bbrc.2009.10.137; Lacorazza HD, 2006, CANCER CELL, V9, P175, DOI 10.1016/j.ccr.2006.02.017; Lu X, 2010, CELL CYCLE, V9, P2719, DOI 10.4161/cc.9.14.12181; Ma Y, 2003, ONCOGENE, V22, P4924, DOI 10.1038/sj.onc.1206728; Miyamoto K, 2007, CELL STEM CELL, V1, P101, DOI 10.1016/j.stem.2007.02.001; Mongelard F, 2007, TRENDS CELL BIOL, V17, P80, DOI 10.1016/j.tcb.2006.11.010; Nakamura N, 2006, DNA RES, V13, P169, DOI 10.1093/dnares/dsl006; O'Connell RM, 2010, P NATL ACAD SCI USA, V107, P14235, DOI 10.1073/pnas.1009798107; Orford KW, 2008, NAT REV GENET, V9, P115, DOI 10.1038/nrg2269; Otake Y, 2007, BLOOD, V109, P3069, DOI 10.1182/blood-2006-08-043257; Passegue E, 2006, DEV CELL, V10, P415, DOI 10.1016/j.devcel.2006.03.002; Passegue E, 2005, J EXP MED, V202, P1599, DOI 10.1084/jem.20050967; Pear WS, 1998, BLOOD, V92, P3780, DOI 10.1182/blood.V92.10.3780.422k15_3780_3792; Purton LE, 2000, BLOOD, V95, P470, DOI 10.1182/blood.V95.2.470; RUSSELL L, 1991, DNA CELL BIOL, V10, P581, DOI 10.1089/dna.1991.10.581; Sandberg ML, 2005, DEV CELL, V8, P153, DOI 10.1016/j.devcel.2004.12.015; Srivastava M, 1999, FASEB J, V13, P1911, DOI 10.1096/fasebj.13.14.1911; Storck Sebastien, 2007, Subcell Biochem, V41, P125; Teunissen BEJ, 2007, CARDIOVASC RES, V75, P519, DOI 10.1016/j.cardiores.2007.04.026; Thorsteinsdottir U, 1999, BLOOD, V94, P2605, DOI 10.1182/blood.V94.8.2605.420k19_2605_2612; Tokumaru Y, 2004, CANCER RES, V64, P5982, DOI 10.1158/0008-5472.CAN-04-0993; Ugrinova I, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-66; Visalli G, 2010, CELL CYCLE, V9, P2130, DOI 10.4161/cc.9.11.11754; Wang ZQ, 2009, BLOOD, V113, P4856, DOI 10.1182/blood-2008-09-181107; Yang XY, 2010, CELL METAB, V11, P194, DOI 10.1016/j.cmet.2010.02.003; Yoon IK, 2004, EXP GERONTOL, V39, P1369, DOI 10.1016/j.exger.2004.07.002; Yuan YZ, 2004, NAT CELL BIOL, V6, P436, DOI 10.1038/ncb1126; Zandbergen F, 2005, BIOCHEM J, V392, P313, DOI 10.1042/BJ20050636; Zhang JW, 2006, NATURE, V441, P518, DOI 10.1038/nature04747; Zhang KM, 2009, EUR J DERMATOL, V19, P141, DOI 10.1684/ejd.2008.0618	53	39	39	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38280	10.1371/journal.pone.0038280	http://dx.doi.org/10.1371/journal.pone.0038280			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693613	Green Submitted, gold, Green Published			2022-12-27	WOS:000305338500124
J	Klein, K; Aeschlimann, A; Jordan, S; Gay, R; Gay, S; Sprott, H				Klein, Kerstin; Aeschlimann, Andre; Jordan, Suzana; Gay, Renate; Gay, Steffen; Sprott, Haiko			ATP Induced Brain-Derived Neurotrophic Factor Expression and Release from Osteoarthritis Synovial Fibroblasts Is Mediated by Purinergic Receptor P2X4	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; FACTOR MESSENGER-RNA; RHEUMATOID-ARTHRITIS; NEUROPATHIC PAIN; SPINAL MICROGLIA; KNEE-JOINT; IN-VITRO; BDNF; CELLS; RAT	Brain-derived neurotrophic factor (BDNF), a neuromodulator involved in nociceptive hypersensitivity in the central nervous system, is also expressed in synoviocytes of osteoarthritis (OA) and rheumatoid arthritis (RA) patients. We investigated the role of P2 purinoreceptors in the induction of BDNF expression in synovial fibroblasts (SF) of OA and RA patients. Cultured SF from patients with symptomatic knee OA and RA were stimulated with purinoreceptor agonists ATP, ADP, or UTP. The expression of BDNF mRNA was measured by quantitative TaqMan PCR. BDNF release into cell culture supernatants was monitored by ELISA. P2X4 expression in synovial tissue was detected by immunohistochemistry. Endogenous P2X4 expression was decreased by siRNA transfection before ATP stimulation. Kinase pathways were blocked before ATP stimulation. BDNF mRNA expression levels in OASF were increased 2 h and 5 h after ATP stimulation. Mean BDNF levels in cell culture supernatants of unstimulated OASF and RASF were 19 (+/- 9) and 67 (+/- 49) pg/ml, respectively. BDNF levels in SF supernatants were only elevated 5 h after ATP stimulation. BDNF mRNA expression in OASF was induced both by P2X receptor agonists ATP and ADP, but not by UTP, an agonist of P2Y purinergic receptors. The ATP-induced BDNF mRNA expression in OASF was decreased by siRNA-mediated reduction of endogenous P2X4 levels compared to scrambled controls. Inhibition of p38, but not p44/42 signalling reduced the ATP-mediated BDNF mRNA induction. Here we show a functional role of the purinergic receptor P2X4 and p38 kinase in the ATP-induced expression and release of the neurotrophin BDNF in SF.	[Klein, Kerstin; Jordan, Suzana; Gay, Renate; Gay, Steffen; Sprott, Haiko] Univ Zurich Hosp, Ctr Expt Rheumatol, Div Rheumatol, CH-8091 Zurich, Switzerland; [Klein, Kerstin; Jordan, Suzana; Gay, Renate; Gay, Steffen; Sprott, Haiko] Univ Zurich Hosp, Inst Med Phys, CH-8091 Zurich, Switzerland; [Klein, Kerstin; Jordan, Suzana; Gay, Renate; Gay, Steffen; Sprott, Haiko] Zurich Ctr Integrat Human Physiol ZIHP, Zurich, Switzerland; [Aeschlimann, Andre] RehaClinic, Bad Zurzach, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP)	Klein, K (corresponding author), Univ Zurich Hosp, Ctr Expt Rheumatol, Div Rheumatol, CH-8091 Zurich, Switzerland.	haiko.sprott@painclinic.eu	Distler, Oliver/AAE-6225-2019	Distler, Oliver/0000-0002-0546-8310; Klein, Kerstin/0000-0001-5303-8027; Jordan, Suzana/0000-0002-8114-8239	Swiss National Science Foundation [3200B0_119892]; Zurzach Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Zurzach Foundation	This work was supported by the Swiss National Science Foundation (Project 3200B0_119892) and the Zurzach Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN R, 1986, ARTHRITIS RHEUM, V29, P1039, DOI 10.1002/art.1780290816; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Bai O, 2003, J NEUROSCI RES, V71, P127, DOI 10.1002/jnr.10440; Barthel C, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2716; Brock M, 2009, CIRC RES, V104, P1184, DOI 10.1161/CIRCRESAHA.109.197491; Caporali F, 2008, J MOL MED, V86, P937, DOI 10.1007/s00109-008-0365-8; Chessell IP, 2005, PAIN, V114, P386, DOI 10.1016/j.pain.2005.01.002; Coull JAM, 2005, NATURE, V438, P1017, DOI 10.1038/nature04223; Delafoy L, 2006, GUT, V55, P940, DOI 10.1136/gut.2005.064063; Dowd E, 1998, BRIT J PHARMACOL, V125, P341, DOI 10.1038/sj.bjp.0702080; Forsgren S, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2754; Fukuoka T, 2001, J NEUROSCI, V21, P4891, DOI 10.1523/JNEUROSCI.21-13-04891.2001; Greenberg ME, 2009, J NEUROSCI, V29, P12764, DOI 10.1523/JNEUROSCI.3566-09.2009; Grimsholm O, 2008, CLIN RHEUMATOL, V27, P1289, DOI 10.1007/s10067-008-0910-4; Grimsholm O, 2008, CELLS TISSUES ORGANS, V188, P299, DOI 10.1159/000121432; Gunosewoyo H, 2010, EXPERT OPIN THER PAT, V20, P625, DOI 10.1517/13543771003702424; Hatami H, 2007, NEUROPEPTIDES, V41, P321, DOI 10.1016/j.npep.2007.04.007; Heberlein A, 2010, PSYCHOPHARMACOLOGY, V209, P213, DOI 10.1007/s00213-010-1781-3; Hellweg R, 2008, PHARMACOPSYCHIATRY, V41, P66, DOI 10.1055/s-2007-1004594; Hutchinson AJ, 2009, NEUROCHEM INT, V54, P439, DOI 10.1016/j.neuint.2009.01.018; Jungel A, 2004, ARTHRITIS RHEUM, V50, P1468, DOI 10.1002/art.20218; Kawanokuchi J, 2008, J NEUROIMMUNOL, V194, P54, DOI 10.1016/j.jneuroim.2007.11.006; Kerschensteiner M, 1999, J EXP MED, V189, P865, DOI 10.1084/jem.189.5.865; Kidd BL, 2006, PAIN, V123, P6, DOI 10.1016/j.pain.2006.04.009; Kobayashi K, 2008, J NEUROSCI, V28, P2892, DOI 10.1523/JNEUROSCI.5589-07.2008; Kumahashi N, 2010, KNEE; Lee BH, 2010, J CLIN PSYCHOPHARM, V30, P623, DOI 10.1097/JCP.0b013e3181f13f0b; Miller LE, 2000, FASEB J, V14, P2097, DOI 10.1096/fj.99-1082com; North RA, 2000, ANNU REV PHARMACOL, V40, P563, DOI 10.1146/annurev.pharmtox.40.1.563; Oddiah D, 1998, NEUROREPORT, V9, P1455, DOI 10.1097/00001756-199805110-00038; Ospelt C, 2008, BEST PRACT RES CL RH, V22, P239, DOI 10.1016/j.berh.2008.01.004; Ray FR, 2002, ATHEROSCLEROSIS, V162, P55, DOI 10.1016/S0021-9150(01)00681-5; Raychaudhuri SP, 2009, SCAND J RHEUMATOL, V38, P207, DOI 10.1080/03009740802448866; Ritchlin C, 2000, ARTHRITIS RES, V2, P356, DOI 10.1186/ar112; Schulte-Herbruggen O, 2005, J NEUROIMMUNOL, V160, P204, DOI 10.1016/j.jneuroim.2004.10.026; Shu XQ, 1999, PAIN, V80, P463, DOI 10.1016/S0304-3959(99)00042-1; Takasaki I, 2008, GLIA, V56, P1369, DOI 10.1002/glia.20704; Takayama N, 2005, J NEUROSCI, V25, P430, DOI 10.1523/JNEUROSCI.3170-04.2005; Tozaki-Saitoh H, 2008, J NEUROSCI, V28, P4949, DOI 10.1523/JNEUROSCI.0323-08.2008; Trang T, 2009, J NEUROSCI, V29, P3518, DOI 10.1523/JNEUROSCI.5714-08.2009; Tsuda M, 2003, NATURE, V424, P778, DOI 10.1038/nature01786; Tsuda M, 2010, BRAIN RES REV, V63, P222, DOI 10.1016/j.brainresrev.2009.11.003; Ulmann L, 2010, EMBO J, V29, P2290, DOI 10.1038/emboj.2010.126; Vanelderen P, 2010, EUR J PAIN, V14, pe471; Varani K, 2010, CELL PHYSIOL BIOCHEM, V25, P325, DOI 10.1159/000276565; Weidler C, 2005, ANN RHEUM DIS, V64, P13, DOI 10.1136/ard.2003.016154; Yang J, 2010, EUR J PAIN, V14, P574, DOI 10.1016/j.ejpain.2009.10.007; Zhang HN, 2006, EUR J NEUROSCI, V23, P984, DOI 10.1111/j.1460-9568.2006.04621.x; Zhou XF, 2000, EUR J NEUROSCI, V12, P100, DOI 10.1046/j.1460-9568.2000.00884.x; Zhu ZW, 2001, DIGEST DIS SCI, V46, P1633, DOI 10.1023/A:1010684916863	51	25	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e36693	10.1371/journal.pone.0036693	http://dx.doi.org/10.1371/journal.pone.0036693			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22715356	Green Published, Green Accepted, gold			2022-12-27	WOS:000305342300014
J	Kumar, M; Ahmad, S; Ahmad, E; Saifi, MA; Khan, RH				Kumar, Manish; Ahmad, Shadab; Ahmad, Ejaz; Saifi, Muheet Alam; Khan, Rizwan Hasan			In Silico Prediction and Analysis of Caenorhabditis EF-hand Containing Proteins	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; CALCIUM-BINDING; ELEGANS; DOMAIN; GENE; CALMODULIN; CALCINEURIN; PHOSPHATASE; POLARITY; FAMILY	Calcium (Ca+2) is a ubiquitous messenger in eukaryotes including Caenorhabditis. Ca+2-mediated signalling processes are usually carried out through well characterized proteins like calmodulin (CaM) and other Ca+2 binding proteins (CaBP). These proteins interact with different targets and activate it by bringing conformational changes. Majority of the EF-hand proteins in Caenorhabditis contain Ca+2 binding motifs. Here, we have performed homology modelling of CaM-like proteins using the crystal structure of Drosophila melanogaster CaM as a template. Molecular docking was applied to explore the binding mechanism of CaM-like proteins and IQ1 motif which is a similar to 25 residues and conform to the consensus sequence (I, L, V) QXXXRXXXX(R,K) to serve as a binding site for different EF hand proteins. We made an attempt to identify all the EF-hand (a helix-loop-helix structure characterized by a 12 residues loop sequence involved in metal coordination) containing proteins and their Ca+2 binding affinity in Caenorhabditis by analysing the complete genome sequence. Docking studies revealed that F165, F169, L29, E33, F44, L57, M61, M96, M97, M108, G65, V115, F93, N104, E144 of CaM-like protein is involved in the interaction with IQ1 motif. A maximum of 170 EF-hand proteins and 39 non-EF-hand proteins with Ca+2/metal binding motif were identified. Diverse proteins including enzyme, transcription, translation and large number of unknown proteins have one or more putative EF-hands. Phylogenetic analysis revealed seven major classes/groups that contain some families of proteins. Various domains that we identified in the EF-hand proteins (uncharacterized) would help in elucidating their functions. It is the first report of its kind where calcium binding loop sequences of EF-hand proteins were analyzed to decipher their calcium affinities. Variation in Ca+2-binding affinity of EF-hand CaBP could be further used to study the behaviour of these proteins. Our analyses postulated that Ca+2 is likely to be key player in Caenorhabditis cell signalling.	[Kumar, Manish] Jawaharlal Nehru Univ, Adv Instrumentat Res Facil, New Delhi 110067, India; [Ahmad, Shadab] Jawaharlal Nehru Univ, Ctr Computat Biol & Bioinformat, New Delhi 110067, India; [Ahmad, Ejaz; Khan, Rizwan Hasan] Aligarh Muslim Univ, Interdisciplinary Biotechnol Unit, Aligarh, Uttar Pradesh, India; [Saifi, Muheet Alam] King Saud Univ, Coll Sci, Dept Zool, Riyadh 11451, Saudi Arabia	Jawaharlal Nehru University, New Delhi; Jawaharlal Nehru University, New Delhi; Aligarh Muslim University; King Saud University	Kumar, M (corresponding author), Jawaharlal Nehru Univ, Adv Instrumentat Res Facil, New Delhi 110067, India.	rizwanhkhan@hotmail.com	Khan, Rizwan/GXZ-5789-2022; Khan, Rizwan Hasan/F-8276-2014; Ahmad, Ejaz/L-1506-2013	Khan, Rizwan Hasan/0000-0002-9965-8982; Ahmad, Ejaz/0000-0002-5713-6713	Department of Science and Technology (DST), Government of India; Council of Scientific and Industrial Research (CSIR)	Department of Science and Technology (DST), Government of India(Department of Science & Technology (India)); Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India)	Financial assistance to MK in the form of Research Associate was supported by Department of Science and Technology (DST), Government of India, and to EA was in the form of a Senior Research Fellowship by the Council of Scientific and Industrial Research (CSIR). SA is a trainee, MAS is an assistant professor in KSU, and RHK is an associate professor in AMU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBAGLI O, 1995, CELL GROWTH DIFFER, V6, P1193; Amata I, 2008, BIOCHEMISTRY-US, V47, P12332, DOI 10.1021/bi801178t; Apweiler R, 2001, NUCLEIC ACIDS RES, V29, P37, DOI 10.1093/nar/29.1.37; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Bahler M, 2002, FEBS LETT, V513, P107, DOI 10.1016/S0014-5793(01)03239-2; Bandyopadhyay J, 2002, MOL BIOL CELL, V13, P3281, DOI 10.1091/mbc.E02-01-0005; Bandyopadhyay J, 2004, MOL CELLS, V18, P10; BARSTEAD RJ, 1991, CELL MOTIL CYTOSKEL, V20, P69, DOI 10.1002/cm.970200108; Berchtold MW, 1996, GUIDEBOOK CALCIUM BI, P123; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Boutet Emmanuel, 2007, V406, P89; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; DECASTRO E, 1995, BIOCHEM BIOPH RES CO, V216, P133, DOI 10.1006/bbrc.1995.2601; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gifford JL, 2007, BIOCHEM J, V405, P199, DOI 10.1042/BJ20070255; Giles RH, 1998, TRENDS GENET, V14, P178, DOI 10.1016/S0168-9525(98)01438-3; GODDARD JM, 1986, P NATL ACAD SCI USA, V83, P2172, DOI 10.1073/pnas.83.7.2172; Gower NJD, 2005, MOL BIOL CELL, V16, P3978, DOI 10.1091/mbc.E05-02-0096; Grant B, 2001, NAT CELL BIOL, V3, P573, DOI 10.1038/35078549; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kilby PM, 1996, STRUCTURE, V4, P1041, DOI 10.1016/S0969-2126(96)00111-6; Klopfenstein DR, 2004, MOL BIOL CELL, V15, P3729, DOI 10.1091/mbc.E04-04-0326; KRETSINGER RH, 1973, J BIOL CHEM, V248, P3313; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lewit-Bentley A, 2000, CURR OPIN STRUC BIOL, V10, P637, DOI 10.1016/S0959-440X(00)00142-1; LINSE S, 1991, J BIOL CHEM, V266, P8050; Maupetit J, 2009, NUCLEIC ACIDS RES, V37, pW498, DOI 10.1093/nar/gkp323; MELDRUM E, 1991, BIOCHIM BIOPHYS ACTA, V1092, P49, DOI 10.1016/0167-4889(91)90177-Y; Menetrey J, 2005, NATURE, V435, P779, DOI 10.1038/nature03592; Moorthy S, 2000, J CELL BIOL, V149, P915, DOI 10.1083/jcb.149.4.915; Moreno SNJ, 2003, CURR OPIN MICROBIOL, V6, P359, DOI 10.1016/S1369-5274(03)00091-2; Muller A, 1999, J MOL BIOL, V293, P1257, DOI 10.1006/jmbi.1999.3233; Nakayama N, 2000, TOP BIOL INORG CHEM, V3, P29; Nalefski EA, 1996, PROTEIN SCI, V5, P2375, DOI 10.1002/pro.5560051201; Norman KR, 2002, J CELL BIOL, V157, P665, DOI 10.1083/jcb.200111051; Olsen R, 2005, J MOL EVOL, V61, P659, DOI 10.1007/s00239-005-0060-0; RHYNER JA, 1992, BIOCHEMISTRY-US, V31, P12826, DOI 10.1021/bi00166a017; Robatzek M, 2000, GENETICS, V156, P1069; Salcini AE, 2001, NAT CELL BIOL, V3, P755, DOI 10.1038/35087075; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Shelton CA, 1999, J CELL BIOL, V146, P439, DOI 10.1083/jcb.146.2.439; Shen XC, 2008, CELL CALCIUM, V43, P444, DOI 10.1016/j.ceca.2007.07.008; Shi AB, 2010, MOL BIOL CELL, V21, P2930, DOI 10.1091/mbc.E10-02-0149; Sigrist Christian J A, 2002, Brief Bioinform, V3, P265, DOI 10.1093/bib/3.3.265; SPIETH J, 1985, MOL CELL BIOL, V5, P2495, DOI 10.1128/MCB.5.10.2495; Stein LD, 2003, PLOS BIOL, V1, P166, DOI 10.1371/journal.pbio.0000045; Symersky J, 2003, PROTEINS, V53, P947, DOI 10.1002/prot.10517; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Terami H, 1999, J CELL BIOL, V146, P193, DOI 10.1083/jcb.146.1.193; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Todorov PT, 2001, BIOCHEM J, V354, P267, DOI 10.1042/0264-6021:3540267; Tovchigrechko A, 2006, NUCLEIC ACIDS RES, V34, pW310, DOI 10.1093/nar/gkl206; TSIEN RW, 1990, ANNU REV CELL BIOL, V6, P715, DOI 10.1146/annurev.cb.06.110190.003435; Ueda T, 2001, BBA-PROTEIN STRUCT M, V1548, P220, DOI 10.1016/S0167-4838(01)00234-5; Vazquez-Manrique RP, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000043; WALTERS JRF, 1990, BIOCHEM BIOPH RES CO, V170, P603, DOI 10.1016/0006-291X(90)92134-L; Wang W, 2008, TRAFFIC, V9, P742, DOI 10.1111/j.1600-0854.2008.00712.x; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; WONG WT, 1995, P NATL ACAD SCI USA, V92, P9530, DOI 10.1073/pnas.92.21.9530; YUAN JY, 1992, DEVELOPMENT, V116, P309	62	8	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e36770	10.1371/journal.pone.0036770	http://dx.doi.org/10.1371/journal.pone.0036770			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22701514	Green Submitted, Green Published, gold			2022-12-27	WOS:000305342300016
J	Meng, SR; Zhu, YZ; Guo, T; Liu, XL; Chen, J; Liang, Y				Meng, Sheng-Rong; Zhu, Ying-Zhu; Guo, Tong; Liu, Xiao-Ling; Chen, Jie; Liang, Yi			Fibril-Forming Motifs Are Essential and Sufficient for the Fibrillization of Human Tau	PLOS ONE			English	Article							PAIRED HELICAL FILAMENTS; BETA-AMYLOID FIBRILS; ALZHEIMERS-DISEASE; PRION PROTEIN; IN-VITRO; SEQUENCE; SEGMENTS; BETA(2)-MICROGLOBULIN; BIOGENESIS; PREDICTION	Background: The misfolding of amyloidogenic proteins including human Tau protein, human prion protein, and human alpha-synuclein is involved in neurodegenerative diseases such as Alzheimer disease, prion disease, and Parkinson disease. Although a lot of research on such amyloidogenic proteins has been done, we do not know the determinants that drive these proteins to form fibrils and thereby induce neurodegenerative diseases. In this study, we want to know the role of fibril-forming motifs from such amyloidogenic proteins in the fibrillization of human Tau protein. Methodology/Principal Findings: As evidenced by thioflavin T binding and turbidity assays, transmission electron microscopy, and circular dichroism, fibril-forming motifs are essential and sufficient for the fibrillization of microtubule-associated protein Tau: only when both of its fibril-forming motifs, PHF6 and PHF6*, are deleted can recombinant human Tau fragment Tau(244-372) lose its ability to form fibrils, and the insertion of unrelated fibril-forming motifs from other amyloidogenic proteins, such as human prion protein, yeast prion protein, human alpha-synuclein, and human amyloid beta, into the disabled Tau protein can retrieve its ability to form fibrils. Furthermore, this retrieval is independent of the insertion location on Tau(244-372). Conclusions/Significance: We demonstrate for the first time that insertion of fibril-forming motifs can replace PHF6/PHF6* motifs, driving human Tau protein to form fibrils with different morphologies and different kinetic parameters. Our results suggest that fibril-forming motifs play a key role in the fibrillization of human Tau protein and could be the determinants of amyloidogenic proteins tending to misfold, thereby causing the initiation and development of neurodegenerative diseases. Our study also touches on the importance of amyloid "strains": changes to the amyloidgenic driver region results in altered structural morphologies at the macromolecular level.	[Meng, Sheng-Rong; Zhu, Ying-Zhu; Guo, Tong; Liu, Xiao-Ling; Chen, Jie; Liang, Yi] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China	Wuhan University	Meng, SR (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China.	liangyi@whu.edu.cn	Liang, Yi/V-1396-2017; Liu, Xiaoling/HGD-3566-2022	Liang, Yi/0000-0002-7349-8300; Yingzhu, Zhu/0000-0002-3041-3303	National Key Basic Research Foundation of China [2012CB911003]; National Natural Science Foundation of China [31170744, 30970599]; Fundamental Research Funds for the Central Universities of China [1104006]	National Key Basic Research Foundation of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities)	This study was supported by National Key Basic Research Foundation of China (http://www.most.gov.cn/, Grant no. 2012CB911003, YL), National Natural Science Foundation of China (http://www.nsfc.gov.cn/, Grant nos. 31170744 and 30970599, YL), and Fundamental Research Funds for the Central Universities of China (http://www.moe.edu.cn/, Grant no. 1104006, YL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti S, 2009, CELL, V137, P146, DOI 10.1016/j.cell.2009.02.044; ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Bibow S, 2011, ANGEW CHEM INT EDIT, V50, P11520, DOI 10.1002/anie.201105493; Blanco LP, 2012, TRENDS MICROBIOL, V20, P66, DOI 10.1016/j.tim.2011.11.005; Breydo L, 2012, BBA-MOL BASIS DIS, V1822, P261, DOI 10.1016/j.bbadis.2011.10.002; BUSH AI, 1994, SCIENCE, V265, P1464, DOI 10.1126/science.8073293; Colby DW, 2006, NAT CHEM BIOL, V2, P319, DOI 10.1038/nchembio792; de la Paz ML, 2004, P NATL ACAD SCI USA, V101, P87, DOI 10.1073/pnas.2634884100; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Fowler DM, 2006, PLOS BIOL, V4, P100, DOI 10.1371/journal.pbio.0040006; Garbuzynskiy SO, 2010, BIOINFORMATICS, V26, P326, DOI 10.1093/bioinformatics/btp691; GOEDERT M, 1993, TRENDS NEUROSCI, V16, P460, DOI 10.1016/0166-2236(93)90078-Z; Goldschmidt L, 2010, P NATL ACAD SCI USA, V107, P3487, DOI 10.1073/pnas.0915166107; Guest WC, 2011, J TOXICOL ENV HEAL A, V74, P1433, DOI 10.1080/15287394.2011.618967; Ivanova MI, 2009, P NATL ACAD SCI USA, V106, P18990, DOI 10.1073/pnas.0910080106; Ivanova MI, 2006, P NATL ACAD SCI USA, V103, P4079, DOI 10.1073/pnas.0511298103; Kallberg Y, 2001, J BIOL CHEM, V276, P12945, DOI 10.1074/jbc.M010402200; Kong FL, 2011, CHEM-BIOL INTERACT, V194, P69, DOI 10.1016/j.cbi.2011.08.003; KOSIK KS, 1986, P NATL ACAD SCI USA, V83, P4044, DOI 10.1073/pnas.83.11.4044; Kuret J, 2005, BBA-MOL BASIS DIS, V1739, P167, DOI 10.1016/j.bbadis.2004.06.016; Landau M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001080; Li WK, 2006, BIOCHEMISTRY-US, V45, P15692, DOI 10.1021/bi061422+; Maji SK, 2009, SCIENCE, V325, P328, DOI 10.1126/science.1173155; Makarava N, 2008, J BIOL CHEM, V283, P15988, DOI 10.1074/jbc.M800562200; MANDELKOW E, 1995, NEUROBIOL AGING, V16, P347, DOI 10.1016/0197-4580(95)00026-B; Men D, 2009, NANO LETT, V9, P2246, DOI 10.1021/nl9003464; MIYATA T, 1993, J CLIN INVEST, V92, P1243, DOI 10.1172/JCI116696; Mo ZY, 2009, J BIOL CHEM, V284, P34648, DOI 10.1074/jbc.M109.058883; Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Petkova AT, 2002, P NATL ACAD SCI USA, V99, P16742, DOI 10.1073/pnas.262663499; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Rossetti G, 2011, J MOL BIOL, V411, P700, DOI 10.1016/j.jmb.2011.06.008; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Sievers SA, 2011, NATURE, V475, P96, DOI 10.1038/nature10154; Soto C, 2011, TRENDS BIOCHEM SCI, V36, P151, DOI 10.1016/j.tibs.2010.11.001; Teng PK, 2009, PROTEIN ENG DES SEL, V22, P531, DOI 10.1093/protein/gzp037; Thompson MJ, 2006, P NATL ACAD SCI USA, V103, P4074, DOI 10.1073/pnas.0511295103; Tjernberg LO, 1999, J BIOL CHEM, V274, P12619, DOI 10.1074/jbc.274.18.12619; von Bergen M, 2001, J BIOL CHEM, V276, P48165, DOI 10.1074/jbc.M105196200; von Bergen M, 2000, P NATL ACAD SCI USA, V97, P5129, DOI 10.1073/pnas.97.10.5129; Wang X, 2010, P NATL ACAD SCI USA, V107, P163, DOI 10.1073/pnas.0908714107; Williams AD, 2004, J MOL BIOL, V335, P833, DOI 10.1016/j.jmb.2003.11.008; Zhang ZQ, 2007, BIOINFORMATICS, V23, P2218, DOI 10.1093/bioinformatics/btm325; Zhou Z, 2011, BIOPHYS J, V101, P1483, DOI 10.1016/j.bpj.2011.08.018; Zhou Z, 2009, J BIOL CHEM, V284, P30148, DOI 10.1074/jbc.M109.002832; Zhu HL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025020; Zhu HL, 2010, J BIOL CHEM, V285, P3592, DOI 10.1074/jbc.M109.035691	50	20	20	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2012	7	6							e38903	10.1371/journal.pone.0038903	http://dx.doi.org/10.1371/journal.pone.0038903			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TU	22701727	Green Published, Green Submitted, gold			2022-12-27	WOS:000305337600054
J	Wren, L; Parsons, MS; Isitman, G; Center, RJ; Kelleher, AD; Stratov, I; Bernard, NF; Kent, SJ				Wren, Leia; Parsons, Matthew S.; Isitman, Gamze; Center, Robert J.; Kelleher, Anthony D.; Stratov, Ivan; Bernard, Nicole F.; Kent, Stephen J.			Influence of Cytokines on HIV-Specific Antibody-Dependent Cellular Cytotoxicity Activation Profile of Natural Killer Cells	PLOS ONE			English	Article							BLOOD MONONUCLEAR-CELLS; NECROSIS-FACTOR-ALPHA; HUMAN NK CELLS; MHC CLASS-I; DISEASE PROGRESSION; MEDIATED CYTOTOXICITY; INFECTED INDIVIDUALS; EFFECTOR FUNCTIONS; TYPE-1 INFECTION; IFN-GAMMA	There is growing interest in HIV-specific antibody-dependent cellular cytotoxicity (ADCC) as an effective immune response to prevent or control HIV infection. ADCC relies on innate immune effector cells, particularly NK cells, to mediate control of virus-infected cells. The activation of NK cells (i.e., expression of cytokines and/or degranulation) by ADCC antibodies in serum is likely subject to the influence of other factors that are also present. We observed that the HIV-specific ADCC antibodies, within serum samples from a panel of HIV-infected individuals induced divergent activation profiles of NK cells from the same donor. Some serum samples primarily induced NK cell cytokine expression (i.e., IFN gamma), some primarily initiated NK cell expression of a degranulation marker (CD107a) and others initiated a similar magnitude of responses across both effector functions. We therefore evaluated a number of HIV-relevant soluble factors for their influence on the activation of NK cells by HIV-specific ADCC antibodies. Key findings were that the cytokines IL-15 and IL-10 consistently enhanced the ability of NK cells to respond to HIV-specific ADCC antibodies. Furthermore, IL-15 was demonstrated to potently activate "educated'' KIR3DL1(+) NK cells from individuals carrying its HLA-Bw4 ligand. The cytokine was also demonstrated to activate "uneducated'' KIR3DL1+ NK cells from HLA-Bw6 homozygotes, but to a lesser extent. Our results show that cytokines influence the ability of NK cells to respond to ADCC antibodies in vitro. Manipulating the immunological environment to enhance the potency of NK cell-mediated HIV-specific ADCC effector functions could be a promising immunotherapy or vaccine strategy.	[Wren, Leia; Parsons, Matthew S.; Isitman, Gamze; Center, Robert J.; Stratov, Ivan; Kent, Stephen J.] Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic 3010, Australia; [Parsons, Matthew S.; Bernard, Nicole F.] McGill Univ, Div Expt Med, Montreal, PQ, Canada; [Kelleher, Anthony D.] Univ New S Wales, Kirby Inst, Sydney, NSW, Australia; [Stratov, Ivan; Kent, Stephen J.] Alfred Hlth, Melbourne Sexual Hlth Clin, Carlton, Vic, Australia	University of Melbourne; McGill University; University of New South Wales Sydney; Kirby Institute	Wren, L (corresponding author), Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic 3010, Australia.	skent@unimelb.edu.au	Stratov, Ivan/AAJ-4516-2020; Kent, Stephen/AAL-5101-2020	Kent, Stephen/0000-0002-8539-4891	Australian National Health and Medical Research Council awards [510448, 455350]; Australian Research Council award [LP0991498]; National Institutes of Health award [R21AI081541]; Canadian Institutes of Health Research Vanier Scholarship; Michael Smith Foreign Study Supplement; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI081541] Funding Source: NIH RePORTER	Australian National Health and Medical Research Council awards(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council award(Australian Research Council); National Institutes of Health award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research Vanier Scholarship(Canadian Institutes of Health Research (CIHR)); Michael Smith Foreign Study Supplement(Canadian Institutes of Health Research (CIHR)Social Sciences and Humanities Research Council of Canada (SSHRC)Natural Sciences and Engineering Research Council of Canada (NSERC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by Australian National Health and Medical Research Council awards 510448 and 455350, Australian Research Council award LP0991498, and National Institutes of Health award R21AI081541. MSP is supported by a Canadian Institutes of Health Research Vanier Scholarship and a Michael Smith Foreign Study Supplement. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anfossi N, 2006, IMMUNITY, V25, P331, DOI 10.1016/j.immuni.2006.06.013; Baum LL, 1996, J IMMUNOL, V157, P2168; Boulet S, 2008, AIDS, V22, P595, DOI 10.1097/QAD.0b013e3282f56b23; Boulet S, 2010, J IMMUNOL, V184, P2057, DOI 10.4049/jimmunol.0902621; Boyer JD, 2007, P NATL ACAD SCI USA, V104, P18648, DOI 10.1073/pnas.0709198104; Brocca-Cofano E, 2011, VACCINE, V29, P3310, DOI 10.1016/j.vaccine.2011.02.066; Brockman MA, 2009, BLOOD, V114, P346, DOI 10.1182/blood-2008-12-191296; Brodin P, 2009, BLOOD, V113, P2434, DOI 10.1182/blood-2008-05-156836; Cai GF, 1999, EUR J IMMUNOL, V29, P2658, DOI 10.1002/(SICI)1521-4141(199909)29:09<2658::AID-IMMU2658>3.3.CO;2-7; Center RJ, 2009, VACCINE, V27, P6605, DOI 10.1016/j.vaccine.2009.08.016; Chatterjee A, 2009, J CLIN IMMUNOL, V29, P71, DOI 10.1007/s10875-008-9220-5; Chung AW, 2011, JAIDS-J ACQ IMM DEF, V58, P127, DOI 10.1097/QAI.0b013e31822c62b9; Chung AW, 2011, P NATL ACAD SCI USA, V108, P7505, DOI 10.1073/pnas.1016048108; Chung AW, 2009, J IMMUNOL, V182, P1202, DOI 10.4049/jimmunol.182.2.1202; d'Ettorre G, 2002, AIDS, V16, P181, DOI 10.1097/00002030-200201250-00006; DEBLAKERHOHE DF, 1995, CELL IMMUNOL, V165, P33, DOI 10.1006/cimm.1995.1184; Douek Daniel, 2007, Top HIV Med, V15, P114; Fauriat C, 2010, BLOOD, V115, P1166, DOI 10.1182/blood-2009-09-245746; Gregson JNS, 2009, AIDS, V23, P29, DOI 10.1097/QAD.0b013e3283199780; Hessell AJ, 2007, NATURE, V449, P101, DOI 10.1038/nature06106; HOBER D, 1993, MICROBIOL IMMUNOL, V37, P785, DOI 10.1111/j.1348-0421.1993.tb01706.x; Hoglund P, 2010, NAT REV IMMUNOL, V10, P724, DOI 10.1038/nri2835; Iannello A, 2008, J LEUKOCYTE BIOL, V84, P27, DOI 10.1189/jlb.0907649; Isitman G, 2011, VIROLOGY, V412, P110, DOI 10.1016/j.virol.2010.12.044; Johansson SE, 2011, VIRAL IMMUNOL, V24, P359, DOI 10.1089/vim.2011.0025; Juelke K, 2009, EUR J IMMUNOL, V39, P2548, DOI 10.1002/eji.200939307; Karnasuta C, 2005, VACCINE, V23, P2522, DOI 10.1016/j.vaccine.2004.10.028; Lambotte O, 2009, AIDS, V23, P897, DOI 10.1097/QAD.0b013e328329f97d; Lin SJ, 1998, J CLIN IMMUNOL, V18, P335, DOI 10.1023/A:1023290932154; Loubeau M, 1997, J ACQ IMMUN DEF SYND, V16, P137, DOI 10.1097/00042560-199711010-00001; Marshall JD, 1999, BLOOD, V94, P1003, DOI 10.1182/blood.V94.3.1003.415a15_1003_1011; Martin MP, 2007, NAT GENET, V39, P733, DOI 10.1038/ng2035; Mocellin S, 2004, GENES IMMUN, V5, P621, DOI 10.1038/sj.gene.6364135; Moga E, 2011, EXP HEMATOL, V39, P1064, DOI 10.1016/j.exphem.2011.08.006; Mueller YM, 2008, J IMMUNOL, V180, P350, DOI 10.4049/jimmunol.180.1.350; Napolitano LA, 2001, NAT MED, V7, P73, DOI 10.1038/83381; NAVIKAS V, 1994, CLIN EXP IMMUNOL, V96, P59; Oleksyk TK, 2009, GENES IMMUN, V10, P309, DOI 10.1038/gene.2009.9; Parsons MS, 2010, J LEUKOCYTE BIOL, V88, P905, DOI 10.1189/jlb.1009687; Parsons MS, 2010, J INFECT DIS, V202, pS356, DOI 10.1086/655966; Parsons MS, 2012, J VIROL; Patel Dipa, 2010, Human Antibodies, V19, P89, DOI 10.3233/HAB-2010-0232; Peppa D, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001227; RAUTONEN J, 1991, AIDS, V5, P1319, DOI 10.1097/00002030-199111000-00006; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Roberts L, 2010, AIDS, V24, P819, DOI 10.1097/QAD.0b013e3283367836; Roda JM, 2007, CLIN CANCER RES, V13, P6419, DOI 10.1158/1078-0432.CCR-07-0865; Rosenblum LY, 2002, REGUL TOXICOL PHARM, V35, P56, DOI 10.1006/rtph.2001.1504; Scott-Algara D, 2003, J IMMUNOL, V171, P5663, DOI 10.4049/jimmunol.171.11.5663; Srikanth P, 2000, INT J STD AIDS, V11, P49, DOI 10.1258/0956462001914904; Stacey AR, 2009, J VIROL, V83, P3719, DOI 10.1128/JVI.01844-08; Stratov I, 2008, J VIROL, V82, P5450, DOI 10.1128/JVI.01952-07; Sun Y, 2011, J VIROL, V85, P6906, DOI 10.1128/JVI.00326-11; Thobakgale CF, 2011, AIDS RES HUM RETROV, V27, P1005, DOI 10.1089/aid.2010.0227; Walker BD, 2008, SCIENCE, V320, P760, DOI 10.1126/science.1152622; Walter J, 2009, J INFECT DIS, V200, P1498, DOI 10.1086/644603; Wren L, 2011, HUM VACCINES, V7, P467, DOI 10.4161/hv.7.4.14123	57	20	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2012	7	6							e38580	10.1371/journal.pone.0038580	http://dx.doi.org/10.1371/journal.pone.0038580			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TU	22701674	Green Published, gold, Green Submitted			2022-12-27	WOS:000305337600031
J	Araki, M; Uehara, S; Sasaki, K; Monden, K; Tsugawa, M; Watanabe, T; Monga, M; Nasu, Y; Kumon, H				Araki, Motoo; Uehara, Shinya; Sasaki, Katsumi; Monden, Koichi; Tsugawa, Masaya; Watanabe, Toyohiko; Monga, Manoji; Nasu, Yasutomo; Kumon, Hiromi			Ureteroscopic Management of Chronic Unilateral Hematuria: A Single-Center Experience over 22 Years	PLOS ONE			English	Article							FLEXIBLE URETEROPYELOSCOPY; DIAGNOSIS; URETERORENOSCOPY	Objective: To analyze the short and long term safety and efficacy of ureteroscopic evaluation and management of chronic unilateral hematuria. Methods: We retrospectively reviewed patients with chronic unilateral hematuria from 1987 to 2008. The distal to middle ureter was evaluated with a semi-rigid ureteroscope without a guidewire. Subsequently, the flexible ureteroscope was advanced into the upper ureter to the renal pelvis using a low-pressure automated irrigant system (Uromat (TM)). Lesions identified ureteroscopically were treated with diathermy fulguration. Results: One hundred and four (56 male, 48 female) patients were identified, with a median age of 37 (14-80) years and median follow-up of 139 (34-277) months. The median preoperative duration of gross hematuria was 5 (1-144) months. Endoscopic findings included 61 (56%) minute venous rupture (MVR; a venous bleeding without clear abnormalities), 21 (20%) hemangioma (vascular tumor-like structure), 3 (3%) varix (tortuous vein), 1 (1%) calculus and 18 (17%) no lesions. The incidence of "no lesions" was less in the recent 12 years (9%) than the first 10 years (27%), while the incidence of MVR increased from 40 to 66% (p<0.05). All patients were treated endoscopically. Immediate success rate was 96% (100% in the recent 12 years). Long-term recurrent gross hematuria rate was 7%. Six resolved spontaneously and only 1 required ureteroscopy, revealing a different bleeding site. Conclusion: Ureteroscopy and diathermy fulguration is highly useful for evaluation and treatment of chronic unilateral hematuria. Sophisticated technique and improved instrumentation contributes to a better outcome.	[Araki, Motoo; Uehara, Shinya; Sasaki, Katsumi; Monden, Koichi; Tsugawa, Masaya; Watanabe, Toyohiko; Nasu, Yasutomo; Kumon, Hiromi] Okayama Univ, Dept Urol, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008530, Japan; [Monga, Manoji] Cleveland Clin, Glickman Urol & Kidney Inst, Cleveland, OH 44106 USA	Okayama University; Cleveland Clinic Foundation	Araki, M (corresponding author), Okayama Univ, Dept Urol, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008530, Japan.	motoosh@md.okayama-u.ac.jp	Araki, Motoo/AAK-9375-2021	Araki, Motoo/0000-0002-3172-2482; Watanabe, Toyohiko/0000-0002-1138-5642				BAGLEY DH, 1990, UROLOGY, V35, P412, DOI 10.1016/0090-4295(90)80083-Y; BAGLEY DH, 1990, J UROLOGY, V143, P549, DOI 10.1016/S0022-5347(17)40016-4; Brito AH, 2009, J ENDOUROL, V23, P1273, DOI 10.1089/end.2009.0064; KAVOUSSI L, 1989, J UROLOGY, V142, P949, DOI 10.1016/S0022-5347(17)38950-4; KUMON H, 1990, J UROLOGY, V143, P554, DOI 10.1016/S0022-5347(17)40017-6; LANO MD, 1979, MAYO CLIN PROC, V54, P88; Laucirica O, 1992, Actas Urol Esp, V16, P366; MCMURTRY JM, 1987, J ENDOUROL, V1, P145; Mugiya S, 2007, J UROLOGY, V178, P517, DOI 10.1016/j.juro.2007.03.098; Nakada SY, 1997, J UROLOGY, V157, P776, DOI 10.1016/S0022-5347(01)65038-9; Nandy PR, 2004, UROLOGY, V64, P1107, DOI 10.1016/j.urology.2004.07.035; PATTERSON DE, 1984, J UROLOGY, V132, P1199, DOI 10.1016/S0022-5347(17)50095-6; Rowbotham C, 2001, BJU INT, V88, P841, DOI 10.1046/j.1464-4096.2001.01228.x; Serrano Alvaro, 2007, Archivos Espanoles de Urologia, V60, P155; Tawfiek ER, 1998, J UROLOGY, V160, P700, DOI 10.1016/S0022-5347(01)62762-9; WALLACH JB, 1959, J UROLOGY, V81, P515, DOI 10.1016/S0022-5347(17)66057-9	16	15	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2012	7	6							e36729	10.1371/journal.pone.0036729	http://dx.doi.org/10.1371/journal.pone.0036729			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TQ	22715360	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336800001
J	Zhang, W; Ferguson, J; Ng, SM; Hui, K; Goh, G; Lin, AP; Esplugues, E; Flavell, RA; Abraham, C; Zhao, HY; Cho, JH				Zhang, Wei; Ferguson, John; Ng, Sok Meng; Hui, Ken; Goh, Gerald; Lin, Aiping; Esplugues, Enric; Flavell, Richard A.; Abraham, Clara; Zhao, Hongyu; Cho, Judy H.			Effector CD4+T Cell Expression Signatures and Immune-Mediated Disease Associated Genes	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; HUMAN TH17 CELLS; T-CELLS; INTESTINAL INFLAMMATION; RNA-SEQ; IL-23; RESPONSES; RECEPTOR; LOCI; MICE	Genome-wide association studies (GWAS) in immune-mediated diseases have identified over 150 associated genomic loci. Many of these loci play a role in T cell responses, and regulation of T cell differentiation plays a critical role in immune-mediated diseases; however, the relationship between implicated disease loci and T cell differentiation is incompletely understood. To further address this relationship, we examined differential gene expression in naive human CD4+ T cells, as well as in in vitro differentiated Th1, memory Th17-negative and Th17-enriched CD4+ T cells subsets using microarray and RNASeq. We observed a marked enrichment for increased expression in memory CD4+ compared to naive CD4+ T cells of genes contained among immune-mediated disease loci. Within memory T cells, expression of disease-associated genes was typically increased in Th17-enriched compared to Th17-negative cells. Utilizing RNASeq and promoter methylation studies, we identified a differential regulation pattern for genes solely expressed in Th17 cells (IL17A and CCL20) compared to genes expressed in both Th17 and Th1 cells (IL23R and IL12RB2), where high levels of promoter methylation are correlated to near zero RNASeq levels for IL17A and CCL20. These findings have implications for human Th17 cell plasticity and for the regulation of Th17-Th1 expression signatures. Importantly, utilizing RNASeq we found an abundant isoform of IL23R terminating before the transmembrane domain that was enriched in Th17 cells. In addition to molecular resolution, we find that RNASeq provides significantly improved power to define differential gene expression and identify alternative gene variants relative to microarray analysis. The comprehensive integration of differential gene expression between cell subsets with disease-association signals, and functional pathways provides insight into disease pathogenesis.	[Zhang, Wei; Ferguson, John; Ng, Sok Meng; Hui, Ken; Abraham, Clara; Cho, Judy H.] Yale Univ, Sch Med, Dept Med, Sect Digest Dis, New Haven, CT 06510 USA; [Goh, Gerald; Zhao, Hongyu; Cho, Judy H.] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; [Lin, Aiping] Yale Univ, Sch Med, WM Keck Biotechnol Lab, New Haven, CT USA; [Esplugues, Enric; Flavell, Richard A.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT USA; [Zhao, Hongyu] Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06510 USA; [Zhao, Hongyu] Yale Univ, Sch Med, Dept Stat, New Haven, CT USA; [Flavell, Richard A.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA	Yale University; Yale University; Yale University; Yale University; Yale University; Yale University; Howard Hughes Medical Institute; Yale University	Zhang, W (corresponding author), Yale Univ, Sch Med, Dept Med, Sect Digest Dis, New Haven, CT 06510 USA.	judy.cho@yale.edu	Goh, Gerald/E-9158-2014; Esplugues, Enric/AAD-4245-2020; Goh, Gerald/N-1684-2015	Goh, Gerald/0000-0002-3832-6466; Goh, Gerald/0000-0002-3832-6466; Ferguson, John/0000-0001-8475-398X; Esplugues, Enric/0000-0002-9733-8707; Esplugues, Enric/0000-0002-8130-0413	National Institutes of Health [U01DK062422]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK062422] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health U01DK062422. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahern PP, 2010, IMMUNITY, V33, P279, DOI 10.1016/j.immuni.2010.08.010; Anderson CA, 2011, NAT GENET, V43, P246, DOI 10.1038/ng.764; Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663; Bending D, 2009, J CLIN INVEST, V119, P565, DOI 10.1172/JCI37865; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Cargill M, 2007, AM J HUM GENET, V80, P273, DOI 10.1086/511051; Chan JR, 2006, J EXP MED, V203, P2577, DOI 10.1084/jem.20060244; Cheung VG, 2005, NATURE, V437, P1365, DOI 10.1038/nature04244; Cosmi L, 2008, J EXP MED, V205, P1903, DOI 10.1084/jem.20080397; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Di Meglio P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017160; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Hedrick MN, 2009, J CLIN INVEST, V119, P2317, DOI 10.1172/JCI37378; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hirota K, 2011, NAT IMMUNOL, V12, P255, DOI 10.1038/ni.1993; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Izadpanah A, 2001, AM J PHYSIOL-GASTR L, V280, pG710, DOI 10.1152/ajpgi.2001.280.4.G710; Izcue A, 2008, IMMUNITY, V28, P559, DOI 10.1016/j.immuni.2008.02.019; Kang J, 2010, J BIOPHARM STAT, V20, P415, DOI 10.1080/10543400903572829; Kleinschek MA, 2009, J EXP MED, V206, P525, DOI 10.1084/jem.20081712; Lee YK, 2009, IMMUNITY, V30, P92, DOI 10.1016/j.immuni.2008.11.005; Maggi L, 2010, EUR J IMMUNOL, V40, P2174, DOI 10.1002/eji.200940257; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Newport M, 2007, NAT GENET, V39, P1329, DOI 10.1038/ng.2007.17; Parham C, 2002, J IMMUNOL, V168, P5699, DOI 10.4049/jimmunol.168.11.5699; Sarin R, 2011, P NATL ACAD SCI USA, V108, P9560, DOI 10.1073/pnas.1017854108; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Trynka G, 2011, NAT GENET, V43, P1193, DOI 10.1038/ng.998; Uhlig HH, 2006, IMMUNITY, V25, P309, DOI 10.1016/j.immuni.2006.05.017; Varona R, 2001, J CLIN INVEST, V107, pR37, DOI 10.1172/JCI11297; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Yu RY, 2010, J IMMUNOL, V185, P7302, DOI 10.4049/jimmunol.1002410; Zenewicz LA, 2010, CELL, V140, P791, DOI 10.1016/j.cell.2010.03.003	38	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2012	7	6							e38510	10.1371/journal.pone.0038510	http://dx.doi.org/10.1371/journal.pone.0038510			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TQ	22715389	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336800031
J	Schneider, UV; Mikkelsen, ND; Lindqvist, A; Okkels, LM; Johnk, N; Lisby, G				Schneider, Uffe Vest; Mikkelsen, Nikolaj Dam; Lindqvist, Anja; Okkels, Limei Meng; Johnk, Nina; Lisby, Gorm			Improved Efficiency and Robustness in qPCR and Multiplex End-Point PCR by Twisted Intercalating Nucleic Acid Modified Primers	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; AMPLIFICATION; SPECIFICITY; SEQUENCES; TINA; LNA	We introduce quantitative polymerase chain reaction (qPCR) primers and multiplex end-point PCR primers modified by the addition of a single ortho-Twisted Intercalating Nucleic Acid (o-TINA) molecule at the 5'-end. In qPCR, the 5'-o-TINA modified primers allow for a qPCR efficiency of 100% at significantly stressed reaction conditions, increasing the robustness of qPCR assays compared to unmodified primers. In samples spiked with genomic DNA, 5'-o-TINA modified primers improve the robustness by increased sensitivity and specificity compared to unmodified DNA primers. In unspiked samples, replacement of unmodified DNA primers with 5'-o-TINA modified primers permits an increased qPCR stringency. Compared to unmodified DNA primers, this allows for a qPCR efficiency of 100% at lowered primer concentrations and at increased annealing temperatures with unaltered cross-reactivity for primers with single nucleobase mismatches. In a previously published octaplex end-point PCR targeting diarrheagenic Escherichia coli, application of 5'-o-TINA modified primers allows for a further reduction (>45% or approximately one hour) in overall PCR program length, while sustaining the amplification and analytical sensitivity for all targets in crude bacterial lysates. For all crude bacterial lysates, 5'-o-TINA modified primers permit a substantial increase in PCR stringency in terms of lower primer concentrations and higher annealing temperatures for all eight targets. Additionally, crude bacterial lysates spiked with human genomic DNA show lesser formation of nontarget amplicons implying increased robustness. Thus, 5'-o-TINA modified primers are advantageous in PCR assays, where one or more primer pairs are required to perform at stressed reaction conditions.	[Schneider, Uffe Vest; Mikkelsen, Nikolaj Dam; Lindqvist, Anja; Okkels, Limei Meng; Johnk, Nina; Lisby, Gorm] QuantiBact AS, Hvidovre, Denmark		Schneider, UV (corresponding author), QuantiBact AS, Hvidovre, Denmark.	uvs@quantibact.com	Lisby, Gorm/GMX-0386-2022; Schneider, Uffe Vest/GPT-3115-2022	Schneider, Uffe Vest/0000-0003-1372-7885				Bissonnette L, 2010, CLIN MICROBIOL INFEC, V16, P1044, DOI 10.1111/j.1469-0691.2010.03282.x; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Brandal LT, 2007, J MICROBIOL METH, V68, P331, DOI 10.1016/j.mimet.2006.09.013; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chakrabarti R, 2001, NUCLEIC ACIDS RES, V29, P2377, DOI 10.1093/nar/29.11.2377; CHEVET E, 1995, NUCLEIC ACIDS RES, V23, P3343, DOI 10.1093/nar/23.16.3343; Elnifro EM, 2000, CLIN MICROBIOL REV, V13, P559, DOI 10.1128/CMR.13.4.559-570.2000; Filichev VV, 2005, J AM CHEM SOC, V127, P14849, DOI 10.1021/ja053645d; Filichev VV, 2008, CHEM-EUR J, V14, P9968, DOI 10.1002/chem.200800380; Henke W, 1997, NUCLEIC ACIDS RES, V25, P3957, DOI 10.1093/nar/25.19.3957; Hjelmevoll SO, 2006, J MOL DIAGN, V8, P574, DOI 10.2353/jmoldx.2006.060024; Li M, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni183; Markoulatos P, 2002, J CLIN LAB ANAL, V16, P47, DOI 10.1002/jcla.2058; Moreau V, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp661; Niimi H, 2011, J CLIN MICROBIOL, V49, P3316, DOI 10.1128/JCM.00584-11; Noir R, 2008, J AM CHEM SOC, V130, P13500, DOI 10.1021/ja804727a; ORUM H, 1993, NUCLEIC ACIDS RES, V21, P5332, DOI 10.1093/nar/21.23.5332; Petersen M, 2000, J MOL RECOGNIT, V13, P44, DOI 10.1002/(SICI)1099-1352(200001/02)13:1<44::AID-JMR486>3.0.CO;2-6; Prepens S, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-84; Ralser M, 2006, BIOCHEM BIOPH RES CO, V347, P747, DOI 10.1016/j.bbrc.2006.06.151; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SARKAR G, 1990, NUCLEIC ACIDS RES, V18, P7465, DOI 10.1093/nar/18.24.7465; Schneider UV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020565; Schneider UV, 2010, NUCLEIC ACIDS RES, V38, P4394, DOI 10.1093/nar/gkq188	24	13	15	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e38451	10.1371/journal.pone.0038451	http://dx.doi.org/10.1371/journal.pone.0038451			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701644	Green Submitted, Green Published, gold			2022-12-27	WOS:000305348400059
J	Stoltzfus, JD; Massey, HC; Nolan, TJ; Griffith, SD; Lok, JB				Stoltzfus, Jonathan D.; Massey, Holman C., Jr.; Nolan, Thomas J.; Griffith, Sandra D.; Lok, James B.			Strongyloides stercoralis age-1: A Potential Regulator of Infective Larval Development in a Parasitic Nematode	PLOS ONE			English	Article							STRONGYLOIDES-STERCORALIS; CAENORHABDITIS-ELEGANS; C-ELEGANS; GENE-EXPRESSION; CHEMOSENSORY NEURONS; PROPOSED ORTHOLOG; DAUER FORMATION; DNA-BINDING; INSULIN; DAF-16	Infective third-stage larvae (L3i) of the human parasite Strongyloides stercoralis share many morphological, developmental, and behavioral attributes with Caenorhabditis elegans dauer larvae. The 'dauer hypothesis' predicts that the same molecular genetic mechanisms control both dauer larval development in C. elegans and L3i morphogenesis in S. stercoralis. In C. elegans, the phosphatidylinositol-3 (PI3) kinase catalytic subunit AGE-1 functions in the insulin/IGF-1 signaling (IIS) pathway to regulate formation of dauer larvae. Here we identify and characterize Ss-age-1, the S. stercoralis homolog of the gene encoding C. elegans AGE-1. Our analysis of the Ss-age-1 genomic region revealed three exons encoding a predicted protein of 1,209 amino acids, which clustered with C. elegans AGE-1 in phylogenetic analysis. We examined temporal patterns of expression in the S. stercoralis life cycle by reverse transcription quantitative PCR and observed low levels of Ss-age-1 transcripts in all stages. To compare anatomical patterns of expression between the two species, we used Ss-age-1 or Ce-age-1 promoter::enhanced green fluorescent protein reporter constructs expressed in transgenic animals for each species. We observed conservation of expression in amphidial neurons, which play a critical role in developmental regulation of both dauer larvae and L3i. Application of the PI3 kinase inhibitor LY294002 suppressed L3i in vitro activation in a dose-dependent fashion, with 100 mu M resulting in a 90% decrease (odds ratio: 0.10, 95% confidence interval: 0.08-0.13) in the odds of resumption of feeding for treated L3i in comparison to the control. Together, these data support the hypothesis that Ss-age-1 regulates the development of S. stercoralis L3i via an IIS pathway in a manner similar to that observed in C. elegans dauer larvae. Understanding the mechanisms by which infective larvae are formed and activated may lead to novel control measures and treatments for strongyloidiasis and other soil-transmitted helminthiases.	[Stoltzfus, Jonathan D.; Massey, Holman C., Jr.; Nolan, Thomas J.; Lok, James B.] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA; [Griffith, Sandra D.] Univ Penn, Dept Biostat & Epidemiol, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Stoltzfus, JD (corresponding author), Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA.	jlok@vet.upenn.edu	Stoltzfus, Jonathan D./AAU-6735-2020	Stoltzfus, Jonathan D./0000-0002-4006-5306; Nolan, Thomas/0000-0002-6860-7947	U.S. National Institutes of Health (NIH) [AI50688, AI22662, RR02512, AI082390]; NIH [AI007532]; Penn Genome Frontiers Institute; Pennsylvania Department of Health; NATIONAL CANCER INSTITUTE [Z01BC010837] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P40RR002512] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI022662, T32AI007532, R21AI082390] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Penn Genome Frontiers Institute; Pennsylvania Department of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by U.S. National Institutes of Health (NIH) research grants AI50688 and AI22662 to JBL, RR02512 to Mark Haskins, and AI082390 to Robert Greenberg. JDS received support from NIH training grant AI007532. This work was supported in part by the Penn Genome Frontiers Institute and a grant with the Pennsylvania Department of Health. The Department of Health specifically disclaims responsibility for any analyses, interpretations, or conclusions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboobaker AA, 2000, ANN MED, V32, P23, DOI 10.3109/07853890008995906; Anderson R. C., 2000, Nematode parasites of vertebrates: their development and transmission., DOI 10.1079/9780851994215.0000; Ashton FT, 2007, EXP PARASITOL, V115, P92, DOI 10.1016/j.exppara.2006.08.010; Ashton FT, 1998, J PARASITOL, V84, P691, DOI 10.2307/3284571; Babar P, 1999, NEUROBIOL AGING, V20, P513, DOI 10.1016/S0197-4580(99)00094-9; BARGMANN CI, 1991, SCIENCE, V251, P1243, DOI 10.1126/science.2006412; BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; Baugh LR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018086; Bethony J, 2006, LANCET, V367, P1521, DOI 10.1016/S0140-6736(06)68653-4; *BIOR LAB, 2006, REAL TIM PCR APPL GU; Biron D, 2008, P NATL ACAD SCI USA, V105, P11002, DOI 10.1073/pnas.0805004105; Blaxter M, 1998, SCIENCE, V282, P2041, DOI 10.1126/science.282.5396.2041; Blaxter ML, 1998, NATURE, V392, P71, DOI 10.1038/32160; Brand A, 2004, INT J PARASITOL, V34, P909, DOI 10.1016/j.ijpara.2004.04.003; Burglin TR, 1998, INT J PARASITOL, V28, P395, DOI 10.1016/S0020-7519(97)00208-7; Cahill CM, 2001, J BIOL CHEM, V276, P13402, DOI 10.1074/jbc.M010042200; CASSADA RC, 1975, DEV BIOL, V46, P326, DOI 10.1016/0012-1606(75)90109-8; Castelletto ML, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000370; Chan MS, 1997, PARASITOL TODAY, V13, P438, DOI 10.1016/S0169-4758(97)01144-7; Cornils A, 2011, DEVELOPMENT, V138, P1183, DOI 10.1242/dev.060905; Dalzell JJ, 2012, PARASITOLOGY, V139, P589, DOI 10.1017/S0031182011001946; Dalzell JJ, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001176; Drummond AJAB, GENEIOUS V5 5; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Evans TC, TRANSFORMATION MICRO; FANTL WJ, 1992, CELL, V69, P413, DOI 10.1016/0092-8674(92)90444-H; Gao X, 2009, INT J PARASITOL, V39, P407, DOI 10.1016/j.ijpara.2008.09.005; GOLDEN JW, 1982, SCIENCE, V218, P578, DOI 10.1126/science.6896933; GOLDEN JW, 1984, DEV BIOL, V102, P368, DOI 10.1016/0012-1606(84)90201-X; GOTTLIEB S, 1994, GENETICS, V137, P107; Herbert DR, 2002, EXP PARASITOL, V100, P112, DOI 10.1016/S0014-4894(02)00008-5; HOTEZ P, 1993, PARASITOL TODAY, V9, P23, DOI 10.1016/0169-4758(93)90159-D; Hu M, 2010, INT J PARASITOL, V40, P405, DOI 10.1016/j.ijpara.2009.09.005; Hu PJDauer, DAUER; Huang SCC, 2010, INT J PARASITOL, V40, P1619, DOI 10.1016/j.ijpara.2010.06.004; Hunt-Newbury R, 2007, PLOS BIOL, V5, P1981, DOI 10.1371/journal.pbio.0050237; Junio AB, 2008, EXP PARASITOL, V118, P253, DOI 10.1016/j.exppara.2007.08.018; Kao G, 2007, CELL, V128, P577, DOI 10.1016/j.cell.2006.12.031; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li WQ, 2003, GENE DEV, V17, P844, DOI 10.1101/gad.1066503; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; Lok JB, 2012, PARASITOLOGY, V139, P574, DOI 10.1017/S0031182011001387; Lok JB, STRONGYLOIDES STERCO; Marchler-Bauer Aron, 2011, Nucleic Acids Res, V39, pD225, DOI 10.1093/nar/gkq1189; Massey HC, 2006, INT J PARASITOL, V36, P347, DOI 10.1016/j.ijpara.2005.11.007; Massey HC, 2005, MOL BIOCHEM PARASIT, V142, P116, DOI 10.1016/j.molbiopara.2005.03.004; Massey HC, 2003, INT J PARASITOL, V33, P1537, DOI 10.1016/S0020-7519(03)00205-4; Massey HC, 2001, INT J PARASITOL, V31, P377, DOI 10.1016/S0020-7519(01)00117-5; McGhee JD, 2007, DEV BIOL, V302, P627, DOI 10.1016/j.ydbio.2006.10.024; McGhee JD, 2009, DEV BIOL, V327, P551, DOI 10.1016/j.ydbio.2008.11.034; McKay SJ, 2003, COLD SPRING HARB SYM, V68, P159, DOI 10.1101/sqb.2003.68.159; Montes M, 2010, CURR OPIN INFECT DIS, V23, P500, DOI 10.1097/QCO.0b013e32833df718; Morris JZ, 1996, NATURE, V382, P536, DOI 10.1038/382536a0; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; NOBLE ER, 1989, PARASITOLOGY BIOL AN; Nolan TJ, 2004, PARASITOLOGY, V129, P753, DOI 10.1017/S0031182004006092; NOLAN TJ, 1993, J INFECT DIS, V168, P1479, DOI 10.1093/infdis/168.6.1479; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Pierce SB, 2001, GENE DEV, V15, P672, DOI 10.1101/gad.867301; R Core Team, 2021, R LANGUAGE ENV STAT; Ramanathan R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001039; Riddle DL., 1988, NEMATODE CAENORHABDI, P393; ROSE J, 1991, J MOL EVOL, V32, P340, DOI 10.1007/BF02102193; Schackwitz WS, 1996, NEURON, V17, P719, DOI 10.1016/S0896-6273(00)80203-2; Schad G.A., 1989, P85; SCHAD GA, 1984, EXP PARASITOL, V57, P287, DOI 10.1016/0014-4894(84)90103-6; Soblik H, 2011, MOL CELL PROTEOMICS, V10, DOI [10.1074/mcp.M111.010157-1, 10.1074/mcp.M111.010157]; Srinivasan J, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-52; Stiernagle T, MAINTENANCE C ELEGAN; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tissenbaum HA, 2000, P NATL ACAD SCI USA, V97, P460, DOI 10.1073/pnas.97.1.460; Tissenbaum HA, 1998, GENETICS, V148, P703; Tomioka M, 2006, NEURON, V51, P613, DOI 10.1016/j.neuron.2006.07.024; TRIANTAPHYLLOU AC, 1977, J PARASITOL, V63, P961, DOI 10.2307/3279827; VINEY ME, 1994, PARASITOLOGY, V109, P511, DOI 10.1017/S0031182000080768; Viney ME, STRONGYLOIDES SPP; Wang J, 2003, DEVELOPMENT, V130, P1621, DOI 10.1242/dev.00363; Wang Z, 2009, P NATL ACAD SCI USA, V106, P9138, DOI 10.1073/pnas.0904064106; Weinkove D, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-1; Wes PD, 2001, NATURE, V410, P698, DOI 10.1038/35070581; Wolkow CA, 2000, SCIENCE, V290, P147, DOI 10.1126/science.290.5489.147; Wolkow CA, 2002, J BIOL CHEM, V277, P49591, DOI 10.1074/jbc.M207866200; Zhu H, 2011, J COMP NEUROL, V519, P2493, DOI 10.1002/cne.22637	84	36	37	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e38587	10.1371/journal.pone.0038587	http://dx.doi.org/10.1371/journal.pone.0038587			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701676	Green Submitted, Green Published, gold			2022-12-27	WOS:000305348400078
J	Santos-Aberturas, J; Vicente, CM; Payero, TD; Martin-Sanchez, L; Canibano, C; Martin, JF; Aparicio, JF				Santos-Aberturas, Javier; Vicente, Claudia M.; Payero, Tamara D.; Martin-Sanchez, Lara; Canibano, Carmen; Martin, Juan F.; Aparicio, Jesus F.			Hierarchical Control on Polyene Macrolide Biosynthesis: PimR Modulates Pimaricin Production via the PAS-LuxR Transcriptional Activator PimM	PLOS ONE			English	Article							STREPTOMYCES-NATALENSIS; NIKKOMYCIN BIOSYNTHESIS; POLYOXIN BIOSYNTHESIS; CHOLESTEROL OXIDASES; ESCHERICHIA-COLI; REGULATORY GENES; DNA; BINDING; DOMAIN; IDENTIFICATION	Control of polyene macrolide production in Streptomyces natalensis is mediated by the transcriptional activator PimR. This regulator combines an N-terminal domain corresponding to the Streptomyces antibiotic regulatory protein (SARP) family of transcriptional activators with a C-terminal half homologous to guanylate cyclases and large ATP-binding regulators of the LuxR family. The PimR SARP domain (PimR(SARP)) was expressed in Escherichia coli as a glutathione S-transferase (GST)-fused protein. Electrophoretic mobility shift assays showed that GST-PimR(SARP) binds a single target, the intergenic region between the regulatory genes pimR and pimMs in the pimaricin cluster. The PimR(SARP)-binding site was investigated by DNaseI protection studies, revealing that it contains three heptameric direct repeats adjusting to the consensus 5'-CGGCAAG-3'. Transcription start points of pimM and pimR promoters were identified by 5'-RACE, revealing that unlike other SARPs, PimR(SARP) does not interact with the -35 region of its target promoter. Quantitative transcriptional analysis of these regulatory genes on mutants on each of them has allowed the identification of the pimM promoter as the transcriptional target for PimR. Furthermore, the constitutive expression of pimM restored pimaricin production in a pimaricin-deficient strain carrying a deletion mutant of pimR. These results reveal that PimR exerts its positive effect on pimaricin production by controlling pimM expression level, a regulator whose gene product activates transcription from eight different promoters of pimaricin structural genes directly.	[Santos-Aberturas, Javier; Payero, Tamara D.; Aparicio, Jesus F.] Univ Leon, Fac Biol, Area Microbiol, E-24071 Leon, Spain; [Santos-Aberturas, Javier; Vicente, Claudia M.; Payero, Tamara D.; Martin-Sanchez, Lara; Canibano, Carmen; Martin, Juan F.; Aparicio, Jesus F.] Inst Biotechnol INBIOTEC, Leon, Spain	Universidad de Leon	Santos-Aberturas, J (corresponding author), Univ Leon, Fac Biol, Area Microbiol, E-24071 Leon, Spain.	jesus.aparicio@unileon.es	Santos-Aberturas, Javier/AAE-8162-2021; Aparicio, Jesús F./K-8686-2014	Aparicio, Jesús F./0000-0003-4242-4701; Vicente, Claudia M./0000-0001-8205-6486	Spanish Ministerio de Ciencia e Innovacion [BIO2007-67585, BIO2010-19911]; Junta de Castilla y Leon (Grupo de Excelencia) [GR117]; Ministerio de Ciencia e Innovacion [AP2005-3644, AP2007-02055]; Portuguese Fundacao para a Ciencia e a Tecnologia [SFRH/BD/64006/2009]; contract Juan de la Cierva [JCI-2009-05157]	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Junta de Castilla y Leon (Grupo de Excelencia)(Junta de Castilla y Leon); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Portuguese Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and Technology); contract Juan de la Cierva	This work was supported by the Spanish Ministerio de Ciencia e Innovacion (BIO2007-67585 and BIO2010-19911 to J.F.A.); and the Junta de Castilla y Leon (Grupo de Excelencia GR117); F. P. U. fellowships of the Ministerio de Ciencia e Innovacion (AP2005-3644 to J.S-A., AP2007-02055 to T. D. P.); a fellowship from the Portuguese Fundacao para a Ciencia e a Tecnologia (SFRH/BD/64006/2009 to C. M. V.); and a contract Juan de la Cierva (JCI-2009-05157 to C. C.). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or presentation of the manuscript.	Anton N, 2004, J BACTERIOL, V186, P2567, DOI 10.1128/JB.186.9.2567-2575.2004; Anton N, 2007, MICROBIOL-SGM, V153, P3174, DOI 10.1099/mic.0.2007/009126-0; Aparicio JF, 2008, MOL BIOSYST, V4, P804, DOI 10.1039/b717500k; Aparicio JF, 2004, CURR MED CHEM, V11, P1645; Aparicio JF, 1999, J BIOL CHEM, V274, P10133, DOI 10.1074/jbc.274.15.10133; Arias P, 1999, J BACTERIOL, V181, P6958, DOI 10.1128/JB.181.22.6958-6968.1999; Bate N, 2002, MOL MICROBIOL, V43, P449, DOI 10.1046/j.1365-2958.2002.02756.x; Beites T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027472; Bibb MJ, 2005, CURR OPIN MICROBIOL, V8, P208, DOI 10.1016/j.mib.2005.02.016; BIERMAN M, 1992, GENE, V116, P43, DOI 10.1016/0378-1119(92)90627-2; BOURN WR, 1995, NUCLEIC ACIDS RES, V23, P3696, DOI 10.1093/nar/23.18.3696; Browning DF, 2004, NAT REV MICROBIOL, V2, P57, DOI 10.1038/nrmicro787; Caffrey P, 2008, CURR TOP MED CHEM, V8, P639, DOI 10.2174/156802608784221479; Carmody M, 2004, GENE, V343, P107, DOI 10.1016/j.gene.2004.08.006; De Schrijver A, 1999, MICROBIOL-UK, V145, P1287, DOI 10.1099/13500872-145-6-1287; Du YL, 2011, MICROBIOL-SGM, V157, P1300, DOI 10.1099/mic.0.046607-0; Enriquez LL, 2006, FEMS MICROBIOL LETT, V257, P312, DOI 10.1111/j.1574-6968.2006.00189.x; Guerra SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031475; Gust B, 2003, P NATL ACAD SCI USA, V100, P1541, DOI 10.1073/pnas.0337542100; He XH, 2010, MICROBIOL-SGM, V156, P828, DOI 10.1099/mic.0.033605-0; Hefti MH, 2004, EUR J BIOCHEM, V271, P1198, DOI 10.1111/j.1432-1033.2004.04023.x; Hertz GZ, 1999, BIOINFORMATICS, V15, P563, DOI 10.1093/bioinformatics/15.7.563; Ikeda H, 2003, NAT BIOTECHNOL, V21, P526, DOI 10.1038/nbt820; Jang BY, 2011, J KOREAN SOC APPL BI, V54, P141, DOI 10.3839/jksabc.2011.022; Kells PM, 2010, CHEM BIOL, V17, P841, DOI 10.1016/j.chembiol.2010.05.026; Li R, 2010, MOL MICROBIOL, V75, P349, DOI 10.1111/j.1365-2958.2009.06968.x; Li R, 2009, MICROBIOL-SGM, V155, P1819, DOI 10.1099/mic.0.028639-0; Liu G, 2005, MOL MICROBIOL, V55, P1855, DOI 10.1111/j.1365-2958.2005.04512.x; Martin JF, 2009, METHOD ENZYMOL, V459, P215, DOI 10.1016/S0076-6879(09)04610-2; Mendes MV, 2007, CHEM BIOL, V14, P279, DOI 10.1016/j.chembiol.2007.01.010; Mendes MV, 2007, METAB ENG, V9, P217, DOI 10.1016/j.ymben.2006.10.003; Mendes MV, 2005, BIOCHEM J, V386, P57, DOI 10.1042/BJ20040490; Mendes MV, 2001, CHEM BIOL, V8, P635, DOI 10.1016/S1074-5521(01)00033-3; Mizuno T, 1997, MOL MICROBIOL, V24, P665, DOI 10.1046/j.1365-2958.1997.3571723.x; Perez-Rueda E, 2000, NUCLEIC ACIDS RES, V28, P1838, DOI 10.1093/nar/28.8.1838; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rasmussen R, 2000, RAPID CYCLE REAL TIM, P21; Recio E, 2004, J BIOL CHEM, V279, P41586, DOI 10.1074/jbc.M402340200; Recio E, 2006, MICROBIOL-SGM, V152, P3147, DOI 10.1099/mic.0.28953-0; Rozen S, 2000, Methods Mol Biol, V132, P365; Sambrook J., 2001, MOL CLONING LAB MANU; Santos-Aberturas J, 2011, METAB ENG, V13, P756, DOI 10.1016/j.ymben.2011.09.011; Santos-Aberturas J, 2011, J BIOL CHEM, V286, P9150, DOI 10.1074/jbc.M110.182428; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Sekurova ON, 2004, J BACTERIOL, V186, P1345, DOI 10.1128/JB.186.5.1345-1354.2004; Tanaka A, 2007, J MOL BIOL, V369, P322, DOI 10.1016/j.jmb.2007.02.096; Tang L, 1996, MOL MICROBIOL, V22, P801, DOI 10.1046/j.1365-2958.1996.01528.x; Tunca S, 2009, FEBS J, V276, P4814, DOI 10.1111/j.1742-4658.2009.07182.x; van Helden J, 2003, NUCLEIC ACIDS RES, V31, P3593, DOI 10.1093/nar/gkg567; Vicente CM, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-33; Wietzorrek A, 1997, MOL MICROBIOL, V25, P1181, DOI 10.1046/j.1365-2958.1997.5421903.x; Wilkinson CJ, 2002, J MOL MICROB BIOTECH, V4, P417	53	21	28	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e38536	10.1371/journal.pone.0038536	http://dx.doi.org/10.1371/journal.pone.0038536			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22693644	gold, Green Published, Green Submitted			2022-12-27	WOS:000305343900055
J	Phillips, RS; Lehrnbecher, T; Alexander, S; Sung, L				Phillips, Robert S.; Lehrnbecher, Thomas; Alexander, Sarah; Sung, Lillian			Updated Systematic Review and Meta-Analysis of the Performance of Risk Prediction Rules in Children and Young People with Febrile Neutropenia	PLOS ONE			English	Review							CHEMOTHERAPY-INDUCED NEUTROPENIA; INVASIVE BACTERIAL-INFECTION; PEDIATRIC ONCOLOGY PATIENTS; OUTPATIENT MANAGEMENT; BACTEREMIA RISK; CANCER-PATIENTS; FEVER; MODEL; VALIDATION; GUIDELINES	Introduction: Febrile neutropenia is a common and potentially life-threatening complication of treatment for childhood cancer, which has increasingly been subject to targeted treatment based on clinical risk stratification. Our previous meta-analysis demonstrated 16 rules had been described and 2 of them subject to validation in more than one study. We aimed to advance our knowledge of evidence on the discriminatory ability and predictive accuracy of such risk stratification clinical decision rules (CDR) for children and young people with cancer by updating our systematic review. Methods: The review was conducted in accordance with Centre for Reviews and Dissemination methods, searching multiple electronic databases, using two independent reviewers, formal critical appraisal with QUADAS and meta-analysis with random effects models where appropriate. It was registered with PROSPERO: CRD42011001685. Results: We found 9 new publications describing a further 7 new CDR, and validations of 7 rules. Six CDR have now been subject to testing across more than two data sets. Most validations demonstrated the rule to be less efficient than when initially proposed; geographical differences appeared to be one explanation for this. Conclusion: The use of clinical decision rules will require local validation before widespread use. Considerable uncertainty remains over the most effective rule to use in each population, and an ongoing individual-patient-data meta-analysis should develop and test a more reliable CDR to improve stratification and optimise therapy. Despite current challenges, we believe it will be possible to define an internationally effective CDR to harmonise the treatment of children with febrile neutropenia.	[Phillips, Robert S.] Univ York, Ctr Reviews & Disseminat, York YO10 5DD, N Yorkshire, England; [Lehrnbecher, Thomas] Goethe Univ Frankfurt, Dept Paediat Haematol & Oncol, Frankfurt, Germany; [Alexander, Sarah; Sung, Lillian] Hosp Sick Children, Div Haematol Oncol, Toronto, ON M5G 1X8, Canada	University of York - UK; Goethe University Frankfurt; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Phillips, RS (corresponding author), Univ York, Ctr Reviews & Disseminat, York YO10 5DD, N Yorkshire, England.	bob.phillips@york.ac.uk		Phillips, Bob/0000-0002-4938-9673	Medical Research Council (United Kingdom) Research Training Fellowship [G0800472]; New Investigator Award from Canadian Institutes of Health Research; Medical Research Council [G0800472] Funding Source: researchfish; MRC [G0800472] Funding Source: UKRI	Medical Research Council (United Kingdom) Research Training Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); New Investigator Award from Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	RSP is supported by a Medical Research Council (United Kingdom) Research Training Fellowship G0800472. LS is supported by a New Investigator Award from the Canadian Institutes of Health Research. No other author has received specific funding for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agyeman P, 2011, PEDIATR INFECT DIS J, V30, pE114, DOI 10.1097/INF.0b013e318215a290; Alexander SW, 2002, J PEDIAT HEMATOL ONC, V24, P38, DOI 10.1097/00043426-200201000-00011; Ammann RA, 2003, MED PEDIATR ONCOL, V41, P436, DOI 10.1002/mpo.10320; Ammann RA, 2010, J CLIN ONCOL, V28, P2008, DOI 10.1200/JCO.2009.25.8988; [Anonymous], 2009, SYSTEMATIC REV CRDS; Badiei Z, 2011, J PEDIAT HEMATOL ONC, V33, pE9, DOI 10.1097/MPH.0b013e3181f6921a; Baorto EP, 2001, CANCER, V92, P909, DOI 10.1002/1097-0142(20010815)92:4<909::AID-CNCR1400>3.0.CO;2-H; Delebarre M, 2010, PEDIATR BLOOD CANCER, V55, P823; Dellinger RP, 2004, CRIT CARE MED, V32, P858, DOI 10.1097/01.CCM.0000117317.18092.E4; Dommett R, 2009, EUR J CANCER, V45, P2843, DOI 10.1016/j.ejca.2009.06.003; Freifeld AG, 2011, J CLIN ONCOL, V29, P3952, DOI 10.1200/JCO.2011.37.5758; Hakim H, 2010, PEDIATR INFECT DIS J, V29, P53, DOI 10.1097/INF.0b013e3181c3f6f0; Harbord R., 2008, METANDI STATA MODULE; Janssen KJM, 2008, J CLIN EPIDEMIOL, V61, P76, DOI 10.1016/j.jclinepi.2007.04.018; Klaassen RJ, 2000, J CLIN ONCOL, V18, P1012, DOI 10.1200/JCO.2000.18.5.1012; Lijmer JG, 1999, JAMA-J AM MED ASSOC, V282, P1061, DOI 10.1001/jama.282.11.1061; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Macher E, 2010, PEDIATR BLOOD CANCER, V55, P662, DOI 10.1002/pbc.22586; Madsen K, 2002, J PEDIAT HEMATOL ONC, V24, P256, DOI 10.1097/00043426-200205000-00008; Mian A, 2009, CRIT CARE MED, V37, pA344; Miedema KGE, 2011, J CLIN ONCOL, V29, pE182, DOI 10.1200/JCO.2010.32.7767; Phillips B, 2007, ARCH DIS CHILD, V92, P495, DOI 10.1136/adc.2006.102699; Phillips B, 2010, EUR J CANCER, V46, P2950, DOI 10.1016/j.ejca.2010.05.024; Rondinelli PIP, 2006, J PEDIAT HEMATOL ONC, V28, P665, DOI 10.1097/01.mph.0000212996.94929.0b; Rackoff W R, 1996, J Clin Oncol, V14, P919; Santolaya ME, 2002, CLIN INFECT DIS, V35, P678, DOI 10.1086/342064; Santolaya ME, 2001, J CLIN ONCOL, V19, P3415, DOI 10.1200/JCO.2001.19.14.3415; Simel DL, 2009, J CLIN EPIDEMIOL, V62, P1292, DOI 10.1016/j.jclinepi.2009.02.007; Sung L, 2011, EUR J CANCER, V47, P811, DOI 10.1016/j.ejca.2011.01.021; Teuffel O, 2011, ANN ONCOL, V22, P2358, DOI 10.1093/annonc/mdq745; Toll DB, 2008, J CLIN EPIDEMIOL, V61, P1085, DOI 10.1016/j.jclinepi.2008.04.008; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25	32	51	51	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38300	10.1371/journal.pone.0038300	http://dx.doi.org/10.1371/journal.pone.0038300			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693615	Green Published, gold, Green Submitted			2022-12-27	WOS:000305338500126
J	Schrier, RD; Gupta, S; Riggs, P; Cysique, LA; Letendre, S; Jin, H; Spector, SA; Singh, KK; Wolfson, T; Wu, ZY; Hong, KX; Yu, X; Shi, CA; Heaton, RK				Schrier, Rachel D.; Gupta, Saurabh; Riggs, Patricia; Cysique, Lucette A.; Letendre, Scott; Jin, Hua; Spector, Stephen A.; Singh, Kumud K.; Wolfson, Tanya; Wu, Zunyou; Hong, Kun Xue; Yu, Xin; Shi, Chuan; Heaton, Robert K.		HNRC Grp	The Influence of HLA on HIV-Associated Neurocognitive Impairment in Anhui, China	PLOS ONE			English	Article							CLASS-I ALLELES; DISEASE PROGRESSION; APOLIPOPROTEIN-E; PLASMA DONORS; T-CELLS; INFECTION; AIDS; GAG; INDIVIDUALS; RESPONSES	Background: HLA-DR*04 was identified as a predictor of HIV-Associated neurocognitive disorder (HAND), low CD4 T-cell responses to HIV, and low plasma HIV RNA levels in a U.S. cohort. We hypothesized that low CD4 T-cell activation leads to poor immune control of HIV in the CNS, predisposing to HAND, but also provided fewer target (activated CD4 T-cells) for HIV replication. To assess the consistency of these HLA Class II associations in a new cohort and extend analysis to HLA Class I, HLA types, neurocognitive, and virologic status were examined in a cohort of former plasma donors in China. Methods: 178 HIV infected individuals in Anhui China, were HLA typed and underwent neurocognitive evaluations (using locally standardized norms), neuromedical, treatment and virologic assessments at baseline and at 12 months. Results: HLA DR*04 was associated with a higher rate of baseline neurocognitive impairment (p = 0.04), neurocognitive decline (p = 0.04), and lower levels of HIV RNA in plasma (p = 0.05). HLA Class I alleles (B*27,57,58,A*03,33) that specify a CD8 T-cell response to conserved HIV sequences were neuroprotective, associated with less impairment at baseline (p = 0.037), at month 012 (p = 0.013) and less neurocognitive decline (p = 0.023) in the interval. Consistent with the theory that effective CD8 T-cell responses require CD4 T-cell support, the HLA DR*04 allele reduced the neuroprotective effect of the Class I alleles. The presence of HLA-DR*04 and the Alzheimer associated allele ApoE4 in the same individual had a synergistic negative effect on cognition (p = 0.003). Conclusions: Despite major background differences between U. S. and Anhui China cohorts, HLA DR*04 predicted neurocognitive impairment and lower plasma HIV RNA levels in both populations. HLA Class I alleles associated with CD8 T-cell control of HIV were associated with protection from HAND, but protection was reduced in the presence of HLA-DR*04.	[Schrier, Rachel D.] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [Gupta, Saurabh; Jin, Hua; Wolfson, Tanya; Heaton, Robert K.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Riggs, Patricia; Letendre, Scott] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Spector, Stephen A.; Singh, Kumud K.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Cysique, Lucette A.] Univ New S Wales, Sydney, NSW, Australia; [Wu, Zunyou; Hong, Kun Xue; Yu, Xin] Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China; [Shi, Chuan] Peking Univ, Beijing Mental Hlth Inst, Beijing 100871, Peoples R China	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of New South Wales Sydney; Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention; Peking University	Schrier, RD (corresponding author), Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA.	rschrier@ucsd.edu	Cysique, Lucette A./U-1357-2017; Letendre, Scott L./GLU-6874-2022; jin, hua/AAX-1569-2020	Cysique, Lucette A./0000-0002-7711-6373; Riggs, Patricia Katherine/0000-0003-2870-8468	National Institute of Mental Health [5 R01 MH073433-04]; Center award from the National Institute of Mental Health [MH 62512];  [MH083552]; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062512, R01MH073433, R01MH083552] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS077874] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Center award from the National Institute of Mental Health; ; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by the National Institute of Mental Health grant 5 R01 MH073433-04 (RKH, P.I.). The HIV Neurobehavioral Research Center is supported by Center award MH 62512 from the National Institute of Mental Health. Clade analysis for this cohort is supported by MH083552. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashwood P, 2006, J LEUKOCYTE BIOL, V80, P1, DOI 10.1189/jlb.1205707; Asquith B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003486; Bansal A, 2007, AIDS, V21, P2387, DOI 10.1097/QAD.0b013e3282f13823; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; Borghans JAM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000920; Burt TD, 2008, P NATL ACAD SCI USA, V105, P8718, DOI 10.1073/pnas.0803526105; Carey CL, 2004, J CLIN EXP NEUROPSYC, V26, P307, DOI 10.1080/13803390490510031; Cedazo-Minguez A, 2007, J CELL MOL MED, V11, P1227, DOI 10.1111/j.1582-4934.2007.00130.x; Cysique LAJ, 2006, NEUROLOGY, V66, P1447, DOI 10.1212/01.wnl.0000210477.63851.d3; Cysique LA, 2007, J INT NEUROPSYCH SOC, V13, P781, DOI 10.1017/S1355617707071007; Cysique LA, 2011, J CLIN EXP NEUROPSYC, V33, P505, DOI 10.1080/13803395.2010.535504; Cysique LA, 2010, AIDS, V24, P983, DOI 10.1097/QAD.0b013e32833336c8; Dobson CB, 2006, J INFECT DIS, V193, P442, DOI 10.1086/499280; Gudmundsdotter L, 2008, VACCINE, V26, P5182, DOI 10.1016/j.vaccine.2008.03.094; Heaton RK, 2008, J NEUROVIROL, P1, DOI [10.1080/13550280701802543, DOI 10.1080/13550280701802543]; Huang X, 2009, MICROBIOL IMMUNOL, V53, P512, DOI 10.1111/j.1348-0421.2009.00150.x; Li S, 2007, JAIDS-J ACQ IMM DEF, V44, P121, DOI 10.1097/01.qai.0000248355.40877.2a; Mathieu A, 2009, AUTOIMMUN REV, V8, P420, DOI 10.1016/j.autrev.2009.01.003; Navis M, 2008, J INFECT DIS, V197, P871, DOI 10.1086/528695; Okulicz JF, 2009, J INFECT DIS, V200, P1714, DOI 10.1086/646609; Qing ML, 2006, JAIDS-J ACQ IMM DEF, V41, P137, DOI 10.1097/01.qai.0000195607.25262.92; Rauch A, 2008, CLIN INFECT DIS, V46, P1921, DOI 10.1086/588479; Schaubert KL, 2007, J IMMUNOL, V178, P7756, DOI 10.4049/jimmunol.178.12.7756; Schneidewind A, 2007, J VIROL, V81, P12382, DOI 10.1128/JVI.01543-07; SCHRIER RD, 1989, J IMMUNOL, V142, P1166; Schrier RD, 1996, J CLIN INVEST, V98, P731, DOI 10.1172/JCI118845; Spector SA, 2010, AIDS, V24, P1471, DOI 10.1097/QAD.0b013e328339e25c; Streeck H, 2007, J VIROL, V81, P7725, DOI 10.1128/JVI.00708-07; Temkin NR, 1999, J INT NEUROPSYCH SOC, V5, P357, DOI 10.1017/S1355617799544068; Torres AR, 2002, HUM IMMUNOL, V63, P311, DOI 10.1016/S0198-8859(02)00374-9; Xu KY, 2006, DU XUE ZA ZHI, V20, P72; Xu MY, 2004, BIOMED ENVIRON SCI, V17, P203; Yu XG, 2004, AIDS RES HUM RETROV, V20, P557, DOI 10.1089/088922204323087813; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205; Zhai S, 2008, CURR HIV RES, V6, P335, DOI 10.2174/157016208785132473	35	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e32303	10.1371/journal.pone.0032303	http://dx.doi.org/10.1371/journal.pone.0032303			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693541	Green Published, Green Submitted, gold			2022-12-27	WOS:000305338500003
J	Guo, ZS; Zhang, HH; Rao, HY; Jiang, D; Cong, X; Feng, B; Wang, JH; Wei, L; Chen, HS				Guo, Zhongsheng; Zhang, Henghui; Rao, Huiying; Jiang, Dong; Cong, Xu; Feng, Bo; Wang, Jianghua; Wei, Lai; Chen, Hongsong			DCs Pulsed with Novel HLA-A2-Restricted CTL Epitopes against Hepatitis C Virus Induced a Broadly Reactive Anti-HCV-Specific T Lymphocyte Response	PLOS ONE			English	Article							DENDRITIC CELLS; THERAPEUTIC VACCINATION; IMMUNE-RESPONSES; INFECTION; CYTOKINES; IDENTIFICATION; DETERMINANTS; DYSFUNCTION; MATURATION; CD4(+)	Objective: To determine the capacity of dendritic cells (DCs) loaded with single or multiple-peptide mixtures of novel hepatitis C virus (HCV) epitopes to stimulate HCV-specific cytotoxic T lymphocyte (CTL) effector functions. Methods: A bioinformatics approach was used to predict HLA-A2-restricted HCV-specific CTL epitopes, and the predicted peptides identified from this screen were synthesized. Subsequent IFN-gamma ELISPOT analysis detected the stimulating function of these peptides in peripheral blood mononuclear cells (PBMCs) from both chronic and self-limited HCV infected subjects (subjects exhibiting spontaneous HCV clearance). Mature DCs, derived in vitro from CD14(+) monocytes harvested from the study subjects by incubation with appropriate cytokine cocktails, were loaded with novel peptide or epitope peptide mixtures and co-cultured with autologous T lymphocytes. Granzyme B (GrB) and IFN-gamma ELISPOT analysis was used to test for epitope-specific CTL responses. T-cell-derived cytokines contained in the co-cultured supernatant were detected by flow cytometry. Results: We identified 7 novel HLA-A2-restricted HCV-specific CTL epitopes that increased the frequency of IFN-gamma-producing T cells compared to other epitopes, as assayed by measuring spot forming cells (SFCs). Two epitopes had the strongest stimulating capability in the self-limited subjects, one found in the E2 and one in the NS2 region of HCV; five epitopes had a strong stimulating capacity in both chronic and self-limited HCV infection, but were stronger in the self-limited subjects. They were distributed in E2, NS2, NS3, NS4, and NS5 regions of HCV, respectively. We also found that mDCs loaded with novel peptide mixtures could significantly increase GrB and IFN-gamma SFCs as compared to single peptides, especially in chronic HCV infection subjects. Additionally, we found that DCs pulsed with multiple epitope peptide mixtures induced a Th1-biased immune response. Conclusions: Seven novel and strongly stimulating HLA-A2-restricted HCV-specific CTL epitopes were identified. Furthermore, DCs loaded with multiple-epitope peptide mixtures induced epitope-specific CTLs responses.	[Guo, Zhongsheng; Zhang, Henghui; Rao, Huiying; Jiang, Dong; Cong, Xu; Feng, Bo; Wang, Jianghua; Wei, Lai; Chen, Hongsong] Peking Univ, Inst Hepatol, Peoples Hosp, Beijing 100871, Peoples R China; [Guo, Zhongsheng; Zhang, Henghui; Rao, Huiying; Jiang, Dong; Cong, Xu; Feng, Bo; Wang, Jianghua; Wei, Lai; Chen, Hongsong] Beijing Key Lab Hepatitis C & Immunotherapy Liver, Beijing, Peoples R China	Peking University	Guo, ZS (corresponding author), Peking Univ, Inst Hepatol, Peoples Hosp, Beijing 100871, Peoples R China.	weelai@163.com			National S&T Major Project for Infectious Diseases Control in China [2008ZX10002-012, 2008ZX10002-013]	National S&T Major Project for Infectious Diseases Control in China	The work was funded by National S&T Major Project for Infectious Diseases Control (grant nos: 2008ZX10002-012 and 2008ZX10002-013) in China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Lajonchere L, 2009, J VIRAL HEPATITIS, V16, P156, DOI 10.1111/j.1365-2893.2008.01058.x; Averill L, 2007, CLIN IMMUNOL, V123, P40, DOI 10.1016/j.clim.2006.12.001; Bhasin M, 2004, VACCINE, V22, P3195, DOI 10.1016/j.vaccine.2004.02.005; Bi SL, 1993, COMPLETE HEPATITIS C; Bowen DG, 2005, NATURE, V436, P946, DOI 10.1038/nature04079; Cacciarelli TV, 1996, HEPATOLOGY, V24, P6, DOI 10.1053/jhep.1996.v24.pm0008707283; Chaiken IM, 1996, TRENDS BIOTECHNOL, V14, P369, DOI 10.1016/0167-7799(96)10050-0; Cheever MA, 2011, CLIN CANCER RES, V17, P3520, DOI 10.1158/1078-0432.CCR-10-3126; Cox AL, 2005, HEPATOLOGY, V42, P104, DOI 10.1002/hep.20749; Dolganiuc A, 2011, J GASTROENTEROL, V46, P432, DOI 10.1007/s00535-011-0377-y; Eksioglu EA, 2010, J VIRAL HEPATITIS, V17, P757, DOI 10.1111/j.1365-2893.2009.01231.x; Ewen CL, 2006, J IMMUNOL METHODS, V308, P156, DOI 10.1016/j.jim.2005.10.009; Fan XG, 1998, MEDIAT INFLAMM, V7, P295, DOI 10.1080/09629359890992; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Gowans EJ, 2004, J CLIN VIROL, V30, P283, DOI [10.1016/j.jcv.2004.03.006, 10.1016/j.cv.2004.03.006]; Gowans EJ, 2010, J HEPATOL, V53, P599, DOI 10.1016/j.jhep.2010.05.007; Hong X, 2005, WORLD J GASTROENTERO, V11, P7302, DOI 10.3748/wjg.v11.i46.7302; Jiang WZ, 2008, ANTIVIR RES, V77, P50, DOI 10.1016/j.antiviral.2007.08.004; Kim AY, 2011, GASTROENTEROLOGY, V140, P686, DOI 10.1053/j.gastro.2010.09.042; Kim HJ, 2010, VACCINE, V28, P2877, DOI 10.1016/j.vaccine.2010.01.061; Klade CS, 2009, VACCINE, V27, P3099, DOI 10.1016/j.vaccine.2009.02.088; Klade CS, 2008, GASTROENTEROLOGY, V134, P1385, DOI 10.1053/j.gastro.2008.02.058; Lauer GM, 2001, NEW ENGL J MED, V345, P41, DOI 10.1056/NEJM200107053450107; Lauer GM, 2002, J VIROL, V76, P6104, DOI 10.1128/JVI.76.12.6104-6113.2002; Lauer GM, 2004, GASTROENTEROLOGY, V127, P924, DOI 10.1053/j.gastro.2004.06.015; Lee WC, 2005, J IMMUNOTHER, V28, P496, DOI 10.1097/01.cji.0000171291.72039.e2; Li W, 2006, J IMMUNOL, V176, P6065, DOI 10.4049/jimmunol.176.10.6065; Lu W, 2004, NAT MED, V10, P1359, DOI 10.1038/nm1147; Manns MP, 2006, GUT, V55, P1350, DOI 10.1136/gut.2005.076646; Mashiba T, 2007, IMMUNOGENETICS, V59, P197, DOI 10.1007/s00251-006-0185-3; McMahan RH, 2010, J CLIN INVEST, V120, P4546, DOI 10.1172/JCI43127; Navabi H, 2009, VACCINE, V27, P107, DOI 10.1016/j.vaccine.2008.10.024; Neumann-Haefelin C, 2008, HEPATOLOGY, V47, P1824, DOI 10.1002/hep.22242; Neumann-Haefelin C, 2010, HEPATOLOGY, V51, P54, DOI 10.1002/hep.23275; Nevens F, 2003, HEPATOLOGY, V38, P1289, DOI 10.1053/jhep.2003.50474; Penna A, 2007, HEPATOLOGY, V45, P588, DOI 10.1002/hep.21541; Rehermann B, 2005, NAT REV IMMUNOL, V5, P215, DOI 10.1038/nri1573; Rodrigue-Gervais IG, 2010, J IMMUNOL, V184, P3134, DOI 10.4049/jimmunol.0902522; Romani N, 1996, J IMMUNOL METHODS, V196, P137, DOI 10.1016/0022-1759(96)00078-6; Shafer-Weaver K, 2004, J TRANSL MED, V1, P1; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Shi M, 2007, CLIN EXP IMMUNOL, V147, P277, DOI 10.1111/j.1365-2249.2006.03281.x; Shoukry NH, 2004, ANNU REV MICROBIOL, V58, P391, DOI 10.1146/annurev.micro.58.030603.123836; Tian Y, 2007, VIRAL IMMUNOL, V20, P553, DOI 10.1089/vim.2007.0064; Torresi J, 2011, J HEPATOL, V54, P1273, DOI 10.1016/j.jhep.2010.09.040; Tsai SL, 1997, HEPATOLOGY, V25, P449; Tsubouchi E, 2004, CLIN EXP IMMUNOL, V137, P417, DOI 10.1111/j.1365-2249.2004.02544.x; Ulsenheimer A, 2005, HEPATOLOGY, V41, P643, DOI 10.1002/hep.20592; Urbani S, 2001, HEPATOLOGY, V33, P1533, DOI 10.1053/jhep.2001.25091; Wertheimer AM, 2003, HEPATOLOGY, V37, P577, DOI 10.1053/jhep.2003.50115; zur Wiesch JS, 2005, J IMMUNOL, V175, P3603, DOI 10.4049/jimmunol.175.6.3603	51	10	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2012	7	6							e38390	10.1371/journal.pone.0038390	http://dx.doi.org/10.1371/journal.pone.0038390			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UJ	22701633	Green Submitted, gold, Green Published			2022-12-27	WOS:000305340000020
J	Corbin, M; Richiardi, L; Vermeulen, R; Kromhout, H; Merletti, F; Peters, S; Simonato, L; Steenland, K; Pearce, N; Maule, M				Corbin, Marine; Richiardi, Lorenzo; Vermeulen, Roel; Kromhout, Hans; Merletti, Franco; Peters, Susan; Simonato, Lorenzo; Steenland, Kyle; Pearce, Neil; Maule, Milena			Hierarchical Regression for Multiple Comparisons in a Case-Control Study of Occupational Risks for Lung Cancer	PLOS ONE			English	Article							SEMI-BAYES; EMPIRICAL-BAYES; EXPOSURES; SURVEILLANCE	Background: Occupational studies often involve multiple comparisons and therefore suffer from false positive findings. Semi-Bayes adjustment methods have sometimes been used to address this issue. Hierarchical regression is a more general approach, including Semi-Bayes adjustment as a special case, that aims at improving the validity of standard maximum-likelihood estimates in the presence of multiple comparisons by incorporating similarities between the exposures of interest in a second-stage model. Methodology/Principal Findings: We re-analysed data from an occupational case-control study of lung cancer, applying hierarchical regression. In the second-stage model, we included the exposure to three known lung carcinogens (asbestos, chromium and silica) for each occupation, under the assumption that occupations entailing similar carcinogenic exposures are associated with similar risks of lung cancer. Hierarchical regression estimates had smaller confidence intervals than maximum-likelihood estimates. The shrinkage toward the null was stronger for extreme, less stable estimates (e. g., "specialised farmers": maximum-likelihood OR: 3.44, 95% CI 0.90-13.17; hierarchical regression OR: 1.53, 95% CI 0.63-3.68). Unlike Semi-Bayes adjustment toward the global mean, hierarchical regression did not shrink all the ORs towards the null (e. g., "Metal smelting, converting and refining furnacemen": maximum-likelihood OR: 1.07, Semi-Bayes OR: 1.06, hierarchical regression OR: 1.26). Conclusions/Significance: Hierarchical regression could be a valuable tool in occupational studies in which disease risk is estimated for a large amount of occupations when we have information available on the key carcinogenic exposures involved in each occupation. With the constant progress in exposure assessment methods in occupational settings and the availability of Job Exposure Matrices, it should become easier to apply this approach.	[Corbin, Marine; Richiardi, Lorenzo; Merletti, Franco; Maule, Milena] Univ Turin, Dept Med Sci, Canc Epidemiol Unit, CeRMS,CPO Piemonte, Turin, Italy; [Corbin, Marine; Pearce, Neil] Massey Univ, Ctr Publ Hlth Res, Wellington, New Zealand; [Vermeulen, Roel; Kromhout, Hans; Peters, Susan] Univ Utrecht, Inst Risk Assessment Sci, Utrecht, Netherlands; [Simonato, Lorenzo] Univ Padua, Dept Environm Med & Publ Hlth, Padua, Italy; [Steenland, Kyle] Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Pearce, Neil] London Sch Hyg & Trop Med, Fac Epidemiol & Publ Hlth, Dept Med Stat, London WC1, England	Centro di Riferimento per Epidemiologia e la Prevenzione Oncologica in Piemonte; University of Turin; Massey University; Utrecht University; University of Padua; Emory University; Rollins School Public Health; University of London; London School of Hygiene & Tropical Medicine	Corbin, M (corresponding author), Univ Turin, Dept Med Sci, Canc Epidemiol Unit, CeRMS,CPO Piemonte, Turin, Italy.	m.corbin@massey.ac.nz	Peters, Susan/A-5845-2013; Maule, Milena M/K-3858-2018; Kromhout, Hans/A-9159-2008; Vermeulen, Roel/F-8037-2011; richiardi, lorenzo/J-3480-2018	Maule, Milena M/0000-0003-2142-1288; Kromhout, Hans/0000-0002-4233-1890; Vermeulen, Roel/0000-0003-4082-8163; Peters, Susan/0000-0001-5662-1971; richiardi, lorenzo/0000-0003-0316-9402; Pearce, Neil/0000-0002-9938-7852; SIMONATO, LORENZO/0000-0002-9914-1000	Programme Grant from the Health Research Council of New Zealand	Programme Grant from the Health Research Council of New Zealand	The Centre for Public Health Research is supported by a Programme Grant from the Health Research Council of New Zealand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], IARC MON CLASS; [Anonymous], 2006, R LANG ENV STAT COMP; Chen GK, 2007, AM J HUM GENET, V81, P397, DOI 10.1086/519794; Conti DV, 2003, AM J HUM GENET, V72, P351, DOI 10.1086/346117; Corbin M, 2008, EPIDEMIOL PREV, V32, P108; Corbin M, 2011, AM J IND MED, V54, P89, DOI 10.1002/ajim.20906; De Roos AJ, 2001, AM J IND MED, V39, P477, DOI 10.1002/ajim.1041; Greenland S, 2000, INT J EPIDEMIOL, V29, P158, DOI 10.1093/ije/29.1.158; GREENLAND S, 1992, STAT MED, V11, P219, DOI 10.1002/sim.4780110208; GREENLAND S, 1991, EPIDEMIOLOGY, V2, P387, DOI 10.1097/00001648-199109000-00015; GREENLAND S, 1994, ARCH ENVIRON HEALTH, V49, P9, DOI 10.1080/00039896.1994.9934409; Greenland S, 2007, INT J EPIDEMIOL, V36, P195, DOI 10.1093/ije/dyl289; Guha N, ENV HLTH PERSPECT, V118, P303; International Labour Office, 1968, INT STANDARD CLASSIF; McLean D, 2009, INT J EPIDEMIOL, V38, P594, DOI 10.1093/ije/dyn220; Momoli F, 2010, EPIDEMIOLOGY, V21, P144, DOI 10.1097/EDE.0b013e3181c297c7; Peters S, 2011, OCCUP ENVIRON MED, V68, P148, DOI 10.1136/oem.2010.055608; Richiardi L, 2004, CANCER CAUSE CONTROL, V15, P285, DOI 10.1023/B:CACO.0000024223.91059.ed; Richiardi L, INT J CANC IN PRESS; Steenland K, 2000, CANCER EPIDEM BIOMAR, V9, P895; t Mannetje A, 2008, OCCUP ENVIRON MED, V65, P354, DOI 10.1136/oem.2007.035014; *UN, 1971, INT STAND IND CLASS; WITTE JS, 1994, EPIDEMIOLOGY, V5, P612, DOI 10.1097/00001648-199411000-00009	23	9	9	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2012	7	6							e38944	10.1371/journal.pone.0038944	http://dx.doi.org/10.1371/journal.pone.0038944			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TU	22701732	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000305337600059
J	Hagenfeld, D; Borkenhagen, B; Schulz, T; Schillers, H; Schumacher, U; Prehm, P				Hagenfeld, Daniel; Borkenhagen, Beatrice; Schulz, Tobias; Schillers, Hermann; Schumacher, Udo; Prehm, Peter			Hyaluronan Export through Plasma Membranes Depends on Concurrent K+ Efflux by K-ir Channels	PLOS ONE			English	Article							ION CHANNELS; POTASSIUM CHANNELS; MOLECULAR-MODEL; FIBROBLASTS; CELLS; ROPIVACAINE; MRP5; BUPIVACAINE; ASSOCIATION; VESICLES	Hyaluronan is synthesized within the cytoplasm and exported into the extracellular matrix through the cell membrane of fibroblasts by the MRP5 transporter. In order to meet the law of electroneutrality, a cation is required to neutralize the emerging negative hyaluronan charges. As we previously observed an inhibiting of hyaluronan export by inhibitors of K+ channels, hyaluronan export was now analysed by simultaneously measuring membrane potential in the presence of drugs. This was done by both hyaluronan import into inside-out vesicles and by inhibition with antisense siRNA. Hyaluronan export from fibroblast was particularly inhibited by glibenclamide, ropivacain and BaCl2 which all belong to ATP-sensitive inwardly-rectifying K-ir channel inhibitors. Import of hyaluronan into vesicles was activated by 150 mM KCl and this activation was abolished by ATP. siRNA for the K+ channels K(ir)3.4 and K(ir)6.2 inhibited hyaluronan export. Collectively, these results indicated that hyaluronan export depends on concurrent K+ efflux.	[Hagenfeld, Daniel; Borkenhagen, Beatrice; Schulz, Tobias; Prehm, Peter] Munster Univ Hosp, Inst Physiol Chem & Pathobiochem, Munster, Germany; [Schillers, Hermann] Muenster Univ Hosp, Inst Physiol 2, Munster, Germany; [Schumacher, Udo] Univ Klinikum Hamburg Eppendorf, Inst Anat Expt Morphol 2, Hamburg, Germany; [Hagenfeld, Daniel] Univ Heidelberg Hosp, Clin Oral Dent & Maxillofacial Dis, Dept Conservat Dent, Sect Periodontol, Heidelberg, Germany	University of Munster; University of Munster; University of Hamburg; University Medical Center Hamburg-Eppendorf; Ruprecht Karls University Heidelberg	Hagenfeld, D (corresponding author), Munster Univ Hosp, Inst Physiol Chem & Pathobiochem, Munster, Germany.	prehm@uni-muenster.de	Hagenfeld, Daniel/ABA-9972-2021	Prehm, Peter/0000-0002-8063-311X; Schillers, Hermann/0000-0001-6090-4771	Deutsche Forschungsgemeinschaft [SFB 492]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Deutsche Forschungsgemeinschaft (SFB 492). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonucci DE, 2001, NEUROSCIENCE, V108, P69, DOI 10.1016/S0306-4522(01)00476-6; Arcangeli A, 2009, CURR MED CHEM, V16, P66, DOI 10.2174/092986709787002835; Ashcroft FM, 2005, J CLIN INVEST, V115, P2047, DOI 10.1172/JCI25495; BAKY SH, 1982, PHARMACOTHERAPY, V2, P328; BRECHT M, 1986, BIOCHEM J, V239, P445, DOI 10.1042/bj2390445; Chilton L, 2005, AM J PHYSIOL-HEART C, V288, pH2931, DOI 10.1152/ajpheart.01220.2004; Davison HR, 2011, BIOCONJUGATE CHEM, V22, P2593, DOI 10.1021/bc2004457; Dojo M, 2004, ANESTHESIOLOGY, V101, P251, DOI 10.1097/00000542-200407000-00040; ESTACION M, 1991, J PHYSIOL-LONDON, V436, P579, DOI 10.1113/jphysiol.1991.sp018568; Evanko SP, 2004, J HISTOCHEM CYTOCHEM, V52, P1525, DOI 10.1369/jhc.4A6356.2004; Franchini L, 2004, CELL CALCIUM, V35, P449, DOI 10.1016/j.ceca.2003.11.001; FRENCH RJ, 1985, J GEN PHYSIOL, V85, P669, DOI 10.1085/jgp.85.5.669; Friederich P, 2004, ANESTHESIOLOGY, V101, P1347; Gopalakrishnan M, 2003, BRIT J PHARMACOL, V138, P393, DOI 10.1038/sj.bjp.0705048; Hagenfeld D, 2010, J CELL BIOCHEM, V111, P858, DOI 10.1002/jcb.22772; Ishihara K, 2009, BIOCHEM BIOPH RES CO, V380, P832, DOI 10.1016/j.bbrc.2009.01.179; Joerges J, 2012, J CELL BIOCHEM, V113, P340, DOI 10.1002/jcb.23360; Jokela TA, 2008, CONNECT TISSUE RES, V49, P115, DOI 10.1080/03008200802148439; Katsuda Y, 1996, AM J PHYSIOL-HEART C, V270, pH2210; Kawano T, 2004, ANESTHESIOLOGY, V101, P390, DOI 10.1097/00000542-200408000-00020; KLEMPNER MS, 1980, J CELL BIOL, V86, P21, DOI 10.1083/jcb.86.1.21; KLEYMAN TR, 1988, SEMIN NEPHROL, V8, P242; Kochlamazashvili G, 2010, NEURON, V67, P116, DOI 10.1016/j.neuron.2010.05.030; KRASZNAI Z, 1995, J PHOTOCH PHOTOBIO B, V28, P93, DOI 10.1016/1011-1344(94)07099-A; LAURENT TC, 1964, BIOCHEM J, V93, P106, DOI 10.1042/bj0930106; Levite M, 2000, J EXP MED, V191, P1167, DOI 10.1084/jem.191.7.1167; Li GR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007307; LUPPA D, 1987, BIOMED BIOCHIM ACTA, V46, P341; Marcussen M, 1996, CELL MOTIL CYTOSKEL, V35, P94, DOI 10.1002/(SICI)1097-0169(1996)35:2<94::AID-CM2>3.0.CO;2-I; Meszar Z, 2008, BRAIN RES BULL, V75, P414, DOI 10.1016/j.brainresbull.2007.10.052; PHILIPSON LH, 1985, BIOCHEMISTRY-US, V24, P7899, DOI 10.1021/bi00348a008; Prehm P, 2004, BIOCHEM PHARMACOL, V68, P1401, DOI 10.1016/j.bcp.2004.06.017; PREHM P, 1984, BIOCHEM J, V220, P597, DOI 10.1042/bj2200597; Ravna AW, 2007, THEOR BIOL MED MODEL, V4, DOI 10.1186/1742-4682-4-33; Ravna AW, 2008, EUR J MED CHEM, V43, P2557, DOI 10.1016/j.ejmech.2008.01.015; Rilla K, 2008, J HISTOCHEM CYTOCHEM, V56, P901, DOI 10.1369/jhc.2008.951665; SCHLEMMER SR, 1995, ANAL BIOCHEM, V228, P226, DOI 10.1006/abio.1995.1343; Schulz T, 2007, J BIOL CHEM, V282, P20999, DOI 10.1074/jbc.M700915200; Schulz T, 2010, PATHOBIOLOGY, V77, P200, DOI 10.1159/000295859; Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391; WILLERSHAUSENZONNCHEN B, 1991, J CLIN PERIODONTOL, V18, P190, DOI 10.1111/j.1600-051X.1991.tb01132.x	41	10	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2012	7	6							e39096	10.1371/journal.pone.0039096	http://dx.doi.org/10.1371/journal.pone.0039096			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TU	22701748	Green Published, gold, Green Submitted			2022-12-27	WOS:000305337600068
J	McKinnon, JS; Hamele, N; Frey, N; Chou, J; McAleavey, L; Greene, J; Paulson, W				McKinnon, Jeffrey S.; Hamele, Nick; Frey, Nicole; Chou, Jennifer; McAleavey, Leia; Greene, Jess; Paulson, Windi			Male Choice in the Stream-Anadromous Stickleback Complex	PLOS ONE			English	Article							MUTUAL MATE CHOICE; THREESPINE STICKLEBACK; GASTEROSTEUS-ACULEATUS; REPRODUCTIVE ISOLATION; ECOLOGICAL SPECIATION; ISOLATING MECHANISM; COLOR POLYMORPHISM; SPECIES PAIR; HYBRID ZONE; BODY-SIZE	Studies of mating preferences and pre-mating reproductive isolation have often focused on females, but the potential importance of male preferences is increasingly appreciated. We investigated male behavior in the context of reproductive isolation between divergent anadromous and stream-resident populations of threespine stickleback, Gasterosteus aculeatus, using size-manipulated females of both ecotypes. Specifically, we asked if male courtship preferences are present, and if they are based on relative body size, non-size aspects of ecotype, or other traits. Because male behaviors were correlated with each other, we conducted a principal components analysis on the correlations and ran subsequent analyses on the principal components. The two male ecotypes differed in overall behavioral frequencies, with stream-resident males exhibiting consistently more vigorous and positive courtship than anadromous males, and an otherwise aggressive behavior playing a more positive role in anadromous than stream-resident courtship. We observed more vigorous courtship toward smaller females by (relatively small) stream-resident males and the reverse pattern for (relatively large) anadromous males. Thus size-assortative male courtship preferences may contribute to reproductive isolation in this system, although preferences are far from absolute. We found little indication of males responding preferentially to females of their own ecotype independent of body size.	[McKinnon, Jeffrey S.] E Carolina Univ, Dept Biol, Greenville, NC 27858 USA; [Hamele, Nick; Frey, Nicole; Chou, Jennifer; McAleavey, Leia; Greene, Jess; Paulson, Windi] Univ Wisconsin, Dept Biol Sci, Whitewater, WI 53190 USA	University of North Carolina; East Carolina University; University of Wisconsin System	McKinnon, JS (corresponding author), E Carolina Univ, Dept Biol, Greenville, NC 27858 USA.	mckinnonj@ecu.edu			National Science Foundation (NSF) [RUI 9981638, REU 0354140]	National Science Foundation (NSF)(National Science Foundation (NSF))	This work was supported by National Science Foundation (NSF) RUI 9981638 and NSF REU 0354140 (http://www.nsf.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert AYK, 2005, EVOLUTION, V59, P927; Albert AYK, 2004, EVOLUTION, V58, P1099; Baube CL, 2008, ETHOLOGY, V114, P1122, DOI 10.1111/j.1439-0310.2008.01564.x; Bell M.A., 1994, EVOLUTIONARY BIOL TH; Borland M., 1986, SIZE ASSORTATIVE MAT; Boughman Janette Wenrick, 2007, P83; Coyne J.A., 2004, SPECIATION; Delcourt M, 2008, BEHAV ECOL, V19, P1217, DOI 10.1093/beheco/arn084; Edward DA, 2011, TRENDS ECOL EVOL, V26, P647, DOI 10.1016/j.tree.2011.07.012; Foster SA, 2008, BEHAVIOUR, V145, P485, DOI 10.1163/156853908792451421; Gow JL, 2007, J EVOLUTION BIOL, V20, P2173, DOI 10.1111/j.1420-9101.2007.01427.x; Gray SM, 2007, TRENDS ECOL EVOL, V22, P71, DOI 10.1016/j.tree.2006.10.005; HAGEN DW, 1967, J FISH RES BOARD CAN, V24, P1637, DOI 10.1139/f67-138; Head ML, 2009, BIOL LETTERS, V5, P517, DOI 10.1098/rsbl.2009.0216; Hendry AP, 2009, J FISH BIOL, V75, P2000, DOI 10.1111/j.1095-8649.2009.02419.x; Hendry AP, 2009, CAN J FISH AQUAT SCI, V66, P1383, DOI 10.1139/F09-074; Hohenlohe PA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000862; Jones FC, 2008, BEHAVIOUR, V145, P463, DOI 10.1163/156853908792451520; Jones FC, 2006, J EVOLUTION BIOL, V19, P1531, DOI 10.1111/j.1420-9101.2006.01122.x; Karve AD, 2008, ENVIRON BIOL FISH, V81, P287, DOI 10.1007/s10641-007-9200-2; Kozak GM, 2011, P ROY SOC B-BIOL SCI, V278, P2604, DOI 10.1098/rspb.2010.2466; Kozak GM, 2009, BEHAV ECOL, V20, P1282, DOI 10.1093/beheco/arp134; Kozak GM, 2009, EVOLUTION, V63, P353, DOI 10.1111/j.1558-5646.2008.00564.x; McKinnon JS, 2010, MOL ECOL, V19, P5101, DOI 10.1111/j.1365-294X.2010.04846.x; McKinnon JS, 2004, NATURE, V429, P294, DOI 10.1038/nature02556; McKinnon JS, 2002, TRENDS ECOL EVOL, V17, P480, DOI 10.1016/S0169-5347(02)02579-X; McPhail J.D., 1994, P399; MCPHAIL JD, 1983, CAN J ZOOL, V61, P292, DOI 10.1139/z83-039; Ostlund-Nilsson S., 2007, BIOL 3 SPINED STICKL; Raeymaekers JAM, 2010, J EVOLUTION BIOL, V23, P2694, DOI 10.1111/j.1420-9101.2010.02133.x; RICE WR, 1994, BIOMETRICS, V50, P746, DOI 10.2307/2532788; Rick IP, 2008, BEHAV ECOL SOCIOBIOL, V62, P439, DOI 10.1007/s00265-007-0471-6; Rowell JT, 2009, AM NAT, V173, P12, DOI 10.1086/593356; ROWLAND WJ, 1989, ANIM BEHAV, V38, P112, DOI 10.1016/S0003-3472(89)80070-3; Rundle HD, 2005, ECOL LETT, V8, P336, DOI 10.1111/j.1461-0248.2004.00715.x; Rundle HD, 1998, EVOLUTION, V52, P200, DOI 10.1111/j.1558-5646.1998.tb05153.x; SARGENT RC, 1986, ANIM BEHAV, V34, P545, DOI 10.1016/S0003-3472(86)80123-3; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Schluter D, 2010, PHILOS T R SOC B, V365, P2479, DOI 10.1098/rstb.2010.0036; Servedio MR, 2006, EVOLUTION, V60, P674; Servedio MR, 2011, TRENDS ECOL EVOL, V26, P389, DOI 10.1016/j.tree.2011.04.005; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; Wooton, 1976, BIOL STICKLEBACKS	43	7	7	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2012	7	6							e37951	10.1371/journal.pone.0037951	http://dx.doi.org/10.1371/journal.pone.0037951			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TU	22701589	gold, Green Published, Green Submitted			2022-12-27	WOS:000305337600012
J	Said-Mohamed, R; Bernard, JY; Ndzana, AC; Pasquet, P				Said-Mohamed, Rihlat; Bernard, Jonathan Y.; Ndzana, Anne-Christine; Pasquet, Patrick			Is Overweight in Stunted Preschool Children in Cameroon Related to Reductions in Fat Oxidation, Resting Energy Expenditure and Physical Activity?	PLOS ONE			English	Article							NORTH-WEST PROVINCE; SAO-PAULO; BODY-COMPOSITION; METABOLIC-RATE; BIOELECTRICAL-IMPEDANCE; SEDENTARY BEHAVIOR; BIRTH-WEIGHT; OBESITY; SHANTYTOWNS; PREVALENCE	Background: Recent studies suggest that early modifications in metabolic pathways and behaviour, leading to energy conservation and reduced linear growth, could represent adaptations to nutritional constraints during foetal life and infancy. Impaired fat oxidation, low resting energy expenditure and reduced physical activity, resulting from these adaptations, could facilitate fat storage and development of overweight in growth-retarded children that consume more energy-dense food. This study aims at assessing whether: (1) dual-burden preschool children (simultaneously stunted and overweight) of Yaounde (Cameroon) have low birth-weight (indicator of foetal undernutrition) and reductions in fat oxidation, resting energy expenditure (REE) and physical activity, (2) fat oxidation, REE and physical activity are associated with foetal growth. Methodology/Principal Findings: 162 children (24-72 months) were considered: 22 stunted-overweight (SO), 40 stunted (S), 41 overweight (O), and 59 non stunted-non overweight (NSNO). Nutritional status and body composition were assessed using anthropometry and multifrequency bioimpedance analysis. Fasting respiratory quotient (RQ) and REE were measured by indirect calorimetry. Physical activity was determined using accelerometers, food questionnaires were used for diet assessment and birth-weight was noted. Mean RQs and REE (weight adjusted) did not differ between stunted children (SO and S) and non-stunted children (O and NSNO). SO and S children spent more time in sedentary activities than O children (p = 0.01 and p = 0.02, respectively) and less time in moderate-to-vigorous activities than NSNO children (p = 0.05 and p = 0.04, respectively). SO children's diet was less diverse (p = 0.01) with less animal products (p = 0.006). Multiple linear regressions model revealed that birth-weight is predictive of RQ (beta = 0.237, p < 0.01, R-2 = 0.08). Conclusions/Significance: This study showed that growth retardation in stunted-overweight children could be associated with postnatal nutritional deficiencies. Overweight in stunted children could be associated with reduced physical activity in the context of nutrition transition. High birth-weight was a predictor of reduced lipid oxidation, a risk factor of fat deposition.	[Said-Mohamed, Rihlat; Bernard, Jonathan Y.; Pasquet, Patrick] Paris Diderot Univ, Museum Natl Hist Nat, CNRS, UMR Ecoanthropol & Ethnobiol 7206, Paris, France; [Ndzana, Anne-Christine] Inst Med Res & Med Plant Studies, Ctr Food & Nutr Res, Yaounde, Cameroon	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Universite Paris Cite	Said-Mohamed, R (corresponding author), Paris Diderot Univ, Museum Natl Hist Nat, CNRS, UMR Ecoanthropol & Ethnobiol 7206, Paris, France.	rihlat@mnhn.fr	Bernard, Jonathan/T-7064-2017	Bernard, Jonathan/0000-0002-6418-983X; Patrick, Pasquet/0000-0002-7017-3068; SAID MOHAMED, Rihlat/0000-0003-1592-5412	French National Research Agency (ANR); Action Transversal du Museum national d'Histoire naturelle (ATM)	French National Research Agency (ANR)(French National Research Agency (ANR)); Action Transversal du Museum national d'Histoire naturelle (ATM)	This study was included in the project "Anthropologie nutritionnelle des migrants d'Afrique centrale a la ville et en France (ANTRAC)" and was funded by The French National Research Agency (ANR) and the Action Transversal du Museum national d'Histoire naturelle (ATM). Websites. ANR: http://www.agence-nationale-recherche.fr/en/about-us/project-based-funding-to-advance-research/; ATM: http://www.mnhn.fr/museum/foffice/science/science/Recherche/srubPlateformes/ssomPlateformes/fichePlateformes.xsp?ARTICLE_ARTICLE_ID = 21359&idx = 1&nav = liste. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen LG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008192; Arimond M., 2004, DIETARY DIVERSITY DI; Arnuna P, 2008, P NUTR SOC, V67, P82, DOI 10.1017/S0029665108006058; BARACNIETO M, 1978, AM J CLIN NUTR, V31, P23, DOI 10.1093/ajcn/31.1.23; Blond E., 2011, e-SPEN, the European e-Journal of Clinical Nutrition and Metabolism, V6, pe7, DOI 10.1016/j.eclnm.2010.12.001; Bouchard C, 2007, INT J OBESITY, V31, P1337, DOI 10.1038/sj.ijo.0803610; Bouville JF, 1993, CAHIERS SANTE, V3, P433; Cliff DP, 2009, J SCI MED SPORT, V12, P557, DOI 10.1016/j.jsams.2008.10.008; DEHGHAN M, 2008, NUTR J, V7, DOI DOI 10.1186/1475-2891-7-26; DEURENBERG P, 1995, BRIT J NUTR, V73, P349, DOI 10.1079/BJN19950038; EMANUEL I, 1993, ISSUES REV TERATOL, V6, P47; Fernald LC, 2007, EUR J CLIN NUTR, V61, P623, DOI 10.1038/sj.ejcn.1602558; Fezeu LK, 2008, OBESITY, V16, P1144, DOI 10.1038/oby.2008.44; Friedman SM, 2006, NUTR RES, V26, P345, DOI 10.1016/j.nutres.2006.06.018; Frisancho AR, 2003, AM J HUM BIOL, V15, P522, DOI 10.1002/ajhb.10191; Gardner DS, 2009, ADV EXP MED BIOL, V646, P83, DOI 10.1007/978-1-4020-9173-5_9; Gartner A, 2003, EUR J CLIN NUTR, V57, P1097, DOI 10.1038/sj.ejcn.1601649; Grillo LP, 2005, EUR J CLIN NUTR, V59, P835, DOI 10.1038/sj.ejcn.1602150; Hales CN, 2001, BRIT MED BULL, V60, P5, DOI 10.1093/bmb/60.1.5; Haroun D, 2005, INT J OBESITY, V29, P29, DOI 10.1038/sj.ijo.0802834; Hemachandra AH, 2006, AM J HUM BIOL, V18, P791, DOI 10.1002/ajhb.20552; Hoffman DJ, 2007, NUTRITION, V23, P640, DOI 10.1016/j.nut.2007.06.006; Hoffman DJ, 2000, AM J CLIN NUTR, V72, P1025; Hoffman DJ, 2000, J NUTR, V130, P2265, DOI 10.1093/jn/130.9.2265; Hoffman DJ, 2000, AM J CLIN NUTR, V72, P702; Jinabhai CC, 2003, EUR J CLIN NUTR, V57, P358, DOI 10.1038/sj.ejcn.1601534; Kennedy G., 2006, FAO Food and Nutrition Paper, P1; Kyle UG, 2004, CLIN NUTR, V23, P1430, DOI 10.1016/j.clnu.2004.09.012; Kyle UG, 2004, CLIN NUTR, V23, P1226, DOI 10.1016/j.clnu.2004.06.004; Lohman T. G., 1998, ANTROPOMETRIC STANDA; Mamabolo RL, 2007, PUBLIC HEALTH NUTR, V10, P1047, DOI 10.1017/S1368980007668724; Mamabolo RL, 2005, PUBLIC HEALTH NUTR, V8, P501, DOI 10.1079/PHN2005786; Matarese LE, 1997, J AM DIET ASSOC, V97, pS154, DOI 10.1016/S0002-8223(97)00754-2; Mitchell JA, 2009, OBESITY, V17, P1596, DOI 10.1038/oby.2009.42; Mukuddem-Petersen J, 2004, INT J OBESITY, V28, P842, DOI 10.1038/sj.ijo.0802586; Mvo Z, 1999, Curationis, V22, P27; Nielsen BM, 2007, DIABETES OBES METAB, V9, P521, DOI 10.1111/j.1463-1326.2006.00634.x; Oliver M, 2007, SPORTS MED, V37, P1045, DOI 10.2165/00007256-200737120-00004; Pasquet P, 2003, ANN HUM BIOL, V30, P551, DOI 10.1080/0301446032000112652; Pasquet P, 2001, B MEM SOC ANTHRO PAR, V13, P181; Popkin BM, 1996, J NUTR, V126, P3009, DOI 10.1093/jn/126.12.3009; Popkin BM, 2001, J NUTR, V131, p871S, DOI 10.1093/jn/131.3.871S; Puyau MR, 2002, OBES RES, V10, P150, DOI 10.1038/oby.2002.24; Reilly JJ, 2008, ARCH DIS CHILD, V93, P614, DOI 10.1136/adc.2007.133272; Rivera JA, 2003, J NUTR, V133, p4010S, DOI 10.1093/jn/133.11.4010S; Said-Mohamed R, 2009, ANN HUM BIOL, V36, P146, DOI 10.1080/03014460802660526; Savy M, 2005, PUBLIC HEALTH NUTR, V10, P71; SAWAYA AL, 1995, OBES RES, V3, pS107, DOI 10.1002/j.1550-8528.1995.tb00453.x; Sichieri R, 2000, INT J OBESITY, V24, P614, DOI 10.1038/sj.ijo.0801205; Varela-Silva MI, 2007, COLLEGIUM ANTROPOL, V31, P39; Varela-Silva MI, 2012, COLLEGIUM ANTROPOL, V36, P39; Wadsworth MEJ, 2002, INT J EPIDEMIOL, V31, P383, DOI 10.1093/ije/31.2.383; Walker SP, 2002, PUBLIC HEALTH NUTR, V5, P391, DOI 10.1079/PHN2002275; WEIR JBD, 1990, NUTRITION, V6, P213; Wells JCK, 2007, P NUTR SOC, V66, P423, DOI 10.1017/S0029665107005691; Wren RE, 1997, AM J CLIN NUTR, V66, P406, DOI 10.1093/ajcn/66.2.406; Zhang X, 2009, PREV MED, V49, P172, DOI 10.1016/j.ypmed.2009.07.013	57	33	33	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2012	7	6							e39007	10.1371/journal.pone.0039007	http://dx.doi.org/10.1371/journal.pone.0039007			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TU	22701741	Green Published, gold, Green Submitted			2022-12-27	WOS:000305337600065
J	Claros, CS; Tramontano, A				Claros, Carmen Sanchez; Tramontano, Anna			Detecting Mutually Exclusive Interactions in Protein-Protein Interaction Maps	PLOS ONE			English	Article							DATABASE; RESOURCE; EVOLUTIONARY; SIMILARITIES; ANNOTATION; UNIPROT; SERVER	Comprehensive protein interaction maps can complement genetic and biochemical experiments and allow the formulation of new hypotheses to be tested in the system of interest. The computational analysis of the maps may help to focus on interesting cases and thereby to appropriately prioritize the validation experiments. We show here that, by automatically comparing and analyzing structurally similar regions of proteins of known structure interacting with a common partner, it is possible to identify mutually exclusive interactions present in the maps with a sensitivity of 70% and a specificity higher than 85% and that, in about three fourth of the correctly identified complexes, we also correctly recognize at least one residue (five on average) belonging to the interaction interface. Given the present and continuously increasing number of proteins of known structure, the requirement of the knowledge of the structure of the interacting proteins does not substantially impact on the coverage of our strategy that can be estimated to be around 25%. We also introduce here the Estrella server that embodies this strategy, is designed for users interested in validating specific hypotheses about the functional role of a protein-protein interaction and it also allows access to pre-computed data for seven organisms.	[Claros, Carmen Sanchez; Tramontano, Anna] Univ Roma La Sapienza, Dept Phys, I-00185 Rome, Italy; [Tramontano, Anna] Inst Pasteur Fdn Cenci Bolognetti, Rome, Italy; [Tramontano, Anna] Ist Italiano Tecnol, Ctr Life Nano Sci Sapienza, Rome, Italy	Sapienza University Rome; Fondazione Cenci Bolognetti; Istituto Italiano di Tecnologia - IIT	Claros, CS (corresponding author), Univ Roma La Sapienza, Dept Phys, I-00185 Rome, Italy.	Anna.tramontano@uniroma1.it	Tramontano, anna/D-5378-2009	Tramontano, anna/0000-0002-5610-3338	King Abdullah University of Science and Technology (KAUST) [KUK-I1-012-43]	King Abdullah University of Science and Technology (KAUST)(King Abdullah University of Science & Technology)	Award number KUK-I1-012-43 made by King Abdullah University of Science and Technology (KAUST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfarano C, 2005, NUCLEIC ACIDS RES, V33, pD418, DOI 10.1093/nar/gki051; Aloy P, 2006, NAT REV MOL CELL BIO, V7, P188, DOI 10.1038/nrm1859; Andreeva A, 2008, NUCLEIC ACIDS RES, V36, pD419, DOI 10.1093/nar/gkm993; Ausiello G, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S2-S2; Bairoch A, 2005, NUCLEIC ACIDS RES, V33, pD154, DOI 10.1093/nar/gki070; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Berman H, 2007, NUCLEIC ACIDS RES, V35, pD301, DOI 10.1093/nar/gkl971; Brown KR, 2005, BIOINFORMATICS, V21, P2076, DOI 10.1093/bioinformatics/bti273; Camon E, 2004, NUCLEIC ACIDS RES, V32, pD262, DOI 10.1093/nar/gkh021; Chatr-Aryamontri A, 2007, NUCLEIC ACIDS RES, V35, pD572, DOI 10.1093/nar/gkl950; Dayhoff M. O., 1978, ATLAS PROTEIN SEQ S3, P345; Guldener U, 2006, NUCLEIC ACIDS RES, V34, pD436, DOI 10.1093/nar/gkj003; Henikoff S, 2000, ADV PROTEIN CHEM, V54, P73, DOI 10.1016/S0065-3233(00)54003-0; Hermjakob H, 2004, NUCLEIC ACIDS RES, V32, pD452, DOI 10.1093/nar/gkh052; Herraez A, 2006, BIOCHEM MOL BIOL EDU, V34, P255, DOI 10.1002/bmb.2006.494034042644; Keskin O, 2007, STRUCTURE, V15, P341, DOI 10.1016/j.str.2007.01.007; Kim PM, 2006, SCIENCE, V314, P1938, DOI 10.1126/science.1136174; Marcatili P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S2-S11; Mihel J, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-21; Mishra GR, 2006, NUCLEIC ACIDS RES, V34, pD411, DOI 10.1093/nar/gkj141; Moult K, 2011, PROTEIN-STRUCT FUNCT, V79, P1; Orengo CA, 2002, PROTEOMICS, V2, P11; Pagel P, 2005, BIOINFORMATICS, V21, P832, DOI 10.1093/bioinformatics/bti115; Razick S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-405; Ruepp A, 2010, NUCLEIC ACIDS RES, V38, pD497, DOI 10.1093/nar/gkp914; Salwinski L, 2004, NUCLEIC ACIDS RES, V32, pD449, DOI 10.1093/nar/gkh086; Shoemaker BA, 2007, PLOS COMPUT BIOL, V3, P595, DOI 10.1371/journal.pcbi.0030043; Stark C, 2011, NUCLEIC ACIDS RES, V39, pD698, DOI 10.1093/nar/gkq1116; Tuncbag N, 2011, NAT PROTOC, V6, P1341, DOI 10.1038/nprot.2011.367; Tuncbag N, 2009, MOL BIOSYST, V5, P1770, DOI [10.1039/b905661k, 10.1039/B905661K]; von Eichborn J, 2011, BIOINFORMATICS, V27, P1725, DOI 10.1093/bioinformatics/btr195; Wang GL, 2005, NUCLEIC ACIDS RES, V33, pW94, DOI 10.1093/nar/gki402; Wu CH, 2006, NUCLEIC ACIDS RES, V34, pD187, DOI 10.1093/nar/gkj161; Zemla A, 2003, NUCLEIC ACIDS RES, V31, P3370, DOI 10.1093/nar/gkg571; Zhang AD, 2009, PROTEIN INTERACTION NETWORKS: COMPUTATIONAL ANALYSIS, pXIII, DOI 10.1017/CBO9780511626593.001	35	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2012	7	6							e38765	10.1371/journal.pone.0038765	http://dx.doi.org/10.1371/journal.pone.0038765			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TQ	22715412	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336800054
J	Zhao, D; Zhang, X; Cui, DZ; Zhao, M				Zhao, Dan; Zhang, Xi; Cui, Daizong; Zhao, Min			Characterisation of a Novel White Laccase from the Deuteromycete Fungus Myrothecium verrucaria NF-05 and Its Decolourisation of Dyes	PLOS ONE			English	Article							BILIRUBIN OXIDASE; PURIFICATION; EXPRESSION; MUTANTS	A novel 'white' laccase was purified from the deuteromycete fungus, Myrothecium verrucaria NF-05, which was a high laccase-producing strain (40.2 U.ml(-1) on the thirteenth day during fermentation). SDS-PAGE and native-PAGE revealed a single band with laccase activity corresponding to a molecular weight of approximately 66 kDa. The enzyme had three copper and one iron atoms per protein molecule determined by ICP-AES. Furthermore, both UV/visible and EPR spectroscopy remained silence, indicating the enzyme a novel laccase with new metal compositions of active centre and spectral properties. The N-terminal amino acid sequence of the purified protein was APQISPQYPM. Together with MALDI-TOF analysis, the protein revealed a high homology of the protein with that from reported M. verrucaria. The highest activity was detected at pH 4.0 and at 30 degrees C. The enzyme activity was significantly enhanced by Na+, Mn2+, Cu2+ and Zn2+ while inhibited by DTT, NaN3 and halogen anions. The kinetic constant (Km) showed the enzyme was more affinitive to ABTS than other tested aromatic substrates. Twelve structurally different dyes could be effectively decolourised by the laccase within 10 min. The high production of the strain and novel properties of the laccase suggested its potential for biotechnological applications.	[Zhao, Dan; Zhang, Xi; Cui, Daizong; Zhao, Min] NE Forestry Univ, Life Sci Coll, Dept Microbiol, Harbin, Peoples R China; [Zhao, Dan] Heilongjiang Univ, Coll Life Sci, Microbiol Lab, Harbin, Peoples R China	Northeast Forestry University - China; Heilongjiang University	Zhao, D (corresponding author), NE Forestry Univ, Life Sci Coll, Dept Microbiol, Harbin, Peoples R China.	82191513@163.com	Zhao, Min/AAZ-9513-2021	Zhao, Min/0000-0001-9751-454X	National Nature Science Foundation of China [31170553, 30671702, 30170775]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the the National Nature Science Foundation of China (No. 31170553, 30671702, 30170775). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldrian P, 2006, FEMS MICROBIOL REV, V30, P215, DOI 10.1111/j.1574-4976.2005.00010.x; Bendl RF, 2008, ENZYME MICROB TECH, V43, P149, DOI 10.1016/j.enzmictec.2007.11.010; Chakroun H, 2010, PROCESS BIOCHEM, V45, P507, DOI 10.1016/j.procbio.2009.11.009; Couto SR, 2006, BIOTECHNOL ADV, V24, P500, DOI 10.1016/j.biotechadv.2006.04.003; Das N, 1997, APPL ENVIRON MICROB, V63, P4120, DOI 10.1128/AEM.63.10.4120-4122.1997; Halaburgi VM, 2011, PROCESS BIOCHEM, V46, P1146, DOI 10.1016/j.procbio.2011.02.002; Hao JJ, 2007, J IND MICROBIOL BIOT, V34, P233, DOI 10.1007/s10295-006-0191-3; KOIKEDA S, 1993, J BIOL CHEM, V268, P18801; LaFayette PR, 1999, PLANT MOL BIOL, V40, P23, DOI 10.1023/A:1026437406859; Liu ZY, 2010, BIOPROC BIOSYST ENG, V33, P639, DOI 10.1007/s00449-009-0389-7; Liu ZY, 2009, J IND MICROBIOL BIOT, V36, P1315, DOI 10.1007/s10295-009-0615-y; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Miele A, 2010, J APPL MICROBIOL, V108, P998, DOI 10.1111/j.1365-2672.2009.04505.x; Min KL, 2001, ARCH BIOCHEM BIOPHYS, V392, P279, DOI 10.1006/abbi.2001.2459; Minussi RC, 2007, AFR J BIOTECHNOL, V6, P1248; Morozova V, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1136, DOI 10.1134/S0006297907100112; Palmieri G, 1997, J BIOL CHEM, V272, P31301, DOI 10.1074/jbc.272.50.31301; Patrick F., 2009, African Journal of Biochemistry Research, V3, P250; Pozdniakova N N, 2006, Prikl Biokhim Mikrobiol, V42, P63; Sadhasivam S, 2008, PROCESS BIOCHEM, V43, P736, DOI 10.1016/j.procbio.2008.02.017; Sharma P, 2007, WORLD J MICROB BIOT, V23, P823, DOI 10.1007/s11274-006-9305-3; Shimizu A, 1999, BIOCHEMISTRY-US, V38, P3034, DOI 10.1021/bi9819531; Solomon EI, 1996, CHEM REV, V96, P2563, DOI 10.1021/cr950046o; Sulistyaningdyah WT, 2004, FEMS MICROBIOL LETT, V230, P209, DOI 10.1016/S0378-1097(03)00892-9; Valls C, 2010, BIOCHEM ENG J, V49, P401, DOI 10.1016/j.bej.2010.02.002; Wang HT, 2006, ASIAN AUSTRAL J ANIM, V19, P1164, DOI 10.5713/ajas.2006.1164; Wu YR, 2010, BIORESOURCE TECHNOL, V101, P9772, DOI 10.1016/j.biortech.2010.07.091; Zhang GQ, 2010, PROCESS BIOCHEM, V45, P627, DOI 10.1016/j.procbio.2009.12.010; Zhao Min, 2011, Mycosystema, V30, P604	29	58	64	4	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2012	7	6							e38817	10.1371/journal.pone.0038817	http://dx.doi.org/10.1371/journal.pone.0038817			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TQ	22715414	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336800056
J	Sharma, N; Castorena, CM; Cartee, GD				Sharma, Naveen; Castorena, Carlos M.; Cartee, Gregory D.			Tissue-Specific Responses of IGF-1/Insulin and mTOR Signaling in Calorie Restricted Rats	PLOS ONE			English	Article							SYNTHASE KINASE-3 ISOFORMS; SKELETAL-MUSCLE; GLYCOGEN-SYNTHASE; GLUCOSE-UPTAKE; INSULIN ACTION; LIFE-SPAN; INCREASES; LONGEVITY; PHOSPHORYLATION; TOR	Moderate calorie restriction (CR) (similar to 60% of ad libitum, AL, intake) has been associated with numerous favorable physiological outcomes in many species, and the insulin/IGF-1 and mTOR signaling pathways have each been proposed as potential mediators for many of CR's bioeffects. However, few studies have assessed the widely held idea that CR induces the down-regulation of the insulin/IGF-1 and/or mTOR pathways in multiple tissues. Accordingly, we analyzed the phosphorylation status of 11 key signaling proteins from the insulin/IGF-1 (IRTyr1162/1163, IGF-1R(Tyr1135/1136), IRS-1(Ser312), PTENSer380, Akt(Ser473), GSK3 alpha(Ser21), GSK3 beta(Ser9)) and mTOR (TSC2(Ser939), mTOR(Ser2448), P70S6K(Thr412), RPS6(Ser235/236)) pathways in 11 diverse tissues [liver, kidney, lung, aorta, two brain regions (cortex and cerebellum), and two slow-twitch and three fast-twitch skeletal muscles] from 9-month-old male AL and CR Fischer 344 x Brown Norway rats. The rats were studied under two conditions: with endogenous insulin levels (i.e., AL>CR) and with insulin infused during a hyperinsulinemic-euglycemic clamp so that plasma insulin concentrations were matched between the two diet groups. The most striking and consistent effect of CR was greater pAkt in 3 of the 5 skeletal muscles of CR vs. AL rats. There were no significant CR effects on the mTOR signaling pathway and no evidence that CR caused a general attenuation of mTOR signaling across the tissues studied. Rather than supporting the premise of a global downregulation of insulin/IGF-1 and/or mTOR signaling in many tissues, the current results revealed clear tissue-specific CR effects for the insulin signaling pathway without CR effects on the mTOR signaling pathway.	[Sharma, Naveen; Castorena, Carlos M.; Cartee, Gregory D.] Univ Michigan, Sch Kinesiol, Muscle Biol Lab, Ann Arbor, MI 48109 USA; [Cartee, Gregory D.] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Cartee, Gregory D.] Univ Michigan, Inst Gerontol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Sharma, N (corresponding author), Univ Michigan, Sch Kinesiol, Muscle Biol Lab, Ann Arbor, MI 48109 USA.	gcartee@umich.edu	Sharma, Naveen/K-6672-2015	Sharma, Naveen/0000-0003-4705-5116; Cartee, Gregory/0000-0001-5311-1722	National Institute on Aging Grants [AG-010026, AG-013283]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008322] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R29AG010026, P30AG013283, R01AG010026] Funding Source: NIH RePORTER	National Institute on Aging Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by National Institute on Aging Grants AG-010026 and AG-013283. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argentino DP, 2005, EXP GERONTOL, V40, P27, DOI 10.1016/j.exger.2004.09.005; Bjedov I, 2011, BIOCHEM SOC T, V39, P460, DOI 10.1042/BST0390460; Blagosklonny MV, 2010, CELL CYCLE, V9, P683, DOI 10.4161/cc.9.4.10766; Bonkowski MS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004567; Cox LS, 2009, AGING CELL, V8, P607, DOI 10.1111/j.1474-9726.2009.00509.x; Davidson RT, 2002, AM J PHYSIOL-ENDOC M, V282, pE270, DOI 10.1152/ajpendo.00232.2001; Dazert E, 2011, CURR OPIN CELL BIOL, V23, P744, DOI 10.1016/j.ceb.2011.09.003; Dean DJ, 1998, AM J PHYSIOL-ENDOC M, V275, pE957, DOI 10.1152/ajpendo.1998.275.6.E957; Dean DJ, 2000, ACTA PHYSIOL SCAND, V169, P133, DOI 10.1046/j.1365-201x.2000.00723.x; Feuers RJ, 1995, DIETARY RESTRICTION, P181; Gazdag AC, 1999, DIABETES, V48, P1930, DOI 10.2337/diabetes.48.10.1930; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Hasty P, 2010, J MOL CELL BIOL, V2, P17, DOI 10.1093/jmcb/mjp033; Hay N, 2011, BBA-MOL CELL RES, V1813, P1965, DOI 10.1016/j.bbamcr.2011.03.013; Kaeberlein M, 2009, NATURE, V460, P331, DOI 10.1038/460331a; Kapahi P, 2010, CELL METAB, V11, P453, DOI 10.1016/j.cmet.2010.05.001; Katewa SD, 2010, AGING CELL, V9, P105, DOI 10.1111/j.1474-9726.2010.00552.x; Katic M, 2005, CELL MOL LIFE SCI, V62, P320, DOI 10.1007/s00018-004-4297-y; Liang MH, 2007, J BIOL CHEM, V282, P3904, DOI 10.1074/jbc.M605178200; Liang MH, 2006, J BIOL CHEM, V281, P30479, DOI 10.1074/jbc.M607468200; Markou T, 2008, CELL SIGNAL, V20, P206, DOI 10.1016/j.cellsig.2007.10.004; Masoro EJ, 2005, MECH AGEING DEV; McCormick MA, 2011, PHILOS T R SOC B, V366, P17, DOI 10.1098/rstb.2010.0198; McCurdy CE, 2005, DIABETES, V54, P1349, DOI 10.2337/diabetes.54.5.1349; McCurdy CE, 2005, AM J PHYSIOL-ENDOC M, V288, pE996, DOI 10.1152/ajpendo.00566.2004; McCurdy CE, 2003, AM J PHYSIOL-ENDOC M, V285, pE693, DOI 10.1152/ajpendo.00224.2003; McManus EJ, 2005, EMBO J, V24, P1571, DOI 10.1038/sj.emboj.7600633; Mora A, 2005, FEBS LETT, V579, P3632, DOI 10.1016/j.febslet.2005.05.040; Richardson A, 2004, BEST PRACT RES CL EN, V18, P393, DOI 10.1016/j.beem.2004.02.002; Sharma N, 2011, AM J PHYSIOL-ENDOC M, V300, pE966, DOI 10.1152/ajpendo.00659.2010; Sharp ZD, 2010, J GERONTOL A-BIOL, V65, P580, DOI 10.1093/gerona/glp212; Soutar MPM, 2010, J NEUROCHEM, V115, P974, DOI 10.1111/j.1471-4159.2010.06988.x; Speakman JR, 2011, MOL ASPECTS MED, V32, P159, DOI 10.1016/j.mam.2011.07.001; Stanfel MN, 2009, BBA-GEN SUBJECTS, V1790, P1067, DOI 10.1016/j.bbagen.2009.06.007; Turturro A, 1999, J GERONTOL A-BIOL, V54, pB492, DOI 10.1093/gerona/54.11.B492; Wanagat J, 1999, TOXICOL SCI, V52, P35; Wang ZQ, 2009, DIABETES, V58, P1488, DOI 10.2337/db08-0977; Weindruch R, 1996, SCI AM, V274, P46, DOI 10.1038/scientificamerican0196-46; Wetter TJ, 1999, AM J PHYSIOL-ENDOC M, V276, pE728; Zheng YB, 2009, J ENDOCRINOL, V203, P337, DOI 10.1677/JOE-09-0181; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	41	35	36	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e38835	10.1371/journal.pone.0038835	http://dx.doi.org/10.1371/journal.pone.0038835			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701721	Green Published, gold, Green Submitted			2022-12-27	WOS:000305348400096
J	Toseland, CP; Powell, B; Webb, MR				Toseland, Christopher P.; Powell, Ben; Webb, Martin R.			ATPase Cycle and DNA Unwinding Kinetics of RecG Helicase	PLOS ONE			English	Article							SINGLE-STRANDED-DNA; STALLED REPLICATION FORKS; PCRA HELICASE; ESCHERICHIA-COLI; INORGANIC-PHOSPHATE; PLASMID REPLICATION; CRYSTAL-STRUCTURES; INITIATOR PROTEIN; OXYGEN-EXCHANGE; MECHANISM	The superfamily 2 bacterial helicase, RecG, is a monomeric enzyme with a role in DNA repair by reversing stalled replication forks. The helicase must act specifically and rapidly to prevent replication fork collapse. We have shown that RecG binds tightly and rapidly to four-strand oligonucleotide junctions, which mimic a stalled replication fork. The helicase unwinds such DNA junctions with a step-size of approximately four bases per ATP hydrolyzed. To gain an insight into this mechanism, we used fluorescent stopped-flow and quenched-flow to measure individual steps within the ATPase cycle of RecG, when bound to a DNA junction. The fluorescent ATP analogue, mantATP, was used throughout to determine the rate limiting steps, effects due to DNA and the main states in the cycle. Measurements, when possible, were also performed with unlabeled ATP to confirm the mechanism. The data show that the chemical step of hydrolysis is the rate limiting step in the cycle and that this step is greatly accelerated by bound DNA. The ADP release rate is similar to the cleavage rate, so that bound ATP and ADP would be the main states during the ATP cycle. Evidence is provided that the main structural rearrangements, which bring about DNA unwinding, are linked to these states.	[Toseland, Christopher P.; Powell, Ben; Webb, Martin R.] MRC Natl Inst Med Res, London, England	MRC National Institute for Medical Research	Toseland, CP (corresponding author), Univ Munich, Inst Zellulare Physiol, Munich, Germany.	mwebb@nimr.mrc.ac.uk	Toseland, Chris/AAC-8517-2019	Toseland, Chris/0000-0002-1641-7535; Webb, Martin/0000-0002-0134-9621	Medical Research Council, United Kingdom [U117512742]; Medical Research Council [MC_U117512742] Funding Source: researchfish; MRC [MC_U117512742] Funding Source: UKRI	Medical Research Council, United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council, United Kingdom (ref. U117512742. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennett RJ, 2004, CRIT REV BIOCHEM MOL, V39, P79, DOI 10.1080/10409230490460756; Brune M, 1998, BIOCHEMISTRY-US, V37, P10370, DOI 10.1021/bi9804277; BRUNE M, 1994, BIOCHEMISTRY-US, V33, P8262, DOI 10.1021/bi00193a013; Cordin O, 2006, GENE, V367, P17, DOI 10.1016/j.gene.2005.10.019; Cox MM, 2000, NATURE, V404, P37, DOI 10.1038/35003501; Dillingham MS, 2000, BIOCHEMISTRY-US, V39, P205, DOI 10.1021/bi992105o; Dillingham MS, 2002, BIOCHEMISTRY-US, V41, P643, DOI 10.1021/bi011137k; Dillingham MS, 2001, P NATL ACAD SCI USA, V98, P8381, DOI 10.1073/pnas.131009598; ECCLESTON JF, 1991, BIOCHEM SOC T, V19, P432, DOI 10.1042/bst0190432; Flaus A, 2004, CURR OPIN GENET DEV, V14, P165, DOI 10.1016/j.gde.2004.01.007; Flaus A, 2006, NUCLEIC ACIDS RES, V34, P2887, DOI 10.1093/nar/gkl295; Forgacs E, 2006, BIOCHEMISTRY-US, V45, P13035, DOI 10.1021/bi060712n; Henn A, 2008, J MOL BIOL, V377, P193, DOI 10.1016/j.jmb.2007.12.046; Henn A, 2010, P NATL ACAD SCI USA, V107, P4046, DOI 10.1073/pnas.0913081107; HIBBERD MG, 1985, J BIOL CHEM, V260, P3496; HIRATSUKA T, 1983, BIOCHIM BIOPHYS ACTA, V742, P496, DOI 10.1016/0167-4838(83)90267-4; Hsieh J, 1999, J MOL BIOL, V288, P255, DOI 10.1006/jmbi.1999.2666; Jameson DM, 1997, METHOD ENZYMOL, V278, P363; Johnson KA, 2009, ANAL BIOCHEM, V387, P20, DOI 10.1016/j.ab.2008.12.024; Korolev S, 1997, CELL, V90, P635, DOI 10.1016/S0092-8674(00)80525-5; Leatherbarrow R J, 2007, GRAFIT VERSION 6; Lee JY, 2006, CELL, V127, P1349, DOI 10.1016/j.cell.2006.10.049; Mahdi AA, 2003, EMBO J, V22, P724, DOI 10.1093/emboj/cdg043; Martinez-Senac MM, 2005, BIOCHEMISTRY-US, V44, P16967, DOI 10.1021/bi0512851; McGlynn P, 2000, NUCLEIC ACIDS RES, V28, P2324, DOI 10.1093/nar/28.12.2324; McGlynn P, 2001, P NATL ACAD SCI USA, V98, P8235, DOI 10.1073/pnas.121007798; MOORE KJM, 1994, BIOCHEMISTRY-US, V33, P14565, DOI 10.1021/bi00252a024; Niedziela-Majka A, 2007, J BIOL CHEM, V282, P27076, DOI 10.1074/jbc.M704399200; Nixon AE, 1998, ANAL BIOCHEM, V265, P299, DOI 10.1006/abio.1998.2916; Phillips RA, 2003, BIOCHEMISTRY-US, V42, P3956, DOI 10.1021/bi027316z; Singleton MR, 2001, CELL, V107, P79, DOI 10.1016/S0092-8674(01)00501-3; Slatter AF, 2009, BIOCHEMISTRY-US, V48, P6326, DOI 10.1021/bi900101h; Soultanas P, 1999, NUCLEIC ACIDS RES, V27, P1421, DOI 10.1093/nar/27.6.1421; Soultanas P, 1999, J MOL BIOL, V290, P137, DOI 10.1006/jmbi.1999.2873; Toseland CP, 2011, METHODS MOL BIOL, V778, P161, DOI 10.1007/978-1-61779-261-8_11; Toseland CP, 2010, METHODS, V51, P259, DOI 10.1016/j.ymeth.2010.02.012; Toseland CP, 2009, J MOL BIOL, V392, P1020, DOI 10.1016/j.jmb.2009.07.071; Velankar SS, 1999, CELL, V97, P75, DOI 10.1016/S0092-8674(00)80716-3; Webb Martin R., 2003, P131; WEBB MR, 1981, J BIOL CHEM, V256, P910	40	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e38270	10.1371/journal.pone.0038270	http://dx.doi.org/10.1371/journal.pone.0038270			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701618	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000305348400043
J	Xu, PJ; Xu, J; Li, ZG; Yang, Z				Xu, Pengjuan; Xu, Jing; Li, Zhigui; Yang, Zhuo			Expression of TRPC6 in Renal Cortex and Hippocampus of Mouse during Postnatal Development	PLOS ONE			English	Article							CA2+ ENTRY; GLOMERULAR PROTEIN; CHANNELS; LOCALIZATION; ACTIVATION; MUTATION; DISEASE; GROWTH; CELLS; SLIT	TRPC6, a member of the TRPC family, attracts much attention from the public because of its relationship with the disease. In both the brain and kidney, TRPC6 serves a variety of functions. The aim of the present study was to observe the expression and effects of TRPC6 in renal cortex and hippocampus during early postnatal development of the mouse. In the present study, immunohistochemistry and Western blotting were used to detect the expression of TRPC6 in the mouse kidney and hippocampus of postnatal day 1, 3, 5, 7, 14, 21, 28 and 49 (P1, P3, P5, P7, P14, P21, P28 and P49). Results showed that the expression of TRPC6 was increased in the mouse hippocampus, and there was a significant increase between P7 and P14 during the postnatal development. Meanwhile, the expression of TRPC6 was also detected in glomerulus and tubules, and a decreased expression was found during postnatal maturation of mouse renal cortex. From these in vivo experiments, we concluded that the expression of TRPC6 was active in the developing mouse kidney cortex, and followed a loss of expression with the development of kidney. Meanwhile, an increased expression was found in the hippocampus with the development. Together, these data suggested that the developmental changes in TRPC6 expression might be required for proper postnatal kidney cortex development, and played a critical role in the hippocampus during development, which formed the basis for understanding the nephrogenesis and neurogenesis in mice and provided a practically useful knowledge to the clinical and related research.	[Xu, Pengjuan; Xu, Jing; Li, Zhigui; Yang, Zhuo] Nankai Univ, Coll Med, Tianjin 300071, Peoples R China	Nankai University	Xu, PJ (corresponding author), Nankai Univ, Coll Med, Tianjin 300071, Peoples R China.	zhuoyang@nankai.edu.cn	Jingjun, Xu/A-1282-2010; Li, Zhigui/I-9108-2019; xu, jing/GRR-8698-2022	Li, Zhigui/0000-0003-1317-8679; 	National Basic Research Program of China [2011CB944003]	National Basic Research Program of China(National Basic Research Program of China)	This work was supported by a grant from the National Basic Research Program of China (2011CB944003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boute N, 2000, NAT GENET, V24, P349, DOI 10.1038/74166; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Giampa C, 2007, NEUROSCI LETT, V424, P170, DOI 10.1016/j.neulet.2007.07.049; Goel M, 2006, AM J PHYSIOL-RENAL, V290, pF1241, DOI 10.1152/ajprenal.00376.2005; Hardie RC, 2003, ANNU REV PHYSIOL, V65, P735, DOI 10.1146/annurev.physiol.65.092101.142505; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Huang WC, 2007, CELL CALCIUM, V42, P1, DOI 10.1016/j.ceca.2006.11.002; Inoue R, 2001, CIRC RES, V88, P325, DOI 10.1161/01.RES.88.3.325; Jia YC, 2007, NAT NEUROSCI, V10, P559, DOI 10.1038/nn1870; Jordt S. E., 2007, V45, P253; Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X; Kim EY, 2009, MOL PHARMACOL, V75, P466, DOI 10.1124/mol.108.051912; Kim JM, 2003, SCIENCE, V300, P1298, DOI 10.1126/science.1081068; Krall P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012859; Kunert-Keil C, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-159; Kuure S, 2000, MECH DEVELOP, V92, P31, DOI 10.1016/S0925-4773(99)00323-8; Li HS, 1999, NEURON, V24, P261, DOI 10.1016/S0896-6273(00)80838-7; Li Y, 2005, NATURE, V434, P894, DOI 10.1038/nature03477; Moeller CC, 2007, J AM SOC NEPHROL, V18, P29, DOI 10.1681/ASN.2006091010; Montell C, 2002, CELL, V108, P595, DOI 10.1016/S0092-8674(02)00670-0; Montell Craig, 2005, Sci STKE, V2005, pre3, DOI 10.1126/stke.2722005re3; Mukerji N, 2007, BBA-MOL BASIS DIS, V1772, P859, DOI 10.1016/j.bbadis.2007.03.005; Nicotera P, 2003, CELL, V115, P768, DOI 10.1016/S0092-8674(03)01019-5; Nilius B., 2004, NOVART FDN SYMP, V258, P149; Nilius B, 2004, NOVARTIS FDN S, V258, P263; Nilius Bernd, 2004, Novartis Found Symp, V258, P140; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Pedersen SF, 2005, CELL CALCIUM, V38, P233, DOI 10.1016/j.ceca.2005.06.028; Reiser J, 2005, NAT GENET, V37, P739, DOI 10.1038/ng1592; Riedel G, 2003, BEHAV BRAIN RES, V140, P1, DOI 10.1016/S0166-4328(02)00272-3; Schlndorff JS, 2006, SEMIN CELL DEV BIOL, V17, P667, DOI 10.1016/j.semcdb.2006.11.003; Schmitz C, 2003, CELL, V114, P191, DOI 10.1016/S0092-8674(03)00556-7; SOROKIN L, 1992, KIDNEY INT, V41, P657, DOI 10.1038/ki.1992.101; Sweeney M, 2002, AM J PHYSIOL-LUNG C, V283, pL144, DOI 10.1152/ajplung.00412.2001; Tai YL, 2008, J CELL SCI, V121, P2301, DOI 10.1242/jcs.026906; Tiruppathi C, 2002, CIRC RES, V91, P70, DOI 10.1161/01.RES.0000023391.40106.A8; Walz G, 2005, NEPHROL DIAL TRANSPL, V20, P1777, DOI 10.1093/ndt/gfh961; Winn MP, 2005, SCIENCE, V308, P1801, DOI 10.1126/science.1106215; Yu Y, 2004, P NATL ACAD SCI USA, V101, P13861, DOI 10.1073/pnas.0405908101; Zhang YF, 2003, CELL, V112, P293, DOI 10.1016/S0092-8674(03)00071-0; Zhou J, 2008, NAT NEUROSCI, V11, P741, DOI 10.1038/nn.2127; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011	42	11	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e38503	10.1371/journal.pone.0038503	http://dx.doi.org/10.1371/journal.pone.0038503			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701654	gold, Green Published, Green Submitted			2022-12-27	WOS:000305348400065
J	Zhao, CJ; Liu, YM; Zhao, MZ; Liu, YL; Yu, Y; Chen, HB; Sun, QN; Chen, HW; Jiang, W; Liu, YD; Han, SM; Xu, YC; Chen, MJ; Cao, B; Wang, H				Zhao, Chunjiang; Liu, Yingmei; Zhao, Mingze; Liu, Yali; Yu, Yong; Chen, Hongbin; Sun, Qiuning; Chen, Huawei; Jiang, Wei; Liu, Yudong; Han, Shaomei; Xu, Yingchun; Chen, Minjun; Cao, Bin; Wang, Hui			Characterization of Community Acquired Staphylococcus aureus Associated with Skin and Soft Tissue Infection in Beijing: High Prevalence of PVL+ ST398	PLOS ONE			English	Article							CASSETTE CHROMOSOME MEC; METHICILLIN-RESISTANT; CLONES; DISEASE; GENOME; GENES	Adult community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) and methicillin-susceptible S aureus (CA-MSSA) skin and soft tissue infection (SSTI) in China is not well described. A prospective cohort of adults with SSTI was established between January 2009 and August 2010 at 4 hospitals in Beijing. Susceptibility testing and molecular typing, including multilocus sequence typing, spa, agr typing, and toxin detection were assessed for all S. aureus isolates. Overall, 501 SSTI patients were enrolled. Cutaneous abscess (40.7%) was the most common infection, followed by impetigo (6.8%) and cellulitis (4.8%). S. aureus accounted for 32.7% (164/501) of SSTIs. Five isolates (5/164, 3.0%) were CA-MRSA. The most dominant ST in CA-MSSA was ST398 (17.6%). The prevalence of Panton-Valentine Leukocidin (pvl) gene was 41.5% (66/159) in MSSA. Female, younger patients and infections requiring incision or drainage were more commonly associated with pvl-positive S. aureus (P<0.03); sec gene was more often identified in CC5 (P<0.03); seh gene was more prevalent in CC1 (P = 0.001). Importantly, ST59 isolates showed more resistance to erythromycin, clindamycin and tetracycline, and needed more surgical intervention. In conclusion, CA-MRSA infections were rare among adult SSTI patients in Beijing. Six major MSSA clones were identified and associated with unique antimicrobial susceptibility, toxin profiles, and agr types. A high prevalence of livestock ST398 clone (17.1% of all S. aureus infections) was found with no apparent association to animal contact.	[Zhao, Chunjiang; Han, Shaomei; Wang, Hui] Peking Univ, Dept Clin Lab, Peking Univ Peoples Hosp, Beijing 100871, Peoples R China; [Zhao, Chunjiang; Liu, Yali; Chen, Hongbin; Sun, Qiuning; Xu, Yingchun; Chen, Minjun; Wang, Hui] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Beijing 100730, Peoples R China; [Liu, Yingmei; Cao, Bin] Capital Med Univ, Dept Infect Dis & Clin Microbiol, Beijing Chao Yang Hosp, Beijing, Peoples R China; [Zhao, Mingze; Chen, Huawei] Beijing Pinggu Hosp, Dept Clin Lab, Beijing, Peoples R China; [Yu, Yong; Jiang, Wei] Peoples Liberat Army Gen Hosp, Dept Clin Lab, Hosp 1, Beijing, Peoples R China; [Liu, Yudong] Univ Alabama Birmingham, Birmingham, AL USA	Peking University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Capital Medical University; Chinese People's Liberation Army General Hospital; University of Alabama System; University of Alabama Birmingham	Zhao, CJ (corresponding author), Peking Univ, Dept Clin Lab, Peking Univ Peoples Hosp, Beijing 100871, Peoples R China.	caobin1999@gmail.com; whuibj@gmail.com	LIU, YUDONG/FZY-8468-2022; Sun, Qiuning/AAJ-3692-2021	LIU, YUDONG/0000-0002-5153-3400; Sun, Qiuning/0000-0002-1912-341X; Wang, Hui/0000-0001-9220-0357	Beijing Medical Scientific Development Foundation [2007-2015]; Programme for New Century Excellent Talents in University [NCET-10-0205]; National Natural Science Foundation of China [30971571]	Beijing Medical Scientific Development Foundation; Programme for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the Beijing Medical Scientific Development Foundation (No. 2007-2015). It was partially supported by Programme for New Century Excellent Talents in University (NCET-10-0205) and the National Natural Science Foundation of China (No. 30971571). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba T, 2002, LANCET, V359, P1819, DOI 10.1016/S0140-6736(02)08713-5; Bocchini CE, 2006, PEDIATRICS, V117, P433, DOI 10.1542/peds.2005-0566; Chen HB, 2010, ANTIMICROB AGENTS CH, V54, P1842, DOI 10.1128/AAC.01563-09; CLSI, 2018, METHODS DILUTION ANT; David MZ, 2010, CLIN MICROBIOL REV, V23, P616, DOI 10.1128/CMR.00081-09; DeLeo FR, 2010, LANCET, V375, P1557, DOI 10.1016/S0140-6736(09)61999-1; Du JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027328; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; ESSERS L, 1980, J CLIN MICROBIOL, V12, P641, DOI 10.1128/JCM.12.5.641-643.1980; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Fridkin SK, 2005, NEW ENGL J MED, V352, P1436, DOI 10.1056/NEJMoa043252; Holtfreter S, 2007, J CLIN MICROBIOL, V45, P2669, DOI 10.1128/JCM.00204-07; Huijsdens Xander W, 2006, Ann Clin Microbiol Antimicrob, V5, P26, DOI 10.1186/1476-0711-5-26; Kaltsas A, 2011, J CLIN MICROBIOL, V49, P2992, DOI 10.1128/JCM.00704-11; Kock R, 2009, EUR J CLIN MICROBIOL, V28, P1375, DOI 10.1007/s10096-009-0795-4; Koreen L, 2004, J CLIN MICROBIOL, V42, P792, DOI 10.1128/JCM.42.2.792-799.2004; Lindsay Jodi A., 2006, Functional & Integrative Genomics, V6, P186, DOI 10.1007/s10142-005-0019-7; Liu YD, 2009, ANTIMICROB AGENTS CH, V53, P512, DOI 10.1128/AAC.00804-08; Oliveira DC, 2006, ANTIMICROB AGENTS CH, V50, P3457, DOI 10.1128/AAC.00629-06; Sakoulas G, 2002, ANTIMICROB AGENTS CH, V46, P1492, DOI 10.1128/AAC.46.5.1492-1502.2002; Schijffelen MJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-376; Smith TC, 2011, VECTOR-BORNE ZOONOT, V11, P327, DOI 10.1089/vbz.2010.0072; Wu DJ, 2010, DIAGN MICR INFEC DIS, V67, P1, DOI 10.1016/j.diagmicrobio.2009.12.006; Zhang KY, 2005, J CLIN MICROBIOL, V43, P5026, DOI 10.1128/JCM.43.10.5026-5033.2005	24	85	98	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e38577	10.1371/journal.pone.0038577	http://dx.doi.org/10.1371/journal.pone.0038577			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701673	Green Published, gold, Green Submitted			2022-12-27	WOS:000305348400076
J	Esteves, TC; Psathaki, OE; Pfeiffer, MJ; Balbach, ST; Zeuschner, D; Shitara, H; Yonekawa, H; Siatkowski, M; Fuellen, G; Boiani, M				Esteves, Telma C.; Psathaki, Olympia E.; Pfeiffer, Martin J.; Balbach, Sebastian T.; Zeuschner, Dagmar; Shitara, Hiroshi; Yonekawa, Hiromichi; Siatkowski, Marcin; Fuellen, Georg; Boiani, Michele			Mitochondrial Physiology and Gene Expression Analyses Reveal Metabolic and Translational Dysregulation in Oocyte-Induced Somatic Nuclear Reprogramming	PLOS ONE			English	Article							CLONED MOUSE EMBRYOS; ENDOPLASMIC-RETICULUM-STRESS; GREEN FLUORESCENT PROTEIN; REDOX REGULATION; POSTTRANSCRIPTIONAL REGULATION; TRANSGENIC MICE; BOVINE EMBRYOS; IN-VITRO; ACTIVATION; CYTOPLASM	While reprogramming a foreign nucleus after somatic cell nuclear transfer (SCNT), the enucleated oocyte (ooplasm) must signal that biomass and cellular requirements changed compared to the nucleus donor cell. Using cells expressing nuclear-encoded but mitochondria-targeted EGFP, a strategy was developed to directly distinguish maternal and embryonic products, testing ooplasm demands on transcriptional and post-transcriptional activity during reprogramming. Specifically, we compared transcript and protein levels for EGFP and other products in pre-implantation SCNT embryos, side-by-side to fertilized controls (embryos produced from the same oocyte pool, by intracytoplasmic injection of sperm containing the EGFP transgene). We observed that while EGFP transcript abundance is not different, protein levels are significantly lower in SCNT compared to fertilized blastocysts. This was not observed for Gapdh and Actb, whose protein reflected mRNA. This transcript-protein relationship indicates that the somatic nucleus can keep up with ooplasm transcript demands, whilst transcription and translation mismatch occurs after SCNT for certain mRNAs. We further detected metabolic disturbances after SCNT, suggesting a place among forces regulating post-transcriptional changes during reprogramming. Our observations ascribe oocyte-induced reprogramming with previously unsuspected regulatory dimensions, in that presence of functional proteins may no longer be inferred from mRNA, but rather depend on post-transcriptional regulation possibly modulated through metabolism.	[Esteves, Telma C.; Psathaki, Olympia E.; Pfeiffer, Martin J.; Balbach, Sebastian T.; Zeuschner, Dagmar; Boiani, Michele] Max Planck Inst Mol Biomed, Munster, Germany; [Shitara, Hiroshi; Yonekawa, Hiromichi] Tokyo Metropolitan Inst Med Sci, Lab Transgen Technol, Tokyo 113, Japan; [Shitara, Hiroshi; Yonekawa, Hiromichi] Univ Tsukuba, Grad Sch Life & Environm Sci, Ibaraki, Japan; [Siatkowski, Marcin] German Ctr Neurodegenerat Disorders, Rostock, Germany; [Siatkowski, Marcin; Fuellen, Georg] Univ Rostock, Inst Biostat & Informat Med & Ageing Res, Rostock, Germany	Max Planck Society; Tokyo Metropolitan Institute of Medical Science; University of Tsukuba; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Rostock	Esteves, TC (corresponding author), Max Planck Inst Mol Biomed, Munster, Germany.	mboiani@mpi-muenster.mpg.de	Balbach, Sebastian Thomas/A-1107-2009; Pfeiffer, Martin Johannes/A-9332-2011; Boiani, Michele/M-3519-2015	Balbach, Sebastian Thomas/0000-0003-0212-5758; Pfeiffer, Martin Johannes/0000-0001-9264-9218; Boiani, Michele/0000-0003-2765-2781; Esteves, Telma Cristina/0000-0002-8642-4722	Max-Planck Society; Deutsche Forschungsgemeinschaft [BO 2540/4-1]	Max-Planck Society(Max Planck Society); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Funding was provided by the Max-Planck Society, and the Deutsche Forschungsgemeinschaft (BO 2540/4-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amadio M, 2008, CURR PHARM DESIGN, V14, P2651, DOI 10.2174/138161208786264052; Amarnath D, 2011, REPRODUCTION, V142, P295, DOI 10.1530/REP-11-0044; Baena-Gonzalez E, 2010, MOL PLANT, V3, P300, DOI 10.1093/mp/ssp113; Balbach ST, 2010, DEV BIOL, V343, P71, DOI 10.1016/j.ydbio.2010.04.012; Balbach ST, 2007, DEV BIOL, V308, P309, DOI 10.1016/j.ydbio.2007.05.034; Bortvin A, 2003, DEVELOPMENT, V130, P1673, DOI 10.1242/dev.00366; Branco-Price C, 2008, PLANT J, V56, P743, DOI 10.1111/j.1365-313X.2008.03642.x; Butow RA, 2004, MOL CELL, V14, P1, DOI 10.1016/S1097-2765(04)00179-0; Cavaleri FM, 2008, MECH DEVELOP, V125, P153, DOI 10.1016/j.mod.2007.09.007; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Dumollard R, 2004, DEVELOPMENT, V131, P3057, DOI 10.1242/dev.01181; Dumollard R, 2007, DEVELOPMENT, V134, P455, DOI 10.1242/dev.02744; EBERT KM, 1988, J REPROD FERTIL, V82, P145, DOI 10.1530/jrf.0.0820145; Esteves TC, 2011, AGING CELL, V10, P80, DOI 10.1111/j.1474-9726.2010.00644.x; Folmes CDL, 2011, CELL METAB, V14, P264, DOI 10.1016/j.cmet.2011.06.011; Fukuda A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011274; Gebauer F, 2004, NAT REV MOL CELL BIO, V5, P827, DOI 10.1038/nrm1488; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Grossmann S, 2007, BIOINFORMATICS, V23, P3024, DOI 10.1093/bioinformatics/btm440; Guo Y, 2004, STEM CELLS, V22, P259, DOI 10.1634/stemcells.22-3-259; Halbeisen RE, 2008, CELL MOL LIFE SCI, V65, P798, DOI 10.1007/s00018-007-7447-6; Hao LP, 2009, BIOL REPROD, V80, P944, DOI 10.1095/biolreprod.108.072546; Harvey AJ, 2002, REPRODUCTION, V123, P479, DOI 10.1530/rep.0.1230479; Hiendleder S, 2005, REPROD FERT DEVELOP, V17, P69, DOI 10.1071/RD04115; HOWLETT SK, 1987, DEVELOPMENT, V101, P915; Hua S, 2011, ANIM REPROD SCI, V126, P37, DOI 10.1016/j.anireprosci.2011.05.002; Kabe Y, 2005, ANTIOXID REDOX SIGN, V7, P395, DOI 10.1089/ars.2005.7.395; Lloyd RE, 2006, GENETICS, V172, P2515, DOI 10.1534/genetics.105.055145; Malhotra JD, 2008, P NATL ACAD SCI USA, V105, P18525, DOI 10.1073/pnas.0809677105; Mamo S, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-14; Metzler D E, 2003, BIOCH CHEM REACTIONS; Ng RK, 2005, CELL CYCLE, V4, P760, DOI 10.4161/cc.4.6.1743; Paciolla M, 2011, HUM REPROD, V26, P1191, DOI 10.1093/humrep/der040; Peura TT, 1998, MOL REPROD DEV, V50, P185, DOI 10.1002/(SICI)1098-2795(199806)50:2&lt;185::AID-MRD9&gt;3.0.CO;2-G; Pfeiffer MJ, 2010, INT J DEV BIOL, V54, P1649, DOI 10.1387/ijdb.103197mp; Ross PJ, 2010, CELL REPROGRAM, V12, P709, DOI 10.1089/cell.2010.0036; Ross PJ, 2009, REPRODUCTION, V137, P427, DOI 10.1530/REP-08-0419; Sayaka W, 2008, ZYGOTE, V16, P211, DOI 10.1017/S0967199408004620; SCHMIDT EE, 1995, J CELL BIOL, V128, P467, DOI 10.1083/jcb.128.4.467; Sebastiano V, 2005, MOL REPROD DEV, V70, P146, DOI 10.1002/mrd.20144; Sekito T, 2000, MOL BIOL CELL, V11, P2103, DOI 10.1091/mbc.11.6.2103; Sheikh MS, 1999, ONCOGENE, V18, P6121, DOI 10.1038/sj.onc.1203131; Shitara H, 2001, FEBS LETT, V500, P7, DOI 10.1016/S0014-5793(01)02574-1; Shitara H, 2010, EXP ANIM TOKYO, V59, P99, DOI 10.1538/expanim.59.99; Slot JW, 2007, NAT PROTOC, V2, P2480, DOI 10.1038/nprot.2007.365; Song BS, 2011, REPROD FERT DEVELOP, V23, P826, DOI 10.1071/RD10194; Vassena R, 2007, DEV BIOL, V304, P75, DOI 10.1016/j.ydbio.2006.12.015; Wakayama T, 2001, MOL REPROD DEV, V58, P376, DOI 10.1002/1098-2795(20010401)58:4<376::AID-MRD4>3.0.CO;2-L; Wettenhall JM, 2004, BIOINFORMATICS, V20, P3705, DOI 10.1093/bioinformatics/bth449; Yang RQ, 2006, NUCLEIC ACIDS RES, V34, P1224, DOI 10.1093/nar/gkj519	50	3	3	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e36850	10.1371/journal.pone.0036850	http://dx.doi.org/10.1371/journal.pone.0036850			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22693623	Green Submitted, Green Published, gold			2022-12-27	WOS:000305343900002
J	Bellucci, CHS; Wollner, J; Gregorini, F; Birnbock, D; Kozomara, M; Mehnert, U; Kessler, TM				Bellucci, Carlos H. Suzuki; Woellner, Jens; Gregorini, Flavia; Birnboeck, Dorothee; Kozomara, Marko; Mehnert, Ulrich; Kessler, Thomas M.			External Urethral Sphincter Pressure Measurement: An Accurate Method for the Diagnosis of Detrusor External Sphincter Dyssynergia?	PLOS ONE			English	Article							STANDARDIZATION SUB-COMMITTEE; CONTINENCE-SOCIETY; ELECTROMYOGRAPHY	Background: Combined pelvic floor electromyography (EMG) and videocystourethrography (VCUG) during urodynamic investigation are the most acceptable and widely agreed methods for diagnosing detrusor external sphincter dyssynergia (DESD). Theoretically, external urethral sphincter pressure (EUSP) measurement would provide enough information for the diagnosis of DESD and could simplify the urodynamic investigation replacing combined pelvic floor EMG and VCUG. Thus, we evaluated the diagnostic accuracy of EUSP measurement for DESD. Patients & Methods: A consecutive series of 72 patients (36 women, 36 men) with neurogenic lower urinary tract dysfunction able to void spontaneously was prospectively evaluated at a single university spinal cord injury center. Diagnosis of DESD using EUSP measurement (index test) versus combined pelvic floor EMG and VCUG (reference standard) was assessed according to the recommendations of the Standards for Reporting of Diagnostic Accuracy Initiative. Results: Using EUSP measurement (index test) and combined pelvic floor EMG and VCUR (reference standard), DESD was diagnosed in 10 (14%) and in 41 (57%) patients, respectively. More than half of the patients presented discordant diagnosis between the index test and the reference standard. Among 41 patients with DESD diagnosed by combined pelvic floor EMG and VCUR, EUSP measurement identified only 6 patients. EUSP measurement had a sensitivity of 15% (95% CI 5%-25%), specificity of 87% (95% CI 76%-98%), positive predictive value of 60% (95% CI 30%-90%), and negative predictive value of 56% (95% CI 44%-68%) for the diagnosis of DESD. Conclusions: For diagnosis of DESD, EUSP measurement is inaccurate and cannot replace combined pelvic floor EMG and VCUR.	[Bellucci, Carlos H. Suzuki] Spinal Cord Injury Ctr, Zurich, Switzerland; Univ Zurich, Balgrist Univ Hosp, Zurich, Switzerland	University of Zurich	Bellucci, CHS (corresponding author), Spinal Cord Injury Ctr, Zurich, Switzerland.	tkessler@gmx.ch	Bellucci, Carlos HS/J-9698-2016	Bellucci, Carlos HS/0000-0002-3570-859X; Kozomara-Hocke, Marko/0000-0001-5126-9331	Swiss Continence Foundation	Swiss Continence Foundation	This study has been supported by an unrestricted grant from the Swiss Continence Foundation (www.swisscontinencefoundation.ch). The Swiss Continence Foundation had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams P, 2002, NEUROUROL URODYNAM, V21, P167, DOI 10.1002/nau.10052; BLAIVAS JG, 1981, J UROLOGY, V125, P693, DOI 10.1016/S0022-5347(17)55165-4; Bossuyt PM, 2003, BRIT MED J, V326, P41, DOI 10.1136/bmj.326.7379.41; De EJB, 2005, NEUROUROL URODYNAM, V24, P616, DOI 10.1002/nau.20191; Lose G, 2002, NEUROUROL URODYNAM, V21, P258, DOI 10.1002/nau.10051; MAYO ME, 1979, J UROLOGY, V122, P357, DOI 10.1016/S0022-5347(17)56405-8; Podnar S, 2007, CLIN NEUROPHYSIOL, V118, P1423, DOI 10.1016/j.clinph.2007.01.022; ROSSIER AB, 1986, UROLOGY, V27, P371, DOI 10.1016/0090-4295(86)90320-1; Sadananda P, 2011, NEUROUROL URODYNAM, V30, P708, DOI 10.1002/nau.21137; Sakakibara R, 2001, AUTON NEUROSCI-BASIC, V86, P208, DOI 10.1016/S1566-0702(00)00258-7; Schafer W, 2002, NEUROUROL URODYNAM, V21, P261, DOI 10.1002/nau.10066; Weld KJ, 2000, UROLOGY, V56, P565, DOI 10.1016/S0090-4295(00)00761-5; YALLA SV, 1977, J UROLOGY, V118, P1026, DOI 10.1016/S0022-5347(17)58286-5; YALLA SV, 1982, J UROLOGY, V128, P969, DOI 10.1016/S0022-5347(17)53305-4; Zehnder P, 2008, J UROLOGY, V180, P1013, DOI 10.1016/j.juro.2008.05.028	15	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e37996	10.1371/journal.pone.0037996	http://dx.doi.org/10.1371/journal.pone.0037996			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22701539	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000305338500069
J	McAuley, EZ; Scimone, A; Tiwari, Y; Agahi, G; Mowry, BJ; Holliday, EG; Donald, JA; Weickert, CS; Mitchell, PB; Schofield, PR; Fullerton, JM				McAuley, Erica Z.; Scimone, Anna; Tiwari, Yash; Agahi, Giti; Mowry, Bryan J.; Holliday, Elizabeth G.; Donald, Jennifer A.; Weickert, Cynthia Shannon; Mitchell, Phillip B.; Schofield, Peter R.; Fullerton, Janice M.			Identification of Sialyltransferase 8B as a Generalized Susceptibility Gene for Psychotic and Mood Disorders on Chromosome 15q25-26	PLOS ONE			English	Article							CELL-ADHESION MOLECULE; BIPOLAR AFFECTIVE-DISORDER; GENOME-WIDE SCAN; POLYSIALIC ACID; DIAGNOSTIC INTERVIEW; EMBRYONIC FORM; SCHIZOPHRENIA; ASSOCIATION; LINKAGE; POLYSIALYLTRANSFERASE	We previously identified a significant bipolar spectrum disorder linkage peak on 15q25-26 using 35 extended families with a broad clinical phenotype, including bipolar disorder (types I and II), recurrent unipolar depression and schizoaffective disorder. However, the specific gene(s) contributing to this signal had not been identified. By a fine mapping association study in an Australian case-control cohort (n = 385), we find that the sialyltransferase 8B (ST8SIA2) gene, coding for an enzyme that glycosylates proteins involved in neuronal plasticity which has previously shown association to both schizophrenia and autism, is associated with increased risk to bipolar spectrum disorder. Nominal single point association was observed with SNPs in ST8SIA2 (rs4586379, P = 0.0043; rs2168351, P = 0.0045), and a specific risk haplotype was identified (frequency: bipolar vs controls = 0.41 vs 0.31; chi(2) = 6.46, P = 0.011, OR = 1.47). Over-representation of the specific risk haplotype was also observed in an Australian schizophrenia case-control cohort (n = 256) (chi(2) = 8.41, P = 0.004, OR = 1.82). Using GWAS data from the NIMH bipolar disorder (n = 2055) and NIMH schizophrenia (n = 2550) cohorts, the equivalent haplotype was significantly over-represented in bipolar disorder (chi(2) = 5.91, P = 0.015, OR = 1.29), with the same direction of effect in schizophrenia, albeit non-significant (chi(2) = 2.3, P = 0.129, OR = 1.09). We demonstrate marked down-regulation of ST8SIA2 gene expression across human brain development and show a significant haplotype x diagnosis effect on ST8SIA2 mRNA levels in adult cortex (ANOVA: F(1,87) = 6.031, P = 0.016). These findings suggest that variation the ST8SIA2 gene is associated with increased risk to mental illness, acting to restrict neuronal plasticity and disrupt early neuronal network formation, rendering the developing and adult brain more vulnerable to secondary genetic or environmental insults.	[McAuley, Erica Z.; Scimone, Anna; Tiwari, Yash; Agahi, Giti; Weickert, Cynthia Shannon; Schofield, Peter R.; Fullerton, Janice M.] Neurosci Res Australia, Psychiat Genet, Sydney, NSW, Australia; [McAuley, Erica Z.; Tiwari, Yash; Schofield, Peter R.; Fullerton, Janice M.] Univ New S Wales, Sch Med Sci, Sydney, NSW, Australia; [Tiwari, Yash; Weickert, Cynthia Shannon; Schofield, Peter R.; Fullerton, Janice M.] Schizophrenia Res Inst, Sydney, NSW, Australia; [Mowry, Bryan J.; Holliday, Elizabeth G.] Queensland Ctr Mental Hlth Res, Brisbane, Qld, Australia; [Mowry, Bryan J.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia; [Donald, Jennifer A.] Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia; [Weickert, Cynthia Shannon; Mitchell, Phillip B.] Univ New S Wales, Sch Psychiat, Sydney, NSW, Australia; [Mitchell, Phillip B.] Prince Wales Hosp, Black Dog Inst, Sydney, NSW, Australia	Neuroscience Research Australia; University of New South Wales Sydney; Queensland Centre for Mental Health Research; University of Queensland; Macquarie University; University of New South Wales Sydney; Black Dog Institute	McAuley, EZ (corresponding author), Neurosci Res Australia, Psychiat Genet, Sydney, NSW, Australia.	p.schofield@neura.edu.au; j.fullerton@neura.edu.au	Fullerton, Janice/F-8485-2013; Mowry, Bryan/G-5046-2010; Schofield, Peter/C-9669-2011	Fullerton, Janice/0000-0003-4014-4490; Mowry, Bryan/0000-0002-4115-5645; Donald, Jennifer/0000-0002-2732-1379; Mitchell, Philip/0000-0002-7954-5235; Shannon Weickert, Cynthia/0000-0002-4560-0259; Schofield, Peter/0000-0003-2967-9662	Schizophrenia Research Institute (Australia); National Health and Medical Research Council (Australia) [510216, 630574, 510135]; Dora Lush Scholarship [325641]; Howard Florey Centenary Fellowship [325643]; Senior Principal Research Fellowship [157209]	Schizophrenia Research Institute (Australia); National Health and Medical Research Council (Australia)(National Health and Medical Research Council (NHMRC) of Australia); Dora Lush Scholarship; Howard Florey Centenary Fellowship; Senior Principal Research Fellowship	This study was supported by the Schizophrenia Research Institute (Australia), and the National Health and Medical Research Council (Australia) via project grants (510216, 630574), program grant (510135), and personnel support of Dora Lush Scholarship (325641) to EZM, Howard Florey Centenary Fellowship (325643) to JMF, Senior Principal Research Fellowship (157209) to PRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angata K, 2004, J BIOL CHEM, V279, P32603, DOI 10.1074/jbc.M403429200; Angata K, 1997, J BIOL CHEM, V272, P7182, DOI 10.1074/jbc.272.11.7182; Anney R, 2010, HUM MOL GENET, V19, P4072, DOI 10.1093/hmg/ddq307; APA, 1987, DIAGN STAT MAN MENT, V3rd; Arai M, 2006, BIOL PSYCHIAT, V59, P652, DOI 10.1016/j.biopsych.2005.08.016; Arai M, 2004, BIOL PSYCHIAT, V55, P804, DOI 10.1016/j.biopsych.2004.01.009; BARBEAU D, 1995, P NATL ACAD SCI USA, V92, P2785, DOI 10.1073/pnas.92.7.2785; Burgess A, 2008, DEV NEUROBIOL, V68, P1580, DOI 10.1002/dneu.20681; Carroll LS, 2009, GENOME MED, V1, DOI 10.1186/gm102; Castillo-Gomez E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029516; Castle DJ, 2006, PSYCHOL MED, V36, P69, DOI 10.1017/S0033291705005969; Chumakov I, 2002, P NATL ACAD SCI USA, V99, P13675, DOI 10.1073/pnas.182412499; Gao XY, 2008, GENET EPIDEMIOL, V32, P361, DOI 10.1002/gepi.20310; Gershon ES, 2011, AM J PSYCHIAT, V168, P253, DOI 10.1176/appi.ajp.2010.10091340; Glass JD, 2003, NEUROSCIENCE, V117, P203, DOI 10.1016/S0306-4522(02)00817-5; Green EK, 2010, MOL PSYCHIATR, V15, P1016, DOI 10.1038/mp.2009.49; Green EK, 2005, ARCH GEN PSYCHIAT, V62, P642, DOI 10.1001/archpsyc.62.6.642; Hattori E, 2003, AM J HUM GENET, V72, P1131, DOI 10.1086/374822; Hildebrandt H, 2007, J NEUROCHEM, V103, P56, DOI 10.1111/j.1471-4159.2007.04716.x; Hildebrandt H, 2009, BRAIN, V132, P2831, DOI 10.1093/brain/awp117; Hodgkinson CA, 2004, AM J HUM GENET, V75, P862, DOI 10.1086/425586; Holmans P, 2004, AM J HUM GENET, V74, P1154, DOI 10.1086/421333; Isomura R, 2011, J BIOL CHEM, V286, P21535, DOI 10.1074/jbc.M111.221143; Jablensky A, 2000, AUST NZ J PSYCHIAT, V34, P221, DOI 10.1046/j.1440-1614.2000.00728.x; Lee MTM, 2011, MOL PSYCHIATR, V16, P548, DOI 10.1038/mp.2010.43; Lichtenstein P, 2009, LANCET, V373, P234, DOI 10.1016/S0140-6736(09)60072-6; Maziade M, 2005, MOL PSYCHIATR, V10, P486, DOI 10.1038/sj.mp.4001594; McAuley EZ, 2009, MOL PSYCHIATR, V14, P492, DOI 10.1038/sj.mp.4002146; Mitchell PB, 2009, AUST NZ J PSYCHIAT, V43, P109, DOI 10.1080/00048670802607220; NURNBERGER JI, 1994, ARCH GEN PSYCHIAT, V51, P849, DOI 10.1001/archpsyc.1994.03950110009002; Park N, 2004, MOL PSYCHIATR, V9, P1091, DOI 10.1038/sj.mp.4001541; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; Rice TK, 2008, ADV GENET, V60, P293, DOI 10.1016/S0065-2660(07)00412-9; ROUSSELOT P, 1995, J COMP NEUROL, V351, P51, DOI 10.1002/cne.903510106; Rutishauser U, 2008, NAT REV NEUROSCI, V9, P26, DOI 10.1038/nrn2285; STCLAIR D, 1990, LANCET, V336, P13, DOI 10.1016/0140-6736(90)91520-K; Stefansson H, 2002, AM J HUM GENET, V71, P877, DOI 10.1086/342734; Tao R, 2007, SCHIZOPHR RES, V90, P108, DOI 10.1016/j.schres.2006.09.029; Vazza G, 2007, MOL PSYCHIATR, V12, P87, DOI 10.1038/sj.mp.4001895; Verma R, 2008, BIOL PSYCHIAT, V63, P1185, DOI 10.1016/j.biopsych.2008.02.005; Weickert CS, 2009, MOL PSYCHIATR, V14, P558, DOI 10.1038/mp.2009.5; Weickert CS, 2010, AUST NZ J PSYCHIAT, V44, P59, DOI 10.3109/00048670903393662; Williams HJ, 2011, MOL PSYCHIATR, V16, P429, DOI 10.1038/mp.2010.36	45	49	51	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38172	10.1371/journal.pone.0038172	http://dx.doi.org/10.1371/journal.pone.0038172			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693595	gold, Green Published, Green Submitted			2022-12-27	WOS:000305338500101
J	Karim, M; Harris, JA; Morley, JW; Breakspear, M				Karim, Muhsin; Harris, Justin A.; Morley, John W.; Breakspear, Michael			Prior and Present Evidence: How Prior Experience Interacts with Present Information in a Perceptual Decision Making Task	PLOS ONE			English	Article							TIME-ORDER ERRORS; SENSORY-DISCRIMINATION; WORKING-MEMORY; NEURAL CODES; VIBROTACTILE STIMULI; FREQUENCY; FEEDBACK; FLUTTER	Background: Vibrotactile discrimination tasks have been used to examine decision making processes in the presence of perceptual uncertainty, induced by barely discernible frequency differences between paired stimuli or by the presence of embedded noise. One lesser known property of such tasks is that decisions made on a single trial may be biased by information from prior trials. An example is the time-order effect whereby the presentation order of paired stimuli may introduce differences in accuracy. Subjects perform better when the first stimulus lies between the second stimulus and the global mean of all stimuli on the judged dimension ("preferred" time-orders) compared to the alternative presentation order ("nonpreferred" time-orders). This has been conceptualised as a "drift" of the first stimulus representation towards the global mean of the stimulus-set (an internal standard). We describe the influence of prior information in relation to the more traditionally studied factors of interest in a classic discrimination task. Methodology: Sixty subjects performed a vibrotactile discrimination task with different levels of uncertainty parametrically induced by increasing task difficulty, aperiodic stimulus noise, and changing the task instructions whilst maintaining identical stimulus properties (the "context"). Principal Findings: The time-order effect had a greater influence on task performance than two of the explicit factors-task difficulty and noise-but not context. The influence of prior information increased with the distance of the first stimulus from the global mean, suggesting that the "drift" velocity of the first stimulus towards the global mean representation was greater for these trials. Conclusions/Significance: Awareness of the time-order effect and prior information in general is essential when studying perceptual decision making tasks. Implicit mechanisms may have a greater influence than the explicit factors under study. It also affords valuable insights into basic mechanisms of information accumulation, storage, sensory weighting, and processing in neural circuits.	[Karim, Muhsin; Breakspear, Michael] Univ New S Wales, Sch Psychiat, Fac Med, Sydney, NSW, Australia; [Karim, Muhsin; Breakspear, Michael] Black Dog Inst, Sydney, NSW, Australia; [Harris, Justin A.] Univ New S Wales, Sch Psychol, Sydney, NSW, Australia; [Morley, John W.] Univ Western Sydney, Sch Med, Sydney, NSW, Australia; [Breakspear, Michael] Queensland Inst Med Res, Brisbane, Qld 4006, Australia; [Breakspear, Michael] Royal Brisbane & Womens Hosp, Brisbane, Qld, Australia	University of New South Wales Sydney; Black Dog Institute; University of New South Wales Sydney; Western Sydney University; QIMR Berghofer Medical Research Institute; Royal Brisbane & Women's Hospital	Karim, M (corresponding author), Univ New S Wales, Sch Psychiat, Fac Med, Sydney, NSW, Australia.	m.karim@unsw.edu.au	Breakspear, Michael/ABF-6302-2020; Breakspear, Michael/M-5859-2014	Breakspear, Michael/0000-0003-4943-3969; Harris, Justin/0000-0003-3865-8097	Australian Research Council (ARC), ARC [TS0669860]	Australian Research Council (ARC), ARC(Australian Research Council)	The work was supported by funding from the Australian Research Council (ARC), ARC Grant TS0669860 (http://www.arc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adibi M, 2011, J NEUROPHYSIOL, V105, P356, DOI 10.1152/jn.00794.2010; Alcala-Quintana R, 2011, Q J EXP PSYCHOL, V64, P1221, DOI 10.1080/17470218.2010.540018; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brody CD, 2002, PHILOS T R SOC B, V357, P1843, DOI 10.1098/rstb.2002.1167; Brody CD, 2003, CEREB CORTEX, V13, P1196, DOI 10.1093/cercor/bhg100; Daunizeau J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015555; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Gardiner C, 2009, STOCHASTIC METHODS H; Gerdjikov TV, 2010, NEURON, V65, P530, DOI 10.1016/j.neuron.2010.02.007; Hairston IS, 2007, J COGNITIVE NEUROSCI, V19, P1163, DOI 10.1162/jocn.2007.19.7.1163; Hanks TD, 2011, J NEUROSCI, V31, P6339, DOI 10.1523/JNEUROSCI.5613-10.2011; Harris JA, 2002, J NEUROSCI, V22, P8720; Harris JA, 2006, NOVART FDN SYMP, V270, P285; Harris JA, 2006, NOVART FDN SYMP, V270, P246; Harris JA, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000100; Harris Justin A, 2006, Novartis Found Symp, V270, P238; Hegner YL, 2007, J NEUROPHYSIOL, V97, P264, DOI 10.1152/jn.00617.2006; Hellstrom A, 2004, ACTA PSYCHOL, V116, P1, DOI 10.1016/j.actpsy.2003.11.003; Hellstrom A, 2003, PERCEPT PSYCHOPHYS, V65, P1161, DOI 10.3758/BF03194842; HELLSTROM A, 1985, PSYCHOL BULL, V97, P35, DOI 10.1037/0033-2909.97.1.35; HELLSTROM A, 1979, J EXP PSYCHOL HUMAN, V5, P460, DOI 10.1037/0096-1523.5.3.460; Hellstrom A, 2000, J EXP PSYCHOL HUMAN, V26, P6, DOI 10.1037/0096-1523.26.1.6; Hernandez A, 1997, J NEUROSCI, V17, P6391; Hernandez A, 2000, P NATL ACAD SCI USA, V97, P6191, DOI 10.1073/pnas.120018597; Hernandez A, 2010, NEURON, V66, P300, DOI 10.1016/j.neuron.2010.03.031; JAMIESON DG, 1976, ACTA PSYCHOL, V40, P199, DOI 10.1016/0001-6918(76)90011-1; JAMIESON DG, 1975, PERCEPT PSYCHOPHYS, V18, P107, DOI 10.3758/BF03204096; JAMIESON DG, 1975, PERCEPT PSYCHOPHYS, V17, P197, DOI 10.3758/BF03203886; Kleiner M, 2007, PERCEPTION, V36, P14; Luna R, 2005, NAT NEUROSCI, V8, P1210, DOI 10.1038/nn1513; Macmillan NA, 2005, DETECTION THEORY USE; MICHELS WC, 1954, AM J PSYCHOL, V67, P327, DOI 10.2307/1418635; Morgan MJ, 2000, VISION RES, V40, P2341, DOI 10.1016/S0042-6989(00)00093-6; Needham JG, 1962, PSYCHOL BULL, V59, P257; Philiastides MG, 2011, CURR BIOL, V21, P980, DOI 10.1016/j.cub.2011.04.034; Pleger B, 2006, J NEUROSCI, V26, P12596, DOI 10.1523/JNEUROSCI.4275-06.2006; POSTMAN L, 1946, AM J PSYCHOL, V59, P193, DOI 10.2307/1416885; Preuschhof C, 2006, J NEUROSCI, V26, P13231, DOI 10.1523/JNEUROSCI.2767-06.2006; Preuschhof C, 2010, J COGNITIVE NEUROSCI, V22, P875, DOI 10.1162/jocn.2009.21260; Ratcliff R, 2004, PSYCHOL REV, V111, P333, DOI 10.1037/0033-295X.111.2.333; Romo R, 2003, NAT REV NEUROSCI, V4, P203, DOI 10.1038/nrn1058; Romo R, 2003, NEURON, V38, P649, DOI 10.1016/S0896-6273(03)00287-3; Romo R, 2002, ARCH ITAL BIOL, V140, P253; Romo R, 2002, PHILOS T R SOC B, V357, P1039, DOI 10.1098/rstb.2002.1100; Romo R, 2006, NOVART FDN SYMP, V270, P232; Romo R, 2006, NOVART FDN SYMP, V270, P186; Romo Ranulfo, 2006, Novartis Found Symp, V270, P170; Salinas E, 2000, J NEUROSCI, V20, P5503, DOI 10.1523/JNEUROSCI.20-14-05503.2000; Sinclair RJ, 1996, PERCEPT PSYCHOPHYS, V58, P680, DOI 10.3758/BF03213100; Soros P, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-48; Tang K, 2009, J NEUROSCI METH, V178, P65, DOI 10.1016/j.jneumeth.2008.11.024; von Helmholtz H., 1925, TREATISE PHYSL OPTIC, V3; Wang XJ, 2008, NEURON, V60, P215, DOI 10.1016/j.neuron.2008.09.034; Woodrow H, 1935, PSYCHOL REV, V42, P127, DOI 10.1037/h0063696; Woodrow H, 1933, AM J PSYCHOL, V45, P391, DOI 10.2307/1415039; Zwislocki JJ, 2001, P NATL ACAD SCI USA, V98, P4811, DOI 10.1073/pnas.081082598	56	15	15	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e37580	10.1371/journal.pone.0037580	http://dx.doi.org/10.1371/journal.pone.0037580			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959WT	22701521	gold, Green Published, Green Submitted			2022-12-27	WOS:000305349600022
J	Wang, Y; Guo, LH; Cai, SP; Dai, MZ; Yang, QN; Yu, WH; Yan, NH; Zhou, XM; Fu, J; Guo, XW; Han, PF; Wang, J; Liu, XY				Wang, Yun; Guo, Liheng; Cai, Su-Ping; Dai, Meizhi; Yang, Qiaona; Yu, Wenhan; Yan, Naihong; Zhou, Xiaomin; Fu, Jin; Guo, Xinwu; Han, Pengfei; Wang, Jun; Liu, Xuyang			Exome Sequencing Identifies Compound Heterozygous Mutations in CYP4V2 in a Pedigree with Retinitis Pigmentosa	PLOS ONE			English	Article							CORNEO-RETINAL DYSTROPHY; FATTY-ACID; CRYSTALLINE DYSTROPHY; DOCOSAHEXAENOIC ACID; CLINICAL-TRIAL; METABOLISM; GENE; DEFICIENCY; CAPTURE	Retinitis pigmentosa (RP) is a heterogeneous group of progressive retinal degenerations characterized by pigmentation and atrophy in the mid-periphery of the retina. Twenty two subjects from a four-generation Chinese family with RP and thin cornea, congenital cataract and high myopia is reported in this study. All family members underwent complete ophthalmologic examinations. Patients of the family presented with bone spicule-shaped pigment deposits in retina, retinal vascular attenuation, retinal and choroidal dystrophy, as well as punctate opacity of the lens, reduced cornea thickness and high myopia. Peripheral venous blood was obtained from all patients and their family members for genetic analysis. After mutation analysis in a few known RP candidate genes, exome sequencing was used to analyze the exomes of 3 patients III2, III4, III6 and the unaffected mother II2. A total of 34,693 variations shared by 3 patients were subjected to several filtering steps against existing variation databases. Identified variations were verified in the rest family members by PCR and Sanger sequencing. Compound heterozygous c. 802-8_810del17insGC and c. 1091-2A>G mutations of the CYP4V2 gene, known as genetic defects for Bietti crystalline corneoretinal dystrophy, were identified as causative mutations for RP of this family.	[Wang, Yun; Guo, Liheng; Yang, Qiaona; Yu, Wenhan; Yan, Naihong; Zhou, Xiaomin] W China Hosp, Translat Neurosci Ctr, State Key Lab Biotherapy, Ophthalm Labs, Chengdu, Sichuan Provinc, Peoples R China; [Wang, Yun; Guo, Liheng; Yang, Qiaona; Yu, Wenhan; Yan, Naihong; Zhou, Xiaomin] W China Hosp, Translat Neurosci Ctr, State Key Lab Biotherapy, Dept Ophthalmol, Chengdu, Sichuan Provinc, Peoples R China; [Cai, Su-Ping; Liu, Xuyang] Jinan Univ, Shenzhen Eye Hosp, Shenzhen, Peoples R China; [Dai, Meizhi; Fu, Jin; Guo, Xinwu; Han, Pengfei; Wang, Jun] BGI Shenzhen, Shenzhen, Guangdong, Peoples R China	Sichuan University; Sichuan University; Jinan University; Beijing Genomics Institute (BGI)	Wang, Y (corresponding author), W China Hosp, Translat Neurosci Ctr, State Key Lab Biotherapy, Ophthalm Labs, Chengdu, Sichuan Provinc, Peoples R China.	wangj@genomics.org.cn; xliu1213@yahoo.com.cn	Wang, Jun/A-7261-2013; Cai, Shanqing/F-6880-2013; Wang, Jun/C-8434-2016; Wang, Jun/B-9503-2016	Beal, Deryk S./0000-0001-9488-4326; Yu, Wenhan/0000-0002-0125-4358; Wang, Jun/0000-0002-8540-8931; Wang, Jun/0000-0002-2113-5874; Ghosh, Satrajit/0000-0002-5312-6729	National Natural Science Foundation of China (NSFC) [81000370]; National Basic Research Program of China (973 Program) [2011CB510201]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This work was supported by grants from the National Natural Science Foundation of China (NSFC 81000370) and the National Basic Research Program of China (973 Program, 2011CB510201). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON RE, 1987, EXP EYE RES, V44, P155, DOI 10.1016/S0014-4835(87)80034-9; Berson EL, 2004, ARCH OPHTHALMOL-CHIC, V122, P1297, DOI 10.1001/archopht.122.9.1297; Choi M, 2009, P NATL ACAD SCI USA, V106, P19096, DOI 10.1073/pnas.0910672106; CONVERSE CA, 1983, T OPHTHAL SOC UK, V103, P508; Giusto NM, 2000, PROG LIPID RES, V39, P315, DOI 10.1016/S0163-7827(00)00009-6; GONG JX, 1992, INVEST OPHTH VIS SCI, V33, P2596; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Hoffman DR, 2004, AM J OPHTHALMOL, V137, P704, DOI 10.1016/j.ajo.2003.10.045; HOFFMAN DR, 1995, EXP EYE RES, V60, P279, DOI 10.1016/S0014-4835(05)80110-1; HOFFMAN DR, 1993, EXP EYE RES, V57, P359, DOI 10.1006/exer.1993.1135; HUMPHRIES P, 1992, SCIENCE, V256, P804, DOI 10.1126/science.1589761; Innis SM, 2003, J PEDIATR-US, V143, pS1, DOI 10.1067/S0022-3476(03)00396-2; Jin ZB, 2006, JPN J OPHTHALMOL, V50, P426, DOI 10.1007/s10384-006-0350-0; KAISERKUPFER MI, 1994, AM J OPHTHALMOL, V118, P569, DOI 10.1016/S0002-9394(14)76572-9; Kelly EJ, 2011, MOL INTERV, V11, P124, DOI 10.1124/mi.11.2.10; Lai TYY, 2007, INVEST OPHTH VIS SCI, V48, P5212, DOI 10.1167/iovs.07-0660; Lalonde E, 2010, HUM MUTAT, V31, P918, DOI 10.1002/humu.21293; Lee J, 1998, MOL GENET METAB, V65, P143, DOI 10.1006/mgme.1998.2723; Lee J, 2001, INVEST OPHTH VIS SCI, V42, P1707; Lee KYC, 2005, INVEST OPHTH VIS SCI, V46, P3812, DOI 10.1167/iovs.05-0378; Li AR, 2004, AM J HUM GENET, V74, P817, DOI 10.1086/383228; Li GQ, 2009, NUCLEIC ACIDS RES, V37, pD1025, DOI 10.1093/nar/gkn966; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Lin J, 2005, J MED GENET, V42, DOI 10.1136/jmg.2004.029066; NEURINGER M, 1986, P NATL ACAD SCI USA, V83, P4021, DOI 10.1073/pnas.83.11.4021; NEURINGER M, 1984, J CLIN INVEST, V73, P272, DOI 10.1172/JCI111202; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Rivolta C, 2002, HUM MOL GENET, V11, P1219, DOI 10.1093/hmg/11.10.1219; Shan MG, 2005, MOL VIS, V11, P738	29	42	45	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e33673	10.1371/journal.pone.0033673	http://dx.doi.org/10.1371/journal.pone.0033673			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22911857	Green Published, gold, Green Submitted			2022-12-27	WOS:000305338500004
J	Lu, C; Stewart, DJ; Lee, JJ; Ji, L; Ramesh, R; Jayachandran, G; Nunez, MI; Wistuba, II; Erasmus, JJ; Hicks, ME; Grimm, EA; Reuben, JM; Baladandayuthapani, V; Templeton, NS; McMannis, JD; Roth, JA				Lu, Charles; Stewart, David J.; Lee, J. Jack; Ji, Lin; Ramesh, Rajagopal; Jayachandran, Gitanjali; Nunez, Maria I.; Wistuba, Ignacio I.; Erasmus, Jeremy J.; Hicks, Marshall E.; Grimm, Elizabeth A.; Reuben, James M.; Baladandayuthapani, Veerabhadran; Templeton, Nancy S.; McMannis, John D.; Roth, Jack A.			Phase I Clinical Trial of Systemically Administered TUSC2(FUS1)-Nanoparticles Mediating Functional Gene Transfer in Humans	PLOS ONE			English	Article							HOMOZYGOUS DELETION REGION; HUMAN-CHROMOSOME 3P21.3; TUMOR-SUPPRESSOR GENES; LUNG-CANCER CELLS; ADENOVIRUS VECTOR; DNA COMPLEXES; FUS1 PROTEIN; EXPRESSION; P53; LIPOSOME	Background: Tumor suppressor gene TUSC2/FUS1 (TUSC2) is frequently inactivated early in lung cancer development. TUSC2 mediates apoptosis in cancer cells but not normal cells by upregulation of the intrinsic apoptotic pathway. No drug strategies currently exist targeting loss-of-function genetic abnormalities. We report the first in-human systemic gene therapy clinical trial of tumor suppressor gene TUSC2. Methods: Patients with recurrent and/or metastatic lung cancer previously treated with platinum-based chemotherapy were treated with escalating doses of intravenous N-[1-(2,3-dioleoyloxy)propyl]-N,N,N-trimethylammonium chloride (DOTAP): cholesterol nanoparticles encapsulating a TUSC2 expression plasmid (DOTAP: chol-TUSC2) every 3 weeks. Results: Thirty-one patients were treated at 6 dose levels (range 0.01 to 0.09 milligrams per kilogram). The MTD was determined to be 0.06 mg/kg. Five patients achieved stable disease (2.6-10.8 months, including 2 minor responses). One patient had a metabolic response on positron emission tomography (PET) imaging. RT-PCR analysis detected TUSC2 plasmid expression in 7 of 8 post-treatment tumor specimens but not in pretreatment specimens and peripheral blood lymphocyte controls. Proximity ligation assay, performed on paired biopsies from 3 patients, demonstrated low background TUSC2 protein staining in pretreatment tissues compared with intense (10-25 fold increase) TUSC2 protein staining in post-treatment tissues. RT-PCR gene expression profiling analysis of apoptotic pathway genes in two patients with high post-treatment levels of TUSC2 mRNA and protein showed significant post-treatment changes in the intrinsic apoptotic pathway. Twenty-nine genes of the 82 tested in the apoptosis array were identified by Igenuity Pathway Analysis to be significantly altered post-treatment in both patients (Pearson correlation coefficient 0.519; p<0.01). Conclusions: DOTAP: chol-TUSC2 can be safely administered intravenously in lung cancer patients and results in uptake of the gene by human primary and metastatic tumors, transgene and gene product expression, specific alterations in TUSC2-regulated pathways, and anti-tumor effects (to our knowledge for the first time for systemic DOTAP: cholesterol nanoparticle gene therapy).	[Lu, Charles; Stewart, David J.; Lee, J. Jack; Ji, Lin; Jayachandran, Gitanjali; Nunez, Maria I.; Wistuba, Ignacio I.; Erasmus, Jeremy J.; Hicks, Marshall E.; Grimm, Elizabeth A.; Reuben, James M.; Baladandayuthapani, Veerabhadran; McMannis, John D.; Roth, Jack A.] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Ramesh, Rajagopal] Univ Oklahoma, Hlth Sci Ctr, Oklahoma City, OK USA; [Ramesh, Rajagopal] Stephenson Canc Ctr, Oklahoma City, OK USA; [Templeton, Nancy S.] Gradalis Inc, Carrollton, TX USA	University of Texas System; UTMD Anderson Cancer Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Lu, C (corresponding author), Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA.	clu@mdanderson.org	Templeton, Nancy S/C-9565-2011; Lee, Jack/P-7331-2019; Center, Univ of Texas-M D Anderson Cancer/AAE-8182-2019	Lee, Jack/0000-0002-4584-929X; Center, Univ of Texas-M D Anderson Cancer/0000-0001-5469-9214	National Institutes of Health through M. D. Anderson's Cancer Center [CA-016672]; Biostatistics Resource Group; Clinical Trials Support Resource; Clinical and Translational Research Center; Protocol Review and Monitoring Shared Resources, the Commonwealth Phase I Study IV DOTAP [RO1 CA 113450 RR]; Genprex, Inc.; NATIONAL CANCER INSTITUTE [P50CA070907, R01CA113450, P30CA016672] Funding Source: NIH RePORTER	National Institutes of Health through M. D. Anderson's Cancer Center; Biostatistics Resource Group; Clinical Trials Support Resource; Clinical and Translational Research Center; Protocol Review and Monitoring Shared Resources, the Commonwealth Phase I Study IV DOTAP; Genprex, Inc.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported in part by the National Institutes of Health through M. D. Anderson's Cancer Center Support Grant CA-016672 - Lung Program, Research Histopathology Facility; Biostatistics Resource Group; Clinical Trials Support Resource; Clinical and Translational Research Center; and Protocol Review and Monitoring Shared Resources, the Commonwealth Phase I Study IV DOTAP (JAR), RO1 CA 113450 RR), and a generous donation from the Helen & Jin Ryu Fund for Gene Therapy (JAR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; CL: Patent-TUSC2 Therapeutic Response Markers (pending), Co-Inventor JAR: Consultancy, grants, stock: Genprex, Inc.; Patents pending and issued: TUSC2/FUS1 NST: Novel DNA: liposome complexes for increased systemic delivery and gene expression. United States Letters Patent No. 6,413,544 B1 issued July 2, 2002. United States Patent No. 6,770,291 B2 issued August 3, 2004. International Publication Number: WO 98/07408. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Aksentijevich I, 1996, HUM GENE THER, V7, P1111, DOI 10.1089/hum.1996.7.9-1111; BISHOP JM, 1991, CELL, V64, P235, DOI 10.1016/0092-8674(91)90636-D; Buvoli M, 2002, GENE THER, V9, P227, DOI 10.1038/sj.gt.3301640; Clayman GL, 1998, J CLIN ONCOL, V16, P2221, DOI 10.1200/JCO.1998.16.6.2221; Davis ME, 2010, NATURE, V464, P1067, DOI 10.1038/nature08956; Deng WG, 2007, CANCER RES, V67, P709, DOI 10.1158/0008-5472.CAN-06-3463; Du LQ, 2009, MOL CANCER RES, V7, P1234, DOI 10.1158/1541-7786.MCR-08-0507; Firozi P, 2010, GENE THER, V17, P1484, DOI 10.1038/gt.2010.97; HEARING P, 1983, CELL, V33, P695, DOI 10.1016/0092-8674(83)90012-0; Ito I, 2004, CANCER GENE THER, V11, P733, DOI 10.1038/sj.cgt.7700756; Ito I, 2003, MOL THER, V7, P409, DOI 10.1016/S1525-0016(03)00004-2; Ji L, 2002, CANCER RES, V62, P2715; Ji L, 2008, J THORAC ONCOL, V3, P327, DOI 10.1097/JTO.0b013e31816bce65; Ji Lin, 2005, Future Oncol, V1, P79, DOI 10.1517/14796694.1.1.79; Lerman MI, 2000, CANCER RES, V60, P6116; Lowe SW, 2004, NATURE, V432, P307, DOI 10.1038/nature03098; McLachlan G, 2000, GENE THER, V7, P384, DOI 10.1038/sj.gt.3301097; MILLER AB, 1981, CANCER, V47, P207, DOI 10.1002/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6; OQUIGLEY J, 1990, BIOMETRICS, V46, P33, DOI 10.2307/2531628; Prudkin L, 2008, CLIN CANCER RES, V14, P41, DOI 10.1158/1078-0432.CCR-07-1252; Puri A, 2009, CRIT REV THER DRUG, V26, P523, DOI 10.1615/CritRevTherDrugCarrierSyst.v26.i6.10; Ramesh R, 2001, MOL THER, V3, P337, DOI 10.1006/mthe.2001.0266; Roth JA, 2006, EXPERT OPIN BIOL TH, V6, P55, DOI 10.1517/14712598.6.1.55; Roth JA, 1996, NAT MED, V2, P985, DOI 10.1038/nm0996-985; Simberg D, 2005, HUM GENE THER, V16, P1087, DOI 10.1089/hum.2005.16.1087; Simberg D, 2007, P NATL ACAD SCI USA, V104, P932, DOI 10.1073/pnas.0610298104; Swisher SG, 1999, J NATL CANCER I, V91, P763, DOI 10.1093/jnci/91.9.763; Templeton NS, 1997, NAT BIOTECHNOL, V15, P647, DOI 10.1038/nbt0797-647; Tousignant JD, 2000, HUM GENE THER, V11, P2493, DOI 10.1089/10430340050207984; Uno F, 2004, CANCER RES, V64, P2969, DOI 10.1158/0008-5472.CAN-03-3702; WILKINSON GWG, 1992, NUCLEIC ACIDS RES, V20, P2233, DOI 10.1093/nar/20.9.2233; Wistuba II, 1999, ONCOGENE, V18, P643, DOI 10.1038/sj.onc.1202349; Yang JP, 1997, GENE THER, V4, P950, DOI 10.1038/sj.gt.3300485	33	213	218	3	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e34833	10.1371/journal.pone.0034833	http://dx.doi.org/10.1371/journal.pone.0034833			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558101	gold, Green Submitted, Green Published			2022-12-27	WOS:000305345200014
J	Jin, HY; Song, B; Oudit, GY; Davidge, ST; Yu, HM; Jiang, YY; Gao, PJ; Zhu, DL; Ning, G; Kassiri, Z; Penninger, JM; Zhong, JC				Jin, Hai-Yan; Song, Bei; Oudit, Gavin Y.; Davidge, Sandra T.; Yu, Hui-Min; Jiang, Yan-Yan; Gao, Ping-Jin; Zhu, Ding-Liang; Ning, Guang; Kassiri, Zamaneh; Penninger, Josef M.; Zhong, Jiu-Chang			ACE2 Deficiency Enhances Angiotensin II-Mediated Aortic Profilin-1 Expression, Inflammation and Peroxynitrite Production	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; CONVERTING ENZYME 2; SPONTANEOUSLY HYPERTENSIVE-RATS; VASCULAR INFLAMMATION; OXIDATIVE STRESS; NAD(P)H OXIDASE; NULL MICE; OVEREXPRESSION; HYPERTROPHY; DYSFUNCTION	Inflammation and oxidative stress play a crucial role in angiotensin (Ang) II-mediated vascular injury. Angiotensin-converting enzyme 2 (ACE2) has recently been identified as a specific Ang II-degrading enzyme but its role in vascular biology remains elusive. We hypothesized that loss of ACE2 would facilitate Ang II-mediated vascular inflammation and peroxynitrite production. 10-week wildtype (WT, Ace2(+/y)) and ACE2 knockout (ACE2KO, Ace2(-/y)) mice received with mini-osmotic pumps with Ang II (1.5 mg.kg(-1).d(-1)) or saline for 2 weeks. Aortic ACE2 protein was obviously reduced in WT mice in response to Ang II related to increases in profilin-1 protein and plasma levels of Ang II and Ang-(1-7). Loss of ACE2 resulted in greater increases in Ang II-induced mRNA expressions of inflammatory cytokines monocyte chemoattractant protein-1 (MCP-1), interleukin (IL)-1 beta, and IL-6 without affecting tumor necrosis factor-alpha in aortas of ACE2KO mice. Furthermore, ACE2 deficiency led to greater increases in Ang II-mediated profilin-1 expression, NADPH oxidase activity, and superoxide and peroxynitrite production in the aortas of ACE2KO mice associated with enhanced phosphorylated levels of Akt, p70S6 kinase, extracellular signal-regulated kinases (ERK1/2) and endothelial nitric oxide synthase (eNOS). Interestingly, daily treatment with AT1 receptor blocker irbesartan (50 mg/kg) significantly prevented Ang II-mediated aortic profilin-1 expression, inflammation, and peroxynitrite production in WT mice with enhanced ACE2 levels and the suppression of the Akt-ERK-eNOS signaling pathways. Our findings reveal that ACE2 deficiency worsens Ang II-mediated aortic inflammation and peroxynitrite production associated with the augmentation of profilin-1 expression and the activation of the Akt-ERK-eNOS signaling, suggesting potential therapeutic approaches by enhancing ACE2 action for patients with vascular diseases.	[Jin, Hai-Yan; Song, Bei; Gao, Ping-Jin; Zhu, Ding-Liang; Ning, Guang; Zhong, Jiu-Chang] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, State Key Lab Med Genom, Shanghai 200030, Peoples R China; [Jin, Hai-Yan; Song, Bei; Gao, Ping-Jin; Zhu, Ding-Liang; Zhong, Jiu-Chang] Shanghai Res Inst Hypertens, Shanghai Key Lab Vasc Biol, Shanghai, Peoples R China; [Oudit, Gavin Y.; Davidge, Sandra T.; Jiang, Yan-Yan; Kassiri, Zamaneh] Univ Alberta, Dept Med, Div Cardiol, Mazankowski Alberta Heart Inst, Edmonton, AB, Canada; [Davidge, Sandra T.; Jiang, Yan-Yan] Univ Alberta, Dept Obstet, Women & Childrens Hlth Res Inst, Edmonton, AB, Canada; [Davidge, Sandra T.; Jiang, Yan-Yan] Univ Alberta, Dept Gynecol, Women & Childrens Hlth Res Inst, Edmonton, AB, Canada; [Yu, Hui-Min] Guangdong Gen Hosp, Dept Cardiol, Guangzhou, Guangdong, Peoples R China; [Yu, Hui-Min] Guangdong Cardiovasc Inst, Guangzhou, Guangdong, Peoples R China; [Penninger, Josef M.] Austrian Acad Sci, Inst Mol Biotechnol, A-1010 Vienna, Austria	Chinese Academy of Sciences; Shanghai Jiao Tong University; University of Alberta; University of Alberta; University of Alberta; Guangdong Academy of Medical Sciences & Guangdong General Hospital; Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA)	Jin, HY (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, State Key Lab Med Genom, Shanghai 200030, Peoples R China.	jiuchangzhong@yahoo.com.cn	Penninger, Josef M/I-6860-2013; Buchko, Garry/G-6173-2015	Penninger, Josef M/0000-0002-8194-3777; Davidge, Sandra/0000-0002-5559-4905; Buchko, Garry/0000-0002-3639-1061	National Natural Science Foundation of China [30973522, 81170246]; Shanghai Pujiang Talents Program [11PJ1408300]; Health Bureau of Shanghai [2011347]; Canadian Institute for Health Research [86602, 84279]; Alberta Innovates-Health Solutions; Shanghai Jiao Tong University School of Medicine	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Pujiang Talents Program(Shanghai Pujiang Program); Health Bureau of Shanghai; Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Innovates-Health Solutions; Shanghai Jiao Tong University School of Medicine	This work was supported by National Natural Science Foundation of China (Grants. 30973522 & 81170246 to JCZ), Shanghai Pujiang Talents Program (11PJ1408300 to JCZ), Scientific Research Project of Health Bureau of Shanghai (2011347 to HYJ), the Canadian Institute for Health Research (Grants 86602 to GYO, 84279 to ZK), the Alberta Innovates-Health Solutions (JCZ and GYO), and "New Hundred Talents Program" of Shanghai Jiao Tong University School of Medicine to JCZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbate A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027923; Batlle D, 2010, CIRC RES, V107, P822, DOI 10.1161/CIRCRESAHA.110.229831; Bodiga S, 2011, CARDIOVASC RES, V91, P151, DOI 10.1093/cvr/cvr036; Briones AM, 2010, CURR HYPERTENS REP, V12, P135, DOI 10.1007/s11906-010-0100-z; Caglayan E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013608; Cheng JF, 2011, VASC PHARMACOL, V55, P34, DOI 10.1016/j.vph.2011.04.003; Clarke NE, 2012, INT J HYPERTENS, V2012, DOI 10.1155/2012/307315; Crackower MA, 2002, NATURE, V417, P822, DOI 10.1038/nature00786; Ebrahimian T, 2011, HYPERTENSION, V57, P245, DOI 10.1161/HYPERTENSIONAHA.110.159889; Ferrario CM, 2005, CIRCULATION, V111, P2605, DOI 10.1161/CIRCULATIONAHA.104.510461; Gragasin FS, 2003, ARTERIOSCL THROM VAS, V23, P38, DOI 10.1161/01.ATV.0000047868.93732.B7; Guo YJ, 2008, ARCH MED RES, V39, P149, DOI 10.1016/j.arcmed.2007.07.010; Hassona MDH, 2011, J CARDIOVASC PHARM, V57, P550, DOI 10.1097/FJC.0b013e318212b1c2; Horrevoets AJG, 2007, CIRC RES, V101, P328, DOI 10.1161/CIRCRESAHA.107.158881; Ishibashi M, 2004, CIRC RES, V94, P1203, DOI 10.1161/01.RES.0000126924.23467.A3; Kagota S, 2009, J PHARMACOL SCI, V109, P556, DOI 10.1254/jphs.08273FP; Kasina S, 2006, NITRIC OXIDE-BIOL CH, V14, P65, DOI 10.1016/j.niox.2005.09.008; Kassiri Z, 2009, CIRC-HEART FAIL, V2, P446, DOI 10.1161/CIRCHEARTFAILURE.108.840124; Mollnau H, 2002, CIRC RES, V90, pE58, DOI 10.1161/01.RES.0000012569.55432.02; Moustafa-Bayoumi M, 2007, J BIOL CHEM, V282, P37632, DOI 10.1074/jbc.M703227200; Oudit GY, 2007, CARDIOVASC RES, V75, P29, DOI 10.1016/j.cardiores.2007.04.007; Oudit GY, 2010, DIABETES, V59, P529, DOI 10.2337/db09-1218; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Romeo GR, 2007, CIRC RES, V101, P357, DOI 10.1161/CIRCRESAHA.107.151399; Schiffrin EL, 2012, HYPERTENSION, V59, P367, DOI 10.1161/HYPERTENSIONAHA.111.187021; Sriramula S, 2011, CARDIOVASC RES, V92, P401, DOI 10.1093/cvr/cvr242; Wenzel P, 2011, CIRCULATION, V124, P1370, DOI 10.1161/CIRCULATIONAHA.111.034470; Wind S, 2010, HYPERTENSION, V56, P490, DOI 10.1161/HYPERTENSIONAHA.109.149187; Xia HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022682; Zhong JC, 2008, BRIT J PHARMACOL, V153, P66, DOI 10.1038/sj.bjp.0707482; Zhong JC, 2004, HYPERTENSION, V44, P907, DOI 10.1161/01.HYP.0000146400.57221.74; Zhong JC, 2007, CARDIOVASC RES, V74, P388, DOI 10.1016/j.cardiores.2007.02.002; Zhong JC, 2011, REGUL PEPTIDES, V166, P90, DOI 10.1016/j.regpep.2010.09.005; Zhong JC, 2011, HYPERTENSION, V57, P314, DOI 10.1161/HYPERTENSIONAHA.110.164244; Zhong JC, 2010, CIRCULATION, V122, P717, DOI 10.1161/CIRCULATIONAHA.110.955369	35	71	77	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e38502	10.1371/journal.pone.0038502	http://dx.doi.org/10.1371/journal.pone.0038502			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22879982	Green Published, Green Submitted, gold			2022-12-27	WOS:000305343900051
J	Dent, R; Blackmore, A; Peterson, J; Habib, R; Kay, GP; Gervais, A; Taylor, V; Wells, G				Dent, Robert; Blackmore, Angelique; Peterson, Joan; Habib, Rami; Kay, Gary Peter; Gervais, Alan; Taylor, Valerie; Wells, George			Changes in Body Weight and Psychotropic Drugs: A Systematic Synthesis of the Literature	PLOS ONE			English	Review							LONG-TERM TREATMENT; DOUBLE-BLIND; ATYPICAL ANTIPSYCHOTICS; BIPOLAR DISORDER; 2ND-GENERATION ANTIDEPRESSANTS; SCHIZOAFFECTIVE DISORDER; DIABETES-MELLITUS; EXTENDED-RELEASE; HALOPERIDOL DECANOATE; MONITORING PRACTICES	Introduction: Psychotropic medication use is associated with weight gain. While there are studies and reviews comparing weight gain for psychotropics within some classes, clinicians frequently use drugs from different classes to treat psychiatric disorders. Objective: To undertake a systematic review of all classes of psychotropics to provide an all encompassing evidence-based tool that would allow clinicians to determine the risks of weight gain in making both intra-class and interclass choices of psychotropics. Methodology and Results: We developed a novel hierarchical search strategy that made use of systematic reviews that were already available. When such evidence was not available we went on to evaluate randomly controlled trials, followed by cohort and other clinical trials, narrative reviews, and, where necessary, clinical opinion and anecdotal evidence. The data from the publication with the highest level of evidence based on our hierarchical classification was presented. Recommendations from an expert panel supplemented the evidence used to rank these drugs within their respective classes. Approximately 9500 articles were identified in our literature search of which 666 citations were retrieved. We were able to rank most of the psychotropics based on the available evidence and recommendations from subject matter experts. There were few discrepancies between published evidence and the expert panel in ranking these drugs. Conclusion: Potential for weight gain is an important consideration in choice of any psychotropic. This tool will help clinicians select psychotropics on a case-by-case basis in order to minimize the impact of weight gain when making both intra-class and interclass choices.	[Dent, Robert; Blackmore, Angelique; Gervais, Alan] Ottawa Hosp, Weight Management Clin, Toronto, ON, Canada; [Peterson, Joan] Ottawa Hlth Res Inst, Ottawa, ON, Canada; [Dent, Robert; Habib, Rami; Kay, Gary Peter] Univ Ottawa, Dept Psychiat, Ottawa, ON K1N 6N5, Canada; [Taylor, Valerie] Univ Toronto, Toronto, ON, Canada; [Wells, George] Univ Ottawa, Inst Heart, Cardiovasc Res Methods Ctr, Ottawa, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Toronto; University of Ottawa; University of Ottawa Heart Institute	Dent, R (corresponding author), Ottawa Hosp, Weight Management Clin, Toronto, ON, Canada.	bdent@ottawahospital.on.ca	Wells, George A/M-4549-2017; Taylor, Valerie H/H-6242-2015; Hoekstra, Hopi/I-6690-2012	Wells, George A/0000-0002-2289-9139; Peterson, Brant/0000-0002-0433-3035; Taylor, Valerie/0000-0002-8948-638X; Hoekstra, Hopi/0000-0003-1431-1769; Fisher, Heidi S./0000-0001-5622-4335; Weber, Jesse/0000-0003-4839-6684; Delaney, Emily/0000-0003-3609-5702	NIGMS NIH HHS [F32 GM084719] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahmer S, 2005, PSYCHIATR BULL, V29, P302, DOI 10.1192/pb.29.8.302; Allard P, 2004, INT J GERIATR PSYCH, V19, P1123, DOI 10.1002/gps.1190; Allison DB, 2003, PSYCHIAT SERV, V54, P565, DOI 10.1176/appi.ps.54.4.565; Allison DB, 1999, AM J PSYCHIAT, V156, P1686; Allison DB, 2001, J CLIN PSYCHIAT, V62, P22; Alvarez-Jimenez M, 2008, CNS DRUGS, V22, P547, DOI 10.2165/00023210-200822070-00002; Amer Diabet Assoc, 2004, DIABETES CARE, V27, P596, DOI 10.2337/diacare.27.2.596; Anderson IM, 2000, J PSYCHOPHARMACOL, V14, P3, DOI 10.1177/026988110001400101; Anderson T, 2004, PRIM PSYCHIAT, V11, P48; Aronne LJ, 2003, J CLIN PSYCHIAT, V64, P22; Ashton AK, 2005, CURR THER RES CLIN E, V66, P96, DOI 10.1016/j.curtheres.2005.04.006; Bagnall A, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002083.pub2; Barbui C, 2004, J CLIN PSYCHOPHARM, V24, P126, DOI 10.1097/01.jcp.0000115665.45074.0d; Beasley CM, 2007, J CLIN PSYCHOPHARM, V27, P252, DOI 10.1097/JCP.0b013e3180582426; BECHELLI LPC, 1985, CURR THER RES CLIN E, V37, P662; Benazzi F, 1998, PSYCHOTHER PSYCHOSOM, V67, P271, DOI 10.1159/000012291; Bergman RN, 2005, J CLIN PSYCHIAT, V66, P504, DOI 10.4088/JCP.v66n0414; Bisol LW, 2008, J CLIN PSYCHIAT, V69, P1572, DOI 10.4088/JCP.v69n1007; Bitter I, 2004, PROG NEURO-PSYCHOPH, V28, P173, DOI 10.1016/j.pnpbp.2003.09.033; BJERTNAES A, 1982, ACTA PSYCHIAT SCAND, V66, P199, DOI 10.1111/j.1600-0447.1982.tb00928.x; Boilson M, 2003, PSYCHIAT B, V27, P424; Bowden CL, 2006, AM J PSYCHIAT, V163, P1199, DOI 10.1176/appi.ajp.163.7.1199; Bowden CL, 2010, INT CLIN PSYCHOPHARM, V25, P60, DOI 10.1097/YIC.0b013e328333ac1b; Bramlage P, 2004, INT J OBESITY, V28, P1299, DOI 10.1038/sj.ijo.0802752; Buckley PF, 2005, SCHIZOPHR RES, V79, P281, DOI 10.1016/j.schres.2005.04.010; Canas F, 2010, EXPERT OPIN DRUG SAF, V9, P683, DOI 10.1517/14740338.2010.506712; CANTU TG, 1988, DRUG INTEL CLIN PHAR, V22, P755, DOI 10.1177/106002808802201002; Cash TF, 2000, PERCEPT MOTOR SKILL, V90, P453, DOI 10.2466/PMS.90.2.453-456; Chakrabarti A, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001943.pub2; Chwieduk CM, 2010, DRUGS, V70, P1295, DOI 10.2165/11204840-000000000-00000; Citrome L, 2010, INT J CLIN PRACT, V64, P216, DOI 10.1111/j.1742-1241.2009.02240.x; Citrome L, 2009, INT J CLIN PRACT, V63, P1762, DOI 10.1111/j.1742-1241.2009.02228.x; Citrome L, 2007, J CLIN PSYCHIAT, V68, P12; Davidson J, 2004, J CLIN PSYCHOPHARM, V24, P118, DOI 10.1097/01.jcp.0000106222.36344.96; El-Khayat R, 1998, J PSYCHOPHARMACOL, V12, P323, DOI 10.1177/026988119801200401; Feeney Larkin, 2006, Irish Journal of Psychological Medicine, V23, P100, DOI [10.1017/S0790966700009113, 10.1017/S0790966700009721]; FEIGHNER J, 1986, J CLIN PSYCHOPHARM, V6, P27; Fenton M, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001944.pub2; Fontaine KR, 2001, PSYCHIAT RES, V101, P277, DOI 10.1016/S0165-1781(01)00234-7; Gao KM, 2006, J CLIN PSYCHIAT, V67, P1327, DOI 10.4088/JCP.v67n0902; GARLAND EJ, 1988, J CLIN PSYCHOPHARM, V8, P323; Gartlehner G, 2008, ANN INTERN MED, V149, P734, DOI 10.7326/0003-4819-149-10-200811180-00008; Gartlehner G, 2010, J CLIN EPIDEMIOL, V63, P117, DOI 10.1016/j.jclinepi.2008.09.019; Gartlehner G, 2008, DRUG SAFETY, V31, P851, DOI 10.2165/00002018-200831100-00004; Gebhardt S, 2009, J PSYCHIATR RES, V43, P620, DOI 10.1016/j.jpsychires.2008.11.001; Gentile S, 2009, OBES REV, V10, P527, DOI 10.1111/j.1467-789X.2009.00589.x; GITLIN MJ, 1989, J CLIN PSYCHIAT, V50, P127; Goethe JW, 2007, J CLIN PSYCHOPHARM, V27, P451, DOI 10.1097/jcp.0b013e31815152a5; Haddad PM, 2007, CNS DRUGS, V21, P911, DOI 10.2165/00023210-200721110-00004; Hale Katherine S., 2010, JOURNAL OF PHARMACY TECHNOLOGY, V26, P193; Hamer S, 2007, BRIT J PSYCHIAT, V191, pS64, DOI 10.1192/bjp.191.50.s64; Hansen RA, 2005, ANN INTERN MED, V143, P415, DOI 10.7326/0003-4819-143-6-200509200-00006; HARRIS B, 1986, BRIT J PSYCHIAT, V148, P590, DOI 10.1192/bjp.148.5.590; Hedenmalm K, 2002, DRUG SAFETY, V25, P1107, DOI 10.2165/00002018-200225150-00005; Henderson DC, 2007, J CLIN PSYCHIAT, V68, P18; Henderson DC, 2000, AM J PSYCHIAT, V157, P975, DOI 10.1176/appi.ajp.157.6.975; Heres S, 2006, AM J PSYCHIAT, V163, P185, DOI 10.1176/appi.ajp.163.2.185; Jeste DV, 2004, J PSYCHIATR RES, V38, P73, DOI 10.1016/S0022-3956(03)00094-3; Johnsen E, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-31; JOHNSON DAW, 1979, ACTA PSYCHIAT SCAND, V59, P525, DOI 10.1111/j.1600-0447.1979.tb00252.x; Karagianis J, 2008, HUM PSYCHOPHARM CLIN, V23, P275, DOI 10.1002/hup.933; Ketter TA, 2004, J CLIN PSYCHIAT, V65, P668; Kinon BJ, 2001, J CLIN PSYCHIAT, V62, P92, DOI 10.4088/JCP.v62n0204; Komossa K, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006624.pub2; Komossa K, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006654.pub2; Komossa K, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006625.pub2; Komossa K, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006627.pub2; Komossa K, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006569.pub3; Kumar A, 2009, SCHIZOPHRENIA BULL, V35, P855, DOI 10.1093/schbul/sbp077; Kurzthaler I, 2001, J CLIN PSYCHIAT, V62, P32; Kwon JS, 2009, PSYCHIAT CLIN NEUROS, V63, P73, DOI 10.1111/j.1440-1819.2008.01907.x; Lam RW, 2009, J AFFECT DISORDERS, V117, pS26, DOI 10.1016/j.jad.2009.06.041; Lencz Todd, 2009, Dialogues Clin Neurosci, V11, P405; Leslie DL, 2004, AM J PSYCHIAT, V161, P1709, DOI 10.1176/appi.ajp.161.9.1709; Leslie WS, 2007, QJM-INT J MED, V100, P395, DOI 10.1093/qjmed/hcm044; Leucht S, 2009, LANCET, V373, P31, DOI 10.1016/S0140-6736(08)61764-X; Lieberman JA, 2003, NEUROPSYCHOPHARMACOL, V28, P995, DOI 10.1038/sj.npp.1300157; Lieberman JA, 2005, NEW ENGL J MED, V353, P1209, DOI 10.1056/NEJMoa051688; Lindenmayer JP, 2009, J CLIN PSYCHIAT, V70, P990, DOI 10.4088/JCP.08m04221; Lindenmayer JP, 2004, J CLIN PSYCHIAT, V65, P1084; Mackin P, 2007, BMC PSYCHIATRY, V7, DOI 10.1186/1471-244X-7-28; Malone M, 2005, ANN PHARMACOTHER, V39, P2046, DOI 10.1345/aph.1G333; Marder SR, 2004, AM J PSYCHIAT, V161, P1334, DOI 10.1176/appi.ajp.161.8.1334; Marino J, 2010, ANN PHARMACOTHER, V44, P863, DOI 10.1345/aph.1M603; Marques L.O., 2004, COCHRANE DB SYST REV; Masand PS, 2003, CLIN THER, V25, P2289, DOI 10.1016/S0149-2918(03)80220-5; McEvoy JP, 2007, AM J PSYCHIAT, V164, P1050, DOI 10.1176/appi.ajp.164.7.1050; McIntyre RS, 2001, CAN J PSYCHIAT, V46, P273, DOI 10.1177/070674370104600308; Melvin CL, 2008, J PSYCHIATR PRACT, V14, P9, DOI 10.1097/01.pra.0000333583.75741.8b; Montgomery SA, 1998, INT CLIN PSYCHOPHARM, V13, P63, DOI 10.1097/00004850-199803000-00002; Morrato EH, 2009, DIABETES CARE, V32, P1037, DOI 10.2337/dc08-1720; Nasrallah HA, 2003, CNS SPECTRUMS, V8, P23, DOI 10.1017/S1092852900008166; Nasrallah HA, 2007, J CLIN PSYCHIAT, V68, P5; Nasrallah Henry A, 2004, J Clin Psychopharmacol, V24, pS7, DOI 10.1097/01.jcp.0000142282.62336.e9; Newcomer JW, 2004, CLIN THER, V26, P1936, DOI 10.1016/j.clinthera.2004.12.003; Nguyen D, 2009, AUSTRALAS PSYCHIATRY, V17, P295, DOI 10.1080/10398560902842519; Okugawa G, 2009, PSYCHIAT CLIN NEUROS, V63, P322, DOI 10.1111/j.1440-1819.2009.01947.x; OSWALD I, 1980, BRIT MED J, V281, P1039, DOI 10.1136/bmj.281.6247.1039-a; Perkins DO, 2002, J CLIN PSYCHIAT, V63, P1121, DOI 10.4088/JCP.v63n1206; Perry R, 2009, CLIN THER, V31, P1374, DOI 10.1016/j.clinthera.2009.07.012; Perucca E, 2005, ACTA NEUROL SCAND, V112, P30, DOI 10.1111/j.1600-0404.2005.00506.x; Reinstein MJ, 2003, CLIN DRUG INVEST, V23, P671, DOI 10.2165/00044011-200323100-00006; Rosenheck RA, 2009, SCHIZOPHR RES, V107, P22, DOI 10.1016/j.schres.2008.09.031; Sachs GS, 1999, J CLIN PSYCHIAT, V60, P16; Schatzberg AF, 2007, J CLIN PSYCHIAT, V68, P26; Seeman MV, 2009, SCHIZOPHRENIA BULL, V35, P937, DOI 10.1093/schbul/sbn023; Sernyak MJ, 2002, AM J PSYCHIAT, V159, P561, DOI 10.1176/appi.ajp.159.4.561; Serretti A, 2010, J CLIN PSYCHIAT, V71, P1259, DOI 10.4088/JCP.09r05346blu; Shea BJ, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-10; Shelton RC, 2007, PRIMARY PSYCHIAT, V14, P42; Simpson GM, 2005, AM J PSYCHIAT, V162, P1535, DOI 10.1176/appi.ajp.162.8.1535; Sismondo S, 2008, CONTEMP CLIN TRIALS, V29, P109, DOI 10.1016/j.cct.2007.08.001; Sivaraman P, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007779.pub2; Smith MC, 2004, EPILEPSY BEHAV, V5, P746, DOI 10.1016/j.yebeh.2004.07.007; Smits JAJ, 2010, J PSYCHIATR RES, V44, P1010, DOI 10.1016/j.jpsychires.2010.04.007; Spina E, 2000, PSYCHOPHARMACOLOGY, V148, P83, DOI 10.1007/s002130050028; Stoffers J, 2010, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD005653.pub2, 10.1002/1465185.CD005653.pub2]; Sun SX, 2007, CURR MED RES OPIN, V23, P2305, DOI 10.1185/030079907X226050; Suppes T, 2007, PSYCHOPHARMACOL BULL, V40, P22; Sussman N, 2003, J CLIN PSYCHOPHARM, V23, pS21, DOI 10.1097/00004714-200306001-00005; Taylor DM, 2000, ACTA PSYCHIAT SCAND, V101, P416, DOI 10.1034/j.1600-0447.2000.101006416.x; Tham M.S.P., 2007, J MENT HEALTH, V16, P771, DOI [DOI 10.1080/09638230701496352, 10.1080/09638230701496352]; Thieda P, 2003, PSYCHIAT SERV, V54, P508, DOI 10.1176/appi.ps.54.4.508; Tran PV, 1999, BRIT J PSYCHIAT, V174, P15, DOI 10.1192/bjp.174.1.15; Velligan DI, 2009, J CLIN PSYCHIAT, V70, P6; Weiden PJ, 2007, J CLIN PSYCHIAT, V68, P34; Weiden PJ, 2004, SCHIZOPHR RES, V66, P51, DOI 10.1016/S0920-9964(02)00498-X; Westenberg HGM, 2004, J CLIN PSYCHOPHARM, V24, P49, DOI 10.1097/01.jcp.0000104906.75206.8b; WISTEDT B, 1984, CURR THER RES CLIN E, V35, P804; Yuanguang CC, 1998, CHINESE J PSYCHIAT, V31, P43; Zipursky RB, 2005, BRIT J PSYCHIAT, V187, P537, DOI 10.1192/bjp.187.6.537	131	1070	1079	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2012	7	6							e36889	10.1371/journal.pone.0036889	http://dx.doi.org/10.1371/journal.pone.0036889			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WX	22719834	gold, Green Submitted, Green Published			2022-12-27	WOS:000305350000002
J	Thomas, MA; Klaper, RD				Thomas, Michael A.; Klaper, Rebecca D.			Psychoactive Pharmaceuticals Induce Fish Gene Expression Profiles Associated with Human Idiopathic Autism	PLOS ONE			English	Article							SET ENRICHMENT ANALYSIS; SEWAGE-TREATMENT PLANTS; COPY NUMBER VARIATION; WASTE-WATER; PRENATAL EXPOSURE; BIPOLAR DISORDER; SURFACE WATERS; ANTIDEPRESSANTS; BEHAVIOR; DRUGS	Idiopathic autism, caused by genetic susceptibility interacting with unknown environmental triggers, has increased dramatically in the past 25 years. Identifying environmental triggers has been difficult due to poorly understood pathophysiology and subjective definitions of autism. The use of antidepressants by pregnant women has been associated with autism. These and other unmetabolized psychoactive pharmaceuticals (UPPs) have also been found in drinking water from surface sources, providing another possible exposure route and raising questions about human health consequences. Here, we examined gene expression patterns of fathead minnows treated with a mixture of three psychoactive pharmaceuticals (fluoxetine, venlafaxine & carbamazepine) in dosages intended to be similar to the highest observed conservative estimates of environmental concentrations. We conducted microarray experiments examining brain tissue of fish exposed to individual pharmaceuticals and a mixture of all three. We used gene-class analysis to test for enrichment of gene sets involved with ten human neurological disorders. Only sets associated with idiopathic autism were unambiguously enriched. We found that UPPs induce autism-like gene expression patterns in fish. Our findings suggest a new potential trigger for idiopathic autism in genetically susceptible individuals involving an overlooked source of environmental contamination.	[Thomas, Michael A.] Idaho State Univ Sch, Dept Biol Sci, Pocatello, ID 83204 USA; [Klaper, Rebecca D.] Univ Wisconsin, Sch Freshwater Sci, Milwaukee, WI 53201 USA	Idaho; Idaho State University; University of Wisconsin System; University of Wisconsin Milwaukee	Thomas, MA (corresponding author), Idaho State Univ Sch, Dept Biol Sci, Pocatello, ID 83204 USA.	mthomas@isu.edu	Thomas, Michael A/B-7489-2008	Thomas, Michael A/0000-0003-2982-0291; Klaper, Rebecca/0000-0002-9239-6916; Suh, Mina/0000-0002-9557-4933; harris, mark/0000-0002-9007-1587	PhRMA Foundation Sabbatical Fellowship grant; National Institutes of Health from the INBRE Program of the National Center for Research Resources [P20 RR016454]; University Research Committee of Idaho State University [URC-FY2010-05]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016454] Funding Source: NIH RePORTER	PhRMA Foundation Sabbatical Fellowship grant; National Institutes of Health from the INBRE Program of the National Center for Research Resources; University Research Committee of Idaho State University; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	MAT was supported by a PhRMA Foundation Sabbatical Fellowship grant, National Institutes of Health Grant Number P20 RR016454 from the INBRE Program of the National Center for Research Resources, and grant number URC-FY2010-05 from the University Research Committee of Idaho State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baron-Cohen S, 2006, PROG NEURO-PSYCHOPH, V30, P865, DOI 10.1016/j.pnpbp.2006.01.010; Batt AL, 2008, ANAL CHEM, V80, P5021, DOI 10.1021/ac800066n; Berger M, 2009, ANNU REV MED, V60, P355, DOI 10.1146/annurev.med.60.042307.110802; Blalock EM, 2004, P NATL ACAD SCI USA, V101, P2173, DOI 10.1073/pnas.0308512100; Bomprezzi R, 2003, HUM MOL GENET, V12, P2191, DOI 10.1093/hmg/ddg221; Bromley RL, 2008, NEUROLOGY, V71, P1923, DOI 10.1212/01.wnl.0000339399.64213.1a; Bromley RL, 2009, CURR OPIN NEUROL, V22, P162, DOI 10.1097/WCO.0b013e3283292401; Bruce GM, 2010, ENVIRON SCI TECHNOL, V44, P5619, DOI 10.1021/es1004895; Camacho-Munoz MD, 2010, J HAZARD MATER, V177, P1159, DOI 10.1016/j.jhazmat.2010.01.030; Casper RC, 2003, J PEDIATR-US, V142, P402, DOI 10.1067/mpd.2003.139; Celiz MD, 2009, ENVIRON TOXICOL CHEM, V28, P2473, DOI 10.1897/09-173.1; Chakrabarti B, 2009, AUTISM RES, V2, P157, DOI 10.1002/aur.80; Chen M, 2006, WATER QUAL RES J CAN, V41, P351, DOI 10.2166/wqrj.2006.039; Christensen AM, 2009, CHEMOSPHERE, V77, P351, DOI 10.1016/j.chemosphere.2009.07.018; Corcoran J, 2010, CRIT REV TOXICOL, V40, P287, DOI 10.3109/10408440903373590; Croen LA, 2011, ARCH GEN PSYCHIAT AR; Cunningham VL, 2009, REGUL TOXICOL PHARM, V53, P39, DOI 10.1016/j.yrtph.2008.10.006; Currenti SA, 2010, CELL MOL NEUROBIOL, V30, P161, DOI 10.1007/s10571-009-9453-8; DasBanerjee T, 2008, AM J MED GENET B, V147B, P1554, DOI 10.1002/ajmg.b.30877; Dufour-Rainfray D, 2011, NEUROSCI BIOBEHAV R, V35, P1254, DOI 10.1016/j.neubiorev.2010.12.013; Dufour-Rainfray D, 2010, NEUROSCI LETT, V470, P55, DOI 10.1016/j.neulet.2009.12.054; Favreliere S, 2010, ENCEPHALE, V36, pD133, DOI 10.1016/j.encep.2009.06.005; Gentile S, 2010, DEPRESS ANXIETY, V27, P675, DOI 10.1002/da.20706; Gilli F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008962; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; Alonso SG, 2010, ENVIRON INT, V36, P195, DOI 10.1016/j.envint.2009.11.004; Gros M, 2010, ENVIRON INT, V36, P15, DOI 10.1016/j.envint.2009.09.002; Hadjikhani N, 2010, MED HYPOTHESES, V74, P880, DOI 10.1016/j.mehy.2009.11.015; Hallmayer J, 2011, ARCH GEN PSYCHIAT AR; Hollander E, 2009, PSYCHIAT RES, V170, P43, DOI 10.1016/j.psychres.2008.07.014; Hu VW, 2009, AUTISM RES, V2, P78, DOI 10.1002/aur.73; Hu VW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005775; Hughes JR, 2009, EPILEPSY BEHAV, V16, P569, DOI 10.1016/j.yebeh.2009.09.023; Iwamoto K, 2004, MOL PSYCHIATR, V9, P406, DOI 10.1038/sj.mp.4001437; Jjemba PK, 2006, ECOTOX ENVIRON SAFE, V63, P113, DOI 10.1016/j.ecoenv.2004.11.011; Johnson CP, 2007, PEDIATRICS, V120, P1183, DOI 10.1542/peds.2007-2361; Landrigan PJ, 2010, CURR OPIN PEDIATR, V22, P219, DOI 10.1097/MOP.0b013e328336eb9a; Madureira TV, 2010, SCI TOTAL ENVIRON, V408, P5513, DOI 10.1016/j.scitotenv.2010.07.069; Martins-De-Souza D, 2010, WORLD J BIOL PSYCHIA, V11, P110, DOI 10.3109/15622970903490626; Matigian N, 2007, MOL PSYCHIATR, V12, P815, DOI 10.1038/sj.mp.4001998; McDonald ME, 2010, ENVIRON SCI TECHNOL, V44, P2112, DOI 10.1021/es902057k; McGary KL, 2010, P NATL ACAD SCI USA, V107, P6544, DOI 10.1073/pnas.0910200107; McNamara IM, 2008, BRAIN RES, V1189, P203, DOI 10.1016/j.brainres.2007.10.063; Mennigen JA, 2010, AQUAT TOXICOL, V100, P128, DOI 10.1016/j.aquatox.2010.07.022; Metcalfe CD, 2003, ENVIRON TOXICOL CHEM, V22, P2881, DOI 10.1897/02-627; Metcalfe CD, 2010, ENVIRON TOXICOL CHEM, V29, P79, DOI 10.1002/etc.27; Nakamura K, 2011, PROG NEURO-PSYCHOPH, V35, P454, DOI 10.1016/j.pnpbp.2010.11.033; Nakhai-Pour HR, 2010, CAN MED ASSOC J, V182, P1031, DOI 10.1503/cmaj.091208; Nishimura Y, 2007, HUM MOL GENET, V16, P1682, DOI 10.1093/hmg/ddm116; Oberlander TF, 2009, CLIN PHARMACOL THER, V86, P672, DOI 10.1038/clpt.2009.201; Oberlander TF, 2010, ARCH PEDIAT ADOL MED, V164, P444, DOI 10.1001/archpediatrics.2010.51; Olver JS, 2004, HUM PSYCHOPHARM CLIN, V19, P9, DOI 10.1002/hup.551; Painter MM, 2009, ENVIRON TOXICOL CHEM, V28, P2677, DOI 10.1897/08-556.1; Pedersen LH, 2010, PEDIATRICS, V125, pE600, DOI 10.1542/peds.2008-3655; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Rappaport SM, 2010, SCIENCE, V330, P460, DOI 10.1126/science.1192603; Rasalam AD, 2005, DEV MED CHILD NEUROL, V47, P551, DOI 10.1017/S0012162205001076; Rice C, 2010, DISABIL HEALTH J, V3, P186, DOI 10.1016/j.dhjo.2009.10.008; Santos LHMLM, 2010, J HAZARD MATER, V175, P45, DOI 10.1016/j.jhazmat.2009.10.100; Schneider T, 2008, PSYCHONEUROENDOCRINO, V33, P728, DOI 10.1016/j.psyneuen.2008.02.011; Schultzt MM, 2008, ANAL CHEM, V80, P1756, DOI 10.1021/ac702154e; Schwab BW, 2005, REGUL TOXICOL PHARM, V42, P296, DOI 10.1016/j.yrtph.2005.05.005; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Simpson KL, 2011, P NATL ACAD SCI USA, V108, P18465, DOI 10.1073/pnas.1109353108; Stackelberg PE, 2007, SCI TOTAL ENVIRON, V377, P255, DOI 10.1016/j.scitotenv.2007.01.095; Stackelberg PE, 2004, SCI TOTAL ENVIRON, V329, P99, DOI 10.1016/j.scitotenv.2004.03.015; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Ternes TA, 1998, WATER RES, V32, P3245, DOI 10.1016/S0043-1354(98)00099-2; Thomas MA, 2012, COMP BIOCHEM PHYS C, V155, P109, DOI 10.1016/j.cbpc.2011.05.014; Thomas MA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-66; Traynor Jeff, 2002, BMC Med Genet, V3, P12, DOI 10.1186/1471-2350-3-12; Voineagu I, 2011, NATURE, V474, P380, DOI 10.1038/nature10110	72	39	39	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e32917	10.1371/journal.pone.0032917	http://dx.doi.org/10.1371/journal.pone.0032917			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22905163	Green Submitted, Green Published, gold			2022-12-27	WOS:000305348400001
J	Zhang, Y; Luo, Y; Deng, YH; Mu, YG; Wei, GH				Zhang, Yun; Luo, Yin; Deng, Yonghua; Mu, Yuguang; Wei, Guanghong			Lipid Interaction and Membrane Perturbation of Human Islet Amyloid Polypeptide Monomer and Dimer by Molecular Dynamics Simulations	PLOS ONE			English	Article							FIBER FORMATION; HUMAN AMYLIN; MECHANISM; BILAYERS; AGGREGATION; RECOGNITION; DISRUPTION; OLIGOMERS; TOXICITY; PEPTIDE	The aggregation of human islet amyloid polypeptide (hIAPP or amylin) is associated with the pathogenesis of type 2 diabetes mellitus. Increasing evidence suggests that the interaction of hIAPP with beta-cell membranes plays a crucial role in cytotoxicity. However, the hIAPP-lipid interaction and subsequent membrane perturbation is not well understood at atomic level. In this study, as a first step to gain insight into the mechanism of hIAPP-induced cytotoxicity, we have investigated the detailed interactions of hIAPP monomer and dimer with anionic palmitoyloleolyophosphatidylglycerol (POPG) bilayer using all-atom molecular dynamics (MD) simulations. Multiple MD simulations have been performed by employing the initial configurations where the N-terminal region of hIAPP is pre-inserted in POPG bilayer. Our simulations show that electrostatic interaction between hIAPP and POPG bilayer plays a major role in peptide-lipid interaction. In particular, the N-terminal positively-charged residues Lys1 and Arg11 make a dominant contribution to the interaction. During peptide-lipid interaction process, peptide dimerization occurs mostly through the C-terminal 20-37 region containing the amyloidogenic 20-29-residue segment. Membrane-bound hIAPP dimers display a pronounced ability of membrane perturbation than monomers. The higher bilayer perturbation propensity of hIAPP dimer likely results from the cooperativity of the peptide-peptide interaction (or peptide aggregation). This study provides insight into the hIAPP-membrane interaction and the molecular mechanism of membrane disruption by hIAPP oligomers.	[Zhang, Yun; Luo, Yin; Deng, Yonghua; Wei, Guanghong] Fudan Univ, State Key Lab Surface Phys, Key Lab Computat Phys Sci MOE, Shanghai 200433, Peoples R China; [Zhang, Yun; Luo, Yin; Deng, Yonghua; Wei, Guanghong] Fudan Univ, Dept Phys, Shanghai 200433, Peoples R China; [Mu, Yuguang] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore	Fudan University; Fudan University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Zhang, Y (corresponding author), Fudan Univ, State Key Lab Surface Phys, Key Lab Computat Phys Sci MOE, Shanghai 200433, Peoples R China.	ghwei@fudan.edu.cn		Wei, Guanghong/0000-0001-5814-3328; Yao, Dezhong/0000-0002-8042-879X; Zhang, Yangsong/0000-0002-6764-3567	National Natural Science Foundation of China [11074047]; Research Fund for the Doctoral Program of Higher Education of China [RFDP-20100071110006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by the National Natural Science Foundation of China (Grant No. 11074047) and Research Fund for the Doctoral Program of Higher Education of China (RFDP-20100071110006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews MN, 2011, BIOPHYS CHEM, V156, P43, DOI 10.1016/j.bpc.2010.12.007; Apostolidou M, 2008, J BIOL CHEM, V283, P17205, DOI 10.1074/jbc.M801383200; Berendsen H. J. C., 1981, INTERMOLECULAR FORCE, P331, DOI [10.1007/978-94-015-7658-1_21, DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658, DOI 10.1007/978-94-015-7658]; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berger O, 1997, BIOPHYS J, V72, P2002, DOI 10.1016/S0006-3495(97)78845-3; Brender JR, 2008, J AM CHEM SOC, V130, P6424, DOI 10.1021/ja710484d; Brender JR, 2012, ACCOUNTS CHEM RES, V45, P454, DOI 10.1021/ar200189b; Butterfield SM, 2010, ANGEW CHEM INT EDIT, V49, P5628, DOI 10.1002/anie.200906670; Chang ZW, 2011, J PHYS CHEM B, V115, P1165, DOI 10.1021/jp107558e; Colombo G, 2005, PROTEINS, V59, P519, DOI 10.1002/prot.20426; COOPER GJS, 1987, P NATL ACAD SCI USA, V84, P8628, DOI 10.1073/pnas.84.23.8628; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dupuis NF, 2009, J AM CHEM SOC, V131, P18283, DOI 10.1021/ja903814q; Elmore DE, 2006, FEBS LETT, V580, P144, DOI 10.1016/j.febslet.2005.11.064; Engel MFM, 2008, P NATL ACAD SCI USA, V105, P6033, DOI 10.1073/pnas.0708354105; Engel MFM, 2006, J MOL BIOL, V356, P783, DOI 10.1016/j.jmb.2005.12.020; Goldsbury C, 2000, J STRUCT BIOL, V130, P352, DOI 10.1006/jsbi.2000.4268; Gurlo T, 2010, AM J PATHOL, V176, P861, DOI 10.2353/ajpath.2010.090532; Haataja L, 2008, ENDOCR REV, V29, P303, DOI 10.1210/er.2007-0037; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Janson J, 1999, DIABETES, V48, P491, DOI 10.2337/diabetes.48.3.491; Jao CC, 2004, P NATL ACAD SCI USA, V101, P8331, DOI 10.1073/pnas.0400553101; Jaud S, 2009, P NATL ACAD SCI USA, V106, P11588, DOI 10.1073/pnas.0900638106; Jayasinghe SA, 2005, BIOCHEMISTRY-US, V44, P12113, DOI 10.1021/bi050840w; Jayasinghe SA, 2007, BBA-BIOMEMBRANES, V1768, P2002, DOI 10.1016/j.bbamem.2007.01.022; Jiang P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000357; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kandt C, 2007, METHODS, V41, P475, DOI 10.1016/j.ymeth.2006.08.006; Kayed R, 2004, J BIOL CHEM, V279, P46363, DOI 10.1074/jbc.C400260200; Knight JD, 2004, J MOL BIOL, V341, P1175, DOI 10.1016/j.jmb.2004.06.086; Knight JD, 2006, BIOCHEMISTRY-US, V45, P9496, DOI 10.1021/bi060579z; Laghaei R, 2010, J PHYS CHEM B, V114, P7071, DOI 10.1021/jp100205w; Last NB, 2011, P NATL ACAD SCI USA, V108, P9460, DOI 10.1073/pnas.1102356108; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Lopes DHJ, 2007, BIOPHYS J, V93, P3132, DOI 10.1529/biophysj.107.110635; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Mo YX, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3097982; Nanga RPR, 2011, BBA-BIOMEMBRANES, V1808, P2337, DOI 10.1016/j.bbamem.2011.06.012; Patil SM, 2009, J BIOL CHEM, V284, P11982, DOI 10.1074/jbc.M809085200; Patra M, 2003, BIOPHYS J, V84, P3636, DOI 10.1016/S0006-3495(03)75094-2; Quist A, 2005, P NATL ACAD SCI USA, V102, P10427, DOI 10.1073/pnas.0502066102; Reddy AS, 2010, BIOPHYS J, V99, P2208, DOI 10.1016/j.bpj.2010.07.014; Rivera E, 2009, BIOPHYS J, V96, P4552, DOI 10.1016/j.bpj.2009.03.039; Sciacca MFM, 2010, NEW J CHEM, V34, P200, DOI 10.1039/b9nj00253g; Simakova O, 2007, J NEUROSCI, V27, P13719, DOI 10.1523/JNEUROSCI.3006-07.2007; Smith PES, 2009, J AM CHEM SOC, V131, P4470, DOI 10.1021/ja809002a; Tolokh IS, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.031911; van Gunsteren WF, GROMOS 87 MANUAL; Vermeer LS, 2007, EUR BIOPHYS J BIOPHY, V36, P919, DOI 10.1007/s00249-007-0192-9; Wei L, 2011, J BIOL CHEM, V286, P6291, DOI 10.1074/jbc.M110.166678; WIEDMANN T, 1993, BIOCHIM BIOPHYS ACTA, V1167, P114, DOI 10.1016/0005-2760(93)90150-8; Williamson JA, 2009, J MOL BIOL, V393, P383, DOI 10.1016/j.jmb.2009.07.077; Yu X, 2011, J MOL BIOL, DOI [10.1016/j.jmb.2011.1011.1006, DOI 10.1016/J.JMB.2011.1011.1006]	54	89	97	9	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38191	10.1371/journal.pone.0038191	http://dx.doi.org/10.1371/journal.pone.0038191			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22412829	Green Published, gold			2022-12-27	WOS:000305338500105
J	Zhang, YS; Xu, P; Liu, TJ; Hu, J; Zhang, R; Yao, DZ				Zhang, Yangsong; Xu, Peng; Liu, Tiejun; Hu, Jun; Zhang, Rui; Yao, Dezhong			Multiple Frequencies Sequential Coding for SSVEP-Based Brain-Computer Interface	PLOS ONE			English	Article							FLICKER	Background: Steady-state visual evoked potential (SSVEP)-based brain-computer interface (BCI) has become one of the most promising modalities for a practical noninvasive BCI system. Owing to both the limitation of refresh rate of liquid crystal display (LCD) or cathode ray tube (CRT) monitor, and the specific physiological response property that only a very small number of stimuli at certain frequencies could evoke strong SSVEPs, the available frequencies for SSVEP stimuli are limited. Therefore, it may not be enough to code multiple targets with the traditional frequencies coding protocols, which poses a big challenge for the design of a practical SSVEP-based BCI. This study aimed to provide an innovative coding method to tackle this problem. Methodology/Principal Findings: In this study, we present a novel protocol termed multiple frequencies sequential coding (MFSC) for SSVEP-based BCI. In MFSC, multiple frequencies are sequentially used in each cycle to code the targets. To fulfill the sequential coding, each cycle is divided into several coding epochs, and during each epoch, certain frequency is used. Obviously, different frequencies or the same frequency can be presented in the coding epochs, and the different epoch sequence corresponds to the different targets. To show the feasibility of MFSC, we used two frequencies to realize four targets and carried on an offline experiment. The current study shows that: 1) MFSC is feasible and efficient; 2) the performance of SSVEP-based BCI based on MFSC can be comparable to some existed systems. Conclusions/Significance: The proposed protocol could potentially implement much more targets with the limited available frequencies compared with the traditional frequencies coding protocol. The efficiency of the new protocol was confirmed by real data experiment. We propose that the SSVEP-based BCI under MFSC might be a promising choice in the future.	[Zhang, Yangsong; Xu, Peng; Liu, Tiejun; Hu, Jun; Zhang, Rui; Yao, Dezhong] Univ Elect Sci & Technol China, Sch Life Sci & Technol, Minist Educ, Key Lab NeuroInformat, Chengdu 610054, Peoples R China	University of Electronic Science & Technology of China	Zhang, YS (corresponding author), Univ Elect Sci & Technol China, Sch Life Sci & Technol, Minist Educ, Key Lab NeuroInformat, Chengdu 610054, Peoples R China.	xupeng@uestc.edu.cn; dyao@uestc.edu.cn		Wei, Guanghong/0000-0001-5814-3328; Yao, Dezhong/0000-0002-8042-879X; Zhang, Yangsong/0000-0002-6764-3567	National Natural Science Foundation of China [31070881]; Program for Changjiang Scholars and Innovative Research Team in University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was supported by the National Natural Science Foundation of China under Grant No. 31070881, and in part by the project of the Program for Changjiang Scholars and Innovative Research Team in University. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bin GY, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/2/025015; Bin GY, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/4/046002; Cecotti H, 2010, C COMP NEUR, P215; Cecotti H, 2010, IEEE T NEUR SYS REH, V18, P127, DOI 10.1109/TNSRE.2009.2039594; Cheng M, 2002, IEEE T BIO-MED ENG, V49, P1181, DOI 10.1109/TBME.2002.803536; Ding J, 2006, CEREB CORTEX, V16, P1016, DOI 10.1093/cercor/bhj044; Donchin E, 2000, IEEE T REHABIL ENG, V8, P174, DOI 10.1109/86.847808; Friman O, 2001, MAGNET RESON MED, V45, P323, DOI 10.1002/1522-2594(200102)45:2<323::AID-MRM1041>3.0.CO;2-#; Friman O, 2007, IEEE T BIO-MED ENG, V54, P742, DOI 10.1109/TBME.2006.889160; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; Herrmann CS, 2001, EXP BRAIN RES, V137, P346, DOI 10.1007/s002210100682; Jia CA, 2011, IEEE T BIO-MED ENG, V58, P200, DOI 10.1109/TBME.2010.2068571; Lee PL, 2010, ANN BIOMED ENG, V38, P2383, DOI 10.1007/s10439-010-9964-y; Lin ZL, 2006, IEEE T BIO-MED ENG, V53, P2610, DOI 10.1109/TBME.2006.886577; Melzer T, 2003, PATTERN RECOGN, V36, P1961, DOI 10.1016/S0031-3203(03)00058-X; Middendorf M, 2000, IEEE T REHABIL ENG, V8, P211, DOI 10.1109/86.847819; Mukesh TMS, 2006, PHYSIOL MEAS, V27, P61, DOI 10.1088/0967-3334/27/1/006; Panicker R, 2011, IEEE T BIOMED ENG; Parkhomenko E, 2009, STAT APPL GENET MOL, V8, DOI 10.2202/1544-6115.1406; Pfurtscheller G, 2010, FRONTIERS NEUROSCIEN, V4; Pfurtscheller G, 2010, IEEE T NEUR SYS REH, V18, P409, DOI 10.1109/TNSRE.2010.2040837; Regan D., 1989, HUMAN BRAIN ELECTROP; Shyu KK, 2010, NEUROSCI LETT, V483, P28, DOI 10.1016/j.neulet.2010.07.043; Teng F, 2010, P 48 ACM SE C, P50; Vialatte FB, 2010, PROG NEUROBIOL, V90, P418, DOI 10.1016/j.pneurobio.2009.11.005; Wang Y, 2006, IEEE T NEUR SYS REH, V14, P234, DOI 10.1109/TNSRE.2006.875576; Wang YJ, 2008, IEEE ENG MED BIOL, V27, P64, DOI 10.1109/MEMB.2008.923958; Wang YT, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/2/025018; Wolpaw JR, 2002, CLIN NEUROPHYSIOL, V113, P767, DOI 10.1016/S1388-2457(02)00057-3; Wu ZH, 2008, MED ENG PHYS, V30, P1079, DOI 10.1016/j.medengphy.2008.01.004; Wu ZH, 2008, J NEURAL ENG, V5, P36, DOI 10.1088/1741-2560/5/1/004; Xu Peng, 2011, PLoS One, V6, pe14634, DOI 10.1371/journal.pone.0014634; Yan Z, 2011, NEUROSCIENCE LETT; Yao DZ, 2001, PHYSIOL MEAS, V22, P693, DOI 10.1088/0967-3334/22/4/305	35	89	97	9	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2012	7	3							e29519	10.1371/journal.pone.0029519	http://dx.doi.org/10.1371/journal.pone.0029519			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928XD	22412829	Green Published, gold, Green Submitted			2022-12-27	WOS:000303021100001
